Citrus Sinensis ID: 014733

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------42
Protein Sequence
MDTNNSEDSSQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKPCKQDDLCCKQLEVGGSSFSATFISRNMDCSFGYGGFSFSSCCKSSVADFSSPIPSMPSFSFFSPISAVEQGNASLGHKVNMTKLDEKHGESSLESCLFCQVPYFLLGVR
Secondary Structure (PSIPRED)
ccccccccccccccccccccccccccccEEcccccccccccEEEcEEEccccccEEEEEEEcccccEEEEEEEEccccccHHHHHHHHHHHHHHHHccccccEEEEEEEEEEcccEEEEEEcccccHHHHHHHHcccccHHHHHHHHHHHHHHHHHHHHccccccccccccEEccccccccccEEEEccccEEEEcccEEEccccccccccccccccccccccHHHHHHHHHHHHHccccccccccHHHHHHHHHHccccccccccccccHHHHHHHHHHccccccccccHHHHHcccccccccccccccccccHHHHHHHHccccHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccHHHccccccccccccccccccccccccccccccccccEEcccc
Secondary Structure Prediction (SSPRO)
cccccccccccccccccccccccccccccccccccccHHHHEEHHHHccccccEEEEEEEccccccEEEEHHHHHHHcccHHHHHHHHHHHHHHHHHcccccEccEEEEEEcccEEEEEEEcccccEHHHHHHHHccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEEcccccccEEEccccccccccHHHHHcccccccccccHHHHHHcEccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHccccccccccccccHHHHHHHHccccccHHHcccHHHHHHcHHHccccccccccccHHHHHHHHHHHHHHcccHHHHHHHHHcccHHcccccHcccccccccccccccccccccEcccccccccccccccccccccccccHcccccccEEHEEcccccccccc
Coil and Loop (DISEMBL)
mdtnnsedssqlsTQFCnsykvssltgtildatqisnlsDRYVLgkqlgwgqfgvirecsdkftgEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKlsghpnvvdlkavyeEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYChgngvvhrdlkpenillatksssspiklaDFGLATYIKagqnlhgtvgspfyiapevlaggynqaadVWSAGVILYILLsgmppfwgktkSKIFDAVraadlrfpsdpwdhiSASARDLIMGMlrvdpstrLTAAEVLAHSWMEECEQVaqkpckqddlcckqlevggssfsATFISRnmdcsfgyggfsfsscckssvadfsspipsmpsfsffspisaveqgnaslghkvnmtkldekhgesslesclfcqvpyfllgvr
Flexible Loop (DISEMBL)
mdtnnsedssqlsTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLAcksiakdrlvtvedVRSIKLEIEimtklsghpnvvdLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADlrfpsdpwdhISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKPCKQDDLCCKQLEVGGSSFSATFISRNMDCSFGYGGFSFSSCCKSSVADFSSPIPSMPSFSFFSPISAVEQGNASLGHKVNMTKLDEKhgesslesclfcqvpyfllgvr
Low Complexity Region (SEG)
MDTNNSEDSSQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKPCKQDDLCCKQLEVGGSSFSATFISRNMDcsfgyggfsfsscckssVADfsspipsmpsfsffspisAVEQGNASLGHKVNMTKLDEKHGESSLESCLFCQVPYFLLGVR
Disordered region (IsUnstruct)
***************FCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKPCKQDDLCCKQLEVGGSSFSATFISRNMDCSFGYGGFSFSSCCKSSVADF***********FF******************************LESCLFCQVPYFLLG**
Disordered Region (DISOPRED)
*********************************QISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQV*Q**CK***LCCKQLEVGGSSFSATFI*************************************************************************LFCQVPYFLLGVR
Disordered Region (DISEMBL)
*************TQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKPCKQDDLCCKQLEVGGSSFSATFISRNMDCSFGYGGFSFSSCCKSSVADFSSPIPSMPSFSFFSPISAVEQGNASLGHKVNMTKL********LESCLFCQVPYFLLGVR
Disordered Region (DISPRO)
*****************************LDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKPCKQDDLCCKQLEVGGSSFSATFISRNMDCSFGYGGFSFSSCCKSS*ADFSSPIPSMPSFSFFSPISAVEQ****L****NMTKLDE*HGESSLESCLFCQVPYFLLGVR
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MDTNNSEDSSQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKPCKQDDLCCKQLEVGGSSFSATFISRNMDCSFGYGGFSFSSCCKSSVADFSSPIPSMPSFSFFSPISAVEQGNASLGHKVNMTKLDEKHGESSLESCLFCQVPYFLLGVR
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	419	2.2.26 [Sep-21-2011]
Q8RWL2	534	Calcium-dependent protein	no	no	0.682	0.535	0.5	7e-81
Q9FMP5	528	Calcium-dependent protein	no	no	0.642	0.509	0.509	2e-79
Q3E9C0	523	Calcium-dependent protein	no	no	0.658	0.527	0.492	3e-79
P28582	532	Calcium-dependent protein	N/A	no	0.677	0.533	0.484	4e-79
Q9C6P3	521	Calcium-dependent protein	no	no	0.642	0.516	0.513	1e-78
Q9M9V8	545	Calcium-dependent protein	no	no	0.732	0.563	0.452	1e-78
Q38868	541	Calcium-dependent protein	no	no	0.642	0.497	0.505	2e-78
A5A7I7	557	Calcium-dependent protein	N/A	no	0.637	0.479	0.524	3e-78
Q9SSF8	541	Calcium-dependent protein	no	no	0.673	0.521	0.482	2e-77
Q38873	535	Calcium-dependent protein	no	no	0.680	0.532	0.458	2e-77

>sp|Q8RWL2|CDPKT_ARATH Calcium-dependent protein kinase 29 OS=Arabidopsis thaliana GN=CPK29 PE=2 SV=2

 Score =  301 bits (770), Expect = 7e-81,   Method: Compositional matrix adjust.
 Identities = 144/288 (50%), Positives = 193/288 (67%), Gaps = 2/288 (0%)

Query: 24  SLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVED 83
           S  G IL+   I +LS  Y L K+LG GQFG+  +C+DK  G   ACKSI+K +L+  +D
Sbjct: 68  SQIGPILNRPMI-DLSALYDLHKELGRGQFGITYKCTDKSNGREYACKSISKRKLIRRKD 126

Query: 84  VRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEA 143
           +  ++ E+ I+  L+G PN+V+ +  YE++D +HL+MELC+GGELF R+ K G +SE EA
Sbjct: 127 IEDVRREVMILQHLTGQPNIVEFRGAYEDKDNLHLVMELCSGGELFDRIIKKGSYSEKEA 186

Query: 144 RVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT 203
             IFR ++ VV  CH  GVVHRDLKPEN LL +    SPIK  DFGL+ +I+ G+     
Sbjct: 187 ANIFRQIVNVVHVCHFMGVVHRDLKPENFLLVSNEEDSPIKATDFGLSVFIEEGKVYRDI 246

Query: 204 VGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPS 263
           VGS +Y+APEVL   Y +  DVWSAGV+LYILLSG+PPFWG+T+  IF+A+    L   +
Sbjct: 247 VGSAYYVAPEVLHRNYGKEIDVWSAGVMLYILLSGVPPFWGETEKTIFEAILEGKLDLET 306

Query: 264 DPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKPC 311
            PW  IS SA+DLI  ML  DP  R+TAAE L H WM +  +++ KP 
Sbjct: 307 SPWPTISESAKDLIRKMLIRDPKKRITAAEALEHPWMTDT-KISDKPI 353

May play a role in signal transduction pathways that involve calcium as a second messenger.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9FMP5|CDPKH_ARATH Calcium-dependent protein kinase 17 OS=Arabidopsis thaliana GN=CPK17 PE=2 SV=1

 Score =  296 bits (758), Expect = 2e-79,   Method: Compositional matrix adjust.
 Identities = 137/269 (50%), Positives = 181/269 (67%)

Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           Y LGK+LG GQFGV   C+ K TG   ACK+IAK +LV  ED+  ++ E++IM  L+G P
Sbjct: 73  YSLGKELGRGQFGVTHLCTQKATGHQFACKTIAKRKLVNKEDIEDVRREVQIMHHLTGQP 132

Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
           N+V+LK  YE++  VHL+MELCAGGELF R+   G +SE  A  + R ++Q+V  CH  G
Sbjct: 133 NIVELKGAYEDKHSVHLVMELCAGGELFDRIIAKGHYSERAAASLLRTIVQIVHTCHSMG 192

Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGGYNQ 221
           V+HRDLKPEN LL  K  +SP+K  DFGL+ + K G+     VGS +YIAPEVL   Y  
Sbjct: 193 VIHRDLKPENFLLLNKDENSPLKATDFGLSVFYKPGEVFKDIVGSAYYIAPEVLKRKYGP 252

Query: 222 AADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGML 281
            AD+WS GV+LYILL G+PPFW ++++ IF+A+    + F SDPW  IS  A+DL+  ML
Sbjct: 253 EADIWSIGVMLYILLCGVPPFWAESENGIFNAILRGHVDFSSDPWPSISPQAKDLVKKML 312

Query: 282 RVDPSTRLTAAEVLAHSWMEECEQVAQKP 310
             DP  RLTAA+VL H W++E  +    P
Sbjct: 313 NSDPKQRLTAAQVLNHPWIKEDGEAPDVP 341

May play a role in signal transduction pathways that involve calcium as a second messenger.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q3E9C0|CDPKY_ARATH Calcium-dependent protein kinase 34 OS=Arabidopsis thaliana GN=CPK34 PE=2 SV=1

 Score =  296 bits (757), Expect = 3e-79,   Method: Compositional matrix adjust.
 Identities = 136/276 (49%), Positives = 186/276 (67%)

Query: 35  ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
           + ++   Y LGK+LG GQFGV   C+ K TG   ACK+IAK +LV  ED+  ++ E++IM
Sbjct: 61  MEDVKSSYTLGKELGRGQFGVTHLCTQKATGLQFACKTIAKRKLVNKEDIEDVRREVQIM 120

Query: 95  TKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVV 154
             L+G PN+V+LK  YE++  VHL+MELCAGGELF R+   G +SE  A  + R ++Q++
Sbjct: 121 HHLTGQPNIVELKGAYEDKHSVHLVMELCAGGELFDRIIAKGHYSERAAASLLRTIVQII 180

Query: 155 SYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEV 214
             CH  GV+HRDLKPEN LL +K  +SP+K  DFGL+ + K G+     VGS +YIAPEV
Sbjct: 181 HTCHSMGVIHRDLKPENFLLLSKDENSPLKATDFGLSVFYKPGEVFKDIVGSAYYIAPEV 240

Query: 215 LAGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASAR 274
           L   Y   AD+WS GV+LYILL G+PPFW ++++ IF+A+ +  + F SDPW  IS  A+
Sbjct: 241 LRRKYGPEADIWSIGVMLYILLCGVPPFWAESENGIFNAILSGQVDFSSDPWPVISPQAK 300

Query: 275 DLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKP 310
           DL+  ML  DP  RLTAA+VL H W++E  +    P
Sbjct: 301 DLVRKMLNSDPKQRLTAAQVLNHPWIKEDGEAPDVP 336

May play a role in signal transduction pathways that involve calcium as a second messenger.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P28582|CDPK_DAUCA Calcium-dependent protein kinase OS=Daucus carota PE=2 SV=2

 Score =  295 bits (755), Expect = 4e-79,   Method: Compositional matrix adjust.
 Identities = 138/285 (48%), Positives = 190/285 (66%), Gaps = 1/285 (0%)

Query: 26  TGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVR 85
           + TIL      ++  +Y LGK+LG GQFG + +C++  +G++ ACKSI K +LV+  D  
Sbjct: 66  SNTIL-GKPFEDIRGKYTLGKELGRGQFGCVYQCTENSSGQLYACKSILKRKLVSKNDKE 124

Query: 86  SIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARV 145
            IK EI+I+  LSG PN+V+ K V+E+   VHL+MELCAGGELF R+   G +SE  A  
Sbjct: 125 DIKREIQILQHLSGQPNIVEFKGVFEDRQSVHLVMELCAGGELFDRIIAQGHYSERAAAT 184

Query: 146 IFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVG 205
           I R ++ VV  CH  GV+HRDLKPEN LL++K   + +K  DFGL+ +I+ G+     VG
Sbjct: 185 ICRQIVNVVHVCHFMGVMHRDLKPENFLLSSKDKDAMLKATDFGLSVFIEEGKVYRNIVG 244

Query: 206 SPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDP 265
           S +Y+APEVL   Y +  D+WSAGVILYILLSG+PPFW + +  IFDA+    + F S+P
Sbjct: 245 SAYYVAPEVLRRSYGKEIDIWSAGVILYILLSGVPPFWAENEKGIFDAILEGVIDFESEP 304

Query: 266 WDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKP 310
           W  +S SA+DL+  ML  DP  R+T+A+VL H WM E  + + KP
Sbjct: 305 WPSVSNSAKDLVRKMLTQDPRRRITSAQVLDHPWMREGGEASDKP 349

May play a role in signal transduction pathways that involve calcium as a second messenger.

Daucus carota (taxid: 4039)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9C6P3|CDPKX_ARATH Calcium-dependent protein kinase 33 OS=Arabidopsis thaliana GN=CPK33 PE=2 SV=1

 Score =  294 bits (752), Expect = 1e-78,   Method: Compositional matrix adjust.
 Identities = 138/269 (51%), Positives = 184/269 (68%)

Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           Y L K+LG GQFGV   C++K TG+  ACKSI+K +LVT  D   ++ EI+IM  LSG P
Sbjct: 73  YTLSKELGRGQFGVTYLCTEKSTGKRFACKSISKKKLVTKGDKEDMRREIQIMQHLSGQP 132

Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
           N+V+ K  YE+E  V+L+MELCAGGELF R+   G +SE  A  + R ++ VV+ CH  G
Sbjct: 133 NIVEFKGAYEDEKAVNLVMELCAGGELFDRILAKGHYSERAAASVCRQIVNVVNICHFMG 192

Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGGYNQ 221
           V+HRDLKPEN LL++K   + IK  DFGL+ +I+ G+     VGS +Y+APEVL   Y +
Sbjct: 193 VMHRDLKPENFLLSSKDEKALIKATDFGLSVFIEEGRVYKDIVGSAYYVAPEVLKRRYGK 252

Query: 222 AADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGML 281
             D+WSAG+ILYILLSG+PPFW +T+  IFDA+   ++ F S PW  IS SA+DL+  ML
Sbjct: 253 EIDIWSAGIILYILLSGVPPFWAETEKGIFDAILEGEIDFESQPWPSISNSAKDLVRRML 312

Query: 282 RVDPSTRLTAAEVLAHSWMEECEQVAQKP 310
             DP  R++AAEVL H W+ E  + + KP
Sbjct: 313 TQDPKRRISAAEVLKHPWLREGGEASDKP 341

May play a role in signal transduction pathways that involve calcium as a second messenger.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9M9V8|CDPKA_ARATH Calcium-dependent protein kinase 10 OS=Arabidopsis thaliana GN=CPK10 PE=1 SV=1

 Score =  294 bits (752), Expect = 1e-78,   Method: Compositional matrix adjust.
 Identities = 139/307 (45%), Positives = 192/307 (62%)

Query: 4   NNSEDSSQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKF 63
           N     +  +  F  S     +   ++  +  + +SD+Y+LG++LG G+FG+   C+D+ 
Sbjct: 25  NRDRKLNPFAGDFTRSPAPIRVLKDVIPMSNQTQISDKYILGRELGRGEFGITYLCTDRE 84

Query: 64  TGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELC 123
           T E LACKSI+K +L T  D+  ++ E+ IM+ L  HPNVV LKA YE+ + VHL+MELC
Sbjct: 85  THEALACKSISKRKLRTAVDIEDVRREVAIMSTLPEHPNVVKLKASYEDNENVHLVMELC 144

Query: 124 AGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPI 183
            GGELF R+   G ++E  A  + R + +VV  CH NGV+HRDLKPEN L A K  +SP+
Sbjct: 145 EGGELFDRIVARGHYTERAAAAVARTIAEVVMMCHSNGVMHRDLKPENFLFANKKENSPL 204

Query: 184 KLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFW 243
           K  DFGL+ + K G      VGSP+Y+APEVL   Y    DVWSAGVI+YILL G+PPFW
Sbjct: 205 KAIDFGLSVFFKPGDKFTEIVGSPYYMAPEVLKRDYGPGVDVWSAGVIIYILLCGVPPFW 264

Query: 244 GKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEEC 303
            +T+  +  A+    L F  DPW  IS SA+ L+  ML  DP+ RLTA +VLAH W++  
Sbjct: 265 AETEQGVALAILRGVLDFKRDPWPQISESAKSLVKQMLDPDPTKRLTAQQVLAHPWIQNA 324

Query: 304 EQVAQKP 310
           ++    P
Sbjct: 325 KKAPNVP 331

May play a role in signal transduction pathways that involve calcium as a second messenger. May be a positive regulator controlling stress signal transduction.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q38868|CDPK9_ARATH Calcium-dependent protein kinase 9 OS=Arabidopsis thaliana GN=CPK9 PE=1 SV=1

 Score =  293 bits (750), Expect = 2e-78,   Method: Compositional matrix adjust.
 Identities = 136/269 (50%), Positives = 183/269 (68%)

Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           Y LGK+LG GQFGV   C++  TG+  ACKSI+K +LVT  D   ++ EI+IM  LSG P
Sbjct: 91  YTLGKELGRGQFGVTYLCTENSTGKKYACKSISKKKLVTKADKDDMRREIQIMQHLSGQP 150

Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
           N+V+ K  YE+E  V+L+MELCAGGELF R+   G ++E  A  + R ++ VV  CH  G
Sbjct: 151 NIVEFKGAYEDEKAVNLVMELCAGGELFDRIIAKGHYTERAAASVCRQIVNVVKICHFMG 210

Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGGYNQ 221
           V+HRDLKPEN LL++K   + IK  DFGL+ +I+ G+     VGS +Y+APEVL   Y +
Sbjct: 211 VLHRDLKPENFLLSSKDEKALIKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRRYGK 270

Query: 222 AADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGML 281
             D+WSAG+ILYILLSG+PPFW +T+  IFDA+    + F S PW  IS+SA+DL+  ML
Sbjct: 271 EVDIWSAGIILYILLSGVPPFWAETEKGIFDAILEGHIDFESQPWPSISSSAKDLVRRML 330

Query: 282 RVDPSTRLTAAEVLAHSWMEECEQVAQKP 310
             DP  R++AA+VL H W+ E  + + KP
Sbjct: 331 TADPKRRISAADVLQHPWLREGGEASDKP 359

May play a role in signal transduction pathways that involve calcium as a second messenger.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|A5A7I7|CDPK4_SOLTU Calcium-dependent protein kinase 4 OS=Solanum tuberosum GN=CPK4 PE=2 SV=1

 Score =  292 bits (748), Expect = 3e-78,   Method: Compositional matrix adjust.
 Identities = 141/269 (52%), Positives = 183/269 (68%), Gaps = 2/269 (0%)

Query: 37  NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTK 96
           N+ D Y LG++LG GQFG    C++  TG   ACKSI+K +L++ EDV  ++ EI+IM  
Sbjct: 89  NIRDLYTLGRKLGQGQFGTTYLCTENSTGAEYACKSISKRKLISKEDVEDVRREIQIMHH 148

Query: 97  LSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSY 156
           LSGH N+V +K  YE+  YVH++ME+C+GGELF R+ + G +SE +A  + + ++ VV  
Sbjct: 149 LSGHRNIVTIKGAYEDPLYVHIVMEICSGGELFDRIIQRGHYSERKAAELTKIIVGVVEA 208

Query: 157 CHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLA 216
           CH  GV+HRDLKPEN LL  K +   +K  DFGL+ + K GQ     VGSP+Y+APEVL 
Sbjct: 209 CHSLGVMHRDLKPENFLLVNKDNDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL 268

Query: 217 GGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDL 276
             Y   ADVW+AGVILYILLSG+PPFW +T+  IFDAV    + F SDPW  IS SA+DL
Sbjct: 269 KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFDSDPWPLISESAKDL 328

Query: 277 IMGMLRVDPSTRLTAAEVLAHSWMEECEQ 305
           I  ML + PS RLTA EVL H W+  CE 
Sbjct: 329 IRKMLCMQPSERLTAHEVLCHPWI--CEN 355

Regulates the production of reactive oxygen species (ROS) by NADPH oxidase.

Solanum tuberosum (taxid: 4113)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SSF8|CDPKU_ARATH Calcium-dependent protein kinase 30 OS=Arabidopsis thaliana GN=CPK30 PE=1 SV=1

 Score =  290 bits (742), Expect = 2e-77,   Method: Compositional matrix adjust.
 Identities = 136/282 (48%), Positives = 183/282 (64%)

Query: 29  ILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIK 88
           ++  +  S +SD+Y+LG++LG G+FG+   C+D+ T E LACKSI+K +L T  DV  ++
Sbjct: 46  VIPMSHQSQISDKYILGRELGRGEFGITYLCTDRETREALACKSISKRKLRTAVDVEDVR 105

Query: 89  LEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
            E+ IM+ L  HPNVV LKA YE+ + VHL+MELC GGELF R+   G ++E  A  + R
Sbjct: 106 REVTIMSTLPEHPNVVKLKATYEDNENVHLVMELCEGGELFDRIVARGHYTERAAATVAR 165

Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF 208
            + +VV  CH NGV+HRDLKPEN L A K  +S +K  DFGL+   K G+     VGSP+
Sbjct: 166 TIAEVVRMCHVNGVMHRDLKPENFLFANKKENSALKAIDFGLSVLFKPGERFTEIVGSPY 225

Query: 209 YIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDH 268
           Y+APEVL   Y    DVWSAGVILYILL G+PPFW +T+  +  A+    L F  DPW  
Sbjct: 226 YMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVALAILRGVLDFKRDPWSQ 285

Query: 269 ISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKP 310
           IS SA+ L+  ML  D + RLTA +VL H W++  ++    P
Sbjct: 286 ISESAKSLVKQMLEPDSTKRLTAQQVLDHPWIQNAKKAPNVP 327

May play a role in signal transduction pathways that involve calcium as a second messenger. May be a positive regulator controlling stress signal transduction. Acts as a calcium sensor involved in the hormone-signaling pathways.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q38873|CDPK7_ARATH Calcium-dependent protein kinase 7 OS=Arabidopsis thaliana GN=CPK7 PE=1 SV=1

 Score =  289 bits (740), Expect = 2e-77,   Method: Compositional matrix adjust.
 Identities = 133/290 (45%), Positives = 189/290 (65%), Gaps = 5/290 (1%)

Query: 16  FCNSYKVSSLTG-----TILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLAC 70
           + N Y  +  +G     ++L      ++S +Y LG+++G G+FG+   C+DK TGE  AC
Sbjct: 28  YSNEYATTDRSGAGFKLSVLKDPTGHDISLQYDLGREVGRGEFGITYLCTDKETGEKYAC 87

Query: 71  KSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFH 130
           KSI+K +L T  D+  ++ E+EIM  +  HPNVV LK  +E++D VH++MELC GGELF 
Sbjct: 88  KSISKKKLRTAVDIEDVRREVEIMKHMPKHPNVVSLKDSFEDDDAVHIVMELCEGGELFD 147

Query: 131 RLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGL 190
           R+   G ++E  A  + + +++VV  CH  GV+HRDLKPEN L A K  +S +K  DFGL
Sbjct: 148 RIVARGHYTERAAAAVMKTIVEVVQICHKQGVMHRDLKPENFLFANKKETSALKAIDFGL 207

Query: 191 ATYIKAGQNLHGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKI 250
           + + K G+  +  VGSP+Y+APEVL   Y    DVWSAGVILYILL G+PPFW +T+  +
Sbjct: 208 SVFFKPGEQFNEIVGSPYYMAPEVLRRNYGPEIDVWSAGVILYILLCGVPPFWAETEQGV 267

Query: 251 FDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWM 300
             A+  + + F  DPW  +S SA+DL+  ML  DP  RLTAA+VL H+W+
Sbjct: 268 AQAIIRSVIDFKRDPWPRVSDSAKDLVRKMLEPDPKKRLTAAQVLEHTWI 317

May play a role in signal transduction pathways that involve calcium as a second messenger.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	419
225426761	523	PREDICTED: calcium-dependent protein kin	0.971	0.778	0.668	1e-164
255537263	475	calcium-dependent protein kinase, putati	0.935	0.825	0.686	1e-162
449452378	526	PREDICTED: calcium-dependent protein kin	0.954	0.760	0.661	1e-161
225455487	520	PREDICTED: calcium-dependent protein kin	0.928	0.748	0.669	1e-158
224136890	526	predicted protein [Populus trichocarpa]	0.940	0.749	0.647	1e-157
297844122	522	hypothetical protein ARALYDRAFT_471407 [	0.954	0.766	0.644	1e-155
224071696	477	predicted protein [Populus trichocarpa]	0.871	0.765	0.68	1e-153
15222023	522	phosphoenolpyruvate carboxylase-related	0.954	0.766	0.635	1e-152
356559884	518	PREDICTED: calcium-dependent protein kin	0.968	0.783	0.644	1e-151
224120124	512	predicted protein [Populus trichocarpa]	0.940	0.769	0.628	1e-151

>gi|225426761|ref|XP_002275946.1| PREDICTED: calcium-dependent protein kinase 34 [Vitis vinifera] gi|297742607|emb|CBI34756.3| unnamed protein product [Vitis vinifera]

 Score =  584 bits (1505), Expect = e-164,   Method: Compositional matrix adjust.
 Identities = 296/443 (66%), Positives = 337/443 (76%), Gaps = 36/443 (8%)

Query: 1   MDTNNSEDSSQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECS 60
           MD      SS+LST  CN YK + LT  IL+ TQ+SNL DRYVLG+QLG GQFGVIR CS
Sbjct: 1   MDIAQIGKSSELSTWSCNCYKTTGLTEPILELTQVSNLKDRYVLGEQLGCGQFGVIRACS 60

Query: 61  DKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLM 120
           DK TGE+LACKSIAK+RL T +DV S+KLEIEIMT+LSGHPNVVDLKAVYEEEDYVHL+M
Sbjct: 61  DKLTGEMLACKSIAKERLTTSDDVCSVKLEIEIMTRLSGHPNVVDLKAVYEEEDYVHLVM 120

Query: 121 ELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSS 180
           ELCAGGELFHRLEK G FSE EAR IFRHLMQVV YCH  GVVHRDLKPENILLATKSSS
Sbjct: 121 ELCAGGELFHRLEKQGMFSECEARDIFRHLMQVVMYCHDKGVVHRDLKPENILLATKSSS 180

Query: 181 SPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMP 240
           SPIKLADFGLATYIK GQ+LHGTVGSPFYIAPEVLAGGYNQAADVWS GVILYILLSGMP
Sbjct: 181 SPIKLADFGLATYIKPGQSLHGTVGSPFYIAPEVLAGGYNQAADVWSTGVILYILLSGMP 240

Query: 241 PFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWM 300
           PFWGKTKS+IFDAVRAADL FP +PWD+ISASA++LI GML VDPS RLTAA+VLAHSWM
Sbjct: 241 PFWGKTKSRIFDAVRAADLWFPPNPWDYISASAKELITGMLCVDPSKRLTAAQVLAHSWM 300

Query: 301 EECEQVAQKPCKQDDLCCKQLEVGGSSFSATFISRNMDCSFGYGG--------------- 345
           ++  + +Q+P K+ D    QLE+GGSSFS   I+RN D SF Y                 
Sbjct: 301 KDFVESSQEPYKRKDPRSGQLELGGSSFSTPLIARNQDYSFSYESPITSDGQMGTSPAFT 360

Query: 346 --FSFSS-------------------CCKSSVADFSSPIPSMPSFSFFSPISAVEQGNAS 384
              SFS+                   CC+S+  +F SP+PS+PSF+FFSP S +++GN  
Sbjct: 361 CRSSFSTFLVDNNAPCSVSGGFSFSSCCESAAREFPSPVPSLPSFTFFSPSSEIDRGNHL 420

Query: 385 LGHKVNMTKLDEKHGESSLESCL 407
             ++ N++ LD+  GES L   L
Sbjct: 421 PAYEANLSTLDDTSGESRLSKAL 443

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255537263|ref|XP_002509698.1| calcium-dependent protein kinase, putative [Ricinus communis] gi|223549597|gb|EEF51085.1| calcium-dependent protein kinase, putative [Ricinus communis]

 Score =  578 bits (1490), Expect = e-162,   Method: Compositional matrix adjust.
 Identities = 289/421 (68%), Positives = 328/421 (77%), Gaps = 29/421 (6%)

Query: 11  QLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLAC 70
           Q S+  C  YKVS+LT TI++AT+ISNL DRY+LG+QLGWG+FGVIR C DK TG+VLAC
Sbjct: 8   QSSSTSCKCYKVSNLTQTIVNATEISNLKDRYILGEQLGWGRFGVIRACRDKVTGDVLAC 67

Query: 71  KSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFH 130
           KSIAKDRL+T++DVRS+KLEIEIMT+L GHPNVV+L+AVYEE++ VHLLMELCAGGELFH
Sbjct: 68  KSIAKDRLITLDDVRSVKLEIEIMTRLFGHPNVVNLEAVYEEDNDVHLLMELCAGGELFH 127

Query: 131 RLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGL 190
           +LEK G+FSE +A+VIFRHLMQVV YCH NG+VHRDLKPENILLATKSS SPIKLADFGL
Sbjct: 128 QLEKLGKFSEYDAQVIFRHLMQVVQYCHDNGIVHRDLKPENILLATKSSLSPIKLADFGL 187

Query: 191 ATYIKAGQNLHGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKI 250
           ATYIK GQNLHGTVGSPFYIAPEVL GGYNQAAD+WSAGVILYILLSGMPPFWGKTKS+I
Sbjct: 188 ATYIKPGQNLHGTVGSPFYIAPEVLIGGYNQAADLWSAGVILYILLSGMPPFWGKTKSRI 247

Query: 251 FDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKP 310
           FDAVRAADLRFP DPWD ISASA+DLI GML VD S RLTAA+VLAHSWM++C +  Q+ 
Sbjct: 248 FDAVRAADLRFPRDPWDQISASAKDLITGMLCVDSSKRLTAAQVLAHSWMQDCGEPVQEI 307

Query: 311 CKQDDLCCKQLEVGGSSFSATFISRNMDCSFGY--------------------------- 343
            KQD+L   QLE+GG SFS   I R  D SF Y                           
Sbjct: 308 YKQDNLDFAQLEMGGESFSIPVIKREHDYSFNYSSPVVGEGQAEQSPTFTSSFSSMPVEA 367

Query: 344 --GGFSFSSCCKSSVADFSSPIPSMPSFSFFSPISAVEQGNASLGHKVNMTKLDEKHGES 401
             GGFSFS C +S V +  SPIPSM SF+FF P  AVE+G A  G     +K D  HG+ 
Sbjct: 368 ESGGFSFSICDESGVTELPSPIPSMLSFTFFGPNPAVEEGEALFGFCEAESKRDSIHGDV 427

Query: 402 S 402
           S
Sbjct: 428 S 428

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449452378|ref|XP_004143936.1| PREDICTED: calcium-dependent protein kinase 25-like [Cucumis sativus] gi|449495864|ref|XP_004159967.1| PREDICTED: calcium-dependent protein kinase 25-like [Cucumis sativus]

 Score =  572 bits (1475), Expect = e-161,   Method: Compositional matrix adjust.
 Identities = 291/440 (66%), Positives = 341/440 (77%), Gaps = 40/440 (9%)

Query: 1   MDTNNSE-DSSQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIREC 59
           MD   +E D    S QF N +KVSSL+ TIL+ TQ+ NL DRYVLG++LGWGQFGVIR C
Sbjct: 1   MDLAETESDQIGQSIQFYNCFKVSSLSETILETTQVGNLKDRYVLGERLGWGQFGVIRSC 60

Query: 60  SDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL 119
           SD+ TGE+LACKSIAKDRL+TV+DVRS+KLEIEIM++LSGHPNVV+LKAVYEEE+ VHLL
Sbjct: 61  SDRMTGEMLACKSIAKDRLMTVDDVRSVKLEIEIMSRLSGHPNVVNLKAVYEEEECVHLL 120

Query: 120 MELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSS 179
           MELCAGGELFH+LEK+GRFSE++ARV+F+HL+QVV YCH NGVVHRDLKPENILLAT SS
Sbjct: 121 MELCAGGELFHQLEKHGRFSESDARVVFKHLIQVVKYCHENGVVHRDLKPENILLATTSS 180

Query: 180 SSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGM 239
           SSPIKLADFGLATYIK GQNLHGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGM
Sbjct: 181 SSPIKLADFGLATYIKPGQNLHGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGM 240

Query: 240 PPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSW 299
           PPFWGKTKS+IF+AVRAA+LRFPS+ WDH+S SA+DLI  ML +DPS RLTA EVL HSW
Sbjct: 241 PPFWGKTKSRIFEAVRAAELRFPSNLWDHVSTSAKDLISRMLCMDPSKRLTAKEVLGHSW 300

Query: 300 MEECEQVAQKPCKQDDLCCKQLEVGGSSFSATFISRNMDCSF------------GY---- 343
           M++  Q +Q+  KQD   C+++E+G SS  A FI RN D SF            G+    
Sbjct: 301 MKDAAQASQEQEKQDARDCRRVEMGMSSSPAPFIVRNRDFSFSDGTPVICEDQMGHSPVF 360

Query: 344 ---------------------GGFSFSSCCKSSVA-DFSSPIPSMPSFSFFSPISA-VEQ 380
                                GGFSFSSC +   A +FSSPIP +PSF+FFSP S+ V+Q
Sbjct: 361 TCKSSFSSFLLDNVGTPSSVPGGFSFSSCVELDTATEFSSPIPKLPSFTFFSPCSSTVDQ 420

Query: 381 GNASLGHKVNMTKLDEKHGE 400
            N+S+  K N++  +  H E
Sbjct: 421 VNSSMRFKANLSLSETLHEE 440

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225455487|ref|XP_002280303.1| PREDICTED: calcium-dependent protein kinase 25-like [Vitis vinifera]

 Score =  563 bits (1452), Expect = e-158,   Method: Compositional matrix adjust.
 Identities = 283/423 (66%), Positives = 324/423 (76%), Gaps = 34/423 (8%)

Query: 14  TQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSI 73
           T+  + YKV SL  TILD  Q SNL DR+VLG+QLGWGQFGVIR CSDK  GEVLACKSI
Sbjct: 14  TKAPHCYKVESLKETILDTDQTSNLKDRFVLGEQLGWGQFGVIRACSDKLAGEVLACKSI 73

Query: 74  AKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLE 133
           AKDRLVT +DVRS+KLEIEIMTKLSGHPNVVDLKAVYEEEDYVHL+MELCAGGELFH+LE
Sbjct: 74  AKDRLVTQDDVRSVKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLVMELCAGGELFHQLE 133

Query: 134 KYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATY 193
           K+GRFSE EARV+FRHLM+VV YCH  G+VHRDLKPENILLATK+SSSPIKLADFGLATY
Sbjct: 134 KHGRFSEAEARVLFRHLMEVVMYCHDKGIVHRDLKPENILLATKASSSPIKLADFGLATY 193

Query: 194 IKAGQNLHGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDA 253
           IK GQ+L+GTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGKTKS+IFDA
Sbjct: 194 IKPGQSLYGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGKTKSRIFDA 253

Query: 254 VRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKPCKQ 313
           VRAADLRFPSDPWD +S SA +LI GML  DPS RLTA EVL HSW+ +  Q +++P + 
Sbjct: 254 VRAADLRFPSDPWDQLSGSAEELIRGMLCRDPSQRLTAQEVLDHSWIRDHAQSSEEPREH 313

Query: 314 DDLCCKQLEVGGSSFSATFISRNMDCSFGY------------------------------ 343
           ++   + L  GGSSFS TF++RN D SFG                               
Sbjct: 314 ENQSYEHLGEGGSSFS-TFMTRNQDISFGTGPRVICDAQSPQFTCRSSFTSFGLEPSTPC 372

Query: 344 ---GGFSFSSCCKSSVADFSSPIPSMPSFSFFSPISAVEQGNASLGHKVNMTKLDEKHGE 400
              GGFSF S  + +  +FSSP+PSMPSF+FFSP     Q + +L    N++ ++    E
Sbjct: 373 FASGGFSFGSTDEPNTLEFSSPVPSMPSFAFFSPCPITVQESYTLDLSANISTVNAIQKE 432

Query: 401 SSL 403
           +SL
Sbjct: 433 ASL 435

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224136890|ref|XP_002322441.1| predicted protein [Populus trichocarpa] gi|222869437|gb|EEF06568.1| predicted protein [Populus trichocarpa]

 Score =  560 bits (1443), Expect = e-157,   Method: Compositional matrix adjust.
 Identities = 277/428 (64%), Positives = 327/428 (76%), Gaps = 34/428 (7%)

Query: 1   MDTNNSEDSSQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECS 60
           M    S  S +   Q CN Y+VSSLT TILD  QISNL DRYVLG+QLGWGQFGVIR C+
Sbjct: 1   MAVAKSNSSRESLKQPCNCYRVSSLTETILDTHQISNLKDRYVLGEQLGWGQFGVIRVCT 60

Query: 61  DKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLM 120
           DK + EVLACKSI+KDRLVT++D RS+KLEIEIMT+LSGH NVVDLKAVYE+EDYVHL+M
Sbjct: 61  DKLSREVLACKSISKDRLVTLDDARSVKLEIEIMTRLSGHANVVDLKAVYEDEDYVHLVM 120

Query: 121 ELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSS 180
           ELCAGGELFH+LEK+GRFSE EARV+FRHLMQVV YCH NGVVHRDLKPENILLATKSSS
Sbjct: 121 ELCAGGELFHQLEKHGRFSEAEARVLFRHLMQVVLYCHENGVVHRDLKPENILLATKSSS 180

Query: 181 SPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMP 240
           SPIKLADFGLATY+K GQ+LHGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMP
Sbjct: 181 SPIKLADFGLATYVKPGQSLHGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMP 240

Query: 241 PFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWM 300
           PFWGKTKS+IFDAVRAADLRFPSDPWDHI+ SA++L+ GML  DPS R T+ +VL +SWM
Sbjct: 241 PFWGKTKSRIFDAVRAADLRFPSDPWDHITESAKELVRGMLCTDPSQRFTSQQVLDNSWM 300

Query: 301 EECEQVAQKPCKQDDLCCKQLEVGGSSFSATFISRNMDCSFGY----------------- 343
           +      ++  +++   C++ ++GGSS S   ++R+ D SFG                  
Sbjct: 301 KHDGPYPEESSQREKQICEEWDLGGSSLS-ILMARDQDVSFGTGSPIINDVQSPTFTCRS 359

Query: 344 ----------------GGFSFSSCCKSSVADFSSPIPSMPSFSFFSPISAVEQGNASLGH 387
                           GGFSF S   S+  +F SP+ SMPSF+F SP   +EQG+++L  
Sbjct: 360 SFSSFLGEPSTPSFVSGGFSFRSSDDSNALEFISPVSSMPSFAFSSPGPVIEQGSSTLEF 419

Query: 388 KVNMTKLD 395
             N++++D
Sbjct: 420 SSNISRID 427

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297844122|ref|XP_002889942.1| hypothetical protein ARALYDRAFT_471407 [Arabidopsis lyrata subsp. lyrata] gi|297335784|gb|EFH66201.1| hypothetical protein ARALYDRAFT_471407 [Arabidopsis lyrata subsp. lyrata]

 Score =  554 bits (1427), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 283/439 (64%), Positives = 331/439 (75%), Gaps = 39/439 (8%)

Query: 1   MDTNNSEDSSQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECS 60
           MD  + E++S L  +FCN YKV+SLT TIL+   +SNL DRYVLG+QLGWGQFGVIR CS
Sbjct: 3   MDIADKENTSPLLFEFCNCYKVASLTETILNPVNVSNLKDRYVLGEQLGWGQFGVIRVCS 62

Query: 61  DKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLM 120
           DK TGE LACKSI+KDRLVT +D++SIKLEI IM KL+GHPNVV+LKAVYEE+DYVHL+M
Sbjct: 63  DKLTGERLACKSISKDRLVTQDDMKSIKLEIAIMAKLAGHPNVVNLKAVYEEKDYVHLVM 122

Query: 121 ELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSS 180
           ELCAGGELFH+LEKYGR+SE  ARV+F+HLMQVV +CH +G+VHRDLKPENIL+AT SSS
Sbjct: 123 ELCAGGELFHKLEKYGRYSEFRARVLFKHLMQVVKFCHDSGIVHRDLKPENILMATMSSS 182

Query: 181 SPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMP 240
           SPIKLADFGLATYIK G+ L GTVGSPFYIAPEVL+GGYNQAADVWSAGVILYILLSG+P
Sbjct: 183 SPIKLADFGLATYIKPGEKLSGTVGSPFYIAPEVLSGGYNQAADVWSAGVILYILLSGVP 242

Query: 241 PFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWM 300
           PFWGKTKSKIFDAVRAADLRF ++PWDHI++ A+DLI GML VDPS RL+A +VLAHSWM
Sbjct: 243 PFWGKTKSKIFDAVRAADLRFSAEPWDHITSYAKDLIRGMLCVDPSQRLSADDVLAHSWM 302

Query: 301 EECEQVAQKPCKQDDLCCKQLEVGGSSFSATFISRNMDCSF------------------- 341
           E+  +  Q+   QD   C+ L+ GG SFS   ISR  D SF                   
Sbjct: 303 EQLSESGQEQYDQDGFGCEGLDNGGCSFSTQCISREQDYSFSVGQLEQSTDNECKSSFSS 362

Query: 342 -----------GYGGFSFS-SCCKSSVADFSSP-IPSMPSFSFFSPISAVEQGNASLGHK 388
                      G+GGFSF     +S+ A FSS  IPSMPSF+FFSPI A  Q N      
Sbjct: 363 FLPVDNTLPNSGFGGFSFDGKQPESTSACFSSTGIPSMPSFTFFSPIPATTQNN------ 416

Query: 389 VNMTKLDEKHGESSLESCL 407
            N+++ D K  +SS +  L
Sbjct: 417 -NISETDGKVRDSSPKRLL 434

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224071696|ref|XP_002303559.1| predicted protein [Populus trichocarpa] gi|222840991|gb|EEE78538.1| predicted protein [Populus trichocarpa]

 Score =  547 bits (1409), Expect = e-153,   Method: Compositional matrix adjust.
 Identities = 272/400 (68%), Positives = 310/400 (77%), Gaps = 35/400 (8%)

Query: 1   MDTNNSEDSSQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECS 60
           MD  NS++  Q ST  C+ Y++SSLT TILD T+++NL DRYVLG+QLGWGQFG+IR CS
Sbjct: 1   MDIANSDNIIQPSTS-CHCYRISSLTDTILDTTEVANLKDRYVLGEQLGWGQFGIIRACS 59

Query: 61  DKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLM 120
           DK +GEVLACKSIAKDRL T+ DVRS+KLEIEIM++LSGHPNVV+LKAVYEEED+VHLLM
Sbjct: 60  DKLSGEVLACKSIAKDRLATLNDVRSVKLEIEIMSRLSGHPNVVNLKAVYEEEDHVHLLM 119

Query: 121 ELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSS 180
           ELCAGGELFHRLEK+GRFSE  ARVIFRHLMQVV YCH NG+VHRDLKPENILLATKS S
Sbjct: 120 ELCAGGELFHRLEKHGRFSEQNARVIFRHLMQVVQYCHENGIVHRDLKPENILLATKSLS 179

Query: 181 SPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMP 240
           SPIKLADFGLATYIK G NLHGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMP
Sbjct: 180 SPIKLADFGLATYIKPGHNLHGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMP 239

Query: 241 PFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWM 300
           PFWGK+KS+IFDAVRAA+LRFP   W  IS SA+DLI GML  DP  RL  A+VLAHSW+
Sbjct: 240 PFWGKSKSRIFDAVRAAELRFPPKFWHQISTSAKDLITGMLCKDPFKRLNTAQVLAHSWV 299

Query: 301 EECEQVAQKPCKQDDLCCKQLEVGGSSFSATFISRNMDCSFGY----------------- 343
           ++  Q+AQ+   QD+L C+QLE+ G SFS  FI+++   SF Y                 
Sbjct: 300 QDGAQLAQESNMQDNLNCEQLEICGGSFSTPFIAKDQAYSFTYELPVTGGDQQGHSPTPT 359

Query: 344 -----------------GGFSFSSCCKSSVADFSSPIPSM 366
                            GGFSFS+  +    +FSSPI SM
Sbjct: 360 SSCSSFLVNDNTPCSASGGFSFSNHDEPGATEFSSPILSM 399

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|15222023|ref|NP_172719.1| phosphoenolpyruvate carboxylase-related kinase 1 [Arabidopsis thaliana] gi|8778638|gb|AAF79646.1|AC025416_20 F5O11.32 [Arabidopsis thaliana] gi|9502372|gb|AAF88079.1|AC025417_7 T12C24.12 [Arabidopsis thaliana] gi|16323176|gb|AAL15322.1| At1g12580/T12C24_10 [Arabidopsis thaliana] gi|23506015|gb|AAN28867.1| At1g12580/T12C24_10 [Arabidopsis thaliana] gi|332190778|gb|AEE28899.1| phosphoenolpyruvate carboxylase-related kinase 1 [Arabidopsis thaliana]

 Score =  543 bits (1400), Expect = e-152,   Method: Compositional matrix adjust.
 Identities = 279/439 (63%), Positives = 326/439 (74%), Gaps = 39/439 (8%)

Query: 1   MDTNNSEDSSQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECS 60
           MD  + E++S L  +FCN YKV+SLT TIL+   +SNL DRYVLG+QLGWGQFGVIR CS
Sbjct: 3   MDIADKENTSPLLFEFCNCYKVASLTETILNPVNVSNLKDRYVLGEQLGWGQFGVIRVCS 62

Query: 61  DKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLM 120
           DK TGE LACKSI+KDRLVT +D++SIKLEI IM KL+GHPNVV+LKAVYEE+D VHL+M
Sbjct: 63  DKLTGERLACKSISKDRLVTQDDMKSIKLEIAIMAKLAGHPNVVNLKAVYEEKDSVHLVM 122

Query: 121 ELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSS 180
           ELCAGGELFH+LEKYGR+SE  ARV+F+HLMQVV +CH +G+VHRDLKPENIL+AT SSS
Sbjct: 123 ELCAGGELFHKLEKYGRYSEVRARVLFKHLMQVVKFCHDSGIVHRDLKPENILMATMSSS 182

Query: 181 SPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMP 240
           SPIKLADFGLATYIK G+ L GTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSG P
Sbjct: 183 SPIKLADFGLATYIKPGEKLSGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGAP 242

Query: 241 PFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWM 300
           PFWGKTKSKIFDAVRAADLRF ++PWD+I++ A+DLI GML VDPS RL+A EVLAHSWM
Sbjct: 243 PFWGKTKSKIFDAVRAADLRFSAEPWDNITSYAKDLIRGMLCVDPSQRLSADEVLAHSWM 302

Query: 301 EECEQVAQKPCKQDDLCCKQLEVGGSSFSATFISRNMDCSF------------------- 341
           E+  +  Q+   QD   C+ LE GG SFS   +SR  D SF                   
Sbjct: 303 EQLSESGQEQYDQDGFGCEGLENGGCSFSTQCVSREQDYSFSVGQLEQSTDNDFKSSFST 362

Query: 342 -----------GYGGFSFS-SCCKSSVADFSSP-IPSMPSFSFFSPISAVEQGNASLGHK 388
                      G+ GFSF     +S+ A FSS  IPSMPSF+FF    A  Q N      
Sbjct: 363 FLPADNTLPNSGFDGFSFDGKQPESTTAGFSSTGIPSMPSFTFFCTSPARTQNN------ 416

Query: 389 VNMTKLDEKHGESSLESCL 407
            ++T++D K  +SS +  L
Sbjct: 417 -DITEIDGKVRDSSPKRLL 434

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356559884|ref|XP_003548226.1| PREDICTED: calcium-dependent protein kinase 32-like [Glycine max]

 Score =  540 bits (1392), Expect = e-151,   Method: Compositional matrix adjust.
 Identities = 287/445 (64%), Positives = 327/445 (73%), Gaps = 39/445 (8%)

Query: 1   MDTNNSEDSSQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECS 60
           M   NS  S++    + N YKV+ LT TILD + ISNL DRY+LG+QLGWGQFGVIR CS
Sbjct: 1   MAVANSNSSNEPCASY-NCYKVAGLTETILDISHISNLKDRYILGEQLGWGQFGVIRTCS 59

Query: 61  DKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLM 120
           DK TGEVLACKSIAKDRLVT +D++S+KLEIEIM +LSGHPNVVDLKAVYEEE +VHL+M
Sbjct: 60  DKLTGEVLACKSIAKDRLVTSDDLKSVKLEIEIMARLSGHPNVVDLKAVYEEEGFVHLVM 119

Query: 121 ELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSS 180
           ELCAGGELFHRLEK+G FSE++ARV+FRHLMQVV YCH NGVVHRDLKPENILLAT+SSS
Sbjct: 120 ELCAGGELFHRLEKHGWFSESDARVLFRHLMQVVLYCHENGVVHRDLKPENILLATRSSS 179

Query: 181 SPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMP 240
           SPIKLADFGLATYIK GQ+LHG VGSPFYIAPEVLAG YNQAADVWSAGVILYILLSGMP
Sbjct: 180 SPIKLADFGLATYIKPGQSLHGLVGSPFYIAPEVLAGAYNQAADVWSAGVILYILLSGMP 239

Query: 241 PFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWM 300
           PFWGKTKS+IF+AV+AA L+FPS+PWD IS SA+DLI GML  DPS RLTA EVL H WM
Sbjct: 240 PFWGKTKSRIFEAVKAASLKFPSEPWDRISESAKDLIRGMLSTDPSRRLTAREVLDHYWM 299

Query: 301 EECEQVAQK---PCKQDDLCCKQLEVGGSSFSATFISRNMDCSFGY-------------- 343
            EC Q   +    CK  +  C++   GGSSFSA+ +SR+ D SFG               
Sbjct: 300 -ECNQTNPEQLSECKIRN--CEEWNAGGSSFSASLMSRSQDISFGASSPTCDAQSPTFTC 356

Query: 344 ------------------GGFSFSSCCKSSVADFSSPIPSMPSFSFFSPISAVEQGNASL 385
                             GGFSF S   S   +F SP+PSM SFSF SP S VEQ +  L
Sbjct: 357 RSSFSSFLVEPVTPCLVSGGFSFKSAGDSPDLEFCSPVPSMLSFSFLSPSSVVEQKSCKL 416

Query: 386 GHKVNMTKLDEKHGESSLESCLFCQ 410
               NM  ++   GE++L   L  Q
Sbjct: 417 ECSANMADVNAIAGETNLGKLLMLQ 441

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224120124|ref|XP_002318248.1| predicted protein [Populus trichocarpa] gi|222858921|gb|EEE96468.1| predicted protein [Populus trichocarpa]

 Score =  539 bits (1389), Expect = e-151,   Method: Compositional matrix adjust.
 Identities = 269/428 (62%), Positives = 321/428 (75%), Gaps = 34/428 (7%)

Query: 1   MDTNNSEDSSQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECS 60
           M    S  S +   Q CN Y+VSSL  +ILD  Q SNL DRYVLG+QLGWGQFGVIR C+
Sbjct: 1   MAVGKSNSSHEPLKQPCNCYRVSSLIESILDTDQTSNLKDRYVLGEQLGWGQFGVIRVCT 60

Query: 61  DKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLM 120
           DK TGEVLACKSI+KDRLVT +D RS+KLEIEIMT+LSGH NVVDLKAVYE+E+YVHL+M
Sbjct: 61  DKLTGEVLACKSISKDRLVTSDDARSVKLEIEIMTRLSGHDNVVDLKAVYEDENYVHLVM 120

Query: 121 ELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSS 180
           ELCAGGELF +LEK+GRFSE EAR +F+HLMQVV YCH NGVVHRDLKPENILLA+KSSS
Sbjct: 121 ELCAGGELFQQLEKHGRFSEAEARDLFKHLMQVVQYCHENGVVHRDLKPENILLASKSSS 180

Query: 181 SPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMP 240
           SPIKLADFGLATY+K GQ+L GTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMP
Sbjct: 181 SPIKLADFGLATYVKPGQSLRGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMP 240

Query: 241 PFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWM 300
           PFWGKTKS+IFDAVRAADLRFPS+PWDHI+ SA++L+ GML  DPS R TA +VL +SWM
Sbjct: 241 PFWGKTKSRIFDAVRAADLRFPSNPWDHITQSAKELVRGMLCTDPSQRFTAQQVLDNSWM 300

Query: 301 EECEQVAQKPCKQDDLCCKQLEVGGSSFSATFISRNMDCSFGY----------------- 343
           +      ++P +++   C++  +GG SFS T ++R+ D SFG                  
Sbjct: 301 KYDLPYPEEPSQREKQSCQEWGLGGGSFS-TLMARDQDVSFGTGSPIFHDVQSSTFKCRS 359

Query: 344 ----------------GGFSFSSCCKSSVADFSSPIPSMPSFSFFSPISAVEQGNASLGH 387
                           GGFSF +   S+  +F SP+ SMPSF+F S    +E G+++L  
Sbjct: 360 SFSSFLAEPSTPIFAPGGFSFHNGDDSNALEFMSPVSSMPSFAFSSAGPVIELGSSTLEL 419

Query: 388 KVNMTKLD 395
             N++++D
Sbjct: 420 SSNISRID 427

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	419
TAIR|locus:2034720	522	PEPKR1 "phosphoenolpyruvate ca	0.806	0.647	0.736	3e-133
TAIR|locus:2204340	561	CPK29 "calcium-dependent prote	0.680	0.508	0.501	2.2e-73
TAIR|locus:2150225	523	CPK34 "AT5G19360" [Arabidopsis	0.675	0.541	0.485	9.6e-73
TAIR|locus:2011201	545	CDPK1 "calcium-dependent prote	0.668	0.513	0.491	1.2e-72
TAIR|locus:2177023	528	CPK17 "calcium-dependent prote	0.675	0.535	0.489	1.6e-72
TAIR|locus:2015846	521	CPK33 "calcium-dependent prote	0.642	0.516	0.513	8.6e-72
TAIR|locus:2092399	541	CPK9 "calmodulin-domain protei	0.694	0.537	0.479	8.6e-72
TAIR|locus:2138897	531	CPK21 "calcium-dependent prote	0.708	0.559	0.48	2.9e-71
TAIR|locus:2036783	551	CPK19 "calcium-dependent prote	0.718	0.546	0.455	4.8e-71
TAIR|locus:2027227	541	CPK30 "calcium-dependent prote	0.673	0.521	0.482	6.1e-71

TAIR|locus:2034720 PEPKR1 "phosphoenolpyruvate carboxylase-related kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1306 (464.8 bits), Expect = 3.0e-133, P = 3.0e-133
 Identities = 249/338 (73%), Positives = 286/338 (84%)

Query:     1 MDTNNSEDSSQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECS 60
             MD  + E++S L  +FCN YKV+SLT TIL+   +SNL DRYVLG+QLGWGQFGVIR CS
Sbjct:     3 MDIADKENTSPLLFEFCNCYKVASLTETILNPVNVSNLKDRYVLGEQLGWGQFGVIRVCS 62

Query:    61 DKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLM 120
             DK TGE LACKSI+KDRLVT +D++SIKLEI IM KL+GHPNVV+LKAVYEE+D VHL+M
Sbjct:    63 DKLTGERLACKSISKDRLVTQDDMKSIKLEIAIMAKLAGHPNVVNLKAVYEEKDSVHLVM 122

Query:   121 ELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSS 180
             ELCAGGELFH+LEKYGR+SE  ARV+F+HLMQVV +CH +G+VHRDLKPENIL+AT SSS
Sbjct:   123 ELCAGGELFHKLEKYGRYSEVRARVLFKHLMQVVKFCHDSGIVHRDLKPENILMATMSSS 182

Query:   181 SPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMP 240
             SPIKLADFGLATYIK G+ L GTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSG P
Sbjct:   183 SPIKLADFGLATYIKPGEKLSGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGAP 242

Query:   241 PFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWM 300
             PFWGKTKSKIFDAVRAADLRF ++PWD+I++ A+DLI GML VDPS RL+A EVLAHSWM
Sbjct:   243 PFWGKTKSKIFDAVRAADLRFSAEPWDNITSYAKDLIRGMLCVDPSQRLSADEVLAHSWM 302

Query:   301 EECEQVAQKPCKQDDLCCKQLEVGGSSFSATFISRNMD 338
             E+  +  Q+   QD   C+ LE GG SFS   +SR  D
Sbjct:   303 EQLSESGQEQYDQDGFGCEGLENGGCSFSTQCVSREQD 340

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2204340 CPK29 "calcium-dependent protein kinase 29" [Arabidopsis thaliana (taxid:3702)]

 Score = 741 (265.9 bits), Expect = 2.2e-73, P = 2.2e-73
 Identities = 144/287 (50%), Positives = 193/287 (67%)

Query:    24 SLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVED 83
             S  G IL+   I +LS  Y L K+LG GQFG+  +C+DK  G   ACKSI+K +L+  +D
Sbjct:    95 SQIGPILNRPMI-DLSALYDLHKELGRGQFGITYKCTDKSNGREYACKSISKRKLIRRKD 153

Query:    84 VRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEA 143
             +  ++ E+ I+  L+G PN+V+ +  YE++D +HL+MELC+GGELF R+ K G +SE EA
Sbjct:   154 IEDVRREVMILQHLTGQPNIVEFRGAYEDKDNLHLVMELCSGGELFDRIIKKGSYSEKEA 213

Query:   144 RVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT 203
               IFR ++ VV  CH  GVVHRDLKPEN LL +    SPIK  DFGL+ +I+ G+     
Sbjct:   214 ANIFRQIVNVVHVCHFMGVVHRDLKPENFLLVSNEEDSPIKATDFGLSVFIEEGKVYRDI 273

Query:   204 VGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPS 263
             VGS +Y+APEVL   Y +  DVWSAGV+LYILLSG+PPFWG+T+  IF+A+    L   +
Sbjct:   274 VGSAYYVAPEVLHRNYGKEIDVWSAGVMLYILLSGVPPFWGETEKTIFEAILEGKLDLET 333

Query:   264 DPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKP 310
              PW  IS SA+DLI  ML  DP  R+TAAE L H WM + + ++ KP
Sbjct:   334 SPWPTISESAKDLIRKMLIRDPKKRITAAEALEHPWMTDTK-ISDKP 379

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

TAIR|locus:2150225 CPK34 "AT5G19360" [Arabidopsis thaliana (taxid:3702)]

 Score = 735 (263.8 bits), Expect = 9.6e-73, P = 9.6e-73
 Identities = 138/284 (48%), Positives = 189/284 (66%)

Query:    27 GTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRS 86
             G +L    + ++   Y LGK+LG GQFGV   C+ K TG   ACK+IAK +LV  ED+  
Sbjct:    54 GPVL-GRPMEDVKSSYTLGKELGRGQFGVTHLCTQKATGLQFACKTIAKRKLVNKEDIED 112

Query:    87 IKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVI 146
             ++ E++IM  L+G PN+V+LK  YE++  VHL+MELCAGGELF R+   G +SE  A  +
Sbjct:   113 VRREVQIMHHLTGQPNIVELKGAYEDKHSVHLVMELCAGGELFDRIIAKGHYSERAAASL 172

Query:   147 FRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGS 206
              R ++Q++  CH  GV+HRDLKPEN LL +K  +SP+K  DFGL+ + K G+     VGS
Sbjct:   173 LRTIVQIIHTCHSMGVIHRDLKPENFLLLSKDENSPLKATDFGLSVFYKPGEVFKDIVGS 232

Query:   207 PFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW 266
              +YIAPEVL   Y   AD+WS GV+LYILL G+PPFW ++++ IF+A+ +  + F SDPW
Sbjct:   233 AYYIAPEVLRRKYGPEADIWSIGVMLYILLCGVPPFWAESENGIFNAILSGQVDFSSDPW 292

Query:   267 DHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKP 310
               IS  A+DL+  ML  DP  RLTAA+VL H W++E  +    P
Sbjct:   293 PVISPQAKDLVRKMLNSDPKQRLTAAQVLNHPWIKEDGEAPDVP 336

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0080092 "regulation of pollen tube growth" evidence=IMP

GO:0005737 "cytoplasm" evidence=IDA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0004672 "protein kinase activity" evidence=IDA

TAIR|locus:2011201 CDPK1 "calcium-dependent protein kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 734 (263.4 bits), Expect = 1.2e-72, P = 1.2e-72
 Identities = 139/283 (49%), Positives = 186/283 (65%)

Query:    31 DATQISN---LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSI 87
             D   +SN   +SD+Y+LG++LG G+FG+   C+D+ T E LACKSI+K +L T  D+  +
Sbjct:    49 DVIPMSNQTQISDKYILGRELGRGEFGITYLCTDRETHEALACKSISKRKLRTAVDIEDV 108

Query:    88 KLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIF 147
             + E+ IM+ L  HPNVV LKA YE+ + VHL+MELC GGELF R+   G ++E  A  + 
Sbjct:   109 RREVAIMSTLPEHPNVVKLKASYEDNENVHLVMELCEGGELFDRIVARGHYTERAAAAVA 168

Query:   148 RHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSP 207
             R + +VV  CH NGV+HRDLKPEN L A K  +SP+K  DFGL+ + K G      VGSP
Sbjct:   169 RTIAEVVMMCHSNGVMHRDLKPENFLFANKKENSPLKAIDFGLSVFFKPGDKFTEIVGSP 228

Query:   208 FYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWD 267
             +Y+APEVL   Y    DVWSAGVI+YILL G+PPFW +T+  +  A+    L F  DPW 
Sbjct:   229 YYMAPEVLKRDYGPGVDVWSAGVIIYILLCGVPPFWAETEQGVALAILRGVLDFKRDPWP 288

Query:   268 HISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKP 310
              IS SA+ L+  ML  DP+ RLTA +VLAH W++  ++    P
Sbjct:   289 QISESAKSLVKQMLDPDPTKRLTAQQVLAHPWIQNAKKAPNVP 331

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006499 "N-terminal protein myristoylation" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0009409 "response to cold" evidence=RCA

GO:0009414 "response to water deprivation" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009733 "response to auxin stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA;TAS

GO:0009753 "response to jasmonic acid stimulus" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0042538 "hyperosmotic salinity response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2177023 CPK17 "calcium-dependent protein kinase 17" [Arabidopsis thaliana (taxid:3702)]

 Score = 733 (263.1 bits), Expect = 1.6e-72, P = 1.6e-72
 Identities = 139/284 (48%), Positives = 187/284 (65%)

Query:    27 GTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRS 86
             G +L    + ++   Y LGK+LG GQFGV   C+ K TG   ACK+IAK +LV  ED+  
Sbjct:    59 GPVL-GRPMEDVKASYSLGKELGRGQFGVTHLCTQKATGHQFACKTIAKRKLVNKEDIED 117

Query:    87 IKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVI 146
             ++ E++IM  L+G PN+V+LK  YE++  VHL+MELCAGGELF R+   G +SE  A  +
Sbjct:   118 VRREVQIMHHLTGQPNIVELKGAYEDKHSVHLVMELCAGGELFDRIIAKGHYSERAAASL 177

Query:   147 FRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGS 206
              R ++Q+V  CH  GV+HRDLKPEN LL  K  +SP+K  DFGL+ + K G+     VGS
Sbjct:   178 LRTIVQIVHTCHSMGVIHRDLKPENFLLLNKDENSPLKATDFGLSVFYKPGEVFKDIVGS 237

Query:   207 PFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW 266
              +YIAPEVL   Y   AD+WS GV+LYILL G+PPFW ++++ IF+A+    + F SDPW
Sbjct:   238 AYYIAPEVLKRKYGPEADIWSIGVMLYILLCGVPPFWAESENGIFNAILRGHVDFSSDPW 297

Query:   267 DHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKP 310
               IS  A+DL+  ML  DP  RLTAA+VL H W++E  +    P
Sbjct:   298 PSISPQAKDLVKKMLNSDPKQRLTAAQVLNHPWIKEDGEAPDVP 341

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0080092 "regulation of pollen tube growth" evidence=IMP

GO:0005737 "cytoplasm" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2015846 CPK33 "calcium-dependent protein kinase 33" [Arabidopsis thaliana (taxid:3702)]

 Score = 726 (260.6 bits), Expect = 8.6e-72, P = 8.6e-72
 Identities = 138/269 (51%), Positives = 184/269 (68%)

Query:    42 YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
             Y L K+LG GQFGV   C++K TG+  ACKSI+K +LVT  D   ++ EI+IM  LSG P
Sbjct:    73 YTLSKELGRGQFGVTYLCTEKSTGKRFACKSISKKKLVTKGDKEDMRREIQIMQHLSGQP 132

Query:   102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
             N+V+ K  YE+E  V+L+MELCAGGELF R+   G +SE  A  + R ++ VV+ CH  G
Sbjct:   133 NIVEFKGAYEDEKAVNLVMELCAGGELFDRILAKGHYSERAAASVCRQIVNVVNICHFMG 192

Query:   162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGGYNQ 221
             V+HRDLKPEN LL++K   + IK  DFGL+ +I+ G+     VGS +Y+APEVL   Y +
Sbjct:   193 VMHRDLKPENFLLSSKDEKALIKATDFGLSVFIEEGRVYKDIVGSAYYVAPEVLKRRYGK 252

Query:   222 AADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGML 281
               D+WSAG+ILYILLSG+PPFW +T+  IFDA+   ++ F S PW  IS SA+DL+  ML
Sbjct:   253 EIDIWSAGIILYILLSGVPPFWAETEKGIFDAILEGEIDFESQPWPSISNSAKDLVRRML 312

Query:   282 RVDPSTRLTAAEVLAHSWMEECEQVAQKP 310
               DP  R++AAEVL H W+ E  + + KP
Sbjct:   313 TQDPKRRISAAEVLKHPWLREGGEASDKP 341

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2092399 CPK9 "calmodulin-domain protein kinase 9" [Arabidopsis thaliana (taxid:3702)]

 Score = 726 (260.6 bits), Expect = 8.6e-72, P = 8.6e-72
 Identities = 140/292 (47%), Positives = 194/292 (66%)

Query:    19 SYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRL 78
             S K ++ + +IL+     ++   Y LGK+LG GQFGV   C++  TG+  ACKSI+K +L
Sbjct:    69 SPKTTTKSNSILE-NAFEDVKLFYTLGKELGRGQFGVTYLCTENSTGKKYACKSISKKKL 127

Query:    79 VTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRF 138
             VT  D   ++ EI+IM  LSG PN+V+ K  YE+E  V+L+MELCAGGELF R+   G +
Sbjct:   128 VTKADKDDMRREIQIMQHLSGQPNIVEFKGAYEDEKAVNLVMELCAGGELFDRIIAKGHY 187

Query:   139 SETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ 198
             +E  A  + R ++ VV  CH  GV+HRDLKPEN LL++K   + IK  DFGL+ +I+ G+
Sbjct:   188 TERAAASVCRQIVNVVKICHFMGVLHRDLKPENFLLSSKDEKALIKATDFGLSVFIEEGK 247

Query:   199 NLHGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAAD 258
                  VGS +Y+APEVL   Y +  D+WSAG+ILYILLSG+PPFW +T+  IFDA+    
Sbjct:   248 VYRDIVGSAYYVAPEVLRRRYGKEVDIWSAGIILYILLSGVPPFWAETEKGIFDAILEGH 307

Query:   259 LRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKP 310
             + F S PW  IS+SA+DL+  ML  DP  R++AA+VL H W+ E  + + KP
Sbjct:   308 IDFESQPWPSISSSAKDLVRRMLTADPKRRISAADVLQHPWLREGGEASDKP 359

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=TAS

GO:0005886 "plasma membrane" evidence=IDA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0009409 "response to cold" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2138897 CPK21 "calcium-dependent protein kinase 21" [Arabidopsis thaliana (taxid:3702)]

 Score = 721 (258.9 bits), Expect = 2.9e-71, P = 2.9e-71
 Identities = 144/300 (48%), Positives = 191/300 (63%)

Query:    11 QLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLAC 70
             Q+ST   N   V     TIL      ++   Y LGK+LG GQFG+   C +  TG   AC
Sbjct:    51 QISTPSSNPVSVRD-PDTIL-GKPFEDIRKFYSLGKELGRGQFGITYMCKEIGTGNTYAC 108

Query:    71 KSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFH 130
             KSI K +L++ +D   +K EI+IM  LSG PN+V++K  YE+   +HL+MELCAGGELF 
Sbjct:   109 KSILKRKLISKQDKEDVKREIQIMQYLSGQPNIVEIKGAYEDRQSIHLVMELCAGGELFD 168

Query:   131 RLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGL 190
             R+   G +SE  A  I R ++ VV  CH  GVVHRDLKPEN LL++K  ++ +K  DFGL
Sbjct:   169 RIIAQGHYSERAAAGIIRSIVNVVQICHFMGVVHRDLKPENFLLSSKEENAMLKATDFGL 228

Query:   191 ATYIKAGQNLHGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKI 250
             + +I+ G+     VGS +Y+APEVL   Y +  D+WSAGVILYILLSG+PPFW + +  I
Sbjct:   229 SVFIEEGKVYRDIVGSAYYVAPEVLRRSYGKEIDIWSAGVILYILLSGVPPFWAENEKGI 288

Query:   251 FDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKP 310
             FD V   ++ F S+PW  IS SA+DL+  ML  DP  R+TAA+VL H W++  E    KP
Sbjct:   289 FDEVIKGEIDFVSEPWPSISESAKDLVRKMLTKDPKRRITAAQVLEHPWIKGGE-APDKP 347

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0019903 "protein phosphatase binding" evidence=IPI

GO:0009506 "plasmodesma" evidence=IDA

TAIR|locus:2036783 CPK19 "calcium-dependent protein kinase 19" [Arabidopsis thaliana (taxid:3702)]

 Score = 719 (258.2 bits), Expect = 4.8e-71, P = 4.8e-71
 Identities = 139/305 (45%), Positives = 198/305 (64%)

Query:    37 NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTK 96
             ++ ++Y LG++LG GQFG+   C++  +G+  ACKSI K +L+  +D   ++ EI+IM  
Sbjct:    93 DIKEKYSLGRELGRGQFGITYICTEISSGKNFACKSILKRKLIRTKDREDVRREIQIMHY 152

Query:    97 LSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSY 156
             LSG PN+V++K  YE+   VHL+MELC GGELF ++ K G +SE  A  I R +++VV  
Sbjct:   153 LSGQPNIVEIKGAYEDRQSVHLVMELCEGGELFDKITKRGHYSEKAAAEIIRSVVKVVQI 212

Query:   157 CHGNGVVHRDLKPENILLATKS-SSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVL 215
             CH  GV+HRDLKPEN LL++K  +SS +K  DFG++ +I+ G+     VGS +Y+APEVL
Sbjct:   213 CHFMGVIHRDLKPENFLLSSKDEASSMLKATDFGVSVFIEEGKVYEDIVGSAYYVAPEVL 272

Query:   216 AGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARD 275
                Y +A D+WSAGVILYILL G PPFW +T   IF+ +   ++ F S+PW  IS SA+D
Sbjct:   273 KRNYGKAIDIWSAGVILYILLCGNPPFWAETDKGIFEEILRGEIDFESEPWPSISESAKD 332

Query:   276 LIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKPCKQDDLC-CKQLEVGGS--SFSATF 332
             L+  ML+ DP  R TAA+VL H W+ E  + + KP     L   KQL         +  F
Sbjct:   333 LVRNMLKYDPKKRFTAAQVLEHPWIREGGEASDKPIDSAVLSRMKQLRAMNKLKKLAFKF 392

Query:   333 ISRNM 337
             I++N+
Sbjct:   393 IAQNL 397

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2027227 CPK30 "calcium-dependent protein kinase 30" [Arabidopsis thaliana (taxid:3702)]

 Score = 718 (257.8 bits), Expect = 6.1e-71, P = 6.1e-71
 Identities = 136/282 (48%), Positives = 183/282 (64%)

Query:    29 ILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIK 88
             ++  +  S +SD+Y+LG++LG G+FG+   C+D+ T E LACKSI+K +L T  DV  ++
Sbjct:    46 VIPMSHQSQISDKYILGRELGRGEFGITYLCTDRETREALACKSISKRKLRTAVDVEDVR 105

Query:    89 LEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
              E+ IM+ L  HPNVV LKA YE+ + VHL+MELC GGELF R+   G ++E  A  + R
Sbjct:   106 REVTIMSTLPEHPNVVKLKATYEDNENVHLVMELCEGGELFDRIVARGHYTERAAATVAR 165

Query:   149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF 208
              + +VV  CH NGV+HRDLKPEN L A K  +S +K  DFGL+   K G+     VGSP+
Sbjct:   166 TIAEVVRMCHVNGVMHRDLKPENFLFANKKENSALKAIDFGLSVLFKPGERFTEIVGSPY 225

Query:   209 YIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDH 268
             Y+APEVL   Y    DVWSAGVILYILL G+PPFW +T+  +  A+    L F  DPW  
Sbjct:   226 YMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVALAILRGVLDFKRDPWSQ 285

Query:   269 ISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKP 310
             IS SA+ L+  ML  D + RLTA +VL H W++  ++    P
Sbjct:   286 ISESAKSLVKQMLEPDSTKRLTAQQVLDHPWIQNAKKAPNVP 327

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0009612 "response to mechanical stimulus" evidence=RCA

GO:0019722 "calcium-mediated signaling" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=TAS

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.824
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: gw1.XV.3174.1 hypothetical protein (528 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	419
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-103
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-88
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	7e-72
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-62
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	4e-62
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	4e-61
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-58
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-57
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	3e-57
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-56
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-54
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	4e-54
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	5e-52
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-51
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	6e-51
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-50
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-50
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	7e-50
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-49
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	8e-49
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-48
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	4e-48
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	4e-47
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-45
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-45
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-45
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-44
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-44
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	7e-44
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	9e-44
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-42
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-42
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	5e-42
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	9e-42
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	5e-41
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-40
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-40
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	9e-40
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	9e-40
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-39
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-38
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-38
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	7e-38
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	8e-38
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-37
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-37
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	5e-37
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-36
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-36
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-36
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-36
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	8e-36
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	9e-36
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	9e-36
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-35
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-35
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-35
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-35
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-35
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	4e-35
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	5e-35
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	6e-35
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	7e-35
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	9e-35
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-34
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	4e-34
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	8e-34
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	9e-34
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-33
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-33
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-33
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-33
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-33
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	4e-33
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	5e-33
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	5e-33
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	7e-33
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	9e-33
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-32
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-32
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-32
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-32
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-32
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	4e-32
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	5e-32
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	5e-32
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	6e-32
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-31
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-31
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-31
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	3e-31
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	4e-31
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	7e-31
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	7e-31
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	8e-31
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-30
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-30
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	3e-30
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	6e-30
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	8e-30
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	9e-30
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-29
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	3e-29
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-29
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	7e-29
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-28
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-28
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	1e-28
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-28
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	3e-28
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	4e-28
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	4e-28
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	9e-28
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-27
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-27
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-27
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-27
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-27
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-27
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-27
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	5e-27
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	5e-27
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	5e-27
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	6e-27
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	9e-27
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-26
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-26
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-26
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-26
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-26
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-26
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	3e-26
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	3e-26
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-26
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-26
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	4e-26
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	4e-26
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	4e-26
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	4e-26
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	5e-26
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	5e-26
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	7e-26
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	7e-26
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-25
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-25
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-25
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	3e-25
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	3e-25
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	3e-25
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	4e-25
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	5e-25
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	7e-25
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	7e-25
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	7e-25
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	9e-25
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-24
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-24
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	3e-24
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	3e-24
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	3e-24
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	4e-24
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	4e-24
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	4e-24
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-23
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-23
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-23
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-23
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	3e-23
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	3e-23
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	1e-22
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-22
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	5e-22
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-21
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-21
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	4e-21
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	7e-21
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	8e-21
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-20
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	3e-20
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	5e-20
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-19
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	1e-19
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-19
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-19
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-19
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-19
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	3e-19
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	3e-19
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	8e-19
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-18
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-18
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-18
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	6e-18
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	6e-18
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	7e-18
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	7e-18
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-17
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	4e-17
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	5e-17
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	5e-17
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	7e-17
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	7e-17
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	9e-17
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-16
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-16
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-16
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-16
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	3e-16
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	3e-16
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	4e-16
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	4e-16
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	5e-16
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	5e-16
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	7e-16
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-15
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	3e-15
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-15
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	4e-15
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	8e-15
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	9e-15
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-14
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-14
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-14
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-14
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	2e-14
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-14
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	4e-14
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	4e-14
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	6e-14
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	8e-14
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-13
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-13
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-13
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-13
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-13
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-13
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-13
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-13
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-12
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-12
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-12
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-12
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-12
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	3e-12
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	3e-12
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	4e-12
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	4e-12
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	5e-12
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	6e-12
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	7e-12
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	9e-12
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-11
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	2e-11
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	2e-11
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	3e-11
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	3e-11
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	5e-11
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	7e-11
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-10
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-10
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-10
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	3e-10
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	4e-10
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	4e-10
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	6e-10
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-09
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-09
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-09
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	3e-09
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	4e-09
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	5e-09
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	5e-09
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	6e-09
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	8e-09
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-08
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	4e-08
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	5e-08
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	1e-07
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-07
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-07
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	3e-07
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	4e-07
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	8e-07
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-06
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	1e-06
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-06
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-06
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	2e-06
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-06
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-06
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-06
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	8e-06
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	1e-05
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-05
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-05
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	3e-05
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	6e-05
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	8e-05
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	9e-05
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	1e-04
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	1e-04
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-04
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	2e-04
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	3e-04
COG0478	304	COG0478, COG0478, RIO-like serine/threonine protei	6e-04
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	0.001
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	0.001
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	0.002
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	0.002
pfam10707	199	pfam10707, YrbL-PhoP_reg, PhoP regulatory network	0.002
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	0.004
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	0.004

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  307 bits (788), Expect = e-103
 Identities = 122/261 (46%), Positives = 160/261 (61%), Gaps = 9/261 (3%)

Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           Y + ++LG G FG +    DK TG+++A K I K ++   +D   I  EI+I+ KL  HP
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIK--KDRERILREIKILKKL-KHP 57

Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
           N+V L  V+E+ED ++L+ME C GG+LF  L+K GR SE EAR   R ++  + Y H  G
Sbjct: 58  NIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG 117

Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG-GYN 220
           +VHRDLKPENILL        +KLADFGLA  +  G+ L   VG+P Y+APEVL G GY 
Sbjct: 118 IVHRDLKPENILL---DEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYG 174

Query: 221 QAADVWSAGVILYILLSGMPPFWGK-TKSKIFDAVRAADLRFPSDPWDHISASARDLIMG 279
           +A D+WS GVILY LL+G PPF G     ++F  +      FP   WD IS  A+DLI  
Sbjct: 175 KAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWD-ISPEAKDLIRK 233

Query: 280 MLRVDPSTRLTAAEVLAHSWM 300
           +L  DP  RLTA E L H + 
Sbjct: 234 LLVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  268 bits (687), Expect = 2e-88
 Identities = 112/265 (42%), Positives = 158/265 (59%), Gaps = 11/265 (4%)

Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           Y L ++LG G FG + +   K TG+++A K + K    + +D  +   EI I+ +LS HP
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTAR-REIRILRRLS-HP 58

Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
           N+V L   +E++D+++L+ME C GG+LF  L + G  SE EA+ I   +++ + Y H NG
Sbjct: 59  NIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNG 118

Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLA-TYIKAGQNLHGTVGSPFYIAPEVLAGG-- 218
           ++HRDLKPENILL        +K+ADFGLA   +K+  +L   VG+P+Y+APEVL GG  
Sbjct: 119 IIHRDLKPENILLDENGV---VKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNG 175

Query: 219 YNQAADVWSAGVILYILLSGMPPFWGK---TKSKIFDAVRAADLRFPSDPWDHISASARD 275
           Y    DVWS GVILY LL+G PPF G+    + ++   +    L F    W   S  A+D
Sbjct: 176 YGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKD 235

Query: 276 LIMGMLRVDPSTRLTAAEVLAHSWM 300
           LI   L  DPS R TA E+L H W 
Sbjct: 236 LIKKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  225 bits (577), Expect = 7e-72
 Identities = 102/258 (39%), Positives = 152/258 (58%), Gaps = 13/258 (5%)

Query: 48  LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLK 107
           LG G FG +     K TG++ A K + K +++  ++V     E  I+++++ HP +V L 
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN-HPFIVKLH 59

Query: 108 AVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDL 167
             ++ E+ ++L++E   GGELF  L K GRFSE  AR     ++  + Y H  G+++RDL
Sbjct: 60  YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDL 119

Query: 168 KPENILLATKSSSSPIKLADFGLATY-IKAGQNLHGTVGSPFYIAPEVLAG-GYNQAADV 225
           KPENILL    +   IKL DFGLA      G   +   G+P Y+APEVL G GY +A D 
Sbjct: 120 KPENILL---DADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDW 176

Query: 226 WSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDP 285
           WS GV+LY +L+G PPF+ + + +I++ +    LRFP    + +S  ARDLI G+L+ DP
Sbjct: 177 WSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFP----EFLSPEARDLISGLLQKDP 232

Query: 286 STRLT---AAEVLAHSWM 300
           + RL    A E+ AH + 
Sbjct: 233 TKRLGSGGAEEIKAHPFF 250

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  202 bits (516), Expect = 1e-62
 Identities = 89/271 (32%), Positives = 144/271 (53%), Gaps = 22/271 (8%)

Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
            +  G+ LG G FG +    DK TGE++A KS+      + E++ +++ EI I++ L  H
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSG-DSEEELEALEREIRILSSLQ-H 58

Query: 101 PNVV-----DLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS 155
           PN+V     +     EE++ +++ +E  +GG L   L+K+G+  E   R   R +++ ++
Sbjct: 59  PNIVRYYGSERD---EEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLA 115

Query: 156 YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT---VGSPFYIAP 212
           Y H NG+VHRD+K  NIL+    S   +KLADFG A  +   +   GT    G+P+++AP
Sbjct: 116 YLHSNGIVHRDIKGANILV---DSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAP 172

Query: 213 EVL-AGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW--DHI 269
           EV+    Y +AAD+WS G  +  + +G PP+          A           P   +H+
Sbjct: 173 EVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP---MAALYKIGSSGEPPEIPEHL 229

Query: 270 SASARDLIMGMLRVDPSTRLTAAEVLAHSWM 300
           S  A+D +   LR DP  R TA E+L H ++
Sbjct: 230 SEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  199 bits (509), Expect = 4e-62
 Identities = 95/254 (37%), Positives = 135/254 (53%), Gaps = 44/254 (17%)

Query: 48  LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLK 107
           LG G FG +    DK TG+ +A K I   +  +   +  +  EIEI+ KL+ HPN+V L 
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKII--KKEDSSSLLEELLREIEILKKLN-HPNIVKLY 57

Query: 108 AVYEEEDYVHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRD 166
            V+E+E++++L+ME C GG L   L++  G+ SE E   I   +++ + Y H NG++HRD
Sbjct: 58  GVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRD 117

Query: 167 LKPENILLATKSSSSPIKLADFGLATYIK-AGQNLHGTVGSPFYIAPEVL--AGGYNQAA 223
           LKPENILL   S +  +KLADFGL+  +      L   VG+P Y+APEVL   G Y++ +
Sbjct: 118 LKPENILL--DSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKS 175

Query: 224 DVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRV 283
           D+WS GVILY L                                      +DLI  ML+ 
Sbjct: 176 DIWSLGVILYEL-----------------------------------PELKDLIRKMLQK 200

Query: 284 DPSTRLTAAEVLAH 297
           DP  R +A E+L H
Sbjct: 201 DPEKRPSAKEILEH 214

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  199 bits (508), Expect = 4e-61
 Identities = 94/269 (34%), Positives = 147/269 (54%), Gaps = 22/269 (8%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           D +   K LG G FG +     K +G+  A K ++K ++V ++ V  +  E  I+  +  
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR- 59

Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS---Y 156
           HP +V+L   ++++  ++L+ME   GGELF  L K GRF E  AR    +  QVV    Y
Sbjct: 60  HPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARF---YAAQVVLALEY 116

Query: 157 CHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEV-L 215
            H   +V+RDLKPEN+LL +      IK+ DFG A  +K     +   G+P Y+APE+ L
Sbjct: 117 LHSLDIVYRDLKPENLLLDSDGY---IKITDFGFAKRVK--GRTYTLCGTPEYLAPEIIL 171

Query: 216 AGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARD 275
           + GY +A D W+ G+++Y +L+G PPF+     +I++ +    +RFPS      S  A+D
Sbjct: 172 SKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPS----FFSPDAKD 227

Query: 276 LIMGMLRVDPSTRL-----TAAEVLAHSW 299
           LI  +L+VD + RL        ++  H W
Sbjct: 228 LIRNLLQVDLTKRLGNLKNGVNDIKNHPW 256

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  192 bits (489), Expect = 1e-58
 Identities = 90/265 (33%), Positives = 137/265 (51%), Gaps = 19/265 (7%)

Query: 51  GQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVY 110
           G +G +     K TG++ A K I K  ++    V  +  E +I+++    P VV L   +
Sbjct: 4   GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQ-SPYVVKLYYSF 62

Query: 111 EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPE 170
           + +  ++L+ME   GG+L   LE  G   E  AR+    ++  + Y H NG++HRDLKP+
Sbjct: 63  QGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPD 122

Query: 171 NILLATKSSSSPIKLADFGLATYIKAGQNL---------HGTVGSPFYIAPEVLAG-GYN 220
           NIL+    S+  +KL DFGL+      + +            VG+P YIAPEV+ G G++
Sbjct: 123 NILI---DSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHS 179

Query: 221 QAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGM 280
           +  D WS G ILY  L G+PPF G+T  +IF  +    + +P D    +S  A DLI  +
Sbjct: 180 KTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDV--EVSDEAIDLISKL 237

Query: 281 LRVDPSTRLTAA---EVLAHSWMEE 302
           L  DP  RL A    E+  H + + 
Sbjct: 238 LVPDPEKRLGAKSIEEIKNHPFFKG 262

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  190 bits (484), Expect = 1e-57
 Identities = 84/282 (29%), Positives = 138/282 (48%), Gaps = 33/282 (11%)

Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           +  GK +G G F  +    +K T +  A K + K +L+  + V+ +K+E E++T+L+GHP
Sbjct: 3   FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62

Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
            ++ L   +++E+ ++ ++E    GEL   + KYG   E   R     ++  + Y H  G
Sbjct: 63  GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG 122

Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLA---------TYIKAGQNLHGT--------- 203
           ++HRDLKPENILL        IK+ DFG A            K       +         
Sbjct: 123 IIHRDLKPENILLDKDMH---IKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRF 179

Query: 204 ---VGSPFYIAPEVLAGGY-NQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADL 259
              VG+  Y++PE+L      +++D+W+ G I+Y +L+G PPF G  +   F  +   + 
Sbjct: 180 ASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEY 239

Query: 260 RFPSDPWDHISASARDLIMGMLRVDPSTRLTA----AEVLAH 297
            FP     +    A+DLI  +L +DP  RL       E+ AH
Sbjct: 240 SFP----PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  187 bits (478), Expect = 3e-57
 Identities = 88/263 (33%), Positives = 146/263 (55%), Gaps = 12/263 (4%)

Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
            Y LG  +G G FGV+ +  +  TG+ +A K I+ +++   E ++SI  EI+++  L  H
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKE-EALKSIMQEIDLLKNLK-H 58

Query: 101 PNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGN 160
           PN+V      E  D +++++E    G L   ++K+G F E+   V    ++Q ++Y H  
Sbjct: 59  PNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ 118

Query: 161 GVVHRDLKPENILLATKSSSSPIKLADFGLATYI-KAGQNLHGTVGSPFYIAPEVLAG-G 218
           GV+HRD+K  NIL  TK     +KLADFG+AT +    ++    VG+P+++APEV+   G
Sbjct: 119 GVIHRDIKAANILT-TKDGV--VKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSG 175

Query: 219 YNQAADVWSAGVILYILLSGMPPFWG-KTKSKIFDAVRAADLRFPSDPWDHISASARDLI 277
            + A+D+WS G  +  LL+G PP++     + +F  V+      P      IS   +D +
Sbjct: 176 ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEG----ISPELKDFL 231

Query: 278 MGMLRVDPSTRLTAAEVLAHSWM 300
           M   + DP+ R TA ++L H W+
Sbjct: 232 MQCFQKDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  188 bits (480), Expect = 2e-56
 Identities = 99/296 (33%), Positives = 144/296 (48%), Gaps = 45/296 (15%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           D + + K +G G FG +    DK TG+V A K + K  ++    +  ++ E +I+   + 
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILAD-AD 59

Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
            P +V L   +++E++++L+ME   GG+L + L +   F E  AR     L+  +   H 
Sbjct: 60  SPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHK 119

Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLAT-YIKAGQNL------------------ 200
            G +HRD+KP+NIL+    +   IKLADFGL     KA                      
Sbjct: 120 LGFIHRDIKPDNILI---DADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVR 176

Query: 201 -----------HGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGK--- 245
                      + TVG+P YIAPEVL G  Y    D WS GVILY +L G PPF+     
Sbjct: 177 RRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236

Query: 246 -TKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAE-VLAHSW 299
            T +KI +      LRFP DP   +S  A DLI  +L  DP  RL + E + +H +
Sbjct: 237 ETYNKIINWKE--SLRFPPDP--PVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPF 287

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  180 bits (459), Expect = 3e-54
 Identities = 75/261 (28%), Positives = 134/261 (51%), Gaps = 14/261 (5%)

Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
           +Y + KQ+G G FG +     K  G++   K I    + + ++      E++I+ KL+ H
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLN-H 58

Query: 101 PNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGR----FSETEARVIFRHLMQVVSY 156
           PN++     +EE+  + ++ME   GG+L  +++K  +    F E +    F  L   + Y
Sbjct: 59  PNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKY 118

Query: 157 CHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA-TYIKAGQNLHGTVGSPFYIAPEVL 215
            H   ++HRD+KP+NI L   +S+  +KL DFG++             VG+P+Y++PE+ 
Sbjct: 119 LHSRKILHRDIKPQNIFL---TSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELC 175

Query: 216 AG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASAR 274
               YN  +D+WS G +LY L +   PF G+   ++   +      +P  P    S+  R
Sbjct: 176 QNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ--YPPIP-SQYSSELR 232

Query: 275 DLIMGMLRVDPSTRLTAAEVL 295
           +L+  +L+ DP  R + A++L
Sbjct: 233 NLVSSLLQKDPEERPSIAQIL 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  180 bits (459), Expect = 4e-54
 Identities = 90/266 (33%), Positives = 134/266 (50%), Gaps = 22/266 (8%)

Query: 48  LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLK 107
           LG G FG +     K      A K + K  +V       I  E EI+ + + HP +V L 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECN-HPFIVKLY 59

Query: 108 AVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDL 167
             ++++ Y+++LME C GGEL+  L   G F E  AR     ++    Y H  G+++RDL
Sbjct: 60  RTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDL 119

Query: 168 KPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG-GYNQAADVW 226
           KPEN+LL +      +KL DFG A  +K+GQ      G+P Y+APE++   GY+ + D W
Sbjct: 120 KPENLLLDSNGY---VKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYW 176

Query: 227 SAGVILYILLSGMPPFWG------KTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGM 280
           S G++LY LL+G PPF        +  + I        L FP+    +I  +A+DLI  +
Sbjct: 177 SLGILLYELLTGRPPFGEDDEDPMEIYNDILKGN--GKLEFPN----YIDKAAKDLIKQL 230

Query: 281 LRVDPSTRL-----TAAEVLAHSWME 301
           LR +P  RL        ++  H W  
Sbjct: 231 LRRNPEERLGNLKGGIKDIKKHKWFN 256

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  174 bits (444), Expect = 5e-52
 Identities = 82/263 (31%), Positives = 133/263 (50%), Gaps = 12/263 (4%)

Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
             V+GK    G FG +     + T ++ A K + K + V    VR++  E  I+ +L+ H
Sbjct: 5   LRVIGK----GAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELN-H 59

Query: 101 PNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGN 160
           P +V+L   +++E+ ++L+++L  GG+L + L +  +FSE + +     ++  + Y H  
Sbjct: 60  PFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSK 119

Query: 161 GVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG-GY 219
           G++HRD+KP+NILL  +     + + DF +AT +        T G+P Y+APEVL   GY
Sbjct: 120 GIIHRDIKPDNILLDEQGH---VHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGY 176

Query: 220 NQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMG 279
           + A D WS GV  Y  L G  P+ G +   I D +RA             S  A D I  
Sbjct: 177 SVAVDWWSLGVTAYECLRGKRPYRGHS-RTIRDQIRAKQETADVLYPATWSTEAIDAINK 235

Query: 280 MLRVDPSTRL--TAAEVLAHSWM 300
           +L  DP  RL     ++  H + 
Sbjct: 236 LLERDPQKRLGDNLKDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  177 bits (449), Expect = 1e-51
 Identities = 92/287 (32%), Positives = 145/287 (50%), Gaps = 28/287 (9%)

Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           Y + ++LG G FG +    D+   +++A K +AK      ++V     EI+I+  L+  P
Sbjct: 2   YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGR---FSETEARVIFRHLMQVVSYCH 158
           N+V L   +++E  ++L+ME   GG L   L+K GR    SE+EA  I   ++  + Y H
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118

Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT-------VGSPFYIA 211
             G++HRD+KPENILL        +KL DFGLA  +    +           VG+P Y+A
Sbjct: 119 SKGIIHRDIKPENILL--DRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176

Query: 212 PEVLAGG----YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAV---------RAAD 258
           PEVL G      + ++D+WS G+ LY LL+G+PPF G+  S                +  
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236

Query: 259 LRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ 305
                   + IS +A DL+  +L  DP  RL+++  L+H  +   + 
Sbjct: 237 SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKL 283

Length = 384

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  171 bits (436), Expect = 6e-51
 Identities = 101/263 (38%), Positives = 147/263 (55%), Gaps = 14/263 (5%)

Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACK--SIAKDRLVTVEDVRSIKLEIEIMTKLS 98
           R+  G+ LG G FG + E  +   G+  A K  S+A D     E V+ ++ EI +++KL 
Sbjct: 1   RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60

Query: 99  GHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCH 158
            HPN+V       EED +++ +EL  GG L   L+KYG F E   R+  R ++  + Y H
Sbjct: 61  -HPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLH 119

Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLA-- 216
               VHRD+K  NIL+ T      +KLADFG+A  +          GSP+++APEV+A  
Sbjct: 120 DRNTVHRDIKGANILVDTNGV---VKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQ 176

Query: 217 GGYNQAADVWSAGVILYILLSGMPPFWGKTK--SKIFDAVRAADLRFPSDPWDHISASAR 274
           GGY  AAD+WS G  +  + +G PP W + +  + +F   R+ +L  P  P DH+S  A+
Sbjct: 177 GGYGLAADIWSLGCTVLEMATGKPP-WSQLEGVAAVFKIGRSKEL--PPIP-DHLSDEAK 232

Query: 275 DLIMGMLRVDPSTRLTAAEVLAH 297
           D I+  L+ DPS R TAAE+L H
Sbjct: 233 DFILKCLQRDPSLRPTAAELLEH 255

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  173 bits (439), Expect = 1e-50
 Identities = 94/253 (37%), Positives = 145/253 (57%), Gaps = 12/253 (4%)

Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKL 97
           LSD + +G+ LG G FG +R    K TGE  A K + K  ++ ++ V+ +  E  I+ +L
Sbjct: 17  LSD-FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL 75

Query: 98  SGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYC 157
           S HP +V++   +++E+ V+ L+E   GGELF  L K GRF    A+     L+    Y 
Sbjct: 76  S-HPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYL 134

Query: 158 HGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVL-A 216
           H   +++RDLKPEN+LL  K     +K+ DFG A   K         G+P Y+APEV+ +
Sbjct: 135 HSKDIIYRDLKPENLLLDNKGH---VKVTDFGFAK--KVPDRTFTLCGTPEYLAPEVIQS 189

Query: 217 GGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDL 276
            G+ +A D W+ GV+LY  ++G PPF+  T  +I++ + A  L+FP+  W      ARDL
Sbjct: 190 KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPN--W--FDGRARDL 245

Query: 277 IMGMLRVDPSTRL 289
           + G+L+ D + RL
Sbjct: 246 VKGLLQTDHTKRL 258

Length = 329

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  171 bits (436), Expect = 2e-50
 Identities = 86/262 (32%), Positives = 135/262 (51%), Gaps = 16/262 (6%)

Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           K +G G FG +    D+ +    A K +A   ++ ++  + +  E  ++ ++S HP ++ 
Sbjct: 7   KTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS-HPFIIR 65

Query: 106 LKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHR 165
           L     ++ ++++LME   GGELF  L   GRFS +        ++  + Y H   +V+R
Sbjct: 66  LFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYR 125

Query: 166 DLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG-GYNQAAD 224
           DLKPENILL        IKL DFG A   K         G+P Y+APEV+   G+N+A D
Sbjct: 126 DLKPENILL---DKEGHIKLTDFGFAK--KLRDRTWTLCGTPEYLAPEVIQSKGHNKAVD 180

Query: 225 VWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVD 284
            W+ G+++Y +L G PPF+      I++ + A  L FP     H+   A+DLI  +L VD
Sbjct: 181 WWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPR----HLDLYAKDLIKKLLVVD 236

Query: 285 PSTRL-----TAAEVLAHSWME 301
            + RL      A +V  H W +
Sbjct: 237 RTRRLGNMKNGADDVKNHRWFK 258

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  169 bits (432), Expect = 7e-50
 Identities = 92/301 (30%), Positives = 142/301 (47%), Gaps = 63/301 (20%)

Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRL---VTVEDVRSIKLEIEIMTKLS 98
           Y   ++LG G +GV+ +  DK TGE++A K I  D     +    +R    EI ++ +L 
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALR----EISLLKELK 56

Query: 99  GHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKY-----GRFSETEARVIFRHLMQV 153
            HPN+V L  V   E  ++L+ E C        L+KY     G  S    + I   L++ 
Sbjct: 57  -HPNIVKLLDVIHTERKLYLVFEYCD-----MDLKKYLDKRPGPLSPNLIKSIMYQLLRG 110

Query: 154 VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA--------TYIKAGQNLHGTVG 205
           ++YCH + ++HRDLKP+NIL+   +    +KLADFGLA        TY          V 
Sbjct: 111 LAYCHSHRILHRDLKPQNILI---NRDGVLKLADFGLARAFGIPLRTYTH-------EVV 160

Query: 206 SPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAV----- 254
           + +Y APE+L G   Y+ A D+WS G I   +++G P F G ++     KIF  +     
Sbjct: 161 TLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTE 220

Query: 255 ----RAADL--------RFPSDPWDHI----SASARDLIMGMLRVDPSTRLTAAEVLAHS 298
                   L        +FP    + +         DL+  ML+ +P+ R++A E L H 
Sbjct: 221 ESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHP 280

Query: 299 W 299
           +
Sbjct: 281 Y 281

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  169 bits (430), Expect = 1e-49
 Identities = 90/292 (30%), Positives = 140/292 (47%), Gaps = 56/292 (19%)

Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
            ++G G +GV+ +  DK TGE++A K I            +++ EI+++ +L+ HPN++ 
Sbjct: 5   GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALR-EIKLLKELN-HPNIIK 62

Query: 106 LKAVYEEEDYVHLLMELCAGGELFHRLEKYGR-FSETEARVIFRHLMQVVSYCHGNGVVH 164
           L  V+  +  ++L+ E     +L+  ++   R   E+  +     L+Q +++CH +G++H
Sbjct: 63  LLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILH 121

Query: 165 RDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF-----------YIAPE 213
           RDLKPEN+L+   ++   +KLADFGLA           + GSP            Y APE
Sbjct: 122 RDLKPENLLI---NTEGVLKLADFGLAR----------SFGSPVRPYTHYVVTRWYRAPE 168

Query: 214 VL--AGGYNQAADVWSAGVILYILLSGMPPFWGKTK----SKIFD--------------- 252
           +L    GY+   D+WS G I   LLS  P F GK++     KIF                
Sbjct: 169 LLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTS 228

Query: 253 AVRAADLRFPSD---PWDHI----SASARDLIMGMLRVDPSTRLTAAEVLAH 297
             R     FP     P   +    S  A DL+  ML  DP  R+TA + LAH
Sbjct: 229 LARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  167 bits (424), Expect = 8e-49
 Identities = 92/296 (31%), Positives = 136/296 (45%), Gaps = 49/296 (16%)

Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVED------VRSIKLEIEIM 94
           RY +  ++G G  G++ +  D+ TGE +A K +A   L  +E       +R IK      
Sbjct: 1   RYKILGRIGEGAHGIVFKAKDRETGETVALKKVA---LRRLEGGIPNQALREIKALQAC- 56

Query: 95  TKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGR-FSETEARVIFRHLMQV 153
                HP VV L  V+       L+ME      L   L    R   E + +   R L++ 
Sbjct: 57  ----QHPYVVKLLDVFPHGSGFVLVMEYMPSD-LSEVLRDEERPLPEAQVKSYMRMLLKG 111

Query: 154 VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT--VGSPFYIA 211
           V+Y H NG++HRDLKP N+L+   S+   +K+ADFGLA      +    +  V + +Y A
Sbjct: 112 VAYMHANGIMHRDLKPANLLI---SADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRA 168

Query: 212 PEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAV----------- 254
           PE+L G   Y+   D+W+ G I   LL+G P F G+      + +F  +           
Sbjct: 169 PELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGL 228

Query: 255 ----RAADLRFPSD---PWDHI----SASARDLIMGMLRVDPSTRLTAAEVLAHSW 299
                   + FP     P + I    S  A DL+ G+L  DPS RL+AAE L H +
Sbjct: 229 TSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPY 284

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  165 bits (419), Expect = 2e-48
 Identities = 80/258 (31%), Positives = 133/258 (51%), Gaps = 10/258 (3%)

Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           K +  G FG +     + TG+  A K + K  ++    V ++K E  IM      P V  
Sbjct: 2   KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAK 61

Query: 106 LKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHR 165
           L   ++ +DY++L+ME   GG+    ++  G   E  A+     ++  V   H  G++HR
Sbjct: 62  LYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHR 121

Query: 166 DLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG-GYNQAAD 224
           D+KPEN+L+     +  +KL DFGL+   + G      VG+P Y+APE + G G ++ +D
Sbjct: 122 DIKPENLLI---DQTGHLKLTDFGLS---RNGLENKKFVGTPDYLAPETILGVGDDKMSD 175

Query: 225 VWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVD 284
            WS G +++  L G PPF  +T   +FD + +  + +P +  +  S  A DLI  +L +D
Sbjct: 176 WWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMD 235

Query: 285 PSTRLTA---AEVLAHSW 299
           P+ RL A    E+ +H +
Sbjct: 236 PAKRLGANGYQEIKSHPF 253

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  164 bits (417), Expect = 4e-48
 Identities = 80/264 (30%), Positives = 137/264 (51%), Gaps = 18/264 (6%)

Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           + + +++G G FG + +   K TG+ +A K I   +L + E    I  EI+I+ K   HP
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVI---KLESKEKKEKIINEIQILKKCK-HP 57

Query: 102 NVVDLKAVYEEEDYVHLLMELCAGG---ELFHRLEKYGRFSETEARVIFRHLMQVVSYCH 158
           N+V     Y ++D + ++ME C+GG   +L          +E++   + + L++ + Y H
Sbjct: 58  NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLK--STNQTLTESQIAYVCKELLKGLEYLH 115

Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG- 217
            NG++HRD+K  NILL   +S   +KL DFGL+  +   +  +  VG+P+++APEV+ G 
Sbjct: 116 SNGIIHRDIKAANILL---TSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGK 172

Query: 218 GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDA-VRAADLRFPSDPWDH-ISASARD 275
            Y+  AD+WS G+    L  G PP+   ++     A  + A    P        S   +D
Sbjct: 173 PYDYKADIWSLGITAIELAEGKPPY---SELPPMKALFKIATNGPPGLRNPEKWSDEFKD 229

Query: 276 LIMGMLRVDPSTRLTAAEVLAHSW 299
            +   L+ +P  R TA ++L H +
Sbjct: 230 FLKKCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score =  163 bits (415), Expect = 4e-47
 Identities = 99/291 (34%), Positives = 142/291 (48%), Gaps = 43/291 (14%)

Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           K LG G  G +     K TG++ A K + K  ++    V+ +  E EI+  L  HP +  
Sbjct: 7   KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLD-HPFLPT 65

Query: 106 LKAVYEEEDYVHLLMELCAGGELFHRLEKY--GRFSETEARVIFRHLMQVVSYCHGNGVV 163
           L A ++ E Y+ L+M+ C GGELF  L++      SE  AR     ++  + Y H  G+V
Sbjct: 66  LYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIV 125

Query: 164 HRDLKPENILLATKSSSSPIKLADFGLATY--------IKAGQNLHGT------------ 203
           +RDLKPENILL     S  I L+DF L+           KA +                 
Sbjct: 126 YRDLKPENILL---HESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFS 182

Query: 204 ----------VGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFD 252
                     VG+  YIAPEV++G G+  A D W+ G++LY +L G  PF G  + + F 
Sbjct: 183 EEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFS 242

Query: 253 AVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRL----TAAEVLAHSW 299
            +   ++ FP  P   +S+SARDLI  +L  DPS RL     AAE+  H +
Sbjct: 243 NILKKEVTFPGSP--PVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPF 291

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  157 bits (400), Expect = 1e-45
 Identities = 86/270 (31%), Positives = 137/270 (50%), Gaps = 18/270 (6%)

Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
           R+  G ++G G FG +    +  TGE++A K I        + ++ I  E++++  L  H
Sbjct: 1   RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDN-DPKTIKEIADEMKVLELLK-H 58

Query: 101 PNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRF-SETEARVIFRHLMQVVSYCHG 159
           PN+V    V    + V++ ME C+GG L   L ++GR   E   RV    L++ ++Y H 
Sbjct: 59  PNLVKYYGVEVHREKVYIFMEYCSGGTLE-ELLEHGRILDEHVIRVYTLQLLEGLAYLHS 117

Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIK-----AGQNLHGTVGSPFYIAPEV 214
           +G+VHRD+KP NI L     +  IKL DFG A  +K      G+ +    G+P Y+APEV
Sbjct: 118 HGIVHRDIKPANIFLD---HNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEV 174

Query: 215 LAG----GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDP-WDHI 269
           + G    G+ +AAD+WS G ++  + +G  P W +  ++            P  P    +
Sbjct: 175 ITGGKGKGHGRAADIWSLGCVVLEMATGKRP-WSELDNEFQIMFHVGAGHKPPIPDSLQL 233

Query: 270 SASARDLIMGMLRVDPSTRLTAAEVLAHSW 299
           S   +D +   L  DP  R TA+E+L H +
Sbjct: 234 SPEGKDFLDRCLESDPKKRPTASELLQHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  158 bits (401), Expect = 2e-45
 Identities = 95/289 (32%), Positives = 149/289 (51%), Gaps = 36/289 (12%)

Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           Y + KQLG G FG +    +K TGE++A K + K +  + E+  +++ E++ + KL+ HP
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKM-KKKFYSWEECMNLR-EVKSLRKLNEHP 58

Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFH--RLEKYGRFSETEARVIFRHLMQVVSYCHG 159
           N+V LK V+ E D ++ + E    G L+   +  K   FSE+  R I   ++Q +++ H 
Sbjct: 59  NIVKLKEVFRENDELYFVFE-YMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK 117

Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVL--AG 217
           +G  HRDLKPEN+L+   S    +K+ADFGLA  I++       V + +Y APE+L  + 
Sbjct: 118 HGFFHRDLKPENLLV---SGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRST 174

Query: 218 GYNQAADVWSAGVILYILLSGMPPFWGKTK----SKIF------------DAVR-AADLR 260
            Y+   D+W+ G I+  L +  P F G ++     KI             +  + A+ L 
Sbjct: 175 SYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234

Query: 261 F------PSDPWDHI---SASARDLIMGMLRVDPSTRLTAAEVLAHSWM 300
           F      P+     I   S  A DLI  MLR DP  R TA++ L H + 
Sbjct: 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  158 bits (402), Expect = 2e-45
 Identities = 89/314 (28%), Positives = 140/314 (44%), Gaps = 55/314 (17%)

Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVED------VRSIKLEIEIM 94
           RY  GK+LG G + V+ +  DK TG ++A K I        +D      +R    EI+++
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALR----EIKLL 56

Query: 95  TKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLE-----KYGRFSETEARVIFRH 149
            +L  HPN++ L  V+  +  ++L+ E          LE     K    +  + +     
Sbjct: 57  QELK-HPNIIGLLDVFGHKSNINLVFEFMETD-----LEKVIKDKSIVLTPADIKSYMLM 110

Query: 150 LMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA-TYIKAGQNLHGTVGSPF 208
            ++ + Y H N ++HRDLKP N+L+A+      +KLADFGLA ++    + +   V + +
Sbjct: 111 TLRGLEYLHSNWILHRDLKPNNLLIASDGV---LKLADFGLARSFGSPNRKMTHQVVTRW 167

Query: 209 YIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAV-------- 254
           Y APE+L G   Y    D+WS G I   LL  +P   G +      KIF+A+        
Sbjct: 168 YRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENW 227

Query: 255 -RAADL-------RFPSDPWDHI----SASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
                L        FP  P   I    S  A DL+  +L ++P+ R+TA + L H +   
Sbjct: 228 PGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSN 287

Query: 303 CEQVAQKPCKQDDL 316
                  P     L
Sbjct: 288 ----DPAPTPPSQL 297

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score =  157 bits (398), Expect = 1e-44
 Identities = 86/261 (32%), Positives = 135/261 (51%), Gaps = 15/261 (5%)

Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           K LG G FG +    +K TG+  A K + K+ ++  ++V     E  ++ + + HP +  
Sbjct: 1   KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVL-QNTRHPFLTA 59

Query: 106 LKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHR 165
           LK  ++  D +  +ME   GGELF  L +   FSE  AR     ++  + Y H   VV+R
Sbjct: 60  LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYR 119

Query: 166 DLKPENILLATKSSSSPIKLADFGLATY-IKAGQNLHGTVGSPFYIAPEVLA-GGYNQAA 223
           DLK EN++L        IK+ DFGL    I  G  +    G+P Y+APEVL    Y +A 
Sbjct: 120 DLKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAV 176

Query: 224 DVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRV 283
           D W  GV++Y ++ G  PF+ +   K+F+ +   ++RFP      +S  A+ L+ G+L+ 
Sbjct: 177 DWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRT----LSPEAKSLLAGLLKK 232

Query: 284 DPSTRL-----TAAEVLAHSW 299
           DP  RL      A E++ H +
Sbjct: 233 DPKQRLGGGPEDAKEIMEHRF 253

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score =  156 bits (395), Expect = 2e-44
 Identities = 93/276 (33%), Positives = 147/276 (53%), Gaps = 19/276 (6%)

Query: 48  LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLK 107
           +G G FG + +   + T  + A K+I K  +V+  +V     E  ++ +++  P +V LK
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVN-CPFIVPLK 59

Query: 108 AVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDL 167
             ++  + ++L++    GGELFH L++ GRF  + AR     L+  +   H   V++RDL
Sbjct: 60  FSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDL 119

Query: 168 KPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT-VGSPFYIAPEVLAG-GYNQAADV 225
           KPENILL        I L DFGL        +   T  G+P Y+APE+L G GY +A D 
Sbjct: 120 KPENILL---DYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDW 176

Query: 226 WSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDP 285
           W+ GV+LY +L+G+PPF+ +  ++++  +    LRFP    D     A+DL++G+L  DP
Sbjct: 177 WTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFP----DGFDRDAKDLLIGLLSRDP 232

Query: 286 STRL---TAAEVLAH------SWMEECEQVAQKPCK 312
           + RL    A E+  H      SW +   +  Q P K
Sbjct: 233 TRRLGYNGAQEIKNHPFFSQLSWKKLLMKGIQPPFK 268

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  155 bits (394), Expect = 7e-44
 Identities = 94/263 (35%), Positives = 140/263 (53%), Gaps = 15/263 (5%)

Query: 47  QLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDL 106
           Q+G G +G +     K TGE++A K + K  L  + +VR +  E +I+T  +    +V L
Sbjct: 8   QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTT-TKSEWLVKL 66

Query: 107 KAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRD 166
              +++++Y++L ME   GG+    L   G  SE  AR     + + V   H  G +HRD
Sbjct: 67  LYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRD 126

Query: 167 LKPENILLATKSSSSPIKLADFGLATYIKAGQNL-HGTVGSPFYIAPEVLAG-GYNQAAD 224
           LKPEN L+    +S  IKL DFGL+   K      +  VGSP Y+APEVL G GY+   D
Sbjct: 127 LKPENFLI---DASGHIKLTDFGLS---KGIVTYANSVVGSPDYMAPEVLRGKGYDFTVD 180

Query: 225 VWSAGVILYILLSGMPPFWGKTKSKIFDAVR--AADLRFPS--DPWDHISASARDLIMGM 280
            WS G +LY  L G PPF G T ++ ++ ++     L+ P   DP  ++S  A DLI  +
Sbjct: 181 YWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKL 240

Query: 281 LRVDPSTRLTAAE-VLAHSWMEE 302
           +  DPS R  + E +  H + +E
Sbjct: 241 I-NDPSRRFGSLEDIKNHPFFKE 262

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  153 bits (388), Expect = 9e-44
 Identities = 80/264 (30%), Positives = 135/264 (51%), Gaps = 10/264 (3%)

Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           K LG G  GV+ +   K TG++ A K I  D        + +  E++ + +    P VV 
Sbjct: 7   KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFR--KQLLRELKTL-RSCESPYVVK 63

Query: 106 LKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGN-GVVH 164
               + +E  + +++E   GG L   L+K G+  E     I R +++ + Y H    ++H
Sbjct: 64  CYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIH 123

Query: 165 RDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT-VGSPFYIAPEVLAGG-YNQA 222
           RD+KP N+L+   +S   +K+ADFG++  ++   +   T VG+  Y++PE + G  Y+ A
Sbjct: 124 RDIKPSNLLI---NSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYA 180

Query: 223 ADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRA-ADLRFPSDPWDHISASARDLIMGML 281
           AD+WS G+ L     G  PF    +   F+ ++A  D   PS P +  S   RD I   L
Sbjct: 181 ADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACL 240

Query: 282 RVDPSTRLTAAEVLAHSWMEECEQ 305
           + DP  R +AAE+L H ++++ + 
Sbjct: 241 QKDPKKRPSAAELLQHPFIKKADN 264

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  151 bits (384), Expect = 1e-42
 Identities = 79/250 (31%), Positives = 129/250 (51%), Gaps = 9/250 (3%)

Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           K LG G FG +     K T E+ A K + KD ++  +DV     E  ++     HP +  
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60

Query: 106 LKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHR 165
           L + ++ +D +  +ME   GG+L   +++ GRF E  AR     ++  + + H  G+++R
Sbjct: 61  LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYR 120

Query: 166 DLKPENILLATKSSSSPIKLADFGLATY-IKAGQNLHGTVGSPFYIAPEVLAG-GYNQAA 223
           DLK +N+LL    S   IK+ADFG+    I  G       G+P YIAPE+L+   Y  A 
Sbjct: 121 DLKLDNVLL---DSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAV 177

Query: 224 DVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRV 283
           D W+ GV+LY +L+G  PF G  + ++F ++   ++R+P      +S  A+ ++   L  
Sbjct: 178 DWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPR----WLSKEAKSILKSFLTK 233

Query: 284 DPSTRLTAAE 293
           +P  RL    
Sbjct: 234 NPEKRLGCLP 243

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  150 bits (381), Expect = 2e-42
 Identities = 95/293 (32%), Positives = 147/293 (50%), Gaps = 43/293 (14%)

Query: 40  DRY-VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKL-EIEIMTKL 97
           ++Y VLG  +G G +GV+ +C +K TGE++A K   K+     EDV+   L E++++ +L
Sbjct: 1   NKYEVLGV-VGEGAYGVVLKCRNKATGEIVAIKKF-KESEDD-EDVKKTALREVKVLRQL 57

Query: 98  SGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSY 156
             H N+V+LK  +  +  ++L+ E      L   LE   G       R     L+Q ++Y
Sbjct: 58  R-HENIVNLKEAFRRKGRLYLVFEYV-ERTLLELLEASPGGLPPDAVRSYIWQLLQAIAY 115

Query: 157 CHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT--VGSPFYIAPEV 214
           CH + ++HRD+KPENIL+   S S  +KL DFG A  ++A      T  V + +Y APE+
Sbjct: 116 CHSHNIIHRDIKPENILV---SESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPEL 172

Query: 215 LAGG--YNQAADVWSAGVILYILLSGMPPFWGKT------------------KSKIFDA- 253
           L G   Y +  DVW+ G I+  LL G P F G +                    ++F + 
Sbjct: 173 LVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN 232

Query: 254 VRAADLRFPS----DPWDH-----ISASARDLIMGMLRVDPSTRLTAAEVLAH 297
            R A + FP     +  +      +S+ A D +   LR+DP  RLT  E+L H
Sbjct: 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  149 bits (378), Expect = 5e-42
 Identities = 82/290 (28%), Positives = 137/290 (47%), Gaps = 37/290 (12%)

Query: 39  SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLS 98
            + Y   +++G G  G + + +D+ TG+ +A K +     +  ++   I  EI IM K  
Sbjct: 18  RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKM----RLRKQNKELIINEILIM-KDC 72

Query: 99  GHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYG-RFSETEARVIFRHLMQVVSYC 157
            HPN+VD    Y   D + ++ME   GG L   + +   R +E +   + R ++Q + Y 
Sbjct: 73  KHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYL 132

Query: 158 HGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI-KAGQNLHGTVGSPFYIAPEVLA 216
           H   V+HRD+K +NILL   S    +KLADFG A  + K     +  VG+P+++APEV+ 
Sbjct: 133 HSQNVIHRDIKSDNILL---SKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIK 189

Query: 217 GG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRA---------ADLRFPSDPW 266
              Y    D+WS G++   +  G PP+           +RA           L+   + W
Sbjct: 190 RKDYGPKVDIWSLGIMCIEMAEGEPPYLR------EPPLRALFLITTKGIPPLK-NPEKW 242

Query: 267 DHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKPCKQDDL 316
              S   +D +   L  DP  R +A E+L H ++       +K C +++ 
Sbjct: 243 ---SPEFKDFLNKCLVKDPEKRPSAEELLQHPFL-------KKACPKEEF 282

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  148 bits (375), Expect = 9e-42
 Identities = 79/264 (29%), Positives = 132/264 (50%), Gaps = 23/264 (8%)

Query: 48  LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDL- 106
           +G G FG +R+   K  G++L  K I    +   E  + +  E+ I+ +L  HPN+V   
Sbjct: 8   IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVS-EVNILRELK-HPNIVRYY 65

Query: 107 -KAVYEEEDYVHLLMELCAGGELFHRLEKY----GRFSETEARVIFRHLMQVVSYCH--- 158
            + +      ++++ME C GG+L   ++K         E     I   L+  +  CH   
Sbjct: 66  DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRS 125

Query: 159 --GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT-VGSPFYIAPEVL 215
             GN V+HRDLKP NI L   ++   +KL DFGLA  +    +   T VG+P+Y++PE L
Sbjct: 126 DPGNTVLHRDLKPANIFLDANNN---VKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQL 182

Query: 216 AGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHI-SASA 273
               Y++ +D+WS G ++Y L +  PPF  + + ++  A +  + +F      +  S+  
Sbjct: 183 NHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQL--ASKIKEGKFR--RIPYRYSSEL 238

Query: 274 RDLIMGMLRVDPSTRLTAAEVLAH 297
            ++I  ML VDP  R +  E+L  
Sbjct: 239 NEVIKSMLNVDPDKRPSTEELLQL 262

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  146 bits (370), Expect = 5e-41
 Identities = 79/266 (29%), Positives = 130/266 (48%), Gaps = 19/266 (7%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           + + L + +G G FG + +  DK T +V+A K I  +     +++  I+ EI+ +++   
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRS 58

Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
            P +      + +   + ++ME C GG     L K G+  ET    I R ++  + Y H 
Sbjct: 59  -PYITKYYGSFLKGSKLWIIMEYCGGGSCLD-LLKPGKLDETYIAFILREVLLGLEYLHE 116

Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN-LHGTVGSPFYIAPEVLA-G 217
            G +HRD+K  NILL   S    +KLADFG++  + +  +  +  VG+PF++APEV+   
Sbjct: 117 EGKIHRDIKAANILL---SEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQS 173

Query: 218 GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADL----RFPSDPWDHISASA 273
           GY++ AD+WS G+    L  G PP            +R   L      PS   +  S   
Sbjct: 174 GYDEKADIWSLGITAIELAKGEPPLSDL------HPMRVLFLIPKNNPPSLEGNKFSKPF 227

Query: 274 RDLIMGMLRVDPSTRLTAAEVLAHSW 299
           +D +   L  DP  R +A E+L H +
Sbjct: 228 KDFVSLCLNKDPKERPSAKELLKHKF 253

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  145 bits (367), Expect = 1e-40
 Identities = 84/265 (31%), Positives = 139/265 (52%), Gaps = 19/265 (7%)

Query: 44  LGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLV--TVEDVRSIKLEIEIMTKLSGHP 101
            GK LG G FG +  C D  TG  LA K +  D     T ++V +++ EI+++  L  H 
Sbjct: 6   RGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ-HE 64

Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
            +V       +++ + + ME   GG +  +L+ YG  +ET  R   R +++ V Y H N 
Sbjct: 65  RIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM 124

Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKA----GQNLHGTVGSPFYIAPEVLAG 217
           +VHRD+K  NIL   + S+  +KL DFG +  ++     G  +    G+P++++PEV++G
Sbjct: 125 IVHRDIKGANIL---RDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISG 181

Query: 218 -GYNQAADVWSAGVILYILLSGMPPFWGKTK--SKIFD-AVRAADLRFPSDPWDHISASA 273
            GY + ADVWS G  +  +L+  PP W + +  + IF  A +  + + PS    H+S  A
Sbjct: 182 EGYGRKADVWSVGCTVVEMLTEKPP-WAEFEAMAAIFKIATQPTNPQLPS----HVSPDA 236

Query: 274 RDLIMGMLRVDPSTRLTAAEVLAHS 298
           R+ +      +   R +A E+L H 
Sbjct: 237 RNFLRRTFVENAKKRPSAEELLRHF 261

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score =  146 bits (370), Expect = 1e-40
 Identities = 96/288 (33%), Positives = 151/288 (52%), Gaps = 25/288 (8%)

Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVT-VEDVRSIKLEIEIMTKLSGHP 101
           VLGK  G+G+   +R+ +   TG++ A K + K  +V   +D    K E  I+  +  HP
Sbjct: 3   VLGKG-GYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVK-HP 60

Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
            +VDL   ++    ++L++E  +GGELF  LE+ G F E  A      +   + + H  G
Sbjct: 61  FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG 120

Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLAT-YIKAGQNLHGTVGSPFYIAPEVLA-GGY 219
           +++RDLKPENILL    +   +KL DFGL    I  G   H   G+  Y+APE+L   G+
Sbjct: 121 IIYRDLKPENILL---DAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGH 177

Query: 220 NQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMG 279
            +A D WS G ++Y +L+G PPF  + + K  D +    L  P     +++  ARDL+  
Sbjct: 178 GKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPP----YLTPEARDLLKK 233

Query: 280 MLRVDPSTRL-----TAAEVLAHSWMEECEQVAQKPCKQDDLCCKQLE 322
           +L+ +PS+RL      AAEV +H +         +    DDL  +++E
Sbjct: 234 LLKRNPSSRLGAGPGDAAEVQSHPFF--------RHVNWDDLLARKVE 273

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score =  144 bits (364), Expect = 9e-40
 Identities = 83/246 (33%), Positives = 131/246 (53%), Gaps = 9/246 (3%)

Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           K LG G FG +     K T E  A K++ KD ++  +DV    +E  ++     HP +  
Sbjct: 1   KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60

Query: 106 LKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHR 165
           L   ++ ++++  +ME   GG+L   ++  GRF E  AR     ++  + + H  G+++R
Sbjct: 61  LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYR 120

Query: 166 DLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT-VGSPFYIAPEVLAG-GYNQAA 223
           DLK +N+LL        IK+ADFG+      G+    T  G+P YIAPE+L G  YN++ 
Sbjct: 121 DLKLDNVLL---DKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESV 177

Query: 224 DVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRV 283
           D WS GV+LY +L G  PF G+ + ++FD++      FP   W  IS  A+D +  +   
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPR--W--ISKEAKDCLSKLFER 233

Query: 284 DPSTRL 289
           DP+ RL
Sbjct: 234 DPTKRL 239

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  143 bits (363), Expect = 9e-40
 Identities = 86/296 (29%), Positives = 137/296 (46%), Gaps = 56/296 (18%)

Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
            Q+G G +G + +  +K TGE++A K I  +       + +I+ EI+++ KL  HPN+V 
Sbjct: 5   AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIR-EIKLLQKLR-HPNIVR 62

Query: 106 LKAVYEEEDY--VHLLMELC----AGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
           LK +   +    ++++ E       G  L        +F+E++ +   + L++ + Y H 
Sbjct: 63  LKEIVTSKGKGSIYMVFEYMDHDLTG--LLDS--PEVKFTESQIKCYMKQLLEGLQYLHS 118

Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT--VGSPFYIAPEVLAG 217
           NG++HRD+K  NIL+        +KLADFGLA       +   T  V + +Y  PE+L G
Sbjct: 119 NGILHRDIKGSNILINNDGV---LKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLG 175

Query: 218 G--YNQAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAVRAADLRFPSD------- 264
              Y    D+WS G IL  L  G P F G T+     KIF+         P+D       
Sbjct: 176 ATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFEL-----CGSPTDENWPGVS 230

Query: 265 --PW---------------DH----ISASARDLIMGMLRVDPSTRLTAAEVLAHSW 299
             PW               +     I  SA DL+  +L +DP  R++A + L H +
Sbjct: 231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEY 286

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  142 bits (361), Expect = 1e-39
 Identities = 82/262 (31%), Positives = 133/262 (50%), Gaps = 21/262 (8%)

Query: 48  LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKL--SGHPNVVD 105
           +G G +G +       TG V+A K I  D     +DV  I+ E+ ++++L  S  PN+  
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLD--TPDDDVSDIQREVALLSQLRQSQPPNITK 66

Query: 106 LKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHR 165
               Y +   + ++ME   GG +   L K G  +E    VI R ++  + Y H  GV+HR
Sbjct: 67  YYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHR 125

Query: 166 DLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT-VGSPFYIAPEVLAGG--YNQA 222
           D+K  NIL+   +++  +KL DFG+A  +    +   T VG+P+++APEV+  G  Y+  
Sbjct: 126 DIKAANILV---TNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTK 182

Query: 223 ADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADL----RFPSDPWDHISASARDLIM 278
           AD+WS G+ +Y + +G PP+         DA RA  L    + P    +  S   R+ + 
Sbjct: 183 ADIWSLGITIYEMATGNPPYSDV------DAFRAMMLIPKSKPPRLEDNGYSKLLREFVA 236

Query: 279 GMLRVDPSTRLTAAEVLAHSWM 300
             L  +P  RL+A E+L   W+
Sbjct: 237 ACLDEEPKERLSAEELLKSKWI 258

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  141 bits (357), Expect = 2e-38
 Identities = 90/333 (27%), Positives = 157/333 (47%), Gaps = 62/333 (18%)

Query: 37  NLSDRYV-LGKQLGWGQFGVIRECSDKFTGEVLACK-----SIAKDRLVTVEDVRSIKL- 89
           ++S+RY+  G  LG G +G + +  D  TG+++A K      I+ D     + V    + 
Sbjct: 5   SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIH 64

Query: 90  -----EIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEAR 144
                E++IM ++  H N++ L  VY E D+++L+M++ A  +L   +++  R +E++ +
Sbjct: 65  FTTLRELKIMNEIK-HENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVK 122

Query: 145 VIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLAT------------ 192
            I   ++  ++  H    +HRDL P NI + +K      K+ADFGLA             
Sbjct: 123 CILLQILNGLNVLHKWYFMHRDLSPANIFINSKGI---CKIADFGLARRYGYPPYSDTLS 179

Query: 193 ---YIKAGQNLHGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTK 247
               ++  + +   V + +Y APE+L G   Y+ A D+WS G I   LL+G P F G+ +
Sbjct: 180 KDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239

Query: 248 ----SKIFDAV---------RAADLRF-----PSDPWD------HISASARDLIMGMLRV 283
                +IF+ +         +A  L       P  P D      + S  A DL+  +L++
Sbjct: 240 IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKL 299

Query: 284 DPSTRLTAAEVLAHSWMEECEQVAQKPCKQDDL 316
           +P  R++A E L H +     +    PC    L
Sbjct: 300 NPLERISAKEALKHEYF----KSDPLPCDPSQL 328

Length = 335

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score =  140 bits (355), Expect = 2e-38
 Identities = 89/262 (33%), Positives = 134/262 (51%), Gaps = 16/262 (6%)

Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           K LG G FG +    +K TG   A K + K+ +V  ++V     E  ++   S HP +  
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTA 59

Query: 106 LKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGN-GVVH 164
           LK  ++  D +  +ME   GGELF  L +   FSE  AR     ++  + Y H    VV+
Sbjct: 60  LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 119

Query: 165 RDLKPENILLATKSSSSPIKLADFGLATY-IKAGQNLHGTVGSPFYIAPEVLAGG-YNQA 222
           RDLK EN++L        IK+ DFGL    IK G  +    G+P Y+APEVL    Y +A
Sbjct: 120 RDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRA 176

Query: 223 ADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLR 282
            D W  GV++Y ++ G  PF+ +   K+F+ +   ++RFP      +S  A+ L+ G+L+
Sbjct: 177 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRT----LSPEAKSLLSGLLK 232

Query: 283 VDPSTRL-----TAAEVLAHSW 299
            DP  RL      A E++ H +
Sbjct: 233 KDPKQRLGGGPDDAKEIMQHKF 254

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  140 bits (354), Expect = 7e-38
 Identities = 94/303 (31%), Positives = 144/303 (47%), Gaps = 56/303 (18%)

Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           K +G G FG +R    K TG + A K + K  ++  E V  ++ E +I+ + + +P VV 
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAE-ADNPWVVK 65

Query: 106 LKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHR 165
           L   +++E+Y++L+ME   GG++   L K   F+E E R      +  +   H  G +HR
Sbjct: 66  LYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHR 125

Query: 166 DLKPENILLATKSSSSPIKLADFGLATYIKAG------QNL------------------- 200
           D+KP+N+LL    +   IKL+DFGL T +K        + L                   
Sbjct: 126 DIKPDNLLL---DAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182

Query: 201 --------------HGTVGSPFYIAPEV-LAGGYNQAADVWSAGVILYILLSGMPPFWG- 244
                         + TVG+P YIAPEV L  GYN+  D WS GVI+Y +L G PPF   
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSD 242

Query: 245 ---KTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRL---TAAEVLAHS 298
              +T  KI +      L+FP +    +S  A+DLI  +   +   RL      E+ +H 
Sbjct: 243 NPQETYRKIINWKET--LQFPDE--VPLSPEAKDLIKRLC-CEAERRLGNNGVNEIKSHP 297

Query: 299 WME 301
           + +
Sbjct: 298 FFK 300

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score =  139 bits (351), Expect = 8e-38
 Identities = 84/261 (32%), Positives = 133/261 (50%), Gaps = 15/261 (5%)

Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           K LG G FG +    +K TG   A K + K+ ++  ++V     E  ++   + HP +  
Sbjct: 1   KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTA 59

Query: 106 LKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHR 165
           LK  ++  D +  +ME   GGELF  L +   F+E  AR     ++  + Y H   VV+R
Sbjct: 60  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 119

Query: 166 DLKPENILLATKSSSSPIKLADFGLATY-IKAGQNLHGTVGSPFYIAPEVLA-GGYNQAA 223
           D+K EN++L        IK+ DFGL    I  G  +    G+P Y+APEVL    Y +A 
Sbjct: 120 DIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAV 176

Query: 224 DVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRV 283
           D W  GV++Y ++ G  PF+ +   ++F+ +   ++RFP      +S  A+ L+ G+L+ 
Sbjct: 177 DWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT----LSPEAKSLLAGLLKK 232

Query: 284 DPSTRL-----TAAEVLAHSW 299
           DP  RL      A EV+ H +
Sbjct: 233 DPKQRLGGGPSDAKEVMEHRF 253

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  137 bits (346), Expect = 1e-37
 Identities = 86/259 (33%), Positives = 136/259 (52%), Gaps = 14/259 (5%)

Query: 48  LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLK 107
           LG G FG +  C  K TG++ ACK + K RL   +  +    E +I+ K+S    +V L 
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSS-RFIVSLA 59

Query: 108 AVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS---YCHGNGVVH 164
             +E +D + L+M L  GG+L + +   G     EAR IF +  Q++    + H   +V+
Sbjct: 60  YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIF-YAAQIICGLEHLHQRRIVY 118

Query: 165 RDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGG-YNQAA 223
           RDLKPEN+LL        ++++D GLA  +K G+ + G  G+P Y+APEVL G  Y+ + 
Sbjct: 119 RDLKPENVLL---DDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSV 175

Query: 224 DVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRV 283
           D ++ G  LY +++G  PF  + +    + ++   L    +  D  S  A+DL   +L+ 
Sbjct: 176 DWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQK 235

Query: 284 DPSTRL-----TAAEVLAH 297
           DP  RL     +A EV  H
Sbjct: 236 DPEKRLGCRGGSADEVREH 254

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score =  137 bits (348), Expect = 2e-37
 Identities = 82/253 (32%), Positives = 131/253 (51%), Gaps = 15/253 (5%)

Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           K +G G FG +     K  G+  A K + K  ++  ++ + I  E  ++ K   HP +V 
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 106 LKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHR 165
           L   ++  D ++ +++   GGELF  L++   F E  AR     +   + Y H   +++R
Sbjct: 61  LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120

Query: 166 DLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTV----GSPFYIAPEVL-AGGYN 220
           DLKPENILL ++     + L DFGL    K G     T     G+P Y+APEVL    Y+
Sbjct: 121 DLKPENILLDSQGH---VVLTDFGLC---KEGIEHSKTTSTFCGTPEYLAPEVLRKQPYD 174

Query: 221 QAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGM 280
           +  D W  G +LY +L G+PPF+ +  ++++D +    LR   +    IS SAR L+ G+
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPN----ISVSARHLLEGL 230

Query: 281 LRVDPSTRLTAAE 293
           L+ D + RL A +
Sbjct: 231 LQKDRTKRLGAKD 243

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score =  136 bits (344), Expect = 5e-37
 Identities = 89/269 (33%), Positives = 136/269 (50%), Gaps = 25/269 (9%)

Query: 51  GQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVY 110
           G +G +     K T +  A K I K  L+    ++ + +E +I+T  + +P VV +   +
Sbjct: 12  GAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILT-FAENPFVVSMFCSF 70

Query: 111 EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPE 170
           E + ++ ++ME   GG+    L+  G      AR+ F   +  + Y H  G+VHRDLKP+
Sbjct: 71  ETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPD 130

Query: 171 NILLATKSSSSPIKLADFGL--------ATYIKAGQNLHGT--------VGSPFYIAPEV 214
           N+L+   +S   IKL DFGL         T +  G     T         G+P YIAPEV
Sbjct: 131 NLLI---TSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEV 187

Query: 215 -LAGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASA 273
            L  GY +  D W+ G+ILY  L G  PF+G T  ++F  V + D+ +P +  + + A A
Sbjct: 188 ILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP-EGDEALPADA 246

Query: 274 RDLIMGMLRVDPSTRL---TAAEVLAHSW 299
           +DLI  +LR +P  RL    A EV  H +
Sbjct: 247 QDLISRLLRQNPLERLGTGGAFEVKQHRF 275

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score =  136 bits (343), Expect = 1e-36
 Identities = 85/262 (32%), Positives = 136/262 (51%), Gaps = 15/262 (5%)

Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           K LG G FG +    +K +G+  A K + K+ ++  ++V     E  ++ K + HP +  
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVL-KNTRHPFLTS 59

Query: 106 LKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHR 165
           LK  ++ +D +  +ME   GGELF  L +   FSE   R     ++  + Y H   +V+R
Sbjct: 60  LKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYR 119

Query: 166 DLKPENILLATKSSSSPIKLADFGLATY-IKAGQNLHGTVGSPFYIAPEVLA-GGYNQAA 223
           DLK EN++L        IK+ DFGL    I     +    G+P Y+APEVL    Y +A 
Sbjct: 120 DLKLENLML---DKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAV 176

Query: 224 DVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRV 283
           D W  GV++Y ++ G  PF+ +   K+F+ +   D++FP      +SA A+ L+ G+L  
Sbjct: 177 DWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRT----LSADAKSLLSGLLIK 232

Query: 284 DPSTRL-----TAAEVLAHSWM 300
           DP+ RL      A E++ HS+ 
Sbjct: 233 DPNKRLGGGPDDAKEIMRHSFF 254

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  134 bits (338), Expect = 1e-36
 Identities = 86/270 (31%), Positives = 136/270 (50%), Gaps = 27/270 (10%)

Query: 45  GKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVED---VRSIKLEIEIMTKLSGHP 101
           G+QLG G F    +  D  TG ++A K +   R  + E    V +++ EI +M +L+ HP
Sbjct: 5   GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN-HP 63

Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
           +++ +     E+ + +L +E  AGG + H L KYG F E         L++ +SY H N 
Sbjct: 64  HIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ 123

Query: 162 VVHRDLKPENILLATKSSSSPIKLADFG----LATYIKAGQNLHGT-VGSPFYIAPEVLA 216
           ++HRD+K  N+L+   S+   +++ADFG    LA          G  +G+  ++APEVL 
Sbjct: 124 IIHRDVKGANLLI--DSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLR 181

Query: 217 G-GYNQAADVWSAGVILYILLSGMPPFWGKTKS--------KIFDAVRAADLRFPSDPWD 267
           G  Y ++ DVWS G ++  + +  PP W   K         KI  A  A     PS P +
Sbjct: 182 GEQYGRSCDVWSVGCVIIEMATAKPP-WNAEKHSNHLALIFKIASATTA-----PSIP-E 234

Query: 268 HISASARDLIMGMLRVDPSTRLTAAEVLAH 297
           H+S   RD+ +  L + P  R  + E+L H
Sbjct: 235 HLSPGLRDVTLRCLELQPEDRPPSRELLKH 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score =  135 bits (342), Expect = 2e-36
 Identities = 90/271 (33%), Positives = 139/271 (51%), Gaps = 23/271 (8%)

Query: 48  LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLK 107
           +G G FG ++   +K TG++ A K + K  L+  E V   + E +I++ +S  P +  L+
Sbjct: 9   VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILS-ISNSPWIPQLQ 67

Query: 108 AVYEEEDYVHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRD 166
             ++++D ++L+ME   GG+L   L +Y  +F E  A+     L+  +   H  G VHRD
Sbjct: 68  YAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRD 127

Query: 167 LKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT--VGSPFYIAPEVLA-------G 217
           +KPEN+L+     +  IKLADFG A  + A + ++    VG+P YIAPEVL        G
Sbjct: 128 IKPENVLI---DRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKG 184

Query: 218 GYNQAADVWSAGVILYILLSGMPPFW----GKTKSKIFDAVRAADLRFPSDPWDHISASA 273
            Y    D WS GVI Y ++ G  PF      KT + I +  R   L+FP DP   +S+  
Sbjct: 185 TYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRF--LKFPEDP--KVSSDF 240

Query: 274 RDLIMGMLRVDPSTRLTAAEVLAHSWMEECE 304
            DLI  +L      RL    +  H +  + +
Sbjct: 241 LDLIQSLL-CGQKERLGYEGLCCHPFFSKID 270

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  133 bits (336), Expect = 2e-36
 Identities = 89/269 (33%), Positives = 144/269 (53%), Gaps = 22/269 (8%)

Query: 45  GKQLGWGQFGVIRECSDKFTGEVLACKSIA--KDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
           GK LG G FG +  C D  TG  LA K +    +   T ++V +++ EI+++  L  H  
Sbjct: 7   GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ-HER 65

Query: 103 VVDLKAVYEE--EDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGN 160
           +V       +  E  + + ME   GG +  +L+ YG  +E+  R   R +++ +SY H N
Sbjct: 66  IVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSN 125

Query: 161 GVVHRDLKPENILLATKSSSSPIKLADFG----LATYIKAGQNLHGTVGSPFYIAPEVLA 216
            +VHRD+K  NIL   + S+  +KL DFG    L T   +G  +    G+P++++PEV++
Sbjct: 126 MIVHRDIKGANIL---RDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS 182

Query: 217 G-GYNQAADVWSAGVILYILLSGMPPFWGKTK--SKIFD-AVRAADLRFPSDPWDHISAS 272
           G GY + ADVWS G  +  +L+  PP W + +  + IF  A +  + + PS    HIS  
Sbjct: 183 GEGYGRKADVWSLGCTVVEMLTEKPP-WAEYEAMAAIFKIATQPTNPQLPS----HISEH 237

Query: 273 ARDLIMGMLRVDPSTRLTAAEVLAHSWME 301
           ARD + G + V+   R +A E+L H + +
Sbjct: 238 ARDFL-GCIFVEARHRPSAEELLRHPFAQ 265

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  132 bits (333), Expect = 8e-36
 Identities = 78/265 (29%), Positives = 122/265 (46%), Gaps = 31/265 (11%)

Query: 48  LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLK 107
           LG G +G + +   K TG+V+A K +  +     ED++ I  EI I+ K    P +V   
Sbjct: 11  LGEGSYGSVYKAIHKETGQVVAIKVVPVE-----EDLQEIIKEISIL-KQCDSPYIVKYY 64

Query: 108 AVYEEEDYVHLLMELCAGGELFHRLEKYGR-FSETEARVIFRHLMQVVSYCHGNGVVHRD 166
             Y +   + ++ME C  G +   ++   +  +E E   I    ++ + Y H N  +HRD
Sbjct: 65  GSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRD 124

Query: 167 LKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTV-GSPFYIAPEVLAG-GYNQAAD 224
           +K  NILL  +      KLADFG++  +        TV G+PF++APEV+   GYN  AD
Sbjct: 125 IKAGNILLNEEGQ---AKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKAD 181

Query: 225 VWSAGVILYILLSGMPPFWGKTKSKIFDAVRA---------ADLRFPSDPWDHISASARD 275
           +WS G+    +  G PP+           +RA           L  P   W   S    D
Sbjct: 182 IWSLGITAIEMAEGKPPYSD------IHPMRAIFMIPNKPPPTLSDPEK-W---SPEFND 231

Query: 276 LIMGMLRVDPSTRLTAAEVLAHSWM 300
            +   L  DP  R +A ++L H ++
Sbjct: 232 FVKKCLVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score =  133 bits (336), Expect = 9e-36
 Identities = 83/253 (32%), Positives = 137/253 (54%), Gaps = 14/253 (5%)

Query: 46  KQLGWGQFG---VIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
           K LG G FG   ++R+ +    G++ A K + K  L   + VR+ K+E +I+ ++  HP 
Sbjct: 2   KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRT-KMERDILAEV-NHPF 59

Query: 103 VVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGV 162
           +V L   ++ E  ++L+++   GG+LF RL K   F+E + +     L   + + H  G+
Sbjct: 60  IVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGI 119

Query: 163 VHRDLKPENILLATKSSSSPIKLADFGLAT-YIKAGQNLHGTVGSPFYIAPEVL-AGGYN 220
           ++RDLKPENILL        IKL DFGL+   I   +  +   G+  Y+APEV+   G+ 
Sbjct: 120 IYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHT 176

Query: 221 QAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGM 280
           Q+AD WS GV+++ +L+G  PF GK + +    +  A L  P      +S  A+ L+  +
Sbjct: 177 QSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMP----QFLSPEAQSLLRAL 232

Query: 281 LRVDPSTRLTAAE 293
            + +P+ RL A  
Sbjct: 233 FKRNPANRLGAGP 245

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  132 bits (333), Expect = 9e-36
 Identities = 82/275 (29%), Positives = 125/275 (45%), Gaps = 26/275 (9%)

Query: 40  DRYVLGKQLGWGQFGVIR--ECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKL 97
           D Y L + +G G   V+    C      E +A K I  ++  T   V  ++ E++ M+  
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPN--NEKVAIKRIDLEKCQT--SVDELRKEVQAMS-Q 55

Query: 98  SGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLE---KYGRFSETEARVIFRHLMQVV 154
             HPNVV     +   D + L+M   +GG L   ++     G   E     + + +++ +
Sbjct: 56  CNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGL 115

Query: 155 SYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI-KAGQNLHGT----VGSPFY 209
            Y H NG +HRD+K  NILL    S   +K+ADFG++  +   G          VG+P +
Sbjct: 116 EYLHSNGQIHRDIKAGNILLGEDGS---VKIADFGVSASLADGGDRTRKVRKTFVGTPCW 172

Query: 210 IAPEVLA--GGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWD 267
           +APEV+    GY+  AD+WS G+    L +G  P+      K+       D   PS    
Sbjct: 173 MAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQND--PPSLETG 230

Query: 268 ----HISASARDLIMGMLRVDPSTRLTAAEVLAHS 298
                 S S R +I   L+ DPS R TA E+L H 
Sbjct: 231 ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHK 265

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  132 bits (334), Expect = 1e-35
 Identities = 94/302 (31%), Positives = 147/302 (48%), Gaps = 57/302 (18%)

Query: 40  DRY-VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVED---VRSIKL-EIEIM 94
           ++Y  L K +G G +GV+ +C ++ TG+++A K     + V  ED   ++ I L EI  M
Sbjct: 1   EKYEKLSK-IGEGSYGVVFKCRNRETGQIVAIK-----KFVESEDDPVIKKIALREIR-M 53

Query: 95  TKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGR-FSETEARVIFRHLMQV 153
            K   HPN+V+L  V+  +  +HL+ E C    + + LEK  R   E   + I    +Q 
Sbjct: 54  LKQLKHPNLVNLIEVFRRKRKLHLVFEYC-DHTVLNELEKNPRGVPEHLIKKIIWQTLQA 112

Query: 154 VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA-GQNLHGTVGSPFYIAP 212
           V++CH +  +HRD+KPENIL+ TK     IKL DFG A  +   G +    V + +Y AP
Sbjct: 113 VNFCHKHNCIHRDVKPENILI-TKQGQ--IKLCDFGFARILTGPGDDYTDYVATRWYRAP 169

Query: 213 EVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTK------------------SKIF- 251
           E+L G   Y    DVW+ G +   LL+G P + GK+                    +IF 
Sbjct: 170 ELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFS 229

Query: 252 -------------DAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHS 298
                        +     + +FP     +IS+ A   + G L++DP+ RL+  E+L H 
Sbjct: 230 TNQFFKGLSIPEPETREPLESKFP-----NISSPALSFLKGCLQMDPTERLSCEELLEHP 284

Query: 299 WM 300
           + 
Sbjct: 285 YF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score =  133 bits (336), Expect = 1e-35
 Identities = 84/250 (33%), Positives = 134/250 (53%), Gaps = 12/250 (4%)

Query: 48  LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLS--GHPNVVD 105
           LG G FG +     K TGE+ A K++ K  ++  ++V S+  E  I    +   HP +V+
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66

Query: 106 LKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHR 165
           L A ++ ED+V  +ME  AGG+L   +     FSE  A      ++  + Y H N +V+R
Sbjct: 67  LFACFQTEDHVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYR 125

Query: 166 DLKPENILLATKSSSSPIKLADFGLATY-IKAGQNLHGTVGSPFYIAPEVLAG-GYNQAA 223
           DLK +N+LL T+     +K+ADFGL    +  G       G+P ++APEVL    Y +A 
Sbjct: 126 DLKLDNLLLDTEGF---VKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAV 182

Query: 224 DVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRV 283
           D W  GV++Y +L G  PF G  + ++FD++   ++R+P      +S  A  ++  +LR 
Sbjct: 183 DWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPR----FLSREAISIMRRLLRR 238

Query: 284 DPSTRLTAAE 293
           +P  RL + E
Sbjct: 239 NPERRLGSGE 248

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  131 bits (332), Expect = 2e-35
 Identities = 84/275 (30%), Positives = 140/275 (50%), Gaps = 29/275 (10%)

Query: 46  KQLGWGQFG---VIRECSDKFTGEVLACKSIAKDRLV----TVEDVRSIKLEIEIMTKLS 98
           + LG G +G   ++R+      G++ A K + K  +V    T E  R+   E +++  + 
Sbjct: 6   RVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRT---ERQVLEAVR 62

Query: 99  GHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCH 158
             P +V L   ++ +  +HL+++   GGELF  L +   F+E+E RV    ++  + + H
Sbjct: 63  RCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLH 122

Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ--NLHGTVGSPFYIAPEVLA 216
             G+++RD+K ENILL    S   + L DFGL+    A +    +   G+  Y+APEV+ 
Sbjct: 123 QLGIIYRDIKLENILL---DSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIR 179

Query: 217 G---GYNQAADVWSAGVILYILLSGMPPFW----GKTKSKIFDAVRAADLRFPSDPWDHI 269
           G   G+++A D WS GV+ + LL+G  PF       ++S+I   +  +   FP      +
Sbjct: 180 GGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKT----M 235

Query: 270 SASARDLIMGMLRVDPSTRL---TAAEVLAHSWME 301
           SA ARD I  +L  DP  RL    A E+  H + +
Sbjct: 236 SAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQ 270

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score =  133 bits (335), Expect = 2e-35
 Identities = 81/249 (32%), Positives = 129/249 (51%), Gaps = 11/249 (4%)

Query: 48  LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM--TKLSGHPNVVD 105
           +G G FG + +   K T  + A K ++K  +V  ++V     E  I+  T L   P +V 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 106 LKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHR 165
           LK  ++ +  ++L+ +  +GGELF  L+K GRFSE  A+     L+  + + H   +V+R
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120

Query: 166 DLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT-VGSPFYIAPEVL--AGGYNQA 222
           DLKPENILL    ++  I L DFGL+           T  G+  Y+APEVL    GY + 
Sbjct: 121 DLKPENILL---DATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKH 177

Query: 223 ADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLR 282
            D WS GV+++ +  G  PF+ +   +++  +    +RFP +    +S   R  + G+L 
Sbjct: 178 VDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNV---LSDEGRQFVKGLLN 234

Query: 283 VDPSTRLTA 291
            +P  RL A
Sbjct: 235 RNPQHRLGA 243

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  132 bits (335), Expect = 2e-35
 Identities = 90/304 (29%), Positives = 144/304 (47%), Gaps = 50/304 (16%)

Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAK--DRLVTVEDVRSIKLEIEIMTKLS 98
           RY L K +G G +GV+    DK TG  +A K I+   D L+   D + I  EI+++  L 
Sbjct: 1   RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLI---DAKRILREIKLLRHL- 56

Query: 99  GHPNVVDLKAV-----YEEEDYVHLLMELCAGGELFHRLEKYGRF-SETEARVIFRHLMQ 152
            H N++ L  +      E+ + V+++ EL    +L H++ K  +  ++   +     +++
Sbjct: 57  RHENIIGLLDILRPPSPEDFNDVYIVTEL-METDL-HKVIKSPQPLTDDHIQYFLYQILR 114

Query: 153 VVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA----TYIKAGQNLHGTVGSPF 208
            + Y H   V+HRDLKP NIL+   +S+  +K+ DFGLA            L   V + +
Sbjct: 115 GLKYLHSANVIHRDLKPSNILV---NSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRW 171

Query: 209 YIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAV---RAADL 259
           Y APE+L  +  Y +A D+WS G I   LL+  P F G+      + I + +      DL
Sbjct: 172 YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDL 231

Query: 260 RFPSD----------------PWDHI----SASARDLIMGMLRVDPSTRLTAAEVLAHSW 299
           +F +                 P   +    S  A DL+  ML  DP  R+TA E LAH +
Sbjct: 232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPY 291

Query: 300 MEEC 303
           + + 
Sbjct: 292 LAQL 295

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score =  131 bits (332), Expect = 4e-35
 Identities = 77/266 (28%), Positives = 131/266 (49%), Gaps = 16/266 (6%)

Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           K LG G FG +     K T EV A K + KD ++  +DV     E  I+   + HP +  
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60

Query: 106 LKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHR 165
           L   ++ +D +  +ME   GG+L  ++++  +F E  +R     +   + + H +GV++R
Sbjct: 61  LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYR 120

Query: 166 DLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT-VGSPFYIAPEVLAG-GYNQAA 223
           DLK +NILL    +    KLADFG+            T  G+P YIAPE+L    Y  + 
Sbjct: 121 DLKLDNILL---DAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSV 177

Query: 224 DVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRV 283
           D W+ GV++Y +++G PPF    +  +F+++   D+ +P   W  +S  A  ++   +  
Sbjct: 178 DWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPV--W--LSKEAVSILKAFMTK 233

Query: 284 DPSTRL-------TAAEVLAHSWMEE 302
           +P+ RL           +  H + +E
Sbjct: 234 NPNKRLGCVASQGGEDAIKQHPFFKE 259

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  130 bits (328), Expect = 5e-35
 Identities = 83/275 (30%), Positives = 132/275 (48%), Gaps = 34/275 (12%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           + Y L +++G G +G + +  D  TGE++A K I    L   +D   I+ EI ++ K   
Sbjct: 3   EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIK---LEPGDDFEIIQQEISML-KECR 58

Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGG---ELFHRLEKYGRFSETEARVIFRHLMQVVSY 156
           HPN+V     Y   D + ++ME C GG   +++      G  SE +   + R  ++ ++Y
Sbjct: 59  HPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAY 116

Query: 157 CHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT-VGSPFYIAPEVL 215
            H  G +HRD+K  NILL   +    +KLADFG++  + A      + +G+P+++APEV 
Sbjct: 117 LHETGKIHRDIKGANILL---TEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVA 173

Query: 216 A----GGYNQAADVWSAGVILYILLSGMPPFWG---------KTKSKIFDAVRAADLRFP 262
           A    GGY+   D+W+ G+    L    PP +           +KS  F   +  D    
Sbjct: 174 AVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSN-FPPPKLKD---- 228

Query: 263 SDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH 297
            + W   S    D I   L  DP  R TA ++L H
Sbjct: 229 KEKW---SPVFHDFIKKCLTKDPKKRPTATKLLQH 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score =  131 bits (331), Expect = 6e-35
 Identities = 87/278 (31%), Positives = 140/278 (50%), Gaps = 13/278 (4%)

Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           K +G G FG +     K   +  A K + K  ++  ++ + I  E  ++ K   HP +V 
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60

Query: 106 LKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHR 165
           L   ++  D ++ +++   GGELF+ L++   F E  AR     +   + Y H   +V+R
Sbjct: 61  LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120

Query: 166 DLKPENILLATKSSSSPIKLADFGLATY-IKAGQNLHGTVGSPFYIAPEVL-AGGYNQAA 223
           DLKPENILL    S   I L DFGL    I+         G+P Y+APEVL    Y++  
Sbjct: 121 DLKPENILL---DSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTV 177

Query: 224 DVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRV 283
           D W  G +LY +L G+PPF+ +  ++++D +    L+   +    I+ SAR L+ G+L+ 
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPN----ITNSARHLLEGLLQK 233

Query: 284 DPSTRLTAAEVLAHSWMEECEQVAQKPCKQDDLCCKQL 321
           D + RL A +     +ME    +   P   DDL  K++
Sbjct: 234 DRTKRLGAKD----DFMEIKNHIFFSPINWDDLINKKI 267

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score =  131 bits (330), Expect = 7e-35
 Identities = 76/246 (30%), Positives = 128/246 (52%), Gaps = 9/246 (3%)

Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           K LG G FG +     K  GE  A K++ KD ++  +DV    +E  ++     +P +  
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 106 LKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHR 165
           L   ++ ++++  +ME   GG+L   ++  GRF    A      ++  + + H  G+++R
Sbjct: 61  LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYR 120

Query: 166 DLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT-VGSPFYIAPEVLAG-GYNQAA 223
           DLK +N++L        IK+ADFG+      G N   T  G+P YIAPE+L G  Y  + 
Sbjct: 121 DLKLDNVML---DRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSV 177

Query: 224 DVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRV 283
           D WS GV+LY +L G  PF G  + ++F+++R     +P   W  I+  ++D++  +   
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPR--W--ITKESKDILEKLFER 233

Query: 284 DPSTRL 289
           DP+ RL
Sbjct: 234 DPTRRL 239

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score =  129 bits (325), Expect = 9e-35
 Identities = 87/271 (32%), Positives = 142/271 (52%), Gaps = 26/271 (9%)

Query: 44  LGKQLGWGQFGVIRECSDKFTGEVLACKSIA--KDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           LGK LG G FG +  C D  TG  LA K +    +   T ++V +++ EI+++  L  H 
Sbjct: 6   LGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL-HE 64

Query: 102 NVVDLKAVYEE--EDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
            +V       +  E  + + ME   GG +  +L+ YG  +E   R   R +++ VSY H 
Sbjct: 65  RIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHS 124

Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFG----LATYIKAGQNLHGTVGSPFYIAPEVL 215
           N +VHRD+K  NIL   + S   +KL DFG    L T   +G  +    G+P++++PEV+
Sbjct: 125 NMIVHRDIKGANIL---RDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI 181

Query: 216 AG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWD-----HI 269
           +G GY + AD+WS G  +  +L+  PP W +     F+A+ AA  +  + P +     H+
Sbjct: 182 SGEGYGRKADIWSVGCTVVEMLTEKPP-WAE-----FEAM-AAIFKIATQPTNPVLPPHV 234

Query: 270 SASARDLIMGMLRVDPSTRLTAAEVLAHSWM 300
           S   RD +  +  V+   R +A E+L H+++
Sbjct: 235 SDHCRDFLKRIF-VEAKLRPSADELLRHTFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  128 bits (324), Expect = 2e-34
 Identities = 85/267 (31%), Positives = 135/267 (50%), Gaps = 22/267 (8%)

Query: 47  QLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDL 106
           +LG G FG + +   K TG   A K I  +    +ED     +EI+I+++   HPN+V L
Sbjct: 12  ELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELED---FMVEIDILSECK-HPNIVGL 67

Query: 107 KAVYEEEDYVHLLMELCAGGELFHRLEKYGR-FSETEARVIFRHLMQVVSYCHGNGVVHR 165
              Y  E+ + +L+E C GG L   + +  R  +E + R + R +++ +++ H + V+HR
Sbjct: 68  YEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHR 127

Query: 166 DLKPENILLATKSSSSPIKLADFGL-ATYIKAGQNLHGTVGSPFYIAPEVLA------GG 218
           DLK  NILL        +KLADFG+ A      Q     +G+P+++APEV+A        
Sbjct: 128 DLKAGNILLT---LDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNP 184

Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAAD---LRFPSDPWDHISASARD 275
           Y+  AD+WS G+ L  L    PP       ++   +  ++   L  PS      S+S  D
Sbjct: 185 YDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPS----KWSSSFND 240

Query: 276 LIMGMLRVDPSTRLTAAEVLAHSWMEE 302
            +   L  DP  R TAAE+L H ++ +
Sbjct: 241 FLKSCLVKDPDDRPTAAELLKHPFVSD 267

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score =  128 bits (324), Expect = 4e-34
 Identities = 79/263 (30%), Positives = 132/263 (50%), Gaps = 15/263 (5%)

Query: 48  LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLK 107
           LG G FG +     K +G + A K + KD ++  +DV     E  I++    HP +  L 
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62

Query: 108 AVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDL 167
             ++  D +  +ME   GG+L   ++K  RF E  AR     +   + + H  G+++RDL
Sbjct: 63  CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDL 122

Query: 168 KPENILLATKSSSSPIKLADFGLATY-IKAGQNLHGTVGSPFYIAPEVLAGG-YNQAADV 225
           K +N+LL  +      KLADFG+    I  G+      G+P YIAPE+L    Y  + D 
Sbjct: 123 KLDNVLLDHEGHC---KLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDW 179

Query: 226 WSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDP 285
           W+ GV+LY +L G  PF  + +  +F+A+   ++ +P+  W  +S  A D++   +  +P
Sbjct: 180 WAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT--W--LSQDAVDILKAFMTKNP 235

Query: 286 STRLTAAE------VLAHSWMEE 302
           + RL +        +L H + +E
Sbjct: 236 TMRLGSLTLGGEEAILRHPFFKE 258

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  127 bits (319), Expect = 8e-34
 Identities = 87/266 (32%), Positives = 137/266 (51%), Gaps = 22/266 (8%)

Query: 44  LGKQLGWGQFGVIRECSDKFTGEVLACKSIA--KDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           LGK LG G FG +  C D  TG  LA K +    D   T ++V +++ EI+++ K   H 
Sbjct: 6   LGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLL-KNLRHD 64

Query: 102 NVVDLKAVYE--EEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
            +V         EE  + + +E   GG +  +L+ YG  +E   R   R ++Q VSY H 
Sbjct: 65  RIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHS 124

Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIK----AGQNLHGTVGSPFYIAPEVL 215
           N +VHRD+K  NIL   + S+  +KL DFG +  I+    +G  +    G+P++++PEV+
Sbjct: 125 NMIVHRDIKGANIL---RDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVI 181

Query: 216 AG-GYNQAADVWSAGVILYILLSGMPPFWGKTK--SKIFD-AVRAADLRFPSDPWDHISA 271
           +G GY + ADVWS    +  +L+  PP W + +  + IF  A +      P    D +S 
Sbjct: 182 SGEGYGRKADVWSVACTVVEMLTEKPP-WAEYEAMAAIFKIATQPTKPMLP----DGVSD 236

Query: 272 SARDLIMGMLRVDPSTRLTAAEVLAH 297
           + RD  +  + V+   R TA  +L H
Sbjct: 237 ACRDF-LKQIFVEEKRRPTAEFLLRH 261

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  127 bits (322), Expect = 9e-34
 Identities = 86/290 (29%), Positives = 138/290 (47%), Gaps = 44/290 (15%)

Query: 48  LGWGQFGVIRECSDKFTGEVLACKSIAKDRL---VTVEDVRSIKLEIEIMTKLSGHPNVV 104
           +G G +G++    D  +GE++A K +  D     + +  +R    EI ++  L  HPN+V
Sbjct: 15  IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR----EITLLLNLR-HPNIV 69

Query: 105 DLKAVY--EEEDYVHLLMELCAGGELFHRLEKYGR-FSETEARVIFRHLMQVVSYCHGNG 161
           +LK V   +  D + L+ME C   +L   L+     FSE++ + +   L++ + Y H N 
Sbjct: 70  ELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF 128

Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLA-TYIKAGQNLHGTVGSPFYIAPEVLAGG-- 218
           ++HRDLK  N+LL  K     +K+ADFGLA TY    + +   V + +Y APE+L G   
Sbjct: 129 IIHRDLKVSNLLLTDKGC---LKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTT 185

Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTK---------------SKIFDAVR----AADL 259
           Y  A D+W+ G IL  LL+  P   GK++                 I+            
Sbjct: 186 YTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKF 245

Query: 260 RFPSDPWDH-------ISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
             P  P+++       +S +   L+  +L  DP  R TA E L  S+ +E
Sbjct: 246 TLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKE 295

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score =  127 bits (322), Expect = 1e-33
 Identities = 75/249 (30%), Positives = 132/249 (53%), Gaps = 13/249 (5%)

Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
           VLGK    G FG +     K T E+ A K + KD ++  +DV    +E  ++      P 
Sbjct: 7   VLGK----GSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPF 62

Query: 103 VVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGV 162
           +  L + ++  D ++ +ME   GG+L + +++ G+F E  A      +   + + H  G+
Sbjct: 63  LTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGI 122

Query: 163 VHRDLKPENILLATKSSSSPIKLADFGLAT-YIKAGQNLHGTVGSPFYIAPEVLA-GGYN 220
           ++RDLK +N++L    +   IK+ADFG+    I  G+      G+P YIAPE++A   Y 
Sbjct: 123 IYRDLKLDNVML---DAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYG 179

Query: 221 QAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGM 280
           ++ D W+ GV+LY +L+G PPF G+ + ++F ++   ++ +P      +S  A  +  G+
Sbjct: 180 KSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKS----LSKEAVSICKGL 235

Query: 281 LRVDPSTRL 289
           L   P+ RL
Sbjct: 236 LTKHPAKRL 244

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  126 bits (317), Expect = 2e-33
 Identities = 75/281 (26%), Positives = 137/281 (48%), Gaps = 31/281 (11%)

Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVED-------VRSIKLEIEI 93
           ++V G+ +G G +G +    +  TGE++A K +     +           V++++ EIE 
Sbjct: 2   KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIET 61

Query: 94  MTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQV 153
           +  L  H N+V        E+Y+ + +E   GG +   L  YGRF E   R     +++ 
Sbjct: 62  LKDLD-HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEG 120

Query: 154 VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTV------GSP 207
           ++Y H  G++HRDLK +N+L+         K++DFG++   K   +++         GS 
Sbjct: 121 LAYLHSKGILHRDLKADNLLVDADGIC---KISDFGIS---KKSDDIYDNDQNMSMQGSV 174

Query: 208 FYIAPEVL---AGGYNQAADVWSAGVILYILLSGMPPFWGKTKS-----KIFDAVRAADL 259
           F++APEV+   + GY+   D+WS G ++  + +G  P W   ++     K+ +   A  +
Sbjct: 175 FWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP-WSDEEAIAAMFKLGNKRSAPPI 233

Query: 260 RFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWM 300
             P D   ++S  A D +     ++P  R TA E+L H ++
Sbjct: 234 --PPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score =  127 bits (320), Expect = 2e-33
 Identities = 77/246 (31%), Positives = 128/246 (52%), Gaps = 9/246 (3%)

Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           K LG G FG +     K T +  A K++ KD ++  +DV    +E  +++    HP +  
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 106 LKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHR 165
           L   ++ ++ +  +ME   GG+L   ++   +F    A      ++  + + H  G+V+R
Sbjct: 61  LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYR 120

Query: 166 DLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT-VGSPFYIAPEVLAG-GYNQAA 223
           DLK +NILL T      IK+ADFG+      G     T  G+P YIAPE+L G  YN + 
Sbjct: 121 DLKLDNILLDTDGH---IKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSV 177

Query: 224 DVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRV 283
           D WS GV+LY +L G  PF G  + ++F ++R  +  +P   W  ++  A+D+++ +   
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPR--W--LTREAKDILVKLFVR 233

Query: 284 DPSTRL 289
           +P  RL
Sbjct: 234 EPERRL 239

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  128 bits (323), Expect = 2e-33
 Identities = 93/308 (30%), Positives = 138/308 (44%), Gaps = 61/308 (19%)

Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           K +G G FG +R    K TG++ A K++ K  +   + +  +K E +++ + S  P VV 
Sbjct: 7   KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAE-SDSPWVVS 65

Query: 106 LKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHR 165
           L   +++  Y++L+ME   GG+L   L KY  FSE   R      +  +   H  G +HR
Sbjct: 66  LYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHR 125

Query: 166 DLKPENILLATKSSSSPIKLADFGLAT----------YIKAGQ----------------- 198
           D+KP+NIL+        IKL+DFGL+T          Y K  Q                 
Sbjct: 126 DIKPDNILIDRGGH---IKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVD 182

Query: 199 --NL-------------------HGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILL 236
             NL                   + TVG+P YIAPE+    GY Q  D WS G I++  L
Sbjct: 183 SINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECL 242

Query: 237 SGMPPFWGKTKSKIFDAVRA--ADLRFPSDPWDHISASARDLIMGMLRVDPSTRL---TA 291
            G PPF  +   + +  +      L FP D   H+S  A DLI  ++  +   RL    A
Sbjct: 243 IGWPPFCSENSHETYRKIINWRETLYFPDDI--HLSVEAEDLIRRLI-TNAENRLGRGGA 299

Query: 292 AEVLAHSW 299
            E+ +H +
Sbjct: 300 HEIKSHPF 307

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score =  127 bits (319), Expect = 2e-33
 Identities = 87/281 (30%), Positives = 136/281 (48%), Gaps = 19/281 (6%)

Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           K +G G FG +     K  G   A K + K  ++  ++   I  E  ++ K   HP +V 
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60

Query: 106 LKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHR 165
           L   ++  + ++ +++   GGELF  L++   F E  AR     +   + Y H   +++R
Sbjct: 61  LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120

Query: 166 DLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTV----GSPFYIAPEVLAGG-YN 220
           DLKPENILL    S   + L DFGL    K G     T     G+P Y+APEVL    Y+
Sbjct: 121 DLKPENILL---DSQGHVVLTDFGLC---KEGVEPEETTSTFCGTPEYLAPEVLRKEPYD 174

Query: 221 QAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGM 280
           +  D W  G +LY +L G+PPF+ +  S+++D +    L+ P       + +A DL++G+
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGK----TVAACDLLVGL 230

Query: 281 LRVDPSTRLTAAEVLAHSWMEECEQVAQKPCKQDDLCCKQL 321
           L  D   RL A       ++E    V   P   DDL  K++
Sbjct: 231 LHKDQRRRLGAKA----DFLEIKNHVFFSPINWDDLYHKRI 267

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score =  126 bits (317), Expect = 4e-33
 Identities = 73/244 (29%), Positives = 131/244 (53%), Gaps = 9/244 (3%)

Query: 48  LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLK 107
           LG G FG +     K T E+ A K + KD ++  +DV    +E  ++      P +  L 
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67

Query: 108 AVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDL 167
           + ++  D ++ +ME   GG+L + +++ G+F E +A      +   + + H  G+++RDL
Sbjct: 68  SCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDL 127

Query: 168 KPENILLATKSSSSPIKLADFGLAT-YIKAGQNLHGTVGSPFYIAPEVLA-GGYNQAADV 225
           K +N++L    S   IK+ADFG+   ++  G       G+P YIAPE++A   Y ++ D 
Sbjct: 128 KLDNVML---DSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDW 184

Query: 226 WSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDP 285
           W+ GV+LY +L+G PPF G+ + ++F ++   ++ +P      +S  A  +  G++   P
Sbjct: 185 WAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKS----LSKEAVSICKGLMTKHP 240

Query: 286 STRL 289
           S RL
Sbjct: 241 SKRL 244

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score =  125 bits (315), Expect = 5e-33
 Identities = 84/300 (28%), Positives = 154/300 (51%), Gaps = 37/300 (12%)

Query: 42  YVLGKQLGWGQFG---VIRECSDKFTGEVLACKSIAKDRLV----TVEDVRSIKLEIEIM 94
           + L K LG G +G   ++R+ S   +G++ A K + K  +V    T E  R+   E +++
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRT---ERQVL 58

Query: 95  TKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVV 154
             +   P +V L   ++ +  +HL+++   GGELF  L +  RF E E ++    ++  +
Sbjct: 59  EHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLAL 118

Query: 155 SYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN--LHGTVGSPFYIAP 212
            + H  G+++RD+K ENILL    S+  + L DFGL+      +    +   G+  Y+AP
Sbjct: 119 EHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAP 175

Query: 213 EVLAG---GYNQAADVWSAGVILYILLSGMPPFW----GKTKSKIFDAVRAADLRFPSDP 265
           +++ G   G+++A D WS GV++Y LL+G  PF       ++++I   +  ++  +P + 
Sbjct: 176 DIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE- 234

Query: 266 WDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKPCKQ----DDLCCKQL 321
              +SA A+D+I  +L  DP  RL            + +++ + P  Q    DDL  K++
Sbjct: 235 ---MSALAKDIIQRLLMKDPKKRLGCGP-------SDADEIKKHPFFQKINWDDLAAKKV 284

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  124 bits (314), Expect = 5e-33
 Identities = 76/271 (28%), Positives = 134/271 (49%), Gaps = 28/271 (10%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSI-------AKDRLVTVEDVRSIKLEIE 92
             + + K++G GQF V+ +      G V+A K +       AK R         +K EI+
Sbjct: 2   GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKAR------QDCLK-EID 54

Query: 93  IMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSET-EARVIFRHLM 151
           ++ +L  HPNV+   A + E + +++++EL   G+L   ++ + +       R I+++ +
Sbjct: 55  LLKQLD-HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFV 113

Query: 152 QVVS---YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN-LHGTVGSP 207
           Q+ S   + H   ++HRD+KP N+ +        +KL D GL  +  +     H  VG+P
Sbjct: 114 QLCSALEHMHSKRIMHRDIKPANVFITATGV---VKLGDLGLGRFFSSKTTAAHSLVGTP 170

Query: 208 FYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKS--KIFDAVRAADLRFPSD 264
           +Y++PE +   GYN  +D+WS G +LY + +   PF+G   +   +   +   D  +P  
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCD--YPPL 228

Query: 265 PWDHISASARDLIMGMLRVDPSTRLTAAEVL 295
           P DH S   RDL+   +  DP  R   + VL
Sbjct: 229 PADHYSEELRDLVSRCINPDPEKRPDISYVL 259

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  124 bits (313), Expect = 7e-33
 Identities = 79/275 (28%), Positives = 138/275 (50%), Gaps = 23/275 (8%)

Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKL------EIEIM 94
           +++ G  +G G FG +    +  +GE++A K +    +      R   +      EI ++
Sbjct: 1   KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALL 60

Query: 95  TKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVV 154
            +L  H N+V       + D++++ +E   GG +   L  YG F ET  R   R +++ +
Sbjct: 61  KELQ-HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGL 119

Query: 155 SYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA-------GQNLHGTVGSP 207
           +Y H  G++HRD+K  NIL+  K     IK++DFG++  ++A               GS 
Sbjct: 120 NYLHNRGIIHRDIKGANILVDNKGG---IKISDFGISKKLEANSLSTKTNGARPSLQGSV 176

Query: 208 FYIAPEVLA-GGYNQAADVWSAGVILYILLSGMPPFWGKTKSK-IFDAVRAADLRFPSDP 265
           F++APEV+    Y + AD+WS G ++  +L+G  PF   T+ + IF   +  +   P  P
Sbjct: 177 FWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIF---KIGENASPEIP 233

Query: 266 WDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWM 300
             +IS+ A D +     +D + R TAAE+L H ++
Sbjct: 234 -SNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  123 bits (312), Expect = 9e-33
 Identities = 63/225 (28%), Positives = 105/225 (46%), Gaps = 19/225 (8%)

Query: 43  VLGKQLGWGQFGVIREC----SDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLS 98
            LGK+LG G FG + +             +A K++ +D   + + +     E  IM KL 
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDA--SEQQIEEFLREARIMRKLD 59

Query: 99  GHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQV---VS 155
            HPNVV L  V  EE+ ++++ME   GG+L   L K          + F   +Q+   + 
Sbjct: 60  -HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSF--ALQIARGME 116

Query: 156 YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVG-SP-FYIAPE 213
           Y      +HRDL   N L+        +K++DFGL+  +          G  P  ++APE
Sbjct: 117 YLESKNFIHRDLAARNCLVGENLV---VKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPE 173

Query: 214 VL-AGGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRA 256
            L  G +   +DVWS GV+L+ + + G  P+ G +  ++ + ++ 
Sbjct: 174 SLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKN 218

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  123 bits (312), Expect = 1e-32
 Identities = 82/288 (28%), Positives = 134/288 (46%), Gaps = 40/288 (13%)

Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
           +LGK +G G F  + +   + TG+  A K + K    ++E V +++ EI+ + +LS HPN
Sbjct: 3   ILGK-IGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKSLEQVNNLR-EIQALRRLSPHPN 59

Query: 103 VVDLKAV-YEEED-YVHLLMELCAGG--ELFHRLEKYGRFSETEARVIFRHLMQVVSYCH 158
           ++ L  V ++ +   + L+ EL      EL    ++     E   +     L++ + + H
Sbjct: 60  ILRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRP--LPEKRVKSYMYQLLKSLDHMH 117

Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVL--A 216
            NG+ HRD+KPENIL+        +KLADFG    I +       + + +Y APE L   
Sbjct: 118 RNGIFHRDIKPENILIKDDI----LKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTD 173

Query: 217 GGYNQAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAV--------------RAAD 258
           G Y    D+W+ G + + +LS  P F G  +    +KI D +              R  +
Sbjct: 174 GYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN 233

Query: 259 LRFPSD-----PW--DHISASARDLIMGMLRVDPSTRLTAAEVLAHSW 299
             FPS           + SA   DL+  +L  DP  R+TA + L H +
Sbjct: 234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY 281

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score =  125 bits (315), Expect = 2e-32
 Identities = 93/309 (30%), Positives = 144/309 (46%), Gaps = 51/309 (16%)

Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           K +G G FG +R    K TG + A K + K  ++  E V  I+ E +I+ +  G   VV 
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG-AWVVK 65

Query: 106 LKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHR 165
           +   ++++  ++L+ME   GG++   L K    SE   +      +  +   H  G +HR
Sbjct: 66  MFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHR 125

Query: 166 DLKPENILLATKSSSSPIKLADFGLATYIKAG-------------------QNL------ 200
           D+KP+N+LL  K     +KL+DFGL T +K                     QN+      
Sbjct: 126 DIKPDNLLLDAKGH---VKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182

Query: 201 -----------HGTVGSPFYIAPEV-LAGGYNQAADVWSAGVILYILLSGMPPFWGKTKS 248
                      + TVG+P YIAPEV +  GYN+  D WS GVI+Y +L G PPF  +T  
Sbjct: 183 ETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQ 242

Query: 249 KIFDAVR--AADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAA---EVLAHSWME-- 301
           + +  V      L FP  P   IS  A+DLI+     D   R+ +    E+ +H + E  
Sbjct: 243 ETYRKVMNWKETLVFP--PEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGV 299

Query: 302 ECEQVAQKP 310
           +   + ++P
Sbjct: 300 DWGHIRERP 308

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score =  125 bits (316), Expect = 2e-32
 Identities = 88/306 (28%), Positives = 130/306 (42%), Gaps = 61/306 (19%)

Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           K +G G FG +       T  + A K++ K  ++       +K E +I+ + + +  VV 
Sbjct: 7   KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAE-ADNEWVVK 65

Query: 106 LKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHR 165
           L   ++++D ++ +M+   GG++   L + G F E  AR     L   +   H  G +HR
Sbjct: 66  LYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHR 125

Query: 166 DLKPENILLATKSSSSPIKLADFGLAT---------YIKAGQNL---------------- 200
           D+KP+NIL+        IKL DFGL T         Y + G +                 
Sbjct: 126 DIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182

Query: 201 -------------------HGTVGSPFYIAPEVLA-GGYNQAADVWSAGVILYILLSGMP 240
                              H  VG+P YIAPEVL   GY Q  D WS GVILY +L G P
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQP 242

Query: 241 PFW----GKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRL---TAAE 293
           PF      +T+ K+ +      L  P      +S  A DLI+ +       RL    A E
Sbjct: 243 PFLADTPAETQLKVINW--ETTLHIP--SQAKLSREASDLILRLCC-GAEDRLGKNGADE 297

Query: 294 VLAHSW 299
           + AH +
Sbjct: 298 IKAHPF 303

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  123 bits (310), Expect = 2e-32
 Identities = 83/295 (28%), Positives = 138/295 (46%), Gaps = 50/295 (16%)

Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKL-EIEIMTKLSGH 100
           +   ++LG G +  + +  ++ TGE++A K I    L   E   S  + EI +M +L  H
Sbjct: 2   FKQLEKLGEGTYATVYKGRNRTTGEIVALKEI---HLDAEEGTPSTAIREISLMKELK-H 57

Query: 101 PNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVI--FRH-LMQVVSYC 157
            N+V L  V   E+ + L+ E     +L   ++ +G     +   +  F + L++ +++C
Sbjct: 58  ENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFC 116

Query: 158 HGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN-LHGTVGSPFYIAPEVLA 216
           H N V+HRDLKP+N+L+  +     +KLADFGLA       N     V + +Y AP+VL 
Sbjct: 117 HENRVLHRDLKPQNLLINKRGE---LKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLL 173

Query: 217 GG--YNQAADVWSAGVILYILLSGMPPFWGKTKS----KIFDAV---------------- 254
           G   Y+ + D+WS G I+  +++G P F G        KIF  +                
Sbjct: 174 GSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE 233

Query: 255 --------RAADLR--FPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSW 299
                      DL+  FP     H      DL+  +L+++P  R++A + L H W
Sbjct: 234 YKPTFPRYPPQDLQQLFP-----HADPLGIDLLHRLLQLNPELRISAHDALQHPW 283

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  122 bits (308), Expect = 3e-32
 Identities = 62/226 (27%), Positives = 105/226 (46%), Gaps = 20/226 (8%)

Query: 43  VLGKQLGWGQFGVIREC----SDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLS 98
            LGK+LG G FG + +       + T   +A K++ +    + E+      E  IM KLS
Sbjct: 2   ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEG--ASEEEREEFLEEASIMKKLS 59

Query: 99  GHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQV---VS 155
            HPN+V L  V  + + ++++ E   GG+L   L K+G     +  +     +Q+   + 
Sbjct: 60  -HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQM--ALQIAKGME 116

Query: 156 YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNL---HGTVGSPFYIAP 212
           Y      VHRDL   N L+        +K++DFGL+  I          G      ++AP
Sbjct: 117 YLESKNFVHRDLAARNCLVTENLV---VKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAP 173

Query: 213 EVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRA 256
           E L  G +   +DVWS GV+L+ + + G  P+ G +  ++ + +  
Sbjct: 174 ESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLED 219

Length = 258

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score =  122 bits (307), Expect = 4e-32
 Identities = 84/273 (30%), Positives = 126/273 (46%), Gaps = 27/273 (9%)

Query: 42  YVLGKQLGWGQFGVIRECSDKFTGE-VLACKSI-------AKDRLVTVEDVRSIKLEIEI 93
           Y + + LG G FG + +   K  G+ +LA K I        KD+    + +  I  E+ I
Sbjct: 2   YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61

Query: 94  MTKLSGHPNVVDLKAVYEEEDYVHLLMELCAG---GELFHRL-EKYGRFSETEARVIFRH 149
           + +   HPN+V     + E D ++++M+L  G   GE F+ L EK  RF+E     IF  
Sbjct: 62  IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121

Query: 150 LMQVVSYCHGNG-VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF 208
           ++  + Y H    +VHRDL P NI+L        + + DFGLA   +    L   VG+  
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIMLGEDDK---VTITDFGLAKQKQPESKLTSVVGTIL 178

Query: 209 YIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKT----KSKIFDAVRAADLRFPS 263
           Y  PE++    Y + ADVW+ G ILY + +  PPF+        +KI +AV       P 
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP---LPE 235

Query: 264 DPWDHISASARDLIMGMLRVDPSTRLTAAEVLA 296
             +   S    D+I   L  D   R    +V A
Sbjct: 236 GMY---SEDVTDVITSCLTPDAEARPDIIQVSA 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  122 bits (307), Expect = 5e-32
 Identities = 75/268 (27%), Positives = 130/268 (48%), Gaps = 19/268 (7%)

Query: 45  GKQLGWGQFGVIRECSDKFTGEVLACKSIA---KDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           G+ LG G +G +  C     G+++A K +     + L   ++   ++ E++++  L  H 
Sbjct: 5   GEVLGKGAYGTVY-CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK-HV 62

Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
           N+V       +++ + + ME   GG +   L ++G   E       + ++  V+Y H N 
Sbjct: 63  NIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC 122

Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTV--------GSPFYIAPE 213
           VVHRD+K  N++L     +  IKL DFG A  + A   LHGT         G+P+++APE
Sbjct: 123 VVHRDIKGNNVMLM---PNGIIKLIDFGCARRL-AWVGLHGTHSNMLKSMHGTPYWMAPE 178

Query: 214 VL-AGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISAS 272
           V+   GY + +D+WS G  ++ + +G PP     +      + A     P  P D  SA+
Sbjct: 179 VINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLP-DSFSAA 237

Query: 273 ARDLIMGMLRVDPSTRLTAAEVLAHSWM 300
           A D +   L  D   R +A ++L H ++
Sbjct: 238 AIDFVTSCLTRDQHERPSALQLLRHDFL 265

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  121 bits (306), Expect = 5e-32
 Identities = 72/263 (27%), Positives = 128/263 (48%), Gaps = 26/263 (9%)

Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           + +G G FG++  C  K   +++  K I  +++ T ++  + + E +++  LS HPN+++
Sbjct: 6   RVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLLS-HPNIIE 63

Query: 106 LKAVYEEEDYVHLLMELCAGGELFHRLEKYGR--FSETEARVIFRHLMQVVSYCHGNGVV 163
               + E+  + ++ME   GG L   ++K       E      F  ++  + + H   ++
Sbjct: 64  YYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLIL 123

Query: 164 HRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGG-YNQA 222
           HRDLK +NILL        +K+ DFG++  + +    +  VG+P YI+PE+  G  YNQ 
Sbjct: 124 HRDLKTQNILLDKHKMV--VKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQK 181

Query: 223 ADVWSAGVILYILLS--------GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASAR 274
           +D+W+ G +LY L S         +P    K  S  F  +            D  S   R
Sbjct: 182 SDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPIS-----------DRYSPDLR 230

Query: 275 DLIMGMLRVDPSTRLTAAEVLAH 297
            LI+ ML +DPS R   ++++A 
Sbjct: 231 QLILSMLNLDPSKRPQLSQIMAQ 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  122 bits (308), Expect = 6e-32
 Identities = 84/295 (28%), Positives = 129/295 (43%), Gaps = 50/295 (16%)

Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVED------VRSIKLEIEIMT 95
           Y    ++G G +G + +  D  TG  +A K +   R+   E+      +R    EI ++ 
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKV---RVPLSEEGIPLSTLR----EIALLK 53

Query: 96  KL--SGHPNVVDLKAV-----YEEEDYVHLLMELCAGGELFHRLEKYGR--FSETEARVI 146
           +L    HPN+V L  V      + E  + L+ E     +L   L K  +        + +
Sbjct: 54  QLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDL 112

Query: 147 FRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGS 206
            R L++ V + H + +VHRDLKP+NIL+   +S   +K+ADFGLA        L   V +
Sbjct: 113 MRQLLRGVDFLHSHRIVHRDLKPQNILV---TSDGQVKIADFGLARIYSFEMALTSVVVT 169

Query: 207 PFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAV-RAADLR 260
            +Y APEVL    Y    D+WS G I   L    P F G ++     KIFD +   ++  
Sbjct: 170 LWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEE 229

Query: 261 FPSD---PWD---------------HISASARDLIMGMLRVDPSTRLTAAEVLAH 297
           +P +   P                  I     DL+  ML  +P  R++A E L H
Sbjct: 230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  121 bits (305), Expect = 1e-31
 Identities = 89/297 (29%), Positives = 140/297 (47%), Gaps = 64/297 (21%)

Query: 47  QLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVT-VEDVRSIKL-EIEIMTKLSGHPNVV 104
           ++G G +GV+ +  DK TGE++A K I   RL T  E V S  + EI ++ +L+ HPN+V
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVALKKI---RLETEDEGVPSTAIREISLLKELN-HPNIV 61

Query: 105 DLKAVYEEEDYVHLLMELCAGGELFHRLEKY----GRFSETEARVIFRHLMQV---VSYC 157
            L  V   E+ ++L+ E      L   L+KY             +I  +L Q+   ++YC
Sbjct: 62  RLLDVVHSENKLYLVFEF-----LDLDLKKYMDSSPLTGLD-PPLIKSYLYQLLQGIAYC 115

Query: 158 HGNGVVHRDLKPENILLATKSSSSPIKLADFGLA--------TYIKAGQNLHGTVGSPFY 209
           H + V+HRDLKP+N+L+  + +   +KLADFGLA        TY       H  V + +Y
Sbjct: 116 HSHRVLHRDLKPQNLLIDREGA---LKLADFGLARAFGVPVRTYT------HEVV-TLWY 165

Query: 210 IAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAVRAAD----- 258
            APE+L G   Y+   D+WS G I   +++  P F G ++     +IF  +   D     
Sbjct: 166 RAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWP 225

Query: 259 ------------LRFPSDPWDHI----SASARDLIMGMLRVDPSTRLTAAEVLAHSW 299
                        ++       +         DL+  ML  DP+ R++A   L H +
Sbjct: 226 GVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPY 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  121 bits (305), Expect = 2e-31
 Identities = 86/301 (28%), Positives = 137/301 (45%), Gaps = 76/301 (25%)

Query: 51  GQFGVIRECSDKFTGEVLACKSIAKDRLVTVED----VRSIKLEIEIMTKLSGHPNVVDL 106
           G +GV+    DK TGE++A K +  ++    E     + S++ EI I+ KL  HPN+V +
Sbjct: 16  GTYGVVYRARDKKTGEIVALKKLKMEK----EKEGFPITSLR-EINILLKLQ-HPNIVTV 69

Query: 107 K--AVYEEEDYVHLLMELCAGGELFHRL-----EKYGRFSETEARVIFRHLMQVVSYCHG 159
           K   V    D ++++ME      + H L          F ++E + +   L+  V++ H 
Sbjct: 70  KEVVVGSNLDKIYMVMEY-----VEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHD 124

Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSP-----------F 208
           N ++HRDLK  N+LL   ++   +K+ DFGLA             GSP           +
Sbjct: 125 NWILHRDLKTSNLLL---NNRGILKICDFGLARE----------YGSPLKPYTQLVVTLW 171

Query: 209 YIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAV-------- 254
           Y APE+L G   Y+ A D+WS G I   LL+  P F GK++    +KIF  +        
Sbjct: 172 YRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIW 231

Query: 255 -------RAADLRFPSDPW---------DHISASARDLIMGMLRVDPSTRLTAAEVLAHS 298
                   A    F   P+           +S +  DL+  +L  DP+ R++A + L H 
Sbjct: 232 PGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHP 291

Query: 299 W 299
           +
Sbjct: 292 Y 292

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score =  121 bits (305), Expect = 2e-31
 Identities = 75/245 (30%), Positives = 131/245 (53%), Gaps = 11/245 (4%)

Query: 48  LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN-VVDL 106
           LG G FG +     K T E+ A K + KD ++  +DV    +E  ++  LSG P  +  L
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLA-LSGKPPFLTQL 66

Query: 107 KAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRD 166
            + ++  D ++ +ME   GG+L +++++ GRF E  A      +   + + H  G+++RD
Sbjct: 67  HSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRD 126

Query: 167 LKPENILLATKSSSSPIKLADFGLATY-IKAGQNLHGTVGSPFYIAPEVLA-GGYNQAAD 224
           LK +N++L    S   IK+ADFG+    +  G       G+P YIAPE++A   Y ++ D
Sbjct: 127 LKLDNVML---DSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVD 183

Query: 225 VWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVD 284
            W+ GV+LY +L+G  PF G+ + ++F ++   ++ +P      +S  A  +  G++   
Sbjct: 184 WWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKS----MSKEAVAICKGLMTKH 239

Query: 285 PSTRL 289
           P  RL
Sbjct: 240 PGKRL 244

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score =  122 bits (307), Expect = 3e-31
 Identities = 87/257 (33%), Positives = 125/257 (48%), Gaps = 25/257 (9%)

Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           K +G G FG ++    K + +V A K ++K  ++   D      E +IM   +    +V 
Sbjct: 49  KVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMA-HANSEWIVQ 107

Query: 106 LKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHR 165
           L   ++++ Y++++ME   GG+L + +  Y    E  AR     ++  +   H  G +HR
Sbjct: 108 LHYAFQDDKYLYMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMGFIHR 166

Query: 166 DLKPENILLATKSSSSPIKLADFGLATYIKAGQN----LHGTVGSPFYIAPEVLA----- 216
           D+KP+N+LL     S  +KLADFG  T +K   N        VG+P YI+PEVL      
Sbjct: 167 DVKPDNMLL---DKSGHLKLADFG--TCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGD 221

Query: 217 GGYNQAADVWSAGVILYILLSGMPPFWGK----TKSKIFDAVRAADLRFPSDPWDHISAS 272
           G Y +  D WS GV LY +L G  PF+      T SKI D      L FP D    IS  
Sbjct: 222 GYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMD--HKNSLTFPDDI--EISKQ 277

Query: 273 ARDLIMGMLRVDPSTRL 289
           A+DLI   L  D   RL
Sbjct: 278 AKDLICAFL-TDREVRL 293

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  121 bits (305), Expect = 4e-31
 Identities = 94/307 (30%), Positives = 142/307 (46%), Gaps = 49/307 (15%)

Query: 36  SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMT 95
            ++  +Y + ++LG G +G++ +  D+ T EV+A K I  D      D +    EI  + 
Sbjct: 3   KHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIF-DAFRNATDAQRTFREIMFLQ 61

Query: 96  KLSGHPNVVDLKAVYEEED----Y-VHLLMELCAGGELFHRLEKYGRFSETEARVIFRHL 150
           +L  HPN+V L  V + E+    Y V   ME     +L H + +     +   R I   L
Sbjct: 62  ELGDHPNIVKLLNVIKAENDKDIYLVFEYME----TDL-HAVIRANILEDVHKRYIMYQL 116

Query: 151 MQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT------V 204
           ++ + Y H   V+HRDLKP NILL   +S   +KLADFGLA  +   +           V
Sbjct: 117 LKALKYIHSGNVIHRDLKPSNILL---NSDCRVKLADFGLARSLSELEENPENPVLTDYV 173

Query: 205 GSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAV---R 255
            + +Y APE+L G   Y +  D+WS G IL  +L G P F G +      KI + +    
Sbjct: 174 ATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPS 233

Query: 256 AADL-------------RFPSDPWDHI-------SASARDLIMGMLRVDPSTRLTAAEVL 295
           A D+               PS P   +       S  A DL+  +L  +P+ RLTA E L
Sbjct: 234 AEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEAL 293

Query: 296 AHSWMEE 302
            H ++ +
Sbjct: 294 EHPYVAQ 300

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  120 bits (303), Expect = 7e-31
 Identities = 92/305 (30%), Positives = 145/305 (47%), Gaps = 47/305 (15%)

Query: 27  GTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRS 86
           GT+ + T      +RYV  + +G G FG++    D+ TG+ +A K I K     V   R+
Sbjct: 3   GTVFEIT------NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRT 56

Query: 87  IKLEIEIMTKLSGHPNVVDLKAVY--EEEDYVHLLMELCAGGELFHRLEKYGRFSETEAR 144
            + E++++  L  H N++ L  ++    ED ++ + EL   G   HRL       +   +
Sbjct: 57  YR-ELKLLKHLR-HENIISLSDIFISPLED-IYFVTELL--GTDLHRLLTSRPLEKQFIQ 111

Query: 145 VIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTV 204
                +++ + Y H  GVVHRDLKP NIL+   + +  +K+ DFGLA  I+  Q + G V
Sbjct: 112 YFLYQILRGLKYVHSAGVVHRDLKPSNILI---NENCDLKICDFGLAR-IQDPQ-MTGYV 166

Query: 205 GSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGK----------------- 245
            + +Y APE++     Y+   D+WSAG I   +L G P F GK                 
Sbjct: 167 STRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPP 226

Query: 246 -------TKSKIFDAVRAADLRFP---SDPWDHISASARDLIMGMLRVDPSTRLTAAEVL 295
                          V++   R P   S+ + +   SA DL+  ML  DP  R++AAE L
Sbjct: 227 DDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEAL 286

Query: 296 AHSWM 300
           AH ++
Sbjct: 287 AHPYL 291

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  118 bits (299), Expect = 7e-31
 Identities = 85/289 (29%), Positives = 135/289 (46%), Gaps = 47/289 (16%)

Query: 39  SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLS 98
           +  + L + +G G +G + +   K TG+++A K +     +  ++   IK E  I+ K S
Sbjct: 5   TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD----IIEDEEEEIKEEYNILRKYS 60

Query: 99  GHPNVVDLKAVY------EEEDYVHLLMELCAGG---ELFHRLEKYG-RFSETEARVIFR 148
            HPN+      +        +D + L+MELC GG   +L   L K G R  E     I R
Sbjct: 61  NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILR 120

Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT-VGSP 207
             ++ ++Y H N V+HRD+K +NILL TK++   +KL DFG++  + +      T +G+P
Sbjct: 121 ETLRGLAYLHENKVIHRDIKGQNILL-TKNAE--VKLVDFGVSAQLDSTLGRRNTFIGTP 177

Query: 208 FYIAPEVLA------GGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFD--AVRAADL 259
           +++APEV+A        Y+  +DVWS G+    L  G PP          D   +RA   
Sbjct: 178 YWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPL--------CDMHPMRAL-F 228

Query: 260 RFPSDP---------WDHISASARDLIMGMLRVDPSTRLTAAEVLAHSW 299
           + P +P         W   S    D I   L  +   R    E+L H +
Sbjct: 229 KIPRNPPPTLKSPENW---SKKFNDFISECLIKNYEQRPFMEELLEHPF 274

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  118 bits (298), Expect = 8e-31
 Identities = 72/269 (26%), Positives = 123/269 (45%), Gaps = 31/269 (11%)

Query: 43  VLGKQLGWGQFGVIREC----SDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLS 98
            LGK+LG G FG + +             +A K++ +D   + + +     E  IM KL 
Sbjct: 2   TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKED--ASEQQIEEFLREARIMRKLD 59

Query: 99  GHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEA-RVIFRHLMQV---V 154
            HPN+V L  V  EE+ + ++ME   GG+L   L K      + +  + F   +Q+   +
Sbjct: 60  -HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSF--ALQIARGM 116

Query: 155 SYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVG-SP-FYIAP 212
            Y      +HRDL   N L+        +K++DFGL+  +          G  P  ++AP
Sbjct: 117 EYLESKNFIHRDLAARNCLVGENLV---VKISDFGLSRDLYDDDYYKVKGGKLPIRWMAP 173

Query: 213 EVL-AGGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAAD-LRFPSDPWDHI 269
           E L  G +   +DVWS GV+L+ + + G  P+ G + +++ + ++    L  P +     
Sbjct: 174 ESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCPP-- 231

Query: 270 SASARDLIMGMLR---VDPSTRLTAAEVL 295
                +L   ML+    DP  R T +E++
Sbjct: 232 -----ELYKLMLQCWAEDPEDRPTFSELV 255

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  118 bits (297), Expect = 2e-30
 Identities = 84/296 (28%), Positives = 147/296 (49%), Gaps = 58/296 (19%)

Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVED---VRSIKL-EIEIMTKLS 98
            LG  +G G +G++ +C  K TG+++A K     + +  ED   V+ I + EI ++ +L 
Sbjct: 5   NLGL-VGEGSYGMVMKCKHKETGQIVAIK-----KFLESEDDKMVKKIAMREIRMLKQLR 58

Query: 99  GHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKY--GRFSETEARVIFRHLMQVVSY 156
            H N+V+L  V+  +  ++L+ E      +   LEKY  G       + +F+ +++ + +
Sbjct: 59  -HENLVNLIEVFRRKKRLYLVFEF-VDHTVLDDLEKYPNGLDESRVRKYLFQ-ILRGIEF 115

Query: 157 CHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT-VGSPFYIAPEVL 215
           CH + ++HRD+KPENIL+   S S  +KL DFG A  + A   ++   V + +Y APE+L
Sbjct: 116 CHSHNIIHRDIKPENILV---SQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELL 172

Query: 216 AGG--YNQAADVWSAGVILYILLSGMPPFWGKT------------------------KSK 249
            G   Y +A D+W+ G ++  +L+G P F G +                        K+ 
Sbjct: 173 VGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP 232

Query: 250 IFDAVRAADL--------RFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH 297
           +F  +R  ++        RFP      +S    DL    LR+DP  R +++++L H
Sbjct: 233 LFAGMRLPEVKEIEPLEKRFPK-----LSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score =  118 bits (298), Expect = 2e-30
 Identities = 78/253 (30%), Positives = 123/253 (48%), Gaps = 15/253 (5%)

Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           K +G G FG +     K  G+  A K + K  ++  ++ + I  E  ++ K   HP +V 
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 106 LKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHR 165
           L   ++  + ++ +++   GGELF  L++   F E  AR     +   + Y H   +V+R
Sbjct: 61  LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYR 120

Query: 166 DLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTV----GSPFYIAPEVL-AGGYN 220
           DLKPENILL    S   + L DFGL    K G     T     G+P Y+APEV+    Y+
Sbjct: 121 DLKPENILL---DSQGHVVLTDFGLC---KEGIAQSDTTTTFCGTPEYLAPEVIRKQPYD 174

Query: 221 QAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGM 280
              D W  G +LY +L G+PPF+ +  ++++D +    L  P       S +A  ++  +
Sbjct: 175 NTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNI----LHKPLVLRPGASLTAWSILEEL 230

Query: 281 LRVDPSTRLTAAE 293
           L  D   RL A E
Sbjct: 231 LEKDRQRRLGAKE 243

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score =  118 bits (298), Expect = 3e-30
 Identities = 86/266 (32%), Positives = 139/266 (52%), Gaps = 25/266 (9%)

Query: 42  YVLGKQLGWGQFG---VIRECSDKFTGEVLACKSIAKDRLV----TVEDVRSIKLEIEIM 94
           + L K LG G +G   ++R+ +   TG++ A K + K  LV    TVE  R+   E  ++
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRT---ERNVL 58

Query: 95  TKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVV 154
             +   P +V L   ++ E  +HL+++  +GGE+F  L +   FSE E R     ++  +
Sbjct: 59  EHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILAL 118

Query: 155 SYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI--KAGQNLHGTVGSPFYIAP 212
            + H  G+V+RD+K ENILL    S   + L DFGL+     +  +  +   G+  Y+AP
Sbjct: 119 EHLHKLGIVYRDIKLENILL---DSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAP 175

Query: 213 EVLAG--GYNQAADVWSAGVILYILLSGMPPFW----GKTKSKIFDAVRAADLRFPSDPW 266
           E++ G  G+ +A D WS G++++ LL+G  PF       T+S++   +   D  FPS   
Sbjct: 176 EIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPS--- 232

Query: 267 DHISASARDLIMGMLRVDPSTRLTAA 292
             I   A+DL+  +LR DP  RL A 
Sbjct: 233 -FIGPEAQDLLHKLLRKDPKKRLGAG 257

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score =  116 bits (293), Expect = 6e-30
 Identities = 81/259 (31%), Positives = 125/259 (48%), Gaps = 14/259 (5%)

Query: 48  LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKL-EIEIMTKLSGHPNVVDL 106
           LG G FG +  C  + TG++ ACK + K R +      ++ L E +I+ K++    VV L
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKR-IKKRKGEAMALNEKQILEKVNS-RFVVSL 65

Query: 107 KAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIF--RHLMQVVSYCHGNGVVH 164
              YE +D + L++ L  GG+L   +   G     E R +F    +   +   H   +V+
Sbjct: 66  AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVY 125

Query: 165 RDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGG-YNQAA 223
           RDLKPENILL        I+++D GLA  I  G+ + G VG+  Y+APEV+    Y  + 
Sbjct: 126 RDLKPENILL---DDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSP 182

Query: 224 DVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRV 283
           D W  G ++Y ++ G  PF  + +    + V         +  +  S +AR +   +L  
Sbjct: 183 DWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLTK 242

Query: 284 DPSTRL-----TAAEVLAH 297
           DP  RL      A EV AH
Sbjct: 243 DPGFRLGCRGEGAEEVKAH 261

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score =  118 bits (296), Expect = 8e-30
 Identities = 87/272 (31%), Positives = 131/272 (48%), Gaps = 45/272 (16%)

Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           K +G G FG +R    K TG V A K + K  ++  E V  I+ E +I+ + +    VV 
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVE-ADSLWVVK 65

Query: 106 LKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHR 165
           +   ++++  ++L+ME   GG++   L K    +E E +      +  +   H  G +HR
Sbjct: 66  MFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHR 125

Query: 166 DLKPENILLATKSSSSPIKLADFGLATYIKAG-------------------QNLH----- 201
           D+KP+N+LL +K     +KL+DFGL T +K                     QN++     
Sbjct: 126 DIKPDNLLLDSKGH---VKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182

Query: 202 ------------GTVGSPFYIAPEV-LAGGYNQAADVWSAGVILYILLSGMPPFWGKTKS 248
                        TVG+P YIAPEV +  GYN+  D WS GVI+Y +L G PPF  +T  
Sbjct: 183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQ 242

Query: 249 KIFDAVR--AADLRFPSDPWDHISASARDLIM 278
           + +  V      L FP  P   IS  A+DLI+
Sbjct: 243 ETYKKVMNWKETLIFP--PEVPISEKAKDLIL 272

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score =  115 bits (290), Expect = 9e-30
 Identities = 83/270 (30%), Positives = 131/270 (48%), Gaps = 15/270 (5%)

Query: 37  NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTK 96
           N  + + L +++G G +G + +  +  TGE+ A K I   +L   ED   ++ EI IM K
Sbjct: 6   NPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVI---KLEPGEDFAVVQQEI-IMMK 61

Query: 97  LSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSY 156
              H N+V     Y   D + + ME C GG L       G  SE++   + R  +Q + Y
Sbjct: 62  DCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYY 121

Query: 157 CHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG-QNLHGTVGSPFYIAPEVL 215
            H  G +HRD+K  NILL   + +  +KLADFG++  I A        +G+P+++APEV 
Sbjct: 122 LHSKGKMHRDIKGANILL---TDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVA 178

Query: 216 A----GGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHI-- 269
           A    GGYNQ  D+W+ G+    L    PP +     +    +  ++ + P    D +  
Sbjct: 179 AVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQ-PPKLKDKMKW 237

Query: 270 SASARDLIMGMLRVDPSTRLTAAEVLAHSW 299
           S S    +   L  +P  R TA ++L H +
Sbjct: 238 SNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  116 bits (292), Expect = 1e-29
 Identities = 95/309 (30%), Positives = 140/309 (45%), Gaps = 61/309 (19%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           D++ +  Q+G G +G + +  DK TGE++A K +  D       + +I+ EI+I+ +L+ 
Sbjct: 7   DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-EIKILRQLN- 64

Query: 100 HPNVVDLK-----------------AVYEEEDYV-HLLMELCAGGELFHRLEKYGRFSET 141
           H N+V+LK                 A Y   +Y+ H LM L   G L H       FSE 
Sbjct: 65  HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESG-LVH-------FSED 116

Query: 142 EARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLAT-YIKAGQNL 200
             +   + L++ ++YCH    +HRD+K  NILL  K     IKLADFGLA  Y       
Sbjct: 117 HIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQ---IKLADFGLARLYNSEESRP 173

Query: 201 H-GTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTK-------SKI 250
           +   V + +Y  PE+L G   Y  A DVWS G IL  L +  P F    +       S++
Sbjct: 174 YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRL 233

Query: 251 -----------------FDAVRAADL--RFPSDPWDHISASARDLIMGMLRVDPSTRLTA 291
                            F+ ++      R   + +  I   A DL+  ML +DPS R TA
Sbjct: 234 CGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTA 293

Query: 292 AEVLAHSWM 300
            E L   W+
Sbjct: 294 EEALNSPWL 302

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  114 bits (286), Expect = 3e-29
 Identities = 69/266 (25%), Positives = 132/266 (49%), Gaps = 20/266 (7%)

Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
            + + K+LG G +G + +       +  A K +    +   E   ++  EI I+  ++ H
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVN-EIRILASVN-H 58

Query: 101 PNVVDLKAVYEEEDYVHLLMELCAGGELFH---RLEKYGRFSETEARVIFRHLMQVV--- 154
           PN++  K  + + + + ++ME    G+L     + +K  +    +   I+R  +Q++   
Sbjct: 59  PNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQE--IWRIFIQLLRGL 116

Query: 155 SYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT-VGSPFYIAPE 213
              H   ++HRDLK  NILL    ++  +K+ D G++  +K  +N+  T +G+P Y+APE
Sbjct: 117 QALHEQKILHRDLKSANILL---VANDLVKIGDLGISKVLK--KNMAKTQIGTPHYMAPE 171

Query: 214 VLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISAS 272
           V  G  Y+  +D+WS G +LY + +  PPF  ++   +   V+    ++P  P  + S  
Sbjct: 172 VWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRG--KYPPIPPIY-SQD 228

Query: 273 ARDLIMGMLRVDPSTRLTAAEVLAHS 298
            ++ I  ML+V P  R    ++LA  
Sbjct: 229 LQNFIRSMLQVKPKLRPNCDKILASP 254

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score =  115 bits (288), Expect = 3e-29
 Identities = 82/258 (31%), Positives = 124/258 (48%), Gaps = 12/258 (4%)

Query: 48  LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLK 107
           LG G FG +  C  + TG++ ACK + K R+   +       E +I+ K++    VV L 
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSR-FVVSLA 66

Query: 108 AVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIF--RHLMQVVSYCHGNGVVHR 165
             YE +D + L++ L  GG+L   +   G     E R +F    +   +   H   +V+R
Sbjct: 67  YAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYR 126

Query: 166 DLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGG-YNQAAD 224
           DLKPENILL        I+++D GLA ++  GQ + G VG+  Y+APEV+    Y  + D
Sbjct: 127 DLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPD 183

Query: 225 VWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVD 284
            W+ G +LY +++G  PF  + K    + V         +  +  S  AR L   +L  D
Sbjct: 184 WWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLCKD 243

Query: 285 PSTRL-----TAAEVLAH 297
           P  RL      A EV  H
Sbjct: 244 PKERLGCQGGGAREVKEH 261

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  115 bits (289), Expect = 7e-29
 Identities = 83/298 (27%), Positives = 135/298 (45%), Gaps = 44/298 (14%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           DRY     +G G +G +    D  TG  +A K +++    +    +    E+ ++ K   
Sbjct: 15  DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRP-FQSAIHAKRTYRELRLL-KHMD 72

Query: 100 HPNVVDLKAVY----EEEDY--VHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQV 153
           H NV+ L  V+      ED+  V+L+  L  G +L + + K  + S+   + +   +++ 
Sbjct: 73  HENVIGLLDVFTPASSLEDFQDVYLVTHL-MGADL-NNIVKCQKLSDDHIQFLVYQILRG 130

Query: 154 VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPE 213
           + Y H  G++HRDLKP NI +   +    +K+ DFGLA        + G V + +Y APE
Sbjct: 131 LKYIHSAGIIHRDLKPSNIAV---NEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPE 185

Query: 214 VLA--GGYNQAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAVRAADLRF------ 261
           ++     YNQ  D+WS G I+  LL+G   F G        +I + V   D         
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISS 245

Query: 262 -------------PSDPWDHI----SASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
                        P   +  +    +  A DL+  ML +DP  R+TAAE LAH ++ E
Sbjct: 246 ESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAE 303

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  113 bits (284), Expect = 1e-28
 Identities = 90/295 (30%), Positives = 142/295 (48%), Gaps = 62/295 (21%)

Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVT-VEDVRSIKL-EIEIMTKLSGHPNV 103
           +++G G +GV+ +  +K TGEV+A K I   RL T  E V S  + EI ++ +L+ HPN+
Sbjct: 6   EKIGEGTYGVVYKARNKLTGEVVALKKI---RLDTETEGVPSTAIREISLLKELN-HPNI 61

Query: 104 VDLKAVYEEEDYVHLLMELCAGGELFHRLEKY------GRFSETEARVIFRHLMQVVSYC 157
           V L  V   E+ ++L+ E      L   L+K+              +     L+Q +++C
Sbjct: 62  VKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFC 116

Query: 158 HGNGVVHRDLKPENILLATKSSSSPIKLADFGLA--------TYIKAGQNLHGTVGSPFY 209
           H + V+HRDLKP+N+L+ T+ +   IKLADFGLA        TY       H  V + +Y
Sbjct: 117 HSHRVLHRDLKPQNLLINTEGA---IKLADFGLARAFGVPVRTYT------HEVV-TLWY 166

Query: 210 IAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTKS----KIFDAVRAAD----- 258
            APE+L G   Y+ A D+WS G I   +++    F G ++     +IF  +   D     
Sbjct: 167 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 226

Query: 259 ------------LRFPSDPWDHI----SASARDLIMGMLRVDPSTRLTAAEVLAH 297
                        ++    +  +        RDL+  ML  DP+ R++A   LAH
Sbjct: 227 GVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score =  112 bits (282), Expect = 1e-28
 Identities = 66/253 (26%), Positives = 129/253 (50%), Gaps = 10/253 (3%)

Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           + + K++G GQF  +   +    G  +A K +    L+  +       EI+++ +L+ HP
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HP 62

Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSE-TEARVIFRHLMQVVS---YC 157
           NV+   A + E++ +++++EL   G+L   ++ + +       + ++++ +Q+ S   + 
Sbjct: 63  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122

Query: 158 HGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNL-HGTVGSPFYIAPE-VL 215
           H   V+HRD+KP N+ +   +++  +KL D GL  +  +     H  VG+P+Y++PE + 
Sbjct: 123 HSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 179

Query: 216 AGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARD 275
             GYN  +D+WS G +LY + +   PF+G   +      +     +P  P DH S   R 
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ 239

Query: 276 LIMGMLRVDPSTR 288
           L+   +  DP  R
Sbjct: 240 LVNMCINPDPEKR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  112 bits (282), Expect = 1e-28
 Identities = 72/260 (27%), Positives = 133/260 (51%), Gaps = 14/260 (5%)

Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
           +YV  K++G G FG       K  G+    K I   ++   E   S K E+ +++ +  H
Sbjct: 1   KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRK-EVAVLSNMK-H 58

Query: 101 PNVVDLKAVYEEEDYVHLLMELCAGGELFHRL--EKYGRFSETEARVIFRHLMQVVSYCH 158
           PN+V  +  +EE   ++++M+ C GG+L+ ++  ++   F E +    F  +   + + H
Sbjct: 59  PNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH 118

Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT-VGSPFYIAPEVLAG 217
              ++HRD+K +NI L TK  +  IKL DFG+A  + +   L  T +G+P+Y++PE+   
Sbjct: 119 DRKILHRDIKSQNIFL-TKDGT--IKLGDFGIARVLNSTVELARTCIGTPYYLSPEICEN 175

Query: 218 G-YNQAADVWSAGVILYILLSGMPPF-WGKTKSKIFDAVRAADLRFPSDPWDHISASARD 275
             YN  +D+W+ G +LY + +    F  G  K+ +   +R +   +P     H S   R+
Sbjct: 176 RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGS---YPPVS-SHYSYDLRN 231

Query: 276 LIMGMLRVDPSTRLTAAEVL 295
           L+  + + +P  R +   +L
Sbjct: 232 LVSQLFKRNPRDRPSVNSIL 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score =  113 bits (283), Expect = 1e-28
 Identities = 81/278 (29%), Positives = 137/278 (49%), Gaps = 24/278 (8%)

Query: 47  QLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDL 106
           +LG G FG + +  +K TG + A K I       +ED     +EIEI+   + HP +V L
Sbjct: 19  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDY---MVEIEILATCN-HPYIVKL 74

Query: 107 KAVYEEEDYVHLLMELCAGGELFHRLEKYGR-FSETEARVIFRHLMQVVSYCHGNGVVHR 165
              +  +  + +++E C GG +   + +  R  +E + +VI R +++ + Y H   ++HR
Sbjct: 75  LGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHR 134

Query: 166 DLKPENILLATKSSSSPIKLADFGL-ATYIKAGQNLHGTVGSPFYIAPEVLA------GG 218
           DLK  N+LL        IKLADFG+ A  +K  Q     +G+P+++APEV+         
Sbjct: 135 DLKAGNVLLTLDGD---IKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTP 191

Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAAD---LRFPSDPWDHISASARD 275
           Y+  AD+WS G+ L  +    PP       ++   +  ++   L  PS  W   S   RD
Sbjct: 192 YDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSK-W---SMEFRD 247

Query: 276 LIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKPCKQ 313
            +   L   P TR +AA++L H ++      + +P ++
Sbjct: 248 FLKTALDKHPETRPSAAQLLEHPFVSSV--TSNRPLRE 283

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score =  113 bits (285), Expect = 3e-28
 Identities = 94/285 (32%), Positives = 138/285 (48%), Gaps = 26/285 (9%)

Query: 16  FCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAK 75
           F N YK      TI     +   ++ Y + K +G G FG ++    K T +V A K ++K
Sbjct: 24  FLNRYK-----DTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSK 78

Query: 76  DRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKY 135
             ++   D      E +IM   +  P VV L   ++++ Y++++ME   GG+L + +  Y
Sbjct: 79  FEMIKRSDSAFFWEERDIMA-FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY 137

Query: 136 GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI- 194
               E  AR     ++  +   H  G +HRD+KP+N+LL     S  +KLADFG    + 
Sbjct: 138 D-VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMN 193

Query: 195 KAGQ-NLHGTVGSPFYIAPEVLA-----GGYNQAADVWSAGVILYILLSGMPPFWGK--- 245
           K G       VG+P YI+PEVL      G Y +  D WS GV LY +L G  PF+     
Sbjct: 194 KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV 253

Query: 246 -TKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRL 289
            T SKI +   +  L FP D  + IS  A++LI   L  D   RL
Sbjct: 254 GTYSKIMNHKNS--LTFPDD--NDISKEAKNLICAFL-TDREVRL 293

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  112 bits (281), Expect = 4e-28
 Identities = 76/279 (27%), Positives = 140/279 (50%), Gaps = 16/279 (5%)

Query: 28  TILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSI 87
            ++D     +  D +V   ++G G  G++   +DK TG  +A K +     +  +  R +
Sbjct: 10  LVVDPGDPRSYLDNFV---KIGEGSTGIVCIATDKSTGRQVAVKKMD----LRKQQRREL 62

Query: 88  KL-EIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVI 146
              E+ IM     HPN+V++ + Y   D + ++ME   GG L   +  + R +E +   +
Sbjct: 63  LFNEVVIMRDYQ-HPNIVEMYSSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATV 120

Query: 147 FRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI-KAGQNLHGTVG 205
              +++ +S+ H  GV+HRD+K ++ILL    S   +KL+DFG    + K        VG
Sbjct: 121 CLAVLKALSFLHAQGVIHRDIKSDSILLT---SDGRVKLSDFGFCAQVSKEVPRRKSLVG 177

Query: 206 SPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSD 264
           +P+++APEV++   Y    D+WS G+++  ++ G PP++ +   +    +R        +
Sbjct: 178 TPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKN 237

Query: 265 PWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEEC 303
               +S   R  +  ML  DP+ R TAAE+L H ++ + 
Sbjct: 238 L-HKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKA 275

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  111 bits (278), Expect = 4e-28
 Identities = 78/264 (29%), Positives = 129/264 (48%), Gaps = 17/264 (6%)

Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRL-VTVEDVRSIKLEIEIMTKLSG 99
           +Y + + +G G FG         + +  A K I   RL  +   V   + E  ++ K+  
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEI---RLPKSSSAVEDSRKEAVLLAKMK- 56

Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRL-EKYGR-FSETEARVIFRHLMQVVSYC 157
           HPN+V  K  +E + +++++ME C GG+L  ++  + G+ F E      F  +   V + 
Sbjct: 57  HPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHI 116

Query: 158 HGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT-VGSPFYIAPEVLA 216
           H   V+HRD+K +NI L   + +  +KL DFG A  + +      T VG+P+Y+ PE+  
Sbjct: 117 HEKRVLHRDIKSKNIFL---TQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWE 173

Query: 217 G-GYNQAADVWSAGVILYILLSGMPPFWGKT-KSKIFDAVRAADLRFPSDPWDHISASAR 274
              YN  +D+WS G ILY L +   PF   + K+ I    + +    PS    H S   R
Sbjct: 174 NMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPS----HYSYELR 229

Query: 275 DLIMGMLRVDPSTRLTAAEVLAHS 298
            LI  M + +P +R +A  +L+  
Sbjct: 230 SLIKQMFKRNPRSRPSATTILSRG 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  110 bits (277), Expect = 9e-28
 Identities = 72/268 (26%), Positives = 120/268 (44%), Gaps = 28/268 (10%)

Query: 46  KQLGWGQFGVIR--ECSDKFTGEVL-ACKSI-AKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           K+LG G FG +   +   K       A K++         +D      E  +M KL GHP
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLK---EARVMKKL-GHP 56

Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYG--RFSETEARVIFRHL----MQV-- 153
           NVV L  V  EE+ ++L++E   GG+L   L K      S  ++ +  + L    +Q+  
Sbjct: 57  NVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAK 116

Query: 154 -VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYI-- 210
            + Y      VHRDL   N L+        +K++DFGL+  +          G    I  
Sbjct: 117 GMEYLASKKFVHRDLAARNCLVGEDLV---VKISDFGLSRDVYDDDYYRKKTGGKLPIRW 173

Query: 211 -APEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWD 267
            APE L  G +   +DVWS GV+L+ + + G  P+ G +  ++ + +R         P +
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKG--YRLPKP-E 230

Query: 268 HISASARDLIMGMLRVDPSTRLTAAEVL 295
           +      +L++   ++DP  R T +E++
Sbjct: 231 YCPDELYELMLSCWQLDPEDRPTFSELV 258

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score =  110 bits (276), Expect = 1e-27
 Identities = 86/264 (32%), Positives = 134/264 (50%), Gaps = 18/264 (6%)

Query: 41  RYVLGKQLGWGQFGVIRECSDK--FTGEVL-ACKSIAKDRLVTVEDVRSIKLEIEIMTKL 97
           RY+L ++LG G FG +    DK     E L   K I    L   E V++   E ++++KL
Sbjct: 1   RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQA-NQEAQLLSKL 59

Query: 98  SGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSET--EARVI--FRHLMQV 153
             HP +V   A + E D   ++ E C G +L  +LE+     +T  E +V   F  L+  
Sbjct: 60  D-HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLG 118

Query: 154 VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT-VGSPFYIAP 212
           V Y H   ++HRDLK +NI L     ++ +K+ DFG++  +    +L  T  G+P+Y++P
Sbjct: 119 VHYMHQRRILHRDLKAKNIFL----KNNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSP 174

Query: 213 EVLA-GGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISA 271
           E L   GY+  +D+WS G ILY +      F G+    +   +R  +   PS P +  S 
Sbjct: 175 EALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSV--VLRIVEGPTPSLP-ETYSR 231

Query: 272 SARDLIMGMLRVDPSTRLTAAEVL 295
               ++  ML  DPS R +AAE+L
Sbjct: 232 QLNSIMQSMLNKDPSLRPSAAEIL 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score =  110 bits (276), Expect = 1e-27
 Identities = 78/284 (27%), Positives = 137/284 (48%), Gaps = 20/284 (7%)

Query: 48  LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN-VVDL 106
           LG G FG +  C  + TG++ ACK + K RL   +      +E  I+ K+  H   +V L
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV--HSRFIVSL 58

Query: 107 KAVYEEEDYVHLLMELCAGGELFHRL----EKYGRFSETEARVIFRHLMQVVSYCHGNGV 162
              ++ +  + L+M +  GG+L + +    E+   F E  A      ++  + + H   +
Sbjct: 59  AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRI 118

Query: 163 VHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN-LHGTVGSPFYIAPEVLAG-GYN 220
           ++RDLKPEN+LL    +   ++++D GLA  +K GQ+   G  G+P ++APE+L G  Y+
Sbjct: 119 IYRDLKPENVLL---DNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYD 175

Query: 221 QAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGM 280
            + D ++ GV LY +++   PF  + +      ++   L       D  S +++     +
Sbjct: 176 FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEAL 235

Query: 281 LRVDPSTRLTAAEVLAHSWMEECEQVAQKPCKQDDLCCKQLEVG 324
           L  DP  RL   +         C+ +   P  + DL  +QLE G
Sbjct: 236 LAKDPEKRLGFRD-------GNCDGLRTHPLFR-DLNWRQLEAG 271

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score =  111 bits (279), Expect = 1e-27
 Identities = 77/269 (28%), Positives = 126/269 (46%), Gaps = 17/269 (6%)

Query: 46  KQLGWGQFG-VIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVV 104
           + LG G FG VI           +A K   K +++  + V  +  E +I+  ++ HP  V
Sbjct: 36  RTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN-HPFCV 94

Query: 105 DLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVH 164
           +L   +++E Y++L++E   GGE F  L +  RF           ++ +  Y     +V+
Sbjct: 95  NLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVY 154

Query: 165 RDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG-GYNQAA 223
           RDLKPEN+LL        IK+ DFG A  +      +   G+P YIAPE+L   G+ +AA
Sbjct: 155 RDLKPENLLL---DKDGFIKMTDFGFAKVVDT--RTYTLCGTPEYIAPEILLNVGHGKAA 209

Query: 224 DVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRV 283
           D W+ G+ +Y +L G PPF+      I+  +    + FP      +  + + L+  +L  
Sbjct: 210 DWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPK----FLDNNCKHLMKKLLSH 265

Query: 284 DPSTRL-----TAAEVLAHSWMEECEQVA 307
           D + R       A  V  H W    + V+
Sbjct: 266 DLTKRYGNLKKGAQNVKEHPWFGNIDWVS 294

Length = 340

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score =  110 bits (275), Expect = 1e-27
 Identities = 81/250 (32%), Positives = 126/250 (50%), Gaps = 17/250 (6%)

Query: 48  LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH---PNVV 104
           +G G FG +  C    TG++ A K + K R + ++   ++ L   IM  L      P +V
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKR-IKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 105 DLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVH 164
            +   +   D +  +++L  GG+L + L ++G FSE E R     ++  + + H   VV+
Sbjct: 61  CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVY 120

Query: 165 RDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGG--YNQA 222
           RDLKP NILL        ++++D GLA    + +  H +VG+  Y+APEVL  G  Y+ +
Sbjct: 121 RDLKPANILL---DEHGHVRISDLGLACDF-SKKKPHASVGTHGYMAPEVLQKGVAYDSS 176

Query: 223 ADVWSAGVILYILLSGMPPFWG-KTKSK--IFDAVRAADLRFPSDPWDHISASARDLIMG 279
           AD +S G +L+ LL G  PF   KTK K  I        +  P    D  S   R L+ G
Sbjct: 177 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP----DSFSPELRSLLEG 232

Query: 280 MLRVDPSTRL 289
           +L+ D + RL
Sbjct: 233 LLQRDVNRRL 242

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score =  110 bits (275), Expect = 2e-27
 Identities = 80/261 (30%), Positives = 124/261 (47%), Gaps = 12/261 (4%)

Query: 48  LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLK 107
           LG G FG +  C  + TG++ ACK + K R+   +       E +I+ K++    VV+L 
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQ-FVVNLA 66

Query: 108 AVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIF--RHLMQVVSYCHGNGVVHR 165
             YE +D + L++ +  GG+L   +   G     E R +F    ++  +   H    V+R
Sbjct: 67  YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYR 126

Query: 166 DLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGG-YNQAAD 224
           DLKPENILL        I+++D GLA  I  G+++ G VG+  Y+APEVL    Y  + D
Sbjct: 127 DLKPENILL---DDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPD 183

Query: 225 VWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVD 284
            W  G ++Y ++ G  PF G+ +    + V    L          S  A+ +   +L  D
Sbjct: 184 YWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKD 243

Query: 285 PSTRL-----TAAEVLAHSWM 300
           P  RL      A EV  H + 
Sbjct: 244 PKQRLGCQEEGAGEVKRHPFF 264

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  110 bits (277), Expect = 2e-27
 Identities = 78/262 (29%), Positives = 124/262 (47%), Gaps = 25/262 (9%)

Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           +++G G FG +    D  T EV+A K ++     + E  + I  E+  + +L  HPN ++
Sbjct: 21  REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR-HPNTIE 79

Query: 106 LKAVYEEEDYVHLLMELCAG--GELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVV 163
            K  Y  E    L+ME C G   ++    +K     E E   I    +Q ++Y H +  +
Sbjct: 80  YKGCYLREHTAWLVMEYCLGSASDILEVHKK--PLQEVEIAAICHGALQGLAYLHSHERI 137

Query: 164 HRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEV-LA---GGY 219
           HRD+K  NILL   +    +KLADFG A+ +    +    VG+P+++APEV LA   G Y
Sbjct: 138 HRDIKAGNILL---TEPGTVKLADFGSASLVSPANSF---VGTPYWMAPEVILAMDEGQY 191

Query: 220 NQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRA----ADLRFPSDPWDHISASARD 275
           +   DVWS G+    L    PP +        +A+ A    A    P+   +  S   R+
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLFN------MNAMSALYHIAQNDSPTLSSNDWSDYFRN 245

Query: 276 LIMGMLRVDPSTRLTAAEVLAH 297
            +   L+  P  R ++ E+L H
Sbjct: 246 FVDSCLQKIPQDRPSSEELLKH 267

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score =  111 bits (279), Expect = 2e-27
 Identities = 88/288 (30%), Positives = 137/288 (47%), Gaps = 30/288 (10%)

Query: 39  SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLS 98
           ++ Y + K +G G FG ++    K + +V A K ++K  ++   D      E +IM   +
Sbjct: 42  AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMA-FA 100

Query: 99  GHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCH 158
             P VV L   ++++ Y++++ME   GG+L + +  Y    E  A+     ++  +   H
Sbjct: 101 NSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYTAEVVLALDAIH 159

Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLH--GTVGSPFYIAPEVLA 216
             G++HRD+KP+N+LL        +KLADFG    +     +     VG+P YI+PEVL 
Sbjct: 160 SMGLIHRDVKPDNMLL---DKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLK 216

Query: 217 -----GGYNQAADVWSAGVILYILLSGMPPFWGK----TKSKIFDAVRAADLRFPSDPWD 267
                G Y +  D WS GV L+ +L G  PF+      T SKI D      L FP D   
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMD--HKNSLNFPEDV-- 272

Query: 268 HISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKPCKQDD 315
            IS  A++LI   L  D   RL    V         E++ Q P  ++D
Sbjct: 273 EISKHAKNLICAFL-TDREVRLGRNGV---------EEIKQHPFFKND 310

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score =  109 bits (274), Expect = 5e-27
 Identities = 68/253 (26%), Positives = 121/253 (47%), Gaps = 18/253 (7%)

Query: 48  LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLK 107
           +G G +  +     K T  + A K + K+ +   ED+  ++ E  +  + S HP +V L 
Sbjct: 3   IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62

Query: 108 AVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDL 167
           + ++ E  +  ++E   GG+L   +++  +  E  AR     +   ++Y H  G+++RDL
Sbjct: 63  SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDL 122

Query: 168 KPENILLATKSSSSPIKLADFGLATY-IKAGQNLHGTVGSPFYIAPEVLAG-GYNQAADV 225
           K +N+LL    S   IKL D+G+    ++ G       G+P YIAPE+L G  Y  + D 
Sbjct: 123 KLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW 179

Query: 226 WSAGVILYILLSGMPPF---------WGKTKSKIFDAVRAADLRFPSDPWDHISASARDL 276
           W+ GV+++ +++G  PF            T+  +F  +    +R P      +S  A  +
Sbjct: 180 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS----LSVKAASV 235

Query: 277 IMGMLRVDPSTRL 289
           +   L  DP  RL
Sbjct: 236 LKSFLNKDPKERL 248

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  108 bits (272), Expect = 5e-27
 Identities = 80/272 (29%), Positives = 123/272 (45%), Gaps = 30/272 (11%)

Query: 48  LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLK 107
           LG G  G + +C  K TG + A K+I  D    ++  + I  E+EI       P +V   
Sbjct: 9   LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQ--KQILRELEINKSCK-SPYIVKYY 65

Query: 108 AVY--EEEDYVHLLMELCAGGEL---FHR-LEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
             +  E    + + ME C GG L   + +  ++ GR  E     I   +++ +SY H   
Sbjct: 66  GAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK 125

Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT-VGSPFYIAPEVLAGG-Y 219
           ++HRD+KP NILL  K     +KL DFG++   +   +L GT  G+ FY+APE + G  Y
Sbjct: 126 IIHRDIKPSNILLTRKGQ---VKLCDFGVSG--ELVNSLAGTFTGTSFYMAPERIQGKPY 180

Query: 220 NQAADVWSAGVILYILLSGMPPFWGKTKSKIFDA---------VRAADLRFPSDPWDHI- 269
           +  +DVWS G+ L  +     PF                    V   +     +P + I 
Sbjct: 181 SITSDVWSLGLTLLEVAQNRFPF---PPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIK 237

Query: 270 -SASARDLIMGMLRVDPSTRLTAAEVLAHSWM 300
            S   +D I   L  DP+ R T  ++L H W+
Sbjct: 238 WSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWI 269

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score =  108 bits (270), Expect = 5e-27
 Identities = 82/272 (30%), Positives = 130/272 (47%), Gaps = 19/272 (6%)

Query: 37  NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTK 96
           N    Y L +++G G +G + +  +  TGE+ A K I   +L   +D   I+ EI  M K
Sbjct: 6   NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKII---KLEPGDDFSLIQQEI-FMVK 61

Query: 97  LSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSY 156
              H N+V     Y   + + + ME C GG L       G  SE +   + R  +Q ++Y
Sbjct: 62  ECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAY 121

Query: 157 CHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT-VGSPFYIAPEVL 215
            H  G +HRD+K  NILL   + +  +KLADFG+A  I A      + +G+P+++APEV 
Sbjct: 122 LHSKGKMHRDIKGANILL---TDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVA 178

Query: 216 A----GGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFP----SDPWD 267
           A    GGYNQ  D+W+ G+    L    PP +     +    +  ++ + P       W 
Sbjct: 179 AVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKW- 237

Query: 268 HISASARDLIMGMLRVDPSTRLTAAEVLAHSW 299
             S++  + +   L  +P  R TA  +L H +
Sbjct: 238 --SSTFHNFVKISLTKNPKKRPTAERLLTHLF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score =  110 bits (276), Expect = 6e-27
 Identities = 92/308 (29%), Positives = 133/308 (43%), Gaps = 57/308 (18%)

Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           K LG G FG +       T  + A K++ K  ++    V  +K E +I+ + + +  VV 
Sbjct: 7   KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAE-ADNEWVVR 65

Query: 106 LKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHR 165
           L   ++++D ++ +M+   GG++   L + G F E  AR     L   V   H  G +HR
Sbjct: 66  LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHR 125

Query: 166 DLKPENILLATKSSSSPIKLADFGLAT---------YIKAGQNL---------------- 200
           D+KP+NIL+        IKL DFGL T         Y ++G ++                
Sbjct: 126 DIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182

Query: 201 -----------------------HGTVGSPFYIAPEV-LAGGYNQAADVWSAGVILYILL 236
                                  H  VG+P YIAPEV L  GY Q  D WS GVILY +L
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242

Query: 237 SGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRL---TAAE 293
            G PPF  +T  +    V          P   +S  A DLI+ + R  P  RL    A E
Sbjct: 243 VGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCR-GPEDRLGKNGADE 301

Query: 294 VLAHSWME 301
           + AH + +
Sbjct: 302 IKAHPFFK 309

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  108 bits (271), Expect = 9e-27
 Identities = 90/306 (29%), Positives = 148/306 (48%), Gaps = 53/306 (17%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSI---AKDRLVTVEDVRSIKLEIEIMTK 96
           D+Y   +++G G +GV+ +  D+ T E +A K I    +D  V    +R I L  E+   
Sbjct: 2   DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ-- 59

Query: 97  LSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQV--- 153
              H N+V L+ V   E  ++L+ E     +L   ++    F++   R+I  +L Q+   
Sbjct: 60  ---HGNIVRLQDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNP-RLIKTYLYQILRG 114

Query: 154 VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATY--IKAGQNLHGTVGSPFYIA 211
           ++YCH + V+HRDLKP+N+L+  ++++  +KLADFGLA    I      H  V + +Y A
Sbjct: 115 IAYCHSHRVLHRDLKPQNLLIDRRTNA--LKLADFGLARAFGIPVRTFTHEVV-TLWYRA 171

Query: 212 PEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAVRAADLRFPSDP 265
           PE+L G   Y+   D+WS G I   +++  P F G ++     KIF  +   +     + 
Sbjct: 172 PEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPN----EET 227

Query: 266 W-------DHISA------------------SARDLIMGMLRVDPSTRLTAAEVLAHSWM 300
           W       D+ SA                  +  DL+  MLR+DPS R+TA   L H + 
Sbjct: 228 WPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYF 287

Query: 301 EECEQV 306
           ++    
Sbjct: 288 KDLGDA 293

Length = 294

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  107 bits (268), Expect = 1e-26
 Identities = 79/260 (30%), Positives = 126/260 (48%), Gaps = 13/260 (5%)

Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
           RY + K++G G FG I     K   E    K I   ++   E   S K E+ ++ K+  H
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEAS-KKEVILLAKMK-H 58

Query: 101 PNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYG--RFSETEARVIFRHLMQVVSYCH 158
           PN+V   A ++E   + ++ME C GG+L  R+ +     FSE +    F  +   + + H
Sbjct: 59  PNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH 118

Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT-VGSPFYIAPEVLAG 217
              ++HRD+K +NI L+     +  KL DFG+A  +     L  T VG+P+Y++PE+   
Sbjct: 119 DRKILHRDIKSQNIFLSKNGMVA--KLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQN 176

Query: 218 G-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRF-PSDPWDHISASARD 275
             YN   D+WS G +LY L +   PF G    ++   ++     F P  P  + S   R 
Sbjct: 177 RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQL--VLKICQGYFAPISP--NFSRDLRS 232

Query: 276 LIMGMLRVDPSTRLTAAEVL 295
           LI  + +V P  R +   +L
Sbjct: 233 LISQLFKVSPRDRPSITSIL 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score =  107 bits (268), Expect = 1e-26
 Identities = 76/257 (29%), Positives = 126/257 (49%), Gaps = 12/257 (4%)

Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           +++G G FG + +  D  T +V+A K I  D     +++  I+ EI ++++    P V  
Sbjct: 10  EKIGKGSFGEVFKGIDNRTQKVVAIKII--DLEEAEDEIEDIQQEITVLSQCDS-PYVTK 66

Query: 106 LKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHR 165
               Y ++  + ++ME   GG     LE  G   ET+   I R +++ + Y H    +HR
Sbjct: 67  YYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHR 125

Query: 166 DLKPENILLATKSSSSPIKLADFGLATYIKAGQ-NLHGTVGSPFYIAPEVLA-GGYNQAA 223
           D+K  N+LL   S    +KLADFG+A  +   Q   +  VG+PF++APEV+    Y+  A
Sbjct: 126 DIKAANVLL---SEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKA 182

Query: 224 DVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRV 283
           D+WS G+    L  G PP       K+   +   +   P     + S   ++ +   L  
Sbjct: 183 DIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNN---PPTLEGNYSKPLKEFVEACLNK 239

Query: 284 DPSTRLTAAEVLAHSWM 300
           +PS R TA E+L H ++
Sbjct: 240 EPSFRPTAKELLKHKFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  106 bits (267), Expect = 1e-26
 Identities = 80/267 (29%), Positives = 132/267 (49%), Gaps = 26/267 (9%)

Query: 41  RYVLGKQLGWGQFG---VIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKL-EIEIMTK 96
            Y+  + LG G FG   + R   D     ++  K +   RL   E  R   L EI I++ 
Sbjct: 1   HYIPIRVLGKGAFGEATLYRRTED---DSLVVWKEVNLTRLS--EKERRDALNEIVILSL 55

Query: 97  LSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRL--EKYGRFSETEARVIFRHLMQVV 154
           L  HPN++     + +++ + + ME   GG L+ ++  +K   F E    ++  +L Q+V
Sbjct: 56  LQ-HPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEE---EMVLWYLFQIV 111

Query: 155 S---YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT-VGSPFYI 210
           S   Y H  G++HRD+K  NI L TK+    IKL DFG++  + +  ++  T VG+P+Y+
Sbjct: 112 SAVSYIHKAGILHRDIKTLNIFL-TKAGL--IKLGDFGISKILGSEYSMAETVVGTPYYM 168

Query: 211 APEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHI 269
           +PE+  G  YN  +D+W+ G +LY LL+    F       +   +   +       +   
Sbjct: 169 SPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVY--- 225

Query: 270 SASARDLIMGMLRVDPSTRLTAAEVLA 296
           S+    L+  +L+ DP  R TA EVL 
Sbjct: 226 SSELISLVHSLLQQDPEKRPTADEVLD 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  108 bits (272), Expect = 2e-26
 Identities = 75/303 (24%), Positives = 133/303 (43%), Gaps = 44/303 (14%)

Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKL 97
           +  RY   + +G G +GV+    D  +G+ +A K I     V     R+++ E++I+   
Sbjct: 3   VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLR-ELKILRHF 61

Query: 98  SGHPNVVDLKAVY----EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQV 153
             H N++ ++ +      +   V+++M+L    +L H +      +E   R     L++ 
Sbjct: 62  K-HDNIIAIRDILRPPGADFKDVYVVMDL-MESDLHHIIHSDQPLTEEHIRYFLYQLLRG 119

Query: 154 VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT-----VGSPF 208
           + Y H   V+HRDLKP N+L+   +    +++ DFG+A  + +    H       V + +
Sbjct: 120 LKYIHSANVIHRDLKPSNLLV---NEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRW 176

Query: 209 YIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGKT---------------KSKIF 251
           Y APE+L     Y  A D+WS G I   +L     F GK                  ++ 
Sbjct: 177 YRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236

Query: 252 DAVRAADLR-----FPSD---PWDHI----SASARDLIMGMLRVDPSTRLTAAEVLAHSW 299
           + + +  +R      P     PW  I    S  A DL+  ML+ DP  R+T  + L H +
Sbjct: 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPF 296

Query: 300 MEE 302
           + +
Sbjct: 297 LAQ 299

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  107 bits (269), Expect = 2e-26
 Identities = 90/292 (30%), Positives = 143/292 (48%), Gaps = 55/292 (18%)

Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVED-VRSIKL-EIEIMTKLSGHPNV 103
           +++G G +GV+ +  +K TG+++A K I   RL + E+ V S  + EI ++ +L  HPN+
Sbjct: 6   EKIGEGTYGVVYKGRNKKTGQIVAMKKI---RLESEEEGVPSTAIREISLLKELQ-HPNI 61

Query: 104 VDLKAVYEEEDYVHLLMELCAGGELFHRLEKY------GRFSETE-ARVIFRHLMQVVSY 156
           V L+ V  +E  ++L+ E      L   L+KY      G++ + E  +     ++Q + +
Sbjct: 62  VCLQDVLMQESRLYLIFEF-----LSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILF 116

Query: 157 CHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATY--IKAGQNLHGTVGSPFYIAPEV 214
           CH   V+HRDLKP+N+L+  K     IKLADFGLA    I      H  V + +Y APEV
Sbjct: 117 CHSRRVLHRDLKPQNLLIDNKGV---IKLADFGLARAFGIPVRVYTHEVV-TLWYRAPEV 172

Query: 215 LAGG--YNQAADVWSAGVILYILLSGMPPFWGKTK-SKIFDAVRAADLRFPS-DPWD--- 267
           L G   Y+   D+WS G I   + +  P F G ++  ++F   R   L  P+ D W    
Sbjct: 173 LLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRI--LGTPTEDVWPGVT 230

Query: 268 ----------------------HISASARDLIMGMLRVDPSTRLTAAEVLAH 297
                                 ++     DL+  ML  DP+ R++A + L H
Sbjct: 231 SLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  107 bits (268), Expect = 2e-26
 Identities = 74/269 (27%), Positives = 131/269 (48%), Gaps = 11/269 (4%)

Query: 35  ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
           I +   +Y   +++G G  G +    D  TG+ +A K I   +    E + +   EI +M
Sbjct: 14  IGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIIN---EILVM 70

Query: 95  TKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVV 154
            +L  +PN+V+    +   D + ++ME  AGG L   + +     E +   + R  +Q +
Sbjct: 71  KELK-NPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETC-MDEAQIAAVCRECLQAL 128

Query: 155 SYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT-VGSPFYIAPE 213
            + H N V+HRD+K +N+LL    S   +KL DFG    I   Q+   T VG+P+++APE
Sbjct: 129 EFLHANQVIHRDIKSDNVLLGMDGS---VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 185

Query: 214 VLA-GGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISAS 272
           V+    Y    D+WS G++   ++ G PP+  +   +    +         +P + +S  
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP-EKLSPI 244

Query: 273 ARDLIMGMLRVDPSTRLTAAEVLAHSWME 301
            RD +   L +D   R +A E+L H +++
Sbjct: 245 FRDFLNRCLEMDVEKRGSAKELLQHPFLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score =  106 bits (266), Expect = 3e-26
 Identities = 85/267 (31%), Positives = 133/267 (49%), Gaps = 22/267 (8%)

Query: 48  LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH---PNVV 104
           +G G FG +  C    TG++ A K + K R + ++   ++ L   IM  L      P +V
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKR-IKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 105 DLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVH 164
            +   +   D +  +++L  GG+L + L ++G FSE E R     ++  + + H   VV+
Sbjct: 61  CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVY 120

Query: 165 RDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGG--YNQA 222
           RDLKP NILL        ++++D GLA    + +  H +VG+  Y+APEVL  G  Y+ +
Sbjct: 121 RDLKPANILL---DEHGHVRISDLGLACDF-SKKKPHASVGTHGYMAPEVLQKGTAYDSS 176

Query: 223 ADVWSAGVILYILLSGMPPF-WGKTKSK--IFDAVRAADLRFPSDPWDHISASARDLIMG 279
           AD +S G +L+ LL G  PF   KTK K  I       ++  P    D  S   + L+ G
Sbjct: 177 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELP----DSFSPELKSLLEG 232

Query: 280 MLRVDPSTRL-----TAAEVLAHSWME 301
           +L+ D S RL      A EV  H + +
Sbjct: 233 LLQRDVSKRLGCLGRGAQEVKEHVFFK 259

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score =  107 bits (267), Expect = 3e-26
 Identities = 80/261 (30%), Positives = 122/261 (46%), Gaps = 18/261 (6%)

Query: 48  LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLK 107
           LG G FG +  C  + TG++ ACK + K R+   +       E  I+ K++    VV L 
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSR-FVVSLA 66

Query: 108 AVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIF--RHLMQVVSYCHGNGVVHR 165
             YE +D + L++ +  GG+L   +   G     E R IF    L   +       +V+R
Sbjct: 67  YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYR 126

Query: 166 DLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG-GYNQAAD 224
           DLKPENILL  +     I+++D GLA  I  G+ + G VG+  Y+APEV+    Y  + D
Sbjct: 127 DLKPENILLDDRGH---IRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPD 183

Query: 225 VWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDP---WDHISASARDLIMGML 281
            W  G ++Y ++ G  PF  + +    + V   D R   D     +  S  A+ +   +L
Sbjct: 184 WWGLGCLIYEMIQGQSPFRKRKERVKREEV---DRRVKEDQEEYSEKFSEDAKSICRMLL 240

Query: 282 RVDPSTRL-----TAAEVLAH 297
             +P  RL      AA V  H
Sbjct: 241 TKNPKERLGCRGNGAAGVKQH 261

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  107 bits (269), Expect = 3e-26
 Identities = 79/317 (24%), Positives = 128/317 (40%), Gaps = 76/317 (23%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
            +Y    ++G G FG + +   K T +++A K +  +       + +++ EI+I+  L  
Sbjct: 12  SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR-EIKILQLLK- 69

Query: 100 HPNVVDLKAV----------YEEEDYVHLLMELCAGGELFHRL-----EKYGRFSETEAR 144
           H NVV+L  +          Y+   Y  L+ E C      H L      K  +F+ +E +
Sbjct: 70  HENVVNLIEICRTKATPYNRYKGSFY--LVFEFCE-----HDLAGLLSNKNVKFTLSEIK 122

Query: 145 VIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA----TYIKAGQNL 200
            + + L+  + Y H N ++HRD+K  NIL+ TK     +KLADFGLA        +  N 
Sbjct: 123 KVMKMLLNGLYYIHRNKILHRDMKAANILI-TKDGI--LKLADFGLARAFSLSKNSKPNR 179

Query: 201 HGT-VGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFW-------------- 243
           +   V + +Y  PE+L G   Y    D+W AG I       M   W              
Sbjct: 180 YTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCI-------MAEMWTRSPIMQGNTEQHQ 232

Query: 244 --------GKTKSKIFDAVRAADL----RFPSDPWDHI---------SASARDLIMGMLR 282
                   G    +++  V   +L      P      +            A DLI  +L 
Sbjct: 233 LTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLV 292

Query: 283 VDPSTRLTAAEVLAHSW 299
           +DP+ R+ A   L H +
Sbjct: 293 LDPAKRIDADTALNHDF 309

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score =  107 bits (267), Expect = 3e-26
 Identities = 74/258 (28%), Positives = 134/258 (51%), Gaps = 13/258 (5%)

Query: 47  QLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDL 106
           ++G G  G++   ++K TG+ +A K +   +    +  R +     ++ +   H NVVD+
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRK----QQRRELLFNEVVIMRDYHHENVVDM 84

Query: 107 KAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRD 166
              Y   D + ++ME   GG L   +  + R +E +   +   +++ +SY H  GV+HRD
Sbjct: 85  YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRD 143

Query: 167 LKPENILLATKSSSSPIKLADFGLATYI-KAGQNLHGTVGSPFYIAPEVLAG-GYNQAAD 224
           +K ++ILL   +S   IKL+DFG    + K        VG+P+++APEV++   Y    D
Sbjct: 144 IKSDSILL---TSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVD 200

Query: 225 VWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDH-ISASARDLIMGMLRV 283
           +WS G+++  ++ G PP++ +   +    +R  D   P     H +S+  R  +  ML  
Sbjct: 201 IWSLGIMVIEMIDGEPPYFNEPPLQAMRRIR--DNLPPRVKDSHKVSSVLRGFLDLMLVR 258

Query: 284 DPSTRLTAAEVLAHSWME 301
           +PS R TA E+L H +++
Sbjct: 259 EPSQRATAQELLQHPFLK 276

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score =  107 bits (267), Expect = 4e-26
 Identities = 76/258 (29%), Positives = 123/258 (47%), Gaps = 17/258 (6%)

Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           +++G G FG +    D  T EV+A K ++     + E  + I  E++ + ++  HPN ++
Sbjct: 31  REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK-HPNSIE 89

Query: 106 LKAVYEEEDYVHLLMELCAGGELFHRLEKYGR-FSETEARVIFRHLMQVVSYCHGNGVVH 164
            K  Y  E    L+ME C G      LE + +   E E   I    +Q ++Y H + ++H
Sbjct: 90  YKGCYLREHTAWLVMEYCLGSA-SDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIH 148

Query: 165 RDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVL----AGGYN 220
           RD+K  NILL   +    +KLADFG A+      +    VG+P+++APEV+     G Y+
Sbjct: 149 RDIKAGNILL---TEPGQVKLADFGSASIASPANSF---VGTPYWMAPEVILAMDEGQYD 202

Query: 221 QAADVWSAGVILYILLSGMPPFWG-KTKSKIFDAVRAADLRFPSDPWDHISASARDLIMG 279
              DVWS G+    L    PP +     S ++   +       S+ W   S   R+ +  
Sbjct: 203 GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEW---SDYFRNFVDS 259

Query: 280 MLRVDPSTRLTAAEVLAH 297
            L+  P  R T+ E+L H
Sbjct: 260 CLQKIPQDRPTSEELLKH 277

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  105 bits (265), Expect = 4e-26
 Identities = 77/266 (28%), Positives = 123/266 (46%), Gaps = 25/266 (9%)

Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
            +LG G  GV+ +   + TG+++A K+I  +  +     + I  E++I+ K    P +V 
Sbjct: 7   GELGAGNSGVVSKVLHRPTGKIMAVKTIRLE--INEAIQKQILRELDILHK-CNSPYIVG 63

Query: 106 LKAVYEEEDYVHLLMELCAGGELFHRL-EKYGRFSETEARVIFRHLMQVVSYCHGN-GVV 163
               +     + + ME   GG L   L E  GR  E     I   +++ ++Y H    ++
Sbjct: 64  FYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKII 123

Query: 164 HRDLKPENILLATKSSSSPIKLADFGLATYI---KAGQNLHGTVGSPFYIAPEVLAGG-Y 219
           HRD+KP NIL+   +S   IKL DFG++  +    A       VG+  Y+APE + G  Y
Sbjct: 124 HRDVKPSNILV---NSRGQIKLCDFGVSGQLVNSLAKTF----VGTSSYMAPERIQGNDY 176

Query: 220 NQAADVWSAGVILYILLSG-MP-PFWGKTKSKIFD----AVRAADLRFPSDPWDHISASA 273
           +  +D+WS G+ L  L +G  P P        IF+     V     R PS  +   S   
Sbjct: 177 SVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKF---SPDF 233

Query: 274 RDLIMGMLRVDPSTRLTAAEVLAHSW 299
           +D +   L  DP  R +  E+L H +
Sbjct: 234 QDFVNLCLIKDPRERPSYKELLEHPF 259

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  106 bits (265), Expect = 4e-26
 Identities = 84/283 (29%), Positives = 134/283 (47%), Gaps = 40/283 (14%)

Query: 48  LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLK 107
           +G G +GV+ +C  K T E++A K   KD     E+V+   L    M +     N+V+LK
Sbjct: 9   VGEGAYGVVLKCRHKETKEIVAIKKF-KDSEEN-EEVKETTLRELKMLRTLKQENIVELK 66

Query: 108 AVYEEEDYVHLLMELCAGGELFHRLEKY--GRFSETEARVIFRHLMQVVSYCHGNGVVHR 165
             +     ++L+ E      +   LE+   G   E     I++ L++ + +CH N +VHR
Sbjct: 67  EAFRRRGKLYLVFEYVEK-NMLELLEEMPNGVPPEKVRSYIYQ-LIKAIHWCHKNDIVHR 124

Query: 166 DLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT--VGSPFYIAPEVLAGG-YNQA 222
           D+KPEN+L+   S +  +KL DFG A  +  G N + T  V + +Y +PE+L G  Y +A
Sbjct: 125 DIKPENLLI---SHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKA 181

Query: 223 ADVWSAGVILYILLSGMPPFWGKT------------------KSKIF-DAVRAADLRFPS 263
            D+WS G IL  L  G P F G++                  + K+F    R   LRFP+
Sbjct: 182 VDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPA 241

Query: 264 DPWDH---------ISASARDLIMGMLRVDPSTRLTAAEVLAH 297
                         +S    DL+  +L+++P+ R    + L H
Sbjct: 242 VNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score =  107 bits (267), Expect = 4e-26
 Identities = 77/260 (29%), Positives = 126/260 (48%), Gaps = 17/260 (6%)

Query: 47  QLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDL 106
           ++G G FG +   ++  T EV+A K ++     T E  + I  E++ + +L  HPN ++ 
Sbjct: 28  EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK-HPNTIEY 86

Query: 107 KAVYEEEDYVHLLMELCAGGELFHRLEKYGR-FSETEARVIFRHLMQVVSYCHGNGVVHR 165
           K  Y +E    L+ME C G      LE + +   E E   I    +Q ++Y H + ++HR
Sbjct: 87  KGCYLKEHTAWLVMEYCLGSA-SDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHR 145

Query: 166 DLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVL----AGGYNQ 221
           D+K  NILL   +    +KLADFG A+      +    VG+P+++APEV+     G Y+ 
Sbjct: 146 DIKAGNILL---TEPGQVKLADFGSASKSSPANSF---VGTPYWMAPEVILAMDEGQYDG 199

Query: 222 AADVWSAGVILYILLSGMPPFWG-KTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGM 280
             DVWS G+    L    PP +     S ++   +       S+ W   + S R  +   
Sbjct: 200 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEW---TDSFRGFVDYC 256

Query: 281 LRVDPSTRLTAAEVLAHSWM 300
           L+  P  R  +AE+L H ++
Sbjct: 257 LQKIPQERPASAELLRHDFV 276

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score =  105 bits (264), Expect = 5e-26
 Identities = 76/264 (28%), Positives = 131/264 (49%), Gaps = 20/264 (7%)

Query: 47  QLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDL 106
           +LG G FG + +  +K TG + A K I      + E++    +EI+I+     HPN+V L
Sbjct: 12  ELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILASCD-HPNIVKL 67

Query: 107 KAVYEEEDYVHLLMELCAGGELFHRLEKYGR-FSETEARVIFRHLMQVVSYCHGNGVVHR 165
              +  E+ + +L+E CAGG +   + +  R  +E + RV+ +  ++ ++Y H N ++HR
Sbjct: 68  LDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHR 127

Query: 166 DLKPENILLATKSSSSPIKLADFGL-ATYIKAGQNLHGTVGSPFYIAPEVLA------GG 218
           DLK  NIL         IKLADFG+ A   +  Q     +G+P+++APEV+         
Sbjct: 128 DLKAGNILFTLDGD---IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRP 184

Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDP--WDHISASARDL 276
           Y+  ADVWS G+ L  +    PP       ++   +  ++    + P  W   S+  +D 
Sbjct: 185 YDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRW---SSEFKDF 241

Query: 277 IMGMLRVDPSTRLTAAEVLAHSWM 300
           +   L  +   R T  ++L H ++
Sbjct: 242 LKKCLEKNVDARWTTTQLLQHPFV 265

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score =  110 bits (276), Expect = 5e-26
 Identities = 85/288 (29%), Positives = 137/288 (47%), Gaps = 35/288 (12%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           + Y + K++G G+FG +     K T E    K+I+   L   E  + + +E+ +M +L  
Sbjct: 13  NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLV-IEVNVMRELK- 70

Query: 100 HPNVVDL--KAVYEEEDYVHLLMELCAGGELFHRLEK----YGRFSETEARVIFRHLMQV 153
           H N+V    + + +    +++LME C  G+L   ++K    +G+  E     I R L+  
Sbjct: 71  HKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHA 130

Query: 154 VSYCH-------GNGVVHRDLKPENILLAT-------------KSSSSPI-KLADFGLAT 192
           ++YCH       G  V+HRDLKP+NI L+T               +  PI K+ DFGL+ 
Sbjct: 131 LAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK 190

Query: 193 YIKAGQNLHGTVGSPFYIAPEVL---AGGYNQAADVWSAGVILYILLSGMPPFWGKTKSK 249
            I      H  VG+P+Y +PE+L      Y+  +D+W+ G I+Y L SG  PF    K+ 
Sbjct: 191 NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF---HKAN 247

Query: 250 IFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH 297
            F  + +   R P  P    S     LI  +L +    R +A + L +
Sbjct: 248 NFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGY 295

Length = 1021

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  105 bits (263), Expect = 7e-26
 Identities = 81/273 (29%), Positives = 130/273 (47%), Gaps = 30/273 (10%)

Query: 36  SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSI-AKDRLVTVEDVRSIKLEIEIM 94
               +R VLGK    G +G++    D  T   +A K I  +D       V+ +  EI + 
Sbjct: 8   DENGERVVLGK----GTYGIVYAARDLSTQVRIAIKEIPERDS----RYVQPLHEEIALH 59

Query: 95  TKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLE-KYGRFSETEARVIF--RHLM 151
           + L  H N+V       E  +  + ME   GG L   L  K+G   + E  +IF  + ++
Sbjct: 60  SYLK-HRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL 118

Query: 152 QVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFG----LATYIKAGQNLHGTVGSP 207
           + + Y H N +VHRD+K +N+L+ T S    +K++DFG    LA      +   GT+   
Sbjct: 119 EGLKYLHDNQIVHRDIKGDNVLVNTYSGV--VKISDFGTSKRLAGINPCTETFTGTLQ-- 174

Query: 208 FYIAPEVL---AGGYNQAADVWSAGVILYILLSGMPPFW--GKTKSKIFDAVRAADLRFP 262
            Y+APEV+     GY   AD+WS G  +  + +G PPF   G+ ++ +F          P
Sbjct: 175 -YMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKI--HP 231

Query: 263 SDPWDHISASARDLIMGMLRVDPSTRLTAAEVL 295
             P + +SA A++ I+     DP  R +A ++L
Sbjct: 232 EIP-ESLSAEAKNFILRCFEPDPDKRASAHDLL 263

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  105 bits (264), Expect = 7e-26
 Identities = 80/288 (27%), Positives = 134/288 (46%), Gaps = 46/288 (15%)

Query: 47  QLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKL-EIEIMTKLSGHPNVVD 105
           ++G G +G + +  ++ T E++A K +  D     E V S  L EI ++ +L  H N+V 
Sbjct: 7   KIGEGTYGTVFKAKNRETHEIVALKRVRLDD--DDEGVPSSALREICLLKELK-HKNIVR 63

Query: 106 LKAVYEEEDYVHLLMELCAGGELFHRLEKY-----GRFSETEARVIFRHLMQVVSYCHGN 160
           L  V   +  + L+ E C        L+KY     G       +     L++ +++CH +
Sbjct: 64  LYDVLHSDKKLTLVFEYCD-----QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH 118

Query: 161 GVVHRDLKPENILLATKSSSSPIKLADFGLA-TYIKAGQNLHGTVGSPFYIAPEVLAG-- 217
            V+HRDLKP+N+L+        +KLADFGLA  +    +     V + +Y  P+VL G  
Sbjct: 119 NVLHRDLKPQNLLINKNGE---LKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 175

Query: 218 GYNQAADVWSAGVILYILL-SGMPPFWGKTKS----KIF------------DAVRAADLR 260
            Y+ + D+WSAG I   L  +G P F G        +IF               +  D +
Sbjct: 176 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYK 235

Query: 261 -FPSDP----WDHI----SASARDLIMGMLRVDPSTRLTAAEVLAHSW 299
            +P  P      ++    +++ RDL+  +L  +P  R++A E L H +
Sbjct: 236 PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score =  105 bits (263), Expect = 1e-25
 Identities = 75/278 (26%), Positives = 136/278 (48%), Gaps = 16/278 (5%)

Query: 29  ILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIK 88
           ++D     +L + Y+   ++G G  G++    +K +G  +A K +   +    +  R + 
Sbjct: 13  VVDQGDPRSLLENYI---KIGEGSTGIVCIAREKHSGRQVAVKMMDLRK----QQRRELL 65

Query: 89  LEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
               ++ +   H NVV++   Y   + + +LME   GG L   + +  R +E +   +  
Sbjct: 66  FNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQT-RLNEEQIATVCE 124

Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI-KAGQNLHGTVGSP 207
            ++Q + Y H  GV+HRD+K ++ILL        +KL+DFG    I K        VG+P
Sbjct: 125 SVLQALCYLHSQGVIHRDIKSDSILLTLDGR---VKLSDFGFCAQISKDVPKRKSLVGTP 181

Query: 208 FYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW 266
           +++APEV++   Y    D+WS G+++  ++ G PP++  +  +    +R  D   P    
Sbjct: 182 YWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR--DSPPPKLKN 239

Query: 267 DH-ISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEEC 303
            H IS   RD +  ML  +P  R TA E+L H ++ + 
Sbjct: 240 AHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQT 277

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score =  104 bits (261), Expect = 1e-25
 Identities = 63/253 (24%), Positives = 130/253 (51%), Gaps = 10/253 (3%)

Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           + + K++G GQF  +   +     + +A K +    ++  +  +    EI+++ +L+ HP
Sbjct: 4   FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN-HP 62

Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSE-TEARVIFRHLMQVVS---YC 157
           NV+     + E++ +++++EL   G+L   ++ + +       R ++++ +Q+ S   + 
Sbjct: 63  NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122

Query: 158 HGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNL-HGTVGSPFYIAPE-VL 215
           H   V+HRD+KP N+ +   +++  +KL D GL  +  +     H  VG+P+Y++PE + 
Sbjct: 123 HSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 179

Query: 216 AGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARD 275
             GYN  +D+WS G +LY + +   PF+G   +      +     +P  P +H S   R+
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRE 239

Query: 276 LIMGMLRVDPSTR 288
           L+   +  DP  R
Sbjct: 240 LVSMCIYPDPDQR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score =  104 bits (261), Expect = 2e-25
 Identities = 74/262 (28%), Positives = 119/262 (45%), Gaps = 17/262 (6%)

Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           +++G G FG +    D    EV+A K ++     + E  + I  E+  + KL  HPN + 
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQ 79

Query: 106 LKAVYEEEDYVHLLMELCAGGELFHRLEKYGR-FSETEARVIFRHLMQVVSYCHGNGVVH 164
            +  Y  E    L+ME C G      LE + +   E E   +    +Q ++Y H + ++H
Sbjct: 80  YRGCYLREHTAWLVMEYCLGSA-SDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIH 138

Query: 165 RDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVL----AGGYN 220
           RD+K  NILL   S    +KL DFG A+ +         VG+P+++APEV+     G Y+
Sbjct: 139 RDVKAGNILL---SEPGLVKLGDFGSASIMAPANXF---VGTPYWMAPEVILAMDEGQYD 192

Query: 221 QAADVWSAGVILYILLSGMPPFWG-KTKSKIFDAVRAADLRFPSDPWDHISASARDLIMG 279
              DVWS G+    L    PP +     S ++   +       S  W   S   R+ +  
Sbjct: 193 GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW---SEYFRNFVDS 249

Query: 280 MLRVDPSTRLTAAEVLAHSWME 301
            L+  P  R T+  +L H ++ 
Sbjct: 250 CLQKIPQDRPTSEVLLKHRFVL 271

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  105 bits (263), Expect = 3e-25
 Identities = 89/320 (27%), Positives = 151/320 (47%), Gaps = 57/320 (17%)

Query: 37  NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIA--KDRLVTVEDVRSIKLEIEIM 94
           ++  RY     +G G +G++   + K TG  +A K I+  + +      +R    EI+I+
Sbjct: 2   DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR----EIKIL 57

Query: 95  TKLSGHPNVVDLKAV-----YEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRH 149
            +   H N++ +  +     +E  + V+++ EL       ++L K    S    +     
Sbjct: 58  RRFK-HENIIGILDIIRPPSFESFNDVYIVQELMETD--LYKLIKTQHLSNDHIQYFLYQ 114

Query: 150 LMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT-----V 204
           +++ + Y H   V+HRDLKP N+LL   +++  +K+ DFGLA  I   ++ H       V
Sbjct: 115 ILRGLKYIHSANVLHRDLKPSNLLL---NTNCDLKICDFGLAR-IADPEHDHTGFLTEYV 170

Query: 205 GSPFYIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGK----TKSKIFD------ 252
            + +Y APE++  + GY +A D+WS G IL  +LS  P F GK      + I        
Sbjct: 171 ATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPS 230

Query: 253 --------AVRAAD----LRF-PSDPWD----HISASARDLIMGMLRVDPSTRLTAAEVL 295
                   ++RA +    L F P  PW+    +    A DL+  ML  +P  R+T  E L
Sbjct: 231 QEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEAL 290

Query: 296 AHSWMEEC-----EQVAQKP 310
           AH ++E+      E VA++P
Sbjct: 291 AHPYLEQYHDPSDEPVAEEP 310

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score =  105 bits (264), Expect = 3e-25
 Identities = 89/315 (28%), Positives = 132/315 (41%), Gaps = 57/315 (18%)

Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           +V  K LG G FG +       T  + A K++ K  ++    V  +K E +I+ + + + 
Sbjct: 3   FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAE-ADNE 61

Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
            VV L   ++++D ++ +M+   GG++   L +   F E  AR     L   +   H  G
Sbjct: 62  WVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG 121

Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLAT---------YIKAGQNL------------ 200
            +HRD+KP+NIL+        IKL DFGL T         Y + G ++            
Sbjct: 122 FIHRDIKPDNILIDLDGH---IKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWD 178

Query: 201 ---------------------------HGTVGSPFYIAPEV-LAGGYNQAADVWSAGVIL 232
                                      H  VG+P YIAPEV L  GY Q  D WS GVIL
Sbjct: 179 DVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238

Query: 233 YILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRL--- 289
           + +L G PPF   T ++    V   +      P   +S  A DLI   L      RL   
Sbjct: 239 FEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLI-TKLCCSAEERLGRN 297

Query: 290 TAAEVLAHSWMEECE 304
            A ++ AH +  E +
Sbjct: 298 GADDIKAHPFFSEVD 312

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score =  104 bits (260), Expect = 3e-25
 Identities = 74/263 (28%), Positives = 130/263 (49%), Gaps = 11/263 (4%)

Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
           +Y   +++G G  G +    D  TG+ +A K +   +    E + +   EI +M + + +
Sbjct: 20  KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIIN---EILVMRE-NKN 75

Query: 101 PNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGN 160
           PN+V+    Y   D + ++ME  AGG L   + +     E +   + R  +Q + + H N
Sbjct: 76  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALDFLHSN 134

Query: 161 GVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT-VGSPFYIAPEVLA-GG 218
            V+HRD+K +NILL    S   +KL DFG    I   Q+   T VG+P+++APEV+    
Sbjct: 135 QVIHRDIKSDNILLGMDGS---VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 191

Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           Y    D+WS G++   ++ G PP+  +   +    +         +P + +SA  RD + 
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP-ERLSAVFRDFLN 250

Query: 279 GMLRVDPSTRLTAAEVLAHSWME 301
             L +D   R +A E+L H +++
Sbjct: 251 RCLEMDVDRRGSAKELLQHPFLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score =  103 bits (258), Expect = 4e-25
 Identities = 76/257 (29%), Positives = 121/257 (47%), Gaps = 12/257 (4%)

Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           +++G G FG + +  D  T EV+A K I  D     +++  I+ EI ++++    P +  
Sbjct: 10  ERIGKGSFGEVYKGIDNRTKEVVAIKII--DLEEAEDEIEDIQQEITVLSQCDS-PYITR 66

Query: 106 LKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHR 165
               Y +   + ++ME   GG     L K G   ET    I R +++ + Y H    +HR
Sbjct: 67  YYGSYLKGTKLWIIMEYLGGGSALDLL-KPGPLEETYIATILREILKGLDYLHSERKIHR 125

Query: 166 DLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT-VGSPFYIAPEVLA-GGYNQAA 223
           D+K  N+LL   S    +KLADFG+A  +   Q    T VG+PF++APEV+    Y+  A
Sbjct: 126 DIKAANVLL---SEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKA 182

Query: 224 DVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRV 283
           D+WS G+    L  G PP       ++   +       P       S   ++ +   L  
Sbjct: 183 DIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNS---PPTLEGQYSKPFKEFVEACLNK 239

Query: 284 DPSTRLTAAEVLAHSWM 300
           DP  R TA E+L H ++
Sbjct: 240 DPRFRPTAKELLKHKFI 256

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score =  103 bits (258), Expect = 5e-25
 Identities = 87/302 (28%), Positives = 135/302 (44%), Gaps = 44/302 (14%)

Query: 25  LTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDV 84
           L+G  +      + SD + + + +G G +G + +  +K  G   A K      L  + D+
Sbjct: 3   LSGKTIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKI-----LDPIHDI 57

Query: 85  -RSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVH-----LLMELCAGG---ELFHRLEKY 135
              I+ E  I+  LS HPNVV    +Y ++D  +     L++ELC GG   +L     K 
Sbjct: 58  DEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKR 117

Query: 136 G-RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI 194
           G R  E     I    +  + + H N  +HRD+K  NILL T+     +KL DFG++  +
Sbjct: 118 GERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGG---VKLVDFGVSAQL 174

Query: 195 KAGQNLHGT-VGSPFYIAPEVLA------GGYNQAADVWSAGVILYILLSGMPPFWGKTK 247
            + +    T VG+PF++APEV+A        Y+   DVWS G+    L  G PP      
Sbjct: 175 TSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL----- 229

Query: 248 SKIFDAVRAADLRFPSDP---------WDHISASARDLIMGMLRVDPSTRLTAAEVLAHS 298
                 +RA   + P +P         W   S    D I   L  D   R T +++L H 
Sbjct: 230 -ADLHPMRAL-FKIPRNPPPTLHQPELW---SNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284

Query: 299 WM 300
           ++
Sbjct: 285 FI 286

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score =  103 bits (257), Expect = 7e-25
 Identities = 88/296 (29%), Positives = 135/296 (45%), Gaps = 44/296 (14%)

Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKL--EIEIMTKLS 98
           +Y    ++G G +G + +  D  +G  +A KS+   R+ T ED   +    E+ ++ +L 
Sbjct: 1   QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSV---RVQTNEDGLPLSTVREVALLKRLE 57

Query: 99  G--HPNVVDLKAV-----YEEEDYVHLLMELCAGGELFHRLEKY---GRFSETEARVIFR 148
              HPN+V L  V      + E  V L+ E     +L   L+K    G  +ET  + + R
Sbjct: 58  AFDHPNIVRLMDVCATSRTDRETKVTLVFEH-VDQDLRTYLDKVPPPGLPAET-IKDLMR 115

Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF 208
             ++ + + H N +VHRDLKPENIL+   +S   +KLADFGLA        L   V + +
Sbjct: 116 QFLRGLDFLHANCIVHRDLKPENILV---TSGGQVKLADFGLARIYSCQMALTPVVVTLW 172

Query: 209 YIAPEV-LAGGYNQAADVWSAGVILYILLSGMPPFWGKTKS----KIFDAV-RAADLRFP 262
           Y APEV L   Y    D+WS G I   +    P F G +++    KIFD +    +  +P
Sbjct: 173 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 232

Query: 263 SD--------------PWD----HISASARDLIMGMLRVDPSTRLTAAEVLAHSWM 300
            D              P       I  S   L++ ML  +P  R++A   L H + 
Sbjct: 233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score =  103 bits (259), Expect = 7e-25
 Identities = 65/251 (25%), Positives = 121/251 (48%), Gaps = 16/251 (6%)

Query: 48  LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLK 107
           +G G +  +     K   ++ A K + K+ +   ED+  ++ E  +  + S +P +V L 
Sbjct: 3   IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62

Query: 108 AVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDL 167
           + ++    + L++E   GG+L   +++  +  E  AR     +   +++ H  G+++RDL
Sbjct: 63  SCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDL 122

Query: 168 KPENILLATKSSSSPIKLADFGLATY-IKAGQNLHGTVGSPFYIAPEVLAG-GYNQAADV 225
           K +N+LL    +   IKL D+G+    +  G       G+P YIAPE+L G  Y  + D 
Sbjct: 123 KLDNVLL---DADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDW 179

Query: 226 WSAGVILYILLSGMPPF-------WGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           W+ GV+++ +++G  PF          T+  +F  +    +R P      +S  A  ++ 
Sbjct: 180 WALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPR----FLSVKASHVLK 235

Query: 279 GMLRVDPSTRL 289
           G L  DP  RL
Sbjct: 236 GFLNKDPKERL 246

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  103 bits (257), Expect = 7e-25
 Identities = 77/272 (28%), Positives = 131/272 (48%), Gaps = 17/272 (6%)

Query: 35  ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
           + +   +Y   +++G G  G +    D  TG+ +A K +    L        I  EI +M
Sbjct: 14  VGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQM---NLQQQPKKELIINEILVM 70

Query: 95  TKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVV 154
            +   HPN+V+    Y   D + ++ME  AGG L   + +     E +   + R  +Q +
Sbjct: 71  RENK-HPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQAL 128

Query: 155 SYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT-VGSPFYIAPE 213
            + H N V+HRD+K +NILL    S   +KL DFG    I   Q+   T VG+P+++APE
Sbjct: 129 EFLHSNQVIHRDIKSDNILLGMDGS---VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 185

Query: 214 VLA-GGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRA---ADLRFPSDPWDHI 269
           V+    Y    D+WS G++   ++ G PP+  +   +    +      +L+ P    + +
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP----EKL 241

Query: 270 SASARDLIMGMLRVDPSTRLTAAEVLAHSWME 301
           SA  RD +   L +D   R +A E+L H +++
Sbjct: 242 SAIFRDFLNRCLEMDVEKRGSAKELLQHPFLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score =  103 bits (259), Expect = 9e-25
 Identities = 69/253 (27%), Positives = 122/253 (48%), Gaps = 18/253 (7%)

Query: 48  LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLK 107
           +G G +  +     K T  + A K I K+ +   ED+  ++ E  +    S HP +V L 
Sbjct: 3   IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62

Query: 108 AVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDL 167
           + ++ E  +  ++E  +GG+L   +++  +  E  AR     +   +++ H  G+++RDL
Sbjct: 63  SCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDL 122

Query: 168 KPENILLATKSSSSPIKLADFGLATY-IKAGQNLHGTVGSPFYIAPEVLAG-GYNQAADV 225
           K +N+LL    +   IKL D+G+    I+ G       G+P YIAPE+L G  Y  + D 
Sbjct: 123 KLDNVLL---DAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW 179

Query: 226 WSAGVILYILLSGMPPF---------WGKTKSKIFDAVRAADLRFPSDPWDHISASARDL 276
           W+ GV+++ +++G  PF            T+  +F  +    +R P      +S  A  +
Sbjct: 180 WALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRS----LSVKASSV 235

Query: 277 IMGMLRVDPSTRL 289
           + G L  DP  RL
Sbjct: 236 LKGFLNKDPKERL 248

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score =  102 bits (257), Expect = 2e-24
 Identities = 92/335 (27%), Positives = 148/335 (44%), Gaps = 67/335 (20%)

Query: 36  SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIK---LEIE 92
            +L  RY+  + LG G  G++    D         K +A  ++V + D +S+K    EI+
Sbjct: 1   FDLGSRYMDLRPLGCGSNGLVFSAVDS-----DCDKRVAVKKIV-LTDPQSVKHALREIK 54

Query: 93  IMTKL--------------SGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRF 138
           I+ +L              SG     D+ ++ E  + V+++ E     +L + LE+ G  
Sbjct: 55  IIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTEL-NSVYIVQE-YMETDLANVLEQ-GPL 111

Query: 139 SETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLAT-----Y 193
           SE  AR+    L++ + Y H   V+HRDLKP N+ + T+     +K+ DFGLA      Y
Sbjct: 112 SEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLV--LKIGDFGLARIVDPHY 169

Query: 194 IKAGQNLHGTVGSPFYIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGKTKSK-- 249
              G    G V + +Y +P +L     Y +A D+W+AG I   +L+G P F G  + +  
Sbjct: 170 SHKGYLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQM 228

Query: 250 --IFDAV---RAADLR-----FPS----DPWD----------HISASARDLIMGMLRVDP 285
             I ++V   R  D        PS    D  +           ++  A D +  +L  +P
Sbjct: 229 QLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNP 288

Query: 286 STRLTAAEVLAHSWME-----ECEQVAQKPCKQDD 315
             RLTA E L H +M        E V+  P   +D
Sbjct: 289 MDRLTAEEALMHPYMSCYSCPFDEPVSLHPFHIED 323

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score =  101 bits (253), Expect = 2e-24
 Identities = 74/254 (29%), Positives = 125/254 (49%), Gaps = 16/254 (6%)

Query: 48  LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLK 107
           LG G FG +     K TG++ ACK + K RL      +   LE EI+ K++  P +V+L 
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNS-PFIVNLA 59

Query: 108 AVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS---YCHGNGVVH 164
             +E + ++ L+M L  GG+L + +   G       RVI  +  Q+     + H   +V+
Sbjct: 60  YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIH-YSAQITCGILHLHSMDIVY 118

Query: 165 RDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLA-GGYNQAA 223
           RD+KPEN+LL  + +    +L+D GLA  +K G+ +    G+  Y+APE+L    Y+   
Sbjct: 119 RDMKPENVLLDDQGNC---RLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPV 175

Query: 224 DVWSAGVILYILLSGMPPFWG-KTKSKIFDAVRAA---DLRFPSDPWDHISASARDLIMG 279
           D ++ G  +Y +++G  PF   K K    +  R     +++F    +      ++D+   
Sbjct: 176 DWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFT---EESKDICRL 232

Query: 280 MLRVDPSTRLTAAE 293
            L   P  RL + E
Sbjct: 233 FLAKKPEDRLGSRE 246

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score =  101 bits (252), Expect = 3e-24
 Identities = 72/263 (27%), Positives = 129/263 (49%), Gaps = 11/263 (4%)

Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
           +Y   +++G G  G +    D  TG+ +A + +   +    E + +   EI +M + + +
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN---EILVMRE-NKN 76

Query: 101 PNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGN 160
           PN+V+    Y   D + ++ME  AGG L   + +     E +   + R  +Q + + H N
Sbjct: 77  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSN 135

Query: 161 GVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHG-TVGSPFYIAPEVLA-GG 218
            V+HRD+K +NILL    S   +KL DFG    I   Q+     VG+P+++APEV+    
Sbjct: 136 QVIHRDIKSDNILLGMDGS---VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 192

Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           Y    D+WS G++   ++ G PP+  +   +    +         +P + +SA  RD + 
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP-EKLSAIFRDFLN 251

Query: 279 GMLRVDPSTRLTAAEVLAHSWME 301
             L +D   R +A E+L H +++
Sbjct: 252 RCLDMDVEKRGSAKELLQHQFLK 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score =  100 bits (251), Expect = 3e-24
 Identities = 75/261 (28%), Positives = 123/261 (47%), Gaps = 20/261 (7%)

Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           +++G G FG + +  D  T +V+A K I  D     +++  I+ EI ++++    P V  
Sbjct: 10  ERIGKGSFGEVFKGIDNRTQQVVAIKII--DLEEAEDEIEDIQQEITVLSQCDS-PYVTK 66

Query: 106 LKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHR 165
               Y +   + ++ME   GG     L + G F E +   + + +++ + Y H    +HR
Sbjct: 67  YYGSYLKGTKLWIIMEYLGGGSALDLL-RAGPFDEFQIATMLKEILKGLDYLHSEKKIHR 125

Query: 166 DLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT-VGSPFYIAPEVL-AGGYNQAA 223
           D+K  N+LL   S    +KLADFG+A  +   Q    T VG+PF++APEV+    Y+  A
Sbjct: 126 DIKAANVLL---SEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKA 182

Query: 224 DVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDP----WDHISASARDLIMG 279
           D+WS G+    L  G PP       ++           P +         S   ++ I  
Sbjct: 183 DIWSLGITAIELAKGEPPNSDMHPMRVL-------FLIPKNNPPTLTGEFSKPFKEFIDA 235

Query: 280 MLRVDPSTRLTAAEVLAHSWM 300
            L  DPS R TA E+L H ++
Sbjct: 236 CLNKDPSFRPTAKELLKHKFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score =  100 bits (250), Expect = 3e-24
 Identities = 68/264 (25%), Positives = 135/264 (51%), Gaps = 13/264 (4%)

Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           Y   + +G G +G +     +  G+    K +   R  +  + ++ + E +++++L  HP
Sbjct: 2   YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKL-NLRNASRRERKAAEQEAQLLSQLK-HP 59

Query: 102 NVVDLKAVYEEED-YVHLLMELCAGGELFHRL-EKYGRF-SETEARVIFRHLMQVVSYCH 158
           N+V  +  +E ED  ++++M  C GG+L+H+L E+ G+   E +    F  +   + Y H
Sbjct: 60  NIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH 119

Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT-VGSPFYIAPEVLAG 217
              ++HRDLK +N+ L   + ++ IK+ D G+A  ++   ++  T +G+P+Y++PE+ + 
Sbjct: 120 EKHILHRDLKTQNVFL---TRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSN 176

Query: 218 G-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDL 276
             YN  +DVW+ G  +Y + +    F  K  + +    R  + + P  P D+ S    +L
Sbjct: 177 KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL--VYRIIEGKLPPMPKDY-SPELGEL 233

Query: 277 IMGMLRVDPSTRLTAAEVLAHSWM 300
           I  ML   P  R +   +L   ++
Sbjct: 234 IATMLSKRPEKRPSVKSILRQPYI 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  101 bits (253), Expect = 4e-24
 Identities = 87/324 (26%), Positives = 130/324 (40%), Gaps = 76/324 (23%)

Query: 35  ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSI----AKDRLVTVEDVRSIKLE 90
            S L D  +LGK LG G FG + +     TG V+A K I     KD    +  +R    E
Sbjct: 4   CSKLRDYEILGK-LGEGTFGEVYKARQIKTGRVVALKKILMHNEKD-GFPITALR----E 57

Query: 91  IEIMTKLSGHPNVVDL-KAVYEEEDYVHLLMELCAGGELF-------HRLEKYG------ 136
           I+I+ KL  HPNVV L     E  D           G ++       H L   G      
Sbjct: 58  IKILKKLK-HPNVVPLIDMAVERPDKSKRKR-----GSVYMVTPYMDHDLS--GLLENPS 109

Query: 137 -RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA-TYI 194
            + +E++ +     L++ ++Y H N ++HRD+K  NIL+    +   +K+ADFGLA  Y 
Sbjct: 110 VKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILI---DNQGILKIADFGLARPYD 166

Query: 195 KAGQNLH-----------GTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPP 241
               N               V + +Y  PE+L G   Y  A D+W  G +   + +  P 
Sbjct: 167 GPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPI 226

Query: 242 FWGKTK----SKIFDAVRA----------------ADLRFPSDP------WDHISASARD 275
             GK+       IF                         F + P      +  +     D
Sbjct: 227 LQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLD 286

Query: 276 LIMGMLRVDPSTRLTAAEVLAHSW 299
           L+  +L +DP  RLTA++ L H +
Sbjct: 287 LLSKLLSLDPYKRLTASDALEHPY 310

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score =  100 bits (251), Expect = 4e-24
 Identities = 67/256 (26%), Positives = 131/256 (51%), Gaps = 11/256 (4%)

Query: 47  QLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDL 106
           ++G G  G++   + K +G+++A K +   +    +  R +     ++ +   H NVV++
Sbjct: 27  KIGEGSTGIVCIATVKSSGKLVAVKKMDLRK----QQRRELLFNEVVIMRDYQHENVVEM 82

Query: 107 KAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRD 166
              Y   D + ++ME   GG L   +  + R +E +   +   +++ +S  H  GV+HRD
Sbjct: 83  YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRD 141

Query: 167 LKPENILLATKSSSSPIKLADFGLATYI-KAGQNLHGTVGSPFYIAPEVLAG-GYNQAAD 224
           +K ++ILL   +    +KL+DFG    + K        VG+P+++APE+++   Y    D
Sbjct: 142 IKSDSILL---THDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVD 198

Query: 225 VWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVD 284
           +WS G+++  ++ G PP++ +   K    +R  +L         +S S +  +  +L  D
Sbjct: 199 IWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR-DNLPPKLKNLHKVSPSLKGFLDRLLVRD 257

Query: 285 PSTRLTAAEVLAHSWM 300
           P+ R TAAE+L H ++
Sbjct: 258 PAQRATAAELLKHPFL 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score =  101 bits (253), Expect = 4e-24
 Identities = 80/257 (31%), Positives = 125/257 (48%), Gaps = 21/257 (8%)

Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           K +G G FG +     K TG+V A K + K  ++   +    + E +++        + +
Sbjct: 7   KVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVN-GDRRWITN 65

Query: 106 LKAVYEEEDYVHLLMELCAGGELFHRLEKYG-RFSETEARVIFRHLMQVVSYCHGNGVVH 164
           L   +++E+ ++L+M+   GG+L   L K+  R  E  AR     ++  +   H  G VH
Sbjct: 66  LHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVH 125

Query: 165 RDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT--VGSPFYIAPEVL------A 216
           RD+KP+N+LL        I+LADFG    + A   +     VG+P YI+PE+L       
Sbjct: 126 RDIKPDNVLLDKNGH---IRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGK 182

Query: 217 GGYNQAADVWSAGVILYILLSGMPPFWG----KTKSKIFDAVRAADLRFPSDPWDHISAS 272
           G Y    D WS GV +Y +L G  PF+     +T  KI +       +FP D  D +S  
Sbjct: 183 GRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN--HKEHFQFPPDVTD-VSEE 239

Query: 273 ARDLIMGMLRVDPSTRL 289
           A+DLI  ++   P TRL
Sbjct: 240 AKDLIRRLI-CSPETRL 255

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 98.3 bits (245), Expect = 1e-23
 Identities = 62/258 (24%), Positives = 116/258 (44%), Gaps = 12/258 (4%)

Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           + +  ++G G FGV+ +   K    V A K I   ++   E   +I  E  ++ KL    
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAID-EARVLAKLD-SS 59

Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYG--RFSETEARVIFRHLMQVVSYCHG 159
            ++     + ++  ++++ME    G+L   L+        E +    F  ++  +++ H 
Sbjct: 60  YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS 119

Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT-VGSPFYIAPEVLAGG 218
             ++HRD+K  N+ L    +   +K+ D G+A  +    N   T VG+P+Y++PE+    
Sbjct: 120 KKILHRDIKSLNLFL---DAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDK 176

Query: 219 -YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLI 277
            YN+ +DVW+ GV+LY   +G  PF    +  +   ++     FP     + S     LI
Sbjct: 177 PYNEKSDVWALGVVLYECCTGKHPFDANNQGALI--LKIIRGVFPPVSQMY-SQQLAQLI 233

Query: 278 MGMLRVDPSTRLTAAEVL 295
              L  D   R    ++L
Sbjct: 234 DQCLTKDYRQRPDTFQLL 251

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score =  100 bits (250), Expect = 1e-23
 Identities = 87/318 (27%), Positives = 136/318 (42%), Gaps = 57/318 (17%)

Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
           RY + + +G G +GV+    D  TGE +A K I  D    V D   I  EI+++ +L  H
Sbjct: 1   RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI-NDVFEHVSDATRILREIKLL-RLLRH 58

Query: 101 PNVVDLKAVY-----EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS 155
           P++V++K +       E   ++++ EL    +L   ++     +    +     L++ + 
Sbjct: 59  PDIVEIKHIMLPPSRREFKDIYVVFEL-MESDLHQVIKANDDLTPEHHQFFLYQLLRALK 117

Query: 156 YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA--TYIKAGQNLHGT--VGSPFYIA 211
           Y H   V HRDLKP+NIL    ++   +K+ DFGLA   +      +  T  V + +Y A
Sbjct: 118 YIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 174

Query: 212 PEVLA---GGYNQAADVWSAGVILYILLSGMPPFWGKT---------------KSKIFDA 253
           PE+       Y  A D+WS G I   +L+G P F GK                  +    
Sbjct: 175 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234

Query: 254 VRAADLR-----------------FP-SDPWDHISASARDLIMGMLRVDPSTRLTAAEVL 295
           VR    R                 FP +DP       A  L+  +L  DP  R TA E L
Sbjct: 235 VRNEKARRYLSSMRKKQPVPFSQKFPNADP------LALRLLERLLAFDPKDRPTAEEAL 288

Query: 296 AHSWMEECEQVAQKPCKQ 313
           A  + +   +V ++P  Q
Sbjct: 289 ADPYFKGLAKVEREPSAQ 306

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  100 bits (250), Expect = 2e-23
 Identities = 89/314 (28%), Positives = 138/314 (43%), Gaps = 47/314 (14%)

Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAK---DRLVTVEDVRSIKLEIEIM 94
           +  +YV  K +G G +G++    +  T E +A K IA    +R+     +R IKL     
Sbjct: 3   VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKL----- 57

Query: 95  TKLSGHPNVVDLKAVYEEEDY-----VHLLMELCAGGELFHRLEKYGRFSETEARVIFRH 149
            +   H NV+ +K +           V+++ EL    +L   +      S+   +     
Sbjct: 58  LRHLDHENVIAIKDIMPPPHREAFNDVYIVYEL-MDTDLHQIIRSSQTLSDDHCQYFLYQ 116

Query: 150 LMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA-TYIKAGQNLHGTVGSPF 208
           L++ + Y H   V+HRDLKP N+LL   +++  +K+ DFGLA T  + G  +   V + +
Sbjct: 117 LLRGLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLARTTSEKGDFMTEYVVTRW 173

Query: 209 YIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGKTK-------SKIFDAVRAADL 259
           Y APE+L     Y  A DVWS G I   LL   P F GK         +++  +    DL
Sbjct: 174 YRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDL 233

Query: 260 RF-------------PSDP-------WDHISASARDLIMGMLRVDPSTRLTAAEVLAHSW 299
            F             P  P       + H +  A DL+  ML  DPS R+T  E LAH +
Sbjct: 234 GFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPY 293

Query: 300 MEECEQVAQKPCKQ 313
           +      + +P  Q
Sbjct: 294 LASLHDPSDEPVCQ 307

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 98.7 bits (246), Expect = 2e-23
 Identities = 88/302 (29%), Positives = 137/302 (45%), Gaps = 47/302 (15%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVED-VRSIKL-EIEIMTKL 97
           D Y   +++G G +G + +  DK TG+++A K   K RL   E+ +    L EI ++  L
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALK---KTRLEMDEEGIPPTALREISLLQML 57

Query: 98  SGHPNVVDLKAV-YEEEDY----VHLLMELCAGGELFHRLEKYGR-----FSETEARVIF 147
           S    +V L  V + EE      ++L+ E     +L   ++  GR           +   
Sbjct: 58  SESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFM 116

Query: 148 RHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGL--ATYIKAGQNLHGTVG 205
             L++ V++CH +GV+HRDLKP+N+L+        +K+AD GL  A  I      H  V 
Sbjct: 117 YQLLKGVAHCHKHGVMHRDLKPQNLLV--DKQKGLLKIADLGLGRAFSIPVKSYTHEIV- 173

Query: 206 SPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTKS----KIFDAV----- 254
           + +Y APEVL G   Y+   D+WS G I   +    P F G ++      IF  +     
Sbjct: 174 TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTE 233

Query: 255 ----RAADLR----FP-------SDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSW 299
                 + LR    FP       S     +S    DL+  MLR DP+ R++A   L H +
Sbjct: 234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293

Query: 300 ME 301
            +
Sbjct: 294 FD 295

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 98.5 bits (245), Expect = 3e-23
 Identities = 72/240 (30%), Positives = 116/240 (48%), Gaps = 25/240 (10%)

Query: 20  YKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLV 79
           Y +     ++L    + + +D + + + +G G +G + + ++K  G + A K      L 
Sbjct: 2   YGLFPYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKI-----LD 56

Query: 80  TVEDV-RSIKLEIEIMTKLSGHPNVVDLKAVYEEEDY-----VHLLMELCAGG---ELFH 130
            + DV   I+ E  I+  L  HPNVV    ++ + D      + L++ELC GG   EL  
Sbjct: 57  PISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVK 116

Query: 131 RLEKYG-RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFG 189
            L   G R  E     I    +  + + H N ++HRD+K  NILL T+     +KL DFG
Sbjct: 117 GLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGG---VKLVDFG 173

Query: 190 LATYIKAGQNLHGT-VGSPFYIAPEVLA------GGYNQAADVWSAGVILYILLSGMPPF 242
           ++  + + +    T VG+PF++APEV+A        Y+   DVWS G+    L  G PP 
Sbjct: 174 VSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 98.9 bits (247), Expect = 3e-23
 Identities = 74/269 (27%), Positives = 108/269 (40%), Gaps = 64/269 (23%)

Query: 90  EIEIMTKLSGHPNVVDL---------KAVYEEEDYV-HLLMELCAGGELFHRLEKYGRFS 139
           EI ++ +L  H NVV L         K+VY   DY  H L ++      FHR  K     
Sbjct: 52  EIALLRELK-HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIK----FHRQAKRVSIP 106

Query: 140 ETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILL-ATKSSSSPIKLADFGLATY----I 194
            +  + +   ++  V Y H N V+HRDLKP NIL+         +K+ D GLA      +
Sbjct: 107 PSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPL 166

Query: 195 KAGQNLHGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTKS---- 248
           K   +L   V + +Y APE+L G   Y +A D+W+ G I   LL+  P F G+       
Sbjct: 167 KPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKS 226

Query: 249 ---------KIF----------------------DAVRAADLRFPSD---PWDHI----S 270
                    +IF                               +PS+    W        
Sbjct: 227 NPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPD 286

Query: 271 ASARDLIMGMLRVDPSTRLTAAEVLAHSW 299
           +   DL+  +L  DP+ R+TA E L H +
Sbjct: 287 SQGFDLLRKLLEYDPTKRITAEEALEHPY 315

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 97.4 bits (242), Expect = 1e-22
 Identities = 73/254 (28%), Positives = 124/254 (48%), Gaps = 18/254 (7%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           D + + K +G G FG +     K T  + A K + K  ++   +    + E  ++  ++G
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVL--VNG 58

Query: 100 HPN-VVDLKAVYEEEDYVHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYC 157
               +  L   +++E+Y++L+M+   GG+L   L K+  R  E  AR     ++  +   
Sbjct: 59  DCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSI 118

Query: 158 HGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTV--GSPFYIAPEVL 215
           H    VHRD+KP+N+LL        I+LADFG    +     +  +V  G+P YI+PE+L
Sbjct: 119 HQLHYVHRDIKPDNVLLDMNGH---IRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEIL 175

Query: 216 A------GGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLR--FPSDPWD 267
                  G Y    D WS GV +Y +L G  PF+ ++  + +  +   + R  FPS   D
Sbjct: 176 QAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITD 235

Query: 268 HISASARDLIMGML 281
            +S  A+DLI  ++
Sbjct: 236 -VSEEAKDLIQRLI 248

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 96.9 bits (241), Expect = 2e-22
 Identities = 87/312 (27%), Positives = 137/312 (43%), Gaps = 56/312 (17%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAK---DRLVTVEDVRSIKLEIEIMTK 96
           DRY   KQ+G G +G +    D+ TG  +A K + +     L      R ++L      K
Sbjct: 15  DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRL-----LK 69

Query: 97  LSGHPNVVDLKAVYEEEDYV------HLLMELCAGGELFHRLEKYGRFSETEARVIFRHL 150
              H NV+ L  V+  +  +      +L+M     G    +L K+ + SE   + +   +
Sbjct: 70  HMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQM 127

Query: 151 MQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYI 210
           ++ + Y H  G++HRDLKP N+ +   +    +K+ DFGLA   +    + G V + +Y 
Sbjct: 128 LKGLKYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLAR--QTDSEMTGYVVTRWYR 182

Query: 211 APEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGK--------------TKSKIF--- 251
           APEV+     Y Q  D+WS G I+  +L+G P F G               T SK F   
Sbjct: 183 APEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQK 242

Query: 252 ----DA---------VRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHS 298
               DA          R  D R       + +  A +++  ML +D  +R+TAAE LAH 
Sbjct: 243 LQSEDAKNYVKKLPRFRKKDFR---SLLPNANPLAVNVLEKMLVLDAESRITAAEALAHP 299

Query: 299 WMEECEQVAQKP 310
           + EE      + 
Sbjct: 300 YFEEFHDPEDET 311

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 95.5 bits (238), Expect = 5e-22
 Identities = 82/317 (25%), Positives = 136/317 (42%), Gaps = 59/317 (18%)

Query: 41  RYVLGKQLGWGQFGVIRECSDKFT----GEVLACKSIAK---DRLVTVEDVRSIKLEIEI 93
           RY L K+LG G +G++  CS +       E +A K I      +++    +R +KL    
Sbjct: 1   RYELIKELGQGAYGIV--CSARNAETSEEETVAIKKITNVFSKKILAKRALRELKL---- 54

Query: 94  MTKLSGHPNVV---DLKAV-YEEEDYVHLLMELCAGGELFHRLEKYG-RFSETEARVIFR 148
           +    GH N+    D+  V     + ++L  EL       H++ + G   ++   +    
Sbjct: 55  LRHFRGHKNITCLYDMDIVFPGNFNELYLYEELMEAD--LHQIIRSGQPLTDAHFQSFIY 112

Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN-----LHGT 203
            ++  + Y H   V+HRDLKP N+L+   ++   +K+ DFGLA             +   
Sbjct: 113 QILCGLKYIHSANVLHRDLKPGNLLV---NADCELKICDFGLARGFSENPGENAGFMTEY 169

Query: 204 VGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGK---------------- 245
           V + +Y APE++     Y +A DVWS G IL  LL   P F GK                
Sbjct: 170 VATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTP 229

Query: 246 ---TKSKIFDAVRAADL--RFPSDP-----WDHISAS--ARDLIMGMLRVDPSTRLTAAE 293
              T S+I  + +A +     P+ P         +A+  A DL+  +L  DP+ R++  E
Sbjct: 230 DEETLSRI-GSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEE 288

Query: 294 VLAHSWMEECEQVAQKP 310
            L H ++        +P
Sbjct: 289 ALEHPYLAIWHDPDDEP 305

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 93.4 bits (232), Expect = 2e-21
 Identities = 77/272 (28%), Positives = 125/272 (45%), Gaps = 32/272 (11%)

Query: 47  QLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVE-DVRSIKLEIEIMTKLSGHPNVVD 105
           +LG G +G + +   + TG  +A K I   RL   E     I +E++I+ K    P +VD
Sbjct: 8   ELGKGNYGSVYKVLHRPTGVTMAMKEI---RLELDESKFNQIIMELDILHKAVS-PYIVD 63

Query: 106 LKAVYEEEDYVHLLMELCAGGELFHRLEK-YGRFSETE-------ARVIFRHLMQVVSYC 157
               +  E  V++ ME    G L    +K Y     TE        R+ +  +  +    
Sbjct: 64  FYGAFFIEGAVYMCMEYMDAGSL----DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK 119

Query: 158 HGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT-VGSPFYIAPEVLA 216
             + ++HRD+KP N+L+        +KL DFG++  + A  +L  T +G   Y+APE + 
Sbjct: 120 EEHNIIHRDVKPTNVLVNGNGQ---VKLCDFGVSGNLVA--SLAKTNIGCQSYMAPERIK 174

Query: 217 GG-------YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRA-ADLRFPSDPWDH 268
            G       Y   +DVWS G+ +  +  G  P+  +T + IF  + A  D   P+ P   
Sbjct: 175 SGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLP-SG 233

Query: 269 ISASARDLIMGMLRVDPSTRLTAAEVLAHSWM 300
            S  A+D +   L   P+ R T A++L H W+
Sbjct: 234 YSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWL 265

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 92.4 bits (229), Expect = 3e-21
 Identities = 77/290 (26%), Positives = 138/290 (47%), Gaps = 29/290 (10%)

Query: 30  LDATQISNLSDR---YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRS 86
           LD   +S L D    + L + +G G +G + +     TG++ A K +     VT ++   
Sbjct: 3   LDDIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTEDEEEE 58

Query: 87  IKLEIEIMTKLSGHPNVVDL------KAVYEEEDYVHLLMELCAGGELFHRLE--KYGRF 138
           IKLEI ++ K S H N+         K+    +D + L+ME C  G +   ++  K    
Sbjct: 59  IKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNAL 118

Query: 139 SETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ 198
            E     I R +++ +++ H + V+HRD+K +N+LL   + ++ +KL DFG++  +    
Sbjct: 119 KEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQLDRTV 175

Query: 199 NLHGT-VGSPFYIAPEVLA------GGYNQAADVWSAGVILYILLSGMPPFWGKTKSK-I 250
               T +G+P+++APEV+A        Y+  +D+WS G+    +  G PP       + +
Sbjct: 176 GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL 235

Query: 251 FDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWM 300
           F   R    +  S  W   S    D I G L  +  +R +  ++L H ++
Sbjct: 236 FLIPRNPPPKLKSKKW---SKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 94.7 bits (235), Expect = 4e-21
 Identities = 88/319 (27%), Positives = 141/319 (44%), Gaps = 68/319 (21%)

Query: 39  SDRYVLGKQLGWGQFGVIRE--CSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTK 96
           +  Y LG  +G G FGV+ E  C D  T E +A K +       ++D +    E+ IM  
Sbjct: 65  NKSYKLGNIIGNGSFGVVYEAICID--TSEKVAIKKV-------LQDPQYKNRELLIMKN 115

Query: 97  LSGHPNVVDLKAVY--------EEEDYVHLLMELCAGGELFHRLEK-YGRFSETEARVIF 147
           L+ H N++ LK  Y        E+  +++++ME     +  H+  K Y R +      + 
Sbjct: 116 LN-HINIIFLKDYYYTECFKKNEKNIFLNVVMEFIP--QTVHKYMKHYARNNHALPLFLV 172

Query: 148 R----HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT 203
           +     L + ++Y H   + HRDLKP+N+L+   + +  +KL DFG A  + AGQ     
Sbjct: 173 KLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHT--LKLCDFGSAKNLLAGQRSVSY 230

Query: 204 VGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKT--------------- 246
           + S FY APE++ G   Y    D+WS G I+  ++ G P F G++               
Sbjct: 231 ICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTP 290

Query: 247 ---KSKI---------FDAVRAADLR--FPSDPWDHISASARDLIMGMLRVDPSTRLTAA 292
              + K          F  V+  DL+  FP    D     A + I   L+ +P  RL   
Sbjct: 291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPD----DAINFISQFLKYEPLKRLNPI 346

Query: 293 EVLAHSWMEECEQVAQKPC 311
           E LA  + ++     + PC
Sbjct: 347 EALADPFFDDL----RDPC 361

Length = 440

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 92.9 bits (231), Expect = 7e-21
 Identities = 96/332 (28%), Positives = 147/332 (44%), Gaps = 72/332 (21%)

Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
           RY   K +G G  G++    D  TG+ +A K +++         R+ + E+ +M KL  H
Sbjct: 17  RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYR-ELVLM-KLVNH 74

Query: 101 PNVVDLKAVY------EEEDYVHLLME-----LCAGGELFHRLEKYGRFSETEARVIFRH 149
            N++ L  V+      EE   V+L+ME     LC   ++      + R S      +   
Sbjct: 75  KNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLC---QVIQMDLDHERMS-----YLLYQ 126

Query: 150 LMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT--VGSP 207
           ++  + + H  G++HRDLKP NI++  KS  + +K+ DFGLA    AG +   T  V + 
Sbjct: 127 MLCGIKHLHSAGIIHRDLKPSNIVV--KSDCT-LKILDFGLAR--TAGTSFMMTPYVVTR 181

Query: 208 FYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPF--------WGK------TKSKIF- 251
           +Y APEV+ G GY +  D+WS G I+  ++ G   F        W K      T S  F 
Sbjct: 182 YYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM 241

Query: 252 ----DAVRA-----------------ADLRFP--SDPWDHISAS-ARDLIMGMLRVDPST 287
                 VR                   D+ FP  S+  + + AS ARDL+  ML +DP  
Sbjct: 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEK 301

Query: 288 RLTAAEVLAHS----WMEECEQVAQKPCKQDD 315
           R++  + L H     W +  E  A  P   D 
Sbjct: 302 RISVDDALQHPYINVWYDPSEVEAPPPAPYDH 333

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 92.3 bits (229), Expect = 8e-21
 Identities = 89/318 (27%), Positives = 145/318 (45%), Gaps = 53/318 (16%)

Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKL 97
           L +RY   KQ+G G +G +    DK TGE +A K +++     +   R+ + E+ ++  +
Sbjct: 13  LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR-ELTLLKHM 71

Query: 98  SGHPNVVDLKAVY-------EEEDYVHLLMELCAGGELFHRLEKY--GRFSETEARVIFR 148
             H NV+ L  V+       E +D+ +L+M       +   L+K      SE + + +  
Sbjct: 72  Q-HENVIGLLDVFTSAVSGDEFQDF-YLVMPY-----MQTDLQKIMGHPLSEDKVQYLVY 124

Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF 208
            ++  + Y H  G++HRDLKP N+ +   +    +K+ DFGLA +  A   + G V + +
Sbjct: 125 QMLCGLKYIHSAGIIHRDLKPGNLAV---NEDCELKILDFGLARHADA--EMTGYVVTRW 179

Query: 209 YIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTK------------------- 247
           Y APEV+     YNQ  D+WS G I+  +L+G   F GK                     
Sbjct: 180 YRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFV 239

Query: 248 SKIFD-AVRAADLRFPSDP-------WDHISASARDLIMGMLRVDPSTRLTAAEVLAHSW 299
            K+ D A ++     P  P       +   S  A DL+  ML +D   RLTA E L H +
Sbjct: 240 QKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPY 299

Query: 300 MEECEQVAQKPCKQ--DD 315
            +      ++  +Q  DD
Sbjct: 300 FDSFRDADEETEQQPYDD 317

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 92.1 bits (228), Expect = 1e-20
 Identities = 68/243 (27%), Positives = 117/243 (48%), Gaps = 16/243 (6%)

Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           K +G G FG +     K   +V A K + K  ++   +    + E +++     +  +  
Sbjct: 7   KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN-GDNQWITT 65

Query: 106 LKAVYEEEDYVHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVH 164
           L   +++E+ ++L+M+   GG+L   L K+  R  E  AR     ++  +   H    VH
Sbjct: 66  LHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVH 125

Query: 165 RDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT--VGSPFYIAPEVL------A 216
           RD+KP+NIL+     +  I+LADFG    +     +  +  VG+P YI+PE+L       
Sbjct: 126 RDIKPDNILM---DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGK 182

Query: 217 GGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAV--RAADLRFPSDPWDHISASAR 274
           G Y    D WS GV +Y +L G  PF+ ++  + +  +       +FP+   D +S  A+
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTD-VSEDAK 241

Query: 275 DLI 277
           DLI
Sbjct: 242 DLI 244

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 90.1 bits (224), Expect = 3e-20
 Identities = 81/302 (26%), Positives = 129/302 (42%), Gaps = 58/302 (19%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDV--RSIKLEIEIMTKL 97
           + Y    +LG G +  + +   K TG+++A K I   RL   E     +I+ E  ++  L
Sbjct: 5   ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEI---RLEHEEGAPFTAIR-EASLLKDL 60

Query: 98  SGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRF-SETEARVIFRHLMQVVSY 156
             H N+V L  +   +  + L+ E     +L   ++  G   S    R+    L++ ++Y
Sbjct: 61  K-HANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAY 118

Query: 157 CHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA--------TYIKAGQNLHGTVGSPF 208
           CH   V+HRDLKP+N+L+   S    +KLADFGLA        TY          V + +
Sbjct: 119 CHQRRVLHRDLKPQNLLI---SERGELKLADFGLARAKSVPSKTY-------SNEVVTLW 168

Query: 209 YIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTKS-----KIF---------- 251
           Y  P+VL G   Y+ + D+W  G I Y + +G P F G T       KIF          
Sbjct: 169 YRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEET 228

Query: 252 -------DAVRAADLRF-PSDPWDHI------SASARDLIMGMLRVDPSTRLTAAEVLAH 297
                     +     F P  P  +            +L +  L+ +P  R++AAE + H
Sbjct: 229 WPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288

Query: 298 SW 299
            +
Sbjct: 289 PY 290

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 90.5 bits (224), Expect = 5e-20
 Identities = 99/364 (27%), Positives = 153/364 (42%), Gaps = 75/364 (20%)

Query: 10  SQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLA 69
           S+  +QF  S +V+  T T+L          RY   K +G G  G++    D   G  +A
Sbjct: 1   SEEDSQF-YSVQVADSTFTVLK---------RYQQLKPIGSGAQGIVCAAFDTVLGINVA 50

Query: 70  CKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVY------EEEDYVHLLMELC 123
            K +++         R+ + E+ ++ K   H N++ L  V+      EE   V+L+MEL 
Sbjct: 51  VKKLSRPFQNQTHAKRAYR-EL-VLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM 108

Query: 124 AGG--ELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSS 181
                ++ H    + R S      +   ++  + + H  G++HRDLKP NI++    S  
Sbjct: 109 DANLCQVIHMELDHERMS-----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDC 160

Query: 182 PIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMP 240
            +K+ DFGLA        +   V + +Y APEV+ G GY +  D+WS G I+  L+ G  
Sbjct: 161 TLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSV 220

Query: 241 PF--------WGKT-----------KSKIFDAVRA-----------------ADLRFPSD 264
            F        W K             +++   VR                   D  FPS+
Sbjct: 221 IFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSE 280

Query: 265 P-WDHISAS-ARDLIMGMLRVDPSTRLTAAEVLAHS----WMEECEQVAQKPCKQDDLCC 318
              D +  S ARDL+  ML +DP  R++  E L H     W +  E  A  P   D    
Sbjct: 281 SERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPAEAEAPPPQIYD---- 336

Query: 319 KQLE 322
            QLE
Sbjct: 337 AQLE 340

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 88.2 bits (218), Expect = 1e-19
 Identities = 70/269 (26%), Positives = 127/269 (47%), Gaps = 26/269 (9%)

Query: 48  LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLK 107
           +G G +G + +     TG++ A K +     VT ++   IK EI ++ K S H N+    
Sbjct: 14  VGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSHHRNIATYY 69

Query: 108 AVYEE------EDYVHLLMELCAGGELFHRLE--KYGRFSETEARVIFRHLMQVVSYCHG 159
             + +      +D + L+ME C  G +   ++  K     E     I R +++ +S+ H 
Sbjct: 70  GAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ 129

Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT-VGSPFYIAPEVLA-- 216
           + V+HRD+K +N+LL   + ++ +KL DFG++  +        T +G+P+++APEV+A  
Sbjct: 130 HKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACD 186

Query: 217 ----GGYNQAADVWSAGVILYILLSGMPPFWGKTKSK-IFDAVRAADLRFPSDPWDHISA 271
                 Y+  +D+WS G+    +  G PP       + +F   R    R  S  W   S 
Sbjct: 187 ENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKW---SK 243

Query: 272 SARDLIMGMLRVDPSTRLTAAEVLAHSWM 300
             +  I   L  + S R T  +++ H ++
Sbjct: 244 KFQSFIESCLVKNHSQRPTTEQLMKHPFI 272

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 87.9 bits (218), Expect = 1e-19
 Identities = 60/222 (27%), Positives = 103/222 (46%), Gaps = 21/222 (9%)

Query: 40  DRYVLGKQLGWGQFGVIREC------SDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEI 93
           +   LG+ +G GQFG + +       ++K    V  CK+                 E  I
Sbjct: 6   EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSP-----SVREKFLQEAYI 60

Query: 94  MTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIF-RHLMQ 152
           M +   HP++V L  V  E + V ++MEL   GEL   L+      +  + +++   L  
Sbjct: 61  MRQFD-HPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLST 118

Query: 153 VVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGS-PF-YI 210
            ++Y      VHRD+   N+L+++      +KL DFGL+ Y++       + G  P  ++
Sbjct: 119 ALAYLESKRFVHRDIAARNVLVSSPDC---VKLGDFGLSRYLEDESYYKASKGKLPIKWM 175

Query: 211 APEVLA-GGYNQAADVWSAGVILY-ILLSGMPPFWGKTKSKI 250
           APE +    +  A+DVW  GV ++ IL+ G+ PF G   + +
Sbjct: 176 APESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV 217

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 90.5 bits (224), Expect = 1e-19
 Identities = 62/201 (30%), Positives = 106/201 (52%), Gaps = 16/201 (7%)

Query: 110 YEEEDYVHLLMELCAGGELF----HRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHR 165
           ++ +D + L+ME  +GG+L      RL+++  F E E  ++F  ++  +   H   ++HR
Sbjct: 134 FKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHR 193

Query: 166 DLKPENILLATKSSSSPIKLADFGLATYIKAGQNL---HGTVGSPFYIAPEVLAGG-YNQ 221
           DLK  NI L     +  IKL DFG +       +L       G+P+Y+APE+     Y++
Sbjct: 194 DLKSANIFLM---PTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSK 250

Query: 222 AADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWD-HISASARDLIMGM 280
            AD+WS GVILY LL+   PF G ++ +I   V    L    DP+   +S+  + L+  +
Sbjct: 251 KADMWSLGVILYELLTLHRPFKGPSQREIMQQV----LYGKYDPFPCPVSSGMKALLDPL 306

Query: 281 LRVDPSTRLTAAEVLAHSWME 301
           L  +P+ R T  ++L   +++
Sbjct: 307 LSKNPALRPTTQQLLHTEFLK 327

Length = 478

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 89.0 bits (220), Expect = 1e-19
 Identities = 75/306 (24%), Positives = 135/306 (44%), Gaps = 44/306 (14%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           +RY     +G G +G +    D    + +A K +++     +   R+ + E+ ++  +  
Sbjct: 15  ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYR-ELRLLKHMK- 72

Query: 100 HPNVVDLKAVY------EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQV 153
           H NV+ L  V+      E  + V+L+  L  G +L + + K  + S+   + +   L++ 
Sbjct: 73  HENVIGLLDVFTPATSIENFNEVYLVTNL-MGADL-NNIVKCQKLSDEHVQFLIYQLLRG 130

Query: 154 VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPE 213
           + Y H  G++HRDLKP N+ +   +    +++ DFGLA   +A   + G V + +Y APE
Sbjct: 131 LKYIHSAGIIHRDLKPSNVAV---NEDCELRILDFGLAR--QADDEMTGYVATRWYRAPE 185

Query: 214 VLAG--GYNQAADVWSAGVILYILLSGMPPF---------------WGKTKSKIFDAVRA 256
           ++     YNQ  D+WS G I+  LL G   F                G    ++   + +
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISS 245

Query: 257 ADLR-----FPSDPWDHISASAR-------DLIMGMLRVDPSTRLTAAEVLAHSWMEECE 304
              R      P  P   +    R       DL+  ML +D   R++A+E LAH +  +  
Sbjct: 246 EHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYH 305

Query: 305 QVAQKP 310
               +P
Sbjct: 306 DPEDEP 311

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 88.6 bits (219), Expect = 2e-19
 Identities = 76/311 (24%), Positives = 140/311 (45%), Gaps = 44/311 (14%)

Query: 35  ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
           I  + +RY     +G G +G +    D  TG  +A K +++     +   R+ + E+ ++
Sbjct: 12  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLL 70

Query: 95  TKLSGHPNVVDLKAVY------EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
             +  H NV+ L  V+      EE + V+L+  L  G +L + + K  + ++   + +  
Sbjct: 71  KHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHL-MGADL-NNIVKCQKLTDDHVQFLIY 127

Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF 208
            +++ + Y H   ++HRDLKP N+ +   +    +K+ DFGLA +      + G V + +
Sbjct: 128 QILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARH--TDDEMTGYVATRW 182

Query: 209 YIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPF---------------WGKTKSKIF 251
           Y APE++     YNQ  D+WS G I+  LL+G   F                G   +++ 
Sbjct: 183 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 242

Query: 252 DAVRAADLR-----FPSDPWDHIS-------ASARDLIMGMLRVDPSTRLTAAEVLAHSW 299
             + +   R         P  + +         A DL+  ML +D   R+TAA+ LAH++
Sbjct: 243 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 302

Query: 300 MEECEQVAQKP 310
             +      +P
Sbjct: 303 FAQYHDPDDEP 313

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 89.0 bits (221), Expect = 2e-19
 Identities = 83/299 (27%), Positives = 132/299 (44%), Gaps = 53/299 (17%)

Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAK--DRLVTVEDV-RSIKLEIEIMTKLSGHPN 102
           + +G+G FGV+   +D   G+ +A K +      LV+ + V R +K     M     H N
Sbjct: 6   RPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELK-----MLCFFKHDN 60

Query: 103 VVDLKAVYE-------EEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS 155
           V+    + +       EE YV  + EL    +L   +      S    +V    +++ + 
Sbjct: 61  VLSALDILQPPHIDPFEEIYV--VTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLK 117

Query: 156 YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT--VGSPFYIAPE 213
           Y H  G++HRD+KP N+L+   +S+  +K+ DFGLA   +  ++ H T  V + +Y APE
Sbjct: 118 YLHSAGILHRDIKPGNLLV---NSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPE 174

Query: 214 VLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFD------------------- 252
           +L G   Y  A D+WS G I   LL     F  ++  +  D                   
Sbjct: 175 ILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE 234

Query: 253 AVRAADLRFPSDP---------WDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
             RA  LR P  P             +  A  L+  ML  DP  R++AA+ LAH +++E
Sbjct: 235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDE 293

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 87.0 bits (215), Expect = 3e-19
 Identities = 80/293 (27%), Positives = 130/293 (44%), Gaps = 43/293 (14%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKL-EIEIMTKLS 98
           + YV   +LG G +  + +   K T  ++A K I   RL   E      + E+ ++  L 
Sbjct: 5   ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEI---RLEHEEGAPCTAIREVSLLKNLK 61

Query: 99  GHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRF-SETEARVIFRHLMQVVSYC 157
            H N+V L  +   E  + L+ E     +L   L+  G   S    ++    L++ +SYC
Sbjct: 62  -HANIVTLHDIIHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYC 119

Query: 158 HGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT-VGSPFYIAPEVLA 216
           H   ++HRDLKP+N+L+  K     +KLADFGLA         +   V + +Y  P+VL 
Sbjct: 120 HKRKILHRDLKPQNLLINEKGE---LKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLL 176

Query: 217 GG--YNQAADVWSAGVILYILLSGMPPFWGKT-KSKIFDAVRAADLRFPS-DPWDHISAS 272
           G   Y+   D+W  G ILY + +G P F G T K ++    R   L  P+ + W  I+++
Sbjct: 177 GSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRL--LGTPTEETWPGITSN 234

Query: 273 AR--------------------------DLIMGMLRVDPSTRLTAAEVLAHSW 299
                                       DL+  +L  +  +R++A   L HS+
Sbjct: 235 EEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSY 287

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 86.7 bits (215), Expect = 3e-19
 Identities = 70/258 (27%), Positives = 116/258 (44%), Gaps = 28/258 (10%)

Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           + L ++LG G FG + E   K    V A K +  D L+  +D    + E++ + +L  H 
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRV-AIKILKSDDLLKQQD---FQKEVQALKRLR-HK 62

Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVI-FRHLM----QV--- 153
           +++ L AV    + V+++ EL   G L   L         E +V+    L+    QV   
Sbjct: 63  HLISLFAVCSVGEPVYIITELMEKGSLLAFL------RSPEGQVLPVASLIDMACQVAEG 116

Query: 154 VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF-YIAP 212
           ++Y      +HRDL   NIL+         K+ADFGLA  IK    L      P+ + AP
Sbjct: 117 MAYLEEQNSIHRDLAARNILVGEDLVC---KVADFGLARLIKEDVYLSSDKKIPYKWTAP 173

Query: 213 EVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHIS 270
           E  + G ++  +DVWS G++LY + + G  P+ G    +++D +  A  R P        
Sbjct: 174 EAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI-TAGYRMPCPA--KCP 230

Query: 271 ASARDLIMGMLRVDPSTR 288
                +++     +P  R
Sbjct: 231 QEIYKIMLECWAAEPEDR 248

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 85.7 bits (212), Expect = 8e-19
 Identities = 69/263 (26%), Positives = 117/263 (44%), Gaps = 23/263 (8%)

Query: 47  QLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDL 106
            LG G  G + +     T  +LA K I  D  +TVE  + I  E+EI+ K    P ++  
Sbjct: 8   ILGHGNGGTVYKAYHLLTRRILAVKVIPLD--ITVELQKQIMSELEILYKCDS-PYIIGF 64

Query: 107 KAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRD 166
              +  E+ + +  E   GG L    + Y +  E     I   +++ ++Y     ++HRD
Sbjct: 65  YGAFFVENRISICTEFMDGGSL----DVYRKIPEHVLGRIAVAVVKGLTYLWSLKILHRD 120

Query: 167 LKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT-VGSPFYIAPEVLAG-GYNQAAD 224
           +KP N+L+ T+     +KL DFG++T +    ++  T VG+  Y+APE ++G  Y   +D
Sbjct: 121 VKPSNMLVNTRGQ---VKLCDFGVSTQLV--NSIAKTYVGTNAYMAPERISGEQYGIHSD 175

Query: 225 VWSAGVILYILLSGMPPFWGKTKS-------KIFDAVRAADLRFPSDPWDHISASARDLI 277
           VWS G+    L  G  P+    K+       ++   +   D   P  P    S      I
Sbjct: 176 VWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCI--VDEDPPVLPVGQFSEKFVHFI 233

Query: 278 MGMLRVDPSTRLTAAEVLAHSWM 300
              +R  P  R     ++ H ++
Sbjct: 234 TQCMRKQPKERPAPENLMDHPFI 256

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 84.9 bits (211), Expect = 1e-18
 Identities = 70/257 (27%), Positives = 119/257 (46%), Gaps = 25/257 (9%)

Query: 51  GQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVY 110
           G+FG +     K T ++   K I        ++  +I  E  +   +  +PN + L    
Sbjct: 27  GKFGKVSVLKHKPTQKLFVQKIIKA------KNFNAI--EPMVHQLMKDNPNFIKLYYSV 78

Query: 111 EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPE 170
                  L+M+    G+LF  L+K G+ SE E + I R L++ ++  H + ++H D+K E
Sbjct: 79  TTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLE 138

Query: 171 NILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG-GYNQAADVWSAG 229
           N+L         I L D+GL   I       GT+    Y +PE + G  Y+ + D W+ G
Sbjct: 139 NVLYDRAKDR--IYLCDYGLCKIIGTPSCYDGTLD---YFSPEKIKGHNYDVSFDWWAVG 193

Query: 230 VILYILLSGMPPFWGKTKSKIFD----AVR-AADLRFPSDPWDHISASARDLIMGMLRVD 284
           V+ Y LL+G  PF  + + +  D      R    L F      ++S +A D +  ML+ +
Sbjct: 194 VLTYELLTGKHPF-KEDEDEELDLESLLKRQQKKLPFIK----NVSKNANDFVQSMLKYN 248

Query: 285 PSTRLTA-AEVLAHSWM 300
            + RLT   E++ H ++
Sbjct: 249 INYRLTNYNEIIKHPFL 265

Length = 267

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 84.4 bits (209), Expect = 2e-18
 Identities = 57/198 (28%), Positives = 92/198 (46%), Gaps = 15/198 (7%)

Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
            LG  +G G+FG +      + G+ +A K + KD     +   +   E  +MT L  HPN
Sbjct: 9   KLGATIGKGEFGDVML--GDYRGQKVAVKCL-KDDSTAAQ---AFLAEASVMTTLR-HPN 61

Query: 103 VVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGR-FSETEARVIF-RHLMQVVSYCHGN 160
           +V L  V  + + ++++ E  A G L   L   GR       ++ F   + + + Y    
Sbjct: 62  LVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK 121

Query: 161 GVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGG-Y 219
             VHRDL   N+L+   S     K++DFGLA   +A Q          + APE L    +
Sbjct: 122 NFVHRDLAARNVLV---SEDLVAKVSDFGLAK--EASQGQDSGKLPVKWTAPEALREKKF 176

Query: 220 NQAADVWSAGVILYILLS 237
           +  +DVWS G++L+ + S
Sbjct: 177 STKSDVWSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 84.4 bits (209), Expect = 2e-18
 Identities = 68/212 (32%), Positives = 97/212 (45%), Gaps = 34/212 (16%)

Query: 46  KQLGWGQFGVIRECSDKF----TGEVLACKSIAKDRLVTVEDVRS-IKLEIEIMTKLSGH 100
           KQLG G FG +  C        TGE +A KS+        E  RS  + EIEI+  L  H
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHS---GEEQHRSDFEREIEILRTLD-H 65

Query: 101 PNVVDLKAVYEE--EDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS--- 155
            N+V  K V E+     + L+ME    G L   L++         ++  + L+   S   
Sbjct: 66  ENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQR------HRDQINLKRLLLFSSQIC 119

Query: 156 ----YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSP---- 207
               Y      +HRDL   NIL+    S   +K++DFGLA  +   ++ +  V  P    
Sbjct: 120 KGMDYLGSQRYIHRDLAARNILV---ESEDLVKISDFGLAKVLPEDKDYY-YVKEPGESP 175

Query: 208 -FYIAPEVLAGG-YNQAADVWSAGVILYILLS 237
            F+ APE L    ++ A+DVWS GV LY L +
Sbjct: 176 IFWYAPECLRTSKFSSASDVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 84.4 bits (208), Expect = 6e-18
 Identities = 91/338 (26%), Positives = 139/338 (41%), Gaps = 75/338 (22%)

Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
           RY   K +G G  G++    D      +A K +++         R+ + E+ +M K   H
Sbjct: 18  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLM-KCVNH 75

Query: 101 PNVVDLKAVY------EEEDYVHLLMELCAGG-------ELFHRLEKYGRFSETEARVIF 147
            N++ L  V+      EE   V+L+MEL           EL H    Y          + 
Sbjct: 76  KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSY----------LL 125

Query: 148 RHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSP 207
             ++  + + H  G++HRDLKP NI++    S   +K+ DFGLA        +   V + 
Sbjct: 126 YQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTR 182

Query: 208 FYIAPEVLAG-GYNQAADVWSAGVIL------YILLSGM-----------------PPFW 243
           +Y APEV+ G GY +  D+WS G I+       IL  G                  P F 
Sbjct: 183 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242

Query: 244 GKTKSKIFDAV----RAADLRFPSDPWDHI-----------SASARDLIMGMLRVDPSTR 288
            K +  + + V    + A L FP    D +           ++ ARDL+  ML +DP+ R
Sbjct: 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR 302

Query: 289 LTAAEVLAHS----WMEECEQVAQKPCKQDDLCCKQLE 322
           ++  E L H     W +  E  A  P   D    KQL+
Sbjct: 303 ISVDEALQHPYINVWYDPAEVEAPPPQIYD----KQLD 336

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 82.9 bits (205), Expect = 6e-18
 Identities = 71/211 (33%), Positives = 98/211 (46%), Gaps = 33/211 (15%)

Query: 46  KQLGWGQFGVIRECS-DKF---TGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           +QLG G FG +  C  D     TGEV+A K +      T E +R  + EIEI+  L  H 
Sbjct: 10  QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSLQ-HD 65

Query: 102 NVVDLKAV-YEE-EDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS---- 155
           N+V  K V Y      + L+ME    G L   L+K+        R+  R L+   S    
Sbjct: 66  NIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKH------RERLDHRKLLLYASQICK 119

Query: 156 ---YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSP----- 207
              Y      VHRDL   NIL+    S + +K+ DFGL   +   +  +  V  P     
Sbjct: 120 GMEYLGSKRYVHRDLATRNILVE---SENRVKIGDFGLTKVLPQDKEYY-KVREPGESPI 175

Query: 208 FYIAPEVLAGG-YNQAADVWSAGVILYILLS 237
           F+ APE L    ++ A+DVWS GV+LY L +
Sbjct: 176 FWYAPESLTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 82.5 bits (204), Expect = 7e-18
 Identities = 66/220 (30%), Positives = 115/220 (52%), Gaps = 18/220 (8%)

Query: 44  LGKQLGWGQFGVIRECSDKFTGEV-LACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
             K+LG GQFGV+     K+ G++ +A K I ++  ++ +D      E ++M KLS HPN
Sbjct: 8   FLKELGSGQFGVVH--LGKWRGKIDVAIKMI-REGAMSEDDFIE---EAKVMMKLS-HPN 60

Query: 103 VVDLKAVYEEEDYVHLLMELCAGGELFHRL-EKYGRFSETEARVIFRHLMQVVSYCHGNG 161
           +V L  V  ++  + ++ E  A G L + L E+ G+        +   + + + Y   NG
Sbjct: 61  LVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG 120

Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYI---APEVLA-G 217
            +HRDL   N L+      + +K++DFGLA Y+   Q    + G+ F +    PEV    
Sbjct: 121 FIHRDLAARNCLV---GEDNVVKVSDFGLARYVLDDQYT-SSQGTKFPVKWAPPEVFDYS 176

Query: 218 GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRA 256
            ++  +DVWS GV+++ + S G  P+   + S++ ++V A
Sbjct: 177 RFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSA 216

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 83.1 bits (205), Expect = 7e-18
 Identities = 75/293 (25%), Positives = 123/293 (41%), Gaps = 44/293 (15%)

Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           Y+  ++LG G +  + +   +  G+++A K I+   + T E V    +    + K   H 
Sbjct: 7   YLNLEKLGEGSYATVYKGISRINGQLVALKVIS---MKTEEGVPFTAIREASLLKGLKHA 63

Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
           N+V L  +   ++ +  + E        + ++  G       R+    L++ ++Y HG  
Sbjct: 64  NIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH 123

Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIK-AGQNLHGTVGSPFYIAPEVLAGG-- 218
           ++HRDLKP+N+L+   S    +KLADFGLA       Q     V + +Y  P+VL G   
Sbjct: 124 ILHRDLKPQNLLI---SYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATD 180

Query: 219 YNQAADVWSAGVILYILLSGMPPFWG------------------------------KTKS 248
           Y+ A D+W AG I   +L G P F G                                K 
Sbjct: 181 YSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKP 240

Query: 249 KIFDAVRAADLRFPSDPWDHIS--ASARDLIMGMLRVDPSTRLTAAEVLAHSW 299
           + F   +   LR     W  +S    A DL   ML + P  R++A + L H +
Sbjct: 241 EWFLPCKPQQLR---VVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPY 290

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 82.0 bits (202), Expect = 2e-17
 Identities = 87/289 (30%), Positives = 135/289 (46%), Gaps = 47/289 (16%)

Query: 47  QLGWGQFGVIRECSD-KFTGEVLACKSIAKDRLVTVED---VRSIKLEIEIMTKLSG--H 100
           ++G G +G + +  D K  G  +A K +   R+ T E+   + +I+ E+ ++  L    H
Sbjct: 8   EIGEGAYGKVFKARDLKNGGRFVALKRV---RVQTGEEGMPLSTIR-EVAVLRHLETFEH 63

Query: 101 PNVVDLKAV-----YEEEDYVHLLMELCAGGELFHRLEKY---GRFSETEARVIFRHLMQ 152
           PNVV L  V      + E  + L+ E     +L   L+K    G  +ET   ++F+ L++
Sbjct: 64  PNVVRLFDVCTVSRTDRETKLTLVFEH-VDQDLTTYLDKVPEPGVPTETIKDMMFQ-LLR 121

Query: 153 VVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAP 212
            + + H + VVHRDLKP+NIL+   +SS  IKLADFGLA        L   V + +Y AP
Sbjct: 122 GLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 178

Query: 213 EV-LAGGYNQAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAV------------- 254
           EV L   Y    D+WS G I   +    P F G +      KI D +             
Sbjct: 179 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 238

Query: 255 --RAADLRFPSDPWDH----ISASARDLIMGMLRVDPSTRLTAAEVLAH 297
             R A     + P +     I    +DL++  L  +P+ R++A   L+H
Sbjct: 239 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 81.8 bits (202), Expect = 4e-17
 Identities = 73/263 (27%), Positives = 125/263 (47%), Gaps = 23/263 (8%)

Query: 45  GKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVV 104
             ++G G  G + +   + TG + A K I  +   TV   R I  EIEI+  ++ HPNVV
Sbjct: 79  VNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVR--RQICREIEILRDVN-HPNVV 135

Query: 105 DLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVH 164
               +++    + +L+E   GG L    E      E     + R ++  ++Y H   +VH
Sbjct: 136 KCHDMFDHNGEIQVLLEFMDGGSL----EGTHIADEQFLADVARQILSGIAYLHRRHIVH 191

Query: 165 RDLKPENILLATKSSSSPIKLADFGLATYIKAGQN-LHGTVGSPFYIAPEVLAGGYNQ-- 221
           RD+KP N+L+   +S+  +K+ADFG++  +    +  + +VG+  Y++PE +    N   
Sbjct: 192 RDIKPSNLLI---NSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGA 248

Query: 222 ----AADVWSAGV-ILYILLSGMPPFWGKTK--SKIFDAVRAADLRFPSDPWDHISASAR 274
               A D+WS GV IL   L   P   G+    + +  A+  +    P +     S   R
Sbjct: 249 YDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQ---PPEAPATASREFR 305

Query: 275 DLIMGMLRVDPSTRLTAAEVLAH 297
             I   L+ +P+ R +A ++L H
Sbjct: 306 HFISCCLQREPAKRWSAMQLLQH 328

Length = 353

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 83.4 bits (206), Expect = 5e-17
 Identities = 60/244 (24%), Positives = 100/244 (40%), Gaps = 15/244 (6%)

Query: 64  TGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYE-EEDYVHLLMEL 122
           TG  +A K +  D           + E  +  +L  HPN+V L    E     +  + E 
Sbjct: 2   TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLY-HPNIVALLDSGEAPPGLLFAVFEY 60

Query: 123 CAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSP 182
             G  L   L   G     E   +   ++  ++  H  G+VHRDLKP+NI+++       
Sbjct: 61  VPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPH 120

Query: 183 IKLADFGLATYIKAGQNL--------HGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILY 233
            K+ DFG+ T +   ++            +G+P Y APE L G      +D+++ G+I  
Sbjct: 121 AKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFL 180

Query: 234 ILLSGMPPFWGKTKSKI-FDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAA 292
             L+G     G + ++I +  +   D+  P     H       ++   L  DP  R  +A
Sbjct: 181 ECLTGQRVVQGASVAEILYQQLSPVDVSLPPWIAGHPLG---QVLRKALNKDPRQRAASA 237

Query: 293 EVLA 296
             LA
Sbjct: 238 PALA 241

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 80.3 bits (198), Expect = 5e-17
 Identities = 72/268 (26%), Positives = 115/268 (42%), Gaps = 36/268 (13%)

Query: 48  LGWGQFGVIRECSDK-----FTGEV-LACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           LG G FG + E +        +G + +A K++ K    T ++ +    E  +M+  + HP
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKG--ATDQEKKEFLKEAHLMSNFN-HP 59

Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVV------- 154
           N+V L  V    +  +++MEL  GG+L   L            +  + L+ +        
Sbjct: 60  NIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119

Query: 155 SYCHGNGVVHRDLKPENILLATKSSSSP--IKLADFGLAT-------YIKAGQNLHGTVG 205
            Y      +HRDL   N L++ K   +   +K+ DFGLA        Y K G+ L     
Sbjct: 120 VYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR- 178

Query: 206 SPFYIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGKTKSKIFDAVRAAD-LRFP 262
              ++APE L  G +   +DVWS GV+++ IL  G  P+      ++   V A   L+ P
Sbjct: 179 ---WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKP 235

Query: 263 SDPWDHISASARDLIMGMLRVDPSTRLT 290
            +  D I      L+      DPS R T
Sbjct: 236 ENCPDKI----YQLMTNCWAQDPSERPT 259

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 81.2 bits (200), Expect = 7e-17
 Identities = 91/338 (26%), Positives = 139/338 (41%), Gaps = 75/338 (22%)

Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
           RY   K +G G  G++    D      +A K +++         R+ + E+ +M K   H
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLM-KCVNH 82

Query: 101 PNVVDLKAVY------EEEDYVHLLMELCAGG-------ELFHRLEKYGRFSETEARVIF 147
            N++ L  V+      EE   V+++MEL           EL H    Y          + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY----------LL 132

Query: 148 RHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSP 207
             ++  + + H  G++HRDLKP NI++    S   +K+ DFGLA        +   V + 
Sbjct: 133 YQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTR 189

Query: 208 FYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPF--------WGKT-----------K 247
           +Y APEV+ G GY +  D+WS G I+  ++ G   F        W K             
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 249

Query: 248 SKIFDAVRA-----------------ADLRFPSDP-WDHISAS-ARDLIMGMLRVDPSTR 288
            K+   VR                   D+ FP+D   + + AS ARDL+  ML +D S R
Sbjct: 250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 309

Query: 289 LTAAEVLAHS----WMEECEQVAQKPCKQDDLCCKQLE 322
           ++  E L H     W +  E  A  P   D    KQL+
Sbjct: 310 ISVDEALQHPYINVWYDPSEAEAPPPKIPD----KQLD 343

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 79.3 bits (196), Expect = 7e-17
 Identities = 67/231 (29%), Positives = 100/231 (43%), Gaps = 24/231 (10%)

Query: 46  KQLGWGQFGVIREC-SDKFTGEVL--ACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
           K+LG G FGV+R        G+V+  A K +  D+L  + D      E  IM  L  H N
Sbjct: 1   KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMD--DFLKEAAIMHSLD-HEN 57

Query: 103 VVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVV---SYCHG 159
           ++ L  V      + ++ EL   G L  RL K           +  + +Q+     Y   
Sbjct: 58  LIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLES 115

Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ-----NLHGTVGSPF-YIAPE 213
              +HRDL   NILLA+      +K+ DFGL   +   +       H  V  PF + APE
Sbjct: 116 KRFIHRDLAARNILLASDDK---VKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPE 170

Query: 214 VL-AGGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFP 262
            L    ++ A+DVW  GV L+ + + G  P+ G + S+I   +     R  
Sbjct: 171 SLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLE 221

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 79.1 bits (195), Expect = 9e-17
 Identities = 61/219 (27%), Positives = 111/219 (50%), Gaps = 16/219 (7%)

Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           K+LG GQFGV+     +   +V A K+I  +  ++ ED      E ++M KLS HP +V 
Sbjct: 10  KELGSGQFGVVHLGKWRAQIKV-AIKAI-NEGAMSEEDFIE---EAKVMMKLS-HPKLVQ 63

Query: 106 LKAVYEEEDYVHLLMELCAGGELFHRL-EKYGRFSETEARVIFRHLMQVVSYCHGNGVVH 164
           L  V  ++  ++++ E    G L + L ++ G+ S+     + + + + + Y   N  +H
Sbjct: 64  LYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIH 123

Query: 165 RDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYI---APEVLA-GGYN 220
           RDL   N L+   SS+  +K++DFG+  Y+   +    + G+ F +    PEV     Y+
Sbjct: 124 RDLAARNCLV---SSTGVVKVSDFGMTRYVLDDEYT-SSSGAKFPVKWSPPEVFNFSKYS 179

Query: 221 QAADVWSAGVILY-ILLSGMPPFWGKTKSKIFDAVRAAD 258
             +DVWS GV+++ +   G  PF  K+  ++ + +    
Sbjct: 180 SKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGF 218

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 79.1 bits (195), Expect = 1e-16
 Identities = 65/216 (30%), Positives = 104/216 (48%), Gaps = 22/216 (10%)

Query: 47  QLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDL 106
           +LG GQ+G + E   K     +A K++ +D +   E ++    E  +M ++  HPN+V L
Sbjct: 13  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK----EAAVMKEIK-HPNLVQL 67

Query: 107 KAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQV---VSYCHGNGVV 163
             V   E   +++ E    G L   L +  R  E  A V+     Q+   + Y      +
Sbjct: 68  LGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLEKKNFI 126

Query: 164 HRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYI---APEVLAGGYN 220
           HRDL   N L+     +  +K+ADFGL+  +  G       G+ F I   APE LA  YN
Sbjct: 127 HRDLAARNCLV---GENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLA--YN 180

Query: 221 Q---AADVWSAGVILY-ILLSGMPPFWGKTKSKIFD 252
           +    +DVW+ GV+L+ I   GM P+ G   S++++
Sbjct: 181 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 216

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 79.3 bits (196), Expect = 1e-16
 Identities = 77/286 (26%), Positives = 129/286 (45%), Gaps = 28/286 (9%)

Query: 28  TILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSI 87
           TI      ++L+D   LG ++G G  G + +   K TG V+A K +   R    E+ + I
Sbjct: 4   TIDGQKYPADLNDLENLG-EIGSGTCGQVYKMRFKKTGHVMAVKQMR--RTGNKEENKRI 60

Query: 88  KLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEK--YGRFSETEARV 145
            ++++++ K    P +V     +  +  V + MEL +      +L K   G   E    +
Sbjct: 61  LMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS--TCLDKLLKRIQGPIPE---DI 115

Query: 146 IFRHLMQVVSYCH----GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLH 201
           + +  + +V   H     +GV+HRD+KP NILL    +S  +KL DFG++  +   +   
Sbjct: 116 LGKMTVAIVKALHYLKEKHGVIHRDVKPSNILL---DASGNVKLCDFGISGRLVDSKAKT 172

Query: 202 GTVGSPFYIAPEVL-----AGGYNQAADVWSAGVILYILLSGMPPFWG-KTKSKIFDAV- 254
            + G   Y+APE +        Y+  ADVWS G+ L  L +G  P+   KT+   F+ + 
Sbjct: 173 RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE---FEVLT 229

Query: 255 RAADLRFPSDPWD-HISASARDLIMGMLRVDPSTRLTAAEVLAHSW 299
           +      PS P +   S      +   L  D   R    E+L H +
Sbjct: 230 KILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPF 275

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 79.4 bits (195), Expect = 2e-16
 Identities = 74/300 (24%), Positives = 127/300 (42%), Gaps = 46/300 (15%)

Query: 39  SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLS 98
           +D Y   ++LG G +  + +   K  G+++A K I   RL   E      +    + K  
Sbjct: 4   ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVI---RLQEEEGTPFTAIREASLLKGL 60

Query: 99  GHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYC 157
            H N+V L  +   ++ + L+ E     +L   ++K+ G       ++    L++ +SY 
Sbjct: 61  KHANIVLLHDIIHTKETLTLVFEY-VHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYI 119

Query: 158 HGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT-VGSPFYIAPEVLA 216
           H   ++HRDLKP+N+L+   S +  +KLADFGLA       + +   V + +Y  P+VL 
Sbjct: 120 HQRYILHRDLKPQNLLI---SDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLL 176

Query: 217 GG--YNQAADVWSAGVILYILLSGMPPFWGKT---------------------------- 246
           G   Y+   D+W  G I   ++ G+  F G                              
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP 236

Query: 247 --KSKIFDAVRAADLRFPSDPWDHIS--ASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
             K + F      +LR     W+ +S    A DL   +L+  P  RL+A   L+H +  +
Sbjct: 237 HFKPERFTLYSPKNLR---QAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSD 293

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 81.4 bits (201), Expect = 2e-16
 Identities = 76/289 (26%), Positives = 121/289 (41%), Gaps = 42/289 (14%)

Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKL-EIEIMTKLSG 99
           RY + + +G G  G +    D      +A K I +D L     ++   L E +I   L  
Sbjct: 3   RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIRED-LSENPLLKKRFLREAKIAADLI- 60

Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRL----EKYGRFSETEARV-------IFR 148
           HP +V + ++  + D V+  M    G  L   L    +K     E   +        IF 
Sbjct: 61  HPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFH 120

Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT----- 203
            +   + Y H  GV+HRDLKP+NILL        + + D+G A + K  +          
Sbjct: 121 KICATIEYVHSKGVLHRDLKPDNILLGLFGE---VVILDWGAAIFKKLEEEDLLDIDVDE 177

Query: 204 --------------VGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKS 248
                         VG+P Y+APE L G   +++ D+++ GVILY +L+   P+  K   
Sbjct: 178 RNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR 237

Query: 249 KIFDAVRAADLRFPSD--PWDHISASARDLIMGMLRVDPSTRLTAAEVL 295
           KI        +  P +  P+  I      + M  L VDP+ R ++ + L
Sbjct: 238 KISYRDV---ILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQEL 283

Length = 932

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 78.2 bits (193), Expect = 3e-16
 Identities = 65/272 (23%), Positives = 127/272 (46%), Gaps = 29/272 (10%)

Query: 47  QLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDL 106
           +LG G +GV+ +     TG ++A K I     V  ++ + + ++++I  +    P  V  
Sbjct: 8   ELGRGAYGVVDKMRHVPTGTIMAVKRIRAT--VNSQEQKRLLMDLDISMRSVDCPYTVTF 65

Query: 107 -KAVYEEEDYVHLLMELCAGG--ELFHRLEKYGRFSETEARVIFRHLMQVVS---YCHGN 160
             A++ E D V + ME+      + + ++   G     +  ++ +  + +V    Y H  
Sbjct: 66  YGALFREGD-VWICMEVMDTSLDKFYKKVYDKGLTIPED--ILGKIAVSIVKALEYLHSK 122

Query: 161 -GVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTV--GSPFYIAPEVL-- 215
             V+HRD+KP N+L+   + +  +KL DFG++ Y+    ++  T+  G   Y+APE +  
Sbjct: 123 LSVIHRDVKPSNVLI---NRNGQVKLCDFGISGYLV--DSVAKTIDAGCKPYMAPERINP 177

Query: 216 ---AGGYNQAADVWSAGVILYILLSGMPPF--WGKTKSKIFDAVRAADLRFPSDPWDHIS 270
                GY+  +DVWS G+ +  L +G  P+  W     ++   V     + P++ +   S
Sbjct: 178 ELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKF---S 234

Query: 271 ASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
              +D +   L+ +   R    E+L H + E 
Sbjct: 235 PEFQDFVNKCLKKNYKERPNYPELLQHPFFEL 266

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 77.7 bits (191), Expect = 3e-16
 Identities = 71/250 (28%), Positives = 120/250 (48%), Gaps = 23/250 (9%)

Query: 44  LGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNV 103
           LG+ +G G+FG + +   ++TG+ +A K+I  D  VT +   +   E  +MTKL  H N+
Sbjct: 10  LGEIIGEGEFGAVLQ--GEYTGQKVAVKNIKCD--VTAQ---AFLEETAVMTKLH-HKNL 61

Query: 104 VDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVI-FR-HLMQVVSYCHGNG 161
           V L  V      ++++MEL + G L + L   GR   +  +++ F   + + + Y     
Sbjct: 62  VRLLGVILHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK 120

Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF-YIAPEVLAGG-Y 219
           +VHRDL   NIL+   S     K++DFGLA   + G         P  + APE L    +
Sbjct: 121 LVHRDLAARNILV---SEDGVAKVSDFGLA---RVGSMGVDNSKLPVKWTAPEALKHKKF 174

Query: 220 NQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           +  +DVWS GV+L+ + S G  P+   +  ++ + V      +  +P +   A    L+ 
Sbjct: 175 SSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKG---YRMEPPEGCPADVYVLMT 231

Query: 279 GMLRVDPSTR 288
                +P  R
Sbjct: 232 SCWETEPKKR 241

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 77.3 bits (190), Expect = 4e-16
 Identities = 62/223 (27%), Positives = 113/223 (50%), Gaps = 16/223 (7%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
               L +++G GQFG++         +V A K+I ++  ++ ED      E ++M KLS 
Sbjct: 4   SELTLVQEIGSGQFGLVWLGYWLEKRKV-AIKTI-REGAMSEED---FIEEAQVMMKLS- 57

Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLE-KYGRFSETEARVIFRHLMQVVSYCH 158
           HP +V L  V  E   + L+ E    G L   L  + G+FS+     +   + + ++Y  
Sbjct: 58  HPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE 117

Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF---YIAPEVL 215
            + V+HRDL   N L+     +  +K++DFG+  ++   Q    T G+ F   + +PEV 
Sbjct: 118 SSNVIHRDLAARNCLV---GENQVVKVSDFGMTRFVLDDQYTSST-GTKFPVKWSSPEVF 173

Query: 216 A-GGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRA 256
           +   Y+  +DVWS GV+++ + S G  P+  ++ S++ + + A
Sbjct: 174 SFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINA 216

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 79.5 bits (196), Expect = 4e-16
 Identities = 55/170 (32%), Positives = 90/170 (52%), Gaps = 17/170 (10%)

Query: 134 KYGR-FSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLAT 192
           K  R F E EA ++F  ++  V + H   ++HRD+K  NILL    S+  +KL DFG + 
Sbjct: 135 KTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLC---SNGLVKLGDFGFSK 191

Query: 193 YIKA------GQNLHGTVGSPFYIAPEVL-AGGYNQAADVWSAGVILYILLSGMPPFWGK 245
              A      G+   GT   P+Y+APE+     Y++ AD++S GV+LY LL+   PF G+
Sbjct: 192 MYAATVSDDVGRTFCGT---PYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE 248

Query: 246 TKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVL 295
              ++     A   R+   P   IS   ++++  +L  DP  R +++++L
Sbjct: 249 NMEEVMHKTLAG--RYDPLP-PSISPEMQEIVTALLSSDPKRRPSSSKLL 295

Length = 496

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 78.1 bits (192), Expect = 5e-16
 Identities = 61/212 (28%), Positives = 100/212 (47%), Gaps = 13/212 (6%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKL-EIEIMTKLS 98
           + Y+   +LG G +  + +   K T  ++A K I   RL   E      + E+ ++  L 
Sbjct: 6   ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEI---RLEHEEGAPCTAIREVSLLKDLK 62

Query: 99  GHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETE-ARVIFRHLMQVVSYC 157
            H N+V L  +   E  + L+ E     +L   L+  G        ++    L++ ++YC
Sbjct: 63  -HANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYC 120

Query: 158 HGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT-VGSPFYIAPEVLA 216
           H   V+HRDLKP+N+L+  +     +KLADFGLA         +   V + +Y  P++L 
Sbjct: 121 HRRKVLHRDLKPQNLLINERGE---LKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILL 177

Query: 217 GG--YNQAADVWSAGVILYILLSGMPPFWGKT 246
           G   Y+   D+W  G I Y + +G P F G T
Sbjct: 178 GSTDYSTQIDMWGVGCIFYEMSTGRPLFPGST 209

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 78.1 bits (192), Expect = 5e-16
 Identities = 72/293 (24%), Positives = 129/293 (44%), Gaps = 39/293 (13%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKL-EIEIMTKLS 98
           + Y+  ++LG G +  + +   K T  ++A K I   RL   E      + E+ ++  L 
Sbjct: 6   ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEI---RLEHEEGAPCTAIREVSLLKDLK 62

Query: 99  GHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGR-FSETEARVIFRHLMQVVSYC 157
            H N+V L  +   +  + L+ E     +L   ++  G   S    ++    +++ ++YC
Sbjct: 63  -HANIVTLHDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYC 120

Query: 158 HGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT-VGSPFYIAPEVLA 216
           H   V+HRDLKP+N+L+  +     +KLADFGLA         +   V + +Y  P+VL 
Sbjct: 121 HRRKVLHRDLKPQNLLINERGE---LKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLL 177

Query: 217 GG--YNQAADVWSAGVILYILLSGMPPFWGKT---------------KSKIFDAVRAAD- 258
           G   Y+   D+W  G I + + SG P F G T                 + +  + + D 
Sbjct: 178 GSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE 237

Query: 259 ---LRFPS-DPWDHISASAR------DLIMGMLRVDPSTRLTAAEVLAHSWME 301
                FP   P   I+ + R      +L+   L+ +   R++A E + H++  
Sbjct: 238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFR 290

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 76.7 bits (189), Expect = 7e-16
 Identities = 73/238 (30%), Positives = 111/238 (46%), Gaps = 36/238 (15%)

Query: 44  LGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNV 103
           L ++LG GQFG + E     T  V A K++    +    D +    E +IM KL  HP +
Sbjct: 10  LLRKLGAGQFGEVWEGLWNNTTPV-AVKTLKPGTM----DPKDFLAEAQIMKKLR-HPKL 63

Query: 104 VDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLM-----QVVS--- 155
           + L AV   E+ ++++ EL   G L   L+          R +    +     QV S   
Sbjct: 64  IQLYAVCTLEEPIYIVTELMKYGSLLEYLQG------GAGRALKLPQLIDMAAQVASGMA 117

Query: 156 YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLH-GTVGSPFYI---A 211
           Y      +HRDL   N+L+     ++  K+ADFGLA  IK  ++++    G+ F I   A
Sbjct: 118 YLEAQNYIHRDLAARNVLVG---ENNICKVADFGLARVIK--EDIYEAREGAKFPIKWTA 172

Query: 212 PEVLAGGYNQ---AADVWSAGVILY-ILLSGMPPFWGKTKSKIFDAVRAADLRFPSDP 265
           PE  A  YN+    +DVWS G++L  I+  G  P+ G T +++   V     R P  P
Sbjct: 173 PE--AALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV-DQGYRMPCPP 227

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 76.1 bits (187), Expect = 2e-15
 Identities = 64/207 (30%), Positives = 99/207 (47%), Gaps = 24/207 (11%)

Query: 46  KQLGWGQFGVIREC-----SDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
           + LG G FG +  C      D  TGE +A KS+  +       +  +K EIEI+  L  H
Sbjct: 10  RDLGEGHFGKVELCRYDPEGDN-TGEQVAVKSLKPES--GGNHIADLKKEIEILRNLY-H 65

Query: 101 PNVVDLKAVYEEE--DYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQV---VS 155
            N+V  K +  E+  + + L+ME    G L   L +    ++   +   ++ +Q+   + 
Sbjct: 66  ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPR--NKNKINLKQQLKYAVQICKGMD 123

Query: 156 YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT---VGSP-FYIA 211
           Y      VHRDL   N+L+    S   +K+ DFGL   I+  +  +     + SP F+ A
Sbjct: 124 YLGSRQYVHRDLAARNVLV---ESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYA 180

Query: 212 PEVL-AGGYNQAADVWSAGVILYILLS 237
           PE L    +  A+DVWS GV LY LL+
Sbjct: 181 PECLIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 75.1 bits (185), Expect = 3e-15
 Identities = 59/215 (27%), Positives = 102/215 (47%), Gaps = 18/215 (8%)

Query: 46  KQLGWGQFGVIRE--CSDKFTGEV-LACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
           K+LG G FG + +     K   EV +A K++ ++ +   +  +    E  +M +L  HP 
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGK--KEFLREASVMAQLD-HPC 57

Query: 103 VVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGV 162
           +V L  V + E  + L+MEL   G L   L+K      ++ + +   +   ++Y      
Sbjct: 58  IVRLIGVCKGEPLM-LVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHF 116

Query: 163 VHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNL-----HGTVGSPFYIAPEVLA- 216
           VHRDL   N+LL  +      K++DFG++  + AG +       G     +Y APE +  
Sbjct: 117 VHRDLAARNVLLVNRHQ---AKISDFGMSRALGAGSDYYRATTAGRWPLKWY-APECINY 172

Query: 217 GGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKI 250
           G ++  +DVWS GV L+   S G  P+     +++
Sbjct: 173 GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEV 207

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 75.1 bits (185), Expect = 3e-15
 Identities = 62/215 (28%), Positives = 107/215 (49%), Gaps = 15/215 (6%)

Query: 90  EIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGEL--FHRLEKYGRFSETEARVIF 147
           E  IM +   HPN++ L+ V  +   V ++ E    G L  F R E  G+F+  +   + 
Sbjct: 55  EASIMGQFD-HPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLR-ENDGKFTVGQLVGML 112

Query: 148 RHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSP 207
           R +   + Y      VHRDL   NIL+   +S+   K++DFGL+  ++  +  + T G  
Sbjct: 113 RGIASGMKYLSEMNYVHRDLAARNILV---NSNLVCKVSDFGLSRRLEDSEATYTTKGGK 169

Query: 208 FYI---APEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFP 262
             I   APE +A   +  A+DVWS G++++ ++S G  P+W  +   +  AV     R P
Sbjct: 170 IPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVE-DGYRLP 228

Query: 263 SDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH 297
             P D  SA  + L++   + D + R T +++++ 
Sbjct: 229 P-PMDCPSALYQ-LMLDCWQKDRNERPTFSQIVST 261

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 74.9 bits (184), Expect = 4e-15
 Identities = 63/203 (31%), Positives = 98/203 (48%), Gaps = 18/203 (8%)

Query: 46  KQLGWGQFG-VIRECSDKF---TGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           + LG G FG V   C D     TGE++A K++ ++     ++    K EI I+  L  H 
Sbjct: 10  RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRE--CGQQNTSGWKKEINILKTLY-HE 66

Query: 102 NVVDLKAVYEE--EDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
           N+V  K    E     + L+ME    G L   L K+ + +  +  +  + + + ++Y H 
Sbjct: 67  NIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHS 125

Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTV---GSP-FYIAPEVL 215
              +HRDL   N+LL    +   +K+ DFGLA  +  G   +       SP F+ A E L
Sbjct: 126 QHYIHRDLAARNVLL---DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECL 182

Query: 216 A-GGYNQAADVWSAGVILYILLS 237
               ++ A+DVWS GV LY LL+
Sbjct: 183 KENKFSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 75.5 bits (185), Expect = 8e-15
 Identities = 70/260 (26%), Positives = 105/260 (40%), Gaps = 62/260 (23%)

Query: 86  SIKLEIEIMT-KLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSET--- 141
           +I+LE EI+      H N++ ++ +   E   +++           +   +  +S     
Sbjct: 207 AIQLENEILALGRLNHENILKIEEILRSEANTYMIT----------QKYDFDLYSFMYDE 256

Query: 142 -----------EARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGL 190
                      + R I + L+  V Y H   ++HRD+K ENI L   +    I L DFG 
Sbjct: 257 AFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFL---NCDGKIVLGDFGT 313

Query: 191 ATYIKAGQNL--HGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKT 246
           A   +  +    +G VG+    +PE+LAG GY +  D+WS G+IL  +LS    P     
Sbjct: 314 AMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGG 373

Query: 247 KS------KIFDAVRAADLRFPSDP-----------WDHISASARDLI--MG-------- 279
                   KI D++   D  FP  P            DH   S   LI  +G        
Sbjct: 374 GKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYP 433

Query: 280 ---MLRVDPSTRLTAAEVLA 296
              ML  D   R  AAE+LA
Sbjct: 434 LVKMLTFDWHLRPGAAELLA 453

Length = 501

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 73.5 bits (181), Expect = 9e-15
 Identities = 67/220 (30%), Positives = 102/220 (46%), Gaps = 21/220 (9%)

Query: 44  LGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNV 103
           L ++LG GQFG +   +   T +V A K++ K   ++ E       E +IM KL  H  +
Sbjct: 10  LERKLGAGQFGEVWMGTWNGTTKV-AVKTL-KPGTMSPEAFLQ---EAQIMKKLR-HDKL 63

Query: 104 VDLKAVYEEEDYVHLLMELCAGGELFHRL-EKYGRFSETEARVIFRHLMQVVS---YCHG 159
           V L AV  EE+ ++++ E  + G L   L    G+       V      Q+     Y   
Sbjct: 64  VQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDM--AAQIAEGMAYLES 121

Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYI---APE-VL 215
              +HRDL   NIL+     +   K+ADFGLA  I+  +      G+ F I   APE   
Sbjct: 122 RNYIHRDLAARNILV---GENLVCKIADFGLARLIEDDE-YTAREGAKFPIKWTAPEAAN 177

Query: 216 AGGYNQAADVWSAGVILY-ILLSGMPPFWGKTKSKIFDAV 254
            G +   +DVWS G++L  I+  G  P+ G T  ++ + V
Sbjct: 178 YGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQV 217

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 74.5 bits (183), Expect = 1e-14
 Identities = 47/203 (23%), Positives = 80/203 (39%), Gaps = 44/203 (21%)

Query: 136 GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIK 195
                 +A +I + +++ + Y H   ++HRD+K ENI +   +    + + D G A +  
Sbjct: 152 RPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFI---NDVDQVCIGDLGAAQFPV 208

Query: 196 AGQNLHGTVGSPFYIAPEVLA-GGYNQAADVWSAGVILYILL-----------SGMPPFW 243
                 G  G+    APEVLA   YN  AD+WSAG++L+ +L           S    + 
Sbjct: 209 VAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYV 268

Query: 244 GKTKSKIFDAVRAADL---RFPSDP-------WDHISASARD------------------ 275
               S +   +    +    FP DP       +   ++  R                   
Sbjct: 269 KSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGE 328

Query: 276 -LIMGMLRVDPSTRLTAAEVLAH 297
            L+  ML  D + R +A E+L +
Sbjct: 329 FLVHKMLTFDAAMRPSAEEILNY 351

Length = 357

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 73.6 bits (180), Expect = 2e-14
 Identities = 54/178 (30%), Positives = 82/178 (46%), Gaps = 34/178 (19%)

Query: 90  EIEIMTKLSGHPNVVDLKAV--------------YEEEDYVHLLMELCAGGELFHRLEKY 135
           EI ++ +L  HPNV+ L+ V              Y E D  H++         FHR  K 
Sbjct: 48  EIALLRELK-HPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIK--------FHRASKA 98

Query: 136 GR----FSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENIL-LATKSSSSPIKLADFGL 190
            +       +  + +   ++  + Y H N V+HRDLKP NIL +        +K+AD G 
Sbjct: 99  NKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158

Query: 191 A----TYIKAGQNLHGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPF 242
           A    + +K   +L   V + +Y APE+L G   Y +A D+W+ G I   LL+  P F
Sbjct: 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 73.2 bits (179), Expect = 2e-14
 Identities = 59/204 (28%), Positives = 90/204 (44%), Gaps = 45/204 (22%)

Query: 90  EIEIMTKLSGHPNVVDLKAV--------------YEEEDYVHLLMELCAGGELFHRLEKY 135
           EI ++ +L  HPNV+ L+ V              Y E D  H++         FHR  K 
Sbjct: 48  EIALLRELK-HPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIK--------FHRASKA 98

Query: 136 GR----FSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENIL-LATKSSSSPIKLADFGL 190
            +          + +   ++  + Y H N V+HRDLKP NIL +        +K+AD G 
Sbjct: 99  NKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158

Query: 191 A----TYIKAGQNLHGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWG 244
           A    + +K   +L   V + +Y APE+L G   Y +A D+W+ G I   LL+  P F  
Sbjct: 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF-- 216

Query: 245 KTKSKIFDAVRAADLRFPSDPWDH 268
                     R  D++  S+P+ H
Sbjct: 217 --------HCRQEDIK-TSNPYHH 231

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 74.9 bits (184), Expect = 2e-14
 Identities = 47/150 (31%), Positives = 77/150 (51%), Gaps = 4/150 (2%)

Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           +V+ K +  G FG +     K   ++ A K + K  ++    V  ++ E + +  LS  P
Sbjct: 6   FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALA-LSKSP 64

Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
            +V L    +  + V+L+ME   GG++   L  YG F E  A      +   + Y H +G
Sbjct: 65  FIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHG 124

Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLA 191
           ++HRDLKP+N+L+   S+   IKL DFGL+
Sbjct: 125 IIHRDLKPDNMLI---SNEGHIKLTDFGLS 151

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 71.8 bits (176), Expect = 2e-14
 Identities = 62/236 (26%), Positives = 95/236 (40%), Gaps = 27/236 (11%)

Query: 61  DKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLM 120
           D  T +    K + K    + E +  I             PN+V L      ED V L++
Sbjct: 14  DTRTQQTFILKGLRKSSEYSRERLTIIP---------HCVPNMVCLHKYIVSEDSVFLVL 64

Query: 121 ELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSS 180
           +   GG+L+  + K+    E   +     ++  +   H  G+V RDL P NILL      
Sbjct: 65  QHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILL---DDR 121

Query: 181 SPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGGYNQ---AADVWSAGVILYILLS 237
             I+L  F    + +   +  G      Y APEV  GG ++   A D WS G IL+ LL+
Sbjct: 122 GHIQLTYFS--RWSEVEDSCDGEAVENMYCAPEV--GGISEETEACDWWSLGAILFELLT 177

Query: 238 GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAE 293
           G        +           L  P    + +S  AR L+  +L+ +P+ RL A  
Sbjct: 178 GK----TLVECHPSGINTHTTLNIP----EWVSEEARSLLQQLLQFNPTERLGAGV 225

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 72.5 bits (178), Expect = 3e-14
 Identities = 57/216 (26%), Positives = 98/216 (45%), Gaps = 15/216 (6%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDV---RSIKLEIEIMTK 96
           +    GK LG G FG + E +     +  A   +A   L          ++  E++IM+ 
Sbjct: 35  NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94

Query: 97  LSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGR-FSETEARVIFRH-LMQVV 154
           L  H N+V+L         + ++ E C  G+L + L +    F   E  + F + + + +
Sbjct: 95  LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGM 154

Query: 155 SYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF----YI 210
           ++      +HRDL   N+LL   +    +K+ DFGLA  I    N +   G+      ++
Sbjct: 155 AFLASKNCIHRDLAARNVLL---THGKIVKICDFGLARDIMNDSN-YVVKGNARLPVKWM 210

Query: 211 APE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWG 244
           APE +    Y   +DVWS G++L+ + S G  P+ G
Sbjct: 211 APESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPG 246

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 73.8 bits (181), Expect = 4e-14
 Identities = 35/96 (36%), Positives = 53/96 (55%), Gaps = 19/96 (19%)

Query: 148 RHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSP 207
           R L+  + Y HG G++HRD+K EN+L+        I L DFG A + +      G+  +P
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVNGPED---ICLGDFGAACFAR------GSWSTP 317

Query: 208 FYI---------APEVLAGG-YNQAADVWSAGVILY 233
           F+          APEVLAG  Y  + D+WSAG++++
Sbjct: 318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIF 353

Length = 461

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 73.0 bits (179), Expect = 4e-14
 Identities = 58/205 (28%), Positives = 102/205 (49%), Gaps = 18/205 (8%)

Query: 52  QFGVIRECSDKFTGEVLAC--KSIAKDRLVTVEDV---RSIKLEIEIMTKLSGHPNVVDL 106
           Q+ ++   +    GEV  C      + + V V+ V   ++   EI+I+  +S H  +++L
Sbjct: 93  QYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPGREIDILKTIS-HRAIINL 151

Query: 107 KAVYEEEDYVHLLMEL--CAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVH 164
              Y  +  V ++M    C   +LF  +++ G     +A  I R L++ ++Y HG G++H
Sbjct: 152 IHAYRWKSTVCMVMPKYKC---DLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIH 208

Query: 165 RDLKPENILLATKSSSSPIKLADFGLATYIKAGQNL---HGTVGSPFYIAPEVLA-GGYN 220
           RD+K ENI L    ++    L DFG A  + A  +    +G  G+    +PE+LA   Y 
Sbjct: 209 RDVKTENIFLDEPENAV---LGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYC 265

Query: 221 QAADVWSAGVILYILLSGMPPFWGK 245
              D+WSAG++L+ +       +GK
Sbjct: 266 AKTDIWSAGLVLFEMSVKNVTLFGK 290

Length = 392

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 71.0 bits (174), Expect = 6e-14
 Identities = 67/266 (25%), Positives = 114/266 (42%), Gaps = 36/266 (13%)

Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           +++G G FG + +   K   EV A K+      +  +  R    E EI+ +   HPN+V 
Sbjct: 1   EKIGKGNFGDVYKGVLKGNTEV-AVKTCRST--LPPDLKRKFLQEAEILKQYD-HPNIVK 56

Query: 106 LKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVV-------SYCH 158
           L  V  ++  ++++MEL  GG L   L K       + R+  + L+Q+         Y  
Sbjct: 57  LIGVCVQKQPIYIVMELVPGGSLLTFLRK------KKNRLTVKKLLQMSLDAAAGMEYLE 110

Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLA------TYIKAGQNLHGTVGSPF-YIA 211
               +HRDL   N L+   +    +K++DFG++       Y  +     G    P  + A
Sbjct: 111 SKNCIHRDLAARNCLVGENNV---LKISDFGMSREEEGGIYTVSD----GLKQIPIKWTA 163

Query: 212 PEVL-AGGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHI 269
           PE L  G Y   +DVWS G++L+   S G  P+ G +  +  + + +   R P       
Sbjct: 164 PEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESG-YRMP--APQLC 220

Query: 270 SASARDLIMGMLRVDPSTRLTAAEVL 295
                 L++     DP  R + +E+ 
Sbjct: 221 PEEIYRLMLQCWAYDPENRPSFSEIY 246

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 71.0 bits (174), Expect = 8e-14
 Identities = 71/270 (26%), Positives = 116/270 (42%), Gaps = 32/270 (11%)

Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
             LG G  G + +     TG V+A K +      +V   + I  E++IM +    P +V 
Sbjct: 11  SDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVR--KQILRELQIMHECRS-PYIVS 67

Query: 106 LKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG-NGVVH 164
               +  E+ + + ME    G L    +K G         I   +++ ++Y +  + ++H
Sbjct: 68  FYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMH 127

Query: 165 RDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT----VGSPFYIAPEVLAGG-Y 219
           RD+KP NIL+   +S   IKL DFG+     +G+ ++      VG+  Y++PE + GG Y
Sbjct: 128 RDIKPSNILV---NSRGQIKLCDFGV-----SGELINSIADTFVGTSTYMSPERIQGGKY 179

Query: 220 NQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRF------------PSDPWD 267
              +DVWS G+ +  L  G  PF     S I D  +   +              P  P  
Sbjct: 180 TVKSDVWSLGISIIELALGKFPF---AFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSS 236

Query: 268 HISASARDLIMGMLRVDPSTRLTAAEVLAH 297
                 RD +   L  DP+ R T  ++ A 
Sbjct: 237 DFPEDLRDFVDACLLKDPTERPTPQQLCAM 266

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 70.3 bits (172), Expect = 1e-13
 Identities = 67/242 (27%), Positives = 114/242 (47%), Gaps = 20/242 (8%)

Query: 30  LDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKL 89
           +DA+ I        + K +G G+FG +     K  G+     +I   +    E  R   L
Sbjct: 1   IDASCIK-------IEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFL 53

Query: 90  -EIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKY-GRFSETEARVIF 147
            E  IM +   HPN++ L+ V  +   V ++ E    G L   L K+ G+F+  +   + 
Sbjct: 54  SEASIMGQFD-HPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGML 112

Query: 148 RHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG-QNLHGTVGS 206
           R +   + Y    G VHRDL   NIL+   +S+   K++DFGL+  ++   +  + T G 
Sbjct: 113 RGIASGMKYLSDMGYVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 169

Query: 207 PFYI---APEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRF 261
              I   APE +A   +  A+DVWS G++++ ++S G  P+W  +   +  A+     R 
Sbjct: 170 KIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG-YRL 228

Query: 262 PS 263
           P+
Sbjct: 229 PA 230

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 70.1 bits (171), Expect = 1e-13
 Identities = 63/232 (27%), Positives = 107/232 (46%), Gaps = 35/232 (15%)

Query: 48  LGWGQFG-VIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDL 106
           +G G FG V++    K    + A     K+   + +D R    E+E++ KL  HPN+++L
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHPNIINL 61

Query: 107 KAVYEEEDYVHLLMELCAGGELFHRLEK---------YGRFSETEARVIFRHLMQVVS-- 155
               E   Y++L +E    G L   L K         +   + T + +  + L+   +  
Sbjct: 62  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121

Query: 156 -----YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA----TYIKAGQNLHGTVGS 206
                Y      +HRDL   NIL+     +   K+ADFGL+     Y+K       T+G 
Sbjct: 122 ARGMDYLSQKQFIHRDLAARNILVGENYVA---KIADFGLSRGQEVYVKK------TMGR 172

Query: 207 -PF-YIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAV 254
            P  ++A E L    Y   +DVWS GV+L+ ++S G  P+ G T +++++ +
Sbjct: 173 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 224

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 70.5 bits (173), Expect = 1e-13
 Identities = 74/302 (24%), Positives = 125/302 (41%), Gaps = 55/302 (18%)

Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRS-IKLEIEIMTKLSGHPNVV 104
            +LG G  GV+ +   + +G ++A K I    L     +R+ I  E++++ + +  P +V
Sbjct: 7   GELGAGNGGVVTKVLHRPSGLIMARKLI---HLEIKPAIRNQIIRELKVLHECNS-PYIV 62

Query: 105 DLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGN-GVV 163
                +  +  + + ME   GG L   L+K GR  E     I   +++ ++Y      ++
Sbjct: 63  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIM 122

Query: 164 HRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT-----VGSPFYIAPEVLAGG 218
           HRD+KP NIL+   +S   IKL DFG+     +GQ L  +     VG+  Y++PE L G 
Sbjct: 123 HRDVKPSNILV---NSRGEIKLCDFGV-----SGQ-LIDSMANSFVGTRSYMSPERLQGT 173

Query: 219 -YNQAADVWSAGVILYILLSGM---PPFWGKTKSKIFD----AVRAADLRF--------- 261
            Y   +D+WS G+ L  +  G    PP   K    +F        A +            
Sbjct: 174 HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS 233

Query: 262 ------------------PSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEEC 303
                             P  P    S   +D +   L+ +P  R    E+  H +++  
Sbjct: 234 PRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293

Query: 304 EQ 305
           E 
Sbjct: 294 EL 295

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 69.9 bits (171), Expect = 2e-13
 Identities = 61/216 (28%), Positives = 112/216 (51%), Gaps = 18/216 (8%)

Query: 46  KQLGWGQFGVIRECSDKFTGEV-LACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVV 104
           K+LG GQFGV++    K+ G+  +A K I +  +   E +     E ++M KLS H  +V
Sbjct: 10  KELGTGQFGVVK--YGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMKLS-HEKLV 62

Query: 105 DLKAVYEEEDYVHLLMELCAGGELFHRLEKYG-RFSETEARVIFRHLMQVVSYCHGNGVV 163
            L  V  ++  ++++ E  + G L + L ++G RF  ++   + + + + ++Y      +
Sbjct: 63  QLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFI 122

Query: 164 HRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF---YIAPEVLA-GGY 219
           HRDL   N L+        +K++DFGL+ Y+   +    +VGS F   +  PEVL    +
Sbjct: 123 HRDLAARNCLV---DDQGCVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLLYSKF 178

Query: 220 NQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAV 254
           +  +DVW+ GV+++ + S G  P+     S+  + V
Sbjct: 179 SSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKV 214

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 70.1 bits (172), Expect = 2e-13
 Identities = 66/245 (26%), Positives = 107/245 (43%), Gaps = 37/245 (15%)

Query: 40  DRYVLGKQLGWGQFGVI-----RECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
           DR  LGK LG G FG +         +      +A K +  D   T +D+  +  E+E+M
Sbjct: 12  DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMM 69

Query: 95  TKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGEL--FHR-------LEKYGRFSETEARV 145
             +  H N+++L  V  +E  +++++E  A G L  F R                 E  +
Sbjct: 70  KMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETL 129

Query: 146 IFRHLM----QV---VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA------T 192
             + L+    QV   + +      +HRDL   N+L+   +    +K+ADFGLA       
Sbjct: 130 TQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV---TEDHVMKIADFGLARDIHHID 186

Query: 193 YIKAGQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGKTKSKI 250
           Y +   N    V    ++APE L    Y   +DVWS GV+L+ I   G  P+ G    ++
Sbjct: 187 YYRKTTNGRLPVK---WMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 243

Query: 251 FDAVR 255
           F  ++
Sbjct: 244 FKLLK 248

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 70.0 bits (171), Expect = 2e-13
 Identities = 66/230 (28%), Positives = 109/230 (47%), Gaps = 35/230 (15%)

Query: 48  LGWGQFG-VIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDL 106
           +G G FG VIR    K   ++ A   + K+   +  D R    E+E++ KL  HPN+++L
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMNAAIKMLKE-FASENDHRDFAGELEVLCKLGHHPNIINL 68

Query: 107 KAVYEEEDYVHLLMELCAGGELFHRLEK---------YGRFSETEARVIFRHLMQVVS-- 155
               E   Y+++ +E    G L   L K         + +   T + +  + L+Q  S  
Sbjct: 69  LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDV 128

Query: 156 -----YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA----TYIKAGQNLHGTVGS 206
                Y      +HRDL   N+L+    +S   K+ADFGL+     Y+K       T+G 
Sbjct: 129 ATGMQYLSEKQFIHRDLAARNVLVGENLAS---KIADFGLSRGEEVYVKK------TMGR 179

Query: 207 -PF-YIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFD 252
            P  ++A E L    Y   +DVWS GV+L+ ++S G  P+ G T +++++
Sbjct: 180 LPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYE 229

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 69.3 bits (169), Expect = 2e-13
 Identities = 65/222 (29%), Positives = 108/222 (48%), Gaps = 27/222 (12%)

Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           K+LG GQFG +       + +V A K++    +     V++   E  +M  L  H  +V 
Sbjct: 12  KKLGAGQFGEVWMGYYNNSTKV-AVKTLKPGTM----SVQAFLEEANLMKTLQ-HDKLVR 65

Query: 106 LKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQV-------VSYCH 158
           L AV  +E+ ++++ E  A G L   L+     S+   +V+   L+         ++Y  
Sbjct: 66  LYAVVTKEEPIYIITEYMAKGSLLDFLK-----SDEGGKVLLPKLIDFSAQIAEGMAYIE 120

Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYI---APEVL 215
               +HRDL+  N+L+   S S   K+ADFGLA  I+  +      G+ F I   APE +
Sbjct: 121 RKNYIHRDLRAANVLV---SESLMCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEAI 176

Query: 216 A-GGYNQAADVWSAGVILY-ILLSGMPPFWGKTKSKIFDAVR 255
             G +   +DVWS G++LY I+  G  P+ G + S +  A++
Sbjct: 177 NFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQ 218

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 69.1 bits (169), Expect = 3e-13
 Identities = 62/229 (27%), Positives = 107/229 (46%), Gaps = 17/229 (7%)

Query: 48  LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKL-EIEIMTKLSGHPNVVDL 106
           +G G+FG +     K  G+     +I   +    E  R   L E  IM +   HPN++ L
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD-HPNIIHL 70

Query: 107 KAVYEEEDYVHLLMELCAGGEL--FHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVH 164
           + V  +   V ++ E    G L  F R    G+F+  +   + R +   + Y      VH
Sbjct: 71  EGVVTKSRPVMIITEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEMNYVH 129

Query: 165 RDLKPENILLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYI---APEVLA-G 217
           RDL   NIL+   +S+   K++DFGL+ +++   +      ++G    I   APE +A  
Sbjct: 130 RDLAARNILV---NSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR 186

Query: 218 GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDP 265
            +  A+DVWS G++++ ++S G  P+W  +   + +A+   D R P   
Sbjct: 187 KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE-QDYRLPPPM 234

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 68.1 bits (167), Expect = 1e-12
 Identities = 51/215 (23%), Positives = 91/215 (42%), Gaps = 22/215 (10%)

Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
            ++GK         + +     T  ++A K I  D     ED++ ++ EI I ++   HP
Sbjct: 4   TLIGKCFEDLMIVHLAKHKP--TNTLVAVKKINLDSCSK-EDLKLLQQEI-ITSRQLQHP 59

Query: 102 NVVDLKAVYEEEDYVHLLMELCAGG---ELFHRLEKYGRFSETEARVIFRHLMQVVSYCH 158
           N++     +  +  ++++  L A G   +L       G   E     I + ++  + Y H
Sbjct: 60  NILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEG-LPELAIAFILKDVLNALDYIH 118

Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLA-TYIKAGQNLHGTVGSPFYI------- 210
             G +HR +K  +ILL   S    + L+    + + IK G+        P          
Sbjct: 119 SKGFIHRSVKASHILL---SGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWL 175

Query: 211 APEVLAG---GYNQAADVWSAGVILYILLSGMPPF 242
           +PEVL     GYN+ +D++S G+    L +G  PF
Sbjct: 176 SPEVLQQNLQGYNEKSDIYSVGITACELANGHVPF 210

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 67.1 bits (164), Expect = 2e-12
 Identities = 70/236 (29%), Positives = 103/236 (43%), Gaps = 36/236 (15%)

Query: 44  LGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIK---------LEIEIM 94
           L + LG G FG +      + G        A +  V V+ +             +E  IM
Sbjct: 10  LLRALGHGAFGEV------YEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIM 63

Query: 95  TKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGEL--FHRLE--KYGR-FSETEARVIF-- 147
           +K + H N+V L  V  E     +L+EL AGG+L  F R    +  R  S T   ++F  
Sbjct: 64  SKFN-HQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCA 122

Query: 148 RHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLAT-------YIKAGQNL 200
           R + +   Y   N  +HRD+   N LL  K      K+ADFG+A        Y K G+ +
Sbjct: 123 RDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAM 182

Query: 201 HGTVGSPFYIAPEV-LAGGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAV 254
                 P    PE  L G +    DVWS GV+L+ + S G  P+ G+T  ++ + V
Sbjct: 183 LPIKWMP----PEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV 234

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 67.1 bits (164), Expect = 2e-12
 Identities = 62/237 (26%), Positives = 113/237 (47%), Gaps = 34/237 (14%)

Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKL------EIEIMTKLSG 99
           ++LG G FG + +       E L+  S+A   + T+++    K+      E E+M+ L  
Sbjct: 11  EELGEGAFGKVYKGELTGPNERLSATSVA---IKTLKENAEPKVQQEFRQEAELMSDLQ- 66

Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVI------------F 147
           HPN+V L  V  +E    +L E  A G+L   L +    S+  A               F
Sbjct: 67  HPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDF 126

Query: 148 RHL-MQVVS---YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG---QNL 200
            H+ +Q+ +   Y   +  VHRDL   N L+    +   +K++DFGL+  I +    +  
Sbjct: 127 LHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLT---VKISDFGLSRDIYSADYYRVQ 183

Query: 201 HGTVGSPFYIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVR 255
             ++    ++ PE +L G +   +D+WS GV+L+ + S G+ P++G +  ++ + +R
Sbjct: 184 SKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR 240

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 67.0 bits (163), Expect = 2e-12
 Identities = 69/249 (27%), Positives = 114/249 (45%), Gaps = 43/249 (17%)

Query: 40  DRYVLGKQLGWGQFGVI---------RECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLE 90
           DR VLGK LG G FG +         +E  ++ T   +A K +  D   T +D+  +  E
Sbjct: 18  DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTK--VAVKMLKSD--ATEKDLSDLISE 73

Query: 91  IEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEK---------YGRFSET 141
           +E+M  +  H N+++L     ++  +++++E  + G L   L           Y      
Sbjct: 74  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVP 133

Query: 142 EARVIFRHLM----QV---VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA--- 191
           E ++ F+ L+    QV   + Y      +HRDL   N+L+   +  + +K+ADFGLA   
Sbjct: 134 EEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDI 190

Query: 192 ---TYIKAGQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGKT 246
               Y K   N    V    ++APE L    Y   +DVWS GV+L+ I   G  P+ G  
Sbjct: 191 HHIDYYKKTTNGRLPVK---WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 247

Query: 247 KSKIFDAVR 255
             ++F  ++
Sbjct: 248 VEELFKLLK 256

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 66.9 bits (163), Expect = 2e-12
 Identities = 73/252 (28%), Positives = 113/252 (44%), Gaps = 49/252 (19%)

Query: 40  DRYVLGKQLGWGQFG-VIRECSDKFTGEVLACKSIAKDRLVTV-----------EDVRSI 87
           DR VLGK LG G FG V+R        E         D+ VTV           +D+  +
Sbjct: 12  DRLVLGKPLGEGCFGQVVR-------AEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADL 64

Query: 88  KLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGEL--FHRLEKYGRFSET---- 141
             E+E+M  +  H N+++L  V  +E  +++++E  A G L  F R  +      T    
Sbjct: 65  ISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDIT 124

Query: 142 ---EARVIFRHLM----QV---VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA 191
              E ++ F+ L+    QV   + Y      +HRDL   N+L+      + +K+ADFGLA
Sbjct: 125 KVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT---EDNVMKIADFGLA 181

Query: 192 ------TYIKAGQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFW 243
                  Y K   N    V    ++APE L    Y   +DVWS G++++ I   G  P+ 
Sbjct: 182 RGVHDIDYYKKTSNGRLPVK---WMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYP 238

Query: 244 GKTKSKIFDAVR 255
           G    ++F  +R
Sbjct: 239 GIPVEELFKLLR 250

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 66.2 bits (161), Expect = 3e-12
 Identities = 63/208 (30%), Positives = 96/208 (46%), Gaps = 16/208 (7%)

Query: 90  EIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLE-KYGRFSETEARVIF- 147
           E ++M KL  H  +V L AV  EE  ++++ E  + G L   L+ + G++      V   
Sbjct: 51  EAQVMKKLR-HEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMA 108

Query: 148 RHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSP 207
             +   ++Y      VHRDL+  NIL+     +   K+ADFGLA  I+  +      G+ 
Sbjct: 109 AQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNE-YTARQGAK 164

Query: 208 F---YIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFP 262
           F   + APE  L G +   +DVWS G++L  L + G  P+ G    ++ D V     R P
Sbjct: 165 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMP 223

Query: 263 SDPWDHISASARDLIMGMLRVDPSTRLT 290
             P      S  DL+    R +P  R T
Sbjct: 224 CPP--ECPESLHDLMCQCWRKEPEERPT 249

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 66.6 bits (162), Expect = 3e-12
 Identities = 72/272 (26%), Positives = 121/272 (44%), Gaps = 36/272 (13%)

Query: 48  LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLK 107
           +G G FG + +   K  G  +           + +D R    E+E++ KL  HPN+++L 
Sbjct: 15  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74

Query: 108 AVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRH-----------------L 150
              E   Y++L +E    G L   L K  R  ET+      +                 +
Sbjct: 75  GACEHRGYLYLAIEYAPHGNLLDFLRK-SRVLETDPAFAIANSTASTLSSQQLLHFAADV 133

Query: 151 MQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLH--GTVGS-P 207
            + + Y      +HRDL   NIL+     +   K+ADFGL+     GQ ++   T+G  P
Sbjct: 134 ARGMDYLSQKQFIHRDLAARNILVGENYVA---KIADFGLSR----GQEVYVKKTMGRLP 186

Query: 208 F-YIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAV-RAADLRFPS 263
             ++A E L    Y   +DVWS GV+L+ ++S G  P+ G T +++++ + +   L  P 
Sbjct: 187 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL 246

Query: 264 DPWDHISASARDLIMGMLRVDPSTRLTAAEVL 295
           +  D +     DL+    R  P  R + A++L
Sbjct: 247 NCDDEVY----DLMRQCWREKPYERPSFAQIL 274

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 66.6 bits (162), Expect = 4e-12
 Identities = 61/211 (28%), Positives = 107/211 (50%), Gaps = 14/211 (6%)

Query: 47  QLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDL 106
           +LG G  GV+ + S K +G ++A K I  +    + +   I  E++++ + +  P +V  
Sbjct: 12  ELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRN--QIIRELQVLHECNS-PYIVGF 68

Query: 107 KAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYC-HGNGVVHR 165
              +  +  + + ME   GG L   L+K GR  E     +   +++ ++Y    + ++HR
Sbjct: 69  YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHR 128

Query: 166 DLKPENILLATKSSSSPIKLADFGLA-TYIKAGQNLHGTVGSPFYIAPEVLAGG-YNQAA 223
           D+KP NIL+   +S   IKL DFG++   I +  N    VG+  Y++PE L G  Y+  +
Sbjct: 129 DVKPSNILV---NSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPERLQGTHYSVQS 183

Query: 224 DVWSAGVILYILLSG---MPPFWGKTKSKIF 251
           D+WS G+ L  +  G   +PP   K    +F
Sbjct: 184 DIWSMGLSLVEMAIGRYPIPPPDAKELELMF 214

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 65.8 bits (161), Expect = 4e-12
 Identities = 74/288 (25%), Positives = 128/288 (44%), Gaps = 34/288 (11%)

Query: 36  SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVE-DVRSIKLEIEIM 94
            +L D   LG ++G G FG + +   K +G ++A K I   R    E + + + ++++++
Sbjct: 4   EDLKD---LG-EIGRGAFGTVNKMLHKPSGTIMAVKRI---RSTVDEKEQKRLLMDLDVV 56

Query: 95  TKLSGHPNVVDL-KAVYEEEDYVHLLMELCAGGELFHRLEK-YGRFSETEARVIFRHLMQ 152
            + S  P +V    A++ E D   + MEL     +   L+K Y    E    VI   ++ 
Sbjct: 57  MRSSDCPYIVKFYGALFREGD-CWICMEL-----MDISLDKFYKYVYEVLKSVIPEEILG 110

Query: 153 VVSYCHGNG---------VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT 203
            ++               ++HRD+KP NILL    +   IKL DFG++  +         
Sbjct: 111 KIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGN---IKLCDFGISGQLVDSIAKTRD 167

Query: 204 VGSPFYIAPEVLA----GGYNQAADVWSAGVILYILLSGMPPF--WGKTKSKIFDAVRAA 257
            G   Y+APE +      GY+  +DVWS G+ LY + +G  P+  W     ++   V+  
Sbjct: 168 AGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGD 227

Query: 258 DLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ 305
                +      S S  + I   L  D S R    E+L H ++++ E+
Sbjct: 228 PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEE 275

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 65.8 bits (160), Expect = 5e-12
 Identities = 65/246 (26%), Positives = 110/246 (44%), Gaps = 37/246 (15%)

Query: 40  DRYVLGKQLGWGQFG--VIREC----SDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEI 93
           D+  LGK LG G FG  V+ E      DK    V     + KD   T +D+  +  E+E+
Sbjct: 15  DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEM 73

Query: 94  MTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLE---------KYGRFSETEAR 144
           M  +  H N+++L     ++  +++++E  + G L   L           Y      + +
Sbjct: 74  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQ 133

Query: 145 VIFRHLMQV-------VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA------ 191
           + F+ L+         + Y      +HRDL   N+L+   + ++ +K+ADFGLA      
Sbjct: 134 MTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLARDVNNI 190

Query: 192 TYIKAGQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGKTKSK 249
            Y K   N    V    ++APE L    Y   +DVWS GV+++ I   G  P+ G    +
Sbjct: 191 DYYKKTTNGRLPVK---WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 247

Query: 250 IFDAVR 255
           +F  ++
Sbjct: 248 LFKLLK 253

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 65.0 bits (158), Expect = 6e-12
 Identities = 61/221 (27%), Positives = 104/221 (47%), Gaps = 30/221 (13%)

Query: 48  LGWGQFGVIRECS--DKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMT-----KLSGH 100
           LG G FG + + +  DK    V  CK          ED+   +L+I+ ++     K   H
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCK----------EDLPQ-ELKIKFLSEARILKQYDH 51

Query: 101 PNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS---YC 157
           PN+V L  V  +   ++++MEL  GG+    L K  +  E + + + +  +   +   Y 
Sbjct: 52  PNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRK--KKDELKTKQLVKFALDAAAGMAYL 109

Query: 158 HGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG-QNLHGTVGSPF-YIAPEVL 215
                +HRDL   N L+     ++ +K++DFG++     G  +  G    P  + APE L
Sbjct: 110 ESKNCIHRDLAARNCLVG---ENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEAL 166

Query: 216 A-GGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAV 254
             G Y+  +DVWS G++L+   S G+ P+ G T  +  + V
Sbjct: 167 NYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQV 207

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 65.0 bits (158), Expect = 7e-12
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 31/211 (14%)

Query: 65  GEVLACKSIAKDRLVTVEDVRS---------IKLEIEIMTKLSGHPNVVDLKAVYEEEDY 115
           GEV + +  A +  V V+  R             E  I+ + S HPN+V L  V  ++  
Sbjct: 9   GEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYS-HPNIVRLIGVCTQKQP 67

Query: 116 VHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVV-------SYCHGNGVVHRDLK 168
           ++++MEL  GG+    L   G       R+  + L+Q+V        Y      +HRDL 
Sbjct: 68  IYIVMELVQGGDFLTFLRTEG------PRLKVKELIQMVENAAAGMEYLESKHCIHRDLA 121

Query: 169 PENILLATKSSSSPIKLADFGLATYIKAG--QNLHGTVGSPF-YIAPEVLA-GGYNQAAD 224
             N L+  K+    +K++DFG++   + G   +  G    P  + APE L  G Y+  +D
Sbjct: 122 ARNCLVTEKNV---LKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESD 178

Query: 225 VWSAGVILYILLS-GMPPFWGKTKSKIFDAV 254
           VWS G++L+   S G  P+   +  +  +A+
Sbjct: 179 VWSFGILLWEAFSLGAVPYANLSNQQTREAI 209

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 65.0 bits (158), Expect = 9e-12
 Identities = 67/240 (27%), Positives = 107/240 (44%), Gaps = 26/240 (10%)

Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKL-EIEIMTKLSGHPNVV 104
           K +G G+FG +     K  G      +I   +    E  R   L E  IM + S H N++
Sbjct: 11  KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS-HHNII 69

Query: 105 DLKAVYEEEDYVHLLMELCAGGELFHRL-EKYGRFSETEARVIFRHLMQVVSYCHGNGVV 163
            L+ V  +     ++ E    G L   L +  G FS  +   + R +   + Y      V
Sbjct: 70  RLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYV 129

Query: 164 HRDLKPENILLATKSSSSPIKLADFGL---------ATYIKAGQNLHGTVGSPF-YIAPE 213
           HRDL   NIL+   +S+   K++DFGL          TY  +G  +      P  + APE
Sbjct: 130 HRDLAARNILV---NSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI------PIRWTAPE 180

Query: 214 VLA-GGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISA 271
            +A   +  A+DVWS G++++ ++S G  P+W  +  ++  A+     R P+ P D  SA
Sbjct: 181 AIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDG-FRLPA-PMDCPSA 238

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 64.7 bits (158), Expect = 1e-11
 Identities = 63/284 (22%), Positives = 116/284 (40%), Gaps = 43/284 (15%)

Query: 40  DRYVLGKQLGWGQFGVIRE-----CSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
           ++  L ++LG G FG++ E              +A K++ ++   ++ +      E  +M
Sbjct: 6   EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNEN--ASMRERIEFLNEASVM 63

Query: 95  TKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARV--------I 146
            + + H +VV L  V        ++MEL A G+L   L    R                 
Sbjct: 64  KEFNCH-HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSR-RPEAENNPGLGPPTLQKF 121

Query: 147 FRHLMQV---VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLAT-------YIKA 196
            +   ++   ++Y      VHRDL   N ++   +    +K+ DFG+         Y K 
Sbjct: 122 IQMAAEIADGMAYLAAKKFVHRDLAARNCMV---AEDLTVKIGDFGMTRDIYETDYYRKG 178

Query: 197 GQNLHGTVGSPF-YIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGKTKSKIFDA 253
           G+ L      P  ++APE L  G +   +DVWS GV+L+ +      P+ G +  ++   
Sbjct: 179 GKGL-----LPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKF 233

Query: 254 VRAAD-LRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLA 296
           V     L  P +  D +     +L+    + +P  R T  E+++
Sbjct: 234 VIDGGHLDLPENCPDKL----LELMRMCWQYNPKMRPTFLEIVS 273

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 64.6 bits (157), Expect = 2e-11
 Identities = 40/142 (28%), Positives = 72/142 (50%), Gaps = 7/142 (4%)

Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
           HP+++ LK  +    +  L++      +L+  L      +  +   I R +++ + Y H 
Sbjct: 142 HPSIIQLKGTFTYNKFTCLILPRYKT-DLYCYLAAKRNIAICDILAIERSVLRAIQYLHE 200

Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATY-IKAGQN-LHGTVGSPFYIAPEVLA- 216
           N ++HRD+K ENI +   +    + L DFG A + +    N  +G  G+    APE+LA 
Sbjct: 201 NRIIHRDIKAENIFI---NHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLAR 257

Query: 217 GGYNQAADVWSAGVILYILLSG 238
             Y  A D+WSAG++L+ + + 
Sbjct: 258 DPYGPAVDIWSAGIVLFEMATC 279

Length = 391

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 65.0 bits (158), Expect = 2e-11
 Identities = 86/344 (25%), Positives = 139/344 (40%), Gaps = 88/344 (25%)

Query: 39  SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTK-- 96
           + R+ +   LG G FG + E  D+   E  A K +      T    R  K+EI+ M K  
Sbjct: 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYT----RDAKIEIQFMEKVR 183

Query: 97  LSGHPNVVDLKAV--YEEEDYVHLLMELCAGGE-LFHRLEKYGRFSETEARVIFRHLMQV 153
            +   +   L  +  Y + +  H+ + +   G  L   + K+G FS        RHL Q+
Sbjct: 184 QADPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSH-------RHLAQI 236

Query: 154 V-------SYCHGN-GVVHRDLKPENILLATKSSS-----------SP--IKLADFGLAT 192
           +        Y H    ++H DLKPENIL+ T  +             P  +++ D G   
Sbjct: 237 IFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCC 296

Query: 193 YIKAGQNLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSG------------- 238
             +  +     V +  Y +PEV+ G G+  + D+WS G I+Y L +G             
Sbjct: 297 DERHSRT--AIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHL 354

Query: 239 ---------MPPFW----GKTKSK-IFDAVRAADLRFPSDPWDHISASAR---------- 274
                    +P  W    G  +++ ++++  A  LR  +DP  H++  AR          
Sbjct: 355 HLMEKTLGRLPSEWAGRCGTEEARLLYNS--AGQLRPCTDP-KHLARIARARPVREVIRD 411

Query: 275 ----DLIMGMLRVDPSTRLTAAEVLAHSWM----EECEQVAQKP 310
               DLI G+L  D   RL A ++  H ++     EC Q    P
Sbjct: 412 DLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKYYPECRQHPNYP 455

Length = 467

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 64.3 bits (156), Expect = 3e-11
 Identities = 60/211 (28%), Positives = 105/211 (49%), Gaps = 14/211 (6%)

Query: 47  QLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDL 106
           +LG G  GV+ +   K +G ++A K I  +    + +   I  E++++ + +  P +V  
Sbjct: 12  ELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRN--QIIRELQVLHECNS-PYIVGF 68

Query: 107 KAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYC-HGNGVVHR 165
              +  +  + + ME   GG L   L++  R  E     +   +++ ++Y    + ++HR
Sbjct: 69  YGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHR 128

Query: 166 DLKPENILLATKSSSSPIKLADFGLA-TYIKAGQNLHGTVGSPFYIAPEVLAGG-YNQAA 223
           D+KP NIL+   +S   IKL DFG++   I +  N    VG+  Y++PE L G  Y+  +
Sbjct: 129 DVKPSNILV---NSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPERLQGTHYSVQS 183

Query: 224 DVWSAGVILYILLSG---MPPFWGKTKSKIF 251
           D+WS G+ L  L  G   +PP   K    IF
Sbjct: 184 DIWSMGLSLVELAIGRYPIPPPDAKELEAIF 214

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 63.4 bits (154), Expect = 3e-11
 Identities = 59/212 (27%), Positives = 102/212 (48%), Gaps = 24/212 (11%)

Query: 46  KQLGWGQFGVIRE--CSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEI----EIMTKLSG 99
            +LG G FG +++     K + + +A K +  D      +  ++K E+     +M +L  
Sbjct: 1   GELGSGNFGTVKKGMYKMKKSEKTVAVKILKND-----NNDPALKDELLREANVMQQLD- 54

Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
           +P +V +  + E E ++ L+MEL   G L   L+K    +E     +   +   + Y   
Sbjct: 55  NPYIVRMIGICEAESWM-LVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEE 113

Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNL-----HGTVGSPFYIAPEV 214
              VHRDL   N+LL T+  +   K++DFGL+  + A +N      HG     +Y APE 
Sbjct: 114 TNFVHRDLAARNVLLVTQHYA---KISDFGLSKALGADENYYKAKTHGKWPVKWY-APEC 169

Query: 215 LA-GGYNQAADVWSAGVILYILLS-GMPPFWG 244
           +    ++  +DVWS GV+++   S G  P+ G
Sbjct: 170 MNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKG 201

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 63.0 bits (153), Expect = 5e-11
 Identities = 63/228 (27%), Positives = 104/228 (45%), Gaps = 35/228 (15%)

Query: 40  DRYVLGKQLGWGQFGVIRECS----DKFTGEVLACKSIAKDR-LVTVEDVRS-------- 86
            R    ++LG GQFG +  C     +KF  +  +         LV V+ +R         
Sbjct: 5   KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARN 64

Query: 87  --IKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGEL---FHRLEKYGRFSET 141
             +K EI+IM++L   PN++ L AV    D + ++ E    G+L     R E      + 
Sbjct: 65  DFLK-EIKIMSRLK-DPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKA 122

Query: 142 EARVI-FRHLM----QVVS---YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATY 193
           +   I +  L+    Q+ S   Y      VHRDL   N L+    +   IK+ADFG++  
Sbjct: 123 DVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYT---IKIADFGMSRN 179

Query: 194 IKAGQ--NLHGTVGSPF-YIAPE-VLAGGYNQAADVWSAGVILYILLS 237
           + +G    + G    P  +++ E +L G +  A+DVW+ GV L+ +L+
Sbjct: 180 LYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 61.9 bits (150), Expect = 7e-11
 Identities = 61/206 (29%), Positives = 97/206 (47%), Gaps = 22/206 (10%)

Query: 44  LGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNV 103
           L + +G G+FG +      + G  +A K I  D        ++   E  +MT+L  H N+
Sbjct: 10  LLQTIGKGEFGDVM--LGDYRGNKVAVKCIKND-----ATAQAFLAEASVMTQLR-HSNL 61

Query: 104 VDLKAV-YEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQV---VSYCHG 159
           V L  V  EE+  ++++ E  A G L   L   GR S      + +  + V   + Y   
Sbjct: 62  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEA 120

Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF-YIAPEVL-AG 217
           N  VHRDL   N+L+   S  +  K++DFGL     + Q+   T   P  + APE L   
Sbjct: 121 NNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQD---TGKLPVKWTAPEALREK 174

Query: 218 GYNQAADVWSAGVILYILLS-GMPPF 242
            ++  +DVWS G++L+ + S G  P+
Sbjct: 175 KFSTKSDVWSFGILLWEIYSFGRVPY 200

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 61.2 bits (148), Expect = 1e-10
 Identities = 75/255 (29%), Positives = 117/255 (45%), Gaps = 23/255 (9%)

Query: 44  LGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNV 103
           L K+LG GQFG +   +     +V A K++    +       S   E +IM KL  H  +
Sbjct: 10  LIKKLGNGQFGEVWMGTWNGNTKV-AVKTLKPGTM----SPESFLEEAQIMKKLR-HDKL 63

Query: 104 VDLKAVYEEEDYVHLLMELCAGGELFHRLEK-YGRFSETEARV-IFRHLMQVVSYCHGNG 161
           V L AV  EE  ++++ E  + G L   L+   GR  +    V +   +   ++Y     
Sbjct: 64  VQLYAVVSEEP-IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN 122

Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYI---APEV-LAG 217
            +HRDL+  NIL+         K+ADFGLA  I+  +      G+ F I   APE  L G
Sbjct: 123 YIHRDLRSANILVG---DGLVCKIADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYG 178

Query: 218 GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAV-RAADLRFPSDPWDHISASARD 275
            +   +DVWS G++L  L++ G  P+ G    ++ + V R   +  P D       S  +
Sbjct: 179 RFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQD----CPISLHE 234

Query: 276 LIMGMLRVDPSTRLT 290
           L++   + DP  R T
Sbjct: 235 LMLQCWKKDPEERPT 249

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 69/245 (28%), Positives = 110/245 (44%), Gaps = 37/245 (15%)

Query: 41  RYVLGKQLGWGQFG--VIREC----SDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
           R  LGK LG G FG  V+ E      DK    V     + KD   T +D+  +  E+E+M
Sbjct: 13  RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMM 71

Query: 95  TKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLE---------KYGRFSETEARV 145
             +  H N+++L     ++  +++L+E  + G L   L           +      E ++
Sbjct: 72  KMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQL 131

Query: 146 IFRHLM----QV---VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA------T 192
            F+ L+    QV   + Y      +HRDL   N+L+   +  + +K+ADFGLA       
Sbjct: 132 TFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLV---TEDNVMKIADFGLARDVHNID 188

Query: 193 YIKAGQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGKTKSKI 250
           Y K   N    V    ++APE L    Y   +DVWS GV+L+ I   G  P+ G    ++
Sbjct: 189 YYKKTTNGRLPVK---WMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 245

Query: 251 FDAVR 255
           F  ++
Sbjct: 246 FKLLK 250

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 72/253 (28%), Positives = 113/253 (44%), Gaps = 35/253 (13%)

Query: 44  LGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIE------IMTKL 97
           LGK LG G+FG + E      G++    SI K  + T++     + E+E      +  K 
Sbjct: 3   LGKTLGEGEFGSVME------GQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKE 56

Query: 98  SGHPNVVDLKAV----YEEEDYVH--LLMELCAGGELFHRLEKYGRFSET----EARVIF 147
             HPNV+ L  V     E E Y    +++     G+L H    Y R  +       +++ 
Sbjct: 57  FDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDL-HSFLLYSRLGDCPQYLPTQMLV 115

Query: 148 RHLMQVVS---YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNL-HGT 203
           + +  + S   Y      +HRDL   N +L    +   + +ADFGL+  I  G     G 
Sbjct: 116 KFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMN---VCVADFGLSKKIYNGDYYRQGR 172

Query: 204 VGS-PF-YIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGKTKSKIFDAVRAAD- 258
           +   P  +IA E LA   Y   +DVWS GV ++ I   G  P+ G   S+I+D +R  + 
Sbjct: 173 IAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNR 232

Query: 259 LRFPSDPWDHISA 271
           L+ P D  D + +
Sbjct: 233 LKQPPDCLDGLYS 245

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 60.8 bits (147), Expect = 3e-10
 Identities = 64/227 (28%), Positives = 106/227 (46%), Gaps = 34/227 (14%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDR---LVTVEDVRS---------- 86
            +  L ++LG GQFG +  C  +   E L   +   D    LV V+ +R+          
Sbjct: 5   QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDF 64

Query: 87  IKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRL---EKYGRFSETE- 142
           +K EI+IM++L  +PN++ L  V   +D + ++ E    G+L   L   E    F+    
Sbjct: 65  LK-EIKIMSRLK-NPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANN 122

Query: 143 -ARVIFRHLM----QVVS---YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI 194
              V   +L+    Q+ S   Y      VHRDL   N L+    +   IK+ADFG++  +
Sbjct: 123 IPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV---GNHYTIKIADFGMSRNL 179

Query: 195 KAGQ--NLHGTVGSPF-YIAPE-VLAGGYNQAADVWSAGVILYILLS 237
            +G    + G    P  ++A E +L G +  A+DVW+ GV L+ + +
Sbjct: 180 YSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 61.4 bits (149), Expect = 4e-10
 Identities = 32/95 (33%), Positives = 57/95 (60%), Gaps = 2/95 (2%)

Query: 204 VGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFP 262
           +G+P Y+APE+L G  +  A D W+ GV L+  L+G+PPF  +T  ++F  +   D+ +P
Sbjct: 541 LGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWP 600

Query: 263 SDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH 297
            +  + +S +A++ I  +L +DP+ R    E+  H
Sbjct: 601 -EGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQH 634

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 59.6 bits (144), Expect = 4e-10
 Identities = 61/208 (29%), Positives = 103/208 (49%), Gaps = 22/208 (10%)

Query: 47  QLGWGQFGVIRECSDKFTGEVL--ACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVV 104
           +LG G FG +++   K   + +  A K +  +   +V D   +  E EIM +L  +P +V
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRD--EMMREAEIMHQLD-NPYIV 58

Query: 105 DLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS----YCHGN 160
            +  V E E  + L+ME+ +GG L ++     +   T + V+   LM  VS    Y  G 
Sbjct: 59  RMIGVCEAEALM-LVMEMASGGPL-NKFLSGKKDEITVSNVV--ELMHQVSMGMKYLEGK 114

Query: 161 GVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHG--TVGS-PF-YIAPE-VL 215
             VHRDL   N+LL  +  +   K++DFGL+  + A  + +   + G  P  + APE + 
Sbjct: 115 NFVHRDLAARNVLLVNQHYA---KISDFGLSKALGADDSYYKARSAGKWPLKWYAPECIN 171

Query: 216 AGGYNQAADVWSAGVILYILLS-GMPPF 242
              ++  +DVWS G+ ++   S G  P+
Sbjct: 172 FRKFSSRSDVWSYGITMWEAFSYGQKPY 199

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 59.1 bits (143), Expect = 6e-10
 Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 20/215 (9%)

Query: 44  LGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNV 103
           L K+LG GQFG +         +V A KS+ +  +       +   E  +M +L  HP +
Sbjct: 10  LVKKLGAGQFGEVWMGYYNGHTKV-AIKSLKQGSM----SPEAFLAEANLMKQLQ-HPRL 63

Query: 104 VDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQV---VSYCHGN 160
           V L AV  +E  ++++ E    G L   L K     +     +     Q+   +++    
Sbjct: 64  VRLYAVVTQEP-IYIITEYMENGSLVDFL-KTPEGIKLTINKLIDMAAQIAEGMAFIERK 121

Query: 161 GVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYI---APEVLA- 216
             +HRDL+  NIL+   S +   K+ADFGLA  I+  +      G+ F I   APE +  
Sbjct: 122 NYIHRDLRAANILV---SETLCCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINY 177

Query: 217 GGYNQAADVWSAGVILY-ILLSGMPPFWGKTKSKI 250
           G +   +DVWS G++L  I+  G  P+ G T  ++
Sbjct: 178 GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV 212

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 58.5 bits (141), Expect = 1e-09
 Identities = 52/192 (27%), Positives = 91/192 (47%), Gaps = 26/192 (13%)

Query: 90  EIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRL------EKYGRFSETEA 143
           E  +M +L  HPN+V L  V  +E  V +L E    G+L   L         G  S+ + 
Sbjct: 57  EASLMAELH-HPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDG 115

Query: 144 RVI-------FRHL-MQVVS---YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLAT 192
            V        F H+ +Q+ +   Y   +  VH+DL   NIL+  +     +K++D GL+ 
Sbjct: 116 TVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLH---VKISDLGLSR 172

Query: 193 YIKAGQNLHGTVGSPF---YIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWGKTK 247
            I +         S     ++ PE ++ G ++  +D+WS GV+L+ + S G+ P++G + 
Sbjct: 173 EIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN 232

Query: 248 SKIFDAVRAADL 259
            ++ + VR   L
Sbjct: 233 QEVIEMVRKRQL 244

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 61/226 (26%), Positives = 92/226 (40%), Gaps = 41/226 (18%)

Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGEL--FHR--------------------LEKYGR 137
           HPN+V L  V      + LL E  A G+L  F R                          
Sbjct: 67  HPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLP 126

Query: 138 FSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGL------A 191
            S TE   I + +   ++Y      VHRDL   N L+     +  +K+ADFGL      A
Sbjct: 127 LSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLV---GENMVVKIADFGLSRNIYSA 183

Query: 192 TYIKAGQNLHGTVGSPFYIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWGKTKSK 249
            Y KA +N    +    ++ PE +    Y   +DVW+ GV+L+ + S GM P++G    +
Sbjct: 184 DYYKASENDAIPIR---WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240

Query: 250 IFDAVRAAD-LRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEV 294
           +   VR  + L  P    D+      +L+       PS R + A +
Sbjct: 241 VIYYVRDGNVLSCP----DNCPLELYNLMRLCWSKLPSDRPSFASI 282

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 57.7 bits (139), Expect = 2e-09
 Identities = 64/224 (28%), Positives = 107/224 (47%), Gaps = 30/224 (13%)

Query: 44  LGKQLGWGQFG-VIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
           L K+LG GQFG V     +K T   +A K++    +     V +   E  +M  L  H  
Sbjct: 10  LEKKLGAGQFGEVWMATYNKHTK--VAVKTMKPGSM----SVEAFLAEANVMKTLQ-HDK 62

Query: 103 VVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQV-------VS 155
           +V L AV  +E  ++++ E  A G L   L+     S+  ++     L+         ++
Sbjct: 63  LVKLHAVVTKEP-IYIITEFMAKGSLLDFLK-----SDEGSKQPLPKLIDFSAQIAEGMA 116

Query: 156 YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYI---AP 212
           +      +HRDL+  NIL+   S+S   K+ADFGLA  I+  +      G+ F I   AP
Sbjct: 117 FIEQRNYIHRDLRAANILV---SASLVCKIADFGLARVIEDNEYT-AREGAKFPIKWTAP 172

Query: 213 EVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAV 254
           E +  G +   +DVWS G++L  +++ G  P+ G +  ++  A+
Sbjct: 173 EAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL 216

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 57.2 bits (138), Expect = 3e-09
 Identities = 62/245 (25%), Positives = 106/245 (43%), Gaps = 28/245 (11%)

Query: 42  YVLGKQLGWGQFGVIREC---SDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLS 98
           + LG+ LG G+FG +RE    S+  + + +A K +  D + +  D+     E   M +  
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKAD-IFSSSDIEEFLREAACMKEFD 59

Query: 99  GHPNVVDLKAVYEEE------DYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQ 152
            HPNV+ L  V              +++     G+L H      R  E    +  + L++
Sbjct: 60  -HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDL-HTFLLMSRIGEEPFTLPLQTLVR 117

Query: 153 VV-------SYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVG 205
            +        Y      +HRDL   N +L    +   + +ADFGL+  I +G        
Sbjct: 118 FMIDIASGMEYLSSKNFIHRDLAARNCMLNENMT---VCVADFGLSKKIYSGDYYRQGCA 174

Query: 206 SPF---YIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGKTKSKIFDAVRAAD-L 259
           S     ++A E LA   Y   +DVW+ GV ++ I+  G  P+ G   S+I++ +   + L
Sbjct: 175 SKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRL 234

Query: 260 RFPSD 264
           + P D
Sbjct: 235 KQPPD 239

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 56.7 bits (137), Expect = 4e-09
 Identities = 72/269 (26%), Positives = 114/269 (42%), Gaps = 32/269 (11%)

Query: 44  LGKQLGWGQFGVIRECS---DKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
           LGK LG G+FG + E     D  +   +A K++  D + T  ++     E   M     H
Sbjct: 3   LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLD-IHTYSEIEEFLSEAACMKDFD-H 60

Query: 101 PNVVDLKAV-YEEEDYVHL-----LMELCAGGELFHRLEKYGRFSETEARVIFRHLMQV- 153
           PNV+ L  V +E      +     ++     G+L H    Y R      ++  + L++  
Sbjct: 61  PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDL-HSFLLYSRLGGLPEKLPLQTLLKFM 119

Query: 154 ------VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSP 207
                 + Y      +HRDL   N +L    +   + +ADFGL+  I +G        + 
Sbjct: 120 VDIALGMEYLSNRNFIHRDLAARNCMLREDMT---VCVADFGLSKKIYSGDYYRQGRIAK 176

Query: 208 F---YIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGKTKSKIFDAVRAAD-LRF 261
               +IA E LA   Y   +DVW+ GV ++ I   G  P+ G    +I+D +R  + L+ 
Sbjct: 177 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQ 236

Query: 262 PSDPWDHISASARDLIMGMLRVDPSTRLT 290
           P D  D +     DL+    R DP  R T
Sbjct: 237 PEDCLDEL----YDLMYSCWRADPKDRPT 261

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 56.6 bits (136), Expect = 5e-09
 Identities = 53/172 (30%), Positives = 85/172 (49%), Gaps = 13/172 (7%)

Query: 90  EIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRL-EKYGRFSETEARV-IF 147
           E +IM KL  H  +V L AV  EE  ++++ E    G L   L E  G++ +    V + 
Sbjct: 51  EAQIMKKLR-HDKLVPLYAVVSEEP-IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMA 108

Query: 148 RHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSP 207
             +   ++Y      +HRDL+  NIL+     +   K+ADFGLA  I+  +      G+ 
Sbjct: 109 AQIADGMAYIERMNYIHRDLRAANILVG---DNLVCKIADFGLARLIEDNE-YTARQGAK 164

Query: 208 F---YIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAV 254
           F   + APE  L G +   +DVWS G++L  L++ G  P+ G    ++ + V
Sbjct: 165 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQV 216

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 56.7 bits (137), Expect = 5e-09
 Identities = 68/283 (24%), Positives = 116/283 (40%), Gaps = 45/283 (15%)

Query: 43  VLGKQLGWGQFG-VIR-ECSDKFTG---EVLACKSIAKDRLVTVEDVR-SIKLEIEIMTK 96
           VL ++LG G FG V   EC         E++A K++ K+      D R   + E E++T 
Sbjct: 8   VLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTL-KE--TASNDARKDFEREAELLTN 64

Query: 97  LSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGR-------FSETEARVIFRH 149
              H N+V    V  E D   ++ E    G+L   L  +G               +    
Sbjct: 65  F-QHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQ 123

Query: 150 LMQVVS-------YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA------TYIKA 196
           L+Q+         Y      VHRDL   N L+        +K+ DFG++       Y + 
Sbjct: 124 LLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV---VKIGDFGMSRDVYTTDYYRV 180

Query: 197 GQNLHGTVGSPF-YIAPE-VLAGGYNQAADVWSAGVILY-ILLSGMPPFWGKTKSKIFDA 253
           G    G    P  ++ PE ++   +   +DVWS GV+L+ I   G  P++G +  ++ + 
Sbjct: 181 G----GHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIEC 236

Query: 254 VRAAD-LRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVL 295
           +     L+ P      +     D+++G  + DP  R+   ++ 
Sbjct: 237 ITQGRLLQRPRTCPSEV----YDIMLGCWKRDPQQRINIKDIH 275

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 56.6 bits (137), Expect = 6e-09
 Identities = 63/227 (27%), Positives = 99/227 (43%), Gaps = 39/227 (17%)

Query: 43  VLGKQLGWGQFGVIREC---------------SDKFTGEVL-ACKSIAKDRLVTV-EDVR 85
              ++LG GQFG +  C               +D     VL A K +  D      ED  
Sbjct: 8   NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFL 67

Query: 86  SIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEA-- 143
               E++I+++LS  PN+  L  V   +  + ++ME    G+L   L+K+   +   A  
Sbjct: 68  K---EVKILSRLS-DPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACN 123

Query: 144 --RVIFRHLM----QVVS---YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLAT-- 192
              + F  L+    Q+ S   Y      VHRDL   N L+     +  IK+ADFG++   
Sbjct: 124 SKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLV---GKNYTIKIADFGMSRNL 180

Query: 193 YIKAGQNLHGTVGSPF-YIAPE-VLAGGYNQAADVWSAGVILYILLS 237
           Y      + G    P  ++A E VL G +   +DVW+ GV L+ +L+
Sbjct: 181 YSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 56.2 bits (135), Expect = 8e-09
 Identities = 67/292 (22%), Positives = 125/292 (42%), Gaps = 59/292 (20%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDR------LVTVEDVRSIKLEIE- 92
           ++  + ++LG G FG++ E            K + KD       + TV +  S++  IE 
Sbjct: 6   EKITMSRELGQGSFGMVYEG---------IAKGVVKDEPETRVAIKTVNEAASMRERIEF 56

Query: 93  -----IMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGEL---FHRLEKYGRFSETEAR 144
                +M + + H +VV L  V  +     ++MEL   G+L      L      +  +A 
Sbjct: 57  LNEASVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAP 115

Query: 145 VIFRHLMQV-------VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLAT----- 192
              + ++Q+       ++Y + N  VHRDL   N ++A   +   +K+ DFG+       
Sbjct: 116 PSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT---VKIGDFGMTRDIYET 172

Query: 193 --YIKAGQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGKTKS 248
             Y K G+ L        +++PE L  G +   +DVWS GV+L+ I      P+ G +  
Sbjct: 173 DYYRKGGKGLLPVR----WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE 228

Query: 249 KIFDAVRAADLRFPSDPWDHISASARDLIMGMLRV----DPSTRLTAAEVLA 296
           ++   V    L    D       +  D++  ++R+    +P  R +  E+++
Sbjct: 229 QVLRFVMEGGLLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIIS 273

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 54/222 (24%), Positives = 100/222 (45%), Gaps = 35/222 (15%)

Query: 112 EEDYVHLLMELC--AGGELFHRLEKYG----RFSETEARVIFRHLM----QV---VSYCH 158
           +  +V  L+ +C  +  +L  +L  +G       E +  +  ++L+    Q+   ++Y  
Sbjct: 67  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 126

Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLH----GTVGSPFYIAPEV 214
              +VHRDL   N+L+ T      +K+ DFGLA  + A +  +    G V   +     +
Sbjct: 127 ERRLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESI 183

Query: 215 LAGGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASA 273
           L   Y   +DVWS GV ++ L++ G  P+ G   S+I   +   + R P  P   I    
Sbjct: 184 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-RLPQPPICTI---- 238

Query: 274 RDLIMGMLR---VDPSTRLTAAEVLAHSWMEECEQVAQKPCK 312
            D+ M M++   +D  +R    E++      E  ++A+ P +
Sbjct: 239 -DVYMIMVKCWMIDADSRPKFRELII-----EFSKMARDPQR 274

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 54.8 bits (132), Expect = 4e-08
 Identities = 54/212 (25%), Positives = 86/212 (40%), Gaps = 54/212 (25%)

Query: 40  DRYVLGKQLGWGQFG------------------VIRECSDKFTGEV---------LACKS 72
           D +VLGK+LG G FG                  V+++ ++   G V          AC +
Sbjct: 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATE--YGAVEIWMNERVRRACPN 189

Query: 73  IAKDRLVTVEDVRSIKLEIE--IMTKLSGHPNVVDLKAV----YEEEDYVHLLMELCAGG 126
              D +    +  S K E E  ++ +  G   + DL       Y  E Y           
Sbjct: 190 SCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPY----------- 238

Query: 127 ELFHRLEKYGRFSETEARVI---FRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPI 183
            L  +++   +  E E ++I    R ++  +   H  G+VHRD+KP+NI+ +  S S   
Sbjct: 239 -LLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGS--F 295

Query: 184 KLADFGLATYIKAGQNLHGT--VGSPFYIAPE 213
           K+ D G A  ++ G N      +  P Y APE
Sbjct: 296 KIIDLGAAADLRVGINYIPKEFLLDPRYAAPE 327

Length = 566

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 53.6 bits (129), Expect = 5e-08
 Identities = 35/105 (33%), Positives = 53/105 (50%), Gaps = 8/105 (7%)

Query: 155 SYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN-LHGTVGS-PF-YIA 211
           SY     +VHRDL   N+L+ T      +K+ DFGLA  +   +   H   G  P  ++A
Sbjct: 123 SYLEEKRLVHRDLAARNVLVKTPQH---VKITDFGLAKLLDVDEKEYHAEGGKVPIKWMA 179

Query: 212 PE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAV 254
            E +L   Y   +DVWS GV ++ L++ G  P+ G    +I D +
Sbjct: 180 LESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLL 224

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 58/240 (24%), Positives = 108/240 (45%), Gaps = 36/240 (15%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIE------I 93
           ++  L ++LG G FG++ E + +   +++  ++  +  + TV +  S++  IE      +
Sbjct: 6   EKITLLRELGQGSFGMVYEGNAR---DIIKGEAETRVAVKTVNESASLRERIEFLNEASV 62

Query: 94  MTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQV 153
           M   + H +VV L  V  +     ++MEL A G+L   L      +E         L ++
Sbjct: 63  MKGFTCH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 121

Query: 154 V----------SYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLAT-------YIKA 196
           +          +Y +    VHRDL   N ++A   +   +K+ DFG+         Y K 
Sbjct: 122 IQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT---VKIGDFGMTRDIYETDYYRKG 178

Query: 197 GQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAV 254
           G+ L         +APE L  G +  ++D+WS GV+L+ + S    P+ G +  ++   V
Sbjct: 179 GKGLLPVRW----MAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 234

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 66/291 (22%), Positives = 133/291 (45%), Gaps = 53/291 (18%)

Query: 43  VLGKQLGWGQFG-VIRECSDKFTG----EVLACKSIAKDRLVTVEDVRSIKLEIEIMTKL 97
           VLGK LG G+FG V++  + +  G      +A K + ++   +  ++R +  E  ++ ++
Sbjct: 3   VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKEN--ASSSELRDLLSEFNLLKQV 60

Query: 98  SGHPNVVDLKAVYEEEDYVHLLMELCAGGEL--FHRLEK---------------YGRFSE 140
           + HP+V+ L     ++  + L++E    G L  F R  +                   + 
Sbjct: 61  N-HPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNP 119

Query: 141 TEARVIFRHLM-------QVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA-- 191
            E  +    L+       + + Y     +VHRDL   N+L+A       +K++DFGL+  
Sbjct: 120 DERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVA---EGRKMKISDFGLSRD 176

Query: 192 -----TYIKAGQNLHGTVGSPF-YIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFW 243
                +Y+K  +   G +  P  ++A E L    Y   +DVWS GV+L+ +++ G  P+ 
Sbjct: 177 VYEEDSYVKRSK---GRI--PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 231

Query: 244 GKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEV 294
           G    ++F+ ++     +  +  ++ S    +L++   + +P  R T A++
Sbjct: 232 GIAPERLFNLLKTG---YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADI 279

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 52.0 bits (124), Expect = 2e-07
 Identities = 43/177 (24%), Positives = 86/177 (48%), Gaps = 24/177 (13%)

Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSET----EARVI--------F 147
           HPN+V L  V  +E  + ++   C+  +L   L      S+     + + +        F
Sbjct: 67  HPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADF 126

Query: 148 RHLMQVVS----YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ--NLH 201
            H++  ++    +   + VVH+DL   N+L+  K +   +K++D GL   + A     L 
Sbjct: 127 VHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLN---VKISDLGLFREVYAADYYKLM 183

Query: 202 GTVGSPF-YIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVR 255
           G    P  +++PE ++ G ++  +D+WS GV+L+ + S G+ P+ G +   + + +R
Sbjct: 184 GNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR 240

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 51.3 bits (123), Expect = 3e-07
 Identities = 58/239 (24%), Positives = 103/239 (43%), Gaps = 32/239 (13%)

Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKL---------EIEIMTK 96
             LG G+FG      + F  +    +    + LV V+ ++  K          E+++  K
Sbjct: 11  TTLGRGEFG------EVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRK 64

Query: 97  LSGHPNVVDLKAVYEEEDYVHLLMELCAGGEL--FHRLEKYGRFSE------TEARVIFR 148
           LS H NVV L  +  E +  ++++E    G+L  F R  K            T+ +V   
Sbjct: 65  LS-HKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALC 123

Query: 149 H-LMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA--TYIKAGQNLHGTVG 205
             +   + +      VHRDL   N L+   SS   +K++   L+   Y      L   + 
Sbjct: 124 TQIALGMDHLSNARFVHRDLAARNCLV---SSQREVKVSLLSLSKDVYNSEYYKLRNALI 180

Query: 206 SPFYIAPE-VLAGGYNQAADVWSAGVILY-ILLSGMPPFWGKTKSKIFDAVRAADLRFP 262
              ++APE V    ++  +DVWS GV+++ +   G  PF+G +  ++ + ++A  L  P
Sbjct: 181 PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELP 239

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 51.1 bits (122), Expect = 4e-07
 Identities = 62/237 (26%), Positives = 105/237 (44%), Gaps = 47/237 (19%)

Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACK---SIAKDR--LVTVEDVRS--------- 86
             +  ++LG GQFG +  C      ++   +   ++ K R  LV V+ +R          
Sbjct: 6   HLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARND 65

Query: 87  -IKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGEL-----FHRLEKYGRFSE 140
            +K E++I+++L   PN++ L  V  +ED + ++ E    G+L      H L+   +   
Sbjct: 66  FLK-EVKILSRLK-DPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDD--KEEN 121

Query: 141 TEARVIFRHLMQVVSY----------CHGN------GVVHRDLKPENILLATKSSSSPIK 184
               V   H +  +SY            G         VHRDL   N L+    +   IK
Sbjct: 122 GNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLT---IK 178

Query: 185 LADFGLATYIKAGQ--NLHGTVGSPF-YIAPE-VLAGGYNQAADVWSAGVILYILLS 237
           +ADFG++  + AG    + G    P  ++A E +L G +  A+DVW+ GV L+ +L 
Sbjct: 179 IADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 49.8 bits (119), Expect = 8e-07
 Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 34/215 (15%)

Query: 48  LGWGQFGVIRECSDKFTGEVL---------ACKSIAKDRLVTVEDVRSIKLEIEIMTKLS 98
           +G G FG +      + G ++         A KS+  +R+  +E+V     E  IM   S
Sbjct: 3   IGKGHFGCV------YHGTLIDSDGQKIHCAVKSL--NRITDLEEVEQFLKEGIIMKDFS 54

Query: 99  GHPNVVDLKAV-YEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQV---V 154
            HPNV+ L  +    E    +++     G+L + +         +  + F   +QV   +
Sbjct: 55  -HPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFG--LQVAKGM 111

Query: 155 SYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA--TYIKAGQNLHGTVGSPF---Y 209
            Y      VHRDL   N +L     S  +K+ADFGLA   Y K   ++H   G+     +
Sbjct: 112 EYLASKKFVHRDLAARNCML---DESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKW 168

Query: 210 IAPEVL-AGGYNQAADVWSAGVILYILLS-GMPPF 242
           +A E L    +   +DVWS GV+L+ L++ G PP+
Sbjct: 169 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 203

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 42/143 (29%), Positives = 70/143 (48%), Gaps = 20/143 (13%)

Query: 163 VHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNL--HGTVGSPF-YIAPE-VLAGG 218
           +HRDL   NILL   S ++ +K+ DFGLA  I    +    G+   P  ++APE +    
Sbjct: 196 IHRDLAARNILL---SENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKV 252

Query: 219 YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIF-----DAVRAADLRFPSDPWDHISAS 272
           Y   +DVWS GV+L+ + S G  P+ G   ++ F     D  R   +R P    ++ +  
Sbjct: 253 YTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTR---MRAP----ENATPE 305

Query: 273 ARDLIMGMLRVDPSTRLTAAEVL 295
              +++   + DP  R T + ++
Sbjct: 306 IYRIMLACWQGDPKERPTFSALV 328

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 49.5 bits (118), Expect = 1e-06
 Identities = 67/280 (23%), Positives = 110/280 (39%), Gaps = 48/280 (17%)

Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLS------- 98
            ++G G FG +        GE     S A+   V V+++R+     E +  L        
Sbjct: 1   DEIGNGWFGKV------LLGEAHRGMSKAR---VVVKELRASATPDEQLLFLQEVQPYRE 51

Query: 99  -GHPNVVDLKAVYEEEDYVHLLMELCAGGEL--FHRLEKYGRFSETEARVIFRHLMQVVS 155
             HPNV+       E     L++E C  G+L  + R  +       +  V+ R   +V S
Sbjct: 52  LNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVAS 111

Query: 156 ---YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA-------TYIKAGQNLHGTVG 205
              + H    +H DL   N  L    S   +K+ D+GLA        YI    +      
Sbjct: 112 GLLWLHQADFIHSDLALRNCQLTADLS---VKIGDYGLALEQYPEDYYITKDCHA----- 163

Query: 206 SPF-YIAPEV--------LAGGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFD-AV 254
            P  ++APE+        L     + +++WS GV ++ L +    P+   +  ++    V
Sbjct: 164 VPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVV 223

Query: 255 RAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEV 294
           R  D++ P    D   +     +M    +DP TR TA EV
Sbjct: 224 REQDIKLPKPQLDLKYSDRWYEVMQFCWLDPETRPTAEEV 263

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 51/195 (26%), Positives = 86/195 (44%), Gaps = 30/195 (15%)

Query: 115 YVHLLMELCAGG--ELFHRLEKYG----RFSETEARVIFRHLM----QV---VSYCHGNG 161
           YV  L+ +C     +L  +L  YG       E + R+  + L+    Q+   +SY     
Sbjct: 70  YVCRLLGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR 129

Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLH----GTVGSPFYIAPEVLAG 217
           +VHRDL   N+L+    S + +K+ DFGLA  +   +  +    G V   +     +L  
Sbjct: 130 LVHRDLAARNVLV---KSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHR 186

Query: 218 GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDL 276
            +   +DVWS GV ++ L++ G  P+ G    +I D +   + R P  P         D+
Sbjct: 187 RFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGE-RLPQPP-----ICTIDV 240

Query: 277 IMGMLR---VDPSTR 288
            M M++   +D   R
Sbjct: 241 YMIMVKCWMIDSECR 255

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 49.6 bits (118), Expect = 1e-06
 Identities = 64/281 (22%), Positives = 121/281 (43%), Gaps = 42/281 (14%)

Query: 43  VLGKQLGWGQFG--VIREC------SDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
           VL ++LG G FG   + EC       DK    ++A K++    L   +D +    E E++
Sbjct: 8   VLKRELGEGAFGKVFLAECYNLSPTKDKM---LVAVKALKDPTLAARKDFQR---EAELL 61

Query: 95  TKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYG---------RFSETEARV 145
           T L  H ++V    V  + D + ++ E    G+L   L  +G         +  + +  +
Sbjct: 62  TNLQ-HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGEL 120

Query: 146 IFRHLMQVVS-------YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ 198
               ++ + S       Y      VHRDL   N L+    ++  +K+ DFG++  + +  
Sbjct: 121 GLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG---ANLLVKIGDFGMSRDVYSTD 177

Query: 199 --NLHGTVGSPF-YIAPE-VLAGGYNQAADVWSAGVILY-ILLSGMPPFWGKTKSKIFDA 253
              + G    P  ++ PE ++   +   +DVWS GVIL+ I   G  P++  + +++ + 
Sbjct: 178 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC 237

Query: 254 VRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEV 294
           +     R    P         D+++G  + +P  RL   E+
Sbjct: 238 ITQG--RVLERP-RVCPKEVYDIMLGCWQREPQQRLNIKEI 275

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 49.2 bits (117), Expect = 2e-06
 Identities = 39/162 (24%), Positives = 73/162 (45%), Gaps = 14/162 (8%)

Query: 93  IMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKY--GRFSETEARVIFRHL 150
           +++    HPN++    V+    ++ ++    A G     L+ Y     SE     I    
Sbjct: 51  VLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGA 110

Query: 151 MQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFY- 209
           ++ ++Y H NG +HR++K  +IL++     S   L+   L + ++ GQ        P + 
Sbjct: 111 LRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSH--LYSLVRNGQKAKVVYDFPQFS 168

Query: 210 ------IAPEVLA---GGYNQAADVWSAGVILYILLSGMPPF 242
                 ++PE+L     GYN  +D++S G+    L +G  PF
Sbjct: 169 TSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPF 210

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 33/94 (35%), Positives = 52/94 (55%), Gaps = 8/94 (8%)

Query: 156 YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLAT--YIKAGQNLHGTVGSPF-YIAP 212
           Y   + +VHR+L   NILL    S S +++ADFG+A   Y    +  +    +P  ++A 
Sbjct: 124 YLEEHRMVHRNLAARNILL---KSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMAL 180

Query: 213 E-VLAGGYNQAADVWSAGVILYILLS-GMPPFWG 244
           E +L G Y   +DVWS GV ++ ++S G  P+ G
Sbjct: 181 ESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAG 214

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 49.3 bits (117), Expect = 2e-06
 Identities = 42/132 (31%), Positives = 63/132 (47%), Gaps = 12/132 (9%)

Query: 163 VHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF----YIAPE-VLAG 217
           VHRDL   N+LLA       +K+ DFGLA  I    N + + GS F    ++APE +   
Sbjct: 259 VHRDLAARNVLLA---QGKIVKICDFGLARDIMHDSN-YVSKGSTFLPVKWMAPESIFDN 314

Query: 218 GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDL 276
            Y   +DVWS G++L+ + S G  P+ G      F     +  R  + P DH +    D+
Sbjct: 315 LYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRM-AKP-DHATQEVYDI 372

Query: 277 IMGMLRVDPSTR 288
           ++     +P  R
Sbjct: 373 MVKCWNSEPEKR 384

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 48.5 bits (115), Expect = 2e-06
 Identities = 54/234 (23%), Positives = 101/234 (43%), Gaps = 28/234 (11%)

Query: 43  VLGKQLGWGQFG--VIRECSD--KFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLS 98
           VL ++LG G FG   + EC +      ++L      KD   +    +    E E++T L 
Sbjct: 8   VLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD--ASDNARKDFHREAELLTNLQ 65

Query: 99  GHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYG-------------RFSETEARV 145
            H ++V    V  E D + ++ E    G+L   L  +G               ++++   
Sbjct: 66  -HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124

Query: 146 IFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA--TYIKAGQNLHGT 203
           I + +   + Y      VHRDL   N L+     +  +K+ DFG++   Y      + G 
Sbjct: 125 IAQQIAAGMVYLASQHFVHRDLATRNCLVG---ENLLVKIGDFGMSRDVYSTDYYRVGGH 181

Query: 204 VGSPF-YIAPE-VLAGGYNQAADVWSAGVILY-ILLSGMPPFWGKTKSKIFDAV 254
              P  ++ PE ++   +   +DVWS GV+L+ I   G  P++  + +++ + +
Sbjct: 182 TMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI 235

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 47.2 bits (112), Expect = 8e-06
 Identities = 41/145 (28%), Positives = 68/145 (46%), Gaps = 20/145 (13%)

Query: 163 VHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNL--HGTVGSPF-YIAPE-VLAGG 218
           +HRDL   NILL   S ++ +K+ DFGLA  I    +    G    P  ++APE +    
Sbjct: 195 IHRDLAARNILL---SENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKV 251

Query: 219 YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIF-----DAVRAADLRFPSDPWDHISAS 272
           Y   +DVWS GV+L+ + S G  P+ G    + F     +  R   +R P    ++ +  
Sbjct: 252 YTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTR---MRAP----EYATPE 304

Query: 273 ARDLIMGMLRVDPSTRLTAAEVLAH 297
              +++     +P  R T +E++  
Sbjct: 305 IYSIMLDCWHNNPEDRPTFSELVEI 329

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 46.5 bits (110), Expect = 1e-05
 Identities = 42/170 (24%), Positives = 80/170 (47%), Gaps = 11/170 (6%)

Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCH 158
           H N+V L+ V    + + ++ E  + G L   L K+ G+    +   +   L   + Y  
Sbjct: 65  HSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS 124

Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVG--SP-FYIAPEVL 215
             G VH+ L    +L+   +S    K++ F      K+ + ++ T+   SP  + APE +
Sbjct: 125 EMGYVHKGLAAHKVLV---NSDLVCKISGFRRLQEDKS-EAIYTTMSGKSPVLWAAPEAI 180

Query: 216 A-GGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPS 263
               ++ A+DVWS G++++ ++S G  P+W  +   +  AV     R P+
Sbjct: 181 QYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDG-FRLPA 229

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 46.6 bits (110), Expect = 1e-05
 Identities = 57/232 (24%), Positives = 104/232 (44%), Gaps = 29/232 (12%)

Query: 90  EIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRH 149
           E  IM  +  HP++V L  V      + L+ +L   G L   + ++       ++++   
Sbjct: 59  EALIMASMD-HPHLVRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHK--DNIGSQLLLNW 114

Query: 150 LMQVVS---YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGS 206
            +Q+     Y     +VHRDL   N+L+    S + +K+ DFGLA  ++  +  +   G 
Sbjct: 115 CVQIAKGMMYLEERRLVHRDLAARNVLV---KSPNHVKITDFGLARLLEGDEKEYNADGG 171

Query: 207 PF---YIAPEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRF 261
                ++A E +    +   +DVWS GV ++ L++ G  P+ G    +I D +   + R 
Sbjct: 172 KMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGE-RL 230

Query: 262 PSDPWDHISASARDLIMGMLR---VDPSTRLTAAEVLAHSWMEECEQVAQKP 310
           P  P   I     D+ M M++   +D  +R    E+ A     E  ++A+ P
Sbjct: 231 PQPPICTI-----DVYMVMVKCWMIDADSRPKFKELAA-----EFSRMARDP 272

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 43/142 (30%), Positives = 67/142 (47%), Gaps = 14/142 (9%)

Query: 163 VHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNL--HGTVGSPF-YIAPEVLAGG- 218
           +HRDL   NILL   S ++ +K+ DFGLA  I    +    G    P  ++APE +    
Sbjct: 201 IHRDLAARNILL---SENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV 257

Query: 219 YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIF--DAVRAADLRFPSDPWDHISASARD 275
           Y   +DVWS GV+L+ + S G  P+ G    + F         +R P    D+ +     
Sbjct: 258 YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAP----DYTTPEMYQ 313

Query: 276 LIMGMLRVDPSTRLTAAEVLAH 297
            ++     +PS R T +E++ H
Sbjct: 314 TMLDCWHGEPSQRPTFSELVEH 335

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 45.3 bits (107), Expect = 3e-05
 Identities = 32/87 (36%), Positives = 46/87 (52%), Gaps = 8/87 (9%)

Query: 163 VHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN--LHGTVGSPF-YIAPE-VLAGG 218
           +HRDL   NILL   +     K+ DFGLA  I+   N  + G    P  ++APE +    
Sbjct: 236 IHRDLAARNILL---THGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCV 292

Query: 219 YNQAADVWSAGVILYILLS-GMPPFWG 244
           Y   +DVWS G++L+ + S G  P+ G
Sbjct: 293 YTFESDVWSYGILLWEIFSLGSSPYPG 319

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 44.2 bits (104), Expect = 6e-05
 Identities = 51/234 (21%), Positives = 98/234 (41%), Gaps = 26/234 (11%)

Query: 43  VLGKQLGWGQFG--VIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
           VL  +LG G FG   + EC +    +     ++   +  +    +  + E E++T L  H
Sbjct: 8   VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQ-H 66

Query: 101 PNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGR----FSETE----ARVIFRHLMQ 152
            ++V    V  E   + ++ E    G+L   L  +G      +  E     ++    ++ 
Sbjct: 67  QHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLA 126

Query: 153 VVS-------YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ--NLHGT 203
           + S       Y      VHRDL   N L+        +K+ DFG++  I +     + G 
Sbjct: 127 IASQIASGMVYLASLHFVHRDLATRNCLVG---QGLVVKIGDFGMSRDIYSTDYYRVGGR 183

Query: 204 VGSPF-YIAPE-VLAGGYNQAADVWSAGVILY-ILLSGMPPFWGKTKSKIFDAV 254
              P  ++ PE +L   +   +D+WS GV+L+ I   G  P++  + ++  + +
Sbjct: 184 TMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI 237

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 43.8 bits (103), Expect = 8e-05
 Identities = 51/195 (26%), Positives = 88/195 (45%), Gaps = 24/195 (12%)

Query: 64  TGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELC 123
           TGE +  + I  +   T E V  ++ E+ + +KL  HPN+V  +A +  ++ + ++    
Sbjct: 24  TGEYVTVRRINLE-ACTNEMVTFLQGELHV-SKLFNHPNIVPYRATFIADNELWVVTSFM 81

Query: 124 AGGE-----LFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKS 178
           A G        H ++     SE     I + +++ + Y H  G VHR +K  +IL+   S
Sbjct: 82  AYGSAKDLICTHFMDG---MSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI---S 135

Query: 179 SSSPIKLADF-GLATYIKAGQNLHGTVGSPFY-------IAPEVLA---GGYNQAADVWS 227
               + L+      + I  GQ L      P Y       ++PEVL     GY+  +D++S
Sbjct: 136 VDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYS 195

Query: 228 AGVILYILLSGMPPF 242
            G+    L +G  PF
Sbjct: 196 VGITACELANGHVPF 210

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 44.3 bits (104), Expect = 9e-05
 Identities = 25/72 (34%), Positives = 37/72 (51%), Gaps = 5/72 (6%)

Query: 146 IFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVG 205
           + R ++  +   H  G+VHRD+KPEN+L+        +K+ DFG A  +  G N +   G
Sbjct: 314 VMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQ---VKIIDFGAAVDMCTGINFNPLYG 370

Query: 206 --SPFYIAPEVL 215
              P Y  PE L
Sbjct: 371 MLDPRYSPPEEL 382

Length = 507

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 43.8 bits (103), Expect = 1e-04
 Identities = 31/85 (36%), Positives = 44/85 (51%), Gaps = 11/85 (12%)

Query: 163 VHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF----YIAPE-VLAG 217
           VHRDL   N+L+        +K+ DFGLA  I    N + + GS F    ++APE +   
Sbjct: 261 VHRDLAARNVLIC---EGKLVKICDFGLARDIMRDSN-YISKGSTFLPLKWMAPESIFNN 316

Query: 218 GYNQAADVWSAGVILY--ILLSGMP 240
            Y   +DVWS G++L+    L G P
Sbjct: 317 LYTTLSDVWSFGILLWEIFTLGGTP 341

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 43.3 bits (102), Expect = 1e-04
 Identities = 30/87 (34%), Positives = 45/87 (51%), Gaps = 8/87 (9%)

Query: 163 VHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN--LHGTVGSPF-YIAPE-VLAGG 218
           +HRD+   N+LL   +     K+ DFGLA  I    N  + G    P  ++APE +    
Sbjct: 234 IHRDVAARNVLL---TDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCV 290

Query: 219 YNQAADVWSAGVILYILLS-GMPPFWG 244
           Y   +DVWS G++L+ + S G  P+ G
Sbjct: 291 YTVQSDVWSYGILLWEIFSLGKSPYPG 317

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 42.8 bits (101), Expect = 2e-04
 Identities = 30/101 (29%), Positives = 46/101 (45%), Gaps = 15/101 (14%)

Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGL------ATYIKAGQNLHG 202
            +   +SY H  GV+H+D+   N ++        +K+ D  L        Y   G N + 
Sbjct: 125 QIACGMSYLHKRGVIHKDIAARNCVID---EELQVKITDNALSRDLFPMDYHCLGDNENR 181

Query: 203 TVGSPFYIAPEVLAGG-YNQAADVWSAGVILYIL--LSGMP 240
            V    ++A E L    Y+ A+DVWS GV+L+ L  L   P
Sbjct: 182 PVK---WMALESLVNKEYSSASDVWSFGVLLWELMTLGQTP 219

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 42.6 bits (100), Expect = 2e-04
 Identities = 66/277 (23%), Positives = 114/277 (41%), Gaps = 42/277 (15%)

Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLS------- 98
           K++G G FG +        GEV +  + A+   V V+++R      E M  L        
Sbjct: 1   KEIGNGWFGKV------ILGEVNSGYTPAQ---VVVKELRVSASVQEQMKFLEEAQPYRS 51

Query: 99  -GHPNVVDLKAVYEEEDYVHLLMELCAGGEL--FHRLEKYGRFSETEARVIFRHLMQVVS 155
             H N++       E     L+ME C  G+L  + R  +       +   + R   ++  
Sbjct: 52  LQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIAL 111

Query: 156 ---YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF---- 208
              + H N  +H DL   N LL   ++   +K+ D+GL+ + K  ++ + T    +    
Sbjct: 112 GLLHLHKNNFIHSDLALRNCLL---TADLTVKIGDYGLS-HNKYKEDYYVTPDQLWVPLR 167

Query: 209 YIAPE--------VLAGGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFD-AVRAAD 258
           +IAPE        +L     + ++VWS GV ++ L   G  P+   +  ++    VR   
Sbjct: 168 WIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQ 227

Query: 259 LRFPSDPWDHISASARDL-IMGMLRVDPSTRLTAAEV 294
           L+ P  P   +  S R   +M    + P  R +A EV
Sbjct: 228 LKLPK-PRLKLPLSDRWYEVMQFCWLQPEQRPSAEEV 263

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 41.8 bits (98), Expect = 3e-04
 Identities = 36/112 (32%), Positives = 55/112 (49%), Gaps = 10/112 (8%)

Query: 145 VIFRHLMQVVSYCHGNGVVHRDLKPENILLATK---SSSSP-IKLADFGLATYIKAGQNL 200
            + + L   +SY     +VH ++  +NILLA       +SP IKL+D G++    + +  
Sbjct: 121 TVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREE- 179

Query: 201 HGTVGSPFYIAPEVLAGGYN--QAADVWSAG-VILYILLSGMPPFWGKTKSK 249
              V    +IAPE + GG +   AAD WS G  +L I   G  P   +T S+
Sbjct: 180 --RVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|223554 COG0478, COG0478, RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

 Score = 41.1 bits (97), Expect = 6e-04
 Identities = 43/198 (21%), Positives = 72/198 (36%), Gaps = 34/198 (17%)

Query: 19  SYKVSSLTGTILDATQISNLSDR---YVLGKQLGWGQFGVIRECSDKFTGEVLACK---- 71
           SY+   LT +  DA  +  L  R     +G ++G G+   +    D   G  +A K    
Sbjct: 67  SYEGYQLTFSGYDALALHALVKRGIVEAIGTKIGVGKESDVYVAID-PKGRKVAVKFHRL 125

Query: 72  ------------SIAKDRLVT---VEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYV 116
                           D+           + + E E + +L  +P  V +        + 
Sbjct: 126 GRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRL--YPEGVKVPKPIAWNRHA 183

Query: 117 HLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLAT 176
            ++ME   G EL+ RL    R        I   +++ V   +  G+VH DL   NIL+  
Sbjct: 184 -VVMEYIEGVELY-RL----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILV-- 235

Query: 177 KSSSSPIKLADFGLATYI 194
            +    I + D+  A  I
Sbjct: 236 -TEDGDIVVIDWPQAVPI 252

Length = 304

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 40.3 bits (94), Expect = 0.001
 Identities = 43/199 (21%), Positives = 78/199 (39%), Gaps = 49/199 (24%)

Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKS---IAKDRLVTVEDVRSIKLEIEIMTKL 97
            + + K +G G FG + E           C S   I    +  +E++ +  + +E +   
Sbjct: 13  EWKIDKLIGCGGFGCVYETQ---------CASDHCINNQAVAKIENLENETIVMETLVYN 63

Query: 98  SGHP-NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRF----------SETEARV- 145
           + +  + + L       D  HL +    G   F R   Y RF           E   R+ 
Sbjct: 64  NIYDIDKIALWKNIHNID--HLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIK 121

Query: 146 ---------IFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI-- 194
                    I + ++  + Y H +G+ H D+KPENI++   +    I   D+G+A++   
Sbjct: 122 CKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYII---DYGIASHFII 178

Query: 195 --------KAGQNLH-GTV 204
                   K  ++LH GT+
Sbjct: 179 HGKHIEYSKEQKDLHRGTL 197

Length = 294

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 39.3 bits (92), Expect = 0.001
 Identities = 43/174 (24%), Positives = 65/174 (37%), Gaps = 23/174 (13%)

Query: 132 LEKYGR-FSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGL 190
           LE  GR  +E E   +    +  +   H         K  NILL          L   G 
Sbjct: 7   LEVRGRPLNEEEIWAVCLQCLGALRELHRQA------KSGNILLTW-----DGLLKLDGS 55

Query: 191 ATYIKAGQNLHGTVGSPFYIAPEVL-AGGYNQAADVWSAGVILYILLSGMPPFWGKTK-S 248
             +    Q+       P+++APEV+    Y + AD++S G+ LY  L    P+  + + S
Sbjct: 56  VAFKTPEQSR----PDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS 111

Query: 249 KIFDAV---RAADLRFPSDPWDHISA--SARDLIMGMLRVDPSTRLTAAEVLAH 297
            I + +     AD        + +SA  S  D +       P  R  A   LAH
Sbjct: 112 AILEILLNGMPADDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREAANHYLAH 165

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 39.8 bits (93), Expect = 0.002
 Identities = 27/93 (29%), Positives = 48/93 (51%), Gaps = 4/93 (4%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRL---VTVEDVRSIKLEIEIMTK 96
           DR  LGK LG G FG + + S     +  +C+++A   L    T  + +++  E++I+  
Sbjct: 7   DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIH 66

Query: 97  LSGHPNVVD-LKAVYEEEDYVHLLMELCAGGEL 128
           +  H NVV+ L A  +    + +++E C  G L
Sbjct: 67  IGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNL 99

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 39.6 bits (92), Expect = 0.002
 Identities = 28/93 (30%), Positives = 46/93 (49%), Gaps = 4/93 (4%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRL---VTVEDVRSIKLEIEIMTK 96
           DR  LGK LG G FG + E       +   C+++A   L    T  + R++  E++I+  
Sbjct: 7   DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 66

Query: 97  LSGHPNVVD-LKAVYEEEDYVHLLMELCAGGEL 128
           +  H NVV+ L A  +    + +++E C  G L
Sbjct: 67  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 99

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|151200 pfam10707, YrbL-PhoP_reg, PhoP regulatory network protein YrbL

 Score = 38.8 bits (91), Expect = 0.002
 Identities = 24/86 (27%), Positives = 33/86 (38%), Gaps = 11/86 (12%)

Query: 118 LLMEL--CAGGEL---FHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENI 172
           L+ E    A G +      L K G  +      +   L +   Y   N +V RDL P NI
Sbjct: 94  LVTERIRDADGNISPTLEDLLKNGGLTA----ALREALNEFKRYLLDNHIVARDLNPHNI 149

Query: 173 LLATKSSSSP-IKLAD-FGLATYIKA 196
           +   +S     + L D FG  T I  
Sbjct: 150 VYGRRSEGEYELVLVDGFGDPTLIPL 175

This is a family of proteins that are activated by PhoP. PhoP protein controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multicomponent loop in Salmonella where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner. Length = 199

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 38.8 bits (90), Expect = 0.004
 Identities = 38/158 (24%), Positives = 68/158 (43%), Gaps = 10/158 (6%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRL---VTVEDVRSIKLEIEIMTK 96
           DR  LGK LG G FG + E S     +  +C ++A   L    T  + +++  E++I+  
Sbjct: 7   DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIH 66

Query: 97  LSGHPNVVD-LKAVYEEEDYVHLLMELCAGGEL--FHRLEKYG----RFSETEARVIFRH 149
           +  H NVV+ L A  +    + +++E C  G L  F R ++      R    + R  FR 
Sbjct: 67  IGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRA 126

Query: 150 LMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLAD 187
           +++              +       +T  S++P +  D
Sbjct: 127 MVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 38.8 bits (90), Expect = 0.004
 Identities = 25/98 (25%), Positives = 47/98 (47%), Gaps = 3/98 (3%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTV---EDVRSIKLEIEIMTK 96
           D  VLG+ LG G FG + E +        +   +A   L +     + +++  E++IM+ 
Sbjct: 37  DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSH 96

Query: 97  LSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEK 134
           L  H N+V+L     +   ++++ E C  G+L   L +
Sbjct: 97  LGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHR 134

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	419
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.98
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.97
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.96
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.96
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.95
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.95
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.94
PRK09188	365	serine/threonine protein kinase; Provisional	99.94
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.93
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.93
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.91
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.9
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.9
PRK12274	218	serine/threonine protein kinase; Provisional	99.88
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.88
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.88
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.88
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.87
PRK10345	210	hypothetical protein; Provisional	99.86
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.83
smart00090	237	RIO RIO-like kinase.	99.82
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.81
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.8
PRK14879	211	serine/threonine protein kinase; Provisional	99.78
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.76
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.76
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.75
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.75
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.75
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.72
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.67
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.66
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.65
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.49
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.47
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.45
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.43
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.43
KOG1243	690	consensus Protein kinase [General function predict	99.42
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.42
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.28
KOG3087	229	consensus Serine/threonine protein kinase [General	99.27
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.18
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.16
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.15
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.05
COG4248	637	Uncharacterized protein with protein kinase and he	99.01
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.01
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.94
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.87
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.65
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.59
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.59
PRK09902	216	hypothetical protein; Provisional	98.59
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.53
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.41
PF01636	239	APH: Phosphotransferase enzyme family This family	98.35
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.33
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.32
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.23
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.23
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.18
PLN02876	822	acyl-CoA dehydrogenase	98.17
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.95
KOG1235	538	consensus Predicted unusual protein kinase [Genera	97.91
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.83
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.76
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.72
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.67
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.65
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.63
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.57
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.55
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.45
PRK05231	319	homoserine kinase; Provisional	97.32
KOG2270	520	consensus Serine/threonine protein kinase involved	97.17
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.12
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.0
PLN02236	344	choline kinase	96.87
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.86
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.82
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.73
PLN02756	418	S-methyl-5-thioribose kinase	96.67
PRK10593	297	hypothetical protein; Provisional	96.65
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.17
PRK12396	409	5-methylribose kinase; Reviewed	96.11
PTZ00384	383	choline kinase; Provisional	96.11
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	95.82
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.37
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	95.3
PRK11768	325	serine/threonine protein kinase; Provisional	95.01
KOG1236	565	consensus Predicted unusual protein kinase [Genera	94.69
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	94.68
PRK06148	1013	hypothetical protein; Provisional	94.31
PF02958	294	EcKinase: Ecdysteroid kinase; InterPro: IPR004119	94.04
PTZ00296	442	choline kinase; Provisional	93.26
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	92.9

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-62  Score=467.37  Aligned_cols=268  Identities=38%  Similarity=0.691  Sum_probs=247.3

Q ss_pred             cccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCC----HHhHHHHHHHHHHHHHccCCCCceeeeEEEE
Q 014733           36 SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVT----VEDVRSIKLEIEIMTKLSGHPNVVDLKAVYE  111 (419)
Q Consensus        36 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~----~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~  111 (419)
                      +.+.+.|.+.+.||.|+||.|.+|..+.+|+.||||++.+.....    ......+.+|++||++|+ |||||+++++|+
T Consensus       168 ks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~-HP~IV~~~d~f~  246 (475)
T KOG0615|consen  168 KSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLS-HPNIVRIKDFFE  246 (475)
T ss_pred             chhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcC-CCCEEEEeeeee
Confidence            447899999999999999999999999999999999998876543    224456889999999996 999999999999


Q ss_pred             eCCEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccce
Q 014733          112 EEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA  191 (419)
Q Consensus       112 ~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla  191 (419)
                      .....||||||+.||+|++.+-.++.+.+..-+.++.||+.||.|||+.||+||||||+|||+..+.++..+||+|||+|
T Consensus       247 ~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlA  326 (475)
T KOG0615|consen  247 VPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLA  326 (475)
T ss_pred             cCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchh
Confidence            99999999999999999999999999999999999999999999999999999999999999987777789999999999


Q ss_pred             eeeccCCccccccCCCccCCcccccCC----CCCchhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhcCCCCCCCCC
Q 014733          192 TYIKAGQNLHGTVGSPFYIAPEVLAGG----YNQAADVWSAGVILYILLSGMPPFWGKTKSK-IFDAVRAADLRFPSDPW  266 (419)
Q Consensus       192 ~~~~~~~~~~~~~gt~~y~aPE~l~~~----~s~~sDvwSlGvil~elltG~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~  266 (419)
                      +..+....+.+.||||.|.|||++.+.    +..++|+|||||+||-+++|++||.+..... +.++|..+.+.+-+..|
T Consensus       327 K~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w  406 (475)
T KOG0615|consen  327 KVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQW  406 (475)
T ss_pred             hccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhh
Confidence            998877778889999999999999763    4558999999999999999999998776655 89999999999999999


Q ss_pred             CCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccch
Q 014733          267 DHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECE  304 (419)
Q Consensus       267 ~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~  304 (419)
                      ..+++++.+||.+||..||++|||++|+|+||||+...
T Consensus       407 ~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~  444 (475)
T KOG0615|consen  407 DRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP  444 (475)
T ss_pred             hhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence            99999999999999999999999999999999998543

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.2e-59  Score=461.50  Aligned_cols=263  Identities=38%  Similarity=0.635  Sum_probs=247.5

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      .+|..++.||+|||+.||.+++..+|+.||+|++.++.+......+.+.+|++|.+.|+ |||||+++++|+|.+++|||
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~-HpnIV~f~~~FEDs~nVYiv   96 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLK-HPNIVQFYHFFEDSNNVYIV   96 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcC-CCcEEeeeeEeecCCceEEE
Confidence            58999999999999999999999999999999999999888889999999999999996 99999999999999999999


Q ss_pred             EeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccC-C
Q 014733          120 MELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG-Q  198 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~-~  198 (419)
                      +|+|..++|.+++++.+.++|.+++.+.+||+.||.|||+++|||||||..|+|+   +++-+|||+|||+|..+..+ +
T Consensus        97 LELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL---~~~~~VKIgDFGLAt~le~~~E  173 (592)
T KOG0575|consen   97 LELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFL---NENMNVKIGDFGLATQLEYDGE  173 (592)
T ss_pred             EEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheee---cCcCcEEecccceeeeecCccc
Confidence            9999999999999998999999999999999999999999999999999999999   56778999999999998855 6


Q ss_pred             ccccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHH
Q 014733          199 NLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLI  277 (419)
Q Consensus       199 ~~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li  277 (419)
                      ...+.||||.|+|||++.. +++..+||||+||+||.|++|+|||...+-.+.+++|+..++.+|.    .+|.++++||
T Consensus       174 rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~----~ls~~A~dLI  249 (592)
T KOG0575|consen  174 RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPS----HLSAEAKDLI  249 (592)
T ss_pred             ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccccc----ccCHHHHHHH
Confidence            6778899999999999876 5999999999999999999999999999999999999999999887    7999999999


Q ss_pred             HhhhhcCCCCCCCHHHHHhccccccchhhhcCC
Q 014733          278 MGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKP  310 (419)
Q Consensus       278 ~~~L~~dP~~Rps~~eil~hp~~~~~~~~~~~~  310 (419)
                      .+||+.||.+|||+++||.|+||+....+...|
T Consensus       250 ~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p~~lp  282 (592)
T KOG0575|consen  250 RKLLRPNPSERPSLDEVLDHPFFKSGFTPARLP  282 (592)
T ss_pred             HHHhcCCcccCCCHHHHhcCHhhhCCCcCCCCC
Confidence            999999999999999999999996554444333

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-58  Score=435.85  Aligned_cols=262  Identities=38%  Similarity=0.687  Sum_probs=244.2

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEE
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHL  118 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~l  118 (419)
                      .++|+++++||+|+||+|+.++.+++++.+|+|+++|+.+......+.+.+|..||.+++ ||+||+++..|++...+|+
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~-hPFiv~l~ysFQt~~kLyl  102 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIK-HPFIVKLIYSFQTEEKLYL  102 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCC-CCcEeeeEEecccCCeEEE
Confidence            579999999999999999999999999999999999999988889999999999999996 9999999999999999999


Q ss_pred             EEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeee-ccC
Q 014733          119 LMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI-KAG  197 (419)
Q Consensus       119 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~-~~~  197 (419)
                      |+||+.||+|+.+|++.+.|++..++.++.+|+.||.|||++|||||||||+||||   +.+|+|+|+|||+++.. ..+
T Consensus       103 Vld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILL---d~~GHi~LtDFgL~k~~~~~~  179 (357)
T KOG0598|consen  103 VLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILL---DEQGHIKLTDFGLCKEDLKDG  179 (357)
T ss_pred             EEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeee---cCCCcEEEeccccchhcccCC
Confidence            99999999999999999999999999999999999999999999999999999999   77899999999999954 444


Q ss_pred             CccccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHH
Q 014733          198 QNLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDL  276 (419)
Q Consensus       198 ~~~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~l  276 (419)
                      ....+.|||+.|||||++.+ +|+.++|+||||+++|+|++|.+||.+.+..++.++|.......+..   .++.+++++
T Consensus       180 ~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~---~ls~~ardl  256 (357)
T KOG0598|consen  180 DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPG---YLSEEARDL  256 (357)
T ss_pred             CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCc---cCCHHHHHH
Confidence            55667799999999999877 59999999999999999999999999999999999999887554443   589999999


Q ss_pred             HHhhhhcCCCCCC----CHHHHHhccccccchhhh
Q 014733          277 IMGMLRVDPSTRL----TAAEVLAHSWMEECEQVA  307 (419)
Q Consensus       277 i~~~L~~dP~~Rp----s~~eil~hp~~~~~~~~~  307 (419)
                      |+++|++||++|+    .+.+|.+||||..+.+..
T Consensus       257 l~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~  291 (357)
T KOG0598|consen  257 LKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEK  291 (357)
T ss_pred             HHHHhccCHHHhcCCCCChHHhhcCcccccCCHHH
Confidence            9999999999996    799999999999987743

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-58  Score=413.00  Aligned_cols=280  Identities=41%  Similarity=0.803  Sum_probs=261.7

Q ss_pred             ccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEE
Q 014733           37 NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYV  116 (419)
Q Consensus        37 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~  116 (419)
                      .+.+.|.+.+.||+|.|++||++.+..+|+.+|+|++..+.+.. ...+.+.+|+.|.+.|+ |||||++.+.+.+....
T Consensus         8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~-~~~e~l~rEarIC~~Lq-HP~IvrL~~ti~~~~~~   85 (355)
T KOG0033|consen    8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQ-HPNIVRLHDSIQEESFH   85 (355)
T ss_pred             ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhcc-ccHHHHHHHHHHHHhcC-CCcEeehhhhhccccee
Confidence            46789999999999999999999999999999999998877644 47889999999999996 99999999999999999


Q ss_pred             EEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeecc
Q 014733          117 HLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA  196 (419)
Q Consensus       117 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~  196 (419)
                      |||+|++.|++|..-+-..--++|..+..+++||++||.|||.++|||||+||+|+++..+.....+||+|||+|..+++
T Consensus        86 ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~  165 (355)
T KOG0033|consen   86 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND  165 (355)
T ss_pred             EEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCC
Confidence            99999999999987776656689999999999999999999999999999999999999888888999999999999998


Q ss_pred             CCccccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 014733          197 GQNLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARD  275 (419)
Q Consensus       197 ~~~~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~  275 (419)
                      +....+.+|||.|||||++.. +|+..+|||+.|||||.|+.|++||++.+..++++.|..+.+.++.+.|+.+++++++
T Consensus       166 g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~  245 (355)
T KOG0033|consen  166 GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKS  245 (355)
T ss_pred             ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHH
Confidence            888899999999999999987 5999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHhhhhcCCCCCCCHHHHHhccccccchhhhcCCCCcccccc
Q 014733          276 LIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKPCKQDDLCC  318 (419)
Q Consensus       276 li~~~L~~dP~~Rps~~eil~hp~~~~~~~~~~~~~~~~~~~~  318 (419)
                      ||++||..||.+|+|+.|+|+|||+.+-+..+.....++...|
T Consensus       246 LvrrML~~dP~kRIta~EAL~HpWi~~r~~~As~~H~~dtvd~  288 (355)
T KOG0033|consen  246 LIRRMLTVNPKKRITADEALKHPWICNRERVASAIHRQDTVDC  288 (355)
T ss_pred             HHHHHhccChhhhccHHHHhCCchhcchHHHHHHhhhHHHHHH
Confidence            9999999999999999999999999998887777666665544

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.5e-56  Score=439.56  Aligned_cols=273  Identities=33%  Similarity=0.544  Sum_probs=244.9

Q ss_pred             cchhhccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEE
Q 014733           30 LDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAV  109 (419)
Q Consensus        30 ~~~~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~  109 (419)
                      +.-.....-.++|+++.+||+|+||.||+|+.+.||+.+|+|+++|+.+....++..++.|..+|... .+|+||+|+..
T Consensus       131 lR~~R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~-ds~~vVKLyYs  209 (550)
T KOG0605|consen  131 LRLRRTRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEV-DSPWVVKLYYS  209 (550)
T ss_pred             HHhccccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhc-CCCcEEEEEEE
Confidence            33444455678999999999999999999999999999999999999999999999999999999996 59999999999


Q ss_pred             EEeCCEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeecc
Q 014733          110 YEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFG  189 (419)
Q Consensus       110 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFg  189 (419)
                      |++..++||||||++||++..+|.+.+.|++.+++.++.+++.|++.||++|+|||||||+|+||   +..|++||+|||
T Consensus       210 FQD~~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLi---D~~GHiKLSDFG  286 (550)
T KOG0605|consen  210 FQDKEYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLI---DAKGHIKLSDFG  286 (550)
T ss_pred             ecCCCeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheee---cCCCCEeecccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999   678999999999


Q ss_pred             ceeeecc----------------------C--C----c--------------------cccccCCCccCCcccccC-CCC
Q 014733          190 LATYIKA----------------------G--Q----N--------------------LHGTVGSPFYIAPEVLAG-GYN  220 (419)
Q Consensus       190 la~~~~~----------------------~--~----~--------------------~~~~~gt~~y~aPE~l~~-~~s  220 (419)
                      |+.-+..                      .  .    .                    ..+++|||.|||||++.+ +|+
T Consensus       287 Ls~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~  366 (550)
T KOG0605|consen  287 LSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYG  366 (550)
T ss_pred             ccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCC
Confidence            9853310                      0  0    0                    123489999999999988 499


Q ss_pred             CchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCC---CHHHHHhc
Q 014733          221 QAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRL---TAAEVLAH  297 (419)
Q Consensus       221 ~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp---s~~eil~h  297 (419)
                      ..+|+||||||+||||.|++||.+.+..+.+++|..+...+..+.-..++.+++|||.+||+ ||++|+   .++||.+|
T Consensus       367 ~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~H  445 (550)
T KOG0605|consen  367 KECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKH  445 (550)
T ss_pred             ccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcC
Confidence            99999999999999999999999999999999998887443333334889999999999999 999999   59999999


Q ss_pred             cccccchhhh
Q 014733          298 SWMEECEQVA  307 (419)
Q Consensus       298 p~~~~~~~~~  307 (419)
                      |||+.+++..
T Consensus       446 PfF~~v~W~~  455 (550)
T KOG0605|consen  446 PFFKGVDWDH  455 (550)
T ss_pred             CccccCCcch
Confidence            9999998743

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-56  Score=409.85  Aligned_cols=260  Identities=33%  Similarity=0.646  Sum_probs=246.0

Q ss_pred             cccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEE
Q 014733           38 LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVH  117 (419)
Q Consensus        38 ~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~  117 (419)
                      --++|+++..||.|+||.|.+++++.+|..+|+|++.+......+.++.+.+|..+|+.+. ||+++++++.+.+.+.+|
T Consensus        42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~-~PFlv~l~~t~~d~~~ly  120 (355)
T KOG0616|consen   42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVS-HPFLVKLYGTFKDNSNLY  120 (355)
T ss_pred             chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhcc-CceeEEEEEeeccCCeEE
Confidence            3478999999999999999999999999999999999998888889999999999999997 999999999999999999


Q ss_pred             EEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccC
Q 014733          118 LLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG  197 (419)
Q Consensus       118 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~  197 (419)
                      |||||++||+|+.++++.++|++..++.++.||+.||+|||+++|++|||||+||||   +.+|++||+|||+|+.+...
T Consensus       121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLl---D~~G~iKitDFGFAK~v~~r  197 (355)
T KOG0616|consen  121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLL---DQNGHIKITDFGFAKRVSGR  197 (355)
T ss_pred             EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeee---ccCCcEEEEeccceEEecCc
Confidence            999999999999999999999999999999999999999999999999999999999   67899999999999987655


Q ss_pred             CccccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHH
Q 014733          198 QNLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDL  276 (419)
Q Consensus       198 ~~~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~l  276 (419)
                        ..+.||||.|+|||++.. +|+.++|+|||||++|||+.|++||.+.+..+++++|..+.+.+|.    .++.++++|
T Consensus       198 --T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~----~fs~~~kdL  271 (355)
T KOG0616|consen  198 --TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPS----YFSSDAKDL  271 (355)
T ss_pred             --EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCc----ccCHHHHHH
Confidence              567899999999999887 5999999999999999999999999999999999999999999987    789999999


Q ss_pred             HHhhhhcCCCCCC-----CHHHHHhccccccchhhh
Q 014733          277 IMGMLRVDPSTRL-----TAAEVLAHSWMEECEQVA  307 (419)
Q Consensus       277 i~~~L~~dP~~Rp-----s~~eil~hp~~~~~~~~~  307 (419)
                      |+++|++|-.+|.     ...+|..||||+.+.+..
T Consensus       272 l~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~  307 (355)
T KOG0616|consen  272 LKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEA  307 (355)
T ss_pred             HHHHHhhhhHhhhcCcCCCccccccCcccccccHHH
Confidence            9999999999994     677999999999987744

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-56  Score=438.66  Aligned_cols=263  Identities=36%  Similarity=0.649  Sum_probs=247.3

Q ss_pred             cccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEE
Q 014733           38 LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVH  117 (419)
Q Consensus        38 ~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~  117 (419)
                      -..+|..++.||.|+|++|++|+++.+++.||||++.|+.+..+..++.+..|-++|.+|.+||.|++|+..|+|+..+|
T Consensus        71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY  150 (604)
T KOG0592|consen   71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY  150 (604)
T ss_pred             ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence            35689999999999999999999999999999999999999888899999999999999988999999999999999999


Q ss_pred             EEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccC
Q 014733          118 LLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG  197 (419)
Q Consensus       118 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~  197 (419)
                      +|+||+++|+|.++|++.+.|++.-++.++.+|+.||+|||++|||||||||+||||   +.++++||+|||.|+.+.+.
T Consensus       151 FvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILL---d~dmhikITDFGsAK~l~~~  227 (604)
T KOG0592|consen  151 FVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILL---DKDGHIKITDFGSAKILSPS  227 (604)
T ss_pred             EEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeE---cCCCcEEEeeccccccCChh
Confidence            999999999999999999999999999999999999999999999999999999999   67899999999999987542


Q ss_pred             Ccc--------------ccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC
Q 014733          198 QNL--------------HGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFP  262 (419)
Q Consensus       198 ~~~--------------~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~  262 (419)
                      ...              .+.+||..|.+||++..+ .++.+|+|+||||||.|+.|.+||.+.+.--++++|...++.+|
T Consensus       228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp  307 (604)
T KOG0592|consen  228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFP  307 (604)
T ss_pred             hccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCC
Confidence            211              447999999999999876 78999999999999999999999999999999999999999988


Q ss_pred             CCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchhhh
Q 014733          263 SDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVA  307 (419)
Q Consensus       263 ~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~~~  307 (419)
                      .    ++++.++|||+++|..||++|+|..+|.+||||..+.+..
T Consensus       308 ~----~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~n  348 (604)
T KOG0592|consen  308 E----GFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWEN  348 (604)
T ss_pred             C----CCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhh
Confidence            7    6789999999999999999999999999999999988754

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-55  Score=411.46  Aligned_cols=257  Identities=27%  Similarity=0.426  Sum_probs=230.5

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCE-EE
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDY-VH  117 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~-~~  117 (419)
                      .++.+.++.||+|..|+||+++|+.+++.+|+|++...  ..+...+++.+|+++++.. +||+||++|+.|..++. ++
T Consensus        78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~-~spyIV~~ygaF~~~~~~is  154 (364)
T KOG0581|consen   78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSC-QSPYIVGFYGAFYSNGEEIS  154 (364)
T ss_pred             HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhC-CCCCeeeEeEEEEeCCceEE
Confidence            45777889999999999999999999999999999554  5667889999999999999 59999999999999995 99


Q ss_pred             EEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeccCCCCcEEEeecCCCCCeEEeeccceeeecc
Q 014733          118 LLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG-NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA  196 (419)
Q Consensus       118 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~-~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~  196 (419)
                      |+||||.||+|..++...++++|.....++.++++||.|||+ .+||||||||+|||+   ...|.|||||||.+..+-.
T Consensus       155 I~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLv---NskGeVKicDFGVS~~lvn  231 (364)
T KOG0581|consen  155 ICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLV---NSKGEVKICDFGVSGILVN  231 (364)
T ss_pred             eehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeee---ccCCCEEeccccccHHhhh
Confidence            999999999999999998999999999999999999999995 999999999999999   6788999999999988765


Q ss_pred             CCccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhcCCCCCCCCCC-CC
Q 014733          197 GQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGK-----TKSKIFDAVRAADLRFPSDPWD-HI  269 (419)
Q Consensus       197 ~~~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~-----~~~~~~~~i~~~~~~~~~~~~~-~~  269 (419)
                      . ...+.+||..|||||.+.+. |+.++||||||+.++|+.+|+.||...     ..-+++..|..+..+   ..+. .+
T Consensus       232 S-~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP---~lP~~~f  307 (364)
T KOG0581|consen  232 S-IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPP---RLPEGEF  307 (364)
T ss_pred             h-hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCC---CCCcccC
Confidence            5 45778999999999999985 999999999999999999999999764     556777777664332   2223 59


Q ss_pred             CHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          270 SASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       270 s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                      |+++++||..||++||.+|+|+.|+++|||+++...
T Consensus       308 S~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~  343 (364)
T KOG0581|consen  308 SPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFED  343 (364)
T ss_pred             CHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccc
Confidence            999999999999999999999999999999986543

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-55  Score=414.66  Aligned_cols=265  Identities=34%  Similarity=0.649  Sum_probs=242.9

Q ss_pred             ccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEE
Q 014733           37 NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYV  116 (419)
Q Consensus        37 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~  116 (419)
                      ...++|.+.+.||+|+|++||+|+++.++..||||.+.++.+ ..+.++.+..|+++|+.|+ |||||.+++++.+.+.+
T Consensus         7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~-H~nIV~l~d~~~~~~~i   84 (429)
T KOG0595|consen    7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELK-HPNIVRLLDCIEDDDFI   84 (429)
T ss_pred             cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcC-CcceeeEEEEEecCCeE
Confidence            346899999999999999999999999999999999999876 6678888999999999996 99999999999999999


Q ss_pred             EEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCC---CCeEEeeccceee
Q 014733          117 HLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSS---SPIKLADFGLATY  193 (419)
Q Consensus       117 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~---~~vKL~DFgla~~  193 (419)
                      |+|||||.||+|.+++++.+.+++..++.++.||+.||++||+++||||||||+||||.....+   -.+||+|||+|+.
T Consensus        85 ~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~  164 (429)
T KOG0595|consen   85 YLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF  164 (429)
T ss_pred             EEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence            9999999999999999999999999999999999999999999999999999999999765223   5789999999999


Q ss_pred             eccCCccccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHH
Q 014733          194 IKAGQNLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISAS  272 (419)
Q Consensus       194 ~~~~~~~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  272 (419)
                      +.++....+.||++.|||||+++. +|+-|+|+||+|+|||+|++|++||...+..+++..++.+....+.. ...++..
T Consensus       165 L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~-~~~~s~~  243 (429)
T KOG0595|consen  165 LQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVL-PAELSNP  243 (429)
T ss_pred             CCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCch-hhhccCc
Confidence            998888888999999999999965 69999999999999999999999999999999999887776544433 3467788


Q ss_pred             HHHHHHhhhhcCCCCCCCHHHHHhccccccch
Q 014733          273 ARDLIMGMLRVDPSTRLTAAEVLAHSWMEECE  304 (419)
Q Consensus       273 l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~  304 (419)
                      +.+++...|+.+|..|.+..+-+.|+++....
T Consensus       244 ~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p  275 (429)
T KOG0595|consen  244 LRELLISLLQRNPKDRISFEDFFDHPFLAANP  275 (429)
T ss_pred             hhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence            88999999999999999999999999987654

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.2e-54  Score=430.71  Aligned_cols=262  Identities=41%  Similarity=0.674  Sum_probs=245.3

Q ss_pred             cccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCE
Q 014733           36 SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDY  115 (419)
Q Consensus        36 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~  115 (419)
                      .+..+-|++++-||.|+-|.|.+|++..||+..|||++.+..-.+......+.+||-||+.|. ||||+++|++++++.+
T Consensus         8 ~~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~-HpnVl~LydVwe~~~~   86 (786)
T KOG0588|consen    8 KNTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIE-HPNVLRLYDVWENKQH   86 (786)
T ss_pred             cccccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhc-CCCeeeeeeeeccCce
Confidence            345578999999999999999999999999999999999886566667788999999999996 9999999999999999


Q ss_pred             EEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeec
Q 014733          116 VHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIK  195 (419)
Q Consensus       116 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~  195 (419)
                      +|+|.||++||.|++++-+.+++++.++..+++||+.|+.|||..+|+||||||+|+||+   ..++|||+|||+|..-.
T Consensus        87 lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd---~~~nIKIADFGMAsLe~  163 (786)
T KOG0588|consen   87 LYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLD---VKNNIKIADFGMASLEV  163 (786)
T ss_pred             EEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhh---cccCEeeeccceeeccc
Confidence            999999999999999999999999999999999999999999999999999999999995   45569999999999877


Q ss_pred             cCCccccccCCCccCCcccccCC-C-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 014733          196 AGQNLHGTVGSPFYIAPEVLAGG-Y-NQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASA  273 (419)
Q Consensus       196 ~~~~~~~~~gt~~y~aPE~l~~~-~-s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l  273 (419)
                      ++..+.+.||+|.|.|||++.|. | +.++||||.|||||.|++|+.||.+.+...++.+++.+.+..|.    .+|.++
T Consensus       164 ~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs----~Is~ea  239 (786)
T KOG0588|consen  164 PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPS----NISSEA  239 (786)
T ss_pred             CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCC----cCCHHH
Confidence            77778888999999999999985 6 68999999999999999999999999999999999999998884    799999


Q ss_pred             HHHHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          274 RDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       274 ~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                      ++||++||.+||++|+|.+||++|||+.+...
T Consensus       240 QdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~  271 (786)
T KOG0588|consen  240 QDLLRRMLDVDPSTRITTEEILKHPFLSGYTS  271 (786)
T ss_pred             HHHHHHHhccCccccccHHHHhhCchhhcCCC
Confidence            99999999999999999999999999988754

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-53  Score=429.16  Aligned_cols=262  Identities=32%  Similarity=0.555  Sum_probs=243.6

Q ss_pred             cccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEE
Q 014733           38 LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVH  117 (419)
Q Consensus        38 ~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~  117 (419)
                      --++|+++++||+|.||+|++|..+.+++.+|||+++|..+...++++....|.+|+....+||.++.++.+|++.+++|
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~  445 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF  445 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence            35789999999999999999999999999999999999999999999999999999999988999999999999999999


Q ss_pred             EEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeec-c
Q 014733          118 LLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIK-A  196 (419)
Q Consensus       118 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~-~  196 (419)
                      +||||+.||++..+++. +.|++..++.++..++.||+|||++||||||||.+||||   +..|++||+|||+++.-- .
T Consensus       446 fvmey~~Ggdm~~~~~~-~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLL---D~eGh~kiADFGlcKe~m~~  521 (694)
T KOG0694|consen  446 FVMEYVAGGDLMHHIHT-DVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLL---DTEGHVKIADFGLCKEGMGQ  521 (694)
T ss_pred             EEEEecCCCcEEEEEec-ccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEE---cccCcEEecccccccccCCC
Confidence            99999999996655543 789999999999999999999999999999999999999   678999999999999754 4


Q ss_pred             CCccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 014733          197 GQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARD  275 (419)
Q Consensus       197 ~~~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~  275 (419)
                      +....+.||||.|||||++.+. |+.++|+|||||+||||+.|..||.+.+.+++++.|...+..+|.    .+|.++.+
T Consensus       522 g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~----~ls~ea~~  597 (694)
T KOG0694|consen  522 GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPR----FLSKEAIA  597 (694)
T ss_pred             CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCC----cccHHHHH
Confidence            5556778999999999999885 999999999999999999999999999999999999999888776    68999999


Q ss_pred             HHHhhhhcCCCCCCC-----HHHHHhccccccchhhh
Q 014733          276 LIMGMLRVDPSTRLT-----AAEVLAHSWMEECEQVA  307 (419)
Q Consensus       276 li~~~L~~dP~~Rps-----~~eil~hp~~~~~~~~~  307 (419)
                      +++++|++||++|+.     +++|.+||||+.+.+..
T Consensus       598 il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~  634 (694)
T KOG0694|consen  598 IMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDD  634 (694)
T ss_pred             HHHHHhccCcccccCCCCCCchhhhhCCccccCCHHH
Confidence            999999999999995     58899999999998743

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-53  Score=419.42  Aligned_cols=262  Identities=43%  Similarity=0.752  Sum_probs=238.4

Q ss_pred             cccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCC--HHhHHHHHHHHHHHHHccCCCCceeeeEEEEeC
Q 014733           36 SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVT--VEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEE  113 (419)
Q Consensus        36 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~--~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~  113 (419)
                      ....++|++++.||+|+||+|++|.+..+|..||+|++.++....  ....+.+.+|+.+++++..||||+++++++...
T Consensus        13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~   92 (370)
T KOG0583|consen   13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP   92 (370)
T ss_pred             ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence            456789999999999999999999999999999999887753321  134567889999999996699999999999999


Q ss_pred             CEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCC-CCeEEeecccee
Q 014733          114 DYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSS-SPIKLADFGLAT  192 (419)
Q Consensus       114 ~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~-~~vKL~DFgla~  192 (419)
                      ..+|+||||+.||+|++++...+++.|.+++.+|+||+.|++|||++||+||||||+|||++   .+ +++||+|||++.
T Consensus        93 ~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld---~~~~~~Kl~DFG~s~  169 (370)
T KOG0583|consen   93 TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLD---GNEGNLKLSDFGLSA  169 (370)
T ss_pred             CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEec---CCCCCEEEecccccc
Confidence            99999999999999999999989999999999999999999999999999999999999995   44 899999999999


Q ss_pred             ee-ccCCccccccCCCccCCcccccC-C-C-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCC
Q 014733          193 YI-KAGQNLHGTVGSPFYIAPEVLAG-G-Y-NQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDH  268 (419)
Q Consensus       193 ~~-~~~~~~~~~~gt~~y~aPE~l~~-~-~-s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  268 (419)
                      .. ..+......|||+.|+|||++.+ . | +.++||||+||+||.|++|+.||.+.+...++..|..+.+.+|...  .
T Consensus       170 ~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~--~  247 (370)
T KOG0583|consen  170 ISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYL--L  247 (370)
T ss_pred             ccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCc--C
Confidence            87 46667788899999999999987 4 6 4899999999999999999999999999999999999988888642  1


Q ss_pred             CCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccc
Q 014733          269 ISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEEC  303 (419)
Q Consensus       269 ~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~  303 (419)
                       |.++++||++||..||.+|+|+.+++.||||+..
T Consensus       248 -S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~~  281 (370)
T KOG0583|consen  248 -SPEARSLIEKMLVPDPSTRITLLEILEHPWFQKE  281 (370)
T ss_pred             -CHHHHHHHHHHcCCCcccCCCHHHHhhChhhccC
Confidence             9999999999999999999999999999999973

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-53  Score=418.64  Aligned_cols=271  Identities=52%  Similarity=0.937  Sum_probs=255.2

Q ss_pred             hccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeC
Q 014733           34 QISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEE  113 (419)
Q Consensus        34 ~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~  113 (419)
                      ....+.+.|.+.+.||+|.||+||+|+++.+|+.+|+|++.+..+........+.+|+.+|+++++|||||.++++|++.
T Consensus        29 ~~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~  108 (382)
T KOG0032|consen   29 FSEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDP  108 (382)
T ss_pred             ccccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC
Confidence            45678889999999999999999999999999999999999988877677889999999999998899999999999999


Q ss_pred             CEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCC-CCCeEEeecccee
Q 014733          114 DYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSS-SSPIKLADFGLAT  192 (419)
Q Consensus       114 ~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~-~~~vKL~DFgla~  192 (419)
                      +.+++|||++.||+|++.+... .+++..+..+++|+++++.|||+.||+||||||+|+|+..... ++.+|++|||++.
T Consensus       109 ~~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~  187 (382)
T KOG0032|consen  109 DSVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK  187 (382)
T ss_pred             CeEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence            9999999999999999999876 5999999999999999999999999999999999999976544 4589999999999


Q ss_pred             eeccCCccccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCH
Q 014733          193 YIKAGQNLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISA  271 (419)
Q Consensus       193 ~~~~~~~~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  271 (419)
                      ....+......+||+.|+|||++.. .|+..+||||+|+++|.|++|.+||++.+....+.+|..+.+.+...+|..++.
T Consensus       188 ~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~  267 (382)
T KOG0032|consen  188 FIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISE  267 (382)
T ss_pred             EccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCH
Confidence            9888777888999999999999985 699999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          272 SARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       272 ~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                      .++++|+.||..||.+|+|+.++|+|||++....
T Consensus       268 ~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~  301 (382)
T KOG0032|consen  268 SAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGE  301 (382)
T ss_pred             HHHHHHHHhcccCcccCCCHHHHhcCccccCCcc
Confidence            9999999999999999999999999999987644

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.7e-53  Score=400.12  Aligned_cols=262  Identities=39%  Similarity=0.690  Sum_probs=248.8

Q ss_pred             hccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeC
Q 014733           34 QISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEE  113 (419)
Q Consensus        34 ~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~  113 (419)
                      ...++..||++.+.||+|.||+|.+|.+...|..||||.|+++.+...+++-.+++||+||..| |||||+.+|++|+..
T Consensus        47 hkhnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsL-NHPhII~IyEVFENk  125 (668)
T KOG0611|consen   47 HKHNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSL-NHPHIIQIYEVFENK  125 (668)
T ss_pred             cccchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhc-CCCceeehhhhhcCC
Confidence            4556889999999999999999999999999999999999999999999999999999999999 599999999999999


Q ss_pred             CEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceee
Q 014733          114 DYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATY  193 (419)
Q Consensus       114 ~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~  193 (419)
                      +.+.|||||..+|+|++++...+.+++.+++.+|+||+.|+.|||+++++|||||.+|||+   +.++++||+|||++..
T Consensus       126 dKIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILL---D~N~NiKIADFGLSNl  202 (668)
T KOG0611|consen  126 DKIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILL---DQNNNIKIADFGLSNL  202 (668)
T ss_pred             ceEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheee---cCCCCeeeeccchhhh
Confidence            9999999999999999999999999999999999999999999999999999999999999   6678999999999999


Q ss_pred             eccCCccccccCCCccCCcccccCC-C-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCH
Q 014733          194 IKAGQNLHGTVGSPFYIAPEVLAGG-Y-NQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISA  271 (419)
Q Consensus       194 ~~~~~~~~~~~gt~~y~aPE~l~~~-~-s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  271 (419)
                      +..+..+.++||+|.|.+||++.|. | ++.+|.||||++||.|+.|.+||.+.+...+.++|..+.++.|..+     .
T Consensus       203 y~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~P-----S  277 (668)
T KOG0611|consen  203 YADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPETP-----S  277 (668)
T ss_pred             hccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCCC-----c
Confidence            9998889999999999999999985 5 7999999999999999999999999999999999999999887654     7


Q ss_pred             HHHHHHHhhhhcCCCCCCCHHHHHhccccccch
Q 014733          272 SARDLIMGMLRVDPSTRLTAAEVLAHSWMEECE  304 (419)
Q Consensus       272 ~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~  304 (419)
                      .+..||+.||.+||++|.|+.+|-.|-|++...
T Consensus       278 dA~gLIRwmLmVNP~RRATieDiAsHWWvNwgy  310 (668)
T KOG0611|consen  278 DASGLIRWMLMVNPERRATIEDIASHWWVNWGY  310 (668)
T ss_pred             hHHHHHHHHHhcCcccchhHHHHhhhheeeccc
Confidence            899999999999999999999999999987643

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.6e-53  Score=385.42  Aligned_cols=272  Identities=39%  Similarity=0.699  Sum_probs=249.7

Q ss_pred             chhhccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCcc-----CCHHhHHHHHHHHHHHHHccCCCCcee
Q 014733           31 DATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRL-----VTVEDVRSIKLEIEIMTKLSGHPNVVD  105 (419)
Q Consensus        31 ~~~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~-----~~~~~~~~~~~Ei~il~~l~~hpnIv~  105 (419)
                      +..+-+.+-..|.-.+.||+|..++|.++.++.+|..+|+|++....-     .-....+....|+.||+++.+||+|++
T Consensus         8 d~~aa~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~   87 (411)
T KOG0599|consen    8 DKDAAKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIID   87 (411)
T ss_pred             chhhHhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEE
Confidence            344556677888889999999999999999999999999999975321     112345667889999999999999999


Q ss_pred             eeEEEEeCCEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEE
Q 014733          106 LKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKL  185 (419)
Q Consensus       106 l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL  185 (419)
                      +.++|+.+..+++|+|.|+.|.|+++|...-.+++.+.+.|++||++|+.|||..+||||||||+|||+   +++.++||
T Consensus        88 l~D~yes~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILl---ddn~~i~i  164 (411)
T KOG0599|consen   88 LQDVYESDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILL---DDNMNIKI  164 (411)
T ss_pred             eeeeccCcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheee---ccccceEE
Confidence            999999999999999999999999999887789999999999999999999999999999999999999   56778999


Q ss_pred             eeccceeeeccCCccccccCCCccCCcccccC-------CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC
Q 014733          186 ADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG-------GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAAD  258 (419)
Q Consensus       186 ~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~-------~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~  258 (419)
                      +|||+++.+.+++.+...||||+|+|||.+..       +|+..+|+|++|||+|.|+.|-+|||.....-+++.|..+.
T Consensus       165 sDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGk  244 (411)
T KOG0599|consen  165 SDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGK  244 (411)
T ss_pred             eccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcc
Confidence            99999999999999999999999999999752       48999999999999999999999999998889999999999


Q ss_pred             CCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          259 LRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       259 ~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                      +.|..+.|.++|...+|||++||++||.+|.|++|+|+||||.++..
T Consensus       245 yqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~  291 (411)
T KOG0599|consen  245 YQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQ  291 (411)
T ss_pred             cccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHH
Confidence            99999999999999999999999999999999999999999987654

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.3e-51  Score=391.78  Aligned_cols=263  Identities=35%  Similarity=0.584  Sum_probs=242.2

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEE
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHL  118 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~l  118 (419)
                      -+.|++++.||+|.-|+||+|+.+.++..+|+|++.+..+...+.+.+++.|.+||+.+. ||.++.||..|+.+...|+
T Consensus        76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lD-HPFlPTLYa~fet~~~~cl  154 (459)
T KOG0610|consen   76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLD-HPFLPTLYASFETDKYSCL  154 (459)
T ss_pred             HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcC-CCccchhhheeeccceeEE
Confidence            468899999999999999999999999999999999999988899999999999999995 9999999999999999999


Q ss_pred             EEeecCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeecc
Q 014733          119 LMELCAGGELFHRLEKY--GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA  196 (419)
Q Consensus       119 V~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~  196 (419)
                      +||||+||+|..++++.  +.|++..++.++.+++-||+|||-.|||+|||||+||||   .++|+|.|+||.++....-
T Consensus       155 ~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILv---redGHIMLsDFDLS~~~~~  231 (459)
T KOG0610|consen  155 VMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILV---REDGHIMLSDFDLSLRCPV  231 (459)
T ss_pred             EEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEE---ecCCcEEeeeccccccCCC
Confidence            99999999999999775  459999999999999999999999999999999999999   7899999999998753310


Q ss_pred             ---------------------------------C-C-----------------------ccccccCCCccCCcccccC-C
Q 014733          197 ---------------------------------G-Q-----------------------NLHGTVGSPFYIAPEVLAG-G  218 (419)
Q Consensus       197 ---------------------------------~-~-----------------------~~~~~~gt~~y~aPE~l~~-~  218 (419)
                                                       . .                       ...+.+||..|+|||++.| +
T Consensus       232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G  311 (459)
T KOG0610|consen  232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG  311 (459)
T ss_pred             CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence                                             0 0                       0123479999999999998 4


Q ss_pred             CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCC----HHHH
Q 014733          219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLT----AAEV  294 (419)
Q Consensus       219 ~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps----~~ei  294 (419)
                      .+.++|+|+||++||||+.|..||.|.+..+.+.+|....+.+|..+  .++..++|||+++|.+||.+|+.    +.||
T Consensus       312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~--~vs~~akDLIr~LLvKdP~kRlg~~rGA~eI  389 (459)
T KOG0610|consen  312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEP--EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEI  389 (459)
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCC--cchhHHHHHHHHHhccChhhhhccccchHHh
Confidence            89999999999999999999999999999999999999999999887  89999999999999999999998    9999


Q ss_pred             Hhccccccchhhh
Q 014733          295 LAHSWMEECEQVA  307 (419)
Q Consensus       295 l~hp~~~~~~~~~  307 (419)
                      .+||||+++.+..
T Consensus       390 K~HpFF~gVnWaL  402 (459)
T KOG0610|consen  390 KRHPFFEGVNWAL  402 (459)
T ss_pred             hcCccccCCChhh
Confidence            9999999998864

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-52  Score=403.02  Aligned_cols=263  Identities=34%  Similarity=0.550  Sum_probs=229.6

Q ss_pred             ccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCC-E
Q 014733           37 NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEED-Y  115 (419)
Q Consensus        37 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~-~  115 (419)
                      .+-+||.++++||.|.||.||+|+.+.+|+.||||.++++.. +.++... .+|+..|++|..||||+++.+++.+.+ .
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~-s~ee~~n-LREvksL~kln~hpniikL~Evi~d~~~~   84 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFY-SWEECMN-LREVKSLRKLNPHPNIIKLKEVIRDNDRI   84 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhc-cHHHHHH-HHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence            456899999999999999999999999999999999976643 4444443 469999999966999999999999887 9


Q ss_pred             EEEEEeecCCCChHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeee
Q 014733          116 VHLLMELCAGGELFHRLEKYGR-FSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI  194 (419)
Q Consensus       116 ~~lV~E~~~ggsL~~~l~~~~~-l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~  194 (419)
                      +|+||||| ..+|+++++.+++ |++..++.|+.||++||+|+|++|+.|||+||||||+   .....|||+|||+|+.+
T Consensus        85 L~fVfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi---~~~~~iKiaDFGLARev  160 (538)
T KOG0661|consen   85 LYFVFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILI---SGNDVIKIADFGLAREV  160 (538)
T ss_pred             EeeeHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEe---cccceeEeccccccccc
Confidence            99999999 6799999987654 9999999999999999999999999999999999999   44668999999999999


Q ss_pred             ccCCccccccCCCccCCcccccC-C-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc---------------
Q 014733          195 KAGQNLHGTVGSPFYIAPEVLAG-G-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAA---------------  257 (419)
Q Consensus       195 ~~~~~~~~~~gt~~y~aPE~l~~-~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~---------------  257 (419)
                      ........++.|++|+|||++.. + |+.+.||||+|||++|+.+-++.|.|.+.-+.+-+|...               
T Consensus       161 ~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L  240 (538)
T KOG0661|consen  161 RSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL  240 (538)
T ss_pred             ccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence            99888899999999999999764 3 999999999999999999999999998887777666432               


Q ss_pred             ----CCCCCCCC-------CCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          258 ----DLRFPSDP-------WDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       258 ----~~~~~~~~-------~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                          .+++|...       ....+.++.++|.+||.+||++|||+.|+|+||||+....
T Consensus       241 a~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~  299 (538)
T KOG0661|consen  241 ASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRA  299 (538)
T ss_pred             HHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccccc
Confidence                22333321       2347899999999999999999999999999999987544

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.7e-52  Score=371.31  Aligned_cols=258  Identities=34%  Similarity=0.633  Sum_probs=241.5

Q ss_pred             ccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEE
Q 014733           37 NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYV  116 (419)
Q Consensus        37 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~  116 (419)
                      ..-++|++++.||+|.||.||+|+.+.++..||+|++.++.+......+++.+|++|-..|+ ||||+++|++|.++..+
T Consensus        19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~-hpnilrlY~~fhd~~ri   97 (281)
T KOG0580|consen   19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLR-HPNILRLYGYFHDSKRI   97 (281)
T ss_pred             cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccC-CccHHhhhhheecccee
Confidence            34588999999999999999999999999999999999988877777889999999999996 99999999999999999


Q ss_pred             EEEEeecCCCChHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeee
Q 014733          117 HLLMELCAGGELFHRLE--KYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI  194 (419)
Q Consensus       117 ~lV~E~~~ggsL~~~l~--~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~  194 (419)
                      |+++||.++|+|+..|.  ...++++..++.++.|++.||.|+|..+||||||||+|+|+   +..+.+||+|||.+...
T Consensus        98 yLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLl---g~~~~lkiAdfGwsV~~  174 (281)
T KOG0580|consen   98 YLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLL---GSAGELKIADFGWSVHA  174 (281)
T ss_pred             EEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhcc---CCCCCeeccCCCceeec
Confidence            99999999999999998  66779999999999999999999999999999999999999   77889999999999875


Q ss_pred             ccCCccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 014733          195 KAGQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASA  273 (419)
Q Consensus       195 ~~~~~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l  273 (419)
                      + .....+.|||..|.+||+..+. ++..+|+|++|++.||++.|.+||...+..+.+++|...++.+|.    .++.++
T Consensus       175 p-~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~----~is~~a  249 (281)
T KOG0580|consen  175 P-SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPS----TISGGA  249 (281)
T ss_pred             C-CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCc----ccChhH
Confidence            4 4445678999999999999985 999999999999999999999999999999999999999999884    799999


Q ss_pred             HHHHHhhhhcCCCCCCCHHHHHhccccccc
Q 014733          274 RDLIMGMLRVDPSTRLTAAEVLAHSWMEEC  303 (419)
Q Consensus       274 ~~li~~~L~~dP~~Rps~~eil~hp~~~~~  303 (419)
                      +|+|.+||..+|.+|.+..|++.|||+...
T Consensus       250 ~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~  279 (281)
T KOG0580|consen  250 ADLISRLLVKNPIERLALTEVMDHPWIVAN  279 (281)
T ss_pred             HHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence            999999999999999999999999999754

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-51  Score=396.61  Aligned_cols=269  Identities=35%  Similarity=0.615  Sum_probs=237.3

Q ss_pred             ccchhhccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHH-----------hHHHHHHHHHHHHHc
Q 014733           29 ILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVE-----------DVRSIKLEIEIMTKL   97 (419)
Q Consensus        29 ~~~~~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~-----------~~~~~~~Ei~il~~l   97 (419)
                      .++..+....-++|++++.||+|.||+|.+|++..+++.||||++.+.......           .++.+++||.||++|
T Consensus        86 ~~~~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl  165 (576)
T KOG0585|consen   86 RYDDDQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKL  165 (576)
T ss_pred             eecCcccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhc
Confidence            556677777889999999999999999999999999999999999876542221           246899999999999


Q ss_pred             cCCCCceeeeEEEEe--CCEEEEEEeecCCCChHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEE
Q 014733           98 SGHPNVVDLKAVYEE--EDYVHLLMELCAGGELFHRLEKYGR-FSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILL  174 (419)
Q Consensus        98 ~~hpnIv~l~~~~~~--~~~~~lV~E~~~ggsL~~~l~~~~~-l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl  174 (419)
                      . |||||+|+++.++  .+.+|||+|||..|.+...-.. ++ +++.+++.++++++.||+|||.+|||||||||+|+||
T Consensus       166 ~-H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d-~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl  243 (576)
T KOG0585|consen  166 H-HPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPD-KPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLL  243 (576)
T ss_pred             C-CcCeeEEEEeecCcccCceEEEEEeccCCccccCCCC-cccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEE
Confidence            7 9999999999986  4689999999999887554333 44 9999999999999999999999999999999999999


Q ss_pred             eecCCCCCeEEeeccceeeecc------CCccccccCCCccCCcccccC---C--CCCchhHHHHHHHHHHHHhCCCCCC
Q 014733          175 ATKSSSSPIKLADFGLATYIKA------GQNLHGTVGSPFYIAPEVLAG---G--YNQAADVWSAGVILYILLSGMPPFW  243 (419)
Q Consensus       175 ~~~~~~~~vKL~DFgla~~~~~------~~~~~~~~gt~~y~aPE~l~~---~--~s~~sDvwSlGvil~elltG~~Pf~  243 (419)
                         +++|+|||+|||.+.....      ...+..++|||.|+|||.+.+   .  .+.+.||||+||.||-|+.|+.||.
T Consensus       244 ---~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~  320 (576)
T KOG0585|consen  244 ---SSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFF  320 (576)
T ss_pred             ---cCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcc
Confidence               6779999999999987632      223455799999999998765   2  3689999999999999999999999


Q ss_pred             CCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccch
Q 014733          244 GKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECE  304 (419)
Q Consensus       244 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~  304 (419)
                      +....+++.+|....+.+|..+  ++.+.++|||.+||++||++|.++.+|..|||+....
T Consensus       321 ~~~~~~l~~KIvn~pL~fP~~p--e~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g  379 (576)
T KOG0585|consen  321 DDFELELFDKIVNDPLEFPENP--EINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDG  379 (576)
T ss_pred             cchHHHHHHHHhcCcccCCCcc--cccHHHHHHHHHHhhcChhheeehhhheecceeccCC
Confidence            9999999999999999998876  7899999999999999999999999999999997763

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=8.3e-52  Score=380.56  Aligned_cols=260  Identities=30%  Similarity=0.597  Sum_probs=223.8

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      +.|+.+.++|+|+||+||+|+++.||+.||||++..+. ..+...+-..+|+++|++|+ |+|+|.++++|.....+++|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLk-H~NLVnLiEVFrrkrklhLV   79 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLK-HENLVNLIEVFRRKRKLHLV   79 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcc-cchHHHHHHHHHhcceeEEE
Confidence            46889999999999999999999999999999996543 23344556779999999997 99999999999999999999


Q ss_pred             EeecCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeec-cC
Q 014733          120 MELCAGGELFHRLEKYG-RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIK-AG  197 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~-~~  197 (419)
                      +|||+. ++.+.+++.. .++...++.++.|++.|+.|||++++|||||||+||||   ..+|.+||||||+|+.+. ++
T Consensus        80 FE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILi---t~~gvvKLCDFGFAR~L~~pg  155 (396)
T KOG0593|consen   80 FEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILI---TQNGVVKLCDFGFARTLSAPG  155 (396)
T ss_pred             eeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEE---ecCCcEEeccchhhHhhcCCc
Confidence            999955 6666666654 49999999999999999999999999999999999999   678899999999999887 66


Q ss_pred             CccccccCCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC----------------
Q 014733          198 QNLHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADL----------------  259 (419)
Q Consensus       198 ~~~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~----------------  259 (419)
                      +....++.|.+|+|||.+.|  +|+..+||||+||++.||++|.+.|.+.+.-++.-.|...-.                
T Consensus       156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F  235 (396)
T KOG0593|consen  156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF  235 (396)
T ss_pred             chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence            66777899999999999887  599999999999999999999999999888777666643211                


Q ss_pred             ---CCCCC--------CCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          260 ---RFPSD--------PWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       260 ---~~~~~--------~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                         ++|..        ....++.-+.||++.||..||.+|++.+|+|.||||.....
T Consensus       236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~e  292 (396)
T KOG0593|consen  236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFIE  292 (396)
T ss_pred             eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHHH
Confidence               11111        13457788999999999999999999999999999976544

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=3.1e-51  Score=402.30  Aligned_cols=257  Identities=32%  Similarity=0.631  Sum_probs=236.5

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      ++|.+.+.||+|+||.||+|+.+.+.+.||+|.+.|... ..++++.+.+|++|+++|+ |||||.++++|+...++++|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr-~~k~l~~l~~ev~i~r~lk-Hpniv~m~esfEt~~~~~vV   79 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR-NEKELKNLRQEVRILRSLK-HPNIVEMLESFETSAHLWVV   79 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCC-chHHHHHHHHHHHHHHhcC-CcchhhHHHhhcccceEEEE
Confidence            579999999999999999999999999999999988764 5678899999999999996 99999999999999999999


Q ss_pred             EeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCCc
Q 014733          120 MELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN  199 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~~  199 (419)
                      +||+.| +|+.+++..+.++|+.++.++.+++.||.|||+++|+|||+||+|||+   +..+.+|+||||+|+.+..+..
T Consensus        80 te~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl---~~~~~~KlcdFg~Ar~m~~~t~  155 (808)
T KOG0597|consen   80 TEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILL---EKGGTLKLCDFGLARAMSTNTS  155 (808)
T ss_pred             ehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeee---cCCCceeechhhhhhhcccCce
Confidence            999976 999999999999999999999999999999999999999999999999   6788999999999998765543


Q ss_pred             -cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHH
Q 014733          200 -LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLI  277 (419)
Q Consensus       200 -~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li  277 (419)
                       .....|||.|||||.+.++ |+..+|+||||||+|||++|++||......++.+.|.......|.    .++..+++|+
T Consensus       156 vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~----~~S~~f~nfl  231 (808)
T KOG0597|consen  156 VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPS----TASSSFVNFL  231 (808)
T ss_pred             eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcc----cccHHHHHHH
Confidence             3456899999999999875 999999999999999999999999998888888888877655554    7999999999


Q ss_pred             HhhhhcCCCCCCCHHHHHhccccccchhh
Q 014733          278 MGMLRVDPSTRLTAAEVLAHSWMEECEQV  306 (419)
Q Consensus       278 ~~~L~~dP~~Rps~~eil~hp~~~~~~~~  306 (419)
                      ..+|.+||.+|+|..+++.|||+++-...
T Consensus       232 ~gLL~kdP~~RltW~~Ll~HpF~k~~~~~  260 (808)
T KOG0597|consen  232 QGLLIKDPAQRLTWTDLLGHPFWKGKINI  260 (808)
T ss_pred             HHHhhcChhhcccHHHHhcChHHhhhhhh
Confidence            99999999999999999999999875443

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.3e-52  Score=379.82  Aligned_cols=246  Identities=30%  Similarity=0.581  Sum_probs=219.6

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeE-EEEeCCE-E
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKA-VYEEEDY-V  116 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~-~~~~~~~-~  116 (419)
                      ..+|++.++||+|+||.||++.+..+|+.+|.|.+.... .+.+..+.+..|+.+|++|. |||||++++ .+.+++. +
T Consensus        18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~-md~k~rq~~v~Ei~lLkQL~-HpNIVqYy~~~f~~~~evl   95 (375)
T KOG0591|consen   18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGM-MDAKARQDCVKEISLLKQLN-HPNIVQYYAHSFIEDNEVL   95 (375)
T ss_pred             HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhh-ccHHHHHHHHHHHHHHHhcC-CchHHHHHHHhhhccchhh
Confidence            357999999999999999999999999999999998554 46678889999999999995 999999998 5655555 8


Q ss_pred             EEEEeecCCCChHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHh--CC--CeeccCCCCcEEEeecCCCCCeEEeec
Q 014733          117 HLLMELCAGGELFHRLEKY----GRFSETEARVIFRHLMQVVSYCHG--NG--VVHRDLKPENILLATKSSSSPIKLADF  188 (419)
Q Consensus       117 ~lV~E~~~ggsL~~~l~~~----~~l~~~~~~~i~~qll~aL~~LH~--~~--IvHrDLkp~NILl~~~~~~~~vKL~DF  188 (419)
                      +||||||.+|+|.+.++..    +.++|..+|.++.|++.||..+|+  ..  |+||||||.||+|   +.+|.|||+||
T Consensus        96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl---~~~gvvKLGDf  172 (375)
T KOG0591|consen   96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFL---TANGVVKLGDF  172 (375)
T ss_pred             HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEE---cCCCceeeccc
Confidence            9999999999999999654    349999999999999999999999  44  9999999999999   57889999999


Q ss_pred             cceeeeccCCc-cccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 014733          189 GLATYIKAGQN-LHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW  266 (419)
Q Consensus       189 gla~~~~~~~~-~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  266 (419)
                      |+++.+..... ..+.+|||.||+||.+.+ +|+.++||||+||++|||+.-++||.+.+-.++-++|..++++..+  -
T Consensus       173 GL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p--~  250 (375)
T KOG0591|consen  173 GLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLP--D  250 (375)
T ss_pred             hhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCc--H
Confidence            99998876544 456799999999999987 5999999999999999999999999999999999999999765222  2


Q ss_pred             CCCCHHHHHHHHhhhhcCCCCCCCH
Q 014733          267 DHISASARDLIMGMLRVDPSTRLTA  291 (419)
Q Consensus       267 ~~~s~~l~~li~~~L~~dP~~Rps~  291 (419)
                      ..+|.++..+|..|+.+||+.||+.
T Consensus       251 ~~YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  251 EHYSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             HHhhhHHHHHHHHHccCCcccCCCc
Confidence            3789999999999999999999985

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.9e-49  Score=389.78  Aligned_cols=257  Identities=35%  Similarity=0.665  Sum_probs=230.8

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEE
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHL  118 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~l  118 (419)
                      -++|++.+.||+|+||.||+|.++.+++.||+|++.+.........+.+.+|+.+++++. ||||+++++++.+++.+|+
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~l   95 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS-HPFIVNMMCSFQDENRVYF   95 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCCCcEEEEEEcCCEEEE
Confidence            478999999999999999999999999999999997655444456678899999999995 9999999999999999999


Q ss_pred             EEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC
Q 014733          119 LMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ  198 (419)
Q Consensus       119 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~  198 (419)
                      ||||+.|++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++...... 
T Consensus        96 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~-  171 (329)
T PTZ00263         96 LLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLL---DNKGHVKVTDFGFAKKVPDR-  171 (329)
T ss_pred             EEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEE---CCCCCEEEeeccCceEcCCC-
Confidence            99999999999999988889999999999999999999999999999999999999   56788999999999876433 


Q ss_pred             ccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHH
Q 014733          199 NLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLI  277 (419)
Q Consensus       199 ~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li  277 (419)
                       ....+||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+....+..+.+......++.    .++..+++||
T Consensus       172 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li  246 (329)
T PTZ00263        172 -TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPN----WFDGRARDLV  246 (329)
T ss_pred             -cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCC----CCCHHHHHHH
Confidence             2345799999999998875 899999999999999999999999998888888888877665543    5789999999


Q ss_pred             HhhhhcCCCCCCC-----HHHHHhccccccchh
Q 014733          278 MGMLRVDPSTRLT-----AAEVLAHSWMEECEQ  305 (419)
Q Consensus       278 ~~~L~~dP~~Rps-----~~eil~hp~~~~~~~  305 (419)
                      .+||+.||.+|++     +.+++.||||....+
T Consensus       247 ~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~  279 (329)
T PTZ00263        247 KGLLQTDHTKRLGTLKGGVADVKNHPYFHGANW  279 (329)
T ss_pred             HHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCH
Confidence            9999999999997     799999999987543

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2.5e-49  Score=387.85  Aligned_cols=252  Identities=34%  Similarity=0.616  Sum_probs=224.9

Q ss_pred             eeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEEeecCC
Q 014733           46 KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAG  125 (419)
Q Consensus        46 ~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~g  125 (419)
                      +.||+|+||.||+|.++.+|+.||+|++.+...........+.+|+.+++++. ||||+++++++.+.+.+|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~~~~~~lv~e~~~~   79 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTR-HPFLTALKYSFQTHDRLCFVMEYANG   79 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCCCEEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999999999999999998765445556677889999999996 99999999999999999999999999


Q ss_pred             CChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeecc-CCcccccc
Q 014733          126 GELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA-GQNLHGTV  204 (419)
Q Consensus       126 gsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~-~~~~~~~~  204 (419)
                      ++|..++...+.+++..++.++.||+.||+|||+.||+||||||+|||+   +.++.+||+|||++..... .......+
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll---~~~~~~kl~DfG~a~~~~~~~~~~~~~~  156 (323)
T cd05571          80 GELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFC  156 (323)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE---CCCCCEEEeeCCCCcccccCCCccccee
Confidence            9999999888889999999999999999999999999999999999999   5677899999999875322 22334567


Q ss_pred             CCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhc
Q 014733          205 GSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRV  283 (419)
Q Consensus       205 gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~  283 (419)
                      ||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+.+.......+......++.    .++.++.+||++||+.
T Consensus       157 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~----~~~~~~~~li~~~L~~  232 (323)
T cd05571         157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLSPEAKSLLAGLLKK  232 (323)
T ss_pred             cCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHHHHHccC
Confidence            99999999998764 899999999999999999999999998888888888777665543    6899999999999999


Q ss_pred             CCCCCC-----CHHHHHhccccccchh
Q 014733          284 DPSTRL-----TAAEVLAHSWMEECEQ  305 (419)
Q Consensus       284 dP~~Rp-----s~~eil~hp~~~~~~~  305 (419)
                      ||++||     ++.++++||||....+
T Consensus       233 dP~~R~~~~~~~~~~ll~h~~f~~~~~  259 (323)
T cd05571         233 DPKQRLGGGPEDAKEIMEHRFFASINW  259 (323)
T ss_pred             CHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence            999999     8999999999988654

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-51  Score=377.16  Aligned_cols=270  Identities=36%  Similarity=0.672  Sum_probs=241.5

Q ss_pred             ccccCeee-eeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCE
Q 014733           37 NLSDRYVL-GKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDY  115 (419)
Q Consensus        37 ~~~~~y~i-~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~  115 (419)
                      .+.+-|++ .+.||+|+|+.|-.|....+|..||||++.+...   ....++.+|++++.+.++|+||+.++++|+++..
T Consensus        74 ~F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~g---HsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~  150 (463)
T KOG0607|consen   74 KFEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPG---HSRSRVFREVETFYQCQGHKNILQLIEFFEDDTR  150 (463)
T ss_pred             hHHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCc---hHHHHHHHHHHHHHHhcCCccHHHHHHHhcccce
Confidence            46667777 5789999999999999999999999999988733   5678899999999999999999999999999999


Q ss_pred             EEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeec
Q 014733          116 VHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIK  195 (419)
Q Consensus       116 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~  195 (419)
                      +|+|||-+.||.|..+|.+...|++.++.++.++|+.||+|||.+||.||||||+|||....+.-..||||||.+...+.
T Consensus       151 FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k  230 (463)
T KOG0607|consen  151 FYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIK  230 (463)
T ss_pred             EEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccc
Confidence            99999999999999999999999999999999999999999999999999999999999765555689999999987653


Q ss_pred             cCC--------ccccccCCCccCCccccc---C---CCCCchhHHHHHHHHHHHHhCCCCCCCCC---------------
Q 014733          196 AGQ--------NLHGTVGSPFYIAPEVLA---G---GYNQAADVWSAGVILYILLSGMPPFWGKT---------------  246 (419)
Q Consensus       196 ~~~--------~~~~~~gt~~y~aPE~l~---~---~~s~~sDvwSlGvil~elltG~~Pf~~~~---------------  246 (419)
                      -..        .+.+.+|+..|||||++.   +   .|+.++|.||||||||.|+.|++||.+..               
T Consensus       231 ~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~C  310 (463)
T KOG0607|consen  231 LNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVC  310 (463)
T ss_pred             cCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHH
Confidence            222        234458999999999853   3   38999999999999999999999996642               


Q ss_pred             HHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchhhhcC
Q 014733          247 KSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQK  309 (419)
Q Consensus       247 ~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~~~~~  309 (419)
                      ...+++.|+.+.+.||...|..+|.+++|+|+.+|..|+..|.++.++++|||++.+......
T Consensus       311 Q~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ekal  373 (463)
T KOG0607|consen  311 QNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPEKAL  373 (463)
T ss_pred             HHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchhccC
Confidence            478999999999999999999999999999999999999999999999999999988665333

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-49  Score=383.28  Aligned_cols=256  Identities=33%  Similarity=0.602  Sum_probs=229.6

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      ++|++.+.||+|+||.||+|.++.+|+.||+|++...........+.+.+|+.+++++. ||||+++++++.+.+.+|+|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv   79 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS-HPFIIRLFWTEHDQRFLYML   79 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCC-CCcHhhhHhhhccCCeEEEE
Confidence            57999999999999999999999999999999997654444455677899999999996 99999999999999999999


Q ss_pred             EeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCCc
Q 014733          120 MELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN  199 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~~  199 (419)
                      |||+++++|.+++...+.+++..+..++.|++.||+|||++||+||||||+|||+   +.++.+||+|||++......  
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli---~~~~~~kl~Dfg~~~~~~~~--  154 (291)
T cd05612          80 MEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILL---DKEGHIKLTDFGFAKKLRDR--  154 (291)
T ss_pred             EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEEEecCcchhccCC--
Confidence            9999999999999988889999999999999999999999999999999999999   56778999999999865432  


Q ss_pred             cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHH
Q 014733          200 LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM  278 (419)
Q Consensus       200 ~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~  278 (419)
                      ....+||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+....+..+.+......++.    .++..+++||+
T Consensus       155 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~li~  230 (291)
T cd05612         155 TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPR----HLDLYAKDLIK  230 (291)
T ss_pred             cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCc----cCCHHHHHHHH
Confidence            2345799999999998774 899999999999999999999999999888888888877665543    56899999999


Q ss_pred             hhhhcCCCCCCC-----HHHHHhccccccchh
Q 014733          279 GMLRVDPSTRLT-----AAEVLAHSWMEECEQ  305 (419)
Q Consensus       279 ~~L~~dP~~Rps-----~~eil~hp~~~~~~~  305 (419)
                      +||+.||.+|++     +.++++||||+....
T Consensus       231 ~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~  262 (291)
T cd05612         231 KLLVVDRTRRLGNMKNGADDVKNHRWFKSVDW  262 (291)
T ss_pred             HHcCCCHHHccCCccCCHHHHhcCccccCCCH
Confidence            999999999995     999999999987654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=5.1e-49  Score=391.87  Aligned_cols=262  Identities=32%  Similarity=0.490  Sum_probs=226.0

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      ++|++++.||+|+||+||+|.++.+++.||+|++.+...........+.+|+.++.++. ||||+++++.+.+...+|+|
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~-~~~iv~~~~~~~~~~~~~lv   79 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEAD-SLWVVKMFYSFQDKLNLYLI   79 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCC-CCCcceEEEEEecCCeEEEE
Confidence            57999999999999999999999999999999998765444556678899999999995 99999999999999999999


Q ss_pred             EeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC-
Q 014733          120 MELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ-  198 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~-  198 (419)
                      |||++||+|.+++.+.+.+++.+++.++.|++.||+|||++||+||||||+|||+   +.++.+||+|||+++.+.... 
T Consensus        80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi---~~~~~vkL~DFGla~~~~~~~~  156 (363)
T cd05628          80 MEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLL---DSKGHVKLSDFGLCTGLKKAHR  156 (363)
T ss_pred             EcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE---CCCCCEEEeeccCccccccccc
Confidence            9999999999999988889999999999999999999999999999999999999   567899999999987543211 


Q ss_pred             -----------------------------------ccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCC
Q 014733          199 -----------------------------------NLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPF  242 (419)
Q Consensus       199 -----------------------------------~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf  242 (419)
                                                         .....+||+.|+|||++.+. ++.++|||||||++|||++|+.||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf  236 (363)
T cd05628         157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF  236 (363)
T ss_pred             ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence                                               01235799999999998764 899999999999999999999999


Q ss_pred             CCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCC---CCCCHHHHHhccccccchhh
Q 014733          243 WGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPS---TRLTAAEVLAHSWMEECEQV  306 (419)
Q Consensus       243 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~---~Rps~~eil~hp~~~~~~~~  306 (419)
                      .+....+...++..............++++++++|.+|+. +|.   .||+++|+++||||+...+.
T Consensus       237 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~~~  302 (363)
T cd05628         237 CSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVDWE  302 (363)
T ss_pred             CCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCCHH
Confidence            9988888888887644333222233689999999999876 444   46899999999999987553

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.3e-49  Score=360.43  Aligned_cols=257  Identities=31%  Similarity=0.526  Sum_probs=224.4

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      ++|...++||+|.||+||+|++..+|+.||||.++..... ...-....+||+.|+.++ |+||+.++++|...+.+.+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~k-dGi~~talREIK~Lqel~-h~nIi~LiD~F~~~~~l~lV   79 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAK-DGINRTALREIKLLQELK-HPNIIELIDVFPHKSNLSLV   79 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccc-cCccHHHHHHHHHHHHcc-CcchhhhhhhccCCCceEEE
Confidence            6899999999999999999999999999999999876432 222356778999999997 99999999999999999999


Q ss_pred             EeecCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC
Q 014733          120 MELCAGGELFHRLEKYG-RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ  198 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~  198 (419)
                      +||++ .+|...++... .++..+++.++.++++||+|||++.|+||||||.|+|+   +.+|.+||+|||+|+.+.+..
T Consensus        80 fEfm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLi---s~~g~lKiADFGLAr~f~~p~  155 (318)
T KOG0659|consen   80 FEFMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLI---SSDGQLKIADFGLARFFGSPN  155 (318)
T ss_pred             EEecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEE---cCCCcEEeecccchhccCCCC
Confidence            99994 68998887654 49999999999999999999999999999999999999   788999999999999887654


Q ss_pred             ccc-cccCCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCC---------
Q 014733          199 NLH-GTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW---------  266 (419)
Q Consensus       199 ~~~-~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~---------  266 (419)
                      ... ..+.|.+|.|||.+.|  .|+..+||||.|||+.||+.|.+-|.|.+.-++...|.+.-.....+.|         
T Consensus       156 ~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY  235 (318)
T KOG0659|consen  156 RIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY  235 (318)
T ss_pred             cccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence            433 2378999999999887  3999999999999999999999999999988888877554333333333         


Q ss_pred             ---------------CCCCHHHHHHHHhhhhcCCCCCCCHHHHHhcccccc
Q 014733          267 ---------------DHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE  302 (419)
Q Consensus       267 ---------------~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~  302 (419)
                                     ...+.++.||+.+||..||.+|+|+.|+|+|+||..
T Consensus       236 ~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~  286 (318)
T KOG0659|consen  236 VKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS  286 (318)
T ss_pred             HHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence                           345788899999999999999999999999999986

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-49  Score=390.86  Aligned_cols=261  Identities=33%  Similarity=0.564  Sum_probs=227.9

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      ++|++++.||+|+||+||+|.++.+|+.||+|++.+...........+.+|+.+|+.+. ||||+++++++.+.+.+|+|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~~~~~~~~~~~~~lv   79 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEAD-NPWVVKLYYSFQDENYLYLI   79 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceEEEEEcCCeEEEE
Confidence            57999999999999999999999999999999998655444456677889999999996 99999999999999999999


Q ss_pred             EeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC-
Q 014733          120 MELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ-  198 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~-  198 (419)
                      |||++||+|.+++...+.+++..++.++.||+.||+|||+.||+||||||+|||+   +.++.+||+|||++..+.... 
T Consensus        80 ~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~  156 (364)
T cd05599          80 MEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLL---DAKGHIKLSDFGLCTGLKKSHR  156 (364)
T ss_pred             ECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEeecccceecccccc
Confidence            9999999999999888889999999999999999999999999999999999999   567899999999987543211 


Q ss_pred             --------------------------------------ccccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHhCC
Q 014733          199 --------------------------------------NLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGM  239 (419)
Q Consensus       199 --------------------------------------~~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~elltG~  239 (419)
                                                            .....+||+.|+|||++.+ .++.++|||||||++|+|++|+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~  236 (364)
T cd05599         157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY  236 (364)
T ss_pred             ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence                                                  0113469999999999876 4899999999999999999999


Q ss_pred             CCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCC---HHHHHhccccccchh
Q 014733          240 PPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLT---AAEVLAHSWMEECEQ  305 (419)
Q Consensus       240 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps---~~eil~hp~~~~~~~  305 (419)
                      +||.+....+....+..............+++++++||.+||. +|.+|++   +.+++.||||+....
T Consensus       237 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~~  304 (364)
T cd05599         237 PPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVDW  304 (364)
T ss_pred             CCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCCH
Confidence            9999888888777776654443333334689999999999997 9999998   999999999988754

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-49  Score=388.12  Aligned_cols=258  Identities=30%  Similarity=0.521  Sum_probs=226.3

Q ss_pred             cccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeC--CE
Q 014733           38 LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEE--DY  115 (419)
Q Consensus        38 ~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~--~~  115 (419)
                      -.+.|+.+++||+|.||.||+|++..+|+.||+|.++.+.. .+.......+||.||++|. ||||++|.+...+.  ..
T Consensus       115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~-~~~~~~t~~REI~ILr~l~-HpNIikL~eivt~~~~~s  192 (560)
T KOG0600|consen  115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE-KEGFPITAIREIKILRRLD-HPNIIKLEEIVTSKLSGS  192 (560)
T ss_pred             chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccC-CCcchHHHHHHHHHHHhcC-CCcccceeeEEEecCCce
Confidence            35789999999999999999999999999999999988764 2345566788999999995 99999999999876  78


Q ss_pred             EEEEEeecCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeee
Q 014733          116 VHLLMELCAGGELFHRLEKYG-RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI  194 (419)
Q Consensus       116 ~~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~  194 (419)
                      +|||+|||+ -+|.-++...+ .|++.+++.++.||++||+|||+.||+|||||.+||||   +.+|.+||+|||+|+.+
T Consensus       193 iYlVFeYMd-hDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLi---dn~G~LKiaDFGLAr~y  268 (560)
T KOG0600|consen  193 IYLVFEYMD-HDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILI---DNNGVLKIADFGLARFY  268 (560)
T ss_pred             EEEEEeccc-chhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEE---cCCCCEEeccccceeec
Confidence            999999995 47877776643 59999999999999999999999999999999999999   67889999999999977


Q ss_pred             ccCC--ccccccCCCccCCcccccCC--CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCC----
Q 014733          195 KAGQ--NLHGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW----  266 (419)
Q Consensus       195 ~~~~--~~~~~~gt~~y~aPE~l~~~--~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~----  266 (419)
                      ....  .....+-|++|.|||.+.|.  |+.++|+||.||||.||+.|++.|.+.+..+.+..|...........|    
T Consensus       269 ~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k  348 (560)
T KOG0600|consen  269 TPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK  348 (560)
T ss_pred             cCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence            6544  45667899999999999884  999999999999999999999999999999998888664433333333    


Q ss_pred             ---------------------CCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccc
Q 014733          267 ---------------------DHISASARDLIMGMLRVDPSTRLTAAEVLAHSWME  301 (419)
Q Consensus       267 ---------------------~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~  301 (419)
                                           ..++..+.+|+..||..||.+|.|+.++|+|+||.
T Consensus       349 LP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~  404 (560)
T KOG0600|consen  349 LPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFT  404 (560)
T ss_pred             CCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccc
Confidence                                 34678899999999999999999999999999993

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9e-50  Score=382.22  Aligned_cols=258  Identities=32%  Similarity=0.592  Sum_probs=218.8

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCC--EE
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEED--YV  116 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~--~~  116 (419)
                      ..++..++.||+|+||.||++.+..+|...|+|.+.....   ...+.+.+|+.+|.+|+ |||||++++......  .+
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~---~~~~~l~~Ei~iL~~l~-~p~IV~~~G~~~~~~~~~~   91 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS---PTSESLEREIRILSRLN-HPNIVQYYGSSSSRENDEY   91 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccc---hhHHHHHHHHHHHHhCC-CCCEEeeCCccccccCeee
Confidence            4668889999999999999999999999999999976622   22788999999999997 999999999854444  69


Q ss_pred             EEEEeecCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCC-CCCeEEeeccceeee
Q 014733          117 HLLMELCAGGELFHRLEKYG-RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSS-SSPIKLADFGLATYI  194 (419)
Q Consensus       117 ~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~-~~~vKL~DFgla~~~  194 (419)
                      ++.|||+++|+|.+++.+.+ .+++..++.+.+||++||+|||++|||||||||+|||++   . ++.+||+|||+++..
T Consensus        92 ~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~---~~~~~~KlaDFG~a~~~  168 (313)
T KOG0198|consen   92 NIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLD---PSNGDVKLADFGLAKKL  168 (313)
T ss_pred             EeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEe---CCCCeEEeccCcccccc
Confidence            99999999999999999987 799999999999999999999999999999999999994   4 679999999999876


Q ss_pred             cc----CCccccccCCCccCCcccccCCC--CCchhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcCCCCCCCCCC
Q 014733          195 KA----GQNLHGTVGSPFYIAPEVLAGGY--NQAADVWSAGVILYILLSGMPPFWG-KTKSKIFDAVRAADLRFPSDPWD  267 (419)
Q Consensus       195 ~~----~~~~~~~~gt~~y~aPE~l~~~~--s~~sDvwSlGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~  267 (419)
                      ..    ........||+.|||||++..+.  .+++|||||||++.||+||.+||.. ....+..-.+.... ..| ..+.
T Consensus       169 ~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~-~~P-~ip~  246 (313)
T KOG0198|consen  169 ESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED-SLP-EIPD  246 (313)
T ss_pred             ccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC-CCC-CCCc
Confidence            63    12234568999999999998543  3599999999999999999999987 33333333433333 122 3345


Q ss_pred             CCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          268 HISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       268 ~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                      .+|.++++||.+||.+||++|||+.++|+|||.++...
T Consensus       247 ~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  247 SLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             ccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence            79999999999999999999999999999999987654

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.9e-48  Score=381.73  Aligned_cols=252  Identities=33%  Similarity=0.613  Sum_probs=223.9

Q ss_pred             eeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEEeecCC
Q 014733           46 KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAG  125 (419)
Q Consensus        46 ~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~g  125 (419)
                      +.||+|+||.||++.++.+|+.||+|++.+...........+.+|+.+++.+. ||||+++++++.+.+.+|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~i~~~~~~~~~~~~~~lv~E~~~~   79 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDRLCFVMEYANG   79 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCcceeeEEecCCEEEEEEeCCCC
Confidence            46999999999999999999999999998765444556677888999999996 99999999999999999999999999


Q ss_pred             CChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeecc-CCcccccc
Q 014733          126 GELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA-GQNLHGTV  204 (419)
Q Consensus       126 gsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~-~~~~~~~~  204 (419)
                      ++|..++...+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++..... .......+
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~  156 (323)
T cd05595          80 GELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFC  156 (323)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---cCCCCEEecccHHhccccCCCCcccccc
Confidence            9999999888889999999999999999999999999999999999999   5677899999999875322 22334467


Q ss_pred             CCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhc
Q 014733          205 GSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRV  283 (419)
Q Consensus       205 gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~  283 (419)
                      ||+.|+|||++.+. ++.++|||||||++|+|++|+.||...+..+....+......++.    .++++++++|.+||+.
T Consensus       157 gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~----~~~~~~~~li~~~L~~  232 (323)
T cd05595         157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLLKK  232 (323)
T ss_pred             CCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCC----CCCHHHHHHHHHHccC
Confidence            99999999998764 899999999999999999999999988888888887776665543    6899999999999999


Q ss_pred             CCCCCC-----CHHHHHhccccccchh
Q 014733          284 DPSTRL-----TAAEVLAHSWMEECEQ  305 (419)
Q Consensus       284 dP~~Rp-----s~~eil~hp~~~~~~~  305 (419)
                      ||++|+     ++.++++||||.+..+
T Consensus       233 dP~~R~~~~~~~~~~~l~h~~~~~~~~  259 (323)
T cd05595         233 DPKQRLGGGPSDAKEVMEHRFFLSINW  259 (323)
T ss_pred             CHHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence            999998     9999999999987654

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-50  Score=370.41  Aligned_cols=267  Identities=38%  Similarity=0.718  Sum_probs=239.1

Q ss_pred             ccccCeeee-eeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEe---
Q 014733           37 NLSDRYVLG-KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEE---  112 (419)
Q Consensus        37 ~~~~~y~i~-~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~---  112 (419)
                      .+.++|.+- ++||-|-.|+|..|.++.|++.+|+|++...        ...++|++.--..++|||||.++++|+.   
T Consensus        58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~  129 (400)
T KOG0604|consen   58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSYQ  129 (400)
T ss_pred             cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhcc
Confidence            467888885 6799999999999999999999999987532        4455677765556689999999999864   


Q ss_pred             -CCEEEEEEeecCCCChHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeecc
Q 014733          113 -EDYVHLLMELCAGGELFHRLEKYGR--FSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFG  189 (419)
Q Consensus       113 -~~~~~lV~E~~~ggsL~~~l~~~~~--l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFg  189 (419)
                       ..++.+|||.++||+|++.++..+.  |+|.++..|++||..|+.|||+.+|.||||||+|+|......+..+||+|||
T Consensus       130 ~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfG  209 (400)
T KOG0604|consen  130 GRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFG  209 (400)
T ss_pred             CceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccc
Confidence             4678899999999999999988766  9999999999999999999999999999999999999888888899999999


Q ss_pred             ceeeeccCCccccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhcCCCCCCC
Q 014733          190 LATYIKAGQNLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKT----KSKIFDAVRAADLRFPSD  264 (419)
Q Consensus       190 la~~~~~~~~~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~----~~~~~~~i~~~~~~~~~~  264 (419)
                      +|+.......+.+.|-||.|.|||++.. +|+..+|+||+||++|.|++|++||....    ...+..+|..+.+.||.+
T Consensus       210 FAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~p  289 (400)
T KOG0604|consen  210 FAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEP  289 (400)
T ss_pred             cccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCCh
Confidence            9998776677788899999999999976 59999999999999999999999997654    357888999999999999


Q ss_pred             CCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchhhhcCCC
Q 014733          265 PWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKPC  311 (419)
Q Consensus       265 ~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~~~~~~~  311 (419)
                      .|+.+|+.++|+|+.+|..+|.+|+|+.+++.|||+.+...+...+.
T Consensus       290 EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~tpl  336 (400)
T KOG0604|consen  290 EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQTPL  336 (400)
T ss_pred             hHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCCCCc
Confidence            99999999999999999999999999999999999998776655443

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.5e-48  Score=375.31  Aligned_cols=260  Identities=29%  Similarity=0.453  Sum_probs=220.2

Q ss_pred             eeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEEe
Q 014733           42 YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLME  121 (419)
Q Consensus        42 y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  121 (419)
                      |++.+.||+|+||.||+|.++.+|+.||+|.+.+...........+.+|+.+++++. |+||+++++++.+.+.+++|||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVN-SRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcC-CCcEEEEEEEEccCCeEEEEEE
Confidence            788999999999999999999999999999997665433344556788999999995 9999999999999999999999


Q ss_pred             ecCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCCc
Q 014733          122 LCAGGELFHRLEKY--GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN  199 (419)
Q Consensus       122 ~~~ggsL~~~l~~~--~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~~  199 (419)
                      |+++|+|..++...  ..+++..+..++.|++.||+|||+.+|+||||||+|||+   +.++.+||+|||++........
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill---~~~~~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILL---DDRGHIRISDLGLAVQIPEGET  157 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE---CCCCCEEEeeCCCcEEcCCCCe
Confidence            99999998887543  358999999999999999999999999999999999999   5677899999999987655444


Q ss_pred             cccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHH
Q 014733          200 LHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM  278 (419)
Q Consensus       200 ~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~  278 (419)
                      .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.........+..............++.++.+||+
T Consensus       158 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  237 (285)
T cd05631         158 VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICR  237 (285)
T ss_pred             ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHH
Confidence            455689999999999876 4899999999999999999999999876543333322222222222333478999999999


Q ss_pred             hhhhcCCCCCCC-----HHHHHhccccccchh
Q 014733          279 GMLRVDPSTRLT-----AAEVLAHSWMEECEQ  305 (419)
Q Consensus       279 ~~L~~dP~~Rps-----~~eil~hp~~~~~~~  305 (419)
                      +||+.||++||+     ++++++||||++..+
T Consensus       238 ~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~  269 (285)
T cd05631         238 MLLTKNPKERLGCRGNGAAGVKQHPIFKNINF  269 (285)
T ss_pred             HHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCH
Confidence            999999999997     999999999988754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-48  Score=389.21  Aligned_cols=261  Identities=31%  Similarity=0.525  Sum_probs=224.1

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      ++|++++.||+|+||+||+|.++.+++.||+|++.+...........+.+|+++++++. ||||+++++++.+.+.+|+|
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~~~~~~~~~~~~~lv   79 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESD-SPWVVSLYYSFQDAQYLYLI   79 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCC-CCCcceEEEEEEcCCeeEEE
Confidence            47999999999999999999999999999999997654444556778899999999995 99999999999999999999


Q ss_pred             EeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC-
Q 014733          120 MELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ-  198 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~-  198 (419)
                      |||++||+|.+++...+.+++..++.++.|++.||+|||+.||+||||||+|||+   +.++.+||+|||+++.+.... 
T Consensus        80 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll---~~~~~~kl~DfGla~~~~~~~~  156 (377)
T cd05629          80 MEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILI---DRGGHIKLSDFGLSTGFHKQHD  156 (377)
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---CCCCCEEEeecccccccccccc
Confidence            9999999999999888889999999999999999999999999999999999999   567889999999986331100 


Q ss_pred             -----------------------------------------------ccccccCCCccCCcccccCC-CCCchhHHHHHH
Q 014733          199 -----------------------------------------------NLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGV  230 (419)
Q Consensus       199 -----------------------------------------------~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGv  230 (419)
                                                                     .....+||+.|+|||++.+. ++.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv  236 (377)
T cd05629         157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA  236 (377)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence                                                           00124799999999998764 999999999999


Q ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCC---CCHHHHHhccccccchh
Q 014733          231 ILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTR---LTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       231 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~R---ps~~eil~hp~~~~~~~  305 (419)
                      ++|||++|++||.+....+.+..+..............++.++++||.+||+ +|.+|   +++.+++.||||+....
T Consensus       237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~~~  313 (377)
T cd05629         237 IMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGVDW  313 (377)
T ss_pred             hhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCCCH
Confidence            9999999999999888877777776543333323334689999999999998 77765   59999999999987654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-48  Score=382.97  Aligned_cols=260  Identities=32%  Similarity=0.543  Sum_probs=229.0

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.+. ||||+++++++.+.+.+|+|
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~iv~~~~~~~~~~~~~lv   79 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTK-SEWLVKLLYAFQDDEYLYLA   79 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCC-CCCCccEEEEEEcCCEEEEE
Confidence            57999999999999999999999999999999998765444456678899999999996 99999999999999999999


Q ss_pred             EeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCCc
Q 014733          120 MELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN  199 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~~  199 (419)
                      |||++|++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||+   +.++.+||+|||++.....  .
T Consensus        80 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kL~Dfg~a~~~~~--~  154 (333)
T cd05600          80 MEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLI---DASGHIKLTDFGLSKGIVT--Y  154 (333)
T ss_pred             EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCCEEEEeCcCCccccc--c
Confidence            9999999999999888889999999999999999999999999999999999999   5678999999999986543  3


Q ss_pred             cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCC----CCCCHHHH
Q 014733          200 LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW----DHISASAR  274 (419)
Q Consensus       200 ~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~----~~~s~~l~  274 (419)
                      ....+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.+..+....+...........+    ..++.++.
T Consensus       155 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~  234 (333)
T cd05600         155 ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAW  234 (333)
T ss_pred             cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHH
Confidence            3456799999999998774 899999999999999999999999998888887777654332222211    25789999


Q ss_pred             HHHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          275 DLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       275 ~li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                      ++|.+||+.+|.+||++.++++||||.....
T Consensus       235 ~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~  265 (333)
T cd05600         235 DLITKLINDPSRRFGSLEDIKNHPFFKEVDW  265 (333)
T ss_pred             HHHHHHhhChhhhcCCHHHHHhCcccCCCCH
Confidence            9999999999999999999999999987643

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=3.5e-48  Score=388.36  Aligned_cols=262  Identities=32%  Similarity=0.481  Sum_probs=224.4

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      ..|++++.||+|+||+||+|.++.+++.||+|++.+...........+.+|+.+++++. ||||+++++++.+.+.+|+|
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~l~~~~~~~~~~~lv   79 (381)
T cd05626           1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEAD-NEWVVKLYYSFQDKDNLYFV   79 (381)
T ss_pred             CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcC-CCCeeeeEEEEecCCEEEEE
Confidence            36899999999999999999999999999999998766555566788999999999996 99999999999999999999


Q ss_pred             EeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC-
Q 014733          120 MELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ-  198 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~-  198 (419)
                      |||++||+|.+++...+.+++..++.++.||+.||+|||+.||+||||||+|||+   +.++.+||+|||++....... 
T Consensus        80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili---~~~~~~kL~DFGl~~~~~~~~~  156 (381)
T cd05626          80 MDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILI---DLDGHIKLTDFGLCTGFRWTHN  156 (381)
T ss_pred             EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEE---CCCCCEEEeeCcCCcccccccc
Confidence            9999999999999888889999999999999999999999999999999999999   567899999999875331100 


Q ss_pred             -----------------------------------------------ccccccCCCccCCcccccCC-CCCchhHHHHHH
Q 014733          199 -----------------------------------------------NLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGV  230 (419)
Q Consensus       199 -----------------------------------------------~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGv  230 (419)
                                                                     .....+||+.|+|||++.+. ++.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~  236 (381)
T cd05626         157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV  236 (381)
T ss_pred             cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence                                                           01234799999999998764 899999999999


Q ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhc--CCCCCCCHHHHHhccccccchh
Q 014733          231 ILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRV--DPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       231 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~--dP~~Rps~~eil~hp~~~~~~~  305 (419)
                      ++|||++|+.||......+....+...........+..+++++++||.+|+..  +|..|+++.+++.||||.+..+
T Consensus       237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~~  313 (381)
T cd05626         237 ILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDF  313 (381)
T ss_pred             HHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCCh
Confidence            99999999999988877766666654433333334447899999999996654  5555999999999999987654

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-49  Score=384.18  Aligned_cols=263  Identities=37%  Similarity=0.655  Sum_probs=243.4

Q ss_pred             ccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEE
Q 014733           37 NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYV  116 (419)
Q Consensus        37 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~  116 (419)
                      .+.+-|.+.+.||+|.|++|.+|+|.++|+.||||++.+.++.. .....+..|++.|+.++ |||||++|++.+....+
T Consensus        15 kIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~-~st~hlfqEVRCMKLVQ-HpNiVRLYEViDTQTKl   92 (864)
T KOG4717|consen   15 KIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDT-LSTGHLFQEVRCMKLVQ-HPNIVRLYEVIDTQTKL   92 (864)
T ss_pred             ceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccch-hhhhHHHHHHHHHHHhc-CcCeeeeeehhcccceE
Confidence            36678999999999999999999999999999999999987643 34567888999999996 99999999999999999


Q ss_pred             EEEEeecCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeec
Q 014733          117 HLLMELCAGGELFHRLEKYG-RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIK  195 (419)
Q Consensus       117 ~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~  195 (419)
                      |+|+|+-.+|+|+++|.++. .+.|..++.+|.||+.|+.|||+..+|||||||+||.+.+  +-|-|||+|||++..+.
T Consensus        93 yLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFE--KlGlVKLTDFGFSNkf~  170 (864)
T KOG4717|consen   93 YLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFE--KLGLVKLTDFGFSNKFQ  170 (864)
T ss_pred             EEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEee--ecCceEeeeccccccCC
Confidence            99999999999999997764 4999999999999999999999999999999999998864  56899999999999999


Q ss_pred             cCCccccccCCCccCCcccccCC-CC-CchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 014733          196 AGQNLHGTVGSPFYIAPEVLAGG-YN-QAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASA  273 (419)
Q Consensus       196 ~~~~~~~~~gt~~y~aPE~l~~~-~s-~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l  273 (419)
                      +++.+.+.||+..|.|||++.|. |+ +++||||||||||.|++|++||...+..+.+..|....+..|.    .+|.++
T Consensus       171 PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPs----hvS~eC  246 (864)
T KOG4717|consen  171 PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPS----HVSKEC  246 (864)
T ss_pred             CcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCch----hhhHHH
Confidence            99999999999999999999885 75 8999999999999999999999999999999999999888876    799999


Q ss_pred             HHHHHhhhhcCCCCCCCHHHHHhccccccchhhh
Q 014733          274 RDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVA  307 (419)
Q Consensus       274 ~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~~~  307 (419)
                      ++||..||..||++|.+.++|..|+|++..+...
T Consensus       247 rdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~  280 (864)
T KOG4717|consen  247 RDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGL  280 (864)
T ss_pred             HHHHHHHHhcCchhhccHHHHhccccccCCCCCc
Confidence            9999999999999999999999999999887643

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=2.3e-48  Score=383.99  Aligned_cols=258  Identities=29%  Similarity=0.532  Sum_probs=229.5

Q ss_pred             cccCeeeeeeecccCceEEEEEEecCCC-cEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEE
Q 014733           38 LSDRYVLGKQLGWGQFGVIRECSDKFTG-EVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYV  116 (419)
Q Consensus        38 ~~~~y~i~~~LG~G~~g~V~~a~~~~~g-~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~  116 (419)
                      -.++|.+.+.||+|+||.||+|.++.++ ..||+|.+.+...........+.+|+.+++.+. ||||+++++++.+.+.+
T Consensus        28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~~~~~  106 (340)
T PTZ00426         28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN-HPFCVNLYGSFKDESYL  106 (340)
T ss_pred             ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCCcceEEEEEeCCEE
Confidence            3468999999999999999999876554 689999997665444556678899999999996 99999999999999999


Q ss_pred             EEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeecc
Q 014733          117 HLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA  196 (419)
Q Consensus       117 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~  196 (419)
                      |+||||+++|+|.+++...+.+++..+..++.||+.||.|||+.||+||||||+|||+   +.++.+||+|||++.....
T Consensus       107 ~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl---~~~~~ikL~DFG~a~~~~~  183 (340)
T PTZ00426        107 YLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLL---DKDGFIKMTDFGFAKVVDT  183 (340)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE---CCCCCEEEecCCCCeecCC
Confidence            9999999999999999988889999999999999999999999999999999999999   5678999999999987543


Q ss_pred             CCccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 014733          197 GQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARD  275 (419)
Q Consensus       197 ~~~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~  275 (419)
                      .  ....+||+.|+|||++.+. ++.++|+|||||++|+|++|.+||.+.+.....+.+......++.    .++.++++
T Consensus       184 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~  257 (340)
T PTZ00426        184 R--TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPK----FLDNNCKH  257 (340)
T ss_pred             C--cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCC----CCCHHHHH
Confidence            2  3456899999999998774 899999999999999999999999998888888888777655543    67899999


Q ss_pred             HHHhhhhcCCCCCC-----CHHHHHhccccccchh
Q 014733          276 LIMGMLRVDPSTRL-----TAAEVLAHSWMEECEQ  305 (419)
Q Consensus       276 li~~~L~~dP~~Rp-----s~~eil~hp~~~~~~~  305 (419)
                      +|++||+.||.+|+     +++++++||||....+
T Consensus       258 li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~  292 (340)
T PTZ00426        258 LMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDW  292 (340)
T ss_pred             HHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence            99999999999995     8999999999987654

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-49  Score=370.41  Aligned_cols=272  Identities=31%  Similarity=0.544  Sum_probs=230.8

Q ss_pred             hccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEe-
Q 014733           34 QISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEE-  112 (419)
Q Consensus        34 ~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~-  112 (419)
                      +.-.+..+|...+.||+|+||.|..|.++.+|+.||+|.+... .......++..+|+++|+.++ |+||+.+.+++.. 
T Consensus        16 ~~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~-F~~~~~akRtlRElklLr~~~-HeNIi~l~di~~p~   93 (359)
T KOG0660|consen   16 ELFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP-FENQIDAKRTLRELKLLRHLR-HENIIGLLDIFRPP   93 (359)
T ss_pred             eEEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhh-hhchHHHHHHHHHHHHHHHhc-CCCcceEEeecccc
Confidence            4455677888899999999999999999999999999998632 234567788999999999997 9999999999864 


Q ss_pred             ----CCEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeec
Q 014733          113 ----EDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADF  188 (419)
Q Consensus       113 ----~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DF  188 (419)
                          -+.+|+|+|+| +.+|.+.++....+++.++..++.||+.||+|+|+.+|+||||||.|+|+   +.+..+||+||
T Consensus        94 ~~~~f~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~---n~~c~lKI~DF  169 (359)
T KOG0660|consen   94 SRDKFNDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLL---NADCDLKICDF  169 (359)
T ss_pred             cccccceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheee---ccCCCEEeccc
Confidence                46799999999 77999999887779999999999999999999999999999999999999   55677899999


Q ss_pred             cceeeecc---CCccccccCCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc------
Q 014733          189 GLATYIKA---GQNLHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAA------  257 (419)
Q Consensus       189 gla~~~~~---~~~~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~------  257 (419)
                      |+|+....   ....+..+.|.+|.|||++..  .|+.+.||||+|||+.||++|++-|.|.+....++.|...      
T Consensus       170 GLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~  249 (359)
T KOG0660|consen  170 GLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSE  249 (359)
T ss_pred             cceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCH
Confidence            99998754   344567799999999998765  4999999999999999999999999887765544444221      


Q ss_pred             -----------------CCCCCCCC----CCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchhhhcCCC
Q 014733          258 -----------------DLRFPSDP----WDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKPC  311 (419)
Q Consensus       258 -----------------~~~~~~~~----~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~~~~~~~  311 (419)
                                       ....+..+    +.++++.+.||+.+||..||.+|+|++|+|+|||+.....+...|.
T Consensus       250 e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~  324 (359)
T KOG0660|consen  250 EDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPV  324 (359)
T ss_pred             HHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCC
Confidence                             11222222    4578999999999999999999999999999999998877665553

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-49  Score=389.63  Aligned_cols=259  Identities=27%  Similarity=0.481  Sum_probs=228.7

Q ss_pred             cccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCE
Q 014733           36 SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDY  115 (419)
Q Consensus        36 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~  115 (419)
                      .+=...|...++||+|+-|.||.|....+++.||+|.+.+..-   ...+-+.+|+.+|+.++ |+|||++++.|...+.
T Consensus       269 ~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q---~~keLilnEi~Vm~~~~-H~NiVnfl~Sylv~de  344 (550)
T KOG0578|consen  269 GDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ---PKKELLLNEILVMRDLH-HPNIVNFLDSYLVGDE  344 (550)
T ss_pred             CChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccC---CchhhhHHHHHHHHhcc-chHHHHHHHHhcccce
Confidence            3345688899999999999999999999999999999987643   34566889999999996 9999999999999999


Q ss_pred             EEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeec
Q 014733          116 VHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIK  195 (419)
Q Consensus       116 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~  195 (419)
                      +++||||++||+|.+.+.. ..++|.+++.+++++++||+|||.+||+|||||.+|||+   +.+|.+||+|||++..+.
T Consensus       345 LWVVMEym~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL---~~~g~vKltDFGFcaqi~  420 (550)
T KOG0578|consen  345 LWVVMEYMEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILL---TMDGSVKLTDFGFCAQIS  420 (550)
T ss_pred             eEEEEeecCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEe---ccCCcEEEeeeeeeeccc
Confidence            9999999999999998876 559999999999999999999999999999999999999   677889999999999887


Q ss_pred             cCC-ccccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 014733          196 AGQ-NLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASA  273 (419)
Q Consensus       196 ~~~-~~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l  273 (419)
                      ... ...+.+|||.|||||++.. .|+++.||||||++++||+-|.+||...++...+..|..... .....+..+|.++
T Consensus       421 ~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~-P~lk~~~klS~~~  499 (550)
T KOG0578|consen  421 EEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT-PKLKNPEKLSPEL  499 (550)
T ss_pred             cccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCC-CCcCCccccCHHH
Confidence            665 3455699999999999876 599999999999999999999999987777777766655432 2333446899999


Q ss_pred             HHHHHhhhhcCCCCCCCHHHHHhccccccc
Q 014733          274 RDLIMGMLRVDPSTRLTAAEVLAHSWMEEC  303 (419)
Q Consensus       274 ~~li~~~L~~dP~~Rps~~eil~hp~~~~~  303 (419)
                      ++|+.+||+.|+++|+++.|+|+||||+..
T Consensus       500 kdFL~~cL~~dv~~RasA~eLL~HpFl~~a  529 (550)
T KOG0578|consen  500 KDFLDRCLVVDVEQRASAKELLEHPFLKMA  529 (550)
T ss_pred             HHHHHHHhhcchhcCCCHHHHhcChhhhhc
Confidence            999999999999999999999999999543

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=3.2e-48  Score=388.63  Aligned_cols=261  Identities=34%  Similarity=0.527  Sum_probs=226.0

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      .+|+++++||+|+||+||+|+++.+++.+|+|++.+...........+.+|+.+++++. ||||+++++++.+.+.+|+|
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~-h~~iv~~~~~~~~~~~~~lv   79 (382)
T cd05625           1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEAD-NEWVVRLYYSFQDKDNLYFV   79 (382)
T ss_pred             CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCC-CCcCCeEEEEEEeCCEEEEE
Confidence            36999999999999999999999999999999998765444556778999999999995 99999999999999999999


Q ss_pred             EeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccC--
Q 014733          120 MELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG--  197 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~--  197 (419)
                      |||+++|+|.+++.+.+.+++..++.++.||+.||+|||+.||+||||||+|||+   +.++.+||+|||++......  
T Consensus        80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl---~~~g~~kL~DFGla~~~~~~~~  156 (382)
T cd05625          80 MDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHD  156 (382)
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEEeECCCCcccccccc
Confidence            9999999999999888889999999999999999999999999999999999999   56789999999997532100  


Q ss_pred             ----------------------------------------------CccccccCCCccCCcccccC-CCCCchhHHHHHH
Q 014733          198 ----------------------------------------------QNLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGV  230 (419)
Q Consensus       198 ----------------------------------------------~~~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGv  230 (419)
                                                                    ......+||+.|+|||++.+ .|+.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv  236 (382)
T cd05625         157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV  236 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence                                                          00123479999999999876 4999999999999


Q ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCC---HHHHHhccccccchh
Q 014733          231 ILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLT---AAEVLAHSWMEECEQ  305 (419)
Q Consensus       231 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps---~~eil~hp~~~~~~~  305 (419)
                      ++|||++|++||.+.+..+....+..............+++++.++|.+|+ .||.+|++   +.++++||||+....
T Consensus       237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~  313 (382)
T cd05625         237 ILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTIDF  313 (382)
T ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCcCh
Confidence            999999999999988877777776654444444444578999999999986 59999997   999999999988654

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=9.7e-48  Score=377.57  Aligned_cols=252  Identities=33%  Similarity=0.605  Sum_probs=223.4

Q ss_pred             eeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEEeecCC
Q 014733           46 KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAG  125 (419)
Q Consensus        46 ~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~g  125 (419)
                      +.||+|+||.||+|.++.+|+.||+|++.+...........+.+|+.+++.+. ||||+++++++.+.+.+|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~Ey~~~   79 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTR-HPFLTSLKYSFQTKDRLCFVMEYVNG   79 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999999999999999998765555566778889999999996 99999999999999999999999999


Q ss_pred             CChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeecc-CCcccccc
Q 014733          126 GELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA-GQNLHGTV  204 (419)
Q Consensus       126 gsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~-~~~~~~~~  204 (419)
                      |+|..++...+.+++.+++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++..... .......+
T Consensus        80 g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll---~~~~~~kL~DfG~~~~~~~~~~~~~~~~  156 (328)
T cd05593          80 GELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLML---DKDGHIKITDFGLCKEGITDAATMKTFC  156 (328)
T ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEE---CCCCcEEEecCcCCccCCCccccccccc
Confidence            9999999888889999999999999999999999999999999999999   5677899999999875322 22234457


Q ss_pred             CCCccCCcccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhc
Q 014733          205 GSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRV  283 (419)
Q Consensus       205 gt~~y~aPE~l~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~  283 (419)
                      ||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+....+..+.+......++.    .++.++.+||++||++
T Consensus       157 gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~----~~~~~~~~li~~~L~~  232 (328)
T cd05593         157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPR----TLSADAKSLLSGLLIK  232 (328)
T ss_pred             CCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCC----CCCHHHHHHHHHHcCC
Confidence            9999999999876 4899999999999999999999999988888887777666555543    6899999999999999


Q ss_pred             CCCCCC-----CHHHHHhccccccchh
Q 014733          284 DPSTRL-----TAAEVLAHSWMEECEQ  305 (419)
Q Consensus       284 dP~~Rp-----s~~eil~hp~~~~~~~  305 (419)
                      ||++|+     ++.++++||||.....
T Consensus       233 dP~~R~~~~~~~~~~il~h~~~~~~~~  259 (328)
T cd05593         233 DPNKRLGGGPDDAKEIMRHSFFTGVNW  259 (328)
T ss_pred             CHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence            999997     8999999999987644

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-48  Score=383.83  Aligned_cols=259  Identities=36%  Similarity=0.636  Sum_probs=229.2

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      ++|++.+.||+|+||+||+|.+..+|+.||+|++.+...........+..|+.++..+. ||||+++++++.+.+.+|+|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv   79 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADAD-SPWIVKLYYSFQDEEHLYLV   79 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcC-CCCccchhhheecCCeEEEE
Confidence            57999999999999999999999999999999998765444456678899999999996 99999999999999999999


Q ss_pred             EeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC-
Q 014733          120 MELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ-  198 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~-  198 (419)
                      |||+++++|.+++.+.+.+++..++.++.||+.||+|||+.||+||||||+|||+   +.++.+||+|||++....... 
T Consensus        80 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~  156 (350)
T cd05573          80 MEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILI---DADGHIKLADFGLCKKMNKAKD  156 (350)
T ss_pred             EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEeecCCCCccCcccCc
Confidence            9999999999999888889999999999999999999999999999999999999   567889999999998664433 


Q ss_pred             -----------------------------ccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q 014733          199 -----------------------------NLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKS  248 (419)
Q Consensus       199 -----------------------------~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~  248 (419)
                                                   ......||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~  236 (350)
T cd05573         157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ  236 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence                                         12345799999999998875 899999999999999999999999988888


Q ss_pred             HHHHHHHh--cCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCC-HHHHHhccccccchh
Q 014733          249 KIFDAVRA--ADLRFPSDPWDHISASARDLIMGMLRVDPSTRLT-AAEVLAHSWMEECEQ  305 (419)
Q Consensus       249 ~~~~~i~~--~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps-~~eil~hp~~~~~~~  305 (419)
                      +....+..  ....++..  ..+++++.+||.+||+ ||.+|++ +.++++||||+....
T Consensus       237 ~~~~~i~~~~~~~~~p~~--~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~~  293 (350)
T cd05573         237 ETYNKIINWKESLRFPPD--PPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGIDW  293 (350)
T ss_pred             HHHHHHhccCCcccCCCC--CCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCCH
Confidence            87777776  33334333  3589999999999998 9999999 999999999987654

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1e-47  Score=376.51  Aligned_cols=258  Identities=28%  Similarity=0.537  Sum_probs=228.1

Q ss_pred             CeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEE
Q 014733           41 RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLM  120 (419)
Q Consensus        41 ~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~  120 (419)
                      +|++.+.||+|+||.||+|.++.+++.||+|++.+.........+.+..|..++..+..|++|+++++++.+.+.+|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            58999999999999999999999999999999987654445567788899999999975567999999999999999999


Q ss_pred             eecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeecc-CCc
Q 014733          121 ELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA-GQN  199 (419)
Q Consensus       121 E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~-~~~  199 (419)
                      ||++||+|..++...+.+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++..... ...
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~  157 (324)
T cd05587          81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DAEGHIKIADFGMCKENIFGGKT  157 (324)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---cCCCCEEEeecCcceecCCCCCc
Confidence            999999999999888889999999999999999999999999999999999999   5677899999999875322 223


Q ss_pred             cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHH
Q 014733          200 LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM  278 (419)
Q Consensus       200 ~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~  278 (419)
                      ....+||+.|+|||++.+. ++.++||||+||++|+|++|+.||.+....+....+......++.    .++.++.++|.
T Consensus       158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~li~  233 (324)
T cd05587         158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK----SLSKEAVSICK  233 (324)
T ss_pred             eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHHH
Confidence            3445799999999998875 899999999999999999999999999888888888776655443    68999999999


Q ss_pred             hhhhcCCCCCCCH-----HHHHhccccccchh
Q 014733          279 GMLRVDPSTRLTA-----AEVLAHSWMEECEQ  305 (419)
Q Consensus       279 ~~L~~dP~~Rps~-----~eil~hp~~~~~~~  305 (419)
                      +||+.||.+|++.     .++++||||+...+
T Consensus       234 ~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~  265 (324)
T cd05587         234 GLLTKHPAKRLGCGPTGERDIREHAFFRRIDW  265 (324)
T ss_pred             HHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence            9999999999976     89999999987654

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=3e-48  Score=387.91  Aligned_cols=261  Identities=32%  Similarity=0.499  Sum_probs=225.4

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      ++|++++.||+|+||.||+|.++.+++.||+|++.+...........+.+|+.+|+++. ||||+++++.+.+++.+|+|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~~~~~~~~~~~~~lv   79 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEAD-NEWVVKLYYSFQDKDNLYFV   79 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCC-CCCcceEEEEEEcCCEEEEE
Confidence            47999999999999999999999999999999997654433445677889999999996 99999999999999999999


Q ss_pred             EeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccC--
Q 014733          120 MELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG--  197 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~--  197 (419)
                      |||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++..+...  
T Consensus        80 ~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill---~~~~~ikL~DFG~a~~~~~~~~  156 (376)
T cd05598          80 MDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHD  156 (376)
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEE---CCCCCEEEEeCCCCcccccccc
Confidence            9999999999999888889999999999999999999999999999999999999   56789999999997532100  


Q ss_pred             ------------------------------------------CccccccCCCccCCcccccCC-CCCchhHHHHHHHHHH
Q 014733          198 ------------------------------------------QNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYI  234 (419)
Q Consensus       198 ------------------------------------------~~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~e  234 (419)
                                                                ......+||+.|+|||++.+. ++.++|||||||++|+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye  236 (376)
T cd05598         157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE  236 (376)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence                                                      001134799999999998774 8999999999999999


Q ss_pred             HHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCC---CHHHHHhccccccchh
Q 014733          235 LLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRL---TAAEVLAHSWMEECEQ  305 (419)
Q Consensus       235 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp---s~~eil~hp~~~~~~~  305 (419)
                      |++|+.||.+....+....+...........+..++.++.++|.+|+ .+|.+|+   ++.++++||||+....
T Consensus       237 ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~~~  309 (376)
T cd05598         237 MLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGIDF  309 (376)
T ss_pred             hhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCCCH
Confidence            99999999988877777766655444444444578999999999977 5999999   9999999999987654

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-49  Score=365.20  Aligned_cols=262  Identities=34%  Similarity=0.630  Sum_probs=246.0

Q ss_pred             cccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEE
Q 014733           38 LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVH  117 (419)
Q Consensus        38 ~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~  117 (419)
                      --++|..+++||+|.||+|-+++.+.+++.+|+|+++++.....+.+..-..|-++|+..+ ||.+..+...|+..+++|
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~-HPFLt~LKYsFQt~drlC  244 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCR-HPFLTSLKYSFQTQDRLC  244 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhcc-CcHHHHhhhhhccCceEE
Confidence            4578889999999999999999999999999999999998888888999999999999996 999999999999999999


Q ss_pred             EEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceee-ecc
Q 014733          118 LLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATY-IKA  196 (419)
Q Consensus       118 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~-~~~  196 (419)
                      +||||+.||+|+.+|.+...|++..++.+-.+|+.||.|||+.+||+||||.+|.|+   +++|+|||+|||+++. +..
T Consensus       245 FVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlL---DkDGHIKitDFGLCKE~I~~  321 (516)
T KOG0690|consen  245 FVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLL---DKDGHIKITDFGLCKEEIKY  321 (516)
T ss_pred             EEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhhee---ccCCceEeeecccchhcccc
Confidence            999999999999999998889999999999999999999999999999999999999   6789999999999985 344


Q ss_pred             CCccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 014733          197 GQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARD  275 (419)
Q Consensus       197 ~~~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~  275 (419)
                      +....+.||||.|+|||++... |+.++|+|.+||++|||++|+.||...+...+++.|...++++|.    .++++++.
T Consensus       322 g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr----~ls~eAkt  397 (516)
T KOG0690|consen  322 GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPR----TLSPEAKT  397 (516)
T ss_pred             cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCc----cCCHHHHH
Confidence            5566788999999999999875 999999999999999999999999999999999999999999987    68999999


Q ss_pred             HHHhhhhcCCCCCC-----CHHHHHhccccccchhhh
Q 014733          276 LIMGMLRVDPSTRL-----TAAEVLAHSWMEECEQVA  307 (419)
Q Consensus       276 li~~~L~~dP~~Rp-----s~~eil~hp~~~~~~~~~  307 (419)
                      |+..+|.+||.+|+     .+.||.+|+||..+.+..
T Consensus       398 LLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~  434 (516)
T KOG0690|consen  398 LLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEA  434 (516)
T ss_pred             HHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHH
Confidence            99999999999999     689999999999988754

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.8e-47  Score=373.62  Aligned_cols=253  Identities=29%  Similarity=0.545  Sum_probs=220.6

Q ss_pred             eeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEEeecCC
Q 014733           46 KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAG  125 (419)
Q Consensus        46 ~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~g  125 (419)
                      +.||+|+||.||+|.++.+|+.||+|++.+..............|..++..+.+||||+++++++.+.+.+|+||||++|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            47999999999999999999999999998654333345667788888888765799999999999999999999999999


Q ss_pred             CChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeecc-CCcccccc
Q 014733          126 GELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA-GQNLHGTV  204 (419)
Q Consensus       126 gsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~-~~~~~~~~  204 (419)
                      ++|..++...+++++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++..... .......+
T Consensus        81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (316)
T cd05620          81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVML---DRDGHIKIADFGMCKENVFGDNRASTFC  157 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEeCccCCCeecccCCCceeccC
Confidence            9999999888889999999999999999999999999999999999999   5677899999999875322 22234567


Q ss_pred             CCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhc
Q 014733          205 GSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRV  283 (419)
Q Consensus       205 gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~  283 (419)
                      ||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+....+..+.+......++.    .++.+++++|.+||+.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~  233 (316)
T cd05620         158 GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPR----WITKESKDILEKLFER  233 (316)
T ss_pred             CCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHHHHHHHHHHccC
Confidence            99999999998874 899999999999999999999999998888888888766544433    5789999999999999


Q ss_pred             CCCCCCCH-HHHHhccccccchh
Q 014733          284 DPSTRLTA-AEVLAHSWMEECEQ  305 (419)
Q Consensus       284 dP~~Rps~-~eil~hp~~~~~~~  305 (419)
                      ||++|+++ +++++||||+....
T Consensus       234 dP~~R~~~~~~~~~h~~f~~~~~  256 (316)
T cd05620         234 DPTRRLGVVGNIRGHPFFKTINW  256 (316)
T ss_pred             CHHHcCCChHHHHcCCCcCCCCH
Confidence            99999998 58889999988654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6e-48  Score=376.18  Aligned_cols=249  Identities=35%  Similarity=0.641  Sum_probs=221.6

Q ss_pred             ecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEEeecCCCC
Q 014733           48 LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGE  127 (419)
Q Consensus        48 LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~ggs  127 (419)
                      ||+|+||+||+|.+..+++.||+|++.+...........+.+|+.+++++. ||||+++++++.+.+..|+||||+++|+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~g~   79 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVN-CPFIVPLKFSFQSPEKLYLVLAFINGGE   79 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCcEeceeeEEecCCeEEEEEcCCCCCc
Confidence            799999999999999999999999997655445566778889999999995 9999999999999999999999999999


Q ss_pred             hHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccC-CccccccCC
Q 014733          128 LFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG-QNLHGTVGS  206 (419)
Q Consensus       128 L~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~-~~~~~~~gt  206 (419)
                      |.+++...+++++..+..++.||+.||.|||+.||+||||||+|||+   +.++.+||+|||++...... ......+||
T Consensus        80 L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  156 (312)
T cd05585          80 LFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILL---DYQGHIALCDFGLCKLNMKDDDKTNTFCGT  156 (312)
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEE---CCCCcEEEEECcccccCccCCCccccccCC
Confidence            99999888889999999999999999999999999999999999999   56788999999998754322 223345799


Q ss_pred             CccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCC
Q 014733          207 PFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDP  285 (419)
Q Consensus       207 ~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP  285 (419)
                      +.|+|||++.+. ++.++|||||||++|+|++|+.||.+....+..+.+......++    ..++++++++|.+||+.||
T Consensus       157 ~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~L~~dp  232 (312)
T cd05585         157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFP----DGFDRDAKDLLIGLLSRDP  232 (312)
T ss_pred             cccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCC----CcCCHHHHHHHHHHcCCCH
Confidence            999999998774 89999999999999999999999999888888888877655554    3688999999999999999


Q ss_pred             CCCC---CHHHHHhccccccch
Q 014733          286 STRL---TAAEVLAHSWMEECE  304 (419)
Q Consensus       286 ~~Rp---s~~eil~hp~~~~~~  304 (419)
                      .+||   ++.+++.||||.+..
T Consensus       233 ~~R~~~~~~~e~l~hp~~~~~~  254 (312)
T cd05585         233 TRRLGYNGAQEIKNHPFFSQLS  254 (312)
T ss_pred             HHcCCCCCHHHHHcCCCcCCCC
Confidence            9997   589999999998764

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.1e-47  Score=376.48  Aligned_cols=252  Identities=34%  Similarity=0.610  Sum_probs=223.2

Q ss_pred             eeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEEeecCC
Q 014733           46 KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAG  125 (419)
Q Consensus        46 ~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~g  125 (419)
                      +.||+|+||.||+|.++.+|+.||+|++.+...........+.+|+.+++.+. ||||+++++++.+.+.+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~-hp~i~~~~~~~~~~~~~~lv~E~~~~   79 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR-HPFLTALKYSFQTHDRLCFVMEYANG   79 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999999999999999998765444556677888999999995 99999999999999999999999999


Q ss_pred             CChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeccCCCCcEEEeecCCCCCeEEeeccceeeecc-CCccccc
Q 014733          126 GELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG-NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA-GQNLHGT  203 (419)
Q Consensus       126 gsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~-~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~-~~~~~~~  203 (419)
                      |+|..++...+.+++..++.++.||+.||+|||+ .||+||||||+|||+   +.++.+||+|||++..... .......
T Consensus        80 ~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~  156 (325)
T cd05594          80 GELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTF  156 (325)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEE---CCCCCEEEecCCCCeecCCCCcccccc
Confidence            9999999888889999999999999999999997 799999999999999   5677899999999875432 2233445


Q ss_pred             cCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhh
Q 014733          204 VGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLR  282 (419)
Q Consensus       204 ~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~  282 (419)
                      +||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+....+..+.+......++.    .+++++.++|.+||+
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li~~~L~  232 (325)
T cd05594         157 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLSPEAKSLLSGLLK  232 (325)
T ss_pred             cCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCC----CCCHHHHHHHHHHhh
Confidence            799999999998764 899999999999999999999999988888888887776665543    688999999999999


Q ss_pred             cCCCCCC-----CHHHHHhccccccchh
Q 014733          283 VDPSTRL-----TAAEVLAHSWMEECEQ  305 (419)
Q Consensus       283 ~dP~~Rp-----s~~eil~hp~~~~~~~  305 (419)
                      .||++|+     ++.++++||||.....
T Consensus       233 ~dP~~R~~~~~~~~~~il~h~~~~~~~~  260 (325)
T cd05594         233 KDPKQRLGGGPDDAKEIMQHKFFAGIVW  260 (325)
T ss_pred             cCHHHhCCCCCCCHHHHhcCCCcCCCCH
Confidence            9999997     9999999999987644

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=7.2e-48  Score=377.13  Aligned_cols=253  Identities=30%  Similarity=0.568  Sum_probs=223.7

Q ss_pred             eeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEEeecCC
Q 014733           46 KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAG  125 (419)
Q Consensus        46 ~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~g  125 (419)
                      +.||+|+||+||+|.++.+++.||+|++.+...........+..|..++..+.+||||+++++++.+.+.+|+||||++|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999999999999999998654444456677888999998876799999999999999999999999999


Q ss_pred             CChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeecc-CCcccccc
Q 014733          126 GELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA-GQNLHGTV  204 (419)
Q Consensus       126 gsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~-~~~~~~~~  204 (419)
                      |+|..++...+.+++..+..++.|++.||+|||+++|+||||||+|||+   +.++.+||+|||++..... .......+
T Consensus        81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli---~~~~~~kL~DfG~~~~~~~~~~~~~~~~  157 (320)
T cd05590          81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLL---DHEGHCKLADFGMCKEGIFNGKTTSTFC  157 (320)
T ss_pred             chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE---CCCCcEEEeeCCCCeecCcCCCcccccc
Confidence            9999999888889999999999999999999999999999999999999   5677899999999875432 22334457


Q ss_pred             CCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhc
Q 014733          205 GSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRV  283 (419)
Q Consensus       205 gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~  283 (419)
                      ||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+.+..++.+.+......++.    .++.++.++|++||+.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~li~~~L~~  233 (320)
T cd05590         158 GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT----WLSQDAVDILKAFMTK  233 (320)
T ss_pred             cCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCC----CCCHHHHHHHHHHccc
Confidence            99999999998764 899999999999999999999999999988888888776655443    5889999999999999


Q ss_pred             CCCCCCCH------HHHHhccccccchh
Q 014733          284 DPSTRLTA------AEVLAHSWMEECEQ  305 (419)
Q Consensus       284 dP~~Rps~------~eil~hp~~~~~~~  305 (419)
                      ||++|+++      ++++.||||+...+
T Consensus       234 dP~~R~~~~~~~~~~~~~~h~~f~~~~~  261 (320)
T cd05590         234 NPTMRLGSLTLGGEEAILRHPFFKELDW  261 (320)
T ss_pred             CHHHCCCCCCCCCHHHHHcCCCcCCCCH
Confidence            99999998      99999999987644

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-47  Score=368.29  Aligned_cols=265  Identities=31%  Similarity=0.507  Sum_probs=230.1

Q ss_pred             ccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCC
Q 014733           35 ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEED  114 (419)
Q Consensus        35 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~  114 (419)
                      ...-.+.|++.+.||.|..++||+|+..-+++.||||++..++..  ..++.+.+|+..|+.+. ||||++++.+|..+.
T Consensus        21 ~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~--~~ld~l~kE~~~msl~~-HPNIv~~~~sFvv~~   97 (516)
T KOG0582|consen   21 FPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCN--NDLDALRKEVQTMSLID-HPNIVTYHCSFVVDS   97 (516)
T ss_pred             CCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhh--hhHHHHHHHHHHhhhcC-CCCcceEEEEEEecc
Confidence            344568999999999999999999999999999999999988653  44899999999999995 999999999999999


Q ss_pred             EEEEEEeecCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeecccee
Q 014733          115 YVHLLMELCAGGELFHRLEKYG--RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLAT  192 (419)
Q Consensus       115 ~~~lV~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~  192 (419)
                      .+|+||.||.+|++.+++...-  .++|..+..+.+++++||.|||++|-||||||+.||||   +.+|.|||+|||.+.
T Consensus        98 ~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi---~~dG~VkLadFgvsa  174 (516)
T KOG0582|consen   98 ELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILI---DSDGTVKLADFGVSA  174 (516)
T ss_pred             eeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEE---cCCCcEEEcCceeee
Confidence            9999999999999999998753  39999999999999999999999999999999999999   778999999999765


Q ss_pred             eecc-CCc----cccccCCCccCCcccccC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC----
Q 014733          193 YIKA-GQN----LHGTVGSPFYIAPEVLAG---GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLR----  260 (419)
Q Consensus       193 ~~~~-~~~----~~~~~gt~~y~aPE~l~~---~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~----  260 (419)
                      .+-. +..    ....+||++|||||+++.   +|+.|+||||||+...||.+|+.||....+.+++..-..+..+    
T Consensus       175 ~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t  254 (516)
T KOG0582|consen  175 SLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLT  254 (516)
T ss_pred             eecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCccc
Confidence            4432 211    144589999999999654   5999999999999999999999999988877766554444443    


Q ss_pred             --CCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          261 --FPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       261 --~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                        ++.+....++..++.+|..||++||.+|||+.++|+|+||++...
T Consensus       255 ~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~  301 (516)
T KOG0582|consen  255 SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKS  301 (516)
T ss_pred             ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccc
Confidence              233334567889999999999999999999999999999988654

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.6e-47  Score=374.91  Aligned_cols=258  Identities=28%  Similarity=0.519  Sum_probs=229.2

Q ss_pred             CeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEE
Q 014733           41 RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLM  120 (419)
Q Consensus        41 ~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~  120 (419)
                      +|++.+.||+|+||.||+|.++.+++.||+|++.+...........+..|..++..+..|++|+++++++.+.+.+|+||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            58899999999999999999999999999999987654444556677888999988877899999999999999999999


Q ss_pred             eecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeecc-CCc
Q 014733          121 ELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA-GQN  199 (419)
Q Consensus       121 E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~-~~~  199 (419)
                      ||+++|+|...+...+.+++.++..++.||+.||+|||+.||+||||||+|||+   +.++.+||+|||++..... ...
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill---~~~~~~kL~DfG~~~~~~~~~~~  157 (323)
T cd05616          81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENMWDGVT  157 (323)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEE---CCCCcEEEccCCCceecCCCCCc
Confidence            999999999999888889999999999999999999999999999999999999   5678899999999986432 223


Q ss_pred             cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHH
Q 014733          200 LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM  278 (419)
Q Consensus       200 ~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~  278 (419)
                      ....+||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+....++...+......++.    .++.++.+++.
T Consensus       158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~  233 (323)
T cd05616         158 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVAICK  233 (323)
T ss_pred             cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----cCCHHHHHHHH
Confidence            3456799999999998874 899999999999999999999999999888888888877665543    68999999999


Q ss_pred             hhhhcCCCCCCC-----HHHHHhccccccchh
Q 014733          279 GMLRVDPSTRLT-----AAEVLAHSWMEECEQ  305 (419)
Q Consensus       279 ~~L~~dP~~Rps-----~~eil~hp~~~~~~~  305 (419)
                      +||+.||.+|++     ..++++||||+...+
T Consensus       234 ~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~  265 (323)
T cd05616         234 GLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW  265 (323)
T ss_pred             HHcccCHHhcCCCCCCCHHHHhcCCCcCCCCH
Confidence            999999999997     489999999987654

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2.3e-47  Score=367.61  Aligned_cols=254  Identities=28%  Similarity=0.501  Sum_probs=212.9

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      ++|++.++||.|+||.||+|.++.++..||+|++.....  ......+.+|+.+++++. ||||+++++++.+.+..++|
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv   81 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKNLK-HANIVTLHDIIHTERCLTLV   81 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc--CCcchhHHHHHHHHHhCC-CCCEeeEEEEEcCCCeEEEE
Confidence            579999999999999999999999999999999975432  223456778999999996 99999999999999999999


Q ss_pred             EeecCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC
Q 014733          120 MELCAGGELFHRLEKYG-RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ  198 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~  198 (419)
                      |||+++ +|.+++...+ .+++..+..++.||++||+|||++||+||||||+|||+   +.++.+||+|||++.......
T Consensus        82 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~DfG~~~~~~~~~  157 (288)
T cd07871          82 FEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLI---NEKGELKLADFGLARAKSVPT  157 (288)
T ss_pred             EeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEECcCcceeeccCCC
Confidence            999974 8998887654 47999999999999999999999999999999999999   567789999999997654322


Q ss_pred             -ccccccCCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC---------------
Q 014733          199 -NLHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLR---------------  260 (419)
Q Consensus       199 -~~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---------------  260 (419)
                       ......+++.|+|||++.+  .++.++||||+||++|+|++|++||.+.+..+....+......               
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd07871         158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF  237 (288)
T ss_pred             ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence             2344578999999999865  3899999999999999999999999887766655544322111               


Q ss_pred             ----CCC-------CCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhcccc
Q 014733          261 ----FPS-------DPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWM  300 (419)
Q Consensus       261 ----~~~-------~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~  300 (419)
                          ++.       .....++.++++||++||++||.+|||++|+++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence                110       0123578899999999999999999999999999997

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.7e-47  Score=375.70  Aligned_cols=262  Identities=31%  Similarity=0.510  Sum_probs=226.7

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      ++|.+.+.||+|+||+||+|.++.+|+.||+|++.+...........+..|+.+++.+. ||||+++++++.+.+.+|+|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~-~~~i~~~~~~~~~~~~~~lv   79 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN-SPWIPQLQYAFQDKDNLYLV   79 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceeeEEecCCeEEEE
Confidence            57999999999999999999999999999999998765444456677889999999985 99999999999999999999


Q ss_pred             EeecCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC
Q 014733          120 MELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ  198 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~  198 (419)
                      |||+++++|.+++.+. +.+++..++.++.||+.||.|||+.+|+||||||+|||+   +.++.+||+|||++.......
T Consensus        80 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll---~~~~~~kL~Dfg~a~~~~~~~  156 (330)
T cd05601          80 MEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLI---DRTGHIKLADFGSAARLTANK  156 (330)
T ss_pred             ECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEE---CCCCCEEeccCCCCeECCCCC
Confidence            9999999999999876 679999999999999999999999999999999999999   567899999999998765433


Q ss_pred             cc--ccccCCCccCCccccc------C-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCC
Q 014733          199 NL--HGTVGSPFYIAPEVLA------G-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHI  269 (419)
Q Consensus       199 ~~--~~~~gt~~y~aPE~l~------~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  269 (419)
                      ..  ....||+.|+|||++.      + .++.++|||||||++|+|++|+.||......+.+..+..............+
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  236 (330)
T cd05601         157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKV  236 (330)
T ss_pred             ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCC
Confidence            22  2347899999999985      2 3789999999999999999999999988887777777654322222222368


Q ss_pred             CHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchhh
Q 014733          270 SASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQV  306 (419)
Q Consensus       270 s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~~  306 (419)
                      +.++.+||.+||+ ||.+|||+.+++.||||......
T Consensus       237 ~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~~  272 (330)
T cd05601         237 SSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDWN  272 (330)
T ss_pred             CHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCHH
Confidence            9999999999998 99999999999999999876543

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=8.3e-48  Score=382.63  Aligned_cols=262  Identities=32%  Similarity=0.523  Sum_probs=226.5

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      ++|++++.||+|+||+||+|.++.+++.||+|++.+...........+.+|+.++..+. ||||+++++.+.+.+.+|+|
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~~~~lv   79 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEAD-GAWVVKMFYSFQDKRNLYLI   79 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCEEEEE
Confidence            57999999999999999999999999999999997654444556778899999999995 99999999999999999999


Q ss_pred             EeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC-
Q 014733          120 MELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ-  198 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~-  198 (419)
                      |||++||+|.+++...+.+++..++.++.|++.||+|||+.||+||||||+|||+   +.++.+||+|||++....... 
T Consensus        80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli---~~~~~vkL~DfG~~~~~~~~~~  156 (360)
T cd05627          80 MEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLL---DAKGHVKLSDFGLCTGLKKAHR  156 (360)
T ss_pred             EeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE---CCCCCEEEeeccCCcccccccc
Confidence            9999999999999888889999999999999999999999999999999999999   567899999999987542210 


Q ss_pred             -----------------------------------ccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCC
Q 014733          199 -----------------------------------NLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPF  242 (419)
Q Consensus       199 -----------------------------------~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf  242 (419)
                                                         .....+||+.|+|||++.+. ++.++|||||||++|+|++|++||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf  236 (360)
T cd05627         157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF  236 (360)
T ss_pred             cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence                                               01234799999999998764 999999999999999999999999


Q ss_pred             CCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCC---CHHHHHhccccccchhh
Q 014733          243 WGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRL---TAAEVLAHSWMEECEQV  306 (419)
Q Consensus       243 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp---s~~eil~hp~~~~~~~~  306 (419)
                      .+.+..+....+..............++.+++++|.+|+. ||.+|+   ++.++++||||+...+.
T Consensus       237 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~~~~  302 (360)
T cd05627         237 CSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGVDWG  302 (360)
T ss_pred             CCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCCCHH
Confidence            9988888888877644333222223589999999999874 999998   58999999999987553

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.9e-47  Score=381.64  Aligned_cols=266  Identities=28%  Similarity=0.445  Sum_probs=229.1

Q ss_pred             ccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCC
Q 014733           35 ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEED  114 (419)
Q Consensus        35 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~  114 (419)
                      ...-.++|++.+.||+|+||.||+|.++.+++.||+|++.+...........+.+|+.+++.+. ||||+++++++.+.+
T Consensus        38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~-h~~iv~~~~~~~~~~  116 (370)
T cd05596          38 LRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHAN-SEWIVQLHYAFQDDK  116 (370)
T ss_pred             CCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCcceEEEEEecCC
Confidence            3344579999999999999999999999999999999997654444445566888999999995 999999999999999


Q ss_pred             EEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeee
Q 014733          115 YVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI  194 (419)
Q Consensus       115 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~  194 (419)
                      .+|+||||++||+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++...
T Consensus       117 ~~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl---~~~~~~kL~DfG~~~~~  192 (370)
T cd05596         117 YLYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKM  192 (370)
T ss_pred             EEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---cCCCCEEEEeccceeec
Confidence            99999999999999998865 568999999999999999999999999999999999999   56789999999999876


Q ss_pred             ccCCc--cccccCCCccCCcccccC-----CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCC
Q 014733          195 KAGQN--LHGTVGSPFYIAPEVLAG-----GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWD  267 (419)
Q Consensus       195 ~~~~~--~~~~~gt~~y~aPE~l~~-----~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  267 (419)
                      .....  ....+||+.|+|||++.+     .++.++|||||||++|+|++|++||.+......+..+.............
T Consensus       193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  272 (370)
T cd05596         193 DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDI  272 (370)
T ss_pred             cCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcC
Confidence            43321  234579999999999864     27899999999999999999999999988888888887654333333334


Q ss_pred             CCCHHHHHHHHhhhhcCCCC--CCCHHHHHhccccccchh
Q 014733          268 HISASARDLIMGMLRVDPST--RLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       268 ~~s~~l~~li~~~L~~dP~~--Rps~~eil~hp~~~~~~~  305 (419)
                      .+|.++++||.+||+.+|.+  |+|++++++||||+...+
T Consensus       273 ~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~  312 (370)
T cd05596         273 EISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQW  312 (370)
T ss_pred             CCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCCh
Confidence            68999999999999999998  999999999999987543

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=2.3e-47  Score=375.04  Aligned_cols=258  Identities=31%  Similarity=0.513  Sum_probs=217.8

Q ss_pred             CeeeeeeecccCceEEEEEEec---CCCcEEEEEEeccCccC-CHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEE
Q 014733           41 RYVLGKQLGWGQFGVIRECSDK---FTGEVLACKSIAKDRLV-TVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYV  116 (419)
Q Consensus        41 ~y~i~~~LG~G~~g~V~~a~~~---~~g~~vaiK~i~~~~~~-~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~  116 (419)
                      +|++++.||+|+||+||++++.   .+++.||+|++.+.... .....+.+..|+.+++.+++||||+++++++.+++.+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            5899999999999999998864   57899999999754322 2234567889999999997799999999999999999


Q ss_pred             EEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeecc
Q 014733          117 HLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA  196 (419)
Q Consensus       117 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~  196 (419)
                      ++||||+++|+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++.....
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili---~~~~~~kl~DfG~~~~~~~  157 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILL---DSEGHVVLTDFGLSKEFLS  157 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEE---CCCCCEEEeeCcCCccccc
Confidence            9999999999999999887889999999999999999999999999999999999999   5677999999999986533


Q ss_pred             CC--ccccccCCCccCCcccccCC--CCCchhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHhcCCCCCCCCCCC
Q 014733          197 GQ--NLHGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGK----TKSKIFDAVRAADLRFPSDPWDH  268 (419)
Q Consensus       197 ~~--~~~~~~gt~~y~aPE~l~~~--~s~~sDvwSlGvil~elltG~~Pf~~~----~~~~~~~~i~~~~~~~~~~~~~~  268 (419)
                      ..  .....+||+.|+|||++.+.  ++.++|||||||++|+|++|+.||...    ........+......+    +..
T Consensus       158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~----~~~  233 (332)
T cd05614         158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPF----PSF  233 (332)
T ss_pred             cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCC----CCC
Confidence            22  22345799999999998763  788999999999999999999999643    2333444444433333    246


Q ss_pred             CCHHHHHHHHhhhhcCCCCCC-----CHHHHHhccccccchh
Q 014733          269 ISASARDLIMGMLRVDPSTRL-----TAAEVLAHSWMEECEQ  305 (419)
Q Consensus       269 ~s~~l~~li~~~L~~dP~~Rp-----s~~eil~hp~~~~~~~  305 (419)
                      ++..+.++|.+||+.||++||     ++.++++||||+....
T Consensus       234 ~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~  275 (332)
T cd05614         234 IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDW  275 (332)
T ss_pred             CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence            899999999999999999999     8999999999987543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.2e-48  Score=360.31  Aligned_cols=262  Identities=31%  Similarity=0.445  Sum_probs=221.3

Q ss_pred             ccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEe--
Q 014733           35 ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEE--  112 (419)
Q Consensus        35 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~--  112 (419)
                      ..+--+.|+.+.+|++|.||+||+|+++.+++.||+|.++.+....--.+ .-.+||++|.+++ |||||.+.++..-  
T Consensus        71 gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPI-tsLREIniLl~~~-H~NIV~vkEVVvG~~  148 (419)
T KOG0663|consen   71 GCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPI-TSLREINILLKAR-HPNIVEVKEVVVGSN  148 (419)
T ss_pred             CcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcc-hhHHHHHHHHhcC-CCCeeeeEEEEeccc
Confidence            34445689999999999999999999999999999999987653211112 2456999999996 9999999999864  


Q ss_pred             CCEEEEEEeecCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccce
Q 014733          113 EDYVHLLMELCAGGELFHRLEKYG-RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA  191 (419)
Q Consensus       113 ~~~~~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla  191 (419)
                      -+.+|||||||+ -+|..+++.-+ +|...+++.+..|++.||+|||.+.|+||||||+|+|+   ...|.+||+|||+|
T Consensus       149 ~d~iy~VMe~~E-hDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm---~~~G~lKiaDFGLA  224 (419)
T KOG0663|consen  149 MDKIYIVMEYVE-HDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLL---SHKGILKIADFGLA  224 (419)
T ss_pred             cceeeeeHHHHH-hhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheee---ccCCcEEecccchh
Confidence            457999999995 58999988765 79999999999999999999999999999999999999   67889999999999


Q ss_pred             eeeccC-CccccccCCCccCCcccccCC--CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC--------
Q 014733          192 TYIKAG-QNLHGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLR--------  260 (419)
Q Consensus       192 ~~~~~~-~~~~~~~gt~~y~aPE~l~~~--~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~--------  260 (419)
                      +.++.. ......+.|.+|+|||.+.|.  |+.+.|+||+|||+.||+++++.|.|....+...+|...-..        
T Consensus       225 R~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg  304 (419)
T KOG0663|consen  225 REYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPG  304 (419)
T ss_pred             hhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCC
Confidence            988765 334556889999999999884  999999999999999999999999999988888777443211        


Q ss_pred             -----------CCCCC---------CCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhcccccc
Q 014733          261 -----------FPSDP---------WDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE  302 (419)
Q Consensus       261 -----------~~~~~---------~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~  302 (419)
                                 ++..+         +..+++...+|+..+|..||.+|.|+.|.|+|+||.+
T Consensus       305 ~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e  366 (419)
T KOG0663|consen  305 YSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRE  366 (419)
T ss_pred             ccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccccccc
Confidence                       11111         1125688899999999999999999999999999986

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.9e-47  Score=374.18  Aligned_cols=253  Identities=30%  Similarity=0.539  Sum_probs=224.6

Q ss_pred             eeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEEeecCC
Q 014733           46 KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAG  125 (419)
Q Consensus        46 ~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~g  125 (419)
                      +.||+|+||.||+|.++.+++.||+|++.+.........+.+..|..++..+.+||||+++++++.+.+.+|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999999999999999998765545556677888999998876799999999999999999999999999


Q ss_pred             CChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccC-Ccccccc
Q 014733          126 GELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG-QNLHGTV  204 (419)
Q Consensus       126 gsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~-~~~~~~~  204 (419)
                      ++|...+...+.+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++...... ......+
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~  157 (321)
T cd05591          81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILL---DAEGHCKLADFGMCKEGILNGVTTTTFC  157 (321)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEeecccceecccCCccccccc
Confidence            9999999888889999999999999999999999999999999999999   56789999999998754322 2234457


Q ss_pred             CCCccCCcccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhc
Q 014733          205 GSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRV  283 (419)
Q Consensus       205 gt~~y~aPE~l~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~  283 (419)
                      ||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..+..+.+......++.    .++.++.++|.+||+.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~ll~~~L~~  233 (321)
T cd05591         158 GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPV----WLSKEAVSILKAFMTK  233 (321)
T ss_pred             cCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHHHHHhcc
Confidence            9999999999876 4899999999999999999999999999998988888877655443    5789999999999999


Q ss_pred             CCCCCC-------CHHHHHhccccccchh
Q 014733          284 DPSTRL-------TAAEVLAHSWMEECEQ  305 (419)
Q Consensus       284 dP~~Rp-------s~~eil~hp~~~~~~~  305 (419)
                      ||++|+       ++.++++||||....+
T Consensus       234 dp~~R~~~~~~~~~~~~~~~hp~~~~~~~  262 (321)
T cd05591         234 NPNKRLGCVASQGGEDAIKQHPFFKEIDW  262 (321)
T ss_pred             CHHHcCCCCCCCCCHHHHhcCCccCCCCH
Confidence            999999       9999999999987654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=2.7e-47  Score=366.02  Aligned_cols=256  Identities=29%  Similarity=0.494  Sum_probs=214.1

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      ++|++.+.||+|+||.||+|+++.+++.+|+|++..... .....+.+.+|+.+++++. ||||+++++++.+.+.+|+|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv   78 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLK-QENIVELKEAFRRRGKLYLV   78 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCC-CccccchhhhEecCCEEEEE
Confidence            579999999999999999999999999999999976532 2344567889999999996 99999999999999999999


Q ss_pred             EeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC-
Q 014733          120 MELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ-  198 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~-  198 (419)
                      |||++++.+..+......+++..++.++.|++.||.|||+.+|+||||||+||++   +.++.+||+|||++....... 
T Consensus        79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~  155 (287)
T cd07848          79 FEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLI---SHNDVLKLCDFGFARNLSEGSN  155 (287)
T ss_pred             EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEEeeccCccccccccc
Confidence            9999988776665555679999999999999999999999999999999999999   567789999999998764332 


Q ss_pred             -ccccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC----------------
Q 014733          199 -NLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLR----------------  260 (419)
Q Consensus       199 -~~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~----------------  260 (419)
                       ......||+.|+|||++.+ .++.++|+|||||++|+|++|++||.+.+..+....+......                
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07848         156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH  235 (287)
T ss_pred             ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence             2233578999999999876 4899999999999999999999999877655444333221111                


Q ss_pred             ---CCC---------CCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhcccc
Q 014733          261 ---FPS---------DPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWM  300 (419)
Q Consensus       261 ---~~~---------~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~  300 (419)
                         .+.         ..+..+|.++.+||++||++||++|||++++++||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence               110         0112478899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=2.4e-47  Score=374.84  Aligned_cols=253  Identities=27%  Similarity=0.538  Sum_probs=218.0

Q ss_pred             eeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEEeecCC
Q 014733           46 KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAG  125 (419)
Q Consensus        46 ~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~g  125 (419)
                      +.||+|+||.||+|.++.+++.||+|++.+...........+..|..+++++.+||||+++++++.+.+.+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999999999999999998765545556777899999999997799999999999999999999999999


Q ss_pred             CChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeee-ccCCcccccc
Q 014733          126 GELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI-KAGQNLHGTV  204 (419)
Q Consensus       126 gsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~-~~~~~~~~~~  204 (419)
                      |+|..++...+++++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++... .........+
T Consensus        81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~  157 (329)
T cd05588          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLL---DAEGHIKLTDYGMCKEGIRPGDTTSTFC  157 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEECcCccccccccCCCcccccc
Confidence            9999999888889999999999999999999999999999999999999   56778999999998753 2233334568


Q ss_pred             CCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCC---------CHHHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 014733          205 GSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGK---------TKSKIFDAVRAADLRFPSDPWDHISASAR  274 (419)
Q Consensus       205 gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~---------~~~~~~~~i~~~~~~~~~~~~~~~s~~l~  274 (419)
                      ||+.|+|||++.+. ++.++|+|||||++|+|++|+.||...         ......+.+......+|    ..++.++.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p----~~~~~~~~  233 (329)
T cd05588         158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIP----RSLSVKAS  233 (329)
T ss_pred             CCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCC----CCCCHHHH
Confidence            99999999998874 899999999999999999999999531         12234455555544444    36889999


Q ss_pred             HHHHhhhhcCCCCCCC------HHHHHhccccccchh
Q 014733          275 DLIMGMLRVDPSTRLT------AAEVLAHSWMEECEQ  305 (419)
Q Consensus       275 ~li~~~L~~dP~~Rps------~~eil~hp~~~~~~~  305 (419)
                      ++|.+||+.||.+|++      +.++++||||....+
T Consensus       234 ~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~  270 (329)
T cd05588         234 SVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDW  270 (329)
T ss_pred             HHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence            9999999999999987      799999999987654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.2e-46  Score=368.03  Aligned_cols=253  Identities=30%  Similarity=0.551  Sum_probs=220.2

Q ss_pred             eeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEEeecCC
Q 014733           46 KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAG  125 (419)
Q Consensus        46 ~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~g  125 (419)
                      +.||+|+||+||+|.++.+++.||+|++.+..............|..++..+.+||||+++++++.+.+.+++||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999999999999999998654333345566777888888765699999999999999999999999999


Q ss_pred             CChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeecc-CCcccccc
Q 014733          126 GELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA-GQNLHGTV  204 (419)
Q Consensus       126 gsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~-~~~~~~~~  204 (419)
                      |+|..++.....+++.++..++.|++.||+|||+.||+||||||+|||+   +.++.+||+|||++..... .......+
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (316)
T cd05619          81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILL---DTDGHIKIADFGMCKENMLGDAKTCTFC  157 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE---CCCCCEEEccCCcceECCCCCCceeeec
Confidence            9999999887889999999999999999999999999999999999999   5677899999999875322 22234567


Q ss_pred             CCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhc
Q 014733          205 GSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRV  283 (419)
Q Consensus       205 gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~  283 (419)
                      ||+.|+|||++.+. ++.++||||+||++|+|++|+.||.+.+..+..+.+......++.    .++.+++++|.+||+.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~li~~~l~~  233 (316)
T cd05619         158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPR----WLTREAKDILVKLFVR  233 (316)
T ss_pred             CCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc----cCCHHHHHHHHHHhcc
Confidence            99999999998774 899999999999999999999999998888888887766544332    5889999999999999


Q ss_pred             CCCCCCCHH-HHHhccccccchh
Q 014733          284 DPSTRLTAA-EVLAHSWMEECEQ  305 (419)
Q Consensus       284 dP~~Rps~~-eil~hp~~~~~~~  305 (419)
                      ||++|+++. ++++||||+....
T Consensus       234 ~P~~R~~~~~~l~~h~~~~~~~~  256 (316)
T cd05619         234 EPERRLGVKGDIRQHPFFREIDW  256 (316)
T ss_pred             CHhhcCCChHHHHcCcccCCCCH
Confidence            999999996 8999999988654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=6.2e-47  Score=369.89  Aligned_cols=253  Identities=32%  Similarity=0.583  Sum_probs=220.3

Q ss_pred             eeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEEeecCC
Q 014733           46 KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAG  125 (419)
Q Consensus        46 ~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~g  125 (419)
                      +.||+|+||+||+|.++.+++.||+|++.+.........+.+..|..++..+.+||||+++++++.+.+.+|+||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999999999999999998654444455666777888887765799999999999999999999999999


Q ss_pred             CChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccC-Ccccccc
Q 014733          126 GELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG-QNLHGTV  204 (419)
Q Consensus       126 gsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~-~~~~~~~  204 (419)
                      |+|..++...+.+++..+..++.||+.||+|||+.+|+||||||+|||+   +.++.+||+|||++...... ......+
T Consensus        81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill---~~~~~~kL~Dfg~a~~~~~~~~~~~~~~  157 (316)
T cd05592          81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLL---DKDGHIKIADFGMCKENMNGEGKASTFC  157 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEE---CCCCCEEEccCcCCeECCCCCCcccccc
Confidence            9999999888889999999999999999999999999999999999999   56778999999999864332 2234457


Q ss_pred             CCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhc
Q 014733          205 GSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRV  283 (419)
Q Consensus       205 gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~  283 (419)
                      ||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+.+..++...+......++    ..++.++.++|.+||+.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~ll~~~l~~  233 (316)
T cd05592         158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFP----RWISKEAKDCLSKLFER  233 (316)
T ss_pred             CCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHccC
Confidence            99999999998774 89999999999999999999999999888888888766544333    35889999999999999


Q ss_pred             CCCCCCCH-HHHHhccccccchh
Q 014733          284 DPSTRLTA-AEVLAHSWMEECEQ  305 (419)
Q Consensus       284 dP~~Rps~-~eil~hp~~~~~~~  305 (419)
                      ||++||++ .++++||||....+
T Consensus       234 ~P~~R~~~~~~l~~h~~~~~~~~  256 (316)
T cd05592         234 DPTKRLGVDGDIRQHPFFRGIDW  256 (316)
T ss_pred             CHHHcCCChHHHHcCcccCCCCH
Confidence            99999986 48889999987654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=5.7e-47  Score=371.24  Aligned_cols=256  Identities=33%  Similarity=0.564  Sum_probs=222.8

Q ss_pred             eeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHcc--CCCCceeeeEEEEeCCEEEEE
Q 014733           42 YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLS--GHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        42 y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~--~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      |++.+.||+|+||.||+|.++.+|+.||+|++.+.........+.+..|+.++..++  +||||+++++++.+.+.+|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            788999999999999999999999999999998664444455677778877765332  499999999999999999999


Q ss_pred             EeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeecc-CC
Q 014733          120 MELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA-GQ  198 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~-~~  198 (419)
                      |||++|++|...+.. +.+++.++..++.||+.||+|||+.||+||||||+|||+   +.++.+||+|||++..... ..
T Consensus        81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~~  156 (324)
T cd05589          81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLL---DTEGFVKIADFGLCKEGMGFGD  156 (324)
T ss_pred             EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE---CCCCcEEeCcccCCccCCCCCC
Confidence            999999999988865 679999999999999999999999999999999999999   5678999999999875332 22


Q ss_pred             ccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHH
Q 014733          199 NLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLI  277 (419)
Q Consensus       199 ~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li  277 (419)
                      .....+||+.|+|||++.+. ++.++|+|||||++|+|++|+.||.+.+..+....+......++.    .++.++.++|
T Consensus       157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li  232 (324)
T cd05589         157 RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPR----FLSREAISIM  232 (324)
T ss_pred             cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHHHHHHH
Confidence            23446799999999998774 899999999999999999999999998888888888777665543    6899999999


Q ss_pred             HhhhhcCCCCCC-----CHHHHHhccccccchh
Q 014733          278 MGMLRVDPSTRL-----TAAEVLAHSWMEECEQ  305 (419)
Q Consensus       278 ~~~L~~dP~~Rp-----s~~eil~hp~~~~~~~  305 (419)
                      .+||+.||.+||     ++.++++||||+....
T Consensus       233 ~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~  265 (324)
T cd05589         233 RRLLRRNPERRLGSGEKDAEDVKKQPFFRDINW  265 (324)
T ss_pred             HHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCH
Confidence            999999999999     7999999999987654

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-48  Score=409.68  Aligned_cols=269  Identities=31%  Similarity=0.530  Sum_probs=241.9

Q ss_pred             chhhccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEE
Q 014733           31 DATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVY  110 (419)
Q Consensus        31 ~~~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~  110 (419)
                      ...+..--.++|.++++||+|+||.|.+++++.+++.||+|++.+-.+.......-|..|..||..- +.+.|+.++..|
T Consensus        66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~-ns~Wiv~LhyAF  144 (1317)
T KOG0612|consen   66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFG-NSEWIVQLHYAF  144 (1317)
T ss_pred             HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcC-CcHHHHHHHHHh
Confidence            3444555678999999999999999999999999999999999986666666777899999999876 599999999999


Q ss_pred             EeCCEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccc
Q 014733          111 EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGL  190 (419)
Q Consensus       111 ~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgl  190 (419)
                      +|++++|+||||++||+|..++.+.+++++..++.++..|+.||+-||+.|.|||||||+||||   +..|+|||+|||.
T Consensus       145 QD~~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLl---d~~GHikLADFGs  221 (1317)
T KOG0612|consen  145 QDERYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLL---DKSGHIKLADFGS  221 (1317)
T ss_pred             cCccceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEe---cccCcEeeccchh
Confidence            9999999999999999999999999999999999999999999999999999999999999999   6789999999999


Q ss_pred             eeeeccCC-c-cccccCCCccCCccccc------CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--CCC
Q 014733          191 ATYIKAGQ-N-LHGTVGSPFYIAPEVLA------GGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAA--DLR  260 (419)
Q Consensus       191 a~~~~~~~-~-~~~~~gt~~y~aPE~l~------~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~  260 (419)
                      +..+..+. . ....+|||.|++||++.      +.|++.+|+||+||++|||+.|..||...+--+.+.+|..-  .+.
T Consensus       222 Clkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~  301 (1317)
T KOG0612|consen  222 CLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLS  301 (1317)
T ss_pred             HHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcC
Confidence            88776433 2 24458999999999984      23899999999999999999999999999999999999776  677


Q ss_pred             CCCCCCCCCCHHHHHHHHhhhhcCCCCCCC---HHHHHhccccccchhh
Q 014733          261 FPSDPWDHISASARDLIMGMLRVDPSTRLT---AAEVLAHSWMEECEQV  306 (419)
Q Consensus       261 ~~~~~~~~~s~~l~~li~~~L~~dP~~Rps---~~eil~hp~~~~~~~~  306 (419)
                      ||...  .+|+++++||+++++ +|+.|+.   ++++..||||.++.|.
T Consensus       302 FP~~~--~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~  347 (1317)
T KOG0612|consen  302 FPDET--DVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWD  347 (1317)
T ss_pred             CCccc--ccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChh
Confidence            77443  699999999999999 9999998   9999999999999874

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=4.7e-47  Score=370.96  Aligned_cols=253  Identities=32%  Similarity=0.585  Sum_probs=224.2

Q ss_pred             eeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEEeecCC
Q 014733           46 KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAG  125 (419)
Q Consensus        46 ~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~g  125 (419)
                      +.||+|+||+||+|.++.+++.||+|++.+...........+..|+.+++.+.+||||+++++++.+.+.+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999999999999999998765544556777888999999886799999999999999999999999999


Q ss_pred             CChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeecc-CCcccccc
Q 014733          126 GELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA-GQNLHGTV  204 (419)
Q Consensus       126 gsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~-~~~~~~~~  204 (419)
                      ++|..++...+.+++..+..++.||+.||.|||+.+|+||||||+|||+   +.++.+||+|||++..... .......+
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (318)
T cd05570          81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLL---DSEGHIKIADFGMCKEGILGGVTTSTFC  157 (318)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEE---CCCCcEEecccCCCeecCcCCCccccee
Confidence            9999999888889999999999999999999999999999999999999   5677899999999875322 22234457


Q ss_pred             CCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhc
Q 014733          205 GSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRV  283 (419)
Q Consensus       205 gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~  283 (419)
                      ||+.|+|||++.+. ++.++|+|||||++|+|++|+.||.+....+....+......++.    .++.++.+||.+||+.
T Consensus       158 g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~li~~~l~~  233 (318)
T cd05570         158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPR----WLSKEAKSILKSFLTK  233 (318)
T ss_pred             cCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC----cCCHHHHHHHHHHccC
Confidence            99999999998774 899999999999999999999999988888888888776655443    6889999999999999


Q ss_pred             CCCCCCCH-----HHHHhccccccchh
Q 014733          284 DPSTRLTA-----AEVLAHSWMEECEQ  305 (419)
Q Consensus       284 dP~~Rps~-----~eil~hp~~~~~~~  305 (419)
                      ||++||++     .+++.||||+...+
T Consensus       234 dP~~R~s~~~~~~~~ll~~~~~~~~~~  260 (318)
T cd05570         234 NPEKRLGCLPTGEQDIKGHPFFREIDW  260 (318)
T ss_pred             CHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence            99999999     99999999987644

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=5.4e-47  Score=378.38  Aligned_cols=265  Identities=27%  Similarity=0.441  Sum_probs=227.2

Q ss_pred             hccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeC
Q 014733           34 QISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEE  113 (419)
Q Consensus        34 ~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~  113 (419)
                      ......++|++.+.||+|+||.||+|.++.+++.+|+|++.+...........+.+|+.+++.+. ||||+++++++.++
T Consensus        37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~-hp~iv~~~~~~~~~  115 (370)
T cd05621          37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFCAFQDD  115 (370)
T ss_pred             hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCEeeEEEEEEcC
Confidence            44455689999999999999999999999999999999997654444455667889999999995 99999999999999


Q ss_pred             CEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceee
Q 014733          114 DYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATY  193 (419)
Q Consensus       114 ~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~  193 (419)
                      +.+|+||||++||+|.+++.. ..+++..+..++.||+.||+|||+++|+||||||+|||+   +.++.+||+|||++..
T Consensus       116 ~~~~lv~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl---~~~~~~kL~DFG~a~~  191 (370)
T cd05621         116 KYLYMVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLL---DKHGHLKLADFGTCMK  191 (370)
T ss_pred             CEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---CCCCCEEEEeccccee
Confidence            999999999999999999876 468999999999999999999999999999999999999   5678999999999987


Q ss_pred             eccCCc--cccccCCCccCCcccccC-----CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 014733          194 IKAGQN--LHGTVGSPFYIAPEVLAG-----GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW  266 (419)
Q Consensus       194 ~~~~~~--~~~~~gt~~y~aPE~l~~-----~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  266 (419)
                      ......  ....+||+.|+|||++.+     .++.++|+||+||++|+|++|+.||.+.+.......+............
T Consensus       192 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~  271 (370)
T cd05621         192 MDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPED  271 (370)
T ss_pred             cccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCc
Confidence            643322  234579999999999864     2788999999999999999999999998888888887765433333333


Q ss_pred             CCCCHHHHHHHHhhhhcCCCC--CCCHHHHHhccccccc
Q 014733          267 DHISASARDLIMGMLRVDPST--RLTAAEVLAHSWMEEC  303 (419)
Q Consensus       267 ~~~s~~l~~li~~~L~~dP~~--Rps~~eil~hp~~~~~  303 (419)
                      ..++..++++|..||+.++.+  |+++.++++||||+..
T Consensus       272 ~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~  310 (370)
T cd05621         272 VEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND  310 (370)
T ss_pred             ccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence            468999999999999865544  8999999999999864

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-46  Score=367.69  Aligned_cols=262  Identities=29%  Similarity=0.506  Sum_probs=222.7

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      ++|++++.||+|+||+||++.++.+++.||+|++.+.........+.+.+|+.+++.+. |+||+++++++.+++.+|+|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv   79 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGD-RRWITNLHYAFQDENNLYLV   79 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCCCceEEEEecCCeEEEE
Confidence            57999999999999999999999999999999997654444455677889999999995 99999999999999999999


Q ss_pred             EeecCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC
Q 014733          120 MELCAGGELFHRLEK-YGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ  198 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~  198 (419)
                      |||++|++|.+++.+ ...+++..++.++.||+.||+|||+.+|+||||||+|||+   +.++.+||+|||++.......
T Consensus        80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~  156 (331)
T cd05597          80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLL---DKNGHIRLADFGSCLRLLADG  156 (331)
T ss_pred             EecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEE---CCCCCEEEEECCceeecCCCC
Confidence            999999999999976 3569999999999999999999999999999999999999   567889999999987654433


Q ss_pred             cc--ccccCCCccCCcccccC------CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC--CCCCCCCCC
Q 014733          199 NL--HGTVGSPFYIAPEVLAG------GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADL--RFPSDPWDH  268 (419)
Q Consensus       199 ~~--~~~~gt~~y~aPE~l~~------~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~  268 (419)
                      ..  ...+||+.|+|||++.+      .++.++||||+||++|+|++|+.||.+....+....+.....  .++.. ...
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~-~~~  235 (331)
T cd05597         157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPD-VTD  235 (331)
T ss_pred             CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCc-cCC
Confidence            22  22469999999999862      378899999999999999999999998887777777755432  22222 235


Q ss_pred             CCHHHHHHHHhhhhcCCCC--CCCHHHHHhccccccchhh
Q 014733          269 ISASARDLIMGMLRVDPST--RLTAAEVLAHSWMEECEQV  306 (419)
Q Consensus       269 ~s~~l~~li~~~L~~dP~~--Rps~~eil~hp~~~~~~~~  306 (419)
                      ++.+++++|++||+.++++  |+++.++++||||....+.
T Consensus       236 ~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~~  275 (331)
T cd05597         236 VSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWD  275 (331)
T ss_pred             CCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCHH
Confidence            8999999999999765544  8899999999999876543

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.1e-46  Score=365.36  Aligned_cols=259  Identities=26%  Similarity=0.440  Sum_probs=209.8

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEE
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHL  118 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~l  118 (419)
                      .++|++.+.||+|+||+||+|.++.+++.||+|++.....  ......+.+|+.+++.+. ||||+++++++.+....++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~l   80 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE--EGTPFTAIREASLLKGLK-HANIVLLHDIIHTKETLTL   80 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc--cccchhHHHHHHHHhhCC-CCCcCeEEEEEecCCeEEE
Confidence            4789999999999999999999999999999999875432  123345678999999996 9999999999999999999


Q ss_pred             EEeecCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccC
Q 014733          119 LMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG  197 (419)
Q Consensus       119 V~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~  197 (419)
                      ||||+. ++|.+++... +.+++..++.++.||+.||+|||+.+|+||||||+|||+   +.++.+||+|||++......
T Consensus        81 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~  156 (303)
T cd07869          81 VFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLI---SDTGELKLADFGLARAKSVP  156 (303)
T ss_pred             EEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECCCCcceeccCC
Confidence            999995 6777777654 568999999999999999999999999999999999999   56778999999998754322


Q ss_pred             -CccccccCCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhcCCC-------------
Q 014733          198 -QNLHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTK-SKIFDAVRAADLR-------------  260 (419)
Q Consensus       198 -~~~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~-~~~~~~i~~~~~~-------------  260 (419)
                       .......||+.|+|||++.+  .++.++||||+||++|+|++|..||.+... .+..+.+......             
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (303)
T cd07869         157 SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP  236 (303)
T ss_pred             CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcc
Confidence             22344678999999999865  378999999999999999999999976432 2222222111000             


Q ss_pred             -CCCC--------------CCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccch
Q 014733          261 -FPSD--------------PWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECE  304 (419)
Q Consensus       261 -~~~~--------------~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~  304 (419)
                       +...              ....++.++++||.+||+.||++|||+.|+++||||+...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~  295 (303)
T cd07869         237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP  295 (303)
T ss_pred             ccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence             0000              0012457899999999999999999999999999998754

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1e-46  Score=376.62  Aligned_cols=274  Identities=28%  Similarity=0.441  Sum_probs=232.4

Q ss_pred             cccccchhhccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCcee
Q 014733           26 TGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD  105 (419)
Q Consensus        26 ~~~~~~~~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~  105 (419)
                      ..++....+...-.++|++.+.||+|+||.||+|.++.+++.+|+|++.+...........+.+|+.+++.+. ||||++
T Consensus        29 ~~~~~~~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~-hp~iv~  107 (371)
T cd05622          29 KDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQ  107 (371)
T ss_pred             hhHhhHHhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCCe
Confidence            3445556666666799999999999999999999999999999999997654444455667888999999995 999999


Q ss_pred             eeEEEEeCCEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEE
Q 014733          106 LKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKL  185 (419)
Q Consensus       106 l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL  185 (419)
                      +++++.+.+.+|+||||++||+|.+++.. ..+++..+..++.||+.||+|||+.||+||||||+|||+   +.++.+||
T Consensus       108 ~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll---~~~~~ikL  183 (371)
T cd05622         108 LFYAFQDDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKL  183 (371)
T ss_pred             EEEEEEcCCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEE---CCCCCEEE
Confidence            99999999999999999999999999876 568999999999999999999999999999999999999   56789999


Q ss_pred             eeccceeeeccCCc--cccccCCCccCCcccccC-----CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC
Q 014733          186 ADFGLATYIKAGQN--LHGTVGSPFYIAPEVLAG-----GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAAD  258 (419)
Q Consensus       186 ~DFgla~~~~~~~~--~~~~~gt~~y~aPE~l~~-----~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~  258 (419)
                      +|||++........  ....+||+.|+|||++.+     .++.++|||||||++|+|++|..||.+.+....+..+....
T Consensus       184 ~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~  263 (371)
T cd05622         184 ADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK  263 (371)
T ss_pred             EeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Confidence            99999987643322  234579999999999864     27899999999999999999999999988888888887654


Q ss_pred             CCCCCCCCCCCCHHHHHHHHhhhhcCCCC--CCCHHHHHhccccccch
Q 014733          259 LRFPSDPWDHISASARDLIMGMLRVDPST--RLTAAEVLAHSWMEECE  304 (419)
Q Consensus       259 ~~~~~~~~~~~s~~l~~li~~~L~~dP~~--Rps~~eil~hp~~~~~~  304 (419)
                      ..........++.+++++|..||+.++.+  |+++.++++|+||++..
T Consensus       264 ~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~  311 (371)
T cd05622         264 NSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ  311 (371)
T ss_pred             CcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCC
Confidence            33333333479999999999999844433  78999999999998743

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.9e-46  Score=367.49  Aligned_cols=253  Identities=34%  Similarity=0.570  Sum_probs=219.8

Q ss_pred             eeeecccCceEEEEEEec---CCCcEEEEEEeccCccC-CHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEE
Q 014733           45 GKQLGWGQFGVIRECSDK---FTGEVLACKSIAKDRLV-TVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLM  120 (419)
Q Consensus        45 ~~~LG~G~~g~V~~a~~~---~~g~~vaiK~i~~~~~~-~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~  120 (419)
                      ++.||+|+||.||+|++.   .+++.||+|++.+.... .......+.+|+.+|+.+. ||||+++++++.+++.+|+||
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~~~~~~~~~~~~~lv~   79 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVK-HPFIVDLIYAFQTGGKLYLIL   79 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCC-CCchhceeeEEecCCeEEEEE
Confidence            368999999999999864   57899999999764332 2234566789999999996 999999999999999999999


Q ss_pred             eecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccC-Cc
Q 014733          121 ELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG-QN  199 (419)
Q Consensus       121 E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~-~~  199 (419)
                      ||++|++|.+++...+.+.+..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++...... ..
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~  156 (323)
T cd05584          80 EYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILL---DAQGHVKLTDFGLCKESIHEGTV  156 (323)
T ss_pred             eCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEeeCcCCeecccCCCc
Confidence            999999999999988889999999999999999999999999999999999999   56789999999998754322 22


Q ss_pred             cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHH
Q 014733          200 LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM  278 (419)
Q Consensus       200 ~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~  278 (419)
                      ....+||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+.+..+....+......++.    .+++++.++|.
T Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~  232 (323)
T cd05584         157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPP----YLTPEARDLLK  232 (323)
T ss_pred             ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHHH
Confidence            3345799999999998764 889999999999999999999999998888888888776655443    67899999999


Q ss_pred             hhhhcCCCCCC-----CHHHHHhccccccchh
Q 014733          279 GMLRVDPSTRL-----TAAEVLAHSWMEECEQ  305 (419)
Q Consensus       279 ~~L~~dP~~Rp-----s~~eil~hp~~~~~~~  305 (419)
                      +||++||++||     ++.+++.||||.....
T Consensus       233 ~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~  264 (323)
T cd05584         233 KLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNW  264 (323)
T ss_pred             HHcccCHhHcCCCCCCCHHHHhcCCCcCCCCH
Confidence            99999999999     8999999999987543

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.4e-46  Score=369.42  Aligned_cols=262  Identities=29%  Similarity=0.479  Sum_probs=213.9

Q ss_pred             CeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeC-----CE
Q 014733           41 RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEE-----DY  115 (419)
Q Consensus        41 ~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~-----~~  115 (419)
                      +|++.+.||+|+||.||+|.++.+|..||+|++.... ........+.+|++++++++ ||||+++++++...     ..
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~~~   78 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF-EHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFKD   78 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh-ccchhHHHHHHHHHHHHhCC-CCCEeeecceEeccCCCCCce
Confidence            6999999999999999999999999999999986432 22334567889999999996 99999999988543     35


Q ss_pred             EEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeec
Q 014733          116 VHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIK  195 (419)
Q Consensus       116 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~  195 (419)
                      +|+||||+ +++|.+++.....+++..+..++.||++||.|||+.||+||||||+|||+   +.++.+||+|||++....
T Consensus        79 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kL~Dfg~~~~~~  154 (338)
T cd07859          79 IYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILA---NADCKLKICDFGLARVAF  154 (338)
T ss_pred             EEEEEecC-CCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCcEEEccCccccccc
Confidence            89999999 57899999887889999999999999999999999999999999999999   567899999999997543


Q ss_pred             cCCc----cccccCCCccCCcccccC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-----------
Q 014733          196 AGQN----LHGTVGSPFYIAPEVLAG---GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAA-----------  257 (419)
Q Consensus       196 ~~~~----~~~~~gt~~y~aPE~l~~---~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-----------  257 (419)
                      ....    .....||+.|+|||++.+   .++.++|||||||++|+|++|++||.+.+.......+...           
T Consensus       155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (338)
T cd07859         155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR  234 (338)
T ss_pred             cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            2211    134579999999999864   4899999999999999999999999776544333222110           


Q ss_pred             ----------------CCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchhhhc
Q 014733          258 ----------------DLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQ  308 (419)
Q Consensus       258 ----------------~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~~~~  308 (419)
                                      ........+..+++++.++|.+||+.||++|||+.++++||||+.......
T Consensus       235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~~~  301 (338)
T cd07859         235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVER  301 (338)
T ss_pred             hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCcccc
Confidence                            000011122357889999999999999999999999999999987665443

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1e-46  Score=370.43  Aligned_cols=253  Identities=28%  Similarity=0.532  Sum_probs=217.1

Q ss_pred             eeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEEeecCC
Q 014733           46 KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAG  125 (419)
Q Consensus        46 ~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~g  125 (419)
                      +.||+|+||+||+|.++.+++.+|+|++.+...........+..|+.++.++.+||||+++++++.+.+.+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999999999999999998765445556677889999998886799999999999999999999999999


Q ss_pred             CChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeec-cCCcccccc
Q 014733          126 GELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIK-AGQNLHGTV  204 (419)
Q Consensus       126 gsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~-~~~~~~~~~  204 (419)
                      ++|..++...+.+++..++.++.||+.||+|||+++|+||||||+|||+   +.++.+||+|||++.... ........+
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili---~~~~~~kL~DfG~~~~~~~~~~~~~~~~  157 (329)
T cd05618          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFC  157 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---CCCCCEEEeeCCccccccCCCCcccccc
Confidence            9999999888889999999999999999999999999999999999999   567899999999987532 222334567


Q ss_pred             CCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCC---------CCHHHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 014733          205 GSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWG---------KTKSKIFDAVRAADLRFPSDPWDHISASAR  274 (419)
Q Consensus       205 gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~---------~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~  274 (419)
                      ||+.|+|||++.+. ++.++|+|||||++|+|++|+.||..         .......+.+......+|    ..++.++.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p----~~~~~~~~  233 (329)
T cd05618         158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP----RSLSVKAA  233 (329)
T ss_pred             CCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCC----CCCCHHHH
Confidence            99999999998875 89999999999999999999999952         112234445555544444    36889999


Q ss_pred             HHHHhhhhcCCCCCCC------HHHHHhccccccchh
Q 014733          275 DLIMGMLRVDPSTRLT------AAEVLAHSWMEECEQ  305 (419)
Q Consensus       275 ~li~~~L~~dP~~Rps------~~eil~hp~~~~~~~  305 (419)
                      ++|.+||+.||++|++      +.++++||||+...+
T Consensus       234 ~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~  270 (329)
T cd05618         234 SVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW  270 (329)
T ss_pred             HHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence            9999999999999998      589999999987644

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.5e-46  Score=368.33  Aligned_cols=258  Identities=28%  Similarity=0.529  Sum_probs=227.5

Q ss_pred             CeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEE
Q 014733           41 RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLM  120 (419)
Q Consensus        41 ~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~  120 (419)
                      +|+..+.||+|+||+||+|.++.+|+.||+|++.+.........+.+..|..++..+.+|++|+++++++.+.+.+|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            47889999999999999999999999999999987654444556778889999998876788999999999999999999


Q ss_pred             eecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccC-Cc
Q 014733          121 ELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG-QN  199 (419)
Q Consensus       121 E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~-~~  199 (419)
                      ||++||+|.+++...+.+++.++..++.||+.||+|||+.||+||||||+|||+   +.++.+||+|||++...... ..
T Consensus        81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill---~~~~~ikL~Dfg~~~~~~~~~~~  157 (323)
T cd05615          81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVML---DSEGHIKIADFGMCKEHMVDGVT  157 (323)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEeccccccccCCCCcc
Confidence            999999999999888889999999999999999999999999999999999999   56778999999998754322 22


Q ss_pred             cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHH
Q 014733          200 LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM  278 (419)
Q Consensus       200 ~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~  278 (419)
                      ....+||+.|+|||++.+. ++.++|+||+||++|+|++|+.||.+.......+.+......++.    .++.++.+++.
T Consensus       158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li~  233 (323)
T cd05615         158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK----SLSKEAVSICK  233 (323)
T ss_pred             ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc----cCCHHHHHHHH
Confidence            3345799999999998764 899999999999999999999999998888888888776655443    68899999999


Q ss_pred             hhhhcCCCCCCC-----HHHHHhccccccchh
Q 014733          279 GMLRVDPSTRLT-----AAEVLAHSWMEECEQ  305 (419)
Q Consensus       279 ~~L~~dP~~Rps-----~~eil~hp~~~~~~~  305 (419)
                      +||+.||.+|++     ..++++||||+...+
T Consensus       234 ~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~  265 (323)
T cd05615         234 GLMTKHPSKRLGCGPEGERDIREHAFFRRIDW  265 (323)
T ss_pred             HHcccCHhhCCCCCCCCHHHHhcCcccCCCCH
Confidence            999999999997     579999999998654

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-46  Score=360.47  Aligned_cols=261  Identities=30%  Similarity=0.477  Sum_probs=220.9

Q ss_pred             CeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEE
Q 014733           41 RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLM  120 (419)
Q Consensus        41 ~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~  120 (419)
                      .|++.+.||+|+||+||++.+..+++.||+|++.............+.+|+.+++++. ||||+++++++.+.+.+++||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~   79 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN-SRFVVSLAYAYETKDALCLVL   79 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcC-CCCEeeeeeeecCCCeEEEEE
Confidence            4889999999999999999999999999999997654433334456778999999995 999999999999999999999


Q ss_pred             eecCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC
Q 014733          121 ELCAGGELFHRLEKY--GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ  198 (419)
Q Consensus       121 E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~  198 (419)
                      ||+++++|..++...  ..+++..+..++.|++.||.|||+.+|+||||||+||++   ++++.++|+|||++.......
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05605          80 TLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILL---DDYGHIRISDLGLAVEIPEGE  156 (285)
T ss_pred             eccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEE---CCCCCEEEeeCCCceecCCCC
Confidence            999999999887653  358999999999999999999999999999999999999   567889999999998765544


Q ss_pred             ccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHH
Q 014733          199 NLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLI  277 (419)
Q Consensus       199 ~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li  277 (419)
                      .....+|++.|+|||++.+. ++.++|+||+||++|+|++|+.||.+.......+.+.......+...+..++..+.+||
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  236 (285)
T cd05605         157 TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSIC  236 (285)
T ss_pred             ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHH
Confidence            44556899999999998764 89999999999999999999999987665444333332222222233346899999999


Q ss_pred             HhhhhcCCCCCC-----CHHHHHhccccccchh
Q 014733          278 MGMLRVDPSTRL-----TAAEVLAHSWMEECEQ  305 (419)
Q Consensus       278 ~~~L~~dP~~Rp-----s~~eil~hp~~~~~~~  305 (419)
                      .+||+.||++||     +++++++||||.....
T Consensus       237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~  269 (285)
T cd05605         237 RQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANF  269 (285)
T ss_pred             HHHccCCHHHhcCCCCCCHHHHhcCcCccCCCH
Confidence            999999999999     9999999999987544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=3.5e-46  Score=366.89  Aligned_cols=262  Identities=27%  Similarity=0.473  Sum_probs=223.9

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      ++|++.+.||+|+||.||+++++.+++.||+|++.+...........+.+|+.++..+. |+||+++++++.+.+..|+|
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~l~~~~~~~~~~~lv   79 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGD-CQWITTLHYAFQDENYLYLV   79 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCEEEEE
Confidence            58999999999999999999999999999999997644334445667888999999985 99999999999999999999


Q ss_pred             EeecCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC
Q 014733          120 MELCAGGELFHRLEK-YGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ  198 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~  198 (419)
                      |||++||+|.+++.. .+.+++..+..++.|++.||+|||+.+|+||||||+|||+   +.++.+||+|||++.......
T Consensus        80 ~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~  156 (331)
T cd05624          80 MDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLL---DMNGHIRLADFGSCLKMNQDG  156 (331)
T ss_pred             EeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEE---cCCCCEEEEeccceeeccCCC
Confidence            999999999999987 4679999999999999999999999999999999999999   567789999999998765433


Q ss_pred             cc--ccccCCCccCCcccccC------CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC-CCCCCC
Q 014733          199 NL--HGTVGSPFYIAPEVLAG------GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPS-DPWDHI  269 (419)
Q Consensus       199 ~~--~~~~gt~~y~aPE~l~~------~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~  269 (419)
                      ..  ...+||+.|+|||++.+      .++.++|+|||||++|+|++|+.||......+....+.....+++. ..+..+
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~  236 (331)
T cd05624         157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDV  236 (331)
T ss_pred             ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccC
Confidence            22  23479999999999864      4788999999999999999999999988887877777665433321 223468


Q ss_pred             CHHHHHHHHhhhhcCCCC--CCCHHHHHhccccccchh
Q 014733          270 SASARDLIMGMLRVDPST--RLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       270 s~~l~~li~~~L~~dP~~--Rps~~eil~hp~~~~~~~  305 (419)
                      +.+++++|.+||+.++++  |++++++++||||+...+
T Consensus       237 ~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~  274 (331)
T cd05624         237 SEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDW  274 (331)
T ss_pred             CHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCH
Confidence            999999999999976654  569999999999987654

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-46  Score=368.69  Aligned_cols=248  Identities=28%  Similarity=0.453  Sum_probs=214.5

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcE-EEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCC-EEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEV-LACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEED-YVH  117 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~-vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~-~~~  117 (419)
                      +...+.+.||+|+||+||+|.++  |+. ||+|++......... .+.+.+|+.+|.+++ |||||++++++.+.. ..+
T Consensus        41 ~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~-HpNIV~f~G~~~~~~~~~~  116 (362)
T KOG0192|consen   41 DELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDES-RKAFRREASLLSRLR-HPNIVQFYGACTSPPGSLC  116 (362)
T ss_pred             HHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHH-HHHHHHHHHHHHhCC-CCCeeeEEEEEcCCCCceE
Confidence            34445667999999999999876  666 999999765543333 789999999999996 999999999999887 799


Q ss_pred             EEEeecCCCChHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCC-CeeccCCCCcEEEeecCCCC-CeEEeeccceee
Q 014733          118 LLMELCAGGELFHRLEK--YGRFSETEARVIFRHLMQVVSYCHGNG-VVHRDLKPENILLATKSSSS-PIKLADFGLATY  193 (419)
Q Consensus       118 lV~E~~~ggsL~~~l~~--~~~l~~~~~~~i~~qll~aL~~LH~~~-IvHrDLkp~NILl~~~~~~~-~vKL~DFgla~~  193 (419)
                      +||||+++|+|.+++.+  .+.++...+..++.+|++||.|||+.+ ||||||||+|||+   +.++ ++||+|||+++.
T Consensus       117 iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv---~~~~~~~KI~DFGlsr~  193 (362)
T KOG0192|consen  117 IVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILV---DLKGKTLKIADFGLSRE  193 (362)
T ss_pred             EEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEE---cCCCCEEEECCCcccee
Confidence            99999999999999988  567999999999999999999999999 9999999999999   4554 899999999987


Q ss_pred             eccC-CccccccCCCccCCcccccC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCC
Q 014733          194 IKAG-QNLHGTVGSPFYIAPEVLAG---GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHI  269 (419)
Q Consensus       194 ~~~~-~~~~~~~gt~~y~aPE~l~~---~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  269 (419)
                      .... .......||+.|||||++.+   .|+.++||||||++||||+||+.||.+.........+.....+.+...  ..
T Consensus       194 ~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~--~~  271 (362)
T KOG0192|consen  194 KVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPK--EC  271 (362)
T ss_pred             eccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCc--cC
Confidence            6554 34444789999999999994   399999999999999999999999999888777776665555443332  48


Q ss_pred             CHHHHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          270 SASARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       270 s~~l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                      ++.+..++.+||..||++||++.+++.
T Consensus       272 ~~~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  272 PPHLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             CHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence            899999999999999999999999976

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=2.7e-46  Score=366.24  Aligned_cols=252  Identities=32%  Similarity=0.589  Sum_probs=217.1

Q ss_pred             eeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHH-HHHccCCCCceeeeEEEEeCCEEEEEEeecC
Q 014733           46 KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEI-MTKLSGHPNVVDLKAVYEEEDYVHLLMELCA  124 (419)
Q Consensus        46 ~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~i-l~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~  124 (419)
                      +.||+|+||+||+|.++.+|+.||+|++.+...........+..|..+ ++.+. ||||+++++++.+.+.+|+||||++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~   79 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVK-HPFLVGLHYSFQTADKLYFVLDYVN   79 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCC-CCCCCCeeEEEEeCCEEEEEEcCCC
Confidence            469999999999999999999999999976544333444556666554 56675 9999999999999999999999999


Q ss_pred             CCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeecc-CCccccc
Q 014733          125 GGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA-GQNLHGT  203 (419)
Q Consensus       125 ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~-~~~~~~~  203 (419)
                      +++|..++...+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++..... .......
T Consensus        80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll---~~~~~~kl~Dfg~~~~~~~~~~~~~~~  156 (323)
T cd05575          80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILL---DSQGHVVLTDFGLCKEGIEHSKTTSTF  156 (323)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE---CCCCcEEEeccCCCcccccCCCccccc
Confidence            99999999888889999999999999999999999999999999999999   5677899999999875322 2223445


Q ss_pred             cCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhh
Q 014733          204 VGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLR  282 (419)
Q Consensus       204 ~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~  282 (419)
                      +||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+.+..+..+.+.......+    ..++.++.++|.+||+
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~  232 (323)
T cd05575         157 CGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLK----PNISVSARHLLEGLLQ  232 (323)
T ss_pred             cCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHhh
Confidence            799999999998774 89999999999999999999999999888888888876655443    3679999999999999


Q ss_pred             cCCCCCCCH----HHHHhccccccchh
Q 014733          283 VDPSTRLTA----AEVLAHSWMEECEQ  305 (419)
Q Consensus       283 ~dP~~Rps~----~eil~hp~~~~~~~  305 (419)
                      .||.+||++    .++++||||.....
T Consensus       233 ~~p~~R~~~~~~~~~il~~~~~~~~~~  259 (323)
T cd05575         233 KDRTKRLGAKDDFLEIKNHVFFSSINW  259 (323)
T ss_pred             cCHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence            999999987    69999999976543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=5.9e-46  Score=365.19  Aligned_cols=258  Identities=24%  Similarity=0.376  Sum_probs=219.1

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEE
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHL  118 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~l  118 (419)
                      .++|++.+.||+|+||.||+|.+..+|..+|+|.+...  ........+.+|+++|+++. ||||+++++++.+.+.+++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~l   80 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLE--IKPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGEISI   80 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecc--cCHHHHHHHHHHHHHHHHCC-CCCCCeEEEEEEECCEEEE
Confidence            58999999999999999999999999999999998764  23455678999999999996 9999999999999999999


Q ss_pred             EEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC-CCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccC
Q 014733          119 LMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGN-GVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG  197 (419)
Q Consensus       119 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~-~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~  197 (419)
                      ||||+++++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||+   +.++.+||+|||++......
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~  157 (331)
T cd06649          81 CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDS  157 (331)
T ss_pred             EeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEE---cCCCcEEEccCccccccccc
Confidence            999999999999998888899999999999999999999986 69999999999999   56778999999998765432


Q ss_pred             CccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC------------------
Q 014733          198 QNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAAD------------------  258 (419)
Q Consensus       198 ~~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~------------------  258 (419)
                       ......||+.|+|||++.+. ++.++|+|||||++|+|++|+.||......++...+....                  
T Consensus       158 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (331)
T cd06649         158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPP  236 (331)
T ss_pred             -ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccc
Confidence             23445799999999998874 8999999999999999999999997665544433221100                  


Q ss_pred             --------------------------CCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccc
Q 014733          259 --------------------------LRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEEC  303 (419)
Q Consensus       259 --------------------------~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~  303 (419)
                                                ...+......++.++++||.+||++||++|||+.++++||||+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  307 (331)
T cd06649         237 GRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS  307 (331)
T ss_pred             cccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence                                      001111123478899999999999999999999999999999854

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-46  Score=370.26  Aligned_cols=252  Identities=32%  Similarity=0.582  Sum_probs=220.2

Q ss_pred             ecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHcc--CCCCceeeeEEEEeCCEEEEEEeecCC
Q 014733           48 LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLS--GHPNVVDLKAVYEEEDYVHLLMELCAG  125 (419)
Q Consensus        48 LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~--~hpnIv~l~~~~~~~~~~~lV~E~~~g  125 (419)
                      ||+|+||+||+|+++.+|+.||+|++.+..............|..++.++.  +||||+++++++.+.+.+|+||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999999999999999997654444445556667778887664  699999999999999999999999999


Q ss_pred             CChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeecc-CCcccccc
Q 014733          126 GELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA-GQNLHGTV  204 (419)
Q Consensus       126 gsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~-~~~~~~~~  204 (419)
                      |+|..++...+.+++..++.++.||++||+|||++||+||||||+|||+   +.++.+||+|||++..... .......+
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  157 (330)
T cd05586          81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILL---DATGHIALCDFGLSKANLTDNKTTNTFC  157 (330)
T ss_pred             ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEecCCcCcCCCCCCCCccCcc
Confidence            9999999888889999999999999999999999999999999999999   5677899999999875432 22234567


Q ss_pred             CCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhh
Q 014733          205 GSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLR  282 (419)
Q Consensus       205 gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~  282 (419)
                      ||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+....+..+.+......++..   .++.++.++|.+||+
T Consensus       158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~---~~~~~~~~li~~~L~  234 (330)
T cd05586         158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKN---VLSDEGRQFVKGLLN  234 (330)
T ss_pred             CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCc---cCCHHHHHHHHHHcC
Confidence            9999999999865  37999999999999999999999999988888888888777666543   578999999999999


Q ss_pred             cCCCCCC----CHHHHHhccccccchh
Q 014733          283 VDPSTRL----TAAEVLAHSWMEECEQ  305 (419)
Q Consensus       283 ~dP~~Rp----s~~eil~hp~~~~~~~  305 (419)
                      .||.+||    ++.++++||||+...+
T Consensus       235 ~~P~~R~~~~~~~~~ll~h~~~~~~~~  261 (330)
T cd05586         235 RNPQHRLGAHRDAVELKEHPFFADIDW  261 (330)
T ss_pred             CCHHHCCCCCCCHHHHhcCccccCCCH
Confidence            9999998    7999999999987653

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-48  Score=372.13  Aligned_cols=256  Identities=29%  Similarity=0.521  Sum_probs=228.2

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEE
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHL  118 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~l  118 (419)
                      ...|...+.||+|+||.||+|.+..+++.||+|++..+.  ....++.++.|+.+|..+. ++||.++|+.+.....+++
T Consensus        12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~--~~deIediqqei~~Ls~~~-~~~it~yygsyl~g~~Lwi   88 (467)
T KOG0201|consen   12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE--AEDEIEDIQQEISVLSQCD-SPNITEYYGSYLKGTKLWI   88 (467)
T ss_pred             ccccccchhccccccceeeeeeeccccceEEEEEechhh--cchhhHHHHHHHHHHHhcC-cchHHhhhhheeecccHHH
Confidence            456788899999999999999999999999999998874  4567889999999999996 9999999999999999999


Q ss_pred             EEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC
Q 014733          119 LMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ  198 (419)
Q Consensus       119 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~  198 (419)
                      +||||.||++.+.++..+.+.+.++..++++++.||.|||..+.+|||||+.|||+   ..+|.+||+|||.+..+....
T Consensus        89 iMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~---s~~g~vkl~DfgVa~ql~~~~  165 (467)
T KOG0201|consen   89 IMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILL---SESGDVKLADFGVAGQLTNTV  165 (467)
T ss_pred             HHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeE---eccCcEEEEecceeeeeechh
Confidence            99999999999999987778999999999999999999999999999999999999   556899999999998876554


Q ss_pred             cc-ccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHH
Q 014733          199 NL-HGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDL  276 (419)
Q Consensus       199 ~~-~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~l  276 (419)
                      .. .+++|||.|||||++.+ +|+.++||||||++.+||++|.+|+....+...+-.|-..   .|+..-..+|+.+++|
T Consensus       166 ~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~---~PP~L~~~~S~~~kEF  242 (467)
T KOG0201|consen  166 KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKS---APPRLDGDFSPPFKEF  242 (467)
T ss_pred             hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCC---CCCccccccCHHHHHH
Confidence            33 67799999999999987 5999999999999999999999999888775444444332   2333334789999999


Q ss_pred             HHhhhhcCCCCCCCHHHHHhccccccc
Q 014733          277 IMGMLRVDPSTRLTAAEVLAHSWMEEC  303 (419)
Q Consensus       277 i~~~L~~dP~~Rps~~eil~hp~~~~~  303 (419)
                      |..||++||+.||++.++|+|+|++..
T Consensus       243 V~~CL~k~P~~RpsA~~LLKh~FIk~a  269 (467)
T KOG0201|consen  243 VEACLDKNPEFRPSAKELLKHKFIKRA  269 (467)
T ss_pred             HHHHhhcCcccCcCHHHHhhhHHHHhc
Confidence            999999999999999999999999874

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.7e-46  Score=354.76  Aligned_cols=262  Identities=28%  Similarity=0.460  Sum_probs=221.6

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCC-ceeeeEEEEeCC---
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN-VVDLKAVYEEED---  114 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpn-Iv~l~~~~~~~~---  114 (419)
                      -..|..+++||+|+||+||+|+++.+|+.||+|+++.+... +-.-....+|+.+|+.|+ |+| ||++++++.+.+   
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~-~~~~iv~L~dv~~~~~~~~   87 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLS-HANHIVRLHDVIHTSNNHR   87 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhC-CCcceEEEEeeeeeccccc
Confidence            35688889999999999999999999999999999876431 112244678999999996 999 999999999877   


Q ss_pred             ---EEEEEEeecCCCChHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEee
Q 014733          115 ---YVHLLMELCAGGELFHRLEKYG----RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLAD  187 (419)
Q Consensus       115 ---~~~lV~E~~~ggsL~~~l~~~~----~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~D  187 (419)
                         .+++|+||+ .-+|..++....    .++...++.+++||+.||+|||+++|+||||||+||||   +++|.+||+|
T Consensus        88 ~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi---~~~G~lKlaD  163 (323)
T KOG0594|consen   88 GIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLI---SSSGVLKLAD  163 (323)
T ss_pred             ccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEE---CCCCcEeeec
Confidence               899999999 679999998765    47788999999999999999999999999999999999   5688999999


Q ss_pred             ccceeeec-cCCccccccCCCccCCcccccCC--CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC
Q 014733          188 FGLATYIK-AGQNLHGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSD  264 (419)
Q Consensus       188 Fgla~~~~-~~~~~~~~~gt~~y~aPE~l~~~--~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~  264 (419)
                      ||+|+... +.......++|.+|+|||++.|.  |+...||||+|||++||+++++.|.+....+....|.+.-......
T Consensus       164 FGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~  243 (323)
T KOG0594|consen  164 FGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEK  243 (323)
T ss_pred             cchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCcc
Confidence            99999765 34445667899999999999884  9999999999999999999999999998877777774432221111


Q ss_pred             CC--------------------------CCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchhh
Q 014733          265 PW--------------------------DHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQV  306 (419)
Q Consensus       265 ~~--------------------------~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~~  306 (419)
                      .|                          +..+++..+++.+||+.+|.+|.|++.+|.||||......
T Consensus       244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~  311 (323)
T KOG0594|consen  244 DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEK  311 (323)
T ss_pred             CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccc
Confidence            11                          2234588999999999999999999999999999987543

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=3.5e-46  Score=366.30  Aligned_cols=253  Identities=26%  Similarity=0.521  Sum_probs=217.7

Q ss_pred             eeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEEeecCC
Q 014733           46 KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAG  125 (419)
Q Consensus        46 ~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~g  125 (419)
                      +.||+|+||+||+|.++.+++.+|+|++.+.........+.+..|+.++.++.+||||+++++++.+.+.+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999999999999999998765545556778899999999997799999999999999999999999999


Q ss_pred             CChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeec-cCCcccccc
Q 014733          126 GELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIK-AGQNLHGTV  204 (419)
Q Consensus       126 gsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~-~~~~~~~~~  204 (419)
                      ++|..++...+.+++.+++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++.... ........+
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (327)
T cd05617          81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLL---DADGHIKLTDYGMCKEGLGPGDTTSTFC  157 (327)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---eCCCCEEEeccccceeccCCCCceeccc
Confidence            9999999888889999999999999999999999999999999999999   567789999999987532 233334568


Q ss_pred             CCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCC-------CHHHHHHHHHhcCCCCCCCCCCCCCHHHHHH
Q 014733          205 GSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGK-------TKSKIFDAVRAADLRFPSDPWDHISASARDL  276 (419)
Q Consensus       205 gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~-------~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~l  276 (419)
                      ||+.|+|||++.+. ++.++|||||||++|+|++|+.||...       ......+.+......+|    ..++.++.++
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~l  233 (327)
T cd05617         158 GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIP----RFLSVKASHV  233 (327)
T ss_pred             CCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCC----CCCCHHHHHH
Confidence            99999999998764 899999999999999999999999532       22334444444443333    3688999999


Q ss_pred             HHhhhhcCCCCCCC------HHHHHhccccccchh
Q 014733          277 IMGMLRVDPSTRLT------AAEVLAHSWMEECEQ  305 (419)
Q Consensus       277 i~~~L~~dP~~Rps------~~eil~hp~~~~~~~  305 (419)
                      |.+||+.||++|++      +.+++.||||+...+
T Consensus       234 i~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~  268 (327)
T cd05617         234 LKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDW  268 (327)
T ss_pred             HHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCH
Confidence            99999999999997      579999999988754

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=6.7e-46  Score=356.89  Aligned_cols=256  Identities=29%  Similarity=0.423  Sum_probs=209.8

Q ss_pred             cCeeeeeeecccCceEEEEEEecC-CCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHcc--CCCCceeeeEEEE-----
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKF-TGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLS--GHPNVVDLKAVYE-----  111 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~-~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~--~hpnIv~l~~~~~-----  111 (419)
                      ++|++.+.||+|+||+||+|.+.. ++..||+|.+...... ......+.+|+.+++.+.  .||||+++++++.     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~   79 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   79 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCC-CCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence            479999999999999999999854 5788999998754322 222345567888877764  4999999999985     


Q ss_pred             eCCEEEEEEeecCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeecc
Q 014733          112 EEDYVHLLMELCAGGELFHRLEKY--GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFG  189 (419)
Q Consensus       112 ~~~~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFg  189 (419)
                      ....+++||||+. ++|.+++...  ..+++..++.++.|++.||+|||+.||+||||||+|||+   +.++.+||+|||
T Consensus        80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~---~~~~~~kl~Dfg  155 (290)
T cd07862          80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFG  155 (290)
T ss_pred             CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---cCCCCEEEcccc
Confidence            3456899999995 6898888754  348999999999999999999999999999999999999   567789999999


Q ss_pred             ceeeeccCCccccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC-----
Q 014733          190 LATYIKAGQNLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPS-----  263 (419)
Q Consensus       190 la~~~~~~~~~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~-----  263 (419)
                      ++.............||+.|+|||++.+ .++.++|||||||++|+|++|++||.+....+....+.........     
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~  235 (290)
T cd07862         156 LARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR  235 (290)
T ss_pred             ceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchh
Confidence            9987655544455679999999999866 4899999999999999999999999988877766666442111000     


Q ss_pred             ------------------CCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhcccc
Q 014733          264 ------------------DPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWM  300 (419)
Q Consensus       264 ------------------~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~  300 (419)
                                        .....++..++++|.+||+.||++|||+.++|+||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         236 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             hhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence                              0113578889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.4e-46  Score=378.06  Aligned_cols=262  Identities=30%  Similarity=0.455  Sum_probs=221.9

Q ss_pred             cccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccC-----CCCceeeeEEE
Q 014733           36 SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG-----HPNVVDLKAVY  110 (419)
Q Consensus        36 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~-----hpnIv~l~~~~  110 (419)
                      +.+..+|.+.+.||+|+||.|.+|++..|++.||||+++.+    ..-.++-..|+.+|..|++     .-|+|+++++|
T Consensus       182 d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F  257 (586)
T KOG0667|consen  182 DHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF  257 (586)
T ss_pred             ceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc
Confidence            44566999999999999999999999999999999999854    3566778889999999973     46899999999


Q ss_pred             EeCCEEEEEEeecCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeec
Q 014733          111 EEEDYVHLLMELCAGGELFHRLEKYG--RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADF  188 (419)
Q Consensus       111 ~~~~~~~lV~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DF  188 (419)
                      .-.+++|||+|++ +.+|+++++.++  .|+...++.++.||+.||.+||+++|||+|||||||||.... ...|||+||
T Consensus       258 ~fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~-r~~vKVIDF  335 (586)
T KOG0667|consen  258 YFRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPK-RSRIKVIDF  335 (586)
T ss_pred             ccccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCC-cCceeEEec
Confidence            9999999999999 789999998764  489999999999999999999999999999999999997643 348999999


Q ss_pred             cceeeeccCCccccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC--------
Q 014733          189 GLATYIKAGQNLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADL--------  259 (419)
Q Consensus       189 gla~~~~~~~~~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~--------  259 (419)
                      |.++...  +....++.++.|+|||++.| +|+.+.||||||||++||++|.+.|.|.+..+++..|.....        
T Consensus       336 GSSc~~~--q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~  413 (586)
T KOG0667|consen  336 GSSCFES--QRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLD  413 (586)
T ss_pred             ccccccC--CcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            9999743  33457889999999999988 599999999999999999999999999988877777733210        


Q ss_pred             --------------------------------------------CCCCC--CC----C-CCCHHHHHHHHhhhhcCCCCC
Q 014733          260 --------------------------------------------RFPSD--PW----D-HISASARDLIMGMLRVDPSTR  288 (419)
Q Consensus       260 --------------------------------------------~~~~~--~~----~-~~s~~l~~li~~~L~~dP~~R  288 (419)
                                                                  ..|..  .+    . .-...+.|||++||.+||.+|
T Consensus       414 ~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R  493 (586)
T KOG0667|consen  414 TAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAER  493 (586)
T ss_pred             hccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhc
Confidence                                                        01100  00    0 112456899999999999999


Q ss_pred             CCHHHHHhccccccchh
Q 014733          289 LTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       289 ps~~eil~hp~~~~~~~  305 (419)
                      +|+.++|+|||+.....
T Consensus       494 ~tp~qal~Hpfl~~~~~  510 (586)
T KOG0667|consen  494 ITPAQALNHPFLTGTSL  510 (586)
T ss_pred             CCHHHHhcCcccccccc
Confidence            99999999999986544

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=5.2e-46  Score=356.82  Aligned_cols=254  Identities=27%  Similarity=0.477  Sum_probs=211.2

Q ss_pred             ecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEEeecCCCC
Q 014733           48 LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGE  127 (419)
Q Consensus        48 LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~ggs  127 (419)
                      ||+|+||+||++.++.+++.+|+|.+.+.........+.+..|+.+++++. |+||+++.+++.+.+.+|+||||+++|+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~g~   79 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVH-SRFIVSLAYAFQTKTDLCLVMTIMNGGD   79 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCC-CCcEeeeeEEEcCCCeEEEEEeCCCCCC
Confidence            799999999999999999999999997665444445567888999999995 9999999999999999999999999999


Q ss_pred             hHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCCc-ccc
Q 014733          128 LFHRLEK----YGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN-LHG  202 (419)
Q Consensus       128 L~~~l~~----~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~~-~~~  202 (419)
                      |...+..    ...+++..+..++.||+.||+|||+.+|+||||||+||++   +.++.+||+|||++........ ...
T Consensus        80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~~~~~~~  156 (280)
T cd05608          80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLL---DNDGNVRISDLGLAVELKDGQSKTKG  156 (280)
T ss_pred             HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEeeCccceecCCCCccccc
Confidence            9887743    3458999999999999999999999999999999999999   5577899999999987654432 234


Q ss_pred             ccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhh
Q 014733          203 TVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGML  281 (419)
Q Consensus       203 ~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L  281 (419)
                      ..||+.|+|||++.+. ++.++|+|||||++|+|++|+.||...........+.......+......++.++.+++.+||
T Consensus       157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  236 (280)
T cd05608         157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALL  236 (280)
T ss_pred             cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHh
Confidence            5789999999998774 899999999999999999999999765432222222221122222233468999999999999


Q ss_pred             hcCCCCCC-----CHHHHHhccccccchh
Q 014733          282 RVDPSTRL-----TAAEVLAHSWMEECEQ  305 (419)
Q Consensus       282 ~~dP~~Rp-----s~~eil~hp~~~~~~~  305 (419)
                      +.||++||     +++++++||||+...+
T Consensus       237 ~~~P~~R~~~~~~~~~~~l~h~~~~~~~~  265 (280)
T cd05608         237 AKDPEKRLGFRDGNCDGLRTHPLFRDLNW  265 (280)
T ss_pred             cCCHHHhcCCCCCCHHHHhcChhhhcCCH
Confidence            99999999     8899999999987543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=8.1e-46  Score=362.50  Aligned_cols=252  Identities=31%  Similarity=0.568  Sum_probs=215.9

Q ss_pred             eeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHH-HHHHccCCCCceeeeEEEEeCCEEEEEEeecC
Q 014733           46 KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIE-IMTKLSGHPNVVDLKAVYEEEDYVHLLMELCA  124 (419)
Q Consensus        46 ~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~-il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~  124 (419)
                      +.||+|+||+||+|+++.+|+.||+|++.+...........+..|.. +++.+. ||||+++++++.+.+.+|+||||++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~-h~~iv~~~~~~~~~~~~~lv~e~~~   79 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLK-HPFLVGLHYSFQTAEKLYFVLDYVN   79 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCC-CCCccceeeEEEcCCEEEEEEcCCC
Confidence            47999999999999999999999999997654433344455666655 567775 9999999999999999999999999


Q ss_pred             CCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeecc-CCccccc
Q 014733          125 GGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA-GQNLHGT  203 (419)
Q Consensus       125 ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~-~~~~~~~  203 (419)
                      |++|...+.....+++..++.++.||++||+|||+.||+||||||+|||+   +.++.+||+|||++..... .......
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~~~~~~  156 (321)
T cd05603          80 GGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILL---DSQGHVVLTDFGLCKEGVEPEETTSTF  156 (321)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEccCCCCccCCCCCCccccc
Confidence            99999999887889999999999999999999999999999999999999   5677899999999875322 2223445


Q ss_pred             cCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhh
Q 014733          204 VGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLR  282 (419)
Q Consensus       204 ~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~  282 (419)
                      +||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+.+..+..+.+......++    ...+.++.++|.+||+
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~  232 (321)
T cd05603         157 CGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLP----GGKTVAACDLLVGLLH  232 (321)
T ss_pred             cCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHcc
Confidence            799999999998764 89999999999999999999999999888888888776654443    3578999999999999


Q ss_pred             cCCCCCCCH----HHHHhccccccchh
Q 014733          283 VDPSTRLTA----AEVLAHSWMEECEQ  305 (419)
Q Consensus       283 ~dP~~Rps~----~eil~hp~~~~~~~  305 (419)
                      .||.+|+++    .++++|+||.....
T Consensus       233 ~~p~~R~~~~~~~~~~~~~~~~~~~~~  259 (321)
T cd05603         233 KDQRRRLGAKADFLEIKNHVFFSPINW  259 (321)
T ss_pred             CCHhhcCCCCCCHHHHhCCCCcCCCCH
Confidence            999999865    59999999986554

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2.5e-45  Score=360.91  Aligned_cols=262  Identities=26%  Similarity=0.456  Sum_probs=222.9

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      ++|++.++||+|+||.||++.++.+++.+|+|++.+...........+..|+.++..+. |+||+++++++.+.+.+|+|
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv   79 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGD-NQWITTLHYAFQDENNLYLV   79 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCC-CCCEeeEEEEEecCCEEEEE
Confidence            47999999999999999999999999999999997644333445566888999999985 99999999999999999999


Q ss_pred             EeecCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC
Q 014733          120 MELCAGGELFHRLEK-YGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ  198 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~  198 (419)
                      |||+++|+|.+++.+ ...+++..++.++.||+.||+|||+.+|+||||||+|||+   +.++.+||+|||++.......
T Consensus        80 ~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili---~~~~~~kL~DfG~a~~~~~~~  156 (332)
T cd05623          80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLMEDG  156 (332)
T ss_pred             EeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---CCCCCEEEeecchheecccCC
Confidence            999999999999977 3569999999999999999999999999999999999999   567789999999987653332


Q ss_pred             c--cccccCCCccCCccccc------CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC-CCCCCC
Q 014733          199 N--LHGTVGSPFYIAPEVLA------GGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPS-DPWDHI  269 (419)
Q Consensus       199 ~--~~~~~gt~~y~aPE~l~------~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~  269 (419)
                      .  ....+||+.|+|||++.      +.++.++|||||||++|+|++|+.||......+....+......++. .....+
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~  236 (332)
T cd05623         157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDV  236 (332)
T ss_pred             cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccC
Confidence            2  22357999999999985      24789999999999999999999999988888888887665433321 223468


Q ss_pred             CHHHHHHHHhhhhcCCCC--CCCHHHHHhccccccchh
Q 014733          270 SASARDLIMGMLRVDPST--RLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       270 s~~l~~li~~~L~~dP~~--Rps~~eil~hp~~~~~~~  305 (419)
                      ++++++||++||+.++++  |+++.++++||||....+
T Consensus       237 s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~  274 (332)
T cd05623         237 SEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDW  274 (332)
T ss_pred             CHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCH
Confidence            999999999999765554  789999999999988654

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.3e-46  Score=363.98  Aligned_cols=252  Identities=33%  Similarity=0.556  Sum_probs=219.8

Q ss_pred             eeeecccCceEEEEEEe---cCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEEe
Q 014733           45 GKQLGWGQFGVIRECSD---KFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLME  121 (419)
Q Consensus        45 ~~~LG~G~~g~V~~a~~---~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  121 (419)
                      ++.||+|+||.||++++   +.+|+.+|+|++.+... .......+..|+++|+++. ||||+++++++.+++.+|+|||
T Consensus         1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e   78 (318)
T cd05582           1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL-KVRDRVRTKMERDILAEVN-HPFIVKLHYAFQTEGKLYLILD   78 (318)
T ss_pred             CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHhCC-CCCcccEEEEEEcCCEEEEEEc
Confidence            36799999999999886   35789999999976542 2234456778999999996 9999999999999999999999


Q ss_pred             ecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccC-Ccc
Q 014733          122 LCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG-QNL  200 (419)
Q Consensus       122 ~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~-~~~  200 (419)
                      |+++++|.+++.+...+++.+++.++.||++||+|||+.+|+||||||+|||+   +.++.+||+|||++...... ...
T Consensus        79 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kL~Dfg~~~~~~~~~~~~  155 (318)
T cd05582          79 FLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKA  155 (318)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEE---CCCCcEEEeeccCCcccCCCCCce
Confidence            99999999999887889999999999999999999999999999999999999   56778999999998865433 223


Q ss_pred             ccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHh
Q 014733          201 HGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMG  279 (419)
Q Consensus       201 ~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~  279 (419)
                      ...+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+....+....+......++.    .+++++.++|++
T Consensus       156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li~~  231 (318)
T cd05582         156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQ----FLSPEAQSLLRA  231 (318)
T ss_pred             ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHHHH
Confidence            45679999999999876 4899999999999999999999999988888888887776655443    688999999999


Q ss_pred             hhhcCCCCCCC-----HHHHHhccccccchh
Q 014733          280 MLRVDPSTRLT-----AAEVLAHSWMEECEQ  305 (419)
Q Consensus       280 ~L~~dP~~Rps-----~~eil~hp~~~~~~~  305 (419)
                      ||+.||++||+     +.+++.||||....+
T Consensus       232 ~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~  262 (318)
T cd05582         232 LFKRNPANRLGAGPDGVEEIKRHPFFSTIDW  262 (318)
T ss_pred             HhhcCHhHcCCCCCCCHHHHhCCCCcCCCCH
Confidence            99999999999     788999999987654

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=3.8e-46  Score=365.53  Aligned_cols=252  Identities=30%  Similarity=0.544  Sum_probs=217.5

Q ss_pred             eeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHH-HHHccCCCCceeeeEEEEeCCEEEEEEeecC
Q 014733           46 KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEI-MTKLSGHPNVVDLKAVYEEEDYVHLLMELCA  124 (419)
Q Consensus        46 ~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~i-l~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~  124 (419)
                      +.||+|+||+||+|.++.+|+.+|+|++.++..........+..|..+ ++.+ +||||+++++++.+.+.+|+||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~hp~iv~~~~~~~~~~~~~lv~e~~~   79 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNV-KHPFLVGLHYSFQTTEKLYFVLDFVN   79 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhC-CCCCCccEEEEEecCCEEEEEEcCCC
Confidence            469999999999999999999999999976644444455566666664 5667 49999999999999999999999999


Q ss_pred             CCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeecc-CCccccc
Q 014733          125 GGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA-GQNLHGT  203 (419)
Q Consensus       125 ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~-~~~~~~~  203 (419)
                      |++|..++...+.+++..+..++.||+.||+|||+.||+||||||+|||+   +.++.+||+|||++..... .......
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll---~~~~~~kL~DfG~~~~~~~~~~~~~~~  156 (325)
T cd05604          80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILL---DSQGHVVLTDFGLCKEGIAQSDTTTTF  156 (325)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEEeecCCcccCCCCCCCcccc
Confidence            99999999888889999999999999999999999999999999999999   5677999999999875322 2233445


Q ss_pred             cCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhh
Q 014733          204 VGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLR  282 (419)
Q Consensus       204 ~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~  282 (419)
                      +||+.|+|||++.+. ++.++|||||||++|+|++|.+||...+..++.+.+.......+    ..++..+.++|.+||+
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~ll~~ll~  232 (325)
T cd05604         157 CGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR----PGASLTAWSILEELLE  232 (325)
T ss_pred             cCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCC----CCCCHHHHHHHHHHhc
Confidence            799999999998774 89999999999999999999999999888888888776654433    2588999999999999


Q ss_pred             cCCCCCCCH----HHHHhccccccchh
Q 014733          283 VDPSTRLTA----AEVLAHSWMEECEQ  305 (419)
Q Consensus       283 ~dP~~Rps~----~eil~hp~~~~~~~  305 (419)
                      .||.+||++    .++++||||....+
T Consensus       233 ~~p~~R~~~~~~~~~i~~h~~f~~~~~  259 (325)
T cd05604         233 KDRQRRLGAKEDFLEIQEHPFFESLSW  259 (325)
T ss_pred             cCHHhcCCCCCCHHHHhcCCCcCCCCH
Confidence            999999976    59999999987543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.5e-46  Score=369.17  Aligned_cols=257  Identities=32%  Similarity=0.534  Sum_probs=234.0

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCE-EE
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDY-VH  117 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~-~~  117 (419)
                      -++|..++++|+|+||.+++++++..+..+++|.+...+.. ....+....|+.+++++. |||||.+.+.|.+++. ++
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t-~~~r~~A~~E~~lis~~~-hP~iv~y~ds~~~~~~~l~   80 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLT-EPERRSAIQEMDLLSKLL-HPNIVEYKDSFEEDGQLLC   80 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccC-chhhHHHHHHHHHHHhcc-CCCeeeeccchhcCCceEE
Confidence            36899999999999999999999999999999999988754 455668889999999996 9999999999998887 99


Q ss_pred             EEEeecCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeec
Q 014733          118 LLMELCAGGELFHRLEKYG--RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIK  195 (419)
Q Consensus       118 lV~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~  195 (419)
                      |||+||+||+|.+.+.+.+  .|+++.+..|+.|++.|+.|||+++|+|||||+.|||+   ..++.|||+|||+|+.+.
T Consensus        81 Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifl---tk~~~VkLgDfGlaK~l~  157 (426)
T KOG0589|consen   81 IVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFL---TKDKKVKLGDFGLAKILN  157 (426)
T ss_pred             EEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhc---cccCceeecchhhhhhcC
Confidence            9999999999999997654  49999999999999999999999999999999999999   667789999999999988


Q ss_pred             cCC-ccccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 014733          196 AGQ-NLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASA  273 (419)
Q Consensus       196 ~~~-~~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l  273 (419)
                      +.. ...+.+||+.|+.||++.+ +|+.++|+|||||++|||++-+++|.+.+...+..+|........   ...++.++
T Consensus       158 ~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Pl---p~~ys~el  234 (426)
T KOG0589|consen  158 PEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPL---PSMYSSEL  234 (426)
T ss_pred             CchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCC---CccccHHH
Confidence            776 5567799999999999998 599999999999999999999999999999999999988873222   23789999


Q ss_pred             HHHHHhhhhcCCCCCCCHHHHHhccccccc
Q 014733          274 RDLIMGMLRVDPSTRLTAAEVLAHSWMEEC  303 (419)
Q Consensus       274 ~~li~~~L~~dP~~Rps~~eil~hp~~~~~  303 (419)
                      +.+|+.||+.+|..||++.++|.+|.++..
T Consensus       235 ~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~  264 (426)
T KOG0589|consen  235 RSLVKSMLRKNPEHRPSALELLRRPHLLRY  264 (426)
T ss_pred             HHHHHHHhhcCCccCCCHHHHhhChhhhhH
Confidence            999999999999999999999999988743

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.4e-45  Score=368.99  Aligned_cols=253  Identities=23%  Similarity=0.385  Sum_probs=207.2

Q ss_pred             cccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEE
Q 014733           38 LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVH  117 (419)
Q Consensus        38 ~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~  117 (419)
                      ..++|++++.||+|+||.||+|.+..+++.||+|....         ..+.+|+.+|++|+ ||||+++++++......+
T Consensus        90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~  159 (391)
T PHA03212         90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAIN-HPSIIQLKGTFTYNKFTC  159 (391)
T ss_pred             ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCC-CCCCCCEeEEEEECCeeE
Confidence            34689999999999999999999999999999996432         34678999999996 999999999999999999


Q ss_pred             EEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccC
Q 014733          118 LLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG  197 (419)
Q Consensus       118 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~  197 (419)
                      +|+|++ +++|..++.....+++.+++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++......
T Consensus       160 lv~e~~-~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll---~~~~~vkL~DFG~a~~~~~~  235 (391)
T PHA03212        160 LILPRY-KTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFI---NHPGDVCLGDFGAACFPVDI  235 (391)
T ss_pred             EEEecC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEE---cCCCCEEEEeCCcccccccc
Confidence            999999 57899988887889999999999999999999999999999999999999   56678999999999753322


Q ss_pred             --CccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhc----------
Q 014733          198 --QNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKT-------KSKIFDAVRAA----------  257 (419)
Q Consensus       198 --~~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~-------~~~~~~~i~~~----------  257 (419)
                        ......+||+.|+|||++.+. ++.++|||||||++|+|++|+.||....       .......+...          
T Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~  315 (391)
T PHA03212        236 NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI  315 (391)
T ss_pred             cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence              223345899999999998764 8999999999999999999998875421       11111111110          


Q ss_pred             ----------------CCCCCCC--C---CCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccch
Q 014733          258 ----------------DLRFPSD--P---WDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECE  304 (419)
Q Consensus       258 ----------------~~~~~~~--~---~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~  304 (419)
                                      ....+..  .   ...++.++.+||.+||++||.+|||+.|+|+||||+...
T Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~  383 (391)
T PHA03212        316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIP  383 (391)
T ss_pred             chhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCC
Confidence                            0000100  0   113567899999999999999999999999999998754

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=2.1e-45  Score=374.82  Aligned_cols=259  Identities=29%  Similarity=0.470  Sum_probs=211.1

Q ss_pred             cccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeC--
Q 014733           36 SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEE--  113 (419)
Q Consensus        36 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~--  113 (419)
                      ....++|++++.||+|+||+||+|.+..+++.||+|++....       ....+|+.+|+.+. ||||+++++++...  
T Consensus        62 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~-h~niv~l~~~~~~~~~  133 (440)
T PTZ00036         62 RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLN-HINIIFLKDYYYTECF  133 (440)
T ss_pred             cCcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcC-CCCCcceeeeEeeccc
Confidence            344578999999999999999999999999999999885432       23457999999996 99999998887432  


Q ss_pred             ------CEEEEEEeecCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCe
Q 014733          114 ------DYVHLLMELCAGGELFHRLEK----YGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPI  183 (419)
Q Consensus       114 ------~~~~lV~E~~~ggsL~~~l~~----~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~v  183 (419)
                            ..+++||||+++ +|.+++..    ...+++..++.++.||+.||+|||+.+|+||||||+|||++.  .++.+
T Consensus       134 ~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~--~~~~v  210 (440)
T PTZ00036        134 KKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDP--NTHTL  210 (440)
T ss_pred             ccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcC--CCCce
Confidence                  357799999964 77666642    356999999999999999999999999999999999999942  23479


Q ss_pred             EEeeccceeeeccCCccccccCCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC---
Q 014733          184 KLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAAD---  258 (419)
Q Consensus       184 KL~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~---  258 (419)
                      ||+|||+++.+..........||+.|+|||++.+  .|+.++|||||||++|+|++|++||.+....+....+....   
T Consensus       211 kL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p  290 (440)
T PTZ00036        211 KLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTP  290 (440)
T ss_pred             eeeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            9999999987765555556788999999999865  48999999999999999999999998877665555443211   


Q ss_pred             --------------CCCCCC--------CCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          259 --------------LRFPSD--------PWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       259 --------------~~~~~~--------~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                                    ..++..        .....+.++++||.+||++||.+|||+.|+++||||..+..
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~  359 (440)
T PTZ00036        291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD  359 (440)
T ss_pred             CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence                          111111        01246789999999999999999999999999999987654

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-47  Score=370.32  Aligned_cols=263  Identities=36%  Similarity=0.657  Sum_probs=238.1

Q ss_pred             cccCeee--eeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCE
Q 014733           38 LSDRYVL--GKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDY  115 (419)
Q Consensus        38 ~~~~y~i--~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~  115 (419)
                      +..-|+|  .++||.|.||+||-|.++.+|+.||||+|.|.+....+ ..++++|+.||+.+. ||.||.+-..|++.+.
T Consensus       560 ~stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq-esqlR~EVaILq~l~-HPGiV~le~M~ET~er  637 (888)
T KOG4236|consen  560 ISTVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ-ESQLRNEVAILQNLH-HPGIVNLECMFETPER  637 (888)
T ss_pred             HHHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCch-HHHHHHHHHHHHhcC-CCCeeEEEEeecCCce
Confidence            4445666  47999999999999999999999999999998876544 488999999999996 9999999999999999


Q ss_pred             EEEEEeecCCCChHHHH-H-HcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceee
Q 014733          116 VHLLMELCAGGELFHRL-E-KYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATY  193 (419)
Q Consensus       116 ~~lV~E~~~ggsL~~~l-~-~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~  193 (419)
                      +++|||-+.| ++...| . ..+++++...+.++.||+.||.|||.++|+|+||||+|||+...+.--.+||||||+|+.
T Consensus       638 vFVVMEKl~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARi  716 (888)
T KOG4236|consen  638 VFVVMEKLHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARI  716 (888)
T ss_pred             EEEEehhhcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceee
Confidence            9999999955 555544 3 347899999999999999999999999999999999999997765556899999999999


Q ss_pred             eccCCccccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHH
Q 014733          194 IKAGQNLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISAS  272 (419)
Q Consensus       194 ~~~~~~~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  272 (419)
                      ++...-..+.+|||.|+|||+++. +|+...|+||.|||+|--++|..||..  .+++-++|++..+.+|..+|.+++.+
T Consensus       717 IgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE--dEdIndQIQNAaFMyPp~PW~eis~~  794 (888)
T KOG4236|consen  717 IGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE--DEDINDQIQNAAFMYPPNPWSEISPE  794 (888)
T ss_pred             cchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC--ccchhHHhhccccccCCCchhhcCHH
Confidence            988887888899999999999987 599999999999999999999999964  46788899999999999999999999


Q ss_pred             HHHHHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          273 ARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       273 l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                      +.|||..+|++.-.+|.|+++.|.|||+++...
T Consensus       795 AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq~  827 (888)
T KOG4236|consen  795 AIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQT  827 (888)
T ss_pred             HHHHHHHHHHHHHHHhcchHhhccchhhhcchH
Confidence            999999999999999999999999999998754

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=2.5e-45  Score=353.10  Aligned_cols=261  Identities=31%  Similarity=0.489  Sum_probs=217.7

Q ss_pred             CeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEE
Q 014733           41 RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLM  120 (419)
Q Consensus        41 ~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~  120 (419)
                      .|++.+.||+|+||.||+|.+..+++.+|+|.+.+...........+.+|+.++++++ |+||+.+++.+.+.+.+++||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~~~~~~~lv~   79 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVN-SRFVVSLAYAYETKDALCLVL   79 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCC-CCCeeeeeEEEecCCEEEEEE
Confidence            3788899999999999999999999999999987665444444566788999999996 999999999999999999999


Q ss_pred             eecCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC
Q 014733          121 ELCAGGELFHRLEKYG--RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ  198 (419)
Q Consensus       121 E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~  198 (419)
                      ||++|++|.+++...+  .+++..+..++.|++.||.|||+.+|+||||||+||++   +.++.++|+|||++.......
T Consensus        80 e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05630          80 TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQ  156 (285)
T ss_pred             EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE---CCCCCEEEeeccceeecCCCc
Confidence            9999999998885433  58999999999999999999999999999999999999   567789999999998765544


Q ss_pred             ccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHH
Q 014733          199 NLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLI  277 (419)
Q Consensus       199 ~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li  277 (419)
                      ......|+..|+|||++.+. ++.++|+||+|+++|+|++|+.||...................+......+++++.+|+
T Consensus       157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  236 (285)
T cd05630         157 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLC  236 (285)
T ss_pred             cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHH
Confidence            44556899999999998764 89999999999999999999999976543221111111111112223346889999999


Q ss_pred             HhhhhcCCCCCCC-----HHHHHhccccccchh
Q 014733          278 MGMLRVDPSTRLT-----AAEVLAHSWMEECEQ  305 (419)
Q Consensus       278 ~~~L~~dP~~Rps-----~~eil~hp~~~~~~~  305 (419)
                      .+||+.||++|||     ++++++||||++...
T Consensus       237 ~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~  269 (285)
T cd05630         237 KMLLCKDPKERLGCQGGGAREVKEHPLFKQINF  269 (285)
T ss_pred             HHHhhcCHHHccCCCCCchHHHHcChhhhccCH
Confidence            9999999999999     999999999987533

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1e-45  Score=362.55  Aligned_cols=252  Identities=32%  Similarity=0.561  Sum_probs=215.3

Q ss_pred             eeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHH-HHHHccCCCCceeeeEEEEeCCEEEEEEeecC
Q 014733           46 KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIE-IMTKLSGHPNVVDLKAVYEEEDYVHLLMELCA  124 (419)
Q Consensus        46 ~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~-il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~  124 (419)
                      +.||+|+||+||+|.++.+++.+|+|++.+...........+..|.. +++.+. ||||+++++++.+.+.+|+||||++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~-h~~Iv~~~~~~~~~~~~~lv~e~~~   79 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK-HPFLVGLHFSFQTADKLYFVLDYIN   79 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCC-CCCCCceeEEEEcCCeEEEEEeCCC
Confidence            46999999999999999999999999997654333333444555544 466774 9999999999999999999999999


Q ss_pred             CCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeecc-CCccccc
Q 014733          125 GGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA-GQNLHGT  203 (419)
Q Consensus       125 ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~-~~~~~~~  203 (419)
                      |++|.+++...+.+++..++.++.||++||+|||++||+||||||+|||+   +.++.+||+|||++..... .......
T Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili---~~~~~~kl~DfG~a~~~~~~~~~~~~~  156 (325)
T cd05602          80 GGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL---DSQGHIVLTDFGLCKENIEHNGTTSTF  156 (325)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEEccCCCCcccccCCCCcccc
Confidence            99999999888889999999999999999999999999999999999999   5677899999999875432 2223445


Q ss_pred             cCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhh
Q 014733          204 VGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLR  282 (419)
Q Consensus       204 ~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~  282 (419)
                      +||+.|+|||++.+. ++.++|||||||++|+|++|++||.+.+..+....+......++    ..++.++.++|.+||+
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~  232 (325)
T cd05602         157 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----PNITNSARHLLEGLLQ  232 (325)
T ss_pred             cCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCC----CCCCHHHHHHHHHHcc
Confidence            799999999998774 89999999999999999999999999888888888776544433    3689999999999999


Q ss_pred             cCCCCCCCHH----HHHhccccccchh
Q 014733          283 VDPSTRLTAA----EVLAHSWMEECEQ  305 (419)
Q Consensus       283 ~dP~~Rps~~----eil~hp~~~~~~~  305 (419)
                      .||.+|+++.    ++++|+||....+
T Consensus       233 ~~p~~R~~~~~~~~~i~~~~~~~~~~~  259 (325)
T cd05602         233 KDRTKRLGAKDDFMEIKNHIFFSPINW  259 (325)
T ss_pred             cCHHHCCCCCCCHHHHhcCcccCCCCH
Confidence            9999999876    8999999976543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=2.7e-45  Score=352.08  Aligned_cols=255  Identities=30%  Similarity=0.481  Sum_probs=208.8

Q ss_pred             CeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHcc--CCCCceeeeEEEEe-----C
Q 014733           41 RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLS--GHPNVVDLKAVYEE-----E  113 (419)
Q Consensus        41 ~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~--~hpnIv~l~~~~~~-----~  113 (419)
                      +|++.+.||+|+||+||+|.++.+|+.||+|.+...... ......+.+|+.++++++  +||||+++++++.+     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~   79 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNE-DGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE   79 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCC-CCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence            689999999999999999999999999999998764321 122334567788777764  59999999999864     3


Q ss_pred             CEEEEEEeecCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccce
Q 014733          114 DYVHLLMELCAGGELFHRLEKYG--RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA  191 (419)
Q Consensus       114 ~~~~lV~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla  191 (419)
                      ..++++|||++ ++|..++....  .+++.+++.++.|++.||.|||+.||+||||||+|||+   +.++.+||+|||++
T Consensus        80 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili---~~~~~~kl~dfg~~  155 (288)
T cd07863          80 TKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV---TSGGQVKLADFGLA  155 (288)
T ss_pred             ceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECccCcc
Confidence            46899999996 58888887643  48999999999999999999999999999999999999   56778999999999


Q ss_pred             eeeccCCccccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-----------
Q 014733          192 TYIKAGQNLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADL-----------  259 (419)
Q Consensus       192 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-----------  259 (419)
                      .............||..|+|||++.+ .++.++||||+||++|+|++|++||.+....+....+.....           
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07863         156 RIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV  235 (288)
T ss_pred             ccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence            87654444445678999999999876 489999999999999999999999988776665555433110           


Q ss_pred             C-----CC-------CCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhcccc
Q 014733          260 R-----FP-------SDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWM  300 (419)
Q Consensus       260 ~-----~~-------~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~  300 (419)
                      .     +.       ......++.++.++|.+||++||++|||+.+++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         236 TLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             cccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            0     00       01123578889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=2.9e-45  Score=364.20  Aligned_cols=260  Identities=27%  Similarity=0.462  Sum_probs=211.8

Q ss_pred             ccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeC---
Q 014733           37 NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEE---  113 (419)
Q Consensus        37 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~---  113 (419)
                      .+.++|++.+.||+|+||.||+|.+..+|..||+|++.+.. ........+.+|+.+++.+. ||||+++++++...   
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~   95 (359)
T cd07876          18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF-QNQTHAKRAYRELVLLKCVN-HKNIISLLNVFTPQKSL   95 (359)
T ss_pred             hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc-cchhHHHHHHHHHHHHHhCC-CCCEeeeeeeeccCCCc
Confidence            45689999999999999999999999999999999987543 23345667889999999996 99999999998654   


Q ss_pred             ---CEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccc
Q 014733          114 ---DYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGL  190 (419)
Q Consensus       114 ---~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgl  190 (419)
                         ..+|+||||+.+ +|.+.+.  ..+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+
T Consensus        96 ~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~---~~~~~~kl~Dfg~  169 (359)
T cd07876          96 EEFQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGL  169 (359)
T ss_pred             cccceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEecCCC
Confidence               357999999965 6666654  358899999999999999999999999999999999999   5678999999999


Q ss_pred             eeeeccCCccccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-------------
Q 014733          191 ATYIKAGQNLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRA-------------  256 (419)
Q Consensus       191 a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~-------------  256 (419)
                      +.............||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..+.+..+..             
T Consensus       170 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (359)
T cd07876         170 ARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL  249 (359)
T ss_pred             ccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence            986544444455688999999999877 489999999999999999999999987665443322211             


Q ss_pred             ---------cCCCCCC----------------CCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccch
Q 014733          257 ---------ADLRFPS----------------DPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECE  304 (419)
Q Consensus       257 ---------~~~~~~~----------------~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~  304 (419)
                               .....+.                ......+.++++||.+||+.||++|||+.|+|+||||....
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  322 (359)
T cd07876         250 QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWY  322 (359)
T ss_pred             HHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhc
Confidence                     1111110                01112467899999999999999999999999999998643

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=2.3e-45  Score=364.12  Aligned_cols=255  Identities=26%  Similarity=0.411  Sum_probs=210.7

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEE
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHL  118 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~l  118 (419)
                      .++|+++++||+|+||.||+|.+..+++.||+|++....  .......+.+|+++++++. |+||+++++++.+.+.+++
T Consensus        73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~l  149 (353)
T PLN00034         73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVN-HPNVVKCHDMFDHNGEIQV  149 (353)
T ss_pred             HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCC-CCCcceeeeEeccCCeEEE
Confidence            467889999999999999999999999999999986542  3345677899999999996 9999999999999999999


Q ss_pred             EEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC
Q 014733          119 LMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ  198 (419)
Q Consensus       119 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~  198 (419)
                      ||||+.+++|...    ....+..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++..+....
T Consensus       150 v~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~~~~kL~DfG~~~~~~~~~  222 (353)
T PLN00034        150 LLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLI---NSAKNVKIADFGVSRILAQTM  222 (353)
T ss_pred             EEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE---cCCCCEEEcccccceeccccc
Confidence            9999999998642    345778888999999999999999999999999999999   567789999999998764332


Q ss_pred             -ccccccCCCccCCcccccC-----C-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCH
Q 014733          199 -NLHGTVGSPFYIAPEVLAG-----G-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISA  271 (419)
Q Consensus       199 -~~~~~~gt~~y~aPE~l~~-----~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  271 (419)
                       ......||..|+|||++..     . .+.++|||||||++|+|++|+.||......+....+.......+......++.
T Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (353)
T PLN00034        223 DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASR  302 (353)
T ss_pred             ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCH
Confidence             2234579999999998743     2 35689999999999999999999974433332222222222222333347899


Q ss_pred             HHHHHHHhhhhcCCCCCCCHHHHHhccccccc
Q 014733          272 SARDLIMGMLRVDPSTRLTAAEVLAHSWMEEC  303 (419)
Q Consensus       272 ~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~  303 (419)
                      ++++||.+||+.||++|||+.|+++||||...
T Consensus       303 ~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~  334 (353)
T PLN00034        303 EFRHFISCCLQREPAKRWSAMQLLQHPFILRA  334 (353)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence            99999999999999999999999999999864

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1e-44  Score=356.89  Aligned_cols=259  Identities=25%  Similarity=0.394  Sum_probs=216.5

Q ss_pred             cccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEE
Q 014733           38 LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVH  117 (419)
Q Consensus        38 ~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~  117 (419)
                      ..++|++.+.||.|+||.||+|.+..++..+|+|.+...  ........+.+|+++++++. ||||+++++++.+.+.++
T Consensus         3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~   79 (333)
T cd06650           3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLE--IKPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGEIS   79 (333)
T ss_pred             chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecc--cCHHHHHHHHHHHHHHHHCC-CCcccceeEEEEECCEEE
Confidence            358999999999999999999999999999999998754  23445677899999999996 999999999999999999


Q ss_pred             EEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC-CCeeccCCCCcEEEeecCCCCCeEEeeccceeeecc
Q 014733          118 LLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGN-GVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA  196 (419)
Q Consensus       118 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~-~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~  196 (419)
                      +||||+++++|.+++...+.+++..+..++.+++.||.|||+. +|+||||||+|||+   +.++.+||+|||++.....
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~~~~~~~  156 (333)
T cd06650          80 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLID  156 (333)
T ss_pred             EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEE---cCCCCEEEeeCCcchhhhh
Confidence            9999999999999998888899999999999999999999985 79999999999999   5567899999999876533


Q ss_pred             CCccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc------------------
Q 014733          197 GQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAA------------------  257 (419)
Q Consensus       197 ~~~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~------------------  257 (419)
                      . ......||..|+|||++.+. ++.++|+|||||++|+|++|+.||......+....+...                  
T Consensus       157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (333)
T cd06650         157 S-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPG  235 (333)
T ss_pred             h-ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCcc
Confidence            2 22345789999999998774 899999999999999999999999765543332211000                  


Q ss_pred             ------------------------CCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccc
Q 014733          258 ------------------------DLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEEC  303 (419)
Q Consensus       258 ------------------------~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~  303 (419)
                                              ....+......++.++++||.+||++||++|||+.|++.||||+..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  305 (333)
T cd06650         236 RPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  305 (333)
T ss_pred             chhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence                                    0000111112367899999999999999999999999999999854

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=4.2e-45  Score=355.23  Aligned_cols=259  Identities=25%  Similarity=0.476  Sum_probs=214.3

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      ++|++.+.||+|+||.||+|+++.+++.+|+|.+.....  ......+.+|+.++++++ ||||+++++++.+++..++|
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv   82 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKDLK-HANIVTLHDIVHTDKSLTLV   82 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc--CCcchhHHHHHHHHHhCC-CCCcceEEEEEeeCCeEEEE
Confidence            679999999999999999999999999999999875432  223345678999999996 99999999999999999999


Q ss_pred             EeecCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC
Q 014733          120 MELCAGGELFHRLEKYG-RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ  198 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~  198 (419)
                      |||+++ +|.+++...+ .+++..++.++.||+.||+|||+.||+||||||+|||+   +.++.+||+|||++.......
T Consensus        83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~  158 (309)
T cd07872          83 FEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLI---NERGELKLADFGLARAKSVPT  158 (309)
T ss_pred             EeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECccccceecCCCc
Confidence            999964 8888876544 48999999999999999999999999999999999999   567789999999987643322


Q ss_pred             -ccccccCCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC----------------
Q 014733          199 -NLHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADL----------------  259 (419)
Q Consensus       199 -~~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~----------------  259 (419)
                       ......+|+.|+|||++.+  .++.++|||||||++|+|++|++||.+.+..+....+.....                
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
T cd07872         159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF  238 (309)
T ss_pred             cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence             2234578899999999865  388999999999999999999999988776555544432110                


Q ss_pred             ---CCCC-------CCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          260 ---RFPS-------DPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       260 ---~~~~-------~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                         .++.       .....++.++++||.+||+.||.+|||+.|+++||||+....
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~  294 (309)
T cd07872         239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGT  294 (309)
T ss_pred             hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhccc
Confidence               0111       011357889999999999999999999999999999987643

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=6.3e-45  Score=348.72  Aligned_cols=251  Identities=27%  Similarity=0.458  Sum_probs=209.8

Q ss_pred             ecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEEeecCCCC
Q 014733           48 LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGE  127 (419)
Q Consensus        48 LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~ggs  127 (419)
                      ||+|+||.||++.++.+|+.+|+|.+.++..........+..|+++++++. ||||+++++++.+...+++||||++|++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~i~~~~~~~~~~~~~~lv~e~~~g~~   79 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVN-SPFIVNLAYAFESKTHLCLVMSLMNGGD   79 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcC-CCcEEEEEEEEecCCeEEEEEecCCCCC
Confidence            799999999999999999999999997654433334455667999999995 9999999999999999999999999999


Q ss_pred             hHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCCccccccC
Q 014733          128 LFHRLEKYG--RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVG  205 (419)
Q Consensus       128 L~~~l~~~~--~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~~~~~~~g  205 (419)
                      |..++...+  .+++..+..++.|++.||+|||+.||+||||||+||++   +.++.+||+|||++.............|
T Consensus        80 L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  156 (277)
T cd05607          80 LKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLL---DDQGNCRLSDLGLAVELKDGKTITQRAG  156 (277)
T ss_pred             HHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEE---cCCCCEEEeeceeeeecCCCceeeccCC
Confidence            998886543  48899999999999999999999999999999999999   5677899999999987655444445678


Q ss_pred             CCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhh
Q 014733          206 SPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAVRAADLRFPSDPWDHISASARDLIMGM  280 (419)
Q Consensus       206 t~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~  280 (419)
                      +..|+|||++.+. ++.++|+||+||++|+|++|+.||.....    .++...+.......+   ...++.+++++|.+|
T Consensus       157 ~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~  233 (277)
T cd05607         157 TNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFE---HQNFTEESKDICRLF  233 (277)
T ss_pred             CCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccc---cccCCHHHHHHHHHH
Confidence            9999999998764 89999999999999999999999976433    223233222222222   236899999999999


Q ss_pred             hhcCCCCCCCH----HHHHhccccccchh
Q 014733          281 LRVDPSTRLTA----AEVLAHSWMEECEQ  305 (419)
Q Consensus       281 L~~dP~~Rps~----~eil~hp~~~~~~~  305 (419)
                      |+.||++||++    ++++.||||+....
T Consensus       234 L~~~P~~R~~~~~~~~~~~~h~~f~~~~~  262 (277)
T cd05607         234 LAKKPEDRLGSREKNDDPRKHEFFKTINF  262 (277)
T ss_pred             hccCHhhCCCCccchhhhhcChhhcCCCH
Confidence            99999999999    77889999987643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=7.8e-45  Score=373.65  Aligned_cols=263  Identities=26%  Similarity=0.389  Sum_probs=209.3

Q ss_pred             cccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHcc-----CCCCceeeeEEE
Q 014733           36 SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLS-----GHPNVVDLKAVY  110 (419)
Q Consensus        36 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----~hpnIv~l~~~~  110 (419)
                      ....++|+++++||+|+||+||+|.+..+++.||+|++...    ....+....|+.+++.+.     +|.+++++++++
T Consensus       125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~  200 (467)
T PTZ00284        125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV----PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF  200 (467)
T ss_pred             ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc----hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence            33468999999999999999999999999999999998643    123445667888888775     244588999988


Q ss_pred             EeC-CEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeccCCCCcEEEeecCC---------
Q 014733          111 EEE-DYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG-NGVVHRDLKPENILLATKSS---------  179 (419)
Q Consensus       111 ~~~-~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~-~~IvHrDLkp~NILl~~~~~---------  179 (419)
                      ... .++++|||++ |++|.+++.+.+.+++.+++.++.||+.||+|||+ .|||||||||+|||++.++.         
T Consensus       201 ~~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~  279 (467)
T PTZ00284        201 QNETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRA  279 (467)
T ss_pred             EcCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccc
Confidence            764 5789999988 78999999888889999999999999999999998 59999999999999964321         


Q ss_pred             ----CCCeEEeeccceeeeccCCccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 014733          180 ----SSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAV  254 (419)
Q Consensus       180 ----~~~vKL~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i  254 (419)
                          ...+||+|||.+....  ......+||+.|+|||++.+. |+.++|||||||++|||++|++||.+....+....+
T Consensus       280 ~~~~~~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i  357 (467)
T PTZ00284        280 LPPDPCRVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLM  357 (467)
T ss_pred             cCCCCceEEECCCCccccCc--cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence                1259999999886432  223456899999999998874 999999999999999999999999887765555444


Q ss_pred             HhcCCCCCCC------------------------------------CC--CCCCHHHHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          255 RAADLRFPSD------------------------------------PW--DHISASARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       255 ~~~~~~~~~~------------------------------------~~--~~~s~~l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                      ......++..                                    .+  ...++.+.|||.+||++||++|||++|+|+
T Consensus       358 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~  437 (467)
T PTZ00284        358 EKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT  437 (467)
T ss_pred             HHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence            3321111100                                    00  011456789999999999999999999999


Q ss_pred             ccccccchh
Q 014733          297 HSWMEECEQ  305 (419)
Q Consensus       297 hp~~~~~~~  305 (419)
                      ||||.+...
T Consensus       438 Hp~~~~~~~  446 (467)
T PTZ00284        438 HPYVLKYYP  446 (467)
T ss_pred             CccccccCC
Confidence            999987543

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.4e-44  Score=359.94  Aligned_cols=260  Identities=26%  Similarity=0.432  Sum_probs=213.5

Q ss_pred             ccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeC---
Q 014733           37 NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEE---  113 (419)
Q Consensus        37 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~---  113 (419)
                      .+.++|++.+.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.+. ||||+++++++...   
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~ii~~~~~~~~~~~~   98 (364)
T cd07875          21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVN-HKNIIGLLNVFTPQKSL   98 (364)
T ss_pred             chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc-cCchhHHHHHHHHHHHHhcC-CCCccccceeecccccc
Confidence            35689999999999999999999999999999999987543 23345567888999999995 99999999987543   


Q ss_pred             ---CEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccc
Q 014733          114 ---DYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGL  190 (419)
Q Consensus       114 ---~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgl  190 (419)
                         ..+|+||||++ ++|...+..  .+++..+..++.|++.||+|||++||+||||||+|||+   +.++.+||+|||+
T Consensus        99 ~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~  172 (364)
T cd07875          99 EEFQDVYIVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGL  172 (364)
T ss_pred             cccCeEEEEEeCCC-CCHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEE---CCCCcEEEEeCCC
Confidence               46899999996 477777643  48899999999999999999999999999999999999   5677899999999


Q ss_pred             eeeeccCCccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC---------
Q 014733          191 ATYIKAGQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLR---------  260 (419)
Q Consensus       191 a~~~~~~~~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---------  260 (419)
                      +.............||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+.+..+.+..+......         
T Consensus       173 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (364)
T cd07875         173 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL  252 (364)
T ss_pred             ccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence            9876554444556899999999998774 899999999999999999999999887766655544321100         


Q ss_pred             -------------C--------------C--CCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccch
Q 014733          261 -------------F--------------P--SDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECE  304 (419)
Q Consensus       261 -------------~--------------~--~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~  304 (419)
                                   +              +  .......+.++++||.+||+.||.+|||+.++|+||||....
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~  325 (364)
T cd07875         253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY  325 (364)
T ss_pred             hHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccccc
Confidence                         0              0  001112356889999999999999999999999999997543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.7e-44  Score=347.26  Aligned_cols=261  Identities=30%  Similarity=0.489  Sum_probs=221.2

Q ss_pred             CeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEE
Q 014733           41 RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLM  120 (419)
Q Consensus        41 ~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~  120 (419)
                      .|+..+.||.|+||+||+|.+..+++.+|+|.+.+...........+.+|+.+|++++ |+||+.+.+.+.+++..+++|
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~~~~~~~lv~   79 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVN-SQFVVNLAYAYETKDALCLVL   79 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC-CcCceeEEEEEecCCEEEEEE
Confidence            3788899999999999999999999999999997665444444566788999999995 999999999999999999999


Q ss_pred             eecCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC
Q 014733          121 ELCAGGELFHRLEKY--GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ  198 (419)
Q Consensus       121 E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~  198 (419)
                      ||+++++|..++...  ..+++..+..++.|++.||.|||+.+|+||||||+||++   +.++.+||+|||++.......
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05632          80 TIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILL---DDYGHIRISDLGLAVKIPEGE  156 (285)
T ss_pred             EeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE---CCCCCEEEecCCcceecCCCC
Confidence            999999999888653  359999999999999999999999999999999999999   556789999999997655444


Q ss_pred             ccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHH
Q 014733          199 NLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLI  277 (419)
Q Consensus       199 ~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li  277 (419)
                      ......|+..|+|||++.+. ++.++|+||+|+++|+|++|..||.+.......+.+..............++.++.+|+
T Consensus       157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  236 (285)
T cd05632         157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSIC  236 (285)
T ss_pred             cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHH
Confidence            44456799999999998764 89999999999999999999999987765544444433222222333457889999999


Q ss_pred             HhhhhcCCCCCCC-----HHHHHhccccccchh
Q 014733          278 MGMLRVDPSTRLT-----AAEVLAHSWMEECEQ  305 (419)
Q Consensus       278 ~~~L~~dP~~Rps-----~~eil~hp~~~~~~~  305 (419)
                      .+||+.||++||+     +.+++.|+||+....
T Consensus       237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~  269 (285)
T cd05632         237 KMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNF  269 (285)
T ss_pred             HHHccCCHhHcCCCcccChHHHHcChhhhcCCH
Confidence            9999999999999     889999999987644

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=3.6e-45  Score=344.97  Aligned_cols=254  Identities=39%  Similarity=0.671  Sum_probs=213.8

Q ss_pred             eeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEEe
Q 014733           42 YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLME  121 (419)
Q Consensus        42 y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  121 (419)
                      |++++.||+|+||+||++.+..+++.+|+|++...... ........+|+.++++++ ||||+++++++.+....+++||
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~-~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~~v~~   78 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIE-EEEREENIREIKILRRLR-HPNIVQILDVFQDDNYLYIVME   78 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHH-HHHHHHHHHHHHHHHHHT-BTTBCHEEEEEEESSEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccc-ccccchhhhhhhcccccc-cccccccccccccccccccccc
Confidence            89999999999999999999999999999999876431 222334456999999995 9999999999999999999999


Q ss_pred             ecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeee-ccCCcc
Q 014733          122 LCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI-KAGQNL  200 (419)
Q Consensus       122 ~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~-~~~~~~  200 (419)
                      |+++++|.+++...+.+++.++..++.||++||++||+.+|+|+||||+||++   +.++.++|+|||.+... ......
T Consensus        79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~---~~~~~~~l~Dfg~~~~~~~~~~~~  155 (260)
T PF00069_consen   79 YCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILL---DENGEVKLIDFGSSVKLSENNENF  155 (260)
T ss_dssp             EETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEE---STTSEEEESSGTTTEESTSTTSEB
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccc
Confidence            99999999999977889999999999999999999999999999999999999   56788999999999864 223344


Q ss_pred             ccccCCCccCCccccc-C-CCCCchhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 014733          201 HGTVGSPFYIAPEVLA-G-GYNQAADVWSAGVILYILLSGMPPFWGKTK---SKIFDAVRAADLRFPSDPWDHISASARD  275 (419)
Q Consensus       201 ~~~~gt~~y~aPE~l~-~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~s~~l~~  275 (419)
                      ....++..|+|||++. + .++.++|+||||+++|+|++|..||.....   ......................+.++.+
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  235 (260)
T PF00069_consen  156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRD  235 (260)
T ss_dssp             SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHH
Confidence            5568899999999987 4 489999999999999999999999988733   3333333332222222222233489999


Q ss_pred             HHHhhhhcCCCCCCCHHHHHhcccc
Q 014733          276 LIMGMLRVDPSTRLTAAEVLAHSWM  300 (419)
Q Consensus       276 li~~~L~~dP~~Rps~~eil~hp~~  300 (419)
                      +|.+||+.||++||++.++++||||
T Consensus       236 li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  236 LIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             HHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             HHHHHccCChhHCcCHHHHhcCCCC
Confidence            9999999999999999999999997

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.5e-44  Score=358.35  Aligned_cols=260  Identities=27%  Similarity=0.440  Sum_probs=212.2

Q ss_pred             ccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeC---
Q 014733           37 NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEE---  113 (419)
Q Consensus        37 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~---  113 (419)
                      .+.++|++.+.||+|+||.||+|.+..+++.+|+|.+.... ........+.+|+.+++.++ ||||+++++++...   
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~   91 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQKSL   91 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcc-cChHHHHHHHHHHHHHHHhC-CCchhceeeeeeccccc
Confidence            45689999999999999999999999999999999986543 23345677888999999996 99999999998643   


Q ss_pred             ---CEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccc
Q 014733          114 ---DYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGL  190 (419)
Q Consensus       114 ---~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgl  190 (419)
                         ..+|+||||+++ +|.+.+..  .+++..+..++.|+++||+|||+.||+||||||+|||+   +.++.+||+|||+
T Consensus        92 ~~~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill---~~~~~~kl~Dfg~  165 (355)
T cd07874          92 EEFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGL  165 (355)
T ss_pred             cccceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE---CCCCCEEEeeCcc
Confidence               357999999965 67666643  58899999999999999999999999999999999999   5677899999999


Q ss_pred             eeeeccCCccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-----------
Q 014733          191 ATYIKAGQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAAD-----------  258 (419)
Q Consensus       191 a~~~~~~~~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-----------  258 (419)
                      +.............||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+....+.+..+....           
T Consensus       166 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (355)
T cd07874         166 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL  245 (355)
T ss_pred             cccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence            9876554444556899999999998774 8999999999999999999999998776544433221110           


Q ss_pred             -----------CC-----CC-----------CCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccch
Q 014733          259 -----------LR-----FP-----------SDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECE  304 (419)
Q Consensus       259 -----------~~-----~~-----------~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~  304 (419)
                                 ..     ++           .......+.++++||.+||+.||++|||+.|+|+||||....
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~  318 (355)
T cd07874         246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWY  318 (355)
T ss_pred             cHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhccc
Confidence                       00     00           011123467889999999999999999999999999997653

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.9e-44  Score=349.19  Aligned_cols=260  Identities=25%  Similarity=0.466  Sum_probs=215.7

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      ++|++.+.||.|+||.||+|.++.+++.||+|.+.....  ......+.+|+.+++++. ||||+++++++.+.+.+++|
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~nI~~~~~~~~~~~~~~lv   82 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLK-HANIVTLHDIIHTEKSLTLV   82 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc--cCchhHHHHHHHHHHhcC-CCCcceEEEEEecCCeEEEE
Confidence            679999999999999999999999999999999875432  223345678999999996 99999999999999999999


Q ss_pred             EeecCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC
Q 014733          120 MELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ  198 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~  198 (419)
                      |||++ ++|..++... ..+++..+..++.||++||+|||+.+|+|+||||+|||+   +.++.+||+|||++.......
T Consensus        83 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~  158 (301)
T cd07873          83 FEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLI---NERGELKLADFGLARAKSIPT  158 (301)
T ss_pred             Eeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEE---CCCCcEEECcCcchhccCCCC
Confidence            99996 5888888654 458999999999999999999999999999999999999   566789999999987543222


Q ss_pred             -ccccccCCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC---------------
Q 014733          199 -NLHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLR---------------  260 (419)
Q Consensus       199 -~~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---------------  260 (419)
                       ......+++.|+|||++.+  .++.++|||||||++|+|++|++||.+.+..+....+......               
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (301)
T cd07873         159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF  238 (301)
T ss_pred             CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc
Confidence             2234567899999999865  3788999999999999999999999887766655544332110               


Q ss_pred             ----CCC-------CCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchhh
Q 014733          261 ----FPS-------DPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQV  306 (419)
Q Consensus       261 ----~~~-------~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~~  306 (419)
                          .+.       .....++.++++||.+||+.||.+|||+.++++||||+...+.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~~  295 (301)
T cd07873         239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGER  295 (301)
T ss_pred             cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccch
Confidence                110       0123578899999999999999999999999999999877653

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-44  Score=339.21  Aligned_cols=255  Identities=29%  Similarity=0.514  Sum_probs=218.3

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCC--HHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVT--VEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVH  117 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~--~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~  117 (419)
                      +.|.+.+.||.|++|.||.|.+..++..+|+|.+.......  ......+.+|+++++++. ||||+++++++.+...++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~   80 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ-HERIVQYYGCLRDDETLS   80 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCC-CCCeeeeEEEEccCCeEE
Confidence            56999999999999999999999999999999987553321  234567899999999995 999999999999999999


Q ss_pred             EEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccC
Q 014733          118 LLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG  197 (419)
Q Consensus       118 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~  197 (419)
                      +++||+++++|.+++...+.+++..+..++.|++.||.|||+.||+|+||+|+||++   +.++.+||+|||++......
T Consensus        81 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv---~~~~~~~l~dfg~~~~~~~~  157 (263)
T cd06625          81 IFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKRLQTI  157 (263)
T ss_pred             EEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeecccceecccc
Confidence            999999999999999888889999999999999999999999999999999999999   55678999999998765432


Q ss_pred             Ccc----ccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHH
Q 014733          198 QNL----HGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISAS  272 (419)
Q Consensus       198 ~~~----~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  272 (419)
                      ...    ....|+..|+|||++.+. ++.++||||||+++|+|++|+.||..........++.......  .....++.+
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  235 (263)
T cd06625         158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNP--QLPSHVSPD  235 (263)
T ss_pred             ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCC--CCCccCCHH
Confidence            211    234678899999998875 8999999999999999999999998766555544444332222  223468999


Q ss_pred             HHHHHHhhhhcCCCCCCCHHHHHhcccc
Q 014733          273 ARDLIMGMLRVDPSTRLTAAEVLAHSWM  300 (419)
Q Consensus       273 l~~li~~~L~~dP~~Rps~~eil~hp~~  300 (419)
                      +.++|.+||..+|++|||+.++++||||
T Consensus       236 ~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         236 ARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             HHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence            9999999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.3e-44  Score=361.34  Aligned_cols=258  Identities=26%  Similarity=0.475  Sum_probs=215.5

Q ss_pred             CeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCC-----E
Q 014733           41 RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEED-----Y  115 (419)
Q Consensus        41 ~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~-----~  115 (419)
                      +|++++.||+|+||.||+|.+..+|+.||+|.+.... ......+.+.+|+.+++.++ ||||+++++++.+.+     .
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~   78 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFK-HDNVLSALDILQPPHIDPFEE   78 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCC-CCCcCCHhheecCCCccccce
Confidence            4789999999999999999999999999999986432 23345677889999999996 999999999998776     8


Q ss_pred             EEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeec
Q 014733          116 VHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIK  195 (419)
Q Consensus       116 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~  195 (419)
                      .|+||||+. ++|...+...+.+++..++.++.||+.||+|||+.||+||||||+|||+   +.++.+||+|||++....
T Consensus        79 ~~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~a~~~~  154 (372)
T cd07853          79 IYVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLV---NSNCVLKICDFGLARVEE  154 (372)
T ss_pred             EEEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEE---CCCCCEEeccccceeecc
Confidence            999999995 6888888777889999999999999999999999999999999999999   567899999999998654


Q ss_pred             cCC--ccccccCCCccCCcccccCC--CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--------------
Q 014733          196 AGQ--NLHGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAA--------------  257 (419)
Q Consensus       196 ~~~--~~~~~~gt~~y~aPE~l~~~--~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--------------  257 (419)
                      ...  ......+|+.|+|||++.+.  ++.++||||+||++|+|++|+.||.+.+..+....+...              
T Consensus       155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  234 (372)
T cd07853         155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE  234 (372)
T ss_pred             cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence            322  22334688999999998763  799999999999999999999999887766555544321              


Q ss_pred             ---------CCCCCC-----CCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccch
Q 014733          258 ---------DLRFPS-----DPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECE  304 (419)
Q Consensus       258 ---------~~~~~~-----~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~  304 (419)
                               ....+.     ......++++.+||.+||+.||++|||+.++++||||++..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  295 (372)
T cd07853         235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR  295 (372)
T ss_pred             HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence                     111110     11235688999999999999999999999999999998753

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.2e-45  Score=348.72  Aligned_cols=258  Identities=30%  Similarity=0.554  Sum_probs=219.7

Q ss_pred             cccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeC--C-
Q 014733           38 LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEE--D-  114 (419)
Q Consensus        38 ~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~--~-  114 (419)
                      ..=.|.-.+++|+|+||+||.|....+++.||||.+..++.       --.+|+.+|+.+. |||||++..+|...  + 
T Consensus        22 ~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-------~knrEl~im~~l~-HpNIV~L~~~f~~~~~~d   93 (364)
T KOG0658|consen   22 VEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-------YKNRELQIMRKLD-HPNIVRLLYFFSSSTESD   93 (364)
T ss_pred             eEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-------cCcHHHHHHHhcC-CcCeeeEEEEEEecCCCc
Confidence            34468889999999999999999999999999999865432       2346899999995 99999999988532  2 


Q ss_pred             --EEEEEEeecCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeec
Q 014733          115 --YVHLLMELCAGGELFHRLEK----YGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADF  188 (419)
Q Consensus       115 --~~~lV~E~~~ggsL~~~l~~----~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DF  188 (419)
                        +..+||||++ .+|.+.++.    ..+++.-+++-+..||++||.|||+.||+||||||+|+|+|  ...|.+|||||
T Consensus        94 ~~~lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD--~~tg~LKicDF  170 (364)
T KOG0658|consen   94 EVYLNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVD--PDTGVLKICDF  170 (364)
T ss_pred             hhHHHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEc--CCCCeEEeccC
Confidence              4568999996 589888874    36689999999999999999999999999999999999996  45689999999


Q ss_pred             cceeeeccCCccccccCCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC--------
Q 014733          189 GLATYIKAGQNLHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAAD--------  258 (419)
Q Consensus       189 gla~~~~~~~~~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--------  258 (419)
                      |.|+.+..++...++..|+.|+|||.+.|  .|+.+.||||.||++.||+-|++-|.|.+..++...|...-        
T Consensus       171 GSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I  250 (364)
T KOG0658|consen  171 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDI  250 (364)
T ss_pred             CcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            99999998888888899999999999887  49999999999999999999999999988877776663321        


Q ss_pred             ---------CCC---CCCC-----CCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchhh
Q 014733          259 ---------LRF---PSDP-----WDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQV  306 (419)
Q Consensus       259 ---------~~~---~~~~-----~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~~  306 (419)
                               ..+   ....     ....++++.+|+.++|+.+|.+|.++.|++.||||......
T Consensus       251 ~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~  315 (364)
T KOG0658|consen  251 KSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP  315 (364)
T ss_pred             hhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence                     111   1112     24578999999999999999999999999999999887653

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=2.7e-44  Score=346.35  Aligned_cols=257  Identities=35%  Similarity=0.656  Sum_probs=228.7

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      ++|.+.+.||+|++|.||++.+..+++.+|+|++.+...........+.+|+++++++. ||||+++++++.+.+.+|+|
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v   79 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR-HPFLVNLYGSFQDDSNLYLV   79 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCccceeeEEEcCCeEEEE
Confidence            57999999999999999999999999999999997665545556778999999999996 99999999999999999999


Q ss_pred             EeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCCc
Q 014733          120 MELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN  199 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~~  199 (419)
                      |||+++++|.+++...+.+++..+..++.||++||.|||+.||+|+||+|.|||+   +.++.+||+|||++......  
T Consensus        80 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili---~~~~~~kl~dfg~~~~~~~~--  154 (290)
T cd05580          80 MEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLL---DSDGYIKITDFGFAKRVKGR--  154 (290)
T ss_pred             EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---CCCCCEEEeeCCCccccCCC--
Confidence            9999999999999888889999999999999999999999999999999999999   56678999999999876444  


Q ss_pred             cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHH
Q 014733          200 LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM  278 (419)
Q Consensus       200 ~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~  278 (419)
                      .....|++.|+|||.+.+. ++.++|+||||+++|+|++|+.||......+..+.+......++.    .++..++++|.
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~  230 (290)
T cd05580         155 TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPS----FFSPDAKDLIR  230 (290)
T ss_pred             CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCc----cCCHHHHHHHH
Confidence            3445789999999988764 789999999999999999999999888777777777665554443    56899999999


Q ss_pred             hhhhcCCCCCC-----CHHHHHhccccccchhh
Q 014733          279 GMLRVDPSTRL-----TAAEVLAHSWMEECEQV  306 (419)
Q Consensus       279 ~~L~~dP~~Rp-----s~~eil~hp~~~~~~~~  306 (419)
                      +||+.||.+|+     ++.++++||||+...+.
T Consensus       231 ~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~  263 (290)
T cd05580         231 NLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWI  263 (290)
T ss_pred             HHccCCHHHccCcccCCHHHHHcCcccccCCHH
Confidence            99999999999     99999999999876653

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=4.2e-44  Score=369.06  Aligned_cols=256  Identities=25%  Similarity=0.409  Sum_probs=221.6

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCC-CcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEE
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFT-GEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVH  117 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~-g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~  117 (419)
                      ...|.+.+.||+|++|.||+|.+..+ +..||+|.+...   .......+.+|+.+|+.+. ||||+++++++.+.+.+|
T Consensus        66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~-Hpniv~~~~~~~~~~~~~  141 (478)
T PTZ00267         66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACD-HFGIVKHFDDFKSDDKLL  141 (478)
T ss_pred             ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEEECCEEE
Confidence            44599999999999999999998877 788999977543   3345567888999999996 999999999999999999


Q ss_pred             EEEeecCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceee
Q 014733          118 LLMELCAGGELFHRLEK----YGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATY  193 (419)
Q Consensus       118 lV~E~~~ggsL~~~l~~----~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~  193 (419)
                      +||||++||+|.+++..    ..++++.++..++.||+.||+|||+.+|+||||||+|||+   +.++.+||+|||++..
T Consensus       142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll---~~~~~~kL~DFgla~~  218 (478)
T PTZ00267        142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFL---MPTGIIKLGDFGFSKQ  218 (478)
T ss_pred             EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEE---CCCCcEEEEeCcCcee
Confidence            99999999999987753    3468999999999999999999999999999999999999   5678899999999987


Q ss_pred             eccCCc---cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCC
Q 014733          194 IKAGQN---LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHI  269 (419)
Q Consensus       194 ~~~~~~---~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  269 (419)
                      ......   ....+||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+....++...+..+....   ....+
T Consensus       219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~---~~~~~  295 (478)
T PTZ00267        219 YSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDP---FPCPV  295 (478)
T ss_pred             cCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC---CCccC
Confidence            654322   2345799999999998764 8999999999999999999999999888888888777654432   12368


Q ss_pred             CHHHHHHHHhhhhcCCCCCCCHHHHHhccccccch
Q 014733          270 SASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECE  304 (419)
Q Consensus       270 s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~  304 (419)
                      +.++.++|.+||+.||++||++.+++.|+|++...
T Consensus       296 s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~~  330 (478)
T PTZ00267        296 SSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYVA  330 (478)
T ss_pred             CHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHHH
Confidence            89999999999999999999999999999997654

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-46  Score=358.00  Aligned_cols=264  Identities=32%  Similarity=0.533  Sum_probs=236.4

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEE
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHL  118 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~l  118 (419)
                      .+.|+.-.+||+|+||.|+-++.+.||+.+|+|.+.++++..........+|-.||++++ .+.||.+-..|++.+.+++
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~-s~FiVslaYAfeTkd~LCl  262 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVS-SPFIVSLAYAFETKDALCL  262 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhc-cCcEEEEeeeecCCCceEE
Confidence            467888899999999999999999999999999999988766667777889999999996 9999999999999999999


Q ss_pred             EEeecCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeecc
Q 014733          119 LMELCAGGELFHRLEKYG--RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA  196 (419)
Q Consensus       119 V~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~  196 (419)
                      ||..|+||+|.-+|-..+  .|++..+..++.+|+-||++||+.+||+|||||+|||+   ++.|+|+|+|.|+|..+..
T Consensus       263 VLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILL---Dd~GhvRISDLGLAvei~~  339 (591)
T KOG0986|consen  263 VLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILL---DDHGHVRISDLGLAVEIPE  339 (591)
T ss_pred             EEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheee---ccCCCeEeeccceEEecCC
Confidence            999999999988876655  59999999999999999999999999999999999999   6789999999999999999


Q ss_pred             CCccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 014733          197 GQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARD  275 (419)
Q Consensus       197 ~~~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~  275 (419)
                      +....+.+||.+|||||++.+. |+...|+|||||+||||+.|+.||.......-.+.+.......+.......|+++++
T Consensus       340 g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eaks  419 (591)
T KOG0986|consen  340 GKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAKS  419 (591)
T ss_pred             CCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHHH
Confidence            9998888999999999999875 999999999999999999999999765544444344444444444555689999999


Q ss_pred             HHHhhhhcCCCCCC-----CHHHHHhccccccchhh
Q 014733          276 LIMGMLRVDPSTRL-----TAAEVLAHSWMEECEQV  306 (419)
Q Consensus       276 li~~~L~~dP~~Rp-----s~~eil~hp~~~~~~~~  306 (419)
                      +.+.+|++||++|+     .+.++.+||||+.+.+.
T Consensus       420 lc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~  455 (591)
T KOG0986|consen  420 LCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWR  455 (591)
T ss_pred             HHHHHHccCHHHhccCCCcCcchhhhCcccccCCHh
Confidence            99999999999998     67799999999998764

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=3.3e-44  Score=370.87  Aligned_cols=264  Identities=25%  Similarity=0.424  Sum_probs=225.9

Q ss_pred             hhccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEe
Q 014733           33 TQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEE  112 (419)
Q Consensus        33 ~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~  112 (419)
                      ...+...++|++.+.||+|+||+||+|.+..+|+.||+|++..... .......+.+|+.++..+. |+||+++++.+..
T Consensus        25 ~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~-h~~iv~~~~~~~~  102 (496)
T PTZ00283         25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCD-FFSIVKCHEDFAK  102 (496)
T ss_pred             ccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCC-CCcEEEeecceec
Confidence            3445567899999999999999999999999999999999977653 4566778889999999995 9999999887754


Q ss_pred             CC--------EEEEEEeecCCCChHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCC
Q 014733          113 ED--------YVHLLMELCAGGELFHRLEKY----GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSS  180 (419)
Q Consensus       113 ~~--------~~~lV~E~~~ggsL~~~l~~~----~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~  180 (419)
                      ..        .+++||||+++|+|.+++...    ..+++.++..++.|++.||.|||+.+|+||||||+|||+   +.+
T Consensus       103 ~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl---~~~  179 (496)
T PTZ00283        103 KDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILL---CSN  179 (496)
T ss_pred             ccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---eCC
Confidence            32        478999999999999988643    458999999999999999999999999999999999999   557


Q ss_pred             CCeEEeeccceeeeccC---CccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 014733          181 SPIKLADFGLATYIKAG---QNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRA  256 (419)
Q Consensus       181 ~~vKL~DFgla~~~~~~---~~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~  256 (419)
                      +.+||+|||+++.....   ......+||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+.+..+....+..
T Consensus       180 ~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~  259 (496)
T PTZ00283        180 GLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLA  259 (496)
T ss_pred             CCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc
Confidence            78999999999865432   122345799999999999874 89999999999999999999999999888888877766


Q ss_pred             cCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccch
Q 014733          257 ADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECE  304 (419)
Q Consensus       257 ~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~  304 (419)
                      .....   ....+++++.+++.+||+.||.+||++.++++|||++...
T Consensus       260 ~~~~~---~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~~  304 (496)
T PTZ00283        260 GRYDP---LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFI  304 (496)
T ss_pred             CCCCC---CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHhh
Confidence            54332   2246899999999999999999999999999999987643

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-44  Score=357.50  Aligned_cols=260  Identities=27%  Similarity=0.489  Sum_probs=213.8

Q ss_pred             ccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeC---
Q 014733           37 NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEE---  113 (419)
Q Consensus        37 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~---  113 (419)
                      .+.++|++++.||.|+||+||+|.+..+++.||+|++.+.. ........+.+|+.+|+++. ||||+++++++...   
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~   89 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF-QSLIHARRTYRELRLLKHMK-HENVIGLLDVFTPATSI   89 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchh-hhhHHHHHHHHHHHHHHhcC-CCchhhhhhhhcccccc
Confidence            46789999999999999999999999999999999987542 22234566788999999996 99999999988543   


Q ss_pred             ---CEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccc
Q 014733          114 ---DYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGL  190 (419)
Q Consensus       114 ---~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgl  190 (419)
                         ...|++++++ +++|.+++.. +.+++..++.++.||++||+|||++||+||||||+|||+   +.++.+||+|||+
T Consensus        90 ~~~~~~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~---~~~~~~kl~Dfg~  164 (343)
T cd07878          90 ENFNEVYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAV---NEDCELRILDFGL  164 (343)
T ss_pred             cccCcEEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEE---CCCCCEEEcCCcc
Confidence               4578999998 7899887754 679999999999999999999999999999999999999   5678899999999


Q ss_pred             eeeeccCCccccccCCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC--------
Q 014733          191 ATYIKAGQNLHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLR--------  260 (419)
Q Consensus       191 a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~--------  260 (419)
                      +.....  ......||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+....+....+......        
T Consensus       165 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (343)
T cd07878         165 ARQADD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKK  242 (343)
T ss_pred             ceecCC--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            986543  2345679999999999876  3899999999999999999999999876655444433221100        


Q ss_pred             ---------------CCC----CCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          261 ---------------FPS----DPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       261 ---------------~~~----~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                                     .+.    ..+...++.+.+||.+||+.||.+|||+.++++||||.+...
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~  306 (343)
T cd07878         243 ISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHD  306 (343)
T ss_pred             cchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCC
Confidence                           000    012246678899999999999999999999999999987544

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.9e-45  Score=364.41  Aligned_cols=263  Identities=38%  Similarity=0.642  Sum_probs=243.1

Q ss_pred             ccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCC
Q 014733           35 ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEED  114 (419)
Q Consensus        35 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~  114 (419)
                      -.+-.+.|.+...||+|.|++|.+|++..++..||||++.+..+. ...++.+.+|+++|+.|. |||||+++.+.+...
T Consensus        51 ~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln-~~~~~k~~rev~imk~l~-HPnIvkl~~v~~t~~  128 (596)
T KOG0586|consen   51 DSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLN-PSKRQKLGREVDIMKSLN-HPNIVKLFSVIETEA  128 (596)
T ss_pred             ccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccC-hHHHHHHHHHHHHHHhcC-Ccceeeeeeeeeecc
Confidence            345568899999999999999999999999999999999988764 345566999999999995 999999999999999


Q ss_pred             EEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeee
Q 014733          115 YVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI  194 (419)
Q Consensus       115 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~  194 (419)
                      .+|+||||+.+|++++++.++++..+.+++.+|.|++.|++|||+++|||||||++||||   +.+.++||+|||++..+
T Consensus       129 ~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL---~~~mnikIaDfgfS~~~  205 (596)
T KOG0586|consen  129 TLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILL---DENMNIKIADFGFSTFF  205 (596)
T ss_pred             eeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhccc---ccccceeeeccccceee
Confidence            999999999999999999999999999999999999999999999999999999999999   55667999999999999


Q ss_pred             ccCCccccccCCCccCCcccccCC-C-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHH
Q 014733          195 KAGQNLHGTVGSPFYIAPEVLAGG-Y-NQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISAS  272 (419)
Q Consensus       195 ~~~~~~~~~~gt~~y~aPE~l~~~-~-s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  272 (419)
                      ..+....+.||++.|.|||++.+. | ++++|+||+|++||.|+.|..||.+.+-.++......+.++++.    .++.+
T Consensus       206 ~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~----~ms~d  281 (596)
T KOG0586|consen  206 DYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPF----YMSCD  281 (596)
T ss_pred             cccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccc----eeech
Confidence            988888999999999999999885 5 68999999999999999999999999998988888888888876    68899


Q ss_pred             HHHHHHhhhhcCCCCCCCHHHHHhccccccchhh
Q 014733          273 ARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQV  306 (419)
Q Consensus       273 l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~~  306 (419)
                      ++++|+++|..+|.+|++.+++..|.|+......
T Consensus       282 ce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~  315 (596)
T KOG0586|consen  282 CEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA  315 (596)
T ss_pred             hHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence            9999999999999999999999999999765443

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-43  Score=345.73  Aligned_cols=261  Identities=36%  Similarity=0.583  Sum_probs=226.6

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      ++|++.+.||+|++|.||+|.+..+++.+|+|.+.+.........+.+..|+++++++. ||||+++++.+.+.+..|+|
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv   79 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLD-HPFLPTLYASFQTETYLCLV   79 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCC-CCCchhheeeeecCCEEEEE
Confidence            47999999999999999999999999999999998765544456778999999999996 99999999999999999999


Q ss_pred             EeecCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccC
Q 014733          120 MELCAGGELFHRLEKY--GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG  197 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~  197 (419)
                      |||+.|++|.+++...  ..+++..+..++.|+++||+|||+.|++|+||||+||++   +.++.++|+|||++......
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~  156 (316)
T cd05574          80 MDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILL---HESGHIMLSDFDLSKQSDVE  156 (316)
T ss_pred             EEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEE---cCCCCEEEeecchhhccccc
Confidence            9999999999998764  468999999999999999999999999999999999999   55678999999988754321


Q ss_pred             C------------------------------ccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 014733          198 Q------------------------------NLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKT  246 (419)
Q Consensus       198 ~------------------------------~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~  246 (419)
                      .                              ......||..|+|||++.+. ++.++||||||+++|+|++|..||.+..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~  236 (316)
T cd05574         157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN  236 (316)
T ss_pred             ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence            1                              01123688899999998764 8999999999999999999999999888


Q ss_pred             HHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCC----HHHHHhccccccchhh
Q 014733          247 KSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLT----AAEVLAHSWMEECEQV  306 (419)
Q Consensus       247 ~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps----~~eil~hp~~~~~~~~  306 (419)
                      ..+.+..+......++..  ..++.++.++|.+||..||++|||    +.+++.||||++..+.
T Consensus       237 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~  298 (316)
T cd05574         237 RDETFSNILKKEVTFPGS--PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWA  298 (316)
T ss_pred             hHHHHHHHhcCCccCCCc--cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChh
Confidence            777777776655554443  247999999999999999999999    9999999999886543

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=6.9e-44  Score=351.03  Aligned_cols=250  Identities=25%  Similarity=0.421  Sum_probs=203.0

Q ss_pred             ccCeeeeeeecccCceEEEEEEe-----cCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeC
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSD-----KFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEE  113 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~-----~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~  113 (419)
                      .++|+++++||.|+||.||+|.+     ..++..||+|++...  ........+.+|+.+|.++.+||||+++++++...
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG--ATASEHKALMSELKILIHIGNHLNVVNLLGACTKP   83 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc--cchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence            47999999999999999999975     244578999998654  23345677899999999996699999999988764


Q ss_pred             -CEEEEEEeecCCCChHHHHHHc---------------------------------------------------------
Q 014733          114 -DYVHLLMELCAGGELFHRLEKY---------------------------------------------------------  135 (419)
Q Consensus       114 -~~~~lV~E~~~ggsL~~~l~~~---------------------------------------------------------  135 (419)
                       +.++++|||+++|+|.+++...                                                         
T Consensus        84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (338)
T cd05102          84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET  163 (338)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence             4689999999999999998652                                                         


Q ss_pred             -----CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCCc---cccccCCC
Q 014733          136 -----GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSP  207 (419)
Q Consensus       136 -----~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~~---~~~~~gt~  207 (419)
                           .++++.++..++.||++||+|||+.||+||||||+|||+   +.++.+||+|||++........   .....++.
T Consensus       164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~  240 (338)
T cd05102         164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPDYVRKGSARLPL  240 (338)
T ss_pred             cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEE---cCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence                 237788899999999999999999999999999999999   4567899999999986533221   12234567


Q ss_pred             ccCCcccccCC-CCCchhHHHHHHHHHHHHh-CCCCCCCCCHHH-HHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcC
Q 014733          208 FYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSK-IFDAVRAADLRFPSDPWDHISASARDLIMGMLRVD  284 (419)
Q Consensus       208 ~y~aPE~l~~~-~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~d  284 (419)
                      .|+|||++.+. ++.++|||||||++|||++ |..||.+....+ ....+..... .  .....+++++.++|.+||+.|
T Consensus       241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~l~~li~~cl~~d  317 (338)
T cd05102         241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTR-M--RAPENATPEIYRIMLACWQGD  317 (338)
T ss_pred             cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCC-C--CCCCCCCHHHHHHHHHHccCC
Confidence            89999998764 8999999999999999997 999998765433 3333333321 1  123468899999999999999


Q ss_pred             CCCCCCHHHHHh
Q 014733          285 PSTRLTAAEVLA  296 (419)
Q Consensus       285 P~~Rps~~eil~  296 (419)
                      |++|||+.++++
T Consensus       318 p~~RPs~~el~~  329 (338)
T cd05102         318 PKERPTFSALVE  329 (338)
T ss_pred             hhhCcCHHHHHH
Confidence            999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=2e-43  Score=343.53  Aligned_cols=257  Identities=25%  Similarity=0.396  Sum_probs=215.6

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      ++|++.+.||+|+||.||++.+..++..+|+|.+...  ........+.+|++++++++ ||||+++++++.+++.++++
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv   77 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLE--IKPAIRNQIIRELKVLHECN-SPYIVGFYGAFYSDGEISIC   77 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccc--cCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEeeCCEEEEE
Confidence            4799999999999999999999999999999998654  23445677889999999995 99999999999999999999


Q ss_pred             EeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC
Q 014733          120 MELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG-NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ  198 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~-~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~  198 (419)
                      |||+++++|.+++...+++++..+..++.|+++||.|||+ .+++|+||||+|||+   +.++.+||+|||++...... 
T Consensus        78 ~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~-  153 (308)
T cd06615          78 MEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDS-  153 (308)
T ss_pred             eeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEE---ecCCcEEEccCCCccccccc-
Confidence            9999999999999888889999999999999999999997 589999999999999   45678999999998765332 


Q ss_pred             ccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-----------------
Q 014733          199 NLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLR-----------------  260 (419)
Q Consensus       199 ~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-----------------  260 (419)
                      ......|++.|+|||++.+. ++.++|+||||+++|+|++|+.||...........+......                 
T Consensus       154 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (308)
T cd06615         154 MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS  233 (308)
T ss_pred             ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCc
Confidence            22445789999999998764 889999999999999999999999765543333222111000                 


Q ss_pred             -----------------CCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccc
Q 014733          261 -----------------FPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEEC  303 (419)
Q Consensus       261 -----------------~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~  303 (419)
                                       .+..+...++.+++++|.+||..||++|||+.++++||||...
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  293 (308)
T cd06615         234 PRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA  293 (308)
T ss_pred             cchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence                             0111122468899999999999999999999999999999764

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=6.8e-44  Score=347.65  Aligned_cols=249  Identities=27%  Similarity=0.468  Sum_probs=194.4

Q ss_pred             eeeecccCceEEEEEEec--CCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEe--CCEEEEEE
Q 014733           45 GKQLGWGQFGVIRECSDK--FTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEE--EDYVHLLM  120 (419)
Q Consensus        45 ~~~LG~G~~g~V~~a~~~--~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~--~~~~~lV~  120 (419)
                      +.+||+|+||+||+|.++  .+++.+|+|.+.....     ...+.+|+.+|+++. ||||+++++++.+  ...++++|
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~lv~   79 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELK-HPNVISLQKVFLSHADRKVWLLF   79 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcC-CCCCcceeeeEecCCCcEEEEEE
Confidence            568999999999999976  4678999999865432     245678999999996 9999999999854  56789999


Q ss_pred             eecCCCChHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeec-CCCCCeEEeeccc
Q 014733          121 ELCAGGELFHRLEKY---------GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATK-SSSSPIKLADFGL  190 (419)
Q Consensus       121 E~~~ggsL~~~l~~~---------~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~-~~~~~vKL~DFgl  190 (419)
                      ||+ +++|.+++...         ..+++..++.++.||+.||+|||+.||+||||||+|||+..+ +.++.+||+|||+
T Consensus        80 e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07868          80 DYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             ecc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence            998 45888877532         248999999999999999999999999999999999999543 3456899999999


Q ss_pred             eeeeccCC----ccccccCCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCH---------HHHHHHHH
Q 014733          191 ATYIKAGQ----NLHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTK---------SKIFDAVR  255 (419)
Q Consensus       191 a~~~~~~~----~~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~---------~~~~~~i~  255 (419)
                      +.......    ......||+.|+|||++.+  .++.++||||+||++|+|++|++||.....         .+....+.
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~  238 (317)
T cd07868         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF  238 (317)
T ss_pred             eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHH
Confidence            98764322    2234578999999999876  389999999999999999999999964332         11111111


Q ss_pred             hcCCC-----------CC-----------------------CCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhcccc
Q 014733          256 AADLR-----------FP-----------------------SDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWM  300 (419)
Q Consensus       256 ~~~~~-----------~~-----------------------~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~  300 (419)
                      .....           .+                       .......+.++.+||.+||++||.+|||++|+|+||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             HhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            10000           00                       00011245678999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-43  Score=334.23  Aligned_cols=254  Identities=30%  Similarity=0.535  Sum_probs=218.7

Q ss_pred             eeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEEeecCC
Q 014733           46 KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAG  125 (419)
Q Consensus        46 ~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~g  125 (419)
                      +.||.|+||.||+|.+..+|+.||+|++.+...........+..|..++....+|+||+++++++.+.+.+|+|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            57999999999999999999999999997654433344455666766665554699999999999999999999999999


Q ss_pred             CChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCCccccccC
Q 014733          126 GELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVG  205 (419)
Q Consensus       126 gsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~~~~~~~g  205 (419)
                      ++|.+++...+.+++..+..++.|+++||.|||+.+++|+||+|+||++   +.++.+||+|||++.....   .....|
T Consensus        82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~---~~~~~~  155 (260)
T cd05611          82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLI---DQTGHLKLTDFGLSRNGLE---NKKFVG  155 (260)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCcEEEeecccceeccc---cccCCC
Confidence            9999999888889999999999999999999999999999999999999   5567899999999875432   233468


Q ss_pred             CCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcC
Q 014733          206 SPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVD  284 (419)
Q Consensus       206 t~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~d  284 (419)
                      +..|+|||.+.+. ++.++|+||||+++|+|++|..||...+..+....+.......+......++.++.++|.+||+.|
T Consensus       156 ~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  235 (260)
T cd05611         156 TPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMD  235 (260)
T ss_pred             CcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCC
Confidence            8899999998775 799999999999999999999999988888888877776665555555578999999999999999


Q ss_pred             CCCCC---CHHHHHhccccccchh
Q 014733          285 PSTRL---TAAEVLAHSWMEECEQ  305 (419)
Q Consensus       285 P~~Rp---s~~eil~hp~~~~~~~  305 (419)
                      |++||   ++.|++.||||+...+
T Consensus       236 p~~R~~~~~~~~~l~~~~~~~~~~  259 (260)
T cd05611         236 PAKRLGANGYQEIKSHPFFKSINW  259 (260)
T ss_pred             HHHccCCCcHHHHHcChHhhcCCC
Confidence            99999   5579999999987543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2.5e-43  Score=337.65  Aligned_cols=256  Identities=30%  Similarity=0.564  Sum_probs=214.3

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      ++|++.+.||+|++|.||+|.++.+|+.||+|++..... .....+.+.+|+.+++++. ||||+++++++.+...+++|
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~~v   78 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLK-HPNLVNLIEVFRRKRKLHLV   78 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCC-CCCEeeeeeEEeeCCEEEEE
Confidence            589999999999999999999999999999999875432 2223456788999999996 99999999999999999999


Q ss_pred             EeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC-
Q 014733          120 MELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ-  198 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~-  198 (419)
                      |||+++++|..++.....+++..+..++.||+.+|+|||+.+|+|+||||+||++   +.++.+||+|||++....... 
T Consensus        79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~  155 (286)
T cd07847          79 FEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILI---TKQGQIKLCDFGFARILTGPGD  155 (286)
T ss_pred             EeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEE---cCCCcEEECccccceecCCCcc
Confidence            9999998888887776779999999999999999999999999999999999999   556789999999998765443 


Q ss_pred             ccccccCCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-----------------
Q 014733          199 NLHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADL-----------------  259 (419)
Q Consensus       199 ~~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-----------------  259 (419)
                      ......++..|+|||++.+  .++.++|+||||+++|+|++|++||.+....+....+.....                 
T Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd07847         156 DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK  235 (286)
T ss_pred             cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccc
Confidence            2234467889999999865  378999999999999999999999987766554443322100                 


Q ss_pred             --CCCCC--------CCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhcccc
Q 014733          260 --RFPSD--------PWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWM  300 (419)
Q Consensus       260 --~~~~~--------~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~  300 (419)
                        ..+..        ....++..+.+||.+||+.||++||++.+++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             cccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence              01110        123578899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=6.3e-43  Score=329.62  Aligned_cols=252  Identities=23%  Similarity=0.497  Sum_probs=216.0

Q ss_pred             CeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEe-CCEEEEE
Q 014733           41 RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEE-EDYVHLL  119 (419)
Q Consensus        41 ~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~-~~~~~lV  119 (419)
                      +|++.+.||+|++|.||++.++.+++.+|+|.+..... .....+.+.+|++++++++ |+|++++++.+.. ++.+|++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~lv   78 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQLK-HPNIVAYRESWEGEDGLLYIV   78 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc-CHHHHHHHHHHHHHHHhCC-CCCeeeeeeeecCCCCEEEEE
Confidence            58999999999999999999999999999999875432 3445677899999999996 9999999998864 5578999


Q ss_pred             EeecCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccC
Q 014733          120 MELCAGGELFHRLEKY--GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG  197 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~  197 (419)
                      |||+++++|.+++...  ..+++.++..++.+++.||++||+.|++|+||||+||++   +.++.++|+|||++......
T Consensus        79 ~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~---~~~~~~~l~df~~~~~~~~~  155 (257)
T cd08223          79 MGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFL---TRTNIIKVGDLGIARVLENQ  155 (257)
T ss_pred             ecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEE---ecCCcEEEecccceEEeccc
Confidence            9999999999998763  358999999999999999999999999999999999999   55778999999999876433


Q ss_pred             Cc-cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 014733          198 QN-LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARD  275 (419)
Q Consensus       198 ~~-~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~  275 (419)
                      .. .....+++.|+|||++.+. ++.++|+||+|+++|+|++|+.||...+.......+.......   ....+++++.+
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  232 (257)
T cd08223         156 CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPP---MPKDYSPELGE  232 (257)
T ss_pred             CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC---CccccCHHHHH
Confidence            22 2334688999999998765 8899999999999999999999998877766666655544321   22468899999


Q ss_pred             HHHhhhhcCCCCCCCHHHHHhcccc
Q 014733          276 LIMGMLRVDPSTRLTAAEVLAHSWM  300 (419)
Q Consensus       276 li~~~L~~dP~~Rps~~eil~hp~~  300 (419)
                      +|.+||+.||++|||+.++++||||
T Consensus       233 li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         233 LIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             HHHHHhccCcccCCCHHHHhcCCCC
Confidence            9999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=2e-43  Score=336.04  Aligned_cols=255  Identities=25%  Similarity=0.443  Sum_probs=213.6

Q ss_pred             ccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeC---
Q 014733           37 NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEE---  113 (419)
Q Consensus        37 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~---  113 (419)
                      ...++|++.+.||+|+||.||+|.+..+++.+|+|.+....    .....+..|+.+++++.+|+||+++++++.+.   
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~   78 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP   78 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCC
Confidence            45688999999999999999999999999999999987542    23457888999999996699999999998753   


Q ss_pred             ---CEEEEEEeecCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeec
Q 014733          114 ---DYVHLLMELCAGGELFHRLEKY--GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADF  188 (419)
Q Consensus       114 ---~~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DF  188 (419)
                         ..+|++|||+++++|.+++...  ..+++..+..++.|++.||+|||+.+|+|+||||+||++   +.++.+||+||
T Consensus        79 ~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili---~~~~~~~l~Df  155 (272)
T cd06637          79 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL---TENAEVKLVDF  155 (272)
T ss_pred             CCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEE---CCCCCEEEccC
Confidence               4689999999999999998764  358999999999999999999999999999999999999   56678999999


Q ss_pred             cceeeeccCC-ccccccCCCccCCcccccC------CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC
Q 014733          189 GLATYIKAGQ-NLHGTVGSPFYIAPEVLAG------GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRF  261 (419)
Q Consensus       189 gla~~~~~~~-~~~~~~gt~~y~aPE~l~~------~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~  261 (419)
                      |++....... ......|+..|+|||++.+      .++.++|+||+||++|+|++|..||...........+....  .
T Consensus       156 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~--~  233 (272)
T cd06637         156 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP--A  233 (272)
T ss_pred             CCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCC--C
Confidence            9998654322 2234578999999999752      37889999999999999999999997766544444433322  2


Q ss_pred             CCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhcccc
Q 014733          262 PSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWM  300 (419)
Q Consensus       262 ~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~  300 (419)
                      +......++.++.+|+.+||..||.+|||+.++++||||
T Consensus       234 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         234 PRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             CCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            222234688999999999999999999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=4.1e-43  Score=340.68  Aligned_cols=262  Identities=33%  Similarity=0.543  Sum_probs=226.6

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      ++|++.+.||+|+||.||++.++.+++.|++|.+.+...........+.+|+++++.+. ||||+++++.+.+++.+++|
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv   79 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAE-NPFVVSMFCSFETKRHLCMV   79 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-CCCeeeeEEEEecCCEEEEE
Confidence            47999999999999999999999999999999987664434455678889999999995 99999999999999999999


Q ss_pred             EeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC-
Q 014733          120 MELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ-  198 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~-  198 (419)
                      |||++|++|.+++...+.+++..+..++.|++.||.|||+.+++||||||+||++   +.++.+||+|||++....... 
T Consensus        80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll---~~~~~~~l~dfg~~~~~~~~~~  156 (305)
T cd05609          80 MEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLI---TSMGHIKLTDFGLSKIGLMSLT  156 (305)
T ss_pred             EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEE---CCCCCEEEeeCCCccccCcCcc
Confidence            9999999999999888889999999999999999999999999999999999999   567789999999886321000 


Q ss_pred             ---------------ccccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC
Q 014733          199 ---------------NLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFP  262 (419)
Q Consensus       199 ---------------~~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~  262 (419)
                                     ......++..|+|||.+.+ .++.++|+||||+++|+|++|..||.+....+....+.......+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  236 (305)
T cd05609         157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP  236 (305)
T ss_pred             ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC
Confidence                           0112357888999999866 489999999999999999999999998888888888777665555


Q ss_pred             CCCCCCCCHHHHHHHHhhhhcCCCCCCC---HHHHHhccccccchhh
Q 014733          263 SDPWDHISASARDLIMGMLRVDPSTRLT---AAEVLAHSWMEECEQV  306 (419)
Q Consensus       263 ~~~~~~~s~~l~~li~~~L~~dP~~Rps---~~eil~hp~~~~~~~~  306 (419)
                      .... .++.++.++|.+||+.||++||+   +.++++||||......
T Consensus       237 ~~~~-~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~  282 (305)
T cd05609         237 EGDE-ALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWN  282 (305)
T ss_pred             Cccc-cCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHH
Confidence            4432 68899999999999999999997   7999999999776543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.9e-43  Score=379.38  Aligned_cols=265  Identities=29%  Similarity=0.514  Sum_probs=220.6

Q ss_pred             ccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEe--
Q 014733           35 ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEE--  112 (419)
Q Consensus        35 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~--  112 (419)
                      .....++|++++.||+|+||+||+|.++.++..+|+|++..... .......+..|+.+|++|. |||||+++++|.+  
T Consensus         8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l-~e~~~~~~~~EI~IL~~L~-HPNIVrl~d~f~de~   85 (1021)
T PTZ00266          8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMRELK-HKNIVRYIDRFLNKA   85 (1021)
T ss_pred             CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc-CHHHHHHHHHHHHHHHHcC-CCCcCeEEEEEEecC
Confidence            45566899999999999999999999999999999999976543 3455678899999999996 9999999999854  


Q ss_pred             CCEEEEEEeecCCCChHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC-------CCeeccCCCCcEEEeec----
Q 014733          113 EDYVHLLMELCAGGELFHRLEKY----GRFSETEARVIFRHLMQVVSYCHGN-------GVVHRDLKPENILLATK----  177 (419)
Q Consensus       113 ~~~~~lV~E~~~ggsL~~~l~~~----~~l~~~~~~~i~~qll~aL~~LH~~-------~IvHrDLkp~NILl~~~----  177 (419)
                      ...+||||||+++++|.++|...    +.+++..++.|+.||+.||+|||+.       +||||||||+||||+.+    
T Consensus        86 ~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l  165 (1021)
T PTZ00266         86 NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI  165 (1021)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence            46799999999999999998653    5699999999999999999999985       49999999999999542    


Q ss_pred             ----------CCCCCeEEeeccceeeeccCCccccccCCCccCCcccccC---CCCCchhHHHHHHHHHHHHhCCCCCCC
Q 014733          178 ----------SSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG---GYNQAADVWSAGVILYILLSGMPPFWG  244 (419)
Q Consensus       178 ----------~~~~~vKL~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~---~~s~~sDvwSlGvil~elltG~~Pf~~  244 (419)
                                +....+||+|||++..+.........+||+.|+|||++.+   .++.++|||||||+||+|++|..||..
T Consensus       166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~  245 (1021)
T PTZ00266        166 GKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK  245 (1021)
T ss_pred             ccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence                      1234589999999987654444455689999999999854   388999999999999999999999976


Q ss_pred             CCHH-HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          245 KTKS-KIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       245 ~~~~-~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                      .... .+...+... ..   .+....+.++.+||..||+.+|.+||++.++|.|+|++....
T Consensus       246 ~~~~~qli~~lk~~-p~---lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~  303 (1021)
T PTZ00266        246 ANNFSQLISELKRG-PD---LPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGP  303 (1021)
T ss_pred             CCcHHHHHHHHhcC-CC---CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCC
Confidence            5443 333333322 22   223467899999999999999999999999999999987654

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=6.1e-43  Score=329.29  Aligned_cols=252  Identities=23%  Similarity=0.410  Sum_probs=219.6

Q ss_pred             CeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEE
Q 014733           41 RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLM  120 (419)
Q Consensus        41 ~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~  120 (419)
                      +|.+.+.||+|++|.||+|.++.+++.+++|.+..... .......+.+|+.++++++ ||||+++++++.+.+.+|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM-NRREREEAIDEARVLAKLD-SSYIIRYYESFLDKGKLNIVM   78 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhC-CHHHHHHHHHHHHHHHhcC-CCCeehheeeeccCCEEEEEE
Confidence            48899999999999999999999999999999876543 3456778999999999996 999999999999999999999


Q ss_pred             eecCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC
Q 014733          121 ELCAGGELFHRLEKY--GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ  198 (419)
Q Consensus       121 E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~  198 (419)
                      ||++|++|.+++...  ..+++..++.++.+++.||.|||+.|++|+||||+||++   +.++.+||+|||++.......
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili---~~~~~~~l~df~~~~~~~~~~  155 (256)
T cd08529          79 EYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFL---DAYDNVKIGDLGVAKLLSDNT  155 (256)
T ss_pred             EeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE---eCCCCEEEcccccceeccCcc
Confidence            999999999999764  468999999999999999999999999999999999999   456789999999988765433


Q ss_pred             c-cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHH
Q 014733          199 N-LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDL  276 (419)
Q Consensus       199 ~-~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~l  276 (419)
                      . .....|++.|+|||++.+. ++.++|+||||+++|+|++|+.||......+....+.........   ..++.++.++
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  232 (256)
T cd08529         156 NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVS---QMYSQQLAQL  232 (256)
T ss_pred             chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc---cccCHHHHHH
Confidence            2 2334688999999998764 889999999999999999999999888877776666554432211   2678999999


Q ss_pred             HHhhhhcCCCCCCCHHHHHhcccc
Q 014733          277 IMGMLRVDPSTRLTAAEVLAHSWM  300 (419)
Q Consensus       277 i~~~L~~dP~~Rps~~eil~hp~~  300 (419)
                      |.+||+.+|++||++.++++|||+
T Consensus       233 i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         233 IDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             HHHHccCCcccCcCHHHHhhCCCC
Confidence            999999999999999999999995

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-44  Score=361.06  Aligned_cols=251  Identities=27%  Similarity=0.475  Sum_probs=218.2

Q ss_pred             eecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEEeecCCC
Q 014733           47 QLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGG  126 (419)
Q Consensus        47 ~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~gg  126 (419)
                      +||+|.||+||.|+|..+...+|||.+..+   .....+.+..||.+-++|+ |.|||++.+++.+++.+-|.||-++||
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek---dsr~~QPLhEEIaLH~~Lr-HkNIVrYLGs~senGf~kIFMEqVPGG  657 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK---DSREVQPLHEEIALHSTLR-HKNIVRYLGSVSENGFFKIFMEQVPGG  657 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccc---cchhhccHHHHHHHHHHHh-hHhHHHHhhccCCCCeEEEEeecCCCC
Confidence            699999999999999999999999999765   3356788999999999997 999999999999999999999999999


Q ss_pred             ChHHHHHHc-CCC--CHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCCcc-cc
Q 014733          127 ELFHRLEKY-GRF--SETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNL-HG  202 (419)
Q Consensus       127 sL~~~l~~~-~~l--~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~~~-~~  202 (419)
                      +|..+++.. +++  ++..+..+.+||++||.|||++.|||||||-+|||++  .-.|.+||+|||.++.+..-... .+
T Consensus       658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvN--TySGvlKISDFGTsKRLAginP~TET  735 (1226)
T KOG4279|consen  658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVN--TYSGVLKISDFGTSKRLAGINPCTET  735 (1226)
T ss_pred             cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEe--eccceEEecccccchhhccCCccccc
Confidence            999999754 677  8889999999999999999999999999999999996  45789999999999987665443 34


Q ss_pred             ccCCCccCCcccccC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHh
Q 014733          203 TVGSPFYIAPEVLAG---GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMG  279 (419)
Q Consensus       203 ~~gt~~y~aPE~l~~---~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~  279 (419)
                      ..||..|||||++..   +|+.++|||||||.+.||.||++||.......... .+-+.++..++.+..+|.+++.||.+
T Consensus       736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM-FkVGmyKvHP~iPeelsaeak~Filr  814 (1226)
T KOG4279|consen  736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM-FKVGMYKVHPPIPEELSAEAKNFILR  814 (1226)
T ss_pred             cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh-hhhcceecCCCCcHHHHHHHHHHHHH
Confidence            579999999999975   49999999999999999999999997544332221 22344555555556899999999999


Q ss_pred             hhhcCCCCCCCHHHHHhccccccch
Q 014733          280 MLRVDPSTRLTAAEVLAHSWMEECE  304 (419)
Q Consensus       280 ~L~~dP~~Rps~~eil~hp~~~~~~  304 (419)
                      |+.+||.+||++.++|++||++...
T Consensus       815 cFepd~~~R~sA~~LL~DpFlq~~~  839 (1226)
T KOG4279|consen  815 CFEPDPCDRPSAKDLLQDPFLQHNN  839 (1226)
T ss_pred             HcCCCcccCccHHHhccCcccccCC
Confidence            9999999999999999999998763

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-43  Score=335.40  Aligned_cols=256  Identities=28%  Similarity=0.515  Sum_probs=221.1

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      ++|++.+.||.|++|.||+|.+..+++.+|+|.+....  .......+.+|+.+++.+. |+||+++++++.+...+|+|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v   77 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCR-SPYITKYYGSFLKGSKLWII   77 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcC-CCCeeeeeEEEEECCeEEEE
Confidence            57999999999999999999999999999999987653  2345667889999999996 99999999999999999999


Q ss_pred             EeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC-
Q 014733          120 MELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ-  198 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~-  198 (419)
                      +||+++++|.+++... ++++..++.++.|++.||.|||+.+++|+||+|+||++   +.++.++|+|||++....... 
T Consensus        78 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~~  153 (274)
T cd06609          78 MEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILL---SEEGDVKLADFGVSGQLTSTMS  153 (274)
T ss_pred             EEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEcccccceeeccccc
Confidence            9999999999999864 89999999999999999999999999999999999999   567789999999998775442 


Q ss_pred             ccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHH
Q 014733          199 NLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLI  277 (419)
Q Consensus       199 ~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li  277 (419)
                      ......+++.|+|||++.+. ++.++||||||+++|+|++|++||......+....+.........  ...++.++.+++
T Consensus       154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l  231 (274)
T cd06609         154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLE--GNKFSKPFKDFV  231 (274)
T ss_pred             ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCc--ccccCHHHHHHH
Confidence            23345788899999998764 899999999999999999999999877666655555544322211  123889999999


Q ss_pred             HhhhhcCCCCCCCHHHHHhccccccch
Q 014733          278 MGMLRVDPSTRLTAAEVLAHSWMEECE  304 (419)
Q Consensus       278 ~~~L~~dP~~Rps~~eil~hp~~~~~~  304 (419)
                      .+||..||++|||+.++++||||....
T Consensus       232 ~~~l~~~p~~Rpt~~~il~~~~~~~~~  258 (274)
T cd06609         232 SLCLNKDPKERPSAKELLKHKFIKKAK  258 (274)
T ss_pred             HHHhhCChhhCcCHHHHhhChhhcCCC
Confidence            999999999999999999999997643

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.1e-43  Score=353.94  Aligned_cols=255  Identities=26%  Similarity=0.417  Sum_probs=207.2

Q ss_pred             ccccCeeeeeeecccCceEEEEEEec--CCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCC
Q 014733           37 NLSDRYVLGKQLGWGQFGVIRECSDK--FTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEED  114 (419)
Q Consensus        37 ~~~~~y~i~~~LG~G~~g~V~~a~~~--~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~  114 (419)
                      .+..+|++++.||+|+||.||+|...  .++..||+|.+...        ....+|+++|+++. ||||+++++++...+
T Consensus        89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~-h~~iv~~~~~~~~~~  159 (392)
T PHA03207         89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTIS-HRAIINLIHAYRWKS  159 (392)
T ss_pred             hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcC-CCCccceeeeEeeCC
Confidence            34578999999999999999999754  45678999987543        23457999999996 999999999999999


Q ss_pred             EEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeee
Q 014733          115 YVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI  194 (419)
Q Consensus       115 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~  194 (419)
                      .++++||++ +++|..++...+.+++.+++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++...
T Consensus       160 ~~~lv~e~~-~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill---~~~~~~~l~DfG~a~~~  235 (392)
T PHA03207        160 TVCMVMPKY-KCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFL---DEPENAVLGDFGAACKL  235 (392)
T ss_pred             EEEEEehhc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---cCCCCEEEccCcccccc
Confidence            999999999 46899988777889999999999999999999999999999999999999   56778999999999765


Q ss_pred             ccCCc---cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHh----cCCCCCC
Q 014733          195 KAGQN---LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKS---KIFDAVRA----ADLRFPS  263 (419)
Q Consensus       195 ~~~~~---~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~---~~~~~i~~----~~~~~~~  263 (419)
                      .....   .....||+.|+|||++.+. |+.++|||||||++|+|++|+.||.+....   ..+..+..    ....++.
T Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~  315 (392)
T PHA03207        236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ  315 (392)
T ss_pred             CcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence            44322   2345799999999998764 899999999999999999999999765321   11111111    0111110


Q ss_pred             C--------------------C------CCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccch
Q 014733          264 D--------------------P------WDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECE  304 (419)
Q Consensus       264 ~--------------------~------~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~  304 (419)
                      .                    .      ...++.+++++|++||+.||++|||+.++|.||||.+..
T Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~  382 (392)
T PHA03207        316 NGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEP  382 (392)
T ss_pred             ccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccc
Confidence            0                    0      023567899999999999999999999999999997643

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=7.2e-43  Score=336.15  Aligned_cols=270  Identities=26%  Similarity=0.437  Sum_probs=223.9

Q ss_pred             cccccccchhhccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCc
Q 014733           24 SLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNV  103 (419)
Q Consensus        24 ~~~~~~~~~~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnI  103 (419)
                      ..+.++++..++....++|.+.+.||.|+||.||+|.++.+++.+|+|++....    .....+.+|+.+++++.+||||
T Consensus         6 ~~~~~~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni   81 (291)
T cd06639           6 PYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNV   81 (291)
T ss_pred             CCChhhhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCe
Confidence            345567788888889999999999999999999999999999999999986532    2345678899999999669999


Q ss_pred             eeeeEEEEeC-----CEEEEEEeecCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEE
Q 014733          104 VDLKAVYEEE-----DYVHLLMELCAGGELFHRLEK----YGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILL  174 (419)
Q Consensus       104 v~l~~~~~~~-----~~~~lV~E~~~ggsL~~~l~~----~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl  174 (419)
                      +++++++...     +.+++||||+++++|.+++..    ...+++..++.++.|++.||+|||+.+|+|+||||+||++
T Consensus        82 ~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili  161 (291)
T cd06639          82 VKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILL  161 (291)
T ss_pred             EEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE
Confidence            9999998753     468999999999999988753    3568999999999999999999999999999999999999


Q ss_pred             eecCCCCCeEEeeccceeeeccCCc-cccccCCCccCCcccccC------CCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q 014733          175 ATKSSSSPIKLADFGLATYIKAGQN-LHGTVGSPFYIAPEVLAG------GYNQAADVWSAGVILYILLSGMPPFWGKTK  247 (419)
Q Consensus       175 ~~~~~~~~vKL~DFgla~~~~~~~~-~~~~~gt~~y~aPE~l~~------~~s~~sDvwSlGvil~elltG~~Pf~~~~~  247 (419)
                         +.++.+||+|||++........ .....|+..|+|||++..      .++.++|+|||||++|+|++|++||.....
T Consensus       162 ---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~  238 (291)
T cd06639         162 ---TTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP  238 (291)
T ss_pred             ---cCCCCEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH
Confidence               5567899999999886543321 233568899999998753      267899999999999999999999987766


Q ss_pred             HHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccc
Q 014733          248 SKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWME  301 (419)
Q Consensus       248 ~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~  301 (419)
                      .+....+....... ......++..+.++|.+||+.||++||++.++++||||+
T Consensus       239 ~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         239 VKTLFKIPRNPPPT-LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             HHHHHHHhcCCCCC-CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence            55555544332211 111235778899999999999999999999999999984

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=2.5e-43  Score=334.76  Aligned_cols=254  Identities=31%  Similarity=0.515  Sum_probs=214.0

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEE
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHL  118 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~l  118 (419)
                      .++|++.+.||+|+||.||+|.+..+++.+|+|.+....   ......+.+|+.+++.+. ||||+++++++.+.+.+|+
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~-h~~ii~~~~~~~~~~~~~l   83 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCK-HSNIVAYFGSYLRRDKLWI   83 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCCEEEE
Confidence            368999999999999999999999999999999987542   234566888999999995 9999999999999999999


Q ss_pred             EEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC
Q 014733          119 LMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ  198 (419)
Q Consensus       119 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~  198 (419)
                      +|||+++++|.+++...+.+++.++..++.|++.||.|||+.||+|+||||+||++   ..++.+||+|||++.......
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili---~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06645          84 CMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILL---TDNGHVKLADFGVSAQITATI  160 (267)
T ss_pred             EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECcceeeeEccCcc
Confidence            99999999999999888889999999999999999999999999999999999999   567789999999987654322


Q ss_pred             -ccccccCCCccCCccccc----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC-CCCCCCCHH
Q 014733          199 -NLHGTVGSPFYIAPEVLA----GGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPS-DPWDHISAS  272 (419)
Q Consensus       199 -~~~~~~gt~~y~aPE~l~----~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~s~~  272 (419)
                       ......|+..|+|||++.    +.++.++|+|||||++|+|++|..||...........+.......+. .....++..
T Consensus       161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (267)
T cd06645         161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNS  240 (267)
T ss_pred             cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHH
Confidence             223457899999999873    24889999999999999999999999765543333333222222211 112257889


Q ss_pred             HHHHHHhhhhcCCCCCCCHHHHHhccc
Q 014733          273 ARDLIMGMLRVDPSTRLTAAEVLAHSW  299 (419)
Q Consensus       273 l~~li~~~L~~dP~~Rps~~eil~hp~  299 (419)
                      +.++|.+||+.||++|||++++++|||
T Consensus       241 ~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         241 FHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             HHHHHHHHccCCchhCcCHHHHhcCCC
Confidence            999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-45  Score=347.36  Aligned_cols=260  Identities=29%  Similarity=0.527  Sum_probs=239.8

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      .+|..+.+||+|+||+|.+|..+.+.+.+|||+++++.....++++--..|-++|......|.+++++.+|++-+++|+|
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV  428 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV  428 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence            46788999999999999999999999999999999998888888888888999998887889999999999999999999


Q ss_pred             EeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeee-ccCC
Q 014733          120 MELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI-KAGQ  198 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~-~~~~  198 (419)
                      |||+.||+|.-.++..++|.+..+..++.+|+-||-+||++|||+||||.+|||+   +.+|+|||+|||+++.- -++.
T Consensus       429 MEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmL---d~eGHiKi~DFGmcKEni~~~~  505 (683)
T KOG0696|consen  429 MEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENIFDGV  505 (683)
T ss_pred             EEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEe---ccCCceEeeecccccccccCCc
Confidence            9999999999999999999999999999999999999999999999999999999   67899999999999853 2345


Q ss_pred             ccccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHH
Q 014733          199 NLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLI  277 (419)
Q Consensus       199 ~~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li  277 (419)
                      ...+.||||.|+|||++.- +|+..+|+||+||+||||+.|++||.+.+..++++.|......+|.    .+|.++.++.
T Consensus       506 TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPK----slSkEAv~ic  581 (683)
T KOG0696|consen  506 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPK----SLSKEAVAIC  581 (683)
T ss_pred             ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcc----cccHHHHHHH
Confidence            5667899999999999875 5999999999999999999999999999999999999998777765    7999999999


Q ss_pred             HhhhhcCCCCCCC-----HHHHHhccccccchhh
Q 014733          278 MGMLRVDPSTRLT-----AAEVLAHSWMEECEQV  306 (419)
Q Consensus       278 ~~~L~~dP~~Rps-----~~eil~hp~~~~~~~~  306 (419)
                      +.+|.+.|.+|+.     -.+|-.||||+.+++.
T Consensus       582 kg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWe  615 (683)
T KOG0696|consen  582 KGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWE  615 (683)
T ss_pred             HHHhhcCCccccCCCCccccchhhCcchhhccHH
Confidence            9999999999994     4688999999998764

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=5.2e-43  Score=335.51  Aligned_cols=251  Identities=26%  Similarity=0.418  Sum_probs=210.8

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      ++|++.+.||+|++|.||+|.+..+++.+|+|.+....  .......+.+|+++++++. ||||+++++.+.+.+..++|
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv   77 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCD-SPYIIGFYGAFFVENRISIC   77 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEECCEEEEE
Confidence            46889999999999999999999999999999987542  3445667889999999995 99999999999999999999


Q ss_pred             EeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCCc
Q 014733          120 MELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN  199 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~~  199 (419)
                      |||+++++|..+    ..+++..+..++.|++.||+|||+.||+|+||||+|||+   +.++.+||+|||++...... .
T Consensus        78 ~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill---~~~~~~~l~dfg~~~~~~~~-~  149 (279)
T cd06619          78 TEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLV---NTRGQVKLCDFGVSTQLVNS-I  149 (279)
T ss_pred             EecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEE---CCCCCEEEeeCCcceecccc-c
Confidence            999999998644    357899999999999999999999999999999999999   56789999999999865433 2


Q ss_pred             cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhcCCCCCCCCCCCCCH
Q 014733          200 LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTK-------SKIFDAVRAADLRFPSDPWDHISA  271 (419)
Q Consensus       200 ~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~-------~~~~~~i~~~~~~~~~~~~~~~s~  271 (419)
                      ....+||..|+|||++.+. ++.++|+||||+++|+|++|+.||.....       .+..+.+....  .+......++.
T Consensus       150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  227 (279)
T cd06619         150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED--PPVLPVGQFSE  227 (279)
T ss_pred             ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC--CCCCCCCcCCH
Confidence            3446899999999998764 89999999999999999999999964321       12222222221  11222345789


Q ss_pred             HHHHHHHhhhhcCCCCCCCHHHHHhccccccc
Q 014733          272 SARDLIMGMLRVDPSTRLTAAEVLAHSWMEEC  303 (419)
Q Consensus       272 ~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~  303 (419)
                      ++.++|.+||+.||++||+++++++||||...
T Consensus       228 ~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~  259 (279)
T cd06619         228 KFVHFITQCMRKQPKERPAPENLMDHPFIVQY  259 (279)
T ss_pred             HHHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence            99999999999999999999999999999765

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=5.4e-43  Score=332.18  Aligned_cols=253  Identities=29%  Similarity=0.526  Sum_probs=215.4

Q ss_pred             CeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCH------HhHHHHHHHHHHHHHccCCCCceeeeEEEEeCC
Q 014733           41 RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTV------EDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEED  114 (419)
Q Consensus        41 ~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~------~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~  114 (419)
                      +|.+...||.|++|.||+|.+..++..+|+|.+........      ...+.+.+|+.+++++. ||||+++++++.+.+
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~   79 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ-HENIVQYLGSSLDAD   79 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCC
Confidence            57889999999999999999998999999999876543221      23467889999999996 999999999999999


Q ss_pred             EEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeee
Q 014733          115 YVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI  194 (419)
Q Consensus       115 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~  194 (419)
                      ..+++|||+++++|.+++...+.+++..+..++.|++.||+|||+.|++||||+|+||++   +.++.+||+|||.+...
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~---~~~~~~~l~dfg~~~~~  156 (267)
T cd06628          80 HLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILV---DNKGGIKISDFGISKKL  156 (267)
T ss_pred             ccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEE---cCCCCEEecccCCCccc
Confidence            999999999999999999888889999999999999999999999999999999999999   56778999999998876


Q ss_pred             ccCCc-------cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 014733          195 KAGQN-------LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW  266 (419)
Q Consensus       195 ~~~~~-------~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  266 (419)
                      .....       .....|+..|+|||.+.+. ++.++|+||+|+++|+|++|+.||.+.........+....   .....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~  233 (267)
T cd06628         157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA---SPEIP  233 (267)
T ss_pred             ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccC---CCcCC
Confidence            53211       1224578899999998764 8899999999999999999999998766555444443321   11222


Q ss_pred             CCCCHHHHHHHHhhhhcCCCCCCCHHHHHhcccc
Q 014733          267 DHISASARDLIMGMLRVDPSTRLTAAEVLAHSWM  300 (419)
Q Consensus       267 ~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~  300 (419)
                      ..++.++.++|.+||+.||.+||++.++++||||
T Consensus       234 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         234 SNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             cccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence            4688999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=8.1e-43  Score=337.57  Aligned_cols=265  Identities=27%  Similarity=0.477  Sum_probs=224.9

Q ss_pred             hhhccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEE
Q 014733           32 ATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYE  111 (419)
Q Consensus        32 ~~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~  111 (419)
                      ..+......+|++.+.||.|++|.||+|.+..+|+.|++|.+.....   .....+.+|+.+++.++ ||||+++++.+.
T Consensus        11 ~~~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~   86 (296)
T cd06655          11 IVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ---PKKELIINEILVMKELK-NPNIVNFLDSFL   86 (296)
T ss_pred             HHhcCCCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC---chHHHHHHHHHHHHhcC-CCceeeeeeeEe
Confidence            34455566789999999999999999999999999999999875432   34567889999999996 999999999999


Q ss_pred             eCCEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccce
Q 014733          112 EEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA  191 (419)
Q Consensus       112 ~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla  191 (419)
                      +...+|+|+||+++++|..++.. ..+++.++..++.+++.||+|||+.|++|+||||+||++   +.++.+||+|||++
T Consensus        87 ~~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili---~~~~~~kl~dfg~~  162 (296)
T cd06655          87 VGDELFVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLL---GMDGSVKLTDFGFC  162 (296)
T ss_pred             cCceEEEEEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEccCccc
Confidence            99999999999999999998865 568999999999999999999999999999999999999   55778999999998


Q ss_pred             eeeccCCc-cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCC
Q 014733          192 TYIKAGQN-LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHI  269 (419)
Q Consensus       192 ~~~~~~~~-~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  269 (419)
                      ........ .....++..|+|||.+.+. ++.++|+|||||++|+|++|+.||......+....+...... ....+..+
T Consensus       163 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~  241 (296)
T cd06655         163 AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTP-ELQNPEKL  241 (296)
T ss_pred             hhcccccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCc-ccCCcccC
Confidence            76544332 2334688899999998764 899999999999999999999999887765555555443222 22233478


Q ss_pred             CHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          270 SASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       270 s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                      +..+.++|.+||..||.+||++.+++.||||+....
T Consensus       242 ~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~  277 (296)
T cd06655         242 SPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKP  277 (296)
T ss_pred             CHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhccc
Confidence            999999999999999999999999999999986543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=4.2e-43  Score=336.10  Aligned_cols=254  Identities=29%  Similarity=0.460  Sum_probs=208.4

Q ss_pred             CeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEE
Q 014733           41 RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLM  120 (419)
Q Consensus        41 ~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~  120 (419)
                      +|++.+.||.|++|.||+|.++.+++.||+|.+..... .......+.+|+.+++++. ||||+++++++.+++.+|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~   78 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQ-HPNIVCLQDVLMQESRLYLIF   78 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcC-CCCEeeeEEEEeeCCeEEEEE
Confidence            58999999999999999999999999999999875432 2233467888999999996 999999999999999999999


Q ss_pred             eecCCCChHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccC
Q 014733          121 ELCAGGELFHRLEKY---GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG  197 (419)
Q Consensus       121 E~~~ggsL~~~l~~~---~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~  197 (419)
                      ||++ ++|.+++...   ..+++..++.++.||++||+|||+.+|+|+||||+||++   +.++.+||+|||++......
T Consensus        79 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~  154 (285)
T cd07861          79 EFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLI---DNKGVIKLADFGLARAFGIP  154 (285)
T ss_pred             ecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE---cCCCcEEECcccceeecCCC
Confidence            9996 6888887643   458999999999999999999999999999999999999   56788999999998765432


Q ss_pred             C-ccccccCCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC----------------
Q 014733          198 Q-NLHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAAD----------------  258 (419)
Q Consensus       198 ~-~~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~----------------  258 (419)
                      . ......+++.|+|||++.+  .++.++|+||||+++|+|++|++||.+.........+....                
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
T cd07861         155 VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD  234 (285)
T ss_pred             cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence            2 1233467889999998865  37899999999999999999999998765433222211100                


Q ss_pred             ---------CCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhcccc
Q 014733          259 ---------LRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWM  300 (419)
Q Consensus       259 ---------~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~  300 (419)
                               ..........+++++.++|.+||+.||.+|||+.+++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence                     000011234578999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=3.1e-43  Score=334.06  Aligned_cols=255  Identities=30%  Similarity=0.489  Sum_probs=213.6

Q ss_pred             cccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEE
Q 014733           38 LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVH  117 (419)
Q Consensus        38 ~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~  117 (419)
                      ..++|++++.||+|+||.||+|.+..+++.+|+|++.....   .....+.+|+.+++++. ||||+++++++.+.+.++
T Consensus         7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~~e~~~l~~~~-h~~ii~~~~~~~~~~~~~   82 (267)
T cd06646           7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG---DDFSLIQQEIFMVKECK-HCNIVAYFGSYLSREKLW   82 (267)
T ss_pred             chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc---chHHHHHHHHHHHHhcC-CCCeeeeeEEEEeCCEEE
Confidence            35689999999999999999999999999999999875422   34456888999999996 999999999999999999


Q ss_pred             EEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccC
Q 014733          118 LLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG  197 (419)
Q Consensus       118 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~  197 (419)
                      +||||+++++|.+++...+.+++..+..++.|++.||+|||+.+|+||||||+||++   +.++.+||+|||++......
T Consensus        83 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill---~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd06646          83 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILL---TDNGDVKLADFGVAAKITAT  159 (267)
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCCEEECcCccceeeccc
Confidence            999999999999999887889999999999999999999999999999999999999   56778999999999876433


Q ss_pred             C-ccccccCCCccCCcccccC----CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC-CCCCCCCH
Q 014733          198 Q-NLHGTVGSPFYIAPEVLAG----GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPS-DPWDHISA  271 (419)
Q Consensus       198 ~-~~~~~~gt~~y~aPE~l~~----~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~s~  271 (419)
                      . ......|++.|+|||.+.+    .++.++|+||+||++|+|++|+.||......+....+.......+. .....++.
T Consensus       160 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (267)
T cd06646         160 IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSS  239 (267)
T ss_pred             ccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCH
Confidence            2 2234578899999998742    3788999999999999999999999655443333222222222111 11235789


Q ss_pred             HHHHHHHhhhhcCCCCCCCHHHHHhccc
Q 014733          272 SARDLIMGMLRVDPSTRLTAAEVLAHSW  299 (419)
Q Consensus       272 ~l~~li~~~L~~dP~~Rps~~eil~hp~  299 (419)
                      .+.++|++||+.||++|||++++++|+|
T Consensus       240 ~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         240 TFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             HHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence            9999999999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=5.5e-43  Score=331.35  Aligned_cols=255  Identities=30%  Similarity=0.490  Sum_probs=217.7

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      ++|++++.||.|++|+||+|....++..+++|++......  .....+.+|+.+++.+. |+||+++++.+.+.+.++++
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~iv   77 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQ--TSVDELRKEVQAMSQCN-HPNVVKYYTSFVVGDELWLV   77 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcc--hHHHHHHHHHHHHHhcC-CCCEEEEEEEEeeCCEEEEE
Confidence            5799999999999999999999889999999998765432  36778999999999996 99999999999999999999


Q ss_pred             EeecCCCChHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeecc
Q 014733          120 MELCAGGELFHRLEKY---GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA  196 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~~---~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~  196 (419)
                      ||++++++|.+++...   ..+++..++.++.|++.||+|||+.||+|+||+|+||++   ++++.+||+|||++.....
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~---~~~~~~~l~df~~~~~~~~  154 (267)
T cd06610          78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILL---GEDGSVKIADFGVSASLAD  154 (267)
T ss_pred             EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEE---cCCCCEEEcccchHHHhcc
Confidence            9999999999999764   358999999999999999999999999999999999999   4567899999999876654


Q ss_pred             CCcc-----ccccCCCccCCcccccCC--CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-CCC-CCC
Q 014733          197 GQNL-----HGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRF-PSD-PWD  267 (419)
Q Consensus       197 ~~~~-----~~~~gt~~y~aPE~l~~~--~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~-~~~-~~~  267 (419)
                      ....     ....|+..|+|||++...  ++.++|+||||+++|+|++|+.||...+..+....+....... +.. .+.
T Consensus       155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (267)
T cd06610         155 GGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYK  234 (267)
T ss_pred             CccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccc
Confidence            3221     334688999999998653  8899999999999999999999998776665555544432221 111 124


Q ss_pred             CCCHHHHHHHHhhhhcCCCCCCCHHHHHhcccc
Q 014733          268 HISASARDLIMGMLRVDPSTRLTAAEVLAHSWM  300 (419)
Q Consensus       268 ~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~  300 (419)
                      .+++++.+++.+||+.||++||++.++++||||
T Consensus       235 ~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         235 KYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             cccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence            678999999999999999999999999999997

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.5e-44  Score=355.18  Aligned_cols=264  Identities=33%  Similarity=0.501  Sum_probs=233.9

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEE
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHL  118 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~l  118 (419)
                      +..|..++.||-|+||+|-++...+|...||+|.+++........+..++.|..||..-. .+.||+||..|+|.+++|+
T Consensus       628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEAD-n~WVVrLyySFQDkdnLYF  706 (1034)
T KOG0608|consen  628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEAD-NEWVVRLYYSFQDKDNLYF  706 (1034)
T ss_pred             ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcC-CcceEEEEEEeccCCceEE
Confidence            567889999999999999999999999999999999988888888999999999999984 9999999999999999999


Q ss_pred             EEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeecc--
Q 014733          119 LMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA--  196 (419)
Q Consensus       119 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~--  196 (419)
                      ||||++||++..+|-+.+.|.|..++.++.+|..|+++.|+.|.|||||||+||||   +.+|+|||+||||++-++.  
T Consensus       707 VMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILI---DrdGHIKLTDFGLCTGfRWTH  783 (1034)
T KOG0608|consen  707 VMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTH  783 (1034)
T ss_pred             EEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEE---ccCCceeeeeccccccceecc
Confidence            99999999999999999999999999999999999999999999999999999999   6789999999999975521  


Q ss_pred             -------CC----------------------------------ccccccCCCccCCcccccC-CCCCchhHHHHHHHHHH
Q 014733          197 -------GQ----------------------------------NLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYI  234 (419)
Q Consensus       197 -------~~----------------------------------~~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~e  234 (419)
                             +.                                  .....+||+.|+|||++.. +|+.-+|+||.||||||
T Consensus       784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e  863 (1034)
T KOG0608|consen  784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE  863 (1034)
T ss_pred             ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence                   00                                  0123379999999999876 69999999999999999


Q ss_pred             HHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCC---CHHHHHhccccccchhhh
Q 014733          235 LLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRL---TAAEVLAHSWMEECEQVA  307 (419)
Q Consensus       235 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp---s~~eil~hp~~~~~~~~~  307 (419)
                      |+.|++||...+..+...++.++.-.+...+..++|.++.++|.++.+ ++++|+   .+++|..||||+.++...
T Consensus       864 m~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkgIDfss  938 (1034)
T KOG0608|consen  864 MLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKGIDFSS  938 (1034)
T ss_pred             HhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCccccccchHh
Confidence            999999998888777766666655555455556899999999999877 889998   577899999999997643

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.5e-43  Score=334.56  Aligned_cols=252  Identities=31%  Similarity=0.523  Sum_probs=220.6

Q ss_pred             CeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEE
Q 014733           41 RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLM  120 (419)
Q Consensus        41 ~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~  120 (419)
                      +|++.+.||.|+||.||+|.+..+++.+|+|++.+.........+.+.+|+++++++. ||||+++++++.+...+++|+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~   79 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELN-HPFLVNLWYSFQDEENMYLVV   79 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCC-CCChHHHHHhhcCCCeEEEEE
Confidence            5899999999999999999999999999999998766555566788999999999995 999999999999999999999


Q ss_pred             eecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCCcc
Q 014733          121 ELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNL  200 (419)
Q Consensus       121 E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~~~  200 (419)
                      ||+.|++|..++....++++..+..++.||++||.|||+++++|+||+|+||++   ++++.++|+|||.+.........
T Consensus        80 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~---~~~~~~~l~d~~~~~~~~~~~~~  156 (258)
T cd05578          80 DLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILL---DEQGHVHITDFNIATKVTPDTLT  156 (258)
T ss_pred             eCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE---cCCCCEEEeecccccccCCCccc
Confidence            999999999999887789999999999999999999999999999999999999   56778999999999876555444


Q ss_pred             ccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhcCCCCCCCCCCCCCHHHHHH
Q 014733          201 HGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTK---SKIFDAVRAADLRFPSDPWDHISASARDL  276 (419)
Q Consensus       201 ~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~s~~l~~l  276 (419)
                      ....|+..|+|||++.+. ++.++|+||||+++|+|++|..||.....   ............    .....++.++.++
T Consensus       157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~  232 (258)
T cd05578         157 TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADV----LYPATWSTEAIDA  232 (258)
T ss_pred             cccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccc----cCcccCcHHHHHH
Confidence            556788999999998764 79999999999999999999999987663   333333222222    2223678999999


Q ss_pred             HHhhhhcCCCCCCCH--HHHHhcccc
Q 014733          277 IMGMLRVDPSTRLTA--AEVLAHSWM  300 (419)
Q Consensus       277 i~~~L~~dP~~Rps~--~eil~hp~~  300 (419)
                      |.+||+.||.+||+.  .++++||||
T Consensus       233 i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         233 INKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             HHHHccCChhHcCCccHHHHhcCCCC
Confidence            999999999999999  999999997

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=7.2e-43  Score=337.82  Aligned_cols=263  Identities=27%  Similarity=0.464  Sum_probs=222.5

Q ss_pred             hhhccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEE
Q 014733           32 ATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYE  111 (419)
Q Consensus        32 ~~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~  111 (419)
                      ...+.....+|++.+.||+|++|.||+|.+..++..+++|.+.....   .....+.+|+.+++.+. ||||+++++.+.
T Consensus        12 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~---~~~~~~~~e~~~l~~~~-h~~v~~~~~~~~   87 (296)
T cd06654          12 IVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENK-NPNIVNYLDSYL   87 (296)
T ss_pred             ccccCCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc---chHHHHHHHHHHHHhCC-CCCEeeEEEEEE
Confidence            45566777899999999999999999999999999999999876543   33567889999999995 999999999999


Q ss_pred             eCCEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccce
Q 014733          112 EEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA  191 (419)
Q Consensus       112 ~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla  191 (419)
                      +....|+||||+++++|.+++.. ..+++.++..++.|++.||+|||+.||+||||||+|||+   +.++.+||+|||++
T Consensus        88 ~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill---~~~~~~kl~dfg~~  163 (296)
T cd06654          88 VGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFC  163 (296)
T ss_pred             eCCEEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---cCCCCEEECccccc
Confidence            99999999999999999999865 568999999999999999999999999999999999999   55678999999998


Q ss_pred             eeeccCCc-cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCC
Q 014733          192 TYIKAGQN-LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHI  269 (419)
Q Consensus       192 ~~~~~~~~-~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  269 (419)
                      ........ .....|++.|+|||.+.+. ++.++|+|||||++|+|++|+.||...........+..... .+......+
T Consensus       164 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~  242 (296)
T cd06654         164 AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-PELQNPEKL  242 (296)
T ss_pred             hhccccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCC-CCCCCcccc
Confidence            76543322 2334788999999998764 88999999999999999999999987766444433332221 111223468


Q ss_pred             CHHHHHHHHhhhhcCCCCCCCHHHHHhccccccc
Q 014733          270 SASARDLIMGMLRVDPSTRLTAAEVLAHSWMEEC  303 (419)
Q Consensus       270 s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~  303 (419)
                      +..+.++|.+||..||++|||+.++++||||...
T Consensus       243 ~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~  276 (296)
T cd06654         243 SAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA  276 (296)
T ss_pred             CHHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence            8999999999999999999999999999999754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=3.4e-43  Score=336.29  Aligned_cols=254  Identities=33%  Similarity=0.544  Sum_probs=214.2

Q ss_pred             ecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEEeecCCCC
Q 014733           48 LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGE  127 (419)
Q Consensus        48 LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~ggs  127 (419)
                      ||+|+||+||+|.++.+|+.+|+|.+.+...........+.+|++++++++ ||||+++++++...+.+|+||||+++++
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVS-SRFIVSLAYAFETKDDLCLVMTLMNGGD   79 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCC-CCCEeeeeeEEecCCeEEEEEecCCCCc
Confidence            689999999999999999999999997654433344566778999999996 9999999999999999999999999999


Q ss_pred             hHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCCccccccC
Q 014733          128 LFHRLEKYG--RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVG  205 (419)
Q Consensus       128 L~~~l~~~~--~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~~~~~~~g  205 (419)
                      |.+++...+  .+++.++..++.|++.||.|||+.|++|+||+|+||++   +.++.+||+|||.+.............+
T Consensus        80 L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~  156 (277)
T cd05577          80 LKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLL---DDHGNVRISDLGLAVELKGGKKIKGRAG  156 (277)
T ss_pred             HHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEccCcchhhhccCCccccccC
Confidence            999997765  69999999999999999999999999999999999999   5677899999999886654444445578


Q ss_pred             CCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcC
Q 014733          206 SPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVD  284 (419)
Q Consensus       206 t~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~d  284 (419)
                      +..|+|||++.+. ++.++|+||+|+++|+|++|+.||...........+.......+......+++++.++|.+||+.|
T Consensus       157 ~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  236 (277)
T cd05577         157 TPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD  236 (277)
T ss_pred             CCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCC
Confidence            8899999998764 889999999999999999999999765542222233332223333334568999999999999999


Q ss_pred             CCCCC-----CHHHHHhccccccchh
Q 014733          285 PSTRL-----TAAEVLAHSWMEECEQ  305 (419)
Q Consensus       285 P~~Rp-----s~~eil~hp~~~~~~~  305 (419)
                      |.+||     ++.+++.||||....+
T Consensus       237 p~~R~~~~~~~~~~ll~h~~~~~~~~  262 (277)
T cd05577         237 PEKRLGCRGGSADEVREHPLFKDLNW  262 (277)
T ss_pred             hhHccCCCcccHHHHHhChhhhcCCh
Confidence            99999     9999999999987654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-43  Score=335.51  Aligned_cols=258  Identities=31%  Similarity=0.523  Sum_probs=221.0

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEE
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHL  118 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~l  118 (419)
                      .++|++.+.||.|+||.||+|.+..+++.+|+|.+...   .....+.+..|+++++++. ||||+++++.+.+.+.+|+
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l   79 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECK-HPNIVGLYEAYFYENKLWI   79 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCC-CCceeEEEEEEecCCeEEE
Confidence            36799999999999999999999889999999998654   3456678889999999996 9999999999999999999


Q ss_pred             EEeecCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccC
Q 014733          119 LMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG  197 (419)
Q Consensus       119 V~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~  197 (419)
                      ||||+++++|.+++... ..+++..++.++.|++.||.|||+.+|+|+||||+||++   +.++.+||+|||++......
T Consensus        80 v~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili---~~~~~~~l~d~g~~~~~~~~  156 (280)
T cd06611          80 LIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILL---TLDGDVKLADFGVSAKNKST  156 (280)
T ss_pred             EeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---CCCCCEEEccCccchhhccc
Confidence            99999999999998764 469999999999999999999999999999999999999   56788999999988754332


Q ss_pred             C-ccccccCCCccCCcccccC------CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCC
Q 014733          198 Q-NLHGTVGSPFYIAPEVLAG------GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHIS  270 (419)
Q Consensus       198 ~-~~~~~~gt~~y~aPE~l~~------~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  270 (419)
                      . ......+++.|+|||++..      .++.++|+||||+++|+|++|++||......+....+........ .....++
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  235 (280)
T cd06611         157 LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTL-DQPSKWS  235 (280)
T ss_pred             ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCc-CCcccCC
Confidence            2 2234568999999998742      367899999999999999999999988777666666655432211 1224688


Q ss_pred             HHHHHHHHhhhhcCCCCCCCHHHHHhccccccch
Q 014733          271 ASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECE  304 (419)
Q Consensus       271 ~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~  304 (419)
                      .++.++|.+||+.||.+||++.++++||||....
T Consensus       236 ~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  269 (280)
T cd06611         236 SSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQS  269 (280)
T ss_pred             HHHHHHHHHHhccChhhCcCHHHHhcChhhcccc
Confidence            9999999999999999999999999999998653

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.3e-43  Score=350.54  Aligned_cols=250  Identities=24%  Similarity=0.372  Sum_probs=200.8

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEE
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHL  118 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~l  118 (419)
                      ..+|++++.||+|+||.||+|.+..++..||+|+..+.         ....|+.+++++. ||||+++++++.+.+..++
T Consensus        65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~l  134 (357)
T PHA03209         65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVN-HPSVIRMKDTLVSGAITCM  134 (357)
T ss_pred             hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCC-CCCCcChhheEEeCCeeEE
Confidence            35799999999999999999999999999999975433         2245899999996 9999999999999999999


Q ss_pred             EEeecCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccC
Q 014733          119 LMELCAGGELFHRLEK-YGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG  197 (419)
Q Consensus       119 V~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~  197 (419)
                      |||++. ++|..++.. ...+++.++..++.||+.||.|||+.||+||||||+|||+   +.++.+||+|||++......
T Consensus       135 v~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~  210 (357)
T PHA03209        135 VLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFI---NDVDQVCIGDLGAAQFPVVA  210 (357)
T ss_pred             EEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEecCccccccccC
Confidence            999995 688887755 4569999999999999999999999999999999999999   56778999999999754433


Q ss_pred             CccccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHhCCCCC-CCCCH----------HHHHHHHHhcC---CCCC
Q 014733          198 QNLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPF-WGKTK----------SKIFDAVRAAD---LRFP  262 (419)
Q Consensus       198 ~~~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~elltG~~Pf-~~~~~----------~~~~~~i~~~~---~~~~  262 (419)
                      ....+..||+.|+|||++.+ .++.++|||||||++|||+++..++ .....          ..+...+....   ..++
T Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  290 (357)
T PHA03209        211 PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP  290 (357)
T ss_pred             cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcC
Confidence            33445679999999999876 4899999999999999999865554 32111          11111111100   0011


Q ss_pred             C--------------------------CCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhcccccc
Q 014733          263 S--------------------------DPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE  302 (419)
Q Consensus       263 ~--------------------------~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~  302 (419)
                      .                          .....++.++.+||.+||+.||.+|||+.|+|+||||++
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~  356 (357)
T PHA03209        291 RDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ  356 (357)
T ss_pred             CCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence            0                          001246778889999999999999999999999999986

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=4e-43  Score=339.76  Aligned_cols=265  Identities=27%  Similarity=0.464  Sum_probs=222.5

Q ss_pred             hhhccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEE
Q 014733           32 ATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYE  111 (419)
Q Consensus        32 ~~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~  111 (419)
                      .....+..++|.+.+.||.|++|.||+|.+..+++.||+|.+.....   ...+.+.+|+.+++.+. |+||+++++++.
T Consensus        11 ~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~   86 (297)
T cd06656          11 IVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ---PKKELIINEILVMRENK-NPNIVNYLDSYL   86 (297)
T ss_pred             hcccCChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc---chHHHHHHHHHHHHhCC-CCCEeeEEEEEe
Confidence            34566778999999999999999999999999999999999875432   34466889999999995 999999999999


Q ss_pred             eCCEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccce
Q 014733          112 EEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA  191 (419)
Q Consensus       112 ~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla  191 (419)
                      ..+.+++||||+++++|.+++.. ..+++..+..++.|++.||.|||+.+|+||||||+|||+   +.++.+||+|||++
T Consensus        87 ~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili---~~~~~~~l~Dfg~~  162 (297)
T cd06656          87 VGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFC  162 (297)
T ss_pred             cCCEEEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEECcCccc
Confidence            99999999999999999999865 568999999999999999999999999999999999999   56778999999998


Q ss_pred             eeeccCCc-cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCC
Q 014733          192 TYIKAGQN-LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHI  269 (419)
Q Consensus       192 ~~~~~~~~-~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  269 (419)
                      ........ .....+++.|+|||.+.+. ++.++|+|||||++|+|++|..||.+.........+.... ..+......+
T Consensus       163 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~  241 (297)
T cd06656         163 AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPELQNPERL  241 (297)
T ss_pred             eEccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCC-CCCCCCcccc
Confidence            86544332 2234688999999998764 8899999999999999999999997765533332222221 1111223468


Q ss_pred             CHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          270 SASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       270 s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                      +..++++|.+||+.||++||++.++++||||+....
T Consensus       242 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  277 (297)
T cd06656         242 SAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKP  277 (297)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcCchhccccc
Confidence            899999999999999999999999999999986544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.1e-42  Score=335.20  Aligned_cols=259  Identities=28%  Similarity=0.491  Sum_probs=219.5

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEE
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHL  118 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~l  118 (419)
                      .+.|+++++||.|+||.||+|.+..+++.+++|.+...   .....+.+.+|+.+++.+. ||||+++++++..++.+++
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l   86 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCN-HPYIVKLLGAFYWDGKLWI   86 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCC-CCcEeeeEEEEEeCCeEEE
Confidence            47799999999999999999999999999999998754   3456778899999999996 9999999999999999999


Q ss_pred             EEeecCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccC
Q 014733          119 LMELCAGGELFHRLEK-YGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG  197 (419)
Q Consensus       119 V~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~  197 (419)
                      ||||+++++|..++.. ...+++..+..++.|++.+|+|||+.+|+||||||+||++   +.++.+||+|||++......
T Consensus        87 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~~~~  163 (292)
T cd06644          87 MIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLL---TLDGDIKLADFGVSAKNVKT  163 (292)
T ss_pred             EEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEE---cCCCCEEEccCccceecccc
Confidence            9999999999887754 3568999999999999999999999999999999999999   55778999999988754322


Q ss_pred             -CccccccCCCccCCcccccC------CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCC
Q 014733          198 -QNLHGTVGSPFYIAPEVLAG------GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHIS  270 (419)
Q Consensus       198 -~~~~~~~gt~~y~aPE~l~~------~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  270 (419)
                       .......+++.|+|||++.+      .++.++|+|||||++|+|++|.+||...+..+...++...... .......++
T Consensus       164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  242 (292)
T cd06644         164 LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP-TLSQPSKWS  242 (292)
T ss_pred             ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCc-cCCCCcccC
Confidence             22234568889999999742      3688999999999999999999999887766665555443221 111224678


Q ss_pred             HHHHHHHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          271 ASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       271 ~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                      .++.++|.+||..||++||++.++++||||.....
T Consensus       243 ~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  277 (292)
T cd06644         243 MEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTS  277 (292)
T ss_pred             HHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence            99999999999999999999999999999986544

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4e-43  Score=336.90  Aligned_cols=258  Identities=27%  Similarity=0.426  Sum_probs=217.4

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      ++|++++.||+|+||.||+|.+..+|..+|+|.+...  ........+.+|+.+++++. ||||+++++.+...+.+|+|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv   77 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE--LDESKFNQIIMELDILHKAV-SPYIVDFYGAFFIEGAVYMC   77 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc--cCHHHHHHHHHHHHHHHhcC-CCcHHhhhhheecCCeEEEE
Confidence            5799999999999999999999999999999998654  24455678899999999995 99999999999999999999


Q ss_pred             EeecCCCChHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHh-CCCeeccCCCCcEEEeecCCCCCeEEeeccceeeec
Q 014733          120 MELCAGGELFHRLEKY---GRFSETEARVIFRHLMQVVSYCHG-NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIK  195 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~~---~~l~~~~~~~i~~qll~aL~~LH~-~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~  195 (419)
                      |||+++++|..++...   ..+++..+..++.||+.||.|||+ .+|+|+||||+||++   +.++.+||+|||++....
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~  154 (286)
T cd06622          78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLV---NGNGQVKLCDFGVSGNLV  154 (286)
T ss_pred             EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEE---CCCCCEEEeecCCccccc
Confidence            9999999999988763   369999999999999999999997 599999999999999   457789999999987653


Q ss_pred             cCCccccccCCCccCCcccccCC-------CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCC
Q 014733          196 AGQNLHGTVGSPFYIAPEVLAGG-------YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDH  268 (419)
Q Consensus       196 ~~~~~~~~~gt~~y~aPE~l~~~-------~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  268 (419)
                      ... .....+++.|+|||++.+.       ++.++|+|||||++|+|++|+.||...........+.......+...+..
T Consensus       155 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd06622         155 ASL-AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSG  233 (286)
T ss_pred             CCc-cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcc
Confidence            322 2334688899999987542       57899999999999999999999976655555444333222222333346


Q ss_pred             CCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccch
Q 014733          269 ISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECE  304 (419)
Q Consensus       269 ~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~  304 (419)
                      ++.++.++|.+||+.+|++||++.+++.||||....
T Consensus       234 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~  269 (286)
T cd06622         234 YSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK  269 (286)
T ss_pred             cCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence            899999999999999999999999999999997654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=6.5e-43  Score=330.96  Aligned_cols=251  Identities=35%  Similarity=0.638  Sum_probs=217.4

Q ss_pred             ecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEEeecCCCC
Q 014733           48 LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGE  127 (419)
Q Consensus        48 LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~ggs  127 (419)
                      ||.|++|.||+|.+..+++.+|+|++.+.........+.+.+|+.+++++. ||||+++++.+.+.+.++++|||+++++
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECN-HPFIVKLYRTFKDKKYIYMLMEYCLGGE   79 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCC-CCCEeeeeeeEEcCCccEEEEecCCCCc
Confidence            799999999999999999999999998765544456678999999999995 9999999999999999999999999999


Q ss_pred             hHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCCccccccCCC
Q 014733          128 LFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSP  207 (419)
Q Consensus       128 L~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~~~~~~~gt~  207 (419)
                      |.+++.+...+++..+..++.||++||+|||+.+++|+||+|+||++   +.++.+||+|||++.............+++
T Consensus        80 L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  156 (262)
T cd05572          80 LWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLL---DSNGYVKLVDFGFAKKLKSGQKTWTFCGTP  156 (262)
T ss_pred             HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEE---cCCCCEEEeeCCcccccCcccccccccCCc
Confidence            99999887789999999999999999999999999999999999999   557789999999998765543334457899


Q ss_pred             ccCCcccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcC
Q 014733          208 FYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKT--KSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVD  284 (419)
Q Consensus       208 ~y~aPE~l~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~d  284 (419)
                      .|++||.+.+ .++.++|+||+|+++|+|++|..||....  ..+....+.........  ....+.++.++|.+||+.|
T Consensus       157 ~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~i~~~l~~~  234 (262)
T cd05572         157 EYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEF--PNYIDKAAKDLIKQLLRRN  234 (262)
T ss_pred             CccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCC--CcccCHHHHHHHHHHccCC
Confidence            9999999866 48999999999999999999999998776  55566665532222221  1245899999999999999


Q ss_pred             CCCCCC-----HHHHHhccccccch
Q 014733          285 PSTRLT-----AAEVLAHSWMEECE  304 (419)
Q Consensus       285 P~~Rps-----~~eil~hp~~~~~~  304 (419)
                      |++||+     +.|+++||||+...
T Consensus       235 p~~R~~~~~~~~~~l~~~~~~~~~~  259 (262)
T cd05572         235 PEERLGNLKGGIKDIKKHKWFNGFD  259 (262)
T ss_pred             hhhCcCCcccCHHHHhcChhhhCCC
Confidence            999999     99999999998654

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.4e-42  Score=326.91  Aligned_cols=253  Identities=28%  Similarity=0.498  Sum_probs=220.1

Q ss_pred             CeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEE
Q 014733           41 RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLM  120 (419)
Q Consensus        41 ~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~  120 (419)
                      +|++.+.||+|++|.||+|.+..+++.+|+|.+..... .......+.+|+.+++++. ||||+++++.+...+..++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLLS-HPNIIEYYENFLEDKALMIVM   78 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc-ccHHHHHHHHHHHHHhhCC-CCchhheeeeEecCCEEEEEE
Confidence            58999999999999999999999999999999986644 3455788999999999996 999999999999999999999


Q ss_pred             eecCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC
Q 014733          121 ELCAGGELFHRLEKY--GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ  198 (419)
Q Consensus       121 E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~  198 (419)
                      ||+++++|.+++...  ..+++..+..++.+++.+|+|||++|++|+||||+||+++.  .++.+||+|||++.......
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~--~~~~~~l~d~~~~~~~~~~~  156 (256)
T cd08220          79 EYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDK--HKMVVKIGDFGISKILSSKS  156 (256)
T ss_pred             ecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC--CCCEEEEccCCCceecCCCc
Confidence            999999999999764  34899999999999999999999999999999999999953  34468999999998776554


Q ss_pred             ccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHH
Q 014733          199 NLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLI  277 (419)
Q Consensus       199 ~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li  277 (419)
                      ......|+..|+|||.+.+. ++.++|+||+|+++|+|++|+.||...+.......+.......   ....++.++.+++
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li  233 (256)
T cd08220         157 KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAP---ISDRYSPDLRQLI  233 (256)
T ss_pred             cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCC---CCCCcCHHHHHHH
Confidence            44456789999999998764 7899999999999999999999998877777666665543321   2235889999999


Q ss_pred             HhhhhcCCCCCCCHHHHHhcccc
Q 014733          278 MGMLRVDPSTRLTAAEVLAHSWM  300 (419)
Q Consensus       278 ~~~L~~dP~~Rps~~eil~hp~~  300 (419)
                      .+||+.||++|||+.++++||||
T Consensus       234 ~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         234 LSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             HHHccCChhhCCCHHHHhhCCCC
Confidence            99999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=2.1e-43  Score=338.33  Aligned_cols=254  Identities=28%  Similarity=0.488  Sum_probs=207.3

Q ss_pred             CeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEE
Q 014733           41 RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLM  120 (419)
Q Consensus        41 ~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~  120 (419)
                      +|++.+.||+|++|.||+|.++.+|+.+|+|.+..... .......+.+|+.+++++. ||||+++++++.+.+.+++++
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~~~~lv~   78 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELK-HKNIVRLYDVLHSDKKLTLVF   78 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcC-CCCeeeHHHHhccCCceEEEE
Confidence            68999999999999999999999999999999975432 2223456778999999996 999999999999999999999


Q ss_pred             eecCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC-
Q 014733          121 ELCAGGELFHRLEK-YGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ-  198 (419)
Q Consensus       121 E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~-  198 (419)
                      ||+. ++|.+++.. .+.+++..++.++.||++||.|||+.+|+||||||+||++   +.++.+||+|||++....... 
T Consensus        79 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~---~~~~~~~l~dfg~~~~~~~~~~  154 (284)
T cd07839          79 EYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGIPVR  154 (284)
T ss_pred             ecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---cCCCcEEECccchhhccCCCCC
Confidence            9996 578777754 4669999999999999999999999999999999999999   556789999999988654332 


Q ss_pred             ccccccCCCccCCcccccCC--CCCchhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHhcCCC---------------
Q 014733          199 NLHGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPF-WGKTKSKIFDAVRAADLR---------------  260 (419)
Q Consensus       199 ~~~~~~gt~~y~aPE~l~~~--~s~~sDvwSlGvil~elltG~~Pf-~~~~~~~~~~~i~~~~~~---------------  260 (419)
                      ......+++.|+|||++.+.  ++.++|+|||||++|+|++|..|| .+.+..+..+.+......               
T Consensus       155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07839         155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY  234 (284)
T ss_pred             CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence            22335678899999998763  789999999999999999988885 444444444433221000               


Q ss_pred             --CCC--------CCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhcccc
Q 014733          261 --FPS--------DPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWM  300 (419)
Q Consensus       261 --~~~--------~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~  300 (419)
                        ++.        .....++++++++|.+||+.||.+|||+.+++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence              000        0113578999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=2.4e-42  Score=325.73  Aligned_cols=252  Identities=28%  Similarity=0.477  Sum_probs=221.5

Q ss_pred             CeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEE
Q 014733           41 RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLM  120 (419)
Q Consensus        41 ~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~  120 (419)
                      +|++.+.||.|+||.||.+.+..+++.+++|.+..... +......+.+|+.+++++. |+||+++++++.+.+.++++|
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~~~~   78 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL-SEKERRDALNEIVILSLLQ-HPNIIAYYNHFMDDNTLLIEM   78 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeeccc-chhHHHHHHHHHHHHHhCC-CCCeeEEEeEEecCCeEEEEE
Confidence            69999999999999999999999999999999876543 3455677889999999995 999999999999999999999


Q ss_pred             eecCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC
Q 014733          121 ELCAGGELFHRLEKY--GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ  198 (419)
Q Consensus       121 E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~  198 (419)
                      ||+++++|.+++...  ..+++..+..++.|++.+|.|||+.+++|+||+|+||++   +.++.+||+|||++.......
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~---~~~~~~kl~d~~~~~~~~~~~  155 (256)
T cd08221          79 EYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFL---TKAGLIKLGDFGISKILGSEY  155 (256)
T ss_pred             EecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEE---eCCCCEEECcCcceEEccccc
Confidence            999999999999765  458999999999999999999999999999999999999   456789999999998764433


Q ss_pred             -ccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHH
Q 014733          199 -NLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDL  276 (419)
Q Consensus       199 -~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~l  276 (419)
                       ......|++.|+|||++.+. ++.++|+||||+++|+|++|..||......+....+..+......   ..++.++.++
T Consensus       156 ~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  232 (256)
T cd08221         156 SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVV---SVYSSELISL  232 (256)
T ss_pred             ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCc---cccCHHHHHH
Confidence             22345789999999998764 889999999999999999999999988887877777665443322   4688999999


Q ss_pred             HHhhhhcCCCCCCCHHHHHhcccc
Q 014733          277 IMGMLRVDPSTRLTAAEVLAHSWM  300 (419)
Q Consensus       277 i~~~L~~dP~~Rps~~eil~hp~~  300 (419)
                      |.+||+.||++||++.++++|||+
T Consensus       233 i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         233 VHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             HHHHcccCcccCCCHHHHhhCcCC
Confidence            999999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=6.6e-43  Score=342.76  Aligned_cols=257  Identities=22%  Similarity=0.325  Sum_probs=207.5

Q ss_pred             eeeeeccc--CceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEEe
Q 014733           44 LGKQLGWG--QFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLME  121 (419)
Q Consensus        44 i~~~LG~G--~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  121 (419)
                      ++++||+|  ++++||++.++.+|+.||+|.+..... .....+.+.+|+.+++.+. ||||+++++++.+++..++|||
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e   79 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFN-HPNIVPYRATFIADNELWVVTS   79 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEECCEEEEEEe
Confidence            57889999  678999999999999999999876543 3345667888999999995 9999999999999999999999


Q ss_pred             ecCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccC-C
Q 014733          122 LCAGGELFHRLEKY--GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG-Q  198 (419)
Q Consensus       122 ~~~ggsL~~~l~~~--~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~-~  198 (419)
                      |+++++|.+++...  ..+++..++.++.|++.||+|||+++|+||||||+|||+   +.++.++++||+........ .
T Consensus        80 ~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~---~~~~~~~l~~~~~~~~~~~~~~  156 (327)
T cd08227          80 FMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI---SVDGKVYLSGLRSNLSMINHGQ  156 (327)
T ss_pred             ccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEE---ecCCcEEEcccchhhccccccc
Confidence            99999999998653  458999999999999999999999999999999999999   45678999999865433211 1


Q ss_pred             c-------cccccCCCccCCcccccC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC------
Q 014733          199 N-------LHGTVGSPFYIAPEVLAG---GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFP------  262 (419)
Q Consensus       199 ~-------~~~~~gt~~y~aPE~l~~---~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~------  262 (419)
                      .       .....++..|+|||++.+   .++.++|||||||++|+|++|+.||....................      
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (327)
T cd08227         157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTI  236 (327)
T ss_pred             cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccch
Confidence            0       112356778999999865   388999999999999999999999976554443333222211100      


Q ss_pred             ------------------------------------CCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          263 ------------------------------------SDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       263 ------------------------------------~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                                                          ......+++++.+||++||+.||++|||+.++++||||++...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~~  315 (327)
T cd08227         237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKR  315 (327)
T ss_pred             hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcch
Confidence                                                0011235778999999999999999999999999999987653

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.2e-42  Score=329.80  Aligned_cols=254  Identities=27%  Similarity=0.495  Sum_probs=214.0

Q ss_pred             CeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCcc---CCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEE
Q 014733           41 RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRL---VTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVH  117 (419)
Q Consensus        41 ~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~---~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~  117 (419)
                      +|++++.||.|+||.||+|.+. +|+.+|+|.+..+..   ........+.+|+.+++++. |+||+++++++.+.+.++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~   78 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK-HVNIVQYLGTCLDDNTIS   78 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcC-CCCEeeEeeEeecCCeEE
Confidence            5889999999999999999874 788999999875432   12334567899999999996 999999999999999999


Q ss_pred             EEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccC
Q 014733          118 LLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG  197 (419)
Q Consensus       118 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~  197 (419)
                      ++|||+++++|.+++.+.+++++..+..++.|++.||+|||+.+|+|+||+|+||++   +.++.+||+|||++......
T Consensus        79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~  155 (265)
T cd06631          79 IFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVML---MPNGIIKLIDFGCARRLAWV  155 (265)
T ss_pred             EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEE---CCCCeEEeccchhhHhhhhc
Confidence            999999999999999887889999999999999999999999999999999999999   56778999999998754221


Q ss_pred             -------CccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCC
Q 014733          198 -------QNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHI  269 (419)
Q Consensus       198 -------~~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  269 (419)
                             .......|+..|+|||++.+. ++.++|+||||+++|+|++|..||...........+.......+. ....+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~  234 (265)
T cd06631         156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPR-LPDSF  234 (265)
T ss_pred             cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCC-CCCCC
Confidence                   112234688999999998764 889999999999999999999999876655444444333222222 23468


Q ss_pred             CHHHHHHHHhhhhcCCCCCCCHHHHHhcccc
Q 014733          270 SASARDLIMGMLRVDPSTRLTAAEVLAHSWM  300 (419)
Q Consensus       270 s~~l~~li~~~L~~dP~~Rps~~eil~hp~~  300 (419)
                      +.++.++|.+||+.+|++||++.+++.||||
T Consensus       235 ~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         235 SAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             CHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            9999999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=8.8e-43  Score=336.49  Aligned_cols=260  Identities=29%  Similarity=0.462  Sum_probs=216.1

Q ss_pred             CeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccC--CHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEE
Q 014733           41 RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLV--TVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHL  118 (419)
Q Consensus        41 ~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~--~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~l  118 (419)
                      +|.+.+.||.|++|.||+|.++.+|+.||+|.+......  .......+..|+.++++++ |+||+++++++.+.+..++
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~l   79 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK-HPNIIGLLDVFGHKSNINL   79 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcC-CCCChhhhheeecCCEEEE
Confidence            588999999999999999999989999999999765432  1223456778999999996 9999999999999999999


Q ss_pred             EEeecCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccC
Q 014733          119 LMELCAGGELFHRLEKYG-RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG  197 (419)
Q Consensus       119 V~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~  197 (419)
                      ||||+ +++|.+++.... .+++.++..++.||++||.|||++||+|+||||+||++   +.++.+||+|||++......
T Consensus        80 v~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill---~~~~~~~l~dfg~~~~~~~~  155 (298)
T cd07841          80 VFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLI---ASDGVLKLADFGLARSFGSP  155 (298)
T ss_pred             EEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEE---cCCCCEEEccceeeeeccCC
Confidence            99999 899999998765 79999999999999999999999999999999999999   55778999999999876543


Q ss_pred             C-ccccccCCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC------------
Q 014733          198 Q-NLHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFP------------  262 (419)
Q Consensus       198 ~-~~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~------------  262 (419)
                      . ......+++.|+|||.+.+  .++.++|+|||||++|+|++|.+||.+....+....+........            
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (298)
T cd07841         156 NRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPD  235 (298)
T ss_pred             CccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccc
Confidence            2 2233457888999998865  378999999999999999999998887666555544432110000            


Q ss_pred             ------------CCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          263 ------------SDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       263 ------------~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                                  ...+...+.++.++|.+||++||++|||+.++++||||++...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~  290 (298)
T cd07841         236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPA  290 (298)
T ss_pred             cccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCC
Confidence                        0012346789999999999999999999999999999987543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.4e-42  Score=332.96  Aligned_cols=263  Identities=28%  Similarity=0.430  Sum_probs=214.6

Q ss_pred             cchhhccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEE
Q 014733           30 LDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAV  109 (419)
Q Consensus        30 ~~~~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~  109 (419)
                      +.........++|++.+.||+|+||.||+|.++.+++.+|+|++....    .....+.+|+.+++.+.+||||++++++
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~   83 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGM   83 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeee
Confidence            334566778899999999999999999999999999999999876432    2235678899999999669999999998


Q ss_pred             EE-----eCCEEEEEEeecCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCC
Q 014733          110 YE-----EEDYVHLLMELCAGGELFHRLEK----YGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSS  180 (419)
Q Consensus       110 ~~-----~~~~~~lV~E~~~ggsL~~~l~~----~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~  180 (419)
                      +.     +.+.+++||||++|++|.+++..    ...+++..++.++.|+++||.|||+.+|+||||||+||++   +.+
T Consensus        84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili---~~~  160 (286)
T cd06638          84 YYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILL---TTE  160 (286)
T ss_pred             eeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEE---CCC
Confidence            74     45679999999999999988753    2458899999999999999999999999999999999999   556


Q ss_pred             CCeEEeeccceeeeccCC-ccccccCCCccCCcccccC------CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 014733          181 SPIKLADFGLATYIKAGQ-NLHGTVGSPFYIAPEVLAG------GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDA  253 (419)
Q Consensus       181 ~~vKL~DFgla~~~~~~~-~~~~~~gt~~y~aPE~l~~------~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~  253 (419)
                      +.+||+|||++....... ......|++.|+|||++..      .++.++||||+||++|+|++|+.||...........
T Consensus       161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~  240 (286)
T cd06638         161 GGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFK  240 (286)
T ss_pred             CCEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhh
Confidence            789999999998764332 2233468999999998742      378899999999999999999999987665444333


Q ss_pred             HHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhcccc
Q 014733          254 VRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWM  300 (419)
Q Consensus       254 i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~  300 (419)
                      +..... ........++.++.++|.+||+.||++|||+.++++|+||
T Consensus       241 ~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         241 IPRNPP-PTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             ccccCC-CcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence            322211 1111123467899999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.2e-42  Score=332.77  Aligned_cols=255  Identities=35%  Similarity=0.544  Sum_probs=214.5

Q ss_pred             CeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEE
Q 014733           41 RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLM  120 (419)
Q Consensus        41 ~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~  120 (419)
                      +|++.+.||.|++|.||+|.+..+|+.+++|++..... .......+.+|+.+++++. ||||+++++++.+.+.+++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~~v~   78 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRL-EGGIPNQALREIKALQACQ-HPYVVKLLDVFPHGSGFVLVM   78 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccc-cchhhHHHHHHHHHHHhCC-CCCCcceeeEEecCCeeEEEe
Confidence            68999999999999999999998999999999976543 2344567899999999996 999999999999999999999


Q ss_pred             eecCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC-
Q 014733          121 ELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ-  198 (419)
Q Consensus       121 E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~-  198 (419)
                      ||+ +++|.+++... ..+++.+++.++.||++||+|||+.+++|+||||+||++   +.++.++|+|||++....... 
T Consensus        79 e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~---~~~~~~~l~dfg~~~~~~~~~~  154 (286)
T cd07832          79 EYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLI---SADGVLKIADFGLARLFSEEEP  154 (286)
T ss_pred             ccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEE---cCCCcEEEeeeeecccccCCCC
Confidence            999 99999998653 569999999999999999999999999999999999999   457789999999988765433 


Q ss_pred             -ccccccCCCccCCcccccCC--CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC----------------
Q 014733          199 -NLHGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADL----------------  259 (419)
Q Consensus       199 -~~~~~~gt~~y~aPE~l~~~--~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~----------------  259 (419)
                       ......|+..|+|||++.+.  ++.++||||+|+++|+|++|.+||.+....+....+.....                
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07832         155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDY  234 (286)
T ss_pred             CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchh
Confidence             13345789999999998653  68999999999999999999999987766555544433110                


Q ss_pred             ---CCCCC-------CCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccc
Q 014733          260 ---RFPSD-------PWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWME  301 (419)
Q Consensus       260 ---~~~~~-------~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~  301 (419)
                         .++..       .....+.++.++|.+||+.||++|||++++++||||.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence               01110       1235678999999999999999999999999999983

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=7.1e-43  Score=334.69  Aligned_cols=256  Identities=28%  Similarity=0.499  Sum_probs=214.0

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      ++|++.+.||+|++|.||+|.++.+++.+|+|.+.+.... ....+.+.+|+++++.+. ||||+++++++.+.+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   78 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD-KMVKKIAMREIRMLKQLR-HENLVNLIEVFRRKKRLYLV   78 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCc-chhhHHHHHHHHHHHhcC-CcchhhHHHhcccCCeEEEE
Confidence            4799999999999999999999989999999998765432 234567888999999995 99999999999999999999


Q ss_pred             EeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCCc
Q 014733          120 MELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN  199 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~~  199 (419)
                      |||+++++|..+......+++.++..++.|+++||+|||+.+|+|+||+|+||++   ++++.+||+|||++........
T Consensus        79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~---~~~~~~~l~dfg~~~~~~~~~~  155 (286)
T cd07846          79 FEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILV---SQSGVVKLCDFGFARTLAAPGE  155 (286)
T ss_pred             EecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCcEEEEeeeeeeeccCCcc
Confidence            9999999998887766679999999999999999999999999999999999999   5677899999999887544322


Q ss_pred             -cccccCCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC----------------
Q 014733          200 -LHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLR----------------  260 (419)
Q Consensus       200 -~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~----------------  260 (419)
                       .....++..|+|||++.+  .++.++||||||+++|+|++|++||......+....+......                
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd07846         156 VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFA  235 (286)
T ss_pred             ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhh
Confidence             233468889999999865  3788999999999999999999999776654443333321111                


Q ss_pred             ---CCC--------CCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhcccc
Q 014733          261 ---FPS--------DPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWM  300 (419)
Q Consensus       261 ---~~~--------~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~  300 (419)
                         .+.        ..+..++..+.+++.+||+.||++||++.++++||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             ccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence               010        0124678899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.1e-42  Score=332.54  Aligned_cols=252  Identities=29%  Similarity=0.486  Sum_probs=208.3

Q ss_pred             eeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeC--CEEEEE
Q 014733           42 YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEE--DYVHLL  119 (419)
Q Consensus        42 y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~--~~~~lV  119 (419)
                      |++.+.||+|+||.||+|.+..+++.+|+|++.+... . .......+|+.+++++.+|+||+++++++.+.  +.+++|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv   78 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK-S-LEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV   78 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC-C-chhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence            7889999999999999999999999999999875432 1 12233457899999997799999999999987  899999


Q ss_pred             EeecCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC
Q 014733          120 MELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ  198 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~  198 (419)
                      |||++ ++|.+.+... ..+++.++..++.|++.||+|||+.+|+||||||+||+++   . +.+||+|||++.......
T Consensus        79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~---~-~~~kl~dfg~~~~~~~~~  153 (282)
T cd07831          79 FELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIK---D-DILKLADFGSCRGIYSKP  153 (282)
T ss_pred             EecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEc---C-CCeEEEecccccccccCC
Confidence            99996 5788777653 5689999999999999999999999999999999999994   4 899999999998765544


Q ss_pred             ccccccCCCccCCcccccC-C-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC------------------
Q 014733          199 NLHGTVGSPFYIAPEVLAG-G-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAAD------------------  258 (419)
Q Consensus       199 ~~~~~~gt~~y~aPE~l~~-~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~------------------  258 (419)
                      ......++..|+|||++.+ + ++.++|+||+||++|+|++|.+||.+.+..+....+....                  
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
T cd07831         154 PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN  233 (282)
T ss_pred             CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccc
Confidence            4445568899999997654 3 7899999999999999999999998877665555443211                  


Q ss_pred             CCCCCCC-------CCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhcccc
Q 014733          259 LRFPSDP-------WDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWM  300 (419)
Q Consensus       259 ~~~~~~~-------~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~  300 (419)
                      ..++...       ...++.++.++|.+||++||++||++.++++||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             ccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            1111110       12568999999999999999999999999999997

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.7e-42  Score=333.43  Aligned_cols=242  Identities=15%  Similarity=0.171  Sum_probs=209.0

Q ss_pred             eeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEe----CCEEEEEEe
Q 014733           46 KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEE----EDYVHLLME  121 (419)
Q Consensus        46 ~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~----~~~~~lV~E  121 (419)
                      ..||+|+++.||+|..  +|+.||+|.+.+.........+.+.+|+.+|++++ ||||+++++++.+    ...+++|||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~g~~~~~~~~~~~~~lv~E  102 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRID-SNNILKIYGFIIDIVDDLPRLSLILE  102 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcC-CCCEEEEeeeEEecccCCCceEEEEE
Confidence            5689999999999987  68999999997654444444678889999999996 9999999999877    457899999


Q ss_pred             ecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC-CCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCCcc
Q 014733          122 LCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGN-GVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNL  200 (419)
Q Consensus       122 ~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~-~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~~~  200 (419)
                      |+++|+|.+++...+.+++.....++.+++.||.|||+. +++||||||+|||+   +.++.+||+|||++......  .
T Consensus       103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill---~~~~~~kl~dfg~~~~~~~~--~  177 (283)
T PHA02988        103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLV---TENYKLKIICHGLEKILSSP--P  177 (283)
T ss_pred             eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEE---CCCCcEEEcccchHhhhccc--c
Confidence            999999999998888899999999999999999999984 99999999999999   56788999999998865332  2


Q ss_pred             ccccCCCccCCcccccC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHH
Q 014733          201 HGTVGSPFYIAPEVLAG---GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLI  277 (419)
Q Consensus       201 ~~~~gt~~y~aPE~l~~---~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li  277 (419)
                      ....|+..|+|||++.+   .++.++|||||||++|||++|+.||.+.+..++...+.....+.+..  ...++++++++
T Consensus       178 ~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~~~~l~~li  255 (283)
T PHA02988        178 FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLP--LDCPLEIKCIV  255 (283)
T ss_pred             ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC--CcCcHHHHHHH
Confidence            34568899999999865   58999999999999999999999999888888888776554444332  26789999999


Q ss_pred             HhhhhcCCCCCCCHHHHHhc
Q 014733          278 MGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       278 ~~~L~~dP~~Rps~~eil~h  297 (419)
                      .+||+.||++|||+.++++.
T Consensus       256 ~~cl~~dp~~Rps~~ell~~  275 (283)
T PHA02988        256 EACTSHDSIKRPNIKEILYN  275 (283)
T ss_pred             HHHhcCCcccCcCHHHHHHH
Confidence            99999999999999999863

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-42  Score=329.47  Aligned_cols=256  Identities=28%  Similarity=0.486  Sum_probs=213.8

Q ss_pred             ccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCC--
Q 014733           37 NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEED--  114 (419)
Q Consensus        37 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~--  114 (419)
                      ...++|++.+.||.|++|.||+|.++.+++.+++|++....    .....+.+|+.+++++.+|+||+++++++.+..  
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~   78 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPP   78 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCC
Confidence            45689999999999999999999999889999999987543    244678999999999966999999999997644  


Q ss_pred             ----EEEEEEeecCCCChHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEe
Q 014733          115 ----YVHLLMELCAGGELFHRLEKY----GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLA  186 (419)
Q Consensus       115 ----~~~lV~E~~~ggsL~~~l~~~----~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~  186 (419)
                          .+++||||+++++|.+++...    ..+++..++.++.|+++||.|||+.+++|+||+|+||++   +.++.+||+
T Consensus        79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~---~~~~~~~l~  155 (275)
T cd06608          79 GNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILL---TKNAEVKLV  155 (275)
T ss_pred             CcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE---ccCCeEEEC
Confidence                589999999999999988653    469999999999999999999999999999999999999   556789999


Q ss_pred             eccceeeeccCCc-cccccCCCccCCcccccC------CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC
Q 014733          187 DFGLATYIKAGQN-LHGTVGSPFYIAPEVLAG------GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADL  259 (419)
Q Consensus       187 DFgla~~~~~~~~-~~~~~gt~~y~aPE~l~~------~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~  259 (419)
                      |||++........ .....|+..|+|||++..      .++.++||||||+++|+|++|++||...........+.....
T Consensus       156 d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~  235 (275)
T cd06608         156 DFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPP  235 (275)
T ss_pred             CCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCC
Confidence            9999876543322 234568899999998753      267899999999999999999999987665555554443322


Q ss_pred             CCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhcccc
Q 014733          260 RFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWM  300 (419)
Q Consensus       260 ~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~  300 (419)
                      . .......++.+++++|.+||..||++|||+.++++|||+
T Consensus       236 ~-~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         236 P-TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             C-CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence            1 111122478899999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-42  Score=326.18  Aligned_cols=254  Identities=30%  Similarity=0.537  Sum_probs=217.5

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEE
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHL  118 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~l  118 (419)
                      .++|++.+.||.|++|.||+|.+..+++.+++|++....   ....+.+.+|+.+++++. ||||+++++++.+.+.+|+
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~l   77 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP---GDDFEIIQQEISMLKECR-HPNIVAYFGSYLRRDKLWI   77 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc---hhhHHHHHHHHHHHHhCC-CCChhceEEEEEeCCEEEE
Confidence            478999999999999999999999899999999997653   235678999999999995 9999999999999999999


Q ss_pred             EEeecCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccC
Q 014733          119 LMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG  197 (419)
Q Consensus       119 V~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~  197 (419)
                      +|||+++++|..++... ..+++.++..++.|++.||+|||+++|+|+||||+||++   +.++.+||+|||++......
T Consensus        78 ~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~  154 (262)
T cd06613          78 VMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILL---TEDGDVKLADFGVSAQLTAT  154 (262)
T ss_pred             EEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEE---CCCCCEEECccccchhhhhh
Confidence            99999999999998776 679999999999999999999999999999999999999   56778999999998865443


Q ss_pred             C-ccccccCCCccCCcccccC----CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC-CCCCCCCH
Q 014733          198 Q-NLHGTVGSPFYIAPEVLAG----GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPS-DPWDHISA  271 (419)
Q Consensus       198 ~-~~~~~~gt~~y~aPE~l~~----~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~s~  271 (419)
                      . ......++..|+|||.+.+    .++.++|+||||+++|+|++|.+||......+....+....+..+. .....++.
T Consensus       155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (262)
T cd06613         155 IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSP  234 (262)
T ss_pred             hhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhH
Confidence            2 2234578889999998754    4788999999999999999999999887766555555444332211 11235678


Q ss_pred             HHHHHHHhhhhcCCCCCCCHHHHHhccc
Q 014733          272 SARDLIMGMLRVDPSTRLTAAEVLAHSW  299 (419)
Q Consensus       272 ~l~~li~~~L~~dP~~Rps~~eil~hp~  299 (419)
                      ++.++|++||..||.+|||+.+++.|+|
T Consensus       235 ~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         235 VFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             HHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence            8999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.2e-42  Score=333.53  Aligned_cols=253  Identities=30%  Similarity=0.479  Sum_probs=205.1

Q ss_pred             eecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHcc--CCCCceeeeEEEEeCCEEEEEEeecC
Q 014733           47 QLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLS--GHPNVVDLKAVYEEEDYVHLLMELCA  124 (419)
Q Consensus        47 ~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~--~hpnIv~l~~~~~~~~~~~lV~E~~~  124 (419)
                      .||+|+||.||++.+..+++.+|+|.+.+.............+|..+++.+.  +||||+.+++.+.+.+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999999999999999997665433332333444554444432  59999999999999999999999999


Q ss_pred             CCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCCcccccc
Q 014733          125 GGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTV  204 (419)
Q Consensus       125 ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~~~~~~~  204 (419)
                      +++|..++...+.+++..+..++.|++.||+|||+.+|+||||||+|||+   +.++.+||+|||++....... .....
T Consensus        81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~---~~~~~~~l~dfg~~~~~~~~~-~~~~~  156 (279)
T cd05633          81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKK-PHASV  156 (279)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEE---CCCCCEEEccCCcceeccccC-ccCcC
Confidence            99999999888889999999999999999999999999999999999999   566789999999987654332 23457


Q ss_pred             CCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhh
Q 014733          205 GSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLR  282 (419)
Q Consensus       205 gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~  282 (419)
                      |+..|+|||.+.+  .++.++|+||+||++|+|++|+.||........ ..+.......+...+..++.++.++|++||+
T Consensus       157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  235 (279)
T cd05633         157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTVNVELPDSFSPELKSLLEGLLQ  235 (279)
T ss_pred             CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH-HHHHHHhhcCCcCCccccCHHHHHHHHHHhc
Confidence            8999999998863  389999999999999999999999975432211 1122222222333344689999999999999


Q ss_pred             cCCCCCC-----CHHHHHhccccccch
Q 014733          283 VDPSTRL-----TAAEVLAHSWMEECE  304 (419)
Q Consensus       283 ~dP~~Rp-----s~~eil~hp~~~~~~  304 (419)
                      .||.+|+     ++.++++||||+...
T Consensus       236 ~~p~~R~~~~~~~~~~~~~h~~~~~~~  262 (279)
T cd05633         236 RDVSKRLGCLGRGAQEVKEHVFFKGID  262 (279)
T ss_pred             CCHHHhcCCCCCCHHHHHhCccccCCC
Confidence            9999999     699999999998754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=6e-43  Score=331.25  Aligned_cols=256  Identities=28%  Similarity=0.450  Sum_probs=216.6

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      ++|++.+.||.|++|.||+|.++.+++.+++|.+....  .......+.+|+++++++. ||||+++++.+...+.++++
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv   77 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI--NEAIQKQILRELDILHKCN-SPYIVGFYGAFYNNGDISIC   77 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc--ChHHHHHHHHHHHHHHHCC-CCchhhhheeeecCCEEEEE
Confidence            47889999999999999999999999999999987653  2355677899999999996 99999999999999999999


Q ss_pred             EeecCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHh-CCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccC
Q 014733          120 MELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHG-NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG  197 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~-~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~  197 (419)
                      +||+++++|.+++... ..+++..+..++.|+++||+|||+ .+++|+||||+||++   +.++.+||+|||.+......
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~---~~~~~~~l~d~g~~~~~~~~  154 (265)
T cd06605          78 MEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILV---NSRGQIKLCDFGVSGQLVNS  154 (265)
T ss_pred             EEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEE---CCCCCEEEeecccchhhHHH
Confidence            9999999999999876 679999999999999999999999 999999999999999   55778999999998765433


Q ss_pred             CccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhcCCCCCCCCCCCCCH
Q 014733          198 QNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGK-----TKSKIFDAVRAADLRFPSDPWDHISA  271 (419)
Q Consensus       198 ~~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~-----~~~~~~~~i~~~~~~~~~~~~~~~s~  271 (419)
                      ... ...++..|+|||.+.+. ++.++|+||||+++|+|++|+.||...     ...+..+.+....  .+..+...++.
T Consensus       155 ~~~-~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  231 (265)
T cd06605         155 LAK-TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP--PPRLPSGKFSP  231 (265)
T ss_pred             Hhh-cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCC--CCCCChhhcCH
Confidence            222 26788899999998764 899999999999999999999999654     2223333332221  11112223889


Q ss_pred             HHHHHHHhhhhcCCCCCCCHHHHHhccccccch
Q 014733          272 SARDLIMGMLRVDPSTRLTAAEVLAHSWMEECE  304 (419)
Q Consensus       272 ~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~  304 (419)
                      ++.++|.+||..||++|||+.+++.||||+..+
T Consensus       232 ~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~~  264 (265)
T cd06605         232 DFQDFVNLCLIKDPRERPSYKELLEHPFIKKYE  264 (265)
T ss_pred             HHHHHHHHHcCCCchhCcCHHHHhhCchhhccc
Confidence            999999999999999999999999999998654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=2.6e-42  Score=330.79  Aligned_cols=256  Identities=28%  Similarity=0.482  Sum_probs=216.7

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      +.|++.+.||.|+||.||+|.+..++..+++|.+...   .......+.+|+++++.+. ||||+++++++.+.+..++|
T Consensus         5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~-h~~ii~~~~~~~~~~~~~~v   80 (282)
T cd06643           5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILASCD-HPNIVKLLDAFYYENNLWIL   80 (282)
T ss_pred             HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC---CHHHHHHHHHHHHHHHHCC-CCCeeeEEEEEeeCCEEEEE
Confidence            3478899999999999999999999999999998654   3456778889999999996 99999999999999999999


Q ss_pred             EeecCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC
Q 014733          120 MELCAGGELFHRLEK-YGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ  198 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~  198 (419)
                      |||+++++|..++.+ ..++++..+..++.|+++||.|||+.||+||||||+|||+   +.++.+||+|||++.......
T Consensus        81 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili---~~~~~~kl~dfg~~~~~~~~~  157 (282)
T cd06643          81 IEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILF---TLDGDIKLADFGVSAKNTRTI  157 (282)
T ss_pred             EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEE---ccCCCEEEccccccccccccc
Confidence            999999999888765 4569999999999999999999999999999999999999   556789999999987543321


Q ss_pred             -ccccccCCCccCCcccccC------CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCH
Q 014733          199 -NLHGTVGSPFYIAPEVLAG------GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISA  271 (419)
Q Consensus       199 -~~~~~~gt~~y~aPE~l~~------~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  271 (419)
                       ......++..|+|||++..      .++.++|+||+||++|+|++|++||...+..+....+........ .....++.
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  236 (282)
T cd06643         158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL-AQPSRWSS  236 (282)
T ss_pred             cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCC-CCccccCH
Confidence             2234578999999999742      377899999999999999999999988776666555544322211 12236889


Q ss_pred             HHHHHHHhhhhcCCCCCCCHHHHHhccccccc
Q 014733          272 SARDLIMGMLRVDPSTRLTAAEVLAHSWMEEC  303 (419)
Q Consensus       272 ~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~  303 (419)
                      ++.++|.+||+.||.+||++.++++||||...
T Consensus       237 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  268 (282)
T cd06643         237 EFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN  268 (282)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence            99999999999999999999999999999754

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=3e-42  Score=327.58  Aligned_cols=255  Identities=31%  Similarity=0.543  Sum_probs=212.0

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCcc--CCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEe--CCE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRL--VTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEE--EDY  115 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~--~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~--~~~  115 (419)
                      ..|.+.+.||+|+||.||+|.+..++..+++|.+.....  ........+.+|+.++++++ ||||+++++++.+  ...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~   80 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ-HERIVQYYGCLRDRAEKT   80 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcC-CCCeeeEEEEEEcCCCCE
Confidence            468999999999999999999999999999999875432  22345677899999999996 9999999999876  467


Q ss_pred             EEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeec
Q 014733          116 VHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIK  195 (419)
Q Consensus       116 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~  195 (419)
                      +++++||+++++|.+++...+.+++...+.++.|++.||+|||+.+|+|+||||+||++   +.++.+||+|||++....
T Consensus        81 ~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~---~~~~~~~l~dfg~~~~~~  157 (266)
T cd06651          81 LTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKRLQ  157 (266)
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEEEccCCCccccc
Confidence            89999999999999999887889999999999999999999999999999999999999   556789999999987653


Q ss_pred             cCC----ccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCC
Q 014733          196 AGQ----NLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHIS  270 (419)
Q Consensus       196 ~~~----~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  270 (419)
                      ...    ......++..|+|||.+.+. ++.++|+||+||++|+|++|+.||......+....+.....  .......++
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~  235 (266)
T cd06651         158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPT--NPQLPSHIS  235 (266)
T ss_pred             cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCC--CCCCchhcC
Confidence            311    11234588899999998764 89999999999999999999999987655544444332221  111123578


Q ss_pred             HHHHHHHHhhhhcCCCCCCCHHHHHhccccc
Q 014733          271 ASARDLIMGMLRVDPSTRLTAAEVLAHSWME  301 (419)
Q Consensus       271 ~~l~~li~~~L~~dP~~Rps~~eil~hp~~~  301 (419)
                      +.++++| +||..+|++||+++++++||||+
T Consensus       236 ~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         236 EHARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             HHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence            8999999 57778999999999999999986

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.7e-42  Score=331.91  Aligned_cols=257  Identities=25%  Similarity=0.453  Sum_probs=213.1

Q ss_pred             ccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEe--
Q 014733           35 ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEE--  112 (419)
Q Consensus        35 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~--  112 (419)
                      ...-.++|++.+.||.|+||.||+|.+..+++.+|+|++...    ......+..|+.+++++.+|+||+++++++..  
T Consensus        11 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~   86 (282)
T cd06636          11 LRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT----EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS   86 (282)
T ss_pred             hcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC----hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence            344568999999999999999999999999999999998653    23456788999999999779999999999853  


Q ss_pred             ----CCEEEEEEeecCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEe
Q 014733          113 ----EDYVHLLMELCAGGELFHRLEKY--GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLA  186 (419)
Q Consensus       113 ----~~~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~  186 (419)
                          .+.++++|||+++++|.+++...  ..+++..+..++.||++||.|||+.+|+|+||||+||++   +.++.+||+
T Consensus        87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili---~~~~~~~l~  163 (282)
T cd06636          87 PPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLL---TENAEVKLV  163 (282)
T ss_pred             ccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEe
Confidence                56889999999999999998753  348888999999999999999999999999999999999   567789999


Q ss_pred             eccceeeeccCC-ccccccCCCccCCcccccC------CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC
Q 014733          187 DFGLATYIKAGQ-NLHGTVGSPFYIAPEVLAG------GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADL  259 (419)
Q Consensus       187 DFgla~~~~~~~-~~~~~~gt~~y~aPE~l~~------~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~  259 (419)
                      |||++....... ......|++.|+|||++..      .++.++|+|||||++|+|++|..||......+....+.... 
T Consensus       164 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~-  242 (282)
T cd06636         164 DFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP-  242 (282)
T ss_pred             eCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCC-
Confidence            999987653221 2234578999999998752      37889999999999999999999997665444333333221 


Q ss_pred             CCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhcccc
Q 014733          260 RFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWM  300 (419)
Q Consensus       260 ~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~  300 (419)
                       .+......++.++.++|.+||+.||.+|||+.++++||||
T Consensus       243 -~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         243 -PPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             -CCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence             1222234688999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=3.9e-42  Score=326.43  Aligned_cols=255  Identities=30%  Similarity=0.532  Sum_probs=212.9

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCcc--CCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEe--CCE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRL--VTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEE--EDY  115 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~--~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~--~~~  115 (419)
                      .+|++.+.||+|+||.||+|.+..+|..||+|.+.....  ......+.+.+|+.+++++. ||||+++++++.+  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~   80 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL-HERIVQYYGCLRDPMERT   80 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcC-CCCeeeEEeEeccCCCce
Confidence            479999999999999999999999999999999864322  22345678899999999996 9999999999876  357


Q ss_pred             EEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeec
Q 014733          116 VHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIK  195 (419)
Q Consensus       116 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~  195 (419)
                      ++++|||+++++|.+++...+.+++..+..++.|++.||+|||+.+|+|+||||+||++   +.++.+||+|||++....
T Consensus        81 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~~l~Dfg~~~~~~  157 (265)
T cd06652          81 LSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILR---DSVGNVKLGDFGASKRLQ  157 (265)
T ss_pred             EEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEe---cCCCCEEECcCccccccc
Confidence            88999999999999999887889999999999999999999999999999999999999   567789999999987653


Q ss_pred             cC----CccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCC
Q 014733          196 AG----QNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHIS  270 (419)
Q Consensus       196 ~~----~~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  270 (419)
                      ..    .......|+..|+|||++.+. ++.++|+||||+++|+|++|+.||...........+..... . ...+..++
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~-~~~~~~~~  235 (265)
T cd06652         158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPT-N-PVLPPHVS  235 (265)
T ss_pred             cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCC-C-CCCchhhC
Confidence            21    112334688899999998764 88999999999999999999999987655544444332211 1 11234678


Q ss_pred             HHHHHHHHhhhhcCCCCCCCHHHHHhccccc
Q 014733          271 ASARDLIMGMLRVDPSTRLTAAEVLAHSWME  301 (419)
Q Consensus       271 ~~l~~li~~~L~~dP~~Rps~~eil~hp~~~  301 (419)
                      ..+.++|.+|+. +|++||+++++++|||+.
T Consensus       236 ~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         236 DHCRDFLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             HHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence            899999999995 999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.5e-42  Score=324.17  Aligned_cols=254  Identities=35%  Similarity=0.577  Sum_probs=217.4

Q ss_pred             CeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCcc--CCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEE
Q 014733           41 RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRL--VTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHL  118 (419)
Q Consensus        41 ~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~--~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~l  118 (419)
                      +|+..+.||+|++|+||+|.+..++..|++|.+.....  ...+..+.+.+|+.+++++. |+||+++++++.+...+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~l   79 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ-HPNIVQYLGTEREEDNLYI   79 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcC-CCCchheeeeEecCCeEEE
Confidence            58889999999999999999988999999999875432  23345678999999999995 9999999999999999999


Q ss_pred             EEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC
Q 014733          119 LMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ  198 (419)
Q Consensus       119 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~  198 (419)
                      ++||+++++|.+++.+.+.+++..+..++.||++||+|||+.||+|+||+|+||++   +.++.+||+|||++.......
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~---~~~~~~kl~d~~~~~~~~~~~  156 (258)
T cd06632          80 FLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILV---DTNGVVKLADFGMAKQVVEFS  156 (258)
T ss_pred             EEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEccCccceeccccc
Confidence            99999999999999887789999999999999999999999999999999999999   567789999999988765444


Q ss_pred             ccccccCCCccCCcccccC-C-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHH
Q 014733          199 NLHGTVGSPFYIAPEVLAG-G-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDL  276 (419)
Q Consensus       199 ~~~~~~gt~~y~aPE~l~~-~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~l  276 (419)
                      ......|+..|+|||.+.. . ++.++|+||||+++|+|++|+.||......+....+.... . ....+..+++.+.++
T Consensus       157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~l  234 (258)
T cd06632         157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSK-E-LPPIPDHLSDEAKDF  234 (258)
T ss_pred             cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcc-c-CCCcCCCcCHHHHHH
Confidence            3445678999999998765 3 7899999999999999999999997766544444433311 1 112234688999999


Q ss_pred             HHhhhhcCCCCCCCHHHHHhcccc
Q 014733          277 IMGMLRVDPSTRLTAAEVLAHSWM  300 (419)
Q Consensus       277 i~~~L~~dP~~Rps~~eil~hp~~  300 (419)
                      +.+||+.+|++||++.+++.|||+
T Consensus       235 i~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         235 ILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             HHHHhhcCcccCcCHHHHhcCCCC
Confidence            999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.9e-42  Score=336.40  Aligned_cols=261  Identities=32%  Similarity=0.493  Sum_probs=214.1

Q ss_pred             cccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeC--CE
Q 014733           38 LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEE--DY  115 (419)
Q Consensus        38 ~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~--~~  115 (419)
                      -.++|++.+.||+|+||.||+|.++.+|+.||+|.+...... ......+.+|+.++++++ |+||+++++++.+.  +.
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~   82 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNER-DGIPISSLREITLLLNLR-HPNIVELKEVVVGKHLDS   82 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCC-CCCcchhhHHHHHHHhCC-CCCCcceEEEEecCCCCe
Confidence            357899999999999999999999999999999998754321 122234567999999996 99999999999765  57


Q ss_pred             EEEEEeecCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeee
Q 014733          116 VHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI  194 (419)
Q Consensus       116 ~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~  194 (419)
                      +++||||+. ++|.+++... ..+++.++..++.||++||+|||+.|++||||||+||++   +.++.+||+|||++...
T Consensus        83 ~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~kL~dfg~~~~~  158 (309)
T cd07845          83 IFLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLL---TDKGCLKIADFGLARTY  158 (309)
T ss_pred             EEEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECccceeeec
Confidence            899999996 5888888753 568999999999999999999999999999999999999   56778999999999876


Q ss_pred             ccCC-ccccccCCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC------------
Q 014733          195 KAGQ-NLHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADL------------  259 (419)
Q Consensus       195 ~~~~-~~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~------------  259 (419)
                      .... ......+++.|+|||++.+  .++.++|+||||+++|+|++|++||.+.+..+....+.....            
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
T cd07845         159 GLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSD  238 (309)
T ss_pred             CCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhc
Confidence            5432 2223356788999999865  378999999999999999999999998887777666654211            


Q ss_pred             -------CCCCCC-------CCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccch
Q 014733          260 -------RFPSDP-------WDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECE  304 (419)
Q Consensus       260 -------~~~~~~-------~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~  304 (419)
                             ..+...       ...+++++.++|.+||++||++|||+.++++||||+...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~  297 (309)
T cd07845         239 LPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKP  297 (309)
T ss_pred             ccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCC
Confidence                   111111       123588999999999999999999999999999997543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=2.2e-42  Score=332.98  Aligned_cols=258  Identities=28%  Similarity=0.420  Sum_probs=209.0

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCE----
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDY----  115 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~----  115 (419)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|.+..... .......+.+|+.+++++.+||||+++++++...+.    
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~   79 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP   79 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence            579999999999999999999999999999999865432 222345678899999999768999999999987665    


Q ss_pred             -EEEEEeecCCCChHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeecc
Q 014733          116 -VHLLMELCAGGELFHRLEKY-----GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFG  189 (419)
Q Consensus       116 -~~lV~E~~~ggsL~~~l~~~-----~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFg  189 (419)
                       .|+||||+++ +|.+++...     ..+++..++.++.||++||.|||+.+|+||||||+||+++.  .++.+||+|||
T Consensus        80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~--~~~~~kl~dfg  156 (295)
T cd07837          80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDK--QKGLLKIADLG  156 (295)
T ss_pred             eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEec--CCCeEEEeecc
Confidence             8999999975 788887543     34799999999999999999999999999999999999953  26789999999


Q ss_pred             ceeeeccCC-ccccccCCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-----
Q 014733          190 LATYIKAGQ-NLHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRF-----  261 (419)
Q Consensus       190 la~~~~~~~-~~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~-----  261 (419)
                      ++....... ......+++.|+|||++.+  .++.++|+||||+++|+|++|.+||.+.+..+....+.......     
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (295)
T cd07837         157 LGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW  236 (295)
T ss_pred             cceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence            987653321 2223467888999998865  37899999999999999999999998776554444332211000     


Q ss_pred             ------------C-------CCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccc
Q 014733          262 ------------P-------SDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWME  301 (419)
Q Consensus       262 ------------~-------~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~  301 (419)
                                  +       ......++.++.++|.+||++||.+||++.+++.||||+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence                        0       001135789999999999999999999999999999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=4.7e-42  Score=324.71  Aligned_cols=254  Identities=33%  Similarity=0.553  Sum_probs=215.6

Q ss_pred             CeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEE
Q 014733           41 RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLM  120 (419)
Q Consensus        41 ~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~  120 (419)
                      ||++.+.||+|++|.||+|.+..++..+++|.+..... .....+.+..|+.+++++. |+||+++++.+.+.+.+++|+
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~lv~   78 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDN-DPKTIKEIADEMKVLELLK-HPNLVKYYGVEVHREKVYIFM   78 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECccc-chHHHHHHHHHHHHHHhCC-CCChhheeeeEecCCEEEEEE
Confidence            69999999999999999999998999999999976653 2457788999999999995 999999999999999999999


Q ss_pred             eecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCCcc
Q 014733          121 ELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNL  200 (419)
Q Consensus       121 E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~~~  200 (419)
                      ||+++++|.+++.....+++..+..++.+++.||.|||+.+|+|+||+|+||++   +.++.+||+|||++.........
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~---~~~~~~kl~d~g~~~~~~~~~~~  155 (264)
T cd06626          79 EYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFL---DHNGVIKLGDFGCAVKLKNNTTT  155 (264)
T ss_pred             ecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEcccccccccCCCCCc
Confidence            999999999999887779999999999999999999999999999999999999   55778999999998876443221


Q ss_pred             -----ccccCCCccCCcccccCC----CCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhcCCCCCCCCCCCCC
Q 014733          201 -----HGTVGSPFYIAPEVLAGG----YNQAADVWSAGVILYILLSGMPPFWGKTK-SKIFDAVRAADLRFPSDPWDHIS  270 (419)
Q Consensus       201 -----~~~~gt~~y~aPE~l~~~----~s~~sDvwSlGvil~elltG~~Pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~s  270 (419)
                           ....++..|+|||++.+.    ++.++||||||+++|+|++|+.||..... ......+.. ........+..++
T Consensus       156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  234 (264)
T cd06626         156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHKPPIPDSLQLS  234 (264)
T ss_pred             ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCCCCCCcccccC
Confidence                 234678899999998652    68899999999999999999999976532 222222222 2222222333568


Q ss_pred             HHHHHHHHhhhhcCCCCCCCHHHHHhcccc
Q 014733          271 ASARDLIMGMLRVDPSTRLTAAEVLAHSWM  300 (419)
Q Consensus       271 ~~l~~li~~~L~~dP~~Rps~~eil~hp~~  300 (419)
                      ..+.++|.+||+.||++|||+.+++.|||+
T Consensus       235 ~~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         235 PEGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             HHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            999999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=4.2e-42  Score=324.35  Aligned_cols=252  Identities=31%  Similarity=0.573  Sum_probs=218.5

Q ss_pred             CeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEe--CCEEEE
Q 014733           41 RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEE--EDYVHL  118 (419)
Q Consensus        41 ~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~--~~~~~l  118 (419)
                      +|++.+.||.|+||.||+|.+..++..+|+|.+..... .....+.+..|+.++++++ ||||+++++.+..  ....++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~~   78 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELK-HPNIVRYYDRIIDRSNQTLYI   78 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcC-CCccceeeeeeecCCCCEEEE
Confidence            58999999999999999999999999999999876543 4556678899999999996 9999999998753  467899


Q ss_pred             EEeecCCCChHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH-----hCCCeeccCCCCcEEEeecCCCCCeEEeecc
Q 014733          119 LMELCAGGELFHRLEKY----GRFSETEARVIFRHLMQVVSYCH-----GNGVVHRDLKPENILLATKSSSSPIKLADFG  189 (419)
Q Consensus       119 V~E~~~ggsL~~~l~~~----~~l~~~~~~~i~~qll~aL~~LH-----~~~IvHrDLkp~NILl~~~~~~~~vKL~DFg  189 (419)
                      +|||+++++|.+++...    .++++..++.++.||+.||+|||     +.+++|+||||+||++   +.++.+||+|||
T Consensus        79 ~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili---~~~~~~kl~d~g  155 (265)
T cd08217          79 VMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFL---DANNNVKLGDFG  155 (265)
T ss_pred             EehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEE---ecCCCEEEeccc
Confidence            99999999999998753    56899999999999999999999     8999999999999999   456899999999


Q ss_pred             ceeeeccCCc-cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCC
Q 014733          190 LATYIKAGQN-LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWD  267 (419)
Q Consensus       190 la~~~~~~~~-~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  267 (419)
                      ++........ .....+++.|+|||++.+. ++.++|+||||+++|+|++|+.||......+..+.+.......   ...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~  232 (265)
T cd08217         156 LAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRR---IPY  232 (265)
T ss_pred             ccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCC---Ccc
Confidence            9987655443 3345789999999998764 8899999999999999999999999888777777766654322   223


Q ss_pred             CCCHHHHHHHHhhhhcCCCCCCCHHHHHhcccc
Q 014733          268 HISASARDLIMGMLRVDPSTRLTAAEVLAHSWM  300 (419)
Q Consensus       268 ~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~  300 (419)
                      .++.++.+++.+||+.+|++||++.+|++|||+
T Consensus       233 ~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         233 RYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             ccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence            688999999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=3.7e-42  Score=324.49  Aligned_cols=252  Identities=25%  Similarity=0.522  Sum_probs=218.5

Q ss_pred             CeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEE
Q 014733           41 RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLM  120 (419)
Q Consensus        41 ~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~  120 (419)
                      +|++.+.||+|+||.||++.+..+|+.+|+|.+..... .......+.+|+.+++++. ||||+++++++.+.+..++||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM-SPKEREESRKEVAVLSNMK-HPNIVQYQESFEENGNLYIVM   78 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC-ChHHHHHHHHHHHHHHhCC-CCCeeeeEeeecCCCeEEEEE
Confidence            68999999999999999999999999999999876543 3345678899999999996 999999999999999999999


Q ss_pred             eecCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC
Q 014733          121 ELCAGGELFHRLEKYG--RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ  198 (419)
Q Consensus       121 E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~  198 (419)
                      ||+.+++|.+.+....  .+++..+..++.|++.||.|||+.+++|+||+|+||++   +.++.++|+|||++.......
T Consensus        79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~---~~~~~~~l~d~~~~~~~~~~~  155 (256)
T cd08218          79 DYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL---TKDGTIKLGDFGIARVLNSTV  155 (256)
T ss_pred             ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEEeeccceeecCcch
Confidence            9999999999987643  57899999999999999999999999999999999999   556789999999998654432


Q ss_pred             cc-ccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHH
Q 014733          199 NL-HGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDL  276 (419)
Q Consensus       199 ~~-~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~l  276 (419)
                      .. ....|++.|+|||++.+. ++.++|+||||+++|+|++|+.||......+....+..+....   ....++.++.++
T Consensus       156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l  232 (256)
T cd08218         156 ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPP---VSSHYSYDLRNL  232 (256)
T ss_pred             hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCC---CcccCCHHHHHH
Confidence            22 234588899999998764 7899999999999999999999998877777777665554322   123688999999


Q ss_pred             HHhhhhcCCCCCCCHHHHHhcccc
Q 014733          277 IMGMLRVDPSTRLTAAEVLAHSWM  300 (419)
Q Consensus       277 i~~~L~~dP~~Rps~~eil~hp~~  300 (419)
                      |.+||+.+|++||++.++++||||
T Consensus       233 i~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         233 VSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             HHHHhhCChhhCcCHHHHhhCcCC
Confidence            999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.6e-42  Score=354.05  Aligned_cols=250  Identities=26%  Similarity=0.445  Sum_probs=204.6

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEE
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHL  118 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~l  118 (419)
                      ..+|.+.+.||+|+||.||+|.+..+++.||+|....         ..+.+|+.+|++|. |+|||++++++...+..++
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~-HpnIv~l~~~~~~~~~~~l  237 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLS-HPAVLALLDVRVVGGLTCL  237 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCC-CCCCCcEEEEEEECCEEEE
Confidence            5689999999999999999999999999999996421         23567999999996 9999999999999999999


Q ss_pred             EEeecCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccC
Q 014733          119 LMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG  197 (419)
Q Consensus       119 V~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~  197 (419)
                      |||++ .++|..++... ..+++.+++.++.||+.||.|||+.||+||||||+|||+   +.++.+||+|||+++.....
T Consensus       238 v~e~~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl---~~~~~vkL~DFGla~~~~~~  313 (461)
T PHA03211        238 VLPKY-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLV---NGPEDICLGDFGAACFARGS  313 (461)
T ss_pred             EEEcc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEE---CCCCCEEEcccCCceecccc
Confidence            99999 46888887654 469999999999999999999999999999999999999   56678999999999876433


Q ss_pred             Cc---cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhcCCC---CC
Q 014733          198 QN---LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKT--------KSKIFDAVRAADLR---FP  262 (419)
Q Consensus       198 ~~---~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~--------~~~~~~~i~~~~~~---~~  262 (419)
                      ..   .....||+.|+|||++.+. ++.++|||||||+||||++|..|+....        ...+.+.+......   ++
T Consensus       314 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~  393 (461)
T PHA03211        314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFP  393 (461)
T ss_pred             cccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCC
Confidence            22   2245799999999998775 8999999999999999999886653321        22333333332211   11


Q ss_pred             ------------------------CCCC---CCCCHHHHHHHHhhhhcCCCCCCCHHHHHhcccccc
Q 014733          263 ------------------------SDPW---DHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE  302 (419)
Q Consensus       263 ------------------------~~~~---~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~  302 (419)
                                              ...|   ..++.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus       394 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        394 QHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             CCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence                                    1112   145678999999999999999999999999999963

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3e-42  Score=328.25  Aligned_cols=256  Identities=28%  Similarity=0.529  Sum_probs=213.8

Q ss_pred             CeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccC-------CHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeC
Q 014733           41 RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLV-------TVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEE  113 (419)
Q Consensus        41 ~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~-------~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~  113 (419)
                      +|.+.+.||.|++|.||+|.+..+|+.+|+|.+......       .....+.+..|+.+++++. ||||+++++++...
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~   80 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD-HLNIVQYLGFETTE   80 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcC-CCCcceEEEEeccC
Confidence            588999999999999999999989999999988643211       1123457888999999996 99999999999999


Q ss_pred             CEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceee
Q 014733          114 DYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATY  193 (419)
Q Consensus       114 ~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~  193 (419)
                      +.+++||||+++++|.+++...+.+++..+..++.|++.||.|||+.+++|+||+|+||++   +.++.+||+|||++..
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~---~~~~~~~l~d~~~~~~  157 (272)
T cd06629          81 EYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLV---DADGICKISDFGISKK  157 (272)
T ss_pred             CceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEE---cCCCeEEEeecccccc
Confidence            9999999999999999999888889999999999999999999999999999999999999   5678899999999876


Q ss_pred             eccCC---ccccccCCCccCCcccccC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--CCCCCCCC
Q 014733          194 IKAGQ---NLHGTVGSPFYIAPEVLAG---GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAA--DLRFPSDP  265 (419)
Q Consensus       194 ~~~~~---~~~~~~gt~~y~aPE~l~~---~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~~~~~  265 (419)
                      .....   ......|+..|+|||++.+   .++.++|+||||+++|+|++|..||......+....+...  ...++...
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (272)
T cd06629         158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDV  237 (272)
T ss_pred             ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccc
Confidence            43221   1223468889999999765   2789999999999999999999999765544333332222  22333334


Q ss_pred             CCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhcccc
Q 014733          266 WDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWM  300 (419)
Q Consensus       266 ~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~  300 (419)
                      ...++.++.++|.+||.++|++|||+.++++||||
T Consensus       238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         238 SMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             cccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence            45679999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=2.6e-42  Score=342.18  Aligned_cols=261  Identities=26%  Similarity=0.455  Sum_probs=213.0

Q ss_pred             ccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeC---
Q 014733           37 NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEE---  113 (419)
Q Consensus        37 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~---  113 (419)
                      .+.++|++.+.||+|+||.||+|.+..+|+.||+|.+.+.. ........+.+|+.+++++. ||||+++++++...   
T Consensus        13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~   90 (353)
T cd07850          13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF-QNVTHAKRAYRELVLMKLVN-HKNIIGLLNVFTPQKSL   90 (353)
T ss_pred             hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccc-cChhHHHHHHHHHHHHHhcC-CCCCcceeeeeccCCCc
Confidence            35789999999999999999999999999999999986532 23345567788999999995 99999999998643   


Q ss_pred             ---CEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccc
Q 014733          114 ---DYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGL  190 (419)
Q Consensus       114 ---~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgl  190 (419)
                         ..+|+||||+. ++|.+.+...  +++..+..++.|++.||+|||+.||+||||||+||++   +.++.+||+|||+
T Consensus        91 ~~~~~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~---~~~~~~kL~Dfg~  164 (353)
T cd07850          91 EEFQDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGL  164 (353)
T ss_pred             cccCcEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEEEccCcc
Confidence               35799999995 5888887653  8999999999999999999999999999999999999   5677899999999


Q ss_pred             eeeeccCCccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC---------
Q 014733          191 ATYIKAGQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLR---------  260 (419)
Q Consensus       191 a~~~~~~~~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---------  260 (419)
                      +.............+++.|+|||++.+. ++.++|||||||++|+|++|+.||...+....+..+......         
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (353)
T cd07850         165 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRL  244 (353)
T ss_pred             ceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence            9876554443445788999999998764 899999999999999999999999876654444433221000         


Q ss_pred             -------------C--------------CC---CCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          261 -------------F--------------PS---DPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       261 -------------~--------------~~---~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                                   .              +.   ......+.+++++|.+||+.||++|||+.|+|+||||+....
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~  319 (353)
T cd07850         245 QPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYD  319 (353)
T ss_pred             hhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccC
Confidence                         0              00   001235677899999999999999999999999999986544

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2.2e-42  Score=325.48  Aligned_cols=252  Identities=27%  Similarity=0.480  Sum_probs=214.6

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEE
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHL  118 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~l  118 (419)
                      .++|++.+.||.|++|.||+|.+..++..+++|.+...     ...+.+.+|+.+++++. ||||+++++++.+...+|+
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~-----~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~l   75 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE-----EDLQEIIKEISILKQCD-SPYIVKYYGSYFKNTDLWI   75 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecH-----HHHHHHHHHHHHHHhCC-CCcEeeeeeeeecCCcEEE
Confidence            37899999999999999999999988999999998643     22678999999999995 9999999999999999999


Q ss_pred             EEeecCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccC
Q 014733          119 LMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG  197 (419)
Q Consensus       119 V~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~  197 (419)
                      ++||+++++|.+++... ..+++..++.++.|++.||.|||+.+|+|+||+|+||++   +.++.+||+|||++......
T Consensus        76 ~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~---~~~~~~~l~dfg~~~~~~~~  152 (256)
T cd06612          76 VMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILL---NEEGQAKLADFGVSGQLTDT  152 (256)
T ss_pred             EEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE---CCCCcEEEcccccchhcccC
Confidence            99999999999999753 458999999999999999999999999999999999999   55778999999999876543


Q ss_pred             C-ccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 014733          198 Q-NLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARD  275 (419)
Q Consensus       198 ~-~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~  275 (419)
                      . ......++..|+|||++.+. ++.++||||||+++|+|++|+.||......+....+...... .......++.++.+
T Consensus       153 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  231 (256)
T cd06612         153 MAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPP-TLSDPEKWSPEFND  231 (256)
T ss_pred             ccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCC-CCCchhhcCHHHHH
Confidence            3 22334578899999998764 899999999999999999999999876655444443322111 11122357889999


Q ss_pred             HHHhhhhcCCCCCCCHHHHHhcccc
Q 014733          276 LIMGMLRVDPSTRLTAAEVLAHSWM  300 (419)
Q Consensus       276 li~~~L~~dP~~Rps~~eil~hp~~  300 (419)
                      +|.+||+.||++|||+.++++||||
T Consensus       232 ~i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         232 FVKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             HHHHHHhcChhhCcCHHHHhcCCCC
Confidence            9999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-42  Score=341.13  Aligned_cols=262  Identities=29%  Similarity=0.504  Sum_probs=211.4

Q ss_pred             ccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeC---
Q 014733           37 NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEE---  113 (419)
Q Consensus        37 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~---  113 (419)
                      .++++|++.+.||+|++|.||+|.++.+|+.||+|.+...  ........+.+|+.++++++ ||||+++++++...   
T Consensus         2 ~~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~   78 (336)
T cd07849           2 DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF--EHQTFCQRTLREIKILRRFK-HENIIGILDIIRPPSFE   78 (336)
T ss_pred             ccccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc--ccchhHHHHHHHHHHHHhCC-CCCcCchhheeeccccc
Confidence            3678999999999999999999999999999999998642  12334566788999999996 99999999987654   


Q ss_pred             --CEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccce
Q 014733          114 --DYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA  191 (419)
Q Consensus       114 --~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla  191 (419)
                        ..+|+++||+. ++|.+.+.. .++++..++.++.|+++||.|||+.||+||||||+|||+   +.++.+||+|||++
T Consensus        79 ~~~~~~lv~e~~~-~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~  153 (336)
T cd07849          79 SFNDVYIVQELME-TDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTNCDLKICDFGLA  153 (336)
T ss_pred             ccceEEEEehhcc-cCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---CCCCCEEECcccce
Confidence              35899999995 588877754 679999999999999999999999999999999999999   56788999999998


Q ss_pred             eeeccCCc----cccccCCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-------
Q 014733          192 TYIKAGQN----LHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAAD-------  258 (419)
Q Consensus       192 ~~~~~~~~----~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-------  258 (419)
                      ........    .....||+.|+|||++.+  .++.++||||+||++|+|++|++||.+.........+....       
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~  233 (336)
T cd07849         154 RIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQED  233 (336)
T ss_pred             eeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence            86543221    123478999999998754  48999999999999999999999997765433332221100       


Q ss_pred             ---------------CCC-CCC----CCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchhh
Q 014733          259 ---------------LRF-PSD----PWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQV  306 (419)
Q Consensus       259 ---------------~~~-~~~----~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~~  306 (419)
                                     ... +..    ....++.++.++|.+||+.||++|||+.++++||||+.....
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~  301 (336)
T cd07849         234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP  301 (336)
T ss_pred             HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence                           000 000    113568889999999999999999999999999999976543

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2e-42  Score=328.26  Aligned_cols=258  Identities=29%  Similarity=0.521  Sum_probs=213.7

Q ss_pred             CeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCC---HHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEE
Q 014733           41 RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVT---VEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVH  117 (419)
Q Consensus        41 ~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~---~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~  117 (419)
                      +|+.++.||+|++|.||+|.+..+++.+|+|++.......   ....+.+.+|++++++++ |+||+++++++.+.+.++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~   79 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN-HPHIIRMLGATCEDSHFN   79 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcC-CCceehhhceeccCCeEE
Confidence            4888999999999999999999999999999997543211   234678999999999996 999999999999999999


Q ss_pred             EEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccC
Q 014733          118 LLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG  197 (419)
Q Consensus       118 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~  197 (419)
                      +||||++|++|.+++...+++++..+..++.||+.||.|||+.|++|+||+|+||+++.  .+..+||+|||.+......
T Consensus        80 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~--~~~~~~l~dfg~~~~~~~~  157 (268)
T cd06630          80 LFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDS--TGQRLRIADFGAAARLAAK  157 (268)
T ss_pred             EEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC--CCCEEEEcccccccccccc
Confidence            99999999999999988888999999999999999999999999999999999999942  2236999999998766432


Q ss_pred             Cc-----cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCCCCCCCCCCCC
Q 014733          198 QN-----LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAA-DLRFPSDPWDHIS  270 (419)
Q Consensus       198 ~~-----~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~s  270 (419)
                      ..     .....|+..|+|||++.+. ++.++|+||+|+++|+|++|+.||...........+... ...........++
T Consensus       158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (268)
T cd06630         158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLS  237 (268)
T ss_pred             cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhC
Confidence            11     1234688899999998764 889999999999999999999999654433323322221 1111222234688


Q ss_pred             HHHHHHHHhhhhcCCCCCCCHHHHHhccccc
Q 014733          271 ASARDLIMGMLRVDPSTRLTAAEVLAHSWME  301 (419)
Q Consensus       271 ~~l~~li~~~L~~dP~~Rps~~eil~hp~~~  301 (419)
                      +++.+++.+||+.||++||++.++++||||+
T Consensus       238 ~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         238 PGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             HHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence            9999999999999999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=2e-42  Score=329.79  Aligned_cols=252  Identities=26%  Similarity=0.429  Sum_probs=204.8

Q ss_pred             ccccccCeeeeeee--cccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEe
Q 014733           35 ISNLSDRYVLGKQL--GWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEE  112 (419)
Q Consensus        35 ~~~~~~~y~i~~~L--G~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~  112 (419)
                      .....+.|.+.+.+  |.|+||.||++.++.++..+|+|.+.......        .|+.....+.+||||+++++++..
T Consensus         9 ~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~   80 (267)
T PHA03390          9 LVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTT   80 (267)
T ss_pred             HHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEec
Confidence            34455677787776  99999999999999999999999987543211        123333333369999999999999


Q ss_pred             CCEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCC-CeEEeeccce
Q 014733          113 EDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSS-PIKLADFGLA  191 (419)
Q Consensus       113 ~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~-~vKL~DFgla  191 (419)
                      .+.+|+||||+++++|.+++.....+++.++..++.|+++||.|||+.|++||||||+||+++   .++ .++|+|||++
T Consensus        81 ~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~---~~~~~~~l~dfg~~  157 (267)
T PHA03390         81 LKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYD---RAKDRIYLCDYGLC  157 (267)
T ss_pred             CCeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEe---CCCCeEEEecCccc
Confidence            999999999999999999998877899999999999999999999999999999999999995   344 8999999998


Q ss_pred             eeeccCCccccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhcCCCCCCCCCCCC
Q 014733          192 TYIKAGQNLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIF-DAVRAADLRFPSDPWDHI  269 (419)
Q Consensus       192 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~-~~i~~~~~~~~~~~~~~~  269 (419)
                      ......   ....++..|+|||++.+ .++.++|+||+|+++|+|++|+.||......... ..+.... ..+...+..+
T Consensus       158 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  233 (267)
T PHA03390        158 KIIGTP---SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKKLPFIKNV  233 (267)
T ss_pred             eecCCC---ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cccCCccccc
Confidence            865432   23468889999999876 4899999999999999999999999755433221 1111111 2222333478


Q ss_pred             CHHHHHHHHhhhhcCCCCCCC-HHHHHhccccc
Q 014733          270 SASARDLIMGMLRVDPSTRLT-AAEVLAHSWME  301 (419)
Q Consensus       270 s~~l~~li~~~L~~dP~~Rps-~~eil~hp~~~  301 (419)
                      +..+.++|.+||+.||.+|++ ++++|+||||+
T Consensus       234 ~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~  266 (267)
T PHA03390        234 SKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK  266 (267)
T ss_pred             CHHHHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence            999999999999999999996 69999999996

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-43  Score=345.57  Aligned_cols=245  Identities=25%  Similarity=0.401  Sum_probs=210.3

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      ..+++++.||+|.||.||.|.++. ...||+|.++...+    ..+.+.+|+.+|++|+ |+|||++++++..+.-+|||
T Consensus       206 ~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m----~~~~f~~Ea~iMk~L~-H~~lV~l~gV~~~~~piyIV  279 (468)
T KOG0197|consen  206 EELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSM----SPEAFLREAQIMKKLR-HEKLVKLYGVCTKQEPIYIV  279 (468)
T ss_pred             HHHHHHHHhcCCccceEEEEEEcC-CCcccceEEecccc----ChhHHHHHHHHHHhCc-ccCeEEEEEEEecCCceEEE
Confidence            345568899999999999999873 34799999976543    2356779999999997 99999999999998899999


Q ss_pred             EeecCCCChHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccC
Q 014733          120 MELCAGGELFHRLEK--YGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG  197 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~--~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~  197 (419)
                      |||++.|+|.++|..  .+.+...+...++.||++|++||+++++|||||-..||||   +++..+||+|||+|+...++
T Consensus       280 tE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV---~~~~~vKIsDFGLAr~~~d~  356 (468)
T KOG0197|consen  280 TEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILV---DEDLVVKISDFGLARLIGDD  356 (468)
T ss_pred             EEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheee---ccCceEEEcccccccccCCC
Confidence            999999999999987  3459999999999999999999999999999999999999   66779999999999955443


Q ss_pred             Cccc--cccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 014733          198 QNLH--GTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASA  273 (419)
Q Consensus       198 ~~~~--~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l  273 (419)
                      .-..  +..-...|.|||.+.. .++.++|||||||+||||+| |+.||.+.+..++++.+.++ ++.|.+  ..+|.++
T Consensus       357 ~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~G-yRlp~P--~~CP~~v  433 (468)
T KOG0197|consen  357 EYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERG-YRLPRP--EGCPDEV  433 (468)
T ss_pred             ceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhcc-CcCCCC--CCCCHHH
Confidence            3221  1122345999999875 59999999999999999999 99999999999999999876 444444  3799999


Q ss_pred             HHHHHhhhhcCCCCCCCHHHHHh
Q 014733          274 RDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       274 ~~li~~~L~~dP~~Rps~~eil~  296 (419)
                      .+++..||..+|++|||++.+..
T Consensus       434 Y~lM~~CW~~~P~~RPtF~~L~~  456 (468)
T KOG0197|consen  434 YELMKSCWHEDPEDRPTFETLRE  456 (468)
T ss_pred             HHHHHHHhhCCcccCCCHHHHHH
Confidence            99999999999999999997753

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=5.1e-42  Score=324.20  Aligned_cols=256  Identities=30%  Similarity=0.477  Sum_probs=221.2

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      ++|++.+.||.|++|.||+|.+..+++.+++|++.....  ......+.+|+.++.+++ |+||+++++++...+.+++|
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~--~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv   77 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD--EEFRKQLLRELKTLRSCE-SPYVVKCYGAFYKEGEISIV   77 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc--hHHHHHHHHHHHHHHhcC-CCCeeeEEEEEccCCeEEEE
Confidence            478999999999999999999999999999999876532  245678999999999996 99999999999999999999


Q ss_pred             EeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC
Q 014733          120 MELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG-NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ  198 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~-~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~  198 (419)
                      |||+++++|.+++.....+++..+..++.|+++||+|||+ .+++|+||+|+||++   +.++.++|+|||.+.......
T Consensus        78 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~---~~~~~~~l~df~~~~~~~~~~  154 (264)
T cd06623          78 LEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLI---NSKGEVKIADFGISKVLENTL  154 (264)
T ss_pred             EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEE---CCCCCEEEccCccceecccCC
Confidence            9999999999999887889999999999999999999999 999999999999999   567889999999998765443


Q ss_pred             ccc-cccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 014733          199 NLH-GTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGK---TKSKIFDAVRAADLRFPSDPWDHISASA  273 (419)
Q Consensus       199 ~~~-~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~---~~~~~~~~i~~~~~~~~~~~~~~~s~~l  273 (419)
                      ... ...++..|+|||.+.+. ++.++|+||||+++|+|++|+.||...   ...+..+.+......  ......++..+
T Consensus       155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l  232 (264)
T cd06623         155 DQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPP--SLPAEEFSPEF  232 (264)
T ss_pred             CcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCC--CCCcccCCHHH
Confidence            332 45688899999998765 889999999999999999999999776   445555555433221  11222288999


Q ss_pred             HHHHHhhhhcCCCCCCCHHHHHhccccccc
Q 014733          274 RDLIMGMLRVDPSTRLTAAEVLAHSWMEEC  303 (419)
Q Consensus       274 ~~li~~~L~~dP~~Rps~~eil~hp~~~~~  303 (419)
                      .++|.+||..+|++||++.++++|||++..
T Consensus       233 ~~li~~~l~~~p~~R~~~~~ll~~~~~~~~  262 (264)
T cd06623         233 RDFISACLQKDPKKRPSAAELLQHPFIKKA  262 (264)
T ss_pred             HHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence            999999999999999999999999999764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-43  Score=327.60  Aligned_cols=262  Identities=26%  Similarity=0.519  Sum_probs=238.2

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEE
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHL  118 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~l  118 (419)
                      .++|+++.+||+|+|++|.+++++.|.+.+|+|+++++-....+++.=++.|-.+..+-++||.+|-++.+|+++..+++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            46899999999999999999999999999999999988777777888899999999999999999999999999999999


Q ss_pred             EEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceee-eccC
Q 014733          119 LMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATY-IKAG  197 (419)
Q Consensus       119 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~-~~~~  197 (419)
                      |.||++||+|.-++++...+++++++.+..+|..||.|||+.|||+||||.+|||+   +..|++||+|+|+++. +.++
T Consensus       329 vieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvll---daeghikltdygmcke~l~~g  405 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLL---DAEGHIKLTDYGMCKEGLGPG  405 (593)
T ss_pred             EEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEE---ccCCceeecccchhhcCCCCC
Confidence            99999999999999888899999999999999999999999999999999999999   6788999999999885 4566


Q ss_pred             CccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCC--------CCCHHHHHHHHHhcCCCCCCCCCCC
Q 014733          198 QNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFW--------GKTKSKIFDAVRAADLRFPSDPWDH  268 (419)
Q Consensus       198 ~~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~--------~~~~~~~~~~i~~~~~~~~~~~~~~  268 (419)
                      ...++.||||.|+|||+++|. |+..+|+|+|||+++||+.|+.||.        .++..-+++.|.....++|.    .
T Consensus       406 d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiripr----s  481 (593)
T KOG0695|consen  406 DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPR----S  481 (593)
T ss_pred             cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccc----e
Confidence            677888999999999999995 9999999999999999999999994        23445677788887777775    5


Q ss_pred             CCHHHHHHHHhhhhcCCCCCC------CHHHHHhccccccchhhh
Q 014733          269 ISASARDLIMGMLRVDPSTRL------TAAEVLAHSWMEECEQVA  307 (419)
Q Consensus       269 ~s~~l~~li~~~L~~dP~~Rp------s~~eil~hp~~~~~~~~~  307 (419)
                      +|-.+..+++..|++||.+|+      .+.++..|+||+.+++..
T Consensus       482 lsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~  526 (593)
T KOG0695|consen  482 LSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDL  526 (593)
T ss_pred             eehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHH
Confidence            778888999999999999998      578999999999887743

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.9e-42  Score=330.00  Aligned_cols=254  Identities=33%  Similarity=0.656  Sum_probs=224.0

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      ++|.+.+.||+|++|.||+|.+..+|+.+|+|++.+...........+.+|..+++++.+||||+++++++.+.+.++++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            47999999999999999999999999999999998766555566788999999999996699999999999999999999


Q ss_pred             EeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCCc
Q 014733          120 MELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN  199 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~~  199 (419)
                      |||+.+++|.+++.+.+.+++..++.++.|++.||.+||+.|++|+||+|+||++   +.++.++|+|||++........
T Consensus        81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i---~~~~~~~l~df~~~~~~~~~~~  157 (280)
T cd05581          81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILL---DKDMHIKITDFGTAKVLDPNSS  157 (280)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEecCCccccccCCccc
Confidence            9999999999999988889999999999999999999999999999999999999   5678899999999886543221


Q ss_pred             ---------------------cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 014733          200 ---------------------LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAA  257 (419)
Q Consensus       200 ---------------------~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~  257 (419)
                                           .....++..|+|||++.+. ++.++|+||||++++++++|+.||........++.+...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~  237 (280)
T cd05581         158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKL  237 (280)
T ss_pred             cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc
Confidence                                 1223578899999987764 889999999999999999999999887776666666655


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCH----HHHHhcccc
Q 014733          258 DLRFPSDPWDHISASARDLIMGMLRVDPSTRLTA----AEVLAHSWM  300 (419)
Q Consensus       258 ~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~----~eil~hp~~  300 (419)
                      ...++.    .+++.+.++|.+||+.||++||++    .++++||||
T Consensus       238 ~~~~~~----~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         238 EYSFPP----NFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             CCCCCC----ccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            444443    678999999999999999999999    999999997

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=4e-42  Score=329.02  Aligned_cols=256  Identities=25%  Similarity=0.399  Sum_probs=207.5

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      ++|++.+.||+|+||.||+|.++.+|+.||+|.+.....  ......+..|+.++.+..+||||+++++++.+++.+|++
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv   78 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN--SQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC   78 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCC--cHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence            579999999999999999999999999999999876532  223345566777644444699999999999999999999


Q ss_pred             EeecCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC-CCeeccCCCCcEEEeecCCCCCeEEeeccceeee
Q 014733          120 MELCAGGELFHRLEK----YGRFSETEARVIFRHLMQVVSYCHGN-GVVHRDLKPENILLATKSSSSPIKLADFGLATYI  194 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~----~~~l~~~~~~~i~~qll~aL~~LH~~-~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~  194 (419)
                      |||++ ++|.+++..    ...+++..++.++.|++.||+|||++ +++||||||+||++   +.++.+||+|||++...
T Consensus        79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~---~~~~~~kl~dfg~~~~~  154 (283)
T cd06617          79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLI---NRNGQVKLCDFGISGYL  154 (283)
T ss_pred             hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE---CCCCCEEEeeccccccc
Confidence            99996 688777654    23589999999999999999999997 99999999999999   56778999999999876


Q ss_pred             ccCCccccccCCCccCCcccccC-----CCCCchhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhcCCCCCCCCCC
Q 014733          195 KAGQNLHGTVGSPFYIAPEVLAG-----GYNQAADVWSAGVILYILLSGMPPFWGKT--KSKIFDAVRAADLRFPSDPWD  267 (419)
Q Consensus       195 ~~~~~~~~~~gt~~y~aPE~l~~-----~~s~~sDvwSlGvil~elltG~~Pf~~~~--~~~~~~~i~~~~~~~~~~~~~  267 (419)
                      ..........|+..|+|||++.+     .++.++|+|||||++|+|++|+.||....  .......+......++   ..
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~  231 (283)
T cd06617         155 VDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLP---AE  231 (283)
T ss_pred             ccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCC---cc
Confidence            44333334568889999998754     36889999999999999999999996432  2233333222222222   23


Q ss_pred             CCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccch
Q 014733          268 HISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECE  304 (419)
Q Consensus       268 ~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~  304 (419)
                      .+|.++.++|.+||..+|++||++.++++||||+...
T Consensus       232 ~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  268 (283)
T cd06617         232 KFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL  268 (283)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence            5889999999999999999999999999999998754

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.1e-43  Score=344.82  Aligned_cols=255  Identities=27%  Similarity=0.437  Sum_probs=208.7

Q ss_pred             cccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEE
Q 014733           38 LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVH  117 (419)
Q Consensus        38 ~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~  117 (419)
                      -+..|+++++||+||.+.||++..... ..+|+|.+.... .....+..+.+|+..|.+|++|.+||+|+++-..++++|
T Consensus       359 kg~~Yeilk~iG~GGSSkV~kV~~s~~-~iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY  436 (677)
T KOG0596|consen  359 KGREYEILKQIGSGGSSKVFKVLNSDK-QIYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY  436 (677)
T ss_pred             CcchhhHHHhhcCCCcceeeeeecCCC-cchhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence            357899999999999999999987644 456666554332 466788999999999999999999999999999999999


Q ss_pred             EEEeecCCCChHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeecc
Q 014733          118 LLMELCAGGELFHRLEKYGR-FSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA  196 (419)
Q Consensus       118 lV~E~~~ggsL~~~l~~~~~-l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~  196 (419)
                      |||||= ..+|.++|..... .+...++.+..|+++|+.++|++||||.||||.|+|+.    .|.+||+|||.|..+..
T Consensus       437 mvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV----kG~LKLIDFGIA~aI~~  511 (677)
T KOG0596|consen  437 MVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV----KGRLKLIDFGIANAIQP  511 (677)
T ss_pred             EEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE----eeeEEeeeechhcccCc
Confidence            999974 6799999987655 44458888999999999999999999999999999994    67999999999998877


Q ss_pred             CCcc---ccccCCCccCCcccccC------------CCCCchhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhcCC-
Q 014733          197 GQNL---HGTVGSPFYIAPEVLAG------------GYNQAADVWSAGVILYILLSGMPPFWGKT-KSKIFDAVRAADL-  259 (419)
Q Consensus       197 ~~~~---~~~~gt~~y~aPE~l~~------------~~s~~sDvwSlGvil~elltG~~Pf~~~~-~~~~~~~i~~~~~-  259 (419)
                      +...   .+.+||..||+||.+..            +.++++||||||||||+|+.|++||..-. ...-+..|..... 
T Consensus       512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~  591 (677)
T KOG0596|consen  512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHE  591 (677)
T ss_pred             cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCcc
Confidence            6542   35599999999998742            15689999999999999999999995432 2233334444433 


Q ss_pred             -CCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhcccccc
Q 014733          260 -RFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE  302 (419)
Q Consensus       260 -~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~  302 (419)
                       .||..+   -..++.++++.||.+||++|||+.++|+|||++-
T Consensus       592 Iefp~~~---~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~  632 (677)
T KOG0596|consen  592 IEFPDIP---ENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI  632 (677)
T ss_pred             ccccCCC---CchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence             333321   1133999999999999999999999999999975

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=2.8e-42  Score=335.86  Aligned_cols=250  Identities=27%  Similarity=0.456  Sum_probs=192.9

Q ss_pred             eeeeecccCceEEEEEEecC--CCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEE--eCCEEEEE
Q 014733           44 LGKQLGWGQFGVIRECSDKF--TGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYE--EEDYVHLL  119 (419)
Q Consensus        44 i~~~LG~G~~g~V~~a~~~~--~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~--~~~~~~lV  119 (419)
                      .+.+||+|+||+||+|.++.  ++..+|+|.+....     ....+.+|+.++++++ ||||+++++++.  .+..+++|
T Consensus         5 ~g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~lv   78 (317)
T cd07867           5 EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-----ISMSACREIALLRELK-HPNVIALQKVFLSHSDRKVWLL   78 (317)
T ss_pred             eceEeccCCCeeEEEEEecCCCccceEEEEEecCCC-----CcHHHHHHHHHHHhCC-CCCeeeEEEEEeccCCCeEEEE
Confidence            35689999999999999753  56889999886542     2245778999999996 999999999985  45678999


Q ss_pred             EeecCCCChHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeec-CCCCCeEEeecc
Q 014733          120 MELCAGGELFHRLEKY---------GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATK-SSSSPIKLADFG  189 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~~---------~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~-~~~~~vKL~DFg  189 (419)
                      |||+. ++|.+.+...         ..+++..++.++.||+.||.|||+.+|+||||||+|||+..+ +.++.+||+|||
T Consensus        79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG  157 (317)
T cd07867          79 FDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG  157 (317)
T ss_pred             EeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence            99985 5787776422         248899999999999999999999999999999999999543 345789999999


Q ss_pred             ceeeeccCC----ccccccCCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---------HHHHHH
Q 014733          190 LATYIKAGQ----NLHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKS---------KIFDAV  254 (419)
Q Consensus       190 la~~~~~~~----~~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~---------~~~~~i  254 (419)
                      ++.......    ......||+.|+|||++.+  .++.++|||||||++|+|++|++||......         .....+
T Consensus       158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~  237 (317)
T cd07867         158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRI  237 (317)
T ss_pred             ceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHH
Confidence            998764332    1234578999999999876  3799999999999999999999999643321         111111


Q ss_pred             HhcCC--------------C------------CC--------CCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhcccc
Q 014733          255 RAADL--------------R------------FP--------SDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWM  300 (419)
Q Consensus       255 ~~~~~--------------~------------~~--------~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~  300 (419)
                      .....              .            ..        .......+..+.+||.+||+.||.+|||+.|+|+||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         238 FSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             HHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            10000              0            00        00011345678899999999999999999999999997

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=4.2e-42  Score=329.08  Aligned_cols=249  Identities=23%  Similarity=0.377  Sum_probs=213.1

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCC-----cEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCC
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTG-----EVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEED  114 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g-----~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~  114 (419)
                      ++|++.+.||+|+||.||+|.+...+     ..+++|.+....  .......+.+|+.+++++. ||||+++++++.+.+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~   81 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQ-HPNIVCLLGVCTKEQ   81 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcC-CcccceEEEEEcCCC
Confidence            57999999999999999999876554     679999886442  3455677899999999996 999999999999999


Q ss_pred             EEEEEEeecCCCChHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecC
Q 014733          115 YVHLLMELCAGGELFHRLEKY----------------GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKS  178 (419)
Q Consensus       115 ~~~lV~E~~~ggsL~~~l~~~----------------~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~  178 (419)
                      ..+++|||+++++|.+++...                ..+++.++..++.|++.||.|||+.+++|+||||+||++   +
T Consensus        82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~---~  158 (283)
T cd05048          82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLV---G  158 (283)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEE---c
Confidence            999999999999999999764                347889999999999999999999999999999999999   5


Q ss_pred             CCCCeEEeeccceeeeccCCc---cccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 014733          179 SSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDA  253 (419)
Q Consensus       179 ~~~~vKL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~  253 (419)
                      +++.+||+|||++........   .....+++.|+|||.+.+ .++.++|||||||++|||++ |..||.+....+....
T Consensus       159 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~  238 (283)
T cd05048         159 EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM  238 (283)
T ss_pred             CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            567899999999986543321   223456788999998765 48999999999999999998 9999999888888887


Q ss_pred             HHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          254 VRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       254 i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      +.......   ....++.++.+|+.+||+.||.+||++.+++++
T Consensus       239 i~~~~~~~---~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         239 IRSRQLLP---CPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HHcCCcCC---CcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            76654322   224789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=2e-45  Score=337.95  Aligned_cols=255  Identities=27%  Similarity=0.468  Sum_probs=220.1

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEE
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHL  118 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~l  118 (419)
                      ..-|.++++||+|+||.||+|.|+.+|..+|||.+..+     .+++.+..|+.||++.. .|++|++|+.|-.+..+++
T Consensus        32 EEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-----sDLQEIIKEISIMQQC~-S~yVVKYYGSYFK~sDLWI  105 (502)
T KOG0574|consen   32 EEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-----TDLQEIIKEISIMQQCK-SKYVVKYYGSYFKHSDLWI  105 (502)
T ss_pred             HHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-----chHHHHHHHHHHHHHcC-CchhhhhhhhhccCCceEe
Confidence            34578899999999999999999999999999998754     57889999999999996 9999999999999999999


Q ss_pred             EEeecCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccC
Q 014733          119 LMELCAGGELFHRLEK-YGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG  197 (419)
Q Consensus       119 V~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~  197 (419)
                      |||||..|++.+.+.. ++++++.++..+++..+.||+|||...-||||||..|||+   ..+|+.||+|||.|..+.+.
T Consensus       106 VMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILL---NT~G~AKLADFGVAGQLTDT  182 (502)
T KOG0574|consen  106 VMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILL---NTDGIAKLADFGVAGQLTDT  182 (502)
T ss_pred             ehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEE---cccchhhhhhccccchhhhh
Confidence            9999999999999864 4569999999999999999999999999999999999999   67889999999999876544


Q ss_pred             Cc-cccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 014733          198 QN-LHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARD  275 (419)
Q Consensus       198 ~~-~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~  275 (419)
                      .. ..+..|||.|||||++.. +|+.++||||||+...||..|++||.+-.+....-.|-.. .+.....+..+|.++.|
T Consensus       183 MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~-PPPTF~KPE~WS~~F~D  261 (502)
T KOG0574|consen  183 MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTK-PPPTFKKPEEWSSEFND  261 (502)
T ss_pred             HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCC-CCCCCCChHhhhhHHHH
Confidence            33 345689999999999987 6999999999999999999999999876654332222111 11111223468899999


Q ss_pred             HHHhhhhcCCCCCCCHHHHHhccccccc
Q 014733          276 LIMGMLRVDPSTRLTAAEVLAHSWMEEC  303 (419)
Q Consensus       276 li~~~L~~dP~~Rps~~eil~hp~~~~~  303 (419)
                      ||+.||.++|++|.|+.++++|||++..
T Consensus       262 Fi~~CLiK~PE~R~TA~~L~~H~FiknA  289 (502)
T KOG0574|consen  262 FIRSCLIKKPEERKTALRLCEHTFIKNA  289 (502)
T ss_pred             HHHHHhcCCHHHHHHHHHHhhhhhhcCC
Confidence            9999999999999999999999999763

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-42  Score=330.00  Aligned_cols=255  Identities=28%  Similarity=0.503  Sum_probs=205.6

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEE
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHL  118 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~l  118 (419)
                      .++|++.+.||.|++|.||+|.++.+++.||+|.+.....  ......+.+|+++++++. |+||+++++++.+.+..++
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~l   80 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE--EGAPFTAIREASLLKDLK-HANIVTLHDIIHTKKTLTL   80 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc--cCCchhHHHHHHHHhhCC-CcceeeEEEEEecCCeEEE
Confidence            3789999999999999999999998999999999875432  122344668999999995 9999999999999999999


Q ss_pred             EEeecCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccC
Q 014733          119 LMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG  197 (419)
Q Consensus       119 V~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~  197 (419)
                      ||||+.+ +|.+++... ..+++..++.++.|+++||.|||+.+|+||||||+||++   +.++.+||+|||++......
T Consensus        81 v~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~  156 (291)
T cd07844          81 VFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLI---SERGELKLADFGLARAKSVP  156 (291)
T ss_pred             EEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEE---cCCCCEEECccccccccCCC
Confidence            9999974 899888764 458999999999999999999999999999999999999   56778999999998754321


Q ss_pred             C-ccccccCCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhcCCC-------------
Q 014733          198 Q-NLHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKT-KSKIFDAVRAADLR-------------  260 (419)
Q Consensus       198 ~-~~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~-~~~~~~~i~~~~~~-------------  260 (419)
                      . ......++..|+|||++.+  .++.++||||+|+++|+|++|+.||.+.. ..+....+......             
T Consensus       157 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (291)
T cd07844         157 SKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNP  236 (291)
T ss_pred             CccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcc
Confidence            1 1223357888999999865  37899999999999999999999997655 33333322211000             


Q ss_pred             ------CCC-------CCCCCCC--HHHHHHHHhhhhcCCCCCCCHHHHHhcccc
Q 014733          261 ------FPS-------DPWDHIS--ASARDLIMGMLRVDPSTRLTAAEVLAHSWM  300 (419)
Q Consensus       261 ------~~~-------~~~~~~s--~~l~~li~~~L~~dP~~Rps~~eil~hp~~  300 (419)
                            .+.       .....++  .++.++|.+||+.||++|||+.++++||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             ccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence                  000       0011344  888999999999999999999999999997

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-42  Score=330.31  Aligned_cols=256  Identities=32%  Similarity=0.565  Sum_probs=213.3

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      ++|++.+.||+|++|.||+|.++.+++.|++|++..... .......+.+|+++++++. |+||+++++++.+.+..+++
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~iv   78 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLR-HENIVNLKEAFRRKGRLYLV   78 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcC-CCCeeehhheEEECCEEEEE
Confidence            579999999999999999999999999999999875432 2344577899999999996 99999999999999999999


Q ss_pred             EeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC-
Q 014733          120 MELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ-  198 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~-  198 (419)
                      |||++++.+..+......+++.++..++.|++.||.|||+.+++|+||+|+||++   +.++.+||+|||++....... 
T Consensus        79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~---~~~~~~kl~d~g~~~~~~~~~~  155 (288)
T cd07833          79 FEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILV---SESGVLKLCDFGFARALRARPA  155 (288)
T ss_pred             EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEEeeecccccCCCcc
Confidence            9999887777666666679999999999999999999999999999999999999   557899999999988765443 


Q ss_pred             -ccccccCCCccCCcccccCC--CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC---------------
Q 014733          199 -NLHGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLR---------------  260 (419)
Q Consensus       199 -~~~~~~gt~~y~aPE~l~~~--~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---------------  260 (419)
                       ......++..|+|||++.+.  ++.++|+||||+++|+|++|++||.+....+....+......               
T Consensus       156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07833         156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF  235 (288)
T ss_pred             ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccc
Confidence             23345788899999998653  789999999999999999999999876554443333221100               


Q ss_pred             ----CCC---------CCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhcccc
Q 014733          261 ----FPS---------DPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWM  300 (419)
Q Consensus       261 ----~~~---------~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~  300 (419)
                          .+.         .....++.++.+||.+||..||++|||+.++++||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence                000         0112358999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2.5e-42  Score=325.88  Aligned_cols=251  Identities=35%  Similarity=0.620  Sum_probs=220.0

Q ss_pred             ecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEEeecCCCC
Q 014733           48 LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGE  127 (419)
Q Consensus        48 LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~ggs  127 (419)
                      ||.|++|.||++.+..+|+.+++|.+.............+.+|+++++++. ||||+++++.+.+.+..|++|||+++++
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQ-SPYVVKLYYSFQGKKNLYLVMEYLPGGD   79 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCC-CcchhHHHHheecCcEEEEEEecCCCCc
Confidence            689999999999999899999999997665544566788999999999996 9999999999999999999999999999


Q ss_pred             hHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC---------
Q 014733          128 LFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ---------  198 (419)
Q Consensus       128 L~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~---------  198 (419)
                      |.+++.+.+.+++..+..++.||++||+|||+.+++|+||+|+||++   +.++.+||+|||++.......         
T Consensus        80 L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  156 (265)
T cd05579          80 LASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILI---DSNGHLKLTDFGLSKVGLVRRQINLNDDEK  156 (265)
T ss_pred             HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEE---cCCCCEEEEecccchhcccCcccccccccc
Confidence            99999887889999999999999999999999999999999999999   567789999999987543321         


Q ss_pred             ccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHH
Q 014733          199 NLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLI  277 (419)
Q Consensus       199 ~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li  277 (419)
                      ......++..|+|||.+.+. ++.++|+||||+++|+|++|..||......+....+.......+...  .++..+.+++
T Consensus       157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~i  234 (265)
T cd05579         157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDV--EVSDEAIDLI  234 (265)
T ss_pred             cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccc--cCCHHHHHHH
Confidence            12234678899999988764 88999999999999999999999998888888888777555544332  3589999999


Q ss_pred             HhhhhcCCCCCCCH---HHHHhccccccch
Q 014733          278 MGMLRVDPSTRLTA---AEVLAHSWMEECE  304 (419)
Q Consensus       278 ~~~L~~dP~~Rps~---~eil~hp~~~~~~  304 (419)
                      .+||+.+|++|||+   .++++||||+.+.
T Consensus       235 ~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~  264 (265)
T cd05579         235 SKLLVPDPEKRLGAKSIEEIKNHPFFKGID  264 (265)
T ss_pred             HHHhcCCHhhcCCCccHHHHhcCccccCCC
Confidence            99999999999999   9999999998653

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-42  Score=327.77  Aligned_cols=256  Identities=29%  Similarity=0.549  Sum_probs=217.2

Q ss_pred             CeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHcc--CCCCceeeeEEEEeCCEEEE
Q 014733           41 RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLS--GHPNVVDLKAVYEEEDYVHL  118 (419)
Q Consensus        41 ~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~--~hpnIv~l~~~~~~~~~~~l  118 (419)
                      .|++.+.||+|+||.||+|.+..+++.+|+|.+....  .......+.+|+.+++++.  .|||++++++++.+...+++
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l   79 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI   79 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence            5888999999999999999999999999999987542  3345677889999999995  49999999999999999999


Q ss_pred             EEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC
Q 014733          119 LMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ  198 (419)
Q Consensus       119 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~  198 (419)
                      ||||+++++|.+++.. +.+++..+..++.|+++||.|||+.||+|+||+|+||++   +.++.++|+|||++.......
T Consensus        80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06917          80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILV---TNTGNVKLCDFGVAALLNQNS  155 (277)
T ss_pred             EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEE---cCCCCEEEccCCceeecCCCc
Confidence            9999999999998866 579999999999999999999999999999999999999   457889999999998765433


Q ss_pred             c-cccccCCCccCCcccccCC--CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 014733          199 N-LHGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARD  275 (419)
Q Consensus       199 ~-~~~~~gt~~y~aPE~l~~~--~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~  275 (419)
                      . .....|+..|+|||.+.++  ++.++|+||||+++|+|++|..||.+.........+...  ..+......++.++.+
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~  233 (277)
T cd06917         156 SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS--KPPRLEDNGYSKLLRE  233 (277)
T ss_pred             cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC--CCCCCCcccCCHHHHH
Confidence            2 2334788999999998653  689999999999999999999999876655544433222  1222222347899999


Q ss_pred             HHHhhhhcCCCCCCCHHHHHhccccccch
Q 014733          276 LIMGMLRVDPSTRLTAAEVLAHSWMEECE  304 (419)
Q Consensus       276 li~~~L~~dP~~Rps~~eil~hp~~~~~~  304 (419)
                      ++.+||+.||++||++.+++.|+||++..
T Consensus       234 ~i~~~l~~~p~~R~~~~~il~~~~~~~~~  262 (277)
T cd06917         234 FVAACLDEEPKERLSAEELLKSKWIKAHS  262 (277)
T ss_pred             HHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence            99999999999999999999999997654

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2.5e-42  Score=345.27  Aligned_cols=251  Identities=24%  Similarity=0.371  Sum_probs=205.6

Q ss_pred             ccCeeeeeeecccCceEEEEEEecC-----CCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeC
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKF-----TGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEE  113 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~-----~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~  113 (419)
                      .++|++++.||+|+||.||+|++..     ++..||+|.+....  .......+.+|+.+++.+.+|+||+++++++.+.
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~  114 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA--HTDEREALMSELKILSHLGQHKNIVNLLGACTHG  114 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC--CHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence            4689999999999999999998643     34579999997553  3345677889999999995599999999999999


Q ss_pred             CEEEEEEeecCCCChHHHHHHc----------------------------------------------------------
Q 014733          114 DYVHLLMELCAGGELFHRLEKY----------------------------------------------------------  135 (419)
Q Consensus       114 ~~~~lV~E~~~ggsL~~~l~~~----------------------------------------------------------  135 (419)
                      +.+++||||+++|+|.+++...                                                          
T Consensus       115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (374)
T cd05106         115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS  194 (374)
T ss_pred             CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence            9999999999999999988542                                                          


Q ss_pred             ------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCCcc---
Q 014733          136 ------------GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNL---  200 (419)
Q Consensus       136 ------------~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~~~---  200 (419)
                                  .++++.+++.++.||++||+|||++||+||||||+|||+   +.++.+||+|||++.........   
T Consensus       195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~---~~~~~~kL~DfGla~~~~~~~~~~~~  271 (374)
T cd05106         195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLL---TDGRVAKICDFGLARDIMNDSNYVVK  271 (374)
T ss_pred             ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEE---eCCCeEEEeeceeeeeccCCcceeec
Confidence                        237888999999999999999999999999999999999   45678999999999865433221   


Q ss_pred             ccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHH
Q 014733          201 HGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM  278 (419)
Q Consensus       201 ~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~  278 (419)
                      ....++..|+|||++.+ .++.++|||||||++|+|++ |+.||...........+.........  ...+++++.++|.
T Consensus       272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~  349 (374)
T cd05106         272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSR--PDFAPPEIYSIMK  349 (374)
T ss_pred             cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccC--CCCCCHHHHHHHH
Confidence            12234567999999876 48999999999999999997 99999876554444444333332222  2357899999999


Q ss_pred             hhhhcCCCCCCCHHHHHh
Q 014733          279 GMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       279 ~~L~~dP~~Rps~~eil~  296 (419)
                      +||+.||.+|||+.++++
T Consensus       350 ~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         350 MCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             HHcCCChhhCcCHHHHHH
Confidence            999999999999999976

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=8.7e-42  Score=331.03  Aligned_cols=252  Identities=23%  Similarity=0.315  Sum_probs=204.6

Q ss_pred             ccCeeeeeeecccCceEEEEEEecC----------------CCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCC
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKF----------------TGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN  102 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~----------------~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpn  102 (419)
                      .++|++.++||+|+||.||+|.+..                ++..||+|++...  ........+.+|+.+|++++ |||
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~n   80 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPD--ANKNARNDFLKEVKILSRLK-DPN   80 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCC--CCHHHHHHHHHHHHHHhhcC-CCC
Confidence            4789999999999999999998542                3457999998754  23455678999999999996 999


Q ss_pred             ceeeeEEEEeCCEEEEEEeecCCCChHHHHHHcC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 014733          103 VVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYG-------------------RFSETEARVIFRHLMQVVSYCHGNGVV  163 (419)
Q Consensus       103 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~-------------------~l~~~~~~~i~~qll~aL~~LH~~~Iv  163 (419)
                      |+++++++.+.+..++||||+++++|.+++....                   .+++..+..++.||+.||.|||+.||+
T Consensus        81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv  160 (304)
T cd05096          81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV  160 (304)
T ss_pred             eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            9999999999999999999999999999886532                   267788999999999999999999999


Q ss_pred             eccCCCCcEEEeecCCCCCeEEeeccceeeeccCCc---cccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh--
Q 014733          164 HRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS--  237 (419)
Q Consensus       164 HrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt--  237 (419)
                      ||||||+|||+   +.++.+||+|||++........   .....++..|+|||++.+ .++.++||||||+++|+|++  
T Consensus       161 H~dlkp~Nill---~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~  237 (304)
T cd05096         161 HRDLATRNCLV---GENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC  237 (304)
T ss_pred             ccCcchhheEE---cCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHcc
Confidence            99999999999   5677899999999986543322   122345778999999765 48999999999999999986  


Q ss_pred             CCCCCCCCCHHHHHHHHHhc----CCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          238 GMPPFWGKTKSKIFDAVRAA----DLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       238 G~~Pf~~~~~~~~~~~i~~~----~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                      +..||.+....+....+...    ...........++..+.++|.+||+.||++|||+.+|.+
T Consensus       238 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~  300 (304)
T cd05096         238 KEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA  300 (304)
T ss_pred             CCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence            67888877766665544321    111111112367899999999999999999999999954

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=5.8e-42  Score=328.36  Aligned_cols=251  Identities=31%  Similarity=0.477  Sum_probs=205.0

Q ss_pred             eecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHc--cCCCCceeeeEEEEeCCEEEEEEeecC
Q 014733           47 QLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKL--SGHPNVVDLKAVYEEEDYVHLLMELCA  124 (419)
Q Consensus        47 ~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l--~~hpnIv~l~~~~~~~~~~~lV~E~~~  124 (419)
                      .||+|+||.||+|.+..+++.||+|.+.++.............|..+++.+  .+||+|+++++++.+.+.+++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999999999999999999876443222222333444443332  159999999999999999999999999


Q ss_pred             CCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCCcccccc
Q 014733          125 GGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTV  204 (419)
Q Consensus       125 ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~~~~~~~  204 (419)
                      |++|..++...+.+++..+..++.|++.||.|||+.+|+||||||+||++   +.++.+||+|||++....... .....
T Consensus        81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili---~~~~~~kl~dfg~~~~~~~~~-~~~~~  156 (278)
T cd05606          81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKK-PHASV  156 (278)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEE---CCCCCEEEccCcCccccCccC-CcCcC
Confidence            99999999887889999999999999999999999999999999999999   556789999999987654332 23457


Q ss_pred             CCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHh
Q 014733          205 GSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKT---KSKIFDAVRAADLRFPSDPWDHISASARDLIMG  279 (419)
Q Consensus       205 gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~  279 (419)
                      |+..|+|||++.+  .++.++|+||+|+++|+|++|+.||.+..   .......+......    .+..++.++.++|.+
T Consensus       157 ~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~s~~~~~li~~  232 (278)
T cd05606         157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE----LPDSFSPELRSLLEG  232 (278)
T ss_pred             CCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCC----CCCcCCHHHHHHHHH
Confidence            8999999999864  38999999999999999999999997663   33333333222222    223578999999999


Q ss_pred             hhhcCCCCCC-----CHHHHHhccccccchh
Q 014733          280 MLRVDPSTRL-----TAAEVLAHSWMEECEQ  305 (419)
Q Consensus       280 ~L~~dP~~Rp-----s~~eil~hp~~~~~~~  305 (419)
                      ||..||.+|+     ++.++++||||+....
T Consensus       233 ~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~  263 (278)
T cd05606         233 LLQRDVNRRLGCLGRGAQEVKEHPFFRSLDW  263 (278)
T ss_pred             HhhcCHHhccCCCCCCHHHHHhCccccCCCc
Confidence            9999999999     9999999999987654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=9.6e-42  Score=323.64  Aligned_cols=252  Identities=26%  Similarity=0.518  Sum_probs=213.3

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      ++|++.+.||+|+||.||+|+++.+++.||+|.+.............+.+|+.++++++ ||||+++++++.+.+..+++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN-HPNVIKYLDSFIEDNELNIV   80 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC-CcceeeeeeeEEECCeEEEE
Confidence            68999999999999999999999999999999987655555566778899999999996 99999999999999999999


Q ss_pred             EeecCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeec
Q 014733          120 MELCAGGELFHRLEK----YGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIK  195 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~----~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~  195 (419)
                      +||+++++|..++..    ...+++..+..++.|++.||.|||+++++|+||||+||++   +.++.++|+|||++....
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~---~~~~~~~l~d~g~~~~~~  157 (267)
T cd08228          81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEE---cCCCCEEECccccceecc
Confidence            999999999988853    2348999999999999999999999999999999999999   556789999999988764


Q ss_pred             cCCc-cccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhcCCCCCCCCCCCCCH
Q 014733          196 AGQN-LHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKT--KSKIFDAVRAADLRFPSDPWDHISA  271 (419)
Q Consensus       196 ~~~~-~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~s~  271 (419)
                      .... .....|++.|+|||.+.+ .++.++|+||+|+++|+|++|+.||....  ..+....+....  .+......++.
T Consensus       158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  235 (267)
T cd08228         158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCD--YPPLPTEHYSE  235 (267)
T ss_pred             chhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCC--CCCCChhhcCH
Confidence            4322 223468889999999876 48899999999999999999999996543  234444443322  33333346789


Q ss_pred             HHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          272 SARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       272 ~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      .+.++|.+||+.+|++||++.++++.
T Consensus       236 ~~~~li~~cl~~~p~~Rp~~~~vl~~  261 (267)
T cd08228         236 KLRELVSMCIYPDPDQRPDIGYVHQI  261 (267)
T ss_pred             HHHHHHHHHCCCCcccCcCHHHHHHH
Confidence            99999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=3e-42  Score=344.82  Aligned_cols=252  Identities=24%  Similarity=0.394  Sum_probs=204.8

Q ss_pred             ccCeeeeeeecccCceEEEEEEe-----cCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeC
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSD-----KFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEE  113 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~-----~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~  113 (419)
                      .++|++++.||+|+||+||+|.+     ..++..||+|++....  .....+.+.+|+.+|+.+.+||||+++++++.+.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~  111 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHINIVNLLGACTVG  111 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc--CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence            35899999999999999999974     3467789999986443  2345567889999999996699999999999999


Q ss_pred             CEEEEEEeecCCCChHHHHHHcC---------------------------------------------------------
Q 014733          114 DYVHLLMELCAGGELFHRLEKYG---------------------------------------------------------  136 (419)
Q Consensus       114 ~~~~lV~E~~~ggsL~~~l~~~~---------------------------------------------------------  136 (419)
                      +..++||||+++|+|.+++....                                                         
T Consensus       112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (375)
T cd05104         112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS  191 (375)
T ss_pred             CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence            99999999999999999886421                                                         


Q ss_pred             ------------------CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC
Q 014733          137 ------------------RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ  198 (419)
Q Consensus       137 ------------------~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~  198 (419)
                                        .+++..+..++.||+.||+|||+.+|+||||||+|||++   .++.+||+|||++.......
T Consensus       192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~---~~~~~kl~DfG~a~~~~~~~  268 (375)
T cd05104         192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLT---HGRITKICDFGLARDIRNDS  268 (375)
T ss_pred             ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEE---CCCcEEEecCccceeccCcc
Confidence                              367888999999999999999999999999999999994   56789999999998664332


Q ss_pred             cc---ccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 014733          199 NL---HGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASA  273 (419)
Q Consensus       199 ~~---~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l  273 (419)
                      ..   ....++..|+|||++.+. ++.++|||||||++|+|++ |..||.+..................  .+...+.++
T Consensus       269 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l  346 (375)
T cd05104         269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRML--SPECAPSEM  346 (375)
T ss_pred             cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCC--CCCCCCHHH
Confidence            21   122345679999998764 8999999999999999998 8999977654433333333222222  123568899


Q ss_pred             HHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          274 RDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       274 ~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      ++||.+||+.||++|||+.++++.
T Consensus       347 ~~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         347 YDIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             HHHHHHHccCChhHCcCHHHHHHH
Confidence            999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.3e-42  Score=329.82  Aligned_cols=255  Identities=25%  Similarity=0.370  Sum_probs=215.1

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      ++|++.+.||+|+||+||++.+..+|+.+|+|++....  .......+.+|+++++.+. ||||+++++.+.+.+.+++|
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   81 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECR-SPYIVSFYGAFLNENNICMC   81 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcC-CCCcceEeeeEecCCEEEEE
Confidence            68999999999999999999999999999999986542  3345678899999999996 99999999999999999999


Q ss_pred             EeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC
Q 014733          120 MELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG-NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ  198 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~-~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~  198 (419)
                      |||+++++|..++...+.+++..+..++.+++.+|.|||+ .+++||||||+||++   +.++.++|+|||++.......
T Consensus        82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~---~~~~~~~l~d~gl~~~~~~~~  158 (284)
T cd06620          82 MEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILV---NSRGQIKLCDFGVSGELINSI  158 (284)
T ss_pred             EecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEE---CCCCcEEEccCCcccchhhhc
Confidence            9999999999999887889999999999999999999997 689999999999999   567789999999987543222


Q ss_pred             ccccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-----------HHHHHHHhcCCCCCCCCC
Q 014733          199 NLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKS-----------KIFDAVRAADLRFPSDPW  266 (419)
Q Consensus       199 ~~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~-----------~~~~~i~~~~~~~~~~~~  266 (419)
                       .....|+..|+|||++.+ .++.++|+|||||++|+|++|+.||......           +....+.....  +....
T Consensus       159 -~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~  235 (284)
T cd06620         159 -ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP--PRLPS  235 (284)
T ss_pred             -cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC--CCCCc
Confidence             234578999999999865 4889999999999999999999999765431           22233322211  11112


Q ss_pred             CCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccc
Q 014733          267 DHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEEC  303 (419)
Q Consensus       267 ~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~  303 (419)
                      ..++.++.+||.+||+.||++|||+.++++|+||.+.
T Consensus       236 ~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~  272 (284)
T cd06620         236 SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA  272 (284)
T ss_pred             hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence            2478899999999999999999999999999999754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.5e-42  Score=331.61  Aligned_cols=256  Identities=28%  Similarity=0.479  Sum_probs=217.0

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEE
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHL  118 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~l  118 (419)
                      .+.|++.+.||.|+||.||+|.+..++..||+|.+....  .....+.+.+|+.+++++. ||||+++++++.+++.+|+
T Consensus         3 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l   79 (277)
T cd06642           3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCD-SPYITRYYGSYLKGTKLWI   79 (277)
T ss_pred             HHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc--chHHHHHHHHHHHHHHcCC-CCccHhhhcccccCCceEE
Confidence            456888899999999999999999899999999987543  2345678999999999996 9999999999999999999


Q ss_pred             EEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC
Q 014733          119 LMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ  198 (419)
Q Consensus       119 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~  198 (419)
                      ||||+++++|.+++.. +.+++..+..++.|+++||.|||+.+++|+||+|+||++   ..++.+||+|||++.......
T Consensus        80 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i---~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06642          80 IMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLL---SEQGDVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             EEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEE---eCCCCEEEccccccccccCcc
Confidence            9999999999998865 678999999999999999999999999999999999999   456789999999987654332


Q ss_pred             c-cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHH
Q 014733          199 N-LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDL  276 (419)
Q Consensus       199 ~-~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~l  276 (419)
                      . .....|+..|+|||++.+. ++.++|+||||+++|+|++|+.||...........+.....   ......++.++.++
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l  232 (277)
T cd06642         156 IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP---PTLEGQYSKPFKEF  232 (277)
T ss_pred             hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCC---CCCCcccCHHHHHH
Confidence            2 1234678899999998774 88999999999999999999999977665555444433221   11223578899999


Q ss_pred             HHhhhhcCCCCCCCHHHHHhccccccch
Q 014733          277 IMGMLRVDPSTRLTAAEVLAHSWMEECE  304 (419)
Q Consensus       277 i~~~L~~dP~~Rps~~eil~hp~~~~~~  304 (419)
                      |.+||+.+|++||++.++++||||....
T Consensus       233 i~~~l~~~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06642         233 VEACLNKDPRFRPTAKELLKHKFITRYT  260 (277)
T ss_pred             HHHHccCCcccCcCHHHHHHhHHHHHHh
Confidence            9999999999999999999999997654

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-42  Score=354.71  Aligned_cols=252  Identities=33%  Similarity=0.450  Sum_probs=213.6

Q ss_pred             hccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEE-EEe
Q 014733           34 QISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAV-YEE  112 (419)
Q Consensus        34 ~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~-~~~  112 (419)
                      .+..-..+++|.++|.+|||+.||+|.+...|..||+|++...   ....++.+.+|+.+|++|++|+|||.+++. ...
T Consensus        31 ~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~  107 (738)
T KOG1989|consen   31 TFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAIN  107 (738)
T ss_pred             EEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEecccccc
Confidence            3444567899999999999999999999988899999988654   567899999999999999999999999993 321


Q ss_pred             ---C---CEEEEEEeecCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC--CeeccCCCCcEEEeecCCCCC
Q 014733          113 ---E---DYVHLLMELCAGGELFHRLEKY--GRFSETEARVIFRHLMQVVSYCHGNG--VVHRDLKPENILLATKSSSSP  182 (419)
Q Consensus       113 ---~---~~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qll~aL~~LH~~~--IvHrDLkp~NILl~~~~~~~~  182 (419)
                         +   -.+.|.||||+||.|.+++..+  .+|++.+++.|+.++++|+++||...  |||||||-|||||   ..+++
T Consensus       108 ~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLl---s~~g~  184 (738)
T KOG1989|consen  108 RSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLL---SADGN  184 (738)
T ss_pred             ccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEE---cCCCC
Confidence               1   2477899999999999999743  45999999999999999999999998  9999999999999   66789


Q ss_pred             eEEeeccceeeeccCC-cc---------ccccCCCccCCccccc---C-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q 014733          183 IKLADFGLATYIKAGQ-NL---------HGTVGSPFYIAPEVLA---G-GYNQAADVWSAGVILYILLSGMPPFWGKTKS  248 (419)
Q Consensus       183 vKL~DFgla~~~~~~~-~~---------~~~~gt~~y~aPE~l~---~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~  248 (419)
                      .||||||.|+-.-... ..         ....-|+.|+|||++.   + +.+.|+|||+|||+||.|+....||.+... 
T Consensus       185 ~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-  263 (738)
T KOG1989|consen  185 YKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-  263 (738)
T ss_pred             EEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-
Confidence            9999999987432211 11         1225689999999974   3 489999999999999999999999976533 


Q ss_pred             HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          249 KIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       249 ~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                         -.|..+.+.+|..+  .++..+++||+.||+.||++||++.+++.+
T Consensus       264 ---laIlng~Y~~P~~p--~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~  307 (738)
T KOG1989|consen  264 ---LAILNGNYSFPPFP--NYSDRLKDLIRTMLQPNPDERPNIYQVLEE  307 (738)
T ss_pred             ---eeEEeccccCCCCc--cHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence               24567788888764  899999999999999999999999999875

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2e-43  Score=352.54  Aligned_cols=258  Identities=24%  Similarity=0.443  Sum_probs=226.4

Q ss_pred             ccCe-eeeeeecccCceEEEEEEecCCCcEEEEEEeccCcc-CCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCC--
Q 014733           39 SDRY-VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRL-VTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEED--  114 (419)
Q Consensus        39 ~~~y-~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~-~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~--  114 (419)
                      .+|| +..++||+|+|-+||+|.|..+|..||.-.+....+ ..+..++++..|+.+|+.|+ ||||+++|.++.+..  
T Consensus        38 ~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~-H~NIirfy~SW~d~~n~  116 (632)
T KOG0584|consen   38 TGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLK-HPNIIRFYDSWVDTDNK  116 (632)
T ss_pred             CCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCC-CCceeeeeeheecCCCc
Confidence            3566 446889999999999999999999999776654333 45567899999999999996 999999999998755  


Q ss_pred             EEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--CeeccCCCCcEEEeecCCCCCeEEeecccee
Q 014733          115 YVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG--VVHRDLKPENILLATKSSSSPIKLADFGLAT  192 (419)
Q Consensus       115 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~--IvHrDLkp~NILl~~~~~~~~vKL~DFgla~  192 (419)
                      ++.+|+|++.+|+|..+++++++.+...++.|++||++||.|||++.  |||||||-+||||+  +..|.|||+|.|+|+
T Consensus       117 ~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFin--G~~G~VKIGDLGLAt  194 (632)
T KOG0584|consen  117 TINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVN--GNLGEVKIGDLGLAT  194 (632)
T ss_pred             eeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEc--CCcCceeecchhHHH
Confidence            48899999999999999999999999999999999999999999986  99999999999995  678899999999999


Q ss_pred             eeccCCccccccCCCccCCcccccCCCCCchhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHhcCCCCCCCCCCCCCH
Q 014733          193 YIKAGQNLHGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFW-GKTKSKIFDAVRAADLRFPSDPWDHISA  271 (419)
Q Consensus       193 ~~~~~~~~~~~~gt~~y~aPE~l~~~~s~~sDvwSlGvil~elltG~~Pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~s~  271 (419)
                      ..+...... .+|||.|||||++...|+..+||||||++++||+|+..||. ..+..++++++..+..+-....  --.+
T Consensus       195 l~r~s~aks-vIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~k--V~dP  271 (632)
T KOG0584|consen  195 LLRKSHAKS-VIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSK--VKDP  271 (632)
T ss_pred             Hhhccccce-eccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhc--cCCH
Confidence            877665544 78999999999999999999999999999999999999995 5677888888887754322211  2368


Q ss_pred             HHHHHHHhhhhcCCCCCCCHHHHHhccccccc
Q 014733          272 SARDLIMGMLRVDPSTRLTAAEVLAHSWMEEC  303 (419)
Q Consensus       272 ~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~  303 (419)
                      ++++||.+||.. .++|+|+.|+|+||||...
T Consensus       272 evr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  272 EVREFIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             HHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence            999999999998 9999999999999999875

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=7.2e-42  Score=327.07  Aligned_cols=257  Identities=28%  Similarity=0.499  Sum_probs=219.4

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEE
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHL  118 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~l  118 (419)
                      ...|+..+.||.|+||.||+|.+..++..+|+|.+....  .......+.+|+.+++++. ||||+++++++.+++.+++
T Consensus         3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l   79 (277)
T cd06640           3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEITVLSQCD-SPYVTKYYGSYLKGTKLWI   79 (277)
T ss_pred             HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc--cHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECCEEEE
Confidence            357888999999999999999999899999999987542  2455678999999999995 9999999999999999999


Q ss_pred             EEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC
Q 014733          119 LMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ  198 (419)
Q Consensus       119 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~  198 (419)
                      ||||++|++|.+++.. +++++..+..++.|++.||+|||+.+++|+||+|+||++   +.++.++|+|||++.......
T Consensus        80 v~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~---~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06640          80 IMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLL---SEQGDVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             EEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEE---cCCCCEEEcccccceeccCCc
Confidence            9999999999998865 678999999999999999999999999999999999999   556789999999997654432


Q ss_pred             c-cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHH
Q 014733          199 N-LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDL  276 (419)
Q Consensus       199 ~-~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~l  276 (419)
                      . .....++..|+|||++.+. ++.++|+||||+++|+|++|.+||...........+....   +......++..+.++
T Consensus       156 ~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l  232 (277)
T cd06640         156 IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNN---PPTLTGEFSKPFKEF  232 (277)
T ss_pred             cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCC---CCCCchhhhHHHHHH
Confidence            2 2234678889999998764 8999999999999999999999998877666555443332   222234678899999


Q ss_pred             HHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          277 IMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       277 i~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                      |.+||+.+|++||++.+++.|+||.....
T Consensus       233 i~~~l~~~p~~Rp~~~~il~~~~~~~~~~  261 (277)
T cd06640         233 IDACLNKDPSFRPTAKELLKHKFIVKNAK  261 (277)
T ss_pred             HHHHcccCcccCcCHHHHHhChHhhhcch
Confidence            99999999999999999999999976543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=9.7e-42  Score=324.46  Aligned_cols=249  Identities=20%  Similarity=0.319  Sum_probs=210.0

Q ss_pred             ccCeeeeeeecccCceEEEEEEec---CCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCE
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDK---FTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDY  115 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~---~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~  115 (419)
                      .++|++.+.||+|+||.||+|.++   ..+..||+|.+...  ........+.+|+.++++++ ||||+++++++...+.
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~   80 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAG--CSDKQRRGFLAEALTLGQFD-HSNIVRLEGVITRGNT   80 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCC--CCHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEecCCC
Confidence            367999999999999999999865   45678999998754  23445677889999999995 9999999999999999


Q ss_pred             EEEEEeecCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeee
Q 014733          116 VHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI  194 (419)
Q Consensus       116 ~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~  194 (419)
                      .++||||+++++|.+++... +.+++..++.++.||+.||+|||+.+++||||||+|||+   +.++.+||+|||.+...
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili---~~~~~~~l~dfg~~~~~  157 (266)
T cd05064          81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLV---NSDLVCKISGFRRLQED  157 (266)
T ss_pred             cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEE---cCCCcEEECCCcccccc
Confidence            99999999999999999764 468999999999999999999999999999999999999   56778999999987654


Q ss_pred             ccCCcc--ccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCC
Q 014733          195 KAGQNL--HGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHIS  270 (419)
Q Consensus       195 ~~~~~~--~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  270 (419)
                      ......  ....++..|+|||++.+ .++.++|||||||++|+|++ |..||.+....+..+.+..... .+  .+..++
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~-~~--~~~~~~  234 (266)
T cd05064         158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFR-LP--APRNCP  234 (266)
T ss_pred             cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC-CC--CCCCCC
Confidence            322111  12235678999998876 48999999999999999775 9999999888887777765432 22  234788


Q ss_pred             HHHHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          271 ASARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       271 ~~l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                      ..+.+++.+||+.+|++||++++|++
T Consensus       235 ~~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         235 NLLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             HHHHHHHHHHcCCCchhCCCHHHHHH
Confidence            99999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.1e-42  Score=338.63  Aligned_cols=264  Identities=30%  Similarity=0.476  Sum_probs=215.0

Q ss_pred             cccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeC----
Q 014733           38 LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEE----  113 (419)
Q Consensus        38 ~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~----  113 (419)
                      +.++|++.+.||+|+||+||+|.+..+++.||+|.+..... .......+.+|+.+++.+. |+||+++++++...    
T Consensus         3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~ni~~~~~~~~~~~~~~   80 (337)
T cd07858           3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHLD-HENVIAIKDIMPPPHREA   80 (337)
T ss_pred             cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc-ccchhHHHHHHHHHHHhcC-CCCccchHHheecccccc
Confidence            56789999999999999999999999999999999875422 2334556778999999995 99999999988654    


Q ss_pred             -CEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeecccee
Q 014733          114 -DYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLAT  192 (419)
Q Consensus       114 -~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~  192 (419)
                       ..+|+++||+. ++|.+++...+++++..+..++.|++.||.|||+.+++||||||+||++   +.++.+||+|||++.
T Consensus        81 ~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~---~~~~~~kL~Dfg~~~  156 (337)
T cd07858          81 FNDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLAR  156 (337)
T ss_pred             cCcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEECcCcccc
Confidence             35899999995 7899999887889999999999999999999999999999999999999   556789999999998


Q ss_pred             eeccC-CccccccCCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-----------
Q 014733          193 YIKAG-QNLHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAAD-----------  258 (419)
Q Consensus       193 ~~~~~-~~~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-----------  258 (419)
                      ..... .......++..|+|||.+.+  .++.++|+|||||++|+|++|++||.+.+.......+....           
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
T cd07858         157 TTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFI  236 (337)
T ss_pred             ccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence            65443 22234468889999998764  48899999999999999999999997765433332221100           


Q ss_pred             ------------CCCC----CCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchhhh
Q 014733          259 ------------LRFP----SDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVA  307 (419)
Q Consensus       259 ------------~~~~----~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~~~  307 (419)
                                  ...+    ......++.++.++|.+||+.||++|||+.++++||||.......
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~  301 (337)
T cd07858         237 RNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPS  301 (337)
T ss_pred             CchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcc
Confidence                        0000    011246889999999999999999999999999999998764433

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.3e-41  Score=330.51  Aligned_cols=258  Identities=29%  Similarity=0.482  Sum_probs=217.1

Q ss_pred             cccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCE
Q 014733           36 SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDY  115 (419)
Q Consensus        36 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~  115 (419)
                      .....+|++.+.||+|++|.||+|.+..+|+.||+|.+...........+.+.+|+.+++.+. ||||+++++++.+.+.
T Consensus        11 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~~~~~~~~~~~   89 (307)
T cd06607          11 DDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR-HPNTIEYKGCYLREHT   89 (307)
T ss_pred             CCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEEeCCe
Confidence            445578999999999999999999999899999999987654445556678899999999996 9999999999999999


Q ss_pred             EEEEEeecCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeee
Q 014733          116 VHLLMELCAGGELFHRLEK-YGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI  194 (419)
Q Consensus       116 ~~lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~  194 (419)
                      .|+||||+. |+|.+.+.. .+.+++..+..++.|++.||.|||+.+|+|+||+|+||++   +.++.+||+|||++...
T Consensus        90 ~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~---~~~~~~kL~dfg~~~~~  165 (307)
T cd06607          90 AWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILL---TEPGTVKLADFGSASLV  165 (307)
T ss_pred             EEEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEE---CCCCCEEEeecCcceec
Confidence            999999996 577666654 4569999999999999999999999999999999999999   56778999999998765


Q ss_pred             ccCCccccccCCCccCCccccc----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCC
Q 014733          195 KAGQNLHGTVGSPFYIAPEVLA----GGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHIS  270 (419)
Q Consensus       195 ~~~~~~~~~~gt~~y~aPE~l~----~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  270 (419)
                      ...   ....++..|+|||++.    +.++.++||||||+++|+|++|++||.+.........+.....  +......++
T Consensus       166 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~  240 (307)
T cd06607         166 SPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS--PTLSSNDWS  240 (307)
T ss_pred             CCC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCC--CCCCchhhC
Confidence            332   2356788999999874    2488999999999999999999999987766555444433221  222223578


Q ss_pred             HHHHHHHHhhhhcCCCCCCCHHHHHhccccccc
Q 014733          271 ASARDLIMGMLRVDPSTRLTAAEVLAHSWMEEC  303 (419)
Q Consensus       271 ~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~  303 (419)
                      .++.++|.+||+.||++||++.+++.||||...
T Consensus       241 ~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  273 (307)
T cd06607         241 DYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRE  273 (307)
T ss_pred             HHHHHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence            899999999999999999999999999999764

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=3.2e-42  Score=330.91  Aligned_cols=257  Identities=25%  Similarity=0.371  Sum_probs=209.7

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      ++|...+.||+|+||.||++.+..+++.+|+|.+.+...  ......+.+|+.++.++.+|+||+++++++.+++..+++
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~   81 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD--EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC   81 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC--hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence            466778899999999999999999999999999876532  245667889999999997799999999999999999999


Q ss_pred             EeecCCCChHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHhC-CCeeccCCCCcEEEeecCCCCCeEEeeccceee
Q 014733          120 MELCAGGELFHRLE-----KYGRFSETEARVIFRHLMQVVSYCHGN-GVVHRDLKPENILLATKSSSSPIKLADFGLATY  193 (419)
Q Consensus       120 ~E~~~ggsL~~~l~-----~~~~l~~~~~~~i~~qll~aL~~LH~~-~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~  193 (419)
                      |||+. ++|.++..     ....+++..+..++.+++.||+|||+. +|+||||||+||++   +.++.+||+|||++..
T Consensus        82 ~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~  157 (288)
T cd06616          82 MELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILL---DRNGNIKLCDFGISGQ  157 (288)
T ss_pred             Eeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEE---ccCCcEEEeecchhHH
Confidence            99985 45544332     235699999999999999999999975 99999999999999   4567899999999976


Q ss_pred             eccCCccccccCCCccCCcccccCC----CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---c-CCCCCCCC
Q 014733          194 IKAGQNLHGTVGSPFYIAPEVLAGG----YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRA---A-DLRFPSDP  265 (419)
Q Consensus       194 ~~~~~~~~~~~gt~~y~aPE~l~~~----~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~---~-~~~~~~~~  265 (419)
                      ...........|+..|+|||++.+.    ++.++||||+||++|+|++|+.||....  ...+.+..   . ....+...
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd06616         158 LVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN--SVFDQLTQVVKGDPPILSNSE  235 (288)
T ss_pred             hccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc--hHHHHHhhhcCCCCCcCCCcC
Confidence            5544444445788999999998653    7899999999999999999999996543  22222222   1 11222222


Q ss_pred             CCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccch
Q 014733          266 WDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECE  304 (419)
Q Consensus       266 ~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~  304 (419)
                      +..++.++.+||.+||+.||++|||++++++||||+...
T Consensus       236 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~  274 (288)
T cd06616         236 EREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE  274 (288)
T ss_pred             CCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence            345899999999999999999999999999999998654

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.8e-41  Score=319.88  Aligned_cols=248  Identities=29%  Similarity=0.488  Sum_probs=214.5

Q ss_pred             CeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEE
Q 014733           41 RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLM  120 (419)
Q Consensus        41 ~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~  120 (419)
                      +|++.+.||.|+||.||++.++.+++.+|+|.+....  .....+.+.+|+.+++++. |+||+++++.+.+.+.+|++|
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~   77 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMK-HPNIVAFKESFEADGHLYIVM   77 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc--chHHHHHHHHHHHHHHhCC-CCCcceEEEEEEECCEEEEEE
Confidence            5899999999999999999999999999999987543  2345678889999999996 999999999999999999999


Q ss_pred             eecCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC
Q 014733          121 ELCAGGELFHRLEKY--GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ  198 (419)
Q Consensus       121 E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~  198 (419)
                      ||+++++|.+++...  ..+++..+..++.|++.||.|||+.||+|+||||+||++   +.++.++|+|||++.......
T Consensus        78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~~~~  154 (255)
T cd08219          78 EYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFL---TQNGKVKLGDFGSARLLTSPG  154 (255)
T ss_pred             eeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEE---CCCCcEEEcccCcceeecccc
Confidence            999999999988653  358999999999999999999999999999999999999   567789999999998664332


Q ss_pred             c-cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHH
Q 014733          199 N-LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDL  276 (419)
Q Consensus       199 ~-~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~l  276 (419)
                      . .....|++.|+|||++.+. ++.++|+||||+++|+|++|..||...+.......+........   ...++..+.++
T Consensus       155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l  231 (255)
T cd08219         155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPL---PSHYSYELRSL  231 (255)
T ss_pred             cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCC---CcccCHHHHHH
Confidence            2 2345688999999998764 89999999999999999999999998877777766665543322   23678999999


Q ss_pred             HHhhhhcCCCCCCCHHHHHhc
Q 014733          277 IMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       277 i~~~L~~dP~~Rps~~eil~h  297 (419)
                      |.+||+.||++|||+.+++.-
T Consensus       232 i~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         232 IKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             HHHHHhCCcccCCCHHHHhhc
Confidence            999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=4e-42  Score=331.29  Aligned_cols=255  Identities=31%  Similarity=0.465  Sum_probs=210.8

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeC--CEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEE--DYVH  117 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~--~~~~  117 (419)
                      ++|++.+.||.|++|.||+|.++.+++.+++|.+...... ......+.+|+.+++++. ||||+++++++...  +.+|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~~~   82 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQ-HPNIVTVKEVVVGSNLDKIY   82 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcC-CCCEEEEEEEEEecCCCcEE
Confidence            5799999999999999999999999999999999755432 233345678999999996 99999999999877  8999


Q ss_pred             EEEeecCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeecc
Q 014733          118 LLMELCAGGELFHRLEKYG-RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA  196 (419)
Q Consensus       118 lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~  196 (419)
                      +||||++ ++|.+++.... .+++.+++.++.|++.||+|||+.+++|+||||+||++   +.++.+||+|||++.....
T Consensus        83 lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili---~~~~~~~l~d~g~~~~~~~  158 (293)
T cd07843          83 MVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLL---NNRGILKICDFGLAREYGS  158 (293)
T ss_pred             EEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE---CCCCcEEEeecCceeeccC
Confidence            9999996 59988887644 48999999999999999999999999999999999999   5668899999999987654


Q ss_pred             C-CccccccCCCccCCcccccCC--CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC------------
Q 014733          197 G-QNLHGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRF------------  261 (419)
Q Consensus       197 ~-~~~~~~~gt~~y~aPE~l~~~--~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~------------  261 (419)
                      . .......+++.|+|||.+.+.  ++.++|+||+|+++|+|++|.+||......+....+.......            
T Consensus       159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
T cd07843         159 PLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP  238 (293)
T ss_pred             CccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence            3 223345678899999998653  6899999999999999999999998776655554443211000            


Q ss_pred             --------------CCCCCCC--CCHHHHHHHHhhhhcCCCCCCCHHHHHhcccc
Q 014733          262 --------------PSDPWDH--ISASARDLIMGMLRVDPSTRLTAAEVLAHSWM  300 (419)
Q Consensus       262 --------------~~~~~~~--~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~  300 (419)
                                    .......  +++.+.++|.+||+.||++|||+.|++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence                          0000111  58889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-43  Score=349.83  Aligned_cols=252  Identities=29%  Similarity=0.465  Sum_probs=223.9

Q ss_pred             CeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEE
Q 014733           41 RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLM  120 (419)
Q Consensus        41 ~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~  120 (419)
                      .|.-+..||+|+||-||.|++..+.+.||||.+....-.+...++.+..|+..|++|. |||++.+.+||-.+.+.++||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~-HPntieYkgCyLre~TaWLVM  105 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLR-HPNTIEYKGCYLREHTAWLVM  105 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhcc-CCCcccccceeeccchHHHHH
Confidence            4555788999999999999999999999999998877777788999999999999996 999999999999999999999


Q ss_pred             eecCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCCc
Q 014733          121 ELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN  199 (419)
Q Consensus       121 E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~~  199 (419)
                      ||| -|+-.++++-. +++.+.++..|+.+.+.||+|||+++.||||||..|||+   .+.|.|||+|||.|....+   
T Consensus       106 EYC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILL---se~g~VKLaDFGSAsi~~P---  178 (948)
T KOG0577|consen  106 EYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILL---SEPGLVKLADFGSASIMAP---  178 (948)
T ss_pred             HHH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEe---cCCCeeeeccccchhhcCc---
Confidence            999 66888888654 569999999999999999999999999999999999999   6789999999999987544   


Q ss_pred             cccccCCCccCCccccc----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 014733          200 LHGTVGSPFYIAPEVLA----GGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARD  275 (419)
Q Consensus       200 ~~~~~gt~~y~aPE~l~----~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~  275 (419)
                      ..+++|||.|||||++.    |.|+-++||||||+...||...++|+...+....+.-|...+.+..  ..+++|..+++
T Consensus       179 AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtL--qs~eWS~~F~~  256 (948)
T KOG0577|consen  179 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTL--QSNEWSDYFRN  256 (948)
T ss_pred             hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCC--CCchhHHHHHH
Confidence            35689999999999974    3599999999999999999999999988877776666655543322  23478899999


Q ss_pred             HHHhhhhcCCCCCCCHHHHHhcccccc
Q 014733          276 LIMGMLRVDPSTRLTAAEVLAHSWMEE  302 (419)
Q Consensus       276 li~~~L~~dP~~Rps~~eil~hp~~~~  302 (419)
                      |+..||++-|.+|||.+++|.|+|+..
T Consensus       257 Fvd~CLqKipqeRptse~ll~H~fv~R  283 (948)
T KOG0577|consen  257 FVDSCLQKIPQERPTSEELLKHRFVLR  283 (948)
T ss_pred             HHHHHHhhCcccCCcHHHHhhcchhcc
Confidence            999999999999999999999999865

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=5.5e-42  Score=328.47  Aligned_cols=254  Identities=31%  Similarity=0.504  Sum_probs=208.4

Q ss_pred             CeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEE
Q 014733           41 RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLM  120 (419)
Q Consensus        41 ~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~  120 (419)
                      +|++.+.||.|++|.||+|.++.+|+.+|+|.+..+.. .......+.+|+++++++. ||||+++++++.+.+..++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~   78 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELN-HPNIVKLLDVIHTENKLYLVF   78 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcC-CCCCcchhhhcccCCcEEEEe
Confidence            48999999999999999999999999999999875432 2233457889999999996 999999999999999999999


Q ss_pred             eecCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC
Q 014733          121 ELCAGGELFHRLEKY--GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ  198 (419)
Q Consensus       121 E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~  198 (419)
                      ||+. ++|..++...  ..+++..+..++.|+++||+|||+.+++|+||+|+||++   +.++.+||+|||++.......
T Consensus        79 e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill---~~~~~~~l~dfg~~~~~~~~~  154 (284)
T cd07860          79 EFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPV  154 (284)
T ss_pred             eccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEeeccchhhcccCc
Confidence            9995 6888888653  458999999999999999999999999999999999999   567789999999987654332


Q ss_pred             -ccccccCCCccCCcccccCC--CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC----------------
Q 014733          199 -NLHGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADL----------------  259 (419)
Q Consensus       199 -~~~~~~gt~~y~aPE~l~~~--~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~----------------  259 (419)
                       ......++..|+|||++.+.  ++.++|+||||+++|+|++|+.||.+....+....+.....                
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07860         155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDY  234 (284)
T ss_pred             cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHH
Confidence             22334578889999988653  68899999999999999999999987665443333222110                


Q ss_pred             --CCCC-------CCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhcccc
Q 014733          260 --RFPS-------DPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWM  300 (419)
Q Consensus       260 --~~~~-------~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~  300 (419)
                        .++.       .....++.+++++|.+||+.||.+|||+.++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         235 KPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             HhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence              0000       0123478899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-44  Score=347.70  Aligned_cols=261  Identities=31%  Similarity=0.547  Sum_probs=240.1

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      .+.+++..||.|+||.|-++..+.....+|+|++++.+....+..+.+..|.+||...+ .|+||++|..|.++.++||.
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~-s~fIvrLYrTfrd~kyvYmL  498 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECR-SDFIVRLYRTFRDSKYVYML  498 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcC-chHHHHHHHHhccchhhhhh
Confidence            45667888999999999998877666679999999999988889999999999999997 99999999999999999999


Q ss_pred             EeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCCc
Q 014733          120 MELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN  199 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~~  199 (419)
                      ||-|-||+|+..+...+.|++..++.++..+++|++|||++|||+|||||+|.|+   +.+|-+||.|||+|+.+..+..
T Consensus       499 mEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllL---d~~Gy~KLVDFGFAKki~~g~K  575 (732)
T KOG0614|consen  499 MEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLL---DNRGYLKLVDFGFAKKIGSGRK  575 (732)
T ss_pred             HHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheee---ccCCceEEeehhhHHHhccCCc
Confidence            9999999999999999999999999999999999999999999999999999999   6788999999999999999888


Q ss_pred             cccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHH
Q 014733          200 LHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM  278 (419)
Q Consensus       200 ~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~  278 (419)
                      .-+.||||.|.|||++.+ +.+.++|.||||+++|||++|.+||.+.++...++.|..+--.+..+  ..++..+.+||+
T Consensus       576 TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~P--r~I~k~a~~Lik  653 (732)
T KOG0614|consen  576 TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFP--RRITKTATDLIK  653 (732)
T ss_pred             eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcc--cccchhHHHHHH
Confidence            888999999999998776 58999999999999999999999999999999999998875444332  478999999999


Q ss_pred             hhhhcCCCCCCC-----HHHHHhccccccchhh
Q 014733          279 GMLRVDPSTRLT-----AAEVLAHSWMEECEQV  306 (419)
Q Consensus       279 ~~L~~dP~~Rps-----~~eil~hp~~~~~~~~  306 (419)
                      ++.+.+|.+|+.     +.+|.+|-||...++.
T Consensus       654 ~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdwe  686 (732)
T KOG0614|consen  654 KLCRDNPTERLGYQKGGINDIKKHRWFEGFDWE  686 (732)
T ss_pred             HHHhcCcHhhhccccCChHHHHhhhhhhcCChh
Confidence            999999999995     9999999999877663

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=9.5e-42  Score=330.41  Aligned_cols=260  Identities=27%  Similarity=0.432  Sum_probs=207.8

Q ss_pred             ccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCC
Q 014733           35 ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEED  114 (419)
Q Consensus        35 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~  114 (419)
                      +...-++|++.+.||+|+||.||+|.++.+++.||+|.+..... .......+.+|+.++++++ ||||+++++++.+..
T Consensus         7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~   84 (310)
T cd07865           7 FCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE-KEGFPITALREIKILQLLK-HENVVNLIEICRTKA   84 (310)
T ss_pred             ccchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC-cCCchhHHHHHHHHHHhCC-CCCccceEEEEeccc
Confidence            33445689999999999999999999999999999999865432 1222345567999999996 999999999987643


Q ss_pred             --------EEEEEEeecCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEE
Q 014733          115 --------YVHLLMELCAGGELFHRLEKYG-RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKL  185 (419)
Q Consensus       115 --------~~~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL  185 (419)
                              ..++||||+. ++|.+.+.... .+++.+++.++.||++||+|||++|++|+||||+||++   +.++.+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl  160 (310)
T cd07865          85 TPYNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILI---TKDGILKL  160 (310)
T ss_pred             ccccCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---CCCCcEEE
Confidence                    4699999995 58888776543 68999999999999999999999999999999999999   56778999


Q ss_pred             eeccceeeeccCCc-----cccccCCCccCCcccccCC--CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC
Q 014733          186 ADFGLATYIKAGQN-----LHGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAAD  258 (419)
Q Consensus       186 ~DFgla~~~~~~~~-----~~~~~gt~~y~aPE~l~~~--~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~  258 (419)
                      +|||++........     .....++..|+|||.+.+.  ++.++|+||||+++|+|++|++||.+.........+....
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~  240 (310)
T cd07865         161 ADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLC  240 (310)
T ss_pred             CcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            99999976543221     1234678889999987663  7889999999999999999999998877655544443321


Q ss_pred             CCCCCCC----------------------------CCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhcccc
Q 014733          259 LRFPSDP----------------------------WDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWM  300 (419)
Q Consensus       259 ~~~~~~~----------------------------~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~  300 (419)
                      ..++...                            ....+..+.++|.+||+.||.+|||++++++||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         241 GSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             CCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence            1111110                            01135678899999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=7.1e-42  Score=331.94  Aligned_cols=250  Identities=26%  Similarity=0.379  Sum_probs=207.2

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEE--EEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVL--ACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVH  117 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~v--aiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~  117 (419)
                      ++|++.+.||+|+||.||+|.++.++..+  ++|.+..  .........+.+|+.++.++.+||||+++++++.+.+.+|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~--~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~   84 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE--YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY   84 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecc--cCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence            58899999999999999999998777654  6665542  2344566788999999999956999999999999999999


Q ss_pred             EEEeecCCCChHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCC
Q 014733          118 LLMELCAGGELFHRLEKYG----------------RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSS  181 (419)
Q Consensus       118 lV~E~~~ggsL~~~l~~~~----------------~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~  181 (419)
                      +||||+++++|.+++...+                .+++..++.++.||+.||+|||+.||+||||||+|||+   +.++
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili---~~~~  161 (303)
T cd05088          85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENY  161 (303)
T ss_pred             EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEe---cCCC
Confidence            9999999999999997542                47899999999999999999999999999999999999   5667


Q ss_pred             CeEEeeccceeeeccCCccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCC
Q 014733          182 PIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADL  259 (419)
Q Consensus       182 ~vKL~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~  259 (419)
                      .+||+|||++.............++..|+|||++.+. ++.++|||||||++|+|++ |..||.+....+..+.+.... 
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-  240 (303)
T cd05088         162 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY-  240 (303)
T ss_pred             cEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCC-
Confidence            8999999998643221111222345679999988764 8899999999999999998 999998887777776654331 


Q ss_pred             CCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          260 RFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       260 ~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                        ....+..++.++.++|.+||+.+|++||++.+++.+
T Consensus       241 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         241 --RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             --cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence              112233578999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.4e-41  Score=327.58  Aligned_cols=261  Identities=28%  Similarity=0.483  Sum_probs=212.0

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      ++|++.+.||.|++|+||+|.++.+|+.||+|.+..... .......+.+|+++++++. ||||+++++++.+.+.+|+|
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   79 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQ-HGNIVRLQDVVHSEKRLYLV   79 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhcc-CCCEeeEEEEEecCCeEEEE
Confidence            579999999999999999999999999999999876532 2234466888999999995 99999999999999999999


Q ss_pred             EeecCCCChHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccC
Q 014733          120 MELCAGGELFHRLEKYGR--FSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG  197 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~~~~--l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~  197 (419)
                      |||++ ++|.+.+.....  +++..++.++.||+.||+|||+++|+|+||+|+||+++.  .++.+||+|||++......
T Consensus        80 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~--~~~~~kl~dfg~~~~~~~~  156 (294)
T PLN00009         80 FEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDR--RTNALKLADFGLARAFGIP  156 (294)
T ss_pred             Eeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEEC--CCCEEEEcccccccccCCC
Confidence            99995 588887765443  578889999999999999999999999999999999953  3457999999999765432


Q ss_pred             C-ccccccCCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC--------------
Q 014733          198 Q-NLHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLR--------------  260 (419)
Q Consensus       198 ~-~~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~--------------  260 (419)
                      . ......+++.|+|||++.+  .++.++|+||+|+++|+|++|++||......+...++......              
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (294)
T PLN00009        157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD  236 (294)
T ss_pred             ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence            2 1233467889999998865  3789999999999999999999999877655444433221000              


Q ss_pred             ----C---CC----CCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          261 ----F---PS----DPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       261 ----~---~~----~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                          .   +.    .....++.++.++|.+||+.||++||++.++++||||.....
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~~  292 (294)
T PLN00009        237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGD  292 (294)
T ss_pred             hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHhc
Confidence                0   00    012357889999999999999999999999999999987654

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.8e-41  Score=326.16  Aligned_cols=258  Identities=28%  Similarity=0.498  Sum_probs=219.6

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEE
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHL  118 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~l  118 (419)
                      ..+|...+.||.|++|.||++.++.+++.+++|.+...   .....+.+.+|+.+++++. ||||+++++++...+..++
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~~~-h~~vv~~~~~~~~~~~~~~   93 (285)
T cd06648          18 RSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR---KQQRRELLFNEVVIMRDYQ-HPNIVEMYSSYLVGDELWV   93 (285)
T ss_pred             hHhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc---chhHHHHHHHHHHHHHHcC-CCChheEEEEEEcCCeEEE
Confidence            34666678999999999999999989999999988643   2244566889999999996 9999999999999999999


Q ss_pred             EEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC
Q 014733          119 LMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ  198 (419)
Q Consensus       119 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~  198 (419)
                      ++||++|++|.+++.. +++++.++..++.|++.||+|||++||+||||+|+||++   +.++.++|+|||.+.......
T Consensus        94 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~d~g~~~~~~~~~  169 (285)
T cd06648          94 VMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILL---TSDGRVKLSDFGFCAQVSKEV  169 (285)
T ss_pred             EEeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEE---cCCCcEEEcccccchhhccCC
Confidence            9999999999999887 679999999999999999999999999999999999999   567899999999887554322


Q ss_pred             c-cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHH
Q 014733          199 N-LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDL  276 (419)
Q Consensus       199 ~-~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~l  276 (419)
                      . .....|++.|+|||.+.+. ++.++|+||+|+++|+|++|+.||...+.......+........ .....++..+.++
T Consensus       170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l  248 (285)
T cd06648         170 PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKL-KNLHKVSPRLRSF  248 (285)
T ss_pred             cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCC-cccccCCHHHHHH
Confidence            2 2334689999999998764 89999999999999999999999988777777766665532222 1223478999999


Q ss_pred             HHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          277 IMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       277 i~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                      |.+||+.||++|||+.++++||||++...
T Consensus       249 i~~~l~~~p~~Rpt~~~il~~~~~~~~~~  277 (285)
T cd06648         249 LDRMLVRDPAQRATAAELLNHPFLAKAGP  277 (285)
T ss_pred             HHHHcccChhhCcCHHHHccCcccccCCC
Confidence            99999999999999999999999987553

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=9.4e-42  Score=329.53  Aligned_cols=267  Identities=27%  Similarity=0.467  Sum_probs=221.6

Q ss_pred             ccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCC
Q 014733           35 ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEED  114 (419)
Q Consensus        35 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~  114 (419)
                      .....++|++.+.||+|+||.||++.+..++..+++|.+....   ....+.+.+|+.+++++. ||||+++++++...+
T Consensus        14 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~~~   89 (293)
T cd06647          14 VGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENK-HPNIVNYLDSYLVGD   89 (293)
T ss_pred             ccCchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhcC-CCCeeehhheeeeCC
Confidence            4445689999999999999999999998899999999986542   234567889999999996 999999999999999


Q ss_pred             EEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeee
Q 014733          115 YVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI  194 (419)
Q Consensus       115 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~  194 (419)
                      .+|+|+||+++++|.+++.+ ..+++.++..++.|++.||.|||+.|++|+||||+||++   +.++.+||+|||++...
T Consensus        90 ~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili---~~~~~~kL~dfg~~~~~  165 (293)
T cd06647          90 ELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQI  165 (293)
T ss_pred             cEEEEEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEE---cCCCCEEEccCcceecc
Confidence            99999999999999999875 468899999999999999999999999999999999999   55678999999988765


Q ss_pred             ccCCc-cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHH
Q 014733          195 KAGQN-LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISAS  272 (419)
Q Consensus       195 ~~~~~-~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  272 (419)
                      ..... .....|++.|+|||.+.+. ++.++|+||||+++|+|++|+.||...........+..... .....+..++..
T Consensus       166 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  244 (293)
T cd06647         166 TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT-PELQNPEKLSAI  244 (293)
T ss_pred             cccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCC-CCCCCccccCHH
Confidence            44322 2334688899999988664 88999999999999999999999977655443333322211 111223467889


Q ss_pred             HHHHHHhhhhcCCCCCCCHHHHHhccccccchhhhcCC
Q 014733          273 ARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKP  310 (419)
Q Consensus       273 l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~~~~~~  310 (419)
                      ++++|++||..+|++||++.+++.|+||+.....++.+
T Consensus       245 l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~~~~~~  282 (293)
T cd06647         245 FRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKPLSSLT  282 (293)
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcCHHHhcCccccccc
Confidence            99999999999999999999999999998766544443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=4.8e-42  Score=331.50  Aligned_cols=260  Identities=28%  Similarity=0.486  Sum_probs=218.7

Q ss_pred             ccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEE
Q 014733           37 NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYV  116 (419)
Q Consensus        37 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~  116 (419)
                      ...+.|.....||.|+||.||++.+..++..||+|.+...   .....+.+.+|+.+++.++ |+||+++++.+...+..
T Consensus        19 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~ii~~~~~~~~~~~~   94 (292)
T cd06658          19 DPREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR---KQQRRELLFNEVVIMRDYH-HENVVDMYNSYLVGDEL   94 (292)
T ss_pred             chHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc---hHHHHHHHHHHHHHHHhCC-CCcHHHHHHheecCCeE
Confidence            3445666678899999999999999989999999998653   2345667889999999996 99999999999999999


Q ss_pred             EEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeecc
Q 014733          117 HLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA  196 (419)
Q Consensus       117 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~  196 (419)
                      ++||||+++++|..++.. +.+++.++..++.||+.||+|||+.+|+||||||+||++   +.++.+||+|||++.....
T Consensus        95 ~lv~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill---~~~~~~kL~dfg~~~~~~~  170 (292)
T cd06658          95 WVVMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILL---TSDGRIKLSDFGFCAQVSK  170 (292)
T ss_pred             EEEEeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE---cCCCCEEEccCcchhhccc
Confidence            999999999999998854 578999999999999999999999999999999999999   4567899999999875533


Q ss_pred             CC-ccccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 014733          197 GQ-NLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASAR  274 (419)
Q Consensus       197 ~~-~~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~  274 (419)
                      .. ......|+..|+|||.+.+ .++.++|+||+|+++|+|++|+.||......+....+..... ........++..+.
T Consensus       171 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  249 (292)
T cd06658         171 EVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLP-PRVKDSHKVSSVLR  249 (292)
T ss_pred             ccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-CccccccccCHHHH
Confidence            22 2233578999999999876 489999999999999999999999988777666655544321 11122235789999


Q ss_pred             HHHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          275 DLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       275 ~li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                      +++.+||..||.+|||+.++++||||+....
T Consensus       250 ~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~  280 (292)
T cd06658         250 GFLDLMLVREPSQRATAQELLQHPFLKLAGP  280 (292)
T ss_pred             HHHHHHccCChhHCcCHHHHhhChhhhccCC
Confidence            9999999999999999999999999986544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-43  Score=351.95  Aligned_cols=258  Identities=28%  Similarity=0.483  Sum_probs=226.6

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEE
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHL  118 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~l  118 (419)
                      .+.|.|+..||-|+||+||+|..+.++-..|.|+|..+   +...++.+.-||+||.... ||+||+|++.|.-++.++|
T Consensus        31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk---seEELEDylVEIeILa~Cd-HP~ivkLl~ayy~enkLwi  106 (1187)
T KOG0579|consen   31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK---SEEELEDYLVEIEILAECD-HPVIVKLLSAYYFENKLWI  106 (1187)
T ss_pred             HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc---chhHHhhhhhhhhhhhcCC-ChHHHHHHHHHhccCceEE
Confidence            35678888999999999999999999999999999765   4578899999999999995 9999999999999999999


Q ss_pred             EEeecCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeee-cc
Q 014733          119 LMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI-KA  196 (419)
Q Consensus       119 V~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~-~~  196 (419)
                      ..|||.||-....+-.- ..+++.++..+++|++.||.|||+++|||||||..|||+   ..+|.|+|+|||.+... ..
T Consensus       107 liEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~---TldGdirLADFGVSAKn~~t  183 (1187)
T KOG0579|consen  107 LIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILL---TLDGDIRLADFGVSAKNKST  183 (1187)
T ss_pred             EEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEE---EecCcEeeecccccccchhH
Confidence            99999999998876554 459999999999999999999999999999999999999   56788999999986543 33


Q ss_pred             CCccccccCCCccCCcccccC------CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCC
Q 014733          197 GQNLHGTVGSPFYIAPEVLAG------GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHIS  270 (419)
Q Consensus       197 ~~~~~~~~gt~~y~aPE~l~~------~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  270 (419)
                      .....++.|||.|||||+++.      +|++++||||||+.|.||..+.+|-...+...++-+|.....+-.. .+..++
T Consensus       184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLl-qPS~Ws  262 (1187)
T KOG0579|consen  184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLL-QPSHWS  262 (1187)
T ss_pred             HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCccc-Ccchhh
Confidence            344567899999999999753      4999999999999999999999999998888888888776544322 345889


Q ss_pred             HHHHHHHHhhhhcCCCCCCCHHHHHhccccccch
Q 014733          271 ASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECE  304 (419)
Q Consensus       271 ~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~  304 (419)
                      ..+.||+.+||.+||..||++.++|+|||+....
T Consensus       263 ~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~  296 (1187)
T KOG0579|consen  263 RSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAP  296 (1187)
T ss_pred             hHHHHHHHHHHhcCCccCCCHHHHhhCcccccCC
Confidence            9999999999999999999999999999998654

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.4e-41  Score=325.47  Aligned_cols=253  Identities=29%  Similarity=0.530  Sum_probs=209.3

Q ss_pred             CeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEE
Q 014733           41 RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLM  120 (419)
Q Consensus        41 ~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~  120 (419)
                      +|++.+.||.|++|.||+|.++.+|+.||+|.+.....  ......+.+|+.+++++. ||||+++++++.+.+..++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~   77 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELK-HENIVRLHDVIHTENKLMLVF   77 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhc-CCCEeeeeeeEeeCCcEEEEE
Confidence            58999999999999999999999999999999876532  223456778999999995 999999999999999999999


Q ss_pred             eecCCCChHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccC
Q 014733          121 ELCAGGELFHRLEKYG---RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG  197 (419)
Q Consensus       121 E~~~ggsL~~~l~~~~---~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~  197 (419)
                      ||+++ +|.+++....   .+++..+..++.|+++||+|||+.|++||||||+||++   +.++.+||+|||++......
T Consensus        78 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~---~~~~~~~l~d~g~~~~~~~~  153 (284)
T cd07836          78 EYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLI---NKRGELKLADFGLARAFGIP  153 (284)
T ss_pred             ecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---CCCCcEEEeecchhhhhcCC
Confidence            99975 8888876543   58999999999999999999999999999999999999   56778999999998755432


Q ss_pred             C-ccccccCCCccCCcccccCC--CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC--------------
Q 014733          198 Q-NLHGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLR--------------  260 (419)
Q Consensus       198 ~-~~~~~~gt~~y~aPE~l~~~--~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~--------------  260 (419)
                      . ......++..|++||++.+.  ++.++|+||||+++|+|++|+.||.+.+..+....+......              
T Consensus       154 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07836         154 VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE  233 (284)
T ss_pred             ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence            2 12334678899999988653  789999999999999999999999877766555544321100              


Q ss_pred             ----CCC-------CCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhcccc
Q 014733          261 ----FPS-------DPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWM  300 (419)
Q Consensus       261 ----~~~-------~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~  300 (419)
                          ++.       .....++.++.++|.+||+.||.+||++.++++||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence                000       0012457889999999999999999999999999997

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-43  Score=351.45  Aligned_cols=256  Identities=35%  Similarity=0.577  Sum_probs=221.7

Q ss_pred             ccccchhhccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceee
Q 014733           27 GTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDL  106 (419)
Q Consensus        27 ~~~~~~~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l  106 (419)
                      ..++....-..+.+.|.+...+|.|+|+.|..+.+..+++..++|++.+..       .+..+|+.++.+..+||||+++
T Consensus       309 ~~il~~~~~~~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-------~~~~~e~~~~~~~~~h~niv~~  381 (612)
T KOG0603|consen  309 PGVLEDAVTAPFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-------DDNQDEIPISLLVRDHPNIVKS  381 (612)
T ss_pred             hHHhhccccCCcchhhccccccCCCCccceeeeeccccccchhheeccccc-------cccccccchhhhhcCCCcceee
Confidence            344444444457889999999999999999999999999999999998652       2334578788888899999999


Q ss_pred             eEEEEeCCEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEe
Q 014733          107 KAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLA  186 (419)
Q Consensus       107 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~  186 (419)
                      ++++.+..+.|+|||++.|+.|.+.+.....+. .++..|+.+|+.|+.|||++|||||||||+|||++  +..++++|+
T Consensus       382 ~~v~~~~~~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~--~~~g~lrlt  458 (612)
T KOG0603|consen  382 HDVYEDGKEIYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD--GSAGHLRLT  458 (612)
T ss_pred             cceecCCceeeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec--CCCCcEEEE
Confidence            999999999999999999999999887755555 88889999999999999999999999999999996  467899999


Q ss_pred             eccceeeeccCCccccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhcCCCCCCC
Q 014733          187 DFGLATYIKAGQNLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKS-KIFDAVRAADLRFPSD  264 (419)
Q Consensus       187 DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~-~~~~~i~~~~~~~~~~  264 (419)
                      |||.++..+..  ..+.|-|..|.|||++.. +|++++||||||++||+|++|+.||...... ++...+..+.+.    
T Consensus       459 yFG~a~~~~~~--~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s----  532 (612)
T KOG0603|consen  459 YFGFWSELERS--CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS----  532 (612)
T ss_pred             EechhhhCchh--hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc----
Confidence            99999987655  444577889999999986 4999999999999999999999999876655 566665554433    


Q ss_pred             CCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhcccc
Q 014733          265 PWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWM  300 (419)
Q Consensus       265 ~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~  300 (419)
                        ..+|.++++||++||++||.+|+++.+++.|||+
T Consensus       533 --~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  533 --ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             --cccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence              4799999999999999999999999999999999

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=5.3e-42  Score=337.34  Aligned_cols=264  Identities=26%  Similarity=0.454  Sum_probs=215.5

Q ss_pred             cccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEE----eC
Q 014733           38 LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYE----EE  113 (419)
Q Consensus        38 ~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~----~~  113 (419)
                      +.++|++.+.||.|++|.||+|.++.+|+.||+|++..... .......+.+|+.+|+++. ||||+++++++.    ..
T Consensus         3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~   80 (334)
T cd07855           3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFK-HDNIIAIRDILRPPGADF   80 (334)
T ss_pred             hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcC-CCCccCHHHhccccCCCC
Confidence            46899999999999999999999999999999999876432 2234567788999999996 999999999885    34


Q ss_pred             CEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceee
Q 014733          114 DYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATY  193 (419)
Q Consensus       114 ~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~  193 (419)
                      ..+++||||+. ++|.+++...+.+++..++.++.||+.||.|||+.+|+||||||+||++   +.++.+||+|||++..
T Consensus        81 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~dfg~~~~  156 (334)
T cd07855          81 KDVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLV---NEDCELRIGDFGMARG  156 (334)
T ss_pred             ceEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEeccccccee
Confidence            57899999995 6899999877789999999999999999999999999999999999999   5678899999999976


Q ss_pred             eccCCc-----cccccCCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC--------
Q 014733          194 IKAGQN-----LHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAAD--------  258 (419)
Q Consensus       194 ~~~~~~-----~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--------  258 (419)
                      ......     .....|+..|+|||++.+  .++.++|+||||+++|+|++|++||.+.........+....        
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~  236 (334)
T cd07855         157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL  236 (334)
T ss_pred             ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence            543221     123478899999999765  38899999999999999999999997765433332221110        


Q ss_pred             ---------------CCCCCC----CCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchhhh
Q 014733          259 ---------------LRFPSD----PWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVA  307 (419)
Q Consensus       259 ---------------~~~~~~----~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~~~  307 (419)
                                     ......    .....+.++.++|.+||+.||++|||+.+++.||||++.....
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~  304 (334)
T cd07855         237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPD  304 (334)
T ss_pred             hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCc
Confidence                           000111    1235789999999999999999999999999999998765543

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.5e-41  Score=324.55  Aligned_cols=249  Identities=23%  Similarity=0.407  Sum_probs=212.7

Q ss_pred             ccCeeeeeeecccCceEEEEEEecC-----CCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeC
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKF-----TGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEE  113 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~-----~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~  113 (419)
                      .++|.+.+.||+|+||.||+|.+..     ++..+|+|.+...  ......+.+.+|+++|+++. ||||+++++++.+.
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~   80 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKET--ASNDARKDFEREAELLTNFQ-HENIVKFYGVCTEG   80 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeeccc--CCHHHHHHHHHHHHHHHhcC-CCCchheeeEEecC
Confidence            3678999999999999999998753     4678999998654  23345678999999999996 99999999999999


Q ss_pred             CEEEEEEeecCCCChHHHHHHcC--------------CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCC
Q 014733          114 DYVHLLMELCAGGELFHRLEKYG--------------RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSS  179 (419)
Q Consensus       114 ~~~~lV~E~~~ggsL~~~l~~~~--------------~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~  179 (419)
                      ...+++|||+++++|.+++...+              .+++..+..++.|++.||.|||++|++||||||+||++   +.
T Consensus        81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili---~~  157 (280)
T cd05049          81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLV---GY  157 (280)
T ss_pred             CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEE---cC
Confidence            99999999999999999997643              37889999999999999999999999999999999999   56


Q ss_pred             CCCeEEeeccceeeeccCCc---cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 014733          180 SSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAV  254 (419)
Q Consensus       180 ~~~vKL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i  254 (419)
                      ++.+||+|||++........   .....+++.|+|||++.+. ++.++||||||+++|+|++ |..||.+....+....+
T Consensus       158 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~  237 (280)
T cd05049         158 DLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECI  237 (280)
T ss_pred             CCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence            68999999999976533221   1233567789999998764 8999999999999999998 99999988888888887


Q ss_pred             HhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          255 RAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       255 ~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                      ..+....+.   ..++.++.+++.+||+.||++||++.|+++
T Consensus       238 ~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         238 TQGRLLQRP---RTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             HcCCcCCCC---CCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            765443332   368899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=3.5e-41  Score=322.33  Aligned_cols=254  Identities=29%  Similarity=0.501  Sum_probs=216.8

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      +-|++.+.||.|+||.||+|.+..++..+|+|++....  .......+.+|+.+++++. ||||+++++++.+++.+++|
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv   80 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCD-SPYVTKYYGSYLKDTKLWII   80 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHHHhcC-CCCEeEEEEEEEeCCeEEEE
Confidence            45778999999999999999998899999999986543  2345677899999999996 99999999999999999999


Q ss_pred             EeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCCc
Q 014733          120 MELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN  199 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~~  199 (419)
                      |||+++++|..++.. ..+++..+..++.+++.+|.+||+.+++|+||||+||++   +.++.++|+|||++........
T Consensus        81 ~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i---~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06641          81 MEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL---SEHGEVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             EEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEE---CCCCCEEEeecccceecccchh
Confidence            999999999998865 568999999999999999999999999999999999999   5567899999999876543221


Q ss_pred             -cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHH
Q 014733          200 -LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLI  277 (419)
Q Consensus       200 -~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li  277 (419)
                       .....++..|+|||.+.+. ++.++|+|||||++|+|++|..||...........+.....   ......++.++.++|
T Consensus       157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~i  233 (277)
T cd06641         157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP---PTLEGNYSKPLKEFV  233 (277)
T ss_pred             hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCC---CCCCcccCHHHHHHH
Confidence             2234678899999998764 78899999999999999999999987776665555543322   112236789999999


Q ss_pred             HhhhhcCCCCCCCHHHHHhccccccc
Q 014733          278 MGMLRVDPSTRLTAAEVLAHSWMEEC  303 (419)
Q Consensus       278 ~~~L~~dP~~Rps~~eil~hp~~~~~  303 (419)
                      .+||+.+|.+||++.++++||||.+.
T Consensus       234 ~~~l~~~p~~Rp~~~~~l~~~~~~~~  259 (277)
T cd06641         234 EACLNKEPSFRPTAKELLKHKFIVRF  259 (277)
T ss_pred             HHHccCChhhCcCHHHHHhCHHHhhh
Confidence            99999999999999999999999864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.6e-41  Score=322.07  Aligned_cols=251  Identities=27%  Similarity=0.521  Sum_probs=212.2

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      ++|++.+.||+|++|.||+|.++.++..+++|.+.............+.+|+.+++.+. ||||+++++++.+.+..+++
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIEDNELNIV   80 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHcc-CCchhhhhheeEeCCeEEEE
Confidence            57899999999999999999999999999999887655445556678899999999995 99999999999999999999


Q ss_pred             EeecCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeec
Q 014733          120 MELCAGGELFHRLEK----YGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIK  195 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~----~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~  195 (419)
                      |||+++++|.+++..    ...+++..++.++.||+.||.|||+.|++|+||||+||++   +.++.++|+|||++....
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~  157 (267)
T cd08229          81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEECcchhhhccc
Confidence            999999999998864    2458999999999999999999999999999999999999   456789999999987654


Q ss_pred             cCCc-cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhcCCCCCCCCCCCCCH
Q 014733          196 AGQN-LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTK--SKIFDAVRAADLRFPSDPWDHISA  271 (419)
Q Consensus       196 ~~~~-~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~s~  271 (419)
                      .... .....|+..|+|||++.+. ++.++|+||||+++|+|++|..||.+...  .+....+...  ..+...+..++.
T Consensus       158 ~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~  235 (267)
T cd08229         158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC--DYPPLPSDHYSE  235 (267)
T ss_pred             cCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcC--CCCCCCcccccH
Confidence            3322 2345788999999998764 88999999999999999999999976543  2333333332  233334456889


Q ss_pred             HHHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          272 SARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       272 ~l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                      +++++|.+||..||++|||+.+|++
T Consensus       236 ~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         236 ELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             HHHHHHHHhcCCCcccCCCHHHHHH
Confidence            9999999999999999999998865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.5e-41  Score=335.49  Aligned_cols=262  Identities=29%  Similarity=0.478  Sum_probs=212.3

Q ss_pred             ccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeC---
Q 014733           37 NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEE---  113 (419)
Q Consensus        37 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~---  113 (419)
                      .+.++|++.+.||.|+||.||+|.++.+|+.||+|.+.....   ...+.+.+|++++++++ ||||+++++++...   
T Consensus         2 ~~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~-h~~i~~~~~~~~~~~~~   77 (342)
T cd07854           2 DLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLD-HDNIVKVYEVLGPSGSD   77 (342)
T ss_pred             CcCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcC-CCcchhhHhhhcccccc
Confidence            457999999999999999999999999999999999876542   45577889999999995 99999999876543   


Q ss_pred             -----------CEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCC
Q 014733          114 -----------DYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSP  182 (419)
Q Consensus       114 -----------~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~  182 (419)
                                 ...|+||||++ ++|.+++.. +++++..++.++.||++||.|||+.||+||||||+||+++.  .++.
T Consensus        78 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~--~~~~  153 (342)
T cd07854          78 LTEDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINT--EDLV  153 (342)
T ss_pred             cccccccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcC--CCce
Confidence                       46899999996 588887764 57999999999999999999999999999999999999953  3457


Q ss_pred             eEEeeccceeeeccCCc----cccccCCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 014733          183 IKLADFGLATYIKAGQN----LHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRA  256 (419)
Q Consensus       183 vKL~DFgla~~~~~~~~----~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~  256 (419)
                      +||+|||++........    .....++..|+|||++.+  .++.++|+|||||++|+|++|+.||.+....+....+..
T Consensus       154 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~  233 (342)
T cd07854         154 LKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILE  233 (342)
T ss_pred             EEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            89999999976533211    122367889999998754  378999999999999999999999987765544443322


Q ss_pred             cCC----------------------CCCCC----CCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchhh
Q 014733          257 ADL----------------------RFPSD----PWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQV  306 (419)
Q Consensus       257 ~~~----------------------~~~~~----~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~~  306 (419)
                      ...                      ..+..    ....++.++.+||.+||+.||++|||+.+++.||||+....+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~  309 (342)
T cd07854         234 SVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCP  309 (342)
T ss_pred             hcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccCC
Confidence            110                      00000    123578899999999999999999999999999999876443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5.3e-41  Score=322.92  Aligned_cols=258  Identities=29%  Similarity=0.471  Sum_probs=211.0

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEe--CCEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEE--EDYVH  117 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~--~~~~~  117 (419)
                      ++|+..+.||.|++|.||+|.+..+++.+|+|.+....  .......+.+|+++++++. ||||+++++++.+  .+.+|
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~   77 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP--NPDLQKQILRELEINKSCK-SPYIVKYYGAFLDESSSSIG   77 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC--chHHHHHHHHHHHHHHhCC-CCCeeeeeeEEEccCCCeEE
Confidence            57999999999999999999999999999999987542  2345677899999999996 9999999999865  44789


Q ss_pred             EEEeecCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceee
Q 014733          118 LLMELCAGGELFHRLEK----YGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATY  193 (419)
Q Consensus       118 lV~E~~~ggsL~~~l~~----~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~  193 (419)
                      +||||+++++|.+++..    ...+++..+..++.||++||+|||+.+++|+||+|+||++   +.++.+||+|||++..
T Consensus        78 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~---~~~~~~~l~dfg~~~~  154 (287)
T cd06621          78 IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILL---TRKGQVKLCDFGVSGE  154 (287)
T ss_pred             EEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---ecCCeEEEeecccccc
Confidence            99999999999887653    3458999999999999999999999999999999999999   4567899999999875


Q ss_pred             eccCCccccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhcCCC-CCCCCC
Q 014733          194 IKAGQNLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGK-----TKSKIFDAVRAADLR-FPSDPW  266 (419)
Q Consensus       194 ~~~~~~~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~elltG~~Pf~~~-----~~~~~~~~i~~~~~~-~~~~~~  266 (419)
                      ..... .....++..|+|||.+.+ .++.++|+||||+++|+|++|..||...     ...+....+...... .+....
T Consensus       155 ~~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd06621         155 LVNSL-AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPG  233 (287)
T ss_pred             ccccc-cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCC
Confidence            43322 123467888999999876 4899999999999999999999999765     233444444432211 111111


Q ss_pred             --CCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccch
Q 014733          267 --DHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECE  304 (419)
Q Consensus       267 --~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~  304 (419)
                        ..+++.+.++|.+||+.||.+|||+.|+++||||+...
T Consensus       234 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~  273 (287)
T cd06621         234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM  273 (287)
T ss_pred             CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence              23568899999999999999999999999999996554

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=3.1e-41  Score=324.84  Aligned_cols=255  Identities=28%  Similarity=0.480  Sum_probs=203.7

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEE
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHL  118 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~l  118 (419)
                      .++|++.+.||+|+||.||+|.++.+|..+|+|.+..+..  ......+.+|+.+++.+. |+||+++++++.+.+..|+
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~l   80 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE--EGVPFTAIREASLLKGLK-HANIVLLHDIIHTKETLTF   80 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc--CCCcHHHHHHHHHHHhcC-CCCEeEEEEEEecCCeEEE
Confidence            4789999999999999999999999999999999875532  222345678999999996 9999999999999999999


Q ss_pred             EEeecCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccC
Q 014733          119 LMELCAGGELFHRLEK-YGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG  197 (419)
Q Consensus       119 V~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~  197 (419)
                      ||||+. ++|...+.. ...+++..+..++.|++.||.|||+.+|+|+||||+|||+   +.++.+||+|||++......
T Consensus        81 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~  156 (291)
T cd07870          81 VFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLI---SYLGELKLADFGLARAKSIP  156 (291)
T ss_pred             EEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE---cCCCcEEEeccccccccCCC
Confidence            999995 677766654 3558899999999999999999999999999999999999   56778999999998754322


Q ss_pred             -CccccccCCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhcCC--------------
Q 014733          198 -QNLHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTK-SKIFDAVRAADL--------------  259 (419)
Q Consensus       198 -~~~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~-~~~~~~i~~~~~--------------  259 (419)
                       .......+++.|+|||++.+  .++.++|+||||+++|+|++|..||.+... .+....+.....              
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (291)
T cd07870         157 SQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLP  236 (291)
T ss_pred             CCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcc
Confidence             22234467899999999865  378899999999999999999999975543 122222211000              


Q ss_pred             C-----C----CC---CCCC--CCCHHHHHHHHhhhhcCCCCCCCHHHHHhcccc
Q 014733          260 R-----F----PS---DPWD--HISASARDLIMGMLRVDPSTRLTAAEVLAHSWM  300 (419)
Q Consensus       260 ~-----~----~~---~~~~--~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~  300 (419)
                      .     .    +.   ..+.  ..+.++.+++.+||+.||++|||+.+++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence            0     0    00   0011  135789999999999999999999999999997

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=2.4e-41  Score=318.56  Aligned_cols=253  Identities=29%  Similarity=0.530  Sum_probs=214.8

Q ss_pred             CeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEE
Q 014733           41 RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLM  120 (419)
Q Consensus        41 ~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~  120 (419)
                      +|.+.+.||+|+||.||++.++.+|..+|+|.+..... .....+.+.+|+.++++++ |+||+++++.+.+.+.+++|+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~   78 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM-PVKEKEASKKEVILLAKMK-HPNIVTFFASFQENGRLFIVM   78 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc-cchhhHHHHHHHHHHHhCC-CCChhhhhheeccCCeEEEEE
Confidence            58999999999999999999999999999999976543 2244567889999999996 999999999999999999999


Q ss_pred             eecCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC
Q 014733          121 ELCAGGELFHRLEKYG--RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ  198 (419)
Q Consensus       121 E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~  198 (419)
                      ||+++++|.+++....  .+++..+..++.|+++||.|||+.+++|+||||+||+++.  .+..+||+|||.+.......
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~--~~~~~~l~d~~~~~~~~~~~  156 (257)
T cd08225          79 EYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSK--NGMVAKLGDFGIARQLNDSM  156 (257)
T ss_pred             ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcC--CCCeEEecccccchhccCCc
Confidence            9999999999987643  4799999999999999999999999999999999999943  22357999999988665433


Q ss_pred             cc-ccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHH
Q 014733          199 NL-HGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDL  276 (419)
Q Consensus       199 ~~-~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~l  276 (419)
                      .. ....|++.|+|||++.+ .++.++|+||||+++|+|++|..||...+..+....+.......   ....++.++.++
T Consensus       157 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~  233 (257)
T cd08225         157 ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAP---ISPNFSRDLRSL  233 (257)
T ss_pred             ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCC---CCCCCCHHHHHH
Confidence            22 22368889999998876 48999999999999999999999998777666665554433221   123678999999


Q ss_pred             HHhhhhcCCCCCCCHHHHHhcccc
Q 014733          277 IMGMLRVDPSTRLTAAEVLAHSWM  300 (419)
Q Consensus       277 i~~~L~~dP~~Rps~~eil~hp~~  300 (419)
                      |.+||+.+|++|||+.++++||||
T Consensus       234 i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         234 ISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             HHHHhccChhhCcCHHHHhhCCCC
Confidence            999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=3.3e-41  Score=322.47  Aligned_cols=253  Identities=26%  Similarity=0.393  Sum_probs=212.0

Q ss_pred             ccCeeeeeeecccCceEEEEEEecC-----CCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeC
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKF-----TGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEE  113 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~-----~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~  113 (419)
                      .++|.+.+.||+|++|.||+|.+..     ++..|++|.+...  ........+.+|+.+++++. |+||+++++++.+.
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~--~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~   81 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPES--CSEQDESDFLMEALIMSKFN-HQNIVRLIGVSFER   81 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCC--CCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEccC
Confidence            4789999999999999999999986     7788999987644  23444567889999999996 99999999999999


Q ss_pred             CEEEEEEeecCCCChHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEe
Q 014733          114 DYVHLLMELCAGGELFHRLEKYG-------RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLA  186 (419)
Q Consensus       114 ~~~~lV~E~~~ggsL~~~l~~~~-------~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~  186 (419)
                      +..++||||++|++|.+++...+       .+++..+..++.||+.||+|||+.+++||||||+||+++.++....+||+
T Consensus        82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence            99999999999999999997653       48899999999999999999999999999999999999765545579999


Q ss_pred             eccceeeeccCCcc---ccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCC
Q 014733          187 DFGLATYIKAGQNL---HGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRF  261 (419)
Q Consensus       187 DFgla~~~~~~~~~---~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~  261 (419)
                      |||++.........   .....+..|+|||++.+ .++.++|||||||++|+|++ |+.||.+....+....+..... .
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~-~  240 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGR-L  240 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc-C
Confidence            99999865322211   12233567999999876 49999999999999999997 9999998887777766554322 1


Q ss_pred             CCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          262 PSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       262 ~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                        .....++..+.+++.+||+.||++|||+.++++|
T Consensus       241 --~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         241 --DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             --CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence              1224688999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=8.4e-41  Score=313.57  Aligned_cols=253  Identities=34%  Similarity=0.599  Sum_probs=217.3

Q ss_pred             CeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeC--CEEEE
Q 014733           41 RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEE--DYVHL  118 (419)
Q Consensus        41 ~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~--~~~~l  118 (419)
                      +|++.+.||+|++|.||+|.+..+++.+++|++..... .....+.+.+|+.+++++. ||||+++++.+.+.  +.+++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~l   78 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGD-SEEELEALEREIRILSSLQ-HPNIVRYYGSERDEEKNTLNI   78 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHHcC-CCCEeeEEEEEecCCCCeEEE
Confidence            58899999999999999999998999999999876543 2456788999999999996 99999999999988  89999


Q ss_pred             EEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC
Q 014733          119 LMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ  198 (419)
Q Consensus       119 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~  198 (419)
                      ++||+++++|.+++.....+++..++.++.|++.+|.|||+.+++|+||+|+||++   ..++.+||+|||.+.......
T Consensus        79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~  155 (260)
T cd06606          79 FLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILV---DSDGVVKLADFGCAKRLGDIE  155 (260)
T ss_pred             EEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---cCCCCEEEcccccEEeccccc
Confidence            99999999999999887789999999999999999999999999999999999999   457889999999998876554


Q ss_pred             c---cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 014733          199 N---LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKT-KSKIFDAVRAADLRFPSDPWDHISASA  273 (419)
Q Consensus       199 ~---~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~l  273 (419)
                      .   .....++..|+|||.+.+. ++.++|+||||+++|+|++|..||.... .......+..  ..........++..+
T Consensus       156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l  233 (260)
T cd06606         156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGS--SGEPPEIPEHLSEEA  233 (260)
T ss_pred             ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccc--cCCCcCCCcccCHHH
Confidence            3   3445788999999998765 8999999999999999999999997765 2222222221  111122234678999


Q ss_pred             HHHHHhhhhcCCCCCCCHHHHHhcccc
Q 014733          274 RDLIMGMLRVDPSTRLTAAEVLAHSWM  300 (419)
Q Consensus       274 ~~li~~~L~~dP~~Rps~~eil~hp~~  300 (419)
                      .++|.+||+.||++||++.+++.||||
T Consensus       234 ~~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         234 KDFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             HHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence            999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.2e-41  Score=333.71  Aligned_cols=261  Identities=31%  Similarity=0.484  Sum_probs=220.5

Q ss_pred             CeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCC-----E
Q 014733           41 RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEED-----Y  115 (419)
Q Consensus        41 ~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~-----~  115 (419)
                      +|++.+.||.|++|.||+|.+..+++.+|+|.+.... ......+.+.+|+.+++.+. ||||+++++++.+..     .
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~~   78 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLR-HENIIGLLDILRPPSPEDFND   78 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcC-CcchhhhhhhhcccCcccccc
Confidence            6999999999999999999999899999999987542 22345677899999999996 999999999998775     7


Q ss_pred             EEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeec
Q 014733          116 VHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIK  195 (419)
Q Consensus       116 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~  195 (419)
                      +|++|||++ ++|.+++....++++..++.++.||+.||+|||+.||+|+||||+|||+   +.++.++|+|||++....
T Consensus        79 ~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili---~~~~~~~L~dfg~~~~~~  154 (330)
T cd07834          79 VYIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILV---NSNCDLKICDFGLARGVD  154 (330)
T ss_pred             eEEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEcccCceEeec
Confidence            899999996 5899999877789999999999999999999999999999999999999   556899999999998765


Q ss_pred             cCC----ccccccCCCccCCcccccCC--CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC-----
Q 014733          196 AGQ----NLHGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSD-----  264 (419)
Q Consensus       196 ~~~----~~~~~~gt~~y~aPE~l~~~--~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~-----  264 (419)
                      ...    ......+++.|+|||++.+.  ++.++|+||||+++|+|++|++||.+.+..+....+.......+..     
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  234 (330)
T cd07834         155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI  234 (330)
T ss_pred             ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence            543    23345688999999998763  7899999999999999999999998887766666554432111110     


Q ss_pred             ----------------------CCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchhhh
Q 014733          265 ----------------------PWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVA  307 (419)
Q Consensus       265 ----------------------~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~~~  307 (419)
                                            ....++.++.++|.+||++||++|||+.+++.||||++.....
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~  299 (330)
T cd07834         235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPE  299 (330)
T ss_pred             cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccc
Confidence                                  0124688999999999999999999999999999998866543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=3.1e-41  Score=326.22  Aligned_cols=250  Identities=24%  Similarity=0.358  Sum_probs=207.7

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCc--EEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGE--VLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVH  117 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~--~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~  117 (419)
                      ++|++.+.||.|+||.||+|.++.++.  .+++|.+...  ......+.+.+|+.++.++.+||||+++++++.+.+.++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~   79 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY   79 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence            689999999999999999999887765  4678776532  344556778999999999966999999999999999999


Q ss_pred             EEEeecCCCChHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCC
Q 014733          118 LLMELCAGGELFHRLEKYG----------------RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSS  181 (419)
Q Consensus       118 lV~E~~~ggsL~~~l~~~~----------------~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~  181 (419)
                      ++|||+++++|.+++....                .+++..++.++.|++.||+|||+.||+||||||+|||+   +.++
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~  156 (297)
T cd05089          80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLV---GENL  156 (297)
T ss_pred             EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEE---CCCC
Confidence            9999999999999996532                47889999999999999999999999999999999999   5567


Q ss_pred             CeEEeeccceeeeccCCccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCC
Q 014733          182 PIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADL  259 (419)
Q Consensus       182 ~vKL~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~  259 (419)
                      .+||+|||++..............+..|+|||++.+. ++.++|||||||++|+|++ |..||.+....+..+.+.... 
T Consensus       157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~-  235 (297)
T cd05089         157 ASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY-  235 (297)
T ss_pred             eEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC-
Confidence            8999999998643221111112234569999998764 8999999999999999997 999999888888777765432 


Q ss_pred             CCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          260 RFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       260 ~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      ..  .....++.++.+||.+||+.||.+|||+.++++.
T Consensus       236 ~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         236 RM--EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             CC--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            11  1223688999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-41  Score=324.66  Aligned_cols=253  Identities=30%  Similarity=0.482  Sum_probs=209.0

Q ss_pred             eeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEEe
Q 014733           42 YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLME  121 (419)
Q Consensus        42 y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  121 (419)
                      |++.+.||.|++|.||+|.++.+|..||+|++..+.. .......+.+|+.+++++. ||||+++++++.+.+..|++||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~-~~~iv~~~~~~~~~~~~~iv~e   78 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE-DEGVPSTAIREISLLKELN-HPNIVRLLDVVHSENKLYLVFE   78 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc-cccchhHHHHHHHHHHhcC-CCCccCHhheeccCCeEEEEEe
Confidence            6788999999999999999999999999999976532 2233456788999999996 9999999999999999999999


Q ss_pred             ecCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC-
Q 014733          122 LCAGGELFHRLEKYG--RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ-  198 (419)
Q Consensus       122 ~~~ggsL~~~l~~~~--~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~-  198 (419)
                      |++ ++|.+++....  .+++..+..++.|+++||+|||+.+++|+||+|+||++   +.++.+||+|||++....... 
T Consensus        79 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~---~~~~~~~l~df~~~~~~~~~~~  154 (283)
T cd07835          79 FLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLI---DREGALKLADFGLARAFGVPVR  154 (283)
T ss_pred             ccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEE---cCCCcEEEeecccccccCCCcc
Confidence            994 68999987765  68999999999999999999999999999999999999   457889999999987653322 


Q ss_pred             ccccccCCCccCCcccccCC--CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-----------------
Q 014733          199 NLHGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADL-----------------  259 (419)
Q Consensus       199 ~~~~~~gt~~y~aPE~l~~~--~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-----------------  259 (419)
                      ......++..|+|||++.+.  ++.++|+||||+++|+|++|++||...+..+....+.....                 
T Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07835         155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK  234 (283)
T ss_pred             ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence            22334568899999987653  78999999999999999999999987665443333222100                 


Q ss_pred             --------CCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhcccc
Q 014733          260 --------RFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWM  300 (419)
Q Consensus       260 --------~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~  300 (419)
                              .........++.++.++|.+||+.||.+|||+.++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence                    00111134678899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.3e-41  Score=317.32  Aligned_cols=254  Identities=30%  Similarity=0.521  Sum_probs=214.1

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCc--cCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeC--CE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDR--LVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEE--DY  115 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~--~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~--~~  115 (419)
                      .+|++.+.||+|++|.||+|.++.++..+|+|.+....  .........+.+|+.++++++ |+||+++++++.+.  +.
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~~~~   80 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR-HDRIVQYYGCLRDPEEKK   80 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcC-CCCcceEEEEEEcCCCCE
Confidence            47999999999999999999999999999999885432  123355678999999999996 99999999998764  56


Q ss_pred             EEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeec
Q 014733          116 VHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIK  195 (419)
Q Consensus       116 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~  195 (419)
                      +++++||+++++|.+++...+.+++..+..++.|++.||.|||+.+++|+||||+||++   +.++.++|+|||++....
T Consensus        81 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~~  157 (264)
T cd06653          81 LSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKRIQ  157 (264)
T ss_pred             EEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEECccccccccc
Confidence            89999999999999999887789999999999999999999999999999999999999   556789999999998653


Q ss_pred             cC----CccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCC
Q 014733          196 AG----QNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHIS  270 (419)
Q Consensus       196 ~~----~~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  270 (419)
                      ..    .......|+..|+|||++.+. ++.++|+|||||++|+|++|+.||......+...++.....  +...+..++
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~p~~~~  235 (264)
T cd06653         158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPT--KPMLPDGVS  235 (264)
T ss_pred             cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCC--CCCCCcccC
Confidence            21    112334688999999998764 88999999999999999999999987766555554433221  222345789


Q ss_pred             HHHHHHHHhhhhcCCCCCCCHHHHHhcccc
Q 014733          271 ASARDLIMGMLRVDPSTRLTAAEVLAHSWM  300 (419)
Q Consensus       271 ~~l~~li~~~L~~dP~~Rps~~eil~hp~~  300 (419)
                      +++.++|.+||+ +|.+||++.+++.|||+
T Consensus       236 ~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         236 DACRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             HHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence            999999999999 67999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.8e-41  Score=351.23  Aligned_cols=266  Identities=26%  Similarity=0.343  Sum_probs=198.6

Q ss_pred             hccccccCeeeeeeecccCceEEEEEEecCCC-cEEEEE--------------EeccCccCCHHhHHHHHHHHHHHHHcc
Q 014733           34 QISNLSDRYVLGKQLGWGQFGVIRECSDKFTG-EVLACK--------------SIAKDRLVTVEDVRSIKLEIEIMTKLS   98 (419)
Q Consensus        34 ~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g-~~vaiK--------------~i~~~~~~~~~~~~~~~~Ei~il~~l~   98 (419)
                      ....+.++|++++.||+|+||+||+|..+... ...+.|              .+.+...........+.+|+.+|+++.
T Consensus       142 ~~~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~  221 (501)
T PHA03210        142 HDDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLN  221 (501)
T ss_pred             cchhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCC
Confidence            34456789999999999999999998765322 222222              111111122334567889999999995


Q ss_pred             CCCCceeeeEEEEeCCEEEEEEeecCCCChHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEE
Q 014733           99 GHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKY-----GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENIL  173 (419)
Q Consensus        99 ~hpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~-----~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NIL  173 (419)
                       ||||+++++++.+.+..|++++++ +++|..++...     ......+++.++.||+.||+|||++|||||||||+|||
T Consensus       222 -HpnIv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NIL  299 (501)
T PHA03210        222 -HENILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIF  299 (501)
T ss_pred             -CCCcCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence             999999999999999999999998 56777766432     22446778889999999999999999999999999999


Q ss_pred             EeecCCCCCeEEeeccceeeeccCCc--cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCC-CCC--H
Q 014733          174 LATKSSSSPIKLADFGLATYIKAGQN--LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFW-GKT--K  247 (419)
Q Consensus       174 l~~~~~~~~vKL~DFgla~~~~~~~~--~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~-~~~--~  247 (419)
                      +   +.++.+||+|||++..+.....  ....+||..|+|||++.+. ++.++|||||||++|||++|..++. ...  .
T Consensus       300 l---~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~  376 (501)
T PHA03210        300 L---NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKP  376 (501)
T ss_pred             E---CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCH
Confidence            9   5678899999999987654332  2345799999999998774 9999999999999999999875443 221  1


Q ss_pred             -HHHHHHHHhcC---CCCCCC------------------------CCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccc
Q 014733          248 -SKIFDAVRAAD---LRFPSD------------------------PWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSW  299 (419)
Q Consensus       248 -~~~~~~i~~~~---~~~~~~------------------------~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~  299 (419)
                       ..+.+.+....   ..++..                        ....++.++.++|.+||++||.+|||+.|+|.|||
T Consensus       377 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~  456 (501)
T PHA03210        377 GKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPL  456 (501)
T ss_pred             HHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChh
Confidence             22222221110   001100                        01235677889999999999999999999999999


Q ss_pred             cccch
Q 014733          300 MEECE  304 (419)
Q Consensus       300 ~~~~~  304 (419)
                      |....
T Consensus       457 f~~~~  461 (501)
T PHA03210        457 FSAEE  461 (501)
T ss_pred             hhcCC
Confidence            97643

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=4e-41  Score=321.93  Aligned_cols=253  Identities=31%  Similarity=0.519  Sum_probs=211.5

Q ss_pred             eeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeC--CEEEEE
Q 014733           42 YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEE--DYVHLL  119 (419)
Q Consensus        42 y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~--~~~~lV  119 (419)
                      |++.+.||.|++|.||+|.+..+++.+|+|.+.... ........+.+|+.+++++. |||++++++++.+.  +..++|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~lv   78 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLR-HPNIVRLKEIVTSKGKGSIYMV   78 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhcc-CCCeeeheeeEecCCCCcEEEE
Confidence            788999999999999999999999999999998654 22344567888999999996 99999999999988  899999


Q ss_pred             EeecCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC
Q 014733          120 MELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ  198 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~  198 (419)
                      |||++ ++|..++... ..+++..++.++.||++||+|||+.|++|+||||+||++   ++++.+||+|||++.......
T Consensus        79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~---~~~~~~~l~d~g~~~~~~~~~  154 (287)
T cd07840          79 FEYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILI---NNDGVLKLADFGLARPYTKRN  154 (287)
T ss_pred             ecccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE---cCCCCEEEccccceeeccCCC
Confidence            99996 4888888765 569999999999999999999999999999999999999   567889999999998765443


Q ss_pred             --ccccccCCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCC---------
Q 014733          199 --NLHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDP---------  265 (419)
Q Consensus       199 --~~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~---------  265 (419)
                        ......++..|+|||.+.+  .++.++||||||+++|+|++|+.||...+..+....+...........         
T Consensus       155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07840         155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW  234 (287)
T ss_pred             cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchh
Confidence              2334467888999998765  378999999999999999999999988776665555543211111110         


Q ss_pred             -----------------CCC-CCHHHHHHHHhhhhcCCCCCCCHHHHHhcccc
Q 014733          266 -----------------WDH-ISASARDLIMGMLRVDPSTRLTAAEVLAHSWM  300 (419)
Q Consensus       266 -----------------~~~-~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~  300 (419)
                                       ... ++.++.++|.+||+.||.+||++.++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence                             012 38899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=5.5e-41  Score=322.94  Aligned_cols=257  Identities=23%  Similarity=0.343  Sum_probs=211.0

Q ss_pred             ccCeeeeeeecccCceEEEEEEecC-----CCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeC
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKF-----TGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEE  113 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~-----~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~  113 (419)
                      .++|++.+.||+|+||.||+|.++.     .+..||+|.+....  .......+.+|+.+++++. ||||+++++++.+.
T Consensus         5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~   81 (288)
T cd05061           5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFT-CHHVVRLLGVVSKG   81 (288)
T ss_pred             HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEcCC
Confidence            4799999999999999999997652     34589999876442  2334456788999999995 99999999999999


Q ss_pred             CEEEEEEeecCCCChHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCe
Q 014733          114 DYVHLLMELCAGGELFHRLEKYG----------RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPI  183 (419)
Q Consensus       114 ~~~~lV~E~~~ggsL~~~l~~~~----------~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~v  183 (419)
                      +..|+||||+++|+|.+++...+          .++...+..++.|++.||.|||+++|+||||||+||++   +.++.+
T Consensus        82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili---~~~~~~  158 (288)
T cd05061          82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMV---AHDFTV  158 (288)
T ss_pred             CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEE---cCCCcE
Confidence            99999999999999999997532          24677888999999999999999999999999999999   557789


Q ss_pred             EEeeccceeeeccCCcc---ccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcC
Q 014733          184 KLADFGLATYIKAGQNL---HGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAAD  258 (419)
Q Consensus       184 KL~DFgla~~~~~~~~~---~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~  258 (419)
                      ||+|||++.........   ....++..|+|||.+.+ .++.++|+|||||++|+|++ |..||.+....+....+....
T Consensus       159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~  238 (288)
T cd05061         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG  238 (288)
T ss_pred             EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence            99999998755332211   11245677999999876 48999999999999999998 799998888777777665443


Q ss_pred             CCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHh------ccccccch
Q 014733          259 LRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLA------HSWMEECE  304 (419)
Q Consensus       259 ~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~------hp~~~~~~  304 (419)
                      ....   ....+..+.+++.+||+.||++|||+.++++      ||||..+.
T Consensus       239 ~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~  287 (288)
T cd05061         239 YLDQ---PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVS  287 (288)
T ss_pred             CCCC---CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCC
Confidence            2211   2356899999999999999999999999987      88887653

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=4.8e-41  Score=321.21  Aligned_cols=251  Identities=22%  Similarity=0.346  Sum_probs=208.8

Q ss_pred             cccCeeeeeeecccCceEEEEEEec-----CCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEe
Q 014733           38 LSDRYVLGKQLGWGQFGVIRECSDK-----FTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEE  112 (419)
Q Consensus        38 ~~~~y~i~~~LG~G~~g~V~~a~~~-----~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~  112 (419)
                      ..++|++.+.||+|+||.||+|.++     .++..+|+|.+....  .......+.+|+.+++.+. ||||+++++++.+
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~   80 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFN-CHHVVRLLGVVSQ   80 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEcC
Confidence            5688999999999999999999864     245679999885432  2344567889999999996 9999999999999


Q ss_pred             CCEEEEEEeecCCCChHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCC
Q 014733          113 EDYVHLLMELCAGGELFHRLEKYG----------RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSP  182 (419)
Q Consensus       113 ~~~~~lV~E~~~ggsL~~~l~~~~----------~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~  182 (419)
                      .+..++||||+++++|.+++....          .+++..+..++.|+++||+|||+.+++|+||||+||++   +.++.
T Consensus        81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~---~~~~~  157 (277)
T cd05062          81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDFT  157 (277)
T ss_pred             CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEE---cCCCC
Confidence            999999999999999999986532          25678889999999999999999999999999999999   56778


Q ss_pred             eEEeeccceeeeccCCcc---ccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc
Q 014733          183 IKLADFGLATYIKAGQNL---HGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAA  257 (419)
Q Consensus       183 vKL~DFgla~~~~~~~~~---~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~  257 (419)
                      +||+|||++.........   ....++..|+|||++.+. ++.++|+|||||++|+|++ |..||.+....+....+...
T Consensus       158 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~  237 (277)
T cd05062         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEG  237 (277)
T ss_pred             EEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence            999999998755332211   122457789999998764 8999999999999999999 79999888887777766655


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          258 DLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       258 ~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      .....   ....+..+.+++.+||+.||++|||+.+++++
T Consensus       238 ~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         238 GLLDK---PDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             CcCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            43222   23678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=6.7e-41  Score=357.56  Aligned_cols=150  Identities=30%  Similarity=0.505  Sum_probs=139.6

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEE
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHL  118 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~l  118 (419)
                      -++|+++++||+|+||+||+|.+..+++.||+|++.+...........+..|+.+++.++ ||||+++++++...+.+|+
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~~~~~~l   81 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSK-SPFIVHLYYSLQSANNVYL   81 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcC-CCCcCeEEEEEEECCEEEE
Confidence            378999999999999999999999999999999998766666666788999999999996 9999999999999999999


Q ss_pred             EEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeecccee
Q 014733          119 LMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLAT  192 (419)
Q Consensus       119 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~  192 (419)
                      ||||+.|++|..++...+.+++..++.++.||+.||+|||+.+|+||||||+|||+   +.++.+||+|||+++
T Consensus        82 VmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl---~~~g~vkL~DFGls~  152 (669)
T cd05610          82 VMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLI---SNEGHIKLTDFGLSK  152 (669)
T ss_pred             EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEE---cCCCCEEEEeCCCCc
Confidence            99999999999999888889999999999999999999999999999999999999   456789999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=8.9e-41  Score=313.71  Aligned_cols=252  Identities=29%  Similarity=0.533  Sum_probs=220.0

Q ss_pred             CeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEE
Q 014733           41 RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLM  120 (419)
Q Consensus        41 ~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~  120 (419)
                      +|++.+.||+|++|.||++.+..++..+++|++..... .......+.+|+++++.++ |||++++.+.+.+....++|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~~~~~~~~~~~~~~~~lv~   78 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLN-HPNIIKYYESFEEKGKLCIVM   78 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcC-CCChhheEEEEecCCEEEEEE
Confidence            68999999999999999999999999999999976543 3456677899999999996 999999999999999999999


Q ss_pred             eecCCCChHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeecc
Q 014733          121 ELCAGGELFHRLEKY----GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA  196 (419)
Q Consensus       121 E~~~ggsL~~~l~~~----~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~  196 (419)
                      ||+++++|..++...    ..+++..+..++.+++.||.|||+.|++|+||+|+||++   +.++.++|+|||.+.....
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~---~~~~~~~l~d~~~~~~~~~  155 (258)
T cd08215          79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFL---TSNGLVKLGDFGISKVLSS  155 (258)
T ss_pred             EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEE---cCCCcEEECCccceeeccc
Confidence            999999999999764    669999999999999999999999999999999999999   4567899999999987654


Q ss_pred             CC-ccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 014733          197 GQ-NLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASAR  274 (419)
Q Consensus       197 ~~-~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~  274 (419)
                      .. ......|++.|+|||.+.+. ++.++|+||+|+++|+|++|..||......+....+.......   ....++.++.
T Consensus       156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  232 (258)
T cd08215         156 TVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPP---IPSQYSSELR  232 (258)
T ss_pred             CcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCC---CCCCCCHHHH
Confidence            43 22335788999999987664 8899999999999999999999998877777776665543222   2236889999


Q ss_pred             HHHHhhhhcCCCCCCCHHHHHhcccc
Q 014733          275 DLIMGMLRVDPSTRLTAAEVLAHSWM  300 (419)
Q Consensus       275 ~li~~~L~~dP~~Rps~~eil~hp~~  300 (419)
                      +++.+||..+|++|||+.++++||||
T Consensus       233 ~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         233 NLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             HHHHHHcCCChhhCcCHHHHhcCCCC
Confidence            99999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2e-41  Score=328.01  Aligned_cols=257  Identities=27%  Similarity=0.504  Sum_probs=217.6

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEE
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHL  118 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~l  118 (419)
                      ..-|.....||+|+||.||+|.+..+++.||+|.+.....   ...+.+.+|+.+++.+. ||||+++++++...+..++
T Consensus        20 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~~~~~~i   95 (297)
T cd06659          20 RSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQ-HQNVVEMYKSYLVGEELWV   95 (297)
T ss_pred             hhhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCC-CCchhhhhhheeeCCeEEE
Confidence            3445566789999999999999998999999999865432   33466889999999996 9999999999999999999


Q ss_pred             EEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC
Q 014733          119 LMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ  198 (419)
Q Consensus       119 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~  198 (419)
                      +|||+++++|..++.. ..+++..++.++.|++.||.|||+.+++||||||+||++   +.++.+||+|||++.......
T Consensus        96 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill---~~~~~~kL~dfg~~~~~~~~~  171 (297)
T cd06659          96 LMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILL---TLDGRVKLSDFGFCAQISKDV  171 (297)
T ss_pred             EEecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEE---ccCCcEEEeechhHhhccccc
Confidence            9999999999987755 678999999999999999999999999999999999999   567789999999987554322


Q ss_pred             -ccccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHH
Q 014733          199 -NLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDL  276 (419)
Q Consensus       199 -~~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~l  276 (419)
                       ......|+..|+|||++.+ .++.++|+|||||++|+|++|+.||......+....+...... ....+..++..+.++
T Consensus       172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~~  250 (297)
T cd06659         172 PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPP-KLKNAHKISPVLRDF  250 (297)
T ss_pred             ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCC-CccccCCCCHHHHHH
Confidence             2234578999999999876 4899999999999999999999999877766666655443222 222344688999999


Q ss_pred             HHhhhhcCCCCCCCHHHHHhccccccch
Q 014733          277 IMGMLRVDPSTRLTAAEVLAHSWMEECE  304 (419)
Q Consensus       277 i~~~L~~dP~~Rps~~eil~hp~~~~~~  304 (419)
                      |.+||+.+|++||++.++++||||.+..
T Consensus       251 i~~~l~~~P~~Rps~~~ll~~~~~~~~~  278 (297)
T cd06659         251 LERMLTREPQERATAQELLDHPFLLQTG  278 (297)
T ss_pred             HHHHhcCCcccCcCHHHHhhChhhccCC
Confidence            9999999999999999999999998654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1e-40  Score=311.78  Aligned_cols=251  Identities=31%  Similarity=0.543  Sum_probs=215.2

Q ss_pred             CeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEE
Q 014733           41 RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLM  120 (419)
Q Consensus        41 ~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~  120 (419)
                      +|.+.+.||+|++|.||++.+..+++.+++|++.....   .....+.+|+.+++++. |+||+++++++...+..++++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~l~~   76 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCK-HPNIVKYYGSYLKKDELWIVM   76 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCC-CCCEeEEEEEEecCCeEEEEE
Confidence            58899999999999999999998999999999976532   46678999999999996 999999999999999999999


Q ss_pred             eecCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCCc
Q 014733          121 ELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN  199 (419)
Q Consensus       121 E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~~  199 (419)
                      ||+++++|.+++... ..+++..+..++.|+++||.+||+.|++|+||+|+||++   +.++.+||+|||.+........
T Consensus        77 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~  153 (253)
T cd05122          77 EFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILL---TSDGEVKLIDFGLSAQLSDTKA  153 (253)
T ss_pred             ecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEE---ccCCeEEEeecccccccccccc
Confidence            999999999999876 579999999999999999999999999999999999999   4577899999999987655443


Q ss_pred             cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHH
Q 014733          200 LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM  278 (419)
Q Consensus       200 ~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~  278 (419)
                      .....++..|+|||.+.+. ++.++|+||||+++|+|++|+.||...+.......+....... ......++.++.++|.
T Consensus       154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~  232 (253)
T cd05122         154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPG-LRNPEKWSDEFKDFLK  232 (253)
T ss_pred             ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCC-cCcccccCHHHHHHHH
Confidence            3455788999999998764 7899999999999999999999998775544444443322211 1111234899999999


Q ss_pred             hhhhcCCCCCCCHHHHHhccc
Q 014733          279 GMLRVDPSTRLTAAEVLAHSW  299 (419)
Q Consensus       279 ~~L~~dP~~Rps~~eil~hp~  299 (419)
                      +||+.||++|||+.++++|||
T Consensus       233 ~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         233 KCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             HHccCChhhCCCHHHHhcCCC
Confidence            999999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=8.7e-41  Score=317.67  Aligned_cols=252  Identities=27%  Similarity=0.447  Sum_probs=205.9

Q ss_pred             eeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEEe
Q 014733           42 YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLME  121 (419)
Q Consensus        42 y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  121 (419)
                      ......||+|+||.||+|.+..++..|++|.+...   .....+.+.+|+.++++++ |+||+++++++.+.+.+++++|
T Consensus        10 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e   85 (268)
T cd06624          10 NGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER---DSRYVQPLHEEIALHSYLK-HRNIVQYLGSDSENGFFKIFME   85 (268)
T ss_pred             CCceEEEecCCceEEEEeEecCCCcEEEEEEecCC---CHHHHHHHHHHHHHHHhcC-CCCeeeeeeeeccCCEEEEEEe
Confidence            33446899999999999999989999999988754   2345678999999999996 9999999999999999999999


Q ss_pred             ecCCCChHHHHHHc-CCC--CHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC
Q 014733          122 LCAGGELFHRLEKY-GRF--SETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ  198 (419)
Q Consensus       122 ~~~ggsL~~~l~~~-~~l--~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~  198 (419)
                      |+++++|.+++... ..+  ++..+..++.||+.||+|||+.+|+||||||+||+++.  ..+.+||+|||++.......
T Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~--~~~~~~l~dfg~~~~~~~~~  163 (268)
T cd06624          86 QVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNT--YSGVVKISDFGTSKRLAGIN  163 (268)
T ss_pred             cCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcC--CCCeEEEecchhheecccCC
Confidence            99999999999764 445  88889999999999999999999999999999999953  25689999999987654322


Q ss_pred             c-cccccCCCccCCcccccC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 014733          199 N-LHGTVGSPFYIAPEVLAG---GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASAR  274 (419)
Q Consensus       199 ~-~~~~~gt~~y~aPE~l~~---~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~  274 (419)
                      . .....|++.|+|||++.+   .++.++|+||+|+++|+|++|+.||............ .............+++++.
T Consensus       164 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  242 (268)
T cd06624         164 PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFK-VGMFKIHPEIPESLSAEAK  242 (268)
T ss_pred             CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhh-hhhhccCCCCCcccCHHHH
Confidence            2 223468889999999854   2789999999999999999999999754332211111 1111111222346889999


Q ss_pred             HHHHhhhhcCCCCCCCHHHHHhcccc
Q 014733          275 DLIMGMLRVDPSTRLTAAEVLAHSWM  300 (419)
Q Consensus       275 ~li~~~L~~dP~~Rps~~eil~hp~~  300 (419)
                      +++.+||+.+|.+|||+.+++.||||
T Consensus       243 ~li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         243 NFILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             HHHHHHcCCCchhCCCHHHHHhCCCC
Confidence            99999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=3.7e-41  Score=324.07  Aligned_cols=258  Identities=29%  Similarity=0.515  Sum_probs=215.0

Q ss_pred             CeeeeeeecccCceEEEEEEec---CCCcEEEEEEeccCccC-CHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEE
Q 014733           41 RYVLGKQLGWGQFGVIRECSDK---FTGEVLACKSIAKDRLV-TVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYV  116 (419)
Q Consensus        41 ~y~i~~~LG~G~~g~V~~a~~~---~~g~~vaiK~i~~~~~~-~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~  116 (419)
                      .|++.+.||.|+||.||+|.+.   .+|..||+|++...... .....+.+.+|+.+++++.+|+||+++++++..++.+
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            4889999999999999999875   47899999998754322 1234567888999999997799999999999999999


Q ss_pred             EEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeecc
Q 014733          117 HLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA  196 (419)
Q Consensus       117 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~  196 (419)
                      |+||||+++++|.+++....++++..+..++.|+++||.|||+.|++||||+|+|||+   +.++.+||+|||++.....
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~  157 (290)
T cd05613          81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFHE  157 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE---CCCCCEEEeeCccceeccc
Confidence            9999999999999999888889999999999999999999999999999999999999   5577999999999986544


Q ss_pred             CC--ccccccCCCccCCcccccC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhcCCCCCCCCCC
Q 014733          197 GQ--NLHGTVGSPFYIAPEVLAG---GYNQAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAVRAADLRFPSDPWD  267 (419)
Q Consensus       197 ~~--~~~~~~gt~~y~aPE~l~~---~~s~~sDvwSlGvil~elltG~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~~  267 (419)
                      ..  ......|+..|+|||.+.+   .++.++|+||||+++|+|++|..||.....    .++...+......+    ..
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~  233 (290)
T cd05613         158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY----PQ  233 (290)
T ss_pred             ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCC----Cc
Confidence            32  2234568999999999864   368899999999999999999999964322    23333333332222    23


Q ss_pred             CCCHHHHHHHHhhhhcCCCCCC-----CHHHHHhccccccchh
Q 014733          268 HISASARDLIMGMLRVDPSTRL-----TAAEVLAHSWMEECEQ  305 (419)
Q Consensus       268 ~~s~~l~~li~~~L~~dP~~Rp-----s~~eil~hp~~~~~~~  305 (419)
                      .++..+.+++.+||+.||++|+     ++++++.||||+...+
T Consensus       234 ~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~  276 (290)
T cd05613         234 EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINW  276 (290)
T ss_pred             cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCH
Confidence            5889999999999999999997     8999999999987653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=3.9e-41  Score=331.08  Aligned_cols=263  Identities=30%  Similarity=0.506  Sum_probs=215.2

Q ss_pred             ccccCeee-eeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHH-----------hHHHHHHHHHHHHHccCCCCce
Q 014733           37 NLSDRYVL-GKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVE-----------DVRSIKLEIEIMTKLSGHPNVV  104 (419)
Q Consensus        37 ~~~~~y~i-~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~-----------~~~~~~~Ei~il~~l~~hpnIv  104 (419)
                      .+.++|.. .+.||.|+||+||+|.++.+++.||+|++.........           ....+.+|+++++++. ||||+
T Consensus         5 ~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv   83 (335)
T PTZ00024          5 SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIK-HENIM   83 (335)
T ss_pred             ccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCC-Cccee
Confidence            46788875 57799999999999999999999999998754322100           0124778999999996 99999


Q ss_pred             eeeEEEEeCCEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeE
Q 014733          105 DLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIK  184 (419)
Q Consensus       105 ~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vK  184 (419)
                      ++++++...+..+++|||+. ++|.+++.....+++..+..++.|++.||+|||+.||+|+||+|+||++   +.++.+|
T Consensus        84 ~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill---~~~~~~k  159 (335)
T PTZ00024         84 GLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFI---NSKGICK  159 (335)
T ss_pred             eeeEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEE---CCCCCEE
Confidence            99999999999999999996 6999999887789999999999999999999999999999999999999   5677899


Q ss_pred             Eeeccceeeecc---------------CCccccccCCCccCCcccccCC--CCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q 014733          185 LADFGLATYIKA---------------GQNLHGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTK  247 (419)
Q Consensus       185 L~DFgla~~~~~---------------~~~~~~~~gt~~y~aPE~l~~~--~s~~sDvwSlGvil~elltG~~Pf~~~~~  247 (419)
                      |+|||++.....               ........+++.|+|||++.+.  ++.++|+|||||++|+|++|.+||.+.+.
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~  239 (335)
T PTZ00024        160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE  239 (335)
T ss_pred             ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            999999876541               1112233578889999998763  78999999999999999999999988877


Q ss_pred             HHHHHHHHhcCCCCCCC------------------------CCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccc
Q 014733          248 SKIFDAVRAADLRFPSD------------------------PWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEEC  303 (419)
Q Consensus       248 ~~~~~~i~~~~~~~~~~------------------------~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~  303 (419)
                      .+....+..........                        .....+.++.++|.+||+.||++|||+++++.||||+..
T Consensus       240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~  319 (335)
T PTZ00024        240 IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSD  319 (335)
T ss_pred             HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCC
Confidence            66655543311110000                        012457889999999999999999999999999999865


Q ss_pred             h
Q 014733          304 E  304 (419)
Q Consensus       304 ~  304 (419)
                      .
T Consensus       320 ~  320 (335)
T PTZ00024        320 P  320 (335)
T ss_pred             C
Confidence            3

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=7.4e-41  Score=322.03  Aligned_cols=248  Identities=22%  Similarity=0.383  Sum_probs=210.7

Q ss_pred             ccCeeeeeeecccCceEEEEEEec-----CCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeC
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDK-----FTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEE  113 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~-----~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~  113 (419)
                      .+.|.+.+.||+|+||+||++.+.     .++..+|+|.+...   .......+.+|+.+++++. ||||+++++++...
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~   79 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQ-HEHIVKFYGVCVEG   79 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc---CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEecC
Confidence            468999999999999999999852     35567999988653   3455678999999999996 99999999999999


Q ss_pred             CEEEEEEeecCCCChHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCC
Q 014733          114 DYVHLLMELCAGGELFHRLEKYG-------------RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSS  180 (419)
Q Consensus       114 ~~~~lV~E~~~ggsL~~~l~~~~-------------~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~  180 (419)
                      +.+++||||+++++|.+++...+             .+++..+..++.|++.||+|||+.|++||||||+|||+   +.+
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili---~~~  156 (288)
T cd05093          80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV---GEN  156 (288)
T ss_pred             CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE---ccC
Confidence            99999999999999999987543             38999999999999999999999999999999999999   567


Q ss_pred             CCeEEeeccceeeeccCCc---cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 014733          181 SPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVR  255 (419)
Q Consensus       181 ~~vKL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~  255 (419)
                      +.+||+|||++........   .....++..|+|||++.+. ++.++|+|||||++|+|++ |.+||......+....+.
T Consensus       157 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~  236 (288)
T cd05093         157 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT  236 (288)
T ss_pred             CcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            7899999999986533221   1223457789999998764 8999999999999999998 999998888888888877


Q ss_pred             hcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          256 AADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       256 ~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                      .......   ...++.++.+++.+||+.||.+|||+.+++.
T Consensus       237 ~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         237 QGRVLQR---PRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             cCCcCCC---CCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            6543322   2357899999999999999999999999965

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=6.1e-41  Score=321.95  Aligned_cols=262  Identities=29%  Similarity=0.500  Sum_probs=223.6

Q ss_pred             hhccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEe
Q 014733           33 TQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEE  112 (419)
Q Consensus        33 ~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~  112 (419)
                      -+.....+.|++.+.||.|++|.||+|.+..++..+++|++.....    ....+.+|+++++++. |+||+++++++..
T Consensus        12 ~~~~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~   86 (286)
T cd06614          12 VSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCK-HPNIVDYYDSYLV   86 (286)
T ss_pred             cCCCCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCC-CCCeeEEEEEEEE
Confidence            3345678889999999999999999999998899999999975432    4677889999999996 9999999999999


Q ss_pred             CCEEEEEEeecCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccce
Q 014733          113 EDYVHLLMELCAGGELFHRLEKYG-RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA  191 (419)
Q Consensus       113 ~~~~~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla  191 (419)
                      .+..|+++||+++++|.+++.... .+++.++..++.|++.||.|||+.||+|+||+|+||++   +.++.+||+|||++
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i---~~~~~~~l~d~~~~  163 (286)
T cd06614          87 GDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILL---SKDGSVKLADFGFA  163 (286)
T ss_pred             CCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEE---cCCCCEEECccchh
Confidence            999999999999999999998876 79999999999999999999999999999999999999   56778999999988


Q ss_pred             eeeccCC-ccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCC
Q 014733          192 TYIKAGQ-NLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHI  269 (419)
Q Consensus       192 ~~~~~~~-~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  269 (419)
                      ....... ......++..|++||++.+. ++.++|+||||+++|+|++|+.||...........+...... +......+
T Consensus       164 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~  242 (286)
T cd06614         164 AQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIP-PLKNPEKW  242 (286)
T ss_pred             hhhccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-CCcchhhC
Confidence            7554322 12334578899999998764 899999999999999999999999877766555555443322 11222348


Q ss_pred             CHHHHHHHHhhhhcCCCCCCCHHHHHhccccccc
Q 014733          270 SASARDLIMGMLRVDPSTRLTAAEVLAHSWMEEC  303 (419)
Q Consensus       270 s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~  303 (419)
                      +.+++++|.+||+.+|.+|||+.++++|+||+..
T Consensus       243 ~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~  276 (286)
T cd06614         243 SPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA  276 (286)
T ss_pred             CHHHHHHHHHHhccChhhCcCHHHHhhChHhhcc
Confidence            8999999999999999999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-40  Score=311.60  Aligned_cols=252  Identities=33%  Similarity=0.596  Sum_probs=218.3

Q ss_pred             CeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEE
Q 014733           41 RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLM  120 (419)
Q Consensus        41 ~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~  120 (419)
                      +|++.+.||.|++|.||++.+..+++.+++|.+..... .......+.+|+++++++. |||++++++++.+.+..+++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~   78 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI-KEEALKSIMQEIDLLKNLK-HPNIVKYIGSIETSDSLYIIL   78 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEeccccc-CHHHHHHHHHHHHHHHhCC-CCCccEEEEEEEeCCEEEEEE
Confidence            58999999999999999999998999999999987653 3356788999999999996 999999999999999999999


Q ss_pred             eecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCCc-
Q 014733          121 ELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN-  199 (419)
Q Consensus       121 E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~~-  199 (419)
                      ||+++++|.+++...+.+++..++.++.|++.+|.+||+.||+||||||+||++   +.++.+||+|||.+........ 
T Consensus        79 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~~  155 (254)
T cd06627          79 EYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILT---TKDGVVKLADFGVATKLNDVSKD  155 (254)
T ss_pred             ecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEE---CCCCCEEEeccccceecCCCccc
Confidence            999999999999888889999999999999999999999999999999999999   4567899999999987654432 


Q ss_pred             cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHH
Q 014733          200 LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM  278 (419)
Q Consensus       200 ~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~  278 (419)
                      .....++..|+|||.+.+. ++.++|+||+|+++|+|++|+.||..........++.....   ......++..+.+++.
T Consensus       156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~i~  232 (254)
T cd06627         156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDH---PPLPEGISPELKDFLM  232 (254)
T ss_pred             ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCC---CCCCCCCCHHHHHHHH
Confidence            2345688899999998664 78999999999999999999999987665444433332221   1223468899999999


Q ss_pred             hhhhcCCCCCCCHHHHHhcccc
Q 014733          279 GMLRVDPSTRLTAAEVLAHSWM  300 (419)
Q Consensus       279 ~~L~~dP~~Rps~~eil~hp~~  300 (419)
                      +||..+|++|||+.+++.||||
T Consensus       233 ~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         233 QCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             HHHhCChhhCcCHHHHhcCCCC
Confidence            9999999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-41  Score=328.43  Aligned_cols=258  Identities=29%  Similarity=0.481  Sum_probs=204.5

Q ss_pred             CeeeeeeecccCceEEEEEEecC--CCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeC--CEE
Q 014733           41 RYVLGKQLGWGQFGVIRECSDKF--TGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEE--DYV  116 (419)
Q Consensus        41 ~y~i~~~LG~G~~g~V~~a~~~~--~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~--~~~  116 (419)
                      +|++.+.||+|++|.||+|.++.  ++..||+|.+.............+.+|+.+++++. ||||+++++++.+.  ..+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~   79 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK-HENVVSLVEVFLEHADKSV   79 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcC-CCCccceEEEEeCCCCceE
Confidence            58999999999999999999988  89999999998744222334466788999999996 99999999999988  889


Q ss_pred             EEEEeecCCCChHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecC-CCCCeEEeeccc
Q 014733          117 HLLMELCAGGELFHRLEKY-----GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKS-SSSPIKLADFGL  190 (419)
Q Consensus       117 ~lV~E~~~ggsL~~~l~~~-----~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~-~~~~vKL~DFgl  190 (419)
                      ++||||++ ++|...+...     ..+++..++.++.|++.||.|||+.+|+||||||+||+++.++ .++.+||+|||+
T Consensus        80 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~  158 (316)
T cd07842          80 YLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGL  158 (316)
T ss_pred             EEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCcc
Confidence            99999996 4677666432     2589999999999999999999999999999999999995411 268899999999


Q ss_pred             eeeeccCCc----cccccCCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH---------HHHHHH
Q 014733          191 ATYIKAGQN----LHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSK---------IFDAVR  255 (419)
Q Consensus       191 a~~~~~~~~----~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~---------~~~~i~  255 (419)
                      +........    .....++..|+|||++.+  .++.++|+||||+++|+|++|++||.+.....         ....+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
T cd07842         159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF  238 (316)
T ss_pred             ccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHH
Confidence            886543221    233467889999998765  37899999999999999999999997554321         111110


Q ss_pred             h--------------------------cCCCCCC-------CCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhcccc
Q 014733          256 A--------------------------ADLRFPS-------DPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWM  300 (419)
Q Consensus       256 ~--------------------------~~~~~~~-------~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~  300 (419)
                      .                          ....++.       ..+...+.++.++|.+||+.||++|||+.++++||||
T Consensus       239 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         239 EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence            0                          0000110       0011567889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=6e-41  Score=358.71  Aligned_cols=253  Identities=28%  Similarity=0.396  Sum_probs=207.8

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      ++|+++++||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++++. ||||+++++++.+.+..|++
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~-HPNIVkl~~v~~d~~~lyLV   80 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI-HPGIVPVYSICSDGDPVYYT   80 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCC-CcCcCeEEEEEeeCCEEEEE
Confidence            68999999999999999999999999999999997654444455677999999999996 99999999999999999999


Q ss_pred             EeecCCCChHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeec
Q 014733          120 MELCAGGELFHRLEKY-----------GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADF  188 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~~-----------~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DF  188 (419)
                      |||++|++|.+++...           ..++...+..++.||++||+|||+.||+||||||+|||+   +.++.+||+||
T Consensus        81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILL---d~dg~vKLiDF  157 (932)
T PRK13184         81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILL---GLFGEVVILDW  157 (932)
T ss_pred             EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEE---cCCCCEEEEec
Confidence            9999999999988642           235567788999999999999999999999999999999   56778999999


Q ss_pred             cceeeeccCC-------------------ccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q 014733          189 GLATYIKAGQ-------------------NLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKS  248 (419)
Q Consensus       189 gla~~~~~~~-------------------~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~  248 (419)
                      |++.......                   .....+||+.|+|||++.+. ++.++|||||||++|+|++|+.||......
T Consensus       158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~  237 (932)
T PRK13184        158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR  237 (932)
T ss_pred             CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence            9998652110                   01124699999999998774 899999999999999999999999875544


Q ss_pred             HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          249 KIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       249 ~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      +........ ......++..+++.+.+++.+||+.||++|++..+.+.+
T Consensus       238 ki~~~~~i~-~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~  285 (932)
T PRK13184        238 KISYRDVIL-SPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ  285 (932)
T ss_pred             hhhhhhhcc-ChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            433221111 111112334789999999999999999999877666654

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.3e-41  Score=331.16  Aligned_cols=263  Identities=29%  Similarity=0.469  Sum_probs=216.5

Q ss_pred             ccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCC
Q 014733           35 ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEED  114 (419)
Q Consensus        35 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~  114 (419)
                      +-.+.++|++.+.||.|+||.||+|.+..+|..||+|++.+.. ........+.+|+.+|+++. ||||+++++++....
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~   87 (343)
T cd07880          10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMK-HENVIGLLDVFTPDL   87 (343)
T ss_pred             hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcC-CCCccceeeeecCCc
Confidence            4457899999999999999999999999999999999986532 23344567889999999996 999999999987653


Q ss_pred             ------EEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeec
Q 014733          115 ------YVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADF  188 (419)
Q Consensus       115 ------~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DF  188 (419)
                            .+++||||+ |++|..++.. ..+++..++.++.|+++||+|||+.||+||||||+||++   +.++.+||+||
T Consensus        88 ~~~~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill---~~~~~~kl~df  162 (343)
T cd07880          88 SLDRFHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAV---NEDCELKILDF  162 (343)
T ss_pred             cccccceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeec
Confidence                  468999999 7788887764 679999999999999999999999999999999999999   55778999999


Q ss_pred             cceeeeccCCccccccCCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC----
Q 014733          189 GLATYIKAGQNLHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFP----  262 (419)
Q Consensus       189 gla~~~~~~~~~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~----  262 (419)
                      |++......  .....+++.|+|||++.+  .++.++|+||||+++|+|++|+.||.+.........+.......+    
T Consensus       163 g~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  240 (343)
T cd07880         163 GLARQTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFV  240 (343)
T ss_pred             ccccccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            999865332  234567889999999875  378999999999999999999999987765444443322111100    


Q ss_pred             -----------------------CCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchhh
Q 014733          263 -----------------------SDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQV  306 (419)
Q Consensus       263 -----------------------~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~~  306 (419)
                                             ...+..++.++.++|.+||+.||++|||+.+++.||||+.....
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~  307 (343)
T cd07880         241 QKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP  307 (343)
T ss_pred             HhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCc
Confidence                                   01124678899999999999999999999999999999877543

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=8.3e-41  Score=315.67  Aligned_cols=245  Identities=26%  Similarity=0.419  Sum_probs=207.5

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      ++|++.+.||+|+||.||++..+ .+..+|+|.+.....    ....+.+|+.+++++. ||||+++++++.+.+.+++|
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~iv   77 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAM----SEEDFIEEAKVMMKLS-HPKLVQLYGVCTQQKPLYIV   77 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCc----cHHHHHHHHHHHHHCC-CCCceeEEEEEccCCCEEEE
Confidence            56899999999999999999876 456799998764432    2456888999999996 99999999999999999999


Q ss_pred             EeecCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC
Q 014733          120 MELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ  198 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~  198 (419)
                      |||+++|+|.+++... +.+++..+..++.|++.||+|||++||+||||||+||++   +.++.+||+|||.+.......
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i---~~~~~~kl~d~g~~~~~~~~~  154 (256)
T cd05114          78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLV---SSTGVVKVSDFGMTRYVLDDE  154 (256)
T ss_pred             EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEE---cCCCeEEECCCCCccccCCCc
Confidence            9999999999998753 468999999999999999999999999999999999999   456789999999988654332


Q ss_pred             cc--ccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 014733          199 NL--HGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASAR  274 (419)
Q Consensus       199 ~~--~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~  274 (419)
                      ..  ....++..|+|||++.+ .++.++|+||||+++|+|++ |+.||...+..+....+........   ....+.++.
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~---~~~~~~~~~  231 (256)
T cd05114         155 YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYR---PKLASMTVY  231 (256)
T ss_pred             eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCC---CCCCCHHHH
Confidence            22  12245567999999876 48999999999999999999 9999998888888888776543222   235678999


Q ss_pred             HHHHhhhhcCCCCCCCHHHHHh
Q 014733          275 DLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       275 ~li~~~L~~dP~~Rps~~eil~  296 (419)
                      +++.+||+.||++||++.++++
T Consensus       232 ~li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         232 EVMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             HHHHHHccCCcccCcCHHHHHH
Confidence            9999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1e-40  Score=319.34  Aligned_cols=254  Identities=31%  Similarity=0.466  Sum_probs=209.6

Q ss_pred             eeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHcc--CCCCceeeeEEEEeCCE----
Q 014733           42 YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLS--GHPNVVDLKAVYEEEDY----  115 (419)
Q Consensus        42 y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~--~hpnIv~l~~~~~~~~~----  115 (419)
                      |++.+.||+|++|.||+|.++.+++.+|+|.+..... .......+.+|+.++++++  +||||+++++++.+...    
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~   79 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL   79 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence            7889999999999999999998899999999975543 2223345667888887774  49999999999988776    


Q ss_pred             -EEEEEeecCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeecccee
Q 014733          116 -VHLLMELCAGGELFHRLEKYG--RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLAT  192 (419)
Q Consensus       116 -~~lV~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~  192 (419)
                       ++++|||++ ++|.+++....  .+++..++.++.|+++||.|||+.+++|+||+|+||++   +.++.+||+|||++.
T Consensus        80 ~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili---~~~~~~~l~dfg~~~  155 (287)
T cd07838          80 KLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILV---TSDGQVKIADFGLAR  155 (287)
T ss_pred             eeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEE---ccCCCEEEeccCcce
Confidence             999999996 58988887643  48999999999999999999999999999999999999   456889999999998


Q ss_pred             eeccCCccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-----------
Q 014733          193 YIKAGQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLR-----------  260 (419)
Q Consensus       193 ~~~~~~~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-----------  260 (419)
                      ............++..|+|||++.+. ++.++|+|||||++|+|++|++||.+....+....+......           
T Consensus       156 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07838         156 IYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS  235 (287)
T ss_pred             eccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcc
Confidence            76554444455688899999998764 899999999999999999999999888776666655432100           


Q ss_pred             -----CC-------CCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhcccc
Q 014733          261 -----FP-------SDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWM  300 (419)
Q Consensus       261 -----~~-------~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~  300 (419)
                           ++       ......++..+.++|.+||+.||++||++.+++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         236 LPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             cchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence                 00       00012456888999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1.3e-40  Score=324.62  Aligned_cols=258  Identities=30%  Similarity=0.489  Sum_probs=217.3

Q ss_pred             ccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEE
Q 014733           37 NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYV  116 (419)
Q Consensus        37 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~  116 (419)
                      ...+.|...+.||+|+||+||+|.+..+|+.+++|.+.............+.+|+.+++.++ |||++++++++.+.+..
T Consensus        18 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~   96 (313)
T cd06633          18 DPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK-HPNTIEYKGCYLKEHTA   96 (313)
T ss_pred             CHHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCC-CCCCccEEEEEEeCCEE
Confidence            34456888889999999999999999999999999997665555566678899999999996 99999999999999999


Q ss_pred             EEEEeecCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeec
Q 014733          117 HLLMELCAGGELFHRLEK-YGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIK  195 (419)
Q Consensus       117 ~lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~  195 (419)
                      |+||||+. ++|.+.+.. ..++++.++..++.||+.+|.|||+.||+|+||+|+||++   ..++.+||+|||++....
T Consensus        97 ~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili---~~~~~~kL~dfg~~~~~~  172 (313)
T cd06633          97 WLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL---TEPGQVKLADFGSASKSS  172 (313)
T ss_pred             EEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEE---CCCCCEEEeecCCCcccC
Confidence            99999995 577777755 3568999999999999999999999999999999999999   566789999999886432


Q ss_pred             cCCccccccCCCccCCccccc----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCH
Q 014733          196 AGQNLHGTVGSPFYIAPEVLA----GGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISA  271 (419)
Q Consensus       196 ~~~~~~~~~gt~~y~aPE~l~----~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  271 (419)
                         ......|+..|+|||++.    +.++.++|+||||+++|+|++|.+||...........+.....  +......++.
T Consensus       173 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  247 (313)
T cd06633         173 ---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS--PTLQSNEWTD  247 (313)
T ss_pred             ---CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC--CCCCccccCH
Confidence               223457889999999974    2488899999999999999999999987766555555544322  2222346788


Q ss_pred             HHHHHHHhhhhcCCCCCCCHHHHHhccccccch
Q 014733          272 SARDLIMGMLRVDPSTRLTAAEVLAHSWMEECE  304 (419)
Q Consensus       272 ~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~  304 (419)
                      .+++|+.+||+.+|.+||++.+++.||||....
T Consensus       248 ~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~  280 (313)
T cd06633         248 SFRGFVDYCLQKIPQERPASAELLRHDFVRRDR  280 (313)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence            999999999999999999999999999998643

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1e-40  Score=316.45  Aligned_cols=247  Identities=25%  Similarity=0.399  Sum_probs=211.1

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      .+|.+.+.||+|++|.||+|.++.+++.+|+|++...    ......+.+|+++++++. ||||+++++++...+.++++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~----~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   80 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYII   80 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC----chHHHHHHHHHHHHHhCC-CCChhheEEEEcCCCCcEEE
Confidence            5689999999999999999999999999999998643    234567889999999996 99999999999999999999


Q ss_pred             EeecCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccC
Q 014733          120 MELCAGGELFHRLEKYG--RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG  197 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~  197 (419)
                      |||+++++|.+++....  .+++..+..++.|+++||+|||+.+++||||||+||++   ++++.+||+|||++......
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~df~~~~~~~~~  157 (263)
T cd05052          81 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGD  157 (263)
T ss_pred             EEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEE---cCCCcEEeCCCccccccccc
Confidence            99999999999987543  48999999999999999999999999999999999999   56778999999999876443


Q ss_pred             Ccc--ccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 014733          198 QNL--HGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASA  273 (419)
Q Consensus       198 ~~~--~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l  273 (419)
                      ...  ....++..|+|||.+.+. ++.++|||||||++|+|++ |..||.+....+....+.... .  ......++.++
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~  234 (263)
T cd05052         158 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGY-R--MERPEGCPPKV  234 (263)
T ss_pred             eeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC-C--CCCCCCCCHHH
Confidence            221  122345679999988764 8999999999999999998 999999888877777765532 1  22234688999


Q ss_pred             HHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          274 RDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       274 ~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      .++|.+||+.||++|||+.++++.
T Consensus       235 ~~li~~cl~~~p~~Rp~~~~l~~~  258 (263)
T cd05052         235 YELMRACWQWNPSDRPSFAEIHQA  258 (263)
T ss_pred             HHHHHHHccCCcccCCCHHHHHHH
Confidence            999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=8.1e-41  Score=314.54  Aligned_cols=251  Identities=26%  Similarity=0.459  Sum_probs=218.6

Q ss_pred             CeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEE
Q 014733           41 RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLM  120 (419)
Q Consensus        41 ~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~  120 (419)
                      +|++.+.||+|+||.||++.++.+++.+++|.+..... .......+.+|+.+++.++ |+||+++++++.+....++||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~   78 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM-SQKEREDAVNEIRILASVN-HPNIISYKEAFLDGNKLCIVM   78 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhc-cHHHHHHHHHHHHHHHhCC-CCCchhhhhhhccCCEEEEEe
Confidence            58999999999999999999999999999999876543 3345667788999999996 999999999999999999999


Q ss_pred             eecCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeecc
Q 014733          121 ELCAGGELFHRLEK----YGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA  196 (419)
Q Consensus       121 E~~~ggsL~~~l~~----~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~  196 (419)
                      ||+++++|..++.+    ...+++..++.++.|++.||+|||+.|++|+||+|+||+++   .++.+||+|||++.....
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~---~~~~~kl~d~g~~~~~~~  155 (256)
T cd08530          79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLV---ANDLVKIGDLGISKVLKK  155 (256)
T ss_pred             hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEe---cCCcEEEeeccchhhhcc
Confidence            99999999998866    34589999999999999999999999999999999999994   467899999999987655


Q ss_pred             CCccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 014733          197 GQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARD  275 (419)
Q Consensus       197 ~~~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~  275 (419)
                      . ......++..|++||.+.+. ++.++|+||+|+++|+|++|+.||...+..+....+........   ...++.++++
T Consensus       156 ~-~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  231 (256)
T cd08530         156 N-MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPI---PPIYSQDLQN  231 (256)
T ss_pred             C-CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC---chhhCHHHHH
Confidence            4 33345788999999998764 88999999999999999999999998887777666655443222   1368899999


Q ss_pred             HHHhhhhcCCCCCCCHHHHHhcccc
Q 014733          276 LIMGMLRVDPSTRLTAAEVLAHSWM  300 (419)
Q Consensus       276 li~~~L~~dP~~Rps~~eil~hp~~  300 (419)
                      ++.+||+.+|++||++.++++||++
T Consensus       232 li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         232 FIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             HHHHHcCCCcccCCCHHHHhcCCCC
Confidence            9999999999999999999999974

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.1e-40  Score=319.73  Aligned_cols=249  Identities=22%  Similarity=0.346  Sum_probs=209.1

Q ss_pred             cCeeeeeeecccCceEEEEEEec----CCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDK----FTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDY  115 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~----~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~  115 (419)
                      ++|++.+.||+|+||+||+|...    .++..+++|.+...  ........+.+|+.+++++. ||||+++++++...+.
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~   81 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI--NNPQQWGEFQQEASLMAELH-HPNIVCLLGVVTQEQP   81 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC--CCHHHHHHHHHHHHHHhhCC-CCCeeeEEEEEecCCc
Confidence            67899999999999999999853    45678999998643  23455678899999999996 9999999999999999


Q ss_pred             EEEEEeecCCCChHHHHHHcC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecC
Q 014733          116 VHLLMELCAGGELFHRLEKYG-----------------RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKS  178 (419)
Q Consensus       116 ~~lV~E~~~ggsL~~~l~~~~-----------------~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~  178 (419)
                      .|++|||+++++|.+++....                 .+++..+..++.|++.||+|||+++|+||||||+|||+   +
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili---~  158 (283)
T cd05090          82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILI---G  158 (283)
T ss_pred             eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEE---c
Confidence            999999999999999985322                 37888899999999999999999999999999999999   4


Q ss_pred             CCCCeEEeeccceeeeccCC---ccccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 014733          179 SSSPIKLADFGLATYIKAGQ---NLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDA  253 (419)
Q Consensus       179 ~~~~vKL~DFgla~~~~~~~---~~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~  253 (419)
                      .++.+||+|||++.......   ......++..|+|||++.+ .++.++|+||||+++|+|++ |..||.+....++.+.
T Consensus       159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~  238 (283)
T cd05090         159 EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM  238 (283)
T ss_pred             CCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            56789999999998654322   1223355678999999875 48999999999999999998 9999988777777666


Q ss_pred             HHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          254 VRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       254 i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      +......   ..+..++..+.+++.+||+.||.+||++.+++++
T Consensus       239 ~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         239 VRKRQLL---PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HHcCCcC---CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            6554322   1234688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.8e-40  Score=314.36  Aligned_cols=251  Identities=28%  Similarity=0.554  Sum_probs=212.4

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      ++|++.+.||.|++|.||+|.+..+|+.+|+|.+.............+.+|+++++++. |+||+++++++.+.+..++|
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~-~~~i~~~~~~~~~~~~~~lv   80 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD-HPNVIKYLASFIENNELNIV   80 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCeeeeeeeeecCCeEEEE
Confidence            68999999999999999999999999999999997655555556788999999999995 99999999999999999999


Q ss_pred             EeecCCCChHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeec
Q 014733          120 MELCAGGELFHRLEKY----GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIK  195 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~~----~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~  195 (419)
                      |||+++++|..++...    ..+++..+..++.+++.||.|||+.||+|+||+|+||++   +.++.++|+|||++....
T Consensus        81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~---~~~~~~~l~d~~~~~~~~  157 (267)
T cd08224          81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFI---TATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEE---CCCCcEEEeccceeeecc
Confidence            9999999999988642    348999999999999999999999999999999999999   567789999999987654


Q ss_pred             cCC-ccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhcCCCCCCCCCCCCCH
Q 014733          196 AGQ-NLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKT--KSKIFDAVRAADLRFPSDPWDHISA  271 (419)
Q Consensus       196 ~~~-~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~s~  271 (419)
                      ... ......++..|+|||.+.+. ++.++|+||||+++|+|++|+.||....  ..+..+.+.....  +..+...++.
T Consensus       158 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  235 (267)
T cd08224         158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDY--PPLPADHYSE  235 (267)
T ss_pred             CCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCC--CCCChhhcCH
Confidence            332 22335688899999998764 8999999999999999999999996543  2344444443322  2222336788


Q ss_pred             HHHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          272 SARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       272 ~l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                      ++.++|.+||..+|++|||+.++++
T Consensus       236 ~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         236 ELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             HHHHHHHHHcCCCcccCCCHHHHHH
Confidence            9999999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=9.5e-41  Score=314.33  Aligned_cols=242  Identities=24%  Similarity=0.384  Sum_probs=202.6

Q ss_pred             eeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEEeecCC
Q 014733           46 KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAG  125 (419)
Q Consensus        46 ~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~g  125 (419)
                      +.||+|+||.||+|.++.+++.+|+|.+...  ........+.+|+++++++. ||||+++++++.+.+.+++||||+++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~   77 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET--LPPDLKAKFLQEARILKQYS-HPNIVRLIGVCTQKQPIYIVMELVQG   77 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCcc--CCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEcCCCCeEEEEeeccC
Confidence            4799999999999999999999999988643  23455678999999999996 99999999999999999999999999


Q ss_pred             CChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCCccc---
Q 014733          126 GELFHRLEKYG-RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLH---  201 (419)
Q Consensus       126 gsL~~~l~~~~-~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~~~~---  201 (419)
                      ++|.+++...+ .+++..++.++.|+++||.|||+.+|+||||||+|||+   +.++.+||+|||++..........   
T Consensus        78 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~  154 (252)
T cd05084          78 GDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLV---TEKNVLKISDFGMSREEEDGVYASTGG  154 (252)
T ss_pred             CcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEE---cCCCcEEECccccCcccccccccccCC
Confidence            99999997644 58999999999999999999999999999999999999   556789999999987543321110   


Q ss_pred             cccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHh
Q 014733          202 GTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMG  279 (419)
Q Consensus       202 ~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~  279 (419)
                      ...++..|+|||.+.++ ++.++|+||||+++|+|++ |..||...........+.... ..  ......+.++.+++.+
T Consensus       155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~li~~  231 (252)
T cd05084         155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGV-RL--PCPELCPDAVYRLMER  231 (252)
T ss_pred             CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCC-CC--CCcccCCHHHHHHHHH
Confidence            11224569999998764 8999999999999999998 999998777666666554432 22  2234678999999999


Q ss_pred             hhhcCCCCCCCHHHHHh
Q 014733          280 MLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       280 ~L~~dP~~Rps~~eil~  296 (419)
                      ||+.||++|||+.++++
T Consensus       232 ~l~~~p~~Rps~~~~~~  248 (252)
T cd05084         232 CWEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             HcCCChhhCcCHHHHHH
Confidence            99999999999999975

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=3.9e-41  Score=331.47  Aligned_cols=264  Identities=32%  Similarity=0.506  Sum_probs=215.5

Q ss_pred             ccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeC--C
Q 014733           37 NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEE--D  114 (419)
Q Consensus        37 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~--~  114 (419)
                      .+.++|.+.+.||+|+||.||+|.+..+|+.+|+|.+.+.. ........+.+|+.+++++++||||+++++++...  .
T Consensus         4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~   82 (337)
T cd07852           4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAF-RNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDK   82 (337)
T ss_pred             hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeecccc-CcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence            46789999999999999999999999899999999886532 23344566778999999994599999999998643  4


Q ss_pred             EEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeee
Q 014733          115 YVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI  194 (419)
Q Consensus       115 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~  194 (419)
                      .+|+||||++ ++|..++... .+++..+..++.|++.||+|||+.||+||||||+||++   +.++.+||+|||++...
T Consensus        83 ~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill---~~~~~~kl~d~g~~~~~  157 (337)
T cd07852          83 DIYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILL---NSDCRVKLADFGLARSL  157 (337)
T ss_pred             eEEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEEeeccchhcc
Confidence            6899999996 5998888764 78999999999999999999999999999999999999   56789999999998865


Q ss_pred             ccCC------ccccccCCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-------
Q 014733          195 KAGQ------NLHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADL-------  259 (419)
Q Consensus       195 ~~~~------~~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-------  259 (419)
                      ....      ......|+..|+|||++.+  .++.++|+||||+++|+|++|++||.+....+....+.....       
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
T cd07852         158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI  237 (337)
T ss_pred             ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            4332      1223468899999998754  378999999999999999999999987665544433322211       


Q ss_pred             --------------------CCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchhh
Q 014733          260 --------------------RFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQV  306 (419)
Q Consensus       260 --------------------~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~~  306 (419)
                                          .........++.++.++|.+||+.||++|||+.++++|||+++....
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~  304 (337)
T cd07852         238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNP  304 (337)
T ss_pred             HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccC
Confidence                                11111123478999999999999999999999999999999887543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.2e-40  Score=321.18  Aligned_cols=252  Identities=22%  Similarity=0.304  Sum_probs=209.7

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCC----------------cEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCC
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTG----------------EVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN  102 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g----------------~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpn  102 (419)
                      .++|++++.||+|+||.||+|.+..++                ..+|+|.+....  .......+.+|++++++++ |||
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~   80 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA--SDNAREDFLKEVKILSRLS-DPN   80 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhcC-CCC
Confidence            368999999999999999999876544                458999987552  3456778999999999996 999


Q ss_pred             ceeeeEEEEeCCEEEEEEeecCCCChHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCc
Q 014733          103 VVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYG-----------RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPEN  171 (419)
Q Consensus       103 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~-----------~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~N  171 (419)
                      |+++++++.+++.++++|||+++++|..++....           .+++..++.++.|++.||+|||+++|+||||||+|
T Consensus        81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N  160 (296)
T cd05051          81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN  160 (296)
T ss_pred             EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence            9999999999999999999999999999997765           68999999999999999999999999999999999


Q ss_pred             EEEeecCCCCCeEEeeccceeeeccCCc---cccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh--CCCCCCCC
Q 014733          172 ILLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS--GMPPFWGK  245 (419)
Q Consensus       172 ILl~~~~~~~~vKL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt--G~~Pf~~~  245 (419)
                      |++   +.++.++|+|||++........   .....++..|+|||++.+ .++.++|||||||++|+|++  |..||...
T Consensus       161 ili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~  237 (296)
T cd05051         161 CLV---GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL  237 (296)
T ss_pred             eee---cCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc
Confidence            999   5568899999999876543321   123356778999999876 58999999999999999998  78899877


Q ss_pred             CHHHHHHHHHhc----CCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          246 TKSKIFDAVRAA----DLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       246 ~~~~~~~~i~~~----~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                      ...+.+..+...    ...........++.++.+++.+||+.||.+|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         238 TDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             ChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            776666665433    111111122357899999999999999999999999965

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.8e-41  Score=313.44  Aligned_cols=245  Identities=40%  Similarity=0.732  Sum_probs=216.5

Q ss_pred             ecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEEeecCCCC
Q 014733           48 LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGE  127 (419)
Q Consensus        48 LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~ggs  127 (419)
                      ||.|+||.||++.+..+++.+++|++.+...........+..|+.+++++. ||||+++++.+.+++.++++|||+++++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~~~~   79 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN-HPFIVKLHYAFQTEEKLYLVLEYAPGGE   79 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcC-CCcHHHHHHHeecCCeeEEEEecCCCCc
Confidence            699999999999999899999999998776555556778999999999996 9999999999999999999999999999


Q ss_pred             hHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccC-CccccccCC
Q 014733          128 LFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG-QNLHGTVGS  206 (419)
Q Consensus       128 L~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~-~~~~~~~gt  206 (419)
                      |.+++.....+++..+..++.|+++||.|||+.+++|+||+|+||++   +.++.++|+|||++...... .......++
T Consensus        80 L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~  156 (250)
T cd05123          80 LFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILL---DADGHIKLTDFGLAKELSSEGSRTNTFCGT  156 (250)
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEE---cCCCcEEEeecCcceecccCCCcccCCcCC
Confidence            99999887789999999999999999999999999999999999999   55678999999999876443 223445788


Q ss_pred             CccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCC
Q 014733          207 PFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDP  285 (419)
Q Consensus       207 ~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP  285 (419)
                      ..|+|||.+.+. ++.++|+||||+++|+|++|..||......+..+.+......++.    .++..+.++|.+||..||
T Consensus       157 ~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~~i~~~l~~~p  232 (250)
T cd05123         157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPE----FLSPEARDLISGLLQKDP  232 (250)
T ss_pred             ccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCC----CCCHHHHHHHHHHhcCCH
Confidence            899999998764 788999999999999999999999887776777776654443333    568999999999999999


Q ss_pred             CCCCCH---HHHHhcccc
Q 014733          286 STRLTA---AEVLAHSWM  300 (419)
Q Consensus       286 ~~Rps~---~eil~hp~~  300 (419)
                      ++||++   ++++.||||
T Consensus       233 ~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         233 TKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             hhCCCcccHHHHHhCCCC
Confidence            999999   999999997

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.8e-40  Score=322.10  Aligned_cols=253  Identities=24%  Similarity=0.384  Sum_probs=209.1

Q ss_pred             ccccCeeeeeeecccCceEEEEEEe-----cCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEE
Q 014733           37 NLSDRYVLGKQLGWGQFGVIRECSD-----KFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYE  111 (419)
Q Consensus        37 ~~~~~y~i~~~LG~G~~g~V~~a~~-----~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~  111 (419)
                      -..++|.+.+.||+|+||.||+|.+     ..++..+|+|.+....  .....+.+.+|+.+++++.+||||+++++++.
T Consensus        32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  109 (302)
T cd05055          32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGACT  109 (302)
T ss_pred             ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEEe
Confidence            3457999999999999999999975     2355689999886542  23456778999999999955999999999999


Q ss_pred             eCCEEEEEEeecCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeecc
Q 014733          112 EEDYVHLLMELCAGGELFHRLEKYG--RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFG  189 (419)
Q Consensus       112 ~~~~~~lV~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFg  189 (419)
                      ..+.++++|||+++++|.+++....  .+++.++..++.|++.||+|||+++|+|+||||+|||+   +.++.+||+|||
T Consensus       110 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~~l~dfg  186 (302)
T cd05055         110 IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLL---THGKIVKICDFG  186 (302)
T ss_pred             cCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEE---cCCCeEEECCCc
Confidence            9999999999999999999997643  28999999999999999999999999999999999999   456789999999


Q ss_pred             ceeeeccCCc---cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCC
Q 014733          190 LATYIKAGQN---LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSD  264 (419)
Q Consensus       190 la~~~~~~~~---~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~  264 (419)
                      ++........   .....++..|+|||++.+. ++.++||||+||++|+|++ |..||.+....+.+...........  
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~--  264 (302)
T cd05055         187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMA--  264 (302)
T ss_pred             ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCC--
Confidence            9986543321   1123456789999988764 8999999999999999998 9999987766555544433332222  


Q ss_pred             CCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          265 PWDHISASARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       265 ~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                      .....+.++.+++.+||.++|++|||+.++++
T Consensus       265 ~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         265 QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            22367899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.1e-40  Score=327.64  Aligned_cols=260  Identities=27%  Similarity=0.437  Sum_probs=210.8

Q ss_pred             CeeeeeeecccCceEEEEEEecCC--CcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEe----CC
Q 014733           41 RYVLGKQLGWGQFGVIRECSDKFT--GEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEE----ED  114 (419)
Q Consensus        41 ~y~i~~~LG~G~~g~V~~a~~~~~--g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~----~~  114 (419)
                      +|++.+.||+|+||.||++.+..+  +..+|+|.+.... ......+.+.+|+.+++++.+||||+++++....    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence            589999999999999999999877  8999999986432 1223456678899999999779999999987543    25


Q ss_pred             EEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeee
Q 014733          115 YVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI  194 (419)
Q Consensus       115 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~  194 (419)
                      .+|+++||+. ++|..++.....+++.+++.++.||+.||+|||+.||+||||||+|||+   +.++.+||+|||++...
T Consensus        80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili---~~~~~~kl~Dfg~a~~~  155 (332)
T cd07857          80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLV---NADCELKICDFGLARGF  155 (332)
T ss_pred             cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEE---cCCCCEEeCcCCCceec
Confidence            6789999984 6899999877889999999999999999999999999999999999999   56778999999999865


Q ss_pred             ccCCc-----cccccCCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC--------
Q 014733          195 KAGQN-----LHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADL--------  259 (419)
Q Consensus       195 ~~~~~-----~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~--------  259 (419)
                      .....     .....||+.|+|||++.+  .++.++|+||+|+++|+|++|.+||...........+.....        
T Consensus       156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  235 (332)
T cd07857         156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS  235 (332)
T ss_pred             ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            43221     233478999999998765  489999999999999999999999987665444433222100        


Q ss_pred             ---------------CCC----CCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          260 ---------------RFP----SDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       260 ---------------~~~----~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                                     ..+    ...+...+..+.+++.+||+.||++|||+.+++.|||+.....
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~  300 (332)
T cd07857         236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHD  300 (332)
T ss_pred             hhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcC
Confidence                           000    1122356889999999999999999999999999999987654

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.7e-41  Score=333.70  Aligned_cols=263  Identities=29%  Similarity=0.488  Sum_probs=217.7

Q ss_pred             ccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCC
Q 014733           35 ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEED  114 (419)
Q Consensus        35 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~  114 (419)
                      ...+.++|++...||.|++|.||+|.+..+++.||+|++.... ........+.+|+.+++++. ||||+++.+++....
T Consensus        10 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~   87 (343)
T cd07851          10 VWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF-QSAIHAKRTYRELRLLKHMD-HENVIGLLDVFTPAS   87 (343)
T ss_pred             eecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc-chhhHHHHHHHHHHHHHhcc-CCCHHHHHHHhhccc
Confidence            4567899999999999999999999999999999999886542 22344567788999999995 999999999886655


Q ss_pred             E------EEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeec
Q 014733          115 Y------VHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADF  188 (419)
Q Consensus       115 ~------~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DF  188 (419)
                      .      .++|+||+ +++|.+++.. .++++..++.++.|+++||.|||+.||+||||||+||++   +.++.+||+||
T Consensus        88 ~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill---~~~~~~kL~df  162 (343)
T cd07851          88 SLEDFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV---NEDCELKILDF  162 (343)
T ss_pred             cccccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEccc
Confidence            4      89999999 6799988875 679999999999999999999999999999999999999   56778999999


Q ss_pred             cceeeeccCCccccccCCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC----
Q 014733          189 GLATYIKAGQNLHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFP----  262 (419)
Q Consensus       189 gla~~~~~~~~~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~----  262 (419)
                      |++......  .....++..|+|||.+.+  .++.++||||||+++|+|++|+.||.+....+....+.......+    
T Consensus       163 g~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  240 (343)
T cd07851         163 GLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELL  240 (343)
T ss_pred             ccccccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Confidence            999865332  344578889999999865  478999999999999999999999987766555554433211100    


Q ss_pred             ----------------C-------CCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchhh
Q 014733          263 ----------------S-------DPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQV  306 (419)
Q Consensus       263 ----------------~-------~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~~  306 (419)
                                      .       .....++.++.++|.+||+.||++|||+.++++||||++....
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~  307 (343)
T cd07851         241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP  307 (343)
T ss_pred             hhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCC
Confidence                            0       0112468999999999999999999999999999999876544

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=8.9e-41  Score=336.56  Aligned_cols=250  Identities=26%  Similarity=0.424  Sum_probs=204.8

Q ss_pred             ccCeeeeeeecccCceEEEEEEecC-----CCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeC
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKF-----TGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEE  113 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~-----~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~  113 (419)
                      .++|++++.||+|+||.||+|.+..     .+..||+|++...  ......+.+.+|+++|+++..||||+++++++.+.
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~  113 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPT--ARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS  113 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCC--CChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence            5788999999999999999998743     2357999998654  23345677899999999996699999999999999


Q ss_pred             CEEEEEEeecCCCChHHHHHHc----------------------------------------------------------
Q 014733          114 DYVHLLMELCAGGELFHRLEKY----------------------------------------------------------  135 (419)
Q Consensus       114 ~~~~lV~E~~~ggsL~~~l~~~----------------------------------------------------------  135 (419)
                      +.+|+||||+++|+|.+++...                                                          
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (400)
T cd05105         114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE  193 (400)
T ss_pred             CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence            9999999999999999888542                                                          


Q ss_pred             --------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeec
Q 014733          136 --------------------------------------GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATK  177 (419)
Q Consensus       136 --------------------------------------~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~  177 (419)
                                                            ..+++.++..++.||++||+|||+.+|+||||||+|||+   
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill---  270 (400)
T cd05105         194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLL---  270 (400)
T ss_pred             hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEE---
Confidence                                                  136788889999999999999999999999999999999   


Q ss_pred             CCCCCeEEeeccceeeeccCCc---cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHH-
Q 014733          178 SSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIF-  251 (419)
Q Consensus       178 ~~~~~vKL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~-  251 (419)
                      +.++.+||+|||++........   .....++..|+|||++.+. ++.++|||||||++|+|++ |..||......... 
T Consensus       271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~  350 (400)
T cd05105         271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY  350 (400)
T ss_pred             eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHH
Confidence            4567899999999986543222   2234567889999998764 8999999999999999997 99999776544333 


Q ss_pred             HHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          252 DAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       252 ~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                      ..+.. ....+  ....++.++.+++.+||+.||++|||+.++.+
T Consensus       351 ~~~~~-~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         351 NKIKS-GYRMA--KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             HHHhc-CCCCC--CCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            33333 22222  22478899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=5.3e-41  Score=331.06  Aligned_cols=251  Identities=25%  Similarity=0.405  Sum_probs=203.2

Q ss_pred             ccCeeeeeeecccCceEEEEEEec-----CCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEe-
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDK-----FTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEE-  112 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~-----~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~-  112 (419)
                      .++|++.+.||+|+||.||+|.+.     .+++.||+|++....  .....+.+..|+.+++++.+|+||+++++++.. 
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~   83 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGACTKP   83 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence            368999999999999999999754     345789999986442  334566788899999999669999999998864 


Q ss_pred             CCEEEEEEeecCCCChHHHHHHc---------------------------------------------------------
Q 014733          113 EDYVHLLMELCAGGELFHRLEKY---------------------------------------------------------  135 (419)
Q Consensus       113 ~~~~~lV~E~~~ggsL~~~l~~~---------------------------------------------------------  135 (419)
                      ...++++|||+++++|.+++...                                                         
T Consensus        84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (337)
T cd05054          84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD  163 (337)
T ss_pred             CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence            46789999999999999988542                                                         


Q ss_pred             ----CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCCc---cccccCCCc
Q 014733          136 ----GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPF  208 (419)
Q Consensus       136 ----~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~~---~~~~~gt~~  208 (419)
                          .++++..+..++.||+.||+|||+.+|+||||||+|||++   .++.+||+|||++..+.....   .....++..
T Consensus       164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~---~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd05054         164 ELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDYVRKGDARLPLK  240 (337)
T ss_pred             HHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEe---CCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence                2578999999999999999999999999999999999994   567899999999986533221   122345678


Q ss_pred             cCCcccccCC-CCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHH-HHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCC
Q 014733          209 YIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIF-DAVRAADLRFPSDPWDHISASARDLIMGMLRVDP  285 (419)
Q Consensus       209 y~aPE~l~~~-~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~-~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP  285 (419)
                      |+|||++.+. ++.++|||||||++|+|++ |..||.+....+.+ ..+... ....  .....++++.+++.+||+.+|
T Consensus       241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~~~l~~~cl~~~p  317 (337)
T cd05054         241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEG-TRMR--APEYATPEIYSIMLDCWHNNP  317 (337)
T ss_pred             ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhcc-CCCC--CCccCCHHHHHHHHHHccCCh
Confidence            9999988764 9999999999999999998 99999875543333 333332 2221  123678999999999999999


Q ss_pred             CCCCCHHHHHhc
Q 014733          286 STRLTAAEVLAH  297 (419)
Q Consensus       286 ~~Rps~~eil~h  297 (419)
                      ++||++.++++|
T Consensus       318 ~~RPs~~ell~~  329 (337)
T cd05054         318 EDRPTFSELVEI  329 (337)
T ss_pred             hhCcCHHHHHHH
Confidence            999999999886

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.3e-40  Score=314.93  Aligned_cols=246  Identities=26%  Similarity=0.404  Sum_probs=209.2

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEE
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHL  118 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~l  118 (419)
                      .++|++.++||+|++|.||+|.+. .+..+|+|.+....    ...+.+.+|+.+++++. |+||+++++++.+.+..++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l   78 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT----MSVQAFLEEANLMKTLQ-HDKLVRLYAVVTKEEPIYI   78 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc----hhHHHHHHHHHHHHhCC-CCCeeeEEEEEcCCCCcEE
Confidence            478999999999999999999875 56779999876432    24577899999999996 9999999999999999999


Q ss_pred             EEeecCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeecc
Q 014733          119 LMELCAGGELFHRLEKY--GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA  196 (419)
Q Consensus       119 V~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~  196 (419)
                      +|||+++++|.+++...  ..+++..+..++.|+++||+|||+.+++||||||+||++   +.++.+||+|||++.....
T Consensus        79 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~~  155 (261)
T cd05072          79 ITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLV---SESLMCKIADFGLARVIED  155 (261)
T ss_pred             EEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEe---cCCCcEEECCCccceecCC
Confidence            99999999999998653  458899999999999999999999999999999999999   5677899999999987643


Q ss_pred             CCcc--ccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHH
Q 014733          197 GQNL--HGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISAS  272 (419)
Q Consensus       197 ~~~~--~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  272 (419)
                      ....  ....++..|+|||++.+. ++.++|+||||+++|+|++ |+.||.+....+....+.... ..+  ....++.+
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~  232 (261)
T cd05072         156 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGY-RMP--RMENCPDE  232 (261)
T ss_pred             CceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC-CCC--CCCCCCHH
Confidence            3211  223456679999998764 8999999999999999998 999998888777777776542 222  23468899


Q ss_pred             HHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          273 ARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       273 l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                      +.+++.+||..||++||+++++++
T Consensus       233 ~~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         233 LYDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             HHHHHHHHccCCcccCcCHHHHHH
Confidence            999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.6e-41  Score=330.45  Aligned_cols=267  Identities=27%  Similarity=0.483  Sum_probs=215.7

Q ss_pred             ccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeC-
Q 014733           35 ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEE-  113 (419)
Q Consensus        35 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~-  113 (419)
                      +..+.++|.+.+.||+|+||.||+|.+..+|+.||+|++.+.. ......+.+.+|+.++++++ ||||+++++++... 
T Consensus        12 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~-h~~iv~~~~~~~~~~   89 (345)
T cd07877          12 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPAR   89 (345)
T ss_pred             HhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcc-hhhHHHHHHHHHHHHHHHcC-CCcccceeeeeeecc
Confidence            3456799999999999999999999999999999999987532 22334567888999999996 99999999988643 


Q ss_pred             -----CEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeec
Q 014733          114 -----DYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADF  188 (419)
Q Consensus       114 -----~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DF  188 (419)
                           +.+|++++++ +++|.+++.. ..+++..++.++.|+++||+|||+.||+||||||+||++   +.++.+||+||
T Consensus        90 ~~~~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kl~df  164 (345)
T cd07877          90 SLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDF  164 (345)
T ss_pred             cccccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEE---cCCCCEEEecc
Confidence                 4578888887 7899887765 569999999999999999999999999999999999999   56778999999


Q ss_pred             cceeeeccCCccccccCCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-------
Q 014733          189 GLATYIKAGQNLHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADL-------  259 (419)
Q Consensus       189 gla~~~~~~~~~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-------  259 (419)
                      |++.....  ......++..|+|||++.+  .++.++|+|||||++|+|++|++||...........+.....       
T Consensus       165 g~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (345)
T cd07877         165 GLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL  242 (345)
T ss_pred             cccccccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            99886432  2344578899999998765  378999999999999999999999977665444333322110       


Q ss_pred             ----------------CCCC----CCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchhhhcCC
Q 014733          260 ----------------RFPS----DPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKP  310 (419)
Q Consensus       260 ----------------~~~~----~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~~~~~~  310 (419)
                                      ..+.    ..+...++++.++|.+||+.||.+||++.+++.||||++.......+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~~~~  313 (345)
T cd07877         243 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEP  313 (345)
T ss_pred             hhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCCccc
Confidence                            0111    11224688999999999999999999999999999999866544443

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-40  Score=312.87  Aligned_cols=243  Identities=28%  Similarity=0.438  Sum_probs=211.2

Q ss_pred             eeecccCceEEEEEEecCC---CcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEEee
Q 014733           46 KQLGWGQFGVIRECSDKFT---GEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMEL  122 (419)
Q Consensus        46 ~~LG~G~~g~V~~a~~~~~---g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~  122 (419)
                      +.||+|+||.||+|.+...   +..+++|.+.....  ....+.+.+|+++++.++ |+||+++++++.+...++++|||
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~e~   77 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS--EEERKDFLKEARVMKKLG-HPNVVRLLGVCTEEEPLYLVLEY   77 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccc--hhHHHHHHHHHHHHhhcC-CCChheeeeeecCCCceEEEEEe
Confidence            4799999999999999865   89999999876532  225788999999999997 99999999999999999999999


Q ss_pred             cCCCChHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceee
Q 014733          123 CAGGELFHRLEKY---------GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATY  193 (419)
Q Consensus       123 ~~ggsL~~~l~~~---------~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~  193 (419)
                      +++++|.+++...         ..+++..++.++.|++.||+|||+++++|+||||+||++   +.++.+||+|||.+..
T Consensus        78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili---~~~~~~~l~dfg~~~~  154 (262)
T cd00192          78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLV---GEDLVVKISDFGLSRD  154 (262)
T ss_pred             ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEE---CCCCcEEEcccccccc
Confidence            9999999999875         679999999999999999999999999999999999999   5568999999999987


Q ss_pred             eccCC---ccccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCC
Q 014733          194 IKAGQ---NLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDH  268 (419)
Q Consensus       194 ~~~~~---~~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  268 (419)
                      .....   ......++..|+|||.+.+ .++.++|+||||+++|+|++ |..||......+..+.+..... .  .....
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~  231 (262)
T cd00192         155 VYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYR-L--PKPEY  231 (262)
T ss_pred             cccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-C--CCCcc
Confidence            65432   2234567889999999876 48999999999999999999 6999999888888887775322 1  22236


Q ss_pred             CCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          269 ISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       269 ~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      ++.++.+++.+||+.||++|||+.+++++
T Consensus       232 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         232 CPDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             CChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            78999999999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-40  Score=314.76  Aligned_cols=249  Identities=25%  Similarity=0.419  Sum_probs=211.0

Q ss_pred             cCeeeeeeecccCceEEEEEEecCC---CcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFT---GEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYV  116 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~---g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~  116 (419)
                      ++|++.+.||+|+||+||+|.++..   ...+|+|.+....  .......+.+|+.++++++ ||||+++++.+.+.+.+
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   80 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFD-HPNIIRLEGVVTKSRPV   80 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCC-CCCcceEeEEEecCCce
Confidence            6799999999999999999998644   4579999886542  3445667889999999996 99999999999999999


Q ss_pred             EEEEeecCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeec
Q 014733          117 HLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIK  195 (419)
Q Consensus       117 ~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~  195 (419)
                      +++|||+++++|.+++... +.+++..+..++.|++.||+|||+.+|+|+||||+|||+   +.++.+||+|||++....
T Consensus        81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili---~~~~~~~l~dfg~~~~~~  157 (266)
T cd05033          81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILV---NSNLVCKVSDFGLSRRLE  157 (266)
T ss_pred             EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCCCEEECccchhhccc
Confidence            9999999999999998764 468999999999999999999999999999999999999   567789999999998765


Q ss_pred             cCCcc---ccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCC
Q 014733          196 AGQNL---HGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHIS  270 (419)
Q Consensus       196 ~~~~~---~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  270 (419)
                      .....   ....++..|+|||.+.+ .++.++||||||+++|+|++ |..||......+....+.... ..+.  ...++
T Consensus       158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~~~--~~~~~  234 (266)
T cd05033         158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGY-RLPP--PMDCP  234 (266)
T ss_pred             ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC-CCCC--CCCCC
Confidence            22211   12234568999999876 48999999999999999998 999998888777777776542 2222  23688


Q ss_pred             HHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          271 ASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       271 ~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      ..+.+++.+||+.+|++||++.+++++
T Consensus       235 ~~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         235 SALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             HHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.7e-40  Score=320.72  Aligned_cols=261  Identities=25%  Similarity=0.372  Sum_probs=212.1

Q ss_pred             cccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEE
Q 014733           38 LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVH  117 (419)
Q Consensus        38 ~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~  117 (419)
                      -.++|++.+.||.|++|.||+|.+..+++.+|+|.+.+...  ......+..|+.++.++.+||||+++++++.+....|
T Consensus        13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~   90 (296)
T cd06618          13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVF   90 (296)
T ss_pred             CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC--hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEE
Confidence            45789999999999999999999998899999999976532  2345566778887777767999999999999999999


Q ss_pred             EEEeecCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeccCCCCcEEEeecCCCCCeEEeeccceeeec
Q 014733          118 LLMELCAGGELFHRLEK-YGRFSETEARVIFRHLMQVVSYCHG-NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIK  195 (419)
Q Consensus       118 lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qll~aL~~LH~-~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~  195 (419)
                      ++|||+. ++|..++.. .+.+++..+..++.|++.||+|||+ .+|+||||+|+||++   +.++.+||+|||++..+.
T Consensus        91 ~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill---~~~~~~kL~dfg~~~~~~  166 (296)
T cd06618          91 ICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILL---DASGNVKLCDFGISGRLV  166 (296)
T ss_pred             EEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEE---cCCCCEEECccccchhcc
Confidence            9999984 577777655 3568999999999999999999997 599999999999999   567789999999988765


Q ss_pred             cCCccccccCCCccCCcccccCC-----CCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhcCCCCCCCCCCCC
Q 014733          196 AGQNLHGTVGSPFYIAPEVLAGG-----YNQAADVWSAGVILYILLSGMPPFWGKTK-SKIFDAVRAADLRFPSDPWDHI  269 (419)
Q Consensus       196 ~~~~~~~~~gt~~y~aPE~l~~~-----~s~~sDvwSlGvil~elltG~~Pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~  269 (419)
                      .........++..|+|||.+.+.     ++.++|+||||+++|+|++|+.||..... .+....+........ .....+
T Consensus       167 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  245 (296)
T cd06618         167 DSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSL-PPNEGF  245 (296)
T ss_pred             CCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCC-CCCCCC
Confidence            44444445678899999998642     78899999999999999999999965332 233333333322111 111257


Q ss_pred             CHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          270 SASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       270 s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                      +.++.+||.+||..||++||++.++++||||.....
T Consensus       246 ~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  281 (296)
T cd06618         246 SPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYET  281 (296)
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHhcChhhhccch
Confidence            899999999999999999999999999999986543

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.7e-40  Score=322.56  Aligned_cols=253  Identities=25%  Similarity=0.376  Sum_probs=210.9

Q ss_pred             ccccCeeeeeeecccCceEEEEEEecC-------CCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEE
Q 014733           37 NLSDRYVLGKQLGWGQFGVIRECSDKF-------TGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAV  109 (419)
Q Consensus        37 ~~~~~y~i~~~LG~G~~g~V~~a~~~~-------~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~  109 (419)
                      ...++|.+++.||+|+||.||+|.+..       ++..+|+|.+....  .......+..|+++++++.+||||++++++
T Consensus        15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~   92 (307)
T cd05098          15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGA   92 (307)
T ss_pred             eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence            345899999999999999999998643       23569999987542  345567788999999999669999999999


Q ss_pred             EEeCCEEEEEEeecCCCChHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEE
Q 014733          110 YEEEDYVHLLMELCAGGELFHRLEKYG----------------RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENIL  173 (419)
Q Consensus       110 ~~~~~~~~lV~E~~~ggsL~~~l~~~~----------------~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NIL  173 (419)
                      +.+.+.+|+||||+++++|.+++....                .+++.++..++.|++.||+|||+.|++||||||+||+
T Consensus        93 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil  172 (307)
T cd05098          93 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL  172 (307)
T ss_pred             EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheE
Confidence            999999999999999999999997642                3788999999999999999999999999999999999


Q ss_pred             EeecCCCCCeEEeeccceeeeccCCcc---ccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 014733          174 LATKSSSSPIKLADFGLATYIKAGQNL---HGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKS  248 (419)
Q Consensus       174 l~~~~~~~~vKL~DFgla~~~~~~~~~---~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~  248 (419)
                      +   +.++.+||+|||++.........   ....++..|+|||++.+. ++.++|+|||||++|+|++ |..||.+....
T Consensus       173 l---~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~  249 (307)
T cd05098         173 V---TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE  249 (307)
T ss_pred             E---cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence            9   55678999999998765432211   112345679999998764 8999999999999999998 99999888877


Q ss_pred             HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          249 KIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       249 ~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      +..+.+.....   ...+..++.++.++|.+||..+|++|||+.+++++
T Consensus       250 ~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         250 ELFKLLKEGHR---MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             HHHHHHHcCCC---CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            77777655432   12234688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3e-43  Score=372.84  Aligned_cols=263  Identities=34%  Similarity=0.547  Sum_probs=226.9

Q ss_pred             hhhccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEE
Q 014733           32 ATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYE  111 (419)
Q Consensus        32 ~~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~  111 (419)
                      +...+++.-|+.-+..||.|.||.||.|.+..+|+..|+|.+...... ......+.+|++++..+. |||+|+++++-.
T Consensus      1227 a~~lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~ln-HpNlV~YyGVEv 1304 (1509)
T KOG4645|consen 1227 ASSLSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLN-HPNLVRYYGVEV 1304 (1509)
T ss_pred             HHHhccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhcc-CccccccCceee
Confidence            345666777888899999999999999999999999999999866543 456778999999999995 999999999999


Q ss_pred             eCCEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccce
Q 014733          112 EEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA  191 (419)
Q Consensus       112 ~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla  191 (419)
                      ..+.++|.||||.||+|.++++..+..++...+.+..|+++|+.|||++|||||||||+||+|   +.+|.+|++|||.|
T Consensus      1305 HRekv~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~L---d~~g~iK~~DFGsa 1381 (1509)
T KOG4645|consen 1305 HREKVYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILL---DFNGLIKYGDFGSA 1381 (1509)
T ss_pred             cHHHHHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceee---ecCCcEEeecccce
Confidence            999999999999999999999987778898999999999999999999999999999999999   56779999999999


Q ss_pred             eeeccCC-----ccccccCCCccCCcccccC----CCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhcCCCC
Q 014733          192 TYIKAGQ-----NLHGTVGSPFYIAPEVLAG----GYNQAADVWSAGVILYILLSGMPPFWGKTKS-KIFDAVRAADLRF  261 (419)
Q Consensus       192 ~~~~~~~-----~~~~~~gt~~y~aPE~l~~----~~s~~sDvwSlGvil~elltG~~Pf~~~~~~-~~~~~i~~~~~~~  261 (419)
                      ..+.+..     ......||+.|||||++.+    +...+.|||||||++.||+||+.||...+.+ .++-.+..+..+.
T Consensus      1382 ~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq 1461 (1509)
T KOG4645|consen 1382 VKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQ 1461 (1509)
T ss_pred             eEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCC
Confidence            9886653     2456689999999999976    3568999999999999999999999655443 3444444443322


Q ss_pred             CCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhcccccc
Q 014733          262 PSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE  302 (419)
Q Consensus       262 ~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~  302 (419)
                      .+   ..+|.+.++||..||..||++|.++.|+++|.|-+.
T Consensus      1462 ~P---~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1462 IP---ERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred             Cc---hhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccc
Confidence            11   259999999999999999999999999999988764

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=7.6e-41  Score=323.35  Aligned_cols=259  Identities=32%  Similarity=0.503  Sum_probs=211.4

Q ss_pred             cccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCC-
Q 014733           36 SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEED-  114 (419)
Q Consensus        36 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~-  114 (419)
                      ....++|++.+.||.|++|.||+|.++.+|+.||+|.+..... .......+.+|+.++++++ ||||+++++++.+.. 
T Consensus         3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~-h~~i~~~~~~~~~~~~   80 (302)
T cd07864           3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKILRQLN-HRNIVNLKEIVTDKQD   80 (302)
T ss_pred             hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc-ccCchHHHHHHHHHHHhCC-CCCeeeeeheecCcch
Confidence            3456889999999999999999999999999999999875432 2223456778999999996 999999999987654 


Q ss_pred             ---------EEEEEEeecCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeE
Q 014733          115 ---------YVHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIK  184 (419)
Q Consensus       115 ---------~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vK  184 (419)
                               .+++|+||+++ +|...+... ..+++..++.++.|++.||+|||+.||+|+||||+||++   +.++.+|
T Consensus        81 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili---~~~~~~k  156 (302)
T cd07864          81 ALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILL---NNKGQIK  156 (302)
T ss_pred             hhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCcEE
Confidence                     89999999975 777776653 469999999999999999999999999999999999999   5677899


Q ss_pred             EeeccceeeeccCCc--cccccCCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC
Q 014733          185 LADFGLATYIKAGQN--LHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLR  260 (419)
Q Consensus       185 L~DFgla~~~~~~~~--~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~  260 (419)
                      |+|||++........  .....++..|+|||.+.+  .++.++|||||||++|+|++|++||......+..+.+......
T Consensus       157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~  236 (302)
T cd07864         157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGS  236 (302)
T ss_pred             eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence            999999986643321  223356788999998865  3789999999999999999999999877665555554442111


Q ss_pred             CCC--------------------------CCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhcccc
Q 014733          261 FPS--------------------------DPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWM  300 (419)
Q Consensus       261 ~~~--------------------------~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~  300 (419)
                      ...                          ..+..++..+.++|.+||+.||.+|||+.+++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             CChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence            100                          1123578999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=8.3e-41  Score=328.03  Aligned_cols=257  Identities=21%  Similarity=0.348  Sum_probs=205.4

Q ss_pred             eeeeccc--CceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEEee
Q 014733           45 GKQLGWG--QFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMEL  122 (419)
Q Consensus        45 ~~~LG~G--~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~  122 (419)
                      .+.||+|  +||+||+|.+..+|+.||+|++..... .....+.+.+|+.+++.+. ||||+++++++...+..++||||
T Consensus         3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~~~~~~~v~e~   80 (328)
T cd08226           3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC-TEEHLKALQNEVVLSHFFR-HPNIMTSWTVFTTGSWLWVISPF   80 (328)
T ss_pred             HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC-CHHHHHHHHHHHHHHHhCC-CCCcceEeeeEecCCceEEEEec
Confidence            3456766  899999999999999999999876543 3455678999999999996 99999999999999999999999


Q ss_pred             cCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccC-Cc
Q 014733          123 CAGGELFHRLEKYG--RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG-QN  199 (419)
Q Consensus       123 ~~ggsL~~~l~~~~--~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~-~~  199 (419)
                      +.+++|.+++....  .+++..+..++.|++.||+|||+.||+||||||+|||+   ..++.+|++||+.+...... ..
T Consensus        81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill---~~~~~~~~~~~~~~~~~~~~~~~  157 (328)
T cd08226          81 MAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILI---SGDGLVSLSGLSHLYSLVRNGQK  157 (328)
T ss_pred             ccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---eCCCcEEEechHHHhhhhccCcc
Confidence            99999999987643  48999999999999999999999999999999999999   45678999999854332111 10


Q ss_pred             c-------ccccCCCccCCcccccC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC-------
Q 014733          200 L-------HGTVGSPFYIAPEVLAG---GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFP-------  262 (419)
Q Consensus       200 ~-------~~~~gt~~y~aPE~l~~---~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~-------  262 (419)
                      .       ....++..|+|||++.+   .++.++||||+||++|+|++|++||.+.........+.......+       
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (328)
T cd08226         158 AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFP  237 (328)
T ss_pred             ccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccc
Confidence            0       11234567999999865   378999999999999999999999987655444333322211100       


Q ss_pred             ------------------------------------CCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchhh
Q 014733          263 ------------------------------------SDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQV  306 (419)
Q Consensus       263 ------------------------------------~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~~  306 (419)
                                                          ......++..+.+||++||+.||++|||+.++++||||+.....
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~  317 (328)
T cd08226         238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQ  317 (328)
T ss_pred             hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHh
Confidence                                                01112456789999999999999999999999999999887653

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.4e-40  Score=320.39  Aligned_cols=255  Identities=25%  Similarity=0.380  Sum_probs=212.9

Q ss_pred             ccccccCeeeeeeecccCceEEEEEEecCC-----CcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEE
Q 014733           35 ISNLSDRYVLGKQLGWGQFGVIRECSDKFT-----GEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAV  109 (419)
Q Consensus        35 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~-----g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~  109 (419)
                      ..--.++|++.+.||+|+||.||++.++..     ...+|+|.+...  ........+.+|+.+++++.+|+||++++++
T Consensus         7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~   84 (293)
T cd05053           7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLGV   84 (293)
T ss_pred             cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCC--CCHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence            334457899999999999999999987643     378999998754  2345567788999999999559999999999


Q ss_pred             EEeCCEEEEEEeecCCCChHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEE
Q 014733          110 YEEEDYVHLLMELCAGGELFHRLEKY----------------GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENIL  173 (419)
Q Consensus       110 ~~~~~~~~lV~E~~~ggsL~~~l~~~----------------~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NIL  173 (419)
                      +...+.++++|||+++++|..++...                +.+++..+..++.|++.||+|||+.+|+||||||+|||
T Consensus        85 ~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil  164 (293)
T cd05053          85 CTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVL  164 (293)
T ss_pred             EcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEE
Confidence            99999999999999999999998642                35889999999999999999999999999999999999


Q ss_pred             EeecCCCCCeEEeeccceeeeccCCc---cccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 014733          174 LATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTKS  248 (419)
Q Consensus       174 l~~~~~~~~vKL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~  248 (419)
                      +   +.++.+||+|||++..+.....   .....++..|+|||++.+ .++.++|||||||++|+|++ |..||.+....
T Consensus       165 ~---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~  241 (293)
T cd05053         165 V---TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE  241 (293)
T ss_pred             E---cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH
Confidence            9   5677899999999987644321   112234567999998766 48999999999999999997 99999988887


Q ss_pred             HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          249 KIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       249 ~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      +..+.+..... .  ......+.++.+|+.+||..||++|||+.+++++
T Consensus       242 ~~~~~~~~~~~-~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         242 ELFKLLKEGYR-M--EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             HHHHHHHcCCc-C--CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            77777655432 1  1223678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.5e-40  Score=324.46  Aligned_cols=249  Identities=23%  Similarity=0.335  Sum_probs=206.9

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcE----EEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCC
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEV----LACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEED  114 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~----vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~  114 (419)
                      ..+|++.+.||+|+||.||+|.+..+++.    ||+|.+...  ......+.+..|+.+++.+. ||||+++++++... 
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~-h~niv~~~g~~~~~-   81 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVD-NPHVCRLLGICLTS-   81 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc--CCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEcCC-
Confidence            36799999999999999999998766654    899988643  23455678889999999996 99999999999875 


Q ss_pred             EEEEEEeecCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceee
Q 014733          115 YVHLLMELCAGGELFHRLEKYG-RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATY  193 (419)
Q Consensus       115 ~~~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~  193 (419)
                      ..++++||+++|+|.+++.... .+++..+..++.||+.||+|||+.+|+||||||+|||+   +.++.+||+|||++..
T Consensus        82 ~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill---~~~~~~kl~DfG~a~~  158 (316)
T cd05108          82 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLV---KTPQHVKITDFGLAKL  158 (316)
T ss_pred             CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEe---cCCCcEEEcccccccc
Confidence            4679999999999999997643 58999999999999999999999999999999999999   5667899999999987


Q ss_pred             eccCCcc---ccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCC
Q 014733          194 IKAGQNL---HGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDH  268 (419)
Q Consensus       194 ~~~~~~~---~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  268 (419)
                      .......   ....++..|+|||++.+ .++.++||||||+++|||++ |..||.+....+....+.. ....+..  ..
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~--~~  235 (316)
T cd05108         159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK-GERLPQP--PI  235 (316)
T ss_pred             ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhC-CCCCCCC--CC
Confidence            6543322   22234667999999876 48999999999999999997 9999988776665554433 3333332  35


Q ss_pred             CCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          269 ISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       269 ~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      .+.++.+++.+||..||.+||++.+++.+
T Consensus       236 ~~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         236 CTIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            78899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=8.1e-41  Score=324.05  Aligned_cols=256  Identities=28%  Similarity=0.435  Sum_probs=206.3

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeC-----
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEE-----  113 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~-----  113 (419)
                      .++|++.+.||.|+||.||+|.++.+++.+|+|.+..... .......+.+|++++++++ ||||+++++++.+.     
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~   84 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNE-KDGFPITALREIKILKKLK-HPNVVPLIDMAVERPDKSK   84 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccC-CCCcchhHHHHHHHHHhcC-CCCccchhhheeccccccc
Confidence            5899999999999999999999999999999999875432 1122345678999999996 99999999987543     


Q ss_pred             ---CEEEEEEeecCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeecc
Q 014733          114 ---DYVHLLMELCAGGELFHRLEK-YGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFG  189 (419)
Q Consensus       114 ---~~~~lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFg  189 (419)
                         ..+++||||+. ++|...+.. ...+++..+..++.|+++||+|||+.||+|+||||+||++   +.++.+||+|||
T Consensus        85 ~~~~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg  160 (311)
T cd07866          85 RKRGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILI---DNQGILKIADFG  160 (311)
T ss_pred             ccCceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECcCc
Confidence               35799999995 467766654 3469999999999999999999999999999999999999   567899999999


Q ss_pred             ceeeeccCCc------------cccccCCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 014733          190 LATYIKAGQN------------LHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVR  255 (419)
Q Consensus       190 la~~~~~~~~------------~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~  255 (419)
                      ++........            .....+++.|+|||.+.+  .++.++||||||+++|+|++|++||.+.+.....+.+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~  240 (311)
T cd07866         161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF  240 (311)
T ss_pred             cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            9976543221            112356888999998765  37899999999999999999999998877766555543


Q ss_pred             hcCCCCCC--------------------------CCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhcccc
Q 014733          256 AADLRFPS--------------------------DPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWM  300 (419)
Q Consensus       256 ~~~~~~~~--------------------------~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~  300 (419)
                      ......+.                          ..+..+++.+.++|.+||+.||++|||+.+++.||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            32111000                          0112455788999999999999999999999999997

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-40  Score=315.83  Aligned_cols=250  Identities=22%  Similarity=0.316  Sum_probs=210.0

Q ss_pred             cccCeeeeeeecccCceEEEEEEecCC-----CcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEe
Q 014733           38 LSDRYVLGKQLGWGQFGVIRECSDKFT-----GEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEE  112 (419)
Q Consensus        38 ~~~~y~i~~~LG~G~~g~V~~a~~~~~-----g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~  112 (419)
                      ..++|++.+.||+|+||.||+|.++..     +..+|+|.+....  .......+.+|+.+++.+. ||||+++++++.+
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~   80 (277)
T cd05032           4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFN-CHHVVRLLGVVST   80 (277)
T ss_pred             chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCC-CCceeEEEEEEcC
Confidence            357899999999999999999988643     4789999986442  3345567889999999995 9999999999999


Q ss_pred             CCEEEEEEeecCCCChHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCC
Q 014733          113 EDYVHLLMELCAGGELFHRLEKYG----------RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSP  182 (419)
Q Consensus       113 ~~~~~lV~E~~~ggsL~~~l~~~~----------~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~  182 (419)
                      ....++||||+++++|.+++....          .+++..+..++.|++.||.|||+.+|+||||||+|||+   +.++.
T Consensus        81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill---~~~~~  157 (277)
T cd05032          81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMV---AEDLT  157 (277)
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEE---cCCCC
Confidence            999999999999999999986532          36788999999999999999999999999999999999   56788


Q ss_pred             eEEeeccceeeeccCCc---cccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc
Q 014733          183 IKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAA  257 (419)
Q Consensus       183 vKL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~  257 (419)
                      +||+|||++........   .....++..|+|||.+.+ .++.++|+|||||++|+|++ |..||.+....+..+.+...
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~  237 (277)
T cd05032         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDG  237 (277)
T ss_pred             EEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcC
Confidence            99999999876543321   122356788999998875 48999999999999999998 99999988888887777643


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          258 DLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       258 ~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                      ...   ......+.++.++|.+||+.+|++|||+.+++.
T Consensus       238 ~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         238 GHL---DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             CCC---CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            221   112357899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=3e-40  Score=312.23  Aligned_cols=241  Identities=24%  Similarity=0.347  Sum_probs=203.1

Q ss_pred             eecccCceEEEEEEe--cCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEEeecC
Q 014733           47 QLGWGQFGVIRECSD--KFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCA  124 (419)
Q Consensus        47 ~LG~G~~g~V~~a~~--~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~  124 (419)
                      .||+|+||.||+|.+  +.++..+|+|++.... ......+.+.+|+.+++++. ||||+++++++.+ ...++||||++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~-~~~~lv~e~~~   78 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLD-NPYIVRMIGICEA-ESWMLVMELAE   78 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCC-CCCcceEEEEEcC-CCcEEEEecCC
Confidence            589999999999965  4567899999986543 34456678999999999995 9999999998864 45789999999


Q ss_pred             CCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCCcc----
Q 014733          125 GGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNL----  200 (419)
Q Consensus       125 ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~~~----  200 (419)
                      +++|.+++...+.+++..+..++.|++.||+|||++||+||||||.||++   +.++.+||+|||++.........    
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~  155 (257)
T cd05116          79 LGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLL---VTQHYAKISDFGLSKALGADENYYKAK  155 (257)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEE---cCCCeEEECCCccccccCCCCCeeeec
Confidence            99999999887889999999999999999999999999999999999999   45678999999999876443321    


Q ss_pred             ccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHH
Q 014733          201 HGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM  278 (419)
Q Consensus       201 ~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~  278 (419)
                      ....++..|+|||.+.+ .++.++|+|||||++|||++ |.+||.+....+....+..... .+  .+..++++++++|.
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~-~~--~~~~~~~~l~~li~  232 (257)
T cd05116         156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGER-ME--CPQRCPPEMYDLMK  232 (257)
T ss_pred             CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC-CC--CCCCCCHHHHHHHH
Confidence            12234578999998875 48899999999999999998 9999988888777777765432 11  22368999999999


Q ss_pred             hhhhcCCCCCCCHHHHHh
Q 014733          279 GMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       279 ~~L~~dP~~Rps~~eil~  296 (419)
                      +||+.||++||++.+|.+
T Consensus       233 ~~~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         233 LCWTYGVDERPGFAVVEL  250 (257)
T ss_pred             HHhccCchhCcCHHHHHH
Confidence            999999999999999965

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.1e-40  Score=319.37  Aligned_cols=249  Identities=20%  Similarity=0.332  Sum_probs=209.9

Q ss_pred             cCeeeeeeecccCceEEEEEEecC-----CCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCC
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKF-----TGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEED  114 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~-----~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~  114 (419)
                      .+|++.+.||.|+||.||+|.+..     .+..||+|++....  .....+.+.+|+.++..+. ||||+++++++.+.+
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~~~~   81 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQ-HPNIVCLLGVVTKEQ   81 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEcCCC
Confidence            468899999999999999998753     35789999987542  3344577889999999996 999999999999999


Q ss_pred             EEEEEEeecCCCChHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecC
Q 014733          115 YVHLLMELCAGGELFHRLEKY----------------GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKS  178 (419)
Q Consensus       115 ~~~lV~E~~~ggsL~~~l~~~----------------~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~  178 (419)
                      ..++++||+.+++|..++...                ..+++..+..++.|++.||+|||+.||+||||||+|||+   .
T Consensus        82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~---~  158 (283)
T cd05091          82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLV---F  158 (283)
T ss_pred             ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEe---c
Confidence            999999999999999998532                247888899999999999999999999999999999999   4


Q ss_pred             CCCCeEEeeccceeeeccCCc---cccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 014733          179 SSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDA  253 (419)
Q Consensus       179 ~~~~vKL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~  253 (419)
                      +++.+||+|||++........   .....+++.|+|||++.+ .++.++|||||||++|||++ |..||.+....+..+.
T Consensus       159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~  238 (283)
T cd05091         159 DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM  238 (283)
T ss_pred             CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            567899999999876543221   122345778999999865 58999999999999999998 8999988888888888


Q ss_pred             HHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          254 VRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       254 i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      +.......   ....++.++.+++.+||+.+|.+||++.+|+..
T Consensus       239 i~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         239 IRNRQVLP---CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             HHcCCcCC---CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            77665432   124689999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-40  Score=317.79  Aligned_cols=253  Identities=34%  Similarity=0.516  Sum_probs=209.4

Q ss_pred             eeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEEe
Q 014733           42 YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLME  121 (419)
Q Consensus        42 y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  121 (419)
                      |.+.+.||+|++|+||+|....+++.+++|.+......  .......+|+..++++.+|+||+++++++.+++..++|||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   78 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE   78 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence            77899999999999999999989999999998754321  2233455689999999669999999999999999999999


Q ss_pred             ecCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCCc
Q 014733          122 LCAGGELFHRLEKYG--RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN  199 (419)
Q Consensus       122 ~~~ggsL~~~l~~~~--~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~~  199 (419)
                      |+ +++|.+.+....  .+++..+..++.|++.+|.|||+++++|+||+|+||++   +.++.++|+|||++........
T Consensus        79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i---~~~~~~~l~d~~~~~~~~~~~~  154 (283)
T cd07830          79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLV---SGPEVVKIADFGLAREIRSRPP  154 (283)
T ss_pred             cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---cCCCCEEEeecccceeccCCCC
Confidence            99 889999887754  68999999999999999999999999999999999999   5678999999999987655444


Q ss_pred             cccccCCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC----------------
Q 014733          200 LHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRF----------------  261 (419)
Q Consensus       200 ~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~----------------  261 (419)
                      .....++..|+|||++.+  .++.++|+||||+++++|++|++||......+....+.......                
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07830         155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG  234 (283)
T ss_pred             cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence            445678899999998854  37899999999999999999999997776555444332211100                


Q ss_pred             ---CC-------CCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhcccc
Q 014733          262 ---PS-------DPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWM  300 (419)
Q Consensus       262 ---~~-------~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~  300 (419)
                         +.       ......+..+.++|++||+.||++|||+.|++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence               00       0012336889999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=4.8e-40  Score=321.11  Aligned_cols=257  Identities=28%  Similarity=0.458  Sum_probs=216.9

Q ss_pred             cccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEE
Q 014733           38 LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVH  117 (419)
Q Consensus        38 ~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~  117 (419)
                      ....|...+.||+|+||.||+|.+..++..+|+|.+.............+.+|+.+++++. |||++++++++.+.+..+
T Consensus        23 ~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~  101 (317)
T cd06635          23 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK-HPNSIEYKGCYLREHTAW  101 (317)
T ss_pred             chhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCC-CCCEEEEEEEEeeCCeEE
Confidence            3445888999999999999999999899999999987655445566678999999999996 999999999999999999


Q ss_pred             EEEeecCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeecc
Q 014733          118 LLMELCAGGELFHRLEK-YGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA  196 (419)
Q Consensus       118 lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~  196 (419)
                      +||||+.| +|.+.+.. ..++++.++..++.+++.||.|||+.+|+||||+|+||++   +.++.+||+|||++.....
T Consensus       102 lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~---~~~~~~kl~dfg~~~~~~~  177 (317)
T cd06635         102 LVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL---TEPGQVKLADFGSASIASP  177 (317)
T ss_pred             EEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEE---CCCCCEEEecCCCccccCC
Confidence            99999965 77777654 4568999999999999999999999999999999999999   5577899999999875432


Q ss_pred             CCccccccCCCccCCccccc----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHH
Q 014733          197 GQNLHGTVGSPFYIAPEVLA----GGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISAS  272 (419)
Q Consensus       197 ~~~~~~~~gt~~y~aPE~l~----~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  272 (419)
                         .....|++.|+|||++.    +.++.++|+|||||++|+|++|..||...........+.......  .....++..
T Consensus       178 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  252 (317)
T cd06635         178 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT--LQSNEWSDY  252 (317)
T ss_pred             ---cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCC--CCCccccHH
Confidence               23356888999999874    248899999999999999999999998877666565555443322  222367889


Q ss_pred             HHHHHHhhhhcCCCCCCCHHHHHhccccccch
Q 014733          273 ARDLIMGMLRVDPSTRLTAAEVLAHSWMEECE  304 (419)
Q Consensus       273 l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~  304 (419)
                      ++++|.+||+.+|.+||++.++++|+|+....
T Consensus       253 l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~  284 (317)
T cd06635         253 FRNFVDSCLQKIPQDRPTSEELLKHMFVLRER  284 (317)
T ss_pred             HHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence            99999999999999999999999999996543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.4e-40  Score=328.56  Aligned_cols=259  Identities=30%  Similarity=0.501  Sum_probs=210.9

Q ss_pred             cccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeC----
Q 014733           38 LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEE----  113 (419)
Q Consensus        38 ~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~----  113 (419)
                      +.++|.+.+.||.|+||.||+|.+..+|+.||+|.+.+.. ........+.+|+.+++.+. ||||+++++++...    
T Consensus        13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~   90 (342)
T cd07879          13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPF-QSEIFAKRAYRELTLLKHMQ-HENVIGLLDVFTSAVSGD   90 (342)
T ss_pred             cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcc-ccccchhHHHHHHHHHHhcC-CCCccchhheecccccCC
Confidence            4689999999999999999999999899999999987543 22233456788999999995 99999999998754    


Q ss_pred             --CEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccce
Q 014733          114 --DYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA  191 (419)
Q Consensus       114 --~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla  191 (419)
                        ..+++|+||+. .+|..++  ...+++..+..++.|++.||+|||+.+|+||||||+||++   +.++.+||+|||++
T Consensus        91 ~~~~~~lv~e~~~-~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll---~~~~~~kL~dfg~~  164 (342)
T cd07879          91 EFQDFYLVMPYMQ-TDLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAV---NEDCELKILDFGLA  164 (342)
T ss_pred             CCceEEEEecccc-cCHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEeeCCCC
Confidence              35699999995 4666654  2468999999999999999999999999999999999999   56789999999998


Q ss_pred             eeeccCCccccccCCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-----------
Q 014733          192 TYIKAGQNLHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAAD-----------  258 (419)
Q Consensus       192 ~~~~~~~~~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-----------  258 (419)
                      .....  ......++..|+|||++.+  .++.++|||||||++|+|++|+.||.+.........+....           
T Consensus       165 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (342)
T cd07879         165 RHADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKL  242 (342)
T ss_pred             cCCCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence            76432  2334577889999999865  38899999999999999999999998876555444433211           


Q ss_pred             ------------CCCCCC----CCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchhh
Q 014733          259 ------------LRFPSD----PWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQV  306 (419)
Q Consensus       259 ------------~~~~~~----~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~~  306 (419)
                                  ...+..    .+...+.++.+||.+||+.||++||++.+++.||||+.....
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~  306 (342)
T cd07879         243 EDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA  306 (342)
T ss_pred             cccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence                        001111    123577889999999999999999999999999999887543

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=3e-40  Score=312.48  Aligned_cols=246  Identities=24%  Similarity=0.352  Sum_probs=207.6

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      ++|++.+.||+|++|+||+|.+.. +..+|+|.+.....    ....+.+|+.+++++. ||||+++++++.+.+.++++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   77 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM----SEDEFIEEAKVMMKLS-HEKLVQLYGVCTKQRPIYIV   77 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc----cHHHHHHHHHHHhcCC-CCCeeeEEEEEccCCCcEEE
Confidence            579999999999999999997753 45699998875432    2356888999999996 99999999999999999999


Q ss_pred             EeecCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC
Q 014733          120 MELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ  198 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~  198 (419)
                      |||+.+++|.+++... ..+++..++.++.|++.||+|||+.|++|+||||+||++   +.++.+||+|||.+.......
T Consensus        78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili---~~~~~~kl~d~g~~~~~~~~~  154 (256)
T cd05113          78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLV---DDQGCVKVSDFGLSRYVLDDE  154 (256)
T ss_pred             EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEE---cCCCCEEECCCccceecCCCc
Confidence            9999999999999764 368999999999999999999999999999999999999   556789999999988654332


Q ss_pred             cc--ccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 014733          199 NL--HGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASAR  274 (419)
Q Consensus       199 ~~--~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~  274 (419)
                      ..  .+..++..|+|||++.+ .++.++|+||||+++|+|++ |+.||......+....+........   ....+..+.
T Consensus       155 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  231 (256)
T cd05113         155 YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYR---PHLASEKVY  231 (256)
T ss_pred             eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCC---CCCCCHHHH
Confidence            21  22345667999999876 48999999999999999998 9999988877777777765533222   225689999


Q ss_pred             HHHHhhhhcCCCCCCCHHHHHhc
Q 014733          275 DLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       275 ~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      +++.+||+.||.+||++.+++.+
T Consensus       232 ~li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         232 AIMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             HHHHHHcCCCcccCCCHHHHHHh
Confidence            99999999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=4.2e-40  Score=320.95  Aligned_cols=250  Identities=25%  Similarity=0.390  Sum_probs=209.6

Q ss_pred             ccCeeeeeeecccCceEEEEEEec-------CCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEE
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDK-------FTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYE  111 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~-------~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~  111 (419)
                      .++|.++++||+|+||.||+|.+.       .....+|+|.+...  ........+.+|+.+++++.+||||+++++++.
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   88 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDN--ATDKDLADLISEMELMKLIGKHKNIINLLGVCT   88 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCC--CChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence            478999999999999999999763       23457999988654  234567788999999999966999999999999


Q ss_pred             eCCEEEEEEeecCCCChHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEe
Q 014733          112 EEDYVHLLMELCAGGELFHRLEKY----------------GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLA  175 (419)
Q Consensus       112 ~~~~~~lV~E~~~ggsL~~~l~~~----------------~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~  175 (419)
                      +.+.++++|||+++++|.+++...                ..+++.++..++.||+.||.|||++||+||||||+|||+ 
T Consensus        89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill-  167 (314)
T cd05099          89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV-  167 (314)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEE-
Confidence            999999999999999999999653                237889999999999999999999999999999999999 


Q ss_pred             ecCCCCCeEEeeccceeeeccCCc---cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 014733          176 TKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKI  250 (419)
Q Consensus       176 ~~~~~~~vKL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~  250 (419)
                        +.++.+||+|||+++.......   .....++..|+|||++.+. ++.++|+||||+++|+|++ |..||.+....+.
T Consensus       168 --~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~  245 (314)
T cd05099         168 --TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL  245 (314)
T ss_pred             --cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence              5567899999999986543221   1112344679999998764 8999999999999999999 9999988888888


Q ss_pred             HHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          251 FDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       251 ~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                      ++.+......   .....++.+++++|.+||..||++|||+.++++
T Consensus       246 ~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         246 FKLLREGHRM---DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             HHHHHcCCCC---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            8777654321   122467889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.7e-40  Score=313.23  Aligned_cols=248  Identities=25%  Similarity=0.357  Sum_probs=206.4

Q ss_pred             eeeeeeecccCceEEEEEEecCC---CcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCE---
Q 014733           42 YVLGKQLGWGQFGVIRECSDKFT---GEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDY---  115 (419)
Q Consensus        42 y~i~~~LG~G~~g~V~~a~~~~~---g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~---  115 (419)
                      |.+++.||+|+||.||+|....+   +..+|+|.+.... ........+.+|+.+++.+. ||||+++++++.+...   
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~   78 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDI-HTYSEIEEFLSEAACMKDFD-HPNVMKLIGVCFEASSLQK   78 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCc-CCHHHHHHHHHHHHHHHhCC-CCCeeeEEeeeccCCcccc
Confidence            67899999999999999987643   4789999987543 23456778999999999996 9999999998865443   


Q ss_pred             ---EEEEEeecCCCChHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEe
Q 014733          116 ---VHLLMELCAGGELFHRLEKY------GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLA  186 (419)
Q Consensus       116 ---~~lV~E~~~ggsL~~~l~~~------~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~  186 (419)
                         .+++|||+++++|..++...      ..+++..+..++.|++.||+|||+.+|+||||||+||++   ++++.+||+
T Consensus        79 ~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~  155 (273)
T cd05035          79 IPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCML---REDMTVCVA  155 (273)
T ss_pred             CcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEE---CCCCeEEEC
Confidence               79999999999999888542      258999999999999999999999999999999999999   556789999


Q ss_pred             eccceeeeccCCcc---ccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCC
Q 014733          187 DFGLATYIKAGQNL---HGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRF  261 (419)
Q Consensus       187 DFgla~~~~~~~~~---~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~  261 (419)
                      |||+++........   ....++..|+|||++.+. ++.++|||||||++|||++ |.+||.+....+..+.+...... 
T Consensus       156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~-  234 (273)
T cd05035         156 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRL-  234 (273)
T ss_pred             CccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-
Confidence            99999866433221   122356679999998764 8999999999999999999 99999888887877777654322 


Q ss_pred             CCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          262 PSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       262 ~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                        .....++.++.+++.+||+.||++|||+.+++++
T Consensus       235 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         235 --KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             --CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence              1224688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-40  Score=329.10  Aligned_cols=263  Identities=25%  Similarity=0.347  Sum_probs=210.5

Q ss_pred             cccccchhhccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCcee
Q 014733           26 TGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD  105 (419)
Q Consensus        26 ~~~~~~~~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~  105 (419)
                      ....+...++...++.|.-...||+|+||.||+|... .|..||||.+......  . .++|.+|+.+|.+++ |||+|+
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~--~-~~eF~~Ei~~ls~l~-H~Nlv~  135 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQ--G-EREFLNEVEILSRLR-HPNLVK  135 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCc--c-hhHHHHHHHHHhcCC-CcCccc
Confidence            4566788899999999999999999999999999876 4489999977654321  1 456999999999997 999999


Q ss_pred             eeEEEEeCC-EEEEEEeecCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---CeeccCCCCcEEEeecCC
Q 014733          106 LKAVYEEED-YVHLLMELCAGGELFHRLEKYG--RFSETEARVIFRHLMQVVSYCHGNG---VVHRDLKPENILLATKSS  179 (419)
Q Consensus       106 l~~~~~~~~-~~~lV~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qll~aL~~LH~~~---IvHrDLkp~NILl~~~~~  179 (419)
                      |+|+|.+.+ ..+||+||+++|+|.++|....  +++|..+..|+.++++||+|||+..   |||||||++||||   ++
T Consensus       136 LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILL---D~  212 (361)
T KOG1187|consen  136 LLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILL---DE  212 (361)
T ss_pred             EEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeE---CC
Confidence            999999998 5999999999999999997655  8999999999999999999999864   9999999999999   56


Q ss_pred             CCCeEEeeccceeeecc-CCccccc-cCCCccCCcccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCC---HHHHHH-
Q 014733          180 SSPIKLADFGLATYIKA-GQNLHGT-VGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKT---KSKIFD-  252 (419)
Q Consensus       180 ~~~vKL~DFgla~~~~~-~~~~~~~-~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~---~~~~~~-  252 (419)
                      +...||+|||+|+.... ....... .||.+|+|||++.. ..+.++|||||||+|.||++|+.+.....   ...+.. 
T Consensus       213 ~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w  292 (361)
T KOG1187|consen  213 DFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEW  292 (361)
T ss_pred             CCCEEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHH
Confidence            78899999999976544 3333333 89999999999875 58999999999999999999998886432   111222 


Q ss_pred             ---HHHhcCCCCCCC-C-C-CCCC--HH---HHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          253 ---AVRAADLRFPSD-P-W-DHIS--AS---ARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       253 ---~i~~~~~~~~~~-~-~-~~~s--~~---l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                         .+.......-.+ . . ...+  .+   +..+..+|++.+|++||++.+|++
T Consensus       293 ~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  293 AKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             HHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence               222221111111 1 1 2233  23   456888999999999999999865

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-42  Score=338.31  Aligned_cols=236  Identities=26%  Similarity=0.418  Sum_probs=205.6

Q ss_pred             eeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEEeecC
Q 014733           45 GKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCA  124 (419)
Q Consensus        45 ~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~  124 (419)
                      ++.||.|+.|-||+|+..  ++.||||+++.          .-..+|+.|++|+ ||||+.+.++|...-.++||||||.
T Consensus       129 LeWlGSGaQGAVF~Grl~--netVAVKKV~e----------lkETdIKHLRkLk-H~NII~FkGVCtqsPcyCIiMEfCa  195 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRLH--NETVAVKKVRE----------LKETDIKHLRKLK-HPNIITFKGVCTQSPCYCIIMEFCA  195 (904)
T ss_pred             hhhhccCcccceeeeecc--CceehhHHHhh----------hhhhhHHHHHhcc-CcceeeEeeeecCCceeEEeeeccc
Confidence            678999999999999754  88999997742          2235788999996 9999999999999999999999999


Q ss_pred             CCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCCcccccc
Q 014733          125 GGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTV  204 (419)
Q Consensus       125 ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~~~~~~~  204 (419)
                      .|-|...|+....++......|..+|+.|+.|||.+.|||||||.-||||   ..+..|||+|||.++.+........++
T Consensus       196 ~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLI---s~~d~VKIsDFGTS~e~~~~STkMSFa  272 (904)
T KOG4721|consen  196 QGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILI---SYDDVVKISDFGTSKELSDKSTKMSFA  272 (904)
T ss_pred             cccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEe---eccceEEeccccchHhhhhhhhhhhhh
Confidence            99999999998889999999999999999999999999999999999999   456689999999999877766667789


Q ss_pred             CCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhc
Q 014733          205 GSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRV  283 (419)
Q Consensus       205 gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~  283 (419)
                      ||-.|||||+++.. .+.|+|||||||+||||+||..||.+-....++=-+-...+..|..  ...++.++=||++||+-
T Consensus       273 GTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvP--stcP~GfklL~Kqcw~s  350 (904)
T KOG4721|consen  273 GTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVP--STCPDGFKLLLKQCWNS  350 (904)
T ss_pred             hhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCc--ccCchHHHHHHHHHHhc
Confidence            99999999999985 8999999999999999999999997655443332233333333332  47889999999999999


Q ss_pred             CCCCCCCHHHHHhcc
Q 014733          284 DPSTRLTAAEVLAHS  298 (419)
Q Consensus       284 dP~~Rps~~eil~hp  298 (419)
                      .|..||++.+||.|-
T Consensus       351 KpRNRPSFrqil~Hl  365 (904)
T KOG4721|consen  351 KPRNRPSFRQILLHL  365 (904)
T ss_pred             CCCCCccHHHHHHHH
Confidence            999999999999984

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.3e-40  Score=310.56  Aligned_cols=246  Identities=26%  Similarity=0.389  Sum_probs=208.2

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEE
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHL  118 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~l  118 (419)
                      .++|++.+.||+|++|.||+|.+. .++.||+|.+.....    ..+.+.+|+.+++++. ||||+++++++...+..++
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l   78 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLR-HPKLIQLYAVCTLEEPIYI   78 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCC-CCCccceeEEEecCCCeee
Confidence            467999999999999999999875 457899999875432    3466888999999996 9999999999999999999


Q ss_pred             EEeecCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeecc
Q 014733          119 LMELCAGGELFHRLEKYG--RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA  196 (419)
Q Consensus       119 V~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~  196 (419)
                      +|||+++++|.+++....  .+++..+..++.|++.||.+||+.||+||||||+||++   +.++.+||+|||++.....
T Consensus        79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~dfg~~~~~~~  155 (261)
T cd05068          79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLV---GENNICKVADFGLARVIKE  155 (261)
T ss_pred             eeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEE---cCCCCEEECCcceEEEccC
Confidence            999999999999997644  58999999999999999999999999999999999999   5677899999999987653


Q ss_pred             CCc--cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHH
Q 014733          197 GQN--LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISAS  272 (419)
Q Consensus       197 ~~~--~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  272 (419)
                      ...  ..+...+..|+|||++.+. ++.++|+||||+++|+|++ |+.||.+....+....+... ...+.  ...++..
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~  232 (261)
T cd05068         156 DIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG-YRMPC--PPGCPKE  232 (261)
T ss_pred             CcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-CCCCC--CCcCCHH
Confidence            221  1122234579999998764 8999999999999999999 99999988877777766543 22222  2367899


Q ss_pred             HHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          273 ARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       273 l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                      +.+++.+||+.+|++||++.++++
T Consensus       233 ~~~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         233 LYDIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             HHHHHHHHhhcCcccCCCHHHHHH
Confidence            999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=5.7e-40  Score=314.07  Aligned_cols=248  Identities=23%  Similarity=0.330  Sum_probs=207.1

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCc----EEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCC
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGE----VLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEED  114 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~----~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~  114 (419)
                      .++|++.++||.|+||+||+|.+..++.    .||+|.+...  ........+.+|+.+++.+. ||||+++++++... 
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~-   81 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN--TSPKANKEILDEAYVMAGVG-SPYVCRLLGICLTS-   81 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCC--CCHHHHHHHHHHHHHHHhcC-CCCCceEEEEEcCC-
Confidence            4689999999999999999999876666    4799988654  23455677889999999996 99999999998764 


Q ss_pred             EEEEEEeecCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceee
Q 014733          115 YVHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATY  193 (419)
Q Consensus       115 ~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~  193 (419)
                      ..++++||+++|+|.+++... +.+++..+..++.|++.||+|||+.+|+||||||+|||+   ..++.+||+|||+++.
T Consensus        82 ~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~---~~~~~~kL~dfG~~~~  158 (279)
T cd05109          82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLV---KSPNHVKITDFGLARL  158 (279)
T ss_pred             CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE---cCCCcEEECCCCceee
Confidence            478999999999999999764 469999999999999999999999999999999999999   5567899999999987


Q ss_pred             eccCCcc---ccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCC
Q 014733          194 IKAGQNL---HGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDH  268 (419)
Q Consensus       194 ~~~~~~~---~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  268 (419)
                      .......   ....++..|+|||++.+ .++.++|||||||++|||++ |..||...........+..... .+.  ...
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-~~~--~~~  235 (279)
T cd05109         159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGER-LPQ--PPI  235 (279)
T ss_pred             cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCc-CCC--Ccc
Confidence            6433221   12245678999999866 48999999999999999998 9999988777776666655432 222  246


Q ss_pred             CCHHHHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          269 ISASARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       269 ~s~~l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                      .+.++.++|.+||+.||++||++.+++.
T Consensus       236 ~~~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         236 CTIDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            8899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.7e-40  Score=319.26  Aligned_cols=258  Identities=31%  Similarity=0.513  Sum_probs=213.1

Q ss_pred             CeeeeeeecccCceEEEEEEec---CCCcEEEEEEeccCccC-CHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEE
Q 014733           41 RYVLGKQLGWGQFGVIRECSDK---FTGEVLACKSIAKDRLV-TVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYV  116 (419)
Q Consensus        41 ~y~i~~~LG~G~~g~V~~a~~~---~~g~~vaiK~i~~~~~~-~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~  116 (419)
                      +|++.+.||+|++|.||++.+.   .+++.+|+|.+.+.... .......+.+|+.+++++++||||+++++++.....+
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4889999999999999999864   46789999998754322 1234566889999999997799999999999999999


Q ss_pred             EEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeecc
Q 014733          117 HLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA  196 (419)
Q Consensus       117 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~  196 (419)
                      ++||||+++++|..++.....+++..++.++.|++++|.|||+.+++||||||.||++   +.++.++|+|||++.....
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~  157 (288)
T cd05583          81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILL---DSEGHVVLTDFGLSKEFLA  157 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEEECcccccccc
Confidence            9999999999999999877789999999999999999999999999999999999999   5567899999999876543


Q ss_pred             CCc--cccccCCCccCCcccccCC---CCCchhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhcCCCCCCCCCC
Q 014733          197 GQN--LHGTVGSPFYIAPEVLAGG---YNQAADVWSAGVILYILLSGMPPFWGKT----KSKIFDAVRAADLRFPSDPWD  267 (419)
Q Consensus       197 ~~~--~~~~~gt~~y~aPE~l~~~---~s~~sDvwSlGvil~elltG~~Pf~~~~----~~~~~~~i~~~~~~~~~~~~~  267 (419)
                      ...  .....|+..|+|||.+.+.   .+.++|+||||+++|+|++|..||....    ..+....+.......    ..
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~  233 (288)
T cd05583         158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPF----PK  233 (288)
T ss_pred             ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCC----Cc
Confidence            322  2234688999999998653   6889999999999999999999996432    223333333332222    23


Q ss_pred             CCCHHHHHHHHhhhhcCCCCCCC---HHHHHhccccccchh
Q 014733          268 HISASARDLIMGMLRVDPSTRLT---AAEVLAHSWMEECEQ  305 (419)
Q Consensus       268 ~~s~~l~~li~~~L~~dP~~Rps---~~eil~hp~~~~~~~  305 (419)
                      .++.++.++|.+||+.||++|||   +.++|+||||+...+
T Consensus       234 ~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~  274 (288)
T cd05583         234 TMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDW  274 (288)
T ss_pred             ccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCH
Confidence            57899999999999999999998   567799999998765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=3.9e-40  Score=317.52  Aligned_cols=247  Identities=22%  Similarity=0.378  Sum_probs=208.7

Q ss_pred             cCeeeeeeecccCceEEEEEEec-----CCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCC
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDK-----FTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEED  114 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~-----~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~  114 (419)
                      ++|.+.+.||+|+||.||+|.+.     .++..+++|.+...   .....+.+.+|+.+++++. ||||+++++++.+.+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~   80 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP---TLAARKDFQREAELLTNLQ-HEHIVKFYGVCGDGD   80 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc---cHHHHHHHHHHHHHHhcCC-CCCcceEEEEEccCC
Confidence            57999999999999999999854     34567888987543   2344567889999999996 999999999999999


Q ss_pred             EEEEEEeecCCCChHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecC
Q 014733          115 YVHLLMELCAGGELFHRLEKYG----------------RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKS  178 (419)
Q Consensus       115 ~~~lV~E~~~ggsL~~~l~~~~----------------~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~  178 (419)
                      ..++||||+++++|.+++...+                .+++..++.++.||+.||+|||+++|+||||||+|||+   +
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~---~  157 (291)
T cd05094          81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLV---G  157 (291)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE---c
Confidence            9999999999999999997543                37899999999999999999999999999999999999   5


Q ss_pred             CCCCeEEeeccceeeeccCCc---cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 014733          179 SSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDA  253 (419)
Q Consensus       179 ~~~~vKL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~  253 (419)
                      .++.+||+|||++........   .....++..|+|||++.+. ++.++||||||+++|+|++ |..||......+..+.
T Consensus       158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~  237 (291)
T cd05094         158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC  237 (291)
T ss_pred             cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            567899999999976543221   1234567889999988764 8999999999999999998 9999988888777777


Q ss_pred             HHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          254 VRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       254 i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                      +........   ....+.++.+++.+||+.||++|||+.++++
T Consensus       238 ~~~~~~~~~---~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         238 ITQGRVLER---PRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             HhCCCCCCC---CccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            665543322   2357899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=4.7e-40  Score=318.86  Aligned_cols=254  Identities=23%  Similarity=0.368  Sum_probs=212.9

Q ss_pred             cccccCeeeeeeecccCceEEEEEEec-------CCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeE
Q 014733           36 SNLSDRYVLGKQLGWGQFGVIRECSDK-------FTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKA  108 (419)
Q Consensus        36 ~~~~~~y~i~~~LG~G~~g~V~~a~~~-------~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~  108 (419)
                      ....++|.+.+.||+|+||.||+|.+.       ..+..+|+|.+...  ......+.+.+|+.+++.+.+||||+++++
T Consensus        11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~   88 (304)
T cd05101          11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLG   88 (304)
T ss_pred             cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc--cchHHHHHHHHHHHHHHhhccCCCchheeE
Confidence            345789999999999999999999753       23457999988644  234566789999999999956999999999


Q ss_pred             EEEeCCEEEEEEeecCCCChHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcE
Q 014733          109 VYEEEDYVHLLMELCAGGELFHRLEKY----------------GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENI  172 (419)
Q Consensus       109 ~~~~~~~~~lV~E~~~ggsL~~~l~~~----------------~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NI  172 (419)
                      ++...+.+|++|||+++++|.+++...                ..+++..+..++.||++||.|||++||+||||||+||
T Consensus        89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni  168 (304)
T cd05101          89 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNV  168 (304)
T ss_pred             EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceE
Confidence            999999999999999999999999763                2367888999999999999999999999999999999


Q ss_pred             EEeecCCCCCeEEeeccceeeeccCCc---cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHh-CCCCCCCCCH
Q 014733          173 LLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTK  247 (419)
Q Consensus       173 Ll~~~~~~~~vKL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~ellt-G~~Pf~~~~~  247 (419)
                      ++   +.++.+||+|||++........   .....++..|+|||++.+. ++.++||||||+++|+|++ |..||.+.+.
T Consensus       169 li---~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~  245 (304)
T cd05101         169 LV---TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV  245 (304)
T ss_pred             EE---cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence            99   5667899999999987643221   1223456789999998764 8999999999999999998 8999998888


Q ss_pred             HHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          248 SKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       248 ~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      .++.+.+......   .....++.++.++|.+||..+|++|||+.++++.
T Consensus       246 ~~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         246 EELFKLLKEGHRM---DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             HHHHHHHHcCCcC---CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            8888877654322   1224688999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=3.6e-40  Score=320.73  Aligned_cols=256  Identities=29%  Similarity=0.467  Sum_probs=215.0

Q ss_pred             cccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEE
Q 014733           38 LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVH  117 (419)
Q Consensus        38 ~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~  117 (419)
                      ...+|...+.||+|++|.||+|+++.+++.+++|.+.............+.+|+++++.+. |+|++++++++.+....+
T Consensus        13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~   91 (308)
T cd06634          13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREHTAW   91 (308)
T ss_pred             cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCC-CCCcccEEEEEEcCCeeE
Confidence            4456888999999999999999999999999999987654444556677889999999996 999999999999999999


Q ss_pred             EEEeecCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeecc
Q 014733          118 LLMELCAGGELFHRLEK-YGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA  196 (419)
Q Consensus       118 lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~  196 (419)
                      +||||+. ++|.+.+.. ..++++.++..++.|++.||.|||+.+++||||||+||++   +.++.+||+|||++.....
T Consensus        92 lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~  167 (308)
T cd06634          92 LVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAP  167 (308)
T ss_pred             EEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEE---CCCCcEEECCcccceeecC
Confidence            9999996 578777654 3458999999999999999999999999999999999999   5567899999999886543


Q ss_pred             CCccccccCCCccCCccccc----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHH
Q 014733          197 GQNLHGTVGSPFYIAPEVLA----GGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISAS  272 (419)
Q Consensus       197 ~~~~~~~~gt~~y~aPE~l~----~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  272 (419)
                      .   ....+++.|+|||.+.    +.++.++|||||||++|+|++|..||......+....+.....  +......++..
T Consensus       168 ~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  242 (308)
T cd06634         168 A---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES--PALQSGHWSEY  242 (308)
T ss_pred             c---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCC--CCcCcccccHH
Confidence            2   3346888999999874    2478899999999999999999999977665554444443322  22222368899


Q ss_pred             HHHHHHhhhhcCCCCCCCHHHHHhccccccc
Q 014733          273 ARDLIMGMLRVDPSTRLTAAEVLAHSWMEEC  303 (419)
Q Consensus       273 l~~li~~~L~~dP~~Rps~~eil~hp~~~~~  303 (419)
                      +.++|++||+.+|++||++.++++|||+...
T Consensus       243 ~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~  273 (308)
T cd06634         243 FRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (308)
T ss_pred             HHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence            9999999999999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=4.4e-40  Score=313.07  Aligned_cols=248  Identities=24%  Similarity=0.327  Sum_probs=204.9

Q ss_pred             eeeeeeecccCceEEEEEEecCCCc--EEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEe------C
Q 014733           42 YVLGKQLGWGQFGVIRECSDKFTGE--VLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEE------E  113 (419)
Q Consensus        42 y~i~~~LG~G~~g~V~~a~~~~~g~--~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~------~  113 (419)
                      |.+++.||+|+||.||+|.+..++.  .+|+|.+.... ......+.+.+|+.+++.++ ||||+++++++..      .
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~   78 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEFD-HPNVMRLIGVCLQTVESEGY   78 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEccCCcccCC
Confidence            4578899999999999999887765  58999886543 34566788999999999995 9999999998743      2


Q ss_pred             CEEEEEEeecCCCChHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEee
Q 014733          114 DYVHLLMELCAGGELFHRLEKY------GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLAD  187 (419)
Q Consensus       114 ~~~~lV~E~~~ggsL~~~l~~~------~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~D  187 (419)
                      ...+++|||+++|+|.+++...      ..+++..+..++.|++.||+|||+++|+||||||+|||+   +.++.+||+|
T Consensus        79 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~D  155 (272)
T cd05075          79 PSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCML---NENMNVCVAD  155 (272)
T ss_pred             CCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEE---cCCCCEEECC
Confidence            3578999999999999887421      237899999999999999999999999999999999999   5677899999


Q ss_pred             ccceeeeccCCc---cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCC
Q 014733          188 FGLATYIKAGQN---LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFP  262 (419)
Q Consensus       188 Fgla~~~~~~~~---~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~  262 (419)
                      ||++........   .....+++.|+|||++.+. ++.++|+||||+++|+|++ |+.||.+....+..+.+...... +
T Consensus       156 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~-~  234 (272)
T cd05075         156 FGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRL-K  234 (272)
T ss_pred             CCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC-C
Confidence            999987643321   1122456789999998764 8999999999999999999 89999888877777777665432 1


Q ss_pred             CCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          263 SDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       263 ~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                        ....++..+.++|.+||+.||++|||+.+++++
T Consensus       235 --~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         235 --QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             --CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence              123688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=5.5e-40  Score=312.21  Aligned_cols=248  Identities=27%  Similarity=0.457  Sum_probs=209.3

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCc---EEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGE---VLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYV  116 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~---~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~  116 (419)
                      ++|++++.||+|+||.||+|.++.++.   .+|+|.+....  .......+.+|+.+++++. ||||+++++++.+.+.+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   80 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFD-HPNIIHLEGVVTKSKPV   80 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEecCCcc
Confidence            689999999999999999999865543   79999886542  3455678999999999996 99999999999999999


Q ss_pred             EEEEeecCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeec
Q 014733          117 HLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIK  195 (419)
Q Consensus       117 ~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~  195 (419)
                      ++||||+++++|.+++... +.+++.++..++.|++.||.|||+.+++||||||+|||+   +.++.+||+|||++....
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili---~~~~~~~l~dfg~~~~~~  157 (267)
T cd05066          81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILV---NSNLVCKVSDFGLSRVLE  157 (267)
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEE---CCCCeEEeCCCCcccccc
Confidence            9999999999999999764 458999999999999999999999999999999999999   567789999999998764


Q ss_pred             cCCcc----ccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCC
Q 014733          196 AGQNL----HGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHI  269 (419)
Q Consensus       196 ~~~~~----~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  269 (419)
                      .....    ....++..|+|||++.+ .++.++|+||||+++|++++ |..||.+....+....+... ...+.  ...+
T Consensus       158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~-~~~~~--~~~~  234 (267)
T cd05066         158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG-YRLPA--PMDC  234 (267)
T ss_pred             cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCC-CcCCC--CCCC
Confidence            43221    11123567999999876 48999999999999999886 99999888777777776654 22222  2367


Q ss_pred             CHHHHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          270 SASARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       270 s~~l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                      ++.+.+++.+||+.+|.+||++.++++
T Consensus       235 ~~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         235 PAALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             CHHHHHHHHHHcccCchhCCCHHHHHH
Confidence            899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=4.4e-40  Score=317.94  Aligned_cols=252  Identities=27%  Similarity=0.489  Sum_probs=213.1

Q ss_pred             eeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEEeec
Q 014733           44 LGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELC  123 (419)
Q Consensus        44 i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~  123 (419)
                      ...+||+|+||.||++.++.+|+.+|+|.+...   .......+.+|+.+++.+. |+||+++++.+.+.+..+++|||+
T Consensus        24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~   99 (292)
T cd06657          24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR---KQQRRELLFNEVVIMRDYQ-HENVVEMYNSYLVGDELWVVMEFL   99 (292)
T ss_pred             hHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc---chhHHHHHHHHHHHHHhcC-CcchhheeeEEEeCCEEEEEEecC
Confidence            347899999999999999999999999988543   2345567889999999996 999999999999999999999999


Q ss_pred             CCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC-cccc
Q 014733          124 AGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ-NLHG  202 (419)
Q Consensus       124 ~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~-~~~~  202 (419)
                      ++++|.+++.. +++++..+..++.|++.+|+|||+.|++|+||+|+||++   +.++.++|+|||++....... ....
T Consensus       100 ~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv---~~~~~~~l~dfg~~~~~~~~~~~~~~  175 (292)
T cd06657         100 EGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVPRRKS  175 (292)
T ss_pred             CCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEcccccceecccccccccc
Confidence            99999987754 578999999999999999999999999999999999999   556789999999987654332 2233


Q ss_pred             ccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhh
Q 014733          203 TVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGML  281 (419)
Q Consensus       203 ~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L  281 (419)
                      ..|++.|+|||.+.+ .++.++|+||+|+++|+|++|..||.+....+....+..... ........++..+.+++.+||
T Consensus       176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l  254 (292)
T cd06657         176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PKLKNLHKVSPSLKGFLDRLL  254 (292)
T ss_pred             cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC-cccCCcccCCHHHHHHHHHHH
Confidence            568899999998865 488999999999999999999999988776665555543322 111123467899999999999


Q ss_pred             hcCCCCCCCHHHHHhccccccch
Q 014733          282 RVDPSTRLTAAEVLAHSWMEECE  304 (419)
Q Consensus       282 ~~dP~~Rps~~eil~hp~~~~~~  304 (419)
                      +.||.+||++.+++.||||....
T Consensus       255 ~~~P~~R~~~~~ll~~~~~~~~~  277 (292)
T cd06657         255 VRDPAQRATAAELLKHPFLAKAG  277 (292)
T ss_pred             hCCcccCcCHHHHhcChHHhccC
Confidence            99999999999999999998654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=5.3e-40  Score=313.00  Aligned_cols=243  Identities=27%  Similarity=0.392  Sum_probs=200.7

Q ss_pred             eeecccCceEEEEEEecCCCc--EEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEEeec
Q 014733           46 KQLGWGQFGVIRECSDKFTGE--VLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELC  123 (419)
Q Consensus        46 ~~LG~G~~g~V~~a~~~~~g~--~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~  123 (419)
                      +.||+|+||.||+|.++.++.  .+++|.+...  ........+..|+.++.++.+||||+++++++...+.++++|||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~   78 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA   78 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc--CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence            468999999999999987776  4577876532  234556788899999999966999999999999999999999999


Q ss_pred             CCCChHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEee
Q 014733          124 AGGELFHRLEKYG----------------RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLAD  187 (419)
Q Consensus       124 ~ggsL~~~l~~~~----------------~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~D  187 (419)
                      ++++|.+++....                .+++..+..++.|++.||+|||+.|++||||||+||++   +.++.+||+|
T Consensus        79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili---~~~~~~kl~d  155 (270)
T cd05047          79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIAD  155 (270)
T ss_pred             CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEE---cCCCeEEECC
Confidence            9999999987532                37889999999999999999999999999999999999   5677899999


Q ss_pred             ccceeeeccCCccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCC
Q 014733          188 FGLATYIKAGQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDP  265 (419)
Q Consensus       188 Fgla~~~~~~~~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~  265 (419)
                      ||++..............+..|+|||++.+. ++.++|+||||+++|+|++ |..||.+.+..+..+.+.... ..  ..
T Consensus       156 fgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~-~~--~~  232 (270)
T cd05047         156 FGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY-RL--EK  232 (270)
T ss_pred             CCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCC-CC--CC
Confidence            9998643221111122345679999998664 8999999999999999997 999998888777777664432 11  22


Q ss_pred             CCCCCHHHHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          266 WDHISASARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       266 ~~~~s~~l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                      ...++.++.+++.+||+.||.+|||+.+++.
T Consensus       233 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         233 PLNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             CCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence            2367899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-41  Score=337.54  Aligned_cols=249  Identities=26%  Similarity=0.426  Sum_probs=211.1

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEE
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHL  118 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~l  118 (419)
                      .+...+++.||+|.||+||+|.+-   -+||||++..+.. +++.++.|++|+.+|++-+ |.||+-+.+++..... .|
T Consensus       391 ~~ev~l~~rIGsGsFGtV~Rg~wh---GdVAVK~Lnv~~p-t~~qlqaFKnEVa~lkkTR-H~NIlLFMG~~~~p~~-AI  464 (678)
T KOG0193|consen  391 PEEVLLGERIGSGSFGTVYRGRWH---GDVAVKLLNVDDP-TPEQLQAFKNEVAVLKKTR-HENILLFMGACMNPPL-AI  464 (678)
T ss_pred             HHHhhccceeccccccceeecccc---cceEEEEEecCCC-CHHHHHHHHHHHHHHhhcc-hhhheeeehhhcCCce-ee
Confidence            456678999999999999999875   3699999988774 6678999999999999997 9999999999999887 89


Q ss_pred             EEeecCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeec--
Q 014733          119 LMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIK--  195 (419)
Q Consensus       119 V~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~--  195 (419)
                      |+.||+|.+|+.+++-. ..|.......|++|+++|+.|||.++|||||||..|||+   .+++.|||+|||++..-.  
T Consensus       465 iTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl---~~~~kVkIgDFGLatvk~~w  541 (678)
T KOG0193|consen  465 ITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFL---HEDLKVKIGDFGLATVKTRW  541 (678)
T ss_pred             eehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEE---ccCCcEEEecccceeeeeee
Confidence            99999999999999753 459999999999999999999999999999999999999   556899999999987432  


Q ss_pred             -cCCccccccCCCccCCcccccC----CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-CCCCCCCC
Q 014733          196 -AGQNLHGTVGSPFYIAPEVLAG----GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRF-PSDPWDHI  269 (419)
Q Consensus       196 -~~~~~~~~~gt~~y~aPE~l~~----~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~  269 (419)
                       .........|...|||||+++.    +|++.+||||||+++|||++|..||...+.+.++=.+.++-+.. ......+.
T Consensus       542 ~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~  621 (678)
T KOG0193|consen  542 SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNC  621 (678)
T ss_pred             ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccC
Confidence             2233334467888999999864    49999999999999999999999999766666555555553322 22234567


Q ss_pred             CHHHHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          270 SASARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       270 s~~l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                      +.++++|+..||.+++++||.+.+||.
T Consensus       622 pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  622 PKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             HHHHHHHHHHHHhcCcccCccHHHHHH
Confidence            789999999999999999999999986

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=5.9e-40  Score=322.32  Aligned_cols=262  Identities=31%  Similarity=0.551  Sum_probs=213.1

Q ss_pred             cccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEe-CC
Q 014733           36 SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEE-ED  114 (419)
Q Consensus        36 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~-~~  114 (419)
                      -.+.++|++.+.||.|+||.||+|.++.+++.+|+|++.+... .....+.+.+|+.+++++. ||||+++.+++.. .+
T Consensus         6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~   83 (328)
T cd07856           6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHLR-HENIISLSDIFISPLE   83 (328)
T ss_pred             eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc-ccchhHHHHHHHHHHHhcC-CCCeeeEeeeEecCCC
Confidence            3468999999999999999999999999999999999865432 2334567889999999996 9999999999865 56


Q ss_pred             EEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeee
Q 014733          115 YVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI  194 (419)
Q Consensus       115 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~  194 (419)
                      ..|+++||+ +++|..++.. .++++..+..++.|+++||+|||+.+|+||||+|+||++   +.++.+||+|||++...
T Consensus        84 ~~~lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili---~~~~~~~l~dfg~~~~~  158 (328)
T cd07856          84 DIYFVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILI---NENCDLKICDFGLARIQ  158 (328)
T ss_pred             cEEEEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeE---CCCCCEEeCcccccccc
Confidence            789999998 6688887764 568899999999999999999999999999999999999   56778999999998754


Q ss_pred             ccCCccccccCCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc---------------
Q 014733          195 KAGQNLHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAA---------------  257 (419)
Q Consensus       195 ~~~~~~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~---------------  257 (419)
                      ..  ......++..|+|||++.+  .++.++|+||||+++|+|++|++||...........+.+.               
T Consensus       159 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (328)
T cd07856         159 DP--QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSE  236 (328)
T ss_pred             CC--CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccch
Confidence            32  2234567889999998765  4899999999999999999999999776543322221110               


Q ss_pred             ---------CC--CCC-CCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchhh
Q 014733          258 ---------DL--RFP-SDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQV  306 (419)
Q Consensus       258 ---------~~--~~~-~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~~  306 (419)
                               ..  ..+ ......++.++.++|.+||+.+|++|||+.+++.||||.....+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~  297 (328)
T cd07856         237 NTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDP  297 (328)
T ss_pred             hhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCC
Confidence                     00  000 01123578899999999999999999999999999999866543

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.5e-40  Score=317.65  Aligned_cols=252  Identities=23%  Similarity=0.332  Sum_probs=204.5

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCC--------------cEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCce
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTG--------------EVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVV  104 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g--------------~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv  104 (419)
                      .++|++.+.||+|+||.||+|++..++              ..||+|.+...  ........+.+|+++++++. ||||+
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~ei~~l~~l~-h~~i~   80 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD--VTKTARNDFLKEIKIMSRLK-NPNII   80 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC--CCHHHHHHHHHHHHHHHhCC-CCCcC
Confidence            368999999999999999999875432              35899998754  23455678999999999996 99999


Q ss_pred             eeeEEEEeCCEEEEEEeecCCCChHHHHHHcC------------CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcE
Q 014733          105 DLKAVYEEEDYVHLLMELCAGGELFHRLEKYG------------RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENI  172 (419)
Q Consensus       105 ~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~------------~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NI  172 (419)
                      ++++++...+..++||||+++++|.+++....            .+++..+..++.|++.||+|||+.+++||||||+||
T Consensus        81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni  160 (295)
T cd05097          81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC  160 (295)
T ss_pred             eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence            99999999999999999999999999986532            367889999999999999999999999999999999


Q ss_pred             EEeecCCCCCeEEeeccceeeeccCCcc---ccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh--CCCCCCCCC
Q 014733          173 LLATKSSSSPIKLADFGLATYIKAGQNL---HGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS--GMPPFWGKT  246 (419)
Q Consensus       173 Ll~~~~~~~~vKL~DFgla~~~~~~~~~---~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt--G~~Pf~~~~  246 (419)
                      ++   +.++.+||+|||++.........   ....++..|+|||++.+ .++.++|+||||+++|+|++  |..||....
T Consensus       161 ll---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~  237 (295)
T cd05097         161 LV---GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS  237 (295)
T ss_pred             EE---cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence            99   45678999999998765433211   12245678999998765 48999999999999999988  778998777


Q ss_pred             HHHHHHHHHh----cCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          247 KSKIFDAVRA----ADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       247 ~~~~~~~i~~----~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                      ..+....+..    .............+..+.+||.+||+.||++|||+++|++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         238 DEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             hHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            6665554422    1111111123357899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-40  Score=315.96  Aligned_cols=253  Identities=33%  Similarity=0.565  Sum_probs=211.3

Q ss_pred             eeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEEe
Q 014733           42 YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLME  121 (419)
Q Consensus        42 y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  121 (419)
                      |++.+.||.|++|.||+|.+..+|+.+++|.+..... .......+.+|+.+++++. |+||+++++++.+.+.+++|+|
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~e   78 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE-SEGIPKTALREIKLLKELN-HPNIIKLLDVFRHKGDLYLVFE   78 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc-cchhHHHHHHHHHHHHHhc-CCCcchHHHhhccCCCEEEEEe
Confidence            6788999999999999999998999999999875532 2244567888999999996 9999999999999999999999


Q ss_pred             ecCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC-c
Q 014733          122 LCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ-N  199 (419)
Q Consensus       122 ~~~ggsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~-~  199 (419)
                      |+++ +|.+.+... ..+++..+..++.|+++||.|||+.+|+|+||||+||++   +.++.+||+|||.+....... .
T Consensus        79 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~df~~~~~~~~~~~~  154 (283)
T cd05118          79 FMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLI---NTEGVLKLADFGLARSFGSPVRP  154 (283)
T ss_pred             ccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEE---CCCCcEEEeeeeeeEecCCCccc
Confidence            9965 888877663 579999999999999999999999999999999999999   556789999999998765543 2


Q ss_pred             cccccCCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-----------------
Q 014733          200 LHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLR-----------------  260 (419)
Q Consensus       200 ~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-----------------  260 (419)
                      .....++..|+|||.+.+  .++.++|+||||+++|+|++|+.||...+..+....+......                 
T Consensus       155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd05118         155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK  234 (283)
T ss_pred             ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhh
Confidence            333567888999998865  3789999999999999999999999877765554444221100                 


Q ss_pred             --CCC-------CCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhcccc
Q 014733          261 --FPS-------DPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWM  300 (419)
Q Consensus       261 --~~~-------~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~  300 (419)
                        ++.       ..+..++.++.++|.+||++||.+||++.+++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence              000       1123578899999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=6.8e-40  Score=314.07  Aligned_cols=247  Identities=20%  Similarity=0.341  Sum_probs=208.1

Q ss_pred             cCeeeeeeecccCceEEEEEEec-----CCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCC
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDK-----FTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEED  114 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~-----~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~  114 (419)
                      .+|++.++||+|+||.||++...     .++..+++|.+...   .......+.+|+++++++. |+||+++++++.+.+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~   80 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQ-HQHIVRFYGVCTEGR   80 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcCC-CCCCceEEEEEecCC
Confidence            67889999999999999999643     35678999987643   3456678999999999996 999999999999999


Q ss_pred             EEEEEEeecCCCChHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCC
Q 014733          115 YVHLLMELCAGGELFHRLEKYG---------------RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSS  179 (419)
Q Consensus       115 ~~~lV~E~~~ggsL~~~l~~~~---------------~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~  179 (419)
                      .++++|||+++++|.+++...+               .+++..+..++.||+.||+|||+.||+||||||+|||+   ++
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~---~~  157 (280)
T cd05092          81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLV---GQ  157 (280)
T ss_pred             ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEE---cC
Confidence            9999999999999999987643               37899999999999999999999999999999999999   55


Q ss_pred             CCCeEEeeccceeeeccCCc---cccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 014733          180 SSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAV  254 (419)
Q Consensus       180 ~~~vKL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i  254 (419)
                      ++.+||+|||++........   .....+++.|+|||++.+ .++.++|||||||++|+|++ |.+||......+....+
T Consensus       158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~  237 (280)
T cd05092         158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI  237 (280)
T ss_pred             CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence            77899999999976543221   122345678999998876 48999999999999999998 99999887777777766


Q ss_pred             HhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          255 RAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       255 ~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                      ......   .....+++.+.++|.+||+.||.+||++.++++
T Consensus       238 ~~~~~~---~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         238 TQGREL---ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             HcCccC---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            554322   122368899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-42  Score=324.25  Aligned_cols=263  Identities=31%  Similarity=0.478  Sum_probs=213.1

Q ss_pred             hccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCC-----CCceeeeE
Q 014733           34 QISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH-----PNVVDLKA  108 (419)
Q Consensus        34 ~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~h-----pnIv~l~~  108 (419)
                      ..+.+.+||.+++.+|+|.||.|-.+++..++..||+|+++.    -....+...-|+++|+++..+     --+|.+.+
T Consensus        83 ~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~----V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~  158 (415)
T KOG0671|consen   83 VGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN----VDKYREAALIEIEVLQKINESDPNGKFRCVQMRD  158 (415)
T ss_pred             eccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHH----HHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeeh
Confidence            345678999999999999999999999999999999999863    224556677899999999522     23788888


Q ss_pred             EEEeCCEEEEEEeecCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecC--------
Q 014733          109 VYEEEDYVHLLMELCAGGELFHRLEKYG--RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKS--------  178 (419)
Q Consensus       109 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~--------  178 (419)
                      +|+-.++.++|+|.+ |-++++++..++  +++..+++.++.||++++++||+.+++|.||||+|||+....        
T Consensus       159 wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k  237 (415)
T KOG0671|consen  159 WFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPK  237 (415)
T ss_pred             hhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccC
Confidence            999999999999998 789999998754  599999999999999999999999999999999999994211        


Q ss_pred             ---------CCCCeEEeeccceeeeccCCccccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q 014733          179 ---------SSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKS  248 (419)
Q Consensus       179 ---------~~~~vKL~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~  248 (419)
                               ++..|||+|||.|+.-  .+.....+.|..|.|||++.+ +++.++||||+||||+|+.+|...|......
T Consensus       238 ~~~~~~r~~ks~~I~vIDFGsAtf~--~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~  315 (415)
T KOG0671|consen  238 KKVCFIRPLKSTAIKVIDFGSATFD--HEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENL  315 (415)
T ss_pred             CccceeccCCCcceEEEecCCccee--ccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcH
Confidence                     2346899999999974  334466789999999999988 7999999999999999999999999877655


Q ss_pred             H---HHHHHHhc------------------CCCCCCCCC---------------------CCCCHHHHHHHHhhhhcCCC
Q 014733          249 K---IFDAVRAA------------------DLRFPSDPW---------------------DHISASARDLIMGMLRVDPS  286 (419)
Q Consensus       249 ~---~~~~i~~~------------------~~~~~~~~~---------------------~~~s~~l~~li~~~L~~dP~  286 (419)
                      +   +++.|...                  .+..+....                     +.--.++-|||++||.+||.
T Consensus       316 EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~  395 (415)
T KOG0671|consen  316 EHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA  395 (415)
T ss_pred             HHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence            5   33333110                  111010000                     01123467999999999999


Q ss_pred             CCCCHHHHHhccccccc
Q 014733          287 TRLTAAEVLAHSWMEEC  303 (419)
Q Consensus       287 ~Rps~~eil~hp~~~~~  303 (419)
                      +|+|+.|+|.||||+..
T Consensus       396 ~RiTl~EAL~HpFF~~~  412 (415)
T KOG0671|consen  396 RRITLREALSHPFFARL  412 (415)
T ss_pred             ccccHHHHhcCHHhhcC
Confidence            99999999999999864

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=7.9e-40  Score=311.27  Aligned_cols=248  Identities=25%  Similarity=0.451  Sum_probs=209.6

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCc---EEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGE---VLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYV  116 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~---~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~  116 (419)
                      ++|++.+.||+|+||.||+|.++.+++   .||+|.+...  ........+..|+.+++++. ||||+++++++.+...+
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~   80 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFD-HPNIIHLEGVVTKSRPV   80 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC--CCHHHHHHHHHHHHHHHhCC-CcCcceEEEEECCCCce
Confidence            568999999999999999999887665   5999998654  24556788999999999996 99999999999999999


Q ss_pred             EEEEeecCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeec
Q 014733          117 HLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIK  195 (419)
Q Consensus       117 ~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~  195 (419)
                      ++||||+++++|.+++... +.+++.++..++.|++.||+|||+.|++|+||||+||++   +.++.+||+|||++....
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili---~~~~~~kl~dfg~~~~~~  157 (269)
T cd05065          81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFLE  157 (269)
T ss_pred             EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEE---cCCCcEEECCCccccccc
Confidence            9999999999999998764 458999999999999999999999999999999999999   556789999999987654


Q ss_pred             cCCcccc---cc---CCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCC
Q 014733          196 AGQNLHG---TV---GSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWD  267 (419)
Q Consensus       196 ~~~~~~~---~~---gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  267 (419)
                      .......   ..   .+..|+|||++.+ .++.++||||+||++|||++ |..||......+..+.+... ...+.  ..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~-~~~~~--~~  234 (269)
T cd05065         158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQD-YRLPP--PM  234 (269)
T ss_pred             cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC-CcCCC--cc
Confidence            3322111   11   2457999999876 48999999999999999886 99999988887777777543 23222  24


Q ss_pred             CCCHHHHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          268 HISASARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       268 ~~s~~l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                      .++..+.+++.+||+.+|.+||++.+++.
T Consensus       235 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         235 DCPTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             cCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            68899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-39  Score=308.30  Aligned_cols=241  Identities=24%  Similarity=0.409  Sum_probs=203.0

Q ss_pred             eeecccCceEEEEEEecCCC---cEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEEee
Q 014733           46 KQLGWGQFGVIRECSDKFTG---EVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMEL  122 (419)
Q Consensus        46 ~~LG~G~~g~V~~a~~~~~g---~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~  122 (419)
                      ++||+|+||.||+|....++   ..+|+|.+......  ...+.+.+|+.+++++. ||||+++++++.. +.++++|||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~-~~~~~v~e~   76 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLD-HPCIVRLIGVCKG-EPLMLVMEL   76 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcC-CCCeeeEEEEEcC-CceEEEEEe
Confidence            47999999999999876554   78999998766432  45677899999999996 9999999998764 457999999


Q ss_pred             cCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCCccc-
Q 014733          123 CAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLH-  201 (419)
Q Consensus       123 ~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~~~~-  201 (419)
                      +++++|.+++.....+++..+..++.|++.+|+|||+.+++|+||||+|||+   +.++.+||+|||++.......... 
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili---~~~~~~kl~df~~~~~~~~~~~~~~  153 (257)
T cd05060          77 APLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLL---VNRHQAKISDFGMSRALGAGSDYYR  153 (257)
T ss_pred             CCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEE---cCCCcEEeccccccceeecCCcccc
Confidence            9999999999887789999999999999999999999999999999999999   567789999999998764433211 


Q ss_pred             ---cccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHH
Q 014733          202 ---GTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDL  276 (419)
Q Consensus       202 ---~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~l  276 (419)
                         ...++..|+|||.+.+. ++.++|+||||+++|+|++ |.+||......+....+.....   ......++..+.++
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~l  230 (257)
T cd05060         154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGER---LPRPEECPQEIYSI  230 (257)
T ss_pred             cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCc---CCCCCCCCHHHHHH
Confidence               11234579999998764 8999999999999999998 9999988887777777655432   12234688999999


Q ss_pred             HHhhhhcCCCCCCCHHHHHh
Q 014733          277 IMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       277 i~~~L~~dP~~Rps~~eil~  296 (419)
                      |.+||..||++||++.++++
T Consensus       231 i~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         231 MLSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             HHHHhcCChhhCcCHHHHHH
Confidence            99999999999999999976

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.8e-40  Score=310.13  Aligned_cols=246  Identities=27%  Similarity=0.420  Sum_probs=206.1

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      .+|++.+.||+|++|.||+|.++ ++..+|+|++.+...    ....+.+|+++++.+. ||||+++++++.+.+..|+|
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv   77 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM----SEDDFIEEAKVMMKLS-HPNLVQLYGVCTKQRPIFIV   77 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC----CHHHHHHHHHHHHhCC-CCCEEEEEEEEcCCCceEEE
Confidence            46889999999999999999886 466899999865432    2346778999999996 99999999999999999999


Q ss_pred             EeecCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC
Q 014733          120 MELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ  198 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~  198 (419)
                      |||++|++|.+++... ..+++..+..++.|++.||+|||+.+|+||||||+||++   +.++.+||+|||++.......
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i---~~~~~~kl~dfg~~~~~~~~~  154 (256)
T cd05059          78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLV---GEDNVVKVSDFGLARYVLDDQ  154 (256)
T ss_pred             EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEE---CCCCcEEECCcccceeccccc
Confidence            9999999999998764 468999999999999999999999999999999999999   567789999999988654332


Q ss_pred             cc--ccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 014733          199 NL--HGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASAR  274 (419)
Q Consensus       199 ~~--~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~  274 (419)
                      ..  ....++..|+|||.+.+ .++.++|+||||+++|+|++ |+.||......+....+.... ..+  ....++.++.
T Consensus       155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~  231 (256)
T cd05059         155 YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGY-RLY--RPKLAPTEVY  231 (256)
T ss_pred             ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCC-cCC--CCCCCCHHHH
Confidence            21  12233457999999876 48999999999999999999 899998877777776665432 222  2236899999


Q ss_pred             HHHHhhhhcCCCCCCCHHHHHhc
Q 014733          275 DLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       275 ~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      +++.+||..+|++|||+.++++.
T Consensus       232 ~li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         232 TIMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             HHHHHHhcCChhhCcCHHHHHHH
Confidence            99999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=9.7e-40  Score=321.26  Aligned_cols=252  Identities=24%  Similarity=0.369  Sum_probs=209.9

Q ss_pred             cccCeeeeeeecccCceEEEEEEecC-------CCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEE
Q 014733           38 LSDRYVLGKQLGWGQFGVIRECSDKF-------TGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVY  110 (419)
Q Consensus        38 ~~~~y~i~~~LG~G~~g~V~~a~~~~-------~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~  110 (419)
                      ...+|++++.||+|+||.||+|.+..       .+..+|+|.+...  ......+.+.+|+++++++.+||||+++++++
T Consensus        10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   87 (334)
T cd05100          10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD--ATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC   87 (334)
T ss_pred             CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc--cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence            44689999999999999999998642       2246899987643  23456778999999999996699999999999


Q ss_pred             EeCCEEEEEEeecCCCChHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEE
Q 014733          111 EEEDYVHLLMELCAGGELFHRLEKYG----------------RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILL  174 (419)
Q Consensus       111 ~~~~~~~lV~E~~~ggsL~~~l~~~~----------------~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl  174 (419)
                      .+.+.++++|||+++++|.+++....                .+++..+..++.|+++||.|||++||+||||||+|||+
T Consensus        88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill  167 (334)
T cd05100          88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLV  167 (334)
T ss_pred             ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE
Confidence            99999999999999999999987532                37788899999999999999999999999999999999


Q ss_pred             eecCCCCCeEEeeccceeeeccCCcc---ccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 014733          175 ATKSSSSPIKLADFGLATYIKAGQNL---HGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSK  249 (419)
Q Consensus       175 ~~~~~~~~vKL~DFgla~~~~~~~~~---~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~  249 (419)
                         +.++.+||+|||+++........   ....++..|+|||++.+. ++.++||||||+++|+|++ |..||.+.+..+
T Consensus       168 ---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~  244 (334)
T cd05100         168 ---TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE  244 (334)
T ss_pred             ---cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence               55678999999999865433211   112345679999998764 8999999999999999998 899999888888


Q ss_pred             HHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          250 IFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       250 ~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      ....+......   .....++.++.++|.+||+.+|++|||+.+++++
T Consensus       245 ~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         245 LFKLLKEGHRM---DKPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             HHHHHHcCCCC---CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            87777554321   1223678999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=3.8e-40  Score=311.61  Aligned_cols=248  Identities=24%  Similarity=0.377  Sum_probs=211.8

Q ss_pred             cccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEE
Q 014733           38 LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVH  117 (419)
Q Consensus        38 ~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~  117 (419)
                      -..+|.++++||.|++|.||+|.++. +..+++|++....   ......+.+|+.+++.++ ||||+++++++.+...++
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~   78 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD---LLKQQDFQKEVQALKRLR-HKHLISLFAVCSVGEPVY   78 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc---hhhHHHHHHHHHHHhcCC-CcchhheeeeEecCCCeE
Confidence            34679999999999999999999987 8899999987543   234567889999999996 999999999999999999


Q ss_pred             EEEeecCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeec
Q 014733          118 LLMELCAGGELFHRLEKY--GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIK  195 (419)
Q Consensus       118 lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~  195 (419)
                      +||||+++++|.+++...  ..+++..+..++.||+.||.|||+.||+|+||||+||++   +.++.+||+|||.+....
T Consensus        79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv---~~~~~~kl~d~g~~~~~~  155 (261)
T cd05148          79 IITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILV---GEDLVCKVADFGLARLIK  155 (261)
T ss_pred             EEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEE---cCCceEEEccccchhhcC
Confidence            999999999999999753  358999999999999999999999999999999999999   567789999999997654


Q ss_pred             cCCc-cccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHH
Q 014733          196 AGQN-LHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISAS  272 (419)
Q Consensus       196 ~~~~-~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  272 (419)
                      .... .....++..|+|||++.+ .++.++|+||||+++|+|++ |+.||.+....+....+... ...+.  ....++.
T Consensus       156 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~  232 (261)
T cd05148         156 EDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAG-YRMPC--PAKCPQE  232 (261)
T ss_pred             CccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhC-CcCCC--CCCCCHH
Confidence            3321 122345678999999876 48899999999999999998 89999888877777777643 22222  2478899


Q ss_pred             HHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          273 ARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       273 l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                      +.++|.+||+.||.+|||+.++++
T Consensus       233 ~~~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         233 IYKIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             HHHHHHHHcCCCchhCcCHHHHHH
Confidence            999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=2e-40  Score=314.58  Aligned_cols=245  Identities=33%  Similarity=0.494  Sum_probs=202.8

Q ss_pred             eeeeeecccCceEEEEEEec----CCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEE
Q 014733           43 VLGKQLGWGQFGVIRECSDK----FTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHL  118 (419)
Q Consensus        43 ~i~~~LG~G~~g~V~~a~~~----~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~l  118 (419)
                      .+.+.||.|.||.||+|...    ..+..|++|.+...  ......+.+.+|+++++++ +||||+++++++...+..++
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l-~h~ni~~~~g~~~~~~~~~l   78 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKL-RHPNIVKLYGFCIENEPLFL   78 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTH-SBTTBE-EEEEEESSSSEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeecccccccc-cccccccccccccccccccc
Confidence            46789999999999999987    55688999999543  3455688999999999999 59999999999998888999


Q ss_pred             EEeecCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeecc
Q 014733          119 LMELCAGGELFHRLEKY--GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA  196 (419)
Q Consensus       119 V~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~  196 (419)
                      ||||+++|+|.+++...  ..+++..+..++.||++||.|||+.+++|+||+++||++   +.++.+||+|||++.....
T Consensus        79 v~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill---~~~~~~Kl~~f~~~~~~~~  155 (259)
T PF07714_consen   79 VMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILL---DSNGQVKLSDFGLSRPISE  155 (259)
T ss_dssp             EEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE---ETTTEEEEESTTTGEETTT
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccc
Confidence            99999999999999886  569999999999999999999999999999999999999   4567999999999987622


Q ss_pred             CCc---cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCH
Q 014733          197 GQN---LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISA  271 (419)
Q Consensus       197 ~~~---~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  271 (419)
                      ...   .....+...|+|||.+.+. ++.++||||||+++|||++ |+.||......+....+..... .+  ....++.
T Consensus       156 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~-~~--~~~~~~~  232 (259)
T PF07714_consen  156 KSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQR-LP--IPDNCPK  232 (259)
T ss_dssp             SSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEE-TT--SBTTSBH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ce--eccchhH
Confidence            211   1233566789999998765 8999999999999999999 7899998888888888855433 22  2236899


Q ss_pred             HHHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          272 SARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       272 ~l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                      .+.++|.+||..||++|||+.++++
T Consensus       233 ~~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  233 DIYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             HHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHh
Confidence            9999999999999999999999975

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=9.3e-40  Score=314.05  Aligned_cols=249  Identities=25%  Similarity=0.364  Sum_probs=209.5

Q ss_pred             ccCeeeeeeecccCceEEEEEEecC-----CCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeC
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKF-----TGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEE  113 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~-----~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~  113 (419)
                      .++|++.+.||+|+||.||+|.+..     ++..+|+|.+....  .......+.+|+.+++++. ||||+++++++.+.
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~-h~~iv~~~~~~~~~   80 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFD-HPNIVKLLGVCAVG   80 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcC-CCchheEEEEEcCC
Confidence            4789999999999999999998753     67899999986542  3445677899999999996 99999999999999


Q ss_pred             CEEEEEEeecCCCChHHHHHHcC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCc
Q 014733          114 DYVHLLMELCAGGELFHRLEKYG----------------------RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPEN  171 (419)
Q Consensus       114 ~~~~lV~E~~~ggsL~~~l~~~~----------------------~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~N  171 (419)
                      ..++++|||+++++|.+++....                      .+++..+..++.|++.||+|||+.+++||||||+|
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n  160 (288)
T cd05050          81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN  160 (288)
T ss_pred             CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence            99999999999999999997432                      36788899999999999999999999999999999


Q ss_pred             EEEeecCCCCCeEEeeccceeeeccCCc---cccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 014733          172 ILLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKT  246 (419)
Q Consensus       172 ILl~~~~~~~~vKL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~  246 (419)
                      |++   +.++.+||+|||++........   ......+..|+|||++.+ .++.++|||||||++|+|++ |..||.+..
T Consensus       161 il~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~  237 (288)
T cd05050         161 CLV---GENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA  237 (288)
T ss_pred             eEe---cCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            999   5677899999999876533221   122234667999998875 48999999999999999997 889998888


Q ss_pred             HHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          247 KSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       247 ~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                      ..+....+.......   ....++.++.++|.+||+.||.+|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         238 HEEVIYYVRDGNVLS---CPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             HHHHHHHHhcCCCCC---CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            888877776654321   12367899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1e-39  Score=314.20  Aligned_cols=247  Identities=23%  Similarity=0.402  Sum_probs=206.4

Q ss_pred             CeeeeeeecccCceEEEEEEecC-----CCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCE
Q 014733           41 RYVLGKQLGWGQFGVIRECSDKF-----TGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDY  115 (419)
Q Consensus        41 ~y~i~~~LG~G~~g~V~~a~~~~-----~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~  115 (419)
                      +|++.+.||+|+||.||+|.+..     ....+++|.+....  .......+.+|+.+++.+. ||||+++++.+...+.
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~   77 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVN-HPHVIKLYGACSQDGP   77 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCC-CCCEeeEEEEEecCCC
Confidence            47899999999999999998753     23568888876542  3445678999999999996 9999999999999999


Q ss_pred             EEEEEeecCCCChHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCc
Q 014733          116 VHLLMELCAGGELFHRLEKY------------------------GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPEN  171 (419)
Q Consensus       116 ~~lV~E~~~ggsL~~~l~~~------------------------~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~N  171 (419)
                      .++++||+.+++|.+++...                        .++++..+..++.|++.||+|||+.+|+||||||+|
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~n  157 (290)
T cd05045          78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARN  157 (290)
T ss_pred             cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhhe
Confidence            99999999999999988642                        247888999999999999999999999999999999


Q ss_pred             EEEeecCCCCCeEEeeccceeeeccCCc---cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 014733          172 ILLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKT  246 (419)
Q Consensus       172 ILl~~~~~~~~vKL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~ellt-G~~Pf~~~~  246 (419)
                      ||+   .+++.+||+|||++........   .....++..|+|||++.+. ++.++||||||+++|+|++ |..||.+..
T Consensus       158 ill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~  234 (290)
T cd05045         158 VLV---AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA  234 (290)
T ss_pred             EEE---cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence            999   5567899999999976533221   1223456789999987764 8999999999999999998 999999888


Q ss_pred             HHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          247 KSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       247 ~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                      ..++.+.+.... ..  .....++.++.+++.+||+.||++||++.++++
T Consensus       235 ~~~~~~~~~~~~-~~--~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         235 PERLFNLLKTGY-RM--ERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             HHHHHHHHhCCC-CC--CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            888777665432 22  223468899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=5.4e-40  Score=324.52  Aligned_cols=251  Identities=27%  Similarity=0.424  Sum_probs=201.8

Q ss_pred             ccCeeeeeeecccCceEEEEEEe-----cCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEe-
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSD-----KFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEE-  112 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~-----~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~-  112 (419)
                      .++|++.+.||+|+||+||+|.+     ..+++.||+|++....  .......+.+|+.++.++.+||||+++++++.. 
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKP   83 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence            37899999999999999999984     3567899999987543  334567788999999999779999999998865 


Q ss_pred             CCEEEEEEeecCCCChHHHHHHc---------------------------------------------------------
Q 014733          113 EDYVHLLMELCAGGELFHRLEKY---------------------------------------------------------  135 (419)
Q Consensus       113 ~~~~~lV~E~~~ggsL~~~l~~~---------------------------------------------------------  135 (419)
                      ...++++|||+++|+|.+++...                                                         
T Consensus        84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (343)
T cd05103          84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE  163 (343)
T ss_pred             CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence            45689999999999999988642                                                         


Q ss_pred             ----------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCCc---ccc
Q 014733          136 ----------GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN---LHG  202 (419)
Q Consensus       136 ----------~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~~---~~~  202 (419)
                                ..+++..+..++.|+++||+|||+.+|+||||||+|||+   +.++.+||+|||++........   ...
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~  240 (343)
T cd05103         164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPDYVRKGD  240 (343)
T ss_pred             hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEE---cCCCcEEEEecccccccccCcchhhcCC
Confidence                      136778888999999999999999999999999999999   4567899999999876533221   112


Q ss_pred             ccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHh-CCCCCCCCCHHH-HHHHHHhcCCCCCCCCCCCCCHHHHHHHHh
Q 014733          203 TVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSK-IFDAVRAADLRFPSDPWDHISASARDLIMG  279 (419)
Q Consensus       203 ~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~s~~l~~li~~  279 (419)
                      ..++..|+|||++.+. ++.++|+||||+++|+|++ |..||....... ....+... ...+..  ..+++++.+++.+
T Consensus       241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~~~~~  317 (343)
T cd05103         241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG-TRMRAP--DYTTPEMYQTMLD  317 (343)
T ss_pred             CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhcc-CCCCCC--CCCCHHHHHHHHH
Confidence            2456679999988664 8999999999999999997 999997654333 33333322 222221  2478899999999


Q ss_pred             hhhcCCCCCCCHHHHHhc
Q 014733          280 MLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       280 ~L~~dP~~Rps~~eil~h  297 (419)
                      ||+.||++|||+.++++|
T Consensus       318 cl~~~p~~Rps~~eil~~  335 (343)
T cd05103         318 CWHGEPSQRPTFSELVEH  335 (343)
T ss_pred             HccCChhhCcCHHHHHHH
Confidence            999999999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.1e-39  Score=309.56  Aligned_cols=245  Identities=27%  Similarity=0.366  Sum_probs=204.5

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEE
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHL  118 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~l  118 (419)
                      .++|++.++||+|+||.||+|.+..+ ..+|+|.+.....    ....+.+|+.+++++. ||||+++++.+.+ ...++
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~----~~~~~~~E~~~l~~l~-~~~i~~~~~~~~~-~~~~l   77 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQLYAVVSE-EPIYI   77 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc----CHHHHHHHHHHHHhCC-CCCcceEEEEECC-CCcEE
Confidence            47899999999999999999988755 4599999875432    2356888999999996 9999999998754 45789


Q ss_pred             EEeecCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeecc
Q 014733          119 LMELCAGGELFHRLEKY--GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA  196 (419)
Q Consensus       119 V~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~  196 (419)
                      ||||+++++|.+++...  ..+++..+..++.|+++||+|||+.+|+||||||+||++   +.++.+||+|||.+.....
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill---~~~~~~~L~dfg~~~~~~~  154 (262)
T cd05071          78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIED  154 (262)
T ss_pred             EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEE---cCCCcEEeccCCceeeccc
Confidence            99999999999999763  348899999999999999999999999999999999999   5577899999999986643


Q ss_pred             CCcc--ccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHH
Q 014733          197 GQNL--HGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISAS  272 (419)
Q Consensus       197 ~~~~--~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  272 (419)
                      ....  ....++..|+|||++.+ .++.++|+||||+++|+|++ |+.||.+....+....+.... ..+.  ...++..
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~  231 (262)
T cd05071         155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-RMPC--PPECPES  231 (262)
T ss_pred             cccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCC-CCCC--ccccCHH
Confidence            3221  23346678999998865 48999999999999999999 899998887777776665432 2222  2368899


Q ss_pred             HHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          273 ARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       273 l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                      +.++|.+||++||++||++.++++
T Consensus       232 l~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         232 LHDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             HHHHHHHHccCCcccCCCHHHHHH
Confidence            999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.3e-39  Score=312.14  Aligned_cols=248  Identities=22%  Similarity=0.305  Sum_probs=203.9

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcE----EEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEV----LACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDY  115 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~----vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~  115 (419)
                      ++|++.+.||+|+||+||+|.+..++..    +++|.+...  ........+..|+.+++++. ||||+++++++.. ..
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l~-h~~iv~~~~~~~~-~~   82 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLD-HAYIVRLLGICPG-AS   82 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc--cchHHHHHHHHHHHHHhcCC-CCCcceEEEEECC-Cc
Confidence            6889999999999999999998777764    667766432  22344567888898999995 9999999998764 45


Q ss_pred             EEEEEeecCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeee
Q 014733          116 VHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI  194 (419)
Q Consensus       116 ~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~  194 (419)
                      .++++||+++|+|.+++... +.+++..+..++.||+.||+|||+.+++||||||+|||+   +.++.+||+|||++...
T Consensus        83 ~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili---~~~~~~kl~Dfg~~~~~  159 (279)
T cd05111          83 LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILL---KSDSIVQIADFGVADLL  159 (279)
T ss_pred             cEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEE---cCCCcEEEcCCccceec
Confidence            78899999999999999764 468999999999999999999999999999999999999   55678999999999865


Q ss_pred             ccCCc---cccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCC
Q 014733          195 KAGQN---LHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHI  269 (419)
Q Consensus       195 ~~~~~---~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  269 (419)
                      .....   .....++..|+|||++.+ .++.++||||||+++|||++ |..||.+.......+.+...... +.  ....
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~-~~--~~~~  236 (279)
T cd05111         160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERL-AQ--PQIC  236 (279)
T ss_pred             cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcC-CC--CCCC
Confidence            43321   123356778999999875 48999999999999999998 99999888777666665544322 21  2246


Q ss_pred             CHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          270 SASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       270 s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      +.++.+++.+||..||++|||+.++++.
T Consensus       237 ~~~~~~li~~c~~~~p~~Rps~~el~~~  264 (279)
T cd05111         237 TIDVYMVMVKCWMIDENVRPTFKELANE  264 (279)
T ss_pred             CHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            7889999999999999999999999763

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-40  Score=314.54  Aligned_cols=253  Identities=34%  Similarity=0.556  Sum_probs=211.2

Q ss_pred             eeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEEe
Q 014733           42 YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLME  121 (419)
Q Consensus        42 y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  121 (419)
                      |++.+.||+|++|.||+|.+..+++.+|+|++.... ........+..|+.+++++. |+||+++++++.+.+.+++|||
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~~v~e   78 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELK-HPNIVKLLDVIHTERKLYLVFE   78 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcC-CCCHHHHHhhhhcCCceEEEec
Confidence            678899999999999999999999999999998653 22334567788999999996 9999999999999999999999


Q ss_pred             ecCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC-c
Q 014733          122 LCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ-N  199 (419)
Q Consensus       122 ~~~ggsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~-~  199 (419)
                      |++ ++|.+++... ..+++..+..++.|++.||+|||+.||+||||+|+||++   +.++.+||+|||++....... .
T Consensus        79 ~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~---~~~~~~~l~d~g~~~~~~~~~~~  154 (282)
T cd07829          79 YCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILI---NRDGVLKLADFGLARAFGIPLRT  154 (282)
T ss_pred             CcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEE---cCCCCEEEecCCcccccCCCccc
Confidence            997 5899999876 579999999999999999999999999999999999999   557889999999988654432 2


Q ss_pred             cccccCCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC------------------C
Q 014733          200 LHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAAD------------------L  259 (419)
Q Consensus       200 ~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~------------------~  259 (419)
                      .....++..|+|||.+.+  .++.++|+||||+++|+|++|++||.+.+..+...++....                  .
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (282)
T cd07829         155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP  234 (282)
T ss_pred             cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence            233456788999998765  47899999999999999999999998877655554443211                  0


Q ss_pred             CCCC-------CCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhcccc
Q 014733          260 RFPS-------DPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWM  300 (419)
Q Consensus       260 ~~~~-------~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~  300 (419)
                      .++.       .....++.++.++|.+||+.||++||++.+++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             cccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence            0000       1123457899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.6e-39  Score=308.75  Aligned_cols=249  Identities=25%  Similarity=0.407  Sum_probs=209.8

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCc---EEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCE
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGE---VLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDY  115 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~---~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~  115 (419)
                      .++|...+.||+|++|.||+|.++.++.   .+++|.+....  .....+.+..|+++++++. ||||+++.+++.+.+.
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~   80 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFS-HHNIIRLEGVVTKFKP   80 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEccCCC
Confidence            4678899999999999999999876654   79999886542  3445677899999999996 9999999999999999


Q ss_pred             EEEEEeecCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeee
Q 014733          116 VHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI  194 (419)
Q Consensus       116 ~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~  194 (419)
                      .++||||+++++|.+++... +.+++..+..++.|++.||+|||+.|++|+||||+||++   +.++.+||+|||++...
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~  157 (268)
T cd05063          81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILV---NSNLECKVSDFGLSRVL  157 (268)
T ss_pred             cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEE---cCCCcEEECCCccceec
Confidence            99999999999999998764 568999999999999999999999999999999999999   55778999999998866


Q ss_pred             ccCCccc----cccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCC
Q 014733          195 KAGQNLH----GTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDH  268 (419)
Q Consensus       195 ~~~~~~~----~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  268 (419)
                      .......    ....+..|+|||++.+ .++.++|+|||||++|+|++ |+.||......+....+.... ..+  ....
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~-~~~--~~~~  234 (268)
T cd05063         158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF-RLP--APMD  234 (268)
T ss_pred             ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCC-CCC--CCCC
Confidence            4322111    1123456999999876 48999999999999999997 999999888878777776542 222  2236


Q ss_pred             CCHHHHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          269 ISASARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       269 ~s~~l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                      ++.++.+++.+||+.+|++||++.++++
T Consensus       235 ~~~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         235 CPSAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             CCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            7899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.5e-39  Score=305.90  Aligned_cols=246  Identities=27%  Similarity=0.450  Sum_probs=211.1

Q ss_pred             eeeeeeecccCceEEEEEEecCCC----cEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEE
Q 014733           42 YVLGKQLGWGQFGVIRECSDKFTG----EVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVH  117 (419)
Q Consensus        42 y~i~~~LG~G~~g~V~~a~~~~~g----~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~  117 (419)
                      +.+.+.||.|+||.||+|.+...+    ..+|+|++....  .......+..|+.+++.+ +|+||+++++++.+.+..+
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~   77 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA--DEQQIEEFLREARIMRKL-DHPNIVKLLGVCTEEEPLM   77 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC--ChHHHHHHHHHHHHHHhc-CCCchheEEEEEcCCCeeE
Confidence            357889999999999999998766    899999986553  233677899999999999 5999999999999999999


Q ss_pred             EEEeecCCCChHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeec
Q 014733          118 LLMELCAGGELFHRLEKYGR--FSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIK  195 (419)
Q Consensus       118 lV~E~~~ggsL~~~l~~~~~--l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~  195 (419)
                      ++|||+++++|.+++.....  +++..+..++.|++.||++||+.+++|+||||+||++   +.++.++|+|||++....
T Consensus        78 ~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~---~~~~~~~l~dfg~~~~~~  154 (258)
T smart00219       78 IVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLV---GENLVVKISDFGLSRDLY  154 (258)
T ss_pred             EEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEE---ccCCeEEEcccCCceecc
Confidence            99999999999999976544  9999999999999999999999999999999999999   556789999999998765


Q ss_pred             cCCccc--cccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCH
Q 014733          196 AGQNLH--GTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISA  271 (419)
Q Consensus       196 ~~~~~~--~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  271 (419)
                      ......  ...+++.|+|||.+.+. ++.++|+||||+++|+|++ |++||......+..+.+........   ...++.
T Consensus       155 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~  231 (258)
T smart00219      155 DDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPK---PENCPP  231 (258)
T ss_pred             cccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCC---CCcCCH
Confidence            442222  12367889999998654 8999999999999999998 8999988888888887766543222   235899


Q ss_pred             HHHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          272 SARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       272 ~l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                      ++.+++.+||+.||++|||+.++++
T Consensus       232 ~~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      232 EIYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             HHHHHHHHHCcCChhhCcCHHHHHh
Confidence            9999999999999999999999986

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=5.1e-40  Score=310.77  Aligned_cols=252  Identities=29%  Similarity=0.497  Sum_probs=209.3

Q ss_pred             CeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCcc--CCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEE
Q 014733           41 RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRL--VTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHL  118 (419)
Q Consensus        41 ~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~--~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~l  118 (419)
                      +|.+.+.||+|+||+||++.+..++..+++|++.....  ........+..|+.+++++. ||||+++++.+.+....++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l   79 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD-HPAIVKFHASFLERDAFCI   79 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCC-CCcHHHHHHHHhcCCceEE
Confidence            69999999999999999999987777777776653221  12234456778999999996 9999999999999999999


Q ss_pred             EEeecCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeee
Q 014733          119 LMELCAGGELFHRLEK----YGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI  194 (419)
Q Consensus       119 V~E~~~ggsL~~~l~~----~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~  194 (419)
                      ||||+++++|..++..    ...+++.+++.++.|+++||.|||+.|++|+||+|+||+++    ++.+||+|||++...
T Consensus        80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~----~~~~~l~d~g~~~~~  155 (260)
T cd08222          80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLK----NNLLKIGDFGVSRLL  155 (260)
T ss_pred             EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEee----cCCEeecccCceeec
Confidence            9999999999988864    24589999999999999999999999999999999999994    346999999998876


Q ss_pred             ccCCc-cccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHH
Q 014733          195 KAGQN-LHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISAS  272 (419)
Q Consensus       195 ~~~~~-~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  272 (419)
                      ..... .....|++.|+|||.+.+ .++.++|+||+|+++|+|++|..||......+....+.......   ....++.+
T Consensus       156 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~  232 (260)
T cd08222         156 MGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPS---LPETYSRQ  232 (260)
T ss_pred             CCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCC---CcchhcHH
Confidence            44332 233468889999998865 48889999999999999999999998776666666554432221   22367899


Q ss_pred             HHHHHHhhhhcCCCCCCCHHHHHhcccc
Q 014733          273 ARDLIMGMLRVDPSTRLTAAEVLAHSWM  300 (419)
Q Consensus       273 l~~li~~~L~~dP~~Rps~~eil~hp~~  300 (419)
                      +.++|.+||+.||++||++.++++||||
T Consensus       233 ~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         233 LNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             HHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence            9999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-39  Score=306.12  Aligned_cols=243  Identities=26%  Similarity=0.391  Sum_probs=208.9

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEE
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHL  118 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~l  118 (419)
                      .++|++.+.||.|++|.||+|...  |+.+|+|.+....    ...+++.+|+.+++++. |+||+++++++.+.+..++
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~   77 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDS----TAAQAFLAEASVMTTLR-HPNLVQLLGVVLQGNPLYI   77 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccch----hHHHHHHHHHHHHHhcC-CcceeeeEEEEcCCCCeEE
Confidence            468899999999999999999865  7899999987542    25678899999999996 9999999999999999999


Q ss_pred             EEeecCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeecc
Q 014733          119 LMELCAGGELFHRLEKYG--RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA  196 (419)
Q Consensus       119 V~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~  196 (419)
                      ||||+++++|.+++....  .+++..+..++.|++.||.|||+.+++|+||||+||++   +.++.+||+|||.+.....
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili---~~~~~~~l~d~g~~~~~~~  154 (256)
T cd05039          78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLV---SEDLVAKVSDFGLAKEASQ  154 (256)
T ss_pred             EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEE---eCCCCEEEccccccccccc
Confidence            999999999999997765  68999999999999999999999999999999999999   5677899999999986532


Q ss_pred             CCccccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 014733          197 GQNLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASAR  274 (419)
Q Consensus       197 ~~~~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~  274 (419)
                      ..  ....++..|+|||++.+ .++.++|+||||+++|+|++ |+.||......++...+.... .  ......+++++.
T Consensus       155 ~~--~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~  229 (256)
T cd05039         155 GQ--DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGY-R--MEAPEGCPPEVY  229 (256)
T ss_pred             cc--ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC-C--CCCccCCCHHHH
Confidence            22  23345667999998875 48899999999999999997 999998888777777665432 1  122246789999


Q ss_pred             HHHHhhhhcCCCCCCCHHHHHh
Q 014733          275 DLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       275 ~li~~~L~~dP~~Rps~~eil~  296 (419)
                      ++|.+||..+|++|||+.++++
T Consensus       230 ~li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         230 KVMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             HHHHHHhccChhhCcCHHHHHH
Confidence            9999999999999999999986

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1e-39  Score=328.74  Aligned_cols=252  Identities=23%  Similarity=0.371  Sum_probs=206.3

Q ss_pred             ccCeeeeeeecccCceEEEEEEec-----CCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeC
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDK-----FTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEE  113 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~-----~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~  113 (419)
                      .++|.++++||+|+||.||+|++.     .++..||+|++....  .....+.+.+|+.+|.++..||||+++++++.+.
T Consensus        36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~  113 (401)
T cd05107          36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG  113 (401)
T ss_pred             HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence            467889999999999999999853     355789999997542  2344567889999999996699999999999999


Q ss_pred             CEEEEEEeecCCCChHHHHHHcC---------------------------------------------------------
Q 014733          114 DYVHLLMELCAGGELFHRLEKYG---------------------------------------------------------  136 (419)
Q Consensus       114 ~~~~lV~E~~~ggsL~~~l~~~~---------------------------------------------------------  136 (419)
                      +.+++||||+++|+|.+++.+.+                                                         
T Consensus       114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (401)
T cd05107         114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ  193 (401)
T ss_pred             CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence            99999999999999999986532                                                         


Q ss_pred             -----------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEe
Q 014733          137 -----------------------------------------RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLA  175 (419)
Q Consensus       137 -----------------------------------------~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~  175 (419)
                                                               .+++..+..++.||+.||+|||+.+|+||||||+|||+ 
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl-  272 (401)
T cd05107         194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLI-  272 (401)
T ss_pred             cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEE-
Confidence                                                     25667788899999999999999999999999999999 


Q ss_pred             ecCCCCCeEEeeccceeeeccCCc---cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 014733          176 TKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKI  250 (419)
Q Consensus       176 ~~~~~~~vKL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~  250 (419)
                        +.++.+||+|||++........   .....++..|+|||++.+. ++.++|+||||+++|||++ |..||......+.
T Consensus       273 --~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~  350 (401)
T cd05107         273 --CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ  350 (401)
T ss_pred             --eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH
Confidence              4567899999999986533221   2234678889999998764 8999999999999999998 8999977655554


Q ss_pred             HHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          251 FDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       251 ~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      .........+.+  .+..++.++.+++.+||..+|.+||++.+|++.
T Consensus       351 ~~~~~~~~~~~~--~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         351 FYNAIKRGYRMA--KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             HHHHHHcCCCCC--CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            444333333322  223678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=2e-39  Score=307.10  Aligned_cols=245  Identities=26%  Similarity=0.370  Sum_probs=204.2

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEE
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHL  118 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~l  118 (419)
                      .++|++.+.||+|++|.||+|.+..+ ..+|+|.+.....    ..+.+.+|+.+++++. |||++++++++.+ +..++
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~-~~~~~   77 (260)
T cd05069           5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM----MPEAFLQEAQIMKKLR-HDKLVPLYAVVSE-EPIYI   77 (260)
T ss_pred             hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc----cHHHHHHHHHHHHhCC-CCCeeeEEEEEcC-CCcEE
Confidence            47899999999999999999988754 4589998765432    2356788999999996 9999999998864 45789


Q ss_pred             EEeecCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeecc
Q 014733          119 LMELCAGGELFHRLEKYG--RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA  196 (419)
Q Consensus       119 V~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~  196 (419)
                      +|||+++++|.+++....  .+++..+..++.|+++||.|||+.||+|+||||+||++   ++++.+||+|||++.....
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill---~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05069          78 VTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILV---GDNLVCKIADFGLARLIED  154 (260)
T ss_pred             EEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEE---cCCCeEEECCCccceEccC
Confidence            999999999999997643  37899999999999999999999999999999999999   5677899999999986543


Q ss_pred             CCc--cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHH
Q 014733          197 GQN--LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISAS  272 (419)
Q Consensus       197 ~~~--~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  272 (419)
                      ...  .....++..|+|||++.+. ++.++|+||||+++|+|++ |+.||.+....+....+... ...+  .+..++..
T Consensus       155 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~  231 (260)
T cd05069         155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERG-YRMP--CPQGCPES  231 (260)
T ss_pred             CcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCC--CCcccCHH
Confidence            321  1223456779999988764 8999999999999999999 99999988877777766543 2222  22468899


Q ss_pred             HHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          273 ARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       273 l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                      +.+++++||.+||++||+++++++
T Consensus       232 ~~~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         232 LHELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             HHHHHHHHccCCcccCcCHHHHHH
Confidence            999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-41  Score=287.27  Aligned_cols=258  Identities=28%  Similarity=0.519  Sum_probs=216.8

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      +.|...++||+|.||+||+|+++.+++.||+|.++.+.. .+..-....+|+-+|+.|+ |.|||+++++...++.+-+|
T Consensus         2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddd-degvpssalreicllkelk-hknivrl~dvlhsdkkltlv   79 (292)
T KOG0662|consen    2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELK-HKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_pred             cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCC-CCCCcHHHHHHHHHHHHhh-hcceeehhhhhccCceeEEe
Confidence            357788999999999999999999999999999987643 2223356778999999996 99999999999999999999


Q ss_pred             EeecCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC
Q 014733          120 MELCAGGELFHRLEK-YGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ  198 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~  198 (419)
                      +||| ..+|..+... ++.++.+.++.++.|++.||.++|++++.||||||+|.||   ..+|.+||+|||+++.++-..
T Consensus        80 fe~c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnlli---n~ngelkladfglarafgipv  155 (292)
T KOG0662|consen   80 FEFC-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLI---NRNGELKLADFGLARAFGIPV  155 (292)
T ss_pred             HHHh-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEe---ccCCcEEecccchhhhcCCce
Confidence            9999 5678777755 4569999999999999999999999999999999999999   678899999999998664332


Q ss_pred             -ccccccCCCccCCcccccCC--CCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCC--------
Q 014733          199 -NLHGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPW--------  266 (419)
Q Consensus       199 -~~~~~~gt~~y~aPE~l~~~--~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~--------  266 (419)
                       -.+..+.|.+|.+|.++.|.  |+...|+||.|||+.|+.. |++.|.+.+-.+...+|...-.....+.|        
T Consensus       156 rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpd  235 (292)
T KOG0662|consen  156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPD  235 (292)
T ss_pred             EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCC
Confidence             23445789999999999874  9999999999999999986 88999999888888877553322222222        


Q ss_pred             -----------------CCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccc
Q 014733          267 -----------------DHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEEC  303 (419)
Q Consensus       267 -----------------~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~  303 (419)
                                       +.++..-+|++.++|.-+|.+|++++++++||||...
T Consensus       236 yk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~  289 (292)
T KOG0662|consen  236 YKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF  289 (292)
T ss_pred             CcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence                             2234556799999999999999999999999999753

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-41  Score=303.59  Aligned_cols=258  Identities=25%  Similarity=0.384  Sum_probs=219.8

Q ss_pred             eeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEEee
Q 014733           43 VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMEL  122 (419)
Q Consensus        43 ~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~  122 (419)
                      +.+..||.|..|+||+++.+.+|...|||.+.+.  .+....+++...+.++..-..+|+||+.+++|..+..+++.||.
T Consensus        95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt--~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel  172 (391)
T KOG0983|consen   95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT--GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL  172 (391)
T ss_pred             hhHHhhcCCCccceEEEEEcccceEEEEEeeccc--CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence            3466799999999999999999999999999876  35667788888888887765689999999999999999999999


Q ss_pred             cCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhC-CCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCCcc
Q 014733          123 CAGGELFHRLEK-YGRFSETEARVIFRHLMQVVSYCHGN-GVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNL  200 (419)
Q Consensus       123 ~~ggsL~~~l~~-~~~l~~~~~~~i~~qll~aL~~LH~~-~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~~~  200 (419)
                      | +.-+..++.+ .++++|.-+-.+...++.||.||.++ +|+|||+||+|||+   +..|+|||||||.+-.+-++..+
T Consensus       173 M-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILl---De~GniKlCDFGIsGrlvdSkAh  248 (391)
T KOG0983|consen  173 M-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL---DERGNIKLCDFGISGRLVDSKAH  248 (391)
T ss_pred             H-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEE---ccCCCEEeecccccceeeccccc
Confidence            8 4455566554 35699999999999999999999865 79999999999999   67899999999999888777777


Q ss_pred             ccccCCCccCCcccccC----CCCCchhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 014733          201 HGTVGSPFYIAPEVLAG----GYNQAADVWSAGVILYILLSGMPPFWGK-TKSKIFDAVRAADLRFPSDPWDHISASARD  275 (419)
Q Consensus       201 ~~~~gt~~y~aPE~l~~----~~s~~sDvwSlGvil~elltG~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~  275 (419)
                      ....|-+.|||||.+.-    .|+.++||||||+.|+||.||+.||.+. ..-+++.++.+...+.. +.-..+|+.+++
T Consensus       249 trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L-~~~~gFSp~F~~  327 (391)
T KOG0983|consen  249 TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLL-PGHMGFSPDFQS  327 (391)
T ss_pred             ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCC-CcccCcCHHHHH
Confidence            77889999999999863    3999999999999999999999999873 45566667766443221 222359999999


Q ss_pred             HHHhhhhcCCCCCCCHHHHHhccccccchhhh
Q 014733          276 LIMGMLRVDPSTRLTAAEVLAHSWMEECEQVA  307 (419)
Q Consensus       276 li~~~L~~dP~~Rps~~eil~hp~~~~~~~~~  307 (419)
                      |+..||++|+.+||.-.++|+|||+...+...
T Consensus       328 fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~a~  359 (391)
T KOG0983|consen  328 FVKDCLTKDHRKRPKYNKLLEHPFIKRYETAE  359 (391)
T ss_pred             HHHHHhhcCcccCcchHHHhcCcceeecchhh
Confidence            99999999999999999999999998876643

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=9.8e-40  Score=317.73  Aligned_cols=248  Identities=23%  Similarity=0.390  Sum_probs=198.4

Q ss_pred             CceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEEeecCCCChHHH
Q 014733           52 QFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHR  131 (419)
Q Consensus        52 ~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~  131 (419)
                      +++.||.++++.+++.||+|++.... ........+..|+.++++++ |+||+++++++.+.+..+++|||+++++|.++
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~Ei~~l~~l~-h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~   89 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDS-CSKEDLKLLQQEIITSRQLQ-HPNILPYVTSFIVDSELYVVSPLMAYGSCEDL   89 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccc-cchhHHHHHHHHHHHHHhcC-CcchhhhhheeecCCeEEEEEeccCCCCHHHH
Confidence            44566777777789999999997653 24456788999999999996 99999999999999999999999999999999


Q ss_pred             HHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCCc--------cc
Q 014733          132 LEKY--GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN--------LH  201 (419)
Q Consensus       132 l~~~--~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~~--------~~  201 (419)
                      +...  ..+++..+..++.|+++||+|||+++|+||||||+||++   +.++.+||+|||.+........        ..
T Consensus        90 l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili---~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~  166 (314)
T cd08216          90 LKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILL---SGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPK  166 (314)
T ss_pred             HHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEE---ecCCceEEecCccceeeccccccccccccccc
Confidence            9764  458999999999999999999999999999999999999   4567899999998875532211        12


Q ss_pred             cccCCCccCCcccccC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-------C---------
Q 014733          202 GTVGSPFYIAPEVLAG---GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRF-------P---------  262 (419)
Q Consensus       202 ~~~gt~~y~aPE~l~~---~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~-------~---------  262 (419)
                      ...++..|+|||++.+   .++.++|+||+||++|+|++|..||..............+....       +         
T Consensus       167 ~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (314)
T cd08216         167 SSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQS  246 (314)
T ss_pred             cccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcc
Confidence            2356778999999865   38899999999999999999999997655433322211111100       0         


Q ss_pred             --------------CCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccch
Q 014733          263 --------------SDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECE  304 (419)
Q Consensus       263 --------------~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~  304 (419)
                                    ......++.++.+|+.+||+.||++|||+.++|+||||++..
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~  302 (314)
T cd08216         247 RSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK  302 (314)
T ss_pred             cccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence                          000112356788999999999999999999999999998764

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.5e-39  Score=310.09  Aligned_cols=250  Identities=22%  Similarity=0.371  Sum_probs=211.2

Q ss_pred             cCeeeeeeecccCceEEEEEEecC-----CCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCC
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKF-----TGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEED  114 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~-----~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~  114 (419)
                      ++|++...||+|+||.||+|+.+.     ..+.+++|.+....  .......+.+|+++++++. |+||+++++++.+.+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~   81 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLS-HKNVVRLLGLCREAE   81 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcC-CcceeeeEEEECCCC
Confidence            689999999999999999999753     34679999876542  2235678999999999996 999999999999999


Q ss_pred             EEEEEEeecCCCChHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEE
Q 014733          115 YVHLLMELCAGGELFHRLEKYG---------RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKL  185 (419)
Q Consensus       115 ~~~lV~E~~~ggsL~~~l~~~~---------~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL  185 (419)
                      ..++||||+++++|.+++....         .+++..+..++.||+.||+|||+.+|+||||||+||++   +.++.++|
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili---~~~~~~~l  158 (275)
T cd05046          82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLV---SSQREVKV  158 (275)
T ss_pred             cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEE---eCCCcEEE
Confidence            9999999999999999998655         68999999999999999999999999999999999999   45678999


Q ss_pred             eeccceeeeccCC--ccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCC
Q 014733          186 ADFGLATYIKAGQ--NLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRF  261 (419)
Q Consensus       186 ~DFgla~~~~~~~--~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~  261 (419)
                      +|||++.......  ......++..|+|||.+.+. ++.++||||||+++|+|++ |..||......+....+.......
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~  238 (275)
T cd05046         159 SLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLEL  238 (275)
T ss_pred             cccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCC
Confidence            9999986542221  22334567789999988764 7899999999999999998 889998877777777776555443


Q ss_pred             CCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          262 PSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       262 ~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      +.  ...++..+.+++.+||+.||.+|||+.+++.+
T Consensus       239 ~~--~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         239 PV--PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             CC--CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence            32  23688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.6e-39  Score=311.53  Aligned_cols=249  Identities=27%  Similarity=0.404  Sum_probs=198.4

Q ss_pred             ccCe-eeeeeecccCceEEEEEE----ecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEe-
Q 014733           39 SDRY-VLGKQLGWGQFGVIRECS----DKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEE-  112 (419)
Q Consensus        39 ~~~y-~i~~~LG~G~~g~V~~a~----~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~-  112 (419)
                      .+|| ++.+.||+|+||+||++.    ...++..+|+|.+....  .......+.+|+.+|+++. ||||+++++++.. 
T Consensus         2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~   78 (283)
T cd05080           2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLY-HENIVKYKGCCSEQ   78 (283)
T ss_pred             ChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCC-CCCEeeEEEEEecC
Confidence            4677 999999999999998864    33578899999987542  2345567889999999996 9999999998865 


Q ss_pred             -CCEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccce
Q 014733          113 -EDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA  191 (419)
Q Consensus       113 -~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla  191 (419)
                       ...++++|||+++++|.+++.. ..+++..++.++.|++.||+|||+++|+||||||+|||+   +.++.+||+|||++
T Consensus        79 ~~~~~~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~  154 (283)
T cd05080          79 GGKGLQLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLL---DNDRLVKIGDFGLA  154 (283)
T ss_pred             CCceEEEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEE---cCCCcEEEeecccc
Confidence             3468999999999999999976 469999999999999999999999999999999999999   55678999999999


Q ss_pred             eeeccCCcc----ccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHH--HHH------------H
Q 014733          192 TYIKAGQNL----HGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKS--KIF------------D  252 (419)
Q Consensus       192 ~~~~~~~~~----~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~--~~~------------~  252 (419)
                      .........    ....++..|+|||.+.+ .++.++||||||+++|+|++|..||......  +..            .
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd05080         155 KAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLI  234 (283)
T ss_pred             cccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhh
Confidence            876443221    12245667999999875 4899999999999999999999998543211  000            0


Q ss_pred             HHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          253 AVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       253 ~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                      .........+  ....++.++.+++.+||+.||++|||++++++
T Consensus       235 ~~~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         235 ELLERGMRLP--CPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             hhhhcCCCCC--CCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            0011111111  12367899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.9e-39  Score=306.43  Aligned_cols=241  Identities=26%  Similarity=0.370  Sum_probs=204.1

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEE-EeCCEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVY-EEEDYVHL  118 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~-~~~~~~~l  118 (419)
                      ++|++.+.||+|++|.||++...  |..+++|.+...     ...+.+.+|+.+++++. |+|++++++++ .+.+..++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~-----~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~l   77 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-----ATAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKGGLYI   77 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC-----chHHHHHHHHHHHHhCC-CCCeeeEEEEEEcCCCceEE
Confidence            57999999999999999999764  788999988643     23467889999999996 99999999875 45677999


Q ss_pred             EEeecCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeecc
Q 014733          119 LMELCAGGELFHRLEKYG--RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA  196 (419)
Q Consensus       119 V~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~  196 (419)
                      +|||+++++|.+++...+  .+++..+..++.|++.||+|||++||+||||||+||++   +.++.+||+|||++.....
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~dfg~~~~~~~  154 (256)
T cd05082          78 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASS  154 (256)
T ss_pred             EEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEE---cCCCcEEecCCccceeccc
Confidence            999999999999987644  38899999999999999999999999999999999999   5677899999999886433


Q ss_pred             CCccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 014733          197 GQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASAR  274 (419)
Q Consensus       197 ~~~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~  274 (419)
                      ..  ....++..|+|||++.+. ++.++|||||||++|+|++ |+.||......+....+.....   ......++..+.
T Consensus       155 ~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~  229 (256)
T cd05082         155 TQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK---MDAPDGCPPVVY  229 (256)
T ss_pred             cC--CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC---CCCCCCCCHHHH
Confidence            22  223455679999998764 8999999999999999997 9999988877777777655422   222347889999


Q ss_pred             HHHHhhhhcCCCCCCCHHHHHh
Q 014733          275 DLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       275 ~li~~~L~~dP~~Rps~~eil~  296 (419)
                      +++.+||+.||++|||+.++++
T Consensus       230 ~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         230 DVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             HHHHHHhcCChhhCcCHHHHHH
Confidence            9999999999999999999976

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.9e-39  Score=306.10  Aligned_cols=242  Identities=27%  Similarity=0.405  Sum_probs=204.7

Q ss_pred             eeecccCceEEEEEEecC-CCc--EEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEEee
Q 014733           46 KQLGWGQFGVIRECSDKF-TGE--VLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMEL  122 (419)
Q Consensus        46 ~~LG~G~~g~V~~a~~~~-~g~--~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~  122 (419)
                      ++||+|++|.||+|.+.. .+.  .+|+|.+......  ...+.+.+|+.+++++. ||||+++++.+.+ ..++++|||
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~-~~~~~v~e~   76 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLD-HENLIRLYGVVLT-HPLMMVTEL   76 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcC-CCCccceeEEEcC-CeEEEEEEe
Confidence            468999999999999865 333  6899999776432  56788999999999996 9999999999988 889999999


Q ss_pred             cCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCCcc
Q 014733          123 CAGGELFHRLEKYG--RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNL  200 (419)
Q Consensus       123 ~~ggsL~~~l~~~~--~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~~~  200 (419)
                      +++++|.+++....  .+++..++.++.|+++||+|||+++++|+||||+||++   +.++.+||+|||++..+......
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~  153 (257)
T cd05040          77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILL---ASDDKVKIGDFGLMRALPQNEDH  153 (257)
T ss_pred             cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEE---ecCCEEEeccccccccccccccc
Confidence            99999999997754  58999999999999999999999999999999999999   45678999999999876442211


Q ss_pred             ----ccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 014733          201 ----HGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASAR  274 (419)
Q Consensus       201 ----~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~  274 (419)
                          ....++..|+|||++.+ .++.++|+|||||++|+|++ |+.||...+..+....+.......+.  ...++..+.
T Consensus       154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  231 (257)
T cd05040         154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLER--PEACPQDIY  231 (257)
T ss_pred             eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCC--CccCCHHHH
Confidence                12356778999999876 48999999999999999998 99999888887777776653332222  236789999


Q ss_pred             HHHHhhhhcCCCCCCCHHHHHh
Q 014733          275 DLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       275 ~li~~~L~~dP~~Rps~~eil~  296 (419)
                      +++.+||+.+|++|||+.++++
T Consensus       232 ~li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         232 NVMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             HHHHHHCCCCcccCCCHHHHHH
Confidence            9999999999999999999976

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.8e-39  Score=307.19  Aligned_cols=245  Identities=26%  Similarity=0.366  Sum_probs=204.7

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEE
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHL  118 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~l  118 (419)
                      .++|++.+.||+|+||.||+|.+. .+..+|+|.+.....    ..+.+.+|+.+++++. |+||+++++++.+ +..++
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~E~~~l~~l~-~~~i~~~~~~~~~-~~~~l   77 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM----SPESFLEEAQIMKKLR-HDKLVQLYAVVSE-EPIYI   77 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC----CHHHHHHHHHHHHhcC-CCceEEEEeEECC-CCcEE
Confidence            478999999999999999999876 566799999876432    2356889999999996 9999999998854 55889


Q ss_pred             EEeecCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeecc
Q 014733          119 LMELCAGGELFHRLEKY--GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA  196 (419)
Q Consensus       119 V~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~  196 (419)
                      +|||+++++|.+++...  ..+++..+..++.+++.||+|||+.+|+||||||+||++   +.++.+||+|||++.....
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili---~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05070          78 VTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILV---GDGLVCKIADFGLARLIED  154 (260)
T ss_pred             EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEE---eCCceEEeCCceeeeeccC
Confidence            99999999999998753  348999999999999999999999999999999999999   4567899999999986544


Q ss_pred             CCcc--ccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHH
Q 014733          197 GQNL--HGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISAS  272 (419)
Q Consensus       197 ~~~~--~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  272 (419)
                      ....  ....++..|+|||++.+ .++.++|+||||+++|+|++ |.+||.+....+....+.... ..  ......+..
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~  231 (260)
T cd05070         155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGY-RM--PCPQDCPIS  231 (260)
T ss_pred             cccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CC--CCCCcCCHH
Confidence            3211  22345567999998765 48999999999999999999 999998888777777765432 22  223468899


Q ss_pred             HHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          273 ARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       273 l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                      +.+++.+||.+||++|||+.++++
T Consensus       232 ~~~li~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         232 LHELMLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             HHHHHHHHcccCcccCcCHHHHHH
Confidence            999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=2.5e-39  Score=306.26  Aligned_cols=246  Identities=25%  Similarity=0.383  Sum_probs=206.4

Q ss_pred             cccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEE
Q 014733           38 LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVH  117 (419)
Q Consensus        38 ~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~  117 (419)
                      ..++|+++++||+|+||.||+|..+ +++.+|+|.+.....    ....+.+|+.+++++. |+||+++++++. .+.++
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~-h~~i~~~~~~~~-~~~~~   76 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM----SPEAFLAEANLMKQLQ-HPRLVRLYAVVT-QEPIY   76 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC----cHHHHHHHHHHHHhcC-CcCeeeEEEEEc-cCCcE
Confidence            4688999999999999999999865 578899999875432    3457889999999996 999999999875 45689


Q ss_pred             EEEeecCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeec
Q 014733          118 LLMELCAGGELFHRLEKY--GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIK  195 (419)
Q Consensus       118 lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~  195 (419)
                      ++|||+.+++|.+++...  ..+++.++..++.|++.||+|||+.|++||||||+||++   +.++.++|+|||++....
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~~  153 (260)
T cd05067          77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILV---SETLCCKIADFGLARLIE  153 (260)
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEE---cCCCCEEEccCcceeecC
Confidence            999999999999998653  358999999999999999999999999999999999999   567789999999998654


Q ss_pred             cCCc--cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCH
Q 014733          196 AGQN--LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISA  271 (419)
Q Consensus       196 ~~~~--~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  271 (419)
                      ....  .....++..|+|||++.+. ++.++|+||||+++|+|++ |++||.+....+....+... ...+  .....+.
T Consensus       154 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~--~~~~~~~  230 (260)
T cd05067         154 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERG-YRMP--RPDNCPE  230 (260)
T ss_pred             CCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcC-CCCC--CCCCCCH
Confidence            2221  1233456789999998764 8999999999999999999 99999888777776666443 2222  2346889


Q ss_pred             HHHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          272 SARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       272 ~l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                      ++.++|.+||+.||++||++++++.
T Consensus       231 ~~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         231 ELYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             HHHHHHHHHccCChhhCCCHHHHHH
Confidence            9999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=3e-39  Score=305.92  Aligned_cols=241  Identities=23%  Similarity=0.329  Sum_probs=199.1

Q ss_pred             eecccCceEEEEEEec--CCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEEeecC
Q 014733           47 QLGWGQFGVIRECSDK--FTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCA  124 (419)
Q Consensus        47 ~LG~G~~g~V~~a~~~--~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~  124 (419)
                      .||+|+||.||+|.++  ..+..||+|++...  ......+.+.+|+.++++++ ||||+++++++.. ..+++||||++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~ii~~~~~~~~-~~~~lv~e~~~   77 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE--NEKSVRDEMMREAEIMHQLD-NPYIVRMIGVCEA-EALMLVMEMAS   77 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccc--cChHHHHHHHHHHHHHHhcC-CCCeEEEEEEEcC-CCeEEEEEeCC
Confidence            4899999999999765  44567999988654  23445677999999999996 9999999998864 46899999999


Q ss_pred             CCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCCcc---
Q 014733          125 GGELFHRLEK-YGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNL---  200 (419)
Q Consensus       125 ggsL~~~l~~-~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~~~---  200 (419)
                      +++|.+++.. ...+++..+..++.|++.||+|||++|++||||||+|||+   +.++.+||+|||++.........   
T Consensus        78 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~  154 (257)
T cd05115          78 GGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLL---VNQHYAKISDFGLSKALGADDSYYKA  154 (257)
T ss_pred             CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEE---cCCCcEEeccCCccccccCCccceec
Confidence            9999999875 3568999999999999999999999999999999999999   55678999999998755433221   


Q ss_pred             -ccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHH
Q 014733          201 -HGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLI  277 (419)
Q Consensus       201 -~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li  277 (419)
                       ....++..|+|||++.+ .++.++|+||||+++|+|++ |..||.+....+....+..+... .  .....++++.++|
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~l~~li  231 (257)
T cd05115         155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRL-D--CPAECPPEMYALM  231 (257)
T ss_pred             cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC-C--CCCCCCHHHHHHH
Confidence             11223568999999876 48999999999999999996 99999988887777766554322 1  2236789999999


Q ss_pred             HhhhhcCCCCCCCHHHHHhc
Q 014733          278 MGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       278 ~~~L~~dP~~Rps~~eil~h  297 (419)
                      .+||..||++||++.++++.
T Consensus       232 ~~c~~~~~~~Rp~~~~i~~~  251 (257)
T cd05115         232 KDCWIYKWEDRPNFAKVEER  251 (257)
T ss_pred             HHHcCCChhhCcCHHHHHHH
Confidence            99999999999999999763

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.5e-39  Score=305.04  Aligned_cols=247  Identities=26%  Similarity=0.396  Sum_probs=209.2

Q ss_pred             cccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEE
Q 014733           38 LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVH  117 (419)
Q Consensus        38 ~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~  117 (419)
                      ..++|++.++||+|++|.||+|.++ .+..+|+|.+.....    ....+.+|+.+++++. |+||+++++++.+....+
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~   77 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLR-HDKLVQLYAVCSEEEPIY   77 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc----CHHHHHHHHHHHhhCC-CCCEeeeeeeeecCCceE
Confidence            4589999999999999999999976 557899999875432    3467889999999996 999999999999989999


Q ss_pred             EEEeecCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeec
Q 014733          118 LLMELCAGGELFHRLEKYG--RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIK  195 (419)
Q Consensus       118 lV~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~  195 (419)
                      ++|||+++++|.+++....  .+++..+..++.+++.||.|||+++++|+||||+||++   +.++.+||+|||++....
T Consensus        78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili---~~~~~~~l~d~g~~~~~~  154 (261)
T cd05034          78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILV---GENLVCKIADFGLARLIE  154 (261)
T ss_pred             EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEE---cCCCCEEECccccceecc
Confidence            9999999999999997643  58999999999999999999999999999999999999   567899999999998764


Q ss_pred             cCCc--cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCH
Q 014733          196 AGQN--LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISA  271 (419)
Q Consensus       196 ~~~~--~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  271 (419)
                      ....  .....++..|+|||.+.+. ++.++|+||+|+++|+|++ |+.||.+....+..+.+.... ..+.  ....+.
T Consensus       155 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~-~~~~--~~~~~~  231 (261)
T cd05034         155 DDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGY-RMPR--PPNCPE  231 (261)
T ss_pred             chhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCC--CCCCCH
Confidence            3221  1122345679999998764 8999999999999999998 999998888777777765532 2221  235689


Q ss_pred             HHHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          272 SARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       272 ~l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                      ++.+++.+||+.||++||+++++++
T Consensus       232 ~~~~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         232 ELYDLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             HHHHHHHHHcccCcccCCCHHHHHH
Confidence            9999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=5.2e-39  Score=303.00  Aligned_cols=246  Identities=26%  Similarity=0.419  Sum_probs=207.9

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      .+|++.+.||.|+||.||+|.+. .+..+|+|.+.....    ....+.+|+++++++. ||||+++++++.+....+++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v   77 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM----SEEDFIEEAQVMMKLS-HPKLVQLYGVCTERSPICLV   77 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC----CHHHHHHHHHHHHhCC-CCCeeeEEEEEccCCceEEE
Confidence            57899999999999999999876 477899998865432    2356888999999996 99999999999999999999


Q ss_pred             EeecCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC
Q 014733          120 MELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ  198 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~  198 (419)
                      |||+++++|.+++... +.+++..++.++.+++.+|+|||+.+++|+||||+||++   +.++.+||+|||++.......
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~  154 (256)
T cd05112          78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLV---GENQVVKVSDFGMTRFVLDDQ  154 (256)
T ss_pred             EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEE---cCCCeEEECCCcceeecccCc
Confidence            9999999999998764 468999999999999999999999999999999999999   566789999999988654332


Q ss_pred             c--cccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 014733          199 N--LHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASAR  274 (419)
Q Consensus       199 ~--~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~  274 (419)
                      .  .....++..|+|||++.+ .++.++|+||||+++|+|++ |+.||......+..+.+.........   ...+..+.
T Consensus       155 ~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~  231 (256)
T cd05112         155 YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKP---RLASQSVY  231 (256)
T ss_pred             ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCC---CCCCHHHH
Confidence            1  123345668999999875 48999999999999999998 99999888877777777654322221   24689999


Q ss_pred             HHHHhhhhcCCCCCCCHHHHHhc
Q 014733          275 DLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       275 ~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      +++.+||+.+|++|||+.+++++
T Consensus       232 ~l~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         232 ELMQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             HHHHHHcccChhhCCCHHHHHHh
Confidence            99999999999999999999864

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=3.8e-39  Score=311.34  Aligned_cols=252  Identities=23%  Similarity=0.346  Sum_probs=202.7

Q ss_pred             ccCeeeeeeecccCceEEEEEEecC----------------CCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCC
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKF----------------TGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN  102 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~----------------~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpn  102 (419)
                      .++|++.+.||+|+||.||++.+..                ++..+|+|.+....  .......+.+|+.+++.++ |+|
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~-~~~   80 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLK-DPN   80 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCC
Confidence            4689999999999999999986432                34578999886542  3455678899999999996 999


Q ss_pred             ceeeeEEEEeCCEEEEEEeecCCCChHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCc
Q 014733          103 VVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYG-----------RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPEN  171 (419)
Q Consensus       103 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~-----------~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~N  171 (419)
                      |+++++++.+.+.++++|||+++++|.+++....           .+++..+..++.|++.||+|||+.|++|+||||+|
T Consensus        81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N  160 (296)
T cd05095          81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN  160 (296)
T ss_pred             cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence            9999999999999999999999999999987643           26678899999999999999999999999999999


Q ss_pred             EEEeecCCCCCeEEeeccceeeeccCCc---cccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh--CCCCCCCC
Q 014733          172 ILLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS--GMPPFWGK  245 (419)
Q Consensus       172 ILl~~~~~~~~vKL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt--G~~Pf~~~  245 (419)
                      ||+   +.++.+||+|||++..+.....   .....++..|+|||+..+ .++.++|+|||||++|||++  |..||...
T Consensus       161 ili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~  237 (296)
T cd05095         161 CLV---GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL  237 (296)
T ss_pred             EEE---cCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence            999   4577899999999886543321   112234678999998655 58999999999999999998  78999877


Q ss_pred             CHHHHHHHHHh----cCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          246 TKSKIFDAVRA----ADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       246 ~~~~~~~~i~~----~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                      ...+.......    ............++..+.+|+.+||+.||++||++.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         238 SDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             ChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            66555543321    1111111112357799999999999999999999999975

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=4.4e-39  Score=307.93  Aligned_cols=250  Identities=21%  Similarity=0.264  Sum_probs=209.4

Q ss_pred             cccCeeeeeeecccCceEEEEEEecC----CCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEe-
Q 014733           38 LSDRYVLGKQLGWGQFGVIRECSDKF----TGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEE-  112 (419)
Q Consensus        38 ~~~~y~i~~~LG~G~~g~V~~a~~~~----~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~-  112 (419)
                      -.++|++.+.||+|+||.||+|.+..    ++..|++|.+...  ........+.+|+.+++++. ||||+++++++.+ 
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~   80 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLS-HQNILPILHVCIED   80 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEecC
Confidence            35899999999999999999999875    3688999987643  34566788899999999995 9999999998765 


Q ss_pred             CCEEEEEEeecCCCChHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeE
Q 014733          113 EDYVHLLMELCAGGELFHRLEKY--------GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIK  184 (419)
Q Consensus       113 ~~~~~lV~E~~~ggsL~~~l~~~--------~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vK  184 (419)
                      ....++++||+++++|..++...        ..+++..+..++.|++.||+|||+.+++|+||||+||++   ++++.+|
T Consensus        81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~---~~~~~~k  157 (280)
T cd05043          81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVI---DEELQVK  157 (280)
T ss_pred             CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEE---cCCCcEE
Confidence            57789999999999999998653        348899999999999999999999999999999999999   5668899


Q ss_pred             EeeccceeeeccCCcc---ccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCC
Q 014733          185 LADFGLATYIKAGQNL---HGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADL  259 (419)
Q Consensus       185 L~DFgla~~~~~~~~~---~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~  259 (419)
                      |+|||+++.+......   ....++..|+|||++.+. ++.++||||||+++|++++ |+.||......+....+... .
T Consensus       158 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~  236 (280)
T cd05043         158 ITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDG-Y  236 (280)
T ss_pred             ECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcC-C
Confidence            9999999865433221   123456779999998764 8999999999999999999 99999887777766665543 2


Q ss_pred             CCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          260 RFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       260 ~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                      ..+.  ...+++++.+++.+||+.||++|||+.++++
T Consensus       237 ~~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         237 RLAQ--PINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             CCCC--CCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            2222  3467899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=6.3e-41  Score=309.58  Aligned_cols=264  Identities=30%  Similarity=0.453  Sum_probs=207.3

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCc----EEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEe-C
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGE----VLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEE-E  113 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~----~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~-~  113 (419)
                      ...|++...||+|.||.||+|..+.++.    .+|+|.+.-++..+- .-...-+|+.+++.|+ ||||+.+..++.. +
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tG-iS~SAcREiaL~REl~-h~nvi~Lv~Vfl~~d  100 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTG-ISMSACREIALLRELK-HPNVISLVKVFLSHD  100 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCC-cCHHHHHHHHHHHHhc-CCcchhHHHHHhccC
Confidence            4579999999999999999997665543    789999875533221 1234567999999997 9999999999987 8


Q ss_pred             CEEEEEEeecCCCChHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecC-CCCCeEEee
Q 014733          114 DYVHLLMELCAGGELFHRLEKY-----GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKS-SSSPIKLAD  187 (419)
Q Consensus       114 ~~~~lV~E~~~ggsL~~~l~~~-----~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~-~~~~vKL~D  187 (419)
                      ..+++++||.+ -+|++.|+-+     ..++...++.|+.||+.|+.|||++-|+||||||.|||+..++ +.|.|||+|
T Consensus       101 ~~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  101 KKVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             ceEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeec
Confidence            89999999995 4888888643     2389999999999999999999999999999999999995432 348999999


Q ss_pred             ccceeeeccCC----ccccccCCCccCCcccccCC--CCCchhHHHHHHHHHHHHhCCCCCCCCCH---------HHHHH
Q 014733          188 FGLATYIKAGQ----NLHGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTK---------SKIFD  252 (419)
Q Consensus       188 Fgla~~~~~~~----~~~~~~gt~~y~aPE~l~~~--~s~~sDvwSlGvil~elltG~~Pf~~~~~---------~~~~~  252 (419)
                      ||+++.+...-    .....+.|.+|.|||.+.|.  |+++.|||++|||+.||++..+.|.+...         .+.+.
T Consensus       180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~  259 (438)
T KOG0666|consen  180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD  259 (438)
T ss_pred             ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence            99999876532    23455789999999999884  99999999999999999999999965421         22333


Q ss_pred             HHHhcCCCCCCCCC---------------------------------CCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccc
Q 014733          253 AVRAADLRFPSDPW---------------------------------DHISASARDLIMGMLRVDPSTRLTAAEVLAHSW  299 (419)
Q Consensus       253 ~i~~~~~~~~~~~~---------------------------------~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~  299 (419)
                      +|...-.......|                                 ..-++...+|+.+||+.||.+|.|++++|+|+|
T Consensus       260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~y  339 (438)
T KOG0666|consen  260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPY  339 (438)
T ss_pred             HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccc
Confidence            33222111111111                                 112455889999999999999999999999999


Q ss_pred             cccchh
Q 014733          300 MEECEQ  305 (419)
Q Consensus       300 ~~~~~~  305 (419)
                      |....-
T Consensus       340 F~~d~l  345 (438)
T KOG0666|consen  340 FTEDPL  345 (438)
T ss_pred             cccCCC
Confidence            987643

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=8.6e-39  Score=300.43  Aligned_cols=242  Identities=24%  Similarity=0.364  Sum_probs=201.8

Q ss_pred             eeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEEeecCC
Q 014733           46 KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAG  125 (419)
Q Consensus        46 ~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~g  125 (419)
                      +.||+|+||.||+|... ++..+|+|.+....  .......+.+|+.+++++. ||||+++++++.+.+..++||||+++
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~   76 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL--PQELKIKFLSEARILKQYD-HPNIVKLIGVCTQRQPIYIVMELVPG   76 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCC-CCCcCeEEEEEecCCccEEEEECCCC
Confidence            47999999999999865 68899999886542  3344557889999999995 99999999999999999999999999


Q ss_pred             CChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCCccc--c
Q 014733          126 GELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLH--G  202 (419)
Q Consensus       126 gsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~~~~--~  202 (419)
                      ++|.+++... ..+++..+..++.+++.+|.|||+.|++||||||+||++   +.++.+||+|||++..........  .
T Consensus        77 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~~~~  153 (250)
T cd05085          77 GDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLV---GENNVLKISDFGMSRQEDDGIYSSSGL  153 (250)
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEE---cCCCeEEECCCccceeccccccccCCC
Confidence            9999998754 458999999999999999999999999999999999999   567789999999987543322111  1


Q ss_pred             ccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhh
Q 014733          203 TVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGM  280 (419)
Q Consensus       203 ~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~  280 (419)
                      ..++..|+|||++.+. ++.++|+||||+++|+|++ |..||.+.........+.... ..  .....++.++.+++.+|
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~li~~~  230 (250)
T cd05085         154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY-RM--SCPQKCPDDVYKVMQRC  230 (250)
T ss_pred             CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC-CC--CCCCCCCHHHHHHHHHH
Confidence            2345679999998764 8999999999999999998 999998887777666665432 21  22346889999999999


Q ss_pred             hhcCCCCCCCHHHHHhc
Q 014733          281 LRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       281 L~~dP~~Rps~~eil~h  297 (419)
                      |..+|++||++.++++.
T Consensus       231 l~~~p~~Rp~~~~l~~~  247 (250)
T cd05085         231 WDYKPENRPKFSELQKE  247 (250)
T ss_pred             cccCcccCCCHHHHHHH
Confidence            99999999999999763

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=9.3e-41  Score=296.95  Aligned_cols=257  Identities=26%  Similarity=0.526  Sum_probs=215.7

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEe--CCEE
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEE--EDYV  116 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~--~~~~  116 (419)
                      .++|++..++|+|.|+.||.|....+++.++||+++      +...+.+.+|+.||+.|++||||++++++..+  ....
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLK------PVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp  110 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILK------PVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP  110 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeec------hHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence            579999999999999999999998899999999875      34567899999999999999999999999976  4567


Q ss_pred             EEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeecc
Q 014733          117 HLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA  196 (419)
Q Consensus       117 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~  196 (419)
                      .+|+||+++.+...+..   .++...++.++.+|+.||.|||+.||+|||+||.||+|+.  ....++|+|+|+|.++.+
T Consensus       111 aLiFE~v~n~Dfk~ly~---tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh--~~rkLrlIDWGLAEFYHp  185 (338)
T KOG0668|consen  111 SLIFEYVNNTDFKQLYP---TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHP  185 (338)
T ss_pred             hhHhhhhccccHHHHhh---hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeech--hhceeeeeecchHhhcCC
Confidence            89999998877666554   4899999999999999999999999999999999999963  456899999999999999


Q ss_pred             CCccccccCCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHh-------------cCCC
Q 014733          197 GQNLHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFW-GKTKSKIFDAVRA-------------ADLR  260 (419)
Q Consensus       197 ~~~~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~-~~~~~~~~~~i~~-------------~~~~  260 (419)
                      +......+.+..|-.||.+..  .|+...|+|||||+|..|+..+.||. |.+..+.+.+|..             -...
T Consensus       186 ~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~  265 (338)
T KOG0668|consen  186 GKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQID  265 (338)
T ss_pred             CceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccC
Confidence            988888889999999999876  48999999999999999999998884 4433333333311             1111


Q ss_pred             -----------CCCCCC---------CCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchhh
Q 014733          261 -----------FPSDPW---------DHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQV  306 (419)
Q Consensus       261 -----------~~~~~~---------~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~~  306 (419)
                                 .....|         .-+++++.||+.++|+.|..+|+|+.|++.||||....+.
T Consensus       266 Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~~  331 (338)
T KOG0668|consen  266 LDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVREA  331 (338)
T ss_pred             CChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHHH
Confidence                       111112         2357999999999999999999999999999999876543

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=6.1e-39  Score=305.30  Aligned_cols=249  Identities=26%  Similarity=0.368  Sum_probs=207.1

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCC---CcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCE
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFT---GEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDY  115 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~---g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~  115 (419)
                      .++|.+.+.||+|+||.||+|.+...   ...+++|.+....  .....+.+.+|+.+++++. ||||+++++++.+. .
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~-~   80 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFD-HPHIVKLIGVITEN-P   80 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCC-CCchhceeEEEcCC-C
Confidence            46799999999999999999987644   3468999886542  2455678999999999996 99999999998764 4


Q ss_pred             EEEEEeecCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeee
Q 014733          116 VHLLMELCAGGELFHRLEKYG-RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI  194 (419)
Q Consensus       116 ~~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~  194 (419)
                      .++||||+++++|.+++.... .+++..+..++.+++.||+|||+.+++|+||||+|||+   +.++.+||+|||++...
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili---~~~~~~~l~d~g~~~~~  157 (270)
T cd05056          81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLV---SSPDCVKLGDFGLSRYL  157 (270)
T ss_pred             cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEE---ecCCCeEEccCceeeec
Confidence            789999999999999997644 48999999999999999999999999999999999999   45678999999999876


Q ss_pred             ccCCccc--cccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCC
Q 014733          195 KAGQNLH--GTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHIS  270 (419)
Q Consensus       195 ~~~~~~~--~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  270 (419)
                      .......  ...++..|+|||.+.+ .++.++|+||||+++|+|++ |..||.+....+....+......   ..+..++
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~---~~~~~~~  234 (270)
T cd05056         158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL---PMPPNCP  234 (270)
T ss_pred             ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcC---CCCCCCC
Confidence            4432221  2234567999998865 48999999999999999986 99999888877777666554322   1234788


Q ss_pred             HHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          271 ASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       271 ~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      .++.++|.+||..+|++|||+.+++..
T Consensus       235 ~~~~~li~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         235 PTLYSLMTKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-40  Score=328.48  Aligned_cols=251  Identities=27%  Similarity=0.417  Sum_probs=217.5

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCc---E-EEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGE---V-LACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDY  115 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~---~-vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~  115 (419)
                      ++-.+.++||+|+||.||+|..+..+.   . ||+|....+.......+..+.+|.++|+.+. |||||++||+..+..-
T Consensus       157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~-H~NVVr~yGVa~~~~P  235 (474)
T KOG0194|consen  157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLN-HPNVVRFYGVAVLEEP  235 (474)
T ss_pred             cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEcCCCc
Confidence            566677999999999999999875432   3 8999887655567788999999999999995 9999999999999999


Q ss_pred             EEEEEeecCCCChHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeee
Q 014733          116 VHLLMELCAGGELFHRLEKYGR-FSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI  194 (419)
Q Consensus       116 ~~lV~E~~~ggsL~~~l~~~~~-l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~  194 (419)
                      +++|||+|+||+|.++|.+.+. ++..+...++.+.+.||+|||++++|||||-..|+|+   ..++.+||+|||+++.-
T Consensus       236 l~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~---~~~~~vKISDFGLs~~~  312 (474)
T KOG0194|consen  236 LMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLY---SKKGVVKISDFGLSRAG  312 (474)
T ss_pred             cEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHhee---cCCCeEEeCccccccCC
Confidence            9999999999999999998774 9999999999999999999999999999999999999   55667899999998754


Q ss_pred             ccCCccccc-cCCCccCCcccccCC-CCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCH
Q 014733          195 KAGQNLHGT-VGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISA  271 (419)
Q Consensus       195 ~~~~~~~~~-~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  271 (419)
                      ..-...... .-...|+|||.+... |+.++|||||||++||+++ |..||.+....++..+|....++.+...  ..+.
T Consensus       313 ~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~--~~p~  390 (474)
T KOG0194|consen  313 SQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPS--KTPK  390 (474)
T ss_pred             cceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCC--CCHH
Confidence            311111111 234569999999875 9999999999999999998 8999999999999999977666655544  7889


Q ss_pred             HHHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          272 SARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       272 ~l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                      ++..++.+|+..||++|||+.++.+
T Consensus       391 ~~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  391 ELAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             HHHHHHHHhccCChhhccCHHHHHH
Confidence            9999999999999999999999976

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=9.4e-39  Score=302.52  Aligned_cols=246  Identities=25%  Similarity=0.395  Sum_probs=206.6

Q ss_pred             cccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEE
Q 014733           38 LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVH  117 (419)
Q Consensus        38 ~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~  117 (419)
                      ..++|++.+.||+|+||.||++.+. .+..+++|.+...    ......+.+|+.+++++. |+||+++++++.+ ...+
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~-~~~~   76 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG----SMSVEAFLAEANVMKTLQ-HDKLVKLHAVVTK-EPIY   76 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC----hhHHHHHHHHHHHHHhcC-CCCcceEEEEEcC-CCeE
Confidence            4689999999999999999999865 4567999987643    234567889999999996 9999999999987 7789


Q ss_pred             EEEeecCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeec
Q 014733          118 LLMELCAGGELFHRLEKY--GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIK  195 (419)
Q Consensus       118 lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~  195 (419)
                      ++|||+++++|.+++...  ..+++..+..++.|++.||.|||+.|++|+||||+||++   +.++.+||+|||.+....
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~  153 (260)
T cd05073          77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV---SASLVCKIADFGLARVIE  153 (260)
T ss_pred             EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEE---cCCCcEEECCCcceeecc
Confidence            999999999999999763  347888999999999999999999999999999999999   567799999999998654


Q ss_pred             cCCc--cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCH
Q 014733          196 AGQN--LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISA  271 (419)
Q Consensus       196 ~~~~--~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  271 (419)
                      ....  .....++..|+|||++.+. ++.++|+||||+++|+|++ |+.||.+.+..+....+.... ..+  .....+.
T Consensus       154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~-~~~--~~~~~~~  230 (260)
T cd05073         154 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY-RMP--RPENCPE  230 (260)
T ss_pred             CCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC-CCC--CcccCCH
Confidence            3321  1223456679999998764 8899999999999999998 999999887777777665442 222  2347889


Q ss_pred             HHHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          272 SARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       272 ~l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                      ++.+++.+||++||++||++.+++.
T Consensus       231 ~~~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         231 ELYNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             HHHHHHHHHcccCcccCcCHHHHHH
Confidence            9999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=7.9e-39  Score=304.15  Aligned_cols=252  Identities=29%  Similarity=0.475  Sum_probs=211.5

Q ss_pred             CeeeeeeecccCceEEEEEEecC-CCcEEEEEEeccCcc-------CCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEe
Q 014733           41 RYVLGKQLGWGQFGVIRECSDKF-TGEVLACKSIAKDRL-------VTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEE  112 (419)
Q Consensus        41 ~y~i~~~LG~G~~g~V~~a~~~~-~g~~vaiK~i~~~~~-------~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~  112 (419)
                      .|.+.+.||+|+||.||+|.++. +++.+|+|.+.....       ........+..|+.++.+..+||||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            48889999999999999999987 788999998864321       2334556778899988764469999999999999


Q ss_pred             CCEEEEEEeecCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeccCCCCcEEEeecCCCCCeEEee
Q 014733          113 EDYVHLLMELCAGGELFHRLEK----YGRFSETEARVIFRHLMQVVSYCHG-NGVVHRDLKPENILLATKSSSSPIKLAD  187 (419)
Q Consensus       113 ~~~~~lV~E~~~ggsL~~~l~~----~~~l~~~~~~~i~~qll~aL~~LH~-~~IvHrDLkp~NILl~~~~~~~~vKL~D  187 (419)
                      ++..+++|||++|++|.+++..    ...+++..++.++.|++.+|.|||+ .+++|+||+|+||++   +.++.+||+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~---~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIML---GEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEE---CCCCcEEEec
Confidence            9999999999999999988743    3458999999999999999999996 689999999999999   5677899999


Q ss_pred             ccceeeeccCCccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 014733          188 FGLATYIKAGQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW  266 (419)
Q Consensus       188 Fgla~~~~~~~~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  266 (419)
                      ||.+.............|+..|+|||++.+. ++.++|+||||+++|+|++|++||...........+........  ..
T Consensus       158 fg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~  235 (269)
T cd08528         158 FGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPL--PE  235 (269)
T ss_pred             ccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcC--Cc
Confidence            9999876554444556789999999998764 89999999999999999999999988777666666655443322  22


Q ss_pred             CCCCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          267 DHISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       267 ~~~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      ..++.++.++|.+||+.||++||++.|+..+
T Consensus       236 ~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         236 GMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             ccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence            3578999999999999999999999999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-38  Score=305.46  Aligned_cols=248  Identities=24%  Similarity=0.341  Sum_probs=208.5

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCc----EEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCC
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGE----VLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEED  114 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~----~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~  114 (419)
                      .++|++.+.||+|+||+||+|.++.+|.    .+|+|......  .......+.+|+.+++++. ||||+++++++.. .
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~-~   81 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--SPKANKEILDEAYVMASVD-HPHVVRLLGICLS-S   81 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC--CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEec-C
Confidence            3789999999999999999999876665    58999876553  3455678899999999995 9999999999987 6


Q ss_pred             EEEEEEeecCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceee
Q 014733          115 YVHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATY  193 (419)
Q Consensus       115 ~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~  193 (419)
                      ..+++|||+++|+|.+++... ..+++..+..++.|++.||+|||+.+|+||||||+||++   ..++.+||+|||++..
T Consensus        82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~---~~~~~~kL~dfg~~~~  158 (279)
T cd05057          82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLV---KTPQHVKITDFGLAKL  158 (279)
T ss_pred             ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEE---cCCCeEEECCCccccc
Confidence            789999999999999998764 458999999999999999999999999999999999999   5567899999999987


Q ss_pred             eccCCccc---cccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCC
Q 014733          194 IKAGQNLH---GTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDH  268 (419)
Q Consensus       194 ~~~~~~~~---~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  268 (419)
                      ........   ...++..|+|||.+.. .++.++|+||||+++|+|++ |+.||.+....++...+..... .+.  ...
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-~~~--~~~  235 (279)
T cd05057         159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGER-LPQ--PPI  235 (279)
T ss_pred             ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCC-CCC--CCC
Confidence            65433221   1223567999998865 58999999999999999998 9999998888887777765432 222  125


Q ss_pred             CCHHHHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          269 ISASARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       269 ~s~~l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                      .+.++.+++.+||..||++||++.++++
T Consensus       236 ~~~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         236 CTIDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             CCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            7789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.4e-39  Score=301.04  Aligned_cols=241  Identities=25%  Similarity=0.384  Sum_probs=203.1

Q ss_pred             eeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEEeecCC
Q 014733           46 KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAG  125 (419)
Q Consensus        46 ~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~g  125 (419)
                      ++||.|++|.||+|.+.. ++.|++|.+.....  ......+.+|+++++++. |+||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~--~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~e~~~~   76 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLP--PDLKRKFLQEAEILKQYD-HPNIVKLIGVCVQKQPIYIVMELVPG   76 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCC--HHHHHHHHHHHHHHHhCC-CCCeEEEEEEEecCCCeEEEEEcCCC
Confidence            479999999999999887 99999999876532  245678999999999996 99999999999999999999999999


Q ss_pred             CChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCCcc---c
Q 014733          126 GELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNL---H  201 (419)
Q Consensus       126 gsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~~~---~  201 (419)
                      ++|.+++... ..+++..+..++.+++.+|+|||+++++||||||+||++   +.++.+||+|||++.........   .
T Consensus        77 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~~~~  153 (251)
T cd05041          77 GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLV---GENNVLKISDFGMSREEEGGIYTVSDG  153 (251)
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEE---cCCCcEEEeeccccccccCCcceeccc
Confidence            9999998653 458999999999999999999999999999999999999   56778999999999865422211   1


Q ss_pred             cccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHh
Q 014733          202 GTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMG  279 (419)
Q Consensus       202 ~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~  279 (419)
                      ...++..|+|||.+.+ .++.++|+||||+++|+|++ |..||...........+... ...+  ....++.++.+++.+
T Consensus       154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~~~li~~  230 (251)
T cd05041         154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESG-YRMP--APQLCPEEIYRLMLQ  230 (251)
T ss_pred             cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcC-CCCC--CCccCCHHHHHHHHH
Confidence            1233566999998876 48999999999999999999 89999887776666666543 2222  234688999999999


Q ss_pred             hhhcCCCCCCCHHHHHh
Q 014733          280 MLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       280 ~L~~dP~~Rps~~eil~  296 (419)
                      ||+.+|++|||+.++++
T Consensus       231 ~l~~~p~~Rp~~~ell~  247 (251)
T cd05041         231 CWAYDPENRPSFSEIYN  247 (251)
T ss_pred             HhccChhhCcCHHHHHH
Confidence            99999999999999986

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-40  Score=298.94  Aligned_cols=254  Identities=30%  Similarity=0.411  Sum_probs=210.9

Q ss_pred             ccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEe--
Q 014733           35 ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEE--  112 (419)
Q Consensus        35 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~--  112 (419)
                      +..-.+||++.+.||+|||+.||++.+..++..+|+|++...   +.++.+...+|++..+++. ||||++++++...  
T Consensus        16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~---~~~~~e~~~rEid~~rkf~-s~~vl~l~dh~l~~~   91 (302)
T KOG2345|consen   16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH---SQEDIEEALREIDNHRKFN-SPNVLRLVDHQLREE   91 (302)
T ss_pred             EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeecc---chHHHHHHHHHHHHHHhhC-CcchHHHHHHHHHhh
Confidence            344568999999999999999999999999999999999765   3477889999999999995 9999999877633  


Q ss_pred             ---CCEEEEEEeecCCCChHHHHHHc---C-CCCHHHHHHHHHHHHHHHHHHHhCC--CeeccCCCCcEEEeecCCCCCe
Q 014733          113 ---EDYVHLLMELCAGGELFHRLEKY---G-RFSETEARVIFRHLMQVVSYCHGNG--VVHRDLKPENILLATKSSSSPI  183 (419)
Q Consensus       113 ---~~~~~lV~E~~~ggsL~~~l~~~---~-~l~~~~~~~i~~qll~aL~~LH~~~--IvHrDLkp~NILl~~~~~~~~v  183 (419)
                         ....|+++.|...|+|.+.++..   + .+++.++..|+.+|++||++||+..  .+||||||.|||+   .+.+.+
T Consensus        92 ~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILl---s~~~~~  168 (302)
T KOG2345|consen   92 KDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILL---SDSGLP  168 (302)
T ss_pred             ccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEe---cCCCce
Confidence               34599999999999999988654   2 4899999999999999999999999  9999999999999   567899


Q ss_pred             EEeeccceeeecc----CC------ccccccCCCccCCcccccCC----CCCchhHHHHHHHHHHHHhCCCCCCCC--CH
Q 014733          184 KLADFGLATYIKA----GQ------NLHGTVGSPFYIAPEVLAGG----YNQAADVWSAGVILYILLSGMPPFWGK--TK  247 (419)
Q Consensus       184 KL~DFgla~~~~~----~~------~~~~~~gt~~y~aPE~l~~~----~s~~sDvwSlGvil~elltG~~Pf~~~--~~  247 (419)
                      +|.|||.++...-    ..      .......|.-|+|||.+.-+    .+.++|||||||+||+|+.|..||...  ..
T Consensus       169 vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G  248 (302)
T KOG2345|consen  169 VLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG  248 (302)
T ss_pred             EEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC
Confidence            9999999876531    11      01122467789999997642    689999999999999999999999432  11


Q ss_pred             HHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          248 SKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       248 ~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      ..+.-.+.++.+.+|...  .+|+.+.++|+.||++||.+||++.+++.+
T Consensus       249 gSlaLAv~n~q~s~P~~~--~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  249 GSLALAVQNAQISIPNSS--RYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             CeEEEeeeccccccCCCC--CccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            222234455667777765  599999999999999999999999999864

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=4.5e-39  Score=308.87  Aligned_cols=249  Identities=27%  Similarity=0.400  Sum_probs=200.5

Q ss_pred             cCeeeeeeecccCceEEEEEEe----cCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeC--
Q 014733           40 DRYVLGKQLGWGQFGVIRECSD----KFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEE--  113 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~----~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~--  113 (419)
                      .-|++++.||+|+||.||+|..    +.++..||+|.+...  ........+.+|+.+++++. ||||+++++++.+.  
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~   80 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE--SGGNHIADLKKEIEILRNLY-HENIVKYKGICTEDGG   80 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcc--ccHHHHHHHHHHHHHHHhCC-CCCeeeeeeEEecCCC
Confidence            3468999999999999999974    467889999998644  23455678999999999996 99999999998875  


Q ss_pred             CEEEEEEeecCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeecccee
Q 014733          114 DYVHLLMELCAGGELFHRLEKYG-RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLAT  192 (419)
Q Consensus       114 ~~~~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~  192 (419)
                      ..+++||||++|++|.+++.+.. .+++.++..++.|++.||+|||+.||+||||||+||++   +.++.+||+|||++.
T Consensus        81 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~---~~~~~~~l~dfg~~~  157 (284)
T cd05079          81 NGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV---ESEHQVKIGDFGLTK  157 (284)
T ss_pred             CceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEE---cCCCCEEECCCcccc
Confidence            67899999999999999997643 58999999999999999999999999999999999999   456789999999998


Q ss_pred             eeccCCcc----ccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCC---------------HHHHHH
Q 014733          193 YIKAGQNL----HGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKT---------------KSKIFD  252 (419)
Q Consensus       193 ~~~~~~~~----~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~---------------~~~~~~  252 (419)
                      .+......    ....++..|+|||++.+. ++.++|+||||+++|+|+++..|+....               ......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05079         158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR  237 (284)
T ss_pred             ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence            76443221    233567789999998764 8999999999999999999877653211               011111


Q ss_pred             HHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          253 AVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       253 ~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      .+... ...  ..+..++..+.+||.+||+.||++|||+.+++++
T Consensus       238 ~~~~~-~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         238 VLEEG-KRL--PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             HHHcC-ccC--CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            11111 112  2234689999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.8e-39  Score=307.21  Aligned_cols=240  Identities=21%  Similarity=0.259  Sum_probs=194.1

Q ss_pred             eeecccCceEEEEEEecCCCc-------EEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEE
Q 014733           46 KQLGWGQFGVIRECSDKFTGE-------VLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHL  118 (419)
Q Consensus        46 ~~LG~G~~g~V~~a~~~~~g~-------~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~l  118 (419)
                      +.||+|+||.||+|.++..+.       .+++|.+...   .....+.+..|+.+++.+. ||||+++++++.+.+..++
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~~~-h~~iv~~~~~~~~~~~~~l   76 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---HRNYSESFFEAASMMSQLS-HKHLVLNYGVCVCGDESIM   76 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcch---hHHHHHHHHHHHHHHHhCC-CCChhheeeEEEeCCCcEE
Confidence            479999999999999865444       3888877543   2344567888999999996 9999999999999999999


Q ss_pred             EEeecCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCC-----CCeEEeecccee
Q 014733          119 LMELCAGGELFHRLEKYG-RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSS-----SPIKLADFGLAT  192 (419)
Q Consensus       119 V~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~-----~~vKL~DFgla~  192 (419)
                      ||||+++|+|..++...+ .+++..+..++.||+.||+|||+.+|+||||||+||+++.++..     +.+|++|||++.
T Consensus        77 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~  156 (258)
T cd05078          77 VQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI  156 (258)
T ss_pred             EEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence            999999999999997654 48999999999999999999999999999999999999653221     237999999987


Q ss_pred             eeccCCccccccCCCccCCcccccC--CCCCchhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHhcCCCCCCCCCCCC
Q 014733          193 YIKAGQNLHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSG-MPPFWGKTKSKIFDAVRAADLRFPSDPWDHI  269 (419)
Q Consensus       193 ~~~~~~~~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  269 (419)
                      .....   ....++..|+|||++.+  .++.++|+||||+++|+|++| .+||........... ......++.    ..
T Consensus       157 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~-~~~~~~~~~----~~  228 (258)
T cd05078         157 TVLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF-YEDRHQLPA----PK  228 (258)
T ss_pred             ccCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHH-HHccccCCC----CC
Confidence            54332   23467888999999876  378999999999999999998 467665554443332 233333332    45


Q ss_pred             CHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          270 SASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       270 s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      +.++.++|.+||+.||++|||++++++.
T Consensus       229 ~~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         229 WTELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             cHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence            6889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.2e-38  Score=300.54  Aligned_cols=240  Identities=28%  Similarity=0.439  Sum_probs=202.9

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      ++|++.+.||+|+||.||++.  .+++.+|+|.+...     .....+.+|+.+++++. ||||+++++++..+. .+++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~-----~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~-~~~v   76 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCD-----VTAQAFLEETAVMTKLH-HKNLVRLLGVILHNG-LYIV   76 (254)
T ss_pred             HHceeeeeeccCCCCceEecc--cCCCceEEEeecCc-----chHHHHHHHHHHHHhCC-CCCcCeEEEEEcCCC-cEEE
Confidence            579999999999999999986  46888999998643     23467889999999996 999999999987655 7999


Q ss_pred             EeecCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccC
Q 014733          120 MELCAGGELFHRLEKYG--RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG  197 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~  197 (419)
                      |||+++++|.+++....  .+++..+..++.|++.||.|||+.|++||||||+||++   +.++.+||+|||++......
T Consensus        77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili---~~~~~~kl~Dfg~~~~~~~~  153 (254)
T cd05083          77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILV---SEDGVAKVSDFGLARVGSMG  153 (254)
T ss_pred             EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEE---cCCCcEEECCCccceecccc
Confidence            99999999999997654  47999999999999999999999999999999999999   55678999999998764322


Q ss_pred             CccccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 014733          198 QNLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARD  275 (419)
Q Consensus       198 ~~~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~  275 (419)
                        ......+..|+|||.+.+ .++.++|+||||+++|+|++ |++||......+....+.... ..  .....++.++.+
T Consensus       154 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~  228 (254)
T cd05083         154 --VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGY-RM--EPPEGCPADVYV  228 (254)
T ss_pred             --CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCC-CC--CCCCcCCHHHHH
Confidence              223344567999998875 48999999999999999997 999998888777777665542 22  223478899999


Q ss_pred             HHHhhhhcCCCCCCCHHHHHh
Q 014733          276 LIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       276 li~~~L~~dP~~Rps~~eil~  296 (419)
                      ++.+||+.+|++||++.+++.
T Consensus       229 li~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         229 LMTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             HHHHHcCCChhhCcCHHHHHH
Confidence            999999999999999999976

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=3.6e-39  Score=301.83  Aligned_cols=228  Identities=26%  Similarity=0.381  Sum_probs=189.0

Q ss_pred             cCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEEeecCCCChHH
Q 014733           51 GQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFH  130 (419)
Q Consensus        51 G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~  130 (419)
                      |.+|.||+++++.+++.+|+|.+.+..        ....|...+... .||||+++++++.+.+.++++|||++|++|.+
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   74 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPH-CVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWS   74 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhc-CCCceeehhhheecCCeEEEEEecCCCCCHHH
Confidence            899999999999999999999987542        122344444445 49999999999999999999999999999999


Q ss_pred             HHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCCccccccCCCccC
Q 014733          131 RLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYI  210 (419)
Q Consensus       131 ~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~~~~~~~gt~~y~  210 (419)
                      ++.+...+++..+..++.|+++||+|||+.||+||||||+||++   +.++.++|+|||.+......  .....++..|+
T Consensus        75 ~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~df~~~~~~~~~--~~~~~~~~~y~  149 (237)
T cd05576          75 HISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILL---DDRGHIQLTYFSRWSEVEDS--CDGEAVENMYC  149 (237)
T ss_pred             HHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---cCCCCEEEecccchhccccc--cccCCcCcccc
Confidence            99887789999999999999999999999999999999999999   56678999999987654332  23456678899


Q ss_pred             CcccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCC
Q 014733          211 APEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRL  289 (419)
Q Consensus       211 aPE~l~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp  289 (419)
                      |||.+.+ .++.++|+||+|+++|+|++|+.||........  .  .....+    ...++++++++|.+||+.||++|+
T Consensus       150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~--~--~~~~~~----~~~~~~~~~~li~~~l~~dp~~R~  221 (237)
T cd05576         150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN--T--HTTLNI----PEWVSEEARSLLQQLLQFNPTERL  221 (237)
T ss_pred             CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc--c--ccccCC----cccCCHHHHHHHHHHccCCHHHhc
Confidence            9999875 489999999999999999999998864322100  0  011112    235789999999999999999999


Q ss_pred             CH-----HHHHhcccc
Q 014733          290 TA-----AEVLAHSWM  300 (419)
Q Consensus       290 s~-----~eil~hp~~  300 (419)
                      ++     ++++.||||
T Consensus       222 ~~~~~~~~~~~~h~~~  237 (237)
T cd05576         222 GAGVAGVEDIKSHPFF  237 (237)
T ss_pred             CCCccchHHHHcCCCC
Confidence            85     999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=4.7e-40  Score=347.24  Aligned_cols=275  Identities=30%  Similarity=0.497  Sum_probs=221.6

Q ss_pred             cceeeccccccccchhhccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHc
Q 014733           18 NSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKL   97 (419)
Q Consensus        18 ~~~~~~~~~~~~~~~~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l   97 (419)
                      +.+...+.........+.+....+|+.++.||+||||.||+++++-+|..||||+|....  +......+.+|+..|.+|
T Consensus       457 ~~~~~r~~~~~s~~~r~~SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArL  534 (1351)
T KOG1035|consen  457 PQFRLRFSGAMSPLQRQFSRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARL  534 (1351)
T ss_pred             CccCCCCccccCccccchhhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhc
Confidence            344455555555555555777888999999999999999999999999999999998764  567788899999999999


Q ss_pred             cCCCCceeeeEEEE------------------------------------------------------------------
Q 014733           98 SGHPNVVDLKAVYE------------------------------------------------------------------  111 (419)
Q Consensus        98 ~~hpnIv~l~~~~~------------------------------------------------------------------  111 (419)
                      . |||||+++..+.                                                                  
T Consensus       535 n-HpNVVRYysAWVEs~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~  613 (1351)
T KOG1035|consen  535 N-HPNVVRYYSAWVESTAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYE  613 (1351)
T ss_pred             C-CcceeeeehhhhccCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCcccccccccccccc
Confidence            5 999999985420                                                                  


Q ss_pred             ------------e---------------------------------C--------CEEEEEEeecCCCChHHHHHHcCCC
Q 014733          112 ------------E---------------------------------E--------DYVHLLMELCAGGELFHRLEKYGRF  138 (419)
Q Consensus       112 ------------~---------------------------------~--------~~~~lV~E~~~ggsL~~~l~~~~~l  138 (419)
                                  +                                 +        ..+||-||||+..+|.+++.++...
T Consensus       614 ~~~d~e~~d~dedg~~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~  693 (1351)
T KOG1035|consen  614 SSTDEENDDSDEDGRNLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN  693 (1351)
T ss_pred             ccCCcccccccccccccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc
Confidence                        0                                 0        2478999999887777777664433


Q ss_pred             -CHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeec-------------------cCC
Q 014733          139 -SETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIK-------------------AGQ  198 (419)
Q Consensus       139 -~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~-------------------~~~  198 (419)
                       ....+|++|++|++||+|+|+.|||||||||.||++   ++++.|||+|||+|+...                   +..
T Consensus       694 ~~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFL---d~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~  770 (1351)
T KOG1035|consen  694 SQRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFL---DSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDG  770 (1351)
T ss_pred             hhhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEE---cCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCc
Confidence             588999999999999999999999999999999999   567789999999998721                   011


Q ss_pred             ccccccCCCccCCcccccC----CCCCchhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 014733          199 NLHGTVGSPFYIAPEVLAG----GYNQAADVWSAGVILYILLSGMPPFW-GKTKSKIFDAVRAADLRFPSDPWDHISASA  273 (419)
Q Consensus       199 ~~~~~~gt~~y~aPE~l~~----~~s~~sDvwSlGvil~elltG~~Pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l  273 (419)
                      ..++.+||..|+|||++.+    .|+.|+|+||||++|+||+.   ||. .+....++.+++.+.++.+...+..--+.-
T Consensus       771 ~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e  847 (1351)
T KOG1035|consen  771 DLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEE  847 (1351)
T ss_pred             ccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHH
Confidence            2345689999999999864    49999999999999999984   464 333455667777777777644444444667


Q ss_pred             HHHHHhhhhcCCCCCCCHHHHHhccccc
Q 014733          274 RDLIMGMLRVDPSTRLTAAEVLAHSWME  301 (419)
Q Consensus       274 ~~li~~~L~~dP~~Rps~~eil~hp~~~  301 (419)
                      ..+|+.||+.||.+|||+.|+|++.|+.
T Consensus       848 ~slI~~Ll~hdP~kRPtA~eLL~s~llp  875 (1351)
T KOG1035|consen  848 ASLIRWLLSHDPSKRPTATELLNSELLP  875 (1351)
T ss_pred             HHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence            7899999999999999999999999997

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.9e-38  Score=300.19  Aligned_cols=243  Identities=24%  Similarity=0.316  Sum_probs=196.5

Q ss_pred             eeecccCceEEEEEEecC---CCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEE-eCCEEEEEEe
Q 014733           46 KQLGWGQFGVIRECSDKF---TGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYE-EEDYVHLLME  121 (419)
Q Consensus        46 ~~LG~G~~g~V~~a~~~~---~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~-~~~~~~lV~E  121 (419)
                      +.||+|+||.||+|.+..   .+..+|+|.+...  ........+.+|+.+++.++ ||||+++++++. .++..+++||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~lv~e   77 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDFS-HPNVLSLLGICLPSEGSPLVVLP   77 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCcc--CCHHHHHHHHHHHHHHccCC-CCCcceEEEEeecCCCCcEEEEe
Confidence            468999999999998653   3457999987532  23455678889999999995 999999999765 4667899999


Q ss_pred             ecCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC--
Q 014733          122 LCAGGELFHRLEKYG-RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ--  198 (419)
Q Consensus       122 ~~~ggsL~~~l~~~~-~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~--  198 (419)
                      |+.+++|.+++.... ..++..+..++.|+++||.|||+.+++||||||+|||+   +.++.+||+|||++.......  
T Consensus        78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili---~~~~~~kl~dfg~~~~~~~~~~~  154 (262)
T cd05058          78 YMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCML---DESFTVKVADFGLARDIYDKEYY  154 (262)
T ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEE---cCCCcEEECCccccccccCCcce
Confidence            999999999997643 46788888999999999999999999999999999999   567789999999987553321  


Q ss_pred             ---ccccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 014733          199 ---NLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASA  273 (419)
Q Consensus       199 ---~~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l  273 (419)
                         ......++..|+|||.+.+ .++.++||||||+++|||++ |.+||......+....+.......   ....++..+
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  231 (262)
T cd05058         155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLL---QPEYCPDPL  231 (262)
T ss_pred             eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCC---CCCcCCHHH
Confidence               1123345778999998865 48999999999999999999 577787777666666655443221   123578999


Q ss_pred             HHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          274 RDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       274 ~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      .+++.+||..+|++||++.+++..
T Consensus       232 ~~li~~cl~~~p~~Rp~~~~il~~  255 (262)
T cd05058         232 YEVMLSCWHPKPEMRPTFSELVSR  255 (262)
T ss_pred             HHHHHHHcCCChhhCCCHHHHHHH
Confidence            999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.8e-38  Score=302.91  Aligned_cols=248  Identities=29%  Similarity=0.445  Sum_probs=198.6

Q ss_pred             ccCeeeeeeecccCceEEEEEE----ecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEe--
Q 014733           39 SDRYVLGKQLGWGQFGVIRECS----DKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEE--  112 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~----~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~--  112 (419)
                      ..+|++.+.||+|+||.||+|.    +..++..||+|.+...   .....+.+.+|+.+++++. ||||+++++++..  
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~   78 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSAG   78 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCC-CCCeeEEEEEEccCC
Confidence            3589999999999999999997    4467889999998654   3456678899999999996 9999999998753  


Q ss_pred             CCEEEEEEeecCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccce
Q 014733          113 EDYVHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA  191 (419)
Q Consensus       113 ~~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla  191 (419)
                      ...+++||||+++++|.+++... ..+++..+..++.|++.||+|||+.||+||||||+||++   +.++.+||+|||++
T Consensus        79 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili---~~~~~~~l~dfg~~  155 (284)
T cd05081          79 RRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILV---ESENRVKIGDFGLT  155 (284)
T ss_pred             CCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEE---CCCCeEEECCCccc
Confidence            45689999999999999999764 458999999999999999999999999999999999999   56778999999999


Q ss_pred             eeeccCCcc----ccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHH----------------HH
Q 014733          192 TYIKAGQNL----HGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKS----------------KI  250 (419)
Q Consensus       192 ~~~~~~~~~----~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~----------------~~  250 (419)
                      .........    ....++..|+|||++.+. ++.++|+||||+++|||++|..++......                .+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd05081         156 KVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHL  235 (284)
T ss_pred             ccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHH
Confidence            876443221    111234459999998764 899999999999999999988776432211                11


Q ss_pred             HHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          251 FDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       251 ~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                      .+.+ ......+  ....++.++.++|.+||..+|++|||+.++++
T Consensus       236 ~~~~-~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         236 IELL-KNNGRLP--APPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             HHHH-hcCCcCC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            1111 1112222  22468899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=8.4e-39  Score=303.75  Aligned_cols=245  Identities=26%  Similarity=0.385  Sum_probs=201.1

Q ss_pred             eeecccCceEEEEEEecCCC------cEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           46 KQLGWGQFGVIRECSDKFTG------EVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        46 ~~LG~G~~g~V~~a~~~~~g------~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      +.||+|+||.||+|.++..+      +.+|+|.+.+..  .......+.+|+.+++.+. ||||+++++++.+....+++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v   77 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFN-HPNIVKLLGVCLLNEPQYII   77 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcC-CCCeeeEeeeecCCCCeEEE
Confidence            36899999999999886544      689999886542  2345667889999999996 99999999999999999999


Q ss_pred             EeecCCCChHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecC--CCCCeEEeeccc
Q 014733          120 MELCAGGELFHRLEKY-------GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKS--SSSPIKLADFGL  190 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~~-------~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~--~~~~vKL~DFgl  190 (419)
                      |||+++++|.+++...       ..+++..+..++.|++.||.|||+.+++|+||||+||+++.++  ....+||+|||+
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            9999999999998642       2378899999999999999999999999999999999996533  223799999999


Q ss_pred             eeeeccCCc---cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCC
Q 014733          191 ATYIKAGQN---LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDP  265 (419)
Q Consensus       191 a~~~~~~~~---~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~  265 (419)
                      +........   .....++..|+|||++.+. ++.++||||||+++|+|++ |+.||......+....+..... +  ..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~-~--~~  234 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGR-L--QK  234 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCc-c--CC
Confidence            876543321   1123456789999998764 8999999999999999998 9999988777777666654321 1  22


Q ss_pred             CCCCCHHHHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          266 WDHISASARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       266 ~~~~s~~l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                      ...++..+.++|.+||+.+|.+||+++++++
T Consensus       235 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         235 PENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             cccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            3468899999999999999999999999975

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=2.6e-38  Score=300.97  Aligned_cols=244  Identities=22%  Similarity=0.301  Sum_probs=193.7

Q ss_pred             eeecccCceEEEEEEec--CCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEEeec
Q 014733           46 KQLGWGQFGVIRECSDK--FTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELC  123 (419)
Q Consensus        46 ~~LG~G~~g~V~~a~~~--~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~  123 (419)
                      +.||+|+||.||+|...  .++..+|+|.+....  .......+.+|+.++++++ ||||+++++++.+...+++||||+
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~   77 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA--SVQEQMKFLEEAQPYRSLQ-HSNLLQCLGQCTEVTPYLLVMEFC   77 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhCC-CCCEeeEEEEEcCCCCcEEEEECC
Confidence            36899999999999764  455779999886553  2344557888999999996 999999999999999999999999


Q ss_pred             CCCChHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC
Q 014733          124 AGGELFHRLEKYG-----RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ  198 (419)
Q Consensus       124 ~ggsL~~~l~~~~-----~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~  198 (419)
                      ++|+|.+++....     ..++..+..++.|++.||+|||+.+++|+||||+||++   +.++.+||+|||++.......
T Consensus        78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~---~~~~~~kL~dfg~~~~~~~~~  154 (269)
T cd05087          78 PLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLL---TADLTVKIGDYGLSHNKYKED  154 (269)
T ss_pred             CCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEE---cCCCcEEECCccccccccCcc
Confidence            9999999986532     35677888999999999999999999999999999999   456789999999987543221


Q ss_pred             c---cccccCCCccCCcccccC--------CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH-hcCCCCCCCC
Q 014733          199 N---LHGTVGSPFYIAPEVLAG--------GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVR-AADLRFPSDP  265 (419)
Q Consensus       199 ~---~~~~~gt~~y~aPE~l~~--------~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~-~~~~~~~~~~  265 (419)
                      .   .....++..|+|||++.+        .++.++|+||||+++|+|++ |+.||......+...... ......+...
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (269)
T cd05087         155 YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPR  234 (269)
T ss_pred             eeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCc
Confidence            1   123457788999998753        25789999999999999996 999997766655544322 2222222221


Q ss_pred             -CCCCCHHHHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          266 -WDHISASARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       266 -~~~~s~~l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                       ....+..+.+++.+|+ .+|++|||+++|+.
T Consensus       235 ~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         235 LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             cCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence             1246788999999998 68999999999974

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=2.7e-38  Score=300.67  Aligned_cols=244  Identities=21%  Similarity=0.303  Sum_probs=193.7

Q ss_pred             eeecccCceEEEEEEec--CCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEEeec
Q 014733           46 KQLGWGQFGVIRECSDK--FTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELC  123 (419)
Q Consensus        46 ~~LG~G~~g~V~~a~~~--~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~  123 (419)
                      +.||+|+||.||+|...  .....+++|.+...  ........+.+|+.+++.+. ||||+++++.+.+...+++||||+
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~e~~~~~~l~-h~nii~~~~~~~~~~~~~lv~e~~   77 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRAS--ATPDEQLLFLQEVQPYRELN-HPNVLQCLGQCIESIPYLLVLEFC   77 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCcc--CChHHHHHHHHHHHHHHhCC-CCCcceEEEEECCCCceEEEEEeC
Confidence            36899999999999643  24457888877543  23445567888999999995 999999999999999999999999


Q ss_pred             CCCChHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC
Q 014733          124 AGGELFHRLEKYGR-----FSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ  198 (419)
Q Consensus       124 ~ggsL~~~l~~~~~-----l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~  198 (419)
                      ++|+|.+++.....     .++..+..++.||+.||+|||+.+|+||||||+|||+   +.++.+||+|||++.......
T Consensus        78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~~  154 (269)
T cd05042          78 PLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQL---TADLSVKIGDYGLALEQYPED  154 (269)
T ss_pred             CCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEe---cCCCcEEEeccccccccccch
Confidence            99999999976432     4677889999999999999999999999999999999   557789999999986532221


Q ss_pred             ---ccccccCCCccCCcccccC--------CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH-hcCCCCCCC-
Q 014733          199 ---NLHGTVGSPFYIAPEVLAG--------GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVR-AADLRFPSD-  264 (419)
Q Consensus       199 ---~~~~~~gt~~y~aPE~l~~--------~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~-~~~~~~~~~-  264 (419)
                         ......++..|+|||++..        .++.++|||||||++|+|++ |..||......+....+. ......+.. 
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (269)
T cd05042         155 YYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQ  234 (269)
T ss_pred             heeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCc
Confidence               1123356678999998642        36789999999999999999 889998776665555443 333333322 


Q ss_pred             CCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          265 PWDHISASARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       265 ~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                      ....++..+.+++..|+ .||++|||+++|++
T Consensus       235 ~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         235 LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             ccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence            22367889999999998 59999999999976

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.2e-38  Score=300.93  Aligned_cols=240  Identities=21%  Similarity=0.232  Sum_probs=191.8

Q ss_pred             eeecccCceEEEEEEecC------------CCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeC
Q 014733           46 KQLGWGQFGVIRECSDKF------------TGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEE  113 (419)
Q Consensus        46 ~~LG~G~~g~V~~a~~~~------------~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~  113 (419)
                      +.||+|+||.||+|....            ....+++|.+...   .......+..|+.+++.+. ||||+++++++.++
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~l~~l~-hp~iv~~~~~~~~~   76 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS---HRDISLAFFETASMMRQVS-HKHIVLLYGVCVRD   76 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh---hhhHHHHHHHHHHHHHhCC-CCCEeeEEEEEecC
Confidence            468999999999998532            2235888886543   2344567888999999995 99999999999999


Q ss_pred             CEEEEEEeecCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCC----CCCeEEeec
Q 014733          114 DYVHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSS----SSPIKLADF  188 (419)
Q Consensus       114 ~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~----~~~vKL~DF  188 (419)
                      ...+++|||+++++|..++... ..+++..+..++.||++||+|||+.+|+||||||+|||++.++.    ...+|++||
T Consensus        77 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~  156 (262)
T cd05077          77 VENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP  156 (262)
T ss_pred             CCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence            9999999999999998888753 56999999999999999999999999999999999999964331    113899999


Q ss_pred             cceeeeccCCccccccCCCccCCcccccC--CCCCchhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHhcCCCCCCCC
Q 014733          189 GLATYIKAGQNLHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILL-SGMPPFWGKTKSKIFDAVRAADLRFPSDP  265 (419)
Q Consensus       189 gla~~~~~~~~~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~ell-tG~~Pf~~~~~~~~~~~i~~~~~~~~~~~  265 (419)
                      |++......   ....++..|+|||.+.+  .++.++|||||||++|+|+ +|..||......+... +.......    
T Consensus       157 g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~~~~~~----  228 (262)
T cd05077         157 GIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEGQCML----  228 (262)
T ss_pred             CCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHhcCccC----
Confidence            998754322   23467888999998863  4899999999999999997 5899987765544332 22222222    


Q ss_pred             CCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          266 WDHISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       266 ~~~~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      ....+.++.+||.+||+.||++||++.+|+++
T Consensus       229 ~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         229 VTPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             CCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence            12356889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.1e-38  Score=303.16  Aligned_cols=239  Identities=24%  Similarity=0.278  Sum_probs=192.4

Q ss_pred             eecccCceEEEEEEecCC------------------------CcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCC
Q 014733           47 QLGWGQFGVIRECSDKFT------------------------GEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN  102 (419)
Q Consensus        47 ~LG~G~~g~V~~a~~~~~------------------------g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpn  102 (419)
                      .||+|+||.||+|....+                        ...|++|++....   ......+.+|+.+++.++ |||
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~-h~n   77 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVS-HIH   77 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCC-CCC
Confidence            699999999999975321                        2458888875432   234567888999999996 999


Q ss_pred             ceeeeEEEEeCCEEEEEEeecCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecC---
Q 014733          103 VVDLKAVYEEEDYVHLLMELCAGGELFHRLEK-YGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKS---  178 (419)
Q Consensus       103 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~---  178 (419)
                      |+++++++.+.+..++||||+++++|..++.. .+.+++..+..++.||++||+|||+.+|+||||||+|||++..+   
T Consensus        78 iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~  157 (274)
T cd05076          78 LAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAE  157 (274)
T ss_pred             eeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCccc
Confidence            99999999999999999999999999999865 45689999999999999999999999999999999999996432   


Q ss_pred             -CCCCeEEeeccceeeeccCCccccccCCCccCCcccccC--CCCCchhHHHHHHHHHHH-HhCCCCCCCCCHHHHHHHH
Q 014733          179 -SSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYIL-LSGMPPFWGKTKSKIFDAV  254 (419)
Q Consensus       179 -~~~~vKL~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~el-ltG~~Pf~~~~~~~~~~~i  254 (419)
                       ....+||+|||++......   ....++..|+|||.+.+  .++.++|+||||+++||| ++|+.||......+....+
T Consensus       158 ~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~  234 (274)
T cd05076         158 GTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFY  234 (274)
T ss_pred             CccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHH
Confidence             2235899999987643222   22457788999998865  389999999999999998 4799999877665544433


Q ss_pred             HhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          255 RAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       255 ~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      .. ....+.    ..+.++.++|.+||+.+|++|||+.+++++
T Consensus       235 ~~-~~~~~~----~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         235 EK-KHRLPE----PSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             Hh-ccCCCC----CCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            22 222222    356789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=3e-38  Score=306.34  Aligned_cols=249  Identities=23%  Similarity=0.332  Sum_probs=204.5

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCc----EEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCC
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGE----VLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEED  114 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~----~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~  114 (419)
                      .++|++.+.||+|+||.||+|.+..+|.    .+|+|.+....  .......+.+|+.+++++. ||||+++++++....
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~~~   82 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMD-HPHLVRLLGVCLSPT   82 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCCcccEEEEEcCCC
Confidence            3678899999999999999999887776    46888776442  2344456889999999995 999999999987654


Q ss_pred             EEEEEEeecCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceee
Q 014733          115 YVHLLMELCAGGELFHRLEKYG-RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATY  193 (419)
Q Consensus       115 ~~~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~  193 (419)
                       .++++||+++|+|.+++.... .+++..+..++.|++.||+|||+.+|+||||||+||++   ..++.+||+|||++..
T Consensus        83 -~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill---~~~~~~kL~Dfg~~~~  158 (303)
T cd05110          83 -IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLV---KSPNHVKITDFGLARL  158 (303)
T ss_pred             -ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeee---cCCCceEEcccccccc
Confidence             678999999999999987654 58999999999999999999999999999999999999   4567899999999986


Q ss_pred             eccCCc---cccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCC
Q 014733          194 IKAGQN---LHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDH  268 (419)
Q Consensus       194 ~~~~~~---~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  268 (419)
                      ......   .....++..|+|||++.+ .++.++||||||+++|+|++ |..||.+....+....+.... ..+.  +..
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~--~~~  235 (303)
T cd05110         159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGE-RLPQ--PPI  235 (303)
T ss_pred             ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC-CCCC--CCC
Confidence            643322   122345678999999876 48999999999999999997 999998877666655554332 2222  235


Q ss_pred             CCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          269 ISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       269 ~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      .+..+.+++.+||..+|++||++.++++.
T Consensus       236 ~~~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         236 CTIDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            78899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.8e-38  Score=298.03  Aligned_cols=237  Identities=25%  Similarity=0.281  Sum_probs=191.7

Q ss_pred             eeecccCceEEEEEEecCCC----------cEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCE
Q 014733           46 KQLGWGQFGVIRECSDKFTG----------EVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDY  115 (419)
Q Consensus        46 ~~LG~G~~g~V~~a~~~~~g----------~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~  115 (419)
                      +.||+|+||.||+|.+..++          ..+++|.+....    .....+.+|+.+++++. ||||+++++++.. ..
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~-~~   74 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH----RDSLAFFETASLMSQLS-HKHLVKLYGVCVR-DE   74 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch----hhHHHHHHHHHHHHcCC-CcchhheeeEEec-CC
Confidence            47999999999999998766          347777765432    22677889999999996 9999999999988 77


Q ss_pred             EEEEEeecCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecC----CCCCeEEeeccc
Q 014733          116 VHLLMELCAGGELFHRLEKYG-RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKS----SSSPIKLADFGL  190 (419)
Q Consensus       116 ~~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~----~~~~vKL~DFgl  190 (419)
                      .++||||+++++|.+++.... .+++..+..++.||+.||+|||+.||+||||||+|||++.++    ....+||+|||+
T Consensus        75 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~  154 (259)
T cd05037          75 NIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI  154 (259)
T ss_pred             cEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence            899999999999999998766 689999999999999999999999999999999999996433    112699999999


Q ss_pred             eeeeccCCccccccCCCccCCcccccCC---CCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 014733          191 ATYIKAGQNLHGTVGSPFYIAPEVLAGG---YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPW  266 (419)
Q Consensus       191 a~~~~~~~~~~~~~gt~~y~aPE~l~~~---~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  266 (419)
                      +.....   .....++..|+|||++.+.   ++.++|+||||+++|+|++ |..||......+........ ...+.   
T Consensus       155 a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~-~~~~~---  227 (259)
T cd05037         155 PITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQ-HRLPM---  227 (259)
T ss_pred             cccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcC-CCCCC---
Confidence            986543   2234567789999998653   7899999999999999999 68888766544433333221 11111   


Q ss_pred             CCCCHHHHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          267 DHISASARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       267 ~~~s~~l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                       .....+.++|.+||..||.+|||+.++++
T Consensus       228 -~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         228 -PDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             -CCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence             22378999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=6.2e-38  Score=303.09  Aligned_cols=252  Identities=15%  Similarity=0.213  Sum_probs=190.5

Q ss_pred             ccccccCeeeeeeecccCceEEEEEEecCC---CcEEEEEEeccCccCCHHhH--------HHHHHHHHHHHHccCCCCc
Q 014733           35 ISNLSDRYVLGKQLGWGQFGVIRECSDKFT---GEVLACKSIAKDRLVTVEDV--------RSIKLEIEIMTKLSGHPNV  103 (419)
Q Consensus        35 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~---g~~vaiK~i~~~~~~~~~~~--------~~~~~Ei~il~~l~~hpnI  103 (419)
                      .+...++|++.+.||+|+||+||+|.+..+   +..+|+|+............        .....+...+..+ .|+||
T Consensus         7 ~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~-~h~~i   85 (294)
T PHA02882          7 IDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNI-DHLGI   85 (294)
T ss_pred             eccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccC-CCCCC
Confidence            345668999999999999999999998877   66778876543321110000        1112233344455 49999


Q ss_pred             eeeeEEEEeCC----EEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCC
Q 014733          104 VDLKAVYEEED----YVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSS  179 (419)
Q Consensus       104 v~l~~~~~~~~----~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~  179 (419)
                      +++++++....    ..++++|++ ..++.+.+.....+++..++.++.|+++||+|||+.+|+||||||+|||+   +.
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill---~~  161 (294)
T PHA02882         86 PKYYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMV---DG  161 (294)
T ss_pred             CcEEEeeeEecCCceEEEEEEehh-ccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cC
Confidence            99999876543    457888887 45677777665567899999999999999999999999999999999999   45


Q ss_pred             CCCeEEeeccceeeeccCC--------ccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCH-HH
Q 014733          180 SSPIKLADFGLATYIKAGQ--------NLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTK-SK  249 (419)
Q Consensus       180 ~~~vKL~DFgla~~~~~~~--------~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~-~~  249 (419)
                      ++.+||+|||+++.+....        ......||+.|+|||++.+. ++.++|||||||++|+|++|..||.+... .+
T Consensus       162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~  241 (294)
T PHA02882        162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN  241 (294)
T ss_pred             CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence            6789999999998764221        11234699999999998775 89999999999999999999999977632 22


Q ss_pred             H--------HHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          250 I--------FDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       250 ~--------~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                      .        ...+.....     .....++++.+++..|++.+|++||++.++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        242 LIHAAKCDFIKRLHEGKI-----KIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HHHHhHHHHHHHhhhhhh-----ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            1        222222222     22356899999999999999999999999975

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=3.9e-39  Score=332.29  Aligned_cols=247  Identities=25%  Similarity=0.446  Sum_probs=213.7

Q ss_pred             cCeeeeeeecccCceEEEEEEec-----CCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCC
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDK-----FTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEED  114 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~-----~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~  114 (419)
                      .+-+..+.||+|+||+||+|+-.     .....||||.++.+  .+.+..++|++|+++|..|+ |||||+++|+|.+.+
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~--a~~~~~~dF~REaeLla~l~-H~nIVrLlGVC~~~~  562 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK--AENQARQDFRREAELLAELQ-HPNIVRLLGVCREGD  562 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc--ccHHHHHHHHHHHHHHHhcc-CCCeEEEEEEEccCC
Confidence            45566889999999999999754     23467999988765  45568899999999999996 999999999999999


Q ss_pred             EEEEEEeecCCCChHHHHHHcC--------------CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCC
Q 014733          115 YVHLLMELCAGGELFHRLEKYG--------------RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSS  180 (419)
Q Consensus       115 ~~~lV~E~~~ggsL~~~l~~~~--------------~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~  180 (419)
                      -++||+|||..|+|.++|....              +++..+...|+.||+.|++||-++..|||||-..|+||   +++
T Consensus       563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLV---ge~  639 (774)
T KOG1026|consen  563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLV---GEN  639 (774)
T ss_pred             eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhcee---ccc
Confidence            9999999999999999996432              27889999999999999999999999999999999999   677


Q ss_pred             CCeEEeeccceeeeccCCcc---ccccCCCccCCccccc-CCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 014733          181 SPIKLADFGLATYIKAGQNL---HGTVGSPFYIAPEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVR  255 (419)
Q Consensus       181 ~~vKL~DFgla~~~~~~~~~---~~~~gt~~y~aPE~l~-~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~  255 (419)
                      -.|||+|||+++.+=..+-.   ....-...||+||.+. ++|+.++||||+||+|||+++ |+.||.+...+++++.|+
T Consensus       640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~  719 (774)
T KOG1026|consen  640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIR  719 (774)
T ss_pred             eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHH
Confidence            89999999999875332211   1223355799999765 569999999999999999998 999999999999999999


Q ss_pred             hcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHH
Q 014733          256 AADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVL  295 (419)
Q Consensus       256 ~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil  295 (419)
                      .+.. .+.  +...|.++.+|+.+||+.+|++||++.||=
T Consensus       720 ~g~l-L~~--Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~  756 (774)
T KOG1026|consen  720 AGQL-LSC--PENCPTEVYSLMLECWNENPKRRPSFKEIH  756 (774)
T ss_pred             cCCc-ccC--CCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence            9987 333  348999999999999999999999999983

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=5.9e-38  Score=299.81  Aligned_cols=249  Identities=28%  Similarity=0.433  Sum_probs=202.3

Q ss_pred             ccCeeeeeeecccCceEEEEEEec----CCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEe--
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDK----FTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEE--  112 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~----~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~--  112 (419)
                      .++|++.+.||+|+||.||+|...    .++..+|+|.+.....  ......+.+|+++++++. ||||+++++++..  
T Consensus         3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~ei~~l~~l~-~~~i~~~~~~~~~~~   79 (284)
T cd05038           3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGE--EQHRSDFEREIEILRTLD-HENIVKYKGVCEKPG   79 (284)
T ss_pred             hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccc--hHHHHHHHHHHHHHHhCC-CCChheEEeeeecCC
Confidence            357888999999999999999864    3488999999876532  145678999999999995 9999999999887  


Q ss_pred             CCEEEEEEeecCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccce
Q 014733          113 EDYVHLLMELCAGGELFHRLEKYG-RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA  191 (419)
Q Consensus       113 ~~~~~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla  191 (419)
                      ....+++|||+++++|.+++.... .+++..+..++.|++.||+|||++|++|+||||+||++   +.++.+||+|||++
T Consensus        80 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~  156 (284)
T cd05038          80 GRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILV---ESEDLVKISDFGLA  156 (284)
T ss_pred             CCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEE---cCCCCEEEcccccc
Confidence            568999999999999999997654 58999999999999999999999999999999999999   45688999999999


Q ss_pred             eeeccCCcc----ccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---------------HHH
Q 014733          192 TYIKAGQNL----HGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKS---------------KIF  251 (419)
Q Consensus       192 ~~~~~~~~~----~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~---------------~~~  251 (419)
                      .........    ....++..|+|||.+.+ .++.++|+||||+++|+|++|..||......               ...
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd05038         157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL  236 (284)
T ss_pred             cccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH
Confidence            876533221    11234566999998875 4889999999999999999999998653221               122


Q ss_pred             HHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          252 DAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       252 ~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                      +.+. .....+.  ....+.++.+++.+||+.||++|||+.++++
T Consensus       237 ~~~~-~~~~~~~--~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         237 ELLK-EGERLPR--PPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             HHHH-cCCcCCC--CccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            2222 2222222  2367789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.1e-37  Score=296.79  Aligned_cols=248  Identities=23%  Similarity=0.356  Sum_probs=202.7

Q ss_pred             eeeeeeecccCceEEEEEEec---CCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCC----
Q 014733           42 YVLGKQLGWGQFGVIRECSDK---FTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEED----  114 (419)
Q Consensus        42 y~i~~~LG~G~~g~V~~a~~~---~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~----  114 (419)
                      |.+.+.||+|+||.||+|.++   .++..+|+|++..+. ......+.+.+|+.+++++. ||||+++++++....    
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~   78 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI-FSSSDIEEFLREAACMKEFD-HPNVIKLIGVSLRSRAKGR   78 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc-CChHHHHHHHHHHHHHhcCC-CCCcceEEEEEccCCCCCc
Confidence            678899999999999999865   357899999986543 34456778899999999996 999999999886432    


Q ss_pred             --EEEEEEeecCCCChHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEe
Q 014733          115 --YVHLLMELCAGGELFHRLEKY------GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLA  186 (419)
Q Consensus       115 --~~~lV~E~~~ggsL~~~l~~~------~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~  186 (419)
                        ..++++||+.+++|..++...      ..+++..+..++.|++.||+|||+.+|+||||||+||++   +.++.+||+
T Consensus        79 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili---~~~~~~kl~  155 (273)
T cd05074          79 LPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCML---NENMTVCVA  155 (273)
T ss_pred             ccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEE---cCCCCEEEC
Confidence              347889999999998877432      147889999999999999999999999999999999999   557789999


Q ss_pred             eccceeeeccCCc---cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCC
Q 014733          187 DFGLATYIKAGQN---LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRF  261 (419)
Q Consensus       187 DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~  261 (419)
                      |||++........   .....+++.|++||.+.+. ++.++||||||+++|+|++ |++||.+....+....+...... 
T Consensus       156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~-  234 (273)
T cd05074         156 DFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRL-  234 (273)
T ss_pred             cccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcC-
Confidence            9999886543321   1122456779999998764 8899999999999999999 99999888777777766554321 


Q ss_pred             CCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          262 PSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       262 ~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      .  .....+..+.+++.+||+.+|++|||+.+++++
T Consensus       235 ~--~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         235 K--QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             C--CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            1  113578999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-39  Score=310.37  Aligned_cols=264  Identities=28%  Similarity=0.497  Sum_probs=223.8

Q ss_pred             cccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHh----HHHHHHHHHHHHHccCCCCceeeeEEEE
Q 014733           36 SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVED----VRSIKLEIEIMTKLSGHPNVVDLKAVYE  111 (419)
Q Consensus        36 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~----~~~~~~Ei~il~~l~~hpnIv~l~~~~~  111 (419)
                      ..+.+||-++..||+|+|+.||+|.|......||+|+-...+.+....    .+..-+|..|-+.|. ||.||++|++|.
T Consensus       459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLD-HpRIVKlYDyfs  537 (775)
T KOG1151|consen  459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELD-HPRIVKLYDYFS  537 (775)
T ss_pred             cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccC-cceeeeeeeeee
Confidence            346789999999999999999999999999999999987766544332    344567889999995 999999999995


Q ss_pred             -eCCEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--CeeccCCCCcEEEeecCCCCCeEEeec
Q 014733          112 -EEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG--VVHRDLKPENILLATKSSSSPIKLADF  188 (419)
Q Consensus       112 -~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~--IvHrDLkp~NILl~~~~~~~~vKL~DF  188 (419)
                       +.+.+|-|+|||+|.+|..+|+.++-+++.+++.|+.||+.||.||.+..  |||-||||.|||+.....-|.|||+||
T Consensus       538 lDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDF  617 (775)
T KOG1151|consen  538 LDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDF  617 (775)
T ss_pred             eccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeec
Confidence             66789999999999999999999889999999999999999999999874  999999999999987777789999999


Q ss_pred             cceeeeccCCc--------cccccCCCccCCccccc-C----CCCCchhHHHHHHHHHHHHhCCCCCCCC-CHHHHHH--
Q 014733          189 GLATYIKAGQN--------LHGTVGSPFYIAPEVLA-G----GYNQAADVWSAGVILYILLSGMPPFWGK-TKSKIFD--  252 (419)
Q Consensus       189 gla~~~~~~~~--------~~~~~gt~~y~aPE~l~-~----~~s~~sDvwSlGvil~elltG~~Pf~~~-~~~~~~~--  252 (419)
                      |+++.+.+...        .....||.+|++||.+. +    +.+.++||||+|||+|..+.|+.||... +..++++  
T Consensus       618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeN  697 (775)
T KOG1151|consen  618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQEN  697 (775)
T ss_pred             chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhh
Confidence            99998764321        23347999999999753 3    2688999999999999999999999644 3334433  


Q ss_pred             -HHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhcccccc
Q 014733          253 -AVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE  302 (419)
Q Consensus       253 -~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~  302 (419)
                       -+......||..+  .++.++++||++||++--++|..+.++-.||||..
T Consensus       698 TIlkAtEVqFP~KP--vVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP  746 (775)
T KOG1151|consen  698 TILKATEVQFPPKP--VVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP  746 (775)
T ss_pred             chhcceeccCCCCC--ccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence             2344456677765  79999999999999999999999999999999963

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4e-40  Score=296.57  Aligned_cols=259  Identities=28%  Similarity=0.478  Sum_probs=214.3

Q ss_pred             cccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEE------
Q 014733           38 LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYE------  111 (419)
Q Consensus        38 ~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~------  111 (419)
                      ..+.|..+.+||+|.||.||+|+.+.+|+.||+|++..+.... .--....+|+++|+.|+ |+|++.++++|.      
T Consensus        15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKe-GfpitalreikiL~~lk-Henv~nliEic~tk~Tp~   92 (376)
T KOG0669|consen   15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKE-GFPITALREIKILQLLK-HENVVNLIEICRTKATPT   92 (376)
T ss_pred             cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhcccc-CCcHHHHHHHHHHHHhc-chhHHHHHHHHhhccCCc
Confidence            4567888899999999999999999999999999876532111 11233557999999996 999999998884      


Q ss_pred             --eCCEEEEEEeecCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeec
Q 014733          112 --EEDYVHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADF  188 (419)
Q Consensus       112 --~~~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DF  188 (419)
                        +...+|+|+++|+ -+|.-++... .+++..++..++.+++.||.|+|...|+|||+|++||||   +.+|.+||+||
T Consensus        93 ~r~r~t~ylVf~~ce-hDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLI---t~dgilklADF  168 (376)
T KOG0669|consen   93 NRDRATFYLVFDFCE-HDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLI---TKDGILKLADF  168 (376)
T ss_pred             ccccceeeeeHHHhh-hhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEE---cCCceEEeecc
Confidence              3446999999995 5788777654 569999999999999999999999999999999999999   67889999999


Q ss_pred             cceeeeccCC-----ccccccCCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC
Q 014733          189 GLATYIKAGQ-----NLHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRF  261 (419)
Q Consensus       189 gla~~~~~~~-----~~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~  261 (419)
                      |+++.+....     .....+.|.+|.+||.+.|  .|+++.|+|..|||+.||+++.+.+.+.+....+..|..-...+
T Consensus       169 Glar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~  248 (376)
T KOG0669|consen  169 GLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSI  248 (376)
T ss_pred             ccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccC
Confidence            9997654322     1234467999999999887  39999999999999999999999999999888888776655444


Q ss_pred             CCCCCCCC-------------------------------CHHHHHHHHhhhhcCCCCCCCHHHHHhcccccc
Q 014733          262 PSDPWDHI-------------------------------SASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE  302 (419)
Q Consensus       262 ~~~~~~~~-------------------------------s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~  302 (419)
                      ..+.|+++                               .+++.+|+.+||..||.+|+++++++.|.||..
T Consensus       249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k  320 (376)
T KOG0669|consen  249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK  320 (376)
T ss_pred             CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence            44444332                               347789999999999999999999999999974

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-38  Score=322.57  Aligned_cols=269  Identities=26%  Similarity=0.456  Sum_probs=229.7

Q ss_pred             cccccchhhccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCcee
Q 014733           26 TGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD  105 (419)
Q Consensus        26 ~~~~~~~~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~  105 (419)
                      ...+++.++...=.+-|++.+.||.|.||.||+++++.+++..|+|+.....    +.-+.++.|.+||+.++.|||++.
T Consensus         5 ~~~~~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~----d~deEiE~eynil~~~~~hpnv~~   80 (953)
T KOG0587|consen    5 SLMDIDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE----DEEEEIELEYNMLKKYSHHPNVAT   80 (953)
T ss_pred             cccccchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc----cccHHHHHHHHHHHhccCCCCcce
Confidence            3445566666777789999999999999999999999999999999987543    445678899999999999999999


Q ss_pred             eeEEEEe-----CCEEEEEEeecCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecC
Q 014733          106 LKAVYEE-----EDYVHLLMELCAGGELFHRLEKY--GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKS  178 (419)
Q Consensus       106 l~~~~~~-----~~~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~  178 (419)
                      ++++|..     .+.++||||||.||+..++++..  .++.|..+..|++.++.||.+||.+.++|||||-.|||+   .
T Consensus        81 fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLL---T  157 (953)
T KOG0587|consen   81 FYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLL---T  157 (953)
T ss_pred             EEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEE---e
Confidence            9999953     56899999999999999999754  468999999999999999999999999999999999999   6


Q ss_pred             CCCCeEEeeccceeeeccCC-ccccccCCCccCCcccccC------CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 014733          179 SSSPIKLADFGLATYIKAGQ-NLHGTVGSPFYIAPEVLAG------GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIF  251 (419)
Q Consensus       179 ~~~~vKL~DFgla~~~~~~~-~~~~~~gt~~y~aPE~l~~------~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~  251 (419)
                      .++.|||+|||.+.++.... ...+.+|||.|||||++..      .|+..+|+||||++..||.-|.+|+.+..+...+
T Consensus       158 ~e~~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraL  237 (953)
T KOG0587|consen  158 ENAEVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRAL  237 (953)
T ss_pred             ccCcEEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhh
Confidence            77899999999988775433 3345689999999999864      2778999999999999999999999888776555


Q ss_pred             HHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhcccccc
Q 014733          252 DAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE  302 (419)
Q Consensus       252 ~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~  302 (419)
                      -.|-.. .+.....|...+.++.+||..||.+|-.+||++.++|+|||+..
T Consensus       238 F~IpRN-PPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e  287 (953)
T KOG0587|consen  238 FLIPRN-PPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE  287 (953)
T ss_pred             ccCCCC-CCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence            444332 22222346788999999999999999999999999999999984

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-39  Score=324.32  Aligned_cols=247  Identities=30%  Similarity=0.466  Sum_probs=199.3

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCC-----
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEED-----  114 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~-----  114 (419)
                      .-+..-+.||+|+||.||+++++.+|..||||.+++..  .....+.+-+|+++|++|. |+|||+++++-++..     
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLn-h~NIVk~f~iee~~~~~~~~   89 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKLN-HPNIVKLFDIEETKFLGLVT   89 (732)
T ss_pred             cceeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcC-chhhhhhcccCCccccCccc
Confidence            55667789999999999999999999999999998753  4466788899999999996 999999999976544     


Q ss_pred             -EEEEEEeecCCCChHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecC-CCCCeEEeecc
Q 014733          115 -YVHLLMELCAGGELFHRLEKYG---RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKS-SSSPIKLADFG  189 (419)
Q Consensus       115 -~~~lV~E~~~ggsL~~~l~~~~---~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~-~~~~vKL~DFg  189 (419)
                       ...+|||||.||+|+..+++..   .+++.+...+..++..||.|||++||+||||||.||++.... ....-||+|||
T Consensus        90 ~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG  169 (732)
T KOG4250|consen   90 RLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFG  169 (732)
T ss_pred             ccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccc
Confidence             5679999999999999997643   499999999999999999999999999999999999986532 22246999999


Q ss_pred             ceeeeccCCccccccCCCccCCccccc--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHhc-----
Q 014733          190 LATYIKAGQNLHGTVGSPFYIAPEVLA--GGYNQAADVWSAGVILYILLSGMPPFWGKTKS-----KIFDAVRAA-----  257 (419)
Q Consensus       190 la~~~~~~~~~~~~~gt~~y~aPE~l~--~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~-----~~~~~i~~~-----  257 (419)
                      .|+.+.++....+.+||+.|.+||++.  +.|+..+|.|||||++|+..||..||......     -++..+...     
T Consensus       170 ~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~  249 (732)
T KOG4250|consen  170 AARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVA  249 (732)
T ss_pred             ccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCcee
Confidence            999998888888899999999999987  35899999999999999999999999543222     222222111     


Q ss_pred             ---------------CCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCC
Q 014733          258 ---------------DLRFPSDPWDHISASARDLIMGMLRVDPSTRL  289 (419)
Q Consensus       258 ---------------~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp  289 (419)
                                     .+++|......+-..+..++..+|..||.+|.
T Consensus       250 i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~  296 (732)
T KOG4250|consen  250 IGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG  296 (732)
T ss_pred             EeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence                           11111111111223345688899999999999

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=5.8e-37  Score=291.88  Aligned_cols=243  Identities=19%  Similarity=0.247  Sum_probs=191.7

Q ss_pred             eecccCceEEEEEEecCC--CcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEEeecC
Q 014733           47 QLGWGQFGVIRECSDKFT--GEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCA  124 (419)
Q Consensus        47 ~LG~G~~g~V~~a~~~~~--g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~  124 (419)
                      .||+|+||.||+|.....  ...+++|.+....  .....+.+.+|+.+++.+. ||||+++++.+.+....|+||||++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~   78 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQ-HPNILQCLGQCVEAIPYLLVFEYCE   78 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccC-CcchhheEEEecCCCccEEEEecCC
Confidence            599999999999975422  3456677665432  3345678899999999995 9999999999999999999999999


Q ss_pred             CCChHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccC---
Q 014733          125 GGELFHRLEKY----GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG---  197 (419)
Q Consensus       125 ggsL~~~l~~~----~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~---  197 (419)
                      +|+|.+++...    ..+++..+..++.||++||+|||+.+|+||||||+|||+   +.++.+||+|||++......   
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~---~~~~~~~l~Dfg~~~~~~~~~~~  155 (268)
T cd05086          79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFL---TSDLTVKVGDYGIGPSRYKEDYI  155 (268)
T ss_pred             CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEE---cCCccEEecccccccccCcchhh
Confidence            99999998754    235677788999999999999999999999999999999   56778999999987642221   


Q ss_pred             CccccccCCCccCCcccccC--------CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcC-CCCCC-CCC
Q 014733          198 QNLHGTVGSPFYIAPEVLAG--------GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAAD-LRFPS-DPW  266 (419)
Q Consensus       198 ~~~~~~~gt~~y~aPE~l~~--------~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~~~-~~~  266 (419)
                      ......+++..|+|||++..        .++.++||||||+++|||++ |..||......+....+.... ...+. ...
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (268)
T cd05086         156 ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLE  235 (268)
T ss_pred             hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccC
Confidence            11234578889999998742        25789999999999999997 678997777666666543332 22221 122


Q ss_pred             CCCCHHHHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          267 DHISASARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       267 ~~~s~~l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                      ..+++.+.+++..|| .+|++||++.++++
T Consensus       236 ~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         236 LPYSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             CCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence            357899999999999 68999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-37  Score=330.94  Aligned_cols=249  Identities=27%  Similarity=0.415  Sum_probs=211.7

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCC-Cc----EEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeC
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFT-GE----VLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEE  113 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~-g~----~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~  113 (419)
                      ...-.++..||+|+||.||.|.-... |.    .||+|.+.+  ..+.+....|.+|..+|+.+. |||||++++++.+.
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~--~~~~~~~~~Fl~Ea~~m~~f~-HpNiv~liGv~l~~  767 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKR--LSSEQEVSDFLKEALLMSKFD-HPNIVSLIGVCLDS  767 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccc--cCCHHHHHHHHHHHHHHhcCC-CcceeeEEEeecCC
Confidence            35677889999999999999987633 32    377887654  357788999999999999995 99999999999999


Q ss_pred             CEEEEEEeecCCCChHHHHHHc------C-CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEe
Q 014733          114 DYVHLLMELCAGGELFHRLEKY------G-RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLA  186 (419)
Q Consensus       114 ~~~~lV~E~~~ggsL~~~l~~~------~-~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~  186 (419)
                      ...+|++|||.||+|..+|++.      . .++..+...++.+|++|+.||++++.|||||-..|+||+   ....|||+
T Consensus       768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~---~~r~VKIa  844 (1025)
T KOG1095|consen  768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLD---ERRVVKIA  844 (1025)
T ss_pred             CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeec---ccCcEEEc
Confidence            9999999999999999999876      2 388999999999999999999999999999999999994   55899999


Q ss_pred             eccceeeeccCCccc--cc-cCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCC
Q 014733          187 DFGLATYIKAGQNLH--GT-VGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRF  261 (419)
Q Consensus       187 DFgla~~~~~~~~~~--~~-~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~  261 (419)
                      |||+|+++-..+...  +. .-...|||||.+.. .++.++|||||||+|||+++ |..||.+.+..+++..+.++. +.
T Consensus       845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-RL  923 (1025)
T KOG1095|consen  845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-RL  923 (1025)
T ss_pred             ccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-cc
Confidence            999999654332211  11 12246999999885 59999999999999999999 999999999999988665555 44


Q ss_pred             CCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          262 PSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       262 ~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                      +..  ..++..+.+++..||+.+|++||++..|++
T Consensus       924 ~~P--~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  924 DPP--SYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             CCC--CCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence            333  489999999999999999999999999987

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-39  Score=293.46  Aligned_cols=262  Identities=25%  Similarity=0.323  Sum_probs=218.0

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      ++.+-+..||.|+||+|++..++.+|+..|||.++...  ...+.+++..|.+...+-++.||||++|+..-.++..++.
T Consensus        64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n--~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiC  141 (361)
T KOG1006|consen   64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNN--IEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWIC  141 (361)
T ss_pred             chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeecc--chHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeee
Confidence            45555788999999999999999999999999998764  3567788999999988888999999999999999999999


Q ss_pred             EeecCCCChHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeccCCCCcEEEeecCCCCCeEEeeccceee
Q 014733          120 MELCAGGELFHRLE-----KYGRFSETEARVIFRHLMQVVSYCHG-NGVVHRDLKPENILLATKSSSSPIKLADFGLATY  193 (419)
Q Consensus       120 ~E~~~ggsL~~~l~-----~~~~l~~~~~~~i~~qll~aL~~LH~-~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~  193 (419)
                      ||+| ..+|..+.+     ...+++|.-...+....+.||.||.. +.|||||+||+|||+   +..|.|||||||.+-.
T Consensus       142 MELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILl---dr~G~vKLCDFGIcGq  217 (361)
T KOG1006|consen  142 MELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILL---DRHGDVKLCDFGICGQ  217 (361)
T ss_pred             HHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEE---ecCCCEeeecccchHh
Confidence            9999 567765543     23568999999999999999999986 479999999999999   5678999999999988


Q ss_pred             eccCCccccccCCCccCCcccccC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhcCCCCCCCC--CC
Q 014733          194 IKAGQNLHGTVGSPFYIAPEVLAG---GYNQAADVWSAGVILYILLSGMPPFWGKTK-SKIFDAVRAADLRFPSDP--WD  267 (419)
Q Consensus       194 ~~~~~~~~~~~gt~~y~aPE~l~~---~~s~~sDvwSlGvil~elltG~~Pf~~~~~-~~~~~~i~~~~~~~~~~~--~~  267 (419)
                      +.++.......|-..|||||.+..   +|+.++||||||+.|||+.||..||.+-+. -+....+..++.+.....  .-
T Consensus       218 Lv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~  297 (361)
T KOG1006|consen  218 LVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECV  297 (361)
T ss_pred             HHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCccccc
Confidence            777666666688888999999864   499999999999999999999999965322 233334444444432221  23


Q ss_pred             CCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchhhh
Q 014733          268 HISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVA  307 (419)
Q Consensus       268 ~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~~~  307 (419)
                      +++..+..+|..||.+|-+.||..++++.+||++......
T Consensus       298 ~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~~~  337 (361)
T KOG1006|consen  298 HYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAVEG  337 (361)
T ss_pred             ccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhhcC
Confidence            5899999999999999999999999999999998776543

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.8e-36  Score=280.81  Aligned_cols=242  Identities=48%  Similarity=0.792  Sum_probs=208.8

Q ss_pred             CceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEEeecCCCChHHH
Q 014733           52 QFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHR  131 (419)
Q Consensus        52 ~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~  131 (419)
                      +||.||+|.+..+|+.+++|++........  .+.+.+|+..+++++ |+||+++++.+......++++||+++++|..+
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~   77 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLK-HPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDL   77 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCC-CCcHHHHHhheeeCCEEEEEEeCCCCCCHHHH
Confidence            589999999998899999999976543221  678999999999995 99999999999999999999999999999999


Q ss_pred             HHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCCccccccCCCccCC
Q 014733          132 LEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIA  211 (419)
Q Consensus       132 l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~~~~~~~gt~~y~a  211 (419)
                      +.....+++..++.++.+++.++.+||+.+++|+||+|.||++   +.++.++|+|||.+.............++..|++
T Consensus        78 ~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~  154 (244)
T smart00220       78 LKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILL---DEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMA  154 (244)
T ss_pred             HHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEE---CCCCcEEEccccceeeeccccccccccCCcCCCC
Confidence            9876668999999999999999999999999999999999999   4557899999999998766544556678899999


Q ss_pred             cccccC-CCCCchhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCC
Q 014733          212 PEVLAG-GYNQAADVWSAGVILYILLSGMPPFWG-KTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRL  289 (419)
Q Consensus       212 PE~l~~-~~s~~sDvwSlGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp  289 (419)
                      ||.+.+ .++.++|+||+|+++|+|++|..||.. .......+.+......... .+..++.++.+++.+||..||++||
T Consensus       155 pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~Rp  233 (244)
T smart00220      155 PEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPP-PEWKISPEAKDLIRKLLVKDPEKRL  233 (244)
T ss_pred             HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcc-ccccCCHHHHHHHHHHccCCchhcc
Confidence            999875 488999999999999999999999977 5556666665544433322 2222889999999999999999999


Q ss_pred             CHHHHHhcccc
Q 014733          290 TAAEVLAHSWM  300 (419)
Q Consensus       290 s~~eil~hp~~  300 (419)
                      ++.++++||||
T Consensus       234 ~~~~~~~~~~~  244 (244)
T smart00220      234 TAEEALQHPFF  244 (244)
T ss_pred             CHHHHhhCCCC
Confidence            99999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=8.8e-39  Score=311.91  Aligned_cols=267  Identities=29%  Similarity=0.449  Sum_probs=226.9

Q ss_pred             cccchhhccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHcc-----CCCC
Q 014733           28 TILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLS-----GHPN  102 (419)
Q Consensus        28 ~~~~~~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----~hpn  102 (419)
                      -+|...-.+-+.++|.+....|+|-|++|..|.+...|+.||||+|....    ...+.=..|++||++|.     +.-+
T Consensus       420 GYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE----~M~KtGl~EleiLkKL~~AD~Edk~H  495 (752)
T KOG0670|consen  420 GYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE----VMHKTGLKELEILKKLNDADPEDKFH  495 (752)
T ss_pred             ceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch----HHhhhhhHHHHHHHHhhccCchhhhH
Confidence            35556666778899999999999999999999999999999999998543    34455677999999996     3468


Q ss_pred             ceeeeEEEEeCCEEEEEEeecCCCChHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCC
Q 014733          103 VVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGR---FSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSS  179 (419)
Q Consensus       103 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~---l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~  179 (419)
                      +++|+..|...+++|||+|.+ ..+|...|++.+.   |....++.++.||..||..|...||+|.||||+|||+++  .
T Consensus       496 clrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE--~  572 (752)
T KOG0670|consen  496 CLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNE--S  572 (752)
T ss_pred             HHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEecc--C
Confidence            999999999999999999988 6799999998876   889999999999999999999999999999999999964  3


Q ss_pred             CCCeEEeeccceeeeccCCccccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC
Q 014733          180 SSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAAD  258 (419)
Q Consensus       180 ~~~vKL~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~  258 (419)
                      ...+||||||.|..+...+. ..+..+..|.|||++.| .|+...|+||+||+||||.||+..|.|.+...++.......
T Consensus       573 k~iLKLCDfGSA~~~~enei-tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~K  651 (752)
T KOG0670|consen  573 KNILKLCDFGSASFASENEI-TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELK  651 (752)
T ss_pred             cceeeeccCccccccccccc-cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhc
Confidence            45899999999998765543 34567788999999998 59999999999999999999999999998888877765554


Q ss_pred             CCCCCCCC-------------------------------------------------C-------CCCHHHHHHHHhhhh
Q 014733          259 LRFPSDPW-------------------------------------------------D-------HISASARDLIMGMLR  282 (419)
Q Consensus       259 ~~~~~~~~-------------------------------------------------~-------~~s~~l~~li~~~L~  282 (419)
                      ..+|....                                                 .       .+-.++.+|+.+||.
T Consensus       652 Gk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~  731 (752)
T KOG0670|consen  652 GKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLI  731 (752)
T ss_pred             CCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhc
Confidence            44443221                                                 0       012457899999999


Q ss_pred             cCCCCCCCHHHHHhcccccc
Q 014733          283 VDPSTRLTAAEVLAHSWMEE  302 (419)
Q Consensus       283 ~dP~~Rps~~eil~hp~~~~  302 (419)
                      .||.+|.|+.++|.||||..
T Consensus       732 LdP~KRit~nqAL~HpFi~~  751 (752)
T KOG0670|consen  732 LDPEKRITVNQALKHPFITE  751 (752)
T ss_pred             cChhhcCCHHHHhcCCcccC
Confidence            99999999999999999964

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=1.1e-36  Score=318.36  Aligned_cols=257  Identities=23%  Similarity=0.294  Sum_probs=179.4

Q ss_pred             cccCeeeeeeecccCceEEEEEEecCC----CcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEE----
Q 014733           38 LSDRYVLGKQLGWGQFGVIRECSDKFT----GEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAV----  109 (419)
Q Consensus        38 ~~~~y~i~~~LG~G~~g~V~~a~~~~~----g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~----  109 (419)
                      -.++|++.+.||+|+||.||+|++..+    +..||+|.+.....     .+....|  .++... +.++..+...    
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-----~e~~~~e--~l~~~~-~~~~~~~~~~~~~~  201 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-----VEIWMNE--RVRRAC-PNSCADFVYGFLEP  201 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-----hHHHHHH--HHHhhc-hhhHHHHHHhhhcc
Confidence            467999999999999999999999988    89999998754321     1111111  112221 2333332222    


Q ss_pred             --EEeCCEEEEEEeecCCCChHHHHHHcCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCCeeccC
Q 014733          110 --YEEEDYVHLLMELCAGGELFHRLEKYGR--------------------FSETEARVIFRHLMQVVSYCHGNGVVHRDL  167 (419)
Q Consensus       110 --~~~~~~~~lV~E~~~ggsL~~~l~~~~~--------------------l~~~~~~~i~~qll~aL~~LH~~~IvHrDL  167 (419)
                        ..+...+++||||+.+++|.+++.....                    ..+..+..++.||+.||+|||+.+|+||||
T Consensus       202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDL  281 (566)
T PLN03225        202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDV  281 (566)
T ss_pred             cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcC
Confidence              2456679999999999999999865321                    123346679999999999999999999999


Q ss_pred             CCCcEEEeecCCCCCeEEeeccceeeeccCC--ccccccCCCccCCcccccC-----------------------CCCCc
Q 014733          168 KPENILLATKSSSSPIKLADFGLATYIKAGQ--NLHGTVGSPFYIAPEVLAG-----------------------GYNQA  222 (419)
Q Consensus       168 kp~NILl~~~~~~~~vKL~DFgla~~~~~~~--~~~~~~gt~~y~aPE~l~~-----------------------~~s~~  222 (419)
                      ||+|||++.  .++.+||+|||+++.+....  .....++|+.|+|||.+..                       .++.+
T Consensus       282 KP~NILl~~--~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k  359 (566)
T PLN03225        282 KPQNIIFSE--GSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR  359 (566)
T ss_pred             CHHHEEEeC--CCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence            999999952  35689999999998654332  2245688999999996532                       13346


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-------CC----------CCCCCCCHHHHHHHHhhhhcCC
Q 014733          223 ADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRF-------PS----------DPWDHISASARDLIMGMLRVDP  285 (419)
Q Consensus       223 sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~-------~~----------~~~~~~s~~l~~li~~~L~~dP  285 (419)
                      +||||+||+||||+++..++... .......+.......       ..          ...........+||.+||++||
T Consensus       360 ~DVwSlGviL~el~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP  438 (566)
T PLN03225        360 FDIYSAGLIFLQMAFPNLRSDSN-LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG  438 (566)
T ss_pred             cccHHHHHHHHHHHhCcCCCchH-HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence            69999999999999977765322 111112222111100       00          0011223456699999999999


Q ss_pred             CCCCCHHHHHhccccccchh
Q 014733          286 STRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       286 ~~Rps~~eil~hp~~~~~~~  305 (419)
                      ++|||+.++|+||||+....
T Consensus       439 ~kR~ta~e~L~Hpff~~~~~  458 (566)
T PLN03225        439 RQRISAKAALAHPYFDREGL  458 (566)
T ss_pred             ccCCCHHHHhCCcCcCCCCc
Confidence            99999999999999987654

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-36  Score=293.30  Aligned_cols=269  Identities=26%  Similarity=0.471  Sum_probs=204.4

Q ss_pred             chhhccccc-cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccC-------CCC
Q 014733           31 DATQISNLS-DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG-------HPN  102 (419)
Q Consensus        31 ~~~~~~~~~-~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~-------hpn  102 (419)
                      .+...+.+. +||.+.++||+|.|++||+|+|.++...||+|+++..    ....+....||++|++++.       ...
T Consensus        68 pV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA----qhYtEaAlDEIklL~~v~~~Dp~~~~~~~  143 (590)
T KOG1290|consen   68 PVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA----QHYTEAALDEIKLLQQVREGDPNDPGKKC  143 (590)
T ss_pred             eeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh----hHHHHHHHHHHHHHHHHHhcCCCCCCCce
Confidence            344455676 8999999999999999999999999999999998643    2445667789999999873       357


Q ss_pred             ceeeeEEEEe----CCEEEEEEeecCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC-CCeeccCCCCcEEEe
Q 014733          103 VVDLKAVYEE----EDYVHLLMELCAGGELFHRLEKYG--RFSETEARVIFRHLMQVVSYCHGN-GVVHRDLKPENILLA  175 (419)
Q Consensus       103 Iv~l~~~~~~----~~~~~lV~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qll~aL~~LH~~-~IvHrDLkp~NILl~  175 (419)
                      ||+|++.|.-    ..+++||+|++ |..|..+|....  .++...++.|++||+.||.|||.. ||||.||||+|||+.
T Consensus       144 VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  144 VVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC  222 (590)
T ss_pred             eeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence            9999999964    56999999999 889999998764  499999999999999999999964 999999999999993


Q ss_pred             ecC-----------------------------------------------------------------------------
Q 014733          176 TKS-----------------------------------------------------------------------------  178 (419)
Q Consensus       176 ~~~-----------------------------------------------------------------------------  178 (419)
                      ...                                                                             
T Consensus       223 ~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s  302 (590)
T KOG1290|consen  223 STEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQES  302 (590)
T ss_pred             ccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccc
Confidence            210                                                                             


Q ss_pred             ----------------------------------C---------------------------------------------
Q 014733          179 ----------------------------------S---------------------------------------------  179 (419)
Q Consensus       179 ----------------------------------~---------------------------------------------  179 (419)
                                                        .                                             
T Consensus       303 ~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p  382 (590)
T KOG1290|consen  303 YNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNP  382 (590)
T ss_pred             cccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCC
Confidence                                              0                                             


Q ss_pred             -------CCCeEEeeccceeeeccCCccccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCH----
Q 014733          180 -------SSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTK----  247 (419)
Q Consensus       180 -------~~~vKL~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~----  247 (419)
                             +-.+||+|||-|+.+...  ......|..|+||||+.| +|+..+||||++|+++||+||...|.....    
T Consensus       383 ~~~~~~~di~vKIaDlGNACW~~kh--FT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~  460 (590)
T KOG1290|consen  383 DIPLPECDIRVKIADLGNACWVHKH--FTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYS  460 (590)
T ss_pred             CCCCCccceeEEEeeccchhhhhhh--hchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCC
Confidence                   001456666666543211  223356888999999888 599999999999999999999999954321    


Q ss_pred             --HHHHHHHHh-----------------------cCCCC--CCCCCC-------------CCCHHHHHHHHhhhhcCCCC
Q 014733          248 --SKIFDAVRA-----------------------ADLRF--PSDPWD-------------HISASARDLIMGMLRVDPST  287 (419)
Q Consensus       248 --~~~~~~i~~-----------------------~~~~~--~~~~~~-------------~~s~~l~~li~~~L~~dP~~  287 (419)
                        ++-+..|..                       +.++-  ..++|.             .-..++.+|+.-||+.+|++
T Consensus       461 rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeK  540 (590)
T KOG1290|consen  461 RDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEK  540 (590)
T ss_pred             ccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccc
Confidence              122212211                       11110  001121             12356789999999999999


Q ss_pred             CCCHHHHHhccccccchhh
Q 014733          288 RLTAAEVLAHSWMEECEQV  306 (419)
Q Consensus       288 Rps~~eil~hp~~~~~~~~  306 (419)
                      |||+.++|+|||++.....
T Consensus       541 R~tA~~cl~hPwLn~~~~~  559 (590)
T KOG1290|consen  541 RPTAAQCLKHPWLNPVAGP  559 (590)
T ss_pred             cccHHHHhcCccccCCCCC
Confidence            9999999999999976554

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.6e-35  Score=303.26  Aligned_cols=260  Identities=22%  Similarity=0.305  Sum_probs=189.8

Q ss_pred             ccccCeeeeeeecccCceEEEEEEec----------------CCCcEEEEEEeccCccCCHH-----------hHHHHHH
Q 014733           37 NLSDRYVLGKQLGWGQFGVIRECSDK----------------FTGEVLACKSIAKDRLVTVE-----------DVRSIKL   89 (419)
Q Consensus        37 ~~~~~y~i~~~LG~G~~g~V~~a~~~----------------~~g~~vaiK~i~~~~~~~~~-----------~~~~~~~   89 (419)
                      .-.++|++.++||+|+||+||+|.+.                ..+..||+|.+.........           ..+....
T Consensus       142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v  221 (507)
T PLN03224        142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV  221 (507)
T ss_pred             ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence            34679999999999999999999752                34567999998643211000           1122344


Q ss_pred             HHHHHHHccCCCCc-----eeeeEEEEe--------CCEEEEEEeecCCCChHHHHHHcC--------------------
Q 014733           90 EIEIMTKLSGHPNV-----VDLKAVYEE--------EDYVHLLMELCAGGELFHRLEKYG--------------------  136 (419)
Q Consensus        90 Ei~il~~l~~hpnI-----v~l~~~~~~--------~~~~~lV~E~~~ggsL~~~l~~~~--------------------  136 (419)
                      |+.++.+++ |.++     +++++++..        .+..++||||+++++|.+++....                    
T Consensus       222 E~~~l~~l~-~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~  300 (507)
T PLN03224        222 EAYMCAKIK-RNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN  300 (507)
T ss_pred             HHHHHHHhh-cccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence            777777776 5443     566666642        356899999999999999886421                    


Q ss_pred             ----CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCCccccc--cCCCccC
Q 014733          137 ----RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT--VGSPFYI  210 (419)
Q Consensus       137 ----~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~~~~~~--~gt~~y~  210 (419)
                          .+++..++.++.|++++|.|||+.+|+||||||+|||+   +.++.+||+|||++............  .+|+.|+
T Consensus       301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl---~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~  377 (507)
T PLN03224        301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLV---TVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYS  377 (507)
T ss_pred             cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEE---CCCCcEEEEeCcCccccccCCccCccccCCCccee
Confidence                23567788999999999999999999999999999999   45678999999999765443332222  3478999


Q ss_pred             CcccccCC---------------------CC--CchhHHHHHHHHHHHHhCCC-CCCCCCH-----------HHHHHHHH
Q 014733          211 APEVLAGG---------------------YN--QAADVWSAGVILYILLSGMP-PFWGKTK-----------SKIFDAVR  255 (419)
Q Consensus       211 aPE~l~~~---------------------~s--~~sDvwSlGvil~elltG~~-Pf~~~~~-----------~~~~~~i~  255 (419)
                      |||++...                     |+  .+.|+||+||++|+|++|.. ||.+...           ...++.+.
T Consensus       378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~  457 (507)
T PLN03224        378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYK  457 (507)
T ss_pred             ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhc
Confidence            99987531                     11  24799999999999999986 7743211           11122222


Q ss_pred             hcCCCCCCCCCCCCCHHHHHHHHhhhhcCC---CCCCCHHHHHhcccccc
Q 014733          256 AADLRFPSDPWDHISASARDLIMGMLRVDP---STRLTAAEVLAHSWMEE  302 (419)
Q Consensus       256 ~~~~~~~~~~~~~~s~~l~~li~~~L~~dP---~~Rps~~eil~hp~~~~  302 (419)
                      ...+.+  ..+...++..+||+.+||..+|   .+|+|+.|+|+||||..
T Consensus       458 ~~~~~~--~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        458 GQKYDF--SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             ccCCCc--ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence            233333  3466789999999999999866   78999999999999953

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-37  Score=283.10  Aligned_cols=257  Identities=28%  Similarity=0.481  Sum_probs=214.4

Q ss_pred             cccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEe---
Q 014733           36 SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEE---  112 (419)
Q Consensus        36 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~---  112 (419)
                      -....||.-+..+|.|+- .|-.|.|.-.+..||+|..... .......++..+|...+..+. |+||++++.+|.-   
T Consensus        13 ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~-~~nii~l~n~ftP~~~   89 (369)
T KOG0665|consen   13 FTVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVN-HKNIISLLNVFTPQKT   89 (369)
T ss_pred             eeeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccCccchhhhhhhhhhhhhc-ccceeeeeeccCcccc
Confidence            345679999999999999 7778899999999999998766 445566788899999999995 9999999999953   


Q ss_pred             ---CCEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeecc
Q 014733          113 ---EDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFG  189 (419)
Q Consensus       113 ---~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFg  189 (419)
                         -..+|+|||++ ..+|...+.  -.++...+..++.|++.|++|||+.||+||||||+||++   ..+..+||.|||
T Consensus        90 l~~~~e~y~v~e~m-~~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv---~~~~~lKi~dfg  163 (369)
T KOG0665|consen   90 LEEFQEVYLVMELM-DANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVV---NSDCTLKILDFG  163 (369)
T ss_pred             HHHHHhHHHHHHhh-hhHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCccccee---cchhheeeccch
Confidence               34689999999 668888776  457888999999999999999999999999999999999   677899999999


Q ss_pred             ceeeeccCCccccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC----------
Q 014733          190 LATYIKAGQNLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAAD----------  258 (419)
Q Consensus       190 la~~~~~~~~~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~----------  258 (419)
                      +|......-..+..+.|..|.|||++.+ +|...+||||+||++.||++|...|.|...-+.+.++....          
T Consensus       164 ~ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q  243 (369)
T KOG0665|consen  164 LARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ  243 (369)
T ss_pred             hhcccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence            9997666655667789999999999876 59999999999999999999999998877665555542210          


Q ss_pred             -----------------C----CCCCCCC-------CCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccc
Q 014733          259 -----------------L----RFPSDPW-------DHISASARDLIMGMLRVDPSTRLTAAEVLAHSWME  301 (419)
Q Consensus       259 -----------------~----~~~~~~~-------~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~  301 (419)
                                       .    .+|...|       ..-+..+++++.+||..||++|.+++++|+|||++
T Consensus       244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~  314 (369)
T KOG0665|consen  244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK  314 (369)
T ss_pred             hhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence                             0    0111111       12246688999999999999999999999999998

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-36  Score=301.83  Aligned_cols=252  Identities=25%  Similarity=0.389  Sum_probs=215.2

Q ss_pred             cCeeeeeeecccCceEEEEEEecCC-C--cEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFT-G--EVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYV  116 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~-g--~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~  116 (419)
                      .+..+.|.||+|.||+|++|.++.. |  ..||||.+....+.  .....|.+|+.+|.+|+ |||+++||++..+ .-.
T Consensus       110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~--~~mddflrEas~M~~L~-H~hliRLyGvVl~-qp~  185 (1039)
T KOG0199|consen  110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN--AIMDDFLREASHMLKLQ-HPHLIRLYGVVLD-QPA  185 (1039)
T ss_pred             HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc--hhHHHHHHHHHHHHhcc-CcceeEEeeeecc-chh
Confidence            3456789999999999999998743 3  46999999877653  37889999999999997 9999999999988 668


Q ss_pred             EEEEeecCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeee
Q 014733          117 HLLMELCAGGELFHRLEKY--GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI  194 (419)
Q Consensus       117 ~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~  194 (419)
                      .||||+++.|+|.+.|.+.  ..|.......++.||+.||.||.+++.|||||-..|+||.   ....|||+|||+.+-+
T Consensus       186 mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNllla---sprtVKI~DFGLmRaL  262 (1039)
T KOG0199|consen  186 MMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLA---SPRTVKICDFGLMRAL  262 (1039)
T ss_pred             hHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheec---ccceeeeecccceecc
Confidence            8999999999999999873  3488889999999999999999999999999999999994   4668999999999988


Q ss_pred             ccCCcccccc----CCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCC
Q 014733          195 KAGQNLHGTV----GSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDH  268 (419)
Q Consensus       195 ~~~~~~~~~~----gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  268 (419)
                      ..++......    -...|+|||.++. .++.++|||++||.+|||++ |..||.+.....++++|..+. +.+.  .+.
T Consensus       263 g~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~e-rLpR--Pk~  339 (1039)
T KOG0199|consen  263 GENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGE-RLPR--PKY  339 (1039)
T ss_pred             CCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccc-cCCC--CCC
Confidence            7766554332    2346999999987 49999999999999999998 899999999999999987443 3332  247


Q ss_pred             CCHHHHHHHHhhhhcCCCCCCCHHHHHhccccc
Q 014733          269 ISASARDLIMGMLRVDPSTRLTAAEVLAHSWME  301 (419)
Q Consensus       269 ~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~  301 (419)
                      +++.+.+++.+||..+|.+|||+..|.+.-+..
T Consensus       340 csedIY~imk~cWah~paDRptFsair~~~~l~  372 (1039)
T KOG0199|consen  340 CSEDIYQIMKNCWAHNPADRPTFSAIREDLVLA  372 (1039)
T ss_pred             ChHHHHHHHHHhccCCccccccHHHHHHhHHHH
Confidence            899999999999999999999999997554443

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-35  Score=293.01  Aligned_cols=245  Identities=26%  Similarity=0.407  Sum_probs=211.5

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      -+..+..+||-|.||.||.|.++...-.||||.++.+.    -.++.|..|..+|+.++ |||+|+|+++|..+--+|||
T Consensus       267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt----MeveEFLkEAAvMKeik-HpNLVqLLGVCT~EpPFYIi  341 (1157)
T KOG4278|consen  267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIK-HPNLVQLLGVCTHEPPFYII  341 (1157)
T ss_pred             hheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc----hhHHHHHHHHHHHHhhc-CccHHHHhhhhccCCCeEEE
Confidence            34455788999999999999999888999999987554    35789999999999996 99999999999999999999


Q ss_pred             EeecCCCChHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccC
Q 014733          120 MELCAGGELFHRLEKYGR--FSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG  197 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~~~~--l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~  197 (419)
                      +|||..|+|.++|...++  ++.-...+++.||..|++||..++.|||||-..|.|+   +++..||++|||+++.+..+
T Consensus       342 TEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLV---gEnhiVKvADFGLsRlMtgD  418 (1157)
T KOG4278|consen  342 TEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHIVKVADFGLSRLMTGD  418 (1157)
T ss_pred             EecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccc---cccceEEeeccchhhhhcCC
Confidence            999999999999988765  6777788899999999999999999999999999999   67789999999999987654


Q ss_pred             Cc--cccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 014733          198 QN--LHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASA  273 (419)
Q Consensus       198 ~~--~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l  273 (419)
                      .-  +.+..-..-|.|||-+.- .++.++|||+|||+|||+.| |..||.+-+..+++..+..+ ++.  +.+..+++.+
T Consensus       419 TYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkg-yRM--~~PeGCPpkV  495 (1157)
T KOG4278|consen  419 TYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKG-YRM--DGPEGCPPKV  495 (1157)
T ss_pred             ceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcc-ccc--cCCCCCCHHH
Confidence            32  122233445999998875 48999999999999999998 89999998888887776554 333  3345899999


Q ss_pred             HHHHHhhhhcCCCCCCCHHHHH
Q 014733          274 RDLIMGMLRVDPSTRLTAAEVL  295 (419)
Q Consensus       274 ~~li~~~L~~dP~~Rps~~eil  295 (419)
                      .+|++.||+++|.+||++.|+-
T Consensus       496 YeLMraCW~WsPsDRPsFaeiH  517 (1157)
T KOG4278|consen  496 YELMRACWNWSPSDRPSFAEIH  517 (1157)
T ss_pred             HHHHHHHhcCCcccCccHHHHH
Confidence            9999999999999999999984

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=7e-36  Score=303.41  Aligned_cols=249  Identities=27%  Similarity=0.459  Sum_probs=218.9

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCC---cEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTG---EVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYV  116 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g---~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~  116 (419)
                      ..-.|.++||.|.||.|+.|+.+..|   ..||||.++.-  .+++....|..|..||-++. ||||++|.++.....-+
T Consensus       629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G--ytekqrrdFL~EAsIMGQFd-HPNIIrLEGVVTks~Pv  705 (996)
T KOG0196|consen  629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG--YTEKQRRDFLSEASIMGQFD-HPNIIRLEGVVTKSKPV  705 (996)
T ss_pred             hheEEEEEEecccccceecccccCCCCcceeEEEeeeccC--ccHHHHhhhhhhhhhcccCC-CCcEEEEEEEEecCcee
Confidence            45577899999999999999988666   56999988654  56788899999999999996 99999999999999999


Q ss_pred             EEEEeecCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeec
Q 014733          117 HLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIK  195 (419)
Q Consensus       117 ~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~  195 (419)
                      .||+|||++|+|..+|+.+ +.|+..+..-+.+.|+.|++||-+.+.|||||-..|||+   +.+-..|++|||+++.+.
T Consensus       706 MIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILV---NsnLvCKVsDFGLSRvle  782 (996)
T KOG0196|consen  706 MIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILV---NSNLVCKVSDFGLSRVLE  782 (996)
T ss_pred             EEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheee---ccceEEEeccccceeecc
Confidence            9999999999999999764 569999999999999999999999999999999999999   566789999999999886


Q ss_pred             cCC-ccccccC---CCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCC
Q 014733          196 AGQ-NLHGTVG---SPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHI  269 (419)
Q Consensus       196 ~~~-~~~~~~g---t~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  269 (419)
                      ++. ...++.|   ...|.|||.+.. +++.++||||+|++|||.++ |..|||+.+.+++++.|..+ ++.|.+.  +.
T Consensus       783 dd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~g-yRLPpPm--DC  859 (996)
T KOG0196|consen  783 DDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQG-YRLPPPM--DC  859 (996)
T ss_pred             cCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhc-cCCCCCC--CC
Confidence            554 2223332   356999999986 59999999999999999776 99999999999999999764 6666654  89


Q ss_pred             CHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          270 SASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       270 s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      |..+.+|+..||++|-.+||.+.||+.+
T Consensus       860 P~aL~qLMldCWqkdR~~RP~F~qiV~~  887 (996)
T KOG0196|consen  860 PAALYQLMLDCWQKDRNRRPKFAQIVST  887 (996)
T ss_pred             cHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence            9999999999999999999999999864

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-36  Score=277.37  Aligned_cols=257  Identities=28%  Similarity=0.490  Sum_probs=210.2

Q ss_pred             CeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCC-----E
Q 014733           41 RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEED-----Y  115 (419)
Q Consensus        41 ~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~-----~  115 (419)
                      +.+-.+.||.|+||+||.+.|..+|+.||+|++..- ..+....+.+.+|+++|.-++ |.|++...++.+-.+     .
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv-fq~L~s~krvFre~kmLcfFk-HdNVLSaLDILQPph~dfFqE  131 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV-FQNLASCKRVFREIKMLSSFR-HDNVLSLLDILQPANPSFFQE  131 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchH-HHHHHHHHHHHHHHHHHHhhc-cccHHHHHHhcCCCCchHHHH
Confidence            334456899999999999999999999999987532 123345678999999999996 999999999886543     4


Q ss_pred             EEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeec
Q 014733          116 VHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIK  195 (419)
Q Consensus       116 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~  195 (419)
                      +|+++|++ ..+|...+-....++.++++.+..||++||+|||+.+|.||||||.|.|+   +++..+||||||+++...
T Consensus       132 iYV~TELm-QSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLV---NSNCvLKICDFGLARvee  207 (449)
T KOG0664|consen  132 LYVLTELM-QSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLV---NSNCILKICDFGLARTWD  207 (449)
T ss_pred             HHHHHHHH-HhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEe---ccCceEEecccccccccc
Confidence            67888988 45888888887889999999999999999999999999999999999999   667899999999999876


Q ss_pred             cCCccc--cccCCCccCCcccccCC--CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---------------
Q 014733          196 AGQNLH--GTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRA---------------  256 (419)
Q Consensus       196 ~~~~~~--~~~gt~~y~aPE~l~~~--~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~---------------  256 (419)
                      .++...  ..+.|..|.|||+++|.  |+.+.||||.|||+.||+..+..|...++-+..+.|..               
T Consensus       208 ~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE  287 (449)
T KOG0664|consen  208 QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE  287 (449)
T ss_pred             hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence            655443  34678899999999984  99999999999999999999999987776555555422               


Q ss_pred             --------cCCCCCCCC-------CCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccc
Q 014733          257 --------ADLRFPSDP-------WDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEEC  303 (419)
Q Consensus       257 --------~~~~~~~~~-------~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~  303 (419)
                              +..+.|...       ...-..+..+++.+||.+||++|.+..+++.|++..+.
T Consensus       288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~  349 (449)
T KOG0664|consen  288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG  349 (449)
T ss_pred             hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence                    112222211       11334677899999999999999999999999998764

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-35  Score=288.64  Aligned_cols=252  Identities=23%  Similarity=0.344  Sum_probs=208.5

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEE
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHL  118 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~l  118 (419)
                      .+...++++||+|.||.|.+|.-. .+..||+|+.+..  ........|.+|+++|.+|+ ||||+.++++|..++-+++
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~--a~~~~r~~F~kEIkiLsqLk-hPNIveLvGVC~~DePicm  612 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPD--ATKNARNDFLKEIKILSRLK-HPNIVELLGVCVQDDPLCM  612 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEec-CceEEEEeecCcc--cchhHHHHHHHHHHHHhccC-CCCeeEEEeeeecCCchHH
Confidence            345678999999999999999864 3689999998765  45566789999999999996 9999999999999999999


Q ss_pred             EEeecCCCChHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeecc
Q 014733          119 LMELCAGGELFHRLEKYGR--FSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA  196 (419)
Q Consensus       119 V~E~~~ggsL~~~l~~~~~--l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~  196 (419)
                      |+||++.|+|.+++.++..  .....-..++.||+.|++||.+.++|||||-+.|+|+   +.++++||+|||+++.+-.
T Consensus       613 I~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv---~~e~~iKiadfgmsR~lys  689 (807)
T KOG1094|consen  613 ITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLV---DGEFTIKIADFGMSRNLYS  689 (807)
T ss_pred             HHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceee---cCcccEEecCccccccccc
Confidence            9999999999999988633  3555667799999999999999999999999999999   6788999999999986544


Q ss_pred             CCccc---cccCCCccCCcccc-cCCCCCchhHHHHHHHHHHHH--hCCCCCCCCCHHHHHHHHHhcCCCCCC----CCC
Q 014733          197 GQNLH---GTVGSPFYIAPEVL-AGGYNQAADVWSAGVILYILL--SGMPPFWGKTKSKIFDAVRAADLRFPS----DPW  266 (419)
Q Consensus       197 ~~~~~---~~~gt~~y~aPE~l-~~~~s~~sDvwSlGvil~ell--tG~~Pf~~~~~~~~~~~i~~~~~~~~~----~~~  266 (419)
                      +....   ..+-...|||+|.+ .++++.++|+|+||+.+||++  +...||...+.+++.++........+.    ..+
T Consensus       690 g~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P  769 (807)
T KOG1094|consen  690 GDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRP  769 (807)
T ss_pred             CCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCC
Confidence            33221   12345679999965 567999999999999999976  489999998888888776543221111    123


Q ss_pred             CCCCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          267 DHISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       267 ~~~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      .-++.++.+++.+||+.|-++||+++++..|
T Consensus       770 ~~cp~~lyelml~Cw~~es~~RPsFe~lh~~  800 (807)
T KOG1094|consen  770 PACPQGLYELMLRCWRRESEQRPSFEQLHLF  800 (807)
T ss_pred             CcCcHHHHHHHHHHhchhhhcCCCHHHHHHH
Confidence            4678999999999999999999999999543

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-36  Score=305.19  Aligned_cols=254  Identities=28%  Similarity=0.449  Sum_probs=202.5

Q ss_pred             eeeeeeecccCce-EEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEE
Q 014733           42 YVLGKQLGWGQFG-VIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLM  120 (419)
Q Consensus        42 y~i~~~LG~G~~g-~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~  120 (419)
                      |.-.+.+|.|+.| .||+|..  .|+.||||.+..      ....-..+|+..|+.-..|||||++++.-.+.+..||..
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~------e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIal  582 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLE------EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIAL  582 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee--CCceehHHHHhh------HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEe
Confidence            4445789999998 7888874  588999998743      344567899999999989999999999999999999999


Q ss_pred             eecCCCChHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCC--CeEEeeccceeee
Q 014733          121 ELCAGGELFHRLEKYGR----FSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSS--PIKLADFGLATYI  194 (419)
Q Consensus       121 E~~~ggsL~~~l~~~~~----l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~--~vKL~DFgla~~~  194 (419)
                      |+| ..+|.++++..+.    ......+.+..|+++||++||+.+||||||||+||||...+.++  .++|+|||+++.+
T Consensus       583 ELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl  661 (903)
T KOG1027|consen  583 ELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL  661 (903)
T ss_pred             hHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence            999 6799999987421    12245577889999999999999999999999999997653333  6899999999998


Q ss_pred             ccCCc----cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHhcCCCCCCCCCCC
Q 014733          195 KAGQN----LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSG-MPPFWGKTKSKIFDAVRAADLRFPSDPWDH  268 (419)
Q Consensus       195 ~~~~~----~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  268 (419)
                      ..+..    ..+..||-+|+|||++... -+.++||+||||++|+.++| ..||.+.-..  ..+|..+......-.. .
T Consensus       662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R--~~NIl~~~~~L~~L~~-~  738 (903)
T KOG1027|consen  662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER--QANILTGNYTLVHLEP-L  738 (903)
T ss_pred             CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh--hhhhhcCccceeeecc-C
Confidence            76654    3445799999999999875 67799999999999998886 9999654332  2344444433222111 1


Q ss_pred             CCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchhhh
Q 014733          269 ISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVA  307 (419)
Q Consensus       269 ~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~~~  307 (419)
                      ...+++|||.+||.++|..||++.+||.||+|-..++..
T Consensus       739 ~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ekrL  777 (903)
T KOG1027|consen  739 PDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDSEKRL  777 (903)
T ss_pred             chHHHHHHHHHhcCCCcccCCCHHHHhCCCccCChHHHH
Confidence            112899999999999999999999999999998776644

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-34  Score=285.38  Aligned_cols=243  Identities=29%  Similarity=0.476  Sum_probs=205.3

Q ss_pred             eeeeecccCceEEEEEEecC--CC--cEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           44 LGKQLGWGQFGVIRECSDKF--TG--EVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        44 i~~~LG~G~~g~V~~a~~~~--~g--~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      +.+.||.|.||.||.|....  .|  --||||..+.+  .+.+..+.|..|..+|+.+. ||||++++|++.+.. .++|
T Consensus       393 l~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d--~t~d~tekflqEa~iMrnfd-HphIikLIGv~~e~P-~Wiv  468 (974)
T KOG4257|consen  393 LKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTD--CTPDDTEKFLQEASIMRNFD-HPHIIKLIGVCVEQP-MWIV  468 (974)
T ss_pred             HHHhhcCCcccceeeeEecccccCcceeeeeehhccC--CChhhHHHHHHHHHHHHhCC-Ccchhheeeeeeccc-eeEE
Confidence            35689999999999998542  33  35788877654  45667899999999999996 999999999998765 7899


Q ss_pred             EeecCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC
Q 014733          120 MELCAGGELFHRLEKYG-RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ  198 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~  198 (419)
                      ||+++-|+|..+|+.++ .++......++.||..||+|||+...|||||-..|||+   ....-|||+|||+++.+....
T Consensus       469 mEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLV---sSp~CVKLaDFGLSR~~ed~~  545 (974)
T KOG4257|consen  469 MELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILV---SSPQCVKLADFGLSRYLEDDA  545 (974)
T ss_pred             EecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheee---cCcceeeecccchhhhccccc
Confidence            99999999999998764 48999999999999999999999999999999999999   455679999999999887665


Q ss_pred             ccccccC--CCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 014733          199 NLHGTVG--SPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASAR  274 (419)
Q Consensus       199 ~~~~~~g--t~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~  274 (419)
                      -.....|  ..-|||||-+.= .++.++|||-|||++||++. |..||.+-...++...+.+++ +.|.+  +++++.+.
T Consensus       546 yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGe-RlP~P--~nCPp~LY  622 (974)
T KOG4257|consen  546 YYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGE-RLPCP--PNCPPALY  622 (974)
T ss_pred             hhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCC-CCCCC--CCCChHHH
Confidence            4433333  335999998764 59999999999999999886 999999988888887777664 33333  37999999


Q ss_pred             HHHHhhhhcCCCCCCCHHHHHh
Q 014733          275 DLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       275 ~li~~~L~~dP~~Rps~~eil~  296 (419)
                      .|+.+||..+|.+||.+.++..
T Consensus       623 slmskcWayeP~kRPrftei~~  644 (974)
T KOG4257|consen  623 SLMSKCWAYEPSKRPRFTEIKA  644 (974)
T ss_pred             HHHHHHhccCcccCCcHHHHHH
Confidence            9999999999999999998864

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2.8e-34  Score=319.79  Aligned_cols=243  Identities=23%  Similarity=0.287  Sum_probs=185.8

Q ss_pred             ccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEE
Q 014733           37 NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYV  116 (419)
Q Consensus        37 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~  116 (419)
                      .+...|...+.||+|+||.||+|.++.++..||+|.+.....       ....|++++++++ |||||++++++.+.+..
T Consensus       687 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~l~~l~-HpnIv~~~~~~~~~~~~  758 (968)
T PLN00113        687 DILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-------IPSSEIADMGKLQ-HPNIVKLIGLCRSEKGA  758 (968)
T ss_pred             HHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-------ccHHHHHHHhhCC-CCCcceEEEEEEcCCCC
Confidence            334567778899999999999999998999999998864321       1134688899995 99999999999999999


Q ss_pred             EEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCCeeccCCCCcEEEeecCCCCCeEEeeccceee
Q 014733          117 HLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCH---GNGVVHRDLKPENILLATKSSSSPIKLADFGLATY  193 (419)
Q Consensus       117 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH---~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~  193 (419)
                      |+||||+++|+|.++++.   +++.++..++.|+++||+|||   +.+|+||||||+||+++   .++..++. ||....
T Consensus       759 ~lv~Ey~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~---~~~~~~~~-~~~~~~  831 (968)
T PLN00113        759 YLIHEYIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIID---GKDEPHLR-LSLPGL  831 (968)
T ss_pred             EEEEeCCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEEC---CCCceEEE-eccccc
Confidence            999999999999999964   899999999999999999999   66999999999999994   34455554 555443


Q ss_pred             eccCCccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhc----------CCC
Q 014733          194 IKAGQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTK--SKIFDAVRAA----------DLR  260 (419)
Q Consensus       194 ~~~~~~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~--~~~~~~i~~~----------~~~  260 (419)
                      ....   ....||+.|+|||++.+. ++.++|||||||++|||++|+.||.....  ..+.+.....          +..
T Consensus       832 ~~~~---~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  908 (968)
T PLN00113        832 LCTD---TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPS  908 (968)
T ss_pred             cccC---CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCcc
Confidence            2211   233688999999998764 99999999999999999999999853211  1121111110          000


Q ss_pred             CCCC--CCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          261 FPSD--PWDHISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       261 ~~~~--~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      ....  .......++.+++.+||+.||++|||+.|+++.
T Consensus       909 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        909 IRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             ccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence            0000  000112356789999999999999999999864

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-36  Score=298.83  Aligned_cols=261  Identities=31%  Similarity=0.524  Sum_probs=230.2

Q ss_pred             ccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEE
Q 014733           37 NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYV  116 (419)
Q Consensus        37 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~  116 (419)
                      +=.++|.++.++|.|.||.||+|+++.+++..|+|+++....   ++..-++.|+-+++..+ |||||-+++.+.....+
T Consensus        12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~---dd~~~iqqei~~~~dc~-h~nivay~gsylr~dkl   87 (829)
T KOG0576|consen   12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG---DDFSGIQQEIGMLRDCR-HPNIVAYFGSYLRRDKL   87 (829)
T ss_pred             CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCC---ccccccccceeeeecCC-CcChHHHHhhhhhhcCc
Confidence            556899999999999999999999999999999999987643   56777889999999996 99999999999999999


Q ss_pred             EEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeecc
Q 014733          117 HLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA  196 (419)
Q Consensus       117 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~  196 (419)
                      ++.||||.||+|.+.....+++++.++...++..+++|+|||+.|-+|||||-.|||+   .+.|.+||+|||.+..+..
T Consensus        88 wicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanill---td~gDvklaDfgvsaqita  164 (829)
T KOG0576|consen   88 WICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILL---TDEGDVKLADFGVSAQITA  164 (829)
T ss_pred             EEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceee---cccCceeecccCchhhhhh
Confidence            9999999999999999888999999999999999999999999999999999999999   6788999999998877654


Q ss_pred             CC-ccccccCCCccCCcccc----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC-CCCCCC
Q 014733          197 GQ-NLHGTVGSPFYIAPEVL----AGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSD-PWDHIS  270 (419)
Q Consensus       197 ~~-~~~~~~gt~~y~aPE~l----~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~-~~~~~s  270 (419)
                      .- ....+.||+.|||||+-    .++|+..+|+|++|+...|+-.-++|..+..+...........+..|.. .....+
T Consensus       165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws  244 (829)
T KOG0576|consen  165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWS  244 (829)
T ss_pred             hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccch
Confidence            32 23567999999999984    3569999999999999999999999988877777666665555544432 334688


Q ss_pred             HHHHHHHHhhhhcCCCCCCCHHHHHhccccccch
Q 014733          271 ASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECE  304 (419)
Q Consensus       271 ~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~  304 (419)
                      +.+.+|++.+|.++|++||+++.+|.|||+.+..
T Consensus       245 ~~fh~fvK~altknpKkRptaeklL~h~fvs~~l  278 (829)
T KOG0576|consen  245 EFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQTL  278 (829)
T ss_pred             HHHHHHHHHHhcCCCccCCChhhheeceeeccch
Confidence            9999999999999999999999999999997653

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-34  Score=251.06  Aligned_cols=216  Identities=25%  Similarity=0.417  Sum_probs=182.6

Q ss_pred             ccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCC
Q 014733           35 ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEED  114 (419)
Q Consensus        35 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~  114 (419)
                      .+.-.++...++.||+|+||.|-+.++.++|...|+|.++..  .+.+...+..+|+++..+...+|.+|.+|+.+.++.
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~t--vn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg  118 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRAT--VNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG  118 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhh--cChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccc
Confidence            344456666688999999999999999999999999999765  456777888999999888888999999999999999


Q ss_pred             EEEEEEeecCCCChHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHhC-CCeeccCCCCcEEEeecCCCCCeEEeecc
Q 014733          115 YVHLLMELCAGGELFHRL----EKYGRFSETEARVIFRHLMQVVSYCHGN-GVVHRDLKPENILLATKSSSSPIKLADFG  189 (419)
Q Consensus       115 ~~~lV~E~~~ggsL~~~l----~~~~~l~~~~~~~i~~qll~aL~~LH~~-~IvHrDLkp~NILl~~~~~~~~vKL~DFg  189 (419)
                      .+++.||.| ..+|..+.    .+.+..+|..+-+|+..+++||.|||++ .|||||+||+|||+   +.+|.||+||||
T Consensus       119 dvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLI---n~~GqVKiCDFG  194 (282)
T KOG0984|consen  119 DVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILI---NYDGQVKICDFG  194 (282)
T ss_pred             cEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEE---ccCCcEEEcccc
Confidence            999999999 56776543    4556799999999999999999999986 79999999999999   678899999999


Q ss_pred             ceeeeccCCccccccCCCccCCcccccC-----CCCCchhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHh
Q 014733          190 LATYIKAGQNLHGTVGSPFYIAPEVLAG-----GYNQAADVWSAGVILYILLSGMPPFWG-KTKSKIFDAVRA  256 (419)
Q Consensus       190 la~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~s~~sDvwSlGvil~elltG~~Pf~~-~~~~~~~~~i~~  256 (419)
                      .+-.+.++.......|-..|||||.+..     +|+.++||||||+.+.||.+++.||.. .++-+++.++.+
T Consensus       195 IsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe  267 (282)
T KOG0984|consen  195 ISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE  267 (282)
T ss_pred             cceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence            9998877665555678888999999753     489999999999999999999999942 344444444433

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-35  Score=286.85  Aligned_cols=200  Identities=34%  Similarity=0.599  Sum_probs=179.3

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHh-----HHHHHHHHHHHHHcc--CCCCceeeeEEEEe
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVED-----VRSIKLEIEIMTKLS--GHPNVVDLKAVYEE  112 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~-----~~~~~~Ei~il~~l~--~hpnIv~l~~~~~~  112 (419)
                      .+|..+..+|.|+||.|++|.++.+...|++|.|.|++..-...     +-.+-.||.||.+|.  .|+||++++++|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            35899999999999999999999999999999999988754333     345778999999994  39999999999999


Q ss_pred             CCEEEEEEeec-CCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccce
Q 014733          113 EDYVHLLMELC-AGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA  191 (419)
Q Consensus       113 ~~~~~lV~E~~-~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla  191 (419)
                      ++++|++||.- +|.+|+++|+...+++|.++..|++|++.|+++||+.||||||||-+||++   +.+|-+||+|||.+
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenviv---d~~g~~klidfgsa  717 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIV---DSNGFVKLIDFGSA  717 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEE---ecCCeEEEeeccch
Confidence            99999999975 466999999998999999999999999999999999999999999999999   67889999999999


Q ss_pred             eeeccCCccccccCCCccCCcccccCC-C-CCchhHHHHHHHHHHHHhCCCCCC
Q 014733          192 TYIKAGQNLHGTVGSPFYIAPEVLAGG-Y-NQAADVWSAGVILYILLSGMPPFW  243 (419)
Q Consensus       192 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-~-s~~sDvwSlGvil~elltG~~Pf~  243 (419)
                      .....+ .....+||..|.|||++.|. | +..-|||+||++||.++....||.
T Consensus       718 a~~ksg-pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  718 AYTKSG-PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             hhhcCC-CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            876554 45668999999999999985 4 788999999999999999999985

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=2.1e-34  Score=276.52  Aligned_cols=261  Identities=28%  Similarity=0.451  Sum_probs=207.1

Q ss_pred             ccccccCeeeeeeecccCceEEEEEEecC---CCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEE
Q 014733           35 ISNLSDRYVLGKQLGWGQFGVIRECSDKF---TGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYE  111 (419)
Q Consensus        35 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~---~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~  111 (419)
                      +..+.+.|+++++||.|.|++||+|.+..   .+..||+|.+....     ....+.+|+++|..+.++.||+++.+++.
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-----~p~ri~~El~~L~~~gG~~ni~~~~~~~r  105 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-----SPSRILNELEMLYRLGGSDNIIKLNGCFR  105 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-----CchHHHHHHHHHHHhccchhhhcchhhhc
Confidence            66678899999999999999999999876   78899999987542     34568999999999999999999999999


Q ss_pred             eCCEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccce
Q 014733          112 EEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA  191 (419)
Q Consensus       112 ~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla  191 (419)
                      .++.+.+|+||++..+..++...   ++..+++.+++.++.||+++|++|||||||||+|+|.+.  ..++-.|+|||+|
T Consensus       106 nnd~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~--~t~rg~LvDFgLA  180 (418)
T KOG1167|consen  106 NNDQVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNR--RTQRGVLVDFGLA  180 (418)
T ss_pred             cCCeeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCcccccccc--ccCCceEEechhH
Confidence            99999999999999888777755   789999999999999999999999999999999999964  4456789999999


Q ss_pred             eeeccC---------------C------------------------------ccccccCCCccCCcccccC--CCCCchh
Q 014733          192 TYIKAG---------------Q------------------------------NLHGTVGSPFYIAPEVLAG--GYNQAAD  224 (419)
Q Consensus       192 ~~~~~~---------------~------------------------------~~~~~~gt~~y~aPE~l~~--~~s~~sD  224 (419)
                      ......               .                              ......||++|.|||++..  .-+.++|
T Consensus       181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD  260 (418)
T KOG1167|consen  181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID  260 (418)
T ss_pred             HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence            722100               0                              0011269999999999875  3789999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCCH--------------HHHHH------------------------HHHhc----CCC--
Q 014733          225 VWSAGVILYILLSGMPPFWGKTK--------------SKIFD------------------------AVRAA----DLR--  260 (419)
Q Consensus       225 vwSlGvil~elltG~~Pf~~~~~--------------~~~~~------------------------~i~~~----~~~--  260 (419)
                      |||.|+|+..+++++.||.....              .++.+                        .....    ...  
T Consensus       261 iws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~  340 (418)
T KOG1167|consen  261 IWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSR  340 (418)
T ss_pred             eeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccc
Confidence            99999999999999999932211              00000                        00000    000  


Q ss_pred             ---CCCCC-CCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          261 ---FPSDP-WDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       261 ---~~~~~-~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                         ..... .+..+..+.+|+.+||..||.+|.|++++|+||||.....
T Consensus       341 q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~~  389 (418)
T KOG1167|consen  341 QPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEADR  389 (418)
T ss_pred             ccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchhh
Confidence               00011 1234568999999999999999999999999999985543

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-32  Score=286.94  Aligned_cols=248  Identities=25%  Similarity=0.415  Sum_probs=207.3

Q ss_pred             CeeeeeeecccCceEEEEEEec----C---CCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeC
Q 014733           41 RYVLGKQLGWGQFGVIRECSDK----F---TGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEE  113 (419)
Q Consensus        41 ~y~i~~~LG~G~~g~V~~a~~~----~---~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~  113 (419)
                      +..+.+.||+|+||.|++|.-.    .   ....||+|......  ...+.+.+..|+++|+.+..|+||+.+.+++...
T Consensus       297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~--~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~  374 (609)
T KOG0200|consen  297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENA--SSSEKKDLMSELNVLKELGKHPNIVNLLGACTQD  374 (609)
T ss_pred             hccccceeecccccceEeEEEeecccccccceEEEEEEeccccc--CcHHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence            3356779999999999999743    1   14579999886553  3477889999999999999999999999999999


Q ss_pred             CEEEEEEeecCCCChHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeec
Q 014733          114 DYVHLLMELCAGGELFHRLEKYG----------------RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATK  177 (419)
Q Consensus       114 ~~~~lV~E~~~ggsL~~~l~~~~----------------~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~  177 (419)
                      +.+++|+||+..|+|..+++..+                .++..+...++.||+.|++||++..+|||||-..|||+   
T Consensus       375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi---  451 (609)
T KOG0200|consen  375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLI---  451 (609)
T ss_pred             CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEe---
Confidence            99999999999999999998755                38889999999999999999999999999999999999   


Q ss_pred             CCCCCeEEeeccceeeeccCCccc--cccC--CCccCCcccccCC-CCCchhHHHHHHHHHHHHh-CCCCCCCCC-HHHH
Q 014733          178 SSSSPIKLADFGLATYIKAGQNLH--GTVG--SPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKT-KSKI  250 (419)
Q Consensus       178 ~~~~~vKL~DFgla~~~~~~~~~~--~~~g--t~~y~aPE~l~~~-~s~~sDvwSlGvil~ellt-G~~Pf~~~~-~~~~  250 (419)
                      ..+..+||+|||+|+.........  ...|  ...|||||.+... |+.++||||+|++||||++ |..||.+-. ..++
T Consensus       452 ~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l  531 (609)
T KOG0200|consen  452 TKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEEL  531 (609)
T ss_pred             cCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHH
Confidence            566789999999999754433322  1222  2349999999874 9999999999999999998 889998755 6677


Q ss_pred             HHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          251 FDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       251 ~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                      .+.++.+.-..   .+...+.++.++++.||+.+|++||++.++.+
T Consensus       532 ~~~l~~G~r~~---~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  532 LEFLKEGNRME---QPEHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             HHHHhcCCCCC---CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            77666653322   22367999999999999999999999999976

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-32  Score=263.05  Aligned_cols=248  Identities=25%  Similarity=0.379  Sum_probs=197.9

Q ss_pred             cccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHH--ccCCCCceeeeEEEEeC
Q 014733           36 SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTK--LSGHPNVVDLKAVYEEE  113 (419)
Q Consensus        36 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~--l~~hpnIv~l~~~~~~~  113 (419)
                      ..+..+-.+.+.||+|-||.||+|.++  |+.||||++..      .+.+.+.+|.+|++.  | +|+||+.+++.-..+
T Consensus       207 RTiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~s------rdE~SWfrEtEIYqTvmL-RHENILgFIaaD~~~  277 (513)
T KOG2052|consen  207 RTIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSS------RDERSWFRETEIYQTVML-RHENILGFIAADNKD  277 (513)
T ss_pred             HhhhheeEEEEEecCccccceeecccc--CCceEEEEecc------cchhhhhhHHHHHHHHHh-ccchhhhhhhccccC
Confidence            346678899999999999999999876  99999999853      345778889999876  4 599999999886543


Q ss_pred             ----CEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC--------CCeeccCCCCcEEEeecCCCC
Q 014733          114 ----DYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGN--------GVVHRDLKPENILLATKSSSS  181 (419)
Q Consensus       114 ----~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~--------~IvHrDLkp~NILl~~~~~~~  181 (419)
                          ..++||++|.+.|+|+++|.+ ..++.+...+++..++.||++||-.        .|.|||||..|||+   .+++
T Consensus       278 ~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILV---Kkn~  353 (513)
T KOG2052|consen  278 NGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNG  353 (513)
T ss_pred             CCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEE---ccCC
Confidence                368999999999999999988 7799999999999999999999943        49999999999999   6788


Q ss_pred             CeEEeeccceeeeccCC-----ccccccCCCccCCcccccCCCC-------CchhHHHHHHHHHHHHh----------CC
Q 014733          182 PIKLADFGLATYIKAGQ-----NLHGTVGSPFYIAPEVLAGGYN-------QAADVWSAGVILYILLS----------GM  239 (419)
Q Consensus       182 ~vKL~DFgla~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~s-------~~sDvwSlGvil~ellt----------G~  239 (419)
                      ..-|+|+|+|.......     ..+..+||..|||||++....+       ..+||||||.++||+..          -+
T Consensus       354 ~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~  433 (513)
T KOG2052|consen  354 TCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQ  433 (513)
T ss_pred             cEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhc
Confidence            99999999998765542     2344589999999999976322       46899999999999975          36


Q ss_pred             CCCCC-----CCHHHHHHHHHhcCCCCCCC-CCCCCC--HHHHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          240 PPFWG-----KTKSKIFDAVRAADLRFPSD-PWDHIS--ASARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       240 ~Pf~~-----~~~~~~~~~i~~~~~~~~~~-~~~~~s--~~l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                      +||.+     .+.+++.+-+-...++...+ .|...+  ..+..+++.||..||.-|.|+--|.+
T Consensus       434 ~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK  498 (513)
T KOG2052|consen  434 LPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK  498 (513)
T ss_pred             CCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence            78853     34455555444444443322 333222  34567999999999999999988865

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-32  Score=265.03  Aligned_cols=245  Identities=27%  Similarity=0.361  Sum_probs=192.7

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHcc-CCCCceeeeEEEEeCC----
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLS-GHPNVVDLKAVYEEED----  114 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-~hpnIv~l~~~~~~~~----  114 (419)
                      +.-.+.++||+|.||.||+|...  ++.||||++.      ....+.+.+|-+|.+... .|+||+++++.-....    
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp------~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~  281 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFP------EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRM  281 (534)
T ss_pred             CchhhHHHhhcCccceeehhhcc--CceeEEEecC------HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccc
Confidence            45567889999999999999754  6999999985      356788889998887543 5999999998865444    


Q ss_pred             EEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---------CCeeccCCCCcEEEeecCCCCCeEE
Q 014733          115 YVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGN---------GVVHRDLKPENILLATKSSSSPIKL  185 (419)
Q Consensus       115 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~---------~IvHrDLkp~NILl~~~~~~~~vKL  185 (419)
                      .+.||++|.+.|+|.++|.. ..+++.+..+++..+++||+|||+.         .|+|||||..||||   .++....|
T Consensus       282 eywLVt~fh~kGsL~dyL~~-ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLv---K~DlTccI  357 (534)
T KOG3653|consen  282 EYWLVTEFHPKGSLCDYLKA-NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLV---KNDLTCCI  357 (534)
T ss_pred             ceeEEeeeccCCcHHHHHHh-ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEE---ccCCcEEe
Confidence            78999999999999999987 5689999999999999999999963         59999999999999   66788999


Q ss_pred             eeccceeeeccCCc---cccccCCCccCCcccccCCCC-------CchhHHHHHHHHHHHHhC------------CCCCC
Q 014733          186 ADFGLATYIKAGQN---LHGTVGSPFYIAPEVLAGGYN-------QAADVWSAGVILYILLSG------------MPPFW  243 (419)
Q Consensus       186 ~DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~s-------~~sDvwSlGvil~elltG------------~~Pf~  243 (419)
                      +|||+|..+.++..   ..+.+||..|||||++.|..+       .+.||||+|.+||||++.            ++||.
T Consensus       358 aDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe  437 (534)
T KOG3653|consen  358 ADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFE  437 (534)
T ss_pred             eccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchh
Confidence            99999998876543   345799999999999988533       358999999999999973            23332


Q ss_pred             -----CCCHHHHHHHHHhc--CCCCCCCCCC-CCCHHHHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          244 -----GKTKSKIFDAVRAA--DLRFPSDPWD-HISASARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       244 -----~~~~~~~~~~i~~~--~~~~~~~~~~-~~s~~l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                           ..+.+++.+.+...  ...+|..... ..-..+++.+..||..||+.|+|+.=+-+
T Consensus       438 ~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~e  498 (534)
T KOG3653|consen  438 AEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEE  498 (534)
T ss_pred             HHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHH
Confidence                 12334444444332  2233332211 23356789999999999999999876643

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.98  E-value=1.2e-30  Score=235.47  Aligned_cols=211  Identities=45%  Similarity=0.748  Sum_probs=185.2

Q ss_pred             ecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEEeecCCCC
Q 014733           48 LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGE  127 (419)
Q Consensus        48 LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~ggs  127 (419)
                      ||.|++|.||++.+..+++.+++|++.......  ....+.+|+..++.++ |++|+++++++......++++|+++|++
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~~~~e~~~~~~   77 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLN-HPNIVKLYGVFEDENHLYLVMEYCEGGS   77 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcC-CCCeeeEeeeeecCCeEEEEEecCCCCc
Confidence            689999999999998889999999997653211  4578999999999996 9999999999999999999999999999


Q ss_pred             hHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC-ccccccC
Q 014733          128 LFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ-NLHGTVG  205 (419)
Q Consensus       128 L~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~-~~~~~~g  205 (419)
                      |.+++... ..+++..++.++.+++.+|.+||+.+++|+||+|.||+++..  ++.++|+|||.+....... ......+
T Consensus        78 l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~--~~~~~l~d~~~~~~~~~~~~~~~~~~~  155 (215)
T cd00180          78 LKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSD--NGKVKLADFGLSKLLTSDKSLLKTIVG  155 (215)
T ss_pred             HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCC--CCcEEEecCCceEEccCCcchhhcccC
Confidence            99999875 468999999999999999999999999999999999999431  5789999999998764432 1233567


Q ss_pred             CCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhc
Q 014733          206 SPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRV  283 (419)
Q Consensus       206 t~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~  283 (419)
                      ...|++||.+..  .++.+.|+|++|+++++|                                   ..+.+++.+|++.
T Consensus       156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------~~~~~~l~~~l~~  200 (215)
T cd00180         156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------PELKDLIRKMLQK  200 (215)
T ss_pred             CCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------HHHHHHHHHHhhC
Confidence            888999999876  578999999999999999                                   6789999999999


Q ss_pred             CCCCCCCHHHHHhcc
Q 014733          284 DPSTRLTAAEVLAHS  298 (419)
Q Consensus       284 dP~~Rps~~eil~hp  298 (419)
                      ||++||++.++++|+
T Consensus       201 ~p~~R~~~~~l~~~~  215 (215)
T cd00180         201 DPEKRPSAKEILEHL  215 (215)
T ss_pred             CcccCcCHHHHhhCC
Confidence            999999999999874

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=6.5e-32  Score=275.52  Aligned_cols=244  Identities=23%  Similarity=0.322  Sum_probs=206.9

Q ss_pred             eeeeeecccCceEEEEEEecCCC----cEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEE
Q 014733           43 VLGKQLGWGQFGVIRECSDKFTG----EVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHL  118 (419)
Q Consensus        43 ~i~~~LG~G~~g~V~~a~~~~~g----~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~l  118 (419)
                      +..++||.|+||+||+|.+--.|    -+||+|++....  ..+.-..+..|.-+|.+|. |||+++|++++.... +.|
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t--~~~~s~e~LdeAl~masld-Hpnl~RLLgvc~~s~-~ql  774 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT--SPKASIELLDEALRMASLD-HPNLLRLLGVCMLST-LQL  774 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeeccC--CchhhHHHHHHHHHHhcCC-CchHHHHhhhcccch-HHH
Confidence            44679999999999999875444    468999887653  4455678999999999996 999999999998776 889


Q ss_pred             EEeecCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccC
Q 014733          119 LMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG  197 (419)
Q Consensus       119 V~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~  197 (419)
                      |++|+++|.|.++++.+ +++-......|..||++||.|||++++|||||-..|||+   .+..++||.|||+++.....
T Consensus       775 vtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLV---ksP~hvkitdfgla~ll~~d  851 (1177)
T KOG1025|consen  775 VTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLV---KSPNHVKITDFGLAKLLAPD  851 (1177)
T ss_pred             HHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheee---cCCCeEEEEecchhhccCcc
Confidence            99999999999999764 458999999999999999999999999999999999999   56679999999999988765


Q ss_pred             Cccccc---cCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHH
Q 014733          198 QNLHGT---VGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISAS  272 (419)
Q Consensus       198 ~~~~~~---~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  272 (419)
                      ......   .-.+-|||-|.+.. .|+.++||||+||.+||++| |..|+.+....++-..++.+.- .+..+  ..+.+
T Consensus       852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR-LsqPp--iCtiD  928 (1177)
T KOG1025|consen  852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER-LSQPP--ICTID  928 (1177)
T ss_pred             cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc-CCCCC--CccHH
Confidence            443222   22345888887765 49999999999999999998 9999999999988888776653 44443  68899


Q ss_pred             HHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          273 ARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       273 l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                      +.-++.+||..|++.||+++++..
T Consensus       929 Vy~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  929 VYMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             HHHHHHHHhccCcccCccHHHHHH
Confidence            999999999999999999999864

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=7.2e-32  Score=245.58  Aligned_cols=259  Identities=25%  Similarity=0.373  Sum_probs=204.6

Q ss_pred             ccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEE-EEeCCE
Q 014733           37 NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAV-YEEEDY  115 (419)
Q Consensus        37 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~-~~~~~~  115 (419)
                      ++.+.|.|.+.||+|-||.+.+|.|+.+++.+++|.+.+.    ...++.|.+|..---.|+.|.||+.-|++ |+..+.
T Consensus        21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p----~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~   96 (378)
T KOG1345|consen   21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP----QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDA   96 (378)
T ss_pred             chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc----hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCce
Confidence            4788999999999999999999999999999999998754    34677888888776677789999998766 677888


Q ss_pred             EEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeec
Q 014733          116 VHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIK  195 (419)
Q Consensus       116 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~  195 (419)
                      +++++||++.|+|..-+.. ..+-|...+.++.|++.||.|+|++++||||||.+||||... +.-+|||||||+....+
T Consensus        97 YvF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~-df~rvKlcDFG~t~k~g  174 (378)
T KOG1345|consen   97 YVFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDA-DFYRVKLCDFGLTRKVG  174 (378)
T ss_pred             EEEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecC-CccEEEeeecccccccC
Confidence            9999999999999988876 447889999999999999999999999999999999999753 34489999999987543


Q ss_pred             cCCccccccCCCccCCcccccC----C--CCCchhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhcCCCCCCC
Q 014733          196 AGQNLHGTVGSPFYIAPEVLAG----G--YNQAADVWSAGVILYILLSGMPPFWGKTK-----SKIFDAVRAADLRFPSD  264 (419)
Q Consensus       196 ~~~~~~~~~gt~~y~aPE~l~~----~--~s~~sDvwSlGvil~elltG~~Pf~~~~~-----~~~~~~i~~~~~~~~~~  264 (419)
                      .--  ...--+..|.+||....    .  .++.+|+|.||+++|..+||.+||.....     -+...+....... .++
T Consensus       175 ~tV--~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~-~P~  251 (378)
T KOG1345|consen  175 TTV--KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPA-LPK  251 (378)
T ss_pred             cee--hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCcc-Cch
Confidence            211  11223556999998642    2  57899999999999999999999963211     1222222222222 233


Q ss_pred             CCCCCCHHHHHHHHhhhhcCCCCC---CCHHHHHhccccccch
Q 014733          265 PWDHISASARDLIMGMLRVDPSTR---LTAAEVLAHSWMEECE  304 (419)
Q Consensus       265 ~~~~~s~~l~~li~~~L~~dP~~R---ps~~eil~hp~~~~~~  304 (419)
                      ....+++.+..+.++-|..++++|   .++.......|.....
T Consensus       252 ~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~i  294 (378)
T KOG1345|consen  252 KFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKLI  294 (378)
T ss_pred             hhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhhh
Confidence            446789999999999999999999   5666666666765543

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=4.3e-30  Score=236.12  Aligned_cols=211  Identities=47%  Similarity=0.783  Sum_probs=182.3

Q ss_pred             eeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEEe
Q 014733           42 YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLME  121 (419)
Q Consensus        42 y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  121 (419)
                      |.+.+.||.|++|.||++.+..+++.+++|.+......  .....+.+|++.++++. |+|++++++.+......++++|
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~-~~~i~~~~~~~~~~~~~~~v~e   77 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLK-HPNIVKLYGVFEDPEPLYLVME   77 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCC-CCChhhheeeeecCCceEEEEe
Confidence            67889999999999999999988999999999865422  35678999999999995 9999999999999999999999


Q ss_pred             ecCCCChHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC--
Q 014733          122 LCAGGELFHRLEKYGR-FSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ--  198 (419)
Q Consensus       122 ~~~ggsL~~~l~~~~~-l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~--  198 (419)
                      ++++++|.+++..... +++..+..++.+++.+|.+||+.+++|+||+|.||++   +.++.++|+|||.+.......  
T Consensus        78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v---~~~~~~~l~d~g~~~~~~~~~~~  154 (225)
T smart00221       78 YCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILL---GMDGLVKLADFGLARFIHRDLAA  154 (225)
T ss_pred             ccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeeCceeeEecCcccc
Confidence            9999999999988766 8999999999999999999999999999999999999   455899999999998775543  


Q ss_pred             ccccccCCCccCCcccc-cC-CCCCchhHHHHHHHHHHHHhCCCCCCC--CCHHHHHHHHHhcC
Q 014733          199 NLHGTVGSPFYIAPEVL-AG-GYNQAADVWSAGVILYILLSGMPPFWG--KTKSKIFDAVRAAD  258 (419)
Q Consensus       199 ~~~~~~gt~~y~aPE~l-~~-~~s~~sDvwSlGvil~elltG~~Pf~~--~~~~~~~~~i~~~~  258 (419)
                      ......++..|++||.+ .. .++.++|+|+||+++++|++|+.||..  .....+.+.+..+.
T Consensus       155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~  218 (225)
T smart00221      155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGV  218 (225)
T ss_pred             cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCC
Confidence            33445788889999997 33 378899999999999999999999977  34446666665553

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.97  E-value=7.2e-31  Score=286.24  Aligned_cols=197  Identities=20%  Similarity=0.284  Sum_probs=148.1

Q ss_pred             CCceeeeEEE-------EeCCEEEEEEeecCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcE
Q 014733          101 PNVVDLKAVY-------EEEDYVHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENI  172 (419)
Q Consensus       101 pnIv~l~~~~-------~~~~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NI  172 (419)
                      +||+++++++       .....++.++|++ +++|.+++... ..+++.+++.++.||++||+|||++||+||||||+||
T Consensus        33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~Ni  111 (793)
T PLN00181         33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCF  111 (793)
T ss_pred             HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhE
Confidence            5777777776       2335678889988 67999999753 4599999999999999999999999999999999999


Q ss_pred             EEeec----------------CCCCCeEEeeccceeeeccCC-----------------ccccccCCCccCCcccccC-C
Q 014733          173 LLATK----------------SSSSPIKLADFGLATYIKAGQ-----------------NLHGTVGSPFYIAPEVLAG-G  218 (419)
Q Consensus       173 Ll~~~----------------~~~~~vKL~DFgla~~~~~~~-----------------~~~~~~gt~~y~aPE~l~~-~  218 (419)
                      ||+..                +.++.+||+|||+++......                 .....+||+.|+|||++.+ .
T Consensus       112 Ll~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~  191 (793)
T PLN00181        112 VMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSS  191 (793)
T ss_pred             EEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCC
Confidence            99431                234567888888776422100                 0112368999999999876 4


Q ss_pred             CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhcc
Q 014733          219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHS  298 (419)
Q Consensus       219 ~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp  298 (419)
                      |+.++|||||||+||||++|.+|+....  .....+.....  +... .....+..+++.+||++||.+||++.|+++||
T Consensus       192 ~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~  266 (793)
T PLN00181        192 SNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVL--PPQI-LLNWPKEASFCLWLLHPEPSCRPSMSELLQSE  266 (793)
T ss_pred             CCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhc--Chhh-hhcCHHHHHHHHHhCCCChhhCcChHHHhhch
Confidence            9999999999999999999999975422  22222222211  1111 12245678999999999999999999999999


Q ss_pred             ccccc
Q 014733          299 WMEEC  303 (419)
Q Consensus       299 ~~~~~  303 (419)
                      ||...
T Consensus       267 ~~~~~  271 (793)
T PLN00181        267 FINEP  271 (793)
T ss_pred             hhhhh
Confidence            99764

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.5e-30  Score=261.33  Aligned_cols=244  Identities=30%  Similarity=0.477  Sum_probs=214.1

Q ss_pred             eecccCceEEEEEEe---cCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEEeec
Q 014733           47 QLGWGQFGVIRECSD---KFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELC  123 (419)
Q Consensus        47 ~LG~G~~g~V~~a~~---~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~  123 (419)
                      .+|.|+||.|++++.   ...|..+|+|+..+......... ....|..++...++||.+|+++..++.++..++++++.
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~   79 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL   79 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence            378999999987653   35678899999988776544433 66778899999988999999999999999999999999


Q ss_pred             CCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCCccccc
Q 014733          124 AGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT  203 (419)
Q Consensus       124 ~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~~~~~~  203 (419)
                      .||.|+..+.....+++.....+...++-+++++|+.+|+|||+|++||++   +.+|++|+.|||+++..-..+.   .
T Consensus        80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enill---d~~Ghi~~tdfglske~v~~~~---~  153 (612)
T KOG0603|consen   80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLL---LLEGHIKLTDFGLSKEAVKEKI---A  153 (612)
T ss_pred             ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceee---cccCccccCCchhhhHhHhhhh---c
Confidence            999999999888889999999999999999999999999999999999999   6789999999999986543332   2


Q ss_pred             cCCCccCCcccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhc
Q 014733          204 VGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRV  283 (419)
Q Consensus       204 ~gt~~y~aPE~l~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~  283 (419)
                      |||..|||||++. +...++|+||+|+++++|++|..||.+    ++...|....+..|.    .++.++++++..++..
T Consensus       154 cgt~eymApEI~~-gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~----~l~~~a~~~~~~l~~r  224 (612)
T KOG0603|consen  154 CGTYEYRAPEIIN-GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPR----ELSAEARSLFRQLFKR  224 (612)
T ss_pred             ccchhhhhhHhhh-ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCch----hhhHHHHHHHHHHHhh
Confidence            9999999999998 668899999999999999999999987    777777777777665    6789999999999999


Q ss_pred             CCCCCCC-----HHHHHhccccccchhh
Q 014733          284 DPSTRLT-----AAEVLAHSWMEECEQV  306 (419)
Q Consensus       284 dP~~Rps-----~~eil~hp~~~~~~~~  306 (419)
                      +|..|.-     +.++++|+||+.+.+.
T Consensus       225 ~p~nrLg~~~~~~~eik~h~f~~~i~~~  252 (612)
T KOG0603|consen  225 NPENRLGAGPDGVDEIKQHEFFQSIDWN  252 (612)
T ss_pred             CHHHHhccCcchhHHHhccchheeeeHh
Confidence            9999994     5899999999998876

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.96  E-value=2.7e-28  Score=231.91  Aligned_cols=255  Identities=19%  Similarity=0.260  Sum_probs=207.7

Q ss_pred             hhccccccCeeeeeeecccCceEEEEEEecCCC-----cEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeee
Q 014733           33 TQISNLSDRYVLGKQLGWGQFGVIRECSDKFTG-----EVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLK  107 (419)
Q Consensus        33 ~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g-----~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~  107 (419)
                      .++.....|+++...+-+|.||.||.|.++...     +.|.+|.++..  .++-++..+..|.-.+..+. |||+..+.
T Consensus       277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~s-H~nll~V~  353 (563)
T KOG1024|consen  277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGAS-HPNLLSVL  353 (563)
T ss_pred             HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcCc-CCCcccee
Confidence            344455678999999999999999999766433     34666665433  45566778888999999996 99999999


Q ss_pred             EEEE-eCCEEEEEEeecCCCChHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecC
Q 014733          108 AVYE-EEDYVHLLMELCAGGELFHRLEKY--------GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKS  178 (419)
Q Consensus       108 ~~~~-~~~~~~lV~E~~~ggsL~~~l~~~--------~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~  178 (419)
                      ++.. +....++++.+..-|+|..++...        ..++..+...++.|++.|++|||++||||.||-..|.+|   +
T Consensus       354 ~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvI---d  430 (563)
T KOG1024|consen  354 GVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVI---D  430 (563)
T ss_pred             EEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhccee---h
Confidence            9885 456788899999999999998722        126777888999999999999999999999999999999   4


Q ss_pred             CCCCeEEeeccceeeeccCCcc---ccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 014733          179 SSSPIKLADFGLATYIKAGQNL---HGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDA  253 (419)
Q Consensus       179 ~~~~vKL~DFgla~~~~~~~~~---~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~  253 (419)
                      +.-.|||+|=.+++.+-+..-+   .+.-....||+||.+.+. |+.++|+|||||+||||+| |+.||..-++.++...
T Consensus       431 d~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~y  510 (563)
T KOG1024|consen  431 DQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHY  510 (563)
T ss_pred             hheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHH
Confidence            5678999999999876443321   112234459999999875 9999999999999999998 9999999999888887


Q ss_pred             HHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          254 VRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       254 i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                      ++.+ ++...+  .+.|+++-.++--||..+|++||++.|+..
T Consensus       511 lkdG-yRlaQP--~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  511 LKDG-YRLAQP--FNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             Hhcc-ceecCC--CCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence            7665 444433  389999999999999999999999999864

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=1.3e-28  Score=230.03  Aligned_cols=249  Identities=20%  Similarity=0.322  Sum_probs=197.3

Q ss_pred             ccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEE
Q 014733           37 NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYV  116 (419)
Q Consensus        37 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~  116 (419)
                      ..+-.|+++++||+|.||+++.|.+..+++.||||.-..+     ...-+++.|....+.|.+.++|..+|.+..+..+-
T Consensus        25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk-----S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~N   99 (449)
T KOG1165|consen   25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK-----SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYN   99 (449)
T ss_pred             EecccceeccccccCcceeeecccccccCceEEEEecccc-----CCcchHHHHHHHHHHHcCCCCCCceeeeccccchh
Confidence            4567899999999999999999999999999999976544     34567888999999999999999999999999999


Q ss_pred             EEEEeecCCCChHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCC--CCCeEEeeccceee
Q 014733          117 HLLMELCAGGELFHRLEKYGR-FSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSS--SSPIKLADFGLATY  193 (419)
Q Consensus       117 ~lV~E~~~ggsL~~~l~~~~~-l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~--~~~vKL~DFgla~~  193 (419)
                      .||+|++ |.+|.++..-.++ |+...+..++.|++.-++|+|++.+|+|||||+|+||...+.  ...|.|+|||+|+.
T Consensus       100 iLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~  178 (449)
T KOG1165|consen  100 ILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE  178 (449)
T ss_pred             hhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence            9999999 9999999987665 999999999999999999999999999999999999965432  23689999999998


Q ss_pred             eccCCc--------cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC
Q 014733          194 IKAGQN--------LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSD  264 (419)
Q Consensus       194 ~~~~~~--------~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~  264 (419)
                      +.+...        ..+..||..||+-..-.|. -+.+.|+-|||.+++.++.|..||.+.......++.+.........
T Consensus       179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T  258 (449)
T KOG1165|consen  179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRST  258 (449)
T ss_pred             hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccC
Confidence            876543        3455799999998876664 7899999999999999999999998876554444433322111111


Q ss_pred             ----CCCCCCHHHHHHHHhhhhcCCCCCCCH
Q 014733          265 ----PWDHISASARDLIMGMLRVDPSTRLTA  291 (419)
Q Consensus       265 ----~~~~~s~~l~~li~~~L~~dP~~Rps~  291 (419)
                          ...++|.++..-++-.-+.+=.+-|.-
T Consensus       259 ~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDY  289 (449)
T KOG1165|consen  259 PIEVLCEGFPEEFATYLRYVRRLDFFETPDY  289 (449)
T ss_pred             CHHHHHhcCHHHHHHHHHHHHhcCcccCCCH
Confidence                123455555555554444444444433

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=4.8e-28  Score=215.74  Aligned_cols=162  Identities=27%  Similarity=0.335  Sum_probs=128.4

Q ss_pred             CChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCCcccccc
Q 014733          126 GELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTV  204 (419)
Q Consensus       126 gsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~~~~~~~  204 (419)
                      |+|.+++... .++++.+++.++.|++.||.|||+.+      ||+|||+   +.++.+|+  ||++.......    ..
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~---~~~~~~~~--fG~~~~~~~~~----~~   65 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILL---TWDGLLKL--DGSVAFKTPEQ----SR   65 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeE---cCccceee--ccceEeecccc----CC
Confidence            6899999864 45999999999999999999999998      9999999   56778898  99998754422    36


Q ss_pred             CCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhcCCCC-CC--CCCCCCCH--HHHHHH
Q 014733          205 GSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTK-SKIFDAVRAADLRF-PS--DPWDHISA--SARDLI  277 (419)
Q Consensus       205 gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~-~~~~~~i~~~~~~~-~~--~~~~~~s~--~l~~li  277 (419)
                      ||+.|+|||++.+. |+.++|||||||++|||++|+.||..... ......+....... +.  .....++.  ++.++|
T Consensus        66 g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  145 (176)
T smart00750       66 VDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFM  145 (176)
T ss_pred             CcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHH
Confidence            89999999998774 89999999999999999999999976433 23333332221111 11  11123334  699999


Q ss_pred             HhhhhcCCCCCCCHHHHHhcccccc
Q 014733          278 MGMLRVDPSTRLTAAEVLAHSWMEE  302 (419)
Q Consensus       278 ~~~L~~dP~~Rps~~eil~hp~~~~  302 (419)
                      .+||..||++||++.++++|+|+..
T Consensus       146 ~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      146 RVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             HHHHhcccccccCHHHHHHHHHHHH
Confidence            9999999999999999999999864

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.95  E-value=4.5e-26  Score=217.63  Aligned_cols=255  Identities=36%  Similarity=0.607  Sum_probs=211.2

Q ss_pred             eeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCC-CceeeeEEEEeCCEEEEEE
Q 014733           42 YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP-NVVDLKAVYEEEDYVHLLM  120 (419)
Q Consensus        42 y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hp-nIv~l~~~~~~~~~~~lV~  120 (419)
                      |.+.+.||.|+|+.||++.+.   ..+++|.+.............+.+|+.+++.+. |+ +|+++.+.+......++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~   77 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLN-HPPNIVKLYDFFQDEGSLYLVM   77 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHcc-CCcceeeEEEEEecCCEEEEEE
Confidence            888999999999999999987   788999998775544446788999999999997 66 7999999998888889999


Q ss_pred             eecCCCChHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCC-CeEEeeccceeeecc
Q 014733          121 ELCAGGELFHRLEKYG---RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSS-PIKLADFGLATYIKA  196 (419)
Q Consensus       121 E~~~ggsL~~~l~~~~---~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~-~vKL~DFgla~~~~~  196 (419)
                      +++.++++.+.+....   .+.+.....++.|++.++.|+|+.+++|||+||+||+++   ..+ .++++|||.+.....
T Consensus        78 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~---~~~~~~~l~dfg~~~~~~~  154 (384)
T COG0515          78 EYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLD---RDGRVVKLIDFGLAKLLPD  154 (384)
T ss_pred             ecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeec---CCCCeEEEeccCcceecCC
Confidence            9999999997777664   799999999999999999999999999999999999994   444 699999999986544


Q ss_pred             CC-------ccccccCCCccCCcccccC----CCCCchhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhcCCC-
Q 014733          197 GQ-------NLHGTVGSPFYIAPEVLAG----GYNQAADVWSAGVILYILLSGMPPFWGKT----KSKIFDAVRAADLR-  260 (419)
Q Consensus       197 ~~-------~~~~~~gt~~y~aPE~l~~----~~s~~sDvwSlGvil~elltG~~Pf~~~~----~~~~~~~i~~~~~~-  260 (419)
                      ..       ......||..|+|||.+.+    .++...|+||+|++++++++|..||....    .......+...... 
T Consensus       155 ~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  234 (384)
T COG0515         155 PGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS  234 (384)
T ss_pred             CCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcc
Confidence            33       2355689999999999875    47899999999999999999999987665    35555555555443 


Q ss_pred             CCCCCCCCC----CHHHHHHHHhhhhcCCCCCCCHHHHHhccccccc
Q 014733          261 FPSDPWDHI----SASARDLIMGMLRVDPSTRLTAAEVLAHSWMEEC  303 (419)
Q Consensus       261 ~~~~~~~~~----s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~  303 (419)
                      .........    ...+.+++..++..+|..|.+..+...++|....
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~  281 (384)
T COG0515         235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL  281 (384)
T ss_pred             cccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence            222221122    2578999999999999999999999988666543

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=3.1e-29  Score=262.08  Aligned_cols=261  Identities=31%  Similarity=0.507  Sum_probs=206.0

Q ss_pred             ccCe-eeeeeecccCceEEEEEEecCCCcEEEEEEeccC--ccCCH-HhHHHHHHHHHHHHHccCCCCceeeeEEEEeCC
Q 014733           39 SDRY-VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKD--RLVTV-EDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEED  114 (419)
Q Consensus        39 ~~~y-~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~--~~~~~-~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~  114 (419)
                      .+.| .-...+|.|++|.|+.+......+.++.|.+...  ..... +....+..|.-+-..|. |||++.....+.+..
T Consensus       316 ~~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~-h~~~~e~l~~~~~~~  394 (601)
T KOG0590|consen  316 SEKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLS-HPNIIETLDIVQEID  394 (601)
T ss_pred             ccccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeeccccc-CCchhhhHHHHhhcc
Confidence            3445 4577899999999988888777777777766532  11122 22233677777778886 999988877777666


Q ss_pred             EEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeee
Q 014733          115 YVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI  194 (419)
Q Consensus       115 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~  194 (419)
                      ..+-.||||++ +|+.++...+.++..++..++.||+.||+|+|+.||.|||+|++|+++   ..+|.+||+|||.+...
T Consensus       395 ~~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~---~~~g~lki~Dfg~~~vf  470 (601)
T KOG0590|consen  395 GILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLV---TENGILKIIDFGAASVF  470 (601)
T ss_pred             cchhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEE---ecCCceEEeecCcceee
Confidence            56666999999 999999987799999999999999999999999999999999999999   56779999999998876


Q ss_pred             ccCCc-----cccccCCCccCCcccccCC-CC-CchhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHH---HhcCCCCC
Q 014733          195 KAGQN-----LHGTVGSPFYIAPEVLAGG-YN-QAADVWSAGVILYILLSGMPPFWGKTKSKIF--DAV---RAADLRFP  262 (419)
Q Consensus       195 ~~~~~-----~~~~~gt~~y~aPE~l~~~-~s-~~sDvwSlGvil~elltG~~Pf~~~~~~~~~--~~i---~~~~~~~~  262 (419)
                      .-...     ..+.+|+..|+|||++.+. |+ ...||||.|+++..|.+|+.||......+..  ...   ......-+
T Consensus       471 ~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~  550 (601)
T KOG0590|consen  471 RYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGP  550 (601)
T ss_pred             ccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccCh
Confidence            54332     3567899999999999875 76 4689999999999999999999655443221  111   11111223


Q ss_pred             CCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccch
Q 014733          263 SDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECE  304 (419)
Q Consensus       263 ~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~  304 (419)
                      ...+..++.+.+.+|.+||++||.+|.|+++|++.+||+.+.
T Consensus       551 ~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~  592 (601)
T KOG0590|consen  551 NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE  592 (601)
T ss_pred             HHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence            334567899999999999999999999999999999999765

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=2.2e-25  Score=218.46  Aligned_cols=253  Identities=26%  Similarity=0.302  Sum_probs=197.3

Q ss_pred             CeeeeeeecccCceEEEEEEecCCC-cEEEEEEeccCccCCHHhHHHHHHHHHHHHHcc---CCCCceeeeEEE-EeCCE
Q 014733           41 RYVLGKQLGWGQFGVIRECSDKFTG-EVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLS---GHPNVVDLKAVY-EEEDY  115 (419)
Q Consensus        41 ~y~i~~~LG~G~~g~V~~a~~~~~g-~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~---~hpnIv~l~~~~-~~~~~  115 (419)
                      +|++.++||+|+||.||.+.+..++ ..+|+|........   ....+..|..++..+.   +.+++..+++.+ .....
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~---~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~   95 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGS---KPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF   95 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccC---CCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence            8999999999999999999988664 67898887654221   1126788999999986   246999999999 58888


Q ss_pred             EEEEEeecCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCC--CCeEEeeccce
Q 014733          116 VHLLMELCAGGELFHRLEKY--GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSS--SPIKLADFGLA  191 (419)
Q Consensus       116 ~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~--~~vKL~DFgla  191 (419)
                      .++||+.+ |.+|.++....  +.++...+..++.|++.+|++||+.|++||||||+|+++......  ..+.|.|||++
T Consensus        96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            99999998 89999988654  469999999999999999999999999999999999999654312  57999999999


Q ss_pred             eeec--cCC--------c-cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC
Q 014733          192 TYIK--AGQ--------N-LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADL  259 (419)
Q Consensus       192 ~~~~--~~~--------~-~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~  259 (419)
                      +...  ...        . .....||..|+++++..+. .+.+.|+||++.++.+|+.|..||...........+.....
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~  254 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR  254 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence            8322  111        1 2234699999999987774 89999999999999999999999976554333333322222


Q ss_pred             CCCCC-CCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          260 RFPSD-PWDHISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       260 ~~~~~-~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      ..... .....+.++.++...+-..+...+|....+...
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  255 KLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL  293 (322)
T ss_pred             hhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence            22221 223456788888888888899999988888654

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=3e-26  Score=225.93  Aligned_cols=182  Identities=22%  Similarity=0.246  Sum_probs=140.8

Q ss_pred             cchhhccccccCeeeeeeecccCceEEEEEEecC-CCcEEEEEEeccCcc--CCHHhHHHHHHHHHHHHHccCCCCcee-
Q 014733           30 LDATQISNLSDRYVLGKQLGWGQFGVIRECSDKF-TGEVLACKSIAKDRL--VTVEDVRSIKLEIEIMTKLSGHPNVVD-  105 (419)
Q Consensus        30 ~~~~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~-~g~~vaiK~i~~~~~--~~~~~~~~~~~Ei~il~~l~~hpnIv~-  105 (419)
                      +..++...+.++|.+.+.||+|+||+||+|+++. +++.+|+|++.....  ........+.+|+++|+++. |+||+. 
T Consensus         8 ~~~~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~-h~~iv~~   86 (365)
T PRK09188          8 LPGDQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVR-GIGVVPQ   86 (365)
T ss_pred             CcccccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhcc-CCCCCcE
Confidence            4566778899999999999999999999999876 678889998753311  12334667999999999996 999985 


Q ss_pred             eeEEEEeCCEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccC-CCCcEEEeecCCCCCeE
Q 014733          106 LKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDL-KPENILLATKSSSSPIK  184 (419)
Q Consensus       106 l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDL-kp~NILl~~~~~~~~vK  184 (419)
                      +++    .+..|+||||++|++|.. +.   ...   ...++.+++++|.|||+.||+|||| ||+|||+   +.++.+|
T Consensus        87 l~~----~~~~~LVmE~~~G~~L~~-~~---~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv---~~~~~ik  152 (365)
T PRK09188         87 LLA----TGKDGLVRGWTEGVPLHL-AR---PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLM---GPDGEAA  152 (365)
T ss_pred             EEE----cCCcEEEEEccCCCCHHH-hC---ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEE---cCCCCEE
Confidence            443    245799999999999963 21   111   1467889999999999999999999 9999999   4567899


Q ss_pred             EeeccceeeeccCCc---------cccccCCCccCCcccccCC-------CCCchhHH
Q 014733          185 LADFGLATYIKAGQN---------LHGTVGSPFYIAPEVLAGG-------YNQAADVW  226 (419)
Q Consensus       185 L~DFgla~~~~~~~~---------~~~~~gt~~y~aPE~l~~~-------~s~~sDvw  226 (419)
                      |+|||+++.+.....         .....+++.|.|||++...       .+...|-|
T Consensus       153 LiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW  210 (365)
T PRK09188        153 VIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW  210 (365)
T ss_pred             EEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence            999999997654321         1234688889999998531       34556766

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=9.6e-26  Score=202.64  Aligned_cols=249  Identities=20%  Similarity=0.299  Sum_probs=202.9

Q ss_pred             cccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEE
Q 014733           38 LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVH  117 (419)
Q Consensus        38 ~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~  117 (419)
                      ..+.|+++++||.|+||.+|+|..-.+|+.||||+-..+.     ...++..|.++.+.|++...|..+..+..+..+-.
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-----~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynv   87 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-----KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNV   87 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-----CCcchhHHHHHHHHhccCCCCchhhhhccccccce
Confidence            4689999999999999999999999999999999865432     23456779999999998899999999999999999


Q ss_pred             EEEeecCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeecc
Q 014733          118 LLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA  196 (419)
Q Consensus       118 lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~  196 (419)
                      +||+++ |.+|.++..-. .+|+...+..++-|++.-++|+|.++.|||||||+|+|+.-+..-..+.|+|||+++.+.+
T Consensus        88 lVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d  166 (341)
T KOG1163|consen   88 LVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD  166 (341)
T ss_pred             eeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence            999998 99999998765 4599999999999999999999999999999999999997655556899999999997754


Q ss_pred             CCc--------cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhcCCCCCCC
Q 014733          197 GQN--------LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTK---SKIFDAVRAADLRFPSD  264 (419)
Q Consensus       197 ~~~--------~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~---~~~~~~i~~~~~~~~~~  264 (419)
                      ..+        .....||..|.+-....+. -+.+.|+-|+|.+|..+..|..||.+...   .+-.++|.+.....+..
T Consensus       167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie  246 (341)
T KOG1163|consen  167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIE  246 (341)
T ss_pred             ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHH
Confidence            322        2344799999988776653 68899999999999999999999987644   44555665554444332


Q ss_pred             -CCCCCCHHHHHHHHhhhhcCCCCCCCHH
Q 014733          265 -PWDHISASARDLIMGMLRVDPSTRLTAA  292 (419)
Q Consensus       265 -~~~~~s~~l~~li~~~L~~dP~~Rps~~  292 (419)
                       ....+|.++.-.+.-|-..-=++-|.-.
T Consensus       247 ~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~  275 (341)
T KOG1163|consen  247 VLCKGFPAEFAMYLNYCRGLGFEEKPDYM  275 (341)
T ss_pred             HHhCCCcHHHHHHHHHHhhcCCCCCCcHH
Confidence             3457788888888877766655666443

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.93  E-value=2.7e-26  Score=240.97  Aligned_cols=228  Identities=35%  Similarity=0.572  Sum_probs=184.1

Q ss_pred             hccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeC
Q 014733           34 QISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEE  113 (419)
Q Consensus        34 ~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~  113 (419)
                      ......++|..++.|..|+||-||+.+|+.+.+.+|+| +.++.+.-        +.  ++... +.|.+|         
T Consensus        77 ~~~p~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~lil--------Rn--ilt~a-~npfvv---------  135 (1205)
T KOG0606|consen   77 RRAPSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLIL--------RN--ILTFA-GNPFVV---------  135 (1205)
T ss_pred             ccCCCccccceeEeeccCCCCceeeeeccccccchhhc-ccccchhh--------hc--ccccc-CCccee---------
Confidence            45556789999999999999999999999999999994 55443311        10  34333 366665         


Q ss_pred             CEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceee
Q 014733          114 DYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATY  193 (419)
Q Consensus       114 ~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~  193 (419)
                                  |+=...++..++++...        +.+++|||+.||+|||+||+|++|   ..-|++|++|||+.+.
T Consensus       136 ------------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllI---T~mGhiKlTDfgLsk~  192 (1205)
T KOG0606|consen  136 ------------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLI---TSMGHIKLTDFGLSKK  192 (1205)
T ss_pred             ------------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCccee---eecccccccchhhhhh
Confidence                        33344444445555443        778999999999999999999999   5678999999998874


Q ss_pred             eccCC----------------ccccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 014733          194 IKAGQ----------------NLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRA  256 (419)
Q Consensus       194 ~~~~~----------------~~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~  256 (419)
                      .....                .....||||.|+|||++.. +|+..+|+|++|+|+||++.|..||.+.+.++++..+..
T Consensus       193 GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vis  272 (1205)
T KOG0606|consen  193 GLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS  272 (1205)
T ss_pred             hhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhh
Confidence            32110                0123489999999998754 699999999999999999999999999999999999988


Q ss_pred             cCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCC---CHHHHHhccccccchhh
Q 014733          257 ADLRFPSDPWDHISASARDLIMGMLRVDPSTRL---TAAEVLAHSWMEECEQV  306 (419)
Q Consensus       257 ~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp---s~~eil~hp~~~~~~~~  306 (419)
                      ....++... ..++++++++|.++|+.+|..|.   .+-++.+|+||+.+++.
T Consensus       273 d~i~wpE~d-ea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~  324 (1205)
T KOG0606|consen  273 DDIEWPEED-EALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK  324 (1205)
T ss_pred             hhccccccC-cCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence            888888774 47889999999999999999998   67788999999999876

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.91  E-value=2e-24  Score=204.86  Aligned_cols=234  Identities=24%  Similarity=0.339  Sum_probs=156.4

Q ss_pred             CeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccC---------CCCceeeeEEEE
Q 014733           41 RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG---------HPNVVDLKAVYE  111 (419)
Q Consensus        41 ~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~---------hpnIv~l~~~~~  111 (419)
                      ....++.||.|+++.||.++|..||+.+|+|++..........++++++|.-....+.+         |-.++.-++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            45668899999999999999999999999999987765566678888888766555432         222333333321


Q ss_pred             ---------e---CC-----EEEEEEeecCCCChHHHHH---HcCC----CCHHHHHHHHHHHHHHHHHHHhCCCeeccC
Q 014733          112 ---------E---ED-----YVHLLMELCAGGELFHRLE---KYGR----FSETEARVIFRHLMQVVSYCHGNGVVHRDL  167 (419)
Q Consensus       112 ---------~---~~-----~~~lV~E~~~ggsL~~~l~---~~~~----l~~~~~~~i~~qll~aL~~LH~~~IvHrDL  167 (419)
                               .   .+     +.+++|+-+ .++|..++.   ....    +.......+..|+++.+++||+.|+||+||
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi  171 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI  171 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred             EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence                     1   11     235677777 568877754   2222    223334456689999999999999999999


Q ss_pred             CCCcEEEeecCCCCCeEEeeccceeeeccCCccccccCCCccCCcccccC---------CCCCchhHHHHHHHHHHHHhC
Q 014733          168 KPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG---------GYNQAADVWSAGVILYILLSG  238 (419)
Q Consensus       168 kp~NILl~~~~~~~~vKL~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~---------~~s~~sDvwSlGvil~elltG  238 (419)
                      ||+|+++   +.+|.++|+||+.....+.....  ...+..|.+||....         .++.+.|.|+||+++|.|++|
T Consensus       172 ~~~nfll---~~~G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~  246 (288)
T PF14531_consen  172 KPENFLL---DQDGGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG  246 (288)
T ss_dssp             SGGGEEE----TTS-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred             ceeeEEE---cCCCCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence            9999999   67899999999988764433221  344577999997532         278899999999999999999


Q ss_pred             CCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCC
Q 014733          239 MPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTR  288 (419)
Q Consensus       239 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~R  288 (419)
                      ..||...........        ......++++.+++||..||++||.+|
T Consensus       247 ~lPf~~~~~~~~~~~--------~f~~C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  247 RLPFGLSSPEADPEW--------DFSRCRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             S-STCCCGGGSTSGG--------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred             cCCCCCCCccccccc--------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence            999976543221111        112223789999999999999999988

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.90  E-value=3.7e-23  Score=187.37  Aligned_cols=142  Identities=18%  Similarity=0.189  Sum_probs=111.7

Q ss_pred             eeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHh-----------------------HHHHHHHHHHHHHccCCC
Q 014733           45 GKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVED-----------------------VRSIKLEIEIMTKLSGHP  101 (419)
Q Consensus        45 ~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~-----------------------~~~~~~Ei~il~~l~~hp  101 (419)
                      .+.||+|++|.||+|.+. +|+.||+|+++.........                       ......|+.++.++. ++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~   79 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLV-TA   79 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHH-HC
Confidence            568999999999999987 89999999997653211110                       122345999999996 77


Q ss_pred             CceeeeEEEEeCCEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHH-HhCCCeeccCCCCcEEEeecCCC
Q 014733          102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYC-HGNGVVHRDLKPENILLATKSSS  180 (419)
Q Consensus       102 nIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~L-H~~~IvHrDLkp~NILl~~~~~~  180 (419)
                      ++.....+... + .++||||++|+++.......+.+++..+..++.|++.+|.++ |+.||+||||||+|||++    +
T Consensus        80 ~v~~p~~~~~~-~-~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~----~  153 (190)
T cd05147          80 GIPCPEPILLK-S-HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH----D  153 (190)
T ss_pred             CCCCCcEEEec-C-CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE----C
Confidence            77544333222 2 379999999887766544457899999999999999999999 799999999999999995    3


Q ss_pred             CCeEEeeccceeee
Q 014733          181 SPIKLADFGLATYI  194 (419)
Q Consensus       181 ~~vKL~DFgla~~~  194 (419)
                      +.++|+|||++...
T Consensus       154 ~~v~LiDFG~a~~~  167 (190)
T cd05147         154 GKLYIIDVSQSVEH  167 (190)
T ss_pred             CcEEEEEccccccC
Confidence            57999999999854

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.90  E-value=3e-23  Score=191.30  Aligned_cols=174  Identities=16%  Similarity=0.098  Sum_probs=134.5

Q ss_pred             ccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHH------HHHHHHHHHHccCCCCceeeeEEE
Q 014733           37 NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRS------IKLEIEIMTKLSGHPNVVDLKAVY  110 (419)
Q Consensus        37 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~------~~~Ei~il~~l~~hpnIv~l~~~~  110 (419)
                      -+.++|++.+.||.|+||.||++.+  ++..+|+|++..+....+.....      +.+|+..+.++. |++|..+.+++
T Consensus        28 ~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~-~~GI~~~~d~~  104 (232)
T PRK10359         28 FLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVR-SEGLASLNDFY  104 (232)
T ss_pred             HhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHH-HCCCCcceEee
Confidence            3689999999999999999999755  46689999997665444444344      578999999995 99999999887


Q ss_pred             EeC--------CEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCC
Q 014733          111 EEE--------DYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSP  182 (419)
Q Consensus       111 ~~~--------~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~  182 (419)
                      .+.        +..+++|||++|.+|.++..    +++    ....+++++|..||+.|++|||+||+||+++   .++ 
T Consensus       105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~---~~g-  172 (232)
T PRK10359        105 LLAERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVS---KNG-  172 (232)
T ss_pred             eecccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEe---CCC-
Confidence            643        35789999999999977632    333    2456999999999999999999999999994   455 


Q ss_pred             eEEeeccceeeeccCCccccccCCCccCCcccc-cCCCCCchhHHHHHHHHHHHH
Q 014733          183 IKLADFGLATYIKAGQNLHGTVGSPFYIAPEVL-AGGYNQAADVWSAGVILYILL  236 (419)
Q Consensus       183 vKL~DFgla~~~~~~~~~~~~~gt~~y~aPE~l-~~~~s~~sDvwSlGvil~ell  236 (419)
                      ++|+|||.............           ++ ...|+.++|+|+||+.+..+.
T Consensus       173 i~liDfg~~~~~~e~~a~d~-----------~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        173 LRIIDLSGKRCTAQRKAKDR-----------IDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEEEECCCcccccchhhHHH-----------HHHHhHhcccccccceeEeehHHH
Confidence            99999998875432221110           22 224778999999999877654

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=4.4e-22  Score=180.20  Aligned_cols=188  Identities=19%  Similarity=0.221  Sum_probs=142.0

Q ss_pred             eeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHH-hHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEEe
Q 014733           43 VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVE-DVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLME  121 (419)
Q Consensus        43 ~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~-~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  121 (419)
                      .+...|++|+||+|+++..  .+..++.+.+......... ....+.+|+++|++|.+|++|++++++    +..+++||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme   78 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS   78 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence            4678899999999997765  5677777766543321111 123578999999999867899999886    34689999


Q ss_pred             ecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccC-CCCcEEEeecCCCCCeEEeeccceeeeccCCcc
Q 014733          122 LCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDL-KPENILLATKSSSSPIKLADFGLATYIKAGQNL  200 (419)
Q Consensus       122 ~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDL-kp~NILl~~~~~~~~vKL~DFgla~~~~~~~~~  200 (419)
                      |+.|.+|.+.+..       ....++.|++++|+++|+.||+|||| ||+|||+   +.++.++|+|||++.........
T Consensus        79 yI~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv---~~~g~i~LIDFG~A~~~~~~~~~  148 (218)
T PRK12274         79 YLAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLV---QEDGSPAVIDFQLAVRGNPRARW  148 (218)
T ss_pred             eecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEE---cCCCCEEEEECCCceecCCcchH
Confidence            9999998754422       11357789999999999999999999 7999999   45678999999999865433210


Q ss_pred             --------------ccccCCCccCCccccc--CCCC-CchhHHHHHHHHHHHHhCCCCCCCCC
Q 014733          201 --------------HGTVGSPFYIAPEVLA--GGYN-QAADVWSAGVILYILLSGMPPFWGKT  246 (419)
Q Consensus       201 --------------~~~~gt~~y~aPE~l~--~~~s-~~sDvwSlGvil~elltG~~Pf~~~~  246 (419)
                                    .-...++.|++|+.-.  ...+ ...++++.|..+|.++|+..++++..
T Consensus       149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence                          0013577888888633  2344 57789999999999999999987754

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.88  E-value=2.6e-23  Score=189.84  Aligned_cols=240  Identities=19%  Similarity=0.253  Sum_probs=197.2

Q ss_pred             eeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEEee
Q 014733           43 VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMEL  122 (419)
Q Consensus        43 ~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~  122 (419)
                      .+.-+|.....|..|+|+++  |..++.|++..... +....+.|..|.-.|+.++ ||||+.+++.|....++.+|..|
T Consensus       193 nl~tkl~e~hsgelwrgrwq--gndivakil~vr~~-t~risrdfneefp~lrifs-hpnilpvlgacnsppnlv~isq~  268 (448)
T KOG0195|consen  193 NLITKLAESHSGELWRGRWQ--GNDIVAKILNVREV-TARISRDFNEEFPALRIFS-HPNILPVLGACNSPPNLVIISQY  268 (448)
T ss_pred             hhhhhhccCCCccccccccc--Ccchhhhhhhhhhc-chhhcchhhhhCcceeeec-CCchhhhhhhccCCCCceEeeee
Confidence            34667888999999999876  67788898876653 4455678999999999997 99999999999999999999999


Q ss_pred             cCCCChHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCC--CeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC
Q 014733          123 CAGGELFHRLEKYGR--FSETEARVIFRHLMQVVSYCHGNG--VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ  198 (419)
Q Consensus       123 ~~ggsL~~~l~~~~~--l~~~~~~~i~~qll~aL~~LH~~~--IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~  198 (419)
                      ++.|+|+..++....  .+..++.+++.+++.|++|||+..  |.---|....|+++++- ..++-.+|--++.+     
T Consensus       269 mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedl-tarismad~kfsfq-----  342 (448)
T KOG0195|consen  269 MPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDL-TARISMADTKFSFQ-----  342 (448)
T ss_pred             ccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchh-hhheecccceeeee-----
Confidence            999999999987554  688899999999999999999986  44456889999996532 33455556444432     


Q ss_pred             ccccccCCCccCCcccccCC----CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 014733          199 NLHGTVGSPFYIAPEVLAGG----YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASAR  274 (419)
Q Consensus       199 ~~~~~~gt~~y~aPE~l~~~----~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~  274 (419)
                       ..+..-.|.||+||.+..+    --.++|+|||++++|||.|...||.+....+.-.+|.-+.++...++  +++..+.
T Consensus       343 -e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ipp--gis~hm~  419 (448)
T KOG0195|consen  343 -EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPP--GISRHMN  419 (448)
T ss_pred             -ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCC--CccHHHH
Confidence             2334457889999998764    23689999999999999999999999999888888877777655443  8999999


Q ss_pred             HHHHhhhhcCCCCCCCHHHHH
Q 014733          275 DLIMGMLRVDPSTRLTAAEVL  295 (419)
Q Consensus       275 ~li~~~L~~dP~~Rps~~eil  295 (419)
                      .|++-|++.||.+||.++.|+
T Consensus       420 klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  420 KLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             HHHHHHhcCCCCcCCCcceeh
Confidence            999999999999999998875

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.88  E-value=2e-23  Score=219.68  Aligned_cols=235  Identities=26%  Similarity=0.397  Sum_probs=180.8

Q ss_pred             CeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCc-cCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           41 RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDR-LVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        41 ~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~-~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      .|...+.||.+.|=+|.+|.+. .|. |++|++.+.. ..+.....+...|++ .... ++||.+.+.-+...+..-|||
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~-~~pn~lPfqk~~~t~kAAylv   99 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALM-KAPNCLPFQKVLVTDKAAYLV   99 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhh-cCCcccchHHHHHhhHHHHHH
Confidence            7888999999999999999886 455 8999997765 334444444455555 3334 599999999888888888999


Q ss_pred             EeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceee--eccC
Q 014733          120 MELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATY--IKAG  197 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~--~~~~  197 (419)
                      -+|+ .-+|++.+..+.-+..-+.+.|+-||+.||.-+|..||+|||||.+||||   ..-.-+.|+||..-+-  +..+
T Consensus       100 Rqyv-khnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILi---TSWNW~~LtDFAsFKPtYLPeD  175 (1431)
T KOG1240|consen  100 RQYV-KHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILI---TSWNWLYLTDFASFKPTYLPED  175 (1431)
T ss_pred             HHHH-hhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEE---eeechhhhhcccccCCccCCCC
Confidence            9999 45999999886668899999999999999999999999999999999999   5556789999976542  2222


Q ss_pred             Ccc------ccccCCCccCCcccccC-----------C-CCCchhHHHHHHHHHHHHh-CCCCCCC-----------CCH
Q 014733          198 QNL------HGTVGSPFYIAPEVLAG-----------G-YNQAADVWSAGVILYILLS-GMPPFWG-----------KTK  247 (419)
Q Consensus       198 ~~~------~~~~gt~~y~aPE~l~~-----------~-~s~~sDvwSlGvil~ellt-G~~Pf~~-----------~~~  247 (419)
                      ...      .+...-.+|+|||.+..           . .+++-||||+||++.||++ |++||.-           ...
T Consensus       176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~  255 (1431)
T KOG1240|consen  176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDP  255 (1431)
T ss_pred             CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCH
Confidence            211      11123446999998632           1 4678999999999999988 7999831           122


Q ss_pred             HHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          248 SKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       248 ~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      +..+++|.              +..++++|..|++.||++|.++++.|+.
T Consensus       256 e~~Le~Ie--------------d~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  256 EQLLEKIE--------------DVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             HHHHHhCc--------------CccHHHHHHHHHccCchhccCHHHHHHh
Confidence            22222222              2358999999999999999999999975

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.88  E-value=6.3e-22  Score=179.37  Aligned_cols=145  Identities=19%  Similarity=0.162  Sum_probs=114.5

Q ss_pred             eeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCH---------------------H--hHHHHHHHHHHHHHccCC
Q 014733           44 LGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTV---------------------E--DVRSIKLEIEIMTKLSGH  100 (419)
Q Consensus        44 i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~---------------------~--~~~~~~~Ei~il~~l~~h  100 (419)
                      +.+.||+|++|.||+|.+. +|+.||+|+++.......                     .  ......+|...+.++. |
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~   78 (190)
T cd05145           1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLY-E   78 (190)
T ss_pred             CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHH-h
Confidence            3578999999999999987 899999999986532100                     0  0223468999999996 8


Q ss_pred             CCceeeeEEEEeCCEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeccCCCCcEEEeecCC
Q 014733          101 PNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG-NGVVHRDLKPENILLATKSS  179 (419)
Q Consensus       101 pnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~-~~IvHrDLkp~NILl~~~~~  179 (419)
                      ++|.....+....  .++||||++|+++........+++..++..++.|++.+|.++|+ .||+||||||+|||++    
T Consensus        79 ~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~----  152 (190)
T cd05145          79 AGVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH----  152 (190)
T ss_pred             CCCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE----
Confidence            9886554444333  47999999988665443344678899999999999999999999 9999999999999994    


Q ss_pred             CCCeEEeeccceeeecc
Q 014733          180 SSPIKLADFGLATYIKA  196 (419)
Q Consensus       180 ~~~vKL~DFgla~~~~~  196 (419)
                      ++.++|+|||++.....
T Consensus       153 ~~~~~liDFG~a~~~~~  169 (190)
T cd05145         153 DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             CCCEEEEEcccceecCC
Confidence            57899999999987543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.87  E-value=8.1e-23  Score=195.25  Aligned_cols=191  Identities=27%  Similarity=0.438  Sum_probs=141.5

Q ss_pred             CCCCceeeeEEEEe---------------------------CCEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHH
Q 014733           99 GHPNVVDLKAVYEE---------------------------EDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLM  151 (419)
Q Consensus        99 ~hpnIv~l~~~~~~---------------------------~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll  151 (419)
                      .|||||++...|.+                           ...+|+||.-. ..+|..++.. ...+......++.|++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~-~~~s~r~~~~~laQlL  351 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWT-RHRSYRTGRVILAQLL  351 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhc-CCCchHHHHHHHHHHH
Confidence            69999999887632                           34689999877 5689888876 4567778888999999


Q ss_pred             HHHHHHHhCCCeeccCCCCcEEEeecCCC-CCeEEeeccceeeeccC-------CccccccCCCccCCcccccC---C--
Q 014733          152 QVVSYCHGNGVVHRDLKPENILLATKSSS-SPIKLADFGLATYIKAG-------QNLHGTVGSPFYIAPEVLAG---G--  218 (419)
Q Consensus       152 ~aL~~LH~~~IvHrDLkp~NILl~~~~~~-~~vKL~DFgla~~~~~~-------~~~~~~~gt~~y~aPE~l~~---~--  218 (419)
                      +|+.|||++||.|||+|.+|||+.-+++. -.+.|+|||++---...       ...-..-|...-||||+...   +  
T Consensus       352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a  431 (598)
T KOG4158|consen  352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA  431 (598)
T ss_pred             HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence            99999999999999999999999665332 25799999987532110       01122357778999999754   2  


Q ss_pred             -CC-CchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHH
Q 014733          219 -YN-QAADVWSAGVILYILLSGMPPFWGKTKSKIFD-AVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEV  294 (419)
Q Consensus       219 -~s-~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~-~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ei  294 (419)
                       .+ .++|.|+.|.+.||+++...||.+..+..+.. ..++..++   ...+.+++.+++++..+|+.||++|+++.-+
T Consensus       432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLP---alp~~vpp~~rqlV~~lL~r~pskRvsp~iA  507 (598)
T KOG4158|consen  432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLP---ALPSRVPPVARQLVFDLLKRDPSKRVSPNIA  507 (598)
T ss_pred             eeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCC---CCcccCChHHHHHHHHHhcCCccccCCccHH
Confidence             12 48999999999999999999998743321111 12222222   1224788999999999999999999986543

>PRK10345 hypothetical protein; Provisional

Probab=99.86  E-value=8.3e-21  Score=174.08  Aligned_cols=138  Identities=21%  Similarity=0.217  Sum_probs=109.5

Q ss_pred             eeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHcc----CCCCceeeeEEEEeCC---EEE
Q 014733           45 GKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLS----GHPNVVDLKAVYEEED---YVH  117 (419)
Q Consensus        45 ~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~----~hpnIv~l~~~~~~~~---~~~  117 (419)
                      .+.||+|++|.||.  +..++.. +||++.....   ...+.+.+|+.+++.+.    .||||++++++++++.   .++
T Consensus         7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~---~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~   80 (210)
T PRK10345          7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD---GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY   80 (210)
T ss_pred             cceecCCCceEEEE--CCCCcCe-EEEEEecccc---chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence            56899999999995  7766665 6998876432   24567899999999994    3799999999999874   444


Q ss_pred             -EEEee--cCCCChHHHHHHcCCCCHHHHHHHHHHHHHHH-HHHHhCCCeeccCCCCcEEEeecC-CCCCeEEeeccce
Q 014733          118 -LLMEL--CAGGELFHRLEKYGRFSETEARVIFRHLMQVV-SYCHGNGVVHRDLKPENILLATKS-SSSPIKLADFGLA  191 (419)
Q Consensus       118 -lV~E~--~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL-~~LH~~~IvHrDLkp~NILl~~~~-~~~~vKL~DFgla  191 (419)
                       +|+||  +.+++|.+++.. +.+++.  ..++.+++.++ +|||+++|+||||||+|||++..+ ....++|+||+.+
T Consensus        81 ~~I~e~~G~~~~tL~~~l~~-~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345         81 DVIADFDGKPSITLTEFAEQ-CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             EEEecCCCCcchhHHHHHHc-ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence             78999  557999999976 456665  35677888777 999999999999999999997544 3348999995444

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.83  E-value=2.8e-20  Score=199.29  Aligned_cols=201  Identities=19%  Similarity=0.338  Sum_probs=162.1

Q ss_pred             hhccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHcc--CCCCceeeeEEE
Q 014733           33 TQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLS--GHPNVVDLKAVY  110 (419)
Q Consensus        33 ~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~--~hpnIv~l~~~~  110 (419)
                      +...--+..|.|...||+|+||.||+|.+.. |+.||+|+-.....+      .|.--..++.||+  --+-|..+...+
T Consensus       691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~W------EfYI~~q~~~RLk~~~~~~~~~~~~a~  763 (974)
T KOG1166|consen  691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPW------EFYICLQVMERLKPQMLPSIMHISSAH  763 (974)
T ss_pred             ceeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCce------eeeehHHHHHhhchhhhcchHHHHHHH
Confidence            3444556789999999999999999999986 999999986543221      1222223333432  136666777666


Q ss_pred             EeCCEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEee----cCCCCCeEEe
Q 014733          111 EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLAT----KSSSSPIKLA  186 (419)
Q Consensus       111 ~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~----~~~~~~vKL~  186 (419)
                      .-.+.-++|+||.+-|+|.+++...+..++.....++.|++..|+.||..+|||+||||+|.||..    +....-++|+
T Consensus       764 ~~~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lI  843 (974)
T KOG1166|consen  764 VFQNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLI  843 (974)
T ss_pred             ccCCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEE
Confidence            667777899999999999999998788999999999999999999999999999999999999943    2234469999


Q ss_pred             eccceeeec---cCCccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCC
Q 014733          187 DFGLATYIK---AGQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMP  240 (419)
Q Consensus       187 DFgla~~~~---~~~~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~  240 (419)
                      |||.+..+.   ++....+.++|-.+--+|+..|. +++.+|.|.|+.+++-|+.|+.
T Consensus       844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            999987653   44456777999999999999985 9999999999999999999864

>smart00090 RIO RIO-like kinase

Probab=99.82  E-value=6.7e-20  Score=171.67  Aligned_cols=150  Identities=17%  Similarity=0.102  Sum_probs=115.6

Q ss_pred             cccCeeeeeeecccCceEEEEEE-ecCCCcEEEEEEeccCccCC-------------------HH--hHHHHHHHHHHHH
Q 014733           38 LSDRYVLGKQLGWGQFGVIRECS-DKFTGEVLACKSIAKDRLVT-------------------VE--DVRSIKLEIEIMT   95 (419)
Q Consensus        38 ~~~~y~i~~~LG~G~~g~V~~a~-~~~~g~~vaiK~i~~~~~~~-------------------~~--~~~~~~~Ei~il~   95 (419)
                      -+.-|++.+.||.|++|.||+|. +..+|+.||+|++.......                   ..  ....+.+|+.++.
T Consensus        26 ~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~  105 (237)
T smart00090       26 RGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQ  105 (237)
T ss_pred             cCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHH
Confidence            34468999999999999999999 66789999999997543210                   00  1134678999999


Q ss_pred             HccCCCCceeeeEEEEeCCEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC-CeeccCCCCcEEE
Q 014733           96 KLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG-VVHRDLKPENILL  174 (419)
Q Consensus        96 ~l~~hpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~-IvHrDLkp~NILl  174 (419)
                      ++. +. .+.+..++... ..++||||++|.+|.........+...++..++.|++++|.+||+.| |+||||||+||++
T Consensus       106 ~L~-~~-~i~~p~~~~~~-~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli  182 (237)
T smart00090      106 RLY-EA-GVPVPKPIAWR-RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILV  182 (237)
T ss_pred             HHH-hc-CCCCCeeeEec-CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEE
Confidence            996 43 22222223222 35899999999888766544455777778899999999999999999 9999999999999


Q ss_pred             eecCCCCCeEEeeccceeee
Q 014733          175 ATKSSSSPIKLADFGLATYI  194 (419)
Q Consensus       175 ~~~~~~~~vKL~DFgla~~~  194 (419)
                      +    ++.++|+|||.+...
T Consensus       183 ~----~~~i~LiDFg~a~~~  198 (237)
T smart00090      183 H----DGKVVIIDVSQSVEL  198 (237)
T ss_pred             E----CCCEEEEEChhhhcc
Confidence            4    568999999998854

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.81  E-value=1.3e-20  Score=186.79  Aligned_cols=175  Identities=29%  Similarity=0.495  Sum_probs=137.9

Q ss_pred             CEEEEEEeecCCCChHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccc
Q 014733          114 DYVHLLMELCAGGELFHRLEKYGR---FSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGL  190 (419)
Q Consensus       114 ~~~~lV~E~~~ggsL~~~l~~~~~---l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgl  190 (419)
                      .++||.|++|...+|.+||.+...   .+......++.|++.+++|   ++.+|+|+||.||+.   ..+..+||.|||+
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~---~~d~q~kIgDFgl  402 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFF---SDDDQLKIGDFGL  402 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhcccccccc---ccchhhhhhhhhh
Confidence            468999999999999999975433   6788899999999999999   999999999999999   5566899999999


Q ss_pred             eeeeccCC-------ccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCC
Q 014733          191 ATYIKAGQ-------NLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRF  261 (419)
Q Consensus       191 a~~~~~~~-------~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~  261 (419)
                      ........       .+...+||+.||+||.+.+. |+.++||||||+||+||+. -...|..   ...+..+..+.+  
T Consensus       403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er---~~t~~d~r~g~i--  477 (516)
T KOG1033|consen  403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER---IATLTDIRDGII--  477 (516)
T ss_pred             eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH---HHhhhhhhcCCC--
Confidence            98776544       45566899999999999985 9999999999999999997 3333321   223333333333  


Q ss_pred             CCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhcccc
Q 014733          262 PSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWM  300 (419)
Q Consensus       262 ~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~  300 (419)
                      |...+.+. ++-.+|+.+||.+.|.+||++.+.-.|.|.
T Consensus       478 p~~~~~d~-p~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  478 PPEFLQDY-PEEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             ChHHhhcC-cHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence            32222233 445689999999999999988877777765

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.80  E-value=5.2e-21  Score=200.39  Aligned_cols=260  Identities=32%  Similarity=0.502  Sum_probs=210.7

Q ss_pred             ccCeeeeeeecccCceEEEEEEec-CCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEE
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDK-FTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVH  117 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~-~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~  117 (419)
                      ...|.+...||.|+|+.|-++... .+...+|.|.+.... ........+..|..+=+.+.+|+|++.+++...+.+..+
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~   97 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL   97 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence            356788888999999999888764 344556666665443 233455667778888777767999999999999999999


Q ss_pred             EEEeecCCCChHHHH-HHcC-CCCHHHHHHHHHHHHHHHHHHH-hCCCeeccCCCCcEEEeecCCCC-CeEEeeccceee
Q 014733          118 LLMELCAGGELFHRL-EKYG-RFSETEARVIFRHLMQVVSYCH-GNGVVHRDLKPENILLATKSSSS-PIKLADFGLATY  193 (419)
Q Consensus       118 lV~E~~~ggsL~~~l-~~~~-~l~~~~~~~i~~qll~aL~~LH-~~~IvHrDLkp~NILl~~~~~~~-~vKL~DFgla~~  193 (419)
                      ++++|..|++++..+ +... ..+...+..++.|+..++.|+| ..++.|+||||+|.+++   ..+ .+|++|||+|..
T Consensus        98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~---~s~~~l~~~df~~At~  174 (601)
T KOG0590|consen   98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLD---ESGSALKIADFGLATA  174 (601)
T ss_pred             cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhc---cCCCcccCCCchhhcc
Confidence            999999999999998 6554 5788899999999999999999 99999999999999994   455 899999999987


Q ss_pred             ecc-CC---ccccccC-CCccCCcccccC-C-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhcCCCCCCCC
Q 014733          194 IKA-GQ---NLHGTVG-SPFYIAPEVLAG-G-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIF-DAVRAADLRFPSDP  265 (419)
Q Consensus       194 ~~~-~~---~~~~~~g-t~~y~aPE~l~~-~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~-~~i~~~~~~~~~~~  265 (419)
                      +.. ..   .....+| ++.|+|||...+ . ..+..|+||.|+++..+++|..|+......... .........+...+
T Consensus       175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  254 (601)
T KOG0590|consen  175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLP  254 (601)
T ss_pred             ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCc
Confidence            765 22   2344588 999999999887 3 578999999999999999999999654433211 11122223445677


Q ss_pred             CCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhcccccc
Q 014733          266 WDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE  302 (419)
Q Consensus       266 ~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~  302 (419)
                      |..++....+++.++|..+|..|.+.+++..++|+..
T Consensus       255 ~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  255 WNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             cccCChhhhhcccccccCCchhccccccccccccccc
Confidence            8899999999999999999999999999999999987

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.78  E-value=3.7e-18  Score=156.72  Aligned_cols=137  Identities=23%  Similarity=0.280  Sum_probs=114.1

Q ss_pred             eeecccCceEEEEEEecCCCcEEEEEEeccCccCCH-----HhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEE
Q 014733           46 KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTV-----EDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLM  120 (419)
Q Consensus        46 ~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~-----~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~  120 (419)
                      +.||+|++|.||+|.+  .|..+++|+.........     .....+.+|+.++..+. |++|.....++.+.+..+++|
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~~~~~~~lv~   78 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRAR-KAGVNVPAVYFVDPENFIIVM   78 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHH-HCCCCCCeEEEEeCCCCEEEE
Confidence            5799999999999986  577899998654332111     12346788999999996 999888777777778889999


Q ss_pred             eecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceee
Q 014733          121 ELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATY  193 (419)
Q Consensus       121 E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~  193 (419)
                      ||++|++|.+++.....    +...++.+++.+|.++|+.+++|+|++|.|||++    ++.++|+|||.+..
T Consensus        79 e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~----~~~~~liDf~~a~~  143 (211)
T PRK14879         79 EYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS----GGKIYLIDFGLAEF  143 (211)
T ss_pred             EEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE----CCCEEEEECCcccC
Confidence            99999999999865332    8888999999999999999999999999999995    56799999998875

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.76  E-value=9.2e-18  Score=152.72  Aligned_cols=133  Identities=21%  Similarity=0.262  Sum_probs=106.9

Q ss_pred             eecccCceEEEEEEecCCCcEEEEEEeccCccCCH-----HhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEEe
Q 014733           47 QLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTV-----EDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLME  121 (419)
Q Consensus        47 ~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~-----~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  121 (419)
                      .||+|++|.||+|..  +|..+++|..........     .....+.+|+++++.+. |+++.....++.+.+..++|||
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~~~~~~~lv~e   77 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRAR-KAGVNTPVVYDVDPDNKTIVME   77 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHH-HCCCCCCEEEEEECCCCEEEEE
Confidence            389999999999984  578899998654322111     12466788999999996 7776655555566667789999


Q ss_pred             ecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceee
Q 014733          122 LCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATY  193 (419)
Q Consensus       122 ~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~  193 (419)
                      |++|++|.+.+.....       .++.+++.+|.+||+.|++|+|++|.||+++    ++.++++|||++..
T Consensus        78 ~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~----~~~~~liDfg~a~~  138 (199)
T TIGR03724        78 YIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR----DDKLYLIDFGLGKY  138 (199)
T ss_pred             EECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE----CCcEEEEECCCCcC
Confidence            9999999988765321       7889999999999999999999999999994    57899999999875

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.76  E-value=5.7e-18  Score=154.33  Aligned_cols=140  Identities=19%  Similarity=0.204  Sum_probs=108.5

Q ss_pred             CeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCH-------------------HhHHHHHHHHHHHHHccCCC
Q 014733           41 RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTV-------------------EDVRSIKLEIEIMTKLSGHP  101 (419)
Q Consensus        41 ~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~-------------------~~~~~~~~Ei~il~~l~~hp  101 (419)
                      -|.+.+.||.|++|.||+|.+. +|+.+|+|++........                   ........|..++..+. ++
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~   93 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALY-EE   93 (198)
T ss_pred             hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHH-Hc
Confidence            4888999999999999999875 799999999765431000                   01123678899999995 66


Q ss_pred             C--ceeeeEEEEeCCEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCC
Q 014733          102 N--VVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSS  179 (419)
Q Consensus       102 n--Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~  179 (419)
                      +  ++..++    ....++||||++|++|......      .....++.++++++.++|+.||+||||||+||++   +.
T Consensus        94 ~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill---~~  160 (198)
T cd05144          94 GFPVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILV---DD  160 (198)
T ss_pred             CCCCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEE---cC
Confidence            4  444433    2446899999999998765431      3566788999999999999999999999999999   45


Q ss_pred             CCCeEEeeccceeeec
Q 014733          180 SSPIKLADFGLATYIK  195 (419)
Q Consensus       180 ~~~vKL~DFgla~~~~  195 (419)
                      ++.++|+|||.+....
T Consensus       161 ~~~~~liDfg~~~~~~  176 (198)
T cd05144         161 DEKIYIIDWPQMVSTD  176 (198)
T ss_pred             CCcEEEEECCccccCC
Confidence            7789999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.75  E-value=7.1e-18  Score=169.92  Aligned_cols=198  Identities=22%  Similarity=0.337  Sum_probs=157.0

Q ss_pred             HHccCCCCceeeeEEEEeCCEEEEEEeecCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCC-eeccCCCCcE
Q 014733           95 TKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGV-VHRDLKPENI  172 (419)
Q Consensus        95 ~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~I-vHrDLkp~NI  172 (419)
                      +.+. |.|+.++++.+.+....+.|.+||..|+|.+.+... -.+++.-...++++|+.||.|||+..| .|+.++..|.
T Consensus         2 ~~l~-h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    2 RQLD-HDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             cccc-hhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            4564 999999999999999999999999999999999873 448888888999999999999999876 9999999999


Q ss_pred             EEeecCCCCCeEEeeccceeeecc---CCccccccCCCccCCcccccCC--------CCCchhHHHHHHHHHHHHhCCCC
Q 014733          173 LLATKSSSSPIKLADFGLATYIKA---GQNLHGTVGSPFYIAPEVLAGG--------YNQAADVWSAGVILYILLSGMPP  241 (419)
Q Consensus       173 Ll~~~~~~~~vKL~DFgla~~~~~---~~~~~~~~gt~~y~aPE~l~~~--------~s~~sDvwSlGvil~elltG~~P  241 (419)
                      ++   +..-.+||+|||+......   ........-...|.|||.+++.        .+.+.|+||+|++++|+++...|
T Consensus        81 lv---d~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~  157 (484)
T KOG1023|consen   81 LV---DSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP  157 (484)
T ss_pred             ee---eeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence            99   5567899999999876532   1111222334569999998763        36789999999999999999999


Q ss_pred             CCCC----CHHHHHHHHHh-cCCCCCCCCC--CCCCHHHHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          242 FWGK----TKSKIFDAVRA-ADLRFPSDPW--DHISASARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       242 f~~~----~~~~~~~~i~~-~~~~~~~~~~--~~~s~~l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                      |...    ...++...+.. +...+.+..+  ....+++..++.+||..+|.+||+++++-.
T Consensus       158 ~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~  219 (484)
T KOG1023|consen  158 FDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS  219 (484)
T ss_pred             cccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence            9652    22456666666 3322222222  256678999999999999999999998843

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.75  E-value=5.3e-19  Score=186.57  Aligned_cols=268  Identities=29%  Similarity=0.429  Sum_probs=220.5

Q ss_pred             ccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCC
Q 014733           35 ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEED  114 (419)
Q Consensus        35 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~  114 (419)
                      ...-.+.+.+.+-+-+|+++.++.+.-..+|-..++|+..+..+......+.+..+-+++-... +|.++.....+....
T Consensus       799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~-~P~v~~~~~s~~~rs  877 (1205)
T KOG0606|consen  799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPR-SPAVVRSFPSFPCRS  877 (1205)
T ss_pred             ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCC-CCceecccCCCCCCC
Confidence            3444577888889999999999999888788777777766555544445566666666654443 677887766666677


Q ss_pred             EEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeee
Q 014733          115 YVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI  194 (419)
Q Consensus       115 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~  194 (419)
                      ..+++++|+.|++|...++..+..+.+-++..+..+.+++++||+..+.|+|++|.|+++   ..+++.++.|||.....
T Consensus       878 P~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~---~~~gh~~l~~~~t~~~v  954 (1205)
T KOG0606|consen  878 PLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLI---AYDGHRPLTDFGTLSKV  954 (1205)
T ss_pred             CcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhh---cccCCcccCcccccccc
Confidence            789999999999999999998889999999999999999999999999999999999999   67889999999844322


Q ss_pred             ccC--------------------------------CccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCC
Q 014733          195 KAG--------------------------------QNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPP  241 (419)
Q Consensus       195 ~~~--------------------------------~~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~P  241 (419)
                      .--                                .......||+.|.+||.+.+. ....+|+|+.|++++|.++|.+|
T Consensus       955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen  955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred             ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence            100                                001223689999999998874 78899999999999999999999


Q ss_pred             CCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHH---HHHhccccccchhhh
Q 014733          242 FWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAA---EVLAHSWMEECEQVA  307 (419)
Q Consensus       242 f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~---eil~hp~~~~~~~~~  307 (419)
                      |.....+++++.|..+....+..+ ...+.++++++..+|..+|.+|..+.   ++..|+||+...+..
T Consensus      1035 ~na~tpq~~f~ni~~~~~~~p~g~-~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~ 1102 (1205)
T KOG0606|consen 1035 FNAETPQQIFENILNRDIPWPEGP-EEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWEN 1102 (1205)
T ss_pred             CCCcchhhhhhccccCCCCCCCCc-cccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCccc
Confidence            999999999999988887766554 47899999999999999999999998   899999999887643

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.75  E-value=1.4e-17  Score=174.26  Aligned_cols=144  Identities=20%  Similarity=0.276  Sum_probs=114.2

Q ss_pred             ccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCC-----HHhHHHHHHHHHHHHHccCCCCceeeeEE
Q 014733           35 ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVT-----VEDVRSIKLEIEIMTKLSGHPNVVDLKAV  109 (419)
Q Consensus        35 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~-----~~~~~~~~~Ei~il~~l~~hpnIv~l~~~  109 (419)
                      .......|...+.||+|+||+||++.+.  +..+++|+...+....     ....+.+.+|+++++.++ |++++....+
T Consensus       328 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~  404 (535)
T PRK09605        328 EEEVKRRKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEAR-RAGVPTPVIY  404 (535)
T ss_pred             ccccccccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhc-ccCCCeeEEE
Confidence            3344556677899999999999999865  3344555433221111     122456889999999996 9999988777


Q ss_pred             EEeCCEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeecc
Q 014733          110 YEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFG  189 (419)
Q Consensus       110 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFg  189 (419)
                      +.+....++||||++|++|.+++.        ....++.+++++|.+||+.+++||||||+|||+    .++.++|+|||
T Consensus       405 ~~~~~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl----~~~~~~liDFG  472 (535)
T PRK09605        405 DVDPEEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV----RDDRLYLIDFG  472 (535)
T ss_pred             EEeCCCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE----ECCcEEEEeCc
Confidence            777777899999999999998885        356789999999999999999999999999999    24579999999


Q ss_pred             ceee
Q 014733          190 LATY  193 (419)
Q Consensus       190 la~~  193 (419)
                      +++.
T Consensus       473 la~~  476 (535)
T PRK09605        473 LGKY  476 (535)
T ss_pred             cccc
Confidence            9985

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.72  E-value=5e-17  Score=146.29  Aligned_cols=140  Identities=21%  Similarity=0.280  Sum_probs=100.7

Q ss_pred             eeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHH---------------------HHHHHHHHHHHccCCCC
Q 014733           44 LGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVR---------------------SIKLEIEIMTKLSGHPN  102 (419)
Q Consensus        44 i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~---------------------~~~~Ei~il~~l~~hpn  102 (419)
                      +++.||+|+||+||+|.+. +|+.||+|++............                     ....|...+.++. +..
T Consensus         1 ~~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~   78 (187)
T cd05119           1 VGGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLY-EAG   78 (187)
T ss_pred             CCcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHH-HcC
Confidence            3568999999999999987 8999999998754322111111                     1246777777775 332


Q ss_pred             --ceeeeEEEEeCCEEEEEEeecCCCChH-HHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeccCCCCcEEEeecC
Q 014733          103 --VVDLKAVYEEEDYVHLLMELCAGGELF-HRLEKYGRFSETEARVIFRHLMQVVSYCHG-NGVVHRDLKPENILLATKS  178 (419)
Q Consensus       103 --Iv~l~~~~~~~~~~~lV~E~~~ggsL~-~~l~~~~~l~~~~~~~i~~qll~aL~~LH~-~~IvHrDLkp~NILl~~~~  178 (419)
                        +.+.+++    ...+++|||++|+.+. ..+.... . ..++..++.+++.++.++|. .+|+|+||||+||+++   
T Consensus        79 ~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~---  149 (187)
T cd05119          79 VPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD---  149 (187)
T ss_pred             CCCCceEec----CCCEEEEEEeCCCCccChhhhhhh-h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE---
Confidence              4444433    2358999999985432 1222111 1 16788899999999999999 9999999999999994   


Q ss_pred             CCCCeEEeeccceeeec
Q 014733          179 SSSPIKLADFGLATYIK  195 (419)
Q Consensus       179 ~~~~vKL~DFgla~~~~  195 (419)
                       ++.++|+|||.+....
T Consensus       150 -~~~~~liDfg~a~~~~  165 (187)
T cd05119         150 -DGKVYIIDVPQAVEID  165 (187)
T ss_pred             -CCcEEEEECccccccc
Confidence             6789999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.67  E-value=8.9e-16  Score=144.03  Aligned_cols=137  Identities=21%  Similarity=0.254  Sum_probs=100.9

Q ss_pred             eec-ccCceEEEEEEecCCCcEEEEEEeccCcc----------CCHHhHHHHHHHHHHHHHccCCCCc--eeeeEEEEeC
Q 014733           47 QLG-WGQFGVIRECSDKFTGEVLACKSIAKDRL----------VTVEDVRSIKLEIEIMTKLSGHPNV--VDLKAVYEEE  113 (419)
Q Consensus        47 ~LG-~G~~g~V~~a~~~~~g~~vaiK~i~~~~~----------~~~~~~~~~~~Ei~il~~l~~hpnI--v~l~~~~~~~  113 (419)
                      .|| .|+.|+||.+...  +..+++|.+.....          .+......+.+|++++.+|. |++|  ++.+++....
T Consensus        38 ~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~-~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         38 VVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLY-EAGLPVPRPIAARVVR  114 (239)
T ss_pred             eeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHH-hCCCCCceeEeeeeee
Confidence            455 5666677776553  77899998864321          01123456788999999996 8775  6666664432


Q ss_pred             -C---EEEEEEeecCC-CChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeec
Q 014733          114 -D---YVHLLMELCAG-GELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADF  188 (419)
Q Consensus       114 -~---~~~lV~E~~~g-gsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DF  188 (419)
                       .   ..++|||+++| .+|.+++.. .++++..    +.+|+++|.+||+.||+||||||+|||++   .++.++|+||
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~---~~~~v~LIDf  186 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLD---PDGKFWLIDF  186 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEc---CCCCEEEEEC
Confidence             2   23599999997 688888765 4555543    56899999999999999999999999994   4568999999


Q ss_pred             cceeee
Q 014733          189 GLATYI  194 (419)
Q Consensus       189 gla~~~  194 (419)
                      |.+...
T Consensus       187 g~~~~~  192 (239)
T PRK01723        187 DRGELR  192 (239)
T ss_pred             CCcccC
Confidence            998853

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.66  E-value=1e-15  Score=131.22  Aligned_cols=133  Identities=26%  Similarity=0.232  Sum_probs=111.2

Q ss_pred             eeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCC-CCceeeeEEEEeCCEEEEEEee
Q 014733           44 LGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH-PNVVDLKAVYEEEDYVHLLMEL  122 (419)
Q Consensus        44 i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~h-pnIv~l~~~~~~~~~~~lV~E~  122 (419)
                      +++.||.|.++.||++...  +..+++|.+.....     ...+.+|+.+++.++.+ .++++++.+....+..+++|||
T Consensus         2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~   74 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW   74 (155)
T ss_pred             cceecccccccceEEEEec--CCeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence            4678999999999999875  37899998865421     46788999999999733 6899999988888889999999


Q ss_pred             cCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CCeeccCCCCcEEEeecCCCCCeEEeeccceee
Q 014733          123 CAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGN---GVVHRDLKPENILLATKSSSSPIKLADFGLATY  193 (419)
Q Consensus       123 ~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~---~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~  193 (419)
                      ++|+.+..+       +......++.+++++|+.+|..   +++|+|++|+||+++   +.+.++++|||.+..
T Consensus        75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~---~~~~~~l~Df~~~~~  138 (155)
T cd05120          75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD---DGKILGIIDWEYAGY  138 (155)
T ss_pred             cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEE---CCcEEEEEecccccC
Confidence            998777654       5566777889999999999985   699999999999994   457899999998874

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.65  E-value=1.2e-16  Score=161.28  Aligned_cols=274  Identities=25%  Similarity=0.271  Sum_probs=211.2

Q ss_pred             cccccccchhh-ccccccCeeeeeeecc--cCceEEEEEEe--cCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHcc
Q 014733           24 SLTGTILDATQ-ISNLSDRYVLGKQLGW--GQFGVIRECSD--KFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLS   98 (419)
Q Consensus        24 ~~~~~~~~~~~-~~~~~~~y~i~~~LG~--G~~g~V~~a~~--~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~   98 (419)
                      ++...+++... .+.+..++.+.+.+|.  |.+|.||.+.-  ..++..+|+|.-.... ........-.+|...-+++.
T Consensus        97 ~~~s~~~~~S~~~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~-s~p~~~~~k~~~~~s~~~i~  175 (524)
T KOG0601|consen   97 SLSSPIYGASPFDSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPF-SPPLDSKRKLREFLSHHKID  175 (524)
T ss_pred             cccccccCCCCccchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCC-CCccccccccchhhcccccC
Confidence            34444444433 3345667888999999  99999999987  7888999999743221 11222233345666666777


Q ss_pred             CCCCceeeeEEEEeCCEEEEEEeecCCCChHHHHHHcCC-CCHHHHHHHHHHHHH----HHHHHHhCCCeeccCCCCcEE
Q 014733           99 GHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGR-FSETEARVIFRHLMQ----VVSYCHGNGVVHRDLKPENIL  173 (419)
Q Consensus        99 ~hpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~-l~~~~~~~i~~qll~----aL~~LH~~~IvHrDLkp~NIL  173 (419)
                      -|+|.++.+..++..+..|+-+|++ +.+|..+...... +++...+..+.+..+    ||.++|+.+|+|-|+||.||+
T Consensus       176 ~~~~~v~~~~~~e~~~~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~  254 (524)
T KOG0601|consen  176 SHENPVRDSPAWEGSGILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIF  254 (524)
T ss_pred             ccccccccCcccccCCcceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhhee
Confidence            7999999999999999999999999 5788777766555 899999999999999    999999999999999999999


Q ss_pred             EeecCCC-CCeEEeeccceeeeccCCcccc------ccCCCccCCcccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 014733          174 LATKSSS-SPIKLADFGLATYIKAGQNLHG------TVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGKT  246 (419)
Q Consensus       174 l~~~~~~-~~vKL~DFgla~~~~~~~~~~~------~~gt~~y~aPE~l~~~~s~~sDvwSlGvil~elltG~~Pf~~~~  246 (419)
                      +   ..+ ...+++|||+...+.+......      .-|...|++||...+-++...|++++|.+..+-.++........
T Consensus       255 ~---~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~  331 (524)
T KOG0601|consen  255 T---TSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGK  331 (524)
T ss_pred             c---ccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCC
Confidence            9   445 6789999999998876552221      14667799999999999999999999999999888877664331


Q ss_pred             HHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          247 KSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       247 ~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                      . ..+..+  ....++.+.....+..+...+..|++.+|..|++...++.|+++....-
T Consensus       332 ~-~~W~~~--r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~  387 (524)
T KOG0601|consen  332 N-SSWSQL--RQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLF  387 (524)
T ss_pred             C-CCcccc--ccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhh
Confidence            1 111111  2222555666677888888999999999999999999999999986543

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.49  E-value=4.2e-13  Score=121.34  Aligned_cols=143  Identities=12%  Similarity=0.130  Sum_probs=103.5

Q ss_pred             eeeecccCceEEEEEEecC------CCcEEEEEEeccCccC-------------------CHHhHHHHH----HHHHHHH
Q 014733           45 GKQLGWGQFGVIRECSDKF------TGEVLACKSIAKDRLV-------------------TVEDVRSIK----LEIEIMT   95 (419)
Q Consensus        45 ~~~LG~G~~g~V~~a~~~~------~g~~vaiK~i~~~~~~-------------------~~~~~~~~~----~Ei~il~   95 (419)
                      ...||.|.-+.||.|....      .+..+|+|+++.....                   .......+.    +|.+.|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            4579999999999998653      3579999998542110                   011123344    8999999


Q ss_pred             HccCC-CCceeeeEEEEeCCEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHH-HhCCCeeccCCCCcEE
Q 014733           96 KLSGH-PNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYC-HGNGVVHRDLKPENIL  173 (419)
Q Consensus        96 ~l~~h-pnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~L-H~~~IvHrDLkp~NIL  173 (419)
                      ++... -++.+.+++    ...++||||+.+..+..-.-+...+++.+...+..+++.+|..| |+.||||+||++.|||
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL  157 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML  157 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence            98732 456666654    34679999997654432222223466667778889999999988 8999999999999999


Q ss_pred             EeecCCCCCeEEeeccceeeec
Q 014733          174 LATKSSSSPIKLADFGLATYIK  195 (419)
Q Consensus       174 l~~~~~~~~vKL~DFgla~~~~  195 (419)
                      +.    ++.++|+|||.+....
T Consensus       158 ~~----~~~v~iIDF~qav~~~  175 (197)
T cd05146         158 WH----DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             EE----CCcEEEEECCCceeCC
Confidence            94    4679999999988653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.47  E-value=2.3e-14  Score=134.80  Aligned_cols=234  Identities=16%  Similarity=0.209  Sum_probs=159.9

Q ss_pred             EEEEEEecCCCcEEEEEEeccCcc----CCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeC-----CEEEEEEeecCC
Q 014733           55 VIRECSDKFTGEVLACKSIAKDRL----VTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEE-----DYVHLLMELCAG  125 (419)
Q Consensus        55 ~V~~a~~~~~g~~vaiK~i~~~~~----~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~-----~~~~lV~E~~~g  125 (419)
                      .||++.++..|.+|+.-.+.....    ..+..++.+...   |-.+. |.|||+++.++.+.     ....++.||+..
T Consensus        81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdn---llqlv-HsnlvkfH~yw~d~K~~e~~rviFiteymss  156 (458)
T KOG1266|consen   81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDN---LLQLV-HSNLVKFHKYWTDKKYEEKPRVIFITEYMSS  156 (458)
T ss_pred             HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHH---HHHHH-HHHHHHHHHhhcccccccccceEEEEecccc
Confidence            567777777776665544432111    122223333322   33343 99999999998654     457899999999


Q ss_pred             CChHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC--CeeccCCCCcEEEeecCCCCCeEEeeccceeeeccC--
Q 014733          126 GELFHRLEKYG----RFSETEARVIFRHLMQVVSYCHGNG--VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG--  197 (419)
Q Consensus       126 gsL~~~l~~~~----~l~~~~~~~i~~qll~aL~~LH~~~--IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~--  197 (419)
                      |+|.++|++..    .+......+|+.||+.||.|||+..  |+|+++..+-|++   ..+|-||+.----.. ....  
T Consensus       157 gs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifi---q~ngLIkig~~ap~s-~h~s~~  232 (458)
T KOG1266|consen  157 GSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFI---QHNGLIKIGSVAPDS-THPSVN  232 (458)
T ss_pred             hhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheee---cCCceEEecccCccc-cchhhh
Confidence            99999997643    3788889999999999999999986  9999999999999   566667764321111 1111  


Q ss_pred             ----CccccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHhcCCCCCCCCCCCCCH
Q 014733          198 ----QNLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPP-FWGKTKSKIFDAVRAADLRFPSDPWDHISA  271 (419)
Q Consensus       198 ----~~~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~elltG~~P-f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  271 (419)
                          .......+-++|.|||.=.. +-+-++|||++|+...+|..|..- -.+...-...+.+.+.......       .
T Consensus       233 ~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~len-------~  305 (458)
T KOG1266|consen  233 STREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIGLEN-------G  305 (458)
T ss_pred             hhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheeeccC-------c
Confidence                01122356788999997433 467799999999999999988765 3333333333444333222111       1


Q ss_pred             HHHHHHHhhhhcCCCCCCCHHHHHhccccccc
Q 014733          272 SARDLIMGMLRVDPSTRLTAAEVLAHSWMEEC  303 (419)
Q Consensus       272 ~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~  303 (419)
                      --+++|.+||+..|..||++.+++.||-+-+.
T Consensus       306 lqr~~i~kcl~~eP~~rp~ar~llfHpllfeV  337 (458)
T KOG1266|consen  306 LQRGSITKCLEGEPNGRPDARLLLFHPLLFEV  337 (458)
T ss_pred             cccCcCcccccCCCCCCcchhhhhcCceeeec
Confidence            23568999999999999999999999987554

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.45  E-value=7.6e-13  Score=134.68  Aligned_cols=144  Identities=20%  Similarity=0.261  Sum_probs=97.7

Q ss_pred             eeecccCceEEEEEEecCCCcEEEEEEeccCccCC-HHh--------------------------H----------HHHH
Q 014733           46 KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVT-VED--------------------------V----------RSIK   88 (419)
Q Consensus        46 ~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~-~~~--------------------------~----------~~~~   88 (419)
                      +.||.|++|.||+|+.+ +|+.||||+.+...... ..+                          .          -.+.
T Consensus       123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            57999999999999875 79999999986431000 000                          0          0234


Q ss_pred             HHHHHHHHcc----CCCCceeeeEEEEeCCEEEEEEeecCCCChHHHHHHc-CCCCHHHHHHHHHHHHH-HHHHHHhCCC
Q 014733           89 LEIEIMTKLS----GHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQ-VVSYCHGNGV  162 (419)
Q Consensus        89 ~Ei~il~~l~----~hpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qll~-aL~~LH~~~I  162 (419)
                      +|...+.++.    ++++|.-..-+....+..++||||++|++|.+..... ...   ....++..++. .+..+|..|+
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~g~  278 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRDGF  278 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhCCc
Confidence            4555555553    2344332222223344578999999999998876432 122   23445566665 4678999999


Q ss_pred             eeccCCCCcEEEeecCCCCCeEEeeccceeeecc
Q 014733          163 VHRDLKPENILLATKSSSSPIKLADFGLATYIKA  196 (419)
Q Consensus       163 vHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~  196 (419)
                      +|+|+||.||++   ..++.++|+|||++..+.+
T Consensus       279 ~H~D~hPgNilv---~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       279 FHADLHPGNIFV---LKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             eeCCCCcccEEE---CCCCcEEEEeCCCeeECCH
Confidence            999999999999   5667899999999987643

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.43  E-value=1.2e-13  Score=142.57  Aligned_cols=152  Identities=20%  Similarity=0.280  Sum_probs=98.9

Q ss_pred             ccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCcc--------------------------CCH-----HhHH
Q 014733           37 NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRL--------------------------VTV-----EDVR   85 (419)
Q Consensus        37 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~--------------------------~~~-----~~~~   85 (419)
                      .+-..|.. +.||.|++|+||+|+.+.+|+.||||+.+....                          ...     +..+
T Consensus       117 ~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~  195 (537)
T PRK04750        117 EWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEK  195 (537)
T ss_pred             HHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHH
Confidence            34456766 789999999999999988899999999975421                          000     1112


Q ss_pred             H------HHHHHHHHHHcc---CCCCceeeeEEEEe-CCEEEEEEeecCCCChHHH--HHHcC----CCCHHHHHHHHHH
Q 014733           86 S------IKLEIEIMTKLS---GHPNVVDLKAVYEE-EDYVHLLMELCAGGELFHR--LEKYG----RFSETEARVIFRH  149 (419)
Q Consensus        86 ~------~~~Ei~il~~l~---~hpnIv~l~~~~~~-~~~~~lV~E~~~ggsL~~~--l~~~~----~l~~~~~~~i~~q  149 (419)
                      .      +.+|...+.++.   .+.+.+.+-.++.+ .+..++||||+.|+.+.+.  +...+    .+.+..+..++.|
T Consensus       196 ~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q  275 (537)
T PRK04750        196 TLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ  275 (537)
T ss_pred             HHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence            2      333444444443   13334444444433 4557799999999999764  33333    1334444444444


Q ss_pred             HHHHHHHHHhCCCeeccCCCCcEEEeecC-CCCCeEEeeccceeeecc
Q 014733          150 LMQVVSYCHGNGVVHRDLKPENILLATKS-SSSPIKLADFGLATYIKA  196 (419)
Q Consensus       150 ll~aL~~LH~~~IvHrDLkp~NILl~~~~-~~~~vKL~DFgla~~~~~  196 (419)
                      +       ...|++|+|+||.||+++.++ ..+.++++|||++..+..
T Consensus       276 i-------f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        276 V-------FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             H-------HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            4       458999999999999995432 223899999999987744

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.43  E-value=8.7e-13  Score=116.46  Aligned_cols=129  Identities=16%  Similarity=0.103  Sum_probs=95.7

Q ss_pred             eeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEEeecC
Q 014733           45 GKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCA  124 (419)
Q Consensus        45 ~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~  124 (419)
                      ++.|+.|..+.||++...  +..+++|+......    ....+.+|..+++.+.....+.+++....  ...++||||++
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~   74 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE   74 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence            467899999999998864  78899998764421    12346789999999863333445554433  23479999999


Q ss_pred             CCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCC-----eeccCCCCcEEEeecCCCCCeEEeeccceee
Q 014733          125 GGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGV-----VHRDLKPENILLATKSSSSPIKLADFGLATY  193 (419)
Q Consensus       125 ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~I-----vHrDLkp~NILl~~~~~~~~vKL~DFgla~~  193 (419)
                      |.++...        ......++.+++++|+.||+.++     +|+|++|.||+++    ++.++++|||.+..
T Consensus        75 G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~----~~~~~liDf~~a~~  136 (170)
T cd05151          75 GSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD----DGRLWLIDWEYAGM  136 (170)
T ss_pred             CCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE----CCeEEEEecccccC
Confidence            9887643        01123456789999999999985     9999999999994    45799999998873

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.42  E-value=5.6e-12  Score=129.05  Aligned_cols=183  Identities=17%  Similarity=0.256  Sum_probs=135.8

Q ss_pred             eeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEEe
Q 014733           42 YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLME  121 (419)
Q Consensus        42 y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  121 (419)
                      |.+ +...-++.+....|..+.++.+|.+..+..+..   .....+.+.++-|+.++ ||||+++++.++.++..|+|+|
T Consensus        15 Y~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlR-HP~Il~yL~t~e~~~~~ylvTE   89 (690)
T KOG1243|consen   15 YDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLR-HPNILSYLDTTEEEGTLYLVTE   89 (690)
T ss_pred             ccc-ccccCCCcccccccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhcc-CchhhhhhhhhcccCceEEEee
Confidence            444 444444444333466677888999998876532   44566788889999997 9999999999999999999999


Q ss_pred             ecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-hCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCCc-
Q 014733          122 LCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCH-GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN-  199 (419)
Q Consensus       122 ~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH-~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~~-  199 (419)
                      -+.  -|...++.   +........+.||+.||.||| +.+++|++|.-+.|++   +..|++||++|.++........ 
T Consensus        90 rV~--Pl~~~lk~---l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfV---n~~GeWkLggle~v~~~~~~~~~  161 (690)
T KOG1243|consen   90 RVR--PLETVLKE---LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFV---NESGEWKLGGLELVSKASGFNAP  161 (690)
T ss_pred             ccc--cHHHHHHH---hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEE---cCCCcEEEeeeEEEeccccCCcc
Confidence            873  56666665   447788888999999999998 5689999999999999   6788999999998875433221 


Q ss_pred             cccccCCCccCCcccccCCCCCchhHHHHHHHHHHHHhC
Q 014733          200 LHGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSG  238 (419)
Q Consensus       200 ~~~~~gt~~y~aPE~l~~~~s~~sDvwSlGvil~elltG  238 (419)
                      .....--..|..|+.+... +-..|.|-|||++++++.|
T Consensus       162 ~~~~~~~~s~~~P~~~~~s-~~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  162 AKSLYLIESFDDPEEIDPS-EWSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             cccchhhhcccChhhcCcc-ccchhhhhHHHHHHHHhCc
Confidence            1111112235666554321 1346999999999999999

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.42  E-value=1.4e-13  Score=139.24  Aligned_cols=263  Identities=20%  Similarity=0.193  Sum_probs=192.1

Q ss_pred             ccccchhh-ccccccCeeeeeeecccCceEEEEEEec-CCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCce
Q 014733           27 GTILDATQ-ISNLSDRYVLGKQLGWGQFGVIRECSDK-FTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVV  104 (419)
Q Consensus        27 ~~~~~~~~-~~~~~~~y~i~~~LG~G~~g~V~~a~~~-~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv  104 (419)
                      ..|+.... ......+|.++..||.|.|+.|+....+ ..+..|++|...+.......++.. ..|+-+...+.-|.+++
T Consensus       251 ~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~s-l~ev~l~~~l~~~~~~~  329 (524)
T KOG0601|consen  251 ANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFS-LGEVILEAILGSHLPSV  329 (524)
T ss_pred             hheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcc-hhhhhHhhHhhcccccC
Confidence            34444444 6667789999999999999999988765 678889999876544333333322 33666666666799999


Q ss_pred             eeeEEEEeCCEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeE
Q 014733          105 DLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIK  184 (419)
Q Consensus       105 ~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vK  184 (419)
                      .++..+......|+-.|||.++++...+.-...+++...+++..|++.++.++|+..++|+|+||+||++..++  +.-+
T Consensus       330 g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~--~~~~  407 (524)
T KOG0601|consen  330 GKNSSWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG--FFSK  407 (524)
T ss_pred             CCCCCccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccch--hhhh
Confidence            99999988888889999999998876664445588999999999999999999999999999999999995432  7789


Q ss_pred             EeeccceeeeccCCccccccCCCccC-CcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC
Q 014733          185 LADFGLATYIKAGQNLHGTVGSPFYI-APEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRF  261 (419)
Q Consensus       185 L~DFgla~~~~~~~~~~~~~gt~~y~-aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~  261 (419)
                      +.|||+.+.+.-..  ....+.-++. ..|++..  .+..+.|++|||.-+.+..++.+--+...   ....|..+....
T Consensus       408 ~~~~~~~t~~~~~~--~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~---~~~~i~~~~~p~  482 (524)
T KOG0601|consen  408 LGDFGCWTRLAFSS--GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV---QSLTIRSGDTPN  482 (524)
T ss_pred             ccccccccccceec--ccccccccccccchhhccccccccccccccccccccccccCcccCcccc---cceeeecccccC
Confidence            99999887421111  1112233344 3555544  36789999999999999998876543322   222333332221


Q ss_pred             CCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccc
Q 014733          262 PSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWME  301 (419)
Q Consensus       262 ~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~  301 (419)
                      .    .....+++.+.+.++..++..|+.+.++..|+=|.
T Consensus       483 ~----~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~  518 (524)
T KOG0601|consen  483 L----PGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY  518 (524)
T ss_pred             C----CchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence            1    13448889999999999999999999998876553

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.28  E-value=8.7e-11  Score=103.42  Aligned_cols=134  Identities=25%  Similarity=0.275  Sum_probs=99.6

Q ss_pred             eeecccCceEEEEEEecCCCcEEEEEEeccCccCCHH-----hHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEE
Q 014733           46 KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVE-----DVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLM  120 (419)
Q Consensus        46 ~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~-----~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~  120 (419)
                      ..+++|+-+.++.+..  .|..+++|.=..+..-.+.     ......+|..++.++. --.|..-.-+..+.+...|+|
T Consensus         2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~-~~GV~~P~v~dvD~~~~~I~m   78 (204)
T COG3642           2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAR-EAGVPVPIVYDVDPDNGLIVM   78 (204)
T ss_pred             chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHH-HcCCCCCeEEEEcCCCCEEEE
Confidence            4678999999999854  4556666654333322221     2345778999999886 445554444555666677999


Q ss_pred             eecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceee
Q 014733          121 ELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATY  193 (419)
Q Consensus       121 E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~  193 (419)
                      ||++|..|.+.+...       ...+++.+-..+.-||..||+|+||.++||++.    ++.+.++|||++..
T Consensus        79 e~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~----~~~i~~IDfGLg~~  140 (204)
T COG3642          79 EYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILS----GGRIYFIDFGLGEF  140 (204)
T ss_pred             EEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEe----CCcEEEEECCcccc
Confidence            999998888888764       256777888888999999999999999999993    34599999999985

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.27  E-value=1.4e-10  Score=101.84  Aligned_cols=147  Identities=20%  Similarity=0.216  Sum_probs=110.6

Q ss_pred             eeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCH-----HhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEE
Q 014733           44 LGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTV-----EDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHL  118 (419)
Q Consensus        44 i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~-----~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~l  118 (419)
                      ..+.|-+|+-+.|+++.+  .|+..+||.=..+....+     -...+..+|.+.|.++. --.|.--.-++.|...-.+
T Consensus        11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~-~~GI~~P~l~~~D~~~~~i   87 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCR-ALGIPAPRLIFIDTYGGQI   87 (229)
T ss_pred             cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHH-HhCCCCceEEEEecCCCeE
Confidence            567888999999999875  588888876443333222     23466788999999986 4566555556667766779


Q ss_pred             EEeecCC-CChHHHHHHcC-CCCHHH-HHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceee
Q 014733          119 LMELCAG-GELFHRLEKYG-RFSETE-ARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATY  193 (419)
Q Consensus       119 V~E~~~g-gsL~~~l~~~~-~l~~~~-~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~  193 (419)
                      .|||++| .++.+++.... .-.+++ ...+++.|-+.+.-||..+|+|+||..+||++..++..-.+.|+|||++..
T Consensus        88 ~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   88 YMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            9999977 36677765432 233333 378999999999999999999999999999997766666679999999875

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.18  E-value=1.6e-10  Score=106.27  Aligned_cols=144  Identities=24%  Similarity=0.320  Sum_probs=105.0

Q ss_pred             eeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccC-CCCceeeeEEEEeC---CEEEEEE
Q 014733           45 GKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG-HPNVVDLKAVYEEE---DYVHLLM  120 (419)
Q Consensus        45 ~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~-hpnIv~l~~~~~~~---~~~~lV~  120 (419)
                      .+.|+.|..+.||++... +|+.+++|........  .....+..|.++++.+.. +.++.+++.+....   +..++||
T Consensus         3 ~~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~   79 (223)
T cd05154           3 VRQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVM   79 (223)
T ss_pred             ceecCCCccceEEEEEec-CCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEE
Confidence            367899999999999865 3678999998654321  234578899999999973 23467777776654   3678999


Q ss_pred             eecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------------
Q 014733          121 ELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG-----------------------------------------  159 (419)
Q Consensus       121 E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~-----------------------------------------  159 (419)
                      ||++|.++...+.. ..+++.....++.+++++|..||+                                         
T Consensus        80 e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (223)
T cd05154          80 ERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME  158 (223)
T ss_pred             EEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence            99999888765432 346666666777777777777773                                         


Q ss_pred             ---------------CCCeeccCCCCcEEEeecCCCCCeEEeeccceee
Q 014733          160 ---------------NGVVHRDLKPENILLATKSSSSPIKLADFGLATY  193 (419)
Q Consensus       160 ---------------~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~  193 (419)
                                     ..++|+|++|.|||++.+ .++.+.|+||+.+..
T Consensus       159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~-~~~~~~iID~e~~~~  206 (223)
T cd05154         159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPD-EPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCC-CCcEEEEEecccccc
Confidence                           236999999999999532 145689999998874

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.16  E-value=2e-09  Score=107.47  Aligned_cols=212  Identities=16%  Similarity=0.216  Sum_probs=156.3

Q ss_pred             CceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEE----eCCEEEEEEeecCC-C
Q 014733           52 QFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYE----EEDYVHLLMELCAG-G  126 (419)
Q Consensus        52 ~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~----~~~~~~lV~E~~~g-g  126 (419)
                      .-.+.|+|....+|..|++|+++-.+..+..   ..-.-+++++++. |+|||++.+++.    .+..+++|++|.++ +
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~n---k~t~lve~wkkl~-h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~  363 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTN---KDTSLVEAWKKLC-HTNVVPFREVFLTYTFGDLSLVLVYDYYPSSP  363 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcc---cchHHHHHHHHhc-cCceeehhhhhhhhccCcceEEEEEecCCCCc
Confidence            3468999999999999999999544433321   1223467888996 999999999987    34578999999886 5


Q ss_pred             ChHHHHHHc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccce
Q 014733          127 ELFHRLEKY---------------GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA  191 (419)
Q Consensus       127 sL~~~l~~~---------------~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla  191 (419)
                      +|.++.-..               ...+|...|.++.||..||.++|+.|+.-+-|.|.+||++   .+.+|+|+..|..
T Consensus       364 TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~---G~~RIriS~C~i~  440 (655)
T KOG3741|consen  364 TLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVT---GKMRIRISGCGIM  440 (655)
T ss_pred             hHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEee---CcceEEEecccce
Confidence            777665211               1367899999999999999999999999999999999994   3447888877777


Q ss_pred             eeeccCCccccccCCCccCCcccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-HHHH-HHHHHhcCCCCCCCCCCCC
Q 014733          192 TYIKAGQNLHGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGKT-KSKI-FDAVRAADLRFPSDPWDHI  269 (419)
Q Consensus       192 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~s~~sDvwSlGvil~elltG~~Pf~~~~-~~~~-~~~i~~~~~~~~~~~~~~~  269 (419)
                      ..+..+..             |-+.+  -.+-|.=.||.+++.|.||..--+..+ ..+. .+.|..           .+
T Consensus       441 Dvl~~d~~-------------~~le~--~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~~-----------~y  494 (655)
T KOG3741|consen  441 DVLQEDPT-------------EPLES--QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRITT-----------TY  494 (655)
T ss_pred             eeecCCCC-------------cchhH--HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhhh-----------hh
Confidence            66544330             11111  246799999999999999976633222 1222 333322           57


Q ss_pred             CHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          270 SASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       270 s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      +.+++++|.-+..-++++ -++.+++.|
T Consensus       495 S~D~rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  495 STDLRNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             hHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence            899999999999999887 778888764

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.15  E-value=1.6e-11  Score=126.13  Aligned_cols=233  Identities=18%  Similarity=0.208  Sum_probs=148.7

Q ss_pred             ccccchhhccccccCeeeeeeecccCce---EEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCc
Q 014733           27 GTILDATQISNLSDRYVLGKQLGWGQFG---VIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNV  103 (419)
Q Consensus        27 ~~~~~~~~~~~~~~~y~i~~~LG~G~~g---~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnI  103 (419)
                      ++++.......-..+|++.+.+|..+-|   ++|.+..+..+.....|....         ..+......+++++ |   
T Consensus        24 e~~~~~l~~~~~~~~~~~~~~~~~~g~g~~~~ly~~~~~~sk~~~~~~s~~~---------~~ld~~~~~~~~lr-~---   90 (700)
T KOG2137|consen   24 ETIVQVLPGPKESQSYRSLNQVGSAGPGDAWKLYAGKKSGSKAPTLKKSAVV---------WMLDKRASSLQQLR-G---   90 (700)
T ss_pred             cceeEecCCcccccccccccceeecCCCchhhhhhhhccCccCccccceeee---------eecChhhhHHHHHh-c---
Confidence            4555555666678899999998876665   555555544444332222111         11112233445554 4   


Q ss_pred             eeeeEEEEeCCEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC-CCeeccCCCCcEEEeecCCCCC
Q 014733          104 VDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGN-GVVHRDLKPENILLATKSSSSP  182 (419)
Q Consensus       104 v~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~-~IvHrDLkp~NILl~~~~~~~~  182 (419)
                                      .+++.+            -++ ....=+.+.+.|+.|+|.. ++||++|.|++|.+   ...+.
T Consensus        91 ----------------~~~vs~------------aTe-~~f~nl~~v~dgl~flh~sAk~VH~ni~p~~i~~---na~~~  138 (700)
T KOG2137|consen   91 ----------------LDGVSK------------ATE-DGFANLGNVADGLAFLHRSAKVVHGNIQPEAIVV---NANGD  138 (700)
T ss_pred             ----------------ccchhh------------ccc-HhhhhhhcccchhhhhccCcceeecccchhheee---ccCcc
Confidence                            111100            011 1111122344899999976 79999999999999   56788


Q ss_pred             eEEeeccceeeeccCCcc----------ccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHH-hCCCCCCCCCHHHH
Q 014733          183 IKLADFGLATYIKAGQNL----------HGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILL-SGMPPFWGKTKSKI  250 (419)
Q Consensus       183 vKL~DFgla~~~~~~~~~----------~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~ell-tG~~Pf~~~~~~~~  250 (419)
                      +||+.|+.+....+....          ........|.|||++.+. .+.++|++|+|+++|.+. .|+.-+........
T Consensus       139 wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~  218 (700)
T KOG2137|consen  139 WKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS  218 (700)
T ss_pred             eeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccccccccccceeeeeEEEEEecCCcchhhccCCcch
Confidence            999999988765542211          011345679999998874 689999999999999999 45555544332222


Q ss_pred             HHHHHhcCCCC-CCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          251 FDAVRAADLRF-PSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       251 ~~~i~~~~~~~-~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                      ... ....... .....++++.++++-+.++|..++..||++.+++..|||....-
T Consensus       219 ~~~-~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~~~  273 (700)
T KOG2137|consen  219 YSF-SRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSIPFFSDPGL  273 (700)
T ss_pred             hhh-hhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhcccccCCchh
Confidence            211 1111111 11122589999999999999999999999999999999976543

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.05  E-value=8e-09  Score=98.35  Aligned_cols=139  Identities=16%  Similarity=0.062  Sum_probs=96.2

Q ss_pred             CceEEEEEEecCCCcEEEEEEeccCccC---CH-----HhHHHHHHHHHHHHHccCCCCce--eeeEEEEe-----CCEE
Q 014733           52 QFGVIRECSDKFTGEVLACKSIAKDRLV---TV-----EDVRSIKLEIEIMTKLSGHPNVV--DLKAVYEE-----EDYV  116 (419)
Q Consensus        52 ~~g~V~~a~~~~~g~~vaiK~i~~~~~~---~~-----~~~~~~~~Ei~il~~l~~hpnIv--~l~~~~~~-----~~~~  116 (419)
                      ....|.+..  ..|+.+.+|........   ..     .....+.+|...+.+|. .-+|.  ...++.+.     ...-
T Consensus        34 ~~rrvvr~~--~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~-~~GIptP~pVa~~e~~~~~~~~~s  110 (268)
T PRK15123         34 EGRRTLRFE--LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLH-EVGVDTMTGVAFGERGSNPATRTS  110 (268)
T ss_pred             CCceEEEEE--ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHH-HcCCCCCCeeEEEEecCCCcccee
Confidence            333455543  35778999976432210   00     01124778999888885 33333  33444443     2356


Q ss_pred             EEEEeecCCC-ChHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeec----CCCCCeEEeecc
Q 014733          117 HLLMELCAGG-ELFHRLEK--YGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATK----SSSSPIKLADFG  189 (419)
Q Consensus       117 ~lV~E~~~gg-sL~~~l~~--~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~----~~~~~vKL~DFg  189 (419)
                      ++|||++++. +|.+++..  ..+.+......++.+++..+.-||+.||+|+|+++.|||++.+    +.+..+.|+||+
T Consensus       111 ~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~  190 (268)
T PRK15123        111 FIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLH  190 (268)
T ss_pred             EEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECC
Confidence            8999999876 78888754  2446677888999999999999999999999999999999642    235689999999


Q ss_pred             ceee
Q 014733          190 LATY  193 (419)
Q Consensus       190 la~~  193 (419)
                      .+..
T Consensus       191 r~~~  194 (268)
T PRK15123        191 RAQI  194 (268)
T ss_pred             cccc
Confidence            8864

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.01  E-value=1.1e-08  Score=100.18  Aligned_cols=238  Identities=18%  Similarity=0.187  Sum_probs=160.2

Q ss_pred             eeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEE------EeC-CEE
Q 014733           44 LGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVY------EEE-DYV  116 (419)
Q Consensus        44 i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~------~~~-~~~  116 (419)
                      .+..||+|+-+.+|..-..   ...+.|++.+....   ...   .....|...-.||-+-.-+.+-      -+. ..+
T Consensus        15 ~gr~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa---~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~i   85 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEV---RDQVAKIYHAPPPA---AQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVI   85 (637)
T ss_pred             CCccccCCccceeeecchh---hchhheeecCCCch---HHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCcccee
Confidence            4678999999999865322   23455888765321   111   1233444444455443312111      122 236


Q ss_pred             EEEEeecCCCChHHHH-H------HcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeecc
Q 014733          117 HLLMELCAGGELFHRL-E------KYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFG  189 (419)
Q Consensus       117 ~lV~E~~~ggsL~~~l-~------~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFg  189 (419)
                      -+.|..+.|..=-+.+ .      ......|.-..+.++.|+.+.+.||..|-+-+|++++|+|+   ++++.|.|.|-+
T Consensus        86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lV---sd~~~V~LVdsD  162 (637)
T COG4248          86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLV---SDDSKVVLVDSD  162 (637)
T ss_pred             EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceee---ecCceEEEEccc
Confidence            7888888775332222 1      11237889999999999999999999999999999999999   678889999977


Q ss_pred             ceeeeccCCccccccCCCccCCccccc-C-----CCCCchhHHHHHHHHHHHHhC-CCCCCCCCH-----HHHHHHHHhc
Q 014733          190 LATYIKAGQNLHGTVGSPFYIAPEVLA-G-----GYNQAADVWSAGVILYILLSG-MPPFWGKTK-----SKIFDAVRAA  257 (419)
Q Consensus       190 la~~~~~~~~~~~~~gt~~y~aPE~l~-~-----~~s~~sDvwSlGvil~elltG-~~Pf~~~~~-----~~~~~~i~~~  257 (419)
                      .-.....+......+|...|.+||.-. +     .-+...|.|.||+++++++.| +.||.+-..     .-....|..+
T Consensus       163 sfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g  242 (637)
T COG4248         163 SFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG  242 (637)
T ss_pred             ceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence            665555556666778999999999754 2     246789999999999999886 999965311     1111122222


Q ss_pred             C----------CCC--CCCCCCCCCHHHHHHHHhhhhc--CCCCCCCHHH
Q 014733          258 D----------LRF--PSDPWDHISASARDLIMGMLRV--DPSTRLTAAE  293 (419)
Q Consensus       258 ~----------~~~--~~~~~~~~s~~l~~li~~~L~~--dP~~Rps~~e  293 (419)
                      .          +..  ...+|.-+++.++.|..+|+..  ++.-|||++.
T Consensus       243 ~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a  292 (637)
T COG4248         243 RFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA  292 (637)
T ss_pred             eeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence            1          111  1234677899999999999986  4668999875

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.01  E-value=5.3e-09  Score=94.23  Aligned_cols=130  Identities=22%  Similarity=0.237  Sum_probs=82.6

Q ss_pred             EEEEEEecCCCcEEEEEEeccCccC-----------------------CHHhHHHHHHHHHHHHHccCC-CCceeeeEEE
Q 014733           55 VIRECSDKFTGEVLACKSIAKDRLV-----------------------TVEDVRSIKLEIEIMTKLSGH-PNVVDLKAVY  110 (419)
Q Consensus        55 ~V~~a~~~~~g~~vaiK~i~~~~~~-----------------------~~~~~~~~~~Ei~il~~l~~h-pnIv~l~~~~  110 (419)
                      .||.|... .|+.+|+|+.+.....                       ........++|.+.|.++... -++.+++++ 
T Consensus         1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-   78 (188)
T PF01163_consen    1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-   78 (188)
T ss_dssp             EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE-
T ss_pred             CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE-
Confidence            38888874 6789999998542110                       011234577899999999732 246666644 


Q ss_pred             EeCCEEEEEEeecC--CCChHHHHHHcCCCCHHHHHHHHHHHHHHHHH-HHhCCCeeccCCCCcEEEeecCCCCCeEEee
Q 014733          111 EEEDYVHLLMELCA--GGELFHRLEKYGRFSETEARVIFRHLMQVVSY-CHGNGVVHRDLKPENILLATKSSSSPIKLAD  187 (419)
Q Consensus       111 ~~~~~~~lV~E~~~--ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~-LH~~~IvHrDLkp~NILl~~~~~~~~vKL~D  187 (419)
                       ..  .++||||++  |..+..+...  .++..+...++.+++..+.. +|+.||+|+||.+.|||++    ++.+.|+|
T Consensus        79 -~~--~~ivME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~----~~~~~iID  149 (188)
T PF01163_consen   79 -NR--NVIVMEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVD----DGKVYIID  149 (188)
T ss_dssp             -ET--TEEEEE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEE----TTCEEE--
T ss_pred             -eC--CEEEEEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEee----cceEEEEe
Confidence             23  359999998  6555444332  12245667778888885554 6899999999999999994    23899999


Q ss_pred             ccceeeec
Q 014733          188 FGLATYIK  195 (419)
Q Consensus       188 Fgla~~~~  195 (419)
                      ||.+....
T Consensus       150 f~qav~~~  157 (188)
T PF01163_consen  150 FGQAVDSS  157 (188)
T ss_dssp             GTTEEETT
T ss_pred             cCcceecC
Confidence            99998643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.94  E-value=2.6e-08  Score=91.39  Aligned_cols=111  Identities=22%  Similarity=0.303  Sum_probs=85.9

Q ss_pred             HHHHHHHHHHHHHccC-CCCceeeeEEEEeC----CEEEEEEeecCCC-ChHHHHHHcCCCCHHHHHHHHHHHHHHHHHH
Q 014733           84 VRSIKLEIEIMTKLSG-HPNVVDLKAVYEEE----DYVHLLMELCAGG-ELFHRLEKYGRFSETEARVIFRHLMQVVSYC  157 (419)
Q Consensus        84 ~~~~~~Ei~il~~l~~-hpnIv~l~~~~~~~----~~~~lV~E~~~gg-sL~~~l~~~~~l~~~~~~~i~~qll~aL~~L  157 (419)
                      .....+|...+.+|.. .=.+.+.+++.+..    ..-++|+|++++. +|.+++......+......++.++++.+.-|
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l  134 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL  134 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence            3457778888777751 22244555555542    2458999999884 7999888755577888899999999999999


Q ss_pred             HhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeee
Q 014733          158 HGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI  194 (419)
Q Consensus       158 H~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~  194 (419)
                      |..||+|+|+++.|||+..++....+.|+||+.+...
T Consensus       135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            9999999999999999976554458999999988753

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.87  E-value=1.4e-08  Score=94.67  Aligned_cols=140  Identities=22%  Similarity=0.242  Sum_probs=102.9

Q ss_pred             CeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCcc-----------------CC--HHhHHHHHHHHHHHHHccCC-
Q 014733           41 RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRL-----------------VT--VEDVRSIKLEIEIMTKLSGH-  100 (419)
Q Consensus        41 ~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~-----------------~~--~~~~~~~~~Ei~il~~l~~h-  100 (419)
                      -+.++.+||-|.-+.||.|.+. .|..+|+|.-+.-+.                 .+  .......++|.++|++|..+ 
T Consensus        92 ve~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G  170 (304)
T COG0478          92 VEAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG  170 (304)
T ss_pred             HHhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence            4567899999999999999986 788999996532110                 01  11245577899999999632 


Q ss_pred             CCceeeeEEEEeCCEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCC
Q 014733          101 PNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSS  180 (419)
Q Consensus       101 pnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~  180 (419)
                      -.|.+.++    .+...+|||++.|..|...-     ++......++..|++-+.-+-..||||+|+++-||++   +++
T Consensus       171 ~~VP~P~~----~nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV---~~d  238 (304)
T COG0478         171 VKVPKPIA----WNRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILV---TED  238 (304)
T ss_pred             CCCCCccc----cccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEE---ecC
Confidence            24555543    35567999999987765432     2345566667777777777779999999999999999   567


Q ss_pred             CCeEEeeccceee
Q 014733          181 SPIKLADFGLATY  193 (419)
Q Consensus       181 ~~vKL~DFgla~~  193 (419)
                      |.+.++||-.+..
T Consensus       239 g~~~vIDwPQ~v~  251 (304)
T COG0478         239 GDIVVIDWPQAVP  251 (304)
T ss_pred             CCEEEEeCccccc
Confidence            8899999977664

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.65  E-value=4.4e-07  Score=82.99  Aligned_cols=142  Identities=20%  Similarity=0.213  Sum_probs=94.4

Q ss_pred             ccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHH------HHHHHHHHHHcc--CCCCceeeeE
Q 014733           37 NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRS------IKLEIEIMTKLS--GHPNVVDLKA  108 (419)
Q Consensus        37 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~------~~~Ei~il~~l~--~hpnIv~l~~  108 (419)
                      .+.++|.+.+.+-......|.+-.  ..|+.+++|..+.+....+.....      ..+++..+.++.  +-.....++.
T Consensus        28 i~~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl  105 (229)
T PF06176_consen   28 ILDNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL  105 (229)
T ss_pred             HHhCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence            356789999998888877776654  467899999987543322222222      223344444443  2344444444


Q ss_pred             EEEe-----CCEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCe
Q 014733          109 VYEE-----EDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPI  183 (419)
Q Consensus       109 ~~~~-----~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~v  183 (419)
                      +.+.     ....+++|||++|..|.+...    +++    .+...+++++.-||+.|++|+|.+|.|+++.    ++.+
T Consensus       106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~----~~~i  173 (229)
T PF06176_consen  106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVS----NNGI  173 (229)
T ss_pred             eeeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEE----CCcE
Confidence            4432     234568999999988765532    222    2445688889999999999999999999994    3459


Q ss_pred             EEeecccee
Q 014733          184 KLADFGLAT  192 (419)
Q Consensus       184 KL~DFgla~  192 (419)
                      +++||+..+
T Consensus       174 ~iID~~~k~  182 (229)
T PF06176_consen  174 RIIDTQGKR  182 (229)
T ss_pred             EEEECcccc
Confidence            999998665

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.59  E-value=7.4e-07  Score=96.94  Aligned_cols=212  Identities=20%  Similarity=0.281  Sum_probs=151.0

Q ss_pred             HhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEE----EEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHH
Q 014733           82 EDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVH----LLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYC  157 (419)
Q Consensus        82 ~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~----lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~L  157 (419)
                      ..+.....|++.+.++. |+|++.++.+-.+.....    +..+++...++...+..-+..+....+.+..++++||+++
T Consensus       224 ~~i~~~E~e~~~l~k~~-~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~  302 (1351)
T KOG1035|consen  224 KEIQTTEIELESLSKIA-HDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYL  302 (1351)
T ss_pred             HHHHHHHHHHHHHHhhc-cccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHH
Confidence            34556667888888886 999999999886554333    3457888999999999889999999999999999999999


Q ss_pred             HhCCCeeccCCCCcEEEeecCCCCCeEEe--eccceeeeccCCccccccCCCccCCcccccCC---CCCchhHHHHHHHH
Q 014733          158 HGNGVVHRDLKPENILLATKSSSSPIKLA--DFGLATYIKAGQNLHGTVGSPFYIAPEVLAGG---YNQAADVWSAGVIL  232 (419)
Q Consensus       158 H~~~IvHrDLkp~NILl~~~~~~~~vKL~--DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~~---~s~~sDvwSlGvil  232 (419)
                      |+....|.-+...-..-...+..+.+.++  ||+...............-+..+.++|....+   .....|+|.+|..+
T Consensus       303 h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~  382 (1351)
T KOG1035|consen  303 HSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL  382 (1351)
T ss_pred             HHhccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHH
Confidence            99965555444442222222344556666  88888776555544444556668888887654   23457999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCC-HHHHHHHHhhhhcCCCCCCCHHHHHhccccccchhhhc
Q 014733          233 YILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHIS-ASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQ  308 (419)
Q Consensus       233 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s-~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~~~~  308 (419)
                      ..+..|..+-...   .....+           ....+ ....+.+.+|+.-++++|+++.+++.|+|.+.......
T Consensus       383 ~~~~~~~~i~~~~---~~~~~~-----------l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~~~~~  445 (1351)
T KOG1035|consen  383 LQLSQGEDISEKS---AVPVSL-----------LDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPTDNES  445 (1351)
T ss_pred             hhhhhcCcccccc---cchhhh-----------hccccchhhhhhhhhhcchhhhhccchhhhhhchhccccccccc
Confidence            9998876652111   000010           01111 26888999999999999999999999999976655443

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.59  E-value=5.3e-09  Score=106.85  Aligned_cols=244  Identities=20%  Similarity=0.253  Sum_probs=170.5

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCC-ceeeeEEEEeCCEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN-VVDLKAVYEEEDYVHL  118 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpn-Iv~l~~~~~~~~~~~l  118 (419)
                      .-|.....+++|+++++++.+...+...+ .+.+...        ....-++++|.++. ||| .+..++-++.+.+..+
T Consensus       242 kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n-~P~~~v~~~~d~~~E~~~~i  311 (829)
T KOG0576|consen  242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVN-NPNPVVRYLEDYDGEDYLWI  311 (829)
T ss_pred             cchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHcc-CCCCcccccccCCcccccch
Confidence            34555667889999999998877665544 5555322        45667899999995 999 7788888888889999


Q ss_pred             EEeecCCC-ChH-HHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeecc
Q 014733          119 LMELCAGG-ELF-HRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA  196 (419)
Q Consensus       119 V~E~~~gg-sL~-~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~  196 (419)
                      .++++.++ +-. ......-.+.+.+...+.+.-+++++++|+.--+|+|    ||+.    ..+..|+.||+....+..
T Consensus       312 ~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~----s~~~~~~~~~~v~~~L~~  383 (829)
T KOG0576|consen  312 PMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILG----SEEEVKLLDFAVPPQLTR  383 (829)
T ss_pred             hhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccc----cccccccccccCCcccCc
Confidence            99999876 211 1111112255566677778888999999999878999    8887    346789999999887766


Q ss_pred             CCccccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--CC-CCCCCCCHH
Q 014733          197 GQNLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRF--PS-DPWDHISAS  272 (419)
Q Consensus       197 ~~~~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~--~~-~~~~~~s~~  272 (419)
                      ........+|+.++|||+... .+....|.|++|+--.+|.-|-+|-.....  ..-.+-.+.-.+  .. ..|..... 
T Consensus       384 ~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~--~~~~~g~~p~s~~L~~~~aw~~~~~-  460 (829)
T KOG0576|consen  384 TMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSPPA--VLPMIGNGPNSPMLTDKSAWSPVFH-  460 (829)
T ss_pred             ccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCCcc--ccCCCCCCCCccccchhhhcCcccc-
Confidence            655566789999999998766 488999999999877788878777533110  000000000000  00 01111111 


Q ss_pred             HHHHHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          273 ARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       273 l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                       .++...|+..-|..|+..-.++.|.+|+.+..
T Consensus       461 -~~~~~~~~~g~P~~pkv~mgacfsKvfngCpl  492 (829)
T KOG0576|consen  461 -RDFPAPCLNGLPPTPKVHMGACFSKVFNGCPL  492 (829)
T ss_pred             -cCCcccccCCCCCCCcchhhHHHHHHhccCcc
Confidence             14778899999999999999999999987654

>PRK09902 hypothetical protein; Provisional

Probab=98.59  E-value=1.2e-06  Score=79.75  Aligned_cols=143  Identities=13%  Similarity=0.103  Sum_probs=100.5

Q ss_pred             eecccCceEEEEEEecCCCcEEEEEEeccCccCC---HHhHHHHHHHHHHHHHcc--CCCCceeeeEEEEe----CCEEE
Q 014733           47 QLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVT---VEDVRSIKLEIEIMTKLS--GHPNVVDLKAVYEE----EDYVH  117 (419)
Q Consensus        47 ~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~---~~~~~~~~~Ei~il~~l~--~hpnIv~l~~~~~~----~~~~~  117 (419)
                      .-|+||-+-|+....  .|+.+-+|........+   +.....+.+|...|++|.  +-| +.+.......    ...-+
T Consensus        25 N~~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvP-VP~pvf~~~~k~~~~~rA~  101 (216)
T PRK09902         25 NYRRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVI-VPKIVFGEAVKIEGEWRAL  101 (216)
T ss_pred             CcCCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCC-CCccceeeeeccCCceEEE
Confidence            356788888988653  35567888764111111   335678999999999886  223 4444422211    22457


Q ss_pred             EEEeecCC-CChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceee
Q 014733          118 LLMELCAG-GELFHRLEKY--GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATY  193 (419)
Q Consensus       118 lV~E~~~g-gsL~~~l~~~--~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~  193 (419)
                      ||+|-++| .+|.+++...  .+.+......++.+++..+.-||+.|+.|+|+.+.|||++.++ .-.++++||.-++.
T Consensus       102 LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g-~~~v~lIDlEk~r~  179 (216)
T PRK09902        102 LVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEG-KAEAGFLDLEKSRR  179 (216)
T ss_pred             EEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCC-CeeEEEEEhhccch
Confidence            89997754 5888888653  3467888889999999999999999999999999999996432 23599999986653

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.53  E-value=1.8e-06  Score=80.39  Aligned_cols=73  Identities=21%  Similarity=0.115  Sum_probs=55.3

Q ss_pred             eeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCC-CCceeeeEEEEeCCEEEEEEeecC
Q 014733           46 KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH-PNVVDLKAVYEEEDYVHLLMELCA  124 (419)
Q Consensus        46 ~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~h-pnIv~l~~~~~~~~~~~lV~E~~~  124 (419)
                      .+||.|..+.||+.    .+..+++|......     ....+.+|.++++.+... -.+.+.+.+..+.+...+|||+++
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~   77 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV   77 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence            67899999999983    25567889876432     234578899999998633 225778888888888899999999


Q ss_pred             CCC
Q 014733          125 GGE  127 (419)
Q Consensus       125 ggs  127 (419)
                      |.+
T Consensus        78 G~~   80 (226)
T TIGR02172        78 GKR   80 (226)
T ss_pred             Ccc
Confidence            863

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.41  E-value=1.9e-06  Score=88.99  Aligned_cols=143  Identities=22%  Similarity=0.279  Sum_probs=93.6

Q ss_pred             eeecccCceEEEEEEecCCCcEEEEEEeccCccCCH-Hh--------------------------H----H------HHH
Q 014733           46 KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTV-ED--------------------------V----R------SIK   88 (419)
Q Consensus        46 ~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~-~~--------------------------~----~------~~~   88 (419)
                      +.|+.++-|.||+|+.+ +|+.||||+.+..-...- .+                          +    +      .+.
T Consensus       131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            57999999999999987 599999999864211000 00                          1    1      123


Q ss_pred             HHHHHHHHcc----CCCCceeeeEEEEeCCEEEEEEeecCCCChHHHH--HHcCCCCHHHHHHHHHHHHHH-HHHHHhCC
Q 014733           89 LEIEIMTKLS----GHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRL--EKYGRFSETEARVIFRHLMQV-VSYCHGNG  161 (419)
Q Consensus        89 ~Ei~il~~l~----~hpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l--~~~~~l~~~~~~~i~~qll~a-L~~LH~~~  161 (419)
                      +|...+.+++    +.+++.--.-+++-.+.-.++|||+.|..+.+..  +. ..++..++.   ..++++ +..+-..|
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia---~~~~~~f~~q~~~dg  285 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELA---ELLVRAFLRQLLRDG  285 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHH---HHHHHHHHHHHHhcC
Confidence            3444444443    3344443333444456678999999999888774  44 345533333   233333 23344589


Q ss_pred             CeeccCCCCcEEEeecCCCCCeEEeeccceeeecc
Q 014733          162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKA  196 (419)
Q Consensus       162 IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~  196 (419)
                      .+|.|.+|.||++   ..+|.+.+.|||....+.+
T Consensus       286 ffHaDpHpGNi~v---~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         286 FFHADPHPGNILV---RSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             ccccCCCccceEE---ecCCcEEEEcCcceecCCH
Confidence            9999999999999   5668999999999987654

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.35  E-value=1.1e-05  Score=74.22  Aligned_cols=79  Identities=19%  Similarity=0.155  Sum_probs=58.1

Q ss_pred             eeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCC-CCceeeeEEE---EeCCEEEEEE
Q 014733           45 GKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH-PNVVDLKAVY---EEEDYVHLLM  120 (419)
Q Consensus        45 ~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~h-pnIv~l~~~~---~~~~~~~lV~  120 (419)
                      ++.|+.|..+.||+.....  ..+++|.....     .....+..|..+++.|..+ ..+.+++...   ......+++|
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~   74 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM   74 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence            5679999999999998764  48999987432     4567788999999988733 2356666644   3345689999


Q ss_pred             eecCCCChHH
Q 014733          121 ELCAGGELFH  130 (419)
Q Consensus       121 E~~~ggsL~~  130 (419)
                      ++++|..+..
T Consensus        75 ~~i~g~~~~~   84 (239)
T PF01636_consen   75 EYIPGRPLDD   84 (239)
T ss_dssp             EEESSEEHHH
T ss_pred             EEeccccccc
Confidence            9999988777

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.33  E-value=6.1e-06  Score=76.46  Aligned_cols=152  Identities=18%  Similarity=0.145  Sum_probs=97.6

Q ss_pred             hccccccCeeeee---eecccCceEEEEEEecCCCcEEEEEEeccCccCCHHh----------------H-----HHHHH
Q 014733           34 QISNLSDRYVLGK---QLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVED----------------V-----RSIKL   89 (419)
Q Consensus        34 ~~~~~~~~y~i~~---~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~----------------~-----~~~~~   89 (419)
                      .+..+.++..+-+   .|+.|.-+.||+|.. ..+..+|+|++..........                .     .=..+
T Consensus        39 ~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~k  117 (268)
T COG1718          39 TLRRLLSRGVITELVGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARK  117 (268)
T ss_pred             HHHHHhcCCceeeeEeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHH
Confidence            3444555555544   466677789999875 368899999996543211110                0     11345


Q ss_pred             HHHHHHHcc-CCCCceeeeEEEEeCCEEEEEEeecCCCC-hHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-CCCeecc
Q 014733           90 EIEIMTKLS-GHPNVVDLKAVYEEEDYVHLLMELCAGGE-LFHRLEKYGRFSETEARVIFRHLMQVVSYCHG-NGVVHRD  166 (419)
Q Consensus        90 Ei~il~~l~-~hpnIv~l~~~~~~~~~~~lV~E~~~ggs-L~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~-~~IvHrD  166 (419)
                      |...|+++. .+-.+.+-+.+..    -.+||||+.... -.-.|.. -++...++..+..++++.+.-|-. .++||+|
T Consensus       118 Ef~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgD  192 (268)
T COG1718         118 EFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGD  192 (268)
T ss_pred             HHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcCccccc
Confidence            777777765 1233333333322    358999995431 1112222 123334788888899999987766 8999999


Q ss_pred             CCCCcEEEeecCCCCCeEEeeccceeeec
Q 014733          167 LKPENILLATKSSSSPIKLADFGLATYIK  195 (419)
Q Consensus       167 Lkp~NILl~~~~~~~~vKL~DFgla~~~~  195 (419)
                      |+.-|||+.    ++.+.++|||.|....
T Consensus       193 LSEyNiL~~----~~~p~iID~~QaV~~~  217 (268)
T COG1718         193 LSEYNILVH----DGEPYIIDVSQAVTID  217 (268)
T ss_pred             chhhheEEE----CCeEEEEECccccccC
Confidence            999999993    5689999999998654

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.32  E-value=7.2e-06  Score=76.95  Aligned_cols=77  Identities=17%  Similarity=0.117  Sum_probs=56.3

Q ss_pred             eeecccCc-eEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEEeecC
Q 014733           46 KQLGWGQF-GVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCA  124 (419)
Q Consensus        46 ~~LG~G~~-g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~  124 (419)
                      +.|-.|.. ..||+....  +..+++|+.....      ...+.+|+.+++.+..+--+.+++++....+..++|||+++
T Consensus         4 ~~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~   75 (244)
T cd05150           4 ERVTEGQSGATVYRLDGK--NPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVP   75 (244)
T ss_pred             eecCCCCCcCeEEEEcCC--CCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeC
Confidence            34555666 688988653  4678888765331      34567899999999766566678888877777899999999


Q ss_pred             CCChHH
Q 014733          125 GGELFH  130 (419)
Q Consensus       125 ggsL~~  130 (419)
                      |.+|..
T Consensus        76 G~~l~~   81 (244)
T cd05150          76 GVPAAA   81 (244)
T ss_pred             CccHhH
Confidence            987754

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.23  E-value=4.9e-05  Score=69.08  Aligned_cols=139  Identities=22%  Similarity=0.267  Sum_probs=99.2

Q ss_pred             eeeecccCceEEEEEEecCCCcEEEEEEeccCcc-------------CCHHhHHHHHHHHHHHHHcc-----CCCCceee
Q 014733           45 GKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRL-------------VTVEDVRSIKLEIEIMTKLS-----GHPNVVDL  106 (419)
Q Consensus        45 ~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~-------------~~~~~~~~~~~Ei~il~~l~-----~hpnIv~l  106 (419)
                      ...||+|+.-.||.  |. .+....||+......             ......++..+|+.-...+.     .+.+|.++
T Consensus         6 ~~~i~~G~~R~cy~--HP-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    6 SDLIAQGGERDCYQ--HP-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CcccccCCCceEEE--CC-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            35799999999996  33 456678899876650             00112455666776666553     37889999


Q ss_pred             eEEEEeCCEEEEEEeecCC------CChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCC
Q 014733          107 KAVYEEEDYVHLLMELCAG------GELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSS  180 (419)
Q Consensus       107 ~~~~~~~~~~~lV~E~~~g------gsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~  180 (419)
                      +|+.+++.-.-+|+|.+.+      .+|.+++.. +.+++ +   +...+-+-.+||-+++|+.+|++|.||++...++.
T Consensus        83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~  157 (199)
T PF10707_consen   83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG  157 (199)
T ss_pred             eEEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence            9999999999999998642      367777754 45655 3   33344455678999999999999999999876655


Q ss_pred             C-CeEEee-ccce
Q 014733          181 S-PIKLAD-FGLA  191 (419)
Q Consensus       181 ~-~vKL~D-Fgla  191 (419)
                      . .+.|+| ||..
T Consensus       158 ~~~lvlIDG~G~~  170 (199)
T PF10707_consen  158 EFRLVLIDGLGEK  170 (199)
T ss_pred             ceEEEEEeCCCCc
Confidence            5 688888 4433

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.23  E-value=7.5e-06  Score=72.02  Aligned_cols=130  Identities=22%  Similarity=0.224  Sum_probs=92.2

Q ss_pred             eeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEEee
Q 014733           43 VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMEL  122 (419)
Q Consensus        43 ~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~  122 (419)
                      ++.+.|++|..|.||++.+.  |..+|+|+-+.+     .....++.|.++|..+.+----.+++.+..+.    +.|||
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~d-----s~r~~l~kEakiLeil~g~~~~p~vy~yg~~~----i~me~   93 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWR--GGEVALKVRRRD-----SPRRNLEKEAKILEILAGEGVTPEVYFYGEDF----IRMEY   93 (201)
T ss_pred             hhhhhhhcccccEEEEeecc--CceEEEEEecCC-----cchhhHHHHHHHHHHhhhcCCCceEEEechhh----hhhhh
Confidence            44678999999999999865  778999986543     45678999999999997444445566554443    45999


Q ss_pred             cCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCC-CC-cEEEeecCCCCCeEEeeccceeee
Q 014733          123 CAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLK-PE-NILLATKSSSSPIKLADFGLATYI  194 (419)
Q Consensus       123 ~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLk-p~-NILl~~~~~~~~vKL~DFgla~~~  194 (419)
                      +.|..|..+-...   +.    .-...++++---|-..||-|+.|+ |. ||++    .++.+.|+||..|+.-
T Consensus        94 i~G~~L~~~~~~~---~r----k~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv----~~~~~~iIDFd~At~k  156 (201)
T COG2112          94 IDGRPLGKLEIGG---DR----KHLLRVLEKAYKLDRLGIEHGELSRPWKNVLV----NDRDVYIIDFDSATFK  156 (201)
T ss_pred             hcCcchhhhhhcc---cH----HHHHHHHHHHHHHHHhccchhhhcCCceeEEe----cCCcEEEEEccchhhc
Confidence            9987877665431   22    223345555445777899999986 33 5555    3447999999999843

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.18  E-value=3.1e-05  Score=70.14  Aligned_cols=129  Identities=19%  Similarity=0.227  Sum_probs=92.4

Q ss_pred             cCeeeeeeecccCc-eEEEEEEecCCCcEEEEEEecc---Ccc-------CC--------HHhHHHHHHHHHHHHHcc--
Q 014733           40 DRYVLGKQLGWGQF-GVIRECSDKFTGEVLACKSIAK---DRL-------VT--------VEDVRSIKLEIEIMTKLS--   98 (419)
Q Consensus        40 ~~y~i~~~LG~G~~-g~V~~a~~~~~g~~vaiK~i~~---~~~-------~~--------~~~~~~~~~Ei~il~~l~--   98 (419)
                      ++++.++.||.|.- |.||++..  .|..+|+|++..   ...       ..        ......|..|.+...+|+  
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            88999999999999 99999875  488999999322   110       00        012346888999888876  


Q ss_pred             CCCCc--eeeeEEEEeC------------------CEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH
Q 014733           99 GHPNV--VDLKAVYEEE------------------DYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCH  158 (419)
Q Consensus        99 ~hpnI--v~l~~~~~~~------------------~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH  158 (419)
                      ++.++  |+.+++..-.                  ....||.||++...         .++..    -+.+|++-|..+|
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~----~~~~~~~dl~~~~  181 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIR----DIPQMLRDLKILH  181 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchh----HHHHHHHHHHHHH
Confidence            34555  8999887321                  12457888876543         22222    3456778888999


Q ss_pred             hCCCeeccCCCCcEEEeecCCCCCeEEeeccce
Q 014733          159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLA  191 (419)
Q Consensus       159 ~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla  191 (419)
                      ..||+-+|+++.|..=        -||+|||.+
T Consensus       182 k~gI~~~Dv~~~ny~~--------G~lvDfs~~  206 (207)
T PF13095_consen  182 KLGIVPRDVKPRNYRG--------GKLVDFSSS  206 (207)
T ss_pred             HCCeeeccCccccccC--------CEEEecccC
Confidence            9999999999999763        199999865

>PLN02876 acyl-CoA dehydrogenase

Probab=98.17  E-value=2.2e-05  Score=86.63  Aligned_cols=82  Identities=16%  Similarity=0.213  Sum_probs=58.1

Q ss_pred             eeeeecccCceEEEEEEecCCC--cEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCc--eeeeEEEEeC---CEE
Q 014733           44 LGKQLGWGQFGVIRECSDKFTG--EVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNV--VDLKAVYEEE---DYV  116 (419)
Q Consensus        44 i~~~LG~G~~g~V~~a~~~~~g--~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnI--v~l~~~~~~~---~~~  116 (419)
                      .+++|+.|.+..+|+......+  ..+++|+.......  .....+.+|..+|+.|.+|+++  .+++.++.+.   +..
T Consensus        42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~--~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~  119 (822)
T PLN02876         42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL--QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA  119 (822)
T ss_pred             eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC--ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence            3677899999999998765322  46777776443211  2235688999999999645654  7777777664   467


Q ss_pred             EEEEeecCCCC
Q 014733          117 HLLMELCAGGE  127 (419)
Q Consensus       117 ~lV~E~~~ggs  127 (419)
                      |+||||++|..
T Consensus       120 flVME~v~G~~  130 (822)
T PLN02876        120 FYIMEYLEGRI  130 (822)
T ss_pred             eEEEEecCCcc
Confidence            89999998864

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.95  E-value=4.8e-05  Score=71.04  Aligned_cols=75  Identities=11%  Similarity=0.055  Sum_probs=47.6

Q ss_pred             eeeecccCce-EEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCC--CCceeeeEEEEeC---CEEEE
Q 014733           45 GKQLGWGQFG-VIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH--PNVVDLKAVYEEE---DYVHL  118 (419)
Q Consensus        45 ~~~LG~G~~g-~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~h--pnIv~l~~~~~~~---~~~~l  118 (419)
                      ++.|+.|+.. .||+.     +..+++|.....     .....+.+|.++|+.|.++  -.+.++++.....   ...++
T Consensus         2 ~~~~~~gG~~n~vy~~-----~~~~VlR~~~~~-----~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~   71 (235)
T cd05155           2 IEPVDSGGTDNATFRL-----GDDMSVRLPSAA-----GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWS   71 (235)
T ss_pred             ceeccCCCcccceEEc-----CCceEEEcCCcc-----chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceE
Confidence            3567777776 58875     235778875432     2345788999999988633  1344444443332   24588


Q ss_pred             EEeecCCCChH
Q 014733          119 LMELCAGGELF  129 (419)
Q Consensus       119 V~E~~~ggsL~  129 (419)
                      +|++++|.++.
T Consensus        72 l~~~i~G~~l~   82 (235)
T cd05155          72 VYRWLEGETAT   82 (235)
T ss_pred             EEEeecCCCCC
Confidence            99999997763

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=97.91  E-value=0.00011  Score=76.00  Aligned_cols=162  Identities=20%  Similarity=0.220  Sum_probs=98.0

Q ss_pred             cccchhhccccccCeeee--eeecccCceEEEEEEecCCCcEEEEEEeccCccCC-HHh---------------------
Q 014733           28 TILDATQISNLSDRYVLG--KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVT-VED---------------------   83 (419)
Q Consensus        28 ~~~~~~~~~~~~~~y~i~--~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~-~~~---------------------   83 (419)
                      .+++.+-...+.+-|...  +.||..+.|.|++|+.+. |+.||||+-+..--.. ..+                     
T Consensus       147 ~i~e~ElG~~ie~if~~f~~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~  225 (538)
T KOG1235|consen  147 KIFEEELGAPIEDIFSEFDEEPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLV  225 (538)
T ss_pred             HHHHHHhCCCHHHHHHhcCcchhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchh
Confidence            344444455555656553  579999999999999875 9999999875421100 001                     


Q ss_pred             ------HHH------HHHHHHHHHHcc---CCCC------ceeeeEEEEeCCEEEEEEeecCCCChHHH--HHHcCCCCH
Q 014733           84 ------VRS------IKLEIEIMTKLS---GHPN------VVDLKAVYEEEDYVHLLMELCAGGELFHR--LEKYGRFSE  140 (419)
Q Consensus        84 ------~~~------~~~Ei~il~~l~---~hpn------Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~--l~~~~~l~~  140 (419)
                            .+.      +.+|.+..++.+   .|-+      |.+++-  .-.....|+|||++|..+.+.  +.+.+ ++.
T Consensus       226 ~lvdE~~~~L~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~~g-i~~  302 (538)
T KOG1235|consen  226 WLVDEIAKSLPQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDKRG-ISP  302 (538)
T ss_pred             hHHHHHHhhhHhhcchHHHHHhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHHcC-CCH
Confidence                  111      222333222222   1333      223322  223456899999999877654  44433 444


Q ss_pred             HHHHHHHHHHHHHHH-HHHhCCCeeccCCCCcEEEeecC-CCCCeEEeeccceeeecc
Q 014733          141 TEARVIFRHLMQVVS-YCHGNGVVHRDLKPENILLATKS-SSSPIKLADFGLATYIKA  196 (419)
Q Consensus       141 ~~~~~i~~qll~aL~-~LH~~~IvHrDLkp~NILl~~~~-~~~~vKL~DFgla~~~~~  196 (419)
                      ..   +...+.++.. -+=..|.+|+|=+|.||++..+. .++.+.+-|||+...+..
T Consensus       303 ~~---i~~~l~~~~~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  303 HD---ILNKLVEAYLEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             HH---HHHHHHHHHHHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            43   3334444432 24456899999999999996432 456899999999986543

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.83  E-value=0.00024  Score=66.04  Aligned_cols=76  Identities=20%  Similarity=0.195  Sum_probs=50.1

Q ss_pred             eeeecccCceEEEEEEecC-CCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEEeec
Q 014733           45 GKQLGWGQFGVIRECSDKF-TGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELC  123 (419)
Q Consensus        45 ~~~LG~G~~g~V~~a~~~~-~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~  123 (419)
                      ++.|..|-...+|++.... .++.+++|+......    ..-...+|..+++.+..+.-.++++.... .   .++|||+
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~----~~~d~~~E~~~~~~l~~~gl~P~v~~~~~-~---~~l~e~i   74 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE----LIIDRERELRIHKLLSKHGLAPKLYATFQ-N---GLIYEFI   74 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc----ceecHHHHHHHHHHHHhCCCCCeEEEEeC-C---cEEEEee
Confidence            4567778888999886442 356788997754321    11234579999999864444555654432 2   3799999


Q ss_pred             CCCCh
Q 014733          124 AGGEL  128 (419)
Q Consensus       124 ~ggsL  128 (419)
                      +|.++
T Consensus        75 ~G~~l   79 (235)
T cd05157          75 PGRTL   79 (235)
T ss_pred             CCCcC
Confidence            98775

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.76  E-value=9.2e-05  Score=66.85  Aligned_cols=100  Identities=16%  Similarity=0.177  Sum_probs=79.5

Q ss_pred             HHHHHHHHHccCCCCceeeeEEEEeCCEEEEEEeecCCCChHHH---HHHcCCCCHHHHHHHHHHHHHHHHHHHh---CC
Q 014733           88 KLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHR---LEKYGRFSETEARVIFRHLMQVVSYCHG---NG  161 (419)
Q Consensus        88 ~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~---l~~~~~l~~~~~~~i~~qll~aL~~LH~---~~  161 (419)
                      ..|.-+|+.+.+.+++++++|.|-.    +++.||...+++...   +...-..+|..+..++.++++.+++|+.   ..
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            3588899999866899999999842    468899987766421   1222236899999999999999999998   45


Q ss_pred             CeeccCCCCcEEEeecCCCCCeEEeeccceeee
Q 014733          162 VVHRDLKPENILLATKSSSSPIKLADFGLATYI  194 (419)
Q Consensus       162 IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~  194 (419)
                      +.-.|++++|+-+   .+++++|++|.+.+...
T Consensus        83 ~~lcDv~~~nfgv---~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   83 FYLCDVSPDNFGV---NDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEEeecchHHeEE---eCCCcEEEEechhcchh
Confidence            8889999999999   45678999999977643

Proteins in this uncharacterised family are described as transmembrane proteins.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.72  E-value=0.00088  Score=67.36  Aligned_cols=81  Identities=15%  Similarity=0.131  Sum_probs=55.2

Q ss_pred             eeeecccCceEEEEEEecCCCcEEEEEEeccCcc----CCHHhHHHHHHHHHHHHHccCC--CCceeeeEEEEeCCEEEE
Q 014733           45 GKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRL----VTVEDVRSIKLEIEIMTKLSGH--PNVVDLKAVYEEEDYVHL  118 (419)
Q Consensus        45 ~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~----~~~~~~~~~~~Ei~il~~l~~h--pnIv~l~~~~~~~~~~~l  118 (419)
                      .+.||-|....||++.+...++.++||.-.....    ...-..+....|.+.|+.+..+  .++++++.+  +....++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            4679999999999999864435899998531100    0112456677788888887533  457777766  3344679


Q ss_pred             EEeecCCCC
Q 014733          119 LMELCAGGE  127 (419)
Q Consensus       119 V~E~~~ggs  127 (419)
                      ||||+++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999998744

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.67  E-value=4.1e-05  Score=73.51  Aligned_cols=150  Identities=21%  Similarity=0.245  Sum_probs=100.6

Q ss_pred             chhhcccccc---CeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccC-----------------CHH--hHHHHH
Q 014733           31 DATQISNLSD---RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLV-----------------TVE--DVRSIK   88 (419)
Q Consensus        31 ~~~~~~~~~~---~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~-----------------~~~--~~~~~~   88 (419)
                      +...++.+.+   -|.++++||-|.-+.+|.+.+. .|++.++|.-+.-+..                 ++.  ..-...
T Consensus        80 DyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~  158 (465)
T KOG2268|consen   80 DYLALKTLSNRGSVESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAAT  158 (465)
T ss_pred             hHHHHHHHHhcchhhhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHH
Confidence            3344444433   4677999999999999999875 6888999965432210                 000  112344


Q ss_pred             HHHHHHHHccCCCC-ceeeeEEEEeCCEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccC
Q 014733           89 LEIEIMTKLSGHPN-VVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDL  167 (419)
Q Consensus        89 ~Ei~il~~l~~hpn-Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDL  167 (419)
                      +|...|+.|..|-. |.+.    .+.+..++|||++.|-.|.+.-+-      ..+..+...++.-+--|-.+|+||+|.
T Consensus       159 kEfafmkaL~e~gfpVPkp----iD~~RH~Vvmelv~g~Pl~~v~~v------~d~~~ly~~lm~~Iv~la~~GlIHgDF  228 (465)
T KOG2268|consen  159 KEFAFMKALYERGFPVPKP----IDHNRHCVVMELVDGYPLRQVRHV------EDPPTLYDDLMGLIVRLANHGLIHGDF  228 (465)
T ss_pred             HHHHHHHHHHHcCCCCCCc----ccccceeeHHHhhcccceeeeeec------CChHHHHHHHHHHHHHHHHcCceeccc
Confidence            67777777753332 2222    245667899999988777554322      223345556667777899999999999


Q ss_pred             CCCcEEEeecCCCCCeEEeeccceeee
Q 014733          168 KPENILLATKSSSSPIKLADFGLATYI  194 (419)
Q Consensus       168 kp~NILl~~~~~~~~vKL~DFgla~~~  194 (419)
                      +--||++   .+++.++++||-.....
T Consensus       229 NEFNimv---~dd~~i~vIDFPQmvS~  252 (465)
T KOG2268|consen  229 NEFNIMV---KDDDKIVVIDFPQMVST  252 (465)
T ss_pred             chheeEE---ecCCCEEEeechHhhcc
Confidence            9999999   45778999999866543

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.65  E-value=3.4e-06  Score=93.84  Aligned_cols=211  Identities=12%  Similarity=0.035  Sum_probs=138.1

Q ss_pred             HHHHHHHHHHHHHccCCCCceeeeEEEEe--CCEEEEEEeecCCCChHHHHHHc----CCCCHHHHHHHHHHHHHHHHHH
Q 014733           84 VRSIKLEIEIMTKLSGHPNVVDLKAVYEE--EDYVHLLMELCAGGELFHRLEKY----GRFSETEARVIFRHLMQVVSYC  157 (419)
Q Consensus        84 ~~~~~~Ei~il~~l~~hpnIv~l~~~~~~--~~~~~lV~E~~~ggsL~~~l~~~----~~l~~~~~~~i~~qll~aL~~L  157 (419)
                      .+....|..-++... |++++....-...  ....|.+++|+.+|.+++.+-+.    .++++.-......+.+.+..-+
T Consensus      1273 kemll~e~de~~~~~-h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ 1351 (2724)
T KOG1826|consen 1273 KEMLLSERDELREAK-HYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVI 1351 (2724)
T ss_pred             HHhhhhhhhhhhhhh-ceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchh
Confidence            344445555555665 9998887766543  34567899999999999998553    2233333333334436666666


Q ss_pred             HhCC-----CeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCCc-cccccCCCccCCcccccC-CCCCchhHHHHHH
Q 014733          158 HGNG-----VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN-LHGTVGSPFYIAPEVLAG-GYNQAADVWSAGV  230 (419)
Q Consensus       158 H~~~-----IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~~-~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGv  230 (419)
                      |+..     .+|+++|+-|.+|+   .+-++|+.++|+.+...+... .....+++.|++|+.... .++.++|+|..|+
T Consensus      1352 ls~tnlg~T~v~~~Lkf~lpmIV---tny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~ 1428 (2724)
T KOG1826|consen 1352 LSLTNLGNTNVSKSLKFTLPMIV---TNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSL 1428 (2724)
T ss_pred             hhcccCCccchhhhhhhhcccee---cCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHH
Confidence            6542     78999999999994   456799999999994333322 334578888999988766 5888899999999


Q ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccc
Q 014733          231 ILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWME  301 (419)
Q Consensus       231 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~  301 (419)
                      .+|++..|..+|.......+...+.+.... ..+  .-.|.++......+|-+.-..||.-..++.-+.+.
T Consensus      1429 ~ly~rs~~n~~fi~flq~~Lkgiidn~tf~-sIe--~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1429 SLYLRSDGNAYFIFFLQPALKGIIDNHTFF-SIE--KLKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred             HHHHHhcccHHHHHHHHHHHcCcccccccc-ccc--ccCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence            999999998887432222222222221111 111  12345555566666666777899888888766553

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.63  E-value=0.00039  Score=67.09  Aligned_cols=137  Identities=17%  Similarity=0.115  Sum_probs=80.9

Q ss_pred             eeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCC-CceeeeEE------EEeCCEEE
Q 014733           45 GKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP-NVVDLKAV------YEEEDYVH  117 (419)
Q Consensus        45 ~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hp-nIv~l~~~------~~~~~~~~  117 (419)
                      .+.|..|....+|+...  .+..+++|++..      .....+..|+.+++.|..+- .+.+++..      ....+..+
T Consensus        19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~------~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~   90 (296)
T cd05153          19 FEGISAGIENTNYFVTT--DSGRYVLTLFEK------VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA   90 (296)
T ss_pred             eecccCccccceEEEEe--CCCcEEEEEcCC------CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence            55677788789998754  345788898753      12345777888888885221 24444331      23455678


Q ss_pred             EEEeecCCCChHH----HH----------HHc-CCC----------CHHHH--H--------HHHHHHHHHHHHHHh---
Q 014733          118 LLMELCAGGELFH----RL----------EKY-GRF----------SETEA--R--------VIFRHLMQVVSYCHG---  159 (419)
Q Consensus       118 lV~E~~~ggsL~~----~l----------~~~-~~l----------~~~~~--~--------~i~~qll~aL~~LH~---  159 (419)
                      +++++++|..+..    ..          +.. ..+          .+...  .        .....+..++.++.+   
T Consensus        91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~  170 (296)
T cd05153          91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP  170 (296)
T ss_pred             EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence            9999999876521    11          100 000          10000  0        011112333444443   


Q ss_pred             ----CCCeeccCCCCcEEEeecCCCCCeEEeecccee
Q 014733          160 ----NGVVHRDLKPENILLATKSSSSPIKLADFGLAT  192 (419)
Q Consensus       160 ----~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~  192 (419)
                          .+++|+|+.|.|||++   +++.+.|+||+.+.
T Consensus       171 ~~~~~~l~HgD~~~~Nil~~---~~~~~~iIDfe~a~  204 (296)
T cd05153         171 SDLPRGVIHADLFRDNVLFD---GDELSGVIDFYFAC  204 (296)
T ss_pred             hcCCCcCCccCcCcccEEEe---CCceEEEeehhhhc
Confidence                4699999999999994   34456899999876

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.57  E-value=0.00037  Score=65.89  Aligned_cols=134  Identities=16%  Similarity=0.127  Sum_probs=75.3

Q ss_pred             eecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEEeecCCC
Q 014733           47 QLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGG  126 (419)
Q Consensus        47 ~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~gg  126 (419)
                      .+..|-...+|+..  ..+..+++|.......   ...-...+|..+++.+..+.-..+++...  .+  ++||||++|.
T Consensus         3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~---~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~~--~~v~e~i~G~   73 (256)
T TIGR02721         3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCK---ALGVDRQREYQILQALSALGLAPKPILVN--EH--WLLVEWLEGE   73 (256)
T ss_pred             cCCCcCcCCeEEEE--eCCccEEEeeCCcccc---cccCcHHHHHHHHHHHHhcCCCCceEEEe--CC--EEEEEeccCc
Confidence            34567777899876  3466788887643211   10013577999999987442234444443  22  5899999987


Q ss_pred             ChHHH--------------HH---HcC----CCCHH-HHHHHHHHH---------HHHHHHHHh--------CCCeeccC
Q 014733          127 ELFHR--------------LE---KYG----RFSET-EARVIFRHL---------MQVVSYCHG--------NGVVHRDL  167 (419)
Q Consensus       127 sL~~~--------------l~---~~~----~l~~~-~~~~i~~ql---------l~aL~~LH~--------~~IvHrDL  167 (419)
                      .+...              +.   ...    +++.. .+..+..++         ...+..+-.        ..++|+|+
T Consensus        74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl  153 (256)
T TIGR02721        74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV  153 (256)
T ss_pred             ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence            65321              11   100    11211 111211111         111222221        24899999


Q ss_pred             CCCcEEEeecCCCCCeEEeeccceee
Q 014733          168 KPENILLATKSSSSPIKLADFGLATY  193 (419)
Q Consensus       168 kp~NILl~~~~~~~~vKL~DFgla~~  193 (419)
                      .|.||+++   +++ +.|+||..+..
T Consensus       154 ~~~Nil~~---~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       154 HAYNLVVT---PQG-LKLIDWEYASD  175 (256)
T ss_pred             CcCcEEEe---CCC-CEEEeccccCc
Confidence            99999994   333 78999998874

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.55  E-value=0.00042  Score=67.42  Aligned_cols=138  Identities=20%  Similarity=0.171  Sum_probs=78.6

Q ss_pred             eeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCC-CCceeeeEE------EEeCCEEE
Q 014733           45 GKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH-PNVVDLKAV------YEEEDYVH  117 (419)
Q Consensus        45 ~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~h-pnIv~l~~~------~~~~~~~~  117 (419)
                      ...++.|....+|+.... +| .+++|+.....     ....+..|.++++.|.++ -.+.+++..      ....+..+
T Consensus        27 i~~~~~G~~n~~y~v~t~-~~-~~vLK~~~~~~-----~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~   99 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTD-VG-RYILTLYEKRV-----KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPA   99 (307)
T ss_pred             ccccCCccccceEEEEeC-CC-cEEEEEecCCC-----CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEE
Confidence            456777777899987542 33 57889875421     123455677888777521 123444332      12346678


Q ss_pred             EEEeecCCCChH-----------HHH---HHc-CCCC-------HHHHH----------------HHHHHHHHHHHHHHh
Q 014733          118 LLMELCAGGELF-----------HRL---EKY-GRFS-------ETEAR----------------VIFRHLMQVVSYCHG  159 (419)
Q Consensus       118 lV~E~~~ggsL~-----------~~l---~~~-~~l~-------~~~~~----------------~i~~qll~aL~~LH~  159 (419)
                      ++++|++|..+.           ..+   +.. ..++       ....+                .....+...++++..
T Consensus       100 ~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~  179 (307)
T TIGR00938       100 CLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDK  179 (307)
T ss_pred             EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHh
Confidence            999999885431           111   100 0010       00100                001123334555532


Q ss_pred             -------CCCeeccCCCCcEEEeecCCCCCeEEeecccee
Q 014733          160 -------NGVVHRDLKPENILLATKSSSSPIKLADFGLAT  192 (419)
Q Consensus       160 -------~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~  192 (419)
                             .+++|+|+++.||+++   .++.+.|+||+.+.
T Consensus       180 ~~~~~~~~~l~HgD~~~~Nvl~~---~~~~~~vIDfd~~~  216 (307)
T TIGR00938       180 FWPRDLPRGVIHADLFPDNVLFD---GDSVKGVIDFYFAC  216 (307)
T ss_pred             hhhhcCCCccCCCCCCcCcEEEE---CCceEEEeeccccc
Confidence                   5799999999999994   34456899999876

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.45  E-value=0.00098  Score=64.57  Aligned_cols=77  Identities=12%  Similarity=0.064  Sum_probs=50.1

Q ss_pred             eeeecccCceEEEEEEecC------CCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEE
Q 014733           45 GKQLGWGQFGVIRECSDKF------TGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHL  118 (419)
Q Consensus        45 ~~~LG~G~~g~V~~a~~~~------~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~l  118 (419)
                      ++.|..|--..+|+.....      .++.+++|+.....    .......+|..+++.+..+--..+++..+. +   .+
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~----~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~   74 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV----ELLIDRERELVVFARLSERNLGPKLYGIFP-N---GR   74 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC----cceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cc
Confidence            3456666667888876542      35789999976432    223456789999998874433445565554 2   25


Q ss_pred             EEeecCCCChH
Q 014733          119 LMELCAGGELF  129 (419)
Q Consensus       119 V~E~~~ggsL~  129 (419)
                      |+||++|..+.
T Consensus        75 v~e~i~G~~l~   85 (302)
T cd05156          75 IEEFIPSRTLT   85 (302)
T ss_pred             hhheeCCCcCC
Confidence            89999887664

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK05231 homoserine kinase; Provisional

Probab=97.32  E-value=0.0056  Score=59.74  Aligned_cols=76  Identities=12%  Similarity=-0.016  Sum_probs=44.8

Q ss_pred             eeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCC-CCceeeeE------EEEeCCEEE
Q 014733           45 GKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH-PNVVDLKA------VYEEEDYVH  117 (419)
Q Consensus        45 ~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~h-pnIv~l~~------~~~~~~~~~  117 (419)
                      .+.|+.|....+|+....  +..+++|++. .  ..   ...+..|..+++.|..+ -.+.+.+.      +....+..+
T Consensus        27 ~~~l~~G~~n~~y~v~t~--~g~~vLK~~~-~--~~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~   98 (319)
T PRK05231         27 LKGIAEGIENSNFFLTTT--QGEYVLTLFE-R--LT---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPA   98 (319)
T ss_pred             cchhccccccceEEEEeC--CCcEEEEEec-c--CC---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEE
Confidence            345667777889987643  3368899875 2  12   23344566666666411 11333332      123356788


Q ss_pred             EEEeecCCCCh
Q 014733          118 LLMELCAGGEL  128 (419)
Q Consensus       118 lV~E~~~ggsL  128 (419)
                      ++++|++|..+
T Consensus        99 ~l~~~l~G~~~  109 (319)
T PRK05231         99 AIVTFLEGKWP  109 (319)
T ss_pred             EEEEecCCCCC
Confidence            99999998753

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.17  E-value=0.0032  Score=61.79  Aligned_cols=141  Identities=17%  Similarity=0.233  Sum_probs=94.1

Q ss_pred             eeeecccCceEEEEEEecCCCcEEEEEEeccCccCCH----------------------HhHHH-HHHHHHHHHHccCCC
Q 014733           45 GKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTV----------------------EDVRS-IKLEIEIMTKLSGHP  101 (419)
Q Consensus        45 ~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~----------------------~~~~~-~~~Ei~il~~l~~hp  101 (419)
                      ..-|..|.-+.||.|... +|..+|||++.-+-+.-.                      ..++. ...|++.|.++. ..
T Consensus       149 nGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~-~a  226 (520)
T KOG2270|consen  149 NGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLN-NA  226 (520)
T ss_pred             ccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHH-hc
Confidence            345777888999998765 788899999854322111                      11121 346888888885 44


Q ss_pred             CceeeeEEEEeCCEEEEEEeecCCCCh-HHHHHHcCCCCHHHHHHHHHHHHHHHHHH-HhCCCeeccCCCCcEEEeecCC
Q 014733          102 NVVDLKAVYEEEDYVHLLMELCAGGEL-FHRLEKYGRFSETEARVIFRHLMQVVSYC-HGNGVVHRDLKPENILLATKSS  179 (419)
Q Consensus       102 nIv~l~~~~~~~~~~~lV~E~~~ggsL-~~~l~~~~~l~~~~~~~i~~qll~aL~~L-H~~~IvHrDLkp~NILl~~~~~  179 (419)
                      .|.----+.. . ...|||+++....- .-.| +.-.++...+..+-.+++.-+.-| |..++||.||.--|+|+    -
T Consensus       227 GIP~PePIlL-k-~hVLVM~FlGrdgw~aPkL-Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly----h  299 (520)
T KOG2270|consen  227 GIPCPEPILL-K-NHVLVMEFLGRDGWAAPKL-KDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY----H  299 (520)
T ss_pred             CCCCCCceee-e-cceEeeeeccCCCCcCccc-ccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE----E
Confidence            4332221112 2 24689999953221 1222 224577888888888888888754 56799999999999999    4


Q ss_pred             CCCeEEeeccceeee
Q 014733          180 SSPIKLADFGLATYI  194 (419)
Q Consensus       180 ~~~vKL~DFgla~~~  194 (419)
                      +|.+.++|.+.+...
T Consensus       300 dG~lyiIDVSQSVE~  314 (520)
T KOG2270|consen  300 DGKLYIIDVSQSVEH  314 (520)
T ss_pred             CCEEEEEEccccccC
Confidence            689999999877643

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.12  E-value=0.0044  Score=59.46  Aligned_cols=30  Identities=33%  Similarity=0.478  Sum_probs=23.8

Q ss_pred             CCeeccCCCCcEEEeecCCCCC-eEEeeccceee
Q 014733          161 GVVHRDLKPENILLATKSSSSP-IKLADFGLATY  193 (419)
Q Consensus       161 ~IvHrDLkp~NILl~~~~~~~~-vKL~DFgla~~  193 (419)
                      .++|+|++|.|||++   +++. .-|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~---~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILID---EDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEe---CCCCEEEEECcHhccc
Confidence            389999999999995   2244 46999998874

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.00  E-value=0.0098  Score=58.86  Aligned_cols=78  Identities=13%  Similarity=0.119  Sum_probs=49.2

Q ss_pred             eecccCceEEEEEEecCCCcEEEEEEecc--C--ccCCHHhHHHHHHHHHHHHHccCC-C-CceeeeEEEEeCCEEEEEE
Q 014733           47 QLGWGQFGVIRECSDKFTGEVLACKSIAK--D--RLVTVEDVRSIKLEIEIMTKLSGH-P-NVVDLKAVYEEEDYVHLLM  120 (419)
Q Consensus        47 ~LG~G~~g~V~~a~~~~~g~~vaiK~i~~--~--~~~~~~~~~~~~~Ei~il~~l~~h-p-nIv~l~~~~~~~~~~~lV~  120 (419)
                      .||-|.-..||++.+...++.++||.-..  .  ....+-...+...|.+.|+..... | .+++++.+  +.....+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            47889999999999764336899997531  1  111233456667788888776432 3 35555433  333455899


Q ss_pred             eecCCC
Q 014733          121 ELCAGG  126 (419)
Q Consensus       121 E~~~gg  126 (419)
                      |+++..
T Consensus        80 EdL~~~   85 (370)
T TIGR01767        80 EDLSHH   85 (370)
T ss_pred             hhCccc
Confidence            998653

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PLN02236 choline kinase

Probab=96.87  E-value=0.012  Score=58.20  Aligned_cols=144  Identities=15%  Similarity=0.124  Sum_probs=83.8

Q ss_pred             cCeeeeeeecccCceEEEEEEecC----CCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKF----TGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDY  115 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~----~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~  115 (419)
                      ....-+..|-.|-...+|++....    .++.+++|+.....   ...+. ..+|..+++.+..+.--.++++.+.. + 
T Consensus        36 ~~~~~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~-g-  109 (344)
T PLN02236         36 DEALQVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFD-RDDEIRTFECMSRHGQGPRLLGRFPN-G-  109 (344)
T ss_pred             cCcEEEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeec-hHHHHHHHHHHHHcCCCCceEEEECC-c-
Confidence            334445566567778999986432    34688999876532   12222 36799999998755445566666533 2 


Q ss_pred             EEEEEeecCCCChHHH----------H-------HHcC----C--CCHHHHHHHHHHH-----------------HHHHH
Q 014733          116 VHLLMELCAGGELFHR----------L-------EKYG----R--FSETEARVIFRHL-----------------MQVVS  155 (419)
Q Consensus       116 ~~lV~E~~~ggsL~~~----------l-------~~~~----~--l~~~~~~~i~~ql-----------------l~aL~  155 (419)
                        .|++|++|.+|...          +       +...    .  .....+..+..++                 ...+.
T Consensus       110 --~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~  187 (344)
T PLN02236        110 --RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEIN  187 (344)
T ss_pred             --eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHH
Confidence              57999988776421          0       0100    0  1122222332111                 11122


Q ss_pred             HH----H----hCCCeeccCCCCcEEEeecCCCCCeEEeeccceee
Q 014733          156 YC----H----GNGVVHRDLKPENILLATKSSSSPIKLADFGLATY  193 (419)
Q Consensus       156 ~L----H----~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~  193 (419)
                      .|    .    ...++|+|+++.|||++.  .++.+.|+||..+..
T Consensus       188 ~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~--~~~~~~lID~Eya~~  231 (344)
T PLN02236        188 LLEKELSGDDQEIGFCHNDLQYGNIMIDE--ETRAITIIDYEYASY  231 (344)
T ss_pred             HHHHHhcccCCCceEEeCCCCcCcEEEeC--CCCcEEEEeehhccc
Confidence            22    2    225899999999999953  235799999988763

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.86  E-value=0.0038  Score=63.66  Aligned_cols=166  Identities=20%  Similarity=0.181  Sum_probs=105.9

Q ss_pred             HHHHHHHHHHHccCCCCceeeeEEEEe-CCEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 014733           86 SIKLEIEIMTKLSGHPNVVDLKAVYEE-EDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVH  164 (419)
Q Consensus        86 ~~~~Ei~il~~l~~hpnIv~l~~~~~~-~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvH  164 (419)
                      ++.-...+++.+. |+|...++++-.. ..+..+|||++ +.+|.+.+.... +-....             +     +|
T Consensus        28 ~ilgr~~~lktl~-~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~~s~-------------~-----~~   86 (725)
T KOG1093|consen   28 QILGRFQYLKSLQ-HDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-LKDESL-------------L-----AH   86 (725)
T ss_pred             HHhhhhHHHHhhc-CccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-cchhhh-------------c-----cc
Confidence            4455667888886 9999999888753 34588999999 779998887643 211111             0     22


Q ss_pred             ccCCCCcEEEeecCCCCCeEEeeccceeeeccCCccccccCCCccCCcccccCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 014733          165 RDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWG  244 (419)
Q Consensus       165 rDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~~~s~~sDvwSlGvil~elltG~~Pf~~  244 (419)
                      + +-+.|+          ++.+| -++..               |  |-    ...+++||||+|.++.++..|..-+..
T Consensus        87 ~-~~~~~~----------~~~td-~~~t~---------------~--~~----~~~pKsdVwsl~~i~~el~L~~~l~~~  133 (725)
T KOG1093|consen   87 G-VLHLNI----------IYITD-HFLTK---------------Y--PS----PIGPKSDVWSLGFIILELYLGISLEAE  133 (725)
T ss_pred             c-cceehh----------hhccc-ccccc---------------C--CC----CCCcchhhhhHHHHHHHHHHhhHHHHH
Confidence            2 111222          23344 11110               0  10    112599999999999999999888876


Q ss_pred             CCHHHHHHHHHhcCCCCCCCC--------CCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          245 KTKSKIFDAVRAADLRFPSDP--------WDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       245 ~~~~~~~~~i~~~~~~~~~~~--------~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                      ....+..+.+...........        -..++....++...|+-..|..||...++.+++-|.+...
T Consensus       134 ~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev~~  202 (725)
T KOG1093|consen  134 LTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEVYK  202 (725)
T ss_pred             HHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHHHh
Confidence            666555555544321111000        0135666788999999999999999999999998876533

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.82  E-value=0.012  Score=57.38  Aligned_cols=146  Identities=18%  Similarity=0.206  Sum_probs=82.2

Q ss_pred             eeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccC-CCCceeeeEEEEeCC--EEEE
Q 014733           42 YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG-HPNVVDLKAVYEEED--YVHL  118 (419)
Q Consensus        42 y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~-hpnIv~l~~~~~~~~--~~~l  118 (419)
                      -.+++.+-.|.--.+|...+.  ++.+++....  ............+|..+++.+.. -.-+...++++.+..  ..+.
T Consensus        27 ~~~v~~~~~G~sn~t~~~~~~--~~~~vlR~P~--~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~  102 (321)
T COG3173          27 LLIVEEISGGWSNDTFRLGDT--GQKYVLRKPP--RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFY  102 (321)
T ss_pred             CceeeeccCCcccceEEEecC--CceEEEecCC--ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceE
Confidence            344555544444455555443  7788888322  12233556778889999998842 123334566665554  7799


Q ss_pred             EEeecCCCChHH----------HHH--------H-c----------C---CCCHHHHHHHHHHH--------------HH
Q 014733          119 LMELCAGGELFH----------RLE--------K-Y----------G---RFSETEARVIFRHL--------------MQ  152 (419)
Q Consensus       119 V~E~~~ggsL~~----------~l~--------~-~----------~---~l~~~~~~~i~~ql--------------l~  152 (419)
                      ||+|++|..+..          +..        . +          +   .+...+...+..+.              ..
T Consensus       103 v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~  182 (321)
T COG3173         103 VMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADR  182 (321)
T ss_pred             EEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHH
Confidence            999998833211          111        0 0          0   00111111111111              12


Q ss_pred             HHHHHHhC--------CCeeccCCCCcEEEeecCCCCCeEEeeccceeee
Q 014733          153 VVSYCHGN--------GVVHRDLKPENILLATKSSSSPIKLADFGLATYI  194 (419)
Q Consensus       153 aL~~LH~~--------~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~  194 (419)
                      -..||+.+        .++|+|+++.||+++   ..+.+=+.||+++..-
T Consensus       183 ~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~---~~~~~gVlDwe~~~lG  229 (321)
T COG3173         183 LIKWLEANRPPWAGPPVLVHGDYRPGNLIID---PGRPTGVLDWELATLG  229 (321)
T ss_pred             HHHHHHhcCCCcCCCceeeeCCcccCCEEEe---CCCeeEEEeccccccC
Confidence            23455443        379999999999995   4445889999998853

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.73  E-value=0.014  Score=57.48  Aligned_cols=77  Identities=13%  Similarity=0.099  Sum_probs=47.2

Q ss_pred             eeeeecccCceEEEEEEecCC---CcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEE
Q 014733           44 LGKQLGWGQFGVIRECSDKFT---GEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLM  120 (419)
Q Consensus        44 i~~~LG~G~~g~V~~a~~~~~---g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~  120 (419)
                      .++.|..|--..+|+......   +..|++|+.....   . ..-.-.+|..+++.+..+.--.++++++. ++   +|.
T Consensus        18 ~i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t---~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~   89 (330)
T PLN02421         18 SVERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNT---D-YVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQ   89 (330)
T ss_pred             EEEEeCCcccceEEEEEecCCCCCCceEEEEEecCCc---C-eEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---Eee
Confidence            344555566678888764422   2378899875431   1 12234578899998874444456666653 33   588


Q ss_pred             eecCCCCh
Q 014733          121 ELCAGGEL  128 (419)
Q Consensus       121 E~~~ggsL  128 (419)
                      +|++|.+|
T Consensus        90 ~fi~g~~l   97 (330)
T PLN02421         90 SFINARTL   97 (330)
T ss_pred             hhhcCCCC
Confidence            99987765

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.67  E-value=0.024  Score=57.05  Aligned_cols=78  Identities=9%  Similarity=-0.006  Sum_probs=52.4

Q ss_pred             eeeeecccCceEEEEEEecCCCcEEEEEEeccCcc-CC---HHhHHHHHHHHHHHHHccC--CCCceeeeEEEEeCCEEE
Q 014733           44 LGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRL-VT---VEDVRSIKLEIEIMTKLSG--HPNVVDLKAVYEEEDYVH  117 (419)
Q Consensus        44 i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~-~~---~~~~~~~~~Ei~il~~l~~--hpnIv~l~~~~~~~~~~~  117 (419)
                      ..+.||-|....||+..+.  +..++||.-..... ..   +....+-..|.+.|+.+..  ..++.+++.++.+.  -+
T Consensus        36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~--~v  111 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTM--AL  111 (418)
T ss_pred             eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCC--CE
Confidence            3667899999999998763  45688997652211 11   1244555566777776642  25788888887744  46


Q ss_pred             EEEeecCC
Q 014733          118 LLMELCAG  125 (419)
Q Consensus       118 lV~E~~~g  125 (419)
                      ++||++++
T Consensus       112 lvME~L~~  119 (418)
T PLN02756        112 IGMRYLEP  119 (418)
T ss_pred             EEEeecCC
Confidence            78999976

>PRK10593 hypothetical protein; Provisional

Probab=96.65  E-value=0.017  Score=56.10  Aligned_cols=105  Identities=10%  Similarity=-0.039  Sum_probs=74.4

Q ss_pred             eeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCC--CCceeeeEEEEe---CCEEEE
Q 014733           44 LGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH--PNVVDLKAVYEE---EDYVHL  118 (419)
Q Consensus        44 i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~h--pnIv~l~~~~~~---~~~~~l  118 (419)
                      -.+.||.|..+.||..... .+ .+++|..+ ..    .....+..|...|+.|..+  -.+.++++++.+   .+..++
T Consensus        18 ~~~~i~~G~~~~vy~~~~~-~~-~~~~k~~~-~~----~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~L   90 (297)
T PRK10593         18 RVECISEQPYAALWALYDS-QG-NPMPLMAR-SF----STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVL   90 (297)
T ss_pred             eeeecCCccceeEEEEEcC-CC-CEEEEEec-cc----ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEE
Confidence            3567999999999997543 23 46777743 21    1235788999999999754  468888888764   366899


Q ss_pred             EEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 014733          119 LMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGN  160 (419)
Q Consensus       119 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~  160 (419)
                      |||+++|.++.+.     ..+......+..+++++|+-||+.
T Consensus        91 VmE~i~G~~~~~~-----~~~~~~~~~l~~~l~~~La~LH~~  127 (297)
T PRK10593         91 LLERLRGVSVEAP-----ARTPERWEQLKDQIVEGLLAWHRI  127 (297)
T ss_pred             EEeccCCEecCCC-----CCCHHHHHHHHHHHHHHHHHHhCC
Confidence            9999999877651     123444556667788888888874

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.17  E-value=0.025  Score=54.56  Aligned_cols=74  Identities=19%  Similarity=0.104  Sum_probs=48.8

Q ss_pred             eeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHcc--CCCCceeeeEEEEeCCEEEEEEee
Q 014733           45 GKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLS--GHPNVVDLKAVYEEEDYVHLLMEL  122 (419)
Q Consensus        45 ~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~--~hpnIv~l~~~~~~~~~~~lV~E~  122 (419)
                      .+.++-|....+|+..  .+++.+.+|+-..      .....+..|.+-|+.|.  ..-.+.+++.+....+.-+++|||
T Consensus        22 ~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~------~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~   93 (288)
T PF03881_consen   22 IEPVSGGDINEAYRLD--TDGGSYFVKVNSE------SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEF   93 (288)
T ss_dssp             EEEE--SSSSEEEEEE--TTS-EEEEEEEEG------GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-
T ss_pred             eEecCCCChhheEEEE--CCCccEEEEecCh------hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEe
Confidence            5678889999999876  5678899998652      23456788999888884  345577889988877777999999


Q ss_pred             cCCC
Q 014733          123 CAGG  126 (419)
Q Consensus       123 ~~gg  126 (419)
                      ++.+
T Consensus        94 l~~~   97 (288)
T PF03881_consen   94 LEMG   97 (288)
T ss_dssp             ----
T ss_pred             ecCC
Confidence            8766

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.11  E-value=0.045  Score=54.93  Aligned_cols=79  Identities=14%  Similarity=0.103  Sum_probs=51.2

Q ss_pred             eeeecccCceEEEEEEecCCCcEEEEEEeccCc---cCCHHhHHHHHHHHHHHHHccC-CC-CceeeeEEEEeCCEEEEE
Q 014733           45 GKQLGWGQFGVIRECSDKFTGEVLACKSIAKDR---LVTVEDVRSIKLEIEIMTKLSG-HP-NVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        45 ~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~---~~~~~~~~~~~~Ei~il~~l~~-hp-nIv~l~~~~~~~~~~~lV  119 (419)
                      .+.||-|.-..||++.+...+..++||.-...-   ...+-..++...|.++|+.+.. .| .+++++.+  +.....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            567899999999999875335678998653111   1123356777788888887653 23 45555543  33335688


Q ss_pred             EeecCC
Q 014733          120 MELCAG  125 (419)
Q Consensus       120 ~E~~~g  125 (419)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            998864

>PTZ00384 choline kinase; Provisional

Probab=96.11  E-value=0.053  Score=54.47  Aligned_cols=80  Identities=11%  Similarity=0.066  Sum_probs=49.6

Q ss_pred             eeeeeeecccCceEEEEEEecCC-CcE-----EEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCE
Q 014733           42 YVLGKQLGWGQFGVIRECSDKFT-GEV-----LACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDY  115 (419)
Q Consensus        42 y~i~~~LG~G~~g~V~~a~~~~~-g~~-----vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~  115 (419)
                      -..++.|..|--..+|++..... +..     |.++.....   . ...-.-.+|+.+++.|..+..-.++++.+..   
T Consensus        52 ~i~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~---~-~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~---  124 (383)
T PTZ00384         52 FIEIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY---N-SLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD---  124 (383)
T ss_pred             cEEEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCC---C-ceEeccHHHHHHHHHHHhCCCCCeEEEecCC---
Confidence            34456676688889999865422 122     333332111   1 1112335689999999866666777777753   


Q ss_pred             EEEEEeecCCCChH
Q 014733          116 VHLLMELCAGGELF  129 (419)
Q Consensus       116 ~~lV~E~~~ggsL~  129 (419)
                       +++.||++|.+|.
T Consensus       125 -g~l~efIeGr~l~  137 (383)
T PTZ00384        125 -FTIQEWVEGNTMG  137 (383)
T ss_pred             -EEEEEEeccccCC
Confidence             4899999987764

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=95.82  E-value=0.018  Score=52.72  Aligned_cols=119  Identities=21%  Similarity=0.188  Sum_probs=59.6

Q ss_pred             CcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEEeecCCCChHH-------HHH----
Q 014733           65 GEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFH-------RLE----  133 (419)
Q Consensus        65 g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~-------~l~----  133 (419)
                      ++.|++++.-...    ...-....|..+++.+..+-.-.++++.+.+.    .|++|+.|.+|..       .+.    
T Consensus         2 ~~~~~~Ri~g~~t----~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~g----~v~e~i~g~~l~~~~~~~~~~~~~iA~   73 (211)
T PF01633_consen    2 PEKYLVRIPGEGT----ENFIDRENENEALKLLSEAGLGPKIIYFFENG----RVEEFIEGRTLSPEDFRNPEILKRIAK   73 (211)
T ss_dssp             TSEEEEEEEESCG----CSHHHHHHHHHHHHHHHHTTSSS-EEEEETTE----EEEE--SSEE--CGGGGSHHHHHHHHH
T ss_pred             CCEEEEEeCCCCc----ccccCHHHHHHHHHHHHHcCCCCeEEEEcCCC----cEEEEecccccChhhccChHHHHHHHH
Confidence            4568888876542    23455677999999987555555666654322    5679987766421       110    


Q ss_pred             ---------H--cCC--CCHHHHHHH----------------------HHHHHHHHHHHHh--------CCCeeccCCCC
Q 014733          134 ---------K--YGR--FSETEARVI----------------------FRHLMQVVSYCHG--------NGVVHRDLKPE  170 (419)
Q Consensus       134 ---------~--~~~--l~~~~~~~i----------------------~~qll~aL~~LH~--------~~IvHrDLkp~  170 (419)
                               .  ...  --+..+..+                      +..+.+-+..+.+        .-..|+|+.+.
T Consensus        74 ~l~~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~  153 (211)
T PF01633_consen   74 LLAKLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPG  153 (211)
T ss_dssp             HHHHHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGG
T ss_pred             HHHHHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccc
Confidence                     0  000  001112112                      1112222222221        24789999999


Q ss_pred             cEEEeecCCCCCeEEeeccceee
Q 014733          171 NILLATKSSSSPIKLADFGLATY  193 (419)
Q Consensus       171 NILl~~~~~~~~vKL~DFgla~~  193 (419)
                      |||++  ..++.++|+||..|..
T Consensus       154 Nil~~--~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  154 NILIN--NKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             GEEET--SSSSCEEE--GTT-EE
T ss_pred             cEEec--cCCCeEEEecHHHHhh
Confidence            99993  3567899999998874

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.37  E-value=0.1  Score=51.46  Aligned_cols=118  Identities=19%  Similarity=0.260  Sum_probs=77.0

Q ss_pred             CCCCceeeeEEE-EeCCEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC-CCeeccCCCCcEEEee
Q 014733           99 GHPNVVDLKAVY-EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGN-GVVHRDLKPENILLAT  176 (419)
Q Consensus        99 ~hpnIv~l~~~~-~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~-~IvHrDLkp~NILl~~  176 (419)
                      +.++..+.+-+- .+..+.|++|++- |+.|.. +   .--..+++..++++.+..+.-+..+ ..-|||+...||||  
T Consensus       283 g~~~~e~~~vv~~de~~y~yl~~kdh-gt~is~-i---k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLI--  355 (488)
T COG5072         283 GSVFLETLKVVSLDETLYLYLHFKDH-GTPISI-I---KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILI--  355 (488)
T ss_pred             cchhhhcceEEecCCceEEEEEEecC-Cceeee-e---ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceee--
Confidence            345555555444 4455778889886 555432 2   2246788899999998888777755 58899999999999  


Q ss_pred             cCCCCCeEEeeccceeeeccCCccccccCCCccCCcccccCCCCCchhHHHHH
Q 014733          177 KSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGGYNQAADVWSAG  229 (419)
Q Consensus       177 ~~~~~~vKL~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~~~s~~sDvwSlG  229 (419)
                       + .|+|.|+||-+++. ..++.   ..-....-.|-.+.|.-+..-|||-+.
T Consensus       356 -d-~GnvtLIDfklsRl-~~~q~---~isy~rldhp~lF~G~dd~QFeIYrlM  402 (488)
T COG5072         356 -D-EGNVTLIDFKLSRL-SYSQG---IISYNRLDHPDLFNGVDDYQFEIYRLM  402 (488)
T ss_pred             -e-cCceEEEEeeeeec-ccCCc---eeeccccCchhhhcCccceeeeHHHHH
Confidence             3 78999999999983 22221   111122344545555445666777643

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=95.30  E-value=0.28  Score=47.72  Aligned_cols=30  Identities=20%  Similarity=0.289  Sum_probs=25.9

Q ss_pred             CCeeccCCCCcEEEeecCCCCCeEEeeccceee
Q 014733          161 GVVHRDLKPENILLATKSSSSPIKLADFGLATY  193 (419)
Q Consensus       161 ~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~  193 (419)
                      +++|+|+.+.|||+   +.++.+.++||..+..
T Consensus       197 ~lcHgD~~~~Nvl~---~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLY---DETRGGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEE---cCCCCEEEEEhhhccc
Confidence            69999999999999   4556789999998873

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.01  E-value=0.45  Score=46.71  Aligned_cols=72  Identities=17%  Similarity=0.129  Sum_probs=43.3

Q ss_pred             cCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCC-CCcee---eeE--EEEeCCEEEEEEeecC
Q 014733           51 GQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH-PNVVD---LKA--VYEEEDYVHLLMELCA  124 (419)
Q Consensus        51 G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~h-pnIv~---l~~--~~~~~~~~~lV~E~~~  124 (419)
                      +.-..||.... .+|..+++|+.+...    .....+..|...+..|..+ =.++.   .-+  +...++..+.++++++
T Consensus        36 s~eN~vy~v~~-~~~~~~vlKv~r~~~----~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~  110 (325)
T PRK11768         36 SYENRVYQFGD-EDGRRVVAKFYRPER----WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRG  110 (325)
T ss_pred             cccceEEEEec-CCCCEEEEEEcCccc----CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeC
Confidence            34457888754 356779999876432    2345677788888877522 11222   111  2233567888999998


Q ss_pred             CCC
Q 014733          125 GGE  127 (419)
Q Consensus       125 ggs  127 (419)
                      |..
T Consensus       111 G~~  113 (325)
T PRK11768        111 GRA  113 (325)
T ss_pred             CCC
Confidence            764

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=94.69  E-value=0.13  Score=51.39  Aligned_cols=60  Identities=17%  Similarity=0.183  Sum_probs=43.4

Q ss_pred             EEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHH-HHHhCCCeeccCCCCcEEEee
Q 014733          116 VHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS-YCHGNGVVHRDLKPENILLAT  176 (419)
Q Consensus       116 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~-~LH~~~IvHrDLkp~NILl~~  176 (419)
                      ..++-+|..|.++..++.. ...++.....++.-.+.||. -|--.+.+|.|++|.||++-.
T Consensus       320 ~vl~E~~~~Gl~v~~~v~~-~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf  380 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVKW-KSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRF  380 (565)
T ss_pred             ceeeeeccccccHHhhhhc-ccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEe
Confidence            4566678889999888865 33555566666666666654 344567999999999999954

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=94.68  E-value=0.56  Score=43.56  Aligned_cols=76  Identities=18%  Similarity=0.152  Sum_probs=51.6

Q ss_pred             eeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHcc--CCCCceeeeEEEEeCCEEEEEEeec
Q 014733           46 KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLS--GHPNVVDLKAVYEEEDYVHLLMELC  123 (419)
Q Consensus        46 ~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~--~hpnIv~l~~~~~~~~~~~lV~E~~  123 (419)
                      +.+.-|..-..|...+  ...++.+|+-      .......+..|+.-|+.+.  +.-.+.+++.+..+.++.|+||||+
T Consensus        22 ~~v~gG~inea~~v~d--g~~~~FvK~n------~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L   93 (286)
T COG3001          22 EEVSGGDINEAWRLRD--GTDPFFVKCN------QREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYL   93 (286)
T ss_pred             cccCCccccceeEeec--CCcceEEEec------chhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeec
Confidence            3444454445554433  2356778863      2345677888888777775  2356778888899999999999999


Q ss_pred             CCCChH
Q 014733          124 AGGELF  129 (419)
Q Consensus       124 ~ggsL~  129 (419)
                      +-+.+.
T Consensus        94 ~~~~~d   99 (286)
T COG3001          94 PTGPLD   99 (286)
T ss_pred             cCCCCC
Confidence            876554

>PRK06148 hypothetical protein; Provisional

Probab=94.31  E-value=0.51  Score=53.55  Aligned_cols=140  Identities=18%  Similarity=0.229  Sum_probs=75.9

Q ss_pred             eeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCC------CCceee-----eEEEEe-C
Q 014733           46 KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH------PNVVDL-----KAVYEE-E  113 (419)
Q Consensus        46 ~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~h------pnIv~l-----~~~~~~-~  113 (419)
                      +.|+ |..-.+|+... .+|..+++|+.+...     ....+..|..+|..|..+      |.+++-     +....+ +
T Consensus        31 ~~L~-s~~d~nf~v~~-~~g~~yVLKi~~~~~-----~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~  103 (1013)
T PRK06148         31 TPLD-GERDLNFRLTT-DDGADYILKIVNPSE-----PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPD  103 (1013)
T ss_pred             eecC-CcCCceEEEEe-CCCCeEEEEEcCCcc-----chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCC
Confidence            4564 34567787754 357789999987542     223445566677666422      222321     111222 2


Q ss_pred             C--EEEEEEeecCCCChHHH-------H----------H----HcC------CCCH-----------------HHHHHHH
Q 014733          114 D--YVHLLMELCAGGELFHR-------L----------E----KYG------RFSE-----------------TEARVIF  147 (419)
Q Consensus       114 ~--~~~lV~E~~~ggsL~~~-------l----------~----~~~------~l~~-----------------~~~~~i~  147 (419)
                      +  +++-+++|++|..+.+.       +          +    ...      .+.|                 .+.+.++
T Consensus       104 G~~~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l  183 (1013)
T PRK06148        104 GEPRLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALV  183 (1013)
T ss_pred             CceEEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHH
Confidence            2  56778999999776541       1          0    000      0111                 1112223


Q ss_pred             HHHHHHHH-----HHH--hCCCeeccCCCCcEEEeecCCCCCeE-Eeeccceee
Q 014733          148 RHLMQVVS-----YCH--GNGVVHRDLKPENILLATKSSSSPIK-LADFGLATY  193 (419)
Q Consensus       148 ~qll~aL~-----~LH--~~~IvHrDLkp~NILl~~~~~~~~vK-L~DFgla~~  193 (419)
                      .++++.+.     .+.  ..++||+|+++.|||++.+... .+. |+|||-+..
T Consensus       184 ~~~~~~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~-~isGiIDFgDa~~  236 (1013)
T PRK06148        184 ERFLARFERNVAPRLAALPAQVIHNDANDYNILVDADDGE-RISGLIDFGDAVH  236 (1013)
T ss_pred             HHHHHHHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCc-ceEEEEECccccc
Confidence            33333322     122  2469999999999999643222 455 999998764

>PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function

Probab=94.04  E-value=0.27  Score=47.19  Aligned_cols=75  Identities=16%  Similarity=0.074  Sum_probs=44.3

Q ss_pred             cccCceEEEEEEecC----CC----cEEEEEEeccCccC--CHHhHHHHHHHHHHHHHccC------------CCCceee
Q 014733           49 GWGQFGVIRECSDKF----TG----EVLACKSIAKDRLV--TVEDVRSIKLEIEIMTKLSG------------HPNVVDL  106 (419)
Q Consensus        49 G~G~~g~V~~a~~~~----~g----~~vaiK~i~~~~~~--~~~~~~~~~~Ei~il~~l~~------------hpnIv~l  106 (419)
                      |.|..|.+|++.-..    ++    ..+++|........  .......+.+|+.+++.+..            ...+.++
T Consensus         2 Gd~y~s~~~rv~v~~~~~~~~~~~~~s~ivK~~p~~~~~~~~~~~~~~f~~E~~fY~~~~p~l~~~~~~~~~~~~~~P~~   81 (294)
T PF02958_consen    2 GDNYLSDMYRVTVTYELKGDGKNEPLSLIVKSPPTNPSRREFLREMGSFRREIFFYRELLPELEELQKEAGDPFKFFPKC   81 (294)
T ss_pred             CCcceeEEEEEEEEEEEccCCCceEEEEEEEeCCCchhhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHhccccceeeceE
Confidence            667778888776533    22    35788876522111  11234668888888876530            1234555


Q ss_pred             eEEEEeCCEEEEEEeec
Q 014733          107 KAVYEEEDYVHLLMELC  123 (419)
Q Consensus       107 ~~~~~~~~~~~lV~E~~  123 (419)
                      +....+....+||||-+
T Consensus        82 ~~~~~~~~~~~lvlEDL   98 (294)
T PF02958_consen   82 YYADEDPGDEVLVLEDL   98 (294)
T ss_pred             EEeccCCCceeeehhhh
Confidence            55555555678898865

All known members of this group are proteins from drosophila and Caenorhabditis elegans.

>PTZ00296 choline kinase; Provisional

Probab=93.26  E-value=0.93  Score=46.50  Aligned_cols=77  Identities=18%  Similarity=0.086  Sum_probs=46.8

Q ss_pred             eeeeecccCceEEEEEEecC--------CCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCE
Q 014733           44 LGKQLGWGQFGVIRECSDKF--------TGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDY  115 (419)
Q Consensus        44 i~~~LG~G~~g~V~~a~~~~--------~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~  115 (419)
                      -++.|..|---.+|++....        .++.|+++++-...    ...-.-..|..+++.+..+---.++++.+. +  
T Consensus       109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~t----e~lIdR~~E~~v~~~ls~~gi~P~l~~~f~-g--  181 (442)
T PTZ00296        109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDV----DELYNPISEFEVYKTMSKYRIAPQLLNTFS-G--  181 (442)
T ss_pred             EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCc----cceeCHHHHHHHHHHHHHCCCCCceEEEeC-C--
Confidence            45666667677888886442        14678889875432    112234568888888864333335565543 2  


Q ss_pred             EEEEEeecCCCCh
Q 014733          116 VHLLMELCAGGEL  128 (419)
Q Consensus       116 ~~lV~E~~~ggsL  128 (419)
                       ..|.||++|.+|
T Consensus       182 -g~I~efi~g~~l  193 (442)
T PTZ00296        182 -GRIEEWLYGDPL  193 (442)
T ss_pred             -CEEEEeeCCccC
Confidence             357899988744

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=92.90  E-value=0.5  Score=43.70  Aligned_cols=102  Identities=16%  Similarity=0.131  Sum_probs=64.2

Q ss_pred             EEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEEeecCCCChHHHHHHcCCCCHHHHHHH
Q 014733           67 VLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVI  146 (419)
Q Consensus        67 ~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i  146 (419)
                      +..+|+++.-...  -...-++.+.+++.++.   .|+++..-  +...+-+|.|+|-....         ..    ..+
T Consensus        87 ~L~lKKi~slp~~--~~~~~y~nky~v~Armh---GilrL~ND--n~~~yGvIlE~Cy~~~i---------~~----~N~  146 (308)
T PF07387_consen   87 PLFLKKIRSLPCC--INDALYFNKYRVFARMH---GILRLKND--NNYKYGVILERCYKIKI---------NF----SNF  146 (308)
T ss_pred             hhhhhhccCCCcc--cchhhhhhhhhHHHHhh---heeEeecC--CCceeEEEEeeccCccc---------ch----hHH
Confidence            3455555433221  12244678888988763   67777622  44467789999843110         11    111


Q ss_pred             HHHHHHHHHHHHhC--CCeeccCCCCcEEEeecCCCCCeEEeeccce
Q 014733          147 FRHLMQVVSYCHGN--GVVHRDLKPENILLATKSSSSPIKLADFGLA  191 (419)
Q Consensus       147 ~~qll~aL~~LH~~--~IvHrDLkp~NILl~~~~~~~~vKL~DFgla  191 (419)
                      +..=+.+|.-.|+.  +.+|+|-.|+|||-   ++.|.+||.|=+..
T Consensus       147 i~agi~~L~~fH~~~~~~lHGD~np~NiM~---D~~G~lKlVDP~~L  190 (308)
T PF07387_consen  147 ITAGIKDLMDFHSENQHCLHGDCNPDNIMC---DKFGYLKLVDPVCL  190 (308)
T ss_pred             HHHhHHHHHHhhccCCCeecCCCChhheee---cCCCCEEecChhhh
Confidence            22224567778843  69999999999999   67889999997654

The function of this family is unknown.

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	419
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-60
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-60
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-60
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		5e-60
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-59
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-59
3kk8_A	284	Camkii Substrate Complex A Length = 284		7e-59
3kk9_A	282	Camkii Substrate Complex B Length = 282		8e-59
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		7e-58
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-57
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		3e-57
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		9e-57
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-56
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-56
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-56
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-56
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		1e-55
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		1e-55
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		6e-55
3soa_A	444	Full-Length Human Camkii Length = 444		1e-54
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		6e-54
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		8e-54
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		6e-53
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-52
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-52
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-51
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-51
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		3e-51
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		6e-51
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		8e-50
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-49
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		3e-49
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		5e-49
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		9e-49
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-48
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-48
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-48
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-48
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-48
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		3e-48
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		3e-48
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		3e-48
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		6e-48
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		6e-48
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		6e-48
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		7e-48
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		8e-48
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		8e-48
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		9e-48
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		1e-47
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-47
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		1e-47
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		1e-47
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		1e-47
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		1e-47
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		4e-47
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		5e-47
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		1e-46
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		3e-46
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		4e-46
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		5e-46
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		5e-46
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		6e-46
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		7e-46
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		9e-46
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		9e-46
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-45
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		3e-45
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		3e-45
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-43
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-43
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-43
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-43
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		5e-43
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		6e-43
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		6e-43
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		7e-43
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		3e-42
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		4e-42
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		4e-42
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		6e-42
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		7e-42
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		9e-42
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-41
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		9e-41
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-40
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-40
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-40
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-40
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		3e-40
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		3e-40
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		3e-40
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		3e-40
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		3e-40
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		3e-40
2oza_A	356	Structure Of P38alpha Complex Length = 356		3e-40
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		3e-40
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		3e-40
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		4e-40
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		4e-40
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-40
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-40
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		5e-40
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		7e-40
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		1e-39
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		4e-39
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		4e-39
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		4e-39
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		8e-39
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		8e-39
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		9e-39
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		1e-38
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-38
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-38
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-38
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		4e-38
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		4e-38
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		4e-38
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		7e-38
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-37
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-37
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		2e-37
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		3e-37
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		4e-37
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		4e-37
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-37
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		5e-37
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		5e-37
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		5e-37
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-37
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		5e-37
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		6e-37
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		6e-37
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		6e-37
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		6e-37
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		6e-37
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		6e-37
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		6e-37
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		7e-37
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		8e-37
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		9e-37
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-36
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-36
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-36
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-36
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-36
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-36
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-36
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-36
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-36
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-36
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-36
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-36
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-36
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-36
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-36
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-36
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-36
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-36
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-36
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-36
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-36
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-36
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-36
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-36
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-36
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-36
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-36
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-36
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-36
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-36
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-36
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-36
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-36
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-36
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-36
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		3e-36
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		3e-36
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		3e-36
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		3e-36
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		5e-36
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		5e-36
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		5e-36
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		5e-36
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		5e-36
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		5e-36
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		5e-36
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		5e-36
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		6e-36
4ae9_A	343	Structure And Function Of The Human Sperm-specific		6e-36
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		6e-36
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		7e-36
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		8e-36
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		8e-36
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		8e-36
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		8e-36
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		1e-35
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-35
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		1e-35
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		1e-35
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-35
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-35
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-35
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		1e-35
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-35
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-35
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-35
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-35
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-35
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-35
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-35
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-35
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		3e-35
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-35
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		5e-35
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		6e-35
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		6e-35
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		7e-34
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		1e-33
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-33
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-33
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-33
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		4e-33
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		5e-33
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		5e-33
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		6e-33
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		7e-33
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		7e-33
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		7e-33
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		7e-33
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		7e-33
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		8e-33
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		9e-33
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		9e-33
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		9e-33
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-32
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-32
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-32
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-31
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		4e-31
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		4e-31
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		4e-31
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		6e-31
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		7e-31
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		7e-31
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		8e-31
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		8e-31
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		8e-31
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		8e-31
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		8e-31
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		8e-31
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		8e-31
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		9e-31
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		9e-31
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		9e-31
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		9e-31
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		9e-31
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		9e-31
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-30
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-30
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-30
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-30
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		4e-30
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		5e-30
3g51_A	325	Structural Diversity Of The Active Conformation Of		5e-30
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		5e-30
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		5e-30
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		6e-30
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		8e-30
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-29
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		7e-29
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		7e-29
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		9e-29
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-28
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-28
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-28
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-28
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-28
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-28
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-28
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-28
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-28
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-28
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-28
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-28
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-28
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-28
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-28
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-28
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-28
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		5e-28
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-27
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-27
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-27
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		1e-26
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-26
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-25
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-25
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		3e-25
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		4e-25
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		8e-25
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		8e-25
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		8e-25
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		9e-25
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-24
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-24
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-24
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-24
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-24
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-24
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-24
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-24
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-24
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-24
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-24
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-24
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-24
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-24
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-24
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-24
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-24
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-24
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-24
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-24
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-24
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-24
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-24
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-24
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		4e-24
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-23
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-23
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-23
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-23
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-23
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-23
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-23
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-23
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-23
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		3e-23
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-23
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-23
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		3e-23
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		4e-23
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-23
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		5e-23
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		5e-23
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-23
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		5e-23
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		5e-23
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		6e-23
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		6e-23
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		6e-23
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		6e-23
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		6e-23
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		6e-23
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		6e-23
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		6e-23
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		6e-23
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		6e-23
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		7e-23
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		7e-23
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		7e-23
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		7e-23
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		7e-23
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		7e-23
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		7e-23
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		7e-23
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		7e-23
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		8e-23
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		8e-23
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		8e-23
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		8e-23
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		8e-23
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		9e-23
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		9e-23
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-22
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-22
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		1e-22
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-22
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-22
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-22
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-22
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-22
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-22
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-22
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-22
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-22
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-22
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-22
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		3e-22
3a7f_A	303	Human Mst3 Kinase Length = 303		4e-22
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		4e-22
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		4e-22
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		4e-22
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		4e-22
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-22
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		6e-22
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		7e-22
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-22
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-21
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-21
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-21
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-21
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-21
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-21
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-21
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-21
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-21
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-21
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-21
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-21
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		4e-21
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		4e-21
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		4e-21
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		4e-21
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-21
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		6e-21
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-21
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-21
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		7e-21
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		7e-21
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		7e-21
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		8e-21
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-20
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-20
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-20
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-20
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-20
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-20
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-20
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		3e-20
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-20
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		3e-20
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		4e-20
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		5e-20
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		5e-20
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		5e-20
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		5e-20
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		7e-20
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		9e-20
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-19
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-19
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-19
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-19
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-19
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-19
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-19
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		3e-19
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		4e-19
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		5e-19
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		5e-19
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		5e-19
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		5e-19
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		5e-19
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		6e-19
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		6e-19
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		6e-19
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		6e-19
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		6e-19
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		6e-19
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		6e-19
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		7e-19
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		7e-19
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		7e-19
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		7e-19
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-19
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		8e-19
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		8e-19
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		8e-19
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		8e-19
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		8e-19
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		8e-19
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		8e-19
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		8e-19
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		9e-19
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		9e-19
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		1e-18
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-18
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-18
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-18
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		1e-18
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		1e-18
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-18
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-18
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		1e-18
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		1e-18
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		1e-18
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		1e-18
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		1e-18
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-18
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		1e-18
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		1e-18
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		1e-18
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-18
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		2e-18
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		2e-18
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-18
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		2e-18
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-18
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-18
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-18
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		3e-18
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-18
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		3e-18
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		3e-18
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		3e-18
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		4e-18
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		4e-18
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		4e-18
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		4e-18
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		6e-18
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		6e-18
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		6e-18
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		6e-18
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		7e-18
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		8e-18
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		8e-18
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		9e-18
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-17
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-17
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		1e-17
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-17
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-17
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-17
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-17
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-17
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-17
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-17
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-17
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-17
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-17
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-17
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-17
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-17
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-17
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-17
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-17
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-17
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-17
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-17
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-17
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-17
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		3e-17
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		3e-17
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		3e-17
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		3e-17
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		3e-17
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		3e-17
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		3e-17
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		3e-17
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		3e-17
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		3e-17
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		3e-17
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		3e-17
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		4e-17
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		4e-17
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		4e-17
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		4e-17
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		4e-17
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		4e-17
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		4e-17
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		4e-17
3hec_A	348	P38 In Complex With Imatinib Length = 348		4e-17
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		4e-17
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		4e-17
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		4e-17
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		4e-17
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		4e-17
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		4e-17
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		4e-17
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		4e-17
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		4e-17
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		5e-17
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		5e-17
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		6e-17
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		8e-17
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		8e-17
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		9e-17
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		9e-17
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		9e-17
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		9e-17
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		9e-17
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		9e-17
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		9e-17
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-16
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-16
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-16
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		1e-16
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		1e-16
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-16
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		1e-16
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		1e-16
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-16
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-16
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		2e-16
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-16
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-16
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		2e-16
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-16
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-16
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-16
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-16
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-16
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-16
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-16
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-16
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-16
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-16
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-16
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-16
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-16
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		3e-16
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-16
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		3e-16
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		4e-16
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		4e-16
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		4e-16
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		4e-16
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		4e-16
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		4e-16
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		5e-16
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		5e-16
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		5e-16
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-16
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		6e-16
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		6e-16
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-16
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		7e-16
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		7e-16
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		7e-16
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		8e-16
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		8e-16
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		8e-16
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		9e-16
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		9e-16
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		9e-16
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		1e-15
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-15
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		1e-15
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		1e-15
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		2e-15
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		2e-15
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		4e-15
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		4e-15
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-15
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		6e-15
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-15
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		8e-15
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-15
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-14
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-14
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-14
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-14
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-14
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-14
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-14
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-14
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-14
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-14
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-14
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-14
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-14
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-14
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-14
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-14
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-14
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-14
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-14
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-14
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-14
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-14
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-14
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-14
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		2e-14
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		2e-14
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		2e-14
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		2e-14
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		2e-14
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-14
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		3e-14
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		3e-14
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		3e-14
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		3e-14
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		3e-14
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		3e-14
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		3e-14
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		3e-14
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		3e-14
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		3e-14
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		3e-14
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		3e-14
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		3e-14
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		3e-14
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		3e-14
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		3e-14
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-14
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		4e-14
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		4e-14
4h58_A	275	Braf In Complex With Compound 3 Length = 275		4e-14
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		4e-14
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		4e-14
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-14
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		4e-14
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		4e-14
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		5e-14
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-14
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		5e-14
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		5e-14
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		6e-14
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		6e-14
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		6e-14
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		6e-14
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		6e-14
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		7e-14
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		7e-14
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		7e-14
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		7e-14
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		7e-14
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		7e-14
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		7e-14
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		7e-14
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		7e-14
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		7e-14
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		7e-14
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		8e-14
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		8e-14
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		8e-14
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		8e-14
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		8e-14
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		8e-14
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		8e-14
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		8e-14
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		8e-14
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		8e-14
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		8e-14
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		8e-14
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		8e-14
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		9e-14
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		9e-14
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		9e-14
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		1e-13
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		1e-13
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-13
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-13
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-13
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-13
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-13
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-13
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-13
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-13
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		1e-13
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-13
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-13
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-13
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		2e-13
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-13
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-13
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-13
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		2e-13
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		3e-13
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		3e-13
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-13
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		3e-13
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		3e-13
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		3e-13
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		4e-13
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		4e-13
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		4e-13
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		4e-13
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-13
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		5e-13
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-13
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		5e-13
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		5e-13
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		5e-13
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		6e-13
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		6e-13
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		7e-13
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		7e-13
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-13
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-13
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		7e-13
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		8e-13
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		8e-13
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		9e-13
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-12
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-12
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-12
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-12
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-12
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-12
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		1e-12
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		1e-12
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		1e-12
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-12
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		1e-12
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-12
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		2e-12
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-12
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-12
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		2e-12
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-12
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-12
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		3e-12
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-12
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		3e-12
3a4o_X	286	Lyn Kinase Domain Length = 286		4e-12
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		5e-12
1fvr_A	327	Tie2 Kinase Domain Length = 327		5e-12
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		6e-12
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		6e-12
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		6e-12
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		7e-12
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		7e-12
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-12
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		7e-12
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-12
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-12
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		7e-12
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		8e-12
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		8e-12
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-12
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		8e-12
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		8e-12
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		9e-12
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		9e-12
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-11
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		1e-11
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-11
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		1e-11
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		1e-11
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		1e-11
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		1e-11
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		1e-11
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		2e-11
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-11
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-11
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-11
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-11
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-11
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-11
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-11
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-11
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-11
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-11
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-11
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-11
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-11
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-11
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-11
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-11
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-11
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-11
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		3e-11
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-11
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		3e-11
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		3e-11
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		3e-11
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		3e-11
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-11
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		3e-11
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		3e-11
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		3e-11
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		3e-11
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		4e-11
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		4e-11
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		4e-11
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		4e-11
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		4e-11
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		4e-11
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		5e-11
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		5e-11
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		5e-11
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		6e-11
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		6e-11
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-11
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		6e-11
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-11
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		7e-11
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		7e-11
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		8e-11
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		8e-11
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		8e-11
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		8e-11
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		8e-11
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		9e-11
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-11
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		9e-11
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-10
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-10
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-10
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-10
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-10
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-10
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-10
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-10
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-10
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-10
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-10
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		3e-10
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		3e-10
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-10
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		3e-10
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		3e-10
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		3e-10
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-10
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		3e-10
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-10
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		3e-10
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		3e-10
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		4e-10
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		4e-10
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-10
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		5e-10
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		5e-10
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		5e-10
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		5e-10
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		5e-10
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		6e-10
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		7e-10
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-09
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-09
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-09
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-09
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		1e-09
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-09
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		1e-09
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-09
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-09
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-09
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-09
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-09
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-09
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-09
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-09
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-09
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-09
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-09
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-09
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		2e-09
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-09
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		2e-09
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-09
3uys_A	296	Crystal Structure Of Apo Human Ck1d Length = 296		2e-09
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-09
1ckj_A	317	Casein Kinase I Delta Truncation Mutant Containing		3e-09
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		3e-09
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		3e-09
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		3e-09
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		5e-09
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-09
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		6e-09
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		8e-09
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		8e-09
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		8e-09
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		8e-09
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		1e-08
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		1e-08
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-08
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		1e-08
4hni_A	296	Crystal Structure Of Ck1e In Complex With Pf4800567		1e-08
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-08
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		1e-08
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		1e-08
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-08
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-08
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-08
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		3e-08
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		3e-08
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		3e-08
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		5e-08
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		5e-08
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		6e-08
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		6e-08
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		6e-08
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		7e-08
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		7e-08
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		7e-08
3sv0_A	483	Crystal Structure Of Casein Kinase-1 Like Protein I		9e-08
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		9e-08
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-07
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		1e-07
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-07
2x7g_A	389	Structure Of Human Serine-Arginine-Rich Protein-Spe		1e-07
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		1e-07
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-07
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-07
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-07
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-07
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-07
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-07
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-07
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-07
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-07
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-07
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-07
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		3e-07
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		3e-07
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		3e-07
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-07

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  229 bits (585), Expect = 2e-60,   Method: Compositional matrix adjust.
 Identities = 112/264 (42%), Positives = 162/264 (61%), Gaps = 1/264 (0%)
Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKL 97
            SDRY   + LG G FG +  C DK TG+  A K I+K ++    D  S+  E++++ +L
Sbjct: 24  FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 98  SGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYC 157
             HPN++ L   +E++ Y +L+ E+  GGELF  +    RFSE +A  I R ++  ++Y 
Sbjct: 84  D-HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYM 142
Query: 158 HGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG 217
           H N +VHRDLKPEN+LL +KS  + I++ DFGL+T+ +A + +   +G+ +YIAPEVL G
Sbjct: 143 HKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG 202
Query: 218 GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLI 277
            Y++  DVWS GVILYILLSG PPF G  +  I   V      F    W  +S SA+DLI
Sbjct: 203 TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLI 262
Query: 278 MGMLRVDPSTRLTAAEVLAHSWME 301
             ML   PS R++A + L H W++
Sbjct: 263 RKMLTYVPSMRISARDALDHEWIQ 286

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  229 bits (585), Expect = 2e-60,   Method: Compositional matrix adjust.
 Identities = 112/264 (42%), Positives = 162/264 (61%), Gaps = 1/264 (0%)
Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKL 97
            SDRY   + LG G FG +  C DK TG+  A K I+K ++    D  S+  E++++ +L
Sbjct: 47  FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL 106
Query: 98  SGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYC 157
             HPN++ L   +E++ Y +L+ E+  GGELF  +    RFSE +A  I R ++  ++Y 
Sbjct: 107 D-HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYM 165
Query: 158 HGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG 217
           H N +VHRDLKPEN+LL +KS  + I++ DFGL+T+ +A + +   +G+ +YIAPEVL G
Sbjct: 166 HKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG 225
Query: 218 GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLI 277
            Y++  DVWS GVILYILLSG PPF G  +  I   V      F    W  +S SA+DLI
Sbjct: 226 TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLI 285
Query: 278 MGMLRVDPSTRLTAAEVLAHSWME 301
             ML   PS R++A + L H W++
Sbjct: 286 RKMLTYVPSMRISARDALDHEWIQ 309

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  229 bits (584), Expect = 2e-60,   Method: Compositional matrix adjust.
 Identities = 112/264 (42%), Positives = 162/264 (61%), Gaps = 1/264 (0%)
Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKL 97
            SDRY   + LG G FG +  C DK TG+  A K I+K ++    D  S+  E++++ +L
Sbjct: 48  FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL 107
Query: 98  SGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYC 157
             HPN++ L   +E++ Y +L+ E+  GGELF  +    RFSE +A  I R ++  ++Y 
Sbjct: 108 D-HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYM 166
Query: 158 HGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG 217
           H N +VHRDLKPEN+LL +KS  + I++ DFGL+T+ +A + +   +G+ +YIAPEVL G
Sbjct: 167 HKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG 226
Query: 218 GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLI 277
            Y++  DVWS GVILYILLSG PPF G  +  I   V      F    W  +S SA+DLI
Sbjct: 227 TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLI 286
Query: 278 MGMLRVDPSTRLTAAEVLAHSWME 301
             ML   PS R++A + L H W++
Sbjct: 287 RKMLTYVPSMRISARDALDHEWIQ 310

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  228 bits (581), Expect = 5e-60,   Method: Compositional matrix adjust.
 Identities = 112/264 (42%), Positives = 162/264 (61%), Gaps = 1/264 (0%)
Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKL 97
            SDRY   + LG G FG +  C DK TG+  A K I+K ++    D  S+  E++++ +L
Sbjct: 30  FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL 89
Query: 98  SGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYC 157
             HPN++ L   +E++ Y +L+ E+  GGELF  +    RFSE +A  I R ++  ++Y 
Sbjct: 90  D-HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYM 148
Query: 158 HGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG 217
           H N +VHRDLKPEN+LL +KS  + I++ DFGL+T+ +A + +   +G+ +YIAPEVL G
Sbjct: 149 HKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG 208
Query: 218 GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLI 277
            Y++  DVWS GVILYILLSG PPF G  +  I   V      F    W  +S SA+DLI
Sbjct: 209 TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLI 268
Query: 278 MGMLRVDPSTRLTAAEVLAHSWME 301
             ML   PS R++A + L H W++
Sbjct: 269 RKMLTYVPSMRISARDALDHEWIQ 292

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score =  226 bits (577), Expect = 1e-59,   Method: Compositional matrix adjust.
 Identities = 115/308 (37%), Positives = 181/308 (58%), Gaps = 8/308 (2%)
Query: 36  SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMT 95
           +  SD Y + ++LG G F V+R C  K TG   A K I   +L +  D + ++ E  I  
Sbjct: 25  TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICR 83
Query: 96  KLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS 155
           KL  HPN+V L    +EE + +L+ +L  GGELF  +     +SE +A    + +++ ++
Sbjct: 84  KLQ-HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIA 142
Query: 156 YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVL 215
           YCH NG+VHR+LKPEN+LLA+K+  + +KLADFGLA  +   +  HG  G+P Y++PEVL
Sbjct: 143 YCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVL 202
Query: 216 AGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASAR 274
               Y++  D+W+ GVILYILL G PPFW + + +++  ++A    +PS  WD ++  A+
Sbjct: 203 KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK 262
Query: 275 DLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKPCKQDDLCC-----KQLEVGGSSFS 329
            LI  ML V+P  R+TA + L   W+   E+VA    +QD + C      + ++ G+  +
Sbjct: 263 SLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDCLKKFNARRKLKGAILT 322
Query: 330 ATFISRNM 337
               +RN+
Sbjct: 323 TMIATRNL 330

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  224 bits (572), Expect = 5e-59,   Method: Compositional matrix adjust.
 Identities = 111/264 (42%), Positives = 159/264 (60%), Gaps = 1/264 (0%)
Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKL 97
            SDRY   + LG G FG +  C DK TG+  A K I+K ++    D  S+  E++++ +L
Sbjct: 24  FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 98  SGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYC 157
             HPN+  L   +E++ Y +L+ E+  GGELF  +    RFSE +A  I R ++  ++Y 
Sbjct: 84  D-HPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYX 142
Query: 158 HGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG 217
           H N +VHRDLKPEN+LL +KS  + I++ DFGL+T+ +A +     +G+ +YIAPEVL G
Sbjct: 143 HKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPEVLHG 202
Query: 218 GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLI 277
            Y++  DVWS GVILYILLSG PPF G  +  I   V      F    W  +S SA+DLI
Sbjct: 203 TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLI 262
Query: 278 MGMLRVDPSTRLTAAEVLAHSWME 301
              L   PS R++A + L H W++
Sbjct: 263 RKXLTYVPSXRISARDALDHEWIQ 286

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score =  224 bits (571), Expect = 7e-59,   Method: Compositional matrix adjust.
 Identities = 112/284 (39%), Positives = 171/284 (60%), Gaps = 3/284 (1%)
Query: 36  SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMT 95
           +  SD Y + ++LG G F V+R C  K TG   A K I   +L +  D + ++ E  I  
Sbjct: 2   TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICR 60
Query: 96  KLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS 155
           KL  HPN+V L    +EE + +L+ +L  GGELF  +     +SE +A    + +++ ++
Sbjct: 61  KLQ-HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIA 119
Query: 156 YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVL 215
           YCH NG+VHR+LKPEN+LLA+K+  + +KLADFGLA  +   +  HG  G+P Y++PEVL
Sbjct: 120 YCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVL 179
Query: 216 AGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASAR 274
               Y++  D+W+ GVILYILL G PPFW + + +++  ++A    +PS  WD ++  A+
Sbjct: 180 KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK 239
Query: 275 DLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKPCKQDDLCC 318
            LI  ML V+P  R+TA + L   W+   E+VA    +QD + C
Sbjct: 240 SLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDXVDC 283

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score =  224 bits (570), Expect = 8e-59,   Method: Compositional matrix adjust.
 Identities = 112/284 (39%), Positives = 171/284 (60%), Gaps = 3/284 (1%)
Query: 36  SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMT 95
           +  SD Y + ++LG G F V+R C  K TG   A K I   +L +  D + ++ E  I  
Sbjct: 1   TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICR 59
Query: 96  KLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS 155
           KL  HPN+V L    +EE + +L+ +L  GGELF  +     +SE +A    + +++ ++
Sbjct: 60  KLQ-HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIA 118
Query: 156 YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVL 215
           YCH NG+VHR+LKPEN+LLA+K+  + +KLADFGLA  +   +  HG  G+P Y++PEVL
Sbjct: 119 YCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVL 178
Query: 216 AGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASAR 274
               Y++  D+W+ GVILYILL G PPFW + + +++  ++A    +PS  WD ++  A+
Sbjct: 179 KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK 238
Query: 275 DLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKPCKQDDLCC 318
            LI  ML V+P  R+TA + L   W+   E+VA    +QD + C
Sbjct: 239 SLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDXVDC 282

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score =  221 bits (562), Expect = 7e-58,   Method: Compositional matrix adjust.
 Identities = 116/308 (37%), Positives = 182/308 (59%), Gaps = 9/308 (2%)
Query: 37  NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTK 96
           +++D Y L ++LG G F V+R C    TG+  A K I   +L +  D + ++ E  I  +
Sbjct: 1   SMTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKL-SARDHQKLEREARI-CR 58
Query: 97  LSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSY 156
           L  HPN+V L     EE + +L+ +L  GGELF  +     +SE +A    + +++ V++
Sbjct: 59  LLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNH 118
Query: 157 CHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN-LHGTVGSPFYIAPEVL 215
           CH NG+VHRDLKPEN+LLA+KS  + +KLADFGLA  ++  Q    G  G+P Y++PEVL
Sbjct: 119 CHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVL 178
Query: 216 -AGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASAR 274
               Y +  D+W+ GVILYILL G PPFW + + +++  ++A    FPS  WD ++  A+
Sbjct: 179 RKDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAK 238
Query: 275 DLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKPCKQDDLCC-----KQLEVGGSSFS 329
           DLI  ML ++P+ R+TA+E L H W+ +   VA    +Q+ + C      + ++ G+  +
Sbjct: 239 DLINKMLTINPAKRITASEALKHPWICQRSTVASMMHRQETVDCLKKFNARRKLKGAILT 298
Query: 330 ATFISRNM 337
               +RN 
Sbjct: 299 TMLATRNF 306

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score =  219 bits (558), Expect = 2e-57,   Method: Compositional matrix adjust.
 Identities = 113/284 (39%), Positives = 173/284 (60%), Gaps = 4/284 (1%)
Query: 37  NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTK 96
           +++D Y L ++LG G F V+R C    TG+  A K I   +L +  D + ++ E  I  +
Sbjct: 1   SMTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKL-SARDHQKLEREARI-CR 58
Query: 97  LSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSY 156
           L  HPN+V L     EE + +L+ +L  GGELF  +     +SE +A    + +++ V++
Sbjct: 59  LLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNH 118
Query: 157 CHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN-LHGTVGSPFYIAPEVL 215
           CH NG+VHRDLKPEN+LLA+KS  + +KLADFGLA  ++  Q    G  G+P Y++PEVL
Sbjct: 119 CHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVL 178
Query: 216 -AGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASAR 274
               Y +  D+W+ GVILYILL G PPFW + + +++  ++A    FPS  WD ++  A+
Sbjct: 179 RKDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAK 238
Query: 275 DLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKPCKQDDLCC 318
           DLI  ML ++P+ R+TA+E L H W+ +   VA    +Q+ + C
Sbjct: 239 DLINKMLTINPAKRITASEALKHPWICQRSTVASMMHRQETVDC 282

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  219 bits (557), Expect = 3e-57,   Method: Compositional matrix adjust.
 Identities = 111/265 (41%), Positives = 156/265 (58%), Gaps = 2/265 (0%)
Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKL 97
            ++RY +   LG G FG + +C D+ T +  A K I K      +D  +I  E+E++ KL
Sbjct: 20  FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKAS-AKNKDTSTILREVELLKKL 78
Query: 98  SGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYC 157
             HPN++ L  + E+    +++ EL  GGELF  + K  RFSE +A  I + +   ++Y 
Sbjct: 79  D-HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYM 137
Query: 158 HGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG 217
           H + +VHRDLKPENILL +K     IK+ DFGL+T  +    +   +G+ +YIAPEVL G
Sbjct: 138 HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG 197
Query: 218 GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLI 277
            Y++  DVWSAGVILYILLSG PPF+GK +  I   V      F    W  IS  A+DLI
Sbjct: 198 TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLI 257
Query: 278 MGMLRVDPSTRLTAAEVLAHSWMEE 302
             ML   PS R+TA + L H W+++
Sbjct: 258 RKMLTFHPSLRITATQCLEHPWIQK 282

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  217 bits (553), Expect = 9e-57,   Method: Compositional matrix adjust.
 Identities = 107/263 (40%), Positives = 157/263 (59%), Gaps = 1/263 (0%)
Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKL 97
           LSDRY   K+LG G +G +  C DK TG   A K I K  + T  +  ++  E+ ++ +L
Sbjct: 2   LSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQL 61
Query: 98  SGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYC 157
             HPN++ L   +E++   +L+ME+  GGELF  +    +FSE +A VI + ++   +Y 
Sbjct: 62  D-HPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYL 120
Query: 158 HGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG 217
           H + +VHRDLKPEN+LL +KS  + IK+ DFGL+ + + G  +   +G+ +YIAPEVL  
Sbjct: 121 HKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVLRK 180
Query: 218 GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLI 277
            Y++  DVWS GVILYILL G PPF G+T  +I   V      F    W  +S  A+ L+
Sbjct: 181 KYDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSDEAKQLV 240
Query: 278 MGMLRVDPSTRLTAAEVLAHSWM 300
             ML  +PS R++A E L H W+
Sbjct: 241 KLMLTYEPSKRISAEEALNHPWI 263

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score =  217 bits (552), Expect = 1e-56,   Method: Compositional matrix adjust.
 Identities = 106/266 (39%), Positives = 162/266 (60%), Gaps = 3/266 (1%)
Query: 36  SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMT 95
           +  SD Y + ++LG G F V+R C  K TG   A K I   +L +  D + ++ E  I  
Sbjct: 2   TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICR 60
Query: 96  KLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS 155
           KL  HPN+V L    +EE + +L+ +L  GGELF  +     +SE +A    + +++ ++
Sbjct: 61  KLQ-HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIA 119
Query: 156 YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVL 215
           YCH NG+VHR+LKPEN+LLA+K+  + +KLADFGLA  +   +  HG  G+P Y++PEVL
Sbjct: 120 YCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVL 179
Query: 216 AGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASAR 274
               Y++  D+W+ GVILYILL G PPFW + + +++  ++A    +PS  WD ++  A+
Sbjct: 180 KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK 239
Query: 275 DLIMGMLRVDPSTRLTAAEVLAHSWM 300
            LI  ML V+P  R+TA + L   W+
Sbjct: 240 SLIDSMLTVNPKKRITADQALKVPWI 265

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  217 bits (552), Expect = 1e-56,   Method: Compositional matrix adjust.
 Identities = 111/266 (41%), Positives = 156/266 (58%), Gaps = 2/266 (0%)
Query: 37  NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTK 96
             ++RY +   LG G FG + +C D+ T +  A K I K      +D  +I  E+E++ K
Sbjct: 19  TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKAS-AKNKDTSTILREVELLKK 77
Query: 97  LSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSY 156
           L  HPN++ L  + E+    +++ EL  GGELF  + K  RFSE +A  I + +   ++Y
Sbjct: 78  LD-HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITY 136
Query: 157 CHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLA 216
            H + +VHRDLKPENILL +K     IK+ DFGL+T  +    +   +G+ +YIAPEVL 
Sbjct: 137 MHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR 196
Query: 217 GGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDL 276
           G Y++  DVWSAGVILYILLSG PPF+GK +  I   V      F    W  IS  A+DL
Sbjct: 197 GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256
Query: 277 IMGMLRVDPSTRLTAAEVLAHSWMEE 302
           I  ML   PS R+TA + L H W+++
Sbjct: 257 IRKMLTFHPSLRITATQCLEHPWIQK 282

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  216 bits (551), Expect = 1e-56,   Method: Compositional matrix adjust.
 Identities = 111/266 (41%), Positives = 156/266 (58%), Gaps = 2/266 (0%)
Query: 37  NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTK 96
             ++RY +   LG G FG + +C D+ T +  A K I K      +D  +I  E+E++ K
Sbjct: 19  TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKAS-AKNKDTSTILREVELLKK 77
Query: 97  LSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSY 156
           L  HPN++ L  + E+    +++ EL  GGELF  + K  RFSE +A  I + +   ++Y
Sbjct: 78  LD-HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITY 136
Query: 157 CHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLA 216
            H + +VHRDLKPENILL +K     IK+ DFGL+T  +    +   +G+ +YIAPEVL 
Sbjct: 137 MHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR 196
Query: 217 GGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDL 276
           G Y++  DVWSAGVILYILLSG PPF+GK +  I   V      F    W  IS  A+DL
Sbjct: 197 GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256
Query: 277 IMGMLRVDPSTRLTAAEVLAHSWMEE 302
           I  ML   PS R+TA + L H W+++
Sbjct: 257 IRKMLTFHPSLRITATQCLEHPWIQK 282

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  215 bits (548), Expect = 3e-56,   Method: Compositional matrix adjust.
 Identities = 107/263 (40%), Positives = 157/263 (59%), Gaps = 1/263 (0%)
Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKL 97
           LSDRY   K+LG G +G +  C DK TG   A K I K  + T  +  ++  E+ ++ +L
Sbjct: 19  LSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQL 78
Query: 98  SGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYC 157
             HPN++ L   +E++   +L+ME+  GGELF  +    +FSE +A VI + ++   +Y 
Sbjct: 79  D-HPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYL 137
Query: 158 HGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG 217
           H + +VHRDLKPEN+LL +KS  + IK+ DFGL+ + + G  +   +G+ +YIAPEVL  
Sbjct: 138 HKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVLRK 197
Query: 218 GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLI 277
            Y++  DVWS GVILYILL G PPF G+T  +I   V      F    W  +S  A+ L+
Sbjct: 198 KYDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSDEAKQLV 257
Query: 278 MGMLRVDPSTRLTAAEVLAHSWM 300
             ML  +PS R++A E L H W+
Sbjct: 258 KLMLTYEPSKRISAEEALNHPWI 280

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score =  213 bits (543), Expect = 1e-55,   Method: Compositional matrix adjust.
 Identities = 110/274 (40%), Positives = 154/274 (56%), Gaps = 6/274 (2%)
Query: 37  NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTK 96
           +++  Y L   +G G +G ++    K T    A K I K     VEDV   K EIEIM  
Sbjct: 23  DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPK---YFVEDVDRFKQEIEIMKS 79
Query: 97  LSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSY 156
           L  HPN++ L   +E+   ++L+MELC GGELF R+     F E++A  I + ++  V+Y
Sbjct: 80  LD-HPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAY 138
Query: 157 CHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLA 216
           CH   V HRDLKPEN L  T S  SP+KL DFGLA   K G+ +   VG+P+Y++P+VL 
Sbjct: 139 CHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLE 198
Query: 217 GGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDL 276
           G Y    D WSAGV++Y+LL G PPF   T  ++   +R     FP   W ++S  A  L
Sbjct: 199 GLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNVSPQAESL 258
Query: 277 IMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKP 310
           I  +L   P  R+T+ + L H W E  +Q++  P
Sbjct: 259 IRRLLTKSPKQRITSLQALEHEWFE--KQLSSSP 290

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score =  213 bits (543), Expect = 1e-55,   Method: Compositional matrix adjust.
 Identities = 110/274 (40%), Positives = 154/274 (56%), Gaps = 6/274 (2%)
Query: 37  NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTK 96
           +++  Y L   +G G +G ++    K T    A K I K     VEDV   K EIEIM  
Sbjct: 6   DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPK---YFVEDVDRFKQEIEIMKS 62
Query: 97  LSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSY 156
           L  HPN++ L   +E+   ++L+MELC GGELF R+     F E++A  I + ++  V+Y
Sbjct: 63  LD-HPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAY 121
Query: 157 CHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLA 216
           CH   V HRDLKPEN L  T S  SP+KL DFGLA   K G+ +   VG+P+Y++P+VL 
Sbjct: 122 CHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLE 181
Query: 217 GGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDL 276
           G Y    D WSAGV++Y+LL G PPF   T  ++   +R     FP   W ++S  A  L
Sbjct: 182 GLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNVSPQAESL 241
Query: 277 IMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKP 310
           I  +L   P  R+T+ + L H W E  +Q++  P
Sbjct: 242 IRRLLTKSPKQRITSLQALEHEWFE--KQLSSSP 273

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score =  211 bits (537), Expect = 6e-55,   Method: Compositional matrix adjust.
 Identities = 112/279 (40%), Positives = 164/279 (58%), Gaps = 4/279 (1%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           Y L ++LG G F V+R C     G+  A K I   +L +  D + ++ E  I  +L  HP
Sbjct: 24  YQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKL-SARDHQKLEREARI-CRLLKHP 81
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
           N+V L     EE + +L+ +L  GGELF  +     +SE +A    + +++ V +CH  G
Sbjct: 82  NIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG 141
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN-LHGTVGSPFYIAPEVL-AGGY 219
           VVHRDLKPEN+LLA+K   + +KLADFGLA  ++  Q    G  G+P Y++PEVL    Y
Sbjct: 142 VVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPY 201
Query: 220 NQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMG 279
            +  D+W+ GVILYILL G PPFW + + +++  ++A    FPS  WD ++  A+DLI  
Sbjct: 202 GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINK 261
Query: 280 MLRVDPSTRLTAAEVLAHSWMEECEQVAQKPCKQDDLCC 318
           ML ++PS R+TAAE L H W+     VA    +Q+ + C
Sbjct: 262 MLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDC 300

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score =  210 bits (534), Expect = 1e-54,   Method: Compositional matrix adjust.
 Identities = 113/309 (36%), Positives = 175/309 (56%), Gaps = 9/309 (2%)
Query: 36  SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMT 95
           +  ++ Y L ++LG G F V+R C     G+  A   I   +L +  D + ++ E  I  
Sbjct: 7   TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARI-C 64
Query: 96  KLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS 155
           +L  HPN+V L     EE + +L+ +L  GGELF  +     +SE +A    + +++ V 
Sbjct: 65  RLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVL 124
Query: 156 YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN-LHGTVGSPFYIAPEV 214
           +CH  GVVHR+LKPEN+LLA+K   + +KLADFGLA  ++  Q    G  G+P Y++PEV
Sbjct: 125 HCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEV 184
Query: 215 L-AGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASA 273
           L    Y +  D+W+ GVILYILL G PPFW + + +++  ++A    FPS  WD ++  A
Sbjct: 185 LRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEA 244
Query: 274 RDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKPCKQDDLCC-----KQLEVGGSSF 328
           +DLI  ML ++PS R+TAAE L H W+     VA    +Q+ + C      + ++ G+  
Sbjct: 245 KDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKLKGAIL 304
Query: 329 SATFISRNM 337
           +    +RN 
Sbjct: 305 TVMLATRNF 313

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score =  208 bits (529), Expect = 6e-54,   Method: Compositional matrix adjust.
 Identities = 110/284 (38%), Positives = 166/284 (58%), Gaps = 4/284 (1%)
Query: 37  NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTK 96
           +++D Y L + +G G F V+R C    TG   A K I   +L +  D + ++ E  I  +
Sbjct: 1   SMTDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKL-SARDHQKLEREARI-CR 58
Query: 97  LSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSY 156
           L  H N+V L     EE + +L+ +L  GGELF  +     +SE +A    + +++ V +
Sbjct: 59  LLKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLH 118
Query: 157 CHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN-LHGTVGSPFYIAPEVL 215
           CH  GVVHRDLKPEN+LLA+K   + +KLADFGLA  ++  Q    G  G+P Y++PEVL
Sbjct: 119 CHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVL 178
Query: 216 AG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASAR 274
               Y +  D+W+ GVILYILL G PPFW + + K++  ++A    FPS  WD ++  A+
Sbjct: 179 RKEAYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAK 238
Query: 275 DLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKPCKQDDLCC 318
           +LI  ML ++P+ R+TA E L H W+ +   VA    +Q+ + C
Sbjct: 239 NLINQMLTINPAKRITAHEALKHPWVCQRSTVASMMHRQETVEC 282

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score =  207 bits (527), Expect = 8e-54,   Method: Compositional matrix adjust.
 Identities = 111/309 (35%), Positives = 176/309 (56%), Gaps = 9/309 (2%)
Query: 36  SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMT 95
           +  +D Y L ++LG G F V+R C  K   +  A K I   +L +  D + ++ E  I  
Sbjct: 27  TRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKL-SARDHQKLEREARI-C 84
Query: 96  KLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS 155
           +L  HPN+V L     EE + +L+ +L  GGELF  +     +SE +A      +++ V+
Sbjct: 85  RLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVN 144
Query: 156 YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN-LHGTVGSPFYIAPEV 214
           + H + +VHRDLKPEN+LLA+K   + +KLADFGLA  ++  Q    G  G+P Y++PEV
Sbjct: 145 HIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEV 204
Query: 215 L-AGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASA 273
           L    Y +  D+W+ GVILYILL G PPFW + + K++  ++A    FPS  WD ++  A
Sbjct: 205 LRKDPYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEA 264
Query: 274 RDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKPCKQDDLCC-----KQLEVGGSSF 328
           ++LI  ML ++P+ R+TA + L H W+ +   VA    +Q+ + C      + ++ G+  
Sbjct: 265 KNLINQMLTINPAKRITADQALKHPWVCQRSTVASMMHRQETVECLRKFNARRKLKGAIL 324
Query: 329 SATFISRNM 337
           +   +SRN 
Sbjct: 325 TTMLVSRNF 333

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  204 bits (520), Expect = 6e-53,   Method: Compositional matrix adjust.
 Identities = 104/266 (39%), Positives = 160/266 (60%), Gaps = 2/266 (0%)
Query: 37  NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTK 96
           +LS+ Y   K+LG G +G +  C DK T    A K I K  + T  + + ++ E+ ++ K
Sbjct: 34  HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLE-EVAVL-K 91
Query: 97  LSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSY 156
           L  HPN++ L   +E++   +L+ME   GGELF  +    +F+E +A VI + ++  V+Y
Sbjct: 92  LLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTY 151
Query: 157 CHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLA 216
            H + +VHRDLKPEN+LL +K   + IK+ DFGL+   +  + +   +G+ +YIAPEVL 
Sbjct: 152 LHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR 211
Query: 217 GGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDL 276
             Y++  DVWS GVIL+ILL+G PPF G+T  +I   V      F S  W ++S  A+DL
Sbjct: 212 KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDL 271
Query: 277 IMGMLRVDPSTRLTAAEVLAHSWMEE 302
           I  ML+ D   R++A + L H W++E
Sbjct: 272 IKQMLQFDSQRRISAQQALEHPWIKE 297

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score =  202 bits (514), Expect = 3e-52,   Method: Compositional matrix adjust.
 Identities = 107/273 (39%), Positives = 164/273 (60%), Gaps = 10/273 (3%)
Query: 32  ATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEI 91
           + Q +N+   ++  + LG G F  +     + TG++ A K I K       D  S++ EI
Sbjct: 1   SMQTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP--AFRD-SSLENEI 57
Query: 92  EIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLM 151
            ++ K+  H N+V L+ +YE   + +L+M+L +GGELF R+ + G ++E +A ++ + ++
Sbjct: 58  AVLKKIK-HENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVL 116
Query: 152 QVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN--LHGTVGSPFY 209
             V Y H NG+VHRDLKPEN+L  T   +S I + DFGL+   K  QN  +    G+P Y
Sbjct: 117 SAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLS---KMEQNGIMSTACGTPGY 173
Query: 210 IAPEVLA-GGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDH 268
           +APEVLA   Y++A D WS GVI YILL G PPF+ +T+SK+F+ ++     F S  WD 
Sbjct: 174 VAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDD 233
Query: 269 ISASARDLIMGMLRVDPSTRLTAAEVLAHSWME 301
           IS SA+D I  +L  DP+ R T  + L+H W++
Sbjct: 234 ISESAKDFICHLLEKDPNERYTCEKALSHPWID 266

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score =  201 bits (512), Expect = 5e-52,   Method: Compositional matrix adjust.
 Identities = 104/268 (38%), Positives = 158/268 (58%), Gaps = 4/268 (1%)
Query: 34  QISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEI 93
           Q  ++   +   + LG G F  +    +K TG++ A K I K  L   E   SI+ EI +
Sbjct: 16  QAEDIKKIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKES--SIENEIAV 73
Query: 94  MTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQV 153
           + K+  H N+V L+ +YE  ++++L+M+L +GGELF R+ + G ++E +A  + R ++  
Sbjct: 74  LRKIK-HENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDA 132
Query: 154 VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPE 213
           V Y H  G+VHRDLKPEN+L  ++   S I ++DFGL+     G  +    G+P Y+APE
Sbjct: 133 VYYLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAPE 192
Query: 214 VLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISAS 272
           VLA   Y++A D WS GVI YILL G PPF+ +  SK+F+ +  A+  F S  WD IS S
Sbjct: 193 VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAEYEFDSPYWDDISDS 252
Query: 273 ARDLIMGMLRVDPSTRLTAAEVLAHSWM 300
           A+D I  ++  DP+ R T  +   H W+
Sbjct: 253 AKDFIRNLMEKDPNKRYTCEQAARHPWI 280

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score =  199 bits (506), Expect = 2e-51,   Method: Compositional matrix adjust.
 Identities = 107/268 (39%), Positives = 157/268 (58%), Gaps = 4/268 (1%)
Query: 34  QISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEI 93
           Q  ++ D Y     LG G F  +    DK T +++A K IAK+ L   E   S++ EI +
Sbjct: 12  QAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEG--SMENEIAV 69
Query: 94  MTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQV 153
           + K+  HPN+V L  +YE   +++L+M+L +GGELF R+ + G ++E +A  +   ++  
Sbjct: 70  LHKIK-HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDA 128
Query: 154 VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPE 213
           V Y H  G+VHRDLKPEN+L  +    S I ++DFGL+     G  L    G+P Y+APE
Sbjct: 129 VKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE 188
Query: 214 VLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISAS 272
           VLA   Y++A D WS GVI YILL G PPF+ +  +K+F+ +  A+  F S  WD IS S
Sbjct: 189 VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDS 248
Query: 273 ARDLIMGMLRVDPSTRLTAAEVLAHSWM 300
           A+D I  ++  DP  R T  + L H W+
Sbjct: 249 AKDFIRHLMEKDPEKRFTCEQALQHPWI 276

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score =  199 bits (506), Expect = 2e-51,   Method: Compositional matrix adjust.
 Identities = 107/268 (39%), Positives = 157/268 (58%), Gaps = 4/268 (1%)
Query: 34  QISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEI 93
           Q  ++ D Y     LG G F  +    DK T +++A K IAK+ L   E   S++ EI +
Sbjct: 12  QAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEG--SMENEIAV 69
Query: 94  MTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQV 153
           + K+  HPN+V L  +YE   +++L+M+L +GGELF R+ + G ++E +A  +   ++  
Sbjct: 70  LHKIK-HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDA 128
Query: 154 VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPE 213
           V Y H  G+VHRDLKPEN+L  +    S I ++DFGL+     G  L    G+P Y+APE
Sbjct: 129 VKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE 188
Query: 214 VLA-GGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISAS 272
           VLA   Y++A D WS GVI YILL G PPF+ +  +K+F+ +  A+  F S  WD IS S
Sbjct: 189 VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDS 248
Query: 273 ARDLIMGMLRVDPSTRLTAAEVLAHSWM 300
           A+D I  ++  DP  R T  + L H W+
Sbjct: 249 AKDFIRHLMEKDPEKRFTCEQALQHPWI 276

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score =  199 bits (506), Expect = 3e-51,   Method: Compositional matrix adjust.
 Identities = 107/268 (39%), Positives = 157/268 (58%), Gaps = 4/268 (1%)
Query: 34  QISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEI 93
           Q  ++ D Y     LG G F  +    DK T +++A K IAK+ L   E   S++ EI +
Sbjct: 12  QAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEG--SMENEIAV 69
Query: 94  MTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQV 153
           + K+  HPN+V L  +YE   +++L+M+L +GGELF R+ + G ++E +A  +   ++  
Sbjct: 70  LHKIK-HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDA 128
Query: 154 VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPE 213
           V Y H  G+VHRDLKPEN+L  +    S I ++DFGL+     G  L    G+P Y+APE
Sbjct: 129 VKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE 188
Query: 214 VLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISAS 272
           VLA   Y++A D WS GVI YILL G PPF+ +  +K+F+ +  A+  F S  WD IS S
Sbjct: 189 VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDS 248
Query: 273 ARDLIMGMLRVDPSTRLTAAEVLAHSWM 300
           A+D I  ++  DP  R T  + L H W+
Sbjct: 249 AKDFIRHLMEKDPEKRFTCEQALQHPWI 276

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score =  197 bits (502), Expect = 6e-51,   Method: Compositional matrix adjust.
 Identities = 107/268 (39%), Positives = 156/268 (58%), Gaps = 4/268 (1%)
Query: 34  QISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEI 93
           Q  ++ D Y     LG G F  +    DK T +++A K IAK  L   E   S++ EI +
Sbjct: 12  QAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEG--SMENEIAV 69
Query: 94  MTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQV 153
           + K+  HPN+V L  +YE   +++L+M+L +GGELF R+ + G ++E +A  +   ++  
Sbjct: 70  LHKIK-HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDA 128
Query: 154 VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPE 213
           V Y H  G+VHRDLKPEN+L  +    S I ++DFGL+     G  L    G+P Y+APE
Sbjct: 129 VKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE 188
Query: 214 VLA-GGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISAS 272
           VLA   Y++A D WS GVI YILL G PPF+ +  +K+F+ +  A+  F S  WD IS S
Sbjct: 189 VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDS 248
Query: 273 ARDLIMGMLRVDPSTRLTAAEVLAHSWM 300
           A+D I  ++  DP  R T  + L H W+
Sbjct: 249 AKDFIRHLMEKDPEKRFTCEQALQHPWI 276

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score =  194 bits (493), Expect = 8e-50,   Method: Compositional matrix adjust.
 Identities = 101/273 (36%), Positives = 161/273 (58%), Gaps = 8/273 (2%)
Query: 30  LDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKL 89
           +D +    LSD + +  +LG G   ++  C  K T +  A K + K    TV D + ++ 
Sbjct: 43  IDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKK----TV-DKKIVRT 97
Query: 90  EIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRH 149
           EI ++ +LS HPN++ LK ++E    + L++EL  GGELF R+ + G +SE +A    + 
Sbjct: 98  EIGVLLRLS-HPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQ 156
Query: 150 LMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFY 209
           +++ V+Y H NG+VHRDLKPEN+L AT +  +P+K+ADFGL+  ++    +    G+P Y
Sbjct: 157 ILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGY 216
Query: 210 IAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSK-IFDAVRAADLRFPSDPWD 267
            APE+L G  Y    D+WS G+I YILL G  PF+ +   + +F  +   +  F S  WD
Sbjct: 217 CAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWD 276
Query: 268 HISASARDLIMGMLRVDPSTRLTAAEVLAHSWM 300
            +S +A+DL+  ++ +DP  RLT  + L H W+
Sbjct: 277 EVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWV 309

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score =  192 bits (489), Expect = 2e-49,   Method: Compositional matrix adjust.
 Identities = 109/300 (36%), Positives = 159/300 (53%), Gaps = 15/300 (5%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           K LG G F + R+C  K + +  A K I+K      +       EI  +    GHPN+V 
Sbjct: 17  KPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK------EITALKLCEGHPNIVK 70
Query: 106 LKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHR 165
           L  V+ ++ +  L+MEL  GGELF R++K   FSETEA  I R L+  VS+ H  GVVHR
Sbjct: 71  LHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHR 130
Query: 166 DLKPENILLATKSSSSPIKLADFGLATYIKA-GQNLHGTVGSPFYIAPEVL-AGGYNQAA 223
           DLKPEN+L   ++ +  IK+ DFG A       Q L     +  Y APE+L   GY+++ 
Sbjct: 131 DLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESC 190
Query: 224 DVWSAGVILYILLSGMPPFWGKTKS-------KIFDAVRAADLRFPSDPWDHISASARDL 276
           D+WS GVILY +LSG  PF    +S       +I   ++  D  F  + W ++S  A+DL
Sbjct: 191 DLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDL 250
Query: 277 IMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKPCKQDDLCCKQLEVGGSSFSATFISRN 336
           I G+L VDP+ RL  + +  + W+++  Q++  P    D+         +   ATF + N
Sbjct: 251 IQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAAVHTCVKATFHAFN 310

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score =  192 bits (488), Expect = 3e-49,   Method: Compositional matrix adjust.
 Identities = 104/271 (38%), Positives = 156/271 (57%), Gaps = 6/271 (2%)
Query: 36  SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVE---DVRSIKLEIE 92
           S + D Y +G++LG GQF ++R+C  K TG+  A K I K RL +         I+ E+ 
Sbjct: 1   SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 60
Query: 93  IMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQ 152
           I+ ++  HPN++ L  ++E +  V L++EL +GGELF  L +    +E EA    + ++ 
Sbjct: 61  ILREIR-HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD 119
Query: 153 VVSYCHGNGVVHRDLKPENILLATKSSSSP-IKLADFGLATYIKAGQNLHGTVGSPFYIA 211
            V Y H   + H DLKPENI+L  K+  +P IKL DFG+A  I+AG       G+P ++A
Sbjct: 120 GVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVA 179
Query: 212 PEVLA-GGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHIS 270
           PE++        AD+WS GVI YILLSG  PF G+TK +    + A +  F  + + + S
Sbjct: 180 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTS 239
Query: 271 ASARDLIMGMLRVDPSTRLTAAEVLAHSWME 301
             A+D I  +L  DP  R+T A+ L HSW++
Sbjct: 240 ELAKDFIRRLLVKDPKRRMTIAQSLEHSWIK 270

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score =  191 bits (486), Expect = 5e-49,   Method: Compositional matrix adjust.
 Identities = 106/289 (36%), Positives = 156/289 (53%), Gaps = 10/289 (3%)
Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAK---DRLVTVEDVRSI-KLEIEI 93
           + + Y   ++LG G +G +  C +K      A K I K   D+    +D ++I K   EI
Sbjct: 34  IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEI 93
Query: 94  MTKLS-----GHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
             ++S      HPN++ L  V+E++ Y +L+ E   GGELF ++    +F E +A  I +
Sbjct: 94  YNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMK 153
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF 208
            ++  + Y H + +VHRD+KPENILL  K+S   IK+ DFGL+++      L   +G+ +
Sbjct: 154 QILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAY 213
Query: 209 YIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDH 268
           YIAPEVL   YN+  DVWS GVI+YILL G PPF G+    I   V      F  + W +
Sbjct: 214 YIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKN 273
Query: 269 ISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKPCKQDDLC 317
           IS  A++LI  ML  D + R TA E L   W+++      K   Q  LC
Sbjct: 274 ISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKS-DQKTLC 321

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score =  191 bits (484), Expect = 9e-49,   Method: Compositional matrix adjust.
 Identities = 104/273 (38%), Positives = 156/273 (57%), Gaps = 10/273 (3%)
Query: 36  SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVE---DVRSIKLEIE 92
           S + D Y +G++LG GQF ++R+C  K TG+  A K I K RL +         I+ E+ 
Sbjct: 22  SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVN 81
Query: 93  IMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQ 152
           I+ ++  HPN++ L  ++E +  V L++EL +GGELF  L +    +E EA    + ++ 
Sbjct: 82  ILREIR-HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD 140
Query: 153 VVSYCHGNGVVHRDLKPENILLATKSSSSP-IKLADFGLATYIKAGQNLHGTVGSPFYIA 211
            V Y H   + H DLKPENI+L  K+  +P IKL DFG+A  I+AG       G+P ++A
Sbjct: 141 GVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVA 200
Query: 212 PEVLAGGYNQ---AADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDH 268
           PE++   Y      AD+WS GVI YILLSG  PF G+TK +    + A +  F  + + +
Sbjct: 201 PEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSN 258
Query: 269 ISASARDLIMGMLRVDPSTRLTAAEVLAHSWME 301
            S  A+D I  +L  DP  R+  A+ L HSW++
Sbjct: 259 TSELAKDFIRRLLVKDPKRRMXIAQSLEHSWIK 291

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score =  190 bits (483), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 100/266 (37%), Positives = 153/266 (57%), Gaps = 15/266 (5%)
Query: 48  LGWGQFGVIRECSDKFTGEVLACK--SIAKDRLVT--VEDVR-SIKLEIEIMTKLSGHPN 102
           +G G   V+R C  + TG   A K   +  +RL    +E+VR + + E  I+ +++GHP+
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161
Query: 103 VVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGV 162
           ++ L   YE   ++ L+ +L   GELF  L +    SE E R I R L++ VS+ H N +
Sbjct: 162 IITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNI 221
Query: 163 VHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLA------ 216
           VHRDLKPENILL     +  I+L+DFG + +++ G+ L    G+P Y+APE+L       
Sbjct: 222 VHRDLKPENILL---DDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDET 278
Query: 217 -GGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARD 275
             GY +  D+W+ GVIL+ LL+G PPFW + +  +   +     +F S  WD  S++ +D
Sbjct: 279 HPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKD 338
Query: 276 LIMGMLRVDPSTRLTAAEVLAHSWME 301
           LI  +L+VDP  RLTA + L H + E
Sbjct: 339 LISRLLQVDPEARLTAEQALQHPFFE 364

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score =  190 bits (483), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 102/270 (37%), Positives = 155/270 (57%), Gaps = 6/270 (2%)
Query: 37  NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVE---DVRSIKLEIEI 93
           ++ D Y +G++LG GQF ++R+C  K TG+  A K I K RL +         I+ E+ I
Sbjct: 9   DVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 68
Query: 94  MTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQV 153
           + ++  HPN++ L  ++E +  V L++EL +GGELF  L +    +E EA    + ++  
Sbjct: 69  LREIR-HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDG 127
Query: 154 VSYCHGNGVVHRDLKPENILLATKSSSSP-IKLADFGLATYIKAGQNLHGTVGSPFYIAP 212
           V Y H   + H DLKPENI+L  K+  +P IKL DFG+A  I+AG       G+P ++AP
Sbjct: 128 VHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAP 187
Query: 213 EVLA-GGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISA 271
           E++        AD+WS GVI YILLSG  PF G+TK +    + A +  F  + + + S 
Sbjct: 188 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSE 247
Query: 272 SARDLIMGMLRVDPSTRLTAAEVLAHSWME 301
            A+D I  +L  DP  R+  A+ L HSW++
Sbjct: 248 LAKDFIRRLLVKDPKRRMXIAQSLEHSWIK 277

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score =  189 bits (480), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 100/279 (35%), Positives = 162/279 (58%), Gaps = 8/279 (2%)
Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEI-MTK 96
             D Y L + +G G F V+R C ++ TG+  A K +   +  +   + +  L+ E  +  
Sbjct: 22  FEDVYELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICH 81
Query: 97  LSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGR----FSETEARVIFRHLMQ 152
           +  HP++V+L   Y  +  ++++ E   G +L   + K       +SE  A    R +++
Sbjct: 82  MLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE 141
Query: 153 VVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI-KAGQNLHGTVGSPFYIA 211
            + YCH N ++HRD+KPEN+LLA+K +S+P+KL DFG+A  + ++G    G VG+P ++A
Sbjct: 142 ALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFMA 201
Query: 212 PEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHIS 270
           PEV+    Y +  DVW  GVIL+ILLSG  PF+G TK ++F+ +     +     W HIS
Sbjct: 202 PEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG-TKERLFEGIIKGKYKMNPRQWSHIS 260
Query: 271 ASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQK 309
            SA+DL+  ML +DP+ R+T  E L H W++E ++ A K
Sbjct: 261 ESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYK 299

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  189 bits (480), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 99/275 (36%), Positives = 156/275 (56%), Gaps = 12/275 (4%)
Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVT-----VEDVRSIKLEIE 92
           L D Y++ K LG G  G ++   ++ T + +A K I+K +         +   +++ EIE
Sbjct: 8   LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 67
Query: 93  IMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQ 152
           I+ KL+ HP ++ +K  ++ EDY ++++EL  GGELF ++    R  E   ++ F  ++ 
Sbjct: 68  ILKKLN-HPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 125
Query: 153 VVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAP 212
            V Y H NG++HRDLKPEN+LL+++     IK+ DFG +  +     +    G+P Y+AP
Sbjct: 126 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 185
Query: 213 EVL----AGGYNQAADVWSAGVILYILLSGMPPF-WGKTKSKIFDAVRAADLRFPSDPWD 267
           EVL      GYN+A D WS GVIL+I LSG PPF   +T+  + D + +    F  + W 
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 245
Query: 268 HISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
            +S  A DL+  +L VDP  R T  E L H W+++
Sbjct: 246 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  189 bits (480), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 99/275 (36%), Positives = 156/275 (56%), Gaps = 12/275 (4%)
Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVT-----VEDVRSIKLEIE 92
           L D Y++ K LG G  G ++   ++ T + +A K I+K +         +   +++ EIE
Sbjct: 8   LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 67
Query: 93  IMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQ 152
           I+ KL+ HP ++ +K  ++ EDY ++++EL  GGELF ++    R  E   ++ F  ++ 
Sbjct: 68  ILKKLN-HPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 125
Query: 153 VVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAP 212
            V Y H NG++HRDLKPEN+LL+++     IK+ DFG +  +     +    G+P Y+AP
Sbjct: 126 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 185
Query: 213 EVL----AGGYNQAADVWSAGVILYILLSGMPPF-WGKTKSKIFDAVRAADLRFPSDPWD 267
           EVL      GYN+A D WS GVIL+I LSG PPF   +T+  + D + +    F  + W 
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 245
Query: 268 HISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
            +S  A DL+  +L VDP  R T  E L H W+++
Sbjct: 246 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  189 bits (480), Expect = 3e-48,   Method: Compositional matrix adjust.
 Identities = 99/275 (36%), Positives = 156/275 (56%), Gaps = 12/275 (4%)
Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVT-----VEDVRSIKLEIE 92
           L D Y++ K LG G  G ++   ++ T + +A K I+K +         +   +++ EIE
Sbjct: 8   LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 67
Query: 93  IMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQ 152
           I+ KL+ HP ++ +K  ++ EDY ++++EL  GGELF ++    R  E   ++ F  ++ 
Sbjct: 68  ILKKLN-HPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 125
Query: 153 VVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAP 212
            V Y H NG++HRDLKPEN+LL+++     IK+ DFG +  +     +    G+P Y+AP
Sbjct: 126 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 185
Query: 213 EVL----AGGYNQAADVWSAGVILYILLSGMPPF-WGKTKSKIFDAVRAADLRFPSDPWD 267
           EVL      GYN+A D WS GVIL+I LSG PPF   +T+  + D + +    F  + W 
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 245
Query: 268 HISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
            +S  A DL+  +L VDP  R T  E L H W+++
Sbjct: 246 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  189 bits (480), Expect = 3e-48,   Method: Compositional matrix adjust.
 Identities = 99/275 (36%), Positives = 156/275 (56%), Gaps = 12/275 (4%)
Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVT-----VEDVRSIKLEIE 92
           L D Y++ K LG G  G ++   ++ T + +A K I+K +         +   +++ EIE
Sbjct: 7   LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 66
Query: 93  IMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQ 152
           I+ KL+ HP ++ +K  ++ EDY ++++EL  GGELF ++    R  E   ++ F  ++ 
Sbjct: 67  ILKKLN-HPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 124
Query: 153 VVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAP 212
            V Y H NG++HRDLKPEN+LL+++     IK+ DFG +  +     +    G+P Y+AP
Sbjct: 125 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 184
Query: 213 EVL----AGGYNQAADVWSAGVILYILLSGMPPF-WGKTKSKIFDAVRAADLRFPSDPWD 267
           EVL      GYN+A D WS GVIL+I LSG PPF   +T+  + D + +    F  + W 
Sbjct: 185 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 244
Query: 268 HISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
            +S  A DL+  +L VDP  R T  E L H W+++
Sbjct: 245 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 279

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  189 bits (479), Expect = 3e-48,   Method: Compositional matrix adjust.
 Identities = 99/275 (36%), Positives = 156/275 (56%), Gaps = 12/275 (4%)
Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVT-----VEDVRSIKLEIE 92
           L D Y++ K LG G  G ++   ++ T + +A K I+K +         +   +++ EIE
Sbjct: 14  LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 73
Query: 93  IMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQ 152
           I+ KL+ HP ++ +K  ++ EDY ++++EL  GGELF ++    R  E   ++ F  ++ 
Sbjct: 74  ILKKLN-HPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 131
Query: 153 VVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAP 212
            V Y H NG++HRDLKPEN+LL+++     IK+ DFG +  +     +    G+P Y+AP
Sbjct: 132 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 191
Query: 213 EVL----AGGYNQAADVWSAGVILYILLSGMPPF-WGKTKSKIFDAVRAADLRFPSDPWD 267
           EVL      GYN+A D WS GVIL+I LSG PPF   +T+  + D + +    F  + W 
Sbjct: 192 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 251
Query: 268 HISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
            +S  A DL+  +L VDP  R T  E L H W+++
Sbjct: 252 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 286

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score =  188 bits (477), Expect = 6e-48,   Method: Compositional matrix adjust.
 Identities = 108/273 (39%), Positives = 152/273 (55%), Gaps = 12/273 (4%)
Query: 37  NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRL------VTVEDVRSIKLE 90
           N+ D Y  G++LG GQF V+++C +K TG   A K I K R       V+ ED   I+ E
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED---IERE 64
Query: 91  IEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHL 150
           + I+ ++  HPNV+ L  VYE +  V L++EL AGGELF  L +    +E EA    + +
Sbjct: 65  VSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 151 MQVVSYCHGNGVVHRDLKPENILLATKSSSSP-IKLADFGLATYIKAGQNLHGTVGSPFY 209
           +  V Y H   + H DLKPENI+L  ++   P IK+ DFGLA  I  G       G+P +
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPAF 183
Query: 210 IAPEVLA-GGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDH 268
           +APE++        AD+WS GVI YILLSG  PF G TK +    V A +  F  + + +
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 243
Query: 269 ISASARDLIMGMLRVDPSTRLTAAEVLAHSWME 301
            SA A+D I  +L  DP  R+T  + L H W++
Sbjct: 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  188 bits (477), Expect = 6e-48,   Method: Compositional matrix adjust.
 Identities = 107/312 (34%), Positives = 168/312 (53%), Gaps = 19/312 (6%)
Query: 3   TNNSEDSSQLSTQFCNSYKVSSLTGTILDATQI--SNLSDRYVLGKQLGWGQFGVIRECS 60
            NNSE +  LS       KV       +D   +    L D Y++ K LG G  G ++   
Sbjct: 115 NNNSEIALSLSRN-----KVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAF 169
Query: 61  DKFTGEVLACKSIAKDRLVT-----VEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDY 115
           ++ T + +A + I+K +         +   +++ EIEI+ KL+ HP ++ +K  ++ EDY
Sbjct: 170 ERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN-HPCIIKIKNFFDAEDY 228
Query: 116 VHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLA 175
            ++++EL  GGELF ++    R  E   ++ F  ++  V Y H NG++HRDLKPEN+LL+
Sbjct: 229 -YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLS 287
Query: 176 TKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVL----AGGYNQAADVWSAGVI 231
           ++     IK+ DFG +  +     +    G+P Y+APEVL      GYN+A D WS GVI
Sbjct: 288 SQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVI 347
Query: 232 LYILLSGMPPF-WGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLT 290
           L+I LSG PPF   +T+  + D + +    F  + W  +S  A DL+  +L VDP  R T
Sbjct: 348 LFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFT 407
Query: 291 AAEVLAHSWMEE 302
             E L H W+++
Sbjct: 408 TEEALRHPWLQD 419

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score =  187 bits (476), Expect = 6e-48,   Method: Compositional matrix adjust.
 Identities = 109/275 (39%), Positives = 153/275 (55%), Gaps = 16/275 (5%)
Query: 37  NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRL------VTVEDVRSIKLE 90
           N+ D Y  G++LG GQF V+++C +K TG   A K I K R       V+ ED   I+ E
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED---IERE 64
Query: 91  IEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHL 150
           + I+ ++  HPNV+ L  VYE +  V L++EL AGGELF  L +    +E EA    + +
Sbjct: 65  VSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 151 MQVVSYCHGNGVVHRDLKPENILLATKSSSSP-IKLADFGLATYIKAGQNLHGTVGSPFY 209
           +  V Y H   + H DLKPENI+L  ++   P IK+ DFGLA  I  G       G+P +
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183
Query: 210 IAPEVLAGGYNQ---AADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW 266
           +APE++   Y      AD+WS GVI YILLSG  PF G TK +    V A +  F  + +
Sbjct: 184 VAPEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF 241
Query: 267 DHISASARDLIMGMLRVDPSTRLTAAEVLAHSWME 301
            + SA A+D I  +L  DP  R+T  + L H W++
Sbjct: 242 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  187 bits (476), Expect = 7e-48,   Method: Compositional matrix adjust.
 Identities = 107/312 (34%), Positives = 168/312 (53%), Gaps = 19/312 (6%)
Query: 3   TNNSEDSSQLSTQFCNSYKVSSLTGTILDATQI--SNLSDRYVLGKQLGWGQFGVIRECS 60
            NNSE +  LS       KV       +D   +    L D Y++ K LG G  G ++   
Sbjct: 101 NNNSEIALSLSRN-----KVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAF 155
Query: 61  DKFTGEVLACKSIAKDRLVT-----VEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDY 115
           ++ T + +A + I+K +         +   +++ EIEI+ KL+ HP ++ +K  ++ EDY
Sbjct: 156 ERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN-HPCIIKIKNFFDAEDY 214
Query: 116 VHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLA 175
            ++++EL  GGELF ++    R  E   ++ F  ++  V Y H NG++HRDLKPEN+LL+
Sbjct: 215 -YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLS 273
Query: 176 TKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVL----AGGYNQAADVWSAGVI 231
           ++     IK+ DFG +  +     +    G+P Y+APEVL      GYN+A D WS GVI
Sbjct: 274 SQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVI 333
Query: 232 LYILLSGMPPF-WGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLT 290
           L+I LSG PPF   +T+  + D + +    F  + W  +S  A DL+  +L VDP  R T
Sbjct: 334 LFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFT 393
Query: 291 AAEVLAHSWMEE 302
             E L H W+++
Sbjct: 394 TEEALRHPWLQD 405

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score =  187 bits (476), Expect = 8e-48,   Method: Compositional matrix adjust.
 Identities = 108/273 (39%), Positives = 152/273 (55%), Gaps = 12/273 (4%)
Query: 37  NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRL------VTVEDVRSIKLE 90
           N+ D Y  G++LG GQF V+++C +K TG   A K I K R       V+ ED   I+ E
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED---IERE 64
Query: 91  IEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHL 150
           + I+ ++  HPNV+ L  VYE +  V L++EL AGGELF  L +    +E EA    + +
Sbjct: 65  VSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 151 MQVVSYCHGNGVVHRDLKPENILLATKSSSSP-IKLADFGLATYIKAGQNLHGTVGSPFY 209
           +  V Y H   + H DLKPENI+L  ++   P IK+ DFGLA  I  G       G+P +
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183
Query: 210 IAPEVLA-GGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDH 268
           +APE++        AD+WS GVI YILLSG  PF G TK +    V A +  F  + + +
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 243
Query: 269 ISASARDLIMGMLRVDPSTRLTAAEVLAHSWME 301
            SA A+D I  +L  DP  R+T  + L H W++
Sbjct: 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score =  187 bits (475), Expect = 8e-48,   Method: Compositional matrix adjust.
 Identities = 108/273 (39%), Positives = 152/273 (55%), Gaps = 12/273 (4%)
Query: 37  NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRL------VTVEDVRSIKLE 90
           N+ D Y  G++LG GQF V+++C +K TG   A K I K R       V+ ED   I+ E
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED---IERE 64
Query: 91  IEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHL 150
           + I+ ++  HPNV+ L  VYE +  V L++EL AGGELF  L +    +E EA    + +
Sbjct: 65  VSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 151 MQVVSYCHGNGVVHRDLKPENILLATKSSSSP-IKLADFGLATYIKAGQNLHGTVGSPFY 209
           +  V Y H   + H DLKPENI+L  ++   P IK+ DFGLA  I  G       G+P +
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183
Query: 210 IAPEVLA-GGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDH 268
           +APE++        AD+WS GVI YILLSG  PF G TK +    V A +  F  + + +
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 243
Query: 269 ISASARDLIMGMLRVDPSTRLTAAEVLAHSWME 301
            SA A+D I  +L  DP  R+T  + L H W++
Sbjct: 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score =  187 bits (475), Expect = 9e-48,   Method: Compositional matrix adjust.
 Identities = 109/275 (39%), Positives = 153/275 (55%), Gaps = 16/275 (5%)
Query: 37  NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRL------VTVEDVRSIKLE 90
           N+ D Y  G++LG GQF V+++C +K TG   A K I K R       V+ ED   I+ E
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED---IERE 64
Query: 91  IEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHL 150
           + I+ ++  HPNV+ L  VYE +  V L++EL AGGELF  L +    +E EA    + +
Sbjct: 65  VSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 151 MQVVSYCHGNGVVHRDLKPENILLATKSSSSP-IKLADFGLATYIKAGQNLHGTVGSPFY 209
           +  V Y H   + H DLKPENI+L  ++   P IK+ DFGLA  I  G       G+P +
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183
Query: 210 IAPEVLAGGYNQ---AADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW 266
           +APE++   Y      AD+WS GVI YILLSG  PF G TK +    V A +  F  + +
Sbjct: 184 VAPEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF 241
Query: 267 DHISASARDLIMGMLRVDPSTRLTAAEVLAHSWME 301
            + SA A+D I  +L  DP  R+T  + L H W++
Sbjct: 242 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score =  187 bits (475), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 109/275 (39%), Positives = 153/275 (55%), Gaps = 16/275 (5%)
Query: 37  NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRL------VTVEDVRSIKLE 90
           N+ D Y  G++LG GQF V+++C +K TG   A K I K R       V+ ED   I+ E
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED---IERE 64
Query: 91  IEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHL 150
           + I+ ++  HPNV+ L  VYE +  V L++EL AGGELF  L +    +E EA    + +
Sbjct: 65  VSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 151 MQVVSYCHGNGVVHRDLKPENILLATKSSSSP-IKLADFGLATYIKAGQNLHGTVGSPFY 209
           +  V Y H   + H DLKPENI+L  ++   P IK+ DFGLA  I  G       G+P +
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183
Query: 210 IAPEVLAGGYNQ---AADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW 266
           +APE++   Y      AD+WS GVI YILLSG  PF G TK +    V A +  F  + +
Sbjct: 184 VAPEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF 241
Query: 267 DHISASARDLIMGMLRVDPSTRLTAAEVLAHSWME 301
            + SA A+D I  +L  DP  R+T  + L H W++
Sbjct: 242 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score =  187 bits (474), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 109/275 (39%), Positives = 153/275 (55%), Gaps = 16/275 (5%)
Query: 37  NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRL------VTVEDVRSIKLE 90
           N+ D Y  G++LG GQF V+++C +K TG   A K I K R       V+ ED   I+ E
Sbjct: 7   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED---IERE 63
Query: 91  IEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHL 150
           + I+ ++  HPNV+ L  VYE +  V L++EL AGGELF  L +    +E EA    + +
Sbjct: 64  VSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 122
Query: 151 MQVVSYCHGNGVVHRDLKPENILLATKSSSSP-IKLADFGLATYIKAGQNLHGTVGSPFY 209
           +  V Y H   + H DLKPENI+L  ++   P IK+ DFGLA  I  G       G+P +
Sbjct: 123 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 182
Query: 210 IAPEVLAGGYNQ---AADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW 266
           +APE++   Y      AD+WS GVI YILLSG  PF G TK +    V A +  F  + +
Sbjct: 183 VAPEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF 240
Query: 267 DHISASARDLIMGMLRVDPSTRLTAAEVLAHSWME 301
            + SA A+D I  +L  DP  R+T  + L H W++
Sbjct: 241 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 275

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score =  187 bits (474), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 108/273 (39%), Positives = 152/273 (55%), Gaps = 12/273 (4%)
Query: 37  NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRL------VTVEDVRSIKLE 90
           N+ D Y  G++LG GQF V+++C +K TG   A K I K R       V+ ED   I+ E
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED---IERE 64
Query: 91  IEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHL 150
           + I+ ++  HPNV+ L  VYE +  V L++EL AGGELF  L +    +E EA    + +
Sbjct: 65  VSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 151 MQVVSYCHGNGVVHRDLKPENILLATKSSSSP-IKLADFGLATYIKAGQNLHGTVGSPFY 209
           +  V Y H   + H DLKPENI+L  ++   P IK+ DFGLA  I  G       G+P +
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183
Query: 210 IAPEVLA-GGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDH 268
           +APE++        AD+WS GVI YILLSG  PF G TK +    V A +  F  + + +
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 243
Query: 269 ISASARDLIMGMLRVDPSTRLTAAEVLAHSWME 301
            SA A+D I  +L  DP  R+T  + L H W++
Sbjct: 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score =  187 bits (474), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 108/273 (39%), Positives = 152/273 (55%), Gaps = 12/273 (4%)
Query: 37  NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRL------VTVEDVRSIKLE 90
           N+ D Y  G++LG GQF V+++C +K TG   A K I K R       V+ ED   I+ E
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED---IERE 64
Query: 91  IEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHL 150
           + I+ ++  HPNV+ L  VYE +  V L++EL AGGELF  L +    +E EA    + +
Sbjct: 65  VSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 151 MQVVSYCHGNGVVHRDLKPENILLATKSSSSP-IKLADFGLATYIKAGQNLHGTVGSPFY 209
           +  V Y H   + H DLKPENI+L  ++   P IK+ DFGLA  I  G       G+P +
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183
Query: 210 IAPEVLA-GGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDH 268
           +APE++        AD+WS GVI YILLSG  PF G TK +    V A +  F  + + +
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 243
Query: 269 ISASARDLIMGMLRVDPSTRLTAAEVLAHSWME 301
            SA A+D I  +L  DP  R+T  + L H W++
Sbjct: 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score =  187 bits (474), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 108/273 (39%), Positives = 152/273 (55%), Gaps = 12/273 (4%)
Query: 37  NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRL------VTVEDVRSIKLE 90
           N+ D Y  G++LG GQF V+++C +K TG   A K I K R       V+ ED   I+ E
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED---IERE 64
Query: 91  IEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHL 150
           + I+ ++  HPNV+ L  VYE +  V L++EL AGGELF  L +    +E EA    + +
Sbjct: 65  VSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 151 MQVVSYCHGNGVVHRDLKPENILLATKSSSSP-IKLADFGLATYIKAGQNLHGTVGSPFY 209
           +  V Y H   + H DLKPENI+L  ++   P IK+ DFGLA  I  G       G+P +
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183
Query: 210 IAPEVLA-GGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDH 268
           +APE++        AD+WS GVI YILLSG  PF G TK +    V A +  F  + + +
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 243
Query: 269 ISASARDLIMGMLRVDPSTRLTAAEVLAHSWME 301
            SA A+D I  +L  DP  R+T  + L H W++
Sbjct: 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score =  187 bits (474), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 109/275 (39%), Positives = 153/275 (55%), Gaps = 16/275 (5%)
Query: 37  NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRL------VTVEDVRSIKLE 90
           N+ D Y  G++LG GQF V+++C +K TG   A K I K R       V+ ED   I+ E
Sbjct: 7   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED---IERE 63
Query: 91  IEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHL 150
           + I+ ++  HPNV+ L  VYE +  V L++EL AGGELF  L +    +E EA    + +
Sbjct: 64  VSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 122
Query: 151 MQVVSYCHGNGVVHRDLKPENILLATKSSSSP-IKLADFGLATYIKAGQNLHGTVGSPFY 209
           +  V Y H   + H DLKPENI+L  ++   P IK+ DFGLA  I  G       G+P +
Sbjct: 123 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 182
Query: 210 IAPEVLAGGYNQ---AADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW 266
           +APE++   Y      AD+WS GVI YILLSG  PF G TK +    V A +  F  + +
Sbjct: 183 VAPEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF 240
Query: 267 DHISASARDLIMGMLRVDPSTRLTAAEVLAHSWME 301
            + SA A+D I  +L  DP  R+T  + L H W++
Sbjct: 241 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 275

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score =  185 bits (470), Expect = 4e-47,   Method: Compositional matrix adjust.
 Identities = 107/273 (39%), Positives = 152/273 (55%), Gaps = 12/273 (4%)
Query: 37  NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRL------VTVEDVRSIKLE 90
           N+ D Y  G++LG G+F V+++C +K TG   A K I K R       V+ ED   I+ E
Sbjct: 8   NVDDYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED---IERE 64
Query: 91  IEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHL 150
           + I+ ++  HPNV+ L  VYE +  V L++EL AGGELF  L +    +E EA    + +
Sbjct: 65  VSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 151 MQVVSYCHGNGVVHRDLKPENILLATKSSSSP-IKLADFGLATYIKAGQNLHGTVGSPFY 209
           +  V Y H   + H DLKPENI+L  ++   P IK+ DFGLA  I  G       G+P +
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183
Query: 210 IAPEVLA-GGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDH 268
           +APE++        AD+WS GVI YILLSG  PF G TK +    V A +  F  + + +
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 243
Query: 269 ISASARDLIMGMLRVDPSTRLTAAEVLAHSWME 301
            SA A+D I  +L  DP  R+T  + L H W++
Sbjct: 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score =  185 bits (469), Expect = 5e-47,   Method: Compositional matrix adjust.
 Identities = 109/275 (39%), Positives = 152/275 (55%), Gaps = 16/275 (5%)
Query: 37  NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRL------VTVEDVRSIKLE 90
           N+ D Y  G++LG GQF V+++C +K TG   A K I K R       V+ ED   I+ E
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED---IERE 64
Query: 91  IEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHL 150
           + I+ ++  HPNV+ L  VYE +  V L+ EL AGGELF  L +    +E EA    + +
Sbjct: 65  VSILKEIQ-HPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 151 MQVVSYCHGNGVVHRDLKPENILLATKSSSSP-IKLADFGLATYIKAGQNLHGTVGSPFY 209
           +  V Y H   + H DLKPENI+L  ++   P IK+ DFGLA  I  G       G+P +
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183
Query: 210 IAPEVLAGGYNQ---AADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW 266
           +APE++   Y      AD+WS GVI YILLSG  PF G TK +    V A +  F  + +
Sbjct: 184 VAPEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF 241
Query: 267 DHISASARDLIMGMLRVDPSTRLTAAEVLAHSWME 301
            + SA A+D I  +L  DP  R+T  + L H W++
Sbjct: 242 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score =  183 bits (465), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 107/273 (39%), Positives = 151/273 (55%), Gaps = 12/273 (4%)
Query: 37  NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRL------VTVEDVRSIKLE 90
           N+ D Y  G++LG G F V+++C +K TG   A K I K R       V+ ED   I+ E
Sbjct: 8   NVDDYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED---IERE 64
Query: 91  IEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHL 150
           + I+ ++  HPNV+ L  VYE +  V L++EL AGGELF  L +    +E EA    + +
Sbjct: 65  VSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 151 MQVVSYCHGNGVVHRDLKPENILLATKSSSSP-IKLADFGLATYIKAGQNLHGTVGSPFY 209
           +  V Y H   + H DLKPENI+L  ++   P IK+ DFGLA  I  G       G+P +
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183
Query: 210 IAPEVLA-GGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDH 268
           +APE++        AD+WS GVI YILLSG  PF G TK +    V A +  F  + + +
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 243
Query: 269 ISASARDLIMGMLRVDPSTRLTAAEVLAHSWME 301
            SA A+D I  +L  DP  R+T  + L H W++
Sbjct: 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score =  182 bits (463), Expect = 3e-46,   Method: Compositional matrix adjust.
 Identities = 109/309 (35%), Positives = 163/309 (52%), Gaps = 21/309 (6%)
Query: 37  NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTK 96
             +D Y + + +G G + V + C  K T    A K I K +       R    EIEI+ +
Sbjct: 19  QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK-------RDPTEEIEILLR 71
Query: 97  LSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSY 156
              HPN++ LK VY++  YV+++ EL  GGEL  ++ +   FSE EA  +   + + V Y
Sbjct: 72  YGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEY 131
Query: 157 CHGNGVVHRDLKPENILLATKSSS-SPIKLADFGLATYIKAGQNLHGTVGSPFY----IA 211
            H  GVVHRDLKP NIL   +S +   I++ DFG A  ++A    +G + +P Y    +A
Sbjct: 132 LHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE---NGLLMTPCYTANFVA 188
Query: 212 PEVLA-GGYNQAADVWSAGVILYILLSGMPPFWG---KTKSKIFDAVRAADLRFPSDPWD 267
           PEVL   GY+ A D+WS GV+LY +L+G  PF      T  +I   + +         W+
Sbjct: 189 PEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWN 248
Query: 268 HISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKPCKQDDLCCKQLEVGGSS 327
            +S +A+DL+  ML VDP  RLTAA VL H W+   +Q+ Q    + D     L  G  +
Sbjct: 249 SVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQLNRQD--APHLVKGAMA 306
Query: 328 FSATFISRN 336
            + + ++RN
Sbjct: 307 ATYSALNRN 315

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score =  182 bits (461), Expect = 4e-46,   Method: Compositional matrix adjust.
 Identities = 101/268 (37%), Positives = 145/268 (54%), Gaps = 16/268 (5%)
Query: 48  LGWGQFGVIRECSDKFTGEVLACKSI-----AKDRLVTVEDVRSIKL-EIEIMTKLSGHP 101
           LG G   V+R C  K T +  A K I            V+++R   L E++I+ K+SGHP
Sbjct: 25  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
           N++ LK  YE   +  L+ +L   GELF  L +    SE E R I R L++V+   H   
Sbjct: 85  NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN 144
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLA----- 216
           +VHRDLKPENILL    +   IKL DFG +  +  G+ L    G+P Y+APE++      
Sbjct: 145 IVHRDLKPENILLDDDMN---IKLTDFGFSCQLDPGEKLRSVCGTPSYLAPEIIECSMND 201
Query: 217 --GGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASAR 274
              GY +  D+WS GVI+Y LL+G PPFW + +  +   + + + +F S  WD  S + +
Sbjct: 202 NHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVK 261
Query: 275 DLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
           DL+   L V P  R TA E LAH + ++
Sbjct: 262 DLVSRFLVVQPQKRYTAEEALAHPFFQQ 289

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score =  181 bits (460), Expect = 5e-46,   Method: Compositional matrix adjust.
 Identities = 101/268 (37%), Positives = 145/268 (54%), Gaps = 16/268 (5%)
Query: 48  LGWGQFGVIRECSDKFTGEVLACKSI-----AKDRLVTVEDVRSIKL-EIEIMTKLSGHP 101
           LG G   V+R C  K T +  A K I            V+++R   L E++I+ K+SGHP
Sbjct: 12  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 71
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
           N++ LK  YE   +  L+ +L   GELF  L +    SE E R I R L++V+   H   
Sbjct: 72  NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN 131
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLA----- 216
           +VHRDLKPENILL    +   IKL DFG +  +  G+ L    G+P Y+APE++      
Sbjct: 132 IVHRDLKPENILLDDDMN---IKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMND 188
Query: 217 --GGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASAR 274
              GY +  D+WS GVI+Y LL+G PPFW + +  +   + + + +F S  WD  S + +
Sbjct: 189 NHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVK 248
Query: 275 DLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
           DL+   L V P  R TA E LAH + ++
Sbjct: 249 DLVSRFLVVQPQKRYTAEEALAHPFFQQ 276

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score =  181 bits (460), Expect = 5e-46,   Method: Compositional matrix adjust.
 Identities = 108/308 (35%), Positives = 165/308 (53%), Gaps = 24/308 (7%)
Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKL 97
            SD YV+ + +G G +   + C  K T    A K I K +       R    EIEI+ + 
Sbjct: 25  FSDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSK-------RDPSEEIEILLRY 77
Query: 98  SGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYC 157
             HPN++ LK VY++  +V+L+ EL  GGEL  ++ +   FSE EA  +   + + V Y 
Sbjct: 78  GQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYL 137
Query: 158 HGNGVVHRDLKPENILLATKSSSSP-IKLADFGLATYIKAGQNLHGTVGSPFY----IAP 212
           H  GVVHRDLKP NIL   +S +   +++ DFG A  ++A    +G + +P Y    +AP
Sbjct: 138 HSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAE---NGLLMTPCYTANFVAP 194
Query: 213 EVLA-GGYNQAADVWSAGVILYILLSGMPPFWG---KTKSKIFDAVRAADLRFPSDPWDH 268
           EVL   GY++  D+WS G++LY +L+G  PF      T  +I   + +         W+ 
Sbjct: 195 EVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWNT 254
Query: 269 ISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKPCKQDDLCCKQLEVGGSSF 328
           +S +A+DL+  ML VDP  RLTA +VL H W+ + +++ Q      DL   QL  G  + 
Sbjct: 255 VSETAKDLVSKMLHVDPHQRLTAKQVLQHPWVTQKDKLPQSQLSHQDL---QLVKG--AM 309
Query: 329 SATFISRN 336
           +AT+ + N
Sbjct: 310 AATYSALN 317

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score =  181 bits (459), Expect = 6e-46,   Method: Compositional matrix adjust.
 Identities = 101/268 (37%), Positives = 145/268 (54%), Gaps = 16/268 (5%)
Query: 48  LGWGQFGVIRECSDKFTGEVLACKSI-----AKDRLVTVEDVRSIKL-EIEIMTKLSGHP 101
           LG G   V+R C  K T +  A K I            V+++R   L E++I+ K+SGHP
Sbjct: 25  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
           N++ LK  YE   +  L+ +L   GELF  L +    SE E R I R L++V+   H   
Sbjct: 85  NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN 144
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLA----- 216
           +VHRDLKPENILL    +   IKL DFG +  +  G+ L    G+P Y+APE++      
Sbjct: 145 IVHRDLKPENILLDDDMN---IKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMND 201
Query: 217 --GGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASAR 274
              GY +  D+WS GVI+Y LL+G PPFW + +  +   + + + +F S  WD  S + +
Sbjct: 202 NHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVK 261
Query: 275 DLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
           DL+   L V P  R TA E LAH + ++
Sbjct: 262 DLVSRFLVVQPQKRYTAEEALAHPFFQQ 289

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score =  181 bits (459), Expect = 7e-46,   Method: Compositional matrix adjust.
 Identities = 108/308 (35%), Positives = 165/308 (53%), Gaps = 24/308 (7%)
Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKL 97
            SD YV+ + +G G +   + C  K T    A K I K +       R    EIEI+ + 
Sbjct: 25  FSDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSK-------RDPSEEIEILLRY 77
Query: 98  SGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYC 157
             HPN++ LK VY++  +V+L+ EL  GGEL  ++ +   FSE EA  +   + + V Y 
Sbjct: 78  GQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYL 137
Query: 158 HGNGVVHRDLKPENILLATKSSSSP-IKLADFGLATYIKAGQNLHGTVGSPFY----IAP 212
           H  GVVHRDLKP NIL   +S +   +++ DFG A  ++A    +G + +P Y    +AP
Sbjct: 138 HSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAE---NGLLMTPCYTANFVAP 194
Query: 213 EVLA-GGYNQAADVWSAGVILYILLSGMPPFWG---KTKSKIFDAVRAADLRFPSDPWDH 268
           EVL   GY++  D+WS G++LY +L+G  PF      T  +I   + +         W+ 
Sbjct: 195 EVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWNT 254
Query: 269 ISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKPCKQDDLCCKQLEVGGSSF 328
           +S +A+DL+  ML VDP  RLTA +VL H W+ + +++ Q      DL   QL  G  + 
Sbjct: 255 VSETAKDLVSKMLHVDPHQRLTAKQVLQHPWVTQKDKLPQSQLSHQDL---QLVKG--AM 309
Query: 329 SATFISRN 336
           +AT+ + N
Sbjct: 310 AATYSALN 317

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score =  181 bits (458), Expect = 9e-46,   Method: Compositional matrix adjust.
 Identities = 97/279 (34%), Positives = 159/279 (56%), Gaps = 8/279 (2%)
Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEI-MTK 96
             D Y L + +G G F V+R C ++ TG+  A K +   +  +   + +  L+ E  +  
Sbjct: 22  FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICH 81
Query: 97  LSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGR----FSETEARVIFRHLMQ 152
           +  HP++V+L   Y  +  ++++ E   G +L   + K       +SE  A    R +++
Sbjct: 82  MLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE 141
Query: 153 VVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI-KAGQNLHGTVGSPFYIA 211
            + YCH N ++HRD+KP  +LLA+K +S+P+KL  FG+A  + ++G    G VG+P ++A
Sbjct: 142 ALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMA 201
Query: 212 PEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHIS 270
           PEV+    Y +  DVW  GVIL+ILLSG  PF+G TK ++F+ +     +     W HIS
Sbjct: 202 PEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG-TKERLFEGIIKGKYKMNPRQWSHIS 260
Query: 271 ASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQK 309
            SA+DL+  ML +DP+ R+T  E L H W++E ++ A K
Sbjct: 261 ESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYK 299

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score =  181 bits (458), Expect = 9e-46,   Method: Compositional matrix adjust.
 Identities = 97/279 (34%), Positives = 159/279 (56%), Gaps = 8/279 (2%)
Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEI-MTK 96
             D Y L + +G G F V+R C ++ TG+  A K +   +  +   + +  L+ E  +  
Sbjct: 24  FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICH 83
Query: 97  LSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGR----FSETEARVIFRHLMQ 152
           +  HP++V+L   Y  +  ++++ E   G +L   + K       +SE  A    R +++
Sbjct: 84  MLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE 143
Query: 153 VVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI-KAGQNLHGTVGSPFYIA 211
            + YCH N ++HRD+KP  +LLA+K +S+P+KL  FG+A  + ++G    G VG+P ++A
Sbjct: 144 ALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMA 203
Query: 212 PEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHIS 270
           PEV+    Y +  DVW  GVIL+ILLSG  PF+G TK ++F+ +     +     W HIS
Sbjct: 204 PEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG-TKERLFEGIIKGKYKMNPRQWSHIS 262
Query: 271 ASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQK 309
            SA+DL+  ML +DP+ R+T  E L H W++E ++ A K
Sbjct: 263 ESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYK 301

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score =  179 bits (455), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 108/309 (34%), Positives = 161/309 (52%), Gaps = 21/309 (6%)
Query: 37  NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTK 96
             +D Y + + +G G + V + C  K T    A K I K +       R    EIEI+ +
Sbjct: 19  QFTDGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSK-------RDPTEEIEILLR 71
Query: 97  LSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSY 156
              HPN++ LK VY++  YV+++ EL  GGEL  ++ +   FSE EA  +   + + V Y
Sbjct: 72  YGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTITKTVEY 131
Query: 157 CHGNGVVHRDLKPENILLATKSSS-SPIKLADFGLATYIKAGQNLHGTVGSPFY----IA 211
            H  GVVHRDLKP NIL   +S +   I++ DFG A  ++A    +G + +P Y    +A
Sbjct: 132 LHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE---NGLLXTPCYTANFVA 188
Query: 212 PEVLA-GGYNQAADVWSAGVILYILLSGMPPFWG---KTKSKIFDAVRAADLRFPSDPWD 267
           PEVL   GY+ A D+WS GV+LY  L+G  PF      T  +I   + +         W+
Sbjct: 189 PEVLERQGYDAACDIWSLGVLLYTXLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWN 248
Query: 268 HISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKPCKQDDLCCKQLEVGGSS 327
            +S +A+DL+   L VDP  RLTAA VL H W+   +Q+ Q    + D     L  G  +
Sbjct: 249 SVSDTAKDLVSKXLHVDPHQRLTAALVLRHPWIVHWDQLPQYQLNRQD--APHLVKGAXA 306
Query: 328 FSATFISRN 336
            + + ++RN
Sbjct: 307 ATYSALNRN 315

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score =  179 bits (453), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 100/263 (38%), Positives = 150/263 (57%), Gaps = 10/263 (3%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           YVLG  LG G FG ++    + TG  +A K + + ++ +++ V  IK EI+ + KL  HP
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNL-KLFRHP 71
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
           +++ L  V        ++ME  +GGELF  + K+GR  E EAR +F+ ++  V YCH + 
Sbjct: 72  HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM 131
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGGY-- 219
           VVHRDLKPEN+LL    ++   K+ADFGL+  +  G+ L  + GSP Y APEV++G    
Sbjct: 132 VVHRDLKPENVLLDAHMNA---KIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISGRLYA 188
Query: 220 NQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMG 279
               D+WS GVILY LL G  PF  +    +F  +R      P    ++++ S   L+M 
Sbjct: 189 GPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIP----EYLNRSVATLLMH 244
Query: 280 MLRVDPSTRLTAAEVLAHSWMEE 302
           ML+VDP  R T  ++  H W ++
Sbjct: 245 MLQVDPLKRATIKDIREHEWFKQ 267

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score =  179 bits (453), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 100/263 (38%), Positives = 150/263 (57%), Gaps = 10/263 (3%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           YVLG  LG G FG ++    + TG  +A K + + ++ +++ V  IK EI+ + KL  HP
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNL-KLFRHP 71
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
           +++ L  V        ++ME  +GGELF  + K+GR  E EAR +F+ ++  V YCH + 
Sbjct: 72  HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM 131
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGGY-- 219
           VVHRDLKPEN+LL    ++   K+ADFGL+  +  G+ L  + GSP Y APEV++G    
Sbjct: 132 VVHRDLKPENVLLDAHMNA---KIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYA 188
Query: 220 NQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMG 279
               D+WS GVILY LL G  PF  +    +F  +R      P    ++++ S   L+M 
Sbjct: 189 GPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIP----EYLNRSVATLLMH 244
Query: 280 MLRVDPSTRLTAAEVLAHSWMEE 302
           ML+VDP  R T  ++  H W ++
Sbjct: 245 MLQVDPLKRATIKDIREHEWFKQ 267

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score =  174 bits (440), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 104/271 (38%), Positives = 147/271 (54%), Gaps = 12/271 (4%)
Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKD------RLVTVEDVRSIKLEI 91
           + D Y +G++LG GQF ++++C +K TG   A K I K       R V  E+   I+ E+
Sbjct: 10  VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREE---IEREV 66
Query: 92  EIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLM 151
            I+ ++  HPN++ L  VYE    V L++EL +GGELF  L +    SE EA    + ++
Sbjct: 67  SILRQVL-HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL 125
Query: 152 QVVSYCHGNGVVHRDLKPENILLATKSSSSP-IKLADFGLATYIKAGQNLHGTVGSPFYI 210
             V+Y H   + H DLKPENI+L  K+   P IKL DFGLA  I+ G       G+P ++
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFV 185
Query: 211 APEVLA-GGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHI 269
           APE++        AD+WS GVI YILLSG  PF G TK +    + A    F  + +   
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQT 245
Query: 270 SASARDLIMGMLRVDPSTRLTAAEVLAHSWM 300
           S  A+D I  +L  +   RLT  E L H W+
Sbjct: 246 SELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  173 bits (439), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 104/271 (38%), Positives = 148/271 (54%), Gaps = 12/271 (4%)
Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKD------RLVTVEDVRSIKLEI 91
           + D Y +G++LG GQF ++++C +K TG   A K I K       R V+ E+   I+ E+
Sbjct: 10  VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREE---IEREV 66
Query: 92  EIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLM 151
            I+ ++  H NV+ L  VYE    V L++EL +GGELF  L +    SE EA    + ++
Sbjct: 67  SILRQVLHH-NVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL 125
Query: 152 QVVSYCHGNGVVHRDLKPENILLATKSSSSP-IKLADFGLATYIKAGQNLHGTVGSPFYI 210
             V+Y H   + H DLKPENI+L  K+   P IKL DFGLA  I+ G       G+P ++
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFV 185
Query: 211 APEVLA-GGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHI 269
           APE++        AD+WS GVI YILLSG  PF G TK +    + +    F  + + H 
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHT 245
Query: 270 SASARDLIMGMLRVDPSTRLTAAEVLAHSWM 300
           S  A+D I  +L  +   RLT  E L H W+
Sbjct: 246 SELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score =  173 bits (438), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 104/271 (38%), Positives = 148/271 (54%), Gaps = 12/271 (4%)
Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKD------RLVTVEDVRSIKLEI 91
           + D Y +G++LG GQF ++++C +K TG   A K I K       R V+ E+   I+ E+
Sbjct: 10  VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREE---IEREV 66
Query: 92  EIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLM 151
            I+ ++  H NV+ L  VYE    V L++EL +GGELF  L +    SE EA    + ++
Sbjct: 67  SILRQVLHH-NVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL 125
Query: 152 QVVSYCHGNGVVHRDLKPENILLATKSSSSP-IKLADFGLATYIKAGQNLHGTVGSPFYI 210
             V+Y H   + H DLKPENI+L  K+   P IKL DFGLA  I+ G       G+P ++
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFV 185
Query: 211 APEVLA-GGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHI 269
           APE++        AD+WS GVI YILLSG  PF G TK +    + +    F  + + H 
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHT 245
Query: 270 SASARDLIMGMLRVDPSTRLTAAEVLAHSWM 300
           S  A+D I  +L  +   RLT  E L H W+
Sbjct: 246 SELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score =  172 bits (437), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 104/273 (38%), Positives = 148/273 (54%), Gaps = 12/273 (4%)
Query: 36  SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKD------RLVTVEDVRSIKL 89
             + D Y +G++LG GQF ++++C +K TG   A K I K       R V+ E+   I+ 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREE---IER 64
Query: 90  EIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRH 149
           E+ I+ ++  H NV+ L  VYE    V L++EL +GGELF  L +    SE EA    + 
Sbjct: 65  EVSILRQVLHH-NVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ 123
Query: 150 LMQVVSYCHGNGVVHRDLKPENILLATKSSSSP-IKLADFGLATYIKAGQNLHGTVGSPF 208
           ++  V+Y H   + H DLKPENI+L  K+   P IKL DFGLA  I+ G       G+P 
Sbjct: 124 ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPE 183
Query: 209 YIAPEVLA-GGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWD 267
           ++APE++        AD+WS GVI YILLSG  PF G TK +    + +    F  + + 
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFS 243
Query: 268 HISASARDLIMGMLRVDPSTRLTAAEVLAHSWM 300
           H S  A+D I  +L  +   RLT  E L H W+
Sbjct: 244 HTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  172 bits (435), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 104/271 (38%), Positives = 147/271 (54%), Gaps = 12/271 (4%)
Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKD------RLVTVEDVRSIKLEI 91
           + D Y +G++LG GQF ++++C +K TG   A K I K       R V+ E+   I+ E+
Sbjct: 10  VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREE---IEREV 66
Query: 92  EIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLM 151
            I+ ++  H NV+ L  VYE    V L++EL +GGELF  L +    SE EA    + ++
Sbjct: 67  SILRQVLHH-NVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL 125
Query: 152 QVVSYCHGNGVVHRDLKPENILLATKSSSSP-IKLADFGLATYIKAGQNLHGTVGSPFYI 210
             V+Y H   + H DLKPENI+L  K+   P IKL DFGLA  I+ G       G+P ++
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFV 185
Query: 211 APEVLA-GGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHI 269
           APE++        AD+WS GVI YILLSG  PF G TK +    + A    F  + +   
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQT 245
Query: 270 SASARDLIMGMLRVDPSTRLTAAEVLAHSWM 300
           S  A+D I  +L  +   RLT  E L H W+
Sbjct: 246 SELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score =  171 bits (434), Expect = 6e-43,   Method: Compositional matrix adjust.
 Identities = 106/266 (39%), Positives = 144/266 (54%), Gaps = 10/266 (3%)
Query: 39  SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLS 98
           SDRY L K +G G FGV R   DK + E++A K I +   +      ++K EI I  +  
Sbjct: 17  SDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKID----ENVKREI-INHRSL 71
Query: 99  GHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCH 158
            HPN+V  K V     ++ ++ME  +GGELF R+   GRFSE EAR  F+ L+  VSYCH
Sbjct: 72  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 131
Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEV-LAG 217
              V HRDLK EN LL   S +  +K+ DFG +           TVG+P YIAPEV L  
Sbjct: 132 AMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK 190
Query: 218 GYN-QAADVWSAGVILYILLSGMPPFWGKTKSKIFDAV--RAADLRFPSDPWDHISASAR 274
            Y+ + ADVWS GV LY++L G  PF    + K F     R  ++++    + HIS   R
Sbjct: 191 EYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECR 250
Query: 275 DLIMGMLRVDPSTRLTAAEVLAHSWM 300
            LI  +   DP+ R++  E+  H W 
Sbjct: 251 HLISRIFVADPAKRISIPEIRNHEWF 276

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score =  171 bits (434), Expect = 6e-43,   Method: Compositional matrix adjust.
 Identities = 106/266 (39%), Positives = 144/266 (54%), Gaps = 10/266 (3%)
Query: 39  SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLS 98
           SDRY L K +G G FGV R   DK + E++A K I +   +      ++K EI I  +  
Sbjct: 18  SDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIAA----NVKREI-INHRSL 72
Query: 99  GHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCH 158
            HPN+V  K V     ++ ++ME  +GGELF R+   GRFSE EAR  F+ L+  VSYCH
Sbjct: 73  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 132
Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEV-LAG 217
              V HRDLK EN LL   S +  +K+ DFG +           TVG+P YIAPEV L  
Sbjct: 133 AMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK 191
Query: 218 GYN-QAADVWSAGVILYILLSGMPPFWGKTKSKIFDAV--RAADLRFPSDPWDHISASAR 274
            Y+ + ADVWS GV LY++L G  PF    + K F     R  ++++    + HIS   R
Sbjct: 192 EYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECR 251
Query: 275 DLIMGMLRVDPSTRLTAAEVLAHSWM 300
            LI  +   DP+ R++  E+  H W 
Sbjct: 252 HLISRIFVADPAKRISIPEIRNHEWF 277

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score =  171 bits (433), Expect = 7e-43,   Method: Compositional matrix adjust.
 Identities = 104/271 (38%), Positives = 147/271 (54%), Gaps = 12/271 (4%)
Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKD------RLVTVEDVRSIKLEI 91
           + D Y +G++LG GQF ++++C +K TG   A K I K       R V+ E+   I+ E+
Sbjct: 10  VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREE---IEREV 66
Query: 92  EIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLM 151
            I+ ++  H NV+ L  VYE    V L++EL +GGELF  L +    SE EA    + ++
Sbjct: 67  SILRQVLHH-NVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL 125
Query: 152 QVVSYCHGNGVVHRDLKPENILLATKSSSSP-IKLADFGLATYIKAGQNLHGTVGSPFYI 210
             V+Y H   + H DLKPENI+L  K+   P IKL DFGLA  I+ G       G+P ++
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFV 185
Query: 211 APEVLA-GGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHI 269
           APE++        AD+WS GVI YILLSG  PF G TK +    + A    F  + +   
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQT 245
Query: 270 SASARDLIMGMLRVDPSTRLTAAEVLAHSWM 300
           S  A+D I  +L  +   RLT  E L H W+
Sbjct: 246 SELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  169 bits (428), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 95/263 (36%), Positives = 147/263 (55%), Gaps = 10/263 (3%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           Y+LG  LG G FG ++    + TG  +A K + + ++ +++ V  I+ EI+ + KL  HP
Sbjct: 18  YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNL-KLFRHP 76
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
           +++ L  V      + ++ME  +GGELF  + K GR  E E+R +F+ ++  V YCH + 
Sbjct: 77  HIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM 136
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGGY-- 219
           VVHRDLKPEN+LL    ++   K+ADFGL+  +  G+ L  + GSP Y APEV++G    
Sbjct: 137 VVHRDLKPENVLLDAHMNA---KIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISGRLYA 193
Query: 220 NQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMG 279
               D+WS+GVILY LL G  PF       +F  +       P     +++ S   L+  
Sbjct: 194 GPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQ----YLNPSVISLLKH 249
Query: 280 MLRVDPSTRLTAAEVLAHSWMEE 302
           ML+VDP  R T  ++  H W ++
Sbjct: 250 MLQVDPMKRATIKDIREHEWFKQ 272

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score =  169 bits (427), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 101/286 (35%), Positives = 153/286 (53%), Gaps = 23/286 (8%)
Query: 38  LSDRYVLGKQ-LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTK 96
           ++D Y L KQ LG G  G + EC  + TG+  A K +         D    + E++   +
Sbjct: 7   VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLY--------DSPKARQEVDHHWQ 58
Query: 97  LSGHPNVVDLKAVYEEEDY----VHLLMELCAGGELFHRLEKYG--RFSETEARVIFRHL 150
            SG P++V +  VYE   +    + ++ME   GGELF R+++ G   F+E EA  I R +
Sbjct: 59  ASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDI 118
Query: 151 MQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN-LHGTVGSPFY 209
              + + H + + HRD+KPEN+L  +K   + +KL DFG A   +  QN L     +P+Y
Sbjct: 119 GTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK--ETTQNALQTPCYTPYY 176
Query: 210 IAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDA----VRAADLRFPSD 264
           +APEVL    Y+++ D+WS GVI+YILL G PPF+  T   I       +R     FP+ 
Sbjct: 177 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNP 236
Query: 265 PWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKP 310
            W  +S  A+ LI  +L+ DP+ RLT  + + H W+ +   V Q P
Sbjct: 237 EWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTP 282

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score =  169 bits (427), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 101/286 (35%), Positives = 153/286 (53%), Gaps = 23/286 (8%)
Query: 38  LSDRYVLGKQ-LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTK 96
           ++D Y L KQ LG G  G + EC  + TG+  A K +         D    + E++   +
Sbjct: 26  VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLY--------DSPKARQEVDHHWQ 77
Query: 97  LSGHPNVVDLKAVYEEEDY----VHLLMELCAGGELFHRLEKYG--RFSETEARVIFRHL 150
            SG P++V +  VYE   +    + ++ME   GGELF R+++ G   F+E EA  I R +
Sbjct: 78  ASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDI 137
Query: 151 MQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN-LHGTVGSPFY 209
              + + H + + HRD+KPEN+L  +K   + +KL DFG A   +  QN L     +P+Y
Sbjct: 138 GTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK--ETTQNALQTPCYTPYY 195
Query: 210 IAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDA----VRAADLRFPSD 264
           +APEVL    Y+++ D+WS GVI+YILL G PPF+  T   I       +R     FP+ 
Sbjct: 196 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNP 255
Query: 265 PWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKP 310
            W  +S  A+ LI  +L+ DP+ RLT  + + H W+ +   V Q P
Sbjct: 256 EWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTP 301

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score =  168 bits (425), Expect = 6e-42,   Method: Compositional matrix adjust.
 Identities = 105/266 (39%), Positives = 143/266 (53%), Gaps = 10/266 (3%)
Query: 39  SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLS 98
           SDRY L K +G G FGV R   DK + E++A K I +   +      ++K EI I  +  
Sbjct: 18  SDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKID----ENVKREI-INHRSL 72
Query: 99  GHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCH 158
            HPN+V  K V     ++ ++ME  +GGELF R+   GRFSE EAR  F+ L+  VSYCH
Sbjct: 73  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 132
Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEV-LAG 217
              V HRDLK EN LL   S +  +K+  FG +           TVG+P YIAPEV L  
Sbjct: 133 AMQVCHRDLKLENTLL-DGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK 191
Query: 218 GYN-QAADVWSAGVILYILLSGMPPFWGKTKSKIFDAV--RAADLRFPSDPWDHISASAR 274
            Y+ + ADVWS GV LY++L G  PF    + K F     R  ++++    + HIS   R
Sbjct: 192 EYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECR 251
Query: 275 DLIMGMLRVDPSTRLTAAEVLAHSWM 300
            LI  +   DP+ R++  E+  H W 
Sbjct: 252 HLISRIFVADPAKRISIPEIRNHEWF 277

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score =  167 bits (424), Expect = 7e-42,   Method: Compositional matrix adjust.
 Identities = 105/266 (39%), Positives = 143/266 (53%), Gaps = 10/266 (3%)
Query: 39  SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLS 98
           SDRY L K +G G FGV R   DK + E++A K I +   +      ++K EI I  +  
Sbjct: 18  SDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKID----ENVKREI-INHRSL 72
Query: 99  GHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCH 158
            HPN+V  K V     ++ ++ME  +GGELF R+   GRFSE EAR  F+ L+  VSYCH
Sbjct: 73  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 132
Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEV-LAG 217
              V HRDLK EN LL   S +  +K+  FG +           TVG+P YIAPEV L  
Sbjct: 133 AMQVCHRDLKLENTLL-DGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLLKK 191
Query: 218 GYN-QAADVWSAGVILYILLSGMPPFWGKTKSKIFDAV--RAADLRFPSDPWDHISASAR 274
            Y+ + ADVWS GV LY++L G  PF    + K F     R  ++++    + HIS   R
Sbjct: 192 EYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECR 251
Query: 275 DLIMGMLRVDPSTRLTAAEVLAHSWM 300
            LI  +   DP+ R++  E+  H W 
Sbjct: 252 HLISRIFVADPAKRISIPEIRNHEWF 277

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score =  167 bits (424), Expect = 9e-42,   Method: Compositional matrix adjust.
 Identities = 105/266 (39%), Positives = 142/266 (53%), Gaps = 10/266 (3%)
Query: 39  SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLS 98
           SDRY L K +G G FGV R   DK   E++A K I +   +      ++K EI I  +  
Sbjct: 18  SDRYELVKDIGAGNFGVARLMRDKQANELVAVKYIERGEKID----ENVKREI-INHRSL 72
Query: 99  GHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCH 158
            HPN+V  K V     ++ ++ME  +GGELF R+   GRFSE EAR  F+ L+  VSY H
Sbjct: 73  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYAH 132
Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEV-LAG 217
              V HRDLK EN LL   S +  +K+ADFG +            VG+P YIAPEV L  
Sbjct: 133 AMQVAHRDLKLENTLL-DGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVLLKK 191
Query: 218 GYN-QAADVWSAGVILYILLSGMPPFWGKTKSKIFDAV--RAADLRFPSDPWDHISASAR 274
            Y+ + ADVWS GV LY++L G  PF    + K F     R  ++++    + HIS   R
Sbjct: 192 EYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECR 251
Query: 275 DLIMGMLRVDPSTRLTAAEVLAHSWM 300
            LI  +   DP+ R++  E+  H W 
Sbjct: 252 HLISRIFVADPAKRISIPEIRNHEWF 277

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score =  166 bits (420), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 91/271 (33%), Positives = 147/271 (54%), Gaps = 8/271 (2%)
Query: 37  NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTK 96
            + D ++  ++LG G FG +    ++ +G     K+I KDR  +   +  I+ EIE++  
Sbjct: 19  TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR--SQVPMEQIEAEIEVLKS 76
Query: 97  LSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRL---EKYGR-FSETEARVIFRHLMQ 152
           L  HPN++ +  V+E+   ++++ME C GGEL  R+   +  G+  SE     + + +M 
Sbjct: 77  LD-HPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMN 135
Query: 153 VVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAP 212
            ++Y H   VVH+DLKPENIL    S  SPIK+ DFGLA   K+ ++     G+  Y+AP
Sbjct: 136 ALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAP 195
Query: 213 EVLAGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISAS 272
           EV         D+WSAGV++Y LL+G  PF G +  ++       +  +  +    ++  
Sbjct: 196 EVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVE-CRPLTPQ 254
Query: 273 ARDLIMGMLRVDPSTRLTAAEVLAHSWMEEC 303
           A DL+  ML  DP  R +AA+VL H W ++ 
Sbjct: 255 AVDLLKQMLTKDPERRPSAAQVLHHEWFKQA 285

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score =  164 bits (415), Expect = 9e-41,   Method: Compositional matrix adjust.
 Identities = 94/265 (35%), Positives = 147/265 (55%), Gaps = 11/265 (4%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           D Y + ++LG G FGV+   +++ TG   A K +        E VR    EI+ M+ L  
Sbjct: 51  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRK---EIQTMSVLR- 106
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRL-EKYGRFSETEARVIFRHLMQVVSYCH 158
           HP +V+L   +E+++ + ++ E  +GGELF ++ +++ + SE EA    R + + + + H
Sbjct: 107 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 166
Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG- 217
            N  VH DLKPENI+  TK S+  +KL DFGL  ++   Q++  T G+  + APEV  G 
Sbjct: 167 ENNYVHLDLKPENIMFTTKRSNE-LKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGK 225
Query: 218 --GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARD 275
             GY    D+WS GV+ YILLSG+ PF G+   +    V++ D       +  IS   +D
Sbjct: 226 PVGY--YTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKD 283
Query: 276 LIMGMLRVDPSTRLTAAEVLAHSWM 300
            I  +L  DP+TR+T  + L H W+
Sbjct: 284 FIRKLLLADPNTRMTIHQALEHPWL 308

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score =  164 bits (414), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 94/265 (35%), Positives = 147/265 (55%), Gaps = 11/265 (4%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           D Y + ++LG G FGV+   +++ TG   A K +        E VR    EI+ M+ L  
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRK---EIQTMSVLR- 212
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRL-EKYGRFSETEARVIFRHLMQVVSYCH 158
           HP +V+L   +E+++ + ++ E  +GGELF ++ +++ + SE EA    R + + + + H
Sbjct: 213 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 272
Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG- 217
            N  VH DLKPENI+  TK S+  +KL DFGL  ++   Q++  T G+  + APEV  G 
Sbjct: 273 ENNYVHLDLKPENIMFTTKRSNE-LKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGK 331
Query: 218 --GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARD 275
             GY    D+WS GV+ YILLSG+ PF G+   +    V++ D       +  IS   +D
Sbjct: 332 PVGY--YTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKD 389
Query: 276 LIMGMLRVDPSTRLTAAEVLAHSWM 300
            I  +L  DP+TR+T  + L H W+
Sbjct: 390 FIRKLLLADPNTRMTIHQALEHPWL 414

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score =  163 bits (412), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 103/286 (36%), Positives = 150/286 (52%), Gaps = 34/286 (11%)
Query: 48  LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRS-IKLEIEIMTKLSGHPNVVDL 106
           LG G    ++ C +  T +  A K I K        +RS +  E+E++ +  GH NV++L
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQP----GHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 107 KAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRD 166
              +EEED  +L+ E   GG +   + K   F+E EA V+ + +   + + H  G+ HRD
Sbjct: 77  IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRD 136
Query: 167 LKPENILLATKSSSSPIKLADFGLATYIK--------AGQNLHGTVGSPFYIAPEVL--- 215
           LKPENIL    +  SP+K+ DFGL + IK        +   L    GS  Y+APEV+   
Sbjct: 137 LKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAF 196
Query: 216 ---AGGYNQAADVWSAGVILYILLSGMPPFWGKTKSK---------------IFDAVRAA 257
              A  Y++  D+WS GVILYILLSG PPF G+  S                +F++++  
Sbjct: 197 SEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEG 256
Query: 258 DLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEEC 303
              FP   W HIS +A+DLI  +L  D   RL+AA+VL H W++ C
Sbjct: 257 KYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC 302

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  162 bits (411), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 98/261 (37%), Positives = 139/261 (53%), Gaps = 11/261 (4%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           Y L K +G G F  ++      TG+ +A K I K +L +   ++ +  E+ IM K+  HP
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNS-SSLQKLFREVRIM-KVLNHP 73
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
           N+V L  V E E  ++L+ME  +GGE+F  L  +GR  E EAR  FR ++  V YCH   
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGGYNQ 221
           +VHRDLK EN+LL    +   IK+ADFG +     G  L    GSP Y APE+  G    
Sbjct: 134 IVHRDLKAENLLL---DADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYD 190
Query: 222 A--ADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMG 279
               DVWS GVILY L+SG  PF G+   ++ + V     R P     ++S    +L+  
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF----YMSTDCENLLKK 246
Query: 280 MLRVDPSTRLTAAEVLAHSWM 300
            L ++PS R T  +++   WM
Sbjct: 247 FLILNPSKRGTLEQIMKDRWM 267

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  162 bits (411), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 98/261 (37%), Positives = 139/261 (53%), Gaps = 11/261 (4%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           Y L K +G G F  ++      TG+ +A K I K +L +   ++ +  E+ IM K+  HP
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNS-SSLQKLFREVRIM-KVLNHP 73
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
           N+V L  V E E  ++L+ME  +GGE+F  L  +GR  E EAR  FR ++  V YCH   
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGGYNQ 221
           +VHRDLK EN+LL    +   IK+ADFG +     G  L    GSP Y APE+  G    
Sbjct: 134 IVHRDLKAENLLL---DADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYD 190
Query: 222 A--ADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMG 279
               DVWS GVILY L+SG  PF G+   ++ + V     R P     ++S    +L+  
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF----YMSTDCENLLKK 246
Query: 280 MLRVDPSTRLTAAEVLAHSWM 300
            L ++PS R T  +++   WM
Sbjct: 247 FLILNPSKRGTLEQIMKDRWM 267

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score =  162 bits (411), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 92/284 (32%), Positives = 147/284 (51%), Gaps = 19/284 (6%)
Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKL 97
           + D  V  + LG G  G + +  +K T E  A K         ++D    + E+E+  + 
Sbjct: 66  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK--------MLQDCPKARREVELHWRA 117
Query: 98  SGHPNVVDLKAVYEE----EDYVHLLMELCAGGELFHRLEKYG--RFSETEARVIFRHLM 151
           S  P++V +  VYE        + ++ME   GGELF R++  G   F+E EA  I + + 
Sbjct: 118 SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 177
Query: 152 QVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIA 211
           + + Y H   + HRD+KPEN+L  +K  ++ +KL DFG A    +  +L     +P+Y+A
Sbjct: 178 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 237
Query: 212 PEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDA----VRAADLRFPSDPW 266
           PEVL    Y+++ D+WS GVI+YILL G PPF+      I       +R     FP+  W
Sbjct: 238 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 297
Query: 267 DHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKP 310
             +S   + LI  +L+ +P+ R+T  E + H W+ +  +V Q P
Sbjct: 298 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 341

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score =  162 bits (410), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 92/284 (32%), Positives = 147/284 (51%), Gaps = 19/284 (6%)
Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKL 97
           + D  V  + LG G  G + +  +K T E  A K         ++D    + E+E+  + 
Sbjct: 22  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK--------MLQDCPKARREVELHWRA 73
Query: 98  SGHPNVVDLKAVYEE----EDYVHLLMELCAGGELFHRLEKYG--RFSETEARVIFRHLM 151
           S  P++V +  VYE        + ++ME   GGELF R++  G   F+E EA  I + + 
Sbjct: 74  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 133
Query: 152 QVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIA 211
           + + Y H   + HRD+KPEN+L  +K  ++ +KL DFG A    +  +L     +P+Y+A
Sbjct: 134 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 193
Query: 212 PEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDA----VRAADLRFPSDPW 266
           PEVL    Y+++ D+WS GVI+YILL G PPF+      I       +R     FP+  W
Sbjct: 194 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 253
Query: 267 DHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKP 310
             +S   + LI  +L+ +P+ R+T  E + H W+ +  +V Q P
Sbjct: 254 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 297

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score =  162 bits (410), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 92/284 (32%), Positives = 147/284 (51%), Gaps = 19/284 (6%)
Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKL 97
           + D  V  + LG G  G + +  +K T E  A K         ++D    + E+E+  + 
Sbjct: 60  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK--------MLQDCPKARREVELHWRA 111
Query: 98  SGHPNVVDLKAVYEE----EDYVHLLMELCAGGELFHRLEKYG--RFSETEARVIFRHLM 151
           S  P++V +  VYE        + ++ME   GGELF R++  G   F+E EA  I + + 
Sbjct: 112 SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 171
Query: 152 QVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIA 211
           + + Y H   + HRD+KPEN+L  +K  ++ +KL DFG A    +  +L     +P+Y+A
Sbjct: 172 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 231
Query: 212 PEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDA----VRAADLRFPSDPW 266
           PEVL    Y+++ D+WS GVI+YILL G PPF+      I       +R     FP+  W
Sbjct: 232 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 291
Query: 267 DHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKP 310
             +S   + LI  +L+ +P+ R+T  E + H W+ +  +V Q P
Sbjct: 292 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 335

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score =  162 bits (410), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 92/284 (32%), Positives = 147/284 (51%), Gaps = 19/284 (6%)
Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKL 97
           + D  V  + LG G  G + +  +K T E  A K +        +D    + E+E+  + 
Sbjct: 14  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVELHWRA 65
Query: 98  SGHPNVVDLKAVYEE----EDYVHLLMELCAGGELFHRLEKYG--RFSETEARVIFRHLM 151
           S  P++V +  VYE        + ++ME   GGELF R++  G   F+E EA  I + + 
Sbjct: 66  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 125
Query: 152 QVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIA 211
           + + Y H   + HRD+KPEN+L  +K  ++ +KL DFG A    +  +L     +P+Y+A
Sbjct: 126 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 185
Query: 212 PEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDA----VRAADLRFPSDPW 266
           PEVL    Y+++ D+WS GVI+YILL G PPF+      I       +R     FP+  W
Sbjct: 186 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 245
Query: 267 DHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKP 310
             +S   + LI  +L+ +P+ R+T  E + H W+ +  +V Q P
Sbjct: 246 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 289

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score =  162 bits (410), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 92/284 (32%), Positives = 147/284 (51%), Gaps = 19/284 (6%)
Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKL 97
           + D  V  + LG G  G + +  +K T E  A K         ++D    + E+E+  + 
Sbjct: 15  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK--------MLQDCPKARREVELHWRA 66
Query: 98  SGHPNVVDLKAVYEE----EDYVHLLMELCAGGELFHRLEKYG--RFSETEARVIFRHLM 151
           S  P++V +  VYE        + ++ME   GGELF R++  G   F+E EA  I + + 
Sbjct: 67  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 126
Query: 152 QVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIA 211
           + + Y H   + HRD+KPEN+L  +K  ++ +KL DFG A    +  +L     +P+Y+A
Sbjct: 127 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 186
Query: 212 PEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDA----VRAADLRFPSDPW 266
           PEVL    Y+++ D+WS GVI+YILL G PPF+      I       +R     FP+  W
Sbjct: 187 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 246
Query: 267 DHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKP 310
             +S   + LI  +L+ +P+ R+T  E + H W+ +  +V Q P
Sbjct: 247 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 290

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score =  162 bits (410), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 92/284 (32%), Positives = 147/284 (51%), Gaps = 19/284 (6%)
Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKL 97
           + D  V  + LG G  G + +  +K T E  A K +        +D    + E+E+  + 
Sbjct: 16  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVELHWRA 67
Query: 98  SGHPNVVDLKAVYEE----EDYVHLLMELCAGGELFHRLEKYG--RFSETEARVIFRHLM 151
           S  P++V +  VYE        + ++ME   GGELF R++  G   F+E EA  I + + 
Sbjct: 68  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 127
Query: 152 QVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIA 211
           + + Y H   + HRD+KPEN+L  +K  ++ +KL DFG A    +  +L     +P+Y+A
Sbjct: 128 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 187
Query: 212 PEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDA----VRAADLRFPSDPW 266
           PEVL    Y+++ D+WS GVI+YILL G PPF+      I       +R     FP+  W
Sbjct: 188 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 247
Query: 267 DHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKP 310
             +S   + LI  +L+ +P+ R+T  E + H W+ +  +V Q P
Sbjct: 248 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 291

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score =  162 bits (410), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 92/284 (32%), Positives = 147/284 (51%), Gaps = 19/284 (6%)
Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKL 97
           + D  V  + LG G  G + +  +K T E  A K         ++D    + E+E+  + 
Sbjct: 16  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK--------MLQDCPKARREVELHWRA 67
Query: 98  SGHPNVVDLKAVYEE----EDYVHLLMELCAGGELFHRLEKYG--RFSETEARVIFRHLM 151
           S  P++V +  VYE        + ++ME   GGELF R++  G   F+E EA  I + + 
Sbjct: 68  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 127
Query: 152 QVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIA 211
           + + Y H   + HRD+KPEN+L  +K  ++ +KL DFG A    +  +L     +P+Y+A
Sbjct: 128 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 187
Query: 212 PEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDA----VRAADLRFPSDPW 266
           PEVL    Y+++ D+WS GVI+YILL G PPF+      I       +R     FP+  W
Sbjct: 188 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 247
Query: 267 DHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKP 310
             +S   + LI  +L+ +P+ R+T  E + H W+ +  +V Q P
Sbjct: 248 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 291

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score =  162 bits (410), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 92/284 (32%), Positives = 147/284 (51%), Gaps = 19/284 (6%)
Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKL 97
           + D  V  + LG G  G + +  +K T E  A K +        +D    + E+E+  + 
Sbjct: 20  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVELHWRA 71
Query: 98  SGHPNVVDLKAVYEE----EDYVHLLMELCAGGELFHRLEKYG--RFSETEARVIFRHLM 151
           S  P++V +  VYE        + ++ME   GGELF R++  G   F+E EA  I + + 
Sbjct: 72  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 131
Query: 152 QVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIA 211
           + + Y H   + HRD+KPEN+L  +K  ++ +KL DFG A    +  +L     +P+Y+A
Sbjct: 132 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 191
Query: 212 PEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDA----VRAADLRFPSDPW 266
           PEVL    Y+++ D+WS GVI+YILL G PPF+      I       +R     FP+  W
Sbjct: 192 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 251
Query: 267 DHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKP 310
             +S   + LI  +L+ +P+ R+T  E + H W+ +  +V Q P
Sbjct: 252 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 295

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score =  162 bits (410), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 92/284 (32%), Positives = 147/284 (51%), Gaps = 19/284 (6%)
Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKL 97
           + D  V  + LG G  G + +  +K T E  A K         ++D    + E+E+  + 
Sbjct: 30  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK--------MLQDCPKARREVELHWRA 81
Query: 98  SGHPNVVDLKAVYEE----EDYVHLLMELCAGGELFHRLEKYG--RFSETEARVIFRHLM 151
           S  P++V +  VYE        + ++ME   GGELF R++  G   F+E EA  I + + 
Sbjct: 82  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 141
Query: 152 QVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIA 211
           + + Y H   + HRD+KPEN+L  +K  ++ +KL DFG A    +  +L     +P+Y+A
Sbjct: 142 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 201
Query: 212 PEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDA----VRAADLRFPSDPW 266
           PEVL    Y+++ D+WS GVI+YILL G PPF+      I       +R     FP+  W
Sbjct: 202 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 261
Query: 267 DHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKP 310
             +S   + LI  +L+ +P+ R+T  E + H W+ +  +V Q P
Sbjct: 262 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 305

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score =  162 bits (409), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 92/284 (32%), Positives = 147/284 (51%), Gaps = 19/284 (6%)
Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKL 97
           + D  V  + LG G  G + +  +K T E  A K +        +D    + E+E+  + 
Sbjct: 21  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVELHWRA 72
Query: 98  SGHPNVVDLKAVYEE----EDYVHLLMELCAGGELFHRLEKYG--RFSETEARVIFRHLM 151
           S  P++V +  VYE        + ++ME   GGELF R++  G   F+E EA  I + + 
Sbjct: 73  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 132
Query: 152 QVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIA 211
           + + Y H   + HRD+KPEN+L  +K  ++ +KL DFG A    +  +L     +P+Y+A
Sbjct: 133 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 192
Query: 212 PEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDA----VRAADLRFPSDPW 266
           PEVL    Y+++ D+WS GVI+YILL G PPF+      I       +R     FP+  W
Sbjct: 193 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 252
Query: 267 DHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKP 310
             +S   + LI  +L+ +P+ R+T  E + H W+ +  +V Q P
Sbjct: 253 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 296

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score =  162 bits (409), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 92/284 (32%), Positives = 147/284 (51%), Gaps = 19/284 (6%)
Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKL 97
           + D  V  + LG G  G + +  +K T E  A K         ++D    + E+E+  + 
Sbjct: 14  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK--------MLQDCPKARREVELHWRA 65
Query: 98  SGHPNVVDLKAVYEE----EDYVHLLMELCAGGELFHRLEKYG--RFSETEARVIFRHLM 151
           S  P++V +  VYE        + ++ME   GGELF R++  G   F+E EA  I + + 
Sbjct: 66  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 125
Query: 152 QVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIA 211
           + + Y H   + HRD+KPEN+L  +K  ++ +KL DFG A    +  +L     +P+Y+A
Sbjct: 126 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPYYVA 185
Query: 212 PEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDA----VRAADLRFPSDPW 266
           PEVL    Y+++ D+WS GVI+YILL G PPF+      I       +R     FP+  W
Sbjct: 186 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 245
Query: 267 DHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKP 310
             +S   + LI  +L+ +P+ R+T  E + H W+ +  +V Q P
Sbjct: 246 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 289

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  162 bits (409), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 97/261 (37%), Positives = 139/261 (53%), Gaps = 11/261 (4%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           Y L K +G G F  ++      TG+ +A K I K +L +   ++ +  E+ IM K+  HP
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNS-SSLQKLFREVRIM-KVLNHP 73
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
           N+V L  V E E  ++L+ME  +GGE+F  L  +GR  E EAR  FR ++  V YCH   
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGGYNQ 221
           +VHRDLK EN+LL    +   IK+ADFG +     G  L    G+P Y APE+  G    
Sbjct: 134 IVHRDLKAENLLL---DADMNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYD 190
Query: 222 A--ADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMG 279
               DVWS GVILY L+SG  PF G+   ++ + V     R P     ++S    +L+  
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF----YMSTDCENLLKK 246
Query: 280 MLRVDPSTRLTAAEVLAHSWM 300
            L ++PS R T  +++   WM
Sbjct: 247 FLILNPSKRGTLEQIMKDRWM 267

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  161 bits (408), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 97/261 (37%), Positives = 139/261 (53%), Gaps = 11/261 (4%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           Y L K +G G F  ++      TG+ +A + I K +L +   ++ +  E+ IM K+  HP
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNS-SSLQKLFREVRIM-KVLNHP 73
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
           N+V L  V E E  ++L+ME  +GGE+F  L  +GR  E EAR  FR ++  V YCH   
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGGYNQ 221
           +VHRDLK EN+LL    +   IK+ADFG +     G  L    GSP Y APE+  G    
Sbjct: 134 IVHRDLKAENLLL---DADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYD 190
Query: 222 A--ADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMG 279
               DVWS GVILY L+SG  PF G+   ++ + V     R P     ++S    +L+  
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF----YMSTDCENLLKK 246
Query: 280 MLRVDPSTRLTAAEVLAHSWM 300
            L ++PS R T  +++   WM
Sbjct: 247 FLILNPSKRGTLEQIMKDRWM 267

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score =  161 bits (408), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 104/267 (38%), Positives = 141/267 (52%), Gaps = 12/267 (4%)
Query: 39  SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLS 98
           SDRY   K +G G FGV R   DK T E++A K I +   +     R I     I  +  
Sbjct: 19  SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREI-----INHRSL 73
Query: 99  GHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCH 158
            HPN+V  K V     ++ ++ME  +GGEL+ R+   GRFSE EAR  F+ L+  VSYCH
Sbjct: 74  RHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCH 133
Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEV-LAG 217
              + HRDLK EN LL   S +  +K+ DFG +           TVG+P YIAPEV L  
Sbjct: 134 SMQICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQ 192
Query: 218 GYN-QAADVWSAGVILYILLSGMPPFWGKTKSKIFDAV--RAADLRFPSDPWD-HISASA 273
            Y+ + ADVWS GV LY++L G  PF    + + +     R   +++ S P D  IS   
Sbjct: 193 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKY-SIPDDIRISPEC 251
Query: 274 RDLIMGMLRVDPSTRLTAAEVLAHSWM 300
             LI  +   DP+TR++  E+  HSW 
Sbjct: 252 CHLISRIFVADPATRISIPEIKTHSWF 278

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  161 bits (407), Expect = 7e-40,   Method: Compositional matrix adjust.
 Identities = 97/261 (37%), Positives = 139/261 (53%), Gaps = 11/261 (4%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           Y L K +G G F  ++      TG+ +A + I K +L +   ++ +  E+ IM K+  HP
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNS-SSLQKLFREVRIM-KVLNHP 73
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
           N+V L  V E E  ++L+ME  +GGE+F  L  +GR  E EAR  FR ++  V YCH   
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGGYNQ 221
           +VHRDLK EN+LL    +   IK+ADFG +     G  L    GSP Y APE+  G    
Sbjct: 134 IVHRDLKAENLLL---DADMNIKIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQGKKYD 190
Query: 222 A--ADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMG 279
               DVWS GVILY L+SG  PF G+   ++ + V     R P     ++S    +L+  
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF----YMSTDCENLLKK 246
Query: 280 MLRVDPSTRLTAAEVLAHSWM 300
            L ++PS R T  +++   WM
Sbjct: 247 FLILNPSKRGTLEQIMKDRWM 267

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score =  160 bits (405), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 102/286 (35%), Positives = 149/286 (52%), Gaps = 34/286 (11%)
Query: 48  LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRS-IKLEIEIMTKLSGHPNVVDL 106
           LG G    ++ C +  T +  A K I K        +RS +  E+E++ +  GH NV++L
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQP----GHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 107 KAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRD 166
              +EEED  +L+ E   GG +   + K   F+E EA V+ + +   + + H  G+ HRD
Sbjct: 77  IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRD 136
Query: 167 LKPENILLATKSSSSPIKLADFGLATYIK--------AGQNLHGTVGSPFYIAPEVL--- 215
           LKPENIL    +  SP+K+ DF L + IK        +   L    GS  Y+APEV+   
Sbjct: 137 LKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAF 196
Query: 216 ---AGGYNQAADVWSAGVILYILLSGMPPFWGKTKSK---------------IFDAVRAA 257
              A  Y++  D+WS GVILYILLSG PPF G+  S                +F++++  
Sbjct: 197 SEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEG 256
Query: 258 DLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEEC 303
              FP   W HIS +A+DLI  +L  D   RL+AA+VL H W++ C
Sbjct: 257 KYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC 302

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score =  159 bits (401), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 91/273 (33%), Positives = 149/273 (54%), Gaps = 7/273 (2%)
Query: 35  ISNLSDRYVL-GKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRS-IKLEIE 92
           + N ++ Y+L  K+LG G+F V+R+C  K TG+  A K + K R    +D R+ I  EI 
Sbjct: 23  MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRR--RGQDCRAEILHEIA 80
Query: 93  IMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRL--EKYGRFSETEARVIFRHL 150
           ++      P V++L  VYE    + L++E  AGGE+F     E     SE +   + + +
Sbjct: 81  VLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQI 140
Query: 151 MQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYI 210
           ++ V Y H N +VH DLKP+NILL++      IK+ DFG++  I     L   +G+P Y+
Sbjct: 141 LEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYL 200
Query: 211 APEVLA-GGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHI 269
           APE+L       A D+W+ G+I Y+LL+   PF G+   + +  +   ++ +  + +  +
Sbjct: 201 APEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSV 260
Query: 270 SASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
           S  A D I  +L  +P  R TA   L+HSW+++
Sbjct: 261 SQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQ 293

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score =  158 bits (400), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 94/268 (35%), Positives = 149/268 (55%), Gaps = 15/268 (5%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           D Y + ++LG G FGV+  C +K TG V   K I     +   D  ++K EI IM +L  
Sbjct: 51  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL---DKYTVKNEISIMNQLH- 106
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRL--EKYGRFSETEARVIFRHLMQVVSYC 157
           HP +++L   +E++  + L++E  +GGELF R+  E Y + SE E     R   + + + 
Sbjct: 107 HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY-KMSEAEVINYMRQACEGLKHM 165
Query: 158 HGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVL-- 215
           H + +VH D+KPENI+  TK +SS +K+ DFGLAT +   + +  T  +  + APE++  
Sbjct: 166 HEHSIVHLDIKPENIMCETKKASS-VKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDR 224
Query: 216 --AGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASA 273
              G Y    D+W+ GV+ Y+LLSG+ PF G+   +    V+  D  F  D +  +S  A
Sbjct: 225 EPVGFY---TDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEA 281
Query: 274 RDLIMGMLRVDPSTRLTAAEVLAHSWME 301
           +D I  +L+ +P  RLT  + L H W++
Sbjct: 282 KDFIKNLLQKEPRKRLTVHDALEHPWLK 309

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  158 bits (400), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 97/261 (37%), Positives = 138/261 (52%), Gaps = 11/261 (4%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           Y L K +G G F  ++      TG+ +A K I K +L +   ++ +  E+ IM K+  HP
Sbjct: 9   YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNS-SSLQKLFREVRIM-KVLNHP 66
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
           N+V L  V E E  ++L+ME  +GGE+F  L  +G   E EAR  FR ++  V YCH   
Sbjct: 67  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCHQKF 126
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGGYNQ 221
           +VHRDLK EN+LL    +   IK+ADFG +     G  L    GSP Y APE+  G    
Sbjct: 127 IVHRDLKAENLLL---DADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYD 183
Query: 222 A--ADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMG 279
               DVWS GVILY L+SG  PF G+   ++ + V     R P     ++S    +L+  
Sbjct: 184 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF----YMSTDCENLLKK 239
Query: 280 MLRVDPSTRLTAAEVLAHSWM 300
            L ++PS R T  +++   WM
Sbjct: 240 FLILNPSKRGTLEQIMKDRWM 260

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  157 bits (398), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 96/261 (36%), Positives = 136/261 (52%), Gaps = 11/261 (4%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           Y L K +G G F  ++      TG  +A K I K +L     ++ +  E+ IM K+  HP
Sbjct: 14  YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIM-KILNHP 71
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
           N+V L  V E E  ++L+ME  +GGE+F  L  +GR  E EAR  FR ++  V YCH   
Sbjct: 72  NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR 131
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGGYNQ 221
           +VHRDLK EN+LL    +   IK+ADFG +     G  L    GSP Y APE+  G    
Sbjct: 132 IVHRDLKAENLLL---DADMNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGKKYD 188
Query: 222 A--ADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMG 279
               DVWS GVILY L+SG  PF G+   ++ + V     R P     ++S    +L+  
Sbjct: 189 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF----YMSTDCENLLKR 244
Query: 280 MLRVDPSTRLTAAEVLAHSWM 300
            L ++P  R T  +++   W+
Sbjct: 245 FLVLNPIKRGTLEQIMKDRWI 265

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  157 bits (398), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 97/281 (34%), Positives = 149/281 (53%), Gaps = 11/281 (3%)
Query: 32  ATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEI 91
           AT I    + + +G  LG G F  +       TG  +A K I K  +     V+ ++ E+
Sbjct: 3   ATCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEV 62
Query: 92  EIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLE-KYGRFSETEARVIFRHL 150
           +I  +L  HP++++L   +E+ +YV+L++E+C  GE+   L+ +   FSE EAR     +
Sbjct: 63  KIHCQLK-HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQI 121
Query: 151 MQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTV-GSPFY 209
           +  + Y H +G++HRDL   N+LL    +   IK+ADFGLAT +K     H T+ G+P Y
Sbjct: 122 ITGMLYLHSHGILHRDLTLSNLLLTRNMN---IKIADFGLATQLKMPHEKHYTLCGTPNY 178
Query: 210 IAPEVLA-GGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDH 268
           I+PE+     +   +DVWS G + Y LL G PPF   T     + V  AD   PS     
Sbjct: 179 ISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPS----F 234
Query: 269 ISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQK 309
           +S  A+DLI  +LR +P+ RL+ + VL H +M        K
Sbjct: 235 LSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSSTKSK 275

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  157 bits (397), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 95/261 (36%), Positives = 136/261 (52%), Gaps = 11/261 (4%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           Y L K +G G F  ++      TG  +A K I K +L     ++ +  E+ IM K+  HP
Sbjct: 17  YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIM-KILNHP 74
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
           N+V L  V E E  ++L+ME  +GGE+F  L  +GR  E EAR  FR ++  V YCH   
Sbjct: 75  NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR 134
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGGYNQ 221
           +VHRDLK EN+LL    +   IK+ADFG +     G  L    G+P Y APE+  G    
Sbjct: 135 IVHRDLKAENLLL---DADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYD 191
Query: 222 A--ADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMG 279
               DVWS GVILY L+SG  PF G+   ++ + V     R P     ++S    +L+  
Sbjct: 192 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF----YMSTDCENLLKR 247
Query: 280 MLRVDPSTRLTAAEVLAHSWM 300
            L ++P  R T  +++   W+
Sbjct: 248 FLVLNPIKRGTLEQIMKDRWI 268

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score =  157 bits (396), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 91/284 (32%), Positives = 142/284 (50%), Gaps = 19/284 (6%)
Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKL 97
           + D  V  + LG G  G + +  +K T E  A K +        +D    + E+E+  + 
Sbjct: 60  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKXL--------QDCPKARREVELHWRA 111
Query: 98  SGHPNVVDLKAVYEE----EDYVHLLMELCAGGELFHRLEKYG--RFSETEARVIFRHLM 151
           S  P++V +  VYE        + ++ E   GGELF R++  G   F+E EA  I + + 
Sbjct: 112 SQCPHIVRIVDVYENLYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIG 171
Query: 152 QVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIA 211
           + + Y H   + HRD+KPEN+L  +K  ++ +KL DFG A    +  +L     +P+Y+A
Sbjct: 172 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 231
Query: 212 PEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDA----VRAADLRFPSDPW 266
           PEVL    Y+++ D WS GVI YILL G PPF+      I       +R     FP+  W
Sbjct: 232 PEVLGPEKYDKSCDXWSLGVIXYILLCGYPPFYSNHGLAISPGXKTRIRXGQYEFPNPEW 291
Query: 267 DHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKP 310
             +S   + LI  +L+ +P+ R T  E   H W+ +  +V Q P
Sbjct: 292 SEVSEEVKXLIRNLLKTEPTQRXTITEFXNHPWIXQSTKVPQTP 335

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score =  157 bits (396), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 82/241 (34%), Positives = 130/241 (53%), Gaps = 29/241 (12%)
Query: 90  EIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRH 149
           E+E + +  G+ N+++L   +E++   +L+ E   GG +   ++K   F+E EA  + R 
Sbjct: 60  EVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRD 119
Query: 150 LMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN--------LH 201
           +   + + H  G+ HRDLKPENIL  +    SP+K+ DF L + +K   +        L 
Sbjct: 120 VAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELT 179
Query: 202 GTVGSPFYIAPEVL------AGGYNQAADVWSAGVILYILLSGMPPFWGK---------- 245
              GS  Y+APEV+      A  Y++  D+WS GV+LYI+LSG PPF G           
Sbjct: 180 TPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRG 239
Query: 246 -----TKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWM 300
                 ++K+F++++     FP   W HIS+ A+DLI  +L  D   RL+AA+VL H W+
Sbjct: 240 EVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWV 299
Query: 301 E 301
           +
Sbjct: 300 Q 300

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  156 bits (395), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 88/261 (33%), Positives = 143/261 (54%), Gaps = 14/261 (5%)
Query: 44  LGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNV 103
           +G+ LG G+FG +    ++ +  +LA K + K +L        ++ E+EI + L  HPN+
Sbjct: 16  IGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLR-HPNI 74
Query: 104 VDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVV 163
           + L   + +   V+L++E    G ++  L+K  RF E         L   +SYCH   V+
Sbjct: 75  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKRVI 134
Query: 164 HRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ--NLHGTVGSPFYIAPEVLAGG-YN 220
           HRD+KPEN+LL    S+  +K+ADFG + +  + +   L GT+    Y+ PE++ G  ++
Sbjct: 135 HRDIKPENLLLG---SNGELKIADFGWSVHAPSSRRTTLCGTLD---YLPPEMIEGRMHD 188
Query: 221 QAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGM 280
           +  D+WS GV+ Y  L GMPPF   T  + +  +   +  FP    D ++  ARDLI  +
Sbjct: 189 EKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFP----DFVTEGARDLISRL 244
Query: 281 LRVDPSTRLTAAEVLAHSWME 301
           L+ + S RLT AEVL H W++
Sbjct: 245 LKHNASQRLTLAEVLEHPWIK 265

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 88/261 (33%), Positives = 143/261 (54%), Gaps = 14/261 (5%)
Query: 44  LGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNV 103
           +G+ LG G+FG +    ++ +  +LA K + K +L        ++ E+EI + L  HPN+
Sbjct: 16  IGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLR-HPNI 74
Query: 104 VDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVV 163
           + L   + +   V+L++E    G ++  L+K  RF E         L   +SYCH   V+
Sbjct: 75  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKRVI 134
Query: 164 HRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN--LHGTVGSPFYIAPEVLAGG-YN 220
           HRD+KPEN+LL    S+  +K+ADFG + +  + +   L GT+    Y+ PE++ G  ++
Sbjct: 135 HRDIKPENLLLG---SNGELKIADFGWSVHAPSSRRDTLCGTLD---YLPPEMIEGRMHD 188
Query: 221 QAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGM 280
           +  D+WS GV+ Y  L GMPPF   T  + +  +   +  FP    D ++  ARDLI  +
Sbjct: 189 EKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFP----DFVTEGARDLISRL 244
Query: 281 LRVDPSTRLTAAEVLAHSWME 301
           L+ + S RLT AEVL H W++
Sbjct: 245 LKHNASQRLTLAEVLEHPWIK 265

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  155 bits (392), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 88/278 (31%), Positives = 147/278 (52%), Gaps = 16/278 (5%)
Query: 40  DRYVLGKQLGWGQFGVI---RECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTK 96
           D + +G+ LG G+FG +   RE  +KF   ++A K + K +L        ++ EIEI + 
Sbjct: 15  DDFDIGRPLGKGKFGNVYLAREKQNKF---IMALKVLFKSQLEKEGVEHQLRREIEIQSH 71
Query: 97  LSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSY 156
           L  HPN++ +   + +   ++L++E    GEL+  L+K+GRF E  +      L   + Y
Sbjct: 72  LR-HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHY 130
Query: 157 CHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLA 216
           CH   V+HRD+KPEN+L+  K     +K+ADFG + +  + +      G+  Y+ PE++ 
Sbjct: 131 CHERKVIHRDIKPENLLMGYKGE---LKIADFGWSVHAPSLRR-RXMCGTLDYLPPEMIE 186
Query: 217 GG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARD 275
           G  +++  D+W AGV+ Y  L GMPPF   + ++    +   DL+FP      +S  ++D
Sbjct: 187 GKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPP----FLSDGSKD 242
Query: 276 LIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKPCKQ 313
           LI  +LR  P  RL    V+ H W++   +    P  Q
Sbjct: 243 LISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPPVYQ 280

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  155 bits (392), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 91/284 (32%), Positives = 149/284 (52%), Gaps = 19/284 (6%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           + +G+ LG G+FG +    +K +  +LA K + K +L        ++ E+EI + L  HP
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 73
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
           N++ L   + +   V+L++E    GE++  L+K  +F E         L   +SYCH   
Sbjct: 74  NILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSKR 133
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN--LHGTVGSPFYIAPEVLAGG- 218
           V+HRD+KPEN+LL    S+  +K+ADFG + +  + +   L GT+    Y+ PE++ G  
Sbjct: 134 VIHRDIKPENLLLG---SAGELKIADFGWSVHAPSSRRXXLXGTLD---YLPPEMIEGRM 187
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           +++  D+WS GV+ Y  L G PPF   T  + +  +   +  FP    D ++  ARDLI 
Sbjct: 188 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLIS 243
Query: 279 GMLRVDPSTRLTAAEVLAHSWMEECEQVAQKP--CKQDDLCCKQ 320
            +L+ +PS R    EVL H W+      + KP  C+  +   KQ
Sbjct: 244 RLLKHNPSQRPMLREVLEHPWITAN---SSKPSNCQNKESASKQ 284

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  154 bits (390), Expect = 7e-38,   Method: Compositional matrix adjust.
 Identities = 86/262 (32%), Positives = 141/262 (53%), Gaps = 14/262 (5%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           + +G+ LG G+FG +    +K +  +LA K + K +L        ++ E+EI + L  HP
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 73
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
           N++ L   + +   V+L++E    GE++  L+K  +F E         L   +SYCH   
Sbjct: 74  NILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSKR 133
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN--LHGTVGSPFYIAPEVLAGG- 218
           V+HRD+KPEN+LL    S+  +K+ADFG + +  + +   L GT+    Y+ PE++ G  
Sbjct: 134 VIHRDIKPENLLLG---SAGELKIADFGWSVHAPSSRRTTLCGTLD---YLPPEMIEGRM 187
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           +++  D+WS GV+ Y  L G PPF   T  + +  +   +  FP    D ++  ARDLI 
Sbjct: 188 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLIS 243
Query: 279 GMLRVDPSTRLTAAEVLAHSWM 300
            +L+ +PS R    EVL H W+
Sbjct: 244 RLLKHNPSQRPMLREVLEHPWI 265

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 104/296 (35%), Positives = 149/296 (50%), Gaps = 16/296 (5%)
Query: 23  SSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVE 82
           +S+T    +   I N    Y L K +G G F  ++      TG  +A K I K +L    
Sbjct: 2   NSITSATDEQPHIGN----YRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQL-NPT 56
Query: 83  DVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETE 142
            ++ +  E+ IM K+  HPN+V L  V E E  ++L+ME  +GGE+F  L  +GR  E E
Sbjct: 57  SLQKLFREVRIM-KILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKE 115
Query: 143 ARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHG 202
           AR  FR ++  V YCH   +VHRDLK EN+LL        IK+ADFG +     G  L  
Sbjct: 116 ARAKFRQIVSAVQYCHQKYIVHRDLKAENLLL---DGDMNIKIADFGFSNEFTVGNKLDT 172
Query: 203 TVGSPFYIAPEVLAGGYNQA--ADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLR 260
             GSP Y APE+  G        DVWS GVILY L+SG  PF G+   ++ + V     R
Sbjct: 173 FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR 232
Query: 261 FPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEEC-EQVAQKPCKQDD 315
            P     ++S    +L+  +L ++P  R +  +++   WM    E+   KP  + D
Sbjct: 233 IPF----YMSTDCENLLKKLLVLNPIKRGSLEQIMKDRWMNVGHEEEELKPYTEPD 284

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 85/262 (32%), Positives = 141/262 (53%), Gaps = 14/262 (5%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           + +G+ LG G+FG +    +K +  +LA K + K +L        ++ E+EI + L  HP
Sbjct: 36  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 94
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
           N++ L   + +   V+L++E    G ++  L+K  +F E         L   +SYCH   
Sbjct: 95  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 154
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ--NLHGTVGSPFYIAPEVLAGG- 218
           V+HRD+KPEN+LL    S+  +K+ADFG + +  + +  +L GT+    Y+ PE++ G  
Sbjct: 155 VIHRDIKPENLLLG---SAGELKIADFGWSVHAPSSRRDDLCGTLD---YLPPEMIEGRM 208
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           +++  D+WS GV+ Y  L G PPF   T  + +  +   +  FP    D ++  ARDLI 
Sbjct: 209 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLIS 264
Query: 279 GMLRVDPSTRLTAAEVLAHSWM 300
            +L+ +PS R    EVL H W+
Sbjct: 265 RLLKHNPSQRPMLREVLEHPWI 286

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 99/315 (31%), Positives = 146/315 (46%), Gaps = 52/315 (16%)
Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRL--VTVEDVRSIKLEIEIMT 95
           L  +Y L   +G G +GV+R   +  T  + A K + K+++  +  +DV  IK E+ +M 
Sbjct: 24  LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMK 83
Query: 96  KLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKY-----GR------------- 137
           KL  HPN+  L  VYE+E Y+ L+MELC GG L  +L  +     G+             
Sbjct: 84  KLH-HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPC 142
Query: 138 --------------------FSETEARV--IFRHLMQVVSYCHGNGVVHRDLKPENILLA 175
                               F + E  +  I R +   + Y H  G+ HRD+KPEN L +
Sbjct: 143 PECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFS 202
Query: 176 TKSSSSPIKLADFGLATYIKAGQN-----LHGTVGSPFYIAPEVLAG---GYNQAADVWS 227
           T  S   IKL DFGL+       N     +    G+P+++APEVL      Y    D WS
Sbjct: 203 TNKSFE-IKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261
Query: 228 AGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPST 287
           AGV+L++LL G  PF G   +     V    L F +  ++ +S  ARDL+  +L  +   
Sbjct: 262 AGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDE 321
Query: 288 RLTAAEVLAHSWMEE 302
           R  A   L H W+ +
Sbjct: 322 RFDAMRALQHPWISQ 336

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 85/262 (32%), Positives = 140/262 (53%), Gaps = 14/262 (5%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           + +G+ LG G+FG +    +K +  +LA K + K +L        ++ E+EI + L  HP
Sbjct: 36  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 94
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
           N++ L   + +   V+L++E    G ++  L+K  +F E         L   +SYCH   
Sbjct: 95  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 154
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN--LHGTVGSPFYIAPEVLAGG- 218
           V+HRD+KPEN+LL    S+  +K+ADFG + +  + +   L GT+    Y+ PE++ G  
Sbjct: 155 VIHRDIKPENLLLG---SAGELKIADFGWSVHAPSSRRTTLCGTLD---YLPPEMIEGRM 208
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           +++  D+WS GV+ Y  L G PPF   T  + +  +   +  FP    D ++  ARDLI 
Sbjct: 209 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLIS 264
Query: 279 GMLRVDPSTRLTAAEVLAHSWM 300
            +L+ +PS R    EVL H W+
Sbjct: 265 RLLKHNPSQRPMLREVLEHPWI 286

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  152 bits (384), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 85/262 (32%), Positives = 140/262 (53%), Gaps = 14/262 (5%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           + +G+ LG G+FG +    +K +  +LA K + K +L        ++ E+EI + L  HP
Sbjct: 27  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 85
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
           N++ L   + +   V+L++E    G ++  L+K  +F E         L   +SYCH   
Sbjct: 86  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 145
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN--LHGTVGSPFYIAPEVLAGG- 218
           V+HRD+KPEN+LL    S+  +K+ADFG + +  + +   L GT+    Y+ PE++ G  
Sbjct: 146 VIHRDIKPENLLLG---SAGELKIADFGWSVHAPSSRRTTLCGTLD---YLPPEMIEGRM 199
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           +++  D+WS GV+ Y  L G PPF   T  + +  +   +  FP    D ++  ARDLI 
Sbjct: 200 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLIS 255
Query: 279 GMLRVDPSTRLTAAEVLAHSWM 300
            +L+ +PS R    EVL H W+
Sbjct: 256 RLLKHNPSQRPMLREVLEHPWI 277

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  152 bits (384), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 85/262 (32%), Positives = 140/262 (53%), Gaps = 14/262 (5%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           + +G+ LG G+FG +    +K +  +LA K + K +L        ++ E+EI + L  HP
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 69
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
           N++ L   + +   V+L++E    G ++  L+K  +F E         L   +SYCH   
Sbjct: 70  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 129
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN--LHGTVGSPFYIAPEVLAGG- 218
           V+HRD+KPEN+LL    S+  +K+ADFG + +  + +   L GT+    Y+ PE++ G  
Sbjct: 130 VIHRDIKPENLLLG---SAGELKIADFGWSCHAPSSRRTTLSGTLD---YLPPEMIEGRM 183
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           +++  D+WS GV+ Y  L G PPF   T  + +  +   +  FP    D ++  ARDLI 
Sbjct: 184 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLIS 239
Query: 279 GMLRVDPSTRLTAAEVLAHSWM 300
            +L+ +PS R    EVL H W+
Sbjct: 240 RLLKHNPSQRPMLREVLEHPWI 261

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 94/260 (36%), Positives = 134/260 (51%), Gaps = 11/260 (4%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           Y L K +G G F  ++      TG+ +A K I K +L +   ++ +  E+ I  K+  HP
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNS-SSLQKLFREVRI-XKVLNHP 73
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
           N+V L  V E E  ++L+ E  +GGE+F  L  +GR  E EAR  FR ++  V YCH   
Sbjct: 74  NIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCHQKF 133
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGGYNQ 221
           +VHRDLK EN+LL    +   IK+ADFG +     G  L    G+P Y APE+  G    
Sbjct: 134 IVHRDLKAENLLL---DADXNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYD 190
Query: 222 A--ADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMG 279
               DVWS GVILY L+SG  PF G+   ++ + V     R P     + S    +L+  
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF----YXSTDCENLLKK 246
Query: 280 MLRVDPSTRLTAAEVLAHSW 299
            L ++PS R T  ++    W
Sbjct: 247 FLILNPSKRGTLEQIXKDRW 266

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  152 bits (383), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 84/275 (30%), Positives = 143/275 (52%), Gaps = 10/275 (3%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           D + + + LG G+FG +    +K    ++A K + K +L        ++ EIEI + L  
Sbjct: 14  DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR- 72
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
           HPN++ +   + +   ++L++E    GEL+  L+K+GRF E  +      L   + YCH 
Sbjct: 73  HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHE 132
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGG- 218
             V+HRD+KPEN+L+  K     +K+ADFG + +  + +      G+  Y+ PE++ G  
Sbjct: 133 RKVIHRDIKPENLLMGYKGE---LKIADFGWSVHAPSLRR-RXMCGTLDYLPPEMIEGKT 188
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           +++  D+W AGV+ Y  L GMPPF   + ++    +   DL+FP      +S  ++DLI 
Sbjct: 189 HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPP----FLSDGSKDLIS 244
Query: 279 GMLRVDPSTRLTAAEVLAHSWMEECEQVAQKPCKQ 313
            +LR  P  RL    V+ H W++   +    P  Q
Sbjct: 245 KLLRYHPPQRLPLKGVMEHPWVKANSRRVLPPVYQ 279

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  152 bits (383), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 85/262 (32%), Positives = 141/262 (53%), Gaps = 14/262 (5%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           + +G+ LG G+FG +    +K +  +LA K + K +L        ++ E+EI + L  HP
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 69
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
           N++ L   + +   V+L++E    G ++  L+K  +F E         L   +SYCH   
Sbjct: 70  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 129
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ--NLHGTVGSPFYIAPEVLAGG- 218
           V+HRD+KPEN+LL    S+  +K+ADFG + +  + +  +L GT+    Y+ PE++ G  
Sbjct: 130 VIHRDIKPENLLLG---SAGELKIADFGWSVHAPSSRRTDLCGTLD---YLPPEMIEGRM 183
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           +++  D+WS GV+ Y  L G PPF   T  + +  +   +  FP    D ++  ARDLI 
Sbjct: 184 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLIS 239
Query: 279 GMLRVDPSTRLTAAEVLAHSWM 300
            +L+ +PS R    EVL H W+
Sbjct: 240 RLLKHNPSQRPMLREVLEHPWI 261

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  152 bits (383), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 85/262 (32%), Positives = 140/262 (53%), Gaps = 14/262 (5%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           + +G+ LG G+FG +    +K +  +LA K + K +L        ++ E+EI + L  HP
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 71
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
           N++ L   + +   V+L++E    G ++  L+K  +F E         L   +SYCH   
Sbjct: 72  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 131
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN--LHGTVGSPFYIAPEVLAGG- 218
           V+HRD+KPEN+LL    S+  +K+ADFG + +  + +   L GT+    Y+ PE++ G  
Sbjct: 132 VIHRDIKPENLLLG---SAGELKIADFGWSVHAPSSRRTTLCGTLD---YLPPEMIEGRM 185
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           +++  D+WS GV+ Y  L G PPF   T  + +  +   +  FP    D ++  ARDLI 
Sbjct: 186 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLIS 241
Query: 279 GMLRVDPSTRLTAAEVLAHSWM 300
            +L+ +PS R    EVL H W+
Sbjct: 242 RLLKHNPSQRPMLREVLEHPWI 263

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  151 bits (382), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 85/262 (32%), Positives = 141/262 (53%), Gaps = 14/262 (5%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           + +G+ LG G+FG +    +K +  +LA K + K +L        ++ E+EI + L  HP
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 73
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
           N++ L   + +   V+L++E    G ++  L+K  +F E         L   +SYCH   
Sbjct: 74  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 133
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ--NLHGTVGSPFYIAPEVLAGG- 218
           V+HRD+KPEN+LL    S+  +K+ADFG + +  + +  +L GT+    Y+ PE++ G  
Sbjct: 134 VIHRDIKPENLLLG---SAGELKIADFGWSVHAPSSRRTDLCGTLD---YLPPEMIEGRM 187
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           +++  D+WS GV+ Y  L G PPF   T  + +  +   +  FP    D ++  ARDLI 
Sbjct: 188 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLIS 243
Query: 279 GMLRVDPSTRLTAAEVLAHSWM 300
            +L+ +PS R    EVL H W+
Sbjct: 244 RLLKHNPSQRPMLREVLEHPWI 265

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  151 bits (382), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 90/284 (31%), Positives = 148/284 (52%), Gaps = 19/284 (6%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           + +G+ LG G+FG +    +K +  +LA K + K +L        ++ E+EI + L  HP
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 73
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
           N++ L   + +   V+L++E    G ++  L+K  +F E         L   +SYCH   
Sbjct: 74  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 133
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN--LHGTVGSPFYIAPEVLAGG- 218
           V+HRD+KPEN+LL    S+  +K+ADFG + +  + +   L GT+    Y+ PE++ G  
Sbjct: 134 VIHRDIKPENLLLG---SAGELKIADFGWSVHAPSSRRTTLCGTLD---YLPPEMIEGRM 187
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           +++  D+WS GV+ Y  L G PPF   T  + +  +   +  FP    D ++  ARDLI 
Sbjct: 188 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLIS 243
Query: 279 GMLRVDPSTRLTAAEVLAHSWMEECEQVAQKP--CKQDDLCCKQ 320
            +L+ +PS R    EVL H W+      + KP  C+  +   KQ
Sbjct: 244 RLLKHNPSQRPMLREVLEHPWITAN---SSKPSNCQNKESASKQ 284

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  151 bits (382), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 90/284 (31%), Positives = 148/284 (52%), Gaps = 19/284 (6%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           + +G+ LG G+FG +    +K +  +LA K + K +L        ++ E+EI + L  HP
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 68
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
           N++ L   + +   V+L++E    G ++  L+K  +F E         L   +SYCH   
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 128
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ--NLHGTVGSPFYIAPEVLAGG- 218
           V+HRD+KPEN+LL    S+  +K+ADFG + +  + +   L GT+    Y+ PE++ G  
Sbjct: 129 VIHRDIKPENLLLG---SAGELKIADFGWSVHAPSSRRTTLCGTLD---YLPPEMIEGRM 182
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           +++  D+WS GV+ Y  L G PPF   T  + +  +   +  FP    D ++  ARDLI 
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLIS 238
Query: 279 GMLRVDPSTRLTAAEVLAHSWMEECEQVAQKP--CKQDDLCCKQ 320
            +L+ +PS R    EVL H W+      + KP  C+  +   KQ
Sbjct: 239 RLLKHNPSQRPMLREVLEHPWITAN---SSKPSNCQNKESASKQ 279

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  151 bits (382), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 85/262 (32%), Positives = 141/262 (53%), Gaps = 14/262 (5%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           + +G+ LG G+FG +    +K +  +LA K + K +L        ++ E+EI + L  HP
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 68
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
           N++ L   + +   V+L++E    G ++  L+K  +F E         L   +SYCH   
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 128
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ--NLHGTVGSPFYIAPEVLAGG- 218
           V+HRD+KPEN+LL    S+  +K+ADFG + +  + +  +L GT+    Y+ PE++ G  
Sbjct: 129 VIHRDIKPENLLLG---SAGELKIADFGWSVHAPSSRRTDLCGTLD---YLPPEMIEGRM 182
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           +++  D+WS GV+ Y  L G PPF   T  + +  +   +  FP    D ++  ARDLI 
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLIS 238
Query: 279 GMLRVDPSTRLTAAEVLAHSWM 300
            +L+ +PS R    EVL H W+
Sbjct: 239 RLLKHNPSQRPMLREVLEHPWI 260

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  151 bits (382), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 85/262 (32%), Positives = 141/262 (53%), Gaps = 14/262 (5%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           + +G+ LG G+FG +    +K +  +LA K + K +L        ++ E+EI + L  HP
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 68
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
           N++ L   + +   V+L++E    G ++  L+K  +F E         L   +SYCH   
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 128
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ--NLHGTVGSPFYIAPEVLAGG- 218
           V+HRD+KPEN+LL    S+  +K+ADFG + +  + +  +L GT+    Y+ PE++ G  
Sbjct: 129 VIHRDIKPENLLLG---SAGELKIADFGWSVHAPSSRRTDLCGTLD---YLPPEMIEGRM 182
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           +++  D+WS GV+ Y  L G PPF   T  + +  +   +  FP    D ++  ARDLI 
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLIS 238
Query: 279 GMLRVDPSTRLTAAEVLAHSWM 300
            +L+ +PS R    EVL H W+
Sbjct: 239 RLLKHNPSQRPMLREVLEHPWI 260

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  151 bits (382), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 85/262 (32%), Positives = 140/262 (53%), Gaps = 14/262 (5%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           + +G+ LG G+FG +    +K +  +LA K + K +L        ++ E+EI + L  HP
Sbjct: 12  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 70
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
           N++ L   + +   V+L++E    G ++  L+K  +F E         L   +SYCH   
Sbjct: 71  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 130
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN--LHGTVGSPFYIAPEVLAGG- 218
           V+HRD+KPEN+LL    S+  +K+ADFG + +  + +   L GT+    Y+ PE++ G  
Sbjct: 131 VIHRDIKPENLLLG---SAGELKIADFGWSVHAPSSRRXXLCGTLD---YLPPEMIEGRM 184
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           +++  D+WS GV+ Y  L G PPF   T  + +  +   +  FP    D ++  ARDLI 
Sbjct: 185 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLIS 240
Query: 279 GMLRVDPSTRLTAAEVLAHSWM 300
            +L+ +PS R    EVL H W+
Sbjct: 241 RLLKHNPSQRPMLREVLEHPWI 262

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  151 bits (382), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 90/284 (31%), Positives = 148/284 (52%), Gaps = 19/284 (6%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           + +G+ LG G+FG +    +K +  +LA K + K +L        ++ E+EI + L  HP
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 68
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
           N++ L   + +   V+L++E    G ++  L+K  +F E         L   +SYCH   
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 128
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN--LHGTVGSPFYIAPEVLAGG- 218
           V+HRD+KPEN+LL    S+  +K+ADFG + +  + +   L GT+    Y+ PE++ G  
Sbjct: 129 VIHRDIKPENLLLG---SAGELKIADFGWSVHAPSSRRTELCGTLD---YLPPEMIEGRM 182
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           +++  D+WS GV+ Y  L G PPF   T  + +  +   +  FP    D ++  ARDLI 
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLIS 238
Query: 279 GMLRVDPSTRLTAAEVLAHSWMEECEQVAQKP--CKQDDLCCKQ 320
            +L+ +PS R    EVL H W+      + KP  C+  +   KQ
Sbjct: 239 RLLKHNPSQRPMLREVLEHPWITAN---SSKPSNCQNKESASKQ 279

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  151 bits (382), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 85/262 (32%), Positives = 140/262 (53%), Gaps = 14/262 (5%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           + +G+ LG G+FG +    +K +  +LA K + K +L        ++ E+EI + L  HP
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 69
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
           N++ L   + +   V+L++E    G ++  L+K  +F E         L   +SYCH   
Sbjct: 70  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 129
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN--LHGTVGSPFYIAPEVLAGG- 218
           V+HRD+KPEN+LL    S+  +K+ADFG + +  + +   L GT+    Y+ PE++ G  
Sbjct: 130 VIHRDIKPENLLLG---SAGELKIADFGWSVHAPSSRRDTLCGTLD---YLPPEMIEGRM 183
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           +++  D+WS GV+ Y  L G PPF   T  + +  +   +  FP    D ++  ARDLI 
Sbjct: 184 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLIS 239
Query: 279 GMLRVDPSTRLTAAEVLAHSWM 300
            +L+ +PS R    EVL H W+
Sbjct: 240 RLLKHNPSQRPMLREVLEHPWI 261

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  151 bits (381), Expect = 7e-37,   Method: Compositional matrix adjust.
 Identities = 88/282 (31%), Positives = 146/282 (51%), Gaps = 15/282 (5%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           + +G+ LG G+FG +    +K +  +LA K + K +L        ++ E+EI + L  HP
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 71
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
           N++ L   + +   V+L++E    G ++  L+K  +F E         L   +SYCH   
Sbjct: 72  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 131
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGG-YN 220
           V+HRD+KPEN+LL    S+  +K+ADFG + +  + +      G+  Y+ PE++ G  ++
Sbjct: 132 VIHRDIKPENLLLG---SAGELKIADFGWSVHAPSSRRA-ALCGTLDYLPPEMIEGRMHD 187
Query: 221 QAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGM 280
           +  D+WS GV+ Y  L G PPF   T  + +  +   +  FP    D ++  ARDLI  +
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLISRL 243
Query: 281 LRVDPSTRLTAAEVLAHSWMEECEQVAQKP--CKQDDLCCKQ 320
           L+ +PS R    EVL H W+      + KP  C+  +   KQ
Sbjct: 244 LKHNPSQRPMLREVLEHPWITAN---SSKPSNCQNKESASKQ 282

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  151 bits (381), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 85/262 (32%), Positives = 139/262 (53%), Gaps = 14/262 (5%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           + +G+ LG G+FG +    +K +  +LA K + K +L        ++ E+EI + L  HP
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 73
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
           N++ L   + +   V+L++E    G ++  L+K  +F E         L   +SYCH   
Sbjct: 74  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 133
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN--LHGTVGSPFYIAPEVLAG-G 218
           V+HRD+KPEN+LL    S+  +K+ADFG + +  + +   L GT+    Y+ PE + G  
Sbjct: 134 VIHRDIKPENLLLG---SAGELKIADFGWSVHAPSSRRTTLCGTLD---YLPPEXIEGRX 187
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           +++  D+WS GV+ Y  L G PPF   T  + +  +   +  FP    D ++  ARDLI 
Sbjct: 188 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLIS 243
Query: 279 GMLRVDPSTRLTAAEVLAHSWM 300
            +L+ +PS R    EVL H W+
Sbjct: 244 RLLKHNPSQRPXLREVLEHPWI 265

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score =  150 bits (380), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 147/274 (53%), Gaps = 16/274 (5%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           D++   K LG G FG +     K +G   A K + K ++V ++ +     E  I+  ++ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 99
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
            P +V L+  +++   ++++ME  AGGE+F  L + GRFSE  AR     ++    Y H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPE-VLAGG 218
             +++RDLKPEN+L+  +     I++ DFG A  +K         G+P Y+APE +L+ G
Sbjct: 160 LDLIYRDLKPENLLIDQQGY---IQVTDFGFAKRVKG--RTWXLAGTPEYLAPEIILSKG 214
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           YN+A D W+ GV++Y + +G PPF+     +I++ + +  +RFPS    H S+  +DL+ 
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLR 270
Query: 279 GMLRVDPSTRL-----TAAEVLAHSWMEECEQVA 307
            +L+VD + R         ++  H W    + +A
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIA 304

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  150 bits (380), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 85/262 (32%), Positives = 141/262 (53%), Gaps = 14/262 (5%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           + +G+ LG G+FG +    +K +  +LA K + K +L        ++ E+EI + L  HP
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 71
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
           N++ L   + +   V+L++E    G ++  L+K  +F E         L   +SYCH   
Sbjct: 72  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 131
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ--NLHGTVGSPFYIAPEVLAGG- 218
           V+HRD+KPEN+LL    S+  +K+ADFG + +  + +  +L GT+    Y+ PE++ G  
Sbjct: 132 VIHRDIKPENLLLG---SAGELKIADFGWSVHAPSSRRDDLCGTLD---YLPPEMIEGRM 185
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           +++  D+WS GV+ Y  L G PPF   T  + +  +   +  FP    D ++  ARDLI 
Sbjct: 186 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLIS 241
Query: 279 GMLRVDPSTRLTAAEVLAHSWM 300
            +L+ +PS R    EVL H W+
Sbjct: 242 RLLKHNPSQRPMLREVLEHPWI 263

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score =  150 bits (380), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 146/274 (53%), Gaps = 16/274 (5%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           D++   K LG G FG +     K TG   A K + K ++V ++ +     E  I+  ++ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 99
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
            P +V L+  +++   ++++ME   GGE+F  L + GRFSE  AR     ++    Y H 
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPE-VLAGG 218
             +++RDLKPEN+L+  +     I++ DFG A  +K         G+P Y+APE +L+ G
Sbjct: 160 LDLIYRDLKPENLLIDQQGY---IQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 214
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           YN+A D W+ GV++Y + +G PPF+     +I++ + +  +RFPS    H S+  +DL+ 
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLR 270
Query: 279 GMLRVDPSTRL-----TAAEVLAHSWMEECEQVA 307
            +L+VD + R         ++  H W    + +A
Sbjct: 271 NLLQVDLTKRFGNLKDGVNDIKNHKWFATTDWIA 304

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score =  150 bits (380), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 146/274 (53%), Gaps = 16/274 (5%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           D++   K LG G FG +     K TG   A K + K ++V ++ +     E  I+  ++ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 99
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
            P +V L+  +++   ++++ME   GGE+F  L + GRFSE  AR     ++    Y H 
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPE-VLAGG 218
             +++RDLKPEN+L+  +     I++ DFG A  +K         G+P Y+APE +L+ G
Sbjct: 160 LDLIYRDLKPENLLIDQQGY---IQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 214
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           YN+A D W+ GV++Y + +G PPF+     +I++ + +  +RFPS    H S+  +DL+ 
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLR 270
Query: 279 GMLRVDPSTRL-----TAAEVLAHSWMEECEQVA 307
            +L+VD + R         ++  H W    + +A
Sbjct: 271 NLLQVDLTKRFGNLKDGVNDIKNHKWFATTDWIA 304

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score =  150 bits (380), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 146/274 (53%), Gaps = 16/274 (5%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           D++   K LG G FG +     K TG   A K + K ++V ++ +     E  I+  ++ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 99
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
            P +V L+  +++   ++++ME   GGE+F  L + GRFSE  AR     ++    Y H 
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPE-VLAGG 218
             +++RDLKPEN+L+  +     I++ DFG A  +K         G+P Y+APE +L+ G
Sbjct: 160 LDLIYRDLKPENLLIDQQGY---IQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 214
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           YN+A D W+ GV++Y + +G PPF+     +I++ + +  +RFPS    H S+  +DL+ 
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLR 270
Query: 279 GMLRVDPSTRL-----TAAEVLAHSWMEECEQVA 307
            +L+VD + R         ++  H W    + +A
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIA 304

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score =  150 bits (380), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 146/274 (53%), Gaps = 16/274 (5%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           D++   K LG G FG +     K TG   A K + K ++V ++ +     E  I+  ++ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 100
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
            P +V L+  +++   ++++ME   GGE+F  L + GRFSE  AR     ++    Y H 
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPE-VLAGG 218
             +++RDLKPEN+++  +     IK+ DFG A  +K         G+P Y+APE +L+ G
Sbjct: 161 LDLIYRDLKPENLMIDQQGY---IKVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 215
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           YN+A D W+ GV++Y + +G PPF+     +I++ + +  +RFPS    H S+  +DL+ 
Sbjct: 216 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLR 271
Query: 279 GMLRVDPSTRL-----TAAEVLAHSWMEECEQVA 307
            +L+VD + R         ++  H W    + +A
Sbjct: 272 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIA 305

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 147/274 (53%), Gaps = 16/274 (5%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           D++   K LG G FG +     K +G   A K + K ++V ++ +     E  I+  ++ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 99
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
            P +V L+  +++   ++++ME  AGGE+F  L + GRFSE  AR     ++    Y H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPE-VLAGG 218
             +++RDLKPEN+L+  +     I++ DFG A  +K         G+P Y+APE +L+ G
Sbjct: 160 LDLIYRDLKPENLLIDQQGY---IQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 214
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           YN+A D W+ GV++Y + +G PPF+     +I++ + +  +RFPS    H S+  +DL+ 
Sbjct: 215 YNKAVDWWALGVLIYQMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLR 270
Query: 279 GMLRVDPSTRL-----TAAEVLAHSWMEECEQVA 307
            +L+VD + R         ++  H W    + +A
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIA 304

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 83/260 (31%), Positives = 138/260 (53%), Gaps = 10/260 (3%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           + +G+ LG G+FG +    +K +  +LA K + K +L        ++ E+EI + L  HP
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 68
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
           N++ L   + +   V+L++E    G ++  L+K  +F E         L   +SYCH   
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 128
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGG-YN 220
           V+HRD+KPEN+LL    S+  +K+ADFG + +  + +      G+  Y+ PE++ G  ++
Sbjct: 129 VIHRDIKPENLLLG---SAGELKIADFGWSVHAPSSRRA-ALCGTLDYLPPEMIEGRMHD 184
Query: 221 QAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGM 280
           +  D+WS GV+ Y  L G PPF   T  + +  +   +  FP    D ++  ARDLI  +
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLISRL 240
Query: 281 LRVDPSTRLTAAEVLAHSWM 300
           L+ +PS R    EVL H W+
Sbjct: 241 LKHNPSQRPMLREVLEHPWI 260

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 85/262 (32%), Positives = 140/262 (53%), Gaps = 14/262 (5%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           + +G+ LG G+FG +    +K +  +LA K + K +L        ++ E+EI + L  HP
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 71
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
           N++ L   + +   V+L++E    G ++  L+K  +F E         L   +SYCH   
Sbjct: 72  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 131
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ--NLHGTVGSPFYIAPEVLAGG- 218
           V+HRD+KPEN+LL    S+  +K+ADFG + +  + +   L GT+    Y+ PE++ G  
Sbjct: 132 VIHRDIKPENLLLG---SAGELKIADFGWSVHAPSSRRTTLCGTLD---YLPPEMIEGRM 185
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           +++  D+WS GV+ Y  L G PPF   T  + +  +   +  FP    D ++  ARDLI 
Sbjct: 186 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLIS 241
Query: 279 GMLRVDPSTRLTAAEVLAHSWM 300
            +L+ +PS R    EVL H W+
Sbjct: 242 RLLKHNPSQRPMLREVLEHPWI 263

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 85/262 (32%), Positives = 140/262 (53%), Gaps = 14/262 (5%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           + +G+ LG G+FG +    +K +  +LA K + K +L        ++ E+EI + L  HP
Sbjct: 9   FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 67
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
           N++ L   + +   V+L++E    G ++  L+K  +F E         L   +SYCH   
Sbjct: 68  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 127
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ--NLHGTVGSPFYIAPEVLAGG- 218
           V+HRD+KPEN+LL    S+  +K+ADFG + +  + +   L GT+    Y+ PE++ G  
Sbjct: 128 VIHRDIKPENLLLG---SAGELKIADFGWSVHAPSSRRTTLCGTLD---YLPPEMIEGRM 181
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           +++  D+WS GV+ Y  L G PPF   T  + +  +   +  FP    D ++  ARDLI 
Sbjct: 182 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLIS 237
Query: 279 GMLRVDPSTRLTAAEVLAHSWM 300
            +L+ +PS R    EVL H W+
Sbjct: 238 RLLKHNPSQRPMLREVLEHPWI 259

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 147/274 (53%), Gaps = 16/274 (5%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           D++   K LG G FG +     K +G   A K + K ++V ++ +     E  I+  ++ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 99
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
            P +V L+  +++   ++++ME  AGGE+F  L + GRFSE  AR     ++    Y H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPE-VLAGG 218
             +++RDLKPEN+L+  +     I++ DFG A  +K         G+P Y+APE +L+ G
Sbjct: 160 LDLIYRDLKPENLLIDQQGY---IQVTDFGFAKRVKG--RTWXLXGTPEYLAPEIILSKG 214
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           YN+A D W+ GV++Y + +G PPF+     +I++ + +  +RFPS    H S+  +DL+ 
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLR 270
Query: 279 GMLRVDPSTRL-----TAAEVLAHSWMEECEQVA 307
            +L+VD + R         ++  H W    + +A
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIA 304

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 83/260 (31%), Positives = 137/260 (52%), Gaps = 10/260 (3%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           + +G+ LG G+FG +    +K +  +LA K + K +L        ++ E+EI + L  HP
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 68
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
           N++ L   + +   V+L++E    G ++  L+K  +F E         L   +SYCH   
Sbjct: 69  NILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKK 128
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGG-YN 220
           V+HRD+KPEN+LL    S+  +K+ADFG + +  + +      G+  Y+ PE++ G  ++
Sbjct: 129 VIHRDIKPENLLLG---SAGELKIADFGWSVHAPSSRRA-ALCGTLDYLPPEMIEGRMHD 184
Query: 221 QAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGM 280
           +  D+WS GV+ Y  L G PPF   T    +  +   +  FP    D ++  ARDLI  +
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEFTFP----DFVTEGARDLISRL 240
Query: 281 LRVDPSTRLTAAEVLAHSWM 300
           L+ +PS R    EVL H W+
Sbjct: 241 LKHNPSQRPMLREVLEHPWI 260

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 85/262 (32%), Positives = 140/262 (53%), Gaps = 14/262 (5%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           + +G+ LG G+FG +    +K +  +LA K + K +L        ++ E+EI + L  HP
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 68
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
           N++ L   + +   V+L++E    G ++  L+K  +F E         L   +SYCH   
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 128
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN--LHGTVGSPFYIAPEVLAGG- 218
           V+HRD+KPEN+LL    S+  +K+ADFG + +  + +   L GT+    Y+ PE++ G  
Sbjct: 129 VIHRDIKPENLLLG---SAGELKIADFGWSVHAPSSRRTXLCGTLD---YLPPEMIEGRM 182
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           +++  D+WS GV+ Y  L G PPF   T  + +  +   +  FP    D ++  ARDLI 
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLIS 238
Query: 279 GMLRVDPSTRLTAAEVLAHSWM 300
            +L+ +PS R    EVL H W+
Sbjct: 239 RLLKHNPSQRPMLREVLEHPWI 260

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 146/274 (53%), Gaps = 16/274 (5%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           D++   K LG G FG +     K TG   A K + K ++V ++ +     E  I+  ++ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 100
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
            P +V L+  +++   ++++ME   GGE+F  L + GRFSE  AR     ++    Y H 
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPE-VLAGG 218
             +++RDLKPEN+L+  +     I++ DFG A  +K         G+P Y+APE +L+ G
Sbjct: 161 LDLIYRDLKPENLLIDQQGY---IQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 215
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           YN+A D W+ GV++Y + +G PPF+     +I++ + +  +RFPS    H S+  +DL+ 
Sbjct: 216 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLR 271
Query: 279 GMLRVDPSTRL-----TAAEVLAHSWMEECEQVA 307
            +L+VD + R         ++  H W    + +A
Sbjct: 272 NLLQVDLTKRFGNLKNGVNDIXNHKWFATTDWIA 305

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 85/262 (32%), Positives = 140/262 (53%), Gaps = 14/262 (5%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           + +G+ LG G+FG +    +K +  +LA K + K +L        ++ E+EI + L  HP
Sbjct: 14  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 72
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
           N++ L   + +   V+L++E    G ++  L+K  +F E         L   +SYCH   
Sbjct: 73  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 132
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ--NLHGTVGSPFYIAPEVLAGG- 218
           V+HRD+KPEN+LL    S+  +K+ADFG + +  + +   L GT+    Y+ PE++ G  
Sbjct: 133 VIHRDIKPENLLLG---SAGELKIADFGWSVHAPSSRRTTLCGTLD---YLPPEMIEGRM 186
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           +++  D+WS GV+ Y  L G PPF   T  + +  +   +  FP    D ++  ARDLI 
Sbjct: 187 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLIS 242
Query: 279 GMLRVDPSTRLTAAEVLAHSWM 300
            +L+ +PS R    EVL H W+
Sbjct: 243 RLLKHNPSQRPMLREVLEHPWI 264

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 85/262 (32%), Positives = 140/262 (53%), Gaps = 14/262 (5%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           + +G+ LG G+FG +    +K +  +LA K + K +L        ++ E+EI + L  HP
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 71
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
           N++ L   + +   V+L++E    G ++  L+K  +F E         L   +SYCH   
Sbjct: 72  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 131
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN--LHGTVGSPFYIAPEVLAGG- 218
           V+HRD+KPEN+LL    S+  +K+ADFG + +  + +   L GT+    Y+ PE++ G  
Sbjct: 132 VIHRDIKPENLLLG---SAGELKIADFGWSVHAPSSRRXXLCGTLD---YLPPEMIEGRM 185
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           +++  D+WS GV+ Y  L G PPF   T  + +  +   +  FP    D ++  ARDLI 
Sbjct: 186 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLIS 241
Query: 279 GMLRVDPSTRLTAAEVLAHSWM 300
            +L+ +PS R    EVL H W+
Sbjct: 242 RLLKHNPSQRPMLREVLEHPWI 263

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 85/262 (32%), Positives = 140/262 (53%), Gaps = 14/262 (5%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           + +G+ LG G+FG +    +K +  +LA K + K +L        ++ E+EI + L  HP
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 68
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
           N++ L   + +   V+L++E    G ++  L+K  +F E         L   +SYCH   
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 128
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN--LHGTVGSPFYIAPEVLAGG- 218
           V+HRD+KPEN+LL    S+  +K+ADFG + +  + +   L GT+    Y+ PE++ G  
Sbjct: 129 VIHRDIKPENLLLG---SAGELKIADFGWSVHAPSSRRXXLCGTLD---YLPPEMIEGRM 182
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           +++  D+WS GV+ Y  L G PPF   T  + +  +   +  FP    D ++  ARDLI 
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLIS 238
Query: 279 GMLRVDPSTRLTAAEVLAHSWM 300
            +L+ +PS R    EVL H W+
Sbjct: 239 RLLKHNPSQRPMLREVLEHPWI 260

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 147/274 (53%), Gaps = 16/274 (5%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           D++   K LG G FG +     K +G   A K + K ++V ++ +     E  I+  ++ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 99
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
            P +V L+  +++   ++++ME  AGGE+F  L + GRFSE  AR     ++    Y H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPE-VLAGG 218
             +++RDLKPEN+L+  +     I++ DFG A  +K         G+P Y+APE +L+ G
Sbjct: 160 LDLIYRDLKPENLLIDQQGY---IQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 214
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           YN+A D W+ GV++Y + +G PPF+     +I++ + +  +RFPS    H S+  +DL+ 
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLR 270
Query: 279 GMLRVDPSTRL-----TAAEVLAHSWMEECEQVA 307
            +L+VD + R         ++  H W    + +A
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIA 304

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 147/274 (53%), Gaps = 16/274 (5%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           D++   K LG G FG +     K +G   A K + K ++V ++ +     E  I+  ++ 
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 120
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
            P +V L+  +++   ++++ME  AGGE+F  L + GRFSE  AR     ++    Y H 
Sbjct: 121 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 180
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPE-VLAGG 218
             +++RDLKPEN+L+  +     I++ DFG A  +K         G+P Y+APE +L+ G
Sbjct: 181 LDLIYRDLKPENLLIDQQGY---IQVTDFGFAKRVKGAT--WTLCGTPEYLAPEIILSKG 235
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           YN+A D W+ GV++Y + +G PPF+     +I++ + +  +RFPS    H S+  +DL+ 
Sbjct: 236 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLR 291
Query: 279 GMLRVDPSTRL-----TAAEVLAHSWMEECEQVA 307
            +L+VD + R         ++  H W    + +A
Sbjct: 292 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIA 325

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 147/274 (53%), Gaps = 16/274 (5%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           D++   K LG G FG +     K +G   A K + K ++V ++ +     E  I+  ++ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 99
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
            P +V L+  +++   ++++ME  AGGE+F  L + GRFSE  AR     ++    Y H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPE-VLAGG 218
             +++RDLKPEN+L+  +     I++ DFG A  +K         G+P Y+APE +L+ G
Sbjct: 160 LDLIYRDLKPENLLIDQQGY---IQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 214
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           YN+A D W+ GV++Y + +G PPF+     +I++ + +  +RFPS    H S+  +DL+ 
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLR 270
Query: 279 GMLRVDPSTRL-----TAAEVLAHSWMEECEQVA 307
            +L+VD + R         ++  H W    + +A
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIA 304

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 147/274 (53%), Gaps = 16/274 (5%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           D++   K LG G FG +     K +G   A K + K ++V ++ +     E  I+  ++ 
Sbjct: 42  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 100
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
            P +V L+  +++   ++++ME  AGGE+F  L + GRFSE  AR     ++    Y H 
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPE-VLAGG 218
             +++RDLKPEN+L+  +     I++ DFG A  +K         G+P Y+APE +L+ G
Sbjct: 161 LDLIYRDLKPENLLIDQQGY---IQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 215
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           YN+A D W+ GV++Y + +G PPF+     +I++ + +  +RFPS    H S+  +DL+ 
Sbjct: 216 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLR 271
Query: 279 GMLRVDPSTRL-----TAAEVLAHSWMEECEQVA 307
            +L+VD + R         ++  H W    + +A
Sbjct: 272 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIA 305

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 93/262 (35%), Positives = 135/262 (51%), Gaps = 10/262 (3%)
Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
           RY+ G+ LG G F    E +D  T EV A K + K  L+       +  EI I   L  +
Sbjct: 27  RYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLD-N 85
Query: 101 PNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGN 160
           P+VV     +E++D+V++++E+C    L    ++    +E EAR   R  +Q V Y H N
Sbjct: 86  PHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNN 145
Query: 161 GVVHRDLKPENILLATKSSSSPIKLADFGLATYIK-AGQNLHGTVGSPFYIAPEVL-AGG 218
            V+HRDLK  N+ L   +    +K+ DFGLAT I+  G+      G+P YIAPEVL   G
Sbjct: 146 RVIHRDLKLGNLFL---NDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKG 202
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           ++   D+WS G ILY LL G PPF      + +  ++  +   P     HI+  A  LI 
Sbjct: 203 HSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPR----HINPVASALIR 258
Query: 279 GMLRVDPSTRLTAAEVLAHSWM 300
            ML  DP+ R + AE+L   + 
Sbjct: 259 RMLHADPTLRPSVAELLTDEFF 280

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score =  150 bits (378), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 146/274 (53%), Gaps = 16/274 (5%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           D++   K LG G FG +     K TG   A K + K ++V ++ +     E  I+  ++ 
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 92
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
            P +V L+  +++   ++++ME   GGE+F  L + GRFSE  AR     ++    Y H 
Sbjct: 93  FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 152
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPE-VLAGG 218
             +++RDLKPEN+L+  +     I++ DFG A  +K         G+P Y+APE +L+ G
Sbjct: 153 LDLIYRDLKPENLLIDQQGY---IQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 207
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           YN+A D W+ GV++Y + +G PPF+     +I++ + +  +RFPS    H S+  +DL+ 
Sbjct: 208 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLR 263
Query: 279 GMLRVDPSTRL-----TAAEVLAHSWMEECEQVA 307
            +L+VD + R         ++  H W    + +A
Sbjct: 264 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIA 297

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score =  150 bits (378), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 147/274 (53%), Gaps = 16/274 (5%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           D++   K LG G FG +     K +G   A K + K ++V ++ +     E  I+  ++ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 99
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
            P +V L+  +++   ++++ME  AGGE+F  L + GRFSE  AR     ++    Y H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPE-VLAGG 218
             +++RDLKPEN+L+  +     I++ DFG A  +K         G+P Y+APE +L+ G
Sbjct: 160 LDLIYRDLKPENLLIDQQGY---IQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 214
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           YN+A D W+ GV++Y + +G PPF+     +I++ + +  +RFPS    H S+  +DL+ 
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADEPIQIYEKIVSGKVRFPS----HFSSDLKDLLR 270
Query: 279 GMLRVDPSTRL-----TAAEVLAHSWMEECEQVA 307
            +L+VD + R         ++  H W    + +A
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIA 304

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  150 bits (378), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 89/284 (31%), Positives = 148/284 (52%), Gaps = 19/284 (6%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           + +G+ LG G+FG +    +K +  +LA K + K +L        ++ E+EI + L  HP
Sbjct: 12  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 70
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
           N++ L   + +   V+L++E    G ++  L+K  +F E         L   +SYCH   
Sbjct: 71  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 130
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ--NLHGTVGSPFYIAPEVLAGG- 218
           V+HRD+KPEN+LL    S+  +K+A+FG + +  + +   L GT+    Y+ PE++ G  
Sbjct: 131 VIHRDIKPENLLLG---SAGELKIANFGWSVHAPSSRRTTLCGTLD---YLPPEMIEGRM 184
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           +++  D+WS GV+ Y  L G PPF   T  + +  +   +  FP    D ++  ARDLI 
Sbjct: 185 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLIS 240
Query: 279 GMLRVDPSTRLTAAEVLAHSWMEECEQVAQKP--CKQDDLCCKQ 320
            +L+ +PS R    EVL H W+      + KP  C+  +   KQ
Sbjct: 241 RLLKHNPSQRPMLREVLEHPWITAN---SSKPSNCQNKESASKQ 281

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  150 bits (378), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 147/274 (53%), Gaps = 16/274 (5%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           D++   K LG G FG +     K +G   A K + K ++V ++ +     E  I+  ++ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 99
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
            P +V L+  +++   ++++ME  AGGE+F  L + GRFSE  AR     ++    Y H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPE-VLAGG 218
             +++RDLKPEN+L+  +     I++ DFG A  +K         G+P Y+APE +L+ G
Sbjct: 160 LDLIYRDLKPENLLIDQQGY---IQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 214
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           YN+A D W+ GV++Y + +G PPF+     +I++ + +  +RFPS    H S+  +DL+ 
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLR 270
Query: 279 GMLRVDPSTRL-----TAAEVLAHSWMEECEQVA 307
            +L+VD + R         ++  H W    + +A
Sbjct: 271 NLLQVDLTKRFGNLPNGVNDIKNHKWFATTDWIA 304

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  150 bits (378), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 147/274 (53%), Gaps = 16/274 (5%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           D++   K LG G FG +       TG   A K + K ++V ++++     E  I+  ++ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVN- 99
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
            P +V L+  +++   ++++ME   GGE+F  L + GRFSE  AR     ++    Y H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPE-VLAGG 218
             +++RDLKPEN+++  +     IK+ DFGLA  +K         G+P Y+APE +L+ G
Sbjct: 160 LDLIYRDLKPENLMIDQQGY---IKVTDFGLAKRVKG--RTWXLCGTPEYLAPEIILSKG 214
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           YN+A D W+ GV++Y + +G PPF+     +I++ + +  +RFPS    H S+  +DL+ 
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLR 270
Query: 279 GMLRVDPSTRL-----TAAEVLAHSWMEECEQVA 307
            +L+VD + R         ++  H W    + +A
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIA 304

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score =  150 bits (378), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 93/262 (35%), Positives = 135/262 (51%), Gaps = 10/262 (3%)
Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
           RY+ G+ LG G F    E +D  T EV A K + K  L+       +  EI I   L  +
Sbjct: 43  RYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLD-N 101
Query: 101 PNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGN 160
           P+VV     +E++D+V++++E+C    L    ++    +E EAR   R  +Q V Y H N
Sbjct: 102 PHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNN 161
Query: 161 GVVHRDLKPENILLATKSSSSPIKLADFGLATYIK-AGQNLHGTVGSPFYIAPEVL-AGG 218
            V+HRDLK  N+ L   +    +K+ DFGLAT I+  G+      G+P YIAPEVL   G
Sbjct: 162 RVIHRDLKLGNLFL---NDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKG 218
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           ++   D+WS G ILY LL G PPF      + +  ++  +   P     HI+  A  LI 
Sbjct: 219 HSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPR----HINPVASALIR 274
Query: 279 GMLRVDPSTRLTAAEVLAHSWM 300
            ML  DP+ R + AE+L   + 
Sbjct: 275 RMLHADPTLRPSVAELLTDEFF 296

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score =  150 bits (378), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 146/274 (53%), Gaps = 16/274 (5%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           D++   K LG G FG +     K TG   A K + K ++V ++ +     E  I+  ++ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 100
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
            P +V L+  +++   ++++ME   GGE+F  L + GRFSE  AR     ++    Y H 
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPE-VLAGG 218
             +++RDLKPEN+L+  +     I++ DFG A  +K         G+P Y+APE +L+ G
Sbjct: 161 LDLIYRDLKPENLLIDQQGY---IQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 215
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           YN+A D W+ GV++Y + +G PPF+     +I++ + +  +RFPS    H S+  +DL+ 
Sbjct: 216 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLR 271
Query: 279 GMLRVDPSTRL-----TAAEVLAHSWMEECEQVA 307
            +L+VD + R         ++  H W    + +A
Sbjct: 272 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIA 305

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score =  150 bits (378), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 146/274 (53%), Gaps = 16/274 (5%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           D++   K LG G FG +     K TG   A K + K ++V ++ +     E  I+  ++ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 100
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
            P +V L+  +++   ++++ME   GGE+F  L + GRFSE  AR     ++    Y H 
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPE-VLAGG 218
             +++RDLKPEN+L+  +     I++ DFG A  +K         G+P Y+APE +L+ G
Sbjct: 161 LDLIYRDLKPENLLIDQQGY---IQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 215
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           YN+A D W+ GV++Y + +G PPF+     +I++ + +  +RFPS    H S+  +DL+ 
Sbjct: 216 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLR 271
Query: 279 GMLRVDPSTRL-----TAAEVLAHSWMEECEQVA 307
            +L+VD + R         ++  H W    + +A
Sbjct: 272 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIA 305

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score =  150 bits (378), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 146/274 (53%), Gaps = 16/274 (5%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           D++   K LG G FG +     K TG   A K + K ++V ++ +     E  I+  ++ 
Sbjct: 62  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 120
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
            P +V L+  +++   ++++ME   GGE+F  L + GRFSE  AR     ++    Y H 
Sbjct: 121 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 180
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPE-VLAGG 218
             +++RDLKPEN+L+  +     I++ DFG A  +K         G+P Y+APE +L+ G
Sbjct: 181 LDLIYRDLKPENLLIDQQGY---IQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 235
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           YN+A D W+ GV++Y + +G PPF+     +I++ + +  +RFPS    H S+  +DL+ 
Sbjct: 236 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLR 291
Query: 279 GMLRVDPSTRL-----TAAEVLAHSWMEECEQVA 307
            +L+VD + R         ++  H W    + +A
Sbjct: 292 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIA 325

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score =  149 bits (377), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 93/262 (35%), Positives = 135/262 (51%), Gaps = 10/262 (3%)
Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
           RY+ G+ LG G F    E +D  T EV A K + K  L+       +  EI I   L  +
Sbjct: 43  RYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLD-N 101
Query: 101 PNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGN 160
           P+VV     +E++D+V++++E+C    L    ++    +E EAR   R  +Q V Y H N
Sbjct: 102 PHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNN 161
Query: 161 GVVHRDLKPENILLATKSSSSPIKLADFGLATYIK-AGQNLHGTVGSPFYIAPEVL-AGG 218
            V+HRDLK  N+ L   +    +K+ DFGLAT I+  G+      G+P YIAPEVL   G
Sbjct: 162 RVIHRDLKLGNLFL---NDDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAPEVLCKKG 218
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           ++   D+WS G ILY LL G PPF      + +  ++  +   P     HI+  A  LI 
Sbjct: 219 HSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPR----HINPVASALIR 274
Query: 279 GMLRVDPSTRLTAAEVLAHSWM 300
            ML  DP+ R + AE+L   + 
Sbjct: 275 RMLHADPTLRPSVAELLTDEFF 296

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score =  149 bits (377), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 93/262 (35%), Positives = 135/262 (51%), Gaps = 10/262 (3%)
Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
           RY+ G+ LG G F    E +D  T EV A K + K  L+       +  EI I   L  +
Sbjct: 43  RYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLD-N 101
Query: 101 PNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGN 160
           P+VV     +E++D+V++++E+C    L    ++    +E EAR   R  +Q V Y H N
Sbjct: 102 PHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNN 161
Query: 161 GVVHRDLKPENILLATKSSSSPIKLADFGLATYIK-AGQNLHGTVGSPFYIAPEVL-AGG 218
            V+HRDLK  N+ L   +    +K+ DFGLAT I+  G+      G+P YIAPEVL   G
Sbjct: 162 RVIHRDLKLGNLFL---NDDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAPEVLCKKG 218
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           ++   D+WS G ILY LL G PPF      + +  ++  +   P     HI+  A  LI 
Sbjct: 219 HSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPR----HINPVASALIR 274
Query: 279 GMLRVDPSTRLTAAEVLAHSWM 300
            ML  DP+ R + AE+L   + 
Sbjct: 275 RMLHADPTLRPSVAELLTDEFF 296

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score =  149 bits (377), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 147/274 (53%), Gaps = 16/274 (5%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           D++   K LG G FG +     K +G   A K + K ++V ++ +     E  I+  ++ 
Sbjct: 28  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 86
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
            P +V L+  +++   ++++ME  AGGE+F  L + GRFSE  AR     ++    Y H 
Sbjct: 87  FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 146
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPE-VLAGG 218
             +++RDLKPEN+L+  +     I++ DFG A  +K         G+P Y+APE +L+ G
Sbjct: 147 LDLIYRDLKPENLLIDEQGY---IQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 201
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           YN+A D W+ GV++Y + +G PPF+     +I++ + +  +RFPS    H S+  +DL+ 
Sbjct: 202 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLR 257
Query: 279 GMLRVDPSTRL-----TAAEVLAHSWMEECEQVA 307
            +L+VD + R         ++  H W    + +A
Sbjct: 258 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIA 291

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score =  149 bits (377), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 146/274 (53%), Gaps = 16/274 (5%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           D++   + LG G FG +     K TG   A K + K ++V ++ +     E  I   ++ 
Sbjct: 42  DQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVN- 100
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
            P +V L+  +++   +++++E   GGE+F  L + GRFSE  AR     ++    Y H 
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPE-VLAGG 218
             +++RDLKPEN+L+  +     IK+ADFG A  +K         G+P Y+APE +L+ G
Sbjct: 161 LDLIYRDLKPENLLIDQQGY---IKVADFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 215
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           YN+A D W+ GV++Y + +G PPF+     +I++ + +  +RFPS    H S+  +DL+ 
Sbjct: 216 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLR 271
Query: 279 GMLRVDPSTRL-----TAAEVLAHSWMEECEQVA 307
            +L+VD + R         ++  H W    + +A
Sbjct: 272 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIA 305

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  149 bits (377), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 85/262 (32%), Positives = 139/262 (53%), Gaps = 14/262 (5%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           + +G+ LG G+FG +    +K    +LA K + K +L        ++ E+EI + L  HP
Sbjct: 7   FEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 65
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
           N++ L   + +   V+L++E    G ++  L+K  +F E         L   +SYCH   
Sbjct: 66  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 125
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ--NLHGTVGSPFYIAPEVLAGG- 218
           V+HRD+KPEN+LL    S+  +K+ADFG + +  + +   L GT+    Y+ PE++ G  
Sbjct: 126 VIHRDIKPENLLLG---SAGELKIADFGWSVHAPSSRRTTLCGTLD---YLPPEMIEGRM 179
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           +++  D+WS GV+ Y  L G PPF   T  + +  +   +  FP    D ++  ARDLI 
Sbjct: 180 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLIS 235
Query: 279 GMLRVDPSTRLTAAEVLAHSWM 300
            +L+ +PS R    EVL H W+
Sbjct: 236 RLLKHNPSQRPMLREVLEHPWI 257

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score =  149 bits (376), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 146/274 (53%), Gaps = 16/274 (5%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           D++   K +G G FG +       TG   A K + K ++V ++ +     E  I+  ++ 
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 99
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
            P +V L+  +++   ++++ME   GGE+F  L + GRFSE  AR     ++    Y H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPE-VLAGG 218
             +++RDLKPEN+L+  +     IK+ADFG A  +K         G+P Y+APE +L+ G
Sbjct: 160 LDLIYRDLKPENLLIDQQGY---IKVADFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 214
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           YN+A D W+ GV++Y + +G PPF+     +I++ + +  +RFPS    H S+  +DL+ 
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLR 270
Query: 279 GMLRVDPSTRL-----TAAEVLAHSWMEECEQVA 307
            +L+VD + R         ++  H W    + +A
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIA 304

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score =  149 bits (376), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 146/274 (53%), Gaps = 16/274 (5%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           D++   K LG G FG +       TG   A K + K ++V ++ +     E  I+  ++ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 99
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
            P +V L+  +++   ++++ME  AGGE+F  L + GRFSE  AR     ++    Y H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPE-VLAGG 218
             +++RDLKPEN+L+  +     I++ DFG A  +K         G+P Y+APE +L+ G
Sbjct: 160 LDLIYRDLKPENLLIDQQGY---IQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 214
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           YN+A D W+ GV++Y + +G PPF+     +I++ + +  +RFPS    H S+  +DL+ 
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLR 270
Query: 279 GMLRVDPSTRL-----TAAEVLAHSWMEECEQVA 307
            +L+VD + R         ++  H W    + +A
Sbjct: 271 NLLQVDLTKRFGNLKDGVNDIKNHKWFATTDWIA 304

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  149 bits (376), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 84/262 (32%), Positives = 140/262 (53%), Gaps = 14/262 (5%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           + +G+ LG G+FG +    +K +  +LA K + K +L        ++ E+EI + L  HP
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 71
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
           N++ L   + +   V+L++E    G ++  L+K  +F E         L   +SYCH   
Sbjct: 72  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 131
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN--LHGTVGSPFYIAPEVLAGG- 218
           V+HRD+KPEN+LL    S+  +K+A+FG + +  + +   L GT+    Y+ PE++ G  
Sbjct: 132 VIHRDIKPENLLLG---SAGELKIANFGWSVHAPSSRRTTLCGTLD---YLPPEMIEGRM 185
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           +++  D+WS GV+ Y  L G PPF   T  + +  +   +  FP    D ++  ARDLI 
Sbjct: 186 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLIS 241
Query: 279 GMLRVDPSTRLTAAEVLAHSWM 300
            +L+ +PS R    EVL H W+
Sbjct: 242 RLLKHNPSQRPMLREVLEHPWI 263

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score =  149 bits (376), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 84/274 (30%), Positives = 147/274 (53%), Gaps = 16/274 (5%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           D++   K LG G FG +     K +G   A K + K ++V ++ +     E  I+  ++ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 99
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
            P +V L+  +++   ++++ME  AGGE+F  L + GRF+E  AR     ++    Y H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVLTFEYLHS 159
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPE-VLAGG 218
             +++RDLKPEN+L+  +     I++ DFG A  +K         G+P Y+APE +L+ G
Sbjct: 160 LDLIYRDLKPENLLIDQQGY---IQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 214
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           YN+A D W+ GV++Y + +G PPF+     +I++ + +  +RFPS    H S+  +DL+ 
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLR 270
Query: 279 GMLRVDPSTRL-----TAAEVLAHSWMEECEQVA 307
            +L+VD + R         ++  H W    + +A
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIA 304

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  148 bits (374), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 84/274 (30%), Positives = 146/274 (53%), Gaps = 16/274 (5%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           D++   K LG G FG +     K +G   A K + K ++V ++ +     E  I+  ++ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 99
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
            P +V L+  +++   ++++ME  AGGE+F  L + GRF E  AR     ++    Y H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPE-VLAGG 218
             +++RDLKPEN+L+  +     I++ DFG A  +K         G+P Y+APE +L+ G
Sbjct: 160 LDLIYRDLKPENLLIDQQGY---IQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 214
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           YN+A D W+ GV++Y + +G PPF+     +I++ + +  +RFPS    H S+  +DL+ 
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLR 270
Query: 279 GMLRVDPSTRL-----TAAEVLAHSWMEECEQVA 307
            +L+VD + R         ++  H W    + +A
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIA 304

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score =  148 bits (374), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 84/274 (30%), Positives = 146/274 (53%), Gaps = 16/274 (5%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           D++   K LG G FG +     K +G   A K + K ++V ++ +     E  I+  ++ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 99
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
            P +V L+  +++   ++++ME  AGGE+F  L + GRF E  AR     ++    Y H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPE-VLAGG 218
             +++RDLKPEN+L+  +     I++ DFG A  +K         G+P Y+APE +L+ G
Sbjct: 160 LDLIYRDLKPENLLIDQQGY---IQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 214
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           YN+A D W+ GV++Y + +G PPF+     +I++ + +  +RFPS    H S+  +DL+ 
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLR 270
Query: 279 GMLRVDPSTRL-----TAAEVLAHSWMEECEQVA 307
            +L+VD + R         ++  H W    + +A
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIA 304

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  148 bits (374), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 95/276 (34%), Positives = 145/276 (52%), Gaps = 15/276 (5%)
Query: 28  TILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSI 87
           ++ D   I N    Y + K LG G FG ++      TG+ +A K I K  L   +    I
Sbjct: 6   SLADGAHIGN----YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRI 61
Query: 88  KLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIF 147
           + EI  + +L  HP+++ L  V + +D + +++E  AG ELF  + +  + SE EAR  F
Sbjct: 62  EREISYL-RLLRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFF 119
Query: 148 RHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSP 207
           + ++  V YCH + +VHRDLKPEN+LL    +   +K+ADFGL+  +  G  L  + GSP
Sbjct: 120 QQIISAVEYCHRHKIVHRDLKPENLLLDEHLN---VKIADFGLSNIMTDGNFLKTSCGSP 176
Query: 208 FYIAPEVLAGGY--NQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDP 265
            Y APEV++G        DVWS GVILY++L    PF  ++   +F  +       P   
Sbjct: 177 NYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPK-- 234
Query: 266 WDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWME 301
              +S  A  LI  ML V+P  R++  E++   W +
Sbjct: 235 --FLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFK 268

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score =  148 bits (374), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 84/274 (30%), Positives = 147/274 (53%), Gaps = 16/274 (5%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           D++   K LG G FG +       TG   A K + K ++V ++++     E  I+  ++ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVN- 99
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
            P +V L+  +++   ++++ME   GGE+F  L + GRFSE  AR     ++    Y H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPE-VLAGG 218
             +++RDLKPEN+++  +     I++ DFGLA  +K         G+P Y+APE +L+ G
Sbjct: 160 LDLIYRDLKPENLMIDQQGY---IQVTDFGLAKRVKG--RTWXLCGTPEYLAPEIILSKG 214
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           YN+A D W+ GV++Y + +G PPF+     +I++ + +  +RFPS    H S+  +DL+ 
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLR 270
Query: 279 GMLRVDPSTRL-----TAAEVLAHSWMEECEQVA 307
            +L+VD + R         ++  H W    + +A
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIA 304

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score =  148 bits (374), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 84/274 (30%), Positives = 146/274 (53%), Gaps = 16/274 (5%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           D++   K LG G FG +     K +G   A K + K ++V ++ +     E  I+  ++ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 99
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
            P +V L+  +++   ++++ME  AGGE+F  L + GRF E  AR     ++    Y H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPE-VLAGG 218
             +++RDLKPEN+L+  +     I++ DFG A  +K         G+P Y+APE +L+ G
Sbjct: 160 LDLIYRDLKPENLLIDQQGY---IQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 214
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           YN+A D W+ GV++Y + +G PPF+     +I++ + +  +RFPS    H S+  +DL+ 
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLR 270
Query: 279 GMLRVDPSTRL-----TAAEVLAHSWMEECEQVA 307
            +L+VD + R         ++  H W    + +A
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIA 304

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  148 bits (374), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 95/276 (34%), Positives = 145/276 (52%), Gaps = 15/276 (5%)
Query: 28  TILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSI 87
           ++ D   I N    Y + K LG G FG ++      TG+ +A K I K  L   +    I
Sbjct: 5   SLADGAHIGN----YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRI 60
Query: 88  KLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIF 147
           + EI  + +L  HP+++ L  V + +D + +++E  AG ELF  + +  + SE EAR  F
Sbjct: 61  EREISYL-RLLRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFF 118
Query: 148 RHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSP 207
           + ++  V YCH + +VHRDLKPEN+LL    +   +K+ADFGL+  +  G  L  + GSP
Sbjct: 119 QQIISAVEYCHRHKIVHRDLKPENLLLDEHLN---VKIADFGLSNIMTDGNFLKTSCGSP 175
Query: 208 FYIAPEVLAGGY--NQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDP 265
            Y APEV++G        DVWS GVILY++L    PF  ++   +F  +       P   
Sbjct: 176 NYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPK-- 233
Query: 266 WDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWME 301
              +S  A  LI  ML V+P  R++  E++   W +
Sbjct: 234 --FLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFK 267

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score =  148 bits (374), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 84/274 (30%), Positives = 146/274 (53%), Gaps = 16/274 (5%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           D++   K LG G FG +     K +G   A K + K ++V ++ +     E  I+  ++ 
Sbjct: 36  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 94
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
            P +V L+  +++   ++++ME  AGGE+F  L + GRF E  AR     ++    Y H 
Sbjct: 95  FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 154
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPE-VLAGG 218
             +++RDLKPEN+L+  +     I++ DFG A  +K         G+P Y+APE +L+ G
Sbjct: 155 LDLIYRDLKPENLLIDQQGY---IQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 209
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           YN+A D W+ GV++Y + +G PPF+     +I++ + +  +RFPS    H S+  +DL+ 
Sbjct: 210 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLR 265
Query: 279 GMLRVDPSTRL-----TAAEVLAHSWMEECEQVA 307
            +L+VD + R         ++  H W    + +A
Sbjct: 266 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIA 299

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score =  148 bits (374), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 84/274 (30%), Positives = 146/274 (53%), Gaps = 16/274 (5%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           D++   K LG G FG +     K +G   A K + K ++V ++ +     E  I+  ++ 
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 120
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
            P +V L+  +++   ++++ME  AGGE+F  L + GRF E  AR     ++    Y H 
Sbjct: 121 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 180
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPE-VLAGG 218
             +++RDLKPEN+L+  +     I++ DFG A  +K         G+P Y+APE +L+ G
Sbjct: 181 LDLIYRDLKPENLLIDQQGY---IQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 235
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           YN+A D W+ GV++Y + +G PPF+     +I++ + +  +RFPS    H S+  +DL+ 
Sbjct: 236 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLR 291
Query: 279 GMLRVDPSTRL-----TAAEVLAHSWMEECEQVA 307
            +L+VD + R         ++  H W    + +A
Sbjct: 292 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIA 325

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score =  148 bits (373), Expect = 6e-36,   Method: Compositional matrix adjust.
 Identities = 84/274 (30%), Positives = 145/274 (52%), Gaps = 16/274 (5%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           D++   K LG G FG +       TG   A K + K ++V ++ +     E  I+  ++ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 99
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
            P +V L+  +++   ++++ME   GGE+F  L + GRFSE  AR     ++    Y H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPE-VLAGG 218
             +++RDLKPEN+++  +     IK+ DFG A  +K         G+P Y+APE +L+ G
Sbjct: 160 LDLIYRDLKPENLMIDQQGY---IKVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 214
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           YN+A D W+ GV++Y + +G PPF+     +I++ + +  +RFPS    H S+  +DL+ 
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLR 270
Query: 279 GMLRVDPSTRL-----TAAEVLAHSWMEECEQVA 307
            +L+VD + R         ++  H W    + +A
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIA 304

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score =  148 bits (373), Expect = 6e-36,   Method: Compositional matrix adjust.
 Identities = 84/274 (30%), Positives = 145/274 (52%), Gaps = 16/274 (5%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           D++   K LG G FG +     K TG   A K + K ++V ++ +     E  I+  ++ 
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 92
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
            P +V L+  +++   ++++ME   GGE+F  L + GRF E  AR     ++    Y H 
Sbjct: 93  FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 152
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPE-VLAGG 218
             +++RDLKPEN+L+  +     I++ DFG A  +K         G+P Y+APE +L+ G
Sbjct: 153 LDLIYRDLKPENLLIDQQGY---IQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 207
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           YN+A D W+ GV++Y + +G PPF+     +I++ + +  +RFPS    H S+  +DL+ 
Sbjct: 208 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLR 263
Query: 279 GMLRVDPSTRL-----TAAEVLAHSWMEECEQVA 307
            +L+VD + R         ++  H W    + +A
Sbjct: 264 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIA 297

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score =  148 bits (373), Expect = 6e-36,   Method: Compositional matrix adjust.
 Identities = 83/274 (30%), Positives = 147/274 (53%), Gaps = 16/274 (5%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           D++   K LG G FG +     K +G   A K + K ++V ++ +     E  I+  ++ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 99
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
            P +V L+  +++   ++++ME  AGGE+F  L + GRFSE  AR     ++    Y H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPE-VLAGG 218
             +++RDLKPEN+++  +     I++ DFG A  +K         G+P Y+APE +++ G
Sbjct: 160 LDLIYRDLKPENLIIDQQGY---IQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIIISKG 214
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           YN+A D W+ GV++Y + +G PPF+     +I++ + +  +RFPS    H S+  +DL+ 
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLR 270
Query: 279 GMLRVDPSTRL-----TAAEVLAHSWMEECEQVA 307
            +L+VD + R         ++  H W    + +A
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIA 304

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  148 bits (373), Expect = 7e-36,   Method: Compositional matrix adjust.
 Identities = 84/274 (30%), Positives = 146/274 (53%), Gaps = 16/274 (5%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           D++   K LG G FG +     K +G   A K + K ++V ++ +     E  I+  ++ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 99
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
            P +V L+  +++   ++++ME  AGGE+F  L + GRFSE  AR     ++    Y H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPE-VLAGG 218
             +++RDLKPEN+L+  +     I++ DFG A  +K         G+P Y+AP  +L+ G
Sbjct: 160 LDLIYRDLKPENLLIDQQGY---IQVTDFGFAKRVKG--RTWXLCGTPEYLAPAIILSKG 214
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           YN+A D W+ GV++Y + +G PPF+     +I++ + +  +RFPS    H S+  +DL+ 
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLR 270
Query: 279 GMLRVDPSTRL-----TAAEVLAHSWMEECEQVA 307
            +L+VD + R         ++  H W    + +A
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIA 304

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score =  147 bits (372), Expect = 8e-36,   Method: Compositional matrix adjust.
 Identities = 84/274 (30%), Positives = 146/274 (53%), Gaps = 16/274 (5%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           D++   K +G G FG +       TG   A K + K ++V ++ +     E  I+  ++ 
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 99
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
            P +V L+  +++   ++++ME   GG++F  L + GRFSE  AR     ++    Y H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPE-VLAGG 218
             +++RDLKPEN+L+  +     IK+ADFG A  +K         G+P Y+APE +L+ G
Sbjct: 160 LDLIYRDLKPENLLIDQQGY---IKVADFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 214
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           YN+A D W+ GV++Y + +G PPF+     +I++ + +  +RFPS    H S+  +DL+ 
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLR 270
Query: 279 GMLRVDPSTRL-----TAAEVLAHSWMEECEQVA 307
            +L+VD + R         ++  H W    + +A
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIA 304

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score =  147 bits (372), Expect = 8e-36,   Method: Compositional matrix adjust.
 Identities = 84/274 (30%), Positives = 146/274 (53%), Gaps = 16/274 (5%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           D++   K +G G FG +       TG   A K + K ++V ++ +     E  I+  ++ 
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 99
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
            P +V L+  +++   ++++ME   GG++F  L + GRFSE  AR     ++    Y H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPE-VLAGG 218
             +++RDLKPEN+L+  +     IK+ADFG A  +K         G+P Y+APE +L+ G
Sbjct: 160 LDLIYRDLKPENLLIDQQGY---IKVADFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 214
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           YN+A D W+ GV++Y + +G PPF+     +I++ + +  +RFPS    H S+  +DL+ 
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLR 270
Query: 279 GMLRVDPSTRL-----TAAEVLAHSWMEECEQVA 307
            +L+VD + R         ++  H W    + +A
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIA 304

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score =  147 bits (372), Expect = 8e-36,   Method: Compositional matrix adjust.
 Identities = 88/258 (34%), Positives = 143/258 (55%), Gaps = 9/258 (3%)
Query: 48  LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLK 107
           LG G+FG + +C +  TG  LA K I K R   ++D   +K EI +M +L  H N++ L 
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAK-IIKTR--GMKDKEEVKNEISVMNQLD-HANLIQLY 152
Query: 108 AVYEEEDYVHLLMELCAGGELFHRL--EKYGRFSETEARVIFRHLMQVVSYCHGNGVVHR 165
             +E ++ + L+ME   GGELF R+  E Y   +E +  +  + + + + + H   ++H 
Sbjct: 153 DAFESKNDIVLVMEYVDGGELFDRIIDESYN-LTELDTILFMKQICEGIRHMHQMYILHL 211
Query: 166 DLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGGY-NQAAD 224
           DLKPENIL   + +   IK+ DFGLA   K  + L    G+P ++APEV+   + +   D
Sbjct: 212 DLKPENILCVNRDAKQ-IKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTD 270
Query: 225 VWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVD 284
           +WS GVI Y+LLSG+ PF G   ++  + + A       + +  IS  A++ I  +L  +
Sbjct: 271 MWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKE 330
Query: 285 PSTRLTAAEVLAHSWMEE 302
            S R++A+E L H W+ +
Sbjct: 331 KSWRISASEALKHPWLSD 348

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  147 bits (372), Expect = 8e-36,   Method: Compositional matrix adjust.
 Identities = 95/273 (34%), Positives = 143/273 (52%), Gaps = 15/273 (5%)
Query: 31  DATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLE 90
           D   I N    Y + K LG G FG ++      TG+ +A K I K  L   +    I+ E
Sbjct: 3   DGAHIGN----YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIERE 58
Query: 91  IEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHL 150
           I  + +L  HP+++ L  V + +D + +++E  AG ELF  + +  + SE EAR  F+ +
Sbjct: 59  ISYL-RLLRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQI 116
Query: 151 MQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYI 210
           +  V YCH + +VHRDLKPEN+LL    +   +K+ADFGL+  +  G  L  + GSP Y 
Sbjct: 117 ISAVEYCHRHKIVHRDLKPENLLLDEHLN---VKIADFGLSNIMTDGNFLKTSCGSPNYA 173
Query: 211 APEVLAGGY--NQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDH 268
           APEV++G        DVWS GVILY++L    PF  ++   +F  +       P      
Sbjct: 174 APEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPK----F 229
Query: 269 ISASARDLIMGMLRVDPSTRLTAAEVLAHSWME 301
           +S  A  LI  ML V+P  R++  E++   W +
Sbjct: 230 LSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFK 262

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score =  147 bits (371), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 84/274 (30%), Positives = 145/274 (52%), Gaps = 16/274 (5%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           D++   K LG G FG +       TG   A K + K ++V ++ +     E  I+  ++ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 99
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
            P +V L+  +++   ++++ME   GGE+F  L + GRFSE  AR     ++    Y H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPE-VLAGG 218
             +++RDLKPEN+L+  +     I++ DFG A  +K         G+P Y+APE +L+ G
Sbjct: 160 LDLIYRDLKPENLLIDQQGY---IQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 214
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           YN+A D W+ GV++Y + +G PPF+     +I++ + +  +RFPS    H S+  +DL+ 
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLR 270
Query: 279 GMLRVDPSTRL-----TAAEVLAHSWMEECEQVA 307
            +L+VD + R         ++  H W    + +A
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIA 304

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score =  147 bits (371), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 84/274 (30%), Positives = 145/274 (52%), Gaps = 16/274 (5%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           D++   K LG G FG +       TG   A K + K ++V ++ +     E  I+  ++ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 99
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
            P +V L+  +++   ++++ME   GGE+F  L + GRFSE  AR     ++    Y H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPE-VLAGG 218
             +++RDLKPEN+L+  +     I++ DFG A  +K         G+P Y+APE +L+ G
Sbjct: 160 LDLIYRDLKPENLLIDQQGY---IQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 214
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           YN+A D W+ GV++Y + +G PPF+     +I++ + +  +RFPS    H S+  +DL+ 
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLR 270
Query: 279 GMLRVDPSTRL-----TAAEVLAHSWMEECEQVA 307
            +L+VD + R         ++  H W    + +A
Sbjct: 271 NLLQVDLTKRFGNLKDGVNDIKNHKWFATTDWIA 304

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score =  147 bits (371), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 84/274 (30%), Positives = 145/274 (52%), Gaps = 16/274 (5%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           D++   K LG G FG +       TG   A K + K ++V ++ +     E  I+  ++ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 100
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
            P +V L+  +++   ++++ME   GGE+F  L + GRFSE  AR     ++    Y H 
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPE-VLAGG 218
             +++RDLKPEN+L+  +     I++ DFG A  +K         G+P Y+APE +L+ G
Sbjct: 161 LDLIYRDLKPENLLIDQQGY---IQVTDFGFAKRVKG--RTWTLCGTPEYLAPEIILSKG 215
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           YN+A D W+ GV++Y + +G PPF+     +I++ + +  +RFPS    H S+  +DL+ 
Sbjct: 216 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLR 271
Query: 279 GMLRVDPSTRL-----TAAEVLAHSWMEECEQVA 307
            +L+VD + R         ++  H W    + +A
Sbjct: 272 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIA 305

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score =  147 bits (371), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 84/274 (30%), Positives = 145/274 (52%), Gaps = 16/274 (5%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           D++   K LG G FG +       TG   A K + K ++V ++ +     E  I+  ++ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 99
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
            P +V L+  +++   ++++ME   GGE+F  L + GRFSE  AR     ++    Y H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPE-VLAGG 218
             +++RDLKPEN+L+  +     I++ DFG A  +K         G+P Y+APE +L+ G
Sbjct: 160 LDLIYRDLKPENLLIDQQGY---IQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 214
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           YN+A D W+ GV++Y + +G PPF+     +I++ + +  +RFPS    H S+  +DL+ 
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLR 270
Query: 279 GMLRVDPSTRL-----TAAEVLAHSWMEECEQVA 307
            +L+VD + R         ++  H W    + +A
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIA 304

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score =  147 bits (371), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 84/274 (30%), Positives = 145/274 (52%), Gaps = 16/274 (5%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           D++   K LG G FG +       TG   A K + K ++V ++ +     E  I+  ++ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 100
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
            P +V L+  +++   ++++ME   GGE+F  L + GRFSE  AR     ++    Y H 
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPE-VLAGG 218
             +++RDLKPEN+L+  +     I++ DFG A  +K         G+P Y+APE +L+ G
Sbjct: 161 LDLIYRDLKPENLLIDQQGY---IQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 215
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           YN+A D W+ GV++Y + +G PPF+     +I++ + +  +RFPS    H S+  +DL+ 
Sbjct: 216 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLR 271
Query: 279 GMLRVDPSTRL-----TAAEVLAHSWMEECEQVA 307
            +L+VD + R         ++  H W    + +A
Sbjct: 272 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIA 305

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  147 bits (371), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 84/274 (30%), Positives = 146/274 (53%), Gaps = 16/274 (5%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           D++   K LG G FG +     K +G   A K + K ++V ++ +     E  I+  ++ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 99
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
            P +V L+  +++   ++++ME  AGGE+F  L + GRFSE  AR     ++    Y H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPE-VLAGG 218
             +++RDLKPEN+L+  +     I++ DFG A  +K         G+P Y+APE +L+ G
Sbjct: 160 LDLIYRDLKPENLLIDQQGY---IQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 214
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           YN+A D W+ GV++Y + +G PPF+     +I++ + +  +RFPS    H S+  +DL+ 
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLR 270
Query: 279 GMLRVDPSTRL-----TAAEVLAHSWMEECEQVA 307
            +L+VD +           ++  H W    + +A
Sbjct: 271 NLLQVDLTKAFGNLKNGVNDIKNHKWFATTDWIA 304

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score =  147 bits (371), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 95/284 (33%), Positives = 151/284 (53%), Gaps = 23/284 (8%)
Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLV-TVEDVRSIKLEIEIMTKLSGHP 101
           VLGK  G+G+   +R+ +   TG++ A K + K  +V   +D    K E  I+ ++  HP
Sbjct: 24  VLGKG-GYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK-HP 81
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
            +VDL   ++    ++L++E  +GGELF +LE+ G F E  A      +   + + H  G
Sbjct: 82  FIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG 141
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGL-ATYIKAGQNLHGTVGSPFYIAPEVLA-GGY 219
           +++RDLKPENI+L   +    +KL DFGL    I  G   H   G+  Y+APE+L   G+
Sbjct: 142 IIYRDLKPENIML---NHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGH 198
Query: 220 NQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMG 279
           N+A D WS G ++Y +L+G PPF G+ + K  D +    L  P     +++  ARDL+  
Sbjct: 199 NRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPP----YLTQEARDLLKK 254
Query: 280 MLRVDPSTRL-----TAAEVLAH------SWMEECEQVAQKPCK 312
           +L+ + ++RL      A EV AH      +W E   +  + P K
Sbjct: 255 LLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFK 298

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score =  147 bits (371), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 84/274 (30%), Positives = 145/274 (52%), Gaps = 16/274 (5%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           D++   K LG G FG +       TG   A K + K ++V ++ +     E  I+  ++ 
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 85
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
            P +V L+  +++   ++++ME   GGE+F  L + GRFSE  AR     ++    Y H 
Sbjct: 86  FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 145
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPE-VLAGG 218
             +++RDLKPEN+L+  +     I++ DFG A  +K         G+P Y+APE +L+ G
Sbjct: 146 LDLIYRDLKPENLLIDQQGY---IQVTDFGFAKRVKG--RTWTLCGTPEYLAPEIILSKG 200
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           YN+A D W+ GV++Y + +G PPF+     +I++ + +  +RFPS    H S+  +DL+ 
Sbjct: 201 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLR 256
Query: 279 GMLRVDPSTRL-----TAAEVLAHSWMEECEQVA 307
            +L+VD + R         ++  H W    + +A
Sbjct: 257 NLLQVDLTKRFGNLKDGVNDIKNHKWFATTDWIA 290

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  147 bits (370), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 92/262 (35%), Positives = 140/262 (53%), Gaps = 11/262 (4%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           Y + K LG G FG ++      TG+ +A K I K  L   +    I+ EI  + +L  HP
Sbjct: 6   YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYL-RLLRHP 64
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
           +++ L  V + +D + +++E  AG ELF  + +  + SE EAR  F+ ++  V YCH + 
Sbjct: 65  HIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK 123
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGGY-- 219
           +VHRDLKPEN+LL    +   +K+ADFGL+  +  G  L  + GSP Y APEV++G    
Sbjct: 124 IVHRDLKPENLLLDEHLN---VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYA 180
Query: 220 NQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMG 279
               DVWS GVILY++L    PF  ++   +F  +       P      +S  A  LI  
Sbjct: 181 GPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPK----FLSPGAAGLIKR 236
Query: 280 MLRVDPSTRLTAAEVLAHSWME 301
           ML V+P  R++  E++   W +
Sbjct: 237 MLIVNPLNRISIHEIMQDDWFK 258

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score =  147 bits (370), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 95/284 (33%), Positives = 151/284 (53%), Gaps = 23/284 (8%)
Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLV-TVEDVRSIKLEIEIMTKLSGHP 101
           VLGK  G+G+   +R+ +   TG++ A K + K  +V   +D    K E  I+ ++  HP
Sbjct: 24  VLGKG-GYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK-HP 81
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
            +VDL   ++    ++L++E  +GGELF +LE+ G F E  A      +   + + H  G
Sbjct: 82  FIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG 141
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGL-ATYIKAGQNLHGTVGSPFYIAPEVLA-GGY 219
           +++RDLKPENI+L   +    +KL DFGL    I  G   H   G+  Y+APE+L   G+
Sbjct: 142 IIYRDLKPENIML---NHQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAPEILMRSGH 198
Query: 220 NQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMG 279
           N+A D WS G ++Y +L+G PPF G+ + K  D +    L  P     +++  ARDL+  
Sbjct: 199 NRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPP----YLTQEARDLLKK 254
Query: 280 MLRVDPSTRL-----TAAEVLAH------SWMEECEQVAQKPCK 312
           +L+ + ++RL      A EV AH      +W E   +  + P K
Sbjct: 255 LLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFK 298

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score =  147 bits (370), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 83/274 (30%), Positives = 145/274 (52%), Gaps = 16/274 (5%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           D++   K LG G FG +       TG   A K + K ++V ++ +     E  I+  ++ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 99
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
            P +V L+  +++   ++++ME   GGE+F  L + GRFSE  AR     ++    Y H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPE-VLAGG 218
             +++RDLKPEN+++  +     I++ DFG A  +K         G+P Y+APE +L+ G
Sbjct: 160 LDLIYRDLKPENLMIDQQGY---IQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 214
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           YN+A D W+ GV++Y + +G PPF+     +I++ + +  +RFPS    H S+  +DL+ 
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLR 270
Query: 279 GMLRVDPSTRL-----TAAEVLAHSWMEECEQVA 307
            +L+VD + R         ++  H W    + +A
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIA 304

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  146 bits (369), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 84/274 (30%), Positives = 146/274 (53%), Gaps = 16/274 (5%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           D++   K LG G FG +     K +G   A K + K ++V ++ +     E  I+  ++ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 99
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
            P +V L+  +++   ++++ME  AGGE+F  L + GRFSE  AR     ++    Y H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPE-VLAGG 218
             +++RDLKPEN+L+  +     I++ DFG A  +K         G+P  +APE +L+ G
Sbjct: 160 LDLIYRDLKPENLLIDQQGY---IQVTDFGFAKRVKG--RTWXLCGTPEALAPEIILSKG 214
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           YN+A D W+ GV++Y + +G PPF+     +I++ + +  +RFPS    H S+  +DL+ 
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLR 270
Query: 279 GMLRVDPSTRL-----TAAEVLAHSWMEECEQVA 307
            +L+VD + R         ++  H W    + +A
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIA 304

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score =  146 bits (369), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 83/274 (30%), Positives = 144/274 (52%), Gaps = 16/274 (5%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           D++   K LG G FG +       TG   A K + K ++V ++ +     E  I+  ++ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 100
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
            P +  L+  +++   ++++ME   GGE+F  L + GRFSE  AR     ++    Y H 
Sbjct: 101 FPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPE-VLAGG 218
             +++RDLKPEN+++  +     IK+ DFG A  +K         G+P Y+APE +L+ G
Sbjct: 161 LDLIYRDLKPENLMIDQQGY---IKVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 215
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           YN+A D W+ GV++Y + +G PPF+     +I++ + +  +RFPS    H S+  +DL+ 
Sbjct: 216 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLR 271
Query: 279 GMLRVDPSTRL-----TAAEVLAHSWMEECEQVA 307
            +L+VD + R         ++  H W    + +A
Sbjct: 272 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIA 305

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score =  146 bits (369), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 83/274 (30%), Positives = 144/274 (52%), Gaps = 16/274 (5%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           D++   K LG G FG +       TG   A K + K ++V ++ +     E  I+  ++ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 100
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
            P +  L+  +++   ++++ME   GGE+F  L + GRFSE  AR     ++    Y H 
Sbjct: 101 FPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPE-VLAGG 218
             +++RDLKPEN+++  +     IK+ DFG A  +K         G+P Y+APE +L+ G
Sbjct: 161 LDLIYRDLKPENLMIDQQGY---IKVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 215
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           YN+A D W+ GV++Y + +G PPF+     +I++ + +  +RFPS    H S+  +DL+ 
Sbjct: 216 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLR 271
Query: 279 GMLRVDPSTRL-----TAAEVLAHSWMEECEQVA 307
            +L+VD + R         ++  H W    + +A
Sbjct: 272 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIA 305

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score =  146 bits (369), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 83/274 (30%), Positives = 144/274 (52%), Gaps = 16/274 (5%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           D++   K LG G FG +       TG   A K + K ++V ++ +     E  I+  ++ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 99
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
            P +V L+  +++   ++++ME   GGE+F  L + GRF E  AR     ++    Y H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPE-VLAGG 218
             +++RDLKPEN+++  +     IK+ DFG A  +K         G+P Y+APE +L+ G
Sbjct: 160 LDLIYRDLKPENLMIDQQGY---IKVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 214
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           YN+A D W+ GV++Y + +G PPF+     +I++ + +  +RFPS    H S+  +DL+ 
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLR 270
Query: 279 GMLRVDPSTRL-----TAAEVLAHSWMEECEQVA 307
            +L+VD + R         ++  H W    + +A
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIA 304

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  145 bits (367), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 83/274 (30%), Positives = 144/274 (52%), Gaps = 16/274 (5%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           D++   K LG G FG +       TG   A K + K ++V ++ +     E  I+  ++ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 99
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
            P +V L+  +++   ++++ME   GGE+F  L + GRF E  AR     ++    Y H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPE-VLAGG 218
             +++RDLKPEN+L+  +     I++ DFG A  +K         G+P Y+APE +L+ G
Sbjct: 160 LDLIYRDLKPENLLIDQQGY---IQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 214
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           YN+A D W+ GV++Y + +G PPF+     +I++ + +  +RFPS    H S+  +DL+ 
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLR 270
Query: 279 GMLRVDPSTRL-----TAAEVLAHSWMEECEQVA 307
            +L+VD + R         ++  H W    + +A
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIA 304

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score =  145 bits (367), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 83/274 (30%), Positives = 144/274 (52%), Gaps = 16/274 (5%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           D++   K LG G FG +       TG   A K + K ++V ++ +     E  I+  ++ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 99
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
            P +V L+  +++   ++++ME   GGE+F  L + GRF E  AR     ++    Y H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPE-VLAGG 218
             +++RDLKPEN+L+  +     I++ DFG A  +K         G+P Y+APE +L+ G
Sbjct: 160 LDLIYRDLKPENLLIDQQGY---IQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 214
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           YN+A D W+ GV++Y + +G PPF+     +I++ + +  +RFPS    H S+  +DL+ 
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLR 270
Query: 279 GMLRVDPSTRL-----TAAEVLAHSWMEECEQVA 307
            +L+VD + R         ++  H W    + +A
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIA 304

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score =  145 bits (367), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 83/274 (30%), Positives = 144/274 (52%), Gaps = 16/274 (5%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           D++   K LG G FG +       TG   A K + K ++V ++ +     E  I+  ++ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 100
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
            P +V L+  +++   ++++ME   GGE+F  L + GRF E  AR     ++    Y H 
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 160
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPE-VLAGG 218
             +++RDLKPEN+L+  +     I++ DFG A  +K         G+P Y+APE +L+ G
Sbjct: 161 LDLIYRDLKPENLLIDQQGY---IQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 215
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           YN+A D W+ GV++Y + +G PPF+     +I++ + +  +RFPS    H S+  +DL+ 
Sbjct: 216 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLR 271
Query: 279 GMLRVDPSTRL-----TAAEVLAHSWMEECEQVA 307
            +L+VD + R         ++  H W    + +A
Sbjct: 272 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIA 305

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  145 bits (365), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 88/261 (33%), Positives = 138/261 (52%), Gaps = 11/261 (4%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           Y++ + LG G FG ++  +   T + +A K I++  L   +    ++ EI  + KL  HP
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYL-KLLRHP 69
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
           +++ L  V      + +++E  AGGELF  + +  R +E E R  F+ ++  + YCH + 
Sbjct: 70  HIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK 128
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGGY-- 219
           +VHRDLKPEN+LL     +  +K+ADFGL+  +  G  L  + GSP Y APEV+ G    
Sbjct: 129 IVHRDLKPENLLL---DDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYA 185
Query: 220 NQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMG 279
               DVWS G++LY++L G  PF  +    +F  V +     P    D +S  A+ LI  
Sbjct: 186 GPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMP----DFLSPGAQSLIRR 241
Query: 280 MLRVDPSTRLTAAEVLAHSWM 300
           M+  DP  R+T  E+    W 
Sbjct: 242 MIVADPMQRITIQEIRRDPWF 262

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score =  145 bits (365), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 87/264 (32%), Positives = 142/264 (53%), Gaps = 14/264 (5%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           D + +G+ LG G+FG +    +K +  ++A K + K ++        ++ EIEI   L  
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLH- 81
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
           HPN++ L   + +   ++L++E    GEL+  L+K   F E     I   L   + YCHG
Sbjct: 82  HPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCHG 141
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA--GQNLHGTVGSPFYIAPEVLAG 217
             V+HRD+KPEN+LL  K       +ADFG + +  +   + + GT+    Y+ PE++ G
Sbjct: 142 KKVIHRDIKPENLLLGLKGELK---IADFGWSVHAPSLRRKTMCGTLD---YLPPEMIEG 195
Query: 218 G-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDL 276
             +N+  D+W  GV+ Y LL G PPF   + ++ +  +   DL+FP+     +   A+DL
Sbjct: 196 RMHNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDLKFPAS----VPTGAQDL 251
Query: 277 IMGMLRVDPSTRLTAAEVLAHSWM 300
           I  +LR +PS RL  A+V AH W+
Sbjct: 252 ISKLLRHNPSERLPLAQVSAHPWV 275

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score =  145 bits (365), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 82/274 (29%), Positives = 143/274 (52%), Gaps = 16/274 (5%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           D++   K LG G FG +       TG   A K + K ++V ++ +     E  I+  ++ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 100
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
            P +  L+  +++   ++++ME   GGE+F  L + GRF E  AR     ++    Y H 
Sbjct: 101 FPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 160
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPE-VLAGG 218
             +++RDLKPEN+++  +     IK+ DFG A  +K         G+P Y+APE +L+ G
Sbjct: 161 LDLIYRDLKPENLMIDQQGY---IKVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 215
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           YN+A D W+ GV++Y + +G PPF+     +I++ + +  +RFPS    H S+  +DL+ 
Sbjct: 216 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLR 271
Query: 279 GMLRVDPSTRL-----TAAEVLAHSWMEECEQVA 307
            +L+VD + R         ++  H W    + +A
Sbjct: 272 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIA 305

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score =  141 bits (355), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 83/280 (29%), Positives = 150/280 (53%), Gaps = 13/280 (4%)
Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKL 97
           L ++Y++ + LG G+FG++  C +  + +    K +     V   D   +K EI I+  +
Sbjct: 3   LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK----VKGTDQVLVKKEISILN-I 57
Query: 98  SGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQV---V 154
           + H N++ L   +E  + + ++ E  +G ++F R+       E   R I  ++ QV   +
Sbjct: 58  ARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSA--FELNEREIVSYVHQVCEAL 115
Query: 155 SYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEV 214
            + H + + H D++PENI+  T+ SS+ IK+ +FG A  +K G N      +P Y APEV
Sbjct: 116 QFLHSHNIGHFDIRPENIIYQTRRSST-IKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV 174
Query: 215 LAGGY-NQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASA 273
                 + A D+WS G ++Y+LLSG+ PF  +T  +I + +  A+  F  + +  IS  A
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234
Query: 274 RDLIMGMLRVDPSTRLTAAEVLAHSWM-EECEQVAQKPCK 312
            D +  +L  +  +R+TA+E L H W+ ++ E+V+ K  +
Sbjct: 235 MDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIR 274

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 85/283 (30%), Positives = 135/283 (47%), Gaps = 38/283 (13%)
Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKL 97
           + D  V  + LG G  G + +  +K T E  A K         ++D    + E+E+  + 
Sbjct: 16  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK--------MLQDCPKARREVELHWRA 67
Query: 98  SGHPNVVDLKAVYEE----EDYVHLLMELCAGGELFHRLEKYG--RFSETEARVIFRHLM 151
           S  P++V +  VYE        + ++ME   GGELF R++  G   F+E EA  I + + 
Sbjct: 68  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 127
Query: 152 QVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIA 211
           + + Y H   + HRD+KPEN+L  +K  ++ +KL DFG A                    
Sbjct: 128 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK------------------- 168
Query: 212 PEVLAGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDA----VRAADLRFPSDPWD 267
            E     Y+++ D+WS GVI+YILL G PPF+      I       +R     FP+  W 
Sbjct: 169 -ETTGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 227
Query: 268 HISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKP 310
            +S   + LI  +L+ +P+ R+T  E + H W+ +  +V Q P
Sbjct: 228 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 270

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 89/250 (35%), Positives = 128/250 (51%), Gaps = 10/250 (4%)
Query: 48  LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLK 107
           LG G F    E SD  T EV A K + K  L+       + +EI I   L+ H +VV   
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFH 83
Query: 108 AVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDL 167
             +E+ D+V +++ELC    L    ++    +E EAR   R ++    Y H N V+HRDL
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 143
Query: 168 KPENILLATKSSSSPIKLADFGLATYIKA-GQNLHGTVGSPFYIAPEVLA-GGYNQAADV 225
           K  N+ L   +    +K+ DFGLAT ++  G+      G+P YIAPEVL+  G++   DV
Sbjct: 144 KLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDV 200
Query: 226 WSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDP 285
           WS G I+Y LL G PPF      + +  ++  +   P     HI+  A  LI  ML+ DP
Sbjct: 201 WSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK----HINPVAASLIQKMLQTDP 256
Query: 286 STRLTAAEVL 295
           + R T  E+L
Sbjct: 257 TARPTINELL 266

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score =  139 bits (350), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 89/250 (35%), Positives = 128/250 (51%), Gaps = 10/250 (4%)
Query: 48  LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLK 107
           LG G F    E SD  T EV A K + K  L+       + +EI I   L+ H +VV   
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFH 83
Query: 108 AVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDL 167
             +E+ D+V +++ELC    L    ++    +E EAR   R ++    Y H N V+HRDL
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 143
Query: 168 KPENILLATKSSSSPIKLADFGLATYIKA-GQNLHGTVGSPFYIAPEVLA-GGYNQAADV 225
           K  N+ L   +    +K+ DFGLAT ++  G+      G+P YIAPEVL+  G++   DV
Sbjct: 144 KLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDV 200
Query: 226 WSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDP 285
           WS G I+Y LL G PPF      + +  ++  +   P     HI+  A  LI  ML+ DP
Sbjct: 201 WSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK----HINPVAASLIQKMLQTDP 256
Query: 286 STRLTAAEVL 295
           + R T  E+L
Sbjct: 257 TARPTINELL 266

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score =  139 bits (350), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 89/250 (35%), Positives = 128/250 (51%), Gaps = 10/250 (4%)
Query: 48  LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLK 107
           LG G F    E SD  T EV A K + K  L+       + +EI I   L+ H +VV   
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFH 87
Query: 108 AVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDL 167
             +E+ D+V +++ELC    L    ++    +E EAR   R ++    Y H N V+HRDL
Sbjct: 88  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 147
Query: 168 KPENILLATKSSSSPIKLADFGLATYIKA-GQNLHGTVGSPFYIAPEVLA-GGYNQAADV 225
           K  N+ L   +    +K+ DFGLAT ++  G+      G+P YIAPEVL+  G++   DV
Sbjct: 148 KLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDV 204
Query: 226 WSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDP 285
           WS G I+Y LL G PPF      + +  ++  +   P     HI+  A  LI  ML+ DP
Sbjct: 205 WSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK----HINPVAASLIQKMLQTDP 260
Query: 286 STRLTAAEVL 295
           + R T  E+L
Sbjct: 261 TARPTINELL 270

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score =  139 bits (349), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 89/255 (34%), Positives = 129/255 (50%), Gaps = 10/255 (3%)
Query: 48  LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLK 107
           LG G F    E SD  T EV A K + K  L+       + +EI I   L+ H +VV   
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFH 105
Query: 108 AVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDL 167
             +E+ D+V +++ELC    L    ++    +E EAR   R ++    Y H N V+HRDL
Sbjct: 106 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 165
Query: 168 KPENILLATKSSSSPIKLADFGLATYIKA-GQNLHGTVGSPFYIAPEVLA-GGYNQAADV 225
           K  N+ L   +    +K+ DFGLAT ++  G+      G+P YIAPEVL+  G++   DV
Sbjct: 166 KLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDV 222
Query: 226 WSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDP 285
           WS G I+Y LL G PPF      + +  ++  +   P     HI+  A  LI  ML+ DP
Sbjct: 223 WSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK----HINPVAASLIQKMLQTDP 278
Query: 286 STRLTAAEVLAHSWM 300
           + R T  E+L   + 
Sbjct: 279 TARPTINELLNDEFF 293

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score =  138 bits (348), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 89/255 (34%), Positives = 129/255 (50%), Gaps = 10/255 (3%)
Query: 48  LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLK 107
           LG G F    E SD  T EV A K + K  L+       + +EI I   L+ H +VV   
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFH 107
Query: 108 AVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDL 167
             +E+ D+V +++ELC    L    ++    +E EAR   R ++    Y H N V+HRDL
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 167
Query: 168 KPENILLATKSSSSPIKLADFGLATYIKA-GQNLHGTVGSPFYIAPEVLA-GGYNQAADV 225
           K  N+ L   +    +K+ DFGLAT ++  G+      G+P YIAPEVL+  G++   DV
Sbjct: 168 KLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDV 224
Query: 226 WSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDP 285
           WS G I+Y LL G PPF      + +  ++  +   P     HI+  A  LI  ML+ DP
Sbjct: 225 WSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK----HINPVAASLIQKMLQTDP 280
Query: 286 STRLTAAEVLAHSWM 300
           + R T  E+L   + 
Sbjct: 281 TARPTINELLNDEFF 295

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score =  138 bits (348), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 89/250 (35%), Positives = 128/250 (51%), Gaps = 10/250 (4%)
Query: 48  LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLK 107
           LG G F    E SD  T EV A K + K  L+       + +EI I   L+ H +VV   
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFH 81
Query: 108 AVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDL 167
             +E+ D+V +++ELC    L    ++    +E EAR   R ++    Y H N V+HRDL
Sbjct: 82  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 141
Query: 168 KPENILLATKSSSSPIKLADFGLATYIKA-GQNLHGTVGSPFYIAPEVLA-GGYNQAADV 225
           K  N+ L   +    +K+ DFGLAT ++  G+      G+P YIAPEVL+  G++   DV
Sbjct: 142 KLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDV 198
Query: 226 WSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDP 285
           WS G I+Y LL G PPF      + +  ++  +   P     HI+  A  LI  ML+ DP
Sbjct: 199 WSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK----HINPVAASLIQKMLQTDP 254
Query: 286 STRLTAAEVL 295
           + R T  E+L
Sbjct: 255 TARPTINELL 264

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score =  138 bits (347), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 84/262 (32%), Positives = 133/262 (50%), Gaps = 15/262 (5%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           K LG G FG +    +K TG   A K + K+ ++  ++V     E  ++   + HP +  
Sbjct: 14  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTA 72
Query: 106 LKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHR 165
           LK  ++  D +  +ME   GGELF  L +   F+E  AR     ++  + Y H   VV+R
Sbjct: 73  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 132
Query: 166 DLKPENILLATKSSSSPIKLADFGLATY-IKAGQNLHGTVGSPFYIAPEVLA-GGYNQAA 223
           D+K EN++L        IK+ DFGL    I  G  +    G+P Y+APEVL    Y +A 
Sbjct: 133 DIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAV 189
Query: 224 DVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRV 283
           D W  GV++Y ++ G  PF+ +   ++F+ +   ++RFP      +S  A+ L+ G+L+ 
Sbjct: 190 DWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT----LSPEAKSLLAGLLKK 245
Query: 284 DPSTRL-----TAAEVLAHSWM 300
           DP  RL      A EV+ H + 
Sbjct: 246 DPKQRLGGGPSDAKEVMEHRFF 267

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score =  138 bits (347), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 84/262 (32%), Positives = 133/262 (50%), Gaps = 15/262 (5%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           K LG G FG +    +K TG   A K + K+ ++  ++V     E  ++   + HP +  
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTA 69
Query: 106 LKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHR 165
           LK  ++  D +  +ME   GGELF  L +   F+E  AR     ++  + Y H   VV+R
Sbjct: 70  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 129
Query: 166 DLKPENILLATKSSSSPIKLADFGLATY-IKAGQNLHGTVGSPFYIAPEVLA-GGYNQAA 223
           D+K EN++L        IK+ DFGL    I  G  +    G+P Y+APEVL    Y +A 
Sbjct: 130 DIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAV 186
Query: 224 DVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRV 283
           D W  GV++Y ++ G  PF+ +   ++F+ +   ++RFP      +S  A+ L+ G+L+ 
Sbjct: 187 DWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT----LSPEAKSLLAGLLKK 242
Query: 284 DPSTRL-----TAAEVLAHSWM 300
           DP  RL      A EV+ H + 
Sbjct: 243 DPKQRLGGGPSDAKEVMEHRFF 264

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score =  138 bits (347), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 84/262 (32%), Positives = 133/262 (50%), Gaps = 15/262 (5%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           K LG G FG +    +K TG   A K + K+ ++  ++V     E  ++   + HP +  
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTA 69
Query: 106 LKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHR 165
           LK  ++  D +  +ME   GGELF  L +   F+E  AR     ++  + Y H   VV+R
Sbjct: 70  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 129
Query: 166 DLKPENILLATKSSSSPIKLADFGLATY-IKAGQNLHGTVGSPFYIAPEVLA-GGYNQAA 223
           D+K EN++L        IK+ DFGL    I  G  +    G+P Y+APEVL    Y +A 
Sbjct: 130 DIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAV 186
Query: 224 DVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRV 283
           D W  GV++Y ++ G  PF+ +   ++F+ +   ++RFP      +S  A+ L+ G+L+ 
Sbjct: 187 DWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT----LSPEAKSLLAGLLKK 242
Query: 284 DPSTRL-----TAAEVLAHSWM 300
           DP  RL      A EV+ H + 
Sbjct: 243 DPKQRLGGGPSDAKEVMEHRFF 264

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score =  138 bits (347), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 84/262 (32%), Positives = 133/262 (50%), Gaps = 15/262 (5%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           K LG G FG +    +K TG   A K + K+ ++  ++V     E  ++   + HP +  
Sbjct: 16  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTA 74
Query: 106 LKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHR 165
           LK  ++  D +  +ME   GGELF  L +   F+E  AR     ++  + Y H   VV+R
Sbjct: 75  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 134
Query: 166 DLKPENILLATKSSSSPIKLADFGLATY-IKAGQNLHGTVGSPFYIAPEVLA-GGYNQAA 223
           D+K EN++L        IK+ DFGL    I  G  +    G+P Y+APEVL    Y +A 
Sbjct: 135 DIKLENLML---DKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAV 191
Query: 224 DVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRV 283
           D W  GV++Y ++ G  PF+ +   ++F+ +   ++RFP      +S  A+ L+ G+L+ 
Sbjct: 192 DWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT----LSPEAKSLLAGLLKK 247
Query: 284 DPSTRL-----TAAEVLAHSWM 300
           DP  RL      A EV+ H + 
Sbjct: 248 DPKQRLGGGPSDAKEVMEHRFF 269

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score =  138 bits (347), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 84/262 (32%), Positives = 133/262 (50%), Gaps = 15/262 (5%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           K LG G FG +    +K TG   A K + K+ ++  ++V     E  ++   + HP +  
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTA 69
Query: 106 LKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHR 165
           LK  ++  D +  +ME   GGELF  L +   F+E  AR     ++  + Y H   VV+R
Sbjct: 70  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 129
Query: 166 DLKPENILLATKSSSSPIKLADFGLATY-IKAGQNLHGTVGSPFYIAPEVLA-GGYNQAA 223
           D+K EN++L        IK+ DFGL    I  G  +    G+P Y+APEVL    Y +A 
Sbjct: 130 DIKLENLML---DKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAV 186
Query: 224 DVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRV 283
           D W  GV++Y ++ G  PF+ +   ++F+ +   ++RFP      +S  A+ L+ G+L+ 
Sbjct: 187 DWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT----LSPEAKSLLAGLLKK 242
Query: 284 DPSTRL-----TAAEVLAHSWM 300
           DP  RL      A EV+ H + 
Sbjct: 243 DPKQRLGGGPSDAKEVMEHRFF 264

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score =  138 bits (347), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 84/262 (32%), Positives = 133/262 (50%), Gaps = 15/262 (5%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           K LG G FG +    +K TG   A K + K+ ++  ++V     E  ++   + HP +  
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTA 69
Query: 106 LKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHR 165
           LK  ++  D +  +ME   GGELF  L +   F+E  AR     ++  + Y H   VV+R
Sbjct: 70  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 129
Query: 166 DLKPENILLATKSSSSPIKLADFGLATY-IKAGQNLHGTVGSPFYIAPEVLA-GGYNQAA 223
           D+K EN++L        IK+ DFGL    I  G  +    G+P Y+APEVL    Y +A 
Sbjct: 130 DIKLENLML---DKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAV 186
Query: 224 DVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRV 283
           D W  GV++Y ++ G  PF+ +   ++F+ +   ++RFP      +S  A+ L+ G+L+ 
Sbjct: 187 DWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT----LSPEAKSLLAGLLKK 242
Query: 284 DPSTRL-----TAAEVLAHSWM 300
           DP  RL      A EV+ H + 
Sbjct: 243 DPKQRLGGGPSDAKEVMEHRFF 264

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score =  137 bits (346), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 84/262 (32%), Positives = 133/262 (50%), Gaps = 15/262 (5%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           K LG G FG +    +K TG   A K + K+ ++  ++V     E  ++   + HP +  
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTA 69
Query: 106 LKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHR 165
           LK  ++  D +  +ME   GGELF  L +   F+E  AR     ++  + Y H   VV+R
Sbjct: 70  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 129
Query: 166 DLKPENILLATKSSSSPIKLADFGLATY-IKAGQNLHGTVGSPFYIAPEVLA-GGYNQAA 223
           D+K EN++L        IK+ DFGL    I  G  +    G+P Y+APEVL    Y +A 
Sbjct: 130 DIKLENLML---DKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAV 186
Query: 224 DVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRV 283
           D W  GV++Y ++ G  PF+ +   ++F+ +   ++RFP      +S  A+ L+ G+L+ 
Sbjct: 187 DWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT----LSPEAKSLLAGLLKK 242
Query: 284 DPSTRL-----TAAEVLAHSWM 300
           DP  RL      A EV+ H + 
Sbjct: 243 DPKQRLGGGPSDAKEVMEHRFF 264

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score =  137 bits (346), Expect = 9e-33,   Method: Compositional matrix adjust.
 Identities = 88/263 (33%), Positives = 133/263 (50%), Gaps = 16/263 (6%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           K LG G FG +    +K TG   A K + K+ +V  ++V     E  ++   S HP +  
Sbjct: 14  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTA 72
Query: 106 LKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG-NGVVH 164
           LK  ++  D +  +ME   GGELF  L +   FSE  AR     ++  + Y H    VV+
Sbjct: 73  LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 132
Query: 165 RDLKPENILLATKSSSSPIKLADFGLATY-IKAGQNLHGTVGSPFYIAPEVLAGG-YNQA 222
           RDLK EN++L        IK+ DFGL    IK G  +    G+P Y+APEVL    Y +A
Sbjct: 133 RDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRA 189
Query: 223 ADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLR 282
            D W  GV++Y ++ G  PF+ +   K+F+ +   ++RFP      +   A+ L+ G+L+
Sbjct: 190 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRT----LGPEAKSLLSGLLK 245
Query: 283 VDPSTRL-----TAAEVLAHSWM 300
            DP  RL      A E++ H + 
Sbjct: 246 KDPKQRLGGGSEDAKEIMQHRFF 268

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score =  137 bits (346), Expect = 9e-33,   Method: Compositional matrix adjust.
 Identities = 88/263 (33%), Positives = 133/263 (50%), Gaps = 16/263 (6%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           K LG G FG +    +K TG   A K + K+ +V  ++V     E  ++   S HP +  
Sbjct: 15  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTA 73
Query: 106 LKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG-NGVVH 164
           LK  ++  D +  +ME   GGELF  L +   FSE  AR     ++  + Y H    VV+
Sbjct: 74  LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 133
Query: 165 RDLKPENILLATKSSSSPIKLADFGLATY-IKAGQNLHGTVGSPFYIAPEVLAGG-YNQA 222
           RDLK EN++L        IK+ DFGL    IK G  +    G+P Y+APEVL    Y +A
Sbjct: 134 RDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRA 190
Query: 223 ADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLR 282
            D W  GV++Y ++ G  PF+ +   K+F+ +   ++RFP      +   A+ L+ G+L+
Sbjct: 191 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRT----LGPEAKSLLSGLLK 246
Query: 283 VDPSTRL-----TAAEVLAHSWM 300
            DP  RL      A E++ H + 
Sbjct: 247 KDPKQRLGGGSEDAKEIMQHRFF 269

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score =  137 bits (346), Expect = 9e-33,   Method: Compositional matrix adjust.
 Identities = 88/263 (33%), Positives = 133/263 (50%), Gaps = 16/263 (6%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           K LG G FG +    +K TG   A K + K+ +V  ++V     E  ++   S HP +  
Sbjct: 16  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTA 74
Query: 106 LKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG-NGVVH 164
           LK  ++  D +  +ME   GGELF  L +   FSE  AR     ++  + Y H    VV+
Sbjct: 75  LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 134
Query: 165 RDLKPENILLATKSSSSPIKLADFGLATY-IKAGQNLHGTVGSPFYIAPEVLAGG-YNQA 222
           RDLK EN++L        IK+ DFGL    IK G  +    G+P Y+APEVL    Y +A
Sbjct: 135 RDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRA 191
Query: 223 ADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLR 282
            D W  GV++Y ++ G  PF+ +   K+F+ +   ++RFP      +   A+ L+ G+L+
Sbjct: 192 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRT----LGPEAKSLLSGLLK 247
Query: 283 VDPSTRL-----TAAEVLAHSWM 300
            DP  RL      A E++ H + 
Sbjct: 248 KDPKQRLGGGSEDAKEIMQHRFF 270

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 88/263 (33%), Positives = 133/263 (50%), Gaps = 16/263 (6%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           K LG G FG +    +K TG   A K + K+ +V  ++V     E  ++   S HP +  
Sbjct: 154 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTA 212
Query: 106 LKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG-NGVVH 164
           LK  ++  D +  +ME   GGELF  L +   FSE  AR     ++  + Y H    VV+
Sbjct: 213 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 272
Query: 165 RDLKPENILLATKSSSSPIKLADFGLATY-IKAGQNLHGTVGSPFYIAPEVLAGG-YNQA 222
           RDLK EN++L        IK+ DFGL    IK G  +    G+P Y+APEVL    Y +A
Sbjct: 273 RDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRA 329
Query: 223 ADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLR 282
            D W  GV++Y ++ G  PF+ +   K+F+ +   ++RFP      +   A+ L+ G+L+
Sbjct: 330 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRT----LGPEAKSLLSGLLK 385
Query: 283 VDPSTRL-----TAAEVLAHSWM 300
            DP  RL      A E++ H + 
Sbjct: 386 KDPKQRLGGGSEDAKEIMQHRFF 408

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 88/263 (33%), Positives = 133/263 (50%), Gaps = 16/263 (6%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           K LG G FG +    +K TG   A K + K+ +V  ++V     E  ++   S HP +  
Sbjct: 157 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTA 215
Query: 106 LKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG-NGVVH 164
           LK  ++  D +  +ME   GGELF  L +   FSE  AR     ++  + Y H    VV+
Sbjct: 216 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 275
Query: 165 RDLKPENILLATKSSSSPIKLADFGLATY-IKAGQNLHGTVGSPFYIAPEVLAGG-YNQA 222
           RDLK EN++L        IK+ DFGL    IK G  +    G+P Y+APEVL    Y +A
Sbjct: 276 RDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRA 332
Query: 223 ADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLR 282
            D W  GV++Y ++ G  PF+ +   K+F+ +   ++RFP      +   A+ L+ G+L+
Sbjct: 333 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRT----LGPEAKSLLSGLLK 388
Query: 283 VDPSTRL-----TAAEVLAHSWM 300
            DP  RL      A E++ H + 
Sbjct: 389 KDPKQRLGGGSEDAKEIMQHRFF 411

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 83/273 (30%), Positives = 137/273 (50%), Gaps = 17/273 (6%)
Query: 37  NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTK 96
           +L D  +L + LG G FG +     +  G   A K + K+ +V ++ V     E  +M  
Sbjct: 4   SLQDFQIL-RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDE-RLMLS 61
Query: 97  LSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSY 156
           +  HP ++ +   +++   + ++M+   GGELF  L K  RF    A+     +   + Y
Sbjct: 62  IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEY 121
Query: 157 CHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLA 216
            H   +++RDLKPENILL     +  IK+ DFG A Y+      +   G+P YIAPEV++
Sbjct: 122 LHSKDIIYRDLKPENILL---DKNGHIKITDFGFAKYVP--DVTYXLCGTPDYIAPEVVS 176
Query: 217 -GGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARD 275
              YN++ D WS G+++Y +L+G  PF+     K ++ +  A+LRFP       +   +D
Sbjct: 177 TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP----FFNEDVKD 232
Query: 276 LIMGMLRVDPSTRL-----TAAEVLAHSWMEEC 303
           L+  ++  D S RL        +V  H W +E 
Sbjct: 233 LLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 265

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  132 bits (333), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 87/273 (31%), Positives = 142/273 (52%), Gaps = 13/273 (4%)
Query: 44  LGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNV 103
           L + LG G +G ++   ++ T E +A K +   R V   +  +IK EI I  K+  H NV
Sbjct: 10  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE--NIKKEIXI-NKMLNHENV 66
Query: 104 VDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVV 163
           V       E +  +L +E C+GGELF R+E      E +A+  F  LM  V Y HG G+ 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGIT 126
Query: 164 HRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLAGG-- 218
           HRD+KPEN+LL  + +   +K++DFGLAT  +       L+   G+  Y+APE+L     
Sbjct: 127 HRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           + +  DVWS G++L  +L+G  P W +      +     + +   +PW  I ++   L+ 
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 242
Query: 279 GMLRVDPSTRLTAAEVLAHSWMEE-CEQVAQKP 310
            +L  +PS R+T  ++    W  +  ++ A++P
Sbjct: 243 KILVENPSARITIPDIKKDRWYNKPLKKGAKRP 275

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score =  132 bits (332), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 87/315 (27%), Positives = 159/315 (50%), Gaps = 27/315 (8%)
Query: 30  LDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKL 89
           LD  ++++ +   VLGK    G FG +     K T E+ A K + KD ++  +DV    +
Sbjct: 13  LDRVKLTDFNFLMVLGK----GSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMV 68
Query: 90  EIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRH 149
           E  ++  L   P +  L + ++  D ++ +ME   GG+L + +++ G+F E +A      
Sbjct: 69  EKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAE 128
Query: 150 LMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLAT-YIKAGQNLHGTVGSPF 208
           +   + + H  G+++RDLK +N++L    S   IK+ADFG+   ++  G       G+P 
Sbjct: 129 ISIGLFFLHKRGIIYRDLKLDNVML---DSEGHIKIADFGMCKEHMMDGVTTREFCGTPD 185
Query: 209 YIAPEVLA-GGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWD 267
           YIAPE++A   Y ++ D W+ GV+LY +L+G PPF G+ + ++F ++   ++ +P     
Sbjct: 186 YIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKS--- 242
Query: 268 HISASARDLIMGMLRVDPSTRLTAA-----EVLAHSWM-----EECEQVAQKPCKQDDLC 317
            +S  A  +  G++   P+ RL        +V  H++      E+ E    +P  +  +C
Sbjct: 243 -LSKEAVSICKGLMTKHPAKRLGCGPEGERDVREHAFFRRIDWEKLENREIQPPFKPKVC 301
Query: 318 CKQLEVGGSSFSATF 332
            K    G  +F   F
Sbjct: 302 GK----GAENFDKFF 312

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  132 bits (332), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 87/273 (31%), Positives = 142/273 (52%), Gaps = 13/273 (4%)
Query: 44  LGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNV 103
           L + LG G +G ++   ++ T E +A K +   R V   +  +IK EI I  K+  H NV
Sbjct: 10  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE--NIKKEIXI-NKMLNHENV 66
Query: 104 VDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVV 163
           V       E +  +L +E C+GGELF R+E      E +A+  F  LM  V Y HG G+ 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGIT 126
Query: 164 HRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLAGG-- 218
           HRD+KPEN+LL  + +   +K++DFGLAT  +       L+   G+  Y+APE+L     
Sbjct: 127 HRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           + +  DVWS G++L  +L+G  P W +      +     + +   +PW  I ++   L+ 
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 242
Query: 279 GMLRVDPSTRLTAAEVLAHSWMEE-CEQVAQKP 310
            +L  +PS R+T  ++    W  +  ++ A++P
Sbjct: 243 KILVENPSARITIPDIKKDRWYNKPLKKGAKRP 275

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score =  132 bits (332), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 87/273 (31%), Positives = 142/273 (52%), Gaps = 13/273 (4%)
Query: 44  LGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNV 103
           L + LG G +G ++   ++ T E +A K +   R V   +  +IK EI I  K+  H NV
Sbjct: 11  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE--NIKKEIXI-NKMLNHENV 67
Query: 104 VDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVV 163
           V       E +  +L +E C+GGELF R+E      E +A+  F  LM  V Y HG G+ 
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGIT 127
Query: 164 HRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLAGG-- 218
           HRD+KPEN+LL  + +   +K++DFGLAT  +       L+   G+  Y+APE+L     
Sbjct: 128 HRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 184
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           + +  DVWS G++L  +L+G  P W +      +     + +   +PW  I ++   L+ 
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243
Query: 279 GMLRVDPSTRLTAAEVLAHSWMEE-CEQVAQKP 310
            +L  +PS R+T  ++    W  +  ++ A++P
Sbjct: 244 KILVENPSARITIPDIKKDRWYNKPLKKGAKRP 276

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score =  131 bits (330), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 91/300 (30%), Positives = 153/300 (51%), Gaps = 22/300 (7%)
Query: 44  LGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNV 103
           L + LG G +G ++   ++ T E +A K +   R V   +  +IK EI  + K+  H NV
Sbjct: 10  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE--NIKKEI-CINKMLNHENV 66
Query: 104 VDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVV 163
           V       E +  +L +E C+GGELF R+E      E +A+  F  LM  V Y HG G+ 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGIT 126
Query: 164 HRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLAGG-- 218
           HRD+KPEN+LL  + +   +K++DFGLAT  +       L+   G+  Y+APE+L     
Sbjct: 127 HRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           + +  DVWS G++L  +L+G  P W +      +     + +   +PW  I ++   L+ 
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 242
Query: 279 GMLRVDPSTRLTAAEVLAHSWMEE-CEQVAQKPCKQDDLCCKQLEVGGSSFSATFISRNM 337
            +L  +PS R+T  ++    W  +  ++ A++P         ++  GG S S +  S+++
Sbjct: 243 KILVENPSARITIPDIKKDRWYNKPLKKGAKRP---------RVTSGGVSESPSGFSKHI 293

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  131 bits (330), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 87/273 (31%), Positives = 142/273 (52%), Gaps = 13/273 (4%)
Query: 44  LGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNV 103
           L + LG G +G ++   ++ T E +A K +   R V   +  +IK EI I  K+  H NV
Sbjct: 10  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE--NIKKEICI-NKMLNHENV 66
Query: 104 VDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVV 163
           V       E +  +L +E C+GGELF R+E      E +A+  F  LM  V Y HG G+ 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGIT 126
Query: 164 HRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLAGG-- 218
           HRD+KPEN+LL  + +   +K++DFGLAT  +       L+   G+  Y+APE+L     
Sbjct: 127 HRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           + +  DVWS G++L  +L+G  P W +      +     + +   +PW  I ++   L+ 
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELP-WDQPSDSXQEYSDWKEKKTYLNPWKKIDSAPLALLH 242
Query: 279 GMLRVDPSTRLTAAEVLAHSWMEE-CEQVAQKP 310
            +L  +PS R+T  ++    W  +  ++ A++P
Sbjct: 243 KILVENPSARITIPDIKKDRWYNKPLKKGAKRP 275

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score =  131 bits (329), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 92/300 (30%), Positives = 153/300 (51%), Gaps = 22/300 (7%)
Query: 44  LGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNV 103
           L + LG G +G ++   ++ T E +A K +   R V   +  +IK EI I  K+  H NV
Sbjct: 11  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE--NIKKEICI-NKMLNHENV 67
Query: 104 VDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVV 163
           V       E +  +L +E C+GGELF R+E      E +A+  F  LM  V Y HG G+ 
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGIT 127
Query: 164 HRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLAGG-- 218
           HRD+KPEN+LL  + +   +K++DFGLAT  +       L+   G+  Y+APE+L     
Sbjct: 128 HRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           + +  DVWS G++L  +L+G  P W +      +     + +   +PW  I ++   L+ 
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243
Query: 279 GMLRVDPSTRLTAAEVLAHSWMEE-CEQVAQKPCKQDDLCCKQLEVGGSSFSATFISRNM 337
            +L  +PS R+T  ++    W  +  ++ A++P         ++  GG S S +  S+++
Sbjct: 244 KILVENPSARITIPDIKKDRWYNKPLKKGAKRP---------RVTSGGVSESPSGFSKHI 294

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score =  131 bits (329), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 85/261 (32%), Positives = 135/261 (51%), Gaps = 12/261 (4%)
Query: 44  LGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNV 103
           L + LG G +G ++   ++ T E +A K +   R V   +  +IK EI I  K+  H NV
Sbjct: 10  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE--NIKKEICI-NKMLNHENV 66
Query: 104 VDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVV 163
           V       E +  +L +E C+GGELF R+E      E +A+  F  LM  V Y HG G+ 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGIT 126
Query: 164 HRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLAGG-- 218
           HRD+KPEN+LL  + +   +K++DFGLAT  +       L+   G+  Y+APE+L     
Sbjct: 127 HRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           + +  DVWS G++L  +L+G  P W +      +     + +   +PW  I ++   L+ 
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 242
Query: 279 GMLRVDPSTRLTAAEVLAHSW 299
            +L  +PS R+T  ++    W
Sbjct: 243 KILVENPSARITIPDIKKDRW 263

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score =  131 bits (329), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 87/273 (31%), Positives = 142/273 (52%), Gaps = 13/273 (4%)
Query: 44  LGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNV 103
           L + LG G +G ++   ++ T E +A K +   R V   +  +IK EI I  K+  H NV
Sbjct: 11  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE--NIKKEICI-NKMLNHENV 67
Query: 104 VDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVV 163
           V       E +  +L +E C+GGELF R+E      E +A+  F  LM  V Y HG G+ 
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGIT 127
Query: 164 HRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLAGG-- 218
           HRD+KPEN+LL  + +   +K++DFGLAT  +       L+   G+  Y+APE+L     
Sbjct: 128 HRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           + +  DVWS G++L  +L+G  P W +      +     + +   +PW  I ++   L+ 
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243
Query: 279 GMLRVDPSTRLTAAEVLAHSWMEE-CEQVAQKP 310
            +L  +PS R+T  ++    W  +  ++ A++P
Sbjct: 244 KILVENPSARITIPDIKKDRWYNKPLKKGAKRP 276

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score =  131 bits (329), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 87/273 (31%), Positives = 142/273 (52%), Gaps = 13/273 (4%)
Query: 44  LGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNV 103
           L + LG G +G ++   ++ T E +A K +   R V   +  +IK EI I  K+  H NV
Sbjct: 11  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE--NIKKEICI-NKMLNHENV 67
Query: 104 VDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVV 163
           V       E +  +L +E C+GGELF R+E      E +A+  F  LM  V Y HG G+ 
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGIT 127
Query: 164 HRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLAGG-- 218
           HRD+KPEN+LL  + +   +K++DFGLAT  +       L+   G+  Y+APE+L     
Sbjct: 128 HRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           + +  DVWS G++L  +L+G  P W +      +     + +   +PW  I ++   L+ 
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243
Query: 279 GMLRVDPSTRLTAAEVLAHSWMEE-CEQVAQKP 310
            +L  +PS R+T  ++    W  +  ++ A++P
Sbjct: 244 KILVENPSARITIPDIKKDRWYNKPLKKGAKRP 276

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score =  131 bits (329), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 87/273 (31%), Positives = 142/273 (52%), Gaps = 13/273 (4%)
Query: 44  LGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNV 103
           L + LG G +G ++   ++ T E +A K +   R V   +  +IK EI I  K+  H NV
Sbjct: 11  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE--NIKKEICI-NKMLNHENV 67
Query: 104 VDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVV 163
           V       E +  +L +E C+GGELF R+E      E +A+  F  LM  V Y HG G+ 
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGIT 127
Query: 164 HRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLAGG-- 218
           HRD+KPEN+LL  + +   +K++DFGLAT  +       L+   G+  Y+APE+L     
Sbjct: 128 HRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           + +  DVWS G++L  +L+G  P W +      +     + +   +PW  I ++   L+ 
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243
Query: 279 GMLRVDPSTRLTAAEVLAHSWMEE-CEQVAQKP 310
            +L  +PS R+T  ++    W  +  ++ A++P
Sbjct: 244 KILVENPSARITIPDIKKDRWYNKPLKKGAKRP 276

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score =  131 bits (329), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 87/273 (31%), Positives = 142/273 (52%), Gaps = 13/273 (4%)
Query: 44  LGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNV 103
           L + LG G +G ++   ++ T E +A K +   R V   +  +IK EI I  K+  H NV
Sbjct: 9   LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE--NIKKEICI-NKMLNHENV 65
Query: 104 VDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVV 163
           V       E +  +L +E C+GGELF R+E      E +A+  F  LM  V Y HG G+ 
Sbjct: 66  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGIT 125
Query: 164 HRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLAGG-- 218
           HRD+KPEN+LL  + +   +K++DFGLAT  +       L+   G+  Y+APE+L     
Sbjct: 126 HRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           + +  DVWS G++L  +L+G  P W +      +     + +   +PW  I ++   L+ 
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 241
Query: 279 GMLRVDPSTRLTAAEVLAHSWMEE-CEQVAQKP 310
            +L  +PS R+T  ++    W  +  ++ A++P
Sbjct: 242 KILVENPSARITIPDIKKDRWYNKPLKKGAKRP 274

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  131 bits (329), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 87/273 (31%), Positives = 142/273 (52%), Gaps = 13/273 (4%)
Query: 44  LGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNV 103
           L + LG G +G ++   ++ T E +A K +   R V   +  +IK EI I  K+  H NV
Sbjct: 10  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE--NIKKEICI-NKMLNHENV 66
Query: 104 VDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVV 163
           V       E +  +L +E C+GGELF R+E      E +A+  F  LM  V Y HG G+ 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGIT 126
Query: 164 HRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLAGG-- 218
           HRD+KPEN+LL  + +   +K++DFGLAT  +       L+   G+  Y+APE+L     
Sbjct: 127 HRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           + +  DVWS G++L  +L+G  P W +      +     + +   +PW  I ++   L+ 
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 242
Query: 279 GMLRVDPSTRLTAAEVLAHSWMEE-CEQVAQKP 310
            +L  +PS R+T  ++    W  +  ++ A++P
Sbjct: 243 KILVENPSARITIPDIKKDRWYNKPLKKGAKRP 275

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score =  131 bits (329), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 85/261 (32%), Positives = 135/261 (51%), Gaps = 12/261 (4%)
Query: 44  LGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNV 103
           L + LG G +G ++   ++ T E +A K +   R V   +  +IK EI I  K+  H NV
Sbjct: 11  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE--NIKKEICI-NKMLNHENV 67
Query: 104 VDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVV 163
           V       E +  +L +E C+GGELF R+E      E +A+  F  LM  V Y HG G+ 
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGIT 127
Query: 164 HRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLAGG-- 218
           HRD+KPEN+LL  + +   +K++DFGLAT  +       L+   G+  Y+APE+L     
Sbjct: 128 HRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           + +  DVWS G++L  +L+G  P W +      +     + +   +PW  I ++   L+ 
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243
Query: 279 GMLRVDPSTRLTAAEVLAHSW 299
            +L  +PS R+T  ++    W
Sbjct: 244 KILVENPSARITIPDIKKDRW 264

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score =  131 bits (329), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 87/273 (31%), Positives = 142/273 (52%), Gaps = 13/273 (4%)
Query: 44  LGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNV 103
           L + LG G +G ++   ++ T E +A K +   R V   +  +IK EI I  K+  H NV
Sbjct: 11  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE--NIKKEICI-NKMLNHENV 67
Query: 104 VDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVV 163
           V       E +  +L +E C+GGELF R+E      E +A+  F  LM  V Y HG G+ 
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGIT 127
Query: 164 HRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLAGG-- 218
           HRD+KPEN+LL  + +   +K++DFGLAT  +       L+   G+  Y+APE+L     
Sbjct: 128 HRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           + +  DVWS G++L  +L+G  P W +      +     + +   +PW  I ++   L+ 
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243
Query: 279 GMLRVDPSTRLTAAEVLAHSWMEE-CEQVAQKP 310
            +L  +PS R+T  ++    W  +  ++ A++P
Sbjct: 244 KILVENPSARITIPDIKKDRWYNKPLKKGAKRP 276

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score =  131 bits (329), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 85/261 (32%), Positives = 135/261 (51%), Gaps = 12/261 (4%)
Query: 44  LGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNV 103
           L + LG G +G ++   ++ T E +A K +   R V   +  +IK EI I  K+  H NV
Sbjct: 10  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE--NIKKEICI-NKMLNHENV 66
Query: 104 VDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVV 163
           V       E +  +L +E C+GGELF R+E      E +A+  F  LM  V Y HG G+ 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGIT 126
Query: 164 HRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLAGG-- 218
           HRD+KPEN+LL  + +   +K++DFGLAT  +       L+   G+  Y+APE+L     
Sbjct: 127 HRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           + +  DVWS G++L  +L+G  P W +      +     + +   +PW  I ++   L+ 
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 242
Query: 279 GMLRVDPSTRLTAAEVLAHSW 299
            +L  +PS R+T  ++    W
Sbjct: 243 KILVENPSARITIPDIKKDRW 263

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  131 bits (329), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 86/273 (31%), Positives = 142/273 (52%), Gaps = 13/273 (4%)
Query: 44  LGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNV 103
           L + LG G +G ++   ++ T E +A K +   R V   +  +IK EI  + K+  H NV
Sbjct: 10  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE--NIKKEI-CINKMLNHENV 66
Query: 104 VDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVV 163
           V       E +  +L +E C+GGELF R+E      E +A+  F  LM  V Y HG G+ 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGIT 126
Query: 164 HRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLAGG-- 218
           HRD+KPEN+LL  + +   +K++DFGLAT  +       L+   G+  Y+APE+L     
Sbjct: 127 HRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           + +  DVWS G++L  +L+G  P W +      +     + +   +PW  I ++   L+ 
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 242
Query: 279 GMLRVDPSTRLTAAEVLAHSWMEE-CEQVAQKP 310
            +L  +PS R+T  ++    W  +  ++ A++P
Sbjct: 243 KILVENPSARITIPDIKKDRWYNKPLKKGAKRP 275

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score =  131 bits (329), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 85/261 (32%), Positives = 135/261 (51%), Gaps = 12/261 (4%)
Query: 44  LGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNV 103
           L + LG G +G ++   ++ T E +A K +   R V   +  +IK EI I  K+  H NV
Sbjct: 10  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE--NIKKEICI-NKMLNHENV 66
Query: 104 VDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVV 163
           V       E +  +L +E C+GGELF R+E      E +A+  F  LM  V Y HG G+ 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGIT 126
Query: 164 HRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLAGG-- 218
           HRD+KPEN+LL  + +   +K++DFGLAT  +       L+   G+  Y+APE+L     
Sbjct: 127 HRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           + +  DVWS G++L  +L+G  P W +      +     + +   +PW  I ++   L+ 
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 242
Query: 279 GMLRVDPSTRLTAAEVLAHSW 299
            +L  +PS R+T  ++    W
Sbjct: 243 KILVENPSARITIPDIKKDRW 263

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score =  130 bits (328), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 85/261 (32%), Positives = 135/261 (51%), Gaps = 12/261 (4%)
Query: 44  LGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNV 103
           L + LG G +G ++   ++ T E +A K +   R V   +  +IK EI I  K+  H NV
Sbjct: 10  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE--NIKKEICI-NKMLNHENV 66
Query: 104 VDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVV 163
           V       E +  +L +E C+GGELF R+E      E +A+  F  LM  V Y HG G+ 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGIT 126
Query: 164 HRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLAGG-- 218
           HRD+KPEN+LL  + +   +K++DFGLAT  +       L+   G+  Y+APE+L     
Sbjct: 127 HRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           + +  DVWS G++L  +L+G  P W +      +     + +   +PW  I ++   L+ 
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 242
Query: 279 GMLRVDPSTRLTAAEVLAHSW 299
            +L  +PS R+T  ++    W
Sbjct: 243 KILVENPSARITIPDIKKDRW 263

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score =  130 bits (328), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 85/261 (32%), Positives = 135/261 (51%), Gaps = 12/261 (4%)
Query: 44  LGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNV 103
           L + LG G +G ++   ++ T E +A K +   R V   +  +IK EI I  K+  H NV
Sbjct: 10  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE--NIKKEICI-NKMLNHENV 66
Query: 104 VDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVV 163
           V       E +  +L +E C+GGELF R+E      E +A+  F  LM  V Y HG G+ 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGIT 126
Query: 164 HRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLAGG-- 218
           HRD+KPEN+LL  + +   +K++DFGLAT  +       L+   G+  Y+APE+L     
Sbjct: 127 HRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           + +  DVWS G++L  +L+G  P W +      +     + +   +PW  I ++   L+ 
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 242
Query: 279 GMLRVDPSTRLTAAEVLAHSW 299
            +L  +PS R+T  ++    W
Sbjct: 243 KILVENPSARITIPDIKKDRW 263

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 90/285 (31%), Positives = 142/285 (49%), Gaps = 14/285 (4%)
Query: 39  SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLS 98
           SD + L K +G G FG +     K      A K + K  ++  ++ + I  E  ++ K  
Sbjct: 38  SDFHFL-KVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV 96
Query: 99  GHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCH 158
            HP +V L   ++  D ++ +++   GGELF+ L++   F E  AR     +   + Y H
Sbjct: 97  KHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLH 156
Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGL-ATYIKAGQNLHGTVGSPFYIAPEVL-A 216
              +V+RDLKPENILL    S   I L DFGL    I+         G+P Y+APEVL  
Sbjct: 157 SLNIVYRDLKPENILL---DSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHK 213
Query: 217 GGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDL 276
             Y++  D W  G +LY +L G+PPF+ +  ++++D +    L+   +    I+ SAR L
Sbjct: 214 QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPN----ITNSARHL 269
Query: 277 IMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKPCKQDDLCCKQL 321
           + G+L+ D + RL A +     +ME    V       DDL  K++
Sbjct: 270 LEGLLQKDRTKRLGAKD----DFMEIKSHVFFSLINWDDLINKKI 310

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 90/305 (29%), Positives = 149/305 (48%), Gaps = 47/305 (15%)
Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKL 97
           + ++Y    ++G G +GV+ +C ++ TG+++A K   +     V  ++ I L    M K 
Sbjct: 1   MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPV--IKKIALREIRMLKQ 58
Query: 98  SGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGR-FSETEARVIFRHLMQVVSY 156
             HPN+V+L  V+  +  +HL+ E C    + H L++Y R   E   + I    +Q V++
Sbjct: 59  LKHPNLVNLLEVFRRKRRLHLVFEYC-DHTVLHELDRYQRGVPEHLVKSITWQTLQAVNF 117
Query: 157 CHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLH-GTVGSPFYIAPEVL 215
           CH +  +HRD+KPENIL+   +  S IKL DFG A  +    + +   V + +Y +PE+L
Sbjct: 118 CHKHNCIHRDVKPENILI---TKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELL 174
Query: 216 AGG--YNQAADVWSAGVILYILLSGMPPFWGK------------------------TKSK 249
            G   Y    DVW+ G +   LLSG+P + GK                        + ++
Sbjct: 175 VGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ 234
Query: 250 IFDAVRAAD--------LRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWME 301
            F  V+  D        L+FP+     IS  A  L+ G L +DP+ RLT  ++L H + E
Sbjct: 235 YFSGVKIPDPEDMEPLELKFPN-----ISYPALGLLKGCLHMDPTERLTCEQLLHHPYFE 289
Query: 302 ECEQV 306
              ++
Sbjct: 290 NIREI 294

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 80/274 (29%), Positives = 140/274 (51%), Gaps = 10/274 (3%)
Query: 32  ATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEI 91
           + QI    + ++L K LG G FG +     K T +  A K++ KD ++  +DV    +E 
Sbjct: 9   SLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEK 68
Query: 92  EIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLM 151
            +++    HP +  +   ++ ++ +  +ME   GG+L + ++   +F  + A      ++
Sbjct: 69  RVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEII 128
Query: 152 QVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ-NLHGTVGSPFYI 210
             + + H  G+V+RDLK +NILL        IK+ADFG+      G    +   G+P YI
Sbjct: 129 LGLQFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYI 185
Query: 211 APEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHI 269
           APE+L G  YN + D WS GV+LY +L G  PF G+ + ++F ++R  +  +P   W  +
Sbjct: 186 APEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR--W--L 241
Query: 270 SASARDLIMGMLRVDPSTRL-TAAEVLAHSWMEE 302
              A+DL++ +   +P  RL    ++  H    E
Sbjct: 242 EKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE 275

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 85/261 (32%), Positives = 135/261 (51%), Gaps = 12/261 (4%)
Query: 44  LGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNV 103
           L + LG G +G ++   ++ T E +A K +   R V   +  +IK EI I   L+ H NV
Sbjct: 11  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE--NIKKEICINAMLN-HENV 67
Query: 104 VDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVV 163
           V       E +  +L +E C+GGELF R+E      E +A+  F  LM  V Y HG G+ 
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGIT 127
Query: 164 HRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLAGG-- 218
           HRD+KPEN+LL  + +   +K++DFGLAT  +       L+   G+  Y+APE+L     
Sbjct: 128 HRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           + +  DVWS G++L  +L+G  P W +      +     + +   +PW  I ++   L+ 
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243
Query: 279 GMLRVDPSTRLTAAEVLAHSW 299
            +L  +PS R+T  ++    W
Sbjct: 244 KILVENPSARITIPDIKKDRW 264

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  129 bits (323), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 87/273 (31%), Positives = 141/273 (51%), Gaps = 13/273 (4%)
Query: 44  LGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNV 103
           L + LG G  G ++   ++ T E +A K +   R V   +  +IK EI I  K+  H NV
Sbjct: 10  LVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE--NIKKEICI-NKMLNHENV 66
Query: 104 VDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVV 163
           V       E +  +L +E C+GGELF R+E      E +A+  F  LM  V Y HG G+ 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGIT 126
Query: 164 HRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLAGG-- 218
           HRD+KPEN+LL  + +   +K++DFGLAT  +       L+   G+  Y+APE+L     
Sbjct: 127 HRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           + +  DVWS G++L  +L+G  P W +      +     + +   +PW  I ++   L+ 
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 242
Query: 279 GMLRVDPSTRLTAAEVLAHSWMEE-CEQVAQKP 310
            +L  +PS R+T  ++    W  +  ++ A++P
Sbjct: 243 KILVENPSARITIPDIKKDRWYNKPLKKGAKRP 275

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score =  128 bits (322), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 84/291 (28%), Positives = 141/291 (48%), Gaps = 37/291 (12%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVE----------------- 82
           ++Y L  ++G G +GV++   ++      A K ++K +L+                    
Sbjct: 13  NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGG 72
Query: 83  ------DVRSIKLEIEIMTKLSGHPNVVDLKAVYEE--EDYVHLLMELCAGGELFHRLEK 134
                  +  +  EI I+ KL  HPNVV L  V ++  ED+++++ EL   G +   +  
Sbjct: 73  CIQPRGPIEQVYQEIAILKKLD-HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVM-EVPT 130
Query: 135 YGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI 194
               SE +AR  F+ L++ + Y H   ++HRD+KP N+L+        IK+ADFG++   
Sbjct: 131 LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGH---IKIADFGVSNEF 187
Query: 195 KAGQN-LHGTVGSPFYIAPEVLAGGYN----QAADVWSAGVILYILLSGMPPFWGKTKSK 249
           K     L  TVG+P ++APE L+        +A DVW+ GV LY  + G  PF  +    
Sbjct: 188 KGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC 247
Query: 250 IFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWM 300
           +   +++  L FP  P   I+   +DLI  ML  +P +R+   E+  H W+
Sbjct: 248 LHSKIKSQALEFPDQP--DIAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score =  128 bits (322), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 86/270 (31%), Positives = 145/270 (53%), Gaps = 19/270 (7%)
Query: 41  RYVLGKQLGWGQFG---VIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKL 97
           ++ L K LG G FG   ++++ S     ++ A K + K  L   + VR+ K+E +I+ ++
Sbjct: 25  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-KMERDILVEV 83
Query: 98  SGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYC 157
           + HP +V L   ++ E  ++L+++   GG+LF RL K   F+E + +     L   + + 
Sbjct: 84  N-HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 142
Query: 158 HGNGVVHRDLKPENILLATKSSSSPIKLADFGLAT-YIKAGQNLHGTVGSPFYIAPEVL- 215
           H  G+++RDLKPENILL        IKL DFGL+   I   +  +   G+  Y+APEV+ 
Sbjct: 143 HSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN 199
Query: 216 AGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARD 275
             G+ Q+AD WS GV+++ +L+G  PF GK + +    +  A L  P      +S  A+ 
Sbjct: 200 RRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQ----FLSPEAQS 255
Query: 276 LIMGMLRVDPSTRLTAA-----EVLAHSWM 300
           L+  + + +P+ RL A      E+  HS+ 
Sbjct: 256 LLRMLFKRNPANRLGAGPDGVEEIKRHSFF 285

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score =  128 bits (322), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 86/270 (31%), Positives = 145/270 (53%), Gaps = 19/270 (7%)
Query: 41  RYVLGKQLGWGQFG---VIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKL 97
           ++ L K LG G FG   ++++ S     ++ A K + K  L   + VR+ K+E +I+ ++
Sbjct: 26  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-KMERDILVEV 84
Query: 98  SGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYC 157
           + HP +V L   ++ E  ++L+++   GG+LF RL K   F+E + +     L   + + 
Sbjct: 85  N-HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 143
Query: 158 HGNGVVHRDLKPENILLATKSSSSPIKLADFGLAT-YIKAGQNLHGTVGSPFYIAPEVL- 215
           H  G+++RDLKPENILL        IKL DFGL+   I   +  +   G+  Y+APEV+ 
Sbjct: 144 HSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN 200
Query: 216 AGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARD 275
             G+ Q+AD WS GV+++ +L+G  PF GK + +    +  A L  P      +S  A+ 
Sbjct: 201 RRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQ----FLSPEAQS 256
Query: 276 LIMGMLRVDPSTRLTAA-----EVLAHSWM 300
           L+  + + +P+ RL A      E+  HS+ 
Sbjct: 257 LLRMLFKRNPANRLGAGPDGVEEIKRHSFF 286

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score =  128 bits (322), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 86/270 (31%), Positives = 145/270 (53%), Gaps = 19/270 (7%)
Query: 41  RYVLGKQLGWGQFG---VIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKL 97
           ++ L K LG G FG   ++++ S     ++ A K + K  L   + VR+ K+E +I+ ++
Sbjct: 25  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-KMERDILVEV 83
Query: 98  SGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYC 157
           + HP +V L   ++ E  ++L+++   GG+LF RL K   F+E + +     L   + + 
Sbjct: 84  N-HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 142
Query: 158 HGNGVVHRDLKPENILLATKSSSSPIKLADFGLAT-YIKAGQNLHGTVGSPFYIAPEVL- 215
           H  G+++RDLKPENILL        IKL DFGL+   I   +  +   G+  Y+APEV+ 
Sbjct: 143 HSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN 199
Query: 216 AGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARD 275
             G+ Q+AD WS GV+++ +L+G  PF GK + +    +  A L  P      +S  A+ 
Sbjct: 200 RRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQ----FLSPEAQS 255
Query: 276 LIMGMLRVDPSTRLTAA-----EVLAHSWM 300
           L+  + + +P+ RL A      E+  HS+ 
Sbjct: 256 LLRMLFKRNPANRLGAGPDGVEEIKRHSFF 285

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score =  128 bits (321), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 81/273 (29%), Positives = 136/273 (49%), Gaps = 15/273 (5%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           D +   + LG G FG +     K TG++ A K + KD ++  +DV     E  I++    
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
           HP +  L   ++  D +  +ME   GG+L   ++K  RF E  AR     ++  + + H 
Sbjct: 83  HPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHD 142
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATY-IKAGQNLHGTVGSPFYIAPEVLAGG 218
            G+++RDLK +N+LL  +      KLADFG+    I  G       G+P YIAPE+L   
Sbjct: 143 KGIIYRDLKLDNVLLDHEGHC---KLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEM 199
Query: 219 -YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLI 277
            Y  A D W+ GV+LY +L G  PF  + +  +F+A+   ++ +P+  W H  A+   ++
Sbjct: 200 LYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT--WLHEDATG--IL 255
Query: 278 MGMLRVDPSTRLTAAE------VLAHSWMEECE 304
              +  +P+ RL +        +L H + +E +
Sbjct: 256 KSFMTKNPTMRLGSLTQGGEHAILRHPFFKEID 288

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score =  127 bits (320), Expect = 8e-30,   Method: Compositional matrix adjust.
 Identities = 80/274 (29%), Positives = 139/274 (50%), Gaps = 10/274 (3%)
Query: 32  ATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEI 91
           + QI    + + L K LG G FG +     K T +  A K++ KD ++  +DV    +E 
Sbjct: 10  SLQIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEK 69
Query: 92  EIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLM 151
            +++    HP +  +   ++ ++ +  +ME   GG+L + ++   +F  + A      ++
Sbjct: 70  RVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEII 129
Query: 152 QVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ-NLHGTVGSPFYI 210
             + + H  G+V+RDLK +NILL        IK+ADFG+      G    +   G+P YI
Sbjct: 130 LGLQFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYI 186
Query: 211 APEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHI 269
           APE+L G  YN + D WS GV+LY +L G  PF G+ + ++F ++R  +  +P   W  +
Sbjct: 187 APEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR--W--L 242
Query: 270 SASARDLIMGMLRVDPSTRL-TAAEVLAHSWMEE 302
              A+DL++ +   +P  RL    ++  H    E
Sbjct: 243 EKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE 276

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 83/253 (32%), Positives = 138/253 (54%), Gaps = 14/253 (5%)
Query: 42  YVLGKQLGWGQFG---VIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLS 98
           + L K LG G FG   ++R+ +   +G + A K + K  L   + VR+ K+E +I+  ++
Sbjct: 30  FELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRT-KMERDILADVN 88
Query: 99  GHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCH 158
            HP VV L   ++ E  ++L+++   GG+LF RL K   F+E + +     L   + + H
Sbjct: 89  -HPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGLDHLH 147
Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLAT-YIKAGQNLHGTVGSPFYIAPEVL-A 216
             G+++RDLKPENILL        IKL DFGL+   I   +  +   G+  Y+APEV+  
Sbjct: 148 SLGIIYRDLKPENILL---DEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVVNR 204
Query: 217 GGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDL 276
            G++ +AD WS GV+++ +L+G  PF GK + +    +  A L  P      +S  A+ L
Sbjct: 205 QGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLGMPQ----FLSTEAQSL 260
Query: 277 IMGMLRVDPSTRL 289
           +  + + +P+ RL
Sbjct: 261 LRALFKRNPANRL 273

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score =  124 bits (312), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 76/257 (29%), Positives = 128/257 (49%), Gaps = 12/257 (4%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           +  GK LG G F  +    +  T    A K + K  ++    V  +  E ++M++L  HP
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HP 89
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
             V L   +++++ ++  +     GEL   + K G F ET  R     ++  + Y HG G
Sbjct: 90  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 149
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLAGG 218
           ++HRDLKPENILL   +    I++ DFG A  +         +  VG+  Y++PE+L   
Sbjct: 150 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 206
Query: 219 YN-QAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLI 277
              +++D+W+ G I+Y L++G+PPF    +  IF  +   +  FP    +     ARDL+
Sbjct: 207 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARDLV 262
Query: 278 MGMLRVDPSTRLTAAEV 294
             +L +D + RL   E+
Sbjct: 263 EKLLVLDATKRLGCEEM 279

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score =  124 bits (312), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 76/257 (29%), Positives = 128/257 (49%), Gaps = 12/257 (4%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           +  GK LG G F  +    +  T    A K + K  ++    V  +  E ++M++L  HP
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HP 90
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
             V L   +++++ ++  +     GEL   + K G F ET  R     ++  + Y HG G
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 150
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLAGG 218
           ++HRDLKPENILL   +    I++ DFG A  +         +  VG+  Y++PE+L   
Sbjct: 151 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEK 207
Query: 219 YN-QAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLI 277
              +++D+W+ G I+Y L++G+PPF    +  IF  +   +  FP    +     ARDL+
Sbjct: 208 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARDLV 263
Query: 278 MGMLRVDPSTRLTAAEV 294
             +L +D + RL   E+
Sbjct: 264 EKLLVLDATKRLGCEEM 280

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score =  124 bits (311), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 76/257 (29%), Positives = 128/257 (49%), Gaps = 12/257 (4%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           +  GK LG G F  +    +  T    A K + K  ++    V  +  E ++M++L  HP
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HP 92
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
             V L   +++++ ++  +     GEL   + K G F ET  R     ++  + Y HG G
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLA-G 217
           ++HRDLKPENILL   +    I++ DFG A  +         +  VG+  Y++PE+L   
Sbjct: 153 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 218 GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLI 277
              +++D+W+ G I+Y L++G+PPF    +  IF  +   +  FP    +     ARDL+
Sbjct: 210 SAXKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFP----EKFFPKARDLV 265
Query: 278 MGMLRVDPSTRLTAAEV 294
             +L +D + RL   E+
Sbjct: 266 EKLLVLDATKRLGCEEM 282

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 76/257 (29%), Positives = 128/257 (49%), Gaps = 12/257 (4%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           +  GK LG G F  +    +  T    A K + K  ++    V  +  E ++M++L  HP
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HP 89
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
             V L   +++++ ++  +     GEL   + K G F ET  R     ++  + Y HG G
Sbjct: 90  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 149
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLAGG 218
           ++HRDLKPENILL   +    I++ DFG A  +         +  VG+  Y++PE+L   
Sbjct: 150 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 206
Query: 219 YN-QAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLI 277
              +++D+W+ G I+Y L++G+PPF    +  IF  +   +  FP    +     ARDL+
Sbjct: 207 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARDLV 262
Query: 278 MGMLRVDPSTRLTAAEV 294
             +L +D + RL   E+
Sbjct: 263 EKLLVLDATKRLGCEEM 279

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 79/270 (29%), Positives = 132/270 (48%), Gaps = 18/270 (6%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           +  GK LG G F  +    +  T    A K + K  ++    V  +  E ++M++L  HP
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HP 93
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
             V L   +++++ ++  +     GEL   + K G F ET  R     ++  + Y HG G
Sbjct: 94  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 153
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLAGG 218
           ++HRDLKPENILL   +    I++ DFG A  +         +  VG+  Y++PE+L   
Sbjct: 154 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 210
Query: 219 YN-QAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLI 277
              +++D+W+ G I+Y L++G+PPF    +  IF  +   +  FP    +     ARDL+
Sbjct: 211 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARDLV 266
Query: 278 MGMLRVDPSTRLTAAE------VLAHSWME 301
             +L +D + RL   E      + AH + E
Sbjct: 267 EKLLVLDATKRLGCEEMEGYGPLKAHPFFE 296

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 79/270 (29%), Positives = 132/270 (48%), Gaps = 18/270 (6%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           +  GK LG G F  +    +  T    A K + K  ++    V  +  E ++M++L  HP
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HP 68
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
             V L   +++++ ++  +     GEL   + K G F ET  R     ++  + Y HG G
Sbjct: 69  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 128
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLAGG 218
           ++HRDLKPENILL   +    I++ DFG A  +         +  VG+  Y++PE+L   
Sbjct: 129 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 185
Query: 219 YN-QAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLI 277
              +++D+W+ G I+Y L++G+PPF    +  IF  +   +  FP    +     ARDL+
Sbjct: 186 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARDLV 241
Query: 278 MGMLRVDPSTRLTAAE------VLAHSWME 301
             +L +D + RL   E      + AH + E
Sbjct: 242 EKLLVLDATKRLGCEEMEGYGPLKAHPFFE 271

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 79/270 (29%), Positives = 132/270 (48%), Gaps = 18/270 (6%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           +  GK LG G F  +    +  T    A K + K  ++    V  +  E ++M++L  HP
Sbjct: 9   FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HP 67
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
             V L   +++++ ++  +     GEL   + K G F ET  R     ++  + Y HG G
Sbjct: 68  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 127
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLAGG 218
           ++HRDLKPENILL   +    I++ DFG A  +         +  VG+  Y++PE+L   
Sbjct: 128 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 184
Query: 219 YN-QAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLI 277
              +++D+W+ G I+Y L++G+PPF    +  IF  +   +  FP    +     ARDL+
Sbjct: 185 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARDLV 240
Query: 278 MGMLRVDPSTRLTAAE------VLAHSWME 301
             +L +D + RL   E      + AH + E
Sbjct: 241 EKLLVLDATKRLGCEEMEGYGPLKAHPFFE 270

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 76/257 (29%), Positives = 128/257 (49%), Gaps = 12/257 (4%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           +  GK LG G F  +    +  T    A K + K  ++    V  +  E ++M++L  HP
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HP 90
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
             V L   +++++ ++  +     GEL   + K G F ET  R     ++  + Y HG G
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 150
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLAGG 218
           ++HRDLKPENILL   +    I++ DFG A  +         +  VG+  Y++PE+L   
Sbjct: 151 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 207
Query: 219 YN-QAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLI 277
              +++D+W+ G I+Y L++G+PPF    +  IF  +   +  FP    +     ARDL+
Sbjct: 208 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARDLV 263
Query: 278 MGMLRVDPSTRLTAAEV 294
             +L +D + RL   E+
Sbjct: 264 EKLLVLDATKRLGCEEM 280

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 76/257 (29%), Positives = 128/257 (49%), Gaps = 12/257 (4%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           +  GK LG G F  +    +  T    A K + K  ++    V  +  E ++M++L  HP
Sbjct: 16  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HP 74
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
             V L   +++++ ++  +     GEL   + K G F ET  R     ++  + Y HG G
Sbjct: 75  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 134
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLA-G 217
           ++HRDLKPENILL   +    I++ DFG A  +         +  VG+  Y++PE+L   
Sbjct: 135 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 191
Query: 218 GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLI 277
              +++D+W+ G I+Y L++G+PPF    +  IF  +   +  FP    +     ARDL+
Sbjct: 192 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARDLV 247
Query: 278 MGMLRVDPSTRLTAAEV 294
             +L +D + RL   E+
Sbjct: 248 EKLLVLDATKRLGCEEM 264

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 76/257 (29%), Positives = 128/257 (49%), Gaps = 12/257 (4%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           +  GK LG G F  +    +  T    A K + K  ++    V  +  E ++M++L  HP
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HP 90
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
             V L   +++++ ++  +     GEL   + K G F ET  R     ++  + Y HG G
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 150
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLAGG 218
           ++HRDLKPENILL   +    I++ DFG A  +         +  VG+  Y++PE+L   
Sbjct: 151 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 207
Query: 219 YN-QAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLI 277
              +++D+W+ G I+Y L++G+PPF    +  IF  +   +  FP    +     ARDL+
Sbjct: 208 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARDLV 263
Query: 278 MGMLRVDPSTRLTAAEV 294
             +L +D + RL   E+
Sbjct: 264 EKLLVLDATKRLGCEEM 280

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 79/270 (29%), Positives = 132/270 (48%), Gaps = 18/270 (6%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           +  GK LG G F  +    +  T    A K + K  ++    V  +  E ++M++L  HP
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HP 92
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
             V L   +++++ ++  +     GEL   + K G F ET  R     ++  + Y HG G
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLAGG 218
           ++HRDLKPENILL   +    I++ DFG A  +         +  VG+  Y++PE+L   
Sbjct: 153 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 219 YN-QAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLI 277
              +++D+W+ G I+Y L++G+PPF    +  IF  +   +  FP    +     ARDL+
Sbjct: 210 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARDLV 265
Query: 278 MGMLRVDPSTRLTAAE------VLAHSWME 301
             +L +D + RL   E      + AH + E
Sbjct: 266 EKLLVLDATKRLGCEEMEGYGPLKAHPFFE 295

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 79/270 (29%), Positives = 132/270 (48%), Gaps = 18/270 (6%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           +  GK LG G F  +    +  T    A K + K  ++    V  +  E ++M++L  HP
Sbjct: 12  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HP 70
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
             V L   +++++ ++  +     GEL   + K G F ET  R     ++  + Y HG G
Sbjct: 71  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 130
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLAGG 218
           ++HRDLKPENILL   +    I++ DFG A  +         +  VG+  Y++PE+L   
Sbjct: 131 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 187
Query: 219 YN-QAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLI 277
              +++D+W+ G I+Y L++G+PPF    +  IF  +   +  FP    +     ARDL+
Sbjct: 188 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARDLV 243
Query: 278 MGMLRVDPSTRLTAAE------VLAHSWME 301
             +L +D + RL   E      + AH + E
Sbjct: 244 EKLLVLDATKRLGCEEMEGYGPLKAHPFFE 273

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 76/257 (29%), Positives = 128/257 (49%), Gaps = 12/257 (4%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           +  GK LG G F  +    +  T    A K + K  ++    V  +  E ++M++L  HP
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HP 92
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
             V L   +++++ ++  +     GEL   + K G F ET  R     ++  + Y HG G
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLAGG 218
           ++HRDLKPENILL   +    I++ DFG A  +         +  VG+  Y++PE+L   
Sbjct: 153 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 219 YN-QAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLI 277
              +++D+W+ G I+Y L++G+PPF    +  IF  +   +  FP    +     ARDL+
Sbjct: 210 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARDLV 265
Query: 278 MGMLRVDPSTRLTAAEV 294
             +L +D + RL   E+
Sbjct: 266 EKLLVLDATKRLGCEEM 282

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 79/270 (29%), Positives = 132/270 (48%), Gaps = 18/270 (6%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           +  GK LG G F  +    +  T    A K + K  ++    V  +  E ++M++L  HP
Sbjct: 11  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HP 69
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
             V L   +++++ ++  +     GEL   + K G F ET  R     ++  + Y HG G
Sbjct: 70  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 129
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLAGG 218
           ++HRDLKPENILL   +    I++ DFG A  +         +  VG+  Y++PE+L   
Sbjct: 130 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 186
Query: 219 YN-QAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLI 277
              +++D+W+ G I+Y L++G+PPF    +  IF  +   +  FP    +     ARDL+
Sbjct: 187 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARDLV 242
Query: 278 MGMLRVDPSTRLTAAE------VLAHSWME 301
             +L +D + RL   E      + AH + E
Sbjct: 243 EKLLVLDATKRLGCEEMEGYGPLKAHPFFE 272

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 79/270 (29%), Positives = 132/270 (48%), Gaps = 18/270 (6%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           +  GK LG G F  +    +  T    A K + K  ++    V  +  E ++M++L  HP
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HP 93
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
             V L   +++++ ++  +     GEL   + K G F ET  R     ++  + Y HG G
Sbjct: 94  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 153
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLAGG 218
           ++HRDLKPENILL   +    I++ DFG A  +         +  VG+  Y++PE+L   
Sbjct: 154 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 210
Query: 219 YN-QAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLI 277
              +++D+W+ G I+Y L++G+PPF    +  IF  +   +  FP    +     ARDL+
Sbjct: 211 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARDLV 266
Query: 278 MGMLRVDPSTRLTAAE------VLAHSWME 301
             +L +D + RL   E      + AH + E
Sbjct: 267 EKLLVLDATKRLGCEEMEGYGPLKAHPFFE 296

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 79/270 (29%), Positives = 132/270 (48%), Gaps = 18/270 (6%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           +  GK LG G F  +    +  T    A K + K  ++    V  +  E ++M++L  HP
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HP 92
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
             V L   +++++ ++  +     GEL   + K G F ET  R     ++  + Y HG G
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLAGG 218
           ++HRDLKPENILL   +    I++ DFG A  +         +  VG+  Y++PE+L   
Sbjct: 153 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 219 YN-QAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLI 277
              +++D+W+ G I+Y L++G+PPF    +  IF  +   +  FP    +     ARDL+
Sbjct: 210 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARDLV 265
Query: 278 MGMLRVDPSTRLTAAE------VLAHSWME 301
             +L +D + RL   E      + AH + E
Sbjct: 266 EKLLVLDATKRLGCEEMEGYGPLKAHPFFE 295

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 79/270 (29%), Positives = 132/270 (48%), Gaps = 18/270 (6%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           +  GK LG G F  +    +  T    A K + K  ++    V  +  E ++M++L  HP
Sbjct: 39  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HP 97
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
             V L   +++++ ++  +     GEL   + K G F ET  R     ++  + Y HG G
Sbjct: 98  FFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 157
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLA-G 217
           ++HRDLKPENILL   +    I++ DFG A  +         +  VG+  Y++PE+L   
Sbjct: 158 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 214
Query: 218 GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLI 277
              +++D+W+ G I+Y L++G+PPF    +  IF  +   +  FP    +     ARDL+
Sbjct: 215 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARDLV 270
Query: 278 MGMLRVDPSTRLTAAE------VLAHSWME 301
             +L +D + RL   E      + AH + E
Sbjct: 271 EKLLVLDATKRLGCEEMEGYGPLKAHPFFE 300

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 76/257 (29%), Positives = 128/257 (49%), Gaps = 12/257 (4%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           +  GK LG G F  +    +  T    A K + K  ++    V  +  E ++M++L  HP
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HP 92
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
             V L   +++++ ++  +     GEL   + K G F ET  R     ++  + Y HG G
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLAGG 218
           ++HRDLKPENILL   +    I++ DFG A  +         +  VG+  Y++PE+L   
Sbjct: 153 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 219 YN-QAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLI 277
              +++D+W+ G I+Y L++G+PPF    +  IF  +   +  FP    +     ARDL+
Sbjct: 210 SACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFP----EKFFPKARDLV 265
Query: 278 MGMLRVDPSTRLTAAEV 294
             +L +D + RL   E+
Sbjct: 266 EKLLVLDATKRLGCEEM 282

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 79/270 (29%), Positives = 132/270 (48%), Gaps = 18/270 (6%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           +  GK LG G F  +    +  T    A K + K  ++    V  +  E ++M++L  HP
Sbjct: 37  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HP 95
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
             V L   +++++ ++  +     GEL   + K G F ET  R     ++  + Y HG G
Sbjct: 96  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 155
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLAGG 218
           ++HRDLKPENILL   +    I++ DFG A  +         +  VG+  Y++PE+L   
Sbjct: 156 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 212
Query: 219 YN-QAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLI 277
              +++D+W+ G I+Y L++G+PPF    +  IF  +   +  FP+         ARDL+
Sbjct: 213 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPAA----FFPKARDLV 268
Query: 278 MGMLRVDPSTRLTAAE------VLAHSWME 301
             +L +D + RL   E      + AH + E
Sbjct: 269 EKLLVLDATKRLGCEEMEGYGPLKAHPFFE 298

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 76/257 (29%), Positives = 127/257 (49%), Gaps = 12/257 (4%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           +  GK LG G F       +  T    A K + K  ++    V  +  E ++M++L  HP
Sbjct: 32  FKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HP 90
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
             V L   +++++ ++  +     GEL   + K G F ET  R     ++  + Y HG G
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 150
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLAGG 218
           ++HRDLKPENILL   +    I++ DFG A  +         +  VG+  Y++PE+L   
Sbjct: 151 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 207
Query: 219 YN-QAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLI 277
              +++D+W+ G I+Y L++G+PPF    +  IF  +   +  FP    +     ARDL+
Sbjct: 208 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARDLV 263
Query: 278 MGMLRVDPSTRLTAAEV 294
             +L +D + RL   E+
Sbjct: 264 EKLLVLDATKRLGCEEM 280

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score =  122 bits (305), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 132/270 (48%), Gaps = 18/270 (6%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           +  GK LG G F  +    +  T    A K + K  ++    V  +  E ++M++L  HP
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HP 92
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
             V L   +++++ ++  +     G L   + K G F ET  R     ++  + Y HG G
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLA-G 217
           ++HRDLKPENILL   +    I++ DFG A  +         +  VG+  Y++PE+L   
Sbjct: 153 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 209
Query: 218 GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLI 277
             ++++D+W+ G I+Y L++G+PPF    +  IF  +   +  FP    +     ARDL+
Sbjct: 210 SASKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARDLV 265
Query: 278 MGMLRVDPSTRLTAAE------VLAHSWME 301
             +L +D + RL   E      + AH + E
Sbjct: 266 EKLLVLDATKRLGCEEMEGYGPLKAHPFFE 295

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 75/261 (28%), Positives = 134/261 (51%), Gaps = 13/261 (4%)
Query: 31  DATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLE 90
           D  ++++ +   VLGK    G FG +     K T E+ A K + KD ++  +DV    +E
Sbjct: 336 DRMKLTDFNFLMVLGK----GSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVE 391
Query: 91  IEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHL 150
             ++      P +  L + ++  D ++ +ME   GG+L + +++ GRF E  A      +
Sbjct: 392 KRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEI 451
Query: 151 MQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLAT-YIKAGQNLHGTVGSPFY 209
              + +    G+++RDLK +N++L    S   IK+ADFG+    I  G       G+P Y
Sbjct: 452 AIGLFFLQSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENIWDGVTTKXFCGTPDY 508
Query: 210 IAPEVLA-GGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDH 268
           IAPE++A   Y ++ D W+ GV+LY +L+G  PF G+ + ++F ++   ++ +P      
Sbjct: 509 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKS---- 564
Query: 269 ISASARDLIMGMLRVDPSTRL 289
           +S  A  +  G++   P  RL
Sbjct: 565 MSKEAVAICKGLMTKHPGKRL 585

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 89/303 (29%), Positives = 157/303 (51%), Gaps = 39/303 (12%)
Query: 40  DRYVLGKQLGWGQFG---VIRECSDKFTGEVLACKSIAKDRLV----TVEDVRSIKLEIE 92
           + + L K LG G +G   ++R+ S   TG++ A K + K  +V    T E  R+   E +
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRT---ERQ 110
Query: 93  IMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQ 152
           ++  +   P +V L   ++ E  +HL+++   GGELF  L +  RF+E E ++    ++ 
Sbjct: 111 VLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVL 170
Query: 153 VVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN--LHGTVGSPFYI 210
            + + H  G+++RD+K ENILL    S+  + L DFGL+    A +    +   G+  Y+
Sbjct: 171 ALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 227
Query: 211 APEVLAG---GYNQAADVWSAGVILYILLSGMPPFW----GKTKSKIFDAVRAADLRFPS 263
           AP+++ G   G+++A D WS GV++Y LL+G  PF       ++++I   +  ++  +P 
Sbjct: 228 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ 287
Query: 264 DPWDHISASARDLIMGMLRVDPSTRL-----TAAEVLAHSWMEECEQVAQKPCKQDDLCC 318
           +    +SA A+DLI  +L  DP  RL      A E+  H + ++           DDL  
Sbjct: 288 E----MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK--------INWDDLAA 335
Query: 319 KQL 321
           K++
Sbjct: 336 KKV 338

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 75/261 (28%), Positives = 134/261 (51%), Gaps = 13/261 (4%)
Query: 31  DATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLE 90
           D  ++++ +   VLGK    G FG +     K T E+ A K + KD ++  +DV    +E
Sbjct: 15  DRMKLTDFNFLMVLGK----GSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVE 70
Query: 91  IEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHL 150
             ++      P +  L + ++  D ++ +ME   GG+L + +++ GRF E  A      +
Sbjct: 71  KRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEI 130
Query: 151 MQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLAT-YIKAGQNLHGTVGSPFY 209
              + +    G+++RDLK +N++L    S   IK+ADFG+    I  G       G+P Y
Sbjct: 131 AIGLFFLQSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENIWDGVTTKXFCGTPDY 187
Query: 210 IAPEVLA-GGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDH 268
           IAPE++A   Y ++ D W+ GV+LY +L+G  PF G+ + ++F ++   ++ +P      
Sbjct: 188 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKS---- 243
Query: 269 ISASARDLIMGMLRVDPSTRL 289
           +S  A  +  G++   P  RL
Sbjct: 244 MSKEAVAICKGLMTKHPGKRL 264

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 91/309 (29%), Positives = 150/309 (48%), Gaps = 33/309 (10%)
Query: 39  SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVT---VEDVR--SIKLEIEI 93
           S +Y     LG G FG +    DK   + +  K I K++++    +ED +   + LEI I
Sbjct: 23  SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82
Query: 94  MTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGG-ELFHRLEKYGRFSETEARVIFRHLMQ 152
           ++++  H N++ +  ++E + +  L+ME    G +LF  ++++ R  E  A  IFR L+ 
Sbjct: 83  LSRVE-HANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVS 141
Query: 153 VVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAP 212
            V Y     ++HRD+K ENI++A   +   IKL DFG A Y++ G+  +   G+  Y AP
Sbjct: 142 AVGYLRLKDIIHRDIKDENIVIAEDFT---IKLIDFGSAAYLERGKLFYTFCGTIEYCAP 198
Query: 213 EVLAGGYNQAADV--WSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHIS 270
           EVL G   +  ++  WS GV LY L+    PF      ++ + V AA       P   +S
Sbjct: 199 EVLMGNPYRGPELEMWSLGVTLYTLVFEENPF-----CELEETVEAA-----IHPPYLVS 248
Query: 271 ASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVA----------QKPCKQDDLCCKQ 320
                L+ G+L+  P  R T  +++   W+ +   +A           KP +   L    
Sbjct: 249 KELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFRVNKP-ESGVLSAAS 307
Query: 321 LEVGGSSFS 329
           LE+G  S S
Sbjct: 308 LEMGNRSLS 316

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 84/291 (28%), Positives = 145/291 (49%), Gaps = 30/291 (10%)
Query: 36  SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRS----IKLEI 91
           + L  +Y++G  LG G +G ++E  D    E L  +++   +   +  + +    +K EI
Sbjct: 1   AKLIGKYLMGDLLGEGSYGKVKEVLDS---ETLCRRAVKILKKKKLRRIPNGEANVKKEI 57
Query: 92  EIMTKLSGHPNVVDLKAVY--EEEDYVHLLMELCAGG--ELFHRLEKYGRFSETEARVIF 147
           +++ +L  H NV+ L  V   EE+  ++++ME C  G  E+   + +  RF   +A   F
Sbjct: 58  QLLRRLR-HKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE-KRFPVCQAHGYF 115
Query: 148 RHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIK---AGQNLHGTV 204
             L+  + Y H  G+VH+D+KP N+LL T  +   +K++  G+A  +    A      + 
Sbjct: 116 CQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGT---LKISALGVAEALHPFAADDTCRTSQ 172
Query: 205 GSPFYIAPEVLAG-----GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADL 259
           GSP +  PE+  G     G+    D+WSAGV LY + +G+ PF G    K+F+ +     
Sbjct: 173 GSPAFQPPEIANGLDTFSGFK--VDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSY 230
Query: 260 RFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKP 310
             P D    +S    DL+ GML  +P+ R +  ++  HSW  +    A+ P
Sbjct: 231 AIPGDCGPPLS----DLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAP 277

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 91/279 (32%), Positives = 136/279 (48%), Gaps = 21/279 (7%)
Query: 22  VSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTV 81
           +S    TI     +   ++ Y + K +G G FG ++    K T +V A K ++K  ++  
Sbjct: 51  LSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKR 110
Query: 82  EDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSET 141
            D      E +IM   +  P VV L   ++++ Y++++ME   GG+L + +  Y    E 
Sbjct: 111 SDSAFFWEERDIMA-FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEK 168
Query: 142 EARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI-KAGQ-N 199
            AR     ++  +   H  G +HRD+KP+N+LL     S  +KLADFG    + K G   
Sbjct: 169 WARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVR 225
Query: 200 LHGTVGSPFYIAPEVLA-----GGYNQAADVWSAGVILYILLSGMPPFWGK----TKSKI 250
               VG+P YI+PEVL      G Y +  D WS GV LY +L G  PF+      T SKI
Sbjct: 226 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI 285
Query: 251 FDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRL 289
            +   +  L FP D  + IS  A++LI   L  D   RL
Sbjct: 286 MNHKNS--LTFPDD--NDISKEAKNLICAFL-TDREVRL 319

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 91/279 (32%), Positives = 136/279 (48%), Gaps = 21/279 (7%)
Query: 22  VSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTV 81
           +S    TI     +   ++ Y + K +G G FG ++    K T +V A K ++K  ++  
Sbjct: 56  LSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKR 115
Query: 82  EDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSET 141
            D      E +IM   +  P VV L   ++++ Y++++ME   GG+L + +  Y    E 
Sbjct: 116 SDSAFFWEERDIMA-FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEK 173
Query: 142 EARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI-KAGQ-N 199
            AR     ++  +   H  G +HRD+KP+N+LL     S  +KLADFG    + K G   
Sbjct: 174 WARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVR 230
Query: 200 LHGTVGSPFYIAPEVLA-----GGYNQAADVWSAGVILYILLSGMPPFWGK----TKSKI 250
               VG+P YI+PEVL      G Y +  D WS GV LY +L G  PF+      T SKI
Sbjct: 231 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI 290
Query: 251 FDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRL 289
            +   +  L FP D  + IS  A++LI   L  D   RL
Sbjct: 291 MNHKNS--LTFPDD--NDISKEAKNLICAFL-TDREVRL 324

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 91/279 (32%), Positives = 136/279 (48%), Gaps = 21/279 (7%)
Query: 22  VSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTV 81
           +S    TI     +   ++ Y + K +G G FG ++    K T +V A K ++K  ++  
Sbjct: 56  LSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKR 115
Query: 82  EDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSET 141
            D      E +IM   +  P VV L   ++++ Y++++ME   GG+L + +  Y    E 
Sbjct: 116 SDSAFFWEERDIMA-FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEK 173
Query: 142 EARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI-KAGQ-N 199
            AR     ++  +   H  G +HRD+KP+N+LL     S  +KLADFG    + K G   
Sbjct: 174 WARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVR 230
Query: 200 LHGTVGSPFYIAPEVLA-----GGYNQAADVWSAGVILYILLSGMPPFWGK----TKSKI 250
               VG+P YI+PEVL      G Y +  D WS GV LY +L G  PF+      T SKI
Sbjct: 231 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI 290
Query: 251 FDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRL 289
            +   +  L FP D  + IS  A++LI   L  D   RL
Sbjct: 291 MNHKNS--LTFPDD--NDISKEAKNLICAFL-TDREVRL 324

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 129/253 (50%), Gaps = 10/253 (3%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           + + K++G GQF  +   +    G  +A K +    L+  +       EI+++ +L+ HP
Sbjct: 34  FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HP 92
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSE-TEARVIFRHLMQVVS---YC 157
           NV+   A + E++ +++++EL   G+L   ++ + +       R ++++ +Q+ S   + 
Sbjct: 93  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM 152
Query: 158 HGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNL-HGTVGSPFYIAPE-VL 215
           H   V+HRD+KP N+ +   +++  +KL D GL  +  +     H  VG+P+Y++PE + 
Sbjct: 153 HSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 209
Query: 216 AGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARD 275
             GYN  +D+WS G +LY + +   PF+G   +      +     +P  P DH S   R 
Sbjct: 210 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ 269
Query: 276 LIMGMLRVDPSTR 288
           L+   +  DP  R
Sbjct: 270 LVNMCINPDPEKR 282

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score =  111 bits (277), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 77/265 (29%), Positives = 135/265 (50%), Gaps = 22/265 (8%)
Query: 47  QLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDL 106
           +LG G FG + +  +K TG + A K I      + E++    +EIEI+     HP +V L
Sbjct: 26  ELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYIVEIEILAT-CDHPYIVKL 81
Query: 107 KAVYEEEDYVHLLMELCAGGELFHRLEKYGR-FSETEARVIFRHLMQVVSYCHGNGVVHR 165
              Y  +  + +++E C GG +   + +  R  +E + +V+ R +++ +++ H   ++HR
Sbjct: 82  LGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHR 141
Query: 166 DLKPENILLATKSSSSPIKLADFGL-ATYIKAGQNLHGTVGSPFYIAPEVLA------GG 218
           DLK  N+L+  +     I+LADFG+ A  +K  Q     +G+P+++APEV+         
Sbjct: 142 DLKAGNVLMTLEGD---IRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTP 198
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAAD---LRFPSDPWDHISASARD 275
           Y+  AD+WS G+ L  +    PP       ++   +  +D   L  PS  W   S   RD
Sbjct: 199 YDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSK-W---SVEFRD 254
Query: 276 LIMGMLRVDPSTRLTAAEVLAHSWM 300
            +   L  +P TR +AA++L H ++
Sbjct: 255 FLKIALDKNPETRPSAAQLLEHPFV 279

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score =  111 bits (277), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 97/338 (28%), Positives = 158/338 (46%), Gaps = 57/338 (16%)
Query: 1   MDTNNSEDSSQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECS 60
           M  +  +D S+++T       V +  G   D  Q  + +D  V+G     G FGV+ +  
Sbjct: 26  MKVSRDKDGSKVTT-------VVATPGQGPDRPQEVSYTDTKVIGN----GSFGVVYQAK 74
Query: 61  DKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVY----EEEDYV 116
              +GE++A K + +D+       R    E++IM KL  H N+V L+  +    E++D V
Sbjct: 75  LCDSGELVAIKKVLQDK-------RFKNRELQIMRKLD-HCNIVRLRYFFYSSGEKKDEV 126
Query: 117 HLLMELCAGGELFHRLEK-YGRFSET----EARVIFRHLMQVVSYCHGNGVVHRDLKPEN 171
           +L + L    E  +R+ + Y R  +T      ++    L + ++Y H  G+ HRD+KP+N
Sbjct: 127 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQN 186
Query: 172 ILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGG--YNQAADVWSAG 229
           +LL   ++   +KL DFG A  +  G+     + S +Y APE++ G   Y  + DVWSAG
Sbjct: 187 LLLDPDTAV--LKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAG 244
Query: 230 VILYILLSGMPPFWG----------------KTKSKIFDA-VRAADLRFP---SDPWDHI 269
            +L  LL G P F G                 T+ +I +      + +FP   + PW  +
Sbjct: 245 CVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKV 304
Query: 270 -----SASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
                   A  L   +L   P+ RLT  E  AHS+ +E
Sbjct: 305 FRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 342

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score =  111 bits (277), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 97/338 (28%), Positives = 158/338 (46%), Gaps = 57/338 (16%)
Query: 1   MDTNNSEDSSQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECS 60
           M  +  +D S+++T       V +  G   D  Q  + +D  V+G     G FGV+ +  
Sbjct: 4   MKVSRDKDGSKVTT-------VVATPGQGPDRPQEVSYTDTKVIGN----GSFGVVYQAK 52
Query: 61  DKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVY----EEEDYV 116
              +GE++A K + +D+       R    E++IM KL  H N+V L+  +    E++D V
Sbjct: 53  LCDSGELVAIKKVLQDK-------RFKNRELQIMRKLD-HCNIVRLRYFFYSSGEKKDEV 104
Query: 117 HLLMELCAGGELFHRLEK-YGRFSET----EARVIFRHLMQVVSYCHGNGVVHRDLKPEN 171
           +L + L    E  +R+ + Y R  +T      ++    L + ++Y H  G+ HRD+KP+N
Sbjct: 105 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQN 164
Query: 172 ILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGG--YNQAADVWSAG 229
           +LL   ++   +KL DFG A  +  G+     + S +Y APE++ G   Y  + DVWSAG
Sbjct: 165 LLLDPDTAV--LKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAG 222
Query: 230 VILYILLSGMPPFWG----------------KTKSKIFDA-VRAADLRFP---SDPWDHI 269
            +L  LL G P F G                 T+ +I +      + +FP   + PW  +
Sbjct: 223 CVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKV 282
Query: 270 -----SASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
                   A  L   +L   P+ RLT  E  AHS+ +E
Sbjct: 283 FRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 320

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score =  111 bits (277), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 97/338 (28%), Positives = 158/338 (46%), Gaps = 57/338 (16%)
Query: 1   MDTNNSEDSSQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECS 60
           M  +  +D S+++T       V +  G   D  Q  + +D  V+G     G FGV+ +  
Sbjct: 20  MKVSRDKDGSKVTT-------VVATPGQGPDRPQEVSYTDTKVIGN----GSFGVVYQAK 68
Query: 61  DKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVY----EEEDYV 116
              +GE++A K + +D+       R    E++IM KL  H N+V L+  +    E++D V
Sbjct: 69  LCDSGELVAIKKVLQDK-------RFKNRELQIMRKLD-HCNIVRLRYFFYSSGEKKDEV 120
Query: 117 HLLMELCAGGELFHRLEK-YGRFSET----EARVIFRHLMQVVSYCHGNGVVHRDLKPEN 171
           +L + L    E  +R+ + Y R  +T      ++    L + ++Y H  G+ HRD+KP+N
Sbjct: 121 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQN 180
Query: 172 ILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGG--YNQAADVWSAG 229
           +LL   ++   +KL DFG A  +  G+     + S +Y APE++ G   Y  + DVWSAG
Sbjct: 181 LLLDPDTAV--LKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAG 238
Query: 230 VILYILLSGMPPFWG----------------KTKSKIFDA-VRAADLRFP---SDPWDHI 269
            +L  LL G P F G                 T+ +I +      + +FP   + PW  +
Sbjct: 239 CVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKV 298
Query: 270 -----SASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
                   A  L   +L   P+ RLT  E  AHS+ +E
Sbjct: 299 FRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 336

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 77/265 (29%), Positives = 135/265 (50%), Gaps = 22/265 (8%)
Query: 47  QLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDL 106
           +LG G FG + +  +K TG + A K I      + E++    +EIEI+     HP +V L
Sbjct: 18  ELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYIVEIEILAT-CDHPYIVKL 73
Query: 107 KAVYEEEDYVHLLMELCAGGELFHRLEKYGR-FSETEARVIFRHLMQVVSYCHGNGVVHR 165
              Y  +  + +++E C GG +   + +  R  +E + +V+ R +++ +++ H   ++HR
Sbjct: 74  LGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHR 133
Query: 166 DLKPENILLATKSSSSPIKLADFGL-ATYIKAGQNLHGTVGSPFYIAPEVLA------GG 218
           DLK  N+L+  +     I+LADFG+ A  +K  Q     +G+P+++APEV+         
Sbjct: 134 DLKAGNVLMTLEGD---IRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTP 190
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAAD---LRFPSDPWDHISASARD 275
           Y+  AD+WS G+ L  +    PP       ++   +  +D   L  PS  W   S   RD
Sbjct: 191 YDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSK-W---SVEFRD 246
Query: 276 LIMGMLRVDPSTRLTAAEVLAHSWM 300
            +   L  +P TR +AA++L H ++
Sbjct: 247 FLKIALDKNPETRPSAAQLLEHPFV 271

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 89/297 (29%), Positives = 142/297 (47%), Gaps = 46/297 (15%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           Y   K +G G FGV+ +     +GE++A K + +D+       R    E++IM KL  H 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLD-HC 73
Query: 102 NVVDLKAVY----EEEDYVHLLMELCAGGELFHRLEK-YGRFSET----EARVIFRHLMQ 152
           N+V L+  +    E++D V+L + L    E  +R+ + Y R  +T      ++    L +
Sbjct: 74  NIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 153 VVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAP 212
            ++Y H  G+ HRD+KP+N+LL   ++   +KL DFG A  +  G+     + S +Y AP
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLLDPDTAV--LKLCDFGSAKQLVRGEPNVSXICSRYYRAP 191
Query: 213 EVLAGG--YNQAADVWSAGVILYILLSGMPPFWG----------------KTKSKIFDA- 253
           E++ G   Y  + DVWSAG +L  LL G P F G                 T+ +I +  
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 254 VRAADLRFP---SDPWDHI-----SASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
               + +FP   + PW  +        A  L   +L   P+ RLT  E  AHS+ +E
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 308

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 97/338 (28%), Positives = 158/338 (46%), Gaps = 57/338 (16%)
Query: 1   MDTNNSEDSSQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECS 60
           M  +  +D S+++T       V +  G   D  Q  + +D  V+G     G FGV+ +  
Sbjct: 26  MKVSRDKDGSKVTT-------VVATPGQGPDRPQEVSYTDTKVIGN----GSFGVVYQAK 74
Query: 61  DKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVY----EEEDYV 116
              +GE++A K + +D+       R    E++IM KL  H N+V L+  +    E++D V
Sbjct: 75  LCDSGELVAIKKVLQDK-------RFKNRELQIMRKLD-HCNIVRLRYFFYSSGEKKDEV 126
Query: 117 HLLMELCAGGELFHRLEK-YGRFSET----EARVIFRHLMQVVSYCHGNGVVHRDLKPEN 171
           +L + L    E  +R+ + Y R  +T      ++    L + ++Y H  G+ HRD+KP+N
Sbjct: 127 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQN 186
Query: 172 ILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGG--YNQAADVWSAG 229
           +LL   ++   +KL DFG A  +  G+     + S +Y APE++ G   Y  + DVWSAG
Sbjct: 187 LLLDPDTAV--LKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAG 244
Query: 230 VILYILLSGMPPFWG----------------KTKSKIFDA-VRAADLRFP---SDPWDHI 269
            +L  LL G P F G                 T+ +I +      + +FP   + PW  +
Sbjct: 245 CVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKV 304
Query: 270 -----SASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
                   A  L   +L   P+ RLT  E  AHS+ +E
Sbjct: 305 FRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 342

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 84/258 (32%), Positives = 129/258 (50%), Gaps = 12/258 (4%)
Query: 48  LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLK 107
           LG G FG +  C  + TG++ ACK + K R+   +       E +I+ K++    VV L 
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR-FVVSLA 250
Query: 108 AVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR--HLMQVVSYCHGNGVVHR 165
             YE +D + L++ L  GG+L   +   G+    EAR +F    +   +   H   +V+R
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYR 310
Query: 166 DLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG-GYNQAAD 224
           DLKPENILL        I+++D GLA ++  GQ + G VG+  Y+APEV+    Y  + D
Sbjct: 311 DLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPD 367
Query: 225 VWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVD 284
            W+ G +LY +++G  PF  + K    + V       P +  +  S  AR L   +L  D
Sbjct: 368 WWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKD 427
Query: 285 PSTRL-----TAAEVLAH 297
           P+ RL     +A EV  H
Sbjct: 428 PAERLGCRGGSAREVKEH 445

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 97/338 (28%), Positives = 158/338 (46%), Gaps = 57/338 (16%)
Query: 1   MDTNNSEDSSQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECS 60
           M  +  +D S+++T       V +  G   D  Q  + +D  V+G     G FGV+ +  
Sbjct: 28  MKVSRDKDGSKVTT-------VVATPGQGPDRPQEVSYTDTKVIGN----GSFGVVYQAK 76
Query: 61  DKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVY----EEEDYV 116
              +GE++A K + +D+       R    E++IM KL  H N+V L+  +    E++D V
Sbjct: 77  LCDSGELVAIKKVLQDK-------RFKNRELQIMRKLD-HCNIVRLRYFFYSSGEKKDEV 128
Query: 117 HLLMELCAGGELFHRLEK-YGRFSET----EARVIFRHLMQVVSYCHGNGVVHRDLKPEN 171
           +L + L    E  +R+ + Y R  +T      ++    L + ++Y H  G+ HRD+KP+N
Sbjct: 129 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQN 188
Query: 172 ILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGG--YNQAADVWSAG 229
           +LL   ++   +KL DFG A  +  G+     + S +Y APE++ G   Y  + DVWSAG
Sbjct: 189 LLLDPDTAV--LKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAG 246
Query: 230 VILYILLSGMPPFWG----------------KTKSKIFDA-VRAADLRFP---SDPWDHI 269
            +L  LL G P F G                 T+ +I +      + +FP   + PW  +
Sbjct: 247 CVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKV 306
Query: 270 -----SASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
                   A  L   +L   P+ RLT  E  AHS+ +E
Sbjct: 307 FRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 344

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 86/297 (28%), Positives = 145/297 (48%), Gaps = 47/297 (15%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           Y   K +G G FGV+      F  +++    +A  +++  +D R    E++IM ++  HP
Sbjct: 42  YTNCKVIGNGSFGVV------FQAKLVESDEVAIKKVL--QDKRFKNRELQIM-RIVKHP 92
Query: 102 NVVDLKAVY----EEEDYVHLLMELCAGGELFHRLEK-YGRFSETEARVIFR----HLMQ 152
           NVVDLKA +    +++D V L + L    E  +R  + Y +  +T   ++ +     L++
Sbjct: 93  NVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLR 152
Query: 153 VVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAP 212
            ++Y H  G+ HRD+KP+N+LL   S    +KL DFG A  + AG+     + S +Y AP
Sbjct: 153 SLAYIHSIGICHRDIKPQNLLLDPPSGV--LKLIDFGSAKILIAGEPNVSXICSRYYRAP 210
Query: 213 EVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTK-SKIFDAVRA------------- 256
           E++ G   Y    D+WS G ++  L+ G P F G++   ++ + ++              
Sbjct: 211 ELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMN 270
Query: 257 ---ADLRFP---SDPWDHI-----SASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
               + +FP     P+  +        A DLI  +L   PS RLTA E L H + +E
Sbjct: 271 PNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDE 327

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 89/297 (29%), Positives = 142/297 (47%), Gaps = 46/297 (15%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           Y   K +G G FGV+ +     +GE++A K + +D+       R    E++IM KL  H 
Sbjct: 30  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLD-HC 81
Query: 102 NVVDLKAVY----EEEDYVHLLMELCAGGELFHRLEK-YGRFSET----EARVIFRHLMQ 152
           N+V L+  +    E++D V+L + L    E  +R+ + Y R  +T      ++    L +
Sbjct: 82  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 141
Query: 153 VVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAP 212
            ++Y H  G+ HRD+KP+N+LL   ++   +KL DFG A  +  G+     + S +Y AP
Sbjct: 142 SLAYIHSFGICHRDIKPQNLLLDPDTAV--LKLCDFGSAKQLVRGEPNVSXICSRYYRAP 199
Query: 213 EVLAGG--YNQAADVWSAGVILYILLSGMPPFWG----------------KTKSKIFDA- 253
           E++ G   Y  + DVWSAG +L  LL G P F G                 T+ +I +  
Sbjct: 200 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 259
Query: 254 VRAADLRFP---SDPWDHI-----SASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
               + +FP   + PW  +        A  L   +L   P+ RLT  E  AHS+ +E
Sbjct: 260 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 316

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 97/338 (28%), Positives = 158/338 (46%), Gaps = 57/338 (16%)
Query: 1   MDTNNSEDSSQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECS 60
           M  +  +D S+++T       V +  G   D  Q  + +D  V+G     G FGV+ +  
Sbjct: 30  MKVSRDKDGSKVTT-------VVATPGQGPDRPQEVSYTDTKVIGN----GSFGVVYQAK 78
Query: 61  DKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVY----EEEDYV 116
              +GE++A K + +D+       R    E++IM KL  H N+V L+  +    E++D V
Sbjct: 79  LCDSGELVAIKKVLQDK-------RFKNRELQIMRKLD-HCNIVRLRYFFYSSGEKKDEV 130
Query: 117 HLLMELCAGGELFHRLEK-YGRFSET----EARVIFRHLMQVVSYCHGNGVVHRDLKPEN 171
           +L + L    E  +R+ + Y R  +T      ++    L + ++Y H  G+ HRD+KP+N
Sbjct: 131 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQN 190
Query: 172 ILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGG--YNQAADVWSAG 229
           +LL   ++   +KL DFG A  +  G+     + S +Y APE++ G   Y  + DVWSAG
Sbjct: 191 LLLDPDTAV--LKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAG 248
Query: 230 VILYILLSGMPPFWG----------------KTKSKIFDA-VRAADLRFP---SDPWDHI 269
            +L  LL G P F G                 T+ +I +      + +FP   + PW  +
Sbjct: 249 CVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKV 308
Query: 270 -----SASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
                   A  L   +L   P+ RLT  E  AHS+ +E
Sbjct: 309 FRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 346

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 84/258 (32%), Positives = 129/258 (50%), Gaps = 12/258 (4%)
Query: 48  LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLK 107
           LG G FG +  C  + TG++ ACK + K R+   +       E +I+ K++    VV L 
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR-FVVSLA 250
Query: 108 AVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR--HLMQVVSYCHGNGVVHR 165
             YE +D + L++ L  GG+L   +   G+    EAR +F    +   +   H   +V+R
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYR 310
Query: 166 DLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG-GYNQAAD 224
           DLKPENILL        I+++D GLA ++  GQ + G VG+  Y+APEV+    Y  + D
Sbjct: 311 DLKPENILLDDHGH---IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPD 367
Query: 225 VWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVD 284
            W+ G +LY +++G  PF  + K    + V       P +  +  S  AR L   +L  D
Sbjct: 368 WWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKD 427
Query: 285 PSTRL-----TAAEVLAH 297
           P+ RL     +A EV  H
Sbjct: 428 PAERLGCRGGSAREVKEH 445

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 89/297 (29%), Positives = 142/297 (47%), Gaps = 46/297 (15%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           Y   K +G G FGV+ +     +GE++A K + +D+       R    E++IM KL  H 
Sbjct: 41  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLD-HC 92
Query: 102 NVVDLKAVY----EEEDYVHLLMELCAGGELFHRLEK-YGRFSET----EARVIFRHLMQ 152
           N+V L+  +    E++D V+L + L    E  +R+ + Y R  +T      ++    L +
Sbjct: 93  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 152
Query: 153 VVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAP 212
            ++Y H  G+ HRD+KP+N+LL   ++   +KL DFG A  +  G+     + S +Y AP
Sbjct: 153 SLAYIHSFGICHRDIKPQNLLLDPDTAV--LKLCDFGSAKQLVRGEPNVSXICSRYYRAP 210
Query: 213 EVLAGG--YNQAADVWSAGVILYILLSGMPPFWG----------------KTKSKIFDA- 253
           E++ G   Y  + DVWSAG +L  LL G P F G                 T+ +I +  
Sbjct: 211 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 270
Query: 254 VRAADLRFP---SDPWDHI-----SASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
               + +FP   + PW  +        A  L   +L   P+ RLT  E  AHS+ +E
Sbjct: 271 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 327

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 89/297 (29%), Positives = 142/297 (47%), Gaps = 46/297 (15%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           Y   K +G G FGV+ +     +GE++A K + +D+       R    E++IM KL  H 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLD-HC 73
Query: 102 NVVDLKAVY----EEEDYVHLLMELCAGGELFHRLEK-YGRFSET----EARVIFRHLMQ 152
           N+V L+  +    E++D V+L + L    E  +R+ + Y R  +T      ++    L +
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 153 VVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAP 212
            ++Y H  G+ HRD+KP+N+LL   ++   +KL DFG A  +  G+     + S +Y AP
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLLDPDTAV--LKLCDFGSAKQLVRGEPNVSXICSRYYRAP 191
Query: 213 EVLAGG--YNQAADVWSAGVILYILLSGMPPFWG----------------KTKSKIFDA- 253
           E++ G   Y  + DVWSAG +L  LL G P F G                 T+ +I +  
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 254 VRAADLRFP---SDPWDHI-----SASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
               + +FP   + PW  +        A  L   +L   P+ RLT  E  AHS+ +E
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 308

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 89/297 (29%), Positives = 142/297 (47%), Gaps = 46/297 (15%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           Y   K +G G FGV+ +     +GE++A K + +D+       R    E++IM KL  H 
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLD-HC 85
Query: 102 NVVDLKAVY----EEEDYVHLLMELCAGGELFHRLEK-YGRFSET----EARVIFRHLMQ 152
           N+V L+  +    E++D V+L + L    E  +R+ + Y R  +T      ++    L +
Sbjct: 86  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 145
Query: 153 VVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAP 212
            ++Y H  G+ HRD+KP+N+LL   ++   +KL DFG A  +  G+     + S +Y AP
Sbjct: 146 SLAYIHSFGICHRDIKPQNLLLDPDTAV--LKLCDFGSAKQLVRGEPNVSXICSRYYRAP 203
Query: 213 EVLAGG--YNQAADVWSAGVILYILLSGMPPFWG----------------KTKSKIFDA- 253
           E++ G   Y  + DVWSAG +L  LL G P F G                 T+ +I +  
Sbjct: 204 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 263
Query: 254 VRAADLRFP---SDPWDHI-----SASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
               + +FP   + PW  +        A  L   +L   P+ RLT  E  AHS+ +E
Sbjct: 264 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 320

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 97/338 (28%), Positives = 158/338 (46%), Gaps = 57/338 (16%)
Query: 1   MDTNNSEDSSQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECS 60
           M  +  +D S+++T       V +  G   D  Q  + +D  V+G     G FGV+ +  
Sbjct: 71  MKVSRDKDGSKVTT-------VVATPGQGPDRPQEVSYTDTKVIGN----GSFGVVYQAK 119
Query: 61  DKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVY----EEEDYV 116
              +GE++A K + +D+       R    E++IM KL  H N+V L+  +    E++D V
Sbjct: 120 LCDSGELVAIKKVLQDK-------RFKNRELQIMRKLD-HCNIVRLRYFFYSSGEKKDEV 171
Query: 117 HLLMELCAGGELFHRLEK-YGRFSET----EARVIFRHLMQVVSYCHGNGVVHRDLKPEN 171
           +L + L    E  +R+ + Y R  +T      ++    L + ++Y H  G+ HRD+KP+N
Sbjct: 172 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQN 231
Query: 172 ILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGG--YNQAADVWSAG 229
           +LL   ++   +KL DFG A  +  G+     + S +Y APE++ G   Y  + DVWSAG
Sbjct: 232 LLLDPDTAV--LKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAG 289
Query: 230 VILYILLSGMPPFWG----------------KTKSKIFDA-VRAADLRFP---SDPWDHI 269
            +L  LL G P F G                 T+ +I +      + +FP   + PW  +
Sbjct: 290 CVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKV 349
Query: 270 -----SASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
                   A  L   +L   P+ RLT  E  AHS+ +E
Sbjct: 350 FRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 387

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 69/259 (26%), Positives = 124/259 (47%), Gaps = 18/259 (6%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           + L + +G G +  +     K T  + A K + K+ +   ED+  ++ E  +  + S HP
Sbjct: 22  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 81
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
            +V L + ++ E  +  ++E   GG+L   +++  +  E  AR     +   ++Y H  G
Sbjct: 82  FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 141
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATY-IKAGQNLHGTVGSPFYIAPEVLAG-GY 219
           +++RDLK +N+LL    S   IKL D+G+    ++ G       G+P YIAPE+L G  Y
Sbjct: 142 IIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDY 198
Query: 220 NQAADVWSAGVILYILLSGMPPF---------WGKTKSKIFDAVRAADLRFPSDPWDHIS 270
             + D W+ GV+++ +++G  PF            T+  +F  +    +R P      +S
Sbjct: 199 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----SMS 254
Query: 271 ASARDLIMGMLRVDPSTRL 289
             A  ++   L  DP  RL
Sbjct: 255 VKAASVLKSFLNKDPKERL 273

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 89/297 (29%), Positives = 142/297 (47%), Gaps = 46/297 (15%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           Y   K +G G FGV+ +     +GE++A K + +D+       R    E++IM KL  H 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLD-HC 73
Query: 102 NVVDLKAVY----EEEDYVHLLMELCAGGELFHRLEK-YGRFSET----EARVIFRHLMQ 152
           N+V L+  +    E++D V+L + L    E  +R+ + Y R  +T      ++    L +
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 153 VVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAP 212
            ++Y H  G+ HRD+KP+N+LL   ++   +KL DFG A  +  G+     + S +Y AP
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLLDPDTAV--LKLCDFGSAKQLVRGEPNVSXICSRYYRAP 191
Query: 213 EVLAGG--YNQAADVWSAGVILYILLSGMPPFWG----------------KTKSKIFDA- 253
           E++ G   Y  + DVWSAG +L  LL G P F G                 T+ +I +  
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 254 VRAADLRFP---SDPWDHI-----SASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
               + +FP   + PW  +        A  L   +L   P+ RLT  E  AHS+ +E
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 308

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 89/297 (29%), Positives = 142/297 (47%), Gaps = 46/297 (15%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           Y   K +G G FGV+ +     +GE++A K + +D+       R    E++IM KL  H 
Sbjct: 23  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLD-HC 74
Query: 102 NVVDLKAVY----EEEDYVHLLMELCAGGELFHRLEK-YGRFSET----EARVIFRHLMQ 152
           N+V L+  +    E++D V+L + L    E  +R+ + Y R  +T      ++    L +
Sbjct: 75  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 134
Query: 153 VVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAP 212
            ++Y H  G+ HRD+KP+N+LL   ++   +KL DFG A  +  G+     + S +Y AP
Sbjct: 135 SLAYIHSFGICHRDIKPQNLLLDPDTAV--LKLCDFGSAKQLVRGEPNVSXICSRYYRAP 192
Query: 213 EVLAGG--YNQAADVWSAGVILYILLSGMPPFWG----------------KTKSKIFDA- 253
           E++ G   Y  + DVWSAG +L  LL G P F G                 T+ +I +  
Sbjct: 193 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 252
Query: 254 VRAADLRFP---SDPWDHI-----SASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
               + +FP   + PW  +        A  L   +L   P+ RLT  E  AHS+ +E
Sbjct: 253 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 309

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 89/297 (29%), Positives = 142/297 (47%), Gaps = 46/297 (15%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           Y   K +G G FGV+ +     +GE++A K + +D+       R    E++IM KL  H 
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLD-HC 77
Query: 102 NVVDLKAVY----EEEDYVHLLMELCAGGELFHRLEK-YGRFSET----EARVIFRHLMQ 152
           N+V L+  +    E++D V+L + L    E  +R+ + Y R  +T      ++    L +
Sbjct: 78  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 137
Query: 153 VVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAP 212
            ++Y H  G+ HRD+KP+N+LL   ++   +KL DFG A  +  G+     + S +Y AP
Sbjct: 138 SLAYIHSFGICHRDIKPQNLLLDPDTAV--LKLCDFGSAKQLVRGEPNVSXICSRYYRAP 195
Query: 213 EVLAGG--YNQAADVWSAGVILYILLSGMPPFWG----------------KTKSKIFDA- 253
           E++ G   Y  + DVWSAG +L  LL G P F G                 T+ +I +  
Sbjct: 196 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 255
Query: 254 VRAADLRFP---SDPWDHI-----SASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
               + +FP   + PW  +        A  L   +L   P+ RLT  E  AHS+ +E
Sbjct: 256 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 312

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 89/288 (30%), Positives = 139/288 (48%), Gaps = 30/288 (10%)
Query: 39  SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLS 98
           ++ Y + K +G G FG ++    K + +V A K ++K  ++   D      E +IM   +
Sbjct: 74  AEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMA-FA 132
Query: 99  GHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCH 158
             P VV L   ++++ Y++++ME   GG+L + +  Y    E  A+     ++  +   H
Sbjct: 133 NSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYTAEVVLALDAIH 191
Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLH--GTVGSPFYIAPEVLA 216
             G++HRD+KP+N+LL        +KLADFG    +     +H    VG+P YI+PEVL 
Sbjct: 192 SMGLIHRDVKPDNMLL---DKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLK 248
Query: 217 -----GGYNQAADVWSAGVILYILLSGMPPFWGK----TKSKIFDAVRAADLRFPSDPWD 267
                G Y +  D WS GV L+ +L G  PF+      T SKI D   +  L FP D   
Sbjct: 249 SQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNS--LCFPEDA-- 304
Query: 268 HISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKPCKQDD 315
            IS  A++LI   L  D   RL    V         E++ Q P  ++D
Sbjct: 305 EISKHAKNLICAFL-TDREVRLGRNGV---------EEIKQHPFFKND 342

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 89/297 (29%), Positives = 142/297 (47%), Gaps = 46/297 (15%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           Y   K +G G FGV+ +     +GE++A K + +D+       R    E++IM KL  H 
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLD-HC 78
Query: 102 NVVDLKAVY----EEEDYVHLLMELCAGGELFHRLEK-YGRFSET----EARVIFRHLMQ 152
           N+V L+  +    E++D V+L + L    E  +R+ + Y R  +T      ++    L +
Sbjct: 79  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 138
Query: 153 VVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAP 212
            ++Y H  G+ HRD+KP+N+LL   ++   +KL DFG A  +  G+     + S +Y AP
Sbjct: 139 SLAYIHSFGICHRDIKPQNLLLDPDTAV--LKLCDFGSAKQLVRGEPNVSYICSRYYRAP 196
Query: 213 EVLAGG--YNQAADVWSAGVILYILLSGMPPFWG----------------KTKSKIFDA- 253
           E++ G   Y  + DVWSAG +L  LL G P F G                 T+ +I +  
Sbjct: 197 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 256
Query: 254 VRAADLRFP---SDPWDHI-----SASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
               + +FP   + PW  +        A  L   +L   P+ RLT  E  AHS+ +E
Sbjct: 257 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 313

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 89/297 (29%), Positives = 142/297 (47%), Gaps = 46/297 (15%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           Y   K +G G FGV+ +     +GE++A K + +D+       R    E++IM KL  H 
Sbjct: 35  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLD-HC 86
Query: 102 NVVDLKAVY----EEEDYVHLLMELCAGGELFHRLEK-YGRFSET----EARVIFRHLMQ 152
           N+V L+  +    E++D V+L + L    E  +R+ + Y R  +T      ++    L +
Sbjct: 87  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 146
Query: 153 VVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAP 212
            ++Y H  G+ HRD+KP+N+LL   ++   +KL DFG A  +  G+     + S +Y AP
Sbjct: 147 SLAYIHSFGICHRDIKPQNLLLDPDTAV--LKLCDFGSAKQLVRGEPNVSYICSRYYRAP 204
Query: 213 EVLAGG--YNQAADVWSAGVILYILLSGMPPFWG----------------KTKSKIFDA- 253
           E++ G   Y  + DVWSAG +L  LL G P F G                 T+ +I +  
Sbjct: 205 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 264
Query: 254 VRAADLRFP---SDPWDHI-----SASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
               + +FP   + PW  +        A  L   +L   P+ RLT  E  AHS+ +E
Sbjct: 265 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 321

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 89/297 (29%), Positives = 142/297 (47%), Gaps = 46/297 (15%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           Y   K +G G FGV+ +     +GE++A K + +D+       R    E++IM KL  H 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLD-HC 73
Query: 102 NVVDLKAVY----EEEDYVHLLMELCAGGELFHRLEK-YGRFSET----EARVIFRHLMQ 152
           N+V L+  +    E++D V+L + L    E  +R+ + Y R  +T      ++    L +
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 153 VVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAP 212
            ++Y H  G+ HRD+KP+N+LL   ++   +KL DFG A  +  G+     + S +Y AP
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLLDPDTAV--LKLCDFGSAKQLVRGEPNVSYICSRYYRAP 191
Query: 213 EVLAGG--YNQAADVWSAGVILYILLSGMPPFWG----------------KTKSKIFDA- 253
           E++ G   Y  + DVWSAG +L  LL G P F G                 T+ +I +  
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 254 VRAADLRFP---SDPWDHI-----SASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
               + +FP   + PW  +        A  L   +L   P+ RLT  E  AHS+ +E
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 308

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 69/259 (26%), Positives = 124/259 (47%), Gaps = 18/259 (6%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           + L + +G G +  +     K T  + A K + K+ +   ED+  ++ E  +  + S HP
Sbjct: 7   FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 66
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
            +V L + ++ E  +  ++E   GG+L   +++  +  E  AR     +   ++Y H  G
Sbjct: 67  FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 126
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATY-IKAGQNLHGTVGSPFYIAPEVLAG-GY 219
           +++RDLK +N+LL    S   IKL D+G+    ++ G       G+P YIAPE+L G  Y
Sbjct: 127 IIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDY 183
Query: 220 NQAADVWSAGVILYILLSGMPPF---------WGKTKSKIFDAVRAADLRFPSDPWDHIS 270
             + D W+ GV+++ +++G  PF            T+  +F  +    +R P      +S
Sbjct: 184 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS----LS 239
Query: 271 ASARDLIMGMLRVDPSTRL 289
             A  ++   L  DP  RL
Sbjct: 240 VKAASVLKSFLNKDPKERL 258

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 69/259 (26%), Positives = 124/259 (47%), Gaps = 18/259 (6%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           + L + +G G +  +     K T  + A K + K+ +   ED+  ++ E  +  + S HP
Sbjct: 11  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 70
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
            +V L + ++ E  +  ++E   GG+L   +++  +  E  AR     +   ++Y H  G
Sbjct: 71  FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 130
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATY-IKAGQNLHGTVGSPFYIAPEVLAG-GY 219
           +++RDLK +N+LL    S   IKL D+G+    ++ G       G+P YIAPE+L G  Y
Sbjct: 131 IIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDY 187
Query: 220 NQAADVWSAGVILYILLSGMPPF---------WGKTKSKIFDAVRAADLRFPSDPWDHIS 270
             + D W+ GV+++ +++G  PF            T+  +F  +    +R P      +S
Sbjct: 188 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----SLS 243
Query: 271 ASARDLIMGMLRVDPSTRL 289
             A  ++   L  DP  RL
Sbjct: 244 VKAASVLKSFLNKDPKERL 262

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 68/259 (26%), Positives = 124/259 (47%), Gaps = 18/259 (6%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           + L + +G G +  +     K T  + A + + K+ +   ED+  ++ E  +  + S HP
Sbjct: 54  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHP 113
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
            +V L + ++ E  +  ++E   GG+L   +++  +  E  AR     +   ++Y H  G
Sbjct: 114 FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 173
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATY-IKAGQNLHGTVGSPFYIAPEVLAG-GY 219
           +++RDLK +N+LL    S   IKL D+G+    ++ G       G+P YIAPE+L G  Y
Sbjct: 174 IIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY 230
Query: 220 NQAADVWSAGVILYILLSGMPPF---------WGKTKSKIFDAVRAADLRFPSDPWDHIS 270
             + D W+ GV+++ +++G  PF            T+  +F  +    +R P      +S
Sbjct: 231 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS----LS 286
Query: 271 ASARDLIMGMLRVDPSTRL 289
             A  ++   L  DP  RL
Sbjct: 287 VKAASVLKSFLNKDPKERL 305

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 73/259 (28%), Positives = 135/259 (52%), Gaps = 15/259 (5%)
Query: 47  QLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDL 106
           ++G G  G++   ++K TG+ +A K +   +    +  R +     ++ +   H NVVD+
Sbjct: 52  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRK----QQRRELLFNEVVIMRDYHHDNVVDM 107
Query: 107 KAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRD 166
            + Y   D + ++ME   GG L   +  + R +E +   +   +++ +SY H  GV+HRD
Sbjct: 108 YSSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRD 166
Query: 167 LKPENILLATKSSSSPIKLADFGLATYI-KAGQNLHGTVGSPFYIAPEVLAG-GYNQAAD 224
           +K ++ILL   +S   IKL+DFG    + K        VG+P+++APEV++   Y    D
Sbjct: 167 IKSDSILL---TSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRLPYGTEVD 223
Query: 225 VWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWD--HISASARDLIMGMLR 282
           +WS G+++  ++ G PP++ +   +    +R +    P    D   +S+  R  +  ML 
Sbjct: 224 IWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDS---LPPRVKDLHKVSSVLRGFLDLMLV 280
Query: 283 VDPSTRLTAAEVLAHSWME 301
            +PS R TA E+L H +++
Sbjct: 281 REPSQRATAQELLGHPFLK 299

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 79/248 (31%), Positives = 126/248 (50%), Gaps = 13/248 (5%)
Query: 48  LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH---PNVV 104
           +G G FG +  C    TG++ A K + K R + ++   ++ L   IM  L      P +V
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKR-IKMKQGETLALNERIMLSLVSTGDCPFIV 255
Query: 105 DLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVH 164
            +   +   D +  +++L  GG+L + L ++G FSE + R     ++  + + H   VV+
Sbjct: 256 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVY 315
Query: 165 RDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGG--YNQA 222
           RDLKP NILL        ++++D GLA    + +  H +VG+  Y+APEVL  G  Y+ +
Sbjct: 316 RDLKPANILL---DEHGHVRISDLGLACDF-SKKKPHASVGTHGYMAPEVLQKGVAYDSS 371
Query: 223 ADVWSAGVILYILLSGMPPF-WGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGML 281
           AD +S G +L+ LL G  PF   KTK K    +    L    +  D  S   R L+ G+L
Sbjct: 372 ADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTLTMAVELPDSFSPELRSLLEGLL 429
Query: 282 RVDPSTRL 289
           + D + RL
Sbjct: 430 QRDVNRRL 437

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 79/248 (31%), Positives = 126/248 (50%), Gaps = 13/248 (5%)
Query: 48  LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH---PNVV 104
           +G G FG +  C    TG++ A K + K R + ++   ++ L   IM  L      P +V
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKR-IKMKQGETLALNERIMLSLVSTGDCPFIV 255
Query: 105 DLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVH 164
            +   +   D +  +++L  GG+L + L ++G FSE + R     ++  + + H   VV+
Sbjct: 256 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVY 315
Query: 165 RDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGG--YNQA 222
           RDLKP NILL        ++++D GLA    + +  H +VG+  Y+APEVL  G  Y+ +
Sbjct: 316 RDLKPANILL---DEHGHVRISDLGLACDF-SKKKPHASVGTHGYMAPEVLQKGVAYDSS 371
Query: 223 ADVWSAGVILYILLSGMPPF-WGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGML 281
           AD +S G +L+ LL G  PF   KTK K    +    L    +  D  S   R L+ G+L
Sbjct: 372 ADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTLTMAVELPDSFSPELRSLLEGLL 429
Query: 282 RVDPSTRL 289
           + D + RL
Sbjct: 430 QRDVNRRL 437

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 71/269 (26%), Positives = 131/269 (48%), Gaps = 16/269 (5%)
Query: 29  ILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIK 88
           + D  +  N  D + + + +G G FG +       T ++ A K + K + V   +VR++ 
Sbjct: 5   VFDENEDVNF-DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVF 63
Query: 89  LEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
            E++IM  L  HP +V+L   +++E+ + ++++L  GG+L + L++   F E   ++   
Sbjct: 64  KELQIMQGLE-HPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFIC 122
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF 208
            L+  + Y     ++HRD+KP+NILL        + + DF +A  +     +    G+  
Sbjct: 123 ELVMALDYLQNQRIIHRDMKPDNILL---DEHGHVHITDFNIAAMLPRETQITTMAGTKP 179
Query: 209 YIAPEVLA----GGYNQAADVWSAGVILYILLSGMPPFWGKTKS---KIFDAVRAADLRF 261
           Y+APE+ +     GY+ A D WS GV  Y LL G  P+  ++ +   +I        + +
Sbjct: 180 YMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTY 239
Query: 262 PSDPWDHISASARDLIMGMLRVDPSTRLT 290
           PS  W   S     L+  +L  +P  R +
Sbjct: 240 PS-AW---SQEMVSLLKKLLEPNPDQRFS 264

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 79/248 (31%), Positives = 126/248 (50%), Gaps = 13/248 (5%)
Query: 48  LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH---PNVV 104
           +G G FG +  C    TG++ A K + K R + ++   ++ L   IM  L      P +V
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKR-IKMKQGETLALNERIMLSLVSTGDCPFIV 255
Query: 105 DLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVH 164
            +   +   D +  +++L  GG+L + L ++G FSE + R     ++  + + H   VV+
Sbjct: 256 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVY 315
Query: 165 RDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGG--YNQA 222
           RDLKP NILL        ++++D GLA    + +  H +VG+  Y+APEVL  G  Y+ +
Sbjct: 316 RDLKPANILL---DEHGHVRISDLGLACDF-SKKKPHASVGTHGYMAPEVLQKGVAYDSS 371
Query: 223 ADVWSAGVILYILLSGMPPF-WGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGML 281
           AD +S G +L+ LL G  PF   KTK K    +    L    +  D  S   R L+ G+L
Sbjct: 372 ADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTLTMAVELPDSFSPELRSLLEGLL 429
Query: 282 RVDPSTRL 289
           + D + RL
Sbjct: 430 QRDVNRRL 437

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 79/248 (31%), Positives = 126/248 (50%), Gaps = 13/248 (5%)
Query: 48  LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH---PNVV 104
           +G G FG +  C    TG++ A K + K R + ++   ++ L   IM  L      P +V
Sbjct: 196 IGRGGFGEVYGCRKADTGKMYAMKCLDKKR-IKMKQGETLALNERIMLSLVSTGDCPFIV 254
Query: 105 DLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVH 164
            +   +   D +  +++L  GG+L + L ++G FSE + R     ++  + + H   VV+
Sbjct: 255 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVY 314
Query: 165 RDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGG--YNQA 222
           RDLKP NILL        ++++D GLA    + +  H +VG+  Y+APEVL  G  Y+ +
Sbjct: 315 RDLKPANILL---DEHGHVRISDLGLACDF-SKKKPHASVGTHGYMAPEVLQKGVAYDSS 370
Query: 223 ADVWSAGVILYILLSGMPPF-WGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGML 281
           AD +S G +L+ LL G  PF   KTK K    +    L    +  D  S   R L+ G+L
Sbjct: 371 ADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTLTMAVELPDSFSPELRSLLEGLL 428
Query: 282 RVDPSTRL 289
           + D + RL
Sbjct: 429 QRDVNRRL 436

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 138/293 (47%), Gaps = 15/293 (5%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           ++YV  +++G G FG          G     K I   R+ + E   S + E+ ++  +  
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREES-RREVAVLANMK- 81
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRL--EKYGRFSETEARVIFRHLMQVVSYC 157
           HPN+V  +  +EE   ++++M+ C GG+LF R+  +K   F E +    F  +   + + 
Sbjct: 82  HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHV 141
Query: 158 HGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNL-HGTVGSPFYIAPEVLA 216
           H   ++HRD+K +NI L    +   ++L DFG+A  + +   L    +G+P+Y++PE+  
Sbjct: 142 HDRKILHRDIKSQNIFLTKDGT---VQLGDFGIARVLNSTVELARACIGTPYYLSPEICE 198
Query: 217 GG-YNQAADVWSAGVILYILLSGMPPF-WGKTKSKIFDAVRAADLRFPSDPWDHISASAR 274
              YN  +D+W+ G +LY L +    F  G  K+ +   +  +   FP     H S   R
Sbjct: 199 NKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGS---FPPVSL-HYSYDLR 254
Query: 275 DLIMGMLRVDPSTRLTAAEVLAHSWM-EECEQVAQKPCKQDDLCCKQLEVGGS 326
            L+  + + +P  R +   +L   ++ +  E+        ++ C K     GS
Sbjct: 255 SLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTFSKFGS 307

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 137/276 (49%), Gaps = 16/276 (5%)
Query: 33  TQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIE 92
           T+  N  D + +  +LG G FG + +  +K T  + A K I      + E++    +EI+
Sbjct: 30  TRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEID 86
Query: 93  IMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGR-FSETEARVIFRHLM 151
           I+     HPN+V L   +  E+ + +L+E CAGG +   + +  R  +E++ +V+ +  +
Sbjct: 87  ILASCD-HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL 145
Query: 152 QVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGL-ATYIKAGQNLHGTVGSPFYI 210
             ++Y H N ++HRDLK  NIL         IKLADFG+ A   +  Q     +G+P+++
Sbjct: 146 DALNYLHDNKIIHRDLKAGNILFTLDGD---IKLADFGVSAKNTRTIQRRDSFIGTPYWM 202
Query: 211 APEVLA------GGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSD 264
           APEV+         Y+  ADVWS G+ L  +    PP       ++   +  ++    + 
Sbjct: 203 APEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQ 262
Query: 265 PWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWM 300
           P    S++ +D +   L  +   R T +++L H ++
Sbjct: 263 P-SRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFV 297

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 137/276 (49%), Gaps = 16/276 (5%)
Query: 33  TQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIE 92
           T+  N  D + +  +LG G FG + +  +K T  + A K I      + E++    +EI+
Sbjct: 30  TRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEID 86
Query: 93  IMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGR-FSETEARVIFRHLM 151
           I+     HPN+V L   +  E+ + +L+E CAGG +   + +  R  +E++ +V+ +  +
Sbjct: 87  ILASCD-HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL 145
Query: 152 QVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGL-ATYIKAGQNLHGTVGSPFYI 210
             ++Y H N ++HRDLK  NIL         IKLADFG+ A   +  Q     +G+P+++
Sbjct: 146 DALNYLHDNKIIHRDLKAGNILFTLDGD---IKLADFGVSAKNTRXIQRRDSFIGTPYWM 202
Query: 211 APEVLA------GGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSD 264
           APEV+         Y+  ADVWS G+ L  +    PP       ++   +  ++    + 
Sbjct: 203 APEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQ 262
Query: 265 PWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWM 300
           P    S++ +D +   L  +   R T +++L H ++
Sbjct: 263 P-SRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFV 297

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 90/295 (30%), Positives = 143/295 (48%), Gaps = 46/295 (15%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKL-EIEIMTKLSGHPNVV 104
           +++G G +GV+ +  +K TGEV+A K I  D     E V S  + EI ++ +L+ HPN+V
Sbjct: 11  EKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELN-HPNIV 67
Query: 105 DLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEA------RVIFRHLMQVVSYCH 158
            L  V   E+ ++L+ E      L   L+K+   S          +     L+Q +++CH
Sbjct: 68  KLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 122
Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG-QNLHGTVGSPFYIAPEVLAG 217
            + V+HRDLKPEN+L+ T+ +   IKLADFGLA       +     V + +Y APE+L G
Sbjct: 123 SHRVLHRDLKPENLLINTEGA---IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 179
Query: 218 --GYNQAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAVRAADLRF---------- 261
              Y+ A D+WS G I   +++    F G ++     +IF  +   D             
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 239
Query: 262 -PSDP-WDH---------ISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ 305
            PS P W           +    R L+  ML  DP+ R++A   LAH + ++  +
Sbjct: 240 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 294

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 77/275 (28%), Positives = 135/275 (49%), Gaps = 16/275 (5%)
Query: 29  ILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIK 88
           ++D      L D YV   ++G G  G++    +K +G  +A K +   +    +  R + 
Sbjct: 37  VVDQGDPRLLLDSYV---KIGEGSTGIVCLAREKHSGRQVAVKMMDLRK----QQRRELL 89
Query: 89  LEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
               ++ +   H NVV++   Y   + + +LME   GG L   + +  R +E +   +  
Sbjct: 90  FNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV-RLNEEQIATVCE 148
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI-KAGQNLHGTVGSP 207
            ++Q ++Y H  GV+HRD+K ++ILL        +KL+DFG    I K        VG+P
Sbjct: 149 AVLQALAYLHAQGVIHRDIKSDSILLTLDGR---VKLSDFGFCAQISKDVPKRKXLVGTP 205
Query: 208 FYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW 266
           +++APEV++   Y    D+WS G+++  ++ G PP++  +  +    +R  D   P    
Sbjct: 206 YWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR--DSPPPKLKN 263
Query: 267 DH-ISASARDLIMGMLRVDPSTRLTAAEVLAHSWM 300
            H +S   RD +  ML  DP  R TA E+L H ++
Sbjct: 264 SHKVSPVLRDFLERMLVRDPQERATAQELLDHPFL 298

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 90/295 (30%), Positives = 143/295 (48%), Gaps = 46/295 (15%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKL-EIEIMTKLSGHPNVV 104
           +++G G +GV+ +  +K TGEV+A K I  D     E V S  + EI ++ +L+ HPN+V
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELN-HPNIV 66
Query: 105 DLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEA------RVIFRHLMQVVSYCH 158
            L  V   E+ ++L+ E      L   L+K+   S          +     L+Q +++CH
Sbjct: 67  KLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG-QNLHGTVGSPFYIAPEVLAG 217
            + V+HRDLKPEN+L+ T+ +   IKLADFGLA       +     V + +Y APE+L G
Sbjct: 122 SHRVLHRDLKPENLLINTEGA---IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 178
Query: 218 --GYNQAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAVRAADLRF---------- 261
              Y+ A D+WS G I   +++    F G ++     +IF  +   D             
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 238
Query: 262 -PSDP-WDH---------ISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ 305
            PS P W           +    R L+  ML  DP+ R++A   LAH + ++  +
Sbjct: 239 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 293

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 90/295 (30%), Positives = 143/295 (48%), Gaps = 46/295 (15%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKL-EIEIMTKLSGHPNVV 104
           +++G G +GV+ +  +K TGEV+A K I  D     E V S  + EI ++ +L+ HPN+V
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELN-HPNIV 65
Query: 105 DLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEA------RVIFRHLMQVVSYCH 158
            L  V   E+ ++L+ E      L   L+K+   S          +     L+Q +S+CH
Sbjct: 66  KLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCH 120
Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHG-TVGSPFYIAPEVLAG 217
            + V+HRDLKP+N+L+ T+ +   IKLADFGLA         +   V + +Y APE+L G
Sbjct: 121 SHRVLHRDLKPQNLLINTEGA---IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 177
Query: 218 --GYNQAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAVRAADLRF---------- 261
              Y+ A D+WS G I   +++    F G ++     +IF  +   D             
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 262 -PSDP-WDH---------ISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ 305
            PS P W           +    R L+  ML  DP+ R++A   LAH + ++  +
Sbjct: 238 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 292

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 137/276 (49%), Gaps = 16/276 (5%)
Query: 33  TQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIE 92
           T+  N  D + +  +LG G FG + +  +K T  + A K I      + E++    +EI+
Sbjct: 30  TRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEID 86
Query: 93  IMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGR-FSETEARVIFRHLM 151
           I+     HPN+V L   +  E+ + +L+E CAGG +   + +  R  +E++ +V+ +  +
Sbjct: 87  ILAS-CDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL 145
Query: 152 QVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGL-ATYIKAGQNLHGTVGSPFYI 210
             ++Y H N ++HRDLK  NIL         IKLADFG+ A   +  Q     +G+P+++
Sbjct: 146 DALNYLHDNKIIHRDLKAGNILFTLDGD---IKLADFGVSAKNTRXIQRRDXFIGTPYWM 202
Query: 211 APEVLA------GGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSD 264
           APEV+         Y+  ADVWS G+ L  +    PP       ++   +  ++    + 
Sbjct: 203 APEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQ 262
Query: 265 PWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWM 300
           P    S++ +D +   L  +   R T +++L H ++
Sbjct: 263 P-SRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFV 297

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 142/291 (48%), Gaps = 49/291 (16%)
Query: 48  LGWGQFGVIRECSDKFTGEVLACKSIAK---DRLVTVEDVRSIKLEIEIMTKLSGHPNVV 104
           +G G +G++ +C +K TG ++A K   +   D++V    +R IKL      K   H N+V
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKL-----LKQLRHENLV 87
Query: 105 DLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS---YCHGNG 161
           +L  V +++   +L+ E      +   LE +   +  + +V+ ++L Q+++   +CH + 
Sbjct: 88  NLLEVCKKKKRWYLVFEF-VDHTILDDLELFP--NGLDYQVVQKYLFQIINGIGFCHSHN 144
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKA-GQNLHGTVGSPFYIAPEVLAGG-- 218
           ++HRD+KPENIL+   S S  +KL DFG A  + A G+     V + +Y APE+L G   
Sbjct: 145 IIHRDIKPENILV---SQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVK 201
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKT------------------------KSKIFDAV 254
           Y +A DVW+ G ++  +  G P F G +                        K+ +F  V
Sbjct: 202 YGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGV 261
Query: 255 RAADLRFPSDP----WDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWME 301
           R  +++   +P    +  +S    DL    L +DP  R   AE+L H + +
Sbjct: 262 RLPEIK-EREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQ 311

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 89/295 (30%), Positives = 143/295 (48%), Gaps = 46/295 (15%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKL-EIEIMTKLSGHPNVV 104
           +++G G +GV+ +  +K TGEV+A K I  D     E V S  + EI ++ +L+ HPN+V
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELN-HPNIV 66
Query: 105 DLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEA------RVIFRHLMQVVSYCH 158
            L  V   E+ ++L+ E  +       L+K+   S          +     L+Q +++CH
Sbjct: 67  KLLDVIHTENKLYLVFEFLSMD-----LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG-QNLHGTVGSPFYIAPEVLAG 217
            + V+HRDLKPEN+L+ T+ +   IKLADFGLA       +     V + +Y APE+L G
Sbjct: 122 SHRVLHRDLKPENLLINTEGA---IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 178
Query: 218 --GYNQAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAVRAADLRF---------- 261
              Y+ A D+WS G I   +++    F G ++     +IF  +   D             
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 238
Query: 262 -PSDP-WDH---------ISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ 305
            PS P W           +    R L+  ML  DP+ R++A   LAH + ++  +
Sbjct: 239 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 293

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 89/295 (30%), Positives = 143/295 (48%), Gaps = 46/295 (15%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKL-EIEIMTKLSGHPNVV 104
           +++G G +GV+ +  +K TGEV+A K I  D     E V S  + EI ++ +L+ HPN+V
Sbjct: 16  EKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELN-HPNIV 72
Query: 105 DLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEA------RVIFRHLMQVVSYCH 158
            L  V   E+ ++L+ E      L   L+K+   S          +     L+Q +++CH
Sbjct: 73  KLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 127
Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHG-TVGSPFYIAPEVLAG 217
            + V+HRDLKP+N+L+ T+ +   IKLADFGLA         +   V + +Y APE+L G
Sbjct: 128 SHRVLHRDLKPQNLLINTEGA---IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 184
Query: 218 G--YNQAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAVRAADLRF---------- 261
              Y+ A D+WS G I   +++    F G ++     +IF  +   D             
Sbjct: 185 XKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 244
Query: 262 -PSDP-WDH---------ISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ 305
            PS P W           +    R L+  ML  DP+ R++A   LAH + ++  +
Sbjct: 245 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 299

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 87/297 (29%), Positives = 140/297 (47%), Gaps = 46/297 (15%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           Y   K +G G FGV+ +     +GE++A K + + +            E++IM KL  H 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFK-------NRELQIMRKLD-HC 73
Query: 102 NVVDLKAVY----EEEDYVHLLMELCAGGELFHRLEK-YGRFSET----EARVIFRHLMQ 152
           N+V L+  +    E++D V+L + L    E  +R+ + Y R  +T      ++    L +
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 153 VVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAP 212
            ++Y H  G+ HRD+KP+N+LL   ++   +KL DFG A  +  G+     + S +Y AP
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLLDPDTAV--LKLCDFGSAKQLVRGEPNVSYICSRYYRAP 191
Query: 213 EVLAGG--YNQAADVWSAGVILYILLSGMPPFWG----------------KTKSKIFDA- 253
           E++ G   Y  + DVWSAG +L  LL G P F G                 T+ +I +  
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 254 VRAADLRFP---SDPWDHI-----SASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
               + +FP   + PW  +        A  L   +L   P+ RLT  E  AHS+ +E
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 308

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 89/295 (30%), Positives = 143/295 (48%), Gaps = 46/295 (15%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKL-EIEIMTKLSGHPNVV 104
           +++G G +GV+ +  +K TGEV+A K I  D     E V S  + EI ++ +L+ HPN+V
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELN-HPNIV 68
Query: 105 DLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEA------RVIFRHLMQVVSYCH 158
            L  V   E+ ++L+ E  +       L+K+   S          +     L+Q +++CH
Sbjct: 69  KLLDVIHTENKLYLVFEFLSMD-----LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 123
Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG-QNLHGTVGSPFYIAPEVLAG 217
            + V+HRDLKPEN+L+ T+ +   IKLADFGLA       +     V + +Y APE+L G
Sbjct: 124 SHRVLHRDLKPENLLINTEGA---IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 180
Query: 218 --GYNQAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAVRAADLRF---------- 261
              Y+ A D+WS G I   +++    F G ++     +IF  +   D             
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 240
Query: 262 -PSDP-WDH---------ISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ 305
            PS P W           +    R L+  ML  DP+ R++A   LAH + ++  +
Sbjct: 241 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 295

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 89/295 (30%), Positives = 143/295 (48%), Gaps = 46/295 (15%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKL-EIEIMTKLSGHPNVV 104
           +++G G +GV+ +  +K TGEV+A K I  D     E V S  + EI ++ +L+ HPN+V
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELN-HPNIV 65
Query: 105 DLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEA------RVIFRHLMQVVSYCH 158
            L  V   E+ ++L+ E      L   L+K+   S          +     L+Q +++CH
Sbjct: 66  KLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG-QNLHGTVGSPFYIAPEVLAG 217
            + V+HRDLKP+N+L+ T+ +   IKLADFGLA       +     V + +Y APE+L G
Sbjct: 121 SHRVLHRDLKPQNLLINTEGA---IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 177
Query: 218 --GYNQAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAVRAADLRF---------- 261
              Y+ A D+WS G I   +++    F G ++     +IF  +   D             
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 262 -PSDP-WDH---------ISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ 305
            PS P W           +    R L+  ML  DP+ R++A   LAH + ++  +
Sbjct: 238 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 292

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 89/295 (30%), Positives = 143/295 (48%), Gaps = 46/295 (15%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKL-EIEIMTKLSGHPNVV 104
           +++G G +GV+ +  +K TGEV+A K I  D     E V S  + EI ++ +L+ HPN+V
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELN-HPNIV 65
Query: 105 DLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEA------RVIFRHLMQVVSYCH 158
            L  V   E+ ++L+ E      L   L+K+   S          +     L+Q +++CH
Sbjct: 66  KLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHG-TVGSPFYIAPEVLAG 217
            + V+HRDLKP+N+L+ T+ +   IKLADFGLA         +   V + +Y APE+L G
Sbjct: 121 SHRVLHRDLKPQNLLINTEGA---IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 177
Query: 218 G--YNQAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAVRAADLRF---------- 261
              Y+ A D+WS G I   +++    F G ++     +IF  +   D             
Sbjct: 178 XKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 262 -PSDP-WDH---------ISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ 305
            PS P W           +    R L+  ML  DP+ R++A   LAH + ++  +
Sbjct: 238 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 292

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 89/295 (30%), Positives = 143/295 (48%), Gaps = 46/295 (15%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKL-EIEIMTKLSGHPNVV 104
           +++G G +GV+ +  +K TGEV+A K I  D     E V S  + EI ++ +L+ HPN+V
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELN-HPNIV 64
Query: 105 DLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEA------RVIFRHLMQVVSYCH 158
            L  V   E+ ++L+ E      L   L+K+   S          +     L+Q +++CH
Sbjct: 65  KLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG-QNLHGTVGSPFYIAPEVLAG 217
            + V+HRDLKP+N+L+ T+ +   IKLADFGLA       +     V + +Y APE+L G
Sbjct: 120 SHRVLHRDLKPQNLLINTEGA---IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 176
Query: 218 --GYNQAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAVRAADLRF---------- 261
              Y+ A D+WS G I   +++    F G ++     +IF  +   D             
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 262 -PSDP-WDH---------ISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ 305
            PS P W           +    R L+  ML  DP+ R++A   LAH + ++  +
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 89/295 (30%), Positives = 143/295 (48%), Gaps = 46/295 (15%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKL-EIEIMTKLSGHPNVV 104
           +++G G +GV+ +  +K TGEV+A K I  D     E V S  + EI ++ +L+ HPN+V
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELN-HPNIV 65
Query: 105 DLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEA------RVIFRHLMQVVSYCH 158
            L  V   E+ ++L+ E      L   L+K+   S          +     L+Q +++CH
Sbjct: 66  KLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG-QNLHGTVGSPFYIAPEVLAG 217
            + V+HRDLKP+N+L+ T+ +   IKLADFGLA       +     V + +Y APE+L G
Sbjct: 121 SHRVLHRDLKPQNLLINTEGA---IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 177
Query: 218 --GYNQAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAVRAADLRF---------- 261
              Y+ A D+WS G I   +++    F G ++     +IF  +   D             
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 262 -PSDP-WDH---------ISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ 305
            PS P W           +    R L+  ML  DP+ R++A   LAH + ++  +
Sbjct: 238 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 292

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 89/295 (30%), Positives = 143/295 (48%), Gaps = 46/295 (15%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKL-EIEIMTKLSGHPNVV 104
           +++G G +GV+ +  +K TGEV+A K I  D     E V S  + EI ++ +L+ HPN+V
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELN-HPNIV 64
Query: 105 DLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEA------RVIFRHLMQVVSYCH 158
            L  V   E+ ++L+ E      L   L+K+   S          +     L+Q +++CH
Sbjct: 65  KLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHG-TVGSPFYIAPEVLAG 217
            + V+HRDLKP+N+L+ T+ +   IKLADFGLA         +   V + +Y APE+L G
Sbjct: 120 SHRVLHRDLKPQNLLINTEGA---IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 218 --GYNQAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAVRAADLRF---------- 261
              Y+ A D+WS G I   +++    F G ++     +IF  +   D             
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 262 -PSDP-WDH---------ISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ 305
            PS P W           +    R L+  ML  DP+ R++A   LAH + ++  +
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 89/295 (30%), Positives = 143/295 (48%), Gaps = 46/295 (15%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKL-EIEIMTKLSGHPNVV 104
           +++G G +GV+ +  +K TGEV+A K I  D     E V S  + EI ++ +L+ HPN+V
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELN-HPNIV 65
Query: 105 DLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEA------RVIFRHLMQVVSYCH 158
            L  V   E+ ++L+ E      L   L+K+   S          +     L+Q +++CH
Sbjct: 66  KLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG-QNLHGTVGSPFYIAPEVLAG 217
            + V+HRDLKP+N+L+ T+ +   IKLADFGLA       +     V + +Y APE+L G
Sbjct: 121 SHRVLHRDLKPQNLLINTEGA---IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 177
Query: 218 --GYNQAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAVRAADLRF---------- 261
              Y+ A D+WS G I   +++    F G ++     +IF  +   D             
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 262 -PSDP-WDH---------ISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ 305
            PS P W           +    R L+  ML  DP+ R++A   LAH + ++  +
Sbjct: 238 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 292

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 89/295 (30%), Positives = 143/295 (48%), Gaps = 46/295 (15%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKL-EIEIMTKLSGHPNVV 104
           +++G G +GV+ +  +K TGEV+A K I  D     E V S  + EI ++ +L+ HPN+V
Sbjct: 11  EKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELN-HPNIV 67
Query: 105 DLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEA------RVIFRHLMQVVSYCH 158
            L  V   E+ ++L+ E      L   L+K+   S          +     L+Q +++CH
Sbjct: 68  KLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 122
Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG-QNLHGTVGSPFYIAPEVLAG 217
            + V+HRDLKP+N+L+ T+ +   IKLADFGLA       +     V + +Y APE+L G
Sbjct: 123 SHRVLHRDLKPQNLLINTEGA---IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 179
Query: 218 --GYNQAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAVRAADLRF---------- 261
              Y+ A D+WS G I   +++    F G ++     +IF  +   D             
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 239
Query: 262 -PSDP-WDH---------ISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ 305
            PS P W           +    R L+  ML  DP+ R++A   LAH + ++  +
Sbjct: 240 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 294

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 89/295 (30%), Positives = 143/295 (48%), Gaps = 46/295 (15%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKL-EIEIMTKLSGHPNVV 104
           +++G G +GV+ +  +K TGEV+A K I  D     E V S  + EI ++ +L+ HPN+V
Sbjct: 16  EKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELN-HPNIV 72
Query: 105 DLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEA------RVIFRHLMQVVSYCH 158
            L  V   E+ ++L+ E      L   L+K+   S          +     L+Q +++CH
Sbjct: 73  KLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 127
Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHG-TVGSPFYIAPEVLAG 217
            + V+HRDLKP+N+L+ T+ +   IKLADFGLA         +   V + +Y APE+L G
Sbjct: 128 SHRVLHRDLKPQNLLINTEGA---IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 184
Query: 218 --GYNQAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAVRAADLRF---------- 261
              Y+ A D+WS G I   +++    F G ++     +IF  +   D             
Sbjct: 185 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 244
Query: 262 -PSDP-WDH---------ISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ 305
            PS P W           +    R L+  ML  DP+ R++A   LAH + ++  +
Sbjct: 245 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 299

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 89/295 (30%), Positives = 143/295 (48%), Gaps = 46/295 (15%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKL-EIEIMTKLSGHPNVV 104
           +++G G +GV+ +  +K TGEV+A K I  D     E V S  + EI ++ +L+ HPN+V
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELN-HPNIV 66
Query: 105 DLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEA------RVIFRHLMQVVSYCH 158
            L  V   E+ ++L+ E      L   L+K+   S          +     L+Q +++CH
Sbjct: 67  KLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHG-TVGSPFYIAPEVLAG 217
            + V+HRDLKP+N+L+ T+ +   IKLADFGLA         +   V + +Y APE+L G
Sbjct: 122 SHRVLHRDLKPQNLLINTEGA---IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 178
Query: 218 --GYNQAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAVRAADLRF---------- 261
              Y+ A D+WS G I   +++    F G ++     +IF  +   D             
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 238
Query: 262 -PSDP-WDH---------ISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ 305
            PS P W           +    R L+  ML  DP+ R++A   LAH + ++  +
Sbjct: 239 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 293

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 89/295 (30%), Positives = 143/295 (48%), Gaps = 46/295 (15%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKL-EIEIMTKLSGHPNVV 104
           +++G G +GV+ +  +K TGEV+A K I  D     E V S  + EI ++ +L+ HPN+V
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELN-HPNIV 64
Query: 105 DLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEA------RVIFRHLMQVVSYCH 158
            L  V   E+ ++L+ E      L   L+K+   S          +     L+Q +++CH
Sbjct: 65  KLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG-QNLHGTVGSPFYIAPEVLAG 217
            + V+HRDLKP+N+L+ T+ +   IKLADFGLA       +     V + +Y APE+L G
Sbjct: 120 SHRVLHRDLKPQNLLINTEGA---IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 176
Query: 218 --GYNQAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAVRAADLRF---------- 261
              Y+ A D+WS G I   +++    F G ++     +IF  +   D             
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 262 -PSDP-WDH---------ISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ 305
            PS P W           +    R L+  ML  DP+ R++A   LAH + ++  +
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 89/292 (30%), Positives = 142/292 (48%), Gaps = 46/292 (15%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKL-EIEIMTKLSGHPNVV 104
           +++G G +GV+ +  +K TGEV+A K I  D     E V S  + EI ++ +L+ HPN+V
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELN-HPNIV 65
Query: 105 DLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEA------RVIFRHLMQVVSYCH 158
            L  V   E+ ++L+ E      L   L+K+   S          +     L+Q +++CH
Sbjct: 66  KLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG-QNLHGTVGSPFYIAPEVLAG 217
            + V+HRDLKP+N+L+ T+ +   IKLADFGLA       +     V + +Y APE+L G
Sbjct: 121 SHRVLHRDLKPQNLLINTEGA---IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 177
Query: 218 --GYNQAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAVRAADLRF---------- 261
              Y+ A D+WS G I   +++    F G ++     +IF  +   D             
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 262 -PSDP-WDH---------ISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
            PS P W           +    R L+  ML  DP+ R++A   LAH + ++
Sbjct: 238 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 89/295 (30%), Positives = 143/295 (48%), Gaps = 46/295 (15%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKL-EIEIMTKLSGHPNVV 104
           +++G G +GV+ +  +K TGEV+A K I  D     E V S  + EI ++ +L+ HPN+V
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELN-HPNIV 66
Query: 105 DLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEA------RVIFRHLMQVVSYCH 158
            L  V   E+ ++L+ E      L   L+K+   S          +     L+Q +++CH
Sbjct: 67  KLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG-QNLHGTVGSPFYIAPEVLAG 217
            + V+HRDLKP+N+L+ T+ +   IKLADFGLA       +     V + +Y APE+L G
Sbjct: 122 SHRVLHRDLKPQNLLINTEGA---IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 178
Query: 218 --GYNQAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAVRAADLRF---------- 261
              Y+ A D+WS G I   +++    F G ++     +IF  +   D             
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 238
Query: 262 -PSDP-WDH---------ISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ 305
            PS P W           +    R L+  ML  DP+ R++A   LAH + ++  +
Sbjct: 239 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 293

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  105 bits (261), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 89/295 (30%), Positives = 143/295 (48%), Gaps = 46/295 (15%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKL-EIEIMTKLSGHPNVV 104
           +++G G +GV+ +  +K TGEV+A K I  D     E V S  + EI ++ +L+ HPN+V
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELN-HPNIV 66
Query: 105 DLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEA------RVIFRHLMQVVSYCH 158
            L  V   E+ ++L+ E      L   L+K+   S          +     L+Q +++CH
Sbjct: 67  KLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG-QNLHGTVGSPFYIAPEVLAG 217
            + V+HRDLKP+N+L+ T+ +   IKLADFGLA       +     V + +Y APE+L G
Sbjct: 122 SHRVLHRDLKPQNLLINTEGA---IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 178
Query: 218 --GYNQAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAVRAADLRF---------- 261
              Y+ A D+WS G I   +++    F G ++     +IF  +   D             
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 238
Query: 262 -PSDP-WDH---------ISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ 305
            PS P W           +    R L+  ML  DP+ R++A   LAH + ++  +
Sbjct: 239 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 293

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score =  105 bits (261), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 91/324 (28%), Positives = 144/324 (44%), Gaps = 58/324 (17%)
Query: 35  ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAK--DRLVTVEDVRSIKLEIE 92
           + N+S  + L   LG G +GV+   + K TGE++A K I      L  +  +R IK+   
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKI--- 62
Query: 93  IMTKLSGHPNVVDLKAV-----YEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIF 147
              K   H N++ +  +     +E  + V+++ EL       HR+      S+   +   
Sbjct: 63  --LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYFI 118
Query: 148 RHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI--KAGQNLHGT-- 203
              ++ V   HG+ V+HRDLKP N+L+   +S+  +K+ DFGLA  I   A  N   T  
Sbjct: 119 YQTLRAVKVLHGSNVIHRDLKPSNLLI---NSNCDLKVCDFGLARIIDESAADNSEPTGQ 175
Query: 204 -------VGSPFYIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGKTKSK----I 250
                  V + +Y APEV+  +  Y++A DVWS G IL  L    P F G+        I
Sbjct: 176 QSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLI 235
Query: 251 FDAVRAA----DLR----------------FPSDP----WDHISASARDLIMGMLRVDPS 286
           F  +       DLR                +P+ P    +  ++    DL+  ML  DP+
Sbjct: 236 FGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPA 295
Query: 287 TRLTAAEVLAHSWMEECEQVAQKP 310
            R+TA E L H +++       +P
Sbjct: 296 KRITAKEALEHPYLQTYHDPNDEP 319

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  105 bits (261), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 89/295 (30%), Positives = 143/295 (48%), Gaps = 46/295 (15%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKL-EIEIMTKLSGHPNVV 104
           +++G G +GV+ +  +K TGEV+A K I  D     E V S  + EI ++ +L+ HPN+V
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELN-HPNIV 68
Query: 105 DLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEA------RVIFRHLMQVVSYCH 158
            L  V   E+ ++L+ E      L   L+K+   S          +     L+Q +++CH
Sbjct: 69  KLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 123
Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG-QNLHGTVGSPFYIAPEVLAG 217
            + V+HRDLKP+N+L+ T+ +   IKLADFGLA       +     V + +Y APE+L G
Sbjct: 124 SHRVLHRDLKPQNLLINTEGA---IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 180
Query: 218 --GYNQAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAVRAADLRF---------- 261
              Y+ A D+WS G I   +++    F G ++     +IF  +   D             
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 240
Query: 262 -PSDP-WDH---------ISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ 305
            PS P W           +    R L+  ML  DP+ R++A   LAH + ++  +
Sbjct: 241 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 295

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  105 bits (261), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 89/295 (30%), Positives = 143/295 (48%), Gaps = 46/295 (15%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKL-EIEIMTKLSGHPNVV 104
           +++G G +GV+ +  +K TGEV+A K I  D     E V S  + EI ++ +L+ HPN+V
Sbjct: 13  EKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELN-HPNIV 69
Query: 105 DLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEA------RVIFRHLMQVVSYCH 158
            L  V   E+ ++L+ E      L   L+K+   S          +     L+Q +++CH
Sbjct: 70  KLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 124
Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG-QNLHGTVGSPFYIAPEVLAG 217
            + V+HRDLKP+N+L+ T+ +   IKLADFGLA       +     V + +Y APE+L G
Sbjct: 125 SHRVLHRDLKPQNLLINTEGA---IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 181
Query: 218 --GYNQAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAVRAADLRF---------- 261
              Y+ A D+WS G I   +++    F G ++     +IF  +   D             
Sbjct: 182 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 241
Query: 262 -PSDP-WDH---------ISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ 305
            PS P W           +    R L+  ML  DP+ R++A   LAH + ++  +
Sbjct: 242 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 296

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  105 bits (261), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 89/295 (30%), Positives = 143/295 (48%), Gaps = 46/295 (15%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKL-EIEIMTKLSGHPNVV 104
           +++G G +GV+ +  +K TGEV+A K I  D     E V S  + EI ++ +L+ HPN+V
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELN-HPNIV 65
Query: 105 DLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEA------RVIFRHLMQVVSYCH 158
            L  V   E+ ++L+ E      L   L+K+   S          +     L+Q +++CH
Sbjct: 66  KLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHG-TVGSPFYIAPEVLAG 217
            + V+HRDLKP+N+L+ T+ +   IKLADFGLA         +   V + +Y APE+L G
Sbjct: 121 SHRVLHRDLKPQNLLINTEGA---IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 177
Query: 218 --GYNQAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAVRAADLRF---------- 261
              Y+ A D+WS G I   +++    F G ++     +IF  +   D             
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 262 -PSDP-WDH---------ISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ 305
            PS P W           +    R L+  ML  DP+ R++A   LAH + ++  +
Sbjct: 238 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 292

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  105 bits (261), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 89/295 (30%), Positives = 143/295 (48%), Gaps = 46/295 (15%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKL-EIEIMTKLSGHPNVV 104
           +++G G +GV+ +  +K TGEV+A K I  D     E V S  + EI ++ +L+ HPN+V
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELN-HPNIV 64
Query: 105 DLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEA------RVIFRHLMQVVSYCH 158
            L  V   E+ ++L+ E      L   L+K+   S          +     L+Q +++CH
Sbjct: 65  KLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHG-TVGSPFYIAPEVLAG 217
            + V+HRDLKP+N+L+ T+ +   IKLADFGLA         +   V + +Y APE+L G
Sbjct: 120 SHRVLHRDLKPQNLLINTEGA---IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 218 --GYNQAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAVRAADLRF---------- 261
              Y+ A D+WS G I   +++    F G ++     +IF  +   D             
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 262 -PSDP-WDH---------ISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ 305
            PS P W           +    R L+  ML  DP+ R++A   LAH + ++  +
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score =  104 bits (260), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 91/324 (28%), Positives = 144/324 (44%), Gaps = 58/324 (17%)
Query: 35  ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAK--DRLVTVEDVRSIKLEIE 92
           + N+S  + L   LG G +GV+   + K TGE++A K I      L  +  +R IK+   
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKI--- 62
Query: 93  IMTKLSGHPNVVDLKAV-----YEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIF 147
              K   H N++ +  +     +E  + V+++ EL       HR+      S+   +   
Sbjct: 63  --LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYFI 118
Query: 148 RHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI--KAGQNLHGT-- 203
              ++ V   HG+ V+HRDLKP N+L+   +S+  +K+ DFGLA  I   A  N   T  
Sbjct: 119 YQTLRAVKVLHGSNVIHRDLKPSNLLI---NSNCDLKVCDFGLARIIDESAADNSEPTGQ 175
Query: 204 -------VGSPFYIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGKTKSK----I 250
                  V + +Y APEV+  +  Y++A DVWS G IL  L    P F G+        I
Sbjct: 176 QSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLI 235
Query: 251 FDAVRAA----DLR----------------FPSDP----WDHISASARDLIMGMLRVDPS 286
           F  +       DLR                +P+ P    +  ++    DL+  ML  DP+
Sbjct: 236 FGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPA 295
Query: 287 TRLTAAEVLAHSWMEECEQVAQKP 310
            R+TA E L H +++       +P
Sbjct: 296 KRITAKEALEHPYLQTYHDPNDEP 319

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  104 bits (260), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 89/295 (30%), Positives = 143/295 (48%), Gaps = 46/295 (15%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKL-EIEIMTKLSGHPNVV 104
           +++G G +GV+ +  +K TGEV+A K I  D     E V S  + EI ++ +L+ HPN+V
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELN-HPNIV 65
Query: 105 DLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEA------RVIFRHLMQVVSYCH 158
            L  V   E+ ++L+ E      L   L+K+   S          +     L+Q +++CH
Sbjct: 66  KLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHG-TVGSPFYIAPEVLAG 217
            + V+HRDLKP+N+L+ T+ +   IKLADFGLA         +   V + +Y APE+L G
Sbjct: 121 SHRVLHRDLKPQNLLINTEGA---IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 177
Query: 218 --GYNQAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAVRAADLRF---------- 261
              Y+ A D+WS G I   +++    F G ++     +IF  +   D             
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 262 -PSDP-WDH---------ISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ 305
            PS P W           +    R L+  ML  DP+ R++A   LAH + ++  +
Sbjct: 238 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 292

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score =  104 bits (260), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 91/324 (28%), Positives = 144/324 (44%), Gaps = 58/324 (17%)
Query: 35  ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAK--DRLVTVEDVRSIKLEIE 92
           + N+S  + L   LG G +GV+   + K TGE++A K I      L  +  +R IK+   
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKI--- 62
Query: 93  IMTKLSGHPNVVDLKAV-----YEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIF 147
              K   H N++ +  +     +E  + V+++ EL       HR+      S+   +   
Sbjct: 63  --LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYFI 118
Query: 148 RHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI--KAGQNLHGT-- 203
              ++ V   HG+ V+HRDLKP N+L+   +S+  +K+ DFGLA  I   A  N   T  
Sbjct: 119 YQTLRAVKVLHGSNVIHRDLKPSNLLI---NSNCDLKVCDFGLARIIDESAADNSEPTGQ 175
Query: 204 -------VGSPFYIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGKTKSK----I 250
                  V + +Y APEV+  +  Y++A DVWS G IL  L    P F G+        I
Sbjct: 176 QSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLI 235
Query: 251 FDAVRAA----DLR----------------FPSDP----WDHISASARDLIMGMLRVDPS 286
           F  +       DLR                +P+ P    +  ++    DL+  ML  DP+
Sbjct: 236 FGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPA 295
Query: 287 TRLTAAEVLAHSWMEECEQVAQKP 310
            R+TA E L H +++       +P
Sbjct: 296 KRITAKEALEHPYLQTYHDPNDEP 319

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 89/295 (30%), Positives = 143/295 (48%), Gaps = 46/295 (15%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKL-EIEIMTKLSGHPNVV 104
           +++G G +GV+ +  +K TGEV+A K I  D     E V S  + EI ++ +L+ HPN+V
Sbjct: 13  EKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELN-HPNIV 69
Query: 105 DLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEA------RVIFRHLMQVVSYCH 158
            L  V   E+ ++L+ E      L   L+K+   S          +     L+Q +++CH
Sbjct: 70  KLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 124
Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHG-TVGSPFYIAPEVLAG 217
            + V+HRDLKP+N+L+ T+ +   IKLADFGLA         +   V + +Y APE+L G
Sbjct: 125 SHRVLHRDLKPQNLLINTEGA---IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 181
Query: 218 --GYNQAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAVRAADLRF---------- 261
              Y+ A D+WS G I   +++    F G ++     +IF  +   D             
Sbjct: 182 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 241
Query: 262 -PSDP-WDH---------ISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ 305
            PS P W           +    R L+  ML  DP+ R++A   LAH + ++  +
Sbjct: 242 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 296

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 89/295 (30%), Positives = 143/295 (48%), Gaps = 46/295 (15%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKL-EIEIMTKLSGHPNVV 104
           +++G G +GV+ +  +K TGEV+A K I  D     E V S  + EI ++ +L+ HPN+V
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELN-HPNIV 68
Query: 105 DLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEA------RVIFRHLMQVVSYCH 158
            L  V   E+ ++L+ E      L   L+K+   S          +     L+Q +++CH
Sbjct: 69  KLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 123
Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG-QNLHGTVGSPFYIAPEVLAG 217
            + V+HRDLKP+N+L+ T+ +   IKLADFGLA       +     V + +Y APE+L G
Sbjct: 124 SHRVLHRDLKPQNLLINTEGA---IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 180
Query: 218 --GYNQAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAVRAADLRF---------- 261
              Y+ A D+WS G I   +++    F G ++     +IF  +   D             
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 240
Query: 262 -PSDP-WDH---------ISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ 305
            PS P W           +    R L+  ML  DP+ R++A   LAH + ++  +
Sbjct: 241 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 295

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 89/295 (30%), Positives = 143/295 (48%), Gaps = 46/295 (15%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKL-EIEIMTKLSGHPNVV 104
           +++G G +GV+ +  +K TGEV+A K I  D     E V S  + EI ++ +L+ HPN+V
Sbjct: 11  EKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELN-HPNIV 67
Query: 105 DLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEA------RVIFRHLMQVVSYCH 158
            L  V   E+ ++L+ E      L   L+K+   S          +     L+Q +++CH
Sbjct: 68  KLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 122
Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG-QNLHGTVGSPFYIAPEVLAG 217
            + V+HRDLKP+N+L+ T+ +   IKLADFGLA       +     V + +Y APE+L G
Sbjct: 123 SHRVLHRDLKPQNLLINTEGA---IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 179
Query: 218 --GYNQAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAVRAADLRF---------- 261
              Y+ A D+WS G I   +++    F G ++     +IF  +   D             
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 239
Query: 262 -PSDP-WDH---------ISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ 305
            PS P W           +    R L+  ML  DP+ R++A   LAH + ++  +
Sbjct: 240 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 294

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 138/293 (47%), Gaps = 40/293 (13%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           D Y L + +G G   V++        E +A K I  ++  T  D   +  EI+ M++   
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMD--ELLKEIQAMSQCH- 71
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLE--------KYGRFSETEARVIFRHLM 151
           HPN+V     +  +D + L+M+L +GG +   ++        K G   E+    I R ++
Sbjct: 72  HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131
Query: 152 QVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT------VG 205
           + + Y H NG +HRD+K  NILL    S   +++ADFG++ ++  G ++         VG
Sbjct: 132 EGLEYLHKNGQIHRDVKAGNILLGEDGS---VQIADFGVSAFLATGGDITRNKVRKTFVG 188
Query: 206 SPFYIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPS 263
           +P ++APEV+    GY+  AD+WS G+    L +G  P+        +  ++   L   +
Sbjct: 189 TPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHK------YPPMKVLMLTLQN 242
Query: 264 DP------------WDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECE 304
           DP                  S R +I   L+ DP  R TAAE+L H + ++ +
Sbjct: 243 DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK 295

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 73/263 (27%), Positives = 130/263 (49%), Gaps = 11/263 (4%)
Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
           +Y   +++G G  G +    D  TG+ +A + +   +    E + +   EI +M + + +
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN---EILVMRE-NKN 76
Query: 101 PNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGN 160
           PN+V+    Y   D + ++ME  AGG L   + +     E +   + R  +Q + + H N
Sbjct: 77  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSN 135
Query: 161 GVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT-VGSPFYIAPEVLA-GG 218
            V+HRD+K +NILL    S   +KL DFG    I   Q+   T VG+P+++APEV+    
Sbjct: 136 QVIHRDIKSDNILLGMDGS---VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 192
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           Y    D+WS G++   ++ G PP+  +   +    +         +P + +SA  RD + 
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP-EKLSAIFRDFLN 251
Query: 279 GMLRVDPSTRLTAAEVLAHSWME 301
             L +D   R +A E+L H +++
Sbjct: 252 RCLDMDVEKRGSAKELLQHQFLK 274

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score =  104 bits (260), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 77/257 (29%), Positives = 126/257 (49%), Gaps = 12/257 (4%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           +++G G FG + +  D  T +V+A K I  D     +++  I+ EI ++++    P V  
Sbjct: 33  EKIGKGSFGEVFKGIDNRTQKVVAIKII--DLEEAEDEIEDIQQEITVLSQCDS-PYVTK 89
Query: 106 LKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHR 165
               Y ++  + ++ME   GG     LE  G   ET+   I R +++ + Y H    +HR
Sbjct: 90  YYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHR 148
Query: 166 DLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT-VGSPFYIAPEVLA-GGYNQAA 223
           D+K  N+LL   S    +KLADFG+A  +   Q    T VG+PF++APEV+    Y+  A
Sbjct: 149 DIKAANVLL---SEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKA 205
Query: 224 DVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRV 283
           D+WS G+    L  G PP       K+   +   +   P     + S   ++ +   L  
Sbjct: 206 DIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN---PPTLEGNYSKPLKEFVEACLNK 262
Query: 284 DPSTRLTAAEVLAHSWM 300
           +PS R TA E+L H ++
Sbjct: 263 EPSFRPTAKELLKHKFI 279

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 138/293 (47%), Gaps = 40/293 (13%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           D Y L + +G G   V++        E +A K I  ++  T  D   +  EI+ M++   
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMD--ELLKEIQAMSQCH- 66
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLE--------KYGRFSETEARVIFRHLM 151
           HPN+V     +  +D + L+M+L +GG +   ++        K G   E+    I R ++
Sbjct: 67  HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 126
Query: 152 QVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT------VG 205
           + + Y H NG +HRD+K  NILL    S   +++ADFG++ ++  G ++         VG
Sbjct: 127 EGLEYLHKNGQIHRDVKAGNILLGEDGS---VQIADFGVSAFLATGGDITRNKVRKTFVG 183
Query: 206 SPFYIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPS 263
           +P ++APEV+    GY+  AD+WS G+    L +G  P+        +  ++   L   +
Sbjct: 184 TPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHK------YPPMKVLMLTLQN 237
Query: 264 DP------------WDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECE 304
           DP                  S R +I   L+ DP  R TAAE+L H + ++ +
Sbjct: 238 DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK 290

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 88/298 (29%), Positives = 143/298 (47%), Gaps = 52/298 (17%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKL-EIEIMTKLSGHPNVV 104
           +++G G +GV+ +  +K TGEV+A K I  D     E V S  + EI ++ +L+ HPN+V
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELN-HPNIV 68
Query: 105 DLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEA---------RVIFRHLMQVVS 155
            L  V   E+ ++L+ E        H  +   +F +  A         +     L+Q ++
Sbjct: 69  KLLDVIHTENKLYLVFE--------HVDQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 156 YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG-QNLHGTVGSPFYIAPEV 214
           +CH + V+HRDLKP+N+L+ T+ +   IKLADFGLA       +     V + +Y APE+
Sbjct: 121 FCHSHRVLHRDLKPQNLLINTEGA---IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 177
Query: 215 LAG--GYNQAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAVRAADLRF------- 261
           L G   Y+ A D+WS G I   +++    F G ++     +IF  +   D          
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 237
Query: 262 ----PSDP-WDH---------ISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ 305
               PS P W           +    R L+  ML  DP+ R++A   LAH + ++  +
Sbjct: 238 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 295

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 85/300 (28%), Positives = 140/300 (46%), Gaps = 43/300 (14%)
Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSI---AKDRLVTVEDVRSIKLEIEIM 94
           L ++Y   +++G G +GV+ +  D   G ++A K I   A+D  +    +R I L  E+ 
Sbjct: 19  LMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELH 77
Query: 95  TKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVV 154
                HPN+V L  V   E  + L+ E           E      +++ ++    L++ V
Sbjct: 78  -----HPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGV 132
Query: 155 SYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATY--IKAGQNLHGTVGSPFYIAP 212
           ++CH + ++HRDLKP+N+L+   +S   +KLADFGLA    I      H  V + +Y AP
Sbjct: 133 AHCHQHRILHRDLKPQNLLI---NSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAP 188
Query: 213 EVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAVRAADLR------ 260
           +VL G   Y+ + D+WS G I   +++G P F G T      KIF  +   + R      
Sbjct: 189 DVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQ 248
Query: 261 ------------FPSDPWDHI----SASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECE 304
                       F   PW  I         DL+  ML  DP+ R++A + + H + ++ +
Sbjct: 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 88/289 (30%), Positives = 138/289 (47%), Gaps = 39/289 (13%)
Query: 42  YVLGKQLGWGQFGVI---RECSDKFTGEVLACKSIAKDRLV---TVEDVRSIKLEIEIMT 95
           Y LG  LG G FG +      +D+     +A K I ++R++    + D  +  LE+ ++ 
Sbjct: 33  YRLGPLLGKGGFGTVFAGHRLTDRLQ---VAIKVIPRNRVLGWSPLSDSVTCPLEVALLW 89
Query: 96  KLS---GHPNVVDLKAVYE-EEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLM 151
           K+    GHP V+ L   +E +E ++ +L       +LF  + + G   E  +R  F  ++
Sbjct: 90  KVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVV 149
Query: 152 QVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTV-----GS 206
             + +CH  GVVHRD+K ENIL+  +   +  KL DFG      +G  LH        G+
Sbjct: 150 AAIQHCHSRGVVHRDIKDENILIDLRRGCA--KLIDFG------SGALLHDEPYTDFDGT 201
Query: 207 PFYIAPEVLAGGYNQA--ADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSD 264
             Y  PE ++     A  A VWS G++LY ++ G  PF  +   +I +    A+L FP+ 
Sbjct: 202 RVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPF--ERDQEILE----AELHFPA- 254
Query: 265 PWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWME-ECEQVAQKPCK 312
              H+S     LI   L   PS+R +  E+L   WM+   E V   P K
Sbjct: 255 ---HVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNPSK 300

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 85/300 (28%), Positives = 140/300 (46%), Gaps = 43/300 (14%)
Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSI---AKDRLVTVEDVRSIKLEIEIM 94
           L ++Y   +++G G +GV+ +  D   G ++A K I   A+D  +    +R I L  E+ 
Sbjct: 19  LMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKEL- 76
Query: 95  TKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVV 154
                HPN+V L  V   E  + L+ E           E      +++ ++    L++ V
Sbjct: 77  ----HHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGV 132
Query: 155 SYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATY--IKAGQNLHGTVGSPFYIAP 212
           ++CH + ++HRDLKP+N+L+   +S   +KLADFGLA    I      H  V + +Y AP
Sbjct: 133 AHCHQHRILHRDLKPQNLLI---NSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAP 188
Query: 213 EVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAVRAADLR------ 260
           +VL G   Y+ + D+WS G I   +++G P F G T      KIF  +   + R      
Sbjct: 189 DVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQ 248
Query: 261 ------------FPSDPWDHI----SASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECE 304
                       F   PW  I         DL+  ML  DP+ R++A + + H + ++ +
Sbjct: 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 89/295 (30%), Positives = 142/295 (48%), Gaps = 46/295 (15%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKL-EIEIMTKLSGHPNVV 104
           +++G G +GV+ +  +K TGEV+A K I  D     E V S  + EI ++ +L+ HPN+V
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELN-HPNIV 65
Query: 105 DLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEA------RVIFRHLMQVVSYCH 158
            L  V   E+ ++L+ E      L   L+ +   S          +     L+Q +++CH
Sbjct: 66  KLLDVIHTENKLYLVFEF-----LHQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG-QNLHGTVGSPFYIAPEVLAG 217
            + V+HRDLKPEN+L+ T+ +   IKLADFGLA       +     V + +Y APE+L G
Sbjct: 121 SHRVLHRDLKPENLLINTEGA---IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 177
Query: 218 --GYNQAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAVRAADLRF---------- 261
              Y+ A D+WS G I   +++    F G ++     +IF  +   D             
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 262 -PSDP-WDH---------ISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ 305
            PS P W           +    R L+  ML  DP+ R++A   LAH + ++  +
Sbjct: 238 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 292

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 86/338 (25%), Positives = 145/338 (42%), Gaps = 73/338 (21%)
Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
           +Y L K+LG G +G++ +  D+ TGEV+A K I  D      D +    EI I+T+LSGH
Sbjct: 10  KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIF-DAFQNSTDAQRTFREIMILTELSGH 68
Query: 101 PNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGN 160
            N+V+L  V   ++   + +         H + +         + +   L++V+ Y H  
Sbjct: 69  ENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSG 128
Query: 161 GVVHRDLKPENILLATKSSSSPIKLADFGLA---TYIKAGQN------------------ 199
           G++HRD+KP NILL   ++   +K+ADFGL+     I+   N                  
Sbjct: 129 GLLHRDMKPSNILL---NAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQP 185
Query: 200 -LHGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRA 256
            L   V + +Y APE+L G   Y +  D+WS G IL  +L G P F G +     + +  
Sbjct: 186 ILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIG 245
Query: 257 ADLRFPSD----------------------------------PWDHI----------SAS 272
             + FPS+                                   W ++          +  
Sbjct: 246 V-IDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEE 304
Query: 273 ARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKP 310
           A DL+  +L+ +P+ R++A + L H ++       ++P
Sbjct: 305 ALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEP 342

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 87/297 (29%), Positives = 139/297 (46%), Gaps = 46/297 (15%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           Y   K +G G FGV+ +     +GE++A K + + +            E++IM KL  H 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFK-------NRELQIMRKLD-HC 73
Query: 102 NVVDLKAVY----EEEDYVHLLMELCAGGELFHRLEK-YGRFSET----EARVIFRHLMQ 152
           N+V L+  +    E++D V+L + L    E  +R+ + Y R  +T      ++    L +
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 153 VVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAP 212
            ++Y H  G+ HRD+KP+N+LL   ++   +KL DFG A  +  G+     + S +Y AP
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLLDPDTAV--LKLCDFGSAKQLVRGEPNVSYICSRYYRAP 191
Query: 213 EVLAGG--YNQAADVWSAGVILYILLSGMPPFWG----------------KTKSKIFDA- 253
           E++ G   Y  + DVWSAG +L  LL G P F G                 T+ +I +  
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 254 VRAADLRFP---SDPWDHI-----SASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
               +  FP   + PW  +        A  L   +L   P+ RLT  E  AHS+ +E
Sbjct: 252 PNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 308

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 77/257 (29%), Positives = 126/257 (49%), Gaps = 12/257 (4%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           +++G G FG + +  D  T +V+A K I  D     +++  I+ EI ++++    P V  
Sbjct: 13  EKIGKGSFGEVFKGIDNRTQKVVAIKII--DLEEAEDEIEDIQQEITVLSQCDS-PYVTK 69
Query: 106 LKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHR 165
               Y ++  + ++ME   GG     LE  G   ET+   I R +++ + Y H    +HR
Sbjct: 70  YYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHR 128
Query: 166 DLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT-VGSPFYIAPEVLA-GGYNQAA 223
           D+K  N+LL   S    +KLADFG+A  +   Q    T VG+PF++APEV+    Y+  A
Sbjct: 129 DIKAANVLL---SEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKA 185
Query: 224 DVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRV 283
           D+WS G+    L  G PP       K+   +   +   P     + S   ++ +   L  
Sbjct: 186 DIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN---PPTLEGNYSKPLKEFVEACLNK 242
Query: 284 DPSTRLTAAEVLAHSWM 300
           +PS R TA E+L H ++
Sbjct: 243 EPSFRPTAKELLKHKFI 259

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 87/290 (30%), Positives = 140/290 (48%), Gaps = 36/290 (12%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKL-EIEIMTKLSGHPNVV 104
           +++G G +GV+ +  +K TGEV+A K I  D     E V S  + EI ++ +L+ HPN+V
Sbjct: 11  EKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELN-HPNIV 67
Query: 105 DLKAVYEEEDYVHLLME-LCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVV 163
            L  V   E+ ++L+ E L    + F              +     L+Q +++CH + V+
Sbjct: 68  KLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 127
Query: 164 HRDLKPENILLATKSSSSPIKLADFGLATYIKAG-QNLHGTVGSPFYIAPEVLAG--GYN 220
           HRDLKP+N+L+ T+ +   IKLADFGLA       +     V + +Y APE+L G   Y+
Sbjct: 128 HRDLKPQNLLINTEGA---IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 184
Query: 221 QAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAVRAADLRF-----------PSDP 265
            A D+WS G I   +++    F G ++     +IF  +   D              PS P
Sbjct: 185 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 244
Query: 266 -WDH---------ISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ 305
            W           +    R L+  ML  DP+ R++A   LAH + ++  +
Sbjct: 245 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 294

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 87/290 (30%), Positives = 140/290 (48%), Gaps = 36/290 (12%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKL-EIEIMTKLSGHPNVV 104
           +++G G +GV+ +  +K TGEV+A K I  D     E V S  + EI ++ +L+ HPN+V
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELN-HPNIV 68
Query: 105 DLKAVYEEEDYVHLLME-LCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVV 163
            L  V   E+ ++L+ E L    + F              +     L+Q +++CH + V+
Sbjct: 69  KLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 128
Query: 164 HRDLKPENILLATKSSSSPIKLADFGLATYIKAG-QNLHGTVGSPFYIAPEVLAG--GYN 220
           HRDLKP+N+L+ T+ +   IKLADFGLA       +     V + +Y APE+L G   Y+
Sbjct: 129 HRDLKPQNLLINTEGA---IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 221 QAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAVRAADLRF-----------PSDP 265
            A D+WS G I   +++    F G ++     +IF  +   D              PS P
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 245
Query: 266 -WDH---------ISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ 305
            W           +    R L+  ML  DP+ R++A   LAH + ++  +
Sbjct: 246 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 295

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 87/290 (30%), Positives = 140/290 (48%), Gaps = 36/290 (12%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKL-EIEIMTKLSGHPNVV 104
           +++G G +GV+ +  +K TGEV+A K I  D     E V S  + EI ++ +L+ HPN+V
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELN-HPNIV 68
Query: 105 DLKAVYEEEDYVHLLME-LCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVV 163
            L  V   E+ ++L+ E L    + F              +     L+Q +++CH + V+
Sbjct: 69  KLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 128
Query: 164 HRDLKPENILLATKSSSSPIKLADFGLATYIKAG-QNLHGTVGSPFYIAPEVLAG--GYN 220
           HRDLKP+N+L+ T+ +   IKLADFGLA       +     V + +Y APE+L G   Y+
Sbjct: 129 HRDLKPQNLLINTEGA---IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 221 QAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAVRAADLRF-----------PSDP 265
            A D+WS G I   +++    F G ++     +IF  +   D              PS P
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 245
Query: 266 -WDH---------ISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ 305
            W           +    R L+  ML  DP+ R++A   LAH + ++  +
Sbjct: 246 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 295

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 88/298 (29%), Positives = 142/298 (47%), Gaps = 52/298 (17%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKL-EIEIMTKLSGHPNVV 104
           +++G G +GV+ +  +K TGEV+A K I  D     E V S  + EI ++ +L+ HPN+V
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELN-HPNIV 64
Query: 105 DLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEA---------RVIFRHLMQVVS 155
            L  V   E+ ++L+ E        H  +    F +  A         +     L+Q ++
Sbjct: 65  KLLDVIHTENKLYLVFE--------HVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLA 116
Query: 156 YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHG-TVGSPFYIAPEV 214
           +CH + V+HRDLKP+N+L+ T+ +   IKLADFGLA         +   V + +Y APE+
Sbjct: 117 FCHSHRVLHRDLKPQNLLINTEGA---IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 173
Query: 215 LAG--GYNQAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAVRAADLRF------- 261
           L G   Y+ A D+WS G I   +++    F G ++     +IF  +   D          
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233
Query: 262 ----PSDP-WDH---------ISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ 305
               PS P W           +    R L+  ML  DP+ R++A   LAH + ++  +
Sbjct: 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 72/263 (27%), Positives = 129/263 (49%), Gaps = 11/263 (4%)
Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
           +Y   +++G G  G +    D  TG+ +A + +   +    E + +   EI +M + + +
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN---EILVMRE-NKN 76
Query: 101 PNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGN 160
           PN+V+    Y   D + ++ME  AGG L   + +     E +   + R  +Q + + H N
Sbjct: 77  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSN 135
Query: 161 GVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT-VGSPFYIAPEVLA-GG 218
            V+HRD+K +NILL    S   +KL DFG    I   Q+     VG+P+++APEV+    
Sbjct: 136 QVIHRDIKSDNILLGMDGS---VKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKA 192
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           Y    D+WS G++   ++ G PP+  +   +    +         +P + +SA  RD + 
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP-EKLSAIFRDFLN 251
Query: 279 GMLRVDPSTRLTAAEVLAHSWME 301
             L +D   R +A E+L H +++
Sbjct: 252 RCLEMDVEKRGSAKELLQHQFLK 274

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 88/295 (29%), Positives = 142/295 (48%), Gaps = 46/295 (15%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKL-EIEIMTKLSGHPNVV 104
           +++G G +GV+ +  +K TGEV+A   I  D     E V S  + EI ++ +L+ HPN+V
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALXKIRLD--TETEGVPSTAIREISLLKELN-HPNIV 65
Query: 105 DLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEA------RVIFRHLMQVVSYCH 158
            L  V   E+ ++L+ E      L   L+K+   S          +     L+Q +++CH
Sbjct: 66  KLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHG-TVGSPFYIAPEVLAG 217
            + V+HRDLKP+N+L+ T+ +   IKLADFGLA         +   V + +Y APE+L G
Sbjct: 121 SHRVLHRDLKPQNLLINTEGA---IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 177
Query: 218 --GYNQAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAVRAADLRF---------- 261
              Y+ A D+WS G I   +++    F G ++     +IF  +   D             
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 262 -PSDP-WDH---------ISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ 305
            PS P W           +    R L+  ML  DP+ R++A   LAH + ++  +
Sbjct: 238 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 292

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 88/295 (29%), Positives = 142/295 (48%), Gaps = 46/295 (15%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKL-EIEIMTKLSGHPNVV 104
           +++G G +GV+ +  +K TGEV+A   I  D     E V S  + EI ++ +L+ HPN+V
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALXKIRLD--TETEGVPSTAIREISLLKELN-HPNIV 64
Query: 105 DLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEA------RVIFRHLMQVVSYCH 158
            L  V   E+ ++L+ E      L   L+K+   S          +     L+Q +++CH
Sbjct: 65  KLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHG-TVGSPFYIAPEVLAG 217
            + V+HRDLKP+N+L+ T+ +   IKLADFGLA         +   V + +Y APE+L G
Sbjct: 120 SHRVLHRDLKPQNLLINTEGA---IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 218 --GYNQAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAVRAADLRF---------- 261
              Y+ A D+WS G I   +++    F G ++     +IF  +   D             
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 262 -PSDP-WDH---------ISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ 305
            PS P W           +    R L+  ML  DP+ R++A   LAH + ++  +
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 76/257 (29%), Positives = 126/257 (49%), Gaps = 12/257 (4%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           +++G G FG + +  D  T +V+A K I  D     +++  I+ EI ++++    P V  
Sbjct: 28  EKIGKGSFGEVFKGIDNRTQKVVAIKII--DLEEAEDEIEDIQQEITVLSQCDS-PYVTK 84
Query: 106 LKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHR 165
               Y ++  + ++ME   GG     LE  G   ET+   I R +++ + Y H    +HR
Sbjct: 85  YYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHR 143
Query: 166 DLKPENILLATKSSSSPIKLADFGLATYIKAGQ-NLHGTVGSPFYIAPEVLA-GGYNQAA 223
           D+K  N+LL   S    +KLADFG+A  +   Q   +  VG+PF++APEV+    Y+  A
Sbjct: 144 DIKAANVLL---SEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSKA 200
Query: 224 DVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRV 283
           D+WS G+    L  G PP       K+   +   +   P     + S   ++ +   L  
Sbjct: 201 DIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN---PPTLEGNYSKPLKEFVEACLNK 257
Query: 284 DPSTRLTAAEVLAHSWM 300
           +PS R TA E+L H ++
Sbjct: 258 EPSFRPTAKELLKHKFI 274

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 72/263 (27%), Positives = 129/263 (49%), Gaps = 11/263 (4%)
Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
           +Y   +++G G  G +    D  TG+ +A + +   +    E + +   EI +M + + +
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN---EILVMRE-NKN 76
Query: 101 PNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGN 160
           PN+V+    Y   D + ++ME  AGG L   + +     E +   + R  +Q + + H N
Sbjct: 77  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSN 135
Query: 161 GVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHG-TVGSPFYIAPEVLA-GG 218
            V+HRD+K +NILL    S   +KL DFG    I   Q+     VG+P+++APEV+    
Sbjct: 136 QVIHRDIKSDNILLGMDGS---VKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTRKA 192
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           Y    D+WS G++   ++ G PP+  +   +    +         +P + +SA  RD + 
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP-EKLSAIFRDFLN 251
Query: 279 GMLRVDPSTRLTAAEVLAHSWME 301
             L +D   R +A E+L H +++
Sbjct: 252 RCLDMDVEKRGSAKELLQHQFLK 274

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 71/263 (26%), Positives = 129/263 (49%), Gaps = 11/263 (4%)
Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
           +Y   +++G G  G +    D  TG+ +A + +   +    E + +   EI +M + + +
Sbjct: 22  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN---EILVMRE-NKN 77
Query: 101 PNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGN 160
           PN+V+    Y   D + ++ME  AGG L   + +     E +   + R  +Q + + H N
Sbjct: 78  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSN 136
Query: 161 GVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT-VGSPFYIAPEVLA-GG 218
            V+HRD+K +NILL    S   +KL DFG    I   Q+     VG+P+++APEV+    
Sbjct: 137 QVIHRDIKSDNILLGMDGS---VKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKA 193
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           Y    D+WS G++   ++ G PP+  +   +    +         +P + +SA  RD + 
Sbjct: 194 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP-EKLSAIFRDFLN 252
Query: 279 GMLRVDPSTRLTAAEVLAHSWME 301
             L +D   R +A E++ H +++
Sbjct: 253 RCLEMDVEKRGSAKELIQHQFLK 275

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 71/263 (26%), Positives = 130/263 (49%), Gaps = 11/263 (4%)
Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
           +Y   +++G G  G +    D  TG+ +A + +   +    E + +   EI +M + + +
Sbjct: 22  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN---EILVMRE-NKN 77
Query: 101 PNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGN 160
           PN+V+    Y   D + ++ME  AGG L   + +     E +   + R  +Q + + H N
Sbjct: 78  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSN 136
Query: 161 GVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT-VGSPFYIAPEVLA-GG 218
            V+HR++K +NILL    S   +KL DFG    I   Q+   T VG+P+++APEV+    
Sbjct: 137 QVIHRNIKSDNILLGMDGS---VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 193
Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           Y    D+WS G++   ++ G PP+  +   +    +         +P + +SA  RD + 
Sbjct: 194 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP-EKLSAIFRDFLN 252
Query: 279 GMLRVDPSTRLTAAEVLAHSWME 301
             L +D   R +A E++ H +++
Sbjct: 253 RCLEMDVEKRGSAKELIQHQFLK 275

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 74/268 (27%), Positives = 135/268 (50%), Gaps = 21/268 (7%)
Query: 48  LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDL- 106
           +G G +G  ++   K  G++L  K +    +   E    +  E+ ++ +L  HPN+V   
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVS-EVNLLRELK-HPNIVRYY 71
Query: 107 -KAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSE-TEARVIFRHLMQV---VSYCH--- 158
            + +      ++++ME C GG+L   + K  +  +  +   + R + Q+   +  CH   
Sbjct: 72  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 159 --GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT-VGSPFYIAPEVL 215
             G+ V+HRDLKP N+ L  K +   +KL DFGLA  +    +   T VG+P+Y++PE +
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQN---VKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQM 188
Query: 216 AG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASAR 274
               YN+ +D+WS G +LY L + MPPF   ++ ++   +R    +F   P+ + S    
Sbjct: 189 NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG--KFRRIPYRY-SDELN 245
Query: 275 DLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
           ++I  ML +    R +  E+L +  + E
Sbjct: 246 EIITRMLNLKDYHRPSVEEILENPLILE 273

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 76/257 (29%), Positives = 126/257 (49%), Gaps = 12/257 (4%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           +++G G FG + +  D  T +V+A K I  D     +++  I+ EI ++++    P V  
Sbjct: 13  EKIGKGSFGEVFKGIDNRTQKVVAIKII--DLEEAEDEIEDIQQEITVLSQCDS-PYVTK 69
Query: 106 LKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHR 165
               Y ++  + ++ME   GG     LE  G   ET+   I R +++ + Y H    +HR
Sbjct: 70  YYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHR 128
Query: 166 DLKPENILLATKSSSSPIKLADFGLATYIKAGQ-NLHGTVGSPFYIAPEVLA-GGYNQAA 223
           D+K  N+LL   S    +KLADFG+A  +   Q   +  VG+PF++APEV+    Y+  A
Sbjct: 129 DIKAANVLL---SEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSKA 185
Query: 224 DVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRV 283
           D+WS G+    L  G PP       K+   +   +   P     + S   ++ +   L  
Sbjct: 186 DIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN---PPTLEGNYSKPLKEFVEACLNK 242
Query: 284 DPSTRLTAAEVLAHSWM 300
           +PS R TA E+L H ++
Sbjct: 243 EPSFRPTAKELLKHKFI 259

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 86/297 (28%), Positives = 138/297 (46%), Gaps = 46/297 (15%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           Y   K +G G FGV+ +     +GE++A K + + +            E++IM KL  H 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFK-------NRELQIMRKLD-HC 73
Query: 102 NVVDLKAVY----EEEDYVHLLMELCAGGELFHRLEK-YGRFSET----EARVIFRHLMQ 152
           N+V L+  +    E++D V+L + L       +R+ + Y R  +T      ++    L +
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 153 VVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAP 212
            ++Y H  G+ HRD+KP+N+LL   ++   +KL DFG A  +  G+     + S +Y AP
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLLDPDTAV--LKLCDFGSAKQLVRGEPNVSXICSRYYRAP 191
Query: 213 EVLAGG--YNQAADVWSAGVILYILLSGMPPFWG----------------KTKSKIFDA- 253
           E++ G   Y  + DVWSAG +L  LL G P F G                 T+ +I +  
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 254 VRAADLRFP---SDPWDHI-----SASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
               +  FP   + PW  +        A  L   +L   P+ RLT  E  AHS+ +E
Sbjct: 252 PNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 308

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 135/268 (50%), Gaps = 21/268 (7%)
Query: 48  LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDL- 106
           +G G +G  ++   K  G++L  K +    +   E    +  E+ ++ +L  HPN+V   
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVS-EVNLLRELK-HPNIVRYY 71
Query: 107 -KAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSE-TEARVIFRHLMQV---VSYCH--- 158
            + +      ++++ME C GG+L   + K  +  +  +   + R + Q+   +  CH   
Sbjct: 72  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 159 --GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT-VGSPFYIAPEVL 215
             G+ V+HRDLKP N+ L  K +   +KL DFGLA  +   ++     VG+P+Y++PE +
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQN---VKLGDFGLARILNHDEDFAKEFVGTPYYMSPEQM 188
Query: 216 AG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASAR 274
               YN+ +D+WS G +LY L + MPPF   ++ ++   +R    +F   P+ + S    
Sbjct: 189 NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG--KFRRIPYRY-SDELN 245
Query: 275 DLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
           ++I  ML +    R +  E+L +  + E
Sbjct: 246 EIITRMLNLKDYHRPSVEEILENPLILE 273

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 82/304 (26%), Positives = 133/304 (43%), Gaps = 50/304 (16%)
Query: 48  LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLK 107
           LG G FG + +  +       A K I      T E + +I  E+ ++  L+ H  VV   
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRH----TEEKLSTILSEVMLLASLN-HQYVVRYY 68
Query: 108 AVY-EEEDYVH------------LLMELCAGGELFHRLEKYGRFSET-EARVIFRHLMQV 153
           A + E  ++V             + ME C  G L+  +       +  E   +FR +++ 
Sbjct: 69  AAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEA 128
Query: 154 VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA--------GQNLHGT-- 203
           +SY H  G++HRDLKP NI +     S  +K+ DFGLA  +           QNL G+  
Sbjct: 129 LSYIHSQGIIHRDLKPMNIFI---DESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 204 -----VGSPFYIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRA 256
                +G+  Y+A EVL   G YN+  D++S G+I + ++   P   G  +  I   +R+
Sbjct: 186 NLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVNILKKLRS 243
Query: 257 ADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKPCKQDDL 316
             + FP D  D+     + +I  ++  DP+ R  A  +L   W+         P K  D 
Sbjct: 244 VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL---------PVKHQDE 294
Query: 317 CCKQ 320
             K+
Sbjct: 295 VIKE 298

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 80/274 (29%), Positives = 135/274 (49%), Gaps = 28/274 (10%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVR-SIKLEIEI-MTKL 97
           DR VLGK    G +G++    D      +A K I +       D R S  L  EI + K 
Sbjct: 26  DRVVLGK----GTYGIVYAGRDLSNQVRIAIKEIPE------RDSRYSQPLHEEIALHKH 75
Query: 98  SGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLE-KYGRFSETEARVIF--RHLMQVV 154
             H N+V     + E  ++ + ME   GG L   L  K+G   + E  + F  + +++ +
Sbjct: 76  LKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGL 135
Query: 155 SYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN--LHGTVGSPFYIAP 212
            Y H N +VHRD+K +N+L+ T S    +K++DFG +  + AG N       G+  Y+AP
Sbjct: 136 KYLHDNQIVHRDIKGDNVLINTYSGV--LKISDFGTSKRL-AGINPCTETFTGTLQYMAP 192
Query: 213 EVL---AGGYNQAADVWSAGVILYILLSGMPPFW--GKTKSKIFDAVRAADLRFPSDPWD 267
           E++     GY +AAD+WS G  +  + +G PPF+  G+ ++ +F   +    +   +  +
Sbjct: 193 EIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF---KVGMFKVHPEIPE 249
Query: 268 HISASARDLIMGMLRVDPSTRLTAAEVLAHSWME 301
            +SA A+  I+     DP  R  A ++L   +++
Sbjct: 250 SMSAEAKAFILKCFEPDPDKRACANDLLVDEFLK 283

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 83/300 (27%), Positives = 141/300 (47%), Gaps = 64/300 (21%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSI---AKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
           +++G G +GV+ +  + + GE  A K I    +D  +    +R    EI I+ +L  H N
Sbjct: 8   EKIGEGTYGVVYKAQNNY-GETFALKKIRLEKEDEGIPSTTIR----EISILKELK-HSN 61
Query: 103 VVDLKAVYEEED-----YVHL------LMELCAGGELFHRLEKYGRFSETEARVIFRHLM 151
           +V L  V   +      + HL      L+++C GG                A+     L+
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG-----------LESVTAKSFLLQLL 110
Query: 152 QVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATY--IKAGQNLHGTVGSPFY 209
             ++YCH   V+HRDLKP+N+L+   +    +K+ADFGLA    I   +  H  V + +Y
Sbjct: 111 NGIAYCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFGIPVRKYTHEVV-TLWY 166
Query: 210 IAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTKS----KIFDAVRAADLR--- 260
            AP+VL G   Y+   D+WS G I   +++G P F G +++    +IF  +   + +   
Sbjct: 167 RAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWP 226
Query: 261 --------------FPSDPWDH----ISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
                         +   PW+     +  S  DL+  ML++DP+ R+TA + L H++ +E
Sbjct: 227 NVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 134/268 (50%), Gaps = 21/268 (7%)
Query: 48  LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDL- 106
           +G G +G  ++   K  G++L  K +    +   E    +  E+ ++ +L  HPN+V   
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVS-EVNLLRELK-HPNIVRYY 71
Query: 107 -KAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSE-TEARVIFRHLMQV---VSYCH--- 158
            + +      ++++ME C GG+L   + K  +  +  +   + R + Q+   +  CH   
Sbjct: 72  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 159 --GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNL-HGTVGSPFYIAPEVL 215
             G+ V+HRDLKP N+ L  K +   +KL DFGLA  +    +     VG+P+Y++PE +
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQN---VKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQM 188
Query: 216 AG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASAR 274
               YN+ +D+WS G +LY L + MPPF   ++ ++   +R    +F   P+ + S    
Sbjct: 189 NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG--KFRRIPYRY-SDELN 245
Query: 275 DLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
           ++I  ML +    R +  E+L +  + E
Sbjct: 246 EIITRMLNLKDYHRPSVEEILENPLILE 273

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 83/300 (27%), Positives = 141/300 (47%), Gaps = 64/300 (21%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSI---AKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
           +++G G +GV+ +  + + GE  A K I    +D  +    +R    EI I+ +L  H N
Sbjct: 8   EKIGEGTYGVVYKAQNNY-GETFALKKIRLEKEDEGIPSTTIR----EISILKELK-HSN 61
Query: 103 VVDLKAVYEEED-----YVHL------LMELCAGGELFHRLEKYGRFSETEARVIFRHLM 151
           +V L  V   +      + HL      L+++C GG                A+     L+
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG-----------LESVTAKSFLLQLL 110
Query: 152 QVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATY--IKAGQNLHGTVGSPFY 209
             ++YCH   V+HRDLKP+N+L+   +    +K+ADFGLA    I   +  H  V + +Y
Sbjct: 111 NGIAYCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFGIPVRKYTHEIV-TLWY 166
Query: 210 IAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTKS----KIFDAVRAADLR--- 260
            AP+VL G   Y+   D+WS G I   +++G P F G +++    +IF  +   + +   
Sbjct: 167 RAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWP 226
Query: 261 --------------FPSDPWDH----ISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
                         +   PW+     +  S  DL+  ML++DP+ R+TA + L H++ +E
Sbjct: 227 NVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 83/300 (27%), Positives = 141/300 (47%), Gaps = 64/300 (21%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSI---AKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
           +++G G +GV+ +  + + GE  A K I    +D  +    +R    EI I+ +L  H N
Sbjct: 8   EKIGEGTYGVVYKAQNNY-GETFALKKIRLEKEDEGIPSTTIR----EISILKELK-HSN 61
Query: 103 VVDLKAVYEEED-----YVHL------LMELCAGGELFHRLEKYGRFSETEARVIFRHLM 151
           +V L  V   +      + HL      L+++C GG                A+     L+
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG-----------LESVTAKSFLLQLL 110
Query: 152 QVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATY--IKAGQNLHGTVGSPFY 209
             ++YCH   V+HRDLKP+N+L+   +    +K+ADFGLA    I   +  H  V + +Y
Sbjct: 111 NGIAYCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFGIPVRKYTHEVV-TLWY 166
Query: 210 IAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTKS----KIFDAVRAADLR--- 260
            AP+VL G   Y+   D+WS G I   +++G P F G +++    +IF  +   + +   
Sbjct: 167 RAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKNWP 226
Query: 261 --------------FPSDPWDH----ISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
                         +   PW+     +  S  DL+  ML++DP+ R+TA + L H++ +E
Sbjct: 227 NVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 80/274 (29%), Positives = 135/274 (49%), Gaps = 28/274 (10%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVR-SIKLEIEI-MTKL 97
           DR VLGK    G +G++    D      +A K I +       D R S  L  EI + K 
Sbjct: 12  DRVVLGK----GTYGIVYAGRDLSNQVRIAIKEIPE------RDSRYSQPLHEEIALHKH 61
Query: 98  SGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLE-KYGRFSETEARVIF--RHLMQVV 154
             H N+V     + E  ++ + ME   GG L   L  K+G   + E  + F  + +++ +
Sbjct: 62  LKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGL 121
Query: 155 SYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN--LHGTVGSPFYIAP 212
            Y H N +VHRD+K +N+L+ T S    +K++DFG +  + AG N       G+  Y+AP
Sbjct: 122 KYLHDNQIVHRDIKGDNVLINTYSGV--LKISDFGTSKRL-AGINPCTETFTGTLQYMAP 178
Query: 213 EVL---AGGYNQAADVWSAGVILYILLSGMPPFW--GKTKSKIFDAVRAADLRFPSDPWD 267
           E++     GY +AAD+WS G  +  + +G PPF+  G+ ++ +F   +    +   +  +
Sbjct: 179 EIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF---KVGMFKVHPEIPE 235
Query: 268 HISASARDLIMGMLRVDPSTRLTAAEVLAHSWME 301
            +SA A+  I+     DP  R  A ++L   +++
Sbjct: 236 SMSAEAKAFILKCFEPDPDKRACANDLLVDEFLK 269

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 80/276 (28%), Positives = 132/276 (47%), Gaps = 35/276 (12%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           ++LG G +G + +   K TG+++A K +  +      D++ I  EI IM +    P+VV 
Sbjct: 35  EKLGEGSYGSVYKAIHKETGQIVAIKQVPVE-----SDLQEIIKEISIMQQCDS-PHVVK 88
Query: 106 LKAVYEEEDYVHLLMELCAGGELFHRLEKYGR-FSETEARVIFRHLMQVVSYCHGNGVVH 164
               Y +   + ++ME C  G +   +    +  +E E   I +  ++ + Y H    +H
Sbjct: 89  YYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIH 148
Query: 165 RDLKPENILLATKSSSSPIKLADFGLA---TYIKAGQNLHGTVGSPFYIAPEVLAG-GYN 220
           RD+K  NILL T+  +   KLADFG+A   T   A +N    +G+PF++APEV+   GYN
Sbjct: 149 RDIKAGNILLNTEGHA---KLADFGVAGQLTDXMAKRNX--VIGTPFWMAPEVIQEIGYN 203
Query: 221 QAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDP---------WDHISA 271
             AD+WS G+    +  G PP+           +RA     P++P         W   S 
Sbjct: 204 CVADIWSLGITAIEMAEGKPPYAD------IHPMRAI-FMIPTNPPPTFRKPELW---SD 253
Query: 272 SARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVA 307
           +  D +   L   P  R TA ++L H ++   + V+
Sbjct: 254 NFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVS 289

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 72/297 (24%), Positives = 145/297 (48%), Gaps = 14/297 (4%)
Query: 9   SSQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVL 68
           S Q   Q  +  +  +    ++D     +  D ++   ++G G  G++   + + +G+++
Sbjct: 1   SPQREPQRVSHEQFRAALQLVVDPGDPRSYLDNFI---KIGEGSTGIVCIATVRSSGKLV 57
Query: 69  ACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGEL 128
           A K +   +    +  R +     ++ +   H NVV++   Y   D + ++ME   GG L
Sbjct: 58  AVKKMDLRK----QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 113
Query: 129 FHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADF 188
              +  + R +E +   +   ++Q +S  H  GV+HRD+K ++ILL   +    +KL+DF
Sbjct: 114 TD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDF 169
Query: 189 GLATYI-KAGQNLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKT 246
           G    + K        VG+P+++APE+++   Y    D+WS G+++  ++ G PP++ + 
Sbjct: 170 GFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP 229
Query: 247 KSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEEC 303
             K    +R  +L         +S S +  +  +L  DP+ R TAAE+L H ++ + 
Sbjct: 230 PLKAMKMIR-DNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 285

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 72/297 (24%), Positives = 144/297 (48%), Gaps = 14/297 (4%)
Query: 9   SSQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVL 68
           S Q   Q  +  +  +    ++D     +  D ++   ++G G  G++   + + +G+++
Sbjct: 123 SPQREPQRVSHEQFRAALQLVVDPGDPRSYLDNFI---KIGEGSTGIVCIATVRSSGKLV 179
Query: 69  ACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGEL 128
           A K +     +  +  R +     ++ +   H NVV++   Y   D + ++ME   GG L
Sbjct: 180 AVKKMD----LRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 235
Query: 129 FHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADF 188
              +  + R +E +   +   ++Q +S  H  GV+HRD+K ++ILL        +KL+DF
Sbjct: 236 TD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR---VKLSDF 291
Query: 189 GLATYI-KAGQNLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKT 246
           G    + K        VG+P+++APE+++   Y    D+WS G+++  ++ G PP++ + 
Sbjct: 292 GFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP 351
Query: 247 KSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEEC 303
             K    +R  +L         +S S +  +  +L  DP+ R TAAE+L H ++ + 
Sbjct: 352 PLKAMKMIR-DNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 407

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 72/297 (24%), Positives = 145/297 (48%), Gaps = 14/297 (4%)
Query: 9   SSQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVL 68
           S Q   Q  +  +  +    ++D     +  D ++   ++G G  G++   + + +G+++
Sbjct: 3   SPQREPQRVSHEQFRAALQLVVDPGDPRSYLDNFI---KIGEGSTGIVCIATVRSSGKLV 59
Query: 69  ACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGEL 128
           A K +   +    +  R +     ++ +   H NVV++   Y   D + ++ME   GG L
Sbjct: 60  AVKKMDLRK----QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 115
Query: 129 FHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADF 188
              +  + R +E +   +   ++Q +S  H  GV+HRD+K ++ILL   +    +KL+DF
Sbjct: 116 TD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDF 171
Query: 189 GLATYI-KAGQNLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKT 246
           G    + K        VG+P+++APE+++   Y    D+WS G+++  ++ G PP++ + 
Sbjct: 172 GFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP 231
Query: 247 KSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEEC 303
             K    +R  +L         +S S +  +  +L  DP+ R TAAE+L H ++ + 
Sbjct: 232 PLKAMKMIR-DNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 287

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 72/297 (24%), Positives = 144/297 (48%), Gaps = 14/297 (4%)
Query: 9   SSQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVL 68
           S Q   Q  +  +  +    ++D     +  D ++   ++G G  G++   + + +G+++
Sbjct: 46  SPQREPQRVSHEQFRAALQLVVDPGDPRSYLDNFI---KIGEGSTGIVCIATVRSSGKLV 102
Query: 69  ACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGEL 128
           A K +     +  +  R +     ++ +   H NVV++   Y   D + ++ME   GG L
Sbjct: 103 AVKKMD----LRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 158
Query: 129 FHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADF 188
              +  + R +E +   +   ++Q +S  H  GV+HRD+K ++ILL        +KL+DF
Sbjct: 159 TD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR---VKLSDF 214
Query: 189 GLATYI-KAGQNLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKT 246
           G    + K        VG+P+++APE+++   Y    D+WS G+++  ++ G PP++ + 
Sbjct: 215 GFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP 274
Query: 247 KSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEEC 303
             K    +R  +L         +S S +  +  +L  DP+ R TAAE+L H ++ + 
Sbjct: 275 PLKAMKMIR-DNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 330

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 103/211 (48%), Gaps = 13/211 (6%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           + + ++LG G FG +     + TGE +A K   ++  ++ ++     LEI+IM KL+ HP
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE--LSPKNRERWCLEIQIMKKLN-HP 72
Query: 102 NVVDLKAVYE------EEDYVHLLMELCAGGELFHRLEKYGR---FSETEARVIFRHLMQ 152
           NVV  + V +        D   L ME C GG+L   L ++       E   R +   +  
Sbjct: 73  NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132
Query: 153 VVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAP 212
            + Y H N ++HRDLKPENI+L         K+ D G A  +  G+     VG+  Y+AP
Sbjct: 133 ALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAP 192
Query: 213 EVL-AGGYNQAADVWSAGVILYILLSGMPPF 242
           E+L    Y    D WS G + +  ++G  PF
Sbjct: 193 ELLEQKKYTVTVDYWSFGTLAFECITGFRPF 223

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 67/259 (25%), Positives = 132/259 (50%), Gaps = 11/259 (4%)
Query: 47  QLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDL 106
           ++G G  G++   + + +G+++A K +   +    +  R +     ++ +   H NVV++
Sbjct: 27  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRK----QQRRELLFNEVVIMRDYQHENVVEM 82
Query: 107 KAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRD 166
              Y   D + ++ME   GG L   +  + R +E +   +   ++Q +S  H  GV+HRD
Sbjct: 83  YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRD 141
Query: 167 LKPENILLATKSSSSPIKLADFGLATYI-KAGQNLHGTVGSPFYIAPEVLAG-GYNQAAD 224
           +K ++ILL   +    +KL+DFG    + K        VG+P+++APE+++   Y    D
Sbjct: 142 IKSDSILL---THDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVD 198
Query: 225 VWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVD 284
           +WS G+++  ++ G PP++ +   K    +R  +L         +S S +  +  +L  D
Sbjct: 199 IWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR-DNLPPRLKNLHKVSPSLKGFLDRLLVRD 257
Query: 285 PSTRLTAAEVLAHSWMEEC 303
           P+ R TAAE+L H ++ + 
Sbjct: 258 PAQRATAAELLKHPFLAKA 276

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 103/211 (48%), Gaps = 13/211 (6%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           + + ++LG G FG +     + TGE +A K   ++  ++ ++     LEI+IM KL+ HP
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE--LSPKNRERWCLEIQIMKKLN-HP 73
Query: 102 NVVDLKAVYE------EEDYVHLLMELCAGGELFHRLEKYGR---FSETEARVIFRHLMQ 152
           NVV  + V +        D   L ME C GG+L   L ++       E   R +   +  
Sbjct: 74  NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 133
Query: 153 VVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAP 212
            + Y H N ++HRDLKPENI+L         K+ D G A  +  G+     VG+  Y+AP
Sbjct: 134 ALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAP 193
Query: 213 EVL-AGGYNQAADVWSAGVILYILLSGMPPF 242
           E+L    Y    D WS G + +  ++G  PF
Sbjct: 194 ELLEQKKYTVTVDYWSFGTLAFECITGFRPF 224

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 67/259 (25%), Positives = 132/259 (50%), Gaps = 11/259 (4%)
Query: 47  QLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDL 106
           ++G G  G++   + + +G+++A K +   +    +  R +     ++ +   H NVV++
Sbjct: 31  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRK----QQRRELLFNEVVIMRDYQHENVVEM 86
Query: 107 KAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRD 166
              Y   D + ++ME   GG L   +  + R +E +   +   ++Q +S  H  GV+HRD
Sbjct: 87  YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRD 145
Query: 167 LKPENILLATKSSSSPIKLADFGLATYI-KAGQNLHGTVGSPFYIAPEVLAG-GYNQAAD 224
           +K ++ILL   +    +KL+DFG    + K        VG+P+++APE+++   Y    D
Sbjct: 146 IKSDSILL---THDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVD 202
Query: 225 VWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVD 284
           +WS G+++  ++ G PP++ +   K    +R  +L         +S S +  +  +L  D
Sbjct: 203 IWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR-DNLPPRLKNLHKVSPSLKGFLDRLLVRD 261
Query: 285 PSTRLTAAEVLAHSWMEEC 303
           P+ R TAAE+L H ++ + 
Sbjct: 262 PAQRATAAELLKHPFLAKA 280

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 146/295 (49%), Gaps = 26/295 (8%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           D ++  + LG G FG +  C  K TG++ ACK + K RL   +  +   +E +I+ K+  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRL----EKYGRFSETEARVIFRHLMQVVS 155
              +V L   +E +  + L+M +  GG++ + +    E    F E  A      ++  + 
Sbjct: 245 R-FIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 156 YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ-NLHGTVGSPFYIAPEV 214
           + H   +++RDLKPEN+LL    +   ++++D GLA  +KAGQ    G  G+P ++APE+
Sbjct: 304 HLHQRNIIYRDLKPENVLLDDDGN---VRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360
Query: 215 LAG-GYNQAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAVRAADLRFPSDPWDHI 269
           L G  Y+ + D ++ GV LY +++   PF  + +     ++   V    + +P    D  
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP----DKF 416
Query: 270 SASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKPCKQDDLCCKQLEVG 324
           S +++D    +L+ DP  RL   +         C+ +   P  + D+  +QLE G
Sbjct: 417 SPASKDFCEALLQKDPEKRLGFRD-------GSCDGLRTHPLFR-DISWRQLEAG 463

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 74/260 (28%), Positives = 126/260 (48%), Gaps = 18/260 (6%)
Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKL 97
           +++RY +  +LG G    +    D      +A K+I        E ++  + E+   ++L
Sbjct: 9   INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL 68
Query: 98  SGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYC 157
           S H N+V +  V EE+D  +L+ME   G  L   +E +G  S   A      ++  + + 
Sbjct: 69  S-HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHA 127
Query: 158 HGNGVVHRDLKPENILLATKSSSSPIKLADFGLA-----TYIKAGQNLHGTVGSPFYIAP 212
           H   +VHRD+KP+NIL+    S+  +K+ DFG+A     T +    ++ GTV    Y +P
Sbjct: 128 HDMRIVHRDIKPQNILI---DSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQ---YFSP 181
Query: 213 EVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFP---SDPWDH 268
           E   G   ++  D++S G++LY +L G PPF G+T   I  A++      P   +D    
Sbjct: 182 EQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI--AIKHIQDSVPNVTTDVRKD 239
Query: 269 ISASARDLIMGMLRVDPSTR 288
           I  S  ++I+     D + R
Sbjct: 240 IPQSLSNVILRATEKDKANR 259

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 146/295 (49%), Gaps = 26/295 (8%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           D ++  + LG G FG +  C  K TG++ ACK + K RL   +  +   +E +I+ K+  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRL----EKYGRFSETEARVIFRHLMQVVS 155
              +V L   +E +  + L+M +  GG++ + +    E    F E  A      ++  + 
Sbjct: 245 R-FIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 156 YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ-NLHGTVGSPFYIAPEV 214
           + H   +++RDLKPEN+LL    +   ++++D GLA  +KAGQ    G  G+P ++APE+
Sbjct: 304 HLHQRNIIYRDLKPENVLLDDDGN---VRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360
Query: 215 LAG-GYNQAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAVRAADLRFPSDPWDHI 269
           L G  Y+ + D ++ GV LY +++   PF  + +     ++   V    + +P    D  
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP----DKF 416
Query: 270 SASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKPCKQDDLCCKQLEVG 324
           S +++D    +L+ DP  RL   +         C+ +   P  + D+  +QLE G
Sbjct: 417 SPASKDFCEALLQKDPEKRLGFRD-------GSCDGLRTHPLFR-DISWRQLEAG 463

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 81/304 (26%), Positives = 132/304 (43%), Gaps = 50/304 (16%)
Query: 48  LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLK 107
           LG G FG + +  +       A K I      T E + +I  E+ ++  L+ H  VV   
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRH----TEEKLSTILSEVMLLASLN-HQYVVRYY 68
Query: 108 AVY-EEEDYVH------------LLMELCAGGELFHRLEKYGRFSET-EARVIFRHLMQV 153
           A + E  ++V             + ME C    L+  +       +  E   +FR +++ 
Sbjct: 69  AAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEA 128
Query: 154 VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA--------GQNLHGT-- 203
           +SY H  G++HRDLKP NI +     S  +K+ DFGLA  +           QNL G+  
Sbjct: 129 LSYIHSQGIIHRDLKPMNIFI---DESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 204 -----VGSPFYIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRA 256
                +G+  Y+A EVL   G YN+  D++S G+I + ++   P   G  +  I   +R+
Sbjct: 186 NLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVNILKKLRS 243
Query: 257 ADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKPCKQDDL 316
             + FP D  D+     + +I  ++  DP+ R  A  +L   W+         P K  D 
Sbjct: 244 VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL---------PVKHQDE 294
Query: 317 CCKQ 320
             K+
Sbjct: 295 VIKE 298

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 98.6 bits (244), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 146/295 (49%), Gaps = 26/295 (8%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           D ++  + LG G FG +  C  K TG++ ACK + K RL   +  +   +E +I+ K+  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRL----EKYGRFSETEARVIFRHLMQVVS 155
              +V L   +E +  + L+M +  GG++ + +    E    F E  A      ++  + 
Sbjct: 245 R-FIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 156 YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ-NLHGTVGSPFYIAPEV 214
           + H   +++RDLKPEN+LL    +   ++++D GLA  +KAGQ    G  G+P ++APE+
Sbjct: 304 HLHQRNIIYRDLKPENVLLDDDGN---VRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360
Query: 215 LAG-GYNQAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAVRAADLRFPSDPWDHI 269
           L G  Y+ + D ++ GV LY +++   PF  + +     ++   V    + +P    D  
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP----DKF 416
Query: 270 SASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKPCKQDDLCCKQLEVG 324
           S +++D    +L+ DP  RL   +         C+ +   P  + D+  +QLE G
Sbjct: 417 SPASKDFCEALLQKDPEKRLGFRD-------GSCDGLRTHPLFR-DISWRQLEAG 463

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 146/295 (49%), Gaps = 26/295 (8%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           D ++  + LG G FG +  C  K TG++ ACK + K RL   +  +   +E +I+ K+  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRL----EKYGRFSETEARVIFRHLMQVVS 155
              +V L   +E +  + L+M +  GG++ + +    E    F E  A      ++  + 
Sbjct: 245 R-FIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 156 YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN-LHGTVGSPFYIAPEV 214
           + H   +++RDLKPEN+LL    +   ++++D GLA  +KAGQ    G  G+P ++APE+
Sbjct: 304 HLHQRNIIYRDLKPENVLLDDDGN---VRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360
Query: 215 LAG-GYNQAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAVRAADLRFPSDPWDHI 269
           L G  Y+ + D ++ GV LY +++   PF  + +     ++   V    + +P    D  
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP----DKF 416
Query: 270 SASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKPCKQDDLCCKQLEVG 324
           S +++D    +L+ DP  RL   +         C+ +   P  + D+  +QLE G
Sbjct: 417 SPASKDFCEALLQKDPEKRLGFRD-------GSCDGLRTHPLFR-DISWRQLEAG 463

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 86/284 (30%), Positives = 123/284 (43%), Gaps = 41/284 (14%)
Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
           R  + + L  G F  + E  D  +G   A K +  +     E  R+I  E+  M KLSGH
Sbjct: 29  RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE---EEKNRAIIQEVCFMKKLSGH 85
Query: 101 PNVVDLKAV----YEEEDYVH----LLMELCAGG--ELFHRLEKYGRFSETEARVIFRHL 150
           PN+V   +      EE D       LL ELC G   E   ++E  G  S      IF   
Sbjct: 86  PNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQT 145
Query: 151 MQVVSYCHGNG--VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTV---- 204
            + V + H     ++HRDLK EN+LL+ + +   IKL DFG AT I    +   +     
Sbjct: 146 CRAVQHMHRQKPPIIHRDLKVENLLLSNQGT---IKLCDFGSATTISHYPDYSWSAQRRA 202
Query: 205 ---------GSPFYIAPEVLAGGYN----QAADVWSAGVILYILLSGMPPFWGKTKSKIF 251
                     +P Y  PE++    N    +  D+W+ G ILY+L     PF    K +I 
Sbjct: 203 LVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIV 262
Query: 252 DAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVL 295
           +       ++   P D        LI  ML+V+P  RL+ AEV+
Sbjct: 263 NG------KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVV 300

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 81/275 (29%), Positives = 132/275 (48%), Gaps = 16/275 (5%)
Query: 33  TQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIE 92
           T  S+LSDRY LG+ LG+G    +    D      +A K +  D           + E +
Sbjct: 5   TTPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQ 64
Query: 93  IMTKLSGHPNVVDLKAVYEEEDYV----HLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
               L+ HP +V + A  E E       +++ME   G  L   +   G  +   A  +  
Sbjct: 65  NAAALN-HPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIA 123
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN----LHGTV 204
              Q +++ H NG++HRD+KP NI++   S+++ +K+ DFG+A  I    N        +
Sbjct: 124 DACQALNFSHQNGIIHRDVKPANIMI---SATNAVKVMDFGIARAIADSGNSVTQTAAVI 180
Query: 205 GSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKI-FDAVRAADLRFP 262
           G+  Y++PE   G   +  +DV+S G +LY +L+G PPF G +   + +  VR  D   P
Sbjct: 181 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR-EDPIPP 239
Query: 263 SDPWDHISASARDLIMGMLRVDPSTRL-TAAEVLA 296
           S   + +SA    +++  L  +P  R  TAAE+ A
Sbjct: 240 SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRA 274

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 129/270 (47%), Gaps = 12/270 (4%)
Query: 33  TQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIE 92
             I++  + +   +++G G FG + +  D  T +V+A K I  D     +++  I+ EI 
Sbjct: 16  NNIADPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKII--DLEEAEDEIEDIQQEIT 73
Query: 93  IMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQ 152
           ++++      V      Y +   + ++ME   GG     L + G F E +   + + +++
Sbjct: 74  VLSQCDSS-YVTKYYGSYLKGSKLWIIMEYLGGGSALDLL-RAGPFDEFQIATMLKEILK 131
Query: 153 VVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT-VGSPFYIA 211
            + Y H    +HRD+K  N+LL   S    +KLADFG+A  +   Q    T VG+PF++A
Sbjct: 132 GLDYLHSEKKIHRDIKAANVLL---SEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMA 188
Query: 212 PEVL-AGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHIS 270
           PEV+    Y+  AD+WS G+    L  G PP       ++   +   +   P       +
Sbjct: 189 PEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNN---PPTLVGDFT 245
Query: 271 ASARDLIMGMLRVDPSTRLTAAEVLAHSWM 300
            S ++ I   L  DPS R TA E+L H ++
Sbjct: 246 KSFKEFIDACLNKDPSFRPTAKELLKHKFI 275

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 119/262 (45%), Gaps = 19/262 (7%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           +++G G FG +    D    EV+A K ++     + E  + I  E+  + KL  HPN + 
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQ 79
Query: 106 LKAVYEEEDYVHLLMELCAGG--ELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVV 163
            +  Y  E    L+ME C G   +L    +K     E E   +    +Q ++Y H + ++
Sbjct: 80  YRGCYLREHTAWLVMEYCLGSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSHNMI 137
Query: 164 HRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVL----AGGY 219
           HRD+K  NILL   S    +KL DFG A+ +         VG+P+++APEV+     G Y
Sbjct: 138 HRDVKAGNILL---SEPGLVKLGDFGSASIMAPANXF---VGTPYWMAPEVILAMDEGQY 191
Query: 220 NQAADVWSAGVILYILLSGMPPFWG-KTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           +   DVWS G+    L    PP +     S ++   +       S  W   S   R+ + 
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW---SEYFRNFVD 248
Query: 279 GMLRVDPSTRLTAAEVLAHSWM 300
             L+  P  R T+  +L H ++
Sbjct: 249 SCLQKIPQDRPTSEVLLKHRFV 270

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 74/261 (28%), Positives = 118/261 (45%), Gaps = 17/261 (6%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           +++G G FG +    D    EV+A K ++     + E  + I  E+  + KL  HPN + 
Sbjct: 60  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQ 118
Query: 106 LKAVYEEEDYVHLLMELCAGG--ELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVV 163
            +  Y  E    L+ME C G   +L    +K     E E   +    +Q ++Y H + ++
Sbjct: 119 YRGCYLREHTAWLVMEYCLGSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSHNMI 176
Query: 164 HRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVL----AGGY 219
           HRD+K  NILL   S    +KL DFG A+ +         VG+P+++APEV+     G Y
Sbjct: 177 HRDVKAGNILL---SEPGLVKLGDFGSASIMAPANXF---VGTPYWMAPEVILAMDEGQY 230
Query: 220 NQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMG 279
           +   DVWS G+    L    PP +          +  A    P+    H S   R+ +  
Sbjct: 231 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI--AQNESPALQSGHWSEYFRNFVDS 288
Query: 280 MLRVDPSTRLTAAEVLAHSWM 300
            L+  P  R T+  +L H ++
Sbjct: 289 CLQKIPQDRPTSEVLLKHRFV 309

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 82/275 (29%), Positives = 135/275 (49%), Gaps = 16/275 (5%)
Query: 33  TQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIE 92
           T  S+LSDRY LG+ LG+G    +    D      +A K +  D           + E +
Sbjct: 5   TTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQ 64
Query: 93  IMTKLSGHPNVVDLKAVYEEEDYV----HLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
               L+ HP +V +    E E       +++ME   G  L   +   G  +   A  +  
Sbjct: 65  NAAALN-HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIA 123
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI-KAGQNLHGT---V 204
              Q +++ H NG++HRD+KP NIL+   S+++ +K+ DFG+A  I  +G ++  T   +
Sbjct: 124 DACQALNFSHQNGIIHRDVKPANILI---SATNAVKVVDFGIARAIADSGNSVXQTAAVI 180
Query: 205 GSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKI-FDAVRAADLRFP 262
           G+  Y++PE   G   +  +DV+S G +LY +L+G PPF G +   + +  VR  D   P
Sbjct: 181 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR-EDPIPP 239
Query: 263 SDPWDHISASARDLIMGMLRVDPSTRL-TAAEVLA 296
           S   + +SA    +++  L  +P  R  TAAE+ A
Sbjct: 240 SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRA 274

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 81/275 (29%), Positives = 131/275 (47%), Gaps = 16/275 (5%)
Query: 33  TQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIE 92
           T  S+LSDRY LG+ LG+G    +    D      +A K +  D           + E +
Sbjct: 5   TTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQ 64
Query: 93  IMTKLSGHPNVVDLKAVYEEEDYV----HLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
               L+ HP +V +    E E       +++ME   G  L   +   G  +   A  +  
Sbjct: 65  NAAALN-HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIA 123
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN----LHGTV 204
              Q +++ H NG++HRD+KP NI++   S+++ +K+ DFG+A  I    N        +
Sbjct: 124 DACQALNFSHQNGIIHRDVKPANIMI---SATNAVKVMDFGIARAIADSGNSVTQTAAVI 180
Query: 205 GSPFYIAPEVLAGGYNQA-ADVWSAGVILYILLSGMPPFWGKTKSKI-FDAVRAADLRFP 262
           G+  Y++PE   G    A +DV+S G +LY +L+G PPF G +   + +  VR  D   P
Sbjct: 181 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPDSVAYQHVR-EDPIPP 239
Query: 263 SDPWDHISASARDLIMGMLRVDPSTRL-TAAEVLA 296
           S   + +SA    +++  L  +P  R  TAAE+ A
Sbjct: 240 SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRA 274

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 90/306 (29%), Positives = 137/306 (44%), Gaps = 52/306 (16%)
Query: 39  SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKL--EIEIMTK 96
           + RY    ++G G +G + +  D  +G  +A KS+   R+   E+   I    E+ ++ +
Sbjct: 3   TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSV---RVPNGEEGLPISTVREVALLRR 59
Query: 97  LSG--HPNVVDLKAV-----YEEEDYVHLLMELCAGGELFHRLEKY---GRFSETEARVI 146
           L    HPNVV L  V      + E  V L+ E     +L   L+K    G  +ET  + +
Sbjct: 60  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFE-HVDQDLRTYLDKAPPPGLPAET-IKDL 117
Query: 147 FRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGS 206
            R  ++ + + H N +VHRDLKPENIL+   +S   +KLADFGLA        L   V +
Sbjct: 118 MRQFLRGLDFLHANCIVHRDLKPENILV---TSGGTVKLADFGLARIYSYQMALFPVVVT 174
Query: 207 PFYIAPEV-LAGGYNQAADVWSAGVILYILLSGMPPFWGKTKS----KIFDAVRAADLRF 261
            +Y APEV L   Y    D+WS G I   +    P F G +++    KIFD +       
Sbjct: 175 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP---- 230
Query: 262 PSDPWDH-----------------------ISASARDLIMGMLRVDPSTRLTAAEVLAHS 298
           P D W                         +  S   L++ ML  +P  R++A   L HS
Sbjct: 231 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHS 290
Query: 299 WMEECE 304
           ++ + E
Sbjct: 291 YLHKDE 296

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 90/306 (29%), Positives = 137/306 (44%), Gaps = 52/306 (16%)
Query: 39  SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKL--EIEIMTK 96
           + RY    ++G G +G + +  D  +G  +A KS+   R+   E+   I    E+ ++ +
Sbjct: 3   TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSV---RVPNGEEGLPISTVREVALLRR 59
Query: 97  LSG--HPNVVDLKAV-----YEEEDYVHLLMELCAGGELFHRLEKY---GRFSETEARVI 146
           L    HPNVV L  V      + E  V L+ E     +L   L+K    G  +ET  + +
Sbjct: 60  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFE-HVDQDLRTYLDKAPPPGLPAET-IKDL 117
Query: 147 FRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGS 206
            R  ++ + + H N +VHRDLKPENIL+   +S   +KLADFGLA        L   V +
Sbjct: 118 MRQFLRGLDFLHANCIVHRDLKPENILV---TSGGTVKLADFGLARIYSYQMALDPVVVT 174
Query: 207 PFYIAPEV-LAGGYNQAADVWSAGVILYILLSGMPPFWGKTKS----KIFDAVRAADLRF 261
            +Y APEV L   Y    D+WS G I   +    P F G +++    KIFD +       
Sbjct: 175 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP---- 230
Query: 262 PSDPWDH-----------------------ISASARDLIMGMLRVDPSTRLTAAEVLAHS 298
           P D W                         +  S   L++ ML  +P  R++A   L HS
Sbjct: 231 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHS 290
Query: 299 WMEECE 304
           ++ + E
Sbjct: 291 YLHKDE 296

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 86/301 (28%), Positives = 137/301 (45%), Gaps = 56/301 (18%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKL-EIEIMTKLSGHPNVV 104
           ++LG G +  + +  +K TG  +A K +  D   + E   S  + EI +M +L  H N+V
Sbjct: 11  EKLGNGTYATVYKGLNKTTGVYVALKEVKLD---SEEGTPSTAIREISLMKELK-HENIV 66
Query: 105 DLKAVYEEEDYVHLLMELCAGGELFHRLEKY---------GRFSETEARVIFR-HLMQVV 154
            L  V   E+ + L+ E          L+KY          R  E      F+  L+Q +
Sbjct: 67  RLYDVIHTENKLTLVFEFMDND-----LKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121
Query: 155 SYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT-VGSPFYIAPE 213
           ++CH N ++HRDLKP+N+L+  +     +KL DFGLA       N   + V + +Y AP+
Sbjct: 122 AFCHENKILHRDLKPQNLLINKRGQ---LKLGDFGLARAFGIPVNTFSSEVVTLWYRAPD 178
Query: 214 VLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTKSK----IFDAVRAA---------- 257
           VL G   Y+ + D+WS G IL  +++G P F G    +    IFD +             
Sbjct: 179 VLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK 238
Query: 258 --------------DLRFPSDPW--DHISASARDLIMGMLRVDPSTRLTAAEVLAHSWME 301
                         DLR    P   + +  +  D + G+L+++P  RL+A + L H W  
Sbjct: 239 LPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFA 298
Query: 302 E 302
           E
Sbjct: 299 E 299

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 90/306 (29%), Positives = 137/306 (44%), Gaps = 52/306 (16%)
Query: 39  SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKL--EIEIMTK 96
           + RY    ++G G +G + +  D  +G  +A KS+   R+   E+   I    E+ ++ +
Sbjct: 3   TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSV---RVPNGEEGLPISTVREVALLRR 59
Query: 97  LSG--HPNVVDLKAV-----YEEEDYVHLLMELCAGGELFHRLEKY---GRFSETEARVI 146
           L    HPNVV L  V      + E  V L+ E     +L   L+K    G  +ET  + +
Sbjct: 60  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFE-HVDQDLRTYLDKAPPPGLPAET-IKDL 117
Query: 147 FRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGS 206
            R  ++ + + H N +VHRDLKPENIL+   +S   +KLADFGLA        L   V +
Sbjct: 118 MRQFLRGLDFLHANCIVHRDLKPENILV---TSGGTVKLADFGLARIYSYQMALAPVVVT 174
Query: 207 PFYIAPEV-LAGGYNQAADVWSAGVILYILLSGMPPFWGKTKS----KIFDAVRAADLRF 261
            +Y APEV L   Y    D+WS G I   +    P F G +++    KIFD +       
Sbjct: 175 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP---- 230
Query: 262 PSDPWDH-----------------------ISASARDLIMGMLRVDPSTRLTAAEVLAHS 298
           P D W                         +  S   L++ ML  +P  R++A   L HS
Sbjct: 231 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHS 290
Query: 299 WMEECE 304
           ++ + E
Sbjct: 291 YLHKDE 296

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 75/256 (29%), Positives = 120/256 (46%), Gaps = 12/256 (4%)
Query: 47  QLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDL 106
           ++G G FG + +  D  T EV+A K I  D     +++  I+ EI ++++    P +   
Sbjct: 26  RIGKGSFGEVYKGIDNHTKEVVAIKII--DLEEAEDEIEDIQQEITVLSQCDS-PYITRY 82
Query: 107 KAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRD 166
              Y +   + ++ME   GG     L K G   ET    I R +++ + Y H    +HRD
Sbjct: 83  FGSYLKSTKLWIIMEYLGGGSALDLL-KPGPLEETYIATILREILKGLDYLHSERKIHRD 141
Query: 167 LKPENILLATKSSSSPIKLADFGLATYIKAGQ-NLHGTVGSPFYIAPEVLA-GGYNQAAD 224
           +K  N+LL   S    +KLADFG+A  +   Q   +  VG+PF++APEV+    Y+  AD
Sbjct: 142 IKAANVLL---SEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDFKAD 198
Query: 225 VWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVD 284
           +WS G+    L  G PP       ++   +       P       S   ++ +   L  D
Sbjct: 199 IWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNS---PPTLEGQHSKPFKEFVEACLNKD 255
Query: 285 PSTRLTAAEVLAHSWM 300
           P  R TA E+L H ++
Sbjct: 256 PRFRPTAKELLKHKFI 271

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 80/275 (29%), Positives = 131/275 (47%), Gaps = 16/275 (5%)
Query: 33  TQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIE 92
           T  S+LSDRY LG+ LG+G    +    D      +A K +  D           + E +
Sbjct: 5   TTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQ 64
Query: 93  IMTKLSGHPNVVDLKAVYEEEDYV----HLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
               L+ HP +V +    E E       +++ME   G  L   +   G  +   A  +  
Sbjct: 65  NAAALN-HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIA 123
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN----LHGTV 204
              Q +++ H NG++HRD+KP NI++   S+++ +K+ DFG+A  I    N        +
Sbjct: 124 DACQALNFSHQNGIIHRDVKPANIMI---SATNAVKVMDFGIARAIADSGNSVTQTAAVI 180
Query: 205 GSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKI-FDAVRAADLRFP 262
           G+  Y++PE   G   +  +DV+S G +LY +L+G PPF G +   + +  VR  D   P
Sbjct: 181 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR-EDPIPP 239
Query: 263 SDPWDHISASARDLIMGMLRVDPSTRL-TAAEVLA 296
           S   + +SA    +++  L  +P  R  TAAE+ A
Sbjct: 240 SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRA 274

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 80/275 (29%), Positives = 131/275 (47%), Gaps = 16/275 (5%)
Query: 33  TQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIE 92
           T  S+LSDRY LG+ LG+G    +    D      +A K +  D           + E +
Sbjct: 5   TTPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQ 64
Query: 93  IMTKLSGHPNVVDLKAVYEEEDYV----HLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
               L+ HP +V +    E E       +++ME   G  L   +   G  +   A  +  
Sbjct: 65  NAAALN-HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIA 123
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN----LHGTV 204
              Q +++ H NG++HRD+KP NI++   S+++ +K+ DFG+A  I    N        +
Sbjct: 124 DACQALNFSHQNGIIHRDVKPANIMI---SATNAVKVMDFGIARAIADSGNSVTQTAAVI 180
Query: 205 GSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKI-FDAVRAADLRFP 262
           G+  Y++PE   G   +  +DV+S G +LY +L+G PPF G +   + +  VR  D   P
Sbjct: 181 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR-EDPIPP 239
Query: 263 SDPWDHISASARDLIMGMLRVDPSTRL-TAAEVLA 296
           S   + +SA    +++  L  +P  R  TAAE+ A
Sbjct: 240 SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRA 274

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 89/309 (28%), Positives = 134/309 (43%), Gaps = 49/309 (15%)
Query: 36  SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKL--EIEI 93
           S  + RY    ++G G +G + +  D  +G  +A KS+             I    E+ +
Sbjct: 5   SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64
Query: 94  MTKLSG--HPNVVDLKAV-----YEEEDYVHLLMELCAGGELFHRLEKY---GRFSETEA 143
           + +L    HPNVV L  V      + E  V L+ E     +L   L+K    G  +ET  
Sbjct: 65  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFE-HVDQDLRTYLDKAPPPGLPAET-I 122
Query: 144 RVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT 203
           + + R  ++ + + H N +VHRDLKPENIL+   +S   +KLADFGLA        L   
Sbjct: 123 KDLMRQFLRGLDFLHANCIVHRDLKPENILV---TSGGTVKLADFGLARIYSYQMALTPV 179
Query: 204 VGSPFYIAPEV-LAGGYNQAADVWSAGVILYILLSGMPPFWGKTKS----KIFDAVRAAD 258
           V + +Y APEV L   Y    D+WS G I   +    P F G +++    KIFD +    
Sbjct: 180 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP- 238
Query: 259 LRFPSDPWDH-----------------------ISASARDLIMGMLRVDPSTRLTAAEVL 295
              P D W                         +  S   L++ ML  +P  R++A   L
Sbjct: 239 ---PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRAL 295
Query: 296 AHSWMEECE 304
            HS++ + E
Sbjct: 296 QHSYLHKDE 304

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 89/311 (28%), Positives = 139/311 (44%), Gaps = 44/311 (14%)
Query: 37  NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTK 96
            L   YV    +G G +G +    DK +GE +A K +++     +   R+ + E+ ++ K
Sbjct: 21  ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR-EL-LLLK 78
Query: 97  LSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHR-LEKYG--RFSETEARVIFRHLMQV 153
              H NV+ L  V+     +    +           L+K    +FSE + + +   +++ 
Sbjct: 79  HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKG 138
Query: 154 VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPE 213
           + Y H  GVVHRDLKP N+ +   +    +K+ DFGLA +  A   + G V + +Y APE
Sbjct: 139 LKYIHSAGVVHRDLKPGNLAV---NEDCELKILDFGLARH--ADAEMTGYVVTRWYRAPE 193
Query: 214 VLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTK-------------------SKIFD 252
           V+     YNQ  D+WS G I+  +L+G   F GK                      K+ D
Sbjct: 194 VILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 253
Query: 253 -AVRAADLRFPSDP-------WDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWME--- 301
            A ++     P  P       +   S  A DL+  ML +D   RLTAA+ L H + E   
Sbjct: 254 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 313
Query: 302 --ECEQVAQKP 310
             E E  AQ+P
Sbjct: 314 DPEEETEAQQP 324

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 80/275 (29%), Positives = 131/275 (47%), Gaps = 16/275 (5%)
Query: 33  TQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIE 92
           T  S+LSDRY LG+ LG+G    +    D      +A K +  D           + E +
Sbjct: 22  TTPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQ 81
Query: 93  IMTKLSGHPNVVDLKAVYEEEDYV----HLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
               L+ HP +V +    E E       +++ME   G  L   +   G  +   A  +  
Sbjct: 82  NAAALN-HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIA 140
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN----LHGTV 204
              Q +++ H NG++HRD+KP NI++   S+++ +K+ DFG+A  I    N        +
Sbjct: 141 DACQALNFSHQNGIIHRDVKPANIMI---SATNAVKVMDFGIARAIADSGNSVTQTAAVI 197
Query: 205 GSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKI-FDAVRAADLRFP 262
           G+  Y++PE   G   +  +DV+S G +LY +L+G PPF G +   + +  VR  D   P
Sbjct: 198 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR-EDPIPP 256
Query: 263 SDPWDHISASARDLIMGMLRVDPSTRL-TAAEVLA 296
           S   + +SA    +++  L  +P  R  TAAE+ A
Sbjct: 257 SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRA 291

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 75/263 (28%), Positives = 122/263 (46%), Gaps = 19/263 (7%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           D + + K +G G F  +     K TG+V A K + K  ++   +V   + E +++     
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVN-GD 119
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYG-RFSETEARVIFRHLMQVVSYCH 158
              +  L   +++E+Y++L+ME   GG+L   L K+G R     AR     ++  +   H
Sbjct: 120 RRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH 179
Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHG--TVGSPFYIAPEVLA 216
             G VHRD+KP+NILL        I+LADFG    ++A   +     VG+P Y++PE+L 
Sbjct: 180 RLGYVHRDIKPDNILL---DRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQ 236
Query: 217 G--------GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAV--RAADLRFPSDPW 266
                     Y    D W+ GV  Y +  G  PF+  + ++ +  +      L  P    
Sbjct: 237 AVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVD- 295
Query: 267 DHISASARDLIMGMLRVDPSTRL 289
           + +   ARD I  +L   P TRL
Sbjct: 296 EGVPEEARDFIQRLL-CPPETRL 317

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 69/247 (27%), Positives = 119/247 (48%), Gaps = 16/247 (6%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           K +G G FG +     K T  + A K + K  ++   +    + E +++        +  
Sbjct: 80  KVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVN-GDCQWITA 138
Query: 106 LKAVYEEEDYVHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVH 164
           L   +++E++++L+M+   GG+L   L K+  +  E  AR     ++  +   H    VH
Sbjct: 139 LHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYVH 198
Query: 165 RDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTV--GSPFYIAPEVLA------ 216
           RD+KP+N+LL        I+LADFG    +     +  +V  G+P YI+PE+L       
Sbjct: 199 RDIKPDNVLLDVNGH---IRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGM 255
Query: 217 GGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLR--FPSDPWDHISASAR 274
           G Y    D WS GV +Y +L G  PF+ ++  + +  +   + R  FPS   D +S  A+
Sbjct: 256 GKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVTD-VSEEAK 314
Query: 275 DLIMGML 281
           DLI  ++
Sbjct: 315 DLIQRLI 321

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/247 (27%), Positives = 119/247 (48%), Gaps = 16/247 (6%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           K +G G FG +     K T  + A K + K  ++   +    + E +++        +  
Sbjct: 96  KVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVN-GDCQWITA 154
Query: 106 LKAVYEEEDYVHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVH 164
           L   +++E++++L+M+   GG+L   L K+  +  E  AR     ++  +   H    VH
Sbjct: 155 LHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYVH 214
Query: 165 RDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTV--GSPFYIAPEVLA------ 216
           RD+KP+N+LL        I+LADFG    +     +  +V  G+P YI+PE+L       
Sbjct: 215 RDIKPDNVLLDVNGH---IRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGM 271
Query: 217 GGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLR--FPSDPWDHISASAR 274
           G Y    D WS GV +Y +L G  PF+ ++  + +  +   + R  FPS   D +S  A+
Sbjct: 272 GKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVTD-VSEEAK 330
Query: 275 DLIMGML 281
           DLI  ++
Sbjct: 331 DLIQRLI 337

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 80/305 (26%), Positives = 130/305 (42%), Gaps = 52/305 (17%)
Query: 48  LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLK 107
           LG G FG + +  +       A K I      T E + +I  E+ ++  L+ H  VV   
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRH----TEEKLSTILSEVXLLASLN-HQYVVRYY 68
Query: 108 AVY-EEEDYVH------------LLMELCAGGELFHRLEKYGRFSET-EARVIFRHLMQV 153
           A + E  ++V             +  E C    L+  +       +  E   +FR +++ 
Sbjct: 69  AAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEA 128
Query: 154 VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA--------GQNLHGT-- 203
           +SY H  G++HR+LKP NI +     S  +K+ DFGLA  +           QNL G+  
Sbjct: 129 LSYIHSQGIIHRNLKPXNIFI---DESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 204 -----VGSPFYIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPF-WGKTKSKIFDAVR 255
                +G+  Y+A EVL   G YN+  D +S G+I +     + PF  G  +  I   +R
Sbjct: 186 NLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFF---EXIYPFSTGXERVNILKKLR 242
Query: 256 AADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKPCKQDD 315
           +  + FP D  D+     + +I  ++  DP+ R  A  +L   W+         P K  D
Sbjct: 243 SVSIEFPPDFDDNKXKVEKKIIRLLIDHDPNKRPGARTLLNSGWL---------PVKHQD 293
Query: 316 LCCKQ 320
              K+
Sbjct: 294 EVIKE 298

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 89/311 (28%), Positives = 138/311 (44%), Gaps = 44/311 (14%)
Query: 37  NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTK 96
            L   YV    +G G +G +    DK +GE +A K +++     +   R+ + E+ ++ K
Sbjct: 39  ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR-EL-LLLK 96
Query: 97  LSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHR-LEKYG--RFSETEARVIFRHLMQV 153
              H NV+ L  V+     +    +           L+K     FSE + + +   +++ 
Sbjct: 97  HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKG 156
Query: 154 VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPE 213
           + Y H  GVVHRDLKP N+ +   +    +K+ DFGLA +  A   + G V + +Y APE
Sbjct: 157 LKYIHSAGVVHRDLKPGNLAV---NEDCELKILDFGLARH--ADAEMTGYVVTRWYRAPE 211
Query: 214 VLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTK-------------------SKIFD 252
           V+     YNQ  D+WS G I+  +L+G   F GK                      K+ D
Sbjct: 212 VILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 271
Query: 253 -AVRAADLRFPSDP-------WDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWME--- 301
            A ++     P  P       +   S  A DL+  ML +D   RLTAA+ L H + E   
Sbjct: 272 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 331
Query: 302 --ECEQVAQKP 310
             E E  AQ+P
Sbjct: 332 DPEEETEAQQP 342

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 86/314 (27%), Positives = 141/314 (44%), Gaps = 65/314 (20%)
Query: 32  ATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVED--VRSIKL 89
           A  + + + RY     LG GQF  + +  DK T +++A K I        +D   R+   
Sbjct: 2   ALDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR 61
Query: 90  EIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR- 148
           EI+++ +LS HPN++ L   +  +  + L+ +                F ET+  VI + 
Sbjct: 62  EIKLLQELS-HPNIIGLLDAFGHKSNISLVFD----------------FMETDLEVIIKD 104
Query: 149 --------HL-------MQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA-T 192
                   H+       +Q + Y H + ++HRDLKP N+LL     +  +KLADFGLA +
Sbjct: 105 NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL---DENGVLKLADFGLAKS 161
Query: 193 YIKAGQNLHGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTK--- 247
           +    +     V + +Y APE+L G   Y    D+W+ G IL  LL  +P   G +    
Sbjct: 162 FGSPNRAYXHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ 221
Query: 248 -SKIFDAV------RAADL----------RFPSDPWDHISASA----RDLIMGMLRVDPS 286
            ++IF+ +      +  D+           FP  P  HI ++A     DLI G+   +P 
Sbjct: 222 LTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPC 281
Query: 287 TRLTAAEVLAHSWM 300
            R+TA + L   + 
Sbjct: 282 ARITATQALKMKYF 295

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/247 (27%), Positives = 118/247 (47%), Gaps = 16/247 (6%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           K +G G FG +     K   +V A K + K  ++   +    + E +++        +  
Sbjct: 80  KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN-GDSKWITT 138
Query: 106 LKAVYEEEDYVHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVH 164
           L   +++++ ++L+M+   GG+L   L K+  R  E  AR     ++  +   H    VH
Sbjct: 139 LHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVH 198
Query: 165 RDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT--VGSPFYIAPEVL------A 216
           RD+KP+NIL+        I+LADFG    +     +  +  VG+P YI+PE+L       
Sbjct: 199 RDIKPDNILMDMNGH---IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGK 255
Query: 217 GGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAV--RAADLRFPSDPWDHISASAR 274
           G Y    D WS GV +Y +L G  PF+ ++  + +  +       +FP+   D +S +A+
Sbjct: 256 GRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTD-VSENAK 314
Query: 275 DLIMGML 281
           DLI  ++
Sbjct: 315 DLIRRLI 321

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 83/324 (25%), Positives = 142/324 (43%), Gaps = 51/324 (15%)
Query: 34  QISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEI 93
           Q+ ++  RY     +G G +G++    D      +A K I+     T    R+++ EI+I
Sbjct: 21  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQ-RTLR-EIKI 78
Query: 94  MTKLSGHPNVVDLKAVY-----EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
           + +   H N++ +  +      E+   V+++ +L       ++L K    S         
Sbjct: 79  LLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLY 135
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHG----TV 204
            +++ + Y H   V+HRDLKP N+LL T   +  +K+ DFGLA       +  G     V
Sbjct: 136 QILRGLKYIHSANVLHRDLKPSNLLLNT---TXDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 205 GSPFYIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAV-------- 254
            + +Y APE++  + GY ++ D+WS G IL  +LS  P F GK      + +        
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 252
Query: 255 ------------RAADLRFPSD---PWDHI----SASARDLIMGMLRVDPSTRLTAAEVL 295
                       R   L  P     PW+ +     + A DL+  ML  +P  R+   + L
Sbjct: 253 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 312
Query: 296 AHSWMEEC-----EQVAQKPCKQD 314
           AH ++E+      E +A+ P K D
Sbjct: 313 AHPYLEQYYDPSDEPIAEAPFKFD 336

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 86/324 (26%), Positives = 144/324 (44%), Gaps = 51/324 (15%)
Query: 34  QISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEI 93
           Q+ ++  RY     +G G +G++    D      +A K I+     T    R+++ EI+I
Sbjct: 37  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQ-RTLR-EIKI 94
Query: 94  MTKLSGHPNVVDLKAVY-----EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
           + +   H N++ +  +      E+   V+L+  L  G +L+ +L K    S         
Sbjct: 95  LLRFR-HENIIGINDIIRAPTIEQMKDVYLVTHL-MGADLY-KLLKTQHLSNDHICYFLY 151
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHG----TV 204
            +++ + Y H   V+HRDLKP N+LL T   +  +K+ DFGLA       +  G     V
Sbjct: 152 QILRGLKYIHSANVLHRDLKPSNLLLNT---TXDLKICDFGLARVADPDHDHTGFLTEYV 208
Query: 205 GSPFYIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAV-------- 254
            + +Y APE++  + GY ++ D+WS G IL  +LS  P F GK      + +        
Sbjct: 209 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 268
Query: 255 ------------RAADLRFPSD---PWDHI----SASARDLIMGMLRVDPSTRLTAAEVL 295
                       R   L  P     PW+ +     + A DL+  ML  +P  R+   + L
Sbjct: 269 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 328
Query: 296 AHSWMEEC-----EQVAQKPCKQD 314
           AH ++E+      E +A+ P K D
Sbjct: 329 AHPYLEQYYDPSDEPIAEAPFKFD 352

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 83/325 (25%), Positives = 139/325 (42%), Gaps = 61/325 (18%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLS- 98
           DR+ + +  G G FG ++   +K TG  +A K +       ++D R    E++IM  L+ 
Sbjct: 23  DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV-------IQDPRFRNRELQIMQDLAV 75
Query: 99  -GHPNVVDLKAVY-------EEEDYVHLLMELCAGGELFHR-LEKYGRFSETEARVIFR- 148
             HPN+V L++ +         + Y++++ME     +  HR    Y R       ++ + 
Sbjct: 76  LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP--DTLHRCCRNYYRRQVAPPPILIKV 133
Query: 149 ---HLMQVVSYCH--GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT 203
               L++ +   H     V HRD+KP N+L+    +   +KL DFG A  +   +     
Sbjct: 134 FLFQLIRSIGCLHLPSVNVCHRDIKPHNVLV--NEADGTLKLCDFGSAKKLSPSEPNVAY 191
Query: 204 VGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTKS-KIFDAVRAADLR 260
           + S +Y APE++ G   Y  A D+WS G I   ++ G P F G   + ++ + VR   L 
Sbjct: 192 ICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRV--LG 249
Query: 261 FPSD---------------------PWDHI--------SASARDLIMGMLRVDPSTRLTA 291
            PS                      PW ++        +  A DL+  +L+  P  R+  
Sbjct: 250 CPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKP 309
Query: 292 AEVLAHSWMEECEQVAQKPCKQDDL 316
            E L H + +E    A K     DL
Sbjct: 310 YEALCHPYFDELHDPATKLPNNKDL 334

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 89/338 (26%), Positives = 146/338 (43%), Gaps = 66/338 (19%)
Query: 39  SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDR---------LVTVEDVRSIKL 89
           S +Y LGK LG G FG++ E  D  +G+  A K + +D          +  ++ V  IKL
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKL 65
Query: 90  EIEIMT----------------KLSGHPNVVD--LKAVY---EEEDYVHLLMELCAGGEL 128
                T                KL G  N V+   K+V     +  Y++++ME     + 
Sbjct: 66  VDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP--DT 123
Query: 129 FHRLEKY----GRFSETEARVIFRH-LMQVVSYCHGNGVVHRDLKPENILLATKSSSSPI 183
            H++ K     GR        I+ + L + V + H  G+ HRD+KP+N+L+ +K ++  +
Sbjct: 124 LHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNT--L 181
Query: 184 KLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPP 241
           KL DFG A  +   +     + S FY APE++ G   Y  + D+WS G +   L+ G P 
Sbjct: 182 KLCDFGSAKKLIPSEPSVAXICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPL 241
Query: 242 FWGKT-----------------KSKIFDAVRAADLRFPS---DPWDHI-----SASARDL 276
           F G+T                 +  I       ++RFP+     W  I      + A DL
Sbjct: 242 FSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDL 301
Query: 277 IMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKPCKQD 314
           +  +LR +P  R+   E +AH + +      +   K +
Sbjct: 302 LEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNN 339

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 83/324 (25%), Positives = 142/324 (43%), Gaps = 51/324 (15%)
Query: 34  QISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEI 93
           Q+ ++  RY     +G G +G++    D      +A K I+     T    R+++ EI+I
Sbjct: 21  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQ-RTLR-EIKI 78
Query: 94  MTKLSGHPNVVDLKAVY-----EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
           + +   H N++ +  +      E+   V+++ +L       ++L K    S         
Sbjct: 79  LLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLY 135
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHG----TV 204
            +++ + Y H   V+HRDLKP N+LL T   +  +K+ DFGLA       +  G     V
Sbjct: 136 QILRGLKYIHSANVLHRDLKPSNLLLNT---TXDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 205 GSPFYIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAV-------- 254
            + +Y APE++  + GY ++ D+WS G IL  +LS  P F GK      + +        
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 252
Query: 255 ------------RAADLRFPSD---PWDHI----SASARDLIMGMLRVDPSTRLTAAEVL 295
                       R   L  P     PW+ +     + A DL+  ML  +P  R+   + L
Sbjct: 253 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 312
Query: 296 AHSWMEEC-----EQVAQKPCKQD 314
           AH ++E+      E +A+ P K D
Sbjct: 313 AHPYLEQYYDPSDEPIAEAPFKFD 336

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 83/324 (25%), Positives = 142/324 (43%), Gaps = 51/324 (15%)
Query: 34  QISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEI 93
           Q+ ++  RY     +G G +G++    D      +A K I+     T    R+++ EI+I
Sbjct: 21  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQ-RTLR-EIKI 78
Query: 94  MTKLSGHPNVVDLKAVY-----EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
           + +   H N++ +  +      E+   V+++ +L       ++L K    S         
Sbjct: 79  LLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLY 135
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHG----TV 204
            +++ + Y H   V+HRDLKP N+LL T   +  +K+ DFGLA       +  G     V
Sbjct: 136 QILRGLKYIHSANVLHRDLKPSNLLLNT---TCDLKICDFGLARVADPDHDHTGFLXEXV 192
Query: 205 GSPFYIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAV-------- 254
            + +Y APE++  + GY ++ D+WS G IL  +LS  P F GK      + +        
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 252
Query: 255 ------------RAADLRFPSD---PWDHI----SASARDLIMGMLRVDPSTRLTAAEVL 295
                       R   L  P     PW+ +     + A DL+  ML  +P  R+   + L
Sbjct: 253 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 312
Query: 296 AHSWMEEC-----EQVAQKPCKQD 314
           AH ++E+      E +A+ P K D
Sbjct: 313 AHPYLEQYYDPSDEPIAEAPFKFD 336

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 83/324 (25%), Positives = 142/324 (43%), Gaps = 51/324 (15%)
Query: 34  QISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEI 93
           Q+ ++  RY     +G G +G++    D      +A K I+     T    R+++ EI+I
Sbjct: 22  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQ-RTLR-EIKI 79
Query: 94  MTKLSGHPNVVDLKAVY-----EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
           + +   H N++ +  +      E+   V+++ +L       ++L K    S         
Sbjct: 80  LLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLY 136
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHG----TV 204
            +++ + Y H   V+HRDLKP N+LL T   +  +K+ DFGLA       +  G     V
Sbjct: 137 QILRGLKYIHSANVLHRDLKPSNLLLNT---TCDLKICDFGLARVADPDHDHTGFLXEXV 193
Query: 205 GSPFYIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAV-------- 254
            + +Y APE++  + GY ++ D+WS G IL  +LS  P F GK      + +        
Sbjct: 194 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 253
Query: 255 ------------RAADLRFPSD---PWDHI----SASARDLIMGMLRVDPSTRLTAAEVL 295
                       R   L  P     PW+ +     + A DL+  ML  +P  R+   + L
Sbjct: 254 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 313
Query: 296 AHSWMEEC-----EQVAQKPCKQD 314
           AH ++E+      E +A+ P K D
Sbjct: 314 AHPYLEQYYDPSDEPIAEAPFKFD 337

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 73/252 (28%), Positives = 112/252 (44%), Gaps = 13/252 (5%)
Query: 47  QLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDL 106
           +LG G +G + +   K  G + A K          +  R +  E+    K+  HP  V L
Sbjct: 64  RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLA-EVGSHEKVGQHPCCVRL 122
Query: 107 KAVYEEEDYVHLLMELCAGGELFHRLEKYG-RFSETEARVIFRHLMQVVSYCHGNGVVHR 165
           +  +EE   ++L  ELC G  L    E +G    E +     R  +  +++ H  G+VH 
Sbjct: 123 EQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHL 181
Query: 166 DLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGGYNQAADV 225
           D+KP NI L  +      KL DFGL   +          G P Y+APE+L G Y  AADV
Sbjct: 182 DVKPANIFLGPRGR---CKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGSYGTAADV 238
Query: 226 WSAGVILYILLSGMP-PFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVD 284
           +S G+ +  +   M  P  G+   ++           P +    +S+  R +++ ML  D
Sbjct: 239 FSLGLTILEVACNMELPHGGEGWQQLRQGY------LPPEFTAGLSSELRSVLVMMLEPD 292
Query: 285 PSTRLTAAEVLA 296
           P  R TA  +LA
Sbjct: 293 PKLRATAEALLA 304

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 83/324 (25%), Positives = 142/324 (43%), Gaps = 51/324 (15%)
Query: 34  QISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEI 93
           Q+ ++  RY     +G G +G++    D      +A K I+     T    R+++ EI+I
Sbjct: 15  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQ-RTLR-EIKI 72
Query: 94  MTKLSGHPNVVDLKAVY-----EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
           + +   H N++ +  +      E+   V+++ +L       ++L K    S         
Sbjct: 73  LLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLY 129
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHG----TV 204
            +++ + Y H   V+HRDLKP N+LL T   +  +K+ DFGLA       +  G     V
Sbjct: 130 QILRGLKYIHSANVLHRDLKPSNLLLNT---TCDLKICDFGLARVADPDHDHTGFLTEYV 186
Query: 205 GSPFYIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAV-------- 254
            + +Y APE++  + GY ++ D+WS G IL  +LS  P F GK      + +        
Sbjct: 187 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 246
Query: 255 ------------RAADLRFPSD---PWDHI----SASARDLIMGMLRVDPSTRLTAAEVL 295
                       R   L  P     PW+ +     + A DL+  ML  +P  R+   + L
Sbjct: 247 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 306
Query: 296 AHSWMEEC-----EQVAQKPCKQD 314
           AH ++E+      E +A+ P K D
Sbjct: 307 AHPYLEQYYDPSDEPIAEAPFKFD 330

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 83/324 (25%), Positives = 142/324 (43%), Gaps = 51/324 (15%)
Query: 34  QISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEI 93
           Q+ ++  RY     +G G +G++    D      +A K I+     T    R+++ EI+I
Sbjct: 22  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQ-RTLR-EIKI 79
Query: 94  MTKLSGHPNVVDLKAVY-----EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
           + +   H N++ +  +      E+   V+++ +L       ++L K    S         
Sbjct: 80  LLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLY 136
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHG----TV 204
            +++ + Y H   V+HRDLKP N+LL T   +  +K+ DFGLA       +  G     V
Sbjct: 137 QILRGLKYIHSANVLHRDLKPSNLLLNT---TCDLKICDFGLARVADPDHDHTGFLTEYV 193
Query: 205 GSPFYIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAV-------- 254
            + +Y APE++  + GY ++ D+WS G IL  +LS  P F GK      + +        
Sbjct: 194 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 253
Query: 255 ------------RAADLRFPSD---PWDHI----SASARDLIMGMLRVDPSTRLTAAEVL 295
                       R   L  P     PW+ +     + A DL+  ML  +P  R+   + L
Sbjct: 254 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 313
Query: 296 AHSWMEEC-----EQVAQKPCKQD 314
           AH ++E+      E +A+ P K D
Sbjct: 314 AHPYLEQYYDPSDEPIAEAPFKFD 337

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 83/324 (25%), Positives = 142/324 (43%), Gaps = 51/324 (15%)
Query: 34  QISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEI 93
           Q+ ++  RY     +G G +G++    D      +A K I+     T    R+++ EI+I
Sbjct: 23  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQ-RTLR-EIKI 80
Query: 94  MTKLSGHPNVVDLKAVY-----EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
           + +   H N++ +  +      E+   V+++ +L       ++L K    S         
Sbjct: 81  LLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLY 137
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHG----TV 204
            +++ + Y H   V+HRDLKP N+LL T   +  +K+ DFGLA       +  G     V
Sbjct: 138 QILRGLKYIHSANVLHRDLKPSNLLLNT---TCDLKICDFGLARVADPDHDHTGFLTEYV 194
Query: 205 GSPFYIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAV-------- 254
            + +Y APE++  + GY ++ D+WS G IL  +LS  P F GK      + +        
Sbjct: 195 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 254
Query: 255 ------------RAADLRFPSD---PWDHI----SASARDLIMGMLRVDPSTRLTAAEVL 295
                       R   L  P     PW+ +     + A DL+  ML  +P  R+   + L
Sbjct: 255 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 314
Query: 296 AHSWMEEC-----EQVAQKPCKQD 314
           AH ++E+      E +A+ P K D
Sbjct: 315 AHPYLEQYYDPSDEPIAEAPFKFD 338

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 83/324 (25%), Positives = 142/324 (43%), Gaps = 51/324 (15%)
Query: 34  QISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEI 93
           Q+ ++  RY     +G G +G++    D      +A K I+     T    R+++ EI+I
Sbjct: 14  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQ-RTLR-EIKI 71
Query: 94  MTKLSGHPNVVDLKAVY-----EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
           + +   H N++ +  +      E+   V+++ +L       ++L K    S         
Sbjct: 72  LLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLY 128
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHG----TV 204
            +++ + Y H   V+HRDLKP N+LL T   +  +K+ DFGLA       +  G     V
Sbjct: 129 QILRGLKYIHSANVLHRDLKPSNLLLNT---TCDLKICDFGLARVADPDHDHTGFLTEYV 185
Query: 205 GSPFYIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAV-------- 254
            + +Y APE++  + GY ++ D+WS G IL  +LS  P F GK      + +        
Sbjct: 186 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 245
Query: 255 ------------RAADLRFPSD---PWDHI----SASARDLIMGMLRVDPSTRLTAAEVL 295
                       R   L  P     PW+ +     + A DL+  ML  +P  R+   + L
Sbjct: 246 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 305
Query: 296 AHSWMEEC-----EQVAQKPCKQD 314
           AH ++E+      E +A+ P K D
Sbjct: 306 AHPYLEQYYDPSDEPIAEAPFKFD 329

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 83/324 (25%), Positives = 142/324 (43%), Gaps = 51/324 (15%)
Query: 34  QISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEI 93
           Q+ ++  RY     +G G +G++    D      +A K I+     T    R+++ EI+I
Sbjct: 21  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQ-RTLR-EIKI 78
Query: 94  MTKLSGHPNVVDLKAVY-----EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
           + +   H N++ +  +      E+   V+++ +L       ++L K    S         
Sbjct: 79  LLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLY 135
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHG----TV 204
            +++ + Y H   V+HRDLKP N+LL T   +  +K+ DFGLA       +  G     V
Sbjct: 136 QILRGLKYIHSANVLHRDLKPSNLLLNT---TCDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 205 GSPFYIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAV-------- 254
            + +Y APE++  + GY ++ D+WS G IL  +LS  P F GK      + +        
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 252
Query: 255 ------------RAADLRFPSD---PWDHI----SASARDLIMGMLRVDPSTRLTAAEVL 295
                       R   L  P     PW+ +     + A DL+  ML  +P  R+   + L
Sbjct: 253 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 312
Query: 296 AHSWMEEC-----EQVAQKPCKQD 314
           AH ++E+      E +A+ P K D
Sbjct: 313 AHPYLEQYYDPSDEPIAEAPFKFD 336

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 98/352 (27%), Positives = 149/352 (42%), Gaps = 71/352 (20%)
Query: 10  SQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLA 69
           S + +QF  S +V+  T T+L          RY   K +G G  G++    D   G  +A
Sbjct: 2   SHMDSQFY-SVQVADSTFTVLK---------RYQQLKPIGSGAQGIVCAAFDTVLGINVA 51
Query: 70  CKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVY------EEEDYVHLLMELC 123
            K +++         R+ + E+ ++ K   H N++ L  V+      EE   V+L+MEL 
Sbjct: 52  VKKLSRPFQNQTHAKRAYR-EL-VLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 109
Query: 124 AGG--ELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSS 181
                ++ H    + R S      +   ++  + + H  G++HRDLKP NI++    S  
Sbjct: 110 DANLCQVIHMELDHERMS-----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDC 161
Query: 182 PIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMP 240
            +K+ DFGLA        +   V + +Y APEV+ G GY +  D+WS G I+  L+ G  
Sbjct: 162 TLKILDFGLARTASTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSV 221
Query: 241 PF--------WGK------TKSKIFDAVRAADLR----------------------FPSD 264
            F        W K      T S  F A     +R                      FPS+
Sbjct: 222 IFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVRNYVENRPAYPGIAFEELFPDWIFPSE 281
Query: 265 P-WDHISAS-ARDLIMGMLRVDPSTRLTAAEVLAHS----WMEECEQVAQKP 310
              D I  S ARDL+  ML +DP  R++  E L H     W +  E  A  P
Sbjct: 282 SERDKIKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPAEAEAPPP 333

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 76/298 (25%), Positives = 133/298 (44%), Gaps = 40/298 (13%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           + +G G +G +    D    + +A K +++     +   R+ + E+ ++  L  H NV+ 
Sbjct: 34  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYR-ELRLLKHLK-HENVIG 91
Query: 106 LKAVYEE----EDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
           L  V+      ED+  + +     G   + + K    S+   + +   L++ + Y H  G
Sbjct: 92  LLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLRGLKYIHSAG 151
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG--GY 219
           ++HRDLKP N+ +   +  S +++ DFGLA   +A + + G V + +Y APE++     Y
Sbjct: 152 IIHRDLKPSNVAV---NEDSELRILDFGLAR--QADEEMTGYVATRWYRAPEIMLNWMHY 206
Query: 220 NQAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAV----------------RAADL 259
           NQ  D+WS G I+  LL G   F G        +I + V                R    
Sbjct: 207 NQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQ 266
Query: 260 RFPSDPWDHISASAR-------DLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKP 310
             P  P   +S+  R       DL+  ML +D   R++AAE LAH++  +      +P
Sbjct: 267 SLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPEDEP 324

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 83/324 (25%), Positives = 142/324 (43%), Gaps = 51/324 (15%)
Query: 34  QISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEI 93
           Q+ ++  RY     +G G +G++    D      +A K I+     T    R+++ EI+I
Sbjct: 15  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQ-RTLR-EIKI 72
Query: 94  MTKLSGHPNVVDLKAVY-----EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
           + +   H N++ +  +      E+   V+++ +L       ++L K    S         
Sbjct: 73  LLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLY 129
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHG----TV 204
            +++ + Y H   V+HRDLKP N+LL T   +  +K+ DFGLA       +  G     V
Sbjct: 130 QILRGLKYIHSANVLHRDLKPSNLLLNT---TCDLKICDFGLARVADPDHDHTGFLTEYV 186
Query: 205 GSPFYIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAV-------- 254
            + +Y APE++  + GY ++ D+WS G IL  +LS  P F GK      + +        
Sbjct: 187 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPE 246
Query: 255 ------------RAADLRFPSD---PWDHI----SASARDLIMGMLRVDPSTRLTAAEVL 295
                       R   L  P     PW+ +     + A DL+  ML  +P  R+   + L
Sbjct: 247 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 306
Query: 296 AHSWMEEC-----EQVAQKPCKQD 314
           AH ++E+      E +A+ P K D
Sbjct: 307 AHPYLEQYYDPSDEPIAEAPFKFD 330

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 84/308 (27%), Positives = 137/308 (44%), Gaps = 40/308 (12%)
Query: 10  SQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLA 69
           + L    CN    + L        +   L  +Y +G  LG G FG +           +A
Sbjct: 10  AHLRAAPCNDLHATKLA----PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVA 65
Query: 70  CKSIAKDRLVTVEDVRS---IKLEIEIMTKLS-GHPNVVDLKAVYEEEDYVHLLMELCAG 125
            K + KDR+    ++ +   + +E+ ++ K+S G   V+ L   +E  D   L++E    
Sbjct: 66  IKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEP 125
Query: 126 -GELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIK 184
             +LF  + + G   E  AR  F  +++ V +CH  GV+HRD+K ENIL+        +K
Sbjct: 126 VQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE--LK 183
Query: 185 LADFGLATYIKAGQNLHGTV-----GSPFYIAPEVLAGG--YNQAADVWSAGVILYILLS 237
           L DFG      +G  L  TV     G+  Y  PE +     + ++A VWS G++LY ++ 
Sbjct: 184 LIDFG------SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC 237
Query: 238 GMPPFWGK---TKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEV 294
           G  PF       + ++F   R             +S+  + LI   L + PS R T  E+
Sbjct: 238 GDIPFEHDEEIIRGQVFFRQR-------------VSSECQHLIRWCLALRPSDRPTFEEI 284
Query: 295 LAHSWMEE 302
             H WM++
Sbjct: 285 QNHPWMQD 292

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 80/280 (28%), Positives = 131/280 (46%), Gaps = 36/280 (12%)
Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRS---IKLEIEIM 94
           L  +Y +G  LG G FG +           +A K + KDR+    ++ +   + +E+ ++
Sbjct: 6   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 65
Query: 95  TKLS-GHPNVVDLKAVYEEED-YVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQ 152
            K+S G   V+ L   +E  D +V +L  +    +LF  + + G   E  AR  F  +++
Sbjct: 66  KKVSSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQVLE 125
Query: 153 VVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTV-----GSP 207
            V +CH  GV+HRD+K ENIL+        +KL DFG      +G  L  TV     G+ 
Sbjct: 126 AVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFG------SGALLKDTVYTDFDGTR 177
Query: 208 FYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGK---TKSKIFDAVRAADLRFP 262
            Y  PE +     + ++A VWS G++LY ++ G  PF       + ++F   R       
Sbjct: 178 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR------- 230
Query: 263 SDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
                 +S+  + LI   L + PS R T  E+  H WM++
Sbjct: 231 ------VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 264

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 83/324 (25%), Positives = 142/324 (43%), Gaps = 51/324 (15%)
Query: 34  QISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEI 93
           Q+ ++  RY     +G G +G++    D      +A K I+     T    R+++ EI+I
Sbjct: 17  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQ-RTLR-EIKI 74
Query: 94  MTKLSGHPNVVDLKAVY-----EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
           + +   H N++ +  +      E+   V+++ +L       ++L K    S         
Sbjct: 75  LLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLY 131
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHG----TV 204
            +++ + Y H   V+HRDLKP N+LL T   +  +K+ DFGLA       +  G     V
Sbjct: 132 QILRGLKYIHSANVLHRDLKPSNLLLNT---TXDLKICDFGLARVADPDHDHTGFLTEYV 188
Query: 205 GSPFYIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAV-------- 254
            + +Y APE++  + GY ++ D+WS G IL  +LS  P F GK      + +        
Sbjct: 189 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 248
Query: 255 ------------RAADLRFPSD---PWDHI----SASARDLIMGMLRVDPSTRLTAAEVL 295
                       R   L  P     PW+ +     + A DL+  ML  +P  R+   + L
Sbjct: 249 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 308
Query: 296 AHSWMEEC-----EQVAQKPCKQD 314
           AH ++E+      E +A+ P K D
Sbjct: 309 AHPYLEQYYDPSDEPIAEAPFKFD 332

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 84/308 (27%), Positives = 137/308 (44%), Gaps = 40/308 (12%)
Query: 10  SQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLA 69
           + L    CN    + L        +   L  +Y +G  LG G FG +           +A
Sbjct: 25  AHLRAAPCNDLHATKLA----PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVA 80
Query: 70  CKSIAKDRLVTVEDVRS---IKLEIEIMTKLS-GHPNVVDLKAVYEEEDYVHLLMELCAG 125
            K + KDR+    ++ +   + +E+ ++ K+S G   V+ L   +E  D   L++E    
Sbjct: 81  IKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEP 140
Query: 126 -GELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIK 184
             +LF  + + G   E  AR  F  +++ V +CH  GV+HRD+K ENIL+        +K
Sbjct: 141 VQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE--LK 198
Query: 185 LADFGLATYIKAGQNLHGTV-----GSPFYIAPEVLAGG--YNQAADVWSAGVILYILLS 237
           L DFG      +G  L  TV     G+  Y  PE +     + ++A VWS G++LY ++ 
Sbjct: 199 LIDFG------SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC 252
Query: 238 GMPPFWGK---TKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEV 294
           G  PF       + ++F   R             +S+  + LI   L + PS R T  E+
Sbjct: 253 GDIPFEHDEEIIRGQVFFRQR-------------VSSECQHLIRWCLALRPSDRPTFEEI 299
Query: 295 LAHSWMEE 302
             H WM++
Sbjct: 300 QNHPWMQD 307

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 83/324 (25%), Positives = 142/324 (43%), Gaps = 51/324 (15%)
Query: 34  QISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEI 93
           Q+ ++  RY     +G G +G++    D      +A K I+     T    R+++ EI+I
Sbjct: 19  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQ-RTLR-EIKI 76
Query: 94  MTKLSGHPNVVDLKAVY-----EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
           + +   H N++ +  +      E+   V+++ +L       ++L K    S         
Sbjct: 77  LLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLY 133
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHG----TV 204
            +++ + Y H   V+HRDLKP N+LL T   +  +K+ DFGLA       +  G     V
Sbjct: 134 QILRGLKYIHSANVLHRDLKPSNLLLNT---TCDLKICDFGLARVADPDHDHTGFLTEYV 190
Query: 205 GSPFYIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAV-------- 254
            + +Y APE++  + GY ++ D+WS G IL  +LS  P F GK      + +        
Sbjct: 191 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 250
Query: 255 ------------RAADLRFPSD---PWDHI----SASARDLIMGMLRVDPSTRLTAAEVL 295
                       R   L  P     PW+ +     + A DL+  ML  +P  R+   + L
Sbjct: 251 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 310
Query: 296 AHSWMEEC-----EQVAQKPCKQD 314
           AH ++E+      E +A+ P K D
Sbjct: 311 AHPYLEQYYDPSDEPIAEAPFKFD 334

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 83/324 (25%), Positives = 142/324 (43%), Gaps = 51/324 (15%)
Query: 34  QISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEI 93
           Q+ ++  RY     +G G +G++    D      +A K I+     T    R+++ EI+I
Sbjct: 25  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQ-RTLR-EIKI 82
Query: 94  MTKLSGHPNVVDLKAVY-----EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
           + +   H N++ +  +      E+   V+++ +L       ++L K    S         
Sbjct: 83  LLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLY 139
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHG----TV 204
            +++ + Y H   V+HRDLKP N+LL T   +  +K+ DFGLA       +  G     V
Sbjct: 140 QILRGLKYIHSANVLHRDLKPSNLLLNT---TCDLKICDFGLARVADPDHDHTGFLTEYV 196
Query: 205 GSPFYIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAV-------- 254
            + +Y APE++  + GY ++ D+WS G IL  +LS  P F GK      + +        
Sbjct: 197 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 256
Query: 255 ------------RAADLRFPSD---PWDHI----SASARDLIMGMLRVDPSTRLTAAEVL 295
                       R   L  P     PW+ +     + A DL+  ML  +P  R+   + L
Sbjct: 257 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 316
Query: 296 AHSWMEEC-----EQVAQKPCKQD 314
           AH ++E+      E +A+ P K D
Sbjct: 317 AHPYLEQYYDPSDEPIAEAPFKFD 340

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 83/324 (25%), Positives = 142/324 (43%), Gaps = 51/324 (15%)
Query: 34  QISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEI 93
           Q+ ++  RY     +G G +G++    D      +A K I+     T    R+++ EI+I
Sbjct: 17  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQ-RTLR-EIKI 74
Query: 94  MTKLSGHPNVVDLKAVY-----EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
           + +   H N++ +  +      E+   V+++ +L       ++L K    S         
Sbjct: 75  LLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLY 131
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHG----TV 204
            +++ + Y H   V+HRDLKP N+LL T   +  +K+ DFGLA       +  G     V
Sbjct: 132 QILRGLKYIHSANVLHRDLKPSNLLLNT---TCDLKICDFGLARVADPDHDHTGFLTEYV 188
Query: 205 GSPFYIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAV-------- 254
            + +Y APE++  + GY ++ D+WS G IL  +LS  P F GK      + +        
Sbjct: 189 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 248
Query: 255 ------------RAADLRFPSD---PWDHI----SASARDLIMGMLRVDPSTRLTAAEVL 295
                       R   L  P     PW+ +     + A DL+  ML  +P  R+   + L
Sbjct: 249 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 308
Query: 296 AHSWMEEC-----EQVAQKPCKQD 314
           AH ++E+      E +A+ P K D
Sbjct: 309 AHPYLEQYYDPSDEPIAEAPFKFD 332

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 77/282 (27%), Positives = 139/282 (49%), Gaps = 26/282 (9%)
Query: 24  SLTGTILDATQISNLSDRYV-LGKQLGWGQFGVIRECSDKFTGEVLACKSI----AKDRL 78
           ++ G+    +++  L+D  +   KQ+G G FG++ +        V+A KS+    ++   
Sbjct: 2   AMGGSEFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGET 61
Query: 79  VTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRF 138
             +E  +  + E+ IM+ L+ HPN+V L  +        ++ME    G+L+HRL    + 
Sbjct: 62  EMIEKFQEFQREVFIMSNLN-HPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRL--LDKA 116
Query: 139 SETEARVIFRHLMQV---VSYCHGNG--VVHRDLKPENILLATKSSSSPI--KLADFGLA 191
              +  V  R ++ +   + Y       +VHRDL+  NI L +   ++P+  K+ADFGL+
Sbjct: 117 HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS 176
Query: 192 TYIKAGQNLHGTVGSPFYIAPEVLAG---GYNQAADVWSAGVILYILLSGMPPF--WGKT 246
              ++  ++ G +G+  ++APE +      Y + AD +S  +ILY +L+G  PF  +   
Sbjct: 177 Q--QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG 234
Query: 247 KSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTR 288
           K K  + +R   LR P+ P D      R++I      DP  R
Sbjct: 235 KIKFINMIREEGLR-PTIPED-CPPRLRNVIELCWSGDPKKR 274

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 83/324 (25%), Positives = 142/324 (43%), Gaps = 51/324 (15%)
Query: 34  QISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEI 93
           Q+ ++  RY     +G G +G++    D      +A K I+     T    R+++ EI+I
Sbjct: 17  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQ-RTLR-EIKI 74
Query: 94  MTKLSGHPNVVDLKAVY-----EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
           + +   H N++ +  +      E+   V+++ +L       ++L K    S         
Sbjct: 75  LLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLY 131
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHG----TV 204
            +++ + Y H   V+HRDLKP N+LL T   +  +K+ DFGLA       +  G     V
Sbjct: 132 QILRGLKYIHSANVLHRDLKPSNLLLNT---TXDLKICDFGLARVADPDHDHTGFLTEYV 188
Query: 205 GSPFYIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAV-------- 254
            + +Y APE++  + GY ++ D+WS G IL  +LS  P F GK      + +        
Sbjct: 189 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 248
Query: 255 ------------RAADLRFPSD---PWDHI----SASARDLIMGMLRVDPSTRLTAAEVL 295
                       R   L  P     PW+ +     + A DL+  ML  +P  R+   + L
Sbjct: 249 QEDLNXIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 308
Query: 296 AHSWMEEC-----EQVAQKPCKQD 314
           AH ++E+      E +A+ P K D
Sbjct: 309 AHPYLEQYYDPSDEPIAEAPFKFD 332

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 83/301 (27%), Positives = 135/301 (44%), Gaps = 40/301 (13%)
Query: 17  CNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKD 76
           CN    + L        +   L  +Y +G  LG G FG +           +A K + KD
Sbjct: 5   CNDLHATKLA----PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKD 60
Query: 77  RLVTVEDVRS---IKLEIEIMTKLS-GHPNVVDLKAVYEEEDYVHLLMELCAG-GELFHR 131
           R+    ++ +   + +E+ ++ K+S G   V+ L   +E  D   L++E      +LF  
Sbjct: 61  RISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDF 120
Query: 132 LEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA 191
           + + G   E  AR  F  +++ V +CH  GV+HRD+K ENIL+        +KL DFG  
Sbjct: 121 ITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFG-- 176
Query: 192 TYIKAGQNLHGTV-----GSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWG 244
               +G  L  TV     G+  Y  PE +     + ++A VWS G++LY ++ G  PF  
Sbjct: 177 ----SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 232
Query: 245 K---TKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWME 301
                + ++F   R             +S+  + LI   L + PS R T  E+  H WM+
Sbjct: 233 DEEIIRGQVFFRQR-------------VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 279
Query: 302 E 302
           +
Sbjct: 280 D 280

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 83/301 (27%), Positives = 135/301 (44%), Gaps = 40/301 (13%)
Query: 17  CNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKD 76
           CN    + L        +   L  +Y +G  LG G FG +           +A K + KD
Sbjct: 4   CNDLHATKLA----PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKD 59
Query: 77  RLVTVEDVRS---IKLEIEIMTKLS-GHPNVVDLKAVYEEEDYVHLLMELCAG-GELFHR 131
           R+    ++ +   + +E+ ++ K+S G   V+ L   +E  D   L++E      +LF  
Sbjct: 60  RISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDF 119
Query: 132 LEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA 191
           + + G   E  AR  F  +++ V +CH  GV+HRD+K ENIL+        +KL DFG  
Sbjct: 120 ITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFG-- 175
Query: 192 TYIKAGQNLHGTV-----GSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWG 244
               +G  L  TV     G+  Y  PE +     + ++A VWS G++LY ++ G  PF  
Sbjct: 176 ----SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 231
Query: 245 K---TKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWME 301
                + ++F   R             +S+  + LI   L + PS R T  E+  H WM+
Sbjct: 232 DEEIIRGQVFFRQR-------------VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 278
Query: 302 E 302
           +
Sbjct: 279 D 279

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 83/324 (25%), Positives = 142/324 (43%), Gaps = 51/324 (15%)
Query: 34  QISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEI 93
           Q+ ++  RY     +G G +G++    D      +A K I+     T    R+++ EI+I
Sbjct: 21  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQ-RTLR-EIKI 78
Query: 94  MTKLSGHPNVVDLKAVY-----EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
           + +   H N++ +  +      E+   V+++ +L       ++L K    S         
Sbjct: 79  LLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLLKCQHLSNDHICYFLY 135
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHG----TV 204
            +++ + Y H   V+HRDLKP N+LL T   +  +K+ DFGLA       +  G     V
Sbjct: 136 QILRGLKYIHSANVLHRDLKPSNLLLNT---TCDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 205 GSPFYIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAV-------- 254
            + +Y APE++  + GY ++ D+WS G IL  +LS  P F GK      + +        
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 252
Query: 255 ------------RAADLRFPSD---PWDHI----SASARDLIMGMLRVDPSTRLTAAEVL 295
                       R   L  P     PW+ +     + A DL+  ML  +P  R+   + L
Sbjct: 253 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 312
Query: 296 AHSWMEEC-----EQVAQKPCKQD 314
           AH ++E+      E +A+ P K D
Sbjct: 313 AHPYLEQYYDPSDEPIAEAPFKFD 336

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 83/324 (25%), Positives = 142/324 (43%), Gaps = 51/324 (15%)
Query: 34  QISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEI 93
           Q+ ++  RY     +G G +G++    D      +A K I+     T    R+++ EI+I
Sbjct: 17  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQ-RTLR-EIKI 74
Query: 94  MTKLSGHPNVVDLKAVY-----EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
           + +   H N++ +  +      E+   V+++ +L       ++L K    S         
Sbjct: 75  LLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLY 131
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHG----TV 204
            +++ + Y H   V+HRDLKP N+LL T   +  +K+ DFGLA       +  G     V
Sbjct: 132 QILRGLKYIHSANVLHRDLKPSNLLLNT---TXDLKIXDFGLARVADPDHDHTGFLTEYV 188
Query: 205 GSPFYIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAV-------- 254
            + +Y APE++  + GY ++ D+WS G IL  +LS  P F GK      + +        
Sbjct: 189 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 248
Query: 255 ------------RAADLRFPSD---PWDHI----SASARDLIMGMLRVDPSTRLTAAEVL 295
                       R   L  P     PW+ +     + A DL+  ML  +P  R+   + L
Sbjct: 249 QEDLNXIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 308
Query: 296 AHSWMEEC-----EQVAQKPCKQD 314
           AH ++E+      E +A+ P K D
Sbjct: 309 AHPYLEQYYDPSDEPIAEAPFKFD 332

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 76/298 (25%), Positives = 133/298 (44%), Gaps = 40/298 (13%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           + +G G +G +    D    + +A K +++     +   R+ + E+ ++  L  H NV+ 
Sbjct: 34  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYR-ELRLLKHLK-HENVIG 91
Query: 106 LKAVYEE----EDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
           L  V+      ED+  + +     G   + + K    S+   + +   L++ + Y H  G
Sbjct: 92  LLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAG 151
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG--GY 219
           ++HRDLKP N+ +   +  S +++ DFGLA   +A + + G V + +Y APE++     Y
Sbjct: 152 IIHRDLKPSNVAV---NEDSELRILDFGLAR--QADEEMTGYVATRWYRAPEIMLNWMHY 206
Query: 220 NQAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAV----------------RAADL 259
           NQ  D+WS G I+  LL G   F G        +I + V                R    
Sbjct: 207 NQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQ 266
Query: 260 RFPSDPWDHISASAR-------DLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKP 310
             P  P   +S+  R       DL+  ML +D   R++AAE LAH++  +      +P
Sbjct: 267 SLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPEDEP 324

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 83/324 (25%), Positives = 142/324 (43%), Gaps = 51/324 (15%)
Query: 34  QISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEI 93
           Q+ ++  RY     +G G +G++    D      +A K I+     T    R+++ EI+I
Sbjct: 17  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQ-RTLR-EIKI 74
Query: 94  MTKLSGHPNVVDLKAVY-----EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
           + +   H N++ +  +      E+   V+++ +L       ++L K    S         
Sbjct: 75  LLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLY 131
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHG----TV 204
            +++ + Y H   V+HRDLKP N+LL T   +  +K+ DFGLA       +  G     V
Sbjct: 132 QILRGLKYIHSANVLHRDLKPSNLLLNT---TCDLKICDFGLARVADPDHDHTGFLTEYV 188
Query: 205 GSPFYIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAV-------- 254
            + +Y APE++  + GY ++ D+WS G IL  +LS  P F GK      + +        
Sbjct: 189 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 248
Query: 255 ------------RAADLRFPSD---PWDHI----SASARDLIMGMLRVDPSTRLTAAEVL 295
                       R   L  P     PW+ +     + A DL+  ML  +P  R+   + L
Sbjct: 249 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 308
Query: 296 AHSWMEEC-----EQVAQKPCKQD 314
           AH ++E+      E +A+ P K D
Sbjct: 309 AHPYLEQYYDPSDEPIAEAPFKFD 332

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 83/301 (27%), Positives = 135/301 (44%), Gaps = 40/301 (13%)
Query: 17  CNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKD 76
           CN    + L        +   L  +Y +G  LG G FG +           +A K + KD
Sbjct: 24  CNDLHATKLA----PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKD 79
Query: 77  RLVTVEDVRS---IKLEIEIMTKLS-GHPNVVDLKAVYEEEDYVHLLMELCAG-GELFHR 131
           R+    ++ +   + +E+ ++ K+S G   V+ L   +E  D   L++E      +LF  
Sbjct: 80  RISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDF 139
Query: 132 LEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA 191
           + + G   E  AR  F  +++ V +CH  GV+HRD+K ENIL+        +KL DFG  
Sbjct: 140 ITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFG-- 195
Query: 192 TYIKAGQNLHGTV-----GSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWG 244
               +G  L  TV     G+  Y  PE +     + ++A VWS G++LY ++ G  PF  
Sbjct: 196 ----SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 251
Query: 245 K---TKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWME 301
                + ++F   R             +S+  + LI   L + PS R T  E+  H WM+
Sbjct: 252 DEEIIRGQVFFRQR-------------VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 298
Query: 302 E 302
           +
Sbjct: 299 D 299

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 83/324 (25%), Positives = 142/324 (43%), Gaps = 51/324 (15%)
Query: 34  QISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEI 93
           Q+ ++  RY     +G G +G++    D      +A K I+     T    R+++ EI+I
Sbjct: 37  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQ-RTLR-EIKI 94
Query: 94  MTKLSGHPNVVDLKAVY-----EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
           + +   H N++ +  +      E+   V+++ +L       ++L K    S         
Sbjct: 95  LLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLY 151
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHG----TV 204
            +++ + Y H   V+HRDLKP N+LL T   +  +K+ DFGLA       +  G     V
Sbjct: 152 QILRGLKYIHSANVLHRDLKPSNLLLNT---TCDLKICDFGLARVADPDHDHTGFLTEYV 208
Query: 205 GSPFYIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAV-------- 254
            + +Y APE++  + GY ++ D+WS G IL  +LS  P F GK      + +        
Sbjct: 209 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 268
Query: 255 ------------RAADLRFPSD---PWDHI----SASARDLIMGMLRVDPSTRLTAAEVL 295
                       R   L  P     PW+ +     + A DL+  ML  +P  R+   + L
Sbjct: 269 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 328
Query: 296 AHSWMEEC-----EQVAQKPCKQD 314
           AH ++E+      E +A+ P K D
Sbjct: 329 AHPYLEQYYDPSDEPIAEAPFKFD 352

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 136/292 (46%), Gaps = 29/292 (9%)
Query: 30  LDATQISNLSDR---YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRS 86
           LD   +S L D    + L + +G G +G + +     TG++ A K +     VT ++   
Sbjct: 11  LDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEE 66
Query: 87  IKLEIEIMTKLSGHPNVVDLKAVYEE------EDYVHLLMELCAGGELFHRLE--KYGRF 138
           IK EI ++ K S H N+      + +      +D + L+ME C  G +   ++  K    
Sbjct: 67  IKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTL 126
Query: 139 SETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ 198
            E     I R +++ +S+ H + V+HRD+K +N+LL   + ++ +KL DFG++  +    
Sbjct: 127 KEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQLDRTV 183
Query: 199 NLHGT-VGSPFYIAPEVLA------GGYNQAADVWSAGVILYILLSGMPPFWGKTKSK-I 250
               T +G+P+++APEV+A        Y+  +D+WS G+    +  G PP       + +
Sbjct: 184 GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL 243
Query: 251 FDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
           F   R    R  S  W   S   +  I   L  + S R    +++ H ++ +
Sbjct: 244 FLIPRNPAPRLKSKKW---SKKFQSFIESCLVKNHSQRPATEQLMKHPFIRD 292

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/324 (25%), Positives = 142/324 (43%), Gaps = 51/324 (15%)
Query: 34  QISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEI 93
           Q+ ++  RY     +G G +G++    D      +A + I+     T    R+++ EI+I
Sbjct: 21  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQ-RTLR-EIKI 78
Query: 94  MTKLSGHPNVVDLKAVY-----EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
           + +   H N++ +  +      E+   V+++ +L       ++L K    S         
Sbjct: 79  LLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLY 135
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHG----TV 204
            +++ + Y H   V+HRDLKP N+LL T   +  +K+ DFGLA       +  G     V
Sbjct: 136 QILRGLKYIHSANVLHRDLKPSNLLLNT---TCDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 205 GSPFYIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAV-------- 254
            + +Y APE++  + GY ++ D+WS G IL  +LS  P F GK      + +        
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 252
Query: 255 ------------RAADLRFPSD---PWDHI----SASARDLIMGMLRVDPSTRLTAAEVL 295
                       R   L  P     PW+ +     + A DL+  ML  +P  R+   + L
Sbjct: 253 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 312
Query: 296 AHSWMEEC-----EQVAQKPCKQD 314
           AH ++E+      E +A+ P K D
Sbjct: 313 AHPYLEQYYDPSDEPIAEAPFKFD 336

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 84/308 (27%), Positives = 137/308 (44%), Gaps = 40/308 (12%)
Query: 10  SQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLA 69
           + L    CN    + L        +   L  +Y +G  LG G FG +           +A
Sbjct: 10  AHLRAAPCNDLHATKLA----PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVA 65
Query: 70  CKSIAKDRLVTVEDVRS---IKLEIEIMTKLS-GHPNVVDLKAVYEEEDYVHLLMELCAG 125
            K + KDR+    ++ +   + +E+ ++ K+S G   V+ L   +E  D   L++E    
Sbjct: 66  IKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEP 125
Query: 126 -GELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIK 184
             +LF  + + G   E  AR  F  +++ V +CH  GV+HRD+K ENIL+        +K
Sbjct: 126 VQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE--LK 183
Query: 185 LADFGLATYIKAGQNLHGTV-----GSPFYIAPEVLAGG--YNQAADVWSAGVILYILLS 237
           L DFG      +G  L  TV     G+  Y  PE +     + ++A VWS G++LY ++ 
Sbjct: 184 LIDFG------SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC 237
Query: 238 GMPPFWGKTK---SKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEV 294
           G  PF    +    ++F   R             +S+  + LI   L + PS R T  E+
Sbjct: 238 GDIPFEHDEEIIGGQVFFRQR-------------VSSECQHLIRWCLALRPSDRPTFEEI 284
Query: 295 LAHSWMEE 302
             H WM++
Sbjct: 285 QNHPWMQD 292

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 84/308 (27%), Positives = 136/308 (44%), Gaps = 40/308 (12%)
Query: 10  SQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLA 69
           + L    CN    + L        +   L  +Y +G  LG G FG +           +A
Sbjct: 25  AHLRAAPCNDLHATKLA----PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVA 80
Query: 70  CKSIAKDRLVTVEDVRS---IKLEIEIMTKLS-GHPNVVDLKAVYEEEDYVHLLMELCAG 125
            K + KDR+    ++ +   + +E+ ++ K+S G   V+ L   +E  D   L++E    
Sbjct: 81  IKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEP 140
Query: 126 -GELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIK 184
             +LF  + + G   E  AR  F  +++ V +CH  GV+HRD+K ENIL+        +K
Sbjct: 141 VQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE--LK 198
Query: 185 LADFGLATYIKAGQNLHGTV-----GSPFYIAPEVLAGG--YNQAADVWSAGVILYILLS 237
           L DFG      +G  L  TV     G+  Y  PE +     + ++A VWS G++LY ++ 
Sbjct: 199 LIDFG------SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC 252
Query: 238 GMPPFWGK---TKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEV 294
           G  PF       + ++F   R             +S   + LI   L + PS R T  E+
Sbjct: 253 GDIPFEHDEEIIRGQVFFRQR-------------VSXECQHLIRWCLALRPSDRPTFEEI 299
Query: 295 LAHSWMEE 302
             H WM++
Sbjct: 300 QNHPWMQD 307

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 84/308 (27%), Positives = 137/308 (44%), Gaps = 40/308 (12%)
Query: 10  SQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLA 69
           + L    CN    + L        +   L  +Y +G  LG G FG +           +A
Sbjct: 11  AHLRAAPCNDLHATKLA----PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVA 66
Query: 70  CKSIAKDRLVTVEDVRS---IKLEIEIMTKLS-GHPNVVDLKAVYEEEDYVHLLMELCAG 125
            K + KDR+    ++ +   + +E+ ++ K+S G   V+ L   +E  D   L++E    
Sbjct: 67  IKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEP 126
Query: 126 -GELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIK 184
             +LF  + + G   E  AR  F  +++ V +CH  GV+HRD+K ENIL+        +K
Sbjct: 127 VQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE--LK 184
Query: 185 LADFGLATYIKAGQNLHGTV-----GSPFYIAPEVLAGG--YNQAADVWSAGVILYILLS 237
           L DFG      +G  L  TV     G+  Y  PE +     + ++A VWS G++LY ++ 
Sbjct: 185 LIDFG------SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC 238
Query: 238 GMPPFWGKTK---SKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEV 294
           G  PF    +    ++F   R             +S+  + LI   L + PS R T  E+
Sbjct: 239 GDIPFEHDEEIIGGQVFFRQR-------------VSSECQHLIRWCLALRPSDRPTFEEI 285
Query: 295 LAHSWMEE 302
             H WM++
Sbjct: 286 QNHPWMQD 293

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 84/308 (27%), Positives = 137/308 (44%), Gaps = 40/308 (12%)
Query: 10  SQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLA 69
           + L    CN    + L        +   L  +Y +G  LG G FG +           +A
Sbjct: 11  AHLRAAPCNDLHATKLA----PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVA 66
Query: 70  CKSIAKDRLVTVEDVRS---IKLEIEIMTKLS-GHPNVVDLKAVYEEEDYVHLLMELCAG 125
            K + KDR+    ++ +   + +E+ ++ K+S G   V+ L   +E  D   L++E    
Sbjct: 67  IKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEP 126
Query: 126 -GELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIK 184
             +LF  + + G   E  AR  F  +++ V +CH  GV+HRD+K ENIL+        +K
Sbjct: 127 VQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE--LK 184
Query: 185 LADFGLATYIKAGQNLHGTV-----GSPFYIAPEVLAGG--YNQAADVWSAGVILYILLS 237
           L DFG      +G  L  TV     G+  Y  PE +     + ++A VWS G++LY ++ 
Sbjct: 185 LIDFG------SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC 238
Query: 238 GMPPFWGKTK---SKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEV 294
           G  PF    +    ++F   R             +S+  + LI   L + PS R T  E+
Sbjct: 239 GDIPFEHDEEIIGGQVFFRQR-------------VSSECQHLIRWCLALRPSDRPTFEEI 285
Query: 295 LAHSWMEE 302
             H WM++
Sbjct: 286 QNHPWMQD 293

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 84/308 (27%), Positives = 137/308 (44%), Gaps = 40/308 (12%)
Query: 10  SQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLA 69
           + L    CN    + L        +   L  +Y +G  LG G FG +           +A
Sbjct: 10  AHLRAAPCNDLHATKLA----PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVA 65
Query: 70  CKSIAKDRLVTVEDVRS---IKLEIEIMTKLS-GHPNVVDLKAVYEEEDYVHLLMELCAG 125
            K + KDR+    ++ +   + +E+ ++ K+S G   V+ L   +E  D   L++E    
Sbjct: 66  IKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEP 125
Query: 126 -GELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIK 184
             +LF  + + G   E  AR  F  +++ V +CH  GV+HRD+K ENIL+        +K
Sbjct: 126 VQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE--LK 183
Query: 185 LADFGLATYIKAGQNLHGTV-----GSPFYIAPEVLAGG--YNQAADVWSAGVILYILLS 237
           L DFG      +G  L  TV     G+  Y  PE +     + ++A VWS G++LY ++ 
Sbjct: 184 LIDFG------SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC 237
Query: 238 GMPPFWGKTK---SKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEV 294
           G  PF    +    ++F   R             +S+  + LI   L + PS R T  E+
Sbjct: 238 GDIPFEHDEEIIGGQVFFRQR-------------VSSECQHLIRWCLALRPSDRPTFEEI 284
Query: 295 LAHSWMEE 302
             H WM++
Sbjct: 285 QNHPWMQD 292

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 84/308 (27%), Positives = 136/308 (44%), Gaps = 40/308 (12%)
Query: 10  SQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLA 69
           + L    CN    + L        +   L  +Y +G  LG G FG +           +A
Sbjct: 30  AHLRAAPCNDLHATKLA----PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVA 85
Query: 70  CKSIAKDRLVTVEDVRS---IKLEIEIMTKLS-GHPNVVDLKAVYEEEDYVHLLMELCAG 125
            K + KDR+    ++ +   + +E+ ++ K+S G   V+ L   +E  D   L++E    
Sbjct: 86  IKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEP 145
Query: 126 -GELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIK 184
             +LF  + + G   E  AR  F  +++ V +CH  GV+HRD+K ENIL+        +K
Sbjct: 146 VQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE--LK 203
Query: 185 LADFGLATYIKAGQNLHGTV-----GSPFYIAPEVLAGG--YNQAADVWSAGVILYILLS 237
           L DFG      +G  L  TV     G+  Y  PE +     + ++A VWS G++LY ++ 
Sbjct: 204 LIDFG------SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC 257
Query: 238 GMPPFWGK---TKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEV 294
           G  PF       + ++F   R             +S   + LI   L + PS R T  E+
Sbjct: 258 GDIPFEHDEEIIRGQVFFRQR-------------VSXECQHLIRWCLALRPSDRPTFEEI 304
Query: 295 LAHSWMEE 302
             H WM++
Sbjct: 305 QNHPWMQD 312

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 80/280 (28%), Positives = 130/280 (46%), Gaps = 36/280 (12%)
Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRS---IKLEIEIM 94
           L  +Y +G  LG G FG +           +A K + KDR+    ++ +   + +E+ ++
Sbjct: 7   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 66
Query: 95  TKLS-GHPNVVDLKAVYEEEDYVHLLMELCAG-GELFHRLEKYGRFSETEARVIFRHLMQ 152
            K+S G   V+ L   +E  D   L++E      +LF  + + G   E  AR  F  +++
Sbjct: 67  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 126
Query: 153 VVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTV-----GSP 207
            V +CH  GV+HRD+K ENIL+        +KL DFG      +G  L  TV     G+ 
Sbjct: 127 AVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFG------SGALLKDTVYTDFDGTR 178
Query: 208 FYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGK---TKSKIFDAVRAADLRFP 262
            Y  PE +     + ++A VWS G++LY ++ G  PF       + ++F   R       
Sbjct: 179 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR------- 231
Query: 263 SDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
                 +S+  + LI   L + PS R T  E+  H WM++
Sbjct: 232 ------VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 265

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 83/301 (27%), Positives = 134/301 (44%), Gaps = 40/301 (13%)
Query: 17  CNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKD 76
           CN    + L        +   L  +Y +G  LG G FG +           +A K + KD
Sbjct: 4   CNDLHATKLA----PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKD 59
Query: 77  RLVTVEDVRS---IKLEIEIMTKLS-GHPNVVDLKAVYEEEDYVHLLMELCAG-GELFHR 131
           R+    ++ +   + +E+ ++ K+S G   V+ L   +E  D   L++E      +LF  
Sbjct: 60  RISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDF 119
Query: 132 LEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA 191
           + + G   E  AR  F  +++ V +CH  GV+HRD+K ENIL+        +KL DFG  
Sbjct: 120 ITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFG-- 175
Query: 192 TYIKAGQNLHGTV-----GSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWG 244
               +G  L  TV     G+  Y  PE +     + ++A VWS G++LY ++ G  PF  
Sbjct: 176 ----SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 231
Query: 245 K---TKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWME 301
                + ++F   R             +S   + LI   L + PS R T  E+  H WM+
Sbjct: 232 DEEIIRGQVFFRQR-------------VSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 278
Query: 302 E 302
           +
Sbjct: 279 D 279

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 83/301 (27%), Positives = 134/301 (44%), Gaps = 40/301 (13%)
Query: 17  CNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKD 76
           CN    + L        +   L  +Y +G  LG G FG +           +A K + KD
Sbjct: 5   CNDLHATKLA----PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKD 60
Query: 77  RLVTVEDVRS---IKLEIEIMTKLS-GHPNVVDLKAVYEEEDYVHLLMELCAG-GELFHR 131
           R+    ++ +   + +E+ ++ K+S G   V+ L   +E  D   L++E      +LF  
Sbjct: 61  RISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDF 120
Query: 132 LEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA 191
           + + G   E  AR  F  +++ V +CH  GV+HRD+K ENIL+        +KL DFG  
Sbjct: 121 ITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFG-- 176
Query: 192 TYIKAGQNLHGTV-----GSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWG 244
               +G  L  TV     G+  Y  PE +     + ++A VWS G++LY ++ G  PF  
Sbjct: 177 ----SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 232
Query: 245 K---TKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWME 301
                + ++F   R             +S   + LI   L + PS R T  E+  H WM+
Sbjct: 233 DEEIIRGQVFFRQR-------------VSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 279
Query: 302 E 302
           +
Sbjct: 280 D 280

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 87/305 (28%), Positives = 137/305 (44%), Gaps = 60/305 (19%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIA---KDRLVTVEDVRSIKLEIEIMTK 96
           DRY    +LG G +G + +  D  T E +A K I    ++  V    +R + L  E+   
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQ-- 91
Query: 97  LSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQV-- 153
              H N+++LK+V      +HL+ E          L+KY  +  +   RVI   L Q+  
Sbjct: 92  ---HRNIIELKSVIHHNHRLHLIFEYAEND-----LKKYMDKNPDVSMRVIKSFLYQLIN 143
Query: 154 -VSYCHGNGVVHRDLKPENILLA-TKSSSSPI-KLADFGLATY--IKAGQNLHGTVGSPF 208
            V++CH    +HRDLKP+N+LL+ + +S +P+ K+ DFGLA    I   Q  H  + + +
Sbjct: 144 GVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-TLW 202
Query: 209 YIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAVRAADLRFP 262
           Y  PE+L G   Y+ + D+WS   I   +L   P F G ++     KIF+      L  P
Sbjct: 203 YRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEV-----LGLP 257
Query: 263 SD-PWDHISA-------------SARDLIMG-------------MLRVDPSTRLTAAEVL 295
            D  W  ++A                  ++G             ML +DP  R++A   L
Sbjct: 258 DDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNAL 317
Query: 296 AHSWM 300
            H + 
Sbjct: 318 EHPYF 322

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 80/280 (28%), Positives = 130/280 (46%), Gaps = 36/280 (12%)
Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRS---IKLEIEIM 94
           L  +Y +G  LG G FG +           +A K + KDR+    ++ +   + +E+ ++
Sbjct: 6   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 65
Query: 95  TKLS-GHPNVVDLKAVYEEEDYVHLLMELCAG-GELFHRLEKYGRFSETEARVIFRHLMQ 152
            K+S G   V+ L   +E  D   L++E      +LF  + + G   E  AR  F  +++
Sbjct: 66  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 125
Query: 153 VVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTV-----GSP 207
            V +CH  GV+HRD+K ENIL+        +KL DFG      +G  L  TV     G+ 
Sbjct: 126 AVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFG------SGALLKDTVYTDFDGTR 177
Query: 208 FYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGK---TKSKIFDAVRAADLRFP 262
            Y  PE +     + ++A VWS G++LY ++ G  PF       + ++F   R       
Sbjct: 178 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR------- 230
Query: 263 SDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
                 +S+  + LI   L + PS R T  E+  H WM++
Sbjct: 231 ------VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 264

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 80/280 (28%), Positives = 130/280 (46%), Gaps = 36/280 (12%)
Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRS---IKLEIEIM 94
           L  +Y +G  LG G FG +           +A K + KDR+    ++ +   + +E+ ++
Sbjct: 7   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 66
Query: 95  TKLS-GHPNVVDLKAVYEEEDYVHLLMELCAG-GELFHRLEKYGRFSETEARVIFRHLMQ 152
            K+S G   V+ L   +E  D   L++E      +LF  + + G   E  AR  F  +++
Sbjct: 67  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 126
Query: 153 VVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTV-----GSP 207
            V +CH  GV+HRD+K ENIL+        +KL DFG      +G  L  TV     G+ 
Sbjct: 127 AVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFG------SGALLKDTVYTDFDGTR 178
Query: 208 FYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGK---TKSKIFDAVRAADLRFP 262
            Y  PE +     + ++A VWS G++LY ++ G  PF       + ++F   R       
Sbjct: 179 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR------- 231
Query: 263 SDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
                 +S+  + LI   L + PS R T  E+  H WM++
Sbjct: 232 ------VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 265

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 80/280 (28%), Positives = 130/280 (46%), Gaps = 36/280 (12%)
Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRS---IKLEIEIM 94
           L  +Y +G  LG G FG +           +A K + KDR+    ++ +   + +E+ ++
Sbjct: 7   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 66
Query: 95  TKLS-GHPNVVDLKAVYEEEDYVHLLMELCAG-GELFHRLEKYGRFSETEARVIFRHLMQ 152
            K+S G   V+ L   +E  D   L++E      +LF  + + G   E  AR  F  +++
Sbjct: 67  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 126
Query: 153 VVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTV-----GSP 207
            V +CH  GV+HRD+K ENIL+        +KL DFG      +G  L  TV     G+ 
Sbjct: 127 AVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFG------SGALLKDTVYTDFDGTR 178
Query: 208 FYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGK---TKSKIFDAVRAADLRFP 262
            Y  PE +     + ++A VWS G++LY ++ G  PF       + ++F   R       
Sbjct: 179 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR------- 231
Query: 263 SDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
                 +S+  + LI   L + PS R T  E+  H WM++
Sbjct: 232 ------VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 265

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 76/296 (25%), Positives = 131/296 (44%), Gaps = 44/296 (14%)
Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
           +Y   +++G G +G + +  ++ T E++A K +  D     E V S  L    + K   H
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD--DDEGVPSSALREICLLKELKH 60
Query: 101 PNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKY-----GRFSETEARVIFRHLMQVVS 155
            N+V L  V   +  + L+ E C        L+KY     G       +     L++ + 
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCD-----QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115
Query: 156 YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT-VGSPFYIAPEV 214
           +CH   V+HRDLKP+N+L+   + +  +KLADFGLA         +   V + +Y  P+V
Sbjct: 116 FCHSRNVLHRDLKPQNLLI---NRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDV 172
Query: 215 LAGG--YNQAADVWSAGVILYILLSGMPPFWG-----------------KTKSKIFDAVR 255
           L G   Y+ + D+WSAG I   L +   P +                   T+ +     +
Sbjct: 173 LFGAKLYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232
Query: 256 AADLR-FPSDPW--------DHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
             D + +P  P           ++A+ RDL+  +L+ +P  R++A E L H +  +
Sbjct: 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 80/280 (28%), Positives = 130/280 (46%), Gaps = 36/280 (12%)
Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRS---IKLEIEIM 94
           L  +Y +G  LG G FG +           +A K + KDR+    ++ +   + +E+ ++
Sbjct: 5   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 64
Query: 95  TKLS-GHPNVVDLKAVYEEEDYVHLLMELCAG-GELFHRLEKYGRFSETEARVIFRHLMQ 152
            K+S G   V+ L   +E  D   L++E      +LF  + + G   E  AR  F  +++
Sbjct: 65  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 124
Query: 153 VVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTV-----GSP 207
            V +CH  GV+HRD+K ENIL+        +KL DFG      +G  L  TV     G+ 
Sbjct: 125 AVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFG------SGALLKDTVYTDFDGTR 176
Query: 208 FYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGK---TKSKIFDAVRAADLRFP 262
            Y  PE +     + ++A VWS G++LY ++ G  PF       + ++F   R       
Sbjct: 177 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR------- 229
Query: 263 SDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
                 +S+  + LI   L + PS R T  E+  H WM++
Sbjct: 230 ------VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 263

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 80/280 (28%), Positives = 130/280 (46%), Gaps = 36/280 (12%)
Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRS---IKLEIEIM 94
           L  +Y +G  LG G FG +           +A K + KDR+    ++ +   + +E+ ++
Sbjct: 2   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 95  TKLS-GHPNVVDLKAVYEEEDYVHLLMELCAG-GELFHRLEKYGRFSETEARVIFRHLMQ 152
            K+S G   V+ L   +E  D   L++E      +LF  + + G   E  AR  F  +++
Sbjct: 62  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 121
Query: 153 VVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTV-----GSP 207
            V +CH  GV+HRD+K ENIL+        +KL DFG      +G  L  TV     G+ 
Sbjct: 122 AVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFG------SGALLKDTVYTDFDGTR 173
Query: 208 FYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGK---TKSKIFDAVRAADLRFP 262
            Y  PE +     + ++A VWS G++LY ++ G  PF       + ++F   R       
Sbjct: 174 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR------- 226
Query: 263 SDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
                 +S+  + LI   L + PS R T  E+  H WM++
Sbjct: 227 ------VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 260

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 84/308 (27%), Positives = 136/308 (44%), Gaps = 40/308 (12%)
Query: 10  SQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLA 69
           + L    CN    + L        +   L  +Y +G  LG G FG +           +A
Sbjct: 11  AHLRAAPCNDLHATKLA----PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVA 66
Query: 70  CKSIAKDRLVTVEDVRS---IKLEIEIMTKLS-GHPNVVDLKAVYEEEDYVHLLMELCAG 125
            K + KDR+    ++ +   + +E+ ++ K+S G   V+ L   +E  D   L++E    
Sbjct: 67  IKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEP 126
Query: 126 -GELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIK 184
             +LF  + + G   E  AR  F  +++ V +CH  GV+HRD+K ENIL+        +K
Sbjct: 127 VQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE--LK 184
Query: 185 LADFGLATYIKAGQNLHGTV-----GSPFYIAPEVLAGG--YNQAADVWSAGVILYILLS 237
           L DFG      +G  L  TV     G+  Y  PE +     + ++A VWS G++LY ++ 
Sbjct: 185 LIDFG------SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC 238
Query: 238 GMPPFWGKTK---SKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEV 294
           G  PF    +    ++F   R             +S   + LI   L + PS R T  E+
Sbjct: 239 GDIPFEHDEEIIGGQVFFRQR-------------VSXECQHLIRWCLALRPSDRPTFEEI 285
Query: 295 LAHSWMEE 302
             H WM++
Sbjct: 286 QNHPWMQD 293

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 80/281 (28%), Positives = 129/281 (45%), Gaps = 36/281 (12%)
Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRS---IKLEIEIM 94
           L  +Y +G  LG G FG +           +A K + KDR+    ++ +   + +E+ ++
Sbjct: 2   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 95  TKLS-GHPNVVDLKAVYEEEDYVHLLMELCAG-GELFHRLEKYGRFSETEARVIFRHLMQ 152
            K+S G   V+ L   +E  D   L++E      +LF  + + G   E  AR  F  +++
Sbjct: 62  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 121
Query: 153 VVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTV-----GSP 207
            V +CH  GV+HRD+K ENIL+        +KL DFG      +G  L  TV     G+ 
Sbjct: 122 AVRHCHNXGVLHRDIKDENILIDLNRGE--LKLIDFG------SGALLKDTVYTDFDGTR 173
Query: 208 FYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGK---TKSKIFDAVRAADLRFP 262
            Y  PE +     + ++A VWS G++LY ++ G  PF       + ++F   R       
Sbjct: 174 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR------- 226
Query: 263 SDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEEC 303
                 +S   + LI   L + PS R T  E+  H WM++ 
Sbjct: 227 ------VSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 84/308 (27%), Positives = 136/308 (44%), Gaps = 40/308 (12%)
Query: 10  SQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLA 69
           + L    CN    + L        +   L  +Y +G  LG G FG +           +A
Sbjct: 11  AHLRAAPCNDLHATKLA----PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVA 66
Query: 70  CKSIAKDRLVTVEDVRS---IKLEIEIMTKLS-GHPNVVDLKAVYEEEDYVHLLMELCAG 125
            K + KDR+    ++ +   + +E+ ++ K+S G   V+ L   +E  D   L++E    
Sbjct: 67  IKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEP 126
Query: 126 -GELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIK 184
             +LF  + + G   E  AR  F  +++ V +CH  GV+HRD+K ENIL+        +K
Sbjct: 127 VQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE--LK 184
Query: 185 LADFGLATYIKAGQNLHGTV-----GSPFYIAPEVLAGG--YNQAADVWSAGVILYILLS 237
           L DFG      +G  L  TV     G+  Y  PE +     + ++A VWS G++LY ++ 
Sbjct: 185 LIDFG------SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC 238
Query: 238 GMPPFWGKTK---SKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEV 294
           G  PF    +    ++F   R             +S   + LI   L + PS R T  E+
Sbjct: 239 GDIPFEHDEEIIGGQVFFRQR-------------VSXECQHLIRWCLALRPSDRPTFEEI 285
Query: 295 LAHSWMEE 302
             H WM++
Sbjct: 286 QNHPWMQD 293

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 84/308 (27%), Positives = 136/308 (44%), Gaps = 40/308 (12%)
Query: 10  SQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLA 69
           + L    CN    + L        +   L  +Y +G  LG G FG +           +A
Sbjct: 10  AHLRAAPCNDLHATKLA----PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVA 65
Query: 70  CKSIAKDRLVTVEDVRS---IKLEIEIMTKLS-GHPNVVDLKAVYEEEDYVHLLMELCAG 125
            K + KDR+    ++ +   + +E+ ++ K+S G   V+ L   +E  D   L++E    
Sbjct: 66  IKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEP 125
Query: 126 -GELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIK 184
             +LF  + + G   E  AR  F  +++ V +CH  GV+HRD+K ENIL+        +K
Sbjct: 126 VQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE--LK 183
Query: 185 LADFGLATYIKAGQNLHGTV-----GSPFYIAPEVLAGG--YNQAADVWSAGVILYILLS 237
           L DFG      +G  L  TV     G+  Y  PE +     + ++A VWS G++LY ++ 
Sbjct: 184 LIDFG------SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC 237
Query: 238 GMPPFWGKTK---SKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEV 294
           G  PF    +    ++F   R             +S   + LI   L + PS R T  E+
Sbjct: 238 GDIPFEHDEEIIGGQVFFRQR-------------VSXECQHLIRWCLALRPSDRPTFEEI 284
Query: 295 LAHSWMEE 302
             H WM++
Sbjct: 285 QNHPWMQD 292

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/296 (26%), Positives = 133/296 (44%), Gaps = 44/296 (14%)
Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
           +Y   +++G G +G + +  ++ T E++A K +  D     E V S  L    + K   H
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD--DDEGVPSSALREICLLKELKH 60
Query: 101 PNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKY-----GRFSETEARVIFRHLMQVVS 155
            N+V L  V   +  + L+ E C        L+KY     G       +     L++ + 
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCD-----QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115
Query: 156 YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT-VGSPFYIAPEV 214
           +CH   V+HRDLKP+N+L+   + +  +KLA+FGLA         +   V + +Y  P+V
Sbjct: 116 FCHSRNVLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDV 172
Query: 215 LAGG--YNQAADVWSAGVILYILL-SGMPPFWGK----------------TKSKIFDAVR 255
           L G   Y+ + D+WSAG I   L  +G P F G                 T+ +     +
Sbjct: 173 LFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232
Query: 256 AADLR-FPSDPW--------DHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
             D + +P  P           ++A+ RDL+  +L+ +P  R++A E L H +  +
Sbjct: 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 80/281 (28%), Positives = 129/281 (45%), Gaps = 36/281 (12%)
Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRS---IKLEIEIM 94
           L  +Y +G  LG G FG +           +A K + KDR+    ++ +   + +E+ ++
Sbjct: 29  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 88
Query: 95  TKLS-GHPNVVDLKAVYEEEDYVHLLMELCAG-GELFHRLEKYGRFSETEARVIFRHLMQ 152
            K+S G   V+ L   +E  D   L++E      +LF  + + G   E  AR  F  +++
Sbjct: 89  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 148
Query: 153 VVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTV-----GSP 207
            V +CH  GV+HRD+K ENIL+        +KL DFG      +G  L  TV     G+ 
Sbjct: 149 AVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFG------SGALLKDTVYTDFDGTR 200
Query: 208 FYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGK---TKSKIFDAVRAADLRFP 262
            Y  PE +     + ++A VWS G++LY ++ G  PF       + ++F   R       
Sbjct: 201 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR------- 253
Query: 263 SDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEEC 303
                 +S   + LI   L + PS R T  E+  H WM++ 
Sbjct: 254 ------VSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 288

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 85/328 (25%), Positives = 137/328 (41%), Gaps = 59/328 (17%)
Query: 34  QISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTV--EDVRSIKLEI 91
           Q+ ++  RY     +G G +G++    D      +A K I+     T     +R IK+ +
Sbjct: 19  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 78
Query: 92  EI-------MTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEAR 144
                    +  +   P +  +K VY  +D    LME        ++L K    S     
Sbjct: 79  AFRHENIIGINDIIRAPTIEQMKDVYIVQD----LMETD-----LYKLLKTQHLSNDHIC 129
Query: 145 VIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHG-- 202
                +++ + Y H   V+HRDLKP N+LL T   +S +K+ DFGLA       +  G  
Sbjct: 130 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNT---TSDLKICDFGLARVADPDHDHTGFL 186
Query: 203 --TVGSPFYIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAV---- 254
              V + +Y APE++  + GY ++ D+WS G IL  +LS  P F GK      + +    
Sbjct: 187 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 246
Query: 255 ----------------RAADLRFPSD---PWDHI----SASARDLIMGMLRVDPSTRLTA 291
                           R   L  P     PW+ +     + A DL+  ML  +P  R+  
Sbjct: 247 GSPSQEDLNCGINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV 306
Query: 292 AEVLAHSWMEEC-----EQVAQKPCKQD 314
            + LAH ++ +      E +A+ P K D
Sbjct: 307 EQALAHPYLAQYYDPSDEPIAEAPFKFD 334

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 80/280 (28%), Positives = 130/280 (46%), Gaps = 36/280 (12%)
Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRS---IKLEIEIM 94
           L  +Y +G  LG G FG +           +A K + KDR+    ++ +   + +E+ ++
Sbjct: 2   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 95  TKLS-GHPNVVDLKAVYEEEDYVHLLMELCAG-GELFHRLEKYGRFSETEARVIFRHLMQ 152
            K+S G   V+ L   +E  D   L++E      +LF  + + G   E  AR  F  +++
Sbjct: 62  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 121
Query: 153 VVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTV-----GSP 207
            V +CH  GV+HRD+K ENIL+        +KL DFG      +G  L  TV     G+ 
Sbjct: 122 AVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFG------SGALLKDTVYTDFDGTR 173
Query: 208 FYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTK---SKIFDAVRAADLRFP 262
            Y  PE +     + ++A VWS G++LY ++ G  PF    +    ++F   R       
Sbjct: 174 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQR------- 226
Query: 263 SDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
                 +S+  + LI   L + PS R T  E+  H WM++
Sbjct: 227 ------VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 260

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 77/282 (27%), Positives = 138/282 (48%), Gaps = 26/282 (9%)
Query: 24  SLTGTILDATQISNLSDRYV-LGKQLGWGQFGVIRECSDKFTGEVLACKSI----AKDRL 78
           ++ G+    +++  L+D  +   KQ+G G FG++ +        V+A KS+    ++   
Sbjct: 2   AMGGSEFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGET 61
Query: 79  VTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRF 138
             +E  +  + E+ IM+ L+ HPN+V L  +        ++ME    G+L+HRL    + 
Sbjct: 62  EMIEKFQEFQREVFIMSNLN-HPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRL--LDKA 116
Query: 139 SETEARVIFRHLMQV---VSYCHGNG--VVHRDLKPENILLATKSSSSPI--KLADFGLA 191
              +  V  R ++ +   + Y       +VHRDL+  NI L +   ++P+  K+ADFG  
Sbjct: 117 HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG-- 174
Query: 192 TYIKAGQNLHGTVGSPFYIAPEVLAG---GYNQAADVWSAGVILYILLSGMPPF--WGKT 246
           T  ++  ++ G +G+  ++APE +      Y + AD +S  +ILY +L+G  PF  +   
Sbjct: 175 TSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG 234
Query: 247 KSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTR 288
           K K  + +R   LR P+ P D      R++I      DP  R
Sbjct: 235 KIKFINMIREEGLR-PTIPED-CPPRLRNVIELCWSGDPKKR 274

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 75/298 (25%), Positives = 132/298 (44%), Gaps = 40/298 (13%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           + +G G +G +    D    + +A K +++     +   R+ + E+ ++  L  H NV+ 
Sbjct: 26  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYR-ELRLLKHLK-HENVIG 83
Query: 106 LKAVYEE----EDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
           L  V+      ED+  + +     G   + + K    S+   + +   L++ + Y H  G
Sbjct: 84  LLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAG 143
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG--GY 219
           ++HRDLKP N+ +   +    +++ DFGLA   +A + + G V + +Y APE++     Y
Sbjct: 144 IIHRDLKPSNVAV---NEDCELRILDFGLAR--QADEEMTGYVATRWYRAPEIMLNWMHY 198
Query: 220 NQAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAV----------------RAADL 259
           NQ  D+WS G I+  LL G   F G        +I + V                R    
Sbjct: 199 NQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQ 258
Query: 260 RFPSDPWDHISASAR-------DLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKP 310
             P  P   +S+  R       DL+  ML +D   R++AAE LAH++  +      +P
Sbjct: 259 SLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPEDEP 316

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 76/282 (26%), Positives = 138/282 (48%), Gaps = 26/282 (9%)
Query: 24  SLTGTILDATQISNLSDRYV-LGKQLGWGQFGVIRECSDKFTGEVLACKSI----AKDRL 78
           ++ G+    +++  L+D  +   KQ+G G FG++ +        V+A KS+    ++   
Sbjct: 2   AMGGSEFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGET 61
Query: 79  VTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRF 138
             +E  +  + E+ IM+ L+ HPN+V L  +        ++ME    G+L+HRL    + 
Sbjct: 62  EMIEKFQEFQREVFIMSNLN-HPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRL--LDKA 116
Query: 139 SETEARVIFRHLMQV---VSYCHGNG--VVHRDLKPENILLATKSSSSPI--KLADFGLA 191
              +  V  R ++ +   + Y       +VHRDL+  NI L +   ++P+  K+ADF L+
Sbjct: 117 HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLS 176
Query: 192 TYIKAGQNLHGTVGSPFYIAPEVLAG---GYNQAADVWSAGVILYILLSGMPPF--WGKT 246
              ++  ++ G +G+  ++APE +      Y + AD +S  +ILY +L+G  PF  +   
Sbjct: 177 Q--QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG 234
Query: 247 KSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTR 288
           K K  + +R   LR P+ P D      R++I      DP  R
Sbjct: 235 KIKFINMIREEGLR-PTIPED-CPPRLRNVIELCWSGDPKKR 274

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 76/305 (24%), Positives = 134/305 (43%), Gaps = 59/305 (19%)
Query: 39  SDRYVLGKQLGWGQFGVIRECSDKFTGE---VLACKSIAKDRLVTVEDVRSIKLEIEIMT 95
            D Y L ++LG G++  + E  +    E   V   K + K++         IK EI+I+ 
Sbjct: 36  QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKNK---------IKREIKILE 86
Query: 96  KLSGHPNVVDLKAVYEE--EDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQV 153
            L G PN++ L  + ++       L+ E     + F +L  Y   ++ + R     +++ 
Sbjct: 87  NLRGGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQL--YQTLTDYDIRFYMYEILKA 143
Query: 154 VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPE 213
           + YCH  G++HRD+KP N+++  +     ++L D+GLA +   GQ  +  V S ++  PE
Sbjct: 144 LDYCHSMGIMHRDVKPHNVMIDHEHRK--LRLIDWGLAEFYHPGQEYNVRVASRYFKGPE 201
Query: 214 VLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDA-VRAADLRFPSDPWDHI- 269
           +L     Y+ + D+WS G +L  ++    PF+    +  +D  VR A +    D +D+I 
Sbjct: 202 LLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN--YDQLVRIAKVLGTEDLYDYID 259
Query: 270 ----------------------------------SASARDLIMGMLRVDPSTRLTAAEVL 295
                                             S  A D +  +LR D  +RLTA E +
Sbjct: 260 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 319
Query: 296 AHSWM 300
            H + 
Sbjct: 320 EHPYF 324

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 72/258 (27%), Positives = 125/258 (48%), Gaps = 21/258 (8%)
Query: 90  EIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRH 149
           E++++ +   HPNV+      ++  + ++ +ELCA     +  +K       E   + + 
Sbjct: 67  EVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQ 126
Query: 150 LMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIK--LADFGLATYIKAGQN----LHGT 203
               +++ H   +VHRDLKP NIL++  ++   IK  ++DFGL   +  G++      G 
Sbjct: 127 TTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGV 186
Query: 204 VGSPFYIAPEVLAGGYNQ----AADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAAD 258
            G+  +IAPE+L+    +      D++SAG + Y ++S G  PF GK+  +  + +  A 
Sbjct: 187 PGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPF-GKSLQRQANILLGAC 245
Query: 259 LRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ-------VAQKPC 311
                 P  H    AR+LI  M+ +DP  R +A  VL H +    E+       V+ +  
Sbjct: 246 SLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQLQFFQDVSDRIE 305
Query: 312 KQ--DDLCCKQLEVGGSS 327
           K+  D    KQLE GG +
Sbjct: 306 KESLDGPIVKQLERGGRA 323

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 82/301 (27%), Positives = 133/301 (44%), Gaps = 40/301 (13%)
Query: 17  CNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKD 76
           CN    + L        +   L  +Y +G  LG G FG +           +A K + KD
Sbjct: 5   CNDLHATKLA----PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKD 60
Query: 77  RLVTVEDVRS---IKLEIEIMTKLS-GHPNVVDLKAVYEEEDYVHLLMELCAG-GELFHR 131
           R+    ++ +   + +E+ ++ K+S G   V+ L   +E  D   L++E      +LF  
Sbjct: 61  RISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDF 120
Query: 132 LEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA 191
           + + G   E  AR  F  +++ V +CH  GV+HRD+K ENIL+        +KL DFG  
Sbjct: 121 ITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFG-- 176
Query: 192 TYIKAGQNLHGTV-----GSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWG 244
               +G  L  TV     G+  Y  PE +     + ++A VWS G++LY ++ G  PF  
Sbjct: 177 ----SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 232
Query: 245 K---TKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWME 301
                + ++F   R             +S   + LI   L + P  R T  E+  H WM+
Sbjct: 233 DEEIIRGQVFFRQR-------------VSXECQHLIRWCLALRPXDRPTFEEIQNHPWMQ 279
Query: 302 E 302
           +
Sbjct: 280 D 280

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 89/336 (26%), Positives = 151/336 (44%), Gaps = 55/336 (16%)
Query: 34  QISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEI 93
           Q  ++  RY   + +G G +G++    D      +A K I+     T    R+++ EI+I
Sbjct: 37  QPFDVGPRYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQ-RTLR-EIQI 94
Query: 94  MTKLSGHPNVVDLKAVY-----EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
           + +   H NV+ ++ +      E    V+++ +L       ++L K  + S         
Sbjct: 95  LLRFR-HENVIGIRDILRASTLEAMRDVYIVQDLMETD--LYKLLKSQQLSNDHICYFLY 151
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHG----TV 204
            +++ + Y H   V+HRDLKP N+L+ T   +  +K+ DFGLA       +  G     V
Sbjct: 152 QILRGLKYIHSANVLHRDLKPSNLLINT---TCDLKICDFGLARIADPEHDHTGFLTEXV 208
Query: 205 GSPFYIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGKTKSK-------IFDAVR 255
            + +Y APE++  + GY ++ D+WS G IL  +LS  P F GK           I  +  
Sbjct: 209 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 268
Query: 256 AADLR-------------FPSD---PWDHI----SASARDLIMGMLRVDPSTRLTAAEVL 295
             DL               PS     W  +     + A DL+  ML  +P+ R+T  E L
Sbjct: 269 QEDLNCIINMKARNYLQSLPSKTKVAWAKLFPKSDSKALDLLDRMLTFNPNKRITVEEAL 328
Query: 296 AHSWMEEC-----EQVAQKP----CKQDDLCCKQLE 322
           AH ++E+      E VA++P     + DDL  ++L+
Sbjct: 329 AHPYLEQYYDPTDEPVAEEPFTFAMELDDLPKERLK 364

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 98/352 (27%), Positives = 148/352 (42%), Gaps = 71/352 (20%)
Query: 10  SQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLA 69
           S++  QF  S +V+  T T+L          RY   K +G G  G++    D   G  +A
Sbjct: 4   SKVDNQF-YSVEVADSTFTVLK---------RYQQLKPIGSGAQGIVCAAFDTVLGINVA 53
Query: 70  CKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVY------EEEDYVHLLMELC 123
            K +++         R+ + E+ ++ K   H N++ L  V+      EE   V+L+MEL 
Sbjct: 54  VKKLSRPFQNQTHAKRAYR-EL-VLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 111
Query: 124 AGG--ELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSS 181
                ++ H    + R S      +   ++  + + H  G++HRDLKP NI++    S  
Sbjct: 112 DANLCQVIHMELDHERMS-----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDC 163
Query: 182 PIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMP 240
            +K+ DFGLA        +   V + +Y APEV+ G GY    D+WS G I+  L+ G  
Sbjct: 164 TLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMGELVKGCV 223
Query: 241 PF--------WGK------TKSKIFDAVRAADLR----------------------FPSD 264
            F        W K      T S  F A     +R                      FPS+
Sbjct: 224 IFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVRNYVENRPKYPGIKFEELFPDWIFPSE 283
Query: 265 P-WDHISAS-ARDLIMGMLRVDPSTRLTAAEVLAHS----WMEECEQVAQKP 310
              D I  S ARDL+  ML +DP  R++  E L H     W +  E  A  P
Sbjct: 284 SERDKIKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPAEAEAPPP 335

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 81/319 (25%), Positives = 140/319 (43%), Gaps = 52/319 (16%)
Query: 32  ATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEI 91
           A  I  + +RY     +G G +G +    D  TG  +A K +++     +   R+ + E+
Sbjct: 10  AKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-EL 68
Query: 92  EIMTKLSGHPNVVDLKAVY------EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARV 145
            ++  +  H NV+ L  V+      EE + V+L+  L  G +L + + K  + ++   + 
Sbjct: 69  RLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCAKLTDDHVQF 125
Query: 146 IFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVG 205
           +   +++ + Y H   ++HRDLKP N+ +   +    +K+ DFGLA +      + G V 
Sbjct: 126 LIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARH--TDDEMTGYVA 180
Query: 206 SPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPS 263
           + +Y APE++     YNQ  D+WS G I+  LL+G   F G         +    LR   
Sbjct: 181 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI----LRLVG 236
Query: 264 DPWDHI-----SASAR--------------------------DLIMGMLRVDPSTRLTAA 292
            P   +     S SAR                          DL+  ML +D   R+TAA
Sbjct: 237 TPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 296
Query: 293 EVLAHSWMEECEQVAQKPC 311
           + LAH++  +      +P 
Sbjct: 297 QALAHAYFAQYHDPDDEPV 315

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 90/306 (29%), Positives = 144/306 (47%), Gaps = 52/306 (16%)
Query: 47  QLGWGQFGVIRECSD-KFTGEVLACKSIAKDRLVTVED---VRSIKLEIEIMTKLSG--H 100
           ++G G +G + +  D K  G  +A K +   R+ T E+   + +I+ E+ ++  L    H
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRV---RVQTGEEGMPLSTIR-EVAVLRHLETFEH 73
Query: 101 PNVVDLKAV-----YEEEDYVHLLMELCAGGELFHRLEKY---GRFSETEARVIFRHLMQ 152
           PNVV L  V      + E  + L+ E     +L   L+K    G  +ET   ++F+ L++
Sbjct: 74  PNVVRLFDVCTVSRTDRETKLTLVFE-HVDQDLTTYLDKVPEPGVPTETIKDMMFQ-LLR 131
Query: 153 VVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAP 212
            + + H + VVHRDLKP+NIL+   +SS  IKLADFGLA        L   V + +Y AP
Sbjct: 132 GLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 188
Query: 213 EV-LAGGYNQAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAVR-------AADLR 260
           EV L   Y    D+WS G I   +    P F G +      KI D +          D+ 
Sbjct: 189 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 248
Query: 261 FPSDPWDHISAS------------ARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQ 308
            P   +   SA              +DL++  L  +P+ R++A   L+H + ++ E+   
Sbjct: 249 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER--- 305
Query: 309 KPCKQD 314
             CK++
Sbjct: 306 --CKEN 309

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 81/316 (25%), Positives = 140/316 (44%), Gaps = 52/316 (16%)
Query: 35  ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
           I  + +RY     +G G +G +    D  TG  +A K +++     +   R+ + E+ ++
Sbjct: 19  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLL 77
Query: 95  TKLSGHPNVVDLKAVY------EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
             +  H NV+ L  V+      EE + V+L+  L  G +L + + K  + ++   + +  
Sbjct: 78  KHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIY 134
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF 208
            +++ + Y H   ++HRDLKP N+ +   +  S +K+ DFGLA +      + G V + +
Sbjct: 135 QILRGLKYIHSADIIHRDLKPSNLAV---NEDSELKILDFGLARH--TDDEMTGYVATRW 189
Query: 209 YIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW 266
           Y APE++     YNQ  D+WS G I+  LL+G   F G         +    LR    P 
Sbjct: 190 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI----LRLVGTPG 245
Query: 267 DHI-----SASAR--------------------------DLIMGMLRVDPSTRLTAAEVL 295
             +     S SAR                          DL+  ML +D   R+TAA+ L
Sbjct: 246 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 305
Query: 296 AHSWMEECEQVAQKPC 311
           AH++  +      +P 
Sbjct: 306 AHAYFAQYHDPDDEPV 321

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 81/316 (25%), Positives = 140/316 (44%), Gaps = 52/316 (16%)
Query: 35  ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
           I  + +RY     +G G +G +    D  TG  +A K +++     +   R+ + E+ ++
Sbjct: 23  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLL 81
Query: 95  TKLSGHPNVVDLKAVY------EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
             +  H NV+ L  V+      EE + V+L+  L  G +L + + K  + ++   + +  
Sbjct: 82  KHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIY 138
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF 208
            +++ + Y H   ++HRDLKP N+ +   +  S +K+ DFGLA +      + G V + +
Sbjct: 139 QILRGLKYIHSADIIHRDLKPSNLAV---NEDSELKILDFGLARH--TDDEMTGYVATRW 193
Query: 209 YIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW 266
           Y APE++     YNQ  D+WS G I+  LL+G   F G         +    LR    P 
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI----LRLVGTPG 249
Query: 267 DHI-----SASAR--------------------------DLIMGMLRVDPSTRLTAAEVL 295
             +     S SAR                          DL+  ML +D   R+TAA+ L
Sbjct: 250 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 309
Query: 296 AHSWMEECEQVAQKPC 311
           AH++  +      +P 
Sbjct: 310 AHAYFAQYHDPDDEPV 325

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 79/314 (25%), Positives = 138/314 (43%), Gaps = 46/314 (14%)
Query: 37  NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTK 96
           ++ D Y + + +G G +GV+     + TG+ +A K I     V     R+++ E++I+  
Sbjct: 51  DVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLR-ELKILKH 109
Query: 97  LSGHPNVVDLKAV------YEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHL 150
              H N++ +K +      Y E   V+++++L    +L   +      +    R     L
Sbjct: 110 FK-HDNIIAIKDILRPTVPYGEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQL 167
Query: 151 MQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHG-----TVG 205
           ++ + Y H   V+HRDLKP N+L+   + +  +K+ DFG+A  +      H       V 
Sbjct: 168 LRGLKYMHSAQVIHRDLKPSNLLV---NENCELKIGDFGMARGLCTSPAEHQYFMTEYVA 224
Query: 206 SPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKT---------------KS 248
           + +Y APE++     Y QA D+WS G I   +L+    F GK                  
Sbjct: 225 TRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSP 284
Query: 249 KIFDAVRAADLR-----FPSD---PWDHI----SASARDLIMGMLRVDPSTRLTAAEVLA 296
            +  AV A  +R      P     PW+ +       A  L+  MLR +PS R++AA  L 
Sbjct: 285 AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344
Query: 297 HSWMEECEQVAQKP 310
           H ++ +      +P
Sbjct: 345 HPFLAKYHDPDDEP 358

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 83/328 (25%), Positives = 137/328 (41%), Gaps = 59/328 (17%)
Query: 34  QISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIA--KDRLVTVEDVRSIKLEI 91
           Q+ ++  RY     +G G +G++    D      +A K I+  + +      +R IK+ +
Sbjct: 19  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 78
Query: 92  EI-------MTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEAR 144
                    +  +   P +  +K VY  +D    LME        ++L K    S     
Sbjct: 79  AFRHENIIGINDIIRAPTIEQMKDVYIVQD----LMETD-----LYKLLKTQHLSNDHIC 129
Query: 145 VIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHG-- 202
                +++ + Y H   V+HRDLKP N+LL T   +  +K+ DFGLA       +  G  
Sbjct: 130 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNT---TCDLKICDFGLARVADPDHDHTGFL 186
Query: 203 --TVGSPFYIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAV---- 254
              V + +Y APE++  + GY ++ D+WS G IL  +LS  P F GK      + +    
Sbjct: 187 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 246
Query: 255 ----------------RAADLRFPSD---PWDHI----SASARDLIMGMLRVDPSTRLTA 291
                           R   L  P     PW+ +     + A DL+  ML  +P  R+  
Sbjct: 247 GSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV 306
Query: 292 AEVLAHSWMEEC-----EQVAQKPCKQD 314
            + LAH ++ +      E +A+ P K D
Sbjct: 307 EQALAHPYLAQYYDPSDEPIAEAPFKFD 334

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 132/300 (44%), Gaps = 47/300 (15%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVED-VRSIKLEIEIMTKLSGH 100
           Y + + L  G+F  I  C      +  A K   K  L    D  +S   +I I +K    
Sbjct: 33  YRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDF 90
Query: 101 PN----VVDLKAVY--------EEEDYVHLLME------LCAGGELFHRLEK-YGRFSET 141
            N    + D+K  Y           D V+++ E      +    E F  L+K Y  F   
Sbjct: 91  KNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPI 150
Query: 142 EA-RVIFRHLMQVVSYCHG-NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN 199
           +  + I + ++   SY H    + HRD+KP NIL+     +  +KL+DFG + Y+   + 
Sbjct: 151 QVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM---DKNGRVKLSDFGESEYM-VDKK 206
Query: 200 LHGTVGSPFYIAPEVLAG--GYNQA-ADVWSAGVILYILLSGMPPFWGKTK-SKIFDAVR 255
           + G+ G+  ++ PE  +    YN A  D+WS G+ LY++   + PF  K    ++F+ +R
Sbjct: 207 IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIR 266
Query: 256 AADLRFPSD------PW---------DHISASARDLIMGMLRVDPSTRLTAAEVLAHSWM 300
             ++ +P D      P          + +S    D +   LR +P+ R+T+ + L H W+
Sbjct: 267 TKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWL 326

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/304 (25%), Positives = 135/304 (44%), Gaps = 46/304 (15%)
Query: 37  NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTK 96
           ++ D Y + + +G G +GV+     + TG+ +A K I     V     R+++ E++I+  
Sbjct: 52  DVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLR-ELKILKH 110
Query: 97  LSGHPNVVDLKAV------YEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHL 150
              H N++ +K +      Y E   V+++++L    +L   +      +    R     L
Sbjct: 111 FK-HDNIIAIKDILRPTVPYGEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQL 168
Query: 151 MQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHG-----TVG 205
           ++ + Y H   V+HRDLKP N+L+   + +  +K+ DFG+A  +      H       V 
Sbjct: 169 LRGLKYMHSAQVIHRDLKPSNLLV---NENCELKIGDFGMARGLCTSPAEHQYFMTEYVA 225
Query: 206 SPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKT---------------KS 248
           + +Y APE++     Y QA D+WS G I   +L+    F GK                  
Sbjct: 226 TRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSP 285
Query: 249 KIFDAVRAADLR-----FPSD---PWDHISASAR----DLIMGMLRVDPSTRLTAAEVLA 296
            +  AV A  +R      P     PW+ +   A      L+  MLR +PS R++AA  L 
Sbjct: 286 AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 345
Query: 297 HSWM 300
           H ++
Sbjct: 346 HPFL 349

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 88/297 (29%), Positives = 140/297 (47%), Gaps = 47/297 (15%)
Query: 47  QLGWGQFGVIRECSD-KFTGEVLACKSIAKDRLVTVED---VRSIKLEIEIMTKLSG--H 100
           ++G G +G + +  D K  G  +A K +   R+ T E+   + +I+ E+ ++  L    H
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRV---RVQTGEEGMPLSTIR-EVAVLRHLETFEH 73
Query: 101 PNVVDLKAV-----YEEEDYVHLLMELCAGGELFHRLEKY---GRFSETEARVIFRHLMQ 152
           PNVV L  V      + E  + L+ E     +L   L+K    G  +ET   ++F+ L++
Sbjct: 74  PNVVRLFDVCTVSRTDRETKLTLVFE-HVDQDLTTYLDKVPEPGVPTETIKDMMFQ-LLR 131
Query: 153 VVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAP 212
            + + H + VVHRDLKP+NIL+   +SS  IKLADFGLA        L   V + +Y AP
Sbjct: 132 GLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 188
Query: 213 EV-LAGGYNQAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAVR-------AADLR 260
           EV L   Y    D+WS G I   +    P F G +      KI D +          D+ 
Sbjct: 189 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 248
Query: 261 FPSDPWDHISAS------------ARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ 305
            P   +   SA              +DL++  L  +P+ R++A   L+H + ++ E+
Sbjct: 249 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 305

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 79/316 (25%), Positives = 137/316 (43%), Gaps = 52/316 (16%)
Query: 35  ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
           I  + +RY     +G G +G +    D  TG  +A K +++     +   R+ + E+ ++
Sbjct: 37  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLL 95
Query: 95  TKLSGHPNVVDLKAVY------EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
             +  H NV+ L  V+      EE + V+L+  L   G   + + K  + ++   + +  
Sbjct: 96  KHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIY 152
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF 208
            +++ + Y H   ++HRDLKP N+ +   +    +K+ DFGLA +      + G V + +
Sbjct: 153 QILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARH--TDDEMXGXVATRW 207
Query: 209 YIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW 266
           Y APE++     YNQ  D+WS G I+  LL+G   F G         +    LR    P 
Sbjct: 208 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI----LRLVGTPG 263
Query: 267 DHI-----SASAR--------------------------DLIMGMLRVDPSTRLTAAEVL 295
             +     S SAR                          DL+  ML +D   R+TAA+ L
Sbjct: 264 AELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 323
Query: 296 AHSWMEECEQVAQKPC 311
           AH++  +      +P 
Sbjct: 324 AHAYFAQYHDPDDEPV 339

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 92/338 (27%), Positives = 142/338 (42%), Gaps = 75/338 (22%)
Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
           RY   K +G G  G++    D      +A K +++         R+ + E+ +M K+  H
Sbjct: 25  RYQNLKPIGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLM-KVVNH 82
Query: 101 PNVVDLKAVY------EEEDYVHLLMELCAGG-------ELFHRLEKYGRFSETEARVIF 147
            N++ L  V+      EE   V+++MEL           EL H    Y          + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSY----------LL 132
Query: 148 RHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSP 207
             ++  + + H  G++HRDLKP NI++    S + +K+ DFGLA        +   V + 
Sbjct: 133 YQMLVGIKHLHSAGIIHRDLKPSNIVV---KSDATLKILDFGLARTAGTSFMMTPYVVTR 189
Query: 208 FYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPF--------WGKT-----------K 247
           +Y APEV+ G GY +  D+WS GVI+  ++ G   F        W K             
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFM 249
Query: 248 SKIFDAVRA-----------------ADLRFPSDP-WDHISAS-ARDLIMGMLRVDPSTR 288
            K+   VR                   D+ FP+D   + + AS ARDL+  ML +D S R
Sbjct: 250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 309
Query: 289 LTAAEVLAHS----WMEECEQVAQKPCKQDDLCCKQLE 322
           ++  E L H     W +  E  A  P   D    KQL+
Sbjct: 310 ISVDEALQHPYINVWYDPSEAEAPPPKIPD----KQLD 343

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 80/316 (25%), Positives = 137/316 (43%), Gaps = 52/316 (16%)
Query: 35  ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
           I  + +RY     +G G +G +    D  TG  +A K ++K     +   R+ + E+ ++
Sbjct: 29  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYR-ELRLL 87
Query: 95  TKLSGHPNVVDLKAVY------EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
             +  H NV+ L  V+      EE + V+L+  L   G   + + K  + ++   + +  
Sbjct: 88  KHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIY 144
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF 208
            +++ + Y H   ++HRDLKP N+ +   +    +K+ DFGLA +      + G V + +
Sbjct: 145 QILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARH--TDDEMTGYVATRW 199
Query: 209 YIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW 266
           Y APE++     YNQ  D+WS G I+  LL+G   F G         +    LR    P 
Sbjct: 200 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI----LRLVGTPG 255
Query: 267 DHI-----SASAR--------------------------DLIMGMLRVDPSTRLTAAEVL 295
             +     S SAR                          DL+  ML +D   R+TAA+ L
Sbjct: 256 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 315
Query: 296 AHSWMEECEQVAQKPC 311
           AH++  +      +P 
Sbjct: 316 AHAYFAQYHDPDDEPV 331

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 81/316 (25%), Positives = 140/316 (44%), Gaps = 52/316 (16%)
Query: 35  ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
           I  + +RY     +G G +G +    D  TG  +A K +++     +   R+ + E+ ++
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLL 75
Query: 95  TKLSGHPNVVDLKAVY------EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
             +  H NV+ L  V+      EE + V+L+  L  G +L + + K  + ++   + +  
Sbjct: 76  KHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIY 132
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF 208
            +++ + Y H   ++HRDLKP N+ +   +    +K+ DFGLA +      + G V + +
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARH--TDDEMTGYVATRW 187
Query: 209 YIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW 266
           Y APE++  A  YNQ  D+WS G I+  LL+G   F G         +    LR    P 
Sbjct: 188 YRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI----LRLVGTPG 243
Query: 267 DHI-----SASAR--------------------------DLIMGMLRVDPSTRLTAAEVL 295
             +     S SAR                          DL+  ML +D   R+TAA+ L
Sbjct: 244 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 303
Query: 296 AHSWMEECEQVAQKPC 311
           AH++  +      +P 
Sbjct: 304 AHAYFAQYHDPDDEPV 319

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/316 (25%), Positives = 139/316 (43%), Gaps = 52/316 (16%)
Query: 35  ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
           I  + +RY     +G G +G +    D  TG  +A K +++     +   R+ + E+ ++
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLL 75
Query: 95  TKLSGHPNVVDLKAVY------EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
             +  H NV+ L  V+      EE + V+L+  L  G +L + + K  + ++   + +  
Sbjct: 76  KHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKXQKLTDDHVQFLIY 132
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF 208
            +++ + Y H   ++HRDLKP N+ +   +    +K+ DFGLA +      + G V + +
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAV---NEDXELKILDFGLARH--TDDEMTGYVATRW 187
Query: 209 YIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW 266
           Y APE++     YNQ  D+WS G I+  LL+G   F G         +    LR    P 
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI----LRLVGTPG 243
Query: 267 DHI-----SASAR--------------------------DLIMGMLRVDPSTRLTAAEVL 295
             +     S SAR                          DL+  ML +D   R+TAA+ L
Sbjct: 244 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 303
Query: 296 AHSWMEECEQVAQKPC 311
           AH++  +      +P 
Sbjct: 304 AHAYFAQYHDPDDEPV 319

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/316 (25%), Positives = 139/316 (43%), Gaps = 52/316 (16%)
Query: 35  ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
           I  + +RY     +G G +G +    D  TG  +A K +++     +   R+ + E+ ++
Sbjct: 27  IWEVPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLL 85
Query: 95  TKLSGHPNVVDLKAVY------EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
             +  H NV+ L  V+      EE + V+L+  L  G +L + + K  + ++   + +  
Sbjct: 86  KHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIY 142
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF 208
            +++ + Y H   ++HRDLKP N+ +   +    +K+ DFGLA +      + G V + +
Sbjct: 143 QILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARH--TDDEMTGYVATRW 197
Query: 209 YIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW 266
           Y APE++     YNQ  D+WS G I+  LL+G   F G         +    LR    P 
Sbjct: 198 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI----LRLVGTPG 253
Query: 267 DHI-----SASAR--------------------------DLIMGMLRVDPSTRLTAAEVL 295
             +     S SAR                          DL+  ML +D   R+TAA+ L
Sbjct: 254 AELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 313
Query: 296 AHSWMEECEQVAQKPC 311
           AH++  +      +P 
Sbjct: 314 AHAYFAQYHDPDDEPV 329

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/316 (25%), Positives = 139/316 (43%), Gaps = 52/316 (16%)
Query: 35  ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
           I  + +RY     +G G +G +    D  TG  +A K +++     +   R+ + E+ ++
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLL 75
Query: 95  TKLSGHPNVVDLKAVY------EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
             +  H NV+ L  V+      EE + V+L+  L  G +L + + K  + ++   + +  
Sbjct: 76  KHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIY 132
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF 208
            +++ + Y H   ++HRDLKP N+ +   +    +K+ DFGLA +      + G V + +
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARH--TDDEMTGYVATRW 187
Query: 209 YIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW 266
           Y APE++     YNQ  D+WS G I+  LL+G   F G         +    LR    P 
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI----LRLVGTPG 243
Query: 267 DHI-----SASAR--------------------------DLIMGMLRVDPSTRLTAAEVL 295
             +     S SAR                          DL+  ML +D   R+TAA+ L
Sbjct: 244 AELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 303
Query: 296 AHSWMEECEQVAQKPC 311
           AH++  +      +P 
Sbjct: 304 AHAYFAQYHDPDDEPV 319

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/316 (25%), Positives = 139/316 (43%), Gaps = 52/316 (16%)
Query: 35  ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
           I  + +RY     +G G +G +    D  TG  +A K +++     +   R+ + E+ ++
Sbjct: 13  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLL 71
Query: 95  TKLSGHPNVVDLKAVY------EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
             +  H NV+ L  V+      EE + V+L+  L  G +L + + K  + ++   + +  
Sbjct: 72  KHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIY 128
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF 208
            +++ + Y H   ++HRDLKP N+ +   +    +K+ DFGLA +      + G V + +
Sbjct: 129 QILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARH--TDDEMTGYVATRW 183
Query: 209 YIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW 266
           Y APE++     YNQ  D+WS G I+  LL+G   F G         +    LR    P 
Sbjct: 184 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI----LRLVGTPG 239
Query: 267 DHI-----SASAR--------------------------DLIMGMLRVDPSTRLTAAEVL 295
             +     S SAR                          DL+  ML +D   R+TAA+ L
Sbjct: 240 AELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 299
Query: 296 AHSWMEECEQVAQKPC 311
           AH++  +      +P 
Sbjct: 300 AHAYFAQYHDPDDEPV 315

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 79/316 (25%), Positives = 137/316 (43%), Gaps = 52/316 (16%)
Query: 35  ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
           I  + +RY     +G G +G +    D  TG  +A K +++     +   R+ + E+ ++
Sbjct: 37  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLL 95
Query: 95  TKLSGHPNVVDLKAVY------EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
             +  H NV+ L  V+      EE + V+L+  L   G   + + K  + ++   + +  
Sbjct: 96  KHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIY 152
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF 208
            +++ + Y H   ++HRDLKP N+ +   +    +K+ DFGLA +      + G V + +
Sbjct: 153 QILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARH--TDDEMTGYVATRW 207
Query: 209 YIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW 266
           Y APE++     YNQ  D+WS G I+  LL+G   F G         +    LR    P 
Sbjct: 208 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI----LRLVGTPG 263
Query: 267 DHI-----SASAR--------------------------DLIMGMLRVDPSTRLTAAEVL 295
             +     S SAR                          DL+  ML +D   R+TAA+ L
Sbjct: 264 AELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 323
Query: 296 AHSWMEECEQVAQKPC 311
           AH++  +      +P 
Sbjct: 324 AHAYFAQYHDPDDEPV 339

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 79/316 (25%), Positives = 137/316 (43%), Gaps = 52/316 (16%)
Query: 35  ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
           I  + +RY     +G G +G +    D  TG  +A K +++     +   R+ + E+ ++
Sbjct: 36  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLL 94
Query: 95  TKLSGHPNVVDLKAVY------EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
             +  H NV+ L  V+      EE + V+L+  L   G   + + K  + ++   + +  
Sbjct: 95  KHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIY 151
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF 208
            +++ + Y H   ++HRDLKP N+ +   +    +K+ DFGLA +      + G V + +
Sbjct: 152 QILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARH--TDDEMTGYVATRW 206
Query: 209 YIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW 266
           Y APE++     YNQ  D+WS G I+  LL+G   F G         +    LR    P 
Sbjct: 207 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI----LRLVGTPG 262
Query: 267 DHI-----SASAR--------------------------DLIMGMLRVDPSTRLTAAEVL 295
             +     S SAR                          DL+  ML +D   R+TAA+ L
Sbjct: 263 AELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 322
Query: 296 AHSWMEECEQVAQKPC 311
           AH++  +      +P 
Sbjct: 323 AHAYFAQYHDPDDEPV 338

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/316 (25%), Positives = 139/316 (43%), Gaps = 52/316 (16%)
Query: 35  ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
           I  + +RY     +G G +G +    D  TG  +A K +++     +   R+ + E+ ++
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLL 75
Query: 95  TKLSGHPNVVDLKAVY------EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
             +  H NV+ L  V+      EE + V+L+  L  G +L + + K  + ++   + +  
Sbjct: 76  KHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIY 132
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF 208
            +++ + Y H   ++HRDLKP N+ +   +    +K+ DFGLA +      + G V + +
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARH--TDDEMAGFVATRW 187
Query: 209 YIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW 266
           Y APE++     YNQ  D+WS G I+  LL+G   F G         +    LR    P 
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI----LRLVGTPG 243
Query: 267 DHI-----SASAR--------------------------DLIMGMLRVDPSTRLTAAEVL 295
             +     S SAR                          DL+  ML +D   R+TAA+ L
Sbjct: 244 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 303
Query: 296 AHSWMEECEQVAQKPC 311
           AH++  +      +P 
Sbjct: 304 AHAYFAQYHDPDDEPV 319

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/316 (25%), Positives = 139/316 (43%), Gaps = 52/316 (16%)
Query: 35  ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
           I  + +RY     +G G +G +    D  TG  +A K +++     +   R+ + E+ ++
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLL 75
Query: 95  TKLSGHPNVVDLKAVY------EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
             +  H NV+ L  V+      EE + V+L+  L  G +L + + K  + ++   + +  
Sbjct: 76  KHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIY 132
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF 208
            +++ + Y H   ++HRDLKP N+ +   +    +K+ DFGLA +      + G V + +
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARH--TDDEMAGFVATRW 187
Query: 209 YIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW 266
           Y APE++     YNQ  D+WS G I+  LL+G   F G         +    LR    P 
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI----LRLVGTPG 243
Query: 267 DHI-----SASAR--------------------------DLIMGMLRVDPSTRLTAAEVL 295
             +     S SAR                          DL+  ML +D   R+TAA+ L
Sbjct: 244 AELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 303
Query: 296 AHSWMEECEQVAQKPC 311
           AH++  +      +P 
Sbjct: 304 AHAYFAQYHDPDDEPV 319

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/316 (25%), Positives = 139/316 (43%), Gaps = 52/316 (16%)
Query: 35  ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
           I  + +RY     +G G +G +    D  TG  +A K +++     +   R+ + E+ ++
Sbjct: 13  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLL 71
Query: 95  TKLSGHPNVVDLKAVY------EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
             +  H NV+ L  V+      EE + V+L+  L  G +L + + K  + ++   + +  
Sbjct: 72  KHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIY 128
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF 208
            +++ + Y H   ++HRDLKP N+ +   +    +K+ DFGLA +      + G V + +
Sbjct: 129 QILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARH--TDDEMAGFVATRW 183
Query: 209 YIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW 266
           Y APE++     YNQ  D+WS G I+  LL+G   F G         +    LR    P 
Sbjct: 184 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI----LRLVGTPG 239
Query: 267 DHI-----SASAR--------------------------DLIMGMLRVDPSTRLTAAEVL 295
             +     S SAR                          DL+  ML +D   R+TAA+ L
Sbjct: 240 AELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 299
Query: 296 AHSWMEECEQVAQKPC 311
           AH++  +      +P 
Sbjct: 300 AHAYFAQYHDPDDEPV 315

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/316 (25%), Positives = 139/316 (43%), Gaps = 52/316 (16%)
Query: 35  ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
           I  + +RY     +G G +G +    D  TG  +A K +++     +   R+ + E+ ++
Sbjct: 23  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLL 81
Query: 95  TKLSGHPNVVDLKAVY------EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
             +  H NV+ L  V+      EE + V+L+  L  G +L + + K  + ++   + +  
Sbjct: 82  KHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIY 138
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF 208
            +++ + Y H   ++HRDLKP N+ +   +    +K+ DFGLA +      + G V + +
Sbjct: 139 QILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARH--TDDEMTGYVATRW 193
Query: 209 YIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW 266
           Y APE++     YNQ  D+WS G I+  LL+G   F G         +    LR    P 
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI----LRLVGTPG 249
Query: 267 DHI-----SASAR--------------------------DLIMGMLRVDPSTRLTAAEVL 295
             +     S SAR                          DL+  ML +D   R+TAA+ L
Sbjct: 250 AELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 309
Query: 296 AHSWMEECEQVAQKPC 311
           AH++  +      +P 
Sbjct: 310 AHAYFAQYHDPDDEPV 325

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/316 (25%), Positives = 139/316 (43%), Gaps = 52/316 (16%)
Query: 35  ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
           I  + +RY     +G G +G +    D  TG  +A K +++     +   R+ + E+ ++
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLL 75
Query: 95  TKLSGHPNVVDLKAVY------EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
             +  H NV+ L  V+      EE + V+L+  L  G +L + + K  + ++   + +  
Sbjct: 76  KHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKXQKLTDDHVQFLIY 132
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF 208
            +++ + Y H   ++HRDLKP N+ +   +    +K+ DFGLA +      + G V + +
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARH--TDDEMTGYVATRW 187
Query: 209 YIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW 266
           Y APE++     YNQ  D+WS G I+  LL+G   F G         +    LR    P 
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI----LRLVGTPG 243
Query: 267 DHI-----SASAR--------------------------DLIMGMLRVDPSTRLTAAEVL 295
             +     S SAR                          DL+  ML +D   R+TAA+ L
Sbjct: 244 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 303
Query: 296 AHSWMEECEQVAQKPC 311
           AH++  +      +P 
Sbjct: 304 AHAYFAQYHDPDDEPV 319

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/316 (25%), Positives = 139/316 (43%), Gaps = 52/316 (16%)
Query: 35  ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
           I  + +RY     +G G +G +    D  TG  +A K +++     +   R+ + E+ ++
Sbjct: 22  IWEVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLL 80
Query: 95  TKLSGHPNVVDLKAVY------EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
             +  H NV+ L  V+      EE + V+L+  L  G +L + + K  + ++   + +  
Sbjct: 81  KHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIY 137
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF 208
            +++ + Y H   ++HRDLKP N+ +   +    +K+ DFGLA +      + G V + +
Sbjct: 138 QILRGLKYIHSADIIHRDLKPSNLAV---NEDXELKILDFGLARH--TDDEMTGYVATRW 192
Query: 209 YIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW 266
           Y APE++     YNQ  D+WS G I+  LL+G   F G         +    LR    P 
Sbjct: 193 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI----LRLVGTPG 248
Query: 267 DHI-----SASAR--------------------------DLIMGMLRVDPSTRLTAAEVL 295
             +     S SAR                          DL+  ML +D   R+TAA+ L
Sbjct: 249 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 308
Query: 296 AHSWMEECEQVAQKPC 311
           AH++  +      +P 
Sbjct: 309 AHAYFAQYHDPDDEPV 324

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/316 (25%), Positives = 139/316 (43%), Gaps = 52/316 (16%)
Query: 35  ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
           I  + +RY     +G G +G +    D  TG  +A K +++     +   R+ + E+ ++
Sbjct: 24  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLL 82
Query: 95  TKLSGHPNVVDLKAVY------EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
             +  H NV+ L  V+      EE + V+L+  L  G +L + + K  + ++   + +  
Sbjct: 83  KHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIY 139
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF 208
            +++ + Y H   ++HRDLKP N+ +   +    +K+ DFGLA +      + G V + +
Sbjct: 140 QILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARH--TADEMTGYVATRW 194
Query: 209 YIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW 266
           Y APE++     YNQ  D+WS G I+  LL+G   F G         +    LR    P 
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI----LRLVGTPG 250
Query: 267 DHI-----SASAR--------------------------DLIMGMLRVDPSTRLTAAEVL 295
             +     S SAR                          DL+  ML +D   R+TAA+ L
Sbjct: 251 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 310
Query: 296 AHSWMEECEQVAQKPC 311
           AH++  +      +P 
Sbjct: 311 AHAYFAQYHDPDDEPV 326

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 79/316 (25%), Positives = 137/316 (43%), Gaps = 52/316 (16%)
Query: 35  ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
           I  + +RY     +G G +G +    D  TG  +A K +++     +   R+ + E+ ++
Sbjct: 28  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLL 86
Query: 95  TKLSGHPNVVDLKAVY------EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
             +  H NV+ L  V+      EE + V+L+  L   G   + + K  + ++   + +  
Sbjct: 87  KHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIY 143
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF 208
            +++ + Y H   ++HRDLKP N+ +   +    +K+ DFGLA +      + G V + +
Sbjct: 144 QILRGLKYIHSADIIHRDLKPSNLAV---NEDXELKILDFGLARH--TDDEMTGYVATRW 198
Query: 209 YIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW 266
           Y APE++     YNQ  D+WS G I+  LL+G   F G         +    LR    P 
Sbjct: 199 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI----LRLVGTPG 254
Query: 267 DHI-----SASAR--------------------------DLIMGMLRVDPSTRLTAAEVL 295
             +     S SAR                          DL+  ML +D   R+TAA+ L
Sbjct: 255 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 314
Query: 296 AHSWMEECEQVAQKPC 311
           AH++  +      +P 
Sbjct: 315 AHAYFAQYHDPDDEPV 330

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 79/316 (25%), Positives = 137/316 (43%), Gaps = 52/316 (16%)
Query: 35  ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
           I  + +RY     +G G +G +    D  TG  +A K +++     +   R+ + E+ ++
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLL 75
Query: 95  TKLSGHPNVVDLKAVY------EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
             +  H NV+ L  V+      EE + V+L+  L   G   + + K  + ++   + +  
Sbjct: 76  KHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKSQKLTDDHVQFLIY 132
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF 208
            +++ + Y H   ++HRDLKP N+ +   +  S +K+ DFGL  +      + G V + +
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAV---NEDSELKILDFGLCRH--TDDEMTGYVATRW 187
Query: 209 YIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW 266
           Y APE++     YNQ  D+WS G I+  LL+G   F G         +    LR    P 
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI----LRLVGTPG 243
Query: 267 DHI-----SASAR--------------------------DLIMGMLRVDPSTRLTAAEVL 295
             +     S SAR                          DL+  ML +D   R+TAA+ L
Sbjct: 244 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 303
Query: 296 AHSWMEECEQVAQKPC 311
           AH++  +      +P 
Sbjct: 304 AHAYFAQYHDPDDEPV 319

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/316 (25%), Positives = 139/316 (43%), Gaps = 52/316 (16%)
Query: 35  ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
           I  + +RY     +G G +G +    D  TG  +A K +++     +   R+ + E+ ++
Sbjct: 24  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLL 82
Query: 95  TKLSGHPNVVDLKAVY------EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
             +  H NV+ L  V+      EE + V+L+  L  G +L + + K  + ++   + +  
Sbjct: 83  KHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIY 139
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF 208
            +++ + Y H   ++HRDLKP N+ +   +    +K+ DFGLA +      + G V + +
Sbjct: 140 QILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARH--TADEMTGYVATRW 194
Query: 209 YIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW 266
           Y APE++     YNQ  D+WS G I+  LL+G   F G         +    LR    P 
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI----LRLVGTPG 250
Query: 267 DHI-----SASAR--------------------------DLIMGMLRVDPSTRLTAAEVL 295
             +     S SAR                          DL+  ML +D   R+TAA+ L
Sbjct: 251 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 310
Query: 296 AHSWMEECEQVAQKPC 311
           AH++  +      +P 
Sbjct: 311 AHAYFAQYHDPDDEPV 326

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 92/338 (27%), Positives = 142/338 (42%), Gaps = 75/338 (22%)
Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
           RY   K +G G  G++    D      +A K +++         R+ + E+ +M K+  H
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLM-KVVNH 82
Query: 101 PNVVDLKAVY------EEEDYVHLLMELCAGG-------ELFHRLEKYGRFSETEARVIF 147
            N++ L  V+      EE   V+++MEL           EL H    Y          + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSY----------LL 132
Query: 148 RHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSP 207
             ++  + + H  G++HRDLKP NI++    S + +K+ DFGLA        +   V + 
Sbjct: 133 YQMLVGIKHLHSAGIIHRDLKPSNIVV---KSDATLKILDFGLARTAGTSFMMTPYVVTR 189
Query: 208 FYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPF--------WGKT-----------K 247
           +Y APEV+ G GY +  D+WS GVI+  ++ G   F        W K             
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFM 249
Query: 248 SKIFDAVRA-----------------ADLRFPSDP-WDHISAS-ARDLIMGMLRVDPSTR 288
            K+   VR                   D+ FP+D   + + AS ARDL+  ML +D S R
Sbjct: 250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 309
Query: 289 LTAAEVLAHS----WMEECEQVAQKPCKQDDLCCKQLE 322
           ++  E L H     W +  E  A  P   D    KQL+
Sbjct: 310 ISVDEALQHPYINVWYDPSEAEAPPPKIPD----KQLD 343

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 80/316 (25%), Positives = 139/316 (43%), Gaps = 52/316 (16%)
Query: 35  ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
           I  + +RY     +G G +G +    D  TG  +A K +++     +   R+ + E+ ++
Sbjct: 40  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLL 98
Query: 95  TKLSGHPNVVDLKAVY------EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
             +  H NV+ L  V+      EE + V+L+  L  G +L + + K  + ++   + +  
Sbjct: 99  KHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIY 155
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF 208
            +++ + Y H   ++HRDLKP N+ +   +    +K+ DFGLA +      + G V + +
Sbjct: 156 QILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARH--TDDEMXGYVATRW 210
Query: 209 YIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW 266
           Y APE++     YNQ  D+WS G I+  LL+G   F G         +    LR    P 
Sbjct: 211 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI----LRLVGTPG 266
Query: 267 DHI-----SASAR--------------------------DLIMGMLRVDPSTRLTAAEVL 295
             +     S SAR                          DL+  ML +D   R+TAA+ L
Sbjct: 267 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 326
Query: 296 AHSWMEECEQVAQKPC 311
           AH++  +      +P 
Sbjct: 327 AHAYFAQYHDPDDEPV 342

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 94/366 (25%), Positives = 150/366 (40%), Gaps = 77/366 (21%)
Query: 9   SSQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVL 68
            S++  QF  S +V   T T+L          RY   K +G G  G++    D      +
Sbjct: 3   KSKVDNQFY-SVEVGDSTFTVLK---------RYQNLKPIGSGAQGIVCAAYDAVLDRNV 52
Query: 69  ACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVY------EEEDYVHLLMEL 122
           A K +++         R+ + E+ +M K   H N++ L  V+      EE   V+L+MEL
Sbjct: 53  AIKKLSRPFQNQTHAKRAYR-ELVLM-KXVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 110
Query: 123 CAGG-------ELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLA 175
                      EL H    Y          +   ++  + + H  G++HRDLKP NI++ 
Sbjct: 111 MDANLXQVIQMELDHERMSY----------LLYQMLXGIKHLHSAGIIHRDLKPSNIVV- 159
Query: 176 TKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVIL-- 232
              S   +K+ DFGLA        +   V + +Y APEV+ G GY +  D+WS G I+  
Sbjct: 160 --KSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217
Query: 233 ----YILLSGM-----------------PPFWGKTKSKIFDAV----RAADLRFPSDPWD 267
                IL  G                  P F  K +  + + V    + A L FP    D
Sbjct: 218 MVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPD 277
Query: 268 HI-----------SASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKPCKQDDL 316
            +           ++ ARDL+  ML +DP+ R++  + L H ++      A+       +
Sbjct: 278 SLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQI 337
Query: 317 CCKQLE 322
             KQL+
Sbjct: 338 YDKQLD 343

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 80/316 (25%), Positives = 139/316 (43%), Gaps = 52/316 (16%)
Query: 35  ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
           I  + +RY     +G G +G +    D  TG  +A K +++     +   R+ + E+ ++
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLL 75
Query: 95  TKLSGHPNVVDLKAVY------EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
             +  H NV+ L  V+      EE + V+L+  L  G +L + + K  + ++   + +  
Sbjct: 76  KHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIY 132
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF 208
            +++ + Y H   ++HRDLKP N+ +   +    +K+ DFGLA +      + G V + +
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARH--TDDEMTGXVATRW 187
Query: 209 YIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW 266
           Y APE++     YNQ  D+WS G I+  LL+G   F G         +    LR    P 
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI----LRLVGTPG 243
Query: 267 DHI-----SASAR--------------------------DLIMGMLRVDPSTRLTAAEVL 295
             +     S SAR                          DL+  ML +D   R+TAA+ L
Sbjct: 244 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 303
Query: 296 AHSWMEECEQVAQKPC 311
           AH++  +      +P 
Sbjct: 304 AHAYFAQYHDPDDEPV 319

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 80/316 (25%), Positives = 139/316 (43%), Gaps = 52/316 (16%)
Query: 35  ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
           I  + +RY     +G G +G +    D  TG  +A K +++     +   R+ + E+ ++
Sbjct: 24  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLL 82
Query: 95  TKLSGHPNVVDLKAVY------EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
             +  H NV+ L  V+      EE + V+L+  L  G +L + + K  + ++   + +  
Sbjct: 83  KHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIY 139
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF 208
            +++ + Y H   ++HRDLKP N+ +   +    +K+ DFGLA +      + G V + +
Sbjct: 140 QILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARH--TADEMTGYVATRW 194
Query: 209 YIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW 266
           Y APE++     YNQ  D+WS G I+  LL+G   F G         +    LR    P 
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI----LRLVGTPG 250
Query: 267 DHI-----SASAR--------------------------DLIMGMLRVDPSTRLTAAEVL 295
             +     S SAR                          DL+  ML +D   R+TAA+ L
Sbjct: 251 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 310
Query: 296 AHSWMEECEQVAQKPC 311
           AH++  +      +P 
Sbjct: 311 AHAYFAQYHDPDDEPV 326

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 79/316 (25%), Positives = 137/316 (43%), Gaps = 52/316 (16%)
Query: 35  ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
           I  + +RY     +G G +G +    D  TG  +A K +++     +   R+ + E+ ++
Sbjct: 29  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLL 87
Query: 95  TKLSGHPNVVDLKAVY------EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
             +  H NV+ L  V+      EE + V+L+  L   G   + + K  + ++   + +  
Sbjct: 88  KHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIY 144
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF 208
            +++ + Y H   ++HRDLKP N+ +   +    +K+ DFGLA +      + G V + +
Sbjct: 145 QILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARH--TDDEMTGYVATRW 199
Query: 209 YIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW 266
           Y APE++     YNQ  D+WS G I+  LL+G   F G         +    LR    P 
Sbjct: 200 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI----LRLVGTPG 255
Query: 267 DHI-----SASAR--------------------------DLIMGMLRVDPSTRLTAAEVL 295
             +     S SAR                          DL+  ML +D   R+TAA+ L
Sbjct: 256 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 315
Query: 296 AHSWMEECEQVAQKPC 311
           AH++  +      +P 
Sbjct: 316 AHAYFAQYHDPDDEPV 331

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 79/316 (25%), Positives = 137/316 (43%), Gaps = 52/316 (16%)
Query: 35  ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
           I  + +RY     +G G +G +    D  TG  +A K +++     +   R+ + E+ ++
Sbjct: 29  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLL 87
Query: 95  TKLSGHPNVVDLKAVY------EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
             +  H NV+ L  V+      EE + V+L+  L   G   + + K  + ++   + +  
Sbjct: 88  KHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIY 144
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF 208
            +++ + Y H   ++HRDLKP N+ +   +    +K+ DFGLA +      + G V + +
Sbjct: 145 QILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARH--TDDEMTGYVATRW 199
Query: 209 YIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW 266
           Y APE++     YNQ  D+WS G I+  LL+G   F G         +    LR    P 
Sbjct: 200 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI----LRLVGTPG 255
Query: 267 DHI-----SASAR--------------------------DLIMGMLRVDPSTRLTAAEVL 295
             +     S SAR                          DL+  ML +D   R+TAA+ L
Sbjct: 256 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 315
Query: 296 AHSWMEECEQVAQKPC 311
           AH++  +      +P 
Sbjct: 316 AHAYFAQYHDPDDEPV 331

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 80/316 (25%), Positives = 139/316 (43%), Gaps = 52/316 (16%)
Query: 35  ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
           I  + +RY     +G G +G +    D  TG  +A K +++     +   R+ + E+ ++
Sbjct: 19  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLL 77
Query: 95  TKLSGHPNVVDLKAVY------EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
             +  H NV+ L  V+      EE + V+L+  L  G +L + + K  + ++   + +  
Sbjct: 78  KHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIY 134
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF 208
            +++ + Y H   ++HRDLKP N+ +   +    +K+ DFGLA +      + G V + +
Sbjct: 135 QILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARH--TDDEMTGYVATRW 189
Query: 209 YIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW 266
           Y APE++     YNQ  D+WS G I+  LL+G   F G         +    LR    P 
Sbjct: 190 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI----LRLVGTPG 245
Query: 267 DHI-----SASAR--------------------------DLIMGMLRVDPSTRLTAAEVL 295
             +     S SAR                          DL+  ML +D   R+TAA+ L
Sbjct: 246 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 305
Query: 296 AHSWMEECEQVAQKPC 311
           AH++  +      +P 
Sbjct: 306 AHAYFAQYHDPDDEPV 321

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 80/316 (25%), Positives = 139/316 (43%), Gaps = 52/316 (16%)
Query: 35  ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
           I  + +RY     +G G +G +    D  TG  +A K +++     +   R+ + E+ ++
Sbjct: 23  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLL 81
Query: 95  TKLSGHPNVVDLKAVY------EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
             +  H NV+ L  V+      EE + V+L+  L  G +L + + K  + ++   + +  
Sbjct: 82  KHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIY 138
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF 208
            +++ + Y H   ++HRDLKP N+ +   +    +K+ DFGLA +      + G V + +
Sbjct: 139 QILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARH--TDDEMTGYVATRW 193
Query: 209 YIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW 266
           Y APE++     YNQ  D+WS G I+  LL+G   F G         +    LR    P 
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI----LRLVGTPG 249
Query: 267 DHI-----SASAR--------------------------DLIMGMLRVDPSTRLTAAEVL 295
             +     S SAR                          DL+  ML +D   R+TAA+ L
Sbjct: 250 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 309
Query: 296 AHSWMEECEQVAQKPC 311
           AH++  +      +P 
Sbjct: 310 AHAYFAQYHDPDDEPV 325

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 79/316 (25%), Positives = 137/316 (43%), Gaps = 52/316 (16%)
Query: 35  ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
           I  + +RY     +G G +G +    D  TG  +A K +++     +   R+ + E+ ++
Sbjct: 40  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLL 98
Query: 95  TKLSGHPNVVDLKAVY------EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
             +  H NV+ L  V+      EE + V+L+  L   G   + + K  + ++   + +  
Sbjct: 99  KHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIY 155
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF 208
            +++ + Y H   ++HRDLKP N+ +   +    +K+ DFGLA +      + G V + +
Sbjct: 156 QILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARH--TDDEMTGYVATRW 210
Query: 209 YIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW 266
           Y APE++     YNQ  D+WS G I+  LL+G   F G         +    LR    P 
Sbjct: 211 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI----LRLVGTPG 266
Query: 267 DHI-----SASAR--------------------------DLIMGMLRVDPSTRLTAAEVL 295
             +     S SAR                          DL+  ML +D   R+TAA+ L
Sbjct: 267 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 326
Query: 296 AHSWMEECEQVAQKPC 311
           AH++  +      +P 
Sbjct: 327 AHAYFAQYHDPDDEPV 342

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 80/316 (25%), Positives = 139/316 (43%), Gaps = 52/316 (16%)
Query: 35  ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
           I  + +RY     +G G +G +    D  TG  +A K +++     +   R+ + E+ ++
Sbjct: 22  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLL 80
Query: 95  TKLSGHPNVVDLKAVY------EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
             +  H NV+ L  V+      EE + V+L+  L  G +L + + K  + ++   + +  
Sbjct: 81  KHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIY 137
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF 208
            +++ + Y H   ++HRDLKP N+ +   +    +K+ DFGLA +      + G V + +
Sbjct: 138 QILRGLKYIHSADIIHRDLKPSNLAV---NEDXELKILDFGLARH--TDDEMTGYVATRW 192
Query: 209 YIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW 266
           Y APE++     YNQ  D+WS G I+  LL+G   F G         +    LR    P 
Sbjct: 193 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI----LRLVGTPG 248
Query: 267 DHI-----SASAR--------------------------DLIMGMLRVDPSTRLTAAEVL 295
             +     S SAR                          DL+  ML +D   R+TAA+ L
Sbjct: 249 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 308
Query: 296 AHSWMEECEQVAQKPC 311
           AH++  +      +P 
Sbjct: 309 AHAYFAQYHDPDDEPV 324

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 80/316 (25%), Positives = 139/316 (43%), Gaps = 52/316 (16%)
Query: 35  ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
           I  + +RY     +G G +G +    D  TG  +A K +++     +   R+ + E+ ++
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLL 75
Query: 95  TKLSGHPNVVDLKAVY------EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
             +  H NV+ L  V+      EE + V+L+  L  G +L + + K  + ++   + +  
Sbjct: 76  KHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIY 132
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF 208
            +++ + Y H   ++HRDLKP N+ +   +    +K+ DFGLA +      + G V + +
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARH--TDDEMTGYVATRW 187
Query: 209 YIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW 266
           Y APE++     YNQ  D+WS G I+  LL+G   F G         +    LR    P 
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI----LRLVGTPG 243
Query: 267 DHI-----SASAR--------------------------DLIMGMLRVDPSTRLTAAEVL 295
             +     S SAR                          DL+  ML +D   R+TAA+ L
Sbjct: 244 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 303
Query: 296 AHSWMEECEQVAQKPC 311
           AH++  +      +P 
Sbjct: 304 AHAYFAQYHDPDDEPV 319

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 79/316 (25%), Positives = 137/316 (43%), Gaps = 52/316 (16%)
Query: 35  ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
           I  + +RY     +G G +G +    D  TG  +A K +++     +   R+ + E+ ++
Sbjct: 28  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLL 86
Query: 95  TKLSGHPNVVDLKAVY------EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
             +  H NV+ L  V+      EE + V+L+  L   G   + + K  + ++   + +  
Sbjct: 87  KHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIY 143
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF 208
            +++ + Y H   ++HRDLKP N+ +   +    +K+ DFGLA +      + G V + +
Sbjct: 144 QILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARH--TDDEMTGYVATRW 198
Query: 209 YIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW 266
           Y APE++     YNQ  D+WS G I+  LL+G   F G         +    LR    P 
Sbjct: 199 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI----LRLVGTPG 254
Query: 267 DHI-----SASAR--------------------------DLIMGMLRVDPSTRLTAAEVL 295
             +     S SAR                          DL+  ML +D   R+TAA+ L
Sbjct: 255 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 314
Query: 296 AHSWMEECEQVAQKPC 311
           AH++  +      +P 
Sbjct: 315 AHAYFAQYHDPDDEPV 330

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 80/316 (25%), Positives = 139/316 (43%), Gaps = 52/316 (16%)
Query: 35  ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
           I  + +RY     +G G +G +    D  TG  +A K +++     +   R+ + E+ ++
Sbjct: 14  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLL 72
Query: 95  TKLSGHPNVVDLKAVY------EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
             +  H NV+ L  V+      EE + V+L+  L  G +L + + K  + ++   + +  
Sbjct: 73  KHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIY 129
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF 208
            +++ + Y H   ++HRDLKP N+ +   +    +K+ DFGLA +      + G V + +
Sbjct: 130 QILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARH--TDDEMTGYVATRW 184
Query: 209 YIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW 266
           Y APE++     YNQ  D+WS G I+  LL+G   F G         +    LR    P 
Sbjct: 185 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI----LRLVGTPG 240
Query: 267 DHI-----SASAR--------------------------DLIMGMLRVDPSTRLTAAEVL 295
             +     S SAR                          DL+  ML +D   R+TAA+ L
Sbjct: 241 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 300
Query: 296 AHSWMEECEQVAQKPC 311
           AH++  +      +P 
Sbjct: 301 AHAYFAQYHDPDDEPV 316

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 79/316 (25%), Positives = 137/316 (43%), Gaps = 52/316 (16%)
Query: 35  ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
           I  + +RY     +G G +G +    D  TG  +A K +++     +   R+ + E+ ++
Sbjct: 15  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLL 73
Query: 95  TKLSGHPNVVDLKAVY------EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
             +  H NV+ L  V+      EE + V+L+  L   G   + + K  + ++   + +  
Sbjct: 74  KHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIY 130
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF 208
            +++ + Y H   ++HRDLKP N+ +   +    +K+ DFGLA +      + G V + +
Sbjct: 131 QILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARH--TDDEMTGYVATRW 185
Query: 209 YIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW 266
           Y APE++     YNQ  D+WS G I+  LL+G   F G         +    LR    P 
Sbjct: 186 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI----LRLVGTPG 241
Query: 267 DHI-----SASAR--------------------------DLIMGMLRVDPSTRLTAAEVL 295
             +     S SAR                          DL+  ML +D   R+TAA+ L
Sbjct: 242 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 301
Query: 296 AHSWMEECEQVAQKPC 311
           AH++  +      +P 
Sbjct: 302 AHAYFAQYHDPDDEPV 317

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 79/316 (25%), Positives = 137/316 (43%), Gaps = 52/316 (16%)
Query: 35  ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
           I  + +RY     +G G +G +    D  TG  +A K +++     +   R+ + E+ ++
Sbjct: 19  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLL 77
Query: 95  TKLSGHPNVVDLKAVY------EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
             +  H NV+ L  V+      EE + V+L+  L   G   + + K  + ++   + +  
Sbjct: 78  KHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIY 134
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF 208
            +++ + Y H   ++HRDLKP N+ +   +    +K+ DFGLA +      + G V + +
Sbjct: 135 QILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARH--TDDEMTGYVATRW 189
Query: 209 YIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW 266
           Y APE++     YNQ  D+WS G I+  LL+G   F G         +    LR    P 
Sbjct: 190 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI----LRLVGTPG 245
Query: 267 DHI-----SASAR--------------------------DLIMGMLRVDPSTRLTAAEVL 295
             +     S SAR                          DL+  ML +D   R+TAA+ L
Sbjct: 246 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 305
Query: 296 AHSWMEECEQVAQKPC 311
           AH++  +      +P 
Sbjct: 306 AHAYFAQYHDPDDEPV 321

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 80/316 (25%), Positives = 139/316 (43%), Gaps = 52/316 (16%)
Query: 35  ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
           I  + +RY     +G G +G +    D  TG  +A K +++     +   R+ + E+ ++
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLL 75
Query: 95  TKLSGHPNVVDLKAVY------EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
             +  H NV+ L  V+      EE + V+L+  L  G +L + + K  + ++   + +  
Sbjct: 76  KHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIY 132
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF 208
            +++ + Y H   ++HRDLKP N+ +   +    +K+ DFGLA +      + G V + +
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARH--TDDEMTGYVATRW 187
Query: 209 YIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW 266
           Y APE++     YNQ  D+WS G I+  LL+G   F G         +    LR    P 
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI----LRLVGTPG 243
Query: 267 DHI-----SASAR--------------------------DLIMGMLRVDPSTRLTAAEVL 295
             +     S SAR                          DL+  ML +D   R+TAA+ L
Sbjct: 244 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 303
Query: 296 AHSWMEECEQVAQKPC 311
           AH++  +      +P 
Sbjct: 304 AHAYFAQYHDPDDEPV 319

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 79/316 (25%), Positives = 137/316 (43%), Gaps = 52/316 (16%)
Query: 35  ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
           I  + +RY     +G G +G +    D  TG  +A K +++     +   R+ + E+ ++
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLL 75
Query: 95  TKLSGHPNVVDLKAVY------EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
             +  H NV+ L  V+      EE + V+L+  L   G   + + K  + ++   + +  
Sbjct: 76  KHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIY 132
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF 208
            +++ + Y H   ++HRDLKP N+ +   +    +K+ DFGLA +      + G V + +
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARH--TDDEMTGYVATRW 187
Query: 209 YIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW 266
           Y APE++     YNQ  D+WS G I+  LL+G   F G         +    LR    P 
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI----LRLVGTPG 243
Query: 267 DHI-----SASAR--------------------------DLIMGMLRVDPSTRLTAAEVL 295
             +     S SAR                          DL+  ML +D   R+TAA+ L
Sbjct: 244 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 303
Query: 296 AHSWMEECEQVAQKPC 311
           AH++  +      +P 
Sbjct: 304 AHAYFAQYHDPDDEPV 319

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 79/316 (25%), Positives = 137/316 (43%), Gaps = 52/316 (16%)
Query: 35  ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
           I  + +RY     +G G +G +    D  TG  +A K +++     +   R+ + E+ ++
Sbjct: 36  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLL 94
Query: 95  TKLSGHPNVVDLKAVY------EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
             +  H NV+ L  V+      EE + V+L+  L   G   + + K  + ++   + +  
Sbjct: 95  KHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIY 151
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF 208
            +++ + Y H   ++HRDLKP N+ +   +    +K+ DFGLA +      + G V + +
Sbjct: 152 QILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARH--TDDEMTGYVATRW 206
Query: 209 YIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW 266
           Y APE++     YNQ  D+WS G I+  LL+G   F G         +    LR    P 
Sbjct: 207 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI----LRLVGTPG 262
Query: 267 DHI-----SASAR--------------------------DLIMGMLRVDPSTRLTAAEVL 295
             +     S SAR                          DL+  ML +D   R+TAA+ L
Sbjct: 263 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 322
Query: 296 AHSWMEECEQVAQKPC 311
           AH++  +      +P 
Sbjct: 323 AHAYFAQYHDPDDEPV 338

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 80/316 (25%), Positives = 139/316 (43%), Gaps = 52/316 (16%)
Query: 35  ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
           I  + +RY     +G G +G +    D  TG  +A K +++     +   R+ + E+ ++
Sbjct: 14  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLL 72
Query: 95  TKLSGHPNVVDLKAVY------EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
             +  H NV+ L  V+      EE + V+L+  L  G +L + + K  + ++   + +  
Sbjct: 73  KHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIY 129
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF 208
            +++ + Y H   ++HRDLKP N+ +   +    +K+ DFGLA +      + G V + +
Sbjct: 130 QILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARH--TDDEMTGYVATRW 184
Query: 209 YIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW 266
           Y APE++     YNQ  D+WS G I+  LL+G   F G         +    LR    P 
Sbjct: 185 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI----LRLVGTPG 240
Query: 267 DHI-----SASAR--------------------------DLIMGMLRVDPSTRLTAAEVL 295
             +     S SAR                          DL+  ML +D   R+TAA+ L
Sbjct: 241 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 300
Query: 296 AHSWMEECEQVAQKPC 311
           AH++  +      +P 
Sbjct: 301 AHAYFAQYHDPDDEPV 316

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 80/316 (25%), Positives = 139/316 (43%), Gaps = 52/316 (16%)
Query: 35  ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
           I  + +RY     +G G +G +    D  TG  +A K +++     +   R+ + E+ ++
Sbjct: 23  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLL 81
Query: 95  TKLSGHPNVVDLKAVY------EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
             +  H NV+ L  V+      EE + V+L+  L  G +L + + K  + ++   + +  
Sbjct: 82  KHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIY 138
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF 208
            +++ + Y H   ++HRDLKP N+ +   +    +K+ DFGLA +      + G V + +
Sbjct: 139 QILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARH--TDDEMTGYVATRW 193
Query: 209 YIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW 266
           Y APE++     YNQ  D+WS G I+  LL+G   F G         +    LR    P 
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI----LRLVGTPG 249
Query: 267 DHI-----SASAR--------------------------DLIMGMLRVDPSTRLTAAEVL 295
             +     S SAR                          DL+  ML +D   R+TAA+ L
Sbjct: 250 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 309
Query: 296 AHSWMEECEQVAQKPC 311
           AH++  +      +P 
Sbjct: 310 AHAYFAQYHDPDDEPV 325

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 80/316 (25%), Positives = 139/316 (43%), Gaps = 52/316 (16%)
Query: 35  ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
           I  + +RY     +G G +G +    D  TG  +A K +++     +   R+ + E+ ++
Sbjct: 13  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLL 71
Query: 95  TKLSGHPNVVDLKAVY------EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
             +  H NV+ L  V+      EE + V+L+  L  G +L + + K  + ++   + +  
Sbjct: 72  KHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIY 128
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF 208
            +++ + Y H   ++HRDLKP N+ +   +    +K+ DFGLA +      + G V + +
Sbjct: 129 QILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARH--TDDEMTGYVATRW 183
Query: 209 YIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW 266
           Y APE++     YNQ  D+WS G I+  LL+G   F G         +    LR    P 
Sbjct: 184 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI----LRLVGTPG 239
Query: 267 DHI-----SASAR--------------------------DLIMGMLRVDPSTRLTAAEVL 295
             +     S SAR                          DL+  ML +D   R+TAA+ L
Sbjct: 240 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 299
Query: 296 AHSWMEECEQVAQKPC 311
           AH++  +      +P 
Sbjct: 300 AHAYFAQYHDPDDEPV 315

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 80/316 (25%), Positives = 139/316 (43%), Gaps = 52/316 (16%)
Query: 35  ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
           I  + +RY     +G G +G +    D  TG  +A K +++     +   R+ + E+ ++
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLL 75
Query: 95  TKLSGHPNVVDLKAVY------EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
             +  H NV+ L  V+      EE + V+L+  L  G +L + + K  + ++   + +  
Sbjct: 76  KHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIY 132
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF 208
            +++ + Y H   ++HRDLKP N+ +   +    +K+ DFGLA +      + G V + +
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARH--TDDEMTGYVATRW 187
Query: 209 YIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW 266
           Y APE++     YNQ  D+WS G I+  LL+G   F G         +    LR    P 
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI----LRLVGTPG 243
Query: 267 DHI-----SASAR--------------------------DLIMGMLRVDPSTRLTAAEVL 295
             +     S SAR                          DL+  ML +D   R+TAA+ L
Sbjct: 244 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 303
Query: 296 AHSWMEECEQVAQKPC 311
           AH++  +      +P 
Sbjct: 304 AHAYFAQYHDPDDEPV 319

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 80/316 (25%), Positives = 139/316 (43%), Gaps = 52/316 (16%)
Query: 35  ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
           I  + +RY     +G G +G +    D  TG  +A K +++     +   R+ + E+ ++
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLL 75
Query: 95  TKLSGHPNVVDLKAVY------EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
             +  H NV+ L  V+      EE + V+L+  L  G +L + + K  + ++   + +  
Sbjct: 76  KHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIY 132
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF 208
            +++ + Y H   ++HRDLKP N+ +   +    +K+ DFGLA +      + G V + +
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARH--TDDEMTGYVATRW 187
Query: 209 YIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW 266
           Y APE++     YNQ  D+WS G I+  LL+G   F G         +    LR    P 
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI----LRLVGTPG 243
Query: 267 DHI-----SASAR--------------------------DLIMGMLRVDPSTRLTAAEVL 295
             +     S SAR                          DL+  ML +D   R+TAA+ L
Sbjct: 244 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 303
Query: 296 AHSWMEECEQVAQKPC 311
           AH++  +      +P 
Sbjct: 304 AHAYFAQYHDPDDEPV 319

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 80/316 (25%), Positives = 139/316 (43%), Gaps = 52/316 (16%)
Query: 35  ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
           I  + +RY     +G G +G +    D  TG  +A K +++     +   R+ + E+ ++
Sbjct: 22  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLL 80
Query: 95  TKLSGHPNVVDLKAVY------EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
             +  H NV+ L  V+      EE + V+L+  L  G +L + + K  + ++   + +  
Sbjct: 81  KHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIY 137
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF 208
            +++ + Y H   ++HRDLKP N+ +   +    +K+ DFGLA +      + G V + +
Sbjct: 138 QILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARH--TDDEMTGYVATRW 192
Query: 209 YIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW 266
           Y APE++     YNQ  D+WS G I+  LL+G   F G         +    LR    P 
Sbjct: 193 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI----LRLVGTPG 248
Query: 267 DHI-----SASAR--------------------------DLIMGMLRVDPSTRLTAAEVL 295
             +     S SAR                          DL+  ML +D   R+TAA+ L
Sbjct: 249 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 308
Query: 296 AHSWMEECEQVAQKPC 311
           AH++  +      +P 
Sbjct: 309 AHAYFAQYHDPDDEPV 324

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 80/316 (25%), Positives = 139/316 (43%), Gaps = 52/316 (16%)
Query: 35  ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
           I  + +RY     +G G +G +    D  TG  +A K +++     +   R+ + E+ ++
Sbjct: 16  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLL 74
Query: 95  TKLSGHPNVVDLKAVY------EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
             +  H NV+ L  V+      EE + V+L+  L  G +L + + K  + ++   + +  
Sbjct: 75  KHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIY 131
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF 208
            +++ + Y H   ++HRDLKP N+ +   +    +K+ DFGLA +      + G V + +
Sbjct: 132 QILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARH--TDDEMTGYVATRW 186
Query: 209 YIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW 266
           Y APE++     YNQ  D+WS G I+  LL+G   F G         +    LR    P 
Sbjct: 187 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI----LRLVGTPG 242
Query: 267 DHI-----SASAR--------------------------DLIMGMLRVDPSTRLTAAEVL 295
             +     S SAR                          DL+  ML +D   R+TAA+ L
Sbjct: 243 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 302
Query: 296 AHSWMEECEQVAQKPC 311
           AH++  +      +P 
Sbjct: 303 AHAYFAQYHDPDDEPV 318

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 80/316 (25%), Positives = 139/316 (43%), Gaps = 52/316 (16%)
Query: 35  ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
           I  + +RY     +G G +G +    D  TG  +A K +++     +   R+ + E+ ++
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLL 75
Query: 95  TKLSGHPNVVDLKAVY------EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
             +  H NV+ L  V+      EE + V+L+  L  G +L + + K  + ++   + +  
Sbjct: 76  KHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIY 132
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF 208
            +++ + Y H   ++HRDLKP N+ +   +    +K+ DFGLA +      + G V + +
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARH--TDDEMTGYVATRW 187
Query: 209 YIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW 266
           Y APE++     YNQ  D+WS G I+  LL+G   F G         +    LR    P 
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI----LRLVGTPG 243
Query: 267 DHI-----SASAR--------------------------DLIMGMLRVDPSTRLTAAEVL 295
             +     S SAR                          DL+  ML +D   R+TAA+ L
Sbjct: 244 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 303
Query: 296 AHSWMEECEQVAQKPC 311
           AH++  +      +P 
Sbjct: 304 AHAYFAQYHDPDDEPV 319

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 80/316 (25%), Positives = 139/316 (43%), Gaps = 52/316 (16%)
Query: 35  ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
           I  + +RY     +G G +G +    D  TG  +A K +++     +   R+ + E+ ++
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLL 75
Query: 95  TKLSGHPNVVDLKAVY------EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
             +  H NV+ L  V+      EE + V+L+  L  G +L + + K  + ++   + +  
Sbjct: 76  KHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIY 132
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF 208
            +++ + Y H   ++HRDLKP N+ +   +    +K+ DFGLA +      + G V + +
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARH--TDDEMTGYVATRW 187
Query: 209 YIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW 266
           Y APE++     YNQ  D+WS G I+  LL+G   F G         +    LR    P 
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI----LRLVGTPG 243
Query: 267 DHI-----SASAR--------------------------DLIMGMLRVDPSTRLTAAEVL 295
             +     S SAR                          DL+  ML +D   R+TAA+ L
Sbjct: 244 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 303
Query: 296 AHSWMEECEQVAQKPC 311
           AH++  +      +P 
Sbjct: 304 AHAYFAQYHDPDDEPV 319

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 80/316 (25%), Positives = 139/316 (43%), Gaps = 52/316 (16%)
Query: 35  ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
           I  + +RY     +G G +G +    D  TG  +A K +++     +   R+ + E+ ++
Sbjct: 24  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLL 82
Query: 95  TKLSGHPNVVDLKAVY------EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
             +  H NV+ L  V+      EE + V+L+  L  G +L + + K  + ++   + +  
Sbjct: 83  KHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIY 139
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF 208
            +++ + Y H   ++HRDLKP N+ +   +    +K+ DFGLA +      + G V + +
Sbjct: 140 QILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARH--TDDEMTGYVATRW 194
Query: 209 YIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW 266
           Y APE++     YNQ  D+WS G I+  LL+G   F G         +    LR    P 
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI----LRLVGTPG 250
Query: 267 DHI-----SASAR--------------------------DLIMGMLRVDPSTRLTAAEVL 295
             +     S SAR                          DL+  ML +D   R+TAA+ L
Sbjct: 251 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 310
Query: 296 AHSWMEECEQVAQKPC 311
           AH++  +      +P 
Sbjct: 311 AHAYFAQYHDPDDEPV 326

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 79/316 (25%), Positives = 137/316 (43%), Gaps = 52/316 (16%)
Query: 35  ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
           I  + +RY     +G G +G +    D  TG  +A K +++     +   R+ + E+ ++
Sbjct: 37  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLL 95
Query: 95  TKLSGHPNVVDLKAVY------EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
             +  H NV+ L  V+      EE + V+L+  L   G   + + K  + ++   + +  
Sbjct: 96  KHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIY 152
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF 208
            +++ + Y H   ++HRDLKP N+ +   +    +K+ DFGLA +      + G V + +
Sbjct: 153 QILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARH--TDDEMTGYVATRW 207
Query: 209 YIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW 266
           Y APE++     YNQ  D+WS G I+  LL+G   F G         +    LR    P 
Sbjct: 208 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI----LRLVGTPG 263
Query: 267 DHI-----SASAR--------------------------DLIMGMLRVDPSTRLTAAEVL 295
             +     S SAR                          DL+  ML +D   R+TAA+ L
Sbjct: 264 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 323
Query: 296 AHSWMEECEQVAQKPC 311
           AH++  +      +P 
Sbjct: 324 AHAYFAQYHDPDDEPV 339

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 80/316 (25%), Positives = 139/316 (43%), Gaps = 52/316 (16%)
Query: 35  ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
           I  + +RY     +G G +G +    D  TG  +A K +++     +   R+ + E+ ++
Sbjct: 22  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLL 80
Query: 95  TKLSGHPNVVDLKAVY------EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
             +  H NV+ L  V+      EE + V+L+  L  G +L + + K  + ++   + +  
Sbjct: 81  KHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIY 137
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF 208
            +++ + Y H   ++HRDLKP N+ +   +    +K+ DFGLA +      + G V + +
Sbjct: 138 QILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARH--TDDEMTGYVATRW 192
Query: 209 YIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW 266
           Y APE++     YNQ  D+WS G I+  LL+G   F G         +    LR    P 
Sbjct: 193 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI----LRLVGTPG 248
Query: 267 DHI-----SASAR--------------------------DLIMGMLRVDPSTRLTAAEVL 295
             +     S SAR                          DL+  ML +D   R+TAA+ L
Sbjct: 249 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 308
Query: 296 AHSWMEECEQVAQKPC 311
           AH++  +      +P 
Sbjct: 309 AHAYFAQYHDPDDEPV 324

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 79/316 (25%), Positives = 137/316 (43%), Gaps = 52/316 (16%)
Query: 35  ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
           I  + +RY     +G G +G +    D  TG  +A K +++     +   R+ + E+ ++
Sbjct: 19  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLL 77
Query: 95  TKLSGHPNVVDLKAVY------EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
             +  H NV+ L  V+      EE + V+L+  L   G   + + K  + ++   + +  
Sbjct: 78  KHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIY 134
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF 208
            +++ + Y H   ++HRDLKP N+ +   +    +K+ DFGLA +      + G V + +
Sbjct: 135 QILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARH--TDDEMTGYVATRW 189
Query: 209 YIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW 266
           Y APE++     YNQ  D+WS G I+  LL+G   F G         +    LR    P 
Sbjct: 190 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI----LRLVGTPG 245
Query: 267 DHI-----SASAR--------------------------DLIMGMLRVDPSTRLTAAEVL 295
             +     S SAR                          DL+  ML +D   R+TAA+ L
Sbjct: 246 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 305
Query: 296 AHSWMEECEQVAQKPC 311
           AH++  +      +P 
Sbjct: 306 AHAYFAQYHDPDDEPV 321

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 94/366 (25%), Positives = 150/366 (40%), Gaps = 77/366 (21%)
Query: 9   SSQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVL 68
            S++  QF  S +V   T T+L          RY   K +G G  G++    D      +
Sbjct: 3   KSKVDNQFY-SVEVGDSTFTVLK---------RYQNLKPIGSGAQGIVCAAYDAVLDRNV 52
Query: 69  ACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVY------EEEDYVHLLMEL 122
           A K +++         R+ + E+ +M K   H N++ L  V+      EE   V+L+MEL
Sbjct: 53  AIKKLSRPFQNQTHAKRAYR-ELVLM-KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 110
Query: 123 CAGG-------ELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLA 175
                      EL H    Y          +   ++  + + H  G++HRDLKP NI++ 
Sbjct: 111 MDANLXQVIQMELDHERMSY----------LLYQMLXGIKHLHSAGIIHRDLKPSNIVV- 159
Query: 176 TKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVIL-- 232
              S   +K+ DFGLA        +   V + +Y APEV+ G GY +  D+WS G I+  
Sbjct: 160 --KSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217
Query: 233 ----YILLSGM-----------------PPFWGKTKSKIFDAV----RAADLRFPSDPWD 267
                IL  G                  P F  K +  + + V    + A L FP    D
Sbjct: 218 MVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPD 277
Query: 268 HI-----------SASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKPCKQDDL 316
            +           ++ ARDL+  ML +DP+ R++  + L H ++      A+       +
Sbjct: 278 SLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQI 337
Query: 317 CCKQLE 322
             KQL+
Sbjct: 338 YDKQLD 343

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 94/357 (26%), Positives = 146/357 (40%), Gaps = 81/357 (22%)
Query: 10  SQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLA 69
           S++  QF  S +V   T T+L          RY   K +G G  G++    D      +A
Sbjct: 42  SKVDNQF-YSVEVGDSTFTVLK---------RYQNLKPIGSGAQGIVCAAYDAVLDRNVA 91
Query: 70  CKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVY------EEEDYVHLLMELC 123
            K +++         R+ + E+ +M K   H N++ L  V+      EE   V+L+MEL 
Sbjct: 92  IKKLSRPFQNQTHAKRAYR-ELVLM-KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 149
Query: 124 AGG-------ELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLAT 176
                     EL H    Y          +   ++  + + H  G++HRDLKP NI++  
Sbjct: 150 DANLCQVIQMELDHERMSY----------LLYQMLCGIKHLHSAGIIHRDLKPSNIVV-- 197
Query: 177 KSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVIL--- 232
             S   +K+ DFGLA        +   V + +Y APEV+ G GY +  D+WS G I+   
Sbjct: 198 -KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 256
Query: 233 ---YILLSGM-----------------PPFWGKTKSKIFDAV----RAADLRFPSDPWDH 268
               IL  G                  P F  K +  + + V    + A L FP    D 
Sbjct: 257 VRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDS 316
Query: 269 I-----------SASARDLIMGMLRVDPSTRLTAAEVLAHS----WMEECEQVAQKP 310
           +           ++ ARDL+  ML +DP+ R++  + L H     W +  E  A  P
Sbjct: 317 LFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPP 373

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 90/338 (26%), Positives = 139/338 (41%), Gaps = 75/338 (22%)
Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
           RY   K +G G  G++    D      +A K +++         R+ + E+ +M K   H
Sbjct: 18  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLM-KCVNH 75
Query: 101 PNVVDLKAVY------EEEDYVHLLMELCAGG-------ELFHRLEKYGRFSETEARVIF 147
            N++ L  V+      EE   V+L+MEL           EL H    Y          + 
Sbjct: 76  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSY----------LL 125
Query: 148 RHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSP 207
             ++  + + H  G++HRDLKP NI++    S   +K+ DFGLA        +   V + 
Sbjct: 126 YQMLXGIKHLHSAGIIHRDLKPSNIVV---KSDXTLKILDFGLARTAGTSFMMTPYVVTR 182
Query: 208 FYIAPEVLAG-GYNQAADVWSAGVIL------YILLSGM-----------------PPFW 243
           +Y APEV+ G GY +  D+WS G I+       IL  G                  P F 
Sbjct: 183 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242
Query: 244 GKTKSKIFDAV----RAADLRFPSDPWDHI-----------SASARDLIMGMLRVDPSTR 288
            K +  + + V    + A L FP    D +           ++ ARDL+  ML +DP+ R
Sbjct: 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR 302
Query: 289 LTAAEVLAHS----WMEECEQVAQKPCKQDDLCCKQLE 322
           ++  + L H     W +  E  A  P   D    KQL+
Sbjct: 303 ISVDDALQHPYINVWYDPAEVEAPPPQIYD----KQLD 336

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 78/267 (29%), Positives = 126/267 (47%), Gaps = 20/267 (7%)
Query: 40  DRYVLGKQLGWGQFGVIRE---CSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTK 96
           +R  LG+ +G GQFG + +    S +     +A K+       T + VR   L+  +  +
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN---CTSDSVREKFLQEALTMR 66
Query: 97  LSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR--HLMQVV 154
              HP++V L  V  E + V ++MELC  GEL   L+   +FS   A +I     L   +
Sbjct: 67  QFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQ-VRKFSLDLASLILYAYQLSTAL 124
Query: 155 SYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGS-PF-YIAP 212
           +Y      VHRD+   N+L+   SS+  +KL DFGL+ Y++       + G  P  ++AP
Sbjct: 125 AYLESKRFVHRDIAARNVLV---SSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAP 181
Query: 213 EVLA-GGYNQAADVWSAGVILY-ILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHIS 270
           E +    +  A+DVW  GV ++ IL+ G+ PF G   + +   +   + R P  P  +  
Sbjct: 182 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPP--NCP 238
Query: 271 ASARDLIMGMLRVDPSTRLTAAEVLAH 297
            +   L+      DPS R    E+ A 
Sbjct: 239 PTLYSLMTKCWAYDPSRRPRFTELKAQ 265

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 72/250 (28%), Positives = 119/250 (47%), Gaps = 36/250 (14%)
Query: 68  LACKSIAKDRLVTVEDVRS---IKLEIEIMTKLS-GHPNVVDLKAVYEEEDYVHLLMELC 123
           +A K + KDR+    ++ +   + +E+ ++ K+S G   V+ L   +E  D   L++E  
Sbjct: 79  VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERP 138
Query: 124 AG-GELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSP 182
               +LF  + + G   E  AR  F  +++ V +CH  GV+HRD+K ENIL+        
Sbjct: 139 EPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE-- 196
Query: 183 IKLADFGLATYIKAGQNLHGTV-----GSPFYIAPEVLAGG--YNQAADVWSAGVILYIL 235
           +KL DFG      +G  L  TV     G+  Y  PE +     + ++A VWS G++LY +
Sbjct: 197 LKLIDFG------SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDM 250
Query: 236 LSGMPPFWGK---TKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAA 292
           + G  PF       + ++F   R             +S+  + LI   L + PS R T  
Sbjct: 251 VCGDIPFEHDEEIIRGQVFFRQR-------------VSSECQHLIRWCLALRPSDRPTFE 297
Query: 293 EVLAHSWMEE 302
           E+  H WM++
Sbjct: 298 EIQNHPWMQD 307

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 87/293 (29%), Positives = 137/293 (46%), Gaps = 47/293 (16%)
Query: 47  QLGWGQFGVIRECSD-KFTGEVLACKSIAKDRLVTVED---VRSIKLEIEIMTKLSG--H 100
           ++G G +G + +  D K  G  +A K +   R+ T E+   + +I+ E+ ++  L    H
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRV---RVQTGEEGMPLSTIR-EVAVLRHLETFEH 73
Query: 101 PNVVDLKAV-----YEEEDYVHLLMELCAGGELFHRLEKY---GRFSETEARVIFRHLMQ 152
           PNVV L  V      + E  + L+ E     +L   L+K    G  +ET   ++F+ L++
Sbjct: 74  PNVVRLFDVCTVSRTDRETKLTLVFE-HVDQDLTTYLDKVPEPGVPTETIKDMMFQ-LLR 131
Query: 153 VVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAP 212
            + + H + VVHRDLKP+NIL+   +SS  IKLADFGLA        L   V + +Y AP
Sbjct: 132 GLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 188
Query: 213 EV-LAGGYNQAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAVR-------AADLR 260
           EV L   Y    D+WS G I   +    P F G +      KI D +          D+ 
Sbjct: 189 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 248
Query: 261 FPSDPWDHISAS------------ARDLIMGMLRVDPSTRLTAAEVLAHSWME 301
            P   +   SA              +DL++  L  +P+ R++A   L+H + +
Sbjct: 249 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 301

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 103/217 (47%), Gaps = 20/217 (9%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           ++L   LG G    +     K TG++ A K       +   DV+    E E++ KL+ H 
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQM--REFEVLKKLN-HK 67
Query: 102 NVVDLKAVYEEEDYVH--LLMELCAGGELFHRLEK----YGRFSETEARVIFRHLMQVVS 155
           N+V L A+ EE    H  L+ME C  G L+  LE+    YG   E+E  ++ R ++  ++
Sbjct: 68  NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYG-LPESEFLIVLRDVVGGMN 126
Query: 156 YCHGNGVVHRDLKPENIL-LATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEV 214
           +   NG+VHR++KP NI+ +  +   S  KL DFG A  ++  +      G+  Y+ P++
Sbjct: 127 HLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLYGTEEYLHPDM 186
Query: 215 LAGG---------YNQAADVWSAGVILYILLSGMPPF 242
                        Y    D+WS GV  Y   +G  PF
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 94/358 (26%), Positives = 146/358 (40%), Gaps = 81/358 (22%)
Query: 9   SSQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVL 68
            S++  QF  S +V   T T+L          RY   K +G G  G++    D      +
Sbjct: 4   KSKVDNQFY-SVEVGDSTFTVLK---------RYQNLKPIGSGAQGIVCAAYDAVLDRNV 53
Query: 69  ACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVY------EEEDYVHLLMEL 122
           A K +++         R+ + E+ +M K   H N++ L  V+      EE   V+L+MEL
Sbjct: 54  AIKKLSRPFQNQTHAKRAYR-ELVLM-KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 111
Query: 123 CAGG-------ELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLA 175
                      EL H    Y          +   ++  + + H  G++HRDLKP NI++ 
Sbjct: 112 MDANLCQVIQMELDHERMSY----------LLYQMLCGIKHLHSAGIIHRDLKPSNIVV- 160
Query: 176 TKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVIL-- 232
              S   +K+ DFGLA        +   V + +Y APEV+ G GY +  D+WS G I+  
Sbjct: 161 --KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 218
Query: 233 ----YILLSGM-----------------PPFWGKTKSKIFDAV----RAADLRFPSDPWD 267
                IL  G                  P F  K +  + + V    + A L FP    D
Sbjct: 219 MVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPD 278
Query: 268 HI-----------SASARDLIMGMLRVDPSTRLTAAEVLAHS----WMEECEQVAQKP 310
            +           ++ ARDL+  ML +DP+ R++  + L H     W +  E  A  P
Sbjct: 279 SLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPP 336

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 103/217 (47%), Gaps = 20/217 (9%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           ++L   LG G    +     K TG++ A K       +   DV+    E E++ KL+ H 
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQ--MREFEVLKKLN-HK 67
Query: 102 NVVDLKAVYEEEDYVH--LLMELCAGGELFHRLEK----YGRFSETEARVIFRHLMQVVS 155
           N+V L A+ EE    H  L+ME C  G L+  LE+    YG   E+E  ++ R ++  ++
Sbjct: 68  NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYG-LPESEFLIVLRDVVGGMN 126
Query: 156 YCHGNGVVHRDLKPENIL-LATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEV 214
           +   NG+VHR++KP NI+ +  +   S  KL DFG A  ++  +      G+  Y+ P++
Sbjct: 127 HLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDM 186
Query: 215 LAGG---------YNQAADVWSAGVILYILLSGMPPF 242
                        Y    D+WS GV  Y   +G  PF
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 94/357 (26%), Positives = 146/357 (40%), Gaps = 81/357 (22%)
Query: 10  SQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLA 69
           S++  QF  S +V   T T+L          RY   K +G G  G++    D      +A
Sbjct: 42  SKVDNQFY-SVEVGDSTFTVLK---------RYQNLKPIGSGAQGIVCAAYDAVLDRNVA 91
Query: 70  CKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVY------EEEDYVHLLMELC 123
            K +++         R+ + E+ +M K   H N++ L  V+      EE   V+L+MEL 
Sbjct: 92  IKKLSRPFQNQTHAKRAYR-ELVLM-KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 149
Query: 124 AGG-------ELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLAT 176
                     EL H    Y          +   ++  + + H  G++HRDLKP NI++  
Sbjct: 150 DANLCQVIQMELDHERMSY----------LLYQMLCGIKHLHSAGIIHRDLKPSNIVV-- 197
Query: 177 KSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVIL--- 232
             S   +K+ DFGLA        +   V + +Y APEV+ G GY +  D+WS G I+   
Sbjct: 198 -KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 256
Query: 233 ---YILLSGM-----------------PPFWGKTKSKIFDAV----RAADLRFPSDPWDH 268
               IL  G                  P F  K +  + + V    + A L FP    D 
Sbjct: 257 VRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDS 316
Query: 269 I-----------SASARDLIMGMLRVDPSTRLTAAEVLAHS----WMEECEQVAQKP 310
           +           ++ ARDL+  ML +DP+ R++  + L H     W +  E  A  P
Sbjct: 317 LFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPP 373

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 94/358 (26%), Positives = 146/358 (40%), Gaps = 81/358 (22%)
Query: 9   SSQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVL 68
            S++  QF  S +V   T T+L          RY   K +G G  G++    D      +
Sbjct: 3   KSKVDNQFY-SVEVGDSTFTVLK---------RYQNLKPIGSGAQGIVCAAYDAVLDRNV 52
Query: 69  ACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVY------EEEDYVHLLMEL 122
           A K +++         R+ + E+ +M K   H N++ L  V+      EE   V+L+MEL
Sbjct: 53  AIKKLSRPFQNQTHAKRAYR-ELVLM-KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 110
Query: 123 CAGG-------ELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLA 175
                      EL H    Y          +   ++  + + H  G++HRDLKP NI++ 
Sbjct: 111 MDANLCQVIQMELDHERMSY----------LLYQMLCGIKHLHSAGIIHRDLKPSNIVV- 159
Query: 176 TKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVIL-- 232
              S   +K+ DFGLA        +   V + +Y APEV+ G GY +  D+WS G I+  
Sbjct: 160 --KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217
Query: 233 ----YILLSGM-----------------PPFWGKTKSKIFDAV----RAADLRFPSDPWD 267
                IL  G                  P F  K +  + + V    + A L FP    D
Sbjct: 218 MVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPD 277
Query: 268 HI-----------SASARDLIMGMLRVDPSTRLTAAEVLAHS----WMEECEQVAQKP 310
            +           ++ ARDL+  ML +DP+ R++  + L H     W +  E  A  P
Sbjct: 278 SLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPP 335

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/316 (25%), Positives = 139/316 (43%), Gaps = 52/316 (16%)
Query: 35  ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
           I  + +RY     +G G +G +    D  TG  +A K +++     +   R+ + E+ ++
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLL 75
Query: 95  TKLSGHPNVVDLKAVY------EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
             +  H NV+ L  V+      EE + V+L+  L  G +L + + K  + ++   + +  
Sbjct: 76  KHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIY 132
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF 208
            +++ + Y H   ++HRDLKP N+ +   +    +K+ D+GLA +      + G V + +
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDYGLARH--TDDEMTGYVATRW 187
Query: 209 YIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW 266
           Y APE++     YNQ  D+WS G I+  LL+G   F G         +    LR    P 
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI----LRLVGTPG 243
Query: 267 DHI-----SASAR--------------------------DLIMGMLRVDPSTRLTAAEVL 295
             +     S SAR                          DL+  ML +D   R+TAA+ L
Sbjct: 244 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 303
Query: 296 AHSWMEECEQVAQKPC 311
           AH++  +      +P 
Sbjct: 304 AHAYFAQYHDPDDEPV 319

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 94/358 (26%), Positives = 146/358 (40%), Gaps = 81/358 (22%)
Query: 9   SSQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVL 68
            S++  QF  S +V   T T+L          RY   K +G G  G++    D      +
Sbjct: 3   KSKVDNQFY-SVEVGDSTFTVLK---------RYQNLKPIGSGAQGIVCAAYDAVLDRNV 52
Query: 69  ACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVY------EEEDYVHLLMEL 122
           A K +++         R+ + E+ +M K   H N++ L  V+      EE   V+L+MEL
Sbjct: 53  AIKKLSRPFQNQTHAKRAYR-ELVLM-KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 110
Query: 123 CAGG-------ELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLA 175
                      EL H    Y          +   ++  + + H  G++HRDLKP NI++ 
Sbjct: 111 MDANLCQVIQMELDHERMSY----------LLYQMLCGIKHLHSAGIIHRDLKPSNIVV- 159
Query: 176 TKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVIL-- 232
              S   +K+ DFGLA        +   V + +Y APEV+ G GY +  D+WS G I+  
Sbjct: 160 --KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217
Query: 233 ----YILLSGM-----------------PPFWGKTKSKIFDAV----RAADLRFPSDPWD 267
                IL  G                  P F  K +  + + V    + A L FP    D
Sbjct: 218 MVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPD 277
Query: 268 HI-----------SASARDLIMGMLRVDPSTRLTAAEVLAHS----WMEECEQVAQKP 310
            +           ++ ARDL+  ML +DP+ R++  + L H     W +  E  A  P
Sbjct: 278 SLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPP 335

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 94/358 (26%), Positives = 146/358 (40%), Gaps = 81/358 (22%)
Query: 9   SSQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVL 68
            S++  QF  S +V   T T+L          RY   K +G G  G++    D      +
Sbjct: 4   KSKVDNQFY-SVEVGDSTFTVLK---------RYQNLKPIGSGAQGIVCAAYDAVLDRNV 53
Query: 69  ACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVY------EEEDYVHLLMEL 122
           A K +++         R+ + E+ +M K   H N++ L  V+      EE   V+L+MEL
Sbjct: 54  AIKKLSRPFQNQTHAKRAYR-ELVLM-KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 111
Query: 123 CAGG-------ELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLA 175
                      EL H    Y          +   ++  + + H  G++HRDLKP NI++ 
Sbjct: 112 MDANLCQVIQMELDHERMSY----------LLYQMLCGIKHLHSAGIIHRDLKPSNIVV- 160
Query: 176 TKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVIL-- 232
              S   +K+ DFGLA        +   V + +Y APEV+ G GY +  D+WS G I+  
Sbjct: 161 --KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 218
Query: 233 ----YILLSGM-----------------PPFWGKTKSKIFDAV----RAADLRFPSDPWD 267
                IL  G                  P F  K +  + + V    + A L FP    D
Sbjct: 219 MVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPD 278
Query: 268 HI-----------SASARDLIMGMLRVDPSTRLTAAEVLAHS----WMEECEQVAQKP 310
            +           ++ ARDL+  ML +DP+ R++  + L H     W +  E  A  P
Sbjct: 279 SLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPP 336

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 82/296 (27%), Positives = 138/296 (46%), Gaps = 46/296 (15%)
Query: 37  NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTK 96
           +L +  V  K LG+G  G +      F G  +A K +    L+   D+    +EI+++T+
Sbjct: 12  SLKNLVVSEKILGYGSSGTV-VFQGSFQGRPVAVKRM----LIDFCDI--ALMEIKLLTE 64
Query: 97  LSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARV--------IFR 148
              HPNV+        + ++++ +ELC        L +    S+   ++        + R
Sbjct: 65  SDDHPNVIRYYCSETTDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLLR 122
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSP----------IKLADFGLATYIKAGQ 198
            +   V++ H   ++HRDLKP+NIL++T S  +           I ++DFGL   + +GQ
Sbjct: 123 QIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182
Query: 199 -----NLHGTVGSPFYIAPEVLAGGYN--------QAADVWSAGVILYILLS-GMPPFWG 244
                NL+   G+  + APE+L    N        ++ D++S G + Y +LS G  PF  
Sbjct: 183 SSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242
Query: 245 K--TKSKIFDAVRAAD-LRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH 297
           K   +S I   + + D ++   D    + A A DLI  M+  DP  R TA +VL H
Sbjct: 243 KYSRESNIIRGIFSLDEMKCLHD--RSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 91/338 (26%), Positives = 141/338 (41%), Gaps = 75/338 (22%)
Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
           RY   K +G G  G++    D      +A K +++         R+ + E+ +M K+  H
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLM-KVVNH 82
Query: 101 PNVVDLKAVY------EEEDYVHLLMELCAGG-------ELFHRLEKYGRFSETEARVIF 147
            N++ L  V+      EE   V+++MEL           EL H    Y          + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSY----------LL 132
Query: 148 RHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSP 207
             ++  + + H  G++HRDLKP NI++    S + +K+ DFGLA        +   V + 
Sbjct: 133 YQMLVGIKHLHSAGIIHRDLKPSNIVV---KSDATLKILDFGLARTAGTSFMMTPYVVTR 189
Query: 208 FYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPF--------WGKT-----------K 247
           +Y APEV+ G GY +  D+WS G I+  ++ G   F        W K             
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFM 249
Query: 248 SKIFDAVRA-----------------ADLRFPSDP-WDHISAS-ARDLIMGMLRVDPSTR 288
            K+   VR                   D+ FP+D   + + AS ARDL+  ML +D S R
Sbjct: 250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 309
Query: 289 LTAAEVLAHS----WMEECEQVAQKPCKQDDLCCKQLE 322
           ++  E L H     W +  E  A  P   D    KQL+
Sbjct: 310 ISVDEALQHPYINVWYDPSEAEAPPPKIPD----KQLD 343

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 94/358 (26%), Positives = 146/358 (40%), Gaps = 81/358 (22%)
Query: 9   SSQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVL 68
            S++  QF  S +V   T T+L          RY   K +G G  G++    D      +
Sbjct: 2   KSKVDNQFY-SVEVGDSTFTVLK---------RYQNLKPIGSGAQGIVCAAYDAVLDRNV 51
Query: 69  ACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVY------EEEDYVHLLMEL 122
           A K +++         R+ + E+ +M K   H N++ L  V+      EE   V+L+MEL
Sbjct: 52  AIKKLSRPFQNQTHAKRAYR-ELVLM-KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 109
Query: 123 CAGG-------ELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLA 175
                      EL H    Y          +   ++  + + H  G++HRDLKP NI++ 
Sbjct: 110 MDANLCQVIQMELDHERMSY----------LLYQMLCGIKHLHSAGIIHRDLKPSNIVV- 158
Query: 176 TKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVIL-- 232
              S   +K+ DFGLA        +   V + +Y APEV+ G GY +  D+WS G I+  
Sbjct: 159 --KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 216
Query: 233 ----YILLSGM-----------------PPFWGKTKSKIFDAV----RAADLRFPSDPWD 267
                IL  G                  P F  K +  + + V    + A L FP    D
Sbjct: 217 MVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPD 276
Query: 268 HI-----------SASARDLIMGMLRVDPSTRLTAAEVLAHS----WMEECEQVAQKP 310
            +           ++ ARDL+  ML +DP+ R++  + L H     W +  E  A  P
Sbjct: 277 SLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPP 334

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 82/296 (27%), Positives = 138/296 (46%), Gaps = 46/296 (15%)
Query: 37  NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTK 96
           +L +  V  K LG+G  G +      F G  +A K +    L+   D+    +EI+++T+
Sbjct: 12  SLKNLVVSEKILGYGSSGTV-VFQGSFQGRPVAVKRM----LIDFCDI--ALMEIKLLTE 64
Query: 97  LSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARV--------IFR 148
              HPNV+        + ++++ +ELC        L +    S+   ++        + R
Sbjct: 65  SDDHPNVIRYYCSETTDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLLR 122
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSP----------IKLADFGLATYIKAGQ 198
            +   V++ H   ++HRDLKP+NIL++T S  +           I ++DFGL   + +GQ
Sbjct: 123 QIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182
Query: 199 -----NLHGTVGSPFYIAPEVLAGGYN--------QAADVWSAGVILYILLS-GMPPFWG 244
                NL+   G+  + APE+L    N        ++ D++S G + Y +LS G  PF  
Sbjct: 183 XXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242
Query: 245 K--TKSKIFDAVRAAD-LRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH 297
           K   +S I   + + D ++   D    + A A DLI  M+  DP  R TA +VL H
Sbjct: 243 KYSRESNIIRGIFSLDEMKCLHD--RSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 90/343 (26%), Positives = 143/343 (41%), Gaps = 77/343 (22%)
Query: 10  SQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLA 69
           S++  QF  S +V   T T+L          RY   K +G G  G++    D      +A
Sbjct: 4   SKVDNQFY-SVEVGDSTFTVLK---------RYQNLKPIGSGAQGIVCAAYDAVLDRNVA 53
Query: 70  CKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVY------EEEDYVHLLMELC 123
            K +++         R+ + E+ +M K   H N++ L  V+      EE   V+L+MEL 
Sbjct: 54  IKKLSRPFQNQTHAKRAYR-ELVLM-KXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 111
Query: 124 AGG-------ELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLAT 176
                     EL H    Y          +   ++  + + H  G++HRDLKP NI++  
Sbjct: 112 DANLCQVIQMELDHERMSY----------LLYQMLCGIKHLHSAGIIHRDLKPSNIVV-- 159
Query: 177 KSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVIL--- 232
             S   +K+ DFGLA        +   V + +Y APEV+ G GY +  D+WS G I+   
Sbjct: 160 -KSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218
Query: 233 ---YILLSGM-----------------PPFWGKTKSKIFDAV----RAADLRFPSDPWDH 268
               IL  G                  P F  K +  + + V    + A L FP    D 
Sbjct: 219 VRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDS 278
Query: 269 I-----------SASARDLIMGMLRVDPSTRLTAAEVLAHSWM 300
           +           ++ ARDL+  ML +DP+ R++  + L H ++
Sbjct: 279 LFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 90/343 (26%), Positives = 143/343 (41%), Gaps = 77/343 (22%)
Query: 10  SQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLA 69
           S++  QF  S +V   T T+L          RY   K +G G  G++    D      +A
Sbjct: 4   SKVDNQFY-SVEVGDSTFTVLK---------RYQNLKPIGSGAQGIVCAAYDAVLDRNVA 53
Query: 70  CKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVY------EEEDYVHLLMELC 123
            K +++         R+ + E+ +M K   H N++ L  V+      EE   V+L+MEL 
Sbjct: 54  IKKLSRPFQNQTHAKRAYR-ELVLM-KXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 111
Query: 124 AGG-------ELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLAT 176
                     EL H    Y          +   ++  + + H  G++HRDLKP NI++  
Sbjct: 112 DANLXQVIQMELDHERMSY----------LLYQMLCGIKHLHSAGIIHRDLKPSNIVV-- 159
Query: 177 KSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVIL--- 232
             S   +K+ DFGLA        +   V + +Y APEV+ G GY +  D+WS G I+   
Sbjct: 160 -KSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218
Query: 233 ---YILLSGM-----------------PPFWGKTKSKIFDAV----RAADLRFPSDPWDH 268
               IL  G                  P F  K +  + + V    + A L FP    D 
Sbjct: 219 VRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDS 278
Query: 269 I-----------SASARDLIMGMLRVDPSTRLTAAEVLAHSWM 300
           +           ++ ARDL+  ML +DP+ R++  + L H ++
Sbjct: 279 LFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 76/268 (28%), Positives = 129/268 (48%), Gaps = 22/268 (8%)
Query: 40  DRYVLGKQLGWGQFGVIRE---CSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTK 96
           +R  LG+ +G GQFG + +    S +     +A K+       T + VR   L+  +  +
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN---CTSDSVREKFLQEALTMR 66
Query: 97  LSGHPNVVDLKAVYEEEDYVHLLMELCAGGEL--FHRLEKYGRFSETEARVIFRH-LMQV 153
              HP++V L  V  E + V ++MELC  GEL  F ++ KY    +  + +++ + L   
Sbjct: 67  QFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTA 123
Query: 154 VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGS-PF-YIA 211
           ++Y      VHRD+   N+L+   SS+  +KL DFGL+ Y++       + G  P  ++A
Sbjct: 124 LAYLESKRFVHRDIAARNVLV---SSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 180
Query: 212 PEVLA-GGYNQAADVWSAGVILY-ILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHI 269
           PE +    +  A+DVW  GV ++ IL+ G+ PF G   + +   +   + R P  P  + 
Sbjct: 181 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPP--NC 237
Query: 270 SASARDLIMGMLRVDPSTRLTAAEVLAH 297
             +   L+      DPS R    E+ A 
Sbjct: 238 PPTLYSLMTKCWAYDPSRRPRFTELKAQ 265

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 81/292 (27%), Positives = 137/292 (46%), Gaps = 42/292 (14%)
Query: 37  NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTK 96
           +L +  V  K LG+G  G +      F G  +A K +    L+   D+    +EI+++T+
Sbjct: 30  SLKNLVVSEKILGYGSSGTV-VFQGSFQGRPVAVKRM----LIDFCDI--ALMEIKLLTE 82
Query: 97  LSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARV--------IFR 148
              HPNV+        + ++++ +ELC        L +    S+   ++        + R
Sbjct: 83  SDDHPNVIRYYCSETTDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLLR 140
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSP----------IKLADFGLATYIKAGQ 198
            +   V++ H   ++HRDLKP+NIL++T S  +           I ++DFGL   + +GQ
Sbjct: 141 QIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 200
Query: 199 -----NLHGTVGSPFYIAPEVLAGG----YNQAADVWSAGVILYILLS-GMPPFWGK--T 246
                NL+   G+  + APE+L         ++ D++S G + Y +LS G  PF  K   
Sbjct: 201 XXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 260
Query: 247 KSKIFDAVRAAD-LRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH 297
           +S I   + + D ++   D    + A A DLI  M+  DP  R TA +VL H
Sbjct: 261 ESNIIRGIFSLDEMKCLHD--RSLIAEATDLISQMIDHDPLKRPTAMKVLRH 310

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/267 (29%), Positives = 126/267 (47%), Gaps = 20/267 (7%)
Query: 40  DRYVLGKQLGWGQFGVIRE---CSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTK 96
           +R  LG+ +G GQFG + +    S +     +A K+       T + VR   L+  +  +
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN---CTSDSVREKFLQEALTMR 446
Query: 97  LSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR--HLMQVV 154
              HP++V L  V  E + V ++MELC  GEL   L+   +FS   A +I     L   +
Sbjct: 447 QFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQ-VRKFSLDLASLILYAYQLSTAL 504
Query: 155 SYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGS-PF-YIAP 212
           +Y      VHRD+   N+L+   SS+  +KL DFGL+ Y++       + G  P  ++AP
Sbjct: 505 AYLESKRFVHRDIAARNVLV---SSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 561
Query: 213 EVLA-GGYNQAADVWSAGVILY-ILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHIS 270
           E +    +  A+DVW  GV ++ IL+ G+ PF G   + +   +   + R P  P  +  
Sbjct: 562 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPP--NCP 618
Query: 271 ASARDLIMGMLRVDPSTRLTAAEVLAH 297
            +   L+      DPS R    E+ A 
Sbjct: 619 PTLYSLMTKCWAYDPSRRPRFTELKAQ 645

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/316 (25%), Positives = 138/316 (43%), Gaps = 52/316 (16%)
Query: 35  ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
           I  + +RY     +G G +G +    D  TG  +A K +++     +   R+ + E+ ++
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLL 75
Query: 95  TKLSGHPNVVDLKAVY------EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
             +  H NV+ L  V+      EE + V+L+  L  G +L + + K  + ++   + +  
Sbjct: 76  KHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIY 132
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF 208
            +++ + Y H   ++HRDLKP N+ +   +    +K+ DF LA +      + G V + +
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFYLARH--TDDEMTGYVATRW 187
Query: 209 YIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW 266
           Y APE++     YNQ  D+WS G I+  LL+G   F G         +    LR    P 
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI----LRLVGTPG 243
Query: 267 DHI-----SASAR--------------------------DLIMGMLRVDPSTRLTAAEVL 295
             +     S SAR                          DL+  ML +D   R+TAA+ L
Sbjct: 244 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 303
Query: 296 AHSWMEECEQVAQKPC 311
           AH++  +      +P 
Sbjct: 304 AHAYFAQYHDPDDEPV 319

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 81/292 (27%), Positives = 137/292 (46%), Gaps = 42/292 (14%)
Query: 37  NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTK 96
           +L +  V  K LG+G  G +      F G  +A K +    L+   D+    +EI+++T+
Sbjct: 30  SLKNLVVSEKILGYGSSGTV-VFQGSFQGRPVAVKRM----LIDFCDI--ALMEIKLLTE 82
Query: 97  LSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARV--------IFR 148
              HPNV+        + ++++ +ELC        L +    S+   ++        + R
Sbjct: 83  SDDHPNVIRYYCSETTDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLLR 140
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSP----------IKLADFGLATYIKAGQ 198
            +   V++ H   ++HRDLKP+NIL++T S  +           I ++DFGL   + +GQ
Sbjct: 141 QIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 200
Query: 199 -----NLHGTVGSPFYIAPEVLAGG----YNQAADVWSAGVILYILLS-GMPPFWGK--T 246
                NL+   G+  + APE+L         ++ D++S G + Y +LS G  PF  K   
Sbjct: 201 XXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 260
Query: 247 KSKIFDAVRAAD-LRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH 297
           +S I   + + D ++   D    + A A DLI  M+  DP  R TA +VL H
Sbjct: 261 ESNIIRGIFSLDEMKCLHD--RSLIAEATDLISQMIDHDPLKRPTAMKVLRH 310

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 126/265 (47%), Gaps = 16/265 (6%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           +R  LG+ +G GQFG + +             +I   +  T + VR   L+  +  +   
Sbjct: 13  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 72
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGEL--FHRLEKYGRFSETEARVIFRH-LMQVVSY 156
           HP++V L  V  E + V ++MELC  GEL  F ++ KY    +  + +++ + L   ++Y
Sbjct: 73  HPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSL--DLASLILYAYQLSTALAY 129
Query: 157 CHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGS-PF-YIAPEV 214
                 VHRD+   N+L+   SS+  +KL DFGL+ Y++       + G  P  ++APE 
Sbjct: 130 LESKRFVHRDIAARNVLV---SSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 186
Query: 215 LA-GGYNQAADVWSAGVILY-ILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISAS 272
           +    +  A+DVW  GV ++ IL+ G+ PF G   + +   +   + R P  P  +   +
Sbjct: 187 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPP--NCPPT 243
Query: 273 ARDLIMGMLRVDPSTRLTAAEVLAH 297
              L+      DPS R    E+ A 
Sbjct: 244 LYSLMTKCWAYDPSRRPRFTELKAQ 268

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 91/338 (26%), Positives = 141/338 (41%), Gaps = 75/338 (22%)
Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
           RY   K +G G  G++    D      +A K +++         R+ + E+ +M K+  H
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLM-KVVNH 82
Query: 101 PNVVDLKAVY------EEEDYVHLLMELCAGG-------ELFHRLEKYGRFSETEARVIF 147
            N++ L  V+      EE   V+++MEL           EL H    Y          + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSY----------LL 132
Query: 148 RHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSP 207
             ++  + + H  G++HRDLKP NI++    S + +K+ DFGLA        +   V + 
Sbjct: 133 YQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDATLKILDFGLARTAGTSFMMTPYVVTR 189
Query: 208 FYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPF--------WGKT-----------K 247
           +Y APEV+ G GY +  D+WS G I+  ++ G   F        W K             
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFM 249
Query: 248 SKIFDAVRA-----------------ADLRFPSDP-WDHISAS-ARDLIMGMLRVDPSTR 288
            K+   VR                   D+ FP+D   + + AS ARDL+  ML +D S R
Sbjct: 250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 309
Query: 289 LTAAEVLAHS----WMEECEQVAQKPCKQDDLCCKQLE 322
           ++  E L H     W +  E  A  P   D    KQL+
Sbjct: 310 ISVDEALQHPYINVWYDPSEAEAPPPKIPD----KQLD 343

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 126/265 (47%), Gaps = 16/265 (6%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           +R  LG+ +G GQFG + +             +I   +  T + VR   L+  +  +   
Sbjct: 12  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 71
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGEL--FHRLEKYGRFSETEARVIFRH-LMQVVSY 156
           HP++V L  V  E + V ++MELC  GEL  F ++ KY    +  + +++ + L   ++Y
Sbjct: 72  HPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAY 128
Query: 157 CHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGS-PF-YIAPEV 214
                 VHRD+   N+L+   SS+  +KL DFGL+ Y++       + G  P  ++APE 
Sbjct: 129 LESKRFVHRDIAARNVLV---SSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 185
Query: 215 LA-GGYNQAADVWSAGVILY-ILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISAS 272
           +    +  A+DVW  GV ++ IL+ G+ PF G   + +   +   + R P  P  +   +
Sbjct: 186 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPP--NCPPT 242
Query: 273 ARDLIMGMLRVDPSTRLTAAEVLAH 297
              L+      DPS R    E+ A 
Sbjct: 243 LYSLMTKCWAYDPSRRPRFTELKAQ 267

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 125/265 (47%), Gaps = 16/265 (6%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           +R  LG+ +G GQFG + +             +I   +  T + VR   L+  +  +   
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 69
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGEL--FHRLEKYGRFSETEARVIFRH-LMQVVSY 156
           HP++V L  V  E   V ++MELC  GEL  F ++ KY    +  + +++ + L   ++Y
Sbjct: 70  HPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAY 126
Query: 157 CHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGS-PF-YIAPEV 214
                 VHRD+   N+L+   SS+  +KL DFGL+ Y++       + G  P  ++APE 
Sbjct: 127 LESKRFVHRDIAARNVLV---SSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 183
Query: 215 LA-GGYNQAADVWSAGVILY-ILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISAS 272
           +    +  A+DVW  GV ++ IL+ G+ PF G   + +   +   + R P  P  +   +
Sbjct: 184 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPP--NCPPT 240
Query: 273 ARDLIMGMLRVDPSTRLTAAEVLAH 297
              L+      DPS R    E+ A 
Sbjct: 241 LYSLMTKCWAYDPSRRPRFTELKAQ 265

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 86/326 (26%), Positives = 134/326 (41%), Gaps = 71/326 (21%)
Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
           RY   K +G G  G++    D      +A K +++         R+ + E+ +M K   H
Sbjct: 19  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLM-KCVNH 76
Query: 101 PNVVDLKAVY------EEEDYVHLLMELCAGG-------ELFHRLEKYGRFSETEARVIF 147
            N++ L  V+      EE   V+L+MEL           EL H    Y          + 
Sbjct: 77  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSY----------LL 126
Query: 148 RHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSP 207
             ++  + + H  G++HRDLKP NI++    S   +K+ DFGLA        +   V + 
Sbjct: 127 YQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTR 183
Query: 208 FYIAPEVLAG-GYNQAADVWSAGVIL------YILLSGM-----------------PPFW 243
           +Y APEV+ G GY +  D+WS G I+       IL  G                  P F 
Sbjct: 184 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 243
Query: 244 GKTKSKIFDAV----RAADLRFPSDPWDHI-----------SASARDLIMGMLRVDPSTR 288
            K +  + + V    + A L FP    D +           ++ ARDL+  ML +DP+ R
Sbjct: 244 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR 303
Query: 289 LTAAEVLAHS----WMEECEQVAQKP 310
           ++  + L H     W +  E  A  P
Sbjct: 304 ISVDDALQHPYINVWYDPAEVEAPPP 329

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 125/265 (47%), Gaps = 16/265 (6%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           +R  LG+ +G GQFG + +             +I   +  T + VR   L+  +  +   
Sbjct: 38  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 97
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGEL--FHRLEKYGRFSETEARVIFRH-LMQVVSY 156
           HP++V L  V  E   V ++MELC  GEL  F ++ KY    +  + +++ + L   ++Y
Sbjct: 98  HPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSL--DLASLILYAYQLSTALAY 154
Query: 157 CHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGS-PF-YIAPEV 214
                 VHRD+   N+L+   SS+  +KL DFGL+ Y++       + G  P  ++APE 
Sbjct: 155 LESKRFVHRDIAARNVLV---SSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 211
Query: 215 LA-GGYNQAADVWSAGVILY-ILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISAS 272
           +    +  A+DVW  GV ++ IL+ G+ PF G   + +   +   + R P  P  +   +
Sbjct: 212 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPP--NCPPT 268
Query: 273 ARDLIMGMLRVDPSTRLTAAEVLAH 297
              L+      DPS R    E+ A 
Sbjct: 269 LYSLMTKCWAYDPSRRPRFTELKAQ 293

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 86/326 (26%), Positives = 134/326 (41%), Gaps = 71/326 (21%)
Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
           RY   K +G G  G++    D      +A K +++         R+ + E+ +M K   H
Sbjct: 18  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLM-KCVNH 75
Query: 101 PNVVDLKAVY------EEEDYVHLLMELCAGG-------ELFHRLEKYGRFSETEARVIF 147
            N++ L  V+      EE   V+L+MEL           EL H    Y          + 
Sbjct: 76  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSY----------LL 125
Query: 148 RHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSP 207
             ++  + + H  G++HRDLKP NI++    S   +K+ DFGLA        +   V + 
Sbjct: 126 YQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTR 182
Query: 208 FYIAPEVLAG-GYNQAADVWSAGVIL------YILLSGM-----------------PPFW 243
           +Y APEV+ G GY +  D+WS G I+       IL  G                  P F 
Sbjct: 183 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242
Query: 244 GKTKSKIFDAV----RAADLRFPSDPWDHI-----------SASARDLIMGMLRVDPSTR 288
            K +  + + V    + A L FP    D +           ++ ARDL+  ML +DP+ R
Sbjct: 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR 302
Query: 289 LTAAEVLAHS----WMEECEQVAQKP 310
           ++  + L H     W +  E  A  P
Sbjct: 303 ISVDDALQHPYINVWYDPAEVEAPPP 328

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 86/326 (26%), Positives = 134/326 (41%), Gaps = 71/326 (21%)
Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
           RY   K +G G  G++    D      +A K +++         R+ + E+ +M K   H
Sbjct: 19  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLM-KCVNH 76
Query: 101 PNVVDLKAVY------EEEDYVHLLMELCAGG-------ELFHRLEKYGRFSETEARVIF 147
            N++ L  V+      EE   V+L+MEL           EL H    Y          + 
Sbjct: 77  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSY----------LL 126
Query: 148 RHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSP 207
             ++  + + H  G++HRDLKP NI++    S   +K+ DFGLA        +   V + 
Sbjct: 127 YQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTR 183
Query: 208 FYIAPEVLAG-GYNQAADVWSAGVIL------YILLSGM-----------------PPFW 243
           +Y APEV+ G GY +  D+WS G I+       IL  G                  P F 
Sbjct: 184 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 243
Query: 244 GKTKSKIFDAV----RAADLRFPSDPWDHI-----------SASARDLIMGMLRVDPSTR 288
            K +  + + V    + A L FP    D +           ++ ARDL+  ML +DP+ R
Sbjct: 244 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR 303
Query: 289 LTAAEVLAHS----WMEECEQVAQKP 310
           ++  + L H     W +  E  A  P
Sbjct: 304 ISVDDALQHPYINVWYDPAEVEAPPP 329

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 126/265 (47%), Gaps = 16/265 (6%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           +R  LG+ +G GQFG + +             +I   +  T + VR   L+  +  +   
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGEL--FHRLEKYGRFSETEARVIFRH-LMQVVSY 156
           HP++V L  V  E + V ++MELC  GEL  F ++ KY    +  + +++ + L   ++Y
Sbjct: 67  HPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAY 123
Query: 157 CHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGS-PF-YIAPEV 214
                 VHRD+   N+L+   SS+  +KL DFGL+ Y++       + G  P  ++APE 
Sbjct: 124 LESKRFVHRDIAARNVLV---SSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 180
Query: 215 LA-GGYNQAADVWSAGVILY-ILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISAS 272
           +    +  A+DVW  GV ++ IL+ G+ PF G   + +   +   + R P  P  +   +
Sbjct: 181 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPP--NCPPT 237
Query: 273 ARDLIMGMLRVDPSTRLTAAEVLAH 297
              L+      DPS R    E+ A 
Sbjct: 238 LYSLMTKCWAYDPSRRPRFTELKAQ 262

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/267 (28%), Positives = 126/267 (47%), Gaps = 20/267 (7%)
Query: 40  DRYVLGKQLGWGQFGVIRE---CSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTK 96
           +R  LG+ +G GQFG + +    S +     +A K+       T + VR   L+  +  +
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN---CTSDSVREKFLQEALTMR 66
Query: 97  LSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR--HLMQVV 154
              HP++V L  V  E + V ++MELC  GEL   L+   +FS   A +I     L   +
Sbjct: 67  QFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQ-VRKFSLDLASLILYAYQLSTAL 124
Query: 155 SYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGS-PF-YIAP 212
           +Y      VHRD+   N+L+   S++  +KL DFGL+ Y++       + G  P  ++AP
Sbjct: 125 AYLESKRFVHRDIAARNVLV---SATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 181
Query: 213 EVLA-GGYNQAADVWSAGVILY-ILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHIS 270
           E +    +  A+DVW  GV ++ IL+ G+ PF G   + +   +   + R P  P  +  
Sbjct: 182 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPP--NCP 238
Query: 271 ASARDLIMGMLRVDPSTRLTAAEVLAH 297
            +   L+      DPS R    E+ A 
Sbjct: 239 PTLYSLMTKCWAYDPSRRPRFTELKAQ 265

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 87/326 (26%), Positives = 134/326 (41%), Gaps = 71/326 (21%)
Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
           RY   K +G G  G++    D      +A K +++         R+ + E+ +M K   H
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLM-KCVNH 82
Query: 101 PNVVDLKAVY------EEEDYVHLLMELCAGG-------ELFHRLEKYGRFSETEARVIF 147
            N++ L  V+      EE   V+++MEL           EL H    Y          + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY----------LL 132
Query: 148 RHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSP 207
             ++  + + H  G++HRDLKP NI++    S   +K+ DFGLA        +   V + 
Sbjct: 133 YQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMEPEVVTR 189
Query: 208 FYIAPEVLAG-GYNQAADVWSAGVIL------YILLSGM-----------------PPFW 243
           +Y APEV+ G GY +  D+WS G I+       IL  G                  P F 
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPAFM 249
Query: 244 GKTKSKIFDAVRA-------------ADLRFPSDP-WDHISAS-ARDLIMGMLRVDPSTR 288
            K +  + + V                D+ FP+D   + + AS ARDL+  ML +D S R
Sbjct: 250 KKLQPTVRNYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 309
Query: 289 LTAAEVLAHS----WMEECEQVAQKP 310
           ++  E L H     W +  E  A  P
Sbjct: 310 ISVDEALQHPYINVWYDPSEAEAPPP 335

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 126/265 (47%), Gaps = 16/265 (6%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           +R  LG+ +G GQFG + +             +I   +  T + VR   L+  +  +   
Sbjct: 15  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGEL--FHRLEKYGRFSETEARVIFRH-LMQVVSY 156
           HP++V L  V  E + V ++MELC  GEL  F ++ KY    +  + +++ + L   ++Y
Sbjct: 75  HPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSL--DLASLILYAYQLSTALAY 131
Query: 157 CHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGS-PF-YIAPEV 214
                 VHRD+   N+L+   SS+  +KL DFGL+ Y++       + G  P  ++APE 
Sbjct: 132 LESKRFVHRDIAARNVLV---SSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 188
Query: 215 LA-GGYNQAADVWSAGVILY-ILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISAS 272
           +    +  A+DVW  GV ++ IL+ G+ PF G   + +   +   + R P  P  +   +
Sbjct: 189 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPP--NCPPT 245
Query: 273 ARDLIMGMLRVDPSTRLTAAEVLAH 297
              L+      DPS R    E+ A 
Sbjct: 246 LYSLMTKCWAYDPSRRPRFTELKAQ 270

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/327 (23%), Positives = 145/327 (44%), Gaps = 47/327 (14%)
Query: 35  ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
           I  + +RY     +G G +G +    D  +G  +A K +++     +   R+ + E+ ++
Sbjct: 46  IWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYR-ELRLL 104
Query: 95  TKLSGHPNVVDLKAVY------EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
             +  H NV+ L  V+      EE + V+L+  L  G +L + + K  + ++   + +  
Sbjct: 105 KHMK-HENVIGLLDVFTPATSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIY 161
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF 208
            +++ + Y H   ++HRDLKP N+ +   +    +K+ DFGLA +      + G V + +
Sbjct: 162 QILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARH--TDDEMTGYVATRW 216
Query: 209 YIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPF---------------WGKTKSKIF 251
           Y APE++     YN   D+WS G I+  LL+G   F                G   + + 
Sbjct: 217 YRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGTPPASVI 276
Query: 252 DAVRAADLR-----FPSDPWDHIS-------ASARDLIMGMLRVDPSTRLTAAEVLAHSW 299
             + + + R      P  P  + +         A DL+  ML +D   R+TA+E LAH +
Sbjct: 277 SRMPSHEARNYINSLPQMPKRNFADVFIGANPLAVDLLEKMLVLDTDKRITASEALAHPY 336
Query: 300 MEECEQVAQKPCKQ---DDLCCKQLEV 323
             +      +P  +        +QLE+
Sbjct: 337 FSQYHDPDDEPESEPYDQSFESRQLEI 363

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 76/299 (25%), Positives = 130/299 (43%), Gaps = 40/299 (13%)
Query: 48  LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLK 107
           +G G +G +    D  TG  +A K + +     +   R+ + E+ ++  +  H NV+ L 
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMR-HENVIGLL 90
Query: 108 AVYEEE----DYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVV 163
            V+  +    D+    + +   G    +L K+ +  E   + +   +++ + Y H  G++
Sbjct: 91  DVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGII 150
Query: 164 HRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG--GYNQ 221
           HRDLKP N+ +   +    +K+ DFGLA   +A   + G V + +Y APEV+     Y Q
Sbjct: 151 HRDLKPGNLAV---NEDCELKILDFGLAR--QADSEMXGXVVTRWYRAPEVILNWMRYTQ 205
Query: 222 AADVWSAGVILYILLSGMPPFWG-------KTKSKIFDAVRAADL-RFPSDP-------- 265
             D+WS G I+  +++G   F G       K   K+     A  + R  SD         
Sbjct: 206 TVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGL 265
Query: 266 -----------WDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKPCKQ 313
                        + S  A +L+  ML +D   R+TA E LAH + E       +P  Q
Sbjct: 266 PELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQ 324

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 77/267 (28%), Positives = 126/267 (47%), Gaps = 20/267 (7%)
Query: 40  DRYVLGKQLGWGQFGVIRE---CSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTK 96
           +R  LG+ +G GQFG + +    S +     +A K+       T + VR   L+  +  +
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN---CTSDSVREKFLQEALTMR 446
Query: 97  LSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR--HLMQVV 154
              HP++V L  V  E + V ++MELC  GEL   L+   +FS   A +I     L   +
Sbjct: 447 QFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQ-VRKFSLDLASLILYAYQLSTAL 504
Query: 155 SYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGS-PF-YIAP 212
           +Y      VHRD+   N+L+   S++  +KL DFGL+ Y++       + G  P  ++AP
Sbjct: 505 AYLESKRFVHRDIAARNVLV---SATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 561
Query: 213 EVLA-GGYNQAADVWSAGVILY-ILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHIS 270
           E +    +  A+DVW  GV ++ IL+ G+ PF G   + +   +   + R P  P  +  
Sbjct: 562 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPP--NCP 618
Query: 271 ASARDLIMGMLRVDPSTRLTAAEVLAH 297
            +   L+      DPS R    E+ A 
Sbjct: 619 PTLYSLMTKCWAYDPSRRPRFTELKAQ 645

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 79/316 (25%), Positives = 138/316 (43%), Gaps = 52/316 (16%)
Query: 35  ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
           I  + +RY     +G G +G +    D  TG  +A K +++     +   R+ + E+ ++
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLL 75
Query: 95  TKLSGHPNVVDLKAVY------EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
             +  H NV+ L  V+      EE + V+L+  L  G +L + + K  + ++   + +  
Sbjct: 76  KHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIY 132
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF 208
            +++ + Y H   ++HRDLKP N+ +   +    +K+  FGLA +      + G V + +
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILGFGLARH--TDDEMTGYVATRW 187
Query: 209 YIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW 266
           Y APE++     YNQ  D+WS G I+  LL+G   F G         +    LR    P 
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI----LRLVGTPG 243
Query: 267 DHI-----SASAR--------------------------DLIMGMLRVDPSTRLTAAEVL 295
             +     S SAR                          DL+  ML +D   R+TAA+ L
Sbjct: 244 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 303
Query: 296 AHSWMEECEQVAQKPC 311
           AH++  +      +P 
Sbjct: 304 AHAYFAQYHDPDDEPV 319

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 77/295 (26%), Positives = 130/295 (44%), Gaps = 42/295 (14%)
Query: 42  YVLGKQLGWGQ----FGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKL 97
           Y + KQ+G G     F V+ E       ++ A K +  +     + + S + EI  + KL
Sbjct: 58  YSILKQIGSGGSSKVFQVLNE-----KKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKL 111
Query: 98  SGHPNVVDLKAVYEEED-YVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSY 156
             H + +     YE  D Y++++ME C   +L   L+K       E +  ++++++ V  
Sbjct: 112 QQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHT 170
Query: 157 CHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPE 213
            H +G+VH DLKP N L+        +KL DFG+A  ++           VG+  Y+ PE
Sbjct: 171 IHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 226
Query: 214 VLAG------------GYNQAADVWSAGVILYILLSGMPPFWG--KTKSKIFDAVRAA-D 258
            +                +  +DVWS G ILY +  G  PF       SK+   +    +
Sbjct: 227 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 286
Query: 259 LRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKPCKQ 313
           + FP  P        +D++   L+ DP  R++  E+LAH ++    Q+   P  Q
Sbjct: 287 IEFPDIP----EKDLQDVLKCCLKRDPKQRISIPELLAHPYV----QIQTHPVNQ 333

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 77/295 (26%), Positives = 130/295 (44%), Gaps = 42/295 (14%)
Query: 42  YVLGKQLGWGQ----FGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKL 97
           Y + KQ+G G     F V+ E       ++ A K +  +     + + S + EI  + KL
Sbjct: 30  YSILKQIGSGGSSKVFQVLNE-----KKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKL 83
Query: 98  SGHPNVVDLKAVYEEED-YVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSY 156
             H + +     YE  D Y++++ME C   +L   L+K       E +  ++++++ V  
Sbjct: 84  QQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHT 142
Query: 157 CHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNL---HGTVGSPFYIAPE 213
            H +G+VH DLKP N L+        +KL DFG+A  ++           VG+  Y+ PE
Sbjct: 143 IHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPE 198
Query: 214 VLAG------------GYNQAADVWSAGVILYILLSGMPPFWGKTK--SKIFDAVRAA-D 258
            +                +  +DVWS G ILY +  G  PF       SK+   +    +
Sbjct: 199 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 258
Query: 259 LRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKPCKQ 313
           + FP  P        +D++   L+ DP  R++  E+LAH ++    Q+   P  Q
Sbjct: 259 IEFPDIP----EKDLQDVLKCCLKRDPKQRISIPELLAHPYV----QIQTHPVNQ 305

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 77/295 (26%), Positives = 130/295 (44%), Gaps = 42/295 (14%)
Query: 42  YVLGKQLGWGQ----FGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKL 97
           Y + KQ+G G     F V+ E       ++ A K +  +     + + S + EI  + KL
Sbjct: 30  YSILKQIGSGGSSKVFQVLNE-----KKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKL 83
Query: 98  SGHPNVVDLKAVYEEED-YVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSY 156
             H + +     YE  D Y++++ME C   +L   L+K       E +  ++++++ V  
Sbjct: 84  QQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHT 142
Query: 157 CHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPE 213
            H +G+VH DLKP N L+        +KL DFG+A  ++           VG+  Y+ PE
Sbjct: 143 IHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 198
Query: 214 VLAG------------GYNQAADVWSAGVILYILLSGMPPFWGKTK--SKIFDAVRAA-D 258
            +                +  +DVWS G ILY +  G  PF       SK+   +    +
Sbjct: 199 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 258
Query: 259 LRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKPCKQ 313
           + FP  P        +D++   L+ DP  R++  E+LAH ++    Q+   P  Q
Sbjct: 259 IEFPDIP----EKDLQDVLKCCLKRDPKQRISIPELLAHPYV----QIQTHPVNQ 305

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 77/295 (26%), Positives = 130/295 (44%), Gaps = 42/295 (14%)
Query: 42  YVLGKQLGWGQ----FGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKL 97
           Y + KQ+G G     F V+ E       ++ A K +  +     + + S + EI  + KL
Sbjct: 11  YSILKQIGSGGSSKVFQVLNE-----KKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKL 64
Query: 98  SGHPNVVDLKAVYEEED-YVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSY 156
             H + +     YE  D Y++++ME C   +L   L+K       E +  ++++++ V  
Sbjct: 65  QQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHT 123
Query: 157 CHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPE 213
            H +G+VH DLKP N L+        +KL DFG+A  ++           VG+  Y+ PE
Sbjct: 124 IHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 179
Query: 214 VLAG------------GYNQAADVWSAGVILYILLSGMPPFWG--KTKSKIFDAVRAA-D 258
            +                +  +DVWS G ILY +  G  PF       SK+   +    +
Sbjct: 180 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 239
Query: 259 LRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKPCKQ 313
           + FP  P        +D++   L+ DP  R++  E+LAH ++    Q+   P  Q
Sbjct: 240 IEFPDIP----EKDLQDVLKCCLKRDPKQRISIPELLAHPYV----QIQTHPVNQ 286

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 77/295 (26%), Positives = 130/295 (44%), Gaps = 42/295 (14%)
Query: 42  YVLGKQLGWGQ----FGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKL 97
           Y + KQ+G G     F V+ E       ++ A K +  +     + + S + EI  + KL
Sbjct: 58  YSILKQIGSGGSSKVFQVLNE-----KKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKL 111
Query: 98  SGHPNVVDLKAVYEEED-YVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSY 156
             H + +     YE  D Y++++ME C   +L   L+K       E +  ++++++ V  
Sbjct: 112 QQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHT 170
Query: 157 CHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPE 213
            H +G+VH DLKP N L+        +KL DFG+A  ++           VG+  Y+ PE
Sbjct: 171 IHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 226
Query: 214 VLAG------------GYNQAADVWSAGVILYILLSGMPPFWG--KTKSKIFDAVRAA-D 258
            +                +  +DVWS G ILY +  G  PF       SK+   +    +
Sbjct: 227 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 286
Query: 259 LRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKPCKQ 313
           + FP  P        +D++   L+ DP  R++  E+LAH ++    Q+   P  Q
Sbjct: 287 IEFPDIP----EKDLQDVLKCCLKRDPKQRISIPELLAHPYV----QIQTHPVNQ 333

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 91/338 (26%), Positives = 140/338 (41%), Gaps = 75/338 (22%)
Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
           RY   K +G G  G++    D      +A K +++         R+ + E+ +M K   H
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLM-KCVNH 82
Query: 101 PNVVDLKAVY------EEEDYVHLLMELCAGG-------ELFHRLEKYGRFSETEARVIF 147
            N++ L  V+      EE   V+++MEL           EL H    Y          + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSY----------LL 132
Query: 148 RHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSP 207
             ++  + + H  G++HRDLKP NI++    S + +K+ DFGLA        +   V + 
Sbjct: 133 YQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDATLKILDFGLARTAGTSFMMTPYVVTR 189
Query: 208 FYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPF--------WGKT-----------K 247
           +Y APEV+ G GY +  D+WS G I+  ++ G   F        W K             
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFM 249
Query: 248 SKIFDAVRA-----------------ADLRFPSDP-WDHISAS-ARDLIMGMLRVDPSTR 288
            K+   VR                   D+ FP+D   + + AS ARDL+  ML +D S R
Sbjct: 250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 309
Query: 289 LTAAEVLAHS----WMEECEQVAQKPCKQDDLCCKQLE 322
           ++  E L H     W +  E  A  P   D    KQL+
Sbjct: 310 ISVDEALQHPYINVWYDPSEAEAPPPKIPD----KQLD 343

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 78/316 (24%), Positives = 136/316 (43%), Gaps = 52/316 (16%)
Query: 35  ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
           I  + +RY     +G G +G +    D  TG  +A K +++     +   R+ + E+ ++
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLL 75
Query: 95  TKLSGHPNVVDLKAVY------EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
             +  H NV+ L  V+      EE + V+L+  L   G   + + K  + ++   + +  
Sbjct: 76  KHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIY 132
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF 208
            +++ + Y H   ++HRDLKP N+ +   +    +K+ D GLA +      + G V + +
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDAGLARH--TDDEMTGYVATRW 187
Query: 209 YIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW 266
           Y APE++     YNQ  D+WS G I+  LL+G   F G         +    LR    P 
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI----LRLVGTPG 243
Query: 267 DHI-----SASAR--------------------------DLIMGMLRVDPSTRLTAAEVL 295
             +     S SAR                          DL+  ML +D   R+TAA+ L
Sbjct: 244 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 303
Query: 296 AHSWMEECEQVAQKPC 311
           AH++  +      +P 
Sbjct: 304 AHAYFAQYHDPDDEPV 319

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 93/329 (28%), Positives = 127/329 (38%), Gaps = 72/329 (21%)
Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKL 97
           LS RY +   LG G FG + EC D   G       I K+     E  RS   EI+++  L
Sbjct: 12  LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARS---EIQVLEHL 68
Query: 98  -SGHPN----VVDLKAVYEEEDYVHLLMELCAGGEL-FHRLEKYGRFSETEARVIFRHLM 151
            +  PN     V +   +E   ++ ++ EL       F +   +  F     R +   + 
Sbjct: 69  NTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQIC 128
Query: 152 QVVSYCHGNGVVHRDLKPENILLATKSSSSP----------------IKLADFGLATYIK 195
           + V++ H N + H DLKPENIL      +                  IK+ DFG ATY  
Sbjct: 129 KSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATY-- 186
Query: 196 AGQNLHGT-VGSPFYIAPEV-LAGGYNQAADVWSAGVIL--YIL-------------LSG 238
                H T V +  Y APEV LA G++Q  DVWS G IL  Y L             L+ 
Sbjct: 187 -DDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAM 245
Query: 239 MPPFWGKTKSKIFDAVRAADLRFPSD--PWDHISASAR---------------------- 274
           M    G     +    R     F  D   WD  S++ R                      
Sbjct: 246 MERILGPLPKHMIQKTRKRKY-FHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHER 304
Query: 275 --DLIMGMLRVDPSTRLTAAEVLAHSWME 301
             DLI  ML  DP+ R+T  E L H + +
Sbjct: 305 LFDLIQKMLEYDPAKRITLREALKHPFFD 333

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 77/295 (26%), Positives = 130/295 (44%), Gaps = 42/295 (14%)
Query: 42  YVLGKQLGWGQ----FGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKL 97
           Y + KQ+G G     F V+ E       ++ A K +  +     + + S + EI  + KL
Sbjct: 58  YSILKQIGSGGSSKVFQVLNE-----KKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKL 111
Query: 98  SGHPNVVDLKAVYEEED-YVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSY 156
             H + +     YE  D Y++++ME C   +L   L+K       E +  ++++++ V  
Sbjct: 112 QQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHT 170
Query: 157 CHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPE 213
            H +G+VH DLKP N L+        +KL DFG+A  ++           VG+  Y+ PE
Sbjct: 171 IHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPE 226
Query: 214 VLAG------------GYNQAADVWSAGVILYILLSGMPPFWG--KTKSKIFDAVRAA-D 258
            +                +  +DVWS G ILY +  G  PF       SK+   +    +
Sbjct: 227 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 286
Query: 259 LRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKPCKQ 313
           + FP  P        +D++   L+ DP  R++  E+LAH ++    Q+   P  Q
Sbjct: 287 IEFPDIP----EKDLQDVLKCCLKRDPKQRISIPELLAHPYV----QIQTHPVNQ 333

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 79/316 (25%), Positives = 138/316 (43%), Gaps = 52/316 (16%)
Query: 35  ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
           I  + +RY     +G G +G +    D  TG  +A K +++     +   R+ + E+ ++
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLL 75
Query: 95  TKLSGHPNVVDLKAVY------EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
             +  H NV+ L  V+      EE + V+L+  L  G +L + + K  + ++   + +  
Sbjct: 76  KHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIY 132
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF 208
            +++ + Y H   ++HRDLKP N+ +   +    +K+ D GLA +      + G V + +
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDRGLARH--TDDEMTGYVATRW 187
Query: 209 YIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW 266
           Y APE++     YNQ  D+WS G I+  LL+G   F G         +    LR    P 
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI----LRLVGTPG 243
Query: 267 DHI-----SASAR--------------------------DLIMGMLRVDPSTRLTAAEVL 295
             +     S SAR                          DL+  ML +D   R+TAA+ L
Sbjct: 244 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 303
Query: 296 AHSWMEECEQVAQKPC 311
           AH++  +      +P 
Sbjct: 304 AHAYFAQYHDPDDEPV 319

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 67/247 (27%), Positives = 111/247 (44%), Gaps = 32/247 (12%)
Query: 86  SIKLEIEIMTKLSGHPNVVDLKAVYEEED-YVHLLMELCAGGELFHRLEKYGRFSETEAR 144
           S + EI  + KL  H + +     YE  D Y++++ME C   +L   L+K       E +
Sbjct: 52  SYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERK 110
Query: 145 VIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN---LH 201
             ++++++ V   H +G+VH DLKP N L+        +KL DFG+A  ++         
Sbjct: 111 SYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKD 166
Query: 202 GTVGSPFYIAPEVLAG------------GYNQAADVWSAGVILYILLSGMPPFWGKTK-- 247
             VG+  Y+ PE +                +  +DVWS G ILY +  G  PF       
Sbjct: 167 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 226
Query: 248 SKIFDAVRAA-DLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQV 306
           SK+   +    ++ FP  P        +D++   L+ DP  R++  E+LAH ++    Q+
Sbjct: 227 SKLHAIIDPNHEIEFPDIP----EKDLQDVLKCCLKRDPKQRISIPELLAHPYV----QI 278
Query: 307 AQKPCKQ 313
              P  Q
Sbjct: 279 QTHPVNQ 285

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 77/295 (26%), Positives = 130/295 (44%), Gaps = 42/295 (14%)
Query: 42  YVLGKQLGWGQ----FGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKL 97
           Y + KQ+G G     F V+ E       ++ A K +  +     + + S + EI  + KL
Sbjct: 14  YSILKQIGSGGSSKVFQVLNE-----KKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKL 67
Query: 98  SGHPNVVDLKAVYEEED-YVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSY 156
             H + +     YE  D Y++++ME C   +L   L+K       E +  ++++++ V  
Sbjct: 68  QQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHT 126
Query: 157 CHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPE 213
            H +G+VH DLKP N L+        +KL DFG+A  ++           VG+  Y+ PE
Sbjct: 127 IHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 182
Query: 214 VLAG------------GYNQAADVWSAGVILYILLSGMPPFWGKTK--SKIFDAVRAA-D 258
            +                +  +DVWS G ILY +  G  PF       SK+   +    +
Sbjct: 183 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 242
Query: 259 LRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKPCKQ 313
           + FP  P        +D++   L+ DP  R++  E+LAH ++    Q+   P  Q
Sbjct: 243 IEFPDIP----EKDLQDVLKCCLKRDPKQRISIPELLAHPYV----QIQTHPVNQ 289

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 78/316 (24%), Positives = 136/316 (43%), Gaps = 52/316 (16%)
Query: 35  ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
           I  + +RY     +G G +G +    D  TG  +A K +++     +   R+ + E+ ++
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLL 75
Query: 95  TKLSGHPNVVDLKAVY------EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
             +  H NV+ L  V+      EE + V+L+  L   G   + + K  + ++   + +  
Sbjct: 76  KHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIY 132
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF 208
            +++ + Y H   ++HRDLKP N+ +   +    +K+ D GLA +      + G V + +
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDGGLARH--TDDEMTGYVATRW 187
Query: 209 YIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW 266
           Y APE++     YNQ  D+WS G I+  LL+G   F G         +    LR    P 
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI----LRLVGTPG 243
Query: 267 DHI-----SASAR--------------------------DLIMGMLRVDPSTRLTAAEVL 295
             +     S SAR                          DL+  ML +D   R+TAA+ L
Sbjct: 244 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 303
Query: 296 AHSWMEECEQVAQKPC 311
           AH++  +      +P 
Sbjct: 304 AHAYFAQYHDPDDEPV 319

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 89/338 (26%), Positives = 138/338 (40%), Gaps = 75/338 (22%)
Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
           RY   K +G G  G++    D      +A K +++         R+ + E+ +M K   H
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLM-KCVNH 82
Query: 101 PNVVDLKAVY------EEEDYVHLLMELCAGG-------ELFHRLEKYGRFSETEARVIF 147
            N++ L  V+      EE   V+++MEL           EL H    Y          + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY----------LL 132
Query: 148 RHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSP 207
             ++  + + H  G++HRDLKP NI++    S   +K+ DFGLA        +   V + 
Sbjct: 133 YQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPEVVTR 189
Query: 208 FYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPF--------WGKT-----------K 247
           +Y APEV+ G GY +  D+WS G I+  ++ G   F        W K             
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 249
Query: 248 SKIFDAVRA-----------------ADLRFPSDPWDHI--SASARDLIMGMLRVDPSTR 288
            K+   VR                   D+ FP+D   +   ++ ARDL+  ML +D S R
Sbjct: 250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNALKASQARDLLSKMLVIDASKR 309
Query: 289 LTAAEVLAHS----WMEECEQVAQKPCKQDDLCCKQLE 322
           ++  E L H     W +  E  A  P   D    KQL+
Sbjct: 310 ISVDEALQHPYINVWYDPSEAEAPPPKIPD----KQLD 343

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 86/318 (27%), Positives = 135/318 (42%), Gaps = 70/318 (22%)
Query: 37  NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTK 96
           +L  RY+  K LG G  G++    D    + +A K I    L   + V+    EI+I+ +
Sbjct: 8   DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV---LTDPQSVKHALREIKIIRR 64
Query: 97  LSGHPNVV---------------------DLKAVYEEEDYVHLLMELCAGGELFHRLEKY 135
           L  H N+V                     +L +VY  ++Y+          +L + LE+ 
Sbjct: 65  LD-HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME--------TDLANVLEQ- 114
Query: 136 GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLAT--- 192
           G   E  AR+    L++ + Y H   V+HRDLKP N+ + T+     +K+ DFGLA    
Sbjct: 115 GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLV--LKIGDFGLARIMD 172
Query: 193 --YIKAGQNLHGTVGSPFYIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGKTKS 248
             Y   G    G V + +Y +P +L     Y +A D+W+AG I   +L+G   F G  + 
Sbjct: 173 PHYSHKGHLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL 231
Query: 249 K----IFDAVRAA------------------DLRFPSDPWDH----ISASARDLIMGMLR 282
           +    I +++                     D+  P  P       IS  A D +  +L 
Sbjct: 232 EQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILT 291
Query: 283 VDPSTRLTAAEVLAHSWM 300
             P  RLTA E L+H +M
Sbjct: 292 FSPMDRLTAEEALSHPYM 309

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 91/338 (26%), Positives = 139/338 (41%), Gaps = 75/338 (22%)
Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
           RY   K +G G  G++    D      +A K +++         R+ + E+ +M K   H
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLM-KCVNH 82
Query: 101 PNVVDLKAVY------EEEDYVHLLMELCAGG-------ELFHRLEKYGRFSETEARVIF 147
            N++ L  V+      EE   V+++MEL           EL H    Y          + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY----------LL 132
Query: 148 RHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSP 207
             ++  + + H  G++HRDLKP NI++    S   +K+ DFGLA        +   V + 
Sbjct: 133 YQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTR 189
Query: 208 FYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPF--------WGKT-----------K 247
           +Y APEV+ G GY +  D+WS G I+  ++ G   F        W K             
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFM 249
Query: 248 SKIFDAVRA-----------------ADLRFPSDP-WDHISAS-ARDLIMGMLRVDPSTR 288
            K+   VR                   D+ FP+D   + + AS ARDL+  ML +D S R
Sbjct: 250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 309
Query: 289 LTAAEVLAHS----WMEECEQVAQKPCKQDDLCCKQLE 322
           ++  E L H     W +  E  A  P   D    KQL+
Sbjct: 310 ISVDEALQHPYINVWYDPSEAEAPPPKIPD----KQLD 343

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 91/338 (26%), Positives = 139/338 (41%), Gaps = 75/338 (22%)
Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
           RY   K +G G  G++    D      +A K +++         R+ + E+ +M K   H
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLM-KCVNH 82
Query: 101 PNVVDLKAVY------EEEDYVHLLMELCAGG-------ELFHRLEKYGRFSETEARVIF 147
            N++ L  V+      EE   V+++MEL           EL H    Y          + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSY----------LL 132
Query: 148 RHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSP 207
             ++  + + H  G++HRDLKP NI++    S   +K+ DFGLA        +   V + 
Sbjct: 133 YQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTR 189
Query: 208 FYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPF--------WGKT-----------K 247
           +Y APEV+ G GY +  D+WS G I+  ++ G   F        W K             
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFM 249
Query: 248 SKIFDAVRA-----------------ADLRFPSDP-WDHISAS-ARDLIMGMLRVDPSTR 288
            K+   VR                   D+ FP+D   + + AS ARDL+  ML +D S R
Sbjct: 250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 309
Query: 289 LTAAEVLAHS----WMEECEQVAQKPCKQDDLCCKQLE 322
           ++  E L H     W +  E  A  P   D    KQL+
Sbjct: 310 ISVDEALQHPYINVWYDPSEAEAPPPKIPD----KQLD 343

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 87/326 (26%), Positives = 134/326 (41%), Gaps = 71/326 (21%)
Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
           RY   K +G G  G++    D      +A K +++         R+ + E+ +M K   H
Sbjct: 26  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLM-KCVNH 83
Query: 101 PNVVDLKAVY------EEEDYVHLLMELCAGG-------ELFHRLEKYGRFSETEARVIF 147
            N++ L  V+      EE   V+++MEL           EL H    Y          + 
Sbjct: 84  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY----------LL 133
Query: 148 RHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSP 207
             ++  + + H  G++HRDLKP NI++    S   +K+ DFGLA        +   V + 
Sbjct: 134 YQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTR 190
Query: 208 FYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPF--------WGKT-----------K 247
           +Y APEV+ G GY +  D+WS G I+  ++ G   F        W K             
Sbjct: 191 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 250
Query: 248 SKIFDAVRA-----------------ADLRFPSDP-WDHISAS-ARDLIMGMLRVDPSTR 288
            K+   VR                   D+ FP+D   + + AS ARDL+  ML +D S R
Sbjct: 251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 310
Query: 289 LTAAEVLAHS----WMEECEQVAQKP 310
           ++  E L H     W +  E  A  P
Sbjct: 311 ISVDEALQHPYINVWYDPSEAEAPPP 336

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 87/326 (26%), Positives = 134/326 (41%), Gaps = 71/326 (21%)
Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
           RY   K +G G  G++    D      +A K +++         R+ + E+ +M K   H
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLM-KCVNH 82
Query: 101 PNVVDLKAVY------EEEDYVHLLMELCAGG-------ELFHRLEKYGRFSETEARVIF 147
            N++ L  V+      EE   V+++MEL           EL H    Y          + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY----------LL 132
Query: 148 RHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSP 207
             ++  + + H  G++HRDLKP NI++    S   +K+ DFGLA        +   V + 
Sbjct: 133 YQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTR 189
Query: 208 FYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPF--------WGKT-----------K 247
           +Y APEV+ G GY +  D+WS G I+  ++ G   F        W K             
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 249
Query: 248 SKIFDAVRA-----------------ADLRFPSDP-WDHISAS-ARDLIMGMLRVDPSTR 288
            K+   VR                   D+ FP+D   + + AS ARDL+  ML +D S R
Sbjct: 250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 309
Query: 289 LTAAEVLAHS----WMEECEQVAQKP 310
           ++  E L H     W +  E  A  P
Sbjct: 310 ISVDEALQHPYINVWYDPSEAEAPPP 335

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 101/213 (47%), Gaps = 16/213 (7%)
Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
           RY + K +G G FG + +  D    + +A K +  ++       R    EI I+  L   
Sbjct: 98  RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFH----RQAAEEIRILEHLRKQ 153
Query: 101 P-----NVVDLKAVYEEEDYVHLLMELCAGG--ELFHRLEKYGRFSETEARVIFRHLMQV 153
                 NV+ +   +   +++ +  EL +    EL  +  K+  FS    R     ++Q 
Sbjct: 154 DKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKK-NKFQGFSLPLVRKFAHSILQC 212
Query: 154 VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPE 213
           +   H N ++H DLKPENILL  +  S  IK+ DFG + Y    Q ++  + S FY APE
Sbjct: 213 LDALHKNRIIHCDLKPENILLKQQGRSG-IKVIDFGSSCY--EHQRVYTXIQSRFYRAPE 269
Query: 214 VLAGG-YNQAADVWSAGVILYILLSGMPPFWGK 245
           V+ G  Y    D+WS G IL  LL+G P   G+
Sbjct: 270 VILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 101/213 (47%), Gaps = 16/213 (7%)
Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
           RY + K +G G FG + +  D    + +A K +  ++       R    EI I+  L   
Sbjct: 98  RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFH----RQAAEEIRILEHLRKQ 153
Query: 101 P-----NVVDLKAVYEEEDYVHLLMELCAGG--ELFHRLEKYGRFSETEARVIFRHLMQV 153
                 NV+ +   +   +++ +  EL +    EL  +  K+  FS    R     ++Q 
Sbjct: 154 DKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKK-NKFQGFSLPLVRKFAHSILQC 212
Query: 154 VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPE 213
           +   H N ++H DLKPENILL  +  S  IK+ DFG + Y    Q ++  + S FY APE
Sbjct: 213 LDALHKNRIIHCDLKPENILLKQQGRSG-IKVIDFGSSCY--EHQRVYTXIQSRFYRAPE 269
Query: 214 VLAGG-YNQAADVWSAGVILYILLSGMPPFWGK 245
           V+ G  Y    D+WS G IL  LL+G P   G+
Sbjct: 270 VILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 101/213 (47%), Gaps = 16/213 (7%)
Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
           RY + K +G G FG + +  D    + +A K +  ++       R    EI I+  L   
Sbjct: 98  RYEVLKVIGKGXFGQVVKAYDHKVHQHVALKMVRNEKRFH----RQAAEEIRILEHLRKQ 153
Query: 101 P-----NVVDLKAVYEEEDYVHLLMELCAGG--ELFHRLEKYGRFSETEARVIFRHLMQV 153
                 NV+ +   +   +++ +  EL +    EL  +  K+  FS    R     ++Q 
Sbjct: 154 DKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKK-NKFQGFSLPLVRKFAHSILQC 212
Query: 154 VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPE 213
           +   H N ++H DLKPENILL  +  S  IK+ DFG + Y    Q ++  + S FY APE
Sbjct: 213 LDALHKNRIIHCDLKPENILLKQQGRSG-IKVIDFGSSCY--EHQRVYXXIQSRFYRAPE 269
Query: 214 VLAGG-YNQAADVWSAGVILYILLSGMPPFWGK 245
           V+ G  Y    D+WS G IL  LL+G P   G+
Sbjct: 270 VILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 87/326 (26%), Positives = 133/326 (40%), Gaps = 71/326 (21%)
Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
           RY   K +G G  G++    D      +A K +++         R+ + E+ +M K   H
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLM-KCVNH 82
Query: 101 PNVVDLKAVY------EEEDYVHLLMELCAGG-------ELFHRLEKYGRFSETEARVIF 147
            N++ L  V+      EE   V+++MEL           EL H    Y          + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY----------LL 132
Query: 148 RHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSP 207
             ++  + + H  G++HRDLKP NI++    S   +K+ DFGLA        +   V + 
Sbjct: 133 YQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMEPEVVTR 189
Query: 208 FYIAPEVLAG-GYNQAADVWSAGVIL------YILLSGM-----------------PPFW 243
           +Y APEV+ G GY +  D+WS G I+       IL  G                  P F 
Sbjct: 190 YYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFM 249
Query: 244 GKTKSKIFDAVRA-------------ADLRFPSDP-WDHISAS-ARDLIMGMLRVDPSTR 288
            K +  +   V                D+ FP+D   + + AS ARDL+  ML +D S R
Sbjct: 250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 309
Query: 289 LTAAEVLAHS----WMEECEQVAQKP 310
           ++  E L H     W +  E  A  P
Sbjct: 310 ISVDEALQHPYINVWYDPSEAEAPPP 335

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 87/326 (26%), Positives = 134/326 (41%), Gaps = 71/326 (21%)
Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
           RY   K +G G  G++    D      +A K +++         R+ + E+ +M K   H
Sbjct: 27  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLM-KCVNH 84
Query: 101 PNVVDLKAVY------EEEDYVHLLMELCAGG-------ELFHRLEKYGRFSETEARVIF 147
            N++ L  V+      EE   V+++MEL           EL H    Y          + 
Sbjct: 85  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY----------LL 134
Query: 148 RHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSP 207
             ++  + + H  G++HRDLKP NI++    S   +K+ DFGLA        +   V + 
Sbjct: 135 YQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMVPFVVTR 191
Query: 208 FYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPF--------WGKT-----------K 247
           +Y APEV+ G GY +  D+WS G I+  ++ G   F        W K             
Sbjct: 192 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 251
Query: 248 SKIFDAVRA-----------------ADLRFPSDP-WDHISAS-ARDLIMGMLRVDPSTR 288
            K+   VR                   D+ FP+D   + + AS ARDL+  ML +D S R
Sbjct: 252 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 311
Query: 289 LTAAEVLAHS----WMEECEQVAQKP 310
           ++  E L H     W +  E  A  P
Sbjct: 312 ISVDEALQHPYINVWYDPSEAEAPPP 337

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 93/329 (28%), Positives = 126/329 (38%), Gaps = 72/329 (21%)
Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKL 97
           LS RY +   LG G FG + EC D   G       I K+     E  RS   EI+++  L
Sbjct: 12  LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARS---EIQVLEHL 68
Query: 98  -SGHPN----VVDLKAVYEEEDYVHLLMELCAGGEL-FHRLEKYGRFSETEARVIFRHLM 151
            +  PN     V +   +E   ++ ++ EL       F +   +  F     R +   + 
Sbjct: 69  NTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQIC 128
Query: 152 QVVSYCHGNGVVHRDLKPENILLATKSSSSP----------------IKLADFGLATYIK 195
           + V++ H N + H DLKPENIL      +                  IK+ DFG ATY  
Sbjct: 129 KSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATY-- 186
Query: 196 AGQNLHGT-VGSPFYIAPEV-LAGGYNQAADVWSAGVIL--YIL-------------LSG 238
                H T V    Y APEV LA G++Q  DVWS G IL  Y L             L+ 
Sbjct: 187 -DDEHHSTLVXXRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAM 245
Query: 239 MPPFWGKTKSKIFDAVRAADLRFPSD--PWDHISASAR---------------------- 274
           M    G     +    R     F  D   WD  S++ R                      
Sbjct: 246 MERILGPLPKHMIQKTRKRKY-FHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHER 304
Query: 275 --DLIMGMLRVDPSTRLTAAEVLAHSWME 301
             DLI  ML  DP+ R+T  E L H + +
Sbjct: 305 LFDLIQKMLEYDPAKRITLREALKHPFFD 333

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 76/292 (26%), Positives = 126/292 (43%), Gaps = 52/292 (17%)
Query: 48  LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVR-SIKLEIEIMTKLSGHPNVVDL 106
           LG G FGV+ E  +K      A K I   RL   E  R  +  E++ + KL  HP +V  
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNYAIKRI---RLPNRELAREKVMREVKALAKLE-HPGIVRY 68
Query: 107 KAVYEEED------------YVHLLMELCAGGELFHRLEKYGRFSETEARV---IFRHLM 151
              + E++            Y+++ M+LC    L   +       E E  V   IF  + 
Sbjct: 69  FNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIA 128
Query: 152 QVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLH---------- 201
           + V + H  G++HRDLKP NI          +K+ DFGL T +   +             
Sbjct: 129 EAVEFLHSKGLMHRDLKPSNIFFTMDDV---VKVGDFGLVTAMDQDEEEQTVLTPMPAYA 185
Query: 202 ---GTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAA 257
              G VG+  Y++PE + G  Y+   D++S G+IL+ LL    PF  + + ++       
Sbjct: 186 RHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME-RVRTLTDVR 241
Query: 258 DLRFP-----SDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECE 304
           +L+FP       P +++      ++  ML   P  R  A  ++ ++  E+ +
Sbjct: 242 NLKFPPLFTQKYPCEYV------MVQDMLSPSPMERPEAINIIENAVFEDLD 287

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 87/326 (26%), Positives = 133/326 (40%), Gaps = 71/326 (21%)
Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
           RY   K +G G  G++    D      +A K +++         R+ + E+ +M K   H
Sbjct: 30  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLM-KCVNH 87
Query: 101 PNVVDLKAVY------EEEDYVHLLMELCAGG-------ELFHRLEKYGRFSETEARVIF 147
            N++ L  V+      EE   V+++MEL           EL H    Y          + 
Sbjct: 88  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY----------LL 137
Query: 148 RHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSP 207
             ++  + + H  G++HRDLKP NI++    S   +K+ DFGLA        +   V + 
Sbjct: 138 YQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTR 194
Query: 208 FYIAPEVLAG-GYNQAADVWSAGVIL------YILLSGM-----------------PPFW 243
           +Y APEV+ G GY +  D+WS G I+       IL  G                  P F 
Sbjct: 195 YYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFM 254
Query: 244 GKTKSKIFDAVRA-------------ADLRFPSDP-WDHISAS-ARDLIMGMLRVDPSTR 288
            K +  +   V                D+ FP+D   + + AS ARDL+  ML +D S R
Sbjct: 255 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 314
Query: 289 LTAAEVLAHS----WMEECEQVAQKP 310
           ++  E L H     W +  E  A  P
Sbjct: 315 ISVDEALQHPYINVWYDPSEAEAPPP 340

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 87/326 (26%), Positives = 133/326 (40%), Gaps = 71/326 (21%)
Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
           RY   K +G G  G++    D      +A K +++         R+ + E+ +M K   H
Sbjct: 19  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLM-KCVNH 76
Query: 101 PNVVDLKAVY------EEEDYVHLLMELCAGG-------ELFHRLEKYGRFSETEARVIF 147
            N++ L  V+      EE   V+++MEL           EL H    Y          + 
Sbjct: 77  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY----------LL 126
Query: 148 RHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSP 207
             ++  + + H  G++HRDLKP NI++    S   +K+ DFGLA        +   V + 
Sbjct: 127 YQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTR 183
Query: 208 FYIAPEVLAG-GYNQAADVWSAGVIL------YILLSGM-----------------PPFW 243
           +Y APEV+ G GY +  D+WS G I+       IL  G                  P F 
Sbjct: 184 YYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFM 243
Query: 244 GKTKSKIFDAVRA-------------ADLRFPSDP-WDHISAS-ARDLIMGMLRVDPSTR 288
            K +  +   V                D+ FP+D   + + AS ARDL+  ML +D S R
Sbjct: 244 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 303
Query: 289 LTAAEVLAHS----WMEECEQVAQKP 310
           ++  E L H     W +  E  A  P
Sbjct: 304 ISVDEALQHPYINVWYDPSEAEAPPP 329

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 94/215 (43%), Gaps = 42/215 (19%)
Query: 135 YGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI 194
           Y   ++ + R     +++ + YCH  G++HRD+KP N+++  +     ++L D+GLA + 
Sbjct: 125 YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRK--LRLIDWGLAEFY 182
Query: 195 KAGQNLHGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFD 252
             GQ  +  V S ++  PE+L     Y+ + D+WS G +L  ++    PF+    +  +D
Sbjct: 183 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN--YD 240
Query: 253 A-VRAADLRFPSDPWDHI-----------------------------------SASARDL 276
             VR A +    D +D+I                                   S  A D 
Sbjct: 241 QLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDF 300
Query: 277 IMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKPC 311
           +  +LR D  +RLTA E + H +     +   +PC
Sbjct: 301 LDKLLRYDHQSRLTAREAMEHPYFYPVVKEQSQPC 335

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 88/342 (25%), Positives = 131/342 (38%), Gaps = 78/342 (22%)
Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVR-SIKLEIEIMTK 96
           L +RY +   LG G FG + +C D   G       I K+    VE  + + +LEI ++ K
Sbjct: 31  LQERYEIVSTLGEGTFGRVVQCVDHRRGGARVALKIIKN----VEKYKEAARLEINVLEK 86
Query: 97  LS-GHPNVVDLKAVYEEEDYVHLLMELCAGGEL-------FHRLEKYGRFSETEARVIFR 148
           ++   P+  +L    +  D+      +C   EL       F +   Y  +   + R +  
Sbjct: 87  INEKDPDNKNL--CVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYPIHQVRHMAF 144
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKS----------------SSSPIKLADFGLAT 192
            L Q V + H N + H DLKPENIL                      S+ +++ DFG AT
Sbjct: 145 QLCQAVKFLHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFGSAT 204
Query: 193 YIKAGQNLHGT-VGSPFYIAPEV-LAGGYNQAADVWSAGVILYILLSGMPPF-------- 242
           +       H T V +  Y APEV L  G++Q  DVWS G I++    G   F        
Sbjct: 205 F---DHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYVGFTLFQTHDNREH 261
Query: 243 -------WGKTKSKIFDAVRAADLRFPSD-PWDHISASAR-------------------- 274
                   G   S++    R     +     WD  +++ R                    
Sbjct: 262 LAMMERILGPIPSRMIRKTRKQKYFYRGRLDWDENTSAGRYVRENCKPLRRYLTSEAEEH 321
Query: 275 ----DLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKPCK 312
               DLI  ML  +P+ RLT  E L H +       A+ P K
Sbjct: 322 HQLFDLIESMLEYEPAKRLTLGEALQHPFFARLR--AEPPNK 361

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 120/262 (45%), Gaps = 25/262 (9%)
Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
            +  +LG GQFG + E   K     +A K++ +D +    +V     E  +M ++  HPN
Sbjct: 14  TMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 68
Query: 103 VVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS---YCHG 159
           +V L  V   E   +++ E    G L   L +  R  E  A V+     Q+ S   Y   
Sbjct: 69  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEK 127
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF---YIAPEVLA 216
              +HRDL   N L+     +  +K+ADFGL+  +  G       G+ F   + APE LA
Sbjct: 128 KNFIHRDLAARNCLVG---ENHLVKVADFGLSR-LMTGDTXTAHAGAKFPIKWTAPESLA 183
Query: 217 GGYNQ---AADVWSAGVILY-ILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISAS 272
             YN+    +DVW+ GV+L+ I   GM P+ G   S++++ +   D R      +     
Sbjct: 184 --YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLE-KDYRMERP--EGCPEK 238
Query: 273 ARDLIMGMLRVDPSTRLTAAEV 294
             +L+    + +PS R + AE+
Sbjct: 239 VYELMRACWQWNPSDRPSFAEI 260

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 13/212 (6%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKL-EIEIMTKLS 98
           + Y+   +LG G +  + +   K T  ++A K I   RL   E      + E+ ++  L 
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI---RLEHEEGAPCTAIREVSLLKDLK 58
Query: 99  GHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRF-SETEARVIFRHLMQVVSYC 157
            H N+V L  +   E  + L+ E     +L   L+  G   +    ++    L++ ++YC
Sbjct: 59  -HANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYC 116
Query: 158 HGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIK-AGQNLHGTVGSPFYIAPEVLA 216
           H   V+HRDLKP+N+L+  +     +KLADFGLA       +     V + +Y  P++L 
Sbjct: 117 HRQKVLHRDLKPQNLLINERGE---LKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILL 173
Query: 217 GG--YNQAADVWSAGVILYILLSGMPPFWGKT 246
           G   Y+   D+W  G I Y + +G P F G T
Sbjct: 174 GSTDYSTQIDMWGVGCIFYEMATGRPLFPGST 205

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 120/262 (45%), Gaps = 25/262 (9%)
Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
            +  +LG GQ+G + E   K     +A K++ +D +    +V     E  +M ++  HPN
Sbjct: 14  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 68
Query: 103 VVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS---YCHG 159
           +V L  V   E   +++ E    G L   L +  R  E  A V+     Q+ S   Y   
Sbjct: 69  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEK 127
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF---YIAPEVLA 216
              +HRDL   N L+     +  +K+ADFGL+  +  G       G+ F   + APE LA
Sbjct: 128 KNFIHRDLAARNCLVG---ENHLVKVADFGLSR-LMTGDTFTAHAGAKFPIKWTAPESLA 183
Query: 217 GGYNQ---AADVWSAGVILY-ILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISAS 272
             YN+    +DVW+ GV+L+ I   GM P+ G   S++++ +   D R      +     
Sbjct: 184 --YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLE-KDYRMERP--EGCPEK 238
Query: 273 ARDLIMGMLRVDPSTRLTAAEV 294
             +L+    + +PS R + AE+
Sbjct: 239 VYELMRACWQWNPSDRPSFAEI 260

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 74/273 (27%), Positives = 122/273 (44%), Gaps = 47/273 (17%)
Query: 3   TNNSEDSSQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDK 62
           T ++   SQ   Q    +  S  T ++        + DRY +   +G G +G + E  DK
Sbjct: 16  TQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDK 75
Query: 63  FTGEVLACKSIAK--DRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVY-----EEEDY 115
               V+A K I +  + L+   D + I  EI I+ +L+ H +VV +  +      E+ D 
Sbjct: 76  LEKRVVAIKKILRVFEDLI---DCKRILREIAILNRLN-HDHVVKVLDIVIPKDVEKFDE 131
Query: 116 VHLLMELCAGGELFHRLEKYGRF-SETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILL 174
           +++++E+      F +L +   + +E   + +  +L+  V Y H  G++HRDLKP N L+
Sbjct: 132 LYVVLEIADSD--FKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLV 189
Query: 175 ATKSSSSPIKLADFGLATYIKAGQN----------------------------LHGTVGS 206
               S   +K+ DFGLA  +   +N                            L G V +
Sbjct: 190 NQDCS---VKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVT 246
Query: 207 PFYIAPE--VLAGGYNQAADVWSAGVILYILLS 237
            +Y APE  +L   Y +A DVWS G I   LL+
Sbjct: 247 RWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 121/262 (46%), Gaps = 25/262 (9%)
Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
            +  +LG GQ+G + E   K     +A K++ +D +    +V     E  +M ++  HPN
Sbjct: 14  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 68
Query: 103 VVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS---YCHG 159
           +V L  V   E   ++++E    G L   L +  R  E  A V+     Q+ S   Y   
Sbjct: 69  LVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEK 127
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF---YIAPEVLA 216
              +HRDL   N L+     +  +K+ADFGL+  +  G       G+ F   + APE LA
Sbjct: 128 KNFIHRDLAARNCLVG---ENHLVKVADFGLSR-LMTGDTXTAHAGAKFPIKWTAPESLA 183
Query: 217 GGYNQ---AADVWSAGVILY-ILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISAS 272
             YN+    +DVW+ GV+L+ I   GM P+ G   S++++ +   D R      +     
Sbjct: 184 --YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLE-KDYRMERP--EGCPEK 238
Query: 273 ARDLIMGMLRVDPSTRLTAAEV 294
             +L+    + +PS R + AE+
Sbjct: 239 VYELMRACWQWNPSDRPSFAEI 260

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 121/262 (46%), Gaps = 25/262 (9%)
Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
            +  +LG GQ+G + E   K     +A K++ +D +    +V     E  +M ++  HPN
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 70
Query: 103 VVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS---YCHG 159
           +V L  V   E   ++++E    G L   L +  R  E  A V+     Q+ S   Y   
Sbjct: 71  LVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEK 129
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF---YIAPEVLA 216
              +HRDL   N L+     +  +K+ADFGL+  +  G       G+ F   + APE LA
Sbjct: 130 KNFIHRDLAARNCLVG---ENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLA 185
Query: 217 GGYNQ---AADVWSAGVILY-ILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISAS 272
             YN+    +DVW+ GV+L+ I   GM P+ G   S++++ +   D R      +     
Sbjct: 186 --YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERP--EGCPEK 240
Query: 273 ARDLIMGMLRVDPSTRLTAAEV 294
             +L+    + +PS R + AE+
Sbjct: 241 VYELMRACWQWNPSDRPSFAEI 262

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/260 (27%), Positives = 120/260 (46%), Gaps = 21/260 (8%)
Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
            +  +LG GQ+G + E   K     +A K++ +D +    +V     E  +M ++  HPN
Sbjct: 21  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 75
Query: 103 VVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS---YCHG 159
           +V L  V   E   ++++E    G L   L +  R  E  A V+     Q+ S   Y   
Sbjct: 76  LVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLEK 134
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF---YIAPEVLA 216
              +HRDL   N L+     +  +K+ADFGL+  +  G       G+ F   + APE LA
Sbjct: 135 KNFIHRDLAARNCLVG---ENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLA 190
Query: 217 -GGYNQAADVWSAGVILY-ILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASAR 274
              ++  +DVW+ GV+L+ I   GM P+ G   S++++ +   D R      +       
Sbjct: 191 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERP--EGCPEKVY 247
Query: 275 DLIMGMLRVDPSTRLTAAEV 294
           +L+    + +PS R + AE+
Sbjct: 248 ELMRACWQWNPSDRPSFAEI 267

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 120/262 (45%), Gaps = 25/262 (9%)
Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
            +  +LG GQ+G + E   K     +A K++ +D +    +V     E  +M ++  HPN
Sbjct: 18  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 72
Query: 103 VVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS---YCHG 159
           +V L  V   E   +++ E    G L   L +  R  E  A V+     Q+ S   Y   
Sbjct: 73  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLEK 131
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF---YIAPEVLA 216
              +HRDL   N L+     +  +K+ADFGL+  +  G       G+ F   + APE LA
Sbjct: 132 KNFIHRDLAARNCLVG---ENHLVKVADFGLSR-LMTGDTYTAPAGAKFPIKWTAPESLA 187
Query: 217 GGYNQ---AADVWSAGVILY-ILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISAS 272
             YN+    +DVW+ GV+L+ I   GM P+ G   S++++ +   D R      +     
Sbjct: 188 --YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERP--EGCPEK 242
Query: 273 ARDLIMGMLRVDPSTRLTAAEV 294
             +L+    + +PS R + AE+
Sbjct: 243 VYELMRACWQWNPSDRPSFAEI 264

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 120/262 (45%), Gaps = 25/262 (9%)
Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
            +  +LG GQ+G + E   K     +A K++ +D +    +V     E  +M ++  HPN
Sbjct: 17  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 71
Query: 103 VVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS---YCHG 159
           +V L  V   E   +++ E    G L   L +  R  E  A V+     Q+ S   Y   
Sbjct: 72  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLEK 130
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF---YIAPEVLA 216
              +HRDL   N L+     +  +K+ADFGL+  +  G       G+ F   + APE LA
Sbjct: 131 KNFIHRDLAARNCLVG---ENHLVKVADFGLSR-LMTGDTYTAPAGAKFPIKWTAPESLA 186
Query: 217 GGYNQ---AADVWSAGVILY-ILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISAS 272
             YN+    +DVW+ GV+L+ I   GM P+ G   S++++ +   D R      +     
Sbjct: 187 --YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERP--EGCPEK 241
Query: 273 ARDLIMGMLRVDPSTRLTAAEV 294
             +L+    + +PS R + AE+
Sbjct: 242 VYELMRACWQWNPSDRPSFAEI 263

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 121/262 (46%), Gaps = 25/262 (9%)
Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
            +  +LG GQ+G + E   K     +A K++ +D +    +V     E  +M ++  HPN
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 70
Query: 103 VVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS---YCHG 159
           +V L  V   E   ++++E    G L   L +  R  E  A V+     Q+ S   Y   
Sbjct: 71  LVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEK 129
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF---YIAPEVLA 216
              +HRDL   N L+     +  +K+ADFGL+  +  G       G+ F   + APE LA
Sbjct: 130 KNFIHRDLAARNCLVG---ENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLA 185
Query: 217 GGYNQ---AADVWSAGVILY-ILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISAS 272
             YN+    +DVW+ GV+L+ I   GM P+ G   S++++ +   D R      +     
Sbjct: 186 --YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERP--EGCPEK 240
Query: 273 ARDLIMGMLRVDPSTRLTAAEV 294
             +L+    + +PS R + AE+
Sbjct: 241 VYELMRACWQWNPSDRPSFAEI 262

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 121/262 (46%), Gaps = 25/262 (9%)
Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
            +  +LG GQ+G + E   K     +A K++ +D +    +V     E  +M ++  HPN
Sbjct: 17  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 71
Query: 103 VVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS---YCHG 159
           +V L  V   E   ++++E    G L   L +  R  E  A V+     Q+ S   Y   
Sbjct: 72  LVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLEK 130
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF---YIAPEVLA 216
              +HRDL   N L+     +  +K+ADFGL+  +  G       G+ F   + APE LA
Sbjct: 131 KNFIHRDLAARNCLVG---ENHLVKVADFGLSR-LMTGDTXTAHAGAKFPIKWTAPESLA 186
Query: 217 GGYNQ---AADVWSAGVILY-ILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISAS 272
             YN+    +DVW+ GV+L+ I   GM P+ G   S++++ +   D R      +     
Sbjct: 187 --YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERP--EGCPEK 241
Query: 273 ARDLIMGMLRVDPSTRLTAAEV 294
             +L+    + +PS R + AE+
Sbjct: 242 VYELMRACWQWNPSDRPSFAEI 263

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 106/208 (50%), Gaps = 17/208 (8%)
Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
            +G+++G G FG + +   K+ G+V A K +      T + +++ K E+ ++ K + H N
Sbjct: 15  TVGQRIGSGSFGTVYK--GKWHGDV-AVKMLNVT-APTPQQLQAFKNEVGVLRK-TRHVN 69
Query: 103 VVDLKAVYEEEDYVHLLMELCAGGELFHRLE-KYGRFSETEARVIFRHLMQVVSYCHGNG 161
           ++ L   Y  +  + ++ + C G  L+H L     +F   +   I R   + + Y H   
Sbjct: 70  IL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS 128
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATY---IKAGQNLHGTVGSPFYIAPEVL--- 215
           ++HRDLK  NI L   ++   +K+ DFGLAT               GS  ++APEV+   
Sbjct: 129 IIHRDLKSNNIFLHEDNT---VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 185
Query: 216 -AGGYNQAADVWSAGVILYILLSGMPPF 242
            +  Y+  +DV++ G++LY L++G  P+
Sbjct: 186 DSNPYSFQSDVYAFGIVLYELMTGQLPY 213

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 104/202 (51%), Gaps = 21/202 (10%)
Query: 48  LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLK 107
           +G G FGV+  C  K+  + +A K I  +      + ++  +E+  +++++ HPN+V L 
Sbjct: 17  VGRGAFGVV--CKAKWRAKDVAIKQIESE-----SERKAFIVELRQLSRVN-HPNIVKLY 68
Query: 108 AVYEEEDYVHLLMELCAGGELF---HRLEKYGRFSETEARVIFRHLMQVVSYCHG---NG 161
                 + V L+ME   GG L+   H  E    ++   A        Q V+Y H      
Sbjct: 69  GACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA 126
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG-GYN 220
           ++HRDLKP N+LL   +  + +K+ DFG A  I+   ++    GS  ++APEV  G  Y+
Sbjct: 127 LIHRDLKPPNLLLV--AGGTVLKICDFGTACDIQT--HMTNNKGSAAWMAPEVFEGSNYS 182
Query: 221 QAADVWSAGVILYILLSGMPPF 242
           +  DV+S G+IL+ +++   PF
Sbjct: 183 EKCDVFSWGIILWEVITRRKPF 204

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 120/262 (45%), Gaps = 25/262 (9%)
Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
            +  +LG GQ+G + E   K     +A K++ +D +    +V     E  +M ++  HPN
Sbjct: 18  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 72
Query: 103 VVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS---YCHG 159
           +V L  V   E   +++ E    G L   L +  R  E  A V+     Q+ S   Y   
Sbjct: 73  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLEK 131
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF---YIAPEVLA 216
              +HRDL   N L+     +  +K+ADFGL+  +  G       G+ F   + APE LA
Sbjct: 132 KNFIHRDLAARNCLVG---ENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLA 187
Query: 217 GGYNQ---AADVWSAGVILY-ILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISAS 272
             YN+    +DVW+ GV+L+ I   GM P+ G   S++++ +   D R      +     
Sbjct: 188 --YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERP--EGCPEK 242
Query: 273 ARDLIMGMLRVDPSTRLTAAEV 294
             +L+    + +PS R + AE+
Sbjct: 243 VYELMRACWQWNPSDRPSFAEI 264

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 120/262 (45%), Gaps = 25/262 (9%)
Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
            +  +LG GQ+G + E   K     +A K++ +D +    +V     E  +M ++  HPN
Sbjct: 29  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 83
Query: 103 VVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS---YCHG 159
           +V L  V   E   +++ E    G L   L +  R  E  A V+     Q+ S   Y   
Sbjct: 84  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLEK 142
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF---YIAPEVLA 216
              +HRDL   N L+     +  +K+ADFGL+  +  G       G+ F   + APE LA
Sbjct: 143 KNFIHRDLAARNCLVG---ENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLA 198
Query: 217 GGYNQ---AADVWSAGVILY-ILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISAS 272
             YN+    +DVW+ GV+L+ I   GM P+ G   S++++ +   D R      +     
Sbjct: 199 --YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERP--EGCPEK 253
Query: 273 ARDLIMGMLRVDPSTRLTAAEV 294
             +L+    + +PS R + AE+
Sbjct: 254 VYELMRACWQWNPSDRPSFAEI 275

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 120/262 (45%), Gaps = 25/262 (9%)
Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
            +  +LG GQ+G + E   K     +A K++ +D +    +V     E  +M ++  HPN
Sbjct: 18  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 72
Query: 103 VVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS---YCHG 159
           +V L  V   E   +++ E    G L   L +  R  E  A V+     Q+ S   Y   
Sbjct: 73  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLEK 131
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF---YIAPEVLA 216
              +HRDL   N L+     +  +K+ADFGL+  +  G       G+ F   + APE LA
Sbjct: 132 KNFIHRDLAARNCLVG---ENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLA 187
Query: 217 GGYNQ---AADVWSAGVILY-ILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISAS 272
             YN+    +DVW+ GV+L+ I   GM P+ G   S++++ +   D R      +     
Sbjct: 188 --YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERP--EGCPEK 242
Query: 273 ARDLIMGMLRVDPSTRLTAAEV 294
             +L+    + +PS R + AE+
Sbjct: 243 VYELMRACWQWNPSDRPSFAEI 264

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/260 (27%), Positives = 119/260 (45%), Gaps = 21/260 (8%)
Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
            +  +LG GQ+G + E   K     +A K++ +D +    +V     E  +M ++  HPN
Sbjct: 21  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 75
Query: 103 VVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS---YCHG 159
           +V L  V   E   +++ E    G L   L +  R  E  A V+     Q+ S   Y   
Sbjct: 76  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLEK 134
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF---YIAPEVLA 216
              +HRDL   N L+     +  +K+ADFGL+  +  G       G+ F   + APE LA
Sbjct: 135 KNFIHRDLAARNCLVG---ENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLA 190
Query: 217 -GGYNQAADVWSAGVILY-ILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASAR 274
              ++  +DVW+ GV+L+ I   GM P+ G   S++++ +   D R      +       
Sbjct: 191 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERP--EGCPEKVY 247
Query: 275 DLIMGMLRVDPSTRLTAAEV 294
           +L+    + +PS R + AE+
Sbjct: 248 ELMRACWQWNPSDRPSFAEI 267

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 106/208 (50%), Gaps = 17/208 (8%)
Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
            +G+++G G FG + +   K+ G+V A K +      T + +++ K E+ ++ K + H N
Sbjct: 27  TVGQRIGSGSFGTVYK--GKWHGDV-AVKMLNVT-APTPQQLQAFKNEVGVLRK-TRHVN 81
Query: 103 VVDLKAVYEEEDYVHLLMELCAGGELFHRLE-KYGRFSETEARVIFRHLMQVVSYCHGNG 161
           ++ L   Y  +  + ++ + C G  L+H L     +F   +   I R   + + Y H   
Sbjct: 82  IL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS 140
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLAT---YIKAGQNLHGTVGSPFYIAPEVL--- 215
           ++HRDLK  NI L   ++   +K+ DFGLAT               GS  ++APEV+   
Sbjct: 141 IIHRDLKSNNIFLHEDNT---VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 216 -AGGYNQAADVWSAGVILYILLSGMPPF 242
            +  Y+  +DV++ G++LY L++G  P+
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLPY 225

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 120/262 (45%), Gaps = 25/262 (9%)
Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
            +  +LG GQ+G + E   K     +A K++ +D +    +V     E  +M ++  HPN
Sbjct: 21  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 75
Query: 103 VVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS---YCHG 159
           +V L  V   E   +++ E    G L   L +  R  E  A V+     Q+ S   Y   
Sbjct: 76  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLEK 134
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF---YIAPEVLA 216
              +HRDL   N L+     +  +K+ADFGL+  +  G       G+ F   + APE LA
Sbjct: 135 KNFIHRDLAARNCLVG---ENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLA 190
Query: 217 GGYNQ---AADVWSAGVILY-ILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISAS 272
             YN+    +DVW+ GV+L+ I   GM P+ G   S++++ +   D R      +     
Sbjct: 191 --YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERP--EGCPEK 245
Query: 273 ARDLIMGMLRVDPSTRLTAAEV 294
             +L+    + +PS R + AE+
Sbjct: 246 VYELMRACWQWNPSDRPSFAEI 267

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/260 (27%), Positives = 119/260 (45%), Gaps = 21/260 (8%)
Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
            +  +LG GQ+G + E   K     +A K++ +D +    +V     E  +M ++  HPN
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 70
Query: 103 VVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS---YCHG 159
           +V L  V   E   +++ E    G L   L +  R  E  A V+     Q+ S   Y   
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLEK 129
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF---YIAPEVLA 216
              +HRDL   N L+     +  +K+ADFGL+  +  G       G+ F   + APE LA
Sbjct: 130 KNFIHRDLAARNCLVG---ENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLA 185
Query: 217 -GGYNQAADVWSAGVILY-ILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASAR 274
              ++  +DVW+ GV+L+ I   GM P+ G   S++++ +   D R      +       
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERP--EGCPEKVY 242
Query: 275 DLIMGMLRVDPSTRLTAAEV 294
           +L+    + +PS R + AE+
Sbjct: 243 ELMRACWQWNPSDRPSFAEI 262

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 104/202 (51%), Gaps = 21/202 (10%)
Query: 48  LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLK 107
           +G G FGV+  C  K+  + +A K I  +      + ++  +E+  +++++ HPN+V L 
Sbjct: 16  VGRGAFGVV--CKAKWRAKDVAIKQIESE-----SERKAFIVELRQLSRVN-HPNIVKLY 67
Query: 108 AVYEEEDYVHLLMELCAGGELF---HRLEKYGRFSETEARVIFRHLMQVVSYCHG---NG 161
                 + V L+ME   GG L+   H  E    ++   A        Q V+Y H      
Sbjct: 68  GACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA 125
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG-GYN 220
           ++HRDLKP N+LL   +  + +K+ DFG A  I+   ++    GS  ++APEV  G  Y+
Sbjct: 126 LIHRDLKPPNLLLV--AGGTVLKICDFGTACDIQT--HMTNNKGSAAWMAPEVFEGSNYS 181
Query: 221 QAADVWSAGVILYILLSGMPPF 242
           +  DV+S G+IL+ +++   PF
Sbjct: 182 EKCDVFSWGIILWEVITRRKPF 203

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 120/262 (45%), Gaps = 25/262 (9%)
Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
            +  +LG GQ+G + E   K     +A K++ +D +    +V     E  +M ++  HPN
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 70
Query: 103 VVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS---YCHG 159
           +V L  V   E   +++ E    G L   L +  R  E  A V+     Q+ S   Y   
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEK 129
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF---YIAPEVLA 216
              +HRDL   N L+     +  +K+ADFGL+  +  G       G+ F   + APE LA
Sbjct: 130 KNFIHRDLAARNCLVG---ENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLA 185
Query: 217 GGYNQ---AADVWSAGVILY-ILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISAS 272
             YN+    +DVW+ GV+L+ I   GM P+ G   S++++ +   D R      +     
Sbjct: 186 --YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERP--EGCPEK 240
Query: 273 ARDLIMGMLRVDPSTRLTAAEV 294
             +L+    + +PS R + AE+
Sbjct: 241 VYELMRACWQWNPSDRPSFAEI 262

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 120/262 (45%), Gaps = 25/262 (9%)
Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
            +  +LG GQ+G + E   K     +A K++ +D +    +V     E  +M ++  HPN
Sbjct: 21  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 75
Query: 103 VVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS---YCHG 159
           +V L  V   E   +++ E    G L   L +  R  E  A V+     Q+ S   Y   
Sbjct: 76  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLEK 134
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF---YIAPEVLA 216
              +HRDL   N L+     +  +K+ADFGL+  +  G       G+ F   + APE LA
Sbjct: 135 KNFIHRDLAARNCLVG---ENHLVKVADFGLSR-LMTGDTXTAHAGAKFPIKWTAPESLA 190
Query: 217 GGYNQ---AADVWSAGVILY-ILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISAS 272
             YN+    +DVW+ GV+L+ I   GM P+ G   S++++ +   D R      +     
Sbjct: 191 --YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERP--EGCPEK 245
Query: 273 ARDLIMGMLRVDPSTRLTAAEV 294
             +L+    + +PS R + AE+
Sbjct: 246 VYELMRACWQWNPSDRPSFAEI 267

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 120/262 (45%), Gaps = 25/262 (9%)
Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
            +  +LG GQ+G + E   K     +A K++ +D +    +V     E  +M ++  HPN
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 70
Query: 103 VVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS---YCHG 159
           +V L  V   E   +++ E    G L   L +  R  E  A V+     Q+ S   Y   
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEK 129
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF---YIAPEVLA 216
              +HRDL   N L+     +  +K+ADFGL+  +  G       G+ F   + APE LA
Sbjct: 130 KNFIHRDLAARNCLVG---ENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLA 185
Query: 217 GGYNQ---AADVWSAGVILY-ILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISAS 272
             YN+    +DVW+ GV+L+ I   GM P+ G   S++++ +   D R      +     
Sbjct: 186 --YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERP--EGCPEK 240
Query: 273 ARDLIMGMLRVDPSTRLTAAEV 294
             +L+    + +PS R + AE+
Sbjct: 241 VYELMRACWQWNPSDRPSFAEI 262

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 120/262 (45%), Gaps = 25/262 (9%)
Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
            +  +LG GQ+G + E   K     +A K++ +D +    +V     E  +M ++  HPN
Sbjct: 20  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 74
Query: 103 VVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS---YCHG 159
           +V L  V   E   +++ E    G L   L +  R  E  A V+     Q+ S   Y   
Sbjct: 75  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLEK 133
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF---YIAPEVLA 216
              +HRDL   N L+     +  +K+ADFGL+  +  G       G+ F   + APE LA
Sbjct: 134 KNFIHRDLAARNCLVG---ENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLA 189
Query: 217 GGYNQ---AADVWSAGVILY-ILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISAS 272
             YN+    +DVW+ GV+L+ I   GM P+ G   S++++ +   D R      +     
Sbjct: 190 --YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERP--EGCPEK 244
Query: 273 ARDLIMGMLRVDPSTRLTAAEV 294
             +L+    + +PS R + AE+
Sbjct: 245 VYELMRACWQWNPSDRPSFAEI 266

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 120/262 (45%), Gaps = 25/262 (9%)
Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
            +  +LG GQ+G + E   K     +A K++ +D +    +V     E  +M ++  HPN
Sbjct: 21  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 75
Query: 103 VVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS---YCHG 159
           +V L  V   E   +++ E    G L   L +  R  E  A V+     Q+ S   Y   
Sbjct: 76  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEK 134
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF---YIAPEVLA 216
              +HRDL   N L+     +  +K+ADFGL+  +  G       G+ F   + APE LA
Sbjct: 135 KNFIHRDLAARNCLVG---ENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLA 190
Query: 217 GGYNQ---AADVWSAGVILY-ILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISAS 272
             YN+    +DVW+ GV+L+ I   GM P+ G   S++++ +   D R      +     
Sbjct: 191 --YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERP--EGCPEK 245
Query: 273 ARDLIMGMLRVDPSTRLTAAEV 294
             +L+    + +PS R + AE+
Sbjct: 246 VYELMRACWQWNPSDRPSFAEI 267

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/259 (27%), Positives = 119/259 (45%), Gaps = 21/259 (8%)
Query: 44  LGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNV 103
           +  +LG GQ+G + E   K     +A K++ +D +    +V     E  +M ++  HPN+
Sbjct: 17  MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPNL 71
Query: 104 VDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS---YCHGN 160
           V L  V   E   +++ E    G L   L +  R  E  A V+     Q+ S   Y    
Sbjct: 72  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLEKK 130
Query: 161 GVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF---YIAPEVLA- 216
             +HRDL   N L+     +  +K+ADFGL+  +  G       G+ F   + APE LA 
Sbjct: 131 NFIHRDLAARNCLVG---ENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAY 186
Query: 217 GGYNQAADVWSAGVILY-ILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARD 275
             ++  +DVW+ GV+L+ I   GM P+ G   S++++ +   D R      +       +
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERP--EGCPEKVYE 243
Query: 276 LIMGMLRVDPSTRLTAAEV 294
           L+    + +PS R + AE+
Sbjct: 244 LMRACWQWNPSDRPSFAEI 262

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 119/264 (45%), Gaps = 33/264 (12%)
Query: 1   MDTNNSEDSSQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECS 60
           +D +  ED +Q   +F             LDAT IS       + K +G G+FG +  CS
Sbjct: 23  VDPHTFEDPTQTVHEFAKE----------LDATNIS-------IDKVVGAGEFGEV--CS 63
Query: 61  DKFTGEVLACKSIAKDRL---VTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVH 117
            +         S+A   L    T +  R    E  IM +   HPN++ L+ V  +   V 
Sbjct: 64  GRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD-HPNIIRLEGVVTKSKPVM 122
Query: 118 LLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLAT 176
           ++ E    G L   L K+  +F+  +   + R +   + Y    G VHRDL   NIL+  
Sbjct: 123 IVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI-- 180
Query: 177 KSSSSPIKLADFGLATYIK----AGQNLHGTVGSPFYIAPEVLA-GGYNQAADVWSAGVI 231
            +S+   K++DFGLA  ++    A     G      + +PE +A   +  A+DVWS G++
Sbjct: 181 -NSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIV 239
Query: 232 LYILLS-GMPPFWGKTKSKIFDAV 254
           L+ ++S G  P+W  +   +  AV
Sbjct: 240 LWEVMSYGERPYWEMSNQDVIKAV 263

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 107/209 (51%), Gaps = 19/209 (9%)
Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
           +L  ++G G FG + +   K+ G+V A K I K    T E  ++ + E+ ++ K + H N
Sbjct: 39  MLSTRIGSGSFGTVYK--GKWHGDV-AVK-ILKVVDPTPEQFQAFRNEVAVLRK-TRHVN 93
Query: 103 VVDLKAVYEEEDYVHLLMELCAGGELFHRLE-KYGRFSETEARVIFRHLMQVVSYCHGNG 161
           ++ L   Y  +D + ++ + C G  L+  L  +  +F   +   I R   Q + Y H   
Sbjct: 94  IL-LFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN 152
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKA----GQNLHGTVGSPFYIAPEVLAG 217
           ++HRD+K  NI L        +K+ DFGLAT +K+     Q +    GS  ++APEV+  
Sbjct: 153 IIHRDMKSNNIFL---HEGLTVKIGDFGLAT-VKSRWSGSQQVEQPTGSVLWMAPEVIRM 208
Query: 218 GYNQA----ADVWSAGVILYILLSGMPPF 242
             N      +DV+S G++LY L++G  P+
Sbjct: 209 QDNNPFSFQSDVYSYGIVLYELMTGELPY 237

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 106/248 (42%), Gaps = 43/248 (17%)
Query: 94  MTKLSGHPNVVDLKAVYEEE--DYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLM 151
           +  L G PN+V L  +  ++      L+ E     + F  L  Y   ++ + R     L+
Sbjct: 79  LQNLXGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTD-FKVL--YPTLTDYDIRYYIYELL 135
Query: 152 QVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIA 211
           + + YCH  G++HRD+KP N+++  +     ++L D+GLA +   G+  +  V S ++  
Sbjct: 136 KALDYCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKG 193
Query: 212 PEVLAG--GYNQAADVWSAGVILYILLSGMPPFW-------------------------G 244
           PE+L     Y+ + D+WS G +   ++    PF+                          
Sbjct: 194 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLN 253
Query: 245 KTKSKIFDAVRAADLRFPSDPW--------DH-ISASARDLIMGMLRVDPSTRLTAAEVL 295
           K + ++   + A   R    PW         H +S  A D +  +LR D   RLTA E +
Sbjct: 254 KYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAM 313
Query: 296 AHSWMEEC 303
            H + ++ 
Sbjct: 314 THPYFQQV 321

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 106/248 (42%), Gaps = 43/248 (17%)
Query: 94  MTKLSGHPNVVDLKAVYEEE--DYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLM 151
           +  L G PN+V L  +  ++      L+ E     + F  L  Y   ++ + R     L+
Sbjct: 79  LQNLXGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTD-FKVL--YPTLTDYDIRYYIYELL 135
Query: 152 QVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIA 211
           + + YCH  G++HRD+KP N+++  +     ++L D+GLA +   G+  +  V S ++  
Sbjct: 136 KALDYCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKG 193
Query: 212 PEVLAG--GYNQAADVWSAGVILYILLSGMPPFW-------------------------G 244
           PE+L     Y+ + D+WS G +   ++    PF+                          
Sbjct: 194 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLN 253
Query: 245 KTKSKIFDAVRAADLRFPSDPW--------DH-ISASARDLIMGMLRVDPSTRLTAAEVL 295
           K + ++   + A   R    PW         H +S  A D +  +LR D   RLTA E +
Sbjct: 254 KYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAM 313
Query: 296 AHSWMEEC 303
            H + ++ 
Sbjct: 314 THPYFQQV 321

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 106/248 (42%), Gaps = 43/248 (17%)
Query: 94  MTKLSGHPNVVDLKAVYEEE--DYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLM 151
           +  L G PN+V L  +  ++      L+ E     + F  L  Y   ++ + R     L+
Sbjct: 79  LQNLXGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTD-FKVL--YPTLTDYDIRYYIYELL 135
Query: 152 QVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIA 211
           + + YCH  G++HRD+KP N+++  +     ++L D+GLA +   G+  +  V S ++  
Sbjct: 136 KALDYCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKG 193
Query: 212 PEVLAG--GYNQAADVWSAGVILYILLSGMPPFW-------------------------G 244
           PE+L     Y+ + D+WS G +   ++    PF+                          
Sbjct: 194 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLN 253
Query: 245 KTKSKIFDAVRAADLRFPSDPW--------DH-ISASARDLIMGMLRVDPSTRLTAAEVL 295
           K + ++   + A   R    PW         H +S  A D +  +LR D   RLTA E +
Sbjct: 254 KYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAM 313
Query: 296 AHSWMEEC 303
            H + ++ 
Sbjct: 314 THPYFQQV 321

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 106/248 (42%), Gaps = 43/248 (17%)
Query: 94  MTKLSGHPNVVDLKAVYEEE--DYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLM 151
           +  L G PN+V L  +  ++      L+ E     + F  L  Y   ++ + R     L+
Sbjct: 80  LQNLXGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTD-FKVL--YPTLTDYDIRYYIYELL 136
Query: 152 QVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIA 211
           + + YCH  G++HRD+KP N+++  +     ++L D+GLA +   G+  +  V S ++  
Sbjct: 137 KALDYCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKG 194
Query: 212 PEVLAG--GYNQAADVWSAGVILYILLSGMPPFW-------------------------G 244
           PE+L     Y+ + D+WS G +   ++    PF+                          
Sbjct: 195 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLN 254
Query: 245 KTKSKIFDAVRAADLRFPSDPW--------DH-ISASARDLIMGMLRVDPSTRLTAAEVL 295
           K + ++   + A   R    PW         H +S  A D +  +LR D   RLTA E +
Sbjct: 255 KYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAM 314
Query: 296 AHSWMEEC 303
            H + ++ 
Sbjct: 315 THPYFQQV 322

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 83/328 (25%), Positives = 117/328 (35%), Gaps = 72/328 (21%)
Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKL 97
           L +RY +   LG G FG + EC D   G+      I ++     E  R   LEI ++ K+
Sbjct: 49  LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAAR---LEINVLKKI 105
Query: 98  SGHPNVVDLKAVYEEEDYVHLLMELCAGGEL-------FHRLEKYGRFSETEARVIFRHL 150
                      V    D+ +    +C   EL       F +   +  +     R +   L
Sbjct: 106 KEKDKENKFLCVLMS-DWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQL 164
Query: 151 MQVVSYCHGNGVVHRDLKPENILLATKS----------------SSSPIKLADFGLATYI 194
              + + H N + H DLKPENIL                      ++ I++ADFG AT+ 
Sbjct: 165 CHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF- 223
Query: 195 KAGQNLHGT-VGSPFYIAPEV-LAGGYNQAADVWSAGVILYILLSG-------------- 238
                 H T V +  Y  PEV L  G+ Q  DVWS G IL+    G              
Sbjct: 224 --DHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLV 281
Query: 239 -MPPFWGKTKSKIFDAVRAADLRFPSD-PWDHISASAR---------------------- 274
            M    G   S +    R     +     WD  S+  R                      
Sbjct: 282 MMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQ 341
Query: 275 --DLIMGMLRVDPSTRLTAAEVLAHSWM 300
             DL+  ML  DP+ R+T AE L H + 
Sbjct: 342 LFDLMRRMLEFDPAQRITLAEALLHPFF 369

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 105/208 (50%), Gaps = 17/208 (8%)
Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
            +G+++G G FG + +   K+ G+V A K +      T + +++ K E+ ++ K + H N
Sbjct: 27  TVGQRIGSGSFGTVYK--GKWHGDV-AVKMLNVT-APTPQQLQAFKNEVGVLRK-TRHVN 81
Query: 103 VVDLKAVYEEEDYVHLLMELCAGGELFHRLE-KYGRFSETEARVIFRHLMQVVSYCHGNG 161
           ++ L   Y     + ++ + C G  L+H L     +F   +   I R   + + Y H   
Sbjct: 82  IL-LFMGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS 140
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLAT---YIKAGQNLHGTVGSPFYIAPEVL--- 215
           ++HRDLK  NI L   ++   +K+ DFGLAT               GS  ++APEV+   
Sbjct: 141 IIHRDLKSNNIFLHEDNT---VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 216 -AGGYNQAADVWSAGVILYILLSGMPPF 242
            +  Y+  +DV++ G++LY L++G  P+
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLPY 225

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 83/328 (25%), Positives = 117/328 (35%), Gaps = 72/328 (21%)
Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKL 97
           L +RY +   LG G FG + EC D   G+      I ++     E  R   LEI ++ K+
Sbjct: 26  LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAAR---LEINVLKKI 82
Query: 98  SGHPNVVDLKAVYEEEDYVHLLMELCAGGEL-------FHRLEKYGRFSETEARVIFRHL 150
                      V    D+ +    +C   EL       F +   +  +     R +   L
Sbjct: 83  KEKDKENKFLCVLMS-DWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQL 141
Query: 151 MQVVSYCHGNGVVHRDLKPENILLATKS----------------SSSPIKLADFGLATYI 194
              + + H N + H DLKPENIL                      ++ I++ADFG AT+ 
Sbjct: 142 CHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF- 200
Query: 195 KAGQNLHGT-VGSPFYIAPEV-LAGGYNQAADVWSAGVILYILLSG-------------- 238
                 H T V +  Y  PEV L  G+ Q  DVWS G IL+    G              
Sbjct: 201 --DHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLV 258
Query: 239 -MPPFWGKTKSKIFDAVRAADLRFPSD-PWDHISASAR---------------------- 274
            M    G   S +    R     +     WD  S+  R                      
Sbjct: 259 MMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQ 318
Query: 275 --DLIMGMLRVDPSTRLTAAEVLAHSWM 300
             DL+  ML  DP+ R+T AE L H + 
Sbjct: 319 LFDLMRRMLEFDPAQRITLAEALLHPFF 346

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 106/248 (42%), Gaps = 43/248 (17%)
Query: 94  MTKLSGHPNVVDLKAVYEEE--DYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLM 151
           +  L G PN+V L  +  ++      L+ E     + F  L  Y   ++ + R     L+
Sbjct: 79  LQNLCGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTD-FKVL--YPTLTDYDIRYYIYELL 135
Query: 152 QVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIA 211
           + + YCH  G++HRD+KP N+++  +     ++L D+GLA +   G+  +  V S ++  
Sbjct: 136 KALDYCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKG 193
Query: 212 PEVLAG--GYNQAADVWSAGVILYILLSGMPPFW-------------------------G 244
           PE+L     Y+ + D+WS G +   ++    PF+                          
Sbjct: 194 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLN 253
Query: 245 KTKSKIFDAVRAADLRFPSDPW--------DH-ISASARDLIMGMLRVDPSTRLTAAEVL 295
           K + ++   + A   R    PW         H +S  A D +  +LR D   RLTA E +
Sbjct: 254 KYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAM 313
Query: 296 AHSWMEEC 303
            H + ++ 
Sbjct: 314 THPYFQQV 321

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 72/225 (32%), Positives = 104/225 (46%), Gaps = 33/225 (14%)
Query: 31  DATQISNLSDRYVLGKQLGWGQFGVIRECS----DKFTGEVLACKSIAKDRLVTVEDVRS 86
           D TQ      +++  +QLG G FG +  C        TGEV+A K +      T E +R 
Sbjct: 6   DPTQFEERHLKFL--RQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRD 60
Query: 87  IKLEIEIMTKLSGHPNVVDLKAV-YEE-EDYVHLLMELCAGGELFHRLEKYGRFSETEAR 144
            + EIEI+  L  H N+V  K V Y      + L+ME    G L   L+K+      + R
Sbjct: 61  FEREIEILKSLQ-HDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKH------KER 113
Query: 145 VIFRHLMQVVS-------YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI--- 194
           +    L+Q  S       Y      +HRDL   NIL+  ++    +K+ DFGL   +   
Sbjct: 114 IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQD 170
Query: 195 KAGQNLHGTVGSP-FYIAPEVLA-GGYNQAADVWSAGVILYILLS 237
           K    +     SP F+ APE L    ++ A+DVWS GV+LY L +
Sbjct: 171 KEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 83/328 (25%), Positives = 117/328 (35%), Gaps = 72/328 (21%)
Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKL 97
           L +RY +   LG G FG + EC D   G+      I ++     E  R   LEI ++ K+
Sbjct: 17  LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAAR---LEINVLKKI 73
Query: 98  SGHPNVVDLKAVYEEEDYVHLLMELCAGGEL-------FHRLEKYGRFSETEARVIFRHL 150
                      V    D+ +    +C   EL       F +   +  +     R +   L
Sbjct: 74  KEKDKENKFLCVLMS-DWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQL 132
Query: 151 MQVVSYCHGNGVVHRDLKPENILLATKS----------------SSSPIKLADFGLATYI 194
              + + H N + H DLKPENIL                      ++ I++ADFG AT+ 
Sbjct: 133 CHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF- 191
Query: 195 KAGQNLHGT-VGSPFYIAPEV-LAGGYNQAADVWSAGVILYILLSG-------------- 238
                 H T V +  Y  PEV L  G+ Q  DVWS G IL+    G              
Sbjct: 192 --DHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLV 249
Query: 239 -MPPFWGKTKSKIFDAVRAADLRFPSD-PWDHISASAR---------------------- 274
            M    G   S +    R     +     WD  S+  R                      
Sbjct: 250 MMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQ 309
Query: 275 --DLIMGMLRVDPSTRLTAAEVLAHSWM 300
             DL+  ML  DP+ R+T AE L H + 
Sbjct: 310 LFDLMRRMLEFDPAQRITLAEALLHPFF 337

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 106/248 (42%), Gaps = 43/248 (17%)
Query: 94  MTKLSGHPNVVDLKAVYEEE--DYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLM 151
           +  L G PN+V L  +  ++      L+ E     + F  L  Y   ++ + R     L+
Sbjct: 80  LQNLCGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTD-FKVL--YPTLTDYDIRYYIYELL 136
Query: 152 QVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIA 211
           + + YCH  G++HRD+KP N+++  +     ++L D+GLA +   G+  +  V S ++  
Sbjct: 137 KALDYCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKG 194
Query: 212 PEVLAG--GYNQAADVWSAGVILYILLSGMPPFW-------------------------G 244
           PE+L     Y+ + D+WS G +   ++    PF+                          
Sbjct: 195 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLN 254
Query: 245 KTKSKIFDAVRAADLRFPSDPW--------DH-ISASARDLIMGMLRVDPSTRLTAAEVL 295
           K + ++   + A   R    PW         H +S  A D +  +LR D   RLTA E +
Sbjct: 255 KYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAM 314
Query: 296 AHSWMEEC 303
            H + ++ 
Sbjct: 315 THPYFQQV 322

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 106/248 (42%), Gaps = 43/248 (17%)
Query: 94  MTKLSGHPNVVDLKAVYEEE--DYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLM 151
           +  L G PN+V L  +  ++      L+ E     + F  L  Y   ++ + R     L+
Sbjct: 79  LQNLCGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTD-FKVL--YPTLTDYDIRYYIYELL 135
Query: 152 QVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIA 211
           + + YCH  G++HRD+KP N+++  +     ++L D+GLA +   G+  +  V S ++  
Sbjct: 136 KALDYCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKG 193
Query: 212 PEVLAG--GYNQAADVWSAGVILYILLSGMPPFW-------------------------G 244
           PE+L     Y+ + D+WS G +   ++    PF+                          
Sbjct: 194 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLN 253
Query: 245 KTKSKIFDAVRAADLRFPSDPW--------DH-ISASARDLIMGMLRVDPSTRLTAAEVL 295
           K + ++   + A   R    PW         H +S  A D +  +LR D   RLTA E +
Sbjct: 254 KYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAM 313
Query: 296 AHSWMEEC 303
            H + ++ 
Sbjct: 314 THPYFQQV 321

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 106/248 (42%), Gaps = 43/248 (17%)
Query: 94  MTKLSGHPNVVDLKAVYEEE--DYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLM 151
           +  L G PN+V L  +  ++      L+ E     + F  L  Y   ++ + R     L+
Sbjct: 81  LQNLCGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTD-FKVL--YPTLTDYDIRYYIYELL 137
Query: 152 QVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIA 211
           + + YCH  G++HRD+KP N+++  +     ++L D+GLA +   G+  +  V S ++  
Sbjct: 138 KALDYCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKG 195
Query: 212 PEVLAG--GYNQAADVWSAGVILYILLSGMPPFW-------------------------G 244
           PE+L     Y+ + D+WS G +   ++    PF+                          
Sbjct: 196 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLN 255
Query: 245 KTKSKIFDAVRAADLRFPSDPW--------DH-ISASARDLIMGMLRVDPSTRLTAAEVL 295
           K + ++   + A   R    PW         H +S  A D +  +LR D   RLTA E +
Sbjct: 256 KYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAM 315
Query: 296 AHSWMEEC 303
            H + ++ 
Sbjct: 316 THPYFQQV 323

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 106/248 (42%), Gaps = 43/248 (17%)
Query: 94  MTKLSGHPNVVDLKAVYEEE--DYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLM 151
           +  L G PN+V L  +  ++      L+ E     + F  L  Y   ++ + R     L+
Sbjct: 79  LQNLMGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTD-FKVL--YPTLTDYDIRYYIYELL 135
Query: 152 QVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIA 211
           + + YCH  G++HRD+KP N+++  +     ++L D+GLA +   G+  +  V S ++  
Sbjct: 136 KALDYCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKG 193
Query: 212 PEVLAG--GYNQAADVWSAGVILYILLSGMPPFW-------------------------G 244
           PE+L     Y+ + D+WS G +   ++    PF+                          
Sbjct: 194 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLN 253
Query: 245 KTKSKIFDAVRAADLRFPSDPW--------DH-ISASARDLIMGMLRVDPSTRLTAAEVL 295
           K + ++   + A   R    PW         H +S  A D +  +LR D   RLTA E +
Sbjct: 254 KYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAM 313
Query: 296 AHSWMEEC 303
            H + ++ 
Sbjct: 314 THPYFQQV 321

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 105/208 (50%), Gaps = 17/208 (8%)
Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
            +G+++G G FG + +   K+ G+V A K +      T + +++ K E+ ++ K + H N
Sbjct: 38  TVGQRIGSGSFGTVYK--GKWHGDV-AVKMLNVT-APTPQQLQAFKNEVGVLRK-TRHVN 92
Query: 103 VVDLKAVYEEEDYVHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNG 161
           ++ L   Y  +  + ++ + C G  L+H L     +F   +   I R   Q + Y H   
Sbjct: 93  IL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS 151
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLH---GTVGSPFYIAPEVL--- 215
           ++HRDLK  NI L    +   +K+ DFGLAT        H      GS  ++APEV+   
Sbjct: 152 IIHRDLKSNNIFLHEDLT---VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 208
Query: 216 -AGGYNQAADVWSAGVILYILLSGMPPF 242
               Y+  +DV++ G++LY L++G  P+
Sbjct: 209 DKNPYSFQSDVYAFGIVLYELMTGQLPY 236

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 104/207 (50%), Gaps = 17/207 (8%)
Query: 44  LGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNV 103
           +G+++G G FG + +   K+ G+V A K +      T + +++ K E+ ++ K + H N+
Sbjct: 17  VGQRIGSGSFGTVYK--GKWHGDV-AVKMLNVT-APTPQQLQAFKNEVGVLRK-TRHVNI 71
Query: 104 VDLKAVYEEEDYVHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGV 162
           + L   Y  +  + ++ + C G  L+H L     +F   +   I R   Q + Y H   +
Sbjct: 72  L-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 130
Query: 163 VHRDLKPENILLATKSSSSPIKLADFGLATY---IKAGQNLHGTVGSPFYIAPEVL---- 215
           +HRDLK  NI L    +   +K+ DFGLAT               GS  ++APEV+    
Sbjct: 131 IHRDLKSNNIFLHEDLT---VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 187
Query: 216 AGGYNQAADVWSAGVILYILLSGMPPF 242
              Y+  +DV++ G++LY L++G  P+
Sbjct: 188 KNPYSFQSDVYAFGIVLYELMTGQLPY 214

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 104/207 (50%), Gaps = 17/207 (8%)
Query: 44  LGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNV 103
           +G+++G G FG + +   K+ G+V A K +      T + +++ K E+ ++ K + H N+
Sbjct: 17  VGQRIGSGSFGTVYK--GKWHGDV-AVKML-NVTAPTPQQLQAFKNEVGVLRK-TRHVNI 71
Query: 104 VDLKAVYEEEDYVHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGV 162
           + L   Y  +  + ++ + C G  L+H L     +F   +   I R   Q + Y H   +
Sbjct: 72  L-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 130
Query: 163 VHRDLKPENILLATKSSSSPIKLADFGLATY---IKAGQNLHGTVGSPFYIAPEVL---- 215
           +HRDLK  NI L    +   +K+ DFGLAT               GS  ++APEV+    
Sbjct: 131 IHRDLKSNNIFLHEDLT---VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 187
Query: 216 AGGYNQAADVWSAGVILYILLSGMPPF 242
              Y+  +DV++ G++LY L++G  P+
Sbjct: 188 KNPYSFQSDVYAFGIVLYELMTGQLPY 214

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 104/207 (50%), Gaps = 17/207 (8%)
Query: 44  LGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNV 103
           +G+++G G FG + +   K+ G+V A K +      T + +++ K E+ ++ K + H N+
Sbjct: 14  VGQRIGSGSFGTVYK--GKWHGDV-AVKMLNVT-APTPQQLQAFKNEVGVLRK-TRHVNI 68
Query: 104 VDLKAVYEEEDYVHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGV 162
           + L   Y  +  + ++ + C G  L+H L     +F   +   I R   Q + Y H   +
Sbjct: 69  L-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 127
Query: 163 VHRDLKPENILLATKSSSSPIKLADFGLATY---IKAGQNLHGTVGSPFYIAPEVL---- 215
           +HRDLK  NI L    +   +K+ DFGLAT               GS  ++APEV+    
Sbjct: 128 IHRDLKSNNIFLHEDLT---VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 184
Query: 216 AGGYNQAADVWSAGVILYILLSGMPPF 242
              Y+  +DV++ G++LY L++G  P+
Sbjct: 185 KNPYSFQSDVYAFGIVLYELMTGQLPY 211

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 104/208 (50%), Gaps = 17/208 (8%)
Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
            +G+++G G FG + +   K+ G+V A K +      T + +++ K E+ ++ K + H N
Sbjct: 31  TVGQRIGSGSFGTVYK--GKWHGDV-AVKMLNVT-APTPQQLQAFKNEVGVLRK-TRHVN 85
Query: 103 VVDLKAVYEEEDYVHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNG 161
           ++ L   Y  +  + ++ + C G  L+H L     +F   +   I R   Q + Y H   
Sbjct: 86  IL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS 144
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLAT---YIKAGQNLHGTVGSPFYIAPEVL--- 215
           ++HRDLK  NI L    +   +K+ DFGLAT               GS  ++APEV+   
Sbjct: 145 IIHRDLKSNNIFLHEDLT---VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 201
Query: 216 -AGGYNQAADVWSAGVILYILLSGMPPF 242
               Y+  +DV++ G++LY L++G  P+
Sbjct: 202 DKNPYSFQSDVYAFGIVLYELMTGQLPY 229

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 104/208 (50%), Gaps = 17/208 (8%)
Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
            +G+++G G FG + +   K+ G+V A K +      T + +++ K E+ ++ K + H N
Sbjct: 39  TVGQRIGSGSFGTVYKG--KWHGDV-AVKMLNVT-APTPQQLQAFKNEVGVLRK-TRHVN 93
Query: 103 VVDLKAVYEEEDYVHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNG 161
           ++ L   Y  +  + ++ + C G  L+H L     +F   +   I R   Q + Y H   
Sbjct: 94  IL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS 152
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLAT---YIKAGQNLHGTVGSPFYIAPEVL--- 215
           ++HRDLK  NI L    +   +K+ DFGLAT               GS  ++APEV+   
Sbjct: 153 IIHRDLKSNNIFLHEDLT---VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 209
Query: 216 -AGGYNQAADVWSAGVILYILLSGMPPF 242
               Y+  +DV++ G++LY L++G  P+
Sbjct: 210 DKNPYSFQSDVYAFGIVLYELMTGQLPY 237

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 104/208 (50%), Gaps = 17/208 (8%)
Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
            +G+++G G FG + +   K+ G+V A K +      T + +++ K E+ ++ K + H N
Sbjct: 39  TVGQRIGSGSFGTVYK--GKWHGDV-AVKMLNVT-APTPQQLQAFKNEVGVLRK-TRHVN 93
Query: 103 VVDLKAVYEEEDYVHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNG 161
           ++ L   Y  +  + ++ + C G  L+H L     +F   +   I R   Q + Y H   
Sbjct: 94  IL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS 152
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATY---IKAGQNLHGTVGSPFYIAPEVL--- 215
           ++HRDLK  NI L    +   +K+ DFGLAT               GS  ++APEV+   
Sbjct: 153 IIHRDLKSNNIFLHEDLT---VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 209
Query: 216 -AGGYNQAADVWSAGVILYILLSGMPPF 242
               Y+  +DV++ G++LY L++G  P+
Sbjct: 210 DKNPYSFQSDVYAFGIVLYELMTGQLPY 237

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 106/248 (42%), Gaps = 43/248 (17%)
Query: 94  MTKLSGHPNVVDLKAVYEEE--DYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLM 151
           +  L G PN+V L  +  ++      L+ E     + F  L  Y   ++ + R     L+
Sbjct: 100 LQNLXGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTD-FKVL--YPTLTDYDIRYYIYELL 156
Query: 152 QVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIA 211
           + + YCH  G++HRD+KP N+++  +     ++L D+GLA +   G+  +  V S ++  
Sbjct: 157 KALDYCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKG 214
Query: 212 PEVLAG--GYNQAADVWSAGVILYILLSGMPPFW-------------------------G 244
           PE+L     Y+ + D+WS G +   ++    PF+                          
Sbjct: 215 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNAYLN 274
Query: 245 KTKSKIFDAVRAADLRFPSDPW--------DH-ISASARDLIMGMLRVDPSTRLTAAEVL 295
           K + ++   + A   R    PW         H +S  A D +  +LR D   RLTA E +
Sbjct: 275 KYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAM 334
Query: 296 AHSWMEEC 303
            H + ++ 
Sbjct: 335 THPYFQQV 342

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 119/264 (45%), Gaps = 33/264 (12%)
Query: 1   MDTNNSEDSSQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECS 60
           +D +  ED +Q   +F             LDAT IS       + K +G G+FG +  CS
Sbjct: 23  VDPHTFEDPTQTVHEFAKE----------LDATNIS-------IDKVVGAGEFGEV--CS 63
Query: 61  DKFTGEVLACKSIAKDRL---VTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVH 117
            +         S+A   L    T +  R    E  IM +   HPN++ L+ V  +   V 
Sbjct: 64  GRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD-HPNIIRLEGVVTKSKPVM 122
Query: 118 LLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLAT 176
           ++ E    G L   L K+  +F+  +   + R +   + Y    G VHRDL   NIL+  
Sbjct: 123 IVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGAVHRDLAARNILI-- 180
Query: 177 KSSSSPIKLADFGLATYIK----AGQNLHGTVGSPFYIAPEVLA-GGYNQAADVWSAGVI 231
            +S+   K++DFGL+  ++    A     G      + +PE +A   +  A+DVWS G++
Sbjct: 181 -NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIV 239
Query: 232 LYILLS-GMPPFWGKTKSKIFDAV 254
           L+ ++S G  P+W  +   +  AV
Sbjct: 240 LWEVMSYGERPYWEMSNQDVIKAV 263

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 75/302 (24%), Positives = 133/302 (44%), Gaps = 53/302 (17%)
Query: 39  SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLS 98
            D Y L ++LG G++  + E  +    E +A K +   +   +      K EI+I+  L 
Sbjct: 36  QDDYQLVRKLGRGKYSEVFEAINITNNEKVAVKILKPVKKKKI------KREIKILENLR 89
Query: 99  GHPNVVDLKAVYEE--EDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSY 156
           G PN++ L  + ++       L+ E     + F +L  Y   ++ + R     +++ + Y
Sbjct: 90  GGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQL--YQTLTDYDIRFYMYEILKALDY 146
Query: 157 CHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLA 216
           CH  G++HRD+KP N+L+  +     ++L D+GLA +   GQ  +  V S ++  PE+L 
Sbjct: 147 CHSMGIMHRDVKPHNVLIDHEHRK--LRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLV 204
Query: 217 GG--YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDA-VRAADLRFPSDPWDHI---- 269
               Y+ + D+WS G +L  ++    PF+    +  +D  VR A +    D +D+I    
Sbjct: 205 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN--YDQLVRIAKVLGTEDLYDYIDKYN 262
Query: 270 -------------------------------SASARDLIMGMLRVDPSTRLTAAEVLAHS 298
                                          S  A D +  +LR D  +RLTA E + H 
Sbjct: 263 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 322
Query: 299 WM 300
           + 
Sbjct: 323 YF 324

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 119/264 (45%), Gaps = 33/264 (12%)
Query: 1   MDTNNSEDSSQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECS 60
           +D +  ED +Q   +F             LDAT IS       + K +G G+FG +  CS
Sbjct: 21  VDPHTYEDPTQTVHEFAKE----------LDATNIS-------IDKVVGAGEFGEV--CS 61
Query: 61  DKFTGEVLACKSIAKDRL---VTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVH 117
            +         S+A   L    T +  R    E  IM +   HPN++ L+ V  +   V 
Sbjct: 62  GRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD-HPNIIRLEGVVTKSKPVM 120
Query: 118 LLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLAT 176
           ++ E    G L   L K+  +F+  +   + R +   + Y    G VHRDL   NIL+  
Sbjct: 121 IVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI-- 178
Query: 177 KSSSSPIKLADFGLATYIK----AGQNLHGTVGSPFYIAPEVLA-GGYNQAADVWSAGVI 231
            +S+   K++DFGL+  ++    A     G      + +PE +A   +  A+DVWS G++
Sbjct: 179 -NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIV 237
Query: 232 LYILLS-GMPPFWGKTKSKIFDAV 254
           L+ ++S G  P+W  +   +  AV
Sbjct: 238 LWEVMSYGERPYWEMSNQDVIKAV 261

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 104/207 (50%), Gaps = 17/207 (8%)
Query: 44  LGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNV 103
           +G+++G G FG + +   K+ G+V A K +      T + +++ K E+ ++ K + H N+
Sbjct: 12  VGQRIGSGSFGTVYK--GKWHGDV-AVKMLNVTA-PTPQQLQAFKNEVGVLRK-TRHVNI 66
Query: 104 VDLKAVYEEEDYVHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGV 162
           + L   Y  +  + ++ + C G  L+H L     +F   +   I R   Q + Y H   +
Sbjct: 67  L-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 125
Query: 163 VHRDLKPENILLATKSSSSPIKLADFGLATY---IKAGQNLHGTVGSPFYIAPEVL---- 215
           +HRDLK  NI L    +   +K+ DFGLAT               GS  ++APEV+    
Sbjct: 126 IHRDLKSNNIFLHEDLT---VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 216 AGGYNQAADVWSAGVILYILLSGMPPF 242
              Y+  +DV++ G++LY L++G  P+
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPY 209

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 119/264 (45%), Gaps = 33/264 (12%)
Query: 1   MDTNNSEDSSQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECS 60
           +D +  ED +Q   +F             LDAT IS       + K +G G+FG +  CS
Sbjct: 23  VDPHTYEDPTQTVHEFAKE----------LDATNIS-------IDKVVGAGEFGEV--CS 63
Query: 61  DKFTGEVLACKSIAKDRL---VTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVH 117
            +         S+A   L    T +  R    E  IM +   HPN++ L+ V  +   V 
Sbjct: 64  GRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD-HPNIIRLEGVVTKSKPVM 122
Query: 118 LLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLAT 176
           ++ E    G L   L K+  +F+  +   + R +   + Y    G VHRDL   NIL+  
Sbjct: 123 IVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI-- 180
Query: 177 KSSSSPIKLADFGLATYIK----AGQNLHGTVGSPFYIAPEVLA-GGYNQAADVWSAGVI 231
            +S+   K++DFGL+  ++    A     G      + +PE +A   +  A+DVWS G++
Sbjct: 181 -NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIV 239
Query: 232 LYILLS-GMPPFWGKTKSKIFDAV 254
           L+ ++S G  P+W  +   +  AV
Sbjct: 240 LWEVMSYGERPYWEMSNQDVIKAV 263

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 119/264 (45%), Gaps = 33/264 (12%)
Query: 1   MDTNNSEDSSQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECS 60
           +D +  ED +Q   +F             LDAT IS       + K +G G+FG +  CS
Sbjct: 23  VDPHTYEDPTQTVHEFAKE----------LDATNIS-------IDKVVGAGEFGEV--CS 63
Query: 61  DKFTGEVLACKSIAKDRL---VTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVH 117
            +         S+A   L    T +  R    E  IM +   HPN++ L+ V  +   V 
Sbjct: 64  GRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD-HPNIIRLEGVVTKSKPVM 122
Query: 118 LLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLAT 176
           ++ E    G L   L K+  +F+  +   + R +   + Y    G VHRDL   NIL+  
Sbjct: 123 IVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI-- 180
Query: 177 KSSSSPIKLADFGLATYIK----AGQNLHGTVGSPFYIAPEVLA-GGYNQAADVWSAGVI 231
            +S+   K++DFGL+  ++    A     G      + +PE +A   +  A+DVWS G++
Sbjct: 181 -NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIV 239
Query: 232 LYILLS-GMPPFWGKTKSKIFDAV 254
           L+ ++S G  P+W  +   +  AV
Sbjct: 240 LWEVMSYGERPYWEMSNQDVIKAV 263

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 119/264 (45%), Gaps = 33/264 (12%)
Query: 1   MDTNNSEDSSQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECS 60
           +D +  ED +Q   +F             LDAT IS       + K +G G+FG +  CS
Sbjct: 23  VDPHTFEDPTQTVHEFAKE----------LDATNIS-------IDKVVGAGEFGEV--CS 63
Query: 61  DKFTGEVLACKSIAKDRL---VTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVH 117
            +         S+A   L    T +  R    E  IM +   HPN++ L+ V  +   V 
Sbjct: 64  GRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD-HPNIIRLEGVVTKSKPVM 122
Query: 118 LLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLAT 176
           ++ E    G L   L K+  +F+  +   + R +   + Y    G VHRDL   NIL+  
Sbjct: 123 IVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGFVHRDLAARNILI-- 180
Query: 177 KSSSSPIKLADFGLATYIK----AGQNLHGTVGSPFYIAPEVLA-GGYNQAADVWSAGVI 231
            +S+   K++DFGL+  ++    A     G      + +PE +A   +  A+DVWS G++
Sbjct: 181 -NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIV 239
Query: 232 LYILLS-GMPPFWGKTKSKIFDAV 254
           L+ ++S G  P+W  +   +  AV
Sbjct: 240 LWEVMSYGERPYWEMSNQDVIKAV 263

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 104/207 (50%), Gaps = 17/207 (8%)
Query: 44  LGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNV 103
           +G+++G G FG + +   K+ G+V A K +      T + +++ K E+ ++ K + H N+
Sbjct: 12  VGQRIGSGSFGTVYK--GKWHGDV-AVKMLNVT-APTPQQLQAFKNEVGVLRK-TRHVNI 66
Query: 104 VDLKAVYEEEDYVHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGV 162
           + L   Y  +  + ++ + C G  L+H L     +F   +   I R   Q + Y H   +
Sbjct: 67  L-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 125
Query: 163 VHRDLKPENILLATKSSSSPIKLADFGLAT---YIKAGQNLHGTVGSPFYIAPEVL---- 215
           +HRDLK  NI L    +   +K+ DFGLAT               GS  ++APEV+    
Sbjct: 126 IHRDLKSNNIFLHEDLT---VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 216 AGGYNQAADVWSAGVILYILLSGMPPF 242
              Y+  +DV++ G++LY L++G  P+
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPY 209

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 119/264 (45%), Gaps = 33/264 (12%)
Query: 1   MDTNNSEDSSQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECS 60
           +D +  ED +Q   +F             LDAT IS       + K +G G+FG +  CS
Sbjct: 23  VDPHTYEDPTQTVHEFAKE----------LDATNIS-------IDKVVGAGEFGEV--CS 63
Query: 61  DKFTGEVLACKSIAKDRL---VTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVH 117
            +         S+A   L    T +  R    E  IM +   HPN++ L+ V  +   V 
Sbjct: 64  GRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD-HPNIIRLEGVVTKSKPVM 122
Query: 118 LLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLAT 176
           ++ E    G L   L K+  +F+  +   + R +   + Y    G VHRDL   NIL+  
Sbjct: 123 IVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI-- 180
Query: 177 KSSSSPIKLADFGLATYIK----AGQNLHGTVGSPFYIAPEVLA-GGYNQAADVWSAGVI 231
            +S+   K++DFGL+  ++    A     G      + +PE +A   +  A+DVWS G++
Sbjct: 181 -NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIV 239
Query: 232 LYILLS-GMPPFWGKTKSKIFDAV 254
           L+ ++S G  P+W  +   +  AV
Sbjct: 240 LWEVMSYGERPYWEMSNQDVIKAV 263

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 119/264 (45%), Gaps = 33/264 (12%)
Query: 1   MDTNNSEDSSQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECS 60
           +D +  ED +Q   +F             LDAT IS       + K +G G+FG +  CS
Sbjct: 23  VDPHTFEDPTQTVHEFAKE----------LDATNIS-------IDKVVGAGEFGEV--CS 63
Query: 61  DKFTGEVLACKSIAKDRL---VTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVH 117
            +         S+A   L    T +  R    E  IM +   HPN++ L+ V  +   V 
Sbjct: 64  GRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD-HPNIIRLEGVVTKSKPVM 122
Query: 118 LLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLAT 176
           ++ E    G L   L K+  +F+  +   + R +   + Y    G VHRDL   NIL+  
Sbjct: 123 IVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI-- 180
Query: 177 KSSSSPIKLADFGLATYIK----AGQNLHGTVGSPFYIAPEVLA-GGYNQAADVWSAGVI 231
            +S+   K++DFGL+  ++    A     G      + +PE +A   +  A+DVWS G++
Sbjct: 181 -NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIV 239
Query: 232 LYILLS-GMPPFWGKTKSKIFDAV 254
           L+ ++S G  P+W  +   +  AV
Sbjct: 240 LWEVMSYGERPYWEMSNQDVIKAV 263

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 119/264 (45%), Gaps = 33/264 (12%)
Query: 1   MDTNNSEDSSQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECS 60
           +D +  ED +Q   +F             LDAT IS       + K +G G+FG +  CS
Sbjct: 23  VDPHTFEDPTQTVHEFAKE----------LDATNIS-------IDKVVGAGEFGEV--CS 63
Query: 61  DKFTGEVLACKSIAKDRL---VTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVH 117
            +         S+A   L    T +  R    E  IM +   HPN++ L+ V  +   V 
Sbjct: 64  GRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD-HPNIIRLEGVVTKSKPVM 122
Query: 118 LLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLAT 176
           ++ E    G L   L K+  +F+  +   + R +   + Y    G VHRDL   NIL+  
Sbjct: 123 IVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI-- 180
Query: 177 KSSSSPIKLADFGLATYIK----AGQNLHGTVGSPFYIAPEVLA-GGYNQAADVWSAGVI 231
            +S+   K++DFGL+  ++    A     G      + +PE +A   +  A+DVWS G++
Sbjct: 181 -NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIV 239
Query: 232 LYILLS-GMPPFWGKTKSKIFDAV 254
           L+ ++S G  P+W  +   +  AV
Sbjct: 240 LWEVMSYGERPYWEMSNQDVIKAV 263

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 78/261 (29%), Positives = 119/261 (45%), Gaps = 18/261 (6%)
Query: 43  VLGKQLGWGQFGVIRE-CSDKFTGEVL--ACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           VL + LG G FG + E       GE +  A K+  KD   T+++      E  IM  L  
Sbjct: 15  VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD--CTLDNKEKFMSEAVIMKNLD- 71
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR-HLMQVVSYCH 158
           HP++V L  + EEE    ++MEL   GEL H LE+     +    V++   + + ++Y  
Sbjct: 72  HPHIVKLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE 130
Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGS-PF-YIAPEVLA 216
               VHRD+   NIL+A   S   +KL DFGL+ YI+       +V   P  +++PE + 
Sbjct: 131 SINCVHRDIAVRNILVA---SPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESIN 187
Query: 217 -GGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASAR 274
              +  A+DVW   V ++ +LS G  PF+      +   +   D R P    D       
Sbjct: 188 FRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGD-RLPKP--DLCPPVLY 244
Query: 275 DLIMGMLRVDPSTRLTAAEVL 295
            L+      DPS R    E++
Sbjct: 245 TLMTRCWDYDPSDRPRFTELV 265

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 78/261 (29%), Positives = 119/261 (45%), Gaps = 18/261 (6%)
Query: 43  VLGKQLGWGQFGVIRE-CSDKFTGEVL--ACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           VL + LG G FG + E       GE +  A K+  KD   T+++      E  IM  L  
Sbjct: 27  VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD--CTLDNKEKFMSEAVIMKNLD- 83
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR-HLMQVVSYCH 158
           HP++V L  + EEE    ++MEL   GEL H LE+     +    V++   + + ++Y  
Sbjct: 84  HPHIVKLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE 142
Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGS-PF-YIAPEVLA 216
               VHRD+   NIL+A   S   +KL DFGL+ YI+       +V   P  +++PE + 
Sbjct: 143 SINCVHRDIAVRNILVA---SPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESIN 199
Query: 217 -GGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASAR 274
              +  A+DVW   V ++ +LS G  PF+      +   +   D R P    D       
Sbjct: 200 FRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGD-RLPKP--DLCPPVLY 256
Query: 275 DLIMGMLRVDPSTRLTAAEVL 295
            L+      DPS R    E++
Sbjct: 257 TLMTRCWDYDPSDRPRFTELV 277

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 118/264 (44%), Gaps = 33/264 (12%)
Query: 1   MDTNNSEDSSQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECS 60
           +D +  ED +Q   +F             LDAT IS       + K +G G+FG +  CS
Sbjct: 23  VDPHTFEDPTQTVHEFAKE----------LDATNIS-------IDKVVGAGEFGEV--CS 63
Query: 61  DKFTGEVLACKSIAKDRL---VTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVH 117
            +         S+A   L    T +  R    E  IM +   HPN++ L+ V  +   V 
Sbjct: 64  GRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD-HPNIIRLEGVVTKSKPVM 122
Query: 118 LLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLAT 176
           ++ E    G L   L K+  +F+  +   + R +   + Y    G VHRDL   NIL+  
Sbjct: 123 IVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI-- 180
Query: 177 KSSSSPIKLADFGLATYIK----AGQNLHGTVGSPFYIAPEVLA-GGYNQAADVWSAGVI 231
            +S+   K++DFGL   ++    A     G      + +PE +A   +  A+DVWS G++
Sbjct: 181 -NSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIV 239
Query: 232 LYILLS-GMPPFWGKTKSKIFDAV 254
           L+ ++S G  P+W  +   +  AV
Sbjct: 240 LWEVMSYGERPYWEMSNQDVIKAV 263

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 103/207 (49%), Gaps = 17/207 (8%)
Query: 44  LGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNV 103
           +G+++G G FG + +   K+ G+V A K +      T + +++ K E+ ++ K + H N+
Sbjct: 12  VGQRIGSGSFGTVYK--GKWHGDV-AVKML-NVTAPTPQQLQAFKNEVGVLRK-TRHVNI 66
Query: 104 VDLKAVYEEEDYVHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGV 162
           + L   Y     + ++ + C G  L+H L     +F   +   I R   Q + Y H   +
Sbjct: 67  L-LFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 125
Query: 163 VHRDLKPENILLATKSSSSPIKLADFGLATY---IKAGQNLHGTVGSPFYIAPEVL---- 215
           +HRDLK  NI L    +   +K+ DFGLAT               GS  ++APEV+    
Sbjct: 126 IHRDLKSNNIFLHEDLT---VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 216 AGGYNQAADVWSAGVILYILLSGMPPF 242
              Y+  +DV++ G++LY L++G  P+
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPY 209

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 78/261 (29%), Positives = 119/261 (45%), Gaps = 18/261 (6%)
Query: 43  VLGKQLGWGQFGVIRE-CSDKFTGEVL--ACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           VL + LG G FG + E       GE +  A K+  KD   T+++      E  IM  L  
Sbjct: 11  VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD--CTLDNKEKFMSEAVIMKNLD- 67
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR-HLMQVVSYCH 158
           HP++V L  + EEE    ++MEL   GEL H LE+     +    V++   + + ++Y  
Sbjct: 68  HPHIVKLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE 126
Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGS-PF-YIAPEVLA 216
               VHRD+   NIL+A   S   +KL DFGL+ YI+       +V   P  +++PE + 
Sbjct: 127 SINCVHRDIAVRNILVA---SPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESIN 183
Query: 217 -GGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASAR 274
              +  A+DVW   V ++ +LS G  PF+      +   +   D R P    D       
Sbjct: 184 FRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGD-RLPKP--DLCPPVLY 240
Query: 275 DLIMGMLRVDPSTRLTAAEVL 295
            L+      DPS R    E++
Sbjct: 241 TLMTRCWDYDPSDRPRFTELV 261

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 42/204 (20%)
Query: 135 YGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI 194
           Y   ++ + R     +++ + YCH  G++HRD+KP N+++  +     ++L D+GLA + 
Sbjct: 125 YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRK--LRLIDWGLAEFY 182
Query: 195 KAGQNLHGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFD 252
             GQ  +  V S ++  PE+L     Y+ + D+WS G +L  ++    PF+    +  +D
Sbjct: 183 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN--YD 240
Query: 253 A-VRAADLRFPSDPWDHI-----------------------------------SASARDL 276
             VR A +    D +D+I                                   S  A D 
Sbjct: 241 QLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDF 300
Query: 277 IMGMLRVDPSTRLTAAEVLAHSWM 300
           +  +LR D  +RLTA E + H + 
Sbjct: 301 LDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 42/204 (20%)
Query: 135 YGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI 194
           Y   ++ + R     +++ + YCH  G++HRD+KP N+++  +     ++L D+GLA + 
Sbjct: 124 YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRK--LRLIDWGLAEFY 181
Query: 195 KAGQNLHGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFD 252
             GQ  +  V S ++  PE+L     Y+ + D+WS G +L  ++    PF+    +  +D
Sbjct: 182 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN--YD 239
Query: 253 A-VRAADLRFPSDPWDHI-----------------------------------SASARDL 276
             VR A +    D +D+I                                   S  A D 
Sbjct: 240 QLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDF 299
Query: 277 IMGMLRVDPSTRLTAAEVLAHSWM 300
           +  +LR D  +RLTA E + H + 
Sbjct: 300 LDKLLRYDHQSRLTAREAMEHPYF 323

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 42/204 (20%)
Query: 135 YGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI 194
           Y   ++ + R     +++ + YCH  G++HRD+KP N+++  +     ++L D+GLA + 
Sbjct: 125 YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRK--LRLIDWGLAEFY 182
Query: 195 KAGQNLHGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFD 252
             GQ  +  V S ++  PE+L     Y+ + D+WS G +L  ++    PF+    +  +D
Sbjct: 183 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN--YD 240
Query: 253 A-VRAADLRFPSDPWDHI-----------------------------------SASARDL 276
             VR A +    D +D+I                                   S  A D 
Sbjct: 241 QLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDF 300
Query: 277 IMGMLRVDPSTRLTAAEVLAHSWM 300
           +  +LR D  +RLTA E + H + 
Sbjct: 301 LDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 42/204 (20%)
Query: 135 YGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI 194
           Y   ++ + R     +++ + YCH  G++HRD+KP N+++  +     ++L D+GLA + 
Sbjct: 125 YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRK--LRLIDWGLAEFY 182
Query: 195 KAGQNLHGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFD 252
             GQ  +  V S ++  PE+L     Y+ + D+WS G +L  ++    PF+    +  +D
Sbjct: 183 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN--YD 240
Query: 253 A-VRAADLRFPSDPWDHI-----------------------------------SASARDL 276
             VR A +    D +D+I                                   S  A D 
Sbjct: 241 QLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDF 300
Query: 277 IMGMLRVDPSTRLTAAEVLAHSWM 300
           +  +LR D  +RLTA E + H + 
Sbjct: 301 LDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 72/225 (32%), Positives = 104/225 (46%), Gaps = 33/225 (14%)
Query: 31  DATQISNLSDRYVLGKQLGWGQFGVIRECS----DKFTGEVLACKSIAKDRLVTVEDVRS 86
           D TQ      +++  +QLG G FG +  C        TGEV+A K +      T E +R 
Sbjct: 34  DPTQFEERHLKFL--QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRD 88
Query: 87  IKLEIEIMTKLSGHPNVVDLKAV-YEE-EDYVHLLMELCAGGELFHRLEKYGRFSETEAR 144
            + EIEI+  L  H N+V  K V Y      + L+ME    G L   L+K+      + R
Sbjct: 89  FEREIEILKSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH------KER 141
Query: 145 VIFRHLMQVVS-------YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI--- 194
           +    L+Q  S       Y      +HRDL   NIL+  ++    +K+ DFGL   +   
Sbjct: 142 IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQD 198
Query: 195 KAGQNLHGTVGSP-FYIAPEVLA-GGYNQAADVWSAGVILYILLS 237
           K    +     SP F+ APE L    ++ A+DVWS GV+LY L +
Sbjct: 199 KEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 42/204 (20%)
Query: 135 YGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI 194
           Y   ++ + R     +++ + YCH  G++HRD+KP N+++  +     ++L D+GLA + 
Sbjct: 123 YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRK--LRLIDWGLAEFY 180
Query: 195 KAGQNLHGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFD 252
             GQ  +  V S ++  PE+L     Y+ + D+WS G +L  ++    PF+    +  +D
Sbjct: 181 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN--YD 238
Query: 253 A-VRAADLRFPSDPWDHI-----------------------------------SASARDL 276
             VR A +    D +D+I                                   S  A D 
Sbjct: 239 QLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDF 298
Query: 277 IMGMLRVDPSTRLTAAEVLAHSWM 300
           +  +LR D  +RLTA E + H + 
Sbjct: 299 LDKLLRYDHQSRLTAREAMEHPYF 322

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 72/225 (32%), Positives = 104/225 (46%), Gaps = 33/225 (14%)
Query: 31  DATQISNLSDRYVLGKQLGWGQFGVIRECS----DKFTGEVLACKSIAKDRLVTVEDVRS 86
           D TQ      +++  +QLG G FG +  C        TGEV+A K +      T E +R 
Sbjct: 6   DPTQFEERHLKFL--QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRD 60
Query: 87  IKLEIEIMTKLSGHPNVVDLKAV-YEE-EDYVHLLMELCAGGELFHRLEKYGRFSETEAR 144
            + EIEI+  L  H N+V  K V Y      + L+ME    G L   L+K+      + R
Sbjct: 61  FEREIEILKSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH------KER 113
Query: 145 VIFRHLMQVVS-------YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI--- 194
           +    L+Q  S       Y      +HRDL   NIL+  ++    +K+ DFGL   +   
Sbjct: 114 IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQD 170
Query: 195 KAGQNLHGTVGSP-FYIAPEVLA-GGYNQAADVWSAGVILYILLS 237
           K    +     SP F+ APE L    ++ A+DVWS GV+LY L +
Sbjct: 171 KEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 119/264 (45%), Gaps = 37/264 (14%)
Query: 47  QLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEI---EIMTKLSG--HP 101
           +LG G FG +    DK TG   A              V+ ++LE+   E +   +G   P
Sbjct: 81  RLGRGSFGEVHRMEDKQTGFQCA--------------VKKVRLEVFRAEELMACAGLTSP 126
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
            +V L     E  +V++ MEL  GG L   +++ G   E  A       ++ + Y H   
Sbjct: 127 RIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRR 186
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKA---GQNL---HGTVGSPFYIAPEVL 215
           ++H D+K +N+LL++  S +   L DFG A  ++    G++L       G+  ++APEV+
Sbjct: 187 ILHGDVKADNVLLSSDGSHA--ALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVV 244
Query: 216 AGGYNQA-ADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASAR 274
            G    A  DVWS+  ++  +L+G  P+     ++ F       +     P   I  S  
Sbjct: 245 LGRSCDAKVDVWSSCCMMLHMLNGCHPW-----TQFFRGPLCLKIASEPPPVREIPPSCA 299
Query: 275 DL----IMGMLRVDPSTRLTAAEV 294
            L    I   LR +P  R++AAE+
Sbjct: 300 PLTAQAIQEGLRKEPIHRVSAAEL 323

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 120/262 (45%), Gaps = 25/262 (9%)
Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
            +  +LG GQ+G + E   K     +A K++ +D +    +V     E  +M ++  HPN
Sbjct: 223 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 277
Query: 103 VVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS---YCHG 159
           +V L  V   E   +++ E    G L   L +  R  E  A V+     Q+ S   Y   
Sbjct: 278 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEK 336
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF---YIAPEVLA 216
              +HR+L   N L+     +  +K+ADFGL+  +  G       G+ F   + APE LA
Sbjct: 337 KNFIHRNLAARNCLVG---ENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLA 392
Query: 217 GGYNQ---AADVWSAGVILY-ILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISAS 272
             YN+    +DVW+ GV+L+ I   GM P+ G   S++++ +   D R      +     
Sbjct: 393 --YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERP--EGCPEK 447
Query: 273 ARDLIMGMLRVDPSTRLTAAEV 294
             +L+    + +PS R + AE+
Sbjct: 448 VYELMRACWQWNPSDRPSFAEI 469

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 71/226 (31%), Positives = 103/226 (45%), Gaps = 35/226 (15%)
Query: 31  DATQISNLSDRYVLGKQLGWGQFGVIRECS----DKFTGEVLACKSIAKDRLVTVEDVRS 86
           D TQ      +++  +QLG G FG +  C        TGEV+A K +      T E +R 
Sbjct: 3   DPTQFEERHLKFL--QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRD 57
Query: 87  IKLEIEIMTKLSGHPNVVDLKAV-YEE-EDYVHLLMELCAGGELFHRLEKYGRFSETEAR 144
            + EIEI+  L  H N+V  K V Y      + L+ME    G L   L+K+      + R
Sbjct: 58  FEREIEILKSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH------KER 110
Query: 145 VIFRHLMQVVS-------YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG 197
           +    L+Q  S       Y      +HRDL   NIL+  ++    +K+ DFGL   +   
Sbjct: 111 IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQD 167
Query: 198 QNLHGTVGSP-----FYIAPEVLA-GGYNQAADVWSAGVILYILLS 237
           +     V  P     F+ APE L    ++ A+DVWS GV+LY L +
Sbjct: 168 KEFF-KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 42/204 (20%)
Query: 135 YGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI 194
           Y   ++ + R     +++ + YCH  G++HRD+KP N+++  +     ++L D+GLA + 
Sbjct: 125 YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRK--LRLIDWGLAEFY 182
Query: 195 KAGQNLHGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFD 252
             GQ  +  V S ++  PE+L     Y+ + D+WS G +L  ++    PF+    +  +D
Sbjct: 183 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN--YD 240
Query: 253 A-VRAADLRFPSDPWDHI-----------------------------------SASARDL 276
             VR A +    D +D+I                                   S  A D 
Sbjct: 241 QLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDF 300
Query: 277 IMGMLRVDPSTRLTAAEVLAHSWM 300
           +  +LR D  +RLTA E + H + 
Sbjct: 301 LDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 120/262 (45%), Gaps = 25/262 (9%)
Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
            +  +LG GQ+G + E   K     +A K++ +D +    +V     E  +M ++  HPN
Sbjct: 262 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 316
Query: 103 VVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS---YCHG 159
           +V L  V   E   +++ E    G L   L +  R  E  A V+     Q+ S   Y   
Sbjct: 317 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLEK 375
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF---YIAPEVLA 216
              +HR+L   N L+     +  +K+ADFGL+  +  G       G+ F   + APE LA
Sbjct: 376 KNFIHRNLAARNCLVG---ENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLA 431
Query: 217 GGYNQ---AADVWSAGVILY-ILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISAS 272
             YN+    +DVW+ GV+L+ I   GM P+ G   S++++ +   D R      +     
Sbjct: 432 --YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERP--EGCPEK 486
Query: 273 ARDLIMGMLRVDPSTRLTAAEV 294
             +L+    + +PS R + AE+
Sbjct: 487 VYELMRACWQWNPSDRPSFAEI 508

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 42/204 (20%)
Query: 135 YGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI 194
           Y   ++ + R     +++ + YCH  G++HRD+KP N+++  +     ++L D+GLA + 
Sbjct: 125 YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRK--LRLIDWGLAEFY 182
Query: 195 KAGQNLHGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFD 252
             GQ  +  V S ++  PE+L     Y+ + D+WS G +L  ++    PF+    +  +D
Sbjct: 183 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN--YD 240
Query: 253 A-VRAADLRFPSDPWDHI-----------------------------------SASARDL 276
             VR A +    D +D+I                                   S  A D 
Sbjct: 241 QLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDF 300
Query: 277 IMGMLRVDPSTRLTAAEVLAHSWM 300
           +  +LR D  +RLTA E + H + 
Sbjct: 301 LDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 72/225 (32%), Positives = 104/225 (46%), Gaps = 33/225 (14%)
Query: 31  DATQISNLSDRYVLGKQLGWGQFGVIRECS----DKFTGEVLACKSIAKDRLVTVEDVRS 86
           D TQ      +++  +QLG G FG +  C        TGEV+A K +      T E +R 
Sbjct: 10  DPTQFEERHLKFL--QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRD 64
Query: 87  IKLEIEIMTKLSGHPNVVDLKAV-YEE-EDYVHLLMELCAGGELFHRLEKYGRFSETEAR 144
            + EIEI+  L  H N+V  K V Y      + L+ME    G L   L+K+      + R
Sbjct: 65  FEREIEILKSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH------KER 117
Query: 145 VIFRHLMQVVS-------YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI--- 194
           +    L+Q  S       Y      +HRDL   NIL+  ++    +K+ DFGL   +   
Sbjct: 118 IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQD 174
Query: 195 KAGQNLHGTVGSP-FYIAPEVLA-GGYNQAADVWSAGVILYILLS 237
           K    +     SP F+ APE L    ++ A+DVWS GV+LY L +
Sbjct: 175 KEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 72/225 (32%), Positives = 104/225 (46%), Gaps = 33/225 (14%)
Query: 31  DATQISNLSDRYVLGKQLGWGQFGVIRECS----DKFTGEVLACKSIAKDRLVTVEDVRS 86
           D TQ      +++  +QLG G FG +  C        TGEV+A K +      T E +R 
Sbjct: 9   DPTQFEERHLKFL--QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRD 63
Query: 87  IKLEIEIMTKLSGHPNVVDLKAV-YEE-EDYVHLLMELCAGGELFHRLEKYGRFSETEAR 144
            + EIEI+  L  H N+V  K V Y      + L+ME    G L   L+K+      + R
Sbjct: 64  FEREIEILKSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH------KER 116
Query: 145 VIFRHLMQVVS-------YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI--- 194
           +    L+Q  S       Y      +HRDL   NIL+  ++    +K+ DFGL   +   
Sbjct: 117 IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQD 173
Query: 195 KAGQNLHGTVGSP-FYIAPEVLA-GGYNQAADVWSAGVILYILLS 237
           K    +     SP F+ APE L    ++ A+DVWS GV+LY L +
Sbjct: 174 KEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 72/225 (32%), Positives = 104/225 (46%), Gaps = 33/225 (14%)
Query: 31  DATQISNLSDRYVLGKQLGWGQFGVIRECS----DKFTGEVLACKSIAKDRLVTVEDVRS 86
           D TQ      +++  +QLG G FG +  C        TGEV+A K +      T E +R 
Sbjct: 3   DPTQFEERHLKFL--QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRD 57
Query: 87  IKLEIEIMTKLSGHPNVVDLKAV-YEE-EDYVHLLMELCAGGELFHRLEKYGRFSETEAR 144
            + EIEI+  L  H N+V  K V Y      + L+ME    G L   L+K+      + R
Sbjct: 58  FEREIEILKSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH------KER 110
Query: 145 VIFRHLMQVVS-------YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI--- 194
           +    L+Q  S       Y      +HRDL   NIL+  ++    +K+ DFGL   +   
Sbjct: 111 IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQD 167
Query: 195 KAGQNLHGTVGSP-FYIAPEVLA-GGYNQAADVWSAGVILYILLS 237
           K    +     SP F+ APE L    ++ A+DVWS GV+LY L +
Sbjct: 168 KEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 42/204 (20%)
Query: 135 YGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI 194
           Y   ++ + R     +++ + YCH  G++HRD+KP N+++  +     ++L D+GLA + 
Sbjct: 125 YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRK--LRLIDWGLAEFY 182
Query: 195 KAGQNLHGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFD 252
             GQ  +  V S ++  PE+L     Y+ + D+WS G +L  ++    PF+    +  +D
Sbjct: 183 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN--YD 240
Query: 253 A-VRAADLRFPSDPWDHI-----------------------------------SASARDL 276
             VR A +    D +D+I                                   S  A D 
Sbjct: 241 QLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDF 300
Query: 277 IMGMLRVDPSTRLTAAEVLAHSWM 300
           +  +LR D  +RLTA E + H + 
Sbjct: 301 LDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 72/225 (32%), Positives = 104/225 (46%), Gaps = 33/225 (14%)
Query: 31  DATQISNLSDRYVLGKQLGWGQFGVIRECS----DKFTGEVLACKSIAKDRLVTVEDVRS 86
           D TQ      +++  +QLG G FG +  C        TGEV+A K +      T E +R 
Sbjct: 8   DPTQFEERHLKFL--QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRD 62
Query: 87  IKLEIEIMTKLSGHPNVVDLKAV-YEE-EDYVHLLMELCAGGELFHRLEKYGRFSETEAR 144
            + EIEI+  L  H N+V  K V Y      + L+ME    G L   L+K+      + R
Sbjct: 63  FEREIEILKSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH------KER 115
Query: 145 VIFRHLMQVVS-------YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI--- 194
           +    L+Q  S       Y      +HRDL   NIL+  ++    +K+ DFGL   +   
Sbjct: 116 IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQD 172
Query: 195 KAGQNLHGTVGSP-FYIAPEVLA-GGYNQAADVWSAGVILYILLS 237
           K    +     SP F+ APE L    ++ A+DVWS GV+LY L +
Sbjct: 173 KEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 72/225 (32%), Positives = 104/225 (46%), Gaps = 33/225 (14%)
Query: 31  DATQISNLSDRYVLGKQLGWGQFGVIRECS----DKFTGEVLACKSIAKDRLVTVEDVRS 86
           D TQ      +++  +QLG G FG +  C        TGEV+A K +      T E +R 
Sbjct: 2   DPTQFEERHLKFL--QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRD 56
Query: 87  IKLEIEIMTKLSGHPNVVDLKAV-YEE-EDYVHLLMELCAGGELFHRLEKYGRFSETEAR 144
            + EIEI+  L  H N+V  K V Y      + L+ME    G L   L+K+      + R
Sbjct: 57  FEREIEILKSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH------KER 109
Query: 145 VIFRHLMQVVS-------YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI--- 194
           +    L+Q  S       Y      +HRDL   NIL+  ++    +K+ DFGL   +   
Sbjct: 110 IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQD 166
Query: 195 KAGQNLHGTVGSP-FYIAPEVLA-GGYNQAADVWSAGVILYILLS 237
           K    +     SP F+ APE L    ++ A+DVWS GV+LY L +
Sbjct: 167 KEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 72/225 (32%), Positives = 104/225 (46%), Gaps = 33/225 (14%)
Query: 31  DATQISNLSDRYVLGKQLGWGQFGVIRECS----DKFTGEVLACKSIAKDRLVTVEDVRS 86
           D TQ      +++  +QLG G FG +  C        TGEV+A K +      T E +R 
Sbjct: 7   DPTQFEERHLKFL--QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRD 61
Query: 87  IKLEIEIMTKLSGHPNVVDLKAV-YEE-EDYVHLLMELCAGGELFHRLEKYGRFSETEAR 144
            + EIEI+  L  H N+V  K V Y      + L+ME    G L   L+K+      + R
Sbjct: 62  FEREIEILKSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH------KER 114
Query: 145 VIFRHLMQVVS-------YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI--- 194
           +    L+Q  S       Y      +HRDL   NIL+  ++    +K+ DFGL   +   
Sbjct: 115 IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQD 171
Query: 195 KAGQNLHGTVGSP-FYIAPEVLA-GGYNQAADVWSAGVILYILLS 237
           K    +     SP F+ APE L    ++ A+DVWS GV+LY L +
Sbjct: 172 KEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 119/264 (45%), Gaps = 37/264 (14%)
Query: 47  QLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEI---EIMTKLSG--HP 101
           +LG G FG +    DK TG   A              V+ ++LE+   E +   +G   P
Sbjct: 100 RLGRGSFGEVHRMEDKQTGFQCA--------------VKKVRLEVFRAEELMACAGLTSP 145
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
            +V L     E  +V++ MEL  GG L   +++ G   E  A       ++ + Y H   
Sbjct: 146 RIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRR 205
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKA---GQNL---HGTVGSPFYIAPEVL 215
           ++H D+K +N+LL++  S +   L DFG A  ++    G++L       G+  ++APEV+
Sbjct: 206 ILHGDVKADNVLLSSDGSHA--ALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVV 263
Query: 216 AGGYNQA-ADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASAR 274
            G    A  DVWS+  ++  +L+G  P+     ++ F       +     P   I  S  
Sbjct: 264 LGRSCDAKVDVWSSCCMMLHMLNGCHPW-----TQFFRGPLCLKIASEPPPVREIPPSCA 318
Query: 275 DL----IMGMLRVDPSTRLTAAEV 294
            L    I   LR +P  R++AAE+
Sbjct: 319 PLTAQAIQEGLRKEPIHRVSAAEL 342

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 72/225 (32%), Positives = 104/225 (46%), Gaps = 33/225 (14%)
Query: 31  DATQISNLSDRYVLGKQLGWGQFGVIRECS----DKFTGEVLACKSIAKDRLVTVEDVRS 86
           D TQ      +++  +QLG G FG +  C        TGEV+A K +      T E +R 
Sbjct: 3   DPTQFEERHLKFL--QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRD 57
Query: 87  IKLEIEIMTKLSGHPNVVDLKAV-YEE-EDYVHLLMELCAGGELFHRLEKYGRFSETEAR 144
            + EIEI+  L  H N+V  K V Y      + L+ME    G L   L+K+      + R
Sbjct: 58  FEREIEILKSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH------KER 110
Query: 145 VIFRHLMQVVS-------YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI--- 194
           +    L+Q  S       Y      +HRDL   NIL+  ++    +K+ DFGL   +   
Sbjct: 111 IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQD 167
Query: 195 KAGQNLHGTVGSP-FYIAPEVLA-GGYNQAADVWSAGVILYILLS 237
           K    +     SP F+ APE L    ++ A+DVWS GV+LY L +
Sbjct: 168 KEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 42/204 (20%)
Query: 135 YGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI 194
           Y   ++ + R     +++ + YCH  G++HRD+KP N+++  +     ++L D+GLA + 
Sbjct: 125 YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRK--LRLIDWGLAEFY 182
Query: 195 KAGQNLHGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFD 252
             GQ  +  V S ++  PE+L     Y+ + D+WS G +L  ++    PF+    +  +D
Sbjct: 183 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN--YD 240
Query: 253 A-VRAADLRFPSDPWDHI-----------------------------------SASARDL 276
             VR A +    D +D+I                                   S  A D 
Sbjct: 241 QLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDF 300
Query: 277 IMGMLRVDPSTRLTAAEVLAHSWM 300
           +  +LR D  +RLTA E + H + 
Sbjct: 301 LDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 42/204 (20%)
Query: 135 YGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI 194
           Y   ++ + R     +++ + YCH  G++HRD+KP N+++  +     ++L D+GLA + 
Sbjct: 124 YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRK--LRLIDWGLAEFY 181
Query: 195 KAGQNLHGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFD 252
             GQ  +  V S ++  PE+L     Y+ + D+WS G +L  ++    PF+    +  +D
Sbjct: 182 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN--YD 239
Query: 253 A-VRAADLRFPSDPWDHI-----------------------------------SASARDL 276
             VR A +    D +D+I                                   S  A D 
Sbjct: 240 QLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDF 299
Query: 277 IMGMLRVDPSTRLTAAEVLAHSWM 300
           +  +LR D  +RLTA E + H + 
Sbjct: 300 LDKLLRYDHQSRLTAREAMEHPYF 323

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 68/262 (25%), Positives = 127/262 (48%), Gaps = 11/262 (4%)
Query: 47  QLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDL 106
           +LG G  GV+ + S K +G V+A K I  +    + +   I  E++++ + +  P +V  
Sbjct: 32  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN--QIIRELQVLHECNS-PYIVGF 88
Query: 107 KAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCH-GNGVVHR 165
              +  +  + + ME   GG L   L+K GR  E     +   +++ ++Y    + ++HR
Sbjct: 89  YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHR 148
Query: 166 DLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGG-YNQAAD 224
           D+KP NIL+   +S   IKL DFG++  +      +  VG+  Y++PE L G  Y+  +D
Sbjct: 149 DVKPSNILV---NSRGEIKLCDFGVSGQL-IDSMANSFVGTRSYMSPERLQGTHYSVQSD 204
Query: 225 VWSAGVILYILLSGMPPFW-GKTKSKIFDAV-RAADLRFPSDPWDHISASARDLIMGMLR 282
           +WS G+ L  +  G  P   G     IF+ +    +   P  P    S   +D +   L 
Sbjct: 205 IWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLI 264
Query: 283 VDPSTRLTAAEVLAHSWMEECE 304
            +P+ R    +++ H++++  +
Sbjct: 265 KNPAERADLKQLMVHAFIKRSD 286

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 75/274 (27%), Positives = 126/274 (45%), Gaps = 37/274 (13%)
Query: 44  LGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNV 103
           + +++G G FG +     ++ G  +A K I  ++    E V     E+ IM +L  HPN+
Sbjct: 41  IKEKIGAGSFGTVHRA--EWHGSDVAVK-ILMEQDFHAERVNEFLREVAIMKRLR-HPNI 96
Query: 104 VDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQV---VSYCHGN 160
           V       +   + ++ E  + G L+  L K G   + + R        V   ++Y H  
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 161 G--VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHG--TVGSPFYIAPEVLA 216
              +VHRDLK  N+L+  K +   +K+ DFGL+  +KA   L      G+P ++APEVL 
Sbjct: 157 NPPIVHRDLKSPNLLVDKKYT---VKVCDFGLSR-LKASXFLXSKXAAGTPEWMAPEVLR 212
Query: 217 G-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAV--RAADLRFP----------- 262
               N+ +DV+S GVIL+ L +   P+     +++  AV  +   L  P           
Sbjct: 213 DEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAII 272
Query: 263 -----SDPWDHIS-ASARDLIMGMLR--VDPSTR 288
                ++PW   S A+  DL+  +++  V P  R
Sbjct: 273 EGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNR 306

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 72/225 (32%), Positives = 104/225 (46%), Gaps = 33/225 (14%)
Query: 31  DATQISNLSDRYVLGKQLGWGQFGVIRECS----DKFTGEVLACKSIAKDRLVTVEDVRS 86
           D TQ      +++  +QLG G FG +  C        TGEV+A K +      T E +R 
Sbjct: 1   DPTQFEERHLKFL--QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRD 55
Query: 87  IKLEIEIMTKLSGHPNVVDLKAV-YEE-EDYVHLLMELCAGGELFHRLEKYGRFSETEAR 144
            + EIEI+  L  H N+V  K V Y      + L+ME    G L   L+K+      + R
Sbjct: 56  FEREIEILKSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH------KER 108
Query: 145 VIFRHLMQVVS-------YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI--- 194
           +    L+Q  S       Y      +HRDL   NIL+  ++    +K+ DFGL   +   
Sbjct: 109 IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQD 165
Query: 195 KAGQNLHGTVGSP-FYIAPEVLA-GGYNQAADVWSAGVILYILLS 237
           K    +     SP F+ APE L    ++ A+DVWS GV+LY L +
Sbjct: 166 KEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 108/214 (50%), Gaps = 21/214 (9%)
Query: 44  LGKQLGWGQFGVIRECSDKFTGEVLACKSIA----KDRLVTVEDVRSIKLEIEIMTKLSG 99
           L + +G G FG +      + G+ +A K+      +D   T+E+VR    E ++   L  
Sbjct: 11  LEEIIGIGGFGKVYRAF--WIGDEVAVKAARHDPDEDISQTIENVRQ---EAKLFAMLK- 64
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
           HPN++ L+ V  +E  + L+ME   GG L +R+    R            + + ++Y H 
Sbjct: 65  HPNIIALRGVCLKEPNLCLVMEFARGGPL-NRVLSGKRIPPDILVNWAVQIARGMNYLHD 123
Query: 160 NGVV---HRDLKPENILLATKS-----SSSPIKLADFGLATYIKAGQNLHGTVGSPFYIA 211
             +V   HRDLK  NIL+  K      S+  +K+ DFGLA        +    G+  ++A
Sbjct: 124 EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA-GAYAWMA 182
Query: 212 PEVL-AGGYNQAADVWSAGVILYILLSGMPPFWG 244
           PEV+ A  +++ +DVWS GV+L+ LL+G  PF G
Sbjct: 183 PEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRG 216

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 42/204 (20%)
Query: 135 YGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI 194
           Y   ++ + R     +++ + YCH  G++HRD+KP N+++  +     ++L D+GLA + 
Sbjct: 130 YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRK--LRLIDWGLAEFY 187
Query: 195 KAGQNLHGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFD 252
             GQ  +  V S ++  PE+L     Y+ + D+WS G +L  ++    PF+    +  +D
Sbjct: 188 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN--YD 245
Query: 253 A-VRAADLRFPSDPWDHI-----------------------------------SASARDL 276
             VR A +    D +D+I                                   S  A D 
Sbjct: 246 QLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDF 305
Query: 277 IMGMLRVDPSTRLTAAEVLAHSWM 300
           +  +LR D  +RLTA E + H + 
Sbjct: 306 LDKLLRYDHQSRLTAREAMEHPYF 329

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 101/240 (42%), Gaps = 38/240 (15%)
Query: 35  ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
           +  LS+ + +  ++G G F  +   + +   +V   + IA   L+       I  E++ +
Sbjct: 16  VPQLSNVFKIEDKIGEGTFSSVYLATAQL--QVGPEEKIALKHLIPTSHPIRIAAELQCL 73
Query: 95  TKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVV 154
           T   G  NV+ +K  + + D+V + M           L+     S  E R    +L + +
Sbjct: 74  TVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESF---LDILNSLSFQEVREYMLNLFKAL 130
Query: 155 SYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA-----------TYIKA------- 196
              H  G+VHRD+KP N L   +       L DFGLA            ++++       
Sbjct: 131 KRIHQFGIVHRDVKPSNFLYNRRLKK--YALVDFGLAQGTHDTKIELLKFVQSEAQQERC 188
Query: 197 -----------GQNLHGTVGSPFYIAPEVLAGGYNQ--AADVWSAGVILYILLSGMPPFW 243
                       Q +    G+P + APEVL    NQ  A D+WSAGVI   LLSG  PF+
Sbjct: 189 SQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY 248

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/235 (28%), Positives = 110/235 (46%), Gaps = 23/235 (9%)
Query: 30  LDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRL---VTVEDVRS 86
           LDAT IS       + K +G G+FG +  CS +         S+A   L    T +  R 
Sbjct: 13  LDATNIS-------IDKVVGAGEFGEV--CSGRLKLPSKKEISVAIKTLKVGYTEKQRRD 63
Query: 87  IKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKY-GRFSETEARV 145
              E  IM +   HPN++ L+ V  +   V ++ E    G L   L K+  +F+  +   
Sbjct: 64  FLGEASIMGQFD-HPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVG 122
Query: 146 IFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIK----AGQNLH 201
           + R +   + Y    G VHRDL   NIL+   +S+   K++DFGL+  ++    A     
Sbjct: 123 MLRGIASGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTR 179
Query: 202 GTVGSPFYIAPEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAV 254
           G      + +PE +A   +  A+DVWS G++L+ ++S G  P+W  +   +  AV
Sbjct: 180 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 234

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/235 (28%), Positives = 110/235 (46%), Gaps = 23/235 (9%)
Query: 30  LDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRL---VTVEDVRS 86
           LDAT IS       + K +G G+FG +  CS +         S+A   L    T +  R 
Sbjct: 13  LDATNIS-------IDKVVGAGEFGEV--CSGRLKLPSKKEISVAIKTLKVGYTEKQRRD 63
Query: 87  IKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKY-GRFSETEARV 145
              E  IM +   HPN++ L+ V  +   V ++ E    G L   L K+  +F+  +   
Sbjct: 64  FLGEASIMGQFD-HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVG 122
Query: 146 IFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIK----AGQNLH 201
           + R +   + Y    G VHRDL   NIL+   +S+   K++DFGL+  ++    A     
Sbjct: 123 MLRGIASGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTR 179
Query: 202 GTVGSPFYIAPEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAV 254
           G      + +PE +A   +  A+DVWS G++L+ ++S G  P+W  +   +  AV
Sbjct: 180 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 234

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/271 (26%), Positives = 123/271 (45%), Gaps = 30/271 (11%)
Query: 1   MDTNNSEDSSQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECS 60
           +D    ED ++   QF             LDA+ I        + + +G G+FG +    
Sbjct: 21  IDPETYEDPNRAVHQFAKE----------LDASCIK-------IERVIGAGEFGEVCSGR 63
Query: 61  DKFTGEVLACKSIAKDRL-VTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL 119
            K  G+     +I   ++  T +  R    E  IM +   HPNVV L+ V      V ++
Sbjct: 64  LKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFD-HPNVVHLEGVVTRGKPVMIV 122
Query: 120 MELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKS 178
           +E    G L   L K+ G+F+  +   + R +   + Y    G VHRDL   NIL+   +
Sbjct: 123 IEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYLADMGYVHRDLAARNILV---N 179
Query: 179 SSSPIKLADFGLATYIKAG-QNLHGTVGSPF---YIAPEVLA-GGYNQAADVWSAGVILY 233
           S+   K++DFGL+  I+   + ++ T G      + APE +    +  A+DVWS G++++
Sbjct: 180 SNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMW 239
Query: 234 ILLS-GMPPFWGKTKSKIFDAVRAADLRFPS 263
            ++S G  P+W  +   +  A+     R P+
Sbjct: 240 EVMSYGERPYWDMSNQDVIKAIEEG-YRLPA 269

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/235 (28%), Positives = 110/235 (46%), Gaps = 23/235 (9%)
Query: 30  LDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRL---VTVEDVRS 86
           LDAT IS       + K +G G+FG +  CS +         S+A   L    T +  R 
Sbjct: 30  LDATNIS-------IDKVVGAGEFGEV--CSGRLKLPSKKEISVAIKTLKVGYTEKQRRD 80
Query: 87  IKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKY-GRFSETEARV 145
              E  IM +   HPN++ L+ V  +   V ++ E    G L   L K+  +F+  +   
Sbjct: 81  FLGEASIMGQFD-HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVG 139
Query: 146 IFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIK----AGQNLH 201
           + R +   + Y    G VHRDL   NIL+   +S+   K++DFGL+  ++    A     
Sbjct: 140 MLRGIASGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTR 196
Query: 202 GTVGSPFYIAPEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAV 254
           G      + +PE +A   +  A+DVWS G++L+ ++S G  P+W  +   +  AV
Sbjct: 197 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 251

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 131/268 (48%), Gaps = 17/268 (6%)
Query: 47  QLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDL 106
           +LG G  GV+ + S K +G V+A K I  +    + +   I  E++++ + +  P +V  
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN--QIIRELQVLHECNS-PYIVGF 69
Query: 107 KAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCH-GNGVVHR 165
              +  +  + + ME   GG L   L+K GR  E     +   +++ ++Y    + ++HR
Sbjct: 70  YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHR 129
Query: 166 DLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGG-YNQAAD 224
           D+KP NIL+ ++     IKL DFG++  +      +  VG+  Y++PE L G  Y+  +D
Sbjct: 130 DVKPSNILVNSRGE---IKLCDFGVSGQL-IDSMANSFVGTRSYMSPERLQGTHYSVQSD 185
Query: 225 VWSAGVILYILLSG---MPPFWGKTKSK----IFDAV-RAADLRFPSDPWDHISASARDL 276
           +WS G+ L  +  G   +PP   K  S+    IF+ +    +   P  P    S   +D 
Sbjct: 186 IWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDF 245
Query: 277 IMGMLRVDPSTRLTAAEVLAHSWMEECE 304
           +   L  +P+ R    +++ H++++  +
Sbjct: 246 VNKCLIKNPAERADLKQLMVHAFIKRSD 273

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 110/231 (47%), Gaps = 21/231 (9%)
Query: 48  LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKL-EIEIMTKLSGHPNVVDL 106
           +G G+FG +     K  G+  +C +I   +    E  R   L E  IM +   HPN++ L
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFE-HPNIIRL 82
Query: 107 KAVYEEEDYVHLLMELCAGGEL--FHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVH 164
           + V      V +L E    G L  F RL   G+F+  +   + R +   + Y      VH
Sbjct: 83  EGVVTNSMPVMILTEFMENGALDSFLRLND-GQFTVIQLVGMLRGIASGMRYLAEMSYVH 141
Query: 165 RDLKPENILLATKSSSSPIKLADFGLATYIKAG-------QNLHGTVGSPF-YIAPEVLA 216
           RDL   NIL+   +S+   K++DFGL+ +++          +L G +  P  + APE +A
Sbjct: 142 RDLAARNILV---NSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKI--PIRWTAPEAIA 196
Query: 217 -GGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDP 265
              +  A+D WS G++++ ++S G  P+W  +   + +A+   D R P  P
Sbjct: 197 FRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIE-QDYRLPPPP 246

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 71/284 (25%), Positives = 124/284 (43%), Gaps = 25/284 (8%)
Query: 47  QLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDL 106
           ++G G +G + +   K +G+++A K I     V  ++ + + ++++++ + S  P +V  
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRIRS--TVDEKEQKQLLMDLDVVMRSSDCPYIVQF 86
Query: 107 KAVYEEEDYVHLLMELCAGGELFHRLEKY------GRFSETEARVIFRHLMQVVSYCHGN 160
                 E    + MEL +    F +  KY          E     I    ++ +++   N
Sbjct: 87  YGALFREGDCWICMELMSTS--FDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN 144
Query: 161 -GVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVL---- 215
             ++HRD+KP NILL     S  IKL DFG++  +          G   Y+APE +    
Sbjct: 145 LKIIHRDIKPSNILL---DRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSA 201
Query: 216 -AGGYNQAADVWSAGVILYILLSGMPPF--WGKTKSKIFDAVRAADLRFPSDPWDHISAS 272
              GY+  +DVWS G+ LY L +G  P+  W     ++   V+    +  +      S S
Sbjct: 202 SRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPS 261
Query: 273 ARDLIMGMLRVDPSTRLTAAEVLAHSWM----EECEQVAQKPCK 312
             + +   L  D S R    E+L H ++    E   +VA   CK
Sbjct: 262 FINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEVACYVCK 305

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 103/216 (47%), Gaps = 32/216 (14%)
Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
           VLG+Q+G G FG +     +    ++A KS    R     D+++  L+   + K   HPN
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSC---RETLPPDLKAKFLQEARILKQYSHPN 173
Query: 103 VVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVV-------S 155
           +V L  V  ++  ++++MEL  GG+    L   G      AR+  + L+Q+V        
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG------ARLRVKTLLQMVGDAAAGME 227
Query: 156 YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA------TYIKAGQNLHGTVGSPF- 208
           Y      +HRDL   N L+  K+    +K++DFG++       Y  +G    G    P  
Sbjct: 228 YLESKCCIHRDLAARNCLVTEKNV---LKISDFGMSREEADGVYAASG----GLRQVPVK 280
Query: 209 YIAPEVLA-GGYNQAADVWSAGVILYILLS-GMPPF 242
           + APE L  G Y+  +DVWS G++L+   S G  P+
Sbjct: 281 WTAPEALNYGRYSSESDVWSFGILLWETFSLGASPY 316

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/265 (24%), Positives = 125/265 (47%), Gaps = 18/265 (6%)
Query: 47  QLGWGQFGVIRECSD-KFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           ++G G F  + +  D + T EV  C+   +DR +T  + +  K E E +  L  HPN+V 
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCE--LQDRKLTKSERQRFKEEAEXLKGLQ-HPNIVR 89
Query: 106 LKAVYEE----EDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG 161
               +E     +  + L+ EL   G L   L+++        R   R +++ + + H   
Sbjct: 90  FYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGLQFLHTRT 149
Query: 162 --VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGGY 219
             ++HRDLK +NI +   + S  +K+ D GLAT +K        +G+P + APE     Y
Sbjct: 150 PPIIHRDLKCDNIFITGPTGS--VKIGDLGLAT-LKRASFAKAVIGTPEFXAPEXYEEKY 206
Query: 220 NQAADVWSAGV-ILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHIS-ASARDLI 277
           +++ DV++ G   L    S  P    +  ++I+  V +         +D ++    +++I
Sbjct: 207 DESVDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSG---VKPASFDKVAIPEVKEII 263
Query: 278 MGMLRVDPSTRLTAAEVLAHSWMEE 302
            G +R +   R +  ++L H++ +E
Sbjct: 264 EGCIRQNKDERYSIKDLLNHAFFQE 288

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 110/231 (47%), Gaps = 21/231 (9%)
Query: 48  LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKL-EIEIMTKLSGHPNVVDL 106
           +G G+FG +     K  G+  +C +I   +    E  R   L E  IM +   HPN++ L
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFE-HPNIIRL 80
Query: 107 KAVYEEEDYVHLLMELCAGGEL--FHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVH 164
           + V      V +L E    G L  F RL   G+F+  +   + R +   + Y      VH
Sbjct: 81  EGVVTNSMPVMILTEFMENGALDSFLRLND-GQFTVIQLVGMLRGIASGMRYLAEMSYVH 139
Query: 165 RDLKPENILLATKSSSSPIKLADFGLATYIKAG-------QNLHGTVGSPF-YIAPEVLA 216
           RDL   NIL+   +S+   K++DFGL+ +++          +L G +  P  + APE +A
Sbjct: 140 RDLAARNILV---NSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKI--PIRWTAPEAIA 194
Query: 217 -GGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDP 265
              +  A+D WS G++++ ++S G  P+W  +   + +A+   D R P  P
Sbjct: 195 FRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIE-QDYRLPPPP 244

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/226 (30%), Positives = 104/226 (46%), Gaps = 35/226 (15%)
Query: 31  DATQISNLSDRYVLGKQLGWGQFGVIRECS----DKFTGEVLACKSIAKDRLVTVEDVRS 86
           D TQ      +++  +QLG G FG +  C        TGEV+A K +      T E +R 
Sbjct: 4   DPTQFEERHLKFL--QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRD 58
Query: 87  IKLEIEIMTKLSGHPNVVDLKAV-YEE-EDYVHLLMELCAGGELFHRLEKYGRFSETEAR 144
            + EIEI+  L  H N+V  K V Y      + L+ME    G L   L+K+      + R
Sbjct: 59  FEREIEILKSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH------KER 111
Query: 145 VIFRHLMQVVS-------YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG 197
           +    L+Q  S       Y      +HR+L   NIL+  ++    +K+ DFGL   +   
Sbjct: 112 IDHIKLLQYTSQICKGMEYLGTKRYIHRNLATRNILVENENR---VKIGDFGLTKVLPQD 168
Query: 198 QNLHGTVGSP-----FYIAPEVLA-GGYNQAADVWSAGVILYILLS 237
           +  +  V  P     F+ APE L    ++ A+DVWS GV+LY L +
Sbjct: 169 KEYY-KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 98/210 (46%), Gaps = 31/210 (14%)
Query: 46  KQLGWGQFGVIRECS----DKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           +QLG G FG +  C        TGEV+A K +      T E +R  + EIEI+  L  H 
Sbjct: 34  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ-HD 89
Query: 102 NVVDLKAV-YEE-EDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS---- 155
           N+V  K V Y      + L+ME    G L   L+K+      + R+    L+Q  S    
Sbjct: 90  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH------KERIDHIKLLQYTSQICK 143
Query: 156 ---YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI---KAGQNLHGTVGSP-F 208
              Y      +HRDL   NIL+  ++    +K+ DFGL   +   K    +     SP F
Sbjct: 144 GMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQDKEXXKVKEPGESPIF 200
Query: 209 YIAPEVLA-GGYNQAADVWSAGVILYILLS 237
           + APE L    ++ A+DVWS GV+LY L +
Sbjct: 201 WYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 89/201 (44%), Gaps = 42/201 (20%)
Query: 138 FSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG 197
            ++ + R     +++ + YCH  G++HRD+KP N+++  +     ++L D+GLA +   G
Sbjct: 128 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRK--LRLIDWGLAEFYHPG 185
Query: 198 QNLHGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDA-V 254
           Q  +  V S ++  PE+L     Y+ + D+WS G +L  ++    PF+    +  +D  V
Sbjct: 186 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN--YDQLV 243
Query: 255 RAADLRFPSDPWDHI-----------------------------------SASARDLIMG 279
           R A +    D +D+I                                   S  A D +  
Sbjct: 244 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 303
Query: 280 MLRVDPSTRLTAAEVLAHSWM 300
           +LR D  +RLTA E + H + 
Sbjct: 304 LLRYDHQSRLTAREAMEHPYF 324

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 98/210 (46%), Gaps = 31/210 (14%)
Query: 46  KQLGWGQFGVIRECS----DKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           +QLG G FG +  C        TGEV+A K +      T E +R  + EIEI+  L  H 
Sbjct: 34  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ-HD 89
Query: 102 NVVDLKAV-YEE-EDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS---- 155
           N+V  K V Y      + L+ME    G L   L+K+      + R+    L+Q  S    
Sbjct: 90  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH------KERIDHIKLLQYTSQICK 143
Query: 156 ---YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI---KAGQNLHGTVGSP-F 208
              Y      +HRDL   NIL+  ++    +K+ DFGL   +   K    +     SP F
Sbjct: 144 GMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQDKEXXKVKEPGESPIF 200
Query: 209 YIAPEVLA-GGYNQAADVWSAGVILYILLS 237
           + APE L    ++ A+DVWS GV+LY L +
Sbjct: 201 WYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 126/274 (45%), Gaps = 37/274 (13%)
Query: 44  LGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNV 103
           + +++G G FG +     ++ G  +A K I  ++    E V     E+ IM +L  HPN+
Sbjct: 41  IKEKIGAGSFGTVHRA--EWHGSDVAVK-ILMEQDFHAERVNEFLREVAIMKRLR-HPNI 96
Query: 104 VDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQV---VSYCHGN 160
           V       +   + ++ E  + G L+  L K G   + + R        V   ++Y H  
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 161 G--VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNL--HGTVGSPFYIAPEVLA 216
              +VHR+LK  N+L+  K +   +K+ DFGL+  +KA   L      G+P ++APEVL 
Sbjct: 157 NPPIVHRNLKSPNLLVDKKYT---VKVCDFGLSR-LKASTFLSSKSAAGTPEWMAPEVLR 212
Query: 217 G-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAV--RAADLRFP----------- 262
               N+ +DV+S GVIL+ L +   P+     +++  AV  +   L  P           
Sbjct: 213 DEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAII 272
Query: 263 -----SDPWDHIS-ASARDLIMGMLR--VDPSTR 288
                ++PW   S A+  DL+  +++  V P  R
Sbjct: 273 EGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNR 306

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/260 (25%), Positives = 127/260 (48%), Gaps = 11/260 (4%)
Query: 47  QLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDL 106
           +LG G  GV+ + S K +G V+A K I  +    + +   I  E++++ + +  P +V  
Sbjct: 16  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN--QIIRELQVLHECNS-PYIVGF 72
Query: 107 KAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCH-GNGVVHR 165
              +  +  + + ME   GG L   L+K GR  E     +   +++ ++Y    + ++HR
Sbjct: 73  YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHR 132
Query: 166 DLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGG-YNQAAD 224
           D+KP NIL+ ++     IKL DFG++  +   +  +  VG+  Y++PE L G  Y+  +D
Sbjct: 133 DVKPSNILVNSRGE---IKLCDFGVSGQL-IDEMANEFVGTRSYMSPERLQGTHYSVQSD 188
Query: 225 VWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVD 284
           +WS G+ L  +  G  P       ++ D +   +   P  P    S   +D +   L  +
Sbjct: 189 IWSMGLSLVEMAVGRYPRPPMAIFELLDYI--VNEPPPKLPSAVFSLEFQDFVNKCLIKN 246
Query: 285 PSTRLTAAEVLAHSWMEECE 304
           P+ R    +++ H++++  +
Sbjct: 247 PAERADLKQLMVHAFIKRSD 266

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 93/215 (43%), Gaps = 42/215 (19%)
Query: 135 YGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI 194
           Y   ++ + R     L++ + YCH  G++HRD+KP N+++  +     ++L D+GLA + 
Sbjct: 126 YQILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQQKK--LRLIDWGLAEFY 183
Query: 195 KAGQNLHGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFD 252
              Q  +  V S ++  PE+L     Y+ + D+WS G +L  ++    PF+    +  +D
Sbjct: 184 HPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDN--YD 241
Query: 253 A-VRAADL-------------RFPSDP-------------WDH---------ISASARDL 276
             VR A +                 DP             W++         +S  A DL
Sbjct: 242 QLVRIAKVLGTEELYGYLKKYHIDLDPHFNDILGQHSRKRWENFIHSENRHLVSPEALDL 301
Query: 277 IMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKPC 311
           +  +LR D   RLTA E + H +     +   +P 
Sbjct: 302 LDKLLRYDHQQRLTAKEAMEHPYFYPVVKEQSQPS 336

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 101/212 (47%), Gaps = 24/212 (11%)
Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
           VLG+Q+G G FG +     +    ++A KS    R     D+++  L+   + K   HPN
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSC---RETLPPDLKAKFLQEARILKQYSHPN 173
Query: 103 VVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVV-------S 155
           +V L  V  ++  ++++MEL  GG+    L   G      AR+  + L+Q+V        
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG------ARLRVKTLLQMVGDAAAGME 227
Query: 156 YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLH--GTVGSPF-YIAP 212
           Y      +HRDL   N L+  K+    +K++DFG++     G      G    P  + AP
Sbjct: 228 YLESKCCIHRDLAARNCLVTEKNV---LKISDFGMSREEADGVXAASGGLRQVPVKWTAP 284
Query: 213 EVLA-GGYNQAADVWSAGVILYILLS-GMPPF 242
           E L  G Y+  +DVWS G++L+   S G  P+
Sbjct: 285 EALNYGRYSSESDVWSFGILLWETFSLGASPY 316

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 118/265 (44%), Gaps = 30/265 (11%)
Query: 7   EDSSQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGE 66
           ED +Q   +F    + S +T                 + + +G G+FG +     K  G+
Sbjct: 6   EDPNQAVHEFAKEIEASCIT-----------------IERVIGAGEFGEVCSGRLKLPGK 48
Query: 67  VLACKSIAKDRLVTVEDVRSIKL-EIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAG 125
                +I   ++   E  R   L E  IM +   HPN++ L+ V  +   V ++ E    
Sbjct: 49  RELPVAIKTLKVGYTEKQRRDFLGEASIMGQFD-HPNIIHLEGVVTKSKPVMIVTEYMEN 107
Query: 126 GELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIK 184
           G L   L+K  G+F+  +   + R +   + Y    G VHRDL   NIL+   +S+   K
Sbjct: 108 GSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYLSDMGYVHRDLAARNILI---NSNLVCK 164
Query: 185 LADFGLATYI----KAGQNLHGTVGSPFYIAPEVLA-GGYNQAADVWSAGVILYILLS-G 238
           ++DFGL+  +    +A     G      + APE +A   +  A+DVWS G++++ ++S G
Sbjct: 165 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYG 224
Query: 239 MPPFWGKTKSKIFDAVRAADLRFPS 263
             P+W  T   +  AV     R PS
Sbjct: 225 ERPYWEMTNQDVIKAVEEG-YRLPS 248

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 101/219 (46%), Gaps = 21/219 (9%)
Query: 31  DATQISNLSDRYVLGKQLGWGQFGVIRECS----DKFTGEVLACKSIAKDRLVTVEDVRS 86
           D TQ      +++  +QLG G FG +  C        TGEV+A K +      T E +R 
Sbjct: 6   DPTQFEERHLKFL--QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRD 60
Query: 87  IKLEIEIMTKLSGHPNVVDLKAV-YEE-EDYVHLLMELCAGGELFHRLEKYG-RFSETEA 143
            + EIEI+  L  H N+V  K V Y      + L+ME    G L   L+ +  R    + 
Sbjct: 61  FEREIEILKSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKL 119
Query: 144 RVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI---KAGQNL 200
                 + + + Y      +HRDL   NIL+  ++    +K+ DFGL   +   K    +
Sbjct: 120 LQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQDKEXXKV 176
Query: 201 HGTVGSP-FYIAPEVLA-GGYNQAADVWSAGVILYILLS 237
                SP F+ APE L    ++ A+DVWS GV+LY L +
Sbjct: 177 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 99/207 (47%), Gaps = 24/207 (11%)
Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
           + G+ LG G FG   + + + TGEV+  K + +      E  R+   E+++M  L  HPN
Sbjct: 13  IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR---FDEETQRTFLKEVKVMRCLE-HPN 68
Query: 103 VVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIF-RHLMQVVSYCHGNG 161
           V+    V  ++  ++ + E   GG L   ++          RV F + +   ++Y H   
Sbjct: 69  VLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN 128
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYI---------------KAGQNLHGTVGS 206
           ++HRDL   N L+    +   + +ADFGLA  +                  +  +  VG+
Sbjct: 129 IIHRDLNSHNCLVRENKN---VVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGN 185
Query: 207 PFYIAPEVLAG-GYNQAADVWSAGVIL 232
           P+++APE++ G  Y++  DV+S G++L
Sbjct: 186 PYWMAPEMINGRSYDEKVDVFSFGIVL 212

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 90/204 (44%), Gaps = 42/204 (20%)
Query: 135 YGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI 194
           Y   ++ + R     L++ + YCH  G++HRD+KP N+++  +     ++L D+GLA + 
Sbjct: 131 YQILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQQKK--LRLIDWGLAEFY 188
Query: 195 KAGQNLHGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFD 252
              Q  +  V S ++  PE+L     Y+ + D+WS G +L  ++    PF+    +  +D
Sbjct: 189 HPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDN--YD 246
Query: 253 A-VRAADL-------------RFPSDP-------------WDH---------ISASARDL 276
             VR A +                 DP             W++         +S  A DL
Sbjct: 247 QLVRIAKVLGTEELYGYLKKYHIDLDPHFNDILGQHSRKRWENFIHSENRHLVSPEALDL 306
Query: 277 IMGMLRVDPSTRLTAAEVLAHSWM 300
           +  +LR D   RLTA E + H + 
Sbjct: 307 LDKLLRYDHQQRLTAKEAMEHPYF 330

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 127/293 (43%), Gaps = 33/293 (11%)
Query: 31  DATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRL---VTVEDVRSI 87
           DA++     DR  LGK LG G FG + E       +   C+++A   L    T  + R++
Sbjct: 19  DASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL 78
Query: 88  KLEIEIMTKLSGHPNVVD-LKAVYEEEDYVHLLMELCAGGELFHRLEK------------ 134
             E++I+  +  H NVV+ L A  +    + +++E C  G L   L              
Sbjct: 79  MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPE 138
Query: 135 --YGRFSETEARVIFR-HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA 191
             Y  F   E  + +   + + + +      +HRDL   NILL+ K+    +K+ DFGLA
Sbjct: 139 DLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV---VKICDFGLA 195
Query: 192 TYIKAGQNL--HGTVGSPF-YIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWGKT 246
             I    +    G    P  ++APE +    Y   +DVWS GV+L+ + S G  P+ G  
Sbjct: 196 RDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255
Query: 247 KSKIF--DAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH 297
             + F         +R P    D+ +      ++     +PS R T +E++ H
Sbjct: 256 IDEEFCRRLKEGTRMRAP----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 103/216 (47%), Gaps = 20/216 (9%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           DRY +   +G G FG + +  D+   E +A K I   +      +   ++E+ ++  ++ 
Sbjct: 35  DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAF----LNQAQIEVRLLELMNK 90
Query: 100 HPN-----VVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVV 154
           H       +V LK  +   +++ L+ E+ +     + L +   F      +  +   Q+ 
Sbjct: 91  HDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYN--LYDLLRNTNFRGVSLNLTRKFAQQMC 148
Query: 155 SY-----CHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFY 209
           +           ++H DLKPENILL     S+ IK+ DFG +  +  GQ ++  + S FY
Sbjct: 149 TALLFLATPELSIIHCDLKPENILLCNPKRSA-IKIVDFGSSCQL--GQRIYQXIQSRFY 205
Query: 210 IAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWG 244
            +PEVL G  Y+ A D+WS G IL  + +G P F G
Sbjct: 206 RSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG 241

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 77/294 (26%), Positives = 127/294 (43%), Gaps = 34/294 (11%)
Query: 31  DATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRL---VTVEDVRSI 87
           DA++     DR  LGK LG G FG + E       +   C+++A   L    T  + R++
Sbjct: 18  DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL 77
Query: 88  KLEIEIMTKLSGHPNVVD-LKAVYEEEDYVHLLMELCAGGELFHRLEK------------ 134
             E++I+  +  H NVV+ L A  +    + +++E C  G L   L              
Sbjct: 78  MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAP 137
Query: 135 ---YGRFSETEARVIFR-HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGL 190
              Y  F   E  + +   + + + +      +HRDL   NILL+ K+    +K+ DFGL
Sbjct: 138 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV---VKICDFGL 194
Query: 191 ATYIKAGQNL--HGTVGSPF-YIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWGK 245
           A  I    +    G    P  ++APE +    Y   +DVWS GV+L+ + S G  P+ G 
Sbjct: 195 ARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254
Query: 246 TKSKIF--DAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH 297
              + F         +R P    D+ +      ++     +PS R T +E++ H
Sbjct: 255 KIDEEFCRRLKEGTRMRAP----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 103/216 (47%), Gaps = 20/216 (9%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           DRY +   +G G FG + +  D+   E +A K I   +      +   ++E+ ++  ++ 
Sbjct: 54  DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAF----LNQAQIEVRLLELMNK 109
Query: 100 HPN-----VVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVV 154
           H       +V LK  +   +++ L+ E+ +     + L +   F      +  +   Q+ 
Sbjct: 110 HDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYN--LYDLLRNTNFRGVSLNLTRKFAQQMC 167
Query: 155 SY-----CHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFY 209
           +           ++H DLKPENILL     S+ IK+ DFG  +  + GQ ++  + S FY
Sbjct: 168 TALLFLATPELSIIHCDLKPENILLCNPKRSA-IKIVDFG--SSCQLGQRIYQXIQSRFY 224
Query: 210 IAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWG 244
            +PEVL G  Y+ A D+WS G IL  + +G P F G
Sbjct: 225 RSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG 260

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 76/310 (24%), Positives = 134/310 (43%), Gaps = 74/310 (23%)
Query: 47  QLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDL 106
           ++G G FG + +   + TG+ +A K +  +       + +++ EI+I+ +L  H NVV+L
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKIL-QLLKHENVVNL 82
Query: 107 KAV-------YEE-EDYVHLLMELCA---GGELFHRLEKYGRFSETEARVIFRHLMQVVS 155
             +       Y   +  ++L+ + C     G L + L K   F+ +E + + + L+  + 
Sbjct: 83  IEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQMLLNGLY 139
Query: 156 YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN-----LHGTVGSPFYI 210
           Y H N ++HRD+K  N+L+   +    +KLADFGLA      +N         V + +Y 
Sbjct: 140 YIHRNKILHRDMKAANVLI---TRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYR 196
Query: 211 APEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKT---------------------- 246
            PE+L G   Y    D+W AG I+  + +  P   G T                      
Sbjct: 197 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 256
Query: 247 ----------------KSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLT 290
                           K K+ D ++A    +  DP+      A DLI  +L +DP+ R+ 
Sbjct: 257 VDNYELYEKLELVKGQKRKVKDRLKA----YVRDPY------ALDLIDKLLVLDPAQRID 306
Query: 291 AAEVLAHSWM 300
           + + L H + 
Sbjct: 307 SDDALNHDFF 316

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 77/294 (26%), Positives = 127/294 (43%), Gaps = 34/294 (11%)
Query: 31  DATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRL---VTVEDVRSI 87
           DA++     DR  LGK LG G FG + E       +   C+++A   L    T  + R++
Sbjct: 18  DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL 77
Query: 88  KLEIEIMTKLSGHPNVVD-LKAVYEEEDYVHLLMELCAGGELFHRLEK------------ 134
             E++I+  +  H NVV+ L A  +    + +++E C  G L   L              
Sbjct: 78  MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAP 137
Query: 135 ---YGRFSETEARVIFR-HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGL 190
              Y  F   E  + +   + + + +      +HRDL   NILL+ K+    +K+ DFGL
Sbjct: 138 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV---VKICDFGL 194
Query: 191 ATYIKAGQNL--HGTVGSPF-YIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWGK 245
           A  I    +    G    P  ++APE +    Y   +DVWS GV+L+ + S G  P+ G 
Sbjct: 195 ARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254
Query: 246 TKSKIF--DAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH 297
              + F         +R P    D+ +      ++     +PS R T +E++ H
Sbjct: 255 KIDEEFCRRLKEGTRMRAP----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 77/294 (26%), Positives = 127/294 (43%), Gaps = 34/294 (11%)
Query: 31  DATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRL---VTVEDVRSI 87
           DA++     DR  LGK LG G FG + E       +   C+++A   L    T  + R++
Sbjct: 20  DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL 79
Query: 88  KLEIEIMTKLSGHPNVVD-LKAVYEEEDYVHLLMELCAGGELFHRLEK------------ 134
             E++I+  +  H NVV+ L A  +    + +++E C  G L   L              
Sbjct: 80  MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAP 139
Query: 135 ---YGRFSETEARVIFR-HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGL 190
              Y  F   E  + +   + + + +      +HRDL   NILL+ K+    +K+ DFGL
Sbjct: 140 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV---VKICDFGL 196
Query: 191 ATYIKAGQNL--HGTVGSPF-YIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWGK 245
           A  I    +    G    P  ++APE +    Y   +DVWS GV+L+ + S G  P+ G 
Sbjct: 197 ARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 256
Query: 246 TKSKIF--DAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH 297
              + F         +R P    D+ +      ++     +PS R T +E++ H
Sbjct: 257 KIDEEFCRRLKEGTRMRAP----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 306

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 77/294 (26%), Positives = 127/294 (43%), Gaps = 34/294 (11%)
Query: 31  DATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRL---VTVEDVRSI 87
           DA++     DR  LGK LG G FG + E       +   C+++A   L    T  + R++
Sbjct: 9   DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL 68
Query: 88  KLEIEIMTKLSGHPNVVD-LKAVYEEEDYVHLLMELCAGGELFHRLEK------------ 134
             E++I+  +  H NVV+ L A  +    + +++E C  G L   L              
Sbjct: 69  MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAP 128
Query: 135 ---YGRFSETEARVIFR-HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGL 190
              Y  F   E  + +   + + + +      +HRDL   NILL+ K+    +K+ DFGL
Sbjct: 129 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV---VKICDFGL 185
Query: 191 ATYIKAGQNL--HGTVGSPF-YIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWGK 245
           A  I    +    G    P  ++APE +    Y   +DVWS GV+L+ + S G  P+ G 
Sbjct: 186 ARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 245
Query: 246 TKSKIF--DAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH 297
              + F         +R P    D+ +      ++     +PS R T +E++ H
Sbjct: 246 KIDEEFCRRLKEGTRMRAP----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 295

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 77/294 (26%), Positives = 127/294 (43%), Gaps = 34/294 (11%)
Query: 31  DATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRL---VTVEDVRSI 87
           DA++     DR  LGK LG G FG + E       +   C+++A   L    T  + R++
Sbjct: 18  DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL 77
Query: 88  KLEIEIMTKLSGHPNVVD-LKAVYEEEDYVHLLMELCAGGELFHRLEK------------ 134
             E++I+  +  H NVV+ L A  +    + +++E C  G L   L              
Sbjct: 78  MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAP 137
Query: 135 ---YGRFSETEARVIFR-HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGL 190
              Y  F   E  + +   + + + +      +HRDL   NILL+ K+    +K+ DFGL
Sbjct: 138 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV---VKICDFGL 194
Query: 191 ATYIKAGQNL--HGTVGSPF-YIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWGK 245
           A  I    +    G    P  ++APE +    Y   +DVWS GV+L+ + S G  P+ G 
Sbjct: 195 ARDIYKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254
Query: 246 TKSKIF--DAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH 297
              + F         +R P    D+ +      ++     +PS R T +E++ H
Sbjct: 255 KIDEEFCRRLKEGTRMRAP----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/267 (24%), Positives = 114/267 (42%), Gaps = 38/267 (14%)
Query: 48  LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLK 107
           +G G FG + +   +  G+    K +  +           + E++ + KL  H N+V   
Sbjct: 19  IGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLD-HVNIVHYN 70
Query: 108 AVYEEEDY----------------VHLLMELCAGGELFHRLEKYG--RFSETEARVIFRH 149
             ++  DY                + + ME C  G L   +EK    +  +  A  +F  
Sbjct: 71  GCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQ 130
Query: 150 LMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFY 209
           + + V Y H   +++RDLKP NI L     +  +K+ DFGL T +K       + G+  Y
Sbjct: 131 ITKGVDYIHSKKLINRDLKPSNIFLV---DTKQVKIGDFGLVTSLKNDGKRXRSKGTLRY 187
Query: 210 IAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDH 268
           ++PE ++   Y +  D+++ G+IL  LL      +    SK F  +R   +   SD +D 
Sbjct: 188 MSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF--ETSKFFTDLRDGII---SDIFD- 241
Query: 269 ISASARDLIMGMLRVDPSTRLTAAEVL 295
                + L+  +L   P  R   +E+L
Sbjct: 242 --KKEKTLLQKLLSKKPEDRPNTSEIL 266

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 90/197 (45%), Gaps = 16/197 (8%)
Query: 120 MELCAGGELFHRLEKYG--RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATK 177
           ME C  G L   +EK    +  +  A  +F  + + V Y H   ++HRDLKP NI L   
Sbjct: 113 MEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLV-- 170
Query: 178 SSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILL 236
             +  +K+ DFGL T +K       + G+  Y++PE ++   Y +  D+++ G+IL  LL
Sbjct: 171 -DTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229
Query: 237 SGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLA 296
                 +    SK F  +R   +   SD +D      + L+  +L   P  R   +E+L 
Sbjct: 230 HVCDTAF--ETSKFFTDLRDGII---SDIFD---KKEKTLLQKLLSKKPEDRPNTSEILR 281
Query: 297 --HSWMEECEQVAQKPC 311
               W +  E+  +  C
Sbjct: 282 TLTVWKKSPEKNERHTC 298

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 73/300 (24%), Positives = 130/300 (43%), Gaps = 54/300 (18%)
Query: 47  QLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDL 106
           ++G G FG + +   + TG+ +A K +  +       + +++ EI+I+ +L  H NVV+L
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKIL-QLLKHENVVNL 82
Query: 107 KAV-------YEE-EDYVHLLMELCA---GGELFHRLEKYGRFSETEARVIFRHLMQVVS 155
             +       Y   +  ++L+ + C     G L + L K   F+ +E + + + L+  + 
Sbjct: 83  IEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQMLLNGLY 139
Query: 156 YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN-----LHGTVGSPFYI 210
           Y H N ++HRD+K  N+L+   +    +KLADFGLA      +N         V + +Y 
Sbjct: 140 YIHRNKILHRDMKAANVLI---TRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYR 196
Query: 211 APEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW-- 266
            PE+L G   Y    D+W AG I+  + +  P   G T+      +         + W  
Sbjct: 197 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 256
Query: 267 ---------------------DHISASAR-----DLIMGMLRVDPSTRLTAAEVLAHSWM 300
                                D + A  R     DLI  +L +DP+ R+ + + L H + 
Sbjct: 257 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 316

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 35/209 (16%)
Query: 115 YVHLLMELCAGGELFHRLEKYGRFSETEARV---IFRHLMQVVSYCHGNGVVHRDLKPEN 171
           Y+++ M+LC    L   + +     + E  V   IF  + + V + H  G++HRDLKP N
Sbjct: 135 YLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSN 194
Query: 172 ILLATKSSSSPIKLADFGLATYIKAGQNLH-------------GTVGSPFYIAPEVLAG- 217
           I          +K+ DFGL T +   +                G VG+  Y++PE + G 
Sbjct: 195 IFFTMDDV---VKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSPEQIHGN 251
Query: 218 GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFP-----SDPWDHISAS 272
            Y+   D++S G+IL+ LL          + +I   VR  +L+FP       P +H+   
Sbjct: 252 NYSHKVDIFSLGLILFELLYSFST--QMERVRIITDVR--NLKFPLLFTQKYPQEHM--- 304
Query: 273 ARDLIMGMLRVDPSTRLTAAEVLAHSWME 301
              ++  ML   P+ R  A +++ ++  E
Sbjct: 305 ---MVQDMLSPSPTERPEATDIIENAIFE 330

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 73/300 (24%), Positives = 130/300 (43%), Gaps = 54/300 (18%)
Query: 47  QLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDL 106
           ++G G FG + +   + TG+ +A K +  +       + +++ EI+I+ +L  H NVV+L
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKIL-QLLKHENVVNL 82
Query: 107 KAV-------YEE-EDYVHLLMELCA---GGELFHRLEKYGRFSETEARVIFRHLMQVVS 155
             +       Y   +  ++L+ + C     G L + L K   F+ +E + + + L+  + 
Sbjct: 83  IEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQMLLNGLY 139
Query: 156 YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN-----LHGTVGSPFYI 210
           Y H N ++HRD+K  N+L+   +    +KLADFGLA      +N         V + +Y 
Sbjct: 140 YIHRNKILHRDMKAANVLI---TRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYR 196
Query: 211 APEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW-- 266
            PE+L G   Y    D+W AG I+  + +  P   G T+      +         + W  
Sbjct: 197 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 256
Query: 267 ---------------------DHISASAR-----DLIMGMLRVDPSTRLTAAEVLAHSWM 300
                                D + A  R     DLI  +L +DP+ R+ + + L H + 
Sbjct: 257 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 316

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 76/310 (24%), Positives = 134/310 (43%), Gaps = 74/310 (23%)
Query: 47  QLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDL 106
           ++G G FG + +   + TG+ +A K +  +       + +++ EI+I+ +L  H NVV+L
Sbjct: 24  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKIL-QLLKHENVVNL 81
Query: 107 KAV-------YEE-EDYVHLLMELCA---GGELFHRLEKYGRFSETEARVIFRHLMQVVS 155
             +       Y   +  ++L+ + C     G L + L K   F+ +E + + + L+  + 
Sbjct: 82  IEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQMLLNGLY 138
Query: 156 YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN-----LHGTVGSPFYI 210
           Y H N ++HRD+K  N+L+   +    +KLADFGLA      +N         V + +Y 
Sbjct: 139 YIHRNKILHRDMKAANVLI---TRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYR 195
Query: 211 APEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKT---------------------- 246
            PE+L G   Y    D+W AG I+  + +  P   G T                      
Sbjct: 196 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 255
Query: 247 ----------------KSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLT 290
                           K K+ D ++A    +  DP+      A DLI  +L +DP+ R+ 
Sbjct: 256 VDNYELYEKLELVKGQKRKVKDRLKA----YVRDPY------ALDLIDKLLVLDPAQRID 305
Query: 291 AAEVLAHSWM 300
           + + L H + 
Sbjct: 306 SDDALNHDFF 315

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 77/294 (26%), Positives = 126/294 (42%), Gaps = 34/294 (11%)
Query: 31  DATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRL---VTVEDVRSI 87
           DA++     DR  LGK LG G FG + E       +   C+++A   L    T  + R++
Sbjct: 9   DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL 68
Query: 88  KLEIEIMTKLSGHPNVVD-LKAVYEEEDYVHLLMELCAGGELFHRLEK------------ 134
             E++I+  +  H NVV+ L A  +    + ++ E C  G L   L              
Sbjct: 69  MSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAP 128
Query: 135 ---YGRFSETEARVIFR-HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGL 190
              Y  F   E  + +   + + + +      +HRDL   NILL+ K+    +K+ DFGL
Sbjct: 129 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV---VKICDFGL 185
Query: 191 ATYIKAGQNL--HGTVGSPF-YIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWGK 245
           A  I    +    G    P  ++APE +    Y   +DVWS GV+L+ + S G  P+ G 
Sbjct: 186 ARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 245
Query: 246 TKSKIF--DAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH 297
              + F         +R P    D+ +      ++     +PS R T +E++ H
Sbjct: 246 KIDEEFCRRLKEGTRMRAP----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 295

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 77/294 (26%), Positives = 126/294 (42%), Gaps = 34/294 (11%)
Query: 31  DATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRL---VTVEDVRSI 87
           DA++     DR  LGK LG G FG + E       +   C+++A   L    T  + R++
Sbjct: 9   DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL 68
Query: 88  KLEIEIMTKLSGHPNVVD-LKAVYEEEDYVHLLMELCAGGELFHRLEK------------ 134
             E++I+  +  H NVV+ L A  +    + ++ E C  G L   L              
Sbjct: 69  MSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAP 128
Query: 135 ---YGRFSETEARVIFR-HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGL 190
              Y  F   E  + +   + + + +      +HRDL   NILL+ K+    +K+ DFGL
Sbjct: 129 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV---VKICDFGL 185
Query: 191 ATYIKAGQNL--HGTVGSPF-YIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWGK 245
           A  I    +    G    P  ++APE +    Y   +DVWS GV+L+ + S G  P+ G 
Sbjct: 186 ARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 245
Query: 246 TKSKIF--DAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH 297
              + F         +R P    D+ +      ++     +PS R T +E++ H
Sbjct: 246 KIDEEFCRRLKEGTRMRAP----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 295

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 77/294 (26%), Positives = 127/294 (43%), Gaps = 34/294 (11%)
Query: 31  DATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRL---VTVEDVRSI 87
           DA++     DR  LGK LG G FG + E       +   C+++A   L    T  + R++
Sbjct: 55  DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL 114
Query: 88  KLEIEIMTKLSGHPNVVD-LKAVYEEEDYVHLLMELCAGGELFHRLEK------------ 134
             E++I+  +  H NVV+ L A  +    + +++E C  G L   L              
Sbjct: 115 MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAP 174
Query: 135 ---YGRFSETEARVIFR-HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGL 190
              Y  F   E  + +   + + + +      +HRDL   NILL+ K+    +K+ DFGL
Sbjct: 175 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV---VKICDFGL 231
Query: 191 ATYIKAGQNL--HGTVGSPF-YIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWGK 245
           A  I    +    G    P  ++APE +    Y   +DVWS GV+L+ + S G  P+ G 
Sbjct: 232 ARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 291
Query: 246 TKSKIF--DAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH 297
              + F         +R P    D+ +      ++     +PS R T +E++ H
Sbjct: 292 KIDEEFCRRLKEGTRMRAP----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 79/309 (25%), Positives = 128/309 (41%), Gaps = 60/309 (19%)
Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKL------------ 89
           Y + + +  G +G +    D   G  +A K +      TV D R++ +            
Sbjct: 24  YTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFN----TVSDGRTVNILSDSFLCKRVLR 78
Query: 90  EIEIMTKLSGHPNVVDLKAVYE--EEDYVH---LLMELCAG--GELFHRLEKYGRFSETE 142
           EI ++     HPN++ L+ ++   EE  +H   L+ EL      ++ H  ++    S   
Sbjct: 79  EIRLLNHFH-HPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIH--DQRIVISPQH 135
Query: 143 ARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHG 202
            +    H++  +   H  GVVHRDL P NILLA    ++ I + DF LA    A  N   
Sbjct: 136 IQYFMYHILLGLHVLHEAGVVHRDLHPGNILLA---DNNDITICDFNLAREDTADANKTH 192
Query: 203 TVGSPFYIAPEVLA--GGYNQAADVWSAGVILYILLSGMPPFWGKT-------------K 247
            V   +Y APE++    G+ +  D+WSAG ++  + +    F G T              
Sbjct: 193 YVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGT 252
Query: 248 SKIFDAV-----------RAADLRFPSDPWDHISASAR----DLIMGMLRVDPSTRLTAA 292
            KI D V           R +    P+  W  +  +A     DLI  ML  +P  R++  
Sbjct: 253 PKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTE 312
Query: 293 EVLAHSWME 301
           + L H + E
Sbjct: 313 QALRHPYFE 321

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 79/317 (24%), Positives = 131/317 (41%), Gaps = 60/317 (18%)
Query: 34  QISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKL---- 89
           ++  +   Y + + +  G +G +    D   G  +A K +      TV D R++ +    
Sbjct: 16  ELHAMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFN----TVSDGRTVNILSDS 70
Query: 90  --------EIEIMTKLSGHPNVVDLKAVYE--EEDYVH---LLMELCAG--GELFHRLEK 134
                   EI ++     HPN++ L+ ++   EE  +H   L+ EL      ++ H  ++
Sbjct: 71  FLCKRVLREIRLLNHFH-HPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIH--DQ 127
Query: 135 YGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI 194
               S    +    H++  +   H  GVVHRDL P NILLA    ++ I + DF LA   
Sbjct: 128 RIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLA---DNNDITICDFNLARED 184
Query: 195 KAGQNLHGTVGSPFYIAPEVLA--GGYNQAADVWSAGVILYILLSGMPPFWGKT------ 246
            A  N    V   +Y APE++    G+ +  D+WSAG ++  + +    F G T      
Sbjct: 185 TADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLN 244
Query: 247 -------KSKIFDAV-----------RAADLRFPSDPWDHISASAR----DLIMGMLRVD 284
                    KI D V           R +    P+  W  +  +A     DLI  ML  +
Sbjct: 245 KIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFN 304
Query: 285 PSTRLTAAEVLAHSWME 301
           P  R++  + L H + E
Sbjct: 305 PQRRISTEQALRHPYFE 321

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 22/205 (10%)
Query: 47  QLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG--HPNVV 104
           +LG G FG +    DK TG    C          V+ VR     +E +   +G   P +V
Sbjct: 79  RLGRGSFGEVHRMKDKQTG--FQC---------AVKKVRLEVFRVEELVACAGLSSPRIV 127
Query: 105 DLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVH 164
            L     E  +V++ MEL  GG L   +++ G   E  A       ++ + Y H   ++H
Sbjct: 128 PLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILH 187
Query: 165 RDLKPENILLATKSSSSPIKLADFGLATYIKA---GQNL---HGTVGSPFYIAPEVLAGG 218
            D+K +N+LL++  S +   L DFG A  ++    G++L       G+  ++APEV+ G 
Sbjct: 188 GDVKADNVLLSSDGSRA--ALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 245
Query: 219 YNQA-ADVWSAGVILYILLSGMPPF 242
              A  D+WS+  ++  +L+G  P+
Sbjct: 246 PCDAKVDIWSSCCMMLHMLNGCHPW 270

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 104/225 (46%), Gaps = 13/225 (5%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRL-VTVEDVRSIKLEIEIMTKLSGHPNVV 104
           K +G G+FG +     K  G+   C +I   +   T +  R    E  IM +   HPN++
Sbjct: 35  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFD-HPNII 93
Query: 105 DLKAVYEEEDYVHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVV 163
            L+ V  +   V ++ E    G L   L K  GRF+  +   + R +   + Y      V
Sbjct: 94  HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSAV 153
Query: 164 HRDLKPENILLATKSSSSPIKLADFGLATYI----KAGQNLHGTVGSPFYIAPEVLA-GG 218
           HRDL   NIL+   +S+   K++DFG++  +    +A     G      + APE +A   
Sbjct: 154 HRDLAARNILV---NSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 210
Query: 219 YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFP 262
           +  A+DVWS G++++ ++S G  P+W  +   +  A+     R P
Sbjct: 211 FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEG-YRLP 254

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 125/278 (44%), Gaps = 42/278 (15%)
Query: 11  QLSTQFCNSYKVSSLTGTILDATQI----------SNLSDRYVLGKQLGWGQFGVIRECS 60
           Q+  +   SY+ +S T   +D TQ+          +NL      GK LG G FG + E +
Sbjct: 13  QVRWKIIESYEGNSYT--FIDPTQLPYNEKWEFPRNNLQ----FGKTLGAGAFGKVVEAT 66
Query: 61  DKFTGEVLACKSIAKDRLVTV---EDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVH 117
               G+  A   +A   L +    ++  ++  E++IM+ L  H N+V+L         V 
Sbjct: 67  AFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVL 126
Query: 118 LLMELCAGGELFHRLEKYGRFSETEARVIF-------RHLM-------QVVSYCHGNGVV 163
           ++ E C  G+L + L +  R  ET+            R L+       Q +++      +
Sbjct: 127 VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFLASKNCI 186
Query: 164 HRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN--LHGTVGSPF-YIAPE-VLAGGY 219
           HRD+   N+LL   ++    K+ DFGLA  I    N  + G    P  ++APE +    Y
Sbjct: 187 HRDVAARNVLL---TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVY 243
Query: 220 NQAADVWSAGVILYILLS-GMPPFWG-KTKSKIFDAVR 255
              +DVWS G++L+ + S G+ P+ G    SK +  V+
Sbjct: 244 TVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVK 281

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 77/294 (26%), Positives = 126/294 (42%), Gaps = 34/294 (11%)
Query: 31  DATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRL---VTVEDVRSI 87
           DA++     DR  LGK LG G FG + E       +   C+++A   L    T  + R++
Sbjct: 9   DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL 68
Query: 88  KLEIEIMTKLSGHPNVVD-LKAVYEEEDYVHLLMELCAGGELFHRLEK------------ 134
             E++I+  +  H NVV+ L A  +    + ++ E C  G L   L              
Sbjct: 69  MSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAP 128
Query: 135 ---YGRFSETEARVIFR-HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGL 190
              Y  F   E  + +   + + + +      +HRDL   NILL+ K+    +K+ DFGL
Sbjct: 129 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV---VKICDFGL 185
Query: 191 ATYIKAGQNL--HGTVGSPF-YIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWGK 245
           A  I    +    G    P  ++APE +    Y   +DVWS GV+L+ + S G  P+ G 
Sbjct: 186 ARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 245
Query: 246 TKSKIF--DAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH 297
              + F         +R P    D+ +      ++     +PS R T +E++ H
Sbjct: 246 KIDEEFCRRLKEGTRMRAP----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 295

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 19/208 (9%)
Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRS-IKLEIEIMTKLSGHP 101
           V G ++G G FGV+ +         +A K +A    +T E+++     EI++M K   H 
Sbjct: 34  VGGNKMGEGGFGVVYK--GYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ-HE 90
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRL---EKYGRFSETEARVIFRHLMQVVSYCH 158
           N+V+L     + D + L+      G L  RL   +     S      I +     +++ H
Sbjct: 91  NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH 150
Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTV------GSPFYIAP 212
            N  +HRD+K  NILL    ++   K++DFGLA   +A +    TV      G+  Y+AP
Sbjct: 151 ENHHIHRDIKSANILLDEAFTA---KISDFGLA---RASEKFAQTVMXSRIVGTTAYMAP 204
Query: 213 EVLAGGYNQAADVWSAGVILYILLSGMP 240
           E L G     +D++S GV+L  +++G+P
Sbjct: 205 EALRGEITPKSDIYSFGVVLLEIITGLP 232

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 19/208 (9%)
Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRS-IKLEIEIMTKLSGHP 101
           V G ++G G FGV+ +         +A K +A    +T E+++     EI++M K   H 
Sbjct: 34  VGGNKMGEGGFGVVYKGY--VNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ-HE 90
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRL---EKYGRFSETEARVIFRHLMQVVSYCH 158
           N+V+L     + D + L+      G L  RL   +     S      I +     +++ H
Sbjct: 91  NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH 150
Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTV------GSPFYIAP 212
            N  +HRD+K  NILL    ++   K++DFGLA   +A +    TV      G+  Y+AP
Sbjct: 151 ENHHIHRDIKSANILLDEAFTA---KISDFGLA---RASEKFAQTVMXXRIVGTTAYMAP 204
Query: 213 EVLAGGYNQAADVWSAGVILYILLSGMP 240
           E L G     +D++S GV+L  +++G+P
Sbjct: 205 EALRGEITPKSDIYSFGVVLLEIITGLP 232

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 73/274 (26%), Positives = 123/274 (44%), Gaps = 34/274 (12%)
Query: 11  QLSTQFCNSYKVSSLTGTILDATQISN------LSDRYVLGKQLGWGQFGVIRECSDKFT 64
           Q+  +   SY+ +S T   +D TQ+          +    GK LG G FG + E +    
Sbjct: 13  QVRWKIIESYEGNSYT--FIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGL 70
Query: 65  GEVLACKSIAKDRLVTV---EDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLME 121
           G+  A   +A   L +    ++  ++  E++IM+ L  H N+V+L         V ++ E
Sbjct: 71  GKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITE 130
Query: 122 LCAGGELFHRLEKYGRFSETEARVIF-------RHLM-------QVVSYCHGNGVVHRDL 167
            C  G+L + L +  R  ET+            R L+       Q +++      +HRD+
Sbjct: 131 YCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDV 190
Query: 168 KPENILLATKSSSSPIKLADFGLATYIKAGQN--LHGTVGSPF-YIAPE-VLAGGYNQAA 223
              N+LL   ++    K+ DFGLA  I    N  + G    P  ++APE +    Y   +
Sbjct: 191 AARNVLL---TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQS 247
Query: 224 DVWSAGVILYILLS-GMPPFWG-KTKSKIFDAVR 255
           DVWS G++L+ + S G+ P+ G    SK +  V+
Sbjct: 248 DVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVK 281

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/178 (32%), Positives = 84/178 (47%), Gaps = 34/178 (19%)
Query: 90  EIEIMTKLSGHPNVVDLKAV--------------YEEEDYVHLLMELCAGGELFHRLEKY 135
           EI ++ +L  HPNV+ L+ V              Y E D  H++         FHR  K 
Sbjct: 68  EIALLRELK-HPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIK--------FHRASKA 118
Query: 136 GRFSETEARVIFRHLM-QV---VSYCHGNGVVHRDLKPENIL-LATKSSSSPIKLADFGL 190
            +      R + + L+ Q+   + Y H N V+HRDLKP NIL +        +K+AD G 
Sbjct: 119 NKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 178
Query: 191 A----TYIKAGQNLHGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPF 242
           A    + +K   +L   V + +Y APE+L G   Y +A D+W+ G I   LL+  P F
Sbjct: 179 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 236

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 104/225 (46%), Gaps = 13/225 (5%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRL-VTVEDVRSIKLEIEIMTKLSGHPNVV 104
           K +G G+FG +     K  G+   C +I   +   T +  R    E  IM +   HPN++
Sbjct: 14  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFD-HPNII 72
Query: 105 DLKAVYEEEDYVHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVV 163
            L+ V  +   V ++ E    G L   L K  GRF+  +   + R +   + Y      V
Sbjct: 73  HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSYV 132
Query: 164 HRDLKPENILLATKSSSSPIKLADFGLATYI----KAGQNLHGTVGSPFYIAPEVLA-GG 218
           HRDL   NIL+   +S+   K++DFG++  +    +A     G      + APE +A   
Sbjct: 133 HRDLAARNILV---NSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 189
Query: 219 YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFP 262
           +  A+DVWS G++++ ++S G  P+W  +   +  A+     R P
Sbjct: 190 FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEG-YRLP 233

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 104/225 (46%), Gaps = 13/225 (5%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRL-VTVEDVRSIKLEIEIMTKLSGHPNVV 104
           K +G G+FG +     K  G+   C +I   +   T +  R    E  IM +   HPN++
Sbjct: 20  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFD-HPNII 78
Query: 105 DLKAVYEEEDYVHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVV 163
            L+ V  +   V ++ E    G L   L K  GRF+  +   + R +   + Y      V
Sbjct: 79  HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSYV 138
Query: 164 HRDLKPENILLATKSSSSPIKLADFGLATYI----KAGQNLHGTVGSPFYIAPEVLA-GG 218
           HRDL   NIL+   +S+   K++DFG++  +    +A     G      + APE +A   
Sbjct: 139 HRDLAARNILV---NSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 195
Query: 219 YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFP 262
           +  A+DVWS G++++ ++S G  P+W  +   +  A+     R P
Sbjct: 196 FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEG-YRLP 239

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 101/214 (47%), Gaps = 18/214 (8%)
Query: 47  QLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDL 106
           +LG GQ+G +     K     +A K++ +D +    +V     E  +M ++  HPN+V L
Sbjct: 39  KLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPNLVQL 93
Query: 107 KAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS---YCHGNGVV 163
             V   E   +++ E    G L   L +  R  E  A V+     Q+ S   Y      +
Sbjct: 94  LGVCTLEPPFYIVTEYMPYGNLLDYLRECNR-EEVTAVVLLYMATQISSAMEYLEKKNFI 152
Query: 164 HRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF---YIAPEVLA-GGY 219
           HRDL   N L+     +  +K+ADFGL+  +  G       G+ F   + APE LA   +
Sbjct: 153 HRDLAARNCLVG---ENHVVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNTF 208
Query: 220 NQAADVWSAGVILY-ILLSGMPPFWGKTKSKIFD 252
           +  +DVW+ GV+L+ I   GM P+ G   S+++D
Sbjct: 209 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYD 242

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 102/216 (47%), Gaps = 20/216 (9%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           DRY +   +G G FG + +  D+   E +A K I   +      +   ++E+ ++  ++ 
Sbjct: 54  DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAF----LNQAQIEVRLLELMNK 109
Query: 100 HPN-----VVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVV 154
           H       +V LK  +   +++ L+ E+ +     + L +   F      +  +   Q+ 
Sbjct: 110 HDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYN--LYDLLRNTNFRGVSLNLTRKFAQQMC 167
Query: 155 SY-----CHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFY 209
           +           ++H DLKPENILL      + IK+ DFG  +  + GQ ++  + S FY
Sbjct: 168 TALLFLATPELSIIHCDLKPENILLCNPKRXA-IKIVDFG--SSCQLGQRIYQXIQSRFY 224
Query: 210 IAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWG 244
            +PEVL G  Y+ A D+WS G IL  + +G P F G
Sbjct: 225 RSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG 260

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 111/236 (47%), Gaps = 20/236 (8%)
Query: 48  LGWGQFGVIRECSDKFTGE---VLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVV 104
           +G G+FG +     K  G+    +A K++      T +  R    E  IM +   HPNV+
Sbjct: 41  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFD-HPNVI 97
Query: 105 DLKAVYEEEDYVHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVV 163
            L+ V  +   V ++ E    G L   L +  G+F+  +   + R +   + Y      V
Sbjct: 98  HLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYV 157
Query: 164 HRDLKPENILLATKSSSSPIKLADFGLATYIK---AGQNLHGTVGSPFYI---APEVLA- 216
           HRDL   NIL+   +S+   K++DFGL+ +++   +       +G    I   APE +  
Sbjct: 158 HRDLAARNILV---NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY 214
Query: 217 GGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISA 271
             +  A+DVWS G++++ ++S G  P+W  T   + +A+   D R P  P D  SA
Sbjct: 215 RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE-QDYRLPP-PMDCPSA 268

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 76/328 (23%), Positives = 137/328 (41%), Gaps = 83/328 (25%)
Query: 53  FGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIK-------LEIEIMTKLSGHPNVVD 105
           F VIR+  D   G VL C+ I   +   V+ VR+IK       +E +I+ K+       +
Sbjct: 37  FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNN 96
Query: 106 LKAVYEEE----DYVHLLMELCAGGELFHRLEK--YGRFSETEARVIFRHLMQVVSYCHG 159
               Y  +    D++ L+ E   G  L+  + +  Y  F   + ++    +++ ++Y   
Sbjct: 97  NIVKYHGKFMYYDHMCLIFE-PLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRK 155
Query: 160 NGVVHRDLKPENILL----------------------ATKSSSSPIKLADFGLATYIKAG 197
             + H DLKPENILL                        ++ S+ IKL DFG AT+    
Sbjct: 156 MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATF---K 212
Query: 198 QNLHGT-VGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGK---------- 245
            + HG+ + +  Y APEV+   G++ ++D+WS G +L  L +G   F             
Sbjct: 213 SDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMME 272
Query: 246 ------TKSKIFDAVRAADLRFPSD-----PWDHISASAR-------------------- 274
                  K+ +++A +    ++ +       W   ++S                      
Sbjct: 273 SIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELF 332
Query: 275 -DLIMGMLRVDPSTRLTAAEVLAHSWME 301
            D +  +L++DP+ R + AE+L H ++E
Sbjct: 333 CDFLYSILQIDPTLRPSPAELLKHKFLE 360

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 97/205 (47%), Gaps = 22/205 (10%)
Query: 47  QLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG--HPNVV 104
           ++G G FG +    DK TG    C          V+ VR     +E +   +G   P +V
Sbjct: 65  RVGRGSFGEVHRMKDKQTG--FQC---------AVKKVRLEVFRVEELVACAGLSSPRIV 113
Query: 105 DLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVH 164
            L     E  +V++ MEL  GG L   +++ G   E  A       ++ + Y H   ++H
Sbjct: 114 PLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILH 173
Query: 165 RDLKPENILLATKSSSSPIKLADFGLATYIKA---GQNL---HGTVGSPFYIAPEVLAGG 218
            D+K +N+LL++  S +   L DFG A  ++    G++L       G+  ++APEV+ G 
Sbjct: 174 GDVKADNVLLSSDGSRA--ALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 231
Query: 219 YNQA-ADVWSAGVILYILLSGMPPF 242
              A  D+WS+  ++  +L+G  P+
Sbjct: 232 PCDAKVDIWSSCCMMLHMLNGCHPW 256

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/265 (23%), Positives = 117/265 (44%), Gaps = 19/265 (7%)
Query: 47  QLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDL 106
           +LG G +GV+ +     +G+++A K I     V  ++ + + ++++I  +    P  V  
Sbjct: 58  ELGRGAYGVVEKMRHVPSGQIMAVKRIRA--TVNSQEQKRLLMDLDISMRTVDCPFTVTF 115
Query: 107 KAVYEEEDYVHLLMELCAGG-ELFHR--LEKYGRFSETEARVIFRHLMQVVSYCHGN-GV 162
                 E  V + MEL     + F++  ++K     E     I   +++ + + H    V
Sbjct: 116 YGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSV 175
Query: 163 VHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVL-----AG 217
           +HRD+KP N+L+   ++   +K+ DFG++ Y+          G   Y+APE +       
Sbjct: 176 IHRDVKPSNVLI---NALGQVKMCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQK 232
Query: 218 GYNQAADVWSAGVILYILLSGMPPF--WGKTKSKIFDAVRAADLRFPSDPWDHISASARD 275
           GY+  +D+WS G+ +  L     P+  WG    ++   V       P  P D  SA   D
Sbjct: 233 GYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS---PQLPADKFSAEFVD 289
Query: 276 LIMGMLRVDPSTRLTAAEVLAHSWM 300
                L+ +   R T  E++ H + 
Sbjct: 290 FTSQCLKKNSKERPTYPELMQHPFF 314

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 82/356 (23%), Positives = 141/356 (39%), Gaps = 94/356 (26%)
Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKL 97
           + D Y +   +G G +G +    DK   + +A K + +     + D + I  EI I+ +L
Sbjct: 26  VPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNR-MFEDLIDCKRILREITILNRL 84
Query: 98  SGHPNVVDLKAVYEEEDYV-----HLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQ 152
                ++ L  +   ED +     ++++E+ A  +L    +     +E   + I  +L+ 
Sbjct: 85  KSD-YIIRLHDLIIPEDLLKFDELYIVLEI-ADSDLKKLFKTPIFLTEQHVKTILYNLLL 142
Query: 153 VVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLH----------- 201
              + H +G++HRDLKP N LL    S   +K+ DFGLA  I + +++H           
Sbjct: 143 GEKFIHESGIIHRDLKPANCLLNQDCS---VKICDFGLARTINSDKDIHIVNDLEEKEEN 199
Query: 202 ---------------GTVGSPFYIAPE--VLAGGYNQAADVWSAGVILYILLSGM----- 239
                            V + +Y APE  +L   Y  + D+WS G I   LL+ M     
Sbjct: 200 EEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMKSHIN 259
Query: 240 ------PPFWGKT--------KSK-------------IFDAVRAA---DLR--------- 260
                 P F G +         SK             IF+ +      DL+         
Sbjct: 260 NPTNRFPLFPGSSCFPLSPDHNSKKVHEKSNRDQLNIIFNVIGTPPEEDLKCITKQEVIK 319
Query: 261 ----FP-------SDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ 305
               FP       S  +  IS    DL+  MLR +   R+T  + L+H ++++  +
Sbjct: 320 YIKLFPTRDGIDLSKKYSSISKEGIDLLESMLRFNAQKRITIDKALSHPYLKDVRK 375

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 97/205 (47%), Gaps = 22/205 (10%)
Query: 47  QLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG--HPNVV 104
           ++G G FG +    DK TG    C          V+ VR     +E +   +G   P +V
Sbjct: 81  RVGRGSFGEVHRMKDKQTG--FQC---------AVKKVRLEVFRVEELVACAGLSSPRIV 129
Query: 105 DLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVH 164
            L     E  +V++ MEL  GG L   +++ G   E  A       ++ + Y H   ++H
Sbjct: 130 PLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILH 189
Query: 165 RDLKPENILLATKSSSSPIKLADFGLATYIKA---GQNL---HGTVGSPFYIAPEVLAGG 218
            D+K +N+LL++  S +   L DFG A  ++    G++L       G+  ++APEV+ G 
Sbjct: 190 GDVKADNVLLSSDGSRA--ALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 247
Query: 219 YNQA-ADVWSAGVILYILLSGMPPF 242
              A  D+WS+  ++  +L+G  P+
Sbjct: 248 PCDAKVDIWSSCCMMLHMLNGCHPW 272

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/264 (23%), Positives = 117/264 (44%), Gaps = 19/264 (7%)
Query: 47  QLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDL 106
           +LG G +GV+ +     +G+++A K I     V  ++ + + ++++I  +    P  V  
Sbjct: 14  ELGRGAYGVVEKMRHVPSGQIMAVKRIRA--TVNSQEQKRLLMDLDISMRTVDCPFTVTF 71
Query: 107 KAVYEEEDYVHLLMELCAGG-ELFHR--LEKYGRFSETEARVIFRHLMQVVSYCHGN-GV 162
                 E  V + MEL     + F++  ++K     E     I   +++ + + H    V
Sbjct: 72  YGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSV 131
Query: 163 VHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVL-----AG 217
           +HRD+KP N+L+   ++   +K+ DFG++ Y+          G   Y+APE +       
Sbjct: 132 IHRDVKPSNVLI---NALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQK 188
Query: 218 GYNQAADVWSAGVILYILLSGMPPF--WGKTKSKIFDAVRAADLRFPSDPWDHISASARD 275
           GY+  +D+WS G+ +  L     P+  WG    ++   V       P  P D  SA   D
Sbjct: 189 GYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS---PQLPADKFSAEFVD 245
Query: 276 LIMGMLRVDPSTRLTAAEVLAHSW 299
                L+ +   R T  E++ H +
Sbjct: 246 FTSQCLKKNSKERPTYPELMQHPF 269

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 127/292 (43%), Gaps = 32/292 (10%)
Query: 31  DATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRL---VTVEDVRSI 87
           DA++     DR  LGK LG G FG + E       +    +++A   L    T  + R++
Sbjct: 20  DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRAL 79
Query: 88  KLEIEIMTKLSGHPNVVD-LKAVYEEEDYVHLLMELCAGGELFHRLE-KYGRFSETEARV 145
             E++I+  +  H NVV+ L A  +    + +++E C  G L   L  K   F   +   
Sbjct: 80  MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPED 139
Query: 146 IFRHLMQV-------------VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLAT 192
           +++  + +             + +      +HRDL   NILL+ K+    +K+ DFGLA 
Sbjct: 140 LYKDFLTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNV---VKICDFGLAR 196
Query: 193 YIKAGQNL--HGTVGSPF-YIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWGKTK 247
            I    +    G    P  ++APE +    Y   +DVWS GV+L+ + S G  P+ G   
Sbjct: 197 DIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256
Query: 248 SKIF--DAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH 297
            + F         +R P    D+ +      ++     +PS R T +E++ H
Sbjct: 257 DEEFCRRLKEGTRMRAP----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 108/243 (44%), Gaps = 31/243 (12%)
Query: 40  DRYVLGKQLGWGQFG--VIREC----SDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEI 93
           D+  LGK LG G FG  V+ E      DK    V     + KD   T ED+  +  E+E+
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEEDLSDLVSEMEM 93
Query: 94  MTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLE---------KYGRFSETEAR 144
           M  +  H N+++L     ++  +++++E  + G L   L           Y      E +
Sbjct: 94  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 145 VIFRHLMQV-------VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG 197
           + F+ L+         + Y      +HRDL   N+L+   + ++ +K+ADFGLA  I   
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLARDINNI 210
Query: 198 QNLHGTVGSPF---YIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGKTKSKIFD 252
                T        ++APE L    Y   +DVWS GV+++ I   G  P+ G    ++F 
Sbjct: 211 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270
Query: 253 AVR 255
            ++
Sbjct: 271 LLK 273

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 100/205 (48%), Gaps = 13/205 (6%)
Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRS-IKLEIEIMTKLSGHP 101
           V G ++G G FGV+ +         +A K +A    +T E+++     EI++M K   H 
Sbjct: 28  VGGNKMGEGGFGVVYK--GYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ-HE 84
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRL---EKYGRFSETEARVIFRHLMQVVSYCH 158
           N+V+L     + D + L+      G L  RL   +     S      I +     +++ H
Sbjct: 85  NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH 144
Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLA-TYIKAGQNLHGT--VGSPFYIAPEVL 215
            N  +HRD+K  NILL    ++   K++DFGLA    K  Q +     VG+  Y+APE L
Sbjct: 145 ENHHIHRDIKSANILLDEAFTA---KISDFGLARASEKFAQXVMXXRIVGTTAYMAPEAL 201
Query: 216 AGGYNQAADVWSAGVILYILLSGMP 240
            G     +D++S GV+L  +++G+P
Sbjct: 202 RGEITPKSDIYSFGVVLLEIITGLP 226

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 69/236 (29%), Positives = 114/236 (48%), Gaps = 29/236 (12%)
Query: 31  DATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLE 90
           DA +I   S + V  K+LG GQFG +       + +V A K++    +     V++   E
Sbjct: 6   DAWEIPRESIKLV--KRLGAGQFGEVWMGYYNNSTKV-AVKTLKPGTM----SVQAFLEE 58
Query: 91  IEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHL 150
             +M  L  H  +V L AV   E+ ++++ E  A G L   L+     S+   +V+   L
Sbjct: 59  ANLMKTLQ-HDKLVRLYAVVTREEPIYIITEYMAKGSLLDFLK-----SDEGGKVLLPKL 112
Query: 151 MQV-------VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT 203
           +         ++Y      +HRDL+  N+L+   S S   K+ADFGLA  I+  +     
Sbjct: 113 IDFSAQIAEGMAYIERKNYIHRDLRAANVLV---SESLMCKIADFGLARVIEDNE-YTAR 168
Query: 204 VGSPF---YIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGKTKSKIFDAV 254
            G+ F   + APE +  G +   +DVWS G++LY I+  G  P+ G+T + +  A+
Sbjct: 169 EGAKFPIKWTAPEAINFGCFTIKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTAL 224

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 71/271 (26%), Positives = 122/271 (45%), Gaps = 34/271 (12%)
Query: 48  LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLK 107
           +G G FG + +   K  G  +           + +D R    E+E++ KL  HPN+++L 
Sbjct: 23  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 82
Query: 108 AVYEEEDYVHLLMELCAGGELFHRLEK---------YGRFSETEARVIFRHLMQVVS--- 155
              E   Y++L +E    G L   L K         +   + T + +  + L+   +   
Sbjct: 83  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 142
Query: 156 ----YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLH--GTVGS-PF 208
               Y      +HRDL   NIL+     +   K+ADFGL+     GQ ++   T+G  P 
Sbjct: 143 RGMDYLSQKQFIHRDLAARNILVGENYVA---KIADFGLSR----GQEVYVKKTMGRLPV 195
Query: 209 -YIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAV-RAADLRFPSD 264
            ++A E L    Y   +DVWS GV+L+ ++S G  P+ G T +++++ + +   L  P +
Sbjct: 196 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLN 255
Query: 265 PWDHISASARDLIMGMLRVDPSTRLTAAEVL 295
             D +     DL+    R  P  R + A++L
Sbjct: 256 CDDEVY----DLMRQCWREKPYERPSFAQIL 282

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 71/271 (26%), Positives = 122/271 (45%), Gaps = 34/271 (12%)
Query: 48  LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLK 107
           +G G FG + +   K  G  +           + +D R    E+E++ KL  HPN+++L 
Sbjct: 33  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 92
Query: 108 AVYEEEDYVHLLMELCAGGELFHRLEK---------YGRFSETEARVIFRHLMQVVS--- 155
              E   Y++L +E    G L   L K         +   + T + +  + L+   +   
Sbjct: 93  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 152
Query: 156 ----YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLH--GTVGS-PF 208
               Y      +HRDL   NIL+     +   K+ADFGL+     GQ ++   T+G  P 
Sbjct: 153 RGMDYLSQKQFIHRDLAARNILVGENYVA---KIADFGLSR----GQEVYVKKTMGRLPV 205
Query: 209 -YIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAV-RAADLRFPSD 264
            ++A E L    Y   +DVWS GV+L+ ++S G  P+ G T +++++ + +   L  P +
Sbjct: 206 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLN 265
Query: 265 PWDHISASARDLIMGMLRVDPSTRLTAAEVL 295
             D +     DL+    R  P  R + A++L
Sbjct: 266 CDDEVY----DLMRQCWREKPYERPSFAQIL 292

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 126/290 (43%), Gaps = 30/290 (10%)
Query: 31  DATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRL---VTVEDVRSI 87
           DA++     DR  LGK LG G FG + E       +    +++A   L    T  + R++
Sbjct: 18  DASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRAL 77
Query: 88  KLEIEIMTKLSGHPNVVD-LKAVYEEEDYVHLLMELCAGGELFHRLEK-----------Y 135
             E++I+  +  H NVV+ L A  +    + +++E C  G L   L             Y
Sbjct: 78  MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLY 137
Query: 136 GRFSETEARVIFR-HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI 194
             F   E  + +   + + + +      +HRDL   NILL+ K+    +K+ DFGLA  I
Sbjct: 138 KDFLTLEHLICYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNV---VKICDFGLARDI 194
Query: 195 KAGQNL--HGTVGSPF-YIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWGKTKSK 249
               +    G    P  ++APE +    Y   +DVWS GV+L+ + S G  P+ G    +
Sbjct: 195 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 254
Query: 250 IF--DAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH 297
            F         +R P    D+ +      ++     +PS R T +E++ H
Sbjct: 255 EFCRRLKEGTRMRAP----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 300

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 103/200 (51%), Gaps = 12/200 (6%)
Query: 47  QLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDL 106
           +LG G  GV+ + S K +G V+A K I  +    + +   I  E++++ + +  P +V  
Sbjct: 75  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN--QIIRELQVLHECNS-PYIVGF 131
Query: 107 KAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCH-GNGVVHR 165
              +  +  + + ME   GG L   L+K GR  E     +   +++ ++Y    + ++HR
Sbjct: 132 YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHR 191
Query: 166 DLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGG-YNQAAD 224
           D+KP NIL+ ++     IKL DFG++  +      +  VG+  Y++PE L G  Y+  +D
Sbjct: 192 DVKPSNILVNSRGE---IKLCDFGVSGQL-IDSMANSFVGTRSYMSPERLQGTHYSVQSD 247
Query: 225 VWSAGVILYILLSG---MPP 241
           +WS G+ L  +  G   +PP
Sbjct: 248 IWSMGLSLVEMAVGRYPIPP 267

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 108/243 (44%), Gaps = 31/243 (12%)
Query: 40  DRYVLGKQLGWGQFG--VIREC----SDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEI 93
           D+  LGK LG G FG  V+ E      DK    V     + KD   T +D+  +  E+E+
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEM 93
Query: 94  MTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLE---------KYGRFSETEAR 144
           M  +  H N+++L     ++  +++++E  + G L   L           Y      E +
Sbjct: 94  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQ 153
Query: 145 VIFRHLMQV-------VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG 197
           + F+ L+         + Y      +HRDL   N+L+   + ++ +K+ADFGLA  I   
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLARDINNI 210
Query: 198 QNLHGTVGSPF---YIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGKTKSKIFD 252
                T        ++APE L    Y   +DVWS GV+++ I   G  P+ G    ++F 
Sbjct: 211 DXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270
Query: 253 AVR 255
            ++
Sbjct: 271 LLK 273

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 122/270 (45%), Gaps = 30/270 (11%)
Query: 11  QLSTQFCNSYKVSSLTGTILDATQISN------LSDRYVLGKQLGWGQFGVIRECSDKFT 64
           Q+  +   SY+ +S T   +D TQ+          +    GK LG G FG + E +    
Sbjct: 13  QVRWKIIESYEGNSYT--FIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGL 70
Query: 65  GEVLACKSIAKDRLVTV---EDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLME 121
           G+  A   +A   L +    ++  ++  E++IM+ L  H N+V+L         V ++ E
Sbjct: 71  GKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITE 130
Query: 122 LCAGGELFHRLEKY---------GRFSETEARVIF-RHLMQVVSYCHGNGVVHRDLKPEN 171
            C  G+L + L +          GR  E    + F   + Q +++      +HRD+   N
Sbjct: 131 YCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARN 190
Query: 172 ILLATKSSSSPIKLADFGLATYIKAGQN--LHGTVGSPF-YIAPE-VLAGGYNQAADVWS 227
           +LL   ++    K+ DFGLA  I    N  + G    P  ++APE +    Y   +DVWS
Sbjct: 191 VLL---TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWS 247
Query: 228 AGVILYILLS-GMPPFWG-KTKSKIFDAVR 255
            G++L+ + S G+ P+ G    SK +  V+
Sbjct: 248 YGILLWEIFSLGLNPYPGILVNSKFYKLVK 277

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 108/243 (44%), Gaps = 31/243 (12%)
Query: 40  DRYVLGKQLGWGQFG--VIREC----SDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEI 93
           D+  LGK LG G FG  V+ E      DK    V     + KD   T +D+  +  E+E+
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEM 93
Query: 94  MTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLE---------KYGRFSETEAR 144
           M  +  H N+++L     ++  +++++E  + G L   L           Y      E +
Sbjct: 94  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 145 VIFRHLMQV-------VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG 197
           + F+ L+         + Y      +HRDL   N+L+   + ++ +K+ADFGLA  I   
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLARDINNI 210
Query: 198 QNLHGTVGSPF---YIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGKTKSKIFD 252
                T        ++APE L    Y   +DVWS GV+++ I   G  P+ G    ++F 
Sbjct: 211 DXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270
Query: 253 AVR 255
            ++
Sbjct: 271 LLK 273

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 108/243 (44%), Gaps = 31/243 (12%)
Query: 40  DRYVLGKQLGWGQFG--VIREC----SDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEI 93
           D+  LGK LG G FG  V+ E      DK    V     + KD   T +D+  +  E+E+
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEM 93
Query: 94  MTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLE---------KYGRFSETEAR 144
           M  +  H N+++L     ++  +++++E  + G L   L           Y      E +
Sbjct: 94  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 145 VIFRHLMQV-------VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG 197
           + F+ L+         + Y      +HRDL   N+L+   + ++ +K+ADFGLA  I   
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLARDINNI 210
Query: 198 QNLHGTVGSPF---YIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGKTKSKIFD 252
                T        ++APE L    Y   +DVWS GV+++ I   G  P+ G    ++F 
Sbjct: 211 DYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270
Query: 253 AVR 255
            ++
Sbjct: 271 LLK 273

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 122/270 (45%), Gaps = 30/270 (11%)
Query: 11  QLSTQFCNSYKVSSLTGTILDATQISN------LSDRYVLGKQLGWGQFGVIRECSDKFT 64
           Q+  +   SY+ +S T   +D TQ+          +    GK LG G FG + E +    
Sbjct: 5   QVRWKIIESYEGNSYT--FIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGL 62
Query: 65  GEVLACKSIAKDRLVTV---EDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLME 121
           G+  A   +A   L +    ++  ++  E++IM+ L  H N+V+L         V ++ E
Sbjct: 63  GKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITE 122
Query: 122 LCAGGELFHRLEKY---------GRFSETEARVIF-RHLMQVVSYCHGNGVVHRDLKPEN 171
            C  G+L + L +          GR  E    + F   + Q +++      +HRD+   N
Sbjct: 123 YCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARN 182
Query: 172 ILLATKSSSSPIKLADFGLATYIKAGQN--LHGTVGSPF-YIAPE-VLAGGYNQAADVWS 227
           +LL   ++    K+ DFGLA  I    N  + G    P  ++APE +    Y   +DVWS
Sbjct: 183 VLL---TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWS 239
Query: 228 AGVILYILLS-GMPPFWG-KTKSKIFDAVR 255
            G++L+ + S G+ P+ G    SK +  V+
Sbjct: 240 YGILLWEIFSLGLNPYPGILVNSKFYKLVK 269

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 103/200 (51%), Gaps = 12/200 (6%)
Query: 47  QLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDL 106
           +LG G  GV+ + S K +G V+A K I  +    + +   I  E++++ + +  P +V  
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN--QIIRELQVLHECNS-PYIVGF 69
Query: 107 KAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCH-GNGVVHR 165
              +  +  + + ME   GG L   L+K GR  E     +   +++ ++Y    + ++HR
Sbjct: 70  YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHR 129
Query: 166 DLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGG-YNQAAD 224
           D+KP NIL+ ++     IKL DFG++  +      +  VG+  Y++PE L G  Y+  +D
Sbjct: 130 DVKPSNILVNSRGE---IKLCDFGVSGQL-IDSMANSFVGTRSYMSPERLQGTHYSVQSD 185
Query: 225 VWSAGVILYILLSG---MPP 241
           +WS G+ L  +  G   +PP
Sbjct: 186 IWSMGLSLVEMAVGRYPIPP 205

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 103/200 (51%), Gaps = 12/200 (6%)
Query: 47  QLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDL 106
           +LG G  GV+ + S K +G V+A K I  +    + +   I  E++++ + +  P +V  
Sbjct: 40  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN--QIIRELQVLHECNS-PYIVGF 96
Query: 107 KAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCH-GNGVVHR 165
              +  +  + + ME   GG L   L+K GR  E     +   +++ ++Y    + ++HR
Sbjct: 97  YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHR 156
Query: 166 DLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGG-YNQAAD 224
           D+KP NIL+ ++     IKL DFG++  +      +  VG+  Y++PE L G  Y+  +D
Sbjct: 157 DVKPSNILVNSRGE---IKLCDFGVSGQL-IDSMANSFVGTRSYMSPERLQGTHYSVQSD 212
Query: 225 VWSAGVILYILLSG---MPP 241
           +WS G+ L  +  G   +PP
Sbjct: 213 IWSMGLSLVEMAVGRYPIPP 232

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 126/290 (43%), Gaps = 30/290 (10%)
Query: 31  DATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRL---VTVEDVRSI 87
           DA++     DR  LGK LG G FG + E       +    +++A   L    T  + R++
Sbjct: 18  DASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRAL 77
Query: 88  KLEIEIMTKLSGHPNVVD-LKAVYEEEDYVHLLMELCAGGELFHRLEK-----------Y 135
             E++I+  +  H NVV+ L A  +    + +++E C  G L   L             Y
Sbjct: 78  MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLY 137
Query: 136 GRFSETEARVIFR-HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI 194
             F   E  + +   + + + +      +HRDL   NILL+ K+    +K+ DFGLA  I
Sbjct: 138 KDFLTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNV---VKIXDFGLARDI 194
Query: 195 KAGQNL--HGTVGSPF-YIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWGKTKSK 249
               +    G    P  ++APE +    Y   +DVWS GV+L+ + S G  P+ G    +
Sbjct: 195 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 254
Query: 250 IFDA--VRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH 297
            F         +R P    D+ +      ++     +PS R T +E++ H
Sbjct: 255 EFXRRLKEGTRMRAP----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 300

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 101/198 (51%), Gaps = 9/198 (4%)
Query: 47  QLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDL 106
           +LG G  GV+ + S K +G V+A K I  +    + +   I  E++++ + +  P +V  
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN--QIIRELQVLHECNS-PYIVGF 69
Query: 107 KAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCH-GNGVVHR 165
              +  +  + + ME   GG L   L+K GR  E     +   +++ ++Y    + ++HR
Sbjct: 70  YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHR 129
Query: 166 DLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGG-YNQAAD 224
           D+KP NIL+ ++     IKL DFG++  +      +  VG+  Y++PE L G  Y+  +D
Sbjct: 130 DVKPSNILVNSRGE---IKLCDFGVSGQL-IDSMANSFVGTRSYMSPERLQGTHYSVQSD 185
Query: 225 VWSAGVILYILLSGMPPF 242
           +WS G+ L  +  G  P 
Sbjct: 186 IWSMGLSLVEMAVGRYPI 203

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 101/198 (51%), Gaps = 9/198 (4%)
Query: 47  QLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDL 106
           +LG G  GV+ + S K +G V+A K I  +    + +   I  E++++ + +  P +V  
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN--QIIRELQVLHECNS-PYIVGF 69
Query: 107 KAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCH-GNGVVHR 165
              +  +  + + ME   GG L   L+K GR  E     +   +++ ++Y    + ++HR
Sbjct: 70  YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHR 129
Query: 166 DLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGG-YNQAAD 224
           D+KP NIL+ ++     IKL DFG++  +      +  VG+  Y++PE L G  Y+  +D
Sbjct: 130 DVKPSNILVNSRGE---IKLCDFGVSGQL-IDSMANSFVGTRSYMSPERLQGTHYSVQSD 185
Query: 225 VWSAGVILYILLSGMPPF 242
           +WS G+ L  +  G  P 
Sbjct: 186 IWSMGLSLVEMAVGRYPI 203

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 103/200 (51%), Gaps = 12/200 (6%)
Query: 47  QLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDL 106
           +LG G  GV+ + S K +G V+A K I  +    + +   I  E++++ + +  P +V  
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN--QIIRELQVLHECNS-PYIVGF 69
Query: 107 KAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCH-GNGVVHR 165
              +  +  + + ME   GG L   L+K GR  E     +   +++ ++Y    + ++HR
Sbjct: 70  YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHR 129
Query: 166 DLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGG-YNQAAD 224
           D+KP NIL+ ++     IKL DFG++  +      +  VG+  Y++PE L G  Y+  +D
Sbjct: 130 DVKPSNILVNSRGE---IKLCDFGVSGQL-IDSMANSFVGTRSYMSPERLQGTHYSVQSD 185
Query: 225 VWSAGVILYILLSG---MPP 241
           +WS G+ L  +  G   +PP
Sbjct: 186 IWSMGLSLVEMAVGRYPIPP 205

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 96/206 (46%), Gaps = 22/206 (10%)
Query: 46  KQLGWGQFGVIREC----SDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           + LG G FG +  C        TGE +A KS+  +       +  +K EIEI+  L  H 
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLY-HE 83
Query: 102 NVVDLKAVYEEE--DYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQV---VSY 156
           N+V  K +  E+  + + L+ME    G L   L K    ++   +   ++ +Q+   + Y
Sbjct: 84  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK--NKNKINLKQQLKYAVQICKGMDY 141
Query: 157 CHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI---KAGQNLHGTVGSP-FYIAP 212
                 VHRDL   N+L+    S   +K+ DFGL   I   K    +     SP F+ AP
Sbjct: 142 LGSRQYVHRDLAARNVLV---ESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAP 198
Query: 213 EVL-AGGYNQAADVWSAGVILYILLS 237
           E L    +  A+DVWS GV L+ LL+
Sbjct: 199 ECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 96/206 (46%), Gaps = 22/206 (10%)
Query: 46  KQLGWGQFGVIREC----SDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           + LG G FG +  C        TGE +A KS+  +       +  +K EIEI+  L  H 
Sbjct: 15  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLY-HE 71
Query: 102 NVVDLKAVYEEE--DYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQV---VSY 156
           N+V  K +  E+  + + L+ME    G L   L K    ++   +   ++ +Q+   + Y
Sbjct: 72  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK--NKNKINLKQQLKYAVQICKGMDY 129
Query: 157 CHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI---KAGQNLHGTVGSP-FYIAP 212
                 VHRDL   N+L+    S   +K+ DFGL   I   K    +     SP F+ AP
Sbjct: 130 LGSRQYVHRDLAARNVLV---ESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAP 186
Query: 213 EVL-AGGYNQAADVWSAGVILYILLS 237
           E L    +  A+DVWS GV L+ LL+
Sbjct: 187 ECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 66/232 (28%), Positives = 104/232 (44%), Gaps = 34/232 (14%)
Query: 44  LGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDV---RSIKLEIEIMTKLSGH 100
            GK LG G FG +   +     +      +A   L    D     ++  E+++MT+L  H
Sbjct: 49  FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 108
Query: 101 PNVVDLKAVYEEEDYVHLLMELCAGGELFHRLE-KYGRFSETEAR--------------- 144
            N+V+L         ++L+ E C  G+L + L  K  +FSE E                 
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 145 VIFRHLM----QV---VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG 197
           + F  L+    QV   + +      VHRDL   N+L+   +    +K+ DFGLA  I + 
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLV---THGKVVKICDFGLARDIMSD 225
Query: 198 QN--LHGTVGSPF-YIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWG 244
            N  + G    P  ++APE L  G Y   +DVWS G++L+ + S G+ P+ G
Sbjct: 226 SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 110/236 (46%), Gaps = 20/236 (8%)
Query: 48  LGWGQFGVIRECSDKFTGE---VLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVV 104
           +G G+FG +     K  G+    +A K++      T +  R    E  IM +   HPNV+
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFD-HPNVI 71
Query: 105 DLKAVYEEEDYVHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVV 163
            L+ V  +   V ++ E    G L   L +  G+F+  +   + R +   + Y      V
Sbjct: 72  HLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYV 131
Query: 164 HRDLKPENILLATKSSSSPIKLADFGLATYIK---AGQNLHGTVGSPF---YIAPEVLA- 216
           HR L   NIL+   +S+   K++DFGL+ +++   +       +G      + APE +  
Sbjct: 132 HRALAARNILV---NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY 188
Query: 217 GGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISA 271
             +  A+DVWS G++++ ++S G  P+W  T   + +A+   D R P  P D  SA
Sbjct: 189 RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE-QDYRLPP-PMDCPSA 242

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 109/223 (48%), Gaps = 27/223 (12%)
Query: 44  LGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNV 103
           L K+LG GQFG +       + +V A K++    +     V++   E  +M  L  H  +
Sbjct: 16  LVKKLGAGQFGEVWMGYYNNSTKV-AVKTLKPGTM----SVQAFLEEANLMKTLQ-HDKL 69
Query: 104 VDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQV-------VSY 156
           V L AV  +E+ ++++ E  A G L   L+     S+   +V+   L+         ++Y
Sbjct: 70  VRLYAVVTKEEPIYIITEFMAKGSLLDFLK-----SDEGGKVLLPKLIDFSAQIAEGMAY 124
Query: 157 CHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF---YIAPE 213
                 +HRDL+  N+L+   S S   K+ADFGLA  I+  +      G+ F   + APE
Sbjct: 125 IERKNYIHRDLRAANVLV---SESLMCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPE 180
Query: 214 VLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGKTKSKIFDAV 254
            +  G +   ++VWS G++LY I+  G  P+ G+T + +  A+
Sbjct: 181 AINFGCFTIKSNVWSFGILLYEIVTYGKIPYPGRTNADVMSAL 223

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/275 (23%), Positives = 119/275 (43%), Gaps = 32/275 (11%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           +++G G+FG + +C  +  G + A K   K    +V++  +++ E+     L  H +VV 
Sbjct: 17  EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALR-EVYAHAVLGQHSHVVR 75
Query: 106 LKAVYEEEDYVHLLMELCAGGELFHRLEKYGR----FSETEARVIFRHLMQVVSYCHGNG 161
             + + E+D++ +  E C GG L   + +  R    F E E + +   + + + Y H   
Sbjct: 76  YFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS 135
Query: 162 VVHRDLKPENILLATKSSSSP----------------IKLADFGLATYIKAGQNLHGTVG 205
           +VH D+KP NI ++  S  +                  K+ D G  T I + Q      G
Sbjct: 136 LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV---EEG 192
Query: 206 SPFYIAPEVLAGGYNQ--AADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPS 263
              ++A EVL   Y     AD+++  + + +  +G  P         +  +R    R P 
Sbjct: 193 DSRFLANEVLQENYTHLPKADIFALALTV-VCAAGAEPL--PRNGDQWHEIRQG--RLPR 247
Query: 264 DPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHS 298
            P   +S    +L+  M+  DP  R +A  ++ HS
Sbjct: 248 IP-QVLSQEFTELLKVMIHPDPERRPSAMALVKHS 281

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 122/276 (44%), Gaps = 36/276 (13%)
Query: 11  QLSTQFCNSYKVSSLTGTILDATQISN------LSDRYVLGKQLGWGQFGVIRECSDKFT 64
           Q+  +   SY+ +S T   +D TQ+          +    GK LG G FG + E +    
Sbjct: 13  QVRWKIIESYEGNSYT--FIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGL 70
Query: 65  GEVLACKSIAKDRLVTV---EDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLME 121
           G+  A   +A   L +    ++  ++  E++IM+ L  H N+V+L         V ++ E
Sbjct: 71  GKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITE 130
Query: 122 LCAGGELFHRLEK---------YGRFSETEARVIFRHLM-------QVVSYCHGNGVVHR 165
            C  G+L + L +         Y      E ++  R L+       Q +++      +HR
Sbjct: 131 YCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFLASKNCIHR 190
Query: 166 DLKPENILLATKSSSSPIKLADFGLATYIKAGQN--LHGTVGSPF-YIAPE-VLAGGYNQ 221
           D+   N+LL     +   K+ DFGLA  I    N  + G    P  ++APE +    Y  
Sbjct: 191 DVAARNVLLTNGHVA---KIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTV 247
Query: 222 AADVWSAGVILYILLS-GMPPFWG-KTKSKIFDAVR 255
            +DVWS G++L+ + S G+ P+ G    SK +  V+
Sbjct: 248 QSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVK 283

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/275 (23%), Positives = 119/275 (43%), Gaps = 32/275 (11%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           +++G G+FG + +C  +  G + A K   K    +V++  +++ E+     L  H +VV 
Sbjct: 13  EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALR-EVYAHAVLGQHSHVVR 71
Query: 106 LKAVYEEEDYVHLLMELCAGGELFHRLEKYGR----FSETEARVIFRHLMQVVSYCHGNG 161
             + + E+D++ +  E C GG L   + +  R    F E E + +   + + + Y H   
Sbjct: 72  YFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS 131
Query: 162 VVHRDLKPENILLATKSSSSP----------------IKLADFGLATYIKAGQNLHGTVG 205
           +VH D+KP NI ++  S  +                  K+ D G  T I + Q      G
Sbjct: 132 LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ---VEEG 188
Query: 206 SPFYIAPEVLAGGYNQ--AADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPS 263
              ++A EVL   Y     AD+++  + + +  +G  P         +  +R    R P 
Sbjct: 189 DSRFLANEVLQENYTHLPKADIFALALTV-VXAAGAEPL--PRNGDQWHEIRQG--RLPR 243
Query: 264 DPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHS 298
            P   +S    +L+  M+  DP  R +A  ++ HS
Sbjct: 244 IP-QVLSQEFTELLKVMIHPDPERRPSAMALVKHS 277

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/275 (23%), Positives = 119/275 (43%), Gaps = 32/275 (11%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           +++G G+FG + +C  +  G + A K   K    +V++  +++ E+     L  H +VV 
Sbjct: 15  EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALR-EVYAHAVLGQHSHVVR 73
Query: 106 LKAVYEEEDYVHLLMELCAGGELFHRLEKYGR----FSETEARVIFRHLMQVVSYCHGNG 161
             + + E+D++ +  E C GG L   + +  R    F E E + +   + + + Y H   
Sbjct: 74  YFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS 133
Query: 162 VVHRDLKPENILLATKSSSSP----------------IKLADFGLATYIKAGQNLHGTVG 205
           +VH D+KP NI ++  S  +                  K+ D G  T I + Q      G
Sbjct: 134 LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV---EEG 190
Query: 206 SPFYIAPEVLAGGYNQ--AADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPS 263
              ++A EVL   Y     AD+++  + + +  +G  P         +  +R    R P 
Sbjct: 191 DSRFLANEVLQENYTHLPKADIFALALTV-VCAAGAEPL--PRNGDQWHEIRQG--RLPR 245
Query: 264 DPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHS 298
            P   +S    +L+  M+  DP  R +A  ++ HS
Sbjct: 246 IP-QVLSQEFTELLKVMIHPDPERRPSAMALVKHS 279

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 75/331 (22%), Positives = 137/331 (41%), Gaps = 78/331 (23%)
Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
           RY+L ++LGWG F  +    D      +A K +  D++ T     + + EI+++ +++  
Sbjct: 20  RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT----EAAEDEIKLLQRVNDA 75
Query: 101 PNVVD--------LKAV----YEEEDYVHLLMELCAGGE-LFHRLEKYGR--FSETEARV 145
            N  +        LK +    ++  + VH++M     GE L   ++KY          + 
Sbjct: 76  DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ 135
Query: 146 IFRHLMQVVSYCHGN-GVVHRDLKPENILLATKSSSS---PIKLADFGLATYIKAGQNLH 201
           I + L+  + Y H   G++H D+KPEN+L+    S      IK+AD G A +    ++  
Sbjct: 136 ISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD--EHYT 193
Query: 202 GTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSG---------------------- 238
            ++ +  Y +PEVL G  +   AD+WS   +++ L++G                      
Sbjct: 194 NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 253
Query: 239 ------MPPFW---GKTKSKIFDA-----------------VRAADLRFPSDPWDHISAS 272
                 +P +    GK     F++                 V     +F  D    IS  
Sbjct: 254 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEIS-- 311
Query: 273 ARDLIMGMLRVDPSTRLTAAEVLAHSWMEEC 303
             D +  ML++DP  R  A  ++ H W+++ 
Sbjct: 312 --DFLSPMLQLDPRKRADAGGLVNHPWLKDT 340

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 75/331 (22%), Positives = 137/331 (41%), Gaps = 78/331 (23%)
Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
           RY+L ++LGWG F  +    D      +A K +  D++ T     + + EI+++ +++  
Sbjct: 20  RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT----EAAEDEIKLLQRVNDA 75
Query: 101 PNVVD--------LKAV----YEEEDYVHLLMELCAGGE-LFHRLEKYGR--FSETEARV 145
            N  +        LK +    ++  + VH++M     GE L   ++KY          + 
Sbjct: 76  DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ 135
Query: 146 IFRHLMQVVSYCHGN-GVVHRDLKPENILLATKSSSS---PIKLADFGLATYIKAGQNLH 201
           I + L+  + Y H   G++H D+KPEN+L+    S      IK+AD G A +    ++  
Sbjct: 136 ISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD--EHYT 193
Query: 202 GTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSG---------------------- 238
            ++ +  Y +PEVL G  +   AD+WS   +++ L++G                      
Sbjct: 194 NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 253
Query: 239 ------MPPFW---GKTKSKIFDA-----------------VRAADLRFPSDPWDHISAS 272
                 +P +    GK     F++                 V     +F  D    IS  
Sbjct: 254 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEIS-- 311
Query: 273 ARDLIMGMLRVDPSTRLTAAEVLAHSWMEEC 303
             D +  ML++DP  R  A  ++ H W+++ 
Sbjct: 312 --DFLSPMLQLDPRKRADAGGLVNHPWLKDT 340

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/275 (23%), Positives = 119/275 (43%), Gaps = 32/275 (11%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           +++G G+FG + +C  +  G + A K   K    +V++  +++ E+     L  H +VV 
Sbjct: 15  EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALR-EVYAHAVLGQHSHVVR 73
Query: 106 LKAVYEEEDYVHLLMELCAGGELFHRLEKYGR----FSETEARVIFRHLMQVVSYCHGNG 161
             + + E+D++ +  E C GG L   + +  R    F E E + +   + + + Y H   
Sbjct: 74  YFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS 133
Query: 162 VVHRDLKPENILLATKSSSSP----------------IKLADFGLATYIKAGQNLHGTVG 205
           +VH D+KP NI ++  S  +                  K+ D G  T I + Q      G
Sbjct: 134 LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV---EEG 190
Query: 206 SPFYIAPEVLAGGYNQ--AADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPS 263
              ++A EVL   Y     AD+++  + + +  +G  P         +  +R    R P 
Sbjct: 191 DSRFLANEVLQENYTHLPKADIFALALTV-VCAAGAEPL--PRNGDQWHEIRQG--RLPR 245
Query: 264 DPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHS 298
            P   +S    +L+  M+  DP  R +A  ++ HS
Sbjct: 246 IP-QVLSQEFTELLKVMIHPDPERRPSAMALVKHS 279

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 77/352 (21%), Positives = 143/352 (40%), Gaps = 89/352 (25%)
Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKL 97
           + D Y++   +G G +G +    DK T + +A K + +     + D + I  EI I+ +L
Sbjct: 24  VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR-MFEDLIDCKRILREITILNRL 82
Query: 98  SGHPNVVDLKAVYEEE----DYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQV 153
                +     +  ++    D +++++E+ A  +L    +     +E   + I  +L+  
Sbjct: 83  KSDYIIRLYDLIIPDDLLKFDELYIVLEI-ADSDLKKLFKTPIFLTEEHIKTILYNLLLG 141
Query: 154 VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN-------------- 199
            ++ H +G++HRDLKP N LL    S   +K+ DFGLA  I + ++              
Sbjct: 142 ENFIHESGIIHRDLKPANCLLNQDCS---VKVCDFGLARTINSEKDTNIVNDLEENEEPG 198
Query: 200 ---------LHGTVGSPFYIAPE--VLAGGYNQAADVWSAGVILYILLSGM--------- 239
                    L   V + +Y APE  +L   Y ++ D+WS G I   LL+ +         
Sbjct: 199 PHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN 258
Query: 240 --PPFWGKT--------KSK-------------IFDAVRAA---DLRFPSDP-------- 265
             P F G +         SK             IF+ +      DL+  + P        
Sbjct: 259 RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKL 318
Query: 266 ------------WDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ 305
                       +  IS    +L+  ML+ +P+ R+T  + L H ++++  +
Sbjct: 319 FPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRK 370

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/271 (25%), Positives = 122/271 (45%), Gaps = 34/271 (12%)
Query: 48  LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLK 107
           +G G FG + +   K  G  +           + +D R    E+E++ KL  HPN+++L 
Sbjct: 30  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 89
Query: 108 AVYEEEDYVHLLMELCAGGELFHRLEK---------YGRFSETEARVIFRHLMQVVS--- 155
              E   Y++L +E    G L   L K         +   + T + +  + L+   +   
Sbjct: 90  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 149
Query: 156 ----YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLH--GTVGS-PF 208
               Y      +HR+L   NIL+     +   K+ADFGL+     GQ ++   T+G  P 
Sbjct: 150 RGMDYLSQKQFIHRNLAARNILVGENYVA---KIADFGLSR----GQEVYVKKTMGRLPV 202
Query: 209 -YIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAV-RAADLRFPSD 264
            ++A E L    Y   +DVWS GV+L+ ++S G  P+ G T +++++ + +   L  P +
Sbjct: 203 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLN 262
Query: 265 PWDHISASARDLIMGMLRVDPSTRLTAAEVL 295
             D +     DL+    R  P  R + A++L
Sbjct: 263 CDDEVY----DLMRQCWREKPYERPSFAQIL 289

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 112/246 (45%), Gaps = 37/246 (15%)
Query: 40  DRYVLGKQLGWGQFGVI---------RECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLE 90
           DR VLGK LG G FG +         ++  ++ T   +A K +  D   T +D+  +  E
Sbjct: 21  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTK--VAVKMLKSD--ATEKDLSDLISE 76
Query: 91  IEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLE---------KYGRFSET 141
           +E+M  +  H N+++L     ++  +++++E  + G L   L+          Y      
Sbjct: 77  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 136
Query: 142 EARVIFRHLM----QV---VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI 194
           E ++  + L+    QV   + Y      +HRDL   N+L+   +  + +K+ADFGLA  I
Sbjct: 137 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDI 193
Query: 195 KAGQNLHGTVGSPF---YIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGKTKSK 249
                   T        ++APE L    Y   +DVWS GV+L+ I   G  P+ G    +
Sbjct: 194 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 253
Query: 250 IFDAVR 255
           +F  ++
Sbjct: 254 LFKLLK 259

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 108/243 (44%), Gaps = 31/243 (12%)
Query: 40  DRYVLGKQLGWGQFG--VIREC----SDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEI 93
           D+  LGK LG G FG  V+ E      DK    V     + KD   T +D+  +  E+E+
Sbjct: 22  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEM 80
Query: 94  MTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLE---------KYGRFSETEAR 144
           M  +  H N+++L     ++  +++++E  + G L   L           Y      E +
Sbjct: 81  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 140
Query: 145 VIFRHLMQV-------VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG 197
           + F+ L+         + Y      +HRDL   N+L+   + ++ +K+ADFGLA  I   
Sbjct: 141 MTFKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLV---TENNVMKIADFGLARDINNI 197
Query: 198 QNLHGTVGSPF---YIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGKTKSKIFD 252
                T        ++APE L    Y   +DVWS GV+++ I   G  P+ G    ++F 
Sbjct: 198 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 257
Query: 253 AVR 255
            ++
Sbjct: 258 LLK 260

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 112/246 (45%), Gaps = 37/246 (15%)
Query: 40  DRYVLGKQLGWGQFGVI---------RECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLE 90
           DR VLGK LG G FG +         ++  ++ T   +A K +  D   T +D+  +  E
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTK--VAVKMLKSD--ATEKDLSDLISE 68
Query: 91  IEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEK---------YGRFSET 141
           +E+M  +  H N+++L     ++  +++++E  + G L   L+          Y      
Sbjct: 69  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNP 128
Query: 142 EARVIFRHLM----QV---VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI 194
           E ++  + L+    QV   + Y      +HRDL   N+L+   +  + +K+ADFGLA  I
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDI 185
Query: 195 KAGQNLHGTVGSPF---YIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGKTKSK 249
                   T        ++APE L    Y   +DVWS GV+L+ I   G  P+ G    +
Sbjct: 186 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 245
Query: 250 IFDAVR 255
           +F  ++
Sbjct: 246 LFKLLK 251

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 112/246 (45%), Gaps = 37/246 (15%)
Query: 40  DRYVLGKQLGWGQFGVI---------RECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLE 90
           DR VLGK LG G FG +         ++  ++ T   +A K +  D   T +D+  +  E
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTK--VAVKMLKSD--ATEKDLSDLISE 83
Query: 91  IEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLE---------KYGRFSET 141
           +E+M  +  H N+++L     ++  +++++E  + G L   L+          Y      
Sbjct: 84  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNP 143
Query: 142 EARVIFRHLM----QV---VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI 194
           E ++  + L+    QV   + Y      +HRDL   N+L+   +  + +K+ADFGLA  I
Sbjct: 144 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDI 200
Query: 195 KAGQNLHGTVGSPF---YIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGKTKSK 249
                   T        ++APE L    Y   +DVWS GV+L+ I   G  P+ G    +
Sbjct: 201 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 260
Query: 250 IFDAVR 255
           +F  ++
Sbjct: 261 LFKLLK 266

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 112/246 (45%), Gaps = 37/246 (15%)
Query: 40  DRYVLGKQLGWGQFGVI---------RECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLE 90
           DR VLGK LG G FG +         ++  ++ T   +A K +  D   T +D+  +  E
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTK--VAVKMLKSD--ATEKDLSDLISE 83
Query: 91  IEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLE---------KYGRFSET 141
           +E+M  +  H N+++L     ++  +++++E  + G L   L+          Y      
Sbjct: 84  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 143
Query: 142 EARVIFRHLM----QV---VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI 194
           E ++  + L+    QV   + Y      +HRDL   N+L+   +  + +K+ADFGLA  I
Sbjct: 144 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDI 200
Query: 195 KAGQNLHGTVGSPF---YIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGKTKSK 249
                   T        ++APE L    Y   +DVWS GV+L+ I   G  P+ G    +
Sbjct: 201 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 260
Query: 250 IFDAVR 255
           +F  ++
Sbjct: 261 LFKLLK 266

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 108/243 (44%), Gaps = 31/243 (12%)
Query: 40  DRYVLGKQLGWGQFG--VIREC----SDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEI 93
           D+  LGK LG G FG  V+ E      DK    V     + KD   T +D+  +  E+E+
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEM 139
Query: 94  MTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLE---------KYGRFSETEAR 144
           M  +  H N+++L     ++  +++++E  + G L   L           Y      E +
Sbjct: 140 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 199
Query: 145 VIFRHLMQV-------VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG 197
           + F+ L+         + Y      +HRDL   N+L+   + ++ +K+ADFGLA  I   
Sbjct: 200 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLARDINNI 256
Query: 198 QNLHGTVGSPF---YIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGKTKSKIFD 252
                T        ++APE L    Y   +DVWS GV+++ I   G  P+ G    ++F 
Sbjct: 257 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 316
Query: 253 AVR 255
            ++
Sbjct: 317 LLK 319

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 119/234 (50%), Gaps = 23/234 (9%)
Query: 27  GTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRS 86
           G+++D ++++ +       +++G GQFG++         + +A K+I ++  ++ ED   
Sbjct: 1   GSVIDPSELTFV-------QEIGSGQFGLVH-LGYWLNKDKVAIKTI-REGAMSEEDFIE 51
Query: 87  IKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLE-KYGRFSETEARV 145
              E E+M KLS HP +V L  V  E+  + L+ E    G L   L  + G F+      
Sbjct: 52  ---EAEVMMKLS-HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLG 107
Query: 146 IFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVG 205
           +   + + ++Y     V+HRDL   N L+     +  IK++DFG+  ++   Q    T G
Sbjct: 108 MCLDVCEGMAYLEEASVIHRDLAARNCLVG---ENQVIKVSDFGMTRFVLDDQYTSST-G 163
Query: 206 SPF---YIAPEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAV 254
           + F   + +PEV +   Y+  +DVWS GV+++ + S G  P+  ++ S++ + +
Sbjct: 164 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 217

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 112/246 (45%), Gaps = 37/246 (15%)
Query: 40  DRYVLGKQLGWGQFGVI---------RECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLE 90
           DR VLGK LG G FG +         ++  ++ T   +A K +  D   T +D+  +  E
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTK--VAVKMLKSD--ATEKDLSDLISE 83
Query: 91  IEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEK---------YGRFSET 141
           +E+M  +  H N+++L     ++  +++++E  + G L   L+          Y      
Sbjct: 84  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNP 143
Query: 142 EARVIFRHLM----QV---VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI 194
           E ++  + L+    QV   + Y      +HRDL   N+L+   +  + +K+ADFGLA  I
Sbjct: 144 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDI 200
Query: 195 KAGQNLHGTVGSPF---YIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGKTKSK 249
                   T        ++APE L    Y   +DVWS GV+L+ I   G  P+ G    +
Sbjct: 201 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 260
Query: 250 IFDAVR 255
           +F  ++
Sbjct: 261 LFKLLK 266

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 128/283 (45%), Gaps = 23/283 (8%)
Query: 36  SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMT 95
           + ++D   LG ++G G  G + +   + TG V+A K +   R    E+ + I ++++++ 
Sbjct: 22  AEINDLENLG-EMGSGTCGQVWKMRFRKTGHVIAVKQMR--RSGNKEENKRILMDLDVVL 78
Query: 96  KLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS 155
           K    P +V     +     V + MEL   G    +L+K  +    E R++ +  + +V 
Sbjct: 79  KSHDCPYIVQCFGTFITNTDVFIAMELM--GTCAEKLKKRMQGPIPE-RILGKMTVAIVK 135
Query: 156 YCH----GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIA 211
             +     +GV+HRD+KP NILL  +     IKL DFG++  +   +    + G   Y+A
Sbjct: 136 ALYYLKEKHGVIHRDVKPSNILLDERGQ---IKLCDFGISGRLVDDKAKDRSAGCAAYMA 192
Query: 212 PEVL------AGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDP 265
           PE +         Y+  ADVWS G+ L  L +G  P+  K     F+ +       P   
Sbjct: 193 PERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPY--KNCKTDFEVLTKVLQEEPPLL 250
Query: 266 WDHISASA--RDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQV 306
             H+  S   +  +   L  D   R    ++L HS+++  E +
Sbjct: 251 PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETL 293

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 112/246 (45%), Gaps = 37/246 (15%)
Query: 40  DRYVLGKQLGWGQFGVI---------RECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLE 90
           DR VLGK LG G FG +         ++  ++ T   +A K +  D   T +D+  +  E
Sbjct: 17  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTK--VAVKMLKSD--ATEKDLSDLISE 72
Query: 91  IEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLE---------KYGRFSET 141
           +E+M  +  H N+++L     ++  +++++E  + G L   L+          Y      
Sbjct: 73  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 132
Query: 142 EARVIFRHLM----QV---VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI 194
           E ++  + L+    QV   + Y      +HRDL   N+L+   +  + +K+ADFGLA  I
Sbjct: 133 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDI 189
Query: 195 KAGQNLHGTVGSPF---YIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGKTKSK 249
                   T        ++APE L    Y   +DVWS GV+L+ I   G  P+ G    +
Sbjct: 190 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 249
Query: 250 IFDAVR 255
           +F  ++
Sbjct: 250 LFKLLK 255

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 97/203 (47%), Gaps = 18/203 (8%)
Query: 46  KQLGWGQFGVIR-ECSDKF---TGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           + LG G FG +   C D     TGE++A K++  D     +     K EI+I+  L  H 
Sbjct: 20  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--CGPQHRSGWKQEIDILRTLY-HE 76
Query: 102 NVVDLKAVYEE--EDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
           +++  K   E+  E  + L+ME    G L   L ++      +  +  + + + ++Y H 
Sbjct: 77  HIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLHA 135
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTV---GSP-FYIAPEVL 215
              +HR+L   N+LL    +   +K+ DFGLA  +  G   +       SP F+ APE L
Sbjct: 136 QHYIHRNLAARNVLL---DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 192
Query: 216 AG-GYNQAADVWSAGVILYILLS 237
               +  A+DVWS GV LY LL+
Sbjct: 193 KEYKFYYASDVWSFGVTLYELLT 215

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 108/243 (44%), Gaps = 31/243 (12%)
Query: 40  DRYVLGKQLGWGQFG--VIREC----SDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEI 93
           D+  LGK LG G FG  V+ E      DK    V     + KD   T +D+  +  E+E+
Sbjct: 24  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEM 82
Query: 94  MTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLE---------KYGRFSETEAR 144
           M  +  H N+++L     ++  +++++E  + G L   L           Y      E +
Sbjct: 83  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 142
Query: 145 VIFRHLMQV-------VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG 197
           + F+ L+         + Y      +HRDL   N+L+   + ++ +K+ADFGLA  I   
Sbjct: 143 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLARDINNI 199
Query: 198 QNLHGTVGSPF---YIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGKTKSKIFD 252
                T        ++APE L    Y   +DVWS GV+++ I   G  P+ G    ++F 
Sbjct: 200 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 259
Query: 253 AVR 255
            ++
Sbjct: 260 LLK 262

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 108/243 (44%), Gaps = 31/243 (12%)
Query: 40  DRYVLGKQLGWGQFG--VIREC----SDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEI 93
           D+  LGK LG G FG  V+ E      DK    V     + KD   T +D+  +  E+E+
Sbjct: 27  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEM 85
Query: 94  MTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLE---------KYGRFSETEAR 144
           M  +  H N+++L     ++  +++++E  + G L   L           Y      E +
Sbjct: 86  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 145
Query: 145 VIFRHLMQV-------VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG 197
           + F+ L+         + Y      +HRDL   N+L+   + ++ +K+ADFGLA  I   
Sbjct: 146 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLARDINNI 202
Query: 198 QNLHGTVGSPF---YIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGKTKSKIFD 252
                T        ++APE L    Y   +DVWS GV+++ I   G  P+ G    ++F 
Sbjct: 203 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 262
Query: 253 AVR 255
            ++
Sbjct: 263 LLK 265

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 112/246 (45%), Gaps = 37/246 (15%)
Query: 40  DRYVLGKQLGWGQFGVI---------RECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLE 90
           DR VLGK LG G FG +         ++  ++ T   +A K +  D   T +D+  +  E
Sbjct: 20  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTK--VAVKMLKSD--ATEKDLSDLISE 75
Query: 91  IEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLE---------KYGRFSET 141
           +E+M  +  H N+++L     ++  +++++E  + G L   L+          Y      
Sbjct: 76  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 135
Query: 142 EARVIFRHLM----QV---VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI 194
           E ++  + L+    QV   + Y      +HRDL   N+L+   +  + +K+ADFGLA  I
Sbjct: 136 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDI 192
Query: 195 KAGQNLHGTVGSPF---YIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGKTKSK 249
                   T        ++APE L    Y   +DVWS GV+L+ I   G  P+ G    +
Sbjct: 193 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 252
Query: 250 IFDAVR 255
           +F  ++
Sbjct: 253 LFKLLK 258

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 108/243 (44%), Gaps = 31/243 (12%)
Query: 40  DRYVLGKQLGWGQFG--VIREC----SDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEI 93
           D+  LGK LG G FG  V+ E      DK    V     + KD   T +D+  +  E+E+
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEM 93
Query: 94  MTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLE---------KYGRFSETEAR 144
           M  +  H N+++L     ++  +++++E  + G L   L           Y      E +
Sbjct: 94  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 145 VIFRHLMQV-------VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG 197
           + F+ L+         + Y      +HRDL   N+L+   + ++ +++ADFGLA  I   
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV---TENNVMRIADFGLARDINNI 210
Query: 198 QNLHGTVGSPF---YIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGKTKSKIFD 252
                T        ++APE L    Y   +DVWS GV+++ I   G  P+ G    ++F 
Sbjct: 211 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270
Query: 253 AVR 255
            ++
Sbjct: 271 LLK 273

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 97/203 (47%), Gaps = 18/203 (8%)
Query: 46  KQLGWGQFGVIR-ECSDKF---TGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           + LG G FG +   C D     TGE++A K++  D     +     K EI+I+  L  H 
Sbjct: 20  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--CGPQHRSGWKQEIDILRTLY-HE 76
Query: 102 NVVDLKAVYEE--EDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
           +++  K   E+  E  + L+ME    G L   L ++      +  +  + + + ++Y H 
Sbjct: 77  HIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLHS 135
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTV---GSP-FYIAPEVL 215
              +HR+L   N+LL    +   +K+ DFGLA  +  G   +       SP F+ APE L
Sbjct: 136 QHYIHRNLAARNVLL---DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 192
Query: 216 AG-GYNQAADVWSAGVILYILLS 237
               +  A+DVWS GV LY LL+
Sbjct: 193 KEYKFYYASDVWSFGVTLYELLT 215

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 107/243 (44%), Gaps = 31/243 (12%)
Query: 40  DRYVLGKQLGWGQFG--VIREC----SDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEI 93
           D+  LGK LG G FG  V+ E      DK    V     + KD   T +D+  +  E+E+
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEM 93
Query: 94  MTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLE---------KYGRFSETEAR 144
           M  +  H N++ L     ++  +++++E  + G L   L           Y      E +
Sbjct: 94  MKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 145 VIFRHLMQV-------VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG 197
           + F+ L+         + Y      +HRDL   N+L+   + ++ +K+ADFGLA  I   
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLARDINNI 210
Query: 198 QNLHGTVGSPF---YIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGKTKSKIFD 252
                T        ++APE L    Y   +DVWS GV+++ I   G  P+ G    ++F 
Sbjct: 211 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270
Query: 253 AVR 255
            ++
Sbjct: 271 LLK 273

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/249 (26%), Positives = 114/249 (45%), Gaps = 43/249 (17%)
Query: 40  DRYVLGKQLGWGQFGVI---------RECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLE 90
           DR VLGK LG G FG +         ++  ++ T   +A K +  D   T +D+  +  E
Sbjct: 69  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTK--VAVKMLKSD--ATEKDLSDLISE 124
Query: 91  IEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLE---------KYGRFSET 141
           +E+M  +  H N+++L     ++  +++++E  + G L   L+          Y      
Sbjct: 125 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 184
Query: 142 EARVIFRHLM----QV---VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLAT-- 192
           E ++  + L+    QV   + Y      +HRDL   N+L+   +  + +K+ADFGLA   
Sbjct: 185 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDI 241
Query: 193 ----YIKAGQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGKT 246
               Y K   N    V    ++APE L    Y   +DVWS GV+L+ I   G  P+ G  
Sbjct: 242 HHIDYYKKTTNGRLPVK---WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 298
Query: 247 KSKIFDAVR 255
             ++F  ++
Sbjct: 299 VEELFKLLK 307

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 107/243 (44%), Gaps = 31/243 (12%)
Query: 40  DRYVLGKQLGWGQFG--VIREC----SDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEI 93
           D+  LGK LG G FG  V+ E      DK    V     + KD   T +D+  +  E+E+
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEM 93
Query: 94  MTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLE---------KYGRFSETEAR 144
           M  +  H N++ L     ++  +++++E  + G L   L           Y      E +
Sbjct: 94  MKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 145 VIFRHLMQV-------VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG 197
           + F+ L+         + Y      +HRDL   N+L+   + ++ +K+ADFGLA  I   
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLARDINNI 210
Query: 198 QNLHGTVGSPF---YIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGKTKSKIFD 252
                T        ++APE L    Y   +DVWS GV+++ I   G  P+ G    ++F 
Sbjct: 211 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270
Query: 253 AVR 255
            ++
Sbjct: 271 LLK 273

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 110/223 (49%), Gaps = 19/223 (8%)
Query: 46  KQLGWGQFGVIRECSDKFTGEV-LACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVV 104
           K+LG GQFGV++    K+ G+  +A K I +  +   E +     E ++M  LS H  +V
Sbjct: 14  KELGTGQFGVVK--YGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMNLS-HEKLV 66
Query: 105 DLKAVYEEEDYVHLLMELCAGGELFHRL-EKYGRFSETEARVIFRHLMQVVSYCHGNGVV 163
            L  V  ++  + ++ E  A G L + L E   RF   +   + + + + + Y      +
Sbjct: 67  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL 126
Query: 164 HRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF---YIAPEVLA-GGY 219
           HRDL   N L+   +    +K++DFGL+ Y+        +VGS F   +  PEVL    +
Sbjct: 127 HRDLAARNCLV---NDQGVVKVSDFGLSRYV-LDDEYTSSVGSKFPVRWSPPEVLMYSKF 182
Query: 220 NQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRF 261
           +  +D+W+ GV+++ + S G  P+   T S+  + + A  LR 
Sbjct: 183 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI-AQGLRL 224

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 119/234 (50%), Gaps = 23/234 (9%)
Query: 27  GTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRS 86
           G+++D ++++ +       +++G GQFG++         + +A K+I ++  ++ ED   
Sbjct: 1   GSVIDPSELTFV-------QEIGSGQFGLVH-LGYWLNKDKVAIKTI-REGAMSEEDFIE 51
Query: 87  IKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLE-KYGRFSETEARV 145
              E E+M KLS HP +V L  V  E+  + L+ E    G L   L  + G F+      
Sbjct: 52  ---EAEVMMKLS-HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLG 107
Query: 146 IFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVG 205
           +   + + ++Y     V+HRDL   N L+     +  IK++DFG+  ++   Q    T G
Sbjct: 108 MCLDVCEGMAYLEEACVIHRDLAARNCLVG---ENQVIKVSDFGMTRFVLDDQYTSST-G 163
Query: 206 SPF---YIAPEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAV 254
           + F   + +PEV +   Y+  +DVWS GV+++ + S G  P+  ++ S++ + +
Sbjct: 164 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 217

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 111/223 (49%), Gaps = 19/223 (8%)
Query: 46  KQLGWGQFGVIRECSDKFTGEV-LACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVV 104
           K+LG GQFGV++    K+ G+  +A K I +  +   E +     E ++M  LS H  +V
Sbjct: 30  KELGTGQFGVVK--YGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMNLS-HEKLV 82
Query: 105 DLKAVYEEEDYVHLLMELCAGGELFHRL-EKYGRFSETEARVIFRHLMQVVSYCHGNGVV 163
            L  V  ++  + ++ E  A G L + L E   RF   +   + + + + + Y      +
Sbjct: 83  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL 142
Query: 164 HRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF---YIAPEVLA-GGY 219
           HRDL   N L+   +    +K++DFGL+ Y+   +    +VGS F   +  PEVL    +
Sbjct: 143 HRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEET-SSVGSKFPVRWSPPEVLMYSKF 198
Query: 220 NQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRF 261
           +  +D+W+ GV+++ + S G  P+   T S+  + + A  LR 
Sbjct: 199 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI-AQGLRL 240

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 81/271 (29%), Positives = 121/271 (44%), Gaps = 23/271 (8%)
Query: 27  GTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRS 86
           G   DA +I   S R  L  +LG G FG +   +   T  V A K++    +       +
Sbjct: 7   GLAKDAWEIPRESLR--LEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEA 59
Query: 87  IKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLE-KYGRFSETEARV 145
              E ++M KL  H  +V L AV  EE  ++++ME  + G L   L+ + G++      V
Sbjct: 60  FLQEAQVMKKLR-HEKLVQLYAVVSEEP-IYIVMEYMSKGCLLDFLKGEMGKYLRLPQLV 117
Query: 146 -IFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTV 204
            +   +   ++Y      VHRDL+  NIL+         K+ADFGLA  I+  +      
Sbjct: 118 DMAAQIASGMAYVERMNYVHRDLRAANILVGENLVC---KVADFGLARLIEDNE-YTARQ 173
Query: 205 GSPF---YIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADL 259
           G+ F   + APE  L G +   +DVWS G++L  L + G  P+ G    ++ D V     
Sbjct: 174 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-Y 232
Query: 260 RFPSDPWDHISASARDLIMGMLRVDPSTRLT 290
           R P  P      S  DL+    R DP  R T
Sbjct: 233 RMPCPP--ECPESLHDLMCQCWRKDPEERPT 261

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 112/246 (45%), Gaps = 37/246 (15%)
Query: 40  DRYVLGKQLGWGQFGVI---------RECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLE 90
           DR VLGK LG G FG +         ++  ++ T   +A K +  D   T +D+  +  E
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTK--VAVKMLKSD--ATEKDLSDLISE 83
Query: 91  IEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLE---------KYGRFSET 141
           +E+M  +  H N+++L     ++  +++++E  + G L   L+          +      
Sbjct: 84  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNP 143
Query: 142 EARVIFRHLM----QV---VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI 194
           E ++  + L+    QV   + Y      +HRDL   N+L+   +  + +K+ADFGLA  I
Sbjct: 144 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDI 200
Query: 195 KAGQNLHGTVGSPF---YIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGKTKSK 249
                   T        ++APE L    Y   +DVWS GV+L+ I   G  P+ G    +
Sbjct: 201 HHIDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 260
Query: 250 IFDAVR 255
           +F  ++
Sbjct: 261 LFKLLK 266

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 110/223 (49%), Gaps = 19/223 (8%)
Query: 46  KQLGWGQFGVIRECSDKFTGEV-LACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVV 104
           K+LG GQFGV++    K+ G+  +A K I +  +   E +     E ++M  LS H  +V
Sbjct: 10  KELGTGQFGVVK--YGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMNLS-HEKLV 62
Query: 105 DLKAVYEEEDYVHLLMELCAGGELFHRL-EKYGRFSETEARVIFRHLMQVVSYCHGNGVV 163
            L  V  ++  + ++ E  A G L + L E   RF   +   + + + + + Y      +
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL 122
Query: 164 HRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF---YIAPEVLA-GGY 219
           HRDL   N L+   +    +K++DFGL+ Y+        +VGS F   +  PEVL    +
Sbjct: 123 HRDLAARNCLV---NDQGVVKVSDFGLSRYV-LDDEYTSSVGSKFPVRWSPPEVLMYSKF 178
Query: 220 NQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRF 261
           +  +D+W+ GV+++ + S G  P+   T S+  + + A  LR 
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI-AQGLRL 220

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 110/223 (49%), Gaps = 19/223 (8%)
Query: 46  KQLGWGQFGVIRECSDKFTGEV-LACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVV 104
           K+LG GQFGV++    K+ G+  +A K I +  +   E +     E ++M  LS H  +V
Sbjct: 21  KELGTGQFGVVK--YGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMNLS-HEKLV 73
Query: 105 DLKAVYEEEDYVHLLMELCAGGELFHRL-EKYGRFSETEARVIFRHLMQVVSYCHGNGVV 163
            L  V  ++  + ++ E  A G L + L E   RF   +   + + + + + Y      +
Sbjct: 74  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL 133
Query: 164 HRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF---YIAPEVLA-GGY 219
           HRDL   N L+   +    +K++DFGL+ Y+        +VGS F   +  PEVL    +
Sbjct: 134 HRDLAARNCLV---NDQGVVKVSDFGLSRYV-LDDEYTSSVGSKFPVRWSPPEVLMYSKF 189
Query: 220 NQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRF 261
           +  +D+W+ GV+++ + S G  P+   T S+  + + A  LR 
Sbjct: 190 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI-AQGLRL 231

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 110/223 (49%), Gaps = 19/223 (8%)
Query: 46  KQLGWGQFGVIRECSDKFTGEV-LACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVV 104
           K+LG GQFGV++    K+ G+  +A K I +  +   E +     E ++M  LS H  +V
Sbjct: 30  KELGTGQFGVVK--YGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMNLS-HEKLV 82
Query: 105 DLKAVYEEEDYVHLLMELCAGGELFHRL-EKYGRFSETEARVIFRHLMQVVSYCHGNGVV 163
            L  V  ++  + ++ E  A G L + L E   RF   +   + + + + + Y      +
Sbjct: 83  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL 142
Query: 164 HRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF---YIAPEVLA-GGY 219
           HRDL   N L+   +    +K++DFGL+ Y+        +VGS F   +  PEVL    +
Sbjct: 143 HRDLAARNCLV---NDQGVVKVSDFGLSRYV-LDDEYTSSVGSKFPVRWSPPEVLMYSKF 198
Query: 220 NQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRF 261
           +  +D+W+ GV+++ + S G  P+   T S+  + + A  LR 
Sbjct: 199 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI-AQGLRL 240

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 110/223 (49%), Gaps = 19/223 (8%)
Query: 46  KQLGWGQFGVIRECSDKFTGEV-LACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVV 104
           K+LG GQFGV++    K+ G+  +A K I +  +   E +     E ++M  LS H  +V
Sbjct: 15  KELGTGQFGVVK--YGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMNLS-HEKLV 67
Query: 105 DLKAVYEEEDYVHLLMELCAGGELFHRL-EKYGRFSETEARVIFRHLMQVVSYCHGNGVV 163
            L  V  ++  + ++ E  A G L + L E   RF   +   + + + + + Y      +
Sbjct: 68  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL 127
Query: 164 HRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF---YIAPEVLA-GGY 219
           HRDL   N L+   +    +K++DFGL+ Y+        +VGS F   +  PEVL    +
Sbjct: 128 HRDLAARNCLV---NDQGVVKVSDFGLSRYV-LDDEYTSSVGSKFPVRWSPPEVLMYSKF 183
Query: 220 NQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRF 261
           +  +D+W+ GV+++ + S G  P+   T S+  + + A  LR 
Sbjct: 184 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI-AQGLRL 225

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 105/232 (45%), Gaps = 21/232 (9%)
Query: 44  LGKQLGWGQFGVIRECS-DKFTGEVL--ACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
           L ++LG G FGV+R    D  +G+ +  A K +  D L   E +     E+  M  L  H
Sbjct: 16  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-H 74
Query: 101 PNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQV---VSY 156
            N++ L  V      + ++ EL   G L  RL K+ G F       + R+ +QV   + Y
Sbjct: 75  RNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFL---LGTLSRYAVQVAEGMGY 130
Query: 157 CHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPF-YIAP 212
                 +HRDL   N+LLAT+     +K+ DFGL   +    +   +      PF + AP
Sbjct: 131 LESKRFIHRDLAARNLLLATRDL---VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 187
Query: 213 EVL-AGGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFP 262
           E L    ++ A+D W  GV L+ + + G  P+ G   S+I   +     R P
Sbjct: 188 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 239

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 80/271 (29%), Positives = 121/271 (44%), Gaps = 23/271 (8%)
Query: 27  GTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRS 86
           G   DA +I   S R  L  +LG G FG +   +   T  V A K++    +       +
Sbjct: 7   GLAKDAWEIPRESLR--LEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEA 59
Query: 87  IKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLE-KYGRFSETEARV 145
              E ++M KL  H  +V L AV  EE  +++++E  + G L   L+ + G++      V
Sbjct: 60  FLQEAQVMKKLR-HEKLVQLYAVVSEEP-IYIVIEYMSKGSLLDFLKGEMGKYLRLPQLV 117
Query: 146 -IFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTV 204
            +   +   ++Y      VHRDL+  NIL+         K+ADFGLA  I+  +      
Sbjct: 118 DMAAQIASGMAYVERMNYVHRDLRAANILVGENLVC---KVADFGLARLIEDNEXT-ARQ 173
Query: 205 GSPF---YIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADL 259
           G+ F   + APE  L G +   +DVWS G++L  L + G  P+ G    ++ D V     
Sbjct: 174 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-Y 232
Query: 260 RFPSDPWDHISASARDLIMGMLRVDPSTRLT 290
           R P  P      S  DL+    R DP  R T
Sbjct: 233 RMPCPP--ECPESLHDLMCQCWRKDPEERPT 261

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 13/205 (6%)
Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRS-IKLEIEIMTKLSGHP 101
           V G + G G FGV+ +     T   +A K +A    +T E+++     EI++  K   H 
Sbjct: 25  VGGNKXGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQ-HE 81
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRL---EKYGRFSETEARVIFRHLMQVVSYCH 158
           N+V+L     + D + L+      G L  RL   +     S      I +     +++ H
Sbjct: 82  NLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLH 141
Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLA-TYIKAGQNLHGT--VGSPFYIAPEVL 215
            N  +HRD+K  NILL    ++   K++DFGLA    K  Q +  +  VG+  Y APE L
Sbjct: 142 ENHHIHRDIKSANILLDEAFTA---KISDFGLARASEKFAQXVXXSRIVGTTAYXAPEAL 198
Query: 216 AGGYNQAADVWSAGVILYILLSGMP 240
            G     +D++S GV+L  +++G+P
Sbjct: 199 RGEITPKSDIYSFGVVLLEIITGLP 223

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 71/254 (27%), Positives = 115/254 (45%), Gaps = 25/254 (9%)
Query: 44  LGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNV 103
           L + +G G+FG +      + G  +A K I  D        ++   E  +MT+L  H N+
Sbjct: 197 LLQTIGKGEFGDV--MLGDYRGNKVAVKCIKND-----ATAQAFLAEASVMTQLR-HSNL 248
Query: 104 VDLKAV-YEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQV---VSYCHG 159
           V L  V  EE+  ++++ E  A G L   L   GR S      + +  + V   + Y  G
Sbjct: 249 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEG 307
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF-YIAPEVL-AG 217
           N  VHRDL   N+L+   S  +  K++DFGL    K   +   T   P  + APE L   
Sbjct: 308 NNFVHRDLAARNVLV---SEDNVAKVSDFGLT---KEASSTQDTGKLPVKWTAPEALREK 361
Query: 218 GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDL 276
            ++  +DVWS G++L+ + S G  P+    +  + D V   +  +  D  D    +  D+
Sbjct: 362 KFSTKSDVWSFGILLWEIYSFGRVPY---PRIPLKDVVPRVEKGYKMDAPDGCPPAVYDV 418
Query: 277 IMGMLRVDPSTRLT 290
           +     +D +TR T
Sbjct: 419 MKNCWHLDAATRPT 432

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 96/203 (47%), Gaps = 18/203 (8%)
Query: 46  KQLGWGQFGVIR-ECSDKF---TGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           + LG G FG +   C D     TGE++A K++  D     +     K EI+I+  L  H 
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--AGPQHRSGWKQEIDILRTLY-HE 93
Query: 102 NVVDLKAVYEEEDY--VHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
           +++  K   E+     + L+ME    G L   L ++      +  +  + + + ++Y H 
Sbjct: 94  HIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLHA 152
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTV---GSP-FYIAPEVL 215
              +HRDL   N+LL    +   +K+ DFGLA  +  G   +       SP F+ APE L
Sbjct: 153 QHYIHRDLAARNVLL---DNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECL 209
Query: 216 AG-GYNQAADVWSAGVILYILLS 237
               +  A+DVWS GV LY LL+
Sbjct: 210 KEYKFYYASDVWSFGVTLYELLT 232

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 80/271 (29%), Positives = 121/271 (44%), Gaps = 23/271 (8%)
Query: 27  GTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRS 86
           G   DA +I   S R  L  +LG G FG +   +   T  V A K++    +       +
Sbjct: 7   GLAKDAWEIPRESLR--LEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEA 59
Query: 87  IKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLE-KYGRFSETEARV 145
              E ++M KL  H  +V L AV  EE  +++++E  + G L   L+ + G++      V
Sbjct: 60  FLQEAQVMKKLR-HEKLVQLYAVVSEEP-IYIVIEYMSKGSLLDFLKGEMGKYLRLPQLV 117
Query: 146 -IFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTV 204
            +   +   ++Y      VHRDL+  NIL+         K+ADFGLA  I+  +      
Sbjct: 118 DMAAQIASGMAYVERMNYVHRDLRAANILVGENLVC---KVADFGLARLIEDNE-YTARQ 173
Query: 205 GSPF---YIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADL 259
           G+ F   + APE  L G +   +DVWS G++L  L + G  P+ G    ++ D V     
Sbjct: 174 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-Y 232
Query: 260 RFPSDPWDHISASARDLIMGMLRVDPSTRLT 290
           R P  P      S  DL+    R DP  R T
Sbjct: 233 RMPCPP--ECPESLHDLMCQCWRKDPEERPT 261

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 105/232 (45%), Gaps = 21/232 (9%)
Query: 44  LGKQLGWGQFGVIRECS-DKFTGEVL--ACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
           L ++LG G FGV+R    D  +G+ +  A K +  D L   E +     E+  M  L  H
Sbjct: 16  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-H 74
Query: 101 PNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQV---VSY 156
            N++ L  V      + ++ EL   G L  RL K+ G F       + R+ +QV   + Y
Sbjct: 75  RNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFL---LGTLSRYAVQVAEGMGY 130
Query: 157 CHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPF-YIAP 212
                 +HRDL   N+LLAT+     +K+ DFGL   +    +   +      PF + AP
Sbjct: 131 LESKRFIHRDLAARNLLLATRDL---VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 187
Query: 213 EVL-AGGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFP 262
           E L    ++ A+D W  GV L+ + + G  P+ G   S+I   +     R P
Sbjct: 188 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 239

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 105/232 (45%), Gaps = 21/232 (9%)
Query: 44  LGKQLGWGQFGVIRECS-DKFTGEVL--ACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
           L ++LG G FGV+R    D  +G+ +  A K +  D L   E +     E+  M  L  H
Sbjct: 22  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-H 80
Query: 101 PNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQV---VSY 156
            N++ L  V      + ++ EL   G L  RL K+ G F       + R+ +QV   + Y
Sbjct: 81  RNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFL---LGTLSRYAVQVAEGMGY 136
Query: 157 CHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPF-YIAP 212
                 +HRDL   N+LLAT+     +K+ DFGL   +    +   +      PF + AP
Sbjct: 137 LESKRFIHRDLAARNLLLATRDL---VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 193
Query: 213 EVL-AGGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFP 262
           E L    ++ A+D W  GV L+ + + G  P+ G   S+I   +     R P
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 245

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 105/232 (45%), Gaps = 21/232 (9%)
Query: 44  LGKQLGWGQFGVIRECS-DKFTGEVL--ACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
           L ++LG G FGV+R    D  +G+ +  A K +  D L   E +     E+  M  L  H
Sbjct: 22  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-H 80
Query: 101 PNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQV---VSY 156
            N++ L  V      + ++ EL   G L  RL K+ G F       + R+ +QV   + Y
Sbjct: 81  RNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFL---LGTLSRYAVQVAEGMGY 136
Query: 157 CHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPF-YIAP 212
                 +HRDL   N+LLAT+     +K+ DFGL   +    +   +      PF + AP
Sbjct: 137 LESKRFIHRDLAARNLLLATRDL---VKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAP 193
Query: 213 EVL-AGGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFP 262
           E L    ++ A+D W  GV L+ + + G  P+ G   S+I   +     R P
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 245

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 105/232 (45%), Gaps = 21/232 (9%)
Query: 44  LGKQLGWGQFGVIRECS-DKFTGEVL--ACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
           L ++LG G FGV+R    D  +G+ +  A K +  D L   E +     E+  M  L  H
Sbjct: 12  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-H 70
Query: 101 PNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQV---VSY 156
            N++ L  V      + ++ EL   G L  RL K+ G F       + R+ +QV   + Y
Sbjct: 71  RNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFL---LGTLSRYAVQVAEGMGY 126
Query: 157 CHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPF-YIAP 212
                 +HRDL   N+LLAT+     +K+ DFGL   +    +   +      PF + AP
Sbjct: 127 LESKRFIHRDLAARNLLLATRDL---VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 213 EVL-AGGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFP 262
           E L    ++ A+D W  GV L+ + + G  P+ G   S+I   +     R P
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 235

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 105/232 (45%), Gaps = 21/232 (9%)
Query: 44  LGKQLGWGQFGVIRECS-DKFTGEVL--ACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
           L ++LG G FGV+R    D  +G+ +  A K +  D L   E +     E+  M  L  H
Sbjct: 12  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-H 70
Query: 101 PNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQV---VSY 156
            N++ L  V      + ++ EL   G L  RL K+ G F       + R+ +QV   + Y
Sbjct: 71  RNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFL---LGTLSRYAVQVAEGMGY 126
Query: 157 CHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPF-YIAP 212
                 +HRDL   N+LLAT+     +K+ DFGL   +    +   +      PF + AP
Sbjct: 127 LESKRFIHRDLAARNLLLATRDL---VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 213 EVL-AGGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFP 262
           E L    ++ A+D W  GV L+ + + G  P+ G   S+I   +     R P
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 235

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 107/243 (44%), Gaps = 31/243 (12%)
Query: 40  DRYVLGKQLGWGQFG--VIREC----SDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEI 93
           D+  LGK LG G FG  V+ E      DK    V     + KD   T +D+  +  E+E+
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEM 93
Query: 94  MTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLE---------KYGRFSETEAR 144
           M  +  H N+++L     ++  +++++   + G L   L           Y      E +
Sbjct: 94  MKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 145 VIFRHLMQV-------VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG 197
           + F+ L+         + Y      +HRDL   N+L+   + ++ +K+ADFGLA  I   
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLARDINNI 210
Query: 198 QNLHGTVGSPF---YIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGKTKSKIFD 252
                T        ++APE L    Y   +DVWS GV+++ I   G  P+ G    ++F 
Sbjct: 211 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270
Query: 253 AVR 255
            ++
Sbjct: 271 LLK 273

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 105/232 (45%), Gaps = 21/232 (9%)
Query: 44  LGKQLGWGQFGVIRECS-DKFTGEVL--ACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
           L ++LG G FGV+R    D  +G+ +  A K +  D L   E +     E+  M  L  H
Sbjct: 12  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-H 70
Query: 101 PNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQV---VSY 156
            N++ L  V      + ++ EL   G L  RL K+ G F       + R+ +QV   + Y
Sbjct: 71  RNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFL---LGTLSRYAVQVAEGMGY 126
Query: 157 CHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPF-YIAP 212
                 +HRDL   N+LLAT+     +K+ DFGL   +    +   +      PF + AP
Sbjct: 127 LESKRFIHRDLAARNLLLATRDL---VKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAP 183
Query: 213 EVL-AGGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFP 262
           E L    ++ A+D W  GV L+ + + G  P+ G   S+I   +     R P
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 235

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 104/210 (49%), Gaps = 12/210 (5%)
Query: 47  QLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDL 106
           +LG G  GV+ +   + +G ++A K I  +    + +   I  E++++ + +  P +V  
Sbjct: 23  ELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRN--QIIRELQVLHECNS-PYIVGF 79
Query: 107 KAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCH-GNGVVHR 165
              +  +  + + ME   GG L   L++  R  E     +   +++ ++Y    + ++HR
Sbjct: 80  YGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHR 139
Query: 166 DLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGG-YNQAAD 224
           D+KP NIL+ ++     IKL DFG++  +      +  VG+  Y+APE L G  Y+  +D
Sbjct: 140 DVKPSNILVNSRGE---IKLCDFGVSGQL-IDSMANSFVGTRSYMAPERLQGTHYSVQSD 195
Query: 225 VWSAGVILYILLSG---MPPFWGKTKSKIF 251
           +WS G+ L  L  G   +PP   K    IF
Sbjct: 196 IWSMGLSLVELAVGRYPIPPPDAKELEAIF 225

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 80/271 (29%), Positives = 120/271 (44%), Gaps = 23/271 (8%)
Query: 27  GTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRS 86
           G   DA +I   S R  L  +LG G FG +   +   T  V A K++    +       +
Sbjct: 7   GLAKDAWEIPRESLR--LEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEA 59
Query: 87  IKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLE-KYGRFSETEARV 145
              E ++M KL  H  +V L AV  EE  ++++ E  + G L   L+ + G++      V
Sbjct: 60  FLQEAQVMKKLR-HEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV 117
Query: 146 -IFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTV 204
            +   +   ++Y      VHRDL+  NIL+         K+ADFGLA  I+  +      
Sbjct: 118 DMAAQIASGMAYVERMNYVHRDLRAANILVGENLVC---KVADFGLARLIEDNE-YTARQ 173
Query: 205 GSPF---YIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADL 259
           G+ F   + APE  L G +   +DVWS G++L  L + G  P+ G    ++ D V     
Sbjct: 174 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-Y 232
Query: 260 RFPSDPWDHISASARDLIMGMLRVDPSTRLT 290
           R P  P      S  DL+    R DP  R T
Sbjct: 233 RMPCPP--ECPESLHDLMCQCWRKDPEERPT 261

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 85/199 (42%), Gaps = 24/199 (12%)
Query: 100 HPNVVDLKAVYEEED-----YVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVV 154
           HP++V +    E  D       +++ME   G  L  +  K  +    EA      ++  +
Sbjct: 138 HPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSL--KRSKGQKLPVAEAIAYLLEILPAL 195
Query: 155 SYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEV 214
           SY H  G+V+ DLKPENI+L  +     +KL D G  + I +   L+GT   P + APE+
Sbjct: 196 SYLHSIGLVYNDLKPENIMLTEEQ----LKLIDLGAVSRINSFGYLYGT---PGFQAPEI 248
Query: 215 LAGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASAR 274
           +  G   A D+++ G  L  L   +P   G          R  D     DP      S  
Sbjct: 249 VRTGPTVATDIYTVGRTLAALTLDLPTRNG----------RYVDGLPEDDPVLKTYDSYG 298
Query: 275 DLIMGMLRVDPSTRLTAAE 293
            L+   +  DP  R T AE
Sbjct: 299 RLLRRAIDPDPRQRFTTAE 317

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 80/271 (29%), Positives = 120/271 (44%), Gaps = 23/271 (8%)
Query: 27  GTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRS 86
           G   DA +I   S R  L  +LG G FG +   +   T  V A K++    +       +
Sbjct: 7   GLAKDAWEIPRESLR--LEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEA 59
Query: 87  IKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLE-KYGRFSETEARV 145
              E ++M KL  H  +V L AV  EE  ++++ E  + G L   L+ + G++      V
Sbjct: 60  FLQEAQVMKKLR-HEKLVQLYAVVSEEP-IYIVCEYMSKGSLLDFLKGEMGKYLRLPQLV 117
Query: 146 -IFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTV 204
            +   +   ++Y      VHRDL+  NIL+         K+ADFGLA  I+  +      
Sbjct: 118 DMAAQIASGMAYVERMNYVHRDLRAANILVGENLVC---KVADFGLARLIEDNE-YTARQ 173
Query: 205 GSPF---YIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADL 259
           G+ F   + APE  L G +   +DVWS G++L  L + G  P+ G    ++ D V     
Sbjct: 174 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-Y 232
Query: 260 RFPSDPWDHISASARDLIMGMLRVDPSTRLT 290
           R P  P      S  DL+    R DP  R T
Sbjct: 233 RMPCPP--ECPESLHDLMCQCWRKDPEERPT 261

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 125/284 (44%), Gaps = 24/284 (8%)
Query: 14  TQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSI 73
           T  C + K  +  G   DA +I   S R  L  +LG G FG +   +   T  V A K++
Sbjct: 162 TNVCPTSKPQT-QGLAKDAWEIPRESLR--LEVKLGQGCFGEVWMGTWNGTTRV-AIKTL 217
Query: 74  AKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLE 133
               +       +   E ++M KL  H  +V L AV  EE  ++++ E  + G L   L+
Sbjct: 218 KPGNM----SPEAFLQEAQVMKKLR-HEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLK 271
Query: 134 -KYGRFSETEARV-IFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA 191
            + G++      V +   +   ++Y      VHRDL+  NIL+     +   K+ADFGL 
Sbjct: 272 GEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLG 328
Query: 192 TYIKAGQNLHGTVGSPF---YIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWGKT 246
             I+  +      G+ F   + APE  L G +   +DVWS G++L  L + G  P+ G  
Sbjct: 329 RLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV 387
Query: 247 KSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLT 290
             ++ D V     R P  P      S  DL+    R DP  R T
Sbjct: 388 NREVLDQVERG-YRMPCPP--ECPESLHDLMCQCWRKDPEERPT 428

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 119/282 (42%), Gaps = 31/282 (10%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRL---VTVEDVRSIKLEIEIMTK 96
           +R   GK LG G FG + E +     +  A  ++A   L     + +  ++  E+++++ 
Sbjct: 46  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 105
Query: 97  LSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLE-KYGRF--SETEARVIFR----- 148
           L  H N+V+L           ++ E C  G+L + L  K   F  S+T   ++       
Sbjct: 106 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 165
Query: 149 ----------HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ 198
                      + + +++      +HRDL   NILL   +     K+ DFGLA +IK   
Sbjct: 166 DLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL---THGRITKICDFGLARHIKNDS 222
Query: 199 N--LHGTVGSPF-YIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDA 253
           N  + G    P  ++APE +    Y   +DVWS G+ L+ L S G  P+ G      F  
Sbjct: 223 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 282
Query: 254 VRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVL 295
           +     R  S   +H  A   D++      DP  R T  +++
Sbjct: 283 MIKEGFRMLSP--EHAPAEMYDIMKTCWDADPLKRPTFKQIV 322

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 110/214 (51%), Gaps = 18/214 (8%)
Query: 44  LGKQLGWGQFGVIRECSDKFTGEV-LACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
           L K+LG GQFGV++    K+ G+  +A K I +  +   E  +    E + M KLS HP 
Sbjct: 12  LLKELGSGQFGVVK--LGKWKGQYDVAVKMIKEGSMSEDEFFQ----EAQTMMKLS-HPK 64
Query: 103 VVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGR-FSETEARVIFRHLMQVVSYCHGNG 161
           +V    V  +E  ++++ E  + G L + L  +G+    ++   +   + + +++   + 
Sbjct: 65  LVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ 124
Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF---YIAPEVL-AG 217
            +HRDL   N L+        +K++DFG+  Y+   Q +  +VG+ F   + APEV    
Sbjct: 125 FIHRDLAARNCLV---DRDLCVKVSDFGMTRYVLDDQYV-SSVGTKFPVKWSAPEVFHYF 180
Query: 218 GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKI 250
            Y+  +DVW+ G++++ + S G  P+   T S++
Sbjct: 181 KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV 214

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 107/219 (48%), Gaps = 24/219 (10%)
Query: 46  KQLGWGQFGVIREC----SDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP 101
           +++G GQFG++        DK   + +   S+++D  +          E E+M KLS HP
Sbjct: 33  QEIGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSEDDFIE---------EAEVMMKLS-HP 82
Query: 102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLE-KYGRFSETEARVIFRHLMQVVSYCHGN 160
            +V L  V  E+  + L+ E    G L   L  + G F+      +   + + ++Y    
Sbjct: 83  KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 142
Query: 161 GVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF---YIAPEVLA- 216
            V+HRDL   N L+     +  IK++DFG+  ++   Q    T G+ F   + +PEV + 
Sbjct: 143 CVIHRDLAARNCLVG---ENQVIKVSDFGMTRFVLDDQYTSST-GTKFPVKWASPEVFSF 198
Query: 217 GGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAV 254
             Y+  +DVWS GV+++ + S G  P+  ++ S++ + +
Sbjct: 199 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 237

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 96/208 (46%), Gaps = 16/208 (7%)
Query: 90  EIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLE-KYGRFSETEARV-IF 147
           E ++M KL  H  +V L AV  EE  ++++ E  + G L   L+ + G++      V + 
Sbjct: 52  EAQVMKKLR-HEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMA 109
Query: 148 RHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSP 207
             +   ++Y      VHRDL+  NIL+         K+ADFGLA  I+  +      G+ 
Sbjct: 110 AQIASGMAYVERMNYVHRDLRAANILVGENLVC---KVADFGLARLIEDNE-YTARQGAK 165
Query: 208 F---YIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFP 262
           F   + APE  L G +   +DVWS G++L  L + G  P+ G    ++ D V     R P
Sbjct: 166 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMP 224
Query: 263 SDPWDHISASARDLIMGMLRVDPSTRLT 290
             P      S  DL+    R DP  R T
Sbjct: 225 CPP--ECPESLHDLMCQCWRKDPEERPT 250

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 107/243 (44%), Gaps = 31/243 (12%)
Query: 40  DRYVLGKQLGWGQFG--VIREC----SDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEI 93
           D+  LGK LG G FG  V+ E      DK    V     + KD   T +D+  +  E+E+
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEM 93
Query: 94  MTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLE---------KYGRFSETEAR 144
           M  +  H N+++L     ++  +++++   + G L   L           Y      E +
Sbjct: 94  MKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 145 VIFRHLMQV-------VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG 197
           + F+ L+         + Y      +HRDL   N+L+   + ++ +K+ADFGLA  I   
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLARDINNI 210
Query: 198 QNLHGTVGSPF---YIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGKTKSKIFD 252
                T        ++APE L    Y   +DVWS GV+++ I   G  P+ G    ++F 
Sbjct: 211 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270
Query: 253 AVR 255
            ++
Sbjct: 271 LLK 273

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 96/208 (46%), Gaps = 16/208 (7%)
Query: 90  EIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLE-KYGRFSETEARV-IF 147
           E ++M KL  H  +V L AV  EE  ++++ E  + G L   L+ + G++      V + 
Sbjct: 54  EAQVMKKLR-HEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMA 111
Query: 148 RHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSP 207
             +   ++Y      VHRDL+  NIL+         K+ADFGLA  I+  +      G+ 
Sbjct: 112 AQIASGMAYVERMNYVHRDLRAANILVGENLVC---KVADFGLARLIEDNE-YTARQGAK 167
Query: 208 F---YIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFP 262
           F   + APE  L G +   +DVWS G++L  L + G  P+ G    ++ D V     R P
Sbjct: 168 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMP 226
Query: 263 SDPWDHISASARDLIMGMLRVDPSTRLT 290
             P      S  DL+    R DP  R T
Sbjct: 227 CPP--ECPESLHDLMCQCWRKDPEERPT 252

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 109/215 (50%), Gaps = 16/215 (7%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           +++G GQFG++         + +A K+I ++  ++ ED      E E+M KLS HP +V 
Sbjct: 11  QEIGSGQFGLVH-LGYWLNKDKVAIKTI-REGAMSEEDFIE---EAEVMMKLS-HPKLVQ 64
Query: 106 LKAVYEEEDYVHLLMELCAGGELFHRLE-KYGRFSETEARVIFRHLMQVVSYCHGNGVVH 164
           L  V  E+  + L+ E    G L   L  + G F+      +   + + ++Y     V+H
Sbjct: 65  LYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIH 124
Query: 165 RDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF---YIAPEVLA-GGYN 220
           RDL   N L+     +  IK++DFG+  ++   Q    T G+ F   + +PEV +   Y+
Sbjct: 125 RDLAARNCLVG---ENQVIKVSDFGMTRFVLDDQYTSST-GTKFPVKWASPEVFSFSRYS 180
Query: 221 QAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAV 254
             +DVWS GV+++ + S G  P+  ++ S++ + +
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 215

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 109/215 (50%), Gaps = 16/215 (7%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           +++G GQFG++         + +A K+I ++  ++ ED      E E+M KLS HP +V 
Sbjct: 16  QEIGSGQFGLVH-LGYWLNKDKVAIKTI-REGAMSEEDFIE---EAEVMMKLS-HPKLVQ 69
Query: 106 LKAVYEEEDYVHLLMELCAGGELFHRLE-KYGRFSETEARVIFRHLMQVVSYCHGNGVVH 164
           L  V  E+  + L+ E    G L   L  + G F+      +   + + ++Y     V+H
Sbjct: 70  LYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIH 129
Query: 165 RDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF---YIAPEVLA-GGYN 220
           RDL   N L+     +  IK++DFG+  ++   Q    T G+ F   + +PEV +   Y+
Sbjct: 130 RDLAARNCLVG---ENQVIKVSDFGMTRFVLDDQYTSST-GTKFPVKWASPEVFSFSRYS 185
Query: 221 QAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAV 254
             +DVWS GV+++ + S G  P+  ++ S++ + +
Sbjct: 186 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 220

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 98/204 (48%), Gaps = 20/204 (9%)
Query: 46  KQLGWGQFGVIR-ECSDKF---TGEVLACKSIAKDRLVTVEDVRS-IKLEIEIMTKLSGH 100
           + LG G FG +   C D     TGE++A K++ +        +RS  + EIEI+  L  H
Sbjct: 15  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEG---CGPQLRSGWQREIEILRTLY-H 70
Query: 101 PNVVDLKAVYEE--EDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCH 158
            ++V  K   E+  E  V L+ME    G L   L ++      +  +  + + + ++Y H
Sbjct: 71  EHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHC-VGLAQLLLFAQQICEGMAYLH 129
Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTV---GSP-FYIAPEV 214
               +HR L   N+LL    +   +K+ DFGLA  +  G   +       SP F+ APE 
Sbjct: 130 AQHYIHRALAARNVLL---DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 186
Query: 215 LAG-GYNQAADVWSAGVILYILLS 237
           L    +  A+DVWS GV LY LL+
Sbjct: 187 LKECKFYYASDVWSFGVTLYELLT 210

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 126/284 (44%), Gaps = 24/284 (8%)
Query: 14  TQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSI 73
           T  C + K  +  G   DA +I   S R  L  +LG G FG +   +   T  V A K++
Sbjct: 161 TTVCPTSKPQT-QGLAKDAWEIPRESLR--LEVKLGQGCFGEVWMGTWNGTTRV-AIKTL 216
Query: 74  AKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLE 133
               +       +   E ++M KL  H  +V L AV  EE  ++++ E  + G L   L+
Sbjct: 217 KPGTM----SPEAFLQEAQVMKKLR-HEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLK 270
Query: 134 -KYGRFSETEARV-IFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA 191
            + G++      V +   +   ++Y      VHRDL+  NIL+     +   K+ADFGLA
Sbjct: 271 GETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLA 327
Query: 192 TYIKAGQNLHGTVGSPF---YIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWGKT 246
             I+  +      G+ F   + APE  L G +   +DVWS G++L  L + G  P+ G  
Sbjct: 328 RLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV 386
Query: 247 KSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLT 290
             ++ D V     R P  P      S  DL+    R +P  R T
Sbjct: 387 NREVLDQVERG-YRMPCPP--ECPESLHDLMCQCWRKEPEERPT 427

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 126/284 (44%), Gaps = 24/284 (8%)
Query: 14  TQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSI 73
           T  C + K  +  G   DA +I   S R  L  +LG G FG +   +   T  V A K++
Sbjct: 161 TTVCPTSKPQT-QGLAKDAWEIPRESLR--LEVKLGQGCFGEVWMGTWNGTTRV-AIKTL 216
Query: 74  AKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLE 133
               +       +   E ++M KL  H  +V L AV  EE  ++++ E  + G L   L+
Sbjct: 217 KPGTM----SPEAFLQEAQVMKKLR-HEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLK 270
Query: 134 -KYGRFSETEARV-IFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA 191
            + G++      V +   +   ++Y      VHRDL+  NIL+     +   K+ADFGLA
Sbjct: 271 GETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLA 327
Query: 192 TYIKAGQNLHGTVGSPF---YIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWGKT 246
             I+  +      G+ F   + APE  L G +   +DVWS G++L  L + G  P+ G  
Sbjct: 328 RLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV 386
Query: 247 KSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLT 290
             ++ D V     R P  P      S  DL+    R +P  R T
Sbjct: 387 NREVLDQVERG-YRMPCPP--ECPESLHDLMCQCWRKEPEERPT 427

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 98/204 (48%), Gaps = 20/204 (9%)
Query: 46  KQLGWGQFGVIR-ECSDKF---TGEVLACKSIAKDRLVTVEDVRS-IKLEIEIMTKLSGH 100
           + LG G FG +   C D     TGE++A K++ +        +RS  + EIEI+  L  H
Sbjct: 14  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEG---CGPQLRSGWQREIEILRTLY-H 69
Query: 101 PNVVDLKAVYEE--EDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCH 158
            ++V  K   E+  E  V L+ME    G L   L ++      +  +  + + + ++Y H
Sbjct: 70  EHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHC-VGLAQLLLFAQQICEGMAYLH 128
Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTV---GSP-FYIAPEV 214
               +HR L   N+LL    +   +K+ DFGLA  +  G   +       SP F+ APE 
Sbjct: 129 AQHYIHRALAARNVLL---DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 185
Query: 215 LAG-GYNQAADVWSAGVILYILLS 237
           L    +  A+DVWS GV LY LL+
Sbjct: 186 LKECKFYYASDVWSFGVTLYELLT 209

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 80/271 (29%), Positives = 120/271 (44%), Gaps = 23/271 (8%)
Query: 27  GTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRS 86
           G   DA +I   S R  L  +LG G FG +   +   T  V A K++    +       +
Sbjct: 7   GLAKDAWEIPRESLR--LEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEA 59
Query: 87  IKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLE-KYGRFSETEARV 145
              E ++M KL  H  +V L AV  EE  ++++ E  + G L   L+ + G++      V
Sbjct: 60  FLQEAQVMKKLR-HEKLVQLYAVVSEEP-IYIVTEYMSKGCLLDFLKGEMGKYLRLPQLV 117
Query: 146 -IFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTV 204
            +   +   ++Y      VHRDL+  NIL+         K+ADFGLA  I+  +      
Sbjct: 118 DMAAQIASGMAYVERMNYVHRDLRAANILVGENLVC---KVADFGLARLIEDNE-YTARQ 173
Query: 205 GSPF---YIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADL 259
           G+ F   + APE  L G +   +DVWS G++L  L + G  P+ G    ++ D V     
Sbjct: 174 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-Y 232
Query: 260 RFPSDPWDHISASARDLIMGMLRVDPSTRLT 290
           R P  P      S  DL+    R DP  R T
Sbjct: 233 RMPCPP--ECPESLHDLMCQCWRKDPEERPT 261

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 109/215 (50%), Gaps = 16/215 (7%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           +++G GQFG++         + +A K+I ++  ++ ED      E E+M KLS HP +V 
Sbjct: 14  QEIGSGQFGLVH-LGYWLNKDKVAIKTI-REGAMSEEDFIE---EAEVMMKLS-HPKLVQ 67
Query: 106 LKAVYEEEDYVHLLMELCAGGELFHRLE-KYGRFSETEARVIFRHLMQVVSYCHGNGVVH 164
           L  V  E+  + L+ E    G L   L  + G F+      +   + + ++Y     V+H
Sbjct: 68  LYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIH 127
Query: 165 RDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF---YIAPEVLA-GGYN 220
           RDL   N L+     +  IK++DFG+  ++   Q    T G+ F   + +PEV +   Y+
Sbjct: 128 RDLAARNCLVG---ENQVIKVSDFGMTRFVLDDQYTSST-GTKFPVKWASPEVFSFSRYS 183
Query: 221 QAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAV 254
             +DVWS GV+++ + S G  P+  ++ S++ + +
Sbjct: 184 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 218

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 79/271 (29%), Positives = 120/271 (44%), Gaps = 23/271 (8%)
Query: 27  GTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRS 86
           G   DA +I   S R  L  +LG G FG +   +   T  V A K++    +       +
Sbjct: 7   GLAKDAWEIPRESLR--LEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEA 59
Query: 87  IKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLE-KYGRFSETEARV 145
              E ++M K+  H  +V L AV  EE  ++++ E  + G L   L+ + G++      V
Sbjct: 60  FLQEAQVMKKIR-HEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV 117
Query: 146 -IFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTV 204
            +   +   ++Y      VHRDL+  NIL+         K+ADFGLA  I+  +      
Sbjct: 118 DMAAQIASGMAYVERMNYVHRDLRAANILVGENLVC---KVADFGLARLIEDNE-YTARQ 173
Query: 205 GSPF---YIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADL 259
           G+ F   + APE  L G +   +DVWS G++L  L + G  P+ G    ++ D V     
Sbjct: 174 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-Y 232
Query: 260 RFPSDPWDHISASARDLIMGMLRVDPSTRLT 290
           R P  P      S  DL+    R DP  R T
Sbjct: 233 RMPCPP--ECPESLHDLMCQCWRKDPEERPT 261

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 80/271 (29%), Positives = 119/271 (43%), Gaps = 23/271 (8%)
Query: 27  GTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRS 86
           G   DA +I   S R  L  +LG G FG +   +   T  V A K++    +       +
Sbjct: 7   GLAKDAWEIPRESLR--LEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEA 59
Query: 87  IKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLE-KYGRFSETEARV 145
              E ++M KL  H  +V L AV  EE  ++++ E  + G L   L+ + G++      V
Sbjct: 60  FLQEAQVMKKLR-HEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV 117
Query: 146 -IFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTV 204
            +   +   ++Y      VHRDL   NIL+         K+ADFGLA  I+  +      
Sbjct: 118 DMAAQIASGMAYVERMNYVHRDLAAANILVGENLVC---KVADFGLARLIEDNE-YTARQ 173
Query: 205 GSPF---YIAPEV-LAGGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADL 259
           G+ F   + APE  L G +   +DVWS G++L  L + G  P+ G    ++ D V     
Sbjct: 174 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-Y 232
Query: 260 RFPSDPWDHISASARDLIMGMLRVDPSTRLT 290
           R P  P      S  DL+    R DP  R T
Sbjct: 233 RMPCPP--ECPESLHDLMCQCWRKDPEERPT 261

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 101/204 (49%), Gaps = 18/204 (8%)
Query: 46  KQLGWGQFGVIRECSDKFTGEV-LACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVV 104
           K+LG GQFGV++    K+ G+  +A K I +  +   E +     E ++M  LS H  +V
Sbjct: 15  KELGTGQFGVVK--YGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMNLS-HEKLV 67
Query: 105 DLKAVYEEEDYVHLLMELCAGGELFHRL-EKYGRFSETEARVIFRHLMQVVSYCHGNGVV 163
            L  V  ++  + ++ E  A G L + L E   RF   +   + + + + + Y      +
Sbjct: 68  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL 127
Query: 164 HRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF---YIAPEVLA-GGY 219
           HRDL   N L+   +    +K++DFGL+ Y+        + GS F   +  PEVL    +
Sbjct: 128 HRDLAARNCLV---NDQGVVKVSDFGLSRYV-LDDEYTSSRGSKFPVRWSPPEVLMYSKF 183
Query: 220 NQAADVWSAGVILYILLS-GMPPF 242
           +  +D+W+ GV+++ + S G  P+
Sbjct: 184 SSKSDIWAFGVLMWEIYSLGKMPY 207

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 118/282 (41%), Gaps = 31/282 (10%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRL---VTVEDVRSIKLEIEIMTK 96
           +R   GK LG G FG + E +     +  A  ++A   L     + +  ++  E+++++ 
Sbjct: 39  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 98
Query: 97  LSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLE-KYGRF--SETEARVIFR----- 148
           L  H N+V+L           ++ E C  G+L + L  K   F  S+T   ++       
Sbjct: 99  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 158
Query: 149 ----------HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ 198
                      + + +++      +HRDL   NILL   +     K+ DFGLA  IK   
Sbjct: 159 DLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL---THGRITKICDFGLARDIKNDS 215
Query: 199 N--LHGTVGSPF-YIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDA 253
           N  + G    P  ++APE +    Y   +DVWS G+ L+ L S G  P+ G      F  
Sbjct: 216 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 275
Query: 254 VRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVL 295
           +     R  S   +H  A   D++      DP  R T  +++
Sbjct: 276 MIKEGFRMLSP--EHAPAEMYDIMKTCWDADPLKRPTFKQIV 315

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 118/282 (41%), Gaps = 31/282 (10%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRL---VTVEDVRSIKLEIEIMTK 96
           +R   GK LG G FG + E +     +  A  ++A   L     + +  ++  E+++++ 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 97  LSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLE-KYGRF--SETEARVIFR----- 148
           L  H N+V+L           ++ E C  G+L + L  K   F  S+T   ++       
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 149 ----------HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ 198
                      + + +++      +HRDL   NILL   +     K+ DFGLA  IK   
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL---THGRITKICDFGLARDIKNDS 199
Query: 199 N--LHGTVGSPF-YIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDA 253
           N  + G    P  ++APE +    Y   +DVWS G+ L+ L S G  P+ G      F  
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259
Query: 254 VRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVL 295
           +     R  S   +H  A   D++      DP  R T  +++
Sbjct: 260 MIKEGFRMLSP--EHAPAEMYDIMKTCWDADPLKRPTFKQIV 299

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 95/208 (45%), Gaps = 29/208 (13%)
Query: 47  QLGWGQFGVIRECS-DKF---TGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
           QLG G FG +  C  D     TG ++A K +        +  R  + EI+I+  L     
Sbjct: 17  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQILKALHS--- 70
Query: 103 VVDLKAVYEEEDY------VHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVS 155
             D    Y    Y      + L+ME    G L   L+++  R   +   +    + + + 
Sbjct: 71  --DFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGME 128
Query: 156 YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSP-----FYI 210
           Y      VHRDL   NIL+ +++    +K+ADFGLA  +   ++ +  V  P     F+ 
Sbjct: 129 YLGSRRCVHRDLAARNILVESEAH---VKIADFGLAKLLPLDKDYY-VVREPGQSPIFWY 184
Query: 211 APEVLAGG-YNQAADVWSAGVILYILLS 237
           APE L+   +++ +DVWS GV+LY L +
Sbjct: 185 APESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 95/208 (45%), Gaps = 29/208 (13%)
Query: 47  QLGWGQFGVIRECS-DKF---TGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
           QLG G FG +  C  D     TG ++A K +        +  R  + EI+I+  L     
Sbjct: 18  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQILKALHS--- 71
Query: 103 VVDLKAVYEEEDY------VHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVS 155
             D    Y    Y      + L+ME    G L   L+++  R   +   +    + + + 
Sbjct: 72  --DFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGME 129
Query: 156 YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSP-----FYI 210
           Y      VHRDL   NIL+ +++    +K+ADFGLA  +   ++ +  V  P     F+ 
Sbjct: 130 YLGSRRCVHRDLAARNILVESEAH---VKIADFGLAKLLPLDKDYY-VVREPGQSPIFWY 185
Query: 211 APEVLAGG-YNQAADVWSAGVILYILLS 237
           APE L+   +++ +DVWS GV+LY L +
Sbjct: 186 APESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 126/284 (44%), Gaps = 24/284 (8%)
Query: 14  TQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSI 73
           T  C + K  +  G   DA +I   S R  L  +LG G FG +   +   T  V A K++
Sbjct: 244 TTVCPTSKPQT-QGLAKDAWEIPRESLR--LEVKLGQGCFGEVWMGTWNGTTRV-AIKTL 299
Query: 74  AKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLE 133
               +       +   E ++M KL  H  +V L AV  EE  ++++ E  + G L   L+
Sbjct: 300 KPGTM----SPEAFLQEAQVMKKLR-HEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLK 353
Query: 134 -KYGRFSETEARV-IFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA 191
            + G++      V +   +   ++Y      VHRDL+  NIL+     +   K+ADFGLA
Sbjct: 354 GETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLA 410
Query: 192 TYIKAGQNLHGTVGSPF---YIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWGKT 246
             I+  +      G+ F   + APE  L G +   +DVWS G++L  L + G  P+ G  
Sbjct: 411 RLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV 469
Query: 247 KSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLT 290
             ++ D V     R P  P      S  DL+    R +P  R T
Sbjct: 470 NREVLDQVERG-YRMPCPP--ECPESLHDLMCQCWRKEPEERPT 510

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 126/284 (44%), Gaps = 24/284 (8%)
Query: 14  TQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSI 73
           T  C + K  +  G   DA +I   S R  L  +LG G FG +   +   T  V A K++
Sbjct: 161 TTVCPTSKPQT-QGLAKDAWEIPRESLR--LEVKLGQGCFGEVWMGTWNGTTRV-AIKTL 216
Query: 74  AKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLE 133
               +       +   E ++M KL  H  +V L AV  EE  ++++ E  + G L   L+
Sbjct: 217 KPGTM----SPEAFLQEAQVMKKLR-HEKLVQLYAVVSEEP-IYIVGEYMSKGSLLDFLK 270
Query: 134 -KYGRFSETEARV-IFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA 191
            + G++      V +   +   ++Y      VHRDL+  NIL+     +   K+ADFGLA
Sbjct: 271 GETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLA 327
Query: 192 TYIKAGQNLHGTVGSPF---YIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWGKT 246
             I+  +      G+ F   + APE  L G +   +DVWS G++L  L + G  P+ G  
Sbjct: 328 RLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV 386
Query: 247 KSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLT 290
             ++ D V     R P  P      S  DL+    R +P  R T
Sbjct: 387 NREVLDQVERG-YRMPCPP--ECPESLHDLMCQCWRKEPEERPT 427

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 88/186 (47%), Gaps = 12/186 (6%)
Query: 85  RSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKY-GRFSETEA 143
           R    E  IM +   HPN++ L+ V        ++ E    G L   L  + G+F+  + 
Sbjct: 95  RDFLSEASIMGQFD-HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQL 153
Query: 144 RVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNL-HG 202
             + R +   + Y    G VHRDL   N+L+    S+   K++DFGL+  ++   +  + 
Sbjct: 154 VGMLRGVGAGMRYLSDLGYVHRDLAARNVLV---DSNLVCKVSDFGLSRVLEDDPDAAYT 210
Query: 203 TVGSPFYI---APEVLA-GGYNQAADVWSAGVILY-ILLSGMPPFWGKTKSKIFDAVRAA 257
           T G    I   APE +A   ++ A+DVWS GV+++ +L  G  P+W  T   +  +V   
Sbjct: 211 TTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG 270
Query: 258 DLRFPS 263
             R P+
Sbjct: 271 -YRLPA 275

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 118/282 (41%), Gaps = 31/282 (10%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRL---VTVEDVRSIKLEIEIMTK 96
           +R   GK LG G FG + E +     +  A  ++A   L     + +  ++  E+++++ 
Sbjct: 41  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 100
Query: 97  LSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLE-KYGRF--SETEARVIFR----- 148
           L  H N+V+L           ++ E C  G+L + L  K   F  S+T   ++       
Sbjct: 101 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 160
Query: 149 ----------HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ 198
                      + + +++      +HRDL   NILL   +     K+ DFGLA  IK   
Sbjct: 161 DLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL---THGRITKICDFGLARDIKNDS 217
Query: 199 N--LHGTVGSPF-YIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDA 253
           N  + G    P  ++APE +    Y   +DVWS G+ L+ L S G  P+ G      F  
Sbjct: 218 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 277
Query: 254 VRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVL 295
           +     R  S   +H  A   D++      DP  R T  +++
Sbjct: 278 MIKEGFRMLSP--EHAPAEMYDIMKTCWDADPLKRPTFKQIV 317

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 96/208 (46%), Gaps = 16/208 (7%)
Query: 90  EIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLE-KYGRFSETEARV-IF 147
           E ++M KL  H  +V L AV  EE  ++++ E  + G L   L+ + G++      V + 
Sbjct: 56  EAQVMKKLR-HEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMA 113
Query: 148 RHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSP 207
             +   ++Y      VHRDL+  NIL+         K+ADFGLA  I+  +      G+ 
Sbjct: 114 AQIASGMAYVERMNYVHRDLRAANILVGENLVC---KVADFGLARLIEDNE-YTARQGAK 169
Query: 208 F---YIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFP 262
           F   + APE  L G +   +DVWS G++L  L + G  P+ G    ++ D V     R P
Sbjct: 170 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMP 228
Query: 263 SDPWDHISASARDLIMGMLRVDPSTRLT 290
             P      S  DL+    R +P  R T
Sbjct: 229 CPP--ECPESLHDLMCQCWRKEPEERPT 254

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 95/208 (45%), Gaps = 29/208 (13%)
Query: 47  QLGWGQFGVIRECS-DKF---TGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
           QLG G FG +  C  D     TG ++A K +        +  R  + EI+I+  L     
Sbjct: 30  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQILKALHS--- 83
Query: 103 VVDLKAVYEEEDY------VHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVS 155
             D    Y    Y      + L+ME    G L   L+++  R   +   +    + + + 
Sbjct: 84  --DFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGME 141
Query: 156 YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSP-----FYI 210
           Y      VHRDL   NIL+ +++    +K+ADFGLA  +   ++ +  V  P     F+ 
Sbjct: 142 YLGSRRCVHRDLAARNILVESEAH---VKIADFGLAKLLPLDKDYY-VVREPGQSPIFWY 197
Query: 211 APEVLAGG-YNQAADVWSAGVILYILLS 237
           APE L+   +++ +DVWS GV+LY L +
Sbjct: 198 APESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 118/282 (41%), Gaps = 31/282 (10%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRL---VTVEDVRSIKLEIEIMTK 96
           +R   GK LG G FG + E +     +  A  ++A   L     + +  ++  E+++++ 
Sbjct: 46  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 105
Query: 97  LSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLE-KYGRF--SETEARVIFR----- 148
           L  H N+V+L           ++ E C  G+L + L  K   F  S+T   ++       
Sbjct: 106 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 165
Query: 149 ----------HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ 198
                      + + +++      +HRDL   NILL   +     K+ DFGLA  IK   
Sbjct: 166 DLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL---THGRITKICDFGLARDIKNDS 222
Query: 199 N--LHGTVGSPF-YIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDA 253
           N  + G    P  ++APE +    Y   +DVWS G+ L+ L S G  P+ G      F  
Sbjct: 223 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 282
Query: 254 VRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVL 295
           +     R  S   +H  A   D++      DP  R T  +++
Sbjct: 283 MIKEGFRMLSP--EHAPAEMYDIMKTCWDADPLKRPTFKQIV 322

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 68/266 (25%), Positives = 113/266 (42%), Gaps = 41/266 (15%)
Query: 28  TILDATQISN------LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTV 81
           T +D TQ+          +    GK LG G FG + E +    G+  A   +A   L + 
Sbjct: 13  TFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST 72
Query: 82  ---EDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKY--- 135
              ++  ++  E++IM+ L  H N+V+L         V ++ E C  G+L + L +    
Sbjct: 73  AHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEA 132
Query: 136 -------------------GRFSETEARVIF-RHLMQVVSYCHGNGVVHRDLKPENILLA 175
                              GR  E    + F   + Q +++      +HRD+   N+LL 
Sbjct: 133 MLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT 192
Query: 176 TKSSSSPIKLADFGLATYIKAGQN--LHGTVGSPF-YIAPE-VLAGGYNQAADVWSAGVI 231
               +   K+ DFGLA  I    N  + G    P  ++APE +    Y   +DVWS G++
Sbjct: 193 NGHVA---KIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGIL 249
Query: 232 LYILLS-GMPPFWG-KTKSKIFDAVR 255
           L+ + S G+ P+ G    SK +  V+
Sbjct: 250 LWEIFSLGLNPYPGILVNSKFYKLVK 275

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 73/147 (49%), Gaps = 6/147 (4%)
Query: 101 PNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGN 160
           P+VV +    E +  +++   L  G +L   L + G  +   A  I R +   +   H  
Sbjct: 94  PHVVPIHDFGEIDGQLYVDXRLINGVDLAAXLRRQGPLAPPRAVAIVRQIGSALDAAHAA 153
Query: 161 GVVHRDLKPENILLATKSSSSPIKLADFGL--ATYIKAGQNLHGTVGSPFYIAPEVLAGG 218
           G  HRD+KPENIL++    +    L DFG+  AT  +    L  TVG+ +Y APE  +  
Sbjct: 154 GATHRDVKPENILVSADDFA---YLVDFGIASATTDEKLTQLGNTVGTLYYXAPERFSES 210
Query: 219 Y-NQAADVWSAGVILYILLSGMPPFWG 244
           +    AD+++   +LY  L+G PP+ G
Sbjct: 211 HATYRADIYALTCVLYECLTGSPPYQG 237

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/186 (27%), Positives = 86/186 (46%), Gaps = 12/186 (6%)
Query: 85  RSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKY-GRFSETEA 143
           R    E  IM +   HPN++ L+ V        ++ E    G L   L  + G+F+  + 
Sbjct: 95  RDFLSEASIMGQFD-HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQL 153
Query: 144 RVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIK----AGQN 199
             + R +   + Y    G VHRDL   N+L+    S+   K++DFGL+  ++    A   
Sbjct: 154 VGMLRGVGAGMRYLSDLGYVHRDLAARNVLV---DSNLVCKVSDFGLSRVLEDDPDAAXT 210
Query: 200 LHGTVGSPFYIAPEVLA-GGYNQAADVWSAGVILY-ILLSGMPPFWGKTKSKIFDAVRAA 257
             G      + APE +A   ++ A+DVWS GV+++ +L  G  P+W  T   +  +V   
Sbjct: 211 TTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG 270
Query: 258 DLRFPS 263
             R P+
Sbjct: 271 -YRLPA 275

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 79/271 (29%), Positives = 119/271 (43%), Gaps = 23/271 (8%)
Query: 27  GTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRS 86
           G   DA +I   S R  L  +LG G FG +   +   T  V A K++    +       +
Sbjct: 4   GLAKDAWEIPRESLR--LEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEA 56
Query: 87  IKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLE-KYGRFSETEARV 145
              E ++M KL  H  +V L AV  EE  ++++ E    G L   L+ + G++      V
Sbjct: 57  FLQEAQVMKKLR-HEKLVQLYAVVSEEP-IYIVTEYMNKGSLLDFLKGETGKYLRLPQLV 114
Query: 146 -IFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTV 204
            +   +   ++Y      VHRDL+  NIL+         K+ADFGLA  I+  +      
Sbjct: 115 DMSAQIASGMAYVERMNYVHRDLRAANILVGENLVC---KVADFGLARLIEDNE-YTARQ 170
Query: 205 GSPF---YIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADL 259
           G+ F   + APE  L G +   +DVWS G++L  L + G  P+ G    ++ D V     
Sbjct: 171 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-Y 229
Query: 260 RFPSDPWDHISASARDLIMGMLRVDPSTRLT 290
           R P  P      S  DL+    R +P  R T
Sbjct: 230 RMPCPP--ECPESLHDLMCQCWRKEPEERPT 258

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 93/195 (47%), Gaps = 25/195 (12%)
Query: 90  EIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRL-EKYGRFSETEARVIFR 148
           E  IM + S H N++ L+ V  +   + ++ E    G L   L EK G FS  +   + R
Sbjct: 96  EAGIMGQFSHH-NIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLR 154
Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGL---------ATYIKAGQN 199
            +   + Y      VHRDL   NIL+   +S+   K++DFGL         ATY  +G  
Sbjct: 155 GIAAGMKYLANMNYVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDDPEATYTTSGGK 211
Query: 200 LHGTVGSPF-YIAPEVLA-GGYNQAADVWSAGVILY-ILLSGMPPFWGKTKSKIFDAVRA 256
           +      P  + APE ++   +  A+DVWS G++++ ++  G  P+W  +  ++  A+  
Sbjct: 212 I------PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND 265
Query: 257 ADLRFPSDPWDHISA 271
              R P+ P D  SA
Sbjct: 266 G-FRLPT-PMDCPSA 278

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 79/271 (29%), Positives = 119/271 (43%), Gaps = 23/271 (8%)
Query: 27  GTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRS 86
           G   DA +I   S R  L  +LG G FG +   +   T  V A K++    +       +
Sbjct: 4   GLAKDAWEIPRESLR--LEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEA 56
Query: 87  IKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLE-KYGRFSETEARV 145
              E ++M KL  H  +V L AV  EE  ++++ E    G L   L+ + G++      V
Sbjct: 57  FLQEAQVMKKLR-HEKLVQLYAVVSEEP-IYIVTEYMNKGSLLDFLKGETGKYLRLPQLV 114
Query: 146 -IFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTV 204
            +   +   ++Y      VHRDL+  NIL+         K+ADFGLA  I+  +      
Sbjct: 115 DMSAQIASGMAYVERMNYVHRDLRAANILVGENLVC---KVADFGLARLIEDNE-WTARQ 170
Query: 205 GSPF---YIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADL 259
           G+ F   + APE  L G +   +DVWS G++L  L + G  P+ G    ++ D V     
Sbjct: 171 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-Y 229
Query: 260 RFPSDPWDHISASARDLIMGMLRVDPSTRLT 290
           R P  P      S  DL+    R +P  R T
Sbjct: 230 RMPCPP--ECPESLHDLMCQCWRKEPEERPT 258

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 74/318 (23%), Positives = 131/318 (41%), Gaps = 35/318 (11%)
Query: 9   SSQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRE-----CSDKF 63
           +S + T +  +Y  +  T +I D  ++   +   + G  LG G FG + E       +  
Sbjct: 2   TSTIMTDYNPNYSFAGKTSSISDLKEVPRKNITLIRG--LGHGAFGEVYEGQVSGMPNDP 59
Query: 64  TGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELC 123
           +   +A K++ +  + + +D     +E  I++KL+ H N+V    V  +     +L+EL 
Sbjct: 60  SPLQVAVKTLPE--VCSEQDELDFLMEALIISKLN-HQNIVRCIGVSLQSLPRFILLELM 116
Query: 124 AGGELFHRLEKYGRFSETEARVIFRHLMQVV-------SYCHGNGVVHRDLKPENILLAT 176
           AGG+L   L +        + +    L+ V         Y   N  +HRD+   N LL  
Sbjct: 117 AGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTC 176
Query: 177 KSSSSPIKLADFGL------ATYIKAGQNLHGTVGSPF-YIAPEVLAGG-YNQAADVWSA 228
                  K+ DFG+      A+Y + G    G    P  ++ PE    G +    D WS 
Sbjct: 177 PGPGRVAKIGDFGMARDIYRASYYRKG----GCAMLPVKWMPPEAFMEGIFTSKTDTWSF 232
Query: 229 GVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPST 287
           GV+L+ + S G  P+  K+  ++ + V +       DP  +       ++    +  P  
Sbjct: 233 GVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM---DPPKNCPGPVYRIMTQCWQHQPED 289
Query: 288 RLTAAEVLAHSWMEECEQ 305
           R   A +L    +E C Q
Sbjct: 290 RPNFAIILER--IEYCTQ 305

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 98/206 (47%), Gaps = 22/206 (10%)
Query: 44  LGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNV 103
           L + +G G+FG +      + G  +A K I  D        ++   E  +MT+L  H N+
Sbjct: 16  LLQTIGKGEFGDV--MLGDYRGNKVAVKCIKND-----ATAQAFLAEASVMTQLR-HSNL 67
Query: 104 VDLKAVY-EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQV---VSYCHG 159
           V L  V  EE+  ++++ E  A G L   L   GR S      + +  + V   + Y  G
Sbjct: 68  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEG 126
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF-YIAPEVL-AG 217
           N  VHRDL   N+L+   S  +  K++DFGL     + Q+   T   P  + APE L   
Sbjct: 127 NNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQD---TGKLPVKWTAPEALREA 180
Query: 218 GYNQAADVWSAGVILYILLS-GMPPF 242
            ++  +DVWS G++L+ + S G  P+
Sbjct: 181 AFSTKSDVWSFGILLWEIYSFGRVPY 206

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 29/208 (13%)
Query: 47  QLGWGQFGVIRECS-DKF---TGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
           QLG G FG +  C  D     TG ++A K +        +  R  + EI+I+  L     
Sbjct: 14  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQILKALHS--- 67
Query: 103 VVDLKAVYEEEDY------VHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVS 155
             D    Y    Y      + L+ME    G L   L+++  R   +   +    + + + 
Sbjct: 68  --DFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGME 125
Query: 156 YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSP-----FYI 210
           Y      VHRDL   NIL+ +++    +K+ADFGLA  +   ++    V  P     F+ 
Sbjct: 126 YLGSRRCVHRDLAARNILVESEAH---VKIADFGLAKLLPLDKDXX-VVREPGQSPIFWY 181
Query: 211 APEVLAGG-YNQAADVWSAGVILYILLS 237
           APE L+   +++ +DVWS GV+LY L +
Sbjct: 182 APESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 95/208 (45%), Gaps = 16/208 (7%)
Query: 90  EIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLE-KYGRFSETEARV-IF 147
           E ++M KL  H  +V L AV  EE  + ++ E  + G L   L+ + G++      V + 
Sbjct: 53  EAQVMKKLR-HEKLVQLYAVVSEEP-IXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMA 110
Query: 148 RHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSP 207
             +   ++Y      VHRDL+  NIL+         K+ADFGLA  I+  +      G+ 
Sbjct: 111 AQIASGMAYVERMNYVHRDLRAANILVGENLVC---KVADFGLARLIEDNEX-TARQGAK 166
Query: 208 F---YIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFP 262
           F   + APE  L G +   +DVWS G++L  L + G  P+ G    ++ D V     R P
Sbjct: 167 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMP 225
Query: 263 SDPWDHISASARDLIMGMLRVDPSTRLT 290
             P      S  DL+    R +P  R T
Sbjct: 226 CPP--ECPESLHDLMCQCWRKEPEERPT 251

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 97/206 (47%), Gaps = 22/206 (10%)
Query: 44  LGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNV 103
           L + +G G+FG +      + G  +A K I  D        ++   E  +MT+L  H N+
Sbjct: 25  LLQTIGKGEFGDV--MLGDYRGNKVAVKCIKND-----ATAQAFLAEASVMTQLR-HSNL 76
Query: 104 VDLKAV-YEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQV---VSYCHG 159
           V L  V  EE+  ++++ E  A G L   L   GR S      + +  + V   + Y  G
Sbjct: 77  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEG 135
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF-YIAPEVL-AG 217
           N  VHRDL   N+L+   S  +  K++DFGL    K   +   T   P  + APE L   
Sbjct: 136 NNFVHRDLAARNVLV---SEDNVAKVSDFGLT---KEASSTQDTGKLPVKWTAPEALREK 189
Query: 218 GYNQAADVWSAGVILYILLS-GMPPF 242
            ++  +DVWS G++L+ + S G  P+
Sbjct: 190 KFSTKSDVWSFGILLWEIYSFGRVPY 215

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/268 (23%), Positives = 113/268 (42%), Gaps = 25/268 (9%)
Query: 47  QLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDL 106
           +LG G +GV+ +     +G++ A K I     V  ++ + +  +++I  +    P  V  
Sbjct: 41  ELGRGAYGVVEKXRHVPSGQIXAVKRIRA--TVNSQEQKRLLXDLDISXRTVDCPFTVTF 98
Query: 107 KAVYEEEDYVHLLMELCAGG-ELFHR--LEKYGRFSETEARVIFRHLMQVVSYCHGN-GV 162
                 E  V +  EL     + F++  ++K     E     I   +++ + + H    V
Sbjct: 99  YGALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSV 158
Query: 163 VHRDLKPENILLATKSSSSPIKLADFGLATY--------IKAGQNLHGTVGSPFYIAPEV 214
           +HRD+KP N+L+   ++   +K  DFG++ Y        I AG   +    +P  I PE+
Sbjct: 159 IHRDVKPSNVLI---NALGQVKXCDFGISGYLVDDVAKDIDAGCKPYX---APERINPEL 212
Query: 215 LAGGYNQAADVWSAGVILYILLSGMPPF--WGKTKSKIFDAVRAADLRFPSDPWDHISAS 272
              GY+  +D+WS G+    L     P+  WG    ++   V       P  P D  SA 
Sbjct: 213 NQKGYSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQVVEEPS---PQLPADKFSAE 269
Query: 273 ARDLIMGMLRVDPSTRLTAAEVLAHSWM 300
             D     L+ +   R T  E+  H + 
Sbjct: 270 FVDFTSQCLKKNSKERPTYPELXQHPFF 297

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 97/206 (47%), Gaps = 22/206 (10%)
Query: 44  LGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNV 103
           L + +G G+FG +      + G  +A K I  D        ++   E  +MT+L  H N+
Sbjct: 10  LLQTIGKGEFGDV--MLGDYRGNKVAVKCIKND-----ATAQAFLAEASVMTQLR-HSNL 61
Query: 104 VDLKAV-YEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQV---VSYCHG 159
           V L  V  EE+  ++++ E  A G L   L   GR S      + +  + V   + Y  G
Sbjct: 62  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEG 120
Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF-YIAPEVL-AG 217
           N  VHRDL   N+L+   S  +  K++DFGL    K   +   T   P  + APE L   
Sbjct: 121 NNFVHRDLAARNVLV---SEDNVAKVSDFGLT---KEASSTQDTGKLPVKWTAPEALREK 174
Query: 218 GYNQAADVWSAGVILYILLS-GMPPF 242
            ++  +DVWS G++L+ + S G  P+
Sbjct: 175 KFSTKSDVWSFGILLWEIYSFGRVPY 200

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 74/314 (23%), Positives = 130/314 (41%), Gaps = 27/314 (8%)
Query: 9   SSQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRE-----CSDKF 63
           +S + T +  +Y  +  T +I D  ++   +   + G  LG G FG + E       +  
Sbjct: 19  TSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRG--LGHGAFGEVYEGQVSGMPNDP 76
Query: 64  TGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELC 123
           +   +A K++ +  + + +D     +E  I++K + H N+V    V  +     +L+EL 
Sbjct: 77  SPLQVAVKTLPE--VCSEQDELDFLMEALIISKFN-HQNIVRCIGVSLQSLPRFILLELM 133
Query: 124 AGGELFHRLEKYGRFSETEARVIFRHLMQVV-------SYCHGNGVVHRDLKPENILLAT 176
           AGG+L   L +        + +    L+ V         Y   N  +HRD+   N LL  
Sbjct: 134 AGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTC 193
Query: 177 KSSSSPIKLADFGLATYI-KAGQNLHGTVGS-PF-YIAPEVLAGG-YNQAADVWSAGVIL 232
                  K+ DFG+A  I +AG    G     P  ++ PE    G +    D WS GV+L
Sbjct: 194 PGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLL 253
Query: 233 YILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTA 291
           + + S G  P+  K+  ++ + V +       DP  +       ++    +  P  R   
Sbjct: 254 WEIFSLGYMPYPSKSNQEVLEFVTSGGRM---DPPKNCPGPVYRIMTQCWQHQPEDRPNF 310
Query: 292 AEVLAHSWMEECEQ 305
           A +L    +E C Q
Sbjct: 311 AIILER--IEYCTQ 322

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 64/112 (57%), Gaps = 17/112 (15%)
Query: 139 SETEARVIFRHLMQVVSYCHGNG----VVHRDLKPENILLATKSSSSPIKLADFGLATYI 194
           +ET +R +  +L + V +C G G    + HRD K +N+LL +  ++    LADFGLA   
Sbjct: 118 AETMSRGL-SYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAV---LADFGLAVRF 173
Query: 195 KAGQ---NLHGTVGSPFYIAPEVLAGGYN------QAADVWSAGVILYILLS 237
           + G+   + HG VG+  Y+APEVL G  N         D+++ G++L+ L+S
Sbjct: 174 EPGKPPGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVS 225

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 112/232 (48%), Gaps = 22/232 (9%)
Query: 31  DATQISNLSDRYVLGKQLGWGQFG-VIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKL 89
           DA +I   S +  L K+LG GQFG V     +K T   +A K++    +     V +   
Sbjct: 181 DAWEIPRESLK--LEKKLGAGQFGEVWMATYNKHTK--VAVKTMKPGSM----SVEAFLA 232
Query: 90  EIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVI--F 147
           E  +M  L  H  +V L AV  +E  ++++ E  A G L   L+      +   ++I   
Sbjct: 233 EANVMKTLQ-HDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFS 290
Query: 148 RHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSP 207
             + + +++      +HRDL+  NIL+   S+S   K+ADFGLA  I+  +      G+ 
Sbjct: 291 AQIAEGMAFIEQRNYIHRDLRAANILV---SASLVCKIADFGLARVIEDNE-YTAREGAK 346
Query: 208 F---YIAPEVLA-GGYNQAADVWSAGVILY-ILLSGMPPFWGKTKSKIFDAV 254
           F   + APE +  G +   +DVWS G++L  I+  G  P+ G +  ++  A+
Sbjct: 347 FPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL 398

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 73/318 (22%), Positives = 130/318 (40%), Gaps = 35/318 (11%)
Query: 9   SSQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRE-----CSDKF 63
           +S + T +  +Y  +  T +I D  ++   +   + G  LG G FG + E       +  
Sbjct: 2   TSTIMTDYNPNYSFAGKTSSISDLKEVPRKNITLIRG--LGHGAFGEVYEGQVSGMPNDP 59
Query: 64  TGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELC 123
           +   +A K++ +  + + +D     +E  I++K + H N+V    V  +     +L+EL 
Sbjct: 60  SPLQVAVKTLPE--VCSEQDELDFLMEALIISKFN-HQNIVRCIGVSLQSLPRFILLELM 116
Query: 124 AGGELFHRLEKYGRFSETEARVIFRHLMQVV-------SYCHGNGVVHRDLKPENILLAT 176
           AGG+L   L +        + +    L+ V         Y   N  +HRD+   N LL  
Sbjct: 117 AGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTC 176
Query: 177 KSSSSPIKLADFGL------ATYIKAGQNLHGTVGSPF-YIAPEVLAGG-YNQAADVWSA 228
                  K+ DFG+      A+Y + G    G    P  ++ PE    G +    D WS 
Sbjct: 177 PGPGRVAKIGDFGMAQDIYRASYYRKG----GCAMLPVKWMPPEAFMEGIFTSKTDTWSF 232
Query: 229 GVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPST 287
           GV+L+ + S G  P+  K+  ++ + V +       DP  +       ++    +  P  
Sbjct: 233 GVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM---DPPKNCPGPVYRIMTQCWQHQPED 289
Query: 288 RLTAAEVLAHSWMEECEQ 305
           R   A +L    +E C Q
Sbjct: 290 RPNFAIILER--IEYCTQ 305

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 73/318 (22%), Positives = 130/318 (40%), Gaps = 35/318 (11%)
Query: 9   SSQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRE-----CSDKF 63
           +S + T +  +Y  +  T +I D  ++   +   + G  LG G FG + E       +  
Sbjct: 8   TSTIMTDYNPNYSFAGKTSSISDLKEVPRKNITLIRG--LGHGAFGEVYEGQVSGMPNDP 65
Query: 64  TGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELC 123
           +   +A K++ +  + + +D     +E  I++K + H N+V    V  +     +L+EL 
Sbjct: 66  SPLQVAVKTLPE--VCSEQDELDFLMEALIISKFN-HQNIVRCIGVSLQSLPRFILLELM 122
Query: 124 AGGELFHRLEKYGRFSETEARVIFRHLMQVV-------SYCHGNGVVHRDLKPENILLAT 176
           AGG+L   L +        + +    L+ V         Y   N  +HRD+   N LL  
Sbjct: 123 AGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTC 182
Query: 177 KSSSSPIKLADFGL------ATYIKAGQNLHGTVGSPF-YIAPEVLAGG-YNQAADVWSA 228
                  K+ DFG+      A+Y + G    G    P  ++ PE    G +    D WS 
Sbjct: 183 PGPGRVAKIGDFGMARDIYRASYYRKG----GCAMLPVKWMPPEAFMEGIFTSKTDTWSF 238
Query: 229 GVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPST 287
           GV+L+ + S G  P+  K+  ++ + V +       DP  +       ++    +  P  
Sbjct: 239 GVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM---DPPKNCPGPVYRIMTQCWQHQPED 295
Query: 288 RLTAAEVLAHSWMEECEQ 305
           R   A +L    +E C Q
Sbjct: 296 RPNFAIILER--IEYCTQ 311

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 74/314 (23%), Positives = 130/314 (41%), Gaps = 27/314 (8%)
Query: 9   SSQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRE-----CSDKF 63
           +S + T +  +Y  +  T +I D  ++   +   + G  LG G FG + E       +  
Sbjct: 42  TSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRG--LGHGAFGEVYEGQVSGMPNDP 99
Query: 64  TGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELC 123
           +   +A K++ +  + + +D     +E  I++K + H N+V    V  +     +L+EL 
Sbjct: 100 SPLQVAVKTLPE--VCSEQDELDFLMEALIISKFN-HQNIVRCIGVSLQSLPRFILLELM 156
Query: 124 AGGELFHRLEKYGRFSETEARVIFRHLMQVV-------SYCHGNGVVHRDLKPENILLAT 176
           AGG+L   L +        + +    L+ V         Y   N  +HRD+   N LL  
Sbjct: 157 AGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTC 216
Query: 177 KSSSSPIKLADFGLATYI-KAGQNLHGTVGS-PF-YIAPEVLAGG-YNQAADVWSAGVIL 232
                  K+ DFG+A  I +AG    G     P  ++ PE    G +    D WS GV+L
Sbjct: 217 PGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLL 276
Query: 233 YILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTA 291
           + + S G  P+  K+  ++ + V +       DP  +       ++    +  P  R   
Sbjct: 277 WEIFSLGYMPYPSKSNQEVLEFVTSGGRM---DPPKNCPGPVYRIMTQCWQHQPEDRPNF 333
Query: 292 AEVLAHSWMEECEQ 305
           A +L    +E C Q
Sbjct: 334 AIILER--IEYCTQ 345

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 112/232 (48%), Gaps = 22/232 (9%)
Query: 31  DATQISNLSDRYVLGKQLGWGQFG-VIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKL 89
           DA +I   S +  L K+LG GQFG V     +K T   +A K++    +     V +   
Sbjct: 8   DAWEIPRESLK--LEKKLGAGQFGEVWMATYNKHTK--VAVKTMKPGSM----SVEAFLA 59
Query: 90  EIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVI--F 147
           E  +M  L  H  +V L AV  +E  ++++ E  A G L   L+      +   ++I   
Sbjct: 60  EANVMKTLQ-HDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFS 117
Query: 148 RHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSP 207
             + + +++      +HRDL+  NIL+   S+S   K+ADFGLA  I+  +      G+ 
Sbjct: 118 AQIAEGMAFIEQRNYIHRDLRAANILV---SASLVCKIADFGLARVIEDNE-YTAREGAK 173
Query: 208 F---YIAPEVLA-GGYNQAADVWSAGVILY-ILLSGMPPFWGKTKSKIFDAV 254
           F   + APE +  G +   +DVWS G++L  I+  G  P+ G +  ++  A+
Sbjct: 174 FPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL 225

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 103/217 (47%), Gaps = 22/217 (10%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLA-----CKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
           K+LG G FG +++   +    V        K+ A D  +  E    +  E  +M +L  +
Sbjct: 33  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDE----LLAEANVMQQLD-N 87
Query: 101 PNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGN 160
           P +V +  + E E ++ L+ME+   G L   L++     +     +   +   + Y   +
Sbjct: 88  PYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES 146
Query: 161 GVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNL-----HGTVGSPFYIAPEVL 215
             VHRDL   N+LL T+  +   K++DFGL+  ++A +N      HG     +Y APE +
Sbjct: 147 NFVHRDLAARNVLLVTQHYA---KISDFGLSKALRADENYYKAQTHGKWPVKWY-APECI 202
Query: 216 A-GGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKI 250
               ++  +DVWS GV+++   S G  P+ G   S++
Sbjct: 203 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 239

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 103/217 (47%), Gaps = 22/217 (10%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLA-----CKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
           K+LG G FG +++   +    V        K+ A D  +  E    +  E  +M +L  +
Sbjct: 33  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDE----LLAEANVMQQLD-N 87
Query: 101 PNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGN 160
           P +V +  + E E ++ L+ME+   G L   L++     +     +   +   + Y   +
Sbjct: 88  PYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES 146
Query: 161 GVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNL-----HGTVGSPFYIAPEVL 215
             VHRDL   N+LL T+  +   K++DFGL+  ++A +N      HG     +Y APE +
Sbjct: 147 NFVHRDLAARNVLLVTQHYA---KISDFGLSKALRADENYYKAQTHGKWPVKWY-APECI 202
Query: 216 A-GGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKI 250
               ++  +DVWS GV+++   S G  P+ G   S++
Sbjct: 203 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 239

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 73/318 (22%), Positives = 130/318 (40%), Gaps = 35/318 (11%)
Query: 9   SSQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRE-----CSDKF 63
           +S + T +  +Y  +  T +I D  ++   +   + G  LG G FG + E       +  
Sbjct: 28  TSTIMTDYNPNYSFAGKTSSISDLKEVPRKNITLIRG--LGHGAFGEVYEGQVSGMPNDP 85
Query: 64  TGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELC 123
           +   +A K++ +  + + +D     +E  I++K + H N+V    V  +     +L+EL 
Sbjct: 86  SPLQVAVKTLPE--VCSEQDELDFLMEALIISKFN-HQNIVRCIGVSLQSLPRFILLELM 142
Query: 124 AGGELFHRLEKYGRFSETEARVIFRHLMQVV-------SYCHGNGVVHRDLKPENILLAT 176
           AGG+L   L +        + +    L+ V         Y   N  +HRD+   N LL  
Sbjct: 143 AGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTC 202
Query: 177 KSSSSPIKLADFGL------ATYIKAGQNLHGTVGSPF-YIAPEVLAGG-YNQAADVWSA 228
                  K+ DFG+      A+Y + G    G    P  ++ PE    G +    D WS 
Sbjct: 203 PGPGRVAKIGDFGMARDIYRASYYRKG----GCAMLPVKWMPPEAFMEGIFTSKTDTWSF 258
Query: 229 GVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPST 287
           GV+L+ + S G  P+  K+  ++ + V +       DP  +       ++    +  P  
Sbjct: 259 GVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR---MDPPKNCPGPVYRIMTQCWQHQPED 315
Query: 288 RLTAAEVLAHSWMEECEQ 305
           R   A +L    +E C Q
Sbjct: 316 RPNFAIILER--IEYCTQ 331

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 73/318 (22%), Positives = 130/318 (40%), Gaps = 35/318 (11%)
Query: 9   SSQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRE-----CSDKF 63
           +S + T +  +Y  +  T +I D  ++   +   + G  LG G FG + E       +  
Sbjct: 2   TSTIMTDYNPNYSFAGKTSSISDLKEVPRKNITLIRG--LGHGAFGEVYEGQVSGMPNDP 59
Query: 64  TGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELC 123
           +   +A K++ +  + + +D     +E  I++K + H N+V    V  +     +L+EL 
Sbjct: 60  SPLQVAVKTLPE--VCSEQDELDFLMEALIISKFN-HQNIVRCIGVSLQSLPRFILLELM 116
Query: 124 AGGELFHRLEKYGRFSETEARVIFRHLMQVV-------SYCHGNGVVHRDLKPENILLAT 176
           AGG+L   L +        + +    L+ V         Y   N  +HRD+   N LL  
Sbjct: 117 AGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTC 176
Query: 177 KSSSSPIKLADFGL------ATYIKAGQNLHGTVGSPF-YIAPEVLAGG-YNQAADVWSA 228
                  K+ DFG+      A+Y + G    G    P  ++ PE    G +    D WS 
Sbjct: 177 PGPGRVAKIGDFGMARDIYRASYYRKG----GCAMLPVKWMPPEAFMEGIFTSKTDTWSF 232
Query: 229 GVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPST 287
           GV+L+ + S G  P+  K+  ++ + V +       DP  +       ++    +  P  
Sbjct: 233 GVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM---DPPKNCPGPVYRIMTQCWQHQPED 289
Query: 288 RLTAAEVLAHSWMEECEQ 305
           R   A +L    +E C Q
Sbjct: 290 RPNFAIILER--IEYCTQ 305

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 103/217 (47%), Gaps = 22/217 (10%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLA-----CKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
           K+LG G FG +++   +    V        K+ A D  +  E    +  E  +M +L  +
Sbjct: 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDE----LLAEANVMQQLD-N 429
Query: 101 PNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGN 160
           P +V +  + E E ++ L+ME+   G L   L++     +     +   +   + Y   +
Sbjct: 430 PYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES 488
Query: 161 GVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNL-----HGTVGSPFYIAPEVL 215
             VHRDL   N+LL T+  +   K++DFGL+  ++A +N      HG     +Y APE +
Sbjct: 489 NFVHRDLAARNVLLVTQHYA---KISDFGLSKALRADENYYKAQTHGKWPVKWY-APECI 544
Query: 216 A-GGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKI 250
               ++  +DVWS GV+++   S G  P+ G   S++
Sbjct: 545 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 581

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 103/217 (47%), Gaps = 22/217 (10%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLA-----CKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
           K+LG G FG +++   +    V        K+ A D  +  E    +  E  +M +L  +
Sbjct: 11  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDE----LLAEANVMQQLD-N 65
Query: 101 PNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGN 160
           P +V +  + E E ++ L+ME+   G L   L++     +     +   +   + Y   +
Sbjct: 66  PYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES 124
Query: 161 GVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNL-----HGTVGSPFYIAPEVL 215
             VHRDL   N+LL T+  +   K++DFGL+  ++A +N      HG     +Y APE +
Sbjct: 125 NFVHRDLAARNVLLVTQHYA---KISDFGLSKALRADENYYKAQTHGKWPVKWY-APECI 180
Query: 216 A-GGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKI 250
               ++  +DVWS GV+++   S G  P+ G   S++
Sbjct: 181 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 217

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 103/217 (47%), Gaps = 22/217 (10%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLA-----CKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
           K+LG G FG +++   +    V        K+ A D  +  E    +  E  +M +L  +
Sbjct: 31  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDE----LLAEANVMQQLD-N 85
Query: 101 PNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGN 160
           P +V +  + E E ++ L+ME+   G L   L++     +     +   +   + Y   +
Sbjct: 86  PYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES 144
Query: 161 GVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNL-----HGTVGSPFYIAPEVL 215
             VHRDL   N+LL T+  +   K++DFGL+  ++A +N      HG     +Y APE +
Sbjct: 145 NFVHRDLAARNVLLVTQHYA---KISDFGLSKALRADENYYKAQTHGKWPVKWY-APECI 200
Query: 216 A-GGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKI 250
               ++  +DVWS GV+++   S G  P+ G   S++
Sbjct: 201 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 237

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 103/217 (47%), Gaps = 22/217 (10%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLA-----CKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
           K+LG G FG +++   +    V        K+ A D  +  E    +  E  +M +L  +
Sbjct: 17  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDE----LLAEANVMQQLD-N 71
Query: 101 PNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGN 160
           P +V +  + E E ++ L+ME+   G L   L++     +     +   +   + Y   +
Sbjct: 72  PYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES 130
Query: 161 GVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNL-----HGTVGSPFYIAPEVL 215
             VHRDL   N+LL T+  +   K++DFGL+  ++A +N      HG     +Y APE +
Sbjct: 131 NFVHRDLAARNVLLVTQHYA---KISDFGLSKALRADENXYKAQTHGKWPVKWY-APECI 186
Query: 216 A-GGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKI 250
               ++  +DVWS GV+++   S G  P+ G   S++
Sbjct: 187 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 223

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 103/217 (47%), Gaps = 22/217 (10%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLA-----CKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
           K+LG G FG +++   +    V        K+ A D  +  E    +  E  +M +L  +
Sbjct: 376 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDE----LLAEANVMQQLD-N 430
Query: 101 PNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGN 160
           P +V +  + E E ++ L+ME+   G L   L++     +     +   +   + Y   +
Sbjct: 431 PYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES 489
Query: 161 GVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNL-----HGTVGSPFYIAPEVL 215
             VHRDL   N+LL T+  +   K++DFGL+  ++A +N      HG     +Y APE +
Sbjct: 490 NFVHRDLAARNVLLVTQHYA---KISDFGLSKALRADENYYKAQTHGKWPVKWY-APECI 545
Query: 216 A-GGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKI 250
               ++  +DVWS GV+++   S G  P+ G   S++
Sbjct: 546 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 582

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 103/217 (47%), Gaps = 22/217 (10%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLA-----CKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
           K+LG G FG +++   +    V        K+ A D  +  E    +  E  +M +L  +
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDE----LLAEANVMQQLD-N 67
Query: 101 PNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGN 160
           P +V +  + E E ++ L+ME+   G L   L++     +     +   +   + Y   +
Sbjct: 68  PYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES 126
Query: 161 GVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNL-----HGTVGSPFYIAPEVL 215
             VHRDL   N+LL T+  +   K++DFGL+  ++A +N      HG     +Y APE +
Sbjct: 127 NFVHRDLAARNVLLVTQHYA---KISDFGLSKALRADENYYKAQTHGKWPVKWY-APECI 182
Query: 216 A-GGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKI 250
               ++  +DVWS GV+++   S G  P+ G   S++
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 219

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 103/217 (47%), Gaps = 22/217 (10%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLA-----CKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
           K+LG G FG +++   +    V        K+ A D  +  E    +  E  +M +L  +
Sbjct: 17  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDE----LLAEANVMQQLD-N 71
Query: 101 PNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGN 160
           P +V +  + E E ++ L+ME+   G L   L++     +     +   +   + Y   +
Sbjct: 72  PYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES 130
Query: 161 GVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNL-----HGTVGSPFYIAPEVL 215
             VHRDL   N+LL T+  +   K++DFGL+  ++A +N      HG     +Y APE +
Sbjct: 131 NFVHRDLAARNVLLVTQHYA---KISDFGLSKALRADENYYKAQTHGKWPVKWY-APECI 186
Query: 216 A-GGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKI 250
               ++  +DVWS GV+++   S G  P+ G   S++
Sbjct: 187 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 223

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 103/217 (47%), Gaps = 22/217 (10%)
Query: 46  KQLGWGQFGVIRECSDKFTGEVLA-----CKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
           K+LG G FG +++   +    V        K+ A D  +  E    +  E  +M +L  +
Sbjct: 23  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDE----LLAEANVMQQLD-N 77
Query: 101 PNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGN 160
           P +V +  + E E ++ L+ME+   G L   L++     +     +   +   + Y   +
Sbjct: 78  PYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES 136
Query: 161 GVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNL-----HGTVGSPFYIAPEVL 215
             VHRDL   N+LL T+  +   K++DFGL+  ++A +N      HG     +Y APE +
Sbjct: 137 NFVHRDLAARNVLLVTQHYA---KISDFGLSKALRADENYYKAQTHGKWPVKWY-APECI 192
Query: 216 A-GGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKI 250
               ++  +DVWS GV+++   S G  P+ G   S++
Sbjct: 193 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 229

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 105/236 (44%), Gaps = 21/236 (8%)
Query: 18  NSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIR--ECSDKFTGEVLACKSIAK 75
           +S  ++ +   ++   ++   SDR V+GK    G FGV+   E  D+    +  C   + 
Sbjct: 4   DSALLAEVKDVLIPHERVVTHSDR-VIGK----GHFGVVYHGEYIDQAQNRI-QCAIKSL 57
Query: 76  DRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVY-EEEDYVHLLMELCAGGELFHRLEK 134
            R+  ++ V +   E  +M  L+ HPNV+ L  +    E   H+L+     G+L   +  
Sbjct: 58  SRITEMQQVEAFLREGLLMRGLN-HPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRS 116
Query: 135 YGRFSETEARVIF-RHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLAT- 192
             R    +  + F   + + + Y      VHRDL   N +L     S  +K+ADFGLA  
Sbjct: 117 PQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCML---DESFTVKVADFGLARD 173
Query: 193 -----YIKAGQNLHGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLS-GMPPF 242
                Y    Q+ H  +   +     +    +   +DVWS GV+L+ LL+ G PP+
Sbjct: 174 ILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPY 229

>pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 78/160 (48%), Gaps = 17/160 (10%)
Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRS----IKLEIEI 93
           + +RY LG+++G G FG I   +D   GE +A K         +E V++    + +E +I
Sbjct: 7   VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK---------LECVKTKHPQLHIESKI 57
Query: 94  MTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGG--ELFHRLEKYGRFSETEARVIFRHLM 151
              + G   +  ++    E DY  ++MEL      +LF+   +  +FS     ++   ++
Sbjct: 58  YKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSR--KFSLKTVLLLADQMI 115
Query: 152 QVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA 191
             + Y H    +HRD+KP+N L+      + + + DFGLA
Sbjct: 116 SRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/281 (23%), Positives = 127/281 (45%), Gaps = 39/281 (13%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIE------I 93
           ++  L ++LG G FG++ E + +   +++  ++  +  + TV +  S++  IE      +
Sbjct: 17  EKITLLRELGQGSFGMVYEGNAR---DIIKGEAETRVAVKTVNESASLRERIEFLNEASV 73
Query: 94  MTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGEL---FHRLEKYGRFSETEARVIFRHL 150
           M   + H +VV L  V  +     ++MEL A G+L      L      +        + +
Sbjct: 74  MKGFTCH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 132
Query: 151 MQV-------VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGL-------ATYIKA 196
           +Q+       ++Y +    VHRDL   N ++A   +   +K+ DFG+       A Y K 
Sbjct: 133 IQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT---VKIGDFGMTRDIYETAYYRKG 189
Query: 197 GQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAV 254
           G+ L        ++APE L  G +  ++D+WS GV+L+ + S    P+ G +  ++   V
Sbjct: 190 GKGLLPVR----WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 245
Query: 255 RAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVL 295
              D  +   P D+      DL+    + +P  R T  E++
Sbjct: 246 --MDGGYLDQP-DNCPERVTDLMRMCWQFNPKMRPTFLEIV 283

>pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 78/160 (48%), Gaps = 17/160 (10%)
Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRS----IKLEIEI 93
           + +RY LG+++G G FG I   +D   GE +A K         +E V++    + +E +I
Sbjct: 5   VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK---------LECVKTKHPQLHIESKI 55
Query: 94  MTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGG--ELFHRLEKYGRFSETEARVIFRHLM 151
              + G   +  ++    E DY  ++MEL      +LF+   +  +FS     ++   ++
Sbjct: 56  YKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSR--KFSLKTVLLLADQMI 113
Query: 152 QVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA 191
             + Y H    +HRD+KP+N L+      + + + DFGLA
Sbjct: 114 SRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 153

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 75/256 (29%), Positives = 114/256 (44%), Gaps = 25/256 (9%)
Query: 44  LGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNV 103
           L K+LG GQFG +      + G         K   ++ E   S   E +IM KL  H  +
Sbjct: 13  LIKRLGNGQFGEV--WMGTWNGNTKVAIKTLKPGTMSPE---SFLEEAQIMKKLK-HDKL 66
Query: 104 VDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQV---VSYCHGN 160
           V L AV  EE  ++++ E    G L   L K G     +   +     QV   ++Y    
Sbjct: 67  VQLYAVVSEEP-IYIVTEYMNKGSLLDFL-KDGEGRALKLPNLVDMAAQVAAGMAYIERM 124
Query: 161 GVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF---YIAPEV-LA 216
             +HRDL+  NIL+    +    K+ADFGLA  I+  +      G+ F   + APE  L 
Sbjct: 125 NYIHRDLRSANILVG---NGLICKIADFGLARLIEDNEXT-ARQGAKFPIKWTAPEAALY 180
Query: 217 GGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAV-RAADLRFPSDPWDHISASAR 274
           G +   +DVWS G++L  L++ G  P+ G    ++ + V R   +  P D       S  
Sbjct: 181 GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQD----CPISLH 236
Query: 275 DLIMGMLRVDPSTRLT 290
           +L++   + DP  R T
Sbjct: 237 ELMIHCWKKDPEERPT 252

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 73/318 (22%), Positives = 130/318 (40%), Gaps = 35/318 (11%)
Query: 9   SSQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRE-----CSDKF 63
           +S + T +  +Y  +  T +I D  ++   +   + G  LG G FG + E       +  
Sbjct: 18  TSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRG--LGHGAFGEVYEGQVSGMPNDP 75
Query: 64  TGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELC 123
           +   +A K++ +  + + +D     +E  I++K + H N+V    V  +     +L+EL 
Sbjct: 76  SPLQVAVKTLPE--VCSEQDELDFLMEALIISKFN-HQNIVRCIGVSLQSLPRFILLELM 132
Query: 124 AGGELFHRLEKYGRFSETEARVIFRHLMQVV-------SYCHGNGVVHRDLKPENILLAT 176
           AGG+L   L +        + +    L+ V         Y   N  +HRD+   N LL  
Sbjct: 133 AGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTC 192
Query: 177 KSSSSPIKLADFGL------ATYIKAGQNLHGTVGSPF-YIAPEVLAGG-YNQAADVWSA 228
                  K+ DFG+      A+Y + G    G    P  ++ PE    G +    D WS 
Sbjct: 193 PGPGRVAKIGDFGMARDIYRASYYRKG----GCAMLPVKWMPPEAFMEGIFTSKTDTWSF 248
Query: 229 GVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPST 287
           GV+L+ + S G  P+  K+  ++ + V +       DP  +       ++    +  P  
Sbjct: 249 GVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM---DPPKNCPGPVYRIMTQCWQHQPED 305
Query: 288 RLTAAEVLAHSWMEECEQ 305
           R   A +L    +E C Q
Sbjct: 306 RPNFAIILER--IEYCTQ 321

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 110/232 (47%), Gaps = 32/232 (13%)
Query: 31  DATQISNLSDRYVLGKQLGWGQFG-VIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKL 89
           DA +I   S +  L K+LG GQFG V     +K T   +A K++    +     V +   
Sbjct: 175 DAWEIPRESLK--LEKKLGAGQFGEVWMATYNKHTK--VAVKTMKPGSM----SVEAFLA 226
Query: 90  EIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVI--F 147
           E  +M  L  H  +V L AV  +E  ++++ E  A G L   L+      +   ++I   
Sbjct: 227 EANVMKTLQ-HDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFS 284
Query: 148 RHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSP 207
             + + +++      +HRDL+  NIL+   S+S   K+ADFGLA            VG+ 
Sbjct: 285 AQIAEGMAFIEQRNYIHRDLRAANILV---SASLVCKIADFGLAR-----------VGAK 330
Query: 208 F---YIAPEVLA-GGYNQAADVWSAGVILY-ILLSGMPPFWGKTKSKIFDAV 254
           F   + APE +  G +   +DVWS G++L  I+  G  P+ G +  ++  A+
Sbjct: 331 FPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL 382

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 66/281 (23%), Positives = 126/281 (44%), Gaps = 39/281 (13%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIE------I 93
           ++  L ++LG G FG++ E + +   +++  ++  +  + TV +  S++  IE      +
Sbjct: 16  EKITLLRELGQGSFGMVYEGNAR---DIIKGEAETRVAVKTVNESASLRERIEFLNEASV 72
Query: 94  MTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGEL---FHRLEKYGRFSETEARVIFRHL 150
           M   + H +VV L  V  +     ++MEL A G+L      L      +        + +
Sbjct: 73  MKGFTCH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 131
Query: 151 MQV-------VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLAT-------YIKA 196
           +Q+       ++Y +    VHRDL   N ++A   +   +K+ DFG+         Y K 
Sbjct: 132 IQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT---VKIGDFGMTRDIYETDYYRKG 188
Query: 197 GQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAV 254
           G+ L        ++APE L  G +  ++D+WS GV+L+ + S    P+ G +  ++   V
Sbjct: 189 GKGLLPVR----WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 244
Query: 255 RAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVL 295
              D  +   P D+      DL+    + +P  R T  E++
Sbjct: 245 --MDGGYLDQP-DNCPERVTDLMRMCWQFNPKMRPTFLEIV 282

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 66/281 (23%), Positives = 126/281 (44%), Gaps = 39/281 (13%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIE------I 93
           ++  L ++LG G FG++ E + +   +++  ++  +  + TV +  S++  IE      +
Sbjct: 17  EKITLLRELGQGSFGMVYEGNAR---DIIKGEAETRVAVKTVNESASLRERIEFLNEASV 73
Query: 94  MTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGEL---FHRLEKYGRFSETEARVIFRHL 150
           M   + H +VV L  V  +     ++MEL A G+L      L      +        + +
Sbjct: 74  MKGFTCH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 132
Query: 151 MQV-------VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLAT-------YIKA 196
           +Q+       ++Y +    VHRDL   N ++A   +   +K+ DFG+         Y K 
Sbjct: 133 IQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT---VKIGDFGMTRDIYETDYYRKG 189
Query: 197 GQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAV 254
           G+ L        ++APE L  G +  ++D+WS GV+L+ + S    P+ G +  ++   V
Sbjct: 190 GKGLLPVR----WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 245
Query: 255 RAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVL 295
              D  +   P D+      DL+    + +P  R T  E++
Sbjct: 246 --MDGGYLDQP-DNCPERVTDLMRMCWQFNPKMRPTFLEIV 283

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 16/205 (7%)
Query: 47  QLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDL 106
           +LG G FG +R+   +   + +        +     D   +  E +IM +L  +P +V L
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD-NPYIVRL 75
Query: 107 KAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQV---VSYCHGNGVV 163
             V + E  + L+ME+  GG L   L   G+  E     +   L QV   + Y      V
Sbjct: 76  IGVCQAEA-LMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 132
Query: 164 HRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGS---PF-YIAPEVLA-GG 218
           HRDL   N+LL  +  +   K++DFGL+  + A  + +    +   P  + APE +    
Sbjct: 133 HRDLAARNVLLVNRHYA---KISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 189
Query: 219 YNQAADVWSAGVILYILLS-GMPPF 242
           ++  +DVWS GV ++  LS G  P+
Sbjct: 190 FSSRSDVWSYGVTMWEALSYGQKPY 214

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 66/281 (23%), Positives = 127/281 (45%), Gaps = 39/281 (13%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIE------I 93
           ++  L ++LG G FG++ E + +   +++  ++  +  + TV +  S++  IE      +
Sbjct: 17  EKITLLRELGQGSFGMVYEGNAR---DIIKGEAETRVAVKTVNESASLRERIEFLNEASV 73
Query: 94  MTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGEL---FHRLEKYGRFSETEARVIFRHL 150
           M   + H +VV L  V  +     ++MEL A G+L      L      +        + +
Sbjct: 74  MKGFTCH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 132
Query: 151 MQV-------VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI-------KA 196
           +Q+       ++Y +    VHRDL   N ++A   +   +K+ DFG+   I       K 
Sbjct: 133 IQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT---VKIGDFGMTRDIXETDXXRKG 189
Query: 197 GQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAV 254
           G+ L        ++APE L  G +  ++D+WS GV+L+ + S    P+ G +  ++   V
Sbjct: 190 GKGLLPVR----WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 245
Query: 255 RAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVL 295
              D  +   P D+      DL+    + +P+ R T  E++
Sbjct: 246 --MDGGYLDQP-DNCPERVTDLMRMCWQFNPNMRPTFLEIV 283

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 87/177 (49%), Gaps = 24/177 (13%)
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSET----EARVI--------F 147
           HPNVV L  V  ++  + ++   C+ G+L   L      S+     + R +        F
Sbjct: 88  HPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDF 147
Query: 148 RHLMQVVS----YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ--NLH 201
            HL+  ++    Y   + VVH+DL   N+L+  K +   +K++D GL   + A     L 
Sbjct: 148 VHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLN---VKISDLGLFREVYAADYYKLL 204
Query: 202 GTVGSPF-YIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVR 255
           G    P  ++APE ++ G ++  +D+WS GV+L+ + S G+ P+ G +   + + +R
Sbjct: 205 GNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIR 261

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 72/308 (23%), Positives = 125/308 (40%), Gaps = 35/308 (11%)
Query: 19  SYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRE-----CSDKFTGEVLACKSI 73
           +Y  +  T +I D  ++   +   + G  LG G FG + E       +  +   +A K++
Sbjct: 26  NYCFAGKTSSISDLKEVPRKNITLIRG--LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL 83
Query: 74  AKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLE 133
            +  + + +D     +E  I++K + H N+V    V  +     +LMEL AGG+L   L 
Sbjct: 84  PE--VCSEQDELDFLMEALIISKFN-HQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLR 140
Query: 134 KYGRFSETEARVIFRHLMQVV-------SYCHGNGVVHRDLKPENILLATKSSSSPIKLA 186
           +        + +    L+ V         Y   N  +HRD+   N LL         K+ 
Sbjct: 141 ETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG 200
Query: 187 DFGL------ATYIKAGQNLHGTVGSPF-YIAPEVLAGG-YNQAADVWSAGVILYILLS- 237
           DFG+      A+Y + G    G    P  ++ PE    G +    D WS GV+L+ + S 
Sbjct: 201 DFGMARDIYRASYYRKG----GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL 256
Query: 238 GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH 297
           G  P+  K+  ++ + V +       DP  +       ++    +  P  R   A +L  
Sbjct: 257 GYMPYPSKSNQEVLEFVTSGGRM---DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILER 313
Query: 298 SWMEECEQ 305
             +E C Q
Sbjct: 314 --IEYCTQ 319

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 72/308 (23%), Positives = 125/308 (40%), Gaps = 35/308 (11%)
Query: 19  SYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRE-----CSDKFTGEVLACKSI 73
           +Y  +  T +I D  ++   +   + G  LG G FG + E       +  +   +A K++
Sbjct: 11  NYCFAGKTSSISDLKEVPRKNITLIRG--LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL 68
Query: 74  AKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLE 133
            +  + + +D     +E  I++K + H N+V    V  +     +LMEL AGG+L   L 
Sbjct: 69  PE--VCSEQDELDFLMEALIISKFN-HQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLR 125
Query: 134 KYGRFSETEARVIFRHLMQVV-------SYCHGNGVVHRDLKPENILLATKSSSSPIKLA 186
           +        + +    L+ V         Y   N  +HRD+   N LL         K+ 
Sbjct: 126 ETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG 185
Query: 187 DFGL------ATYIKAGQNLHGTVGSPF-YIAPEVLAGG-YNQAADVWSAGVILYILLS- 237
           DFG+      A+Y + G    G    P  ++ PE    G +    D WS GV+L+ + S 
Sbjct: 186 DFGMARDIYRASYYRKG----GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL 241
Query: 238 GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH 297
           G  P+  K+  ++ + V +       DP  +       ++    +  P  R   A +L  
Sbjct: 242 GYMPYPSKSNQEVLEFVTSGGRM---DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILER 298
Query: 298 SWMEECEQ 305
             +E C Q
Sbjct: 299 --IEYCTQ 304

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 87/177 (49%), Gaps = 24/177 (13%)
Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSET----EARVI--------F 147
           HPNVV L  V  ++  + ++   C+ G+L   L      S+     + R +        F
Sbjct: 71  HPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDF 130
Query: 148 RHLMQVVS----YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ--NLH 201
            HL+  ++    Y   + VVH+DL   N+L+  K +   +K++D GL   + A     L 
Sbjct: 131 VHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLN---VKISDLGLFREVYAADYYKLL 187
Query: 202 GTVGSPF-YIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVR 255
           G    P  ++APE ++ G ++  +D+WS GV+L+ + S G+ P+ G +   + + +R
Sbjct: 188 GNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIR 244

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 72/308 (23%), Positives = 126/308 (40%), Gaps = 35/308 (11%)
Query: 19  SYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRE-----CSDKFTGEVLACKSI 73
           +Y  +  T +I D  ++   +   + G  LG G FG + E       +  +   +A K++
Sbjct: 26  NYCFAGKTSSISDLKEVPRKNITLIRG--LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL 83
Query: 74  AKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLE 133
            +  + + +D     +E  I++KL+ H N+V    V  +     +L+EL AGG+L   L 
Sbjct: 84  PE--VCSEQDELDFLMEALIISKLN-HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLR 140
Query: 134 KYGRFSETEARVIFRHLMQVV-------SYCHGNGVVHRDLKPENILLATKSSSSPIKLA 186
           +        + +    L+ V         Y   N  +HRD+   N LL         K+ 
Sbjct: 141 ETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG 200
Query: 187 DFGL------ATYIKAGQNLHGTVGSPF-YIAPEVLAGG-YNQAADVWSAGVILYILLS- 237
           DFG+      A+Y + G    G    P  ++ PE    G +    D WS GV+L+ + S 
Sbjct: 201 DFGMARDIYRASYYRKG----GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL 256
Query: 238 GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH 297
           G  P+  K+  ++ + V +       DP  +       ++    +  P  R   A +L  
Sbjct: 257 GYMPYPSKSNQEVLEFVTSGGRM---DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILER 313
Query: 298 SWMEECEQ 305
             +E C Q
Sbjct: 314 --IEYCTQ 319

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 66/281 (23%), Positives = 126/281 (44%), Gaps = 39/281 (13%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIE------I 93
           ++  L ++LG G FG++ E + +   +++  ++  +  + TV +  S++  IE      +
Sbjct: 17  EKITLLRELGQGSFGMVYEGNAR---DIIKGEAETRVAVKTVNESASLRERIEFLNEASV 73
Query: 94  MTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGEL---FHRLEKYGRFSETEARVIFRHL 150
           M   + H +VV L  V  +     ++MEL A G+L      L      +        + +
Sbjct: 74  MKGFTCH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 132
Query: 151 MQV-------VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI-------KA 196
           +Q+       ++Y +    VHRDL   N ++A   +   +K+ DFG+   I       K 
Sbjct: 133 IQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT---VKIGDFGMTRDIXETDXXRKG 189
Query: 197 GQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAV 254
           G+ L        ++APE L  G +  ++D+WS GV+L+ + S    P+ G +  ++   V
Sbjct: 190 GKGLLPVR----WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 245
Query: 255 RAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVL 295
              D  +   P D+      DL+    + +P  R T  E++
Sbjct: 246 --MDGGYLDQP-DNCPERVTDLMRMCWQFNPKMRPTFLEIV 283

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 72/275 (26%), Positives = 111/275 (40%), Gaps = 36/275 (13%)
Query: 39  SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLS 98
           +  Y+  ++LG G F  +        G   A K I        +D    + E + M +L 
Sbjct: 28  NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE---QQDREEAQREAD-MHRLF 83
Query: 99  GHPNVVDLKAV-YEEEDYVH---LLMELCAGGELFH---RLEKYGRF-SETEARVIFRHL 150
            HPN++ L A    E    H   LL+     G L++   RL+  G F +E +   +   +
Sbjct: 84  NHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGI 143
Query: 151 MQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG-------QNLHGT 203
            + +   H  G  HRDLKP NILL  +     + L     A     G       Q+    
Sbjct: 144 CRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQ 203
Query: 204 VGSPFYIAPEVLAGG----YNQAADVWSAGVILYILLSGMPPFWGKTKSKIF---DAVRA 256
             +  Y APE+ +       ++  DVWS G +LY ++ G  P+       +F   D+V  
Sbjct: 204 RCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPY-----DMVFQKGDSVAL 258
Query: 257 A---DLRFPSDPWDHISASARDLIMGMLRVDPSTR 288
           A    L  P  P    S++   L+  M+ VDP  R
Sbjct: 259 AVQNQLSIPQSP--RHSSALWQLLNSMMTVDPHQR 291

>pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 79/160 (49%), Gaps = 17/160 (10%)
Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTK- 96
           + ++Y LG+++G G FG I   ++  +GE +A K         +E V++   ++ I +K 
Sbjct: 7   VGNKYRLGRKIGSGSFGDIYLGANIASGEEVAIK---------LECVKTKHPQLHIESKF 57
Query: 97  ---LSGHPNVVDLKAVYEEEDYVHLLMELCAGG--ELFHRLEKYGRFSETEARVIFRHLM 151
              + G   +  +K    E DY  ++MEL      +LF+   +  +FS     ++   ++
Sbjct: 58  YKMMQGGVGIPSIKWCGAEGDYNVMVMELLGPSLEDLFNFCSR--KFSLKTVLLLADQMI 115
Query: 152 QVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA 191
             + Y H    +HRD+KP+N L+      + + + DFGLA
Sbjct: 116 SRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 66/281 (23%), Positives = 126/281 (44%), Gaps = 39/281 (13%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIE------I 93
           ++  L ++LG G FG++ E + +   +++  ++  +  + TV +  S++  IE      +
Sbjct: 14  EKITLLRELGQGSFGMVYEGNAR---DIIKGEAETRVAVKTVNESASLRERIEFLNEASV 70
Query: 94  MTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGEL---FHRLEKYGRFSETEARVIFRHL 150
           M   + H +VV L  V  +     ++MEL A G+L      L      +        + +
Sbjct: 71  MKGFTCH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 129
Query: 151 MQV-------VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI-------KA 196
           +Q+       ++Y +    VHRDL   N ++A   +   +K+ DFG+   I       K 
Sbjct: 130 IQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT---VKIGDFGMTRDIXETDXXRKG 186
Query: 197 GQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAV 254
           G+ L        ++APE L  G +  ++D+WS GV+L+ + S    P+ G +  ++   V
Sbjct: 187 GKGLLPVR----WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 242
Query: 255 RAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVL 295
              D  +   P D+      DL+    + +P  R T  E++
Sbjct: 243 --MDGGYLDQP-DNCPERVTDLMRMCWQFNPKMRPTFLEIV 280

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 65/281 (23%), Positives = 127/281 (45%), Gaps = 39/281 (13%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIE------I 93
           ++  L ++LG G FG++ E + +   +++  ++  +  + TV +  S++  IE      +
Sbjct: 18  EKITLLRELGQGSFGMVYEGNAR---DIIKGEAETRVAVKTVNESASLRERIEFLNEASV 74
Query: 94  MTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGEL---FHRLEKYGRFSETEARVIFRHL 150
           M   + H +VV L  V  +     ++MEL A G+L      L      +        + +
Sbjct: 75  MKGFTCH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 133
Query: 151 MQV-------VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLAT-------YIKA 196
           +Q+       ++Y +    VHR+L   N ++A   +   +K+ DFG+         Y K 
Sbjct: 134 IQMAAEIADGMAYLNAKKFVHRNLAARNCMVAHDFT---VKIGDFGMTRDIYETDYYRKG 190
Query: 197 GQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAV 254
           G+ L        ++APE L  G +  ++D+WS GV+L+ + S    P+ G +  ++   V
Sbjct: 191 GKGLLPVR----WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 246
Query: 255 RAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVL 295
              D  +   P D+      DL+    + +P+ R T  E++
Sbjct: 247 --MDGGYLDQP-DNCPERVTDLMRMCWQFNPNMRPTFLEIV 284

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 65/281 (23%), Positives = 127/281 (45%), Gaps = 39/281 (13%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIE------I 93
           ++  L ++LG G FG++ E + +   +++  ++  +  + TV +  S++  IE      +
Sbjct: 17  EKITLLRELGQGSFGMVYEGNAR---DIIKGEAETRVAVKTVNESASLRERIEFLNEASV 73
Query: 94  MTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGEL---FHRLEKYGRFSETEARVIFRHL 150
           M   + H +VV L  V  +     ++MEL A G+L      L      +        + +
Sbjct: 74  MKGFTCH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 132
Query: 151 MQV-------VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLAT-------YIKA 196
           +Q+       ++Y +    VHR+L   N ++A   +   +K+ DFG+         Y K 
Sbjct: 133 IQMAAEIADGMAYLNAKKFVHRNLAARNCMVAHDFT---VKIGDFGMTRDIYETDYYRKG 189
Query: 197 GQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAV 254
           G+ L        ++APE L  G +  ++D+WS GV+L+ + S    P+ G +  ++   V
Sbjct: 190 GKGLLPVR----WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 245
Query: 255 RAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVL 295
              D  +   P D+      DL+    + +P+ R T  E++
Sbjct: 246 --MDGGYLDQP-DNCPERVTDLMRMCWQFNPNMRPTFLEIV 283

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 71/308 (23%), Positives = 125/308 (40%), Gaps = 35/308 (11%)
Query: 19  SYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRE-----CSDKFTGEVLACKSI 73
           +Y  +  T +I D  ++   +   + G  LG G FG + E       +  +   +A K++
Sbjct: 11  NYCFAGKTSSISDLKEVPRKNITLIRG--LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL 68
Query: 74  AKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLE 133
            +  + + +D     +E  I++K + H N+V    V  +     +L+EL AGG+L   L 
Sbjct: 69  PE--VCSEQDELDFLMEALIISKFN-HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLR 125
Query: 134 KYGRFSETEARVIFRHLMQVV-------SYCHGNGVVHRDLKPENILLATKSSSSPIKLA 186
           +        + +    L+ V         Y   N  +HRD+   N LL         K+ 
Sbjct: 126 ETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG 185
Query: 187 DFGL------ATYIKAGQNLHGTVGSPF-YIAPEVLAGG-YNQAADVWSAGVILYILLS- 237
           DFG+      A+Y + G    G    P  ++ PE    G +    D WS GV+L+ + S 
Sbjct: 186 DFGMARDIYRASYYRKG----GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL 241
Query: 238 GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH 297
           G  P+  K+  ++ + V +       DP  +       ++    +  P  R   A +L  
Sbjct: 242 GYMPYPSKSNQEVLEFVTSGGRM---DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILER 298
Query: 298 SWMEECEQ 305
             +E C Q
Sbjct: 299 --IEYCTQ 304

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 71/308 (23%), Positives = 125/308 (40%), Gaps = 35/308 (11%)
Query: 19  SYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRE-----CSDKFTGEVLACKSI 73
           +Y  +  T +I D  ++   +   + G  LG G FG + E       +  +   +A K++
Sbjct: 3   NYCFAGKTSSISDLKEVPRKNITLIRG--LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL 60
Query: 74  AKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLE 133
            +  + + +D     +E  I++K + H N+V    V  +     +L+EL AGG+L   L 
Sbjct: 61  PE--VCSEQDELDFLMEALIISKFN-HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLR 117
Query: 134 KYGRFSETEARVIFRHLMQVV-------SYCHGNGVVHRDLKPENILLATKSSSSPIKLA 186
           +        + +    L+ V         Y   N  +HRD+   N LL         K+ 
Sbjct: 118 ETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG 177
Query: 187 DFGL------ATYIKAGQNLHGTVGSPF-YIAPEVLAGG-YNQAADVWSAGVILYILLS- 237
           DFG+      A+Y + G    G    P  ++ PE    G +    D WS GV+L+ + S 
Sbjct: 178 DFGMARDIYRASYYRKG----GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL 233
Query: 238 GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH 297
           G  P+  K+  ++ + V +       DP  +       ++    +  P  R   A +L  
Sbjct: 234 GYMPYPSKSNQEVLEFVTSGGRM---DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILER 290
Query: 298 SWMEECEQ 305
             +E C Q
Sbjct: 291 --IEYCTQ 296

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 73/313 (23%), Positives = 133/313 (42%), Gaps = 62/313 (19%)
Query: 27  GTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDR------LVT 80
           G++ D  +++   ++  + ++LG G FG++ E            K + KD       + T
Sbjct: 1   GSVPDEWEVAR--EKITMSRELGQGSFGMVYEG---------VAKGVVKDEPETRVAIKT 49
Query: 81  VEDVRSIKLEIE------IMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEK 134
           V +  S++  IE      +M + + H +VV L  V  +     ++MEL   G+L   L  
Sbjct: 50  VNEAASMRERIEFLNEASVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRS 108
Query: 135 YGRFSETEARVIFRHLMQVV----------SYCHGNGVVHRDLKPENILLATKSSSSPIK 184
                E    +    L +++          +Y + N  VHRDL   N ++A   +   +K
Sbjct: 109 LRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT---VK 165
Query: 185 LADFGLAT-------YIKAGQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILY-IL 235
           + DFG+         Y K G+ L        +++PE L  G +   +DVWS GV+L+ I 
Sbjct: 166 IGDFGMTRDIYETDYYRKGGKGLLPVR----WMSPESLKDGVFTTYSDVWSFGVVLWEIA 221
Query: 236 LSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRV----DPSTRLTA 291
                P+ G +  ++   V    L    D       +  D++  ++R+    +P  R + 
Sbjct: 222 TLAEQPYQGLSNEQVLRFVMEGGLLDKPD-------NCPDMLFELMRMCWQYNPKMRPSF 274
Query: 292 AEVLAHSWMEECE 304
            E+++ S  EE E
Sbjct: 275 LEIIS-SIKEEME 286

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 94/205 (45%), Gaps = 16/205 (7%)
Query: 47  QLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDL 106
           +LG G FG +R+   +   + +        +     D   +  E +IM +L  +P +V L
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD-NPYIVRL 401
Query: 107 KAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQV---VSYCHGNGVV 163
             V + E  + L+ME+  GG L   L   G+  E     +   L QV   + Y      V
Sbjct: 402 IGVCQAEALM-LVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 458
Query: 164 HRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGS---PF-YIAPEVLA-GG 218
           HR+L   N+LL  +  +   K++DFGL+  + A  + +    +   P  + APE +    
Sbjct: 459 HRNLAARNVLLVNRHYA---KISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 515
Query: 219 YNQAADVWSAGVILYILLS-GMPPF 242
           ++  +DVWS GV ++  LS G  P+
Sbjct: 516 FSSRSDVWSYGVTMWEALSYGQKPY 540

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 71/308 (23%), Positives = 125/308 (40%), Gaps = 35/308 (11%)
Query: 19  SYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRE-----CSDKFTGEVLACKSI 73
           +Y  +  T +I D  ++   +   + G  LG G FG + E       +  +   +A K++
Sbjct: 26  NYCFAGKTSSISDLKEVPRKNITLIRG--LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL 83
Query: 74  AKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLE 133
            +  + + +D     +E  I++K + H N+V    V  +     +L+EL AGG+L   L 
Sbjct: 84  PE--VYSEQDELDFLMEALIISKFN-HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLR 140
Query: 134 KYGRFSETEARVIFRHLMQVV-------SYCHGNGVVHRDLKPENILLATKSSSSPIKLA 186
           +        + +    L+ V         Y   N  +HRD+   N LL         K+ 
Sbjct: 141 ETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG 200
Query: 187 DFGL------ATYIKAGQNLHGTVGSPF-YIAPEVLAGG-YNQAADVWSAGVILYILLS- 237
           DFG+      A+Y + G    G    P  ++ PE    G +    D WS GV+L+ + S 
Sbjct: 201 DFGMARDIYRASYYRKG----GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL 256
Query: 238 GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH 297
           G  P+  K+  ++ + V +       DP  +       ++    +  P  R   A +L  
Sbjct: 257 GYMPYPSKSNQEVLEFVTSGGRM---DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILER 313
Query: 298 SWMEECEQ 305
             +E C Q
Sbjct: 314 --IEYCTQ 319

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 72/269 (26%), Positives = 115/269 (42%), Gaps = 31/269 (11%)
Query: 43  VLGKQLGWGQFGVIRECSDKF---TGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           +LGK LG G+FG + E + K    T   +A K++  D   +  ++     E   M   S 
Sbjct: 37  ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDN-SSQREIEEFLSEAACMKDFS- 94
Query: 100 HPNVVDLKAVYEEED-----YVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQV- 153
           HPNV+ L  V  E          +++     G+L H    Y R       +  + L++  
Sbjct: 95  HPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDL-HTYLLYSRLETGPKHIPLQTLLKFM 153
Query: 154 ------VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNL-HGTVGS 206
                 + Y      +HRDL   N +L    +   + +ADFGL+  I +G     G +  
Sbjct: 154 VDIALGMEYLSNRNFLHRDLAARNCMLRDDMT---VCVADFGLSKKIYSGDYYRQGRIAK 210
Query: 207 -PF-YIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGKTKSKIFD-AVRAADLRF 261
            P  +IA E LA   Y   +DVW+ GV ++ I   GM P+ G    +++D  +    L+ 
Sbjct: 211 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQ 270
Query: 262 PSDPWDHISASARDLIMGMLRVDPSTRLT 290
           P D  D +     +++    R DP  R T
Sbjct: 271 PEDCLDELY----EIMYSCWRTDPLDRPT 295

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 33/89 (37%), Positives = 51/89 (57%), Gaps = 12/89 (13%)
Query: 158 HGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ---NLHGTVGSPFYIAPEV 214
           H   + HRD+K +N+LL    ++    +ADFGLA   +AG+   + HG VG+  Y+APEV
Sbjct: 148 HKPAISHRDIKSKNVLLKNNLTAC---IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEV 204
Query: 215 LAGGYN------QAADVWSAGVILYILLS 237
           L G  N         D+++ G++L+ L S
Sbjct: 205 LEGAINFQRDAFLRIDMYAMGLVLWELAS 233

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 64/269 (23%), Positives = 110/269 (40%), Gaps = 30/269 (11%)
Query: 41  RYVLGKQLGWGQFGVIRECSDKFT--GEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLS 98
           ++ LG+ LG G+FG +RE   K      V     + K  ++   D+     E   M +  
Sbjct: 24  QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFD 83
Query: 99  GHPNVVDLKAVYEEE------DYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQ 152
            HP+V  L  V              +++     G+L H      R  E    +  + L++
Sbjct: 84  -HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDL-HAFLLASRIGENPFNLPLQTLVR 141
Query: 153 V-------VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVG 205
                   + Y      +HRDL   N +LA   +   + +ADFGL+  I +G        
Sbjct: 142 FMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMT---VCVADFGLSRKIYSGDYYRQGCA 198
Query: 206 SPF---YIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGKTKSKIFDAVRAAD-L 259
           S     ++A E LA   Y   +DVW+ GV ++ I+  G  P+ G   ++I++ +   + L
Sbjct: 199 SKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRL 258
Query: 260 RFPSDPWDHISASARDLIMGMLRVDPSTR 288
           + P +  + +     DL+      DP  R
Sbjct: 259 KQPPECMEEVY----DLMYQCWSADPKQR 283

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 71/300 (23%), Positives = 126/300 (42%), Gaps = 60/300 (20%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDR------LVTVEDVRSIKLEIE- 92
           ++  + ++LG G FG++ E            K + KD       + TV +  S++  IE 
Sbjct: 18  EKITMSRELGQGSFGMVYEG---------VAKGVVKDEPETRVAIKTVNEAASMRERIEF 68
Query: 93  -----IMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIF 147
                +M + + H +VV L  V  +     ++MEL   G+L   L       E    +  
Sbjct: 69  LNEASVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 127
Query: 148 RHLMQVV----------SYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLAT----- 192
             L +++          +Y + N  VHRDL   N ++A   +   +K+ DFG+       
Sbjct: 128 PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT---VKIGDFGMTRDIYET 184
Query: 193 --YIKAGQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGKTKS 248
             Y K G+ L        +++PE L  G +   +DVWS GV+L+ I      P+ G +  
Sbjct: 185 DYYRKGGKGLLPVR----WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 240
Query: 249 KIFDAVRAADLRFPSDPWDHISASARDLIMGMLRV----DPSTRLTAAEVLAHSWMEECE 304
           ++   V    L    D       +  D++  ++R+    +P  R +  E+++ S  EE E
Sbjct: 241 QVLRFVMEGGLLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIIS-SIKEEME 292

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 71/300 (23%), Positives = 126/300 (42%), Gaps = 60/300 (20%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDR------LVTVEDVRSIKLEIE- 92
           ++  + ++LG G FG++ E            K + KD       + TV +  S++  IE 
Sbjct: 16  EKITMSRELGQGSFGMVYEG---------VAKGVVKDEPETRVAIKTVNEAASMRERIEF 66
Query: 93  -----IMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIF 147
                +M + + H +VV L  V  +     ++MEL   G+L   L       E    +  
Sbjct: 67  LNEASVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 125
Query: 148 RHLMQVV----------SYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLAT----- 192
             L +++          +Y + N  VHRDL   N ++A   +   +K+ DFG+       
Sbjct: 126 PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT---VKIGDFGMTRDIYET 182
Query: 193 --YIKAGQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGKTKS 248
             Y K G+ L        +++PE L  G +   +DVWS GV+L+ I      P+ G +  
Sbjct: 183 DYYRKGGKGLLPVR----WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 238
Query: 249 KIFDAVRAADLRFPSDPWDHISASARDLIMGMLRV----DPSTRLTAAEVLAHSWMEECE 304
           ++   V    L    D       +  D++  ++R+    +P  R +  E+++ S  EE E
Sbjct: 239 QVLRFVMEGGLLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIIS-SIKEEME 290

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 71/300 (23%), Positives = 126/300 (42%), Gaps = 60/300 (20%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDR------LVTVEDVRSIKLEIE- 92
           ++  + ++LG G FG++ E            K + KD       + TV +  S++  IE 
Sbjct: 25  EKITMSRELGQGSFGMVYEG---------VAKGVVKDEPETRVAIKTVNEAASMRERIEF 75
Query: 93  -----IMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIF 147
                +M + + H +VV L  V  +     ++MEL   G+L   L       E    +  
Sbjct: 76  LNEASVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 134
Query: 148 RHLMQVV----------SYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLAT----- 192
             L +++          +Y + N  VHRDL   N ++A   +   +K+ DFG+       
Sbjct: 135 PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT---VKIGDFGMTRDIYET 191
Query: 193 --YIKAGQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGKTKS 248
             Y K G+ L        +++PE L  G +   +DVWS GV+L+ I      P+ G +  
Sbjct: 192 DYYRKGGKGLLPVR----WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 247
Query: 249 KIFDAVRAADLRFPSDPWDHISASARDLIMGMLRV----DPSTRLTAAEVLAHSWMEECE 304
           ++   V    L    D       +  D++  ++R+    +P  R +  E+++ S  EE E
Sbjct: 248 QVLRFVMEGGLLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIIS-SIKEEME 299

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 71/300 (23%), Positives = 127/300 (42%), Gaps = 60/300 (20%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDR------LVTVEDVRSIKLEIE- 92
           ++  + ++LG G FG++ E            K + KD       + TV +  S++  IE 
Sbjct: 10  EKITMSRELGQGSFGMVYEG---------VAKGVVKDEPETRVAIKTVNEAASMRERIEF 60
Query: 93  -----IMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIF 147
                +M + + H +VV L  V  +     ++MEL   G+L   L       E    +  
Sbjct: 61  LNEASVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 119
Query: 148 RHLMQVV----------SYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI--- 194
             L +++          +Y + N  VHRDL   N ++A   +   +K+ DFG+   I   
Sbjct: 120 PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT---VKIGDFGMTRDIXET 176
Query: 195 ----KAGQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGKTKS 248
               K G+ L        +++PE L  G +   +DVWS GV+L+ I      P+ G +  
Sbjct: 177 DXXRKGGKGLLPVR----WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 232
Query: 249 KIFDAVRAADLRFPSDPWDHISASARDLIMGMLRV----DPSTRLTAAEVLAHSWMEECE 304
           ++   V    L    D       +  D+++ ++R+    +P  R +  E+++ S  EE E
Sbjct: 233 QVLRFVMEGGLLDKPD-------NCPDMLLELMRMCWQYNPKMRPSFLEIIS-SIKEEME 284

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 71/300 (23%), Positives = 126/300 (42%), Gaps = 60/300 (20%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDR------LVTVEDVRSIKLEIE- 92
           ++  + ++LG G FG++ E            K + KD       + TV +  S++  IE 
Sbjct: 19  EKITMSRELGQGSFGMVYEG---------VAKGVVKDEPETRVAIKTVNEAASMRERIEF 69
Query: 93  -----IMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIF 147
                +M + + H +VV L  V  +     ++MEL   G+L   L       E    +  
Sbjct: 70  LNEASVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 128
Query: 148 RHLMQVV----------SYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLAT----- 192
             L +++          +Y + N  VHRDL   N ++A   +   +K+ DFG+       
Sbjct: 129 PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT---VKIGDFGMTRDIYET 185
Query: 193 --YIKAGQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGKTKS 248
             Y K G+ L        +++PE L  G +   +DVWS GV+L+ I      P+ G +  
Sbjct: 186 DYYRKGGKGLLPVR----WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 241
Query: 249 KIFDAVRAADLRFPSDPWDHISASARDLIMGMLRV----DPSTRLTAAEVLAHSWMEECE 304
           ++   V    L    D       +  D++  ++R+    +P  R +  E+++ S  EE E
Sbjct: 242 QVLRFVMEGGLLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIIS-SIKEEME 293

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 71/300 (23%), Positives = 126/300 (42%), Gaps = 60/300 (20%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDR------LVTVEDVRSIKLEIE- 92
           ++  + ++LG G FG++ E            K + KD       + TV +  S++  IE 
Sbjct: 18  EKITMSRELGQGSFGMVYEG---------VAKGVVKDEPETRVAIKTVNEAASMRERIEF 68
Query: 93  -----IMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIF 147
                +M + + H +VV L  V  +     ++MEL   G+L   L       E    +  
Sbjct: 69  LNEASVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 127
Query: 148 RHLMQVV----------SYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLAT----- 192
             L +++          +Y + N  VHRDL   N ++A   +   +K+ DFG+       
Sbjct: 128 PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT---VKIGDFGMTRDIYET 184
Query: 193 --YIKAGQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGKTKS 248
             Y K G+ L        +++PE L  G +   +DVWS GV+L+ I      P+ G +  
Sbjct: 185 DYYRKGGKGLLPVR----WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 240
Query: 249 KIFDAVRAADLRFPSDPWDHISASARDLIMGMLRV----DPSTRLTAAEVLAHSWMEECE 304
           ++   V    L    D       +  D++  ++R+    +P  R +  E+++ S  EE E
Sbjct: 241 QVLRFVMEGGLLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIIS-SIKEEME 292

>pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 101/225 (44%), Gaps = 32/225 (14%)
Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRS----IKLEIEI 93
           + +++ LG+++G G FG I   ++  T E +A K         +E+V++    +  E +I
Sbjct: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---------LENVKTKHPQLLYESKI 55
Query: 94  MTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGG--ELFHRLEKYGRFSETEARVIFRHLM 151
              L G   + +++    E DY  L+M+L      +LF+   +  + S     ++   ++
Sbjct: 56  YRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSR--KLSLKTVLMLADQMI 113
Query: 152 QVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATY-----------IKAGQNL 200
             V + H    +HRD+KP+N L+     ++ + + DFGLA              +  +NL
Sbjct: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNL 173
Query: 201 HGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWG 244
            GT     Y +     G   ++  D+ S G +L   L G  P+ G
Sbjct: 174 TGTAR---YASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 71/300 (23%), Positives = 126/300 (42%), Gaps = 60/300 (20%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDR------LVTVEDVRSIKLEIE- 92
           ++  + ++LG G FG++ E            K + KD       + TV +  S++  IE 
Sbjct: 47  EKITMSRELGQGSFGMVYEG---------VAKGVVKDEPETRVAIKTVNEAASMRERIEF 97
Query: 93  -----IMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIF 147
                +M + + H +VV L  V  +     ++MEL   G+L   L       E    +  
Sbjct: 98  LNEASVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 156
Query: 148 RHLMQVV----------SYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLAT----- 192
             L +++          +Y + N  VHRDL   N ++A   +   +K+ DFG+       
Sbjct: 157 PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT---VKIGDFGMTRDIYET 213
Query: 193 --YIKAGQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGKTKS 248
             Y K G+ L        +++PE L  G +   +DVWS GV+L+ I      P+ G +  
Sbjct: 214 DYYRKGGKGLLPVR----WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 269
Query: 249 KIFDAVRAADLRFPSDPWDHISASARDLIMGMLRV----DPSTRLTAAEVLAHSWMEECE 304
           ++   V    L    D       +  D++  ++R+    +P  R +  E+++ S  EE E
Sbjct: 270 QVLRFVMEGGLLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIIS-SIKEEME 321

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 95/206 (46%), Gaps = 16/206 (7%)
Query: 48  LGWGQFGVIRECS--DKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           +G G FG +   +  D   G+ + C   + +R+  + +V     E  IM   S HPNV+ 
Sbjct: 37  IGRGHFGCVYHGTLLDN-DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLS 94
Query: 106 LKAV-YEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIF-RHLMQVVSYCHGNGVV 163
           L  +    E    +++     G+L + +         +  + F   + + + Y      V
Sbjct: 95  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFV 154
Query: 164 HRDLKPENILLATKSSSSPIKLADFGLA--TYIKAGQNLHGTVGSPF---YIAPEVL-AG 217
           HRDL   N +L  K +   +K+ADFGLA   Y K   ++H   G+     ++A E L   
Sbjct: 155 HRDLAARNCMLDEKFT---VKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQTQ 211
Query: 218 GYNQAADVWSAGVILYILLS-GMPPF 242
            +   +DVWS GV+L+ L++ G PP+
Sbjct: 212 KFTTKSDVWSFGVLLWELMTRGAPPY 237

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 71/300 (23%), Positives = 126/300 (42%), Gaps = 60/300 (20%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDR------LVTVEDVRSIKLEIE- 92
           ++  + ++LG G FG++ E            K + KD       + TV +  S++  IE 
Sbjct: 12  EKITMSRELGQGSFGMVYEG---------VAKGVVKDEPETRVAIKTVNEAASMRERIEF 62
Query: 93  -----IMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIF 147
                +M + + H +VV L  V  +     ++MEL   G+L   L       E    +  
Sbjct: 63  LNEASVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 121
Query: 148 RHLMQVV----------SYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLAT----- 192
             L +++          +Y + N  VHRDL   N  +A   +   +K+ DFG+       
Sbjct: 122 PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCXVAEDFT---VKIGDFGMTRDIYET 178
Query: 193 --YIKAGQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGKTKS 248
             Y K G+ L        +++PE L  G +   +DVWS GV+L+ I      P+ G +  
Sbjct: 179 DYYRKGGKGLLPVR----WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 234
Query: 249 KIFDAVRAADLRFPSDPWDHISASARDLIMGMLRV----DPSTRLTAAEVLAHSWMEECE 304
           ++   V    L    D       +  D+++ ++R+    +P  R +  E+++ S  EE E
Sbjct: 235 QVLRFVMEGGLLDKPD-------NCPDMLLELMRMCWQYNPKMRPSFLEIIS-SIKEEME 286

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 71/300 (23%), Positives = 126/300 (42%), Gaps = 60/300 (20%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDR------LVTVEDVRSIKLEIE- 92
           ++  + ++LG G FG++ E            K + KD       + TV +  S++  IE 
Sbjct: 19  EKITMSRELGQGSFGMVYEG---------VAKGVVKDEPETRVAIKTVNEAASMRERIEF 69
Query: 93  -----IMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIF 147
                +M + + H +VV L  V  +     ++MEL   G+L   L       E    +  
Sbjct: 70  LNEASVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 128
Query: 148 RHLMQVV----------SYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI--- 194
             L +++          +Y + N  VHRDL   N ++A   +   +K+ DFG+   I   
Sbjct: 129 PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT---VKIGDFGMTRDIXET 185
Query: 195 ----KAGQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGKTKS 248
               K G+ L        +++PE L  G +   +DVWS GV+L+ I      P+ G +  
Sbjct: 186 DXXRKGGKGLLPVR----WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 241
Query: 249 KIFDAVRAADLRFPSDPWDHISASARDLIMGMLRV----DPSTRLTAAEVLAHSWMEECE 304
           ++   V    L    D       +  D++  ++R+    +P  R +  E+++ S  EE E
Sbjct: 242 QVLRFVMEGGLLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIIS-SIKEEME 293

>pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 79/363 (21%), Positives = 130/363 (35%), Gaps = 110/363 (30%)
Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
           RY + ++LGWG F  +  C D      +A K +   +  T   +  IKL   +       
Sbjct: 32  RYHVIRKLGWGHFSTVWLCWDMQGKRFVAMKVVKSAQHYTETALDEIKLLKCVRESDPSD 91
Query: 101 PN-------VVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEA------RVIF 147
           PN       + D K       +V ++ E+     L H L K+   S  +       + I 
Sbjct: 92  PNKDMVVQLIDDFKISGMNGIHVCMVFEV-----LGHHLLKWIIKSNYQGLPVRCVKSII 146
Query: 148 RHLMQVVSYCHGN-GVVHRDLKPENILLAT----------------KSSSSP-------- 182
           R ++Q + Y H    ++H D+KPENIL+                  K+ + P        
Sbjct: 147 RQVLQGLDYLHSKCKIIHTDIKPENILMCVDDAYVRRMAAEATEWQKAGAPPPSGSAVST 206
Query: 183 --------------------IKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG-GYNQ 221
                               +K+AD G A ++   ++    + +  Y + EVL G GY+ 
Sbjct: 207 APAADLLVNPLDPRNADKIRVKIADLGNACWVH--KHFTEDIQTRQYRSIEVLIGAGYST 264
Query: 222 AADVWSAGVILYILLSG---MPPFWGKTKSKIFDAV------------------------ 254
            AD+WS   + + L +G     P  G+  S+  D +                        
Sbjct: 265 PADIWSTACMAFELATGDYLFEPHSGEDYSRDEDHIAHIIELLGSIPRHFALSGKYSREF 324
Query: 255 --RAADLRFPS--DPWDHI-------------SASARDLIMGMLRVDPSTRLTAAEVLAH 297
             R  +LR  +   PW                +A   D ++ ML + P  R +A E L H
Sbjct: 325 FNRRGELRHITKLKPWSLFDVLVEKYGWPHEDAAQFTDFLIPMLEMVPEKRASAGECLRH 384
Query: 298 SWM 300
            W+
Sbjct: 385 PWL 387

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 95/206 (46%), Gaps = 16/206 (7%)
Query: 48  LGWGQFGVIRECS--DKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           +G G FG +   +  D   G+ + C   + +R+  + +V     E  IM   S HPNV+ 
Sbjct: 56  IGRGHFGCVYHGTLLDN-DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLS 113
Query: 106 LKAV-YEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIF-RHLMQVVSYCHGNGVV 163
           L  +    E    +++     G+L + +         +  + F   + + + Y      V
Sbjct: 114 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFV 173
Query: 164 HRDLKPENILLATKSSSSPIKLADFGLA--TYIKAGQNLHGTVGSPF---YIAPEVL-AG 217
           HRDL   N +L  K +   +K+ADFGLA   Y K   ++H   G+     ++A E L   
Sbjct: 174 HRDLAARNCMLDEKFT---VKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 230
Query: 218 GYNQAADVWSAGVILYILLS-GMPPF 242
            +   +DVWS GV+L+ L++ G PP+
Sbjct: 231 KFTTKSDVWSFGVLLWELMTRGAPPY 256

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 71/300 (23%), Positives = 127/300 (42%), Gaps = 60/300 (20%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDR------LVTVEDVRSIKLEIE- 92
           ++  + ++LG G FG++ E            K + KD       + TV +  S++  IE 
Sbjct: 25  EKITMSRELGQGSFGMVYEG---------VAKGVVKDEPETRVAIKTVNEAASMRERIEF 75
Query: 93  -----IMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGEL---FHRLEKYGRFSETEAR 144
                +M + + H +VV L  V  +     ++MEL   G+L      L      +   A 
Sbjct: 76  LNEASVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 134
Query: 145 VIFRHLMQV-------VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLAT----- 192
                ++Q+       ++Y + N  VHRDL   N ++A   +   +K+ DFG+       
Sbjct: 135 PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT---VKIGDFGMTRDIYET 191
Query: 193 --YIKAGQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGKTKS 248
             Y K G+ L        +++PE L  G +   +DVWS GV+L+ I      P+ G +  
Sbjct: 192 DYYRKGGKGLLPVR----WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 247
Query: 249 KIFDAVRAADLRFPSDPWDHISASARDLIMGMLRV----DPSTRLTAAEVLAHSWMEECE 304
           ++   V    L    D       +  D++  ++R+    +P  R +  E+++ S  EE E
Sbjct: 248 QVLRFVMEGGLLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIIS-SIKEEME 299

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 95/206 (46%), Gaps = 16/206 (7%)
Query: 48  LGWGQFGVIRECS--DKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           +G G FG +   +  D   G+ + C   + +R+  + +V     E  IM   S HPNV+ 
Sbjct: 38  IGRGHFGCVYHGTLLDN-DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLS 95
Query: 106 LKAV-YEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIF-RHLMQVVSYCHGNGVV 163
           L  +    E    +++     G+L + +         +  + F   + + + Y      V
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFV 155
Query: 164 HRDLKPENILLATKSSSSPIKLADFGLA--TYIKAGQNLHGTVGSPF---YIAPEVL-AG 217
           HRDL   N +L  K +   +K+ADFGLA   Y K   ++H   G+     ++A E L   
Sbjct: 156 HRDLAARNCMLDEKFT---VKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 212
Query: 218 GYNQAADVWSAGVILYILLS-GMPPF 242
            +   +DVWS GV+L+ L++ G PP+
Sbjct: 213 KFTTKSDVWSFGVLLWELMTRGAPPY 238

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 95/206 (46%), Gaps = 16/206 (7%)
Query: 48  LGWGQFGVIRECS--DKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           +G G FG +   +  D   G+ + C   + +R+  + +V     E  IM   S HPNV+ 
Sbjct: 30  IGRGHFGCVYHGTLLDN-DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLS 87
Query: 106 LKAV-YEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIF-RHLMQVVSYCHGNGVV 163
           L  +    E    +++     G+L + +         +  + F   + + + Y      V
Sbjct: 88  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFV 147
Query: 164 HRDLKPENILLATKSSSSPIKLADFGLA--TYIKAGQNLHGTVGSPF---YIAPEVL-AG 217
           HRDL   N +L  K +   +K+ADFGLA   Y K   ++H   G+     ++A E L   
Sbjct: 148 HRDLAARNCMLDEKFT---VKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 204
Query: 218 GYNQAADVWSAGVILYILLS-GMPPF 242
            +   +DVWS GV+L+ L++ G PP+
Sbjct: 205 KFTTKSDVWSFGVLLWELMTRGAPPY 230

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 71/300 (23%), Positives = 127/300 (42%), Gaps = 60/300 (20%)
Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDR------LVTVEDVRSIKLEIE- 92
           ++  + ++LG G FG++ E            K + KD       + TV +  S++  IE 
Sbjct: 15  EKITMSRELGQGSFGMVYEG---------VAKGVVKDEPETRVAIKTVNEAASMRERIEF 65
Query: 93  -----IMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGEL---FHRLEKYGRFSETEAR 144
                +M + + H +VV L  V  +     ++MEL   G+L      L      +   A 
Sbjct: 66  LNEASVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 124
Query: 145 VIFRHLMQV-------VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLAT----- 192
                ++Q+       ++Y + N  VHRDL   N ++A   +   +K+ DFG+       
Sbjct: 125 PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT---VKIGDFGMTRDIYET 181
Query: 193 --YIKAGQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGKTKS 248
             Y K G+ L        +++PE L  G +   +DVWS GV+L+ I      P+ G +  
Sbjct: 182 DYYRKGGKGLLPVR----WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 237
Query: 249 KIFDAVRAADLRFPSDPWDHISASARDLIMGMLRV----DPSTRLTAAEVLAHSWMEECE 304
           ++   V    L    D       +  D++  ++R+    +P  R +  E+++ S  EE E
Sbjct: 238 QVLRFVMEGGLLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIIS-SIKEEME 289

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 95/206 (46%), Gaps = 16/206 (7%)
Query: 48  LGWGQFGVIRECS--DKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           +G G FG +   +  D   G+ + C   + +R+  + +V     E  IM   S HPNV+ 
Sbjct: 37  IGRGHFGCVYHGTLLDN-DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLS 94
Query: 106 LKAV-YEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIF-RHLMQVVSYCHGNGVV 163
           L  +    E    +++     G+L + +         +  + F   + + + Y      V
Sbjct: 95  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFV 154
Query: 164 HRDLKPENILLATKSSSSPIKLADFGLA--TYIKAGQNLHGTVGSPF---YIAPEVL-AG 217
           HRDL   N +L  K +   +K+ADFGLA   Y K   ++H   G+     ++A E L   
Sbjct: 155 HRDLAARNCMLDEKFT---VKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 211
Query: 218 GYNQAADVWSAGVILYILLS-GMPPF 242
            +   +DVWS GV+L+ L++ G PP+
Sbjct: 212 KFTTKSDVWSFGVLLWELMTRGAPPY 237

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 95/206 (46%), Gaps = 16/206 (7%)
Query: 48  LGWGQFGVIRECS--DKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           +G G FG +   +  D   G+ + C   + +R+  + +V     E  IM   S HPNV+ 
Sbjct: 35  IGRGHFGCVYHGTLLDN-DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLS 92
Query: 106 LKAV-YEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIF-RHLMQVVSYCHGNGVV 163
           L  +    E    +++     G+L + +         +  + F   + + + Y      V
Sbjct: 93  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFV 152
Query: 164 HRDLKPENILLATKSSSSPIKLADFGLA--TYIKAGQNLHGTVGSPF---YIAPEVL-AG 217
           HRDL   N +L  K +   +K+ADFGLA   Y K   ++H   G+     ++A E L   
Sbjct: 153 HRDLAARNCMLDEKFT---VKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 209
Query: 218 GYNQAADVWSAGVILYILLS-GMPPF 242
            +   +DVWS GV+L+ L++ G PP+
Sbjct: 210 KFTTKSDVWSFGVLLWELMTRGAPPY 235

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 95/206 (46%), Gaps = 16/206 (7%)
Query: 48  LGWGQFGVIRECS--DKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           +G G FG +   +  D   G+ + C   + +R+  + +V     E  IM   S HPNV+ 
Sbjct: 38  IGRGHFGCVYHGTLLDN-DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLS 95
Query: 106 LKAV-YEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIF-RHLMQVVSYCHGNGVV 163
           L  +    E    +++     G+L + +         +  + F   + + + Y      V
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFV 155
Query: 164 HRDLKPENILLATKSSSSPIKLADFGLA--TYIKAGQNLHGTVGSPF---YIAPEVL-AG 217
           HRDL   N +L  K +   +K+ADFGLA   Y K   ++H   G+     ++A E L   
Sbjct: 156 HRDLAARNCMLDEKFT---VKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 212
Query: 218 GYNQAADVWSAGVILYILLS-GMPPF 242
            +   +DVWS GV+L+ L++ G PP+
Sbjct: 213 KFTTKSDVWSFGVLLWELMTRGAPPY 238

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 95/206 (46%), Gaps = 16/206 (7%)
Query: 48  LGWGQFGVIRECS--DKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           +G G FG +   +  D   G+ + C   + +R+  + +V     E  IM   S HPNV+ 
Sbjct: 36  IGRGHFGCVYHGTLLDN-DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLS 93
Query: 106 LKAV-YEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIF-RHLMQVVSYCHGNGVV 163
           L  +    E    +++     G+L + +         +  + F   + + + Y      V
Sbjct: 94  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFV 153
Query: 164 HRDLKPENILLATKSSSSPIKLADFGLA--TYIKAGQNLHGTVGSPF---YIAPEVL-AG 217
           HRDL   N +L  K +   +K+ADFGLA   Y K   ++H   G+     ++A E L   
Sbjct: 154 HRDLAARNCMLDEKFT---VKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 210
Query: 218 GYNQAADVWSAGVILYILLS-GMPPF 242
            +   +DVWS GV+L+ L++ G PP+
Sbjct: 211 KFTTKSDVWSFGVLLWELMTRGAPPY 236

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 95/206 (46%), Gaps = 16/206 (7%)
Query: 48  LGWGQFGVIRECS--DKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           +G G FG +   +  D   G+ + C   + +R+  + +V     E  IM   S HPNV+ 
Sbjct: 57  IGRGHFGCVYHGTLLDN-DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLS 114
Query: 106 LKAV-YEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIF-RHLMQVVSYCHGNGVV 163
           L  +    E    +++     G+L + +         +  + F   + + + Y      V
Sbjct: 115 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFV 174
Query: 164 HRDLKPENILLATKSSSSPIKLADFGLA--TYIKAGQNLHGTVGSPF---YIAPEVL-AG 217
           HRDL   N +L  K +   +K+ADFGLA   Y K   ++H   G+     ++A E L   
Sbjct: 175 HRDLAARNCMLDEKFT---VKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 231
Query: 218 GYNQAADVWSAGVILYILLS-GMPPF 242
            +   +DVWS GV+L+ L++ G PP+
Sbjct: 232 KFTTKSDVWSFGVLLWELMTRGAPPY 257

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 95/206 (46%), Gaps = 16/206 (7%)
Query: 48  LGWGQFGVIRECS--DKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           +G G FG +   +  D   G+ + C   + +R+  + +V     E  IM   S HPNV+ 
Sbjct: 33  IGRGHFGCVYHGTLLDN-DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLS 90
Query: 106 LKAV-YEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIF-RHLMQVVSYCHGNGVV 163
           L  +    E    +++     G+L + +         +  + F   + + + Y      V
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFV 150
Query: 164 HRDLKPENILLATKSSSSPIKLADFGLA--TYIKAGQNLHGTVGSPF---YIAPEVL-AG 217
           HRDL   N +L  K +   +K+ADFGLA   Y K   ++H   G+     ++A E L   
Sbjct: 151 HRDLAARNCMLDEKFT---VKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 207
Query: 218 GYNQAADVWSAGVILYILLS-GMPPF 242
            +   +DVWS GV+L+ L++ G PP+
Sbjct: 208 KFTTKSDVWSFGVLLWELMTRGAPPY 233

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 102/215 (47%), Gaps = 20/215 (9%)
Query: 44  LGKQLGWGQFGVIRECSDKFTGEV-LACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
           L ++LG GQFG +      + G   +A KS+ +  +       +   E  +M +L  H  
Sbjct: 12  LVERLGAGQFGEV--WMGYYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQ-HQR 64
Query: 103 VVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVI--FRHLMQVVSYCHGN 160
           +V L AV  +E  ++++ E    G L   L+       T  +++     + + +++    
Sbjct: 65  LVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 123
Query: 161 GVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF---YIAPEVLA- 216
             +HRDL+  NIL+   S +   K+ADFGLA  I+  +      G+ F   + APE +  
Sbjct: 124 NYIHRDLRAANILV---SDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAINY 179
Query: 217 GGYNQAADVWSAGVILY-ILLSGMPPFWGKTKSKI 250
           G +   +DVWS G++L  I+  G  P+ G T  ++
Sbjct: 180 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV 214

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 102/215 (47%), Gaps = 20/215 (9%)
Query: 44  LGKQLGWGQFGVIRECSDKFTGEV-LACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
           L ++LG GQFG +      + G   +A KS+ +  +       +   E  +M +L  H  
Sbjct: 19  LVERLGAGQFGEV--WMGYYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQ-HQR 71
Query: 103 VVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVI--FRHLMQVVSYCHGN 160
           +V L AV  +E  ++++ E    G L   L+       T  +++     + + +++    
Sbjct: 72  LVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 130
Query: 161 GVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF---YIAPEVLA- 216
             +HRDL+  NIL+   S +   K+ADFGLA  I+  +      G+ F   + APE +  
Sbjct: 131 NYIHRDLRAANILV---SDTLSCKIADFGLARLIEDNEXT-AREGAKFPIKWTAPEAINY 186
Query: 217 GGYNQAADVWSAGVILY-ILLSGMPPFWGKTKSKI 250
           G +   +DVWS G++L  I+  G  P+ G T  ++
Sbjct: 187 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV 221

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 102/215 (47%), Gaps = 20/215 (9%)
Query: 44  LGKQLGWGQFGVIRECSDKFTGEV-LACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
           L ++LG GQFG +      + G   +A KS+ +  +       +   E  +M +L  H  
Sbjct: 23  LVERLGAGQFGEV--WMGYYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQ-HQR 75
Query: 103 VVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVI--FRHLMQVVSYCHGN 160
           +V L AV  +E  ++++ E    G L   L+       T  +++     + + +++    
Sbjct: 76  LVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 134
Query: 161 GVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF---YIAPEVLA- 216
             +HRDL+  NIL+   S +   K+ADFGLA  I+  +      G+ F   + APE +  
Sbjct: 135 NYIHRDLRAANILV---SDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAINY 190
Query: 217 GGYNQAADVWSAGVILY-ILLSGMPPFWGKTKSKI 250
           G +   +DVWS G++L  I+  G  P+ G T  ++
Sbjct: 191 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV 225

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 102/215 (47%), Gaps = 20/215 (9%)
Query: 44  LGKQLGWGQFGVIRECSDKFTGEV-LACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
           L ++LG GQFG +      + G   +A KS+ +  +       +   E  +M +L  H  
Sbjct: 18  LVERLGAGQFGEV--WMGYYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQ-HQR 70
Query: 103 VVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVI--FRHLMQVVSYCHGN 160
           +V L AV  +E  ++++ E    G L   L+       T  +++     + + +++    
Sbjct: 71  LVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 129
Query: 161 GVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF---YIAPEVLA- 216
             +HRDL+  NIL+   S +   K+ADFGLA  I+  +      G+ F   + APE +  
Sbjct: 130 NYIHRDLRAANILV---SDTLSCKIADFGLARLIEDNEXT-AREGAKFPIKWTAPEAINY 185
Query: 217 GGYNQAADVWSAGVILY-ILLSGMPPFWGKTKSKI 250
           G +   +DVWS G++L  I+  G  P+ G T  ++
Sbjct: 186 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV 220

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 102/215 (47%), Gaps = 20/215 (9%)
Query: 44  LGKQLGWGQFGVIRECSDKFTGEV-LACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
           L ++LG GQFG +      + G   +A KS+ +  +       +   E  +M +L  H  
Sbjct: 25  LVERLGAGQFGEV--WMGYYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQ-HQR 77
Query: 103 VVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVI--FRHLMQVVSYCHGN 160
           +V L AV  +E  ++++ E    G L   L+       T  +++     + + +++    
Sbjct: 78  LVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 136
Query: 161 GVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF---YIAPEVLA- 216
             +HRDL+  NIL++   S    K+ADFGLA  I+  +      G+ F   + APE +  
Sbjct: 137 NYIHRDLRAANILVSDTLSC---KIADFGLARLIEDNEXT-AREGAKFPIKWTAPEAINY 192
Query: 217 GGYNQAADVWSAGVILY-ILLSGMPPFWGKTKSKI 250
           G +   +DVWS G++L  I+  G  P+ G T  ++
Sbjct: 193 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV 227
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	419
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-155
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-152
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-151
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-151
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-150
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-148
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-147
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-147
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-147
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-146
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-146
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-146
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-146
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-145
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-145
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-143
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-143
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-142
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-141
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-141
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-140
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-139
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-138
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-138
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-136
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-135
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-133
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-133
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-131
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-130
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-130
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-128
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-128
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-103
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-101
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-101
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-100
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-99
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-97
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	3e-97
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-96
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	5e-95
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-94
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-94
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	3e-94
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	4e-94
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	4e-93
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	4e-93
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	5e-93
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	6e-93
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-92
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-92
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	3e-92
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	4e-91
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-90
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-90
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-89
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	5e-89
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-88
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-88
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	7e-88
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	5e-86
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-81
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	4e-81
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	3e-80
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-78
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-77
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-75
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-71
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	5e-71
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-69
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	9e-69
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-67
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-66
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-66
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	3e-65
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	6e-65
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	8e-63
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-62
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	5e-62
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	9e-62
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	9e-62
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-61
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-61
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	3e-61
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	8e-61
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-60
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-60
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	3e-60
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	4e-60
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	4e-59
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	4e-59
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	4e-59
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	8e-59
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	3e-58
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	4e-58
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	5e-58
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-57
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-57
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	9e-51
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-50
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	4e-50
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-49
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	7e-49
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-48
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-48
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-48
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-48
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-48
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	5e-48
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-47
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-47
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-47
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	5e-47
2dyl_A	318	Dual specificity mitogen-activated protein kinase	5e-47
3an0_A	340	Dual specificity mitogen-activated protein kinase;	6e-47
3aln_A	327	Dual specificity mitogen-activated protein kinase;	7e-47
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-46
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-46
3o0g_A	292	Cell division protein kinase 5; kinase activator c	4e-46
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	6e-46
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	9e-46
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-45
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-45
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	6e-45
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-44
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	6e-43
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-42
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-42
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-42
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	9e-42
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-41
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	3e-41
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	3e-41
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	6e-41
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-40
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	3e-40
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	6e-40
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-39
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-39
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	6e-39
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-38
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-38
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-38
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	4e-38
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	5e-38
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	7e-38
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	3e-37
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	5e-37
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	7e-37
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	8e-37
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	9e-37
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	9e-37
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-36
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-36
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	8e-36
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	9e-36
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-35
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	4e-35
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-34
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	2e-33
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	5e-33
3uqc_A	286	Probable conserved transmembrane protein; structur	5e-32
3rp9_A	458	Mitogen-activated protein kinase; structural genom	8e-30
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-29
3q4u_A	301	Activin receptor type-1; structural genomics conso	6e-29
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-28
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-28
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	4e-28
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-27
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-27
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	5e-27
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-26
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	5e-26
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	5e-26
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	5e-26
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	6e-26
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-25
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	3e-25
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	3e-25
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	5e-25
3soc_A	322	Activin receptor type-2A; structural genomics cons	5e-25
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	6e-25
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	6e-25
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	9e-25
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-24
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-24
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-24
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-24
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-24
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	4e-24
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	5e-24
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	7e-24
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-23
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-23
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-23
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-23
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-23
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	3e-23
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	4e-23
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	8e-23
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	8e-23
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-22
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	3e-22
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	3e-22
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	4e-22
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	4e-22
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	4e-22
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	5e-22
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	5e-22
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	5e-22
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	5e-22
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	5e-22
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	7e-22
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-21
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-21
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	3e-21
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-21
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	8e-21
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	8e-21
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-20
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-20
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	3e-20
4aoj_A	329	High affinity nerve growth factor receptor; transf	4e-20
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	5e-20
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	5e-19
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	5e-19
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-18
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	4e-18
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	3e-17
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	7e-17
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-15
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	2e-14
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	8e-12
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-09
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-08
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-08

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  437 bits (1127), Expect = e-155
 Identities = 112/284 (39%), Positives = 171/284 (60%), Gaps = 3/284 (1%)

Query: 36  SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMT 95
           +  SD Y + ++LG G F V+R C  K TG   A K I   +L +  D + ++ E  I  
Sbjct: 2   TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICR 60

Query: 96  KLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS 155
           KL  HPN+V L    +EE + +L+ +L  GGELF  +     +SE +A    + +++ ++
Sbjct: 61  KLQ-HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIA 119

Query: 156 YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVL 215
           YCH NG+VHR+LKPEN+LLA+K+  + +KLADFGLA  +   +  HG  G+P Y++PEVL
Sbjct: 120 YCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVL 179

Query: 216 AG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASAR 274
               Y++  D+W+ GVILYILL G PPFW + + +++  ++A    +PS  WD ++  A+
Sbjct: 180 KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK 239

Query: 275 DLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKPCKQDDLCC 318
            LI  ML V+P  R+TA + L   W+   E+VA    +QD + C
Sbjct: 240 SLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDC 283

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  432 bits (1112), Expect = e-152
 Identities = 105/275 (38%), Positives = 152/275 (55%), Gaps = 4/275 (1%)

Query: 36  SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMT 95
            +++  Y L   +G G +G ++    K T    A K I K  +  V+  +    EIEIM 
Sbjct: 5   GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQ---EIEIMK 61

Query: 96  KLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS 155
            L  HPN++ L   +E+   ++L+MELC GGELF R+     F E++A  I + ++  V+
Sbjct: 62  SLD-HPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVA 120

Query: 156 YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVL 215
           YCH   V HRDLKPEN L  T S  SP+KL DFGLA   K G+ +   VG+P+Y++P+VL
Sbjct: 121 YCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL 180

Query: 216 AGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARD 275
            G Y    D WSAGV++Y+LL G PPF   T S++   +R     FP   W ++S  A  
Sbjct: 181 EGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAES 240

Query: 276 LIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKP 310
           LI  +L   P  R+T+ + L H W E+    + + 
Sbjct: 241 LIRRLLTKSPKQRITSLQALEHEWFEKQLSSSPRN 275

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  432 bits (1113), Expect = e-151
 Identities = 113/299 (37%), Positives = 174/299 (58%), Gaps = 3/299 (1%)

Query: 23  SSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVE 82
               G+       +  SD Y + ++LG G F V+R C  K TG   A K I   +L +  
Sbjct: 12  QMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SAR 70

Query: 83  DVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETE 142
           D + ++ E  I  KL  HPN+V L    +EE + +L+ +L  GGELF  +     +SE +
Sbjct: 71  DFQKLEREARICRKLQ-HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEAD 129

Query: 143 ARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHG 202
           A    + +++ ++YCH NG+VHR+LKPEN+LLA+K+  + +KLADFGLA  +   +  HG
Sbjct: 130 ASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG 189

Query: 203 TVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRF 261
             G+P Y++PEVL    Y++  D+W+ GVILYILL G PPFW + + +++  ++A    +
Sbjct: 190 FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDY 249

Query: 262 PSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKPCKQDDLCCKQ 320
           PS  WD ++  A+ LI  ML V+P  R+TA + L   W+   E+VA    +QD + C +
Sbjct: 250 PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDCLK 308

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  428 bits (1103), Expect = e-151
 Identities = 111/267 (41%), Positives = 156/267 (58%), Gaps = 2/267 (0%)

Query: 36  SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMT 95
              ++RY +   LG G FG + +C D+ T +  A K I K      +D  +I  E+E++ 
Sbjct: 18  GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLK 76

Query: 96  KLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS 155
           KL  HPN++ L  + E+    +++ EL  GGELF  + K  RFSE +A  I + +   ++
Sbjct: 77  KLD-HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGIT 135

Query: 156 YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVL 215
           Y H + +VHRDLKPENILL +K     IK+ DFGL+T  +    +   +G+ +YIAPEVL
Sbjct: 136 YMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL 195

Query: 216 AGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARD 275
            G Y++  DVWSAGVILYILLSG PPF+GK +  I   V      F    W  IS  A+D
Sbjct: 196 RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKD 255

Query: 276 LIMGMLRVDPSTRLTAAEVLAHSWMEE 302
           LI  ML   PS R+TA + L H W+++
Sbjct: 256 LIRKMLTFHPSLRITATQCLEHPWIQK 282

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  429 bits (1104), Expect = e-150
 Identities = 98/309 (31%), Positives = 155/309 (50%), Gaps = 15/309 (4%)

Query: 5   NSEDSSQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFT 64
              + +Q        ++       + D         +Y     +G G   V+R C  + T
Sbjct: 59  KKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRAT 118

Query: 65  GEVLACKSIAKDRLVTVEDV-----RSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL 119
           G   A K +         +       + + E  I+ +++GHP+++ L   YE   ++ L+
Sbjct: 119 GHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLV 178

Query: 120 MELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSS 179
            +L   GELF  L +    SE E R I R L++ VS+ H N +VHRDLKPENILL     
Sbjct: 179 FDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLD---D 235

Query: 180 SSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG-------GYNQAADVWSAGVIL 232
           +  I+L+DFG + +++ G+ L    G+P Y+APE+L         GY +  D+W+ GVIL
Sbjct: 236 NMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295

Query: 233 YILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAA 292
           + LL+G PPFW + +  +   +     +F S  WD  S++ +DLI  +L+VDP  RLTA 
Sbjct: 296 FTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAE 355

Query: 293 EVLAHSWME 301
           + L H + E
Sbjct: 356 QALQHPFFE 364

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  427 bits (1101), Expect = e-148
 Identities = 110/293 (37%), Positives = 167/293 (56%), Gaps = 4/293 (1%)

Query: 30  LDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKL 89
           +     +  ++ Y L ++LG G F V+R C     G+  A   I   +L +  D + ++ 
Sbjct: 1   MATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLER 59

Query: 90  EIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRH 149
           E  I   L  HPN+V L     EE + +L+ +L  GGELF  +     +SE +A    + 
Sbjct: 60  EARICRLLK-HPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQ 118

Query: 150 LMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA-GQNLHGTVGSPF 208
           +++ V +CH  GVVHR+LKPEN+LLA+K   + +KLADFGLA  ++   Q   G  G+P 
Sbjct: 119 ILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPG 178

Query: 209 YIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWD 267
           Y++PEVL    Y +  D+W+ GVILYILL G PPFW + + +++  ++A    FPS  WD
Sbjct: 179 YLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWD 238

Query: 268 HISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKPCKQDDLCCKQ 320
            ++  A+DLI  ML ++PS R+TAAE L H W+     VA    +Q+ + C +
Sbjct: 239 TVTPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLK 291

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  420 bits (1081), Expect = e-147
 Identities = 101/289 (34%), Positives = 150/289 (51%), Gaps = 16/289 (5%)

Query: 27  GTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSI--AKDRLVTVEDV 84
             +  +       + Y   + LG G   V+R C  K T +  A K I        + E+V
Sbjct: 4   AALPGSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEV 63

Query: 85  RSIKL----EIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSE 140
           + ++     E++I+ K+SGHPN++ LK  YE   +  L+ +L   GELF  L +    SE
Sbjct: 64  QELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSE 123

Query: 141 TEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNL 200
            E R I R L++V+   H   +VHRDLKPENILL        IKL DFG +  +  G+ L
Sbjct: 124 KETRKIMRALLEVICALHKLNIVHRDLKPENILLD---DDMNIKLTDFGFSCQLDPGEKL 180

Query: 201 HGTVGSPFYIAPEVLAG-------GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDA 253
               G+P Y+APE++         GY +  D+WS GVI+Y LL+G PPFW + +  +   
Sbjct: 181 REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM 240

Query: 254 VRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
           + + + +F S  WD  S + +DL+   L V P  R TA E LAH + ++
Sbjct: 241 IMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 289

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  419 bits (1079), Expect = e-147
 Identities = 104/280 (37%), Positives = 158/280 (56%), Gaps = 6/280 (2%)

Query: 36  SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVE---DVRSIKLEIE 92
           S + D Y +G++LG GQF ++R+C  K TG+  A K I K RL +         I+ E+ 
Sbjct: 1   SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 60

Query: 93  IMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQ 152
           I+ ++  HPN++ L  ++E +  V L++EL +GGELF  L +    +E EA    + ++ 
Sbjct: 61  ILREIR-HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD 119

Query: 153 VVSYCHGNGVVHRDLKPENILLATKSSSSP-IKLADFGLATYIKAGQNLHGTVGSPFYIA 211
            V Y H   + H DLKPENI+L  K+  +P IKL DFG+A  I+AG       G+P ++A
Sbjct: 120 GVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVA 179

Query: 212 PEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHIS 270
           PE++        AD+WS GVI YILLSG  PF G+TK +    + A +  F  + + + S
Sbjct: 180 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTS 239

Query: 271 ASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKP 310
             A+D I  +L  DP  R+T A+ L HSW++   +   + 
Sbjct: 240 ELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNVRG 279

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  420 bits (1081), Expect = e-147
 Identities = 91/289 (31%), Positives = 149/289 (51%), Gaps = 5/289 (1%)

Query: 24  SLTGTILDATQISNLSDRYVL-GKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVE 82
            L    L    + N ++ Y+L  K+LG G+F V+R+C  K TG+  A K + K R    +
Sbjct: 12  DLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR-GQD 70

Query: 83  DVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRL--EKYGRFSE 140
               I  EI ++      P V++L  VYE    + L++E  AGGE+F     E     SE
Sbjct: 71  CRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSE 130

Query: 141 TEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNL 200
            +   + + +++ V Y H N +VH DLKP+NILL++      IK+ DFG++  I     L
Sbjct: 131 NDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACEL 190

Query: 201 HGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADL 259
              +G+P Y+APE+L       A D+W+ G+I Y+LL+   PF G+   + +  +   ++
Sbjct: 191 REIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNV 250

Query: 260 RFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQ 308
            +  + +  +S  A D I  +L  +P  R TA   L+HSW+++ +    
Sbjct: 251 DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENL 299

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  424 bits (1093), Expect = e-146
 Identities = 111/284 (39%), Positives = 158/284 (55%), Gaps = 2/284 (0%)

Query: 26  TGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVR 85
           +    +       ++RY +   LG G FG + +C D+ T +  A K I K      +D  
Sbjct: 8   SSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTS 66

Query: 86  SIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARV 145
           +I  E+E++ KL  HPN++ L  + E+    +++ EL  GGELF  + K  RFSE +A  
Sbjct: 67  TILREVELLKKLD-HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR 125

Query: 146 IFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVG 205
           I + +   ++Y H + +VHRDLKPENILL +K     IK+ DFGL+T  +    +   +G
Sbjct: 126 IIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIG 185

Query: 206 SPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDP 265
           + +YIAPEVL G Y++  DVWSAGVILYILLSG PPF+GK +  I   V      F    
Sbjct: 186 TAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQ 245

Query: 266 WDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQK 309
           W  IS  A+DLI  ML   PS R+TA + L H W+++       
Sbjct: 246 WRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPT 289

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  419 bits (1080), Expect = e-146
 Identities = 105/299 (35%), Positives = 164/299 (54%), Gaps = 11/299 (3%)

Query: 21  KVSSLTGTILD-ATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLV 79
            +S   G ILD A       D Y L + +G G F V+R C ++ TG+  A K +   +  
Sbjct: 4   GISGGGGGILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFT 63

Query: 80  TVE--DVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGR 137
           +        +K E  I   L  HP++V+L   Y  +  ++++ E   G +L   + K   
Sbjct: 64  SSPGLSTEDLKREASICHMLK-HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRAD 122

Query: 138 ----FSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATY 193
               +SE  A    R +++ + YCH N ++HRD+KP  +LLA+K +S+P+KL  FG+A  
Sbjct: 123 AGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182

Query: 194 I-KAGQNLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIF 251
           + ++G    G VG+P ++APEV+    Y +  DVW  GVIL+ILLSG  PF+G TK ++F
Sbjct: 183 LGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG-TKERLF 241

Query: 252 DAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKP 310
           + +     +     W HIS SA+DL+  ML +DP+ R+T  E L H W++E ++ A K 
Sbjct: 242 EGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKI 300

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  417 bits (1074), Expect = e-146
 Identities = 90/271 (33%), Positives = 145/271 (53%), Gaps = 8/271 (2%)

Query: 36  SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMT 95
             + D ++  ++LG G FG +    ++ +G     K+I KDR  +   +  I+ EIE++ 
Sbjct: 18  GTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR--SQVPMEQIEAEIEVLK 75

Query: 96  KLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRL----EKYGRFSETEARVIFRHLM 151
            L  HPN++ +  V+E+   ++++ME C GGEL  R+     +    SE     + + +M
Sbjct: 76  SLD-HPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMM 134

Query: 152 QVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIA 211
             ++Y H   VVH+DLKPENIL    S  SPIK+ DFGLA   K+ ++     G+  Y+A
Sbjct: 135 NALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMA 194

Query: 212 PEVLAGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISA 271
           PEV         D+WSAGV++Y LL+G  PF G +  ++       +  +  +    ++ 
Sbjct: 195 PEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECR-PLTP 253

Query: 272 SARDLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
            A DL+  ML  DP  R +AA+VL H W ++
Sbjct: 254 QAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  422 bits (1088), Expect = e-146
 Identities = 112/279 (40%), Positives = 163/279 (58%), Gaps = 1/279 (0%)

Query: 37  NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTK 96
             SDRY   + LG G FG +  C DK TG+  A K I+K ++    D  S+  E++++ +
Sbjct: 23  IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQ 82

Query: 97  LSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSY 156
           L  HPN++ L   +E++ Y +L+ E+  GGELF  +    RFSE +A  I R ++  ++Y
Sbjct: 83  LD-HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITY 141

Query: 157 CHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLA 216
            H N +VHRDLKPEN+LL +KS  + I++ DFGL+T+ +A + +   +G+ +YIAPEVL 
Sbjct: 142 MHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLH 201

Query: 217 GGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDL 276
           G Y++  DVWS GVILYILLSG PPF G  +  I   V      F    W  +S SA+DL
Sbjct: 202 GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDL 261

Query: 277 IMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKPCKQDD 315
           I  ML   PS R++A + L H W++   +          
Sbjct: 262 IRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSL 300

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  422 bits (1088), Expect = e-145
 Identities = 102/322 (31%), Positives = 159/322 (49%), Gaps = 14/322 (4%)

Query: 4   NNSEDSSQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKF 63
           ++   SS     +     ++     +    +   + + Y   ++LG G +G +  C +K 
Sbjct: 3   HHHHHSSGRENLYFQGIAINP---GMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKN 59

Query: 64  TGEVLACKSIAKDRLVTV----------EDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEE 113
                A K I K +              +    I  EI ++  L  HPN++ L  V+E++
Sbjct: 60  GHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD-HPNIIKLFDVFEDK 118

Query: 114 DYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENIL 173
            Y +L+ E   GGELF ++    +F E +A  I + ++  + Y H + +VHRD+KPENIL
Sbjct: 119 KYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENIL 178

Query: 174 LATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGGYNQAADVWSAGVILY 233
           L  K+S   IK+ DFGL+++      L   +G+ +YIAPEVL   YN+  DVWS GVI+Y
Sbjct: 179 LENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMY 238

Query: 234 ILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAE 293
           ILL G PPF G+    I   V      F  + W +IS  A++LI  ML  D + R TA E
Sbjct: 239 ILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEE 298

Query: 294 VLAHSWMEECEQVAQKPCKQDD 315
            L   W+++      K  ++  
Sbjct: 299 ALNSRWIKKYANNINKSDQKTL 320

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  413 bits (1065), Expect = e-145
 Identities = 112/313 (35%), Positives = 163/313 (52%), Gaps = 18/313 (5%)

Query: 36  SNLSDRYVLG---KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIE 92
           S     Y L    K LG G F + R+C  K + +  A K I+K       + +    EI 
Sbjct: 4   SPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRME---ANTQK---EIT 57

Query: 93  IMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQ 152
            +    GHPN+V L  V+ ++ +  L+MEL  GGELF R++K   FSETEA  I R L+ 
Sbjct: 58  ALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVS 117

Query: 153 VVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA-GQNLHGTVGSPFYIA 211
            VS+ H  GVVHRDLKPEN+L   ++ +  IK+ DFG A       Q L     +  Y A
Sbjct: 118 AVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAA 177

Query: 212 PEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKS-------KIFDAVRAADLRFPS 263
           PE+L   GY+++ D+WS GVILY +LSG  PF    +S       +I   ++  D  F  
Sbjct: 178 PELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEG 237

Query: 264 DPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKPCKQDDLCCKQLEV 323
           + W ++S  A+DLI G+L VDP+ RL  + +  + W+++  Q++  P    D+       
Sbjct: 238 EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAA 297

Query: 324 GGSSFSATFISRN 336
             +   ATF + N
Sbjct: 298 VHTCVKATFHAFN 310

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  411 bits (1059), Expect = e-143
 Identities = 104/301 (34%), Positives = 155/301 (51%), Gaps = 13/301 (4%)

Query: 36  SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMT 95
              +D Y + + +G G + V + C  K T    A K I K +            EIEI+ 
Sbjct: 18  IQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILL 70

Query: 96  KLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS 155
           +   HPN++ LK VY++  YV+++ EL  GGEL  ++ +   FSE EA  +   + + V 
Sbjct: 71  RYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVE 130

Query: 156 YCHGNGVVHRDLKPENILLATKS-SSSPIKLADFGLATYIKA-GQNLHGTVGSPFYIAPE 213
           Y H  GVVHRDLKP NIL   +S +   I++ DFG A  ++A    L     +  ++APE
Sbjct: 131 YLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPE 190

Query: 214 VLAG-GYNQAADVWSAGVILYILLSGMPPFWGK---TKSKIFDAVRAADLRFPSDPWDHI 269
           VL   GY+ A D+WS GV+LY +L+G  PF      T  +I   + +         W+ +
Sbjct: 191 VLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSV 250

Query: 270 SASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKPCKQDDLCCKQLEVGGSSFS 329
           S +A+DL+  ML VDP  RLTAA VL H W+   +Q+ Q    + D          +++S
Sbjct: 251 SDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQLNRQDAPHLVKGAMAATYS 310

Query: 330 A 330
           A
Sbjct: 311 A 311

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  408 bits (1051), Expect = e-143
 Identities = 104/298 (34%), Positives = 150/298 (50%), Gaps = 33/298 (11%)

Query: 36  SNLSDRYVLGKQ-LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
               D Y L +  LG G    ++ C +  T +  A K I K        V     E+E++
Sbjct: 8   GRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFR---EVEML 64

Query: 95  TKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVV 154
            +  GH NV++L   +EEED  +L+ E   GG +   + K   F+E EA V+ + +   +
Sbjct: 65  YQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASAL 124

Query: 155 SYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN--------LHGTVGS 206
            + H  G+ HRDLKPENIL    +  SP+K+ DF L + IK   +        L    GS
Sbjct: 125 DFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGS 184

Query: 207 PFYIAPEVL------AGGYNQAADVWSAGVILYILLSGMPPFWGKTKS------------ 248
             Y+APEV+      A  Y++  D+WS GVILYILLSG PPF G+  S            
Sbjct: 185 AEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244

Query: 249 ---KIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEEC 303
               +F++++     FP   W HIS +A+DLI  +L  D   RL+AA+VL H W++ C
Sbjct: 245 CQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC 302

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  414 bits (1067), Expect = e-142
 Identities = 104/284 (36%), Positives = 161/284 (56%), Gaps = 2/284 (0%)

Query: 33  TQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIE 92
           ++  +LS+ Y   K+LG G +G +  C DK T    A K I K  + T      +  E+ 
Sbjct: 30  SKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST-SSNSKLLEEVA 88

Query: 93  IMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQ 152
           ++  L  HPN++ L   +E++   +L+ME   GGELF  +    +F+E +A VI + ++ 
Sbjct: 89  VLKLLD-HPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLS 147

Query: 153 VVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAP 212
            V+Y H + +VHRDLKPEN+LL +K   + IK+ DFGL+   +  + +   +G+ +YIAP
Sbjct: 148 GVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAP 207

Query: 213 EVLAGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISAS 272
           EVL   Y++  DVWS GVIL+ILL+G PPF G+T  +I   V      F S  W ++S  
Sbjct: 208 EVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEG 267

Query: 273 ARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKPCKQDDL 316
           A+DLI  ML+ D   R++A + L H W++E     +   +   L
Sbjct: 268 AKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSL 311

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  404 bits (1040), Expect = e-141
 Identities = 108/300 (36%), Positives = 158/300 (52%), Gaps = 9/300 (3%)

Query: 27  GTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVE---D 83
           GT+    +  N+ D Y  G++LG GQF V+++C +K TG   A K I K R  +      
Sbjct: 1   GTVF---RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVS 57

Query: 84  VRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEA 143
              I+ E+ I+ ++  HPNV+ L  VYE +  V L++EL AGGELF  L +    +E EA
Sbjct: 58  REDIEREVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEA 116

Query: 144 RVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSP-IKLADFGLATYIKAGQNLHG 202
               + ++  V Y H   + H DLKPENI+L  ++   P IK+ DFGLA  I  G     
Sbjct: 117 TEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176

Query: 203 TVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRF 261
             G+P ++APE++        AD+WS GVI YILLSG  PF G TK +    V A +  F
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 236

Query: 262 PSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKPCKQDDLCCKQL 321
             + + + SA A+D I  +L  DP  R+T  + L H W++  +       K   +  ++ 
Sbjct: 237 EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKASAVNMEKF 296

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  403 bits (1037), Expect = e-141
 Identities = 103/270 (38%), Positives = 160/270 (59%), Gaps = 6/270 (2%)

Query: 34  QISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEI 93
           Q +N+   ++  + LG G F  +     + TG++ A K I K        + +   EI +
Sbjct: 3   QTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLEN---EIAV 59

Query: 94  MTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQV 153
           + K+  H N+V L+ +YE   + +L+M+L +GGELF R+ + G ++E +A ++ + ++  
Sbjct: 60  LKKIK-HENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSA 118

Query: 154 VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPE 213
           V Y H NG+VHRDLKPEN+L  T   +S I + DFGL+   + G  +    G+P Y+APE
Sbjct: 119 VKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI-MSTACGTPGYVAPE 177

Query: 214 VLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISAS 272
           VLA   Y++A D WS GVI YILL G PPF+ +T+SK+F+ ++     F S  WD IS S
Sbjct: 178 VLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISES 237

Query: 273 ARDLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
           A+D I  +L  DP+ R T  + L+H W++ 
Sbjct: 238 AKDFICHLLEKDPNERYTCEKALSHPWIDG 267

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  403 bits (1037), Expect = e-140
 Identities = 100/282 (35%), Positives = 160/282 (56%), Gaps = 8/282 (2%)

Query: 21  KVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVT 80
             S +    +D +    LSD + +  +LG G   ++  C  K T +  A K + K     
Sbjct: 34  TASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--- 90

Query: 81  VEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSE 140
             D + ++ EI ++ +LS HPN++ LK ++E    + L++EL  GGELF R+ + G +SE
Sbjct: 91  --DKKIVRTEIGVLLRLS-HPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSE 147

Query: 141 TEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNL 200
            +A    + +++ V+Y H NG+VHRDLKPEN+L AT +  +P+K+ADFGL+  ++    +
Sbjct: 148 RDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM 207

Query: 201 HGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTK-SKIFDAVRAAD 258
               G+P Y APE+L G  Y    D+WS G+I YILL G  PF+ +     +F  +   +
Sbjct: 208 KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCE 267

Query: 259 LRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWM 300
             F S  WD +S +A+DL+  ++ +DP  RLT  + L H W+
Sbjct: 268 YYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWV 309

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  400 bits (1029), Expect = e-139
 Identities = 101/290 (34%), Positives = 149/290 (51%), Gaps = 6/290 (2%)

Query: 37  NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVE---DVRSIKLEIEI 93
            + D Y +G++LG GQF ++++C +K TG   A K I K +            I+ E+ I
Sbjct: 9   KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68

Query: 94  MTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQV 153
           + ++  H NV+ L  VYE    V L++EL +GGELF  L +    SE EA    + ++  
Sbjct: 69  LRQVL-HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDG 127

Query: 154 VSYCHGNGVVHRDLKPENILLATKSSSSP-IKLADFGLATYIKAGQNLHGTVGSPFYIAP 212
           V+Y H   + H DLKPENI+L  K+   P IKL DFGLA  I+ G       G+P ++AP
Sbjct: 128 VNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAP 187

Query: 213 EVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISA 271
           E++        AD+WS GVI YILLSG  PF G TK +    + +    F  + + H S 
Sbjct: 188 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSE 247

Query: 272 SARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKPCKQDDLCCKQL 321
            A+D I  +L  +   RLT  E L H W+   +       ++  +  +  
Sbjct: 248 LAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLENF 297

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  401 bits (1032), Expect = e-138
 Identities = 91/286 (31%), Positives = 146/286 (51%), Gaps = 19/286 (6%)

Query: 36  SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMT 95
           + + D  V  + LG G  G + +  +K T E  A K +           R    E+E+  
Sbjct: 58  AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARR---EVELHW 109

Query: 96  KLSGHPNVVDLKAVYEE----EDYVHLLMELCAGGELFHRLEKYG--RFSETEARVIFRH 149
           + S  P++V +  VYE        + ++ME   GGELF R++  G   F+E EA  I + 
Sbjct: 110 RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKS 169

Query: 150 LMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFY 209
           + + + Y H   + HRD+KPEN+L  +K  ++ +KL DFG A    +  +L     +P+Y
Sbjct: 170 IGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYY 229

Query: 210 IAPEVLA-GGYNQAADVWSAGVILYILLSGMPPFWGK----TKSKIFDAVRAADLRFPSD 264
           +APEVL    Y+++ D+WS GVI+YILL G PPF+          +   +R     FP+ 
Sbjct: 230 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 289

Query: 265 PWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKP 310
            W  +S   + LI  +L+ +P+ R+T  E + H W+ +  +V Q P
Sbjct: 290 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 335

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  397 bits (1021), Expect = e-138
 Identities = 99/276 (35%), Positives = 155/276 (56%), Gaps = 12/276 (4%)

Query: 37  NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVE-----DVRSIKLEI 91
            L D Y++ K LG G  G ++   ++ T + +A K I+K +             +++ EI
Sbjct: 7   ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEI 66

Query: 92  EIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLM 151
           EI+ KL+ HP ++ +K  ++ EDY ++++EL  GGELF ++    R  E   ++ F  ++
Sbjct: 67  EILKKLN-HPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 124

Query: 152 QVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIA 211
             V Y H NG++HRDLKPEN+LL+++     IK+ DFG +  +     +    G+P Y+A
Sbjct: 125 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLA 184

Query: 212 PEVLAG----GYNQAADVWSAGVILYILLSGMPPFWG-KTKSKIFDAVRAADLRFPSDPW 266
           PEVL      GYN+A D WS GVIL+I LSG PPF   +T+  + D + +    F  + W
Sbjct: 185 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 244

Query: 267 DHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
             +S  A DL+  +L VDP  R T  E L H W+++
Sbjct: 245 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  394 bits (1014), Expect = e-136
 Identities = 101/290 (34%), Positives = 149/290 (51%), Gaps = 6/290 (2%)

Query: 37  NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVE---DVRSIKLEIEI 93
            + D Y +G++LG GQF ++++C +K TG   A K I K +            I+ E+ I
Sbjct: 9   KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSI 68

Query: 94  MTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQV 153
           + ++  HPN++ L  VYE    V L++EL +GGELF  L +    SE EA    + ++  
Sbjct: 69  LRQVL-HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDG 127

Query: 154 VSYCHGNGVVHRDLKPENILLATKSSSSP-IKLADFGLATYIKAGQNLHGTVGSPFYIAP 212
           V+Y H   + H DLKPENI+L  K+   P IKL DFGLA  I+ G       G+P ++AP
Sbjct: 128 VNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAP 187

Query: 213 EVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISA 271
           E++        AD+WS GVI YILLSG  PF G TK +    + A    F  + +   S 
Sbjct: 188 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSE 247

Query: 272 SARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKPCKQDDLCCKQL 321
            A+D I  +L  +   RLT  E L H W+   +       ++  +  +  
Sbjct: 248 LAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVVNLENF 297

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  389 bits (1002), Expect = e-135
 Identities = 98/287 (34%), Positives = 149/287 (51%), Gaps = 21/287 (7%)

Query: 36  SNLSDRYVLGKQ-LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
             ++D Y L KQ LG G  G + EC  + TG+  A K +           R    E++  
Sbjct: 24  YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD-----SPKARQ---EVDHH 75

Query: 95  TKLSGHPNVVDLKAVYEE----EDYVHLLMELCAGGELFHRLEKYG--RFSETEARVIFR 148
            + SG P++V +  VYE     +  + ++ME   GGELF R+++ G   F+E EA  I R
Sbjct: 76  WQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMR 135

Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF 208
            +   + + H + + HRD+KPEN+L  +K   + +KL DFG A        L     +P+
Sbjct: 136 DIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA-LQTPCYTPY 194

Query: 209 YIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSK----IFDAVRAADLRFPS 263
           Y+APEVL    Y+++ D+WS GVI+YILL G PPF+  T       +   +R     FP+
Sbjct: 195 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPN 254

Query: 264 DPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKP 310
             W  +S  A+ LI  +L+ DP+ RLT  + + H W+ +   V Q P
Sbjct: 255 PEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTP 301

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  389 bits (1001), Expect = e-133
 Identities = 98/277 (35%), Positives = 155/277 (55%), Gaps = 12/277 (4%)

Query: 36  SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVE-----DVRSIKLE 90
             L D Y++ K LG G  G ++   ++ T + +A + I+K +             +++ E
Sbjct: 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETE 190

Query: 91  IEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHL 150
           IEI+ KL+ HP ++ +K  ++ EDY ++++EL  GGELF ++    R  E   ++ F  +
Sbjct: 191 IEILKKLN-HPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 248

Query: 151 MQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYI 210
           +  V Y H NG++HRDLKPEN+LL+++     IK+ DFG +  +     +    G+P Y+
Sbjct: 249 LLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYL 308

Query: 211 APEVLAG----GYNQAADVWSAGVILYILLSGMPPFWG-KTKSKIFDAVRAADLRFPSDP 265
           APEVL      GYN+A D WS GVIL+I LSG PPF   +T+  + D + +    F  + 
Sbjct: 309 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 368

Query: 266 WDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
           W  +S  A DL+  +L VDP  R T  E L H W+++
Sbjct: 369 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  384 bits (989), Expect = e-133
 Identities = 75/268 (27%), Positives = 137/268 (51%), Gaps = 8/268 (2%)

Query: 37  NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTK 96
            L ++Y++ + LG G+FG++  C +  + +    K +   +      V+    EI I+  
Sbjct: 2   ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKK---EISILNI 57

Query: 97  LSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHR-LEKYGRFSETEARVIFRHLMQVVS 155
              H N++ L   +E  + + ++ E  +G ++F R        +E E       + + + 
Sbjct: 58  A-RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQ 116

Query: 156 YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVL 215
           + H + + H D++PENI+  T+ SS  IK+ +FG A  +K G N      +P Y APEV 
Sbjct: 117 FLHSHNIGHFDIRPENIIYQTRRSS-TIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVH 175

Query: 216 AG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASAR 274
                + A D+WS G ++Y+LLSG+ PF  +T  +I + +  A+  F  + +  IS  A 
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM 235

Query: 275 DLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
           D +  +L  +  +R+TA+E L H W+++
Sbjct: 236 DFVDRLLVKERKSRMTASEALQHPWLKQ 263

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  378 bits (972), Expect = e-131
 Identities = 84/285 (29%), Positives = 134/285 (47%), Gaps = 38/285 (13%)

Query: 36  SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMT 95
           + + D  V  + LG G  G + +  +K T E  A K +           R    E+E+  
Sbjct: 14  AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARR---EVELHW 65

Query: 96  KLSGHPNVVDLKAVYEE----EDYVHLLMELCAGGELFHRLEKYG--RFSETEARVIFRH 149
           + S  P++V +  VYE        + ++ME   GGELF R++  G   F+E EA  I + 
Sbjct: 66  RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKS 125

Query: 150 LMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFY 209
           + + + Y H   + HRD+KPEN+L  +K  ++ +KL DFG                    
Sbjct: 126 IGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF------------------- 166

Query: 210 IAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGK----TKSKIFDAVRAADLRFPSDP 265
            A E     Y+++ D+WS GVI+YILL G PPF+          +   +R     FP+  
Sbjct: 167 -AKETTGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 225

Query: 266 WDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKP 310
           W  +S   + LI  +L+ +P+ R+T  E + H W+ +  +V Q P
Sbjct: 226 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 270

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  378 bits (972), Expect = e-130
 Identities = 99/343 (28%), Positives = 146/343 (42%), Gaps = 52/343 (15%)

Query: 17  CNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKD 76
            + +  S           +  L  +Y L   +G G +GV+R   +  T  + A K + K+
Sbjct: 3   HHHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKN 62

Query: 77  RL--VTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEK 134
           ++  +  +DV  IK E+ +M KL  HPN+  L  VYE+E Y+ L+MELC GG L  +L  
Sbjct: 63  KIRQINPKDVERIKTEVRLMKKLH-HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNV 121

Query: 135 YGR----------------------------------------FSETEARVIFRHLMQVV 154
           +                                            E     I R +   +
Sbjct: 122 FIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181

Query: 155 SYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN-----LHGTVGSPFY 209
            Y H  G+ HRD+KPEN L +T  S   IKL DFGL+       N     +    G+P++
Sbjct: 182 HYLHNQGICHRDIKPENFLFSTNKSF-EIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYF 240

Query: 210 IAPEVLAG---GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW 266
           +APEVL      Y    D WSAGV+L++LL G  PF G   +     V    L F +  +
Sbjct: 241 VAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNY 300

Query: 267 DHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQK 309
           + +S  ARDL+  +L  +   R  A   L H W+ +      K
Sbjct: 301 NVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDKIYK 343

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  378 bits (972), Expect = e-130
 Identities = 88/276 (31%), Positives = 146/276 (52%), Gaps = 7/276 (2%)

Query: 37  NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTK 96
           ++ D Y + ++LG G FGV+  C +K TG V   K I     +    V++   EI IM +
Sbjct: 48  SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKN---EISIMNQ 104

Query: 97  LSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRL-EKYGRFSETEARVIFRHLMQVVS 155
           L  HP +++L   +E++  + L++E  +GGELF R+  +  + SE E     R   + + 
Sbjct: 105 LH-HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLK 163

Query: 156 YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVL 215
           + H + +VH D+KPENI+  TK +S  +K+ DFGLAT +   + +  T  +  + APE++
Sbjct: 164 HMHEHSIVHLDIKPENIMCETKKAS-SVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV 222

Query: 216 AG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASAR 274
                    D+W+ GV+ Y+LLSG+ PF G+   +    V+  D  F  D +  +S  A+
Sbjct: 223 DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK 282

Query: 275 DLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKP 310
           D I  +L+ +P  RLT  + L H W++         
Sbjct: 283 DFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSR 318

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  381 bits (981), Expect = e-128
 Identities = 92/275 (33%), Positives = 148/275 (53%), Gaps = 7/275 (2%)

Query: 37  NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTK 96
           ++ D Y + ++LG G FGV+   +++ TG   A K +        E VR    EI+ M+ 
Sbjct: 154 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRK---EIQTMSV 210

Query: 97  LSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRL-EKYGRFSETEARVIFRHLMQVVS 155
           L  HP +V+L   +E+++ + ++ E  +GGELF ++ +++ + SE EA    R + + + 
Sbjct: 211 LR-HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLC 269

Query: 156 YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVL 215
           + H N  VH DLKPENI+  TK S+  +KL DFGL  ++   Q++  T G+  + APEV 
Sbjct: 270 HMHENNYVHLDLKPENIMFTTKRSNE-LKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA 328

Query: 216 AG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASAR 274
            G       D+WS GV+ YILLSG+ PF G+   +    V++ D       +  IS   +
Sbjct: 329 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK 388

Query: 275 DLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQK 309
           D I  +L  DP+TR+T  + L H W+       + 
Sbjct: 389 DFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRD 423

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  373 bits (960), Expect = e-128
 Identities = 86/271 (31%), Positives = 146/271 (53%), Gaps = 9/271 (3%)

Query: 36  SNLSDRYVLGKQ--LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEI 93
             ++  Y + K   LG G+FG + +C +  TG  LA K I    +   E+V++   EI +
Sbjct: 83  GAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKN---EISV 139

Query: 94  MTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHR-LEKYGRFSETEARVIFRHLMQ 152
           M +L  H N++ L   +E ++ + L+ME   GGELF R +++    +E +  +  + + +
Sbjct: 140 MNQLD-HANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICE 198

Query: 153 VVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAP 212
            + + H   ++H DLKPENIL   + +   IK+ DFGLA   K  + L    G+P ++AP
Sbjct: 199 GIRHMHQMYILHLDLKPENILCVNRDAK-QIKIIDFGLARRYKPREKLKVNFGTPEFLAP 257

Query: 213 EVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISA 271
           EV+     +   D+WS GVI Y+LLSG+ PF G   ++  + + A       + +  IS 
Sbjct: 258 EVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISE 317

Query: 272 SARDLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
            A++ I  +L  + S R++A+E L H W+ +
Sbjct: 318 EAKEFISKLLIKEKSWRISASEALKHPWLSD 348

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  310 bits (797), Expect = e-103
 Identities = 73/291 (25%), Positives = 122/291 (41%), Gaps = 21/291 (7%)

Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
            +     LG G  G I      F    +A K I        E       E++++ +   H
Sbjct: 25  SFCPKDVLGHGAEGTIV-YRGMFDNRDVAVKRILP------ECFSFADREVQLLRESDEH 77

Query: 101 PNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYG-RFSETEARVIFRHLMQVVSYCHG 159
           PNV+      ++  + ++ +ELC    L   +E+        E   + +     +++ H 
Sbjct: 78  PNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS 136

Query: 160 NGVVHRDLKPENILLATKSSSSP--IKLADFGLATYIKAGQN----LHGTVGSPFYIAPE 213
             +VHRDLKP NIL++  ++       ++DFGL   +  G++      G  G+  +IAPE
Sbjct: 137 LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196

Query: 214 VLAG----GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDH 268
           +L+           D++SAG + Y ++S G  PF    + +    + A  L     P  H
Sbjct: 197 MLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLH-PEKH 255

Query: 269 ISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKPCKQDDLCCK 319
               AR+LI  M+ +DP  R +A  VL H +    E+  Q      D   K
Sbjct: 256 EDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQLQFFQDVSDRIEK 306

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  302 bits (777), Expect = e-101
 Identities = 92/263 (34%), Positives = 132/263 (50%), Gaps = 10/263 (3%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
            RYV G+ LG G F    E SD  T EV A K + K  L+       + +EI I   L+ 
Sbjct: 15  RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA- 73

Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
           H +VV     +E+ D+V +++ELC    L    ++    +E EAR   R ++    Y H 
Sbjct: 74  HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 133

Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTV-GSPFYIAPEVLAG- 217
           N V+HRDLK  N+ L        +K+ DFGLAT ++        + G+P YIAPEVL+  
Sbjct: 134 NRVIHRDLKLGNLFLNEDLE---VKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKK 190

Query: 218 GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLI 277
           G++   DVWS G I+Y LL G PPF      + +  ++  +   P     HI+  A  LI
Sbjct: 191 GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK----HINPVAASLI 246

Query: 278 MGMLRVDPSTRLTAAEVLAHSWM 300
             ML+ DP+ R T  E+L   + 
Sbjct: 247 QKMLQTDPTARPTINELLNDEFF 269

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  304 bits (781), Expect = e-101
 Identities = 92/263 (34%), Positives = 132/263 (50%), Gaps = 10/263 (3%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
            RYV G+ LG G F    E SD  T EV A K + K  L+       + +EI I   L+ 
Sbjct: 41  RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA- 99

Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
           H +VV     +E+ D+V +++ELC    L    ++    +E EAR   R ++    Y H 
Sbjct: 100 HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 159

Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTV-GSPFYIAPEVLAG- 217
           N V+HRDLK  N+ L        +K+ DFGLAT ++        + G+P YIAPEVL+  
Sbjct: 160 NRVIHRDLKLGNLFLNEDLE---VKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKK 216

Query: 218 GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLI 277
           G++   DVWS G I+Y LL G PPF      + +  ++  +   P     HI+  A  LI
Sbjct: 217 GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK----HINPVAASLI 272

Query: 278 MGMLRVDPSTRLTAAEVLAHSWM 300
             ML+ DP+ R T  E+L   + 
Sbjct: 273 QKMLQTDPTARPTINELLNDEFF 295

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  298 bits (766), Expect = e-100
 Identities = 96/272 (35%), Positives = 148/272 (54%), Gaps = 11/272 (4%)

Query: 32  ATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEI 91
           AT I    + + +G  LG G F  +       TG  +A K I K  +     V+ ++ E+
Sbjct: 3   ATCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEV 62

Query: 92  EIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRL-EKYGRFSETEARVIFRHL 150
           +I  +L  HP++++L   +E+ +YV+L++E+C  GE+   L  +   FSE EAR     +
Sbjct: 63  KIHCQLK-HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQI 121

Query: 151 MQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTV-GSPFY 209
           +  + Y H +G++HRDL   N+LL   + +  IK+ADFGLAT +K     H T+ G+P Y
Sbjct: 122 ITGMLYLHSHGILHRDLTLSNLLL---TRNMNIKIADFGLATQLKMPHEKHYTLCGTPNY 178

Query: 210 IAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDH 268
           I+PE+     +   +DVWS G + Y LL G PPF   T     + V  AD   PS     
Sbjct: 179 ISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPS----F 234

Query: 269 ISASARDLIMGMLRVDPSTRLTAAEVLAHSWM 300
           +S  A+DLI  +LR +P+ RL+ + VL H +M
Sbjct: 235 LSIEAKDLIHQLLRRNPADRLSLSSVLDHPFM 266

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  302 bits (776), Expect = 1e-99
 Identities = 82/312 (26%), Positives = 132/312 (42%), Gaps = 42/312 (13%)

Query: 37  NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTK 96
           +L +  V  K LG+G  G +      F G  +A K +  D            +EI+++T+
Sbjct: 12  SLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF------CDIALMEIKLLTE 64

Query: 97  LSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFS-------ETEARVIFRH 149
              HPNV+        + ++++ +ELC    L   +E             E     + R 
Sbjct: 65  SDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQ 123

Query: 150 LMQVVSYCHGNGVVHRDLKPENILLATKSSS----------SPIKLADFGLATYIKAGQ- 198
           +   V++ H   ++HRDLKP+NIL++T S              I ++DFGL   + +GQ 
Sbjct: 124 IASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQS 183

Query: 199 ----NLHGTVGSPFYIAPEVLAG--------GYNQAADVWSAGVILYILLS-GMPPFWGK 245
               NL+   G+  + APE+L             ++ D++S G + Y +LS G  PF  K
Sbjct: 184 SFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243

Query: 246 --TKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEEC 303
              +S I   + + D          + A A DLI  M+  DP  R TA +VL H      
Sbjct: 244 YSRESNIIRGIFSLD-EMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPK 302

Query: 304 EQVAQKPCKQDD 315
            +  +   K  D
Sbjct: 303 SKKLEFLLKVSD 314

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  293 bits (753), Expect = 1e-97
 Identities = 67/311 (21%), Positives = 117/311 (37%), Gaps = 43/311 (13%)

Query: 36  SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMT 95
           S  +  ++L   LG G    +     K TG++ A K       +    V     E E++ 
Sbjct: 5   STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLK 62

Query: 96  KLSGHPNVVDLKAVYEEE--DYVHLLMELCAGGELFHRLEKYGR---FSETEARVIFRHL 150
           KL+ H N+V L A+ EE    +  L+ME C  G L+  LE+        E+E  ++ R +
Sbjct: 63  KLN-HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV 121

Query: 151 MQVVSYCHGNGVVHRDLKPENILLATKS-SSSPIKLADFGLATYIKAGQNLHGTVGSPFY 209
           +  +++   NG+VHR++KP NI+        S  KL DFG A  ++  +      G+  Y
Sbjct: 122 VGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEY 181

Query: 210 IAPEVLAG---------GYNQAADVWSAGVILYILLSGMPPFW----GKTKSKIFDAVRA 256
           + P++             Y    D+WS GV  Y   +G  PF      +   ++   +  
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241

Query: 257 AD---------------LRFPSD--PWDHISASARD----LIMGMLRVDPSTRLTAAEVL 295
                            + +  D      +S   +     ++  +L  D        +  
Sbjct: 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFF 301

Query: 296 AHSWMEECEQV 306
           A +        
Sbjct: 302 AETSDILHRGN 312

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  291 bits (747), Expect = 3e-97
 Identities = 82/265 (30%), Positives = 138/265 (52%), Gaps = 12/265 (4%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           + + +G+ LG G+FG +    +K +  +LA K + K +L        ++ E+EI + L  
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR- 67

Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
           HPN++ L   + +   V+L++E    G ++  L+K  +F E         L   +SYCH 
Sbjct: 68  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 127

Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTV-GSPFYIAPEVLAG- 217
             V+HRD+KPEN+LL +      +K+ADFG + +  A  +    + G+  Y+ PE++ G 
Sbjct: 128 KRVIHRDIKPENLLLGSAGE---LKIADFGWSVH--APSSRRTDLCGTLDYLPPEMIEGR 182

Query: 218 GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLI 277
            +++  D+WS GV+ Y  L G PPF   T  + +  +   +  FP      ++  ARDLI
Sbjct: 183 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLI 238

Query: 278 MGMLRVDPSTRLTAAEVLAHSWMEE 302
             +L+ +PS R    EVL H W+  
Sbjct: 239 SRLLKHNPSQRPMLREVLEHPWITA 263

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  290 bits (744), Expect = 1e-96
 Identities = 84/276 (30%), Positives = 141/276 (51%), Gaps = 10/276 (3%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           D + +G+ LG G+FG +    +K    ++A K + K +L        ++ EIEI + L  
Sbjct: 14  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR- 72

Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
           HPN++ +   + +   ++L++E    GEL+  L+K+GRF E  +      L   + YCH 
Sbjct: 73  HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHE 132

Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG-G 218
             V+HRD+KPEN+L+        +K+ADFG + +           G+  Y+ PE++ G  
Sbjct: 133 RKVIHRDIKPENLLM---GYKGELKIADFGWSVHAP-SLRRRTMCGTLDYLPPEMIEGKT 188

Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           +++  D+W AGV+ Y  L GMPPF   + ++    +   DL+FP      +S  ++DLI 
Sbjct: 189 HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPP----FLSDGSKDLIS 244

Query: 279 GMLRVDPSTRLTAAEVLAHSWMEECEQVAQKPCKQD 314
            +LR  P  RL    V+ H W++   +    P  Q 
Sbjct: 245 KLLRYHPPQRLPLKGVMEHPWVKANSRRVLPPVYQS 280

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  285 bits (732), Expect = 5e-95
 Identities = 101/262 (38%), Positives = 147/262 (56%), Gaps = 10/262 (3%)

Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
            YVLG  LG G FG ++    + TG  +A K + + ++ +++ V  IK EI+ + KL  H
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNL-KLFRH 70

Query: 101 PNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGN 160
           P+++ L  V        ++ME  +GGELF  + K+GR  E EAR +F+ ++  V YCH +
Sbjct: 71  PHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH 130

Query: 161 GVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG-GY 219
            VVHRDLKPEN+LL    +    K+ADFGL+  +  G+ L  + GSP Y APEV++G  Y
Sbjct: 131 MVVHRDLKPENVLLDAHMN---AKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLY 187

Query: 220 N-QAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
                D+WS GVILY LL G  PF  +    +F  +R      P     +++ S   L+M
Sbjct: 188 AGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPE----YLNRSVATLLM 243

Query: 279 GMLRVDPSTRLTAAEVLAHSWM 300
            ML+VDP  R T  ++  H W 
Sbjct: 244 HMLQVDPLKRATIKDIREHEWF 265

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  285 bits (731), Expect = 2e-94
 Identities = 74/296 (25%), Positives = 123/296 (41%), Gaps = 41/296 (13%)

Query: 36  SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMT 95
              +  +     LG G FG + +  +       A K I        E + +I  E+ ++ 
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE----EKLSTILSEVMLLA 57

Query: 96  KLSGHPNVVDLKAVYEEED-------------YVHLLMELCAGGELFHRLEKYGRF-SET 141
            L+ H  VV   A + E                + + ME C  G L+  +          
Sbjct: 58  SLN-HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRD 116

Query: 142 EARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA----- 196
           E   +FR +++ +SY H  G++HRDLKP NI +     S  +K+ DFGLA  +       
Sbjct: 117 EYWRLFRQILEALSYIHSQGIIHRDLKPMNIFI---DESRNVKIGDFGLAKNVHRSLDIL 173

Query: 197 ----------GQNLHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWG 244
                       NL   +G+  Y+A EVL G   YN+  D++S G+I + ++   P   G
Sbjct: 174 KLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTG 231

Query: 245 KTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWM 300
             +  I   +R+  + FP D  D+     + +I  ++  DP+ R  A  +L   W+
Sbjct: 232 MERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  286 bits (734), Expect = 3e-94
 Identities = 101/267 (37%), Positives = 138/267 (51%), Gaps = 14/267 (5%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           DRY   K +G G FGV R   DK T E++A K I +   +      +++ EI    +   
Sbjct: 20  DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINH-RSLR 74

Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
           HPN+V  K V     ++ ++ME  +GGEL+ R+   GRFSE EAR  F+ L+  VSYCH 
Sbjct: 75  HPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHS 134

Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG-G 218
             + HRDLK EN LL   S +  +K+ DFG +           TVG+P YIAPEVL    
Sbjct: 135 MQICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQE 193

Query: 219 YN-QAADVWSAGVILYILLSGMPPFWGKTKS----KIFDAVRAADLRFPSDPWDHISASA 273
           Y+ + ADVWS GV LY++L G  PF    +     K    + +     P D    IS   
Sbjct: 194 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIR--ISPEC 251

Query: 274 RDLIMGMLRVDPSTRLTAAEVLAHSWM 300
             LI  +   DP+TR++  E+  HSW 
Sbjct: 252 CHLISRIFVADPATRISIPEIKTHSWF 278

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  285 bits (731), Expect = 3e-94
 Identities = 103/304 (33%), Positives = 152/304 (50%), Gaps = 16/304 (5%)

Query: 23  SSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVE 82
           +S+     +   I N    Y L K +G G F  ++      TG  +A K I K +L    
Sbjct: 2   NSIASCADEQPHIGN----YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPT 56

Query: 83  DVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETE 142
            ++ +  E+ IM  L+ HPN+V L  V E E  ++L+ME  +GGE+F  L  +GR  E E
Sbjct: 57  SLQKLFREVRIMKILN-HPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKE 115

Query: 143 ARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHG 202
           AR  FR ++  V YCH   +VHRDLK EN+LL    +   IK+ADFG +     G  L  
Sbjct: 116 ARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMN---IKIADFGFSNEFTVGGKLDA 172

Query: 203 TVGSPFYIAPEVLAG-GYN-QAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLR 260
             G+P Y APE+  G  Y+    DVWS GVILY L+SG  PF G+   ++ + V     R
Sbjct: 173 FCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR 232

Query: 261 FPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEEC-EQVAQKPCKQDDLCCK 319
            P     ++S    +L+   L ++P  R T  +++   W+    E+   KP  + +L   
Sbjct: 233 IPF----YMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELDIS 288

Query: 320 QLEV 323
             + 
Sbjct: 289 DQKR 292

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  283 bits (726), Expect = 4e-94
 Identities = 84/267 (31%), Positives = 137/267 (51%), Gaps = 14/267 (5%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           + + L + LG G +G ++   ++ T E +A K +   R V  +   +IK EI I  K+  
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICIN-KMLN 63

Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
           H NVV       E +  +L +E C+GGELF R+E      E +A+  F  LM  V Y HG
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123

Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLA 216
            G+ HRD+KPEN+LL  + +   +K++DFGLAT  +       L+   G+  Y+APE+L 
Sbjct: 124 IGITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180

Query: 217 G-GYN-QAADVWSAGVILYILLSGMPPFWGKT-KSKIFDAVRAADLRFPSDPWDHISASA 273
              ++ +  DVWS G++L  +L+G  P+   +   + +   +         PW  I ++ 
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN--PWKKIDSAP 238

Query: 274 RDLIMGMLRVDPSTRLTAAEVLAHSWM 300
             L+  +L  +PS R+T  ++    W 
Sbjct: 239 LALLHKILVENPSARITIPDIKKDRWY 265

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  282 bits (723), Expect = 4e-93
 Identities = 85/267 (31%), Positives = 138/267 (51%), Gaps = 14/267 (5%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           + + L + LG G +G ++   ++ T E +A K +   R V  +   +IK EI I  K+  
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICIN-KMLN 63

Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
           H NVV       E +  +L +E C+GGELF R+E      E +A+  F  LM  V Y HG
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123

Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLA 216
            G+ HRD+KPEN+LL  + +   +K++DFGLAT  +       L+   G+  Y+APE+L 
Sbjct: 124 IGITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180

Query: 217 G-GYN-QAADVWSAGVILYILLSGMPPFWGKTKS-KIFDAVRAADLRFPSDPWDHISASA 273
              ++ +  DVWS G++L  +L+G  P+   + S + +   +         PW  I ++ 
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN--PWKKIDSAP 238

Query: 274 RDLIMGMLRVDPSTRLTAAEVLAHSWM 300
             L+  +L  +PS R+T  ++    W 
Sbjct: 239 LALLHKILVENPSARITIPDIKKDRWY 265

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  284 bits (729), Expect = 5e-93
 Identities = 69/311 (22%), Positives = 117/311 (37%), Gaps = 43/311 (13%)

Query: 36  SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMT 95
           S  +  ++L   LG G    +     K TG++ A K       +   DV     E E++ 
Sbjct: 5   STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDV--QMREFEVLK 62

Query: 96  KLSGHPNVVDLKAVYEEE--DYVHLLMELCAGGELFHRLEKYGR---FSETEARVIFRHL 150
           KL+ H N+V L A+ EE    +  L+ME C  G L+  LE+        E+E  ++ R +
Sbjct: 63  KLN-HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV 121

Query: 151 MQVVSYCHGNGVVHRDLKPENILLATKS-SSSPIKLADFGLATYIKAGQNLHGTVGSPFY 209
           +  +++   NG+VHR++KP NI+        S  KL DFG A  ++  +      G+  Y
Sbjct: 122 VGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEY 181

Query: 210 IAPEVLAG---------GYNQAADVWSAGVILYILLSGMPPFW----GKTKSKIFDAVR- 255
           + P++             Y    D+WS GV  Y   +G  PF      +   ++   +  
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241

Query: 256 ----------------AADLRFPSDPWDHISASARD----LIMGMLRVDPSTRLTAAEVL 295
                             D          +S   +     ++  +L  D        +  
Sbjct: 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFF 301

Query: 296 AHSWMEECEQV 306
           A +       V
Sbjct: 302 AETSDILHRMV 312

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  282 bits (723), Expect = 6e-93
 Identities = 89/272 (32%), Positives = 140/272 (51%), Gaps = 11/272 (4%)

Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
            Y++ + LG G FG ++  +   T + +A K I++  L   +    ++ EI  + KL  H
Sbjct: 10  PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYL-KLLRH 68

Query: 101 PNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGN 160
           P+++ L  V      + +++E  AGGELF  + +  R +E E R  F+ ++  + YCH +
Sbjct: 69  PHIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRH 127

Query: 161 GVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG-GY 219
            +VHRDLKPEN+LL    +   +K+ADFGL+  +  G  L  + GSP Y APEV+ G  Y
Sbjct: 128 KIVHRDLKPENLLLDDNLN---VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLY 184

Query: 220 N-QAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
                DVWS G++LY++L G  PF  +    +F  V +     P      +S  A+ LI 
Sbjct: 185 AGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPD----FLSPGAQSLIR 240

Query: 279 GMLRVDPSTRLTAAEVLAHSWMEECEQVAQKP 310
            M+  DP  R+T  E+    W         +P
Sbjct: 241 RMIVADPMQRITIQEIRRDPWFNVNLPDYLRP 272

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  286 bits (733), Expect = 1e-92
 Identities = 96/262 (36%), Positives = 145/262 (55%), Gaps = 10/262 (3%)

Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
            Y+LG  LG G FG ++    + TG  +A K + + ++ +++ V  I+ EI+ + KL  H
Sbjct: 17  HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNL-KLFRH 75

Query: 101 PNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGN 160
           P+++ L  V      + ++ME  +GGELF  + K GR  E E+R +F+ ++  V YCH +
Sbjct: 76  PHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRH 135

Query: 161 GVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG-GY 219
            VVHRDLKPEN+LL    +    K+ADFGL+  +  G+ L  + GSP Y APEV++G  Y
Sbjct: 136 MVVHRDLKPENVLLDAHMN---AKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLY 192

Query: 220 N-QAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
                D+WS+GVILY LL G  PF       +F  +       P     +++ S   L+ 
Sbjct: 193 AGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQ----YLNPSVISLLK 248

Query: 279 GMLRVDPSTRLTAAEVLAHSWM 300
            ML+VDP  R T  ++  H W 
Sbjct: 249 HMLQVDPMKRATIKDIREHEWF 270

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  279 bits (717), Expect = 2e-92
 Identities = 78/278 (28%), Positives = 124/278 (44%), Gaps = 22/278 (7%)

Query: 32  ATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRS---IK 88
                     Y LG  LG G FG +           +A K I ++R++    +       
Sbjct: 23  GKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCP 82

Query: 89  LEIEIMTKLS---GHPNVVDLKAVYEEEDYVHLLMEL-CAGGELFHRLEKYGRFSETEAR 144
           LE+ ++ K+    GHP V+ L   +E ++   L++E      +LF  + + G   E  +R
Sbjct: 83  LEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSR 142

Query: 145 VIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTV 204
             F  ++  + +CH  GVVHRD+K ENIL+  +      KL DFG    +   +      
Sbjct: 143 CFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGC--AKLIDFGSGALLH-DEPYTDFD 199

Query: 205 GSPFYIAPEVLAG-GYN-QAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFP 262
           G+  Y  PE ++   Y+   A VWS G++LY ++ G  PF    +      +  A+L FP
Sbjct: 200 GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ILEAELHFP 253

Query: 263 SDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWM 300
           +    H+S     LI   L   PS+R +  E+L   WM
Sbjct: 254 A----HVSPDCCALIRRCLAPKPSSRPSLEEILLDPWM 287

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  279 bits (716), Expect = 3e-92
 Identities = 68/285 (23%), Positives = 123/285 (43%), Gaps = 28/285 (9%)

Query: 34  QISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEI 93
            +S     Y + KQ+G G    + +  ++   ++ A K +  +     + + S + EI  
Sbjct: 22  SMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADN-QTLDSYRNEIAY 79

Query: 94  MTKLSGH-PNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQ 152
           + KL  H   ++ L      + Y++++ME C   +L   L+K       E +  ++++++
Sbjct: 80  LNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLE 138

Query: 153 VVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFY 209
            V   H +G+VH DLKP N L+        +KL DFG+A  ++           VG+  Y
Sbjct: 139 AVHTIHQHGIVHSDLKPANFLI----VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNY 194

Query: 210 IAPEVLAG------------GYNQAADVWSAGVILYILLSGMPPFWGKTKS--KIFDAVR 255
           + PE +                +  +DVWS G ILY +  G  PF        K+     
Sbjct: 195 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH---A 251

Query: 256 AADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWM 300
             D     +  D      +D++   L+ DP  R++  E+LAH ++
Sbjct: 252 IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 296

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  277 bits (711), Expect = 4e-91
 Identities = 79/272 (29%), Positives = 132/272 (48%), Gaps = 22/272 (8%)

Query: 37  NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRS-----IKLEI 91
             S +Y     LG G FG +    DK   + +  K I K++++    +       + LEI
Sbjct: 21  EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEI 80

Query: 92  EIMTKLSGHPNVVDLKAVYEEEDYVHLLMEL-CAGGELFHRLEKYGRFSETEARVIFRHL 150
            I++++  H N++ +  ++E + +  L+ME   +G +LF  ++++ R  E  A  IFR L
Sbjct: 81  AILSRVE-HANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQL 139

Query: 151 MQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYI 210
           +  V Y     ++HRD+K ENI++A   +   IKL DFG A Y++ G+  +   G+  Y 
Sbjct: 140 VSAVGYLRLKDIIHRDIKDENIVIAEDFT---IKLIDFGSAAYLERGKLFYTFCGTIEYC 196

Query: 211 APEVLAG-GYN-QAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDH 268
           APEVL G  Y     ++WS GV LY L+    PF         +    A +  P      
Sbjct: 197 APEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE------LEETVEAAIHPPY----L 246

Query: 269 ISASARDLIMGMLRVDPSTRLTAAEVLAHSWM 300
           +S     L+ G+L+  P  R T  +++   W+
Sbjct: 247 VSKELMSLVSGLLQPVPERRTTLEKLVTDPWV 278

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  276 bits (708), Expect = 1e-90
 Identities = 68/291 (23%), Positives = 124/291 (42%), Gaps = 28/291 (9%)

Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
            Y + KQ+G G    + +  ++   ++ A K +  +     + + S + EI  + KL  H
Sbjct: 10  IYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADN-QTLDSYRNEIAYLNKLQQH 67

Query: 101 -PNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
              ++ L      + Y++++ME C   +L   L+K       E +  ++++++ V   H 
Sbjct: 68  SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126

Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLA 216
           +G+VH DLKP N L+        +KL DFG+A  ++           VG+  Y+ PE + 
Sbjct: 127 HGIVHSDLKPANFLI----VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 182

Query: 217 G------------GYNQAADVWSAGVILYILLSGMPPFWGKTKS--KIFDAVRAADLRFP 262
                          +  +DVWS G ILY +  G  PF        K+       D    
Sbjct: 183 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH---AIIDPNHE 239

Query: 263 SDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKPCKQ 313
            +  D      +D++   L+ DP  R++  E+LAH +++       +  K 
Sbjct: 240 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKG 290

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  275 bits (706), Expect = 2e-90
 Identities = 77/272 (28%), Positives = 125/272 (45%), Gaps = 20/272 (7%)

Query: 36  SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRS---IKLEIE 92
             L  +Y +G  LG G FG +           +A K + KDR+    ++ +   + +E+ 
Sbjct: 39  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 98

Query: 93  IMTKLS-GHPNVVDLKAVYEEEDYVHLLMELCAG-GELFHRLEKYGRFSETEARVIFRHL 150
           ++ K+S G   V+ L   +E  D   L++E      +LF  + + G   E  AR  F  +
Sbjct: 99  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 158

Query: 151 MQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYI 210
           ++ V +CH  GV+HRD+K ENIL+        +KL DFG    +K         G+  Y 
Sbjct: 159 LEAVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDT-VYTDFDGTRVYS 215

Query: 211 APEVLAG-GYN-QAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDH 268
            PE +    Y+ ++A VWS G++LY ++ G  PF    +      +    + F       
Sbjct: 216 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ----R 265

Query: 269 ISASARDLIMGMLRVDPSTRLTAAEVLAHSWM 300
           +S+  + LI   L + PS R T  E+  H WM
Sbjct: 266 VSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 297

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  271 bits (696), Expect = 2e-89
 Identities = 82/290 (28%), Positives = 138/290 (47%), Gaps = 37/290 (12%)

Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRS-------------- 86
           +Y L  ++G G +GV++   ++      A K ++K +L+                     
Sbjct: 14  QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73

Query: 87  ---------IKLEIEIMTKLSGHPNVVDLKAVYE--EEDYVHLLMELCAGGELFHRLEKY 135
                    +  EI I+ KL  HPNVV L  V +   ED+++++ EL   G +       
Sbjct: 74  IQPRGPIEQVYQEIAILKKLD-HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL- 131

Query: 136 GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGL-ATYI 194
              SE +AR  F+ L++ + Y H   ++HRD+KP N+L+        IK+ADFG+   + 
Sbjct: 132 KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV---GEDGHIKIADFGVSNEFK 188

Query: 195 KAGQNLHGTVGSPFYIAPEVLAG---GYN-QAADVWSAGVILYILLSGMPPFWGKTKSKI 250
            +   L  TVG+P ++APE L+     ++ +A DVW+ GV LY  + G  PF  +    +
Sbjct: 189 GSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCL 248

Query: 251 FDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWM 300
              +++  L FP      I+   +DLI  ML  +P +R+   E+  H W+
Sbjct: 249 HSKIKSQALEFPD--QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  274 bits (702), Expect = 5e-89
 Identities = 67/276 (24%), Positives = 120/276 (43%), Gaps = 24/276 (8%)

Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
            Y + KQ+G G    + +  ++   ++ A K +  +     + + S + EI  + KL  H
Sbjct: 57  IYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADN-QTLDSYRNEIAYLNKLQQH 114

Query: 101 -PNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
              ++ L      + Y++++ME C   +L   L+K       E +  ++++++ V   H 
Sbjct: 115 SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 173

Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLA 216
           +G+VH DLKP N L+        +KL DFG+A  ++           VG+  Y+ PE + 
Sbjct: 174 HGIVHSDLKPANFLI----VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIK 229

Query: 217 G------------GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSD 264
                          +  +DVWS G ILY +  G  PF       I       D     +
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-ISKLHAIIDPNHEIE 288

Query: 265 PWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWM 300
             D      +D++   L+ DP  R++  E+LAH ++
Sbjct: 289 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 324

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  281 bits (720), Expect = 1e-88
 Identities = 77/304 (25%), Positives = 126/304 (41%), Gaps = 33/304 (10%)

Query: 36  SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMT 95
           +     + + ++LG G FG +     + TGE +A K   ++   + ++     LEI+IM 
Sbjct: 10  TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMK 67

Query: 96  KLSGHPNVVDLKAVYEEEDYVH------LLMELCAGGELFHRLEKYGR---FSETEARVI 146
           KL+ HPNVV  + V +    +       L ME C GG+L   L ++       E   R +
Sbjct: 68  KLN-HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTL 126

Query: 147 FRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGS 206
              +   + Y H N ++HRDLKPENI+L         K+ D G A  +  G+     VG+
Sbjct: 127 LSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGT 186

Query: 207 PFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWG---------KTKSKIFDAVRA 256
             Y+APE+L    Y    D WS G + +  ++G  PF           K + K  + +  
Sbjct: 187 LQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV 246

Query: 257 AD-----LRFPSD--PWDHISASARDL----IMGMLRVDPSTRLTAAEVLAHSWMEECEQ 305
            D     ++F S     +H+S          +  ML      R T  +       +  + 
Sbjct: 247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDS 306

Query: 306 VAQK 309
           +   
Sbjct: 307 ILSL 310

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  270 bits (692), Expect = 2e-88
 Identities = 74/269 (27%), Positives = 115/269 (42%), Gaps = 13/269 (4%)

Query: 36  SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMT 95
           S     +    +LG G +G + +   K  G + A K          +  R +  E+    
Sbjct: 53  SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLA-EVGSHE 111

Query: 96  KLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYG-RFSETEARVIFRHLMQVV 154
           K+  HP  V L+  +EE   ++L  ELC G  L    E +G    E +     R  +  +
Sbjct: 112 KVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLAL 170

Query: 155 SYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEV 214
           ++ H  G+VH D+KP NI L         KL DFGL   +          G P Y+APE+
Sbjct: 171 AHLHSQGLVHLDVKPANIFL---GPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPEL 227

Query: 215 LAGGYNQAADVWSAGVILYILLSGMP-PFWGKTKSKIFDAVRAADLRFPSDPWDHISASA 273
           L G Y  AADV+S G+ +  +   M  P  G+   ++           P +    +S+  
Sbjct: 228 LQGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLR------QGYLPPEFTAGLSSEL 281

Query: 274 RDLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
           R +++ ML  DP  R TA  +LA   + +
Sbjct: 282 RSVLVMMLEPDPKLRATAEALLALPVLRQ 310

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  268 bits (687), Expect = 7e-88
 Identities = 80/271 (29%), Positives = 135/271 (49%), Gaps = 20/271 (7%)

Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRS-IKLEIEIMTKLSG 99
           +Y++G  LG G +G ++E  D  T    A K + K +L  + +  + +K EI+++ +   
Sbjct: 6   KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLL-RRLR 64

Query: 100 HPNVVDLKAVY--EEEDYVHLLMELCAGG--ELFHRLEKYGRFSETEARVIFRHLMQVVS 155
           H NV+ L  V   EE+  ++++ME C  G  E+   + +  RF   +A   F  L+  + 
Sbjct: 65  HKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE-KRFPVCQAHGYFCQLIDGLE 123

Query: 156 YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA---TYIKAGQNLHGTVGSPFYIAP 212
           Y H  G+VH+D+KP N+LL T  +   +K++  G+A       A      + GSP +  P
Sbjct: 124 YLHSQGIVHKDIKPGNLLLTTGGT---LKISALGVAEALHPFAADDTCRTSQGSPAFQPP 180

Query: 213 EVLAG--GYN-QAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHI 269
           E+  G   ++    D+WSAGV LY + +G+ PF G    K+F+ +       P       
Sbjct: 181 EIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIP----GDC 236

Query: 270 SASARDLIMGMLRVDPSTRLTAAEVLAHSWM 300
                DL+ GML  +P+ R +  ++  HSW 
Sbjct: 237 GPPLSDLLKGMLEYEPAKRFSIRQIRQHSWF 267

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  265 bits (678), Expect = 5e-86
 Identities = 68/341 (19%), Positives = 132/341 (38%), Gaps = 59/341 (17%)

Query: 4   NNSEDSSQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKF 63
           +  +  S  S     +  V      I          + Y + + L  G+F  I  C  + 
Sbjct: 5   SMKDILSNYSNLIYLNKYVKEKDKYI----------NDYRIIRTLNQGKFNKIILC--EK 52

Query: 64  TGEVLACKSIAKDRLVTVEDVRS--------------IKLEIEIMTKLSGHPNVVDLKAV 109
             +  A K   K  L    D                  K E++I+T +  +   +  + +
Sbjct: 53  DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK-NEYCLTCEGI 111

Query: 110 YEEEDYVHLLMELCAGGELFHRLEKYG--------RFSETEARVIFRHLMQVVSYCHG-N 160
               D V+++ E      +    E +                + I + ++   SY H   
Sbjct: 112 ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK 171

Query: 161 GVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG--- 217
            + HRD+KP NIL+     +  +KL+DFG + Y+   + + G+ G+  ++ PE  +    
Sbjct: 172 NICHRDVKPSNILM---DKNGRVKLSDFGESEYMVDKK-IKGSRGTYEFMPPEFFSNESS 227

Query: 218 GYNQAADVWSAGVILYILLSGMPPFWGK-TKSKIFDAVRAADLRFPSDP----------- 265
                 D+WS G+ LY++   + PF  K +  ++F+ +R  ++ +P D            
Sbjct: 228 YNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKK 287

Query: 266 ----WDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
                + +S    D +   LR +P+ R+T+ + L H W+ +
Sbjct: 288 STCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLAD 328

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  253 bits (648), Expect = 2e-81
 Identities = 46/312 (14%), Positives = 84/312 (26%), Gaps = 44/312 (14%)

Query: 33  TQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIE 92
           + +S    +  L + L  G   V+    D    E  A K        +  ++  +     
Sbjct: 55  SLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATF 114

Query: 93  IMTKL-----------------------SGHPNVVDLKAVYEEEDYVH--LLMELCAG-- 125
              +L                          P    L    ++    +  LLM   +   
Sbjct: 115 AAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDL 174

Query: 126 ----GELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSS 181
                 L       G        ++   L+++ +     G+VH    P+N+ +       
Sbjct: 175 ELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFI---MPDG 231

Query: 182 PIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGG---YNQAADVWSAGVILYILLSG 238
            + L D       K G     +     Y   E L      +  A + W  G+ +Y +   
Sbjct: 232 RLMLGDVSALW--KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289

Query: 239 MPPFWGKTKSKIFDAVRAADLRFPSDPWD-----HISASARDLIMGMLRVDPSTRLTAAE 293
             PF   T        R +     +D         +    + LI   L  D   RL   E
Sbjct: 290 FLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLE 349

Query: 294 VLAHSWMEECEQ 305
            +      + + 
Sbjct: 350 AMETPEFLQLQN 361

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  252 bits (646), Expect = 4e-81
 Identities = 64/267 (23%), Positives = 126/267 (47%), Gaps = 12/267 (4%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           ++YV  +++G G FG          G     K I   R+ + ++    + E+ ++  +  
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANMK- 81

Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKY--GRFSETEARVIFRHLMQVVSYC 157
           HPN+V  +  +EE   ++++M+ C GG+LF R+       F E +    F  +   + + 
Sbjct: 82  HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHV 141

Query: 158 HGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT-VGSPFYIAPEVLA 216
           H   ++HRD+K +NI L   +    ++L DFG+A  + +   L    +G+P+Y++PE+  
Sbjct: 142 HDRKILHRDIKSQNIFL---TKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICE 198

Query: 217 G-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARD 275
              YN  +D+W+ G +LY L +    F   +   +   + +    FP     H S   R 
Sbjct: 199 NKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGS--FPPVS-LHYSYDLRS 255

Query: 276 LIMGMLRVDPSTRLTAAEVLAHSWMEE 302
           L+  + + +P  R +   +L   ++ +
Sbjct: 256 LVSQLFKRNPRDRPSVNSILEKGFIAK 282

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  247 bits (634), Expect = 3e-80
 Identities = 74/276 (26%), Positives = 131/276 (47%), Gaps = 21/276 (7%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           + Y +   +G G +G  ++   K  G++L  K +    + T  + + +  E+ ++ +L  
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELK- 63

Query: 100 HPNVVDLKAVYEEE--DYVHLLMELCAGGELFHRLEKYGR----FSETEARVIFRHLMQV 153
           HPN+V       +     ++++ME C GG+L   + K  +      E     +   L   
Sbjct: 64  HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123

Query: 154 VSYCH-----GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT-VGSP 207
           +  CH     G+ V+HRDLKP N+ L        +KL DFGLA  +    +   T VG+P
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDFGLARILNHDTSFAKTFVGTP 180

Query: 208 FYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW 266
           +Y++PE +    YN+ +D+WS G +LY L + MPPF   ++ ++   +R    +F   P 
Sbjct: 181 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG--KFRRIP- 237

Query: 267 DHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
              S    ++I  ML +    R +  E+L +  + E
Sbjct: 238 YRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  246 bits (630), Expect = 1e-78
 Identities = 44/315 (13%), Positives = 88/315 (27%), Gaps = 58/315 (18%)

Query: 32  ATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEI 91
            +++       V G  LG        E +D+ TGE                 ++ +K E+
Sbjct: 65  ESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEV 124

Query: 92  EIM------------------------TKLSGHPNVVDLKAVYEEED--YVHLLMELCA- 124
             +                         K      ++ ++    +        L      
Sbjct: 125 LRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQS 184

Query: 125 -----GGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSS 179
                G  L      +          +   ++++++  H  G+VH  L+P +I+L     
Sbjct: 185 NLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL---DQ 241

Query: 180 SSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLA------------GGYNQAADVWS 227
              + L  F              +  S  +  PE+ A                 + D W+
Sbjct: 242 RGGVFLTGFEHL---VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWA 298

Query: 228 AGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPST 287
            G+++Y +     P          + +     R       +I    R L+ G LR     
Sbjct: 299 LGLVIYWIWCADLPITKDAALGGSEWI----FRSC----KNIPQPVRALLEGFLRYPKED 350

Query: 288 RLTAAEVLAHSWMEE 302
           RL   + +     E+
Sbjct: 351 RLLPLQAMETPEYEQ 365

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  241 bits (617), Expect = 3e-77
 Identities = 73/306 (23%), Positives = 134/306 (43%), Gaps = 18/306 (5%)

Query: 1   MDTNNSEDSSQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECS 60
           MD  +         QF     +    G         N    + + K++G GQF  +   +
Sbjct: 1   MDEQSQGMQGPPVPQFQPQKALRPDMG--------YNTLANFRIEKKIGRGQFSEVYRAA 52

Query: 61  DKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLM 120
               G  +A K +    L+  +       EI+++ +L+ HPNV+   A + E++ +++++
Sbjct: 53  CLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIEDNELNIVL 111

Query: 121 ELCAGGELFHRLEKYGR----FSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLAT 176
           EL   G+L   ++ + +      E      F  L   + + H   V+HRD+KP N+ +  
Sbjct: 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI-- 169

Query: 177 KSSSSPIKLADFGLATYIKAGQNLHGT-VGSPFYIAPEVLAG-GYNQAADVWSAGVILYI 234
            +++  +KL D GL  +  +      + VG+P+Y++PE +   GYN  +D+WS G +LY 
Sbjct: 170 -TATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYE 228

Query: 235 LLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEV 294
           + +   PF+G   +      +     +P  P DH S   R L+   +  DP  R     V
Sbjct: 229 MAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYV 288

Query: 295 LAHSWM 300
              +  
Sbjct: 289 YDVAKR 294

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  236 bits (604), Expect = 1e-75
 Identities = 63/289 (21%), Positives = 113/289 (39%), Gaps = 38/289 (13%)

Query: 36  SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMT 95
                 +   + +G G FG + +   +  G+    K +  +           + E++ + 
Sbjct: 7   KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALA 59

Query: 96  KLSGHPNVVDLKAVYEEED----------------YVHLLMELCAGGELFHRLEKY--GR 137
           KL  H N+V     ++  D                 + + ME C  G L   +EK    +
Sbjct: 60  KLD-HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK 118

Query: 138 FSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG 197
             +  A  +F  + + V Y H   +++RDLKP NI L     +  +K+ DFGL T +K  
Sbjct: 119 LDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFL---VDTKQVKIGDFGLVTSLKND 175

Query: 198 QNLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRA 256
                + G+  Y++PE ++   Y +  D+++ G+IL  LL           SK F  +R 
Sbjct: 176 GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA--FETSKFFTDLR- 232

Query: 257 ADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ 305
            D        D      + L+  +L   P  R   +E+L    + +   
Sbjct: 233 -DGIIS----DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  226 bits (579), Expect = 2e-71
 Identities = 64/283 (22%), Positives = 102/283 (36%), Gaps = 32/283 (11%)

Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
            Y+  ++LG G F  +        G   A K I        +D    + E ++  +L  H
Sbjct: 30  HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQ---QDREEAQREADMH-RLFNH 85

Query: 101 PNVVDLKAVYEEED----YVHLLMELCAGGELFHRLEKY----GRFSETEARVIFRHLMQ 152
           PN++ L A    E        LL+     G L++ +E+        +E +   +   + +
Sbjct: 86  PNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICR 145

Query: 153 VVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATY----------IKAGQNLHG 202
            +   H  G  HRDLKP NILL          L D G                  Q+   
Sbjct: 146 GLEAIHAKGYAHRDLKPTNILL---GDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAA 202

Query: 203 TVGSPFYIAPEVLAG----GYNQAADVWSAGVILYILLSGMPPFWGKT-KSKIFDAVRAA 257
              +  Y APE+ +       ++  DVWS G +LY ++ G  P+     K          
Sbjct: 203 QRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN 262

Query: 258 DLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWM 300
            L  P       S++   L+  M+ VDP  R     +L+    
Sbjct: 263 QLSIP--QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEA 303

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  225 bits (575), Expect = 5e-71
 Identities = 80/269 (29%), Positives = 131/269 (48%), Gaps = 24/269 (8%)

Query: 44  LGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNV 103
            GK LG G F  +    +  T    A K + K  ++    V  +  E ++M++L  HP  
Sbjct: 34  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFF 92

Query: 104 VDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS---YCHGN 160
           V L   +++++ ++  +     GEL   + K G F ET  R  F +  ++VS   Y HG 
Sbjct: 93  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTR--F-YTAEIVSALEYLHGK 149

Query: 161 GVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT---VGSPFYIAPEVLAG 217
           G++HRDLKPENILL   +    I++ DFG A  +            VG+  Y++PE+L  
Sbjct: 150 GIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 206

Query: 218 -GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDL 276
               +++D+W+ G I+Y L++G+PPF    +  IF  +   +  FP    +     ARDL
Sbjct: 207 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARDL 262

Query: 277 IMGMLRVDPSTRLT------AAEVLAHSW 299
           +  +L +D + RL          + AH +
Sbjct: 263 VEKLLVLDATKRLGCEEMEGYGPLKAHPF 291

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  221 bits (565), Expect = 1e-69
 Identities = 70/303 (23%), Positives = 120/303 (39%), Gaps = 40/303 (13%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
             +   + LG G FGV+ E  +K      A K I             +  E++ + KL  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLE- 61

Query: 100 HPNVVDLKAVYEEED------------YVHLLMELCAGGELFHRLEKYGRFSETEARVIF 147
           HP +V     + E++            Y+++ M+LC    L   +       E E  V  
Sbjct: 62  HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121

Query: 148 RHLMQVVS---YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT- 203
              +Q+     + H  G++HRDLKP NI     +    +K+ DFGL T +   +      
Sbjct: 122 HIFLQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVVKVGDFGLVTAMDQDEEEQTVL 178

Query: 204 ------------VGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKI 250
                       VG+  Y++PE + G  Y+   D++S G+IL+ LL   P      + + 
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL--YPFSTQMERVRT 236

Query: 251 FDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKP 310
              VR  +L+FP             ++  ML   P  R  A  ++ ++  E+ +   +  
Sbjct: 237 LTDVR--NLKFPPLF-TQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTV 293

Query: 311 CKQ 313
            +Q
Sbjct: 294 LRQ 296

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  218 bits (558), Expect = 9e-69
 Identities = 62/287 (21%), Positives = 117/287 (40%), Gaps = 32/287 (11%)

Query: 36  SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMT 95
           S  +  +   +++G G+FG + +C  +  G + A K   K    +V++  +++ E+    
Sbjct: 7   SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALR-EVYAHA 65

Query: 96  KLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGR----FSETEARVIFRHLM 151
            L  H +VV   + + E+D++ +  E C GG L   + +  R    F E E + +   + 
Sbjct: 66  VLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 125

Query: 152 QVVSYCHGNGVVHRDLKPENILL----------------ATKSSSSPIKLADFGLATYIK 195
           + + Y H   +VH D+KP NI +                   S+    K+ D G  T I 
Sbjct: 126 RGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 185

Query: 196 AGQNLHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDA 253
              +     G   ++A EVL     +   AD+++  + +       P          +  
Sbjct: 186 ---SPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP---RNGDQWHE 239

Query: 254 VRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWM 300
           +R      P  P   +S    +L+  M+  DP  R +A  ++ HS +
Sbjct: 240 IRQGR--LPRIP-QVLSQEFTELLKVMIHPDPERRPSAMALVKHSVL 283

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  217 bits (556), Expect = 1e-67
 Identities = 87/304 (28%), Positives = 148/304 (48%), Gaps = 19/304 (6%)

Query: 3   TNNSEDSSQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDK 62
                   +   +F    K   L      +   + L   +   K LG G FG +     K
Sbjct: 5   AAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQ-FDRIKTLGTGSFGRVMLVKHK 63

Query: 63  FTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMEL 122
            +G   A K + K ++V ++ +     E  I+  ++  P +V L+  +++   ++++ME 
Sbjct: 64  ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKLEFSFKDNSNLYMVMEY 122

Query: 123 CAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSP 182
            AGGE+F  L + GRFSE  AR     ++    Y H   +++RDLKPEN+L+        
Sbjct: 123 VAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGY 179

Query: 183 IKLADFGLATYIKAGQN-LHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMP 240
           I++ DFG A  +K     L GT   P  +APE++   GYN+A D W+ GV++Y + +G P
Sbjct: 180 IQVTDFGFAKRVKGRTWTLCGT---PEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 236

Query: 241 PFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRL-----TAAEVL 295
           PF+     +I++ + +  +RFPS    H S+  +DL+  +L+VD + R         ++ 
Sbjct: 237 PFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIK 292

Query: 296 AHSW 299
            H W
Sbjct: 293 NHKW 296

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  214 bits (547), Expect = 1e-66
 Identities = 83/289 (28%), Positives = 115/289 (39%), Gaps = 41/289 (14%)

Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
           R  + + L  G F  + E  D  +G   A K +  +     E  R+I  E+  M KLSGH
Sbjct: 29  RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGH 85

Query: 101 PNVVDL-------KAVYEEEDYVHLLMELCAGGELFHRLEKY---GRFSETEARVIFRHL 150
           PN+V         K   +      LL+     G+L   L+K    G  S      IF   
Sbjct: 86  PNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQT 145

Query: 151 MQVVSYCHGNG--VVHRDLKPENILLATKSSSSPIKLADFGLAT-------------YIK 195
            + V + H     ++HRDLK EN+LL   S+   IKL DFG AT                
Sbjct: 146 CRAVQHMHRQKPPIIHRDLKVENLLL---SNQGTIKLCDFGSATTISHYPDYSWSAQRRA 202

Query: 196 AGQNLHGTVGSPFYIAPEV--LAGG--YNQAADVWSAGVILYILLSGMPPFWGKTKSKIF 251
             +       +P Y  PE+  L       +  D+W+ G ILY+L     PF    K +I 
Sbjct: 203 LVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIV 262

Query: 252 DAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWM 300
           +         P  P D        LI  ML+V+P  RL+ AEV+     
Sbjct: 263 NG----KYSIP--PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQE 305

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  213 bits (545), Expect = 2e-66
 Identities = 83/273 (30%), Positives = 141/273 (51%), Gaps = 25/273 (9%)

Query: 37  NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTK 96
           +L D + + + LG G FG +     +  G   A K + K+ +V ++ V     E  +++ 
Sbjct: 4   SLQD-FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 62

Query: 97  LSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS- 155
           ++ HP ++ +   +++   + ++M+   GGELF  L K  RF    A+  F +  +V   
Sbjct: 63  VT-HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAK--F-YAAEVCLA 118

Query: 156 --YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTV-GSPFYIAP 212
             Y H   +++RDLKPENILL     +  IK+ DFG A   K   ++  T+ G+P YIAP
Sbjct: 119 LEYLHSKDIIYRDLKPENILL---DKNGHIKITDFGFA---KYVPDVTYTLCGTPDYIAP 172

Query: 213 EVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISA 271
           EV++   YN++ D WS G+++Y +L+G  PF+     K ++ +  A+LRFP       + 
Sbjct: 173 EVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP----FFNE 228

Query: 272 SARDLIMGMLRVDPSTRL-----TAAEVLAHSW 299
             +DL+  ++  D S RL        +V  H W
Sbjct: 229 DVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPW 261

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  212 bits (542), Expect = 3e-65
 Identities = 74/283 (26%), Positives = 134/283 (47%), Gaps = 19/283 (6%)

Query: 37  NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTK 96
           N     +L + +G G FG +       T ++ A K + K + V   +VR++  E++IM  
Sbjct: 13  NFDHFEIL-RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQG 71

Query: 97  LSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSY 156
           L  HP +V+L   +++E+ + ++++L  GG+L + L++   F E   ++    L+  + Y
Sbjct: 72  LE-HPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDY 130

Query: 157 CHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLA 216
                ++HRD+KP+NILL        + + DF +A  +     +    G+  Y+APE+ +
Sbjct: 131 LQNQRIIHRDMKPDNILL---DEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFS 187

Query: 217 ----GGYNQAADVWSAGVILYILLSGMPPFWGKT---KSKIFDAVRAADLRFPSDPWDHI 269
                GY+ A D WS GV  Y LL G  P+  ++     +I        + +PS      
Sbjct: 188 SRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPS----AW 243

Query: 270 SASARDLIMGMLRVDPSTRL-TAAEVLAHSWMEEC--EQVAQK 309
           S     L+  +L  +P  R    ++V    +M +   + V QK
Sbjct: 244 SQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWDAVFQK 286

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  212 bits (541), Expect = 6e-65
 Identities = 48/315 (15%), Positives = 87/315 (27%), Gaps = 54/315 (17%)

Query: 31  DATQISNLSDRYVL---GKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSI 87
                S L +R      G  LG        E +D+ TGE                 ++ +
Sbjct: 66  PFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQM 125

Query: 88  KLEIEIMTKL------------------------SGHPNVVDLKAVYEEEDYVH--LLME 121
           K E+  +  L                             ++ ++    +   +    L  
Sbjct: 126 KEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYP 185

Query: 122 LCAG------GELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLA 175
                       L      +          +   ++++++  H  G+VH  L+P +I+L 
Sbjct: 186 RMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL- 244

Query: 176 TKSSSSPIKLADFGLATYIKAGQNLHGT--VGSPFYIAPEVLAGG------YNQAADVWS 227
                  + L  F       A            P   A  +L  G         A D W+
Sbjct: 245 --DQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWT 302

Query: 228 AGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPST 287
            G+ +Y +     P          + +      F S    +I    R L+ G LR     
Sbjct: 303 LGLAIYWIWCADLPNTDDAALGGSEWI------FRSCK--NIPQPVRALLEGFLRYPKED 354

Query: 288 RLTAAEVLAHSWMEE 302
           RL   + +     E+
Sbjct: 355 RLLPLQAMETPEYEQ 369

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  204 bits (521), Expect = 8e-63
 Identities = 92/268 (34%), Positives = 144/268 (53%), Gaps = 23/268 (8%)

Query: 43  VLGKQLGWGQFG-VI--RECSDKFTGEVLACKSIAKDRLVT-VEDVRSIKLEIEIMTKLS 98
           VLGK    G +G V   R+ +   TG++ A K + K  +V   +D    K E  I+ ++ 
Sbjct: 24  VLGK----GGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK 79

Query: 99  GHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCH 158
            HP +VDL   ++    ++L++E  +GGELF +LE+ G F E  A      +   + + H
Sbjct: 80  -HPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLH 138

Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLA-TYIKAGQNLHGTVGSPFYIAPEVLAG 217
             G+++RDLKPENI+L   +    +KL DFGL    I  G   H   G+  Y+APE+L  
Sbjct: 139 QKGIIYRDLKPENIML---NHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMR 195

Query: 218 -GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDL 276
            G+N+A D WS G ++Y +L+G PPF G+ + K  D +    L  P     +++  ARDL
Sbjct: 196 SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPP----YLTQEARDL 251

Query: 277 IMGMLRVDPSTRL-----TAAEVLAHSW 299
           +  +L+ + ++RL      A EV AH +
Sbjct: 252 LKKLLKRNAASRLGAGPGDAGEVQAHPF 279

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  204 bits (520), Expect = 2e-62
 Identities = 83/281 (29%), Positives = 141/281 (50%), Gaps = 41/281 (14%)

Query: 43  VLGKQLGWGQFG-VI--RECSDKFTGEVLACKSIAKDRLVT-VEDVRSIKLEIEIMTKLS 98
           VLG     G +G V   R+ S   TG++ A K + K  +V   +     + E +++  + 
Sbjct: 61  VLGT----GAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR 116

Query: 99  GHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS--- 155
             P +V L   ++ E  +HL+++   GGELF  L +  RF+E E +    ++ ++V    
Sbjct: 117 QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQ--I-YVGEIVLALE 173

Query: 156 YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTV-----GSPFYI 210
           + H  G+++RD+K ENILL    S+  + L DFGL+   K              G+  Y+
Sbjct: 174 HLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLS---KEFVADETERAYDFCGTIEYM 227

Query: 211 APEVLAG---GYNQAADVWSAGVILYILLSGMPPFWG----KTKSKIFDAVRAADLRFPS 263
           AP+++ G   G+++A D WS GV++Y LL+G  PF       ++++I   +  ++  +P 
Sbjct: 228 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ 287

Query: 264 DPWDHISASARDLIMGMLRVDPSTRL-----TAAEVLAHSW 299
                +SA A+DLI  +L  DP  RL      A E+  H +
Sbjct: 288 ----EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  202 bits (516), Expect = 5e-62
 Identities = 86/270 (31%), Positives = 143/270 (52%), Gaps = 29/270 (10%)

Query: 43  VLGKQLGWGQFG-VI--RECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           VLG+    G FG V   ++ S     ++ A K + K  L   + VR  K+E +I+ +++ 
Sbjct: 31  VLGQ----GSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVR-TKMERDILVEVN- 84

Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS---Y 156
           HP +V L   ++ E  ++L+++   GG+LF RL K   F+E + +  F +L ++     +
Sbjct: 85  HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVK--F-YLAELALALDH 141

Query: 157 CHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA-TYIKAGQNLHGTVGSPFYIAPEVL 215
            H  G+++RDLKPENILL        IKL DFGL+   I   +  +   G+  Y+APEV+
Sbjct: 142 LHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV 198

Query: 216 AG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASAR 274
              G+ Q+AD WS GV+++ +L+G  PF GK + +    +  A L  P      +S  A+
Sbjct: 199 NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQ----FLSPEAQ 254

Query: 275 DLIMGMLRVDPSTRL-----TAAEVLAHSW 299
            L+  + + +P+ RL        E+  HS+
Sbjct: 255 SLLRMLFKRNPANRLGAGPDGVEEIKRHSF 284

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  202 bits (516), Expect = 9e-62
 Identities = 79/265 (29%), Positives = 128/265 (48%), Gaps = 19/265 (7%)

Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
           VLGK    G FG +     K TG++ A K + KD ++  +DV     E  I++    HP 
Sbjct: 30  VLGK----GSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPF 85

Query: 103 VVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGV 162
           +  L   ++  D +  +ME   GG+L   ++K  RF E  AR     ++  + + H  G+
Sbjct: 86  LTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGI 145

Query: 163 VHRDLKPENILLATKSSSSPIKLADFGLA-TYIKAGQNLHGTVGSPFYIAPEVLAG-GYN 220
           ++RDLK +N+LL         KLADFG+    I  G       G+P YIAPE+L    Y 
Sbjct: 146 IYRDLKLDNVLL---DHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYG 202

Query: 221 QAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGM 280
            A D W+ GV+LY +L G  PF  + +  +F+A+   ++ +P+     +   A  ++   
Sbjct: 203 PAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT----WLHEDATGILKSF 258

Query: 281 LRVDPSTRL------TAAEVLAHSW 299
           +  +P+ RL          +L H +
Sbjct: 259 MTKNPTMRLGSLTQGGEHAILRHPF 283

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  202 bits (516), Expect = 9e-62
 Identities = 75/264 (28%), Positives = 133/264 (50%), Gaps = 18/264 (6%)

Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
           VLGK    G FG +     K T E+ A K + KD ++  +DV    +E  ++      P 
Sbjct: 27  VLGK----GSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPF 82

Query: 103 VVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGV 162
           +  L + ++  D ++ +ME   GG+L + +++ GRF E  A      +   + +    G+
Sbjct: 83  LTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGI 142

Query: 163 VHRDLKPENILLATKSSSSPIKLADFGLA-TYIKAGQNLHGTVGSPFYIAPEVLAG-GYN 220
           ++RDLK +N++L    S   IK+ADFG+    I  G       G+P YIAPE++A   Y 
Sbjct: 143 IYRDLKLDNVML---DSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYG 199

Query: 221 QAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGM 280
           ++ D W+ GV+LY +L+G  PF G+ + ++F ++   ++ +P      +S  A  +  G+
Sbjct: 200 KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVAICKGL 255

Query: 281 LRVDPSTRL-----TAAEVLAHSW 299
           +   P  RL        ++  H++
Sbjct: 256 MTKHPGKRLGCGPEGERDIKEHAF 279

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  200 bits (511), Expect = 1e-61
 Identities = 71/278 (25%), Positives = 122/278 (43%), Gaps = 24/278 (8%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           D       LG G +G++    D      +A K I           + +  EI +   L  
Sbjct: 22  DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEI---PERDSRYSQPLHEEIALHKHLK- 77

Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLE-KYGRFSETEA--RVIFRHLMQVVSY 156
           H N+V     + E  ++ + ME   GG L   L  K+G   + E       + +++ + Y
Sbjct: 78  HKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKY 137

Query: 157 CHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT-VGSPFYIAPEVL 215
            H N +VHRD+K +N+L+ T S    +K++DFG +  +        T  G+  Y+APE++
Sbjct: 138 LHDNQIVHRDIKGDNVLINTYSGV--LKISDFGTSKRLAGINPCTETFTGTLQYMAPEII 195

Query: 216 AG---GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRA-----ADLRFPSDPWD 267
                GY +AAD+WS G  +  + +G PPF      ++ +   A          P  P +
Sbjct: 196 DKGPRGYGKAADIWSLGCTIIEMATGKPPF-----YELGEPQAAMFKVGMFKVHPEIP-E 249

Query: 268 HISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ 305
            +SA A+  I+     DP  R  A ++L   +++   +
Sbjct: 250 SMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSK 287

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  202 bits (516), Expect = 2e-61
 Identities = 83/266 (31%), Positives = 133/266 (50%), Gaps = 23/266 (8%)

Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
           V+GK    G FG +     K      A K + K  ++  ++ + I  E  ++ K   HP 
Sbjct: 45  VIGK----GSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPF 100

Query: 103 VVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGV 162
           +V L   ++  D ++ +++   GGELF+ L++   F E  AR     +   + Y H   +
Sbjct: 101 LVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNI 160

Query: 163 VHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT----VGSPFYIAPEVLAG- 217
           V+RDLKPENILL    S   I L DFGL    K     + T     G+P Y+APEVL   
Sbjct: 161 VYRDLKPENILL---DSQGHIVLTDFGLC---KENIEHNSTTSTFCGTPEYLAPEVLHKQ 214

Query: 218 GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLI 277
            Y++  D W  G +LY +L G+PPF+ +  ++++D +    L+       +I+ SAR L+
Sbjct: 215 PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKP----NITNSARHLL 270

Query: 278 MGMLRVDPSTRL----TAAEVLAHSW 299
            G+L+ D + RL       E+ +H +
Sbjct: 271 EGLLQKDRTKRLGAKDDFMEIKSHVF 296

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  200 bits (512), Expect = 3e-61
 Identities = 74/260 (28%), Positives = 132/260 (50%), Gaps = 14/260 (5%)

Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
           +LGK    G FG +     K T +  A K++ KD ++  +DV    +E  +++    HP 
Sbjct: 24  MLGK----GSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPF 79

Query: 103 VVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGV 162
           +  +   ++ ++ +  +ME   GG+L + ++   +F  + A      ++  + + H  G+
Sbjct: 80  LTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGI 139

Query: 163 VHRDLKPENILLATKSSSSPIKLADFGLA-TYIKAGQNLHGTVGSPFYIAPEVLAG-GYN 220
           V+RDLK +NILL        IK+ADFG+    +      +   G+P YIAPE+L G  YN
Sbjct: 140 VYRDLKLDNILL---DKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYN 196

Query: 221 QAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGM 280
            + D WS GV+LY +L G  PF G+ + ++F ++R  +  +P      +   A+DL++ +
Sbjct: 197 HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR----WLEKEAKDLLVKL 252

Query: 281 LRVDPSTRLTAA-EVLAHSW 299
              +P  RL    ++  H  
Sbjct: 253 FVREPEKRLGVRGDIRQHPL 272

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  206 bits (525), Expect = 8e-61
 Identities = 83/269 (30%), Positives = 130/269 (48%), Gaps = 24/269 (8%)

Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
           VLGK    G FG +  C  + TG++ ACK + K R+   +       E +I+ K++    
Sbjct: 191 VLGK----GGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN-SRF 245

Query: 103 VVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGR--FSETEARVIFRHLMQVVSYCHGN 160
           VV L   YE +D + L++ L  GG+L   +   G+  F E  A      +   +   H  
Sbjct: 246 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE 305

Query: 161 GVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG-GY 219
            +V+RDLKPENILL        I+++D GLA ++  GQ + G VG+  Y+APEV+    Y
Sbjct: 306 RIVYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERY 362

Query: 220 NQAADVWSAGVILYILLSGMPPFWGK----TKSKIFDAVRAADLRFPSDPWDHISASARD 275
             + D W+ G +LY +++G  PF  +     + ++   V+     +     +  S  AR 
Sbjct: 363 TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS----ERFSPQARS 418

Query: 276 LIMGMLRVDPSTRL-----TAAEVLAHSW 299
           L   +L  DP+ RL     +A EV  H  
Sbjct: 419 LCSQLLCKDPAERLGCRGGSAREVKEHPL 447

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  200 bits (509), Expect = 1e-60
 Identities = 42/299 (14%), Positives = 90/299 (30%), Gaps = 34/299 (11%)

Query: 33  TQISNLSDRYVLGKQLGWGQFGVI-----RECSDKFTGEVLACKSIAKDRLVTVEDVRSI 87
           T+    S    +   LG G F  +      + +D    +    K           +    
Sbjct: 58  TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIG 114

Query: 88  KLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGR-----FSETE 142
              +E +         +   + +  ++   L+ EL + G L + +  Y         +  
Sbjct: 115 TQLMERLKPSM-QHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGL 173

Query: 143 ARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSP--------IKLADFGLATYI 194
                  ++ ++   H   ++H D+KP+N +L                + L D G +  +
Sbjct: 174 VISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDM 233

Query: 195 KA---GQNLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKI 250
           K    G        +  +   E+L+   +N   D +     +Y +L G          + 
Sbjct: 234 KLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC 293

Query: 251 FDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQK 309
                   L    D W+       +    ML +     L + ++L     +  +Q    
Sbjct: 294 KPEGLFRRL-PHLDMWN-------EFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTN 344

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  207 bits (528), Expect = 2e-60
 Identities = 78/269 (28%), Positives = 128/269 (47%), Gaps = 24/269 (8%)

Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG--H 100
           ++G+    G FG +  C    TG++ A K + K R+   +       E  +++ +S    
Sbjct: 196 IIGR----GGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 251

Query: 101 PNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGN 160
           P +V +   +   D +  +++L  GG+L + L ++G FSE + R     ++  + + H  
Sbjct: 252 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR 311

Query: 161 GVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG--G 218
            VV+RDLKP NILL        ++++D GLA      +  H +VG+  Y+APEVL     
Sbjct: 312 FVVYRDLKPANILLDEHGH---VRISDLGLACDFSKKKP-HASVGTHGYMAPEVLQKGVA 367

Query: 219 YNQAADVWSAGVILYILLSGMPPFWG---KTKSKIFDAVRAADLRFPSDPWDHISASARD 275
           Y+ +AD +S G +L+ LL G  PF     K K +I        +  P    D  S   R 
Sbjct: 368 YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP----DSFSPELRS 423

Query: 276 LIMGMLRVDPSTRL-----TAAEVLAHSW 299
           L+ G+L+ D + RL      A EV    +
Sbjct: 424 LLEGLLQRDVNRRLGCLGRGAQEVKESPF 452

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  198 bits (505), Expect = 3e-60
 Identities = 84/264 (31%), Positives = 133/264 (50%), Gaps = 19/264 (7%)

Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
           +LGK    G FG +    +K TG   A K + K+ ++  ++V     E  ++     HP 
Sbjct: 12  LLGK----GTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPF 66

Query: 103 VVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGV 162
           +  LK  ++  D +  +ME   GGELF  L +   F+E  AR     ++  + Y H   V
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDV 126

Query: 163 VHRDLKPENILLATKSSSSPIKLADFGLA-TYIKAGQNLHGTVGSPFYIAPEVLAG-GYN 220
           V+RD+K EN++L        IK+ DFGL    I  G  +    G+P Y+APEVL    Y 
Sbjct: 127 VYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYG 183

Query: 221 QAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGM 280
           +A D W  GV++Y ++ G  PF+ +   ++F+ +   ++RFP      +S  A+ L+ G+
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGL 239

Query: 281 LRVDPSTRL-----TAAEVLAHSW 299
           L+ DP  RL      A EV+ H +
Sbjct: 240 LKKDPKQRLGGGPSDAKEVMEHRF 263

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  198 bits (504), Expect = 4e-60
 Identities = 68/320 (21%), Positives = 120/320 (37%), Gaps = 33/320 (10%)

Query: 4   NNSEDSSQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKF 63
           + S    +L  +  ++  V           +            ++G G FG +    DK 
Sbjct: 22  SGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQ 81

Query: 64  TGEVLACKSIAKDRLVTVEDVRSIKL-EIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMEL 122
           TG   A K +          +   ++ E+     LS  P +V L     E  +V++ MEL
Sbjct: 82  TGFQCAVKKV---------RLEVFRVEELVACAGLS-SPRIVPLYGAVREGPWVNIFMEL 131

Query: 123 CAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSP 182
             GG L   +++ G   E  A       ++ + Y H   ++H D+K +N+LL++  S   
Sbjct: 132 LEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSR-- 189

Query: 183 IKLADFGLATYIKAGQNLHGT------VGSPFYIAPEVLAG-GYNQAADVWSAGVILYIL 235
             L DFG A  ++               G+  ++APEV+ G   +   D+WS+  ++  +
Sbjct: 190 AALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHM 249

Query: 236 LSGMPPFWGKTKSKIFDAVRAADLRFPSDPW------DHISASARDLIMGMLRVDPSTRL 289
           L+G  P+        +       L+  S+P          +      I   LR +P  R 
Sbjct: 250 LNGCHPWTQ------YFRGPLC-LKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRA 302

Query: 290 TAAEVLAHSWMEECEQVAQK 309
           +A E+         E    K
Sbjct: 303 SAMELRRKVGKALQEVGGLK 322

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  197 bits (503), Expect = 4e-59
 Identities = 77/273 (28%), Positives = 125/273 (45%), Gaps = 26/273 (9%)

Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
           V+G+    G F  +     K TG+V A K + K  ++   +V   + E +++        
Sbjct: 68  VIGR----GAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGD-RRW 122

Query: 103 VVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYG-RFSETEARVIFRHLMQVVSYCHGNG 161
           +  L   +++E+Y++L+ME   GG+L   L K+G R     AR     ++  +   H  G
Sbjct: 123 ITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG 182

Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT--VGSPFYIAPEVL---- 215
            VHRD+KP+NILL        I+LADFG    ++A   +     VG+P Y++PE+L    
Sbjct: 183 YVHRDIKPDNILL---DRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVG 239

Query: 216 ----AGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAV--RAADLRFPSDPWDHI 269
                G Y    D W+ GV  Y +  G  PF+  + ++ +  +      L  P    + +
Sbjct: 240 GGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVD-EGV 298

Query: 270 SASARDLIMGMLRVDPSTRLT---AAEVLAHSW 299
              ARD I  +L   P TRL    A +   H +
Sbjct: 299 PEEARDFIQRLLC-PPETRLGRGGAGDFRTHPF 330

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  197 bits (502), Expect = 4e-59
 Identities = 86/269 (31%), Positives = 128/269 (47%), Gaps = 26/269 (9%)

Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           K +G G FG ++    K T +V A K ++K  ++   D      E +IM   +  P VV 
Sbjct: 75  KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQ 133

Query: 106 LKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS---YCHGNGV 162
           L   ++++ Y++++ME   GG+L + +  Y    E  AR  F +  +VV      H  G 
Sbjct: 134 LFYAFQDDRYLYMVMEYMPGGDLVNLMSNY-DVPEKWAR--F-YTAEVVLALDAIHSMGF 189

Query: 163 VHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT--VGSPFYIAPEVL----- 215
           +HRD+KP+N+LL     S  +KLADFG    +     +     VG+P YI+PEVL     
Sbjct: 190 IHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGG 246

Query: 216 AGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAA--DLRFPSDPWDHISASA 273
            G Y +  D WS GV LY +L G  PF+  +    +  +      L FP D    IS  A
Sbjct: 247 DGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDND--ISKEA 304

Query: 274 RDLIMGMLRVDPSTRLT---AAEVLAHSW 299
           ++LI   L  D   RL      E+  H +
Sbjct: 305 KNLICAFLT-DREVRLGRNGVEEIKRHLF 332

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  195 bits (498), Expect = 4e-59
 Identities = 71/274 (25%), Positives = 128/274 (46%), Gaps = 28/274 (10%)

Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
           V+G+    G +  +     K T  + A K + K+ +   ED+  ++ E  +  + S HP 
Sbjct: 16  VIGR----GSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPF 71

Query: 103 VVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGV 162
           +V L + ++ E  +  ++E   GG+L   +++  +  E  AR     +   ++Y H  G+
Sbjct: 72  LVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGI 131

Query: 163 VHRDLKPENILLATKSSSSPIKLADFGLA-TYIKAGQNLHGTVGSPFYIAPEVLAG-GYN 220
           ++RDLK +N+LL    S   IKL D+G+    ++ G       G+P YIAPE+L G  Y 
Sbjct: 132 IYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYG 188

Query: 221 QAADVWSAGVILYILLSGMPPFW---------GKTKSKIFDAVRAADLRFPSDPWDHISA 271
            + D W+ GV+++ +++G  PF            T+  +F  +    +R P      +S 
Sbjct: 189 FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----SLSV 244

Query: 272 SARDLIMGMLRVDPSTRL------TAAEVLAHSW 299
            A  ++   L  DP  RL        A++  H +
Sbjct: 245 KAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 278

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  200 bits (509), Expect = 8e-59
 Identities = 75/272 (27%), Positives = 132/272 (48%), Gaps = 27/272 (9%)

Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
           VLG+    G FG +  C  K TG++ ACK + K RL   +  +   +E +I+ K+     
Sbjct: 192 VLGR----GGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH-SRF 246

Query: 103 VVDLKAVYEEEDYVHLLMELCAGGELFHRL----EKYGRFSETEARVIFRHLMQVVSYCH 158
           +V L   +E +  + L+M +  GG++ + +    E    F E  A      ++  + + H
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306

Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNL-HGTVGSPFYIAPEVLAG 217
              +++RDLKPEN+LL        ++++D GLA  +KAGQ    G  G+P ++APE+L G
Sbjct: 307 QRNIIYRDLKPENVLL---DDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG 363

Query: 218 -GYNQAADVWSAGVILYILLSGMPPFWGK----TKSKIFDAVRAADLRFPSDPWDHISAS 272
             Y+ + D ++ GV LY +++   PF  +       ++   V    + +P    D  S +
Sbjct: 364 EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP----DKFSPA 419

Query: 273 ARDLIMGMLRVDPSTRL-----TAAEVLAHSW 299
           ++D    +L+ DP  RL     +   +  H  
Sbjct: 420 SKDFCEALLQKDPEKRLGFRDGSCDGLRTHPL 451

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  194 bits (495), Expect = 3e-58
 Identities = 70/274 (25%), Positives = 128/274 (46%), Gaps = 28/274 (10%)

Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
           V+G+    G +  +     K T  + A + + K+ +   ED+  ++ E  +  + S HP 
Sbjct: 59  VIGR----GSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPF 114

Query: 103 VVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGV 162
           +V L + ++ E  +  ++E   GG+L   +++  +  E  AR     +   ++Y H  G+
Sbjct: 115 LVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGI 174

Query: 163 VHRDLKPENILLATKSSSSPIKLADFGLA-TYIKAGQNLHGTVGSPFYIAPEVLAG-GYN 220
           ++RDLK +N+LL    S   IKL D+G+    ++ G       G+P YIAPE+L G  Y 
Sbjct: 175 IYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYG 231

Query: 221 QAADVWSAGVILYILLSGMPPFW---------GKTKSKIFDAVRAADLRFPSDPWDHISA 271
            + D W+ GV+++ +++G  PF            T+  +F  +    +R P      +S 
Sbjct: 232 FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----SLSV 287

Query: 272 SARDLIMGMLRVDPSTRL------TAAEVLAHSW 299
            A  ++   L  DP  RL        A++  H +
Sbjct: 288 KAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 321

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  200 bits (510), Expect = 4e-58
 Identities = 74/267 (27%), Positives = 134/267 (50%), Gaps = 24/267 (8%)

Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
           VLGK    G FG +     K T E+ A K + KD ++  +DV    +E  ++      P 
Sbjct: 348 VLGK----GSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPF 403

Query: 103 VVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGV 162
           +  L + ++  D ++ +ME   GG+L + +++ GRF E  A      +   + +    G+
Sbjct: 404 LTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGI 463

Query: 163 VHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTV----GSPFYIAPEVLAG- 217
           ++RDLK +N++L ++     IK+ADFG+    K       T     G+P YIAPE++A  
Sbjct: 464 IYRDLKLDNVMLDSEGH---IKIADFGMC---KENIWDGVTTKTFCGTPDYIAPEIIAYQ 517

Query: 218 GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLI 277
            Y ++ D W+ GV+LY +L+G  PF G+ + ++F ++   ++ +P      +S  A  + 
Sbjct: 518 PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVAIC 573

Query: 278 MGMLRVDPSTRL-----TAAEVLAHSW 299
            G++   P  RL        ++  H++
Sbjct: 574 KGLMTKHPGKRLGCGPEGERDIKEHAF 600

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  195 bits (497), Expect = 5e-58
 Identities = 88/265 (33%), Positives = 134/265 (50%), Gaps = 20/265 (7%)

Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
           +LGK    G FG +    +K TG   A K + K+ +V  ++V     E  ++   S HP 
Sbjct: 155 LLGK----GTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPF 209

Query: 103 VVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG-NG 161
           +  LK  ++  D +  +ME   GGELF  L +   FSE  AR     ++  + Y H    
Sbjct: 210 LTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN 269

Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLA-TYIKAGQNLHGTVGSPFYIAPEVLAG-GY 219
           VV+RDLK EN++L        IK+ DFGL    IK G  +    G+P Y+APEVL    Y
Sbjct: 270 VVYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDY 326

Query: 220 NQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMG 279
            +A D W  GV++Y ++ G  PF+ +   K+F+ +   ++RFP      +   A+ L+ G
Sbjct: 327 GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLGPEAKSLLSG 382

Query: 280 MLRVDPSTRL-----TAAEVLAHSW 299
           +L+ DP  RL      A E++ H +
Sbjct: 383 LLKKDPKQRLGGGSEDAKEIMQHRF 407

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  189 bits (483), Expect = 1e-57
 Identities = 62/270 (22%), Positives = 130/270 (48%), Gaps = 15/270 (5%)

Query: 41  RYV-LGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           R++    ++G G F  + +  D  T   +A   + +DR +T  + +  K E E++  L  
Sbjct: 26  RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCEL-QDRKLTKSERQRFKEEAEMLKGLQ- 83

Query: 100 HPNVVDLKAVY----EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS 155
           HPN+V     +    + +  + L+ EL   G L   L+++        R   R +++ + 
Sbjct: 84  HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQ 143

Query: 156 YCHGNG--VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPE 213
           + H     ++HRDLK +NI +   + S  +K+ D GLAT +K        +G+P ++APE
Sbjct: 144 FLHTRTPPIIHRDLKCDNIFITGPTGS--VKIGDLGLAT-LKRASFAKAVIGTPEFMAPE 200

Query: 214 VLAGGYNQAADVWSAGVILYILLSGMPPFWG-KTKSKIFDAVRAADLRFPSDPWDHISAS 272
           +    Y+++ DV++ G+ +  + +   P+   +  ++I+  V +     P+         
Sbjct: 201 MYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK--PASFDKVAIPE 258

Query: 273 ARDLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
            +++I G +R +   R +  ++L H++ +E
Sbjct: 259 VKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  194 bits (494), Expect = 1e-57
 Identities = 69/267 (25%), Positives = 121/267 (45%), Gaps = 18/267 (6%)

Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD 105
           K +G G FG +     K   +V A K + K  ++   +    + E +++        +  
Sbjct: 80  KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGD-SKWITT 138

Query: 106 LKAVYEEEDYVHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVH 164
           L   +++++ ++L+M+   GG+L   L K+  R  E  AR     ++  +   H    VH
Sbjct: 139 LHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVH 198

Query: 165 RDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT--VGSPFYIAPEVL------A 216
           RD+KP+NIL+     +  I+LADFG    +     +  +  VG+P YI+PE+L       
Sbjct: 199 RDIKPDNILM---DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGK 255

Query: 217 GGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW-DHISASARD 275
           G Y    D WS GV +Y +L G  PF+ ++  + +  +     RF        +S +A+D
Sbjct: 256 GRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKD 315

Query: 276 LIMGMLRVDPSTRLT---AAEVLAHSW 299
           LI  ++      RL      +   H +
Sbjct: 316 LIRRLIC-SREHRLGQNGIEDFKKHPF 341

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  173 bits (439), Expect = 9e-51
 Identities = 57/229 (24%), Positives = 96/229 (41%), Gaps = 26/229 (11%)

Query: 90  EIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRH 149
           +I  M   S   N V        + Y+++ M+LC    L   + +     + E  V    
Sbjct: 111 KIRRMDPFS-TKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHI 169

Query: 150 LMQVVS---YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIK----------- 195
            +Q+     + H  G++HRDLKP NI     +    +K+ DFGL T +            
Sbjct: 170 FIQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVVKVGDFGLVTAMDQDEEEQTVLTP 226

Query: 196 --AGQNLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFD 252
             A     G VG+  Y++PE + G  Y+   D++S G+IL+ LL          + +I  
Sbjct: 227 MPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL--YSFSTQMERVRIIT 284

Query: 253 AVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWME 301
            VR  +L+FP             ++  ML   P+ R  A +++ ++  E
Sbjct: 285 DVR--NLKFPLLF-TQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFE 330

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  172 bits (438), Expect = 1e-50
 Identities = 86/313 (27%), Positives = 143/313 (45%), Gaps = 59/313 (18%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKL-EIEIMTKLS 98
           ++Y    ++G G +GV+ +C ++ TG+++A K   +        ++ I L EI ++ +L 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE--DDPVIKKIALREIRMLKQLK 60

Query: 99  GHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGR-FSETEARVIFRHLMQVVSYC 157
            HPN+V+L  V+  +  +HL+ E C    + H L++Y R   E   + I    +Q V++C
Sbjct: 61  -HPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFC 118

Query: 158 HGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF--------- 208
           H +  +HRD+KPENIL+   +  S IKL DFG A            +  P          
Sbjct: 119 HKHNCIHRDVKPENILI---TKHSVIKLCDFGFAR----------LLTGPSDYYDDEVAT 165

Query: 209 --YIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAV------ 254
             Y +PE+L G   Y    DVW+ G +   LLSG+P + GK+       I   +      
Sbjct: 166 RWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPR 225

Query: 255 ---------RAADLRFPSDPWD--------HISASARDLIMGMLRVDPSTRLTAAEVLAH 297
                      + ++ P             +IS  A  L+ G L +DP+ RLT  ++L H
Sbjct: 226 HQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285

Query: 298 SWMEECEQVAQKP 310
            + E   ++    
Sbjct: 286 PYFENIREIEDLA 298

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  171 bits (435), Expect = 4e-50
 Identities = 71/287 (24%), Positives = 133/287 (46%), Gaps = 26/287 (9%)

Query: 30  LDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKL 89
           +D + + + +  + L + +G G +G + +     TG++ A K +     VT ++   IK 
Sbjct: 14  IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQ 69

Query: 90  EIEIMTKLSGHPNVVDLKAVY------EEEDYVHLLMELCAGGEL--FHRLEKYGRFSET 141
           EI ++ K S H N+      +        +D + L+ME C  G +    +  K     E 
Sbjct: 70  EINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEE 129

Query: 142 EARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLH 201
               I R +++ +S+ H + V+HRD+K +N+LL   + ++ +KL DFG++  +       
Sbjct: 130 WIAYICREILRGLSHLHQHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQLDRTVGRR 186

Query: 202 GT-VGSPFYIAPEVLA------GGYNQAADVWSAGVILYILLSGMPPFWGKTKSK-IFDA 253
            T +G+P+++APEV+A        Y+  +D+WS G+    +  G PP       + +F  
Sbjct: 187 NTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI 246

Query: 254 VRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWM 300
            R    R  S  W   S   +  I   L  + S R    +++ H ++
Sbjct: 247 PRNPAPRLKSKKW---SKKFQSFIESCLVKNHSQRPATEQLMKHPFI 290

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  169 bits (430), Expect = 1e-49
 Identities = 75/267 (28%), Positives = 129/267 (48%), Gaps = 18/267 (6%)

Query: 39  SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLS 98
            + +   +++G G FG + +  D  T +V+A K I  +     +++  I+ EI ++++  
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCD 78

Query: 99  GHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCH 158
             P V      Y ++  + ++ME   GG     L + G   ET+   I R +++ + Y H
Sbjct: 79  -SPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLH 136

Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT-VGSPFYIAPEVLA- 216
               +HRD+K  N+LL   S    +KLADFG+A  +   Q    T VG+PF++APEV+  
Sbjct: 137 SEKKIHRDIKAANVLL---SEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ 193

Query: 217 GGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDP---WDHISASA 273
             Y+  AD+WS G+    L  G PP            ++   L   ++P     + S   
Sbjct: 194 SAYDSKADIWSLGITAIELARGEPPHSE------LHPMKVLFLIPKNNPPTLEGNYSKPL 247

Query: 274 RDLIMGMLRVDPSTRLTAAEVLAHSWM 300
           ++ +   L  +PS R TA E+L H ++
Sbjct: 248 KEFVEACLNKEPSFRPTAKELLKHKFI 274

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  168 bits (427), Expect = 7e-49
 Identities = 75/311 (24%), Positives = 128/311 (41%), Gaps = 71/311 (22%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKL-EIEIMTKLS 98
           ++Y     +G G +G++ +C +K TG ++A K   +      + V+ I + EI+++ +L 
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD--DDKMVKKIAMREIKLLKQLR 82

Query: 99  GHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKY-----GRFSETEARVIFRHLMQV 153
            H N+V+L  V +++   +L+ E        H +                +     ++  
Sbjct: 83  -HENLVNLLEVCKKKKRWYLVFEFVD-----HTILDDLELFPNGLDYQVVQKYLFQIING 136

Query: 154 VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF----- 208
           + +CH + ++HRD+KPENIL+   S S  +KL DFG A           T+ +P      
Sbjct: 137 IGFCHSHNIIHRDIKPENILV---SQSGVVKLCDFGFA----------RTLAAPGEVYDD 183

Query: 209 ------YIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAV-- 254
                 Y APE+L G   Y +A DVW+ G ++  +  G P F G +       I   +  
Sbjct: 184 EVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGN 243

Query: 255 -------------RAADLRFPSDPWDH----------ISASARDLIMGMLRVDPSTRLTA 291
                          A +R P                +S    DL    L +DP  R   
Sbjct: 244 LIPRHQELFNKNPVFAGVRLP--EIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFC 301

Query: 292 AEVLAHSWMEE 302
           AE+L H + + 
Sbjct: 302 AELLHHDFFQM 312

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  168 bits (427), Expect = 1e-48
 Identities = 85/333 (25%), Positives = 130/333 (39%), Gaps = 75/333 (22%)

Query: 32  ATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVED------VR 85
           A  + + + RY     LG GQF  + +  DK T +++A K I        +D      +R
Sbjct: 2   ALDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR 61

Query: 86  SIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKY-----GRFSE 140
               EI+++ +LS HPN++ L   +  +  + L+ +          LE          + 
Sbjct: 62  ----EIKLLQELS-HPNIIGLLDAFGHKSNISLVFDFME-----TDLEVIIKDNSLVLTP 111

Query: 141 TEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNL 200
           +  +      +Q + Y H + ++HRDLKP N+LL        +KLADFGLA         
Sbjct: 112 SHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGV---LKLADFGLAKS------- 161

Query: 201 HGTVGSPF-----------YIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTK 247
               GSP            Y APE+L G   Y    D+W+ G IL  LL  +P   G + 
Sbjct: 162 ---FGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD 218

Query: 248 ----SKIFDAV---------RAADL-------RFPSDPWDHI----SASARDLIMGMLRV 283
               ++IF+ +             L        FP  P  HI         DLI G+   
Sbjct: 219 LDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLF 278

Query: 284 DPSTRLTAAEVLAHSWMEECEQVAQKPCKQDDL 316
           +P  R+TA + L   +          P     L
Sbjct: 279 NPCARITATQALKMKYFSN----RPGPTPGCQL 307

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  167 bits (424), Expect = 2e-48
 Identities = 69/305 (22%), Positives = 119/305 (39%), Gaps = 67/305 (21%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKL-EIEIMTKLS 98
           + Y+   +LG G +  + +   K T  ++A K I   RL   E      + E+ ++  L 
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI---RLEHEEGAPCTAIREVSLLKDLK 58

Query: 99  GHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKY-----GRFSETEARVIFRHLMQV 153
            H N+V L  +   E  + L+ E          L++Y        +    ++    L++ 
Sbjct: 59  -HANIVTLHDIIHTEKSLTLVFEYLD-----KDLKQYLDDCGNIINMHNVKLFLFQLLRG 112

Query: 154 VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF----- 208
           ++YCH   V+HRDLKP+N+L+   +    +KLADFGLA               P      
Sbjct: 113 LAYCHRQKVLHRDLKPQNLLI---NERGELKLADFGLARAK----------SIPTKTYDN 159

Query: 209 ------YIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAV-- 254
                 Y  P++L G   Y+   D+W  G I Y + +G P F G T       IF  +  
Sbjct: 160 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGT 219

Query: 255 -------------RAADLRFPSDP-------WDHISASARDLIMGMLRVDPSTRLTAAEV 294
                              +P             + +   DL+  +L+ +   R++A + 
Sbjct: 220 PTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDA 279

Query: 295 LAHSW 299
           + H +
Sbjct: 280 MKHPF 284

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  165 bits (421), Expect = 2e-48
 Identities = 72/279 (25%), Positives = 133/279 (47%), Gaps = 26/279 (9%)

Query: 39  SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLS 98
           ++ + +  +LG G FG + +  +K TG + A K I      + E++    +EIEI+    
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIE---TKSEEELEDYIVEIEILATCD 74

Query: 99  GHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYC 157
            HP +V L   Y  +  + +++E C GG +   + +     +E + +V+ R +++ +++ 
Sbjct: 75  -HPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFL 133

Query: 158 HGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT-VGSPFYIAPEVLA 216
           H   ++HRDLK  N+L+   +    I+LADFG++           + +G+P+++APEV+ 
Sbjct: 134 HSKRIIHRDLKAGNVLM---TLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVM 190

Query: 217 ------GGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDP----- 265
                   Y+  AD+WS G+ L  +    PP          + +R       SDP     
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE------LNPMRVLLKIAKSDPPTLLT 244

Query: 266 WDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECE 304
               S   RD +   L  +P TR +AA++L H ++    
Sbjct: 245 PSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT 283

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  166 bits (423), Expect = 2e-48
 Identities = 82/317 (25%), Positives = 130/317 (41%), Gaps = 66/317 (20%)

Query: 30  LDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVED------ 83
           + A   +   DRY    +LG G +G + +  D  T E +A K I   RL   E+      
Sbjct: 24  VSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRI---RLEHEEEGVPGTA 80

Query: 84  VRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEA 143
           +R    E+ ++ +L  H N+++LK+V      +HL+ E     +L   ++K    S    
Sbjct: 81  IR----EVSLLKELQ-HRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVI 134

Query: 144 RVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSP--IKLADFGLATYIKAGQNLH 201
           +     L+  V++CH    +HRDLKP+N+LL+   +S    +K+ DFGLA          
Sbjct: 135 KSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA-------- 186

Query: 202 GTVGSPF-----------YIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTK- 247
              G P            Y  PE+L G   Y+ + D+WS   I   +L   P F G ++ 
Sbjct: 187 --FGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI 244

Query: 248 ---SKIFDAV--------------RAADLRFPSDP--------WDHISASARDLIMGMLR 282
               KIF+ +                    FP              +     DL+  ML 
Sbjct: 245 DQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLE 304

Query: 283 VDPSTRLTAAEVLAHSW 299
           +DP  R++A   L H +
Sbjct: 305 MDPVKRISAKNALEHPY 321

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  168 bits (427), Expect = 5e-48
 Identities = 83/300 (27%), Positives = 137/300 (45%), Gaps = 50/300 (16%)

Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
            Y   K +G G FGV+ +     +GE++A K + +D+       R    E++IM KL  H
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---R----ELQIMRKLD-H 106

Query: 101 PNVVDLKAVY------EEEDYVHLLMELCAGGELFHRLEKY-----GRFSETEARVIFRH 149
            N+V L+  +      ++E Y++L+++     E  +R+ ++             ++    
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKLYMYQ 164

Query: 150 LMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFY 209
           L + ++Y H  G+ HRD+KP+N+LL     ++ +KL DFG A  +  G+     + S +Y
Sbjct: 165 LFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYY 222

Query: 210 IAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAV--------- 254
            APE++ G   Y  + DVWSAG +L  LL G P F G +      +I   +         
Sbjct: 223 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 282

Query: 255 ----RAADLRFPS---DPWD-----HISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
                  + +FP     PW           A  L   +L   P+ RLT  E  AHS+ +E
Sbjct: 283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 342

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  165 bits (421), Expect = 2e-47
 Identities = 86/302 (28%), Positives = 138/302 (45%), Gaps = 51/302 (16%)

Query: 39  SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLS 98
              Y   K +G G FGV+ +     + EV A K + +D+       R    E++IM  + 
Sbjct: 39  EIAYTNCKVIGNGSFGVVFQAKLVESDEV-AIKKVLQDK-------RFKNRELQIMRIVK 90

Query: 99  GHPNVVDLKAVY------EEEDYVHLLMELCAGGELFHRLEKY-----GRFSETEARVIF 147
            HPNVVDLKA +      ++E +++L++E     E  +R  ++             ++  
Sbjct: 91  -HPNVVDLKAFFYSNGDKKDEVFLNLVLEYV--PETVYRASRHYAKLKQTMPMLLIKLYM 147

Query: 148 RHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSP 207
             L++ ++Y H  G+ HRD+KP+N+LL     S  +KL DFG A  + AG+     + S 
Sbjct: 148 YQLLRSLAYIHSIGICHRDIKPQNLLL--DPPSGVLKLIDFGSAKILIAGEPNVSYICSR 205

Query: 208 FYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAV------- 254
           +Y APE++ G   Y    D+WS G ++  L+ G P F G++      +I   +       
Sbjct: 206 YYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQ 265

Query: 255 ------RAADLRFP---SDPWD-----HISASARDLIMGMLRVDPSTRLTAAEVLAHSWM 300
                    + +FP     P+           A DLI  +L   PS RLTA E L H + 
Sbjct: 266 IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFF 325

Query: 301 EE 302
           +E
Sbjct: 326 DE 327

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  163 bits (415), Expect = 2e-47
 Identities = 79/295 (26%), Positives = 130/295 (44%), Gaps = 28/295 (9%)

Query: 31  DATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLE 90
            A   S   D Y L + +G G   V++        E +A K I  ++      +  +  E
Sbjct: 6   SALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK--CQTSMDELLKE 63

Query: 91  IEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFH--------RLEKYGRFSETE 142
           I+ M     HPN+V     +  +D + L+M+L +GG +             K G   E+ 
Sbjct: 64  IQAM-SQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEST 122

Query: 143 ARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHG 202
              I R +++ + Y H NG +HRD+K  NILL        +++ADFG++ ++  G ++  
Sbjct: 123 IATILREVLEGLEYLHKNGQIHRDVKAGNILL---GEDGSVQIADFGVSAFLATGGDITR 179

Query: 203 T------VGSPFYIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIF--- 251
                  VG+P ++APEV+    GY+  AD+WS G+    L +G  P+      K+    
Sbjct: 180 NKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLT 239

Query: 252 ---DAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEEC 303
              D           +       S R +I   L+ DP  R TAAE+L H + ++ 
Sbjct: 240 LQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA 294

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  163 bits (415), Expect = 3e-47
 Identities = 82/315 (26%), Positives = 133/315 (42%), Gaps = 76/315 (24%)

Query: 39  SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKL-EIEIMTKL 97
           S ++   ++LG G +  + +  +K TG  +A K +   +L + E   S  + EI +M +L
Sbjct: 4   SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEV---KLDSEEGTPSTAIREISLMKEL 60

Query: 98  SGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKY----------GRFSETEARVIF 147
             H N+V L  V   E+ + L+ E        + L+KY                  +   
Sbjct: 61  K-HENIVRLYDVIHTENKLTLVFEFMD-----NDLKKYMDSRTVGNTPRGLELNLVKYFQ 114

Query: 148 RHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSP 207
             L+Q +++CH N ++HRDLKP+N+L+   +    +KL DFGLA             G P
Sbjct: 115 WQLLQGLAFCHENKILHRDLKPQNLLI---NKRGQLKLGDFGLA----------RAFGIP 161

Query: 208 F-----------YIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTK----SKI 250
                       Y AP+VL G   Y+ + D+WS G IL  +++G P F G         I
Sbjct: 162 VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLI 221

Query: 251 FDAV------------------------RAADLR--FPSDPWDHISASARDLIMGMLRVD 284
           FD +                           DLR        + +  +  D + G+L+++
Sbjct: 222 FDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLN 281

Query: 285 PSTRLTAAEVLAHSW 299
           P  RL+A + L H W
Sbjct: 282 PDMRLSAKQALHHPW 296

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  161 bits (411), Expect = 5e-47
 Identities = 83/312 (26%), Positives = 133/312 (42%), Gaps = 76/312 (24%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVED------VRSIKLEIEI 93
           ++Y   +++G G +GV+ +  +   GE  A K I   RL   ++      +R    EI I
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKI---RLEKEDEGIPSTTIR----EISI 53

Query: 94  MTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKY-----GRFSETEARVIFR 148
           + +L  H N+V L  V   +  + L+ E          L+K      G      A+    
Sbjct: 54  LKELK-HSNIVKLYDVIHTKKRLVLVFEHLD-----QDLKKLLDVCEGGLESVTAKSFLL 107

Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF 208
            L+  ++YCH   V+HRDLKP+N+L+   +    +K+ADFGLA             G P 
Sbjct: 108 QLLNGIAYCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAF----------GIPV 154

Query: 209 -----------YIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTK----SKIF 251
                      Y AP+VL G   Y+   D+WS G I   +++G P F G ++     +IF
Sbjct: 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIF 214

Query: 252 DA-----------------VRAADLRFPSDPWDHI----SASARDLIMGMLRVDPSTRLT 290
                                     +   PW+        S  DL+  ML++DP+ R+T
Sbjct: 215 RILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRIT 274

Query: 291 AAEVLAHSWMEE 302
           A + L H++ +E
Sbjct: 275 AKQALEHAYFKE 286

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  162 bits (413), Expect = 5e-47
 Identities = 62/276 (22%), Positives = 112/276 (40%), Gaps = 16/276 (5%)

Query: 39  SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLS 98
            +      ++G G  G + +   + TG V+A K + +      E+ + I ++++++ K  
Sbjct: 24  INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS--GNKEENKRILMDLDVVLKSH 81

Query: 99  GHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCH 158
             P +V     +     V + MEL        +    G   E     +   +++ + Y  
Sbjct: 82  DCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK 141

Query: 159 G-NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLA- 216
             +GV+HRD+KP NILL        IKL DFG++  +   +    + G   Y+APE +  
Sbjct: 142 EKHGVIHRDVKPSNILL---DERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDP 198

Query: 217 -----GGYNQAADVWSAGVILYILLSGMPPF--WGKTKSKIFDAVRAADLRFPSDPWDHI 269
                  Y+  ADVWS G+ L  L +G  P+         +   ++      P       
Sbjct: 199 PDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGH--MGF 256

Query: 270 SASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ 305
           S   +  +   L  D   R    ++L HS+++  E 
Sbjct: 257 SGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYET 292

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  162 bits (413), Expect = 7e-47
 Identities = 64/279 (22%), Positives = 121/279 (43%), Gaps = 17/279 (6%)

Query: 39  SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLS 98
           ++      ++G G +G + +   K +G+++A K I     V  ++ + + ++++++ + S
Sbjct: 21  AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRI--RSTVDEKEQKQLLMDLDVVMRSS 78

Query: 99  GHPNVVDLKAVYEEEDYVHLLMELCAGG--ELFHRLEKY--GRFSETEARVIFRHLMQVV 154
             P +V        E    + MEL +    + +  +         E     I    ++ +
Sbjct: 79  DCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKAL 138

Query: 155 SYCHGNG-VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPE 213
           ++   N  ++HRD+KP NILL     S  IKL DFG++  +          G   Y+APE
Sbjct: 139 NHLKENLKIIHRDIKPSNILL---DRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 195

Query: 214 VLAG-----GYNQAADVWSAGVILYILLSGMPPF--WGKTKSKIFDAVRAADLRFPSDPW 266
            +       GY+  +DVWS G+ LY L +G  P+  W     ++   V+    +  +   
Sbjct: 196 RIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEE 255

Query: 267 DHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ 305
              S S  + +   L  D S R    E+L H ++   E+
Sbjct: 256 REFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEE 294

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  161 bits (410), Expect = 1e-46
 Identities = 83/310 (26%), Positives = 135/310 (43%), Gaps = 77/310 (24%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVED------VRSIKLEIEI 93
           ++Y   +++G G +GV+ +  D   G ++A K I   RL   ++      +R    EI +
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRI---RLDAEDEGIPSTAIR----EISL 72

Query: 94  MTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKY-----GRFSETEARVIFR 148
           + +L  HPN+V L  V   E  + L+ E          L+K          +++ ++   
Sbjct: 73  LKELH-HPNIVSLIDVIHSERCLTLVFEFME-----KDLKKVLDENKTGLQDSQIKIYLY 126

Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF 208
            L++ V++CH + ++HRDLKP+N+L+   +S   +KLADFGLA             G P 
Sbjct: 127 QLLRGVAHCHQHRILHRDLKPQNLLI---NSDGALKLADFGLARAF----------GIPV 173

Query: 209 -----------YIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTK----SKIF 251
                      Y AP+VL G   Y+ + D+WS G I   +++G P F G T      KIF
Sbjct: 174 RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIF 233

Query: 252 ------------------DAVRAADLRFPSDPWDHI----SASARDLIMGMLRVDPSTRL 289
                                +     F   PW  I         DL+  ML  DP+ R+
Sbjct: 234 SILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRI 293

Query: 290 TAAEVLAHSW 299
           +A + + H +
Sbjct: 294 SARDAMNHPY 303

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  160 bits (407), Expect = 2e-46
 Identities = 63/278 (22%), Positives = 118/278 (42%), Gaps = 19/278 (6%)

Query: 39  SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLS 98
           +D      +LG G +GV+ +     +G+++A K I     V  ++ + + ++++I  +  
Sbjct: 6   ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRAT--VNSQEQKRLLMDLDISMRTV 63

Query: 99  GHPNVVDLKAVYEEEDYVHLLMELCAGG---ELFHRLEKYGRFSETEARVIFRHLMQVVS 155
             P  V        E  V + MEL            ++K     E     I   +++ + 
Sbjct: 64  DCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALE 123

Query: 156 YCHGNG-VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEV 214
           + H    V+HRD+KP N+L+   ++   +K+ DFG++ Y+          G   Y+APE 
Sbjct: 124 HLHSKLSVIHRDVKPSNVLI---NALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPER 180

Query: 215 LAG-----GYNQAADVWSAGVILYILLSGMPPF--WGKTKSKIFDAVRAADLRFPSDPWD 267
           +       GY+  +D+WS G+ +  L     P+  WG    ++   V     + P+D + 
Sbjct: 181 INPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKF- 239

Query: 268 HISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ 305
             SA   D     L+ +   R T  E++ H +    E 
Sbjct: 240 --SAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHES 275

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  159 bits (405), Expect = 4e-46
 Identities = 80/310 (25%), Positives = 134/310 (43%), Gaps = 76/310 (24%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVED------VRSIKLEIEI 93
            +Y   +++G G +G + +  ++ T E++A K +   RL   ++      +R    EI +
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV---RLDDDDEGVPSSALR----EICL 54

Query: 94  MTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKY-----GRFSETEARVIFR 148
           + +L  H N+V L  V   +  + L+ E C        L+KY     G       +    
Sbjct: 55  LKELK-HKNIVRLHDVLHSDKKLTLVFEFCD-----QDLKKYFDSCNGDLDPEIVKSFLF 108

Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF 208
            L++ + +CH   V+HRDLKP+N+L+   + +  +KLA+FGLA             G P 
Sbjct: 109 QLLKGLGFCHSRNVLHRDLKPQNLLI---NRNGELKLANFGLARAF----------GIPV 155

Query: 209 -----------YIAPEVLAGG--YNQAADVWSAGVILYILLS-GMPPFWGKTK----SKI 250
                      Y  P+VL G   Y+ + D+WSAG I   L + G P F G        +I
Sbjct: 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRI 215

Query: 251 FDAVRA---------ADLR----FPSDP--------WDHISASARDLIMGMLRVDPSTRL 289
           F  +             L     +P  P           ++A+ RDL+  +L+ +P  R+
Sbjct: 216 FRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRI 275

Query: 290 TAAEVLAHSW 299
           +A E L H +
Sbjct: 276 SAEEALQHPY 285

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  159 bits (405), Expect = 6e-46
 Identities = 76/279 (27%), Positives = 133/279 (47%), Gaps = 25/279 (8%)

Query: 39  SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLS 98
            + + + ++LG G +G + +   K TG+++A K +  +      D++ I  EI IM +  
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE-----SDLQEIIKEISIMQQCD 82

Query: 99  GHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLE-KYGRFSETEARVIFRHLMQVVSYC 157
             P+VV     Y +   + ++ME C  G +   +  +    +E E   I +  ++ + Y 
Sbjct: 83  -SPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYL 141

Query: 158 HGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT-VGSPFYIAPEVLA 216
           H    +HRD+K  NILL   ++    KLADFG+A  +        T +G+PF++APEV+ 
Sbjct: 142 HFMRKIHRDIKAGNILL---NTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ 198

Query: 217 -GGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDP------WDHI 269
             GYN  AD+WS G+    +  G PP+           +RA  +  P++P       +  
Sbjct: 199 EIGYNCVADIWSLGITAIEMAEGKPPYAD------IHPMRAIFM-IPTNPPPTFRKPELW 251

Query: 270 SASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQ 308
           S +  D +   L   P  R TA ++L H ++   + V+ 
Sbjct: 252 SDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSI 290

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  160 bits (406), Expect = 9e-46
 Identities = 73/291 (25%), Positives = 120/291 (41%), Gaps = 27/291 (9%)

Query: 29  ILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIK 88
           + +     +    +   +++G G FG +    D    EV+A K ++     + E  + I 
Sbjct: 43  VAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDII 102

Query: 89  LEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR 148
            E+  + KL  HPN +  +  Y  E    L+ME C G              E E   +  
Sbjct: 103 KEVRFLQKLR-HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTH 161

Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPF 208
             +Q ++Y H + ++HRD+K  NILL   S    +KL DFG A+ +    +    VG+P+
Sbjct: 162 GALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAPANSF---VGTPY 215

Query: 209 YIAPEVLA----GGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADL----- 259
           ++APEV+     G Y+   DVWS G+    L    PP +        +A+ A        
Sbjct: 216 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN------MNAMSALYHIAQNE 269

Query: 260 --RFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQ 308
                S  W   S   R+ +   L+  P  R T+  +L H ++        
Sbjct: 270 SPALQSGHW---SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTV 317

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  158 bits (403), Expect = 2e-45
 Identities = 69/305 (22%), Positives = 121/305 (39%), Gaps = 51/305 (16%)

Query: 37  NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTK 96
              D Y L ++LG G++  + E  +    E +  K +   + V     + IK EI+I+  
Sbjct: 33  GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL---KPV---KKKKIKREIKILEN 86

Query: 97  LSGHPNVVDLKAV---YEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQV 153
           L G PN++ L  +           +   +      F +L  Y   ++ + R     +++ 
Sbjct: 87  LRGGPNIITLADIVKDPVSRTPALVFEHV--NNTDFKQL--YQTLTDYDIRFYMYEILKA 142

Query: 154 VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPE 213
           + YCH  G++HRD+KP N+++        ++L D+GLA +   GQ  +  V S ++  PE
Sbjct: 143 LDYCHSMGIMHRDVKPHNVMI--DHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPE 200

Query: 214 VLAGG--YNQAADVWSAGVILYILLSGMPPF-------------------------WGKT 246
           +L     Y+ + D+WS G +L  ++    PF                           K 
Sbjct: 201 LLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 260

Query: 247 KS-------KIFDAVRAADLR--FPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH 297
                     I              S+    +S  A D +  +LR D  +RLTA E + H
Sbjct: 261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320

Query: 298 SWMEE 302
            +   
Sbjct: 321 PYFYT 325

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  158 bits (402), Expect = 2e-45
 Identities = 74/274 (27%), Positives = 129/274 (47%), Gaps = 23/274 (8%)

Query: 39  SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLS 98
                   ++G G  G++    +K +G  +A K +    L   +    +  E+ IM +  
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMM---DLRKQQRRELLFNEVVIM-RDY 99

Query: 99  GHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCH 158
            H NVV++   Y   + + +LME   GG L   +    R +E +   +   ++Q ++Y H
Sbjct: 100 QHFNVVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLH 158

Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT-VGSPFYIAPEVLAG 217
             GV+HRD+K ++ILL   +    +KL+DFG    I        + VG+P+++APEV++ 
Sbjct: 159 AQGVIHRDIKSDSILL---TLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISR 215

Query: 218 -GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDP------WDHIS 270
             Y    D+WS G+++  ++ G PP++  +       V+A   R    P         +S
Sbjct: 216 SLYATEVDIWSLGIMVIEMVDGEPPYFSDS------PVQAM-KRLRDSPPPKLKNSHKVS 268

Query: 271 ASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECE 304
              RD +  ML  DP  R TA E+L H ++ +  
Sbjct: 269 PVLRDFLERMLVRDPQERATAQELLDHPFLLQTG 302

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  156 bits (397), Expect = 6e-45
 Identities = 74/274 (27%), Positives = 128/274 (46%), Gaps = 23/274 (8%)

Query: 39  SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLS 98
             +Y   +++G G  G +    D  TG+ +A + +    L        I  EI +M + +
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVM-REN 74

Query: 99  GHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCH 158
            +PN+V+    Y   D + ++ME  AGG L   +       E +   + R  +Q + + H
Sbjct: 75  KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLH 133

Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT-VGSPFYIAPEVLAG 217
            N V+HRD+K +NILL        +KL DFG    I   Q+   T VG+P+++APEV+  
Sbjct: 134 SNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 190

Query: 218 -GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDP------WDHIS 270
             Y    D+WS G++   ++ G PP+  +        +RA      ++        + +S
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPPYLNEN------PLRAL-YLIATNGTPELQNPEKLS 243

Query: 271 ASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECE 304
           A  RD +   L +D   R +A E+L H +++  +
Sbjct: 244 AIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAK 277

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  156 bits (396), Expect = 1e-44
 Identities = 82/314 (26%), Positives = 119/314 (37%), Gaps = 77/314 (24%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVED---------VRSIKLE 90
            RY    ++G G +G + +  D  +G  +A KS+   R+              VR + L 
Sbjct: 9   SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSV---RVPNGGGGGGGLPISTVREVALL 65

Query: 91  IEIMTKLSGHPNVVDLKAV-----YEEEDYVHLLMELCAGGELFHRLEKY------GRFS 139
             +  +   HPNVV L  V      + E  V L+ E          L  Y          
Sbjct: 66  RRL--EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-----QDLRTYLDKAPPPGLP 118

Query: 140 ETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN 199
               + + R  ++ + + H N +VHRDLKPENIL+   +S   +KLADFGLA        
Sbjct: 119 AETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV---TSGGTVKLADFGLARIY----- 170

Query: 200 LHGTVGSP----------FYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTK- 247
                             +Y APEVL    Y    D+WS G I   +    P F G ++ 
Sbjct: 171 -----SYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA 225

Query: 248 ---SKIFDAV---------------RAADLRFPSDPWDHI----SASARDLIMGMLRVDP 285
               KIFD +               R A       P   +      S   L++ ML  +P
Sbjct: 226 DQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNP 285

Query: 286 STRLTAAEVLAHSW 299
             R++A   L HS+
Sbjct: 286 HKRISAFRALQHSY 299

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  152 bits (386), Expect = 6e-43
 Identities = 77/312 (24%), Positives = 120/312 (38%), Gaps = 75/312 (24%)

Query: 40  DRYVLGKQLGWGQFGVI-RECSDKFTGEVLACKSIAKDRLVTVED------VRSIKLEIE 92
            +Y    ++G G +G + +    K  G  +A K +   R+ T E+      +R + +   
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV---RVQTGEEGMPLSTIREVAVLRH 67

Query: 93  IMTKLSGHPNVVDLKAV-----YEEEDYVHLLMELCAGGELFHRLEKY------GRFSET 141
           +  +   HPNVV L  V      + E  + L+ E          L  Y            
Sbjct: 68  L--ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-----QDLTTYLDKVPEPGVPTE 120

Query: 142 EARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLH 201
             + +   L++ + + H + VVHRDLKP+NIL+   +SS  IKLADFGLA          
Sbjct: 121 TIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFGLARIY------- 170

Query: 202 GTVGSPF----------YIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTK--- 247
                            Y APEVL    Y    D+WS G I   +    P F G +    
Sbjct: 171 ---SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ 227

Query: 248 -SKIFDAV---------------RAADLRFPSDPWDHI----SASARDLIMGMLRVDPST 287
             KI D +               R A     + P +          +DL++  L  +P+ 
Sbjct: 228 LGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAK 287

Query: 288 RLTAAEVLAHSW 299
           R++A   L+H +
Sbjct: 288 RISAYSALSHPY 299

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  152 bits (386), Expect = 1e-42
 Identities = 70/313 (22%), Positives = 124/313 (39%), Gaps = 68/313 (21%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVED-VRSIKL-EIEIMTKL 97
            +Y    ++G G FG + +   + TG+ +A K +    +   ++      L EI+I+  L
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV---LMENEKEGFPITALREIKILQLL 73

Query: 98  SGHPNVVDLKAV--------YEEEDYVHLLMELCAGGELFHRLEKY-----GRFSETEAR 144
             H NVV+L  +           +  ++L+ + C      H L         +F+ +E +
Sbjct: 74  K-HENVVNLIEICRTKASPYNRCKGSIYLVFDFCE-----HDLAGLLSNVLVKFTLSEIK 127

Query: 145 VIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTV 204
            + + L+  + Y H N ++HRD+K  N+L+   +    +KLADFGLA      +N   + 
Sbjct: 128 RVMQMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADFGLARAFSLAKN---SQ 181

Query: 205 GSPF--------YIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTK----SKI 250
            + +        Y  PE+L G   Y    D+W AG I+  + +  P   G T+    + I
Sbjct: 182 PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI 241

Query: 251 FDAV---------------RAADLRFPSD---------PWDHISASARDLIMGMLRVDPS 286
                                  L                      A DLI  +L +DP+
Sbjct: 242 SQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPA 301

Query: 287 TRLTAAEVLAHSW 299
            R+ + + L H +
Sbjct: 302 QRIDSDDALNHDF 314

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  152 bits (386), Expect = 1e-42
 Identities = 70/327 (21%), Positives = 130/327 (39%), Gaps = 52/327 (15%)

Query: 23  SSLTGTILDATQISNLS-DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTV 81
             L   +    ++  L  D +    +LG G  GV+ + S K +G V+A K I    L   
Sbjct: 15  KRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI---HLEIK 71

Query: 82  EDVRS-IKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSE 140
             +R+ I  E++++ + +  P +V     +  +  + + ME   GG L   L+K GR  E
Sbjct: 72  PAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE 130

Query: 141 TEARVIFRHLMQVVSYCHGNG-VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN 199
                +   +++ ++Y      ++HRD+KP NIL+   +S   IKL DFG++  +     
Sbjct: 131 QILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDSMA 187

Query: 200 LHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAAD 258
            +  VG+  Y++PE L G  Y+  +D+WS G+ L  +  G  P       ++        
Sbjct: 188 -NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQV 246

Query: 259 LRF----------------------------------------PSDPWDHISASARDLIM 278
                                                      P  P    S   +D + 
Sbjct: 247 EGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVN 306

Query: 279 GMLRVDPSTRLTAAEVLAHSWMEECEQ 305
             L  +P+ R    +++ H++++  + 
Sbjct: 307 KCLIKNPAERADLKQLMVHAFIKRSDA 333

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  150 bits (380), Expect = 2e-42
 Identities = 73/271 (26%), Positives = 127/271 (46%), Gaps = 25/271 (9%)

Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSI----AKDRLVTVEDVRSIKLEIEIMTKLS 98
              KQ+G G FG++ +        V+A KS+    ++     +E  +  + E+ IM+ L+
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81

Query: 99  GHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQV---VS 155
            HPN+V L  +        ++ME    G+L+HRL         +  V  R ++ +   + 
Sbjct: 82  -HPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAH--PIKWSVKLRLMLDIALGIE 136

Query: 156 YCHGNG--VVHRDLKPENILLATKSSSSP--IKLADFGLATYIKAGQNLHGTVGSPFYIA 211
           Y       +VHRDL+  NI L +   ++P   K+ADFGL+       ++ G +G+  ++A
Sbjct: 137 YMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV--HSVSGLLGNFQWMA 194

Query: 212 PEVLAGG---YNQAADVWSAGVILYILLSGMPPFWGKTKSKI--FDAVRAADLRFPSDPW 266
           PE +      Y + AD +S  +ILY +L+G  PF   +  KI   + +R   LR P+ P 
Sbjct: 195 PETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLR-PTIP- 252

Query: 267 DHISASARDLIMGMLRVDPSTRLTAAEVLAH 297
           +      R++I      DP  R   + ++  
Sbjct: 253 EDCPPRLRNVIELCWSGDPKKRPHFSYIVKE 283

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  148 bits (376), Expect = 9e-42
 Identities = 75/286 (26%), Positives = 130/286 (45%), Gaps = 31/286 (10%)

Query: 23  SSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVE 82
           S + G I++        +RY +  +LG G    +    D      +A K          E
Sbjct: 2   SHMIGKIIN--------ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIK-AIFIPPREKE 52

Query: 83  D-VRSIKLEIEIMTKLSGHPNVVDLKAVY---EEEDYVHLLMELCAGGELFHRLEKYGRF 138
           + ++  + E+   ++LS H N+V   ++    EE+D  +L+ME   G  L   +E +G  
Sbjct: 53  ETLKRFEREVHNSSQLS-HQNIV---SMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPL 108

Query: 139 SETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ 198
           S   A      ++  + + H   +VHRD+KP+NIL+    S+  +K+ DFG+A   KA  
Sbjct: 109 SVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILI---DSNKTLKIFDFGIA---KALS 162

Query: 199 NLHGT-----VGSPFYIAPEVLAGGY-NQAADVWSAGVILYILLSGMPPFWGKTKSKI-F 251
               T     +G+  Y +PE   G   ++  D++S G++LY +L G PPF G+T   I  
Sbjct: 163 ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAI 222

Query: 252 DAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTR-LTAAEVLA 296
             ++ +     +D    I  S  ++I+     D + R  T  E+  
Sbjct: 223 KHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKD 268

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  148 bits (376), Expect = 1e-41
 Identities = 66/262 (25%), Positives = 118/262 (45%), Gaps = 16/262 (6%)

Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
            + +++G G FG +     ++ G  +A K + +      E V     E+ IM +L  HPN
Sbjct: 40  NIKEKIGAGSFGTVHRA--EWHGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLR-HPN 95

Query: 103 VVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQV---VSYCHG 159
           +V       +   + ++ E  + G L+  L K G   + + R        V   ++Y H 
Sbjct: 96  IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN 155

Query: 160 NG--VVHRDLKPENILLATKSSSSPIKLADFGLATYI-KAGQNLHGTVGSPFYIAPEVLA 216
               +VHR+LK  N+L+  K +   +K+ DFGL+        +     G+P ++APEVL 
Sbjct: 156 RNPPIVHRNLKSPNLLVDKKYT---VKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLR 212

Query: 217 GG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARD 275
               N+ +DV+S GVIL+ L +   P+     +++  AV     R    P  +++     
Sbjct: 213 DEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR-LEIP-RNLNPQVAA 270

Query: 276 LIMGMLRVDPSTRLTAAEVLAH 297
           +I G    +P  R + A ++  
Sbjct: 271 IIEGCWTNEPWKRPSFATIMDL 292

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  149 bits (378), Expect = 3e-41
 Identities = 60/322 (18%), Positives = 115/322 (35%), Gaps = 62/322 (19%)

Query: 39  SDRYVLGKQLGWGQ--FGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTK 96
              Y L   +G G      +     K TGE +  + I  +     E V  ++ E+ +   
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSN-EMVTFLQGELHVSKL 82

Query: 97  LSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKY--GRFSETEARVIFRHLMQVV 154
            + HPN+V  +A +  ++ + ++    A G     +  +     +E     I + +++ +
Sbjct: 83  FN-HPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKAL 141

Query: 155 SYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT--------VGS 206
            Y H  G VHR +K  +IL+   S    + L+       + +               V  
Sbjct: 142 DYIHHMGYVHRSVKASHILI---SVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKV 198

Query: 207 PFYIAPEVLA---GGYNQAADVWSAGVILYILLSGMPPF--------------------- 242
             +++PEVL     GY+  +D++S G+    L +G  PF                     
Sbjct: 199 LPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL 258

Query: 243 --------------------WGKTKSKIFDAVRAADLRFPSDPWDHI-SASARDLIMGML 281
                                G + S      R ++   PS P+    S      +   L
Sbjct: 259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCL 318

Query: 282 RVDPSTRLTAAEVLAHSWMEEC 303
           + +P  R +A+ +L HS+ ++ 
Sbjct: 319 QRNPDARPSASTLLNHSFFKQI 340

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  148 bits (376), Expect = 3e-41
 Identities = 75/309 (24%), Positives = 128/309 (41%), Gaps = 57/309 (18%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLS- 98
           DR+ + +  G G FG ++   +K TG  +A K +       ++D R    E++IM  L+ 
Sbjct: 23  DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV-------IQDPRFRNRELQIMQDLAV 75

Query: 99  -GHPNVVDLKAVY-------EEEDYVHLLMELCAGGELFHRLEKYG-----RFSETEARV 145
             HPN+V L++ +         + Y++++ME     +  HR  +              +V
Sbjct: 76  LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV--PDTLHRCCRNYYRRQVAPPPILIKV 133

Query: 146 IFRHLMQVVSYCHGN--GVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT 203
               L++ +   H     V HRD+KP N+L+    +   +KL DFG A  +   +     
Sbjct: 134 FLFQLIRSIGCLHLPSVNVCHRDIKPHNVLV--NEADGTLKLCDFGSAKKLSPSEPNVAY 191

Query: 204 VGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAV--- 254
           + S +Y APE++ G   Y  A D+WS G I   ++ G P F G        +I   +   
Sbjct: 192 ICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCP 251

Query: 255 ----------RAADLRFPSD---PWD--------HISASARDLIMGMLRVDPSTRLTAAE 293
                        D+   +    PW           +  A DL+  +L+  P  R+   E
Sbjct: 252 SREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYE 311

Query: 294 VLAHSWMEE 302
            L H + +E
Sbjct: 312 ALCHPYFDE 320

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  148 bits (375), Expect = 6e-41
 Identities = 82/340 (24%), Positives = 136/340 (40%), Gaps = 90/340 (26%)

Query: 37  NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTK 96
             S +Y LGK LG G FG++ E  D  +G+  A K + +D        R    E++IM  
Sbjct: 4   TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP-------RYKNRELDIMKV 56

Query: 97  LSGHPNVVDLKAVY--------------------------------------EEEDYVHL 118
           L  H N++ L   +                                       +  Y+++
Sbjct: 57  LD-HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNV 115

Query: 119 LMELCAGGELFHRLEKYGRFSE---TEARV------IFRHLMQVVSYCHGNGVVHRDLKP 169
           +ME     +  H++ K    S        +      +FR +     + H  G+ HRD+KP
Sbjct: 116 IMEYV--PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAV----GFIHSLGICHRDIKP 169

Query: 170 ENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG--GYNQAADVWS 227
           +N+L+   S  + +KL DFG A  +   +     + S FY APE++ G   Y  + D+WS
Sbjct: 170 QNLLV--NSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWS 227

Query: 228 AGVILYILLSGMPPFWGKTK----SKIFDAV-------------RAADLRFPS---DPWD 267
            G +   L+ G P F G+T      +I   +                ++RFP+     W 
Sbjct: 228 IGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWR 287

Query: 268 HI-----SASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
            I      + A DL+  +LR +P  R+   E +AH + + 
Sbjct: 288 KILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDH 327

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  147 bits (372), Expect = 2e-40
 Identities = 74/336 (22%), Positives = 129/336 (38%), Gaps = 79/336 (23%)

Query: 32  ATQISNLSDRY-VLGKQLGWGQFG-VIR-ECSDKFTGEVLACKSIAKDRLVTVEDVRSIK 88
           +++   + D +   G ++G G +G V + +  D    +  A K I     +++   R   
Sbjct: 12  SSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG-ISMSACR--- 67

Query: 89  LEIEIMTKLSGHPNVVDLKAVYEE--EDYVHLLMELCAGGELFHRLEKY----------- 135
            EI ++ +L  HPNV+ L+ V+    +  V LL +        H L              
Sbjct: 68  -EIALLRELK-HPNVISLQKVFLSHADRKVWLLFDYAE-----HDLWHIIKFHRASKANK 120

Query: 136 --GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSS-PIKLADFGLAT 192
              +      + +   ++  + Y H N V+HRDLKP NIL+  +      +K+AD G A 
Sbjct: 121 KPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 180

Query: 193 Y----IKAGQNLHGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKT 246
                +K   +L   V + +Y APE+L G   Y +A D+W+ G I   LL+  P F  + 
Sbjct: 181 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240

Query: 247 KSKIFDAVRAAD--------LRFPSD---------PW----------------------- 266
           +          D        + FP+D         P                        
Sbjct: 241 EDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYME 300

Query: 267 ---DHISASARDLIMGMLRVDPSTRLTAAEVLAHSW 299
                  + A  L+  +L +DP  R+T+ + +   +
Sbjct: 301 KHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPY 336

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  145 bits (367), Expect = 3e-40
 Identities = 54/272 (19%), Positives = 114/272 (41%), Gaps = 28/272 (10%)

Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
            +G+ +G G+FG +     ++ GEV A + I  +R    + +++ K E+    +   H N
Sbjct: 36  EIGELIGKGRFGQVYHG--RWHGEV-AIRLIDIERD-NEDQLKAFKREVMAYRQTR-HEN 90

Query: 103 VVDLKAVYEEEDYVHLLMELCAGGELFHRL-EKYGRFSETEARVIFRHLMQVVSYCHGNG 161
           VV          ++ ++  LC G  L+  + +        + R I + +++ + Y H  G
Sbjct: 91  VVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG 150

Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ------NLHGTVGSPFYIAPEVL 215
           ++H+DLK +N+          + + DFGL +     Q       L    G   ++APE++
Sbjct: 151 ILHKDLKSKNVFYDNGK----VVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEII 206

Query: 216 AGG----------YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDP 265
                        +++ +DV++ G I Y L +   PF  +    I   +    ++ P+  
Sbjct: 207 RQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM-GTGMK-PNLS 264

Query: 266 WDHISASARDLIMGMLRVDPSTRLTAAEVLAH 297
              +     D+++     +   R T  +++  
Sbjct: 265 QIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  143 bits (363), Expect = 6e-40
 Identities = 70/264 (26%), Positives = 121/264 (45%), Gaps = 26/264 (9%)

Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
            + + +G G FGV+  C  K+  + +A K I  +      + ++  +E+  +++++ HPN
Sbjct: 11  EVEEVVGRGAFGVV--CKAKWRAKDVAIKQIESE-----SERKAFIVELRQLSRVN-HPN 62

Query: 103 VVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQV---VSYCHG 159
           +V L           L+ME   GG L++ L          A       +Q    V+Y H 
Sbjct: 63  IVKLYGACLNPVC--LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHS 120

Query: 160 ---NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLA 216
                ++HRDLKP N+LL   +  + +K+ DFG A  I+   ++    GS  ++APEV  
Sbjct: 121 MQPKALIHRDLKPPNLLLV--AGGTVLKICDFGTACDIQ--THMTNNKGSAAWMAPEVFE 176

Query: 217 G-GYNQAADVWSAGVILYILLSGMPPFWGKTKS--KIFDAVRAADLRFPSDPWDHISASA 273
           G  Y++  DV+S G+IL+ +++   PF        +I  AV     R P     ++    
Sbjct: 177 GSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVH-NGTR-PPLI-KNLPKPI 233

Query: 274 RDLIMGMLRVDPSTRLTAAEVLAH 297
             L+      DPS R +  E++  
Sbjct: 234 ESLMTRCWSKDPSQRPSMEEIVKI 257

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  141 bits (358), Expect = 2e-39
 Identities = 72/271 (26%), Positives = 118/271 (43%), Gaps = 29/271 (10%)

Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSI----AKDRLVTVEDVRSIKLEIEIMTKLS 98
            L + +G G FG +      + G+ +A K+      +D   T+E+VR    E ++   L 
Sbjct: 10  TLEEIIGIGGFGKVYRA--FWIGDEVAVKAARHDPDEDISQTIENVRQ---EAKLFAMLK 64

Query: 99  GHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQV---VS 155
            HPN++ L+ V  +E  + L+ME   GG L   L            ++    +Q+   ++
Sbjct: 65  -HPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG----KRIPPDILVNWAVQIARGMN 119

Query: 156 YCHGNG---VVHRDLKPENILLATKSSSSP-----IKLADFGLATYIKAGQNLHGTVGSP 207
           Y H      ++HRDLK  NIL+  K  +       +K+ DFGLA             G+ 
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-EWHRTTKMSAAGAY 178

Query: 208 FYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW 266
            ++APEV+    +++ +DVWS GV+L+ LL+G  PF G     +   V    L     P 
Sbjct: 179 AWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLA-LPIP- 236

Query: 267 DHISASARDLIMGMLRVDPSTRLTAAEVLAH 297
                    L+      DP +R +   +L  
Sbjct: 237 STCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  148 bits (376), Expect = 2e-39
 Identities = 65/277 (23%), Positives = 106/277 (38%), Gaps = 51/277 (18%)

Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTV---------EDVRSIK 88
           ++ +Y +   +  G  G I    D      +        R V +         E      
Sbjct: 78  VAGQYEVKGCIAHGGLGWIYLALD----RNVN------GRPVVLKGLVHSGDAEAQAMAM 127

Query: 89  LEIEIMTKLSGHPNVVDLKAVY---EEEDY-----VHLLMELCAGGELFHRLEKYGRFSE 140
            E + + ++  HP++V    ++   E  D       +++ME   G  L        +   
Sbjct: 128 AERQFLAEVV-HPSIV---QIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG--QKLPV 181

Query: 141 TEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNL 200
            EA      ++  +SY H  G+V+ DLKPENI+L    +   +KL D G  + I +   L
Sbjct: 182 AEAIAYLLEILPALSYLHSIGLVYNDLKPENIML----TEEQLKLIDLGAVSRINSFGYL 237

Query: 201 HGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLR 260
           +GT G   + APE++  G   A D+++ G  L  L   +P   G+             L 
Sbjct: 238 YGTPG---FQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRY---------VDGLP 285

Query: 261 FPSDPWDHISASARDLIMGMLRVDPSTR-LTAAEVLA 296
              DP      S   L+   +  DP  R  TA E+ A
Sbjct: 286 -EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSA 321

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  141 bits (358), Expect = 6e-39
 Identities = 78/314 (24%), Positives = 130/314 (41%), Gaps = 58/314 (18%)

Query: 37  NLSDRYVLGKQLGWGQFGVIRECS--DKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
           +L  RY+  K LG G  G++   S  D    + +A K I          V+    EI+I+
Sbjct: 8   DLGSRYMDLKPLGCGGNGLV--FSAVDNDCDKRVAIKKIVLTDPQ---SVKHALREIKII 62

Query: 95  TKLSGHPNVVDLKAV--------------YEEEDYVHLLMELCAGGELFHRLEKYGRFSE 140
            +L  H N+V +  +                E + V+++ E     +L   + + G   E
Sbjct: 63  RRLD-HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEY-METDL-ANVLEQGPLLE 119

Query: 141 TEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNL 200
             AR+    L++ + Y H   V+HRDLKP N+ +   +    +K+ DFGLA  +    + 
Sbjct: 120 EHARLFMYQLLRGLKYIHSANVLHRDLKPANLFI--NTEDLVLKIGDFGLARIMDPHYSH 177

Query: 201 HGT----VGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTK----SKI 250
            G     + + +Y +P +L     Y +A D+W+AG I   +L+G   F G  +      I
Sbjct: 178 KGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI 237

Query: 251 FDAV---RAADLRF---------------PSDPWDHI----SASARDLIMGMLRVDPSTR 288
            +++      D +                P  P   +    S  A D +  +L   P  R
Sbjct: 238 LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDR 297

Query: 289 LTAAEVLAHSWMEE 302
           LTA E L+H +M  
Sbjct: 298 LTAEEALSHPYMSI 311

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  141 bits (358), Expect = 1e-38
 Identities = 85/314 (27%), Positives = 136/314 (43%), Gaps = 50/314 (15%)

Query: 37  NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTK 96
            L   YV    +G G +G +    DK +GE +A K ++     +    +    E+ ++  
Sbjct: 21  ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLS-RPFQSEIFAKRAYRELLLLKH 79

Query: 97  LSGHPNVVDLKAV------YEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHL 150
           +  H NV+ L  V             +L+M      +L  ++    +FSE + + +   +
Sbjct: 80  MQ-HENVIGLLDVFTPASSLRNFYDFYLVMPF-MQTDL-QKIMG-LKFSEEKIQYLVYQM 135

Query: 151 MQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYI 210
           ++ + Y H  GVVHRDLKP N+ +   +    +K+ DFGLA    A   + G V + +Y 
Sbjct: 136 LKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKILDFGLAR--HADAEMTGYVVTRWYR 190

Query: 211 APEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAV---RAADLRF 261
           APEV+     YNQ  D+WS G I+  +L+G   F GK      ++I           ++ 
Sbjct: 191 APEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 250

Query: 262 ----------------PSDPWDHI----SASARDLIMGMLRVDPSTRLTAAEVLAHSWME 301
                           P   +  +    S  A DL+  ML +D   RLTAA+ L H + E
Sbjct: 251 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE 310

Query: 302 -----ECEQVAQKP 310
                E E  AQ+P
Sbjct: 311 PFRDPEEETEAQQP 324

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  140 bits (354), Expect = 1e-38
 Identities = 80/282 (28%), Positives = 131/282 (46%), Gaps = 40/282 (14%)

Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVED-VRSIKLEIEIMTK 96
           LSDRY LG+ LG+G    +    D      +A K + +  L          + E +    
Sbjct: 10  LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVK-VLRADLARDPSFYLRFRREAQNAAA 68

Query: 97  LSGHPNVVDLKAVY---EEED----YVHLLMELCAGGELFHRLEKYGRFSETEARVIFRH 149
           L+ HP +V   AVY   E E       +++ME   G  L   +   G  +   A  +   
Sbjct: 69  LN-HPAIV---AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIAD 124

Query: 150 LMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT------ 203
             Q +++ H NG++HRD+KP NI++   S+++ +K+ DFG+A   +A  +   +      
Sbjct: 125 ACQALNFSHQNGIIHRDVKPANIMI---SATNAVKVMDFGIA---RAIADSGNSVTQTAA 178

Query: 204 -VGSPFYIAPEVLAGGY-NQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAA---- 257
            +G+  Y++PE   G   +  +DV+S G +LY +L+G PPF G +       V  A    
Sbjct: 179 VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS------PVSVAYQHV 232

Query: 258 --DLRFPSDPWDHISASARDLIMGMLRVDPSTR-LTAAEVLA 296
             D   PS   + +SA    +++  L  +P  R  TAAE+ A
Sbjct: 233 REDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRA 274

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  141 bits (357), Expect = 2e-38
 Identities = 78/317 (24%), Positives = 135/317 (42%), Gaps = 51/317 (16%)

Query: 37  NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTK 96
           ++  RY     +G G +G++    D      +A K I           +    EI+I+ +
Sbjct: 24  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLR 81

Query: 97  LSGHPNVVDLKAV-----YEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLM 151
              H N++ +  +      E+   V+++ +L    +L ++L K    S          ++
Sbjct: 82  FR-HENIIGINDIIRAPTIEQMKDVYIVQDL-METDL-YKLLKTQHLSNDHICYFLYQIL 138

Query: 152 QVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT----VGSP 207
           + + Y H   V+HRDLKP N+LL   +++  +K+ DFGLA       +  G     V + 
Sbjct: 139 RGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195

Query: 208 FYIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAV---RAAD 258
           +Y APE++  + GY ++ D+WS G IL  +LS  P F GK      + I   +      D
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 255

Query: 259 LRF----------------PSDPWDHI----SASARDLIMGMLRVDPSTRLTAAEVLAHS 298
           L                     PW+ +     + A DL+  ML  +P  R+   + LAH 
Sbjct: 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 315

Query: 299 WME-----ECEQVAQKP 310
           ++E       E +A+ P
Sbjct: 316 YLEQYYDPSDEPIAEAP 332

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  140 bits (355), Expect = 4e-38
 Identities = 76/301 (25%), Positives = 134/301 (44%), Gaps = 44/301 (14%)

Query: 37  NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTK 96
            + +RY     +G G +G +    D  TG  +A K ++     ++   +    E+ ++  
Sbjct: 26  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKH 84

Query: 97  LSGHPNVVDLKAV------YEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHL 150
           +  H NV+ L  V       EE + V+L+  L  G +L + + K  + ++   + +   +
Sbjct: 85  MK-HENVIGLLDVFTPARSLEEFNDVYLVTHL-MGADL-NNIVKCQKLTDDHVQFLIYQI 141

Query: 151 MQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYI 210
           ++ + Y H   ++HRDLKP N+ +   +    +K+ DFGLA        + G V + +Y 
Sbjct: 142 LRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLAR--HTADEMTGYVATRWYR 196

Query: 211 APEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAV---RAADLRF 261
           APE++     YNQ  D+WS G I+  LL+G   F G         I   V    A  L+ 
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 256

Query: 262 ----------------PSDPWDHI----SASARDLIMGMLRVDPSTRLTAAEVLAHSWME 301
                           P   + ++    +  A DL+  ML +D   R+TAA+ LAH++  
Sbjct: 257 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 316

Query: 302 E 302
           +
Sbjct: 317 Q 317

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  140 bits (354), Expect = 5e-38
 Identities = 77/313 (24%), Positives = 131/313 (41%), Gaps = 49/313 (15%)

Query: 37  NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTK 96
            +   Y   + +G G +G +    D  TG  +A K +      +    +    E+ ++  
Sbjct: 22  EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLY-RPFQSELFAKRAYRELRLLKH 80

Query: 97  LSGHPNVVDLKAV------YEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHL 150
           +  H NV+ L  V       ++    +L+M    G +L  +L K+ +  E   + +   +
Sbjct: 81  MR-HENVIGLLDVFTPDETLDDFTDFYLVMPF-MGTDL-GKLMKHEKLGEDRIQFLVYQM 137

Query: 151 MQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYI 210
           ++ + Y H  G++HRDLKP N+ +   +    +K+ DFGLA   +A   + G V + +Y 
Sbjct: 138 LKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLAR--QADSEMTGYVVTRWYR 192

Query: 211 APEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAV---RAADLRF 261
           APEV+     Y Q  D+WS G I+  +++G   F G        +I        A  ++ 
Sbjct: 193 APEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 252

Query: 262 ----------------PSDPWDHI----SASARDLIMGMLRVDPSTRLTAAEVLAHSWME 301
                               +  I    S  A +L+  ML +D   R+TA E LAH + E
Sbjct: 253 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE 312

Query: 302 -----ECEQVAQK 309
                E E   QK
Sbjct: 313 SLHDTEDEPQVQK 325

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  138 bits (350), Expect = 7e-38
 Identities = 72/285 (25%), Positives = 122/285 (42%), Gaps = 32/285 (11%)

Query: 23  SSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVE 82
            S  GT             Y L + +G G  G + E  D     ++A K +  + L +  
Sbjct: 26  ESREGTQFG---------PYRLRRLVGRGGMGDVYEAEDTVRERIVALK-LMSETLSSDP 75

Query: 83  DVRS-IKLEIEIMTKLSGHPNVVDLKAVY---EEEDYVHLLMELCAGGELFHRLEKYGRF 138
             R+ ++ E     +L   P+VV    ++   E +  +++ M L  G +L   L + G  
Sbjct: 76  VFRTRMQREARTAGRLQ-EPHVV---PIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPL 131

Query: 139 SETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ 198
           +   A  I R +   +   H  G  HRD+KPENIL+   S+     L DFG+A    A  
Sbjct: 132 APPRAVAIVRQIGSALDAAHAAGATHRDVKPENILV---SADDFAYLVDFGIA---SATT 185

Query: 199 NLHGT-----VGSPFYIAPEVLAGGY-NQAADVWSAGVILYILLSGMPPFWGKTKSKIFD 252
           +   T     VG+ +Y+APE  +  +    AD+++   +LY  L+G PP+ G   S +  
Sbjct: 186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGA 245

Query: 253 AVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTR-LTAAEVLA 296
            +    +  PS     I  +   +I   +  +P  R +T  ++ A
Sbjct: 246 HIN-QAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  137 bits (347), Expect = 5e-37
 Identities = 69/311 (22%), Positives = 125/311 (40%), Gaps = 53/311 (17%)

Query: 37  NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTK 96
            +  RY   K +G G  G++    D      +A K ++          +    E+ +M  
Sbjct: 22  TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPFQNQTHAKRAYRELVLMKC 80

Query: 97  LSGHPNVVDLKAV------YEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHL 150
           +  H N++ L  V       EE   V+++MEL     L  ++ +           +   +
Sbjct: 81  V-NHKNIIGLLNVFTPQKSLEEFQDVYIVMEL-MDANL-CQVIQ-MELDHERMSYLLYQM 136

Query: 151 MQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYI 210
           +  + + H  G++HRDLKP NI++    S   +K+ DFGLA        +   V + +Y 
Sbjct: 137 LCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYR 193

Query: 211 APEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAV---RAADLRF- 261
           APEV+ G GY +  D+WS G I+  ++ G   F G       +K+ + +       ++  
Sbjct: 194 APEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 253

Query: 262 --------------PSDPWDHI----------------SASARDLIMGMLRVDPSTRLTA 291
                             ++ +                ++ ARDL+  ML +D S R++ 
Sbjct: 254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 313

Query: 292 AEVLAHSWMEE 302
            E L H ++  
Sbjct: 314 DEALQHPYINV 324

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  135 bits (341), Expect = 7e-37
 Identities = 64/268 (23%), Positives = 116/268 (43%), Gaps = 25/268 (9%)

Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
            +G+++G G FG + +   K+ G+V A K +      T + +++ K E+ ++ K   H N
Sbjct: 27  TVGQRIGSGSFGTVYKG--KWHGDV-AVKMLNVTAP-TPQQLQAFKNEVGVLRKTR-HVN 81

Query: 103 VVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQV---VSYCHG 159
           ++             ++ + C G  L+H L       E +  +      Q    + Y H 
Sbjct: 82  ILLFMGYSTAPQLA-IVTQWCEGSSLYHHLHASETKFEMKKLIDI--ARQTARGMDYLHA 138

Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIK---AGQNLHGTVGSPFYIAPEVLA 216
             ++HRDLK  NI L   ++   +K+ DFGLAT               GS  ++APEV+ 
Sbjct: 139 KSIIHRDLKSNNIFLHEDNT---VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 195

Query: 217 GG----YNQAADVWSAGVILYILLSGMPPFWGKT-KSKIFDAVRAADLRFPSDPW--DHI 269
                 Y+  +DV++ G++LY L++G  P+     + +I + V    L  P       + 
Sbjct: 196 MQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLS-PDLSKVRSNC 254

Query: 270 SASARDLIMGMLRVDPSTRLTAAEVLAH 297
               + L+   L+     R +   +LA 
Sbjct: 255 PKRMKRLMAECLKKKRDERPSFPRILAE 282

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  134 bits (340), Expect = 8e-37
 Identities = 47/266 (17%), Positives = 102/266 (38%), Gaps = 25/266 (9%)

Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
               +L     G +     ++ G  +  K + K R  +    R    E   +   S HPN
Sbjct: 13  NFLTKLNENHSGEL--WKGRWQGNDIVVK-VLKVRDWSTRKSRDFNEECPRLRIFS-HPN 68

Query: 103 VVDLKAVYEEEDYVHL--LMELCAGGELFHRLEKYGRFSETEARVIFRHLMQV---VSYC 157
           V+ +    +     H   +      G L++ L +   F   +++ + +  + +   +++ 
Sbjct: 69  VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAV-KFALDMARGMAFL 127

Query: 158 H--GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVL 215
           H     +    L   ++++         +++   +    ++     G + +P ++APE L
Sbjct: 128 HTLEPLIPRHALNSRSVMI---DEDMTARISMADVKFSFQSP----GRMYAPAWVAPEAL 180

Query: 216 AGG----YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISA 271
                    ++AD+WS  V+L+ L++   PF   +  +I   V    LR P+ P   IS 
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLR-PTIP-PGISP 238

Query: 272 SARDLIMGMLRVDPSTRLTAAEVLAH 297
               L+   +  DP+ R     ++  
Sbjct: 239 HVSKLMKICMNEDPAKRPKFDMIVPI 264

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  138 bits (350), Expect = 9e-37
 Identities = 68/311 (21%), Positives = 125/311 (40%), Gaps = 53/311 (17%)

Query: 37  NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTK 96
            +  RY   K +G G  G++    D      +A K ++          +    E+ +M  
Sbjct: 59  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPFQNQTHAKRAYRELVLMKC 117

Query: 97  LSGHPNVVDLKAV------YEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHL 150
           +  H N++ L  V       EE   V+L+MEL     L  ++ +           +   +
Sbjct: 118 V-NHKNIISLLNVFTPQKTLEEFQDVYLVMEL-MDANL-CQVIQ-MELDHERMSYLLYQM 173

Query: 151 MQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYI 210
           +  + + H  G++HRDLKP NI++    S   +K+ DFGLA        +   V + +Y 
Sbjct: 174 LCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYR 230

Query: 211 APEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAV---RAADLRF- 261
           APEV+ G GY +  D+WS G I+  ++     F G+      +K+ + +       ++  
Sbjct: 231 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290

Query: 262 --------------PSDPWDHI----------------SASARDLIMGMLRVDPSTRLTA 291
                             +  +                ++ ARDL+  ML +DP+ R++ 
Sbjct: 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 350

Query: 292 AEVLAHSWMEE 302
            + L H ++  
Sbjct: 351 DDALQHPYINV 361

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  137 bits (346), Expect = 9e-37
 Identities = 70/327 (21%), Positives = 134/327 (40%), Gaps = 72/327 (22%)

Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLS-- 98
           RY+L ++LGWG F  +    D      +A K +  D++ T     + + EI+++ +++  
Sbjct: 20  RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT----EAAEDEIKLLQRVNDA 75

Query: 99  --------GHPNVVDLKA--VYEEEDYVHLLM--ELCAGGELFHRLEK--YGRFSETEAR 144
                   G  +++ L     ++  + VH++M  E+  G  L   ++K  +        +
Sbjct: 76  DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVK 134

Query: 145 VIFRHLMQVVSYCHGN-GVVHRDLKPENILLATKSSS---SPIKLADFGLATYIKAGQNL 200
            I + L+  + Y H   G++H D+KPEN+L+    S      IK+AD G A +    ++ 
Sbjct: 135 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY--DEHY 192

Query: 201 HGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS---------------------- 237
             ++ +  Y +PEVL G  +   AD+WS   +++ L++                      
Sbjct: 193 TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 252

Query: 238 -----GMPPFW----GKTKSKIFDAVRAADLRFPSDPW----------DHISASAR---D 275
                G  P +    GK     F++            W                A+   D
Sbjct: 253 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISD 312

Query: 276 LIMGMLRVDPSTRLTAAEVLAHSWMEE 302
            +  ML++DP  R  A  ++ H W+++
Sbjct: 313 FLSPMLQLDPRKRADAGGLVNHPWLKD 339

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  135 bits (341), Expect = 1e-36
 Identities = 60/273 (21%), Positives = 115/273 (42%), Gaps = 29/273 (10%)

Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
           + G+ LG G FG   + + + TGEV+  K + +      E  R+   E+++M  L  HPN
Sbjct: 13  IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR---FDEETQRTFLKEVKVMRCLE-HPN 68

Query: 103 VVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQV---VSYCHG 159
           V+    V  ++  ++ + E   GG L   ++          RV F     +   ++Y H 
Sbjct: 69  VLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSF--AKDIASGMAYLHS 126

Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYI---------------KAGQNLHGTV 204
             ++HRDL   N L+     +  + +ADFGLA  +                  +  +  V
Sbjct: 127 MNIIHRDLNSHNCLV---RENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVV 183

Query: 205 GSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPS 263
           G+P+++APE++ G  Y++  DV+S G++L  ++  +          +   +         
Sbjct: 184 GNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRY 243

Query: 264 DPWDHISASARDLIMGMLRVDPSTRLTAAEVLA 296
            P  +   S   + +    +DP  R +  ++  
Sbjct: 244 CP-PNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  136 bits (344), Expect = 1e-36
 Identities = 70/311 (22%), Positives = 122/311 (39%), Gaps = 52/311 (16%)

Query: 37  NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVE--------DVRSIK 88
            +   Y + + +  G +G +    D   G  +A K +                   + + 
Sbjct: 19  AMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVL 77

Query: 89  LEIEIMTKLSGHPNVVDLKAV-----YEEEDYVHLLMELCAGGELFHRLEKYGRFSETEA 143
            EI ++     HPN++ L+ +           ++L+ EL    +L  ++    R   +  
Sbjct: 78  REIRLLNHFH-HPNILGLRDIFVHFEEPAMHKLYLVTEL-MRTDL-AQVIHDQRIVISPQ 134

Query: 144 RV--IFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLH 201
            +     H++  +   H  GVVHRDL P NILL   + ++ I + DF LA    A  N  
Sbjct: 135 HIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL---ADNNDITICDFNLAREDTADANKT 191

Query: 202 GTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAV- 254
             V   +Y APE++    G+ +  D+WSAG ++  + +    F G T     +KI + V 
Sbjct: 192 HYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVG 251

Query: 255 --RAADLRF-----------------PSDPWDHI----SASARDLIMGMLRVDPSTRLTA 291
             +  D+                   P+  W  +       A DLI  ML  +P  R++ 
Sbjct: 252 TPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRIST 311

Query: 292 AEVLAHSWMEE 302
            + L H + E 
Sbjct: 312 EQALRHPYFES 322

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  134 bits (340), Expect = 8e-36
 Identities = 84/354 (23%), Positives = 138/354 (38%), Gaps = 84/354 (23%)

Query: 37  NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAK--DRLVTVEDVRSIKLEIEIM 94
           ++  +Y L K+LG G +G++ +  D+ TGEV+A K I           D +    EI I+
Sbjct: 6   HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNST---DAQRTFREIMIL 62

Query: 95  TKLSGHPNVVDLKAVYEEEDY--VHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQ 152
           T+LSGH N+V+L  V   ++   V+L+ +     +L H + +         + +   L++
Sbjct: 63  TELSGHENIVNLLNVLRADNDRDVYLVFDY-METDL-HAVIRANILEPVHKQYVVYQLIK 120

Query: 153 VVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA-------------TYIKAGQN 199
           V+ Y H  G++HRD+KP NILL   ++   +K+ADFGL+                     
Sbjct: 121 VIKYLHSGGLLHRDMKPSNILL---NAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177

Query: 200 LHGTVGSPF---------YIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGK--- 245
            +     P          Y APE+L G   Y +  D+WS G IL  +L G P F G    
Sbjct: 178 ENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM 237

Query: 246 ---------------------------------------TKSKIFDAVRAADLRFPS-DP 265
                                                   +S   D            +P
Sbjct: 238 NQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINP 297

Query: 266 WDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWME-----ECEQVAQKPCKQD 314
               +  A DL+  +L+ +P+ R++A + L H ++        E          
Sbjct: 298 KADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIITIP 351

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  133 bits (338), Expect = 9e-36
 Identities = 71/337 (21%), Positives = 130/337 (38%), Gaps = 80/337 (23%)

Query: 37  NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSI-AKDRLVTVEDVRSIKLEIEIMT 95
            L++ +++ +++G G FG +  C      +  A K +    +       RS K+E +I+ 
Sbjct: 32  LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYT-----RSAKIEADILK 86

Query: 96  KLSGHP----NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGR--FSETEARVIFRH 149
           K+        N+V     +   D++ L+ E   G  L+  + +     F   + ++    
Sbjct: 87  KIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIE 145

Query: 150 LMQVVSYCHGNGVVHRDLKPENILL----------------------ATKSSSSPIKLAD 187
           +++ ++Y     + H DLKPENILL                        ++ S+ IKL D
Sbjct: 146 ILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLID 205

Query: 188 FGLATYIKAGQNLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWG-- 244
           FG AT+          + +  Y APEV+   G++ ++D+WS G +L  L +G   F    
Sbjct: 206 FGCATF--KSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHE 263

Query: 245 ------------------------KTKSKIFDAVRAADLRFPSDPWDHIS---------- 270
                                   KT    +       L +P +     S          
Sbjct: 264 HMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPL 323

Query: 271 ------ASARDLIMGMLRVDPSTRLTAAEVLAHSWME 301
                     D +  +L++DP+ R + AE+L H ++E
Sbjct: 324 YKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  133 bits (337), Expect = 1e-35
 Identities = 88/328 (26%), Positives = 138/328 (42%), Gaps = 59/328 (17%)

Query: 37  NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTK 96
           N+S  + L   LG G +GV+   + K TGE++A K I  +             EI+I+  
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI--EPFDKPLFALRTLREIKILKH 65

Query: 97  LSGHPNVVDLKAV-----YEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLM 151
              H N++ +  +     +E  + V+++ EL    +L HR+      S+   +      +
Sbjct: 66  FK-HENIITIFNIQRPDSFENFNEVYIIQEL-MQTDL-HRVISTQMLSDDHIQYFIYQTL 122

Query: 152 QVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA--TYIKAGQNLHGTVGSPF- 208
           + V   HG+ V+HRDLKP N+L+   +S+  +K+ DFGLA      A  N   T      
Sbjct: 123 RAVKVLHGSNVIHRDLKPSNLLI---NSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179

Query: 209 --------YIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAV 254
                   Y APEV+  +  Y++A DVWS G IL  L    P F G+        IF  +
Sbjct: 180 VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGII 239

Query: 255 ----RAADLRF----------------PSDPWDHI----SASARDLIMGMLRVDPSTRLT 290
                  DLR                 P+ P + +    +    DL+  ML  DP+ R+T
Sbjct: 240 GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRIT 299

Query: 291 AAEVLAHSWME-----ECEQVAQKPCKQ 313
           A E L H +++       E   +     
Sbjct: 300 AKEALEHPYLQTYHDPNDEPEGEPIPPS 327

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  133 bits (337), Expect = 4e-35
 Identities = 77/326 (23%), Positives = 120/326 (36%), Gaps = 73/326 (22%)

Query: 38  LSDRYVLGKQLGWGQFG-VIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTK 96
           ++ RY + K +G G FG V++   D    + +A K +  ++       R    EI I+  
Sbjct: 95  VAYRYEVLKVIGKGSFGQVVK-AYDHKVHQHVALKMVRNEK----RFHRQAAEEIRILEH 149

Query: 97  LSGHP-----NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEK--YGRFSETEARVIFRH 149
           L         NV+ +   +   +++ +  EL     L+  ++K  +  FS    R     
Sbjct: 150 LRKQDKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHS 208

Query: 150 LMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFY 209
           ++Q +   H N ++H DLKPENILL  +   S IK+ DFG + Y    Q ++  + S FY
Sbjct: 209 ILQCLDALHKNRIIHCDLKPENILL-KQQGRSGIKVIDFGSSCY--EHQRVYTYIQSRFY 265

Query: 210 IAPEVLAG-GYNQAADVWSAGVILYILLSG---------------------MPPFW---- 243
            APEV+ G  Y    D+WS G IL  LL+G                     MP       
Sbjct: 266 RAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDA 325

Query: 244 GKTKSKIFDAV--RAADLRFPSDPWDHISASAR--------------------------- 274
            K       +                 +    R                           
Sbjct: 326 SKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLF 385

Query: 275 -DLIMGMLRVDPSTRLTAAEVLAHSW 299
            D +   L  DP+ R+T  + L H W
Sbjct: 386 LDFLKQCLEWDPAVRMTPGQALRHPW 411

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  131 bits (331), Expect = 1e-34
 Identities = 74/333 (22%), Positives = 121/333 (36%), Gaps = 80/333 (24%)

Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSI-AKDRLVTVEDVRSIKLEIEIMTK 96
             DRY +   +G G FG + +  D+   E +A K I  K   +        ++E+ ++  
Sbjct: 52  WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFL-----NQAQIEVRLLEL 106

Query: 97  LSGHP-----NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGR--FSETEARVIFRH 149
           ++ H       +V LK  +   +++ L+ E+     L+  L        S    R   + 
Sbjct: 107 MNKHDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQ 165

Query: 150 LMQVVSYCHGN--GVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSP 207
           +   + +       ++H DLKPENILL      S IK+ DFG +  +  GQ ++  + S 
Sbjct: 166 MCTALLFLATPELSIIHCDLKPENILL-CNPKRSAIKIVDFGSSCQL--GQRIYQYIQSR 222

Query: 208 FYIAPEVLAG-GYNQAADVWSAGVILYILLSG---------------------MPPFW-- 243
           FY +PEVL G  Y+ A D+WS G IL  + +G                     +PP    
Sbjct: 223 FYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHIL 282

Query: 244 -------------------------------GKTKSKIFDAVRAADLRFPSDPWDHISAS 272
                                               K+ + +                 +
Sbjct: 283 DQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHT 342

Query: 273 AR------DLIMGMLRVDPSTRLTAAEVLAHSW 299
                   DLI+ ML  DP TR+     L HS+
Sbjct: 343 VADYLKFKDLILRMLDYDPKTRIQPYYALQHSF 375

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  127 bits (321), Expect = 2e-33
 Identities = 80/329 (24%), Positives = 120/329 (36%), Gaps = 74/329 (22%)

Query: 37  NLSDRYVLGKQLGWGQFGVIRECSDKFTG-EVLACKSI-AKDRLVTVEDVRSIKLEIEIM 94
            L +RY +   LG G FG + EC D   G   +A K I    +        + +LEI ++
Sbjct: 16  WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYR-----EAARLEINVL 70

Query: 95  TKL-----SGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGR--FSETEARVIF 147
            K+           V +   +    ++ +  EL  G   F  L++     +     R + 
Sbjct: 71  KKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMA 129

Query: 148 RHLMQVVSYCHGNGVVHRDLKPENILLATKS----------------SSSPIKLADFGLA 191
             L   + + H N + H DLKPENIL                      ++ I++ADFG A
Sbjct: 130 YQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA 189

Query: 192 TYIKAGQNLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPF-------- 242
           T+    ++    V +  Y  PEV+   G+ Q  DVWS G IL+    G   F        
Sbjct: 190 TF--DHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH 247

Query: 243 -------WGKTKSKIFDAVRAADLRFPSD-PWDHISASAR-------------------- 274
                   G   S +    R     +     WD  S+  R                    
Sbjct: 248 LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEH 307

Query: 275 ----DLIMGMLRVDPSTRLTAAEVLAHSW 299
               DL+  ML  DP+ R+T AE L H +
Sbjct: 308 VQLFDLMRRMLEFDPAQRITLAEALLHPF 336

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  125 bits (317), Expect = 5e-33
 Identities = 84/329 (25%), Positives = 121/329 (36%), Gaps = 74/329 (22%)

Query: 37  NLSDRYVLGKQLGWGQFGVIRECSD-KFTGEVLACKSI-AKDRLVTVEDVRSIKLEIEIM 94
            LS RY +   LG G FG + EC D K  G  +A K +   DR        + + EI+++
Sbjct: 11  VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYC-----EAARSEIQVL 65

Query: 95  TKL-----SGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGR--FSETEARVIF 147
             L     +     V +   +E   ++ ++ EL  G   +  +++ G   F     R + 
Sbjct: 66  EHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMA 124

Query: 148 RHLMQVVSYCHGNGVVHRDLKPENILLATKS----------------SSSPIKLADFGLA 191
             + + V++ H N + H DLKPENIL                      +  IK+ DFG A
Sbjct: 125 YQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA 184

Query: 192 TYIKAGQNLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKT---- 246
           TY    ++    V +  Y APEV+   G++Q  DVWS G IL     G   F        
Sbjct: 185 TY--DDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH 242

Query: 247 --------------------KSKIFD--------AVRAADLRFP-SDPWDHISASAR--- 274
                               K K F            A         P      S     
Sbjct: 243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEH 302

Query: 275 ----DLIMGMLRVDPSTRLTAAEVLAHSW 299
               DLI  ML  DP+ R+T  E L H +
Sbjct: 303 ERLFDLIQKMLEYDPAKRITLREALKHPF 331

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  122 bits (307), Expect = 5e-32
 Identities = 42/265 (15%), Positives = 73/265 (27%), Gaps = 41/265 (15%)

Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKL 97
            + RY L    G        +  D      +A   +    ++  + ++        ++++
Sbjct: 29  ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI 88

Query: 98  SGHPNVVDLKAVY---EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVV 154
              P V     V           ++ E   GG L    +     S   A    + L    
Sbjct: 89  D-KPGVA---RVLDVVHTRAGGLVVAEWIRGGSLQEVAD--TSPSPVGAIRAMQSLAAAA 142

Query: 155 SYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEV 214
              H  GV      P  + +   S    + LA                       +    
Sbjct: 143 DAAHRAGVALSIDHPSRVRV---SIDGDVVLAYPA-------------------TMPDA- 179

Query: 215 LAGGYNQAADVWSAGVILYILLSGMPPFWGKT-KSKIFDAVR--AADLRFPSDPWDHISA 271
                N   D+   G  LY LL    P      +S +  A R  A     P+D    I  
Sbjct: 180 -----NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPF 234

Query: 272 SARDLIMGMLRVDPSTRLTAAEVLA 296
               +    ++ D   R +A+ +L 
Sbjct: 235 QISAVAARSVQGDGGIR-SASTLLN 258

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  119 bits (299), Expect = 8e-30
 Identities = 86/410 (20%), Positives = 144/410 (35%), Gaps = 104/410 (25%)

Query: 3   TNNSEDSSQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDK 62
           T ++   SQ   Q    +  S  T ++        + DRY +   +G G +G + E  DK
Sbjct: 16  TQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDK 75

Query: 63  FTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDY-----VH 117
               V+A K I +     ++  R ++ EI I+ +L+ H +VV +  +   +D      ++
Sbjct: 76  LEKRVVAIKKILRVFEDLIDCKRILR-EIAILNRLN-HDHVVKVLDIVIPKDVEKFDELY 133

Query: 118 LLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATK 177
           +++E+ A  +           +E   + +  +L+  V Y H  G++HRDLKP N L+   
Sbjct: 134 VVLEI-ADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLV--- 189

Query: 178 SSSSPIKLADFGLA-------------------TYIKAGQNLHGTVGSPF---------Y 209
           +    +K+ DFGLA                     +      H                Y
Sbjct: 190 NQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWY 249

Query: 210 IAPEVLAG--GYNQAADVWSAGVIL-----------YILLSGMPPFWGKTK--------- 247
            APE++     Y +A DVWS G I                   P F G +          
Sbjct: 250 RAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKA 309

Query: 248 ---------------SKIFD-----------AVRAADLR--------FPSDPWDHI---- 269
                          + IF+           A+   D +                     
Sbjct: 310 GNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPAS 369

Query: 270 SASARDLIMGMLRVDPSTRLTAAEVLAHSWME-----ECEQVAQKPCKQD 314
           SA A  L+  ML  +P+ R+T  E LAH + +     E E  A +  +  
Sbjct: 370 SADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVETNATEKVRLP 419

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  117 bits (296), Expect = 2e-29
 Identities = 75/367 (20%), Positives = 139/367 (37%), Gaps = 102/367 (27%)

Query: 37  NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAK--DRLVTVEDVRSIKLEIEIM 94
           ++ D Y++   +G G +G +    DK T + +A K + +  + L+   D + I  EI I+
Sbjct: 23  HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLI---DCKRILREITIL 79

Query: 95  TKLSGHPNVVDLKAV-----YEEEDYVHLLMELCAGGELFHRLEKYG-RFSETEARVIFR 148
            +L     ++ L  +       + D +++++E+ A  +L  +L K     +E   + I  
Sbjct: 80  NRLK-SDYIIRLYDLIIPDDLLKFDELYIVLEI-ADSDL-KKLFKTPIFLTEEHIKTILY 136

Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA--------------TYI 194
           +L+   ++ H +G++HRDLKP N LL   +    +K+ DFGLA                 
Sbjct: 137 NLLLGENFIHESGIIHRDLKPANCLL---NQDCSVKVCDFGLARTINSEKDTNIVNDLEE 193

Query: 195 KAGQNLHGTVGSPF---------YIAPEVL--AGGYNQAADVWSAGVILYILLSGM---- 239
                 H                Y APE++     Y ++ D+WS G I   LL+ +    
Sbjct: 194 NEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253

Query: 240 -------PPFWGKTK---------------------SKIFDAV---RAADLRF------- 261
                  P F G +                      + IF+ +      DL+        
Sbjct: 254 NDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVI 313

Query: 262 ---------PSDPWDHI----SASARDLIMGMLRVDPSTRLTAAEVLAHSWME-----EC 303
                                S    +L+  ML+ +P+ R+T  + L H +++     + 
Sbjct: 314 KYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKL 373

Query: 304 EQVAQKP 310
           E  + K 
Sbjct: 374 ENFSTKK 380

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  113 bits (286), Expect = 6e-29
 Identities = 61/297 (20%), Positives = 110/297 (37%), Gaps = 57/297 (19%)

Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM-TKLSGHP 101
            L + +G G++G +      + GE +A K  +        D +S   E E+  T +  H 
Sbjct: 11  TLLECVGKGRYGEVWRG--SWQGENVAVKIFSS------RDEKSWFRETELYNTVMLRHE 62

Query: 102 NVV-----DLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFR-------H 149
           N++     D+ + +       L+      G L+  L+            I         H
Sbjct: 63  NILGFIASDMTSRHSSTQLW-LITHYHEMGSLYDYLQLT-TLDTVSCLRIVLSIASGLAH 120

Query: 150 L-MQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA-----TYIKAGQNLHGT 203
           L +++        + HRDLK +NIL+          +AD GLA     +  +     +  
Sbjct: 121 LHIEIFGTQGKPAIAHRDLKSKNILVKKNGQ---CCIADLGLAVMHSQSTNQLDVGNNPR 177

Query: 204 VGSPFYIAPEVLAG-------GYNQAADVWSAGVILYILLSG----------MPPFWGKT 246
           VG+  Y+APEVL            +  D+W+ G++L+ +              PPF+   
Sbjct: 178 VGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237

Query: 247 KSK-----IFDAVRAADLR--FPSDPWDHISASA-RDLIMGMLRVDPSTRLTAAEVL 295
            +      +   V     R   P+  +   + ++   L+      +PS RLTA  + 
Sbjct: 238 PNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIK 294

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  114 bits (288), Expect = 1e-28
 Identities = 54/221 (24%), Positives = 96/221 (43%), Gaps = 16/221 (7%)

Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
           VLG+Q+G G FG +     +    ++A KS  +   +  +       E  I+ + S HPN
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET--LPPDLKAKFLQEARILKQYS-HPN 173

Query: 103 VVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS---YCHG 159
           +V L  V  ++  ++++MEL  GG+    L   G     +  +    +    +   Y   
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQM--VGDAAAGMEYLES 231

Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYI---APEVLA 216
              +HRDL   N L+   +  + +K++DFG++     G            +   APE L 
Sbjct: 232 KCCIHRDLAARNCLV---TEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALN 288

Query: 217 GG-YNQAADVWSAGVILY-ILLSGMPPFWGKTKSKIFDAVR 255
            G Y+  +DVWS G++L+     G  P+   +  +  + V 
Sbjct: 289 YGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE 329

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score =  113 bits (284), Expect = 4e-28
 Identities = 74/374 (19%), Positives = 123/374 (32%), Gaps = 122/374 (32%)

Query: 37  NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLA---CKSIAKDRLVTVEDVRSIKLEIEI 93
             + RY + ++LGWG F  +    D    + +A    KS             +   EI +
Sbjct: 34  LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYT-------ETALDEIRL 86

Query: 94  MTKLS-------GHPNVVDLKAVYEEE--DYVH--LLMELCAGGELFHRLEK--YGRFSE 140
           +  +            VV L   ++    +  H  ++ E+  G  L   + K  Y     
Sbjct: 87  LKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEV-LGHHLLKWIIKSNYQGLPL 145

Query: 141 TEARVIFRHLMQVVSYCHG-NGVVHRDLKPENILLA------------------------ 175
              + I + ++Q + Y H    ++H D+KPENILL+                        
Sbjct: 146 PCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPP 205

Query: 176 ----------------------TKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPE 213
                                   +    +K+AD G A +    ++    + +  Y + E
Sbjct: 206 SGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACW--VHKHFTEDIQTRQYRSLE 263

Query: 214 VLAG-GYNQAADVWSAGVILYILLSG----------------------------MPPFW- 243
           VL G GYN  AD+WS   + + L +G                            +P    
Sbjct: 264 VLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLI 323

Query: 244 --GKTKSKIFDAVRAADLRFPSD--PWDHISASAR-------------DLIMGMLRVDPS 286
             GK   + F   +  DL+  +   PW                     D ++ ML + P 
Sbjct: 324 VAGKYSKEFFT--KKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPE 381

Query: 287 TRLTAAEVLAHSWM 300
            R TAAE L H W+
Sbjct: 382 KRATAAECLRHPWL 395

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  109 bits (275), Expect = 2e-27
 Identities = 63/233 (27%), Positives = 93/233 (39%), Gaps = 21/233 (9%)

Query: 43  VLGKQLGWGQFGVIRE----CSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLS 98
            L ++LG G FGV+R          T  V A K +  D L   E +     E+  M  L 
Sbjct: 21  RLLEKLGDGSFGVVRRGEWDAPSGKTVSV-AVKCLKPDVLSQPEAMDDFIREVNAMHSLD 79

Query: 99  GHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS--- 155
            H N++ L  V      + ++ EL   G L  RL K+           +   +QV     
Sbjct: 80  -HRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY--AVQVAEGMG 135

Query: 156 YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNL-HGTVGSPFYI---A 211
           Y      +HRDL   N+LLAT+     +K+ DFGL   +    +               A
Sbjct: 136 YLESKRFIHRDLAARNLLLATRDL---VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 192

Query: 212 PEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFP 262
           PE L    ++ A+D W  GV L+ + + G  P+ G   S+I   +     R P
Sbjct: 193 PESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 245

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  110 bits (276), Expect = 2e-27
 Identities = 65/296 (21%), Positives = 117/296 (39%), Gaps = 55/296 (18%)

Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM-TKLSGHP 101
           VL + +G G+FG +     K+ GE +A K  +        + RS   E EI  T +  H 
Sbjct: 45  VLQESIGKGRFGEVWRG--KWRGEEVAVKIFSS------REERSWFREAEIYQTVMLRHE 96

Query: 102 NVVDLKAVYEEEDYVH----LLMELCAGGELFHRLEKYG-------RFSETEARVIFRHL 150
           N++   A   +++       L+ +    G LF  L +Y        + + + A  +  HL
Sbjct: 97  NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGL-AHL 155

Query: 151 -MQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNL-----HGTV 204
            M++V       + HRDLK +NIL+    +     +AD GLA    +  +      +  V
Sbjct: 156 HMEIVGTQGKPAIAHRDLKSKNILVKKNGT---CCIADLGLAVRHDSATDTIDIAPNHRV 212

Query: 205 GSPFYIAPEVLAGG-------YNQAADVWSAGVILYILLSG----------MPPFWGKTK 247
           G+  Y+APEVL            + AD+++ G++ + +               P++    
Sbjct: 213 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 272

Query: 248 S-----KIFDAVRAADLR--FPSDPWDHISASA-RDLIMGMLRVDPSTRLTAAEVL 295
           S     ++   V    LR   P+      +      ++      + + RLTA  + 
Sbjct: 273 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 328

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  108 bits (271), Expect = 5e-27
 Identities = 60/221 (27%), Positives = 104/221 (47%), Gaps = 18/221 (8%)

Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
            +  +LG GQ+G + E   K     +A K++ K+  + VE+      E  +M ++  HPN
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLK---EAAVMKEIK-HPN 70

Query: 103 VVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS---YCHG 159
           +V L  V   E   +++ E    G L   L +  R   +   ++     Q+ S   Y   
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLL-YMATQISSAMEYLEK 129

Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYI---APEVLA 216
              +HRDL   N L+     +  +K+ADFGL+  +          G+ F I   APE LA
Sbjct: 130 KNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTYTAHA-GAKFPIKWTAPESLA 185

Query: 217 -GGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVR 255
              ++  +DVW+ GV+L+ + + GM P+ G   S++++ + 
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 226

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  105 bits (264), Expect = 3e-26
 Identities = 60/221 (27%), Positives = 104/221 (47%), Gaps = 20/221 (9%)

Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
              +++G GQFG++         +V A K+I ++  ++ ED      E E+M KLS HP 
Sbjct: 11  TFVQEIGSGQFGLVHLGYWLNKDKV-AIKTI-REGAMSEEDFIE---EAEVMMKLS-HPK 64

Query: 103 VVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS---YCHG 159
           +V L  V  E+  + L+ E    G L   L          A  +    + V     Y   
Sbjct: 65  LVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEE 122

Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYI---APEVLA 216
             V+HRDL   N L+     +  IK++DFG+  ++   Q    + G+ F +   +PEV +
Sbjct: 123 ACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFS 178

Query: 217 -GGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVR 255
              Y+  +DVWS GV+++ + S G  P+  ++ S++ + + 
Sbjct: 179 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS 219

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  106 bits (266), Expect = 5e-26
 Identities = 54/234 (23%), Positives = 93/234 (39%), Gaps = 39/234 (16%)

Query: 43  VLGKQLGWGQFGVIREC-----SDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKL 97
              K LG G FG + +       +K    V A K + +    + +  + I  E  +M  +
Sbjct: 18  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREA--TSPKANKEILDEAYVMASV 74

Query: 98  SGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSY 156
             +P+V  L  +      V L+ +L   G L   + ++                  ++++
Sbjct: 75  D-NPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIG----------SQYLLNW 122

Query: 157 CHG----------NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGS 206
           C              +VHRDL   N+L+ T      +K+ DFGLA  + A +  +   G 
Sbjct: 123 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGG 179

Query: 207 PFYI---APEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVR 255
              I   A E +    Y   +DVWS GV ++ L++ G  P+ G   S+I   + 
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  108 bits (272), Expect = 5e-26
 Identities = 57/222 (25%), Positives = 102/222 (45%), Gaps = 16/222 (7%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
               +  +LG GQ+G + E   K     +A K++ K+  + VE+      E  +M ++  
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLK---EAAVMKEIK- 274

Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS---Y 156
           HPN+V L  V   E   +++ E    G L   L +  R   +   ++     Q+ S   Y
Sbjct: 275 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLL-YMATQISSAMEY 333

Query: 157 CHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGS-PF-YIAPEV 214
                 +HR+L   N L+     +  +K+ADFGL+  +             P  + APE 
Sbjct: 334 LEKKNFIHRNLAARNCLV---GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 390

Query: 215 LA-GGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAV 254
           LA   ++  +DVW+ GV+L+ + + GM P+ G   S++++ +
Sbjct: 391 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 432

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  104 bits (263), Expect = 5e-26
 Identities = 61/221 (27%), Positives = 105/221 (47%), Gaps = 20/221 (9%)

Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
            L K+LG GQFGV++    K   +V A K I K+  ++ ++      E + M KLS HP 
Sbjct: 11  TLLKELGSGQFGVVKLGKWKGQYDV-AVKMI-KEGSMSEDEFFQ---EAQTMMKLS-HPK 64

Query: 103 VVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS---YCHG 159
           +V    V  +E  ++++ E  + G L + L  +G+    E   +      V     +   
Sbjct: 65  LVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGK--GLEPSQLLEMCYDVCEGMAFLES 122

Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYI---APEVLA 216
           +  +HRDL   N L+        +K++DFG+  Y+        +VG+ F +   APEV  
Sbjct: 123 HQFIHRDLAARNCLV---DRDLCVKVSDFGMTRYVL-DDQYVSSVGTKFPVKWSAPEVFH 178

Query: 217 -GGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVR 255
              Y+  +DVW+ G++++ + S G  P+   T S++   V 
Sbjct: 179 YFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS 219

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  106 bits (266), Expect = 6e-26
 Identities = 68/297 (22%), Positives = 111/297 (37%), Gaps = 57/297 (19%)

Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM-TKLSGHP 101
            + KQ+G G++G +     K+ GE +A K           +  S   E EI  T L  H 
Sbjct: 40  QMVKQIGKGRYGEVWMG--KWRGEKVAVKVFFT------TEEASWFRETEIYQTVLMRHE 91

Query: 102 NVV-----DLKAVYEEEDYVHLLMELCAGGELFHRLEKYG-------RFSETEARVIFRH 149
           N++     D+K          L+ +    G L+  L+          + + +    +  H
Sbjct: 92  NILGFIAADIKGTGSWTQLY-LITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGL-CH 149

Query: 150 L-MQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNL-----HGT 203
           L  ++ S      + HRDLK +NIL+    +     +AD GLA    +  N      +  
Sbjct: 150 LHTEIFSTQGKPAIAHRDLKSKNILVKKNGT---CCIADLGLAVKFISDTNEVDIPPNTR 206

Query: 204 VGSPFYIAPEVLAGG-------YNQAADVWSAGVILYILLSG----------MPPFWGKT 246
           VG+  Y+ PEVL              AD++S G+IL+ +               P+    
Sbjct: 207 VGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV 266

Query: 247 KS-----KIFDAVRAADLR--FPSDPWDH-ISASARDLIMGMLRVDPSTRLTAAEVL 295
            S      + + V    LR  FP+             L+      +P++RLTA  V 
Sbjct: 267 PSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVK 323

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  104 bits (261), Expect = 2e-25
 Identities = 58/226 (25%), Positives = 100/226 (44%), Gaps = 22/226 (9%)

Query: 43  VLGKQLGWGQFGVIRE---CSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           +  K+LG G FG +++      K    V A K + K+          +  E  +M +L  
Sbjct: 20  LEDKELGSGNFGTVKKGYYQMKKVVKTV-AVKIL-KNEANDPALKDELLAEANVMQQLD- 76

Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS---Y 156
           +P +V +  + E E    L+ME+   G L   L++     +     I   + QV     Y
Sbjct: 77  NPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKN---IIELVHQVSMGMKY 132

Query: 157 CHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNL-HGTVGSPFYI---AP 212
              +  VHRDL   N+LL T+      K++DFGL+  ++A +N         + +   AP
Sbjct: 133 LEESNFVHRDLAARNVLLVTQHY---AKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 189

Query: 213 EVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRA 256
           E +    ++  +DVWS GV+++   S G  P+ G   S++   +  
Sbjct: 190 ECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK 235

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  103 bits (260), Expect = 3e-25
 Identities = 72/287 (25%), Positives = 111/287 (38%), Gaps = 51/287 (17%)

Query: 4   NNSEDSSQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIREC---- 59
           ++  D    +T+               D TQ           +QLG G FG +  C    
Sbjct: 7   HHHHDYDIPTTENLYFQGAMGSAFEDRDPTQFEE--RHLKFLQQLGKGNFGSVEMCRYDP 64

Query: 60  SDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAV--YEEEDYVH 117
               TGEV+A K +      T E +R  + EIEI+  L  H N+V  K V        + 
Sbjct: 65  LQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSAGRRNLK 120

Query: 118 LLMELCAGGELFHRLEKYGRFSETEARVIFRHLM----QVVS---YCHGNGVVHRDLKPE 170
           L+ME    G L   L+K+      + R+    L+    Q+     Y      +HRDL   
Sbjct: 121 LIMEYLPYGSLRDYLQKH------KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATR 174

Query: 171 NILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSP-----FYIAPEVLA-GGYNQAAD 224
           NIL+  ++    +K+ DFGL   +   +  +  V  P     F+ APE L    ++ A+D
Sbjct: 175 NILVENENR---VKIGDFGLTKVLPQDKEYY-KVKEPGESPIFWYAPESLTESKFSVASD 230

Query: 225 VWSAGVILYILLS----------------GMPPFWGKTKSKIFDAVR 255
           VWS GV+LY L +                G           + + ++
Sbjct: 231 VWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 277

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  103 bits (259), Expect = 3e-25
 Identities = 68/259 (26%), Positives = 101/259 (38%), Gaps = 49/259 (18%)

Query: 31  DATQISNLSDRYVLGKQLGWGQFGVIREC----SDKFTGEVLACKSIAKDRLVTVEDVRS 86
           D TQ           +QLG G FG +  C        TGEV+A K +      T E +R 
Sbjct: 3   DPTQFEE--RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRD 57

Query: 87  IKLEIEIMTKLSGHPNVVDLKAV--YEEEDYVHLLMELCAGGELFHRLEKYGRFSETEAR 144
            + EIEI+  L  H N+V  K V        + L+ME    G L   L+K+      + R
Sbjct: 58  FEREIEILKSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH------KER 110

Query: 145 VIFRHLM----QVVS---YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG 197
           +    L+    Q+     Y      +HRDL   NIL+  ++    +K+ DFGL   +   
Sbjct: 111 IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQD 167

Query: 198 QNL-HGTVGSPFYI---APEVLA-GGYNQAADVWSAGVILYILLS--------------- 237
           +            I   APE L    ++ A+DVWS GV+LY L +               
Sbjct: 168 KEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRM 227

Query: 238 -GMPPFWGKTKSKIFDAVR 255
            G           + + ++
Sbjct: 228 IGNDKQGQMIVFHLIELLK 246

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  102 bits (256), Expect = 5e-25
 Identities = 61/227 (26%), Positives = 95/227 (41%), Gaps = 30/227 (13%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
               L + +G G+FG +      + G  +A K I  D   T +   +   E  +MT+L  
Sbjct: 21  KELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKND--ATAQAFLA---EASVMTQLR- 72

Query: 100 HPNVVDLKAV-YEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS--- 155
           H N+V L  V  EE+  ++++ E  A G L   L   GR S      + +  + V     
Sbjct: 73  HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAME 131

Query: 156 YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA--TYIKAGQNLHGTVGSPFYI--- 210
           Y  GN  VHRDL   N+L+   S  +  K++DFGL                     +   
Sbjct: 132 YLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASST-------QDTGKLPVKWT 181

Query: 211 APEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVR 255
           APE L    ++  +DVWS G++L+ + S G  P+       +   V 
Sbjct: 182 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 228

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  103 bits (258), Expect = 5e-25
 Identities = 69/322 (21%), Positives = 121/322 (37%), Gaps = 57/322 (17%)

Query: 18  NSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDR 77
             +     +G  L    +   S    L +    G+FG + +   +   E +A K      
Sbjct: 2   GHHHHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKA--QLLNEYVAVK------ 53

Query: 78  LVTVEDVRSI--KLEIEIMTKLSGHPNVVDLKAVYEEEDYVH----LLMELCAGGELFHR 131
           +  ++D +S   + E+  +  +  H N++      +    V     L+      G L   
Sbjct: 54  IFPIQDKQSWQNEYEVYSLPGMK-HENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDF 112

Query: 132 LEKYGRFSETE----ARVIFR---HLMQVVSYCHGN---GVVHRDLKPENILLATKSSSS 181
           L K    S  E    A  + R   +L + +          + HRD+K +N+LL  K++ +
Sbjct: 113 L-KANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL--KNNLT 169

Query: 182 PIKLADFGLATYIKAGQNL---HGTVGSPFYIAPEVLAGG------YNQAADVWSAGVIL 232
              +ADFGLA   +AG++    HG VG+  Y+APEVL G            D+++ G++L
Sbjct: 170 A-CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVL 228

Query: 233 YILLSG-----------MPPFWGK-----TKSKIFDAV--RAADLRFPSDPWDHISASA- 273
           + L S            M PF  +     +   + + V  +            H   +  
Sbjct: 229 WELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAML 288

Query: 274 RDLIMGMLRVDPSTRLTAAEVL 295
            + I      D   RL+A  V 
Sbjct: 289 CETIEECWDHDAEARLSAGCVG 310

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  105 bits (263), Expect = 6e-25
 Identities = 63/223 (28%), Positives = 99/223 (44%), Gaps = 18/223 (8%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           +   L  +LG G FG +   +   T  V A K++ K   ++ E       E ++M KL  
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTL-KPGTMSPEAFLQ---EAQVMKKLR- 237

Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS---Y 156
           H  +V L AV  EE  ++++ E  + G L   L+          +++     Q+ S   Y
Sbjct: 238 HEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLV-DMAAQIASGMAY 295

Query: 157 CHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGS-PF-YIAPEV 214
                 VHRDL+  NIL+     +   K+ADFGLA  I+  +         P  + APE 
Sbjct: 296 VERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 352

Query: 215 LA-GGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVR 255
              G +   +DVWS G++L  L + G  P+ G    ++ D V 
Sbjct: 353 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 395

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  102 bits (256), Expect = 6e-25
 Identities = 61/226 (26%), Positives = 105/226 (46%), Gaps = 24/226 (10%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           +   L ++LG GQFG +         +V A KS+ K   ++ +   +   E  +M +L  
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSL-KQGSMSPDAFLA---EANLMKQLQ- 66

Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLM--QVVS-- 155
           H  +V L AV  +E  ++++ E    G L   L+       T  +++    M  Q+    
Sbjct: 67  HQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLL---DMAAQIAEGM 122

Query: 156 -YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYI---A 211
            +      +HRDL+  NIL+   S +   K+ADFGLA  I+  +      G+ F I   A
Sbjct: 123 AFIEERNYIHRDLRAANILV---SDTLSCKIADFGLARLIEDNEYTARE-GAKFPIKWTA 178

Query: 212 PEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVR 255
           PE +  G +   +DVWS G++L  +++ G  P+ G T  ++   + 
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 224

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  101 bits (255), Expect = 9e-25
 Identities = 57/221 (25%), Positives = 104/221 (47%), Gaps = 20/221 (9%)

Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
              K+LG GQFGV++    +   +V A K I K+  ++ ++      E ++M  LS H  
Sbjct: 27  TFLKELGTGQFGVVKYGKWRGQYDV-AIKMI-KEGSMSEDEFIE---EAKVMMNLS-HEK 80

Query: 103 VVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS---YCHG 159
           +V L  V  ++  + ++ E  A G L + L +       + + +      V     Y   
Sbjct: 81  LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLES 138

Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYI---APEVLA 216
              +HRDL   N L+   +    +K++DFGL+ Y+   +    +VGS F +    PEVL 
Sbjct: 139 KQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLM 194

Query: 217 -GGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVR 255
              ++  +D+W+ GV+++ + S G  P+   T S+  + + 
Sbjct: 195 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA 235

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  104 bits (262), Expect = 1e-24
 Identities = 60/224 (26%), Positives = 95/224 (42%), Gaps = 30/224 (13%)

Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
            L + +G G+FG +      + G  +A K I  D   T +   +   E  +MT+L  H N
Sbjct: 196 KLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKND--ATAQAFLA---EASVMTQLR-HSN 247

Query: 103 VVDLKAV-YEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS---YCH 158
           +V L  V  EE+  ++++ E  A G L   L   GR       ++ +  + V     Y  
Sbjct: 248 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL-KFSLDVCEAMEYLE 306

Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLA--TYIKAGQNLHGTVGSPFYI---APE 213
           GN  VHRDL   N+L+   S  +  K++DFGL                     +   APE
Sbjct: 307 GNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASST-------QDTGKLPVKWTAPE 356

Query: 214 VLA-GGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVR 255
            L    ++  +DVWS G++L+ + S G  P+       +   V 
Sbjct: 357 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 400

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  102 bits (257), Expect = 1e-24
 Identities = 60/224 (26%), Positives = 96/224 (42%), Gaps = 32/224 (14%)

Query: 43  VLGKQLGWGQFGVIREC----SDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLS 98
               QLG G FG +  C        TG ++A K +         D +    EI+I+  L 
Sbjct: 26  KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQR---EIQILKALH 82

Query: 99  GHPNVVDLKAV--YEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLM----Q 152
               +V  + V        + L+ME    G L   L+++       AR+    L+    Q
Sbjct: 83  -SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRH------RARLDASRLLLYSSQ 135

Query: 153 VVS---YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGS 206
           +     Y      VHRDL   NIL+ +++    +K+ADFGLA  +   ++   +     S
Sbjct: 136 ICKGMEYLGSRRCVHRDLAARNILVESEAH---VKIADFGLAKLLPLDKDYYVVREPGQS 192

Query: 207 P-FYIAPEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGKTK 247
           P F+ APE L+   +++ +DVWS GV+LY L +          +
Sbjct: 193 PIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAE 236

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  102 bits (256), Expect = 1e-24
 Identities = 61/228 (26%), Positives = 102/228 (44%), Gaps = 24/228 (10%)

Query: 43  VLGKQLGWGQFGVIRECSDKFTGE----VLACKSIAKDRLVTVEDVRSIKLEIEIMTKLS 98
            + K +G G  G +     +  G+    V A K++      T    R    E  IM +  
Sbjct: 52  HIEKIIGSGDSGEVCYGRLRVPGQRDVPV-AIKALKAG--YTERQRRDFLSEASIMGQFD 108

Query: 99  GHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVS-- 155
            HPN++ L+ V        ++ E    G L   L  + G+F+  +   +   L  V +  
Sbjct: 109 -HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQ---LVGMLRGVGAGM 164

Query: 156 -YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNL-HGTVGSPFYI--- 210
            Y    G VHRDL   N+L+    S+   K++DFGL+  ++   +  + T G    I   
Sbjct: 165 RYLSDLGYVHRDLAARNVLV---DSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT 221

Query: 211 APEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRA 256
           APE +A   ++ A+DVWS GV+++ +L+ G  P+W  T   +  +V  
Sbjct: 222 APEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEE 269

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  104 bits (261), Expect = 2e-24
 Identities = 63/223 (28%), Positives = 99/223 (44%), Gaps = 18/223 (8%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           +   L  +LG G FG +   +   T  V A K++ K   ++ E       E ++M KL  
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTL-KPGTMSPEAFLQ---EAQVMKKLR- 320

Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS---Y 156
           H  +V L AV  EE  ++++ E  + G L   L+          +++     Q+ S   Y
Sbjct: 321 HEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLV-DMAAQIASGMAY 378

Query: 157 CHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGS-PF-YIAPEV 214
                 VHRDL+  NIL+     +   K+ADFGLA  I+  +         P  + APE 
Sbjct: 379 VERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 435

Query: 215 LA-GGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVR 255
              G +   +DVWS G++L  L + G  P+ G    ++ D V 
Sbjct: 436 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 478

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  100 bits (252), Expect = 2e-24
 Identities = 57/229 (24%), Positives = 95/229 (41%), Gaps = 21/229 (9%)

Query: 40  DRYVLGK-QLGWGQFGVIRECSDKFTGEVL--ACKSIAKDRLVTVEDVRSIKLEIEIMTK 96
           D  ++   +LG G FG +R+   +   + +  A K + +       D   +  E +IM +
Sbjct: 9   DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQ 66

Query: 97  LSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS- 155
           L  +P +V L  V + E  + L+ME+  GG L   L                 L QV   
Sbjct: 67  LD-NPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAEL--LHQVSMG 122

Query: 156 --YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNL-HGTVGSPFYI-- 210
             Y      VHRDL   N+LL  +      K++DFGL+  + A  +         + +  
Sbjct: 123 MKYLEEKNFVHRDLAARNVLLVNRHY---AKISDFGLSKALGADDSYYTARSAGKWPLKW 179

Query: 211 -APEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRA 256
            APE +    ++  +DVWS GV ++  LS G  P+      ++   +  
Sbjct: 180 YAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 228

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  102 bits (255), Expect = 4e-24
 Identities = 63/234 (26%), Positives = 103/234 (44%), Gaps = 38/234 (16%)

Query: 43  VLGKQLGWGQFGVIRE----CSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLS 98
            + K +G G+FG +         K    V A K++      T +  R    E  IM +  
Sbjct: 48  SIDKVVGAGEFGEVCSGRLKLPSKKEISV-AIKTLKVG--YTEKQRRDFLGEASIMGQFD 104

Query: 99  GHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYC 157
            HPN++ L+ V  +   V ++ E    G L   L K+  +F+          ++Q+V   
Sbjct: 105 -HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFT----------VIQLVGML 153

Query: 158 HG----------NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNL-HGTVGS 206
            G           G VHRDL   NIL+   +S+   K++DFGL   ++      + T G 
Sbjct: 154 RGIASGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLGRVLEDDPEAAYTTRGG 210

Query: 207 PFYI---APEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVR 255
              I   +PE +A   +  A+DVWS G++L+ ++S G  P+W  +   +  AV 
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD 264

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  100 bits (252), Expect = 5e-24
 Identities = 58/233 (24%), Positives = 103/233 (44%), Gaps = 37/233 (15%)

Query: 43  VLGKQLGWGQFGVIRE---CSDKFTGEVL-ACKSIAKDRLVTVEDVRSIKLEIEIMTKLS 98
              K +G G+FG + +    +     EV  A K++      T +       E  IM + S
Sbjct: 47  TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG--YTEKQRVDFLGEAGIMGQFS 104

Query: 99  GHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYC 157
            H N++ L+ V  +   + ++ E    G L   L +  G FS          ++Q+V   
Sbjct: 105 -HHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFS----------VLQLVGML 153

Query: 158 HG----------NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNL-HGTVGS 206
            G             VHRDL   NIL+   +S+   K++DFGL+  ++      + T G 
Sbjct: 154 RGIAAGMKYLANMNYVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDDPEATYTTSGG 210

Query: 207 PFYI---APEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAV 254
              I   APE ++   +  A+DVWS G++++ +++ G  P+W  +  ++  A+
Sbjct: 211 KIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI 263

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  100 bits (250), Expect = 7e-24
 Identities = 55/226 (24%), Positives = 95/226 (42%), Gaps = 23/226 (10%)

Query: 43  VLGKQLGWGQFGVIREC-----SDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKL 97
              K LG G FG + +       +K    V A K + +    + +  + I  E  +M  +
Sbjct: 18  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREA--TSPKANKEILDEAYVMASV 74

Query: 98  SGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS-- 155
             +P+V  L  +      V L+ +L   G L   + ++       ++ +    +Q+    
Sbjct: 75  D-NPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGM 130

Query: 156 -YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYI---A 211
            Y     +VHRDL   N+L+ T      +K+ DFGLA  + A +  +   G    I   A
Sbjct: 131 NYLEDRRLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187

Query: 212 PEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVR 255
            E +    Y   +DVWS GV ++ L++ G  P+ G   S+I   + 
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 99.7 bits (249), Expect = 1e-23
 Identities = 49/225 (21%), Positives = 94/225 (41%), Gaps = 21/225 (9%)

Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVL----ACKSIAKDRLVTVEDVRSIKLEIEIMTKLS 98
              K LG G FG + +      GE +      K I        +  +++   +  +  L 
Sbjct: 16  RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDK--SGRQSFQAVTDHMLAIGSLD 73

Query: 99  GHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS--- 155
            H ++V L  +      + L+ +    G L   + ++        +++    +Q+     
Sbjct: 74  -HAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRG--ALGPQLLLNWGVQIAKGMY 129

Query: 156 YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYI---AP 212
           Y   +G+VHR+L   N+LL + S    +++ADFG+A  +           +   I   A 
Sbjct: 130 YLEEHGMVHRNLAARNVLLKSPSQ---VQVADFGVADLLPPDDKQLLYSEAKTPIKWMAL 186

Query: 213 EVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVR 255
           E +  G Y   +DVWS GV ++ L++ G  P+ G   +++ D + 
Sbjct: 187 ESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE 231

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  101 bits (253), Expect = 1e-23
 Identities = 64/225 (28%), Positives = 107/225 (47%), Gaps = 28/225 (12%)

Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN 102
            L K+LG GQFG +   +     +V A K++ K   ++VE   +   E  +M  L  H  
Sbjct: 191 KLEKKLGAGQFGEVWMATYNKHTKV-AVKTM-KPGSMSVEAFLA---EANVMKTLQ-HDK 244

Query: 103 VVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLM----QVVS--- 155
           +V L AV  +E  ++++ E  A G L   L+         ++     L+    Q+     
Sbjct: 245 LVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEG-----SKQPLPKLIDFSAQIAEGMA 298

Query: 156 YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYI---AP 212
           +      +HRDL+  NIL+   S+S   K+ADFGLA  I+  +      G+ F I   AP
Sbjct: 299 FIEQRNYIHRDLRAANILV---SASLVCKIADFGLARVIEDNEYTARE-GAKFPIKWTAP 354

Query: 213 EVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVR 255
           E +  G +   +DVWS G++L  +++ G  P+ G +  ++  A+ 
Sbjct: 355 EAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE 399

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 98.9 bits (247), Expect = 1e-23
 Identities = 64/261 (24%), Positives = 103/261 (39%), Gaps = 47/261 (18%)

Query: 28  TILDATQISNLSDRYVLGKQLGWGQFGVIREC----SDKFTGEVLACKSIAKDRLVTVED 83
           T +D T            + LG G FG +  C        TGE +A KS+  +       
Sbjct: 11  TEVDPTHFEK--RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE--SGGNH 66

Query: 84  VRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDY--VHLLMELCAGGELFHRLEKYGRFSET 141
           +  +K EIEI+  L  H N+V  K +  E+    + L+ME    G L   L K       
Sbjct: 67  IADLKKEIEILRNLY-HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN------ 119

Query: 142 EARVIFRHLM----QVVS---YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI 194
           + ++  +  +    Q+     Y      VHRDL   N+L+ ++     +K+ DFGL   I
Sbjct: 120 KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ---VKIGDFGLTKAI 176

Query: 195 KAGQNL-HGTVGSPFYI---APEVLA-GGYNQAADVWSAGVILYILLS------------ 237
           +  +            +   APE L    +  A+DVWS GV L+ LL+            
Sbjct: 177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALF 236

Query: 238 ---GMPPFWGKTKSKIFDAVR 255
                P     T +++ + ++
Sbjct: 237 LKMIGPTHGQMTVTRLVNTLK 257

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  101 bits (254), Expect = 2e-23
 Identities = 57/224 (25%), Positives = 93/224 (41%), Gaps = 22/224 (9%)

Query: 43  VLGKQLGWGQFGVIRE---CSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           +   +LG G FG +R+      K   +V A K + +       D   +  E +IM +L  
Sbjct: 339 IADIELGCGNFGSVRQGVYRMRKKQIDV-AIKVLKQG--TEKADTEEMMREAQIMHQLD- 394

Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS---Y 156
           +P +V L  V + E  + L+ME+  GG L   L                 L QV     Y
Sbjct: 395 NPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAEL--LHQVSMGMKY 451

Query: 157 CHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNL-HGTVGSPFYI---AP 212
                 VHR+L   N+LL  +      K++DFGL+  + A  +         + +   AP
Sbjct: 452 LEEKNFVHRNLAARNVLLVNRHY---AKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 508

Query: 213 EVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAV 254
           E +    ++  +DVWS GV ++  LS G  P+      ++   +
Sbjct: 509 ECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 552

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 98.9 bits (247), Expect = 2e-23
 Identities = 61/216 (28%), Positives = 93/216 (43%), Gaps = 32/216 (14%)

Query: 40  DRYVLGKQLGWGQFGVIREC----SDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMT 95
                 + LG G FG +       ++  TGE++A K++  D     +     K EI+I+ 
Sbjct: 31  RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--AGPQHRSGWKQEIDILR 88

Query: 96  KLSGHPNVVDLKAVYEEEDY--VHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLM-- 151
            L  H +++  K   E+     + L+ME    G L   L ++         +    L+  
Sbjct: 89  TLY-HEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH--------SIGLAQLLLF 139

Query: 152 --QVVS---YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN---LHGT 203
             Q+     Y H    +HRDL   N+LL        +K+ DFGLA  +  G     +   
Sbjct: 140 AQQICEGMAYLHAQHYIHRDLAARNVLLDNDRL---VKIGDFGLAKAVPEGHEYYRVRED 196

Query: 204 VGSP-FYIAPEVLA-GGYNQAADVWSAGVILYILLS 237
             SP F+ APE L    +  A+DVWS GV LY LL+
Sbjct: 197 GDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 99.0 bits (247), Expect = 3e-23
 Identities = 66/271 (24%), Positives = 113/271 (41%), Gaps = 34/271 (12%)

Query: 9   SSQLSTQFCNSYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIREC------SDK 62
           +S + T +  +Y  +  T +I D  ++        L + LG G FG + E       +D 
Sbjct: 42  TSTIMTDYNPNYCFAGKTSSISDLKEVPR--KNITLIRGLGHGAFGEVYEGQVSGMPNDP 99

Query: 63  FTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMEL 122
              +V A K++ +    + +D     +E  I++K + H N+V    V  +     +L+EL
Sbjct: 100 SPLQV-AVKTLPEV--CSEQDELDFLMEALIISKFN-HQNIVRCIGVSLQSLPRFILLEL 155

Query: 123 CAGGELFHRLEKYGRFSETEARVIFRHLMQVV-------SYCHGNGVVHRDLKPENILLA 175
            AGG+L   L +        + +    L+ V         Y   N  +HRD+   N LL 
Sbjct: 156 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLT 215

Query: 176 TKSSSSPIKLADFGLA-------TYIKAGQNLHGTVGSPF-YIAPEVLA-GGYNQAADVW 226
                   K+ DFG+A        Y K G  +      P  ++ PE    G +    D W
Sbjct: 216 CPGPGRVAKIGDFGMARDIYRAGYYRKGGCAM-----LPVKWMPPEAFMEGIFTSKTDTW 270

Query: 227 SAGVILYILLS-GMPPFWGKTKSKIFDAVRA 256
           S GV+L+ + S G  P+  K+  ++ + V +
Sbjct: 271 SFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS 301

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 98.1 bits (245), Expect = 4e-23
 Identities = 65/260 (25%), Positives = 107/260 (41%), Gaps = 34/260 (13%)

Query: 20  YKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIREC------SDKFTGEVLACKSI 73
           Y  +  T +I D  ++        L + LG G FG + E       +D    +V A K++
Sbjct: 12  YCFAGKTSSISDLKEVPR--KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQV-AVKTL 68

Query: 74  AKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLE 133
            +    + +D     +E  I++K + H N+V    V  +     +LMEL AGG+L   L 
Sbjct: 69  PEV--CSEQDELDFLMEALIISKFN-HQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLR 125

Query: 134 KYGRFSETEARVIFRHLMQVV-------SYCHGNGVVHRDLKPENILLATKSSSSPIKLA 186
           +        + +    L+ V         Y   N  +HRD+   N LL         K+ 
Sbjct: 126 ETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG 185

Query: 187 DFGLA-------TYIKAGQNLHGTVGSPF-YIAPEVLA-GGYNQAADVWSAGVILYILLS 237
           DFG+A        Y K G  +      P  ++ PE    G +    D WS GV+L+ + S
Sbjct: 186 DFGMARDIYRASYYRKGGCAM-----LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

Query: 238 -GMPPFWGKTKSKIFDAVRA 256
            G  P+  K+  ++ + V +
Sbjct: 241 LGYMPYPSKSNQEVLEFVTS 260

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 96.7 bits (241), Expect = 8e-23
 Identities = 58/222 (26%), Positives = 94/222 (42%), Gaps = 21/222 (9%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           +RY LG+++G G FG I   +D   GE +A K               + +E +I   + G
Sbjct: 9   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK-----TKHPQLHIESKIYKMMQG 63

Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGR-FSETEARVIFRHLMQVVSYCH 158
              +  ++    E DY  ++MEL  G  L        R FS     ++   ++  + Y H
Sbjct: 64  GVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 122

Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLAT-YIKAGQNLH-------GTVGSPFYI 210
               +HRD+KP+N L+      + + + DFGLA  Y  A  + H          G+  Y 
Sbjct: 123 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 182

Query: 211 APEVLAGGYNQA--ADVWSAG-VILYILLSGMPPFWGKTKSK 249
           +      G  Q+   D+ S G V++Y  L  +P  W   K+ 
Sbjct: 183 SINTHL-GIEQSRRDDLESLGYVLMYFNLGSLP--WQGLKAA 221

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 96.5 bits (241), Expect = 8e-23
 Identities = 60/224 (26%), Positives = 99/224 (44%), Gaps = 21/224 (9%)

Query: 43  VLGKQLGWGQFGVIRE----CSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLS 98
            LG+ +G GQFG + +      +     V A K+       +         E   M +  
Sbjct: 18  ELGRCIGEGQFGDVHQGIYMSPENPALAV-AIKTCKNC--TSDSVREKFLQEALTMRQFD 74

Query: 99  GHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS--- 155
            HP++V L  V  E   V ++MELC  GEL   L+        +   +  +  Q+ +   
Sbjct: 75  -HPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKY--SLDLASLILYAYQLSTALA 130

Query: 156 YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVG-SPF-YIAPE 213
           Y      VHRD+   N+L+   SS+  +KL DFGL+ Y++       + G  P  ++APE
Sbjct: 131 YLESKRFVHRDIAARNVLV---SSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 187

Query: 214 VLA-GGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVR 255
            +    +  A+DVW  GV ++ +L  G+ PF G   + +   + 
Sbjct: 188 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 231

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 95.8 bits (239), Expect = 2e-22
 Identities = 47/241 (19%), Positives = 79/241 (32%), Gaps = 47/241 (19%)

Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVL-------ACKSIAKDRLVTVEDVRSIKLEIEIMT 95
           +  + LG G F  I +   +  G+           K + K          S      +M+
Sbjct: 11  IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA---HRNYSESFFEAASMMS 67

Query: 96  KLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVV- 154
           KLS H ++V    V    D   L+ E    G L   L+K          +     ++V  
Sbjct: 68  KLS-HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKN------CINILWKLEVAK 120

Query: 155 ------SYCHGNGVVHRDLKPENILLATKSSSSP-----IKLADFGLATYIKAGQNLHGT 203
                  +   N ++H ++  +NILL  +          IKL+D G++  +         
Sbjct: 121 QLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV--------- 171

Query: 204 VGSPFY------IAPEVLA--GGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAV 254
           +           + PE +      N A D WS G  L+ + S G  P       +     
Sbjct: 172 LPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY 231

Query: 255 R 255
            
Sbjct: 232 E 232

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 95.0 bits (237), Expect = 3e-22
 Identities = 66/231 (28%), Positives = 99/231 (42%), Gaps = 35/231 (15%)

Query: 43  VLGKQLGWGQFGVIRE----CSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLS 98
           VL + LG G FG + E            V A K+  KD   T+++      E  IM  L 
Sbjct: 15  VLNRILGEGFFGEVYEGVYTNHKGEKINV-AVKTCKKD--CTLDNKEKFMSEAVIMKNLD 71

Query: 99  GHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS--- 155
            HP++V L  + EEE    ++MEL   GEL H LE+       +   +  + +Q+     
Sbjct: 72  -HPHIVKLIGIIEEEP-TWIIMELYPYGELGHYLERNKN--SLKVLTLVLYSLQICKAMA 127

Query: 156 YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA------TYIKAGQNLHGTVGSPFY 209
           Y      VHRD+   NIL+A+      +KL DFGL+       Y KA         +   
Sbjct: 128 YLESINCVHRDIAVRNILVASPEC---VKLGDFGLSRYIEDEDYYKAS-------VTRLP 177

Query: 210 I---APEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVR 255
           I   +PE +    +  A+DVW   V ++ +LS G  PF+      +   + 
Sbjct: 178 IKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE 228

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 95.5 bits (238), Expect = 3e-22
 Identities = 57/239 (23%), Positives = 99/239 (41%), Gaps = 29/239 (12%)

Query: 40  DRYVLGKQLGWGQFGVIREC----SDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMT 95
            ++ LG+ LG G+FG +RE      D    +V A K + K  ++   D+     E   M 
Sbjct: 23  QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKV-AVKML-KADIIASSDIEEFLREAACMK 80

Query: 96  KLSGHPNVVDLKAV------YEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRH 149
           +   HP+V  L  V              +++     G+L   L    R  E    +  + 
Sbjct: 81  EFD-HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFL-LASRIGENPFNLPLQT 138

Query: 150 LMQVV-------SYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHG 202
           L++ +        Y      +HRDL   N +L   +    + +ADFGL+  I +G     
Sbjct: 139 LVRFMVDIACGMEYLSSRNFIHRDLAARNCML---AEDMTVCVADFGLSRKIYSGDYYRQ 195

Query: 203 TVGSPFYI---APEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRA 256
              S   +   A E LA   Y   +DVW+ GV ++ +++ G  P+ G   ++I++ +  
Sbjct: 196 GCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG 254

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 95.7 bits (238), Expect = 4e-22
 Identities = 58/307 (18%), Positives = 100/307 (32%), Gaps = 66/307 (21%)

Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM-TKLSGHP 101
            L + +G G++G + +         +A K      + +  + ++   E  I    L  H 
Sbjct: 16  KLLELIGRGRYGAVYKG--SLDERPVAVK------VFSFANRQNFINEKNIYRVPLMEHD 67

Query: 102 NVV-----DLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVI--------FR 148
           N+      D +   +      L+ME    G L   L  +     +  R+         + 
Sbjct: 68  NIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYL 127

Query: 149 HLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA---------TYIKAGQN 199
           H        +   + HRDL   N+L+    +     ++DFGL+            +    
Sbjct: 128 HTELPRGDHYKPAISHRDLNSRNVLVKNDGT---CVISDFGLSMRLTGNRLVRPGEEDNA 184

Query: 200 LHGTVGSPFYIAPEVLAGGYN--------QAADVWSAGVILYILLSG------------- 238
               VG+  Y+APEVL G  N        +  D+++ G+I + +                
Sbjct: 185 AISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY 244

Query: 239 MPPFWGK-----TKSKIFDAVRAADLR--FPSDPWDHISASARDLIMGMLR---VDPSTR 288
              F  +     T   +   V     R  FP   W   S + R L   +      D   R
Sbjct: 245 QMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEA-WKENSLAVRSLKETIEDCWDQDAEAR 303

Query: 289 LTAAEVL 295
           LTA    
Sbjct: 304 LTAQXAE 310

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 97.6 bits (243), Expect = 4e-22
 Identities = 60/232 (25%), Positives = 97/232 (41%), Gaps = 37/232 (15%)

Query: 43  VLGKQLGWGQFGVIRE----CSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLS 98
            LG+ +G GQFG + +      +     V A K+       +         E   M +  
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAV-AIKTCKNC--TSDSVREKFLQEALTMRQFD 449

Query: 99  GHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYC 157
            HP++V L  V  E   V ++MELC  GEL   L+                 L  ++ Y 
Sbjct: 450 -HPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKFSLD----------LASLILYA 497

Query: 158 HG----------NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVG-S 206
           +              VHRD+   N+L+   SS+  +KL DFGL+ Y++       + G  
Sbjct: 498 YQLSTALAYLESKRFVHRDIAARNVLV---SSNDCVKLGDFGLSRYMEDSTYYKASKGKL 554

Query: 207 PF-YIAPEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVR 255
           P  ++APE +    +  A+DVW  GV ++ +L  G+ PF G   + +   + 
Sbjct: 555 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 606

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 94.7 bits (236), Expect = 4e-22
 Identities = 52/224 (23%), Positives = 96/224 (42%), Gaps = 23/224 (10%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
             Y +G+++G G FGVI E ++    + +A K   +       D   ++ E      L+G
Sbjct: 10  VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR-----SDAPQLRDEYRTYKLLAG 64

Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGR-FSETEARVIFRHLMQVVSYCH 158
              + ++    +E  +  L+++L  G  L   L+  GR FS     +  + ++  V   H
Sbjct: 65  CTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH 123

Query: 159 GNGVVHRDLKPENILL--ATKSSSSPIKLADFGLAT-YIKAGQNLH-------GTVGSPF 208
              +V+RD+KP+N L+      +++ I + DFG+   Y       H          G+  
Sbjct: 124 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 183

Query: 209 YIAPEVLAGGYNQA--ADVWSAG-VILYILLSGMPPFWGKTKSK 249
           Y++      G  Q+   D+ + G V +Y L   +P  W   K+ 
Sbjct: 184 YMSINTHL-GREQSRRDDLEALGHVFMYFLRGSLP--WQGLKAA 224

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 95.9 bits (239), Expect = 5e-22
 Identities = 64/246 (26%), Positives = 106/246 (43%), Gaps = 35/246 (14%)

Query: 40  DRYVLGKQLGWGQFGV--------IRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEI 91
           D+  LGK LG G FG         I +   K    V A K +  D   T +D+  +  E+
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTV-AVKMLKDD--ATEKDLSDLVSEM 137

Query: 92  EIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGEL--FHR-------LEKYGRFSETE 142
           E+M  +  H N+++L     ++  +++++E  + G L  + R          Y      E
Sbjct: 138 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 197

Query: 143 ARVIFRHLM----QVVS---YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIK 195
            ++ F+ L+    Q+     Y      +HRDL   N+L+   +    +K+ADFGLA  I 
Sbjct: 198 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV---MKIADFGLARDIN 254

Query: 196 AGQNLHGTVGSPFYI---APEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGKTKSKI 250
                  T      +   APE L    Y   +DVWS GV+++ I   G  P+ G    ++
Sbjct: 255 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 314

Query: 251 FDAVRA 256
           F  ++ 
Sbjct: 315 FKLLKE 320

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 97.0 bits (241), Expect = 5e-22
 Identities = 54/222 (24%), Positives = 93/222 (41%), Gaps = 21/222 (9%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           +++ LG+++G G FG I   ++  T E +A K               +  E +I   L G
Sbjct: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKIYRILQG 61

Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGR-FSETEARVIFRHLMQVVSYCH 158
              + +++    E DY  L+M+L  G  L        R  S     ++   ++  V + H
Sbjct: 62  GTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120

Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLAT-YIKAGQNLH-------GTVGSPFYI 210
               +HRD+KP+N L+     ++ + + DFGLA  Y     + H          G+  Y 
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180

Query: 211 APEVLAGGYNQA--ADVWSAG-VILYILLSGMPPFWGKTKSK 249
           +      G  Q+   D+ S G V++Y L   +P  W   K+ 
Sbjct: 181 SVNTHL-GIEQSRRDDLESLGYVLMYFLRGSLP--WQGLKAG 219

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 95.0 bits (237), Expect = 5e-22
 Identities = 65/240 (27%), Positives = 105/240 (43%), Gaps = 28/240 (11%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIA----KDRLVTVEDVRSIKLEIEIMT 95
           +    GK LG G FG + E +    G+  A   +A    K      ++  ++  E++IM+
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST-AHADEKEALMSELKIMS 104

Query: 96  KLSGHPNVVDLKAVYEEEDYVHLLMELCAGGEL--FHR-----LEKYGRFSETEARVIFR 148
            L  H N+V+L         V ++ E C  G+L  F R     LE    F+   +    R
Sbjct: 105 HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTR 164

Query: 149 HLM----QV---VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLH 201
            L+    QV   +++      +HRD+   N+LL   ++    K+ DFGLA  I    N  
Sbjct: 165 DLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL---TNGHVAKIGDFGLARDIMNDSNYI 221

Query: 202 GTVGSPFYI---APEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWG-KTKSKIFDAVR 255
               +   +   APE +    Y   +DVWS G++L+ I   G+ P+ G    SK +  V+
Sbjct: 222 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVK 281

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 94.6 bits (236), Expect = 5e-22
 Identities = 56/227 (24%), Positives = 92/227 (40%), Gaps = 24/227 (10%)

Query: 44  LGKQLGWGQFGVIREC----SDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
             + +G G FG +       +D       A KS+ +     + +V     E  IM   S 
Sbjct: 29  FNEVIGRGHFGCVYHGTLLDNDGKKIHC-AVKSLNRI--TDIGEVSQFLTEGIIMKDFS- 84

Query: 100 HPNVVDLKAV-YEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS--- 155
           HPNV+ L  +    E    +++     G+L + +         +  + F   +QV     
Sbjct: 85  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF--GLQVAKGMK 142

Query: 156 YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ--NLHGTVGSPFYI--- 210
           Y      VHRDL   N +L        +K+ADFGLA  +   +  ++H   G+   +   
Sbjct: 143 YLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 199

Query: 211 APEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVR 255
           A E L    +   +DVWS GV+L+ L++ G PP+       I   + 
Sbjct: 200 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 246

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 95.0 bits (237), Expect = 5e-22
 Identities = 61/243 (25%), Positives = 102/243 (41%), Gaps = 39/243 (16%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVL--ACKSIAKDRLVTVEDVRSIKLEIEIMTKL 97
           +       +G G FG + +   K  G  +  A K + +    + +D R    E+E++ KL
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKL 82

Query: 98  SGHPNVVDLKAVYEEEDYVHLLMELCAGGEL--FHR----LEKYGRFSETEARVIFRHLM 151
             HPN+++L    E   Y++L +E    G L  F R    LE    F+   +        
Sbjct: 83  GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 142

Query: 152 QVVSYCHG----------NGVVHRDLKPENILLATKSSSSPIKLADFGLA----TYIKAG 197
           Q++ +                +HRDL   NIL+     +   K+ADFGL+     Y+K  
Sbjct: 143 QLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLSRGQEVYVKKT 199

Query: 198 QNLHGTVGSPFYI---APEVLA-GGYNQAADVWSAGVILY-ILLSGMPPFWGKTKSKIFD 252
                       +   A E L    Y   +DVWS GV+L+ I+  G  P+ G T +++++
Sbjct: 200 -------MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 252

Query: 253 AVR 255
            + 
Sbjct: 253 KLP 255

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 95.5 bits (238), Expect = 7e-22
 Identities = 63/248 (25%), Positives = 103/248 (41%), Gaps = 41/248 (16%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTV-----------EDVRSIK 88
           DR VLGK LG G FG +         E +       +R+  V           +D+  + 
Sbjct: 69  DRLVLGKPLGEGAFGQV------VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLI 122

Query: 89  LEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRL---------EKYGRFS 139
            E+E+M  +  H N+++L     ++  +++++E  + G L   L           Y    
Sbjct: 123 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 182

Query: 140 ETEARVIFRHLM----QVVS---YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLAT 192
             E ++  + L+    QV     Y      +HRDL   N+L+   +    +K+ADFGLA 
Sbjct: 183 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV---MKIADFGLAR 239

Query: 193 YIKAGQNLHGTVGSPFYI---APEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGKTK 247
            I        T      +   APE L    Y   +DVWS GV+L+ I   G  P+ G   
Sbjct: 240 DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 299

Query: 248 SKIFDAVR 255
            ++F  ++
Sbjct: 300 EELFKLLK 307

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 93.9 bits (234), Expect = 1e-21
 Identities = 64/246 (26%), Positives = 106/246 (43%), Gaps = 35/246 (14%)

Query: 40  DRYVLGKQLGWGQFGV--------IRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEI 91
           D+  LGK LG G FG         I +   K    V A K +  D   T +D+  +  E+
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTV-AVKMLKDD--ATEKDLSDLVSEM 91

Query: 92  EIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGEL--FHR-------LEKYGRFSETE 142
           E+M  +  H N+++L     ++  +++++E  + G L  + R          Y      E
Sbjct: 92  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151

Query: 143 ARVIFRHLM----QVVS---YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIK 195
            ++ F+ L+    Q+     Y      +HRDL   N+L+   +    +K+ADFGLA  I 
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV---MKIADFGLARDIN 208

Query: 196 AGQNLHGTVGSPFYI---APEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGKTKSKI 250
                  T      +   APE L    Y   +DVWS GV+++ I   G  P+ G    ++
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 268

Query: 251 FDAVRA 256
           F  ++ 
Sbjct: 269 FKLLKE 274

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 93.1 bits (232), Expect = 2e-21
 Identities = 59/238 (24%), Positives = 99/238 (41%), Gaps = 28/238 (11%)

Query: 40  DRYVLGKQLGWGQFGVIREC----SDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMT 95
           +  +LGK LG G+FG + E      D  + +V A K++ K    +  ++     E   M 
Sbjct: 34  NLLILGKILGEGEFGSVMEGNLKQEDGTSLKV-AVKTM-KLDNSSQREIEEFLSEAACMK 91

Query: 96  KLSGHPNVVDLKAVYEEEDYVH-----LLMELCAGGELFHRLEKYGRFSETEARVIFRHL 150
             S HPNV+ L  V  E          +++     G+L   L  Y R       +  + L
Sbjct: 92  DFS-HPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYL-LYSRLETGPKHIPLQTL 149

Query: 151 MQVV-------SYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT 203
           ++ +        Y      +HRDL   N +L        + +ADFGL+  I +G      
Sbjct: 150 LKFMVDIALGMEYLSNRNFLHRDLAARNCML---RDDMTVCVADFGLSKKIYSGDYYRQG 206

Query: 204 VGSPFYI---APEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRA 256
             +   +   A E LA   Y   +DVW+ GV ++ + + GM P+ G    +++D +  
Sbjct: 207 RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLH 264

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 92.3 bits (230), Expect = 3e-21
 Identities = 53/221 (23%), Positives = 87/221 (39%), Gaps = 32/221 (14%)

Query: 40  DRYVLGKQLGWGQFGVIRECS----DKFTGEVL-ACKSIAKDRLVTVEDVRSIKLEIEIM 94
           +R   GK LG G FG + E +     K    +  A K +       + +  ++  E++++
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS--AHLTEREALMSELKVL 80

Query: 95  TKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGEL-----------FHRLEKYGRFSETEA 143
           + L  H N+V+L           ++ E C  G+L                      + E 
Sbjct: 81  SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140

Query: 144 RVIFRHLM----QV---VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA 196
            +    L+    QV   +++      +HRDL   NILL   +     K+ DFGLA  IK 
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL---THGRITKICDFGLARDIKN 197

Query: 197 GQNLHGTVGSPFYI---APEVLAGG-YNQAADVWSAGVILY 233
             N      +   +   APE +    Y   +DVWS G+ L+
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLW 238

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 91.9 bits (229), Expect = 3e-21
 Identities = 58/227 (25%), Positives = 95/227 (41%), Gaps = 22/227 (9%)

Query: 43  VLGKQLGWGQFGVIRECSDKFTGEVL---ACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
              + +G G FGV+         +     A KS+++     ++ V +   E  +M  L+ 
Sbjct: 24  HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGLN- 80

Query: 100 HPNVVDLKAV-YEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS--- 155
           HPNV+ L  +    E   H+L+     G+L   +    R    +  + F   +QV     
Sbjct: 81  HPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISF--GLQVARGME 138

Query: 156 YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ--NLHGTVGSPFYI--- 210
           Y      VHRDL   N +L     S  +K+ADFGLA  I   +  ++     +   +   
Sbjct: 139 YLAEQKFVHRDLAARNCML---DESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT 195

Query: 211 APEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVR 255
           A E L    +   +DVWS GV+L+ LL+ G PP+       +   + 
Sbjct: 196 ALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA 242

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 92.1 bits (229), Expect = 8e-21
 Identities = 38/180 (21%), Positives = 73/180 (40%), Gaps = 25/180 (13%)

Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
           ++VLGK++G G FG+I         E  A   +  +     ++   +  E++   +++  
Sbjct: 38  QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEY----QENGPLFSELKFYQRVAKK 93

Query: 101 PNVVDLKA------------------VYEEEDYVHLLMELCAGGELFHRLEKYGRFSETE 142
             +                        ++   Y  ++ME   G +L     + G F ++ 
Sbjct: 94  DCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKST 152

Query: 143 ARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLAT-YIKAGQNLH 201
              +   ++ V+ Y H N  VH D+K  N+LL  K+    + LAD+GL+  Y   G +  
Sbjct: 153 VLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQ-VYLADYGLSYRYCPNGNHKQ 211

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 91.7 bits (228), Expect = 8e-21
 Identities = 54/227 (23%), Positives = 93/227 (40%), Gaps = 31/227 (13%)

Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRS----IKLEIEIMTK 96
            + +GK++G G FG +R   + +T E +A K         +E ++S    + LE     +
Sbjct: 10  NFRVGKKIGCGNFGELRLGKNLYTNEYVAIK---------LEPMKSRAPQLHLEYRFYKQ 60

Query: 97  LSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGR-FSETEARVIFRHLMQVVS 155
           L     +  +        Y  +++EL  G  L    +   R FS     +I   L+  + 
Sbjct: 61  LGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRME 119

Query: 156 YCHGNGVVHRDLKPENILL--ATKSSSSPIKLADFGLAT-YIKAGQNLH-------GTVG 205
           Y H   +++RD+KPEN L+      +   I + DF LA  YI      H          G
Sbjct: 120 YVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTG 179

Query: 206 SPFYIAPEVLAGGYNQA--ADVWSAG-VILYILLSGMPPFWGKTKSK 249
           +  Y++      G  Q+   D+ + G + +Y L   +P  W   K+ 
Sbjct: 180 TARYMSINTHL-GKEQSRRDDLEALGHMFMYFLRGSLP--WQGLKAD 223

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 91.7 bits (228), Expect = 1e-20
 Identities = 55/228 (24%), Positives = 91/228 (39%), Gaps = 24/228 (10%)

Query: 43  VLGKQLGWGQFGVIREC----SDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLS 98
              + +G G FG +       +D       A KS+ +     + +V     E  IM   S
Sbjct: 92  HFNEVIGRGHFGCVYHGTLLDNDGKKIHC-AVKSLNRI--TDIGEVSQFLTEGIIMKDFS 148

Query: 99  GHPNVVDLKAV-YEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS-- 155
            HPNV+ L  +    E    +++     G+L + +         +  + F   +QV    
Sbjct: 149 -HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF--GLQVAKGM 205

Query: 156 -YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG--QNLHGTVGSPFYI-- 210
            +      VHRDL   N +L        +K+ADFGLA  +      ++H   G+   +  
Sbjct: 206 KFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 262

Query: 211 -APEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVR 255
            A E L    +   +DVWS GV+L+ L++ G PP+       I   + 
Sbjct: 263 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 310

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 90.4 bits (225), Expect = 2e-20
 Identities = 54/244 (22%), Positives = 95/244 (38%), Gaps = 40/244 (16%)

Query: 40  DRYVLGKQLGWGQFGVIREC----SDKFTGEVL-ACKSIAKDRLVTVEDVRSIKLEIEIM 94
           ++  + ++LG G FG++ E       K   E   A K++ +    ++ +      E  +M
Sbjct: 25  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVM 82

Query: 95  TKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVV 154
            +     +VV L  V  +     ++MEL   G+L   L            +    L +++
Sbjct: 83  KEF-NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 141

Query: 155 SYCH----------GNGVVHRDLKPENILLATKSSSSPIKLADFGLA-------TYIKAG 197
                          N  VHRDL   N ++A   +   +K+ DFG+         Y K G
Sbjct: 142 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT---VKIGDFGMTRDIYETDYYRKGG 198

Query: 198 QNLHGTVGSPFYI---APEVLA-GGYNQAADVWSAGVILY-ILLSGMPPFWGKTKSKIFD 252
           + L         +   +PE L  G +   +DVWS GV+L+ I      P+ G +  ++  
Sbjct: 199 KGL-------LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 251

Query: 253 AVRA 256
            V  
Sbjct: 252 FVME 255

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 90.0 bits (224), Expect = 3e-20
 Identities = 65/234 (27%), Positives = 98/234 (41%), Gaps = 32/234 (13%)

Query: 40  DRYVLGKQLGWGQFGVIRECS----DKFTGEVL-ACKSIAKDRLVTVEDVRSIKLEIEIM 94
           DR  LGK LG G FG + E      DK       A K + +    T  + R++  E++I+
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKIL 84

Query: 95  TKLSGHPNVVDLKAV-YEEEDYVHLLMELCAGGELFHRL---------EKYGRFSETEAR 144
             +  H NVV+L     +    + +++E C  G L   L          K       +  
Sbjct: 85  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 144

Query: 145 VIFRHLM----QVVS---YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG 197
           +   HL+    QV     +      +HRDL   NILL+ K+    +K+ DFGLA  I   
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV---VKICDFGLARDIYKD 201

Query: 198 QNLHGTVGSPFYI---APEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGKT 246
            +      +   +   APE +    Y   +DVWS GV+L+ I   G  P+ G  
Sbjct: 202 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 89.3 bits (222), Expect = 4e-20
 Identities = 50/242 (20%), Positives = 93/242 (38%), Gaps = 32/242 (13%)

Query: 40  DRYVLGKQLGWGQFGVIREC----SDKFTGEVL-ACKSIAKDRLVTVEDVRSIKLEIEIM 94
              VL  +LG G FG +             ++L A K++ K+   +    +  + E E++
Sbjct: 41  RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KE--ASESARQDFQREAELL 97

Query: 95  TKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGEL-----FHRLEKYGRFSETEARVIFRH 149
           T L  H ++V    V  E   + ++ E    G+L      H  +        +       
Sbjct: 98  TMLQ-HQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLG 156

Query: 150 LMQVVSYCHG----------NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN 199
           L Q+++                 VHRDL   N L+        +K+ DFG++  I +   
Sbjct: 157 LGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV---GQGLVVKIGDFGMSRDIYSTDY 213

Query: 200 LHGTVGSPFYI---APEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAV 254
                 +   I    PE +    +   +DVWS GV+L+ + + G  P++  + ++  D +
Sbjct: 214 YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI 273

Query: 255 RA 256
             
Sbjct: 274 TQ 275

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 88.8 bits (221), Expect = 5e-20
 Identities = 50/243 (20%), Positives = 101/243 (41%), Gaps = 33/243 (13%)

Query: 40  DRYVLGKQLGWGQFGVIREC----SDKFTGEVL-ACKSIAKDRLVTVEDVRSIKLEIEIM 94
              VL ++LG G FG +             ++L A K++ KD   T+   +  + E E++
Sbjct: 15  RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL-KD--PTLAARKDFQREAELL 71

Query: 95  TKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGEL---------FHRLEKYGRFSETEARV 145
           T L  H ++V    V  + D + ++ E    G+L            +   G+  + +  +
Sbjct: 72  TNLQ-HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGEL 130

Query: 146 IFRHLMQVV-------SYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ 198
               ++ +         Y      VHRDL   N L+    ++  +K+ DFG++  + +  
Sbjct: 131 GLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLV---GANLLVKIGDFGMSRDVYSTD 187

Query: 199 NLHGTVGSPFYI---APEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDA 253
                  +   I    PE +    +   +DVWS GVIL+ + + G  P++  + +++ + 
Sbjct: 188 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC 247

Query: 254 VRA 256
           +  
Sbjct: 248 ITQ 250

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 86.1 bits (214), Expect = 5e-19
 Identities = 58/251 (23%), Positives = 102/251 (40%), Gaps = 40/251 (15%)

Query: 40  DRYVLGKQLGWGQFGVIRECS----DKFTGEVL-ACKSIAKDRLVTVEDVRSIKLEIEIM 94
              VLGK LG G+FG + + +        G    A K + ++   +  ++R +  E  ++
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN--ASPSELRDLLSEFNVL 80

Query: 95  TKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGEL--FHR---------------LEKYGR 137
            ++  HP+V+ L     ++  + L++E    G L  F R                     
Sbjct: 81  KQV-NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139

Query: 138 FSETEARVIFRHLM----QVVS---YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGL 190
               E  +    L+    Q+     Y     +VHRDL   NIL+A       +K++DFGL
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRK---MKISDFGL 196

Query: 191 ATYIKAGQNLHGTVGSPFYI---APEVLA-GGYNQAADVWSAGVILY-ILLSGMPPFWGK 245
           +  +    +          +   A E L    Y   +DVWS GV+L+ I+  G  P+ G 
Sbjct: 197 SRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256

Query: 246 TKSKIFDAVRA 256
              ++F+ ++ 
Sbjct: 257 PPERLFNLLKT 267

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 85.7 bits (213), Expect = 5e-19
 Identities = 53/250 (21%), Positives = 95/250 (38%), Gaps = 48/250 (19%)

Query: 40  DRYVLGKQLGWGQFGVIREC------SDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEI 93
                 ++LG  +FG + +         + T  V A K++              + E  +
Sbjct: 9   SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAV-AIKTLKDK--AEGPLREEFRHEAML 65

Query: 94  MTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGEL--F---HRLEKYGRFSETEARVIFR 148
             +L  HPNVV L  V  ++  + ++   C+ G+L  F            ++ +  V   
Sbjct: 66  RARLQ-HPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSA 124

Query: 149 -HLMQVVSYCHG----------NGVVHRDLKPENILLATKSSSSPIKLADFGLA------ 191
                 V               + VVH+DL   N+L+        +K++D GL       
Sbjct: 125 LEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV---YDKLNVKISDLGLFREVYAA 181

Query: 192 -TYIKAGQNLHGTVGSPFYI---APEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGK 245
             Y   G        S   I   APE +  G ++  +D+WS GV+L+ + S G+ P+ G 
Sbjct: 182 DYYKLLG-------NSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY 234

Query: 246 TKSKIFDAVR 255
           +   + + +R
Sbjct: 235 SNQDVVEMIR 244

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 85.4 bits (212), Expect = 1e-18
 Identities = 60/251 (23%), Positives = 103/251 (41%), Gaps = 39/251 (15%)

Query: 40  DRYVLGKQLGWGQFGVIRECS----DKFTGEVL-ACKSIAKDRLVTVEDVRSIKLEIEIM 94
           +    GK LG G FG +   +     K    +  A K + +       +  ++  E+++M
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK--ADSSEREALMSELKMM 102

Query: 95  TKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGEL----------------FHRLEKYGRF 138
           T+L  H N+V+L         ++L+ E C  G+L                 +  +K    
Sbjct: 103 TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 162

Query: 139 SETEARVIFRHLM----QVVS---YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA 191
            E    + F  L+    QV     +      VHRDL   N+L+   +    +K+ DFGLA
Sbjct: 163 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLV---THGKVVKICDFGLA 219

Query: 192 TYIKAGQNLHGTVGSPFYI---APEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWG-K 245
             I +  N      +   +   APE L  G Y   +DVWS G++L+ + S G+ P+ G  
Sbjct: 220 RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279

Query: 246 TKSKIFDAVRA 256
             +  +  ++ 
Sbjct: 280 VDANFYKLIQN 290

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 84.3 bits (209), Expect = 4e-18
 Identities = 52/251 (20%), Positives = 92/251 (36%), Gaps = 40/251 (15%)

Query: 40  DRYVLGKQLGWGQFGVIREC----SDKFTGEVL-ACKSIAKDRLVTVEDVRSIKLEIEIM 94
           +     + +G G FG + +        +    + A K + ++   + +     + E  +M
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE--ASADMQADFQREAALM 104

Query: 95  TKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGEL--F---HRLEKYGRFSETEARVI--- 146
            +   +PN+V L  V      + LL E  A G+L  F            S ++       
Sbjct: 105 AEFD-NPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 163

Query: 147 ---------FRHLMQVV-------SYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGL 190
                        + +        +Y      VHRDL   N L+        +K+ADFGL
Sbjct: 164 SSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMV---VKIADFGL 220

Query: 191 ATYIKAGQNLHGTVGSPFYI---APEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGK 245
           +  I +             I    PE +    Y   +DVW+ GV+L+ + S G+ P++G 
Sbjct: 221 SRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 280

Query: 246 TKSKIFDAVRA 256
              ++   VR 
Sbjct: 281 AHEEVIYYVRD 291

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 81.7 bits (202), Expect = 3e-17
 Identities = 37/199 (18%), Positives = 73/199 (36%), Gaps = 36/199 (18%)

Query: 27  GTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVE---- 82
           G I+        +  + +G  +G G FG I      +  ++ + +S+  D    V+    
Sbjct: 26  GEIITDM----AAAAWKVGLPIGQGGFGCI------YLADMNSSESVGSDAPCVVKVEPS 75

Query: 83  DVRSIKLEIEIMTKLSGHPNVVDLKAV------------------YEEEDYVHLLMELCA 124
           D   +  E++   + +    +                           + Y  ++M+   
Sbjct: 76  DNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF- 134

Query: 125 GGELFHRLEKYGR-FSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPI 183
           G +L    E   + FS      +   ++ ++ Y H +  VH D+K  N+LL  K+    +
Sbjct: 135 GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQ-V 193

Query: 184 KLADFGLAT-YIKAGQNLH 201
            L D+GLA  Y   G +  
Sbjct: 194 YLVDYGLAYRYCPEGVHKA 212

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 80.6 bits (199), Expect = 7e-17
 Identities = 38/227 (16%), Positives = 80/227 (35%), Gaps = 39/227 (17%)

Query: 3   TNNSEDSSQLSTQFCNSYKVSSLTGTILDATQISNLS-DRYVLGKQLGWGQFGVIRECSD 61
            ++      L T+      +++    +   T +++ S  ++ L         G++ E + 
Sbjct: 4   HHHHSSGVDLGTENLYFQSMTTSLEALPTGTVLTDKSGRQWKLKSFQTRDNQGILYEAAP 63

Query: 62  KFTGEVLACKSIAKDRLVTVEDVRSIKLE---------IEIMTKLSGHPNVVDLKAVY-- 110
             T     C S  + +        S+KL+              + +    V   K +Y  
Sbjct: 64  TSTLT---CDSGPQKQKF------SLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYST 114

Query: 111 -------------EEEDYVHLLMELCAGGELFHRLEKYGR--FSETEARVIFRHLMQVVS 155
                         ++ Y  L++    G  L   L+   +   SE     +   L+  + 
Sbjct: 115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALE 173

Query: 156 YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLAT-YIKAGQNLH 201
           + H N  VH ++  ENI +  +  S  + LA +G A  Y  +G+++ 
Sbjct: 174 FLHENEYVHGNVTAENIFVDPEDQSQ-VTLAGYGFAFRYCPSGKHVA 219

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 75.3 bits (186), Expect = 2e-15
 Identities = 45/180 (25%), Positives = 72/180 (40%), Gaps = 52/180 (28%)

Query: 90  EIEIMTKLSGHPNVVDLKA----------VYEEEDYV-------HLLMELCAGGELFHRL 132
           EI++M K   H N+V+L            VY    Y+        L             L
Sbjct: 80  EIKVMAKCQ-HENLVELLGFSSDGDDLCLVYV---YMPNGSLLDRL-----------SCL 124

Query: 133 EKYGRFS-ETEARVIF---RHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADF 188
           +     S     ++       +    ++ H N  +HRD+K  NILL    ++   K++DF
Sbjct: 125 DGTPPLSWHMRCKIAQGAANGI----NFLHENHHIHRDIKSANILLDEAFTA---KISDF 177

Query: 189 GLATYIKAGQNLH------GTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPF 242
           GLA   +            GT     Y+APE L G     +D++S GV+L  +++G+P  
Sbjct: 178 GLARASEKFAQTVMTSRIVGTTA---YMAPEALRGEITPKSDIYSFGVVLLEIITGLPAV 234

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 73.0 bits (180), Expect = 2e-14
 Identities = 47/171 (27%), Positives = 72/171 (42%), Gaps = 34/171 (19%)

Query: 90  EIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSET-----EAR 144
           EIE ++    HP++V L    +E + + L+ +    G L   L  YG    T     E R
Sbjct: 85  EIETLSFCR-HPHLVSLIGFCDERNEMILIYKYMENGNLKRHL--YGSDLPTMSMSWEQR 141

Query: 145 VIFRHLMQVV-------SYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG 197
                 +++         Y H   ++HRD+K  NILL         K+ DFG++      
Sbjct: 142 ------LEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVP---KITDFGISKKGTEL 192

Query: 198 QNLH------GTVGSPFYIAPEVLAGGY-NQAADVWSAGVILYILLSGMPP 241
              H      GT+G   YI PE    G   + +DV+S GV+L+ +L     
Sbjct: 193 DQTHLSTVVKGTLG---YIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSA 240

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 64.9 bits (159), Expect = 8e-12
 Identities = 31/88 (35%), Positives = 47/88 (53%), Gaps = 14/88 (15%)

Query: 162 VVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLH------GTVGSPFYIAPEVL 215
           ++HRD+K  NILL  +  +    + DFGLA  +      H      GT+G   +IAPE L
Sbjct: 155 IIHRDVKAANILLDEEFEA---VVGDFGLAKLMDYKDT-HVTTAVRGTIG---HIAPEYL 207

Query: 216 AGGY-NQAADVWSAGVILYILLSGMPPF 242
           + G  ++  DV+  GV+L  L++G   F
Sbjct: 208 STGKSSEKTDVFGYGVMLLELITGQRAF 235

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 58.0 bits (140), Expect = 2e-09
 Identities = 38/148 (25%), Positives = 60/148 (40%), Gaps = 12/148 (8%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKF-----TGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
           DR  LGK LG G FG + E          T   +A K + +    T  + R++  E++I+
Sbjct: 22  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKIL 79

Query: 95  TKLSGHPNVVDLK-AVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQV 153
             +  H NVV+L  A  +    + +++E C  G L   L    R      +       Q 
Sbjct: 80  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK-RNEFVPYKTKGARFRQG 138

Query: 154 VSYCHGNGVVHRDLKPENILLATKSSSS 181
             Y    G +  DLK     + +  SS+
Sbjct: 139 KDYV---GAIPVDLKRRLDSITSSQSSA 163

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 54.9 bits (132), Expect = 2e-08
 Identities = 31/90 (34%), Positives = 43/90 (47%), Gaps = 8/90 (8%)

Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYI---APEVLA 216
              +HRDL   NILL   S  + +K+ DFGLA  I    +      +   +   APE + 
Sbjct: 212 RKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF 268

Query: 217 GG-YNQAADVWSAGVILY-ILLSGMPPFWG 244
              Y   +DVWS GV+L+ I   G  P+ G
Sbjct: 269 DRVYTIQSDVWSFGVLLWEIFSLGASPYPG 298

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 54.9 bits (131), Expect = 2e-08
 Identities = 38/246 (15%), Positives = 74/246 (30%), Gaps = 60/246 (24%)

Query: 39  SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVE-----DVRSIKLEIEI 93
           +++    +++G G FG + +         +A K IA +    V          I  EI I
Sbjct: 19  TEKLQRCEKIGEGVFGEVFQTIAD--HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 94  MTKLSG--------HPNVVDLKAVY------------------------------EEEDY 115
             +LS             + L +V+                               ++D 
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 116 VHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGN-GVVHRDLKPENIL- 173
           + +++E   GG    ++      S   A+ I   L   ++    +    HRDL   N+L 
Sbjct: 137 LFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLL 195

Query: 174 -------LATKSSSSPIKLADFGLATYI-----KAGQNLHGTVGSPFYIAPEVLAGGYNQ 221
                  L    +     +   GL   I        +     V     +  ++  G  + 
Sbjct: 196 KKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGDY 255

Query: 222 AADVWS 227
             D++ 
Sbjct: 256 QFDIYR 261

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	419
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.92
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.84
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.74
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.43
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.28
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.14
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.11
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.81
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.75
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.71
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.36
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.32
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.21
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.2
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.02
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.86
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.8
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.77
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.7
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.55
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.38
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.34
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.33
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.28
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.18
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.1
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.91
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.9
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.46
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.75
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	94.36
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	82.32
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	80.2

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=3.5e-65  Score=493.56  Aligned_cols=259  Identities=31%  Similarity=0.580  Sum_probs=237.4

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEE
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHL  118 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~l  118 (419)
                      .++|++++.||+|+||+||+|+++.+|+.||+|++.+..+......+.+.+|+++|++|+ |||||++++++++++.+|+
T Consensus        31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~yi  109 (311)
T 4aw0_A           31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQDDEKLYF  109 (311)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEE
T ss_pred             ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeCCEEEE
Confidence            367999999999999999999999999999999998765544456788999999999996 9999999999999999999


Q ss_pred             EEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC
Q 014733          119 LMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ  198 (419)
Q Consensus       119 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~  198 (419)
                      |||||+||+|.+++.+.+.+++.+++.++.||+.||+|||++|||||||||+|||+   +.++.+||+|||+|+.+....
T Consensus       110 vmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl---~~~g~vKl~DFGla~~~~~~~  186 (311)
T 4aw0_A          110 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPES  186 (311)
T ss_dssp             EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECCTTT
T ss_pred             EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEE---cCCCCEEEEEcCCceecCCCC
Confidence            99999999999999998999999999999999999999999999999999999999   667899999999999875432


Q ss_pred             ---ccccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 014733          199 ---NLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASAR  274 (419)
Q Consensus       199 ---~~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~  274 (419)
                         ...+.+||+.|||||++.+ .|+.++|||||||+||+|++|++||.+.+..+++++|....+.+|.    .+|++++
T Consensus       187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~----~~s~~~~  262 (311)
T 4aw0_A          187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPE----KFFPKAR  262 (311)
T ss_dssp             TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT----TCCHHHH
T ss_pred             CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc----ccCHHHH
Confidence               2456799999999999987 4999999999999999999999999999999999999998877664    6899999


Q ss_pred             HHHHhhhhcCCCCCCCHHH------HHhccccccchh
Q 014733          275 DLIMGMLRVDPSTRLTAAE------VLAHSWMEECEQ  305 (419)
Q Consensus       275 ~li~~~L~~dP~~Rps~~e------il~hp~~~~~~~  305 (419)
                      +||.+||++||++|||++|      +++||||+.+.+
T Consensus       263 dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw  299 (311)
T 4aw0_A          263 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTW  299 (311)
T ss_dssp             HHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCC
T ss_pred             HHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCH
Confidence            9999999999999999987      689999988764

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=6e-64  Score=477.98  Aligned_cols=254  Identities=36%  Similarity=0.650  Sum_probs=216.8

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      ++|++++.||+|+||+||+|+++.+|+.||+|++.+...........+.+|+.+|++++ |||||++++++++++.+|+|
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~~iv   91 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR-HPHIIKLYDVIKSKDEIIMV   91 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCC-CCCCCeEEEEEEECCEEEEE
Confidence            68999999999999999999999999999999998877666666788999999999996 99999999999999999999


Q ss_pred             EeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCCc
Q 014733          120 MELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN  199 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~~  199 (419)
                      |||+ +|+|.+++.+.+++++.+++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+|+.......
T Consensus        92 mEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl---~~~~~vkl~DFGla~~~~~~~~  167 (275)
T 3hyh_A           92 IEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLL---DEHLNVKIADFGLSNIMTDGNF  167 (275)
T ss_dssp             EECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE---CTTCCEEECCSSCC--------
T ss_pred             EeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEE---CCCCCEEEeecCCCeecCCCCc
Confidence            9999 78999999998999999999999999999999999999999999999999   5678999999999998766666


Q ss_pred             cccccCCCccCCcccccCC-C-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHH
Q 014733          200 LHGTVGSPFYIAPEVLAGG-Y-NQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLI  277 (419)
Q Consensus       200 ~~~~~gt~~y~aPE~l~~~-~-s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li  277 (419)
                      ..+.+||+.|+|||++.+. | +.++||||+||++|+|++|++||.+.+..++++.+......+|.    .+|+++++||
T Consensus       168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li  243 (275)
T 3hyh_A          168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPK----FLSPGAAGLI  243 (275)
T ss_dssp             -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT----TSCHHHHHHH
T ss_pred             cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHH
Confidence            6678999999999999874 4 68999999999999999999999999999999999988776653    6899999999


Q ss_pred             HhhhhcCCCCCCCHHHHHhcccccc
Q 014733          278 MGMLRVDPSTRLTAAEVLAHSWMEE  302 (419)
Q Consensus       278 ~~~L~~dP~~Rps~~eil~hp~~~~  302 (419)
                      .+||++||++|||+.|+++||||+.
T Consensus       244 ~~~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          244 KRMLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             HHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             HHHccCChhHCcCHHHHHcCccccc
Confidence            9999999999999999999999974

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=6.3e-64  Score=492.39  Aligned_cols=256  Identities=24%  Similarity=0.506  Sum_probs=226.5

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+.+|++|+ |||||++++++++++.+|||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~yiV  101 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANMK-HPNIVQYRESFEENGSLYIV  101 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC-CHHHHHHHHHHHHHHHHCC-CCCCCcEEEEEEECCEEEEE
Confidence            689999999999999999999999999999999987764 4567788999999999996 99999999999999999999


Q ss_pred             EeecCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccC
Q 014733          120 MELCAGGELFHRLEKYG--RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG  197 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~  197 (419)
                      ||||+||+|.+++...+  .+++.+++.++.||+.||+|||++|||||||||+||||   +.++.+||+|||+|+.+...
T Consensus       102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~~  178 (350)
T 4b9d_A          102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL---TKDGTVQLGDFGIARVLNST  178 (350)
T ss_dssp             EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEE---CTTCCEEECSTTEESCCCHH
T ss_pred             EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE---CCCCCEEEcccccceeecCC
Confidence            99999999999997543  47999999999999999999999999999999999999   56789999999999976543


Q ss_pred             Cc-cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 014733          198 QN-LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARD  275 (419)
Q Consensus       198 ~~-~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~  275 (419)
                      .. ....+||+.|||||++.+. |+.++|||||||+||||++|++||.+.+..+++.++.......   .+..+|+++++
T Consensus       179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~---~~~~~s~~~~~  255 (350)
T 4b9d_A          179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPP---VSLHYSYDLRS  255 (350)
T ss_dssp             HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC---CCTTSCHHHHH
T ss_pred             cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC---CCccCCHHHHH
Confidence            32 3456899999999999875 9999999999999999999999999999999999998876532   23479999999


Q ss_pred             HHHhhhhcCCCCCCCHHHHHhccccccc
Q 014733          276 LIMGMLRVDPSTRLTAAEVLAHSWMEEC  303 (419)
Q Consensus       276 li~~~L~~dP~~Rps~~eil~hp~~~~~  303 (419)
                      ||.+||++||++|||+.|+|+||||++.
T Consensus       256 li~~~L~~dP~~R~s~~e~l~hp~~~~~  283 (350)
T 4b9d_A          256 LVSQLFKRNPRDRPSVNSILEKGFIAKR  283 (350)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred             HHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence            9999999999999999999999999753

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=6.3e-63  Score=484.53  Aligned_cols=257  Identities=26%  Similarity=0.475  Sum_probs=231.5

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEE
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHL  118 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~l  118 (419)
                      ..+|+++++||+|+||+||+|+++.+|+.||||++.+....   ..+.+.+|+.+|++++ |||||++++++.+++.+||
T Consensus        73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~~~~~i  148 (346)
T 4fih_A           73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQ-HENVVEMYNSYLVGDELWV  148 (346)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS---SGGGGHHHHHHHHHCC-CTTBCCEEEEEEETTEEEE
T ss_pred             hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh---HHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEEEE
Confidence            46799999999999999999999999999999999765432   3456789999999996 9999999999999999999


Q ss_pred             EEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccC-
Q 014733          119 LMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG-  197 (419)
Q Consensus       119 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~-  197 (419)
                      |||||+||+|.+++.+ +++++.+++.++.||+.||+|||++|||||||||+||||   +.++.+||+|||+|+.+... 
T Consensus       149 vmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~~~  224 (346)
T 4fih_A          149 VMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEV  224 (346)
T ss_dssp             EECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSSS
T ss_pred             EEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEE---CCCCCEEEecCcCceecCCCC
Confidence            9999999999999976 679999999999999999999999999999999999999   56789999999999987544 


Q ss_pred             CccccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHH
Q 014733          198 QNLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDL  276 (419)
Q Consensus       198 ~~~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~l  276 (419)
                      ....+.+||+.|||||++.+ .|+.++|||||||++|||++|++||.+.+..+++..|..... .....+..+|+++++|
T Consensus       225 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~~~~~~~~s~~~~dl  303 (346)
T 4fih_A          225 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PRLKNLHKVSPSLKGF  303 (346)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC-CCCSCGGGSCHHHHHH
T ss_pred             CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CCCCccccCCHHHHHH
Confidence            33456799999999999987 499999999999999999999999999999999988876532 3334456899999999


Q ss_pred             HHhhhhcCCCCCCCHHHHHhccccccch
Q 014733          277 IMGMLRVDPSTRLTAAEVLAHSWMEECE  304 (419)
Q Consensus       277 i~~~L~~dP~~Rps~~eil~hp~~~~~~  304 (419)
                      |.+||++||++|||+.|+|+||||++..
T Consensus       304 i~~~L~~dP~~R~ta~e~l~Hp~~~~~~  331 (346)
T 4fih_A          304 LDRLLVRDPAQRATAAELLKHPFLAKAG  331 (346)
T ss_dssp             HHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             HHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence            9999999999999999999999998654

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.1e-61  Score=466.08  Aligned_cols=257  Identities=23%  Similarity=0.444  Sum_probs=223.2

Q ss_pred             ccCe-eeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEe----C
Q 014733           39 SDRY-VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEE----E  113 (419)
Q Consensus        39 ~~~y-~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~----~  113 (419)
                      .++| ++.++||+|+||+||+|.++.++..||+|++.+... .....+.+.+|+++|++|+ |||||++++++++    +
T Consensus        24 ~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~~  101 (290)
T 3fpq_A           24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGK  101 (290)
T ss_dssp             TSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEEEETTE
T ss_pred             CCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEeeccCCC
Confidence            3455 788899999999999999999999999999987654 4566788999999999996 9999999999975    3


Q ss_pred             CEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--CeeccCCCCcEEEeecCCCCCeEEeeccce
Q 014733          114 DYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG--VVHRDLKPENILLATKSSSSPIKLADFGLA  191 (419)
Q Consensus       114 ~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~--IvHrDLkp~NILl~~~~~~~~vKL~DFgla  191 (419)
                      +.+|||||||+||+|.+++.+.+.+++.+++.++.||+.||+|||+++  ||||||||+||||+  +.++.+||+|||+|
T Consensus       102 ~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~--~~~g~vKl~DFGla  179 (290)
T 3fpq_A          102 KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLA  179 (290)
T ss_dssp             EEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEES--STTSCEEECCTTGG
T ss_pred             cEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEE--CCCCCEEEEeCcCC
Confidence            568999999999999999999899999999999999999999999998  99999999999994  24678999999999


Q ss_pred             eeeccCCccccccCCCccCCcccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhcCCCCCCCCCCCCC
Q 014733          192 TYIKAGQNLHGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGKT-KSKIFDAVRAADLRFPSDPWDHIS  270 (419)
Q Consensus       192 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~s~~sDvwSlGvil~elltG~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s  270 (419)
                      +... .....+.+||+.|||||++.++|+.++|||||||+||||+||++||.+.. ...+...+.....  +...+..++
T Consensus       180 ~~~~-~~~~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~--~~~~~~~~~  256 (290)
T 3fpq_A          180 TLKR-ASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK--PASFDKVAI  256 (290)
T ss_dssp             GGCC-TTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC--CGGGGGCCC
T ss_pred             EeCC-CCccCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCC--CCCCCccCC
Confidence            8543 33445679999999999998889999999999999999999999997654 4555555554422  223345688


Q ss_pred             HHHHHHHHhhhhcCCCCCCCHHHHHhcccccc
Q 014733          271 ASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE  302 (419)
Q Consensus       271 ~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~  302 (419)
                      +++++||.+||++||++|||+.|+|+||||++
T Consensus       257 ~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          257 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence            99999999999999999999999999999975

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.9e-61  Score=485.34  Aligned_cols=258  Identities=26%  Similarity=0.471  Sum_probs=232.1

Q ss_pred             cccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEE
Q 014733           38 LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVH  117 (419)
Q Consensus        38 ~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~  117 (419)
                      -.++|+++++||+|+||+||+|+++.+|+.||||++.+...   ...+.+.+|+.+|++|+ |||||+++++|.+++.+|
T Consensus       149 p~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~~~~~  224 (423)
T 4fie_A          149 PRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDYQ-HENVVEMYNSYLVGDELW  224 (423)
T ss_dssp             GGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC---SSGGGHHHHHHHHHHCC-CTTBCCEEEEEEETTEEE
T ss_pred             hhHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch---hHHHHHHHHHHHHHhCC-CCCCCceEEEEEECCEEE
Confidence            34679999999999999999999999999999999986543   23456889999999996 999999999999999999


Q ss_pred             EEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccC
Q 014733          118 LLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG  197 (419)
Q Consensus       118 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~  197 (419)
                      ||||||+||+|.+++.. +++++.+++.++.||+.||+|||++|||||||||+||||   +.+|.+||+|||+|+.+...
T Consensus       225 iVmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl---~~~g~vKl~DFGla~~~~~~  300 (423)
T 4fie_A          225 VVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKE  300 (423)
T ss_dssp             EEEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEE---CTTCCEEECCCTTCEECCSS
T ss_pred             EEEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE---cCCCCEEEecCccceECCCC
Confidence            99999999999999875 679999999999999999999999999999999999999   56789999999999987544


Q ss_pred             -CccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 014733          198 -QNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARD  275 (419)
Q Consensus       198 -~~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~  275 (419)
                       ....+.+||+.|||||++.+. |+.++|||||||++|||++|++||.+.+..+++..|..... .....+..+|+++++
T Consensus       301 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~~~~~~~~s~~~~d  379 (423)
T 4fie_A          301 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PRLKNLHKVSPSLKG  379 (423)
T ss_dssp             CCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-CCCSCTTSSCHHHHH
T ss_pred             CccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CCCcccccCCHHHHH
Confidence             334567999999999999874 99999999999999999999999999999999988877532 333445689999999


Q ss_pred             HHHhhhhcCCCCCCCHHHHHhccccccch
Q 014733          276 LIMGMLRVDPSTRLTAAEVLAHSWMEECE  304 (419)
Q Consensus       276 li~~~L~~dP~~Rps~~eil~hp~~~~~~  304 (419)
                      ||.+||++||++|||+.|+|+||||++..
T Consensus       380 li~~~L~~dP~~R~ta~ell~Hp~~~~~~  408 (423)
T 4fie_A          380 FLDRLLVRDPAQRATAAELLKHPFLAKAG  408 (423)
T ss_dssp             HHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             HHHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence            99999999999999999999999998654

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.2e-62  Score=475.26  Aligned_cols=257  Identities=32%  Similarity=0.531  Sum_probs=224.8

Q ss_pred             cCeeeeeeecccCceEEEEEEec---CCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDK---FTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYV  116 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~---~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~  116 (419)
                      ++|++++.||+|+||+||+|++.   .+++.||+|++.+.... ......+.+|+.+|++++ |||||++++++++++.+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~  101 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLK-VRDRVRTKMERDILVEVN-HPFIVKLHYAFQTEGKL  101 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEE-EEECC------CCCCCCC-CTTEECEEEEEEETTEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcC-hHHHHHHHHHHHHHHHCC-CCCCCeEEEEEEECCEE
Confidence            68999999999999999999874   57889999999765432 223346788999999996 99999999999999999


Q ss_pred             EEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeecc
Q 014733          117 HLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA  196 (419)
Q Consensus       117 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~  196 (419)
                      |+|||||+||+|.+++.+.+.+++.+++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+|+....
T Consensus       102 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~  178 (304)
T 3ubd_A          102 YLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESID  178 (304)
T ss_dssp             EEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CTTSCEEEESSEEEEC---
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEE---cCCCCEEecccccceeccC
Confidence            9999999999999999998999999999999999999999999999999999999999   6678999999999986544


Q ss_pred             C-CccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 014733          197 G-QNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASAR  274 (419)
Q Consensus       197 ~-~~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~  274 (419)
                      . ....+.+||+.|||||++.+. |+.++|||||||+||||++|++||.+.+..++...|....+.+|.    .+|++++
T Consensus       179 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~----~~s~~~~  254 (304)
T 3ubd_A          179 HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQ----FLSPEAQ  254 (304)
T ss_dssp             --CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHH
T ss_pred             CCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCC----cCCHHHH
Confidence            3 334567999999999999874 999999999999999999999999999999999999988776653    6899999


Q ss_pred             HHHHhhhhcCCCCCCC-----HHHHHhccccccchh
Q 014733          275 DLIMGMLRVDPSTRLT-----AAEVLAHSWMEECEQ  305 (419)
Q Consensus       275 ~li~~~L~~dP~~Rps-----~~eil~hp~~~~~~~  305 (419)
                      +||.+||++||++|||     ++|+++||||+.+++
T Consensus       255 ~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw  290 (304)
T 3ubd_A          255 SLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDW  290 (304)
T ss_dssp             HHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred             HHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCH
Confidence            9999999999999998     689999999998764

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.1e-60  Score=467.09  Aligned_cols=253  Identities=25%  Similarity=0.372  Sum_probs=221.7

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEE
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHL  118 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~l  118 (419)
                      .+.|++.++||+|+||+||+|+++.+|+.||||++.++...        .+|+.+|++|+ |||||++++++.+++.+||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~--------~~E~~il~~l~-HpnIV~l~~~~~~~~~~~i  127 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--------VEELVACAGLS-SPRIVPLYGAVREGPWVNI  127 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--------THHHHTTTTCC-CTTBCCEEEEEEETTEEEE
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH--------HHHHHHHHhCC-CCCCCcEEEEEEECCEEEE
Confidence            46799999999999999999999999999999999876432        35999999996 9999999999999999999


Q ss_pred             EEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCC-CeEEeeccceeeeccC
Q 014733          119 LMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSS-PIKLADFGLATYIKAG  197 (419)
Q Consensus       119 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~-~vKL~DFgla~~~~~~  197 (419)
                      |||||+||+|.+++++.+++++.+++.++.||+.||+|||++|||||||||+||||   +.++ ++||+|||+|+.+...
T Consensus       128 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~~vKl~DFGla~~~~~~  204 (336)
T 4g3f_A          128 FMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLL---SSDGSRAALCDFGHALCLQPD  204 (336)
T ss_dssp             EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEE---CTTSCCEEECCCTTCEEC---
T ss_pred             EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEE---eCCCCEEEEeeCCCCeEccCC
Confidence            99999999999999998999999999999999999999999999999999999999   4455 6999999999977543


Q ss_pred             Cc------cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCC
Q 014733          198 QN------LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHIS  270 (419)
Q Consensus       198 ~~------~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  270 (419)
                      ..      ....+||+.|||||++.+. |+.++|||||||+||||++|++||.+.+..++..+|......+. ..+..+|
T Consensus       205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~s  283 (336)
T 4g3f_A          205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIR-EIPPSCA  283 (336)
T ss_dssp             ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGG-GSCTTSC
T ss_pred             CcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCch-hcCccCC
Confidence            21      1235899999999999875 99999999999999999999999998888888888877654332 2345899


Q ss_pred             HHHHHHHHhhhhcCCCCCCCHHHHH-------------hccccccch
Q 014733          271 ASARDLIMGMLRVDPSTRLTAAEVL-------------AHSWMEECE  304 (419)
Q Consensus       271 ~~l~~li~~~L~~dP~~Rps~~eil-------------~hp~~~~~~  304 (419)
                      +++++||.+||++||++|||+.|++             +|||+.+..
T Consensus       284 ~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~  330 (336)
T 4g3f_A          284 PLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYK  330 (336)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCC
T ss_pred             HHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCC
Confidence            9999999999999999999999984             688886543

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.1e-59  Score=465.90  Aligned_cols=264  Identities=25%  Similarity=0.449  Sum_probs=228.4

Q ss_pred             ccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEe----
Q 014733           37 NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEE----  112 (419)
Q Consensus        37 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~----  112 (419)
                      .+.++|++++.||+|+||+||+|+++.+|+.||||++.+.. ......+.+.+|+.+|++|+ |||||++++++..    
T Consensus        51 ~i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~  128 (398)
T 4b99_A           51 DVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAF-DVVTNAKRTLRELKILKHFK-HDNIIAIKDILRPTVPY  128 (398)
T ss_dssp             CCCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSSCT
T ss_pred             CCCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccc-cchHHHHHHHHHHHHHHhcC-CCCcceEeeeeeccccc
Confidence            45689999999999999999999999999999999997654 34456678899999999996 9999999999864    


Q ss_pred             --CCEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccc
Q 014733          113 --EDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGL  190 (419)
Q Consensus       113 --~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgl  190 (419)
                        .+.+|||||||+ |+|.+++...+++++.+++.++.||+.||+|||++|||||||||+|||+   +.++.+||+|||+
T Consensus       129 ~~~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~---~~~~~~Ki~DFGl  204 (398)
T 4b99_A          129 GEFKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLV---NENCELKIGDFGM  204 (398)
T ss_dssp             TTCCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTCCEEECCCTT
T ss_pred             ccCCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCcccccc---CCCCCEEEeecce
Confidence              367999999995 6899999988899999999999999999999999999999999999999   5678999999999


Q ss_pred             eeeeccC-----CccccccCCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC
Q 014733          191 ATYIKAG-----QNLHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPS  263 (419)
Q Consensus       191 a~~~~~~-----~~~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~  263 (419)
                      |+.+...     ....+.+||+.|+|||++.+  .|+.++||||+||++|||++|++||.+.+..+.+..|.......+.
T Consensus       205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~  284 (398)
T 4b99_A          205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSP  284 (398)
T ss_dssp             CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCG
T ss_pred             eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            9876432     23345699999999999876  3799999999999999999999999999998888887654332221


Q ss_pred             CC---------------------------CCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchhh
Q 014733          264 DP---------------------------WDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQV  306 (419)
Q Consensus       264 ~~---------------------------~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~~  306 (419)
                      ..                           +..+++++++||.+||++||++|||+.|+|+||||++...+
T Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p  354 (398)
T 4b99_A          285 AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDP  354 (398)
T ss_dssp             GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCG
T ss_pred             HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCC
Confidence            11                           23578999999999999999999999999999999876543

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=6.4e-58  Score=453.84  Aligned_cols=260  Identities=28%  Similarity=0.460  Sum_probs=215.3

Q ss_pred             hccccccCeeeeeeecccCceEEEEEEec---CCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEE
Q 014733           34 QISNLSDRYVLGKQLGWGQFGVIRECSDK---FTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVY  110 (419)
Q Consensus        34 ~~~~~~~~y~i~~~LG~G~~g~V~~a~~~---~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~  110 (419)
                      .+..+.++|+++++||+|+||+||+|+++   .+++.||+|.+.+..     ...++.+|+++|+.+.+|||||++++++
T Consensus        15 ~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~   89 (361)
T 4f9c_A           15 AVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCF   89 (361)
T ss_dssp             HSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEE
T ss_pred             hcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEE
Confidence            45678899999999999999999999875   467899999986542     3456788999999997799999999999


Q ss_pred             EeCCEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccc
Q 014733          111 EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGL  190 (419)
Q Consensus       111 ~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgl  190 (419)
                      .+.+++|+||||++||+|.+++.   .+++.+++.++.||+.||+|||++||+||||||+|||++.  +.+.+||+|||+
T Consensus        90 ~~~~~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~--~~~~~kl~DFGl  164 (361)
T 4f9c_A           90 RKNDHVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNR--RLKKYALVDFGL  164 (361)
T ss_dssp             EETTEEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET--TTTEEEECCCTT
T ss_pred             EECCEEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeC--CCCeEEECcCCC
Confidence            99999999999999999999984   5999999999999999999999999999999999999953  346899999999


Q ss_pred             eeeeccCC-----------------------------ccccccCCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCC
Q 014733          191 ATYIKAGQ-----------------------------NLHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGM  239 (419)
Q Consensus       191 a~~~~~~~-----------------------------~~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~  239 (419)
                      |+......                             .....+||+.|+|||++.+  .|+.++||||+||++|||++|+
T Consensus       165 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~  244 (361)
T 4f9c_A          165 AQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGR  244 (361)
T ss_dssp             CEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTC
T ss_pred             CcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCC
Confidence            98654321                             1234589999999999876  3899999999999999999999


Q ss_pred             CCCCCC-CHHHHHHHHHhc--------------------------------------CC------------CCCCCCCCC
Q 014733          240 PPFWGK-TKSKIFDAVRAA--------------------------------------DL------------RFPSDPWDH  268 (419)
Q Consensus       240 ~Pf~~~-~~~~~~~~i~~~--------------------------------------~~------------~~~~~~~~~  268 (419)
                      .||... +..+.+..|...                                      ..            ......|..
T Consensus       245 ~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~  324 (361)
T 4f9c_A          245 YPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNE  324 (361)
T ss_dssp             SSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTT
T ss_pred             CCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccccccccccccc
Confidence            999543 333333333210                                      00            011234668


Q ss_pred             CCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccc
Q 014733          269 ISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEEC  303 (419)
Q Consensus       269 ~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~  303 (419)
                      +|++++|||++||++||++|+|++|+|+||||+++
T Consensus       325 is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i  359 (361)
T 4f9c_A          325 VPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDM  359 (361)
T ss_dssp             CCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred             CCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence            99999999999999999999999999999999865

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.1e-57  Score=477.75  Aligned_cols=263  Identities=34%  Similarity=0.625  Sum_probs=242.9

Q ss_pred             cccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEE
Q 014733           38 LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVH  117 (419)
Q Consensus        38 ~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~  117 (419)
                      +-++|++++.||+|+||+||+|.++.+|+.||+|++.+..   ....+.+.+|+.+|+.|+ |||||++++++.+.+.+|
T Consensus       155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~---~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~  230 (573)
T 3uto_A          155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLR-HPTLVNLHDAFEDDNEMV  230 (573)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHHHTC-CTTBCCEEEEEECSSEEE
T ss_pred             CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc---hhhHHHHHHHHHHHHhCC-CCCCCeEEEEEEECCEEE
Confidence            4579999999999999999999999999999999997653   355678999999999996 999999999999999999


Q ss_pred             EEEeecCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeecc
Q 014733          118 LLMELCAGGELFHRLEK-YGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA  196 (419)
Q Consensus       118 lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~  196 (419)
                      ||||||.||+|++++.. .+.+++.+++.++.||++||+|||++||+||||||+|||++.+ ..+.+||+|||+|+.+..
T Consensus       231 iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~-~~~~vKl~DFG~a~~~~~  309 (573)
T 3uto_A          231 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTK-RSNELKLIDFGLTAHLDP  309 (573)
T ss_dssp             EEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS-SCCCEEECCCSSCEECCT
T ss_pred             EEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCC-CCCCEEEeeccceeEccC
Confidence            99999999999999864 4679999999999999999999999999999999999999542 347899999999999877


Q ss_pred             CCccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 014733          197 GQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARD  275 (419)
Q Consensus       197 ~~~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~  275 (419)
                      .......+||+.|||||++.+. |+.++|||||||++|+|++|++||.+.+..+++..|......++...+..+|+++++
T Consensus       310 ~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~d  389 (573)
T 3uto_A          310 KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKD  389 (573)
T ss_dssp             TSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHH
T ss_pred             CCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence            7777778999999999999875 999999999999999999999999999999999999999988888888899999999


Q ss_pred             HHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          276 LIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       276 li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                      ||++||++||.+|||+.|+|+||||+....
T Consensus       390 li~~~L~~dp~~R~t~~e~l~Hpw~~~~~~  419 (573)
T 3uto_A          390 FIRKLLLADPNTRMTIHQALEHPWLTPGNA  419 (573)
T ss_dssp             HHHTTSCSSGGGSCCHHHHHHSTTTSCCCC
T ss_pred             HHHHHccCChhHCcCHHHHhcCcCcCCCCC
Confidence            999999999999999999999999987544

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=8.8e-58  Score=441.56  Aligned_cols=255  Identities=27%  Similarity=0.484  Sum_probs=202.9

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCC-----
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEED-----  114 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~-----  114 (419)
                      ++|++++.||+|+||+||+|+++.+|+.||+|++....  .....+.+.+|+.+|++|+ |||||++++++.+.+     
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~~~~   81 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLE-HPGIVRYFNAWLEKNTTEKL   81 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEEC-----
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEecCccccc
Confidence            46999999999999999999999999999999997653  4456678999999999996 999999999997644     


Q ss_pred             -------EEEEEEeecCCCChHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeE
Q 014733          115 -------YVHLLMELCAGGELFHRLEKYGR---FSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIK  184 (419)
Q Consensus       115 -------~~~lV~E~~~ggsL~~~l~~~~~---l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vK  184 (419)
                             ++|+|||||+||+|.+++...+.   .++..++.++.||++||+|||++|||||||||+|||+   +.++.+|
T Consensus        82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl---~~~~~vK  158 (299)
T 4g31_A           82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVVK  158 (299)
T ss_dssp             -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEE
T ss_pred             cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEE---CCCCcEE
Confidence                   47999999999999999987655   4566788999999999999999999999999999999   5678999


Q ss_pred             EeeccceeeeccCCc-------------cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCH-HH
Q 014733          185 LADFGLATYIKAGQN-------------LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTK-SK  249 (419)
Q Consensus       185 L~DFgla~~~~~~~~-------------~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~-~~  249 (419)
                      |+|||+|+.+.....             ..+.+||+.|||||++.+. |+.++|||||||++|||++   ||.+... ..
T Consensus       159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~  235 (299)
T 4g31_A          159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVR  235 (299)
T ss_dssp             ECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred             EccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHH
Confidence            999999987654321             2345899999999999875 9999999999999999996   7754322 22


Q ss_pred             HHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchhh
Q 014733          250 IFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQV  306 (419)
Q Consensus       250 ~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~~  306 (419)
                      ....+...  .+|. .+...++.+.+||.+||++||++|||+.|+|+||||++++.+
T Consensus       236 ~~~~~~~~--~~p~-~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~p  289 (299)
T 4g31_A          236 TLTDVRNL--KFPP-LFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFP  289 (299)
T ss_dssp             HHHHHHTT--CCCH-HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC---
T ss_pred             HHHHHhcC--CCCC-CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCCC
Confidence            33333332  2222 223566788999999999999999999999999999987653

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=3.5e-57  Score=474.57  Aligned_cols=259  Identities=29%  Similarity=0.486  Sum_probs=225.8

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHH---HHHHHHccCCCCceeeeEEEEeCCE
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLE---IEIMTKLSGHPNVVDLKAVYEEEDY  115 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~E---i~il~~l~~hpnIv~l~~~~~~~~~  115 (419)
                      -++|++++.||+|+||+||+|+++.+|+.||+|++.+..+........+.+|   +.+++.+ +|||||+++++|++.+.
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~-~HP~IV~l~~~f~~~~~  266 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHTPDK  266 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSS-CCTTBCCEEEEEECSSE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhC-CCCCEeEEEEEEEECCE
Confidence            4789999999999999999999999999999999987654332333444455   4455555 59999999999999999


Q ss_pred             EEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeec
Q 014733          116 VHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIK  195 (419)
Q Consensus       116 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~  195 (419)
                      +||||||++||+|..+|.+.+.+++..++.++.||+.||+|||++|||||||||+||||   +.+|++||+|||+|+.+.
T Consensus       267 lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILl---d~~G~vKL~DFGlA~~~~  343 (689)
T 3v5w_A          267 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFS  343 (689)
T ss_dssp             EEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECS
T ss_pred             EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEE---eCCCCEEecccceeeecC
Confidence            99999999999999999999999999999999999999999999999999999999999   678899999999999775


Q ss_pred             cCCccccccCCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhcCCCCCCCCCCCCC
Q 014733          196 AGQNLHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGK---TKSKIFDAVRAADLRFPSDPWDHIS  270 (419)
Q Consensus       196 ~~~~~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~---~~~~~~~~i~~~~~~~~~~~~~~~s  270 (419)
                      ... ..+.+||+.|||||++.+  .|+.++|||||||+||||++|++||.+.   ...++...+......+|    ..+|
T Consensus       344 ~~~-~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p----~~~S  418 (689)
T 3v5w_A          344 KKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP----DSFS  418 (689)
T ss_dssp             SCC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCC----TTSC
T ss_pred             CCC-CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCC----ccCC
Confidence            443 456799999999999864  4999999999999999999999999753   34456666666665554    4789


Q ss_pred             HHHHHHHHhhhhcCCCCCCC-----HHHHHhccccccchhh
Q 014733          271 ASARDLIMGMLRVDPSTRLT-----AAEVLAHSWMEECEQV  306 (419)
Q Consensus       271 ~~l~~li~~~L~~dP~~Rps-----~~eil~hp~~~~~~~~  306 (419)
                      +++++||.+||++||.+|++     +.||++||||+.+++.
T Consensus       419 ~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~  459 (689)
T 3v5w_A          419 PELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQ  459 (689)
T ss_dssp             HHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHH
T ss_pred             HHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHH
Confidence            99999999999999999998     7999999999998764

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=5.2e-57  Score=435.89  Aligned_cols=255  Identities=21%  Similarity=0.380  Sum_probs=220.7

Q ss_pred             cCeeeeeeecccCceEEEEEEec-----CCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCC
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDK-----FTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEED  114 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~-----~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~  114 (419)
                      ++|.+.+.||+|+||+||+|++.     .++..||||++...   +....+.+.+|+++|++|+ |||||++++++.+.+
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~-HpnIV~l~g~~~~~~   88 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQ-HEHIVKFYGVCVEGD   88 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCC-CCCCccEEEEEeeCC
Confidence            68999999999999999999875     36789999999653   4566788999999999996 999999999999999


Q ss_pred             EEEEEEeecCCCChHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCC
Q 014733          115 YVHLLMELCAGGELFHRLEKYG-------------RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSS  181 (419)
Q Consensus       115 ~~~lV~E~~~ggsL~~~l~~~~-------------~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~  181 (419)
                      .+|||||||++|+|.++|...+             .+++.++..++.||+.||+|||+++||||||||+||||   +.++
T Consensus        89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl---~~~~  165 (299)
T 4asz_A           89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV---GENL  165 (299)
T ss_dssp             SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGG
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEE---CCCC
Confidence            9999999999999999997642             59999999999999999999999999999999999999   5677


Q ss_pred             CeEEeeccceeeeccCCcc---ccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q 014733          182 PIKLADFGLATYIKAGQNL---HGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRA  256 (419)
Q Consensus       182 ~vKL~DFgla~~~~~~~~~---~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~  256 (419)
                      .+||+|||+|+........   ...+||+.|||||++.+ .|+.++|||||||+||||+| |+.||.+.+..++...+..
T Consensus       166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~  245 (299)
T 4asz_A          166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ  245 (299)
T ss_dssp             CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHH
T ss_pred             cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence            9999999999866443322   23469999999999876 59999999999999999998 9999999999999999887


Q ss_pred             cCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchhh
Q 014733          257 ADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQV  306 (419)
Q Consensus       257 ~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~~  306 (419)
                      +....   .+..+|+++.+||.+||+.||++|||+.+|  |+|++.+...
T Consensus       246 ~~~~~---~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~~~~~  290 (299)
T 4asz_A          246 GRVLQ---RPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQNLAKA  290 (299)
T ss_dssp             TCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHHHHHH
T ss_pred             CCCCC---CCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHHHHhc
Confidence            65322   224789999999999999999999999999  5678776543

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.6e-55  Score=426.26  Aligned_cols=249  Identities=24%  Similarity=0.402  Sum_probs=208.1

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      ++++++++||+|+||+||+|+++   ..||||+++... .+....+.+.+|+.+|++++ |||||++++++.+ +.+|||
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~-~~~~~~~~f~~E~~il~~l~-HpNIV~l~g~~~~-~~~~iV  109 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVD-PTPEQFQAFRNEVAVLRKTR-HVNILLFMGYMTK-DNLAIV  109 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSS-CCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECS-SSCEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecC-CCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEC-CeEEEE
Confidence            78899999999999999999864   359999986543 45667889999999999996 9999999998865 458999


Q ss_pred             EeecCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccC-
Q 014733          120 MELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG-  197 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~-  197 (419)
                      ||||+||+|.+++... +++++.++..++.||+.||+|||+++||||||||+||||   +.++.+||+|||+|+..... 
T Consensus       110 mEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl---~~~~~~Ki~DFGla~~~~~~~  186 (307)
T 3omv_A          110 TQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFL---HEGLTVKIGDFGLATVKSRWS  186 (307)
T ss_dssp             EECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEE---ETTEEEEECCCSSCBC-----
T ss_pred             EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEE---CCCCcEEEeeccCceecccCC
Confidence            9999999999999764 569999999999999999999999999999999999999   45778999999999865432 


Q ss_pred             --CccccccCCCccCCcccccC----CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--CCCCCCC
Q 014733          198 --QNLHGTVGSPFYIAPEVLAG----GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFP--SDPWDHI  269 (419)
Q Consensus       198 --~~~~~~~gt~~y~aPE~l~~----~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~~~  269 (419)
                        ......+||+.|||||++.+    .|+.++|||||||+||||+||+.||.+.+.......+.......|  ...+..+
T Consensus       187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~  266 (307)
T 3omv_A          187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNC  266 (307)
T ss_dssp             -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTS
T ss_pred             cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccc
Confidence              22345689999999999853    389999999999999999999999988766555554444433333  2345678


Q ss_pred             CHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          270 SASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       270 s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      ++++.+||.+||+.||++|||+.||+++
T Consensus       267 ~~~l~~li~~cl~~dP~~RPs~~ei~~~  294 (307)
T 3omv_A          267 PKAMKRLVADCVKKVKEERPLFPQILSS  294 (307)
T ss_dssp             CHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred             hHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            9999999999999999999999999765

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2.3e-55  Score=429.87  Aligned_cols=253  Identities=21%  Similarity=0.342  Sum_probs=213.2

Q ss_pred             ccCeeeeeeecccCceEEEEEEec-----CCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeC
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDK-----FTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEE  113 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~-----~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~  113 (419)
                      .++|.+.++||+|+||+||+|+++     .++..||||++...   +....+.+.+|+++|++|+ |||||++++++.+.
T Consensus        40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~-HpnIV~l~g~~~~~  115 (329)
T 4aoj_A           40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQ-HQHIVRFFGVCTEG  115 (329)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSS
T ss_pred             HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEEC
Confidence            368999999999999999999864     46889999999653   4567788999999999996 99999999999999


Q ss_pred             CEEEEEEeecCCCChHHHHHHc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecC
Q 014733          114 DYVHLLMELCAGGELFHRLEKY---------------GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKS  178 (419)
Q Consensus       114 ~~~~lV~E~~~ggsL~~~l~~~---------------~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~  178 (419)
                      +.+|||||||++|+|.+++...               +++++.++..++.||+.||+|||+++||||||||+||||   +
T Consensus       116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl---~  192 (329)
T 4aoj_A          116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV---G  192 (329)
T ss_dssp             SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---E
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEE---C
Confidence            9999999999999999999753               358999999999999999999999999999999999999   4


Q ss_pred             CCCCeEEeeccceeeeccCCc---cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 014733          179 SSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDA  253 (419)
Q Consensus       179 ~~~~vKL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~  253 (419)
                      .++.+||+|||+++.......   ....+||+.|||||++.+. |+.++|||||||+||||+| |+.||.+.+..++...
T Consensus       193 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~  272 (329)
T 4aoj_A          193 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC  272 (329)
T ss_dssp             TTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHH
T ss_pred             CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            677999999999987644322   2345799999999998875 9999999999999999999 9999999999999988


Q ss_pred             HHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccc
Q 014733          254 VRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEEC  303 (419)
Q Consensus       254 i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~  303 (419)
                      +..+.. .  ..+..+++++.+|+.+||+.||++|||+.||+++  ++.+
T Consensus       273 i~~g~~-~--~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~--L~~l  317 (329)
T 4aoj_A          273 ITQGRE-L--ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR--LQAL  317 (329)
T ss_dssp             HHHTCC-C--CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH--HHHH
T ss_pred             HHcCCC-C--CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH--HHHH
Confidence            877642 1  2234789999999999999999999999999874  5444

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.9e-55  Score=426.74  Aligned_cols=249  Identities=22%  Similarity=0.355  Sum_probs=215.9

Q ss_pred             cCeeeeeeecccCceEEEEEEec-----CCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCC
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDK-----FTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEED  114 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~-----~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~  114 (419)
                      +++++.++||+|+||+||+|...     .+++.||||++....  .....+.+.+|+.+|++|+ |||||++++++.+++
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~-HpNIV~l~g~~~~~~  102 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQ-HPNVVCLLGVVTKDQ  102 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCC-CTTBCCEEEEECSSS
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCC-CCCCCCcceEEEECC
Confidence            67889999999999999999853     467899999986542  3345678999999999996 999999999999999


Q ss_pred             EEEEEEeecCCCChHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecC
Q 014733          115 YVHLLMELCAGGELFHRLEKY----------------GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKS  178 (419)
Q Consensus       115 ~~~lV~E~~~ggsL~~~l~~~----------------~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~  178 (419)
                      .+++|||||++|+|.++|...                ..+++.++..++.||+.||+|||+++||||||||+||||   +
T Consensus       103 ~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl---~  179 (308)
T 4gt4_A          103 PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV---Y  179 (308)
T ss_dssp             SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---C
T ss_pred             EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE---C
Confidence            999999999999999999643                348999999999999999999999999999999999999   5


Q ss_pred             CCCCeEEeeccceeeeccCC---ccccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 014733          179 SSSPIKLADFGLATYIKAGQ---NLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDA  253 (419)
Q Consensus       179 ~~~~vKL~DFgla~~~~~~~---~~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~  253 (419)
                      +++.+||+|||+++......   .....+||+.|||||++.+ .|+.++|||||||+||||+| |..||.+.+..++.+.
T Consensus       180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~  259 (308)
T 4gt4_A          180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM  259 (308)
T ss_dssp             GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHH
T ss_pred             CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            67799999999998764432   2334589999999999876 59999999999999999998 8999999999999998


Q ss_pred             HHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          254 VRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       254 i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      +..+... +  .+..++.++.+|+.+||+.||++|||+.||+++
T Consensus       260 i~~~~~~-~--~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          260 IRNRQVL-P--CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             HHTTCCC-C--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHcCCCC-C--CcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            8776432 2  234789999999999999999999999999875

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=8e-54  Score=423.61  Aligned_cols=261  Identities=30%  Similarity=0.557  Sum_probs=232.8

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEE
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHL  118 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~l  118 (419)
                      .++|++++.||+|+||+||+|+++.+|+.||+|++.+...........+.+|..+++.+.+||||+++++++.+.+.+|+
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            47899999999999999999999999999999999876444445677888999999998779999999999999999999


Q ss_pred             EEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeecc-C
Q 014733          119 LMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA-G  197 (419)
Q Consensus       119 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~-~  197 (419)
                      ||||++||+|..++...+.+++.+++.++.||+.||+|||++||+||||||+|||+   +.++++||+|||+++.... .
T Consensus       102 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl---~~~g~ikL~DFG~a~~~~~~~  178 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLL---DHEGHCKLADFGMCKEGICNG  178 (353)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSCC--
T ss_pred             EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEE---CCCCCEEEccccceeecccCC
Confidence            99999999999999988999999999999999999999999999999999999999   5678999999999986332 2


Q ss_pred             CccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHH
Q 014733          198 QNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDL  276 (419)
Q Consensus       198 ~~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~l  276 (419)
                      ......+||+.|+|||++.+. |+.++|||||||++|+|++|++||.+.+..++.+.+......++.    .++.++.+|
T Consensus       179 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~l  254 (353)
T 3txo_A          179 VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT----WLHEDATGI  254 (353)
T ss_dssp             -------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHH
T ss_pred             ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHH
Confidence            334556899999999998774 999999999999999999999999999999999999998777664    589999999


Q ss_pred             HHhhhhcCCCCCCCH------HHHHhccccccchhh
Q 014733          277 IMGMLRVDPSTRLTA------AEVLAHSWMEECEQV  306 (419)
Q Consensus       277 i~~~L~~dP~~Rps~------~eil~hp~~~~~~~~  306 (419)
                      |++||++||.+||++      .++++||||+.+.+.
T Consensus       255 i~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~  290 (353)
T 3txo_A          255 LKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWA  290 (353)
T ss_dssp             HHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHH
T ss_pred             HHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHH
Confidence            999999999999999      899999999987653

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=7e-54  Score=425.26  Aligned_cols=270  Identities=37%  Similarity=0.626  Sum_probs=243.8

Q ss_pred             ccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCH---HhHHHHHHHHHHHHHccCCCCceeeeEEEE
Q 014733           35 ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTV---EDVRSIKLEIEIMTKLSGHPNVVDLKAVYE  111 (419)
Q Consensus        35 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~---~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~  111 (419)
                      ...+.++|++++.||+|+||+||+|.++.+|+.||+|++.+......   ...+.+.+|+.+|+++. ||||+++++++.
T Consensus         7 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~   85 (361)
T 2yab_A            7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL-HPNIITLHDVYE   85 (361)
T ss_dssp             CSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCC-CTTBCCEEEEEE
T ss_pred             CCChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCC-CcCCCcEEEEEE
Confidence            35678999999999999999999999999999999999987654221   13577899999999996 999999999999


Q ss_pred             eCCEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCC-CCCeEEeeccc
Q 014733          112 EEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSS-SSPIKLADFGL  190 (419)
Q Consensus       112 ~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~-~~~vKL~DFgl  190 (419)
                      +.+.+|+||||++||+|.+++...+.+++.+++.++.||+.||.|||+.||+||||||+|||++.++. ...+||+|||+
T Consensus        86 ~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~  165 (361)
T 2yab_A           86 NRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL  165 (361)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred             eCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence            99999999999999999999988888999999999999999999999999999999999999954221 12799999999


Q ss_pred             eeeeccCCccccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCC
Q 014733          191 ATYIKAGQNLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHI  269 (419)
Q Consensus       191 a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  269 (419)
                      +............+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+....+....+.++...|..+
T Consensus       166 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  245 (361)
T 2yab_A          166 AHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQT  245 (361)
T ss_dssp             CEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTS
T ss_pred             ceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCC
Confidence            998776666667789999999999887 4999999999999999999999999999999999999998888877777889


Q ss_pred             CHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          270 SASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       270 s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                      ++++++||.+||+.||.+|||+.|+++||||+....
T Consensus       246 s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~  281 (361)
T 2yab_A          246 SELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDT  281 (361)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSSH
T ss_pred             CHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCch
Confidence            999999999999999999999999999999986543

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.1e-53  Score=423.91  Aligned_cols=272  Identities=40%  Similarity=0.783  Sum_probs=249.1

Q ss_pred             ccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCC
Q 014733           35 ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEED  114 (419)
Q Consensus        35 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~  114 (419)
                      ...+.++|++.+.||+|+||.||+|.++.+|+.||+|++..... .....+.+.+|+.+++++. ||||+++++++.+.+
T Consensus        24 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~  101 (362)
T 2bdw_A           24 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQ-HPNIVRLHDSIQEES  101 (362)
T ss_dssp             CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEECSS
T ss_pred             CCCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeCC
Confidence            44567899999999999999999999999999999999987654 4566788999999999996 999999999999999


Q ss_pred             EEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeee
Q 014733          115 YVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI  194 (419)
Q Consensus       115 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~  194 (419)
                      ..|+||||+.|++|.+.+...+.+++.+++.++.||++||+|||++||+||||||+|||++.++.++.+||+|||++...
T Consensus       102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~  181 (362)
T 2bdw_A          102 FHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  181 (362)
T ss_dssp             EEEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred             EEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence            99999999999999999988888999999999999999999999999999999999999976656678999999999887


Q ss_pred             ccCCccccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 014733          195 KAGQNLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASA  273 (419)
Q Consensus       195 ~~~~~~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l  273 (419)
                      .........+||+.|+|||++.+ .|+.++|||||||++|+|++|++||.+.+..++...+..+...++...|..+++++
T Consensus       182 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  261 (362)
T 2bdw_A          182 NDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA  261 (362)
T ss_dssp             TTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHH
T ss_pred             cCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence            76655566789999999999887 49999999999999999999999999999999999999998888888888999999


Q ss_pred             HHHHHhhhhcCCCCCCCHHHHHhccccccchhhhc
Q 014733          274 RDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQ  308 (419)
Q Consensus       274 ~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~~~~  308 (419)
                      ++||.+||+.||++|||+.++|+||||........
T Consensus       262 ~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~  296 (362)
T 2bdw_A          262 KSLIDSMLTVNPKKRITADQALKVPWICNRERVAS  296 (362)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHTTSHHHHTHHHHSC
T ss_pred             HHHHHHHcCCChhhCcCHHHHhcCcccCCCccccc
Confidence            99999999999999999999999999987654433

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=3.3e-53  Score=414.99  Aligned_cols=262  Identities=37%  Similarity=0.624  Sum_probs=239.0

Q ss_pred             ccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCC
Q 014733           35 ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEED  114 (419)
Q Consensus        35 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~  114 (419)
                      .....++|++++.||+|+||.||+|.+..+|+.||+|++.+... .....+.+.+|+.+|+.++ ||||+++++++.+.+
T Consensus        10 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~   87 (328)
T 3fe3_A           10 EQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILN-HPNIVKLFEVIETEK   87 (328)
T ss_dssp             -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEECSS
T ss_pred             cCCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECC
Confidence            44556899999999999999999999999999999999977653 5566788999999999996 999999999999999


Q ss_pred             EEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeee
Q 014733          115 YVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI  194 (419)
Q Consensus       115 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~  194 (419)
                      .+|+||||++|++|.+++...+++++.+++.++.||+.||+|||+.||+||||||+|||+   +.++.+||+|||++...
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~  164 (328)
T 3fe3_A           88 TLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLL---DADMNIKIADFGFSNEF  164 (328)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSTTCCGGG
T ss_pred             EEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEE---cCCCCEEEeeccCceec
Confidence            999999999999999999888999999999999999999999999999999999999999   56789999999999877


Q ss_pred             ccCCccccccCCCccCCcccccCC-C-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHH
Q 014733          195 KAGQNLHGTVGSPFYIAPEVLAGG-Y-NQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISAS  272 (419)
Q Consensus       195 ~~~~~~~~~~gt~~y~aPE~l~~~-~-s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  272 (419)
                      .........+||+.|+|||++.+. + +.++|||||||++|+|++|+.||.+.+..++.+.+..+...+|.    .++++
T Consensus       165 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~----~~s~~  240 (328)
T 3fe3_A          165 TVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF----YMSTD  240 (328)
T ss_dssp             SSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHH
T ss_pred             CCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHH
Confidence            666666677999999999998874 4 57999999999999999999999999999999999888776654    58999


Q ss_pred             HHHHHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          273 ARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       273 l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                      +.+||++||+.||.+|||+.|+++||||+....
T Consensus       241 ~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~  273 (328)
T 3fe3_A          241 CENLLKRFLVLNPIKRGTLEQIMKDRWINAGHE  273 (328)
T ss_dssp             HHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTCT
T ss_pred             HHHHHHHHCCCChhHCcCHHHHhcCHhhcCCCc
Confidence            999999999999999999999999999987543

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=4.7e-53  Score=415.53  Aligned_cols=260  Identities=32%  Similarity=0.588  Sum_probs=235.1

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEE
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHL  118 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~l  118 (419)
                      -++|++++.||+|+||+||+|+++.+|+.||+|++.+...........+.+|+.+|+.+. ||||+++++++.+.+.+|+
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~~~~~l   82 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDRLCF   82 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-CTTBCCEEEEEECSSEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCC-CCcCcceEEEEEeCCEEEE
Confidence            378999999999999999999999999999999997654333345677889999999996 9999999999999999999


Q ss_pred             EEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeec-cC
Q 014733          119 LMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIK-AG  197 (419)
Q Consensus       119 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~-~~  197 (419)
                      ||||++||+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++++||+|||+++... ..
T Consensus        83 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~~~  159 (337)
T 1o6l_A           83 VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDG  159 (337)
T ss_dssp             EEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSCCTT
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEE---CCCCCEEEeeccchhhcccCC
Confidence            99999999999999988899999999999999999999999999999999999999   567899999999998643 33


Q ss_pred             CccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHH
Q 014733          198 QNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDL  276 (419)
Q Consensus       198 ~~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~l  276 (419)
                      ......+||+.|+|||++.+. |+.++|||||||++|+|++|+.||.+.+..++.+.+......+|.    .+++++++|
T Consensus       160 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~l  235 (337)
T 1o6l_A          160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSL  235 (337)
T ss_dssp             CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHH
T ss_pred             CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHH
Confidence            344567899999999998774 899999999999999999999999999999999998888776654    689999999


Q ss_pred             HHhhhhcCCCCCC-----CHHHHHhccccccchhh
Q 014733          277 IMGMLRVDPSTRL-----TAAEVLAHSWMEECEQV  306 (419)
Q Consensus       277 i~~~L~~dP~~Rp-----s~~eil~hp~~~~~~~~  306 (419)
                      |.+||+.||++||     ++.++++||||+...+.
T Consensus       236 i~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~  270 (337)
T 1o6l_A          236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ  270 (337)
T ss_dssp             HHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred             HHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHH
Confidence            9999999999999     99999999999987653

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=2.1e-54  Score=426.74  Aligned_cols=251  Identities=26%  Similarity=0.397  Sum_probs=212.6

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCC-----CcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEe-
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFT-----GEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEE-  112 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~-----g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~-  112 (419)
                      .++|++++.||+|+||+||+|.+..+     ++.||+|.+...  ......+.+.+|+++|.++..|||||+++++|.+ 
T Consensus        63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~--~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~  140 (353)
T 4ase_A           63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP  140 (353)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred             HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccc--cChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence            47999999999999999999987643     368999998754  3455678899999999999756999999999966 


Q ss_pred             CCEEEEEEeecCCCChHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEee
Q 014733          113 EDYVHLLMELCAGGELFHRLEKY----------------GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLAT  176 (419)
Q Consensus       113 ~~~~~lV~E~~~ggsL~~~l~~~----------------~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~  176 (419)
                      .+.+|+|||||++|+|.++|+..                ..+++.++..++.||++||+|||+++||||||||+|||+  
T Consensus       141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl--  218 (353)
T 4ase_A          141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL--  218 (353)
T ss_dssp             TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceee--
Confidence            45789999999999999999753                238999999999999999999999999999999999999  


Q ss_pred             cCCCCCeEEeeccceeeeccCCc---cccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHH-H
Q 014733          177 KSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTKSK-I  250 (419)
Q Consensus       177 ~~~~~~vKL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~-~  250 (419)
                       +.++.+||+|||+|+.+.....   ....+||+.|||||++.+ .|+.++|||||||+||||+| |+.||.+....+ +
T Consensus       219 -~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~  297 (353)
T 4ase_A          219 -SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF  297 (353)
T ss_dssp             -CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH
T ss_pred             -CCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence             5677999999999987654332   234579999999999876 49999999999999999998 999998866444 4


Q ss_pred             HHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          251 FDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       251 ~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      ...+..+ .+.+.  +..+++++.++|.+||+.||++|||+.||++|
T Consensus       298 ~~~i~~g-~~~~~--p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          298 CRRLKEG-TRMRA--PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             HHHHHHT-CCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHcC-CCCCC--CccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            4455444 22222  24789999999999999999999999999987

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=3.1e-53  Score=431.60  Aligned_cols=270  Identities=40%  Similarity=0.749  Sum_probs=245.4

Q ss_pred             ccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCC
Q 014733           35 ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEED  114 (419)
Q Consensus        35 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~  114 (419)
                      ...+.++|++++.||+|+||+||+|.++.+|+.+|+|++.+... .....+.+.+|+.+++++. ||||+++++++.+.+
T Consensus         6 ~~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~-~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~   83 (444)
T 3soa_A            6 CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICRLLK-HPNIVRLHDSISEEG   83 (444)
T ss_dssp             -CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC-HHHHHHHHHHHHHHHHHCC-BTTBCCEEEEEECSS
T ss_pred             cccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCC-CcCCCeEEEEEEECC
Confidence            45678999999999999999999999999999999999987653 3456678999999999995 999999999999999


Q ss_pred             EEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeee
Q 014733          115 YVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI  194 (419)
Q Consensus       115 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~  194 (419)
                      ..|+||||+.||+|.+.+...+.+++.++..++.||+.||+|||++||+||||||+|||++.+..++.+||+|||++...
T Consensus        84 ~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~  163 (444)
T 3soa_A           84 HHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV  163 (444)
T ss_dssp             EEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred             EEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence            99999999999999999998889999999999999999999999999999999999999976656789999999999876


Q ss_pred             ccCCc-cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHH
Q 014733          195 KAGQN-LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISAS  272 (419)
Q Consensus       195 ~~~~~-~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  272 (419)
                      ..... ....+||+.|+|||++.+. |+.++|||||||++|+|++|++||.+.+..+....+..+...++...|..++++
T Consensus       164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  243 (444)
T 3soa_A          164 EGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPE  243 (444)
T ss_dssp             CTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHH
T ss_pred             cCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHH
Confidence            54432 3456899999999999874 999999999999999999999999999999999999999999998888999999


Q ss_pred             HHHHHHhhhhcCCCCCCCHHHHHhccccccchhh
Q 014733          273 ARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQV  306 (419)
Q Consensus       273 l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~~  306 (419)
                      +++||.+||+.||++|||+.|+|+||||+.....
T Consensus       244 ~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~~~~  277 (444)
T 3soa_A          244 AKDLINKMLTINPSKRITAAEALKHPWISHRSTV  277 (444)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHHHSCTTHHHHHH
T ss_pred             HHHHHHHHcCCChhHCCCHHHHhcCccccCCccc
Confidence            9999999999999999999999999999876543

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=9.2e-53  Score=421.90  Aligned_cols=262  Identities=27%  Similarity=0.522  Sum_probs=231.2

Q ss_pred             cccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEE
Q 014733           38 LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVH  117 (419)
Q Consensus        38 ~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~  117 (419)
                      -.++|++++.||+|+||+||+|+++.+++.||+|++.+.........+.+.+|..+|+++.+||||+++++++.+.+.+|
T Consensus        50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  129 (396)
T 4dc2_A           50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF  129 (396)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence            35789999999999999999999999999999999988766555666778999999998867999999999999999999


Q ss_pred             EEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceee-ecc
Q 014733          118 LLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATY-IKA  196 (419)
Q Consensus       118 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~-~~~  196 (419)
                      +||||++||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++++||+|||+++. ...
T Consensus       130 lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl---~~~g~ikL~DFGla~~~~~~  206 (396)
T 4dc2_A          130 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRP  206 (396)
T ss_dssp             EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCT
T ss_pred             EEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE---CCCCCEEEeecceeeecccC
Confidence            999999999999999988899999999999999999999999999999999999999   6678999999999986 334


Q ss_pred             CCccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCC---------CHHHHHHHHHhcCCCCCCCCC
Q 014733          197 GQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGK---------TKSKIFDAVRAADLRFPSDPW  266 (419)
Q Consensus       197 ~~~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~---------~~~~~~~~i~~~~~~~~~~~~  266 (419)
                      .......+||+.|+|||++.+. |+.++|||||||++|+|++|++||...         ....+.+.+......+|.   
T Consensus       207 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~---  283 (396)
T 4dc2_A          207 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR---  283 (396)
T ss_dssp             TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCT---
T ss_pred             CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCC---
Confidence            4455667999999999999874 999999999999999999999999532         334566777777666654   


Q ss_pred             CCCCHHHHHHHHhhhhcCCCCCCCH------HHHHhccccccchhh
Q 014733          267 DHISASARDLIMGMLRVDPSTRLTA------AEVLAHSWMEECEQV  306 (419)
Q Consensus       267 ~~~s~~l~~li~~~L~~dP~~Rps~------~eil~hp~~~~~~~~  306 (419)
                       .++.++++||++||+.||.+||++      .++++||||+.+.+.
T Consensus       284 -~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~  328 (396)
T 4dc2_A          284 -SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD  328 (396)
T ss_dssp             -TSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHH
T ss_pred             -cCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHH
Confidence             689999999999999999999984      899999999988653

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.6e-52  Score=399.44  Aligned_cols=277  Identities=40%  Similarity=0.780  Sum_probs=252.5

Q ss_pred             cccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCE
Q 014733           36 SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDY  115 (419)
Q Consensus        36 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~  115 (419)
                      ..+.++|++.+.||+|+||.||+|.++.+|+.||+|++..... .....+.+.+|+.++++++ ||||+++++++.+.+.
T Consensus         2 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~   79 (284)
T 3kk8_A            2 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQ-HPNIVRLHDSIQEESF   79 (284)
T ss_dssp             CTTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSE
T ss_pred             chhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcC-CCCcCeEEEEEEcCCE
Confidence            3578999999999999999999999999999999999976653 5566788999999999996 9999999999999999


Q ss_pred             EEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeec
Q 014733          116 VHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIK  195 (419)
Q Consensus       116 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~  195 (419)
                      .++||||+++++|.+.+...+.+++..++.++.|++.||.|||+.||+||||||+||+++.++..+.+||+|||++....
T Consensus        80 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~  159 (284)
T 3kk8_A           80 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  159 (284)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence            99999999999999999888889999999999999999999999999999999999999766666679999999998877


Q ss_pred             cCCccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 014733          196 AGQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASAR  274 (419)
Q Consensus       196 ~~~~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~  274 (419)
                      .........||+.|+|||++.+. ++.++||||||+++|+|++|+.||.+....+....+.......+...+..+++++.
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T 3kk8_A          160 DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK  239 (284)
T ss_dssp             SSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHH
T ss_pred             cCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHH
Confidence            66666667899999999998875 89999999999999999999999999999999999999988888888889999999


Q ss_pred             HHHHhhhhcCCCCCCCHHHHHhccccccchhhhcCCCCcc
Q 014733          275 DLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKPCKQD  314 (419)
Q Consensus       275 ~li~~~L~~dP~~Rps~~eil~hp~~~~~~~~~~~~~~~~  314 (419)
                      +||.+||+.||++|||+.|+++||||++..........++
T Consensus       240 ~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~~~~~~~  279 (284)
T 3kk8_A          240 SLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQD  279 (284)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCGGGSCCCCC
T ss_pred             HHHHHHcccChhhCCCHHHHhcCccccCChhHHhHhhcCC
Confidence            9999999999999999999999999998776665554443

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.8e-53  Score=411.37  Aligned_cols=263  Identities=29%  Similarity=0.574  Sum_probs=240.2

Q ss_pred             ccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEE
Q 014733           37 NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYV  116 (419)
Q Consensus        37 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~  116 (419)
                      .+.++|++++.||+|+||+||+|.++.+++.+|+|.+...    ......+.+|+.+++.+. ||||+++++++.+.+.+
T Consensus         2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~----~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~   76 (321)
T 1tki_A            2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK----GTDQVLVKKEISILNIAR-HRNILHLHESFESMEEL   76 (321)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC----THHHHHHHHHHHHHHHSC-CTTBCCEEEEEEETTEE
T ss_pred             chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC----cccHHHHHHHHHHHHhCC-CCCCCeEeEEEecCCEE
Confidence            5779999999999999999999999999999999998743    245567899999999996 99999999999999999


Q ss_pred             EEEEeecCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeec
Q 014733          117 HLLMELCAGGELFHRLEKYG-RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIK  195 (419)
Q Consensus       117 ~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~  195 (419)
                      ++||||++|++|.+++...+ .+++.+++.++.||+.||.|||++||+||||||+|||++.+ .++.+||+|||++....
T Consensus        77 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~-~~~~~kl~Dfg~a~~~~  155 (321)
T 1tki_A           77 VMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTR-RSSTIKIIEFGQARQLK  155 (321)
T ss_dssp             EEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS-SCCCEEECCCTTCEECC
T ss_pred             EEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccC-CCCCEEEEECCCCeECC
Confidence            99999999999999997654 69999999999999999999999999999999999999542 26799999999999877


Q ss_pred             cCCccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 014733          196 AGQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASAR  274 (419)
Q Consensus       196 ~~~~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~  274 (419)
                      .........||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.+..+....+......++...+..++.++.
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  235 (321)
T 1tki_A          156 PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM  235 (321)
T ss_dssp             TTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred             CCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHH
Confidence            66666667899999999999876 79999999999999999999999999999999999999888887777788999999


Q ss_pred             HHHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          275 DLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       275 ~li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                      +||.+||+.||.+|||+.|+|+||||++...
T Consensus       236 ~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  266 (321)
T 1tki_A          236 DFVDRLLVKERKSRMTASEALQHPWLKQKIE  266 (321)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHHSHHHHSCGG
T ss_pred             HHHHHHcCCChhHCcCHHHHhcChhhccCcc
Confidence            9999999999999999999999999987543

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=6.8e-52  Score=408.45  Aligned_cols=260  Identities=27%  Similarity=0.523  Sum_probs=232.8

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEE
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHL  118 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~l  118 (419)
                      .++|++++.||+|+||.||+|+++.+++.||+|++.+.........+.+.+|..+++++.+||||+++++++.+.+.+|+
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            47899999999999999999999999999999999887766777788899999999998669999999999999999999


Q ss_pred             EEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeec-cC
Q 014733          119 LMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIK-AG  197 (419)
Q Consensus       119 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~-~~  197 (419)
                      ||||++||+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++++||+|||+++... ..
T Consensus        88 v~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~DFG~a~~~~~~~  164 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPG  164 (345)
T ss_dssp             EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCGGGCBCSCCTT
T ss_pred             EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---CCCCCEEEEeccccccccCCC
Confidence            99999999999999988899999999999999999999999999999999999999   567899999999998632 33


Q ss_pred             CccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCC---------CCHHHHHHHHHhcCCCCCCCCCC
Q 014733          198 QNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWG---------KTKSKIFDAVRAADLRFPSDPWD  267 (419)
Q Consensus       198 ~~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~---------~~~~~~~~~i~~~~~~~~~~~~~  267 (419)
                      ......+||+.|+|||++.+. |+.++|||||||++|+|++|+.||..         .....+.+.+......+|.    
T Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~----  240 (345)
T 3a8x_A          165 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----  240 (345)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCT----
T ss_pred             CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCC----
Confidence            344567899999999998874 89999999999999999999999965         3445566777777666553    


Q ss_pred             CCCHHHHHHHHhhhhcCCCCCCCH------HHHHhccccccchh
Q 014733          268 HISASARDLIMGMLRVDPSTRLTA------AEVLAHSWMEECEQ  305 (419)
Q Consensus       268 ~~s~~l~~li~~~L~~dP~~Rps~------~eil~hp~~~~~~~  305 (419)
                      .++.++++||.+||+.||.+||++      .++++||||+.+.+
T Consensus       241 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w  284 (345)
T 3a8x_A          241 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW  284 (345)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCH
T ss_pred             CCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCH
Confidence            689999999999999999999995      89999999998765

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2e-52  Score=408.71  Aligned_cols=269  Identities=39%  Similarity=0.661  Sum_probs=241.0

Q ss_pred             cccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCH---HhHHHHHHHHHHHHHccCCCCceeeeEEEEe
Q 014733           36 SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTV---EDVRSIKLEIEIMTKLSGHPNVVDLKAVYEE  112 (419)
Q Consensus        36 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~---~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~  112 (419)
                      ..+.++|++.+.||+|+||.||+|.++.+|+.||+|++.+......   ...+.+.+|+.+|+++. ||||+++++++.+
T Consensus         7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~   85 (326)
T 2y0a_A            7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITLHEVYEN   85 (326)
T ss_dssp             SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEEC
T ss_pred             CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCC-CCCCCcEEEEEEe
Confidence            4677899999999999999999999999999999999987543221   14678999999999996 9999999999999


Q ss_pred             CCEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecC-CCCCeEEeeccce
Q 014733          113 EDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKS-SSSPIKLADFGLA  191 (419)
Q Consensus       113 ~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~-~~~~vKL~DFgla  191 (419)
                      .+.+++||||+++++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++ ....+||+|||++
T Consensus        86 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a  165 (326)
T 2y0a_A           86 KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  165 (326)
T ss_dssp             SSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence            999999999999999999998888899999999999999999999999999999999999995432 2237999999999


Q ss_pred             eeeccCCccccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCC
Q 014733          192 TYIKAGQNLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHIS  270 (419)
Q Consensus       192 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  270 (419)
                      ............+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+....+......++...+..++
T Consensus       166 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (326)
T 2y0a_A          166 HKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS  245 (326)
T ss_dssp             EECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSC
T ss_pred             eECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCC
Confidence            98766555666789999999999876 48999999999999999999999999999999998888887777766667899


Q ss_pred             HHHHHHHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          271 ASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       271 ~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                      .++.+||.+||+.||++|||+.++|+||||+....
T Consensus       246 ~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~  280 (326)
T 2y0a_A          246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT  280 (326)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCSH
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHhcCCCccCCcc
Confidence            99999999999999999999999999999986543

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=5e-53  Score=434.36  Aligned_cols=271  Identities=41%  Similarity=0.744  Sum_probs=250.7

Q ss_pred             hccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeC
Q 014733           34 QISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEE  113 (419)
Q Consensus        34 ~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~  113 (419)
                      ....+.++|++.+.||+|+||.||+|.++.+|+.||+|++.+...........+.+|+.+++++. ||||+++++++.+.
T Consensus        20 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~   98 (484)
T 3nyv_A           20 STAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD-HPNIMKLYEFFEDK   98 (484)
T ss_dssp             CCCCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCC-CTTBCCEEEEEECS
T ss_pred             CCCcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCC-CCCCCcEEEEEEeC
Confidence            34567899999999999999999999999999999999998766544556788999999999995 99999999999999


Q ss_pred             CEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceee
Q 014733          114 DYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATY  193 (419)
Q Consensus       114 ~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~  193 (419)
                      +.+|+||||+.|++|.+.+...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.++.+||+|||++..
T Consensus        99 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  178 (484)
T 3nyv_A           99 GYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH  178 (484)
T ss_dssp             SEEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred             CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence            99999999999999999998888899999999999999999999999999999999999997666778999999999987


Q ss_pred             eccCCccccccCCCccCCcccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 014733          194 IKAGQNLHGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASA  273 (419)
Q Consensus       194 ~~~~~~~~~~~gt~~y~aPE~l~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l  273 (419)
                      ..........+||+.|+|||++.+.|+.++|||||||++|+|++|++||.+.+..++...+......++...|..+++++
T Consensus       179 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  258 (484)
T 3nyv_A          179 FEASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESA  258 (484)
T ss_dssp             BCCCCSHHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHH
T ss_pred             cccccccccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHH
Confidence            76666566678999999999999899999999999999999999999999999999999999998888888888999999


Q ss_pred             HHHHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          274 RDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       274 ~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                      ++||++||+.||.+|||+.++|+||||+....
T Consensus       259 ~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~  290 (484)
T 3nyv_A          259 KDLIRKMLTYVPSMRISARDALDHEWIQTYTK  290 (484)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred             HHHHHHHCCCChhHCcCHHHHhhChhhccccc
Confidence            99999999999999999999999999987643

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.4e-52  Score=413.35  Aligned_cols=264  Identities=29%  Similarity=0.527  Sum_probs=234.9

Q ss_pred             cccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCE
Q 014733           36 SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDY  115 (419)
Q Consensus        36 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~  115 (419)
                      ..-.++|++.+.||+|+||+||+|+++.+|+.||+|++.+...........+..|..++..+.+||||+++++++.+.+.
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            33458999999999999999999999999999999999765432234567788999999987569999999999999999


Q ss_pred             EEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeec
Q 014733          116 VHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIK  195 (419)
Q Consensus       116 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~  195 (419)
                      +|+||||++||+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||+   +.++++||+|||+++...
T Consensus        93 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~vkL~DFG~a~~~~  169 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKENM  169 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCC
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEE---CCCCCEEEeEChhhhhcc
Confidence            99999999999999999988899999999999999999999999999999999999999   567899999999998643


Q ss_pred             c-CCccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 014733          196 A-GQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASA  273 (419)
Q Consensus       196 ~-~~~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l  273 (419)
                      . .......+||+.|+|||++.+. |+.++|||||||++|+|++|+.||.+.+..++.+.+......++.    .++.++
T Consensus       170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~  245 (345)
T 1xjd_A          170 LGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR----WLEKEA  245 (345)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHH
T ss_pred             cCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCc----ccCHHH
Confidence            2 2334567899999999998874 899999999999999999999999999999999999887766553    589999


Q ss_pred             HHHHHhhhhcCCCCCCCHH-HHHhccccccchhh
Q 014733          274 RDLIMGMLRVDPSTRLTAA-EVLAHSWMEECEQV  306 (419)
Q Consensus       274 ~~li~~~L~~dP~~Rps~~-eil~hp~~~~~~~~  306 (419)
                      ++||.+||+.||++||++. ++++||||+.+.+.
T Consensus       246 ~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w~  279 (345)
T 1xjd_A          246 KDLLVKLFVREPEKRLGVRGDIRQHPLFREINWE  279 (345)
T ss_dssp             HHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHH
T ss_pred             HHHHHHHhcCCHhHcCCChHHHHcCccccCCCHH
Confidence            9999999999999999998 99999999988653

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=3e-52  Score=429.95  Aligned_cols=272  Identities=38%  Similarity=0.680  Sum_probs=244.6

Q ss_pred             hhhccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEE
Q 014733           32 ATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYE  111 (419)
Q Consensus        32 ~~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~  111 (419)
                      ......+.++|++++.||+|+||+||+|+++.++..+|+|++.+... .......+.+|+.+|+.+. ||||+++++++.
T Consensus        29 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~  106 (494)
T 3lij_A           29 TSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSV-STSSNSKLLEEVAVLKLLD-HPNIMKLYDFFE  106 (494)
T ss_dssp             CCCBCCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCC-CTTBCCEEEEEE
T ss_pred             ecCCCchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEecccc-CchHHHHHHHHHHHHHhCC-CCCCCeEEEEEE
Confidence            34456788899999999999999999999999999999999986543 2234567889999999996 999999999999


Q ss_pred             eCCEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccce
Q 014733          112 EEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA  191 (419)
Q Consensus       112 ~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla  191 (419)
                      +.+.+|+||||+.||+|.+.+....++++..++.++.||+.||.|||+.||+||||||+|||++.++.++.+||+|||++
T Consensus       107 ~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a  186 (494)
T 3lij_A          107 DKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLS  186 (494)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             eCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCC
Confidence            99999999999999999999988889999999999999999999999999999999999999976666678999999999


Q ss_pred             eeeccCCccccccCCCccCCcccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCH
Q 014733          192 TYIKAGQNLHGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISA  271 (419)
Q Consensus       192 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  271 (419)
                      ............+||+.|+|||++.+.|+.++||||+||++|+|++|++||.+....++...+......++...|..+++
T Consensus       187 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  266 (494)
T 3lij_A          187 AVFENQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSE  266 (494)
T ss_dssp             EECBTTBCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCH
T ss_pred             eECCCCccccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCH
Confidence            98776666667789999999999988899999999999999999999999999999999999999998888888889999


Q ss_pred             HHHHHHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          272 SARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       272 ~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                      ++++||.+||+.||.+|||+.++|+||||++...
T Consensus       267 ~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~  300 (494)
T 3lij_A          267 GAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCS  300 (494)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHHH
T ss_pred             HHHHHHHHHCCCChhhCccHHHHhcCcccccCcc
Confidence            9999999999999999999999999999987643

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=4.3e-52  Score=405.41  Aligned_cols=258  Identities=31%  Similarity=0.596  Sum_probs=233.8

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEE
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHL  118 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~l  118 (419)
                      -++|++++.||+|+||+||+|+++.+|+.||+|++.+.........+.+.+|+.+++.+. ||||+++++++.+.+.+|+
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~~~~~~l   83 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HPFIIRMWGTFQDAQQIFM   83 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-BTTBCCEEEEEECSSEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCC-CCCCceEeEEEEeCCEEEE
Confidence            478999999999999999999999999999999997654322345677889999999995 9999999999999999999


Q ss_pred             EEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC
Q 014733          119 LMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ  198 (419)
Q Consensus       119 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~  198 (419)
                      ||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++.....  
T Consensus        84 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~Dfg~a~~~~~--  158 (318)
T 1fot_A           84 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL---DKNGHIKITDFGFAKYVPD--  158 (318)
T ss_dssp             EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE---CTTSCEEECCCSSCEECSS--
T ss_pred             EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEE---cCCCCEEEeecCcceecCC--
Confidence            99999999999999988889999999999999999999999999999999999999   5678999999999987543  


Q ss_pred             ccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHH
Q 014733          199 NLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLI  277 (419)
Q Consensus       199 ~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li  277 (419)
                      .....+||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+.+..+....+......++.    .++.+++++|
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li  234 (318)
T 1fot_A          159 VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP----FFNEDVKDLL  234 (318)
T ss_dssp             CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHHH
T ss_pred             ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHHHHHHH
Confidence            23456899999999998774 899999999999999999999999999999999999888776653    6899999999


Q ss_pred             HhhhhcCCCCCC-----CHHHHHhccccccchhh
Q 014733          278 MGMLRVDPSTRL-----TAAEVLAHSWMEECEQV  306 (419)
Q Consensus       278 ~~~L~~dP~~Rp-----s~~eil~hp~~~~~~~~  306 (419)
                      .+||+.||.+||     +++++++||||+...+.
T Consensus       235 ~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~  268 (318)
T 1fot_A          235 SRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE  268 (318)
T ss_dssp             HHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred             HHHhccCHHHcCCCcCCCHHHHhcCccccCCCHH
Confidence            999999999999     99999999999987653

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=4.6e-52  Score=429.62  Aligned_cols=275  Identities=36%  Similarity=0.647  Sum_probs=245.4

Q ss_pred             ccchhhccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCH----------HhHHHHHHHHHHHHHcc
Q 014733           29 ILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTV----------EDVRSIKLEIEIMTKLS   98 (419)
Q Consensus        29 ~~~~~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~----------~~~~~~~~Ei~il~~l~   98 (419)
                      .+-......+.++|+++++||+|+||+||+|.++.+++.||+|++.+......          ...+.+.+|+.+|+++.
T Consensus        25 ~~~~~~~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  104 (504)
T 3q5i_A           25 MYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD  104 (504)
T ss_dssp             GGCCEECSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCC
T ss_pred             heeeccCCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCC
Confidence            33444556788999999999999999999999999999999999986543211          34577899999999996


Q ss_pred             CCCCceeeeEEEEeCCEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecC
Q 014733           99 GHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKS  178 (419)
Q Consensus        99 ~hpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~  178 (419)
                       ||||+++++++.+.+.+|+||||++||+|.+.+...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++
T Consensus       105 -hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~  183 (504)
T 3q5i_A          105 -HPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKN  183 (504)
T ss_dssp             -CTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTT
T ss_pred             -CCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCC
Confidence             9999999999999999999999999999999998888999999999999999999999999999999999999996654


Q ss_pred             CCCCeEEeeccceeeeccCCccccccCCCccCCcccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC
Q 014733          179 SSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAAD  258 (419)
Q Consensus       179 ~~~~vKL~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~  258 (419)
                      ....+||+|||++............+||+.|+|||++.+.|+.++||||+||++|+|++|++||.+.+..++...+....
T Consensus       184 ~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~  263 (504)
T 3q5i_A          184 SLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGK  263 (504)
T ss_dssp             CCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred             CCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Confidence            44579999999999877666666778999999999998889999999999999999999999999999999999999998


Q ss_pred             CCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccch
Q 014733          259 LRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECE  304 (419)
Q Consensus       259 ~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~  304 (419)
                      +.++...|..+|+++++||++||++||.+|||+.|+|+||||+...
T Consensus       264 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  309 (504)
T 3q5i_A          264 YYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA  309 (504)
T ss_dssp             CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred             CCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence            8888777889999999999999999999999999999999998654

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=4.6e-52  Score=395.21  Aligned_cols=266  Identities=41%  Similarity=0.739  Sum_probs=243.7

Q ss_pred             ccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCC
Q 014733           35 ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEED  114 (419)
Q Consensus        35 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~  114 (419)
                      ...+.++|++.+.||+|+||.||+|.++.++..+|+|++.....   ...+.+.+|+.+++++. ||||+++++++.+.+
T Consensus         4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~   79 (277)
T 3f3z_A            4 KGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLD-HPNIIRLYETFEDNT   79 (277)
T ss_dssp             --CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSS
T ss_pred             hhhhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc---chHHHHHHHHHHHHhCC-CCCEeeEEEEEecCC
Confidence            34678999999999999999999999999999999999976543   34577889999999995 999999999999999


Q ss_pred             EEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeee
Q 014733          115 YVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI  194 (419)
Q Consensus       115 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~  194 (419)
                      ..++||||+++++|.+++...+.+++.+++.++.|++.||+|||++||+||||||+|||+..++.++.+||+|||++...
T Consensus        80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~  159 (277)
T 3f3z_A           80 DIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF  159 (277)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             eEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence            99999999999999999988888999999999999999999999999999999999999966667789999999999987


Q ss_pred             ccCCccccccCCCccCCcccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 014733          195 KAGQNLHGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASAR  274 (419)
Q Consensus       195 ~~~~~~~~~~gt~~y~aPE~l~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~  274 (419)
                      ..........||+.|+|||++.+.++.++||||||+++|+|++|+.||.+....+....+......++...+..+++++.
T Consensus       160 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (277)
T 3f3z_A          160 KPGKMMRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAE  239 (277)
T ss_dssp             CTTSCBCCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHH
T ss_pred             cCccchhccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHH
Confidence            76666667789999999999988899999999999999999999999999999999999999888877766678999999


Q ss_pred             HHHHhhhhcCCCCCCCHHHHHhccccccch
Q 014733          275 DLIMGMLRVDPSTRLTAAEVLAHSWMEECE  304 (419)
Q Consensus       275 ~li~~~L~~dP~~Rps~~eil~hp~~~~~~  304 (419)
                      ++|.+||+.||.+|||+.++++||||++..
T Consensus       240 ~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  269 (277)
T 3f3z_A          240 SLIRRLLTKSPKQRITSLQALEHEWFEKQL  269 (277)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred             HHHHHHccCChhhCcCHHHHhcCHHHhccc
Confidence            999999999999999999999999998643

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=2.8e-52  Score=412.58  Aligned_cols=261  Identities=28%  Similarity=0.504  Sum_probs=235.3

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEE
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHL  118 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~l  118 (419)
                      .++|++++.||+|+||+||+|+++.+|+.||+|++.+.........+.+..|..+|..+.+||||+++++++.+.+.+|+
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   98 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   98 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence            47899999999999999999999999999999999865433334567788999999988669999999999999999999


Q ss_pred             EEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeec-cC
Q 014733          119 LMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIK-AG  197 (419)
Q Consensus       119 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~-~~  197 (419)
                      ||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++++||+|||+++... ..
T Consensus        99 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~~~  175 (353)
T 2i0e_A           99 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENIWDG  175 (353)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTT
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE---cCCCcEEEEeCCcccccccCC
Confidence            99999999999999988899999999999999999999999999999999999999   567899999999998643 23


Q ss_pred             CccccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHH
Q 014733          198 QNLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDL  276 (419)
Q Consensus       198 ~~~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~l  276 (419)
                      ......+||+.|+|||++.+ .++.++|||||||++|||++|++||.+.+..++.+.+......+|.    .++.++++|
T Consensus       176 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~l  251 (353)
T 2i0e_A          176 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVAI  251 (353)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHH
T ss_pred             cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHHHHHH
Confidence            34456789999999999876 4899999999999999999999999999999999999988776654    689999999


Q ss_pred             HHhhhhcCCCCCC-----CHHHHHhccccccchhh
Q 014733          277 IMGMLRVDPSTRL-----TAAEVLAHSWMEECEQV  306 (419)
Q Consensus       277 i~~~L~~dP~~Rp-----s~~eil~hp~~~~~~~~  306 (419)
                      |.+||+.||.+||     ++.++++||||+.+.+.
T Consensus       252 i~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~  286 (353)
T 2i0e_A          252 CKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE  286 (353)
T ss_dssp             HHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHH
T ss_pred             HHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHH
Confidence            9999999999999     47999999999987653

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.7e-52  Score=421.97  Aligned_cols=270  Identities=28%  Similarity=0.443  Sum_probs=234.5

Q ss_pred             chhhccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEE
Q 014733           31 DATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVY  110 (419)
Q Consensus        31 ~~~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~  110 (419)
                      .........++|++++.||+|+||+||+|+++.+++.||+|++.+...........+.+|+.+++.+. ||||+++++++
T Consensus        60 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~  138 (410)
T 3v8s_A           60 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFYAF  138 (410)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred             HHHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCC-CCCCCeEEEEE
Confidence            44455666789999999999999999999999999999999997643222223345788999999995 99999999999


Q ss_pred             EeCCEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccc
Q 014733          111 EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGL  190 (419)
Q Consensus       111 ~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgl  190 (419)
                      .+.+.+|+||||++||+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||+   +.++++||+|||+
T Consensus       139 ~~~~~~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl---~~~g~ikL~DFG~  214 (410)
T 3v8s_A          139 QDDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGT  214 (410)
T ss_dssp             ECSSEEEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTT
T ss_pred             EECCEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeE---CCCCCEEEeccce
Confidence            999999999999999999999976 579999999999999999999999999999999999999   6678999999999


Q ss_pred             eeeeccCCc--cccccCCCccCCcccccCC-----CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC
Q 014733          191 ATYIKAGQN--LHGTVGSPFYIAPEVLAGG-----YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPS  263 (419)
Q Consensus       191 a~~~~~~~~--~~~~~gt~~y~aPE~l~~~-----~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~  263 (419)
                      ++.......  ....+||+.|+|||++.+.     |+.++|||||||++|+|++|++||.+.+..+...+|......+..
T Consensus       215 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~  294 (410)
T 3v8s_A          215 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTF  294 (410)
T ss_dssp             CEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCC
T ss_pred             eEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccC
Confidence            987654432  2356899999999998652     789999999999999999999999999999999888765433333


Q ss_pred             CCCCCCCHHHHHHHHhhhhcCCCC--CCCHHHHHhccccccchh
Q 014733          264 DPWDHISASARDLIMGMLRVDPST--RLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       264 ~~~~~~s~~l~~li~~~L~~dP~~--Rps~~eil~hp~~~~~~~  305 (419)
                      ..+..++.++++||.+||+.+|.+  |++++||++||||+...+
T Consensus       295 p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w  338 (410)
T 3v8s_A          295 PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW  338 (410)
T ss_dssp             CTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSC
T ss_pred             CCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCH
Confidence            334579999999999999999988  999999999999998754

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.3e-52  Score=412.67  Aligned_cols=260  Identities=31%  Similarity=0.606  Sum_probs=236.1

Q ss_pred             ccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEE
Q 014733           37 NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYV  116 (419)
Q Consensus        37 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~  116 (419)
                      ...++|++++.||+|+||.||+|+++.+|+.||+|++.+.........+.+.+|+.+|+.+. ||||+++++++.+.+.+
T Consensus        38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~  116 (350)
T 1rdq_E           38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKLEFSFKDNSNL  116 (350)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEE
T ss_pred             CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEcCCEE
Confidence            34689999999999999999999999999999999997654333345678899999999995 99999999999999999


Q ss_pred             EEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeecc
Q 014733          117 HLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA  196 (419)
Q Consensus       117 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~  196 (419)
                      |+||||++||+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++....
T Consensus       117 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~DFg~a~~~~~  193 (350)
T 1rdq_E          117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECSS
T ss_pred             EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEE---CCCCCEEEcccccceeccC
Confidence            9999999999999999988899999999999999999999999999999999999999   5678999999999987644


Q ss_pred             CCccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 014733          197 GQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARD  275 (419)
Q Consensus       197 ~~~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~  275 (419)
                      .  ....+||+.|+|||++.+. ++.++|||||||++|+|++|++||.+.+..++.+.+......++.    .++.++.+
T Consensus       194 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~  267 (350)
T 1rdq_E          194 R--TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKD  267 (350)
T ss_dssp             C--BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TCCHHHHH
T ss_pred             C--cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHH
Confidence            3  3456899999999998774 899999999999999999999999999999999999888776653    68999999


Q ss_pred             HHHhhhhcCCCCCCC-----HHHHHhccccccchhh
Q 014733          276 LIMGMLRVDPSTRLT-----AAEVLAHSWMEECEQV  306 (419)
Q Consensus       276 li~~~L~~dP~~Rps-----~~eil~hp~~~~~~~~  306 (419)
                      +|.+||+.||.+||+     +.++++||||+..++.
T Consensus       268 li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~  303 (350)
T 1rdq_E          268 LLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWI  303 (350)
T ss_dssp             HHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHH
T ss_pred             HHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHH
Confidence            999999999999998     9999999999987653

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=3.4e-52  Score=422.89  Aligned_cols=269  Identities=25%  Similarity=0.452  Sum_probs=232.9

Q ss_pred             hhccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEe
Q 014733           33 TQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEE  112 (419)
Q Consensus        33 ~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~  112 (419)
                      .+.....++|+++++||+|+||+||+|+++.+++.||+|++.+...........+.+|..++..+. ||||+++++++.+
T Consensus        67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~-hp~Iv~l~~~~~~  145 (437)
T 4aw2_A           67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGD-SKWITTLHYAFQD  145 (437)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSC-TTTBCCEEEEEEC
T ss_pred             hcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEee
Confidence            344556789999999999999999999999999999999997643322223344888999999995 9999999999999


Q ss_pred             CCEEEEEEeecCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccce
Q 014733          113 EDYVHLLMELCAGGELFHRLEK-YGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA  191 (419)
Q Consensus       113 ~~~~~lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla  191 (419)
                      .+.+|+||||++||+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++
T Consensus       146 ~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl---~~~g~vkL~DFGla  222 (437)
T 4aw2_A          146 DNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM---DMNGHIRLADFGSC  222 (437)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTC
T ss_pred             CCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeE---cCCCCEEEcchhhh
Confidence            9999999999999999999987 4679999999999999999999999999999999999999   56789999999999


Q ss_pred             eeeccCCcc--ccccCCCccCCccccc-----C-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC--CCC
Q 014733          192 TYIKAGQNL--HGTVGSPFYIAPEVLA-----G-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAAD--LRF  261 (419)
Q Consensus       192 ~~~~~~~~~--~~~~gt~~y~aPE~l~-----~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~  261 (419)
                      +........  ...+||+.|+|||++.     + .|+.++|||||||++|||++|++||.+.+..+...++....  +.+
T Consensus       223 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~  302 (437)
T 4aw2_A          223 LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQF  302 (437)
T ss_dssp             EECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCC
T ss_pred             hhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccC
Confidence            876544332  3458999999999986     2 38999999999999999999999999999988888886543  333


Q ss_pred             CCCCCCCCCHHHHHHHHhhhhcCCCC--CCCHHHHHhccccccchhh
Q 014733          262 PSDPWDHISASARDLIMGMLRVDPST--RLTAAEVLAHSWMEECEQV  306 (419)
Q Consensus       262 ~~~~~~~~s~~l~~li~~~L~~dP~~--Rps~~eil~hp~~~~~~~~  306 (419)
                      |.. +..+++++++||++||+.+|++  |++++|+++||||+.+.+.
T Consensus       303 p~~-~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~  348 (437)
T 4aw2_A          303 PTQ-VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWD  348 (437)
T ss_dssp             CSS-CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTT
T ss_pred             Ccc-cccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHH
Confidence            332 3569999999999999998888  9999999999999988664

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=2.3e-52  Score=429.83  Aligned_cols=267  Identities=42%  Similarity=0.750  Sum_probs=243.2

Q ss_pred             cccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCE
Q 014733           36 SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDY  115 (419)
Q Consensus        36 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~  115 (419)
                      ..+.++|++++.||+|+||+||+|.++.+++.||+|++.+.... ......+.+|+.+|+++. ||||+++++++.+.+.
T Consensus        18 g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~   95 (486)
T 3mwu_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLD-HPNIMKLFEILEDSSS   95 (486)
T ss_dssp             CHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHB-CSCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSE
T ss_pred             CChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEeccccc-chHHHHHHHHHHHHHhCC-CCCcCeEEEEEEcCCE
Confidence            35778999999999999999999999999999999999654321 234577899999999995 9999999999999999


Q ss_pred             EEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeec
Q 014733          116 VHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIK  195 (419)
Q Consensus       116 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~  195 (419)
                      +|+||||+.|++|.+.+...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.++.+||+|||++....
T Consensus        96 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  175 (486)
T 3mwu_A           96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (486)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred             EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence            99999999999999999888899999999999999999999999999999999999999776667789999999998776


Q ss_pred             cCCccccccCCCccCCcccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 014733          196 AGQNLHGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARD  275 (419)
Q Consensus       196 ~~~~~~~~~gt~~y~aPE~l~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~  275 (419)
                      ........+||+.|+|||++.+.|+.++|||||||++|+|++|++||.+....++...+......++...|..+|+++++
T Consensus       176 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  255 (486)
T 3mwu_A          176 QNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKD  255 (486)
T ss_dssp             CC----CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHH
T ss_pred             CCCccCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHH
Confidence            66556667899999999999988999999999999999999999999999999999999999888888888899999999


Q ss_pred             HHHhhhhcCCCCCCCHHHHHhccccccch
Q 014733          276 LIMGMLRVDPSTRLTAAEVLAHSWMEECE  304 (419)
Q Consensus       276 li~~~L~~dP~~Rps~~eil~hp~~~~~~  304 (419)
                      ||.+||+.||.+|||+.++|+||||+...
T Consensus       256 li~~~L~~dp~~R~t~~~~l~hp~~~~~~  284 (486)
T 3mwu_A          256 LIRKMLTFHPSLRITATQCLEHPWIQKYS  284 (486)
T ss_dssp             HHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred             HHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence            99999999999999999999999998754

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=5.8e-52  Score=409.38  Aligned_cols=269  Identities=37%  Similarity=0.699  Sum_probs=222.4

Q ss_pred             cchhhccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEE
Q 014733           30 LDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAV  109 (419)
Q Consensus        30 ~~~~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~  109 (419)
                      .+......+.++|++.+.||+|+||.||+|.++.+++.||+|++....     ..+.+.+|+.+|+++. ||||++++++
T Consensus        43 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~-h~niv~~~~~  116 (349)
T 2w4o_A           43 IDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLS-HPNIIKLKEI  116 (349)
T ss_dssp             CCSSBCSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCC-CTTBCCEEEE
T ss_pred             ccCcccccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCC-CCCCcceeee
Confidence            344556778899999999999999999999999999999999997542     3466888999999996 9999999999


Q ss_pred             EEeCCEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeecc
Q 014733          110 YEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFG  189 (419)
Q Consensus       110 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFg  189 (419)
                      +.+.+.+++||||+++++|.+++...+.+++.+++.++.||+.||.|||+.||+||||||+|||++..+.++.+||+|||
T Consensus       117 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg  196 (349)
T 2w4o_A          117 FETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFG  196 (349)
T ss_dssp             EECSSEEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC
T ss_pred             EecCCeEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCc
Confidence            99999999999999999999999888889999999999999999999999999999999999999654557899999999


Q ss_pred             ceeeeccCCccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhcCCCCCCCCCC
Q 014733          190 LATYIKAGQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKS-KIFDAVRAADLRFPSDPWD  267 (419)
Q Consensus       190 la~~~~~~~~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~  267 (419)
                      ++............+||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+.... .....+......++...+.
T Consensus       197 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~  276 (349)
T 2w4o_A          197 LSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWD  276 (349)
T ss_dssp             ----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTT
T ss_pred             cccccCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhh
Confidence            99876655445567899999999998874 899999999999999999999999766544 4677777777777777778


Q ss_pred             CCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccch
Q 014733          268 HISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECE  304 (419)
Q Consensus       268 ~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~  304 (419)
                      .++.++.+||.+||+.||++|||+.++++||||....
T Consensus       277 ~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  313 (349)
T 2w4o_A          277 EVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA  313 (349)
T ss_dssp             TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred             hCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence            8999999999999999999999999999999998654

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=3.3e-52  Score=411.33  Aligned_cols=267  Identities=36%  Similarity=0.699  Sum_probs=233.1

Q ss_pred             ccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCC--HHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCC
Q 014733           37 NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVT--VEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEED  114 (419)
Q Consensus        37 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~--~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~  114 (419)
                      .+.++|++.+.||+|+||+||+|.++.+|+.||+|++.+.....  ....+.+.+|+.+++.++ ||||+++++++.+.+
T Consensus        21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~   99 (351)
T 3c0i_A           21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK-HPHIVELLETYSSDG   99 (351)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCC-CTTBCCEEEEEEETT
T ss_pred             ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCC-CCCCCcEEEEEEeCC
Confidence            45789999999999999999999999999999999997543211  123577899999999996 999999999999999


Q ss_pred             EEEEEEeecCCCChHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccc
Q 014733          115 YVHLLMELCAGGELFHRLEKY----GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGL  190 (419)
Q Consensus       115 ~~~lV~E~~~ggsL~~~l~~~----~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgl  190 (419)
                      .+|+||||++|++|.+.+...    ..+++..++.++.||+.||+|||++||+||||||+|||++.++..+.+||+|||+
T Consensus       100 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          100 MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            999999999999998877543    2489999999999999999999999999999999999997655566799999999


Q ss_pred             eeeeccCCc-cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCC
Q 014733          191 ATYIKAGQN-LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDH  268 (419)
Q Consensus       191 a~~~~~~~~-~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  268 (419)
                      +........ ....+||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+. ..+....+.......+...|..
T Consensus       180 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~~~~~~~~~  258 (351)
T 3c0i_A          180 AIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMNPRQWSH  258 (351)
T ss_dssp             CEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCCCCHHHHTT
T ss_pred             eeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCCCCcccccc
Confidence            987755433 3456899999999998774 899999999999999999999999874 4567777777777766666678


Q ss_pred             CCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          269 ISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       269 ~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                      ++.++++||.+||+.||++|||+.++++||||+....
T Consensus       259 ~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~~  295 (351)
T 3c0i_A          259 ISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDR  295 (351)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHHH
T ss_pred             CCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCCcc
Confidence            9999999999999999999999999999999987654

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.3e-51  Score=405.93  Aligned_cols=263  Identities=38%  Similarity=0.677  Sum_probs=233.5

Q ss_pred             cccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCE
Q 014733           36 SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDY  115 (419)
Q Consensus        36 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~  115 (419)
                      ..+.++|++.+.||+|+||+||+|.++.+|+.||+|++.+...       ...+|++++.++.+||||+++++++.+.+.
T Consensus        18 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~   90 (342)
T 2qr7_A           18 IQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQHPNIITLKDVYDDGKY   90 (342)
T ss_dssp             -CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-------CCHHHHHHHHHHTTSTTBCCEEEEEECSSE
T ss_pred             cCccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCE
Confidence            3578899999999999999999999999999999999976542       234688889888679999999999999999


Q ss_pred             EEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecC-CCCCeEEeeccceeee
Q 014733          116 VHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKS-SSSPIKLADFGLATYI  194 (419)
Q Consensus       116 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~-~~~~vKL~DFgla~~~  194 (419)
                      +|+||||++||+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||+..++ ..+.+||+|||++...
T Consensus        91 ~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~  170 (342)
T 2qr7_A           91 VYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL  170 (342)
T ss_dssp             EEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence            999999999999999999888899999999999999999999999999999999999984322 2246999999999876


Q ss_pred             ccCC-ccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHHhcCCCCCCCCCCCC
Q 014733          195 KAGQ-NLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWG---KTKSKIFDAVRAADLRFPSDPWDHI  269 (419)
Q Consensus       195 ~~~~-~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~---~~~~~~~~~i~~~~~~~~~~~~~~~  269 (419)
                      .... .....+||+.|+|||++.+. |+.++|||||||++|+|++|+.||.+   ....++...+..+.+.++...|..+
T Consensus       171 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  250 (342)
T 2qr7_A          171 RAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSV  250 (342)
T ss_dssp             BCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTS
T ss_pred             cCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccC
Confidence            5443 34456899999999998774 89999999999999999999999975   4667888899999888888888899


Q ss_pred             CHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          270 SASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       270 s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                      ++++++||++||+.||++|||+.++++||||.....
T Consensus       251 s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~  286 (342)
T 2qr7_A          251 SDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQ  286 (342)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGGG
T ss_pred             CHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCccc
Confidence            999999999999999999999999999999976543

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=4.1e-51  Score=394.12  Aligned_cols=264  Identities=27%  Similarity=0.462  Sum_probs=230.0

Q ss_pred             hhhccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEE
Q 014733           32 ATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYE  111 (419)
Q Consensus        32 ~~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~  111 (419)
                      ...+....++|++.+.||+|+||+||+|.+..+|+.||+|++......   ..+.+.+|+.+++++. ||||+++++++.
T Consensus        12 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~-hp~iv~~~~~~~   87 (297)
T 3fxz_A           12 IVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENK-NPNIVNYLDSYL   87 (297)
T ss_dssp             HSBSSCGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHHCC-CTTBCCEEEEEE
T ss_pred             ccCcCChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc---HHHHHHHHHHHHhcCC-CCCCCeEeEEEE
Confidence            344566788999999999999999999999999999999999765432   3466889999999996 999999999999


Q ss_pred             eCCEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccce
Q 014733          112 EEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA  191 (419)
Q Consensus       112 ~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla  191 (419)
                      +.+.+++||||++|++|.+++.. ..+++.+++.++.|++.||+|||+.||+||||||+|||+   +.++.+||+|||++
T Consensus        88 ~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~  163 (297)
T 3fxz_A           88 VGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFC  163 (297)
T ss_dssp             ETTEEEEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTC
T ss_pred             ECCEEEEEEECCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEE---CCCCCEEEeeCCCc
Confidence            99999999999999999999977 579999999999999999999999999999999999999   56789999999999


Q ss_pred             eeeccCCc-cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCC
Q 014733          192 TYIKAGQN-LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHI  269 (419)
Q Consensus       192 ~~~~~~~~-~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  269 (419)
                      ........ ....+||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+....+....+....... ...+..+
T Consensus       164 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~  242 (297)
T 3fxz_A          164 AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPE-LQNPEKL  242 (297)
T ss_dssp             EECCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCC-CSCGGGS
T ss_pred             eecCCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC-CCCcccc
Confidence            87654433 3456899999999998774 8999999999999999999999999888777666655443322 2223478


Q ss_pred             CHHHHHHHHhhhhcCCCCCCCHHHHHhccccccch
Q 014733          270 SASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECE  304 (419)
Q Consensus       270 s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~  304 (419)
                      +..+.+||.+||+.||++|||+.|+++||||+...
T Consensus       243 ~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  277 (297)
T 3fxz_A          243 SAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAK  277 (297)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhhChhhcccC
Confidence            99999999999999999999999999999998643

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=3.2e-51  Score=391.95  Aligned_cols=262  Identities=34%  Similarity=0.644  Sum_probs=227.5

Q ss_pred             ccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEE
Q 014733           37 NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYV  116 (419)
Q Consensus        37 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~  116 (419)
                      .+.++|++.+.||+|+||.||+|.++.++..+|+|++.....  ....+.+.+|++++++++ ||||+++++++.+.+..
T Consensus        19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~   95 (285)
T 3is5_A           19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVPMEQIEAEIEVLKSLD-HPNIIKIFEVFEDYHNM   95 (285)
T ss_dssp             CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC--CSCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEE
T ss_pred             ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc--chhHHHHHHHHHHHHhCC-CchHHhHHHheecCCeE
Confidence            567899999999999999999999999999999999976542  234678899999999996 99999999999999999


Q ss_pred             EEEEeecCCCChHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeecccee
Q 014733          117 HLLMELCAGGELFHRLEKY----GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLAT  192 (419)
Q Consensus       117 ~lV~E~~~ggsL~~~l~~~----~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~  192 (419)
                      ++||||+++++|.+.+...    ..+++..++.++.||+.||+|||+.||+||||||+|||++.++.++.+||+|||++.
T Consensus        96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~  175 (285)
T 3is5_A           96 YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE  175 (285)
T ss_dssp             EEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred             EEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence            9999999999999988543    679999999999999999999999999999999999999765667889999999998


Q ss_pred             eeccCCccccccCCCccCCcccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHH
Q 014733          193 YIKAGQNLHGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISAS  272 (419)
Q Consensus       193 ~~~~~~~~~~~~gt~~y~aPE~l~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  272 (419)
                      ............||+.|+|||++.+.++.++||||||+++|+|++|+.||.+....+....+........... ..++++
T Consensus       176 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  254 (285)
T 3is5_A          176 LFKSDEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVEC-RPLTPQ  254 (285)
T ss_dssp             C----------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC---CCCCHH
T ss_pred             ecCCcccCcCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccccccc-CcCCHH
Confidence            7766555566789999999999988899999999999999999999999999988888887776655544332 358999


Q ss_pred             HHHHHHhhhhcCCCCCCCHHHHHhcccccc
Q 014733          273 ARDLIMGMLRVDPSTRLTAAEVLAHSWMEE  302 (419)
Q Consensus       273 l~~li~~~L~~dP~~Rps~~eil~hp~~~~  302 (419)
                      +.+||.+||+.||++|||+.|+|+||||++
T Consensus       255 ~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          255 AVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             HHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence            999999999999999999999999999985

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=4.2e-51  Score=408.97  Aligned_cols=264  Identities=34%  Similarity=0.611  Sum_probs=239.0

Q ss_pred             cccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCE
Q 014733           36 SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDY  115 (419)
Q Consensus        36 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~  115 (419)
                      ..+.++|++++.||+|+||.||+|.++.+|+.+|+|++....   ......+.+|+.+|+++. ||||+++++++.+.+.
T Consensus        47 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~  122 (387)
T 1kob_A           47 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLH-HPKLINLHDAFEDKYE  122 (387)
T ss_dssp             SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCC-STTBCCEEEEEECSSE
T ss_pred             CccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc---hhhHHHHHHHHHHHHhCC-CcCCCeEEEEEEeCCE
Confidence            346789999999999999999999999999999999997542   345567899999999996 9999999999999999


Q ss_pred             EEEEEeecCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeee
Q 014733          116 VHLLMELCAGGELFHRLEKYG-RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI  194 (419)
Q Consensus       116 ~~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~  194 (419)
                      +++||||+.|++|.+++...+ .+++.+++.++.||+.||+|||+.||+||||||+|||++.+ ..+.+||+|||++...
T Consensus       123 ~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~-~~~~vkL~DFG~a~~~  201 (387)
T 1kob_A          123 MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK-KASSVKIIDFGLATKL  201 (387)
T ss_dssp             EEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST-TCCCEEECCCTTCEEC
T ss_pred             EEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecC-CCCceEEEecccceec
Confidence            999999999999999987654 69999999999999999999999999999999999999542 3468999999999987


Q ss_pred             ccCCccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 014733          195 KAGQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASA  273 (419)
Q Consensus       195 ~~~~~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l  273 (419)
                      .........+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+....+....+......++...+..+++++
T Consensus       202 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  281 (387)
T 1kob_A          202 NPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEA  281 (387)
T ss_dssp             CTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHH
T ss_pred             CCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHH
Confidence            666555667899999999998874 8999999999999999999999999999989999998888888877788999999


Q ss_pred             HHHHHhhhhcCCCCCCCHHHHHhccccccch
Q 014733          274 RDLIMGMLRVDPSTRLTAAEVLAHSWMEECE  304 (419)
Q Consensus       274 ~~li~~~L~~dP~~Rps~~eil~hp~~~~~~  304 (419)
                      ++||.+||+.||++|||+.++|+||||+...
T Consensus       282 ~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  312 (387)
T 1kob_A          282 KDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  312 (387)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             HHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence            9999999999999999999999999998643

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=2.3e-51  Score=397.70  Aligned_cols=268  Identities=38%  Similarity=0.675  Sum_probs=225.6

Q ss_pred             cccccCeeee-eeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCC
Q 014733           36 SNLSDRYVLG-KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEED  114 (419)
Q Consensus        36 ~~~~~~y~i~-~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~  114 (419)
                      ..+.++|++. +.||+|+||.||+|.+..+++.||+|++....   ......+.+|+.++.++.+||||+++++++.+.+
T Consensus         8 ~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~   84 (316)
T 2ac3_A            8 GRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEED   84 (316)
T ss_dssp             CCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS---SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred             cccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc---chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence            3577899995 78999999999999999999999999997653   2345678899999999656999999999999999


Q ss_pred             EEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeee
Q 014733          115 YVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI  194 (419)
Q Consensus       115 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~  194 (419)
                      .+|+||||+++++|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++....+||+|||++...
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~  164 (316)
T 2ac3_A           85 RFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI  164 (316)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred             EEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence            99999999999999999998888999999999999999999999999999999999999965544456999999998765


Q ss_pred             ccCC--------ccccccCCCccCCcccccC------CCCCchhHHHHHHHHHHHHhCCCCCCCCC--------------
Q 014733          195 KAGQ--------NLHGTVGSPFYIAPEVLAG------GYNQAADVWSAGVILYILLSGMPPFWGKT--------------  246 (419)
Q Consensus       195 ~~~~--------~~~~~~gt~~y~aPE~l~~------~~s~~sDvwSlGvil~elltG~~Pf~~~~--------------  246 (419)
                      ....        .....+||+.|+|||++.+      .++.++|||||||++|+|++|+.||.+..              
T Consensus       165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  244 (316)
T 2ac3_A          165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA  244 (316)
T ss_dssp             -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred             ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence            3221        1223469999999999863      38899999999999999999999997654              


Q ss_pred             -HHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchhh
Q 014733          247 -KSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQV  306 (419)
Q Consensus       247 -~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~~  306 (419)
                       ...+.+.+......++...+..++.++++||.+||+.||++|||+.|+++||||++....
T Consensus       245 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~  305 (316)
T 2ac3_A          245 CQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPE  305 (316)
T ss_dssp             HHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC-----
T ss_pred             HHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCCc
Confidence             245677777877777766566899999999999999999999999999999999876543

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.6e-51  Score=413.52  Aligned_cols=270  Identities=29%  Similarity=0.505  Sum_probs=232.5

Q ss_pred             hhhccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEE
Q 014733           32 ATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYE  111 (419)
Q Consensus        32 ~~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~  111 (419)
                      ..+.....++|++++.||+|+||+||+|+++.+|+.||+|++.+...........+.+|..++..+. ||||+++++++.
T Consensus        53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~-hp~Iv~l~~~~~  131 (412)
T 2vd5_A           53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGD-RRWITQLHFAFQ  131 (412)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSC-TTTBCCEEEEEE
T ss_pred             hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEe
Confidence            3445566799999999999999999999999999999999997654333344556889999999995 999999999999


Q ss_pred             eCCEEEEEEeecCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccc
Q 014733          112 EEDYVHLLMELCAGGELFHRLEKYG-RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGL  190 (419)
Q Consensus       112 ~~~~~~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgl  190 (419)
                      +.+.+|+||||++||+|.+++.+.+ .+++..++.++.||+.||+|||++||+||||||+|||+   +.++++||+|||+
T Consensus       132 ~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl---d~~g~vkL~DFGl  208 (412)
T 2vd5_A          132 DENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILL---DRCGHIRLADFGS  208 (412)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTT
T ss_pred             eCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeee---cCCCCEEEeechh
Confidence            9999999999999999999998764 79999999999999999999999999999999999999   5678999999999


Q ss_pred             eeeeccCCc--cccccCCCccCCccccc--------CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC--
Q 014733          191 ATYIKAGQN--LHGTVGSPFYIAPEVLA--------GGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAAD--  258 (419)
Q Consensus       191 a~~~~~~~~--~~~~~gt~~y~aPE~l~--------~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--  258 (419)
                      ++.......  ....+||+.|+|||++.        +.|+.++|||||||++|||++|++||.+.+..+...+|....  
T Consensus       209 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~  288 (412)
T 2vd5_A          209 CLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEH  288 (412)
T ss_dssp             CEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH
T ss_pred             heeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC
Confidence            987755433  23458999999999986        248999999999999999999999999999888888876532  


Q ss_pred             CCCCCCCCCCCCHHHHHHHHhhhhcCCCCC---CCHHHHHhccccccchhhh
Q 014733          259 LRFPSDPWDHISASARDLIMGMLRVDPSTR---LTAAEVLAHSWMEECEQVA  307 (419)
Q Consensus       259 ~~~~~~~~~~~s~~l~~li~~~L~~dP~~R---ps~~eil~hp~~~~~~~~~  307 (419)
                      ..++. ....+|+++++||++||+ +|.+|   ++++++++||||+.+.+..
T Consensus       289 ~~~p~-~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~  338 (412)
T 2vd5_A          289 LSLPL-VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDG  338 (412)
T ss_dssp             CCCC-----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTT
T ss_pred             cCCCc-cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHH
Confidence            33332 124799999999999999 99998   5999999999999886643

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=3.7e-51  Score=408.71  Aligned_cols=261  Identities=27%  Similarity=0.509  Sum_probs=233.0

Q ss_pred             cccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEE
Q 014733           38 LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVH  117 (419)
Q Consensus        38 ~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~  117 (419)
                      ..++|++++.||+|+||.||+|.++.+++.||+|++.+.........+.+.+|+.+|+.+. ||||+++++++.+.+.+|
T Consensus        13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~   91 (384)
T 4fr4_A           13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE-HPFLVNLWYSFQDEEDMF   91 (384)
T ss_dssp             CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEE
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEeCCEEE
Confidence            3489999999999999999999999999999999997654433445678899999999995 999999999999999999


Q ss_pred             EEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccC
Q 014733          118 LLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG  197 (419)
Q Consensus       118 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~  197 (419)
                      +||||+.||+|..++...+.+++..++.++.||+.||.|||+.||+||||||+|||+   +.++.+||+|||++......
T Consensus        92 lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~~  168 (384)
T 4fr4_A           92 MVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILL---DEHGHVHITDFNIAAMLPRE  168 (384)
T ss_dssp             EEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCTT
T ss_pred             EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE---CCCCCEEEeccceeeeccCC
Confidence            999999999999999988889999999999999999999999999999999999999   66789999999999987766


Q ss_pred             CccccccCCCccCCcccccC----CCCCchhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhcCCCCCCCCCCCCC
Q 014733          198 QNLHGTVGSPFYIAPEVLAG----GYNQAADVWSAGVILYILLSGMPPFWGK---TKSKIFDAVRAADLRFPSDPWDHIS  270 (419)
Q Consensus       198 ~~~~~~~gt~~y~aPE~l~~----~~s~~sDvwSlGvil~elltG~~Pf~~~---~~~~~~~~i~~~~~~~~~~~~~~~s  270 (419)
                      ......+||+.|+|||++.+    .|+.++|||||||++|+|++|+.||...   ...+....+......++.    .++
T Consensus       169 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~----~~s  244 (384)
T 4fr4_A          169 TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPS----AWS  244 (384)
T ss_dssp             CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCT----TSC
T ss_pred             CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCC----cCC
Confidence            66677899999999999863    3899999999999999999999999743   445566666666555543    689


Q ss_pred             HHHHHHHHhhhhcCCCCCCC-HHHHHhccccccchhh
Q 014733          271 ASARDLIMGMLRVDPSTRLT-AAEVLAHSWMEECEQV  306 (419)
Q Consensus       271 ~~l~~li~~~L~~dP~~Rps-~~eil~hp~~~~~~~~  306 (419)
                      .++.+||.+||+.||.+||+ +.++++||||+.+.+.
T Consensus       245 ~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w~  281 (384)
T 4fr4_A          245 QEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWD  281 (384)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCHH
T ss_pred             HHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCHH
Confidence            99999999999999999998 9999999999988663

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=3e-52  Score=409.62  Aligned_cols=259  Identities=33%  Similarity=0.599  Sum_probs=225.8

Q ss_pred             ccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEE
Q 014733           37 NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYV  116 (419)
Q Consensus        37 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~  116 (419)
                      ..-++|++.+.||+|+||+||+|.+..+|+.||+|++.+...........+.+|+.+++.++ ||||+++++++.+.+.+
T Consensus         6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~   84 (336)
T 3h4j_B            6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLR-HPHIIKLYDVITTPTDI   84 (336)
T ss_dssp             SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEE
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeCCEE
Confidence            45689999999999999999999999999999999997543322233467889999999996 99999999999999999


Q ss_pred             EEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeecc
Q 014733          117 HLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA  196 (419)
Q Consensus       117 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~  196 (419)
                      ++||||+ +|+|.+++...+++++.+++.++.||+.||.|||+.||+||||||+|||+   +.++.+||+|||++.....
T Consensus        85 ~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kl~DFG~s~~~~~  160 (336)
T 3h4j_B           85 VMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLL---DDNLNVKIADFGLSNIMTD  160 (336)
T ss_dssp             EEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEE---CTTCCEEECCSSCTBTTTT
T ss_pred             EEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEE---cCCCCEEEEEeccceeccC
Confidence            9999999 78999999888899999999999999999999999999999999999999   5678999999999987766


Q ss_pred             CCccccccCCCccCCcccccCC-C-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 014733          197 GQNLHGTVGSPFYIAPEVLAGG-Y-NQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASAR  274 (419)
Q Consensus       197 ~~~~~~~~gt~~y~aPE~l~~~-~-s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~  274 (419)
                      .......+||+.|+|||++.+. + ++++|||||||++|+|++|+.||.+....+....+......+    +..+++++.
T Consensus       161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~----p~~~s~~~~  236 (336)
T 3h4j_B          161 GNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVM----PDFLSPGAQ  236 (336)
T ss_dssp             SBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCC----CTTSCHHHH
T ss_pred             CcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCC----cccCCHHHH
Confidence            6666777999999999999875 4 789999999999999999999998766554444433333322    236899999


Q ss_pred             HHHHhhhhcCCCCCCCHHHHHhccccccch
Q 014733          275 DLIMGMLRVDPSTRLTAAEVLAHSWMEECE  304 (419)
Q Consensus       275 ~li~~~L~~dP~~Rps~~eil~hp~~~~~~  304 (419)
                      +||++||+.||.+|||+.|+++||||+...
T Consensus       237 ~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  266 (336)
T 3h4j_B          237 SLIRRMIVADPMQRITIQEIRRDPWFNVNL  266 (336)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHTTCHHHHTTC
T ss_pred             HHHHHHcCCChhHCcCHHHHHhChhhccCC
Confidence            999999999999999999999999998643

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=5.2e-51  Score=397.07  Aligned_cols=270  Identities=37%  Similarity=0.626  Sum_probs=239.6

Q ss_pred             ccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCH---HhHHHHHHHHHHHHHccCCCCceeeeEEEE
Q 014733           35 ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTV---EDVRSIKLEIEIMTKLSGHPNVVDLKAVYE  111 (419)
Q Consensus        35 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~---~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~  111 (419)
                      ...+.++|++++.||+|+||.||+|.++.+|+.||+|++........   ...+.+.+|+.+++++. ||||+++++++.
T Consensus         7 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~   85 (321)
T 2a2a_A            7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL-HHNVITLHDVYE   85 (321)
T ss_dssp             CSCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEE
T ss_pred             chhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCC-CCCcceEEEEEe
Confidence            35678899999999999999999999999999999999986543221   13677999999999996 999999999999


Q ss_pred             eCCEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCC-CCCeEEeeccc
Q 014733          112 EEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSS-SSPIKLADFGL  190 (419)
Q Consensus       112 ~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~-~~~vKL~DFgl  190 (419)
                      +.+.+++||||+++++|.+++...+.+++..++.++.||+.||+|||+.||+||||||+|||++.++. ...+||+|||+
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~  165 (321)
T 2a2a_A           86 NRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL  165 (321)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred             cCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence            99999999999999999999988888999999999999999999999999999999999999953221 11799999999


Q ss_pred             eeeeccCCccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCC
Q 014733          191 ATYIKAGQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHI  269 (419)
Q Consensus       191 a~~~~~~~~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  269 (419)
                      +.............||+.|+|||++.+. ++.++||||||+++|+|++|..||.+....+....+......++...+..+
T Consensus       166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  245 (321)
T 2a2a_A          166 AHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHT  245 (321)
T ss_dssp             CEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTC
T ss_pred             ceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhccc
Confidence            9987666555667899999999998764 899999999999999999999999999999998888887776665555688


Q ss_pred             CHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          270 SASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       270 s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                      +.++.+||.+||+.||++|||+.++++||||+....
T Consensus       246 ~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~~  281 (321)
T 2a2a_A          246 SELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDN  281 (321)
T ss_dssp             CHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSSH
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCCc
Confidence            999999999999999999999999999999987643

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=4.2e-51  Score=407.00  Aligned_cols=262  Identities=31%  Similarity=0.531  Sum_probs=225.2

Q ss_pred             ccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHH-HHccCCCCceeeeEEEEeCCE
Q 014733           37 NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM-TKLSGHPNVVDLKAVYEEEDY  115 (419)
Q Consensus        37 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il-~~l~~hpnIv~l~~~~~~~~~  115 (419)
                      ...++|++++.||+|+||+||+|+++.+++.||+|++.+...........+.+|..++ +.+ +||||+++++++.+.+.
T Consensus        35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~-~hp~Iv~l~~~~~~~~~  113 (373)
T 2r5t_A           35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFSFQTADK  113 (373)
T ss_dssp             CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCC-CCTTBCCEEEEEECSSE
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhC-CCCCCCCEEEEEEeCCE
Confidence            3457999999999999999999999999999999999887765556667778888874 556 59999999999999999


Q ss_pred             EEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeec
Q 014733          116 VHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIK  195 (419)
Q Consensus       116 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~  195 (419)
                      +|+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++++||+|||+++...
T Consensus       114 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~ikL~DFG~a~~~~  190 (373)
T 2r5t_A          114 LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL---DSQGHIVLTDFGLCKENI  190 (373)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCBCGGGB
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---CCCCCEEEeeCccccccc
Confidence            99999999999999999988899999999999999999999999999999999999999   567899999999998633


Q ss_pred             -cCCccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 014733          196 -AGQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASA  273 (419)
Q Consensus       196 -~~~~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l  273 (419)
                       ........+||+.|+|||++.+. |+.++|||||||++|||++|++||.+.+..++.+.+......++.    .++.++
T Consensus       191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~  266 (373)
T 2r5t_A          191 EHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKP----NITNSA  266 (373)
T ss_dssp             CCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCS----SSCHHH
T ss_pred             cCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCC----CCCHHH
Confidence             23344567899999999998874 999999999999999999999999999999999999887666553    689999


Q ss_pred             HHHHHhhhhcCCCCCCCH----HHHHhccccccchhh
Q 014733          274 RDLIMGMLRVDPSTRLTA----AEVLAHSWMEECEQV  306 (419)
Q Consensus       274 ~~li~~~L~~dP~~Rps~----~eil~hp~~~~~~~~  306 (419)
                      ++||.+||+.||.+||++    .++++||||+.+.+.
T Consensus       267 ~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~  303 (373)
T 2r5t_A          267 RHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWD  303 (373)
T ss_dssp             HHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHH
T ss_pred             HHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHH
Confidence            999999999999999986    699999999987653

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=2.2e-51  Score=397.78  Aligned_cols=249  Identities=22%  Similarity=0.269  Sum_probs=195.2

Q ss_pred             cccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCC---
Q 014733           38 LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEED---  114 (419)
Q Consensus        38 ~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~---  114 (419)
                      +.++|.+.++||+|+||+||+|++  +|+.||||++....    ......+.|+..+.+++ |||||++++++.+++   
T Consensus         1 Iar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~----~~~~~~e~Ei~~~~~l~-HpNIv~l~g~~~~~~~~~   73 (303)
T 3hmm_A            1 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLR-HENILGFIAADNKDNGTW   73 (303)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECSSS
T ss_pred             CCcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhhHHHHHHHHHHhcCC-CCCCCcEEEEEEecCCCc
Confidence            356899999999999999999987  58999999986432    12223345666667785 999999999998654   


Q ss_pred             -EEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC--------CCeeccCCCCcEEEeecCCCCCeEE
Q 014733          115 -YVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGN--------GVVHRDLKPENILLATKSSSSPIKL  185 (419)
Q Consensus       115 -~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~--------~IvHrDLkp~NILl~~~~~~~~vKL  185 (419)
                       .+||||||+++|+|.++++. .++++..+..++.|++.||+|||++        +||||||||+||||   +.++.+||
T Consensus        74 ~~~~lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl---~~~~~~Ki  149 (303)
T 3hmm_A           74 TQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCI  149 (303)
T ss_dssp             EEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEE---CTTSCEEE
T ss_pred             eEEEEEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEE---CCCCCEEE
Confidence             68999999999999999976 5799999999999999999999987        99999999999999   66789999


Q ss_pred             eeccceeeeccCCcc-----ccccCCCccCCcccccCC-------CCCchhHHHHHHHHHHHHhCCCCCCCC--------
Q 014733          186 ADFGLATYIKAGQNL-----HGTVGSPFYIAPEVLAGG-------YNQAADVWSAGVILYILLSGMPPFWGK--------  245 (419)
Q Consensus       186 ~DFgla~~~~~~~~~-----~~~~gt~~y~aPE~l~~~-------~s~~sDvwSlGvil~elltG~~Pf~~~--------  245 (419)
                      +|||+++........     ...+||+.|||||++.+.       |+.++|||||||+||||+||.+||...        
T Consensus       150 ~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~  229 (303)
T 3hmm_A          150 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY  229 (303)
T ss_dssp             CCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTT
T ss_pred             EeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccch
Confidence            999999877554322     235899999999998653       567999999999999999998766321        


Q ss_pred             -------CHHHHHHHHHhcCCCCCCCC---CCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          246 -------TKSKIFDAVRAADLRFPSDP---WDHISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       246 -------~~~~~~~~i~~~~~~~~~~~---~~~~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                             ...++...+.....+.+.+.   ....+..+.+|+.+||+.||++|||+.||++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  291 (303)
T 3hmm_A          230 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             hcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence                   12334444433333221111   11234578899999999999999999999874

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=3.3e-51  Score=399.92  Aligned_cols=274  Identities=32%  Similarity=0.576  Sum_probs=240.6

Q ss_pred             chhhccccccCeeee-eeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEE
Q 014733           31 DATQISNLSDRYVLG-KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAV  109 (419)
Q Consensus        31 ~~~~~~~~~~~y~i~-~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~  109 (419)
                      .....+.+.++|.+. +.||+|+||+||+|.++.+|+.||+|++.+... .......+.+|+.+++++.+||||++++++
T Consensus        19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~   97 (327)
T 3lm5_A           19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR-GQDCRAEILHEIAVLELAKSCPRVINLHEV   97 (327)
T ss_dssp             CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEET-TEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred             HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence            345567889999998 899999999999999999999999999976543 334467889999999999878999999999


Q ss_pred             EEeCCEEEEEEeecCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEee
Q 014733          110 YEEEDYVHLLMELCAGGELFHRLEKY--GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLAD  187 (419)
Q Consensus       110 ~~~~~~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~D  187 (419)
                      +.+.+.+++||||+.+++|.+++...  +.+++.+++.++.||+.||+|||+.||+||||||+|||++....++.+||+|
T Consensus        98 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~D  177 (327)
T 3lm5_A           98 YENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVD  177 (327)
T ss_dssp             EECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECC
T ss_pred             EEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEee
Confidence            99999999999999999999998543  5699999999999999999999999999999999999996544578999999


Q ss_pred             ccceeeeccCCccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 014733          188 FGLATYIKAGQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW  266 (419)
Q Consensus       188 Fgla~~~~~~~~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  266 (419)
                      ||++............+||+.|+|||++.+. ++.++||||||+++|+|++|+.||.+....+....+.......+...+
T Consensus       178 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  257 (327)
T 3lm5_A          178 FGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETF  257 (327)
T ss_dssp             GGGCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTT
T ss_pred             CccccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhh
Confidence            9999987665555667899999999998764 899999999999999999999999999999999888888888888878


Q ss_pred             CCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          267 DHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       267 ~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                      ..+++.+.+||.+||+.||.+|||+.++|+||||++...
T Consensus       258 ~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~  296 (327)
T 3lm5_A          258 SSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDF  296 (327)
T ss_dssp             TTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCT
T ss_pred             cccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccccc
Confidence            899999999999999999999999999999999987654

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=5.9e-51  Score=409.60  Aligned_cols=261  Identities=33%  Similarity=0.642  Sum_probs=220.2

Q ss_pred             ccccCeeee-eeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEe---
Q 014733           37 NLSDRYVLG-KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEE---  112 (419)
Q Consensus        37 ~~~~~y~i~-~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~---  112 (419)
                      .+.++|.+. +.||+|+||+||+|.++.+|+.||+|++...        ..+.+|+.++.++.+||||+++++++..   
T Consensus        58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~  129 (400)
T 1nxk_A           58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYA  129 (400)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeeccc
Confidence            456677776 7899999999999999999999999998632        3567889888776679999999999976   


Q ss_pred             -CCEEEEEEeecCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeecc
Q 014733          113 -EDYVHLLMELCAGGELFHRLEKYG--RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFG  189 (419)
Q Consensus       113 -~~~~~lV~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFg  189 (419)
                       .+.+|+||||++||+|.+++...+  .+++.+++.++.||+.||+|||+.||+||||||+|||++.++.++.+||+|||
T Consensus       130 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG  209 (400)
T 1nxk_A          130 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG  209 (400)
T ss_dssp             TEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred             CCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecc
Confidence             667999999999999999998653  49999999999999999999999999999999999999765557899999999


Q ss_pred             ceeeeccCCccccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhcCCCCCCC
Q 014733          190 LATYIKAGQNLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKS----KIFDAVRAADLRFPSD  264 (419)
Q Consensus       190 la~~~~~~~~~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~----~~~~~i~~~~~~~~~~  264 (419)
                      +++...........+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+....    .....+..+.+.++..
T Consensus       210 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~  289 (400)
T 1nxk_A          210 FAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP  289 (400)
T ss_dssp             TCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTT
T ss_pred             cccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCc
Confidence            9997765555566789999999999876 4999999999999999999999999765432    3566777788888877


Q ss_pred             CCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          265 PWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       265 ~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                      .|..++.++++||++||+.||++|||+.++++||||.+...
T Consensus       290 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  330 (400)
T 1nxk_A          290 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK  330 (400)
T ss_dssp             TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTTT
T ss_pred             ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCCC
Confidence            78899999999999999999999999999999999986543

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.8e-51  Score=401.91  Aligned_cols=265  Identities=38%  Similarity=0.675  Sum_probs=213.9

Q ss_pred             ccccCeeee---eeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeC
Q 014733           37 NLSDRYVLG---KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEE  113 (419)
Q Consensus        37 ~~~~~y~i~---~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~  113 (419)
                      .+.++|++.   +.||+|+||+||+|.++.+|+.||+|++.+.      ....+.+|+.+++.+.+||||+++++++.+.
T Consensus         5 ~f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~   78 (325)
T 3kn6_A            5 PFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQ   78 (325)
T ss_dssp             HHHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred             cchhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcC
Confidence            345678875   7899999999999999999999999998643      3467788999999997799999999999999


Q ss_pred             CEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceee
Q 014733          114 DYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATY  193 (419)
Q Consensus       114 ~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~  193 (419)
                      +..|+||||++|++|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++....+||+|||++..
T Consensus        79 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~  158 (325)
T 3kn6_A           79 LHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL  158 (325)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred             CEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEecccccee
Confidence            99999999999999999999988899999999999999999999999999999999999997655555899999999986


Q ss_pred             eccCC-ccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhcCCCCCCC
Q 014733          194 IKAGQ-NLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKT-------KSKIFDAVRAADLRFPSD  264 (419)
Q Consensus       194 ~~~~~-~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~-------~~~~~~~i~~~~~~~~~~  264 (419)
                      ..... .....+||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+..       ..+....+..+...++..
T Consensus       159 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  238 (325)
T 3kn6_A          159 KPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGE  238 (325)
T ss_dssp             CCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSH
T ss_pred             cCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcc
Confidence            64432 33456889999999998774 9999999999999999999999997643       356777888877777776


Q ss_pred             CCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchhhh
Q 014733          265 PWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVA  307 (419)
Q Consensus       265 ~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~~~  307 (419)
                      .|..+++++++||.+||+.||.+|||+.++++||||+......
T Consensus       239 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~~~  281 (325)
T 3kn6_A          239 AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLS  281 (325)
T ss_dssp             HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCCCC
T ss_pred             cccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCccCC
Confidence            6778999999999999999999999999999999998765433

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=7.2e-51  Score=414.33  Aligned_cols=261  Identities=33%  Similarity=0.583  Sum_probs=224.7

Q ss_pred             cccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEE
Q 014733           38 LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVH  117 (419)
Q Consensus        38 ~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~  117 (419)
                      ..++|++++.||+|+||.||+|.++.+|+.||+|++.+...........+.+|+.+++.++ ||||+++++++.+.+.+|
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~~~~  224 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR-HPFLTALKYSFQTHDRLC  224 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCS-CTTSCCEEEEEEETTEEE
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCC-CCeEeeEEEEEeeCCEEE
Confidence            4578999999999999999999999999999999998765445556677889999999996 999999999999999999


Q ss_pred             EEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeccCCCCcEEEeecCCCCCeEEeeccceeeecc
Q 014733          118 LLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG-NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA  196 (419)
Q Consensus       118 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~-~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~  196 (419)
                      +||||++|++|..++...+.+++..++.++.||+.||+|||+ .||+||||||+|||+   +.++.+||+|||++.....
T Consensus       225 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~  301 (446)
T 4ejn_A          225 FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIK  301 (446)
T ss_dssp             EEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEE---CSSSCEEECCCCCCCTTCC
T ss_pred             EEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEE---CCCCCEEEccCCCceeccC
Confidence            999999999999999988899999999999999999999998 999999999999999   5677999999999986332


Q ss_pred             -CCccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 014733          197 -GQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASAR  274 (419)
Q Consensus       197 -~~~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~  274 (419)
                       .......+||+.|+|||++.+. |+.++|||||||++|+|++|+.||.+.+..++...+......++.    .+++++.
T Consensus       302 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~  377 (446)
T 4ejn_A          302 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLGPEAK  377 (446)
T ss_dssp             -----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHH
T ss_pred             CCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCc----cCCHHHH
Confidence             3334557899999999998764 999999999999999999999999999999999999888776654    6899999


Q ss_pred             HHHHhhhhcCCCCCC-----CHHHHHhccccccchhh
Q 014733          275 DLIMGMLRVDPSTRL-----TAAEVLAHSWMEECEQV  306 (419)
Q Consensus       275 ~li~~~L~~dP~~Rp-----s~~eil~hp~~~~~~~~  306 (419)
                      +||.+||+.||.+||     ++.|+++||||+.+.+.
T Consensus       378 ~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~  414 (446)
T 4ejn_A          378 SLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQ  414 (446)
T ss_dssp             HHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred             HHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHH
Confidence            999999999999999     99999999999987653

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.1e-50  Score=393.53  Aligned_cols=267  Identities=28%  Similarity=0.488  Sum_probs=220.2

Q ss_pred             hhhccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEE
Q 014733           32 ATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYE  111 (419)
Q Consensus        32 ~~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~  111 (419)
                      ....+.+.++|++++.||+|+||+||+|.+. +|+.||+|++..... .......+.+|+.++++++ ||||+++++++.
T Consensus        13 ~~~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~   89 (311)
T 3niz_A           13 NLYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE-DEGIPSTAIREISLLKELH-HPNIVSLIDVIH   89 (311)
T ss_dssp             --CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCC-CTTBCCEEEEEC
T ss_pred             ceeecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccc-cchhhHHHHHHHHHHHHcC-CCCEeeeeeEEc
Confidence            3456788999999999999999999999986 589999999975532 2334577889999999996 999999999999


Q ss_pred             eCCEEEEEEeecCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccc
Q 014733          112 EEDYVHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGL  190 (419)
Q Consensus       112 ~~~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgl  190 (419)
                      +.+.+++||||++ ++|.+.+... ..+++.+++.++.||+.||+|||+.||+||||||+|||+   +.++.+||+|||+
T Consensus        90 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~  165 (311)
T 3niz_A           90 SERCLTLVFEFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLI---NSDGALKLADFGL  165 (311)
T ss_dssp             CSSCEEEEEECCS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTT
T ss_pred             cCCEEEEEEcCCC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEE---CCCCCEEEccCcC
Confidence            9999999999997 4788877654 449999999999999999999999999999999999999   5678999999999


Q ss_pred             eeeeccC-CccccccCCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCC--
Q 014733          191 ATYIKAG-QNLHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDP--  265 (419)
Q Consensus       191 a~~~~~~-~~~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~--  265 (419)
                      +...... .......||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+....+....+...........  
T Consensus       166 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  245 (311)
T 3niz_A          166 ARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWP  245 (311)
T ss_dssp             CEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSG
T ss_pred             ceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhh
Confidence            9876533 23344588999999999876  389999999999999999999999988777666666544211111111  


Q ss_pred             ------------------------CCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          266 ------------------------WDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       266 ------------------------~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                                              ...+++++.+||.+||++||++|||+.|+|+||||++...
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  309 (311)
T 3niz_A          246 QVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDP  309 (311)
T ss_dssp             GGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCT
T ss_pred             hhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCc
Confidence                                    2357889999999999999999999999999999997653

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=2.7e-50  Score=386.42  Aligned_cols=259  Identities=27%  Similarity=0.473  Sum_probs=217.7

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      ++|++++.||+|+||+||+|.++.+|+.||+|++..... .......+.+|+.++++++ ||||+++++++.+.+.+++|
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv   79 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELK-HKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCC-CCCEeeEEeEEEeCCEEEEE
Confidence            689999999999999999999999999999999986653 3345677889999999996 99999999999999999999


Q ss_pred             EeecCCCChHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC
Q 014733          120 MELCAGGELFHRLE-KYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ  198 (419)
Q Consensus       120 ~E~~~ggsL~~~l~-~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~  198 (419)
                      |||+++ +|.+.+. ..+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++.......
T Consensus        80 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~  155 (292)
T 3o0g_A           80 FEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCSCC
T ss_pred             EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeecccceecCCcc
Confidence            999976 5555554 45779999999999999999999999999999999999999   567899999999998765332


Q ss_pred             -ccccccCCCccCCcccccCC--CCCchhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHhcCCCCCCC----------
Q 014733          199 -NLHGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPP-FWGKTKSKIFDAVRAADLRFPSD----------  264 (419)
Q Consensus       199 -~~~~~~gt~~y~aPE~l~~~--~s~~sDvwSlGvil~elltG~~P-f~~~~~~~~~~~i~~~~~~~~~~----------  264 (419)
                       ......||+.|+|||++.+.  ++.++|||||||++|+|++|..| |.+....+....+..........          
T Consensus       156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  235 (292)
T 3o0g_A          156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD  235 (292)
T ss_dssp             SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred             ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccc
Confidence             33456889999999998763  79999999999999999987776 56666666666664422111111          


Q ss_pred             ---------------CCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccch
Q 014733          265 ---------------PWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECE  304 (419)
Q Consensus       265 ---------------~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~  304 (419)
                                     ....++.++++||.+||+.||++|||+.|+++||||++..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  290 (292)
T 3o0g_A          236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred             ccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence                           1235789999999999999999999999999999998643

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=2.9e-50  Score=393.49  Aligned_cols=261  Identities=33%  Similarity=0.567  Sum_probs=221.1

Q ss_pred             ccccCeeeeeeecccCceEEEEEEec---CCCcEEEEEEeccCccC-CHHhHHHHHHHHHHHHHccCCCCceeeeEEEEe
Q 014733           37 NLSDRYVLGKQLGWGQFGVIRECSDK---FTGEVLACKSIAKDRLV-TVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEE  112 (419)
Q Consensus        37 ~~~~~y~i~~~LG~G~~g~V~~a~~~---~~g~~vaiK~i~~~~~~-~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~  112 (419)
                      ...++|++.+.||+|+||.||+|++.   .+|+.||+|++.+.... .......+.+|+.+|+++. ||||+++++++.+
T Consensus        14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~   92 (327)
T 3a62_A           14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK-HPFIVDLIYAFQT   92 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCC-CTTBCCEEEEEEC
T ss_pred             CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCC-CCCccceeEEEEc
Confidence            34589999999999999999999985   68999999999875432 2234567889999999996 9999999999999


Q ss_pred             CCEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeecccee
Q 014733          113 EDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLAT  192 (419)
Q Consensus       113 ~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~  192 (419)
                      .+.+|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill---~~~~~~kl~Dfg~~~  169 (327)
T 3a62_A           93 GGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIML---NHQGHVKLTDFGLCK  169 (327)
T ss_dssp             SSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE---CTTSCEEECCCSCC-
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEE---CCCCcEEEEeCCccc
Confidence            99999999999999999999988899999999999999999999999999999999999999   567899999999997


Q ss_pred             eeccC-CccccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCC
Q 014733          193 YIKAG-QNLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHIS  270 (419)
Q Consensus       193 ~~~~~-~~~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  270 (419)
                      ..... ......+||+.|+|||++.+ .++.++||||||+++|+|++|+.||.+.+..+....+......++.    .++
T Consensus       170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~----~~~  245 (327)
T 3a62_A          170 ESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPP----YLT  245 (327)
T ss_dssp             ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCT----TSC
T ss_pred             ccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC----CCC
Confidence            64332 23345689999999999876 4899999999999999999999999999998888888887666553    689


Q ss_pred             HHHHHHHHhhhhcCCCCCC-----CHHHHHhccccccchh
Q 014733          271 ASARDLIMGMLRVDPSTRL-----TAAEVLAHSWMEECEQ  305 (419)
Q Consensus       271 ~~l~~li~~~L~~dP~~Rp-----s~~eil~hp~~~~~~~  305 (419)
                      .++++||.+||+.||.+||     ++.++++||||+...+
T Consensus       246 ~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~  285 (327)
T 3a62_A          246 QEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINW  285 (327)
T ss_dssp             HHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCH
T ss_pred             HHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCH
Confidence            9999999999999999999     8999999999987754

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=3e-50  Score=389.02  Aligned_cols=265  Identities=30%  Similarity=0.455  Sum_probs=218.7

Q ss_pred             cccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCC--HHhHHHHHHHHHHHHHcc--CCCCceeeeEEEE
Q 014733           36 SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVT--VEDVRSIKLEIEIMTKLS--GHPNVVDLKAVYE  111 (419)
Q Consensus        36 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~--~~~~~~~~~Ei~il~~l~--~hpnIv~l~~~~~  111 (419)
                      +.+.++|++++.||+|+||+||+|+++.+|+.||+|++.......  ......+.+|+.++++++  +||||+++++++.
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~   84 (308)
T 3g33_A            5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA   84 (308)
T ss_dssp             -----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred             cccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence            356789999999999999999999999999999999997543211  112245667888777764  4999999999998


Q ss_pred             eCC-----EEEEEEeecCCCChHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeE
Q 014733          112 EED-----YVHLLMELCAGGELFHRLEKYGR--FSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIK  184 (419)
Q Consensus       112 ~~~-----~~~lV~E~~~ggsL~~~l~~~~~--l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vK  184 (419)
                      +..     .+++||||+. ++|.+++.....  +++.+++.++.||+.||+|||+.||+||||||+|||+   +.++.+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~---~~~~~~k  160 (308)
T 3g33_A           85 TSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV---TSGGTVK  160 (308)
T ss_dssp             ECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEE---CTTSCEE
T ss_pred             ccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---cCCCCEE
Confidence            765     6899999996 699999987654  9999999999999999999999999999999999999   5678999


Q ss_pred             EeeccceeeeccCCccccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC
Q 014733          185 LADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPS  263 (419)
Q Consensus       185 L~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~  263 (419)
                      |+|||++............+||+.|+|||++.+ .++.++|||||||++|+|++|++||.+....+....+.......+.
T Consensus       161 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  240 (308)
T 3g33_A          161 LADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE  240 (308)
T ss_dssp             ECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             EeeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            999999987766555666789999999999876 4999999999999999999999999999888887777553222222


Q ss_pred             CC-----------------------CCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccch
Q 014733          264 DP-----------------------WDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECE  304 (419)
Q Consensus       264 ~~-----------------------~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~  304 (419)
                      ..                       ...+++++.+||.+||+.||++|||+.|+|+||||++..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~  304 (308)
T 3g33_A          241 DDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE  304 (308)
T ss_dssp             TTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred             hhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence            11                       236889999999999999999999999999999998754

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.1e-50  Score=416.11  Aligned_cols=261  Identities=36%  Similarity=0.662  Sum_probs=235.4

Q ss_pred             ccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCC
Q 014733           35 ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEED  114 (419)
Q Consensus        35 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~  114 (419)
                      .....++|++++.||+|+||+||+|.+..+|+.||+|++.+...........+.+|+.+|+.+. ||||+++++++.+.+
T Consensus        11 ~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~   89 (476)
T 2y94_A           11 GRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR-HPHIIKLYQVISTPS   89 (476)
T ss_dssp             SCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCC-CTTBCCEEEEEECSS
T ss_pred             CCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECC
Confidence            3345689999999999999999999999999999999997654322234678999999999996 999999999999999


Q ss_pred             EEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeee
Q 014733          115 YVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI  194 (419)
Q Consensus       115 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~  194 (419)
                      .+|+||||++|++|.+++...+++++.+++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++...
T Consensus        90 ~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll---~~~~~vkL~DFG~a~~~  166 (476)
T 2y94_A           90 DIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLL---DAHMNAKIADFGLSNMM  166 (476)
T ss_dssp             EEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEE---CTTCCEEECCCSSCEEC
T ss_pred             EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEE---ecCCCeEEEeccchhhc
Confidence            999999999999999999888889999999999999999999999999999999999999   56789999999999987


Q ss_pred             ccCCccccccCCCccCCcccccCC-C-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHH
Q 014733          195 KAGQNLHGTVGSPFYIAPEVLAGG-Y-NQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISAS  272 (419)
Q Consensus       195 ~~~~~~~~~~gt~~y~aPE~l~~~-~-s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  272 (419)
                      .........+||+.|+|||++.+. + +.++|||||||++|+|++|+.||.+.....+...+..+....+    ..++++
T Consensus       167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~  242 (476)
T 2y94_A          167 SDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTP----QYLNPS  242 (476)
T ss_dssp             CTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCC----TTCCHH
T ss_pred             cccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCC----ccCCHH
Confidence            666666677999999999999875 4 7899999999999999999999999988889888888765544    368999


Q ss_pred             HHHHHHhhhhcCCCCCCCHHHHHhccccccc
Q 014733          273 ARDLIMGMLRVDPSTRLTAAEVLAHSWMEEC  303 (419)
Q Consensus       273 l~~li~~~L~~dP~~Rps~~eil~hp~~~~~  303 (419)
                      +.+||.+||+.||.+|||+.++++||||++.
T Consensus       243 ~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~  273 (476)
T 2y94_A          243 VISLLKHMLQVDPMKRATIKDIREHEWFKQD  273 (476)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred             HHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence            9999999999999999999999999999864

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=5.6e-50  Score=392.48  Aligned_cols=261  Identities=35%  Similarity=0.564  Sum_probs=236.0

Q ss_pred             cccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCE
Q 014733           36 SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDY  115 (419)
Q Consensus        36 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~  115 (419)
                      ....++|++++.||+|+||.||+|.+..+++.+|+|++.+.........+.+.+|+.+++++. ||||+++++++.+.+.
T Consensus        37 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~  115 (335)
T 2owb_A           37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFEDNDF  115 (335)
T ss_dssp             TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSE
T ss_pred             cccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEecCCe
Confidence            445689999999999999999999999999999999998776666677888999999999995 9999999999999999


Q ss_pred             EEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeec
Q 014733          116 VHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIK  195 (419)
Q Consensus       116 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~  195 (419)
                      +|+||||+.+++|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++....
T Consensus       116 ~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~~~~~~  192 (335)
T 2owb_A          116 VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATKVE  192 (335)
T ss_dssp             EEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEECC
T ss_pred             EEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEE---cCCCCEEEeeccCceecc
Confidence            99999999999999999888889999999999999999999999999999999999999   567889999999998765


Q ss_pred             cC-CccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 014733          196 AG-QNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASA  273 (419)
Q Consensus       196 ~~-~~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l  273 (419)
                      .. .......||+.|+|||++.+. ++.++||||||+++|+|++|+.||......+....+......++.    .++.++
T Consensus       193 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~  268 (335)
T 2owb_A          193 YDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK----HINPVA  268 (335)
T ss_dssp             STTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCT----TSCHHH
T ss_pred             cCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCc----cCCHHH
Confidence            33 233456799999999998774 899999999999999999999999998888888888777665543    688999


Q ss_pred             HHHHHhhhhcCCCCCCCHHHHHhccccccch
Q 014733          274 RDLIMGMLRVDPSTRLTAAEVLAHSWMEECE  304 (419)
Q Consensus       274 ~~li~~~L~~dP~~Rps~~eil~hp~~~~~~  304 (419)
                      .+||.+||+.||++|||+.++++||||....
T Consensus       269 ~~li~~~l~~dp~~Rps~~ell~~~~~~~~~  299 (335)
T 2owb_A          269 ASLIQKMLQTDPTARPTINELLNDEFFTSGY  299 (335)
T ss_dssp             HHHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred             HHHHHHHccCChhHCcCHHHHhcCccccCCC
Confidence            9999999999999999999999999997643

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.3e-50  Score=387.99  Aligned_cols=257  Identities=32%  Similarity=0.610  Sum_probs=220.3

Q ss_pred             cccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCH-----------------------HhHHHHHHHHHHH
Q 014733           38 LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTV-----------------------EDVRSIKLEIEIM   94 (419)
Q Consensus        38 ~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~-----------------------~~~~~~~~Ei~il   94 (419)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++.+......                       ...+.+.+|+.+|
T Consensus        11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   90 (298)
T 2zv2_A           11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL   90 (298)
T ss_dssp             EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred             eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence            35799999999999999999999999999999999976543211                       2246688999999


Q ss_pred             HHccCCCCceeeeEEEEe--CCEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcE
Q 014733           95 TKLSGHPNVVDLKAVYEE--EDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENI  172 (419)
Q Consensus        95 ~~l~~hpnIv~l~~~~~~--~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NI  172 (419)
                      +++. ||||+++++++.+  .+.+|+||||+++++|.+++. .+++++.+++.++.||+.||+|||++||+||||||+||
T Consensus        91 ~~l~-h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Ni  168 (298)
T 2zv2_A           91 KKLD-HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNL  168 (298)
T ss_dssp             HTCC-CTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred             HhCC-CCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHE
Confidence            9996 9999999999987  678999999999999987654 36799999999999999999999999999999999999


Q ss_pred             EEeecCCCCCeEEeeccceeeeccCCc-cccccCCCccCCcccccCC----CCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q 014733          173 LLATKSSSSPIKLADFGLATYIKAGQN-LHGTVGSPFYIAPEVLAGG----YNQAADVWSAGVILYILLSGMPPFWGKTK  247 (419)
Q Consensus       173 Ll~~~~~~~~vKL~DFgla~~~~~~~~-~~~~~gt~~y~aPE~l~~~----~s~~sDvwSlGvil~elltG~~Pf~~~~~  247 (419)
                      |+   +.++.+||+|||++........ .....||+.|+|||++.+.    ++.++|||||||++|+|++|+.||.+...
T Consensus       169 l~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~  245 (298)
T 2zv2_A          169 LV---GEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI  245 (298)
T ss_dssp             EE---CTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             EE---CCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence            99   5678999999999987654432 3456899999999998763    37789999999999999999999999888


Q ss_pred             HHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccc
Q 014733          248 SKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWME  301 (419)
Q Consensus       248 ~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~  301 (419)
                      ......+......++..  ..+++++.+||.+||+.||++|||+.|+++||||+
T Consensus       246 ~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~  297 (298)
T 2zv2_A          246 MCLHSKIKSQALEFPDQ--PDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT  297 (298)
T ss_dssp             HHHHHHHHHCCCCCCSS--SCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred             HHHHHHHhcccCCCCCc--cccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence            88888887776655543  47899999999999999999999999999999996

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.3e-49  Score=382.08  Aligned_cols=268  Identities=37%  Similarity=0.664  Sum_probs=239.2

Q ss_pred             hccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccC--C----HHhHHHHHHHHHHHHHccCCCCceeee
Q 014733           34 QISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLV--T----VEDVRSIKLEIEIMTKLSGHPNVVDLK  107 (419)
Q Consensus        34 ~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~--~----~~~~~~~~~Ei~il~~l~~hpnIv~l~  107 (419)
                      ....+.++|++.+.||+|+||.||+|.++.+|+.||+|++......  .    ....+.+.+|+.+++++.+||||++++
T Consensus        11 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~   90 (298)
T 1phk_A           11 STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLK   90 (298)
T ss_dssp             ----CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred             CCcchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeee
Confidence            3456789999999999999999999999999999999999765321  1    133567889999999997799999999


Q ss_pred             EEEEeCCEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEee
Q 014733          108 AVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLAD  187 (419)
Q Consensus       108 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~D  187 (419)
                      +++.+.+..++||||+++++|.+++.....+++.+++.++.||+.||+|||++||+||||||+||++   +.++.+||+|
T Consensus        91 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~d  167 (298)
T 1phk_A           91 DTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTD  167 (298)
T ss_dssp             EEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECC
T ss_pred             eeeccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE---cCCCcEEEec
Confidence            9999999999999999999999999988889999999999999999999999999999999999999   5678899999


Q ss_pred             ccceeeeccCCccccccCCCccCCccccc------C-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC
Q 014733          188 FGLATYIKAGQNLHGTVGSPFYIAPEVLA------G-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLR  260 (419)
Q Consensus       188 Fgla~~~~~~~~~~~~~gt~~y~aPE~l~------~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~  260 (419)
                      ||++.............||+.|+|||++.      . .++.++||||||+++|+|++|+.||.+.........+......
T Consensus       168 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~  247 (298)
T 1phk_A          168 FGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ  247 (298)
T ss_dssp             CTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred             ccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcc
Confidence            99999876666566678999999999974      2 4789999999999999999999999999988888888888887


Q ss_pred             CCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccch
Q 014733          261 FPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECE  304 (419)
Q Consensus       261 ~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~  304 (419)
                      ++...+..++.++.++|.+||+.||.+|||+.++++||||++..
T Consensus       248 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (298)
T 1phk_A          248 FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV  291 (298)
T ss_dssp             CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred             cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence            77777778999999999999999999999999999999998754

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=4.4e-50  Score=387.16  Aligned_cols=265  Identities=39%  Similarity=0.715  Sum_probs=235.7

Q ss_pred             ccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCC
Q 014733           35 ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEED  114 (419)
Q Consensus        35 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~  114 (419)
                      ...+.++|++.+.||+|+||.||+|.++.+|+.||+|++.....   .....+.+|+.+++++. ||||+++++++.+.+
T Consensus         4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~   79 (304)
T 2jam_A            4 TTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA---FRDSSLENEIAVLKKIK-HENIVTLEDIYESTT   79 (304)
T ss_dssp             --CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCC-CTTBCCEEEEEECSS
T ss_pred             ccchhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc---cchHHHHHHHHHHHhCC-CCCeeehhhhcccCC
Confidence            45678999999999999999999999999999999999976432   23456889999999996 999999999999999


Q ss_pred             EEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeee
Q 014733          115 YVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI  194 (419)
Q Consensus       115 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~  194 (419)
                      .+++||||+++++|.+++...+.+++.+++.++.||+.||.|||+.||+||||||+||++..++.++.+||+|||++...
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~  159 (304)
T 2jam_A           80 HYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME  159 (304)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred             EEEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence            99999999999999999988888999999999999999999999999999999999999965556789999999998764


Q ss_pred             ccCCccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 014733          195 KAGQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASA  273 (419)
Q Consensus       195 ~~~~~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l  273 (419)
                      ... ......||+.|+|||++.+. ++.++||||||+++|+|++|+.||.+....+..+.+......++...+..++.++
T Consensus       160 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  238 (304)
T 2jam_A          160 QNG-IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESA  238 (304)
T ss_dssp             CCB-TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHH
T ss_pred             CCC-ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHH
Confidence            332 23445799999999998775 8999999999999999999999999999999999999888877777778899999


Q ss_pred             HHHHHhhhhcCCCCCCCHHHHHhccccccch
Q 014733          274 RDLIMGMLRVDPSTRLTAAEVLAHSWMEECE  304 (419)
Q Consensus       274 ~~li~~~L~~dP~~Rps~~eil~hp~~~~~~  304 (419)
                      .++|.+||+.||++|||+.++++||||+...
T Consensus       239 ~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  269 (304)
T 2jam_A          239 KDFICHLLEKDPNERYTCEKALSHPWIDGNT  269 (304)
T ss_dssp             HHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred             HHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence            9999999999999999999999999998643

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=3.3e-50  Score=400.55  Aligned_cols=263  Identities=32%  Similarity=0.591  Sum_probs=231.4

Q ss_pred             cccCeee--eeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCE
Q 014733           38 LSDRYVL--GKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDY  115 (419)
Q Consensus        38 ~~~~y~i--~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~  115 (419)
                      +.+.|.+  .+.||+|+||.||+|.+..+|+.||+|++....   ....+.+.+|+.+|++++ ||||+++++++.+.+.
T Consensus        85 ~~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~  160 (373)
T 2x4f_A           85 VNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG---MKDKEEVKNEISVMNQLD-HANLIQLYDAFESKND  160 (373)
T ss_dssp             GGGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSE
T ss_pred             cccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc---cccHHHHHHHHHHHHhCC-CCCCCeEEEEEEECCE
Confidence            4556666  678999999999999999999999999997653   356678999999999996 9999999999999999


Q ss_pred             EEEEEeecCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeee
Q 014733          116 VHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI  194 (419)
Q Consensus       116 ~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~  194 (419)
                      +++||||+++++|.+++... ..+++.+++.++.||+.||+|||+.||+||||||+|||+.. +.++.+||+|||++...
T Consensus       161 ~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~~~~kl~DFG~a~~~  239 (373)
T 2x4f_A          161 IVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVN-RDAKQIKIIDFGLARRY  239 (373)
T ss_dssp             EEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEE-TTTTEEEECCCSSCEEC
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEec-CCCCcEEEEeCCCceec
Confidence            99999999999999988654 45999999999999999999999999999999999999964 34568999999999987


Q ss_pred             ccCCccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 014733          195 KAGQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASA  273 (419)
Q Consensus       195 ~~~~~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l  273 (419)
                      .........+||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+.+..+....+......++...+..+++++
T Consensus       240 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  319 (373)
T 2x4f_A          240 KPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEA  319 (373)
T ss_dssp             CTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHH
T ss_pred             CCccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHH
Confidence            766666667899999999998765 8999999999999999999999999999999999998887777777777899999


Q ss_pred             HHHHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          274 RDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       274 ~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                      ++||.+||+.||.+|||+.|+|+||||+....
T Consensus       320 ~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~~  351 (373)
T 2x4f_A          320 KEFISKLLIKEKSWRISASEALKHPWLSDHKL  351 (373)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHHHSHHHHCHHH
T ss_pred             HHHHHHHcCCChhhCCCHHHHhcCcCcCCCch
Confidence            99999999999999999999999999987654

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.9e-50  Score=383.70  Aligned_cols=268  Identities=38%  Similarity=0.686  Sum_probs=233.6

Q ss_pred             ccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCH---HhHHHHHHHHHHHHHccCCCCceeeeEEEEeC
Q 014733           37 NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTV---EDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEE  113 (419)
Q Consensus        37 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~---~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~  113 (419)
                      .+.++|++++.||+|+||.||+|.++.+|+.||+|++........   ...+.+.+|+.+++++. ||||+++++++.+.
T Consensus         2 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~   80 (283)
T 3bhy_A            2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR-HPNIITLHDIFENK   80 (283)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEECS
T ss_pred             chhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCC-CCCeeehhheecCC
Confidence            356899999999999999999999999999999999987644221   13678999999999996 99999999999999


Q ss_pred             CEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecC-CCCCeEEeecccee
Q 014733          114 DYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKS-SSSPIKLADFGLAT  192 (419)
Q Consensus       114 ~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~-~~~~vKL~DFgla~  192 (419)
                      +..++||||+++++|.+++.....+++.+++.++.||+.||.|||+.||+||||||+||+++.++ ....+||+|||++.
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~  160 (283)
T 3bhy_A           81 TDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH  160 (283)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             CeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence            99999999999999999998888899999999999999999999999999999999999995432 22389999999998


Q ss_pred             eeccCCccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCH
Q 014733          193 YIKAGQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISA  271 (419)
Q Consensus       193 ~~~~~~~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  271 (419)
                      ............||+.|+|||++.+. ++.++||||||+++|+|++|..||.+....+....+.......+...+..++.
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (283)
T 3bhy_A          161 KIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSE  240 (283)
T ss_dssp             ECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCH
T ss_pred             eccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCH
Confidence            87665555566899999999998764 89999999999999999999999999998888888887776666555568899


Q ss_pred             HHHHHHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          272 SARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       272 ~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                      .+.++|.+||+.||++|||+.++++||||+....
T Consensus       241 ~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  274 (283)
T 3bhy_A          241 LAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR  274 (283)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred             HHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence            9999999999999999999999999999998754

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=3e-50  Score=399.53  Aligned_cols=265  Identities=37%  Similarity=0.700  Sum_probs=237.7

Q ss_pred             ccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccC-CH----HhHHHHHHHHHHHHHccCCCCceeeeEE
Q 014733           35 ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLV-TV----EDVRSIKLEIEIMTKLSGHPNVVDLKAV  109 (419)
Q Consensus        35 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~-~~----~~~~~~~~Ei~il~~l~~hpnIv~l~~~  109 (419)
                      ...+.++|++.+.||+|+||.||+|.++.+|+.||||++...... ..    ...+.+.+|+.+++++.+||||++++++
T Consensus        89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~  168 (365)
T 2y7j_A           89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS  168 (365)
T ss_dssp             HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence            345678999999999999999999999999999999999764321 11    2256788999999999669999999999


Q ss_pred             EEeCCEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeecc
Q 014733          110 YEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFG  189 (419)
Q Consensus       110 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFg  189 (419)
                      +...+..|+||||++|++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||+   +.++.+||+|||
T Consensus       169 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~---~~~~~ikl~DfG  245 (365)
T 2y7j_A          169 YESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILL---DDNMQIRLSDFG  245 (365)
T ss_dssp             EEBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCT
T ss_pred             EeeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEEEecC
Confidence            99999999999999999999999888889999999999999999999999999999999999999   567899999999


Q ss_pred             ceeeeccCCccccccCCCccCCcccccC-------CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC
Q 014733          190 LATYIKAGQNLHGTVGSPFYIAPEVLAG-------GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFP  262 (419)
Q Consensus       190 la~~~~~~~~~~~~~gt~~y~aPE~l~~-------~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~  262 (419)
                      ++..+.........+||+.|+|||++.+       .++.++|||||||++|+|++|+.||.+.........+......++
T Consensus       246 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  325 (365)
T 2y7j_A          246 FSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFS  325 (365)
T ss_dssp             TCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred             cccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence            9998776666667789999999999752       378899999999999999999999999888888888888877776


Q ss_pred             CCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhcccccc
Q 014733          263 SDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE  302 (419)
Q Consensus       263 ~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~  302 (419)
                      ...|..++.++.++|.+||+.||++|||+.++++||||+.
T Consensus       326 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          326 SPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             HHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence            6666789999999999999999999999999999999963

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=2e-50  Score=386.37  Aligned_cols=268  Identities=41%  Similarity=0.747  Sum_probs=241.9

Q ss_pred             ccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCC
Q 014733           35 ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEED  114 (419)
Q Consensus        35 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~  114 (419)
                      ...+.++|++++.||+|+||.||+|.++.+++.||+|++..... .......+.+|+++++++. ||||+++++++.+.+
T Consensus        17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~   94 (287)
T 2wei_A           17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVELLKKLD-HPNIMKLFEILEDSS   94 (287)
T ss_dssp             THHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGB-SSSCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSS
T ss_pred             HHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEeccccc-chHHHHHHHHHHHHHHhcc-CCCccEEEEEEeCCC
Confidence            34567899999999999999999999999999999999976543 2345678899999999995 999999999999999


Q ss_pred             EEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeee
Q 014733          115 YVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI  194 (419)
Q Consensus       115 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~  194 (419)
                      .+++||||+++++|.+.+...+.+++.+++.++.||+.||.|||+.||+||||||+||+++.++.++.+||+|||++...
T Consensus        95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~  174 (287)
T 2wei_A           95 SFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF  174 (287)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred             eEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence            99999999999999999988888999999999999999999999999999999999999976655678999999999876


Q ss_pred             ccCCccccccCCCccCCcccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 014733          195 KAGQNLHGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASAR  274 (419)
Q Consensus       195 ~~~~~~~~~~gt~~y~aPE~l~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~  274 (419)
                      ..........||+.|+|||++.+.++.++||||||+++|+|++|..||.+....+....+......++...+..++.++.
T Consensus       175 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (287)
T 2wei_A          175 QQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAK  254 (287)
T ss_dssp             CCCSSCSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHH
T ss_pred             cCCCccccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHH
Confidence            55554455678999999999988899999999999999999999999999999898898888877777666778999999


Q ss_pred             HHHHhhhhcCCCCCCCHHHHHhccccccch
Q 014733          275 DLIMGMLRVDPSTRLTAAEVLAHSWMEECE  304 (419)
Q Consensus       275 ~li~~~L~~dP~~Rps~~eil~hp~~~~~~  304 (419)
                      ++|.+||+.||++|||+.++++||||++..
T Consensus       255 ~li~~~l~~dp~~Rps~~ell~hp~~~~~~  284 (287)
T 2wei_A          255 DLIRKMLTFHPSLRITATQCLEHPWIQKYS  284 (287)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred             HHHHHHcccChhhCcCHHHHhcCHHHhccc
Confidence            999999999999999999999999998653

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=7.9e-50  Score=395.99  Aligned_cols=259  Identities=39%  Similarity=0.645  Sum_probs=212.2

Q ss_pred             ccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEE
Q 014733           37 NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYV  116 (419)
Q Consensus        37 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~  116 (419)
                      ...++|++++.||+|+||+||+|+++.+++.||+|++......    .+.+.+|+.++++++ ||||+++++++.+.+.+
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~   91 (361)
T 3uc3_A           17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI----DENVQREIINHRSLR-HPNIVRFKEVILTPTHL   91 (361)
T ss_dssp             CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS----CHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEE
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc----cHHHHHHHHHHHhCC-CCCCCcEEEEEeeCCEE
Confidence            4568999999999999999999999999999999999765432    256789999999996 99999999999999999


Q ss_pred             EEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeecc
Q 014733          117 HLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA  196 (419)
Q Consensus       117 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~  196 (419)
                      ++||||+.||+|.+++...+++++.+++.++.||+.||+|||++||+||||||+|||++.+ ..+.+||+|||++.....
T Consensus        92 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~-~~~~~kl~Dfg~a~~~~~  170 (361)
T 3uc3_A           92 AIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVL  170 (361)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSS-SSCCEEECCCCCC-----
T ss_pred             EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCC-CCceEEEeecCccccccc
Confidence            9999999999999999888899999999999999999999999999999999999999532 233599999999986544


Q ss_pred             CCccccccCCCccCCcccccCC-CC-CchhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhcCCCCCCCCCCCCC
Q 014733          197 GQNLHGTVGSPFYIAPEVLAGG-YN-QAADVWSAGVILYILLSGMPPFWGKTK----SKIFDAVRAADLRFPSDPWDHIS  270 (419)
Q Consensus       197 ~~~~~~~~gt~~y~aPE~l~~~-~s-~~sDvwSlGvil~elltG~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~s  270 (419)
                      .......+||+.|+|||++.+. ++ .++|||||||++|+|++|+.||.+...    ......+......++..  ..++
T Consensus       171 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s  248 (361)
T 3uc3_A          171 HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDD--IRIS  248 (361)
T ss_dssp             ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTT--SCCC
T ss_pred             cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCc--CCCC
Confidence            4445567899999999998764 55 449999999999999999999976443    45555555555555443  3689


Q ss_pred             HHHHHHHHhhhhcCCCCCCCHHHHHhccccccc
Q 014733          271 ASARDLIMGMLRVDPSTRLTAAEVLAHSWMEEC  303 (419)
Q Consensus       271 ~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~  303 (419)
                      +++.+||.+||+.||.+|||+.|+++||||...
T Consensus       249 ~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~  281 (361)
T 3uc3_A          249 PECCHLISRIFVADPATRISIPEIKTHSWFLKN  281 (361)
T ss_dssp             HHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence            999999999999999999999999999999653

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.7e-50  Score=431.35  Aligned_cols=261  Identities=28%  Similarity=0.505  Sum_probs=237.1

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEE
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHL  118 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~l  118 (419)
                      .++|++++.||+|+||+||+|.++.+++.||+|++.+.........+.+..|..+|..+.+||+|+++++++++.+.+|+
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l  419 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF  419 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence            46899999999999999999999999999999999865433334567788999999988779999999999999999999


Q ss_pred             EEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeec-cC
Q 014733          119 LMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIK-AG  197 (419)
Q Consensus       119 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~-~~  197 (419)
                      ||||++||+|..++...+.+++.+++.++.||+.||+|||++|||||||||+||||   +.++++||+|||+++... ..
T Consensus       420 V~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl---~~~g~ikL~DFGla~~~~~~~  496 (674)
T 3pfq_A          420 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENIWDG  496 (674)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEE---CSSSCEEECCCTTCEECCCTT
T ss_pred             EEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEE---cCCCcEEEeecceeeccccCC
Confidence            99999999999999998999999999999999999999999999999999999999   567899999999998643 33


Q ss_pred             CccccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHH
Q 014733          198 QNLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDL  276 (419)
Q Consensus       198 ~~~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~l  276 (419)
                      ......+||+.|+|||++.+ .|+.++|||||||++|||++|++||.+.+..++++.|......+|.    .++.++++|
T Consensus       497 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~l  572 (674)
T 3pfq_A          497 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVAI  572 (674)
T ss_dssp             CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCT----TSCHHHHHH
T ss_pred             cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCc----cCCHHHHHH
Confidence            34556789999999999886 4999999999999999999999999999999999999988777664    689999999


Q ss_pred             HHhhhhcCCCCCCCH-----HHHHhccccccchhh
Q 014733          277 IMGMLRVDPSTRLTA-----AEVLAHSWMEECEQV  306 (419)
Q Consensus       277 i~~~L~~dP~~Rps~-----~eil~hp~~~~~~~~  306 (419)
                      |++||++||.+||++     ++|++||||+.+++.
T Consensus       573 i~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~  607 (674)
T 3pfq_A          573 CKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE  607 (674)
T ss_dssp             HHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHH
T ss_pred             HHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHH
Confidence            999999999999997     999999999988654

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.9e-50  Score=402.30  Aligned_cols=264  Identities=32%  Similarity=0.542  Sum_probs=215.8

Q ss_pred             cccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCC-
Q 014733           36 SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEED-  114 (419)
Q Consensus        36 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~-  114 (419)
                      ..+.++|++++.||+|+||+||+|.++.+|+.||+|++.+.. ........+.+|+.+|+++.+||||+++++++...+ 
T Consensus         5 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~   83 (388)
T 3oz6_A            5 RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADND   83 (388)
T ss_dssp             HHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTS
T ss_pred             CcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCC
Confidence            346789999999999999999999999999999999986542 455677888999999999977999999999998654 


Q ss_pred             -EEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceee
Q 014733          115 -YVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATY  193 (419)
Q Consensus       115 -~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~  193 (419)
                       .+|+||||+. ++|..++.. +.+++..+..++.||+.||+|||+.||+||||||+|||+   +.++.+||+|||+++.
T Consensus        84 ~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~  158 (388)
T 3oz6_A           84 RDVYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILL---NAECHVKVADFGLSRS  158 (388)
T ss_dssp             SCEEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEE
T ss_pred             CEEEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEE---cCCCCEEecCCccccc
Confidence             7899999996 689988876 679999999999999999999999999999999999999   5678999999999986


Q ss_pred             eccC----------------------CccccccCCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 014733          194 IKAG----------------------QNLHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSK  249 (419)
Q Consensus       194 ~~~~----------------------~~~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~  249 (419)
                      ....                      ......+||+.|+|||++.+  .|+.++|||||||++|+|++|++||.+.+..+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~  238 (388)
T 3oz6_A          159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN  238 (388)
T ss_dssp             SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            5321                      11234589999999999876  48999999999999999999999999988877


Q ss_pred             HHHHHHhcCCCCCC--------------------------------------------CCCCCCCHHHHHHHHhhhhcCC
Q 014733          250 IFDAVRAADLRFPS--------------------------------------------DPWDHISASARDLIMGMLRVDP  285 (419)
Q Consensus       250 ~~~~i~~~~~~~~~--------------------------------------------~~~~~~s~~l~~li~~~L~~dP  285 (419)
                      ....+.... ..|.                                            ..+..+++++.+||.+||+.||
T Consensus       239 ~~~~i~~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP  317 (388)
T 3oz6_A          239 QLERIIGVI-DFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNP  317 (388)
T ss_dssp             HHHHHHHHH-CCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSG
T ss_pred             HHHHHHHhc-CCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCc
Confidence            777664321 1111                                            0122678999999999999999


Q ss_pred             CCCCCHHHHHhccccccchhh
Q 014733          286 STRLTAAEVLAHSWMEECEQV  306 (419)
Q Consensus       286 ~~Rps~~eil~hp~~~~~~~~  306 (419)
                      ++|||+.|+|+||||+.....
T Consensus       318 ~~R~t~~e~l~Hp~~~~~~~~  338 (388)
T 3oz6_A          318 NKRISANDALKHPFVSIFHNP  338 (388)
T ss_dssp             GGSCCHHHHTTSTTTTTTCCG
T ss_pred             ccCCCHHHHhCCHHHHHhcCC
Confidence            999999999999999876543

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=3.3e-50  Score=392.58  Aligned_cols=259  Identities=33%  Similarity=0.562  Sum_probs=220.0

Q ss_pred             cccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEE
Q 014733           38 LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVH  117 (419)
Q Consensus        38 ~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~  117 (419)
                      +.++|++++.||+|+||+||+|.++.+++.||+|++.....  ....+.+.+|+.+++.+. ||||+++++++.+.+..|
T Consensus         5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~   81 (323)
T 3tki_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLN-HENVVKFYGHRREGNIQY   81 (323)
T ss_dssp             TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCC-CTTBCCEEEEEECSSEEE
T ss_pred             HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc--cchHHHHHHHHHHHHhCC-CCCCCeEEEEEecCCeEE
Confidence            56899999999999999999999999999999999976533  233467889999999996 999999999999999999


Q ss_pred             EEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccC
Q 014733          118 LLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG  197 (419)
Q Consensus       118 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~  197 (419)
                      +||||++|++|.+++.....+++.+++.++.||+.||+|||+.||+||||||+|||+   +.++.+||+|||++......
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~  158 (323)
T 3tki_A           82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYN  158 (323)
T ss_dssp             EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEECEET
T ss_pred             EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEE---eCCCCEEEEEeeccceeccC
Confidence            999999999999999887789999999999999999999999999999999999999   56789999999999876433


Q ss_pred             C---ccccccCCCccCCcccccCC--CCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhcCCCCCCCCCCCCCH
Q 014733          198 Q---NLHGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTKS-KIFDAVRAADLRFPSDPWDHISA  271 (419)
Q Consensus       198 ~---~~~~~~gt~~y~aPE~l~~~--~s~~sDvwSlGvil~elltG~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s~  271 (419)
                      .   .....+||+.|+|||++.+.  ++.++|||||||++|+|++|+.||...... ...........  ....+..++.
T Consensus       159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  236 (323)
T 3tki_A          159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT--YLNPWKKIDS  236 (323)
T ss_dssp             TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCT--TSTTGGGSCH
T ss_pred             CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccc--cCCccccCCH
Confidence            2   23456899999999998764  478999999999999999999999765543 23333333222  2233567999


Q ss_pred             HHHHHHHhhhhcCCCCCCCHHHHHhccccccch
Q 014733          272 SARDLIMGMLRVDPSTRLTAAEVLAHSWMEECE  304 (419)
Q Consensus       272 ~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~  304 (419)
                      ++.+||.+||+.||++|||+.|+++||||++..
T Consensus       237 ~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~  269 (323)
T 3tki_A          237 APLALLHKILVENPSARITIPDIKKDRWYNKPL  269 (323)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence            999999999999999999999999999998643

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.5e-49  Score=397.15  Aligned_cols=266  Identities=20%  Similarity=0.304  Sum_probs=221.4

Q ss_pred             ccccccCeeeeeeeccc--CceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEe
Q 014733           35 ISNLSDRYVLGKQLGWG--QFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEE  112 (419)
Q Consensus        35 ~~~~~~~y~i~~~LG~G--~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~  112 (419)
                      +-...++|++++.||+|  +||.||+|.++.+|+.||+|++..... .....+.+.+|+.++++++ ||||+++++++.+
T Consensus        20 ~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~   97 (389)
T 3gni_B           20 FLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFN-HPNIVPYRATFIA   97 (389)
T ss_dssp             CCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEE
T ss_pred             ccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhCC-CCCCCcEeEEEEE
Confidence            44567899999999999  999999999999999999999987643 4566788999999999996 9999999999999


Q ss_pred             CCEEEEEEeecCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccc
Q 014733          113 EDYVHLLMELCAGGELFHRLEKY--GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGL  190 (419)
Q Consensus       113 ~~~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgl  190 (419)
                      .+.+|+||||+++++|.+++...  +.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||.
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll---~~~~~~kl~dfg~  174 (389)
T 3gni_B           98 DNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI---SVDGKVYLSGLRS  174 (389)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCGGG
T ss_pred             CCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEccccc
Confidence            99999999999999999999876  669999999999999999999999999999999999999   5678999999998


Q ss_pred             eeeeccCC--------ccccccCCCccCCcccccC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC
Q 014733          191 ATYIKAGQ--------NLHGTVGSPFYIAPEVLAG---GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADL  259 (419)
Q Consensus       191 a~~~~~~~--------~~~~~~gt~~y~aPE~l~~---~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~  259 (419)
                      +.......        .....+||+.|+|||++.+   .|+.++|||||||++|+|++|+.||.+....+....+.....
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  254 (389)
T 3gni_B          175 NLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTV  254 (389)
T ss_dssp             CEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----
T ss_pred             ceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC
Confidence            87543221        1123478999999999876   489999999999999999999999987655444433322211


Q ss_pred             C------------------------------------------CCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          260 R------------------------------------------FPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       260 ~------------------------------------------~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      .                                          .....+..+++++.+||.+||+.||++|||+.|+|+|
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          255 PCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             ---------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             CccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence            1                                          0011234688999999999999999999999999999


Q ss_pred             cccccchh
Q 014733          298 SWMEECEQ  305 (419)
Q Consensus       298 p~~~~~~~  305 (419)
                      |||++...
T Consensus       335 p~f~~~~~  342 (389)
T 3gni_B          335 SFFKQIKR  342 (389)
T ss_dssp             GGGGGC--
T ss_pred             HHHHHHhh
Confidence            99987654

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=6e-50  Score=381.26  Aligned_cols=259  Identities=32%  Similarity=0.605  Sum_probs=228.3

Q ss_pred             ccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEE
Q 014733           37 NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYV  116 (419)
Q Consensus        37 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~  116 (419)
                      ...++|++++.||+|+||.||+|.++.+++.||+|++.+...........+.+|+.++++++ ||||+++++++.+.+..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   84 (279)
T 3fdn_A            6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATRV   84 (279)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEE
T ss_pred             eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCC-CCCCcchhheEecCCEE
Confidence            34589999999999999999999999999999999997654323334567889999999996 99999999999999999


Q ss_pred             EEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeecc
Q 014733          117 HLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA  196 (419)
Q Consensus       117 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~  196 (419)
                      ++||||+++++|.+++.....+++..++.++.||+.||+|||+.||+||||||+|||+   +.++.+||+|||++.....
T Consensus        85 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili---~~~~~~~l~Dfg~~~~~~~  161 (279)
T 3fdn_A           85 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVHAPS  161 (279)
T ss_dssp             EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEE---CTTSCEEECSCCEESCC--
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEE---cCCCCEEEEeccccccCCc
Confidence            9999999999999999988899999999999999999999999999999999999999   5678999999999875433


Q ss_pred             CCccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 014733          197 GQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARD  275 (419)
Q Consensus       197 ~~~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~  275 (419)
                      . ......||+.|+|||++.+. ++.++||||||+++|+|++|+.||......+....+......++.    .++.++.+
T Consensus       162 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~  236 (279)
T 3fdn_A          162 S-RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARD  236 (279)
T ss_dssp             -------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCT----TSCHHHHH
T ss_pred             c-cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCC----cCCHHHHH
Confidence            3 23456899999999998875 899999999999999999999999999998888888877665553    58899999


Q ss_pred             HHHhhhhcCCCCCCCHHHHHhccccccch
Q 014733          276 LIMGMLRVDPSTRLTAAEVLAHSWMEECE  304 (419)
Q Consensus       276 li~~~L~~dP~~Rps~~eil~hp~~~~~~  304 (419)
                      ||.+||+.||.+|||+.|+++||||+...
T Consensus       237 li~~~l~~~p~~Rps~~e~l~h~~~~~~~  265 (279)
T 3fdn_A          237 LISRLLKHNPSQRPMLREVLEHPWITANS  265 (279)
T ss_dssp             HHHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred             HHHHHhccChhhCCCHHHHhhCccccCCc
Confidence            99999999999999999999999998654

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=4.1e-50  Score=392.46  Aligned_cols=267  Identities=26%  Similarity=0.455  Sum_probs=215.9

Q ss_pred             cccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCE
Q 014733           36 SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDY  115 (419)
Q Consensus        36 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~  115 (419)
                      ....++|++++.||+|+||+||+|.+..+|+.||+|++..... .......+.+|+.++++++ ||||+++++++.+.+.
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~  107 (329)
T 3gbz_A           30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQ-HRNIIELKSVIHHNHR  107 (329)
T ss_dssp             --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCC-CTTBCCEEEEEEETTE
T ss_pred             ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcC-CCCcceEEEEEecCCE
Confidence            3456799999999999999999999999999999999976542 3344567789999999996 9999999999999999


Q ss_pred             EEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecC--CCCCeEEeeccceee
Q 014733          116 VHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKS--SSSPIKLADFGLATY  193 (419)
Q Consensus       116 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~--~~~~vKL~DFgla~~  193 (419)
                      +++||||++ ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++  ..+.+||+|||++..
T Consensus       108 ~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~  186 (329)
T 3gbz_A          108 LHLIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA  186 (329)
T ss_dssp             EEEEEECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred             EEEEEecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence            999999996 59999999988899999999999999999999999999999999999996432  344699999999986


Q ss_pred             eccC-CccccccCCCccCCcccccC-C-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCC----
Q 014733          194 IKAG-QNLHGTVGSPFYIAPEVLAG-G-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW----  266 (419)
Q Consensus       194 ~~~~-~~~~~~~gt~~y~aPE~l~~-~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~----  266 (419)
                      .... ......+||+.|+|||++.+ . ++.++|||||||++|+|++|++||.+....+....+.......+...|    
T Consensus       187 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (329)
T 3gbz_A          187 FGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVT  266 (329)
T ss_dssp             HC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred             cCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhh
Confidence            6433 23344578999999999876 3 899999999999999999999999998887777766543221111111    


Q ss_pred             ----------------------CCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          267 ----------------------DHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       267 ----------------------~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                                            ..+++++.+||.+||+.||++|||+.|+|+||||++...
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  327 (329)
T 3gbz_A          267 ALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDF  327 (329)
T ss_dssp             GSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCS
T ss_pred             hhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCC
Confidence                                  117899999999999999999999999999999987643

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=5.1e-50  Score=417.87  Aligned_cols=261  Identities=31%  Similarity=0.522  Sum_probs=231.5

Q ss_pred             ccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEE
Q 014733           37 NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYV  116 (419)
Q Consensus        37 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~  116 (419)
                      ...++|++.+.||+|+||.||+|.++.+|+.||+|++.+...........+.+|+.+|+++. ||||+++++++.+.+.+
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~l  259 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN-SRFVVSLAYAYETKDAL  259 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEE
T ss_pred             ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcC-CCCEeeEEEEEeeCCEE
Confidence            45688999999999999999999999999999999997654433344567889999999995 99999999999999999


Q ss_pred             EEEEeecCCCChHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeee
Q 014733          117 HLLMELCAGGELFHRLEKYGR--FSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI  194 (419)
Q Consensus       117 ~lV~E~~~ggsL~~~l~~~~~--l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~  194 (419)
                      |+||||++||+|..++...+.  +++..++.++.||+.||+|||++||+||||||+|||+   +.++++||+|||++...
T Consensus       260 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILl---d~~g~vKL~DFGla~~~  336 (576)
T 2acx_A          260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILL---DDHGHIRISDLGLAVHV  336 (576)
T ss_dssp             EEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTTCEEC
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEE---eCCCCeEEEecccceec
Confidence            999999999999999977544  9999999999999999999999999999999999999   56789999999999987


Q ss_pred             ccCCccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhcCCCCCCCCCCCC
Q 014733          195 KAGQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKT----KSKIFDAVRAADLRFPSDPWDHI  269 (419)
Q Consensus       195 ~~~~~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~----~~~~~~~i~~~~~~~~~~~~~~~  269 (419)
                      .........+||+.|+|||++.+. |+.++|||||||++|+|++|++||.+..    ..++...+......++    ..+
T Consensus       337 ~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p----~~~  412 (576)
T 2acx_A          337 PEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS----ERF  412 (576)
T ss_dssp             CTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCC----TTS
T ss_pred             ccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCC----ccC
Confidence            766666667999999999999875 9999999999999999999999998753    4556666666554443    478


Q ss_pred             CHHHHHHHHhhhhcCCCCCC-----CHHHHHhccccccchh
Q 014733          270 SASARDLIMGMLRVDPSTRL-----TAAEVLAHSWMEECEQ  305 (419)
Q Consensus       270 s~~l~~li~~~L~~dP~~Rp-----s~~eil~hp~~~~~~~  305 (419)
                      ++++++||.+||+.||.+||     ++.|+++||||+.+.+
T Consensus       413 s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w  453 (576)
T 2acx_A          413 SPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNF  453 (576)
T ss_dssp             CHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCH
T ss_pred             CHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCH
Confidence            99999999999999999999     8999999999998765

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.4e-50  Score=409.28  Aligned_cols=268  Identities=35%  Similarity=0.685  Sum_probs=222.2

Q ss_pred             cccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccC-----CHHhHHHHHHHHHHHHHccCCCCceeeeEEE
Q 014733           36 SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLV-----TVEDVRSIKLEIEIMTKLSGHPNVVDLKAVY  110 (419)
Q Consensus        36 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~-----~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~  110 (419)
                      ..+.++|++.+.||+|+||+||+|.++.+++.||+|++.+....     .......+.+|+.+|+++. ||||+++++++
T Consensus       131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~  209 (419)
T 3i6u_A          131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN-HPCIIKIKNFF  209 (419)
T ss_dssp             HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCC-CTTBCCCCEEE
T ss_pred             hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCC-CCCEeeEEEEE
Confidence            34678999999999999999999999999999999999865432     1122345889999999995 99999999998


Q ss_pred             EeCCEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccc
Q 014733          111 EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGL  190 (419)
Q Consensus       111 ~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgl  190 (419)
                      .. +.+|+||||+++++|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+..+||+|||+
T Consensus       210 ~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~  288 (419)
T 3i6u_A          210 DA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH  288 (419)
T ss_dssp             ES-SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSST
T ss_pred             ec-CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeeccc
Confidence            64 55899999999999999998888899999999999999999999999999999999999997655566799999999


Q ss_pred             eeeeccCCccccccCCCccCCcccccC----CCCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhcCCCCCCCC
Q 014733          191 ATYIKAGQNLHGTVGSPFYIAPEVLAG----GYNQAADVWSAGVILYILLSGMPPFWGKTK-SKIFDAVRAADLRFPSDP  265 (419)
Q Consensus       191 a~~~~~~~~~~~~~gt~~y~aPE~l~~----~~s~~sDvwSlGvil~elltG~~Pf~~~~~-~~~~~~i~~~~~~~~~~~  265 (419)
                      +............+||+.|+|||++.+    .|+.++|||||||++|+|++|++||.+... ......+......+....
T Consensus       289 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~  368 (419)
T 3i6u_A          289 SKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV  368 (419)
T ss_dssp             TTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHH
T ss_pred             ceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchh
Confidence            988765555566789999999999853    478899999999999999999999976533 345566667666666666


Q ss_pred             CCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          266 WDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       266 ~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                      +..+++++.+||.+||+.||++|||+.++|+||||+....
T Consensus       369 ~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~  408 (419)
T 3i6u_A          369 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDM  408 (419)
T ss_dssp             HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHHH
T ss_pred             hcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCChhH
Confidence            6789999999999999999999999999999999986543

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=7.2e-50  Score=382.95  Aligned_cols=257  Identities=29%  Similarity=0.490  Sum_probs=214.1

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      ++|++++.||+|+||+||+|.+ .+|+.||+|++..... .......+.+|+.++++++ ||||+++++++.+.+.+++|
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv   78 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE-DEGIPSTTIREISILKELK-HSNIVKLYDVIHTKKRLVLV   78 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCC-CTTBCCEEEEEECSSCEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccc-ccccchhHHHHHHHHHhcC-CCCEeeeeeEEccCCeEEEE
Confidence            6899999999999999999998 5789999999976532 2223467889999999996 99999999999999999999


Q ss_pred             EeecCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccC-
Q 014733          120 MELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG-  197 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~-  197 (419)
                      |||+++ +|.+++... +.+++.+++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++...... 
T Consensus        79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~  154 (288)
T 1ob3_A           79 FEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFGIPV  154 (288)
T ss_dssp             EECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCTTHHHHHCC--
T ss_pred             EEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEEeECccccccCccc
Confidence            999965 999888764 569999999999999999999999999999999999999   56789999999999865432 


Q ss_pred             CccccccCCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC------------
Q 014733          198 QNLHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPS------------  263 (419)
Q Consensus       198 ~~~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~------------  263 (419)
                      .......||+.|+|||++.+  .++.++|||||||++|+|++|++||.+....+....+.......+.            
T Consensus       155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T 1ob3_A          155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY  234 (288)
T ss_dssp             -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccc
Confidence            22344578999999999875  3899999999999999999999999988877776665432111000            


Q ss_pred             -------------CCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccc
Q 014733          264 -------------DPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEEC  303 (419)
Q Consensus       264 -------------~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~  303 (419)
                                   .....+++++.+||.+||+.||++|||+.|+++||||++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  287 (288)
T 1ob3_A          235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN  287 (288)
T ss_dssp             CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred             ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence                         0124588999999999999999999999999999999863

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=7.2e-50  Score=388.74  Aligned_cols=260  Identities=28%  Similarity=0.483  Sum_probs=208.5

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEE
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHL  118 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~l  118 (419)
                      .++|++++.||+|+||+||+|.++.+|+.||+|++....  .....+.+.+|+.++++++ ||||+++++++.+.+.+++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~l   80 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS--EEGTPSTAIREISLMKELK-HENIVRLYDVIHTENKLTL   80 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCS--TTCSCHHHHHHHHHHTTCC-BTTBCCEEEEECCTTEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc--ccccHHHHHHHHHHHHhcC-CCCcceEEEEEEECCeEEE
Confidence            468999999999999999999999999999999997653  2233467888999999996 9999999999999999999


Q ss_pred             EEeecCCCChHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeecccee
Q 014733          119 LMELCAGGELFHRLEKY------GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLAT  192 (419)
Q Consensus       119 V~E~~~ggsL~~~l~~~------~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~  192 (419)
                      ||||++ ++|.+++...      ..+++..++.++.||+.||+|||+.||+||||||+|||+   +.++.+||+|||++.
T Consensus        81 v~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~  156 (317)
T 2pmi_A           81 VFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLI---NKRGQLKLGDFGLAR  156 (317)
T ss_dssp             EEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCSSCE
T ss_pred             EEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEE---cCCCCEEECcCccce
Confidence            999997 5999988654      358999999999999999999999999999999999999   567899999999998


Q ss_pred             eeccCC-ccccccCCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC------
Q 014733          193 YIKAGQ-NLHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPS------  263 (419)
Q Consensus       193 ~~~~~~-~~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~------  263 (419)
                      ...... ......||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+....+....+.......+.      
T Consensus       157 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  236 (317)
T 2pmi_A          157 AFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSV  236 (317)
T ss_dssp             ETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGG
T ss_pred             ecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhh
Confidence            765332 3345689999999999876  3899999999999999999999999998888777766542111100      


Q ss_pred             ------------------------CCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          264 ------------------------DPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       264 ------------------------~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                                              .....++.++.+||.+||+.||++|||+.|+|+||||++...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~  302 (317)
T 2pmi_A          237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYH  302 (317)
T ss_dssp             GGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC
T ss_pred             hhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccc
Confidence                                    011257899999999999999999999999999999987654

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.9e-49  Score=383.48  Aligned_cols=263  Identities=31%  Similarity=0.556  Sum_probs=219.6

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEE
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHL  118 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~l  118 (419)
                      -++|++++.||+|+||+||+|.+..+|+.||+|++.... ......+.+.+|+.++++++ ||||+++++++.+.+..++
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~l   79 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLK-HPNLVNLLEVFRRKRRLHL   79 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhCC-CCCccchhheeecCCeEEE
Confidence            478999999999999999999999999999999987653 34455677889999999996 9999999999999999999


Q ss_pred             EEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC
Q 014733          119 LMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ  198 (419)
Q Consensus       119 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~  198 (419)
                      ||||+++++|..++...+.+++..++.++.|++.||+|||+.||+||||||+|||+   +.++.+||+|||++.......
T Consensus        80 v~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~  156 (311)
T 4agu_A           80 VFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILI---TKHSVIKLCDFGFARLLTGPS  156 (311)
T ss_dssp             EEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECC---
T ss_pred             EEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEE---cCCCCEEEeeCCCchhccCcc
Confidence            99999999999998887889999999999999999999999999999999999999   567899999999998765332


Q ss_pred             -ccccccCCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC----------------
Q 014733          199 -NLHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADL----------------  259 (419)
Q Consensus       199 -~~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~----------------  259 (419)
                       .....+||+.|+|||++.+  .++.++||||||+++|+|++|++||.+....+....+.....                
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (311)
T 4agu_A          157 DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF  236 (311)
T ss_dssp             ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred             cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccc
Confidence             2345689999999999875  489999999999999999999999998887766655543211                


Q ss_pred             ---CCCCC--------CCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchhh
Q 014733          260 ---RFPSD--------PWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQV  306 (419)
Q Consensus       260 ---~~~~~--------~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~~  306 (419)
                         ..+..        .+..++.++.+||.+||+.||.+|||+.|+++||||++....
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  294 (311)
T 4agu_A          237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREI  294 (311)
T ss_dssp             TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC--
T ss_pred             ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCH
Confidence               11111        124688999999999999999999999999999999987543

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=4.8e-50  Score=409.38  Aligned_cols=266  Identities=30%  Similarity=0.490  Sum_probs=205.4

Q ss_pred             cccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEe---
Q 014733           36 SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEE---  112 (419)
Q Consensus        36 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~---  112 (419)
                      ..+.++|++++.||+|+||+||+|+++.+|+.||+|++.+.. ......+.+.+|+.+|++++ ||||+++++++..   
T Consensus        49 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~  126 (458)
T 3rp9_A           49 WQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF-EDLIDCKRILREIAILNRLN-HDHVVKVLDIVIPKDV  126 (458)
T ss_dssp             CCSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSCT
T ss_pred             CccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh-cCHHHHHHHHHHHHHHHhCC-CCCCCceEEEEecCCc
Confidence            456789999999999999999999999999999999996542 35566788999999999995 9999999999943   


Q ss_pred             --CCEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccc
Q 014733          113 --EDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGL  190 (419)
Q Consensus       113 --~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgl  190 (419)
                        .+.+|+||||+ +++|.+++.....+++.+++.++.||+.||+|||+.||+||||||+|||+   +.++.+||+|||+
T Consensus       127 ~~~~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl---~~~~~~kl~DFGl  202 (458)
T 3rp9_A          127 EKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLV---NQDCSVKVCDFGL  202 (458)
T ss_dssp             TTCCCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTCCEEECCCTT
T ss_pred             ccCceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEE---CCCCCEeeccccc
Confidence              35799999998 67999999888889999999999999999999999999999999999999   5678999999999


Q ss_pred             eeeeccCC----------------------------ccccccCCCccCCccccc-C-CCCCchhHHHHHHHHHHHHh---
Q 014733          191 ATYIKAGQ----------------------------NLHGTVGSPFYIAPEVLA-G-GYNQAADVWSAGVILYILLS---  237 (419)
Q Consensus       191 a~~~~~~~----------------------------~~~~~~gt~~y~aPE~l~-~-~~s~~sDvwSlGvil~ellt---  237 (419)
                      ++......                            ...+.+||+.|+|||++. + .|+.++|||||||++|||++   
T Consensus       203 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~  282 (458)
T 3rp9_A          203 ARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIK  282 (458)
T ss_dssp             CBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTST
T ss_pred             chhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcc
Confidence            98754221                            234458899999999864 3 49999999999999999999   


Q ss_pred             --------CCCCCCCCCH--------------------HHHHHHHHhcC--------------------CCCC-------
Q 014733          238 --------GMPPFWGKTK--------------------SKIFDAVRAAD--------------------LRFP-------  262 (419)
Q Consensus       238 --------G~~Pf~~~~~--------------------~~~~~~i~~~~--------------------~~~~-------  262 (419)
                              |+++|.+...                    .+.+..+....                    ..++       
T Consensus       283 ~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  362 (458)
T 3rp9_A          283 ENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDL  362 (458)
T ss_dssp             TTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCG
T ss_pred             ccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCH
Confidence                    7777766431                    11122111100                    0000       


Q ss_pred             CCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchhhh
Q 014733          263 SDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVA  307 (419)
Q Consensus       263 ~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~~~  307 (419)
                      ...+..+++++.+||++||++||++|||++|+|+||||++.....
T Consensus       363 ~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~  407 (458)
T 3rp9_A          363 AERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAE  407 (458)
T ss_dssp             GGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGG
T ss_pred             HHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCc
Confidence            112346799999999999999999999999999999999876543

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.3e-50  Score=395.48  Aligned_cols=269  Identities=36%  Similarity=0.656  Sum_probs=231.1

Q ss_pred             ccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCcc--CCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEe
Q 014733           35 ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRL--VTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEE  112 (419)
Q Consensus        35 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~--~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~  112 (419)
                      +..+.++|++++.||+|+||+||+|.++.+++.||+|++.+...  ......+.+.+|+.++++++ ||||+++++++.+
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~   99 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH-HPNIARLYEVYED   99 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCC-CTTBCCEEEEEEC
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCC-CCCcceeehhhcc
Confidence            45678999999999999999999999999999999999976432  13355678999999999996 9999999999999


Q ss_pred             CCEEEEEEeecCCCChHHHHHHc----------------------------------------CCCCHHHHHHHHHHHHH
Q 014733          113 EDYVHLLMELCAGGELFHRLEKY----------------------------------------GRFSETEARVIFRHLMQ  152 (419)
Q Consensus       113 ~~~~~lV~E~~~ggsL~~~l~~~----------------------------------------~~l~~~~~~~i~~qll~  152 (419)
                      .+..++||||++||+|.+++...                                        ..+++..++.++.||+.
T Consensus       100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~  179 (345)
T 3hko_A          100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS  179 (345)
T ss_dssp             SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence            99999999999999999988521                                        11467888999999999


Q ss_pred             HHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC-----ccccccCCCccCCcccccC---CCCCchh
Q 014733          153 VVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ-----NLHGTVGSPFYIAPEVLAG---GYNQAAD  224 (419)
Q Consensus       153 aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~-----~~~~~~gt~~y~aPE~l~~---~~s~~sD  224 (419)
                      ||+|||+.||+||||||+|||++.+ ....+||+|||++..+....     ......||+.|+|||++.+   .++.++|
T Consensus       180 ~l~~LH~~~ivH~Dlkp~NIll~~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D  258 (345)
T 3hko_A          180 ALHYLHNQGICHRDIKPENFLFSTN-KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD  258 (345)
T ss_dssp             HHHHHHHTTEECCCCCGGGEEESCS-SSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred             HHHHHHHCCccccCCChhhEEEecC-CCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence            9999999999999999999999532 23389999999998764322     1245579999999999864   4899999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccch
Q 014733          225 VWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECE  304 (419)
Q Consensus       225 vwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~  304 (419)
                      |||||+++|+|++|+.||.+....+....+......++...+..+++++.+||.+||+.||.+|||+.++++||||++..
T Consensus       259 iwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~  338 (345)
T 3hko_A          259 AWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS  338 (345)
T ss_dssp             HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred             HHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccCh
Confidence            99999999999999999999999999999888888777777777999999999999999999999999999999998764


Q ss_pred             h
Q 014733          305 Q  305 (419)
Q Consensus       305 ~  305 (419)
                      .
T Consensus       339 ~  339 (345)
T 3hko_A          339 D  339 (345)
T ss_dssp             S
T ss_pred             H
Confidence            3

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=3.4e-49  Score=378.87  Aligned_cols=260  Identities=35%  Similarity=0.570  Sum_probs=234.8

Q ss_pred             cccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCE
Q 014733           36 SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDY  115 (419)
Q Consensus        36 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~  115 (419)
                      ....++|++++.||+|+||.||+|.+..+++.+|+|++.+.........+.+.+|+.+++.+. ||||+++++++.+.+.
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~   89 (294)
T 2rku_A           11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFEDNDF   89 (294)
T ss_dssp             TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSE
T ss_pred             CCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCC-CCCEeeeeeeeccCCE
Confidence            346689999999999999999999999999999999998776666677888999999999995 9999999999999999


Q ss_pred             EEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeec
Q 014733          116 VHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIK  195 (419)
Q Consensus       116 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~  195 (419)
                      .++||||+++++|.+++...+.+++.+++.++.|++.||+|||++||+||||||+|||+   +.++.+||+|||++....
T Consensus        90 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~  166 (294)
T 2rku_A           90 VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATKVE  166 (294)
T ss_dssp             EEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECC
T ss_pred             EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEE---cCCCCEEEEeccCceecc
Confidence            99999999999999999888889999999999999999999999999999999999999   567889999999998765


Q ss_pred             cC-CccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 014733          196 AG-QNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASA  273 (419)
Q Consensus       196 ~~-~~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l  273 (419)
                      .. .......||+.|+|||++.+. ++.++||||||+++|+|++|+.||......+....+.......+.    .++.++
T Consensus       167 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~  242 (294)
T 2rku_A          167 YDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK----HINPVA  242 (294)
T ss_dssp             STTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCT----TSCHHH
T ss_pred             cCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCcc----ccCHHH
Confidence            33 233446799999999998774 899999999999999999999999998888888888776655443    688999


Q ss_pred             HHHHHhhhhcCCCCCCCHHHHHhccccccc
Q 014733          274 RDLIMGMLRVDPSTRLTAAEVLAHSWMEEC  303 (419)
Q Consensus       274 ~~li~~~L~~dP~~Rps~~eil~hp~~~~~  303 (419)
                      .++|.+||+.||++|||+.++++||||...
T Consensus       243 ~~li~~~l~~~p~~Rps~~~ll~~~~~~~~  272 (294)
T 2rku_A          243 ASLIQKMLQTDPTARPTINELLNDEFFTSG  272 (294)
T ss_dssp             HHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred             HHHHHHHcccChhhCcCHHHHhhChheecC
Confidence            999999999999999999999999999754

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=6.4e-50  Score=409.55  Aligned_cols=261  Identities=26%  Similarity=0.420  Sum_probs=214.0

Q ss_pred             ccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeC---
Q 014733           37 NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEE---  113 (419)
Q Consensus        37 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~---  113 (419)
                      .+.++|++++.||+|+||+||+|.+..+|+.||+|++.+.. ......+.+.+|+.+|+.+. ||||+++++++...   
T Consensus        59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~  136 (464)
T 3ttj_A           59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQKTL  136 (464)
T ss_dssp             EEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCCST
T ss_pred             eecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCC-CCCCCcEEEEEccCCcc
Confidence            45789999999999999999999999999999999997653 34566788999999999995 99999999999654   


Q ss_pred             ---CEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccc
Q 014733          114 ---DYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGL  190 (419)
Q Consensus       114 ---~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgl  190 (419)
                         +.+|+||||+.+ +|.+.+.  ..+++.+++.++.||+.||+|||+.||+||||||+|||+   +.++.+||+|||+
T Consensus       137 ~~~~~~~lv~E~~~~-~l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll---~~~~~~kl~DFG~  210 (464)
T 3ttj_A          137 EEFQDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGL  210 (464)
T ss_dssp             TTCCEEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCC
T ss_pred             ccCCeEEEEEeCCCC-CHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEE---eCCCCEEEEEEEe
Confidence               468999999965 5666664  359999999999999999999999999999999999999   5678999999999


Q ss_pred             eeeeccCCccccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC-------
Q 014733          191 ATYIKAGQNLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFP-------  262 (419)
Q Consensus       191 a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~-------  262 (419)
                      +............+||+.|+|||++.+ .|+.++|||||||++|+|++|++||.+.+..+.+..+........       
T Consensus       211 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~  290 (464)
T 3ttj_A          211 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL  290 (464)
T ss_dssp             C-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTS
T ss_pred             eeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHc
Confidence            998766655667799999999999887 499999999999999999999999999887777766644211110       


Q ss_pred             ---------------CCCC-----C-----------CCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          263 ---------------SDPW-----D-----------HISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       263 ---------------~~~~-----~-----------~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                                     ...+     .           ..++++++||.+||++||++|||+.|+|+||||+....
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~  364 (464)
T 3ttj_A          291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD  364 (464)
T ss_dssp             CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCC
T ss_pred             chhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccC
Confidence                           0000     0           01567999999999999999999999999999986543

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.4e-49  Score=385.73  Aligned_cols=258  Identities=29%  Similarity=0.421  Sum_probs=214.8

Q ss_pred             ccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCC
Q 014733           35 ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEED  114 (419)
Q Consensus        35 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~  114 (419)
                      .+.+.++|++.++||+|+||+||+|.++.+|+.||+|++..... ..........|+..+.++.+||||+++++++.+.+
T Consensus        52 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~  130 (311)
T 3p1a_A           52 ESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFR-GPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGG  130 (311)
T ss_dssp             SCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCC-SHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             cchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEeccccc-ChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCC
Confidence            34456899999999999999999999999999999999865432 34455566667777777656999999999999999


Q ss_pred             EEEEEEeecCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceee
Q 014733          115 YVHLLMELCAGGELFHRLEKYG-RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATY  193 (419)
Q Consensus       115 ~~~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~  193 (419)
                      .+++||||+ +++|.+++...+ .+++..++.++.||+.||+|||+.+|+||||||+|||+   +.++.+||+|||++..
T Consensus       131 ~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kl~DFG~a~~  206 (311)
T 3p1a_A          131 ILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFL---GPRGRCKLGDFGLLVE  206 (311)
T ss_dssp             EEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CGGGCEEECCCTTCEE
T ss_pred             EEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---CCCCCEEEccceeeee
Confidence            999999999 778988887654 59999999999999999999999999999999999999   5667899999999988


Q ss_pred             eccCCccccccCCCccCCcccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 014733          194 IKAGQNLHGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASA  273 (419)
Q Consensus       194 ~~~~~~~~~~~gt~~y~aPE~l~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l  273 (419)
                      ...........||+.|+|||++.+.++.++|||||||++|+|++|..|+.+..   ....+....  .+...+..+++++
T Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~---~~~~~~~~~--~~~~~~~~~~~~l  281 (311)
T 3p1a_A          207 LGTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGE---GWQQLRQGY--LPPEFTAGLSSEL  281 (311)
T ss_dssp             CC------CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSSHH---HHHHHTTTC--CCHHHHTTSCHHH
T ss_pred             cccCCCCcccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHhccC--CCcccccCCCHHH
Confidence            76655555668999999999999889999999999999999999977765532   233333322  2223345789999


Q ss_pred             HHHHHhhhhcCCCCCCCHHHHHhcccccc
Q 014733          274 RDLIMGMLRVDPSTRLTAAEVLAHSWMEE  302 (419)
Q Consensus       274 ~~li~~~L~~dP~~Rps~~eil~hp~~~~  302 (419)
                      .++|.+||+.||++|||+.++++||||++
T Consensus       282 ~~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          282 RSVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             HHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence            99999999999999999999999999975

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=2e-49  Score=378.65  Aligned_cols=260  Identities=32%  Similarity=0.615  Sum_probs=230.9

Q ss_pred             ccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEE
Q 014733           37 NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYV  116 (419)
Q Consensus        37 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~  116 (419)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++++. ||||+++++++.+.+..
T Consensus        11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   89 (284)
T 2vgo_A           11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR-HPNILRMYNYFHDRKRI   89 (284)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEE
T ss_pred             hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCC-CCCEeeEEEEEEcCCEE
Confidence            34589999999999999999999999999999999997543222223567899999999996 99999999999999999


Q ss_pred             EEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeecc
Q 014733          117 HLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA  196 (419)
Q Consensus       117 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~  196 (419)
                      ++||||+++++|.+++...+.+++..++.++.||++||.|||+.||+||||||+||++   +.++.+||+|||++.....
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~Dfg~~~~~~~  166 (284)
T 2vgo_A           90 YLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLM---GYKGELKIADFGWSVHAPS  166 (284)
T ss_dssp             EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECSS
T ss_pred             EEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---cCCCCEEEecccccccCcc
Confidence            9999999999999999988889999999999999999999999999999999999999   5677899999999976543


Q ss_pred             CCccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 014733          197 GQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARD  275 (419)
Q Consensus       197 ~~~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~  275 (419)
                      . ......||+.|+|||++.+. ++.++||||||+++|+|++|..||......+....+......++    ..++.++++
T Consensus       167 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~  241 (284)
T 2vgo_A          167 L-RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFP----PFLSDGSKD  241 (284)
T ss_dssp             S-CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC----TTSCHHHHH
T ss_pred             c-ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCC----CcCCHHHHH
Confidence            3 23456899999999998875 89999999999999999999999999888888888877665554    368999999


Q ss_pred             HHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          276 LIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       276 li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                      +|.+||+.||.+|||+.++++||||+....
T Consensus       242 li~~~l~~~p~~Rps~~~ll~h~~~~~~~~  271 (284)
T 2vgo_A          242 LISKLLRYHPPQRLPLKGVMEHPWVKANSR  271 (284)
T ss_dssp             HHHHHSCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred             HHHHHhhcCHhhCCCHHHHhhCHHHHhhcc
Confidence            999999999999999999999999986554

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.5e-49  Score=377.44  Aligned_cols=261  Identities=38%  Similarity=0.683  Sum_probs=222.6

Q ss_pred             ccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCC
Q 014733           35 ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEED  114 (419)
Q Consensus        35 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~  114 (419)
                      .....++|++++.||+|+||.||+|.++.+|+.||+|++...........+.+.+|+.+++.++ ||||+++++++.+.+
T Consensus         6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~   84 (276)
T 2h6d_A            6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR-HPHIIKLYQVISTPT   84 (276)
T ss_dssp             -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSS
T ss_pred             CcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCC-CCCEeEEEEEEecCC
Confidence            3445689999999999999999999999999999999997543222234567899999999996 999999999999999


Q ss_pred             EEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeee
Q 014733          115 YVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI  194 (419)
Q Consensus       115 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~  194 (419)
                      ..++||||+++++|.+++...+.+++.+++.++.||+.||.|||++||+|+||||+||++   +.++.+||+|||++...
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~dfg~~~~~  161 (276)
T 2h6d_A           85 DFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLL---DAHMNAKIADFGLSNMM  161 (276)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEE---CTTSCEEECCCCGGGCC
T ss_pred             eEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEE---CCCCCEEEeeccccccc
Confidence            999999999999999999988889999999999999999999999999999999999999   56778999999999876


Q ss_pred             ccCCccccccCCCccCCcccccCC-C-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHH
Q 014733          195 KAGQNLHGTVGSPFYIAPEVLAGG-Y-NQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISAS  272 (419)
Q Consensus       195 ~~~~~~~~~~gt~~y~aPE~l~~~-~-s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  272 (419)
                      ..........||+.|+|||++.+. + +.++||||||+++|+|++|+.||......+..+.+.......+    ..++.+
T Consensus       162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~  237 (276)
T 2h6d_A          162 SDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIP----EYLNRS  237 (276)
T ss_dssp             CC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHH
T ss_pred             CCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCc----hhcCHH
Confidence            655444556899999999998875 3 6899999999999999999999999888888888887765544    367899


Q ss_pred             HHHHHHhhhhcCCCCCCCHHHHHhccccccc
Q 014733          273 ARDLIMGMLRVDPSTRLTAAEVLAHSWMEEC  303 (419)
Q Consensus       273 l~~li~~~L~~dP~~Rps~~eil~hp~~~~~  303 (419)
                      +.++|.+||+.||.+|||+.++++||||++.
T Consensus       238 l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  268 (276)
T 2h6d_A          238 VATLLMHMLQVDPLKRATIKDIREHEWFKQD  268 (276)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             HHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence            9999999999999999999999999999764

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=2.8e-50  Score=390.27  Aligned_cols=267  Identities=27%  Similarity=0.429  Sum_probs=228.2

Q ss_pred             ccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCC
Q 014733           35 ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEED  114 (419)
Q Consensus        35 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~  114 (419)
                      ...+.++|++++.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++++. ||||+++++++....
T Consensus         7 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~   85 (311)
T 3ork_A            7 PSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN-HPAIVAVYDTGEAET   85 (311)
T ss_dssp             CSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCC-CTTBCCEEEEEEEEE
T ss_pred             cceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCC-CCCcceEEEeeeccC
Confidence            4568899999999999999999999999999999999998766556667788999999999995 999999999987653


Q ss_pred             ----EEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccc
Q 014733          115 ----YVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGL  190 (419)
Q Consensus       115 ----~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgl  190 (419)
                          ..|+||||++|++|.+++...+++++.+++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+
T Consensus        86 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~  162 (311)
T 3ork_A           86 PAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI---SATNAVKVMDFGI  162 (311)
T ss_dssp             TTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---ETTSCEEECCCSC
T ss_pred             CCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEE---cCCCCEEEeeccC
Confidence                459999999999999999988899999999999999999999999999999999999999   4567899999999


Q ss_pred             eeeeccCCc----cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCC
Q 014733          191 ATYIKAGQN----LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDP  265 (419)
Q Consensus       191 a~~~~~~~~----~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~  265 (419)
                      +........    ....+||+.|+|||++.+. ++.++||||||+++|+|++|+.||.+....+....+.......+...
T Consensus       163 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  242 (311)
T 3ork_A          163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR  242 (311)
T ss_dssp             C------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHH
T ss_pred             cccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccc
Confidence            987644321    2335799999999998874 89999999999999999999999999888887777766655554444


Q ss_pred             CCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          266 WDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       266 ~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                      +..++.++.++|.+||+.||++||+..+++.|+|++....
T Consensus       243 ~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~  282 (311)
T 3ork_A          243 HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG  282 (311)
T ss_dssp             STTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred             cCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence            5679999999999999999999999999999999986543

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=2.4e-49  Score=390.95  Aligned_cols=268  Identities=25%  Similarity=0.428  Sum_probs=227.5

Q ss_pred             ccccchhhccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHcc----CCCC
Q 014733           27 GTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLS----GHPN  102 (419)
Q Consensus        27 ~~~~~~~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~----~hpn  102 (419)
                      ..-+.......+.++|+++++||+|+||+||+|.+..+++.||+|++..    .....+.+..|+.+++.+.    +|||
T Consensus        22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~h~~   97 (360)
T 3llt_A           22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN----IKKYTRSAKIEADILKKIQNDDINNNN   97 (360)
T ss_dssp             GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS----CHHHHHHHHHHHHHHHHTCCCSTTGGG
T ss_pred             ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc----chhhhhhhHHHHHHHHHhcccCCCCCC
Confidence            3344556677789999999999999999999999999999999999864    2355677888999999996    5999


Q ss_pred             ceeeeEEEEeCCEEEEEEeecCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeec---
Q 014733          103 VVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYG--RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATK---  177 (419)
Q Consensus       103 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~---  177 (419)
                      |+++++++.+.+..++||||+ +++|.+++....  .+++.+++.++.||+.||+|||+.||+||||||+|||++.+   
T Consensus        98 iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~  176 (360)
T 3llt_A           98 IVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFE  176 (360)
T ss_dssp             BCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCC
T ss_pred             eecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEcccccc
Confidence            999999999999999999999 999999998754  49999999999999999999999999999999999999531   


Q ss_pred             -------------------CCCCCeEEeeccceeeeccCCccccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh
Q 014733          178 -------------------SSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS  237 (419)
Q Consensus       178 -------------------~~~~~vKL~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt  237 (419)
                                         ..++.+||+|||++.....  ......||+.|+|||++.+ .++.++|||||||++|+|++
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~  254 (360)
T 3llt_A          177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT  254 (360)
T ss_dssp             EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHH
T ss_pred             ccccchhcccccccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHH
Confidence                               1367899999999986433  2345689999999999877 49999999999999999999


Q ss_pred             CCCCCCCCCHHHHHHHHHhcCCCCCCCC---------------------C---------------------CCCCHHHHH
Q 014733          238 GMPPFWGKTKSKIFDAVRAADLRFPSDP---------------------W---------------------DHISASARD  275 (419)
Q Consensus       238 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~---------------------~---------------------~~~s~~l~~  275 (419)
                      |+.||.+....+....+.......+...                     |                     ...++.+.+
T Consensus       255 g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  334 (360)
T 3llt_A          255 GSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCD  334 (360)
T ss_dssp             SSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHH
T ss_pred             CCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHH
Confidence            9999998888777776655433322100                     0                     012377889


Q ss_pred             HHHhhhhcCCCCCCCHHHHHhccccc
Q 014733          276 LIMGMLRVDPSTRLTAAEVLAHSWME  301 (419)
Q Consensus       276 li~~~L~~dP~~Rps~~eil~hp~~~  301 (419)
                      ||.+||+.||.+|||+.|+|+||||+
T Consensus       335 li~~~L~~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          335 FLYSILQIDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             HHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred             HHHHHhcCChhhCCCHHHHhcCcccC
Confidence            99999999999999999999999995

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=5.9e-50  Score=389.60  Aligned_cols=267  Identities=36%  Similarity=0.700  Sum_probs=225.0

Q ss_pred             cccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccC-----CHHhHHHHHHHHHHHHHccCCCCceeeeEEE
Q 014733           36 SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLV-----TVEDVRSIKLEIEIMTKLSGHPNVVDLKAVY  110 (419)
Q Consensus        36 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~-----~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~  110 (419)
                      ..+.++|++.+.||+|+||.||+|.++.+++.||+|++......     .......+.+|+.+|+++. ||||+++++++
T Consensus         6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~   84 (322)
T 2ycf_A            6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN-HPCIIKIKNFF   84 (322)
T ss_dssp             HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred             hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCC-CCCCceEeeEE
Confidence            34678999999999999999999999999999999999765431     1223456889999999995 99999999999


Q ss_pred             EeCCEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccc
Q 014733          111 EEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGL  190 (419)
Q Consensus       111 ~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgl  190 (419)
                      ...+ +|+||||+++++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+..+||+|||+
T Consensus        85 ~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~  163 (322)
T 2ycf_A           85 DAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH  163 (322)
T ss_dssp             ESSS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred             cCCc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence            8766 899999999999999998888899999999999999999999999999999999999997655556799999999


Q ss_pred             eeeeccCCccccccCCCccCCccccc----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhcCCCCCCCC
Q 014733          191 ATYIKAGQNLHGTVGSPFYIAPEVLA----GGYNQAADVWSAGVILYILLSGMPPFWGKTK-SKIFDAVRAADLRFPSDP  265 (419)
Q Consensus       191 a~~~~~~~~~~~~~gt~~y~aPE~l~----~~~s~~sDvwSlGvil~elltG~~Pf~~~~~-~~~~~~i~~~~~~~~~~~  265 (419)
                      +.............||+.|+|||++.    ..++.++|||||||++|+|++|+.||..... ..+...+......+....
T Consensus       164 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  243 (322)
T 2ycf_A          164 SKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV  243 (322)
T ss_dssp             CEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHH
T ss_pred             ceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchh
Confidence            98765544444567999999999973    2489999999999999999999999976543 345556666655555445


Q ss_pred             CCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccch
Q 014733          266 WDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECE  304 (419)
Q Consensus       266 ~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~  304 (419)
                      +..++.++.+||.+||+.||++|||+.++++||||+...
T Consensus       244 ~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~~  282 (322)
T 2ycf_A          244 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED  282 (322)
T ss_dssp             HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCHH
T ss_pred             hhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCHH
Confidence            567899999999999999999999999999999998654

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.5e-49  Score=387.68  Aligned_cols=261  Identities=25%  Similarity=0.455  Sum_probs=214.7

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      ++|++++.||+|+||+||+|.++.+++.||+|++.....  ......+.+|+.++++++ ||||+++++++.+.+.+++|
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv   78 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLK-HANIVTLHDIIHTEKSLTLV   78 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCC-CTTBCCEEEEEECSSCEEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc--cccchhHHHHHHHHHhcC-CCCCCeeeeEEeeCCEEEEE
Confidence            689999999999999999999999999999999965431  122224557999999996 99999999999999999999


Q ss_pred             EeecCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC
Q 014733          120 MELCAGGELFHRLEKYG-RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ  198 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~  198 (419)
                      |||+. ++|.+++...+ .+++..++.++.||+.||.|||+.||+||||||+|||+   +.++.+||+|||++.......
T Consensus        79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a~~~~~~~  154 (324)
T 3mtl_A           79 FEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLI---NERGELKLADFGLARAKSIPT  154 (324)
T ss_dssp             EECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEE---CTTCCEEECSSSEEECC----
T ss_pred             ecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEE---CCCCCEEEccCcccccccCCc
Confidence            99996 58988887654 49999999999999999999999999999999999999   567899999999998654332


Q ss_pred             -ccccccCCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCC----------
Q 014733          199 -NLHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDP----------  265 (419)
Q Consensus       199 -~~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~----------  265 (419)
                       ......||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+.+..+....+.......+...          
T Consensus       155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  234 (324)
T 3mtl_A          155 KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF  234 (324)
T ss_dssp             --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHH
T ss_pred             cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhh
Confidence             2344578999999999876  389999999999999999999999999988887777655322222221          


Q ss_pred             ----------------CCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchhhh
Q 014733          266 ----------------WDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVA  307 (419)
Q Consensus       266 ----------------~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~~~  307 (419)
                                      ...+++++.+||.+||+.||++|||+.|+|+||||.......
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  292 (324)
T 3mtl_A          235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERI  292 (324)
T ss_dssp             HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTT
T ss_pred             cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccccc
Confidence                            125789999999999999999999999999999999876543

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=3e-49  Score=410.59  Aligned_cols=261  Identities=28%  Similarity=0.509  Sum_probs=229.7

Q ss_pred             cccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEE
Q 014733           38 LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVH  117 (419)
Q Consensus        38 ~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~  117 (419)
                      ..++|++.+.||+|+||+||+|+++.+|+.||+|++.+...........+.+|+.+|+++. ||||+++++++.+.+.+|
T Consensus       183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~l~  261 (543)
T 3c4z_A          183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH-SRFIVSLAYAFETKTDLC  261 (543)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEE
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcC-CCCEeeEEEEEeeCCEEE
Confidence            4589999999999999999999999999999999997654433344677889999999995 999999999999999999


Q ss_pred             EEEeecCCCChHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceee
Q 014733          118 LLMELCAGGELFHRLEKY----GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATY  193 (419)
Q Consensus       118 lV~E~~~ggsL~~~l~~~----~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~  193 (419)
                      +||||++||+|..++...    ..+++..++.++.||+.||+|||++||+||||||+|||+   +.++++||+|||++..
T Consensus       262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl---~~~g~vkL~DFGla~~  338 (543)
T 3c4z_A          262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLL---DDDGNVRISDLGLAVE  338 (543)
T ss_dssp             EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTTCEE
T ss_pred             EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEE---eCCCCEEEeecceeee
Confidence            999999999999999764    359999999999999999999999999999999999999   5678999999999998


Q ss_pred             eccCCcc-ccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHhcCCCCCCCCCC
Q 014733          194 IKAGQNL-HGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGK----TKSKIFDAVRAADLRFPSDPWD  267 (419)
Q Consensus       194 ~~~~~~~-~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~----~~~~~~~~i~~~~~~~~~~~~~  267 (419)
                      ....... ...+||+.|+|||++.+. |+.++|||||||++|||++|++||.+.    ...++.+.+......++    .
T Consensus       339 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p----~  414 (543)
T 3c4z_A          339 LKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP----D  414 (543)
T ss_dssp             CCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCC----T
T ss_pred             ccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCC----c
Confidence            7655433 345899999999999874 999999999999999999999999765    34667777777665554    3


Q ss_pred             CCCHHHHHHHHhhhhcCCCCCCC-----HHHHHhccccccchhh
Q 014733          268 HISASARDLIMGMLRVDPSTRLT-----AAEVLAHSWMEECEQV  306 (419)
Q Consensus       268 ~~s~~l~~li~~~L~~dP~~Rps-----~~eil~hp~~~~~~~~  306 (419)
                      .++.++++||.+||++||.+||+     +.++++||||+.+.+.
T Consensus       415 ~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~  458 (543)
T 3c4z_A          415 KFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWR  458 (543)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHH
T ss_pred             ccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHH
Confidence            78999999999999999999996     5899999999987653

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.2e-48  Score=396.47  Aligned_cols=265  Identities=26%  Similarity=0.485  Sum_probs=215.0

Q ss_pred             cccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeC--
Q 014733           36 SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEE--  113 (419)
Q Consensus        36 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~--  113 (419)
                      -.+.++|++++.||+|+||+||+|.++.+|+.||+|++.... ......+.+.+|+.+|++++ ||||+++++++...  
T Consensus        22 ~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~   99 (432)
T 3n9x_A           22 VHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-EDLIDCKRILREITILNRLK-SDYIIRLYDLIIPDDL   99 (432)
T ss_dssp             CCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSCT
T ss_pred             ceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcC-CCCcceEEEEEecCCC
Confidence            346789999999999999999999999999999999997542 34566788999999999996 99999999999776  


Q ss_pred             ---CEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccc
Q 014733          114 ---DYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGL  190 (419)
Q Consensus       114 ---~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgl  190 (419)
                         +.+|+||||+. ++|.+++.....+++.+++.++.||+.||+|||+.||+||||||+|||+   +.++.+||+|||+
T Consensus       100 ~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl---~~~~~~kL~DFGl  175 (432)
T 3n9x_A          100 LKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLL---NQDCSVKVCDFGL  175 (432)
T ss_dssp             TTCCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTT
T ss_pred             CcCCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEE---CCCCCEEEccCCC
Confidence               67999999995 6999999887889999999999999999999999999999999999999   5678999999999


Q ss_pred             eeeeccCC-----------------------ccccccCCCccCCccccc-C-CCCCchhHHHHHHHHHHHHh--------
Q 014733          191 ATYIKAGQ-----------------------NLHGTVGSPFYIAPEVLA-G-GYNQAADVWSAGVILYILLS--------  237 (419)
Q Consensus       191 a~~~~~~~-----------------------~~~~~~gt~~y~aPE~l~-~-~~s~~sDvwSlGvil~ellt--------  237 (419)
                      ++......                       .....+||+.|+|||++. + .|+.++|||||||++|||++        
T Consensus       176 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~  255 (432)
T 3n9x_A          176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIND  255 (432)
T ss_dssp             CEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSS
T ss_pred             cccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccc
Confidence            98765432                       125568999999999864 3 49999999999999999998        


Q ss_pred             ---CCCCCCCCCH-----------------HHHH------------------------HHHHhcCCCCCCC---CCCCCC
Q 014733          238 ---GMPPFWGKTK-----------------SKIF------------------------DAVRAADLRFPSD---PWDHIS  270 (419)
Q Consensus       238 ---G~~Pf~~~~~-----------------~~~~------------------------~~i~~~~~~~~~~---~~~~~s  270 (419)
                         |+++|.+...                 .+..                        ..+.......+..   .+..++
T Consensus       256 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  335 (432)
T 3n9x_A          256 PTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSIS  335 (432)
T ss_dssp             GGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSC
T ss_pred             cccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCC
Confidence               4445544320                 1111                        1111111111110   124689


Q ss_pred             HHHHHHHHhhhhcCCCCCCCHHHHHhccccccchhh
Q 014733          271 ASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQV  306 (419)
Q Consensus       271 ~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~~  306 (419)
                      +++.+||.+||++||++|||+.|+|+||||+.....
T Consensus       336 ~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~  371 (432)
T 3n9x_A          336 DDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKK  371 (432)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCT
T ss_pred             HHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCc
Confidence            999999999999999999999999999999987554

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=6.9e-49  Score=386.59  Aligned_cols=259  Identities=26%  Similarity=0.458  Sum_probs=220.6

Q ss_pred             cccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEe-----
Q 014733           38 LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEE-----  112 (419)
Q Consensus        38 ~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~-----  112 (419)
                      ..++|++++.||+|+||+||+|.++.+|+.||+|++..... .......+.+|+.++++++ ||||+++++++.+     
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~   92 (351)
T 3mi9_A           15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLK-HENVVNLIEICRTKASPY   92 (351)
T ss_dssp             BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSC-SSSSCHHHHHHHHHHHHCC-CTTBCCEEEEEEEC----
T ss_pred             cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccc-cccchHHHHHHHHHHHhcc-CCCcccHhheeecccccc
Confidence            45899999999999999999999999999999999876543 2233456778999999996 9999999999987     


Q ss_pred             ---CCEEEEEEeecCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeec
Q 014733          113 ---EDYVHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADF  188 (419)
Q Consensus       113 ---~~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DF  188 (419)
                         .+.+++||||+.+ +|...+... ..+++.+++.++.||+.||+|||+.||+||||||+|||+   +.++.+||+||
T Consensus        93 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~---~~~~~~kl~Df  168 (351)
T 3mi9_A           93 NRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADF  168 (351)
T ss_dssp             ----CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCC
T ss_pred             ccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEE---cCCCCEEEccc
Confidence               4578999999975 777766543 569999999999999999999999999999999999999   56789999999


Q ss_pred             cceeeeccC-----CccccccCCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC
Q 014733          189 GLATYIKAG-----QNLHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRF  261 (419)
Q Consensus       189 gla~~~~~~-----~~~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~  261 (419)
                      |++..+...     .......||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+....+....+.......
T Consensus       169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  248 (351)
T 3mi9_A          169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI  248 (351)
T ss_dssp             TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            999876422     22244578999999999876  38999999999999999999999999999888888777655555


Q ss_pred             CCCCCCCC----------------------------CHHHHHHHHhhhhcCCCCCCCHHHHHhcccccc
Q 014733          262 PSDPWDHI----------------------------SASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE  302 (419)
Q Consensus       262 ~~~~~~~~----------------------------s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~  302 (419)
                      +...|..+                            ++++.+||.+||+.||++|||+.|+|+||||+.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  317 (351)
T 3mi9_A          249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS  317 (351)
T ss_dssp             CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGS
T ss_pred             ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCC
Confidence            44443332                            678999999999999999999999999999974

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-48  Score=388.09  Aligned_cols=262  Identities=26%  Similarity=0.434  Sum_probs=218.3

Q ss_pred             cccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeC--
Q 014733           36 SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEE--  113 (419)
Q Consensus        36 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~--  113 (419)
                      ..+.++|++++.||+|+||.||+|.++.+|+.||+|++.... ......+.+.+|+.+|+.++ ||||+++++++...  
T Consensus        21 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~   98 (367)
T 1cm8_A           21 WEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMR-HENVIGLLDVFTPDET   98 (367)
T ss_dssp             ECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCC-BTTBCCCSEEECSCSS
T ss_pred             eeecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCC-CcCCCCceeeEecCCc
Confidence            356789999999999999999999999999999999986543 34556778999999999996 99999999999765  


Q ss_pred             ----CEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeecc
Q 014733          114 ----DYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFG  189 (419)
Q Consensus       114 ----~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFg  189 (419)
                          ..+|+||||+ +++|.+++.. +.+++.+++.++.||+.||+|||+.||+||||||+|||+   +.++.+||+|||
T Consensus        99 ~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg  173 (367)
T 1cm8_A           99 LDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDFG  173 (367)
T ss_dssp             TTTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCT
T ss_pred             cccCceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEE---cCCCCEEEEeee
Confidence                3469999999 8899999876 679999999999999999999999999999999999999   567899999999


Q ss_pred             ceeeeccCCccccccCCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC------
Q 014733          190 LATYIKAGQNLHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRF------  261 (419)
Q Consensus       190 la~~~~~~~~~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~------  261 (419)
                      ++.....  .....+||+.|+|||++.+  .++.++||||+||++|+|++|++||.+.+..+....+.......      
T Consensus       174 ~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~  251 (367)
T 1cm8_A          174 LARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ  251 (367)
T ss_dssp             TCEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             ccccccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            9987543  2445689999999999876  48999999999999999999999999888777666654321111      


Q ss_pred             -----------------CC----CCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchhh
Q 014733          262 -----------------PS----DPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQV  306 (419)
Q Consensus       262 -----------------~~----~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~~  306 (419)
                                       +.    ..+..+++++.+||.+||+.||.+|||+.++|+||||+.....
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~  317 (367)
T 1cm8_A          252 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT  317 (367)
T ss_dssp             TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred             HhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCC
Confidence                             11    1234679999999999999999999999999999999876543

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=3.1e-48  Score=378.13  Aligned_cols=254  Identities=28%  Similarity=0.502  Sum_probs=223.9

Q ss_pred             CeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEE
Q 014733           41 RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLM  120 (419)
Q Consensus        41 ~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~  120 (419)
                      .|...+.||+|+||.||+|.++.+|+.||+|++.....   ...+.+.+|+.++++++ ||||+++++++...+..++||
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~  121 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQ-HFNVVEMYKSYLVGEELWVLM  121 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---CSHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch---hHHHHHHHHHHHHHhCC-CCCcceEEEEEEECCEEEEEE
Confidence            58888999999999999999999999999999976532   34567889999999996 999999999999999999999


Q ss_pred             eecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC-c
Q 014733          121 ELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ-N  199 (419)
Q Consensus       121 E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~-~  199 (419)
                      ||++|++|.+++.. ..+++..+..++.|++.||+|||+.||+||||||+|||+   +.++.+||+|||++....... .
T Consensus       122 e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~~  197 (321)
T 2c30_A          122 EFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILL---TLDGRVKLSDFGFCAQISKDVPK  197 (321)
T ss_dssp             CCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSSSCC
T ss_pred             ecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCcEEEeeeeeeeecccCccc
Confidence            99999999998865 579999999999999999999999999999999999999   567799999999998765433 2


Q ss_pred             cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHH
Q 014733          200 LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM  278 (419)
Q Consensus       200 ~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~  278 (419)
                      .....||+.|+|||++.+. ++.++||||||+++|+|++|+.||.+....+....+........ .....+++++.++|.
T Consensus       198 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~  276 (321)
T 2c30_A          198 RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKL-KNSHKVSPVLRDFLE  276 (321)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCC-TTGGGSCHHHHHHHH
T ss_pred             cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCc-CccccCCHHHHHHHH
Confidence            3456899999999998775 89999999999999999999999999888888777766543221 223468999999999


Q ss_pred             hhhhcCCCCCCCHHHHHhccccccc
Q 014733          279 GMLRVDPSTRLTAAEVLAHSWMEEC  303 (419)
Q Consensus       279 ~~L~~dP~~Rps~~eil~hp~~~~~  303 (419)
                      +||+.||++|||+.++++||||.+.
T Consensus       277 ~~l~~dp~~Rps~~ell~hp~~~~~  301 (321)
T 2c30_A          277 RMLVRDPQERATAQELLDHPFLLQT  301 (321)
T ss_dssp             HHSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred             HHccCChhhCcCHHHHhcChhhccC
Confidence            9999999999999999999999764

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=3.4e-48  Score=371.18  Aligned_cols=261  Identities=24%  Similarity=0.430  Sum_probs=223.2

Q ss_pred             ccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEe--
Q 014733           35 ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEE--  112 (419)
Q Consensus        35 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~--  112 (419)
                      ...-.+.|++.+.||+|+||.||+|.+..++..||+|++..... .....+.+.+|+.++++++ ||||+++++++..  
T Consensus        21 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~   98 (290)
T 1t4h_A           21 MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTV   98 (290)
T ss_dssp             ECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEES
T ss_pred             cccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh-CHHHHHHHHHHHHHHHhCC-CCCeeeeeeeecccc
Confidence            34456679999999999999999999999999999999976543 4566788999999999996 9999999999876  


Q ss_pred             --CCEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--CeeccCCCCcEEEeecCCCCCeEEeec
Q 014733          113 --EDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG--VVHRDLKPENILLATKSSSSPIKLADF  188 (419)
Q Consensus       113 --~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~--IvHrDLkp~NILl~~~~~~~~vKL~DF  188 (419)
                        ...+++||||+++++|.+++...+.+++..++.++.||+.||.|||+.+  |+||||||+|||++  ..++.+||+||
T Consensus        99 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~--~~~~~~kl~Df  176 (290)
T 1t4h_A           99 KGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDL  176 (290)
T ss_dssp             SSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES--STTSCEEECCT
T ss_pred             CCCceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEE--CCCCCEEEeeC
Confidence              4678999999999999999998888999999999999999999999999  99999999999994  25678999999


Q ss_pred             cceeeeccCCccccccCCCccCCcccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhcCCCCCCCCCC
Q 014733          189 GLATYIKAGQNLHGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGKTK-SKIFDAVRAADLRFPSDPWD  267 (419)
Q Consensus       189 gla~~~~~~~~~~~~~gt~~y~aPE~l~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~-~~~~~~i~~~~~~~~~~~~~  267 (419)
                      |++...... ......||+.|+|||++.+.++.++||||||+++|+|++|+.||.+... ......+.....  +.....
T Consensus       177 g~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~  253 (290)
T 1t4h_A          177 GLATLKRAS-FAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK--PASFDK  253 (290)
T ss_dssp             TGGGGCCTT-SBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC--CGGGGG
T ss_pred             CCccccccc-ccccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCC--ccccCC
Confidence            999754333 3345679999999999988899999999999999999999999987444 444444433322  222234


Q ss_pred             CCCHHHHHHHHhhhhcCCCCCCCHHHHHhcccccc
Q 014733          268 HISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE  302 (419)
Q Consensus       268 ~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~  302 (419)
                      ..++++.++|.+||+.||.+|||+.++++||||++
T Consensus       254 ~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~  288 (290)
T 1t4h_A          254 VAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             CCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             CCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence            67899999999999999999999999999999975

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=3e-49  Score=375.96  Aligned_cols=261  Identities=34%  Similarity=0.584  Sum_probs=200.9

Q ss_pred             cccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCE
Q 014733           36 SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDY  115 (419)
Q Consensus        36 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~  115 (419)
                      ....++|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.++++++ ||||+++++++.+.+.
T Consensus         7 g~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~   85 (278)
T 3cok_A            7 GEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK-HPSILELYNYFEDSNY   85 (278)
T ss_dssp             CSSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBC-CTTBCCEEEEEECSSE
T ss_pred             ccccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCC-CCCeEeEEEEEccCCe
Confidence            344578999999999999999999999999999999997543222233577899999999996 9999999999999999


Q ss_pred             EEEEEeecCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeee
Q 014733          116 VHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI  194 (419)
Q Consensus       116 ~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~  194 (419)
                      .++||||+++++|.+++... ..+++.+++.++.|+++||+|||+.||+||||||+||++   +.++.+||+|||++...
T Consensus        86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili---~~~~~~kl~dfg~~~~~  162 (278)
T 3cok_A           86 VYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLL---TRNMNIKIADFGLATQL  162 (278)
T ss_dssp             EEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEE---CTTCCEEECCCTTCEEC
T ss_pred             EEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEEEeecceeec
Confidence            99999999999999999865 569999999999999999999999999999999999999   56788999999999876


Q ss_pred             ccCC-ccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHH
Q 014733          195 KAGQ-NLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISAS  272 (419)
Q Consensus       195 ~~~~-~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  272 (419)
                      .... ......||+.|+|||++.+. ++.++||||||+++|+|++|+.||......+....+.......    ...++.+
T Consensus       163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~  238 (278)
T 3cok_A          163 KMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEM----PSFLSIE  238 (278)
T ss_dssp             C----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCC----CTTSCHH
T ss_pred             cCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCC----ccccCHH
Confidence            5332 23345799999999998764 8999999999999999999999998776655555443333322    2368999


Q ss_pred             HHHHHHhhhhcCCCCCCCHHHHHhccccccch
Q 014733          273 ARDLIMGMLRVDPSTRLTAAEVLAHSWMEECE  304 (419)
Q Consensus       273 l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~  304 (419)
                      +.++|.+||+.||++|||+.++++||||....
T Consensus       239 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  270 (278)
T 3cok_A          239 AKDLIHQLLRRNPADRLSLSSVLDHPFMSRNS  270 (278)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred             HHHHHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence            99999999999999999999999999998644

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=2e-49  Score=389.06  Aligned_cols=254  Identities=30%  Similarity=0.551  Sum_probs=221.1

Q ss_pred             cccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCH-----HhHHHHHHHHHHHHHccCCCCceeeeEEE
Q 014733           36 SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTV-----EDVRSIKLEIEIMTKLSGHPNVVDLKAVY  110 (419)
Q Consensus        36 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~-----~~~~~~~~Ei~il~~l~~hpnIv~l~~~~  110 (419)
                      ..+.++|++.+.||+|+||+||+|.++.+++.||+|++.+......     .....+.+|+.+|++++ ||||+++++++
T Consensus        20 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~   98 (335)
T 3dls_A           20 GEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVE-HANIIKVLDIF   98 (335)
T ss_dssp             THHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCC-CTTBCCEEEEE
T ss_pred             cccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCC-CCCEeeEEEEE
Confidence            3467899999999999999999999999999999999987653222     13456778999999995 99999999999


Q ss_pred             EeCCEEEEEEeecCCC-ChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeecc
Q 014733          111 EEEDYVHLLMELCAGG-ELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFG  189 (419)
Q Consensus       111 ~~~~~~~lV~E~~~gg-sL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFg  189 (419)
                      .+.+.+++||||+.+| +|.+++...+.+++..++.++.||+.||+|||+.||+||||||+|||+   +.++.+||+|||
T Consensus        99 ~~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg  175 (335)
T 3dls_A           99 ENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVI---AEDFTIKLIDFG  175 (335)
T ss_dssp             ECSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCT
T ss_pred             eeCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEE---cCCCcEEEeecc
Confidence            9999999999998766 999999988889999999999999999999999999999999999999   567899999999


Q ss_pred             ceeeeccCCccccccCCCccCCcccccCC-C-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCC
Q 014733          190 LATYIKAGQNLHGTVGSPFYIAPEVLAGG-Y-NQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWD  267 (419)
Q Consensus       190 la~~~~~~~~~~~~~gt~~y~aPE~l~~~-~-s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  267 (419)
                      ++............+||+.|+|||++.+. + +.++|||||||++|+|++|+.||.....      .    .........
T Consensus       176 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~----~~~~~~~~~  245 (335)
T 3dls_A          176 SAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------T----VEAAIHPPY  245 (335)
T ss_dssp             TCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------G----TTTCCCCSS
T ss_pred             cceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------H----HhhccCCCc
Confidence            99987766666667899999999998774 4 7899999999999999999999975321      1    111112233


Q ss_pred             CCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccc
Q 014733          268 HISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEEC  303 (419)
Q Consensus       268 ~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~  303 (419)
                      .+++++.+||.+||+.||++|||+.++++||||++.
T Consensus       246 ~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~  281 (335)
T 3dls_A          246 LVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP  281 (335)
T ss_dssp             CCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence            689999999999999999999999999999999764

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.5e-49  Score=388.85  Aligned_cols=261  Identities=31%  Similarity=0.529  Sum_probs=221.3

Q ss_pred             cccCeeeeeeecccCceEEEEEEec---CCCcEEEEEEeccCccC-CHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeC
Q 014733           38 LSDRYVLGKQLGWGQFGVIRECSDK---FTGEVLACKSIAKDRLV-TVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEE  113 (419)
Q Consensus        38 ~~~~y~i~~~LG~G~~g~V~~a~~~---~~g~~vaiK~i~~~~~~-~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~  113 (419)
                      ..++|++++.||+|+||+||+|++.   .+|+.||+|++.+.... .......+.+|+.+|+++.+||||+++++++.+.
T Consensus        52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  131 (355)
T 1vzo_A           52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE  131 (355)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred             cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC
Confidence            3479999999999999999999984   58999999998754321 1123455678999999997799999999999999


Q ss_pred             CEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceee
Q 014733          114 DYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATY  193 (419)
Q Consensus       114 ~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~  193 (419)
                      +.+++||||+++++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..
T Consensus       132 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~DfG~a~~  208 (355)
T 1vzo_A          132 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKE  208 (355)
T ss_dssp             TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEESCSSEEEE
T ss_pred             ceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCcEEEeeCCCCee
Confidence            9999999999999999999988899999999999999999999999999999999999999   5678999999999987


Q ss_pred             eccCC--ccccccCCCccCCcccccC---CCCCchhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHhcCCCCCCC
Q 014733          194 IKAGQ--NLHGTVGSPFYIAPEVLAG---GYNQAADVWSAGVILYILLSGMPPFWGK----TKSKIFDAVRAADLRFPSD  264 (419)
Q Consensus       194 ~~~~~--~~~~~~gt~~y~aPE~l~~---~~s~~sDvwSlGvil~elltG~~Pf~~~----~~~~~~~~i~~~~~~~~~~  264 (419)
                      .....  .....+||+.|+|||++.+   .++.++|||||||++|+|++|+.||...    ....+...+......++  
T Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--  286 (355)
T 1vzo_A          209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP--  286 (355)
T ss_dssp             CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCC--
T ss_pred             cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCC--
Confidence            64332  2234589999999999875   2789999999999999999999999643    33445555555443333  


Q ss_pred             CCCCCCHHHHHHHHhhhhcCCCCCC-----CHHHHHhccccccchh
Q 014733          265 PWDHISASARDLIMGMLRVDPSTRL-----TAAEVLAHSWMEECEQ  305 (419)
Q Consensus       265 ~~~~~s~~l~~li~~~L~~dP~~Rp-----s~~eil~hp~~~~~~~  305 (419)
                        ..++..+.+||.+||+.||.+||     ++.++++||||+...+
T Consensus       287 --~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~  330 (355)
T 1vzo_A          287 --QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW  330 (355)
T ss_dssp             --TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred             --cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCCh
Confidence              46899999999999999999999     9999999999998754

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=3.5e-48  Score=368.80  Aligned_cols=258  Identities=24%  Similarity=0.353  Sum_probs=216.9

Q ss_pred             cccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCE
Q 014733           36 SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDY  115 (419)
Q Consensus        36 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~  115 (419)
                      ..+.++|++.+.||+|+||+||+|.++.+++.||+|++..... .......+.+|+.++.++.+||||+++++++.+.+.
T Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~   85 (289)
T 1x8b_A            7 SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLA-GSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDH   85 (289)
T ss_dssp             CHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCT-TSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTE
T ss_pred             ccccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccc-ccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCe
Confidence            3467899999999999999999999999999999999976543 334567788999999999559999999999999999


Q ss_pred             EEEEEeecCCCChHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecC-------------
Q 014733          116 VHLLMELCAGGELFHRLEKY----GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKS-------------  178 (419)
Q Consensus       116 ~~lV~E~~~ggsL~~~l~~~----~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~-------------  178 (419)
                      +++||||+++++|.+++...    +.+++.+++.++.||+.||+|||++||+||||||+|||++.++             
T Consensus        86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           86 MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----------------
T ss_pred             EEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence            99999999999999999765    6699999999999999999999999999999999999996543             


Q ss_pred             ---CCCCeEEeeccceeeeccCCccccccCCCccCCcccccCC--CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 014733          179 ---SSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDA  253 (419)
Q Consensus       179 ---~~~~vKL~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~~--~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~  253 (419)
                         ....+||+|||++.......   ...||+.|+|||++.+.  ++.++|||||||++|+|++|.+++....   ....
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~~~  239 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---QWHE  239 (289)
T ss_dssp             ----CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---HHHH
T ss_pred             ccCCceEEEEcccccccccCCcc---ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---HHHH
Confidence               45589999999998764432   34689999999998764  5679999999999999999998875442   3444


Q ss_pred             HHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccc
Q 014733          254 VRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEEC  303 (419)
Q Consensus       254 i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~  303 (419)
                      +......   .....+++++.++|.+||+.||++|||+.++++||||+..
T Consensus       240 ~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  286 (289)
T 1x8b_A          240 IRQGRLP---RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA  286 (289)
T ss_dssp             HHTTCCC---CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred             HHcCCCC---CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence            4444332   2224789999999999999999999999999999999864

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=5e-49  Score=382.70  Aligned_cols=256  Identities=26%  Similarity=0.467  Sum_probs=211.3

Q ss_pred             ccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCC--
Q 014733           37 NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEED--  114 (419)
Q Consensus        37 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~--  114 (419)
                      .+.++|++++.||+|+||.||+|+++.+|+.||+|++....  .....+.+.+|+.+|++++ ||||+++++++.+..  
T Consensus         3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~   79 (332)
T 3qd2_B            3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLE-HPGIVRYFNAWLETPPE   79 (332)
T ss_dssp             HHHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCC-CTTBCCEEEEEEECCSC
T ss_pred             hhhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCC-CCCEeeEEEEEEEeccc
Confidence            45689999999999999999999999999999999997653  3345678999999999996 999999999986543  


Q ss_pred             -------------------------------------------------------EEEEEEeecCCCChHHHHHHcCC--
Q 014733          115 -------------------------------------------------------YVHLLMELCAGGELFHRLEKYGR--  137 (419)
Q Consensus       115 -------------------------------------------------------~~~lV~E~~~ggsL~~~l~~~~~--  137 (419)
                                                                             .+++||||++|++|.+++.....  
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~  159 (332)
T 3qd2_B           80 KWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLE  159 (332)
T ss_dssp             HHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGG
T ss_pred             hhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCcc
Confidence                                                                   48999999999999999987544  


Q ss_pred             -CCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC-------------ccccc
Q 014733          138 -FSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ-------------NLHGT  203 (419)
Q Consensus       138 -l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~-------------~~~~~  203 (419)
                       .++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++.......             .....
T Consensus       160 ~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~  236 (332)
T 3qd2_B          160 DREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQ  236 (332)
T ss_dssp             GSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECSCC--------------CCCSC
T ss_pred             chhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEE---eCCCCEEEeecCcccccccchhhcccccccccccccccc
Confidence             5667789999999999999999999999999999999   567799999999998765432             22345


Q ss_pred             cCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhh
Q 014733          204 VGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLR  282 (419)
Q Consensus       204 ~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~  282 (419)
                      +||+.|+|||++.+. ++.++|||||||++|+|++|..|+..  .......+....  .+ ..+...++++.+||.+||+
T Consensus       237 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~--~~-~~~~~~~~~~~~li~~~l~  311 (332)
T 3qd2_B          237 VGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLK--FP-LLFTQKYPQEHMMVQDMLS  311 (332)
T ss_dssp             C-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTC--CC-HHHHHHCHHHHHHHHHHHC
T ss_pred             CCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccC--CC-cccccCChhHHHHHHHHcc
Confidence            799999999998874 89999999999999999999887522  222333333322  11 1223567889999999999


Q ss_pred             cCCCCCCCHHHHHhccccccc
Q 014733          283 VDPSTRLTAAEVLAHSWMEEC  303 (419)
Q Consensus       283 ~dP~~Rps~~eil~hp~~~~~  303 (419)
                      .||++|||+.|+++||||+++
T Consensus       312 ~~p~~Rps~~~~l~~~~f~~~  332 (332)
T 3qd2_B          312 PSPTERPEATDIIENAIFENL  332 (332)
T ss_dssp             SSGGGSCCHHHHHHSTTCCCC
T ss_pred             CCCCcCCCHHHHhhchhhhcC
Confidence            999999999999999999863

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=2.4e-48  Score=374.03  Aligned_cols=263  Identities=26%  Similarity=0.402  Sum_probs=222.7

Q ss_pred             ccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCC
Q 014733           35 ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEED  114 (419)
Q Consensus        35 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~  114 (419)
                      .+.+.++|++++.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.++++++ ||||+++++++.+.+
T Consensus         6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~   84 (294)
T 4eqm_A            6 GKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLS-HQNIVSMIDVDEEDD   84 (294)
T ss_dssp             SSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC-BTTBCCEEEEEECSS
T ss_pred             hhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCC-CCCCceEEEeeeeCC
Confidence            3457889999999999999999999999999999999997766666777889999999999996 999999999999999


Q ss_pred             EEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeee
Q 014733          115 YVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI  194 (419)
Q Consensus       115 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~  194 (419)
                      .+|+||||++|++|.+++...+++++.+++.++.||+.||+|||+.||+||||||+|||+   +.++.+||+|||++...
T Consensus        85 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~  161 (294)
T 4eqm_A           85 CYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILI---DSNKTLKIFDFGIAKAL  161 (294)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCSSSTTC
T ss_pred             eEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEEeCCCcccc
Confidence            999999999999999999988899999999999999999999999999999999999999   56789999999999865


Q ss_pred             ccCC--ccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-CCCCCCCCC
Q 014733          195 KAGQ--NLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRF-PSDPWDHIS  270 (419)
Q Consensus       195 ~~~~--~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~s  270 (419)
                      ....  .....+||+.|+|||++.+. ++.++||||||+++|+|++|+.||.+....+............ +......++
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (294)
T 4eqm_A          162 SETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIP  241 (294)
T ss_dssp             -------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSC
T ss_pred             ccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCC
Confidence            4332  22345799999999998875 8999999999999999999999999888766655544443222 122345789


Q ss_pred             HHHHHHHHhhhhcCCCCCCCHHHHHhccccc
Q 014733          271 ASARDLIMGMLRVDPSTRLTAAEVLAHSWME  301 (419)
Q Consensus       271 ~~l~~li~~~L~~dP~~Rps~~eil~hp~~~  301 (419)
                      +.+.++|.+||..||.+||+..+.+.+.|..
T Consensus       242 ~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~  272 (294)
T 4eqm_A          242 QSLSNVILRATEKDKANRYKTIQEMKDDLSS  272 (294)
T ss_dssp             HHHHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred             HHHHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence            9999999999999999999666666666554

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=3.9e-48  Score=387.74  Aligned_cols=259  Identities=25%  Similarity=0.422  Sum_probs=218.1

Q ss_pred             ccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccC-CCCceeeeEEEEeCCE
Q 014733           37 NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG-HPNVVDLKAVYEEEDY  115 (419)
Q Consensus        37 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~-hpnIv~l~~~~~~~~~  115 (419)
                      ...++|++++.||+|+||+||+|.+.. ++.||+|++..... .....+.+.+|+.+|+++.. ||||+++++++.+.+.
T Consensus        53 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~  130 (390)
T 2zmd_A           53 VKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY  130 (390)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             ccCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCE
Confidence            345679999999999999999999875 89999999976643 45677889999999999973 6999999999999999


Q ss_pred             EEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeec
Q 014733          116 VHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIK  195 (419)
Q Consensus       116 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~  195 (419)
                      +|+||| +.+++|.+++...+.+++.+++.++.||+.||.|||+.||+||||||+|||++    ++.+||+|||++....
T Consensus       131 ~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~----~~~~kl~DFG~a~~~~  205 (390)
T 2zmd_A          131 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQ  205 (390)
T ss_dssp             EEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES----SSCEEECCCSSSCCC-
T ss_pred             EEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE----CCeEEEEecCcccccc
Confidence            999999 56889999999888899999999999999999999999999999999999993    4689999999998765


Q ss_pred             cCCc---cccccCCCccCCcccccC------------CCCCchhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhcCC
Q 014733          196 AGQN---LHGTVGSPFYIAPEVLAG------------GYNQAADVWSAGVILYILLSGMPPFWGKT-KSKIFDAVRAADL  259 (419)
Q Consensus       196 ~~~~---~~~~~gt~~y~aPE~l~~------------~~s~~sDvwSlGvil~elltG~~Pf~~~~-~~~~~~~i~~~~~  259 (419)
                      ....   ....+||+.|+|||++.+            .++.++|||||||++|+|++|+.||.+.. .......+.....
T Consensus       206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~  285 (390)
T 2zmd_A          206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH  285 (390)
T ss_dssp             --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTS
T ss_pred             CCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccc
Confidence            4332   235689999999999864            48899999999999999999999997653 3344455554443


Q ss_pred             CCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccch
Q 014733          260 RFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECE  304 (419)
Q Consensus       260 ~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~  304 (419)
                      .....  ...+.++.+||.+||+.||++|||+.|+|+||||+...
T Consensus       286 ~~~~~--~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~  328 (390)
T 2zmd_A          286 EIEFP--DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  328 (390)
T ss_dssp             CCCCC--CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred             cCCCC--ccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence            33322  34588999999999999999999999999999998543

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=3.2e-48  Score=382.66  Aligned_cols=257  Identities=28%  Similarity=0.452  Sum_probs=223.7

Q ss_pred             ccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEE
Q 014733           37 NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYV  116 (419)
Q Consensus        37 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~  116 (419)
                      ...++|++++.||+|+||+||+|.+..+|+.||+|++...........+.+.+|+.++++++ ||||+++++++.+.+..
T Consensus        51 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~  129 (348)
T 1u5q_A           51 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREHTA  129 (348)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEE
T ss_pred             chhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECCeE
Confidence            44577999999999999999999999999999999998765445566778999999999996 99999999999999999


Q ss_pred             EEEEeecCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeec
Q 014733          117 HLLMELCAGGELFHRLEK-YGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIK  195 (419)
Q Consensus       117 ~lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~  195 (419)
                      ++||||+. |+|.+++.. ..++++.+++.++.|++.||+|||+.||+||||||+|||+   +.++.+||+|||++....
T Consensus       130 ~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~a~~~~  205 (348)
T 1u5q_A          130 WLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMA  205 (348)
T ss_dssp             EEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEE---ETTTEEEECCCTTCBSSS
T ss_pred             EEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEEEeeccCceecC
Confidence            99999996 678877754 4679999999999999999999999999999999999999   456789999999998654


Q ss_pred             cCCccccccCCCccCCccccc----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCH
Q 014733          196 AGQNLHGTVGSPFYIAPEVLA----GGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISA  271 (419)
Q Consensus       196 ~~~~~~~~~gt~~y~aPE~l~----~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  271 (419)
                      .   ....+||+.|+|||++.    +.++.++|||||||++|+|++|++||.+.+..+....+.......  .....+++
T Consensus       206 ~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  280 (348)
T 1u5q_A          206 P---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA--LQSGHWSE  280 (348)
T ss_dssp             S---BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC--CCCTTSCH
T ss_pred             C---CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC--CCCCCCCH
Confidence            3   23468999999999984    348999999999999999999999999888777766666554332  22347899


Q ss_pred             HHHHHHHhhhhcCCCCCCCHHHHHhccccccc
Q 014733          272 SARDLIMGMLRVDPSTRLTAAEVLAHSWMEEC  303 (419)
Q Consensus       272 ~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~  303 (419)
                      .+.+||.+||+.||++|||+.++++||||...
T Consensus       281 ~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~  312 (348)
T 1u5q_A          281 YFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  312 (348)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred             HHHHHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence            99999999999999999999999999999753

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.8e-48  Score=387.30  Aligned_cols=261  Identities=25%  Similarity=0.405  Sum_probs=209.7

Q ss_pred             ccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCC--
Q 014733           37 NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEED--  114 (419)
Q Consensus        37 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~--  114 (419)
                      .+.++|++++.||+|+||.||+|.+..+++.||+|++.... ......+.+.+|+.+++.+. ||||+++++++...+  
T Consensus        22 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~   99 (371)
T 2xrw_A           22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVN-HKNIIGLLNVFTPQKSL   99 (371)
T ss_dssp             EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSCCST
T ss_pred             chhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc-CChHHHHHHHHHHHHHHhcC-CCCccceEEeecccccc
Confidence            35689999999999999999999999999999999997643 34566778899999999996 999999999997664  


Q ss_pred             ----EEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccc
Q 014733          115 ----YVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGL  190 (419)
Q Consensus       115 ----~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgl  190 (419)
                          .+|+||||+. ++|.+.+.  ..+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+
T Consensus       100 ~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~  173 (371)
T 2xrw_A          100 EEFQDVYIVMELMD-ANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGL  173 (371)
T ss_dssp             TTCCEEEEEEECCS-EEHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCCCC
T ss_pred             ccccceEEEEEcCC-CCHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE---cCCCCEEEEEeec
Confidence                8899999996 57888875  469999999999999999999999999999999999999   5678999999999


Q ss_pred             eeeeccCCccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC-------
Q 014733          191 ATYIKAGQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFP-------  262 (419)
Q Consensus       191 a~~~~~~~~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~-------  262 (419)
                      +............+||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+.+..+.+..+........       
T Consensus       174 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  253 (371)
T 2xrw_A          174 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL  253 (371)
T ss_dssp             ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTS
T ss_pred             ccccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence            9876655445567899999999998874 89999999999999999999999999888777766654321110       


Q ss_pred             ---------------CCC---------C-------CCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          263 ---------------SDP---------W-------DHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       263 ---------------~~~---------~-------~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                                     ...         .       ...+.++++||.+||+.||++|||+.|+|+||||+....
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~  327 (371)
T 2xrw_A          254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYD  327 (371)
T ss_dssp             CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCC
T ss_pred             hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcC
Confidence                           000         0       011568899999999999999999999999999986533

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-48  Score=383.90  Aligned_cols=265  Identities=26%  Similarity=0.422  Sum_probs=214.7

Q ss_pred             ccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCH--HhHHHHHHHHHHHHHccCCCCceeeeEEEEe
Q 014733           35 ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTV--EDVRSIKLEIEIMTKLSGHPNVVDLKAVYEE  112 (419)
Q Consensus        35 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~--~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~  112 (419)
                      +....++|++++.||+|+||.||+|.+..+|+.||+|++........  ...+.+.+|+.++++++ ||||+++++++.+
T Consensus         5 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~   83 (346)
T 1ua2_A            5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIGLLDAFGH   83 (346)
T ss_dssp             --------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCC-CTTBCCEEEEECC
T ss_pred             hHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCC-CCCCCeEEEEEee
Confidence            45567899999999999999999999999999999999975432111  12346789999999996 9999999999999


Q ss_pred             CCEEEEEEeecCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccce
Q 014733          113 EDYVHLLMELCAGGELFHRLEKYG-RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA  191 (419)
Q Consensus       113 ~~~~~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla  191 (419)
                      .+..++||||+.+ +|..++.... .+++.+++.++.|+++||+|||+.||+||||||+|||+   +.++.+||+|||++
T Consensus        84 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~a  159 (346)
T 1ua2_A           84 KSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL---DENGVLKLADFGLA  159 (346)
T ss_dssp             TTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCCGGG
T ss_pred             CCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEE---cCCCCEEEEecccc
Confidence            9999999999975 8888887643 58999999999999999999999999999999999999   56789999999999


Q ss_pred             eeeccCC-ccccccCCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCC---
Q 014733          192 TYIKAGQ-NLHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDP---  265 (419)
Q Consensus       192 ~~~~~~~-~~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~---  265 (419)
                      ....... .....+||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+....+....+...........   
T Consensus       160 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  239 (346)
T 1ua2_A          160 KSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPD  239 (346)
T ss_dssp             STTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSS
T ss_pred             eeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhh
Confidence            8764332 3345689999999999865  389999999999999999999999999888877777655322111111   


Q ss_pred             ---------------------CCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccch
Q 014733          266 ---------------------WDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECE  304 (419)
Q Consensus       266 ---------------------~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~  304 (419)
                                           +..++.++.+||.+||+.||++|||+.|+++||||+...
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~  299 (346)
T 1ua2_A          240 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP  299 (346)
T ss_dssp             TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred             hccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCC
Confidence                                 145679999999999999999999999999999998643

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=4.2e-48  Score=383.43  Aligned_cols=264  Identities=26%  Similarity=0.462  Sum_probs=223.0

Q ss_pred             ccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeC-
Q 014733           35 ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEE-  113 (419)
Q Consensus        35 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~-  113 (419)
                      +-.+.++|++++.||+|+||.||+|.+..+++.||+|++...  ......+.+.+|+.+|++++ ||||+++++++... 
T Consensus        22 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~   98 (364)
T 3qyz_A           22 VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF--EHQTYCQRTLREIKILLRFR-HENIIGINDIIRAPT   98 (364)
T ss_dssp             BCCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT--TCHHHHHHHHHHHHHHHHCC-CTTBCCCCEEECCSS
T ss_pred             eccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc--cCcHHHHHHHHHHHHHHhcC-CCCCccceeEEecCC
Confidence            445678999999999999999999999999999999998753  34556688999999999996 99999999999765 


Q ss_pred             ----CEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeecc
Q 014733          114 ----DYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFG  189 (419)
Q Consensus       114 ----~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFg  189 (419)
                          ...|+||||+. ++|.+++.. +.+++.+++.++.||+.||+|||+.||+||||||+|||+   +.++.+||+|||
T Consensus        99 ~~~~~~~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg  173 (364)
T 3qyz_A           99 IEQMKDVYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFG  173 (364)
T ss_dssp             TTTCCCEEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCT
T ss_pred             ccccceEEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEE---CCCCCEEEEeCc
Confidence                47899999996 599998876 679999999999999999999999999999999999999   567889999999


Q ss_pred             ceeeeccCCc----cccccCCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--
Q 014733          190 LATYIKAGQN----LHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRF--  261 (419)
Q Consensus       190 la~~~~~~~~----~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~--  261 (419)
                      ++........    ....+||+.|+|||++.+  .++.++|||||||++|+|++|++||.+....+....+.......  
T Consensus       174 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  253 (364)
T 3qyz_A          174 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ  253 (364)
T ss_dssp             TCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCH
T ss_pred             ceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            9987654322    234589999999998754  38999999999999999999999999887766666554321110  


Q ss_pred             ------------------CC-------CCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchhh
Q 014733          262 ------------------PS-------DPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQV  306 (419)
Q Consensus       262 ------------------~~-------~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~~  306 (419)
                                        +.       .....++.++.+||.+||++||++|||+.|+|+||||++....
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~  323 (364)
T 3qyz_A          254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP  323 (364)
T ss_dssp             HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred             HHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCc
Confidence                              00       0124678999999999999999999999999999999886443

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.9e-48  Score=387.26  Aligned_cols=259  Identities=30%  Similarity=0.509  Sum_probs=216.0

Q ss_pred             cccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEe---
Q 014733           36 SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEE---  112 (419)
Q Consensus        36 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~---  112 (419)
                      +...++|++++.||+|+||+||+|.+..+|+.||+|++.....       ...+|+.+|+.+. ||||+++++++..   
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~E~~il~~l~-hpnIv~l~~~~~~~~~   74 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-------YKNRELDIMKVLD-HVNIIKLVDYFYTTGD   74 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHTTCC-CTTBCCEEEEEEEC--
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-------hHHHHHHHHHHcC-CCCccchhheeeecCc
Confidence            4567899999999999999999999999999999999875432       1236999999995 9999999999843   


Q ss_pred             -----------------------------------CCEEEEEEeecCCCChHHHHH----HcCCCCHHHHHHHHHHHHHH
Q 014733          113 -----------------------------------EDYVHLLMELCAGGELFHRLE----KYGRFSETEARVIFRHLMQV  153 (419)
Q Consensus       113 -----------------------------------~~~~~lV~E~~~ggsL~~~l~----~~~~l~~~~~~~i~~qll~a  153 (419)
                                                         ..++++||||++ ++|.+.+.    ....+++..++.++.||+.|
T Consensus        75 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~a  153 (383)
T 3eb0_A           75 EEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRA  153 (383)
T ss_dssp             -----------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHH
Confidence                                               445899999997 57776664    34679999999999999999


Q ss_pred             HHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCCccccccCCCccCCcccccC--CCCCchhHHHHHHH
Q 014733          154 VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVI  231 (419)
Q Consensus       154 L~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvi  231 (419)
                      |+|||+.||+||||||+|||++  ..++.+||+|||++.............||+.|+|||++.+  .++.++||||+||+
T Consensus       154 L~~LH~~gi~H~Dikp~Nil~~--~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i  231 (383)
T 3eb0_A          154 VGFIHSLGICHRDIKPQNLLVN--SKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV  231 (383)
T ss_dssp             HHHHHTTTEECSCCCGGGEEEE--TTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred             HHHHHHCcCccCccCHHHEEEc--CCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence            9999999999999999999995  2467899999999998776666677789999999999876  38999999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHhcC-----------------CCCCCC--------CCCCCCHHHHHHHHhhhhcCCC
Q 014733          232 LYILLSGMPPFWGKTKSKIFDAVRAAD-----------------LRFPSD--------PWDHISASARDLIMGMLRVDPS  286 (419)
Q Consensus       232 l~elltG~~Pf~~~~~~~~~~~i~~~~-----------------~~~~~~--------~~~~~s~~l~~li~~~L~~dP~  286 (419)
                      +|+|++|++||.+....+....+....                 ..++..        ....+++++.+||.+||+.||.
T Consensus       232 l~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  311 (383)
T 3eb0_A          232 FGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD  311 (383)
T ss_dssp             HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred             HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence            999999999999988877766654311                 111110        1235789999999999999999


Q ss_pred             CCCCHHHHHhccccccchh
Q 014733          287 TRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       287 ~Rps~~eil~hp~~~~~~~  305 (419)
                      +|||+.|+++||||+....
T Consensus       312 ~R~t~~e~l~hp~f~~~~~  330 (383)
T 3eb0_A          312 LRINPYEAMAHPFFDHLRN  330 (383)
T ss_dssp             GSCCHHHHHTSGGGHHHHH
T ss_pred             hCCCHHHHhcCHHHHHHHh
Confidence            9999999999999987654

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=2.2e-48  Score=380.12  Aligned_cols=266  Identities=27%  Similarity=0.426  Sum_probs=221.8

Q ss_pred             hccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeC
Q 014733           34 QISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEE  113 (419)
Q Consensus        34 ~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~  113 (419)
                      -.....++|++++.||+|+||.||+|.+..+|+.||+|++.... ......+.+.+|+.++++++ ||||+++++++.+.
T Consensus        19 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~   96 (331)
T 4aaa_A           19 LYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQLR-HENLVNLLEVCKKK   96 (331)
T ss_dssp             CCCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS-SCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEET
T ss_pred             hhhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC-CchHHHHHHHHHHHHHhhCC-CCCEeeEEEEeecC
Confidence            34445689999999999999999999999999999999986553 34455677889999999996 99999999999999


Q ss_pred             CEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceee
Q 014733          114 DYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATY  193 (419)
Q Consensus       114 ~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~  193 (419)
                      +..++||||+++++|..++...+.+++..++.++.||+.||+|||+.||+||||||+|||+   +.++.+||+|||++..
T Consensus        97 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~  173 (331)
T 4aaa_A           97 KRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILV---SQSGVVKLCDFGFART  173 (331)
T ss_dssp             TEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCTTC--
T ss_pred             CEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEE---cCCCcEEEEeCCCcee
Confidence            9999999999999998888777889999999999999999999999999999999999999   5677999999999986


Q ss_pred             eccC-CccccccCCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-----------
Q 014733          194 IKAG-QNLHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADL-----------  259 (419)
Q Consensus       194 ~~~~-~~~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-----------  259 (419)
                      .... .......||+.|+|||++.+  .++.++|||||||++|+|++|++||.+....+....+.....           
T Consensus       174 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (331)
T 4aaa_A          174 LAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFN  253 (331)
T ss_dssp             ----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHH
T ss_pred             ecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhh
Confidence            5443 23345689999999999876  489999999999999999999999998877666555432111           


Q ss_pred             --------CCCCC--------CCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccch
Q 014733          260 --------RFPSD--------PWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECE  304 (419)
Q Consensus       260 --------~~~~~--------~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~  304 (419)
                              ..+..        .+..+++++.+||.+||+.||++|||+.|+|+||||+...
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  314 (331)
T 4aaa_A          254 KNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDG  314 (331)
T ss_dssp             HCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGGG
T ss_pred             hccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccCC
Confidence                    11100        1236789999999999999999999999999999998653

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=4.2e-48  Score=382.27  Aligned_cols=260  Identities=25%  Similarity=0.393  Sum_probs=222.7

Q ss_pred             ccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEE
Q 014733           37 NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYV  116 (419)
Q Consensus        37 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~  116 (419)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|++...  ......+.+.+|+.+++++. ||||+++++++.+.+.+
T Consensus        30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~  106 (360)
T 3eqc_A           30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGEI  106 (360)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECC--CCHHHHHHHHHHHGGGGGCC-CTTBCCEEEEEEETTEE
T ss_pred             cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccc--cCHHHHHHHHHHHHHHHHCC-CCCEEEEeEEEEECCEE
Confidence            3468999999999999999999999999999999999765  34566788999999999995 99999999999999999


Q ss_pred             EEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC-CCeeccCCCCcEEEeecCCCCCeEEeeccceeeec
Q 014733          117 HLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGN-GVVHRDLKPENILLATKSSSSPIKLADFGLATYIK  195 (419)
Q Consensus       117 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~-~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~  195 (419)
                      ++||||++|++|.+++...+.+++..+..++.|++.||.|||+. ||+||||||+|||+   +.++.+||+|||++....
T Consensus       107 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~  183 (360)
T 3eqc_A          107 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLI  183 (360)
T ss_dssp             EEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE---CTTCCEEECCCCCCHHHH
T ss_pred             EEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEE---CCCCCEEEEECCCCcccc
Confidence            99999999999999999888999999999999999999999996 99999999999999   567789999999997653


Q ss_pred             cCCccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---------------------
Q 014733          196 AGQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDA---------------------  253 (419)
Q Consensus       196 ~~~~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~---------------------  253 (419)
                      .. ......||+.|+|||++.+. ++.++|||||||++|+|++|+.||......+....                     
T Consensus       184 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (360)
T 3eqc_A          184 DS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR  262 (360)
T ss_dssp             HH-C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------
T ss_pred             cc-cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCC
Confidence            32 23446899999999998874 89999999999999999999999987665443222                     


Q ss_pred             ---------------------HHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          254 ---------------------VRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       254 ---------------------i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                                           +....  .+......++.++.+||.+||+.||.+|||+.++|+||||+....
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  333 (360)
T 3eqc_A          263 PLNKFGMDSRPPMAIFELLDYIVNEP--PPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA  333 (360)
T ss_dssp             -----------CCCHHHHHHHHHHSC--CCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred             cccccccCCCCcccchhhhhHHhccC--CCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchH
Confidence                                 22221  122223458999999999999999999999999999999987654

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=6.1e-48  Score=375.95  Aligned_cols=256  Identities=25%  Similarity=0.498  Sum_probs=215.4

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEe--CCEE
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEE--EDYV  116 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~--~~~~  116 (419)
                      .++|++++.||+|+||.||+|.+..+++.||+|++...      ..+.+.+|+.+++++++||||+++++++.+  ....
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~  108 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP  108 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc------chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence            58999999999999999999999999999999998643      246788999999999779999999999998  6789


Q ss_pred             EEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeecc
Q 014733          117 HLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA  196 (419)
Q Consensus       117 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~  196 (419)
                      ++||||+.+++|.+++..   +++.+++.++.||+.||+|||++||+||||||+|||++.  ....+||+|||++.....
T Consensus       109 ~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~--~~~~~kl~Dfg~a~~~~~  183 (330)
T 3nsz_A          109 ALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHP  183 (330)
T ss_dssp             EEEEECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET--TTTEEEECCCTTCEECCT
T ss_pred             EEEEeccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcC--CCCEEEEEeCCCceEcCC
Confidence            999999999999988854   899999999999999999999999999999999999952  233799999999998776


Q ss_pred             CCccccccCCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCC-CHHHHHH-------------HHHhcCCC
Q 014733          197 GQNLHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGK-TKSKIFD-------------AVRAADLR  260 (419)
Q Consensus       197 ~~~~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~-~~~~~~~-------------~i~~~~~~  260 (419)
                      ........||+.|+|||++.+  .++.++|||||||++|+|++|+.||... ...+...             .+......
T Consensus       184 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  263 (330)
T 3nsz_A          184 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE  263 (330)
T ss_dssp             TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred             CCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccc
Confidence            666667789999999999876  3899999999999999999999999543 2222222             22222111


Q ss_pred             C--------------------CCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          261 F--------------------PSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       261 ~--------------------~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                      .                    .......+++++.+||.+||++||++|||+.|+|+||||+.+.+
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~  328 (330)
T 3nsz_A          264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK  328 (330)
T ss_dssp             CCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC-
T ss_pred             cccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhcc
Confidence            1                    11112237999999999999999999999999999999987643

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=8.1e-48  Score=378.34  Aligned_cols=260  Identities=26%  Similarity=0.423  Sum_probs=215.0

Q ss_pred             ccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCC-CCceeeeEEEEeC
Q 014733           35 ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH-PNVVDLKAVYEEE  113 (419)
Q Consensus        35 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~h-pnIv~l~~~~~~~  113 (419)
                      ++...++|++++.||+|+||.||+|.+. +++.||+|++.... ......+.+.+|+.+|+++..| |||+++++++.+.
T Consensus         4 i~~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~   81 (343)
T 3dbq_A            4 ISVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD   81 (343)
T ss_dssp             EESSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred             eeeecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccc-cchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeC
Confidence            4556789999999999999999999885 68999999997654 3556678899999999999722 9999999999999


Q ss_pred             CEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceee
Q 014733          114 DYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATY  193 (419)
Q Consensus       114 ~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~  193 (419)
                      +.+|+|||+ .+++|.+++...+.+++.+++.++.||+.||+|||+.||+||||||+|||++    ++.+||+|||++..
T Consensus        82 ~~~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~----~~~~kl~DFG~a~~  156 (343)
T 3dbq_A           82 QYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQ  156 (343)
T ss_dssp             SEEEEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE----TTEEEECCCSSSCC
T ss_pred             CEEEEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE----CCcEEEeecccccc
Confidence            999999995 5889999999988899999999999999999999999999999999999994    46799999999987


Q ss_pred             eccCCc---cccccCCCccCCccccc------------CCCCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhc
Q 014733          194 IKAGQN---LHGTVGSPFYIAPEVLA------------GGYNQAADVWSAGVILYILLSGMPPFWGKTK-SKIFDAVRAA  257 (419)
Q Consensus       194 ~~~~~~---~~~~~gt~~y~aPE~l~------------~~~s~~sDvwSlGvil~elltG~~Pf~~~~~-~~~~~~i~~~  257 (419)
                      ......   ....+||+.|+|||++.            +.++.++|||||||++|+|++|+.||.+... ......+...
T Consensus       157 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~  236 (343)
T 3dbq_A          157 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP  236 (343)
T ss_dssp             C------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCT
T ss_pred             cCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcC
Confidence            654332   23458999999999985            3488999999999999999999999976433 2333333332


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccc
Q 014733          258 DLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEEC  303 (419)
Q Consensus       258 ~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~  303 (419)
                      ....  ......+.++.+||.+||+.||.+|||+.++++||||+..
T Consensus       237 ~~~~--~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  280 (343)
T 3dbq_A          237 NHEI--EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  280 (343)
T ss_dssp             TSCC--CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             Cccc--CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence            2222  2233567899999999999999999999999999999754

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=2.6e-48  Score=381.13  Aligned_cols=262  Identities=36%  Similarity=0.681  Sum_probs=193.9

Q ss_pred             ccccccCeeeee-eecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHH-HHHccCCCCceeeeEEEEe
Q 014733           35 ISNLSDRYVLGK-QLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEI-MTKLSGHPNVVDLKAVYEE  112 (419)
Q Consensus        35 ~~~~~~~y~i~~-~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~i-l~~l~~hpnIv~l~~~~~~  112 (419)
                      ...+.++|++.+ .||+|+||+||+|.++.+|+.||+|++...    ..    ..+|+.. ++.+ +||||+++++++..
T Consensus        23 ~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~----~~~e~~~~~~~~-~h~~i~~~~~~~~~   93 (336)
T 3fhr_A           23 KYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PK----ARQEVDHHWQAS-GGPHIVCILDVYEN   93 (336)
T ss_dssp             CSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HH----HHHHHHHHHHHT-TSTTBCCEEEEEEE
T ss_pred             CccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HH----HHHHHHHHHHhc-CCCChHHHHHHHhh
Confidence            345778999965 699999999999999999999999998643    12    2233333 3444 69999999999976


Q ss_pred             ----CCEEEEEEeecCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEe
Q 014733          113 ----EDYVHLLMELCAGGELFHRLEKYG--RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLA  186 (419)
Q Consensus       113 ----~~~~~lV~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~  186 (419)
                          ...+++||||++||+|.+++...+  .+++.+++.++.||+.||.|||+.||+||||||+|||++.++.++.+||+
T Consensus        94 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~  173 (336)
T 3fhr_A           94 MHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLT  173 (336)
T ss_dssp             EETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred             ccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEe
Confidence                556899999999999999998754  59999999999999999999999999999999999999766667789999


Q ss_pred             eccceeeeccCCccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhcCCCC
Q 014733          187 DFGLATYIKAGQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKI----FDAVRAADLRF  261 (419)
Q Consensus       187 DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~----~~~i~~~~~~~  261 (419)
                      |||++...... .....+||+.|+|||++.+. ++.++||||||+++|+|++|+.||.+......    ...+......+
T Consensus       174 Dfg~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  252 (336)
T 3fhr_A          174 DFGFAKETTQN-ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGF  252 (336)
T ss_dssp             CCTTCEEC-----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CC
T ss_pred             ccccceecccc-ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcccccc
Confidence            99999865433 33456889999999998765 88999999999999999999999976654433    34444555566


Q ss_pred             CCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchhh
Q 014733          262 PSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQV  306 (419)
Q Consensus       262 ~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~~  306 (419)
                      +...+..++.++.+||.+||+.||++|||+.++++||||++....
T Consensus       253 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~  297 (336)
T 3fhr_A          253 PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVV  297 (336)
T ss_dssp             CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGGS
T ss_pred             CchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccccC
Confidence            666677899999999999999999999999999999999876543

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=4.5e-48  Score=366.92  Aligned_cols=259  Identities=33%  Similarity=0.564  Sum_probs=222.4

Q ss_pred             cccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEE
Q 014733           38 LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVH  117 (419)
Q Consensus        38 ~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~  117 (419)
                      +.++|++++.||+|+||.||+|.++.+++.||+|++.....  ....+.+.+|+.+++.+. ||||+++++++.+.+..+
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~   81 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLN-HENVVKFYGHRREGNIQY   81 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC--TTHHHHHHHHHHHHHTCC-CTTBCCEEEEEEETTEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc--hhhhHHHHHHHHHHHhcC-CCCceeeeeEEEcCCEEE
Confidence            45789999999999999999999999999999999976543  235678899999999995 999999999999999999


Q ss_pred             EEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccC
Q 014733          118 LLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG  197 (419)
Q Consensus       118 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~  197 (419)
                      +||||+++++|.+++.....+++.+++.++.|++.||+|||+.||+||||||+||++   +.++.+||+|||++......
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~  158 (276)
T 2yex_A           82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYN  158 (276)
T ss_dssp             EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEECEET
T ss_pred             EEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEE---ccCCCEEEeeCCCccccCCC
Confidence            999999999999999877789999999999999999999999999999999999999   56788999999999876433


Q ss_pred             C---ccccccCCCccCCcccccCC--CCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhcCCCCCCCCCCCCCH
Q 014733          198 Q---NLHGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTKS-KIFDAVRAADLRFPSDPWDHISA  271 (419)
Q Consensus       198 ~---~~~~~~gt~~y~aPE~l~~~--~s~~sDvwSlGvil~elltG~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s~  271 (419)
                      .   ......||+.|+|||++.+.  ++.++||||||+++|+|++|+.||...... .....+......  ...+..++.
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  236 (276)
T 2yex_A          159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY--LNPWKKIDS  236 (276)
T ss_dssp             TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTT--STTGGGSCH
T ss_pred             cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccc--cCchhhcCH
Confidence            2   23445799999999998764  478999999999999999999999775543 233333333222  223457899


Q ss_pred             HHHHHHHhhhhcCCCCCCCHHHHHhccccccch
Q 014733          272 SARDLIMGMLRVDPSTRLTAAEVLAHSWMEECE  304 (419)
Q Consensus       272 ~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~  304 (419)
                      ++.++|.+||+.||++|||+.++++||||++..
T Consensus       237 ~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  269 (276)
T 2yex_A          237 APLALLHKILVENPSARITIPDIKKDRWYNKPL  269 (276)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             HHHHHHHHHCCCCchhCCCHHHHhcCccccChh
Confidence            999999999999999999999999999998654

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=5.6e-48  Score=391.35  Aligned_cols=260  Identities=28%  Similarity=0.404  Sum_probs=218.0

Q ss_pred             ccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHcc-----CCCCceeeeEE
Q 014733           35 ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLS-----GHPNVVDLKAV  109 (419)
Q Consensus        35 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----~hpnIv~l~~~  109 (419)
                      ...+.++|++++.||+|+||+||+|.+..+++.||+|++...    ....+.+.+|+.+++.++     +|+||++++++
T Consensus        92 ~~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~  167 (429)
T 3kvw_A           92 HDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLEN  167 (429)
T ss_dssp             TCEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEE
T ss_pred             CCcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEee
Confidence            345778999999999999999999999999999999999743    345677888999999885     47899999999


Q ss_pred             EEeCCEEEEEEeecCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCC--eEE
Q 014733          110 YEEEDYVHLLMELCAGGELFHRLEKYG--RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSP--IKL  185 (419)
Q Consensus       110 ~~~~~~~~lV~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~--vKL  185 (419)
                      +...+.+++||||+. ++|.+++....  .+++..++.++.||+.||+|||+.||+||||||+|||++   .++.  +||
T Consensus       168 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~---~~~~~~vkL  243 (429)
T 3kvw_A          168 FTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLK---QQGRSGIKV  243 (429)
T ss_dssp             EEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEES---STTSCCEEE
T ss_pred             cccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEc---cCCCcceEE
Confidence            999999999999995 69999987754  499999999999999999999999999999999999994   4444  999


Q ss_pred             eeccceeeeccCCccccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC-
Q 014733          186 ADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPS-  263 (419)
Q Consensus       186 ~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~-  263 (419)
                      +|||++.....  .....+||+.|+|||++.+ .|+.++|||||||++|+|++|++||.+.+..+....+.......+. 
T Consensus       244 ~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~  321 (429)
T 3kvw_A          244 IDFGSSCYEHQ--RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQK  321 (429)
T ss_dssp             CCCTTCEETTC--CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             eecccceecCC--cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHH
Confidence            99999976432  3445689999999999877 4999999999999999999999999998887776655432110000 


Q ss_pred             -------------------------------------------------C-----CCCCCCHHHHHHHHhhhhcCCCCCC
Q 014733          264 -------------------------------------------------D-----PWDHISASARDLIMGMLRVDPSTRL  289 (419)
Q Consensus       264 -------------------------------------------------~-----~~~~~s~~l~~li~~~L~~dP~~Rp  289 (419)
                                                                       .     .....++++.+||.+||++||++||
T Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rp  401 (429)
T 3kvw_A          322 LLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRM  401 (429)
T ss_dssp             HHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSC
T ss_pred             HHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCC
Confidence                                                             0     0012478899999999999999999


Q ss_pred             CHHHHHhccccccch
Q 014733          290 TAAEVLAHSWMEECE  304 (419)
Q Consensus       290 s~~eil~hp~~~~~~  304 (419)
                      |+.|+|+||||+...
T Consensus       402 ta~e~L~Hpw~~~~~  416 (429)
T 3kvw_A          402 TPGQALRHPWLRRRL  416 (429)
T ss_dssp             CHHHHHTSTTTC---
T ss_pred             CHHHHhCChhhccCC
Confidence            999999999998653

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=4.3e-48  Score=377.94  Aligned_cols=253  Identities=19%  Similarity=0.299  Sum_probs=211.0

Q ss_pred             ccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEE
Q 014733           37 NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYV  116 (419)
Q Consensus        37 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~  116 (419)
                      .+.++|++.+.||+|+||.||+|.+..+|+.||+|++.....     .+.+.+|+.+++++.+||||+++++++.+.+..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~   80 (330)
T 2izr_A            6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYN   80 (330)
T ss_dssp             EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEE
T ss_pred             EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCcc
Confidence            467899999999999999999999999999999999875532     235788999999996699999999999999999


Q ss_pred             EEEEeecCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCC--CCeEEeeccceee
Q 014733          117 HLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSS--SPIKLADFGLATY  193 (419)
Q Consensus       117 ~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~--~~vKL~DFgla~~  193 (419)
                      ++||||+ +++|.+++... +.+++.+++.++.||+.||+|||+.||+||||||+|||++.++..  ..+||+|||++..
T Consensus        81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~  159 (330)
T 2izr_A           81 AMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE  159 (330)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred             EEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence            9999999 99999999874 679999999999999999999999999999999999999543221  1299999999987


Q ss_pred             eccCCc--------cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhcCCCC
Q 014733          194 IKAGQN--------LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKT---KSKIFDAVRAADLRF  261 (419)
Q Consensus       194 ~~~~~~--------~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~---~~~~~~~i~~~~~~~  261 (419)
                      ......        ....+||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+..   ..+....+.......
T Consensus       160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~  239 (330)
T 2izr_A          160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT  239 (330)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred             eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence            654332        2356899999999998875 8999999999999999999999998743   344455554433333


Q ss_pred             CCCC-CCCCCHHHHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          262 PSDP-WDHISASARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       262 ~~~~-~~~~s~~l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                      +... ...++ ++.++|..||+.||.+||+++++++
T Consensus       240 ~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          240 PIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             CHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             CHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            3221 12344 9999999999999999999999986

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.8e-49  Score=395.21  Aligned_cols=255  Identities=17%  Similarity=0.189  Sum_probs=209.2

Q ss_pred             ccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHcc--CCCCceeee-------
Q 014733           37 NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLS--GHPNVVDLK-------  107 (419)
Q Consensus        37 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~--~hpnIv~l~-------  107 (419)
                      ...++|++.+.||+|+||+||+|.++.+|+.||+|++.+.........+.+.+|+.+++.++  +||||++++       
T Consensus        70 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~  149 (377)
T 3byv_A           70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF  149 (377)
T ss_dssp             CCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCS
T ss_pred             CCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhh
Confidence            34689999999999999999999999999999999998765555667788999996555543  599999998       


Q ss_pred             EEEEeCCE-----------------EEEEEeecCCCChHHHHHHcCCCCH-------HHHHHHHHHHHHHHHHHHhCCCe
Q 014733          108 AVYEEEDY-----------------VHLLMELCAGGELFHRLEKYGRFSE-------TEARVIFRHLMQVVSYCHGNGVV  163 (419)
Q Consensus       108 ~~~~~~~~-----------------~~lV~E~~~ggsL~~~l~~~~~l~~-------~~~~~i~~qll~aL~~LH~~~Iv  163 (419)
                      +++.+.+.                 .|+||||+ +|+|.+++...+.+++       ..++.++.||+.||+|||++||+
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv  228 (377)
T 3byv_A          150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLV  228 (377)
T ss_dssp             EEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             hhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCee
Confidence            77776643                 88999999 6899999987655555       78888999999999999999999


Q ss_pred             eccCCCCcEEEeecCCCCCeEEeeccceeeeccCCccccccCCCccCCcccccC------------CCCCchhHHHHHHH
Q 014733          164 HRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG------------GYNQAADVWSAGVI  231 (419)
Q Consensus       164 HrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~------------~~s~~sDvwSlGvi  231 (419)
                      ||||||+|||+   +.++.+||+|||++....  ......+| +.|+|||++.+            .++.++|||||||+
T Consensus       229 HrDikp~NIll---~~~~~~kL~DFG~a~~~~--~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i  302 (377)
T 3byv_A          229 HTYLRPVDIVL---DQRGGVFLTGFEHLVRDG--ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV  302 (377)
T ss_dssp             CSCCCGGGEEE---CTTCCEEECCGGGCEETT--CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred             cCCCCHHHEEE---cCCCCEEEEechhheecC--CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence            99999999999   566899999999998632  23445678 99999999864            48999999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchhh
Q 014733          232 LYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQV  306 (419)
Q Consensus       232 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~~  306 (419)
                      +|+|++|+.||.+....+....+.        ..+..+++++.+||.+||+.||++|||+.++++||||+++...
T Consensus       303 l~elltg~~Pf~~~~~~~~~~~~~--------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~  369 (377)
T 3byv_A          303 IYWIWCADLPITKDAALGGSEWIF--------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTE  369 (377)
T ss_dssp             HHHHHHSSCCC------CCSGGGG--------SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHHHH
T ss_pred             HHHHHHCCCCCcccccccchhhhh--------hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHHHH
Confidence            999999999997655433222221        1234789999999999999999999999999999999987653

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=3.5e-48  Score=385.12  Aligned_cols=263  Identities=26%  Similarity=0.464  Sum_probs=206.4

Q ss_pred             cccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeC--
Q 014733           36 SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEE--  113 (419)
Q Consensus        36 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~--  113 (419)
                      -.+.++|++++.||+|+||.||+|.+..+|+.||+|++.... ......+.+.+|+.+|+.++ ||||+++++++...  
T Consensus        25 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~  102 (367)
T 2fst_X           25 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARS  102 (367)
T ss_dssp             EEEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSS
T ss_pred             cCCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEecCCc
Confidence            356689999999999999999999999999999999986543 34556778899999999996 99999999999654  


Q ss_pred             ----CEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeecc
Q 014733          114 ----DYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFG  189 (419)
Q Consensus       114 ----~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFg  189 (419)
                          ..+|+|||++ +++|.+++.. +.+++..++.++.||+.||+|||+.||+||||||+|||+   +.++.+||+|||
T Consensus       103 ~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kL~DFG  177 (367)
T 2fst_X          103 LEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFG  177 (367)
T ss_dssp             GGGCCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECC--
T ss_pred             cccCCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEE---CCCCCEEEeecc
Confidence                5689999999 7899998876 679999999999999999999999999999999999999   567899999999


Q ss_pred             ceeeeccCCccccccCCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-------
Q 014733          190 LATYIKAGQNLHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLR-------  260 (419)
Q Consensus       190 la~~~~~~~~~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-------  260 (419)
                      ++.....  .....+||+.|+|||++.+  .++.++|||||||++|+|++|++||.+.+..+....+......       
T Consensus       178 ~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~  255 (367)
T 2fst_X          178 LARHTAD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK  255 (367)
T ss_dssp             ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred             ccccccc--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            9986543  2345689999999999876  4899999999999999999999999988877766665432111       


Q ss_pred             ----------------CCCC----CCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchhhh
Q 014733          261 ----------------FPSD----PWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVA  307 (419)
Q Consensus       261 ----------------~~~~----~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~~~  307 (419)
                                      .+..    .+..+++++.+||.+||+.||++|||+.++|+||||+......
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~  322 (367)
T 2fst_X          256 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD  322 (367)
T ss_dssp             TCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGG
T ss_pred             HhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCC
Confidence                            1111    1235789999999999999999999999999999999765543

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=2e-47  Score=371.61  Aligned_cols=266  Identities=23%  Similarity=0.430  Sum_probs=221.7

Q ss_pred             cchhhccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEE
Q 014733           30 LDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAV  109 (419)
Q Consensus        30 ~~~~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~  109 (419)
                      ++...+....++|++++.||+|+||.||+|.+..+|+.||+|++....    .....+.+|+.+++++.+||||++++++
T Consensus        14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~   89 (326)
T 2x7f_A           14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGA   89 (326)
T ss_dssp             --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----STTHHHHHHHHHHHHHCCSTTBCCEEEE
T ss_pred             ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc----ccHHHHHHHHHHHHhccCCCCeeeeeeE
Confidence            345567778899999999999999999999999999999999997543    2346788999999999669999999999


Q ss_pred             EEe------CCEEEEEEeecCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCC
Q 014733          110 YEE------EDYVHLLMELCAGGELFHRLEKY--GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSS  181 (419)
Q Consensus       110 ~~~------~~~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~  181 (419)
                      +..      .+.+++||||+++++|.+++...  ..+++..++.++.||+.||.|||+.||+||||||+|||+   +.++
T Consensus        90 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~---~~~~  166 (326)
T 2x7f_A           90 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL---TENA  166 (326)
T ss_dssp             EEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTC
T ss_pred             EeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEE---cCCC
Confidence            987      56899999999999999999864  469999999999999999999999999999999999999   5678


Q ss_pred             CeEEeeccceeeeccCC-ccccccCCCccCCccccc-----C-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 014733          182 PIKLADFGLATYIKAGQ-NLHGTVGSPFYIAPEVLA-----G-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAV  254 (419)
Q Consensus       182 ~vKL~DFgla~~~~~~~-~~~~~~gt~~y~aPE~l~-----~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i  254 (419)
                      .+||+|||++....... ......||+.|+|||++.     + .++.++|||||||++|+|++|..||.+.........+
T Consensus       167 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~  246 (326)
T 2x7f_A          167 EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI  246 (326)
T ss_dssp             CEEECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred             CEEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHh
Confidence            89999999988654332 233457999999999985     2 4899999999999999999999999888877766666


Q ss_pred             HhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccch
Q 014733          255 RAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECE  304 (419)
Q Consensus       255 ~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~  304 (419)
                      ......  ......++..+.+||.+||..||.+|||+.++++||||+...
T Consensus       247 ~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~  294 (326)
T 2x7f_A          247 PRNPAP--RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQP  294 (326)
T ss_dssp             HHSCCC--CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred             hcCccc--cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCc
Confidence            554332  222347899999999999999999999999999999998653

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=4.7e-48  Score=375.69  Aligned_cols=260  Identities=25%  Similarity=0.405  Sum_probs=216.6

Q ss_pred             cccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCC-
Q 014733           36 SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEED-  114 (419)
Q Consensus        36 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~-  114 (419)
                      ..+.++|++.+.||+|+||+||+|.+..+|+.||+|++.....  ....+.+.+|++++++++ ||||+++++++.+.+ 
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~   81 (319)
T 4euu_A            5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLN-HKNIVKLFAIEEETTT   81 (319)
T ss_dssp             ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCC-CTTBCCEEEEEECTTT
T ss_pred             cCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcC-CCCcceEEEEeecCCC
Confidence            4567899999999999999999999999999999999975432  234567789999999996 999999999998765 


Q ss_pred             -EEEEEEeecCCCChHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeec-CCCCCeEEeecc
Q 014733          115 -YVHLLMELCAGGELFHRLEKYGR---FSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATK-SSSSPIKLADFG  189 (419)
Q Consensus       115 -~~~lV~E~~~ggsL~~~l~~~~~---l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~-~~~~~vKL~DFg  189 (419)
                       ..++||||+++++|.+++.....   +++.+++.++.||+.||+|||+.||+||||||+|||+..+ +.++.+||+|||
T Consensus        82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg  161 (319)
T 4euu_A           82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG  161 (319)
T ss_dssp             CCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCT
T ss_pred             ceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCC
Confidence             78999999999999999976543   9999999999999999999999999999999999998432 344579999999


Q ss_pred             ceeeeccCCccccccCCCccCCccccc---------CCCCCchhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHh
Q 014733          190 LATYIKAGQNLHGTVGSPFYIAPEVLA---------GGYNQAADVWSAGVILYILLSGMPPFWGKT----KSKIFDAVRA  256 (419)
Q Consensus       190 la~~~~~~~~~~~~~gt~~y~aPE~l~---------~~~s~~sDvwSlGvil~elltG~~Pf~~~~----~~~~~~~i~~  256 (419)
                      ++.............||+.|+|||++.         ..++.++|||||||++|+|++|+.||....    ..+....+..
T Consensus       162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  241 (319)
T 4euu_A          162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (319)
T ss_dssp             TCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred             CceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence            999877666666778999999999975         358999999999999999999999996432    2444555544


Q ss_pred             cCCC---------------------CCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhcc
Q 014733          257 ADLR---------------------FPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHS  298 (419)
Q Consensus       257 ~~~~---------------------~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp  298 (419)
                      ....                     ........++..+.++|.+||+.||++|||++|+|+||
T Consensus       242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~  304 (319)
T 4euu_A          242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET  304 (319)
T ss_dssp             HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred             CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence            3321                     11111223556888999999999999999999999996

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.9e-47  Score=365.25  Aligned_cols=262  Identities=24%  Similarity=0.329  Sum_probs=201.7

Q ss_pred             cccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCE
Q 014733           36 SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDY  115 (419)
Q Consensus        36 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~  115 (419)
                      +...++|++++.||+|+||+||+|.+..+|+.||+|++..... .....+.+..+...++.+ +||||+++++++.+.+.
T Consensus         3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~-~h~~iv~~~~~~~~~~~   80 (290)
T 3fme_A            3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTV-DCPFTVTFYGALFREGD   80 (290)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSS
T ss_pred             cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhC-CCCeEEEEeeeeeccCC
Confidence            3456899999999999999999999999999999999975532 222333344444446666 59999999999999999


Q ss_pred             EEEEEeecCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC-CCeeccCCCCcEEEeecCCCCCeEEeeccc
Q 014733          116 VHLLMELCAGGELFHRLEK----YGRFSETEARVIFRHLMQVVSYCHGN-GVVHRDLKPENILLATKSSSSPIKLADFGL  190 (419)
Q Consensus       116 ~~lV~E~~~ggsL~~~l~~----~~~l~~~~~~~i~~qll~aL~~LH~~-~IvHrDLkp~NILl~~~~~~~~vKL~DFgl  190 (419)
                      .++||||++ ++|.+++..    ...+++..++.++.||+.||+|||++ ||+||||||+|||+   +.++.+||+|||+
T Consensus        81 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~  156 (290)
T 3fme_A           81 VWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLI---NALGQVKMCDFGI  156 (290)
T ss_dssp             EEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEE---CTTCCEEBCCC--
T ss_pred             EEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE---CCCCCEEEeecCC
Confidence            999999996 588776643    46799999999999999999999998 99999999999999   5677999999999


Q ss_pred             eeeeccCCccccccCCCccCCccccc----C-CCCCchhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcCCCCCCC
Q 014733          191 ATYIKAGQNLHGTVGSPFYIAPEVLA----G-GYNQAADVWSAGVILYILLSGMPPFWG-KTKSKIFDAVRAADLRFPSD  264 (419)
Q Consensus       191 a~~~~~~~~~~~~~gt~~y~aPE~l~----~-~~s~~sDvwSlGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~~~~~  264 (419)
                      +.............||+.|+|||++.    + .++.++||||||+++|+|++|+.||.. ...............  +..
T Consensus       157 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~  234 (290)
T 3fme_A          157 SGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS--PQL  234 (290)
T ss_dssp             -------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCC--CCC
T ss_pred             cccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCC--CCc
Confidence            98776655555568999999999962    3 388999999999999999999999975 333333333333322  222


Q ss_pred             CCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          265 PWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       265 ~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                      ....+++++.++|.+||+.||++|||+.++++||||+....
T Consensus       235 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~~  275 (290)
T 3fme_A          235 PADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHES  275 (290)
T ss_dssp             CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHH
T ss_pred             ccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCcc
Confidence            23478999999999999999999999999999999986543

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=9e-48  Score=370.37  Aligned_cols=261  Identities=30%  Similarity=0.557  Sum_probs=221.2

Q ss_pred             ccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccC-CHHhHHHHHHHHHHHHHccCCCCceeeeEEEE--eC
Q 014733           37 NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLV-TVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYE--EE  113 (419)
Q Consensus        37 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~-~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~--~~  113 (419)
                      .+.++|++++.||+|+||.||+|.+..+++.+|+|++.+.... .......+.+|+.++++++ ||||+++++++.  +.
T Consensus         2 ~l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~   80 (305)
T 2wtk_C            2 KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR-HKNVIQLVDVLYNEEK   80 (305)
T ss_dssp             ---CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEECC--
T ss_pred             ccccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcC-CCCeeEEEEEEEcCCC
Confidence            4568999999999999999999999999999999999764321 1234578999999999996 999999999984  45


Q ss_pred             CEEEEEEeecCCCChHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccce
Q 014733          114 DYVHLLMELCAGGELFHRLEK--YGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA  191 (419)
Q Consensus       114 ~~~~lV~E~~~ggsL~~~l~~--~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla  191 (419)
                      +..++||||+.++ |.+++..  ...+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++
T Consensus        81 ~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~---~~~~~~kl~dfg~~  156 (305)
T 2wtk_C           81 QKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLL---TTGGTLKISALGVA  156 (305)
T ss_dssp             -CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTC
T ss_pred             CeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEE---cCCCcEEeeccccc
Confidence            6889999999776 7777765  3469999999999999999999999999999999999999   56789999999999


Q ss_pred             eeeccC---CccccccCCCccCCcccccCC---CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCC
Q 014733          192 TYIKAG---QNLHGTVGSPFYIAPEVLAGG---YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDP  265 (419)
Q Consensus       192 ~~~~~~---~~~~~~~gt~~y~aPE~l~~~---~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~  265 (419)
                      ......   .......||+.|+|||++.+.   ++.++||||||+++|+|++|+.||.+....+..+.+......++.  
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~--  234 (305)
T 2wtk_C          157 EALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPG--  234 (305)
T ss_dssp             EECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCS--
T ss_pred             cccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCC--
Confidence            876432   222345799999999998763   478999999999999999999999999988888888887665543  


Q ss_pred             CCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchhh
Q 014733          266 WDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQV  306 (419)
Q Consensus       266 ~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~~  306 (419)
                        .+++++.++|.+||+.||.+|||+.++++||||+.....
T Consensus       235 --~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~  273 (305)
T 2wtk_C          235 --DCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPP  273 (305)
T ss_dssp             --SSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC
T ss_pred             --ccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCC
Confidence              688999999999999999999999999999999875543

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=4.3e-47  Score=365.82  Aligned_cols=257  Identities=29%  Similarity=0.493  Sum_probs=226.9

Q ss_pred             ccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEE
Q 014733           37 NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYV  116 (419)
Q Consensus        37 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~  116 (419)
                      ...++|++++.||+|+||.||+|.+..+++.||+|++.....  ....+.+.+|+.+++++. ||||+++++++.+.+.+
T Consensus        19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   95 (303)
T 3a7i_A           19 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCD-SPYVTKYYGSYLKDTKL   95 (303)
T ss_dssp             CGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC--STTHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEE
T ss_pred             ChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc--HHHHHHHHHHHHHHHhCC-CCCEeEEEEEEecCCeE
Confidence            456789999999999999999999999999999999976542  345678999999999995 99999999999999999


Q ss_pred             EEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeecc
Q 014733          117 HLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA  196 (419)
Q Consensus       117 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~  196 (419)
                      ++||||+++++|.+++.. +++++..++.++.||+.||.|||+.||+||||||+||++   +.++.+||+|||++.....
T Consensus        96 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~Dfg~~~~~~~  171 (303)
T 3a7i_A           96 WIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL---SEHGEVKLADFGVAGQLTD  171 (303)
T ss_dssp             EEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECBT
T ss_pred             EEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEE---CCCCCEEEeecccceecCc
Confidence            999999999999999875 679999999999999999999999999999999999999   5678899999999987654


Q ss_pred             CC-ccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 014733          197 GQ-NLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASAR  274 (419)
Q Consensus       197 ~~-~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~  274 (419)
                      .. ......||+.|+|||++.+. ++.++||||||+++|+|++|+.||......+....+......   .....++.++.
T Consensus       172 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~  248 (303)
T 3a7i_A          172 TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPP---TLEGNYSKPLK  248 (303)
T ss_dssp             TBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC---CCCSSCCHHHH
T ss_pred             cccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCC---CCccccCHHHH
Confidence            43 23445799999999998764 899999999999999999999999988887777776654332   22347899999


Q ss_pred             HHHHhhhhcCCCCCCCHHHHHhccccccc
Q 014733          275 DLIMGMLRVDPSTRLTAAEVLAHSWMEEC  303 (419)
Q Consensus       275 ~li~~~L~~dP~~Rps~~eil~hp~~~~~  303 (419)
                      +||.+||+.||.+|||+.++++||||...
T Consensus       249 ~li~~~l~~dp~~Rps~~~ll~~~~~~~~  277 (303)
T 3a7i_A          249 EFVEACLNKEPSFRPTAKELLKHKFILRN  277 (303)
T ss_dssp             HHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred             HHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence            99999999999999999999999999754

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2.2e-47  Score=380.87  Aligned_cols=264  Identities=28%  Similarity=0.443  Sum_probs=219.4

Q ss_pred             hhccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCC-----ceeee
Q 014733           33 TQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN-----VVDLK  107 (419)
Q Consensus        33 ~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpn-----Iv~l~  107 (419)
                      ...+.+.++|++.+.||+|+||+||+|.++.+++.||+|++...    ......+..|+.+++.+..|++     |++++
T Consensus        47 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~  122 (382)
T 2vx3_A           47 KNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLK  122 (382)
T ss_dssp             CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEE
T ss_pred             ecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEee
Confidence            44566789999999999999999999999999999999999743    3456778889999998865664     99999


Q ss_pred             EEEEeCCEEEEEEeecCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--hCCCeeccCCCCcEEEeecCCCCCe
Q 014733          108 AVYEEEDYVHLLMELCAGGELFHRLEKY--GRFSETEARVIFRHLMQVVSYCH--GNGVVHRDLKPENILLATKSSSSPI  183 (419)
Q Consensus       108 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qll~aL~~LH--~~~IvHrDLkp~NILl~~~~~~~~v  183 (419)
                      +++...+.+++||||+. ++|.+++...  +.+++..++.++.||+.||.|||  +.||+||||||+|||++. +.++.+
T Consensus       123 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~-~~~~~~  200 (382)
T 2vx3_A          123 RHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN-PKRSAI  200 (382)
T ss_dssp             EEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESS-TTSCCE
T ss_pred             eeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEec-CCCCcE
Confidence            99999999999999995 5999999875  35999999999999999999999  578999999999999953 235689


Q ss_pred             EEeeccceeeeccCCccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC
Q 014733          184 KLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFP  262 (419)
Q Consensus       184 KL~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~  262 (419)
                      ||+|||++.....  .....+||+.|+|||++.+. ++.++|||||||++|+|++|++||.+.+..+....+.......+
T Consensus       201 kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~  278 (382)
T 2vx3_A          201 KIVDFGSSCQLGQ--RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPP  278 (382)
T ss_dssp             EECCCTTCEETTC--CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCC
T ss_pred             EEEeccCceeccc--ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            9999999987643  33456899999999998874 99999999999999999999999999888777776654211110


Q ss_pred             ------------------CCCC-----------------CC-------------------------CCHHHHHHHHhhhh
Q 014733          263 ------------------SDPW-----------------DH-------------------------ISASARDLIMGMLR  282 (419)
Q Consensus       263 ------------------~~~~-----------------~~-------------------------~s~~l~~li~~~L~  282 (419)
                                        ...|                 ..                         .++++++||.+||+
T Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~  358 (382)
T 2vx3_A          279 AHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLD  358 (382)
T ss_dssp             HHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTC
T ss_pred             HHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcC
Confidence                              0000                 00                         01378999999999


Q ss_pred             cCCCCCCCHHHHHhccccccch
Q 014733          283 VDPSTRLTAAEVLAHSWMEECE  304 (419)
Q Consensus       283 ~dP~~Rps~~eil~hp~~~~~~  304 (419)
                      +||++|||+.|+|+||||++..
T Consensus       359 ~dP~~Rpta~e~L~hp~f~~~~  380 (382)
T 2vx3_A          359 YDPKTRIQPYYALQHSFFKKTA  380 (382)
T ss_dssp             SCTTTSCCHHHHTTSGGGCC--
T ss_pred             CChhhCCCHHHHhcCcccccCC
Confidence            9999999999999999998643

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=2.1e-47  Score=371.21  Aligned_cols=267  Identities=28%  Similarity=0.417  Sum_probs=222.4

Q ss_pred             hccccccCeeeeeeecccCceEEEEEEec-CCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHcc--CCCCceeeeEEE
Q 014733           34 QISNLSDRYVLGKQLGWGQFGVIRECSDK-FTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLS--GHPNVVDLKAVY  110 (419)
Q Consensus        34 ~~~~~~~~y~i~~~LG~G~~g~V~~a~~~-~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~--~hpnIv~l~~~~  110 (419)
                      ......++|++.+.||+|+||.||+|.+. .+|+.||+|++...... ......+.+|+.+++.+.  +||||+++++++
T Consensus         5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~   83 (326)
T 1blx_A            5 GLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVC   83 (326)
T ss_dssp             CCCCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT-TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEE
T ss_pred             cccCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccc-ccCCchhhHHHHHHHhhhccCCCCeEeeeeee
Confidence            34556789999999999999999999995 67899999999754321 122234667888887773  599999999998


Q ss_pred             E-----eCCEEEEEEeecCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCe
Q 014733          111 E-----EEDYVHLLMELCAGGELFHRLEKYG--RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPI  183 (419)
Q Consensus       111 ~-----~~~~~~lV~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~v  183 (419)
                      .     ....+++||||+. ++|.+++....  .+++.+++.++.||+.||.|||+.||+||||||+|||+   +.++.+
T Consensus        84 ~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili---~~~~~~  159 (326)
T 1blx_A           84 TVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQI  159 (326)
T ss_dssp             EEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCE
T ss_pred             eecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEE---cCCCCE
Confidence            7     5678899999997 69999998754  39999999999999999999999999999999999999   567899


Q ss_pred             EEeeccceeeeccCCccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-
Q 014733          184 KLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRF-  261 (419)
Q Consensus       184 KL~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~-  261 (419)
                      ||+|||++.............||+.|+|||++.+. ++.++||||||+++|+|++|+.||.+....+....+....... 
T Consensus       160 kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  239 (326)
T 1blx_A          160 KLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG  239 (326)
T ss_dssp             EECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             EEecCcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence            99999999876655555567899999999998764 8999999999999999999999999988877776665321100 


Q ss_pred             ----------------------CCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          262 ----------------------PSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       262 ----------------------~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                                            ....+..++.++++||.+||+.||.+|||+.++++||||+....
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~  305 (326)
T 1blx_A          240 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER  305 (326)
T ss_dssp             GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             cccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence                                  00123468999999999999999999999999999999987643

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=5.2e-47  Score=369.20  Aligned_cols=264  Identities=30%  Similarity=0.454  Sum_probs=220.8

Q ss_pred             hccccccCeeeeeeecccCceEEEEEEe-cCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCC------Cceee
Q 014733           34 QISNLSDRYVLGKQLGWGQFGVIRECSD-KFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP------NVVDL  106 (419)
Q Consensus        34 ~~~~~~~~y~i~~~LG~G~~g~V~~a~~-~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hp------nIv~l  106 (419)
                      ..+.+.++|++.+.||+|+||+||+|.+ +.+++.||+|++...    ....+.+.+|+.+++.+. |+      +|+++
T Consensus         8 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~-~~~~~~~~~i~~~   82 (339)
T 1z57_A            8 SGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLN-TTDPNSTFRCVQM   82 (339)
T ss_dssp             TTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHH-HHCTTCTTCBCCE
T ss_pred             cCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHhh-hcCCCCceeeEee
Confidence            3456789999999999999999999998 568899999998643    355678899999999986 55      59999


Q ss_pred             eEEEEeCCEEEEEEeecCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCC-----
Q 014733          107 KAVYEEEDYVHLLMELCAGGELFHRLEKYG--RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSS-----  179 (419)
Q Consensus       107 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~-----  179 (419)
                      ++++.+.+.+++||||+ +++|.+++...+  ++++.+++.++.||+.||+|||++||+||||||+|||++.++.     
T Consensus        83 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~  161 (339)
T 1z57_A           83 LEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYN  161 (339)
T ss_dssp             EEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC
T ss_pred             ecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccC
Confidence            99999999999999999 899999998765  5899999999999999999999999999999999999954221     


Q ss_pred             -----------CCCeEEeeccceeeeccCCccccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q 014733          180 -----------SSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTK  247 (419)
Q Consensus       180 -----------~~~vKL~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~  247 (419)
                                 ++.+||+|||++.....  ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||...+.
T Consensus       162 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  239 (339)
T 1z57_A          162 PKIKRDERTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS  239 (339)
T ss_dssp             ----CEEEEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred             CccccccccccCCCceEeeCcccccCcc--ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence                       56899999999986433  2345689999999999877 489999999999999999999999998877


Q ss_pred             HHHHHHHHhcCCCCCCC----------------------------------------CCCCCCHHHHHHHHhhhhcCCCC
Q 014733          248 SKIFDAVRAADLRFPSD----------------------------------------PWDHISASARDLIMGMLRVDPST  287 (419)
Q Consensus       248 ~~~~~~i~~~~~~~~~~----------------------------------------~~~~~s~~l~~li~~~L~~dP~~  287 (419)
                      .+....+.......+..                                        .....++++.+||.+||+.||.+
T Consensus       240 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~  319 (339)
T 1z57_A          240 KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK  319 (339)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred             HHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence            76665554322221110                                        01123567899999999999999


Q ss_pred             CCCHHHHHhccccccchh
Q 014733          288 RLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       288 Rps~~eil~hp~~~~~~~  305 (419)
                      |||+.|+++||||+...+
T Consensus       320 Rpt~~ell~hp~f~~~~~  337 (339)
T 1z57_A          320 RITLREALKHPFFDLLKK  337 (339)
T ss_dssp             SCCHHHHTTSGGGGGGGC
T ss_pred             ccCHHHHhcCHHHHHHhc
Confidence            999999999999987653

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=5e-48  Score=388.40  Aligned_cols=265  Identities=26%  Similarity=0.468  Sum_probs=202.5

Q ss_pred             hhhccccccCeee-eeeecccCceEEEEEEec--CCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeE
Q 014733           32 ATQISNLSDRYVL-GKQLGWGQFGVIRECSDK--FTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKA  108 (419)
Q Consensus        32 ~~~~~~~~~~y~i-~~~LG~G~~g~V~~a~~~--~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~  108 (419)
                      ..+...+.+.|++ +++||+|+||+||+|+++  .+++.||+|++.....     ...+.+|+.+|++++ ||||+++++
T Consensus        12 ~~~~~~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~-hpniv~~~~   85 (405)
T 3rgf_A           12 SSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----SMSACREIALLRELK-HPNVISLQK   85 (405)
T ss_dssp             HHHCCCHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-----CHHHHHHHHHHHHCC-CTTBCCCCE
T ss_pred             hhhhhhhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-----CHHHHHHHHHHHhcC-CCCeeeEee
Confidence            3456778889998 568999999999999966  5789999999975532     245778999999996 999999999


Q ss_pred             EEEe--CCEEEEEEeecCCCChHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeec
Q 014733          109 VYEE--EDYVHLLMELCAGGELFHRLEKY---------GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATK  177 (419)
Q Consensus       109 ~~~~--~~~~~lV~E~~~ggsL~~~l~~~---------~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~  177 (419)
                      ++.+  ...+|+||||+. ++|.+++...         ..+++..++.++.||+.||+|||+.||+||||||+|||+..+
T Consensus        86 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~  164 (405)
T 3rgf_A           86 VFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGE  164 (405)
T ss_dssp             EEEETTTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCS
T ss_pred             EEecCCCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecC
Confidence            9965  678999999995 5888877532         249999999999999999999999999999999999999543


Q ss_pred             -CCCCCeEEeeccceeeeccC----CccccccCCCccCCcccccC-C-CCCchhHHHHHHHHHHHHhCCCCCCCCCH---
Q 014733          178 -SSSSPIKLADFGLATYIKAG----QNLHGTVGSPFYIAPEVLAG-G-YNQAADVWSAGVILYILLSGMPPFWGKTK---  247 (419)
Q Consensus       178 -~~~~~vKL~DFgla~~~~~~----~~~~~~~gt~~y~aPE~l~~-~-~s~~sDvwSlGvil~elltG~~Pf~~~~~---  247 (419)
                       +.++.+||+|||++......    ......+||+.|+|||++.+ . ++.++|||||||++|+|++|++||.+...   
T Consensus       165 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~  244 (405)
T 3rgf_A          165 GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK  244 (405)
T ss_dssp             STTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC----
T ss_pred             CCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcccccc
Confidence             35679999999999876532    22345689999999999876 3 89999999999999999999999976543   


Q ss_pred             ------HHHHHHHHhcCCCCCCCCCC----------------------------------CCCHHHHHHHHhhhhcCCCC
Q 014733          248 ------SKIFDAVRAADLRFPSDPWD----------------------------------HISASARDLIMGMLRVDPST  287 (419)
Q Consensus       248 ------~~~~~~i~~~~~~~~~~~~~----------------------------------~~s~~l~~li~~~L~~dP~~  287 (419)
                            .+.+..+.......+...|.                                  ..+.++.+||.+||++||.+
T Consensus       245 ~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~  324 (405)
T 3rgf_A          245 TSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIK  324 (405)
T ss_dssp             --CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGG
T ss_pred             ccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCccc
Confidence                  23333333222112222221                                  22788999999999999999


Q ss_pred             CCCHHHHHhccccccc
Q 014733          288 RLTAAEVLAHSWMEEC  303 (419)
Q Consensus       288 Rps~~eil~hp~~~~~  303 (419)
                      |||+.|+|+||||...
T Consensus       325 R~ta~e~L~hp~f~~~  340 (405)
T 3rgf_A          325 RITSEQAMQDPYFLED  340 (405)
T ss_dssp             SCCHHHHHTSGGGTSS
T ss_pred             CCCHHHHhcChhhccC
Confidence            9999999999999864

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=2.4e-48  Score=386.16  Aligned_cols=262  Identities=15%  Similarity=0.155  Sum_probs=203.4

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHcc-CCCCceeee-------EEE
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLS-GHPNVVDLK-------AVY  110 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-~hpnIv~l~-------~~~  110 (419)
                      ...|++++.||+|+||+||+|.++.+|+.||+|++...........+.+.+|+.+++.|+ +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            456999999999999999999999999999999998876555667788889977666664 499988755       555


Q ss_pred             EeC-----------------CEEEEEEeecCCCChHHHHHHcC-CCCHHHH------HHHHHHHHHHHHHHHhCCCeecc
Q 014733          111 EEE-----------------DYVHLLMELCAGGELFHRLEKYG-RFSETEA------RVIFRHLMQVVSYCHGNGVVHRD  166 (419)
Q Consensus       111 ~~~-----------------~~~~lV~E~~~ggsL~~~l~~~~-~l~~~~~------~~i~~qll~aL~~LH~~~IvHrD  166 (419)
                      ...                 ..+|+||||++ ++|.+++...+ .+.+..+      ..++.||+.||+|||++||+|||
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD  219 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH  219 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence            543                 34899999998 89999998643 3455555      67779999999999999999999


Q ss_pred             CCCCcEEEeecCCCCCeEEeeccceeeeccCCccccccCCCccCCcccccC---CCCCchhHHHHHHHHHHHHhCCCCCC
Q 014733          167 LKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG---GYNQAADVWSAGVILYILLSGMPPFW  243 (419)
Q Consensus       167 Lkp~NILl~~~~~~~~vKL~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~---~~s~~sDvwSlGvil~elltG~~Pf~  243 (419)
                      |||+|||+   +.++.+||+|||++......  .....+|+.|+|||++.+   .++.++|||||||++|+|++|+.||.
T Consensus       220 ikp~NIll---~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~  294 (371)
T 3q60_A          220 FTPDNLFI---MPDGRLMLGDVSALWKVGTR--GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG  294 (371)
T ss_dssp             CSGGGEEE---CTTSCEEECCGGGEEETTCE--EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTT
T ss_pred             CCHHHEEE---CCCCCEEEEecceeeecCCC--ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCC
Confidence            99999999   56789999999999875332  224567799999999876   38999999999999999999999997


Q ss_pred             CCCHHHHH--HH---HHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchhh
Q 014733          244 GKTKSKIF--DA---VRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQV  306 (419)
Q Consensus       244 ~~~~~~~~--~~---i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~~  306 (419)
                      +.......  ..   ............+..+++++.+||.+||+.||++|||+.++++||||++..+.
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~  362 (371)
T 3q60_A          295 LVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQNE  362 (371)
T ss_dssp             BCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHHHH
T ss_pred             CcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHHHH
Confidence            76432110  00   01111222233345889999999999999999999999999999999987653

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=5.1e-47  Score=372.83  Aligned_cols=264  Identities=29%  Similarity=0.473  Sum_probs=220.9

Q ss_pred             hccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeC
Q 014733           34 QISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEE  113 (419)
Q Consensus        34 ~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~  113 (419)
                      ....+.++|++.+.||+|+||.||+|.+..+|+.||+|++...  ........+.+|+.++++++ ||||+++++++...
T Consensus         5 ~~~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~   81 (353)
T 2b9h_A            5 IVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF--DKPLFALRTLREIKILKHFK-HENIITIFNIQRPD   81 (353)
T ss_dssp             CCCCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--SSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCS
T ss_pred             cccccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc--ccchHHHHHHHHHHHHHhCc-CCCcCCeeeeeccc
Confidence            3556889999999999999999999999999999999999643  34456677889999999996 99999999998754


Q ss_pred             -----CEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeec
Q 014733          114 -----DYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADF  188 (419)
Q Consensus       114 -----~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DF  188 (419)
                           ...++||||+. ++|.+++.. +.+++.+++.++.||+.||+|||++||+||||||+|||+   +.++.+||+||
T Consensus        82 ~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~---~~~~~~kl~Df  156 (353)
T 2b9h_A           82 SFENFNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLI---NSNCDLKVCDF  156 (353)
T ss_dssp             CSTTCCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCC
T ss_pred             ccCccceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---cCCCcEEEEec
Confidence                 67999999996 689998876 679999999999999999999999999999999999999   56788999999


Q ss_pred             cceeeeccCCc-----------cccccCCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 014733          189 GLATYIKAGQN-----------LHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVR  255 (419)
Q Consensus       189 gla~~~~~~~~-----------~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~  255 (419)
                      |++........           ....+||+.|+|||++.+  .++.++|||||||++|+|++|++||.+....+....+.
T Consensus       157 g~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~  236 (353)
T 2b9h_A          157 GLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIF  236 (353)
T ss_dssp             TTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             ccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Confidence            99987643221           123478999999998754  48999999999999999999999999887666555443


Q ss_pred             hcCCC------------------------CCCC----CCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          256 AADLR------------------------FPSD----PWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       256 ~~~~~------------------------~~~~----~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                      .....                        .+..    .+..+++++.+||.+||+.||++|||+.++++||||+....
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  314 (353)
T 2b9h_A          237 GIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHD  314 (353)
T ss_dssp             HHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             HHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCC
Confidence            21110                        0110    12468999999999999999999999999999999987654

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=5.4e-47  Score=367.59  Aligned_cols=256  Identities=25%  Similarity=0.396  Sum_probs=212.4

Q ss_pred             hhhccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEE
Q 014733           32 ATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYE  111 (419)
Q Consensus        32 ~~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~  111 (419)
                      ....+...++|++.+.||+|+||+||+|.+  +|+.||+|++..... .....+.+.+|+.++++++ ||||+++++++.
T Consensus        29 ~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~  104 (309)
T 3p86_A           29 GDDMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLR-HPNIVLFMGAVT  104 (309)
T ss_dssp             ---CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEC
T ss_pred             cccccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEE
Confidence            334445578999999999999999999976  588999999976543 4566788999999999996 999999999999


Q ss_pred             eCCEEEEEEeecCCCChHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHhCC--CeeccCCCCcEEEeecCCCCCeEEe
Q 014733          112 EEDYVHLLMELCAGGELFHRLEKYGR---FSETEARVIFRHLMQVVSYCHGNG--VVHRDLKPENILLATKSSSSPIKLA  186 (419)
Q Consensus       112 ~~~~~~lV~E~~~ggsL~~~l~~~~~---l~~~~~~~i~~qll~aL~~LH~~~--IvHrDLkp~NILl~~~~~~~~vKL~  186 (419)
                      +.+.+++||||+++++|.+++...+.   +++..++.++.||+.||+|||+.|  |+||||||+|||+   +.++.+||+
T Consensus       105 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll---~~~~~~kL~  181 (309)
T 3p86_A          105 QPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLV---DKKYTVKVC  181 (309)
T ss_dssp             STTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEE---CTTCCEEEC
T ss_pred             ECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEE---eCCCcEEEC
Confidence            99999999999999999999987553   999999999999999999999999  9999999999999   567899999


Q ss_pred             eccceeeeccCC-ccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC
Q 014733          187 DFGLATYIKAGQ-NLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSD  264 (419)
Q Consensus       187 DFgla~~~~~~~-~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~  264 (419)
                      |||++....... ......||+.|+|||++.+. ++.++||||||+++|+|++|+.||.+....+....+......... 
T Consensus       182 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~-  260 (309)
T 3p86_A          182 DFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEI-  260 (309)
T ss_dssp             CCC-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCC-
T ss_pred             CCCCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC-
Confidence            999998654332 23446899999999998875 899999999999999999999999998888887777554433322 


Q ss_pred             CCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          265 PWDHISASARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       265 ~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                       ...+++++.+||.+||+.||.+|||+.++++
T Consensus       261 -~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~  291 (309)
T 3p86_A          261 -PRNLNPQVAAIIEGCWTNEPWKRPSFATIMD  291 (309)
T ss_dssp             -CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -CccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence             2478999999999999999999999999987

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=4e-47  Score=384.07  Aligned_cols=257  Identities=30%  Similarity=0.511  Sum_probs=212.8

Q ss_pred             cccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeC----
Q 014733           38 LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEE----  113 (419)
Q Consensus        38 ~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~----  113 (419)
                      ...+|++.+.||+|+||+||+|.++.+|+.||||++.....       ...+|+++|++++ ||||+++++++...    
T Consensus        52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~-hpniv~l~~~~~~~~~~~  123 (420)
T 1j1b_A           52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLD-HCNIVRLRYFFYSSGEKK  123 (420)
T ss_dssp             EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCC-CTTBCCEEEEEEEEETTT
T ss_pred             ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcC-CCCccceeeEEeccCCCC
Confidence            45689999999999999999999999999999999875432       2346999999996 99999999998542    


Q ss_pred             --CEEEEEEeecCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEee
Q 014733          114 --DYVHLLMELCAGGELFHRLEK----YGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLAD  187 (419)
Q Consensus       114 --~~~~lV~E~~~ggsL~~~l~~----~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~D  187 (419)
                        .++++||||+++ +|.+.+..    ...+++..++.++.||+.||+|||++||+||||||+|||++.  +.+.+||+|
T Consensus       124 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~--~~~~~kl~D  200 (420)
T 1j1b_A          124 DEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLCD  200 (420)
T ss_dssp             TEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEET--TTTEEEECC
T ss_pred             cceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeC--CCCeEEecc
Confidence              247799999965 66665542    456999999999999999999999999999999999999953  345689999


Q ss_pred             ccceeeeccCCccccccCCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--------
Q 014733          188 FGLATYIKAGQNLHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAA--------  257 (419)
Q Consensus       188 Fgla~~~~~~~~~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--------  257 (419)
                      ||+++...........+||+.|+|||++.+  .|+.++|||||||++|||++|++||.+....+.+..+...        
T Consensus       201 FG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~  280 (420)
T 1j1b_A          201 FGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ  280 (420)
T ss_dssp             CTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             chhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            999998766655666789999999999865  4899999999999999999999999988776665554331        


Q ss_pred             ---------CCCCCCC---C-----CCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          258 ---------DLRFPSD---P-----WDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       258 ---------~~~~~~~---~-----~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                               .+.++..   .     ...+++++.+||.+||+.||.+|||+.|+++||||+....
T Consensus       281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  345 (420)
T 1j1b_A          281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD  345 (420)
T ss_dssp             HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred             HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccccc
Confidence                     1111111   1     1357899999999999999999999999999999987654

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.6e-47  Score=370.14  Aligned_cols=264  Identities=30%  Similarity=0.454  Sum_probs=216.0

Q ss_pred             ccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEE---
Q 014733           35 ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYE---  111 (419)
Q Consensus        35 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~---  111 (419)
                      ...+.++|++++.||+|+||.||+|.+..+|+.||+|++...   .....+.+.+|+.++++++ ||||+++++++.   
T Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~   81 (320)
T 2i6l_A            6 GFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLD-HDNIVKVFEILGPSG   81 (320)
T ss_dssp             CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECTTS
T ss_pred             cCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcC-CCCeeEEEEeccccc
Confidence            346789999999999999999999999999999999998754   4566788999999999996 999999999873   


Q ss_pred             -----------eCCEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCC
Q 014733          112 -----------EEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSS  180 (419)
Q Consensus       112 -----------~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~  180 (419)
                                 +.+..++||||+. |+|.+++.. +++++..++.++.||+.||+|||+.||+||||||+|||++.  .+
T Consensus        82 ~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~--~~  157 (320)
T 2i6l_A           82 SQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINT--ED  157 (320)
T ss_dssp             CBCCC----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEET--TT
T ss_pred             cccccccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcC--CC
Confidence                       4578999999997 699999865 67999999999999999999999999999999999999952  45


Q ss_pred             CCeEEeeccceeeeccCC----ccccccCCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 014733          181 SPIKLADFGLATYIKAGQ----NLHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAV  254 (419)
Q Consensus       181 ~~vKL~DFgla~~~~~~~----~~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i  254 (419)
                      +.+||+|||++.......    ......+|+.|+|||++.+  .++.++||||||+++|+|++|+.||.+....+....+
T Consensus       158 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  237 (320)
T 2i6l_A          158 LVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI  237 (320)
T ss_dssp             TEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             CeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            689999999998764321    2234468999999998764  4899999999999999999999999988877766665


Q ss_pred             HhcCCCC----------------------CCC----CCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchhh
Q 014733          255 RAADLRF----------------------PSD----PWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQV  306 (419)
Q Consensus       255 ~~~~~~~----------------------~~~----~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~~  306 (419)
                      .......                      +..    .+..++.++++||.+||+.||++|||+.++++||||+....+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p  315 (320)
T 2i6l_A          238 LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFP  315 (320)
T ss_dssp             HHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC-
T ss_pred             HHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCc
Confidence            4432111                      111    124689999999999999999999999999999999865443

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=2.9e-47  Score=366.33  Aligned_cols=262  Identities=27%  Similarity=0.478  Sum_probs=220.8

Q ss_pred             ccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCC
Q 014733           35 ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEED  114 (419)
Q Consensus        35 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~  114 (419)
                      .-...++|++++.||+|+||.||+|.++.+++.+|+|++....   ....+.+.+|+.+++++. ||||+++++++.+.+
T Consensus        14 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~   89 (302)
T 2j7t_A           14 DLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYIVEIEILATCD-HPYIVKLLGAYYHDG   89 (302)
T ss_dssp             SSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCC-CTTBCCEEEEEECC-
T ss_pred             ccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC---HHHHHHHHHHHHHHhcCC-CCCEeeeeeeeeeCC
Confidence            3457789999999999999999999999999999999987542   345678889999999995 999999999999999


Q ss_pred             EEEEEEeecCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceee
Q 014733          115 YVHLLMELCAGGELFHRLEK-YGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATY  193 (419)
Q Consensus       115 ~~~lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~  193 (419)
                      .+++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||+   +.++.+||+|||++..
T Consensus        90 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~  166 (302)
T 2j7t_A           90 KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLM---TLEGDIRLADFGVSAK  166 (302)
T ss_dssp             CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTSCEEECCCHHHHH
T ss_pred             eEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE---CCCCCEEEEECCCCcc
Confidence            99999999999999998875 4569999999999999999999999999999999999999   5677899999998764


Q ss_pred             eccC-CccccccCCCccCCccccc-----C-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 014733          194 IKAG-QNLHGTVGSPFYIAPEVLA-----G-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW  266 (419)
Q Consensus       194 ~~~~-~~~~~~~gt~~y~aPE~l~-----~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  266 (419)
                      .... .......||+.|+|||++.     + .++.++||||||+++|+|++|..||......+....+........ ...
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~  245 (302)
T 2j7t_A          167 NLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTL-LTP  245 (302)
T ss_dssp             HHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC-SSG
T ss_pred             ccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCccc-CCc
Confidence            3221 1223457999999999973     3 489999999999999999999999998888777777666543322 223


Q ss_pred             CCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccch
Q 014733          267 DHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECE  304 (419)
Q Consensus       267 ~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~  304 (419)
                      ..++.++.++|.+||+.||.+|||+.++++||||+...
T Consensus       246 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  283 (302)
T 2j7t_A          246 SKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT  283 (302)
T ss_dssp             GGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred             cccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence            46899999999999999999999999999999998754

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=9.2e-47  Score=365.07  Aligned_cols=260  Identities=27%  Similarity=0.452  Sum_probs=217.4

Q ss_pred             ccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCC
Q 014733           35 ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEED  114 (419)
Q Consensus        35 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~  114 (419)
                      .+...++|++.+.||+|+||.||+|.++.+|+.||+|++....     ..+.+.+|+.+++++. ||||+++++++.+.+
T Consensus        24 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~   97 (314)
T 3com_A           24 TKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCD-SPHVVKYYGSYFKNT   97 (314)
T ss_dssp             ------CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-----CCHHHHHHHHHHHTCC-CTTBCCEEEEEEETT
T ss_pred             hhcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-----HHHHHHHHHHHHHhCC-CCCCccEEEEEEeCC
Confidence            4567889999999999999999999999999999999997542     3467889999999995 999999999999999


Q ss_pred             EEEEEEeecCCCChHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceee
Q 014733          115 YVHLLMELCAGGELFHRLE-KYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATY  193 (419)
Q Consensus       115 ~~~lV~E~~~ggsL~~~l~-~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~  193 (419)
                      .+++||||+++++|.+++. ....+++.+++.++.||+.||.|||+.||+|+||||+||++   +.++.+||+|||++..
T Consensus        98 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~  174 (314)
T 3com_A           98 DLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILL---NTEGHAKLADFGVAGQ  174 (314)
T ss_dssp             EEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEE
T ss_pred             EEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEE---CCCCCEEEeecccchh
Confidence            9999999999999999997 34679999999999999999999999999999999999999   5677899999999987


Q ss_pred             eccCC-ccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCH
Q 014733          194 IKAGQ-NLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISA  271 (419)
Q Consensus       194 ~~~~~-~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  271 (419)
                      ..... ......||+.|+|||++.+. ++.++||||||+++|+|++|+.||...........+...... .......++.
T Consensus       175 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  253 (314)
T 3com_A          175 LTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPP-TFRKPELWSD  253 (314)
T ss_dssp             CBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC-CCSSGGGSCH
T ss_pred             hhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCc-ccCCcccCCH
Confidence            65432 23445799999999998774 899999999999999999999999887776665555444221 1122346789


Q ss_pred             HHHHHHHhhhhcCCCCCCCHHHHHhccccccch
Q 014733          272 SARDLIMGMLRVDPSTRLTAAEVLAHSWMEECE  304 (419)
Q Consensus       272 ~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~  304 (419)
                      ++.++|.+||..||.+|||+.++++||||+...
T Consensus       254 ~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~  286 (314)
T 3com_A          254 NFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK  286 (314)
T ss_dssp             HHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence            999999999999999999999999999998653

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=3.9e-47  Score=377.69  Aligned_cols=260  Identities=30%  Similarity=0.487  Sum_probs=217.4

Q ss_pred             ccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEE
Q 014733           37 NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYV  116 (419)
Q Consensus        37 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~  116 (419)
                      .+.++|++.+.||+|+||.||+|.++.+|+.||+|++.... ........+.+|+.+++.++ ||||+++++++.+.+..
T Consensus        39 ~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~  116 (371)
T 4exu_A           39 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQ-HENVIGLLDVFTPASSL  116 (371)
T ss_dssp             EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSSS
T ss_pred             cccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcC-CCCchhhhhheeccCCc
Confidence            46789999999999999999999999999999999997643 34556788999999999996 99999999999877654


Q ss_pred             ------EEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccc
Q 014733          117 ------HLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGL  190 (419)
Q Consensus       117 ------~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgl  190 (419)
                            ++||||+. ++|.+.+.  ..+++..++.++.||+.||+|||+.||+||||||+|||+   +.++.+||+|||+
T Consensus       117 ~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kL~Dfg~  190 (371)
T 4exu_A          117 RNFYDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKILDFGL  190 (371)
T ss_dssp             TTCCCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECSTTC
T ss_pred             ccceeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEE---CCCCCEEEEecCc
Confidence                  99999996 68887773  459999999999999999999999999999999999999   5678999999999


Q ss_pred             eeeeccCCccccccCCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-------
Q 014733          191 ATYIKAGQNLHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRF-------  261 (419)
Q Consensus       191 a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~-------  261 (419)
                      +.....  .....+||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+....+....+.......       
T Consensus       191 a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  268 (371)
T 4exu_A          191 ARHADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK  268 (371)
T ss_dssp             C----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred             cccccc--CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHH
Confidence            986533  2345688999999999876  48999999999999999999999999888777666654321110       


Q ss_pred             ----------------CC----CCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchhh
Q 014733          262 ----------------PS----DPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQV  306 (419)
Q Consensus       262 ----------------~~----~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~~  306 (419)
                                      +.    ..+..+++++.+||.+||+.||++|||+.|+|+||||+.....
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  333 (371)
T 4exu_A          269 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDP  333 (371)
T ss_dssp             CSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCG
T ss_pred             hhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCc
Confidence                            00    0124678999999999999999999999999999999876443

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.5e-47  Score=384.01  Aligned_cols=261  Identities=30%  Similarity=0.489  Sum_probs=214.1

Q ss_pred             hccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeC
Q 014733           34 QISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEE  113 (419)
Q Consensus        34 ~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~  113 (419)
                      ..+....+|++++.||+|+||+||+|.+..+++ +|+|++......       ..+|+.+|+.++ ||||+++++++...
T Consensus        34 ~~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~-------~~~E~~il~~l~-h~niv~l~~~~~~~  104 (394)
T 4e7w_A           34 TGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF-------KNRELQIMRIVK-HPNVVDLKAFFYSN  104 (394)
T ss_dssp             SCCEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS-------CCHHHHHHHTCC-CTTBCCEEEEEEEE
T ss_pred             CCCcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch-------HHHHHHHHHhCC-CCCcceEEEEEEec
Confidence            345567899999999999999999999987666 788877654321       236999999996 99999999999654


Q ss_pred             C------EEEEEEeecCCCChHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCe
Q 014733          114 D------YVHLLMELCAGGELFHRLE----KYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPI  183 (419)
Q Consensus       114 ~------~~~lV~E~~~ggsL~~~l~----~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~v  183 (419)
                      +      .+++||||++++ +.+.+.    ....+++..++.++.||+.||+|||+.||+||||||+|||++  ..++.+
T Consensus       105 ~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~--~~~~~~  181 (394)
T 4e7w_A          105 GDKKDEVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLD--PPSGVL  181 (394)
T ss_dssp             SSSSSCEEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--TTTTEE
T ss_pred             CCCCCceEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEc--CCCCcE
Confidence            3      488999999764 443332    246799999999999999999999999999999999999994  256789


Q ss_pred             EEeeccceeeeccCCccccccCCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC---
Q 014733          184 KLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAAD---  258 (419)
Q Consensus       184 KL~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~---  258 (419)
                      ||+|||+++............||+.|+|||++.+  .|+.++|||||||++|+|++|++||.+.+..+....+....   
T Consensus       182 kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p  261 (394)
T 4e7w_A          182 KLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTP  261 (394)
T ss_dssp             EECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred             EEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            9999999998766666667789999999999866  38999999999999999999999999988776666554321   


Q ss_pred             --------------CCCCCC--------CCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchhh
Q 014733          259 --------------LRFPSD--------PWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQV  306 (419)
Q Consensus       259 --------------~~~~~~--------~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~~  306 (419)
                                    ..++..        ....+++++.+||.+||++||.+|||+.|+++||||+++...
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  331 (394)
T 4e7w_A          262 SREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTG  331 (394)
T ss_dssp             CHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSS
T ss_pred             CHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccc
Confidence                          111110        123488999999999999999999999999999999987553

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=4.7e-47  Score=360.73  Aligned_cols=259  Identities=27%  Similarity=0.496  Sum_probs=224.5

Q ss_pred             cccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEe--CCE
Q 014733           38 LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEE--EDY  115 (419)
Q Consensus        38 ~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~--~~~  115 (419)
                      ..++|++++.||+|+||.||+|.++.+|+.||+|++..... .....+.+.+|+.++++++ ||||+++++++.+  .+.
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~   81 (279)
T 2w5a_A            4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELK-HPNIVRYYDRIIDRTNTT   81 (279)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEEGGGTE
T ss_pred             chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhcC-CCCCCeEEEEEecCCCce
Confidence            45799999999999999999999999999999999976543 4566788999999999996 9999999998854  678


Q ss_pred             EEEEEeecCCCChHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC-----CeeccCCCCcEEEeecCCCCCeEEe
Q 014733          116 VHLLMELCAGGELFHRLEKY----GRFSETEARVIFRHLMQVVSYCHGNG-----VVHRDLKPENILLATKSSSSPIKLA  186 (419)
Q Consensus       116 ~~lV~E~~~ggsL~~~l~~~----~~l~~~~~~~i~~qll~aL~~LH~~~-----IvHrDLkp~NILl~~~~~~~~vKL~  186 (419)
                      +++||||+++++|.+++...    ..+++..++.++.||+.||+|||+.+     |+||||||+|||+   +.++.+||+
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~---~~~~~~kl~  158 (279)
T 2w5a_A           82 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLG  158 (279)
T ss_dssp             EEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEE---CSSSCEEEC
T ss_pred             EEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEE---cCCCCEEEe
Confidence            99999999999999999754    24999999999999999999999999     9999999999999   567789999


Q ss_pred             eccceeeeccCCc-cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC
Q 014733          187 DFGLATYIKAGQN-LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSD  264 (419)
Q Consensus       187 DFgla~~~~~~~~-~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~  264 (419)
                      |||++........ .....||+.|+|||++.+. ++.++||||||+++|+|++|+.||......++...+........  
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~--  236 (279)
T 2w5a_A          159 DFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI--  236 (279)
T ss_dssp             CCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC--
T ss_pred             cCchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccC--
Confidence            9999986544322 2345789999999998774 89999999999999999999999999888888888877654322  


Q ss_pred             CCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccch
Q 014733          265 PWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECE  304 (419)
Q Consensus       265 ~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~  304 (419)
                       ...++.++.++|.+||+.||.+|||+.++++|+|+.+..
T Consensus       237 -~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~  275 (279)
T 2w5a_A          237 -PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH  275 (279)
T ss_dssp             -CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred             -CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence             236899999999999999999999999999999997643

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=9.8e-47  Score=369.92  Aligned_cols=267  Identities=28%  Similarity=0.447  Sum_probs=220.7

Q ss_pred             hhhccccccCeeeeeeecccCceEEEEEEecCCC-cEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCC------ce
Q 014733           32 ATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTG-EVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN------VV  104 (419)
Q Consensus        32 ~~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g-~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpn------Iv  104 (419)
                      ....+.+.++|++.+.||+|+||+||+|.+..++ ..||+|++...    ....+.+.+|+.+++++. |++      ++
T Consensus        11 ~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~-~~~~~~~~~~~   85 (355)
T 2eu9_A           11 CRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIK-EKDKENKFLCV   85 (355)
T ss_dssp             CCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHH-HHCTTSCSCBC
T ss_pred             cccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHHh-hcCCCCceeEE
Confidence            3445567899999999999999999999998776 78999998643    355677889999999996 655      99


Q ss_pred             eeeEEEEeCCEEEEEEeecCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeec-----
Q 014733          105 DLKAVYEEEDYVHLLMELCAGGELFHRLEKYG--RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATK-----  177 (419)
Q Consensus       105 ~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~-----  177 (419)
                      .+++++...+.+++||||+ +++|.+.+....  .+++.+++.++.||+.||+|||++||+||||||+|||+..+     
T Consensus        86 ~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~  164 (355)
T 2eu9_A           86 LMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETL  164 (355)
T ss_dssp             CEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEE
T ss_pred             EeeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccc
Confidence            9999999999999999999 677777776543  69999999999999999999999999999999999999543     


Q ss_pred             -----------CCCCCeEEeeccceeeeccCCccccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 014733          178 -----------SSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGK  245 (419)
Q Consensus       178 -----------~~~~~vKL~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~elltG~~Pf~~~  245 (419)
                                 ..++.+||+|||++.....  ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.
T Consensus       165 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  242 (355)
T 2eu9_A          165 YNEHKSCEEKSVKNTSIRVADFGSATFDHE--HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH  242 (355)
T ss_dssp             ECCC-CCCEEEESCCCEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ccccccccccccCCCcEEEeecCccccccc--cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence                       2467899999999986433  2345689999999999876 4899999999999999999999999988


Q ss_pred             CHHHHHHHHHhcCCCCCCC----------------CC------------------------CCCCHHHHHHHHhhhhcCC
Q 014733          246 TKSKIFDAVRAADLRFPSD----------------PW------------------------DHISASARDLIMGMLRVDP  285 (419)
Q Consensus       246 ~~~~~~~~i~~~~~~~~~~----------------~~------------------------~~~s~~l~~li~~~L~~dP  285 (419)
                      ...+....+.......|..                .|                        ...+.++.+||.+||+.||
T Consensus       243 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP  322 (355)
T 2eu9_A          243 ENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDP  322 (355)
T ss_dssp             SHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred             CHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCCh
Confidence            8776665554432222110                00                        1124578899999999999


Q ss_pred             CCCCCHHHHHhccccccchhh
Q 014733          286 STRLTAAEVLAHSWMEECEQV  306 (419)
Q Consensus       286 ~~Rps~~eil~hp~~~~~~~~  306 (419)
                      ++|||+.|+++||||++....
T Consensus       323 ~~Rpt~~e~l~hp~f~~~~~~  343 (355)
T 2eu9_A          323 AQRITLAEALLHPFFAGLTPE  343 (355)
T ss_dssp             TTSCCHHHHTTSGGGGGCCHH
T ss_pred             hhCcCHHHHhcChhhcCCChh
Confidence            999999999999999987653

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.3e-47  Score=378.96  Aligned_cols=259  Identities=22%  Similarity=0.314  Sum_probs=222.7

Q ss_pred             cccCeeeeeeecccCceEEEEEE-----ecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEe
Q 014733           38 LSDRYVLGKQLGWGQFGVIRECS-----DKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEE  112 (419)
Q Consensus        38 ~~~~y~i~~~LG~G~~g~V~~a~-----~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~  112 (419)
                      ..++|++++.||+|+||+||+|.     +..++..||+|++...  ........+.+|+.+++++. ||||+++++++.+
T Consensus        69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~  145 (367)
T 3l9p_A           69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFN-HQNIVRCIGVSLQ  145 (367)
T ss_dssp             CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS--CCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECS
T ss_pred             CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc--cChhhHHHHHHHHHHHHhCC-CCCCCeEEEEEec
Confidence            35899999999999999999999     4457789999998643  34566778999999999995 9999999999999


Q ss_pred             CCEEEEEEeecCCCChHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEE
Q 014733          113 EDYVHLLMELCAGGELFHRLEKYG-------RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKL  185 (419)
Q Consensus       113 ~~~~~lV~E~~~ggsL~~~l~~~~-------~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL  185 (419)
                      .+..++||||++||+|.+++...+       .+++.+++.++.||+.||+|||++||+||||||+|||++.++.+..+||
T Consensus       146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL  225 (367)
T 3l9p_A          146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI  225 (367)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEE
Confidence            999999999999999999998653       4899999999999999999999999999999999999976556667999


Q ss_pred             eeccceeeeccC---CccccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCC
Q 014733          186 ADFGLATYIKAG---QNLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLR  260 (419)
Q Consensus       186 ~DFgla~~~~~~---~~~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~  260 (419)
                      +|||+++.....   .......||+.|+|||++.+ .++.++|||||||++|+|++ |..||.+....+....+......
T Consensus       226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~  305 (367)
T 3l9p_A          226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM  305 (367)
T ss_dssp             CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC
T ss_pred             CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence            999999765322   12234568999999999865 59999999999999999998 99999999998888888776533


Q ss_pred             CCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhcccccc
Q 014733          261 FPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE  302 (419)
Q Consensus       261 ~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~  302 (419)
                      .+   ...++.++.+||.+||+.||.+|||+.++++|.|...
T Consensus       306 ~~---~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~  344 (367)
T 3l9p_A          306 DP---PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  344 (367)
T ss_dssp             CC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CC---CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence            22   2478999999999999999999999999999977654

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=3.5e-47  Score=374.97  Aligned_cols=266  Identities=26%  Similarity=0.404  Sum_probs=207.9

Q ss_pred             ccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCC
Q 014733           35 ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEED  114 (419)
Q Consensus        35 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~  114 (419)
                      .....++|++.+.||+|+||+||+|.++.+|+.||+|++.....    .......|+..++.+. ||||+++++++.+.+
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~~~l~~l~-h~niv~~~~~~~~~~   92 (360)
T 3e3p_A           18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR----FRNRELQIMQDLAVLH-HPNIVQLQSYFYTLG   92 (360)
T ss_dssp             HHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT----CCCHHHHHHHHHHHHC-CTTBCCEEEEEEEEC
T ss_pred             chhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc----ccHHHHHHHHHHHhcC-CCCcccHHHhhhccc
Confidence            44456899999999999999999999999999999999865432    2234556778888885 999999999997643


Q ss_pred             -------EEEEEEeecCCCChHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHH--hCCCeeccCCCCcEEEeecCCCC
Q 014733          115 -------YVHLLMELCAGGELFHRL----EKYGRFSETEARVIFRHLMQVVSYCH--GNGVVHRDLKPENILLATKSSSS  181 (419)
Q Consensus       115 -------~~~lV~E~~~ggsL~~~l----~~~~~l~~~~~~~i~~qll~aL~~LH--~~~IvHrDLkp~NILl~~~~~~~  181 (419)
                             .+++||||+++ +|...+    .....+++..++.++.|++.||.|||  +.||+||||||+|||++.  .++
T Consensus        93 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~--~~~  169 (360)
T 3e3p_A           93 ERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNE--ADG  169 (360)
T ss_dssp             SSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEET--TTT
T ss_pred             cccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeC--CCC
Confidence                   38899999976 544443    34456999999999999999999999  999999999999999952  367


Q ss_pred             CeEEeeccceeeeccCCccccccCCCccCCcccccC-C-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC
Q 014733          182 PIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG-G-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADL  259 (419)
Q Consensus       182 ~vKL~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~-~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~  259 (419)
                      .+||+|||++.............||+.|+|||++.+ . ++.++|||||||++|+|++|+.||.+....+....+.....
T Consensus       170 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  249 (360)
T 3e3p_A          170 TLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLG  249 (360)
T ss_dssp             EEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred             cEEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcC
Confidence            899999999998776666666789999999999865 3 89999999999999999999999999888777766644211


Q ss_pred             CCC----------------------------CCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchhhhc
Q 014733          260 RFP----------------------------SDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQ  308 (419)
Q Consensus       260 ~~~----------------------------~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~~~~  308 (419)
                      ..+                            .......+.++.+||.+||+.||.+|||+.|+|+||||++......
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~  326 (360)
T 3e3p_A          250 CPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPAT  326 (360)
T ss_dssp             CCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTC
T ss_pred             CCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCccc
Confidence            100                            0011235789999999999999999999999999999998765443

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=3.9e-47  Score=375.44  Aligned_cols=268  Identities=24%  Similarity=0.394  Sum_probs=214.3

Q ss_pred             hhhccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCcc--------CCHHhHHHHHHHHHHHHHccCCCCc
Q 014733           32 ATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRL--------VTVEDVRSIKLEIEIMTKLSGHPNV  103 (419)
Q Consensus        32 ~~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~--------~~~~~~~~~~~Ei~il~~l~~hpnI  103 (419)
                      ..++..+.++|++++.||+|+||.||+|.+.. |..||+|++.....        ......+.+.+|+.++++++ ||||
T Consensus        14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i   91 (362)
T 3pg1_A           14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH-HPNI   91 (362)
T ss_dssp             HHHHHHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCC-CTTB
T ss_pred             HHHHHHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCC-CcCc
Confidence            45677889999999999999999999999864 99999999865322        12334578999999999996 9999


Q ss_pred             eeeeEEEEe-----CCEEEEEEeecCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeec
Q 014733          104 VDLKAVYEE-----EDYVHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATK  177 (419)
Q Consensus       104 v~l~~~~~~-----~~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~  177 (419)
                      +++++++..     ...+|+||||+. |+|.+.+... ..+++..++.++.||+.||.|||+.||+||||||+|||+   
T Consensus        92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~---  167 (362)
T 3pg1_A           92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL---  167 (362)
T ss_dssp             CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---
T ss_pred             cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEE---
Confidence            999999954     347899999997 6888877654 369999999999999999999999999999999999999   


Q ss_pred             CCCCCeEEeeccceeeeccCCccccccCCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 014733          178 SSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVR  255 (419)
Q Consensus       178 ~~~~~vKL~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~  255 (419)
                      +.++.+||+|||++.............||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+....+....+.
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~  247 (362)
T 3pg1_A          168 ADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIV  247 (362)
T ss_dssp             CTTCCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             cCCCCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            5677899999999987655555566789999999999875  48999999999999999999999999888777666654


Q ss_pred             hcCC------------------------CCCCC----CCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          256 AADL------------------------RFPSD----PWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       256 ~~~~------------------------~~~~~----~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                      ....                        ..+..    ....+++.+.+||.+||+.||.+|||+.++++||||+....
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  325 (362)
T 3pg1_A          248 EVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFD  325 (362)
T ss_dssp             HHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             HHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccC
Confidence            3111                        11111    12356899999999999999999999999999999998644

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.1e-46  Score=374.59  Aligned_cols=253  Identities=24%  Similarity=0.375  Sum_probs=219.2

Q ss_pred             ccccCeeeeeeecccCceEEEEEEec-------CCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEE
Q 014733           37 NLSDRYVLGKQLGWGQFGVIRECSDK-------FTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAV  109 (419)
Q Consensus        37 ~~~~~y~i~~~LG~G~~g~V~~a~~~-------~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~  109 (419)
                      ...++|++++.||+|+||.||+|.+.       .++..||+|++...  ......+.+.+|+.+|+++.+||||++++++
T Consensus        78 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~  155 (370)
T 2psq_A           78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLGA  155 (370)
T ss_dssp             CCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT--CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEE
T ss_pred             ccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC--cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence            34589999999999999999999874       34567999998755  3456678899999999999559999999999


Q ss_pred             EEeCCEEEEEEeecCCCChHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEE
Q 014733          110 YEEEDYVHLLMELCAGGELFHRLEKYG----------------RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENIL  173 (419)
Q Consensus       110 ~~~~~~~~lV~E~~~ggsL~~~l~~~~----------------~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NIL  173 (419)
                      +.+.+.+|+||||+++|+|.+++...+                .+++.+++.++.||+.||+|||++||+||||||+|||
T Consensus       156 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIl  235 (370)
T 2psq_A          156 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL  235 (370)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred             EccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEE
Confidence            999999999999999999999998653                3789999999999999999999999999999999999


Q ss_pred             EeecCCCCCeEEeeccceeeeccCCc---cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 014733          174 LATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKS  248 (419)
Q Consensus       174 l~~~~~~~~vKL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~  248 (419)
                      +   +.++.+||+|||++........   .....+|+.|+|||++.+. ++.++|||||||++|||++ |+.||.+....
T Consensus       236 l---~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~  312 (370)
T 2psq_A          236 V---TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE  312 (370)
T ss_dssp             E---CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred             E---CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence            9   5678999999999987654322   2334678899999998774 8999999999999999999 99999998888


Q ss_pred             HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          249 KIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       249 ~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      ++...+......   .....++.++.++|.+||+.||.+|||+.|++++
T Consensus       313 ~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          313 ELFKLLKEGHRM---DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             GHHHHHHTTCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHhcCCCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            888877665422   2234789999999999999999999999999875

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=4.2e-47  Score=378.48  Aligned_cols=260  Identities=25%  Similarity=0.412  Sum_probs=210.0

Q ss_pred             ccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHcc-------CCCCceeee
Q 014733           35 ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLS-------GHPNVVDLK  107 (419)
Q Consensus        35 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-------~hpnIv~l~  107 (419)
                      .+.+.++|++.+.||+|+||+||+|++..+++.||+|++...    ....+.+.+|+.++++++       +|+||++++
T Consensus        32 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~  107 (397)
T 1wak_A           32 GDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLL  107 (397)
T ss_dssp             TCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEE
T ss_pred             hhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeee
Confidence            455679999999999999999999999999999999999643    455678899999999996       278899999


Q ss_pred             EEEE----eCCEEEEEEeecCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC-CCeeccCCCCcEEEeecC--
Q 014733          108 AVYE----EEDYVHLLMELCAGGELFHRLEKY--GRFSETEARVIFRHLMQVVSYCHGN-GVVHRDLKPENILLATKS--  178 (419)
Q Consensus       108 ~~~~----~~~~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qll~aL~~LH~~-~IvHrDLkp~NILl~~~~--  178 (419)
                      +++.    +...+++||||+ +++|.+.+...  +.+++.+++.++.||+.||+|||++ ||+||||||+|||++.++  
T Consensus       108 ~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~  186 (397)
T 1wak_A          108 DDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQY  186 (397)
T ss_dssp             EEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHH
T ss_pred             cceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchh
Confidence            9997    556899999999 66777666554  4599999999999999999999998 999999999999995432  


Q ss_pred             --------------------------------------------CCCCeEEeeccceeeeccCCccccccCCCccCCccc
Q 014733          179 --------------------------------------------SSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEV  214 (419)
Q Consensus       179 --------------------------------------------~~~~vKL~DFgla~~~~~~~~~~~~~gt~~y~aPE~  214 (419)
                                                                  ....+||+|||++......  ....+||+.|+|||+
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~  264 (397)
T 1wak_A          187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEV  264 (397)
T ss_dssp             HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHH
T ss_pred             hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChh
Confidence                                                        1137999999999876433  345689999999999


Q ss_pred             ccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhcCCCCCC------------------------
Q 014733          215 LAGG-YNQAADVWSAGVILYILLSGMPPFWGKTK------SKIFDAVRAADLRFPS------------------------  263 (419)
Q Consensus       215 l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~------~~~~~~i~~~~~~~~~------------------------  263 (419)
                      +.+. ++.++|||||||++|+|++|+.||.+...      .+....+.......+.                        
T Consensus       265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  344 (397)
T 1wak_A          265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK  344 (397)
T ss_dssp             HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred             hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence            8875 99999999999999999999999976542      2222222111000000                        


Q ss_pred             --------------CCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccc
Q 014733          264 --------------DPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWME  301 (419)
Q Consensus       264 --------------~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~  301 (419)
                                    ......+.++.+||.+||+.||++|||+.|+|+||||+
T Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~  396 (397)
T 1wak_A          345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN  396 (397)
T ss_dssp             CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred             cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence                          00112346788999999999999999999999999996

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=7.1e-47  Score=362.53  Aligned_cols=255  Identities=29%  Similarity=0.547  Sum_probs=214.6

Q ss_pred             cccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEe-----
Q 014733           38 LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEE-----  112 (419)
Q Consensus        38 ~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~-----  112 (419)
                      +.++|++++.||+|+||.||+|.+..+|+.||+|++...    ....+.+.+|+.+++++. ||||+++++++.+     
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~   78 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLN-HQYVVRYYAAWLERRNFV   78 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEECCCCC
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcC-chHHHHHHHHHHhhcchh
Confidence            568999999999999999999999999999999999643    356688999999999996 9999999999865     


Q ss_pred             --------CCEEEEEEeecCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCe
Q 014733          113 --------EDYVHLLMELCAGGELFHRLEKYG-RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPI  183 (419)
Q Consensus       113 --------~~~~~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~v  183 (419)
                              .+.+|+||||+++++|.+++...+ .+++.+++.++.||+.||+|||++||+||||||+|||+   +.++.+
T Consensus        79 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~---~~~~~~  155 (303)
T 1zy4_A           79 KPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFI---DESRNV  155 (303)
T ss_dssp             C------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCE
T ss_pred             hhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEE---cCCCCE
Confidence                    457899999999999999998654 48899999999999999999999999999999999999   567889


Q ss_pred             EEeeccceeeeccC---------------CccccccCCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCC-C
Q 014733          184 KLADFGLATYIKAG---------------QNLHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWG-K  245 (419)
Q Consensus       184 KL~DFgla~~~~~~---------------~~~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~-~  245 (419)
                      ||+|||++......               .......||+.|+|||++.+  .++.++|||||||++|+|++   ||.. .
T Consensus       156 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~  232 (303)
T 1zy4_A          156 KIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM  232 (303)
T ss_dssp             EECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH
T ss_pred             EEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch
Confidence            99999999765421               12234579999999999875  48999999999999999998   5543 3


Q ss_pred             CHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccc
Q 014733          246 TKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEEC  303 (419)
Q Consensus       246 ~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~  303 (419)
                      ...+....+......++.......+..++++|.+||+.||.+|||+.++++||||+..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (303)
T 1zy4_A          233 ERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK  290 (303)
T ss_dssp             HHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred             hHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence            3455666677666667766666788999999999999999999999999999999754

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2e-47  Score=375.06  Aligned_cols=263  Identities=25%  Similarity=0.507  Sum_probs=225.9

Q ss_pred             cccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHH--------------hHHHHHHHHHHHHHccCCC
Q 014733           36 SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVE--------------DVRSIKLEIEIMTKLSGHP  101 (419)
Q Consensus        36 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~--------------~~~~~~~Ei~il~~l~~hp  101 (419)
                      ....++|++++.||+|+||.||+|.+  +|+.||+|++.........              ..+.+.+|+.++++++ ||
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~  103 (348)
T 2pml_X           27 DKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK-NE  103 (348)
T ss_dssp             CEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCC-CT
T ss_pred             ccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCC-CC
Confidence            34568999999999999999999998  8999999999754322111              1278999999999996 99


Q ss_pred             CceeeeEEEEeCCEEEEEEeecCCCChHHH------HHH--cCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeccCCCCcE
Q 014733          102 NVVDLKAVYEEEDYVHLLMELCAGGELFHR------LEK--YGRFSETEARVIFRHLMQVVSYCHG-NGVVHRDLKPENI  172 (419)
Q Consensus       102 nIv~l~~~~~~~~~~~lV~E~~~ggsL~~~------l~~--~~~l~~~~~~~i~~qll~aL~~LH~-~~IvHrDLkp~NI  172 (419)
                      ||+++++++.+.+.+++||||+++++|.++      +..  ...+++..++.++.||+.||.|||+ .||+||||||+||
T Consensus       104 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Ni  183 (348)
T 2pml_X          104 YCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNI  183 (348)
T ss_dssp             TBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGE
T ss_pred             CcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhE
Confidence            999999999999999999999999999988      655  4679999999999999999999999 9999999999999


Q ss_pred             EEeecCCCCCeEEeeccceeeeccCCccccccCCCccCCcccccCC--CCC-chhHHHHHHHHHHHHhCCCCCCCCCH-H
Q 014733          173 LLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGG--YNQ-AADVWSAGVILYILLSGMPPFWGKTK-S  248 (419)
Q Consensus       173 Ll~~~~~~~~vKL~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~~--~s~-~sDvwSlGvil~elltG~~Pf~~~~~-~  248 (419)
                      |+   +.++.+||+|||++...... ......||+.|+|||++.+.  ++. ++||||||+++|+|++|+.||..... .
T Consensus       184 l~---~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~  259 (348)
T 2pml_X          184 LM---DKNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV  259 (348)
T ss_dssp             EE---CTTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH
T ss_pred             EE---cCCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence            99   56789999999999876443 34556899999999998764  555 99999999999999999999988776 7


Q ss_pred             HHHHHHHhcCCCCCCCC---------------CCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          249 KIFDAVRAADLRFPSDP---------------WDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       249 ~~~~~i~~~~~~~~~~~---------------~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                      +..+.+......++...               ...++.++.+||.+||+.||.+|||+.++++||||+....
T Consensus       260 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~~  331 (348)
T 2pml_X          260 ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNI  331 (348)
T ss_dssp             HHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCCH
T ss_pred             HHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCCH
Confidence            77777777666555321               1468999999999999999999999999999999987543

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=2.4e-47  Score=366.45  Aligned_cols=264  Identities=29%  Similarity=0.492  Sum_probs=199.4

Q ss_pred             cccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCE
Q 014733           36 SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDY  115 (419)
Q Consensus        36 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~  115 (419)
                      ....++|++.+.||+|+||.||+|.+..+++.||+|++.....  ....+.+.+|+.+++++. ||||+++++++.+.+.
T Consensus        11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~   87 (303)
T 2vwi_A           11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCH-HPNIVSYYTSFVVKDE   87 (303)
T ss_dssp             --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCC-CTTBCCEEEEEESSSC
T ss_pred             ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcC-CCCEeeEEEEEeecCC
Confidence            3446899999999999999999999998999999999865432  244567889999999996 9999999999999999


Q ss_pred             EEEEEeecCCCChHHHHHH--------cCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEee
Q 014733          116 VHLLMELCAGGELFHRLEK--------YGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLAD  187 (419)
Q Consensus       116 ~~lV~E~~~ggsL~~~l~~--------~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~D  187 (419)
                      .++||||+++++|.+++..        .+.+++..++.++.||+.||.|||+.||+||||||+||++   +.++.+||+|
T Consensus        88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~d  164 (303)
T 2vwi_A           88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILL---GEDGSVQIAD  164 (303)
T ss_dssp             EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTCCEEECC
T ss_pred             cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEE---cCCCCEEEEe
Confidence            9999999999999999874        3559999999999999999999999999999999999999   5678999999


Q ss_pred             ccceeeeccCC------ccccccCCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC
Q 014733          188 FGLATYIKAGQ------NLHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADL  259 (419)
Q Consensus       188 Fgla~~~~~~~------~~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~  259 (419)
                      ||++.......      ......||+.|+|||++.+  .++.++||||||+++|+|++|+.||......+..........
T Consensus       165 fg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  244 (303)
T 2vwi_A          165 FGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDP  244 (303)
T ss_dssp             CHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSC
T ss_pred             ccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCC
Confidence            99987654321      1234579999999999865  589999999999999999999999988776665554444332


Q ss_pred             CCC------CCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          260 RFP------SDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       260 ~~~------~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                      ...      ......++.++.++|.+||+.||.+|||+.++++||||++...
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  296 (303)
T 2vwi_A          245 PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKN  296 (303)
T ss_dssp             CCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-----
T ss_pred             CccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCC
Confidence            211      1223568899999999999999999999999999999987543

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=6e-47  Score=373.19  Aligned_cols=260  Identities=27%  Similarity=0.390  Sum_probs=216.3

Q ss_pred             chhhccccccCeeeeeeecccCceEEEEEE-----ecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCcee
Q 014733           31 DATQISNLSDRYVLGKQLGWGQFGVIRECS-----DKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD  105 (419)
Q Consensus        31 ~~~~~~~~~~~y~i~~~LG~G~~g~V~~a~-----~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~  105 (419)
                      .....+...++|++++.||+|+||.||+|.     +..+++.||+|++...  ......+.+.+|+.+++++.+||||++
T Consensus        13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpniv~   90 (359)
T 3vhe_A           13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILIHIGHHLNVVN   90 (359)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc--CCHHHHHHHHHHHHHHHhhcCCcceee
Confidence            334455567999999999999999999998     5567799999999754  345567789999999999976999999


Q ss_pred             eeEEEEeCC-EEEEEEeecCCCChHHHHHHcCC-----------------------------------------------
Q 014733          106 LKAVYEEED-YVHLLMELCAGGELFHRLEKYGR-----------------------------------------------  137 (419)
Q Consensus       106 l~~~~~~~~-~~~lV~E~~~ggsL~~~l~~~~~-----------------------------------------------  137 (419)
                      +++++.+.+ .+++||||+++|+|.+++.....                                               
T Consensus        91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (359)
T 3vhe_A           91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE  170 (359)
T ss_dssp             EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred             eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence            999998755 48999999999999999976533                                               


Q ss_pred             -------------------CCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC
Q 014733          138 -------------------FSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ  198 (419)
Q Consensus       138 -------------------l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~  198 (419)
                                         +++.+++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++.......
T Consensus       171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kl~Dfg~a~~~~~~~  247 (359)
T 3vhe_A          171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDP  247 (359)
T ss_dssp             -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCGGGSCTTSCT
T ss_pred             cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---cCCCcEEEEeccceeeecccc
Confidence                               8999999999999999999999999999999999999   556789999999998654332


Q ss_pred             ---ccccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 014733          199 ---NLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASA  273 (419)
Q Consensus       199 ---~~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l  273 (419)
                         ......||+.|+|||++.+ .++.++||||||+++|+|++ |+.||.+....+............+  ....+++++
T Consensus       248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l  325 (359)
T 3vhe_A          248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR--APDYTTPEM  325 (359)
T ss_dssp             TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCC--CCTTCCHHH
T ss_pred             cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCC--CCCCCCHHH
Confidence               2234578899999999876 48999999999999999998 9999987765444433333322222  224689999


Q ss_pred             HHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          274 RDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       274 ~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      .++|.+||+.||.+|||+.++++|
T Consensus       326 ~~li~~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          326 YQTMLDCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHccCChhhCCCHHHHHHH
Confidence            999999999999999999999987

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=3.6e-46  Score=367.69  Aligned_cols=260  Identities=30%  Similarity=0.475  Sum_probs=216.3

Q ss_pred             ccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCE-
Q 014733           37 NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDY-  115 (419)
Q Consensus        37 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~-  115 (419)
                      .+.++|.+.+.||+|+||.||+|.++.+|+.||+|++.... ......+.+.+|+.+++++. ||||+++++++.+.+. 
T Consensus        21 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~   98 (353)
T 3coi_A           21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQ-HENVIGLLDVFTPASSL   98 (353)
T ss_dssp             EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSSG
T ss_pred             ccCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcC-CCCcccHhheEeccccc
Confidence            35789999999999999999999999999999999997643 34556778899999999996 9999999999987653 


Q ss_pred             -----EEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccc
Q 014733          116 -----VHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGL  190 (419)
Q Consensus       116 -----~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgl  190 (419)
                           +|+||||+. ++|.+++.  ..+++.+++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+
T Consensus        99 ~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~  172 (353)
T 3coi_A           99 RNFYDFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKILDFGL  172 (353)
T ss_dssp             GGCCCCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CTTCCEEECSTTC
T ss_pred             ccceeEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeE---CCCCcEEEeeccc
Confidence                 599999996 68887764  359999999999999999999999999999999999999   5678999999999


Q ss_pred             eeeeccCCccccccCCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC---------
Q 014733          191 ATYIKAGQNLHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADL---------  259 (419)
Q Consensus       191 a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---------  259 (419)
                      +......  .....||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+.+..+....+.....         
T Consensus       173 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  250 (353)
T 3coi_A          173 ARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK  250 (353)
T ss_dssp             TTC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTT
T ss_pred             ccCCCCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence            9864332  345688999999999876  489999999999999999999999998887666655533110         


Q ss_pred             --------------C----CCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchhh
Q 014733          260 --------------R----FPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQV  306 (419)
Q Consensus       260 --------------~----~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~~  306 (419)
                                    .    .....+..+++++.+||.+||+.||++|||+.++++||||+.....
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~  315 (353)
T 3coi_A          251 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDP  315 (353)
T ss_dssp             CSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCG
T ss_pred             HhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCc
Confidence                          0    0011234689999999999999999999999999999999876443

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-46  Score=368.35  Aligned_cols=255  Identities=22%  Similarity=0.336  Sum_probs=220.9

Q ss_pred             hccccccCeeeeeeecccCceEEEEEEec-----CCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeE
Q 014733           34 QISNLSDRYVLGKQLGWGQFGVIRECSDK-----FTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKA  108 (419)
Q Consensus        34 ~~~~~~~~y~i~~~LG~G~~g~V~~a~~~-----~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~  108 (419)
                      ......++|++++.||+|+||.||+|.+.     .+++.||+|++...  ......+.+.+|+.++++++ ||||+++++
T Consensus        41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~  117 (343)
T 1luf_A           41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE--ASADMQADFQREAALMAEFD-NPNIVKLLG  117 (343)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT--CCHHHHHHHHHHHHHHHTCC-CTTBCCEEE
T ss_pred             eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccc--cCHHHHHHHHHHHHHHHhCC-CCCEEEEEE
Confidence            34556799999999999999999999987     45589999999755  24556788999999999995 999999999


Q ss_pred             EEEeCCEEEEEEeecCCCChHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 014733          109 VYEEEDYVHLLMELCAGGELFHRLEKY------------------------GRFSETEARVIFRHLMQVVSYCHGNGVVH  164 (419)
Q Consensus       109 ~~~~~~~~~lV~E~~~ggsL~~~l~~~------------------------~~l~~~~~~~i~~qll~aL~~LH~~~IvH  164 (419)
                      ++.+.+.+++||||+++++|.+++...                        ..+++.+++.++.||++||.|||++||+|
T Consensus       118 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH  197 (343)
T 1luf_A          118 VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVH  197 (343)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             EEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence            999999999999999999999999764                        56899999999999999999999999999


Q ss_pred             ccCCCCcEEEeecCCCCCeEEeeccceeeeccCC---ccccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CC
Q 014733          165 RDLKPENILLATKSSSSPIKLADFGLATYIKAGQ---NLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GM  239 (419)
Q Consensus       165 rDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~---~~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~  239 (419)
                      |||||+|||+   +.++.+||+|||++.......   ......+|+.|+|||++.+ .++.++||||||+++|+|++ |.
T Consensus       198 ~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~  274 (343)
T 1luf_A          198 RDLATRNCLV---GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL  274 (343)
T ss_dssp             SCCSGGGEEE---CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred             CCCCcceEEE---CCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCC
Confidence            9999999999   566789999999998654332   2234568899999999875 58999999999999999999 99


Q ss_pred             CCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          240 PPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       240 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      .||.+....+....+........   ...++.++.++|.+||+.||.+|||+.+++++
T Consensus       275 ~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~  329 (343)
T 1luf_A          275 QPYYGMAHEEVIYYVRDGNILAC---PENCPLELYNLMRLCWSKLPADRPSFCSIHRI  329 (343)
T ss_dssp             CTTTTSCHHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CcCCCCChHHHHHHHhCCCcCCC---CCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence            99999998888888877654322   24789999999999999999999999999874

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.5e-46  Score=363.01  Aligned_cols=263  Identities=23%  Similarity=0.373  Sum_probs=223.6

Q ss_pred             cccccchhhccccccCeeeeeeecccCceEEEEEEec-----CCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCC
Q 014733           26 TGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDK-----FTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH  100 (419)
Q Consensus        26 ~~~~~~~~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~-----~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~h  100 (419)
                      ...+++....+...++|++.+.||+|+||.||+|.+.     .++..||+|++...  ......+.+.+|+.+++++. |
T Consensus         9 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-h   85 (314)
T 2ivs_A            9 AFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN--ASPSELRDLLSEFNVLKQVN-H   85 (314)
T ss_dssp             -----CCTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT--CCHHHHHHHHHHHHHHTTCC-C
T ss_pred             ceeccCCcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC--CCHHHHHHHHHHHHHHhhCC-C
Confidence            3444555566667899999999999999999999873     45689999998754  34567788999999999995 9


Q ss_pred             CCceeeeEEEEeCCEEEEEEeecCCCChHHHHHHcCC------------------------CCHHHHHHHHHHHHHHHHH
Q 014733          101 PNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGR------------------------FSETEARVIFRHLMQVVSY  156 (419)
Q Consensus       101 pnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~------------------------l~~~~~~~i~~qll~aL~~  156 (419)
                      |||+++++++.+.+..++||||+++++|.+++.....                        +++.+++.++.||++||.|
T Consensus        86 p~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~  165 (314)
T 2ivs_A           86 PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQY  165 (314)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHH
T ss_pred             CceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHH
Confidence            9999999999999999999999999999999986543                        8999999999999999999


Q ss_pred             HHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCCc---cccccCCCccCCcccccCC-CCCchhHHHHHHHH
Q 014733          157 CHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVIL  232 (419)
Q Consensus       157 LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil  232 (419)
                      ||++||+||||||+|||+   +.++.+||+|||++........   .....+|+.|+|||++.+. ++.++||||||+++
T Consensus       166 lH~~~ivH~dikp~NIli---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il  242 (314)
T 2ivs_A          166 LAEMKLVHRDLAARNILV---AEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLL  242 (314)
T ss_dssp             HHHTTEECCCCSGGGEEE---ETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHH
T ss_pred             HHHCCCcccccchheEEE---cCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHH
Confidence            999999999999999999   4567899999999987654332   2334678889999998765 89999999999999


Q ss_pred             HHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          233 YILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       233 ~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      |+|++ |..||.+....++...+......   .....+++++.++|.+||+.||.+|||+.+++++
T Consensus       243 ~el~t~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          243 WEIVTLGGNPYPGIPPERLFNLLKTGHRM---ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             HHHHTTSCCSSTTCCGGGHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHhCCCCCCCCCCHHHHHHHhhcCCcC---CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            99999 99999998888888777665422   2234789999999999999999999999999876

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.8e-46  Score=364.73  Aligned_cols=264  Identities=23%  Similarity=0.352  Sum_probs=201.4

Q ss_pred             hccccccCeeeeeeecccCceEEEEEEecCCCc---EEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEE
Q 014733           34 QISNLSDRYVLGKQLGWGQFGVIRECSDKFTGE---VLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVY  110 (419)
Q Consensus        34 ~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~---~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~  110 (419)
                      +.....++|++++.||+|+||.||+|.+..++.   .||+|++..... .....+.+.+|+.++++++ ||||+++++++
T Consensus        17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~   94 (323)
T 3qup_A           17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII-ASSDIEEFLREAACMKEFD-HPHVAKLVGVS   94 (323)
T ss_dssp             TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTCC-CTTBCCCCEEE
T ss_pred             hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc-CHHHHHHHHHHHHHHHHCC-CCceehhhcee
Confidence            445567899999999999999999999887765   899999976543 3355788999999999995 99999999999


Q ss_pred             EeCCEE------EEEEeecCCCChHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecC
Q 014733          111 EEEDYV------HLLMELCAGGELFHRLEKYG------RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKS  178 (419)
Q Consensus       111 ~~~~~~------~lV~E~~~ggsL~~~l~~~~------~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~  178 (419)
                      .+.+..      ++||||+.+++|.+++....      .+++.+++.++.||+.||+|||+.||+||||||+|||+   +
T Consensus        95 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli---~  171 (323)
T 3qup_A           95 LRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCML---A  171 (323)
T ss_dssp             ECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---C
T ss_pred             eccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEE---c
Confidence            877655      99999999999999986543      59999999999999999999999999999999999999   5


Q ss_pred             CCCCeEEeeccceeeeccCCc---cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 014733          179 SSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDA  253 (419)
Q Consensus       179 ~~~~vKL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~  253 (419)
                      .++.+||+|||++........   .....+++.|+|||++.+. ++.++|||||||++|+|++ |+.||.+....+....
T Consensus       172 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~  251 (323)
T 3qup_A          172 EDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNY  251 (323)
T ss_dssp             TTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH
T ss_pred             CCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHH
Confidence            678999999999987644332   2234567889999998764 8999999999999999999 9999999888888887


Q ss_pred             HHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCC-------HHHHHhccccccchh
Q 014733          254 VRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLT-------AAEVLAHSWMEECEQ  305 (419)
Q Consensus       254 i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps-------~~eil~hp~~~~~~~  305 (419)
                      +.......   ....+++++.+||.+||+.||.+|||       +++++.|||+.....
T Consensus       252 ~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~  307 (323)
T 3qup_A          252 LIGGNRLK---QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQ  307 (323)
T ss_dssp             HHTTCCCC---CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--------
T ss_pred             HhcCCCCC---CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCC
Confidence            76654322   22478999999999999999999999       788888999876543

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=5.4e-46  Score=360.00  Aligned_cols=268  Identities=25%  Similarity=0.408  Sum_probs=217.8

Q ss_pred             cccchhhccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccC-CCCceee
Q 014733           28 TILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG-HPNVVDL  106 (419)
Q Consensus        28 ~~~~~~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~-hpnIv~l  106 (419)
                      .-+....+....++|++++.||+|+||.||+|.+. +++.||+|++.... ......+.+.+|+.+++++.. ||||+++
T Consensus        16 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~~iv~~   93 (313)
T 3cek_A           16 ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRL   93 (313)
T ss_dssp             ----CCEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHHGGGCTTBCCE
T ss_pred             CCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEecccc-ccccchHHHHHHHHHHHhccccCCceEEE
Confidence            33455567777899999999999999999999986 58999999997654 345677889999999999973 6999999


Q ss_pred             eEEEEeCCEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEe
Q 014733          107 KAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLA  186 (419)
Q Consensus       107 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~  186 (419)
                      ++++.+.+..++||| +.+++|.+++...+.+++.+++.++.||++||.|||+.||+||||||+|||++    ++.+||+
T Consensus        94 ~~~~~~~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~----~~~~kL~  168 (313)
T 3cek_A           94 YDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLI  168 (313)
T ss_dssp             EEEEECSSEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE----TTEEEEC
T ss_pred             EEEeecCCEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE----CCeEEEe
Confidence            999999999999999 55889999999888899999999999999999999999999999999999994    3689999


Q ss_pred             eccceeeeccCCc---cccccCCCccCCcccccC------------CCCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHH
Q 014733          187 DFGLATYIKAGQN---LHGTVGSPFYIAPEVLAG------------GYNQAADVWSAGVILYILLSGMPPFWGKTK-SKI  250 (419)
Q Consensus       187 DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~------------~~s~~sDvwSlGvil~elltG~~Pf~~~~~-~~~  250 (419)
                      |||++........   .....||+.|+|||++.+            .++.++||||||+++|+|++|+.||..... ...
T Consensus       169 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~  248 (313)
T 3cek_A          169 DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK  248 (313)
T ss_dssp             CCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH
T ss_pred             eccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHH
Confidence            9999987644322   234579999999999864            478899999999999999999999976533 333


Q ss_pred             HHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccch
Q 014733          251 FDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECE  304 (419)
Q Consensus       251 ~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~  304 (419)
                      ...+........  .....+.++.++|.+||+.||.+|||+.++++||||+...
T Consensus       249 ~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  300 (313)
T 3cek_A          249 LHAIIDPNHEIE--FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  300 (313)
T ss_dssp             HHHHHCTTSCCC--CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred             HHHHHhcccccC--CcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence            334433332222  2235689999999999999999999999999999998643

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=2.7e-46  Score=358.02  Aligned_cols=257  Identities=25%  Similarity=0.442  Sum_probs=208.9

Q ss_pred             CeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEE
Q 014733           41 RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLM  120 (419)
Q Consensus        41 ~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~  120 (419)
                      +|.....||+|+||.||+|.+..+++.||+|.+....   ....+.+.+|+.+++.+. ||||+++++++.+.+..++||
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~   98 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLK-HKNIVQYLGSFSENGFIKIFM   98 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTCC-CTTBCCEEEEEEETTEEEEEE
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCC-CCCEeeEeeEEEeCCcEEEEE
Confidence            3444458999999999999999999999999987653   245677899999999996 999999999999999999999


Q ss_pred             eecCCCChHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccC
Q 014733          121 ELCAGGELFHRLEKYG---RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG  197 (419)
Q Consensus       121 E~~~ggsL~~~l~~~~---~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~  197 (419)
                      ||+++++|.+++....   .+++..++.++.||+.||+|||+.||+||||||+|||++.  .++.+||+|||++......
T Consensus        99 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~--~~~~~kl~Dfg~~~~~~~~  176 (295)
T 2clq_A           99 EQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINT--YSGVLKISDFGTSKRLAGI  176 (295)
T ss_dssp             ECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET--TTCCEEECCTTTCEESCC-
T ss_pred             EeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEEC--CCCCEEEeecccccccCCC
Confidence            9999999999997652   4679999999999999999999999999999999999953  2678999999999876543


Q ss_pred             Cc-cccccCCCccCCcccccCC---CCCchhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhcCCCCCCCCCCCCCHH
Q 014733          198 QN-LHGTVGSPFYIAPEVLAGG---YNQAADVWSAGVILYILLSGMPPFWGKTKSK-IFDAVRAADLRFPSDPWDHISAS  272 (419)
Q Consensus       198 ~~-~~~~~gt~~y~aPE~l~~~---~s~~sDvwSlGvil~elltG~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~s~~  272 (419)
                      .. .....||+.|+|||++.+.   ++.++||||||+++|+|++|+.||....... ........  .........++.+
T Consensus       177 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~  254 (295)
T 2clq_A          177 NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMF--KVHPEIPESMSAE  254 (295)
T ss_dssp             ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHH--CCCCCCCTTSCHH
T ss_pred             CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccc--cccccccccCCHH
Confidence            22 3345799999999998652   7899999999999999999999997543322 22221111  1222233478999


Q ss_pred             HHHHHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          273 ARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       273 l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                      +.++|.+||+.||++|||+.++++||||+....
T Consensus       255 ~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  287 (295)
T 2clq_A          255 AKAFILKCFEPDPDKRACANDLLVDEFLKVSSK  287 (295)
T ss_dssp             HHHHHHHTTCSSTTTSCCHHHHHTSGGGCC---
T ss_pred             HHHHHHHHccCChhhCCCHHHHhcChhhhhccc
Confidence            999999999999999999999999999986543

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=2.9e-46  Score=364.89  Aligned_cols=253  Identities=25%  Similarity=0.400  Sum_probs=217.1

Q ss_pred             cccccCeeeeeeecccCceEEEEEEecCCCc---EEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEe
Q 014733           36 SNLSDRYVLGKQLGWGQFGVIRECSDKFTGE---VLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEE  112 (419)
Q Consensus        36 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~---~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~  112 (419)
                      +...++|++.+.||+|+||.||+|.+..+++   .||+|++...  ......+.+.+|+.++++++ ||||+++++++.+
T Consensus        45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~  121 (325)
T 3kul_A           45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG--YTERQRRDFLSEASIMGQFD-HPNIIRLEGVVTR  121 (325)
T ss_dssp             BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTT--CCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECG
T ss_pred             ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCC--CCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEe
Confidence            3456899999999999999999999986555   5999999754  34566788999999999996 9999999999999


Q ss_pred             CCEEEEEEeecCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccce
Q 014733          113 EDYVHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA  191 (419)
Q Consensus       113 ~~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla  191 (419)
                      .+..++||||++|++|.+++... +.+++.+++.++.||+.||+|||+.||+||||||+|||+   +.++.+||+|||++
T Consensus       122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a  198 (325)
T 3kul_A          122 GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLV---DSNLVCKVSDFGLS  198 (325)
T ss_dssp             GGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCSSC
T ss_pred             CCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE---CCCCCEEECCCCcc
Confidence            99999999999999999999754 579999999999999999999999999999999999999   56789999999999


Q ss_pred             eeeccCCc----cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCC
Q 014733          192 TYIKAGQN----LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDP  265 (419)
Q Consensus       192 ~~~~~~~~----~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~  265 (419)
                      ........    .....+|+.|+|||++.+. ++.++||||||+++|+|++ |..||.+....+....+.... ..+  .
T Consensus       199 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~-~~~--~  275 (325)
T 3kul_A          199 RVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGY-RLP--A  275 (325)
T ss_dssp             EECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTC-CCC--C
T ss_pred             cccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC-CCC--C
Confidence            87654321    2233567789999998764 8999999999999999999 999999999988888877653 222  2


Q ss_pred             CCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          266 WDHISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       266 ~~~~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      ...+++++.++|.+||+.||++|||+.++++.
T Consensus       276 ~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  307 (325)
T 3kul_A          276 PMGCPHALHQLMLDCWHKDRAQRPRFSQIVSV  307 (325)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCcCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            24789999999999999999999999999873

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=6.4e-47  Score=368.42  Aligned_cols=265  Identities=29%  Similarity=0.475  Sum_probs=218.5

Q ss_pred             ccccchhhccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCH---HhHHHHHHHHHHHHHcc-CCCC
Q 014733           27 GTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTV---EDVRSIKLEIEIMTKLS-GHPN  102 (419)
Q Consensus        27 ~~~~~~~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~---~~~~~~~~Ei~il~~l~-~hpn  102 (419)
                      ..+....+.+.+.++|++++.||+|+||.||+|.+..+|+.||+|++........   .....+.+|+.+++++. +|||
T Consensus        30 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~  109 (320)
T 3a99_A           30 TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG  109 (320)
T ss_dssp             ----------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCS
T ss_pred             hccCcccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCC
Confidence            3455667778899999999999999999999999999999999999976543221   12245677999999996 3699


Q ss_pred             ceeeeEEEEeCCEEEEEEeecCC-CChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCC
Q 014733          103 VVDLKAVYEEEDYVHLLMELCAG-GELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSS  181 (419)
Q Consensus       103 Iv~l~~~~~~~~~~~lV~E~~~g-gsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~  181 (419)
                      |+++++++.+.+..++|||++.+ ++|.+++...+.+++..++.++.||++||+|||+.||+||||||+|||++.  .++
T Consensus       110 i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~--~~~  187 (320)
T 3a99_A          110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL--NRG  187 (320)
T ss_dssp             BCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET--TTT
T ss_pred             ceEEEEEEecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeC--CCC
Confidence            99999999999999999999976 899999998889999999999999999999999999999999999999952  467


Q ss_pred             CeEEeeccceeeeccCCccccccCCCccCCcccccCC--CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC
Q 014733          182 PIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADL  259 (419)
Q Consensus       182 ~vKL~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~~--~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~  259 (419)
                      .+||+|||++...... ......||+.|+|||++.+.  ++.++||||||+++|+|++|+.||....      .+.....
T Consensus       188 ~~kL~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~  260 (320)
T 3a99_A          188 ELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQV  260 (320)
T ss_dssp             EEEECCCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCC
T ss_pred             CEEEeeCccccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhcccc
Confidence            8999999999876543 33456799999999998753  4788999999999999999999996532      2223333


Q ss_pred             CCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccch
Q 014733          260 RFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECE  304 (419)
Q Consensus       260 ~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~  304 (419)
                      .++    ..+++++.+||.+||+.||++|||+.++++||||+...
T Consensus       261 ~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~  301 (320)
T 3a99_A          261 FFR----QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  301 (320)
T ss_dssp             CCS----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             ccc----ccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence            222    36899999999999999999999999999999998653

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=3.6e-46  Score=369.21  Aligned_cols=260  Identities=25%  Similarity=0.467  Sum_probs=210.4

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHcc----------CCCCceeeeE
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLS----------GHPNVVDLKA  108 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~----------~hpnIv~l~~  108 (419)
                      .++|++++.||+|+||+||+|.+..+++.||+|++...    ......+.+|+.+++++.          +||||+++++
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~   93 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD   93 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC----ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence            47999999999999999999999999999999999743    345677889999999885          2789999999


Q ss_pred             EEEeCC----EEEEEEeecCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC-CCeeccCCCCcEEEeecC---
Q 014733          109 VYEEED----YVHLLMELCAGGELFHRLEKY--GRFSETEARVIFRHLMQVVSYCHGN-GVVHRDLKPENILLATKS---  178 (419)
Q Consensus       109 ~~~~~~----~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qll~aL~~LH~~-~IvHrDLkp~NILl~~~~---  178 (419)
                      ++...+    .+++||||+ +++|.+++...  ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++   
T Consensus        94 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~  172 (373)
T 1q8y_A           94 HFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE  172 (373)
T ss_dssp             EEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred             HhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCc
Confidence            998654    789999999 99999999864  4599999999999999999999998 999999999999996543   


Q ss_pred             CCCCeEEeeccceeeeccCCccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCC------HHHHH
Q 014733          179 SSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKT------KSKIF  251 (419)
Q Consensus       179 ~~~~vKL~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~------~~~~~  251 (419)
                      ..+.+||+|||++......  .....||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+..      ..+..
T Consensus       173 ~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~  250 (373)
T 1q8y_A          173 NLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI  250 (373)
T ss_dssp             TEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred             CcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHH
Confidence            2347999999999875432  3446899999999998875 8999999999999999999999997654      22222


Q ss_pred             HHHHhcCCCCCC--------------------------------------CCCCCCCHHHHHHHHhhhhcCCCCCCCHHH
Q 014733          252 DAVRAADLRFPS--------------------------------------DPWDHISASARDLIMGMLRVDPSTRLTAAE  293 (419)
Q Consensus       252 ~~i~~~~~~~~~--------------------------------------~~~~~~s~~l~~li~~~L~~dP~~Rps~~e  293 (419)
                      ..+.......|.                                      .....++.++.+||.+||+.||++|||+.|
T Consensus       251 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e  330 (373)
T 1q8y_A          251 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG  330 (373)
T ss_dssp             HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred             HHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHH
Confidence            222211111000                                      001234678899999999999999999999


Q ss_pred             HHhccccccchh
Q 014733          294 VLAHSWMEECEQ  305 (419)
Q Consensus       294 il~hp~~~~~~~  305 (419)
                      +|+||||++...
T Consensus       331 ll~hp~f~~~~~  342 (373)
T 1q8y_A          331 LVNHPWLKDTLG  342 (373)
T ss_dssp             HHTCGGGTTCTT
T ss_pred             HhhChhhhcccC
Confidence            999999987644

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.9e-45  Score=355.44  Aligned_cols=269  Identities=26%  Similarity=0.479  Sum_probs=214.5

Q ss_pred             ccchhhccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeE
Q 014733           29 ILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKA  108 (419)
Q Consensus        29 ~~~~~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~  108 (419)
                      ...........++|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.++++++ ||||+++++
T Consensus        21 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~   99 (310)
T 2wqm_A           21 ALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYA   99 (310)
T ss_dssp             CCCGGGTTSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCC-CTTBCCEEE
T ss_pred             cCCCCcccccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCC-CCCEeeEEE
Confidence            3344445566789999999999999999999999999999999998765566677888999999999996 999999999


Q ss_pred             EEEeCCEEEEEEeecCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeE
Q 014733          109 VYEEEDYVHLLMELCAGGELFHRLEK----YGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIK  184 (419)
Q Consensus       109 ~~~~~~~~~lV~E~~~ggsL~~~l~~----~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vK  184 (419)
                      ++.+.+..++||||+.+++|.+++..    ...+++..++.++.||+.||.|||+.||+||||||+||++   +.++.+|
T Consensus       100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~---~~~~~~k  176 (310)
T 2wqm_A          100 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI---TATGVVK  176 (310)
T ss_dssp             EEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEE
T ss_pred             EEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEE---cCCCCEE
Confidence            99999999999999999999999864    3559999999999999999999999999999999999999   5678999


Q ss_pred             EeeccceeeeccCCc-cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhcCCC
Q 014733          185 LADFGLATYIKAGQN-LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKT--KSKIFDAVRAADLR  260 (419)
Q Consensus       185 L~DFgla~~~~~~~~-~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~--~~~~~~~i~~~~~~  260 (419)
                      |+|||++........ .....||+.|+|||++.+. ++.++||||||+++|+|++|..||.+..  .......+..... 
T Consensus       177 l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-  255 (310)
T 2wqm_A          177 LGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDY-  255 (310)
T ss_dssp             ECCC------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCS-
T ss_pred             EEeccceeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccC-
Confidence            999999986644322 2345789999999998764 8999999999999999999999997643  3345555554433 


Q ss_pred             CCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          261 FPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       261 ~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                       +......++.++.++|.+||+.||.+|||+.+++++  ++++..
T Consensus       256 -~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~--l~~l~~  297 (310)
T 2wqm_A          256 -PPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV--AKRMHA  297 (310)
T ss_dssp             -CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHHH
T ss_pred             -CCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHH--HHHHHH
Confidence             333345789999999999999999999999999974  555544

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.7e-46  Score=363.09  Aligned_cols=251  Identities=23%  Similarity=0.400  Sum_probs=213.0

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEE
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHL  118 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~l  118 (419)
                      .++|++++.||+|+||+||+|.+..+++.||+|++...   .....+.+.+|+.++++++ ||||+++++++.+.+..++
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~l   84 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLE-HPNVLKFIGVLYKDKRLNF   84 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCC-CcCcccEEEEEecCCeeEE
Confidence            47999999999999999999999999999999988543   4567788999999999996 9999999999999999999


Q ss_pred             EEeecCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccC
Q 014733          119 LMELCAGGELFHRLEK-YGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG  197 (419)
Q Consensus       119 V~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~  197 (419)
                      ||||+++++|.+++.. ...+++.++..++.||+.||+|||+.||+||||||+|||+   +.++.+||+|||++......
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~  161 (310)
T 3s95_A           85 ITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLV---RENKNVVVADFGLARLMVDE  161 (310)
T ss_dssp             EEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE---CTTSCEEECCCTTCEECC--
T ss_pred             EEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEE---CCCCCEEEeecccceecccc
Confidence            9999999999999987 4569999999999999999999999999999999999999   56788999999999876433


Q ss_pred             Ccc---------------ccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHH
Q 014733          198 QNL---------------HGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKS------KIFDAVR  255 (419)
Q Consensus       198 ~~~---------------~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~------~~~~~i~  255 (419)
                      ...               ...+||+.|+|||++.+. ++.++||||||+++|+|++|..||......      .......
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~  241 (310)
T 3s95_A          162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD  241 (310)
T ss_dssp             ------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH
T ss_pred             cccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc
Confidence            221               145799999999998875 899999999999999999999998653221      1111111


Q ss_pred             hcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          256 AADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       256 ~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                      ..       ....+++++.++|.+||+.||++|||+.++++  |++.+..
T Consensus       242 ~~-------~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~l~~  282 (310)
T 3s95_A          242 RY-------CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETLRM  282 (310)
T ss_dssp             HT-------CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHHH
T ss_pred             cc-------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHHHHH
Confidence            11       12367889999999999999999999999987  5666554

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-45  Score=368.05  Aligned_cols=259  Identities=24%  Similarity=0.369  Sum_probs=223.6

Q ss_pred             ccccccCeeeeeeecccCceEEEEEEecC-------CCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeee
Q 014733           35 ISNLSDRYVLGKQLGWGQFGVIRECSDKF-------TGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLK  107 (419)
Q Consensus        35 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~-------~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~  107 (419)
                      .+...++|++++.||+|+||.||+|.+..       .+..||+|++...  ........+.+|+++++++.+||||++++
T Consensus        64 ~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~~~  141 (382)
T 3tt0_A           64 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKMIGKHKNIINLL  141 (382)
T ss_dssp             TBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc--cCHHHHHHHHHHHHHHHHhcCCchhhhhe
Confidence            34456899999999999999999999753       3357999998765  35567788999999999995699999999


Q ss_pred             EEEEeCCEEEEEEeecCCCChHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCc
Q 014733          108 AVYEEEDYVHLLMELCAGGELFHRLEKYG----------------RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPEN  171 (419)
Q Consensus       108 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~----------------~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~N  171 (419)
                      +++.+.+.+++||||+++|+|.+++....                .+++.+++.++.||+.||+|||+.||+||||||+|
T Consensus       142 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N  221 (382)
T 3tt0_A          142 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN  221 (382)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred             eeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcce
Confidence            99999999999999999999999998754                49999999999999999999999999999999999


Q ss_pred             EEEeecCCCCCeEEeeccceeeeccCC---ccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 014733          172 ILLATKSSSSPIKLADFGLATYIKAGQ---NLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKT  246 (419)
Q Consensus       172 ILl~~~~~~~~vKL~DFgla~~~~~~~---~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~ellt-G~~Pf~~~~  246 (419)
                      ||+   +.++.+||+|||++.......   ......+|+.|+|||++.+. ++.++|||||||++|+|++ |..||.+..
T Consensus       222 Ill---~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~  298 (382)
T 3tt0_A          222 VLV---TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP  298 (382)
T ss_dssp             EEE---CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             EEE---cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            999   567899999999998765432   22334678899999998775 8999999999999999999 999999999


Q ss_pred             HHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccc
Q 014733          247 KSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEEC  303 (419)
Q Consensus       247 ~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~  303 (419)
                      ..++.+.+.......   ....+++++.+||.+||+.||++|||+.+++++  ++.+
T Consensus       299 ~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~--L~~~  350 (382)
T 3tt0_A          299 VEELFKLLKEGHRMD---KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED--LDRI  350 (382)
T ss_dssp             HHHHHHHHHTTCCCC---CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHH
T ss_pred             HHHHHHHHHcCCCCC---CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH--HHHH
Confidence            888888877654322   224789999999999999999999999999986  5444

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.1e-45  Score=357.73  Aligned_cols=257  Identities=26%  Similarity=0.387  Sum_probs=211.2

Q ss_pred             ccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCC
Q 014733           35 ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEED  114 (419)
Q Consensus        35 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~  114 (419)
                      .....++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++++. ||||+++++++.+.+
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~  107 (309)
T 2h34_A           29 EGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQ-EPHVVPIHDFGEIDG  107 (309)
T ss_dssp             -----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETT
T ss_pred             CCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcC-CCCeeEEEEEEeeCC
Confidence            3445689999999999999999999999999999999998765555566788999999999996 999999999999999


Q ss_pred             EEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeee
Q 014733          115 YVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI  194 (419)
Q Consensus       115 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~  194 (419)
                      .+++||||++|++|.+++...+.+++.+++.++.||+.||+|||+.||+||||||+|||+   +.++.+||+|||++...
T Consensus       108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~---~~~~~~kl~Dfg~~~~~  184 (309)
T 2h34_A          108 QLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILV---SADDFAYLVDFGIASAT  184 (309)
T ss_dssp             EEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSCCC----
T ss_pred             eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEE---cCCCCEEEecCccCccc
Confidence            999999999999999999988889999999999999999999999999999999999999   56779999999999866


Q ss_pred             ccCC--ccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCH
Q 014733          195 KAGQ--NLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISA  271 (419)
Q Consensus       195 ~~~~--~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  271 (419)
                      ....  ......||+.|+|||++.+. ++.++||||||+++|+|++|+.||.+.........+. .....+...+..++.
T Consensus       185 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  263 (309)
T 2h34_A          185 TDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHIN-QAIPRPSTVRPGIPV  263 (309)
T ss_dssp             ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHH-SCCCCGGGTSTTCCT
T ss_pred             cccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhc-cCCCCccccCCCCCH
Confidence            4432  22345799999999998764 8999999999999999999999998876654444443 333334344567999


Q ss_pred             HHHHHHHhhhhcCCCCCC-CHHHHHh
Q 014733          272 SARDLIMGMLRVDPSTRL-TAAEVLA  296 (419)
Q Consensus       272 ~l~~li~~~L~~dP~~Rp-s~~eil~  296 (419)
                      ++.++|.+||+.||++|| +++++++
T Consensus       264 ~l~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          264 AFDAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             HHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             HHHHHHHHhccCCHHHHHHhHHHHHH
Confidence            999999999999999999 8888875

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=5.9e-46  Score=356.21  Aligned_cols=261  Identities=18%  Similarity=0.293  Sum_probs=216.6

Q ss_pred             ccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCC
Q 014733           35 ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEED  114 (419)
Q Consensus        35 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~  114 (419)
                      ...+.++|++.+.||+|+||+||+|.+..+|+.||+|++....     ....+.+|+.+++++.+|+|++++++++.+..
T Consensus         5 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~   79 (298)
T 1csn_A            5 NNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGL   79 (298)
T ss_dssp             -CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETT
T ss_pred             CcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-----ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCc
Confidence            3457789999999999999999999999999999999986543     23457889999999977999999999999999


Q ss_pred             EEEEEEeecCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecC--CCCCeEEeeccce
Q 014733          115 YVHLLMELCAGGELFHRLEKYG-RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKS--SSSPIKLADFGLA  191 (419)
Q Consensus       115 ~~~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~--~~~~vKL~DFgla  191 (419)
                      ..++||||+ +++|.+++...+ ++++.+++.++.||+.||+|||++||+||||||+|||++.++  ..+.+||+|||++
T Consensus        80 ~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~  158 (298)
T 1csn_A           80 HNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV  158 (298)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred             eeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence            999999999 999999998754 599999999999999999999999999999999999996432  2234999999999


Q ss_pred             eeeccCCc--------cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhcCC
Q 014733          192 TYIKAGQN--------LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGK---TKSKIFDAVRAADL  259 (419)
Q Consensus       192 ~~~~~~~~--------~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~---~~~~~~~~i~~~~~  259 (419)
                      ........        .....||+.|+|||++.+. ++.++||||||+++|+|++|+.||.+.   ...+....+.....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  238 (298)
T 1csn_A          159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ  238 (298)
T ss_dssp             EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred             cccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc
Confidence            87654322        2445799999999998874 899999999999999999999999774   33444444433322


Q ss_pred             CCC-CCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccc
Q 014733          260 RFP-SDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEEC  303 (419)
Q Consensus       260 ~~~-~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~  303 (419)
                      ..+ ......+++++.++|.+||+.||++|||+.++++.  ++++
T Consensus       239 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~--l~~~  281 (298)
T 1csn_A          239 STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL--FSKV  281 (298)
T ss_dssp             HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH--HHHH
T ss_pred             CccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH--HHHH
Confidence            221 11223689999999999999999999999999874  4444

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=7.4e-46  Score=351.01  Aligned_cols=253  Identities=27%  Similarity=0.432  Sum_probs=205.9

Q ss_pred             cccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCC-HHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEE
Q 014733           38 LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVT-VEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYV  116 (419)
Q Consensus        38 ~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~-~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~  116 (419)
                      -.++|++.+.||+|+||.||+|.+.  |+.+|+|++....... ....+.+.+|+++++.++ ||||+++++++.+.+..
T Consensus         5 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   81 (271)
T 3dtc_A            5 DFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK-HPNIIALRGVCLKEPNL   81 (271)
T ss_dssp             CTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCC-CTTBCCEEEEECCC--C
T ss_pred             chhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcC-CCCEeeEEEEEecCCce
Confidence            3579999999999999999999975  8899999987643322 234678899999999996 99999999999999999


Q ss_pred             EEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---CeeccCCCCcEEEeecC-----CCCCeEEeec
Q 014733          117 HLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG---VVHRDLKPENILLATKS-----SSSPIKLADF  188 (419)
Q Consensus       117 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~---IvHrDLkp~NILl~~~~-----~~~~vKL~DF  188 (419)
                      ++||||+++++|.+++.. +++++..++.++.|++.||+|||+.|   |+||||||+|||++.+.     .++.+||+||
T Consensus        82 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           82 CLVMEFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             EEEEECCTTEEHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EEEEEcCCCCCHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            999999999999998864 67999999999999999999999999   89999999999996432     2678999999


Q ss_pred             cceeeeccCCccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCC
Q 014733          189 GLATYIKAGQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWD  267 (419)
Q Consensus       189 gla~~~~~~~~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  267 (419)
                      |++....... .....||+.|+|||++.+. ++.++||||||+++|+|++|+.||.+.........+.......+.  ..
T Consensus       161 g~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~  237 (271)
T 3dtc_A          161 GLAREWHRTT-KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPI--PS  237 (271)
T ss_dssp             CC--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCC--CT
T ss_pred             Cccccccccc-ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCC--Cc
Confidence            9998664433 2345799999999998764 899999999999999999999999998887777777666554433  34


Q ss_pred             CCCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          268 HISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       268 ~~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      .+++++.++|.+||+.||.+|||+.++++|
T Consensus       238 ~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          238 TCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            789999999999999999999999999875

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.5e-45  Score=348.68  Aligned_cols=249  Identities=25%  Similarity=0.352  Sum_probs=217.2

Q ss_pred             ccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEE
Q 014733           37 NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYV  116 (419)
Q Consensus        37 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~  116 (419)
                      -..++|++.+.||+|+||.||+|.++ ++..||+|++.....    ..+.+.+|+.++++++ ||||+++++++.+.+..
T Consensus         5 l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~   78 (268)
T 3sxs_A            5 LKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM----SEDEFFQEAQTMMKLS-HPKLVKFYGVCSKEYPI   78 (268)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB----CHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSE
T ss_pred             echhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC----cHHHHHHHHHHHHhCC-CCCEeeEEEEEccCCce
Confidence            34689999999999999999999876 567899999976542    2356889999999996 99999999999999999


Q ss_pred             EEEEeecCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeec
Q 014733          117 HLLMELCAGGELFHRLEKYG-RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIK  195 (419)
Q Consensus       117 ~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~  195 (419)
                      ++||||+++++|.+++...+ .+++.+++.++.|++.||.|||+.||+||||||+||++   +.++.+||+|||++....
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~~l~Dfg~~~~~~  155 (268)
T 3sxs_A           79 YIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLV---DRDLCVKVSDFGMTRYVL  155 (268)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEE---CTTCCEEECCTTCEEECC
T ss_pred             EEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEE---CCCCCEEEccCccceecc
Confidence            99999999999999997754 49999999999999999999999999999999999999   567899999999998765


Q ss_pred             cCCc--cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCH
Q 014733          196 AGQN--LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISA  271 (419)
Q Consensus       196 ~~~~--~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  271 (419)
                      ....  .....+|+.|+|||++.+. ++.++||||||+++|+|++ |+.||......+....+.........   ..+++
T Consensus       156 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~  232 (268)
T 3sxs_A          156 DDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRP---HLASD  232 (268)
T ss_dssp             TTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC---TTSCH
T ss_pred             hhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCC---CcChH
Confidence            4432  2334567789999998764 8999999999999999999 99999998888888877766533332   35789


Q ss_pred             HHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          272 SARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       272 ~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      ++.++|.+||+.||.+|||+.+++++
T Consensus       233 ~l~~li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          233 TIYQIMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             HHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            99999999999999999999999986

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=7.9e-46  Score=350.95  Aligned_cols=247  Identities=25%  Similarity=0.394  Sum_probs=215.5

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEE
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHL  118 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~l  118 (419)
                      .++|++.+.||+|+||.||+|.+. +++.||+|++.....    ..+.+.+|+.++++++ ||||+++++++.+.+..++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~l   82 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLS-HPKLVQLYGVCLEQAPICL   82 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHHTCC-CTTBCCEEEEECSSSSEEE
T ss_pred             hhhceeeheecCCCccEEEEEEec-CCCeEEEEEeccccc----CHHHHHHHHHHHHhCC-CCCEeeEEEEEecCCceEE
Confidence            479999999999999999999987 577899999976542    2356889999999996 9999999999999999999


Q ss_pred             EEeecCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccC
Q 014733          119 LMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG  197 (419)
Q Consensus       119 V~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~  197 (419)
                      ||||+++++|.+++... +.+++..++.++.|++.||+|||+.||+||||||+||++   +.++.+||+|||++......
T Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~  159 (269)
T 4hcu_A           83 VFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDD  159 (269)
T ss_dssp             EEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CGGGCEEECCTTGGGGBCCH
T ss_pred             EEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEE---cCCCCEEecccccccccccc
Confidence            99999999999999654 458999999999999999999999999999999999999   55678999999999865432


Q ss_pred             C--ccccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 014733          198 Q--NLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASA  273 (419)
Q Consensus       198 ~--~~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l  273 (419)
                      .  ......+|+.|+|||++.+ .++.++||||||+++|+|++ |+.||.+....+....+........   ...+++++
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~  236 (269)
T 4hcu_A          160 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---PRLASTHV  236 (269)
T ss_dssp             HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC---CTTSCHHH
T ss_pred             ccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCC---CCcCCHHH
Confidence            2  2234567888999999875 58999999999999999999 9999999998888888876533222   23679999


Q ss_pred             HHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          274 RDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       274 ~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      .++|.+||+.||++|||+.++++|
T Consensus       237 ~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          237 YQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHccCCcccCcCHHHHHHH
Confidence            999999999999999999999986

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=2.3e-45  Score=355.39  Aligned_cols=266  Identities=24%  Similarity=0.344  Sum_probs=202.2

Q ss_pred             hhccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEe
Q 014733           33 TQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEE  112 (419)
Q Consensus        33 ~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~  112 (419)
                      .......++|++++.||+|+||.||+|.++.+|+.||+|++..... .....+.+..+..+++.+ +||||+++++++.+
T Consensus        18 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~   95 (318)
T 2dyl_A           18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN-KEENKRILMDLDVVLKSH-DCPYIVQCFGTFIT   95 (318)
T ss_dssp             SEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC-HHHHHHHHHHHHHHHHTT-TCTTBCCEEEEEEC
T ss_pred             hhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc-chHHHHHHHHHHHHHHhc-CCCceeeEEEEEec
Confidence            3345556899999999999999999999999999999999976532 222233344444566666 59999999999999


Q ss_pred             CCEEEEEEeecCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhC-CCeeccCCCCcEEEeecCCCCCeEEeeccc
Q 014733          113 EDYVHLLMELCAGGELFHRLEK-YGRFSETEARVIFRHLMQVVSYCHGN-GVVHRDLKPENILLATKSSSSPIKLADFGL  190 (419)
Q Consensus       113 ~~~~~lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qll~aL~~LH~~-~IvHrDLkp~NILl~~~~~~~~vKL~DFgl  190 (419)
                      .+.+++||||+ ++.+..+... .+.+++..++.++.||++||.|||+. ||+||||||+|||+   +.++.+||+|||+
T Consensus        96 ~~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~  171 (318)
T 2dyl_A           96 NTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL---DERGQIKLCDFGI  171 (318)
T ss_dssp             SSEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEE---CTTSCEEECCCTT
T ss_pred             CCcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEE---CCCCCEEEEECCC
Confidence            99999999999 5566655544 46799999999999999999999995 99999999999999   5678999999999


Q ss_pred             eeeeccCCccccccCCCccCCccccc-----C-CCCCchhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcCCCCCC
Q 014733          191 ATYIKAGQNLHGTVGSPFYIAPEVLA-----G-GYNQAADVWSAGVILYILLSGMPPFWG-KTKSKIFDAVRAADLRFPS  263 (419)
Q Consensus       191 a~~~~~~~~~~~~~gt~~y~aPE~l~-----~-~~s~~sDvwSlGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~~~~  263 (419)
                      +.............||+.|+|||++.     + .++.++||||||+++|+|++|+.||.. ....+....+........ 
T Consensus       172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-  250 (318)
T 2dyl_A          172 SGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLL-  250 (318)
T ss_dssp             C--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCC-
T ss_pred             chhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCC-
Confidence            98766555555568999999999984     2 488999999999999999999999976 345555666555433222 


Q ss_pred             CCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          264 DPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       264 ~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                      .....++.++.++|.+||+.||.+|||+.++++||||+....
T Consensus       251 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  292 (318)
T 2dyl_A          251 PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYET  292 (318)
T ss_dssp             CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHHH
T ss_pred             CccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhccc
Confidence            222468999999999999999999999999999999987654

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=7.3e-46  Score=361.49  Aligned_cols=260  Identities=23%  Similarity=0.310  Sum_probs=219.3

Q ss_pred             cccCeeeeeeecccCceEEEEEE-----ecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEe
Q 014733           38 LSDRYVLGKQLGWGQFGVIRECS-----DKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEE  112 (419)
Q Consensus        38 ~~~~y~i~~~LG~G~~g~V~~a~-----~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~  112 (419)
                      ..++|++++.||+|+||.||+|.     +..++..||+|++...  ........+.+|+.+++++. ||||+++++++.+
T Consensus        28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~  104 (327)
T 2yfx_A           28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFN-HQNIVRCIGVSLQ  104 (327)
T ss_dssp             CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS--CCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECS
T ss_pred             ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc--cchhhHHHHHHHHHHHhhCC-CCCCCeEEEEEcC
Confidence            45899999999999999999999     5567889999998643  34566778999999999995 9999999999999


Q ss_pred             CCEEEEEEeecCCCChHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEE
Q 014733          113 EDYVHLLMELCAGGELFHRLEKYG-------RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKL  185 (419)
Q Consensus       113 ~~~~~lV~E~~~ggsL~~~l~~~~-------~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL  185 (419)
                      .+..|+||||+++++|.+++....       .+++.+++.++.||+.||.|||+.||+||||||+|||++.++.+..+||
T Consensus       105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl  184 (327)
T 2yfx_A          105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI  184 (327)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEE
Confidence            999999999999999999998753       3899999999999999999999999999999999999976556678999


Q ss_pred             eeccceeeeccCC---ccccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCC
Q 014733          186 ADFGLATYIKAGQ---NLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLR  260 (419)
Q Consensus       186 ~DFgla~~~~~~~---~~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~  260 (419)
                      +|||++.......   ......||+.|+|||++.+ .++.++||||||+++|+|++ |+.||.+....+..+.+......
T Consensus       185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~  264 (327)
T 2yfx_A          185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM  264 (327)
T ss_dssp             CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC
T ss_pred             CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCC
Confidence            9999987553322   1233467899999999865 58999999999999999998 99999998888888877765433


Q ss_pred             CCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccc
Q 014733          261 FPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEEC  303 (419)
Q Consensus       261 ~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~  303 (419)
                      .   ....++..+.++|.+||+.||.+|||+.++++|.|....
T Consensus       265 ~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  304 (327)
T 2yfx_A          265 D---PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  304 (327)
T ss_dssp             C---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             C---CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence            2   234789999999999999999999999999999887543

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.4e-46  Score=362.06  Aligned_cols=260  Identities=30%  Similarity=0.524  Sum_probs=207.0

Q ss_pred             hhccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCH---HhHHHHHHHHHHHHHcc---CCCCceee
Q 014733           33 TQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTV---EDVRSIKLEIEIMTKLS---GHPNVVDL  106 (419)
Q Consensus        33 ~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~---~~~~~~~~Ei~il~~l~---~hpnIv~l  106 (419)
                      ...+.+.++|++++.||+|+||.||+|.+..+++.||+|++........   .....+.+|+.+++++.   +||||+++
T Consensus        24 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~  103 (312)
T 2iwi_A           24 KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRL  103 (312)
T ss_dssp             ---------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCE
T ss_pred             cchhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeE
Confidence            3466788999999999999999999999999999999999976543221   22344667999999983   49999999


Q ss_pred             eEEEEeCCEEEEEEee-cCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEE
Q 014733          107 KAVYEEEDYVHLLMEL-CAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKL  185 (419)
Q Consensus       107 ~~~~~~~~~~~lV~E~-~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL  185 (419)
                      ++++.+.+..++|||+ +.+++|.+++...+.+++..++.++.||+.||+|||+.||+||||||+||+++  ..++.+||
T Consensus       104 ~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~--~~~~~~kl  181 (312)
T 2iwi_A          104 LDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILID--LRRGCAKL  181 (312)
T ss_dssp             EEEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEE--TTTTEEEE
T ss_pred             EEEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEe--CCCCeEEE
Confidence            9999999999999999 78999999999888899999999999999999999999999999999999995  25678999


Q ss_pred             eeccceeeeccCCccccccCCCccCCcccccCC-C-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC
Q 014733          186 ADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGG-Y-NQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPS  263 (419)
Q Consensus       186 ~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~~-~-s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~  263 (419)
                      +|||++...... ......||+.|+|||++.+. + +.++||||||+++|+|++|+.||....      .+......++ 
T Consensus       182 ~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~~-  253 (312)
T 2iwi_A          182 IDFGSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAELHFP-  253 (312)
T ss_dssp             CCCSSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTCCCCC-
T ss_pred             EEcchhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhccCCc-
Confidence            999999876543 34456799999999998653 4 568999999999999999999996531      2223333333 


Q ss_pred             CCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          264 DPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       264 ~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                         ..++.++.++|.+||+.||++|||+.++++||||+....
T Consensus       254 ---~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~  292 (312)
T 2iwi_A          254 ---AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE  292 (312)
T ss_dssp             ---TTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred             ---ccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchh
Confidence               368999999999999999999999999999999987654

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=4.6e-46  Score=362.69  Aligned_cols=262  Identities=24%  Similarity=0.348  Sum_probs=194.8

Q ss_pred             ccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHH-HHHHccCCCCceeeeEEEEeCCE
Q 014733           37 NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIE-IMTKLSGHPNVVDLKAVYEEEDY  115 (419)
Q Consensus        37 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~-il~~l~~hpnIv~l~~~~~~~~~  115 (419)
                      -..++|++++.||+|+||.||+|.++.+|+.||+|++....  .......+..|+. +++.+ +||||+++++++.+.+.
T Consensus        19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~~~-~h~niv~~~~~~~~~~~   95 (327)
T 3aln_A           19 FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV--DEKEQKQLLMDLDVVMRSS-DCPYIVQFYGALFREGD   95 (327)
T ss_dssp             CCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC--CHHHHHHHHHHHHHHHSSC-CCTTBCCEEEEEECSSE
T ss_pred             cCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc--CchHHHHHHHHHHHHHHcC-CCCcEeeeeeEEEeCCc
Confidence            34589999999999999999999999999999999997652  3445556666776 55555 59999999999999999


Q ss_pred             EEEEEeecCCCChHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CCeeccCCCCcEEEeecCCCCCeEEeecc
Q 014733          116 VHLLMELCAGGELFHRLEK-----YGRFSETEARVIFRHLMQVVSYCHGN-GVVHRDLKPENILLATKSSSSPIKLADFG  189 (419)
Q Consensus       116 ~~lV~E~~~ggsL~~~l~~-----~~~l~~~~~~~i~~qll~aL~~LH~~-~IvHrDLkp~NILl~~~~~~~~vKL~DFg  189 (419)
                      .++||||+.+ +|.+++..     ...+++..++.++.|++.||.|||+. ||+||||||+|||+   +.++.+||+|||
T Consensus        96 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll---~~~~~~kl~Dfg  171 (327)
T 3aln_A           96 CWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILL---DRSGNIKLCDFG  171 (327)
T ss_dssp             EEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEE---ETTTEEEECCCS
T ss_pred             eEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEE---cCCCCEEEccCC
Confidence            9999999975 88777763     46799999999999999999999999 99999999999999   456789999999


Q ss_pred             ceeeeccCCccccccCCCccCCccccc----C-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhc-CCCCC
Q 014733          190 LATYIKAGQNLHGTVGSPFYIAPEVLA----G-GYNQAADVWSAGVILYILLSGMPPFWGKTKS-KIFDAVRAA-DLRFP  262 (419)
Q Consensus       190 la~~~~~~~~~~~~~gt~~y~aPE~l~----~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~-~~~~~i~~~-~~~~~  262 (419)
                      ++.............||+.|+|||++.    + .++.++||||||+++|+|++|+.||.+.... +....+... ...++
T Consensus       172 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  251 (327)
T 3aln_A          172 ISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLS  251 (327)
T ss_dssp             SSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCC
T ss_pred             CceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCC
Confidence            998765554444558999999999983    3 4899999999999999999999999764321 111111111 11223


Q ss_pred             CCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          263 SDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       263 ~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                      ...+..++.++.+||.+||+.||.+|||+.++++||||.....
T Consensus       252 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~  294 (327)
T 3aln_A          252 NSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEE  294 (327)
T ss_dssp             CCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHH
T ss_pred             CcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhHh
Confidence            3334578999999999999999999999999999999987654

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.2e-45  Score=356.65  Aligned_cols=255  Identities=25%  Similarity=0.388  Sum_probs=216.4

Q ss_pred             cccccCeeeeeeecccCceEEEEEEe-----cCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEE
Q 014733           36 SNLSDRYVLGKQLGWGQFGVIRECSD-----KFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVY  110 (419)
Q Consensus        36 ~~~~~~y~i~~~LG~G~~g~V~~a~~-----~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~  110 (419)
                      +-..++|++++.||+|+||.||+|.+     ..+++.||+|++....  .....+.+.+|+.+++++.+||||+++++++
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~   96 (313)
T 1t46_A           19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGAC   96 (313)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEEEE
Confidence            34568999999999999999999985     4678899999997553  3456788999999999995599999999999


Q ss_pred             EeCCEEEEEEeecCCCChHHHHHHcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcE
Q 014733          111 EEEDYVHLLMELCAGGELFHRLEKYG------------------RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENI  172 (419)
Q Consensus       111 ~~~~~~~lV~E~~~ggsL~~~l~~~~------------------~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NI  172 (419)
                      .+.+..++||||+++|+|.+++....                  .+++.+++.++.||+.||.|||++||+||||||+||
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni  176 (313)
T 1t46_A           97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI  176 (313)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceE
Confidence            99999999999999999999997654                  389999999999999999999999999999999999


Q ss_pred             EEeecCCCCCeEEeeccceeeeccCCc---cccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCH
Q 014733          173 LLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTK  247 (419)
Q Consensus       173 Ll~~~~~~~~vKL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~  247 (419)
                      |+   +.++.+||+|||++........   .....||+.|+|||++.+ .++.++||||||+++|+|++ |+.||.+...
T Consensus       177 l~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~  253 (313)
T 1t46_A          177 LL---THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV  253 (313)
T ss_dssp             EE---ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred             EE---cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence            99   4567899999999987654432   223457888999998866 48999999999999999998 9999987765


Q ss_pred             HHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          248 SKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       248 ~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      ................  ...++.++.++|.+||+.||.+|||+.+++++
T Consensus       254 ~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          254 DSKFYKMIKEGFRMLS--PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             SHHHHHHHHHTCCCCC--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hhHHHHHhccCCCCCC--cccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            5544444333333222  24789999999999999999999999999985

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.3e-45  Score=358.36  Aligned_cols=260  Identities=21%  Similarity=0.318  Sum_probs=223.6

Q ss_pred             ccchhhccccccCeeeeeeecccCceEEEEEEec-----CCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCc
Q 014733           29 ILDATQISNLSDRYVLGKQLGWGQFGVIRECSDK-----FTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNV  103 (419)
Q Consensus        29 ~~~~~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~-----~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnI  103 (419)
                      ++...+.+...++|++.+.||+|+||.||+|.++     .+++.||+|++...  ........+.+|+.+++++. ||||
T Consensus        14 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~i   90 (322)
T 1p4o_A           14 VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFN-CHHV   90 (322)
T ss_dssp             CCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT--SCHHHHHHHHHHHHHGGGCC-CTTB
T ss_pred             ccChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc--cCHHHHHHHHHHHHHHHhcC-CCCE
Confidence            3445566777899999999999999999999876     46788999998754  34456677999999999996 9999


Q ss_pred             eeeeEEEEeCCEEEEEEeecCCCChHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEE
Q 014733          104 VDLKAVYEEEDYVHLLMELCAGGELFHRLEKY----------GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENIL  173 (419)
Q Consensus       104 v~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~----------~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NIL  173 (419)
                      +++++++.+.+..++||||+++++|.+++...          ..+++..++.++.||+.||.|||++||+||||||+|||
T Consensus        91 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIl  170 (322)
T 1p4o_A           91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCM  170 (322)
T ss_dssp             CCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEE
T ss_pred             eeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEE
Confidence            99999999999999999999999999998753          35799999999999999999999999999999999999


Q ss_pred             EeecCCCCCeEEeeccceeeeccCCc---cccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 014733          174 LATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTKS  248 (419)
Q Consensus       174 l~~~~~~~~vKL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~  248 (419)
                      +   +.++.+||+|||++........   .....+|+.|+|||++.+ .++.++||||||+++|+|++ |..||.+....
T Consensus       171 i---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~  247 (322)
T 1p4o_A          171 V---AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE  247 (322)
T ss_dssp             E---CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH
T ss_pred             E---cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH
Confidence            9   5678999999999986543321   123357889999999876 48999999999999999999 89999998888


Q ss_pred             HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          249 KIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       249 ~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      +....+........   ...++.++.++|.+||+.||.+|||+.++++|
T Consensus       248 ~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~  293 (322)
T 1p4o_A          248 QVLRFVMEGGLLDK---PDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  293 (322)
T ss_dssp             HHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHcCCcCCC---CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            88888776544222   24789999999999999999999999999986

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.2e-45  Score=352.15  Aligned_cols=253  Identities=25%  Similarity=0.368  Sum_probs=205.9

Q ss_pred             ccccccCeeeeeeecccCceEEEEEEecCC---CcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEE
Q 014733           35 ISNLSDRYVLGKQLGWGQFGVIRECSDKFT---GEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYE  111 (419)
Q Consensus        35 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~---g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~  111 (419)
                      .+...++|++++.||+|+||.||+|.+..+   +..||+|++...  ......+.+.+|+.+++++. ||||+++++++.
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~   86 (281)
T 1mp8_A           10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFD-HPHIVKLIGVIT   86 (281)
T ss_dssp             CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC
T ss_pred             eEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc--CCHHHHHHHHHHHHHHHhCC-CCccceEEEEEc
Confidence            455678999999999999999999998653   457999988654  34556778999999999996 999999999985


Q ss_pred             eCCEEEEEEeecCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccc
Q 014733          112 EEDYVHLLMELCAGGELFHRLEKYG-RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGL  190 (419)
Q Consensus       112 ~~~~~~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgl  190 (419)
                       ++..++||||+++++|.+++...+ .+++..++.++.|++.||+|||+.||+||||||+|||++   .++.+||+|||+
T Consensus        87 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~  162 (281)
T 1mp8_A           87 -ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGL  162 (281)
T ss_dssp             -SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECC---
T ss_pred             -cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEEC---CCCCEEECcccc
Confidence             456889999999999999998654 599999999999999999999999999999999999995   457899999999


Q ss_pred             eeeeccCCc--cccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 014733          191 ATYIKAGQN--LHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPW  266 (419)
Q Consensus       191 a~~~~~~~~--~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  266 (419)
                      +........  .....+|+.|+|||++.+ .++.++||||||+++|+|++ |..||.+....+....+......   ...
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~---~~~  239 (281)
T 1mp8_A          163 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL---PMP  239 (281)
T ss_dssp             ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC---CCC
T ss_pred             ccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCC---CCC
Confidence            987654332  223356788999999875 58999999999999999996 99999988888888877665422   123


Q ss_pred             CCCCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          267 DHISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       267 ~~~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      ..+++++.++|.+||+.||++|||+.+++++
T Consensus       240 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          240 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            4789999999999999999999999999875

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.2e-46  Score=362.83  Aligned_cols=254  Identities=22%  Similarity=0.338  Sum_probs=212.5

Q ss_pred             ccccCeeeeeeecccCceEEEEEEe-----cCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEE
Q 014733           37 NLSDRYVLGKQLGWGQFGVIRECSD-----KFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYE  111 (419)
Q Consensus        37 ~~~~~y~i~~~LG~G~~g~V~~a~~-----~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~  111 (419)
                      .-.++|++++.||+|+||.||+|.+     ..++..||+|++....  .....+.+.+|+.+++++.+||||+++++++.
T Consensus        42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  119 (344)
T 1rjb_A           42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACT  119 (344)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            3458999999999999999999997     3466789999997542  33456789999999999955999999999999


Q ss_pred             eCCEEEEEEeecCCCChHHHHHHcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCC
Q 014733          112 EEDYVHLLMELCAGGELFHRLEKYG-----------------------RFSETEARVIFRHLMQVVSYCHGNGVVHRDLK  168 (419)
Q Consensus       112 ~~~~~~lV~E~~~ggsL~~~l~~~~-----------------------~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLk  168 (419)
                      +.+.+++||||+++|+|.+++....                       .+++..++.++.||+.||+|||+.||+|||||
T Consensus       120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dik  199 (344)
T 1rjb_A          120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLA  199 (344)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred             eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence            9999999999999999999997643                       27999999999999999999999999999999


Q ss_pred             CCcEEEeecCCCCCeEEeeccceeeeccCCc---cccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCC
Q 014733          169 PENILLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFW  243 (419)
Q Consensus       169 p~NILl~~~~~~~~vKL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~  243 (419)
                      |+|||+   +.++.+||+|||++........   .....||+.|+|||++.+ .++.++||||||+++|+|++ |..||.
T Consensus       200 p~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  276 (344)
T 1rjb_A          200 ARNVLV---THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP  276 (344)
T ss_dssp             GGGEEE---ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             hhhEEE---cCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence            999999   4567899999999987654332   233467889999998865 58999999999999999998 999998


Q ss_pred             CCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          244 GKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       244 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      +.........+.......+.  ...+++++.+||.+||+.||.+|||+.++++|
T Consensus       277 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  328 (344)
T 1rjb_A          277 GIPVDANFYKLIQNGFKMDQ--PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  328 (344)
T ss_dssp             TCCCSHHHHHHHHTTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCcHHHHHHHHhcCCCCCC--CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            87765555555444433332  24689999999999999999999999999986

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=9.8e-46  Score=360.59  Aligned_cols=250  Identities=26%  Similarity=0.373  Sum_probs=212.4

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEE--EEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVL--ACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVH  117 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~v--aiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~  117 (419)
                      ++|++.+.||+|+||.||+|.++.++..+  |+|.+...  ......+.+.+|+.+++++.+||||+++++++.+.+.++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~  102 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY  102 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc--cchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceE
Confidence            78999999999999999999999888865  99988643  234456778999999999955999999999999999999


Q ss_pred             EEEeecCCCChHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCC
Q 014733          118 LLMELCAGGELFHRLEKYG----------------RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSS  181 (419)
Q Consensus       118 lV~E~~~ggsL~~~l~~~~----------------~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~  181 (419)
                      +||||+++++|.+++...+                .+++.+++.++.||++||+|||++||+||||||+|||+   +.++
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~---~~~~  179 (327)
T 1fvr_A          103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENY  179 (327)
T ss_dssp             EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGG
T ss_pred             EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEE---cCCC
Confidence            9999999999999997654                69999999999999999999999999999999999999   5567


Q ss_pred             CeEEeeccceeeeccCCccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCC
Q 014733          182 PIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADL  259 (419)
Q Consensus       182 ~vKL~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~  259 (419)
                      .+||+|||++.............+++.|+|||++.+. ++.++||||||+++|+|++ |+.||.+....+....+.....
T Consensus       180 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~  259 (327)
T 1fvr_A          180 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR  259 (327)
T ss_dssp             CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC
T ss_pred             eEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCC
Confidence            8999999999854333333444678899999998765 8999999999999999998 9999999988888777655421


Q ss_pred             CCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          260 RFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       260 ~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                         ......+++++.+||.+||+.||.+|||+.+++++
T Consensus       260 ---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          260 ---LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             ---CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence               12234789999999999999999999999999986

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.8e-45  Score=350.79  Aligned_cols=250  Identities=23%  Similarity=0.347  Sum_probs=214.5

Q ss_pred             cccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCE
Q 014733           36 SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDY  115 (419)
Q Consensus        36 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~  115 (419)
                      ..-.++|++++.||+|+||+||+|.+. ++..||+|++.....    ..+.+.+|+.+++++. ||||+++++++.+.+.
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~   93 (283)
T 3gen_A           20 EIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLS-HEKLVQLYGVCTKQRP   93 (283)
T ss_dssp             BCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHHTCC-CTTBCCEEEEECSSSS
T ss_pred             cCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC----CHHHHHHHHHHHhcCC-CCCEeeEEEEEecCCC
Confidence            344689999999999999999999876 677899999976543    2356889999999996 9999999999999999


Q ss_pred             EEEEEeecCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeee
Q 014733          116 VHLLMELCAGGELFHRLEK-YGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI  194 (419)
Q Consensus       116 ~~lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~  194 (419)
                      +++||||+++++|.+++.. ...+++.+++.++.|++.||.|||++||+||||||+|||+   +.++.+||+|||++...
T Consensus        94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili---~~~~~~kl~Dfg~~~~~  170 (283)
T 3gen_A           94 IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYV  170 (283)
T ss_dssp             EEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE---CTTSCEEECSTTGGGGB
T ss_pred             eEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEE---cCCCCEEEccccccccc
Confidence            9999999999999999976 4569999999999999999999999999999999999999   56779999999999865


Q ss_pred             ccCC--ccccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCC
Q 014733          195 KAGQ--NLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHIS  270 (419)
Q Consensus       195 ~~~~--~~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  270 (419)
                      ....  ......+|+.|+|||++.+ .++.++||||||+++|+|++ |+.||......+....+........   ...++
T Consensus       171 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~  247 (283)
T 3gen_A          171 LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR---PHLAS  247 (283)
T ss_dssp             CCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC---CTTCC
T ss_pred             cccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCC---CCcCC
Confidence            4322  2233467788999999875 58999999999999999998 9999999988888888776643322   23678


Q ss_pred             HHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          271 ASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       271 ~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      +.+.++|.+||+.||.+|||+.++++|
T Consensus       248 ~~l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          248 EKVYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             HHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHHHH
Confidence            999999999999999999999999987

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=3.7e-45  Score=349.34  Aligned_cols=254  Identities=26%  Similarity=0.413  Sum_probs=210.0

Q ss_pred             ccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhH----HHHHHHHHHHHHccCCCCceeeeEEEEe
Q 014733           37 NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDV----RSIKLEIEIMTKLSGHPNVVDLKAVYEE  112 (419)
Q Consensus        37 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~----~~~~~Ei~il~~l~~hpnIv~l~~~~~~  112 (419)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|++...........    +.+.+|+.++++++ ||||+++++++.+
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~   94 (287)
T 4f0f_A           16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN-HPNIVKLYGLMHN   94 (287)
T ss_dssp             CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCC-CTTBCCEEEEETT
T ss_pred             hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCC-CCCchhhheeecC
Confidence            345899999999999999999999999999999999976543322222    67899999999996 9999999999977


Q ss_pred             CCEEEEEEeecCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--CeeccCCCCcEEEeecCCC--CCeEEee
Q 014733          113 EDYVHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNG--VVHRDLKPENILLATKSSS--SPIKLAD  187 (419)
Q Consensus       113 ~~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~--IvHrDLkp~NILl~~~~~~--~~vKL~D  187 (419)
                      ..  ++||||+++++|.+.+... ..+++..++.++.|++.||+|||+.|  |+||||||+|||++.++.+  ..+||+|
T Consensus        95 ~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D  172 (287)
T 4f0f_A           95 PP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD  172 (287)
T ss_dssp             TT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred             CC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence            66  6899999999998888654 46999999999999999999999999  9999999999999543211  1399999


Q ss_pred             ccceeeeccCCccccccCCCccCCcccccC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhcCCCCC
Q 014733          188 FGLATYIKAGQNLHGTVGSPFYIAPEVLAG---GYNQAADVWSAGVILYILLSGMPPFWGKTKSKI--FDAVRAADLRFP  262 (419)
Q Consensus       188 Fgla~~~~~~~~~~~~~gt~~y~aPE~l~~---~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~--~~~i~~~~~~~~  262 (419)
                      ||++.....  ......||+.|+|||++.+   .++.++||||||+++|+|++|+.||......+.  ...+......  
T Consensus       173 fg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--  248 (287)
T 4f0f_A          173 FGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLR--  248 (287)
T ss_dssp             CTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCC--
T ss_pred             CCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCC--
Confidence            999985432  3445689999999999843   378999999999999999999999977654443  4444443332  


Q ss_pred             CCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          263 SDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       263 ~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      ......+++++.++|.+||+.||.+|||+.++++.
T Consensus       249 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  283 (287)
T 4f0f_A          249 PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKE  283 (287)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            23335789999999999999999999999999863

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=9.9e-46  Score=368.46  Aligned_cols=251  Identities=24%  Similarity=0.393  Sum_probs=216.6

Q ss_pred             cccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEE
Q 014733           38 LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVH  117 (419)
Q Consensus        38 ~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~  117 (419)
                      -.++|++++.||+|+||.||+|.++.+++.||+|++...  ........+.+|+.+|+++. ||||+++++++.+.+.+|
T Consensus       112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~  188 (377)
T 3cbl_A          112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET--LPPDLKAKFLQEARILKQYS-HPNIVRLIGVCTQKQPIY  188 (377)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT--SCHHHHTTTTHHHHHHTTCC-CTTBCCEEEEECSSSSCE
T ss_pred             chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc--CCHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEecCCCcE
Confidence            357999999999999999999999999999999998754  34455677889999999996 999999999999999999


Q ss_pred             EEEeecCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeecc
Q 014733          118 LLMELCAGGELFHRLEKYG-RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA  196 (419)
Q Consensus       118 lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~  196 (419)
                      +||||+++|+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++.....
T Consensus       189 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~---~~~~~~kl~DfG~s~~~~~  265 (377)
T 3cbl_A          189 IVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLV---TEKNVLKISDFGMSREEAD  265 (377)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCGGGCEECTT
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEE---cCCCcEEECcCCCceecCC
Confidence            9999999999999997654 59999999999999999999999999999999999999   5678999999999986543


Q ss_pred             CCcc---ccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCH
Q 014733          197 GQNL---HGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISA  271 (419)
Q Consensus       197 ~~~~---~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  271 (419)
                      ....   ....++..|+|||++.+. ++.++|||||||++|||++ |..||.+....+..+.+.... ..+.  +..+++
T Consensus       266 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~--~~~~~~  342 (377)
T 3cbl_A          266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGG-RLPC--PELCPD  342 (377)
T ss_dssp             SEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTC-CCCC--CTTCCH
T ss_pred             CceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCC--CCCCCH
Confidence            3211   112356789999998764 8999999999999999998 999999988888777776543 2222  236899


Q ss_pred             HHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          272 SARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       272 ~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      ++.+||.+||+.||++|||+.++++.
T Consensus       343 ~l~~li~~cl~~dP~~Rps~~~i~~~  368 (377)
T 3cbl_A          343 AVFRLMEQCWAYEPGQRPSFSTIYQE  368 (377)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            99999999999999999999999863

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=5.9e-45  Score=356.30  Aligned_cols=258  Identities=23%  Similarity=0.365  Sum_probs=220.7

Q ss_pred             cccccCeeeeeeecccCceEEEEEEec-------CCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeE
Q 014733           36 SNLSDRYVLGKQLGWGQFGVIRECSDK-------FTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKA  108 (419)
Q Consensus        36 ~~~~~~y~i~~~LG~G~~g~V~~a~~~-------~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~  108 (419)
                      .-..++|++++.||+|+||.||+|.+.       .++..||+|++...  ......+.+.+|+.+++++.+||||+++++
T Consensus        31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~  108 (334)
T 2pvf_A           31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLG  108 (334)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccC--CcHHHHHHHHHHHHHHHHhhcCCCEeeEEE
Confidence            334689999999999999999999975       46778999998754  345677889999999999955999999999


Q ss_pred             EEEeCCEEEEEEeecCCCChHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcE
Q 014733          109 VYEEEDYVHLLMELCAGGELFHRLEKYG----------------RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENI  172 (419)
Q Consensus       109 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~----------------~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NI  172 (419)
                      ++.+.+.+++||||+++++|.+++....                .+++.+++.++.||+.||+|||+.||+||||||+||
T Consensus       109 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI  188 (334)
T 2pvf_A          109 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV  188 (334)
T ss_dssp             EECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred             EEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceE
Confidence            9999999999999999999999997643                389999999999999999999999999999999999


Q ss_pred             EEeecCCCCCeEEeeccceeeeccCCc---cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHh-CCCCCCCCCH
Q 014733          173 LLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTK  247 (419)
Q Consensus       173 Ll~~~~~~~~vKL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~ellt-G~~Pf~~~~~  247 (419)
                      |+   +.++.+||+|||++........   .....+|+.|+|||++.+. ++.++||||||+++|+|++ |..||.+...
T Consensus       189 ll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~  265 (334)
T 2pvf_A          189 LV---TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV  265 (334)
T ss_dssp             EE---CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred             EE---cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH
Confidence            99   5678999999999987654332   2234578889999998764 8999999999999999999 9999999988


Q ss_pred             HHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccc
Q 014733          248 SKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEEC  303 (419)
Q Consensus       248 ~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~  303 (419)
                      .++...+.......   ....++.++.++|.+||+.||.+|||+.+++++  ++.+
T Consensus       266 ~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~--L~~l  316 (334)
T 2pvf_A          266 EELFKLLKEGHRMD---KPANCTNELYMMMRDCWHAVPSQRPTFKQLVED--LDRI  316 (334)
T ss_dssp             HHHHHHHHHTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHH
T ss_pred             HHHHHHHhcCCCCC---CCccCCHHHHHHHHHHccCChhhCcCHHHHHHH--HHHH
Confidence            88888777654222   224789999999999999999999999999986  4444

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.9e-45  Score=355.70  Aligned_cols=258  Identities=26%  Similarity=0.401  Sum_probs=215.5

Q ss_pred             hhhccccccCeeeeeeecccCceEEEEEEe-----cCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceee
Q 014733           32 ATQISNLSDRYVLGKQLGWGQFGVIRECSD-----KFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDL  106 (419)
Q Consensus        32 ~~~~~~~~~~y~i~~~LG~G~~g~V~~a~~-----~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l  106 (419)
                      ........++|++++.||+|+||.||+|.+     ..+++.||+|++...  ......+.+.+|+.+++++.+||||+++
T Consensus        19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~   96 (316)
T 2xir_A           19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILIHIGHHLNVVNL   96 (316)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccC--CCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence            344455679999999999999999999985     457789999999765  3455667899999999999669999999


Q ss_pred             eEEEEeCC-EEEEEEeecCCCChHHHHHHcCC----------------CCHHHHHHHHHHHHHHHHHHHhCCCeeccCCC
Q 014733          107 KAVYEEED-YVHLLMELCAGGELFHRLEKYGR----------------FSETEARVIFRHLMQVVSYCHGNGVVHRDLKP  169 (419)
Q Consensus       107 ~~~~~~~~-~~~lV~E~~~ggsL~~~l~~~~~----------------l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp  169 (419)
                      ++++.+.+ .+++||||+++++|.+++.....                +++..++.++.||+.||.|||+.||+||||||
T Consensus        97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp  176 (316)
T 2xir_A           97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAA  176 (316)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred             EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCcc
Confidence            99987754 58999999999999999987543                89999999999999999999999999999999


Q ss_pred             CcEEEeecCCCCCeEEeeccceeeeccCCc---cccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCC
Q 014733          170 ENILLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWG  244 (419)
Q Consensus       170 ~NILl~~~~~~~~vKL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~  244 (419)
                      +|||+   +.++.+||+|||++........   .....||+.|+|||++.+ .++.++||||||+++|+|++ |..||.+
T Consensus       177 ~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~  253 (316)
T 2xir_A          177 RNILL---SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  253 (316)
T ss_dssp             GGEEE---CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             ceEEE---CCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence            99999   5567899999999986543322   233467889999999876 48999999999999999998 9999987


Q ss_pred             CCHHH-HHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          245 KTKSK-IFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       245 ~~~~~-~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      ....+ ....+.... ...  ....+++++.++|.+||+.||.+|||+.++++|
T Consensus       254 ~~~~~~~~~~~~~~~-~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          254 VKIDEEFCRRLKEGT-RMR--APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             CCCSHHHHHHHHHTC-CCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cchhHHHHHHhccCc-cCC--CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            66443 344444432 222  223689999999999999999999999999987

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=3.8e-45  Score=350.28  Aligned_cols=259  Identities=20%  Similarity=0.287  Sum_probs=211.0

Q ss_pred             ccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCce-eeeEEEEeCCE
Q 014733           37 NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVV-DLKAVYEEEDY  115 (419)
Q Consensus        37 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv-~l~~~~~~~~~  115 (419)
                      .+.++|++.+.||+|+||.||+|++..+|+.||+|++.....     ...+.+|+.+++.+. |++++ .+..+..+.+.
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~-~~~~i~~~~~~~~~~~~   79 (296)
T 3uzp_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQ-GGVGIPTIRWCGAEGDY   79 (296)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-----CCHHHHHHHHHHHHT-TSTTCCCEEEEEEETTE
T ss_pred             eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-----hhHHHHHHHHHHHhh-cCCCCCccccccCCCCc
Confidence            467899999999999999999999999999999999876532     235788999999997 65544 55555577889


Q ss_pred             EEEEEeecCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeee
Q 014733          116 VHLLMELCAGGELFHRLEK-YGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI  194 (419)
Q Consensus       116 ~~lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~  194 (419)
                      .++||||+ +++|.+++.. .+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.++.+||+|||++...
T Consensus        80 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~  158 (296)
T 3uzp_A           80 NVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             eEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence            99999999 9999999974 356999999999999999999999999999999999999965446778999999999876


Q ss_pred             ccCCc--------cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhcCCCCC
Q 014733          195 KAGQN--------LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKT---KSKIFDAVRAADLRFP  262 (419)
Q Consensus       195 ~~~~~--------~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~---~~~~~~~i~~~~~~~~  262 (419)
                      .....        .....||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+..   ..+....+.......+
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 3uzp_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence            55432        2345799999999998874 8999999999999999999999997633   2233333333222222


Q ss_pred             C-CCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccch
Q 014733          263 S-DPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECE  304 (419)
Q Consensus       263 ~-~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~  304 (419)
                      . .....+++++.++|.+||+.||++|||+.++++.  ++++.
T Consensus       239 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~--l~~~~  279 (296)
T 3uzp_A          239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQL--FRNLF  279 (296)
T ss_dssp             HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHH--HHHHH
T ss_pred             hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHH--HHHHH
Confidence            1 1124688999999999999999999999999873  54443

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=3.3e-46  Score=362.96  Aligned_cols=261  Identities=20%  Similarity=0.282  Sum_probs=212.3

Q ss_pred             ccchhhccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeE
Q 014733           29 ILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKA  108 (419)
Q Consensus        29 ~~~~~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~  108 (419)
                      .+...++....++|++.+.||+|+||.||+|.++ +|+.||+|++....   ....+.+.+|+.++++++ ||||+++++
T Consensus        28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~~iv~~~~  102 (321)
T 2qkw_B           28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPES---SQGIEEFETEIETLSFCR-HPHLVSLIG  102 (321)
T ss_dssp             --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCC---SSHHHHHHHHHHGGGSCC-CTTBCCEEE
T ss_pred             eecHHHHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccC---hHHHHHHHHHHHHHHhCC-CCCEeeEEE
Confidence            4455667788999999999999999999999975 68999999886542   345678999999999996 999999999


Q ss_pred             EEEeCCEEEEEEeecCCCChHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeE
Q 014733          109 VYEEEDYVHLLMELCAGGELFHRLEKYG----RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIK  184 (419)
Q Consensus       109 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~----~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vK  184 (419)
                      ++.+.+..++||||+++++|.+++....    .+++..++.++.|++.||+|||++||+||||||+|||+   +.++.+|
T Consensus       103 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~k  179 (321)
T 2qkw_B          103 FCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILL---DENFVPK  179 (321)
T ss_dssp             ECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEE---CTTCCEE
T ss_pred             EEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEE---CCCCCEE
Confidence            9999999999999999999999986543    48999999999999999999999999999999999999   5678999


Q ss_pred             EeeccceeeeccCC---ccccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH---H----H
Q 014733          185 LADFGLATYIKAGQ---NLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIF---D----A  253 (419)
Q Consensus       185 L~DFgla~~~~~~~---~~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~---~----~  253 (419)
                      |+|||++.......   ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||.+....+..   .    .
T Consensus       180 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~  259 (321)
T 2qkw_B          180 ITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES  259 (321)
T ss_dssp             ECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHH
T ss_pred             EeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhc
Confidence            99999998654322   1233468999999999865 4999999999999999999999999764432211   1    1


Q ss_pred             HHhcCCC------CCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          254 VRAADLR------FPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       254 i~~~~~~------~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      .....+.      .........+.++.+++.+||+.||++|||+.++++|
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  309 (321)
T 2qkw_B          260 HNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK  309 (321)
T ss_dssp             HTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            1111111      1111112345778999999999999999999999986

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=2.7e-45  Score=353.19  Aligned_cols=243  Identities=33%  Similarity=0.635  Sum_probs=199.1

Q ss_pred             cccccCeeee-eeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEe--
Q 014733           36 SNLSDRYVLG-KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEE--  112 (419)
Q Consensus        36 ~~~~~~y~i~-~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~--  112 (419)
                      ..+.++|.+. +.||+|+||.||+|.++.+++.||+|++...        ..+.+|+.++.++.+||||+++++++.+  
T Consensus        13 ~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~   84 (299)
T 3m2w_A           13 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLY   84 (299)
T ss_dssp             SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred             cccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhc
Confidence            4566778887 7899999999999999999999999998642        3567889998666579999999999987  


Q ss_pred             --CCEEEEEEeecCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeec
Q 014733          113 --EDYVHLLMELCAGGELFHRLEKYG--RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADF  188 (419)
Q Consensus       113 --~~~~~lV~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DF  188 (419)
                        .+.+++||||++|++|.+++...+  .+++.+++.++.||+.||+|||+.||+||||||+|||++.++.++.+||+||
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Df  164 (299)
T 3m2w_A           85 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF  164 (299)
T ss_dssp             TTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred             CCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecc
Confidence              778999999999999999998764  5999999999999999999999999999999999999966544789999999


Q ss_pred             cceeeeccCCccccccCCCccCCcccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----HhcCCCCCCC
Q 014733          189 GLATYIKAGQNLHGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAV----RAADLRFPSD  264 (419)
Q Consensus       189 gla~~~~~~~~~~~~~gt~~y~aPE~l~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i----~~~~~~~~~~  264 (419)
                      |++.....                    ..++.++|||||||++|+|++|+.||.+.........+    ......++..
T Consensus       165 g~a~~~~~--------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (299)
T 3m2w_A          165 GFAKETTG--------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP  224 (299)
T ss_dssp             TTCEECTT--------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHH
T ss_pred             cccccccc--------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCch
Confidence            99875321                    23678999999999999999999999776543332111    1122222222


Q ss_pred             CCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchhh
Q 014733          265 PWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQV  306 (419)
Q Consensus       265 ~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~~  306 (419)
                      .+..+++++.+||.+||+.||.+|||+.++++||||++....
T Consensus       225 ~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~  266 (299)
T 3m2w_A          225 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV  266 (299)
T ss_dssp             HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGS
T ss_pred             hcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccC
Confidence            235789999999999999999999999999999999876543

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=3.8e-45  Score=349.18  Aligned_cols=252  Identities=24%  Similarity=0.370  Sum_probs=219.6

Q ss_pred             ccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCC
Q 014733           35 ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEED  114 (419)
Q Consensus        35 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~  114 (419)
                      .+...++|++.+.||+|+||.||+|.++.++..||+|++....    ...+.+.+|+.++++++ ||||+++++++.+.+
T Consensus         8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~   82 (288)
T 3kfa_A            8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIK-HPNLVQLLGVCTREP   82 (288)
T ss_dssp             TBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS----THHHHHHHHHHHHHHCC-CTTBCCEEEEECSSS
T ss_pred             ccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH----HHHHHHHHHHHHHHhCC-CCCEeeEEEEEccCC
Confidence            3446789999999999999999999999999999999997542    35678899999999996 999999999999999


Q ss_pred             EEEEEEeecCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeecccee
Q 014733          115 YVHLLMELCAGGELFHRLEKYG--RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLAT  192 (419)
Q Consensus       115 ~~~lV~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~  192 (419)
                      .+++||||+.|++|.+++....  .+++..++.++.||+.||+|||+.||+||||||+||++   +.++.+||+|||++.
T Consensus        83 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~~l~Dfg~~~  159 (288)
T 3kfa_A           83 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSR  159 (288)
T ss_dssp             SEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEE---CGGGCEEECCCCGGG
T ss_pred             CEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEE---cCCCCEEEccCccce
Confidence            9999999999999999998743  49999999999999999999999999999999999999   556789999999998


Q ss_pred             eeccCCc--cccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCC
Q 014733          193 YIKAGQN--LHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDH  268 (419)
Q Consensus       193 ~~~~~~~--~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  268 (419)
                      .......  .....+|+.|+|||++.+ .++.++||||||+++|+|++ |..||.+.......+.+......   .....
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~  236 (288)
T 3kfa_A          160 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM---ERPEG  236 (288)
T ss_dssp             TSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC---CCCTT
T ss_pred             eccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCC---CCCCC
Confidence            6654332  233467888999999875 58999999999999999999 99999988888777777654222   22347


Q ss_pred             CCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          269 ISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       269 ~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      +++++.+||.+||+.||.+|||+.++++.
T Consensus       237 ~~~~l~~li~~~l~~dp~~Rps~~~~~~~  265 (288)
T 3kfa_A          237 CPEKVYELMRACWQWNPSDRPSFAEIHQA  265 (288)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHHHHhCCChhhCcCHHHHHHH
Confidence            89999999999999999999999999873

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=2.8e-45  Score=357.88  Aligned_cols=249  Identities=22%  Similarity=0.336  Sum_probs=205.3

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEE----EEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCC
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVL----ACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEED  114 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~v----aiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~  114 (419)
                      .++|++.+.||+|+||+||+|.+..+++.+    |+|.+...  ......+.+.+|+.++++++ ||||+++++++.+..
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~   90 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVD-NPHVCRLLGICLTST   90 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCC-BTTBCCEEEEEESSS
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccc--cCHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEecCC
Confidence            478999999999999999999998777765    66766433  23345678999999999996 999999999998766


Q ss_pred             EEEEEEeecCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceee
Q 014733          115 YVHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATY  193 (419)
Q Consensus       115 ~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~  193 (419)
                       .++|+||+.+|+|.+++... +.+++..++.++.||+.||+|||+.||+||||||+|||++   .++.+||+|||+++.
T Consensus        91 -~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~---~~~~~kl~Dfg~a~~  166 (327)
T 3poz_A           91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAKL  166 (327)
T ss_dssp             -EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---ETTEEEECCTTHHHH
T ss_pred             -eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEEC---CCCCEEEccCcceeE
Confidence             77899999999999999774 5699999999999999999999999999999999999995   466899999999987


Q ss_pred             eccCCcc---ccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCC
Q 014733          194 IKAGQNL---HGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDH  268 (419)
Q Consensus       194 ~~~~~~~---~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  268 (419)
                      .......   ....+|+.|+|||++.+. ++.++|||||||++|+|++ |+.||.+....++...+..... .+.  ...
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~-~~~--~~~  243 (327)
T 3poz_A          167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER-LPQ--PPI  243 (327)
T ss_dssp             HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC-CCC--CTT
T ss_pred             ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCC-CCC--Ccc
Confidence            6543322   234568899999998764 8999999999999999999 9999998888877777665532 222  236


Q ss_pred             CCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          269 ISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       269 ~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      ++.++.+++.+||+.||.+|||+.+++++
T Consensus       244 ~~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          244 CTIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             BCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            88999999999999999999999999986

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.1e-45  Score=370.50  Aligned_cols=260  Identities=25%  Similarity=0.401  Sum_probs=214.3

Q ss_pred             ccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCC
Q 014733           35 ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEED  114 (419)
Q Consensus        35 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~  114 (419)
                      ...+.++|++.+.||+|+||+||+|.++.+|+.||+|++.....  ....+.+.+|++++++++ ||||+++++++.+.+
T Consensus         4 ~~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~   80 (396)
T 4eut_A            4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLN-HKNIVKLFAIEEETT   80 (396)
T ss_dssp             EECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCC-CTTBCCEEEEEECTT
T ss_pred             CCCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcC-CCCCCeEEEeeccCC
Confidence            34567899999999999999999999999999999999975432  234567789999999996 999999999998765


Q ss_pred             --EEEEEEeecCCCChHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeec-CCCCCeEEeec
Q 014733          115 --YVHLLMELCAGGELFHRLEKYGR---FSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATK-SSSSPIKLADF  188 (419)
Q Consensus       115 --~~~lV~E~~~ggsL~~~l~~~~~---l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~-~~~~~vKL~DF  188 (419)
                        ..++||||+++++|.+++.....   +++.+++.++.||+.||+|||+.||+||||||+|||+..+ +.++.+||+||
T Consensus        81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DF  160 (396)
T 4eut_A           81 TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDF  160 (396)
T ss_dssp             TCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCG
T ss_pred             CCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecC
Confidence              78999999999999999976433   9999999999999999999999999999999999998432 33456999999


Q ss_pred             cceeeeccCCccccccCCCccCCcccccC---------CCCCchhHHHHHHHHHHHHhCCCCCCC----CCHHHHHHHHH
Q 014733          189 GLATYIKAGQNLHGTVGSPFYIAPEVLAG---------GYNQAADVWSAGVILYILLSGMPPFWG----KTKSKIFDAVR  255 (419)
Q Consensus       189 gla~~~~~~~~~~~~~gt~~y~aPE~l~~---------~~s~~sDvwSlGvil~elltG~~Pf~~----~~~~~~~~~i~  255 (419)
                      |++............+||+.|+|||++.+         .++.++|||||||++|+|++|+.||..    ....+....+.
T Consensus       161 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~  240 (396)
T 4eut_A          161 GAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII  240 (396)
T ss_dssp             GGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHH
T ss_pred             CCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHh
Confidence            99998766665566789999999999753         377899999999999999999999964    23345555555


Q ss_pred             hcCCCC---------------------CCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          256 AADLRF---------------------PSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       256 ~~~~~~---------------------~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      .+....                     .......++..+.++|.+||+.||++|||+.+++++
T Consensus       241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~  303 (396)
T 4eut_A          241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE  303 (396)
T ss_dssp             HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred             cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence            543211                     111112345678899999999999999999999664

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=3.6e-45  Score=351.01  Aligned_cols=252  Identities=26%  Similarity=0.397  Sum_probs=205.1

Q ss_pred             cccccCeeeeeeecccCceEEEEEE----ecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEE
Q 014733           36 SNLSDRYVLGKQLGWGQFGVIRECS----DKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYE  111 (419)
Q Consensus        36 ~~~~~~y~i~~~LG~G~~g~V~~a~----~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~  111 (419)
                      .-..++|++++.||+|+||+||+|+    +..+++.||+|++...   .....+.+.+|+.++++++ ||||+++++++.
T Consensus         6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~   81 (295)
T 3ugc_A            6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ-HDNIVKYKGVCY   81 (295)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC
T ss_pred             cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEe
Confidence            3456899999999999999999998    5678999999998754   4566788999999999996 999999999985


Q ss_pred             e--CCEEEEEEeecCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeec
Q 014733          112 E--EDYVHLLMELCAGGELFHRLEKYG-RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADF  188 (419)
Q Consensus       112 ~--~~~~~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DF  188 (419)
                      .  ...+++||||+++++|.+++...+ ++++.+++.++.|++.||+|||+.||+||||||+|||++   .++.+||+||
T Consensus        82 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~---~~~~~kl~Df  158 (295)
T 3ugc_A           82 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE---NENRVKIGDF  158 (295)
T ss_dssp             HHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECCC
T ss_pred             cCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEc---CCCeEEEccC
Confidence            4  456899999999999999998754 499999999999999999999999999999999999995   4578999999


Q ss_pred             cceeeeccCCc----cccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---------------
Q 014733          189 GLATYIKAGQN----LHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKS---------------  248 (419)
Q Consensus       189 gla~~~~~~~~----~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~---------------  248 (419)
                      |++........    .....++..|+|||++.+ .++.++||||||+++|+|++|..||......               
T Consensus       159 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~  238 (295)
T 3ugc_A          159 GLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV  238 (295)
T ss_dssp             CSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHH
T ss_pred             cccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhH
Confidence            99987654322    223357778999999876 4899999999999999999999998543211               


Q ss_pred             -HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          249 -KIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       249 -~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                       ...+.+... ...+  ....+++++.++|.+||+.||++|||+.++++.
T Consensus       239 ~~~~~~~~~~-~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~  285 (295)
T 3ugc_A          239 FHLIELLKNN-GRLP--RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR  285 (295)
T ss_dssp             HHHHHHHHTT-CCCC--CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHhcc-CcCC--CCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence             122222222 2222  234789999999999999999999999999864

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.2e-44  Score=347.08  Aligned_cols=256  Identities=22%  Similarity=0.308  Sum_probs=214.4

Q ss_pred             hhhccccccCeeeee-eecccCceEEEEEEe--cCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeE
Q 014733           32 ATQISNLSDRYVLGK-QLGWGQFGVIRECSD--KFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKA  108 (419)
Q Consensus        32 ~~~~~~~~~~y~i~~-~LG~G~~g~V~~a~~--~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~  108 (419)
                      ..++..-.++|++.+ .||+|+||.||+|.+  ..+++.||+|++..... .....+.+.+|+.+++++. ||||+++++
T Consensus         8 ~~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~   85 (291)
T 1xbb_A            8 PKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLD-NPYIVRMIG   85 (291)
T ss_dssp             ---CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCC-CTTBCCEEE
T ss_pred             cceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc-CHHHHHHHHHHHHHHHhCC-CCCEEEEEE
Confidence            344455568999998 999999999999954  56788999999976532 3345678999999999996 999999999


Q ss_pred             EEEeCCEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeec
Q 014733          109 VYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADF  188 (419)
Q Consensus       109 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DF  188 (419)
                      ++ +.+..++||||+++++|.+++...+.+++.+++.++.||+.||+|||+.||+||||||+|||++   .++.+||+||
T Consensus        86 ~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~---~~~~~kl~Df  161 (291)
T 1xbb_A           86 IC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDF  161 (291)
T ss_dssp             EE-ESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---ETTEEEECCC
T ss_pred             EE-CCCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEe---CCCcEEEccC
Confidence            99 5667899999999999999999888899999999999999999999999999999999999995   4568999999


Q ss_pred             cceeeeccCCcc----ccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCC
Q 014733          189 GLATYIKAGQNL----HGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFP  262 (419)
Q Consensus       189 gla~~~~~~~~~----~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~  262 (419)
                      |++.........    ....+++.|+|||++.+. ++.++||||||+++|+|++ |+.||.+....+....+......  
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--  239 (291)
T 1xbb_A          162 GLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM--  239 (291)
T ss_dssp             TTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC--
T ss_pred             CcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC--
Confidence            999876544322    223467889999998764 8899999999999999999 99999998888888877665422  


Q ss_pred             CCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          263 SDPWDHISASARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       263 ~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                       .....+++++.++|.+||+.||.+|||+.++++
T Consensus       240 -~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          240 -GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             -CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             -CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence             123478999999999999999999999999986

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=3.7e-45  Score=347.99  Aligned_cols=247  Identities=25%  Similarity=0.449  Sum_probs=212.6

Q ss_pred             cccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEe---
Q 014733           36 SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEE---  112 (419)
Q Consensus        36 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~---  112 (419)
                      +.+.++|++++.||+|+||.||+|.+..+|+.||+|++....       ..+.+|+.+++++. ||||+++++++..   
T Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~   78 (284)
T 2a19_B            7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLD-HVNIVHYNGCWDGFDY   78 (284)
T ss_dssp             HHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCC-CTTBCCEEEEEEEEEE
T ss_pred             chhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCC-CCCEEEEeeeEecccc
Confidence            456789999999999999999999999999999999997542       34678999999996 9999999999865   


Q ss_pred             -------------CCEEEEEEeecCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeec
Q 014733          113 -------------EDYVHLLMELCAGGELFHRLEKY--GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATK  177 (419)
Q Consensus       113 -------------~~~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~  177 (419)
                                   ...+++||||+++++|.+++...  ..+++..++.++.||+.||.|||+.||+||||||+|||++  
T Consensus        79 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~--  156 (284)
T 2a19_B           79 DPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV--  156 (284)
T ss_dssp             C---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--
T ss_pred             CcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEc--
Confidence                         45689999999999999999754  5699999999999999999999999999999999999995  


Q ss_pred             CCCCCeEEeeccceeeeccCCccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 014733          178 SSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRA  256 (419)
Q Consensus       178 ~~~~~vKL~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~  256 (419)
                       .++.+||+|||++.............||+.|+|||++.+. ++.++||||||+++|+|++|..||..  .......+..
T Consensus       157 -~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~--~~~~~~~~~~  233 (284)
T 2a19_B          157 -DTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE--TSKFFTDLRD  233 (284)
T ss_dssp             -ETTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH--HHHHHHHHHT
T ss_pred             -CCCCEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh--HHHHHHHhhc
Confidence             4568999999999887665555566899999999998774 89999999999999999999999743  2233344433


Q ss_pred             cCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccc
Q 014733          257 ADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWME  301 (419)
Q Consensus       257 ~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~  301 (419)
                      ...      ...++.++.++|.+||+.||.+|||+.++++|.|.-
T Consensus       234 ~~~------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~  272 (284)
T 2a19_B          234 GII------SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW  272 (284)
T ss_dssp             TCC------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccc------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            321      236889999999999999999999999999997764

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=3.2e-45  Score=349.90  Aligned_cols=254  Identities=21%  Similarity=0.255  Sum_probs=209.4

Q ss_pred             cccCeeeeeeecccCceEEEEEEecCCC-------cEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEE
Q 014733           38 LSDRYVLGKQLGWGQFGVIRECSDKFTG-------EVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVY  110 (419)
Q Consensus        38 ~~~~y~i~~~LG~G~~g~V~~a~~~~~g-------~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~  110 (419)
                      ..++|++.+.||+|+||+||+|.++.++       ..||+|++....   ....+.+.+|+.++++++ ||||+++++++
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~   81 (289)
T 4fvq_A            6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLS-HKHLVLNYGVC   81 (289)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSC-CTTBCCEEEEE
T ss_pred             chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCC-CCCEeEEEEEE
Confidence            3589999999999999999999998777       479999986542   345678999999999996 99999999999


Q ss_pred             EeCCEEEEEEeecCCCChHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCC-----CCeE
Q 014733          111 EEEDYVHLLMELCAGGELFHRLEKYGR-FSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSS-----SPIK  184 (419)
Q Consensus       111 ~~~~~~~lV~E~~~ggsL~~~l~~~~~-l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~-----~~vK  184 (419)
                      .+.+..++||||++|++|.+++...+. +++..++.++.||+.||.|||++||+||||||+|||++.++..     +.+|
T Consensus        82 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k  161 (289)
T 4fvq_A           82 VCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIK  161 (289)
T ss_dssp             CCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred             EeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceee
Confidence            999999999999999999999987654 9999999999999999999999999999999999999654321     1299


Q ss_pred             EeeccceeeeccCCccccccCCCccCCcccccC-C-CCCchhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHhcCCCC
Q 014733          185 LADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG-G-YNQAADVWSAGVILYILLSG-MPPFWGKTKSKIFDAVRAADLRF  261 (419)
Q Consensus       185 L~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~-~-~s~~sDvwSlGvil~elltG-~~Pf~~~~~~~~~~~i~~~~~~~  261 (419)
                      |+|||++.....   .....||+.|+|||++.+ . ++.++||||||+++|+|++| .+||............ ......
T Consensus       162 l~Dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~-~~~~~~  237 (289)
T 4fvq_A          162 LSDPGISITVLP---KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY-EDRHQL  237 (289)
T ss_dssp             ECCCCSCTTTSC---HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH-HTTCCC
T ss_pred             eccCcccccccC---ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh-hccCCC
Confidence            999999875432   233468889999999876 3 89999999999999999995 5555555544444333 333333


Q ss_pred             CCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          262 PSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       262 ~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                      +    ...+.++.++|.+||+.||++|||+.++++|  ++.+.+
T Consensus       238 ~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--l~~l~~  275 (289)
T 4fvq_A          238 P----APKAAELANLINNCMDYEPDHRPSFRAIIRD--LNSLFT  275 (289)
T ss_dssp             C----CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH--HHTCC-
T ss_pred             C----CCCCHHHHHHHHHHcCCChhHCcCHHHHHHH--HHHhcC
Confidence            3    2467889999999999999999999999986  554433

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=6.8e-45  Score=355.08  Aligned_cols=256  Identities=23%  Similarity=0.377  Sum_probs=215.8

Q ss_pred             ccccccCeeeeeeecccCceEEEEEEecCCCc-----EEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEE
Q 014733           35 ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGE-----VLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAV  109 (419)
Q Consensus        35 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~-----~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~  109 (419)
                      .....++|++.+.||+|+||.||+|.+..++.     .||+|.+....  .....+.+.+|+.+++++.+||||++++++
T Consensus        41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~  118 (333)
T 2i1m_A           41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGA  118 (333)
T ss_dssp             GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence            44456899999999999999999999876654     79999987542  445678899999999999559999999999


Q ss_pred             EEeCCEEEEEEeecCCCChHHHHHHc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEe
Q 014733          110 YEEEDYVHLLMELCAGGELFHRLEKY--------------GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLA  175 (419)
Q Consensus       110 ~~~~~~~~lV~E~~~ggsL~~~l~~~--------------~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~  175 (419)
                      +.+.+.+++||||+++|+|.+++...              ..+++..++.++.||+.||+|||+.||+||||||+|||++
T Consensus       119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~  198 (333)
T 2i1m_A          119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT  198 (333)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEE
T ss_pred             EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEEC
Confidence            99999999999999999999998753              3589999999999999999999999999999999999994


Q ss_pred             ecCCCCCeEEeeccceeeeccCCc---cccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 014733          176 TKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKI  250 (419)
Q Consensus       176 ~~~~~~~vKL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~  250 (419)
                         .++.+||+|||++........   .....||+.|+|||++.+ .++.++||||||+++|+|++ |..||.+......
T Consensus       199 ---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~  275 (333)
T 2i1m_A          199 ---NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK  275 (333)
T ss_dssp             ---GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH
T ss_pred             ---CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH
Confidence               567899999999986644332   223457888999998876 48999999999999999998 9999988766555


Q ss_pred             HHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          251 FDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       251 ~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      ...+.......+.  ....+.++.++|.+||+.||.+|||+.+++++
T Consensus       276 ~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  320 (333)
T 2i1m_A          276 FYKLVKDGYQMAQ--PAFAPKNIYSIMQACWALEPTHRPTFQQICSF  320 (333)
T ss_dssp             HHHHHHHTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhcCCCCCC--CCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence            5544444333322  23678999999999999999999999999874

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=9.4e-45  Score=342.53  Aligned_cols=247  Identities=17%  Similarity=0.219  Sum_probs=214.4

Q ss_pred             cccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeC--CE
Q 014733           38 LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEE--DY  115 (419)
Q Consensus        38 ~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~--~~  115 (419)
                      -.++|++.+.||+|+||.||+|.++  ++.+|+|++.... ......+.+.+|+.++++++ ||||+++++++.+.  +.
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~   83 (271)
T 3kmu_A            8 DFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRD-WSTRKSRDFNEECPRLRIFS-HPNVLPVLGACQSPPAPH   83 (271)
T ss_dssp             CGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTT-CCHHHHHHHHHHGGGGCCCS-CTTEECEEEEECTTTSSS
T ss_pred             CHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccc-cCHHHHHHHHHHHHHHHhcC-CCchhheEEEEccCCCCC
Confidence            3579999999999999999999985  8899999997654 34566778999999999996 99999999999887  78


Q ss_pred             EEEEEeecCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC--CeeccCCCCcEEEeecCCCCCeEEeeccce
Q 014733          116 VHLLMELCAGGELFHRLEKYG--RFSETEARVIFRHLMQVVSYCHGNG--VVHRDLKPENILLATKSSSSPIKLADFGLA  191 (419)
Q Consensus       116 ~~lV~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qll~aL~~LH~~~--IvHrDLkp~NILl~~~~~~~~vKL~DFgla  191 (419)
                      +++||||+++++|.+++....  .+++.+++.++.||+.||+|||+.+  |+||||||+|||+   +.++.++|+|||++
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~---~~~~~~~l~~~~~~  160 (271)
T 3kmu_A           84 PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMI---DEDMTARISMADVK  160 (271)
T ss_dssp             CEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEE---CTTSCEEEEGGGSC
T ss_pred             eEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEE---cCCcceeEEeccce
Confidence            899999999999999998765  4899999999999999999999999  9999999999999   56778999999887


Q ss_pred             eeeccCCccccccCCCccCCcccccCC-C---CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCC
Q 014733          192 TYIKAGQNLHGTVGSPFYIAPEVLAGG-Y---NQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWD  267 (419)
Q Consensus       192 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-~---s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  267 (419)
                      ...    ......||+.|+|||++.+. +   +.++||||||+++|+|++|+.||.+....+....+........  .+.
T Consensus       161 ~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~  234 (271)
T 3kmu_A          161 FSF----QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPT--IPP  234 (271)
T ss_dssp             CTT----SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCC--CCT
T ss_pred             eee----cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCC--CCC
Confidence            642    22345789999999998764 3   3479999999999999999999999888887777766544433  234


Q ss_pred             CCCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          268 HISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       268 ~~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      .+++++.++|.+||+.||++|||+.++++.
T Consensus       235 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~  264 (271)
T 3kmu_A          235 GISPHVSKLMKICMNEDPAKRPKFDMIVPI  264 (271)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            789999999999999999999999999863

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=4.3e-45  Score=363.60  Aligned_cols=250  Identities=26%  Similarity=0.412  Sum_probs=205.3

Q ss_pred             cccCeeeeeeecccCceEEEEEEec---CCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCC
Q 014733           38 LSDRYVLGKQLGWGQFGVIRECSDK---FTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEED  114 (419)
Q Consensus        38 ~~~~y~i~~~LG~G~~g~V~~a~~~---~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~  114 (419)
                      ..++|++.+.||+|+||.||+|+++   .++..||+|++...  ......+.+.+|+.+++++. ||||+++++++.+.+
T Consensus        43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~  119 (373)
T 2qol_A           43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--YTEKQRRDFLGEASIMGQFD-HPNIIRLEGVVTKSK  119 (373)
T ss_dssp             CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTT--CCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSSS
T ss_pred             CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCc--cCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEeeCC
Confidence            3569999999999999999999887   46778999998754  24566788999999999996 999999999999999


Q ss_pred             EEEEEEeecCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceee
Q 014733          115 YVHLLMELCAGGELFHRLEKYG-RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATY  193 (419)
Q Consensus       115 ~~~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~  193 (419)
                      .+++||||+++++|.+++...+ .+++.+++.++.||+.||+|||+.||+||||||+|||+   +.++.+||+|||++..
T Consensus       120 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~  196 (373)
T 2qol_A          120 PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLGRV  196 (373)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC-----
T ss_pred             ceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE---cCCCCEEECcCccccc
Confidence            9999999999999999998754 59999999999999999999999999999999999999   5678999999999987


Q ss_pred             eccCCc----cccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCC
Q 014733          194 IKAGQN----LHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWD  267 (419)
Q Consensus       194 ~~~~~~----~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  267 (419)
                      ......    .....++..|+|||++.+ .++.++||||||+++|||++ |+.||.+....+....+.... ..+.  ..
T Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~-~~~~--~~  273 (373)
T 2qol_A          197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY-RLPP--PM  273 (373)
T ss_dssp             -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTE-ECCC--CT
T ss_pred             cccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCC--Cc
Confidence            654322    122345778999999876 49999999999999999998 999999998888887776542 2222  23


Q ss_pred             CCCHHHHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          268 HISASARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       268 ~~s~~l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                      .++.++.++|.+||+.||.+||++.++++
T Consensus       274 ~~~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          274 DCPAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             TCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence            78899999999999999999999999987

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.8e-45  Score=358.75  Aligned_cols=249  Identities=21%  Similarity=0.311  Sum_probs=209.0

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcE----EEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCC
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEV----LACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEED  114 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~----vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~  114 (419)
                      .++|++++.||+|+||+||+|.+..+++.    ||+|.+....  .......+.+|+.+++++. ||||+++++++.+ +
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~-~   87 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS--GRQSFQAVTDHMLAIGSLD-HAHIVRLLGLCPG-S   87 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT--SCSCBCSCCHHHHHHHTCC-CTTBCCEEEEECB-S
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc--cHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEcC-C
Confidence            57899999999999999999999888876    6677664332  2233456778999999995 9999999999874 4


Q ss_pred             EEEEEEeecCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceee
Q 014733          115 YVHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATY  193 (419)
Q Consensus       115 ~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~  193 (419)
                      ..++||||+.+|+|.+++... +.+++..++.++.||+.||+|||+.||+||||||+|||+   +.++.+||+|||++..
T Consensus        88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~---~~~~~~kl~Dfg~a~~  164 (325)
T 3kex_A           88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLL---KSPSQVQVADFGVADL  164 (325)
T ss_dssp             SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEE---SSSSCEEECSCSGGGG
T ss_pred             ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEE---CCCCeEEECCCCcccc
Confidence            588999999999999999764 569999999999999999999999999999999999999   5678899999999987


Q ss_pred             eccCCc---cccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCC
Q 014733          194 IKAGQN---LHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDH  268 (419)
Q Consensus       194 ~~~~~~---~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  268 (419)
                      ......   .....||..|+|||++.+ .++.++||||||+++|+|++ |+.||.+....+....+.........   ..
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~  241 (325)
T 3kex_A          165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQP---QI  241 (325)
T ss_dssp             SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCC---TT
T ss_pred             cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCC---Cc
Confidence            644332   234467889999999875 59999999999999999999 99999998888888877765432222   25


Q ss_pred             CCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          269 ISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       269 ~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      ++.++.++|.+||+.||.+|||+.++++|
T Consensus       242 ~~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          242 CTIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             BCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             CcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            78899999999999999999999999987

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.6e-44  Score=349.39  Aligned_cols=257  Identities=24%  Similarity=0.332  Sum_probs=208.5

Q ss_pred             hhccccccCeeeeeeecccCceEEEEEEecC---CCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEE
Q 014733           33 TQISNLSDRYVLGKQLGWGQFGVIRECSDKF---TGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAV  109 (419)
Q Consensus        33 ~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~---~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~  109 (419)
                      ..+....++|++++.||+|+||.||+|.+..   ++..||+|++.... ......+.+.+|+.++++++ ||||++++++
T Consensus        27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~  104 (313)
T 3brb_A           27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDN-SSQREIEEFLSEAACMKDFS-HPNVIRLLGV  104 (313)
T ss_dssp             TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---C-CCHHHHHHHHHHHHHHHTCC-CTTBCCCCEE
T ss_pred             HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccc-cchhHHHHHHHHHHHHhcCC-CCCeeeeeEE
Confidence            4445567899999999999999999998764   55689999987654 34566788999999999996 9999999999


Q ss_pred             EEeCC-----EEEEEEeecCCCChHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecC
Q 014733          110 YEEED-----YVHLLMELCAGGELFHRLEK------YGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKS  178 (419)
Q Consensus       110 ~~~~~-----~~~lV~E~~~ggsL~~~l~~------~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~  178 (419)
                      +.+.+     ..++||||+++++|.+++..      ...+++..++.++.||+.||.|||+.||+||||||+|||+   +
T Consensus       105 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli---~  181 (313)
T 3brb_A          105 CIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCML---R  181 (313)
T ss_dssp             EEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEE---C
T ss_pred             EeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---c
Confidence            98755     35999999999999999843      2459999999999999999999999999999999999999   5


Q ss_pred             CCCCeEEeeccceeeeccCCc---cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 014733          179 SSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDA  253 (419)
Q Consensus       179 ~~~~vKL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~  253 (419)
                      .++.+||+|||++........   .....+++.|+|||++.+. ++.++||||||+++|+|++ |..||.+....+....
T Consensus       182 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~  261 (313)
T 3brb_A          182 DDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDY  261 (313)
T ss_dssp             TTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH
T ss_pred             CCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHH
Confidence            677999999999987644321   2234578899999998774 8999999999999999999 9999998888888877


Q ss_pred             HHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          254 VRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       254 i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      +......   .....+++++.++|.+||+.||.+|||+.+++++
T Consensus       262 ~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          262 LLHGHRL---KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             HHTTCCC---CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHcCCCC---CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            7665322   2234789999999999999999999999999886

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=9.4e-45  Score=347.22  Aligned_cols=260  Identities=20%  Similarity=0.286  Sum_probs=205.6

Q ss_pred             ccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCce-eeeEEEEeCCE
Q 014733           37 NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVV-DLKAVYEEEDY  115 (419)
Q Consensus        37 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv-~l~~~~~~~~~  115 (419)
                      .+.++|++.+.||+|+||+||+|.+..+++.||+|++....     ....+.+|+.+++.+. |++++ .+..++.+.+.
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~e~~~l~~l~-~~~~i~~~~~~~~~~~~   79 (296)
T 4hgt_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-----KHPQLHIESKIYKMMQ-GGVGIPTIRWCGAEGDY   79 (296)
T ss_dssp             -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC--------CCCHHHHHHHHHHHT-TSTTCCCEEEEEEETTE
T ss_pred             ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc-----cchHHHHHHHHHHHhc-CCCCCCeeeeecCCCCc
Confidence            46789999999999999999999999999999999876543     2245788999999997 55554 55555578889


Q ss_pred             EEEEEeecCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeee
Q 014733          116 VHLLMELCAGGELFHRLEK-YGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI  194 (419)
Q Consensus       116 ~~lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~  194 (419)
                      .++||||+ +++|.+++.. .+.+++.+++.++.||+.||.|||++||+||||||+|||+..++.++.+||+|||++...
T Consensus        80 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~  158 (296)
T 4hgt_A           80 NVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             eEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence            99999999 9999999985 356999999999999999999999999999999999999965556778999999999876


Q ss_pred             ccCCc--------cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhcCCCCC
Q 014733          195 KAGQN--------LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTK---SKIFDAVRAADLRFP  262 (419)
Q Consensus       195 ~~~~~--------~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~---~~~~~~i~~~~~~~~  262 (419)
                      .....        .....||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+...   ......+.......+
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 4hgt_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence            54432        2345799999999998874 89999999999999999999999976432   223333322222222


Q ss_pred             C-CCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          263 S-DPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       263 ~-~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                      . .....+++++.++|.+||+.||++|||+.++++.  ++++..
T Consensus       239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~--l~~~~~  280 (296)
T 4hgt_A          239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQL--FRNLFH  280 (296)
T ss_dssp             HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHH--HHHHHH
T ss_pred             hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHH--HHHHHH
Confidence            1 1124678999999999999999999999999872  544433

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.1e-44  Score=341.84  Aligned_cols=247  Identities=25%  Similarity=0.391  Sum_probs=215.1

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEE
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHL  118 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~l  118 (419)
                      .++|++.+.||+|+||.||+|.+. ++..||+|++.....    ..+.+.+|+.++++++ ||||+++++++.+.+..++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l   80 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLS-HPKLVQLYGVCLEQAPICL   80 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB----CHHHHHHHHHHHHTCC-CTTBCCEEEEECSSSSCEE
T ss_pred             hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC----CHHHHHHHHHHHHhCC-CCCEeeEEEEEccCCCeEE
Confidence            478999999999999999999987 678899999976542    2367889999999996 9999999999999999999


Q ss_pred             EEeecCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccC
Q 014733          119 LMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG  197 (419)
Q Consensus       119 V~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~  197 (419)
                      ||||+++++|.+++... +.+++..++.++.|++.||.|||+.||+||||||+||++   +.++.+||+|||++......
T Consensus        81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili---~~~~~~kl~dfg~~~~~~~~  157 (267)
T 3t9t_A           81 VTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDD  157 (267)
T ss_dssp             EECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CGGGCEEECCTTGGGGBCCH
T ss_pred             EEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEE---CCCCCEEEcccccccccccc
Confidence            99999999999999775 458999999999999999999999999999999999999   55678999999999865432


Q ss_pred             C--ccccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 014733          198 Q--NLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASA  273 (419)
Q Consensus       198 ~--~~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l  273 (419)
                      .  ......+++.|+|||++.+ .++.++||||||+++|+|++ |+.||.+....+....+........   ...++.++
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~---~~~~~~~l  234 (267)
T 3t9t_A          158 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---PRLASTHV  234 (267)
T ss_dssp             HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC---CTTSCHHH
T ss_pred             cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCC---CccCcHHH
Confidence            1  2234567888999999875 58999999999999999999 9999999888888888776533222   23678999


Q ss_pred             HHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          274 RDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       274 ~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      .++|.+||+.||++|||+.+++++
T Consensus       235 ~~li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          235 YQIMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHccCChhhCcCHHHHHHH
Confidence            999999999999999999999875

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-44  Score=344.13  Aligned_cols=252  Identities=22%  Similarity=0.326  Sum_probs=214.7

Q ss_pred             cccCeeeee-eecccCceEEEEEEec--CCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCC
Q 014733           38 LSDRYVLGK-QLGWGQFGVIRECSDK--FTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEED  114 (419)
Q Consensus        38 ~~~~y~i~~-~LG~G~~g~V~~a~~~--~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~  114 (419)
                      -.++|.+.+ .||+|+||.||+|.++  .++..||+|++...  ......+.+.+|+.++++++ ||||+++++++ +.+
T Consensus         7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~-~~~   82 (287)
T 1u59_A            7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLD-NPYIVRLIGVC-QAE   82 (287)
T ss_dssp             CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS--CCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEE-ESS
T ss_pred             cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc--cchhHHHHHHHHHHHHHhCC-CCCEeEEEEEe-cCC
Confidence            457888887 9999999999999864  46788999999765  34567788999999999995 99999999999 455


Q ss_pred             EEEEEEeecCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceee
Q 014733          115 YVHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATY  193 (419)
Q Consensus       115 ~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~  193 (419)
                      ..++||||+++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++   .++.+||+|||++..
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~---~~~~~kl~Dfg~~~~  159 (287)
T 1u59_A           83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV---NRHYAKISDFGLSKA  159 (287)
T ss_dssp             SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE---ETTEEEECCCTTCEE
T ss_pred             CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEc---CCCCEEECcccceee
Confidence            689999999999999999654 4599999999999999999999999999999999999995   456899999999987


Q ss_pred             eccCCcc----ccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCC
Q 014733          194 IKAGQNL----HGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWD  267 (419)
Q Consensus       194 ~~~~~~~----~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  267 (419)
                      .......    ....+|+.|+|||++.+. ++.++||||||+++|+|++ |+.||.+....+....+......   ....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~---~~~~  236 (287)
T 1u59_A          160 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM---ECPP  236 (287)
T ss_dssp             CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC---CCCT
T ss_pred             eccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcC---CCCC
Confidence            6543321    233568899999998754 8999999999999999998 99999988888888777665422   1224


Q ss_pred             CCCHHHHHHHHhhhhcCCCCCCCHHHHHhccc
Q 014733          268 HISASARDLIMGMLRVDPSTRLTAAEVLAHSW  299 (419)
Q Consensus       268 ~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~  299 (419)
                      .+++++.++|.+||+.||++||++.++++|.+
T Consensus       237 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~  268 (287)
T 1u59_A          237 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMR  268 (287)
T ss_dssp             TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             CcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            78999999999999999999999999998743

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.7e-44  Score=343.89  Aligned_cols=253  Identities=28%  Similarity=0.383  Sum_probs=212.0

Q ss_pred             ccccccCeeeeeeecccCceEEEEEEecC---CCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEE
Q 014733           35 ISNLSDRYVLGKQLGWGQFGVIRECSDKF---TGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYE  111 (419)
Q Consensus        35 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~---~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~  111 (419)
                      .....++|++.+.||+|+||+||+|.+..   ++..||+|++...  ......+.+.+|+.++++++ ||||+++++++.
T Consensus         7 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~   83 (281)
T 3cc6_A            7 YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD--CTLDNKEKFMSEAVIMKNLD-HPHIVKLIGIIE   83 (281)
T ss_dssp             CSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTT--SCHHHHHHHHHHHHHHHHHC-CTTBCCEEEEEC
T ss_pred             ceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccc--cCchHHHHHHHHHHHHHhCC-CCCcceEEEEEc
Confidence            34456899999999999999999998653   3456999998765  24566788999999999996 999999999987


Q ss_pred             eCCEEEEEEeecCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccc
Q 014733          112 EEDYVHLLMELCAGGELFHRLEKYG-RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGL  190 (419)
Q Consensus       112 ~~~~~~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgl  190 (419)
                      +.. .++||||+++++|.+++...+ .+++..++.++.|++.||.|||++||+||||||+|||++   .++.+||+|||+
T Consensus        84 ~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~  159 (281)
T 3cc6_A           84 EEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVA---SPECVKLGDFGL  159 (281)
T ss_dssp             SSS-CEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEE---ETTEEEECCCCG
T ss_pred             CCC-CEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEC---CCCcEEeCccCC
Confidence            654 689999999999999997654 599999999999999999999999999999999999995   456899999999


Q ss_pred             eeeeccCCc--cccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 014733          191 ATYIKAGQN--LHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPW  266 (419)
Q Consensus       191 a~~~~~~~~--~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  266 (419)
                      +........  .....+|+.|+|||++.+ .++.++||||||+++|+|++ |+.||......+....+.......   ..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~---~~  236 (281)
T 3cc6_A          160 SRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLP---KP  236 (281)
T ss_dssp             GGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCC---CC
T ss_pred             CcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCC---CC
Confidence            986644322  233467889999999875 58999999999999999998 999998887777777776653322   22


Q ss_pred             CCCCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          267 DHISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       267 ~~~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      ..+++.+.++|.+||+.||++|||+.+++++
T Consensus       237 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          237 DLCPPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence            3689999999999999999999999999976

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.1e-44  Score=367.74  Aligned_cols=259  Identities=29%  Similarity=0.433  Sum_probs=202.9

Q ss_pred             cccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCE
Q 014733           36 SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDY  115 (419)
Q Consensus        36 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~  115 (419)
                      ..+.+.|.+.+.||+|+||+||.+ ...+|+.||+|++..+      ..+.+.+|+.+|+++.+||||+++++++.+.+.
T Consensus        11 ~~l~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~------~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~   83 (434)
T 2rio_A           11 QSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLID------FCDIALMEIKLLTESDDHPNVIRYYCSETTDRF   83 (434)
T ss_dssp             CSCSSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGG------GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSE
T ss_pred             hhhhheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHH------HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCe
Confidence            346788888999999999999875 4568999999998643      235678899999987569999999999999999


Q ss_pred             EEEEEeecCCCChHHHHHHcCCC-------CHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeec----------C
Q 014733          116 VHLLMELCAGGELFHRLEKYGRF-------SETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATK----------S  178 (419)
Q Consensus       116 ~~lV~E~~~ggsL~~~l~~~~~l-------~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~----------~  178 (419)
                      +|+||||+. |+|.+++......       ++..++.++.||+.||+|||++||+||||||+|||++.+          .
T Consensus        84 ~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~  162 (434)
T 2rio_A           84 LYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGA  162 (434)
T ss_dssp             EEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCC
T ss_pred             EEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCC
Confidence            999999995 6999999865432       233457899999999999999999999999999999653          2


Q ss_pred             CCCCeEEeeccceeeeccCCc-----cccccCCCccCCcccccC--------CCCCchhHHHHHHHHHHHHh-CCCCCCC
Q 014733          179 SSSPIKLADFGLATYIKAGQN-----LHGTVGSPFYIAPEVLAG--------GYNQAADVWSAGVILYILLS-GMPPFWG  244 (419)
Q Consensus       179 ~~~~vKL~DFgla~~~~~~~~-----~~~~~gt~~y~aPE~l~~--------~~s~~sDvwSlGvil~ellt-G~~Pf~~  244 (419)
                      .+..+||+|||++........     ....+||+.|+|||++.+        .++.++|||||||++|+|++ |+.||.+
T Consensus       163 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~  242 (434)
T 2rio_A          163 ENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD  242 (434)
T ss_dssp             CSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred             CceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCC
Confidence            345899999999997755432     234579999999999864        38899999999999999999 9999976


Q ss_pred             CCHHHHHHHHHhcCCCCCCCC---CCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccch
Q 014733          245 KTKSKIFDAVRAADLRFPSDP---WDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECE  304 (419)
Q Consensus       245 ~~~~~~~~~i~~~~~~~~~~~---~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~  304 (419)
                      ....+  ..+.......+...   ...++.++.+||.+||+.||.+|||+.++++||||....
T Consensus       243 ~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~~~  303 (434)
T 2rio_A          243 KYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPKS  303 (434)
T ss_dssp             TTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSCHH
T ss_pred             chhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCCcH
Confidence            55433  23334433333221   123568899999999999999999999999999997543

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=6.3e-45  Score=354.66  Aligned_cols=248  Identities=25%  Similarity=0.317  Sum_probs=201.2

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCC----
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEED----  114 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~----  114 (419)
                      .++|++++.||+|+||+||+|.+.  ++.||+|++...    .........|+.++++++ ||||+++++++.+..    
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~   95 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ----DKQSWQNEYEVYSLPGMK-HENILQFIGAEKRGTSVDV   95 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGG----GHHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECSSSE
T ss_pred             hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecC----chHHHHHHHHHHHHhcCC-CCCchhhcceeccCCCCCc
Confidence            579999999999999999999875  799999998654    234455667999999996 999999999998743    


Q ss_pred             EEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC----------CCeeccCCCCcEEEeecCCCCCeE
Q 014733          115 YVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGN----------GVVHRDLKPENILLATKSSSSPIK  184 (419)
Q Consensus       115 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~----------~IvHrDLkp~NILl~~~~~~~~vK  184 (419)
                      .+++||||+++|+|.+++.. +.+++.+++.++.|++.||+|||+.          +|+||||||+|||+   +.++.+|
T Consensus        96 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill---~~~~~~k  171 (322)
T 3soc_A           96 DLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL---KNNLTAC  171 (322)
T ss_dssp             EEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEE---CTTCCEE
T ss_pred             eEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEE---CCCCeEE
Confidence            57999999999999999976 5699999999999999999999999          99999999999999   5678999


Q ss_pred             EeeccceeeeccCCc---cccccCCCccCCcccccC------CCCCchhHHHHHHHHHHHHhCCCCCCCCC---------
Q 014733          185 LADFGLATYIKAGQN---LHGTVGSPFYIAPEVLAG------GYNQAADVWSAGVILYILLSGMPPFWGKT---------  246 (419)
Q Consensus       185 L~DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~------~~s~~sDvwSlGvil~elltG~~Pf~~~~---------  246 (419)
                      |+|||++........   ....+||+.|+|||++.+      .++.++|||||||++|+|++|+.||.+..         
T Consensus       172 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~  251 (322)
T 3soc_A          172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE  251 (322)
T ss_dssp             ECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHH
T ss_pred             EccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhh
Confidence            999999987654432   234579999999999876      25668899999999999999999996532         


Q ss_pred             -------HHHHHHHHHhcCCCCCCCC-C--CCCCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          247 -------KSKIFDAVRAADLRFPSDP-W--DHISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       247 -------~~~~~~~i~~~~~~~~~~~-~--~~~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                             ..+....+........... +  ...+.++.+||.+||+.||++|||+.++++.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  312 (322)
T 3soc_A          252 EIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER  312 (322)
T ss_dssp             HHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                   2223333222222211110 0  1224569999999999999999999999874

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5e-44  Score=350.04  Aligned_cols=253  Identities=24%  Similarity=0.370  Sum_probs=210.8

Q ss_pred             cccccCeeeeeeecccCceEEEEEEecCCC----cEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEE
Q 014733           36 SNLSDRYVLGKQLGWGQFGVIRECSDKFTG----EVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYE  111 (419)
Q Consensus        36 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g----~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~  111 (419)
                      +...++|++.+.||+|+||+||+|.++.++    ..||+|++...  ........+.+|+.+++++. ||||+++++++.
T Consensus        40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~  116 (333)
T 1mqb_A           40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG--YTEKQRVDFLGEAGIMGQFS-HHNIIRLEGVIS  116 (333)
T ss_dssp             BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC
T ss_pred             cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCC--CCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEe
Confidence            345689999999999999999999987543    45999998754  24556678999999999996 999999999999


Q ss_pred             eCCEEEEEEeecCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccc
Q 014733          112 EEDYVHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGL  190 (419)
Q Consensus       112 ~~~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgl  190 (419)
                      +.+..++||||+++++|.+++... +.+++.+++.++.||+.||.|||+.||+||||||+|||+   +.++.+||+|||+
T Consensus       117 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~  193 (333)
T 1mqb_A          117 KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV---NSNLVCKVSDFGL  193 (333)
T ss_dssp             SSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC
T ss_pred             cCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEE---CCCCcEEECCCCc
Confidence            999999999999999999999765 569999999999999999999999999999999999999   5678999999999


Q ss_pred             eeeeccCCc----cccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCC
Q 014733          191 ATYIKAGQN----LHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSD  264 (419)
Q Consensus       191 a~~~~~~~~----~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~  264 (419)
                      +........    .....+|+.|+|||++.+ .++.++||||||+++|+|++ |+.||.+....++...+.... ..+. 
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~-~~~~-  271 (333)
T 1mqb_A          194 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF-RLPT-  271 (333)
T ss_dssp             -----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-CCCC-
T ss_pred             chhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCC-cCCC-
Confidence            987654321    122356788999999876 48999999999999999999 999999988888888776653 2222 


Q ss_pred             CCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          265 PWDHISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       265 ~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                       ...++.++.++|.+||+.||.+||++.+++++
T Consensus       272 -~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          272 -PMDCPSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             -CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             -cccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence             24789999999999999999999999999875

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=2.7e-44  Score=345.61  Aligned_cols=250  Identities=26%  Similarity=0.402  Sum_probs=205.2

Q ss_pred             cccCeeeeeeecccCceEEEEEE----ecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeC
Q 014733           38 LSDRYVLGKQLGWGQFGVIRECS----DKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEE  113 (419)
Q Consensus        38 ~~~~y~i~~~LG~G~~g~V~~a~----~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~  113 (419)
                      ..++|++++.||+|+||.||+|+    +..+++.||+|++....  .....+.+.+|+.++++++ ||||+++++++.+.
T Consensus        19 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~   95 (302)
T 4e5w_A           19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLY-HENIVKYKGICTED   95 (302)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCC-CTTBCCEEEEEEC-
T ss_pred             hhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCC-CCCeeeeeeEEecC
Confidence            35789999999999999999998    56789999999997553  3345678999999999996 99999999999876


Q ss_pred             --CEEEEEEeecCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccc
Q 014733          114 --DYVHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGL  190 (419)
Q Consensus       114 --~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgl  190 (419)
                        +.+++||||+++++|.+++... ..+++..++.++.|++.||+|||+.||+||||||+|||++   .++.+||+|||+
T Consensus        96 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~---~~~~~kl~Dfg~  172 (302)
T 4e5w_A           96 GGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVE---SEHQVKIGDFGL  172 (302)
T ss_dssp             --CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---ETTEEEECCCTT
T ss_pred             CCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEc---CCCCEEECcccc
Confidence              6789999999999999999554 5699999999999999999999999999999999999995   456899999999


Q ss_pred             eeeeccCCc----cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCC--------------C-HHHH
Q 014733          191 ATYIKAGQN----LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGK--------------T-KSKI  250 (419)
Q Consensus       191 a~~~~~~~~----~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~--------------~-~~~~  250 (419)
                      +........    .....||..|+|||++.+. ++.++||||||+++|+|++|..|+...              . ....
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  252 (302)
T 4e5w_A          173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL  252 (302)
T ss_dssp             CEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHH
T ss_pred             cccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHH
Confidence            987755432    2344688889999998764 889999999999999999999986321              1 1222


Q ss_pred             HHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          251 FDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       251 ~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                      ...+... ...+  .+..+++++.+||.+||+.||.+|||+.++++
T Consensus       253 ~~~~~~~-~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          253 VNTLKEG-KRLP--CPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             HHHHHTT-CCCC--CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             HHHHhcc-CCCC--CCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            2222222 2222  23478999999999999999999999999986

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.7e-44  Score=351.55  Aligned_cols=250  Identities=34%  Similarity=0.502  Sum_probs=191.3

Q ss_pred             ccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEE---
Q 014733           35 ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYE---  111 (419)
Q Consensus        35 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~---  111 (419)
                      ++....+|++.+.||+|+||.||+|.+..+|+.||+|++...   .....+.+.+|+.+++++.+||||+++++++.   
T Consensus        23 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~   99 (337)
T 3ll6_A           23 VELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGK   99 (337)
T ss_dssp             EEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECT
T ss_pred             eeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC---chHHHHHHHHHHHHHHHhccCCChhhccccccccc
Confidence            344567999999999999999999999999999999998654   34567788999999999977999999999994   


Q ss_pred             -----eCCEEEEEEeecCCCChHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC--CeeccCCCCcEEEeecCCCC
Q 014733          112 -----EEDYVHLLMELCAGGELFHRLEK---YGRFSETEARVIFRHLMQVVSYCHGNG--VVHRDLKPENILLATKSSSS  181 (419)
Q Consensus       112 -----~~~~~~lV~E~~~ggsL~~~l~~---~~~l~~~~~~~i~~qll~aL~~LH~~~--IvHrDLkp~NILl~~~~~~~  181 (419)
                           ....++++|||+. |+|.+++..   .+++++.+++.++.||+.||+|||+.|  |+||||||+|||+   +.++
T Consensus       100 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~---~~~~  175 (337)
T 3ll6_A          100 EESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLL---SNQG  175 (337)
T ss_dssp             TTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEE---CTTS
T ss_pred             cccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEE---CCCC
Confidence                 3456899999995 789888865   456999999999999999999999999  9999999999999   5677


Q ss_pred             CeEEeeccceeeeccCCcc-------------ccccCCCccCCccccc---C-CCCCchhHHHHHHHHHHHHhCCCCCCC
Q 014733          182 PIKLADFGLATYIKAGQNL-------------HGTVGSPFYIAPEVLA---G-GYNQAADVWSAGVILYILLSGMPPFWG  244 (419)
Q Consensus       182 ~vKL~DFgla~~~~~~~~~-------------~~~~gt~~y~aPE~l~---~-~~s~~sDvwSlGvil~elltG~~Pf~~  244 (419)
                      .+||+|||++.........             ....||+.|+|||++.   + .++.++||||||+++|+|++|+.||.+
T Consensus       176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~  255 (337)
T 3ll6_A          176 TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED  255 (337)
T ss_dssp             CEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred             CEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence            9999999999876543221             1446899999999983   3 378999999999999999999999976


Q ss_pred             CCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          245 KTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       245 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      ........    .....+  .....+..+.+||.+||+.||.+|||+.++++|
T Consensus       256 ~~~~~~~~----~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  302 (337)
T 3ll6_A          256 GAKLRIVN----GKYSIP--PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQ  302 (337)
T ss_dssp             --------------CCCC--TTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             hhHHHhhc----CcccCC--cccccchHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            55433322    222222  234678899999999999999999999999997

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=8.1e-45  Score=359.82  Aligned_cols=257  Identities=17%  Similarity=0.176  Sum_probs=197.9

Q ss_pred             ccccCeeeeeeecccCceEEEEEEecCC-----CcEEEEEEeccCccCCHHh--------HHHHHHHHHHHHHccCCCCc
Q 014733           37 NLSDRYVLGKQLGWGQFGVIRECSDKFT-----GEVLACKSIAKDRLVTVED--------VRSIKLEIEIMTKLSGHPNV  103 (419)
Q Consensus        37 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~-----g~~vaiK~i~~~~~~~~~~--------~~~~~~Ei~il~~l~~hpnI  103 (419)
                      ...++|++++.||+|+||.||+|.++.+     ++.||+|++..........        ...+..|+..++.+. ||||
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~-h~~i  110 (364)
T 3op5_A           32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLK-YLGV  110 (364)
T ss_dssp             TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCS-CCCS
T ss_pred             cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhcc-CCCC
Confidence            4567999999999999999999998754     5889999987542100000        011223444555554 9999


Q ss_pred             eeeeEEEEeC----CEEEEEEeecCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecC
Q 014733          104 VDLKAVYEEE----DYVHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKS  178 (419)
Q Consensus       104 v~l~~~~~~~----~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~  178 (419)
                      +++++++.+.    ...++||||+ |++|.+++... +.+++.+++.++.||+.||+|||+.||+||||||+|||++. .
T Consensus       111 v~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~-~  188 (364)
T 3op5_A          111 PKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNY-K  188 (364)
T ss_dssp             CCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEES-S
T ss_pred             CeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEec-C
Confidence            9999999764    5689999999 99999999876 56999999999999999999999999999999999999963 2


Q ss_pred             CCCCeEEeeccceeeeccCCcc--------ccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 014733          179 SSSPIKLADFGLATYIKAGQNL--------HGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSK  249 (419)
Q Consensus       179 ~~~~vKL~DFgla~~~~~~~~~--------~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~  249 (419)
                      .++.+||+|||+++.+......        ...+||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+.....
T Consensus       189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~  268 (364)
T 3op5_A          189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP  268 (364)
T ss_dssp             CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred             CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence            5679999999999876543221        234599999999998875 9999999999999999999999997543222


Q ss_pred             HHHHHHhcCC--CCC-----CCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          250 IFDAVRAADL--RFP-----SDPWDHISASARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       250 ~~~~i~~~~~--~~~-----~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                      ..........  ..+     ......++.++.++|..||..||.+||++.++++
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          269 KYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             HHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            2111111000  000     0011367899999999999999999999999986

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=2e-44  Score=351.33  Aligned_cols=249  Identities=25%  Similarity=0.407  Sum_probs=209.4

Q ss_pred             ccCeeeeeeecccCceEEEEEE----ecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEE--e
Q 014733           39 SDRYVLGKQLGWGQFGVIRECS----DKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYE--E  112 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~----~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~--~  112 (419)
                      .++|++++.||+|+||.||+|.    +..+++.||+|++...   .....+.+.+|+.+++++. ||||+++++++.  +
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~   97 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQILKALH-SDFIVKYRGVSYGPG   97 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC---CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEECSS
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC---CHHHHHHHHHHHHHHHhcC-CCceeEEEEEEecCC
Confidence            4799999999999999999998    5678999999998754   3466778999999999995 999999999987  5


Q ss_pred             CCEEEEEEeecCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccce
Q 014733          113 EDYVHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA  191 (419)
Q Consensus       113 ~~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla  191 (419)
                      .+.+++||||+++++|.+++... ..+++..++.++.||+.||+|||+.||+||||||+|||++   .++.+||+|||++
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~---~~~~~kl~Dfg~~  174 (327)
T 3lxl_A           98 RQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVE---SEAHVKIADFGLA  174 (327)
T ss_dssp             SCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---ETTEEEECCGGGC
T ss_pred             CceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEEC---CCCCEEEcccccc
Confidence            67799999999999999999764 5699999999999999999999999999999999999995   4678999999999


Q ss_pred             eeeccCCc----cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCH---------------HHHH
Q 014733          192 TYIKAGQN----LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTK---------------SKIF  251 (419)
Q Consensus       192 ~~~~~~~~----~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~---------------~~~~  251 (419)
                      ........    .....||+.|+|||++.+. ++.++||||||+++|+|++|..||.....               ....
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  254 (327)
T 3lxl_A          175 KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL  254 (327)
T ss_dssp             EECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH
T ss_pred             eecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH
Confidence            87654332    2234688889999998765 89999999999999999999999854332               1222


Q ss_pred             HHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          252 DAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       252 ~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      ..+... ...+  ....+++++.+||.+||+.||++|||+.+++++
T Consensus       255 ~~~~~~-~~~~--~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          255 ELLEEG-QRLP--APPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             HHHHTT-CCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHhhcc-cCCC--CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            222222 2222  234789999999999999999999999999875

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.1e-44  Score=346.16  Aligned_cols=253  Identities=25%  Similarity=0.395  Sum_probs=206.7

Q ss_pred             cccCeeeeeeecccCceEEEEEEecC-CCc--EEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCC
Q 014733           38 LSDRYVLGKQLGWGQFGVIRECSDKF-TGE--VLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEED  114 (419)
Q Consensus        38 ~~~~y~i~~~LG~G~~g~V~~a~~~~-~g~--~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~  114 (419)
                      ..++|++.+.||+|+||+||+|.+.. +++  .||+|++...........+.+.+|+.+++++. ||||+++++++.+.+
T Consensus        16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~   94 (291)
T 1u46_A           16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVVLTPP   94 (291)
T ss_dssp             CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSSS
T ss_pred             chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCC-CCCcccEEEEEccCC
Confidence            35799999999999999999998643 333  68999987665444566788999999999996 999999999998766


Q ss_pred             EEEEEEeecCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceee
Q 014733          115 YVHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATY  193 (419)
Q Consensus       115 ~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~  193 (419)
                       .++||||+++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++..
T Consensus        95 -~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~---~~~~~kl~Dfg~~~~  170 (291)
T 1u46_A           95 -MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLA---TRDLVKIGDFGLMRA  170 (291)
T ss_dssp             -CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE---ETTEEEECCCTTCEE
T ss_pred             -ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEc---CCCCEEEcccccccc
Confidence             88999999999999998764 5699999999999999999999999999999999999995   456899999999987


Q ss_pred             eccCCc----cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCC
Q 014733          194 IKAGQN----LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWD  267 (419)
Q Consensus       194 ~~~~~~----~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  267 (419)
                      ......    .....+|..|+|||++.+. ++.++||||||+++|+|++ |+.||.+....+....+.......+..  .
T Consensus       171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~  248 (291)
T 1u46_A          171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRP--E  248 (291)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCC--T
T ss_pred             ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCC--c
Confidence            654332    1234678889999998765 8899999999999999999 999999999888888887765544433  4


Q ss_pred             CCCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          268 HISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       268 ~~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      .++.++.++|.+||..||.+|||+.+++++
T Consensus       249 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  278 (291)
T 1u46_A          249 DCPQDIYNVMVQCWAHKPEDRPTFVALRDF  278 (291)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CcCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            789999999999999999999999999874

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.8e-44  Score=352.51  Aligned_cols=249  Identities=22%  Similarity=0.328  Sum_probs=205.5

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEE----EEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCC
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVL----ACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEED  114 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~v----aiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~  114 (419)
                      .++|++++.||+|+||.||+|.+..+++.+    |+|.+...  ......+.+.+|+.++++++ ||||+++++++.+..
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~--~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~   90 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVD-NPHVCRLLGICLTST   90 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCC--SSCCCHHHHHHHHHHHTTCC-BTTBCCCCEEEESSS
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccc--cCHHHHHHHHHHHHHHHhCC-CCCeeEEEEEEecCC
Confidence            589999999999999999999998888766    55555432  23345678999999999996 999999999998776


Q ss_pred             EEEEEEeecCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceee
Q 014733          115 YVHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATY  193 (419)
Q Consensus       115 ~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~  193 (419)
                       .++|+||+.+|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++..
T Consensus        91 -~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~---~~~~~kL~DfG~a~~  166 (327)
T 3lzb_A           91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAKL  166 (327)
T ss_dssp             -EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---ETTEEEECCTTC---
T ss_pred             -ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEc---CCCCEEEccCcceeE
Confidence             78899999999999999764 5699999999999999999999999999999999999994   456899999999987


Q ss_pred             eccCCc---cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCC
Q 014733          194 IKAGQN---LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDH  268 (419)
Q Consensus       194 ~~~~~~---~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  268 (419)
                      ......   .....+|+.|+|||++.+. ++.++|||||||++|+|++ |..||.+....+....+...... +.  ...
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~-~~--~~~  243 (327)
T 3lzb_A          167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL-PQ--PPI  243 (327)
T ss_dssp             -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC-CC--CTT
T ss_pred             ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC-CC--Ccc
Confidence            644322   2334568889999998764 8999999999999999999 99999998888887777655422 22  236


Q ss_pred             CCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          269 ISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       269 ~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      ++.++.++|.+||+.||.+|||+.++++.
T Consensus       244 ~~~~l~~li~~~l~~dp~~Rps~~ell~~  272 (327)
T 3lzb_A          244 CTIDVYMIMRKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             BCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            89999999999999999999999999874

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=3e-44  Score=344.05  Aligned_cols=255  Identities=24%  Similarity=0.421  Sum_probs=202.2

Q ss_pred             hccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeC
Q 014733           34 QISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEE  113 (419)
Q Consensus        34 ~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~  113 (419)
                      ..+...++|++.++||+|+||+||+|.+.   ..+|+|++.... ......+.+.+|+.++++++ ||||++++++. ..
T Consensus        18 ~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~-~~   91 (289)
T 3og7_A           18 DWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTR-HVNILLFMGYS-TA   91 (289)
T ss_dssp             CCBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSS-CCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEE-CS
T ss_pred             CCccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccC-CCHHHHHHHHHHHHHHHhCC-CCcEEEEEeec-cC
Confidence            34556789999999999999999999864   359999997654 35567788999999999996 99999999965 55


Q ss_pred             CEEEEEEeecCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeecccee
Q 014733          114 DYVHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLAT  192 (419)
Q Consensus       114 ~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~  192 (419)
                      ...++||||+.+++|.+++... ..+++.+++.++.||+.||.|||+.||+||||||+|||++   .++.+||+|||++.
T Consensus        92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~---~~~~~kl~Dfg~~~  168 (289)
T 3og7_A           92 PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLH---EDNTVKIGDFGLAT  168 (289)
T ss_dssp             SSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---TTTEEEECCCC---
T ss_pred             CccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEEC---CCCCEEEccceecc
Confidence            5689999999999999999643 4599999999999999999999999999999999999994   56789999999997


Q ss_pred             eeccC---CccccccCCCccCCccccc---C-CCCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhcCCCCC-C
Q 014733          193 YIKAG---QNLHGTVGSPFYIAPEVLA---G-GYNQAADVWSAGVILYILLSGMPPFWGKTK-SKIFDAVRAADLRFP-S  263 (419)
Q Consensus       193 ~~~~~---~~~~~~~gt~~y~aPE~l~---~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~-~~~~~~i~~~~~~~~-~  263 (419)
                      .....   .......||+.|+|||++.   + .++.++||||||+++|+|++|+.||.+... ....+.+........ .
T Consensus       169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  248 (289)
T 3og7_A          169 EKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLS  248 (289)
T ss_dssp             ---------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTT
T ss_pred             ccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchh
Confidence            65432   2223457999999999985   2 478899999999999999999999987544 444455555443332 2


Q ss_pred             CCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          264 DPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       264 ~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      .....+++++.+||.+||+.||.+|||+.++++.
T Consensus       249 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  282 (289)
T 3og7_A          249 KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAE  282 (289)
T ss_dssp             SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hccccCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence            2345789999999999999999999999999863

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=6.4e-45  Score=369.25  Aligned_cols=259  Identities=27%  Similarity=0.417  Sum_probs=203.6

Q ss_pred             cccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEE
Q 014733           38 LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVH  117 (419)
Q Consensus        38 ~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~  117 (419)
                      -..+|.+.+.||+|+||+|+. ....+|+.||||++.....      ..+.+|+.+|+.+.+||||+++++++.+.+..|
T Consensus        22 ~~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~   94 (432)
T 3p23_A           22 GKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQY   94 (432)
T ss_dssp             TTEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE------EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEE
T ss_pred             ccEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH------HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEE
Confidence            345799999999999998763 4456899999999865432      235679999999956999999999999999999


Q ss_pred             EEEeecCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCC--CCeEEeeccceeee
Q 014733          118 LLMELCAGGELFHRLEKYG-RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSS--SPIKLADFGLATYI  194 (419)
Q Consensus       118 lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~--~~vKL~DFgla~~~  194 (419)
                      +||||+. |+|.+++.... .+.+.+++.++.||+.||+|||++||+||||||+|||++.++.+  ..+||+|||++...
T Consensus        95 lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~  173 (432)
T 3p23_A           95 IAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL  173 (432)
T ss_dssp             EEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred             EEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence            9999995 69999997654 36666788999999999999999999999999999999643333  36789999999876


Q ss_pred             ccCC----ccccccCCCccCCcccccC----CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCC
Q 014733          195 KAGQ----NLHGTVGSPFYIAPEVLAG----GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDP  265 (419)
Q Consensus       195 ~~~~----~~~~~~gt~~y~aPE~l~~----~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~  265 (419)
                      ....    .....+||+.|+|||++.+    .++.++|||||||++|+|++ |..||...........+....... ...
T Consensus       174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~-~~~  252 (432)
T 3p23_A          174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDC-LHP  252 (432)
T ss_dssp             ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTT-SCT
T ss_pred             cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccc-cCc
Confidence            5432    2344679999999999863    37889999999999999999 999996655444333222221111 112


Q ss_pred             CCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          266 WDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       266 ~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                      ....+..+.+||.+||+.||.+|||+.++++||||....+
T Consensus       253 ~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~~  292 (432)
T 3p23_A          253 EKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEK  292 (432)
T ss_dssp             TCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHHH
T ss_pred             cccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChHH
Confidence            2345667899999999999999999999999999987655

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=6.5e-44  Score=363.67  Aligned_cols=244  Identities=27%  Similarity=0.379  Sum_probs=210.2

Q ss_pred             ccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCC-E
Q 014733           37 NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEED-Y  115 (419)
Q Consensus        37 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~-~  115 (419)
                      .-.++|++.+.||+|+||.||+|.++  |+.||+|++....     ..+.+.+|+.+|++++ ||||+++++++.+.. .
T Consensus       190 i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~  261 (450)
T 1k9a_A          190 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKGG  261 (450)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-----TSHHHHHHHHHHHTCC-CTTBCCEEEEEECTTSC
T ss_pred             cChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-----HHHHHHHHHHHHHhcc-CCCEEEEEEEEEcCCCc
Confidence            34579999999999999999999875  7899999997542     4567899999999996 999999999987665 7


Q ss_pred             EEEEEeecCCCChHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceee
Q 014733          116 VHLLMELCAGGELFHRLEKYGR--FSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATY  193 (419)
Q Consensus       116 ~~lV~E~~~ggsL~~~l~~~~~--l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~  193 (419)
                      +|+||||+++|+|.+++...+.  +++..+..++.||+.||+|||+++|+||||||+|||+   +.++.+||+|||+++.
T Consensus       262 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~  338 (450)
T 1k9a_A          262 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKE  338 (450)
T ss_dssp             EEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTSCEEECCCTTCEE
T ss_pred             eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEE---CCCCCEEEeeCCCccc
Confidence            9999999999999999987654  7999999999999999999999999999999999999   5678999999999986


Q ss_pred             eccCCccccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCH
Q 014733          194 IKAGQNLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISA  271 (419)
Q Consensus       194 ~~~~~~~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  271 (419)
                      ....  .....++..|+|||++.+ .++.++||||||+++|||++ |+.||.+....+....+..+. +.  ..+..+++
T Consensus       339 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~-~~--~~p~~~~~  413 (450)
T 1k9a_A          339 ASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY-KM--DAPDGCPP  413 (450)
T ss_dssp             CC--------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTC-CC--CCCTTCCH
T ss_pred             cccc--ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CC--CCCCcCCH
Confidence            4332  223367889999999876 49999999999999999998 999999888878877776552 22  22347899


Q ss_pred             HHHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          272 SARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       272 ~l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                      ++.++|.+||+.||.+|||+.++++
T Consensus       414 ~l~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          414 AVYDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHHH
Confidence            9999999999999999999999986

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=4.6e-44  Score=369.07  Aligned_cols=249  Identities=24%  Similarity=0.388  Sum_probs=216.9

Q ss_pred             ccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEE
Q 014733           37 NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYV  116 (419)
Q Consensus        37 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~  116 (419)
                      .-.++|++.+.||+|+||.||+|.++.++..||+|++....    ...+.+.+|+.+|++++ ||||+++++++.+.+.+
T Consensus       217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~  291 (495)
T 1opk_A          217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPPF  291 (495)
T ss_dssp             CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS----SCHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSC
T ss_pred             cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc----cchHHHHHHHHHHHhcC-CCCEeeEEEEEecCCcE
Confidence            34578999999999999999999999889999999997543    23577899999999996 99999999999999999


Q ss_pred             EEEEeecCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeee
Q 014733          117 HLLMELCAGGELFHRLEKY--GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI  194 (419)
Q Consensus       117 ~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~  194 (419)
                      |+||||+++|+|.+++...  ..+++..+..++.||+.||+|||+++|+||||||+|||+   +.++.+||+|||+++..
T Consensus       292 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~  368 (495)
T 1opk_A          292 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLV---GENHLVKVADFGLSRLM  368 (495)
T ss_dssp             EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGGCEEECCTTCEECC
T ss_pred             EEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEE---CCCCcEEEeecccceec
Confidence            9999999999999999864  348999999999999999999999999999999999999   55678999999999876


Q ss_pred             ccCCc--cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCC
Q 014733          195 KAGQN--LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHIS  270 (419)
Q Consensus       195 ~~~~~--~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  270 (419)
                      .....  .....++..|+|||++.+. ++.++|||||||++|||++ |..||.+....++.+.+.... +.  ..+..++
T Consensus       369 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~--~~~~~~~  445 (495)
T 1opk_A          369 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY-RM--ERPEGCP  445 (495)
T ss_dssp             TTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC-CC--CCCTTCC
T ss_pred             cCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CC--CCCCCCC
Confidence            44321  2334567889999998764 8999999999999999999 999999988888777765542 22  2234789


Q ss_pred             HHHHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          271 ASARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       271 ~~l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                      +++.+||.+||+.||++|||+.++++
T Consensus       446 ~~l~~li~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          446 EKVYELMRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHcCcChhHCcCHHHHHH
Confidence            99999999999999999999999976

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=6.5e-44  Score=342.51  Aligned_cols=254  Identities=22%  Similarity=0.290  Sum_probs=211.8

Q ss_pred             ccccccCeeeeeeecccCceEEEEEEecCC---CcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEE-
Q 014733           35 ISNLSDRYVLGKQLGWGQFGVIRECSDKFT---GEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVY-  110 (419)
Q Consensus        35 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~---g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~-  110 (419)
                      +.....+|++.+.||+|+||.||+|.+..+   +..+|+|.+...  ......+.+.+|+.++++++ ||||+++++++ 
T Consensus        20 i~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~   96 (298)
T 3f66_A           20 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICL   96 (298)
T ss_dssp             CCGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEC
T ss_pred             cCccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC--CCHHHHHHHHHHHHHHHhCC-CCCEeeeeeEEE
Confidence            445567899999999999999999997543   346899988653  34566788999999999996 99999999986 


Q ss_pred             EeCCEEEEEEeecCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeecc
Q 014733          111 EEEDYVHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFG  189 (419)
Q Consensus       111 ~~~~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFg  189 (419)
                      .+++..++||||+++++|.+++... ..+++.+++.++.|++.||+|||+.||+||||||+|||+   +.++.+||+|||
T Consensus        97 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg  173 (298)
T 3f66_A           97 RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCML---DEKFTVKVADFG  173 (298)
T ss_dssp             CSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECSCG
T ss_pred             cCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE---CCCCCEEECccc
Confidence            4566889999999999999999764 458999999999999999999999999999999999999   567899999999


Q ss_pred             ceeeeccCC-----ccccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCC
Q 014733          190 LATYIKAGQ-----NLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFP  262 (419)
Q Consensus       190 la~~~~~~~-----~~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~  262 (419)
                      ++.......     ......||+.|+|||++.+ .++.++||||||+++|+|++ |.+||.+....+....+........
T Consensus       174 ~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (298)
T 3f66_A          174 LARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ  253 (298)
T ss_dssp             GGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCC
T ss_pred             ccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCC
Confidence            998664332     1234467889999999876 48999999999999999999 7788887777777777666544332


Q ss_pred             CCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          263 SDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       263 ~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      .   ..++.++.++|.+||+.||++|||+.++++.
T Consensus       254 ~---~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  285 (298)
T 3f66_A          254 P---EYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  285 (298)
T ss_dssp             C---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             C---ccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            2   3688999999999999999999999999873

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=2.2e-44  Score=348.79  Aligned_cols=250  Identities=25%  Similarity=0.363  Sum_probs=205.3

Q ss_pred             cccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEe----C
Q 014733           38 LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEE----E  113 (419)
Q Consensus        38 ~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~----~  113 (419)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++...   .....+.+.+|+.+++++. ||||+++++++..    .
T Consensus        27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~  102 (317)
T 2buj_A           27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFN-HPNILRLVAYCLRERGAK  102 (317)
T ss_dssp             TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEEEETTE
T ss_pred             CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcC-CCCeeeEEEEEEeccCCC
Confidence            357999999999999999999999999999999998653   3466788999999999995 9999999999873    3


Q ss_pred             CEEEEEEeecCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeecc
Q 014733          114 DYVHLLMELCAGGELFHRLEK----YGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFG  189 (419)
Q Consensus       114 ~~~~lV~E~~~ggsL~~~l~~----~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFg  189 (419)
                      ...++||||+.+++|.+++..    ...+++.+++.++.||++||.|||+.||+||||||+|||+   +.++.+||+|||
T Consensus       103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~dfg  179 (317)
T 2buj_A          103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILL---GDEGQPVLMDLG  179 (317)
T ss_dssp             EEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCS
T ss_pred             ceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---cCCCCEEEEecC
Confidence            478999999999999999876    3569999999999999999999999999999999999999   567889999999


Q ss_pred             ceeeeccCCc----------cccccCCCccCCcccccCC----CCCchhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHH
Q 014733          190 LATYIKAGQN----------LHGTVGSPFYIAPEVLAGG----YNQAADVWSAGVILYILLSGMPPFWGKT--KSKIFDA  253 (419)
Q Consensus       190 la~~~~~~~~----------~~~~~gt~~y~aPE~l~~~----~s~~sDvwSlGvil~elltG~~Pf~~~~--~~~~~~~  253 (419)
                      ++........          .....||+.|+|||++.+.    ++.++||||||+++|+|++|+.||....  .......
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~  259 (317)
T 2buj_A          180 SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA  259 (317)
T ss_dssp             SCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHH
T ss_pred             cchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHH
Confidence            9876432111          1233679999999998653    6899999999999999999999995311  1112222


Q ss_pred             HHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          254 VRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       254 i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      +. .....+.  ...++.++.++|.+||+.||.+|||+.+++++
T Consensus       260 ~~-~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          260 VQ-NQLSIPQ--SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             HH-CC--CCC--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hh-ccCCCCc--cccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence            22 2333332  34789999999999999999999999999986

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1e-44  Score=356.54  Aligned_cols=258  Identities=19%  Similarity=0.207  Sum_probs=201.6

Q ss_pred             ccccCeeeeeeecccCceEEEEEEecC---CCcEEEEEEeccCccCCHH--------hHHHHHHHHHHHHHccCCCCcee
Q 014733           37 NLSDRYVLGKQLGWGQFGVIRECSDKF---TGEVLACKSIAKDRLVTVE--------DVRSIKLEIEIMTKLSGHPNVVD  105 (419)
Q Consensus        37 ~~~~~y~i~~~LG~G~~g~V~~a~~~~---~g~~vaiK~i~~~~~~~~~--------~~~~~~~Ei~il~~l~~hpnIv~  105 (419)
                      ...++|++++.||+|+||.||+|.+..   ++..+|+|++.........        ....+.+|+.+++.+. ||||++
T Consensus        34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~-h~ni~~  112 (345)
T 2v62_A           34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLD-YLGIPL  112 (345)
T ss_dssp             TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCS-CCCCCC
T ss_pred             ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhcccc-ccCcce
Confidence            346899999999999999999999987   7889999998765321111        1123567888888885 999999


Q ss_pred             eeEEEEe----CCEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCC
Q 014733          106 LKAVYEE----EDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSS  181 (419)
Q Consensus       106 l~~~~~~----~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~  181 (419)
                      +++++.+    ....|+||||+ +++|.+++...+.+++.+++.++.||+.||+|||+.||+||||||+|||++.++ .+
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~  190 (345)
T 2v62_A          113 FYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKN-PD  190 (345)
T ss_dssp             EEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSS-TT
T ss_pred             eecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCC-CC
Confidence            9999988    78999999999 999999998877899999999999999999999999999999999999996532 23


Q ss_pred             CeEEeeccceeeeccCCc--------cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCC--CHHHH
Q 014733          182 PIKLADFGLATYIKAGQN--------LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGK--TKSKI  250 (419)
Q Consensus       182 ~vKL~DFgla~~~~~~~~--------~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~--~~~~~  250 (419)
                      .+||+|||+++.+.....        .....||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+.  .....
T Consensus       191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~  270 (345)
T 2v62_A          191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV  270 (345)
T ss_dssp             SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHH
T ss_pred             cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHH
Confidence            899999999987643221        1345799999999998875 899999999999999999999999652  22222


Q ss_pred             HHHHHhcCCCCCCC-----CCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          251 FDAVRAADLRFPSD-----PWDHISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       251 ~~~i~~~~~~~~~~-----~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      ...........+..     ....++.++.++|.+||+.||++|||+.++++.
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  322 (345)
T 2v62_A          271 QTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI  322 (345)
T ss_dssp             HHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             HHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence            22222211111110     112688999999999999999999999999873

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=7.8e-44  Score=338.76  Aligned_cols=249  Identities=24%  Similarity=0.332  Sum_probs=213.2

Q ss_pred             ccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCC
Q 014733           35 ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEED  114 (419)
Q Consensus        35 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~  114 (419)
                      .....++|++++.||+|+||.||+|.+. ++..||+|++....    ...+.+.+|+++++++. ||||+++++++.++ 
T Consensus         8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~-   80 (279)
T 1qpc_A            8 WEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS----MSPDAFLAEANLMKQLQ-HQRLVRLYAVVTQE-   80 (279)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS----SCHHHHHHHHHHHHHCC-CTTBCCEEEEECSS-
T ss_pred             cccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc----ccHHHHHHHHHHHHhCC-CcCcceEEEEEcCC-
Confidence            3445689999999999999999999976 56789999987543    23567889999999996 99999999998754 


Q ss_pred             EEEEEEeecCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeecccee
Q 014733          115 YVHLLMELCAGGELFHRLEKYG--RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLAT  192 (419)
Q Consensus       115 ~~~lV~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~  192 (419)
                      ..++||||+++++|.+++....  .+++.++..++.|++.||+|||++||+||||||+|||+   +.++.+||+|||++.
T Consensus        81 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~  157 (279)
T 1qpc_A           81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV---SDTLSCKIADFGLAR  157 (279)
T ss_dssp             SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCE
T ss_pred             CcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEE---cCCCCEEECCCcccc
Confidence            5889999999999999997543  69999999999999999999999999999999999999   567899999999998


Q ss_pred             eeccCCc--cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCC
Q 014733          193 YIKAGQN--LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDH  268 (419)
Q Consensus       193 ~~~~~~~--~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  268 (419)
                      .......  .....++..|+|||++.+. ++.++||||||+++|+|++ |+.||.+....+....+......   .....
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~  234 (279)
T 1qpc_A          158 LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM---VRPDN  234 (279)
T ss_dssp             ECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---CCCTT
T ss_pred             cccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCC---CCccc
Confidence            7654332  2334678889999998754 8999999999999999999 99999998888888877665322   22347


Q ss_pred             CCHHHHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          269 ISASARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       269 ~s~~l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                      ++.++.++|.+||+.||++|||+.++++
T Consensus       235 ~~~~l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          235 CPEELYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            8999999999999999999999999986

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=4.4e-44  Score=347.94  Aligned_cols=262  Identities=25%  Similarity=0.394  Sum_probs=212.3

Q ss_pred             hhhccccccCe-eeeeeecccCceEEEEEE----ecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceee
Q 014733           32 ATQISNLSDRY-VLGKQLGWGQFGVIRECS----DKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDL  106 (419)
Q Consensus        32 ~~~~~~~~~~y-~i~~~LG~G~~g~V~~a~----~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l  106 (419)
                      ..+...+.++| ++++.||+|+||+||++.    +..+++.||+|++...  ......+.+.+|+.++++++ ||||+++
T Consensus        22 pg~~~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~   98 (318)
T 3lxp_A           22 PGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--AGPQHRSGWKQEIDILRTLY-HEHIIKY   98 (318)
T ss_dssp             --CCCBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT--CCHHHHHHHHHHHHHHHHCC-CTTBCCE
T ss_pred             CCCCceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc--cChHHHHHHHHHHHHHHhCC-CcchhhE
Confidence            33455577777 999999999999998775    4458899999999765  34566788999999999996 9999999


Q ss_pred             eEEEEe--CCEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeE
Q 014733          107 KAVYEE--EDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIK  184 (419)
Q Consensus       107 ~~~~~~--~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vK  184 (419)
                      ++++.+  ...+++||||+++++|.+++.. ..+++.+++.++.||+.||+|||+.||+||||||+|||+   +.++.+|
T Consensus        99 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~---~~~~~~k  174 (318)
T 3lxp_A           99 KGCCEDAGAASLQLVMEYVPLGSLRDYLPR-HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLL---DNDRLVK  174 (318)
T ss_dssp             EEEEEETTTTEEEEEECCCTTCBHHHHGGG-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEE
T ss_pred             EEEEecCCCceEEEEEecccCCcHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE---cCCCCEE
Confidence            999988  4689999999999999999976 459999999999999999999999999999999999999   5678899


Q ss_pred             EeeccceeeeccCCc----cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHH-----------
Q 014733          185 LADFGLATYIKAGQN----LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKS-----------  248 (419)
Q Consensus       185 L~DFgla~~~~~~~~----~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~-----------  248 (419)
                      |+|||++........    .....||..|+|||++.+. ++.++||||||+++|+|++|..||......           
T Consensus       175 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~  254 (318)
T 3lxp_A          175 IGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQ  254 (318)
T ss_dssp             ECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHH
T ss_pred             ECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccc
Confidence            999999988755432    2334688889999998774 889999999999999999999999653221           


Q ss_pred             ----HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          249 ----KIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       249 ----~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                          +..+.+... ...  .....++.++.+||.+||+.||++|||+.++++  +++.+..
T Consensus       255 ~~~~~~~~~~~~~-~~~--~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~--~L~~l~~  310 (318)
T 3lxp_A          255 MTVLRLTELLERG-ERL--PRPDKCPAEVYHLMKNCWETEASFRPTFENLIP--ILKTVHE  310 (318)
T ss_dssp             HHHHHHHHHHHTT-CCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHHH
T ss_pred             hhHHHHHHHHhcc-cCC--CCCccccHHHHHHHHHHcCCCcccCcCHHHHHH--HHHHHHH
Confidence                112222222 222  223478999999999999999999999999986  3555443

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=9.3e-45  Score=353.07  Aligned_cols=263  Identities=22%  Similarity=0.288  Sum_probs=210.4

Q ss_pred             cchhhccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEE
Q 014733           30 LDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAV  109 (419)
Q Consensus        30 ~~~~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~  109 (419)
                      +...++....++|++.+.||+|+||.||+|.+. +|+.||+|++.....  ......+.+|+.+++.+. ||||++++++
T Consensus        20 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~iv~~~~~   95 (326)
T 3uim_A           20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERT--QGGELQFQTEVEMISMAV-HRNLLRLRGF   95 (326)
T ss_dssp             CCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-------CCCHHHHHHHGGGTCC-CTTBCCCCEE
T ss_pred             ecHHHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccC--chHHHHHHHHHHHHHhcc-CCCccceEEE
Confidence            456677888999999999999999999999854 689999999876532  222336889999999996 9999999999


Q ss_pred             EEeCCEEEEEEeecCCCChHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CCeeccCCCCcEEEeecCCCCC
Q 014733          110 YEEEDYVHLLMELCAGGELFHRLEKYG----RFSETEARVIFRHLMQVVSYCHGN---GVVHRDLKPENILLATKSSSSP  182 (419)
Q Consensus       110 ~~~~~~~~lV~E~~~ggsL~~~l~~~~----~l~~~~~~~i~~qll~aL~~LH~~---~IvHrDLkp~NILl~~~~~~~~  182 (419)
                      +.+.+..++||||+.+++|.+++....    .+++..++.++.|++.||+|||+.   ||+||||||+|||+   +.++.
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~---~~~~~  172 (326)
T 3uim_A           96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILL---DEEFE  172 (326)
T ss_dssp             ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEE---CTTCC
T ss_pred             EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEE---CCCCC
Confidence            999999999999999999999997643    399999999999999999999999   99999999999999   56789


Q ss_pred             eEEeeccceeeeccCCc--cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCC-----CCHHHHHHHH
Q 014733          183 IKLADFGLATYIKAGQN--LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWG-----KTKSKIFDAV  254 (419)
Q Consensus       183 vKL~DFgla~~~~~~~~--~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~-----~~~~~~~~~i  254 (419)
                      +||+|||++........  .....||+.|+|||++.+. ++.++||||||+++|+|++|+.||..     .........+
T Consensus       173 ~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  252 (326)
T 3uim_A          173 AVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV  252 (326)
T ss_dssp             EEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHH
T ss_pred             EEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHH
Confidence            99999999987654332  2344699999999998664 89999999999999999999999942     1111111121


Q ss_pred             HhcCCC----------CCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccc
Q 014733          255 RAADLR----------FPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSW  299 (419)
Q Consensus       255 ~~~~~~----------~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~  299 (419)
                      ......          .........+.++.+++.+||+.||.+|||+.++++|-+
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  307 (326)
T 3uim_A          253 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE  307 (326)
T ss_dssp             TTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred             HHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence            111000          001111223477999999999999999999999999743

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=7.8e-44  Score=363.42  Aligned_cols=250  Identities=24%  Similarity=0.378  Sum_probs=214.6

Q ss_pred             hccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeC
Q 014733           34 QISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEE  113 (419)
Q Consensus        34 ~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~  113 (419)
                      ......++|++.+.||+|+||+||+|.++ .+..||+|++....    ...+.+.+|+.+|++++ ||||+++++++. .
T Consensus       182 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~-~  254 (454)
T 1qcf_A          182 AWEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQ-HDKLVKLHAVVT-K  254 (454)
T ss_dssp             CSBCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS----BCHHHHHHHHHHHTTCC-CTTBCCEEEEEC-S
T ss_pred             ceeechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC----ccHHHHHHHHHHHhhCC-CCCEeeEEEEEe-C
Confidence            34445689999999999999999999986 57789999997543    24678999999999996 999999999986 5


Q ss_pred             CEEEEEEeecCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccce
Q 014733          114 DYVHLLMELCAGGELFHRLEKY--GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA  191 (419)
Q Consensus       114 ~~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla  191 (419)
                      +.+++||||+.+|+|.+++...  ..+++..+..++.||+.||+|||+++|+||||||+|||+   +.++.+||+|||++
T Consensus       255 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DFG~a  331 (454)
T 1qcf_A          255 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV---SASLVCKIADFGLA  331 (454)
T ss_dssp             SSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE---CTTCCEEECSTTGG
T ss_pred             CccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE---CCCCcEEEeeCCCc
Confidence            5689999999999999999754  368999999999999999999999999999999999999   56789999999999


Q ss_pred             eeeccCC--ccccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCC
Q 014733          192 TYIKAGQ--NLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWD  267 (419)
Q Consensus       192 ~~~~~~~--~~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  267 (419)
                      +......  ......+|..|+|||++.+ .++.++|||||||++|||++ |+.||.+....++...+..+. +.+.  ..
T Consensus       332 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~-~~~~--~~  408 (454)
T 1qcf_A          332 RVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY-RMPR--PE  408 (454)
T ss_dssp             GGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTC-CCCC--CT
T ss_pred             eEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCC--CC
Confidence            8754322  1233456788999999875 59999999999999999999 999999999888888877652 2222  24


Q ss_pred             CCCHHHHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          268 HISASARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       268 ~~s~~l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                      .+++++.++|.+||+.||++|||+.+|+.
T Consensus       409 ~~~~~l~~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          409 NCPEELYNIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence            78999999999999999999999999976

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=6.7e-44  Score=342.40  Aligned_cols=249  Identities=26%  Similarity=0.368  Sum_probs=199.9

Q ss_pred             cccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHH--ccCCCCceeeeEEEEe-
Q 014733           36 SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTK--LSGHPNVVDLKAVYEE-  112 (419)
Q Consensus        36 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~--l~~hpnIv~l~~~~~~-  112 (419)
                      ..+.++|++.+.||+|+||+||+|.+  +|+.||+|++...      ....+..|.+++..  + +||||+++++++.+ 
T Consensus         4 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l-~h~niv~~~~~~~~~   74 (301)
T 3q4u_A            4 RTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR------DEKSWFRETELYNTVML-RHENILGFIASDMTS   74 (301)
T ss_dssp             CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHHHTCC-CCTTBCCEEEEEEEE
T ss_pred             ccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc------cchhhHHHHHHHHHhhc-cCcCeeeEEEeeccc
Confidence            45789999999999999999999987  5899999998643      34556677888777  6 59999999999754 


Q ss_pred             ---CCEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------hCCCeeccCCCCcEEEeecCCCC
Q 014733          113 ---EDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCH--------GNGVVHRDLKPENILLATKSSSS  181 (419)
Q Consensus       113 ---~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH--------~~~IvHrDLkp~NILl~~~~~~~  181 (419)
                         ...+++||||+++|+|.++++. ..+++..++.++.||+.||+|||        +.+|+||||||+|||+   +.++
T Consensus        75 ~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill---~~~~  150 (301)
T 3q4u_A           75 RHSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV---KKNG  150 (301)
T ss_dssp             ETTEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEE---CTTS
T ss_pred             cCCCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEE---cCCC
Confidence               3568999999999999999965 67999999999999999999999        9999999999999999   5678


Q ss_pred             CeEEeeccceeeeccCCcc-----ccccCCCccCCcccccCC-------CCCchhHHHHHHHHHHHHhC----------C
Q 014733          182 PIKLADFGLATYIKAGQNL-----HGTVGSPFYIAPEVLAGG-------YNQAADVWSAGVILYILLSG----------M  239 (419)
Q Consensus       182 ~vKL~DFgla~~~~~~~~~-----~~~~gt~~y~aPE~l~~~-------~s~~sDvwSlGvil~elltG----------~  239 (419)
                      .+||+|||++.........     ...+||+.|+|||++.+.       ++.++|||||||++|+|++|          .
T Consensus       151 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~  230 (301)
T 3q4u_A          151 QCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK  230 (301)
T ss_dssp             CEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred             CEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccc
Confidence            9999999999876544322     234799999999998764       33689999999999999999          8


Q ss_pred             CCCCCCC----HHHHHHHHHhcCCCCCCCC----CCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          240 PPFWGKT----KSKIFDAVRAADLRFPSDP----WDHISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       240 ~Pf~~~~----~~~~~~~i~~~~~~~~~~~----~~~~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      .||....    ...............+..+    ....+.++.+||.+||+.||++|||+.++++.
T Consensus       231 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~  296 (301)
T 3q4u_A          231 PPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKT  296 (301)
T ss_dssp             CTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             ccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence            8985432    1222233222222212111    12355789999999999999999999999863

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-43  Score=338.74  Aligned_cols=256  Identities=23%  Similarity=0.288  Sum_probs=212.5

Q ss_pred             ccccCeeeeeeecccCceEEEEEEecCCCc---EEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeC
Q 014733           37 NLSDRYVLGKQLGWGQFGVIRECSDKFTGE---VLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEE  113 (419)
Q Consensus        37 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~---~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~  113 (419)
                      .-.-+|++.+.||+|+||+||+|.+..++.   .+|+|++...  ......+.+.+|+.++++++ ||||+++++++.+.
T Consensus        18 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~   94 (298)
T 3pls_A           18 HERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGLN-HPNVLALIGIMLPP   94 (298)
T ss_dssp             GGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCC-CTTBCCCCEEECCS
T ss_pred             ccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc--ccHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEecC
Confidence            334577888999999999999999765444   7999998653  34566788999999999995 99999999999876


Q ss_pred             CEE-EEEEeecCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccce
Q 014733          114 DYV-HLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA  191 (419)
Q Consensus       114 ~~~-~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla  191 (419)
                      +.. ++||||+.+++|.+++... ..+++.+++.++.|++.||+|||+.||+||||||+|||+   +.++.+||+|||++
T Consensus        95 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili---~~~~~~kl~Dfg~~  171 (298)
T 3pls_A           95 EGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCML---DESFTVKVADFGLA  171 (298)
T ss_dssp             SSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECCTTSS
T ss_pred             CCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCCcEEeCcCCCc
Confidence            554 9999999999999999763 558999999999999999999999999999999999999   56779999999999


Q ss_pred             eeeccCC-----ccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCC
Q 014733          192 TYIKAGQ-----NLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSD  264 (419)
Q Consensus       192 ~~~~~~~-----~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~  264 (419)
                      .......     ......+|+.|+|||.+.+. ++.++||||||+++|+|++ |.+||......+....+.......   
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~---  248 (298)
T 3pls_A          172 RDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLP---  248 (298)
T ss_dssp             CTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCC---
T ss_pred             ccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCC---
Confidence            8654322     22334678899999998874 8999999999999999999 566677777777777666554222   


Q ss_pred             CCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccc
Q 014733          265 PWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEEC  303 (419)
Q Consensus       265 ~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~  303 (419)
                      ....+++++.++|.+||+.||.+|||+.++++.  ++++
T Consensus       249 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~--l~~~  285 (298)
T 3pls_A          249 QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGE--VEQI  285 (298)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHH
T ss_pred             CCccchHHHHHHHHHHccCChhhCcCHHHHHHH--HHHH
Confidence            224689999999999999999999999999874  4443

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=5.2e-44  Score=352.27  Aligned_cols=246  Identities=18%  Similarity=0.245  Sum_probs=203.2

Q ss_pred             ccCeeeeeeecccCceEEEEEEecC--------CCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCcee-----
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKF--------TGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVD-----  105 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~--------~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~-----  105 (419)
                      .++|++.+.||+|+||.||+|.+..        .++.||+|++...        +.+.+|++++++++ ||||++     
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~-h~niv~~~~~~  111 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAA-KPLQVNKWKKL  111 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHC-CHHHHHHHHHH
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhc-ccchhhhhhhh
Confidence            6899999999999999999999987        4889999998754        35778999999996 999887     


Q ss_pred             ----------eeEEEEe-CCEEEEEEeecCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcE
Q 014733          106 ----------LKAVYEE-EDYVHLLMELCAGGELFHRLEKY--GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENI  172 (419)
Q Consensus       106 ----------l~~~~~~-~~~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NI  172 (419)
                                +++++.. .+..|+||||+ +++|.+++...  ..+++.+++.++.||+.||+|||++||+||||||+||
T Consensus       112 ~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NI  190 (352)
T 2jii_A          112 YSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENI  190 (352)
T ss_dssp             TTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGE
T ss_pred             ccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHE
Confidence                      6777776 78899999999 99999999876  6799999999999999999999999999999999999


Q ss_pred             EEeecCCCC--CeEEeeccceeeeccCCc--------cccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHhCCCC
Q 014733          173 LLATKSSSS--PIKLADFGLATYIKAGQN--------LHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPP  241 (419)
Q Consensus       173 Ll~~~~~~~--~vKL~DFgla~~~~~~~~--------~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~elltG~~P  241 (419)
                      |++   .++  .+||+|||++........        .....||+.|+|||++.+ .++.++|||||||++|+|++|+.|
T Consensus       191 l~~---~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p  267 (352)
T 2jii_A          191 FVD---PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP  267 (352)
T ss_dssp             EEE---TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred             EEc---CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence            995   444  899999999987643321        133479999999999887 489999999999999999999999


Q ss_pred             CCCCC--HHHHHHHHH---hcCCCC--CCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          242 FWGKT--KSKIFDAVR---AADLRF--PSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       242 f~~~~--~~~~~~~i~---~~~~~~--~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      |.+..  ...+.....   .....+  ....+..++.++.+||.+||+.||++|||+.++++.
T Consensus       268 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  330 (352)
T 2jii_A          268 WTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNN  330 (352)
T ss_dssp             TGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             cccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence            97653  333333322   221111  112234679999999999999999999999999873

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=8.3e-44  Score=365.55  Aligned_cols=254  Identities=19%  Similarity=0.284  Sum_probs=212.2

Q ss_pred             ccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEE
Q 014733           37 NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYV  116 (419)
Q Consensus        37 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~  116 (419)
                      .+.++|+++++||+|+||.||+|.+..+++.||||++.....     ...+.+|+++++.|..|++|..+..++.+.+..
T Consensus         4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~   78 (483)
T 3sv0_A            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYN   78 (483)
T ss_dssp             EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-----SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEE
T ss_pred             CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEE
Confidence            467899999999999999999999999999999998875532     234778999999998667888888888899999


Q ss_pred             EEEEeecCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeec
Q 014733          117 HLLMELCAGGELFHRLEK-YGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIK  195 (419)
Q Consensus       117 ~lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~  195 (419)
                      ++||||+ +++|.+++.. .+.+++.+++.++.||+.||+|||++||+||||||+||||+.++.++.+||+|||+++.+.
T Consensus        79 ~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~  157 (483)
T 3sv0_A           79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR  157 (483)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             EEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence            9999999 9999999985 4569999999999999999999999999999999999999655567899999999998775


Q ss_pred             cCCcc--------ccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhcCCCCCC
Q 014733          196 AGQNL--------HGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTK---SKIFDAVRAADLRFPS  263 (419)
Q Consensus       196 ~~~~~--------~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~---~~~~~~i~~~~~~~~~  263 (419)
                      .....        ...+||+.|+|||++.+. ++.++|||||||+||+|++|+.||.+...   .+.+..+.........
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  237 (483)
T 3sv0_A          158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI  237 (483)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred             CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence            54321        256899999999998874 89999999999999999999999976443   3333333332221111


Q ss_pred             -CCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          264 -DPWDHISASARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       264 -~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                       .....++.++.+||.+||+.||++||++.+|++
T Consensus       238 ~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          238 EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence             112367899999999999999999999998876

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=5.8e-44  Score=344.33  Aligned_cols=251  Identities=25%  Similarity=0.328  Sum_probs=205.0

Q ss_pred             CeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCcc-CCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           41 RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRL-VTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        41 ~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~-~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      .|..++.||+|+||.||+|.+  +++.||+|++..... ......+.+.+|+.++++++ ||||+++++++.+.+..++|
T Consensus        32 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv  108 (307)
T 2nru_A           32 ISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ-HENLVELLGFSSDGDDLCLV  108 (307)
T ss_dssp             TTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSCEEE
T ss_pred             ccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC-CCCeEEEEEEEecCCceEEE
Confidence            344559999999999999986  588999999875432 23345678999999999996 99999999999999999999


Q ss_pred             EeecCCCChHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeecc
Q 014733          120 MELCAGGELFHRLEK---YGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA  196 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~---~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~  196 (419)
                      |||+++++|.+++..   ..++++..++.++.||+.||.|||+.||+||||||+|||+   +.++.+||+|||++.....
T Consensus       109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~kl~Dfg~~~~~~~  185 (307)
T 2nru_A          109 YVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILL---DEAFTAKISDFGLARASEK  185 (307)
T ss_dssp             EECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEECCS
T ss_pred             EEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEE---cCCCcEEEeeccccccccc
Confidence            999999999999864   2459999999999999999999999999999999999999   5678999999999987644


Q ss_pred             CCc---cccccCCCccCCcccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhcCCC-------CC
Q 014733          197 GQN---LHGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGKTKS----KIFDAVRAADLR-------FP  262 (419)
Q Consensus       197 ~~~---~~~~~gt~~y~aPE~l~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~----~~~~~i~~~~~~-------~~  262 (419)
                      ...   .....||+.|+|||++.+.++.++||||||+++|+|++|++||......    .+.+.+......       ..
T Consensus       186 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (307)
T 2nru_A          186 FAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKM  265 (307)
T ss_dssp             CSSCEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSC
T ss_pred             ccccccccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccc
Confidence            322   2335799999999999888999999999999999999999999765432    222222222111       01


Q ss_pred             CCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          263 SDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       263 ~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      .......+..+.++|.+||+.||.+|||+.+++++
T Consensus       266 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          266 NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            11112345778999999999999999999999875

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=7.4e-44  Score=338.98  Aligned_cols=244  Identities=25%  Similarity=0.366  Sum_probs=202.6

Q ss_pred             cccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeC-CEE
Q 014733           38 LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEE-DYV  116 (419)
Q Consensus        38 ~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~-~~~  116 (419)
                      ..++|++.+.||+|+||.||+|.++  |+.||+|++...     ...+.+.+|+.++++++ ||||+++++++.+. +.+
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~   90 (278)
T 1byg_A           19 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-----ATAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKGGL   90 (278)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC-----C--HHHHHTHHHHTTCC-CTTBCCEEEEECCC--CC
T ss_pred             ChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecch-----hHHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCCce
Confidence            4589999999999999999999874  889999998654     24567889999999996 99999999997544 578


Q ss_pred             EEEEeecCCCChHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeee
Q 014733          117 HLLMELCAGGELFHRLEKYGR--FSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI  194 (419)
Q Consensus       117 ~lV~E~~~ggsL~~~l~~~~~--l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~  194 (419)
                      ++||||+++++|.+++...+.  +++..++.++.|++.||+|||+.||+||||||+||++   +.++.+||+|||++...
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~Dfg~~~~~  167 (278)
T 1byg_A           91 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEA  167 (278)
T ss_dssp             EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTSCEEECCCCC----
T ss_pred             EEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEE---eCCCcEEEeeccccccc
Confidence            999999999999999976544  8999999999999999999999999999999999999   56779999999999865


Q ss_pred             ccCCccccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHH
Q 014733          195 KAGQNLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISAS  272 (419)
Q Consensus       195 ~~~~~~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  272 (419)
                      ...  .....+++.|+|||++.+ .++.++||||||+++|+|++ |+.||......+....+.....   ......++++
T Consensus       168 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  242 (278)
T 1byg_A          168 SST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK---MDAPDGCPPA  242 (278)
T ss_dssp             ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCC---CCCCTTCCHH
T ss_pred             ccc--ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC---CCCcccCCHH
Confidence            432  223467889999999876 48999999999999999998 9999998887777777655421   2233478999


Q ss_pred             HHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          273 ARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       273 l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      +.++|.+||+.||.+|||+.++++.
T Consensus       243 l~~li~~~l~~~p~~Rps~~~l~~~  267 (278)
T 1byg_A          243 VYEVMKNCWHLDAAMRPSFLQLREQ  267 (278)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHhcCChhhCCCHHHHHHH
Confidence            9999999999999999999999863

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=9.5e-44  Score=352.10  Aligned_cols=255  Identities=16%  Similarity=0.198  Sum_probs=202.7

Q ss_pred             chhhccccccCeeeeeeecccCceEEEEE-----EecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHcc--CCCCc
Q 014733           31 DATQISNLSDRYVLGKQLGWGQFGVIREC-----SDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLS--GHPNV  103 (419)
Q Consensus        31 ~~~~~~~~~~~y~i~~~LG~G~~g~V~~a-----~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~--~hpnI  103 (419)
                      ....+....++|++.+.||+|+||+||+|     .+..+++.||+|++...      ....+..|+.+++++.  .|+||
T Consensus        56 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~~~~l~~~~~~~i  129 (365)
T 3e7e_A           56 PKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA------NPWEFYIGTQLMERLKPSMQHMF  129 (365)
T ss_dssp             SSCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC------CHHHHHHHHHHHHHSCGGGGGGB
T ss_pred             cceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC------ChhHHHHHHHHHHHhhhhhhhhh
Confidence            34455566789999999999999999999     46778999999998653      2356777888888875  28999


Q ss_pred             eeeeEEEEeCCEEEEEEeecCCCChHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEee--
Q 014733          104 VDLKAVYEEEDYVHLLMELCAGGELFHRLEK-----YGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLAT--  176 (419)
Q Consensus       104 v~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~-----~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~--  176 (419)
                      +++++++.+.+..|+||||+++|+|.+++..     ...+++.+++.++.||+.||+|||+.||+||||||+|||++.  
T Consensus       130 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~  209 (365)
T 3e7e_A          130 MKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGF  209 (365)
T ss_dssp             CCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGG
T ss_pred             hhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccc
Confidence            9999999999999999999999999999974     356999999999999999999999999999999999999954  


Q ss_pred             ------cCCCCCeEEeeccceeeec---cCCccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 014733          177 ------KSSSSPIKLADFGLATYIK---AGQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKT  246 (419)
Q Consensus       177 ------~~~~~~vKL~DFgla~~~~---~~~~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~  246 (419)
                            +..++.+||+|||++..+.   ........+||+.|+|||++.+. |+.++|||||||++|+|++|+.||....
T Consensus       210 ~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~  289 (365)
T 3e7e_A          210 LEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNE  289 (365)
T ss_dssp             TCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEE
T ss_pred             cCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCC
Confidence                  2226899999999997654   23334556899999999999875 8999999999999999999999996432


Q ss_pred             HHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccc
Q 014733          247 KSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSW  299 (419)
Q Consensus       247 ~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~  299 (419)
                      ....     .....+..   ...++.+.+++..||+.+|.+|++..+.+.+.+
T Consensus       290 ~~~~-----~~~~~~~~---~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l  334 (365)
T 3e7e_A          290 GGEC-----KPEGLFRR---LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKL  334 (365)
T ss_dssp             TTEE-----EECSCCTT---CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHH
T ss_pred             CCce-----eechhccc---cCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHH
Confidence            2100     00001111   134678999999999999999976655555443

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=4.4e-45  Score=385.03  Aligned_cols=269  Identities=27%  Similarity=0.440  Sum_probs=217.3

Q ss_pred             ccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEe----
Q 014733           37 NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEE----  112 (419)
Q Consensus        37 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~----  112 (419)
                      ...++|++.+.||+|+||.||+|.+..+|+.||+|++...  ......+.+.+|+.+++++. ||||+++++++.+    
T Consensus        11 ~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~--~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~v~~~~~~~   87 (676)
T 3qa8_A           11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE--LSPKNRERWCLEIQIMKKLN-HPNVVSAREVPDGLQKL   87 (676)
T ss_dssp             ------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC--CCHHHHHHHHHHHHHHHHCC-BTTBCCEEECCTTTCCC
T ss_pred             CCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc--CCHHHHHHHHHHHHHHHhCC-CCCCCceeeeecccccc
Confidence            3458999999999999999999999999999999998754  35567788999999999996 9999999999765    


Q ss_pred             --CCEEEEEEeecCCCChHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEee
Q 014733          113 --EDYVHLLMELCAGGELFHRLEKYG---RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLAD  187 (419)
Q Consensus       113 --~~~~~lV~E~~~ggsL~~~l~~~~---~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~D  187 (419)
                        .+..++||||++|++|.+++....   .+++..++.++.||+.||+|||+.||+||||||+|||++.++....+||+|
T Consensus        88 ~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~D  167 (676)
T 3qa8_A           88 APNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIID  167 (676)
T ss_dssp             CTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred             cCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcc
Confidence              677899999999999999998754   599999999999999999999999999999999999997655555699999


Q ss_pred             ccceeeeccCCccccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---------HH---
Q 014733          188 FGLATYIKAGQNLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFD---------AV---  254 (419)
Q Consensus       188 Fgla~~~~~~~~~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~---------~i---  254 (419)
                      ||++.............||+.|+|||++.+ .++.++||||||+++|+|++|..||.+......+.         .+   
T Consensus       168 FG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~  247 (676)
T 3qa8_A          168 LGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVY  247 (676)
T ss_dssp             CCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSC
T ss_pred             cccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhh
Confidence            999998766655566789999999999876 48999999999999999999999997653322110         00   


Q ss_pred             --HhcCC------CCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchhhhc
Q 014733          255 --RAADL------RFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQ  308 (419)
Q Consensus       255 --~~~~~------~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~~~~  308 (419)
                        ..+..      ..+......+++.+.+||.+||++||++|||+.++++||||+.+.....
T Consensus       248 ~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~  309 (676)
T 3qa8_A          248 DDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS  309 (676)
T ss_dssp             CCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred             hhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence              00111      1111222346789999999999999999999999999999998876543

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.9e-43  Score=339.69  Aligned_cols=241  Identities=28%  Similarity=0.472  Sum_probs=195.9

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEE
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHL  118 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~l  118 (419)
                      .++|++.+.||+|+||+||+|.+.  ++.||+|++...     ...+.+.+|+.++++++ ||||+++++++.+.  .++
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~--~~l   76 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE-----SERKAFIVELRQLSRVN-HPNIVKLYGACLNP--VCL   76 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST-----THHHHHHHHHHHHHHCC-CTTBCCEEEBCTTT--TEE
T ss_pred             HhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh-----hHHHHHHHHHHHHhcCC-CCCcCeEEEEEcCC--cEE
Confidence            478999999999999999999875  788999998643     35678899999999996 99999999988743  789


Q ss_pred             EEeecCCCChHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHh---CCCeeccCCCCcEEEeecCCCCC-eEEeeccce
Q 014733          119 LMELCAGGELFHRLEKYGR---FSETEARVIFRHLMQVVSYCHG---NGVVHRDLKPENILLATKSSSSP-IKLADFGLA  191 (419)
Q Consensus       119 V~E~~~ggsL~~~l~~~~~---l~~~~~~~i~~qll~aL~~LH~---~~IvHrDLkp~NILl~~~~~~~~-vKL~DFgla  191 (419)
                      ||||+++++|.+++.....   +++..+..++.|+++||+|||+   +||+||||||+|||++   .++. +||+|||++
T Consensus        77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~---~~~~~~kl~Dfg~~  153 (307)
T 2eva_A           77 VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLV---AGGTVLKICDFGTA  153 (307)
T ss_dssp             EEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEE---TTTTEEEECCCCC-
T ss_pred             EEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEe---CCCCEEEEcccccc
Confidence            9999999999999986553   7899999999999999999999   8999999999999995   3444 799999999


Q ss_pred             eeeccCCccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhcCCCCCCCCCCC
Q 014733          192 TYIKAGQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTK--SKIFDAVRAADLRFPSDPWDH  268 (419)
Q Consensus       192 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~--~~~~~~i~~~~~~~~~~~~~~  268 (419)
                      ......  .....||+.|+|||++.+. ++.++||||||+++|+|++|+.||.....  ......+....   .......
T Consensus       154 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~  228 (307)
T 2eva_A          154 CDIQTH--MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT---RPPLIKN  228 (307)
T ss_dssp             -------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTC---CCCCBTT
T ss_pred             cccccc--cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCC---CCCcccc
Confidence            865432  2345799999999998874 89999999999999999999999975432  23333333322   2223357


Q ss_pred             CCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          269 ISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       269 ~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      ++..+.++|.+||+.||.+|||+.+++++
T Consensus       229 ~~~~l~~li~~~l~~dp~~Rps~~ell~~  257 (307)
T 2eva_A          229 LPKPIESLMTRCWSKDPSQRPSMEEIVKI  257 (307)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            89999999999999999999999999874

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.8e-44  Score=354.17  Aligned_cols=252  Identities=21%  Similarity=0.264  Sum_probs=202.4

Q ss_pred             ccccCeeeeeeecccCceEEEEEEecCCC---cEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEE-e
Q 014733           37 NLSDRYVLGKQLGWGQFGVIRECSDKFTG---EVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYE-E  112 (419)
Q Consensus        37 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~g---~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~-~  112 (419)
                      .-..+|++.+.||+|+||+||+|.+..++   ..||+|.+...  ......+.+.+|+.++++++ ||||+++++++. .
T Consensus        86 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~  162 (373)
T 3c1x_A           86 PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRS  162 (373)
T ss_dssp             STTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTCC-CTTBCCCCEEECCC
T ss_pred             hhhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEcC
Confidence            33457899999999999999999876432   46899988643  34466788999999999996 999999999865 4


Q ss_pred             CCEEEEEEeecCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccce
Q 014733          113 EDYVHLLMELCAGGELFHRLEKYG-RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA  191 (419)
Q Consensus       113 ~~~~~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla  191 (419)
                      ++..++||||+++|+|.+++...+ .+++.++..++.||++||+|||++||+||||||+|||+   +.++.+||+|||++
T Consensus       163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~~~~kL~DFG~a  239 (373)
T 3c1x_A          163 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLA  239 (373)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC---
T ss_pred             CCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEE---CCCCCEEEeecccc
Confidence            567899999999999999997654 48999999999999999999999999999999999999   56789999999999


Q ss_pred             eeeccCCc-----cccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCC
Q 014733          192 TYIKAGQN-----LHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSD  264 (419)
Q Consensus       192 ~~~~~~~~-----~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~  264 (419)
                      +.......     .....+|+.|+|||++.+ .++.++|||||||++|+|++ |.+||.+....+....+........  
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~--  317 (373)
T 3c1x_A          240 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ--  317 (373)
T ss_dssp             ------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCC--
T ss_pred             ccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCC--
Confidence            86543321     233467888999999876 48999999999999999999 7889987777666666665543222  


Q ss_pred             CCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          265 PWDHISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       265 ~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                       ...++.++.++|.+||+.||++|||+.+++++
T Consensus       318 -p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          318 -PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             -CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence             23689999999999999999999999999875

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=5.3e-43  Score=371.15  Aligned_cols=242  Identities=24%  Similarity=0.330  Sum_probs=205.8

Q ss_pred             eeecccCceEEEEEEe--cCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEEeec
Q 014733           46 KQLGWGQFGVIRECSD--KFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELC  123 (419)
Q Consensus        46 ~~LG~G~~g~V~~a~~--~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~  123 (419)
                      +.||+|+||+||+|.+  +.+++.||||++.... ......+.+.+|+.+|++++ |||||++++++.++ .+++||||+
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~-~~~lv~E~~  451 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLD-NPYIVRMIGICEAE-SWMLVMEMA  451 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG-GCGGGHHHHHHHHHHHHHCC-CTTBCCEEEEEESS-SEEEEEECC
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEecccc-CCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEecC-CEEEEEEcc
Confidence            4799999999999955  4567899999997643 23455688999999999996 99999999999755 478999999


Q ss_pred             CCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCCc----
Q 014733          124 AGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN----  199 (419)
Q Consensus       124 ~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~~----  199 (419)
                      .+|+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++   .++.+||+|||+++.+.....    
T Consensus       452 ~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~---~~~~~kL~DFGla~~~~~~~~~~~~  528 (635)
T 4fl3_A          452 ELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRADENYYKA  528 (635)
T ss_dssp             TTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECCTTHHHHTTC-------
T ss_pred             CCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEe---CCCCEEEEEcCCccccccCcccccc
Confidence            9999999999888899999999999999999999999999999999999995   456899999999987654332    


Q ss_pred             cccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHH
Q 014733          200 LHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLI  277 (419)
Q Consensus       200 ~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li  277 (419)
                      .....+|+.|+|||++.+ .++.++|||||||++|||++ |+.||.+....++...+..+....   ....++.++.+||
T Consensus       529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~---~p~~~~~~l~~li  605 (635)
T 4fl3_A          529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG---CPAGCPREMYDLM  605 (635)
T ss_dssp             ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC---CCTTCCHHHHHHH
T ss_pred             ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---CCCCCCHHHHHHH
Confidence            122356788999999876 59999999999999999998 999999999988888887664321   2247899999999


Q ss_pred             HhhhhcCCCCCCCHHHHHh
Q 014733          278 MGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       278 ~~~L~~dP~~Rps~~eil~  296 (419)
                      .+||+.||++|||+.++++
T Consensus       606 ~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          606 NLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             HHHTCSSTTTSCCHHHHHH
T ss_pred             HHHcCCCHhHCcCHHHHHH
Confidence            9999999999999999986

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=4.4e-43  Score=357.70  Aligned_cols=248  Identities=26%  Similarity=0.349  Sum_probs=207.6

Q ss_pred             cccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCE
Q 014733           36 SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDY  115 (419)
Q Consensus        36 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~  115 (419)
                      ..-.++|++.+.||+|+||.||+|.++. +..||+|++.....    ..+.+.+|+.+|++++ ||||+++++++.+ +.
T Consensus       180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~-~~  252 (452)
T 1fmk_A          180 EIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQLYAVVSE-EP  252 (452)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS----CHHHHHHHHHHHHHCC-CTTBCCEEEEECS-SS
T ss_pred             ccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC----CHHHHHHHHHHHHhCC-CCCEeeEEEEEcC-Cc
Confidence            3445889999999999999999999874 46799999976532    3467899999999996 9999999999876 66


Q ss_pred             EEEEEeecCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceee
Q 014733          116 VHLLMELCAGGELFHRLEKY--GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATY  193 (419)
Q Consensus       116 ~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~  193 (419)
                      +++||||+++|+|.+++...  ..+++.++..++.||+.||+|||+++|+||||||+|||+   +.++.+||+|||++..
T Consensus       253 ~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~  329 (452)
T 1fmk_A          253 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARL  329 (452)
T ss_dssp             CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCTTC-
T ss_pred             eEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEE---CCCCCEEECCCcccee
Confidence            89999999999999999743  569999999999999999999999999999999999999   5567899999999987


Q ss_pred             eccCCc--cccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCC
Q 014733          194 IKAGQN--LHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHI  269 (419)
Q Consensus       194 ~~~~~~--~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  269 (419)
                      ......  .....++..|+|||++.+ .++.++||||||+++|||++ |+.||.+....+....+..+. +.+.  ...+
T Consensus       330 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~-~~~~--~~~~  406 (452)
T 1fmk_A          330 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-RMPC--PPEC  406 (452)
T ss_dssp             -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-CCCC--CTTS
T ss_pred             cCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCC--CCCC
Confidence            644321  233457788999999875 59999999999999999999 999999998888888876552 2222  2478


Q ss_pred             CHHHHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          270 SASARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       270 s~~l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                      ++++.++|.+||+.||++|||+.++++
T Consensus       407 ~~~l~~li~~cl~~dP~~Rpt~~~l~~  433 (452)
T 1fmk_A          407 PESLHDLMCQCWRKEPEERPTFEYLQA  433 (452)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            999999999999999999999999986

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.3e-43  Score=340.10  Aligned_cols=258  Identities=23%  Similarity=0.306  Sum_probs=201.6

Q ss_pred             hhhccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHcc-CCCCceeeeEEE
Q 014733           32 ATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLS-GHPNVVDLKAVY  110 (419)
Q Consensus        32 ~~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-~hpnIv~l~~~~  110 (419)
                      ......+.++|++++.||+|+||.||+|.++  |+.||+|++...      .......|.+++..+. +||||+++++++
T Consensus        29 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~------~~~~~~~e~~~~~~~~~~h~~i~~~~~~~  100 (337)
T 3mdy_A           29 LLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT------EEASWFRETEIYQTVLMRHENILGFIAAD  100 (337)
T ss_dssp             HHHHTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG------GHHHHHHHHHHHTSTTCCCTTBCCEEEEE
T ss_pred             cccccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc------ccchhhhHHHHHHHHhhcCCCeeeEEEEE
Confidence            3445667899999999999999999999875  899999998643      2334455666665541 599999999999


Q ss_pred             EeC----CEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC--------CCeeccCCCCcEEEeecC
Q 014733          111 EEE----DYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGN--------GVVHRDLKPENILLATKS  178 (419)
Q Consensus       111 ~~~----~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~--------~IvHrDLkp~NILl~~~~  178 (419)
                      .+.    ..+++||||+++|+|.+++.. ..+++..++.++.|++.||.|||+.        ||+||||||+|||+   +
T Consensus       101 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill---~  176 (337)
T 3mdy_A          101 IKGTGSWTQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV---K  176 (337)
T ss_dssp             EESCGGGCEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEE---C
T ss_pred             ccCCCCCCceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEE---C
Confidence            887    789999999999999999976 5799999999999999999999999        99999999999999   5


Q ss_pred             CCCCeEEeeccceeeeccCCcc-----ccccCCCccCCcccccCC-CCCc------hhHHHHHHHHHHHHhC--------
Q 014733          179 SSSPIKLADFGLATYIKAGQNL-----HGTVGSPFYIAPEVLAGG-YNQA------ADVWSAGVILYILLSG--------  238 (419)
Q Consensus       179 ~~~~vKL~DFgla~~~~~~~~~-----~~~~gt~~y~aPE~l~~~-~s~~------sDvwSlGvil~elltG--------  238 (419)
                      .++.+||+|||++.........     ...+||+.|+|||++.+. ++..      +|||||||++|||++|        
T Consensus       177 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~  256 (337)
T 3mdy_A          177 KNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVE  256 (337)
T ss_dssp             TTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred             CCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccc
Confidence            6779999999999876443322     245799999999998774 4443      9999999999999999        


Q ss_pred             --CCCCCCCC-----HHHHHHHHHhcCCCCCCCC---CCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccc
Q 014733          239 --MPPFWGKT-----KSKIFDAVRAADLRFPSDP---WDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEEC  303 (419)
Q Consensus       239 --~~Pf~~~~-----~~~~~~~i~~~~~~~~~~~---~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~  303 (419)
                        ..||....     .......+...........   ...+++++.++|.+||+.||.+|||+.++++|  ++.+
T Consensus       257 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~--L~~l  329 (337)
T 3mdy_A          257 EYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT--LAKM  329 (337)
T ss_dssp             CCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH--HHHH
T ss_pred             cccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH--HHHH
Confidence              77775432     1222222222222111110   12456789999999999999999999999986  4443

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.6e-43  Score=342.81  Aligned_cols=259  Identities=19%  Similarity=0.298  Sum_probs=213.0

Q ss_pred             hhccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEe
Q 014733           33 TQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEE  112 (419)
Q Consensus        33 ~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~  112 (419)
                      .......++|++.+.||+|+||.||+|.+..   .+|+|++..... .....+.+.+|+.++++++ ||||+++++++.+
T Consensus        26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~  100 (319)
T 2y4i_B           26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERD-NEDQLKAFKREVMAYRQTR-HENVVLFMGACMS  100 (319)
T ss_dssp             GGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSC-CCCCCCCCCTTGGGGTTCC-CTTBCCCCEEEEC
T ss_pred             ccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCC-CHHHHHHHHHHHHHHhcCC-CCCEeEEEEEEec
Confidence            3444456899999999999999999998763   499999876532 2234456778999999996 9999999999999


Q ss_pred             CCEEEEEEeecCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccce
Q 014733          113 EDYVHLLMELCAGGELFHRLEKYG-RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA  191 (419)
Q Consensus       113 ~~~~~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla  191 (419)
                      .+.+++||||++|++|.+++...+ .+++..++.++.||+.||+|||+.||+||||||+|||++    ++.+||+|||++
T Consensus       101 ~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~----~~~~~l~Dfg~~  176 (319)
T 2y4i_B          101 PPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD----NGKVVITDFGLF  176 (319)
T ss_dssp             SSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC------CCEECCCSCC
T ss_pred             CCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe----CCCEEEeecCCc
Confidence            999999999999999999997754 599999999999999999999999999999999999994    468999999998


Q ss_pred             eeeccC------CccccccCCCccCCcccccC----------CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 014733          192 TYIKAG------QNLHGTVGSPFYIAPEVLAG----------GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVR  255 (419)
Q Consensus       192 ~~~~~~------~~~~~~~gt~~y~aPE~l~~----------~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~  255 (419)
                      ......      .......||+.|+|||++.+          .++.++||||||+++|+|++|+.||...........+.
T Consensus       177 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~  256 (319)
T 2y4i_B          177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMG  256 (319)
T ss_dssp             C----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHH
T ss_pred             cccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhc
Confidence            754321      12233468999999999863          37889999999999999999999999988888887776


Q ss_pred             hcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccch
Q 014733          256 AADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECE  304 (419)
Q Consensus       256 ~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~  304 (419)
                      .......  ....++.++.++|.+||..||++|||+.++++.  ++.+.
T Consensus       257 ~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~--l~~l~  301 (319)
T 2y4i_B          257 TGMKPNL--SQIGMGKEISDILLFCWAFEQEERPTFTKLMDM--LEKLP  301 (319)
T ss_dssp             TTCCCCC--CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH--HTTC-
T ss_pred             cCCCCCC--CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH--HHHHH
Confidence            6543322  223688999999999999999999999999874  44443

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=8.1e-43  Score=339.97  Aligned_cols=254  Identities=26%  Similarity=0.395  Sum_probs=207.0

Q ss_pred             hccccccCeeeeeeecccCceEEEEEE----ecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEE
Q 014733           34 QISNLSDRYVLGKQLGWGQFGVIRECS----DKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAV  109 (419)
Q Consensus        34 ~~~~~~~~y~i~~~LG~G~~g~V~~a~----~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~  109 (419)
                      ......++|++++.||+|+||.||+|.    +..+|+.||+|++...   .....+.+.+|+.++++++ ||||++++++
T Consensus        35 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~  110 (326)
T 2w1i_A           35 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ-HDNIVKYKGV  110 (326)
T ss_dssp             --CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCC-CTTBCCEEEE
T ss_pred             ccccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCC-CCCeeeEEEE
Confidence            344456789999999999999999998    4678999999998754   3456778999999999996 9999999999


Q ss_pred             EEeCC--EEEEEEeecCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEe
Q 014733          110 YEEED--YVHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLA  186 (419)
Q Consensus       110 ~~~~~--~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~  186 (419)
                      +...+  .+++||||+++++|.+++... ..+++.+++.++.||+.||+|||+.||+||||||+|||++   .++.+||+
T Consensus       111 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~---~~~~~kL~  187 (326)
T 2w1i_A          111 CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE---NENRVKIG  187 (326)
T ss_dssp             ECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE---ETTEEEEC
T ss_pred             EEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEc---CCCcEEEe
Confidence            86543  789999999999999999876 4599999999999999999999999999999999999995   45689999


Q ss_pred             eccceeeeccCCc----cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHH-------------
Q 014733          187 DFGLATYIKAGQN----LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKS-------------  248 (419)
Q Consensus       187 DFgla~~~~~~~~----~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~-------------  248 (419)
                      |||++........    .....++..|+|||++.+. ++.++||||||+++|+|++|..||......             
T Consensus       188 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~  267 (326)
T 2w1i_A          188 DFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM  267 (326)
T ss_dssp             CCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHH
T ss_pred             cCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhh
Confidence            9999987654432    1233577789999998764 899999999999999999999998542110             


Q ss_pred             ---HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          249 ---KIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       249 ---~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                         .+.+.+... ...+  ....++.++.++|.+||+.||++|||+.++++.
T Consensus       268 ~~~~~~~~~~~~-~~~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~  316 (326)
T 2w1i_A          268 IVFHLIELLKNN-GRLP--RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR  316 (326)
T ss_dssp             HHHHHHHHHHTT-CCCC--CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             hHHHHHHHhhcC-CCCC--CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence               112222222 2222  234789999999999999999999999999863

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.9e-42  Score=338.54  Aligned_cols=257  Identities=22%  Similarity=0.308  Sum_probs=208.8

Q ss_pred             hhhccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHH--ccCCCCceeeeEE
Q 014733           32 ATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTK--LSGHPNVVDLKAV  109 (419)
Q Consensus        32 ~~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~--l~~hpnIv~l~~~  109 (419)
                      ......+.++|++.+.||+|+||.||+|.+  +|+.||+|++...      ....+.+|.++++.  + +||||++++++
T Consensus        34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l-~h~ni~~~~~~  104 (342)
T 1b6c_B           34 LLVQRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR------EERSWFREAEIYQTVML-RHENILGFIAA  104 (342)
T ss_dssp             HHHHHHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHHHSCC-CCTTBCCEEEE
T ss_pred             eeecccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch------hHHHHHHHHHHHHHhhc-CCCcEEEEEee
Confidence            333456778999999999999999999987  4899999998643      34667889999988  5 59999999999


Q ss_pred             EEeCC----EEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------hCCCeeccCCCCcEEEeec
Q 014733          110 YEEED----YVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCH--------GNGVVHRDLKPENILLATK  177 (419)
Q Consensus       110 ~~~~~----~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH--------~~~IvHrDLkp~NILl~~~  177 (419)
                      +.+..    .+++||||+++|+|.+++.. ..+++.+++.++.|++.||.|||        +.+|+||||||+|||+   
T Consensus       105 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll---  180 (342)
T 1b6c_B          105 DNKDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---  180 (342)
T ss_dssp             EECCCSSCCCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEE---
T ss_pred             ecccCCccceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEE---
Confidence            98876    89999999999999999976 57999999999999999999999        8999999999999999   


Q ss_pred             CCCCCeEEeeccceeeeccCCc-----cccccCCCccCCcccccCC-------CCCchhHHHHHHHHHHHHhC-------
Q 014733          178 SSSSPIKLADFGLATYIKAGQN-----LHGTVGSPFYIAPEVLAGG-------YNQAADVWSAGVILYILLSG-------  238 (419)
Q Consensus       178 ~~~~~vKL~DFgla~~~~~~~~-----~~~~~gt~~y~aPE~l~~~-------~s~~sDvwSlGvil~elltG-------  238 (419)
                      +.++.+||+|||++........     .....||+.|+|||++.+.       ++.++||||||+++|+|++|       
T Consensus       181 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~  260 (342)
T 1b6c_B          181 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH  260 (342)
T ss_dssp             CTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred             CCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcc
Confidence            5677999999999987755432     2345799999999998764       22689999999999999999       


Q ss_pred             ---CCCCCCCC-----HHHHHHHHHhcCCCCCCCC---CCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccc
Q 014733          239 ---MPPFWGKT-----KSKIFDAVRAADLRFPSDP---WDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEEC  303 (419)
Q Consensus       239 ---~~Pf~~~~-----~~~~~~~i~~~~~~~~~~~---~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~  303 (419)
                         ..||....     .......+...........   ....+..+.+||.+||+.||++|||+.++++|  ++.+
T Consensus       261 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~--L~~i  334 (342)
T 1b6c_B          261 EDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT--LSQL  334 (342)
T ss_dssp             CCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH--HHHH
T ss_pred             cccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH--HHHH
Confidence               78986542     3344444433322221110   11344689999999999999999999999986  5444

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=4.2e-44  Score=361.11  Aligned_cols=253  Identities=18%  Similarity=0.171  Sum_probs=198.5

Q ss_pred             cccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCC-CCcee-----------
Q 014733           38 LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH-PNVVD-----------  105 (419)
Q Consensus        38 ~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~h-pnIv~-----------  105 (419)
                      -...|++++.||+|+||+||+|.+..+|+.||||++...........+.+.+|+.+++.+. | +|...           
T Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~-~~~~~~~~~~~~~~~~~~  154 (413)
T 3dzo_A           76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR-GIKNQKQAKVHLRFIFPF  154 (413)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGST-TCCSHHHHHHHTCBCCCC
T ss_pred             CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhc-cCCCHHHHHHhcccccch
Confidence            3456889999999999999999999999999999998655445556788999999999986 5 32211           


Q ss_pred             ----------eeEEEEe-----CCEEEEEEeecCCCChHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 014733          106 ----------LKAVYEE-----EDYVHLLMELCAGGELFHRLEK-------YGRFSETEARVIFRHLMQVVSYCHGNGVV  163 (419)
Q Consensus       106 ----------l~~~~~~-----~~~~~lV~E~~~ggsL~~~l~~-------~~~l~~~~~~~i~~qll~aL~~LH~~~Iv  163 (419)
                                +..++..     ...++++|+++ +++|.++++.       .+.+++..+..++.||++||+|||++||+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ii  233 (413)
T 3dzo_A          155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLV  233 (413)
T ss_dssp             EEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             hhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence                      1111111     22467778876 7899988852       12377889999999999999999999999


Q ss_pred             eccCCCCcEEEeecCCCCCeEEeeccceeeeccCCccccccCCCccCCcccc----------cC-CCCCchhHHHHHHHH
Q 014733          164 HRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVL----------AG-GYNQAADVWSAGVIL  232 (419)
Q Consensus       164 HrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~~~~~~~gt~~y~aPE~l----------~~-~~s~~sDvwSlGvil  232 (419)
                      ||||||+|||+   +.++.+||+|||+++.....  ....+| +.|+|||++          .+ .++.++|||||||++
T Consensus       234 HrDiKp~NILl---~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil  307 (413)
T 3dzo_A          234 HTYLRPVDIVL---DQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI  307 (413)
T ss_dssp             CSCCCGGGEEE---CTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred             cCCcccceEEE---ecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence            99999999999   56778999999999865433  445678 999999998          33 278899999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchhh
Q 014733          233 YILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQV  306 (419)
Q Consensus       233 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~~  306 (419)
                      |+|++|+.||.+....+..+.+.        ..+..+++++.+||.+||+.||++|||+.++++||||+++...
T Consensus       308 ~elltg~~Pf~~~~~~~~~~~~~--------~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~~~~  373 (413)
T 3dzo_A          308 YWIWCADLPNTDDAALGGSEWIF--------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTE  373 (413)
T ss_dssp             HHHHHSSCCCCTTGGGSCSGGGG--------SSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHH
T ss_pred             HHHHHCCCCCCCcchhhhHHHHH--------hhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHHHHH
Confidence            99999999998765543332221        1224788999999999999999999999999999999987654

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=9.9e-43  Score=367.85  Aligned_cols=248  Identities=22%  Similarity=0.334  Sum_probs=206.4

Q ss_pred             ccCeeeee-eecccCceEEEEEEec--CCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCE
Q 014733           39 SDRYVLGK-QLGWGQFGVIRECSDK--FTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDY  115 (419)
Q Consensus        39 ~~~y~i~~-~LG~G~~g~V~~a~~~--~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~  115 (419)
                      .+++.+.+ .||+|+||.||+|.++  .++..||+|++....  .....+.+.+|+++|++++ |||||++++++.+ +.
T Consensus       334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~-~~  409 (613)
T 2ozo_A          334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLD-NPYIVRLIGVCQA-EA  409 (613)
T ss_dssp             TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCC-CTTBCCEEEEEES-SS
T ss_pred             ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCC-CCCEeeEEEEecc-CC
Confidence            45566666 8999999999999875  356679999997652  3345688999999999995 9999999999987 45


Q ss_pred             EEEEEeecCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeee
Q 014733          116 VHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI  194 (419)
Q Consensus       116 ~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~  194 (419)
                      +++||||+.+|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++   .++.+||+|||+++..
T Consensus       410 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~---~~~~vkL~DFGla~~~  486 (613)
T 2ozo_A          410 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLV---NRHYAKISDFGLSKAL  486 (613)
T ss_dssp             EEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECCCSTTTTC
T ss_pred             eEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEc---CCCcEEEeeccCcccc
Confidence            89999999999999999654 4599999999999999999999999999999999999995   4568999999999876


Q ss_pred             ccCCcc----ccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCC
Q 014733          195 KAGQNL----HGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDH  268 (419)
Q Consensus       195 ~~~~~~----~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  268 (419)
                      ......    ....+|+.|+|||++.+ .++.++|||||||++|||++ |+.||.+....++...+..+...   .....
T Consensus       487 ~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~---~~p~~  563 (613)
T 2ozo_A          487 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM---ECPPE  563 (613)
T ss_dssp             C--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCC---CCCTT
T ss_pred             cCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC---CCCCc
Confidence            433221    12345688999999875 59999999999999999998 99999998888888888765422   12247


Q ss_pred             CCHHHHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          269 ISASARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       269 ~s~~l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                      +++++.++|.+||+.||++||++.++++
T Consensus       564 ~~~~l~~li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          564 CPPELYALMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             CCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            8999999999999999999999999965

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.2e-42  Score=361.80  Aligned_cols=248  Identities=26%  Similarity=0.350  Sum_probs=212.3

Q ss_pred             cccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCE
Q 014733           36 SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDY  115 (419)
Q Consensus        36 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~  115 (419)
                      +...++|++.+.||+|+||.||+|.++. +..||+|++.....    ..+.+.+|+.+|++++ ||||+++++++.+ +.
T Consensus       263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-hpniv~~~~~~~~-~~  335 (535)
T 2h8h_A          263 EIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQLYAVVSE-EP  335 (535)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS----CHHHHHHHHHHHHHCC-CTTBCCEEEEECS-SS
T ss_pred             ecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC----CHHHHHHHHHHHHhCC-CCCEeeEEEEEee-cc
Confidence            3446889999999999999999999874 46799999976542    3467899999999996 9999999999876 66


Q ss_pred             EEEEEeecCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceee
Q 014733          116 VHLLMELCAGGELFHRLEKY--GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATY  193 (419)
Q Consensus       116 ~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~  193 (419)
                      +|+||||+.+|+|.+++...  ..+++.++..++.||+.||+|||+++|+||||||+|||+   +.++.+||+|||++..
T Consensus       336 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~  412 (535)
T 2h8h_A          336 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARL  412 (535)
T ss_dssp             CEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCTTSTTT
T ss_pred             ceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEE---cCCCcEEEccccccee
Confidence            89999999999999999743  569999999999999999999999999999999999999   5567899999999986


Q ss_pred             eccCC--ccccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCC
Q 014733          194 IKAGQ--NLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHI  269 (419)
Q Consensus       194 ~~~~~--~~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  269 (419)
                      .....  ......++..|+|||++.+ .++.++|||||||+||||++ |+.||.+....++...+..+. +.+.  ...+
T Consensus       413 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~-~~~~--~~~~  489 (535)
T 2h8h_A          413 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-RMPC--PPEC  489 (535)
T ss_dssp             CCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTC-CCCC--CTTC
T ss_pred             cCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCC--CCCC
Confidence            54321  1233456788999998875 59999999999999999999 999999998888888876542 2222  2478


Q ss_pred             CHHHHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          270 SASARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       270 s~~l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                      +.++.+||.+||+.||++|||+.+|++
T Consensus       490 ~~~l~~li~~cl~~dP~~RPt~~~l~~  516 (535)
T 2h8h_A          490 PESLHDLMCQCWRKEPEERPTFEYLQA  516 (535)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            999999999999999999999999986

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=6.7e-44  Score=349.09  Aligned_cols=251  Identities=19%  Similarity=0.231  Sum_probs=200.0

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccC-----CHHhHHHHHHHHHHHHHcc--------CCCCcee
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLV-----TVEDVRSIKLEIEIMTKLS--------GHPNVVD  105 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~-----~~~~~~~~~~Ei~il~~l~--------~hpnIv~  105 (419)
                      .++|++++.||+|+||+||+|++  +|+.||+|++.+....     .....+.+.+|+.+|+.++        +||||++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            57899999999999999999998  6899999999876431     2334578899999999986        4888888


Q ss_pred             eeEEEE------------------------------eCCEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHH
Q 014733          106 LKAVYE------------------------------EEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS  155 (419)
Q Consensus       106 l~~~~~------------------------------~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~  155 (419)
                      +.+++.                              +.+.+|+||||+++|++.+.+.+ +.+++.+++.++.||+.||+
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~  175 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLA  175 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHH
Confidence            877653                              26789999999999987776644 67899999999999999999


Q ss_pred             HHH-hCCCeeccCCCCcEEEeecCC-----------------CCCeEEeeccceeeeccCCccccccCCCccCCcccccC
Q 014733          156 YCH-GNGVVHRDLKPENILLATKSS-----------------SSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG  217 (419)
Q Consensus       156 ~LH-~~~IvHrDLkp~NILl~~~~~-----------------~~~vKL~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~  217 (419)
                      ||| ++||+||||||+|||++.++.                 ...+||+|||+++.....    ..+||+.|+|||++.+
T Consensus       176 ~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~g  251 (336)
T 2vuw_A          176 VAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFTG  251 (336)
T ss_dssp             HHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGCC
T ss_pred             HHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhcC
Confidence            999 999999999999999976431                 128999999999976543    3589999999999988


Q ss_pred             CCCCchhHHHHHHH-HHHHHhCCCCCCCCCH-HHHHHHHHhc-CCC--CCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHH
Q 014733          218 GYNQAADVWSAGVI-LYILLSGMPPFWGKTK-SKIFDAVRAA-DLR--FPSDPWDHISASARDLIMGMLRVDPSTRLTAA  292 (419)
Q Consensus       218 ~~s~~sDvwSlGvi-l~elltG~~Pf~~~~~-~~~~~~i~~~-~~~--~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~  292 (419)
                      ..+.++||||+|++ .++++.|..||.+... ....+.+... ...  .+...+..+++++++||++||++|     |+.
T Consensus       252 ~~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~  326 (336)
T 2vuw_A          252 DGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SAT  326 (336)
T ss_dssp             CSSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHH
T ss_pred             CCccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHH
Confidence            77899999998766 7789999999843211 1222333221 111  111123457899999999999987     999


Q ss_pred             HHH-hccccc
Q 014733          293 EVL-AHSWME  301 (419)
Q Consensus       293 eil-~hp~~~  301 (419)
                      |+| +||||+
T Consensus       327 e~l~~Hp~f~  336 (336)
T 2vuw_A          327 DLLCQHSLFK  336 (336)
T ss_dssp             HHHHHCGGGC
T ss_pred             HHHhcCCCcC
Confidence            999 999995

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=6.2e-42  Score=364.21  Aligned_cols=254  Identities=25%  Similarity=0.366  Sum_probs=213.2

Q ss_pred             hccccccCeeeeeeecccCceEEEEEEecCC---CcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEE
Q 014733           34 QISNLSDRYVLGKQLGWGQFGVIRECSDKFT---GEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVY  110 (419)
Q Consensus        34 ~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~---g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~  110 (419)
                      ......++|++++.||+|+||.||+|.+..+   +..||+|.+...  ......+.+.+|+.+++++. ||||+++++++
T Consensus       384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~  460 (656)
T 2j0j_A          384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC--TSDSVREKFLQEALTMRQFD-HPHIVKLIGVI  460 (656)
T ss_dssp             GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST--TCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred             ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc--CCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEE
Confidence            3445568999999999999999999998643   467999987653  34556678999999999996 99999999998


Q ss_pred             EeCCEEEEEEeecCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeecc
Q 014733          111 EEEDYVHLLMELCAGGELFHRLEKYG-RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFG  189 (419)
Q Consensus       111 ~~~~~~~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFg  189 (419)
                      .+ +..++||||+++|+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++   .++.+||+|||
T Consensus       461 ~~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~---~~~~vkL~DFG  536 (656)
T 2j0j_A          461 TE-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFG  536 (656)
T ss_dssp             CS-SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECCCC
T ss_pred             ec-CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEe---CCCCEEEEecC
Confidence            54 56899999999999999998654 599999999999999999999999999999999999995   45789999999


Q ss_pred             ceeeeccCCcc--ccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCC
Q 014733          190 LATYIKAGQNL--HGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDP  265 (419)
Q Consensus       190 la~~~~~~~~~--~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~  265 (419)
                      ++.........  ....+|+.|+|||++.+ .++.++|||||||++|||++ |..||.+....+....+.......   .
T Consensus       537 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~---~  613 (656)
T 2j0j_A          537 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP---M  613 (656)
T ss_dssp             CCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCC---C
T ss_pred             CCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC---C
Confidence            99876443322  23356789999999876 48999999999999999997 999999998888888887654321   2


Q ss_pred             CCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          266 WDHISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       266 ~~~~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      ...+++++.++|.+||..||.+|||+.++++.
T Consensus       614 ~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~  645 (656)
T 2j0j_A          614 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  645 (656)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CccccHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            24789999999999999999999999999874

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=3.7e-42  Score=335.90  Aligned_cols=246  Identities=22%  Similarity=0.301  Sum_probs=188.6

Q ss_pred             cccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHH--HHHccCCCCceeeeEEEEe---
Q 014733           38 LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEI--MTKLSGHPNVVDLKAVYEE---  112 (419)
Q Consensus        38 ~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~i--l~~l~~hpnIv~l~~~~~~---  112 (419)
                      -.++|++++.||+|+||.||+|.+  +++.||+|++...      ....+..|.++  +..+ +||||+++++.+..   
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~~-~h~~i~~~~~~~~~~~~   81 (336)
T 3g2f_A           11 DLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFA------NRQNFINEKNIYRVPLM-EHDNIARFIVGDERVTA   81 (336)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGG------GHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECT
T ss_pred             ChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeecc------chhhHHHHHHHHHHHhc-cCcchhhheeccccccc
Confidence            458999999999999999999976  6899999998643      22334444444  4446 49999999986643   


Q ss_pred             --CCEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---------CCeeccCCCCcEEEeecCCCC
Q 014733          113 --EDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGN---------GVVHRDLKPENILLATKSSSS  181 (419)
Q Consensus       113 --~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~---------~IvHrDLkp~NILl~~~~~~~  181 (419)
                        ...+++||||+++|+|.+++.. ...++..++.++.||+.||+|||+.         ||+||||||+|||+   +.++
T Consensus        82 ~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill---~~~~  157 (336)
T 3g2f_A           82 DGRMEYLLVMEYYPNGSLXKYLSL-HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV---KNDG  157 (336)
T ss_dssp             TSCEEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEE---CTTS
T ss_pred             CCCceEEEEEecCCCCcHHHHHhh-cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEE---cCCC
Confidence              3367999999999999999976 4569999999999999999999999         99999999999999   5678


Q ss_pred             CeEEeeccceeeeccCC---------ccccccCCCccCCcccccC--------CCCCchhHHHHHHHHHHHHhCCCCCCC
Q 014733          182 PIKLADFGLATYIKAGQ---------NLHGTVGSPFYIAPEVLAG--------GYNQAADVWSAGVILYILLSGMPPFWG  244 (419)
Q Consensus       182 ~vKL~DFgla~~~~~~~---------~~~~~~gt~~y~aPE~l~~--------~~s~~sDvwSlGvil~elltG~~Pf~~  244 (419)
                      .+||+|||++..+....         .....+||+.|+|||++.+        .++.++|||||||++|||++|..||..
T Consensus       158 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~  237 (336)
T 3g2f_A          158 TCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP  237 (336)
T ss_dssp             CEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGST
T ss_pred             cEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCC
Confidence            99999999998764321         1224579999999999876        256789999999999999999776632


Q ss_pred             CC------------------HHHHHHHHHhcCCC--CCCC--CCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          245 KT------------------KSKIFDAVRAADLR--FPSD--PWDHISASARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       245 ~~------------------~~~~~~~i~~~~~~--~~~~--~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                      ..                  ..+....+.....+  ++..  ....+++++.+||.+||+.||++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~  311 (336)
T 3g2f_A          238 GESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE  311 (336)
T ss_dssp             TSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence            21                  11111111111111  1111  11124568999999999999999999999965

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=5e-42  Score=329.25  Aligned_cols=229  Identities=17%  Similarity=0.106  Sum_probs=191.8

Q ss_pred             ccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEE
Q 014733           37 NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYV  116 (419)
Q Consensus        37 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~  116 (419)
                      .+.++|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.++.++. ||||+++++++.+.+..
T Consensus        28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~  106 (286)
T 3uqc_A           28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRID-KPGVARVLDVVHTRAGG  106 (286)
T ss_dssp             ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEETTEE
T ss_pred             EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCC-CCCcceeeEEEEECCcE
Confidence            46789999999999999999999999999999999998776656677788999999999995 99999999999999999


Q ss_pred             EEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeecc
Q 014733          117 HLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA  196 (419)
Q Consensus       117 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~  196 (419)
                      |+||||++|++|.++++. + ....++..++.||+.||+|||++||+||||||+|||+   +.++.+||++++       
T Consensus       107 ~lv~e~~~g~~L~~~l~~-~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll---~~~g~~kl~~~~-------  174 (286)
T 3uqc_A          107 LVVAEWIRGGSLQEVADT-S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRV---SIDGDVVLAYPA-------  174 (286)
T ss_dssp             EEEEECCCEEEHHHHHTT-C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---ETTSCEEECSCC-------
T ss_pred             EEEEEecCCCCHHHHHhc-C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEE---cCCCCEEEEecc-------
Confidence            999999999999999954 3 4666889999999999999999999999999999999   456789987443       


Q ss_pred             CCccccccCCCccCCcccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHhcCCCCCCCCCCCCCHHH
Q 014733          197 GQNLHGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFD---AVRAADLRFPSDPWDHISASA  273 (419)
Q Consensus       197 ~~~~~~~~gt~~y~aPE~l~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~---~i~~~~~~~~~~~~~~~s~~l  273 (419)
                                  |++|      ++.++|||||||++|+|++|+.||.+.+..+...   .........+......+++++
T Consensus       175 ------------~~~~------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (286)
T 3uqc_A          175 ------------TMPD------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQI  236 (286)
T ss_dssp             ------------CCTT------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHH
T ss_pred             ------------ccCC------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHH
Confidence                        3433      6889999999999999999999998765432110   000111111112235789999


Q ss_pred             HHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          274 RDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       274 ~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      .++|.+||+.||++| |+.++++.
T Consensus       237 ~~li~~~l~~dP~~R-s~~el~~~  259 (286)
T 3uqc_A          237 SAVAARSVQGDGGIR-SASTLLNL  259 (286)
T ss_dssp             HHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred             HHHHHHHcccCCccC-CHHHHHHH
Confidence            999999999999999 99999873

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4.2e-42  Score=367.51  Aligned_cols=249  Identities=25%  Similarity=0.353  Sum_probs=207.4

Q ss_pred             ccccccCeeeeeeecccCceEEEEEEecC-CCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeC
Q 014733           35 ISNLSDRYVLGKQLGWGQFGVIRECSDKF-TGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEE  113 (419)
Q Consensus        35 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~-~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~  113 (419)
                      .+.+.++|++.+.||+|+||+||+|.+.. +|+.||+|++...  ........+.+|+.++++++ ||||+++++++.+.
T Consensus        75 g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~  151 (681)
T 2pzi_A           75 GDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS--GDAEAQAMAMAERQFLAEVV-HPSIVQIFNFVEHT  151 (681)
T ss_dssp             TCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS--CCHHHHHHHHHHHGGGGGCC-CTTBCCEEEEEEEE
T ss_pred             CCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc--CCHHHHHHHHHHHHHHHhcC-CCCcCeEeeeEeec
Confidence            34567999999999999999999999976 7899999998654  34456678899999999996 99999999999876


Q ss_pred             CE-----EEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeec
Q 014733          114 DY-----VHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADF  188 (419)
Q Consensus       114 ~~-----~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DF  188 (419)
                      +.     .|+||||++|++|.+++..  ++++.+++.++.||+.||.|||++||+||||||+|||++   . +.+||+||
T Consensus       152 ~~~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~---~-~~~kl~DF  225 (681)
T 2pzi_A          152 DRHGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLT---E-EQLKLIDL  225 (681)
T ss_dssp             CTTSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---S-SCEEECCC
T ss_pred             CCCCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEe---C-CcEEEEec
Confidence            65     7999999999999988754  799999999999999999999999999999999999994   2 38999999


Q ss_pred             cceeeeccCCccccccCCCccCCcccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCC
Q 014733          189 GLATYIKAGQNLHGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDH  268 (419)
Q Consensus       189 gla~~~~~~~~~~~~~gt~~y~aPE~l~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  268 (419)
                      |+++.....   ...+||+.|+|||++.+.++.++|||||||++|+|++|.+||.+....         ... .......
T Consensus       226 G~a~~~~~~---~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~---------~~~-~~~~~~~  292 (681)
T 2pzi_A          226 GAVSRINSF---GYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVD---------GLP-EDDPVLK  292 (681)
T ss_dssp             TTCEETTCC---SCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEETTEECS---------SCC-TTCHHHH
T ss_pred             ccchhcccC---CccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCCCcccccc---------ccc-ccccccc
Confidence            999876443   446799999999999888899999999999999999999998653211         000 1111113


Q ss_pred             CCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          269 ISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       269 ~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                      .++.+.++|.+||++||++||+..+++.|+|+.....
T Consensus       293 ~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~  329 (681)
T 2pzi_A          293 TYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLRE  329 (681)
T ss_dssp             HCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHH
T ss_pred             cCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHH
Confidence            4678999999999999999999999999999876543

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=1.6e-36  Score=317.46  Aligned_cols=237  Identities=19%  Similarity=0.141  Sum_probs=167.1

Q ss_pred             eeeecccCceEEEEEEecCCCcEEEEEEeccCccC-------CHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEE
Q 014733           45 GKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLV-------TVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVH  117 (419)
Q Consensus        45 ~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~-------~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~  117 (419)
                      ....+.|+.|.+..++...+|+.+++|++.+....       .....+.+.+|+++|+++..|+||+++++++++++.+|
T Consensus       239 ~~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~y  318 (569)
T 4azs_A          239 QNQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGW  318 (569)
T ss_dssp             ECC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEE
T ss_pred             hhccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEE
Confidence            34567788888888888889999999999765332       12345779999999999977999999999999999999


Q ss_pred             EEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccC
Q 014733          118 LLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG  197 (419)
Q Consensus       118 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~  197 (419)
                      |||||++|++|.++|...+++++.   .|+.||++||+|||++|||||||||+|||+   +.+|.+||+|||+|+.....
T Consensus       319 LVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL---~~dg~vKL~DFGlAr~~~~~  392 (569)
T 4azs_A          319 LVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMV---DARQHARLIDFGSIVTTPQD  392 (569)
T ss_dssp             EEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEE---CTTSCEEECCCTTEESCC--
T ss_pred             EEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEE---CCCCCEEEeecccCeeCCCC
Confidence            999999999999999998888775   478999999999999999999999999999   56789999999999876543


Q ss_pred             C-ccccccCCCccCCcccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHH
Q 014733          198 Q-NLHGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDL  276 (419)
Q Consensus       198 ~-~~~~~~gt~~y~aPE~l~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~l  276 (419)
                      . ...+.+||+.|+|||++.+.+..++|+||+|+++++|.++..++        ...+...    +...     ..+.++
T Consensus       393 ~~~~~t~vGTp~YmAPE~l~g~~~~~~d~~s~g~~~~~l~~~~~~~--------~~~l~~~----~~~~-----~~~~~l  455 (569)
T 4azs_A          393 CSWPTNLVQSFFVFVNELFAENKSWNGFWRSAPVHPFNLPQPWSNW--------LYAVWQE----PVER-----WNFVLL  455 (569)
T ss_dssp             -CCSHHHHHHHHHHHHHHC-----------------CCCCTTHHHH--------HHHHHTS----CGGG-----CSHHHH
T ss_pred             CccccCceechhhccHHHhCCCCCCcccccccccchhhhccccchh--------HHHhhcC----CCCC-----CcHHHH
Confidence            2 34456899999999999998888999999999998887665443        1111111    1111     125667


Q ss_pred             HHhhhhcCCCCCCCHHHHHhccccccch
Q 014733          277 IMGMLRVDPSTRLTAAEVLAHSWMEECE  304 (419)
Q Consensus       277 i~~~L~~dP~~Rps~~eil~hp~~~~~~  304 (419)
                      ...++..+|..|+.......|+|.....
T Consensus       456 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~  483 (569)
T 4azs_A          456 LALFEKKAKLPSAEQQRGATEQWIIAQE  483 (569)
T ss_dssp             HHHHHTGGGSCCGGGSSCCHHHHHHHHH
T ss_pred             HHHHhCCCCCCCCChhhhccchhHHHHH
Confidence            7778888888888887777787775543

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=8.8e-29  Score=257.29  Aligned_cols=185  Identities=16%  Similarity=0.179  Sum_probs=146.5

Q ss_pred             eeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHH-----hHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEE
Q 014733           43 VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVE-----DVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVH  117 (419)
Q Consensus        43 ~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~-----~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~  117 (419)
                      ...+.||+|+||+||+|.  ..+..+++|....+......     ..+.+.+|+++|++++ ||||+++..++.+.+..|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~~~~~  415 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVK-DFGIPAPYIFDVDLDNKR  415 (540)
T ss_dssp             ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGG-GGTCCCCCEEEEETTTTE
T ss_pred             CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcC-CCCcCceEEEEEeCCccE
Confidence            446789999999999994  45788999987655433222     2456899999999996 999997666666777789


Q ss_pred             EEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccC
Q 014733          118 LLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG  197 (419)
Q Consensus       118 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~  197 (419)
                      +||||++|++|.+++..        +..++.|+++||+|||++||+||||||+|||++   .  .+||+|||+++.....
T Consensus       416 lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~---~--~~kL~DFGla~~~~~~  482 (540)
T 3en9_A          416 IMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFD---K--DLYIIDFGLGKISNLD  482 (540)
T ss_dssp             EEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEES---S--SEEECCCTTCEECCCH
T ss_pred             EEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEEC---C--eEEEEECccCEECCCc
Confidence            99999999999999865        668999999999999999999999999999994   3  8999999999987553


Q ss_pred             Cc--------cccccCCCccCCcccccC---CCCCchhHHHHHHHHHHHHhCCCCCC
Q 014733          198 QN--------LHGTVGSPFYIAPEVLAG---GYNQAADVWSAGVILYILLSGMPPFW  243 (419)
Q Consensus       198 ~~--------~~~~~gt~~y~aPE~l~~---~~s~~sDvwSlGvil~elltG~~Pf~  243 (419)
                      ..        ....+||+.|+|||++.+   .|+..+|+|+..+-..+.+.++.+|.
T Consensus       483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            22        135589999999999875   48888999999998888888877763

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.92  E-value=2.7e-25  Score=212.46  Aligned_cols=149  Identities=21%  Similarity=0.232  Sum_probs=118.3

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCH---------------HhHHHHHHHHHHHHHccCCCCc
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTV---------------EDVRSIKLEIEIMTKLSGHPNV  103 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~---------------~~~~~~~~Ei~il~~l~~hpnI  103 (419)
                      ...|.+++.||+|+||.||+|.+ .+|+.||+|++........               .....+.+|+.+|+++. |   
T Consensus        89 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-~---  163 (282)
T 1zar_A           89 GKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-G---  163 (282)
T ss_dssp             TSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-T---
T ss_pred             CeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-C---
Confidence            45566679999999999999999 7899999999965322111               24567899999999996 4   


Q ss_pred             eeeeEEEEeCCEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCe
Q 014733          104 VDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPI  183 (419)
Q Consensus       104 v~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~v  183 (419)
                      +++.+++.. +..|+||||++|++|.+ +.      ..+...++.|++.||.|||+.||+||||||+|||++    ++.+
T Consensus       164 ~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~----~~~v  231 (282)
T 1zar_A          164 LAVPKVYAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS----EEGI  231 (282)
T ss_dssp             SSSCCEEEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE----TTEE
T ss_pred             CCcCeEEec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE----CCcE
Confidence            555555544 44699999999999988 42      134557999999999999999999999999999994    6789


Q ss_pred             EEeeccceeeeccCCccccccCCCccCCccccc
Q 014733          184 KLADFGLATYIKAGQNLHGTVGSPFYIAPEVLA  216 (419)
Q Consensus       184 KL~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~  216 (419)
                      ||+|||++..            +..++|||++.
T Consensus       232 kl~DFG~a~~------------~~~~~a~e~l~  252 (282)
T 1zar_A          232 WIIDFPQSVE------------VGEEGWREILE  252 (282)
T ss_dssp             EECCCTTCEE------------TTSTTHHHHHH
T ss_pred             EEEECCCCeE------------CCCCCHHHHHH
Confidence            9999999974            33478899874

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.84  E-value=4.9e-21  Score=180.41  Aligned_cols=142  Identities=18%  Similarity=0.164  Sum_probs=108.8

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcE--EEEEEeccCccCC---------------------HHhHHHHHHHHHHHHH
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEV--LACKSIAKDRLVT---------------------VEDVRSIKLEIEIMTK   96 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~--vaiK~i~~~~~~~---------------------~~~~~~~~~Ei~il~~   96 (419)
                      ..|++.+.||+|+||.||+|.+..+|+.  ||+|++.......                     ......+.+|+.+|++
T Consensus        47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~  126 (258)
T 1zth_A           47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER  126 (258)
T ss_dssp             SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred             CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence            3578999999999999999999778999  9999976432110                     0112367899999999


Q ss_pred             ccCCCCc--eeeeEEEEeCCEEEEEEeecCC-C----ChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-hCCCeeccCC
Q 014733           97 LSGHPNV--VDLKAVYEEEDYVHLLMELCAG-G----ELFHRLEKYGRFSETEARVIFRHLMQVVSYCH-GNGVVHRDLK  168 (419)
Q Consensus        97 l~~hpnI--v~l~~~~~~~~~~~lV~E~~~g-g----sL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH-~~~IvHrDLk  168 (419)
                      +. |+++  +.++..    +..++||||+.+ |    +|.+....   .++.++..++.|++.+|.||| +.||+|||||
T Consensus       127 l~-~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlk  198 (258)
T 1zth_A          127 AK-EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLS  198 (258)
T ss_dssp             HH-HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCS
T ss_pred             HH-hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCC
Confidence            96 7764  333332    245799999942 3    66655432   345678899999999999999 9999999999


Q ss_pred             CCcEEEeecCCCCCeEEeeccceeee
Q 014733          169 PENILLATKSSSSPIKLADFGLATYI  194 (419)
Q Consensus       169 p~NILl~~~~~~~~vKL~DFgla~~~  194 (419)
                      |+|||++   .  .++|+|||+|...
T Consensus       199 p~NILl~---~--~~~liDFG~a~~~  219 (258)
T 1zth_A          199 EYNIMYI---D--KVYFIDMGQAVTL  219 (258)
T ss_dssp             TTSEEES---S--SEEECCCTTCEET
T ss_pred             HHHEEEc---C--cEEEEECcccccC
Confidence            9999993   3  8999999999864

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.74  E-value=6.4e-18  Score=167.08  Aligned_cols=144  Identities=16%  Similarity=0.229  Sum_probs=103.0

Q ss_pred             CeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccC--------------CHHh-H----HHHHHHHHHHHHccCCC
Q 014733           41 RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLV--------------TVED-V----RSIKLEIEIMTKLSGHP  101 (419)
Q Consensus        41 ~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~--------------~~~~-~----~~~~~Ei~il~~l~~hp  101 (419)
                      -|+++..||.|++|.||+|.+. +|+.||||+++.....              .... .    -...+|...|.++. +.
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~-~~  173 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALY-EE  173 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHH-HT
T ss_pred             EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHH-hc
Confidence            3999999999999999999985 6999999998643210              0000 0    11245777888884 44


Q ss_pred             CceeeeEEEEeCCEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCC
Q 014733          102 NVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSS  181 (419)
Q Consensus       102 nIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~  181 (419)
                      ++....-+....  .++||||++|++|.++.      ....+..++.||+.+|.+||+.|||||||||.|||++.+++..
T Consensus       174 gv~vp~p~~~~~--~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~  245 (397)
T 4gyi_A          174 GFPVPEPIAQSR--HTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAE  245 (397)
T ss_dssp             TCSCCCEEEEET--TEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSS
T ss_pred             CCCCCeeeeccC--ceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcc
Confidence            443222222222  36999999998886543      2234567889999999999999999999999999997644211


Q ss_pred             -------CeEEeeccceeee
Q 014733          182 -------PIKLADFGLATYI  194 (419)
Q Consensus       182 -------~vKL~DFgla~~~  194 (419)
                             .+.|+||+.+...
T Consensus       246 d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          246 DPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             CTTSEEEEEEECCCTTCEET
T ss_pred             cccccccceEEEEeCCcccC
Confidence                   3789999988753

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.43  E-value=6e-13  Score=124.59  Aligned_cols=143  Identities=18%  Similarity=0.163  Sum_probs=113.3

Q ss_pred             cccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEE
Q 014733           38 LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVH  117 (419)
Q Consensus        38 ~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~  117 (419)
                      .-+.|++...++.|+.+.||++...  +..+++|+......   .....+.+|..+++.|.++..+.++++++.+.+..|
T Consensus        12 ~l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~---~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~   86 (263)
T 3tm0_A           12 LIEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYK---GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN   86 (263)
T ss_dssp             HHTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGT---TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred             HhccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccC---CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceE
Confidence            3356999999999999999998754  68899999864311   112358899999999976788899999999999999


Q ss_pred             EEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 014733          118 LLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG--------------------------------------  159 (419)
Q Consensus       118 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~--------------------------------------  159 (419)
                      +||||++|.+|.+.+.     +......++.++.++|..||+                                      
T Consensus        87 lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (263)
T 3tm0_A           87 LLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED  161 (263)
T ss_dssp             EEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred             EEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence            9999999999876531     223345778899999999998                                      


Q ss_pred             ---------------------CCCeeccCCCCcEEEeecCCCCCeEEeeccceee
Q 014733          160 ---------------------NGVVHRDLKPENILLATKSSSSPIKLADFGLATY  193 (419)
Q Consensus       160 ---------------------~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~  193 (419)
                                           ..++|+|++|.|||++   .++.+.|+||+.+..
T Consensus       162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~---~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK---DGKVSGFIDLGRSGR  213 (263)
T ss_dssp             CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEE---TTEEEEECCCTTCEE
T ss_pred             ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEE---CCcEEEEEEchhccc
Confidence                                 3489999999999994   334457999998764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.28  E-value=9.9e-12  Score=115.40  Aligned_cols=141  Identities=16%  Similarity=0.061  Sum_probs=102.3

Q ss_pred             ccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCC-ceeeeEEEEeC
Q 014733           35 ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN-VVDLKAVYEEE  113 (419)
Q Consensus        35 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpn-Iv~l~~~~~~~  113 (419)
                      +......|.+....+.|..+.||++.. .+|..+++|+....      ....+.+|..+++.+..+.- +.+++++..+.
T Consensus        15 l~~~~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~------~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~   87 (264)
T 1nd4_A           15 WVERLFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG------ALNELQDEAARLSWLATTGVPCAAVLDVVTEA   87 (264)
T ss_dssp             GTTTTTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECS
T ss_pred             HHHhcCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc------cchhhhHHHHHHHHHHhCCCCCCeEEEeccCC
Confidence            344455676655555666799999864 46778999997543      12457789999999974422 56788888888


Q ss_pred             CEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------
Q 014733          114 DYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG--------------------------------  161 (419)
Q Consensus       114 ~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~--------------------------------  161 (419)
                      +..++||||++|.+|.  .   ...+   ...++.++++.|..||+..                                
T Consensus        88 ~~~~~v~e~i~G~~l~--~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (264)
T 1nd4_A           88 GRDWLLLGEVPGQDLL--S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLD  159 (264)
T ss_dssp             SCEEEEEECCSSEETT--T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCC
T ss_pred             CCCEEEEEecCCcccC--c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhh
Confidence            8899999999998884  2   1122   2356677777788888653                                


Q ss_pred             --------------------------CeeccCCCCcEEEeecCCCCCeEEeeccceee
Q 014733          162 --------------------------VVHRDLKPENILLATKSSSSPIKLADFGLATY  193 (419)
Q Consensus       162 --------------------------IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~  193 (419)
                                                ++|+|++|.|||++   .++.+.|+||+.+..
T Consensus       160 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~---~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          160 EEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVE---NGRFSGFIDCGRLGV  214 (264)
T ss_dssp             GGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEE---TTEEEEECCCTTCEE
T ss_pred             hhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEE---CCcEEEEEcchhccc
Confidence                                      99999999999994   334557999998874

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.14  E-value=1.6e-10  Score=113.31  Aligned_cols=144  Identities=22%  Similarity=0.364  Sum_probs=105.8

Q ss_pred             eeeeeecccCceEEEEEEecCCCcEEEEEEec--cCccCCHHhHHHHHHHHHHHHHccC-CCCceeeeEEEEeC---CEE
Q 014733           43 VLGKQLGWGQFGVIRECSDKFTGEVLACKSIA--KDRLVTVEDVRSIKLEIEIMTKLSG-HPNVVDLKAVYEEE---DYV  116 (419)
Q Consensus        43 ~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~--~~~~~~~~~~~~~~~Ei~il~~l~~-hpnIv~l~~~~~~~---~~~  116 (419)
                      ..++.|+.|.++.||++...  +..+++|+..  ....  ......+.+|..+++.|.. +..+++++.++.+.   +..
T Consensus        41 ~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~--~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~  116 (359)
T 3dxp_A           41 LSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKL--LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRA  116 (359)
T ss_dssp             CEEEECCC-CCSCEEEEECS--SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSC
T ss_pred             ceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCC--CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCe
Confidence            34678999999999998754  4678888765  3221  1234578889999999973 34578888888776   458


Q ss_pred             EEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------
Q 014733          117 HLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG-------------------------------------  159 (419)
Q Consensus       117 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~-------------------------------------  159 (419)
                      |+||||++|..+.+..  ...++..+...++.++++.|..||+                                     
T Consensus       117 ~~vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (359)
T 3dxp_A          117 FYIMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI  194 (359)
T ss_dssp             EEEEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred             EEEEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence            8999999998875311  1347788889999999999999997                                     


Q ss_pred             ---------------------CCCeeccCCCCcEEEeecCCCCCeEEeeccceee
Q 014733          160 ---------------------NGVVHRDLKPENILLATKSSSSPIKLADFGLATY  193 (419)
Q Consensus       160 ---------------------~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~  193 (419)
                                           ..++|+|+++.|||++.++. ..+.|+||+.+..
T Consensus       195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~-~v~~viDwe~a~~  248 (359)
T 3dxp_A          195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEP-RVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSS-CEEEECCCTTCEE
T ss_pred             hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCC-cEEEEECcccccc
Confidence                                 35899999999999953221 2368999999875

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.11  E-value=1.4e-10  Score=111.10  Aligned_cols=185  Identities=15%  Similarity=0.165  Sum_probs=124.5

Q ss_pred             eeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCC--ceeeeEEEEeCC---EEEEE
Q 014733           45 GKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPN--VVDLKAVYEEED---YVHLL  119 (419)
Q Consensus        45 ~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpn--Iv~l~~~~~~~~---~~~lV  119 (419)
                      ++.++.|....||++.     ..+++|+...     ......+.+|..+|+.+..+..  +.+++......+   ..|+|
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~-----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v   94 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKH-----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG   94 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESS-----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCC-----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence            4568999999999863     4688998642     2456789999999999853433  334444433333   34789


Q ss_pred             EeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 014733          120 MELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG----------------------------------------  159 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~----------------------------------------  159 (419)
                      |++++|.+|.....  ..++..+...++.+++..|..||+                                        
T Consensus        95 m~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (304)
T 3sg8_A           95 FTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK  172 (304)
T ss_dssp             EECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred             EcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence            99999998875432  347788888888889888888886                                        


Q ss_pred             ------------------CCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCCccccccCCCccCCccccc---CC
Q 014733          160 ------------------NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLA---GG  218 (419)
Q Consensus       160 ------------------~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~---~~  218 (419)
                                        ..++|+|++|.||+++.+ ..+.+.|+||+.+..-..............-..|+...   ..
T Consensus       173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~-~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~  251 (304)
T 3sg8_A          173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTE-KNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNH  251 (304)
T ss_dssp             HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETT-TTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHH
T ss_pred             HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCC-CCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHH
Confidence                              136999999999999532 13467899999987532221111111100002333321   11


Q ss_pred             CC------------CchhHHHHHHHHHHHHhCCCCC
Q 014733          219 YN------------QAADVWSAGVILYILLSGMPPF  242 (419)
Q Consensus       219 ~s------------~~sDvwSlGvil~elltG~~Pf  242 (419)
                      |.            ...+.|+++.++|.+.+|..+|
T Consensus       252 Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          252 YKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             cCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            21            1258999999999999999887

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.75  E-value=1.7e-07  Score=89.72  Aligned_cols=138  Identities=16%  Similarity=0.169  Sum_probs=96.4

Q ss_pred             eeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCC--CceeeeEEEE-eCCEEEEEEe
Q 014733           45 GKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP--NVVDLKAVYE-EEDYVHLLME  121 (419)
Q Consensus        45 ~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hp--nIv~l~~~~~-~~~~~~lV~E  121 (419)
                      ++.++.|....||+.     |..+++|+..     .......+.+|..+|+.|..+-  .+.+++.+.. ..+..++|||
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~-----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e   93 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPK-----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR   93 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEES-----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecC-----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence            456788988999987     5678889853     2345678999999999997432  3556666664 4556789999


Q ss_pred             ecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 014733          122 LCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGN-----------------------------------------  160 (419)
Q Consensus       122 ~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~-----------------------------------------  160 (419)
                      +++|..|....-  ..++..+...++.++.+.|..||+.                                         
T Consensus        94 ~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~  171 (306)
T 3tdw_A           94 KVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY  171 (306)
T ss_dssp             CCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred             ccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence            999988876321  2345555555555666655555542                                         


Q ss_pred             -------------------CCeeccCCCCcEEEeecCCCCCe-EEeeccceeee
Q 014733          161 -------------------GVVHRDLKPENILLATKSSSSPI-KLADFGLATYI  194 (419)
Q Consensus       161 -------------------~IvHrDLkp~NILl~~~~~~~~v-KL~DFgla~~~  194 (419)
                                         .++|+|++|.|||++.++.++.+ .|+||+.+..-
T Consensus       172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                               35999999999999532224554 89999988753

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.71  E-value=2.7e-07  Score=86.13  Aligned_cols=134  Identities=21%  Similarity=0.195  Sum_probs=98.9

Q ss_pred             eecccCce-EEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEEeecCC
Q 014733           47 QLGWGQFG-VIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAG  125 (419)
Q Consensus        47 ~LG~G~~g-~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~g  125 (419)
                      .+..|..+ .||+......+..+++|+...      .....+.+|..+|+.|..+-.+.+++.++.+.+..++|||+++|
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~------~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G  104 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG------SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPG  104 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEET------HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCS
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCC------CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCC
Confidence            34445554 689887777778899998642      34567889999999997665678899999999999999999999


Q ss_pred             CChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---------------------------------------------
Q 014733          126 GELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGN---------------------------------------------  160 (419)
Q Consensus       126 gsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~---------------------------------------------  160 (419)
                      .++.+.....    ......+..++...|.-||+.                                             
T Consensus       105 ~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (272)
T 4gkh_A          105 KTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW  180 (272)
T ss_dssp             EEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred             ccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence            8887765431    123334555666666666631                                             


Q ss_pred             -------------CCeeccCCCCcEEEeecCCCCCeEEeeccceee
Q 014733          161 -------------GVVHRDLKPENILLATKSSSSPIKLADFGLATY  193 (419)
Q Consensus       161 -------------~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~  193 (419)
                                   .++|+|+++.|||++   .++.+-|+||+.+..
T Consensus       181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~---~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          181 KEMHKLLPFSPDSVVTHGDFSLDNLIFD---EGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHTTCCCCCCEEEECSCCCTTSEEEE---TTEEEEECCCTTCEE
T ss_pred             HHHHhcccccCCcEEEcCCCCCCeEEEE---CCeEEEEEECccccc
Confidence                         158999999999994   344556999998874

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.32  E-value=2.1e-06  Score=84.96  Aligned_cols=82  Identities=15%  Similarity=0.142  Sum_probs=51.6

Q ss_pred             eeeeecccCceEEEEEEecCCCcEEEEEEeccCcc-CCH---HhHHHHHHHHHHHHHccCC-CC-ceeeeEEEEeCCEEE
Q 014733           44 LGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRL-VTV---EDVRSIKLEIEIMTKLSGH-PN-VVDLKAVYEEEDYVH  117 (419)
Q Consensus        44 i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~-~~~---~~~~~~~~Ei~il~~l~~h-pn-Iv~l~~~~~~~~~~~  117 (419)
                      ..+.||.|..+.||++.....+..+++|....... ...   .....+..|.++|+.+..+ +. +.+++.+  +....+
T Consensus        34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~  111 (397)
T 2olc_A           34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV  111 (397)
T ss_dssp             EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred             EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence            46689999999999998766678899998653211 000   1234567799999988533 33 3455543  344467


Q ss_pred             EEEeecCCCC
Q 014733          118 LLMELCAGGE  127 (419)
Q Consensus       118 lV~E~~~ggs  127 (419)
                      +|||+++|..
T Consensus       112 lvmE~l~g~~  121 (397)
T 2olc_A          112 TVMEDLSHLK  121 (397)
T ss_dssp             EEECCCTTSE
T ss_pred             EEEEeCCCcc
Confidence            9999997743

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.21  E-value=9.5e-07  Score=85.98  Aligned_cols=86  Identities=10%  Similarity=0.035  Sum_probs=57.0

Q ss_pred             eeeee-cccCceEEEEEEec--C----CCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCC--CCceeeeEEEEeC-
Q 014733           44 LGKQL-GWGQFGVIRECSDK--F----TGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH--PNVVDLKAVYEEE-  113 (419)
Q Consensus        44 i~~~L-G~G~~g~V~~a~~~--~----~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~h--pnIv~l~~~~~~~-  113 (419)
                      ..+.| +.|....+|+....  .    .+..+++|+..............+.+|..+|+.|..+  -.+.+++.+..+. 
T Consensus        24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~  103 (357)
T 3ats_A           24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD  103 (357)
T ss_dssp             EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred             EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence            45677 88889999987643  1    1567899986543200000124577899999988744  3567788777655 


Q ss_pred             --CEEEEEEeecCCCChH
Q 014733          114 --DYVHLLMELCAGGELF  129 (419)
Q Consensus       114 --~~~~lV~E~~~ggsL~  129 (419)
                        +..++|||+++|..+.
T Consensus       104 ~~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          104 VLGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             TTSSCEEEEECCCCBCCC
T ss_pred             ccCCceEEEEecCCCChh
Confidence              3568999999886653

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.02  E-value=0.00018  Score=68.87  Aligned_cols=75  Identities=11%  Similarity=0.147  Sum_probs=43.8

Q ss_pred             eeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCC-CCceeeeE------EEEeCCEEE
Q 014733           45 GKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH-PNVVDLKA------VYEEEDYVH  117 (419)
Q Consensus        45 ~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~h-pnIv~l~~------~~~~~~~~~  117 (419)
                      .+.|+.|..+.||++...  +..+++|+....    .   ..+..|..+++.|..+ -.+.+++.      +..+.+..+
T Consensus        37 ~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~----~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~  107 (346)
T 2q83_A           37 IDVIQGNQMALVWKVHTD--SGAVCLKRIHRP----E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLF  107 (346)
T ss_dssp             EEECC----CEEEEEEET--TEEEEEEEECSC----H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEE
T ss_pred             eeeccccccCcEEEEEeC--CCCEEEEecCCC----H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEE
Confidence            455666778899998753  345899988642    1   3344566666655411 12333332      224577889


Q ss_pred             EEEeecCCCCh
Q 014733          118 LLMELCAGGEL  128 (419)
Q Consensus       118 lV~E~~~ggsL  128 (419)
                      ++|+|++|.++
T Consensus       108 ~l~~~i~G~~~  118 (346)
T 2q83_A          108 VVYDWIEGRPF  118 (346)
T ss_dssp             EEEECCCCBCC
T ss_pred             EEEEeecCccC
Confidence            99999998654

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.86  E-value=8.8e-05  Score=73.91  Aligned_cols=78  Identities=9%  Similarity=-0.024  Sum_probs=45.9

Q ss_pred             eeeeecccCceEEEEEEecCCCcEEEEEEeccCcc-CCH-----HhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEE
Q 014733           44 LGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRL-VTV-----EDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVH  117 (419)
Q Consensus        44 i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~-~~~-----~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~  117 (419)
                      -.+.||.|..+.||++..  .+..+++|....... ...     .....+..|+..+..-.....+.+++.+.  .+..+
T Consensus        38 ~i~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~  113 (420)
T 2pyw_A           38 VIKEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMAL  113 (420)
T ss_dssp             EEEECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTE
T ss_pred             EEEEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccE
Confidence            456789999999999854  467899994321110 000     02233344443332211234566777665  45678


Q ss_pred             EEEeec-CC
Q 014733          118 LLMELC-AG  125 (419)
Q Consensus       118 lV~E~~-~g  125 (419)
                      +||||+ +|
T Consensus       114 lv~e~l~~g  122 (420)
T 2pyw_A          114 IGMRYLEPP  122 (420)
T ss_dssp             EEECCCCTT
T ss_pred             EEEeecCCc
Confidence            999999 77

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.80  E-value=0.00016  Score=69.18  Aligned_cols=76  Identities=16%  Similarity=0.097  Sum_probs=61.3

Q ss_pred             eeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCC--CCceeeeEEEEeCCEEEEEEee
Q 014733           45 GKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH--PNVVDLKAVYEEEDYVHLLMEL  122 (419)
Q Consensus        45 ~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~h--pnIv~l~~~~~~~~~~~lV~E~  122 (419)
                      .+.|+.|....+|+...  .+..+++|+....      ....+..|...|+.|..+  ..+++++.+....+..++||||
T Consensus        41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~  112 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND--EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEA  112 (312)
T ss_dssp             EEEECCSSSSEEEEEES--SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEEC
T ss_pred             eEEeCCccceeeeEEEE--CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEe
Confidence            56799999999999874  4678899987532      356788999999988633  6688899888888899999999


Q ss_pred             cCCCCh
Q 014733          123 CAGGEL  128 (419)
Q Consensus       123 ~~ggsL  128 (419)
                      ++|..+
T Consensus       113 l~G~~~  118 (312)
T 3jr1_A          113 LNKSKN  118 (312)
T ss_dssp             CCCCCC
T ss_pred             ccCCCC
Confidence            998764

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.77  E-value=0.00028  Score=63.50  Aligned_cols=135  Identities=18%  Similarity=0.146  Sum_probs=89.6

Q ss_pred             CChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH-HhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCCccccc
Q 014733          126 GELFHRLEKY-GRFSETEARVIFRHLMQVVSYC-HGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT  203 (419)
Q Consensus       126 gsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~L-H~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~~~~~~  203 (419)
                      .+|.+.|... .+++++++|.++.|.+.+|.-+ +...-..+=+.|..|++   ..+|.|-..+ +.+.           
T Consensus        33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l---~~dG~V~f~~-~~s~-----------   97 (229)
T 2yle_A           33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRV---WRDGAVTLAP-AADD-----------   97 (229)
T ss_dssp             EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEE---ETTSCEEECC-C--------------
T ss_pred             ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEE---ecCCceeccc-cccc-----------
Confidence            4788888765 5799999999999999998775 22222234455688888   4566665543 1110           


Q ss_pred             cCCCccCCcccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhc
Q 014733          204 VGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRV  283 (419)
Q Consensus       204 ~gt~~y~aPE~l~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~  283 (419)
                      .....+.+||......+.+.=|||||+++|.-+-                     +..+......+|+.+.+||..|..-
T Consensus        98 ~~~~~~~~pe~~~~~~te~~~IysLG~tLY~ALD---------------------ygL~e~eE~eLS~~LE~LL~~Mt~~  156 (229)
T 2yle_A           98 AGEPPPVAGKLGYSQCMETEVIESLGIIIYKALD---------------------YGLKENEERELSPPLEQLIDHMANT  156 (229)
T ss_dssp             ---------CCSSSSSCHHHHHHHHHHHHHHHHT---------------------TTCCTTEEECCCHHHHHHHHHHTTC
T ss_pred             ccccCCCChhhccccchHHHHHHHHHHHHHHHhh---------------------cCCCcccchhhCHHHHHHHHHHHhc
Confidence            1122367888875556678899999999999874                     3333333347999999999999865


Q ss_pred             C-------------------------CCCCCCHHHHHh
Q 014733          284 D-------------------------PSTRLTAAEVLA  296 (419)
Q Consensus       284 d-------------------------P~~Rps~~eil~  296 (419)
                      +                         +..|.+..+|++
T Consensus       157 ~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~  194 (229)
T 2yle_A          157 VEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMK  194 (229)
T ss_dssp             CC--------------------CCSCCCCCCSHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCcCCHHHHHH
Confidence            2                         468888988864

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.70  E-value=9.5e-05  Score=70.09  Aligned_cols=73  Identities=8%  Similarity=-0.082  Sum_probs=46.8

Q ss_pred             eeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEEeec-
Q 014733           45 GKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELC-  123 (419)
Q Consensus        45 ~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~-  123 (419)
                      ++.|+.|....+|++      ..+++|+.....    ...-...+|..+++.+..+.-..+++...  ...-++++||+ 
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~----~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~   90 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGT----EEYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIA   90 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCT
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCc----cceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecC
Confidence            778989999999998      458889876431    11112356888888876443334565543  33346899999 


Q ss_pred             CCCChH
Q 014733          124 AGGELF  129 (419)
Q Consensus       124 ~ggsL~  129 (419)
                      +|.+|.
T Consensus        91 ~g~~l~   96 (301)
T 3dxq_A           91 GAQTMS   96 (301)
T ss_dssp             TCEECC
T ss_pred             CCccCC
Confidence            776553

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.55  E-value=0.00012  Score=69.83  Aligned_cols=139  Identities=16%  Similarity=0.082  Sum_probs=77.5

Q ss_pred             eeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCC-CceeeeEE------EEeCCEEE
Q 014733           45 GKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP-NVVDLKAV------YEEEDYVH  117 (419)
Q Consensus        45 ~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hp-nIv~l~~~------~~~~~~~~  117 (419)
                      .+.|+.|....+|+.... .| .+++|+....     .....+..|..+++.|..+. .+.+++..      ....+..+
T Consensus        27 ~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~-----~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~   99 (322)
T 2ppq_A           27 YKGIAEGVENSNFLLHTT-KD-PLILTLYEKR-----VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPA   99 (322)
T ss_dssp             EEEECC---EEEEEEEES-SC-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEE
T ss_pred             eeccCCCcccceEEEEeC-Cc-cEEEEEeCCC-----CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEE
Confidence            456777888899998653 33 6889988642     12234567888888776321 12333321      23456789


Q ss_pred             EEEeecCCCChHH--------------HHHHc-CC--------CC---HHHHHH------------HHHHHHHHHHHHHh
Q 014733          118 LLMELCAGGELFH--------------RLEKY-GR--------FS---ETEARV------------IFRHLMQVVSYCHG  159 (419)
Q Consensus       118 lV~E~~~ggsL~~--------------~l~~~-~~--------l~---~~~~~~------------i~~qll~aL~~LH~  159 (419)
                      ++|+|++|..+..              .++.. ..        ..   +.....            +...+.+.++.+.+
T Consensus       100 ~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~  179 (322)
T 2ppq_A          100 ALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAA  179 (322)
T ss_dssp             EEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHH
T ss_pred             EEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHh
Confidence            9999999865310              11111 01        11   111000            00123444555552


Q ss_pred             -------CCCeeccCCCCcEEEeecCCCCCeEEeeccceee
Q 014733          160 -------NGVVHRDLKPENILLATKSSSSPIKLADFGLATY  193 (419)
Q Consensus       160 -------~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~  193 (419)
                             .+++|+|+++.|||++   .++.+.|+||+.+..
T Consensus       180 ~~~~~~~~~liHgDl~~~Nil~~---~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          180 HWPKDLPAGVIHADLFQDNVFFL---GDELSGLIDFYFACN  217 (322)
T ss_dssp             HCCCSSCEEEECSCCCGGGEEEE---TTEEEEECCCTTCEE
T ss_pred             hCcccCCcccCCCCCCccCEEEe---CCceEEEecchhccC
Confidence                   3589999999999994   333447999998764

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.38  E-value=0.0021  Score=60.25  Aligned_cols=82  Identities=13%  Similarity=0.015  Sum_probs=56.9

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCC--CceeeeEEEEeCCEE
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP--NVVDLKAVYEEEDYV  116 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hp--nIv~l~~~~~~~~~~  116 (419)
                      +....-++.+|.|..+.||+.... +|+.+++|+......   .....+..|...|+.|....  .+.+++.+  +..  
T Consensus        14 G~~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~---~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~~--   85 (288)
T 3f7w_A           14 GREVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAP---ALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DDR--   85 (288)
T ss_dssp             CCCEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCC---CCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ETT--
T ss_pred             CCCeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCc---chhhHHHHHHHHHHHHHhhCCCCcceEEec--cCc--
Confidence            345666888999999999998754 788999998654321   12345788999999986332  24444443  333  


Q ss_pred             EEEEeecCCCCh
Q 014733          117 HLLMELCAGGEL  128 (419)
Q Consensus       117 ~lV~E~~~ggsL  128 (419)
                      ++||||+.++..
T Consensus        86 ~lv~e~l~~~~~   97 (288)
T 3f7w_A           86 TLAMEWVDERPP   97 (288)
T ss_dssp             EEEEECCCCCCC
T ss_pred             eEEEEeecccCC
Confidence            689999987654

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.34  E-value=0.00037  Score=68.52  Aligned_cols=141  Identities=16%  Similarity=0.186  Sum_probs=83.2

Q ss_pred             eeeecccCceEEEEEEecC-------CCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEE
Q 014733           45 GKQLGWGQFGVIRECSDKF-------TGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVH  117 (419)
Q Consensus        45 ~~~LG~G~~g~V~~a~~~~-------~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~  117 (419)
                      ++.|..|....+|++....       .+..+++|+.-..    ......+.+|..+++.|..+.-..++++.+.+    .
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~----~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g  126 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI----LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----G  126 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----E
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc----cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----c
Confidence            4567778888899987642       3578999986321    12345667899999998755445667665543    2


Q ss_pred             EEEeecCCCChHH--------------HH---HHc----C-CCC--HHHHHHHHHHHHH-------------------HH
Q 014733          118 LLMELCAGGELFH--------------RL---EKY----G-RFS--ETEARVIFRHLMQ-------------------VV  154 (419)
Q Consensus       118 lV~E~~~ggsL~~--------------~l---~~~----~-~l~--~~~~~~i~~qll~-------------------aL  154 (419)
                      +||||++|.+|..              .+   +..    + ...  +..+..+..++-.                   .+
T Consensus       127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~  206 (379)
T 3feg_A          127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM  206 (379)
T ss_dssp             EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred             cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence            8999999865531              11   111    1 111  3445555544322                   23


Q ss_pred             HHH----HhC----CCeeccCCCCcEEEeec-CCCCCeEEeeccceee
Q 014733          155 SYC----HGN----GVVHRDLKPENILLATK-SSSSPIKLADFGLATY  193 (419)
Q Consensus       155 ~~L----H~~----~IvHrDLkp~NILl~~~-~~~~~vKL~DFgla~~  193 (419)
                      +.|    ...    .++|+|+.+.|||++.+ +..+.+.|+||..+..
T Consensus       207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            333    222    48999999999999643 1236899999998874

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.33  E-value=0.00053  Score=65.72  Aligned_cols=141  Identities=13%  Similarity=0.101  Sum_probs=72.5

Q ss_pred             eeeecccCceE-EEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCC-CceeeeEEEEeCCEEEEEEee
Q 014733           45 GKQLGWGQFGV-IRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP-NVVDLKAVYEEEDYVHLLMEL  122 (419)
Q Consensus        45 ~~~LG~G~~g~-V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hp-nIv~l~~~~~~~~~~~lV~E~  122 (419)
                      .+.|+.|+... +|+... .+|..+++|......      ...+..|..+++.|..+. .+.+++.+..+.+  +++||+
T Consensus        23 ~~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~------~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~   93 (333)
T 3csv_A           23 RTPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEE------GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIED   93 (333)
T ss_dssp             ECC--------CCEEEEC-TTCCEEEEEECCTTT------TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECC
T ss_pred             eeECCCCCCCceEEEEEc-CCCCeEEEEECCCCC------CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEee
Confidence            44565555444 556543 225677777643321      133456788888776332 3556666533333  689999


Q ss_pred             cCCCChHHHHHHc--------------------------CCCCHHHHH-------HHH-------------HHHHHHHHH
Q 014733          123 CAGGELFHRLEKY--------------------------GRFSETEAR-------VIF-------------RHLMQVVSY  156 (419)
Q Consensus       123 ~~ggsL~~~l~~~--------------------------~~l~~~~~~-------~i~-------------~qll~aL~~  156 (419)
                      +.+..+.+.+...                          ..++.....       .+.             ..+...++.
T Consensus        94 l~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~  173 (333)
T 3csv_A           94 LGDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQ  173 (333)
T ss_dssp             CCSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHH
T ss_pred             CCCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHH
Confidence            9776665443221                          012221110       000             011122223


Q ss_pred             H------HhCCCeeccCCCCcEEEeecCC-CCCeEEeeccceeee
Q 014733          157 C------HGNGVVHRDLKPENILLATKSS-SSPIKLADFGLATYI  194 (419)
Q Consensus       157 L------H~~~IvHrDLkp~NILl~~~~~-~~~vKL~DFgla~~~  194 (419)
                      +      +...++|+|+++.|||++.+.. .+.+.|+||+.+..-
T Consensus       174 l~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          174 ILSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             HHHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             HHHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            3      2346999999999999943111 157899999988753

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.28  E-value=0.0011  Score=63.28  Aligned_cols=77  Identities=13%  Similarity=0.148  Sum_probs=49.5

Q ss_pred             eeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCC-CceeeeEE-----EEeCCEEEEE
Q 014733           46 KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHP-NVVDLKAV-----YEEEDYVHLL  119 (419)
Q Consensus        46 ~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hp-nIv~l~~~-----~~~~~~~~lV  119 (419)
                      ..|+ |....||+.... +|+.+++|.......    ....+..|..+++.|..+. .+++++..     ....+..+++
T Consensus        32 ~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~----~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l  105 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDE-DRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV  105 (328)
T ss_dssp             EEEC-CSSSEEEEECCT-TCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred             Eeec-CcccceEEEEcC-CCCEEEEEEcCCCCC----CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence            4566 778899987543 466799999863321    2345677888888876321 23444432     2345677899


Q ss_pred             EeecCCCCh
Q 014733          120 MELCAGGEL  128 (419)
Q Consensus       120 ~E~~~ggsL  128 (419)
                      |++++|..+
T Consensus       106 ~~~i~G~~~  114 (328)
T 1zyl_A          106 FPSVGGRQF  114 (328)
T ss_dssp             EECCCCEEC
T ss_pred             EEecCCCCC
Confidence            999988543

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.18  E-value=0.00088  Score=66.97  Aligned_cols=76  Identities=16%  Similarity=0.044  Sum_probs=51.4

Q ss_pred             eeeeecccCceEEEEEEecC-------CCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEE
Q 014733           44 LGKQLGWGQFGVIRECSDKF-------TGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYV  116 (419)
Q Consensus        44 i~~~LG~G~~g~V~~a~~~~-------~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~  116 (419)
                      -++.|+.|....||++....       .+..+++|+....  ..   ...+..|..+++.|..+.-..++++.+.  +  
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--  147 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ET---ESHLVAESVIFTLLSERHLGPKLYGIFS--G--  147 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CC---HHHHHHHHHHHHHHHHTTSSSCEEEEET--T--
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--Cc---HHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--
Confidence            35678888889999997642       2578999988432  11   1344579999999874444466766543  3  


Q ss_pred             EEEEeecCCCCh
Q 014733          117 HLLMELCAGGEL  128 (419)
Q Consensus       117 ~lV~E~~~ggsL  128 (419)
                      .+|+||++|.+|
T Consensus       148 g~v~e~l~G~~l  159 (429)
T 1nw1_A          148 GRLEEYIPSRPL  159 (429)
T ss_dssp             EEEECCCCEEEC
T ss_pred             CEEEEEeCCccc
Confidence            289999987443

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.10  E-value=0.001  Score=64.85  Aligned_cols=77  Identities=17%  Similarity=0.085  Sum_probs=46.7

Q ss_pred             eeeeecccCceEEEEEEecC--------CCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCE
Q 014733           44 LGKQLGWGQFGVIRECSDKF--------TGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDY  115 (419)
Q Consensus        44 i~~~LG~G~~g~V~~a~~~~--------~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~  115 (419)
                      -.+.|+.|....+|++....        .+..+++|+.....    ........|..+++.|..+.-+.++++..  .+ 
T Consensus        37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~----~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~-  109 (369)
T 3c5i_A           37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV----DELYNTISEFEVYKTMSKYKIAPQLLNTF--NG-  109 (369)
T ss_dssp             EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG----GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT-
T ss_pred             EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc----cceecHHHHHHHHHHHHhcCCCCceEEec--CC-
Confidence            35678888888999987543        13678999875421    11122467888999887443345666543  33 


Q ss_pred             EEEEEeecCCCCh
Q 014733          116 VHLLMELCAGGEL  128 (419)
Q Consensus       116 ~~lV~E~~~ggsL  128 (419)
                       ++||||++|.++
T Consensus       110 -~~v~e~i~G~~l  121 (369)
T 3c5i_A          110 -GRIEEWLYGDPL  121 (369)
T ss_dssp             -EEEEECCCSEEC
T ss_pred             -cEEEEEecCCcC
Confidence             589999988543

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.91  E-value=0.0095  Score=59.97  Aligned_cols=77  Identities=10%  Similarity=0.028  Sum_probs=49.7

Q ss_pred             eeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEEeec
Q 014733           44 LGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELC  123 (419)
Q Consensus        44 i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~  123 (419)
                      -++.|+.|-...+|++.....+..+++|+......    ..-...+|..+++.|..+.-..++++.+  .+.  +||||+
T Consensus       112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~----~~idR~~E~~vl~~L~~~gl~P~ll~~~--~~G--~v~e~I  183 (458)
T 2qg7_A          112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTD----EIINREREKKISCILYNKNIAKKIYVFF--TNG--RIEEFM  183 (458)
T ss_dssp             EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CC----SCSCHHHHHHHHHHHTTSSSBCCEEEEE--TTE--EEEECC
T ss_pred             EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChh----hhcCHHHHHHHHHHHHhcCCCCCEEEEe--CCe--EEEEee
Confidence            35678888889999988654457899998753211    1111257999999997544446777766  232  599999


Q ss_pred             CCCCh
Q 014733          124 AGGEL  128 (419)
Q Consensus       124 ~ggsL  128 (419)
                      +|.+|
T Consensus       184 ~G~~l  188 (458)
T 2qg7_A          184 DGYAL  188 (458)
T ss_dssp             CSEEC
T ss_pred             CCccC
Confidence            87554

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.90  E-value=0.0085  Score=57.67  Aligned_cols=69  Identities=6%  Similarity=-0.022  Sum_probs=44.2

Q ss_pred             cccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccC--CCCceeeeEE------EEeCCEEEEEE
Q 014733           49 GWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG--HPNVVDLKAV------YEEEDYVHLLM  120 (419)
Q Consensus        49 G~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~--hpnIv~l~~~------~~~~~~~~lV~  120 (419)
                      |.|....||+.... .| .+++|+......         ..|..+++.|..  -|++++.+..      ....+..+++|
T Consensus        32 G~g~~N~vy~v~~~-~g-~~vLK~~~~~~~---------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~  100 (339)
T 3i1a_A           32 GADTNAFAYQADSE-SK-SYFIKLKYGYHD---------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAY  100 (339)
T ss_dssp             TSCSSCEEEEEECS-SC-EEEEEEEECSSC---------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEE
T ss_pred             cCccccceEEEEeC-CC-CEEEEEecCccc---------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEE
Confidence            33446789998643 44 899998765431         356667766652  2334454432      23467889999


Q ss_pred             eecCCCCh
Q 014733          121 ELCAGGEL  128 (419)
Q Consensus       121 E~~~ggsL  128 (419)
                      +|++|..+
T Consensus       101 ~~i~G~~~  108 (339)
T 3i1a_A          101 PFIHAPNG  108 (339)
T ss_dssp             ECCCCCBT
T ss_pred             eccCCCcC
Confidence            99998765

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.75  E-value=0.014  Score=58.19  Aligned_cols=77  Identities=17%  Similarity=0.046  Sum_probs=50.4

Q ss_pred             eeeeecccCceEEEEEEecC-------CCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEE
Q 014733           44 LGKQLGWGQFGVIRECSDKF-------TGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYV  116 (419)
Q Consensus        44 i~~~LG~G~~g~V~~a~~~~-------~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~  116 (419)
                      -++.|..|....+|+.....       .+..+++++.....    ...-...+|..+++.|..+.-..++++.  ..+  
T Consensus        74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t----~~~idR~~E~~~l~~L~~~gi~P~l~~~--~~~--  145 (424)
T 3mes_A           74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV----GKFYDSKVELDVFRYLSNINIAPNIIAD--FPE--  145 (424)
T ss_dssp             EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-----CCCCHHHHHHHHHHHHHTTSSCCEEEE--ETT--
T ss_pred             EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc----chhcCHHHHHHHHHHHHhcCCCCCEEEE--cCC--
Confidence            35667777888999987652       15789999875421    1112345789999888755445566653  333  


Q ss_pred             EEEEeecCCCCh
Q 014733          117 HLLMELCAGGEL  128 (419)
Q Consensus       117 ~lV~E~~~ggsL  128 (419)
                      ++||||++|.+|
T Consensus       146 ~~I~efI~G~~l  157 (424)
T 3mes_A          146 GRIEEFIDGEPL  157 (424)
T ss_dssp             EEEEECCCSEEC
T ss_pred             CEEEEEeCCccC
Confidence            589999998664

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=94.36  E-value=0.18  Score=49.42  Aligned_cols=32  Identities=34%  Similarity=0.534  Sum_probs=26.1

Q ss_pred             CeeccCCCCcEEEeec---CCCCCeEEeeccceee
Q 014733          162 VVHRDLKPENILLATK---SSSSPIKLADFGLATY  193 (419)
Q Consensus       162 IvHrDLkp~NILl~~~---~~~~~vKL~DFgla~~  193 (419)
                      ++|+|+.+.|||+..+   +++..++++||..|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            5799999999999542   3456899999998874

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=82.32  E-value=3.5  Score=36.78  Aligned_cols=120  Identities=15%  Similarity=0.204  Sum_probs=80.4

Q ss_pred             HHHHHHHccCCCCceeeeEEEEeCCEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHH-HHHhCCCeeccCC
Q 014733           90 EIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS-YCHGNGVVHRDLK  168 (419)
Q Consensus        90 Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~-~LH~~~IvHrDLk  168 (419)
                      |..+|..  .||++  -..+-.+++.+.+.++.-+++.=+..++   .++..+.++++..|+.... ++  ..-+|--|+
T Consensus        41 e~~lL~~--~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~---~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~  111 (219)
T 4ano_A           41 ELEVLKE--VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR---KTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVC  111 (219)
T ss_dssp             GGGGGGG--SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH---TSCHHHHHHHHHHHHHHHSSCC--SSSEECCCC
T ss_pred             HHHHHhc--cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH---hcCHHHHHHHHHHHHHHHHHhh--hCceeEEEe
Confidence            3444443  48888  4455577888888888765554455554   3889999999888888665 33  445788899


Q ss_pred             CCcEEEeecCCCCCeEEeeccceeeeccCCccccccCCCccCCcccccCCCCCchhHH-HHHHHHHHHHhCCCCC
Q 014733          169 PENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGGYNQAADVW-SAGVILYILLSGMPPF  242 (419)
Q Consensus       169 p~NILl~~~~~~~~vKL~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~~~s~~sDvw-SlGvil~elltG~~Pf  242 (419)
                      |+||++   +.++.+++.-.|.-..+                +|.-+    + .-|.| .+=|++..++.++..|
T Consensus       112 P~NL~f---~~~~~p~i~hRGi~~~l----------------pP~e~----~-ee~fl~qyKali~all~~K~~F  162 (219)
T 4ano_A          112 PENLMF---NRALEPFFLHVGVKESL----------------PPDEW----D-DERLLREVKATVLALTEGEYRF  162 (219)
T ss_dssp             GGGEEE---CTTCCEEESCCEETTTB----------------SSCSC----C-HHHHHHHHHHHHHHHTTCSSCH
T ss_pred             CceEEE---eCCCcEEEEEcCCcccC----------------CCCCC----C-HHHHHHHHHHHHHHHHcCCCCH
Confidence            999999   66788999877754432                22211    1 22333 5667788888877776

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=80.20  E-value=4.5  Score=35.90  Aligned_cols=122  Identities=11%  Similarity=0.173  Sum_probs=82.1

Q ss_pred             HHHHHHHccCCCCceeeeEEEEeCCEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCC
Q 014733           90 EIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKP  169 (419)
Q Consensus        90 Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp  169 (419)
                      |+.+|..  .||+.+.. .+-++++.+.+.++.-+.+.=+..+.   .++..+.++++..|+....++  ..-+|--|+|
T Consensus        36 el~LL~~--~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik---~~~~~eKlr~l~ni~~l~~~~--~~r~tf~L~P  107 (215)
T 4ann_A           36 LMYLLEQ--HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK---SFTKNEKLRYLLNIKNLEEVN--RTRYTFVLAP  107 (215)
T ss_dssp             GGGGGGS--CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG---GSCHHHHHHHHHHGGGGGGGG--GSSEECCCSG
T ss_pred             HHHHHhc--cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH---hcCHHHHHHHHHHHHHHHHHh--cCceEEEEec
Confidence            5556654  48999977 56677777777777654333333343   388999999999999887444  3347888999


Q ss_pred             CcEEEeecCCCCCeEEeeccceeeeccCCccccccCCCccCCcccccCCCCCchhHHHHHHHHHHHHhCCCCC
Q 014733          170 ENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPF  242 (419)
Q Consensus       170 ~NILl~~~~~~~~vKL~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~~~s~~sDvwSlGvil~elltG~~Pf  242 (419)
                      +||++   +.++.+++.-.|.-..+                +|.-    ++...=+-.+=+++..+++++..|
T Consensus       108 ~NL~f---~~~~~p~i~~RGik~~l----------------~P~~----~~ee~fL~qyKAliiall~~K~~F  157 (215)
T 4ann_A          108 DELFF---TRDGLPIAKTRGLQNVV----------------DPLP----VSEAEFLTRYKALVICAFNEKQSF  157 (215)
T ss_dssp             GGEEE---CTTSCEEESCCEETTTB----------------SCCC----CCHHHHHHHHHHHHHHHHCTTCCH
T ss_pred             ceEEE---cCCCCEEEEEccCccCC----------------CCCC----CCHHHHHHHHHHHHHHHHcCCCCH
Confidence            99999   67778888877654322                1210    111222336677888888888887

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	419
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-88
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-87
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	3e-87
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	4e-87
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-85
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-84
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	8e-82
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	6e-81
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	7e-81
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-80
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-79
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	4e-79
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-77
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	6e-77
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	5e-75
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-74
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-73
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-73
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-72
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	6e-72
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	6e-70
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	9e-69
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-68
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	5e-67
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	6e-66
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	5e-64
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	6e-64
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-63
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	8e-62
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-61
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-61
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-61
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	4e-61
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	3e-60
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	6e-60
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	7e-59
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	8e-59
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-58
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-57
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-57
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-57
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	3e-57
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	6e-57
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	6e-57
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	6e-57
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-56
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-56
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	7e-56
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	9e-56
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	6e-54
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-53
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	3e-53
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	3e-53
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-52
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-51
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	7e-51
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-48
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	8e-48
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-47
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-47
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-46
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-44
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	3e-19

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  269 bits (689), Expect = 3e-88
 Identities = 90/268 (33%), Positives = 148/268 (55%), Gaps = 7/268 (2%)

Query: 37  NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTK 96
           ++ D Y + ++LG G FGV+   +++ TG   A K +         D  +++ EI+ M+ 
Sbjct: 23  HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSV 79

Query: 97  LSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRL-EKYGRFSETEARVIFRHLMQVVS 155
           L  HP +V+L   +E+++ + ++ E  +GGELF ++ +++ + SE EA    R + + + 
Sbjct: 80  LR-HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLC 138

Query: 156 YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVL 215
           + H N  VH DLKPENI+  TK S+  +KL DFGL  ++   Q++  T G+  + APEV 
Sbjct: 139 HMHENNYVHLDLKPENIMFTTKRSNE-LKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA 197

Query: 216 AGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASAR 274
            G       D+WS GV+ YILLSG+ PF G+   +    V++ D       +  IS   +
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK 257

Query: 275 DLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
           D I  +L  DP+TR+T  + L H W+  
Sbjct: 258 DFIRKLLLADPNTRMTIHQALEHPWLTP 285

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  267 bits (684), Expect = 2e-87
 Identities = 90/267 (33%), Positives = 146/267 (54%), Gaps = 7/267 (2%)

Query: 37  NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTK 96
           ++ D Y + ++LG G FGV+  C +K TG V   K I         D  ++K EI IM +
Sbjct: 26  SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQ 82

Query: 97  LSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYG-RFSETEARVIFRHLMQVVS 155
           L  HP +++L   +E++  + L++E  +GGELF R+     + SE E     R   + + 
Sbjct: 83  LH-HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLK 141

Query: 156 YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVL 215
           + H + +VH D+KPENI+  TK +SS +K+ DFGLAT +   + +  T  +  + APE++
Sbjct: 142 HMHEHSIVHLDIKPENIMCETKKASS-VKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV 200

Query: 216 AGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASAR 274
                    D+W+ GV+ Y+LLSG+ PF G+   +    V+  D  F  D +  +S  A+
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK 260

Query: 275 DLIMGMLRVDPSTRLTAAEVLAHSWME 301
           D I  +L+ +P  RLT  + L H W++
Sbjct: 261 DFIKNLLQKEPRKRLTVHDALEHPWLK 287

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  265 bits (679), Expect = 3e-87
 Identities = 107/268 (39%), Positives = 156/268 (58%), Gaps = 4/268 (1%)

Query: 34  QISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEI 93
           Q  ++ D Y     LG G F  +    DK T +++A K IAK  L   E   S++ EI +
Sbjct: 3   QAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEG--SMENEIAV 60

Query: 94  MTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQV 153
           + K+  HPN+V L  +YE   +++L+M+L +GGELF R+ + G ++E +A  +   ++  
Sbjct: 61  LHKIK-HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDA 119

Query: 154 VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPE 213
           V Y H  G+VHRDLKPEN+L  +    S I ++DFGL+     G  L    G+P Y+APE
Sbjct: 120 VKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE 179

Query: 214 VLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISAS 272
           VLA   Y++A D WS GVI YILL G PPF+ +  +K+F+ +  A+  F S  WD IS S
Sbjct: 180 VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDS 239

Query: 273 ARDLIMGMLRVDPSTRLTAAEVLAHSWM 300
           A+D I  ++  DP  R T  + L H W+
Sbjct: 240 AKDFIRHLMEKDPEKRFTCEQALQHPWI 267

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  264 bits (675), Expect = 4e-87
 Identities = 100/276 (36%), Positives = 144/276 (52%), Gaps = 16/276 (5%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTV------EDVRSIKLEIEI 93
           + Y   + LG G   V+R C  K T +  A K I      +       E   +   E++I
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 94  MTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQV 153
           + K+SGHPN++ LK  YE   +  L+ +L   GELF  L +    SE E R I R L++V
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122

Query: 154 VSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPE 213
           +   H   +VHRDLKPENILL        IKL DFG +  +  G+ L    G+P Y+APE
Sbjct: 123 ICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPE 179

Query: 214 VLAG-------GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW 266
           ++         GY +  D+WS GVI+Y LL+G PPFW + +  +   + + + +F S  W
Sbjct: 180 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW 239

Query: 267 DHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
           D  S + +DL+   L V P  R TA E LAH + ++
Sbjct: 240 DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  261 bits (668), Expect = 2e-85
 Identities = 75/267 (28%), Positives = 136/267 (50%), Gaps = 8/267 (2%)

Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKL 97
           L ++Y++ + LG G+FG++  C +  + +    K +         D   +K EI I+   
Sbjct: 3   LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIA 58

Query: 98  SGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYG-RFSETEARVIFRHLMQVVSY 156
             H N++ L   +E  + + ++ E  +G ++F R+       +E E       + + + +
Sbjct: 59  R-HRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQF 117

Query: 157 CHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLA 216
            H + + H D++PENI+      SS IK+ +FG A  +K G N      +P Y APEV  
Sbjct: 118 LHSHNIGHFDIRPENIIY-QTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQ 176

Query: 217 GG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARD 275
               + A D+WS G ++Y+LLSG+ PF  +T  +I + +  A+  F  + +  IS  A D
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD 236

Query: 276 LIMGMLRVDPSTRLTAAEVLAHSWMEE 302
            +  +L  +  +R+TA+E L H W+++
Sbjct: 237 FVDRLLVKERKSRMTASEALQHPWLKQ 263

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  257 bits (658), Expect = 1e-84
 Identities = 83/262 (31%), Positives = 137/262 (52%), Gaps = 10/262 (3%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           + + +G+ LG G+FG +    +K +  +LA K + K +L        ++ E+EI + L  
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR- 64

Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
           HPN++ L   + +   V+L++E    G ++  L+K  +F E         L   +SYCH 
Sbjct: 65  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 124

Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGG- 218
             V+HRD+KPEN+LL    S+  +K+ADFG + +           G+  Y+ PE++ G  
Sbjct: 125 KRVIHRDIKPENLLL---GSAGELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRM 180

Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           +++  D+WS GV+ Y  L G PPF   T  + +  +   +  FP    D ++  ARDLI 
Sbjct: 181 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLIS 236

Query: 279 GMLRVDPSTRLTAAEVLAHSWM 300
            +L+ +PS R    EVL H W+
Sbjct: 237 RLLKHNPSQRPMLREVLEHPWI 258

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  252 bits (645), Expect = 8e-82
 Identities = 92/284 (32%), Positives = 147/284 (51%), Gaps = 19/284 (6%)

Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKL 97
           + D  V  + LG G  G + +  +K T E  A K +        +D    + E+E+  + 
Sbjct: 10  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVELHWRA 61

Query: 98  SGHPNVVDLKAVYE----EEDYVHLLMELCAGGELFHRLEKYG--RFSETEARVIFRHLM 151
           S  P++V +  VYE        + ++ME   GGELF R++  G   F+E EA  I + + 
Sbjct: 62  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 121

Query: 152 QVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIA 211
           + + Y H   + HRD+KPEN+L  +K  ++ +KL DFG A    +  +L     +P+Y+A
Sbjct: 122 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 181

Query: 212 PEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDA----VRAADLRFPSDPW 266
           PEVL    Y+++ D+WS GVI+YILL G PPF+      I       +R     FP+  W
Sbjct: 182 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 241

Query: 267 DHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKP 310
             +S   + LI  +L+ +P+ R+T  E + H W+ +  +V Q P
Sbjct: 242 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 285

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  248 bits (635), Expect = 6e-81
 Identities = 105/269 (39%), Positives = 148/269 (55%), Gaps = 6/269 (2%)

Query: 37  NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVED---VRSIKLEIEI 93
           N+ D Y  G++LG GQF V+++C +K TG   A K I K R  +         I+ E+ I
Sbjct: 7   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 66

Query: 94  MTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQV 153
           + ++  HPNV+ L  VYE +  V L++EL AGGELF  L +    +E EA    + ++  
Sbjct: 67  LKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 125

Query: 154 VSYCHGNGVVHRDLKPENILLATKSSSSP-IKLADFGLATYIKAGQNLHGTVGSPFYIAP 212
           V Y H   + H DLKPENI+L  ++   P IK+ DFGLA  I  G       G+P ++AP
Sbjct: 126 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 185

Query: 213 EVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISA 271
           E++        AD+WS GVI YILLSG  PF G TK +    V A +  F  + + + SA
Sbjct: 186 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 245

Query: 272 SARDLIMGMLRVDPSTRLTAAEVLAHSWM 300
            A+D I  +L  DP  R+T  + L H W+
Sbjct: 246 LAKDFIRRLLVKDPKKRMTIQDSLQHPWI 274

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  248 bits (635), Expect = 7e-81
 Identities = 73/272 (26%), Positives = 135/272 (49%), Gaps = 16/272 (5%)

Query: 37  NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTK 96
           N  D + +  +LG G FG + +  +K T  + A K I      + E++    +EI+I+  
Sbjct: 9   NPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDILAS 65

Query: 97  LSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGR-FSETEARVIFRHLMQVVS 155
              HPN+V L   +  E+ + +L+E CAGG +   + +  R  +E++ +V+ +  +  ++
Sbjct: 66  CD-HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALN 124

Query: 156 YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT-VGSPFYIAPEV 214
           Y H N ++HRDLK  NIL    +    IKLADFG++           + +G+P+++APEV
Sbjct: 125 YLHDNKIIHRDLKAGNILF---TLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEV 181

Query: 215 LAG------GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDH 268
           +         Y+  ADVWS G+ L  +    PP       ++   +  ++    + P   
Sbjct: 182 VMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQP-SR 240

Query: 269 ISASARDLIMGMLRVDPSTRLTAAEVLAHSWM 300
            S++ +D +   L  +   R T +++L H ++
Sbjct: 241 WSSNFKDFLKKCLEKNVDARWTTSQLLQHPFV 272

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  248 bits (633), Expect = 1e-80
 Identities = 76/265 (28%), Positives = 130/265 (49%), Gaps = 12/265 (4%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           + +  GK LG G F  +    +  T    A K + K  ++    V  +  E ++M++L  
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD- 66

Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
           HP  V L   +++++ ++  +     GEL   + K G F ET  R     ++  + Y HG
Sbjct: 67  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 126

Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT---VGSPFYIAPEVLA 216
            G++HRDLKPENILL   +    I++ DFG A  +            VG+  Y++PE+L 
Sbjct: 127 KGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 183

Query: 217 GG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARD 275
                +++D+W+ G I+Y L++G+PPF    +  IF  +   +  FP    +     ARD
Sbjct: 184 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARD 239

Query: 276 LIMGMLRVDPSTRLTAAEVLAHSWM 300
           L+  +L +D + RL   E+  +  +
Sbjct: 240 LVEKLLVLDATKRLGCEEMEGYGPL 264

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  244 bits (624), Expect = 2e-79
 Identities = 88/279 (31%), Positives = 139/279 (49%), Gaps = 19/279 (6%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           + + L + LG G +G ++   ++ T E +A K +   R V  +   +IK EI I   L+ 
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN- 61

Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
           H NVV       E +  +L +E C+GGELF R+E      E +A+  F  LM  V Y HG
Sbjct: 62  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121

Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLA 216
            G+ HRD+KPEN+LL        +K++DFGLAT  +       L+   G+  Y+APE+L 
Sbjct: 122 IGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178

Query: 217 GG--YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASAR 274
               + +  DVWS G++L  +L+G  P+   + S    +       +  +PW  I ++  
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL-NPWKKIDSAPL 237

Query: 275 DLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKPCKQ 313
            L+  +L  +PS R+T  ++    W         KP K+
Sbjct: 238 ALLHKILVENPSARITIPDIKKDRWY-------NKPLKK 269

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  244 bits (625), Expect = 4e-79
 Identities = 71/268 (26%), Positives = 117/268 (43%), Gaps = 13/268 (4%)

Query: 37  NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTK 96
           +    +   +++G G FG +    D    EV+A K ++     + E  + I  E+  + K
Sbjct: 12  DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQK 71

Query: 97  LSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSY 156
           L  HPN +  +  Y  E    L+ME C G              E E   +    +Q ++Y
Sbjct: 72  LR-HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAY 130

Query: 157 CHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLA 216
            H + ++HRD+K  NILL   S    +KL DFG A+ +      +  VG+P+++APEV+ 
Sbjct: 131 LHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIM---APANSFVGTPYWMAPEVIL 184

Query: 217 ----GGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISAS 272
               G Y+   DVWS G+    L    PP +          +   +   P+    H S  
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE--SPALQSGHWSEY 242

Query: 273 ARDLIMGMLRVDPSTRLTAAEVLAHSWM 300
            R+ +   L+  P  R T+  +L H ++
Sbjct: 243 FRNFVDSCLQKIPQDRPTSEVLLKHRFV 270

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  241 bits (616), Expect = 1e-77
 Identities = 89/327 (27%), Positives = 156/327 (47%), Gaps = 26/327 (7%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           + ++L K LG G FG +     K T +  A K++ KD ++  +DV    +E  +++    
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
           HP +  +   ++ ++ +  +ME   GG+L + ++   +F  + A      ++  + + H 
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS 121

Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT-VGSPFYIAPEVLAGG 218
            G+V+RDLK +NIL         IK+ADFG+      G     T  G+P YIAPE+L G 
Sbjct: 122 KGIVYRDLKLDNIL---LDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQ 178

Query: 219 -YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLI 277
            YN + D WS GV+LY +L G  PF G+ + ++F ++R  +  +P      +   A+DL+
Sbjct: 179 KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP----RWLEKEAKDLL 234

Query: 278 MGMLRVDPSTRLTAA-EVLAHSWMEEC--EQVAQK-------PCKQDDLCCKQL------ 321
           + +   +P  RL    ++  H    E   E++ +K       P  +    C         
Sbjct: 235 VKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNFDKEFLN 294

Query: 322 EVGGSSFSATFISRNMDCSFGYGGFSF 348
           E    SF+   +  +MD +  +  FSF
Sbjct: 295 EKPRLSFADRALINSMDQNM-FRNFSF 320

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  238 bits (609), Expect = 6e-77
 Identities = 72/278 (25%), Positives = 131/278 (47%), Gaps = 11/278 (3%)

Query: 35  ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
           + +   +Y   +++G G  G +    D  TG+ +A + +   +         I  EI +M
Sbjct: 15  VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVM 71

Query: 95  TKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVV 154
            +   +PN+V+    Y   D + ++ME  AGG L   + +     E +   + R  +Q +
Sbjct: 72  RENK-NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQAL 129

Query: 155 SYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT-VGSPFYIAPE 213
            + H N V+HRD+K +NILL        +KL DFG    I   Q+   T VG+P+++APE
Sbjct: 130 EFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 186

Query: 214 VLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISAS 272
           V+    Y    D+WS G++   ++ G PP+  +   +    + A +        + +SA 
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI-ATNGTPELQNPEKLSAI 245

Query: 273 ARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKP 310
            RD +   L +D   R +A E+L H +++  + ++   
Sbjct: 246 FRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLT 283

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  232 bits (594), Expect = 5e-75
 Identities = 61/272 (22%), Positives = 125/272 (45%), Gaps = 15/272 (5%)

Query: 38  LSDRYV-LGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTK 96
              R++    ++G G F  + +  D  T   +A   +   +L T  + +  K E E++  
Sbjct: 6   NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKG 64

Query: 97  LSGHPNVVDLKAVYEE----EDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQ 152
           L  HPN+V     +E     +  + L+ EL   G L   L+++        R   R +++
Sbjct: 65  LQ-HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILK 123

Query: 153 VVSYCH--GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYI 210
            + + H     ++HRDLK +NI +   + S  +K+ D GLAT +K        +G+P ++
Sbjct: 124 GLQFLHTRTPPIIHRDLKCDNIFITGPTGS--VKIGDLGLAT-LKRASFAKAVIGTPEFM 180

Query: 211 APEVLAGGYNQAADVWSAGVILYILLSGMPPFWGK-TKSKIFDAVRAADLRFPSDPWDHI 269
           APE+    Y+++ DV++ G+ +  + +   P+      ++I+  V       P+      
Sbjct: 181 APEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT--SGVKPASFDKVA 238

Query: 270 SASARDLIMGMLRVDPSTRLTAAEVLAHSWME 301
               +++I G +R +   R +  ++L H++ +
Sbjct: 239 IPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  231 bits (589), Expect = 3e-74
 Identities = 73/274 (26%), Positives = 124/274 (45%), Gaps = 13/274 (4%)

Query: 36  SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMT 95
           S+LSDRY LG+ LG+G    +    D      +A K +  D           + E +   
Sbjct: 3   SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAA 62

Query: 96  KLSGHPNVVDLKAVYEEED----YVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLM 151
            L+ HP +V +    E E       +++ME   G  L   +   G  +   A  +     
Sbjct: 63  ALN-HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADAC 121

Query: 152 QVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN----LHGTVGSP 207
           Q +++ H NG++HRD+KP NI++   S+++ +K+ DFG+A  I    N        +G+ 
Sbjct: 122 QALNFSHQNGIIHRDVKPANIMI---SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178

Query: 208 FYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW 266
            Y++PE   G   +  +DV+S G +LY +L+G PPF G +   +       D   PS   
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 238

Query: 267 DHISASARDLIMGMLRVDPSTRLTAAEVLAHSWM 300
           + +SA    +++  L  +P  R   A  +    +
Sbjct: 239 EGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  229 bits (585), Expect = 1e-73
 Identities = 69/273 (25%), Positives = 124/273 (45%), Gaps = 21/273 (7%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           + Y +   +G G +G  ++   K  G++L  K +    + T  + + +  E+ ++ +L  
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELK- 61

Query: 100 HPNVVDLKAVYEEE--DYVHLLMELCAGGELFHRLEKYGR----FSETEARVIFRHLMQV 153
           HPN+V       +     ++++ME C GG+L   + K  +      E     +   L   
Sbjct: 62  HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 121

Query: 154 VSYCH-----GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVG-SP 207
           +  CH     G+ V+HRDLKP N+ L        +KL DFGLA  +    +       +P
Sbjct: 122 LKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDFGLARILNHDTSFAKAFVGTP 178

Query: 208 FYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW 266
           +Y++PE +    YN+ +D+WS G +LY L + MPPF   ++ ++   +R    R      
Sbjct: 179 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR---IP 235

Query: 267 DHISASARDLIMGMLRVDPSTRLTAAEVLAHSW 299
              S    ++I  ML +    R +  E+L +  
Sbjct: 236 YRYSDELNEIITRMLNLKDYHRPSVEEILENPL 268

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  231 bits (590), Expect = 1e-73
 Identities = 66/307 (21%), Positives = 125/307 (40%), Gaps = 49/307 (15%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           D +    +LG G  GV+ + S K +G V+A K I  +  +       I  E++++ + + 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECN- 62

Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCH- 158
            P +V     +  +  + + ME   GG L   L+K GR  E     +   +++ ++Y   
Sbjct: 63  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 122

Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGG 218
            + ++HRD+KP NIL+   +S   IKL DFG++  +      +  VG+  Y++PE L G 
Sbjct: 123 KHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGT 178

Query: 219 -YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRA--------------------- 256
            Y+  +D+WS G+ L  +  G  P       ++                           
Sbjct: 179 HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLS 238

Query: 257 -------------------ADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH 297
                               +   P  P    S   +D +   L  +P+ R    +++ H
Sbjct: 239 SYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298

Query: 298 SWMEECE 304
           ++++  +
Sbjct: 299 AFIKRSD 305

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  228 bits (583), Expect = 3e-72
 Identities = 77/272 (28%), Positives = 129/272 (47%), Gaps = 14/272 (5%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLS- 98
           + + + + +G G FG +  C    TG++ A K + K R+   +       E  +++ +S 
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 99  -GHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYC 157
              P +V +   +   D +  +++L  GG+L + L ++G FSE + R     ++  + + 
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 123

Query: 158 HGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG 217
           H   VV+RDLKP NILL        ++++D GLA      +  H +VG+  Y+APEVL  
Sbjct: 124 HNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQK 179

Query: 218 G--YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARD 275
           G  Y+ +AD +S G +L+ LL G  PF         +  R   L    +  D  S   R 
Sbjct: 180 GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR-MTLTMAVELPDSFSPELRS 238

Query: 276 LIMGMLRVDPSTRLT-----AAEVLAHSWMEE 302
           L+ G+L+ D + RL      A EV    +   
Sbjct: 239 LLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  225 bits (574), Expect = 6e-72
 Identities = 76/272 (27%), Positives = 126/272 (46%), Gaps = 20/272 (7%)

Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVT---VEDVRSIKLEIEIM 94
           L  +Y +G  LG G FG +           +A K + KDR+     + +   + +E+ ++
Sbjct: 2   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61

Query: 95  TKLS-GHPNVVDLKAVYEEEDYVHLLMELCAGG-ELFHRLEKYGRFSETEARVIFRHLMQ 152
            K+S G   V+ L   +E  D   L++E      +LF  + + G   E  AR  F  +++
Sbjct: 62  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 121

Query: 153 VVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAP 212
            V +CH  GV+HRD+K ENIL+    +   +KL DFG    +K         G+  Y  P
Sbjct: 122 AVRHCHNCGVLHRDIKDENILIDL--NRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPP 178

Query: 213 EVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHIS 270
           E +     + ++A VWS G++LY ++ G  PF    +      +    + F       +S
Sbjct: 179 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFR----QRVS 228

Query: 271 ASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
           +  + LI   L + PS R T  E+  H WM++
Sbjct: 229 SECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 260

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  221 bits (564), Expect = 6e-70
 Identities = 79/269 (29%), Positives = 136/269 (50%), Gaps = 16/269 (5%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
             + + + LG G FG +     +  G   A K + K+ +V ++ V     E  +++ ++ 
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT- 62

Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
           HP ++ +   +++   + ++M+   GGELF  L K  RF    A+     +   + Y H 
Sbjct: 63  HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 122

Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGG- 218
             +++RDLKPENILL     +  IK+ DFG A Y+      +   G+P YIAPEV++   
Sbjct: 123 KDIIYRDLKPENILL---DKNGHIKITDFGFAKYVP--DVTYTLCGTPDYIAPEVVSTKP 177

Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           YN++ D WS G+++Y +L+G  PF+     K ++ +  A+LRFP       +   +DL+ 
Sbjct: 178 YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP----PFFNEDVKDLLS 233

Query: 279 GMLRVDPSTRL-----TAAEVLAHSWMEE 302
            ++  D S RL        +V  H W +E
Sbjct: 234 RLITRDLSQRLGNLQNGTEDVKNHPWFKE 262

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  217 bits (553), Expect = 9e-69
 Identities = 66/268 (24%), Positives = 117/268 (43%), Gaps = 19/268 (7%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
            +  +G+++G G FG + +   K+ G+V A K +      T + +++ K E+ ++ K   
Sbjct: 8   GQITVGQRIGSGSFGTVYKG--KWHGDV-AVKMLNVTAP-TPQQLQAFKNEVGVLRKTR- 62

Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCH 158
           H N++     Y     + ++ + C G  L+H L     +F   +   I R   Q + Y H
Sbjct: 63  HVNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 121

Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT---VGSPFYIAPEVL 215
              ++HRDLK  NI L        +K+ DFGLAT        H      GS  ++APEV+
Sbjct: 122 AKSIIHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178

Query: 216 ----AGGYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFP--SDPWDHI 269
                  Y+  +DV++ G++LY L++G  P+           +       P  S    + 
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238

Query: 270 SASARDLIMGMLRVDPSTRLTAAEVLAH 297
             + + L+   L+     R    ++LA 
Sbjct: 239 PKAMKRLMAECLKKKRDERPLFPQILAS 266

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  218 bits (557), Expect = 1e-68
 Identities = 83/270 (30%), Positives = 134/270 (49%), Gaps = 15/270 (5%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           + +   K LG G FG +    +K TG   A K + K+ ++  ++V     E  ++     
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR- 63

Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
           HP +  LK  ++  D +  +ME   GGELF  L +   F+E  AR     ++  + Y H 
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123

Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA-GQNLHGTVGSPFYIAPEVLAGG 218
             VV+RD+K EN++L        IK+ DFGL     + G  +    G+P Y+APEVL   
Sbjct: 124 RDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN 180

Query: 219 -YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLI 277
            Y +A D W  GV++Y ++ G  PF+ +   ++F+ +   ++RFP      +S  A+ L+
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEAKSLL 236

Query: 278 MGMLRVDPSTRL-----TAAEVLAHSWMEE 302
            G+L+ DP  RL      A EV+ H +   
Sbjct: 237 AGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  214 bits (545), Expect = 5e-67
 Identities = 81/277 (29%), Positives = 141/277 (50%), Gaps = 17/277 (6%)

Query: 40  DRYVLGKQLGWGQFGVI---RECSDKFTGEVLACKSIAKDRLV-TVEDVRSIKLEIEIMT 95
           + + L K LG G +G +   R+ S   TG++ A K + K  +V   +     + E +++ 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 96  KLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVS 155
            +   P +V L   ++ E  +HL+++   GGELF  L +  RF+E E ++    ++  + 
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALE 143

Query: 156 YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA--GQNLHGTVGSPFYIAPE 213
           + H  G+++RD+K ENILL    S+  + L DFGL+    A   +  +   G+  Y+AP+
Sbjct: 144 HLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 200

Query: 214 VLAG---GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHIS 270
           ++ G   G+++A D WS GV++Y LL+G  PF    +      +    L+        +S
Sbjct: 201 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 260

Query: 271 ASARDLIMGMLRVDPSTRL-----TAAEVLAHSWMEE 302
           A A+DLI  +L  DP  RL      A E+  H + ++
Sbjct: 261 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (540), Expect = 6e-66
 Identities = 74/323 (22%), Positives = 130/323 (40%), Gaps = 49/323 (15%)

Query: 34  QISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEI 93
           Q+ ++  RY     +G G +G++    D      +A K I+          +    EI+I
Sbjct: 2   QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKI 59

Query: 94  MTKLSGHPNVVDLKAVYEEEDYVHL----LMELCAGGELFHRLEKYGRFSETEARVIFRH 149
           + +   H N++ +  +        +    L+    G +L+  L K    S          
Sbjct: 60  LLRFR-HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL-KTQHLSNDHICYFLYQ 117

Query: 150 LMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT----VG 205
           +++ + Y H   V+HRDLKP N+LL   +++  +K+ DFGLA       +  G     V 
Sbjct: 118 ILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLARVADPDHDHTGFLTEYVA 174

Query: 206 SPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPS 263
           + +Y APE++     Y ++ D+WS G IL  +LS  P F GK      + +         
Sbjct: 175 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 234

Query: 264 DPWD---------------------------HISASARDLIMGMLRVDPSTRLTAAEVLA 296
           +  +                           +  + A DL+  ML  +P  R+   + LA
Sbjct: 235 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294

Query: 297 HSWMEE-----CEQVAQKPCKQD 314
           H ++E+      E +A+ P K D
Sbjct: 295 HPYLEQYYDPSDEPIAEAPFKFD 317

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (523), Expect = 5e-64
 Identities = 69/286 (24%), Positives = 115/286 (40%), Gaps = 33/286 (11%)

Query: 46  KQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVED--VRSIKLEIEIMTKLSGHPNV 103
             LG GQF  + +  DK T +++A K I        +D   R+   EI+++ +LS HPN+
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNI 62

Query: 104 VDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVV 163
           + L   +  +  + L+ +           +     + +  +      +Q + Y H + ++
Sbjct: 63  IGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWIL 122

Query: 164 HRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHG-TVGSPFYIAPEVLAG--GYN 220
           HRDLKP N+LL     +  +KLADFGLA    +    +   V + +Y APE+L G   Y 
Sbjct: 123 HRDLKPNNLLL---DENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYG 179

Query: 221 QAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWD------------- 267
              D+W+ G IL  LL  +P   G +       +         + W              
Sbjct: 180 VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239

Query: 268 -----------HISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
                             DLI G+   +P  R+TA + L   +   
Sbjct: 240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  206 bits (526), Expect = 6e-64
 Identities = 81/269 (30%), Positives = 140/269 (52%), Gaps = 16/269 (5%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           D++   K LG G FG +     K +G   A K + K ++V ++ +     E  I+  ++ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 99

Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
            P +V L+  +++   ++++ME  AGGE+F  L + GRFSE  AR     ++    Y H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159

Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG-G 218
             +++RDLKPEN+L+        I++ DFG A  +K         G+P  +APE++   G
Sbjct: 160 LDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK--GRTWTLCGTPEALAPEIILSKG 214

Query: 219 YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM 278
           YN+A D W+ GV++Y + +G PPF+     +I++ + +  +RFP     H S+  +DL+ 
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLR 270

Query: 279 GMLRVDPSTRL-----TAAEVLAHSWMEE 302
            +L+VD + R         ++  H W   
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  205 bits (522), Expect = 1e-63
 Identities = 67/298 (22%), Positives = 127/298 (42%), Gaps = 49/298 (16%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           D Y L ++LG G++  + E  +    E +  K +           + IK EI+I+  L G
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP------VKKKKIKREIKILENLRG 88

Query: 100 HPNVVDLKAVYEEED--YVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYC 157
            PN++ L  + ++       L+ E     +       Y   ++ + R     +++ + YC
Sbjct: 89  GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYC 145

Query: 158 HGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG 217
           H  G++HRD+KP N+++  +     ++L D+GLA +   GQ  +  V S ++  PE+L  
Sbjct: 146 HSMGIMHRDVKPHNVMIDHEHRK--LRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 203

Query: 218 --GYNQAADVWSAGVILYILLSGMPPFWGKTKSK--------------IFDAVRAADLR- 260
              Y+ + D+WS G +L  ++    PF+    +               ++D +   ++  
Sbjct: 204 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263

Query: 261 -------------------FPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSW 299
                                S+    +S  A D +  +LR D  +RLTA E + H +
Sbjct: 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 321

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (512), Expect = 8e-62
 Identities = 78/299 (26%), Positives = 125/299 (41%), Gaps = 46/299 (15%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
             Y   K +G G FGV+ +     +GE++A K + +D+       R    E++IM KL  
Sbjct: 20  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLD- 71

Query: 100 HPNVVDLKAVYEEED------YVHLLMELCAGG---ELFHRLEKYGRFSETEARVIFRHL 150
           H N+V L+  +          Y++L+++           H             ++    L
Sbjct: 72  HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL 131

Query: 151 MQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYI 210
            + ++Y H  G+ HRD+KP+N+LL     ++ +KL DFG A  +  G+     + S +Y 
Sbjct: 132 FRSLAYIHSFGICHRDIKPQNLLLDPD--TAVLKLCDFGSAKQLVRGEPNVSYICSRYYR 189

Query: 211 APEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAV-------------- 254
           APE++ G   Y  + DVWSAG +L  LL G P F G +       +              
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249

Query: 255 ---RAADLRFPSDP--------WDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
                 + +FP                  A  L   +L   P+ RLT  E  AHS+ +E
Sbjct: 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 308

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (509), Expect = 2e-61
 Identities = 72/312 (23%), Positives = 128/312 (41%), Gaps = 44/312 (14%)

Query: 37  NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTK 96
            +   Y   + +G G +G +    D  TG  +A K + +    +    +    E+ ++  
Sbjct: 15  EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKH 73

Query: 97  LSGHPNVVDLKAVYEEED------YVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHL 150
           +  H NV+ L  V+  ++        +L+M     G    +L K+ +  E   + +   +
Sbjct: 74  MR-HENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQM 130

Query: 151 MQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYI 210
           ++ + Y H  G++HRDLKP N+ +   +    +K+ DFGLA   +A   + G V + +Y 
Sbjct: 131 LKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLAR--QADSEMTGYVVTRWYR 185

Query: 211 APEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWD- 267
           APEV+     Y Q  D+WS G I+  +++G   F G         +       P++    
Sbjct: 186 APEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 245

Query: 268 --------------------------HISASARDLIMGMLRVDPSTRLTAAEVLAHSWME 301
                                     + S  A +L+  ML +D   R+TA E LAH + E
Sbjct: 246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE 305

Query: 302 ECEQVAQKPCKQ 313
                  +P  Q
Sbjct: 306 SLHDTEDEPQVQ 317

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (505), Expect = 2e-61
 Identities = 75/308 (24%), Positives = 124/308 (40%), Gaps = 42/308 (13%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFT-GEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLS 98
            +Y    ++G G +G + +  D    G  +A K +          + +I+ E+ ++  L 
Sbjct: 7   QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR-EVAVLRHLE 65

Query: 99  G--HPNVVDLKAVY-----EEEDYVHLLMELCAGGEL-FHRLEKYGRFSETEARVIFRHL 150
              HPNVV L  V      + E  + L+ E        +              + +   L
Sbjct: 66  TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 125

Query: 151 MQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYI 210
           ++ + + H + VVHRDLKP+NIL+   +SS  IKLADFGLA        L   V + +Y 
Sbjct: 126 LRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFGLARIYSFQMALTSVVVTLWYR 182

Query: 211 APEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW--- 266
           APEVL    Y    D+WS G I   +    P F G +       +         + W   
Sbjct: 183 APEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 242

Query: 267 --------------------DHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQV 306
                                 I    +DL++  L  +P+ R++A   L+H + ++ E+ 
Sbjct: 243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER- 301

Query: 307 AQKPCKQD 314
               CK++
Sbjct: 302 ----CKEN 305

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (506), Expect = 2e-61
 Identities = 67/306 (21%), Positives = 125/306 (40%), Gaps = 48/306 (15%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
            +Y    ++G G FG + +   + TG+ +A K +  +       + +++ EI+I+  L  
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLLK- 67

Query: 100 HPNVVDLKAVYEE--------EDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLM 151
           H NVV+L  +           +  ++L+ + C             +F+ +E + + + L+
Sbjct: 68  HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL 127

Query: 152 QVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLH-----GTVGS 206
             + Y H N ++HRD+K  N+L+   +    +KLADFGLA      +N         V +
Sbjct: 128 NGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 184

Query: 207 PFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSD 264
            +Y  PE+L G   Y    D+W AG I+  + +  P   G T+      +         +
Sbjct: 185 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 244

Query: 265 PWDHI----------------------------SASARDLIMGMLRVDPSTRLTAAEVLA 296
            W ++                               A DLI  +L +DP+ R+ + + L 
Sbjct: 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304

Query: 297 HSWMEE 302
           H +   
Sbjct: 305 HDFFWS 310

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  197 bits (502), Expect = 4e-61
 Identities = 74/291 (25%), Positives = 127/291 (43%), Gaps = 34/291 (11%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           ++Y   +++G G +GV+ +  +   GE  A K I  ++        +   EI I+ +L  
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKELK- 58

Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
           H N+V L  V   +  + L+ E              G      A+     L+  ++YCH 
Sbjct: 59  HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118

Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA-GQNLHGTVGSPFYIAPEVLAG- 217
             V+HRDLKP+N+L+   +    +K+ADFGLA       +     + + +Y AP+VL G 
Sbjct: 119 RRVLHRDLKPQNLLI---NREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175

Query: 218 -GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWD--------- 267
             Y+   D+WS G I   +++G P F G +++     +        S  W          
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235

Query: 268 ----------------HISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
                            +  S  DL+  ML++DP+ R+TA + L H++ +E
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (499), Expect = 3e-60
 Identities = 57/289 (19%), Positives = 106/289 (36%), Gaps = 36/289 (12%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRL---VTVEDVRSIKLEIEIMTK 96
           +    GK LG G FG +   +     +      +A   L       +  ++  E+++MT+
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 97  LSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEK---------------------- 134
           L  H N+V+L         ++L+ E C  G+L + L                        
Sbjct: 97  LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 135 -YGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATY 193
                +  +       + + + +      VHRDL   N+L+   +    +K+ DFGLA  
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLV---THGKVVKICDFGLARD 213

Query: 194 IKAGQNLH---GTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKS 248
           I +  N            ++APE L  G Y   +DVWS G++L+ + S G+ P+ G    
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273

Query: 249 KIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH 297
             F  +     +       + +     ++      D   R +   + + 
Sbjct: 274 ANFYKLIQNGFKMD--QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (496), Expect = 6e-60
 Identities = 62/276 (22%), Positives = 109/276 (39%), Gaps = 24/276 (8%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           +       +G G FG + +   K  G  +           + +D R    E+E++ KL  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKY----------------GRFSETEA 143
           HPN+++L    E   Y++L +E    G L   L K                    S  + 
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 144 RVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT 203
                 + + + Y      +HRDL   NIL+     +   K+ADFGL+   +        
Sbjct: 130 LHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLSRGQEVYVKKTMG 186

Query: 204 VGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRF 261
                ++A E L    Y   +DVWS GV+L+ ++S G  P+ G T +++++ +      +
Sbjct: 187 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG---Y 243

Query: 262 PSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH 297
             +   +      DL+    R  P  R + A++L  
Sbjct: 244 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (488), Expect = 7e-59
 Identities = 77/292 (26%), Positives = 130/292 (44%), Gaps = 34/292 (11%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           + +   +++G G +GV+ +  +K TGEV+A K I  D   T     +   EI ++ +L+ 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELN- 59

Query: 100 HPNVVDLKAVYEEEDYVHLLMELCA-GGELFHRLEKYGRFSETEARVIFRHLMQVVSYCH 158
           HPN+V L  V   E+ ++L+ E      + F              +     L+Q +++CH
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119

Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT-VGSPFYIAPEVLAG 217
            + V+HRDLKP+N+L+   ++   IKLADFGLA         +   V + +Y APE+L G
Sbjct: 120 SHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176

Query: 218 G--YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWD-------- 267
              Y+ A D+WS G I   +++    F G ++      +           W         
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236

Query: 268 -----------------HISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
                             +    R L+  ML  DP+ R++A   LAH + ++
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  191 bits (487), Expect = 8e-59
 Identities = 51/281 (18%), Positives = 104/281 (37%), Gaps = 21/281 (7%)

Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKL 97
           + +RY LG+++G G FG I   +D   GE +A K               + +E +I   +
Sbjct: 5   VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK-----TKHPQLHIESKIYKMM 59

Query: 98  SGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYC 157
            G   +  ++    E DY  ++MEL              +FS     ++   ++  + Y 
Sbjct: 60  QGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 119

Query: 158 HGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN--------LHGTVGSPFY 209
           H    +HRD+KP+N L+      + + + DFGLA   +  +              G+  Y
Sbjct: 120 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179

Query: 210 IAPEVLAGG-YNQAADVWSAGVILYILLSGMPPF---WGKTKSKIFDAVRAADLRFPSDP 265
            +     G   ++  D+ S G +L     G  P+      TK + ++ +    +  P + 
Sbjct: 180 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239

Query: 266 -WDHISASARDLIMGMLRVDPSTRLTAAEV---LAHSWMEE 302
                 +     +     +    +   + +     + +  +
Sbjct: 240 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (484), Expect = 2e-58
 Identities = 70/292 (23%), Positives = 124/292 (42%), Gaps = 34/292 (11%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
            +Y   +++G G +G + +  ++ T E++A K +  D         S   EI ++ +L  
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELK- 59

Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG 159
           H N+V L  V   +  + L+ E C      +     G       +     L++ + +CH 
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119

Query: 160 NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA-GQNLHGTVGSPFYIAPEVLAGG 218
             V+HRDLKP+N+L+   + +  +KLA+FGLA       +     V + +Y  P+VL G 
Sbjct: 120 RNVLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176

Query: 219 --YNQAADVWSAGVILYILLSG-MPPFWGKTKSKIFDAVRAADLRFPSDPWD-------- 267
             Y+ + D+WSAG I   L +   P F G         +         + W         
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236

Query: 268 -----------------HISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE 302
                             ++A+ RDL+  +L+ +P  R++A E L H +  +
Sbjct: 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  189 bits (480), Expect = 1e-57
 Identities = 65/283 (22%), Positives = 125/283 (44%), Gaps = 26/283 (9%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGE---VLACKSIAKDRLVTVEDVRSIKLEIEIMTK 96
               + + +G G+FG +     K  G+    +A K++      T +  R    E  IM +
Sbjct: 26  SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQ 83

Query: 97  LSGHPNVVDLKAVYEEEDYVHLLMELCAGGELF-HRLEKYGRFSETEARVIFRHLMQVVS 155
              HPNV+ L+ V  +   V ++ E    G L     +  G+F+  +   + R +   + 
Sbjct: 84  FD-HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMK 142

Query: 156 YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLH------GTVGSPFY 209
           Y      VHRDL   NIL+   +S+   K++DFGL+ +++   +        G      +
Sbjct: 143 YLADMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRW 199

Query: 210 IAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWD 267
            APE +    +  A+DVWS G++++ ++S G  P+W  T   + +A+   D R P  P  
Sbjct: 200 TAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE-QDYRLP--PPM 256

Query: 268 HISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKP 310
              ++   L++   + D + R    +++        +++ + P
Sbjct: 257 DCPSALHQLMLDCWQKDRNHRPKFGQIV-----NTLDKMIRNP 294

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (476), Expect = 1e-57
 Identities = 62/263 (23%), Positives = 109/263 (41%), Gaps = 21/263 (7%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
               L + +G G+FG +      + G  +A K I  D        ++   E  +MT+L  
Sbjct: 7   KELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKND-----ATAQAFLAEASVMTQLR- 58

Query: 100 HPNVVDLKAV-YEEEDYVHLLMELCAGGELFHRLEKYGR--FSETEARVIFRHLMQVVSY 156
           H N+V L  V  EE+  ++++ E  A G L   L   GR              + + + Y
Sbjct: 59  HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 118

Query: 157 CHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLA 216
             GN  VHRDL   N+L++  +     K++DFGL     + Q+         + APE L 
Sbjct: 119 LEGNNFVHRDLAARNVLVSEDNV---AKVSDFGLTKEASSTQD--TGKLPVKWTAPEALR 173

Query: 217 GG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASAR 274
              ++  +DVWS G++L+ + S G  P+       +   V      +  D  D    +  
Sbjct: 174 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG---YKMDAPDGCPPAVY 230

Query: 275 DLIMGMLRVDPSTRLTAAEVLAH 297
           +++     +D + R +  ++   
Sbjct: 231 EVMKNCWHLDAAMRPSFLQLREQ 253

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (475), Expect = 3e-57
 Identities = 61/263 (23%), Positives = 116/263 (44%), Gaps = 17/263 (6%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
                 +++G GQFG++         + +A K+I +  +   + +     E E+M KLS 
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIE----EAEVMMKLS- 58

Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELF-HRLEKYGRFSETEARVIFRHLMQVVSYCH 158
           HP +V L  V  E+  + L+ E    G L  +   + G F+      +   + + ++Y  
Sbjct: 59  HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 118

Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ--NLHGTVGSPFYIAPEVLA 216
              V+HRDL   N L+     +  IK++DFG+  ++   Q  +  GT     + +PEV +
Sbjct: 119 EACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS 175

Query: 217 GG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASAR 274
              Y+  +DVWS GV+++ + S G  P+  ++ S++ + +      F        S    
Sbjct: 176 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG---FRLYKPRLASTHVY 232

Query: 275 DLIMGMLRVDPSTRLTAAEVLAH 297
            ++    +  P  R   + +L  
Sbjct: 233 QIMNHCWKERPEDRPAFSRLLRQ 255

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  187 bits (476), Expect = 3e-57
 Identities = 65/283 (22%), Positives = 122/283 (43%), Gaps = 22/283 (7%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
               +  +LG GQ+G + E   K     +A K++ +D +    +V     E  +M ++  
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK- 71

Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGR--FSETEARVIFRHLMQVVSYC 157
           HPN+V L  V   E   +++ E    G L   L +  R   S      +   +   + Y 
Sbjct: 72  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 131

Query: 158 HGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLH--GTVGSPFYIAPEVL 215
                +HRDL   N L+     +  +K+ADFGL+  +         G      + APE L
Sbjct: 132 EKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 188

Query: 216 AGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASA 273
           A   ++  +DVW+ GV+L+ + + GM P+ G   S++++ +      +  +  +      
Sbjct: 189 AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK---DYRMERPEGCPEKV 245

Query: 274 RDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKPCKQDDL 316
            +L+    + +PS R + AE+      +  E + Q+    D++
Sbjct: 246 YELMRACWQWNPSDRPSFAEIH-----QAFETMFQESSISDEV 283

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 6e-57
 Identities = 62/277 (22%), Positives = 115/277 (41%), Gaps = 22/277 (7%)

Query: 40  DRYVLG---KQLGWGQFGVIREC--SDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
           DR +L    K+LG G FG +++     K   + +A K + K+          +  E  +M
Sbjct: 4   DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVM 62

Query: 95  TKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVV 154
            +L  +P +V +  + E E ++ L+ME+   G L   L++     +     +   +   +
Sbjct: 63  QQLD-NPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGM 120

Query: 155 SYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT----VGSPFYI 210
            Y   +  VHRDL   N+LL    +    K++DFGL+  ++A +N +           + 
Sbjct: 121 KYLEESNFVHRDLAARNVLL---VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY 177

Query: 211 APEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDH 268
           APE +    ++  +DVWS GV+++   S G  P+ G   S++   +   +          
Sbjct: 178 APECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE---RMGCPAG 234

Query: 269 ISASARDLIMGMLRVDPSTRLTAAEVLA--HSWMEEC 303
                 DL+      D   R   A V     ++  + 
Sbjct: 235 CPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 271

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (474), Expect = 6e-57
 Identities = 72/273 (26%), Positives = 112/273 (41%), Gaps = 21/273 (7%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           +   L  +LG G FG +   +   T  V A K++    +       +   E ++M KL  
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLR- 70

Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGEL--FHRLEKYGRFSETEARVIFRHLMQVVSYC 157
           H  +V L AV  EE   +++ E  + G L  F + E        +   +   +   ++Y 
Sbjct: 71  HEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 129

Query: 158 HGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN--LHGTVGSPFYIAPEVL 215
                VHRDL+  NIL+     +   K+ADFGLA  I+  +     G      + APE  
Sbjct: 130 ERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 186

Query: 216 AGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASA 273
             G +   +DVWS G++L  L + G  P+ G    ++ D V     R P  P      S 
Sbjct: 187 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPP--ECPESL 243

Query: 274 RDLIMGMLRVDPSTRLTAAEVLA--HSWMEECE 304
            DL+    R +P  R T   + A    +    E
Sbjct: 244 HDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (472), Expect = 6e-57
 Identities = 58/263 (22%), Positives = 110/263 (41%), Gaps = 17/263 (6%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
                 K+LG GQFGV++    +     +A K I +  +   E +     E ++M  LS 
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIE----EAKVMMNLS- 57

Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLE-KYGRFSETEARVIFRHLMQVVSYCH 158
           H  +V L  V  ++  + ++ E  A G L + L     RF   +   + + + + + Y  
Sbjct: 58  HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 117

Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLH--GTVGSPFYIAPEVLA 216
               +HRDL   N L+   +    +K++DFGL+ Y+   +     G+     +  PEVL 
Sbjct: 118 SKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLM 174

Query: 217 GG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASAR 274
              ++  +D+W+ GV+++ + S G  P+   T S+  + +               S    
Sbjct: 175 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG---LRLYRPHLASEKVY 231

Query: 275 DLIMGMLRVDPSTRLTAAEVLAH 297
            ++          R T   +L++
Sbjct: 232 TIMYSCWHEKADERPTFKILLSN 254

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (476), Expect = 2e-56
 Identities = 66/307 (21%), Positives = 127/307 (41%), Gaps = 40/307 (13%)

Query: 37  NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTK 96
            + +RY     +G G +G +    D  TG  +A K +++    ++   +    E+ ++  
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKH 73

Query: 97  LSGHPNVVDLKAVYEEE----DYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQ 152
           +  H NV+ L  V+       ++  + +     G   + + K  + ++   + +   +++
Sbjct: 74  MK-HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 132

Query: 153 VVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGSPFYIAP 212
            + Y H   ++HRDLKP N+     +    +K+ DFGLA +      + G V + +Y AP
Sbjct: 133 GLKYIHSADIIHRDLKPSNLA---VNEDCELKILDFGLARHT--DDEMTGYVATRWYRAP 187

Query: 213 EVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFP-------- 262
           E++     YNQ  D+WS G I+  LL+G   F G         +                
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247

Query: 263 -------------------SDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEEC 303
                              ++ +   +  A DL+  ML +D   R+TAA+ LAH++  + 
Sbjct: 248 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307

Query: 304 EQVAQKP 310
                +P
Sbjct: 308 HDPDDEP 314

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (469), Expect = 2e-56
 Identities = 62/275 (22%), Positives = 105/275 (38%), Gaps = 19/275 (6%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFT---GEVLACKSIAKDRLVTVEDVRSIKLEIEIMTK 96
               L ++LG G FGV+R             +A K +  D L   E +     E+  M  
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 97  LSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRL-EKYGRFSETEARVIFRHLMQVVS 155
           L  H N++ L  V        ++ EL   G L  RL +  G F           + + + 
Sbjct: 68  LD-HRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 125

Query: 156 YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT----VGSPFYIA 211
           Y      +HRDL   N+LL   ++   +K+ DFGL   +    + +           + A
Sbjct: 126 YLESKRFIHRDLAARNLLL---ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182

Query: 212 PEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHI 269
           PE L    ++ A+D W  GV L+ + + G  P+ G   S+I   +     R P    +  
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR--PEDC 240

Query: 270 SASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECE 304
                ++++      P  R T   +    ++ E +
Sbjct: 241 PQDIYNVMVQCWAHKPEDRPTFVALR--DFLLEAQ 273

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 7e-56
 Identities = 69/271 (25%), Positives = 115/271 (42%), Gaps = 16/271 (5%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRS-IKLEIEIMTKLS 98
           +R  LG+ +G GQFG + +             +I   +  T + VR     E   M +  
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 99  GHPNVVDLKAVYEEEDYVHLLMELCAGGELF-HRLEKYGRFSETEARVIFRHLMQVVSYC 157
            HP++V L  V  E + V ++MELC  GEL      +          +    L   ++Y 
Sbjct: 67  -HPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 124

Query: 158 HGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT--VGSPFYIAPEVL 215
                VHRD+   N+L+   SS+  +KL DFGL+ Y++       +       ++APE +
Sbjct: 125 ESKRFVHRDIAARNVLV---SSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 181

Query: 216 AGG-YNQAADVWSAGVILY-ILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASA 273
               +  A+DVW  GV ++ IL+ G+ PF G   + +   +   +         +   + 
Sbjct: 182 NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE---RLPMPPNCPPTL 238

Query: 274 RDLIMGMLRVDPSTRLTAAEVLAH--SWMEE 302
             L+      DPS R    E+ A   + +EE
Sbjct: 239 YSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (465), Expect = 9e-56
 Identities = 59/263 (22%), Positives = 112/263 (42%), Gaps = 19/263 (7%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSG 99
           +   L ++LG GQFG +           +A KS+ +  +       +   E  +M +L  
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQ- 66

Query: 100 HPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYG--RFSETEARVIFRHLMQVVSYC 157
           H  +V L AV  +E  ++++ E    G L   L+     + +  +   +   + + +++ 
Sbjct: 67  HQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 125

Query: 158 HGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLH--GTVGSPFYIAPEVL 215
                +HRDL+  NIL+   S +   K+ADFGLA  I+  +     G      + APE +
Sbjct: 126 EERNYIHRDLRAANILV---SDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 182

Query: 216 AGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASA 273
             G +   +DVWS G++L  +++ G  P+ G T  ++   +      +     D+     
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG---YRMVRPDNCPEEL 239

Query: 274 RDLIMGMLRVDPSTRLTAAEVLA 296
             L+    +  P  R T   + +
Sbjct: 240 YQLMRLCWKERPEDRPTFDYLRS 262

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (456), Expect = 6e-54
 Identities = 63/284 (22%), Positives = 107/284 (37%), Gaps = 35/284 (12%)

Query: 40  DRYVLGKQLGWGQFGVIRECSD-----KFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
           +R   GK LG G FG + E +            +A K +       + +  ++  E++++
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVL 80

Query: 95  TKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYG------------------ 136
           + L  H N+V+L           ++ E C  G+L + L +                    
Sbjct: 81  SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140

Query: 137 RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA 196
                +       + + +++      +HRDL   NILL   +     K+ DFGLA  IK 
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL---THGRITKICDFGLARDIKN 197

Query: 197 GQNLHGT---VGSPFYIAPEVLAGGY-NQAADVWSAGVILYILLS-GMPPFWGKTKSKIF 251
             N            ++APE +        +DVWS G+ L+ L S G  P+ G      F
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257

Query: 252 DAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVL 295
             +     R  S   +H  A   D++      DP  R T  +++
Sbjct: 258 YKMIKEGFRMLS--PEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  178 bits (451), Expect = 2e-53
 Identities = 44/272 (16%), Positives = 97/272 (35%), Gaps = 20/272 (7%)

Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKL 97
           +   Y +G+++G G FGVI E ++    + +A K   +       D   ++ E      L
Sbjct: 3   VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR-----SDAPQLRDEYRTYKLL 57

Query: 98  SGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYC 157
           +G   + ++    +E  +  L+++L              +FS     +  + ++  V   
Sbjct: 58  AGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSI 117

Query: 158 HGNGVVHRDLKPENILLA--TKSSSSPIKLADFGLATYIKAG--------QNLHGTVGSP 207
           H   +V+RD+KP+N L+      +++ I + DFG+  + +          +      G+ 
Sbjct: 118 HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177

Query: 208 FYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDP- 265
            Y++     G   ++  D+ + G +    L G  P+ G   +           +  S P 
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237

Query: 266 ---WDHISASARDLIMGMLRVDPSTRLTAAEV 294
                         +     +          +
Sbjct: 238 RELCAGFPEEFYKYMHYARNLAFDATPDYDYL 269

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (452), Expect = 3e-53
 Identities = 56/271 (20%), Positives = 106/271 (39%), Gaps = 15/271 (5%)

Query: 34  QISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAK--DRLVTVEDVRSIKLEI 91
           +I   ++ +   K LG G FG + +      GE +      K      + +  + I  E 
Sbjct: 4   RILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 62

Query: 92  EIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLM 151
            +M  +  +P+V  L  +        +   +  G  L +  E                + 
Sbjct: 63  YVMASVD-NPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 121

Query: 152 QVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLH---GTVGSPF 208
           + ++Y     +VHRDL   N+L+    +   +K+ DFGLA  + A +  +   G      
Sbjct: 122 KGMNYLEDRRLVHRDLAARNVLV---KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 178

Query: 209 YIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPW 266
           ++A E +    Y   +DVWS GV ++ L++ G  P+ G   S+I   +     R P  P 
Sbjct: 179 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPP- 236

Query: 267 DHISASARDLIMGMLRVDPSTRLTAAEVLAH 297
              +     +++    +D  +R    E++  
Sbjct: 237 -ICTIDVYMIMVKCWMIDADSRPKFRELIIE 266

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 3e-53
 Identities = 59/280 (21%), Positives = 105/280 (37%), Gaps = 23/280 (8%)

Query: 40  DRYVLGK-QLGWGQFGVIRECSDKFTGE--VLACKSIAKDRLVTVEDVRSIKLEIEIMTK 96
           D  ++   +LG G FG +R+   +   +   +A K + +       D   +  E +IM +
Sbjct: 8   DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQ 65

Query: 97  LSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRL-EKYGRFSETEARVIFRHLMQVVS 155
           L  +P +V L  V + E    L+ME+  GG L   L  K      +    +   +   + 
Sbjct: 66  LD-NPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMK 123

Query: 156 YCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLH----GTVGSPFYIA 211
           Y      VHRDL   N+LL    +    K++DFGL+  + A  + +           + A
Sbjct: 124 YLEEKNFVHRDLAARNVLL---VNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA 180

Query: 212 PEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHI 269
           PE +    ++  +DVWS GV ++  LS G  P+      ++   +         +     
Sbjct: 181 PECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK---RMECPPEC 237

Query: 270 SASARDLIMGMLRVDPSTRLTAAEV---LAHSWMEECEQV 306
                 L+          R     V   +   +     +V
Sbjct: 238 PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 277

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  175 bits (444), Expect = 2e-52
 Identities = 60/300 (20%), Positives = 112/300 (37%), Gaps = 46/300 (15%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDK-----FTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
           +     + +G G FG + +             ++A K + ++   + +     + E  +M
Sbjct: 13  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALM 70

Query: 95  TKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGR----------------- 137
            +   +PN+V L  V      + LL E  A G+L   L                      
Sbjct: 71  AEFD-NPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 129

Query: 138 -------FSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGL 190
                   S  E   I R +   ++Y      VHRDL   N L+     +  +K+ADFGL
Sbjct: 130 SSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV---GENMVVKIADFGL 186

Query: 191 ATYIKAGQNLHGT---VGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGK 245
           +  I +               ++ PE +    Y   +DVW+ GV+L+ + S G+ P++G 
Sbjct: 187 SRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 246

Query: 246 TKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE-CE 304
              ++   VR  ++       ++      +L+       P+ R +   +  H  ++  CE
Sbjct: 247 AHEEVIYYVRDGNIL---ACPENCPLELYNLMRLCWSKLPADRPSFCSI--HRILQRMCE 301

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (438), Expect = 2e-51
 Identities = 56/283 (19%), Positives = 108/283 (38%), Gaps = 30/283 (10%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGE-------VLACKSIAKDRLVTVEDVRSIKLEIE 92
           DR VLGK LG G FG +         +        +A K +  D   T +D+  +  E+E
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEME 70

Query: 93  IMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYG---------------- 136
           +M  +  H N+++L     ++  +++++E  + G L   L+                   
Sbjct: 71  MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130

Query: 137 RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA 196
           + S  +       + + + Y      +HRDL   N+L+   +              +I  
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190

Query: 197 GQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAV 254
            +          ++APE L    Y   +DVWS GV+L+ + + G  P+ G    ++F  +
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 250

Query: 255 RAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH 297
           +        D   + +     ++       PS R T  +++  
Sbjct: 251 KEG---HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (438), Expect = 7e-51
 Identities = 81/349 (23%), Positives = 138/349 (39%), Gaps = 62/349 (17%)

Query: 19  SYKVSSLTGTILDATQISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRL 78
           S +V   T T+L          RY   K +G G  G++    D      +A K +++   
Sbjct: 5   SVEVGDSTFTVLK---------RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-F 54

Query: 79  VTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVY------EEEDYVHLLMELCAGGELFHRL 132
                 +    E+ +M  ++ H N++ L  V+      EE   V+L+MEL          
Sbjct: 55  QNQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI- 112

Query: 133 EKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLAT 192
                        +   ++  + + H  G++HRDLKP NI++    S   +K+ DFGLA 
Sbjct: 113 --QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLAR 167

Query: 193 YIKAGQNLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIF 251
                  +   V + +Y APEV+ G GY +  D+WS G I+  ++     F G+     +
Sbjct: 168 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW 227

Query: 252 DAV---------------------------RAADLRFP-----------SDPWDHISASA 273
           + V                           + A L FP           S+     ++ A
Sbjct: 228 NKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQA 287

Query: 274 RDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKPCKQDDLCCKQLE 322
           RDL+  ML +DP+ R++  + L H ++      A+       +  KQL+
Sbjct: 288 RDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLD 336

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (418), Expect = 2e-48
 Identities = 68/283 (24%), Positives = 113/283 (39%), Gaps = 30/283 (10%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRL---VTVEDVRSIKLEIEIMTK 96
           DR  LGK LG G FG + E       +   C+++A   L    T  + R++  E++I+  
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 97  LSGHPNVVDLK-AVYEEEDYVHLLMELCAGGELFHRLEKYGR----------------FS 139
           +  H NVV+L  A  +    + +++E C  G L   L                      +
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 140 ETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN 199
                     + + + +      +HRDL   NILL   S  + +K+ DFGLA  I    +
Sbjct: 133 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPD 189

Query: 200 LHGT---VGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGM-PPFWGKTKSKIFDAV 254
                       ++APE +    Y   +DVWS GV+L+ + S    P+ G    + F   
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249

Query: 255 RAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH 297
                R      D+ +      ++     +PS R T +E++ H
Sbjct: 250 LKEGTRMR--APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (411), Expect = 8e-48
 Identities = 59/282 (20%), Positives = 117/282 (41%), Gaps = 25/282 (8%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDKFTGE----VLACKSIAKDRLVTVEDVRSIKLEIEIMT 95
                 K +G G+FG + +   K +       +A K++      T +       E  IM 
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMG 64

Query: 96  KLSGHPNVVDLKAVYEEEDYVHLLMELCAGG-ELFHRLEKYGRFSETEARVIFRHLMQVV 154
           + S H N++ L+ V  +   + ++ E    G       EK G FS  +   + R +   +
Sbjct: 65  QFS-HHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGM 123

Query: 155 SYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN----LHGTVGSPFYI 210
            Y      VHRDL   NIL+ +       K++DFGL+  ++          G      + 
Sbjct: 124 KYLANMNYVHRDLAARNILVNSNLV---CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180

Query: 211 APEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDH 268
           APE ++   +  A+DVWS G++++ +++ G  P+W  +  ++  A+      F       
Sbjct: 181 APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND---GFRLPTPMD 237

Query: 269 ISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQKP 310
             ++   L+M   + + + R   A+++        +++ + P
Sbjct: 238 CPSAIYQLMMQCWQQERARRPKFADIV-----SILDKLIRAP 274

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (412), Expect = 1e-47
 Identities = 64/301 (21%), Positives = 114/301 (37%), Gaps = 55/301 (18%)

Query: 38  LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKL 97
           ++   VL + +G G+FG +     K+ GE +A K  +        + RS   E EI   +
Sbjct: 1   IARTIVLQESIGKGRFGEVWRG--KWRGEEVAVKIFSS------REERSWFREAEIYQTV 52

Query: 98  S-GHPNVVDLKAVYEEED----YVHLLMELCAGGELFHRLEKYGRFSET-------EARV 145
              H N++   A   +++     + L+ +    G LF  L +Y    E         A  
Sbjct: 53  MLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASG 112

Query: 146 IFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN-----L 200
           +    M++V       + HRDLK +NIL+     +    +AD GLA    +  +      
Sbjct: 113 LAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTIDIAP 169

Query: 201 HGTVGSPFYIAPEVLAGG-------YNQAADVWSAGVILYILLSGMPPFWGK-------- 245
           +  VG+  Y+APEVL            + AD+++ G++ + +                  
Sbjct: 170 NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 229

Query: 246 -------TKSKIFDAVRAADLRFPSDPWDHISASA----RDLIMGMLRVDPSTRLTAAEV 294
                  +  ++   V    LR P+ P    S  A      ++      + + RLTA  +
Sbjct: 230 DLVPSDPSVEEMRKVVCEQKLR-PNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI 288

Query: 295 L 295
            
Sbjct: 289 K 289

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (411), Expect = 2e-47
 Identities = 56/278 (20%), Positives = 114/278 (41%), Gaps = 29/278 (10%)

Query: 40  DRYVLGKQLGWGQFGVIRECSDK-----FTGEVLACKSIAKDRLVTVEDVRSIKLEIEIM 94
           ++  + ++LG G FG++ E   K          +A K++ +    ++ +      E  +M
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVM 77

Query: 95  TKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRF----------SETEAR 144
            + +   +VV L  V  +     ++MEL   G+L   L                S ++  
Sbjct: 78  KEFN-CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136

Query: 145 VIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGT- 203
            +   +   ++Y + N  VHRDL   N ++   +    +K+ DFG+   I          
Sbjct: 137 QMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDFTVKIGDFGMTRDIYETDYYRKGG 193

Query: 204 --VGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGM-PPFWGKTKSKIFDAVRAADL 259
             +    +++PE L  G +   +DVWS GV+L+ + +    P+ G +  ++   V    L
Sbjct: 194 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL 253

Query: 260 RFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH 297
               D  D+      +L+    + +P  R +  E+++ 
Sbjct: 254 L---DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (405), Expect = 2e-46
 Identities = 56/266 (21%), Positives = 104/266 (39%), Gaps = 21/266 (7%)

Query: 44  LGKQLGWGQFGVI---RECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH 100
             + +G G FG +       +       A KS+  +R+  + +V     E  IM   S H
Sbjct: 31  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFS-H 87

Query: 101 PNVVDLKAV-YEEEDYVHLLMELCAGGELF-HRLEKYGRFSETEARVIFRHLMQVVSYCH 158
           PNV+ L  +    E    +++     G+L      +    +  +       + + + +  
Sbjct: 88  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 147

Query: 159 GNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ-----NLHGTVGSPFYIAPE 213
               VHRDL   N +L        +K+ADFGLA  +   +     N  G      ++A E
Sbjct: 148 SKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 204

Query: 214 VLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISA 271
            L    +   +DVWS GV+L+ L++ G PP+       I   +     R    P ++   
Sbjct: 205 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG--RRLLQP-EYCPD 261

Query: 272 SARDLIMGMLRVDPSTRLTAAEVLAH 297
              ++++         R + +E+++ 
Sbjct: 262 PLYEVMLKCWHPKAEMRPSFSELVSR 287

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  156 bits (395), Expect = 1e-44
 Identities = 67/322 (20%), Positives = 122/322 (37%), Gaps = 62/322 (19%)

Query: 41  RYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEI------M 94
           RY+L ++LGWG F  +    D      +A K +  D++ T      IKL   +       
Sbjct: 14  RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTK 73

Query: 95  TKLSGHPNVVDLKAVYEE--EDYVHLLMELCAGG---ELFHRLEKYGRFSETEARVIFRH 149
               G  +++ L   +     + VH++M     G       +  ++        + I + 
Sbjct: 74  EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133

Query: 150 LMQVVSYCHGN-GVVHRDLKPENILLATKSSSSP---IKLADFGLATYIKAGQNLHGTVG 205
           L+  + Y H   G++H D+KPEN+L+    S      IK+AD G A +    ++   ++ 
Sbjct: 134 LLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD--EHYTNSIQ 191

Query: 206 SPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPF---------------------W 243
           +  Y +PEVL G  +   AD+WS   +++ L++G   F                      
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELL 251

Query: 244 GKTKSKIFDAVRAADLRFPSDP-----------------------WDHISASARDLIMGM 280
           G+  S +    +     F S                             +    D +  M
Sbjct: 252 GELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPM 311

Query: 281 LRVDPSTRLTAAEVLAHSWMEE 302
           L++DP  R  A  ++ H W+++
Sbjct: 312 LQLDPRKRADAGGLVNHPWLKD 333

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 82.9 bits (204), Expect = 3e-19
 Identities = 41/215 (19%), Positives = 70/215 (32%), Gaps = 47/215 (21%)

Query: 42  YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLV---------------TVEDVRS 86
             +GK +G G+   +  C  +        K                       +V  +RS
Sbjct: 2   DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60

Query: 87  IKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVI 146
            + E   + KL     V  + A         +LMEL    EL+    +           +
Sbjct: 61  ARNEFRALQKLQ-GLAVPKVYAWEGN----AVLMELIDAKELYRVRVENPDE-------V 108

Query: 147 FRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNLHGTVGS 206
              +++ V+  +  G+VH DL   N+L+    S   I + DF  +  +       G  G 
Sbjct: 109 LDMILEEVAKFYHRGIVHGDLSQYNVLV----SEEGIWIIDFPQSVEV-------GEEGW 157

Query: 207 PFYIAPEV------LAGGYNQAADVWSAGVILYIL 235
              +  +V       +  Y    D+ S   I  IL
Sbjct: 158 REILERDVRNIITYFSRTYRTEKDINS--AIDRIL 190

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	419
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.91
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.6
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.2
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.97
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.26
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.05
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.82

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.5e-62  Score=474.65  Aligned_cols=267  Identities=40%  Similarity=0.699  Sum_probs=227.0

Q ss_pred             hccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeC
Q 014733           34 QISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEE  113 (419)
Q Consensus        34 ~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~  113 (419)
                      +.+++.++|++++.||+|+||+||+|+++.+|+.||+|++.++...  .....+.+|+.+|++++ |||||++++++.++
T Consensus         3 ~~edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~   79 (307)
T d1a06a_           3 QAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE--GKEGSMENEIAVLHKIK-HPNIVALDDIYESG   79 (307)
T ss_dssp             ECSCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCC-CTTBCCEEEEEECS
T ss_pred             CCCCCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh--hHHHHHHHHHHHHHhCC-CCCCCcEEEEEEEC
Confidence            4567889999999999999999999999999999999999876542  23466889999999996 99999999999999


Q ss_pred             CEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceee
Q 014733          114 DYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATY  193 (419)
Q Consensus       114 ~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~  193 (419)
                      +.+|+||||++||+|.+++...+++++.+++.++.||+.||+|||++||+||||||+|||+...+.++.+||+|||+++.
T Consensus        80 ~~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~  159 (307)
T d1a06a_          80 GHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM  159 (307)
T ss_dssp             SEEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred             CEEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEE
Confidence            99999999999999999999888999999999999999999999999999999999999997666678999999999998


Q ss_pred             eccCCccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHH
Q 014733          194 IKAGQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISAS  272 (419)
Q Consensus       194 ~~~~~~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  272 (419)
                      ..........+||+.|+|||++.+. |+.++|||||||++|+|++|++||.+....++...+......++...+..+|++
T Consensus       160 ~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  239 (307)
T d1a06a_         160 EDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDS  239 (307)
T ss_dssp             -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHH
T ss_pred             ccCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHH
Confidence            7666666677899999999999875 999999999999999999999999999999999999999888888778899999


Q ss_pred             HHHHHHhhhhcCCCCCCCHHHHHhccccccc
Q 014733          273 ARDLIMGMLRVDPSTRLTAAEVLAHSWMEEC  303 (419)
Q Consensus       273 l~~li~~~L~~dP~~Rps~~eil~hp~~~~~  303 (419)
                      +++||.+||++||++|||+.|+++||||++.
T Consensus       240 ~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  270 (307)
T d1a06a_         240 AKDFIRHLMEKDPEKRFTCEQALQHPWIAGD  270 (307)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred             HHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence            9999999999999999999999999999753

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-62  Score=462.22  Aligned_cols=254  Identities=32%  Similarity=0.626  Sum_probs=232.5

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      ++|++++.||+|+||+||+|+++.+|+.||+|++.+.........+.+.+|+++|++++ |||||++++++.+++.+|+|
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~iv   84 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATRVYLI   84 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcC-CCCCCeEEEEEEECCEEEEE
Confidence            68999999999999999999999999999999997654433345677899999999996 99999999999999999999


Q ss_pred             EeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCCc
Q 014733          120 MELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN  199 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~~  199 (419)
                      |||++||+|.+++...+++++.+++.++.||++||+|||++||+||||||+|||+   +.++.+||+|||++...... .
T Consensus        85 mEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill---~~~~~~kl~DFG~a~~~~~~-~  160 (263)
T d2j4za1          85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVHAPSS-R  160 (263)
T ss_dssp             EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCSCSCCCCC-C
T ss_pred             EeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeecccccee---cCCCCEeecccceeeecCCC-c
Confidence            9999999999999998999999999999999999999999999999999999999   56789999999999876443 3


Q ss_pred             cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHH
Q 014733          200 LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM  278 (419)
Q Consensus       200 ~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~  278 (419)
                      ....+||+.|+|||++.+. |+.++|||||||++|+|++|+.||.+.+..++...+....+.+|.    .+|+++++||.
T Consensus       161 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~  236 (263)
T d2j4za1         161 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLIS  236 (263)
T ss_dssp             CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCT----TSCHHHHHHHH
T ss_pred             ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCc----cCCHHHHHHHH
Confidence            3456899999999999885 899999999999999999999999999999999999888766553    68999999999


Q ss_pred             hhhhcCCCCCCCHHHHHhcccccc
Q 014733          279 GMLRVDPSTRLTAAEVLAHSWMEE  302 (419)
Q Consensus       279 ~~L~~dP~~Rps~~eil~hp~~~~  302 (419)
                      +||++||++|||+.|+|+||||..
T Consensus       237 ~~L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         237 RLLKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             HHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred             HHccCCHhHCcCHHHHHcCcCcCC
Confidence            999999999999999999999975

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-61  Score=462.13  Aligned_cols=270  Identities=39%  Similarity=0.655  Sum_probs=243.4

Q ss_pred             ccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCH---HhHHHHHHHHHHHHHccCCCCceeeeEEEE
Q 014733           35 ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTV---EDVRSIKLEIEIMTKLSGHPNVVDLKAVYE  111 (419)
Q Consensus        35 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~---~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~  111 (419)
                      ..++.++|++++.||+|+||+||+|+++.+|+.||+|++.+......   ...+.+.+|+.+|++++ |||||++++++.
T Consensus         5 ~~~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~   83 (293)
T d1jksa_           5 QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITLHEVYE   83 (293)
T ss_dssp             CSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEE
T ss_pred             CCCcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCC-CCCCCcEEEEEE
Confidence            34577999999999999999999999999999999999987654322   24678999999999996 999999999999


Q ss_pred             eCCEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCC-CCCeEEeeccc
Q 014733          112 EEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSS-SSPIKLADFGL  190 (419)
Q Consensus       112 ~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~-~~~vKL~DFgl  190 (419)
                      +.+.+|+||||++||+|.+++...+.+++.+++.++.||+.||+|||+.+|+||||||+|||++.++. ...+||+|||+
T Consensus        84 ~~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~  163 (293)
T d1jksa_          84 NKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL  163 (293)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             ECCEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhh
Confidence            99999999999999999999998889999999999999999999999999999999999999965432 23699999999


Q ss_pred             eeeeccCCccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCC
Q 014733          191 ATYIKAGQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHI  269 (419)
Q Consensus       191 a~~~~~~~~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  269 (419)
                      +.............||+.|+|||++.+. |+.++||||+||++|+|++|+.||.+.+..+....+......++...+..+
T Consensus       164 a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  243 (293)
T d1jksa_         164 AHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT  243 (293)
T ss_dssp             CEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTS
T ss_pred             hhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCC
Confidence            9988776666777899999999999875 999999999999999999999999999999999999998887777666789


Q ss_pred             CHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          270 SASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       270 s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                      |.++++||++||+.||++|||+.|+++||||+...+
T Consensus       244 s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~  279 (293)
T d1jksa_         244 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT  279 (293)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC---
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCh
Confidence            999999999999999999999999999999986543

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-61  Score=457.16  Aligned_cols=257  Identities=33%  Similarity=0.577  Sum_probs=220.2

Q ss_pred             cccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEE
Q 014733           38 LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVH  117 (419)
Q Consensus        38 ~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~  117 (419)
                      +.++|++++.||+|+||+||+|+++.+|+.||+|++.++..  .+..+.+.+|+++|++++ |||||++++++.+++.+|
T Consensus         3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~-HpnIv~~~~~~~~~~~~~   79 (271)
T d1nvra_           3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLN-HENVVKFYGHRREGNIQY   79 (271)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCC-CTTBCCEEEEEEETTEEE
T ss_pred             CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHhCC-CCCEeeEeeeeccCceeE
Confidence            45789999999999999999999999999999999987643  234567899999999996 999999999999999999


Q ss_pred             EEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccC
Q 014733          118 LLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG  197 (419)
Q Consensus       118 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~  197 (419)
                      +||||++||+|.+++...+.+++.+++.++.||++||+|||++||+||||||+|||+   +.++.+||+|||+|+.....
T Consensus        80 ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl---~~~~~~KL~DFG~a~~~~~~  156 (271)
T d1nvra_          80 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYN  156 (271)
T ss_dssp             EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEECEET
T ss_pred             EEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEE---CCCCCEEEccchhheeeccC
Confidence            999999999999999887889999999999999999999999999999999999999   56778999999999976543


Q ss_pred             C---ccccccCCCccCCcccccCC-C-CCchhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhcCCCCCCCCCCCCCH
Q 014733          198 Q---NLHGTVGSPFYIAPEVLAGG-Y-NQAADVWSAGVILYILLSGMPPFWGKTKSK-IFDAVRAADLRFPSDPWDHISA  271 (419)
Q Consensus       198 ~---~~~~~~gt~~y~aPE~l~~~-~-s~~sDvwSlGvil~elltG~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~s~  271 (419)
                      .   .....+||+.|+|||++.+. + +.++|||||||++|+|++|++||....... ....+....  .....+..+|+
T Consensus       157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~s~  234 (271)
T d1nvra_         157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK--TYLNPWKKIDS  234 (271)
T ss_dssp             TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTC--TTSTTGGGSCH
T ss_pred             CccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC--CCCCccccCCH
Confidence            2   23456899999999998774 4 678999999999999999999997655433 333333322  22334568999


Q ss_pred             HHHHHHHhhhhcCCCCCCCHHHHHhcccccc
Q 014733          272 SARDLIMGMLRVDPSTRLTAAEVLAHSWMEE  302 (419)
Q Consensus       272 ~l~~li~~~L~~dP~~Rps~~eil~hp~~~~  302 (419)
                      ++++||.+||+.||++|||++|+|+||||++
T Consensus       235 ~~~~li~~~L~~dP~~R~t~~eil~hpwf~~  265 (271)
T d1nvra_         235 APLALLHKILVENPSARITIPDIKKDRWYNK  265 (271)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence            9999999999999999999999999999974

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-61  Score=460.34  Aligned_cols=258  Identities=31%  Similarity=0.583  Sum_probs=231.4

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEE
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHL  118 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~l  118 (419)
                      .++|++++.||+|+||+||+|+++.+|+.||+|++.+.........+.+.+|+++|++++ ||||+++++++.+++.+|+
T Consensus         7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~i   85 (288)
T d1uu3a_           7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQDDEKLYF   85 (288)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-STTBCCEEEEEECSSEEEE
T ss_pred             CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcC-CCCeeEEEEEEEECCEEEE
Confidence            368999999999999999999999999999999998655434445678999999999996 9999999999999999999


Q ss_pred             EEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC
Q 014733          119 LMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ  198 (419)
Q Consensus       119 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~  198 (419)
                      ||||++||+|.+++...+.+++.+++.++.|++.||+|||+.|||||||||+|||+   +.++.+||+|||+|+.+....
T Consensus        86 vmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll---~~~~~vkl~DFG~a~~~~~~~  162 (288)
T d1uu3a_          86 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPES  162 (288)
T ss_dssp             EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECC---
T ss_pred             EEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCcccccc---CCCceEEecccccceecccCC
Confidence            99999999999999998999999999999999999999999999999999999999   567899999999999775332


Q ss_pred             ---ccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 014733          199 ---NLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASAR  274 (419)
Q Consensus       199 ---~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~  274 (419)
                         .....+||+.|+|||++.+. |+.++|||||||++|+|++|+.||.+.+..++.+++....+.+|.    .++++++
T Consensus       163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~  238 (288)
T d1uu3a_         163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE----KFFPKAR  238 (288)
T ss_dssp             -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCT----TCCHHHH
T ss_pred             cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCc----cCCHHHH
Confidence               23456899999999999875 999999999999999999999999999999999999888776653    6899999


Q ss_pred             HHHHhhhhcCCCCCCCHHH------HHhccccccch
Q 014733          275 DLIMGMLRVDPSTRLTAAE------VLAHSWMEECE  304 (419)
Q Consensus       275 ~li~~~L~~dP~~Rps~~e------il~hp~~~~~~  304 (419)
                      +||++||++||++|||++|      +++||||+.+.
T Consensus       239 ~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~  274 (288)
T d1uu3a_         239 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT  274 (288)
T ss_dssp             HHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred             HHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCC
Confidence            9999999999999999987      58899998764

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-60  Score=454.18  Aligned_cols=256  Identities=27%  Similarity=0.471  Sum_probs=227.0

Q ss_pred             cccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEE
Q 014733           38 LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVH  117 (419)
Q Consensus        38 ~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~  117 (419)
                      ..++|++.+.||+|+||+||+|.++.+|+.||+|++.+....   ..+.+.+|+.+|++++ |||||++++++.+++.+|
T Consensus        18 p~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~   93 (293)
T d1yhwa1          18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENK-NPNIVNYLDSYLVGDELW   93 (293)
T ss_dssp             TTTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEE
T ss_pred             cccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh---HHHHHHHHHHHHHhCC-CCCEeeEeEEEEECCEEE
Confidence            356899999999999999999999999999999999866432   3467899999999996 999999999999999999


Q ss_pred             EEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccC
Q 014733          118 LLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG  197 (419)
Q Consensus       118 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~  197 (419)
                      +||||++||+|.+++.+ +.+++.+++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++.+...
T Consensus        94 ivmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl---~~~~~vkl~DFG~a~~~~~~  169 (293)
T d1yhwa1          94 VVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPE  169 (293)
T ss_dssp             EEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCST
T ss_pred             EEEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEE---CCCCcEeeccchhheeeccc
Confidence            99999999999998866 679999999999999999999999999999999999999   56789999999999987544


Q ss_pred             C-ccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 014733          198 Q-NLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARD  275 (419)
Q Consensus       198 ~-~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~  275 (419)
                      . .....+||+.|+|||++.+. |+.++|||||||++|+|++|++||.+.+..+....+...... ....+..+|+++++
T Consensus       170 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~~  248 (293)
T d1yhwa1         170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP-ELQNPEKLSAIFRD  248 (293)
T ss_dssp             TCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSC-CCSSGGGSCHHHHH
T ss_pred             cccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC-CCCCcccCCHHHHH
Confidence            3 34556899999999999875 899999999999999999999999988877776666554322 22334579999999


Q ss_pred             HHHhhhhcCCCCCCCHHHHHhcccccc
Q 014733          276 LIMGMLRVDPSTRLTAAEVLAHSWMEE  302 (419)
Q Consensus       276 li~~~L~~dP~~Rps~~eil~hp~~~~  302 (419)
                      ||.+||++||++|||+.|+|+||||+.
T Consensus       249 li~~~L~~dP~~R~s~~eil~Hp~~~~  275 (293)
T d1yhwa1         249 FLNRCLDMDVEKRGSAKELLQHQFLKI  275 (293)
T ss_dssp             HHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred             HHHHHccCChhHCcCHHHHhcCHhhCC
Confidence            999999999999999999999999974

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2e-60  Score=467.56  Aligned_cols=263  Identities=34%  Similarity=0.628  Sum_probs=241.1

Q ss_pred             ccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEE
Q 014733           37 NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYV  116 (419)
Q Consensus        37 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~  116 (419)
                      ++-++|++++.||+|+||+||+|+++.+|+.||+|++.+..   ....+.+.+|+.+|++++ |||||++++++.+++.+
T Consensus        23 ~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~   98 (350)
T d1koaa2          23 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLR-HPTLVNLHDAFEDDNEM   98 (350)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS---HHHHHHHHHHHHHHHHTC-CTTBCCEEEEEEETTEE
T ss_pred             CCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc---hhhHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEE
Confidence            34579999999999999999999999999999999997653   355678999999999996 99999999999999999


Q ss_pred             EEEEeecCCCChHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeec
Q 014733          117 HLLMELCAGGELFHRLE-KYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIK  195 (419)
Q Consensus       117 ~lV~E~~~ggsL~~~l~-~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~  195 (419)
                      |+||||++||+|.+++. ..+++++.+++.++.||+.||+|||++|||||||||+|||++.+ .++.+||+|||+++.+.
T Consensus        99 ~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~-~~~~vkL~DFG~a~~~~  177 (350)
T d1koaa2          99 VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTK-RSNELKLIDFGLTAHLD  177 (350)
T ss_dssp             EEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST-TSCCEEECCCTTCEECC
T ss_pred             EEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccC-CCCeEEEeecchheecc
Confidence            99999999999999985 44679999999999999999999999999999999999999642 35789999999999887


Q ss_pred             cCCccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 014733          196 AGQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASAR  274 (419)
Q Consensus       196 ~~~~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~  274 (419)
                      ........+||+.|+|||++.+. |+.++|||||||++|+|++|+.||.+.+..+++..+......++...+..+|++++
T Consensus       178 ~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  257 (350)
T d1koaa2         178 PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK  257 (350)
T ss_dssp             TTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHH
T ss_pred             cccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence            77666778999999999999875 89999999999999999999999999999999999999988888777778999999


Q ss_pred             HHHHhhhhcCCCCCCCHHHHHhccccccch
Q 014733          275 DLIMGMLRVDPSTRLTAAEVLAHSWMEECE  304 (419)
Q Consensus       275 ~li~~~L~~dP~~Rps~~eil~hp~~~~~~  304 (419)
                      +||.+||++||++|||+.|+|+||||+...
T Consensus       258 ~li~~~L~~dP~~R~t~~eil~hp~~~~~~  287 (350)
T d1koaa2         258 DFIRKLLLADPNTRMTIHQALEHPWLTPGN  287 (350)
T ss_dssp             HHHHHHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred             HHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence            999999999999999999999999998654

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-60  Score=462.26  Aligned_cols=258  Identities=32%  Similarity=0.597  Sum_probs=237.0

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      ++|++++.||+|+||+||+|+++.+|+.||+|++.++........+.+.+|+.+|+++. ||||+++++++.+.+.+|+|
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-CTTBCCEEEEEECSSEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCC-CCCEEEEEeeeccccccccc
Confidence            68999999999999999999999999999999998765444456788999999999996 99999999999999999999


Q ss_pred             EeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeecc-CC
Q 014733          120 MELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA-GQ  198 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~-~~  198 (419)
                      |||++||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||+   +.+|.+||+|||+|+.... ..
T Consensus        84 ~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl---~~~g~vkl~DFG~a~~~~~~~~  160 (337)
T d1o6la_          84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGA  160 (337)
T ss_dssp             EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSCCTTC
T ss_pred             eeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEe---cCCCCEEEeecccccccccCCc
Confidence            9999999999999999999999999999999999999999999999999999999   5678999999999987644 34


Q ss_pred             ccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHH
Q 014733          199 NLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLI  277 (419)
Q Consensus       199 ~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li  277 (419)
                      .....+||+.|+|||++.+. |+.++|||||||++|||++|++||.+.+..++.+.+....+.+|.    .+|+++++||
T Consensus       161 ~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~dli  236 (337)
T d1o6la_         161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLL  236 (337)
T ss_dssp             CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHHH
T ss_pred             ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCc----cCCHHHHHHH
Confidence            45567999999999999874 999999999999999999999999999999999999998877654    6899999999


Q ss_pred             HhhhhcCCCCCCC-----HHHHHhccccccchh
Q 014733          278 MGMLRVDPSTRLT-----AAEVLAHSWMEECEQ  305 (419)
Q Consensus       278 ~~~L~~dP~~Rps-----~~eil~hp~~~~~~~  305 (419)
                      .+||++||.+|++     +.|+++||||+++.+
T Consensus       237 ~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~  269 (337)
T d1o6la_         237 AGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW  269 (337)
T ss_dssp             HHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred             HhhccCCchhhcccccccHHHHHcCcccccCCH
Confidence            9999999999994     999999999988654

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=4.4e-60  Score=465.45  Aligned_cols=263  Identities=33%  Similarity=0.608  Sum_probs=241.2

Q ss_pred             ccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEE
Q 014733           37 NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYV  116 (419)
Q Consensus        37 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~  116 (419)
                      .+.++|++++.||+|+||+||+|+++.+|+.||+|++.+..   ......+.+|+.+|++|+ |||||++++++.+++.+
T Consensus        26 ~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~  101 (352)
T d1koba_          26 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLH-HPKLINLHDAFEDKYEM  101 (352)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCC-STTBCCEEEEEECSSEE
T ss_pred             CcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc---hhHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEE
Confidence            35678999999999999999999999999999999997653   345677889999999996 99999999999999999


Q ss_pred             EEEEeecCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeec
Q 014733          117 HLLMELCAGGELFHRLEKYG-RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIK  195 (419)
Q Consensus       117 ~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~  195 (419)
                      |+|||||+||+|.+.+...+ ++++.+++.++.||+.||+|||++|||||||||+|||++. ..++.+||+|||+|..+.
T Consensus       102 ~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~-~~~~~vkL~DFGla~~~~  180 (352)
T d1koba_         102 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET-KKASSVKIIDFGLATKLN  180 (352)
T ss_dssp             EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTCCCEEECCCTTCEECC
T ss_pred             EEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccc-cCCCeEEEeecccceecC
Confidence            99999999999998876544 6999999999999999999999999999999999999954 246799999999999887


Q ss_pred             cCCccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 014733          196 AGQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASAR  274 (419)
Q Consensus       196 ~~~~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~  274 (419)
                      ........+||+.|+|||++.+. |+.++|||||||++|+|++|++||.+.+..++...+......++...+..+|++++
T Consensus       181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  260 (352)
T d1koba_         181 PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK  260 (352)
T ss_dssp             TTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHH
T ss_pred             CCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence            77666777999999999999875 99999999999999999999999999999999999999998888888889999999


Q ss_pred             HHHHhhhhcCCCCCCCHHHHHhccccccch
Q 014733          275 DLIMGMLRVDPSTRLTAAEVLAHSWMEECE  304 (419)
Q Consensus       275 ~li~~~L~~dP~~Rps~~eil~hp~~~~~~  304 (419)
                      +||.+||++||.+|||+.|+|+||||++..
T Consensus       261 ~li~~~L~~dp~~R~s~~eil~Hp~~~~~~  290 (352)
T d1koba_         261 DFIKNLLQKEPRKRLTVHDALEHPWLKGDH  290 (352)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             HHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence            999999999999999999999999998643

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.4e-59  Score=447.21  Aligned_cols=262  Identities=38%  Similarity=0.682  Sum_probs=240.5

Q ss_pred             cccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCC------HHhHHHHHHHHHHHHHccCCCCceeeeEEEE
Q 014733           38 LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVT------VEDVRSIKLEIEIMTKLSGHPNVVDLKAVYE  111 (419)
Q Consensus        38 ~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~------~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~  111 (419)
                      +.++|++++.||+|+||+||+|+++.+|+.||+|++.+.....      ....+.+.+|+.+|++++.||||+++++++.
T Consensus         1 f~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~   80 (277)
T d1phka_           1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   80 (277)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             CcccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc
Confidence            4689999999999999999999999999999999998765432      1234568899999999977999999999999


Q ss_pred             eCCEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccce
Q 014733          112 EEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA  191 (419)
Q Consensus       112 ~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla  191 (419)
                      +++.+||||||++||+|.+++...+++++.+++.++.||++||+|||++||+||||||+|||+   +.++.+||+|||++
T Consensus        81 ~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill---~~~~~~kl~DFG~a  157 (277)
T d1phka_          81 TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFS  157 (277)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTC
T ss_pred             cCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEE---cCCCCeEEccchhe
Confidence            999999999999999999999988999999999999999999999999999999999999999   67789999999999


Q ss_pred             eeeccCCccccccCCCccCCcccccC-------CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC
Q 014733          192 TYIKAGQNLHGTVGSPFYIAPEVLAG-------GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSD  264 (419)
Q Consensus       192 ~~~~~~~~~~~~~gt~~y~aPE~l~~-------~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~  264 (419)
                      +...........+||+.|+|||++.+       .++.++||||+||++|+|++|+.||.+.+..+..+.+..+....+..
T Consensus       158 ~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~  237 (277)
T d1phka_         158 CQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP  237 (277)
T ss_dssp             EECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred             eEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCc
Confidence            98876666666789999999999853       36889999999999999999999999999999999999988888877


Q ss_pred             CCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhcccccc
Q 014733          265 PWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE  302 (419)
Q Consensus       265 ~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~  302 (419)
                      .+..+|+++++||.+||++||++|||++|+|+||||++
T Consensus       238 ~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~  275 (277)
T d1phka_         238 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ  275 (277)
T ss_dssp             TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred             ccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence            77899999999999999999999999999999999985

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-59  Score=443.37  Aligned_cols=256  Identities=23%  Similarity=0.443  Sum_probs=222.5

Q ss_pred             ccCe-eeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEe----C
Q 014733           39 SDRY-VLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEE----E  113 (419)
Q Consensus        39 ~~~y-~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~----~  113 (419)
                      .+|| ++.++||+|+||+||+|.++.+++.||+|++..... .....+.+.+|+++|++++ |||||++++++.+    .
T Consensus         7 ~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~   84 (270)
T d1t4ha_           7 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGK   84 (270)
T ss_dssp             TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEESSSC
T ss_pred             CCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEeeccccC
Confidence            3455 778899999999999999999999999999987654 4566788999999999996 9999999999975    4


Q ss_pred             CEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--CeeccCCCCcEEEeecCCCCCeEEeeccce
Q 014733          114 DYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNG--VVHRDLKPENILLATKSSSSPIKLADFGLA  191 (419)
Q Consensus       114 ~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~--IvHrDLkp~NILl~~~~~~~~vKL~DFgla  191 (419)
                      ..+|+||||++||+|.+++.+.+.+++.+++.++.||++||+|||+++  |+||||||+|||++  ++++.+||+|||++
T Consensus        85 ~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~--~~~~~~Kl~DFGla  162 (270)
T d1t4ha_          85 KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLA  162 (270)
T ss_dssp             EEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES--STTSCEEECCTTGG
T ss_pred             CEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceee--CCCCCEEEeecCcc
Confidence            578999999999999999998889999999999999999999999998  99999999999994  24678999999999


Q ss_pred             eeeccCCccccccCCCccCCcccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhcCCCCCCCCCCCCC
Q 014733          192 TYIKAGQNLHGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGKT-KSKIFDAVRAADLRFPSDPWDHIS  270 (419)
Q Consensus       192 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~s~~sDvwSlGvil~elltG~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s  270 (419)
                      +.... ......+||+.|+|||++.++|+.++|||||||++|||++|+.||.+.. ..++.+.+.....  +...+...+
T Consensus       163 ~~~~~-~~~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~--~~~~~~~~~  239 (270)
T d1t4ha_         163 TLKRA-SFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK--PASFDKVAI  239 (270)
T ss_dssp             GGCCT-TSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC--CGGGGGCCC
T ss_pred             eeccC-CccCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCC--CcccCccCC
Confidence            86433 3345678999999999999899999999999999999999999997654 4555566554322  223334688


Q ss_pred             HHHHHHHHhhhhcCCCCCCCHHHHHhccccc
Q 014733          271 ASARDLIMGMLRVDPSTRLTAAEVLAHSWME  301 (419)
Q Consensus       271 ~~l~~li~~~L~~dP~~Rps~~eil~hp~~~  301 (419)
                      +++++||.+||++||++|||+.|+|+||||+
T Consensus       240 ~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         240 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             HHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence            9999999999999999999999999999996

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-59  Score=456.23  Aligned_cols=261  Identities=29%  Similarity=0.582  Sum_probs=239.9

Q ss_pred             ccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEE
Q 014733           37 NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYV  116 (419)
Q Consensus        37 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~  116 (419)
                      .+.++|++++.||+|+||+||+|.++.+|+.||+|++.++.    .....+.+|+++|++++ |||||++++++++++.+
T Consensus         2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~   76 (321)
T d1tkia_           2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIAR-HRNILHLHESFESMEEL   76 (321)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSC-CTTBCCEEEEEEETTEE
T ss_pred             CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc----ccHHHHHHHHHHHHhCC-CCCCCeEEEEEEECCEE
Confidence            57799999999999999999999999999999999997653    34456889999999996 99999999999999999


Q ss_pred             EEEEeecCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeec
Q 014733          117 HLLMELCAGGELFHRLEKYG-RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIK  195 (419)
Q Consensus       117 ~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~  195 (419)
                      |+|||||+||+|.+++...+ ++++.+++.++.||++||+|||++||+||||||+|||++.+ ....+||+|||++....
T Consensus        77 ~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~-~~~~ikl~DFG~~~~~~  155 (321)
T d1tkia_          77 VMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTR-RSSTIKIIEFGQARQLK  155 (321)
T ss_dssp             EEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS-SCCCEEECCCTTCEECC
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCC-CceEEEEcccchhhccc
Confidence            99999999999999998665 69999999999999999999999999999999999999542 34589999999999876


Q ss_pred             cCCccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 014733          196 AGQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASAR  274 (419)
Q Consensus       196 ~~~~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~  274 (419)
                      ........+||+.|+|||.+.+. |+.++|||||||++|+|++|++||.+.+..++...|......++...+..+|++++
T Consensus       156 ~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  235 (321)
T d1tkia_         156 PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM  235 (321)
T ss_dssp             TTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred             cCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHH
Confidence            66666667899999999998875 89999999999999999999999999999999999999988888877788999999


Q ss_pred             HHHHhhhhcCCCCCCCHHHHHhccccccc
Q 014733          275 DLIMGMLRVDPSTRLTAAEVLAHSWMEEC  303 (419)
Q Consensus       275 ~li~~~L~~dP~~Rps~~eil~hp~~~~~  303 (419)
                      +||.+||+.||++|||++|+++||||++.
T Consensus       236 ~li~~~L~~dp~~R~s~~eil~hp~~~~~  264 (321)
T d1tkia_         236 DFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             HHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence            99999999999999999999999999764

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-59  Score=448.79  Aligned_cols=256  Identities=27%  Similarity=0.476  Sum_probs=227.0

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEE
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHL  118 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~l  118 (419)
                      .+.|++++.||+|+||+||+|+++.+|+.||+|++.+..   ....+.+.+|+++|++++ |||||++++++.+++.+|+
T Consensus        11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~l   86 (288)
T d2jfla1          11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCD-HPNIVKLLDAFYYENNLWI   86 (288)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS---SGGGGGTHHHHHHHHHCC-CTTBCCEEEEEEETTEEEE
T ss_pred             ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCC-CCCCCeEEEEEeeCCeEEE
Confidence            367999999999999999999999999999999997653   345678899999999996 9999999999999999999


Q ss_pred             EEeecCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccC
Q 014733          119 LMELCAGGELFHRLEK-YGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG  197 (419)
Q Consensus       119 V~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~  197 (419)
                      ||||++||+|.+++.+ .+++++.+++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+|......
T Consensus        87 vmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll---~~~~~~Kl~DFG~a~~~~~~  163 (288)
T d2jfla1          87 LIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILF---TLDGDIKLADFGVSAKNTRT  163 (288)
T ss_dssp             EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECHHH
T ss_pred             EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeE---CCCCCEEEEechhhhccCCC
Confidence            9999999999998765 4569999999999999999999999999999999999999   56789999999999875433


Q ss_pred             C-ccccccCCCccCCcccccC------CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCC
Q 014733          198 Q-NLHGTVGSPFYIAPEVLAG------GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHIS  270 (419)
Q Consensus       198 ~-~~~~~~gt~~y~aPE~l~~------~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  270 (419)
                      . .....+||+.|+|||++.+      .|+.++|||||||++|+|++|++||.+.+..+.+.++........ ..+..+|
T Consensus       164 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~s  242 (288)
T d2jfla1         164 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTL-AQPSRWS  242 (288)
T ss_dssp             HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCC-SSGGGSC
T ss_pred             cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC-CccccCC
Confidence            2 2345689999999999842      389999999999999999999999999998888888887654332 2235789


Q ss_pred             HHHHHHHHhhhhcCCCCCCCHHHHHhcccccc
Q 014733          271 ASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE  302 (419)
Q Consensus       271 ~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~  302 (419)
                      +++++||.+||++||++|||+.|+|+||||+.
T Consensus       243 ~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~  274 (288)
T d2jfla1         243 SNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV  274 (288)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence            99999999999999999999999999999974

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.6e-59  Score=452.58  Aligned_cols=256  Identities=31%  Similarity=0.605  Sum_probs=234.6

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      ++|++++.||+|+||+||+|+++.+|+.||+|++.+.........+.+.+|+.+|++++ |||||++++++.+.+.+|+|
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~iv   82 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HPFIIRMWGTFQDAQQIFMI   82 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-BTTBCCEEEEEECSSEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhcc-CcChhheeeeEeeCCeeeeE
Confidence            57999999999999999999999999999999997654433445678999999999996 99999999999999999999


Q ss_pred             EeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCCc
Q 014733          120 MELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN  199 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~~  199 (419)
                      |||+.||+|..++.....+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+|+.....  
T Consensus        83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl---~~~g~vkL~DFG~a~~~~~~--  157 (316)
T d1fota_          83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL---DKNGHIKITDFGFAKYVPDV--  157 (316)
T ss_dssp             ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE---CTTSCEEECCCSSCEECSSC--
T ss_pred             eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeE---cCCCCEEEecCccceEeccc--
Confidence            9999999999999998899999999999999999999999999999999999999   56789999999999976443  


Q ss_pred             cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHH
Q 014733          200 LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM  278 (419)
Q Consensus       200 ~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~  278 (419)
                      ....+||+.|+|||++.+. |+.++|||||||++|+|++|+.||.+.+..++..++......+|.    .+|++++++|.
T Consensus       158 ~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~  233 (316)
T d1fota_         158 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP----FFNEDVKDLLS  233 (316)
T ss_dssp             BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHHHH
T ss_pred             cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCC----CCCHHHHHHHH
Confidence            3457899999999999875 999999999999999999999999999999999999888766653    68999999999


Q ss_pred             hhhhcCCCCCC-----CHHHHHhccccccchh
Q 014733          279 GMLRVDPSTRL-----TAAEVLAHSWMEECEQ  305 (419)
Q Consensus       279 ~~L~~dP~~Rp-----s~~eil~hp~~~~~~~  305 (419)
                      +||++||.+|+     |++++++||||+++.+
T Consensus       234 ~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~  265 (316)
T d1fota_         234 RLITRDLSQRLGNLQNGTEDVKNHPWFKEVVW  265 (316)
T ss_dssp             HHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCH
T ss_pred             HHhhhCHHhccccchhhHHHHHcCcccccCCH
Confidence            99999999996     9999999999998754

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.8e-59  Score=451.87  Aligned_cols=255  Identities=27%  Similarity=0.435  Sum_probs=229.6

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEE
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHL  118 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~l  118 (419)
                      ..+|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|++++ |||||++++++.+++.+|+
T Consensus        14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~~i   92 (309)
T d1u5ra_          14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREHTAWL   92 (309)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEE
T ss_pred             HHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCC-CCCEeeEEEEEEECCEEEE
Confidence            356999999999999999999999999999999998876666667788999999999996 9999999999999999999


Q ss_pred             EEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC
Q 014733          119 LMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ  198 (419)
Q Consensus       119 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~  198 (419)
                      |||||.+|+|..++...+++++.+++.++.||+.||.|||++|||||||||+|||+   +.++.+||+|||++.....  
T Consensus        93 v~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl---~~~~~~Kl~DFG~a~~~~~--  167 (309)
T d1u5ra_          93 VMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAP--  167 (309)
T ss_dssp             EEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEE---ETTTEEEECCCTTCBSSSS--
T ss_pred             EEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEE---CCCCCEEEeecccccccCC--
Confidence            99999999998888777889999999999999999999999999999999999999   4577899999999986533  


Q ss_pred             ccccccCCCccCCcccccC----CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 014733          199 NLHGTVGSPFYIAPEVLAG----GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASAR  274 (419)
Q Consensus       199 ~~~~~~gt~~y~aPE~l~~----~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~  274 (419)
                       ....+||+.|+|||++.+    .|+.++|||||||++|||++|+.||.+.+..+....+.........  ...+|++++
T Consensus       168 -~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~s~~~~  244 (309)
T d1u5ra_         168 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ--SGHWSEYFR  244 (309)
T ss_dssp             -BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCS--CTTSCHHHH
T ss_pred             -CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC--CCCCCHHHH
Confidence             345689999999999853    4899999999999999999999999998888888877766544332  347899999


Q ss_pred             HHHHhhhhcCCCCCCCHHHHHhcccccc
Q 014733          275 DLIMGMLRVDPSTRLTAAEVLAHSWMEE  302 (419)
Q Consensus       275 ~li~~~L~~dP~~Rps~~eil~hp~~~~  302 (419)
                      +||.+||+.||++|||+.|+|+||||..
T Consensus       245 ~li~~~L~~dP~~Rpt~~ell~Hp~~~~  272 (309)
T d1u5ra_         245 NFVDSCLQKIPQDRPTSEVLLKHRFVLR  272 (309)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred             HHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence            9999999999999999999999999975

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-59  Score=443.35  Aligned_cols=253  Identities=28%  Similarity=0.515  Sum_probs=215.1

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEe--CCEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEE--EDYVH  117 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~--~~~~~  117 (419)
                      ++|++++.||+|+||+||+|+++.+|+.||+|++.+... .....+.+.+|+++|++++ |||||++++++.+  ++.+|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~~~   81 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELK-HPNIVRYYDRIIDRTNTTLY   81 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSCC-CTTBCCEEEEEEC----CEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC-CHHHHHHHHHHHHHHHHCC-CCCEeeEEEEEEeCCCCEEE
Confidence            689999999999999999999999999999999987654 5566788999999999996 9999999999864  56689


Q ss_pred             EEEeecCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC-----CeeccCCCCcEEEeecCCCCCeEEeec
Q 014733          118 LLMELCAGGELFHRLEK----YGRFSETEARVIFRHLMQVVSYCHGNG-----VVHRDLKPENILLATKSSSSPIKLADF  188 (419)
Q Consensus       118 lV~E~~~ggsL~~~l~~----~~~l~~~~~~~i~~qll~aL~~LH~~~-----IvHrDLkp~NILl~~~~~~~~vKL~DF  188 (419)
                      +||||++||+|.+++.+    .+.+++..++.++.||+.||+|||+.+     ||||||||+|||+   +.++.+||+||
T Consensus        82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll---~~~~~vkl~DF  158 (269)
T d2java1          82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDF  158 (269)
T ss_dssp             EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEE---CTTSCEEECCH
T ss_pred             EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCc---CCCCcEEEeec
Confidence            99999999999999864    356999999999999999999999976     9999999999999   56789999999


Q ss_pred             cceeeeccCCc-cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 014733          189 GLATYIKAGQN-LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW  266 (419)
Q Consensus       189 gla~~~~~~~~-~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  266 (419)
                      |+++.+..... ....+||+.|+|||++.+. |+.++|||||||++|||++|++||.+.+..++..++........   +
T Consensus       159 G~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~---~  235 (269)
T d2java1         159 GLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI---P  235 (269)
T ss_dssp             HHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC---C
T ss_pred             cceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC---C
Confidence            99987654432 3456899999999999774 99999999999999999999999999999999999888765422   2


Q ss_pred             CCCCHHHHHHHHhhhhcCCCCCCCHHHHHhcccc
Q 014733          267 DHISASARDLIMGMLRVDPSTRLTAAEVLAHSWM  300 (419)
Q Consensus       267 ~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~  300 (419)
                      ..+|+++++||.+||+.||++|||+.|+++|||+
T Consensus       236 ~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         236 YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             cccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence            4789999999999999999999999999999996

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-59  Score=454.68  Aligned_cols=259  Identities=25%  Similarity=0.391  Sum_probs=220.7

Q ss_pred             cccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEE
Q 014733           38 LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVH  117 (419)
Q Consensus        38 ~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~  117 (419)
                      ..++|+++++||+|+||+||+|+++.+|+.||+|++.++.  .....+.+.+|+.+|++++ |||||++++++.+++.+|
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~   80 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGEIS   80 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCC-CTTBCCEEEEEECSSEEE
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEEE
Confidence            4689999999999999999999999999999999997653  3345678899999999996 999999999999999999


Q ss_pred             EEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeccCCCCcEEEeecCCCCCeEEeeccceeeecc
Q 014733          118 LLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG-NGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA  196 (419)
Q Consensus       118 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~-~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~  196 (419)
                      +||||++||+|.+++.+.+.+++.+++.++.||++||.|||+ +||+||||||+|||+   +.++.+||+|||+|+....
T Consensus        81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl---~~~~~vkl~DFGla~~~~~  157 (322)
T d1s9ja_          81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLID  157 (322)
T ss_dssp             EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE---CTTCCEEECCCCCCHHHHH
T ss_pred             EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeE---CCCCCEEEeeCCCccccCC
Confidence            999999999999999988999999999999999999999997 599999999999999   5678999999999987644


Q ss_pred             CCccccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-----------------------
Q 014733          197 GQNLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFD-----------------------  252 (419)
Q Consensus       197 ~~~~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~-----------------------  252 (419)
                      .. ..+.+||+.|+|||++.+ .|+.++||||+||++|||++|+.||.+.+..+...                       
T Consensus       158 ~~-~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (322)
T d1s9ja_         158 SM-ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP  236 (322)
T ss_dssp             HT-C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred             Cc-cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence            32 345689999999999987 49999999999999999999999997654332211                       


Q ss_pred             -------------------HHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          253 -------------------AVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       253 -------------------~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                                         .+...  ..+..+...+|.++++||.+||++||++|||++|+|+||||++...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~  306 (322)
T d1s9ja_         237 LSSYGMDSRPPMAIFELLDYIVNE--PPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA  306 (322)
T ss_dssp             ---------CCCCHHHHHHHHHTS--CCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred             ccccccccccchhHHHHHhhhhcc--CCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCc
Confidence                               11110  1111222357899999999999999999999999999999987554

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-59  Score=452.31  Aligned_cols=258  Identities=30%  Similarity=0.564  Sum_probs=231.2

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      ++|++++.||+|+||+||+|+++.+|+.||+|++.+.........+.+..|..++.+..+|||||++++++.+++.+|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            68999999999999999999999999999999997654433345667778888776433599999999999999999999


Q ss_pred             EeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC-
Q 014733          120 MELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ-  198 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~-  198 (419)
                      |||++||+|.+++...+++++.+++.++.||+.||+|||+++|+||||||+|||+   +.++++||+|||+++...... 
T Consensus        82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~---~~~~~~kl~DFG~a~~~~~~~~  158 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGDA  158 (320)
T ss_dssp             EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTTC
T ss_pred             EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceee---cCCCceeccccchhhhcccccc
Confidence            9999999999999998999999999999999999999999999999999999999   567899999999998765433 


Q ss_pred             ccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHH
Q 014733          199 NLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLI  277 (419)
Q Consensus       199 ~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li  277 (419)
                      .....+||+.|+|||++.+. |+.++|||||||++|+|++|+.||.+.+..++..++....+.+|.    .+|+++++||
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~----~~s~~~~dli  234 (320)
T d1xjda_         159 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR----WLEKEAKDLL  234 (320)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHHH
T ss_pred             cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc----cCCHHHHHHH
Confidence            33456899999999999874 999999999999999999999999999999999999888766553    6899999999


Q ss_pred             HhhhhcCCCCCCCHH-HHHhccccccch
Q 014733          278 MGMLRVDPSTRLTAA-EVLAHSWMEECE  304 (419)
Q Consensus       278 ~~~L~~dP~~Rps~~-eil~hp~~~~~~  304 (419)
                      .+||++||.+|||+. ++++||||+++.
T Consensus       235 ~~~L~~dP~~R~s~~~~l~~hpff~~~~  262 (320)
T d1xjda_         235 VKLFVREPEKRLGVRGDIRQHPLFREIN  262 (320)
T ss_dssp             HHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred             HHhcccCCCCCcCHHHHHHhCchhccCC
Confidence            999999999999996 899999998864

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.9e-59  Score=459.35  Aligned_cols=256  Identities=32%  Similarity=0.616  Sum_probs=234.4

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      ++|++++.||+|+||+||+|+++.+|+.||+|++.+.........+.+.+|+.+|+.+. |||||++++++.+.+.+++|
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~~v  119 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcC-CCcEeecccccccccccccc
Confidence            78999999999999999999999999999999997654433445678899999999995 99999999999999999999


Q ss_pred             EeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCCc
Q 014733          120 MELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN  199 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~~  199 (419)
                      |||+.||+|..++.+.+.+++.+++.++.||+.||.|||++|||||||||+|||+   +.++.+||+|||+|+.+...  
T Consensus       120 ~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl---~~~g~ikL~DFG~a~~~~~~--  194 (350)
T d1rdqe_         120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGR--  194 (350)
T ss_dssp             EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECSSC--
T ss_pred             cccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHccc---CCCCCEEeeeceeeeecccc--
Confidence            9999999999999998999999999999999999999999999999999999999   56789999999999986543  


Q ss_pred             cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHH
Q 014733          200 LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLIM  278 (419)
Q Consensus       200 ~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~  278 (419)
                      ....+||+.|+|||++.+. |+.++|||||||++|+|++|++||.+.+...+..++......++.    .+++++.+||+
T Consensus       195 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~  270 (350)
T d1rdqe_         195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLR  270 (350)
T ss_dssp             BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TCCHHHHHHHH
T ss_pred             cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCc----cCCHHHHHHHH
Confidence            3456899999999999875 999999999999999999999999999999999999888766553    78999999999


Q ss_pred             hhhhcCCCCCC-----CHHHHHhccccccchh
Q 014733          279 GMLRVDPSTRL-----TAAEVLAHSWMEECEQ  305 (419)
Q Consensus       279 ~~L~~dP~~Rp-----s~~eil~hp~~~~~~~  305 (419)
                      +||++||.+|+     |++++++||||+...+
T Consensus       271 ~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~  302 (350)
T d1rdqe_         271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW  302 (350)
T ss_dssp             HHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred             HHhhhCHHhccccccccHHHHHcCccccCCCH
Confidence            99999999995     9999999999987754

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-59  Score=453.85  Aligned_cols=262  Identities=33%  Similarity=0.632  Sum_probs=225.8

Q ss_pred             cccccCeeeee-eecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEe--
Q 014733           36 SNLSDRYVLGK-QLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEE--  112 (419)
Q Consensus        36 ~~~~~~y~i~~-~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~--  112 (419)
                      ..+-++|++.+ .||+|+||+||+|+++.+|+.||||++.+.        ..+.+|+.++.++.+|||||+++++|++  
T Consensus         7 ~~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~   78 (335)
T d2ozaa1           7 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLY   78 (335)
T ss_dssp             SCGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred             CCcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeecc
Confidence            34567899875 599999999999999999999999998643        4567899998777579999999999976  


Q ss_pred             --CCEEEEEEeecCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeec
Q 014733          113 --EDYVHLLMELCAGGELFHRLEKY--GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADF  188 (419)
Q Consensus       113 --~~~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DF  188 (419)
                        ++.+|+|||||+||+|.+++...  .++++.+++.++.||+.||+|||++||+||||||+|||++.++..+.+||+||
T Consensus        79 ~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DF  158 (335)
T d2ozaa1          79 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF  158 (335)
T ss_dssp             TTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred             cCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccccc
Confidence              46799999999999999999764  35999999999999999999999999999999999999987666788999999


Q ss_pred             cceeeeccCCccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHHhcCCCCCC
Q 014733          189 GLATYIKAGQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFD----AVRAADLRFPS  263 (419)
Q Consensus       189 gla~~~~~~~~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~----~i~~~~~~~~~  263 (419)
                      |+|+...........+||+.|+|||++.+. |+.++|||||||+||+|++|++||.+.+..+...    .+......++.
T Consensus       159 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~  238 (335)
T d2ozaa1         159 GFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN  238 (335)
T ss_dssp             TTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCT
T ss_pred             ceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCC
Confidence            999988777666778999999999999874 9999999999999999999999998766544433    33444555666


Q ss_pred             CCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          264 DPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       264 ~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                      ..+..+|+++++||.+||++||++|||+.|+++||||++...
T Consensus       239 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~  280 (335)
T d2ozaa1         239 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK  280 (335)
T ss_dssp             THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTS
T ss_pred             cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCCC
Confidence            556679999999999999999999999999999999976443

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.6e-57  Score=449.23  Aligned_cols=260  Identities=29%  Similarity=0.475  Sum_probs=221.3

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHH---HHHHHHccCCCCceeeeEEEEeCCEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLE---IEIMTKLSGHPNVVDLKAVYEEEDYV  116 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~E---i~il~~l~~hpnIv~l~~~~~~~~~~  116 (419)
                      ++|++++.||+|+||+||+|+++.+|+.||+|++.+...........+.+|   +.+++.+ +|||||++++++.+.+.+
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~-~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSS-CCTTBCCEEEEEECSSEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcC-CCCcEEEEEEEEEECCEE
Confidence            689999999999999999999999999999999976544322333344444   5555556 499999999999999999


Q ss_pred             EEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeecc
Q 014733          117 HLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA  196 (419)
Q Consensus       117 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~  196 (419)
                      |+||||++||+|.+++...+.+++.+++.++.||+.||+|||++|||||||||+|||+   +.++.+||+|||+|+.+..
T Consensus        83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl---~~~g~iKl~DFGla~~~~~  159 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSK  159 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CSSSCEEECCCTTCEECSS
T ss_pred             EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEE---cCCCcEEEeeeceeeecCC
Confidence            9999999999999999998999999999999999999999999999999999999999   5678999999999997754


Q ss_pred             CCccccccCCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 014733          197 GQNLHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASAR  274 (419)
Q Consensus       197 ~~~~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~  274 (419)
                      .. ....+||+.|+|||++.+  .|+.++|||||||+||+|++|+.||.+....+...... .....+...+..+|++++
T Consensus       160 ~~-~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~-~~~~~~~~~~~~~s~~~~  237 (364)
T d1omwa3         160 KK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR-MTLTMAVELPDSFSPELR  237 (364)
T ss_dssp             SC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHH-HSSSCCCCCCSSSCHHHH
T ss_pred             Cc-ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-hcccCCCCCCCCCCHHHH
Confidence            43 455689999999999864  38999999999999999999999998765444333222 233334444558999999


Q ss_pred             HHHHhhhhcCCCCCCC-----HHHHHhccccccchh
Q 014733          275 DLIMGMLRVDPSTRLT-----AAEVLAHSWMEECEQ  305 (419)
Q Consensus       275 ~li~~~L~~dP~~Rps-----~~eil~hp~~~~~~~  305 (419)
                      +||.+||++||++|||     ++|+++||||+.+.+
T Consensus       238 ~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~  273 (364)
T d1omwa3         238 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW  273 (364)
T ss_dssp             HHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCH
T ss_pred             HHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCH
Confidence            9999999999999999     799999999998764

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-57  Score=432.34  Aligned_cols=256  Identities=26%  Similarity=0.395  Sum_probs=215.2

Q ss_pred             eeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCH--HhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEEe
Q 014733           44 LGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTV--EDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLME  121 (419)
Q Consensus        44 i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~--~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  121 (419)
                      .+++||+|+||+||+|+++.+|+.||||++.+......  ...+.+.+|+.+|++++ |||||++++++.+++++|+|||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~~~~~~~~~~~~~ivmE   80 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIGLLDAFGHKSNISLVFD   80 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCC-CTTBCCEEEEECCTTCCEEEEE
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCC-CCCEeEEEeeeccCCceeehhh
Confidence            57899999999999999999999999999976543221  12356889999999996 9999999999999999999999


Q ss_pred             ecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC-cc
Q 014733          122 LCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ-NL  200 (419)
Q Consensus       122 ~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~-~~  200 (419)
                      |+.++++..+......+++.+++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++...... ..
T Consensus        81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli---~~~~~~KL~DFG~a~~~~~~~~~~  157 (299)
T d1ua2a_          81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL---DENGVLKLADFGLAKSFGSPNRAY  157 (299)
T ss_dssp             CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCCGGGSTTTSCCCCC
T ss_pred             hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEe---cCCCccccccCccccccCCCcccc
Confidence            99988877777666779999999999999999999999999999999999999   567899999999998764433 33


Q ss_pred             ccccCCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--------------
Q 014733          201 HGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSD--------------  264 (419)
Q Consensus       201 ~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~--------------  264 (419)
                      ...+||+.|+|||++.+  .|+.++||||+||++|||++|.+||.+.+..+...+|..........              
T Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~  237 (299)
T d1ua2a_         158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF  237 (299)
T ss_dssp             CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCC
T ss_pred             cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhh
Confidence            45689999999999864  38999999999999999999999999999888887775432111111              


Q ss_pred             ----------CCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccc
Q 014733          265 ----------PWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEEC  303 (419)
Q Consensus       265 ----------~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~  303 (419)
                                ....+++++++||.+||+.||++|||++|+|+||||+..
T Consensus       238 ~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~  286 (299)
T d1ua2a_         238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR  286 (299)
T ss_dssp             CCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred             ccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence                      023578999999999999999999999999999999753

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-56  Score=425.75  Aligned_cols=253  Identities=30%  Similarity=0.505  Sum_probs=218.3

Q ss_pred             cccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHH---hHHHHHHHHHHHHHcc-CCCCceeeeEEEEeC
Q 014733           38 LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVE---DVRSIKLEIEIMTKLS-GHPNVVDLKAVYEEE  113 (419)
Q Consensus        38 ~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~---~~~~~~~Ei~il~~l~-~hpnIv~l~~~~~~~  113 (419)
                      +.++|++++.||+|+||+||+|+++.+|+.||+|++.+.......   ....+.+|+.+|++++ +|||||++++++.+.
T Consensus         2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~   81 (273)
T d1xwsa_           2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP   81 (273)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence            578999999999999999999999999999999999876543221   2234678999999995 489999999999999


Q ss_pred             CEEEEEEeecCC-CChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeecccee
Q 014733          114 DYVHLLMELCAG-GELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLAT  192 (419)
Q Consensus       114 ~~~~lV~E~~~g-gsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~  192 (419)
                      +.+|+||||+.+ +++.+++...+.+++.+++.++.||++||+|||++||+||||||+|||++.  +++.+||+|||+++
T Consensus        82 ~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~--~~~~vkl~DFG~a~  159 (273)
T d1xwsa_          82 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL--NRGELKLIDFGSGA  159 (273)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET--TTTEEEECCCTTCE
T ss_pred             CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEec--CCCeEEECccccce
Confidence            999999999976 678888888889999999999999999999999999999999999999953  34689999999998


Q ss_pred             eeccCCccccccCCCccCCcccccC-C-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCC
Q 014733          193 YIKAGQNLHGTVGSPFYIAPEVLAG-G-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHIS  270 (419)
Q Consensus       193 ~~~~~~~~~~~~gt~~y~aPE~l~~-~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  270 (419)
                      ..... .....+||+.|+|||++.+ . ++.++|||||||++|+|++|+.||.+.      +.+......++    ..+|
T Consensus       160 ~~~~~-~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~------~~i~~~~~~~~----~~~s  228 (273)
T d1xwsa_         160 LLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFR----QRVS  228 (273)
T ss_dssp             ECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHCCCCCS----SCCC
T ss_pred             ecccc-cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc------hHHhhcccCCC----CCCC
Confidence            75433 3456789999999999875 3 467899999999999999999999753      23445544444    3689


Q ss_pred             HHHHHHHHhhhhcCCCCCCCHHHHHhccccccc
Q 014733          271 ASARDLIMGMLRVDPSTRLTAAEVLAHSWMEEC  303 (419)
Q Consensus       271 ~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~  303 (419)
                      +++++||.+||++||++|||++|+++||||++.
T Consensus       229 ~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~  261 (273)
T d1xwsa_         229 SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV  261 (273)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred             HHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence            999999999999999999999999999999865

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=3.9e-56  Score=423.35  Aligned_cols=262  Identities=27%  Similarity=0.439  Sum_probs=225.5

Q ss_pred             cccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCC-
Q 014733           36 SNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEED-  114 (419)
Q Consensus        36 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~-  114 (419)
                      ..+.++|++++.||+|+||+||+|+++.+|+.||+|++.+...........+.+|+.+|++++ |||||++++++.+.+ 
T Consensus         3 ~~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~-hpniv~~~~~~~~~~~   81 (277)
T d1o6ya_           3 SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN-HPAIVAVYDTGEAETP   81 (277)
T ss_dssp             SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEEECS
T ss_pred             cCccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcC-CCCCCcccceeeeccC
Confidence            457899999999999999999999999999999999998876666677788999999999996 999999999997653 


Q ss_pred             ---EEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccce
Q 014733          115 ---YVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA  191 (419)
Q Consensus       115 ---~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla  191 (419)
                         .+|+||||++|++|..++...+++++.+++.++.||+.||+|||++||+||||||+|||+   +.++.++|+|||.+
T Consensus        82 ~~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll---~~~~~~~l~d~~~~  158 (277)
T d1o6ya_          82 AGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI---SATNAVKVMDFGIA  158 (277)
T ss_dssp             SSEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---ETTSCEEECCCTTC
T ss_pred             CCceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCccccc---Cccccceeehhhhh
Confidence               489999999999999999998999999999999999999999999999999999999999   45778999999998


Q ss_pred             eeeccCC----ccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 014733          192 TYIKAGQ----NLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPW  266 (419)
Q Consensus       192 ~~~~~~~----~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  266 (419)
                      .......    .....+||+.|+|||++.+. |+.++|||||||++|+|++|++||.+.+..+...++.......+...+
T Consensus       159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  238 (277)
T d1o6ya_         159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH  238 (277)
T ss_dssp             EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTS
T ss_pred             hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhc
Confidence            7654322    23445899999999999875 999999999999999999999999999988888888887777666667


Q ss_pred             CCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccc
Q 014733          267 DHISASARDLIMGMLRVDPSTRLTAAEVLAHSWME  301 (419)
Q Consensus       267 ~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~  301 (419)
                      ..+|+++.+||.+||++||++||+..+.+.|+|.+
T Consensus       239 ~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         239 EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             SSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             cCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence            78999999999999999999999444444567764

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-55  Score=423.85  Aligned_cols=261  Identities=29%  Similarity=0.446  Sum_probs=216.7

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      |+|+++++||+|+||+||+|.++.+|+.||+|++..... .....+.+.+|+++|+++. |||||++++++.+.+.+|+|
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~-Hp~Iv~~~~~~~~~~~~~iv   79 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELN-HPNIVKLLDVIHTENKLYLV   79 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCC-CCcEEEeccccccccceeEE
Confidence            689999999999999999999999999999999976532 3344678899999999996 99999999999999999999


Q ss_pred             EeecCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccC-
Q 014733          120 MELCAGGELFHRLEK-YGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG-  197 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~-  197 (419)
                      |||+.++.+...... .+.+++.+++.++.||+.||+|||++|||||||||+|||+   +.++.+||+|||+++..... 
T Consensus        80 ~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~---~~~~~~kl~DFG~a~~~~~~~  156 (298)
T d1gz8a_          80 FEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPV  156 (298)
T ss_dssp             EECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSTTHHHHHCCCS
T ss_pred             EeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheee---cccCcceeccCCcceeccCCc
Confidence            999965444433333 3559999999999999999999999999999999999999   56779999999999876543 


Q ss_pred             CccccccCCCccCCcccccCC--CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCC----------
Q 014733          198 QNLHGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDP----------  265 (419)
Q Consensus       198 ~~~~~~~gt~~y~aPE~l~~~--~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~----------  265 (419)
                      .......||+.|+|||++...  ++.++|+||+||++|+|++|+.||.+.+..+....+...........          
T Consensus       157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  236 (298)
T d1gz8a_         157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY  236 (298)
T ss_dssp             BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccc
Confidence            334456899999999987653  68999999999999999999999998887777666543211111111          


Q ss_pred             ---------------CCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          266 ---------------WDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       266 ---------------~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                                     ...+++++++||++||++||++|||++|+|+||||+++..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~  291 (298)
T d1gz8a_         237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK  291 (298)
T ss_dssp             CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             ccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCC
Confidence                           2357899999999999999999999999999999987654

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-55  Score=424.43  Aligned_cols=264  Identities=27%  Similarity=0.380  Sum_probs=219.4

Q ss_pred             ccccCeeeeeeecccCceEEEEEEecCC-CcEEEEEEeccCccCCHHhHHHHHHHHHHHHHcc--CCCCceeeeEEEEe-
Q 014733           37 NLSDRYVLGKQLGWGQFGVIRECSDKFT-GEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLS--GHPNVVDLKAVYEE-  112 (419)
Q Consensus        37 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~-g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~--~hpnIv~l~~~~~~-  112 (419)
                      ...++|++++.||+|+||+||+|++..+ ++.||+|++...... ......+.+|+.+|+.|+  +||||+++++++.. 
T Consensus         4 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~   82 (305)
T d1blxa_           4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS   82 (305)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT-TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred             CCcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhcc-chHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccc
Confidence            3458999999999999999999999765 677999999765432 222344667888887774  59999999999863 


Q ss_pred             ----CCEEEEEEeecCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEee
Q 014733          113 ----EDYVHLLMELCAGGELFHRLEK-YGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLAD  187 (419)
Q Consensus       113 ----~~~~~lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~D  187 (419)
                          ...++++|||+.++.+...... ...+++..++.++.|++.||+|||+++||||||||+|||+   +..+.+||+|
T Consensus        83 ~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi---~~~~~~kl~d  159 (305)
T d1blxa_          83 RTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLAD  159 (305)
T ss_dssp             ECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECS
T ss_pred             ccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEE---cCCCCeeecc
Confidence                3578999999988776544433 3459999999999999999999999999999999999999   5678999999


Q ss_pred             ccceeeeccCCccccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-----
Q 014733          188 FGLATYIKAGQNLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRF-----  261 (419)
Q Consensus       188 Fgla~~~~~~~~~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~-----  261 (419)
                      ||++............+||+.|+|||++.+ .|+.++||||+||++|||++|++||.+.+..+....+.......     
T Consensus       160 fg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  239 (305)
T d1blxa_         160 FGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW  239 (305)
T ss_dssp             CCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred             hhhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence            999987766666677899999999999876 49999999999999999999999999998888777765421110     


Q ss_pred             ------------------CCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccch
Q 014733          262 ------------------PSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECE  304 (419)
Q Consensus       262 ------------------~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~  304 (419)
                                        ....+..+++++++||++||++||++|||+.|+|+||||++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~  300 (305)
T d1blxa_         240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE  300 (305)
T ss_dssp             CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             cccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCch
Confidence                              0012346889999999999999999999999999999998765

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=7e-55  Score=416.35  Aligned_cols=257  Identities=28%  Similarity=0.455  Sum_probs=217.9

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      ++|+++++||+|+||+||+|+++ +|+.||+|++..... .....+.+.+|+.+|++++ |||||++++++.+++..+++
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~i~   78 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKELK-HSNIVKLYDVIHTKKRLVLV   78 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCC-CTTBCCEEEEEECSSCEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCC-CCcEEeeeeecccCCceeEE
Confidence            69999999999999999999986 789999999976543 3344678999999999996 99999999999999999999


Q ss_pred             EeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC-
Q 014733          120 MELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ-  198 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~-  198 (419)
                      ||++.++.+..+....+.+++..++.++.||+.||+|||+.+||||||||+|||+   +.++.+||+|||.+....... 
T Consensus        79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll---~~~~~~kl~DfG~a~~~~~~~~  155 (286)
T d1ob3a_          79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFGIPVR  155 (286)
T ss_dssp             EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCTTHHHHHCC---
T ss_pred             EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeE---cCCCCEEecccccceecccCcc
Confidence            9999887777777777889999999999999999999999999999999999999   567899999999998764432 


Q ss_pred             ccccccCCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC-------------
Q 014733          199 NLHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPS-------------  263 (419)
Q Consensus       199 ~~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~-------------  263 (419)
                      ......|++.|+|||.+.+  .++.++|+|||||++|||++|+.||.+.+..+...++.......+.             
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T d1ob3a_         156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD  235 (286)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred             ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcc
Confidence            2345579999999999875  3799999999999999999999999998887777766432111110             


Q ss_pred             ------------CCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhcccccc
Q 014733          264 ------------DPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE  302 (419)
Q Consensus       264 ------------~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~  302 (419)
                                  .....+++++.|||++||++||++|||+.|+|+||||++
T Consensus       236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             cccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence                        112457899999999999999999999999999999974

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-54  Score=420.14  Aligned_cols=260  Identities=26%  Similarity=0.451  Sum_probs=215.9

Q ss_pred             cccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCC---
Q 014733           38 LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEED---  114 (419)
Q Consensus        38 ~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~---  114 (419)
                      +.++|+++++||+|+||+||+|.++.+|+.||||++.+.. ......+.+.+|+.+|++++ |||||+++++|.+.+   
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~-hpniv~l~~~~~~~~~~~   93 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMR-HENVIGLLDVFTPDETLD   93 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCC-BTTBCCCSEEECSCSSTT
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh-cChHHHHHHHHHHHHHHhcC-CCCeeEEEEEeccCcccc
Confidence            6789999999999999999999999999999999997654 35566788999999999996 999999999997654   


Q ss_pred             ---EEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccce
Q 014733          115 ---YVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA  191 (419)
Q Consensus       115 ---~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla  191 (419)
                         .+|+||||+ +.+|..+++. +++++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++
T Consensus        94 ~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~---~~~~~~kl~Dfg~a  168 (346)
T d1cm8a_          94 DFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLA  168 (346)
T ss_dssp             TCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTC
T ss_pred             ccceEEEEEecc-cccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhc---ccccccccccccce
Confidence               579999999 6677776654 789999999999999999999999999999999999999   67789999999999


Q ss_pred             eeeccCCccccccCCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC---------
Q 014733          192 TYIKAGQNLHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLR---------  260 (419)
Q Consensus       192 ~~~~~~~~~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---------  260 (419)
                      .....  .....+||+.|+|||++.+  .++.++||||+||++|+|++|++||.+.+..+....+......         
T Consensus       169 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (346)
T d1cm8a_         169 RQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL  246 (346)
T ss_dssp             EECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred             eccCC--ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhh
Confidence            87543  3456789999999999876  3789999999999999999999999988776665554332111         


Q ss_pred             --------------CCC----CCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchhh
Q 014733          261 --------------FPS----DPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQV  306 (419)
Q Consensus       261 --------------~~~----~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~~  306 (419)
                                    ...    .....+++++.+||.+||+.||++|||+.|+|+||||+.+...
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~  310 (346)
T d1cm8a_         247 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT  310 (346)
T ss_dssp             SCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred             cchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCc
Confidence                          111    1124678999999999999999999999999999999986543

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-54  Score=414.78  Aligned_cols=259  Identities=25%  Similarity=0.429  Sum_probs=217.1

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEe------
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEE------  112 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~------  112 (419)
                      -++|++++.||+|+||+||+|+++.+|+.||||++.++.. ......++.+|+.+|++++ ||||+++++++..      
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~-h~nii~~~~~~~~~~~~~~   86 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLK-HENVVNLIEICRTKASPYN   86 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C-TTSSCHHHHHHHHHHHHCC-CTTBCCEEEEEEC------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHHhc-CCCccceEeeeeccccccc
Confidence            4899999999999999999999999999999999976643 3345577889999999996 9999999999854      


Q ss_pred             --CCEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccc
Q 014733          113 --EDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGL  190 (419)
Q Consensus       113 --~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgl  190 (419)
                        ++.+|+||||+.++.+.........+++..++.++.||++||.|||++||+||||||+|||+   +.++.+||+|||+
T Consensus        87 ~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl---~~~~~~kl~dfg~  163 (318)
T d3blha1          87 RCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADFGL  163 (318)
T ss_dssp             ----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTT
T ss_pred             ccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheee---cCCCcEEeeecce
Confidence              45689999999877776666666779999999999999999999999999999999999999   5678999999999


Q ss_pred             eeeeccCC-----ccccccCCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC
Q 014733          191 ATYIKAGQ-----NLHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPS  263 (419)
Q Consensus       191 a~~~~~~~-----~~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~  263 (419)
                      +.......     .....+||+.|+|||++.+  .|++++||||+||++|||++|++||.+.+..+....+......++.
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~  243 (318)
T d3blha1         164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP  243 (318)
T ss_dssp             CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            98765322     2344589999999999875  4899999999999999999999999998888887777665444333


Q ss_pred             CCCCC----------------------------CCHHHHHHHHhhhhcCCCCCCCHHHHHhcccccc
Q 014733          264 DPWDH----------------------------ISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEE  302 (419)
Q Consensus       264 ~~~~~----------------------------~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~  302 (419)
                      ..+..                            .++++.|||.+||++||++|||++|+|+||||+.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~  310 (318)
T d3blha1         244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS  310 (318)
T ss_dssp             TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred             hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence            32222                            3678899999999999999999999999999974

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=8.8e-54  Score=411.56  Aligned_cols=250  Identities=26%  Similarity=0.449  Sum_probs=207.0

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCc---EEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCE
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGE---VLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDY  115 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~---~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~  115 (419)
                      .++|++.+.||+|+||+||+|+++.+|+   .||+|.+...  ......+.+.+|+.+|++++ |||||++++++.+.+.
T Consensus        25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~~~  101 (299)
T d1jpaa_          25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFD-HPNVIHLEGVVTKSTP  101 (299)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS--CCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSSSS
T ss_pred             hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCC-CCCCccEEEEEeeCCE
Confidence            4789999999999999999999986664   5888887654  35566788999999999996 9999999999999999


Q ss_pred             EEEEEeecCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeee
Q 014733          116 VHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI  194 (419)
Q Consensus       116 ~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~  194 (419)
                      +++||||+++|+|.+++... +.+++.++..++.||++||+|||+++|+||||||+||||   +.++.+||+|||+++..
T Consensus       102 ~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl---~~~~~~Kl~DFGla~~~  178 (299)
T d1jpaa_         102 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFL  178 (299)
T ss_dssp             CEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC------
T ss_pred             EEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEE---CCCCcEEECCcccceEc
Confidence            99999999999999988764 469999999999999999999999999999999999999   56789999999999876


Q ss_pred             ccCCcc------ccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 014733          195 KAGQNL------HGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPW  266 (419)
Q Consensus       195 ~~~~~~------~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  266 (419)
                      ......      .+..||+.|+|||++.++ |+.++|||||||++|||+| |++||.+....++...+.... +.+  .+
T Consensus       179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~-~~~--~~  255 (299)
T d1jpaa_         179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDY-RLP--PP  255 (299)
T ss_dssp             -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-CCC--CC
T ss_pred             cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCC--CC
Confidence            543321      223578999999998764 9999999999999999998 899999999988888887653 222  23


Q ss_pred             CCCCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          267 DHISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       267 ~~~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      ..+++++.+||.+||+.||++|||+.||+++
T Consensus       256 ~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         256 MDCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            4789999999999999999999999999875

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-54  Score=419.06  Aligned_cols=251  Identities=22%  Similarity=0.353  Sum_probs=212.7

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCc-----EEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCC
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGE-----VLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEED  114 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~-----~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~  114 (419)
                      ++|+++++||+|+||+||+|+++.+++     .||+|.+....  .......+.+|+.+|.++.+|||||++++++.+.+
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~  114 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  114 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence            789999999999999999999875543     68999886543  33456778999999999966999999999999999


Q ss_pred             EEEEEEeecCCCChHHHHHHc-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCc
Q 014733          115 YVHLLMELCAGGELFHRLEKY-----------------------GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPEN  171 (419)
Q Consensus       115 ~~~lV~E~~~ggsL~~~l~~~-----------------------~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~N  171 (419)
                      .+|+||||+++|+|.+++...                       +.+++.+++.++.||++||+|||+++||||||||+|
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~N  194 (325)
T d1rjba_         115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN  194 (325)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGG
T ss_pred             eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhc
Confidence            999999999999999999653                       248999999999999999999999999999999999


Q ss_pred             EEEeecCCCCCeEEeeccceeeeccCCc---cccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 014733          172 ILLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKT  246 (419)
Q Consensus       172 ILl~~~~~~~~vKL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~  246 (419)
                      ||+   +.++.+||+|||+|+.......   ..+..||+.|+|||++.+ .|+.++|||||||++|||++ |++||.+.+
T Consensus       195 ill---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~  271 (325)
T d1rjba_         195 VLV---THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  271 (325)
T ss_dssp             EEE---ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             ccc---ccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence            999   4567999999999987654432   234568999999999875 59999999999999999997 899998877


Q ss_pred             HHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          247 KSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       247 ~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      ..+.+.++.....+.+.  +..+|+++++||.+||+.||++|||++||++|
T Consensus       272 ~~~~~~~~~~~~~~~~~--p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         272 VDANFYKLIQNGFKMDQ--PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             CSHHHHHHHHTTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHhcCCCCCC--CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            76666666555554433  34789999999999999999999999999986

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.1e-54  Score=410.35  Aligned_cols=247  Identities=24%  Similarity=0.364  Sum_probs=213.2

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEE
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHL  118 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~l  118 (419)
                      .++|++++.||+|+||+||+|.++.+|+.||+|++..+.    ...+++.+|+.+|++++ |||||++++++.+.+.+++
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~----~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~i   90 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYI   90 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC----SCHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSCEE
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc----chHHHHHHHHHHHHhCC-CCCEecCCccEeeCCeeEE
Confidence            378999999999999999999999999999999987543    24567899999999996 9999999999999999999


Q ss_pred             EEeecCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeecc
Q 014733          119 LMELCAGGELFHRLEKY--GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA  196 (419)
Q Consensus       119 V~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~  196 (419)
                      ||||+++|+|..++...  ..+++..+..++.||++||+|||++||+||||||+|||+   +.++.+||+|||+++....
T Consensus        91 v~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl---~~~~~~Kl~DFG~a~~~~~  167 (287)
T d1opja_          91 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTG  167 (287)
T ss_dssp             EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCCTTTCCS
T ss_pred             EeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEE---CCCCcEEEccccceeecCC
Confidence            99999999999999764  458999999999999999999999999999999999999   5567999999999987654


Q ss_pred             CCc--cccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHhcCCCCCCCCCCCCCHH
Q 014733          197 GQN--LHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPP-FWGKTKSKIFDAVRAADLRFPSDPWDHISAS  272 (419)
Q Consensus       197 ~~~--~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~elltG~~P-f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  272 (419)
                      ...  ..+..||+.|+|||++.+ .|+.++|||||||++|||++|..| |.+.+..++.+.+... .+.  ..+..+|++
T Consensus       168 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~-~~~--~~~~~~~~~  244 (287)
T d1opja_         168 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YRM--ERPEGCPEK  244 (287)
T ss_dssp             SSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT-CCC--CCCTTCCHH
T ss_pred             CCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcC-CCC--CCCccchHH
Confidence            432  234468999999999876 599999999999999999996554 5566666666666543 222  233478999


Q ss_pred             HHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          273 ARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       273 l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                      +++||.+||+.||++|||+.++++
T Consensus       245 l~~li~~cl~~dP~~Rps~~ei~~  268 (287)
T d1opja_         245 VYELMRACWQWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHcCCCHhHCcCHHHHHH
Confidence            999999999999999999999976

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.6e-53  Score=414.76  Aligned_cols=255  Identities=25%  Similarity=0.492  Sum_probs=214.5

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEe--CCEE
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEE--EDYV  116 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~--~~~~  116 (419)
                      .++|+++++||+|+||+||+|+++.+|+.||+|++.+.      ..+.+.+|+.+|+++++||||+++++++..  ...+
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~------~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~  107 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP  107 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH------HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence            47899999999999999999999999999999998653      246788999999999779999999999984  4579


Q ss_pred             EEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeecc
Q 014733          117 HLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA  196 (419)
Q Consensus       117 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~  196 (419)
                      ++||||+.+++|....   +.+++.+++.++.||+.||+|||++||+||||||+|||++.  +++.+||+|||++.....
T Consensus       108 ~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~--~~~~vkl~DFG~a~~~~~  182 (328)
T d3bqca1         108 ALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHP  182 (328)
T ss_dssp             EEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET--TTTEEEECCGGGCEECCT
T ss_pred             eEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcC--CCCeeeecccccceeccC
Confidence            9999999999997764   56999999999999999999999999999999999999953  334699999999998877


Q ss_pred             CCccccccCCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHh-------------cCCC
Q 014733          197 GQNLHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTK-SKIFDAVRA-------------ADLR  260 (419)
Q Consensus       197 ~~~~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~-~~~~~~i~~-------------~~~~  260 (419)
                      .......+||+.|+|||++.+  .++.++|+||+||++|+|++|+.||..... .+....+..             ....
T Consensus       183 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~  262 (328)
T d3bqca1         183 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE  262 (328)
T ss_dssp             TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred             CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccc
Confidence            766777889999999999876  389999999999999999999999965442 222222111             0000


Q ss_pred             --------------------CCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccch
Q 014733          261 --------------------FPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECE  304 (419)
Q Consensus       261 --------------------~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~  304 (419)
                                          .+...+..+++++.|||++||++||++|||++|+|+||||+.+.
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~  326 (328)
T d3bqca1         263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV  326 (328)
T ss_dssp             CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred             cCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence                                11122345789999999999999999999999999999998754

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-53  Score=405.51  Aligned_cols=248  Identities=23%  Similarity=0.331  Sum_probs=209.3

Q ss_pred             eeecccCceEEEEEEec--CCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEEEeec
Q 014733           46 KQLGWGQFGVIRECSDK--FTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLLMELC  123 (419)
Q Consensus        46 ~~LG~G~~g~V~~a~~~--~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~  123 (419)
                      ++||+|+||+||+|.++  .+++.||+|++.... ......+.+.+|+++|++++ |||||++++++.++ ..++||||+
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~-HpnIv~~~g~~~~~-~~~lvmE~~   89 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLD-NPYIVRMIGICEAE-SWMLVMEMA   89 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCC-CTTBCCEEEEEESS-SEEEEEECC
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh-CCHHHHHHHHHHHHHHHhCC-CCCCceEEEEeccC-CEEEEEEcC
Confidence            46999999999999864  456789999997553 23445678999999999996 99999999999765 478999999


Q ss_pred             CCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCCcc---
Q 014733          124 AGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQNL---  200 (419)
Q Consensus       124 ~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~~~---  200 (419)
                      ++|+|.+++....++++.++..++.||+.||+|||+++|+||||||+|||++   .++.+||+|||+++........   
T Consensus        90 ~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~---~~~~~kl~DFGla~~~~~~~~~~~~  166 (277)
T d1xbba_          90 ELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRADENYYKA  166 (277)
T ss_dssp             TTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---ETTEEEECCCTTCEECCTTCSEEEC
T ss_pred             CCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhccc---ccCcccccchhhhhhcccccccccc
Confidence            9999999999988999999999999999999999999999999999999994   5678999999999876544322   


Q ss_pred             -ccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHH
Q 014733          201 -HGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASARDLI  277 (419)
Q Consensus       201 -~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li  277 (419)
                       ....||+.|+|||++.+. |+.++|||||||++|||++ |++||.+.+..++...+..+...   ..+..+|+++.+||
T Consensus       167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~---~~p~~~~~~~~~li  243 (277)
T d1xbba_         167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM---GCPAGCPREMYDLM  243 (277)
T ss_dssp             ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---CCCTTCCHHHHHHH
T ss_pred             ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCC---CCCcccCHHHHHHH
Confidence             234789999999998765 8999999999999999998 89999999988888888765322   22347899999999


Q ss_pred             HhhhhcCCCCCCCHHHHH---hcccccc
Q 014733          278 MGMLRVDPSTRLTAAEVL---AHSWMEE  302 (419)
Q Consensus       278 ~~~L~~dP~~Rps~~eil---~hp~~~~  302 (419)
                      .+||+.||++|||+.+|+   +|+|++.
T Consensus       244 ~~cl~~dp~~RPs~~~i~~~L~~~~~~~  271 (277)
T d1xbba_         244 NLCWTYDVENRPGFAAVELRLRNYYYDV  271 (277)
T ss_dssp             HHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             HHHcCCCHhHCcCHHHHHHHhhCHHhhc
Confidence            999999999999999984   5666543

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-54  Score=407.43  Aligned_cols=250  Identities=24%  Similarity=0.407  Sum_probs=207.2

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEE
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHL  118 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~l  118 (419)
                      .++|++++.||+|+||+||+|+.+   ..||||++..... .....+.+.+|+.+|++++ |||||++++++.+ +.+++
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~~-~~~~l   80 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTR-HVNILLFMGYSTA-PQLAI   80 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSC-CTTHHHHHHHHHHHHTTCC-CTTBCCEEEEECS-SSCEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCC-CCCEeeeeEEEec-cEEEE
Confidence            478999999999999999999754   3699999976543 4456788999999999996 9999999998754 55899


Q ss_pred             EEeecCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccC
Q 014733          119 LMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAG  197 (419)
Q Consensus       119 V~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~  197 (419)
                      ||||++||+|.+++... .++++..+..++.||++||+|||+++||||||||+|||+   +.++.+||+|||+|+.....
T Consensus        81 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl---~~~~~~Kl~DFGla~~~~~~  157 (276)
T d1uwha_          81 VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRW  157 (276)
T ss_dssp             EEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---ETTSSEEECCCCCSCC----
T ss_pred             EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEE---cCCCCEEEccccceeecccc
Confidence            99999999999999754 569999999999999999999999999999999999999   45779999999999876432


Q ss_pred             C---ccccccCCCccCCcccccC----CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--CCCCCC
Q 014733          198 Q---NLHGTVGSPFYIAPEVLAG----GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFP--SDPWDH  268 (419)
Q Consensus       198 ~---~~~~~~gt~~y~aPE~l~~----~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~~  268 (419)
                      .   ......||+.|+|||++.+    .|+.++|||||||+||||+||+.||.+.+.......+.......+  ...+..
T Consensus       158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~  237 (276)
T d1uwha_         158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSN  237 (276)
T ss_dssp             --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTT
T ss_pred             CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhcccc
Confidence            2   2345589999999999863    389999999999999999999999988765554444433333222  233457


Q ss_pred             CCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          269 ISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       269 ~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      +++++.+||.+||+.||++|||+.||+++
T Consensus       238 ~~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         238 CPKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             chHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            89999999999999999999999999987

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-53  Score=414.11  Aligned_cols=266  Identities=26%  Similarity=0.469  Sum_probs=217.6

Q ss_pred             ccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCC
Q 014733           35 ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEED  114 (419)
Q Consensus        35 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~  114 (419)
                      +-+++++|++++.||+|+||+||+|+++.+|+.||||++.+..  .....+.+.+|+.+|++|+ ||||+++++++....
T Consensus         3 ~~~i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~-hp~iv~~~~~~~~~~   79 (345)
T d1pmea_           3 VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFR-HENIIGINDIIRAPT   79 (345)
T ss_dssp             CCCCCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCC-CTTBCCCCEEECCSS
T ss_pred             ccCcCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcC-CCCCCcEEEEEeecc
Confidence            3457789999999999999999999999999999999997643  4556778999999999996 999999999997643


Q ss_pred             -----EEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeecc
Q 014733          115 -----YVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFG  189 (419)
Q Consensus       115 -----~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFg  189 (419)
                           .+|++ +|+.||+|.+++.. +++++..++.++.||+.||+|||++|||||||||+|||+   +.++.+||+|||
T Consensus        80 ~~~~~~~~l~-~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl---~~~~~~kl~DfG  154 (345)
T d1pmea_          80 IEQMKDVYLV-THLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFG  154 (345)
T ss_dssp             TTTCCCEEEE-EECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCT
T ss_pred             ccccceEEEE-EeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEE---CCCCCEEEcccC
Confidence                 34555 55669999999976 579999999999999999999999999999999999999   567899999999


Q ss_pred             ceeeeccCCc----cccccCCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC---
Q 014733          190 LATYIKAGQN----LHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLR---  260 (419)
Q Consensus       190 la~~~~~~~~----~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---  260 (419)
                      ++........    ....+||+.|+|||++..  .++.++||||+||++|+|++|+.||.+....+...........   
T Consensus       155 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~  234 (345)
T d1pmea_         155 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ  234 (345)
T ss_dssp             TCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH
T ss_pred             ceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCCh
Confidence            9987654332    344579999999999854  3789999999999999999999999887765555444221100   


Q ss_pred             -----------------CCC-------CCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchhhhc
Q 014733          261 -----------------FPS-------DPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVAQ  308 (419)
Q Consensus       261 -----------------~~~-------~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~~~~  308 (419)
                                       .+.       ..+..+++++++||.+||++||++|||+.|+|+||||++......
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~~  306 (345)
T d1pmea_         235 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD  306 (345)
T ss_dssp             HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGGG
T ss_pred             hhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCcc
Confidence                             111       113468899999999999999999999999999999987655433

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-53  Score=414.18  Aligned_cols=256  Identities=30%  Similarity=0.488  Sum_probs=213.7

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEe------C
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEE------E  113 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~------~  113 (419)
                      -+|+.+++||+|+||+||+|+++.+|+.||||++.++...       ..+|+.+|++++ ||||+++++++..      .
T Consensus        20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-------~~~Ei~il~~l~-h~niv~~~~~~~~~~~~~~~   91 (350)
T d1q5ka_          20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQIMRKLD-HCNIVRLRYFFYSSGEKKDE   91 (350)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-------CCHHHHHHHHCC-CTTBCCEEEEEEEC--CCSC
T ss_pred             CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH-------HHHHHHHHHhcC-CCCCCcEEEEEEecCccCCc
Confidence            4799999999999999999999999999999999765422       236999999995 9999999999854      3


Q ss_pred             CEEEEEEeecCCCChHHHH---HHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccc
Q 014733          114 DYVHLLMELCAGGELFHRL---EKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGL  190 (419)
Q Consensus       114 ~~~~lV~E~~~ggsL~~~l---~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgl  190 (419)
                      .++|+||||++++.+..+.   .....+++.+++.++.||+.||+|||++||+||||||+|||++.  +...+||+|||+
T Consensus        92 ~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~--~~~~~kl~DFG~  169 (350)
T d1q5ka_          92 VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLCDFGS  169 (350)
T ss_dssp             CEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECT--TTCCEEECCCTT
T ss_pred             eEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEec--CCCceeEecccc
Confidence            4689999999766433332   33456999999999999999999999999999999999999942  234799999999


Q ss_pred             eeeeccCCccccccCCCccCCcccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-----------
Q 014733          191 ATYIKAGQNLHGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAA-----------  257 (419)
Q Consensus       191 a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-----------  257 (419)
                      +............+||+.|+|||++.+  .|+.++||||+||++|||++|++||...+..+....+...           
T Consensus       170 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~  249 (350)
T d1q5ka_         170 AKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE  249 (350)
T ss_dssp             CEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred             hhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence            998877766777899999999998765  4899999999999999999999999988877766655331           


Q ss_pred             ------CCCCCC--------CCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchh
Q 014733          258 ------DLRFPS--------DPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQ  305 (419)
Q Consensus       258 ------~~~~~~--------~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~  305 (419)
                            ...++.        .....+++++.+||.+||++||++|||+.|+|+||||+++..
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  311 (350)
T d1q5ka_         250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD  311 (350)
T ss_dssp             HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred             hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence                  111111        112357899999999999999999999999999999988754

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-53  Score=401.06  Aligned_cols=250  Identities=25%  Similarity=0.392  Sum_probs=207.6

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      ++|++++.||+|+||+||+|+++ +++.||||++.+...    ..+.+.+|++++++++ |||||++++++.+++.+++|
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~----~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~~~~~lv   78 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLS-HPKLVQLYGVCLEQAPICLV   78 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSS----CHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSCEEE
T ss_pred             HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcC----cHHHHHHHHHHHHhcC-CCCcccccceeccCCceEEE
Confidence            68999999999999999999986 567899999976432    3467899999999996 99999999999999999999


Q ss_pred             EeecCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC
Q 014733          120 MELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ  198 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~  198 (419)
                      |||+++|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||+   +.++.+||+|||+++......
T Consensus        79 ~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill---~~~~~~Kl~DFGla~~~~~~~  155 (263)
T d1sm2a_          79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQ  155 (263)
T ss_dssp             EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEE---CGGGCEEECSCC---------
T ss_pred             EEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheee---cCCCCeEecccchheeccCCC
Confidence            9999999999998755 458999999999999999999999999999999999999   566789999999998765443


Q ss_pred             c--cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 014733          199 N--LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASAR  274 (419)
Q Consensus       199 ~--~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~  274 (419)
                      .  .....||+.|+|||++.+. |+.++|||||||++|||+| |++||...+..++.+.+..+.....   +...++++.
T Consensus       156 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~---p~~~~~~l~  232 (263)
T d1sm2a_         156 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---PRLASTHVY  232 (263)
T ss_dssp             ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCC---CTTSCHHHH
T ss_pred             ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCC---ccccCHHHH
Confidence            2  2345789999999998874 9999999999999999999 6788888888888888877533222   246899999


Q ss_pred             HHHHhhhhcCCCCCCCHHHHHhccccccc
Q 014733          275 DLIMGMLRVDPSTRLTAAEVLAHSWMEEC  303 (419)
Q Consensus       275 ~li~~~L~~dP~~Rps~~eil~hp~~~~~  303 (419)
                      +||.+||+.||++|||++||++|  ++++
T Consensus       233 ~li~~cl~~~p~~Rps~~~il~~--L~~i  259 (263)
T d1sm2a_         233 QIMNHCWKERPEDRPAFSRLLRQ--LAEI  259 (263)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHH--HHHH
T ss_pred             HHHHHHccCCHhHCcCHHHHHHH--HHHH
Confidence            99999999999999999999987  5443

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-53  Score=405.08  Aligned_cols=253  Identities=23%  Similarity=0.342  Sum_probs=215.9

Q ss_pred             ccCeeeeee-ecccCceEEEEEEecC--CCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCE
Q 014733           39 SDRYVLGKQ-LGWGQFGVIRECSDKF--TGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDY  115 (419)
Q Consensus        39 ~~~y~i~~~-LG~G~~g~V~~a~~~~--~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~  115 (419)
                      .++|.+.+. ||+|+||+||+|.++.  ++..||||++...  ......+.+.+|+++|++++ |||||++++++.++ .
T Consensus         7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~-~   82 (285)
T d1u59a_           7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLD-NPYIVRLIGVCQAE-A   82 (285)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS--CCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEESS-S
T ss_pred             ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh--cCHHHHHHHHHHHHHHHhCC-CCCEeeEeeeeccC-e
Confidence            367888885 9999999999998764  4557999998754  35567788999999999996 99999999999765 4


Q ss_pred             EEEEEeecCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeee
Q 014733          116 VHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI  194 (419)
Q Consensus       116 ~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~  194 (419)
                      +|+||||+++|+|.+++... +.+++.++..++.||++||+|||+++|+||||||+|||++   .++.+||+|||+++.+
T Consensus        83 ~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~---~~~~~Kl~DFGla~~~  159 (285)
T d1u59a_          83 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV---NRHYAKISDFGLSKAL  159 (285)
T ss_dssp             EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE---ETTEEEECCCTTCEEC
T ss_pred             EEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeec---cCCceeeccchhhhcc
Confidence            78999999999999987654 5699999999999999999999999999999999999995   4678999999999987


Q ss_pred             ccCCc----cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCC
Q 014733          195 KAGQN----LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDH  268 (419)
Q Consensus       195 ~~~~~----~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  268 (419)
                      .....    .....||+.|+|||++.++ ++.++|||||||++|||+| |+.||.+.+..++...+..+...   ..+..
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~---~~p~~  236 (285)
T d1u59a_         160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM---ECPPE  236 (285)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC---CCCTT
T ss_pred             cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCCc
Confidence            54432    2234789999999998764 9999999999999999998 99999998888888888765432   22347


Q ss_pred             CCHHHHHHHHhhhhcCCCCCCCHHHH---Hhccccc
Q 014733          269 ISASARDLIMGMLRVDPSTRLTAAEV---LAHSWME  301 (419)
Q Consensus       269 ~s~~l~~li~~~L~~dP~~Rps~~ei---l~hp~~~  301 (419)
                      +|+++.+||.+||+.||++|||+.+|   |+|+|+.
T Consensus       237 ~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         237 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            99999999999999999999999998   5677764

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-54  Score=416.41  Aligned_cols=263  Identities=30%  Similarity=0.499  Sum_probs=222.6

Q ss_pred             cCeeeeeeecccCceEEEEEEe---cCCCcEEEEEEeccCccC-CHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSD---KFTGEVLACKSIAKDRLV-TVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDY  115 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~---~~~g~~vaiK~i~~~~~~-~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~  115 (419)
                      ++|++++.||+|+||+||+|++   +.+|+.||+|++.+.... .....+.+.+|+++|++++.||||+++++++.+.+.
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            7899999999999999999987   457899999999765432 123356688999999999845899999999999999


Q ss_pred             EEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeec
Q 014733          116 VHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIK  195 (419)
Q Consensus       116 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~  195 (419)
                      ++++|||+.+|+|.+++...+.+++..++.++.||+.||+|||+++|+||||||+|||+   +.++.+||+|||+++.+.
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill---~~~~~vkL~DFG~a~~~~  180 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFV  180 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEESCSSEEEECC
T ss_pred             eeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceee---cCCCCEEEeeccchhhhc
Confidence            99999999999999999999999999999999999999999999999999999999999   567899999999998764


Q ss_pred             cCC--ccccccCCCccCCcccccC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCC
Q 014733          196 AGQ--NLHGTVGSPFYIAPEVLAG---GYNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFPSDPWDHIS  270 (419)
Q Consensus       196 ~~~--~~~~~~gt~~y~aPE~l~~---~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  270 (419)
                      ...  ......|++.|+|||.+.+   .++.++|||||||+||+|++|+.||.+....+....+...........+..+|
T Consensus       181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s  260 (322)
T d1vzoa_         181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS  260 (322)
T ss_dssp             GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSC
T ss_pred             ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCC
Confidence            432  2345689999999999865   26889999999999999999999997765544444443333233333334799


Q ss_pred             HHHHHHHHhhhhcCCCCCC-----CHHHHHhccccccchh
Q 014733          271 ASARDLIMGMLRVDPSTRL-----TAAEVLAHSWMEECEQ  305 (419)
Q Consensus       271 ~~l~~li~~~L~~dP~~Rp-----s~~eil~hp~~~~~~~  305 (419)
                      +++.+||++||++||.+||     |++|+++||||+++.+
T Consensus       261 ~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~  300 (322)
T d1vzoa_         261 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW  300 (322)
T ss_dssp             HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred             HHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCH
Confidence            9999999999999999999     5899999999987653

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-53  Score=403.16  Aligned_cols=251  Identities=23%  Similarity=0.342  Sum_probs=215.1

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEE
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHL  118 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~l  118 (419)
                      .++|++++.||+|+||+||+|.++ ++..||||++....    ...+.+.+|+.+|++++ |||||++++++.+ +.+++
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~-~~~~i   84 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS----MSPDAFLAEANLMKQLQ-HQRLVRLYAVVTQ-EPIYI   84 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS----SCHHHHHHHHHHHHHCC-CTTBCCEEEEECS-SSCEE
T ss_pred             HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc----CCHHHHHHHHHHHHhCC-CCCEeEEEeeecc-CCeEE
Confidence            479999999999999999999986 67889999997543    23467899999999996 9999999998765 45789


Q ss_pred             EEeecCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeecc
Q 014733          119 LMELCAGGELFHRLEKY--GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA  196 (419)
Q Consensus       119 V~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~  196 (419)
                      ||||+++|+|.+++...  .++++.++..++.||++||.|||+++|+||||||+||||   +.++.+||+|||+|+....
T Consensus        85 v~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll---~~~~~~Kl~DFGla~~~~~  161 (272)
T d1qpca_          85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV---SDTLSCKIADFGLARLIED  161 (272)
T ss_dssp             EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECSS
T ss_pred             EEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheee---ecccceeeccccceEEccC
Confidence            99999999999877433  359999999999999999999999999999999999999   5678999999999998755


Q ss_pred             CCc--cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHH
Q 014733          197 GQN--LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISAS  272 (419)
Q Consensus       197 ~~~--~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  272 (419)
                      ...  .....||+.|+|||++.++ |+.++|||||||++|||+| |++||......++.+.+..+....   .+..++++
T Consensus       162 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~---~p~~~~~~  238 (272)
T d1qpca_         162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV---RPDNCPEE  238 (272)
T ss_dssp             SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC---CCTTCCHH
T ss_pred             CccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC---CcccChHH
Confidence            432  3345789999999998764 9999999999999999999 567777778888888887653222   22478999


Q ss_pred             HHHHHHhhhhcCCCCCCCHHHHHh--cccccc
Q 014733          273 ARDLIMGMLRVDPSTRLTAAEVLA--HSWMEE  302 (419)
Q Consensus       273 l~~li~~~L~~dP~~Rps~~eil~--hp~~~~  302 (419)
                      +.+||.+||+.||++|||+++|++  |+||..
T Consensus       239 l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         239 LYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence            999999999999999999999998  788753

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-52  Score=401.59  Aligned_cols=259  Identities=26%  Similarity=0.434  Sum_probs=222.9

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      ++|+++++||+|+||+||+|+++.+|+.||||++.+... ......++.+|+.+|++++ ||||+++++++.+....+++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~~~~iv   79 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELK-HKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcC-cCCEEeeccccccccceeEE
Confidence            689999999999999999999999999999999976643 4456788999999999996 99999999999999999999


Q ss_pred             EeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC-
Q 014733          120 MELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ-  198 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~-  198 (419)
                      ++++.+++|..++...+.+++.+++.++.|+++||+|||++||+||||||+|||+   +.++.+||+|||.+....... 
T Consensus        80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli---~~~~~~kl~DFG~a~~~~~~~~  156 (292)
T d1unla_          80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPVR  156 (292)
T ss_dssp             EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSCCS
T ss_pred             eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCccccc---ccCCceeeeecchhhcccCCCc
Confidence            9999999999998888899999999999999999999999999999999999999   566789999999999875443 


Q ss_pred             ccccccCCCccCCcccccCC--CCCchhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHhcCCCC--------------
Q 014733          199 NLHGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPF-WGKTKSKIFDAVRAADLRF--------------  261 (419)
Q Consensus       199 ~~~~~~gt~~y~aPE~l~~~--~s~~sDvwSlGvil~elltG~~Pf-~~~~~~~~~~~i~~~~~~~--------------  261 (419)
                      ......+++.|+|||++.+.  ++.++||||+||++|||++|+.|| .+.+..+....+.......              
T Consensus       157 ~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (292)
T d1unla_         157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY  236 (292)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred             cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccc
Confidence            33345678889999998763  799999999999999999999885 5556666666654321111              


Q ss_pred             -----------CCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccc
Q 014733          262 -----------PSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEEC  303 (419)
Q Consensus       262 -----------~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~  303 (419)
                                 .......+++++.+||++||++||++|||++|+|+||||++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~  289 (292)
T d1unla_         237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF  289 (292)
T ss_dssp             CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred             cccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence                       111234678999999999999999999999999999999864

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-53  Score=396.22  Aligned_cols=246  Identities=23%  Similarity=0.347  Sum_probs=217.3

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLL  119 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~lV  119 (419)
                      ++|+++++||+|+||+||+|+++ ++..||||++.+...    ..+.+.+|++++++++ ||||+++++++.+++.+++|
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~----~~~~~~~Ev~~~~~l~-HpnIv~~~g~~~~~~~~~iv   77 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLS-HEKLVQLYGVCTKQRPIFII   77 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS----CHHHHHHHHHHHHTCC-CTTBCCEEEEECCSSSEEEE
T ss_pred             HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC----CHHHHHHHHHHHHhcC-CCceeeEEEEEeeCCceEEE
Confidence            68999999999999999999985 788999999987643    2457899999999996 99999999999999999999


Q ss_pred             EeecCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCC
Q 014733          120 MELCAGGELFHRLEK-YGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQ  198 (419)
Q Consensus       120 ~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~  198 (419)
                      |||+.+|+|..++.. ...+++..+..++.|+++||+|||++||+||||||+|||+   +.++.+||+|||+++......
T Consensus        78 ~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill---~~~~~~kl~DfG~a~~~~~~~  154 (258)
T d1k2pa_          78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDE  154 (258)
T ss_dssp             EECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEE---CTTCCEEECCCSSCCBCSSSS
T ss_pred             EEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEE---cCCCcEEECcchhheeccCCC
Confidence            999999999988654 4569999999999999999999999999999999999999   567899999999998765443


Q ss_pred             c--cccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 014733          199 N--LHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASAR  274 (419)
Q Consensus       199 ~--~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~  274 (419)
                      .  .....||+.|+|||++.+ .|+.++|||||||++|||+| |+.||.+.+..++..++..+... +  .+...++++.
T Consensus       155 ~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~-~--~p~~~~~~l~  231 (258)
T d1k2pa_         155 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL-Y--RPHLASEKVY  231 (258)
T ss_dssp             CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC-C--CCTTCCHHHH
T ss_pred             ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCC-C--CcccccHHHH
Confidence            2  234578999999999876 59999999999999999998 89999999999999888775332 2  2347899999


Q ss_pred             HHHHhhhhcCCCCCCCHHHHHhc
Q 014733          275 DLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       275 ~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      +||.+||+.||++|||+.++++|
T Consensus       232 ~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         232 TIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             HHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHccCCHhHCcCHHHHHHH
Confidence            99999999999999999999987

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-53  Score=413.20  Aligned_cols=262  Identities=25%  Similarity=0.426  Sum_probs=218.5

Q ss_pred             cccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeC----
Q 014733           38 LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEE----  113 (419)
Q Consensus        38 ~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~----  113 (419)
                      +.+||+++++||+|+||+||+|+++.+|+.||||++.+.. .+....+.+.+|+.+|++++ |||||++++++...    
T Consensus        16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~-h~~iv~~~~~~~~~~~~~   93 (348)
T d2gfsa1          16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLE   93 (348)
T ss_dssp             EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSSTT
T ss_pred             CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchh-cChHHHHHHHHHHHHHHhcC-CCCeeeEEEEEeeccccc
Confidence            4689999999999999999999999999999999998654 34556778999999999996 99999999999632    


Q ss_pred             -CEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeecccee
Q 014733          114 -DYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLAT  192 (419)
Q Consensus       114 -~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~  192 (419)
                       ...+++|+|+.||+|.+++.. +++++.+++.++.||+.||+|||++||+||||||+|||+   +.++.+|++|||++.
T Consensus        94 ~~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi---~~~~~~kl~dfg~a~  169 (348)
T d2gfsa1          94 EFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLAR  169 (348)
T ss_dssp             TCCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCC----
T ss_pred             cCceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccc---cccccccccccchhc
Confidence             334566777789999998865 679999999999999999999999999999999999999   567899999999998


Q ss_pred             eeccCCccccccCCCccCCcccccCC--CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--------
Q 014733          193 YIKAGQNLHGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADLRFP--------  262 (419)
Q Consensus       193 ~~~~~~~~~~~~gt~~y~aPE~l~~~--~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--------  262 (419)
                      ...  ....+..||+.|+|||++.+.  ++.++|||||||++|+|++|++||.+.+.......+.......+        
T Consensus       170 ~~~--~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~  247 (348)
T d2gfsa1         170 HTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS  247 (348)
T ss_dssp             CCT--GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCC
T ss_pred             ccC--cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhcc
Confidence            643  334556899999999987663  68999999999999999999999999887777766644322211        


Q ss_pred             ---------------CC----CCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccchhhh
Q 014733          263 ---------------SD----PWDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECEQVA  307 (419)
Q Consensus       263 ---------------~~----~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~~~~  307 (419)
                                     ..    .+..+++++++||++||+.||.+|||+.|+|+||||++.....
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~  311 (348)
T d2gfsa1         248 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD  311 (348)
T ss_dssp             CHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTT
T ss_pred             chhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCc
Confidence                           11    1246899999999999999999999999999999999865433

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-52  Score=410.18  Aligned_cols=259  Identities=25%  Similarity=0.401  Sum_probs=206.1

Q ss_pred             cccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEe-----
Q 014733           38 LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEE-----  112 (419)
Q Consensus        38 ~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~-----  112 (419)
                      +.++|+++++||+|+||+||+|+++.+|+.||||++.+.. .+......+.+|+.+|++++ |||||++++++..     
T Consensus        15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~-hpnIv~~~~~f~~~~~~~   92 (355)
T d2b1pa1          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQKTLE   92 (355)
T ss_dssp             EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCCSTT
T ss_pred             ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhh-cCHHHHHHHHHHHHHHHhcC-CCCeeEEEEEEecccccc
Confidence            5589999999999999999999999999999999997664 35566778999999999995 9999999999963     


Q ss_pred             -CCEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccce
Q 014733          113 -EDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLA  191 (419)
Q Consensus       113 -~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla  191 (419)
                       .+.+|+||||+.++ +.+.+  ...+++.+++.++.||+.||+|||++||+||||||+|||+   ..++.+|++|||++
T Consensus        93 ~~~~~~iv~Ey~~~~-l~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~---~~~~~~kl~df~~~  166 (355)
T d2b1pa1          93 EFQDVYLVMELMDAN-LCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLA  166 (355)
T ss_dssp             TCCEEEEEEECCSEE-HHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC-
T ss_pred             cCceeEEEEeccchH-HHHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCcccccc---ccccceeeechhhh
Confidence             47899999999665 44444  3569999999999999999999999999999999999999   56788999999999


Q ss_pred             eeeccCCccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-----------
Q 014733          192 TYIKAGQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAVRAADL-----------  259 (419)
Q Consensus       192 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-----------  259 (419)
                      ............+||+.|+|||++.+. +++++||||+||++|+|++|++||.+.+......++.....           
T Consensus       167 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~  246 (355)
T d2b1pa1         167 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ  246 (355)
T ss_dssp             --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred             hccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence            877666666667899999999999874 89999999999999999999999998877666655532111           


Q ss_pred             -----------CCCCCC----------------CCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhccccccch
Q 014733          260 -----------RFPSDP----------------WDHISASARDLIMGMLRVDPSTRLTAAEVLAHSWMEECE  304 (419)
Q Consensus       260 -----------~~~~~~----------------~~~~s~~l~~li~~~L~~dP~~Rps~~eil~hp~~~~~~  304 (419)
                                 ......                ....++++++||++||++||++|||++|+|+||||+...
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~  318 (355)
T d2b1pa1         247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY  318 (355)
T ss_dssp             HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred             hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence                       111000                012467889999999999999999999999999998754

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-52  Score=394.46  Aligned_cols=249  Identities=26%  Similarity=0.375  Sum_probs=204.3

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCC---cEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCE
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTG---EVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDY  115 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g---~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~  115 (419)
                      .++|++++.||+|+||+||+|.+..++   ..||+|.+...  ......+.+.+|+.+|++++ |||||++++++. ++.
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~-~~~   81 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFD-HPHIVKLIGVIT-ENP   81 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC-SSS
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEe-cCe
Confidence            479999999999999999999986543   46888887543  34566788999999999996 999999999996 456


Q ss_pred             EEEEEeecCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeee
Q 014733          116 VHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI  194 (419)
Q Consensus       116 ~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~  194 (419)
                      +|+||||+++|+|..++... ..+++..++.++.||++||.|||+++|+||||||+||+++   .++.+||+|||+++..
T Consensus        82 ~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~---~~~~~Kl~DfG~a~~~  158 (273)
T d1mp8a_          82 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYM  158 (273)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECC-------
T ss_pred             EEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeec---CCCcEEEccchhheec
Confidence            89999999999999987654 4699999999999999999999999999999999999995   4678999999999876


Q ss_pred             ccCCc--cccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCC
Q 014733          195 KAGQN--LHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHIS  270 (419)
Q Consensus       195 ~~~~~--~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  270 (419)
                      .....  .....||+.|+|||++.+ .|+.++|||||||++|||++ |.+||.+.+..++..++..+...   ..+..+|
T Consensus       159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~---~~~~~~~  235 (273)
T d1mp8a_         159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL---PMPPNCP  235 (273)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC---CCCTTCC
T ss_pred             cCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCC
Confidence            54332  234468999999999876 59999999999999999998 89999999999998888776432   2335799


Q ss_pred             HHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          271 ASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       271 ~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      +++.+||.+||+.||++|||+.||++|
T Consensus       236 ~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         236 PTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            999999999999999999999999987

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-51  Score=390.13  Aligned_cols=248  Identities=24%  Similarity=0.370  Sum_probs=205.9

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCC----cEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTG----EVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDY  115 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g----~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~  115 (419)
                      +.|++.+.||+|+||+||+|.++.++    ..||||++...  ........+.+|+++|++++ |||||++++++.+.+.
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~il~~l~-H~nIv~~~g~~~~~~~   83 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG--YTEKQRVDFLGEAGIMGQFS-HHNIIRLEGVISKYKP   83 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECSSSS
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcc--cChHHHHHHHHHHHHHHhcC-CCCEeeeeEEEecCCc
Confidence            67999999999999999999987554    47999998654  34566678999999999996 9999999999999999


Q ss_pred             EEEEEeecCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeee
Q 014733          116 VHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI  194 (419)
Q Consensus       116 ~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~  194 (419)
                      .++||||+.++++.+.+... +.+++.++..++.||+.||+|||+++|+||||||+||||   +.++.+||+|||+++.+
T Consensus        84 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl---~~~~~~Kl~DFGla~~~  160 (283)
T d1mqba_          84 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV---NSNLVCKVSDFGLSRVL  160 (283)
T ss_dssp             EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC----
T ss_pred             eEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEE---CCCCeEEEcccchhhcc
Confidence            99999999999999887654 569999999999999999999999999999999999999   56789999999999876


Q ss_pred             ccCC----ccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHhcCCCCCCCCCCC
Q 014733          195 KAGQ----NLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSG-MPPFWGKTKSKIFDAVRAADLRFPSDPWDH  268 (419)
Q Consensus       195 ~~~~----~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  268 (419)
                      ....    ......||+.|+|||++.++ |+.++|||||||++|||++| .+||.+....++.+.+..+. +.+  .+..
T Consensus       161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~-~~~--~~~~  237 (283)
T d1mqba_         161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF-RLP--TPMD  237 (283)
T ss_dssp             -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-CCC--CCTT
T ss_pred             cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccC-CCC--Cchh
Confidence            5432    22345789999999998774 99999999999999999985 56667777777877776653 222  2347


Q ss_pred             CCHHHHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          269 ISASARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       269 ~s~~l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                      ++.++.+||.+||+.||++|||+.||++
T Consensus       238 ~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         238 CPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             CBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             hHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence            8999999999999999999999999987

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-52  Score=399.35  Aligned_cols=250  Identities=26%  Similarity=0.364  Sum_probs=212.5

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcE--EEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEV--LACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVH  117 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~--vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~  117 (419)
                      ++|++.++||+|+||+||+|.++.+|..  ||||.+...  ...+..+.+.+|+++|+++.+|||||++++++.+++.++
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~   87 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY   87 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcc--cChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeE
Confidence            7899999999999999999999988875  566666433  344566789999999999956999999999999999999


Q ss_pred             EEEeecCCCChHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCC
Q 014733          118 LLMELCAGGELFHRLEKY----------------GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSS  181 (419)
Q Consensus       118 lV~E~~~ggsL~~~l~~~----------------~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~  181 (419)
                      +||||++||+|.+++...                ..+++..+..++.||++||.|||+.+|+||||||+|||+   +.++
T Consensus        88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~---~~~~  164 (309)
T d1fvra_          88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENY  164 (309)
T ss_dssp             EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGG
T ss_pred             EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEE---cCCC
Confidence            999999999999999654                458999999999999999999999999999999999999   5567


Q ss_pred             CeEEeeccceeeeccCCccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHhcCC
Q 014733          182 PIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSG-MPPFWGKTKSKIFDAVRAADL  259 (419)
Q Consensus       182 ~vKL~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG-~~Pf~~~~~~~~~~~i~~~~~  259 (419)
                      .+||+|||+++............||..|+|||.+.++ |+.++|||||||++|||++| .+||.+.+..++.+.+..+. 
T Consensus       165 ~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~-  243 (309)
T d1fvra_         165 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY-  243 (309)
T ss_dssp             CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC-
T ss_pred             ceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcC-
Confidence            8999999999876655555566799999999998765 99999999999999999996 56898889888888876642 


Q ss_pred             CCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          260 RFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       260 ~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      +  ...+..+++++++||.+||+.||++|||+.+|++|
T Consensus       244 ~--~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         244 R--LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             C--CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             C--CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            2  22334789999999999999999999999999987

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-51  Score=394.14  Aligned_cols=252  Identities=27%  Similarity=0.377  Sum_probs=202.0

Q ss_pred             ccCeeeeeeecccCceEEEEEEecC-----CCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeC
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKF-----TGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEE  113 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~-----~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~  113 (419)
                      .++|++++.||+|+||+||+|.+..     +++.||+|++...  ......+.+.+|..++.++.+|+||+.+++++.+.
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~   89 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP   89 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccc--cCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence            4789999999999999999999753     4578999998654  34556778889999999987799999999998654


Q ss_pred             -CEEEEEEeecCCCChHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEee
Q 014733          114 -DYVHLLMELCAGGELFHRLEKY----------------GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLAT  176 (419)
Q Consensus       114 -~~~~lV~E~~~ggsL~~~l~~~----------------~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~  176 (419)
                       +.+++||||+++|+|.+++...                ..+++.++..++.||++||.|||+++||||||||+||||  
T Consensus        90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl--  167 (299)
T d1ywna1          90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL--  167 (299)
T ss_dssp             TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--
T ss_pred             CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeE--
Confidence             5689999999999999999653                248899999999999999999999999999999999999  


Q ss_pred             cCCCCCeEEeeccceeeeccCCc---cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhC-CCCCCCCCHHHHH
Q 014733          177 KSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSG-MPPFWGKTKSKIF  251 (419)
Q Consensus       177 ~~~~~~vKL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG-~~Pf~~~~~~~~~  251 (419)
                       +.++.+||+|||+|+.......   .....||+.|+|||++.+. |+.++|||||||++|||++| .+||.+....+.+
T Consensus       168 -~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~  246 (299)
T d1ywna1         168 -SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF  246 (299)
T ss_dssp             -CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred             -CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence             5677999999999987644322   2345799999999998764 99999999999999999986 5688776554444


Q ss_pred             HHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          252 DAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       252 ~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      ..+.....+.+  .+..+++++++||.+||+.||++|||+.|+++|
T Consensus       247 ~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         247 CRRLKEGTRMR--APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             HHHHHHTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHhcCCCCC--CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            43333333222  234789999999999999999999999999987

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-51  Score=396.64  Aligned_cols=248  Identities=23%  Similarity=0.334  Sum_probs=206.7

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCc----EEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGE----VLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDY  115 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~----~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~  115 (419)
                      ++|++++.||+|+||+||+|.+..+|+    .||+|.+...  ......+.+.+|+.+|++++ |||||++++++.+++ 
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~~-   84 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVD-NPHVCRLLGICLTST-   84 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCC-CTTBCCEEEEEESSS-
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEecCC-
Confidence            469999999999999999999988876    4777776543  23445678999999999996 999999999998765 


Q ss_pred             EEEEEeecCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeee
Q 014733          116 VHLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYI  194 (419)
Q Consensus       116 ~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~  194 (419)
                      .++++||+.+++|.+.+... ..+++..+..++.||+.||+|||+++||||||||+|||++   .++.+||+|||+++..
T Consensus        85 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~---~~~~~kl~DFGla~~~  161 (317)
T d1xkka_          85 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAKLL  161 (317)
T ss_dssp             EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---ETTEEEECCCSHHHHT
T ss_pred             eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeC---CCCCeEeeccccceec
Confidence            67888999999999887664 5699999999999999999999999999999999999995   4678999999999876


Q ss_pred             ccCCc---cccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCC
Q 014733          195 KAGQN---LHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHI  269 (419)
Q Consensus       195 ~~~~~---~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  269 (419)
                      .....   .....||+.|+|||++.+ .|+.++|||||||++|||+| |.+||.+.+..++...+..+.. .+  .+..+
T Consensus       162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~-~~--~p~~~  238 (317)
T d1xkka_         162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER-LP--QPPIC  238 (317)
T ss_dssp             TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCC-CC--CCTTB
T ss_pred             ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC-CC--CCccc
Confidence            54332   233468999999999876 49999999999999999998 8999999888888888776542 22  22478


Q ss_pred             CHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          270 SASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       270 s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                      ++++.+||.+||+.||++|||+.|+++|
T Consensus       239 ~~~~~~li~~cl~~dP~~RPs~~eil~~  266 (317)
T d1xkka_         239 TIDVYMIMVKCWMIDADSRPKFRELIIE  266 (317)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence            9999999999999999999999999988

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-51  Score=390.87  Aligned_cols=252  Identities=26%  Similarity=0.348  Sum_probs=208.4

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEEE
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHL  118 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~l  118 (419)
                      .++|++++.||+|+||+||+|+++.+ +.||||++.....    ..+.+.+|+.+|++++ |||||++++++.++ .+++
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~----~~~~~~~E~~~l~~l~-h~nIv~~~g~~~~~-~~~l   88 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQLYAVVSEE-PIYI   88 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS----CHHHHHHHHHHHHHCC-CTTBCCEEEEECSS-SCEE
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccC----CHHHHHHHHHHHHhcc-cCCEeEEEEEEecC-CeEE
Confidence            37899999999999999999998754 5699999975432    3467899999999996 99999999998654 5789


Q ss_pred             EEeecCCCChHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeecc
Q 014733          119 LMELCAGGELFHRLEK--YGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA  196 (419)
Q Consensus       119 V~E~~~ggsL~~~l~~--~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~  196 (419)
                      ||||+++|+|..++..  .+.+++.++..++.||+.||+|||+++|+||||||+||||   +.++.+||+|||+++....
T Consensus        89 v~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll---~~~~~~kl~DfGla~~~~~  165 (285)
T d1fmka3          89 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIED  165 (285)
T ss_dssp             EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCTTC----
T ss_pred             EEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEE---CCCCcEEEcccchhhhccC
Confidence            9999999999988854  3569999999999999999999999999999999999999   5567899999999987654


Q ss_pred             CCc--cccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHH
Q 014733          197 GQN--LHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSG-MPPFWGKTKSKIFDAVRAADLRFPSDPWDHISAS  272 (419)
Q Consensus       197 ~~~--~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~elltG-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  272 (419)
                      ...  .....||+.|+|||++.+ .++.++|||||||++|||++| ++|+.+....++...+.... +.+  .+..++++
T Consensus       166 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~-~~~--~~~~~~~~  242 (285)
T d1fmka3         166 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-RMP--CPPECPES  242 (285)
T ss_dssp             ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-CCC--CCTTSCHH
T ss_pred             CCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC-CCC--CCcccCHH
Confidence            332  234578999999999876 599999999999999999994 66667777777887776643 222  23478999


Q ss_pred             HHHHHHhhhhcCCCCCCCHHHHHh--ccccccc
Q 014733          273 ARDLIMGMLRVDPSTRLTAAEVLA--HSWMEEC  303 (419)
Q Consensus       273 l~~li~~~L~~dP~~Rps~~eil~--hp~~~~~  303 (419)
                      +++||.+||+.||++|||+++|++  |+||...
T Consensus       243 l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         243 LHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             HHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence            999999999999999999999987  7888654

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-51  Score=390.19  Aligned_cols=250  Identities=26%  Similarity=0.392  Sum_probs=205.2

Q ss_pred             cCeeeeeeecccCceEEEEEEec-CCC--cEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDK-FTG--EVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYV  116 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~-~~g--~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~  116 (419)
                      ++|++.+.||+|+||+||+|+.. .++  ..||+|++.+.........+.+.+|+.+|++++ |||||++++++.++ .+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~~~g~~~~~-~~   85 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVVLTP-PM   85 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSS-SC
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEeec-ch
Confidence            67999999999999999999864 333  468999998776656667788999999999996 99999999999765 57


Q ss_pred             EEEEeecCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeec
Q 014733          117 HLLMELCAGGELFHRLEKY-GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIK  195 (419)
Q Consensus       117 ~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~  195 (419)
                      ++||||+++|+|.+.+... +.+++..+..++.||++||.|||+++|+||||||+|||++.   ++.+||+|||+++...
T Consensus        86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~---~~~vkl~DfGl~~~~~  162 (273)
T d1u46a_          86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLAT---RDLVKIGDFGLMRALP  162 (273)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEE---TTEEEECCCTTCEECC
T ss_pred             heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhcccc---ccceeeccchhhhhcc
Confidence            8999999999999877554 56999999999999999999999999999999999999954   5689999999999875


Q ss_pred             cCCc----cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCC
Q 014733          196 AGQN----LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHI  269 (419)
Q Consensus       196 ~~~~----~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  269 (419)
                      ....    .....|+..|+|||++.+. ++.++|||||||++|||++ |++||.+.+..+...++.....+++.  +..+
T Consensus       163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~  240 (273)
T d1u46a_         163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR--PEDC  240 (273)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCC--CTTC
T ss_pred             cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCC--cccc
Confidence            4432    2233678899999998875 8999999999999999998 89999999999999998877665543  3579


Q ss_pred             CHHHHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          270 SASARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       270 s~~l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                      |+++.+||.+||+.||++|||+.+|++
T Consensus       241 ~~~l~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         241 PQDIYNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            999999999999999999999999964

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.1e-50  Score=390.24  Aligned_cols=249  Identities=22%  Similarity=0.327  Sum_probs=216.1

Q ss_pred             ccCeeeeeeecccCceEEEEEEec-----CCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeC
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDK-----FTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEE  113 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~-----~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~  113 (419)
                      .++|++++.||+|+||+||+|+++     .+++.||||++...  ...+..+.+.+|+.+|++++ ||||+++++++.+.
T Consensus        12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~   88 (301)
T d1lufa_          12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE--ASADMQADFQREAALMAEFD-NPNIVKLLGVCAVG   88 (301)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT--CCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECSS
T ss_pred             HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh--cChHHHHHHHHHHHHHHhcC-CCCcccceeeeccC
Confidence            478999999999999999999875     35678999998754  34556778999999999996 99999999999999


Q ss_pred             CEEEEEEeecCCCChHHHHHHcC------------------------CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCC
Q 014733          114 DYVHLLMELCAGGELFHRLEKYG------------------------RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKP  169 (419)
Q Consensus       114 ~~~~lV~E~~~ggsL~~~l~~~~------------------------~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp  169 (419)
                      +..+++|||+++|+|.+++....                        .+++.++..++.||+.||+|||+++||||||||
T Consensus        89 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp  168 (301)
T d1lufa_          89 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT  168 (301)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred             CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcc
Confidence            99999999999999999996532                        388999999999999999999999999999999


Q ss_pred             CcEEEeecCCCCCeEEeeccceeeeccCCc---cccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHhCC-CCCCC
Q 014733          170 ENILLATKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGM-PPFWG  244 (419)
Q Consensus       170 ~NILl~~~~~~~~vKL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~elltG~-~Pf~~  244 (419)
                      +|||+   +.++.+||+|||+++...+...   ....+||+.|+|||++.+ .|+.++|||||||++|||++|. +||.+
T Consensus       169 ~NILl---d~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~  245 (301)
T d1lufa_         169 RNCLV---GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG  245 (301)
T ss_dssp             GGEEE---CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             cceEE---CCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCC
Confidence            99999   5577899999999986644322   234578999999999877 4999999999999999999985 78999


Q ss_pred             CCHHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          245 KTKSKIFDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       245 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                      .+..++...+..+....   .+..+++++.+||.+||+.||++|||+.||++
T Consensus       246 ~~~~e~~~~v~~~~~~~---~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         246 MAHEEVIYYVRDGNILA---CPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             SCHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHHcCCCCC---CCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            99999999888765322   23478999999999999999999999999965

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-50  Score=388.76  Aligned_cols=250  Identities=25%  Similarity=0.398  Sum_probs=213.4

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCC-------cEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEE
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTG-------EVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYE  111 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g-------~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~  111 (419)
                      .++|++++.||+|+||.||+|++..++       ..||+|++.++  ........+.+|...+.++.+|||||++++++.
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~   89 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKMIGKHKNIINLLGACT   89 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcc--cChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence            489999999999999999999876544       47999998765  355667889999999999966999999999999


Q ss_pred             eCCEEEEEEeecCCCChHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEe
Q 014733          112 EEDYVHLLMELCAGGELFHRLEKY----------------GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLA  175 (419)
Q Consensus       112 ~~~~~~lV~E~~~ggsL~~~l~~~----------------~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~  175 (419)
                      +++.+++||||+.+|+|.+++...                ..+++.++..++.||+.||+|||+.+||||||||+|||+ 
T Consensus        90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl-  168 (299)
T d1fgka_          90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV-  168 (299)
T ss_dssp             SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE-
T ss_pred             cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceee-
Confidence            999999999999999999999654                248999999999999999999999999999999999999 


Q ss_pred             ecCCCCCeEEeeccceeeeccCCc---cccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 014733          176 TKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKI  250 (419)
Q Consensus       176 ~~~~~~~vKL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~  250 (419)
                        +.++.+||+|||+++.......   .....||+.|+|||++.+ .|+.++|||||||++|||++ |++||.+.+..++
T Consensus       169 --~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~  246 (299)
T d1fgka_         169 --TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL  246 (299)
T ss_dssp             --CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred             --cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHH
Confidence              5678999999999997755432   233578999999999875 59999999999999999998 7999999999888


Q ss_pred             HHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          251 FDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       251 ~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                      ++.+..+. +.+  .+..+++++.+||.+||+.||++|||+.||++
T Consensus       247 ~~~i~~~~-~~~--~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         247 FKLLKEGH-RMD--KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             HHHHHTTC-CCC--CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHcCC-CCC--CCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            88887653 222  23478999999999999999999999999987

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-50  Score=382.18  Aligned_cols=246  Identities=24%  Similarity=0.368  Sum_probs=204.2

Q ss_pred             cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEe-CCEEEE
Q 014733           40 DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEE-EDYVHL  118 (419)
Q Consensus        40 ~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~-~~~~~l  118 (419)
                      ++|++++.||+|+||.||+|.++  |+.||+|+++++     ...+.+.+|++++++++ ||||+++++++.+ .+.+|+
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~-----~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~~~~~~l   78 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-----ATAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKGGLYI   78 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC-----C--HHHHHTHHHHTTCC-CTTBCCEEEEECCC--CCEE
T ss_pred             HHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcH-----HHHHHHHHHHHHHHhCC-CCCEeeEEEEEEecCCcEEE
Confidence            67999999999999999999974  789999999654     23467899999999996 9999999999854 566899


Q ss_pred             EEeecCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeecc
Q 014733          119 LMELCAGGELFHRLEKYG--RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA  196 (419)
Q Consensus       119 V~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~  196 (419)
                      ||||+++|+|.+++...+  .+++..+..++.||+.||.|||+.+|+||||||+|||+   +.++.+||+|||+++....
T Consensus        79 v~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~---~~~~~~kl~dfg~s~~~~~  155 (262)
T d1byga_          79 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASS  155 (262)
T ss_dssp             EECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTSCEEECCCCC------
T ss_pred             EEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhhee---cCCCCEeecccccceecCC
Confidence            999999999999996543  48999999999999999999999999999999999999   5678999999999987543


Q ss_pred             CCccccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 014733          197 GQNLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKIFDAVRAADLRFPSDPWDHISASAR  274 (419)
Q Consensus       197 ~~~~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~  274 (419)
                      .  .....+|..|+|||++.+ .++.++|||||||++|||+| |++||...+..++...+.... +.+  ....+++++.
T Consensus       156 ~--~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~-~~~--~~~~~~~~~~  230 (262)
T d1byga_         156 T--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY-KMD--APDGCPPAVY  230 (262)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC-CCC--CCTTCCHHHH
T ss_pred             C--CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-CCC--CCccCCHHHH
Confidence            3  334578899999999875 59999999999999999998 799999988888888886542 222  2347899999


Q ss_pred             HHHHhhhhcCCCCCCCHHHHHhccccccc
Q 014733          275 DLIMGMLRVDPSTRLTAAEVLAHSWMEEC  303 (419)
Q Consensus       275 ~li~~~L~~dP~~Rps~~eil~hp~~~~~  303 (419)
                      +||.+||+.||.+|||+.+++++  ++++
T Consensus       231 ~li~~cl~~dP~~Rps~~~l~~~--L~~i  257 (262)
T d1byga_         231 EVMKNCWHLDAAMRPSFLQLREQ--LEHI  257 (262)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHH--HHHH
T ss_pred             HHHHHHcccCHhHCcCHHHHHHH--HHHH
Confidence            99999999999999999999885  5544

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.5e-50  Score=386.03  Aligned_cols=258  Identities=20%  Similarity=0.292  Sum_probs=206.4

Q ss_pred             cccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEEE
Q 014733           38 LSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYVH  117 (419)
Q Consensus        38 ~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~~  117 (419)
                      ++++|+++++||+|+||+||+|+++.+|+.||||++..+..     ...+..|+++++.+..|++|+.+..++.+.+..+
T Consensus         5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~   79 (299)
T d1ckia_           5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV   79 (299)
T ss_dssp             ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEE
T ss_pred             ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-----CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEE
Confidence            56899999999999999999999999999999999876532     2347789999999975555667777788999999


Q ss_pred             EEEeecCCCChHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeecc
Q 014733          118 LLMELCAGGELFHRLE-KYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKA  196 (419)
Q Consensus       118 lV~E~~~ggsL~~~l~-~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~  196 (419)
                      +||||+ +++|...+. ..+.+++..+..++.|++.||+|||++|||||||||+|||++..+.+..+||+|||+|+.+..
T Consensus        80 ivme~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~  158 (299)
T d1ckia_          80 MVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  158 (299)
T ss_dssp             EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred             EEEEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence            999999 556655554 445799999999999999999999999999999999999997666677899999999998754


Q ss_pred             CCc--------cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HhcCCCCCC-
Q 014733          197 GQN--------LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTKSKIFDAV---RAADLRFPS-  263 (419)
Q Consensus       197 ~~~--------~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i---~~~~~~~~~-  263 (419)
                      ...        ....+||+.|+|||++.+. ++.++|||||||++|||++|+.||...........+   .......+. 
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (299)
T d1ckia_         159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE  238 (299)
T ss_dssp             TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH
T ss_pred             cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChh
Confidence            322        2345799999999998874 999999999999999999999999776554333222   111111111 


Q ss_pred             CCCCCCCHHHHHHHHhhhhcCCCCCCCHHHH---Hhccccc
Q 014733          264 DPWDHISASARDLIMGMLRVDPSTRLTAAEV---LAHSWME  301 (419)
Q Consensus       264 ~~~~~~s~~l~~li~~~L~~dP~~Rps~~ei---l~hp~~~  301 (419)
                      .....+|+++.++|.+||+.||++||++.++   |+|+|.+
T Consensus       239 ~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~  279 (299)
T d1ckia_         239 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  279 (299)
T ss_dssp             HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence            1234789999999999999999999998755   5666553

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-50  Score=386.29  Aligned_cols=251  Identities=25%  Similarity=0.401  Sum_probs=214.9

Q ss_pred             ccCeeeeeeecccCceEEEEEEec-----CCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeC
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDK-----FTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEE  113 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~-----~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~  113 (419)
                      .++|+++++||+|+||.||+|++.     .+++.||||++.+..  .......+.+|+.+++++.+|||||++++++.+.
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~   99 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACTIG   99 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence            389999999999999999999863     567899999997653  4566778999999999997799999999999999


Q ss_pred             CEEEEEEeecCCCChHHHHHHcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEe
Q 014733          114 DYVHLLMELCAGGELFHRLEKYG------------------RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLA  175 (419)
Q Consensus       114 ~~~~lV~E~~~ggsL~~~l~~~~------------------~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~  175 (419)
                      +.+++||||+++|+|..++.+..                  .+++..+..++.||+.||+|||+++||||||||+|||+ 
T Consensus       100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~-  178 (311)
T d1t46a_         100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL-  178 (311)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE-
T ss_pred             CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccc-
Confidence            99999999999999999997543                  48999999999999999999999999999999999999 


Q ss_pred             ecCCCCCeEEeeccceeeeccCCc---cccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 014733          176 TKSSSSPIKLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGKTKSKI  250 (419)
Q Consensus       176 ~~~~~~~vKL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~  250 (419)
                        +.++.+||+|||.++.......   ....+||+.|+|||++.+ .++.++|||||||++|||+| |.+||.+....+.
T Consensus       179 --~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~  256 (311)
T d1t46a_         179 --THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK  256 (311)
T ss_dssp             --ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred             --cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH
Confidence              4567899999999987654322   234578999999999876 48999999999999999998 6777777766666


Q ss_pred             HHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          251 FDAVRAADLRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       251 ~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                      +.++.....+...  ...+++++.+||.+||+.||++|||+.+|++
T Consensus       257 ~~~~i~~~~~~~~--~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         257 FYKMIKEGFRMLS--PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             HHHHHHHTCCCCC--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHhcCCCCCC--cccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            5555444443332  2478999999999999999999999999986

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-49  Score=382.35  Aligned_cols=249  Identities=22%  Similarity=0.343  Sum_probs=216.5

Q ss_pred             ccCeeeeeeecccCceEEEEEEec-----CCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeC
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDK-----FTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEE  113 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~-----~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~  113 (419)
                      .++|++++.||+|+||+||+|.++     .++..||||++.+.  ........+.+|+.+++++. |||||++++++..+
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~--~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~   95 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFN-CHHVVRLLGVVSQG   95 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT--SCHHHHHHHHHHHHHGGGCC-CTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc--cChHHHHHHHHHHHHHHHcC-CCCEeeeeeEEecC
Confidence            489999999999999999999875     24578999998754  35566778999999999996 99999999999999


Q ss_pred             CEEEEEEeecCCCChHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCe
Q 014733          114 DYVHLLMELCAGGELFHRLEKY----------GRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPI  183 (419)
Q Consensus       114 ~~~~lV~E~~~ggsL~~~l~~~----------~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~v  183 (419)
                      +..++||||+++|+|.+++...          ..+++..+..++.|+++||.|||+++|+||||||+|||+   +.++++
T Consensus        96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLl---d~~~~~  172 (308)
T d1p4oa_          96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDFTV  172 (308)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE---CTTCCE
T ss_pred             CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceee---cCCceE
Confidence            9999999999999999988643          237899999999999999999999999999999999999   567899


Q ss_pred             EEeeccceeeeccCCc---cccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHhcC
Q 014733          184 KLADFGLATYIKAGQN---LHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSG-MPPFWGKTKSKIFDAVRAAD  258 (419)
Q Consensus       184 KL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG-~~Pf~~~~~~~~~~~i~~~~  258 (419)
                      ||+|||+++.......   .....||+.|+|||.+.+. ++.++||||||+++|||+|| .+||.+.+..+....+..+.
T Consensus       173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~  252 (308)
T d1p4oa_         173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG  252 (308)
T ss_dssp             EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC
T ss_pred             EEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCC
Confidence            9999999987654332   2334689999999998764 89999999999999999998 58899999999998887754


Q ss_pred             CCCCCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          259 LRFPSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       259 ~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                      ...   .+..+++++.++|.+||+.||++|||+.+|++
T Consensus       253 ~~~---~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~  287 (308)
T d1p4oa_         253 LLD---KPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS  287 (308)
T ss_dssp             CCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCC---CcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            322   22478999999999999999999999999998

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-48  Score=374.84  Aligned_cols=248  Identities=20%  Similarity=0.256  Sum_probs=203.1

Q ss_pred             eeeecccCceEEEEEEecCCC---cEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEe-CCEEEEEE
Q 014733           45 GKQLGWGQFGVIRECSDKFTG---EVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEE-EDYVHLLM  120 (419)
Q Consensus        45 ~~~LG~G~~g~V~~a~~~~~g---~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~-~~~~~lV~  120 (419)
                      .++||+|+||+||+|++..++   ..||||++.+.  ......+.+.+|+++|++++ ||||+++++++.+ ++..++||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~~~~~~lv~  108 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPLVVL  108 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEETTTEEEEEE
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCC-CCCEeEEeEEEEecCCceEEEE
Confidence            678999999999999986543   36899998643  45677889999999999996 9999999999875 56899999


Q ss_pred             eecCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEeeccceeeeccCCc
Q 014733          121 ELCAGGELFHRLEKYG-RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLADFGLATYIKAGQN  199 (419)
Q Consensus       121 E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~~~~~~~  199 (419)
                      ||+++|+|.+++.... .+++..+..++.|++.||.|||+.+|+||||||+|||+   +.++.+||+|||+++.......
T Consensus       109 E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl---~~~~~~kL~DFG~~~~~~~~~~  185 (311)
T d1r0pa_         109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEF  185 (311)
T ss_dssp             ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECSSGGGCCTTTTTC
T ss_pred             EEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeE---CCCCCEEEecccchhhcccccc
Confidence            9999999999887544 47888999999999999999999999999999999999   5678999999999987654322


Q ss_pred             -----cccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcCCCCCCCCCCCCCHH
Q 014733          200 -----LHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWG-KTKSKIFDAVRAADLRFPSDPWDHISAS  272 (419)
Q Consensus       200 -----~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~  272 (419)
                           .....||+.|+|||++.+ .++.++||||||+++|||++|..||.. .+..++...+..+.. .+  ....++++
T Consensus       186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~-~~--~p~~~~~~  262 (311)
T d1r0pa_         186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR-LL--QPEYCPDP  262 (311)
T ss_dssp             CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCC-CC--CCTTCCHH
T ss_pred             ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC-CC--CcccCcHH
Confidence                 223468999999999875 599999999999999999997766654 344455566555432 22  22478999


Q ss_pred             HHHHHHhhhhcCCCCCCCHHHHHhccccccc
Q 014733          273 ARDLIMGMLRVDPSTRLTAAEVLAHSWMEEC  303 (419)
Q Consensus       273 l~~li~~~L~~dP~~Rps~~eil~hp~~~~~  303 (419)
                      +.+||.+||+.||++|||+.||++|  ++.+
T Consensus       263 l~~li~~cl~~dP~~RPs~~ei~~~--L~~i  291 (311)
T d1r0pa_         263 LYEVMLKCWHPKAEMRPSFSELVSR--ISAI  291 (311)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH--HHHH
T ss_pred             HHHHHHHHcCCCHhHCcCHHHHHHH--HHHH
Confidence            9999999999999999999999987  5444

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=8e-48  Score=368.78  Aligned_cols=254  Identities=18%  Similarity=0.273  Sum_probs=210.3

Q ss_pred             ccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEE
Q 014733           37 NLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYV  116 (419)
Q Consensus        37 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~  116 (419)
                      .++++|++++.||+|+||+||+|+++.+|+.||+|++.....     ...+.+|+++++.|.+|+||+.+++++.+....
T Consensus         2 vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~   76 (293)
T d1csna_           2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN   76 (293)
T ss_dssp             EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred             CCCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCcc
Confidence            357899999999999999999999999999999999865432     235678999999998679999999999999999


Q ss_pred             EEEEeecCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecC--CCCCeEEeeccceee
Q 014733          117 HLLMELCAGGELFHRLEKYG-RFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKS--SSSPIKLADFGLATY  193 (419)
Q Consensus       117 ~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~--~~~~vKL~DFgla~~  193 (419)
                      ++||||+ +++|.+++...+ .+++.++..++.|++.||+|||++||+||||||+|||++.+.  ..+.+||+|||+|+.
T Consensus        77 ~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~  155 (293)
T d1csna_          77 VLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  155 (293)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             EEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEE
Confidence            9999999 789999887654 599999999999999999999999999999999999996532  356899999999987


Q ss_pred             eccCC--------ccccccCCCccCCcccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhcCCCC
Q 014733          194 IKAGQ--------NLHGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGKTK---SKIFDAVRAADLRF  261 (419)
Q Consensus       194 ~~~~~--------~~~~~~gt~~y~aPE~l~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~---~~~~~~i~~~~~~~  261 (419)
                      .....        .....+||+.|+|||++.+. ++.++|||||||++|||++|..||.+...   ......+.......
T Consensus       156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (293)
T d1csna_         156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST  235 (293)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred             cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence            65332        12345799999999999875 99999999999999999999999975433   33333333222111


Q ss_pred             -CCCCCCCCCHHHHHHHHhhhhcCCCCCCCHHHHHh
Q 014733          262 -PSDPWDHISASARDLIMGMLRVDPSTRLTAAEVLA  296 (419)
Q Consensus       262 -~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~eil~  296 (419)
                       +......+|+++.+++..|+..+|++||+.+.+.+
T Consensus       236 ~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         236 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             ChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence             11223468899999999999999999999887754

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-47  Score=365.04  Aligned_cols=246  Identities=23%  Similarity=0.296  Sum_probs=192.8

Q ss_pred             ccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHH--HHHHHHHHccCCCCceeeeEEEEeCC--
Q 014733           39 SDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIK--LEIEIMTKLSGHPNVVDLKAVYEEED--  114 (419)
Q Consensus        39 ~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~--~Ei~il~~l~~hpnIv~l~~~~~~~~--  114 (419)
                      ..+|.+.+.||+|+||+||+|++  +|+.||||++..+      ..+...  .|+..+.+++ |||||++++++.+.+  
T Consensus         2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~------~~~~~~~e~ei~~~~~~~-HpnIv~~~~~~~~~~~~   72 (303)
T d1vjya_           2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR------EERSWFREAEIYQTVMLR-HENILGFIAADNKDNGT   72 (303)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECSS
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc------chhHHHHHHHHHHHhhCC-CCcCcceEEEEEeCCCc
Confidence            46899999999999999999986  5899999998643      223333  4445555675 999999999997654  


Q ss_pred             --EEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh--------CCCeeccCCCCcEEEeecCCCCCeE
Q 014733          115 --YVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHG--------NGVVHRDLKPENILLATKSSSSPIK  184 (419)
Q Consensus       115 --~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~--------~~IvHrDLkp~NILl~~~~~~~~vK  184 (419)
                        .+++||||+++|+|.+++++ ..+++..+..++.|++.||+|||+        +|||||||||+||||   +.++.+|
T Consensus        73 ~~~~~lv~Ey~~~g~L~~~l~~-~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl---~~~~~~K  148 (303)
T d1vjya_          73 WTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCC  148 (303)
T ss_dssp             SEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEE---CTTSCEE
T ss_pred             ceEEEEEEecccCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEE---cCCCCeE
Confidence              68999999999999999987 579999999999999999999996        599999999999999   5678999


Q ss_pred             EeeccceeeeccCCc-----cccccCCCccCCcccccCC-------CCCchhHHHHHHHHHHHHhCCCCCCCC-------
Q 014733          185 LADFGLATYIKAGQN-----LHGTVGSPFYIAPEVLAGG-------YNQAADVWSAGVILYILLSGMPPFWGK-------  245 (419)
Q Consensus       185 L~DFgla~~~~~~~~-----~~~~~gt~~y~aPE~l~~~-------~s~~sDvwSlGvil~elltG~~Pf~~~-------  245 (419)
                      |+|||++........     ....+||+.|+|||++.+.       ++.++|||||||+||||+||.+||...       
T Consensus       149 l~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~  228 (303)
T d1vjya_         149 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY  228 (303)
T ss_dssp             ECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT
T ss_pred             EEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccch
Confidence            999999988755432     2345799999999998753       467899999999999999999887321       


Q ss_pred             --------CHHHHHHHHHhcCCCCCCC-CC--CCCCHHHHHHHHhhhhcCCCCCCCHHHHHhc
Q 014733          246 --------TKSKIFDAVRAADLRFPSD-PW--DHISASARDLIMGMLRVDPSTRLTAAEVLAH  297 (419)
Q Consensus       246 --------~~~~~~~~i~~~~~~~~~~-~~--~~~s~~l~~li~~~L~~dP~~Rps~~eil~h  297 (419)
                              ........+.....+.+.. .+  ......+.+|+.+||+.||++|||+.||+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~  291 (303)
T d1vjya_         229 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             hhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence                    2233333333322221111 11  1233568999999999999999999999874

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.8e-45  Score=359.37  Aligned_cols=264  Identities=24%  Similarity=0.433  Sum_probs=200.7

Q ss_pred             ccccc-cCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHcc----------CCCCc
Q 014733           35 ISNLS-DRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLS----------GHPNV  103 (419)
Q Consensus        35 ~~~~~-~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~----------~hpnI  103 (419)
                      .+.+. +||+++++||+|+||+||+|+++.+|+.||||+++++.    ...+.+.+|+.+++.+.          +|+||
T Consensus         7 g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~----~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~i   82 (362)
T d1q8ya_           7 GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHI   82 (362)
T ss_dssp             TCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTB
T ss_pred             CCCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc----cchHHHHHHHHHHHHhcchhhhhhhhcCcCce
Confidence            44454 57999999999999999999999999999999997542    34467788999988875          36889


Q ss_pred             eeeeEEEE--eCCEEEEEEeecCCCChHHHH-H--HcCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeccCCCCcEEEeec
Q 014733          104 VDLKAVYE--EEDYVHLLMELCAGGELFHRL-E--KYGRFSETEARVIFRHLMQVVSYCHG-NGVVHRDLKPENILLATK  177 (419)
Q Consensus       104 v~l~~~~~--~~~~~~lV~E~~~ggsL~~~l-~--~~~~l~~~~~~~i~~qll~aL~~LH~-~~IvHrDLkp~NILl~~~  177 (419)
                      +++++++.  .....+++|+++..+...... .  ....+++..++.++.||+.||+|||+ .||+||||||+|||++.+
T Consensus        83 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~  162 (362)
T d1q8ya_          83 LKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIV  162 (362)
T ss_dssp             CCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEE
T ss_pred             EEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeecc
Confidence            99998885  456777788777655443332 2  23458999999999999999999998 899999999999999754


Q ss_pred             CCCC---CeEEeeccceeeeccCCccccccCCCccCCcccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-----
Q 014733          178 SSSS---PIKLADFGLATYIKAGQNLHGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGKTKS-----  248 (419)
Q Consensus       178 ~~~~---~vKL~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~-----  248 (419)
                      +...   .+||+|||.+.....  .....+||+.|+|||++.+ .|+.++|+||+||++++|++|+.||......     
T Consensus       163 ~~~~~~~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~  240 (362)
T d1q8ya_         163 DSPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD  240 (362)
T ss_dssp             ETTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred             CcccccceeeEeeccccccccc--ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccch
Confidence            3322   489999999986433  3456789999999998876 4999999999999999999999999654321     


Q ss_pred             -HHHHHHHh------------cC--------C----CC--------------CCCCCCCCCHHHHHHHHhhhhcCCCCCC
Q 014733          249 -KIFDAVRA------------AD--------L----RF--------------PSDPWDHISASARDLIMGMLRVDPSTRL  289 (419)
Q Consensus       249 -~~~~~i~~------------~~--------~----~~--------------~~~~~~~~s~~l~~li~~~L~~dP~~Rp  289 (419)
                       +.......            ..        .    ..              ....+...+++++|||.+||++||.+||
T Consensus       241 ~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rp  320 (362)
T d1q8ya_         241 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA  320 (362)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred             hHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCc
Confidence             11111100            00        0    00              0001123467899999999999999999


Q ss_pred             CHHHHHhccccccch
Q 014733          290 TAAEVLAHSWMEECE  304 (419)
Q Consensus       290 s~~eil~hp~~~~~~  304 (419)
                      |++|+|+||||++..
T Consensus       321 ta~e~L~Hp~f~~~~  335 (362)
T d1q8ya_         321 DAGGLVNHPWLKDTL  335 (362)
T ss_dssp             CHHHHHTCGGGTTCT
T ss_pred             CHHHHhcCcccCCCC
Confidence            999999999998553

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.91  E-value=1.6e-25  Score=199.43  Aligned_cols=165  Identities=21%  Similarity=0.223  Sum_probs=121.6

Q ss_pred             eeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccC---------------CHHhHHHHHHHHHHHHHccCCCCceee
Q 014733           42 YVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLV---------------TVEDVRSIKLEIEIMTKLSGHPNVVDL  106 (419)
Q Consensus        42 y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~---------------~~~~~~~~~~Ei~il~~l~~hpnIv~l  106 (419)
                      |.++++||+|+||+||+|.+. +|+.||+|+++.....               .........+|...+.++. |.+++..
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~v~~~   79 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-GLAVPKV   79 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-TSSSCCE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHcc-CCCcceE
Confidence            568999999999999999985 7899999987532110               0111234567889999996 9999988


Q ss_pred             eEEEEeCCEEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCcEEEeecCCCCCeEEe
Q 014733          107 KAVYEEEDYVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGNGVVHRDLKPENILLATKSSSSPIKLA  186 (419)
Q Consensus       107 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~~IvHrDLkp~NILl~~~~~~~~vKL~  186 (419)
                      +++.  .  .+++|||+++..+.+       +++..+..++.|++++|.|||++||+||||||+|||++    ++.++|+
T Consensus        80 ~~~~--~--~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~----~~~~~li  144 (191)
T d1zara2          80 YAWE--G--NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS----EEGIWII  144 (191)
T ss_dssp             EEEE--T--TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE----TTEEEEC
T ss_pred             EEec--C--CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeee----CCCEEEE
Confidence            7653  2  268999998765432       55666788999999999999999999999999999995    2358999


Q ss_pred             eccceeeeccCCccccccCCCccCC------cccccCCCCCchhHHHHHH
Q 014733          187 DFGLATYIKAGQNLHGTVGSPFYIA------PEVLAGGYNQAADVWSAGV  230 (419)
Q Consensus       187 DFgla~~~~~~~~~~~~~gt~~y~a------PE~l~~~~s~~sDvwSlGv  230 (419)
                      |||+|.........       .|..      .+.+...|+.++|+||+.-
T Consensus       145 DFG~a~~~~~~~~~-------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~  187 (191)
T d1zara2         145 DFPQSVEVGEEGWR-------EILERDVRNIITYFSRTYRTEKDINSAID  187 (191)
T ss_dssp             CCTTCEETTSTTHH-------HHHHHHHHHHHHHHHHHHCCCCCHHHHHH
T ss_pred             ECCCcccCCCCCcH-------HHHHHHHHHHHHHHcCCCCCcccHHHHHH
Confidence            99999865432211       0111      1223345889999999753

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.60  E-value=1.1e-07  Score=86.23  Aligned_cols=146  Identities=18%  Similarity=0.153  Sum_probs=97.4

Q ss_pred             ccccccCeeeeeeecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCC
Q 014733           35 ISNLSDRYVLGKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEED  114 (419)
Q Consensus        35 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~  114 (419)
                      +..+-..|+..+..+-++.+.||+..  ..++.+++|+......   .....+.+|..+++.|..+--+.+++.+..+++
T Consensus         9 l~~~~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~---~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~   83 (263)
T d1j7la_           9 LKKLIEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYK---GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDG   83 (263)
T ss_dssp             HHHHHTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGT---TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETT
T ss_pred             HHHhhhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcc---cchhhHHHHHHHHHHHhccCCCCcEEEEEecCC
Confidence            33444577777765555567899875  3566788888754322   123356789999998876655788888889999


Q ss_pred             EEEEEEeecCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------
Q 014733          115 YVHLLMELCAGGELFHRLEKYGRFSETEARVIFRHLMQVVSYCHGN----------------------------------  160 (419)
Q Consensus       115 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qll~aL~~LH~~----------------------------------  160 (419)
                      ..++||++++|.++......     ......++.++.+.+..||+.                                  
T Consensus        84 ~~~lv~~~l~G~~~~~~~~~-----~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (263)
T d1j7la_          84 WSNLLMSEADGVLCSEEYED-----EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW  158 (263)
T ss_dssp             EEEEEEECCSSEEHHHHTTT-----CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred             ceEEEEEecccccccccccc-----cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence            99999999999887554321     111222333444444444421                                  


Q ss_pred             -------------------------CCeeccCCCCcEEEeecCCCCCeEEeeccceee
Q 014733          161 -------------------------GVVHRDLKPENILLATKSSSSPIKLADFGLATY  193 (419)
Q Consensus       161 -------------------------~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~  193 (419)
                                               .++|+|+.|.|||++   +++.+-|+||+.+..
T Consensus       159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~---~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK---DGKVSGFIDLGRSGR  213 (263)
T ss_dssp             STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEE---TTEEEEECCCTTCEE
T ss_pred             cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeec---CCceEEEeechhccc
Confidence                                     268999999999994   334456999998874

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.20  E-value=3.2e-06  Score=81.48  Aligned_cols=82  Identities=13%  Similarity=0.097  Sum_probs=51.5

Q ss_pred             eeeecccCceEEEEEEecCCCcEEEEEEeccCccC----CHHhHHHHHHHHHHHHHccCC--CCceeeeEEEEeCCEEEE
Q 014733           45 GKQLGWGQFGVIRECSDKFTGEVLACKSIAKDRLV----TVEDVRSIKLEIEIMTKLSGH--PNVVDLKAVYEEEDYVHL  118 (419)
Q Consensus        45 ~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~----~~~~~~~~~~Ei~il~~l~~h--pnIv~l~~~~~~~~~~~l  118 (419)
                      .+.||.|....||++.+...++.+++|........    ......+...|.+.|+.+..+  ..+.+++.+  +....++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            55789999999999988777889999975421111    112334566788888877544  335555543  4444578


Q ss_pred             EEeecCCCCh
Q 014733          119 LMELCAGGEL  128 (419)
Q Consensus       119 V~E~~~ggsL  128 (419)
                      |||++.+..+
T Consensus       109 vmE~L~~~~~  118 (392)
T d2pula1         109 VMEDLSHLKI  118 (392)
T ss_dssp             EECCCTTSEE
T ss_pred             EEeccCCccc
Confidence            9999977554

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.97  E-value=1.4e-05  Score=71.25  Aligned_cols=75  Identities=19%  Similarity=0.128  Sum_probs=52.7

Q ss_pred             eecccCc-eEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCC-CCceeeeEEEEeCCEEEEEEeecC
Q 014733           47 QLGWGQF-GVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH-PNVVDLKAVYEEEDYVHLLMELCA  124 (419)
Q Consensus        47 ~LG~G~~-g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~h-pnIv~l~~~~~~~~~~~lV~E~~~  124 (419)
                      .+..|.. +.||+.... .+..+++|......      ...+..|...|+.|..+ -.+.+++.+..+.+..++||++++
T Consensus        17 ~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~   89 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP   89 (255)
T ss_dssp             ECSCTTSSCEEEEEECT-TSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred             EcCCcccCCeEEEEEeC-CCCEEEEEeCCccC------HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeee
Confidence            3444543 678987653 56678889865432      23467788888877633 226678888888889999999998


Q ss_pred             CCCh
Q 014733          125 GGEL  128 (419)
Q Consensus       125 ggsL  128 (419)
                      |.++
T Consensus        90 G~~~   93 (255)
T d1nd4a_          90 GQDL   93 (255)
T ss_dssp             SEET
T ss_pred             cccc
Confidence            8665

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.26  E-value=0.00048  Score=65.60  Aligned_cols=76  Identities=16%  Similarity=0.053  Sum_probs=52.6

Q ss_pred             eeeeecccCceEEEEEEecC-------CCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCceeeeEEEEeCCEE
Q 014733           44 LGKQLGWGQFGVIRECSDKF-------TGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNVVDLKAVYEEEDYV  116 (419)
Q Consensus        44 i~~~LG~G~~g~V~~a~~~~-------~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnIv~l~~~~~~~~~~  116 (419)
                      -++.|+-|---.+|++....       ..+.|++++.-..     .......+|..+++.+..+.-..++++++.+    
T Consensus        46 ~v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-----~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----  116 (395)
T d1nw1a_          46 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-----ETESHLVAESVIFTLLSERHLGPKLYGIFSG----  116 (395)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-----CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred             EEEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-----chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----
Confidence            35678888888999987652       3456778876522     1223466899999999866555677777642    


Q ss_pred             EEEEeecCCCCh
Q 014733          117 HLLMELCAGGEL  128 (419)
Q Consensus       117 ~lV~E~~~ggsL  128 (419)
                      .+|+||++|.+|
T Consensus       117 g~I~efi~g~~l  128 (395)
T d1nw1a_         117 GRLEEYIPSRPL  128 (395)
T ss_dssp             EEEECCCCEEEC
T ss_pred             ceEEEEeccccC
Confidence            478999987554

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.05  E-value=0.0009  Score=61.87  Aligned_cols=70  Identities=11%  Similarity=0.115  Sum_probs=46.6

Q ss_pred             CceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCCCCc--eee-----eEEEEeCCEEEEEEeecC
Q 014733           52 QFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGHPNV--VDL-----KAVYEEEDYVHLLMELCA  124 (419)
Q Consensus        52 ~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpnI--v~l-----~~~~~~~~~~~lV~E~~~  124 (419)
                      ..-.||++.. .+|+.+++|+.+...    ...+++..|...+..|..+ +|  +..     -..+...+..+.++++++
T Consensus        34 ~EN~vy~v~~-~dg~~~VlK~~rp~~----~s~~~i~~E~~~l~~L~~~-gipv~~p~~~~g~~~~~~~~~~~~l~~~~~  107 (325)
T d1zyla1          34 YENRVYQFQD-EDRRRFVVKFYRPER----WTADQILEEHQFALQLVND-EVPVAAPVAFNGQTLLNHQGFYFAVFPSVG  107 (325)
T ss_dssp             SSSEEEEECC-TTCCCEEEEEECTTT----SCHHHHHHHHHHHHHHHHT-TCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred             ccceeEEEEc-CCCCEEEEEEeCCCC----CCHHHHHHHHHHHHHHHhc-CCCCCCceecCCCeeeeeeeEEEEEEeecC
Confidence            3458999875 478889999986542    2346677899988888622 11  111     122355778899999998


Q ss_pred             CCC
Q 014733          125 GGE  127 (419)
Q Consensus       125 ggs  127 (419)
                      |..
T Consensus       108 G~~  110 (325)
T d1zyla1         108 GRQ  110 (325)
T ss_dssp             CEE
T ss_pred             CcC
Confidence            744

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.82  E-value=0.0017  Score=59.36  Aligned_cols=155  Identities=17%  Similarity=0.159  Sum_probs=82.3

Q ss_pred             ccchhhccccccCeeeeee-----ecccCceEEEEEEecCCCcEEEEEEeccCccCCHHhHHHHHHHHHHHHHccCC---
Q 014733           29 ILDATQISNLSDRYVLGKQ-----LGWGQFGVIRECSDKFTGEVLACKSIAKDRLVTVEDVRSIKLEIEIMTKLSGH---  100 (419)
Q Consensus        29 ~~~~~~~~~~~~~y~i~~~-----LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~~h---  100 (419)
                      -++.+++..+..+|.+++.     |..|.--+.|+.... .| .+++|++...     .....+..|++++..|..+   
T Consensus         2 ~ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~-~g-~yVLri~~~~-----~~~~~l~~~~~~l~~L~~~g~p   74 (316)
T d2ppqa1           2 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKR-----VEKNDLPFFLGLMQHLAAKGLS   74 (316)
T ss_dssp             CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEES-SC-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCC
T ss_pred             CCCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEEC-CC-cEEEEEcCCC-----CCHHHHHHHHHHHHhhhhcccc
Confidence            3556677777778877543     445666788987654 34 5899998643     1234566677788777622   


Q ss_pred             -CCceee---eEEEEeCCEEEEEEeecCCCChHH--------------HHHHcC---------CCCH-------------
Q 014733          101 -PNVVDL---KAVYEEEDYVHLLMELCAGGELFH--------------RLEKYG---------RFSE-------------  140 (419)
Q Consensus       101 -pnIv~l---~~~~~~~~~~~lV~E~~~ggsL~~--------------~l~~~~---------~l~~-------------  140 (419)
                       |..+..   ..+..-......++.+..|.....              .++...         ....             
T Consensus        75 vp~pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (316)
T d2ppqa1          75 CPLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEER  154 (316)
T ss_dssp             CCCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGG
T ss_pred             ccccceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHh
Confidence             222211   011233456667777766643210              000000         0000             


Q ss_pred             -----HHHHHHHHHHHHHHHHHHh----CCCeeccCCCCcEEEeecCCCCCeEEeeccceee
Q 014733          141 -----TEARVIFRHLMQVVSYCHG----NGVVHRDLKPENILLATKSSSSPIKLADFGLATY  193 (419)
Q Consensus       141 -----~~~~~i~~qll~aL~~LH~----~~IvHrDLkp~NILl~~~~~~~~vKL~DFgla~~  193 (419)
                           ......+..+...+.-.+.    .|+||+|+.++||+++   .+...-|+||+.+..
T Consensus       155 ~~~~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~---~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         155 ADEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFL---GDELSGLIDFYFACN  213 (316)
T ss_dssp             GGGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEE---TTEEEEECCCTTCEE
T ss_pred             hhhcchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcc---cccceeEeccccccc
Confidence                 0111122223333333332    3699999999999994   344457999998874